id|nct_id|result_group_id|ctgov_group_code|period|reason|count
7485330|NCT04993339|25924503|P2|Overall Study|no MRI scan|1
7485331|NCT04993339|25924504|P1|Overall Study|no MRI scan|3
7485332|NCT04993339|25924503|P2|Overall Study|Lost to Follow-up|1
7485333|NCT04993339|25924504|P1|Overall Study|Lost to Follow-up|0
7485334|NCT04919161|25924762|P2|Overall Study|Acute ankle sprain after session 1|1
7485335|NCT04919161|25924763|P1|Overall Study|Acute ankle sprain after session 1|0
7485336|NCT04919161|25924762|P2|Overall Study|Flare-up of existing orthopedic condition after session 4|1
7485337|NCT04919161|25924763|P1|Overall Study|Flare-up of existing orthopedic condition after session 4|0
7485338|NCT04919161|25924762|P2|Overall Study|Early participant discharge from rehabilitation program after session 4|0
7485339|NCT04919161|25924763|P1|Overall Study|Early participant discharge from rehabilitation program after session 4|1
7485340|NCT04883541|25924924|P2|Overall Study|Not attending the pregnancy school|9
7485341|NCT04883541|25924925|P1|Overall Study|Not attending the pregnancy school|0
7485342|NCT04883541|25924924|P2|Overall Study|Not attending regular yoga class|0
7485343|NCT04883541|25924925|P1|Overall Study|Not attending regular yoga class|16
7485344|NCT04851314|25924951|P2|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
7485345|NCT04851314|25924952|P1|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
7485346|NCT04851314|25924951|P2|Overall Study|Unable to complete research set-up procedures|2
7485347|NCT04851314|25924952|P1|Overall Study|Unable to complete research set-up procedures|0
7485348|NCT04821245|25924991|P1|Overall Study|Protocol Violation|5
7485349|NCT04821245|25924991|P1|Overall Study|Physician Decision|1
7485350|NCT04821245|25924991|P1|Overall Study|Withdrawal by Subject|3
7485351|NCT04799782|25925028|P2|Washout|Lost to Follow-up|1
7485352|NCT04799782|25925029|P1|Washout|Lost to Follow-up|0
7485353|NCT04799782|25925028|P2|Washout|Withdrawal by Subject|2
7485354|NCT04799782|25925029|P1|Washout|Withdrawal by Subject|0
7485355|NCT04799782|25925028|P2|Washout|Physician Decision|0
7485356|NCT04799782|25925029|P1|Washout|Physician Decision|2
7485357|NCT04755595|25925100|P1|Overall Study|Lost to Follow-up|1
7485358|NCT04749745|25925105|P2|Overall Study|Withdrawal by Subject|0
7485359|NCT04749745|25925106|P1|Overall Study|Withdrawal by Subject|1
7485360|NCT04748341|25925114|P2|Overall Study|Lost to Follow-up|1
7485361|NCT04748341|25925115|P1|Overall Study|Lost to Follow-up|1
7485362|NCT04737278|25925127|P2|Overall Study|failure to complete questionnaire|1
7485363|NCT04737278|25925128|P1|Overall Study|failure to complete questionnaire|1
7485364|NCT04737278|25925127|P2|Overall Study|Protocol Violation|1
7485365|NCT04737278|25925128|P1|Overall Study|Protocol Violation|1
7485366|NCT04737278|25925127|P2|Overall Study|Withdrawal by Subject|0
7485367|NCT04737278|25925128|P1|Overall Study|Withdrawal by Subject|1
7485368|NCT04737278|25925127|P2|Overall Study|Lost to Follow-up|1
7485369|NCT04737278|25925128|P1|Overall Study|Lost to Follow-up|1
7485370|NCT04732338|25925230|P2|Overall Study|Lost to Follow-up|3
7485371|NCT04732338|25925231|P1|Overall Study|Lost to Follow-up|3
7485372|NCT04728802|25925241|P2|Overall Study|Other|0
7485373|NCT04728802|25925242|P1|Overall Study|Other|3
7485374|NCT04728802|25925241|P2|Overall Study|Death|5
7485375|NCT04728802|25925242|P1|Overall Study|Death|4
7485376|NCT04728802|25925241|P2|Overall Study|Transfer|0
7485377|NCT04728802|25925242|P1|Overall Study|Transfer|1
7485378|NCT04728802|25925241|P2|Overall Study|Protocol Violation|4
7485379|NCT04728802|25925242|P1|Overall Study|Protocol Violation|10
7485380|NCT04728802|25925241|P2|Overall Study|Physician Decision|7
7485381|NCT04728802|25925242|P1|Overall Study|Physician Decision|7
7485382|NCT04728802|25925241|P2|Overall Study|Withdrawal by Subject|20
7485383|NCT04728802|25925242|P1|Overall Study|Withdrawal by Subject|4
7485384|NCT04725500|25925271|P1|2 Week Take Home|Screen Fail|5
7485385|NCT04725500|25925271|P1|Screening|Withdrawal by Subject|1
7485386|NCT04725500|25925271|P1|Screening|Screen Failure|26
7485387|NCT04716426|25925310|P2|Overall Study|Contamination|0
7485388|NCT04716426|25925311|P1|Overall Study|Contamination|1
7485389|NCT04716426|25925310|P2|Overall Study|Vaccination|1
7485390|NCT04716426|25925311|P1|Overall Study|Vaccination|1
7485391|NCT04698993|25925351|P2|Overall Study|incomplete documentation of kit assessment prior to testing|0
7485392|NCT04698993|25925352|P1|Overall Study|incomplete documentation of kit assessment prior to testing|1
7485393|NCT04698993|25925351|P2|Overall Study|PCR results not accessible|7
7485394|NCT04698993|25925352|P1|Overall Study|PCR results not accessible|2
7485395|NCT04674644|25925404|P1|Overall Study|with missing data|37
7485396|NCT04668989|25925424|P2|Second Intervention|Adverse Event|1
7485397|NCT04668989|25925425|P1|Second Intervention|Adverse Event|0
7485398|NCT04668989|25925424|P2|First Intervention|Covid-19 related self-isolation|1
7485399|NCT04668989|25925425|P1|First Intervention|Covid-19 related self-isolation|0
7485400|NCT04646109|25925547|P2|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
7485401|NCT04646109|25925548|P1|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
7485402|NCT04633642|25925644|P2|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
7485403|NCT04633642|25925645|P1|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
7485404|NCT04633564|25925663|P2|Period 2|Terminated by Sponsor|3
7485405|NCT04633564|25925664|P1|Period 2|Terminated by Sponsor|9
7485406|NCT04633564|25925663|P2|Period 2|Progressive Disease|82
7485407|NCT04633564|25925664|P1|Period 2|Progressive Disease|74
7485408|NCT04633564|25925663|P2|Period 2|Withdrawal by Subject|1
7485409|NCT04633564|25925664|P1|Period 2|Withdrawal by Subject|5
7485410|NCT04633564|25925663|P2|Period 2|Physician Decision|4
7485411|NCT04633564|25925664|P1|Period 2|Physician Decision|2
7485412|NCT04633564|25925663|P2|Period 2|Lost to Follow-up|1
7485413|NCT04633564|25925664|P1|Period 2|Lost to Follow-up|0
7485414|NCT04633564|25925663|P2|Period 2|Death|2
7485415|NCT04633564|25925664|P1|Period 2|Death|0
7485416|NCT04633564|25925663|P2|Period 2|Adverse Event|4
7485417|NCT04633564|25925664|P1|Period 2|Adverse Event|3
7485418|NCT04633564|25925663|P2|Period 1|Terminated by Sponsor|6
7485419|NCT04633564|25925664|P1|Period 1|Terminated by Sponsor|8
7485420|NCT04633564|25925663|P2|Period 1|Progressive disease|51
7485421|NCT04633564|25925664|P1|Period 1|Progressive disease|47
7485422|NCT04633564|25925663|P2|Period 1|Withdrawal by Subject|8
7485423|NCT04633564|25925664|P1|Period 1|Withdrawal by Subject|10
7485424|NCT04633564|25925663|P2|Period 1|Protocol Violation|1
7485425|NCT04633564|25925664|P1|Period 1|Protocol Violation|0
7485426|NCT04633564|25925663|P2|Period 1|Physician Decision|12
7485427|NCT04633564|25925664|P1|Period 1|Physician Decision|4
7485428|NCT04633564|25925663|P2|Period 1|Lost to Follow-up|5
7485429|NCT04633564|25925664|P1|Period 1|Lost to Follow-up|3
7485430|NCT04633564|25925663|P2|Period 1|Death|7
7485431|NCT04633564|25925664|P1|Period 1|Death|8
7485432|NCT04633564|25925663|P2|Period 1|Adverse Event|19
7485433|NCT04633564|25925664|P1|Period 1|Adverse Event|28
7485434|NCT04608500|25925779|P2|Overall Study|Other|2
7485435|NCT04608500|25925780|P1|Overall Study|Other|6
7485436|NCT04608500|25925779|P2|Overall Study|Protocol Violation|0
7485437|NCT04608500|25925780|P1|Overall Study|Protocol Violation|1
7485438|NCT04608500|25925779|P2|Overall Study|Participant request|7
7485439|NCT04608500|25925780|P1|Overall Study|Participant request|11
7485440|NCT04608500|25925779|P2|Overall Study|Lost to Follow-up|9
7485441|NCT04608500|25925780|P1|Overall Study|Lost to Follow-up|15
7485442|NCT04608500|25925779|P2|Overall Study|Adverse Event|0
7485443|NCT04608500|25925780|P1|Overall Study|Adverse Event|2
7485444|NCT04590027|25925839|P2|Overall Study|Protocol Violation|3
7485445|NCT04590027|25925840|P1|Overall Study|Protocol Violation|0
7485446|NCT04590027|25925839|P2|Overall Study|Lost to Follow-up|14
7485447|NCT04590027|25925840|P1|Overall Study|Lost to Follow-up|17
7485448|NCT04578457|25925855|P1|Hearing Aid With NR (4)|Withdrawal by Subject|2
7485449|NCT04578457|25925855|P1|Hearing Aid With NR (2)|Withdrawal by Subject|2
7485450|NCT04578457|25925855|P1|Hearing Aid With NR (1)|Withdrawal by Subject|2
7485451|NCT04578457|25925855|P1|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
7485452|NCT04577183|25925875|P1|Overall Study|Early termination|2
7485453|NCT04577183|25925875|P1|Overall Study|Withdrawal by Subject|3
7485454|NCT04577183|25925875|P1|Overall Study|Death|1
7485455|NCT04574999|25925881|P2|Overall Study|Previous planned surgery|0
7485456|NCT04574999|25925882|P1|Overall Study|Previous planned surgery|1
7485457|NCT04574999|25925881|P2|Overall Study|Personal problems|0
7485458|NCT04574999|25925882|P1|Overall Study|Personal problems|1
7485459|NCT04574999|25925881|P2|Overall Study|Lost to Follow-up|0
7485460|NCT04574999|25925882|P1|Overall Study|Lost to Follow-up|1
7485461|NCT04574999|25925881|P2|Overall Study|Withdrawal by Subject|2
7485462|NCT04574999|25925882|P1|Overall Study|Withdrawal by Subject|2
7485463|NCT04574999|25925881|P2|Overall Study|Protocol Violation|0
7485464|NCT04574999|25925882|P1|Overall Study|Protocol Violation|1
7485465|NCT04574999|25925881|P2|Overall Study|Lack of Efficacy|3
7485466|NCT04574999|25925882|P1|Overall Study|Lack of Efficacy|2
7485467|NCT04574999|25925881|P2|Overall Study|Adverse Event|0
7485468|NCT04574999|25925882|P1|Overall Study|Adverse Event|1
7485469|NCT04572997|25925898|P1|Overall Study|Adverse Event|1
7485470|NCT04570670|25925924|P2|Overall Study|Withdrawal by Subject|0
7485471|NCT04570670|25925925|P1|Overall Study|Withdrawal by Subject|1
7485472|NCT04542694|25926233|P2|Overall Study|Protocol Violation|0
7485473|NCT04542694|25926234|P1|Overall Study|Protocol Violation|1
7485474|NCT04542694|25926233|P2|Overall Study|Adverse Event|0
7485475|NCT04542694|25926234|P1|Overall Study|Adverse Event|1
7485476|NCT04542694|25926233|P2|Overall Study|The need for prohibited therapy|0
7485477|NCT04542694|25926234|P1|Overall Study|The need for prohibited therapy|2
7485478|NCT04534491|25926360|P1|Overall Study|Non-verifiable users|58
7485479|NCT04534491|25926360|P1|Overall Study|Non-users|70
7485480|NCT04534491|25926360|P1|Overall Study|Not completed end-of-study interview|24
7485481|NCT04533204|25926457|P2|Overall Study|Unable to understand training instructions|1
7485482|NCT04533204|25926458|P1|Overall Study|Unable to understand training instructions|1
7485483|NCT04532164|25926466|P1|Overall Study|Withdrawal by Subject|14
7485484|NCT04532164|25926466|P1|Overall Study|Found to be Ineligible|3
7485485|NCT04532164|25926466|P1|Overall Study|Lost to Follow-up|1
7485486|NCT04532164|25926466|P1|Overall Study|Protocol Violation|5
7485487|NCT04532164|25926466|P1|Overall Study|Adverse Event|1
7485488|NCT04531813|25926477|P1|Overall Study|Withdrawal by Subject|1
7485489|NCT04531813|25926477|P1|Overall Study|Protocol Violation|1
7485490|NCT04531540|25926481|P1|Overall Study|Found to be Ineligible|1
7485491|NCT04531540|25926481|P1|Overall Study|Withdrawal by Subject|4
7485492|NCT04531540|25926481|P1|Overall Study|Protocol Violation|3
7485493|NCT04531540|25926481|P1|Overall Study|Adverse Event|1
7485494|NCT04531527|25926488|P1|Overall Study|Found to be Ineligible|3
7485495|NCT04523831|25926504|P2|Overall Study|Adverse Event|0
7485496|NCT04523831|25926505|P1|Overall Study|Adverse Event|2
7485497|NCT04523831|25926504|P2|Overall Study|Death|3
7485498|NCT04523831|25926505|P1|Overall Study|Death|0
7485499|NCT04523831|25926504|P2|Overall Study|Lost to Follow-up|17
7485500|NCT04523831|25926505|P1|Overall Study|Lost to Follow-up|15
7485501|NCT04521777|25926517|P1|Overall Study|Withdrawal by Subject|2
7485502|NCT04521777|25926517|P1|Overall Study|Death|2
7485503|NCT04512482|25926558|P2|Second Intervention (1 Day)|Protocol Violation|1
7485504|NCT04512482|25926559|P1|Second Intervention (1 Day)|Protocol Violation|2
7485505|NCT04507867|25926586|P2|Overall Study|Death|1
7485506|NCT04507867|25926587|P1|Overall Study|Death|7
7485507|NCT04507776|25926643|P1|Overall Study|Participants did not meet the entrance criteria|201
7485508|NCT04502979|25926657|P2|Overall Study|Withdrawal by Subject|1
7485509|NCT04502979|25926658|P1|Overall Study|Withdrawal by Subject|2
7485510|NCT04502979|25926657|P2|Overall Study|Lost to Follow-up|3
7485511|NCT04502979|25926658|P1|Overall Study|Lost to Follow-up|1
7485512|NCT04498403|25926751|P2|Overall Study|Study Terminated By Sponsor|10
7485513|NCT04498403|25926752|P1|Overall Study|Study Terminated By Sponsor|29
7485514|NCT04498403|25926751|P2|Overall Study|Adverse Event|0
7485515|NCT04498403|25926752|P1|Overall Study|Adverse Event|1
7485516|NCT04495374|25926779|P2|Overall Study|Protocol Violation|1
7485517|NCT04495374|25926780|P1|Overall Study|Protocol Violation|2
7485518|NCT04491994|25926817|P2|Overall Study|Lost to Follow-up|3
7485519|NCT04491994|25926818|P1|Overall Study|Lost to Follow-up|4
7485520|NCT04491994|25926817|P2|Overall Study|Protocol Violation|2
7485521|NCT04491994|25926818|P1|Overall Study|Protocol Violation|11
7485522|NCT04491994|25926817|P2|Overall Study|developed fever > 3 days|1
7485523|NCT04491994|25926818|P1|Overall Study|developed fever > 3 days|4
7485524|NCT04491994|25926817|P2|Overall Study|Withdrawal by Subject|5
7485525|NCT04491994|25926818|P1|Overall Study|Withdrawal by Subject|10
7485526|NCT04490499|25926856|P1|Overall Study|Withdrawal by Subject|2
7485527|NCT04486235|25926876|P2|Overall Study|Lost to Follow-up|0
7485528|NCT04486235|25926877|P1|Overall Study|Lost to Follow-up|1
7485529|NCT04486235|25926876|P2|Overall Study|Pregnancy|0
7485530|NCT04486235|25926877|P1|Overall Study|Pregnancy|1
7485531|NCT04483011|25926888|P2|Washout (7 Days)|Withdrawal by Subject|1
7485532|NCT04483011|25926889|P1|Washout (7 Days)|Withdrawal by Subject|0
7485533|NCT04475588|25926919|P2|Overall Study|Adverse Event|0
7485534|NCT04475588|25926920|P1|Overall Study|Adverse Event|2
7485535|NCT04474405|25926981|P6|Overall Study|Other|0
7485536|NCT04474405|25926982|P5|Overall Study|Other|3
7485537|NCT04474405|25926983|P4|Overall Study|Other|0
7485538|NCT04474405|25926984|P3|Overall Study|Other|0
7485539|NCT04474405|25926985|P2|Overall Study|Other|0
7485540|NCT04474405|25926986|P1|Overall Study|Other|0
7485541|NCT04474405|25926981|P6|Overall Study|Withdrawal by Subject|0
7485542|NCT04474405|25926982|P5|Overall Study|Withdrawal by Subject|1
7485543|NCT04474405|25926983|P4|Overall Study|Withdrawal by Subject|0
7485544|NCT04474405|25926984|P3|Overall Study|Withdrawal by Subject|1
7485545|NCT04474405|25926985|P2|Overall Study|Withdrawal by Subject|0
7485546|NCT04474405|25926986|P1|Overall Study|Withdrawal by Subject|0
7485547|NCT04468347|25927013|P4|Overall Study|Protocol Violation|0
7485548|NCT04468347|25927014|P3|Overall Study|Protocol Violation|0
7485549|NCT04468347|25927015|P2|Overall Study|Protocol Violation|0
7485550|NCT04468347|25927016|P1|Overall Study|Protocol Violation|1
7485551|NCT04468347|25927013|P4|Overall Study|Physician Decision|0
7485552|NCT04468347|25927014|P3|Overall Study|Physician Decision|2
7485553|NCT04468347|25927015|P2|Overall Study|Physician Decision|0
7485554|NCT04468347|25927016|P1|Overall Study|Physician Decision|1
7485555|NCT04468347|25927013|P4|Overall Study|Lost to Follow-up|1
7485556|NCT04468347|25927014|P3|Overall Study|Lost to Follow-up|1
7485557|NCT04468347|25927015|P2|Overall Study|Lost to Follow-up|0
7485558|NCT04468347|25927016|P1|Overall Study|Lost to Follow-up|0
7485559|NCT04468347|25927013|P4|Overall Study|Withdrawal by Subject|3
7485560|NCT04468347|25927014|P3|Overall Study|Withdrawal by Subject|3
7485561|NCT04468347|25927015|P2|Overall Study|Withdrawal by Subject|1
7485562|NCT04468347|25927016|P1|Overall Study|Withdrawal by Subject|0
7485563|NCT04465422|25927051|P2|Overall Study|Lost to Follow-up|2
7485564|NCT04465422|25927052|P1|Overall Study|Lost to Follow-up|0
7485565|NCT04463069|25927062|P2|Overall Study|Participants' parents refused to participate after learning the assignment results|13
7485566|NCT04463069|25927063|P1|Overall Study|Participants' parents refused to participate after learning the assignment results|0
7485567|NCT04463069|25927062|P2|Overall Study|Withdrawal by Subject|10
7485568|NCT04463069|25927063|P1|Overall Study|Withdrawal by Subject|2
7485569|NCT04450381|25927225|P1|Overall Study|Wrong device setting|2
7485570|NCT04450381|25927225|P1|Overall Study|Protocol Violation|4
7485571|NCT04449341|25927232|P2|Overall Study|Protocol Violation|0
7485572|NCT04449341|25927233|P1|Overall Study|Protocol Violation|1
7485573|NCT04448561|25927252|P2|Overall Study|Noncompliance|0
7485574|NCT04448561|25927253|P1|Overall Study|Noncompliance|1
7485575|NCT04446429|25927360|P2|Overall Study|Lost to Follow-up|0
7485576|NCT04446429|25927361|P1|Overall Study|Lost to Follow-up|6
7485577|NCT04440449|25927398|P2|Overall Study|Lost to Follow-up|0
7485578|NCT04440449|25927399|P1|Overall Study|Lost to Follow-up|2
7485579|NCT04439344|25927412|P1|Overall Study|Alternative therapy|1
7485580|NCT04439344|25927412|P1|Overall Study|Withdrawal by Subject|2
7485581|NCT04439344|25927412|P1|Overall Study|Disease progression|29
7485582|NCT04439344|25927412|P1|Overall Study|Death|2
7485583|NCT04439344|25927412|P1|Overall Study|Adverse Event|13
7485584|NCT04439344|25927412|P1|Overall Study|Ineligible|3
7485585|NCT04439344|25927412|P1|Overall Study|Never started threapy|3
7485586|NCT04439279|25927418|P1|Overall Study|Treatment still ongoing|1
7485587|NCT04439279|25927418|P1|Overall Study|Ineligible|1
7485588|NCT04439279|25927418|P1|Overall Study|Withdrawal by Subject|2
7485589|NCT04439279|25927418|P1|Overall Study|Complicating disease|3
7623105|NCT01729754|26526378|P2|Part 3|Death|0
7485590|NCT04439279|25927418|P1|Overall Study|Disease progression|17
7485591|NCT04439279|25927418|P1|Overall Study|Death|4
7485592|NCT04439279|25927418|P1|Overall Study|Adverse Event|7
7485593|NCT04439240|25927424|P1|Overall Study|Clinical progression|1
7485594|NCT04439240|25927424|P1|Overall Study|Pogression of the lymphadenopathy|1
7485595|NCT04439240|25927424|P1|Overall Study|Symptomatic decline|1
7485596|NCT04439240|25927424|P1|Overall Study|Clinical concerns for progression and increasing tumor marker|1
7485597|NCT04439240|25927424|P1|Overall Study|Withdrawal by Subject|3
7485598|NCT04439240|25927424|P1|Overall Study|Other diseases|2
7485599|NCT04439240|25927424|P1|Overall Study|Disease progression|25
7485600|NCT04439240|25927424|P1|Overall Study|Death|2
7485601|NCT04439240|25927424|P1|Overall Study|Adverse Event|12
7485602|NCT04439240|25927424|P1|Overall Study|Never started treatment|2
7485603|NCT04439240|25927424|P1|Overall Study|Ineligible|2
7485604|NCT04439214|25927430|P1|Overall Study|Ineligible|5
7485605|NCT04439214|25927430|P1|Overall Study|Still receiving treatment at the time of the analysis|9
7485606|NCT04439214|25927430|P1|Overall Study|Declining health|1
7485607|NCT04439214|25927430|P1|Overall Study|Withdrawal by Subject|2
7485608|NCT04439214|25927430|P1|Overall Study|Death|1
7485609|NCT04439214|25927430|P1|Overall Study|Disease progression|16
7485610|NCT04439214|25927430|P1|Overall Study|Adverse Event|13
7485611|NCT04439123|25927436|P1|Overall Study|Still on treatment|2
7485612|NCT04439123|25927436|P1|Overall Study|Withdrawal by Subject|2
7485613|NCT04439123|25927436|P1|Overall Study|Disease progression|19
7485614|NCT04439123|25927436|P1|Overall Study|Death|1
7485615|NCT04439123|25927436|P1|Overall Study|Adverse Event|11
7485616|NCT04439110|25927442|P1|Overall Study|Still on treatment|1
7485617|NCT04439110|25927442|P1|Overall Study|Personal reasons|1
7485618|NCT04439110|25927442|P1|Overall Study|Other complicating disease|1
7485619|NCT04439110|25927442|P1|Overall Study|Alternative therapy|1
7485620|NCT04439110|25927442|P1|Overall Study|Withdrawal by Subject|1
7485621|NCT04439110|25927442|P1|Overall Study|Disease proression|25
7485622|NCT04439110|25927442|P1|Overall Study|Death|2
7485623|NCT04439110|25927442|P1|Overall Study|Adverse Event|4
7485624|NCT04439110|25927442|P1|Overall Study|Ineligible|2
7485625|NCT04438785|25927450|P2|Overall Study|change of weight, give up intervention|10
7485626|NCT04438785|25927451|P1|Overall Study|change of weight, give up intervention|2
7485627|NCT04435808|25927475|P2|Overall Study|Study stopped by DSMB|1
7485628|NCT04435808|25927476|P1|Overall Study|Study stopped by DSMB|0
7485629|NCT04428502|25927589|P1|Overall Study|Did not meet entrance criteria|14
7485630|NCT04428424|25927598|P1|Overall Study|Lost to Follow-up|115
7485631|NCT04428424|25927598|P1|Overall Study|Does not meet entrance criteria|132
7485632|NCT04425863|25927633|P3|Overall Study|Death|1
7485633|NCT04425863|25927634|P2|Overall Study|Death|0
7485634|NCT04425863|25927635|P1|Overall Study|Death|0
7485635|NCT04422561|25927679|P2|Overall Study|Lost to Follow-up|11
7485636|NCT04422561|25927680|P1|Overall Study|Lost to Follow-up|25
7485637|NCT04419311|25927699|P2|Overall Study|Lost to Follow-up|0
7485638|NCT04419311|25927700|P1|Overall Study|Lost to Follow-up|1
7485639|NCT04411667|25927770|P2|Overall Study|Physician Decision|0
7485640|NCT04411667|25927771|P1|Overall Study|Physician Decision|1
7485641|NCT04407507|25927820|P2|Overall Study|Withdrawal by Subject|1
7485642|NCT04407507|25927821|P1|Overall Study|Withdrawal by Subject|0
7485643|NCT04406194|25927833|P2|Period 1|Withdrawal by Subject|1
7485644|NCT04406194|25927834|P1|Period 1|Withdrawal by Subject|0
7485645|NCT04404010|25927857|P2|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
7485646|NCT04404010|25927858|P1|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
7485647|NCT04403399|25927870|P2|Period 2|Physician Decision|1
7485648|NCT04403399|25927871|P1|Period 2|Physician Decision|0
7485649|NCT04401579|25927925|P2|Overall Study|Transferred to another hospital|2
7485650|NCT04401579|25927926|P1|Overall Study|Transferred to another hospital|1
7485651|NCT04401579|25927925|P2|Overall Study|Scheduling error|2
7485652|NCT04401579|25927926|P1|Overall Study|Scheduling error|1
7485653|NCT04401579|25927925|P2|Overall Study|Adverse Event|1
7485654|NCT04401579|25927926|P1|Overall Study|Adverse Event|2
7485655|NCT04401579|25927925|P2|Overall Study|Enrolled but treatment not administered|9
7485656|NCT04401579|25927926|P1|Overall Study|Enrolled but treatment not administered|7
7485657|NCT04401579|25927925|P2|Overall Study|Became ineligible after enrollment|1
7485658|NCT04401579|25927926|P1|Overall Study|Became ineligible after enrollment|1
7485659|NCT04401579|25927925|P2|Overall Study|Physician Decision|2
7485660|NCT04401579|25927926|P1|Overall Study|Physician Decision|1
7485661|NCT04401579|25927925|P2|Overall Study|Withdrawal by Subject|16
7485662|NCT04401579|25927926|P1|Overall Study|Withdrawal by Subject|8
7485663|NCT04401579|25927925|P2|Overall Study|Lost to Follow-up|41
7485664|NCT04401579|25927926|P1|Overall Study|Lost to Follow-up|40
7485665|NCT04401579|25927925|P2|Overall Study|Death|36
7485666|NCT04401579|25927926|P1|Overall Study|Death|23
7485667|NCT04401202|25928016|P2|Overall Study|Hospitalized|1
7485668|NCT04401202|25928017|P1|Overall Study|Hospitalized|4
7485669|NCT04401202|25928016|P2|Overall Study|Adverse Event|1
7485670|NCT04401202|25928017|P1|Overall Study|Adverse Event|0
7485671|NCT04401202|25928016|P2|Overall Study|Lost to Follow-up|2
7485672|NCT04401202|25928017|P1|Overall Study|Lost to Follow-up|2
7485673|NCT04400682|25928033|P2|Period 1|Withdrawal by Subject|4
7485674|NCT04400682|25928034|P1|Period 1|Withdrawal by Subject|1
7485675|NCT04399161|25928062|P3|Overall Study|Protocol Violation|0
7485676|NCT04399161|25928063|P2|Overall Study|Protocol Violation|2
7485677|NCT04399161|25928064|P1|Overall Study|Protocol Violation|1
7485678|NCT04399161|25928062|P3|Overall Study|Withdrawal by Subject|2
7485679|NCT04399161|25928063|P2|Overall Study|Withdrawal by Subject|0
7485680|NCT04399161|25928064|P1|Overall Study|Withdrawal by Subject|1
7485681|NCT04399122|25928074|P2|Overall Study|Withdrawal by Subject|0
7485682|NCT04399122|25928075|P1|Overall Study|Withdrawal by Subject|1
7485683|NCT04399122|25928074|P2|Overall Study|Lost to Follow-up|0
7485684|NCT04399122|25928075|P1|Overall Study|Lost to Follow-up|2
7485685|NCT04397445|25928083|P4|Overall Study|Withdrawal by Subject|0
7485686|NCT04397445|25928084|P3|Overall Study|Withdrawal by Subject|0
7485687|NCT04397445|25928085|P2|Overall Study|Withdrawal by Subject|0
7485688|NCT04397445|25928086|P1|Overall Study|Withdrawal by Subject|1
7485689|NCT04396639|25928143|P1|Overall Study|Other|1
7485690|NCT04396639|25928143|P1|Overall Study|Withdrawal by Subject|1
7485691|NCT04393493|25928155|P2|First 4 Days of Intervention|Early improvement|7
7485692|NCT04393493|25928156|P1|First 4 Days of Intervention|Early improvement|5
7485693|NCT04391842|25928307|P1|Overall Study|Withdrawal by Subject|2
7485694|NCT04386902|25928329|P1|Overall Study|Technical problems in the recording|5
7485695|NCT04386902|25928329|P1|Overall Study|Withdrawal by Subject|5
7485696|NCT04384523|25928350|P6|Overall Study|Withdrawal by Subject|0
7485697|NCT04384523|25928351|P5|Overall Study|Withdrawal by Subject|0
7485698|NCT04384523|25928352|P4|Overall Study|Withdrawal by Subject|0
7485699|NCT04384523|25928353|P3|Overall Study|Withdrawal by Subject|0
7485700|NCT04384523|25928354|P2|Overall Study|Withdrawal by Subject|0
7485701|NCT04384523|25928355|P1|Overall Study|Withdrawal by Subject|1
7485702|NCT04384523|25928350|P6|Overall Study|Protocol Violation|0
7485703|NCT04384523|25928351|P5|Overall Study|Protocol Violation|0
7485704|NCT04384523|25928352|P4|Overall Study|Protocol Violation|0
7485705|NCT04384523|25928353|P3|Overall Study|Protocol Violation|0
7485706|NCT04384523|25928354|P2|Overall Study|Protocol Violation|1
7485707|NCT04384523|25928355|P1|Overall Study|Protocol Violation|0
7485708|NCT04384523|25928350|P6|Overall Study|Lost to Follow-up|1
7485709|NCT04384523|25928351|P5|Overall Study|Lost to Follow-up|0
7485710|NCT04384523|25928352|P4|Overall Study|Lost to Follow-up|0
7485711|NCT04384523|25928353|P3|Overall Study|Lost to Follow-up|0
7485712|NCT04384523|25928354|P2|Overall Study|Lost to Follow-up|0
7485713|NCT04384523|25928355|P1|Overall Study|Lost to Follow-up|0
7485714|NCT04382066|25928418|P3|Overall Study|Death|1
7485715|NCT04382066|25928419|P2|Overall Study|Death|0
7485716|NCT04382066|25928420|P1|Overall Study|Death|1
7485717|NCT04382066|25928418|P3|Overall Study|Adverse Event|0
7485718|NCT04382066|25928419|P2|Overall Study|Adverse Event|0
7485719|NCT04382066|25928420|P1|Overall Study|Adverse Event|1
7485720|NCT04380688|25928634|P2|Overall Study|Withdrawal by Subject|3
7485721|NCT04380688|25928635|P1|Overall Study|Withdrawal by Subject|3
7485722|NCT04380688|25928634|P2|Overall Study|Lost to Follow-up|4
7485723|NCT04380688|25928635|P1|Overall Study|Lost to Follow-up|2
7485724|NCT04380688|25928634|P2|Overall Study|Death|2
7485725|NCT04380688|25928635|P1|Overall Study|Death|2
7485726|NCT04376060|25928675|P1|Overall Study|Physician Decision|1
7485727|NCT04372186|25928710|P2|Overall Study|Transferred to a different facility for care|2
7485728|NCT04372186|25928711|P1|Overall Study|Transferred to a different facility for care|0
7485729|NCT04372186|25928710|P2|Overall Study|Death|11
7485730|NCT04372186|25928711|P1|Overall Study|Death|24
7485731|NCT04370028|25928831|P1|Overall Study|Adverse Event|3
7485732|NCT04370028|25928831|P1|Overall Study|Protocol Violation|9
7485733|NCT04370028|25928831|P1|Overall Study|Withdrawal by Subject|695
7485734|NCT04368429|25928850|P2|Overall Study|Adverse Event|0
7485735|NCT04368429|25928851|P1|Overall Study|Adverse Event|1
7485736|NCT04365699|25928891|P3|Overall Study|Death|15
7485737|NCT04365699|25928892|P2|Overall Study|Death|5
7485738|NCT04365699|25928893|P1|Overall Study|Death|2
7485739|NCT04363736|25928937|P2|Overall Study|Death|6
7485740|NCT04363736|25928938|P1|Overall Study|Death|8
7485741|NCT04363736|25928937|P2|Overall Study|Lost to Follow-up|7
7485742|NCT04363736|25928938|P1|Overall Study|Lost to Follow-up|10
7485743|NCT04363736|25928937|P2|Overall Study|Withdrawal by Subject|0
7485744|NCT04363736|25928938|P1|Overall Study|Withdrawal by Subject|1
7485745|NCT04362813|25928968|P2|Overall Study|Enrolled but did not receive treatment|4
7485746|NCT04362813|25928969|P1|Overall Study|Enrolled but did not receive treatment|2
7485747|NCT04362813|25928968|P2|Overall Study|Lost to Follow-up|1
7485748|NCT04362813|25928969|P1|Overall Study|Lost to Follow-up|1
7485749|NCT04362813|25928968|P2|Overall Study|Protocol Violation|3
7485750|NCT04362813|25928969|P1|Overall Study|Protocol Violation|0
7485751|NCT04362813|25928968|P2|Overall Study|Withdrawal by Subject|1
7485752|NCT04362813|25928969|P1|Overall Study|Withdrawal by Subject|3
7485753|NCT04362813|25928968|P2|Overall Study|Death|16
7485754|NCT04362813|25928969|P1|Overall Study|Death|12
7485755|NCT04362137|25928987|P2|Overall Study|Protocol deviation|0
7485756|NCT04362137|25928988|P1|Overall Study|Protocol deviation|1
7485757|NCT04362137|25928987|P2|Overall Study|Lost to Follow-up|0
7485758|NCT04362137|25928988|P1|Overall Study|Lost to Follow-up|1
7485759|NCT04362137|25928987|P2|Overall Study|Adverse Event|0
7485760|NCT04362137|25928988|P1|Overall Study|Adverse Event|1
7485761|NCT04362137|25928987|P2|Overall Study|Patient decision|3
7485762|NCT04362137|25928988|P1|Overall Study|Patient decision|6
7485763|NCT04362137|25928987|P2|Overall Study|Death|3
7485764|NCT04362137|25928988|P1|Overall Study|Death|9
7485765|NCT04359771|25929024|P2|Overall Study|Lack of Efficacy|2
7485766|NCT04359771|25929025|P1|Overall Study|Lack of Efficacy|2
7623106|NCT01729754|26526379|P1|Part 3|Death|0
7485767|NCT04358081|25929040|P3|Study Completion Phase|Lost to Follow-up|1
7485768|NCT04358081|25929041|P2|Study Completion Phase|Lost to Follow-up|0
7485769|NCT04358081|25929042|P1|Study Completion Phase|Lost to Follow-up|1
7485770|NCT04358081|25929040|P3|Study Completion Phase|Death|1
7485771|NCT04358081|25929041|P2|Study Completion Phase|Death|0
7485772|NCT04358081|25929042|P1|Study Completion Phase|Death|0
7485773|NCT04358081|25929040|P3|Treatment Phase of Study|Protocol Violation|0
7485774|NCT04358081|25929041|P2|Treatment Phase of Study|Protocol Violation|0
7485775|NCT04358081|25929042|P1|Treatment Phase of Study|Protocol Violation|1
7485776|NCT04358081|25929040|P3|Treatment Phase of Study|Physician Decision|1
7485777|NCT04358081|25929041|P2|Treatment Phase of Study|Physician Decision|0
7485778|NCT04358081|25929042|P1|Treatment Phase of Study|Physician Decision|2
7485779|NCT04358081|25929040|P3|Treatment Phase of Study|Adverse Event|1
7485780|NCT04358081|25929041|P2|Treatment Phase of Study|Adverse Event|0
7485781|NCT04358081|25929042|P1|Treatment Phase of Study|Adverse Event|1
7485782|NCT04358081|25929040|P3|Treatment Phase of Study|Withdrawal by Subject|1
7485783|NCT04358081|25929041|P2|Treatment Phase of Study|Withdrawal by Subject|1
7485784|NCT04358081|25929042|P1|Treatment Phase of Study|Withdrawal by Subject|0
7485787|NCT04356937|25929095|P2|Treatment (mITT Population)|Intubated before receiving study treatment|1
7485788|NCT04356937|25929096|P1|Treatment (mITT Population)|Intubated before receiving study treatment|0
7485789|NCT04355663|25929121|P3|Overall Study|Withdrawal by Subject|3
7485790|NCT04355663|25929122|P2|Overall Study|Withdrawal by Subject|8
7485791|NCT04355663|25929123|P1|Overall Study|Withdrawal by Subject|0
7485792|NCT04355663|25929121|P3|Overall Study|Adverse Event|1
7485793|NCT04355663|25929122|P2|Overall Study|Adverse Event|0
7485794|NCT04355663|25929123|P1|Overall Study|Adverse Event|0
7485795|NCT04355663|25929121|P3|Overall Study|Physician Decision|0
7485796|NCT04355663|25929122|P2|Overall Study|Physician Decision|7
7485797|NCT04355663|25929123|P1|Overall Study|Physician Decision|2
7485798|NCT04354870|25929145|P2|Overall Study|Did not complete all study visits|5
7485799|NCT04354870|25929146|P1|Overall Study|Did not complete all study visits|6
7485800|NCT04354870|25929145|P2|Overall Study|Withdrawal by Subject|16
7485801|NCT04354870|25929146|P1|Overall Study|Withdrawal by Subject|10
7485802|NCT04354870|25929145|P2|Overall Study|Lost to Follow-up|12
7485803|NCT04354870|25929146|P1|Overall Study|Lost to Follow-up|32
7485804|NCT04350788|25929179|P2|Overall Study|Protocol Violation|0
7485805|NCT04350788|25929180|P1|Overall Study|Protocol Violation|4
7485806|NCT04350788|25929179|P2|Overall Study|Withdrawal by Subject|4
7485807|NCT04350788|25929180|P1|Overall Study|Withdrawal by Subject|2
7485808|NCT04350788|25929179|P2|Overall Study|Lost to Follow-up|2
7485809|NCT04350788|25929180|P1|Overall Study|Lost to Follow-up|6
7485810|NCT04349917|25929234|P2|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
7485811|NCT04349917|25929235|P1|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
7485812|NCT04349917|25929234|P2|First Intervention (2-4 Hours)|Withdrawal by Subject|1
7485813|NCT04349917|25929235|P1|First Intervention (2-4 Hours)|Withdrawal by Subject|0
7485814|NCT04348851|25929256|P4|Post-Test 2|Stroke survivor death|1
7485815|NCT04348851|25929257|P3|Post-Test 2|Stroke survivor death|0
7485816|NCT04348851|25929258|P2|Post-Test 2|Stroke survivor death|1
7485817|NCT04348851|25929259|P1|Post-Test 2|Stroke survivor death|0
7485818|NCT04348851|25929256|P4|Post-Test 1|Lost to Follow-up|0
7485819|NCT04348851|25929257|P3|Post-Test 1|Lost to Follow-up|0
7485820|NCT04348851|25929258|P2|Post-Test 1|Lost to Follow-up|1
7485821|NCT04348851|25929259|P1|Post-Test 1|Lost to Follow-up|0
7485822|NCT04348851|25929256|P4|Post-Test 1|Withdrawal by Subject|0
7485823|NCT04348851|25929257|P3|Post-Test 1|Withdrawal by Subject|0
7485824|NCT04348851|25929258|P2|Post-Test 1|Withdrawal by Subject|1
7485825|NCT04348851|25929259|P1|Post-Test 1|Withdrawal by Subject|0
7485826|NCT04346199|25929379|P2|Overall Study|Withdrawal by Subject|1
7485827|NCT04346199|25929380|P1|Overall Study|Withdrawal by Subject|5
7485828|NCT04346199|25929379|P2|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0
7485829|NCT04346199|25929380|P1|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2
7485830|NCT04346199|25929379|P2|Overall Study|Lost to Follow-up|1
7485831|NCT04346199|25929380|P1|Overall Study|Lost to Follow-up|0
7485832|NCT04346199|25929379|P2|Overall Study|Death|9
7485833|NCT04346199|25929380|P1|Overall Study|Death|8
7485834|NCT04345653|25929420|P1|Overall Study|Withdrawal by Subject|2
7485835|NCT04343261|25929427|P1|Overall Study|received inadequate amount of antibodies|7
7485836|NCT04343261|25929427|P1|Overall Study|Adverse Event|1
7485837|NCT04342897|25929468|P2|Overall Study|Withdrawal by Subject|2
7485838|NCT04342897|25929469|P1|Overall Study|Withdrawal by Subject|1
7485839|NCT04342897|25929468|P2|Overall Study|Lost to Follow-up|6
7485840|NCT04342897|25929469|P1|Overall Study|Lost to Follow-up|6
7485841|NCT04342897|25929468|P2|Overall Study|Death|4
7485842|NCT04342897|25929469|P1|Overall Study|Death|7
7485843|NCT04340557|25929507|P2|Overall Study|Transferred to ICU and/or death|2
7485844|NCT04340557|25929508|P1|Overall Study|Transferred to ICU and/or death|1
7485845|NCT04339972|25929524|P2|Overall Study|Claustraphobia|1
7485846|NCT04339972|25929525|P1|Overall Study|Claustraphobia|0
7485847|NCT04339972|25929524|P2|Overall Study|Technical issues|0
7485848|NCT04339972|25929525|P1|Overall Study|Technical issues|1
7485849|NCT04339972|25929524|P2|Overall Study|dropout|1
7485850|NCT04339972|25929525|P1|Overall Study|dropout|1
7485851|NCT04339972|25929524|P2|Overall Study|Scheduling Issues|3
7485852|NCT04339972|25929525|P1|Overall Study|Scheduling Issues|3
7485853|NCT04339296|25929535|P2|Overall Study|Discontinued intervention|3
7485854|NCT04339296|25929536|P1|Overall Study|Discontinued intervention|5
7485855|NCT04339296|25929535|P2|Overall Study|Lost to Follow-up|4
7485856|NCT04339296|25929536|P1|Overall Study|Lost to Follow-up|0
7485857|NCT04339296|25929535|P2|Overall Study|Withdrew after completion of baseline|1
7485858|NCT04339296|25929536|P1|Overall Study|Withdrew after completion of baseline|2
7485859|NCT04339296|25929535|P2|Overall Study|Refuse to participate after allocation|1
7485860|NCT04339296|25929536|P1|Overall Study|Refuse to participate after allocation|1
7485861|NCT04336475|25929585|P2|Overall Study|Lost to Follow-up|2
7485862|NCT04336475|25929586|P1|Overall Study|Lost to Follow-up|0
7485863|NCT04336475|25929585|P2|Overall Study|upper respiratory infection|0
7485864|NCT04336475|25929586|P1|Overall Study|upper respiratory infection|1
7485865|NCT04336475|25929585|P2|Overall Study|pain|0
7485866|NCT04336475|25929586|P1|Overall Study|pain|1
7485867|NCT04335929|25929592|P1|Overall Study|Lost to Follow-up|10
7485868|NCT04335812|25929606|P2|Overall Study|Did not engage in the intervention|18
7485869|NCT04335812|25929607|P1|Overall Study|Did not engage in the intervention|22
7485870|NCT04335812|25929606|P2|Overall Study|Lost to Follow-up|12
7485871|NCT04335812|25929607|P1|Overall Study|Lost to Follow-up|12
7485872|NCT04335812|25929606|P2|Overall Study|Withdrawal by Subject|3
7485873|NCT04335812|25929607|P1|Overall Study|Withdrawal by Subject|1
7485874|NCT04335136|25929676|P2|Overall Study|Erroneously randomized|0
7485875|NCT04335136|25929677|P1|Overall Study|Erroneously randomized|2
7485876|NCT04335136|25929676|P2|Overall Study|Adverse Event|1
7485877|NCT04335136|25929677|P1|Overall Study|Adverse Event|0
7485878|NCT04335136|25929676|P2|Overall Study|Health-threatening condition|1
7485879|NCT04335136|25929677|P1|Overall Study|Health-threatening condition|0
7485880|NCT04335136|25929676|P2|Overall Study|Withdrawal by Subject|1
7485881|NCT04335136|25929677|P1|Overall Study|Withdrawal by Subject|1
7485882|NCT04335136|25929676|P2|Overall Study|Protocol Violation|0
7485883|NCT04335136|25929677|P1|Overall Study|Protocol Violation|1
7485884|NCT04335136|25929676|P2|Overall Study|Lost to Follow-up|0
7485885|NCT04335136|25929677|P1|Overall Study|Lost to Follow-up|2
7485886|NCT04335136|25929676|P2|Overall Study|Death|4
7485887|NCT04335136|25929677|P1|Overall Study|Death|8
7485888|NCT04334148|25929737|P2|Overall Study|positive nasal swab at baseline|1
7485889|NCT04334148|25929738|P1|Overall Study|positive nasal swab at baseline|0
7485890|NCT04333199|25929762|P3|Evaluated Patients|Lost to Follow-up|2
7485891|NCT04333199|25929763|P2|Evaluated Patients|Lost to Follow-up|1
7485892|NCT04333199|25929764|P1|Evaluated Patients|Lost to Follow-up|0
7485893|NCT04332419|25929903|P1|Overall Study|Withdrawal by Subject|1
7485894|NCT04332107|25929910|P2|Day 21|Lost to Follow-up|2
7485895|NCT04332107|25929911|P1|Day 21|Lost to Follow-up|10
7485896|NCT04332107|25929910|P2|Day 14|Missing outcome data|4
7485897|NCT04332107|25929911|P1|Day 14|Missing outcome data|4
7485898|NCT04332107|25929910|P2|Day 14|Lost to Follow-up|4
7485899|NCT04332107|25929911|P1|Day 14|Lost to Follow-up|13
7485900|NCT04332107|25929910|P2|Day 3|Missing outcome data|6
7485901|NCT04332107|25929911|P1|Day 3|Missing outcome data|3
7485902|NCT04332107|25929910|P2|Day 3|Lost to Follow-up|14
7485903|NCT04332107|25929911|P1|Day 3|Lost to Follow-up|23
7485904|NCT04331899|25929944|P2|Overall Study|Withdrawal by Subject|2
7485905|NCT04331899|25929945|P1|Overall Study|Withdrawal by Subject|2
7485906|NCT04331899|25929944|P2|Overall Study|Continuing in follow-up|43
7485907|NCT04331899|25929945|P1|Overall Study|Continuing in follow-up|42
7485908|NCT04330157|25929967|P1|Overall Study|Not extubated within 24 h postoperatively|3
7485909|NCT04330157|25929967|P1|Overall Study|Protocol Violation|4
7485910|NCT04329923|25929982|P6|Overall Study|positive SARS-COV2 PCR at baseline|2
7485911|NCT04329923|25929983|P5|Overall Study|positive SARS-COV2 PCR at baseline|0
7485912|NCT04329923|25929984|P4|Overall Study|positive SARS-COV2 PCR at baseline|0
7485913|NCT04329923|25929985|P3|Overall Study|positive SARS-COV2 PCR at baseline|0
7485914|NCT04329923|25929986|P2|Overall Study|positive SARS-COV2 PCR at baseline|0
7485915|NCT04329923|25929987|P1|Overall Study|positive SARS-COV2 PCR at baseline|0
7485916|NCT04329923|25929982|P6|Overall Study|early termination of study|2
7485917|NCT04329923|25929983|P5|Overall Study|early termination of study|1
7485918|NCT04329923|25929984|P4|Overall Study|early termination of study|0
7485919|NCT04329923|25929985|P3|Overall Study|early termination of study|0
7485920|NCT04329923|25929986|P2|Overall Study|early termination of study|0
7485921|NCT04329923|25929987|P1|Overall Study|early termination of study|0
7485922|NCT04329923|25929982|P6|Overall Study|Withdrawal by Subject|1
7485923|NCT04329923|25929983|P5|Overall Study|Withdrawal by Subject|1
7485924|NCT04329923|25929984|P4|Overall Study|Withdrawal by Subject|1
7485925|NCT04329923|25929985|P3|Overall Study|Withdrawal by Subject|1
7485926|NCT04329923|25929986|P2|Overall Study|Withdrawal by Subject|4
7485927|NCT04329923|25929987|P1|Overall Study|Withdrawal by Subject|1
7485928|NCT04328467|25930008|P3|Overall Study|Did not meet inclusion criteria after randomization|1
7485929|NCT04328467|25930009|P2|Overall Study|Did not meet inclusion criteria after randomization|2
7485930|NCT04328467|25930010|P1|Overall Study|Did not meet inclusion criteria after randomization|4
7485931|NCT04327388|25930053|P3|Overall Study|Randomized and not treated|2
7485932|NCT04327388|25930054|P2|Overall Study|Randomized and not treated|0
7485933|NCT04327388|25930055|P1|Overall Study|Randomized and not treated|2
7485934|NCT04327388|25930053|P3|Overall Study|Other|0
7485935|NCT04327388|25930054|P2|Overall Study|Other|2
7485936|NCT04327388|25930055|P1|Overall Study|Other|1
7485937|NCT04327388|25930053|P3|Overall Study|Adverse Event|9
7485938|NCT04327388|25930054|P2|Overall Study|Adverse Event|18
7485939|NCT04327388|25930055|P1|Overall Study|Adverse Event|17
7485940|NCT04322682|25930223|P2|Overall Study|Admitted to Hospital and Intubated|0
7485941|NCT04322682|25930224|P1|Overall Study|Admitted to Hospital and Intubated|1
7485942|NCT04322682|25930223|P2|Overall Study|Lost to Follow-up|8
7485943|NCT04322682|25930224|P1|Overall Study|Lost to Follow-up|4
7485944|NCT04322682|25930223|P2|Overall Study|Death|9
7485945|NCT04322682|25930224|P1|Overall Study|Death|5
7485946|NCT04322682|25930223|P2|Overall Study|Withdrawal by Subject|47
7485947|NCT04322682|25930224|P1|Overall Study|Withdrawal by Subject|33
7485948|NCT04322526|25930240|P2|Washout (1 Week)|Lost to Follow-up|2
7485949|NCT04322526|25930241|P1|Washout (1 Week)|Lost to Follow-up|1
7485950|NCT04322526|25930240|P2|First Intervention (1 Day)|Withdrawal by Subject|1
7485951|NCT04322526|25930241|P1|First Intervention (1 Day)|Withdrawal by Subject|1
7485952|NCT04320615|25930345|P2|Overall Study|Death|71
7485953|NCT04320615|25930346|P1|Overall Study|Death|35
7485954|NCT04320615|25930345|P2|Overall Study|Lost to Follow-up|23
7485955|NCT04320615|25930346|P1|Overall Study|Lost to Follow-up|5
7485956|NCT04320615|25930345|P2|Overall Study|Other|0
7485957|NCT04320615|25930346|P1|Overall Study|Other|2
7485958|NCT04320615|25930345|P2|Overall Study|Physician Decision|0
7485959|NCT04320615|25930346|P1|Overall Study|Physician Decision|2
7485960|NCT04320615|25930345|P2|Overall Study|Withdrawal by Subject|10
7485961|NCT04320615|25930346|P1|Overall Study|Withdrawal by Subject|4
7485962|NCT04318535|25930380|P3|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
7485963|NCT04318535|25930381|P2|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
7485964|NCT04318535|25930382|P1|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
7485965|NCT04317040|25930432|P2|Overall Study|Incomplete assessments|1
7485966|NCT04317040|25930433|P1|Overall Study|Incomplete assessments|0
7485967|NCT04317040|25930432|P2|Overall Study|Withdrawal by Subject|1
7485968|NCT04317040|25930433|P1|Overall Study|Withdrawal by Subject|0
7485969|NCT04317040|25930432|P2|Overall Study|Death|18
7485970|NCT04317040|25930433|P1|Overall Study|Death|16
7485971|NCT04317040|25930432|P2|Overall Study|Lost to Follow-up|0
7485972|NCT04317040|25930433|P1|Overall Study|Lost to Follow-up|2
7485973|NCT04315298|25930521|P19|Overall Study|Death|0
7485974|NCT04315298|25930522|P18|Overall Study|Death|1
7485975|NCT04315298|25930523|P17|Overall Study|Death|3
7485976|NCT04315298|25930524|P16|Overall Study|Death|4
7485977|NCT04315298|25930525|P15|Overall Study|Death|6
7485978|NCT04315298|25930526|P14|Overall Study|Death|4
7485979|NCT04315298|25930527|P13|Overall Study|Death|3
7485980|NCT04315298|25930528|P12|Overall Study|Death|40
7485981|NCT04315298|25930529|P11|Overall Study|Death|40
7485982|NCT04315298|25930530|P10|Overall Study|Death|16
7485983|NCT04315298|25930531|P9|Overall Study|Death|21
7485984|NCT04315298|25930532|P8|Overall Study|Death|12
7485985|NCT04315298|25930533|P7|Overall Study|Death|9
7485986|NCT04315298|25930534|P6|Overall Study|Death|114
7485987|NCT04315298|25930535|P5|Overall Study|Death|70
7485988|NCT04315298|25930536|P4|Overall Study|Death|59
7485989|NCT04315298|25930537|P3|Overall Study|Death|49
7485990|NCT04315298|25930538|P2|Overall Study|Death|60
7485991|NCT04315298|25930539|P1|Overall Study|Death|24
7485992|NCT04315298|25930521|P19|Overall Study|Lost to Follow-up|0
7485993|NCT04315298|25930522|P18|Overall Study|Lost to Follow-up|0
7485994|NCT04315298|25930523|P17|Overall Study|Lost to Follow-up|0
7485995|NCT04315298|25930524|P16|Overall Study|Lost to Follow-up|2
7485996|NCT04315298|25930525|P15|Overall Study|Lost to Follow-up|0
7485997|NCT04315298|25930526|P14|Overall Study|Lost to Follow-up|0
7485998|NCT04315298|25930527|P13|Overall Study|Lost to Follow-up|0
7485999|NCT04315298|25930528|P12|Overall Study|Lost to Follow-up|1
7486000|NCT04315298|25930529|P11|Overall Study|Lost to Follow-up|2
7486001|NCT04315298|25930530|P10|Overall Study|Lost to Follow-up|0
7486002|NCT04315298|25930531|P9|Overall Study|Lost to Follow-up|14
7486003|NCT04315298|25930532|P8|Overall Study|Lost to Follow-up|16
7486004|NCT04315298|25930533|P7|Overall Study|Lost to Follow-up|9
7486005|NCT04315298|25930534|P6|Overall Study|Lost to Follow-up|13
7486006|NCT04315298|25930535|P5|Overall Study|Lost to Follow-up|12
7486007|NCT04315298|25930536|P4|Overall Study|Lost to Follow-up|8
7486008|NCT04315298|25930537|P3|Overall Study|Lost to Follow-up|6
7486009|NCT04315298|25930538|P2|Overall Study|Lost to Follow-up|10
7486010|NCT04315298|25930539|P1|Overall Study|Lost to Follow-up|5
7486011|NCT04315298|25930521|P19|Overall Study|Physician Decision|0
7486012|NCT04315298|25930522|P18|Overall Study|Physician Decision|0
7486013|NCT04315298|25930523|P17|Overall Study|Physician Decision|0
7486014|NCT04315298|25930524|P16|Overall Study|Physician Decision|0
7486015|NCT04315298|25930525|P15|Overall Study|Physician Decision|0
7486016|NCT04315298|25930526|P14|Overall Study|Physician Decision|0
7486017|NCT04315298|25930527|P13|Overall Study|Physician Decision|0
7486018|NCT04315298|25930528|P12|Overall Study|Physician Decision|0
7486019|NCT04315298|25930529|P11|Overall Study|Physician Decision|0
7486020|NCT04315298|25930530|P10|Overall Study|Physician Decision|0
7486021|NCT04315298|25930531|P9|Overall Study|Physician Decision|0
7486022|NCT04315298|25930532|P8|Overall Study|Physician Decision|0
7486023|NCT04315298|25930533|P7|Overall Study|Physician Decision|0
7486024|NCT04315298|25930534|P6|Overall Study|Physician Decision|0
7486025|NCT04315298|25930535|P5|Overall Study|Physician Decision|1
7486026|NCT04315298|25930536|P4|Overall Study|Physician Decision|0
7486027|NCT04315298|25930537|P3|Overall Study|Physician Decision|0
7486028|NCT04315298|25930538|P2|Overall Study|Physician Decision|0
7486029|NCT04315298|25930539|P1|Overall Study|Physician Decision|0
7486030|NCT04315298|25930521|P19|Overall Study|Withdrawal by Subject|0
7486031|NCT04315298|25930522|P18|Overall Study|Withdrawal by Subject|0
7486032|NCT04315298|25930523|P17|Overall Study|Withdrawal by Subject|0
7486033|NCT04315298|25930524|P16|Overall Study|Withdrawal by Subject|0
7486034|NCT04315298|25930525|P15|Overall Study|Withdrawal by Subject|0
7486035|NCT04315298|25930526|P14|Overall Study|Withdrawal by Subject|0
7486036|NCT04315298|25930527|P13|Overall Study|Withdrawal by Subject|0
7486037|NCT04315298|25930528|P12|Overall Study|Withdrawal by Subject|0
7486038|NCT04315298|25930529|P11|Overall Study|Withdrawal by Subject|0
7486039|NCT04315298|25930530|P10|Overall Study|Withdrawal by Subject|1
7486040|NCT04315298|25930531|P9|Overall Study|Withdrawal by Subject|1
7486041|NCT04315298|25930532|P8|Overall Study|Withdrawal by Subject|1
7486042|NCT04315298|25930533|P7|Overall Study|Withdrawal by Subject|0
7486043|NCT04315298|25930534|P6|Overall Study|Withdrawal by Subject|2
7486044|NCT04315298|25930535|P5|Overall Study|Withdrawal by Subject|2
7486045|NCT04315298|25930536|P4|Overall Study|Withdrawal by Subject|2
7486046|NCT04315298|25930537|P3|Overall Study|Withdrawal by Subject|0
7486047|NCT04315298|25930538|P2|Overall Study|Withdrawal by Subject|0
7486048|NCT04315298|25930539|P1|Overall Study|Withdrawal by Subject|0
7486049|NCT04314037|25930999|P2|Treatment Period 3|Adverse Event|1
7486050|NCT04314037|25931000|P1|Treatment Period 3|Adverse Event|0
7486051|NCT04314037|25930999|P2|Treatment Period 3|Protocol Violation|0
7486052|NCT04314037|25931000|P1|Treatment Period 3|Protocol Violation|1
7486053|NCT04314037|25930999|P2|Treatment Period 2|Adverse Event|0
7486054|NCT04314037|25931000|P1|Treatment Period 2|Adverse Event|1
7486055|NCT04308668|25931151|P2|Overall Study|Withdrawal by Subject|4
7486056|NCT04308668|25931152|P1|Overall Study|Withdrawal by Subject|4
7486057|NCT04308668|25931151|P2|Overall Study|Lost to Follow-up|38
7486058|NCT04308668|25931152|P1|Overall Study|Lost to Follow-up|32
7486059|NCT04308239|25931176|P2|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
7486060|NCT04308239|25931177|P1|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
7486061|NCT04308239|25931176|P2|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
7486062|NCT04308239|25931177|P1|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
7486063|NCT04308239|25931176|P2|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
7486064|NCT04308239|25931177|P1|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
7486065|NCT04308239|25931176|P2|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
7486066|NCT04308239|25931177|P1|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
7486067|NCT04307940|25931202|P3|Overall Study|Lost to Follow-up|1
7486068|NCT04307940|25931203|P2|Overall Study|Lost to Follow-up|0
7486069|NCT04307940|25931204|P1|Overall Study|Lost to Follow-up|2
7486070|NCT04307940|25931202|P3|Overall Study|Withdrawal by Subject|1
7486071|NCT04307940|25931203|P2|Overall Study|Withdrawal by Subject|3
7486072|NCT04307940|25931204|P1|Overall Study|Withdrawal by Subject|2
7486073|NCT04307940|25931202|P3|Overall Study|Adverse Event|0
7486074|NCT04307940|25931203|P2|Overall Study|Adverse Event|0
7486075|NCT04307940|25931204|P1|Overall Study|Adverse Event|1
7486076|NCT04302545|25931238|P2|Overall Study|Lost to Follow-up|4
7486077|NCT04302545|25931239|P1|Overall Study|Lost to Follow-up|3
7486078|NCT04297241|25931272|P1|Overall Study|Physician Decision|3
7486079|NCT04297241|25931272|P1|Overall Study|Adverse Event|1
7486080|NCT04297241|25931272|P1|Overall Study|Withdrawal by Subject|1
7486081|NCT04295356|25931307|P2|Overall Study|Protocol Violation|1
7486082|NCT04295356|25931308|P1|Overall Study|Protocol Violation|0
7486083|NCT04295356|25931307|P2|Overall Study|Lost to Follow-up|3
7486084|NCT04295356|25931308|P1|Overall Study|Lost to Follow-up|0
7486085|NCT04295356|25931307|P2|Overall Study|Physician Decision|0
7486086|NCT04295356|25931308|P1|Overall Study|Physician Decision|1
7486087|NCT04292899|25931336|P4|Overall Study|Protocol Violation|1
7486088|NCT04292899|25931337|P3|Overall Study|Protocol Violation|0
7486089|NCT04292899|25931338|P2|Overall Study|Protocol Violation|0
7486090|NCT04292899|25931339|P1|Overall Study|Protocol Violation|0
7486091|NCT04292899|25931336|P4|Overall Study|Non-compliance With Study Drug|1
7486092|NCT04292899|25931337|P3|Overall Study|Non-compliance With Study Drug|0
7486093|NCT04292899|25931338|P2|Overall Study|Non-compliance With Study Drug|0
7486094|NCT04292899|25931339|P1|Overall Study|Non-compliance With Study Drug|0
7486095|NCT04292899|25931336|P4|Overall Study|Investigator's Discretion|3
7486096|NCT04292899|25931337|P3|Overall Study|Investigator's Discretion|0
7486097|NCT04292899|25931338|P2|Overall Study|Investigator's Discretion|0
7486098|NCT04292899|25931339|P1|Overall Study|Investigator's Discretion|0
7486099|NCT04292899|25931336|P4|Overall Study|Adverse Event|2
7486100|NCT04292899|25931337|P3|Overall Study|Adverse Event|2
7486101|NCT04292899|25931338|P2|Overall Study|Adverse Event|1
7486102|NCT04292899|25931339|P1|Overall Study|Adverse Event|2
7486103|NCT04292899|25931336|P4|Overall Study|Withdrew consent|32
7486104|NCT04292899|25931337|P3|Overall Study|Withdrew consent|11
7486105|NCT04292899|25931338|P2|Overall Study|Withdrew consent|0
7486106|NCT04292899|25931339|P1|Overall Study|Withdrew consent|1
7486107|NCT04292899|25931336|P4|Overall Study|Lost to Follow-up|235
7486108|NCT04292899|25931337|P3|Overall Study|Lost to Follow-up|22
7486109|NCT04292899|25931338|P2|Overall Study|Lost to Follow-up|4
7486110|NCT04292899|25931339|P1|Overall Study|Lost to Follow-up|8
7486111|NCT04292899|25931336|P4|Overall Study|Death|371
7486112|NCT04292899|25931337|P3|Overall Study|Death|188
7486113|NCT04292899|25931338|P2|Overall Study|Death|28
7486114|NCT04292899|25931339|P1|Overall Study|Death|21
7486115|NCT04292730|25931353|P4|Overall Study|Randomized but not Treated|14
7486116|NCT04292730|25931354|P3|Overall Study|Randomized but not Treated|0
7486117|NCT04292730|25931355|P2|Overall Study|Randomized but not Treated|4
7486118|NCT04292730|25931356|P1|Overall Study|Randomized but not Treated|8
7486119|NCT04292730|25931353|P4|Overall Study|Protocol Violation|0
7486120|NCT04292730|25931354|P3|Overall Study|Protocol Violation|1
7486121|NCT04292730|25931355|P2|Overall Study|Protocol Violation|0
7486122|NCT04292730|25931356|P1|Overall Study|Protocol Violation|0
7486123|NCT04292730|25931353|P4|Overall Study|Non-Compliance with Study Drug|0
7486124|NCT04292730|25931354|P3|Overall Study|Non-Compliance with Study Drug|0
7486125|NCT04292730|25931355|P2|Overall Study|Non-Compliance with Study Drug|1
7486126|NCT04292730|25931356|P1|Overall Study|Non-Compliance with Study Drug|0
7486127|NCT04292730|25931353|P4|Overall Study|Withdrew Consent|6
7486128|NCT04292730|25931354|P3|Overall Study|Withdrew Consent|5
7486129|NCT04292730|25931355|P2|Overall Study|Withdrew Consent|2
7486130|NCT04292730|25931356|P1|Overall Study|Withdrew Consent|2
7486131|NCT04292730|25931353|P4|Overall Study|Death|12
7486132|NCT04292730|25931354|P3|Overall Study|Death|4
7486133|NCT04292730|25931355|P2|Overall Study|Death|2
7486134|NCT04292730|25931356|P1|Overall Study|Death|2
7486135|NCT04292730|25931353|P4|Overall Study|Lost to Follow-up|48
7486136|NCT04292730|25931354|P3|Overall Study|Lost to Follow-up|12
7486137|NCT04292730|25931355|P2|Overall Study|Lost to Follow-up|12
7486138|NCT04292730|25931356|P1|Overall Study|Lost to Follow-up|8
7486139|NCT04292535|25931386|P14|Overall Study|Equipment Failure|0
7486140|NCT04292535|25931387|P13|Overall Study|Equipment Failure|0
7486141|NCT04292535|25931388|P12|Overall Study|Equipment Failure|1
7486142|NCT04292535|25931389|P11|Overall Study|Equipment Failure|0
7486143|NCT04292535|25931390|P10|Overall Study|Equipment Failure|0
7486144|NCT04292535|25931391|P9|Overall Study|Equipment Failure|0
7486145|NCT04292535|25931392|P8|Overall Study|Equipment Failure|0
7486146|NCT04292535|25931393|P7|Overall Study|Equipment Failure|0
7486147|NCT04292535|25931394|P6|Overall Study|Equipment Failure|0
7486148|NCT04292535|25931395|P5|Overall Study|Equipment Failure|0
7486149|NCT04292535|25931396|P4|Overall Study|Equipment Failure|0
7486150|NCT04292535|25931397|P3|Overall Study|Equipment Failure|0
7486151|NCT04292535|25931398|P2|Overall Study|Equipment Failure|0
7486152|NCT04292535|25931399|P1|Overall Study|Equipment Failure|0
7486153|NCT04292535|25931386|P14|Overall Study|Report of Dizziness|1
7486154|NCT04292535|25931387|P13|Overall Study|Report of Dizziness|0
7486155|NCT04292535|25931388|P12|Overall Study|Report of Dizziness|0
7486156|NCT04292535|25931389|P11|Overall Study|Report of Dizziness|0
7486157|NCT04292535|25931390|P10|Overall Study|Report of Dizziness|0
7486158|NCT04292535|25931391|P9|Overall Study|Report of Dizziness|0
7486159|NCT04292535|25931392|P8|Overall Study|Report of Dizziness|0
7486160|NCT04292535|25931393|P7|Overall Study|Report of Dizziness|0
7486161|NCT04292535|25931394|P6|Overall Study|Report of Dizziness|0
7486162|NCT04292535|25931395|P5|Overall Study|Report of Dizziness|0
7486163|NCT04292535|25931396|P4|Overall Study|Report of Dizziness|0
7486164|NCT04292535|25931397|P3|Overall Study|Report of Dizziness|0
7486165|NCT04292535|25931398|P2|Overall Study|Report of Dizziness|0
7486166|NCT04292535|25931399|P1|Overall Study|Report of Dizziness|0
7486167|NCT04292535|25931386|P14|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7486168|NCT04292535|25931387|P13|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7486169|NCT04292535|25931388|P12|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486170|NCT04292535|25931389|P11|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486171|NCT04292535|25931390|P10|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486172|NCT04292535|25931391|P9|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486173|NCT04292535|25931392|P8|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7486174|NCT04292535|25931393|P7|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486175|NCT04292535|25931394|P6|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486176|NCT04292535|25931395|P5|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486177|NCT04292535|25931396|P4|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486178|NCT04292535|25931397|P3|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486179|NCT04292535|25931398|P2|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486180|NCT04292535|25931399|P1|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7486181|NCT04292535|25931386|P14|Overall Study|Withdrawal by Subject|0
7486182|NCT04292535|25931387|P13|Overall Study|Withdrawal by Subject|0
7486183|NCT04292535|25931388|P12|Overall Study|Withdrawal by Subject|0
7486184|NCT04292535|25931389|P11|Overall Study|Withdrawal by Subject|0
7486185|NCT04292535|25931390|P10|Overall Study|Withdrawal by Subject|0
7486186|NCT04292535|25931391|P9|Overall Study|Withdrawal by Subject|0
7486187|NCT04292535|25931392|P8|Overall Study|Withdrawal by Subject|1
7486188|NCT04292535|25931393|P7|Overall Study|Withdrawal by Subject|0
7486189|NCT04292535|25931394|P6|Overall Study|Withdrawal by Subject|0
7486190|NCT04292535|25931395|P5|Overall Study|Withdrawal by Subject|0
7486191|NCT04292535|25931396|P4|Overall Study|Withdrawal by Subject|0
7486192|NCT04292535|25931397|P3|Overall Study|Withdrawal by Subject|0
7486193|NCT04292535|25931398|P2|Overall Study|Withdrawal by Subject|0
7486194|NCT04292535|25931399|P1|Overall Study|Withdrawal by Subject|0
7486195|NCT04292171|25931557|P2|Overall Study|Delivered prior to procedure|1
7486196|NCT04292171|25931558|P1|Overall Study|Delivered prior to procedure|0
7486197|NCT04292171|25931557|P2|Overall Study|Pharmacy error|0
7486198|NCT04292171|25931558|P1|Overall Study|Pharmacy error|2
7486199|NCT04289623|25931647|P6|Wave 1 Emails|Email was not delivered|0
7486200|NCT04289623|25931648|P5|Wave 1 Emails|Email was not delivered|0
7486201|NCT04289623|25931649|P4|Wave 1 Emails|Email was not delivered|0
7486202|NCT04289623|25931650|P3|Wave 1 Emails|Email was not delivered|0
7486203|NCT04289623|25931651|P2|Wave 1 Emails|Email was not delivered|257
7486204|NCT04289623|25931652|P1|Wave 1 Emails|Email was not delivered|268
7486205|NCT04287517|25931683|P2|Overall Study|Withdrawal by Subject|1
7486206|NCT04287517|25931684|P1|Overall Study|Withdrawal by Subject|1
7486207|NCT04280705|25931773|P2|Overall Study|Transferred to another hospital|1
7486208|NCT04280705|25931774|P1|Overall Study|Transferred to another hospital|1
7486209|NCT04280705|25931773|P2|Overall Study|Adverse Event|4
7486210|NCT04280705|25931774|P1|Overall Study|Adverse Event|0
7486211|NCT04280705|25931773|P2|Overall Study|Withdrawal by Subject|9
7486212|NCT04280705|25931774|P1|Overall Study|Withdrawal by Subject|7
7486213|NCT04280705|25931773|P2|Overall Study|Physician Decision|0
7486214|NCT04280705|25931774|P1|Overall Study|Physician Decision|1
7486215|NCT04280705|25931773|P2|Overall Study|Enrolled but not treated|10
7486216|NCT04280705|25931774|P1|Overall Study|Enrolled but not treated|4
7486217|NCT04276207|25931871|P2|Period 1|Withdrawal by Subject|1
7486218|NCT04276207|25931872|P1|Period 1|Withdrawal by Subject|0
7486219|NCT04275336|25931887|P3|Overall Study|Failed specimen of saliva|4
7486220|NCT04275336|25931888|P2|Overall Study|Failed specimen of saliva|3
7486221|NCT04275336|25931889|P1|Overall Study|Failed specimen of saliva|4
7486222|NCT04275336|25931887|P3|Overall Study|Unscheduled venipuncture|7
7486223|NCT04275336|25931888|P2|Overall Study|Unscheduled venipuncture|13
7486224|NCT04275336|25931889|P1|Overall Study|Unscheduled venipuncture|9
7486225|NCT04275336|25931887|P3|Overall Study|First venipuncture failed|5
7486226|NCT04275336|25931888|P2|Overall Study|First venipuncture failed|6
7486227|NCT04275336|25931889|P1|Overall Study|First venipuncture failed|4
7486228|NCT04272775|25932004|P2|Overall Study|Progressive Disease|1
7486229|NCT04272775|25932005|P1|Overall Study|Progressive Disease|3
7486230|NCT04272775|25932004|P2|Overall Study|Adverse Event|2
7486231|NCT04272775|25932005|P1|Overall Study|Adverse Event|1
7486232|NCT04272775|25932004|P2|Overall Study|Withdrawal by Subject|2
7486233|NCT04272775|25932005|P1|Overall Study|Withdrawal by Subject|1
7486234|NCT04272775|25932004|P2|Overall Study|Symptomatic Deterioration|1
7486235|NCT04272775|25932005|P1|Overall Study|Symptomatic Deterioration|1
7486236|NCT04272775|25932004|P2|Overall Study|Protocol Violation|1
7486237|NCT04272775|25932005|P1|Overall Study|Protocol Violation|0
7486238|NCT04272775|25932004|P2|Overall Study|Study Terminated by Sponsor|0
7486239|NCT04272775|25932005|P1|Overall Study|Study Terminated by Sponsor|1
7486240|NCT04271605|25932032|P1|Overall Study|The study was terminated because of the duration of funding was only one year.|5
7486241|NCT04268316|25932067|P3|Overall Study|Withdrawal by Subject|0
7486242|NCT04268316|25932068|P2|Overall Study|Withdrawal by Subject|1
7486243|NCT04268316|25932069|P1|Overall Study|Withdrawal by Subject|2
7486244|NCT04263142|25932160|P5|Part 2 Period 2 (Day 1)|Physician Decision|1
7486245|NCT04263142|25932161|P4|Part 2 Period 2 (Day 1)|Physician Decision|0
7486246|NCT04263142|25932162|P3|Part 2 Period 2 (Day 1)|Physician Decision|0
7486247|NCT04263142|25932163|P2|Part 2 Period 2 (Day 1)|Physician Decision|0
7486248|NCT04263142|25932164|P1|Part 2 Period 2 (Day 1)|Physician Decision|0
7486249|NCT04263142|25932160|P5|Part 2 Period 1 (Day 1)|Adverse Event|1
7486250|NCT04263142|25932161|P4|Part 2 Period 1 (Day 1)|Adverse Event|0
7486251|NCT04263142|25932162|P3|Part 2 Period 1 (Day 1)|Adverse Event|0
7486252|NCT04263142|25932163|P2|Part 2 Period 1 (Day 1)|Adverse Event|0
7486253|NCT04263142|25932164|P1|Part 2 Period 1 (Day 1)|Adverse Event|0
7486254|NCT04258995|25932418|P2|Overall Study|Lost to Follow-up|1
7486255|NCT04258995|25932419|P1|Overall Study|Lost to Follow-up|1
7486256|NCT04256785|25932445|P2|Overall Study|Surgery or quarantined due to Covid-19|7
7486257|NCT04256785|25932446|P1|Overall Study|Surgery or quarantined due to Covid-19|5
7486258|NCT04256785|25932445|P2|Overall Study|Withdrawal by Subject|1
7486259|NCT04256785|25932446|P1|Overall Study|Withdrawal by Subject|4
7486260|NCT04256785|25932445|P2|Overall Study|Protocol Violation|0
7486261|NCT04256785|25932446|P1|Overall Study|Protocol Violation|1
7486262|NCT04256785|25932445|P2|Overall Study|Lost to Follow-up|7
7486263|NCT04256785|25932446|P1|Overall Study|Lost to Follow-up|7
7486264|NCT04256785|25932445|P2|Overall Study|Lack of Efficacy|4
7486265|NCT04256785|25932446|P1|Overall Study|Lack of Efficacy|3
7486266|NCT04256785|25932445|P2|Overall Study|Adverse Event|6
7486267|NCT04256785|25932446|P1|Overall Study|Adverse Event|8
7486268|NCT04249336|25932520|P4|Overall Study|Lost to Follow-up|3
7486269|NCT04249336|25932521|P3|Overall Study|Lost to Follow-up|3
7486270|NCT04249336|25932522|P2|Overall Study|Lost to Follow-up|3
7486271|NCT04249336|25932523|P1|Overall Study|Lost to Follow-up|3
7486272|NCT04247061|25932577|P1|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
7486273|NCT04247061|25932577|P1|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
7486274|NCT04247061|25932577|P1|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
7486275|NCT04245202|25932589|P2|Overall Study|Lack of Efficacy|1
7486276|NCT04245202|25932590|P1|Overall Study|Lack of Efficacy|10
7486277|NCT04238663|25932698|P3|Overall Study|Lost to Follow-up|0
7486278|NCT04238663|25932699|P2|Overall Study|Lost to Follow-up|1
7486279|NCT04238663|25932700|P1|Overall Study|Lost to Follow-up|0
7486280|NCT04238650|25932731|P2|Overall Study|Withdrawal by Subject|1
7486281|NCT04238650|25932732|P1|Overall Study|Withdrawal by Subject|0
7486282|NCT04228302|25932862|P6|Overall Study|Adverse Event|0
7486283|NCT04228302|25932863|P5|Overall Study|Adverse Event|1
7486284|NCT04228302|25932864|P4|Overall Study|Adverse Event|0
7486285|NCT04228302|25932865|P3|Overall Study|Adverse Event|0
7486286|NCT04228302|25932866|P2|Overall Study|Adverse Event|0
7486287|NCT04228302|25932867|P1|Overall Study|Adverse Event|0
7486288|NCT04223687|25932963|P2|Overall Study|Missing primary outcome|0
7486289|NCT04223687|25932964|P1|Overall Study|Missing primary outcome|1
7486290|NCT04223232|25933039|P1|Overall Study|Withdrawal by Subject|1
7486291|NCT04222725|25933072|P4|Overall Study|Adverse Event|0
7486292|NCT04222725|25933073|P3|Overall Study|Adverse Event|0
7486293|NCT04222725|25933074|P2|Overall Study|Adverse Event|1
7486294|NCT04222725|25933075|P1|Overall Study|Adverse Event|0
7486295|NCT04222699|25933085|P1|Overall Study|Lost to Follow-up|2
7486296|NCT04214600|25933120|P2|Overall Study|Lost to Follow-up|14
7486297|NCT04214600|25933121|P1|Overall Study|Lost to Follow-up|9
7486298|NCT04209530|25933156|P2|Overall Study|Withdrawal by Subject|1
7486299|NCT04209530|25933157|P1|Overall Study|Withdrawal by Subject|0
7486300|NCT04209530|25933156|P2|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
7486301|NCT04209530|25933157|P1|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
7486302|NCT04207840|25933225|P3|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
7486303|NCT04207840|25933226|P2|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
7486304|NCT04207840|25933227|P1|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
7486305|NCT04207840|25933225|P3|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
7486306|NCT04207840|25933226|P2|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
7486307|NCT04207840|25933227|P1|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
7486308|NCT04206384|25933278|P1|Overall Study|Adverse Event|2
7486309|NCT04206384|25933278|P1|Overall Study|Withdrawal by Subject|8
7486310|NCT04206293|25933283|P1|Overall Study|Consent withdrawal|1
7486311|NCT04202497|25933375|P4|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7486312|NCT04202497|25933376|P3|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7486313|NCT04202497|25933377|P2|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7486314|NCT04202497|25933378|P1|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
7486315|NCT04195893|25933438|P2|Second Intervention|Withdrawal by Subject|0
7486316|NCT04195893|25933439|P1|Second Intervention|Withdrawal by Subject|1
7486317|NCT04195581|25933572|P1|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
7486318|NCT04195581|25933572|P1|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
7486319|NCT04195581|25933572|P1|Fanfilcon A With All in One Light|Withdrawal by Subject|1
7486320|NCT04195581|25933572|P1|Comfilcon A With Refine One Step|Withdrawal by Subject|1
7486321|NCT04195581|25933572|P1|Comfilcon A With Hy-Care|Withdrawal by Subject|5
7486322|NCT04195581|25933572|P1|Comfilcon A With All in One Light|Withdrawal by Subject|4
7486323|NCT04194151|25933652|P6|Overall Study|Monitorization problem|0
7486324|NCT04194151|25933653|P5|Overall Study|Monitorization problem|0
7486325|NCT04194151|25933654|P4|Overall Study|Monitorization problem|0
7486326|NCT04194151|25933655|P3|Overall Study|Monitorization problem|0
7486327|NCT04194151|25933656|P2|Overall Study|Monitorization problem|1
7486328|NCT04194151|25933657|P1|Overall Study|Monitorization problem|0
7486329|NCT04194151|25933652|P6|Overall Study|Physician Decision|1
7486330|NCT04194151|25933653|P5|Overall Study|Physician Decision|0
7486331|NCT04194151|25933654|P4|Overall Study|Physician Decision|1
7486332|NCT04194151|25933655|P3|Overall Study|Physician Decision|1
7486333|NCT04194151|25933656|P2|Overall Study|Physician Decision|1
7486334|NCT04194151|25933657|P1|Overall Study|Physician Decision|1
7486335|NCT04194008|25933695|P1|Treatment Phase With Nerivio|Lost to Follow-up|1
7486336|NCT04194008|25933695|P1|Treatment Phase With Nerivio|Missing data|4
7486337|NCT04194008|25933695|P1|Treatment Phase With Nerivio|Withdrawal by Subject|3
7486338|NCT04194008|25933695|P1|Baseline (Run-in) Phase|Lost to Follow-up|2
7486339|NCT04194008|25933695|P1|Baseline (Run-in) Phase|Withdrawal by Subject|6
7486340|NCT04194008|25933695|P1|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
7486341|NCT04189224|25933721|P2|Period 2|Adverse Event|1
7486342|NCT04189224|25933722|P1|Period 2|Adverse Event|0
7486343|NCT04189081|25933743|P3|Overall Study|Withdrawal by Subject|1
7486344|NCT04189081|25933744|P2|Overall Study|Withdrawal by Subject|0
7486345|NCT04189081|25933745|P1|Overall Study|Withdrawal by Subject|0
7486346|NCT04189081|25933743|P3|Overall Study|Lost to Follow-up|0
7486347|NCT04189081|25933744|P2|Overall Study|Lost to Follow-up|0
7486348|NCT04189081|25933745|P1|Overall Study|Lost to Follow-up|1
7486349|NCT04186806|25933758|P2|Period 1: 7 Days|Adverse Event|0
7486350|NCT04186806|25933759|P1|Period 1: 7 Days|Adverse Event|1
7486351|NCT04179838|25933942|P2|Second Intervention (1 Day)|Protocol Violation|1
7486352|NCT04179838|25933943|P1|Second Intervention (1 Day)|Protocol Violation|0
7486353|NCT04179838|25933942|P2|First Intervention (1 Day)|Withdrawal by Subject|3
7486354|NCT04179838|25933943|P1|First Intervention (1 Day)|Withdrawal by Subject|0
7486355|NCT04179461|25934018|P1|Overall Study|Lost to Follow-up|4
7486360|NCT04178590|25934039|P1|Overall Study|Lost to Follow-up|1
7486361|NCT04178590|25934039|P1|Overall Study|Pregnancy|1
7486362|NCT04177862|25934149|P2|Overall Study|Protocol Violation|7
7486363|NCT04177862|25934150|P1|Overall Study|Protocol Violation|2
7486364|NCT04175808|25934180|P7|Part A|Miscellaneous|0
7486365|NCT04175808|25934181|P6|Part A|Miscellaneous|0
7486366|NCT04175808|25934182|P5|Part A|Miscellaneous|0
7486367|NCT04175808|25934183|P4|Part A|Miscellaneous|0
7486368|NCT04175808|25934184|P3|Part A|Miscellaneous|0
7486369|NCT04175808|25934185|P2|Part A|Miscellaneous|0
7486370|NCT04175808|25934186|P1|Part A|Miscellaneous|2
7486371|NCT04173741|25934303|P2|Overall Study|IVC measurement cannot be done|1
7486372|NCT04173741|25934304|P1|Overall Study|IVC measurement cannot be done|1
7486373|NCT04170686|25934336|P2|Randomization and Treatment|Lost to Follow-up|15
7486374|NCT04170686|25934337|P1|Randomization and Treatment|Lost to Follow-up|26
7486375|NCT04170686|25934336|P2|Screening|Physician Decision|13
7486376|NCT04170686|25934337|P1|Screening|Physician Decision|12
7486377|NCT04169061|25934404|P1|Overall Study|Protocol Violation|1
7486378|NCT04169061|25934404|P1|Overall Study|Withdrawal by Subject|1
7486379|NCT04169061|25934404|P1|Overall Study|Death|1
7486380|NCT04169061|25934404|P1|Overall Study|Adverse Event|2
7486381|NCT04164758|25934415|P3|Overall Study|Adverse Event|0
7486382|NCT04164758|25934416|P2|Overall Study|Adverse Event|1
7486383|NCT04164758|25934417|P1|Overall Study|Adverse Event|0
7486384|NCT04164758|25934415|P3|Overall Study|COVID-19 withdrawal of consent|0
7486385|NCT04164758|25934416|P2|Overall Study|COVID-19 withdrawal of consent|0
7486386|NCT04164758|25934417|P1|Overall Study|COVID-19 withdrawal of consent|1
7486387|NCT04162795|25934425|P1|Overall Study|Screen failures|10
7486388|NCT04162795|25934425|P1|Overall Study|Other|16
7486389|NCT04161807|25934439|P1|Overall Study|Performed only 1 treatment|2
7486390|NCT04161807|25934439|P1|Overall Study|Withdrawal by Subject|2
7486391|NCT04161144|25934453|P2|Overall Study|Protocol Violation|0
7486392|NCT04161144|25934454|P1|Overall Study|Protocol Violation|1
7486393|NCT04161144|25934453|P2|Overall Study|Withdrawal by Subject|1
7486394|NCT04161144|25934454|P1|Overall Study|Withdrawal by Subject|0
7486395|NCT04161131|25934464|P1|Overall Study|Lost to Follow-up|4
7486396|NCT04161131|25934464|P1|Overall Study|Ineligible|2
7486397|NCT04161079|25934483|P1|Clinical Investigation 2010-040|Adverse Event|1
7486398|NCT04160988|25934503|P1|Overall Study|poor image quality|28
7486399|NCT04157738|25934575|P2|Overall Study|Did not show up to the Follow-up appointment|0
7486400|NCT04157738|25934576|P1|Overall Study|Did not show up to the Follow-up appointment|1
7486401|NCT04157738|25934575|P2|Overall Study|Moved out of state|2
7486402|NCT04157738|25934576|P1|Overall Study|Moved out of state|0
7486403|NCT04156646|25934592|P2|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
7486404|NCT04156646|25934593|P1|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
7486405|NCT04155047|25934718|P2|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
7486406|NCT04155047|25934719|P1|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
7486407|NCT04155047|25934718|P2|Overall Study|Adverse Event|0
7486408|NCT04155047|25934719|P1|Overall Study|Adverse Event|1
7486409|NCT04154605|25934727|P2|Overall Study|Withdrawal by Subject|0
7486410|NCT04154605|25934728|P1|Overall Study|Withdrawal by Subject|1
7486411|NCT04154605|25934727|P2|Overall Study|Missed follow up|1
7486412|NCT04154605|25934728|P1|Overall Study|Missed follow up|1
7486413|NCT04154605|25934727|P2|Overall Study|Procedure Canceled|1
7486414|NCT04154605|25934728|P1|Overall Study|Procedure Canceled|1
7486415|NCT04152083|25934759|P2|Overall Study|Randomized but not treated|2
7486416|NCT04152083|25934760|P1|Overall Study|Randomized but not treated|3
7486417|NCT04152083|25934759|P2|Overall Study|Adverse Event|0
7486418|NCT04152083|25934760|P1|Overall Study|Adverse Event|1
7486419|NCT04152083|25934759|P2|Overall Study|Lost to Follow-up|1
7486420|NCT04152083|25934760|P1|Overall Study|Lost to Follow-up|2
7486421|NCT04150250|25934838|P2|Overall Study|Lost to Follow-up|2
7486422|NCT04150250|25934839|P1|Overall Study|Lost to Follow-up|0
7486423|NCT04149353|25935027|P1|Overall Study|Study terminated|1
7486424|NCT04148651|25935032|P1|Overall Study|Lost to Follow-up|2
7486425|NCT04147611|25935042|P2|Overall Study|Physician Decision|1
7486426|NCT04147611|25935043|P1|Overall Study|Physician Decision|0
7486427|NCT04144166|25935137|P1|Overall Study|Nail polish could not be removed from finger|1
7486428|NCT04144166|25935137|P1|Overall Study|Pregnancy|1
7486429|NCT04144166|25935137|P1|Overall Study|Discharged before study start|1
7486430|NCT04142450|25935175|P1|Overall Study|Lost to Follow-up|1
7486431|NCT04142450|25935175|P1|Overall Study|Screen Failure|1
7486432|NCT04142242|25935190|P6|Overall Study|Ongoing|0
7486433|NCT04142242|25935191|P5|Overall Study|Ongoing|0
7486434|NCT04142242|25935192|P4|Overall Study|Ongoing|39
7486435|NCT04142242|25935193|P3|Overall Study|Ongoing|31
7486436|NCT04142242|25935194|P2|Overall Study|Ongoing|0
7486437|NCT04142242|25935195|P1|Overall Study|Ongoing|0
7486438|NCT04142242|25935190|P6|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7486439|NCT04142242|25935191|P5|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7486440|NCT04142242|25935192|P4|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7486441|NCT04142242|25935193|P3|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7486442|NCT04142242|25935194|P2|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
7486443|NCT04142242|25935195|P1|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7486444|NCT04142242|25935190|P6|Overall Study|Non-compliance with the protocol|1
7486445|NCT04142242|25935191|P5|Overall Study|Non-compliance with the protocol|0
7486446|NCT04142242|25935192|P4|Overall Study|Non-compliance with the protocol|0
7486447|NCT04142242|25935193|P3|Overall Study|Non-compliance with the protocol|0
7641276|NCT01595009|26583021|P2|Core|Death|6
7486448|NCT04142242|25935194|P2|Overall Study|Non-compliance with the protocol|0
7486449|NCT04142242|25935195|P1|Overall Study|Non-compliance with the protocol|1
7486450|NCT04142216|25935217|P2|Overall Study|Use of clove|1
7486451|NCT04142216|25935218|P1|Overall Study|Use of clove|0
7486452|NCT04142216|25935217|P2|Overall Study|Referral to another hemodialysis unit|2
7486453|NCT04142216|25935218|P1|Overall Study|Referral to another hemodialysis unit|3
7486454|NCT04142216|25935217|P2|Overall Study|Death|1
7486455|NCT04142216|25935218|P1|Overall Study|Death|3
7486456|NCT04142216|25935217|P2|Overall Study|Hospitalization|2
7486457|NCT04142216|25935218|P1|Overall Study|Hospitalization|0
7486458|NCT04140890|25935247|P2|Overall Study|Withdrawal by Subject|1
7486459|NCT04140890|25935248|P1|Overall Study|Withdrawal by Subject|0
7486460|NCT04139018|25935276|P2|Overall Study|Lost to Follow-up|1
7486461|NCT04139018|25935277|P1|Overall Study|Lost to Follow-up|0
7486462|NCT04139018|25935276|P2|Overall Study|Withdrawal by Subject|0
7486463|NCT04139018|25935277|P1|Overall Study|Withdrawal by Subject|2
7486464|NCT04139018|25935276|P2|Overall Study|Screen fail|0
7486465|NCT04139018|25935277|P1|Overall Study|Screen fail|1
7486466|NCT04138810|25935287|P2|Overall Study|Subject cancelled surgery|0
7486467|NCT04138810|25935288|P1|Overall Study|Subject cancelled surgery|1
7486468|NCT04138810|25935287|P2|Overall Study|Withdrawal by Subject|1
7486469|NCT04138810|25935288|P1|Overall Study|Withdrawal by Subject|0
7486470|NCT04138043|25935372|P2|Overall Study|Withdrawal by Subject|1
7486471|NCT04138043|25935373|P1|Overall Study|Withdrawal by Subject|0
7486472|NCT04136444|25935449|P2|Overall Study|Sponsor request due to undisclosed concomitant medication|1
7486473|NCT04136444|25935450|P1|Overall Study|Sponsor request due to undisclosed concomitant medication|0
7486474|NCT04132336|25935529|P7|Overall Study|Investigator Decision|0
7486475|NCT04132336|25935530|P6|Overall Study|Investigator Decision|0
7486476|NCT04132336|25935531|P5|Overall Study|Investigator Decision|0
7486477|NCT04132336|25935532|P4|Overall Study|Investigator Decision|0
7486478|NCT04132336|25935533|P3|Overall Study|Investigator Decision|0
7486479|NCT04132336|25935534|P2|Overall Study|Investigator Decision|1
7486480|NCT04132336|25935535|P1|Overall Study|Investigator Decision|0
7486481|NCT04131556|25935635|P1|Overall Study|Withdrawal by Subject|1
7486482|NCT04131556|25935635|P1|Overall Study|Adverse Event|1
7486483|NCT04128319|25935721|P1|Overall Study|Death|3
7486484|NCT04128293|25935755|P4|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7486485|NCT04128293|25935756|P3|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7486486|NCT04128293|25935757|P2|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7486487|NCT04128293|25935758|P1|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7486488|NCT04126343|25935962|P6|Overall Study|Related to COVID-19 pandemic|3
7486489|NCT04126343|25935963|P5|Overall Study|Related to COVID-19 pandemic|3
7486490|NCT04126343|25935964|P4|Overall Study|Related to COVID-19 pandemic|3
7486491|NCT04126343|25935965|P3|Overall Study|Related to COVID-19 pandemic|3
7486492|NCT04126343|25935966|P2|Overall Study|Related to COVID-19 pandemic|4
7486493|NCT04126343|25935967|P1|Overall Study|Related to COVID-19 pandemic|3
7486494|NCT04126343|25935962|P6|Overall Study|Withdrawal by Subject|0
7486495|NCT04126343|25935963|P5|Overall Study|Withdrawal by Subject|0
7486496|NCT04126343|25935964|P4|Overall Study|Withdrawal by Subject|1
7486497|NCT04126343|25935965|P3|Overall Study|Withdrawal by Subject|0
7486498|NCT04126343|25935966|P2|Overall Study|Withdrawal by Subject|0
7486499|NCT04126343|25935967|P1|Overall Study|Withdrawal by Subject|0
7486500|NCT04126343|25935962|P6|Overall Study|Adverse Event|1
7486501|NCT04126343|25935963|P5|Overall Study|Adverse Event|0
7486502|NCT04126343|25935964|P4|Overall Study|Adverse Event|0
7486503|NCT04126343|25935965|P3|Overall Study|Adverse Event|0
7486504|NCT04126343|25935966|P2|Overall Study|Adverse Event|0
7486505|NCT04126343|25935967|P1|Overall Study|Adverse Event|0
7486506|NCT04126174|25936020|P2|Overall Study|Lost to Follow-up|3
7486507|NCT04126174|25936021|P1|Overall Study|Lost to Follow-up|3
7486508|NCT04124952|25936035|P1|Overall Study|Lost to Follow-up|1
7486509|NCT04123665|25936087|P2|Overall Study|Lost to Follow-up|0
7486510|NCT04123665|25936088|P1|Overall Study|Lost to Follow-up|1
7486511|NCT04123665|25936087|P2|Overall Study|Withdrawal by Subject|0
7486512|NCT04123665|25936088|P1|Overall Study|Withdrawal by Subject|7
7486513|NCT04122534|25936110|P1|Overall Study|Lost to Follow-up|4
7486514|NCT04117607|25936139|P14|Overall Study|Early Termination|0
7486515|NCT04117607|25936140|P13|Overall Study|Early Termination|0
7486516|NCT04117607|25936141|P12|Overall Study|Early Termination|0
7486517|NCT04117607|25936142|P11|Overall Study|Early Termination|0
7486518|NCT04117607|25936143|P10|Overall Study|Early Termination|0
7486519|NCT04117607|25936144|P9|Overall Study|Early Termination|0
7486520|NCT04117607|25936145|P8|Overall Study|Early Termination|0
7486521|NCT04117607|25936146|P7|Overall Study|Early Termination|1
7486522|NCT04117607|25936147|P6|Overall Study|Early Termination|0
7486523|NCT04117607|25936148|P5|Overall Study|Early Termination|0
7486524|NCT04117607|25936149|P4|Overall Study|Early Termination|0
7486525|NCT04117607|25936150|P3|Overall Study|Early Termination|0
7486526|NCT04117607|25936151|P2|Overall Study|Early Termination|1
7486527|NCT04117607|25936152|P1|Overall Study|Early Termination|0
7486528|NCT04115358|25936351|P3|Overall Study|exfoliation|1
7486529|NCT04115358|25936352|P2|Overall Study|exfoliation|0
7486530|NCT04115358|25936353|P1|Overall Study|exfoliation|0
7486531|NCT04113694|25936476|P1|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
7486532|NCT04113694|25936476|P1|Overall Study|Withdrawal by Subject|6
7486533|NCT04113694|25936476|P1|Overall Study|Lost to Follow-up|2
7641277|NCT01595009|26583022|P1|Core|Death|3
7486534|NCT04113694|25936476|P1|Overall Study|Adverse Event|2
7486535|NCT04109222|25936571|P3|Overall Study|Adverse Event|0
7486536|NCT04109222|25936572|P2|Overall Study|Adverse Event|0
7486537|NCT04109222|25936573|P1|Overall Study|Adverse Event|1
7486538|NCT04106817|25936591|P3|Overall Study|Lost to Follow-up|0
7486539|NCT04106817|25936592|P2|Overall Study|Lost to Follow-up|0
7486540|NCT04106817|25936593|P1|Overall Study|Lost to Follow-up|1
7486541|NCT04105972|25936609|P2|Overall Study|Adverse Event|1
7486542|NCT04105972|25936610|P1|Overall Study|Adverse Event|2
7486543|NCT04105218|25936624|P2|Overall Study|Failed screening tests|1
7486544|NCT04105218|25936625|P1|Overall Study|Failed screening tests|2
7486545|NCT04105218|25936624|P2|Overall Study|Study was terminated; unable to complete study visits|3
7486546|NCT04105218|25936625|P1|Overall Study|Study was terminated; unable to complete study visits|1
7486547|NCT04105218|25936624|P2|Overall Study|Withdrawal by Subject|2
7486548|NCT04105218|25936625|P1|Overall Study|Withdrawal by Subject|3
7486549|NCT04102540|25936683|P1|Overall Study|Lost to Follow-up|6
7486550|NCT04102540|25936683|P1|Overall Study|Withdrawn by PI|2
7486551|NCT04102345|25936700|P2|Overall Study|Withdrawal by Subject|0
7486552|NCT04102345|25936701|P1|Overall Study|Withdrawal by Subject|1
7486553|NCT04099277|25936721|P1|Overall Study|Withdrawal by Subject|1
7486554|NCT04099277|25936721|P1|Overall Study|Physician Decision|1
7486555|NCT04098809|25936734|P2|Overall Study|Physician Decision|1
7486556|NCT04098809|25936735|P1|Overall Study|Physician Decision|2
7486557|NCT04098809|25936734|P2|Overall Study|Withdrawal by Subject|3
7486558|NCT04098809|25936735|P1|Overall Study|Withdrawal by Subject|1
7486559|NCT04098458|25936813|P1|Overall Study|did not meet study inclusion criteria|3
7486560|NCT04098458|25936813|P1|Overall Study|Death|1
7486561|NCT04096365|25936931|P1|Overall Study|Adverse Event|1
7486562|NCT04095286|25936939|P6|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7486563|NCT04095286|25936940|P5|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
7486564|NCT04095286|25936941|P4|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7486565|NCT04095286|25936942|P3|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7486566|NCT04095286|25936943|P2|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7486567|NCT04095286|25936944|P1|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7486568|NCT04095286|25936939|P6|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486569|NCT04095286|25936940|P5|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486570|NCT04095286|25936941|P4|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486571|NCT04095286|25936942|P3|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
7486572|NCT04095286|25936943|P2|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486573|NCT04095286|25936944|P1|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486574|NCT04095286|25936939|P6|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7486575|NCT04095286|25936940|P5|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7486576|NCT04095286|25936941|P4|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7486577|NCT04095286|25936942|P3|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
7486578|NCT04095286|25936943|P2|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7486579|NCT04095286|25936944|P1|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7486580|NCT04095286|25936939|P6|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7486581|NCT04095286|25936940|P5|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7486582|NCT04095286|25936941|P4|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7486583|NCT04095286|25936942|P3|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7486584|NCT04095286|25936943|P2|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7486585|NCT04095286|25936944|P1|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
7486586|NCT04095286|25936939|P6|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486587|NCT04095286|25936940|P5|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486588|NCT04095286|25936941|P4|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486589|NCT04095286|25936942|P3|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486590|NCT04095286|25936943|P2|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
7486591|NCT04095286|25936944|P1|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7486592|NCT04094883|25936985|P1|Overall Study|Withdrawal by Subject|1
7486593|NCT04093258|25936992|P2|Period 2|Subject no longer meets the eligibility criteria|0
7486594|NCT04093258|25936993|P1|Period 2|Subject no longer meets the eligibility criteria|1
7486595|NCT04091659|25937016|P2|Overall Study|Lost to Follow-up|1
7486596|NCT04091659|25937017|P1|Overall Study|Lost to Follow-up|0
7486597|NCT04091659|25937016|P2|Overall Study|Protocol Violation|0
7486598|NCT04091659|25937017|P1|Overall Study|Protocol Violation|3
7486599|NCT04090242|25937068|P2|Overall Study|Withdrawal by Subject|0
7486600|NCT04090242|25937069|P1|Overall Study|Withdrawal by Subject|1
7486601|NCT04090164|25937101|P2|Overall Study|incomplete data on file|0
7486602|NCT04090164|25937102|P1|Overall Study|incomplete data on file|245
7486603|NCT04089761|25937128|P1|"Treatment Phase"|Lost to Follow-up|1
7486604|NCT04089761|25937128|P1|"Treatment Phase"|No evaluable data|5
7486605|NCT04089761|25937128|P1|"Run In Phase"|Lost to Follow-up|1
7486606|NCT04089761|25937128|P1|"Run In Phase"|Not eligible to proceed to the treatment phase|14
7486607|NCT04086641|25937179|P2|Foot 1 (Two Week Utilization)|COVID-19|2
7486608|NCT04086641|25937180|P1|Foot 1 (Two Week Utilization)|COVID-19|1
7486609|NCT04086472|25937227|P5|Overall Study|Various reasons|1
7486610|NCT04086472|25937228|P4|Overall Study|Various reasons|3
7486611|NCT04086472|25937229|P3|Overall Study|Various reasons|0
7486612|NCT04086472|25937230|P2|Overall Study|Various reasons|0
7486613|NCT04086472|25937231|P1|Overall Study|Various reasons|2
7486614|NCT04086472|25937227|P5|Overall Study|Withdrawal by Subject|0
7486615|NCT04086472|25937228|P4|Overall Study|Withdrawal by Subject|0
7486616|NCT04086472|25937229|P3|Overall Study|Withdrawal by Subject|1
7486617|NCT04086472|25937230|P2|Overall Study|Withdrawal by Subject|1
7486618|NCT04086472|25937231|P1|Overall Study|Withdrawal by Subject|1
7486619|NCT04086472|25937227|P5|Overall Study|Physician Decision|0
7486620|NCT04086472|25937228|P4|Overall Study|Physician Decision|0
7486621|NCT04086472|25937229|P3|Overall Study|Physician Decision|1
7486622|NCT04086472|25937230|P2|Overall Study|Physician Decision|1
7486623|NCT04086472|25937231|P1|Overall Study|Physician Decision|0
7486624|NCT04086472|25937227|P5|Overall Study|Lost to Follow-up|1
7486625|NCT04086472|25937228|P4|Overall Study|Lost to Follow-up|0
7486626|NCT04086472|25937229|P3|Overall Study|Lost to Follow-up|0
7486627|NCT04086472|25937230|P2|Overall Study|Lost to Follow-up|0
7486628|NCT04086472|25937231|P1|Overall Study|Lost to Follow-up|1
7486629|NCT04085289|25937301|P3|Overall Study|Withdrawal by Subject|1
7486630|NCT04085289|25937302|P2|Overall Study|Withdrawal by Subject|0
7486631|NCT04085289|25937303|P1|Overall Study|Withdrawal by Subject|0
7486632|NCT04084769|25937316|P4|Overall Study|Lost to Follow-up|0
7486633|NCT04084769|25937317|P3|Overall Study|Lost to Follow-up|0
7486634|NCT04084769|25937318|P2|Overall Study|Lost to Follow-up|0
7486635|NCT04084769|25937319|P1|Overall Study|Lost to Follow-up|2
7486636|NCT04084769|25937316|P4|Overall Study|Withdrawal by parent/guardian|1
7486637|NCT04084769|25937317|P3|Overall Study|Withdrawal by parent/guardian|0
7486638|NCT04084769|25937318|P2|Overall Study|Withdrawal by parent/guardian|0
7486639|NCT04084769|25937319|P1|Overall Study|Withdrawal by parent/guardian|1
7486640|NCT04084769|25937316|P4|Overall Study|Withdrawal by Subject|0
7486641|NCT04084769|25937317|P3|Overall Study|Withdrawal by Subject|0
7486642|NCT04084769|25937318|P2|Overall Study|Withdrawal by Subject|1
7486643|NCT04084769|25937319|P1|Overall Study|Withdrawal by Subject|0
7486644|NCT04084769|25937316|P4|Overall Study|Protocol Violation|1
7486645|NCT04084769|25937317|P3|Overall Study|Protocol Violation|0
7486646|NCT04084769|25937318|P2|Overall Study|Protocol Violation|3
7486647|NCT04084769|25937319|P1|Overall Study|Protocol Violation|1
7486648|NCT04082663|25937432|P1|Overall Study|Lost to Follow-up|1
7486649|NCT04082663|25937432|P1|Overall Study|Adverse Event|6
7486650|NCT04080297|25937515|P2|Overall Study|concurrent illness|0
7486651|NCT04080297|25937516|P1|Overall Study|concurrent illness|1
7486652|NCT04080297|25937515|P2|Overall Study|Adverse Event|3
7486653|NCT04080297|25937516|P1|Overall Study|Adverse Event|1
7486654|NCT04079803|25937537|P3|Overall Study|Withdrawal by Subject|1
7486655|NCT04079803|25937538|P2|Overall Study|Withdrawal by Subject|0
7486656|NCT04079803|25937539|P1|Overall Study|Withdrawal by Subject|0
7486657|NCT04079790|25937584|P4|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7486658|NCT04079790|25937585|P3|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
7486659|NCT04079790|25937586|P2|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7486660|NCT04079790|25937587|P1|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7486661|NCT04079790|25937584|P4|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7486662|NCT04079790|25937585|P3|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
7486663|NCT04079790|25937586|P2|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7486664|NCT04079790|25937587|P1|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7486665|NCT04079790|25937584|P4|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7486666|NCT04079790|25937585|P3|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7486667|NCT04079790|25937586|P2|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7486668|NCT04079790|25937587|P1|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
7486669|NCT04079114|25937731|P1|Overall Study|Study prematuely terminated.|166
7486670|NCT04073407|25937872|P2|Part 2|Withdrawal by Subject|1
7486671|NCT04073407|25937873|P1|Part 2|Withdrawal by Subject|0
7486672|NCT04073407|25937872|P2|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
7486673|NCT04073407|25937873|P1|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
7486674|NCT04073407|25937872|P2|Part 1|Withdrawal by Subject|0
7486675|NCT04073407|25937873|P1|Part 1|Withdrawal by Subject|1
7486676|NCT04073368|25937883|P4|Overall Study|Subject noncompliance|0
7486677|NCT04073368|25937884|P3|Overall Study|Subject noncompliance|0
7486678|NCT04073368|25937885|P2|Overall Study|Subject noncompliance|4
7486679|NCT04073368|25937886|P1|Overall Study|Subject noncompliance|7
7486680|NCT04073368|25937883|P4|Overall Study|Protocol Violation|0
7486681|NCT04073368|25937884|P3|Overall Study|Protocol Violation|0
7486682|NCT04073368|25937885|P2|Overall Study|Protocol Violation|1
7486683|NCT04073368|25937886|P1|Overall Study|Protocol Violation|0
7486684|NCT04073368|25937883|P4|Overall Study|Lost to Follow-up|0
7486685|NCT04073368|25937884|P3|Overall Study|Lost to Follow-up|1
7486686|NCT04073368|25937885|P2|Overall Study|Lost to Follow-up|1
7486687|NCT04073368|25937886|P1|Overall Study|Lost to Follow-up|1
7486688|NCT04073368|25937883|P4|Overall Study|Withdrawal by Subject|1
7486689|NCT04073368|25937884|P3|Overall Study|Withdrawal by Subject|1
7486690|NCT04073368|25937885|P2|Overall Study|Withdrawal by Subject|2
7486691|NCT04073368|25937886|P1|Overall Study|Withdrawal by Subject|2
7486692|NCT04073368|25937883|P4|Overall Study|Adverse Event|1
7486693|NCT04073368|25937884|P3|Overall Study|Adverse Event|1
7486694|NCT04073368|25937885|P2|Overall Study|Adverse Event|0
7486695|NCT04073368|25937886|P1|Overall Study|Adverse Event|2
7486696|NCT04073186|25937916|P1|Second Wearing Cycle|Adverse Event|1
7486697|NCT04073186|25937916|P1|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
7486698|NCT04073186|25937916|P1|First Wearing Cycle|Lens Discomfort|2
7486699|NCT04073186|25937916|P1|First Wearing Cycle|Protocol Violation|1
7486700|NCT04073186|25937916|P1|First Wearing Cycle|Withdrawal by Subject|1
7486701|NCT04073186|25937916|P1|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
7486702|NCT04071301|25938156|P1|Overall Study|Death|1
7486703|NCT04071301|25938156|P1|Overall Study|Withdrawal by Subject|6
7486704|NCT04071158|25938165|P5|Overall Study|Randomized but not treated|0
7486705|NCT04071158|25938166|P4|Overall Study|Randomized but not treated|0
7486706|NCT04071158|25938167|P3|Overall Study|Randomized but not treated|0
7486707|NCT04071158|25938168|P2|Overall Study|Randomized but not treated|2
7486708|NCT04071158|25938169|P1|Overall Study|Randomized but not treated|2
7486709|NCT04071158|25938165|P5|Overall Study|Lost to Follow-up|5
7486710|NCT04071158|25938166|P4|Overall Study|Lost to Follow-up|3
7486711|NCT04071158|25938167|P3|Overall Study|Lost to Follow-up|3
7486712|NCT04071158|25938168|P2|Overall Study|Lost to Follow-up|2
7486713|NCT04071158|25938169|P1|Overall Study|Lost to Follow-up|1
7486714|NCT04069715|25938268|P2|Overall Study|Withdrawal by Subject|3
7486715|NCT04069715|25938269|P1|Overall Study|Withdrawal by Subject|3
7486716|NCT04069715|25938268|P2|Overall Study|Physician Decision|1
7486717|NCT04069715|25938269|P1|Overall Study|Physician Decision|1
7486718|NCT04069715|25938268|P2|Overall Study|Lost to Follow-up|1
7486719|NCT04069715|25938269|P1|Overall Study|Lost to Follow-up|1
7486720|NCT04067401|25938329|P2|Overall Study|no data provided|0
7486721|NCT04067401|25938330|P1|Overall Study|no data provided|1
7486722|NCT04067401|25938329|P2|Overall Study|Withdrawal by Subject|0
7486723|NCT04067401|25938330|P1|Overall Study|Withdrawal by Subject|7
7486724|NCT04067141|25938350|P2|Second Intervention|Adverse Event|2
7486725|NCT04067141|25938351|P1|Second Intervention|Adverse Event|0
7486726|NCT04067141|25938350|P2|First Intervention|Withdrawal by Subject|1
7486727|NCT04067141|25938351|P1|First Intervention|Withdrawal by Subject|0
7486728|NCT04067050|25938399|P2|Two Month|Adverse Event|0
7486729|NCT04067050|25938400|P1|Two Month|Adverse Event|1
7486730|NCT04067050|25938399|P2|Two Month|Lost to Follow-up|0
7486731|NCT04067050|25938400|P1|Two Month|Lost to Follow-up|1
7486732|NCT04067050|25938399|P2|One Month|Lost to Follow-up|0
7486733|NCT04067050|25938400|P1|One Month|Lost to Follow-up|4
7486734|NCT04067011|25938503|P3|Overall Study|Missing|0
7486735|NCT04067011|25938504|P2|Overall Study|Missing|2
7486736|NCT04067011|25938505|P1|Overall Study|Missing|0
7486737|NCT04067011|25938503|P3|Overall Study|Other Reasons|1
7486738|NCT04067011|25938504|P2|Overall Study|Other Reasons|0
7486739|NCT04067011|25938505|P1|Overall Study|Other Reasons|2
7486740|NCT04067011|25938503|P3|Overall Study|Physician Decision|0
7486741|NCT04067011|25938504|P2|Overall Study|Physician Decision|1
7486742|NCT04067011|25938505|P1|Overall Study|Physician Decision|1
7486743|NCT04067011|25938503|P3|Overall Study|Lost to Follow-up|1
7486744|NCT04067011|25938504|P2|Overall Study|Lost to Follow-up|0
7486745|NCT04067011|25938505|P1|Overall Study|Lost to Follow-up|0
7486746|NCT04067011|25938503|P3|Overall Study|Withdrawal by Subject|1
7486747|NCT04067011|25938504|P2|Overall Study|Withdrawal by Subject|2
7486748|NCT04067011|25938505|P1|Overall Study|Withdrawal by Subject|6
7486749|NCT04067011|25938503|P3|Overall Study|Adverse Event|0
7486750|NCT04067011|25938504|P2|Overall Study|Adverse Event|1
7486751|NCT04067011|25938505|P1|Overall Study|Adverse Event|2
7486752|NCT04067011|25938503|P3|Overall Study|Not Treated|5
7486753|NCT04067011|25938504|P2|Overall Study|Not Treated|7
7486754|NCT04067011|25938505|P1|Overall Study|Not Treated|8
7486755|NCT04065074|25938561|P1|Overall Study|Protocol Non-Compliance after injection|1
7486756|NCT04065074|25938561|P1|Overall Study|Adverse Event|1
7486757|NCT04060654|25938609|P1|Overall Study|Lost to Follow-up|5
7486758|NCT04060654|25938609|P1|Overall Study|Withdrawal by Subject|1
7486759|NCT04059094|25938625|P5|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7486760|NCT04059094|25938626|P4|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7486761|NCT04059094|25938627|P3|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7486762|NCT04059094|25938628|P2|Overall Study|Not willing to travel due to COVID-19 pandemic|2
7486763|NCT04059094|25938629|P1|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7486764|NCT04059094|25938625|P5|Overall Study|Adverse Event|1
7486765|NCT04059094|25938626|P4|Overall Study|Adverse Event|0
7486766|NCT04059094|25938627|P3|Overall Study|Adverse Event|0
7486767|NCT04059094|25938628|P2|Overall Study|Adverse Event|0
7486768|NCT04059094|25938629|P1|Overall Study|Adverse Event|0
7486769|NCT04058353|25938687|P2|Overall Study|Other|0
7486770|NCT04058353|25938688|P1|Overall Study|Other|1
7486771|NCT04058353|25938687|P2|Overall Study|Physician Decision|0
7486772|NCT04058353|25938688|P1|Overall Study|Physician Decision|1
7486773|NCT04058353|25938687|P2|Overall Study|Adverse Event|1
7486774|NCT04058353|25938688|P1|Overall Study|Adverse Event|2
7486775|NCT04054765|25938747|P2|6-month Follow up|Lost to Follow-up|32
7486776|NCT04054765|25938748|P1|6-month Follow up|Lost to Follow-up|32
7486777|NCT04054765|25938747|P2|3-month Follow up|Withdrawal by Subject|3
7486778|NCT04054765|25938748|P1|3-month Follow up|Withdrawal by Subject|0
7486779|NCT04054765|25938747|P2|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
7486780|NCT04054765|25938748|P1|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
7486781|NCT04054765|25938747|P2|Baseline|Withdrawal by Subject|3
7486782|NCT04054765|25938748|P1|Baseline|Withdrawal by Subject|5
7486783|NCT04054193|25938827|P1|Cycles 2-3|Various reasons|17
7486784|NCT04054193|25938827|P1|Cycles 2-3|Consent withdrawn by parent/guardian|2
7486785|NCT04054193|25938827|P1|Cycles 2-3|Physician Decision|2
7486786|NCT04054193|25938827|P1|Cycle 1|Allocated but not treated|3
7486787|NCT04054193|25938827|P1|Cycle 1|Consent withdrawn by parent/guardian|1
7486788|NCT04054193|25938827|P1|Cycle 1|Physician Decision|1
7486789|NCT04054011|25938833|P1|Overall Study|COVID|3
7486790|NCT04053465|25938843|P2|Overall Study|Withdrawal by Subject|4
7486791|NCT04053465|25938844|P1|Overall Study|Withdrawal by Subject|4
7486792|NCT04053023|25938873|P2|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
7486793|NCT04053023|25938874|P1|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
7486794|NCT04052204|25939106|P3|Overall Study|Other|0
7486795|NCT04052204|25939107|P2|Overall Study|Other|0
7486796|NCT04052204|25939108|P1|Overall Study|Other|1
7486797|NCT04052204|25939106|P3|Overall Study|Progressive disease|0
7486798|NCT04052204|25939107|P2|Overall Study|Progressive disease|0
7486799|NCT04052204|25939108|P1|Overall Study|Progressive disease|1
7486800|NCT04052204|25939106|P3|Overall Study|Death|0
7486801|NCT04052204|25939107|P2|Overall Study|Death|0
7486802|NCT04052204|25939108|P1|Overall Study|Death|1
7486803|NCT04050865|25939184|P2|Overall Study|Withdrawal by Subject|1
7486804|NCT04050865|25939185|P1|Overall Study|Withdrawal by Subject|0
7486805|NCT04050865|25939184|P2|Overall Study|Physician Decision|1
7486806|NCT04050865|25939185|P1|Overall Study|Physician Decision|0
7486807|NCT04050865|25939184|P2|Overall Study|Only 1 insert|3
7486808|NCT04050865|25939185|P1|Overall Study|Only 1 insert|2
7486809|NCT04050865|25939184|P2|Overall Study|no insert|0
7486810|NCT04050865|25939185|P1|Overall Study|no insert|1
7486811|NCT04050865|25939184|P2|Overall Study|Adverse Event|0
7486812|NCT04050865|25939185|P1|Overall Study|Adverse Event|1
7486813|NCT04050722|25939197|P2|Overall Study|Withdrawal by Subject|0
7486814|NCT04050722|25939198|P1|Overall Study|Withdrawal by Subject|1
7486815|NCT04050618|25939216|P2|Second Intervention|Withdrawal by Subject|0
7486816|NCT04050618|25939217|P1|Second Intervention|Withdrawal by Subject|1
7486817|NCT04050618|25939216|P2|First Intervention|Withdrawal by Subject|0
7486818|NCT04050618|25939217|P1|First Intervention|Withdrawal by Subject|2
7486819|NCT04050371|25939387|P2|Overall Study|Withdrawal by Subject|0
7486820|NCT04050371|25939388|P1|Overall Study|Withdrawal by Subject|1
7486821|NCT04049578|25939398|P1|Overall Study|Physician Decision|1
7486822|NCT04049552|25939408|P1|Overall Study|Lost to Follow-up|1
7486823|NCT04048681|25939416|P5|Overall Study|family emergency|0
7486824|NCT04048681|25939417|P4|Overall Study|family emergency|1
7486825|NCT04048681|25939418|P3|Overall Study|family emergency|0
7486826|NCT04048681|25939419|P2|Overall Study|family emergency|0
7486827|NCT04048681|25939420|P1|Overall Study|family emergency|0
7486828|NCT04046341|25939720|P1|Overall Study|Withdrawal by Subject|1
7486829|NCT04046341|25939720|P1|Overall Study|Lost to Follow-up|2
7486830|NCT04046250|25939734|P2|Overall Study|Withdrawal by Subject|3
7486831|NCT04046250|25939735|P1|Overall Study|Withdrawal by Subject|3
7486832|NCT04046250|25939734|P2|Overall Study|Death|1
7486833|NCT04046250|25939735|P1|Overall Study|Death|0
7486834|NCT04044352|25939775|P1|Overall Study|Withdrawal by Subject|2
7486835|NCT04044352|25939775|P1|Overall Study|Lost to Follow-up|9
7486836|NCT04043728|25939823|P3|Overall Study|Lost to Follow-up|0
7486837|NCT04043728|25939824|P2|Overall Study|Lost to Follow-up|2
7486838|NCT04043728|25939825|P1|Overall Study|Lost to Follow-up|1
7486839|NCT04043416|25939838|P2|Washout|Change in health condition|1
7486840|NCT04043416|25939839|P1|Washout|Change in health condition|0
7486841|NCT04041700|25939895|P1|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
7486842|NCT04041700|25939895|P1|Overall Study|Pregnancy|1
7486843|NCT04041414|25939953|P2|Overall Study|Lost to Follow-up|2
7486844|NCT04041414|25939954|P1|Overall Study|Lost to Follow-up|1
7486845|NCT04040933|25939984|P1|Overall Study|Withdrawal by Subject|2
7486846|NCT04040933|25939984|P1|Overall Study|Protocol Violation|1
7486847|NCT04039919|25940072|P5|Treatment Period 5|Withdrawal by Subject|0
7486848|NCT04039919|25940073|P4|Treatment Period 5|Withdrawal by Subject|0
7486849|NCT04039919|25940074|P3|Treatment Period 5|Withdrawal by Subject|0
7486850|NCT04039919|25940075|P2|Treatment Period 5|Withdrawal by Subject|0
7486851|NCT04039919|25940076|P1|Treatment Period 5|Withdrawal by Subject|1
7486852|NCT04039919|25940072|P5|Treatment Period 1|Sponsor's decision|16
7486853|NCT04039919|25940073|P4|Treatment Period 1|Sponsor's decision|0
7486854|NCT04039919|25940074|P3|Treatment Period 1|Sponsor's decision|0
7486855|NCT04039919|25940075|P2|Treatment Period 1|Sponsor's decision|0
7486856|NCT04039919|25940076|P1|Treatment Period 1|Sponsor's decision|0
7486857|NCT04039919|25940072|P5|Treatment Period 1|Withdrawal by Subject|0
7486858|NCT04039919|25940073|P4|Treatment Period 1|Withdrawal by Subject|0
7486859|NCT04039919|25940074|P3|Treatment Period 1|Withdrawal by Subject|0
7486860|NCT04039919|25940075|P2|Treatment Period 1|Withdrawal by Subject|0
7486861|NCT04039919|25940076|P1|Treatment Period 1|Withdrawal by Subject|1
7486862|NCT04037748|25940196|P2|Treatment Period 2|Protocol Violation|0
7486863|NCT04037748|25940197|P1|Treatment Period 2|Protocol Violation|2
7486864|NCT04037748|25940196|P2|Treatment Period 2|Adverse Event|1
7486865|NCT04037748|25940197|P1|Treatment Period 2|Adverse Event|0
7486866|NCT04037748|25940196|P2|Treatment Period 1|Protocol Violation|5
7486867|NCT04037748|25940197|P1|Treatment Period 1|Protocol Violation|4
7486868|NCT04037748|25940196|P2|Treatment Period 1|Adverse Event|1
7486869|NCT04037748|25940197|P1|Treatment Period 1|Adverse Event|1
7486870|NCT04037748|25940196|P2|Treatment Period 1|Withdrawal by Subject|0
7486871|NCT04037748|25940197|P1|Treatment Period 1|Withdrawal by Subject|3
7486872|NCT04036110|25940222|P3|Overall Study|Study Suspended|1
7486873|NCT04036110|25940223|P2|Overall Study|Study Suspended|5
7486874|NCT04036110|25940224|P1|Overall Study|Study Suspended|4
7486875|NCT04036110|25940222|P3|Overall Study|Lost to Follow-up|1
7486876|NCT04036110|25940223|P2|Overall Study|Lost to Follow-up|2
7486877|NCT04036110|25940224|P1|Overall Study|Lost to Follow-up|3
7486878|NCT04035577|25940378|P1|Overall Study|Withdrawal by Subject|1
7486879|NCT04035577|25940378|P1|Overall Study|Lost to Follow-up|1
7486880|NCT04035564|25940398|P2|Overall Study|Guardian declined consent|2
7486881|NCT04035564|25940399|P1|Overall Study|Guardian declined consent|1
7486882|NCT04035564|25940398|P2|Overall Study|No laboratory available|2
7486883|NCT04035564|25940399|P1|Overall Study|No laboratory available|2
7486884|NCT04035564|25940398|P2|Overall Study|Protocol Violation|2
7486885|NCT04035564|25940399|P1|Overall Study|Protocol Violation|1
7486886|NCT04032977|25940458|P2|Overall Study|Pregnancy|0
7486887|NCT04032977|25940459|P1|Overall Study|Pregnancy|1
7486888|NCT04032977|25940458|P2|Overall Study|Lost to Follow-up|7
7486889|NCT04032977|25940459|P1|Overall Study|Lost to Follow-up|2
7486890|NCT04032977|25940458|P2|Overall Study|Withdrawal by Subject|1
7486891|NCT04032977|25940459|P1|Overall Study|Withdrawal by Subject|6
7486892|NCT04032652|25940475|P2|Overall Study|The study was terminated and the PI has|1
7486893|NCT04032652|25940476|P1|Overall Study|The study was terminated and the PI has|1
7486894|NCT04032613|25940486|P2|Overall Study|Did not complete post-program assessment|2
7486895|NCT04032613|25940487|P1|Overall Study|Did not complete post-program assessment|5
7486896|NCT04032171|25940497|P2|Overall Study|Study Termination|0
7486897|NCT04032171|25940498|P1|Overall Study|Study Termination|1
7486898|NCT04032158|25940552|P2|Overall Study|Study Termination|1
7486899|NCT04032158|25940553|P1|Overall Study|Study Termination|2
7486900|NCT04031404|25940622|P2|Washout (5 Day Min)|Lost to Follow-up|0
7486901|NCT04031404|25940623|P1|Washout (5 Day Min)|Lost to Follow-up|1
7486902|NCT04031404|25940622|P2|Pre-randomization|Disqualified by TMS safety screening|0
7486903|NCT04031404|25940623|P1|Pre-randomization|Disqualified by TMS safety screening|1
7486904|NCT04031404|25940622|P2|Pre-randomization|Withdrawn for COVID19 precautions|3
7486905|NCT04031404|25940623|P1|Pre-randomization|Withdrawn for COVID19 precautions|1
7486906|NCT04031404|25940622|P2|Baseline|Did not meet full inclusion/exclusion.|4
7486907|NCT04031404|25940623|P1|Baseline|Did not meet full inclusion/exclusion.|2
7486908|NCT04031404|25940622|P2|Baseline|Lost to Follow-up|1
7486909|NCT04031404|25940623|P1|Baseline|Lost to Follow-up|0
7486910|NCT04029961|25940650|P2|Overall Study|Change in Treatment Course|1
7486911|NCT04029961|25940651|P1|Overall Study|Change in Treatment Course|0
7486912|NCT04029961|25940650|P2|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
7486913|NCT04029961|25940651|P1|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
7486914|NCT04029519|25940697|P1|Overall Study|Lost to Follow-up|1
7486915|NCT04029519|25940697|P1|Overall Study|Withdrawal by Subject|3
7486916|NCT04029519|25940697|P1|Overall Study|Protocol Violation|1
7486917|NCT04027686|25940788|P2|Overall Study|Withdrawal by Subject|1
7486918|NCT04027686|25940789|P1|Overall Study|Withdrawal by Subject|0
7486919|NCT04027686|25940788|P2|Overall Study|Lost to Follow-up|0
7486920|NCT04027686|25940789|P1|Overall Study|Lost to Follow-up|2
7486921|NCT04025684|25941007|P4|Overall Study|Multiple reasons|1
7486922|NCT04025684|25941008|P3|Overall Study|Multiple reasons|0
7486923|NCT04025684|25941009|P2|Overall Study|Multiple reasons|3
7486924|NCT04025684|25941010|P1|Overall Study|Multiple reasons|1
7486925|NCT04025684|25941007|P4|Overall Study|Withdrawal by Subject|0
7486926|NCT04025684|25941008|P3|Overall Study|Withdrawal by Subject|0
7486927|NCT04025684|25941009|P2|Overall Study|Withdrawal by Subject|1
7486928|NCT04025684|25941010|P1|Overall Study|Withdrawal by Subject|1
7486929|NCT04024228|25941153|P2|Overall Study|Withdrawal by Subject|4
7486930|NCT04024228|25941154|P1|Overall Study|Withdrawal by Subject|3
7486931|NCT04024228|25941153|P2|Overall Study|Protocol Deviation|2
7486932|NCT04024228|25941154|P1|Overall Study|Protocol Deviation|0
7486933|NCT04024228|25941153|P2|Overall Study|Adverse Event|0
7486934|NCT04024228|25941154|P1|Overall Study|Adverse Event|1
7486935|NCT04023994|25941192|P6|Overall Study|Withdrawal by Subject|0
7486936|NCT04023994|25941193|P5|Overall Study|Withdrawal by Subject|0
7486937|NCT04023994|25941194|P4|Overall Study|Withdrawal by Subject|1
7486938|NCT04023994|25941195|P3|Overall Study|Withdrawal by Subject|0
7486939|NCT04023994|25941196|P2|Overall Study|Withdrawal by Subject|0
7486940|NCT04023994|25941197|P1|Overall Study|Withdrawal by Subject|0
7486941|NCT04023994|25941192|P6|Overall Study|Lost to Follow-up|0
7486942|NCT04023994|25941193|P5|Overall Study|Lost to Follow-up|0
7486943|NCT04023994|25941194|P4|Overall Study|Lost to Follow-up|0
7486944|NCT04023994|25941195|P3|Overall Study|Lost to Follow-up|2
7486945|NCT04023994|25941196|P2|Overall Study|Lost to Follow-up|1
7486946|NCT04023994|25941197|P1|Overall Study|Lost to Follow-up|0
7486947|NCT04023682|25941277|P1|Overall Study|Clinical schedules did not allow continued participation|6
7486948|NCT04019054|25941449|P2|Overall Study|Withdrawal by Subject|1
7486949|NCT04019054|25941450|P1|Overall Study|Withdrawal by Subject|3
7486950|NCT04019054|25941449|P2|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
7486951|NCT04019054|25941450|P1|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
7486952|NCT04017611|25941599|P1|Overall Study|Withdrawn prior to completion|1
7486953|NCT04016311|25941661|P2|Overall Study|Withdrawal by Subject|0
7486954|NCT04016311|25941662|P1|Overall Study|Withdrawal by Subject|1
7486955|NCT04015232|25941745|P2|Overall Study|Medical Grounds|3
7486956|NCT04015232|25941746|P1|Overall Study|Medical Grounds|3
7486957|NCT04015232|25941745|P2|Overall Study|Protocol Violation|0
7486958|NCT04015232|25941746|P1|Overall Study|Protocol Violation|1
7486959|NCT04015232|25941745|P2|Overall Study|Withdrawal by Subject|4
7486960|NCT04015232|25941746|P1|Overall Study|Withdrawal by Subject|7
7486961|NCT04014062|25941818|P2|Period I: Dosing|Withdrawal by Subject|1
7486962|NCT04014062|25941819|P1|Period I: Dosing|Withdrawal by Subject|3
7486963|NCT04014062|25941818|P2|Period I: Dosing|Medical Grounds|5
7486964|NCT04014062|25941819|P1|Period I: Dosing|Medical Grounds|4
7486965|NCT04013191|25941876|P2|Overall Study|Adverse Event|0
7486966|NCT04013191|25941877|P1|Overall Study|Adverse Event|1
7486967|NCT04011735|25941927|P3|Overall Study|Met exclusion criteria after study entry|0
7486968|NCT04011735|25941928|P2|Overall Study|Met exclusion criteria after study entry|1
7486969|NCT04011735|25941929|P1|Overall Study|Met exclusion criteria after study entry|0
7486970|NCT04011735|25941927|P3|Overall Study|Withdrawal by Subject|1
7486971|NCT04011735|25941928|P2|Overall Study|Withdrawal by Subject|0
7486972|NCT04011735|25941929|P1|Overall Study|Withdrawal by Subject|1
7486973|NCT04009577|25942014|P4|Extension Phase|Not Treated|0
7486974|NCT04009577|25942015|P3|Extension Phase|Not Treated|2
7486975|NCT04009577|25942016|P2|Extension Phase|Not Treated|0
7486976|NCT04009577|25942017|P1|Extension Phase|Not Treated|0
7486977|NCT04009577|25942014|P4|Extension Phase|Withdrawal by Subject|0
7486978|NCT04009577|25942015|P3|Extension Phase|Withdrawal by Subject|1
7486979|NCT04009577|25942016|P2|Extension Phase|Withdrawal by Subject|0
7486980|NCT04009577|25942017|P1|Extension Phase|Withdrawal by Subject|0
7486981|NCT04009577|25942014|P4|Extension Phase|Inadequate therapeutic effect|0
7486982|NCT04009577|25942015|P3|Extension Phase|Inadequate therapeutic effect|1
7486983|NCT04009577|25942016|P2|Extension Phase|Inadequate therapeutic effect|0
7486984|NCT04009577|25942017|P1|Extension Phase|Inadequate therapeutic effect|0
7486985|NCT04009577|25942014|P4|Extension Phase|Adverse Event|1
7486986|NCT04009577|25942015|P3|Extension Phase|Adverse Event|0
7486987|NCT04009577|25942016|P2|Extension Phase|Adverse Event|0
7486988|NCT04009577|25942017|P1|Extension Phase|Adverse Event|0
7486989|NCT04009577|25942014|P4|Core Study|Other|1
7486990|NCT04009577|25942015|P3|Core Study|Other|0
7486991|NCT04009577|25942016|P2|Core Study|Other|0
7486992|NCT04009577|25942017|P1|Core Study|Other|0
7486993|NCT04009577|25942014|P4|Core Study|Withdrawal by Subject|0
7486994|NCT04009577|25942015|P3|Core Study|Withdrawal by Subject|2
7486995|NCT04009577|25942016|P2|Core Study|Withdrawal by Subject|0
7486996|NCT04009577|25942017|P1|Core Study|Withdrawal by Subject|0
7486997|NCT04009577|25942014|P4|Core Study|Adverse Event|4
7486998|NCT04009577|25942015|P3|Core Study|Adverse Event|2
7486999|NCT04009577|25942016|P2|Core Study|Adverse Event|0
7487000|NCT04009577|25942017|P1|Core Study|Adverse Event|1
7487001|NCT04007159|25942050|P1|Challenge Phase|missed study visits|3
7487002|NCT04007159|25942050|P1|Induction Phase|Adverse Event|2
7487003|NCT04007159|25942050|P1|Induction Phase|Withdrawal by Subject|4
7487004|NCT04007159|25942050|P1|Induction Phase|(missed study visits)|16
7487005|NCT04007107|25942065|P4|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7487006|NCT04007107|25942066|P3|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7487007|NCT04007107|25942067|P2|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
7487008|NCT04007107|25942068|P1|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7487009|NCT04006366|25942096|P1|Overall Study|Withdrawal by Subject|1
7487010|NCT04006145|25942104|P2|Overall Study|Other|2
7487011|NCT04006145|25942105|P1|Overall Study|Other|1
7487012|NCT04006145|25942104|P2|Overall Study|Lost to Follow-up|1
7487013|NCT04006145|25942105|P1|Overall Study|Lost to Follow-up|0
7487014|NCT04005885|25942111|P2|Second Intervention|Withdrawal by Subject|2
7487015|NCT04005885|25942112|P1|Second Intervention|Withdrawal by Subject|0
7487016|NCT04005885|25942111|P2|First Intervention|Withdrawal by Subject|1
7487017|NCT04005885|25942112|P1|First Intervention|Withdrawal by Subject|1
7487018|NCT04005755|25942156|P1|Overall Study|Lost to Follow-up|1
7487019|NCT04005755|25942156|P1|Overall Study|Withdrawal by Subject|3
7487020|NCT04005755|25942156|P1|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
7487021|NCT04005755|25942156|P1|Overall Study|Physician Decision|3
7487022|NCT04005755|25942156|P1|Overall Study|Adverse Event|6
7487023|NCT04004260|25942255|P2|Overall Study|Did not engage in intervention|17
7487024|NCT04004260|25942256|P1|Overall Study|Did not engage in intervention|13
7487025|NCT04004260|25942255|P2|Overall Study|Lost to Follow-up|12
7487026|NCT04004260|25942256|P1|Overall Study|Lost to Follow-up|22
7487027|NCT04004260|25942255|P2|Overall Study|Withdrawal by Subject|3
7487028|NCT04004260|25942256|P1|Overall Study|Withdrawal by Subject|7
7487029|NCT04002960|25942282|P1|Overall Study|Withdrawn prior to Completion|2
7487030|NCT04002648|25942299|P2|Overall Study|Lost to Follow-up|0
7487031|NCT04002648|25942300|P1|Overall Study|Lost to Follow-up|2
7487032|NCT04000815|25942311|P3|Overall Study|Hypertension occured on follow up|2
7487033|NCT04000815|25942312|P2|Overall Study|Hypertension occured on follow up|0
7487034|NCT04000815|25942313|P1|Overall Study|Hypertension occured on follow up|0
7487035|NCT04000815|25942311|P3|Overall Study|Right ovarian cyst occured|0
7487036|NCT04000815|25942312|P2|Overall Study|Right ovarian cyst occured|0
7487037|NCT04000815|25942313|P1|Overall Study|Right ovarian cyst occured|1
7487038|NCT04000815|25942311|P3|Overall Study|Withdrawal by Subject|2
7487039|NCT04000815|25942312|P2|Overall Study|Withdrawal by Subject|3
7487040|NCT04000815|25942313|P1|Overall Study|Withdrawal by Subject|4
7487041|NCT04000815|25942311|P3|Overall Study|Lost to Follow-up|3
7487042|NCT04000815|25942312|P2|Overall Study|Lost to Follow-up|2
7487043|NCT04000815|25942313|P1|Overall Study|Lost to Follow-up|9
7487044|NCT04000581|25942329|P2|Overall Study|Withdrawal by Subject|1
7487045|NCT04000581|25942330|P1|Overall Study|Withdrawal by Subject|0
7487046|NCT03997825|25942402|P1|Overall Study|Refused participation|1
7487047|NCT03997825|25942402|P1|Overall Study|Withdrawal by Subject|3
7487048|NCT03997825|25942402|P1|Overall Study|Lost to Follow-up|10
7487049|NCT03997825|25942402|P1|Overall Study|Death|3
7487050|NCT03996694|25942411|P6|Third Washout (7 Days)|Withdrawal by Subject|0
7487051|NCT03996694|25942412|P5|Third Washout (7 Days)|Withdrawal by Subject|1
7487052|NCT03996694|25942413|P4|Third Washout (7 Days)|Withdrawal by Subject|0
7487053|NCT03996694|25942414|P3|Third Washout (7 Days)|Withdrawal by Subject|0
7487054|NCT03996694|25942415|P2|Third Washout (7 Days)|Withdrawal by Subject|0
7487055|NCT03996694|25942416|P1|Third Washout (7 Days)|Withdrawal by Subject|0
7487056|NCT03996694|25942411|P6|First Washout (7 Days)|Lost to Follow-up|0
7487057|NCT03996694|25942412|P5|First Washout (7 Days)|Lost to Follow-up|0
7487058|NCT03996694|25942413|P4|First Washout (7 Days)|Lost to Follow-up|0
7487059|NCT03996694|25942414|P3|First Washout (7 Days)|Lost to Follow-up|1
7487060|NCT03996694|25942415|P2|First Washout (7 Days)|Lost to Follow-up|0
7487061|NCT03996694|25942416|P1|First Washout (7 Days)|Lost to Follow-up|0
7487062|NCT03996694|25942411|P6|First Washout (7 Days)|Adverse Event|0
7487063|NCT03996694|25942412|P5|First Washout (7 Days)|Adverse Event|0
7487064|NCT03996694|25942413|P4|First Washout (7 Days)|Adverse Event|0
7487065|NCT03996694|25942414|P3|First Washout (7 Days)|Adverse Event|0
7487066|NCT03996694|25942415|P2|First Washout (7 Days)|Adverse Event|1
7487067|NCT03996694|25942416|P1|First Washout (7 Days)|Adverse Event|0
7487068|NCT03996694|25942411|P6|First Washout (7 Days)|positive urine drug screen|0
7487069|NCT03996694|25942412|P5|First Washout (7 Days)|positive urine drug screen|0
7487070|NCT03996694|25942413|P4|First Washout (7 Days)|positive urine drug screen|0
7487071|NCT03996694|25942414|P3|First Washout (7 Days)|positive urine drug screen|1
7487072|NCT03996694|25942415|P2|First Washout (7 Days)|positive urine drug screen|0
7487073|NCT03996694|25942416|P1|First Washout (7 Days)|positive urine drug screen|0
7487074|NCT03995784|25942448|P1|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
7487075|NCT03993392|25942494|P1|Overall Study|Did not meet Day 1 check-in criteria|1
7487076|NCT03993392|25942494|P1|Overall Study|Lost to Follow-up|2
7487077|NCT03993392|25942494|P1|Overall Study|Withdrawal by Subject|3
7487078|NCT03993288|25942507|P2|Overall Study|Withdrawal by Subject|1
7487079|NCT03993288|25942508|P1|Overall Study|Withdrawal by Subject|1
7487080|NCT03993288|25942507|P2|Overall Study|Adverse Event|0
7487081|NCT03993288|25942508|P1|Overall Study|Adverse Event|1
7487082|NCT03993288|25942507|P2|Overall Study|did not follow the treatment regimen|0
7487083|NCT03993288|25942508|P1|Overall Study|did not follow the treatment regimen|1
7487084|NCT03993288|25942507|P2|Overall Study|did not follow the treatment schedule|0
7487085|NCT03993288|25942508|P1|Overall Study|did not follow the treatment schedule|1
7487086|NCT03993288|25942507|P2|Overall Study|consent withdrawal|0
7487087|NCT03993288|25942508|P1|Overall Study|consent withdrawal|1
7487088|NCT03993288|25942507|P2|Overall Study|developed SAE|0
7487089|NCT03993288|25942508|P1|Overall Study|developed SAE|2
7487090|NCT03993288|25942507|P2|Overall Study|prescribed with prohibited concomitant therapy|0
7487091|NCT03993288|25942508|P1|Overall Study|prescribed with prohibited concomitant therapy|1
7487092|NCT03993288|25942507|P2|Overall Study|improper enrollment|1
7487093|NCT03993288|25942508|P1|Overall Study|improper enrollment|0
7487094|NCT03993288|25942507|P2|Overall Study|wrong randomization|1
7487095|NCT03993288|25942508|P1|Overall Study|wrong randomization|0
7487096|NCT03993288|25942507|P2|Overall Study|non-compliance to the inclusion criteria|1
7487097|NCT03993288|25942508|P1|Overall Study|non-compliance to the inclusion criteria|0
7487098|NCT03993288|25942507|P2|Overall Study|Lost to Follow-up|1
7487099|NCT03993288|25942508|P1|Overall Study|Lost to Follow-up|2
7487100|NCT03991494|25942850|P1|Overall Study|Progressive Disease|4
7487101|NCT03990649|25942878|P3|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
7487102|NCT03990649|25942879|P2|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
7487103|NCT03990649|25942880|P1|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
7487104|NCT03990649|25942878|P3|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
7487105|NCT03990649|25942879|P2|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
7487106|NCT03990649|25942880|P1|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
7487107|NCT03990649|25942878|P3|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
7487108|NCT03990649|25942879|P2|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
7487109|NCT03990649|25942880|P1|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
7487110|NCT03990649|25942878|P3|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
7487111|NCT03990649|25942879|P2|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
7487112|NCT03990649|25942880|P1|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
7487113|NCT03990649|25942878|P3|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
7487114|NCT03990649|25942879|P2|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
7487115|NCT03990649|25942880|P1|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
7487116|NCT03990649|25942878|P3|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
7487117|NCT03990649|25942879|P2|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
7487118|NCT03990649|25942880|P1|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
7487119|NCT03990649|25942878|P3|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
7487120|NCT03990649|25942879|P2|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
7487121|NCT03990649|25942880|P1|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
7487122|NCT03988907|25942979|P2|Overall Study|Unable to complete visit|1
7487123|NCT03988907|25942980|P1|Overall Study|Unable to complete visit|0
7487124|NCT03988842|25943012|P1|Overall Study|Death|1
7487125|NCT03988803|25943027|P1|Period 2|Adverse Event|1
7487126|NCT03988803|25943027|P1|Period 2|Prematurely discontinued from medication|2
7487127|NCT03988088|25943089|P4|Open-Label Addendum|Lost to Follow-up|0
7487128|NCT03988088|25943090|P3|Open-Label Addendum|Lost to Follow-up|1
7487129|NCT03988088|25943091|P2|Open-Label Addendum|Lost to Follow-up|0
7487130|NCT03988088|25943092|P1|Open-Label Addendum|Lost to Follow-up|0
7487131|NCT03988088|25943089|P4|Single-Dose Pharmacokinetic Study|Adverse Event|0
7487132|NCT03988088|25943090|P3|Single-Dose Pharmacokinetic Study|Adverse Event|0
7487133|NCT03988088|25943091|P2|Single-Dose Pharmacokinetic Study|Adverse Event|1
7487134|NCT03988088|25943092|P1|Single-Dose Pharmacokinetic Study|Adverse Event|0
7487135|NCT03987932|25943114|P3|Overall Study|Non-study related elective surgery|1
7487136|NCT03987932|25943115|P2|Overall Study|Non-study related elective surgery|0
7487137|NCT03987932|25943116|P1|Overall Study|Non-study related elective surgery|0
7487138|NCT03987932|25943114|P3|Overall Study|Lost to Follow-up|1
7487139|NCT03987932|25943115|P2|Overall Study|Lost to Follow-up|1
7487140|NCT03987932|25943116|P1|Overall Study|Lost to Follow-up|2
7487141|NCT03987620|25943150|P2|Overall Study|Other|5
7487142|NCT03987620|25943151|P1|Overall Study|Other|2
7487143|NCT03987620|25943150|P2|Overall Study|Withdrawal by Subject|1
7487144|NCT03987620|25943151|P1|Overall Study|Withdrawal by Subject|7
7487145|NCT03987620|25943150|P2|Overall Study|Pregnancy|0
7487146|NCT03987620|25943151|P1|Overall Study|Pregnancy|1
7487147|NCT03987620|25943150|P2|Overall Study|Physician Decision|1
7487148|NCT03987620|25943151|P1|Overall Study|Physician Decision|0
7487149|NCT03987620|25943150|P2|Overall Study|Lost to Follow-up|2
7487150|NCT03987620|25943151|P1|Overall Study|Lost to Follow-up|1
7487151|NCT03987620|25943150|P2|Overall Study|Adverse Event|0
7487152|NCT03987620|25943151|P1|Overall Study|Adverse Event|3
7487153|NCT03987620|25943150|P2|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
7487154|NCT03987620|25943151|P1|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
7487155|NCT03987191|25943167|P2|Overall Study|COVID-19 related research disruption|2
7487156|NCT03987191|25943168|P1|Overall Study|COVID-19 related research disruption|0
7487157|NCT03987074|25943191|P5|Overall Study|Investigator's Discretion|0
7487158|NCT03987074|25943192|P4|Overall Study|Investigator's Discretion|1
7487159|NCT03987074|25943193|P3|Overall Study|Investigator's Discretion|0
7487160|NCT03987074|25943194|P2|Overall Study|Investigator's Discretion|0
7487161|NCT03987074|25943195|P1|Overall Study|Investigator's Discretion|0
7487162|NCT03987074|25943191|P5|Overall Study|Lost to Follow-up|0
7487163|NCT03987074|25943192|P4|Overall Study|Lost to Follow-up|1
7487164|NCT03987074|25943193|P3|Overall Study|Lost to Follow-up|1
7487165|NCT03987074|25943194|P2|Overall Study|Lost to Follow-up|0
7487166|NCT03987074|25943195|P1|Overall Study|Lost to Follow-up|0
7487167|NCT03987074|25943191|P5|Overall Study|Adverse Event|1
7487168|NCT03987074|25943192|P4|Overall Study|Adverse Event|0
7487169|NCT03987074|25943193|P3|Overall Study|Adverse Event|0
7487170|NCT03987074|25943194|P2|Overall Study|Adverse Event|1
7487171|NCT03987074|25943195|P1|Overall Study|Adverse Event|2
7487172|NCT03987074|25943191|P5|Overall Study|Withdrew Consent|1
7487173|NCT03987074|25943192|P4|Overall Study|Withdrew Consent|2
7487174|NCT03987074|25943193|P3|Overall Study|Withdrew Consent|0
7487175|NCT03987074|25943194|P2|Overall Study|Withdrew Consent|1
7487176|NCT03987074|25943195|P1|Overall Study|Withdrew Consent|1
7487177|NCT03984825|25943285|P1|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
7487178|NCT03984825|25943285|P1|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
7487179|NCT03984825|25943285|P1|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
7487191|NCT03983317|25943716|P1|Overall Study|Physician Decision|5
7487192|NCT03982433|25943723|P1|Overall Study|Lost to Follow-up|1
7487193|NCT03982069|25943738|P4|Overall Study|Specimen loss|1
7487194|NCT03982069|25943739|P3|Overall Study|Specimen loss|1
7487195|NCT03982069|25943740|P2|Overall Study|Specimen loss|3
7487196|NCT03982069|25943741|P1|Overall Study|Specimen loss|3
7487197|NCT03982069|25943738|P4|Overall Study|Withdrawal by Subject|2
7487198|NCT03982069|25943739|P3|Overall Study|Withdrawal by Subject|5
7487199|NCT03982069|25943740|P2|Overall Study|Withdrawal by Subject|1
7487200|NCT03982069|25943741|P1|Overall Study|Withdrawal by Subject|2
7487201|NCT03982069|25943738|P4|Overall Study|Physician Decision|0
7487202|NCT03982069|25943739|P3|Overall Study|Physician Decision|0
7487203|NCT03982069|25943740|P2|Overall Study|Physician Decision|1
7487204|NCT03982069|25943741|P1|Overall Study|Physician Decision|0
7487205|NCT03982069|25943738|P4|Overall Study|Lost to Follow-up|5
7487206|NCT03982069|25943739|P3|Overall Study|Lost to Follow-up|3
7487207|NCT03982069|25943740|P2|Overall Study|Lost to Follow-up|5
7487208|NCT03982069|25943741|P1|Overall Study|Lost to Follow-up|5
7487209|NCT03981861|25943778|P1|Overall Study|Withdrawal by Subject|3
7487210|NCT03981822|25943794|P8|Overall Study|COVID-19 Related|1
7487211|NCT03981822|25943795|P7|Overall Study|COVID-19 Related|2
7487212|NCT03981822|25943796|P6|Overall Study|COVID-19 Related|1
7487213|NCT03981822|25943797|P5|Overall Study|COVID-19 Related|2
7487214|NCT03981822|25943798|P4|Overall Study|COVID-19 Related|0
7487215|NCT03981822|25943799|P3|Overall Study|COVID-19 Related|0
7487216|NCT03981822|25943800|P2|Overall Study|COVID-19 Related|0
7487217|NCT03981822|25943801|P1|Overall Study|COVID-19 Related|0
7487218|NCT03981822|25943794|P8|Overall Study|Withdrawal by Subject|2
7487219|NCT03981822|25943795|P7|Overall Study|Withdrawal by Subject|0
7487220|NCT03981822|25943796|P6|Overall Study|Withdrawal by Subject|1
7487221|NCT03981822|25943797|P5|Overall Study|Withdrawal by Subject|0
7487222|NCT03981822|25943798|P4|Overall Study|Withdrawal by Subject|0
7487223|NCT03981822|25943799|P3|Overall Study|Withdrawal by Subject|0
7487224|NCT03981822|25943800|P2|Overall Study|Withdrawal by Subject|1
7487225|NCT03981822|25943801|P1|Overall Study|Withdrawal by Subject|0
7487226|NCT03981822|25943794|P8|Overall Study|Lost to Follow-up|2
7487227|NCT03981822|25943795|P7|Overall Study|Lost to Follow-up|4
7487228|NCT03981822|25943796|P6|Overall Study|Lost to Follow-up|4
7487229|NCT03981822|25943797|P5|Overall Study|Lost to Follow-up|6
7487230|NCT03981822|25943798|P4|Overall Study|Lost to Follow-up|0
7487231|NCT03981822|25943799|P3|Overall Study|Lost to Follow-up|1
7487232|NCT03981822|25943800|P2|Overall Study|Lost to Follow-up|1
7487233|NCT03981822|25943801|P1|Overall Study|Lost to Follow-up|0
7487234|NCT03980522|25943854|P5|Treatment Period|Adverse Event|0
7487235|NCT03980522|25943855|P4|Treatment Period|Adverse Event|0
7487236|NCT03980522|25943856|P3|Treatment Period|Adverse Event|0
7487237|NCT03980522|25943857|P2|Treatment Period|Adverse Event|0
7487238|NCT03980522|25943858|P1|Treatment Period|Adverse Event|1
7487239|NCT03979820|25943918|P4|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
7487240|NCT03979820|25943919|P3|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
7487241|NCT03979820|25943920|P2|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
7487242|NCT03979820|25943921|P1|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
7487243|NCT03979820|25943918|P4|Overall Study|Withdrawal by Subject|0
7487244|NCT03979820|25943919|P3|Overall Study|Withdrawal by Subject|1
7487245|NCT03979820|25943920|P2|Overall Study|Withdrawal by Subject|0
7487246|NCT03979820|25943921|P1|Overall Study|Withdrawal by Subject|0
7487247|NCT03979820|25943918|P4|Overall Study|Protocol Violation|0
7487248|NCT03979820|25943919|P3|Overall Study|Protocol Violation|0
7487249|NCT03979820|25943920|P2|Overall Study|Protocol Violation|0
7487250|NCT03979820|25943921|P1|Overall Study|Protocol Violation|1
7487251|NCT03979638|25943951|P2|Period 2|Study terminated by Sponsor|1
7487252|NCT03979638|25943952|P1|Period 2|Study terminated by Sponsor|1
7487253|NCT03979638|25943951|P2|Period 1|Protocol Violation|0
7487254|NCT03979638|25943952|P1|Period 1|Protocol Violation|1
7487255|NCT03979638|25943951|P2|Period 1|Study terminated by Sponsor|3
7487256|NCT03979638|25943952|P1|Period 1|Study terminated by Sponsor|1
7487257|NCT03979638|25943951|P2|Period 1|Withdrawal by Subject|3
7487258|NCT03979638|25943952|P1|Period 1|Withdrawal by Subject|4
7487259|NCT03979638|25943951|P2|Period 1|Physician Decision|1
7487260|NCT03979638|25943952|P1|Period 1|Physician Decision|1
7487261|NCT03979274|25943983|P2|Treatment Period 2|Withdrawal by Subject|1
7487262|NCT03979274|25943984|P1|Treatment Period 2|Withdrawal by Subject|0
7487263|NCT03978832|25944033|P1|Overall Study|did not pass screening criteria|44
7487264|NCT03978832|25944033|P1|Overall Study|Physician Decision|2
7487265|NCT03978832|25944033|P1|Overall Study|Withdrawal by Subject|6
7487266|NCT03978832|25944033|P1|Overall Study|Lost to Follow-up|1
7487267|NCT03978832|25944033|P1|Overall Study|Adverse Event|1
7487268|NCT03977727|25944090|P2|Second Treatment|Lost to Follow-up|3
7487269|NCT03977727|25944091|P1|Second Treatment|Lost to Follow-up|0
7487270|NCT03977155|25944138|P3|Overall Study|Participant was unable to come in for the Visit|0
7487271|NCT03977155|25944139|P2|Overall Study|Participant was unable to come in for the Visit|0
7487272|NCT03977155|25944140|P1|Overall Study|Participant was unable to come in for the Visit|1
7487273|NCT03977155|25944138|P3|Overall Study|Withdrawal by Subject|2
7487274|NCT03977155|25944139|P2|Overall Study|Withdrawal by Subject|1
7487275|NCT03977155|25944140|P1|Overall Study|Withdrawal by Subject|1
7487276|NCT03977155|25944138|P3|Overall Study|Lost to Follow-up|0
7487277|NCT03977155|25944139|P2|Overall Study|Lost to Follow-up|1
7487278|NCT03977155|25944140|P1|Overall Study|Lost to Follow-up|0
7487279|NCT03977155|25944138|P3|Overall Study|Adverse Event|0
7487280|NCT03977155|25944139|P2|Overall Study|Adverse Event|0
7487281|NCT03977155|25944140|P1|Overall Study|Adverse Event|3
7487282|NCT03976466|25944243|P2|Overall Study|Lost to Follow-up|3
7487283|NCT03976466|25944244|P1|Overall Study|Lost to Follow-up|1
7487284|NCT03974334|25944505|P1|Overall Study|Lost to Follow-up|1
7487285|NCT03972137|25944601|P1|Overall Study|Withdrawal by Subject|4
7487286|NCT03972137|25944601|P1|Overall Study|Lost to Follow-up|2
7487287|NCT03970824|25944634|P3|Overall Study|Adverse Event|0
7487288|NCT03970824|25944635|P2|Overall Study|Adverse Event|0
7487289|NCT03970824|25944636|P1|Overall Study|Adverse Event|1
7487290|NCT03970824|25944634|P3|Overall Study|Lost to Follow-up|1
7487291|NCT03970824|25944635|P2|Overall Study|Lost to Follow-up|2
7487292|NCT03970824|25944636|P1|Overall Study|Lost to Follow-up|0
7487293|NCT03970824|25944634|P3|Overall Study|Withdrawal by Subject|3
7487294|NCT03970824|25944635|P2|Overall Study|Withdrawal by Subject|1
7487295|NCT03970824|25944636|P1|Overall Study|Withdrawal by Subject|1
7487296|NCT03970733|25944659|P3|Overall Study|Other|0
7487297|NCT03970733|25944660|P2|Overall Study|Other|0
7487298|NCT03970733|25944661|P1|Overall Study|Other|1
7487299|NCT03970733|25944659|P3|Overall Study|Lost to Follow-up|1
7487300|NCT03970733|25944660|P2|Overall Study|Lost to Follow-up|1
7487301|NCT03970733|25944661|P1|Overall Study|Lost to Follow-up|2
7487302|NCT03970733|25944659|P3|Overall Study|e.g.: moved from study area|0
7487303|NCT03970733|25944660|P2|Overall Study|e.g.: moved from study area|0
7487304|NCT03970733|25944661|P1|Overall Study|e.g.: moved from study area|1
7487305|NCT03970733|25944659|P3|Overall Study|Withdrawal by Subject|1
7487306|NCT03970733|25944660|P2|Overall Study|Withdrawal by Subject|5
7487307|NCT03970733|25944661|P1|Overall Study|Withdrawal by Subject|0
7487308|NCT03970395|25944671|P2|Overall Study|Lost to Follow-up|8
7487309|NCT03970395|25944672|P1|Overall Study|Lost to Follow-up|4
7487310|NCT03970395|25944671|P2|Overall Study|Withdrawal by Subject|4
7487311|NCT03970395|25944672|P1|Overall Study|Withdrawal by Subject|3
7487312|NCT03968978|25944690|P2|Overall Study|Adverse Event|0
7487313|NCT03968978|25944691|P1|Overall Study|Adverse Event|1
7487314|NCT03967444|25944741|P2|Overall Study|Lost to Follow-up|2
7487315|NCT03967444|25944742|P1|Overall Study|Lost to Follow-up|1
7487316|NCT03966911|25944756|P2|Overall Study|Unable to complete study visits due to COVID-19|13
7487317|NCT03966911|25944757|P1|Overall Study|Unable to complete study visits due to COVID-19|0
7487318|NCT03966911|25944756|P2|Overall Study|Withdrawal by Subject|2
7487319|NCT03966911|25944757|P1|Overall Study|Withdrawal by Subject|8
7487320|NCT03966911|25944756|P2|Overall Study|Adverse Event|1
7487321|NCT03966911|25944757|P1|Overall Study|Adverse Event|1
7487322|NCT03966365|25944767|P2|Overall Study|Protocol Violation|0
7487323|NCT03966365|25944768|P1|Overall Study|Protocol Violation|1
7487324|NCT03965403|25944903|P1|Overall Study|Subject not meeting eligibility criteria|1
7487325|NCT03965351|25944916|P2|Second Intervention (4 Weeks)|Adverse Event|1
7487326|NCT03965351|25944917|P1|Second Intervention (4 Weeks)|Adverse Event|0
7487327|NCT03965351|25944916|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
7487328|NCT03965351|25944917|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
7487329|NCT03965052|25944935|P2|Overall Study|Protocol Violation|0
7487330|NCT03965052|25944936|P1|Overall Study|Protocol Violation|1
7487331|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|Other|1
7487332|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|Other|1
7487333|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|Other|1
7487334|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|Other|0
7487335|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|Other|1
7487336|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|Other|1
7487337|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7487338|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7487339|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7487340|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7487341|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7487342|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
7487343|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7487344|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7487345|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
7487346|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
7487347|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7487348|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
7487349|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7487350|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7487351|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7487352|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7487353|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7487354|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
7487355|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7487356|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7487357|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7487358|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
7487359|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7487360|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7487361|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7487362|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7487363|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7487364|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
7487365|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7487366|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
7487367|NCT03963401|25945539|P6|Extension Period (Week 17 - Week 52)|Adverse Event|3
7487368|NCT03963401|25945540|P5|Extension Period (Week 17 - Week 52)|Adverse Event|4
7487369|NCT03963401|25945541|P4|Extension Period (Week 17 - Week 52)|Adverse Event|0
7487370|NCT03963401|25945542|P3|Extension Period (Week 17 - Week 52)|Adverse Event|2
7487371|NCT03963401|25945543|P2|Extension Period (Week 17 - Week 52)|Adverse Event|3
7487372|NCT03963401|25945544|P1|Extension Period (Week 17 - Week 52)|Adverse Event|6
7487373|NCT03963401|25945539|P6|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7487374|NCT03963401|25945540|P5|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7487375|NCT03963401|25945541|P4|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7487376|NCT03963401|25945542|P3|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7487377|NCT03963401|25945543|P2|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
7487378|NCT03963401|25945544|P1|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7487379|NCT03963401|25945539|P6|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
7487380|NCT03963401|25945540|P5|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
7487381|NCT03963401|25945541|P4|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7487382|NCT03963401|25945542|P3|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7487383|NCT03963401|25945543|P2|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7487384|NCT03963401|25945544|P1|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
7487385|NCT03963401|25945539|P6|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7487386|NCT03963401|25945540|P5|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7487387|NCT03963401|25945541|P4|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
7487388|NCT03963401|25945542|P3|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
7487389|NCT03963401|25945543|P2|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7487390|NCT03963401|25945544|P1|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7487391|NCT03963401|25945539|P6|Initial Period (Day 1 - Week 16)|Adverse Event|2
7487392|NCT03963401|25945540|P5|Initial Period (Day 1 - Week 16)|Adverse Event|1
7487393|NCT03963401|25945541|P4|Initial Period (Day 1 - Week 16)|Adverse Event|0
7487394|NCT03963401|25945542|P3|Initial Period (Day 1 - Week 16)|Adverse Event|0
7487395|NCT03963401|25945543|P2|Initial Period (Day 1 - Week 16)|Adverse Event|2
7487396|NCT03963401|25945544|P1|Initial Period (Day 1 - Week 16)|Adverse Event|1
7487397|NCT03962790|25945728|P2|Period 1|Withdrawal by Subject|0
7487398|NCT03962790|25945729|P1|Period 1|Withdrawal by Subject|1
7487399|NCT03962790|25945728|P2|Period 1|No Longer Meets Eligibility Criteria|0
7487400|NCT03962790|25945729|P1|Period 1|No Longer Meets Eligibility Criteria|1
7487401|NCT03962790|25945728|P2|Period 1|Failed to meet all eligibility criteria|1
7487402|NCT03962790|25945729|P1|Period 1|Failed to meet all eligibility criteria|1
7487403|NCT03962790|25945728|P2|Period 1|Adverse Event|1
7487404|NCT03962790|25945729|P1|Period 1|Adverse Event|0
7487405|NCT03962738|25945745|P4|Overall Study|Lost to Follow-up|0
7487406|NCT03962738|25945746|P3|Overall Study|Lost to Follow-up|1
7487407|NCT03962738|25945747|P2|Overall Study|Lost to Follow-up|0
7487408|NCT03962738|25945748|P1|Overall Study|Lost to Follow-up|0
7487409|NCT03962738|25945745|P4|Overall Study|Withdrawal by Subject|0
7487410|NCT03962738|25945746|P3|Overall Study|Withdrawal by Subject|0
7487411|NCT03962738|25945747|P2|Overall Study|Withdrawal by Subject|0
7487412|NCT03962738|25945748|P1|Overall Study|Withdrawal by Subject|4
7487413|NCT03962738|25945745|P4|Overall Study|Protocol Deviation|1
7487414|NCT03962738|25945746|P3|Overall Study|Protocol Deviation|1
7487415|NCT03962738|25945747|P2|Overall Study|Protocol Deviation|0
7487416|NCT03962738|25945748|P1|Overall Study|Protocol Deviation|3
7487417|NCT03962101|25945849|P1|Overall Study|Not related to medical events|1
7487418|NCT03962101|25945849|P1|Overall Study|Physician Decision|2
7487419|NCT03962101|25945849|P1|Overall Study|Adverse Event|1
7487420|NCT03961308|25945859|P2|Overall Study|Adverse Event|1
7487421|NCT03961308|25945860|P1|Overall Study|Adverse Event|0
7487422|NCT03961308|25945859|P2|Overall Study|Lost to Follow-up|1
7487423|NCT03961308|25945860|P1|Overall Study|Lost to Follow-up|0
7487424|NCT03961308|25945859|P2|Overall Study|Other|0
7487425|NCT03961308|25945860|P1|Overall Study|Other|1
7487426|NCT03961308|25945859|P2|Overall Study|Withdrawal by Subject|0
7487427|NCT03961308|25945860|P1|Overall Study|Withdrawal by Subject|1
7487428|NCT03959137|25945993|P1|Overall Study|Protocol Violation|6
7487429|NCT03958955|25945997|P1|Overall Study|Adverse Event|1
7487430|NCT03958656|25946018|P4|Overall Study|Started anti-cancer treatment|0
7487431|NCT03958656|25946019|P3|Overall Study|Started anti-cancer treatment|1
7487432|NCT03958656|25946020|P2|Overall Study|Started anti-cancer treatment|0
7487433|NCT03958656|25946021|P1|Overall Study|Started anti-cancer treatment|0
7487434|NCT03958656|25946018|P4|Overall Study|No longer meets eligibility criteria|0
7487435|NCT03958656|25946019|P3|Overall Study|No longer meets eligibility criteria|1
7487436|NCT03958656|25946020|P2|Overall Study|No longer meets eligibility criteria|0
7487437|NCT03958656|25946021|P1|Overall Study|No longer meets eligibility criteria|0
7487438|NCT03958656|25946018|P4|Overall Study|Received anti-myeloma prescription (Rx)|0
7487439|NCT03958656|25946019|P3|Overall Study|Received anti-myeloma prescription (Rx)|0
7487440|NCT03958656|25946020|P2|Overall Study|Received anti-myeloma prescription (Rx)|1
7487441|NCT03958656|25946021|P1|Overall Study|Received anti-myeloma prescription (Rx)|0
7487442|NCT03958149|25946041|P2|Overall Study|Withdrawal by Subject|1
7487443|NCT03958149|25946042|P1|Overall Study|Withdrawal by Subject|0
7487444|NCT03956862|25946083|P2|Overall Study|Withdrawal by Subject|1
7487445|NCT03956862|25946084|P1|Overall Study|Withdrawal by Subject|1
7487446|NCT03956862|25946083|P2|Overall Study|Lost to Follow-up|1
7487447|NCT03956862|25946084|P1|Overall Study|Lost to Follow-up|1
7487448|NCT03956550|25946109|P3|Overall Study|Withdrawal by Subject|6
7487449|NCT03956550|25946110|P2|Overall Study|Withdrawal by Subject|5
7487450|NCT03956550|25946111|P1|Overall Study|Withdrawal by Subject|5
7487451|NCT03956550|25946109|P3|Overall Study|Adverse Event|0
7487452|NCT03956550|25946110|P2|Overall Study|Adverse Event|1
7487453|NCT03956550|25946111|P1|Overall Study|Adverse Event|0
7487454|NCT03956550|25946109|P3|Overall Study|Sponsor decision|64
7487455|NCT03956550|25946110|P2|Overall Study|Sponsor decision|66
7487456|NCT03956550|25946111|P1|Overall Study|Sponsor decision|65
7487457|NCT03956225|25946145|P2|Overall Study|Other Reasons|1
7487458|NCT03956225|25946146|P1|Overall Study|Other Reasons|2
7487459|NCT03956225|25946145|P2|Overall Study|Withdrawal by Subject|1
7487460|NCT03956225|25946146|P1|Overall Study|Withdrawal by Subject|2
7487461|NCT03956225|25946145|P2|Overall Study|Lost to Follow-up|1
7487462|NCT03956225|25946146|P1|Overall Study|Lost to Follow-up|0
7487463|NCT03956225|25946145|P2|Overall Study|Lack of Efficacy|1
7487464|NCT03956225|25946146|P1|Overall Study|Lack of Efficacy|1
7487465|NCT03954743|25946164|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7487466|NCT03954743|25946165|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7487467|NCT03954743|25946164|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
7487468|NCT03954743|25946165|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
7487469|NCT03954743|25946164|P2|Overall Study|Protocol Violation|0
7487470|NCT03954743|25946165|P1|Overall Study|Protocol Violation|1
7487471|NCT03954743|25946164|P2|Overall Study|Lost to Follow-up|4
7487472|NCT03954743|25946165|P1|Overall Study|Lost to Follow-up|6
7487473|NCT03954743|25946164|P2|Overall Study|Adverse Event|0
7487474|NCT03954743|25946165|P1|Overall Study|Adverse Event|1
7487475|NCT03954444|25946184|P3|Overall Study|Miscellaneous|1
7487476|NCT03954444|25946185|P2|Overall Study|Miscellaneous|2
7487477|NCT03954444|25946186|P1|Overall Study|Miscellaneous|3
7487478|NCT03954444|25946184|P3|Overall Study|Administrative reasons|1
7487479|NCT03954444|25946185|P2|Overall Study|Administrative reasons|0
7487480|NCT03954444|25946186|P1|Overall Study|Administrative reasons|0
7487481|NCT03954444|25946184|P3|Overall Study|Non-compliant with study drug application|0
7487482|NCT03954444|25946185|P2|Overall Study|Non-compliant with study drug application|2
7487483|NCT03954444|25946186|P1|Overall Study|Non-compliant with study drug application|2
7487484|NCT03954444|25946184|P3|Overall Study|Lost to Follow-up|1
7487485|NCT03954444|25946185|P2|Overall Study|Lost to Follow-up|0
7487486|NCT03954444|25946186|P1|Overall Study|Lost to Follow-up|1
7487487|NCT03954444|25946184|P3|Overall Study|Use of prohibited therapy|2
7487488|NCT03954444|25946185|P2|Overall Study|Use of prohibited therapy|1
7487489|NCT03954444|25946186|P1|Overall Study|Use of prohibited therapy|1
7487490|NCT03954444|25946184|P3|Overall Study|Protocol Violation|5
7487491|NCT03954444|25946185|P2|Overall Study|Protocol Violation|3
7487492|NCT03954444|25946186|P1|Overall Study|Protocol Violation|0
7487493|NCT03954444|25946184|P3|Overall Study|Adverse Event|2
7487494|NCT03954444|25946185|P2|Overall Study|Adverse Event|3
7487495|NCT03954444|25946186|P1|Overall Study|Adverse Event|1
7487496|NCT03954444|25946184|P3|Overall Study|Withdrawal by Subject|5
7487497|NCT03954444|25946185|P2|Overall Study|Withdrawal by Subject|5
7487498|NCT03954444|25946186|P1|Overall Study|Withdrawal by Subject|5
7487499|NCT03953820|25946263|P3|Two-Sequence, Two-Way Crossover|Physician Decision|0
7487500|NCT03953820|25946264|P2|Two-Sequence, Two-Way Crossover|Physician Decision|0
7487501|NCT03953820|25946265|P1|Two-Sequence, Two-Way Crossover|Physician Decision|1
7487502|NCT03953820|25946263|P3|Two-Sequence, Two-Way Crossover|Adverse Event|0
7487503|NCT03953820|25946264|P2|Two-Sequence, Two-Way Crossover|Adverse Event|0
7487504|NCT03953820|25946265|P1|Two-Sequence, Two-Way Crossover|Adverse Event|1
7487505|NCT03953183|25946281|P2|Overall Study|Withdrawal by Subject|1
7487506|NCT03953183|25946282|P1|Overall Study|Withdrawal by Subject|0
7487507|NCT03953183|25946281|P2|Overall Study|Physician Decision|1
7487508|NCT03953183|25946282|P1|Overall Study|Physician Decision|0
7487509|NCT03951805|25946322|P4|Overall Study|Adverse Event|0
7487510|NCT03951805|25946323|P3|Overall Study|Adverse Event|0
7487511|NCT03951805|25946324|P2|Overall Study|Adverse Event|0
7487512|NCT03951805|25946325|P1|Overall Study|Adverse Event|1
7487513|NCT03951766|25946367|P1|Follow-up Phase|Lost to Follow-up|10
7487514|NCT03951766|25946367|P1|Treatment Phase|Lost to Follow-up|1
7487515|NCT03950856|25946426|P4|Overall Study|Unable to phone|2
7487516|NCT03950856|25946427|P3|Overall Study|Unable to phone|7
7487517|NCT03950856|25946428|P2|Overall Study|Unable to phone|6
7487518|NCT03950856|25946429|P1|Overall Study|Unable to phone|7
7487519|NCT03950856|25946426|P4|Overall Study|Withdrawal by Subject|1
7487520|NCT03950856|25946427|P3|Overall Study|Withdrawal by Subject|3
7487521|NCT03950856|25946428|P2|Overall Study|Withdrawal by Subject|1
7487522|NCT03950856|25946429|P1|Overall Study|Withdrawal by Subject|4
7487523|NCT03950856|25946426|P4|Overall Study|Protocol Violation|1
7487524|NCT03950856|25946427|P3|Overall Study|Protocol Violation|0
7487525|NCT03950856|25946428|P2|Overall Study|Protocol Violation|0
7487526|NCT03950856|25946429|P1|Overall Study|Protocol Violation|2
7487527|NCT03950856|25946426|P4|Overall Study|Lost to Follow-up|2
7487528|NCT03950856|25946427|P3|Overall Study|Lost to Follow-up|8
7487529|NCT03950856|25946428|P2|Overall Study|Lost to Follow-up|6
7487530|NCT03950856|25946429|P1|Overall Study|Lost to Follow-up|5
7487531|NCT03950856|25946426|P4|Overall Study|Death|0
7487532|NCT03950856|25946427|P3|Overall Study|Death|0
7487533|NCT03950856|25946428|P2|Overall Study|Death|2
7487534|NCT03950856|25946429|P1|Overall Study|Death|1
7487535|NCT03950674|25946481|P2|Overall Study|Ongoing in Study|8
7487536|NCT03950674|25946482|P1|Overall Study|Ongoing in Study|22
7487537|NCT03950674|25946481|P2|Overall Study|Death|7
7487538|NCT03950674|25946482|P1|Overall Study|Death|3
7487539|NCT03950622|25946503|P2|Overall Study|Death|1
7487540|NCT03950622|25946504|P1|Overall Study|Death|1
7487541|NCT03950622|25946503|P2|Overall Study|Lost to Follow-up|5
7487542|NCT03950622|25946504|P1|Overall Study|Lost to Follow-up|5
7487543|NCT03950622|25946503|P2|Overall Study|Physician Decision|0
7487544|NCT03950622|25946504|P1|Overall Study|Physician Decision|1
7487545|NCT03950622|25946503|P2|Overall Study|Protocol Deviation|1
7487546|NCT03950622|25946504|P1|Overall Study|Protocol Deviation|0
7487547|NCT03950622|25946503|P2|Overall Study|Withdrawal by Subject|0
7487548|NCT03950622|25946504|P1|Overall Study|Withdrawal by Subject|1
7487549|NCT03948581|25946581|P2|Overall Study|Lost to Follow-up|1
7487550|NCT03948581|25946582|P1|Overall Study|Lost to Follow-up|0
7487551|NCT03948334|25946622|P2|Overall Study|Subject Decision /Guardian Decision|7
7487552|NCT03948334|25946623|P1|Overall Study|Subject Decision /Guardian Decision|4
7487553|NCT03948334|25946622|P2|Overall Study|Study terminated by Sponsor|51
7487554|NCT03948334|25946623|P1|Overall Study|Study terminated by Sponsor|50
7487555|NCT03948334|25946622|P2|Overall Study|Protocol Deviation|0
7487556|NCT03948334|25946623|P1|Overall Study|Protocol Deviation|1
7487557|NCT03948334|25946622|P2|Overall Study|Pregnancy|1
7487558|NCT03948334|25946623|P1|Overall Study|Pregnancy|0
7487559|NCT03948334|25946622|P2|Overall Study|Physician Decision|0
7487560|NCT03948334|25946623|P1|Overall Study|Physician Decision|1
7487561|NCT03948334|25946622|P2|Overall Study|Lost to Follow-up|0
7487562|NCT03948334|25946623|P1|Overall Study|Lost to Follow-up|1
7487563|NCT03948334|25946622|P2|Overall Study|Lack of Efficacy|0
7487564|NCT03948334|25946623|P1|Overall Study|Lack of Efficacy|2
7487565|NCT03948334|25946622|P2|Overall Study|Adverse Event|4
7487566|NCT03948334|25946623|P1|Overall Study|Adverse Event|1
7487567|NCT03946124|25946708|P1|Overall Study|Withdrawal by Subject|19
7487572|NCT03944707|25946771|P2|Overall Study|Subject decision|1
7487573|NCT03944707|25946772|P1|Overall Study|Subject decision|0
7487574|NCT03944707|25946771|P2|Overall Study|Study terminated by sponsor|7
7487575|NCT03944707|25946772|P1|Overall Study|Study terminated by sponsor|12
7487576|NCT03944707|25946771|P2|Overall Study|Adverse Event|2
7487577|NCT03944707|25946772|P1|Overall Study|Adverse Event|0
7487578|NCT03943290|25946810|P9|Overall Study|Withdrawal by Subject|0
7487579|NCT03943290|25946811|P8|Overall Study|Withdrawal by Subject|0
7487580|NCT03943290|25946812|P7|Overall Study|Withdrawal by Subject|0
7487581|NCT03943290|25946813|P6|Overall Study|Withdrawal by Subject|0
7487582|NCT03943290|25946814|P5|Overall Study|Withdrawal by Subject|0
7487583|NCT03943290|25946815|P4|Overall Study|Withdrawal by Subject|0
7487584|NCT03943290|25946816|P3|Overall Study|Withdrawal by Subject|1
7487585|NCT03943290|25946817|P2|Overall Study|Withdrawal by Subject|0
7487586|NCT03943290|25946818|P1|Overall Study|Withdrawal by Subject|0
7487587|NCT03943290|25946810|P9|Overall Study|Lost to Follow-up|0
7487588|NCT03943290|25946811|P8|Overall Study|Lost to Follow-up|1
7487589|NCT03943290|25946812|P7|Overall Study|Lost to Follow-up|0
7487590|NCT03943290|25946813|P6|Overall Study|Lost to Follow-up|0
7487591|NCT03943290|25946814|P5|Overall Study|Lost to Follow-up|0
7487592|NCT03943290|25946815|P4|Overall Study|Lost to Follow-up|0
7487593|NCT03943290|25946816|P3|Overall Study|Lost to Follow-up|1
7487594|NCT03943290|25946817|P2|Overall Study|Lost to Follow-up|0
7487595|NCT03943290|25946818|P1|Overall Study|Lost to Follow-up|1
7487596|NCT03943290|25946810|P9|Overall Study|Sponsor Terminated Study|8
7487597|NCT03943290|25946811|P8|Overall Study|Sponsor Terminated Study|7
7487598|NCT03943290|25946812|P7|Overall Study|Sponsor Terminated Study|6
7487599|NCT03943290|25946813|P6|Overall Study|Sponsor Terminated Study|6
7487600|NCT03943290|25946814|P5|Overall Study|Sponsor Terminated Study|7
7487601|NCT03943290|25946815|P4|Overall Study|Sponsor Terminated Study|6
7487602|NCT03943290|25946816|P3|Overall Study|Sponsor Terminated Study|11
7487603|NCT03943290|25946817|P2|Overall Study|Sponsor Terminated Study|1
7487604|NCT03943290|25946818|P1|Overall Study|Sponsor Terminated Study|6
7487605|NCT03943095|25946902|P2|Overall Study|Withdrawal by Subject|0
7487606|NCT03943095|25946903|P1|Overall Study|Withdrawal by Subject|1
7487607|NCT03943095|25946902|P2|Overall Study|Incorrectly dispensed wrong box kit|1
7487608|NCT03943095|25946903|P1|Overall Study|Incorrectly dispensed wrong box kit|0
7487609|NCT03942042|25946949|P2|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
7487610|NCT03942042|25946950|P1|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
7487611|NCT03942042|25946949|P2|Induction Dosing Period (12 Weeks)|Adverse Event|1
7487612|NCT03942042|25946950|P1|Induction Dosing Period (12 Weeks)|Adverse Event|0
7487613|NCT03937778|25947047|P1|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
7487614|NCT03937778|25947047|P1|Overall Study|Withdrawal by Subject|1
7487615|NCT03937479|25947059|P5|Overall Study|Physician Decision|1
7487616|NCT03937479|25947060|P4|Overall Study|Physician Decision|0
7487617|NCT03937479|25947061|P3|Overall Study|Physician Decision|1
7487618|NCT03937479|25947062|P2|Overall Study|Physician Decision|0
7487619|NCT03937479|25947063|P1|Overall Study|Physician Decision|0
7487620|NCT03937479|25947059|P5|Overall Study|Lost to Follow-up|0
7487621|NCT03937479|25947060|P4|Overall Study|Lost to Follow-up|1
7487622|NCT03937479|25947061|P3|Overall Study|Lost to Follow-up|0
7487623|NCT03937479|25947062|P2|Overall Study|Lost to Follow-up|1
7487624|NCT03937479|25947063|P1|Overall Study|Lost to Follow-up|0
7487625|NCT03937479|25947059|P5|Overall Study|Protocol Violation|2
7487626|NCT03937479|25947060|P4|Overall Study|Protocol Violation|3
7487627|NCT03937479|25947061|P3|Overall Study|Protocol Violation|4
7487628|NCT03937479|25947062|P2|Overall Study|Protocol Violation|6
7487629|NCT03937479|25947063|P1|Overall Study|Protocol Violation|5
7487630|NCT03937479|25947059|P5|Overall Study|Withdrawal by Subject|1
7487631|NCT03937479|25947060|P4|Overall Study|Withdrawal by Subject|2
7487632|NCT03937479|25947061|P3|Overall Study|Withdrawal by Subject|2
7487633|NCT03937479|25947062|P2|Overall Study|Withdrawal by Subject|5
7487634|NCT03937479|25947063|P1|Overall Study|Withdrawal by Subject|3
7487635|NCT03937479|25947059|P5|Overall Study|Adverse Event|1
7487636|NCT03937479|25947060|P4|Overall Study|Adverse Event|0
7487637|NCT03937479|25947061|P3|Overall Study|Adverse Event|0
7487638|NCT03937479|25947062|P2|Overall Study|Adverse Event|3
7487639|NCT03937479|25947063|P1|Overall Study|Adverse Event|2
7487640|NCT03936244|25947171|P2|Overall Study|Physician Decision|3
7487641|NCT03936244|25947172|P1|Overall Study|Physician Decision|7
7487642|NCT03936244|25947171|P2|Overall Study|Lost to Follow-up|1
7487643|NCT03936244|25947172|P1|Overall Study|Lost to Follow-up|5
7487644|NCT03935126|25947259|P1|Overall Study|Study termination by sponsor|3
7487645|NCT03933462|25947543|P2|Overall Study|Adverse Event|0
7487646|NCT03933462|25947544|P1|Overall Study|Adverse Event|2
7487647|NCT03933449|25947568|P2|Overall Study|Ongoing in Study|6
7487648|NCT03933449|25947569|P1|Overall Study|Ongoing in Study|20
7487649|NCT03933449|25947568|P2|Overall Study|Death|51
7487650|NCT03933449|25947569|P1|Overall Study|Death|36
7487651|NCT03933449|25947568|P2|Overall Study|Adverse Event|4
7487652|NCT03933449|25947569|P1|Overall Study|Adverse Event|6
7487653|NCT03931785|25947595|P4|Overall Study|Pregnancy|1
7487654|NCT03931785|25947596|P3|Overall Study|Pregnancy|0
7487655|NCT03931785|25947597|P2|Overall Study|Pregnancy|0
7487656|NCT03931785|25947598|P1|Overall Study|Pregnancy|0
7487657|NCT03931785|25947595|P4|Overall Study|Withdrawal by Subject|1
7487658|NCT03931785|25947596|P3|Overall Study|Withdrawal by Subject|4
7487659|NCT03931785|25947597|P2|Overall Study|Withdrawal by Subject|2
7487660|NCT03931785|25947598|P1|Overall Study|Withdrawal by Subject|0
7487661|NCT03931785|25947595|P4|Overall Study|Other Not specified|2
7487662|NCT03931785|25947596|P3|Overall Study|Other Not specified|2
7487663|NCT03931785|25947597|P2|Overall Study|Other Not specified|2
7487664|NCT03931785|25947598|P1|Overall Study|Other Not specified|0
7487665|NCT03931785|25947595|P4|Overall Study|Noncompliance With Study drug|0
7487666|NCT03931785|25947596|P3|Overall Study|Noncompliance With Study drug|0
7487667|NCT03931785|25947597|P2|Overall Study|Noncompliance With Study drug|1
7487668|NCT03931785|25947598|P1|Overall Study|Noncompliance With Study drug|0
7487669|NCT03931785|25947595|P4|Overall Study|Protocol Violation|0
7487670|NCT03931785|25947596|P3|Overall Study|Protocol Violation|0
7487671|NCT03931785|25947597|P2|Overall Study|Protocol Violation|1
7487672|NCT03931785|25947598|P1|Overall Study|Protocol Violation|0
7487673|NCT03931785|25947595|P4|Overall Study|Adverse Event|4
7487674|NCT03931785|25947596|P3|Overall Study|Adverse Event|3
7487675|NCT03931785|25947597|P2|Overall Study|Adverse Event|0
7487676|NCT03931785|25947598|P1|Overall Study|Adverse Event|1
7487677|NCT03931785|25947595|P4|Overall Study|Lost to Follow-up|3
7487678|NCT03931785|25947596|P3|Overall Study|Lost to Follow-up|4
7487679|NCT03931785|25947597|P2|Overall Study|Lost to Follow-up|1
7487680|NCT03931785|25947598|P1|Overall Study|Lost to Follow-up|4
7487681|NCT03931330|25947612|P1|Overall Study|Physician Decision|1
7487682|NCT03927950|25947725|P1|Overall Study|Adverse Event|9
7487683|NCT03927846|25947732|P2|Overall Study|Lost to Follow-up|11
7487684|NCT03927846|25947733|P1|Overall Study|Lost to Follow-up|10
7487685|NCT03927105|25947777|P1|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
7487686|NCT03927105|25947777|P1|Overall Study|In observation for potential re-treatment|2
7487687|NCT03927105|25947777|P1|Overall Study|Death|1
7487688|NCT03923933|25947836|P2|Overall Study|Withdrawal by Subject|1
7487689|NCT03923933|25947837|P1|Overall Study|Withdrawal by Subject|0
7487690|NCT03923933|25947836|P2|Overall Study|Lost to Follow-up|0
7487691|NCT03923933|25947837|P1|Overall Study|Lost to Follow-up|1
7487692|NCT03923530|25947855|P1|Overall Study|screen failure|3
7487693|NCT03923530|25947855|P1|Overall Study|Withdrawal by Subject|1
7487694|NCT03922750|25947868|P3|Overall Study|Adverse Event|0
7487695|NCT03922750|25947869|P2|Overall Study|Adverse Event|1
7487696|NCT03922750|25947870|P1|Overall Study|Adverse Event|0
7487697|NCT03922750|25947868|P3|Overall Study|Unclassified|1
7487698|NCT03922750|25947869|P2|Overall Study|Unclassified|0
7487699|NCT03922750|25947870|P1|Overall Study|Unclassified|0
7487700|NCT03921723|25947902|P1|Period 3 (4 Days)|Withdrawal by Subject|1
7487701|NCT03921723|25947902|P1|Period 2 (4 Days)|Withdrawal by Subject|3
7487702|NCT03920670|25948070|P2|Overall Study|Adverse Event|0
7487703|NCT03920670|25948071|P1|Overall Study|Adverse Event|1
7487704|NCT03920670|25948070|P2|Overall Study|Protocol Violation|2
7487705|NCT03920670|25948071|P1|Overall Study|Protocol Violation|2
7487706|NCT03918239|25948121|P2|Overall Study|positive urine drug screening results|1
7487707|NCT03918239|25948122|P1|Overall Study|positive urine drug screening results|4
7487708|NCT03918239|25948121|P2|Overall Study|Withdrawal by Subject|3
7487709|NCT03918239|25948122|P1|Overall Study|Withdrawal by Subject|3
7487710|NCT03918239|25948121|P2|Overall Study|Pregnancy|2
7487711|NCT03918239|25948122|P1|Overall Study|Pregnancy|0
7487712|NCT03918239|25948121|P2|Overall Study|Lost to Follow-up|1
7487713|NCT03918239|25948122|P1|Overall Study|Lost to Follow-up|3
7487714|NCT03917823|25948148|P2|Overall Study|Withdrawal by Subject|1
7487715|NCT03917823|25948149|P1|Overall Study|Withdrawal by Subject|0
7487716|NCT03917823|25948148|P2|Overall Study|Lost to Follow-up|1
7487717|NCT03917823|25948149|P1|Overall Study|Lost to Follow-up|1
7487718|NCT03914950|25948163|P1|Overall Study|Physician Decision|54
7487719|NCT03914417|25948173|P1|Overall Study|Withdrawal by Subject|2
7487720|NCT03913377|25948180|P3|Period 1|No Longer Meets Eligibility Criteria|1
7487721|NCT03913377|25948181|P2|Period 1|No Longer Meets Eligibility Criteria|0
7487722|NCT03913377|25948182|P1|Period 1|No Longer Meets Eligibility Criteria|0
7487723|NCT03913377|25948180|P3|Period 1|Test Article no longer available|0
7487724|NCT03913377|25948181|P2|Period 1|Test Article no longer available|1
7487725|NCT03913377|25948182|P1|Period 1|Test Article no longer available|0
7487726|NCT03912259|25948199|P2|Overall Study|Withdrawal by Subject|1
7487727|NCT03912259|25948200|P1|Overall Study|Withdrawal by Subject|11
7487728|NCT03912259|25948199|P2|Overall Study|Lack of Efficacy|1
7487729|NCT03912259|25948200|P1|Overall Study|Lack of Efficacy|4
7487730|NCT03912259|25948199|P2|Overall Study|Adverse Event (AE)|4
7487731|NCT03912259|25948200|P1|Overall Study|Adverse Event (AE)|2
7487732|NCT03911960|25948258|P2|Overall Study|Lost to Follow-up|3
7487733|NCT03911960|25948259|P1|Overall Study|Lost to Follow-up|5
7487734|NCT03911843|25948280|P2|Overall Study|Lost to Follow-up|1
7487735|NCT03911843|25948281|P1|Overall Study|Lost to Follow-up|0
7487736|NCT03911843|25948280|P2|Overall Study|Protocol Violation|0
7487737|NCT03911843|25948281|P1|Overall Study|Protocol Violation|2
7487738|NCT03911843|25948280|P2|Overall Study|Adverse Event|0
7487739|NCT03911843|25948281|P1|Overall Study|Adverse Event|2
7487740|NCT03911401|25948316|P3|Overall Study|Withdrawal by parent/guardian|11
7487741|NCT03911401|25948317|P2|Overall Study|Withdrawal by parent/guardian|4
7487742|NCT03911401|25948318|P1|Overall Study|Withdrawal by parent/guardian|4
7487743|NCT03911401|25948316|P3|Overall Study|Withdrawal by Subject|0
7487744|NCT03911401|25948317|P2|Overall Study|Withdrawal by Subject|2
7487745|NCT03911401|25948318|P1|Overall Study|Withdrawal by Subject|1
7487746|NCT03911401|25948316|P3|Overall Study|Physician Decision|1
7487747|NCT03911401|25948317|P2|Overall Study|Physician Decision|0
7487748|NCT03911401|25948318|P1|Overall Study|Physician Decision|0
7487749|NCT03911401|25948316|P3|Overall Study|Lack of Efficacy|8
7487750|NCT03911401|25948317|P2|Overall Study|Lack of Efficacy|1
7487751|NCT03911401|25948318|P1|Overall Study|Lack of Efficacy|1
7487752|NCT03911401|25948316|P3|Overall Study|Adverse Event|5
7487753|NCT03911401|25948317|P2|Overall Study|Adverse Event|2
7487754|NCT03911401|25948318|P1|Overall Study|Adverse Event|1
7487755|NCT03909295|25948355|P1|Overall Study|Study terminated by sponsor|50
7487756|NCT03909295|25948355|P1|Overall Study|Adverse Event|2
7487757|NCT03909100|25948378|P1|Overall Study|Reason not Specified|4
7487758|NCT03909100|25948378|P1|Overall Study|Lost to Follow-up|1
7487759|NCT03909100|25948378|P1|Overall Study|Withdrawal by Subject|4
7487760|NCT03909100|25948378|P1|Overall Study|Technical Problems|4
7487761|NCT03909100|25948378|P1|Overall Study|Protocol Deviation|2
7487762|NCT03908970|25948416|P2|Overall Study|Withdrawal by Subject|22
7487763|NCT03908970|25948417|P1|Overall Study|Withdrawal by Subject|9
7487764|NCT03908970|25948416|P2|Overall Study|Physician Decision|4
7487765|NCT03908970|25948417|P1|Overall Study|Physician Decision|1
7487766|NCT03908970|25948416|P2|Overall Study|Adverse Event|21
7487767|NCT03908970|25948417|P1|Overall Study|Adverse Event|7
7487768|NCT03907072|25948578|P3|Overall Study|Study Terminated by Sponsor|2
7487769|NCT03907072|25948579|P2|Overall Study|Study Terminated by Sponsor|2
7487770|NCT03907072|25948580|P1|Overall Study|Study Terminated by Sponsor|2
7487772|NCT03905642|25948673|P1|Overall Study|Completed study but not 24 of 28 days|2
7487773|NCT03905642|25948673|P1|Overall Study|Lack of Efficacy|1
7487774|NCT03905642|25948673|P1|Overall Study|Adverse Event|1
7487775|NCT03905642|25948673|P1|Overall Study|Pregnancy|1
7487776|NCT03905642|25948673|P1|Overall Study|Withdrawal by Subject|3
7487777|NCT03905096|25948684|P2|Period 2 for Trial Part 1 and 2|Adverse Event|0
7487778|NCT03905096|25948685|P1|Period 2 for Trial Part 1 and 2|Adverse Event|1
7487779|NCT03904420|25948707|P2|Overall Study|Study terminated|2
7487780|NCT03904420|25948708|P1|Overall Study|Study terminated|2
7487781|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Other|0
7487782|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Other|0
7487783|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Other|0
7487784|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Other|0
7487785|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Other|0
7487786|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Other|0
7487787|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Other|1
7487788|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Other|1
7487789|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487790|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487791|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
7487792|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487793|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487794|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487795|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487796|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7487797|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7487798|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7487799|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7487800|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7487801|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7487802|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7487803|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
7487804|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7487805|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Pregnancy|0
7487806|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Pregnancy|0
7487807|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Pregnancy|0
7487808|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Pregnancy|1
7487809|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Pregnancy|1
7487810|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Pregnancy|0
7487811|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Pregnancy|0
7487812|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Pregnancy|0
7487813|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Lost to Follow-up|3
7487814|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Lost to Follow-up|1
7487815|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7487816|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7487817|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7487818|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7487819|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7487820|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Lost to Follow-up|2
7487821|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487822|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487823|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487824|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Lack of Efficacy|1
7487825|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487826|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487827|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487828|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7487829|NCT03903822|25948722|P8|Follow up Phase (4 Weeks)|Adverse Event|0
7487830|NCT03903822|25948723|P7|Follow up Phase (4 Weeks)|Adverse Event|1
7487831|NCT03903822|25948724|P6|Follow up Phase (4 Weeks)|Adverse Event|5
7487832|NCT03903822|25948725|P5|Follow up Phase (4 Weeks)|Adverse Event|0
7487833|NCT03903822|25948726|P4|Follow up Phase (4 Weeks)|Adverse Event|1
7487834|NCT03903822|25948727|P3|Follow up Phase (4 Weeks)|Adverse Event|1
7487835|NCT03903822|25948728|P2|Follow up Phase (4 Weeks)|Adverse Event|2
7487836|NCT03903822|25948729|P1|Follow up Phase (4 Weeks)|Adverse Event|3
7487837|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Other|0
7487838|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Other|0
7487839|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Other|1
7487840|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Other|1
7487841|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Other|0
7487842|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Other|0
7487843|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Other|1
7487844|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Other|2
7487845|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7487846|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7487847|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Refused Further Treatment|1
7487848|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7487849|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7487850|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7487851|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7487852|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Refused Further Treatment|2
7487853|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
7487854|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
7487855|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7487856|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
7487857|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7487858|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7487859|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
7487860|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7487861|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Protocol Violation|0
7487862|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Protocol Violation|0
7487863|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Protocol Violation|0
7487864|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Protocol Violation|0
7487865|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Protocol Violation|1
7487866|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Protocol Violation|0
7487867|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Protocol Violation|0
7487868|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Protocol Violation|0
7487869|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Pregnancy|0
7487870|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Pregnancy|0
7487871|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Pregnancy|0
7487872|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Pregnancy|1
7487873|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Pregnancy|1
7487874|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Pregnancy|0
7487875|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Pregnancy|0
7487876|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Pregnancy|0
7487877|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Physician Decision|0
7487878|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Physician Decision|0
7487879|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Physician Decision|0
7487880|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Physician Decision|0
7487881|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Physician Decision|0
7487882|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Physician Decision|0
7487883|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Physician Decision|2
7487884|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Physician Decision|0
7487885|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Lost to Follow-up|1
7487886|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Lost to Follow-up|1
7487887|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7487888|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7487889|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7487890|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7487891|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7487892|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7487893|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7487894|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7487895|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Lack of Efficacy|1
7487896|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Lack of Efficacy|1
7487897|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7487898|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7487899|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7487900|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7487901|NCT03903822|25948722|P8|Treatment Phase (6 Weeks)|Adverse Event|0
7487902|NCT03903822|25948723|P7|Treatment Phase (6 Weeks)|Adverse Event|1
7487903|NCT03903822|25948724|P6|Treatment Phase (6 Weeks)|Adverse Event|6
7487904|NCT03903822|25948725|P5|Treatment Phase (6 Weeks)|Adverse Event|1
7487905|NCT03903822|25948726|P4|Treatment Phase (6 Weeks)|Adverse Event|1
7487906|NCT03903822|25948727|P3|Treatment Phase (6 Weeks)|Adverse Event|1
7487907|NCT03903822|25948728|P2|Treatment Phase (6 Weeks)|Adverse Event|3
7487908|NCT03903822|25948729|P1|Treatment Phase (6 Weeks)|Adverse Event|3
7487909|NCT03903159|25948955|P1|Overall Study|Discharged Against Staff Advice|1
7487910|NCT03903159|25948955|P1|Overall Study|Discharged at Staff Request|2
7487911|NCT03903159|25948955|P1|Overall Study|Discharged with Staff Approval|2
7487912|NCT03902613|25948962|P1|Overall Study|Physician Decision|1
7487913|NCT03902574|25948969|P3|Overall Study|Urinary drug test was positive on Day 20|1
7487914|NCT03902574|25948970|P2|Overall Study|Urinary drug test was positive on Day 20|0
7487915|NCT03902574|25948971|P1|Overall Study|Urinary drug test was positive on Day 20|0
7487916|NCT03902392|25948984|P2|Overall Study|Lost to Follow-up|7
7487917|NCT03902392|25948985|P1|Overall Study|Lost to Follow-up|7
7487918|NCT03900728|25949044|P3|Overall Study|No text responses|4
7487919|NCT03900728|25949045|P2|Overall Study|No text responses|0
7487920|NCT03900728|25949046|P1|Overall Study|No text responses|0
7487921|NCT03899064|25949067|P1|Overall Study|Other|2
7487922|NCT03899064|25949067|P1|Overall Study|Withdrawal by Subject|2
7487923|NCT03899064|25949067|P1|Overall Study|Protocol Violation|2
7487924|NCT03899064|25949067|P1|Overall Study|Lost to Follow-up|1
7487925|NCT03898063|25949084|P2|Overall Study|Withdrawal by Subject|8
7487926|NCT03898063|25949085|P1|Overall Study|Withdrawal by Subject|10
7487927|NCT03897179|25949101|P1|Overall Study|Withdrawal by Subject|1
7487928|NCT03896022|25949119|P3|Overall Study|Did not have procedure|0
7487929|NCT03896022|25949120|P2|Overall Study|Did not have procedure|0
7487930|NCT03896022|25949121|P1|Overall Study|Did not have procedure|3
7487931|NCT03896022|25949119|P3|Overall Study|Withdrawal by Subject|0
7487932|NCT03896022|25949120|P2|Overall Study|Withdrawal by Subject|0
7487933|NCT03896022|25949121|P1|Overall Study|Withdrawal by Subject|1
7487934|NCT03895372|25949164|P8|Extension Treatment Period|Withdrawal by Subject|1
7487935|NCT03895372|25949165|P7|Extension Treatment Period|Withdrawal by Subject|1
7487936|NCT03895372|25949166|P6|Extension Treatment Period|Withdrawal by Subject|1
7487937|NCT03895372|25949167|P5|Extension Treatment Period|Withdrawal by Subject|1
7487938|NCT03895372|25949168|P4|Extension Treatment Period|Withdrawal by Subject|0
7487939|NCT03895372|25949169|P3|Extension Treatment Period|Withdrawal by Subject|0
7487940|NCT03895372|25949170|P2|Extension Treatment Period|Withdrawal by Subject|1
7487941|NCT03895372|25949171|P1|Extension Treatment Period|Withdrawal by Subject|2
7487942|NCT03895372|25949164|P8|Extension Treatment Period|Pregnancy|0
7487943|NCT03895372|25949165|P7|Extension Treatment Period|Pregnancy|0
7487944|NCT03895372|25949166|P6|Extension Treatment Period|Pregnancy|0
7487945|NCT03895372|25949167|P5|Extension Treatment Period|Pregnancy|1
7487946|NCT03895372|25949168|P4|Extension Treatment Period|Pregnancy|0
7487947|NCT03895372|25949169|P3|Extension Treatment Period|Pregnancy|0
7487948|NCT03895372|25949170|P2|Extension Treatment Period|Pregnancy|0
7487949|NCT03895372|25949171|P1|Extension Treatment Period|Pregnancy|0
7487950|NCT03895372|25949164|P8|Extension Treatment Period|Other|2
7487951|NCT03895372|25949165|P7|Extension Treatment Period|Other|0
7487952|NCT03895372|25949166|P6|Extension Treatment Period|Other|0
7487953|NCT03895372|25949167|P5|Extension Treatment Period|Other|1
7487954|NCT03895372|25949168|P4|Extension Treatment Period|Other|0
7487955|NCT03895372|25949169|P3|Extension Treatment Period|Other|0
7487956|NCT03895372|25949170|P2|Extension Treatment Period|Other|3
7487957|NCT03895372|25949171|P1|Extension Treatment Period|Other|1
7487958|NCT03895372|25949164|P8|Extension Treatment Period|Adverse Event|3
7487959|NCT03895372|25949165|P7|Extension Treatment Period|Adverse Event|3
7487960|NCT03895372|25949166|P6|Extension Treatment Period|Adverse Event|0
7487961|NCT03895372|25949167|P5|Extension Treatment Period|Adverse Event|0
7487962|NCT03895372|25949168|P4|Extension Treatment Period|Adverse Event|1
7487963|NCT03895372|25949169|P3|Extension Treatment Period|Adverse Event|0
7487964|NCT03895372|25949170|P2|Extension Treatment Period|Adverse Event|1
7487965|NCT03895372|25949171|P1|Extension Treatment Period|Adverse Event|0
7487966|NCT03895372|25949164|P8|Investigational Treatment Period|Withdrawal by Subject|0
7487967|NCT03895372|25949165|P7|Investigational Treatment Period|Withdrawal by Subject|3
7487968|NCT03895372|25949166|P6|Investigational Treatment Period|Withdrawal by Subject|1
7487969|NCT03895372|25949167|P5|Investigational Treatment Period|Withdrawal by Subject|0
7487970|NCT03895372|25949168|P4|Investigational Treatment Period|Withdrawal by Subject|1
7487971|NCT03895372|25949169|P3|Investigational Treatment Period|Withdrawal by Subject|1
7487972|NCT03895372|25949170|P2|Investigational Treatment Period|Withdrawal by Subject|3
7487973|NCT03895372|25949171|P1|Investigational Treatment Period|Withdrawal by Subject|2
7487974|NCT03895372|25949164|P8|Investigational Treatment Period|Protocol Violation|0
7487975|NCT03895372|25949165|P7|Investigational Treatment Period|Protocol Violation|0
7487976|NCT03895372|25949166|P6|Investigational Treatment Period|Protocol Violation|0
7487977|NCT03895372|25949167|P5|Investigational Treatment Period|Protocol Violation|0
7487978|NCT03895372|25949168|P4|Investigational Treatment Period|Protocol Violation|1
7487979|NCT03895372|25949169|P3|Investigational Treatment Period|Protocol Violation|0
7487980|NCT03895372|25949170|P2|Investigational Treatment Period|Protocol Violation|0
7487981|NCT03895372|25949171|P1|Investigational Treatment Period|Protocol Violation|0
7487982|NCT03895372|25949164|P8|Investigational Treatment Period|Other|2
7487983|NCT03895372|25949165|P7|Investigational Treatment Period|Other|0
7487984|NCT03895372|25949166|P6|Investigational Treatment Period|Other|1
7487985|NCT03895372|25949167|P5|Investigational Treatment Period|Other|0
7487986|NCT03895372|25949168|P4|Investigational Treatment Period|Other|0
7487987|NCT03895372|25949169|P3|Investigational Treatment Period|Other|0
7487988|NCT03895372|25949170|P2|Investigational Treatment Period|Other|0
7487989|NCT03895372|25949171|P1|Investigational Treatment Period|Other|0
7487990|NCT03895372|25949164|P8|Investigational Treatment Period|Lost to Follow-up|0
7487991|NCT03895372|25949165|P7|Investigational Treatment Period|Lost to Follow-up|1
7487992|NCT03895372|25949166|P6|Investigational Treatment Period|Lost to Follow-up|0
7487993|NCT03895372|25949167|P5|Investigational Treatment Period|Lost to Follow-up|0
7487994|NCT03895372|25949168|P4|Investigational Treatment Period|Lost to Follow-up|0
7487995|NCT03895372|25949169|P3|Investigational Treatment Period|Lost to Follow-up|0
7487996|NCT03895372|25949170|P2|Investigational Treatment Period|Lost to Follow-up|0
7487997|NCT03895372|25949171|P1|Investigational Treatment Period|Lost to Follow-up|0
7487998|NCT03895372|25949164|P8|Investigational Treatment Period|Lack of Efficacy|0
7487999|NCT03895372|25949165|P7|Investigational Treatment Period|Lack of Efficacy|0
7488000|NCT03895372|25949166|P6|Investigational Treatment Period|Lack of Efficacy|0
7488001|NCT03895372|25949167|P5|Investigational Treatment Period|Lack of Efficacy|0
7488002|NCT03895372|25949168|P4|Investigational Treatment Period|Lack of Efficacy|0
7488003|NCT03895372|25949169|P3|Investigational Treatment Period|Lack of Efficacy|0
7488004|NCT03895372|25949170|P2|Investigational Treatment Period|Lack of Efficacy|0
7488005|NCT03895372|25949171|P1|Investigational Treatment Period|Lack of Efficacy|1
7488006|NCT03895372|25949164|P8|Investigational Treatment Period|Adverse Event|3
7488007|NCT03895372|25949165|P7|Investigational Treatment Period|Adverse Event|4
7488008|NCT03895372|25949166|P6|Investigational Treatment Period|Adverse Event|0
7488009|NCT03895372|25949167|P5|Investigational Treatment Period|Adverse Event|0
7488010|NCT03895372|25949168|P4|Investigational Treatment Period|Adverse Event|0
7488011|NCT03895372|25949169|P3|Investigational Treatment Period|Adverse Event|0
7488012|NCT03895372|25949170|P2|Investigational Treatment Period|Adverse Event|0
7488013|NCT03895372|25949171|P1|Investigational Treatment Period|Adverse Event|1
7488014|NCT03895034|25949420|P1|Overall Study|Lost to Follow-up|2
7488015|NCT03894969|25949429|P5|Overall Study|Other|3
7488016|NCT03894969|25949430|P4|Overall Study|Other|0
7488017|NCT03894969|25949431|P3|Overall Study|Other|0
7488018|NCT03894969|25949432|P2|Overall Study|Other|0
7488019|NCT03894969|25949433|P1|Overall Study|Other|0
7488020|NCT03894969|25949429|P5|Overall Study|Withdrawal by Subject|8
7488021|NCT03894969|25949430|P4|Overall Study|Withdrawal by Subject|3
7488022|NCT03894969|25949431|P3|Overall Study|Withdrawal by Subject|1
7488023|NCT03894969|25949432|P2|Overall Study|Withdrawal by Subject|1
7488024|NCT03894969|25949433|P1|Overall Study|Withdrawal by Subject|1
7488025|NCT03894969|25949429|P5|Overall Study|Lost to Follow-up|0
7488026|NCT03894969|25949430|P4|Overall Study|Lost to Follow-up|0
7488027|NCT03894969|25949431|P3|Overall Study|Lost to Follow-up|1
7488028|NCT03894969|25949432|P2|Overall Study|Lost to Follow-up|0
7488029|NCT03894969|25949433|P1|Overall Study|Lost to Follow-up|1
7488030|NCT03894969|25949429|P5|Overall Study|Adverse Event|3
7488031|NCT03894969|25949430|P4|Overall Study|Adverse Event|3
7488032|NCT03894969|25949431|P3|Overall Study|Adverse Event|0
7488033|NCT03894969|25949432|P2|Overall Study|Adverse Event|2
7488034|NCT03894969|25949433|P1|Overall Study|Adverse Event|0
7488035|NCT03894813|25949490|P2|Overall Study|Complain of the research staff and refused to continue the trial|1
7488036|NCT03894813|25949491|P1|Overall Study|Complain of the research staff and refused to continue the trial|0
7488037|NCT03894813|25949490|P2|Overall Study|Withdrawal by Subject|3
7488038|NCT03894813|25949491|P1|Overall Study|Withdrawal by Subject|1
7488039|NCT03894813|25949490|P2|Overall Study|Protocol Violation|7
7488040|NCT03894813|25949491|P1|Overall Study|Protocol Violation|3
7488041|NCT03894813|25949490|P2|Overall Study|Pregnancy|1
7488042|NCT03894813|25949491|P1|Overall Study|Pregnancy|2
7488043|NCT03894813|25949490|P2|Overall Study|Lost to Follow-up|0
7488044|NCT03894813|25949491|P1|Overall Study|Lost to Follow-up|1
7488045|NCT03894813|25949490|P2|Overall Study|Lack of Efficacy|3
7488046|NCT03894813|25949491|P1|Overall Study|Lack of Efficacy|3
7488047|NCT03894813|25949490|P2|Overall Study|Adverse Event|1
7488048|NCT03894813|25949491|P1|Overall Study|Adverse Event|1
7488049|NCT03892889|25949626|P1|Overall Study|Reason not Specified|5
7488050|NCT03892889|25949626|P1|Overall Study|Physician Decision|8
7488051|NCT03892889|25949626|P1|Overall Study|Study Terminated by Sponsor|50
7488052|NCT03892889|25949626|P1|Overall Study|Withdrawal by Caregiver|1
7488053|NCT03892889|25949626|P1|Overall Study|Withdrawal by Subject|50
7488054|NCT03892889|25949626|P1|Overall Study|Protocol Deviation|3
7488055|NCT03892889|25949626|P1|Overall Study|Pregnancy|1
7488056|NCT03892889|25949626|P1|Overall Study|Non-compliance with study drug|22
7488057|NCT03892889|25949626|P1|Overall Study|Lost to Follow-up|46
7488058|NCT03892889|25949626|P1|Overall Study|Lack of Efficacy|1
7488059|NCT03892889|25949626|P1|Overall Study|Adverse Event|17
7488060|NCT03892707|25949633|P2|Overall Study|Other (long business trip)|1
7488061|NCT03892707|25949634|P1|Overall Study|Other (long business trip)|0
7488062|NCT03892707|25949633|P2|Overall Study|Withdrawal by Subject|1
7488063|NCT03892707|25949634|P1|Overall Study|Withdrawal by Subject|0
7488064|NCT03892707|25949633|P2|Overall Study|Pain resolution|4
7488065|NCT03892707|25949634|P1|Overall Study|Pain resolution|0
7488066|NCT03892707|25949633|P2|Overall Study|Screen failure|0
7488067|NCT03892707|25949634|P1|Overall Study|Screen failure|6
7488068|NCT03892564|25949663|P1|Overall Study|Withdrawal by Subject|2
7488069|NCT03891862|25949700|P3|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
7488070|NCT03891862|25949701|P2|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
7488071|NCT03891862|25949702|P1|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
7488072|NCT03891862|25949700|P3|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
7488073|NCT03891862|25949701|P2|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
7488074|NCT03891862|25949702|P1|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
7488075|NCT03891862|25949700|P3|Placebo-controlled Period and Follow-up|Protocol Violation|1
7488076|NCT03891862|25949701|P2|Placebo-controlled Period and Follow-up|Protocol Violation|2
7488077|NCT03891862|25949702|P1|Placebo-controlled Period and Follow-up|Protocol Violation|0
7488078|NCT03891862|25949700|P3|Placebo-controlled Period and Follow-up|Adverse Event|1
7488079|NCT03891862|25949701|P2|Placebo-controlled Period and Follow-up|Adverse Event|1
7488080|NCT03891862|25949702|P1|Placebo-controlled Period and Follow-up|Adverse Event|0
7488081|NCT03891862|25949700|P3|Open-label Period|Lost to Follow-up|0
7488082|NCT03891862|25949701|P2|Open-label Period|Lost to Follow-up|0
7488083|NCT03891862|25949702|P1|Open-label Period|Lost to Follow-up|2
7488084|NCT03891862|25949700|P3|Open-label Period|Death|0
7488085|NCT03891862|25949701|P2|Open-label Period|Death|0
7488086|NCT03891862|25949702|P1|Open-label Period|Death|1
7488087|NCT03891862|25949700|P3|Open-label Period|Withdrawal by Subject|0
7488088|NCT03891862|25949701|P2|Open-label Period|Withdrawal by Subject|0
7488089|NCT03891862|25949702|P1|Open-label Period|Withdrawal by Subject|6
7488090|NCT03891862|25949700|P3|Open-label Period|Protocol Violation|0
7488091|NCT03891862|25949701|P2|Open-label Period|Protocol Violation|0
7488092|NCT03891862|25949702|P1|Open-label Period|Protocol Violation|5
7488093|NCT03891862|25949700|P3|Open-label Period|Adverse Event|0
7488094|NCT03891862|25949701|P2|Open-label Period|Adverse Event|0
7488095|NCT03891862|25949702|P1|Open-label Period|Adverse Event|2
7488096|NCT03891641|25949715|P2|Overall Study|Study Stoppage Due to COVID-19|2
7488097|NCT03891641|25949716|P1|Overall Study|Study Stoppage Due to COVID-19|2
7488098|NCT03890367|25949747|P3|Overall Study|Lost to Follow-up|0
7488099|NCT03890367|25949748|P2|Overall Study|Lost to Follow-up|1
7488100|NCT03890367|25949749|P1|Overall Study|Lost to Follow-up|1
7488101|NCT03890367|25949747|P3|Overall Study|Protocol deviation|1
7488102|NCT03890367|25949748|P2|Overall Study|Protocol deviation|2
7488103|NCT03890367|25949749|P1|Overall Study|Protocol deviation|2
7488104|NCT03890367|25949747|P3|Overall Study|Withdrawal by parent/guardian|0
7488105|NCT03890367|25949748|P2|Overall Study|Withdrawal by parent/guardian|3
7488106|NCT03890367|25949749|P1|Overall Study|Withdrawal by parent/guardian|1
7488107|NCT03889704|25949780|P1|Overall Study|Study terminated due to pandemic|1
7488108|NCT03888482|25949835|P2|Second Wear (8 -1/+2 Days)|Other|0
7488109|NCT03888482|25949836|P1|Second Wear (8 -1/+2 Days)|Other|1
7488110|NCT03888482|25949835|P2|Second Wear (8 -1/+2 Days)|Adverse Event|1
7488111|NCT03888482|25949836|P1|Second Wear (8 -1/+2 Days)|Adverse Event|0
7488112|NCT03888391|25949855|P1|Overall Study|Lost to Follow-up|15
7488113|NCT03887442|25949927|P2|Overall Study|Adverse Event|0
7488114|NCT03887442|25949928|P1|Overall Study|Adverse Event|1
7488115|NCT03886493|25950009|P1|Overall Study|Adverse Event|1
7488116|NCT03885934|25950029|P6|Overall Study|Withdrawn by Parent/Guardian|0
7488117|NCT03885934|25950030|P5|Overall Study|Withdrawn by Parent/Guardian|0
7488118|NCT03885934|25950031|P4|Overall Study|Withdrawn by Parent/Guardian|0
7488119|NCT03885934|25950032|P3|Overall Study|Withdrawn by Parent/Guardian|0
7488120|NCT03885934|25950033|P2|Overall Study|Withdrawn by Parent/Guardian|0
7488121|NCT03885934|25950034|P1|Overall Study|Withdrawn by Parent/Guardian|1
7488122|NCT03885726|25950072|P1|Overall Study|Early discharge from hospital|3
7488123|NCT03885726|25950072|P1|Overall Study|Staffing issues/lost interest|1
7488124|NCT03883386|25950165|P2|First Assignment|Withdrawal by Subject|1
7488125|NCT03883386|25950166|P1|First Assignment|Withdrawal by Subject|1
7488126|NCT03883386|25950165|P2|First Assignment|Lost to Follow-up|0
7488127|NCT03883386|25950166|P1|First Assignment|Lost to Follow-up|1
7488128|NCT03883113|25950176|P2|Overall Study|Lost to Follow-up|0
7488129|NCT03883113|25950177|P1|Overall Study|Lost to Follow-up|1
7488130|NCT03883113|25950176|P2|Overall Study|Withdrawal by Subject|2
7488131|NCT03883113|25950177|P1|Overall Study|Withdrawal by Subject|1
7488132|NCT03883113|25950176|P2|Overall Study|Adverse Event|1
7488133|NCT03883113|25950177|P1|Overall Study|Adverse Event|0
7488134|NCT03883113|25950176|P2|Overall Study|Pregnancy|0
7488135|NCT03883113|25950177|P1|Overall Study|Pregnancy|1
7488136|NCT03883113|25950176|P2|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
7488137|NCT03883113|25950177|P1|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
7488138|NCT03883113|25950176|P2|Overall Study|Physician Decision|2
7488139|NCT03883113|25950177|P1|Overall Study|Physician Decision|4
7488140|NCT03882801|25950225|P2|Period 2|Non-compliance with study drug|1
7488141|NCT03882801|25950226|P1|Period 2|Non-compliance with study drug|0
7488142|NCT03882801|25950225|P2|Washout Period|Physician Decision|1
7488143|NCT03882801|25950226|P1|Washout Period|Physician Decision|0
7488144|NCT03882801|25950225|P2|Period 1|Never treated with study drug|0
7488145|NCT03882801|25950226|P1|Period 1|Never treated with study drug|1
7488146|NCT03882801|25950225|P2|Period 1|Non-compliance with study drug|1
7488147|NCT03882801|25950226|P1|Period 1|Non-compliance with study drug|1
7488148|NCT03882801|25950225|P2|Period 1|Adverse Event|1
7488149|NCT03882801|25950226|P1|Period 1|Adverse Event|0
7488150|NCT03882424|25950248|P3|Overall Study|schedule conflict|0
7488151|NCT03882424|25950249|P2|Overall Study|schedule conflict|0
7488152|NCT03882424|25950250|P1|Overall Study|schedule conflict|1
7488153|NCT03882424|25950248|P3|Overall Study|Lost to Follow-up|0
7488154|NCT03882424|25950249|P2|Overall Study|Lost to Follow-up|0
7488155|NCT03882424|25950250|P1|Overall Study|Lost to Follow-up|3
7488156|NCT03882047|25950273|P3|Overall Study|Did Not Meet Eligibility|1
7488157|NCT03882047|25950274|P2|Overall Study|Did Not Meet Eligibility|0
7488158|NCT03882047|25950275|P1|Overall Study|Did Not Meet Eligibility|0
7488159|NCT03882047|25950273|P3|Overall Study|Noncompliance With Protocol|0
7488160|NCT03882047|25950274|P2|Overall Study|Noncompliance With Protocol|0
7488161|NCT03882047|25950275|P1|Overall Study|Noncompliance With Protocol|2
7488162|NCT03882047|25950273|P3|Overall Study|Did Not Wish to Continue|1
7488163|NCT03882047|25950274|P2|Overall Study|Did Not Wish to Continue|4
7488164|NCT03882047|25950275|P1|Overall Study|Did Not Wish to Continue|1
7488165|NCT03882047|25950273|P3|Overall Study|Lost to Follow-up|0
7488166|NCT03882047|25950274|P2|Overall Study|Lost to Follow-up|1
7488167|NCT03882047|25950275|P1|Overall Study|Lost to Follow-up|0
7488168|NCT03882047|25950273|P3|Overall Study|Treatment Failure|12
7488169|NCT03882047|25950274|P2|Overall Study|Treatment Failure|3
7488170|NCT03882047|25950275|P1|Overall Study|Treatment Failure|3
7488171|NCT03882047|25950273|P3|Overall Study|Adverse Event|2
7488172|NCT03882047|25950274|P2|Overall Study|Adverse Event|2
7488173|NCT03882047|25950275|P1|Overall Study|Adverse Event|0
7488174|NCT03881059|25950350|P3|Overall Study|Other|0
7488175|NCT03881059|25950351|P2|Overall Study|Other|1
7488176|NCT03881059|25950352|P1|Overall Study|Other|2
7488177|NCT03881059|25950350|P3|Overall Study|Withdrawal by Subject|3
7488178|NCT03881059|25950351|P2|Overall Study|Withdrawal by Subject|2
7488179|NCT03881059|25950352|P1|Overall Study|Withdrawal by Subject|5
7488180|NCT03881059|25950350|P3|Overall Study|Randomized by mistake with study treatment|1
7488181|NCT03881059|25950351|P2|Overall Study|Randomized by mistake with study treatment|1
7488182|NCT03881059|25950352|P1|Overall Study|Randomized by mistake with study treatment|0
7488183|NCT03881059|25950350|P3|Overall Study|Adverse Event|4
7488184|NCT03881059|25950351|P2|Overall Study|Adverse Event|3
7488185|NCT03881059|25950352|P1|Overall Study|Adverse Event|1
7488186|NCT03880266|25950521|P8|Overall Study|Withdrawal by Subject|0
7488187|NCT03880266|25950522|P7|Overall Study|Withdrawal by Subject|0
7488188|NCT03880266|25950523|P6|Overall Study|Withdrawal by Subject|0
7488189|NCT03880266|25950524|P5|Overall Study|Withdrawal by Subject|0
7488190|NCT03880266|25950525|P4|Overall Study|Withdrawal by Subject|0
7488191|NCT03880266|25950526|P3|Overall Study|Withdrawal by Subject|1
7488192|NCT03880266|25950527|P2|Overall Study|Withdrawal by Subject|1
7488193|NCT03880266|25950528|P1|Overall Study|Withdrawal by Subject|0
7488194|NCT03880227|25950580|P4|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7488195|NCT03880227|25950581|P3|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
7488196|NCT03880227|25950582|P2|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7488197|NCT03880227|25950583|P1|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7488198|NCT03880227|25950580|P4|1 Week Washout/ Delay|Withdrawal by Subject|0
7488199|NCT03880227|25950581|P3|1 Week Washout/ Delay|Withdrawal by Subject|2
7488200|NCT03880227|25950582|P2|1 Week Washout/ Delay|Withdrawal by Subject|0
7488201|NCT03880227|25950583|P1|1 Week Washout/ Delay|Withdrawal by Subject|0
7488202|NCT03880227|25950580|P4|1 Week Washout/ Delay|Lost to Follow-up|0
7488203|NCT03880227|25950581|P3|1 Week Washout/ Delay|Lost to Follow-up|0
7488204|NCT03880227|25950582|P2|1 Week Washout/ Delay|Lost to Follow-up|1
7488205|NCT03880227|25950583|P1|1 Week Washout/ Delay|Lost to Follow-up|0
7488206|NCT03880227|25950580|P4|First Visit|Withdrawal by Subject|0
7488207|NCT03880227|25950581|P3|First Visit|Withdrawal by Subject|0
7488208|NCT03880227|25950582|P2|First Visit|Withdrawal by Subject|0
7488209|NCT03880227|25950583|P1|First Visit|Withdrawal by Subject|1
7488210|NCT03879772|25950610|P5|Overall Study|Did Not Meet Entry Requirements|0
7488211|NCT03879772|25950611|P4|Overall Study|Did Not Meet Entry Requirements|0
7488212|NCT03879772|25950612|P3|Overall Study|Did Not Meet Entry Requirements|1
7488213|NCT03879772|25950613|P2|Overall Study|Did Not Meet Entry Requirements|0
7488214|NCT03879772|25950614|P1|Overall Study|Did Not Meet Entry Requirements|1
7488215|NCT03879772|25950610|P5|Overall Study|Protocol Violation|2
7488216|NCT03879772|25950611|P4|Overall Study|Protocol Violation|1
7488217|NCT03879772|25950612|P3|Overall Study|Protocol Violation|3
7488218|NCT03879772|25950613|P2|Overall Study|Protocol Violation|0
7488219|NCT03879772|25950614|P1|Overall Study|Protocol Violation|0
7488220|NCT03879772|25950610|P5|Overall Study|Withdrawal by Subject|1
7488221|NCT03879772|25950611|P4|Overall Study|Withdrawal by Subject|1
7488222|NCT03879772|25950612|P3|Overall Study|Withdrawal by Subject|3
7488223|NCT03879772|25950613|P2|Overall Study|Withdrawal by Subject|1
7488224|NCT03879772|25950614|P1|Overall Study|Withdrawal by Subject|0
7488225|NCT03879772|25950610|P5|Overall Study|Lost to Follow-up|1
7488226|NCT03879772|25950611|P4|Overall Study|Lost to Follow-up|0
7488227|NCT03879772|25950612|P3|Overall Study|Lost to Follow-up|0
7488228|NCT03879772|25950613|P2|Overall Study|Lost to Follow-up|0
7488229|NCT03879772|25950614|P1|Overall Study|Lost to Follow-up|0
7488230|NCT03879772|25950610|P5|Overall Study|Treatment Failure|1
7488231|NCT03879772|25950611|P4|Overall Study|Treatment Failure|2
7488232|NCT03879772|25950612|P3|Overall Study|Treatment Failure|0
7488233|NCT03879772|25950613|P2|Overall Study|Treatment Failure|0
7488234|NCT03879772|25950614|P1|Overall Study|Treatment Failure|1
7488235|NCT03879772|25950610|P5|Overall Study|Adverse Event|3
7488236|NCT03879772|25950611|P4|Overall Study|Adverse Event|4
7488237|NCT03879772|25950612|P3|Overall Study|Adverse Event|3
7488238|NCT03879772|25950613|P2|Overall Study|Adverse Event|2
7488239|NCT03879772|25950614|P1|Overall Study|Adverse Event|2
7488240|NCT03878758|25950716|P1|Overall Study|Improper consent documentation|1
7488241|NCT03878758|25950716|P1|Overall Study|Protocol defined|2
7488242|NCT03878758|25950716|P1|Overall Study|Withdrawal by Subject|1
7488243|NCT03878602|25950755|P2|Overall Study|incomplete data collection|0
7488244|NCT03878602|25950756|P1|Overall Study|incomplete data collection|2
7488245|NCT03878602|25950755|P2|Overall Study|cord blood donation|1
7488246|NCT03878602|25950756|P1|Overall Study|cord blood donation|7
7488247|NCT03878160|25950783|P3|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
7488248|NCT03878160|25950784|P2|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
7488249|NCT03878160|25950785|P1|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
7488250|NCT03878160|25950783|P3|Overall Study|Lost to Follow-up|1
7488251|NCT03878160|25950784|P2|Overall Study|Lost to Follow-up|1
7488252|NCT03878160|25950785|P1|Overall Study|Lost to Follow-up|1
7488253|NCT03878108|25950834|P2|Overall Study|Adverse Event|0
7488254|NCT03878108|25950835|P1|Overall Study|Adverse Event|1
7488255|NCT03877237|25950867|P2|Overall Study|Withdrawal by Subject|2
7488256|NCT03877237|25950868|P1|Overall Study|Withdrawal by Subject|0
7488257|NCT03877237|25950867|P2|Overall Study|Physician Decision|0
7488258|NCT03877237|25950868|P1|Overall Study|Physician Decision|1
7488259|NCT03877237|25950867|P2|Overall Study|Death|2
7488260|NCT03877237|25950868|P1|Overall Study|Death|3
7488261|NCT03877237|25950867|P2|Overall Study|Adverse Event|2
7488262|NCT03877237|25950868|P1|Overall Study|Adverse Event|1
7488263|NCT03876743|25950884|P4|Overall Study|Lost to Follow-up|7
7488264|NCT03876743|25950885|P3|Overall Study|Lost to Follow-up|4
7488265|NCT03876743|25950886|P2|Overall Study|Lost to Follow-up|4
7488266|NCT03876743|25950887|P1|Overall Study|Lost to Follow-up|6
7488267|NCT03875508|25950982|P1|Overall Study|Other, not specified|2
7488268|NCT03875508|25950982|P1|Overall Study|Lack of Efficacy|1
7488269|NCT03875508|25950982|P1|Overall Study|Lost to Follow-up|8
7488270|NCT03875508|25950982|P1|Overall Study|Adverse Event|1
7488271|NCT03875482|25950995|P2|Overall Study|Lack of Efficacy|11
7488272|NCT03875482|25950996|P1|Overall Study|Lack of Efficacy|0
7488273|NCT03875482|25950995|P2|Overall Study|Lost to Follow-up|2
7488274|NCT03875482|25950996|P1|Overall Study|Lost to Follow-up|8
7488275|NCT03875482|25950995|P2|Overall Study|Withdrew consent|6
7488276|NCT03875482|25950996|P1|Overall Study|Withdrew consent|5
7488277|NCT03875482|25950995|P2|Overall Study|Adverse Event|1
7488278|NCT03875482|25950996|P1|Overall Study|Adverse Event|0
7488279|NCT03875118|25951012|P2|Overall Study|Withdrawal by Subject|4
7488280|NCT03875118|25951013|P1|Overall Study|Withdrawal by Subject|4
7488281|NCT03874013|25951034|P2|Overall Study|Adverse Event|1
7488282|NCT03874013|25951035|P1|Overall Study|Adverse Event|0
7488283|NCT03873987|25951051|P2|Overall Study|Lost to Follow-up|1
7488284|NCT03873987|25951052|P1|Overall Study|Lost to Follow-up|0
7488285|NCT03873987|25951051|P2|Overall Study|staff was unable to start a new IV line|0
7488286|NCT03873987|25951052|P1|Overall Study|staff was unable to start a new IV line|1
7488287|NCT03873987|25951051|P2|Overall Study|Adverse Event|0
7488288|NCT03873987|25951052|P1|Overall Study|Adverse Event|1
7488289|NCT03873116|25951065|P3|Overall Study|Study drug discontinuation due to rash|1
7488290|NCT03873116|25951066|P2|Overall Study|Study drug discontinuation due to rash|0
7488291|NCT03873116|25951067|P1|Overall Study|Study drug discontinuation due to rash|0
7488292|NCT03872843|25951086|P2|Overall Study|Lost to Follow-up|7
7488293|NCT03872843|25951087|P1|Overall Study|Lost to Follow-up|5
7488294|NCT03870997|25951103|P6|Overall Study|Did not complete mid-study/final survey|10531
7488295|NCT03870997|25951104|P5|Overall Study|Did not complete mid-study/final survey|10588
7488296|NCT03870997|25951105|P4|Overall Study|Did not complete mid-study/final survey|10947
7488297|NCT03870997|25951106|P3|Overall Study|Did not complete mid-study/final survey|10978
7488298|NCT03870997|25951107|P2|Overall Study|Did not complete mid-study/final survey|10431
7488299|NCT03870997|25951108|P1|Overall Study|Did not complete mid-study/final survey|10544
7488300|NCT03870555|25951175|P3|Period 3 (2 Days)|Adverse Event|0
7488301|NCT03870555|25951176|P2|Period 3 (2 Days)|Adverse Event|0
7488302|NCT03870555|25951177|P1|Period 3 (2 Days)|Adverse Event|1
7488303|NCT03869684|25951245|P3|Overall Study|Study prematurely terminated by sponsor|2
7488304|NCT03869684|25951246|P2|Overall Study|Study prematurely terminated by sponsor|0
7488305|NCT03869684|25951247|P1|Overall Study|Study prematurely terminated by sponsor|0
7488306|NCT03869684|25951245|P3|Overall Study|Lost to Follow-up|0
7488307|NCT03869684|25951246|P2|Overall Study|Lost to Follow-up|0
7488308|NCT03869684|25951247|P1|Overall Study|Lost to Follow-up|1
7488309|NCT03869684|25951245|P3|Overall Study|Withdrawal by Subject|0
7488310|NCT03869684|25951246|P2|Overall Study|Withdrawal by Subject|0
7488311|NCT03869684|25951247|P1|Overall Study|Withdrawal by Subject|1
7488312|NCT03869684|25951245|P3|Overall Study|Adverse Event|1
7488313|NCT03869684|25951246|P2|Overall Study|Adverse Event|3
7488314|NCT03869684|25951247|P1|Overall Study|Adverse Event|0
7488315|NCT03869333|25951328|P4|Overall Study|Physician Decision|0
7488316|NCT03869333|25951329|P3|Overall Study|Physician Decision|0
7488317|NCT03869333|25951330|P2|Overall Study|Physician Decision|1
7488318|NCT03869333|25951331|P1|Overall Study|Physician Decision|0
7488319|NCT03869333|25951328|P4|Overall Study|Pregnancy|0
7488320|NCT03869333|25951329|P3|Overall Study|Pregnancy|0
7488321|NCT03869333|25951330|P2|Overall Study|Pregnancy|0
7488322|NCT03869333|25951331|P1|Overall Study|Pregnancy|1
7488323|NCT03869333|25951328|P4|Overall Study|Lost to Follow-up|0
7488324|NCT03869333|25951329|P3|Overall Study|Lost to Follow-up|0
7488325|NCT03869333|25951330|P2|Overall Study|Lost to Follow-up|0
7488326|NCT03869333|25951331|P1|Overall Study|Lost to Follow-up|1
7488327|NCT03868631|25951407|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
7488328|NCT03868631|25951408|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
7488329|NCT03868631|25951407|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
7488330|NCT03868631|25951408|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
7488331|NCT03868631|25951407|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
7488332|NCT03868631|25951408|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
7488333|NCT03868631|25951407|P2|Baseline to Week 6|Withdrawal by Subject|0
7488334|NCT03868631|25951408|P1|Baseline to Week 6|Withdrawal by Subject|3
7488335|NCT03868631|25951407|P2|Baseline to Week 6|Protocol Violation|1
7488336|NCT03868631|25951408|P1|Baseline to Week 6|Protocol Violation|1
7488337|NCT03868631|25951407|P2|Baseline to Week 6|Adverse Event|3
7488338|NCT03868631|25951408|P1|Baseline to Week 6|Adverse Event|0
7488339|NCT03868059|25951445|P1|Overall Study|Withdrawal by Subject|6
7488340|NCT03868059|25951445|P1|Overall Study|Lost to Follow-up|3
7488341|NCT03868059|25951445|P1|Overall Study|Adverse Event|3
7488342|NCT03865953|25951497|P2|Second Intervention (4 Weeks)|Lost to Follow-up|2
7488343|NCT03865953|25951498|P1|Second Intervention (4 Weeks)|Lost to Follow-up|0
7488344|NCT03865953|25951497|P2|First Intervention (4 Weeks)|Protocol Violation|1
7488345|NCT03865953|25951498|P1|First Intervention (4 Weeks)|Protocol Violation|0
7488346|NCT03865953|25951497|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
7488347|NCT03865953|25951498|P1|First Intervention (4 Weeks)|Lost to Follow-up|2
7488348|NCT03865407|25951557|P2|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
7488349|NCT03865407|25951558|P1|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
7488350|NCT03865407|25951557|P2|Overall Study|Withdrawal by Subject|0
7488351|NCT03865407|25951558|P1|Overall Study|Withdrawal by Subject|1
7488352|NCT03865407|25951557|P2|Overall Study|Adverse Event|0
7488353|NCT03865407|25951558|P1|Overall Study|Adverse Event|1
7488354|NCT03865381|25951574|P1|Overall Study|Withdrawal by Subject|2
7488355|NCT03865381|25951574|P1|Overall Study|Protocol Violation/Non-Compliance|3
7488356|NCT03864900|25951596|P2|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
7488357|NCT03864900|25951597|P1|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
7488358|NCT03864900|25951596|P2|Overall Study|Withdrawal by Subject|1
7488359|NCT03864900|25951597|P1|Overall Study|Withdrawal by Subject|1
7488360|NCT03864653|25951613|P1|Overall Study|Withdrawal by Subject|1
7488361|NCT03864627|25951620|P2|Overall Study|Study terminated by sponsor|1
7488362|NCT03864627|25951621|P1|Overall Study|Study terminated by sponsor|0
7488363|NCT03864627|25951620|P2|Overall Study|Withdrawal by Subject|8
7488364|NCT03864627|25951621|P1|Overall Study|Withdrawal by Subject|4
7488365|NCT03864627|25951620|P2|Overall Study|Lost to Follow-up|1
7488366|NCT03864627|25951621|P1|Overall Study|Lost to Follow-up|0
7488367|NCT03864627|25951620|P2|Overall Study|Lack of Efficacy|1
7488368|NCT03864627|25951621|P1|Overall Study|Lack of Efficacy|0
7488369|NCT03864627|25951620|P2|Overall Study|Adverse Event|1
7488370|NCT03864627|25951621|P1|Overall Study|Adverse Event|0
7488373|NCT03861936|25951740|P3|Overall Study|Reason not Specified|3
7488374|NCT03861936|25951741|P2|Overall Study|Reason not Specified|5
7488375|NCT03861936|25951742|P1|Overall Study|Reason not Specified|5
7488376|NCT03861936|25951740|P3|Overall Study|Protocol Deviation|1
7488377|NCT03861936|25951741|P2|Overall Study|Protocol Deviation|0
7488378|NCT03861936|25951742|P1|Overall Study|Protocol Deviation|0
7488379|NCT03861936|25951740|P3|Overall Study|Physician Decision|0
7488380|NCT03861936|25951741|P2|Overall Study|Physician Decision|1
7488381|NCT03861936|25951742|P1|Overall Study|Physician Decision|0
7488382|NCT03861936|25951740|P3|Overall Study|Lost to Follow-up|3
7488383|NCT03861936|25951741|P2|Overall Study|Lost to Follow-up|3
7488384|NCT03861936|25951742|P1|Overall Study|Lost to Follow-up|5
7488385|NCT03861936|25951740|P3|Overall Study|Withdrawal by Subject|3
7488386|NCT03861936|25951741|P2|Overall Study|Withdrawal by Subject|1
7488387|NCT03861936|25951742|P1|Overall Study|Withdrawal by Subject|4
7488388|NCT03861559|25951804|P2|Overall Study|Did not meet eligibility requirements|0
7488389|NCT03861559|25951805|P1|Overall Study|Did not meet eligibility requirements|1
7488390|NCT03861559|25951804|P2|Overall Study|Noncompliance|1
7488391|NCT03861559|25951805|P1|Overall Study|Noncompliance|1
7488392|NCT03861559|25951804|P2|Overall Study|Treatment failure|2
7488393|NCT03861559|25951805|P1|Overall Study|Treatment failure|0
7488394|NCT03861559|25951804|P2|Overall Study|Adverse Event|2
7488395|NCT03861559|25951805|P1|Overall Study|Adverse Event|0
7488396|NCT03859323|25952049|P13|Overall Study|Pregnancy|0
7488397|NCT03859323|25952050|P12|Overall Study|Pregnancy|0
7488398|NCT03859323|25952051|P11|Overall Study|Pregnancy|0
7488399|NCT03859323|25952052|P10|Overall Study|Pregnancy|1
7488400|NCT03859323|25952053|P9|Overall Study|Pregnancy|0
7488401|NCT03859323|25952054|P8|Overall Study|Pregnancy|0
7488402|NCT03859323|25952055|P7|Overall Study|Pregnancy|0
7488403|NCT03859323|25952056|P6|Overall Study|Pregnancy|0
7488404|NCT03859323|25952057|P5|Overall Study|Pregnancy|0
7488405|NCT03859323|25952058|P4|Overall Study|Pregnancy|0
7488406|NCT03859323|25952059|P3|Overall Study|Pregnancy|0
7488407|NCT03859323|25952060|P2|Overall Study|Pregnancy|0
7488408|NCT03859323|25952061|P1|Overall Study|Pregnancy|0
7488409|NCT03859323|25952049|P13|Overall Study|Withdrawal by Subject|1
7488410|NCT03859323|25952050|P12|Overall Study|Withdrawal by Subject|2
7488411|NCT03859323|25952051|P11|Overall Study|Withdrawal by Subject|1
7488412|NCT03859323|25952052|P10|Overall Study|Withdrawal by Subject|1
7488413|NCT03859323|25952053|P9|Overall Study|Withdrawal by Subject|0
7488414|NCT03859323|25952054|P8|Overall Study|Withdrawal by Subject|0
7488415|NCT03859323|25952055|P7|Overall Study|Withdrawal by Subject|0
7488416|NCT03859323|25952056|P6|Overall Study|Withdrawal by Subject|1
7488417|NCT03859323|25952057|P5|Overall Study|Withdrawal by Subject|0
7488418|NCT03859323|25952058|P4|Overall Study|Withdrawal by Subject|0
7488419|NCT03859323|25952059|P3|Overall Study|Withdrawal by Subject|1
7488420|NCT03859323|25952060|P2|Overall Study|Withdrawal by Subject|0
7488421|NCT03859323|25952061|P1|Overall Study|Withdrawal by Subject|0
7488422|NCT03859323|25952049|P13|Overall Study|Lost to Follow-up|0
7488423|NCT03859323|25952050|P12|Overall Study|Lost to Follow-up|0
7488424|NCT03859323|25952051|P11|Overall Study|Lost to Follow-up|0
7488425|NCT03859323|25952052|P10|Overall Study|Lost to Follow-up|0
7488426|NCT03859323|25952053|P9|Overall Study|Lost to Follow-up|0
7488427|NCT03859323|25952054|P8|Overall Study|Lost to Follow-up|0
7488428|NCT03859323|25952055|P7|Overall Study|Lost to Follow-up|1
7488429|NCT03859323|25952056|P6|Overall Study|Lost to Follow-up|0
7488430|NCT03859323|25952057|P5|Overall Study|Lost to Follow-up|0
7488431|NCT03859323|25952058|P4|Overall Study|Lost to Follow-up|0
7488432|NCT03859323|25952059|P3|Overall Study|Lost to Follow-up|0
7488433|NCT03859323|25952060|P2|Overall Study|Lost to Follow-up|0
7488434|NCT03859323|25952061|P1|Overall Study|Lost to Follow-up|0
7488435|NCT03857841|25952283|P4|Overall Study|Study Terminated by Sponsor|0
7488436|NCT03857841|25952284|P3|Overall Study|Study Terminated by Sponsor|0
7488437|NCT03857841|25952285|P2|Overall Study|Study Terminated by Sponsor|0
7488438|NCT03857841|25952286|P1|Overall Study|Study Terminated by Sponsor|1
7488439|NCT03857841|25952283|P4|Overall Study|Death|0
7488440|NCT03857841|25952284|P3|Overall Study|Death|0
7488441|NCT03857841|25952285|P2|Overall Study|Death|0
7488442|NCT03857841|25952286|P1|Overall Study|Death|1
7488443|NCT03855228|25952401|P4|Overall Study|Did Not Meet Entry Requirements|1
7488444|NCT03855228|25952402|P3|Overall Study|Did Not Meet Entry Requirements|1
7488445|NCT03855228|25952403|P2|Overall Study|Did Not Meet Entry Requirements|2
7488446|NCT03855228|25952404|P1|Overall Study|Did Not Meet Entry Requirements|0
7488447|NCT03855228|25952401|P4|Overall Study|Protocol Violation|1
7488448|NCT03855228|25952402|P3|Overall Study|Protocol Violation|2
7488449|NCT03855228|25952403|P2|Overall Study|Protocol Violation|1
7488450|NCT03855228|25952404|P1|Overall Study|Protocol Violation|0
7488451|NCT03855228|25952401|P4|Overall Study|Lost to Follow-up|1
7488452|NCT03855228|25952402|P3|Overall Study|Lost to Follow-up|0
7488453|NCT03855228|25952403|P2|Overall Study|Lost to Follow-up|0
7488454|NCT03855228|25952404|P1|Overall Study|Lost to Follow-up|0
7488455|NCT03855228|25952401|P4|Overall Study|Treatment Failure|8
7488456|NCT03855228|25952402|P3|Overall Study|Treatment Failure|1
7488457|NCT03855228|25952403|P2|Overall Study|Treatment Failure|2
7488458|NCT03855228|25952404|P1|Overall Study|Treatment Failure|1
7488459|NCT03855228|25952401|P4|Overall Study|Adverse Event|8
7488460|NCT03855228|25952402|P3|Overall Study|Adverse Event|4
7488461|NCT03855228|25952403|P2|Overall Study|Adverse Event|4
7488462|NCT03855228|25952404|P1|Overall Study|Adverse Event|2
7488463|NCT03855189|25952453|P3|Overall Study|Did Not Return|0
7488464|NCT03855189|25952454|P2|Overall Study|Did Not Return|3
7488465|NCT03855189|25952455|P1|Overall Study|Did Not Return|4
7488466|NCT03855189|25952453|P3|Overall Study|Noncompliance with Protocol|0
7488467|NCT03855189|25952454|P2|Overall Study|Noncompliance with Protocol|1
7488468|NCT03855189|25952455|P1|Overall Study|Noncompliance with Protocol|0
7488469|NCT03855189|25952453|P3|Overall Study|Treatment Failure|2
7488470|NCT03855189|25952454|P2|Overall Study|Treatment Failure|1
7488471|NCT03855189|25952455|P1|Overall Study|Treatment Failure|1
7488472|NCT03855189|25952453|P3|Overall Study|Adverse Event|4
7488473|NCT03855189|25952454|P2|Overall Study|Adverse Event|2
7488474|NCT03855189|25952455|P1|Overall Study|Adverse Event|5
7488475|NCT03853551|25952580|P1|Overall Study|7 patients discontinued the study because of disease progression.|7
7488476|NCT03853551|25952580|P1|Overall Study|Death|2
7488477|NCT03853213|25952586|P2|Overall Study|Other (e.g., too busy)|2
7488478|NCT03853213|25952587|P1|Overall Study|Other (e.g., too busy)|0
7488479|NCT03853213|25952586|P2|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
7488480|NCT03853213|25952587|P1|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
7488481|NCT03851094|25952666|P2|Overall Study|Participant returned device|2
7488482|NCT03851094|25952667|P1|Overall Study|Participant returned device|0
7488483|NCT03851094|25952666|P2|Overall Study|Participant lost device|1
7488484|NCT03851094|25952667|P1|Overall Study|Participant lost device|0
7488485|NCT03851094|25952666|P2|Overall Study|Withdrawal by Subject|1
7488486|NCT03851094|25952667|P1|Overall Study|Withdrawal by Subject|0
7488487|NCT03851016|25952681|P2|First Intervention (3 Weeks)|Withdrawal by Subject|2
7488488|NCT03851016|25952682|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
7488489|NCT03850509|25952694|P2|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
7488490|NCT03850509|25952695|P1|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
7488491|NCT03850496|25952718|P3|Overall Study|Lost to Follow-up|4
7488492|NCT03850496|25952719|P2|Overall Study|Lost to Follow-up|1
7488493|NCT03850496|25952720|P1|Overall Study|Lost to Follow-up|0
7488494|NCT03850496|25952718|P3|Overall Study|Withdrawal by Subject|0
7488495|NCT03850496|25952719|P2|Overall Study|Withdrawal by Subject|0
7488496|NCT03850496|25952720|P1|Overall Study|Withdrawal by Subject|1
7488497|NCT03850444|25952742|P2|Overall Study|Ongoing in Study|59
7488498|NCT03850444|25952743|P1|Overall Study|Ongoing in Study|78
7488499|NCT03850444|25952742|P2|Overall Study|Withdrawal by Subject|1
7488500|NCT03850444|25952743|P1|Overall Study|Withdrawal by Subject|0
7488501|NCT03850444|25952742|P2|Overall Study|Lost to Follow-up|1
7488502|NCT03850444|25952743|P1|Overall Study|Lost to Follow-up|0
7488503|NCT03850444|25952742|P2|Overall Study|Death|64
7488504|NCT03850444|25952743|P1|Overall Study|Death|38
7488505|NCT03850444|25952742|P2|Overall Study|Adverse Event|9
7488506|NCT03850444|25952743|P1|Overall Study|Adverse Event|12
7488507|NCT03850093|25952899|P3|Overall Study|Withdrawal by Subject|2
7488508|NCT03850093|25952900|P2|Overall Study|Withdrawal by Subject|0
7488509|NCT03850093|25952901|P1|Overall Study|Withdrawal by Subject|1
7488510|NCT03849300|25952981|P4|Overall Study|scheduling/transportation conflict|2
7488511|NCT03849300|25952982|P3|Overall Study|scheduling/transportation conflict|3
7488512|NCT03849300|25952983|P2|Overall Study|scheduling/transportation conflict|4
7488513|NCT03849300|25952984|P1|Overall Study|scheduling/transportation conflict|4
7488514|NCT03849300|25952981|P4|Overall Study|move out to different area|4
7488515|NCT03849300|25952982|P3|Overall Study|move out to different area|1
7488516|NCT03849300|25952983|P2|Overall Study|move out to different area|3
7488517|NCT03849300|25952984|P1|Overall Study|move out to different area|1
7488518|NCT03848949|25953040|P2|Overall Study|Lost to Follow-up|7
7488519|NCT03848949|25953041|P1|Overall Study|Lost to Follow-up|5
7488520|NCT03848416|25953097|P3|Overall Study|Death|1
7488521|NCT03848416|25953098|P2|Overall Study|Death|0
7488522|NCT03848416|25953099|P1|Overall Study|Death|0
7488523|NCT03848416|25953097|P3|Overall Study|Withdrawal by Subject|0
7488524|NCT03848416|25953098|P2|Overall Study|Withdrawal by Subject|0
7488525|NCT03848416|25953099|P1|Overall Study|Withdrawal by Subject|1
7488526|NCT03848403|25953113|P3|Period 2 (Day 8)|Sponsor Decision|5
7488527|NCT03848403|25953114|P2|Period 2 (Day 8)|Sponsor Decision|6
7488528|NCT03848403|25953115|P1|Period 2 (Day 8)|Sponsor Decision|8
7488529|NCT03848403|25953113|P3|Period 2 (Day 8)|Physician Decision|0
7488530|NCT03848403|25953114|P2|Period 2 (Day 8)|Physician Decision|1
7488531|NCT03848403|25953115|P1|Period 2 (Day 8)|Physician Decision|0
7488532|NCT03848403|25953113|P3|Period 2 (Day 8)|Adverse Event|2
7488533|NCT03848403|25953114|P2|Period 2 (Day 8)|Adverse Event|2
7488534|NCT03848403|25953115|P1|Period 2 (Day 8)|Adverse Event|1
7488535|NCT03847987|25953200|P2|Overall Study|Adverse Event|0
7488536|NCT03847987|25953201|P1|Overall Study|Adverse Event|2
7488537|NCT03847987|25953200|P2|Overall Study|Lost to Follow-up|0
7488538|NCT03847987|25953201|P1|Overall Study|Lost to Follow-up|1
7488539|NCT03847610|25953224|P1|Overall Study|Withdrawal by Subject|1
7488540|NCT03846219|25953266|P3|Overall Study|Physician Decision|2
7488541|NCT03846219|25953267|P2|Overall Study|Physician Decision|0
7488542|NCT03846219|25953268|P1|Overall Study|Physician Decision|0
7488543|NCT03846219|25953266|P3|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
7488544|NCT03846219|25953267|P2|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
7488545|NCT03846219|25953268|P1|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
7488546|NCT03846219|25953266|P3|Overall Study|Withdrawal by Subject|2
7488547|NCT03846219|25953267|P2|Overall Study|Withdrawal by Subject|2
7488548|NCT03846219|25953268|P1|Overall Study|Withdrawal by Subject|3
7488549|NCT03844945|25953455|P4|Overall Study|Lack of Efficacy|1
7488550|NCT03844945|25953456|P3|Overall Study|Lack of Efficacy|0
7488551|NCT03844945|25953457|P2|Overall Study|Lack of Efficacy|0
7488552|NCT03844945|25953458|P1|Overall Study|Lack of Efficacy|0
7488553|NCT03844945|25953455|P4|Overall Study|Withdrawal by Subject|0
7488554|NCT03844945|25953456|P3|Overall Study|Withdrawal by Subject|1
7488555|NCT03844945|25953457|P2|Overall Study|Withdrawal by Subject|0
7488556|NCT03844945|25953458|P1|Overall Study|Withdrawal by Subject|0
7488557|NCT03844945|25953455|P4|Overall Study|Adverse Event|0
7488558|NCT03844945|25953456|P3|Overall Study|Adverse Event|4
7488559|NCT03844945|25953457|P2|Overall Study|Adverse Event|1
7488560|NCT03844945|25953458|P1|Overall Study|Adverse Event|1
7488561|NCT03843632|25953517|P4|Overall Study|Withdrawal by Subject|0
7488562|NCT03843632|25953518|P3|Overall Study|Withdrawal by Subject|0
7488563|NCT03843632|25953519|P2|Overall Study|Withdrawal by Subject|0
7488564|NCT03843632|25953520|P1|Overall Study|Withdrawal by Subject|1
7488565|NCT03841331|25953624|P2|Overall Study|Lost to Follow-up|1
7488566|NCT03841331|25953625|P1|Overall Study|Lost to Follow-up|5
7488567|NCT03841331|25953624|P2|Overall Study|Withdrawal by Subject|9
7488568|NCT03841331|25953625|P1|Overall Study|Withdrawal by Subject|4
7488569|NCT03840811|25953648|P3|Overall Study|Lost to Follow-up|1
7488570|NCT03840811|25953649|P2|Overall Study|Lost to Follow-up|0
7488571|NCT03840811|25953650|P1|Overall Study|Lost to Follow-up|0
7488572|NCT03840135|25953688|P2|Overall Study|Withdrawal by Subject|0
7488573|NCT03840135|25953689|P1|Overall Study|Withdrawal by Subject|1
7488574|NCT03840135|25953688|P2|Overall Study|Protocol Violation|1
7488575|NCT03840135|25953689|P1|Overall Study|Protocol Violation|6
7488576|NCT03839641|25953717|P2|Overall Study|Withdrawal by Subject|1
7488577|NCT03839641|25953718|P1|Overall Study|Withdrawal by Subject|1
7488578|NCT03839355|25953743|P2|Overall Study|Withdrawal by Subject|0
7488579|NCT03839355|25953744|P1|Overall Study|Withdrawal by Subject|1
7488580|NCT03839212|25953754|P1|Overall Study|COVID-19 related suspension of research activities.|4
7488581|NCT03838731|25953787|P2|Overall Study|Withdrawal of consent|0
7488582|NCT03838731|25953788|P1|Overall Study|Withdrawal of consent|1
7488583|NCT03838731|25953787|P2|Overall Study|Pregnancy|1
7488584|NCT03838731|25953788|P1|Overall Study|Pregnancy|0
7488585|NCT03838198|25953812|P4|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
7488586|NCT03838198|25953813|P3|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
7488587|NCT03838198|25953814|P2|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
7488588|NCT03838198|25953815|P1|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
7488589|NCT03838198|25953812|P4|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7488590|NCT03838198|25953813|P3|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
7488591|NCT03838198|25953814|P2|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7488592|NCT03838198|25953815|P1|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7488593|NCT03837028|25953838|P4|Overall Study|Withdrawal by Subject|7
7488594|NCT03837028|25953839|P3|Overall Study|Withdrawal by Subject|11
7488595|NCT03837028|25953840|P2|Overall Study|Withdrawal by Subject|11
7488596|NCT03837028|25953841|P1|Overall Study|Withdrawal by Subject|12
7488597|NCT03837028|25953838|P4|Overall Study|Lost to Follow-up|0
7488598|NCT03837028|25953839|P3|Overall Study|Lost to Follow-up|2
7488599|NCT03837028|25953840|P2|Overall Study|Lost to Follow-up|0
7488600|NCT03837028|25953841|P1|Overall Study|Lost to Follow-up|4
7488601|NCT03836729|25953923|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
7488602|NCT03836677|25954035|P2|Period 2|Severe non-compliance to protocol|0
7488603|NCT03836677|25954036|P1|Period 2|Severe non-compliance to protocol|1
7488604|NCT03836677|25954035|P2|Period 1|Adverse Event|1
7488605|NCT03836677|25954036|P1|Period 1|Adverse Event|0
7488606|NCT03836664|25954054|P2|Overall Study|Didn't complete forms and lost drug|3
7488607|NCT03836664|25954055|P1|Overall Study|Didn't complete forms and lost drug|3
7488608|NCT03835975|25954070|P5|Overall Study|Withdrawal by Subject|0
7488609|NCT03835975|25954071|P4|Overall Study|Withdrawal by Subject|1
7488610|NCT03835975|25954072|P3|Overall Study|Withdrawal by Subject|1
7488611|NCT03835975|25954073|P2|Overall Study|Withdrawal by Subject|0
7488612|NCT03835975|25954074|P1|Overall Study|Withdrawal by Subject|1
7488613|NCT03835975|25954070|P5|Overall Study|Protocol Violation|0
7488614|NCT03835975|25954071|P4|Overall Study|Protocol Violation|0
7488615|NCT03835975|25954072|P3|Overall Study|Protocol Violation|2
7488616|NCT03835975|25954073|P2|Overall Study|Protocol Violation|1
7488617|NCT03835975|25954074|P1|Overall Study|Protocol Violation|1
7488618|NCT03835975|25954070|P5|Overall Study|No longer met eligibility criteria|0
7488619|NCT03835975|25954071|P4|Overall Study|No longer met eligibility criteria|0
7488620|NCT03835975|25954072|P3|Overall Study|No longer met eligibility criteria|0
7488621|NCT03835975|25954073|P2|Overall Study|No longer met eligibility criteria|1
7488622|NCT03835975|25954074|P1|Overall Study|No longer met eligibility criteria|0
7488623|NCT03835975|25954070|P5|Overall Study|Lost to Follow-up|0
7488624|NCT03835975|25954071|P4|Overall Study|Lost to Follow-up|0
7488625|NCT03835975|25954072|P3|Overall Study|Lost to Follow-up|0
7488626|NCT03835975|25954073|P2|Overall Study|Lost to Follow-up|1
7488627|NCT03835975|25954074|P1|Overall Study|Lost to Follow-up|1
7488628|NCT03835221|25954149|P1|Methafilcon A|Withdrawal by Subject|1
7488629|NCT03832738|25954360|P3|Overall Study|Pregnancy|0
7488630|NCT03832738|25954361|P2|Overall Study|Pregnancy|1
7488631|NCT03832738|25954362|P1|Overall Study|Pregnancy|0
7488632|NCT03832738|25954360|P3|Overall Study|Adverse Event|1
7488633|NCT03832738|25954361|P2|Overall Study|Adverse Event|3
7488634|NCT03832738|25954362|P1|Overall Study|Adverse Event|2
7488635|NCT03832738|25954360|P3|Overall Study|Physician Decision|2
7488636|NCT03832738|25954361|P2|Overall Study|Physician Decision|1
7488637|NCT03832738|25954362|P1|Overall Study|Physician Decision|0
7488638|NCT03832738|25954360|P3|Overall Study|Withdrawal by Subject|16
7488639|NCT03832738|25954361|P2|Overall Study|Withdrawal by Subject|7
7488640|NCT03832738|25954362|P1|Overall Study|Withdrawal by Subject|6
7488641|NCT03832387|25954410|P2|Overall Study|EXCLUSION CRITERIA|1
7488642|NCT03832387|25954411|P1|Overall Study|EXCLUSION CRITERIA|3
7488643|NCT03832387|25954410|P2|Overall Study|Protocol Violation|6
7488644|NCT03832387|25954411|P1|Overall Study|Protocol Violation|2
7488645|NCT03832322|25954441|P2|Overall Study|Failed cecal intubation in 2nd exam|1
7488646|NCT03832322|25954442|P1|Overall Study|Failed cecal intubation in 2nd exam|3
7488647|NCT03831945|25954471|P2|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
7488648|NCT03831945|25954472|P1|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
7488649|NCT03831945|25954471|P2|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
7488650|NCT03831945|25954472|P1|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
7488651|NCT03831945|25954471|P2|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
7488652|NCT03831945|25954472|P1|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
7488653|NCT03831880|25954482|P2|Period 2 (12 Weeks)|Protocol Deviation|1
7488654|NCT03831880|25954483|P1|Period 2 (12 Weeks)|Protocol Deviation|0
7488655|NCT03831880|25954482|P2|Period 1 (12 Weeks)|Adverse event, not serious|1
7488656|NCT03831880|25954483|P1|Period 1 (12 Weeks)|Adverse event, not serious|0
7488657|NCT03831282|25954601|P1|Overall Study|Could not place sensor|1
7488658|NCT03831191|25954609|P15|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7488659|NCT03831191|25954610|P14|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488660|NCT03831191|25954611|P13|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488661|NCT03831191|25954612|P12|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488662|NCT03831191|25954613|P11|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488663|NCT03831191|25954614|P10|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488664|NCT03831191|25954615|P9|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488665|NCT03831191|25954616|P8|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488666|NCT03831191|25954617|P7|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488667|NCT03831191|25954618|P6|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488668|NCT03831191|25954619|P5|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488669|NCT03831191|25954620|P4|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488670|NCT03831191|25954621|P3|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488671|NCT03831191|25954622|P2|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488672|NCT03831191|25954623|P1|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7488673|NCT03831191|25954609|P15|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7488674|NCT03831191|25954610|P14|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488675|NCT03831191|25954611|P13|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488676|NCT03831191|25954612|P12|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488677|NCT03831191|25954613|P11|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488678|NCT03831191|25954614|P10|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488679|NCT03831191|25954615|P9|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488680|NCT03831191|25954616|P8|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488681|NCT03831191|25954617|P7|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488682|NCT03831191|25954618|P6|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488683|NCT03831191|25954619|P5|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488684|NCT03831191|25954620|P4|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488685|NCT03831191|25954621|P3|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488686|NCT03831191|25954622|P2|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488687|NCT03831191|25954623|P1|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7488688|NCT03831191|25954609|P15|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
7488689|NCT03831191|25954610|P14|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7488690|NCT03831191|25954611|P13|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7488691|NCT03831191|25954612|P12|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
7488692|NCT03831191|25954613|P11|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7488693|NCT03831191|25954614|P10|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7488694|NCT03831191|25954615|P9|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
7488695|NCT03831191|25954616|P8|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7488696|NCT03831191|25954617|P7|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
7488697|NCT03831191|25954618|P6|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
7488698|NCT03831191|25954619|P5|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7488699|NCT03831191|25954620|P4|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7488700|NCT03831191|25954621|P3|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7488701|NCT03831191|25954622|P2|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7488702|NCT03831191|25954623|P1|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7488703|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Sponsor Decision|0
7488704|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Sponsor Decision|0
7488705|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Sponsor Decision|0
7488706|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Sponsor Decision|0
7488707|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Sponsor Decision|0
7488708|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Sponsor Decision|0
7488709|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Sponsor Decision|0
7488710|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Sponsor Decision|0
7488711|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Sponsor Decision|0
7488712|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Sponsor Decision|0
7488713|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Sponsor Decision|0
7488714|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Sponsor Decision|1
7488715|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Sponsor Decision|0
7488716|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Sponsor Decision|0
7488717|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Sponsor Decision|0
7488718|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488719|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488720|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488721|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488722|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488723|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488724|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488725|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488726|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488727|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488728|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7488729|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
7488730|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
7488731|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
7488732|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
7488733|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488734|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488735|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488736|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488737|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488738|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488739|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488740|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488741|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488742|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488743|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
7488744|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Withdrawal by Subject|3
7488745|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Withdrawal by Subject|1
7488746|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Withdrawal by Subject|2
7488747|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Withdrawal by Subject|7
7488748|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Protocol Violation|0
7488749|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Protocol Violation|0
7488750|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Protocol Violation|0
7488751|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Protocol Violation|0
7488752|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Protocol Violation|0
7488753|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Protocol Violation|0
7488754|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Protocol Violation|0
7488755|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Protocol Violation|0
7488756|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Protocol Violation|0
7488757|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Protocol Violation|0
7488758|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Protocol Violation|0
7488759|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Protocol Violation|2
7488760|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Protocol Violation|0
7488761|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Protocol Violation|0
7488762|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Protocol Violation|0
7488763|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Pregnancy|0
7488764|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Pregnancy|0
7488765|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Pregnancy|0
7488766|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Pregnancy|0
7488767|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Pregnancy|0
7488768|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Pregnancy|0
7488769|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Pregnancy|0
7488770|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Pregnancy|0
7488771|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Pregnancy|0
7488772|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Pregnancy|0
7488773|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Pregnancy|0
7488774|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Pregnancy|0
7488775|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Pregnancy|1
7488776|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Pregnancy|0
7488777|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Pregnancy|0
7488778|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Lack of Efficacy|0
7488779|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Lack of Efficacy|0
7488780|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Lack of Efficacy|0
7488781|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Lack of Efficacy|0
7488782|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Lack of Efficacy|0
7488783|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Lack of Efficacy|0
7488784|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Lack of Efficacy|0
7488785|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Lack of Efficacy|0
7488786|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Lack of Efficacy|0
7488787|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Lack of Efficacy|0
7488788|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Lack of Efficacy|0
7488789|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Lack of Efficacy|0
7488790|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Lack of Efficacy|0
7488791|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Lack of Efficacy|3
7488792|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Lack of Efficacy|2
7488793|NCT03831191|25954609|P15|Induction Period (16 Weeks)|Adverse Event|0
7488794|NCT03831191|25954610|P14|Induction Period (16 Weeks)|Adverse Event|0
7488795|NCT03831191|25954611|P13|Induction Period (16 Weeks)|Adverse Event|0
7488796|NCT03831191|25954612|P12|Induction Period (16 Weeks)|Adverse Event|0
7488797|NCT03831191|25954613|P11|Induction Period (16 Weeks)|Adverse Event|0
7488798|NCT03831191|25954614|P10|Induction Period (16 Weeks)|Adverse Event|0
7488799|NCT03831191|25954615|P9|Induction Period (16 Weeks)|Adverse Event|0
7488800|NCT03831191|25954616|P8|Induction Period (16 Weeks)|Adverse Event|0
7488801|NCT03831191|25954617|P7|Induction Period (16 Weeks)|Adverse Event|0
7488802|NCT03831191|25954618|P6|Induction Period (16 Weeks)|Adverse Event|0
7488803|NCT03831191|25954619|P5|Induction Period (16 Weeks)|Adverse Event|0
7488804|NCT03831191|25954620|P4|Induction Period (16 Weeks)|Adverse Event|4
7488805|NCT03831191|25954621|P3|Induction Period (16 Weeks)|Adverse Event|3
7488806|NCT03831191|25954622|P2|Induction Period (16 Weeks)|Adverse Event|1
7488807|NCT03831191|25954623|P1|Induction Period (16 Weeks)|Adverse Event|2
7488808|NCT03830892|25954678|P2|Overall Study|Withdrawal by Subject|2
7488809|NCT03830892|25954679|P1|Overall Study|Withdrawal by Subject|0
7488810|NCT03830892|25954678|P2|Overall Study|Protocol Violation|1
7488811|NCT03830892|25954679|P1|Overall Study|Protocol Violation|0
7488812|NCT03830892|25954678|P2|Overall Study|Study terminated due to COVID|0
7488813|NCT03830892|25954679|P1|Overall Study|Study terminated due to COVID|4
7488814|NCT03830892|25954678|P2|Overall Study|Physician Decision|3
7488815|NCT03830892|25954679|P1|Overall Study|Physician Decision|2
7488816|NCT03830281|25954712|P2|Treatment Period (16 Weeks)|Withdrawal by Subject|6
7488817|NCT03830281|25954713|P1|Treatment Period (16 Weeks)|Withdrawal by Subject|5
7488818|NCT03830281|25954712|P2|Treatment Period (16 Weeks)|Physician Decision|0
7488819|NCT03830281|25954713|P1|Treatment Period (16 Weeks)|Physician Decision|1
7488820|NCT03830281|25954712|P2|Treatment Period (16 Weeks)|Sponsor Decision|1
7488821|NCT03830281|25954713|P1|Treatment Period (16 Weeks)|Sponsor Decision|1
7488822|NCT03830281|25954712|P2|Treatment Period (16 Weeks)|Lost to Follow-up|3
7488823|NCT03830281|25954713|P1|Treatment Period (16 Weeks)|Lost to Follow-up|4
7488824|NCT03830281|25954712|P2|Treatment Period (16 Weeks)|Adverse Event|7
7488825|NCT03830281|25954713|P1|Treatment Period (16 Weeks)|Adverse Event|1
7488826|NCT03830281|25954712|P2|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
7488827|NCT03830281|25954713|P1|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
7488828|NCT03830281|25954712|P2|Lead-in Period (2 Weeks)|Physician Decision|0
7488829|NCT03830281|25954713|P1|Lead-in Period (2 Weeks)|Physician Decision|2
7488830|NCT03830281|25954712|P2|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
7488831|NCT03830281|25954713|P1|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
7488832|NCT03830281|25954712|P2|Lead-in Period (2 Weeks)|Adverse Event|0
7488833|NCT03830281|25954713|P1|Lead-in Period (2 Weeks)|Adverse Event|2
7488834|NCT03828617|25954790|P4|Overall Study|Withdrawal by Subject|0
7488835|NCT03828617|25954791|P3|Overall Study|Withdrawal by Subject|2
7488836|NCT03828617|25954792|P2|Overall Study|Withdrawal by Subject|0
7488837|NCT03828617|25954793|P1|Overall Study|Withdrawal by Subject|2
7488838|NCT03828617|25954790|P4|Overall Study|Protocol Violation|0
7488839|NCT03828617|25954791|P3|Overall Study|Protocol Violation|0
7488840|NCT03828617|25954792|P2|Overall Study|Protocol Violation|2
7488841|NCT03828617|25954793|P1|Overall Study|Protocol Violation|0
7488842|NCT03828617|25954790|P4|Overall Study|No longer met eligibility criteria|3
7488843|NCT03828617|25954791|P3|Overall Study|No longer met eligibility criteria|1
7488844|NCT03828617|25954792|P2|Overall Study|No longer met eligibility criteria|1
7488845|NCT03828617|25954793|P1|Overall Study|No longer met eligibility criteria|0
7488846|NCT03828617|25954790|P4|Overall Study|Lost to Follow-up|7
7488847|NCT03828617|25954791|P3|Overall Study|Lost to Follow-up|23
7488848|NCT03828617|25954792|P2|Overall Study|Lost to Follow-up|12
7488849|NCT03828617|25954793|P1|Overall Study|Lost to Follow-up|22
7488850|NCT03828539|25954821|P2|Overall Study|New therapy for study indication|0
7488851|NCT03828539|25954822|P1|Overall Study|New therapy for study indication|1
7488852|NCT03828539|25954821|P2|Overall Study|Withdrawal of informed consent|1
7488853|NCT03828539|25954822|P1|Overall Study|Withdrawal of informed consent|2
7488854|NCT03828539|25954821|P2|Overall Study|Protocol Violation|2
7488855|NCT03828539|25954822|P1|Overall Study|Protocol Violation|3
7488856|NCT03828539|25954821|P2|Overall Study|Lost to Follow-up|2
7488857|NCT03828539|25954822|P1|Overall Study|Lost to Follow-up|4
7488858|NCT03828539|25954821|P2|Overall Study|Patient's/guardian's decision|5
7488859|NCT03828539|25954822|P1|Overall Study|Patient's/guardian's decision|3
7488860|NCT03828539|25954821|P2|Overall Study|Adverse Event|12
7488861|NCT03828539|25954822|P1|Overall Study|Adverse Event|3
7488862|NCT03828487|25954834|P1|Overall Study|Physician Decision|1
7488863|NCT03827564|25954849|P2|Overall Study|Discontinued due to Study Termination|0
7488864|NCT03827564|25954850|P1|Overall Study|Discontinued due to Study Termination|1
7488865|NCT03827473|25954858|P2|Overall Study|Withdrawal by Subject|0
7488866|NCT03827473|25954859|P1|Overall Study|Withdrawal by Subject|1
7488867|NCT03827395|25954875|P2|Overall Study|Became ineligible after enrollment|2
7488868|NCT03827395|25954876|P1|Overall Study|Became ineligible after enrollment|1
7488869|NCT03827395|25954875|P2|Overall Study|Protocol Violation|0
7488870|NCT03827395|25954876|P1|Overall Study|Protocol Violation|1
7488871|NCT03827395|25954875|P2|Overall Study|Lost to Follow-up|0
7488872|NCT03827395|25954876|P1|Overall Study|Lost to Follow-up|1
7488873|NCT03826914|25954902|P2|Overall Study|Withdrawal by Subject|1
7488874|NCT03826914|25954903|P1|Overall Study|Withdrawal by Subject|1
7488875|NCT03825042|25954954|P2|Overall Study|Withdrawal by Subject|0
7488876|NCT03825042|25954955|P1|Overall Study|Withdrawal by Subject|1
7488877|NCT03825042|25954954|P2|Overall Study|Adverse Event|0
7488878|NCT03825042|25954955|P1|Overall Study|Adverse Event|1
7488879|NCT03824912|25954968|P3|Overall Study|Participation in another study|0
7488880|NCT03824912|25954969|P2|Overall Study|Participation in another study|1
7488881|NCT03824912|25954970|P1|Overall Study|Participation in another study|0
7488882|NCT03824912|25954968|P3|Overall Study|Withdrawal by Subject|1
7488883|NCT03824912|25954969|P2|Overall Study|Withdrawal by Subject|2
7488884|NCT03824912|25954970|P1|Overall Study|Withdrawal by Subject|3
7488885|NCT03824912|25954968|P3|Overall Study|Protocol Violation|1
7488886|NCT03824912|25954969|P2|Overall Study|Protocol Violation|4
7488887|NCT03824912|25954970|P1|Overall Study|Protocol Violation|1
7488888|NCT03824912|25954968|P3|Overall Study|Non-Compliance with Study Drug|1
7488889|NCT03824912|25954969|P2|Overall Study|Non-Compliance with Study Drug|0
7488890|NCT03824912|25954970|P1|Overall Study|Non-Compliance with Study Drug|0
7488891|NCT03824912|25954968|P3|Overall Study|Negative Baseline Culture Result|57
7488892|NCT03824912|25954969|P2|Overall Study|Negative Baseline Culture Result|112
7488893|NCT03824912|25954970|P1|Overall Study|Negative Baseline Culture Result|118
7488894|NCT03824912|25954968|P3|Overall Study|Lost to Follow-up|8
7488895|NCT03824912|25954969|P2|Overall Study|Lost to Follow-up|15
7488896|NCT03824912|25954970|P1|Overall Study|Lost to Follow-up|18
7488897|NCT03824704|25954990|P1|Overall Study|Study Terminated by Sponsor|1
7488898|NCT03824236|25955001|P3|Overall Study|Lost to Follow-up|1
7488899|NCT03824236|25955002|P2|Overall Study|Lost to Follow-up|0
7488900|NCT03824236|25955003|P1|Overall Study|Lost to Follow-up|0
7488901|NCT03823391|25955057|P2|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
7488902|NCT03823391|25955058|P1|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
7488903|NCT03823391|25955057|P2|Period 2: Weeks 12 to Week 24|Adverse Event|1
7488904|NCT03823391|25955058|P1|Period 2: Weeks 12 to Week 24|Adverse Event|1
7488905|NCT03823378|25955082|P6|Overall Study|Other, not specified|7
7488906|NCT03823378|25955083|P5|Overall Study|Other, not specified|17
7488907|NCT03823378|25955084|P4|Overall Study|Other, not specified|8
7488908|NCT03823378|25955085|P3|Overall Study|Other, not specified|6
7488909|NCT03823378|25955086|P2|Overall Study|Other, not specified|12
7488910|NCT03823378|25955087|P1|Overall Study|Other, not specified|19
7488911|NCT03823378|25955082|P6|Overall Study|Withdrawal by Subject|1
7488912|NCT03823378|25955083|P5|Overall Study|Withdrawal by Subject|0
7488913|NCT03823378|25955084|P4|Overall Study|Withdrawal by Subject|2
7488914|NCT03823378|25955085|P3|Overall Study|Withdrawal by Subject|4
7488915|NCT03823378|25955086|P2|Overall Study|Withdrawal by Subject|1
7488916|NCT03823378|25955087|P1|Overall Study|Withdrawal by Subject|0
7488917|NCT03823378|25955082|P6|Overall Study|Lost to Follow-up|0
7488918|NCT03823378|25955083|P5|Overall Study|Lost to Follow-up|1
7488919|NCT03823378|25955084|P4|Overall Study|Lost to Follow-up|0
7488920|NCT03823378|25955085|P3|Overall Study|Lost to Follow-up|0
7488921|NCT03823378|25955086|P2|Overall Study|Lost to Follow-up|1
7488922|NCT03823378|25955087|P1|Overall Study|Lost to Follow-up|0
7488923|NCT03823378|25955082|P6|Overall Study|Adverse Event|0
7488924|NCT03823378|25955083|P5|Overall Study|Adverse Event|0
7488925|NCT03823378|25955084|P4|Overall Study|Adverse Event|0
7488926|NCT03823378|25955085|P3|Overall Study|Adverse Event|0
7488927|NCT03823378|25955086|P2|Overall Study|Adverse Event|2
7488928|NCT03823378|25955087|P1|Overall Study|Adverse Event|2
7488929|NCT03822884|25955209|P6|Overall Study|Withdrawal by Subject|0
7488930|NCT03822884|25955210|P5|Overall Study|Withdrawal by Subject|1
7488931|NCT03822884|25955211|P4|Overall Study|Withdrawal by Subject|0
7488932|NCT03822884|25955212|P3|Overall Study|Withdrawal by Subject|0
7488933|NCT03822884|25955213|P2|Overall Study|Withdrawal by Subject|0
7488934|NCT03822884|25955214|P1|Overall Study|Withdrawal by Subject|0
7488935|NCT03822416|25955245|P2|Overall Study|Withdrawal by Subject|1
7488936|NCT03822416|25955246|P1|Overall Study|Withdrawal by Subject|0
7488937|NCT03822416|25955245|P2|Overall Study|Lost to Follow-up|0
7488938|NCT03822416|25955246|P1|Overall Study|Lost to Follow-up|1
7488939|NCT03822182|25955278|P3|Overall Study|Protocol Violation|1
7488940|NCT03822182|25955279|P2|Overall Study|Protocol Violation|1
7488941|NCT03822182|25955280|P1|Overall Study|Protocol Violation|0
7488942|NCT03821064|25955368|P1|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
7488943|NCT03820024|25955471|P2|Overall Study|Physician Decision|2
7488944|NCT03820024|25955472|P1|Overall Study|Physician Decision|1
7488945|NCT03819634|25955478|P1|Overall Study|Physician Decision|2
7488946|NCT03819218|25955496|P1|Overall Study|Protocol Violation|1
7488947|NCT03817879|25955522|P2|Overall Study|Withdrawal by Subject|1
7488948|NCT03817879|25955523|P1|Overall Study|Withdrawal by Subject|0
7488949|NCT03817879|25955522|P2|Overall Study|Drop out|12
7488950|NCT03817879|25955523|P1|Overall Study|Drop out|5
7488984|NCT03816761|25955576|P6|Second Treatment Period (7 Days)|Unclassified|0
7488985|NCT03816761|25955577|P5|Second Treatment Period (7 Days)|Unclassified|0
7488986|NCT03816761|25955578|P4|Second Treatment Period (7 Days)|Unclassified|1
7488987|NCT03816761|25955579|P3|Second Treatment Period (7 Days)|Unclassified|0
7488988|NCT03816761|25955580|P2|Second Treatment Period (7 Days)|Unclassified|0
7488989|NCT03816761|25955581|P1|Second Treatment Period (7 Days)|Unclassified|0
7488990|NCT03816761|25955576|P6|First Treatment Period (7 Days)|Withdrawal by Subject|1
7488991|NCT03816761|25955577|P5|First Treatment Period (7 Days)|Withdrawal by Subject|0
7488992|NCT03816761|25955578|P4|First Treatment Period (7 Days)|Withdrawal by Subject|0
7488993|NCT03816761|25955579|P3|First Treatment Period (7 Days)|Withdrawal by Subject|0
7488994|NCT03816761|25955580|P2|First Treatment Period (7 Days)|Withdrawal by Subject|0
7488995|NCT03816761|25955581|P1|First Treatment Period (7 Days)|Withdrawal by Subject|0
7488996|NCT03812679|25955915|P1|Overall Study|Water device replacement|1
7488997|NCT03812679|25955915|P1|Overall Study|Termination of study|2
7488998|NCT03812679|25955915|P1|Overall Study|Withdrawal by Subject|1
7488999|NCT03812679|25955915|P1|Overall Study|Renal transplant|1
7489000|NCT03812679|25955915|P1|Overall Study|Missed >4 consecutive therapy days|1
7489001|NCT03812679|25955915|P1|Overall Study|Adverse Event|2
7489002|NCT03812510|25955922|P1|Overall Study|Adverse Event|5
7489003|NCT03812510|25955922|P1|Overall Study|Did Not Start Study Medication|55
7489004|NCT03812510|25955922|P1|Overall Study|Study Terminated by Sponsor|9
7489005|NCT03812510|25955922|P1|Overall Study|Physician Decision|2
7489006|NCT03812510|25955922|P1|Overall Study|Withdrawal by Subject|42
7489007|NCT03812510|25955922|P1|Overall Study|Lost to Follow-up|39
7489008|NCT03812224|25955969|P2|Overall Study|Decision by Sponsor|1
7489009|NCT03812224|25955970|P1|Overall Study|Decision by Sponsor|0
7489010|NCT03812224|25955969|P2|Overall Study|Withdrawal by Subject|2
7489011|NCT03812224|25955970|P1|Overall Study|Withdrawal by Subject|4
7489012|NCT03811834|25955991|P1|Period 1 ( 7 Days)|Adverse Event|1
7489013|NCT03811093|25956041|P2|Overall Study|Unable to measure body fat percentage|0
7489014|NCT03811093|25956042|P1|Overall Study|Unable to measure body fat percentage|2
7489015|NCT03811093|25956041|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
7489016|NCT03811093|25956042|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
7489017|NCT03810235|25956054|P2|Overall Study|Withdrawal by Subject|0
7489018|NCT03810235|25956055|P1|Overall Study|Withdrawal by Subject|2
7489019|NCT03810183|25956085|P2|Overall Study|Study terminated by Sponsor|1
7489020|NCT03810183|25956086|P1|Overall Study|Study terminated by Sponsor|2
7489021|NCT03810014|25956102|P4|Overall Study|Pregnancy|2
7489022|NCT03810014|25956103|P3|Overall Study|Pregnancy|0
7489023|NCT03810014|25956104|P2|Overall Study|Pregnancy|2
7489024|NCT03810014|25956105|P1|Overall Study|Pregnancy|2
7489025|NCT03809611|25956162|P2|Overall Study|Withdrawal by Subject|1
7489026|NCT03809611|25956163|P1|Overall Study|Withdrawal by Subject|1
7489027|NCT03809104|25956195|P1|Overall Study|Withdrawal by Subject|3
7489028|NCT03809039|25956260|P9|Part 3|Withdrawn by study termination|6
7489029|NCT03809039|25956261|P8|Part 3|Withdrawn by study termination|2
7489030|NCT03809039|25956262|P7|Part 3|Withdrawn by study termination|0
7489031|NCT03809039|25956263|P6|Part 3|Withdrawn by study termination|0
7489032|NCT03809039|25956264|P5|Part 3|Withdrawn by study termination|0
7489033|NCT03809039|25956265|P4|Part 3|Withdrawn by study termination|0
7489034|NCT03809039|25956266|P3|Part 3|Withdrawn by study termination|0
7489035|NCT03809039|25956267|P2|Part 3|Withdrawn by study termination|0
7489036|NCT03809039|25956268|P1|Part 3|Withdrawn by study termination|0
7489037|NCT03809039|25956260|P9|Part 1|Withdrawal by Subject|0
7489038|NCT03809039|25956261|P8|Part 1|Withdrawal by Subject|0
7489039|NCT03809039|25956262|P7|Part 1|Withdrawal by Subject|0
7489040|NCT03809039|25956263|P6|Part 1|Withdrawal by Subject|0
7489041|NCT03809039|25956264|P5|Part 1|Withdrawal by Subject|0
7489042|NCT03809039|25956265|P4|Part 1|Withdrawal by Subject|1
7489043|NCT03809039|25956266|P3|Part 1|Withdrawal by Subject|0
7489044|NCT03809039|25956267|P2|Part 1|Withdrawal by Subject|0
7489045|NCT03809039|25956268|P1|Part 1|Withdrawal by Subject|1
7489046|NCT03808688|25956380|P2|Overall Study|Medication Non-Compliance|1
7489047|NCT03808688|25956381|P1|Overall Study|Medication Non-Compliance|0
7489048|NCT03808688|25956380|P2|Overall Study|Visit Out of Window|1
7489049|NCT03808688|25956381|P1|Overall Study|Visit Out of Window|0
7489050|NCT03808688|25956380|P2|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
7489051|NCT03808688|25956381|P1|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
7489052|NCT03808688|25956380|P2|Overall Study|IOP Too High|1
7489053|NCT03808688|25956381|P1|Overall Study|IOP Too High|1
7489054|NCT03808688|25956380|P2|Overall Study|Intolerance to Conjunctival Hyperemia|0
7489055|NCT03808688|25956381|P1|Overall Study|Intolerance to Conjunctival Hyperemia|1
7489056|NCT03808688|25956380|P2|Overall Study|Withdrawal by Subject|0
7489057|NCT03808688|25956381|P1|Overall Study|Withdrawal by Subject|1
7489058|NCT03808688|25956380|P2|Overall Study|Lost to Follow-up|2
7489059|NCT03808688|25956381|P1|Overall Study|Lost to Follow-up|0
7489060|NCT03808688|25956380|P2|Overall Study|Lack of Efficacy|0
7489061|NCT03808688|25956381|P1|Overall Study|Lack of Efficacy|2
7489062|NCT03808688|25956380|P2|Overall Study|Adverse Event|17
7489063|NCT03808688|25956381|P1|Overall Study|Adverse Event|13
7489064|NCT03808298|25956426|P1|Overall Study|Positive Urine Drug Screen at Check-in|3
7489065|NCT03808298|25956426|P1|Overall Study|Withdrawal by Subject|1
7489066|NCT03808298|25956426|P1|Overall Study|Physician Decision|1
7489067|NCT03808298|25956426|P1|Overall Study|Adverse Event|3
7489068|NCT03807739|25956503|P4|Overall Study|Withdrawal by Subject|0
7489069|NCT03807739|25956504|P3|Overall Study|Withdrawal by Subject|0
7489070|NCT03807739|25956505|P2|Overall Study|Withdrawal by Subject|0
7489071|NCT03807739|25956506|P1|Overall Study|Withdrawal by Subject|1
7489072|NCT03807739|25956503|P4|Overall Study|Adverse Event|0
7489073|NCT03807739|25956504|P3|Overall Study|Adverse Event|0
7489074|NCT03807739|25956505|P2|Overall Study|Adverse Event|0
7489075|NCT03807739|25956506|P1|Overall Study|Adverse Event|1
7489076|NCT03807700|25956522|P2|Overall Study|Withdrawal by Subject|1
7489077|NCT03807700|25956523|P1|Overall Study|Withdrawal by Subject|2
7489078|NCT03806231|25956663|P2|Overall Study|Withdrawal by Subject|0
7489079|NCT03806231|25956664|P1|Overall Study|Withdrawal by Subject|1
7489080|NCT03806231|25956663|P2|Overall Study|Physician Decision|0
7489081|NCT03806231|25956664|P1|Overall Study|Physician Decision|1
7489082|NCT03806127|25956694|P2|Overall Study|Covid 19 Concern; Possible Site Closure|1
7489083|NCT03806127|25956695|P1|Overall Study|Covid 19 Concern; Possible Site Closure|0
7489084|NCT03806127|25956694|P2|Overall Study|Withdrawn Due to Work/School Schedule|1
7489085|NCT03806127|25956695|P1|Overall Study|Withdrawn Due to Work/School Schedule|0
7489086|NCT03806127|25956694|P2|Overall Study|Covid 19 Restrictions|0
7489087|NCT03806127|25956695|P1|Overall Study|Covid 19 Restrictions|2
7489088|NCT03806127|25956694|P2|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
7489089|NCT03806127|25956695|P1|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
7489090|NCT03806127|25956694|P2|Overall Study|Prescribed Exclusionary Medication (Med)|0
7489091|NCT03806127|25956695|P1|Overall Study|Prescribed Exclusionary Medication (Med)|1
7489092|NCT03806127|25956694|P2|Overall Study|Could Not Come Due to Covid|0
7489093|NCT03806127|25956695|P1|Overall Study|Could Not Come Due to Covid|1
7489094|NCT03806127|25956694|P2|Overall Study|Physician Decision|1
7489095|NCT03806127|25956695|P1|Overall Study|Physician Decision|1
7489096|NCT03806127|25956694|P2|Overall Study|Lost to Follow-up|1
7489097|NCT03806127|25956695|P1|Overall Study|Lost to Follow-up|5
7489098|NCT03806127|25956694|P2|Overall Study|Pregnancy|1
7489099|NCT03806127|25956695|P1|Overall Study|Pregnancy|0
7489100|NCT03806127|25956694|P2|Overall Study|Unable to Complete Procedures|1
7489101|NCT03806127|25956695|P1|Overall Study|Unable to Complete Procedures|0
7489102|NCT03806127|25956694|P2|Overall Study|Adverse Event|0
7489103|NCT03806127|25956695|P1|Overall Study|Adverse Event|3
7489104|NCT03806127|25956694|P2|Overall Study|Protocol Violation|1
7489105|NCT03806127|25956695|P1|Overall Study|Protocol Violation|3
7489106|NCT03806127|25956694|P2|Overall Study|Withdrawal by Subject|5
7489107|NCT03806127|25956695|P1|Overall Study|Withdrawal by Subject|4
7489108|NCT03805971|25956713|P1|Overall Study|Protocol Violation|2
7489109|NCT03805971|25956713|P1|Overall Study|Withdrawal by Subject|1
7489110|NCT03805438|25956735|P1|Overall Study|Protocol Violation|1
7489111|NCT03805438|25956735|P1|Overall Study|Lack of Efficacy|1
7489112|NCT03804918|25956766|P1|Overall Study|Participant did not use the app|1
7489113|NCT03804710|25956773|P2|Overall Study|Other|1
7489114|NCT03804710|25956774|P1|Overall Study|Other|0
7489115|NCT03804710|25956773|P2|Overall Study|Withdrawal by Subject|1
7489116|NCT03804710|25956774|P1|Overall Study|Withdrawal by Subject|2
7489117|NCT03804710|25956773|P2|Overall Study|Adverse Event|3
7489118|NCT03804710|25956774|P1|Overall Study|Adverse Event|0
7489119|NCT03803475|25956829|P1|Overall Study|Physician Decision|1
7489120|NCT03802994|25956855|P5|Overall Study|Lost to Follow-up|2
7489121|NCT03802994|25956856|P4|Overall Study|Lost to Follow-up|2
7489122|NCT03802994|25956857|P3|Overall Study|Lost to Follow-up|3
7489123|NCT03802994|25956858|P2|Overall Study|Lost to Follow-up|2
7489124|NCT03802994|25956859|P1|Overall Study|Lost to Follow-up|0
7489125|NCT03802916|25956888|P2|Overall Study|Withdrawal by Subject|1
7489126|NCT03802916|25956889|P1|Overall Study|Withdrawal by Subject|0
7489127|NCT03802916|25956888|P2|Overall Study|Adverse Event|1
7489128|NCT03802916|25956889|P1|Overall Study|Adverse Event|0
7489129|NCT03802565|25956925|P5|Overall Study|Elevated Enzymes|2
7489130|NCT03802565|25956926|P4|Overall Study|Elevated Enzymes|0
7489131|NCT03802565|25956927|P3|Overall Study|Elevated Enzymes|0
7489132|NCT03802565|25956928|P2|Overall Study|Elevated Enzymes|0
7489133|NCT03802565|25956929|P1|Overall Study|Elevated Enzymes|0
7489134|NCT03802565|25956925|P5|Overall Study|Subjects Related to Each Other|1
7489135|NCT03802565|25956926|P4|Overall Study|Subjects Related to Each Other|2
7489136|NCT03802565|25956927|P3|Overall Study|Subjects Related to Each Other|0
7489137|NCT03802565|25956928|P2|Overall Study|Subjects Related to Each Other|0
7489138|NCT03802565|25956929|P1|Overall Study|Subjects Related to Each Other|1
7489139|NCT03802565|25956925|P5|Overall Study|Lost to Follow-up|0
7489140|NCT03802565|25956926|P4|Overall Study|Lost to Follow-up|0
7489141|NCT03802565|25956927|P3|Overall Study|Lost to Follow-up|1
7489142|NCT03802565|25956928|P2|Overall Study|Lost to Follow-up|0
7489143|NCT03802565|25956929|P1|Overall Study|Lost to Follow-up|0
7489144|NCT03802565|25956925|P5|Overall Study|Protocol Violation|1
7489145|NCT03802565|25956926|P4|Overall Study|Protocol Violation|5
7489146|NCT03802565|25956927|P3|Overall Study|Protocol Violation|4
7489147|NCT03802565|25956928|P2|Overall Study|Protocol Violation|1
7489148|NCT03802565|25956929|P1|Overall Study|Protocol Violation|2
7489149|NCT03802565|25956925|P5|Overall Study|Withdrawal by Subject|1
7489150|NCT03802565|25956926|P4|Overall Study|Withdrawal by Subject|0
7489151|NCT03802565|25956927|P3|Overall Study|Withdrawal by Subject|2
7489152|NCT03802565|25956928|P2|Overall Study|Withdrawal by Subject|2
7489153|NCT03802565|25956929|P1|Overall Study|Withdrawal by Subject|2
7489154|NCT03802565|25956925|P5|Overall Study|Adverse Event|1
7489155|NCT03802565|25956926|P4|Overall Study|Adverse Event|1
7489156|NCT03802565|25956927|P3|Overall Study|Adverse Event|2
7489157|NCT03802565|25956928|P2|Overall Study|Adverse Event|1
7489158|NCT03802565|25956929|P1|Overall Study|Adverse Event|0
7489159|NCT03801928|25956980|P6|Overall Study|Other|1
7489160|NCT03801928|25956981|P5|Overall Study|Other|0
7489161|NCT03801928|25956982|P4|Overall Study|Other|1
7489162|NCT03801928|25956983|P3|Overall Study|Other|0
7489163|NCT03801928|25956984|P2|Overall Study|Other|2
7489164|NCT03801928|25956985|P1|Overall Study|Other|0
7489165|NCT03801928|25956980|P6|Overall Study|Withdrawal by Subject|0
7489166|NCT03801928|25956981|P5|Overall Study|Withdrawal by Subject|0
7489167|NCT03801928|25956982|P4|Overall Study|Withdrawal by Subject|1
7489168|NCT03801928|25956983|P3|Overall Study|Withdrawal by Subject|2
7489169|NCT03801928|25956984|P2|Overall Study|Withdrawal by Subject|0
7489170|NCT03801928|25956985|P1|Overall Study|Withdrawal by Subject|0
7489171|NCT03801928|25956980|P6|Overall Study|Lost to Follow-up|2
7489172|NCT03801928|25956981|P5|Overall Study|Lost to Follow-up|4
7489173|NCT03801928|25956982|P4|Overall Study|Lost to Follow-up|4
7489174|NCT03801928|25956983|P3|Overall Study|Lost to Follow-up|1
7489175|NCT03801928|25956984|P2|Overall Study|Lost to Follow-up|1
7489176|NCT03801928|25956985|P1|Overall Study|Lost to Follow-up|5
7489177|NCT03801928|25956980|P6|Overall Study|Lack of Efficacy|0
7489178|NCT03801928|25956981|P5|Overall Study|Lack of Efficacy|0
7489179|NCT03801928|25956982|P4|Overall Study|Lack of Efficacy|0
7489180|NCT03801928|25956983|P3|Overall Study|Lack of Efficacy|1
7489181|NCT03801928|25956984|P2|Overall Study|Lack of Efficacy|0
7489182|NCT03801928|25956985|P1|Overall Study|Lack of Efficacy|0
7489183|NCT03801928|25956980|P6|Overall Study|Adverse Event|2
7489184|NCT03801928|25956981|P5|Overall Study|Adverse Event|0
7489185|NCT03801928|25956982|P4|Overall Study|Adverse Event|2
7489186|NCT03801928|25956983|P3|Overall Study|Adverse Event|1
7489187|NCT03801928|25956984|P2|Overall Study|Adverse Event|0
7489188|NCT03801928|25956985|P1|Overall Study|Adverse Event|1
7489189|NCT03801148|25957295|P4|Follow-Up (12 Days)|Lost to Follow-up|0
7489190|NCT03801148|25957296|P3|Follow-Up (12 Days)|Lost to Follow-up|1
7489191|NCT03801148|25957297|P2|Follow-Up (12 Days)|Lost to Follow-up|1
7489192|NCT03801148|25957298|P1|Follow-Up (12 Days)|Lost to Follow-up|0
7489193|NCT03801148|25957295|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7489194|NCT03801148|25957296|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7489195|NCT03801148|25957297|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7489196|NCT03801148|25957298|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7489197|NCT03801148|25957295|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
7489198|NCT03801148|25957296|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7489199|NCT03801148|25957297|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7489200|NCT03801148|25957298|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7489201|NCT03801148|25957295|P4|Period 1 (2 Days)|Adverse Event|0
7489202|NCT03801148|25957296|P3|Period 1 (2 Days)|Adverse Event|0
7489203|NCT03801148|25957297|P2|Period 1 (2 Days)|Adverse Event|1
7489204|NCT03801148|25957298|P1|Period 1 (2 Days)|Adverse Event|1
7489205|NCT03800173|25957344|P5|Overall Study|Lost to Follow-up|1
7489206|NCT03800173|25957345|P4|Overall Study|Lost to Follow-up|0
7489207|NCT03800173|25957346|P3|Overall Study|Lost to Follow-up|0
7489208|NCT03800173|25957347|P2|Overall Study|Lost to Follow-up|0
7489209|NCT03800173|25957348|P1|Overall Study|Lost to Follow-up|0
7489210|NCT03799952|25957402|P2|Overall Study|Lost to Follow-up|2
7489211|NCT03799952|25957403|P1|Overall Study|Lost to Follow-up|0
7489212|NCT03799952|25957402|P2|Overall Study|Program was too easy, discontinued|0
7489213|NCT03799952|25957403|P1|Overall Study|Program was too easy, discontinued|1
7489214|NCT03799211|25957477|P2|Overall Study|Withdrawal by Subject|0
7489215|NCT03799211|25957478|P1|Overall Study|Withdrawal by Subject|2
7489216|NCT03799211|25957477|P2|Overall Study|Lost to Follow-up|13
7489217|NCT03799211|25957478|P1|Overall Study|Lost to Follow-up|2
7489222|NCT03798717|25957543|P6|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7489223|NCT03798717|25957544|P5|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
7489224|NCT03798717|25957545|P4|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7489225|NCT03798717|25957546|P3|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7489226|NCT03798717|25957547|P2|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7489227|NCT03798717|25957548|P1|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7489228|NCT03798717|25957543|P6|Overall Study|Adverse Event|0
7489229|NCT03798717|25957544|P5|Overall Study|Adverse Event|0
7489230|NCT03798717|25957545|P4|Overall Study|Adverse Event|0
7489231|NCT03798717|25957546|P3|Overall Study|Adverse Event|0
7489232|NCT03798717|25957547|P2|Overall Study|Adverse Event|1
7489233|NCT03798717|25957548|P1|Overall Study|Adverse Event|0
7489234|NCT03798717|25957543|P6|Overall Study|Lost to Follow-up|0
7489235|NCT03798717|25957544|P5|Overall Study|Lost to Follow-up|0
7489236|NCT03798717|25957545|P4|Overall Study|Lost to Follow-up|1
7489237|NCT03798717|25957546|P3|Overall Study|Lost to Follow-up|0
7489238|NCT03798717|25957547|P2|Overall Study|Lost to Follow-up|0
7489239|NCT03798717|25957548|P1|Overall Study|Lost to Follow-up|1
7489240|NCT03798717|25957543|P6|Overall Study|Withdrawal by Subject|0
7489241|NCT03798717|25957544|P5|Overall Study|Withdrawal by Subject|0
7489242|NCT03798717|25957545|P4|Overall Study|Withdrawal by Subject|1
7489243|NCT03798717|25957546|P3|Overall Study|Withdrawal by Subject|0
7489244|NCT03798717|25957547|P2|Overall Study|Withdrawal by Subject|0
7489245|NCT03798717|25957548|P1|Overall Study|Withdrawal by Subject|0
7489246|NCT03798717|25957543|P6|Overall Study|Physician Decision|0
7489247|NCT03798717|25957544|P5|Overall Study|Physician Decision|0
7489248|NCT03798717|25957545|P4|Overall Study|Physician Decision|0
7489249|NCT03798717|25957546|P3|Overall Study|Physician Decision|1
7489250|NCT03798717|25957547|P2|Overall Study|Physician Decision|0
7489251|NCT03798717|25957548|P1|Overall Study|Physician Decision|1
7489252|NCT03798717|25957543|P6|Overall Study|Failed Screening|1
7489253|NCT03798717|25957544|P5|Overall Study|Failed Screening|0
7489254|NCT03798717|25957545|P4|Overall Study|Failed Screening|0
7489255|NCT03798717|25957546|P3|Overall Study|Failed Screening|0
7489256|NCT03798717|25957547|P2|Overall Study|Failed Screening|0
7489257|NCT03798717|25957548|P1|Overall Study|Failed Screening|0
7489258|NCT03798483|25957574|P1|Overall Study|Lost to Follow-up|2
7489259|NCT03798366|25957597|P2|Overall Study|Lost to Follow-up|1
7489260|NCT03798366|25957598|P1|Overall Study|Lost to Follow-up|0
7489261|NCT03797144|25957629|P2|24 Month|Early termination cut-off date|1
7489262|NCT03797144|25957630|P1|24 Month|Early termination cut-off date|1
7489263|NCT03797144|25957629|P2|12 Month|Early termination cut-off date|9
7489264|NCT03797144|25957630|P1|12 Month|Early termination cut-off date|8
7489265|NCT03797144|25957629|P2|3 Month|Early termination cut-off date|0
7489266|NCT03797144|25957630|P1|3 Month|Early termination cut-off date|2
7489267|NCT03797144|25957629|P2|Surgery|Protocol Violation|0
7489268|NCT03797144|25957630|P1|Surgery|Protocol Violation|1
7489269|NCT03797144|25957629|P2|Enrollment|Protocol Violation|1
7489270|NCT03797144|25957630|P1|Enrollment|Protocol Violation|4
7489271|NCT03796728|25957659|P1|Overall Study|Reason not Specified|16
7489272|NCT03796728|25957659|P1|Overall Study|Lost to Follow-up|8
7489273|NCT03796676|25957674|P3|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
7489274|NCT03796676|25957675|P2|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
7489275|NCT03796676|25957676|P1|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
7489276|NCT03796676|25957674|P3|Overall Study|Withdrawal by Subject|0
7489277|NCT03796676|25957675|P2|Overall Study|Withdrawal by Subject|1
7489278|NCT03796676|25957676|P1|Overall Study|Withdrawal by Subject|1
7489279|NCT03796676|25957674|P3|Overall Study|Protocol Violation|1
7489280|NCT03796676|25957675|P2|Overall Study|Protocol Violation|0
7489281|NCT03796676|25957676|P1|Overall Study|Protocol Violation|0
7489282|NCT03796676|25957674|P3|Overall Study|Lost to Follow-up|0
7489283|NCT03796676|25957675|P2|Overall Study|Lost to Follow-up|1
7489284|NCT03796676|25957676|P1|Overall Study|Lost to Follow-up|2
7489285|NCT03796676|25957674|P3|Overall Study|Adverse Event|2
7489286|NCT03796676|25957675|P2|Overall Study|Adverse Event|1
7489287|NCT03796676|25957676|P1|Overall Study|Adverse Event|2
7489288|NCT03796039|25957855|P2|Overall Study|Withdrawal by Subject|4
7489289|NCT03796039|25957856|P1|Overall Study|Withdrawal by Subject|7
7489290|NCT03796039|25957855|P2|Overall Study|Death|1
7489291|NCT03796039|25957856|P1|Overall Study|Death|2
7489292|NCT03793556|25957960|P2|Overall Study|Lost to Follow-up|1
7489293|NCT03793556|25957961|P1|Overall Study|Lost to Follow-up|1
7489294|NCT03793556|25957960|P2|Overall Study|Withdrawal by Subject|1
7489295|NCT03793556|25957961|P1|Overall Study|Withdrawal by Subject|12
7489296|NCT03793010|25958005|P2|Overall Study|Did not meet eligibility criteria|0
7489297|NCT03793010|25958006|P1|Overall Study|Did not meet eligibility criteria|1
7489298|NCT03793010|25958005|P2|Overall Study|Withdrew to pursue other treatment|0
7489299|NCT03793010|25958006|P1|Overall Study|Withdrew to pursue other treatment|1
7489300|NCT03793010|25958005|P2|Overall Study|Patient couldn't sit still for injection|0
7489301|NCT03793010|25958006|P1|Overall Study|Patient couldn't sit still for injection|1
7489302|NCT03793010|25958005|P2|Overall Study|Lost to Follow-up|2
7489303|NCT03793010|25958006|P1|Overall Study|Lost to Follow-up|1
7489304|NCT03793010|25958005|P2|Overall Study|Withdrawn by Investigator or Sponsor|18
7489305|NCT03793010|25958006|P1|Overall Study|Withdrawn by Investigator or Sponsor|19
7489306|NCT03793010|25958005|P2|Overall Study|Withdrawal by Subject|7
7489307|NCT03793010|25958006|P1|Overall Study|Withdrawal by Subject|5
7489308|NCT03792672|25958029|P6|Treatment Period 4 (2 Days)|Other|0
7489309|NCT03792672|25958030|P5|Treatment Period 4 (2 Days)|Other|0
7489310|NCT03792672|25958031|P4|Treatment Period 4 (2 Days)|Other|0
7489311|NCT03792672|25958032|P3|Treatment Period 4 (2 Days)|Other|0
7489312|NCT03792672|25958033|P2|Treatment Period 4 (2 Days)|Other|0
7489313|NCT03792672|25958034|P1|Treatment Period 4 (2 Days)|Other|1
7489314|NCT03792672|25958029|P6|Washout Period 3 (10 Days)|Physician Decision|0
7489315|NCT03792672|25958030|P5|Washout Period 3 (10 Days)|Physician Decision|0
7489316|NCT03792672|25958031|P4|Washout Period 3 (10 Days)|Physician Decision|0
7489317|NCT03792672|25958032|P3|Washout Period 3 (10 Days)|Physician Decision|1
7489318|NCT03792672|25958033|P2|Washout Period 3 (10 Days)|Physician Decision|0
7489319|NCT03792672|25958034|P1|Washout Period 3 (10 Days)|Physician Decision|0
7489320|NCT03792672|25958029|P6|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7489321|NCT03792672|25958030|P5|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7489322|NCT03792672|25958031|P4|Washout Period 3 (10 Days)|Withdrawal by Subject|2
7489323|NCT03792672|25958032|P3|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7489324|NCT03792672|25958033|P2|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7489325|NCT03792672|25958034|P1|Washout Period 3 (10 Days)|Withdrawal by Subject|1
7489326|NCT03792477|25958059|P5|Overall Study|Other|1
7489327|NCT03792477|25958060|P4|Overall Study|Other|0
7489328|NCT03792477|25958061|P3|Overall Study|Other|0
7489329|NCT03792477|25958062|P2|Overall Study|Other|0
7489330|NCT03792477|25958063|P1|Overall Study|Other|0
7489331|NCT03792477|25958059|P5|Overall Study|Lost to Follow-up|0
7489332|NCT03792477|25958060|P4|Overall Study|Lost to Follow-up|0
7489333|NCT03792477|25958061|P3|Overall Study|Lost to Follow-up|2
7489334|NCT03792477|25958062|P2|Overall Study|Lost to Follow-up|0
7489335|NCT03792477|25958063|P1|Overall Study|Lost to Follow-up|0
7489336|NCT03792477|25958059|P5|Overall Study|Adverse Event|0
7489337|NCT03792477|25958060|P4|Overall Study|Adverse Event|1
7489338|NCT03792477|25958061|P3|Overall Study|Adverse Event|0
7489339|NCT03792477|25958062|P2|Overall Study|Adverse Event|0
7489340|NCT03792477|25958063|P1|Overall Study|Adverse Event|0
7489341|NCT03790917|25958113|P1|Overall Study|Death|1
7489342|NCT03787615|25958282|P1|Overall Study|Lost to Follow-up|2
7489343|NCT03787615|25958282|P1|Overall Study|Withdrawal by Subject|2
7489344|NCT03787212|25958296|P2|Period 1|Study Termination|2
7489345|NCT03787212|25958297|P1|Period 1|Study Termination|2
7489346|NCT03786718|25958317|P1|Overall Study|diagnosis changed from type 2 to type 1|1
7489347|NCT03786718|25958317|P1|Overall Study|Did not use the intervention|2
7489348|NCT03786718|25958317|P1|Overall Study|Withdrawal by Subject|1
7489349|NCT03786718|25958317|P1|Overall Study|Lost to Follow-up|3
7489350|NCT03785548|25958334|P2|Overall Study|no Postop queries|0
7489351|NCT03785548|25958335|P1|Overall Study|no Postop queries|1
7489352|NCT03785548|25958334|P2|Overall Study|age > 80|0
7489353|NCT03785548|25958335|P1|Overall Study|age > 80|1
7489354|NCT03784963|25958347|P4|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
7489355|NCT03784963|25958348|P3|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
7489356|NCT03784963|25958349|P2|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
7489357|NCT03784963|25958350|P1|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
7489358|NCT03783962|25958892|P2|Overall Study|Protocol Violation|1
7489359|NCT03783962|25958893|P1|Overall Study|Protocol Violation|0
7489360|NCT03783962|25958892|P2|Overall Study|Lost to Follow-up|6
7489361|NCT03783962|25958893|P1|Overall Study|Lost to Follow-up|3
7489362|NCT03783780|25958919|P1|Overall Study|Withdrawn prior to completion|1
7489363|NCT03783702|25958926|P2|Overall Study|Protocol Violation|3
7489364|NCT03783702|25958927|P1|Overall Study|Protocol Violation|1
7489365|NCT03783702|25958926|P2|Overall Study|Lost to Follow-up|8
7489366|NCT03783702|25958927|P1|Overall Study|Lost to Follow-up|6
7489367|NCT03783039|25959025|P2|Overall Study|Death|1
7489368|NCT03783039|25959026|P1|Overall Study|Death|2
7489369|NCT03782571|25959054|P4|Period 3|Adverse Event|0
7489370|NCT03782571|25959055|P3|Period 3|Adverse Event|0
7489371|NCT03782571|25959056|P2|Period 3|Adverse Event|0
7489372|NCT03782571|25959057|P1|Period 3|Adverse Event|1
7489373|NCT03782571|25959054|P4|Period 3|Subject Unable to Attend V5|0
7489374|NCT03782571|25959055|P3|Period 3|Subject Unable to Attend V5|0
7489375|NCT03782571|25959056|P2|Period 3|Subject Unable to Attend V5|0
7489376|NCT03782571|25959057|P1|Period 3|Subject Unable to Attend V5|1
7489377|NCT03782571|25959054|P4|Period 1|Withdrawal by Subject|0
7489378|NCT03782571|25959055|P3|Period 1|Withdrawal by Subject|0
7489379|NCT03782571|25959056|P2|Period 1|Withdrawal by Subject|0
7489380|NCT03782571|25959057|P1|Period 1|Withdrawal by Subject|1
7489381|NCT03781375|25959206|P2|Open-label Phase|Other|2
7489382|NCT03781375|25959207|P1|Open-label Phase|Other|2
7489383|NCT03781375|25959206|P2|Open-label Phase|Suboptimal Clinical Response|0
7489384|NCT03781375|25959207|P1|Open-label Phase|Suboptimal Clinical Response|1
7489385|NCT03781375|25959206|P2|Open-label Phase|Protocol Issues|1
7489386|NCT03781375|25959207|P1|Open-label Phase|Protocol Issues|0
7489387|NCT03781375|25959206|P2|Double-blind Phase|Other|3
7489388|NCT03781375|25959207|P1|Double-blind Phase|Other|1
7489389|NCT03781375|25959206|P2|Double-blind Phase|Lack of Response|2
7489390|NCT03781375|25959207|P1|Double-blind Phase|Lack of Response|6
7489391|NCT03781375|25959206|P2|Double-blind Phase|Adverse Event|1
7489392|NCT03781375|25959207|P1|Double-blind Phase|Adverse Event|0
7489393|NCT03781336|25959220|P2|Overall Study|Withdrawal by Subject|2
7489394|NCT03781336|25959221|P1|Overall Study|Withdrawal by Subject|2
7489395|NCT03780959|25959255|P3|Part 2|Response Status|6
7489396|NCT03780959|25959256|P2|Part 2|Response Status|18
7489397|NCT03780959|25959257|P1|Part 2|Response Status|0
7489398|NCT03780959|25959255|P3|Part 2|Withdrawal by Parent/Guardian|0
7489399|NCT03780959|25959256|P2|Part 2|Withdrawal by Parent/Guardian|1
7489400|NCT03780959|25959257|P1|Part 2|Withdrawal by Parent/Guardian|0
7489401|NCT03780959|25959255|P3|Part 1|Response Status|0
7489402|NCT03780959|25959256|P2|Part 1|Response Status|0
7489403|NCT03780959|25959257|P1|Part 1|Response Status|2
7489404|NCT03780959|25959255|P3|Part 1|Withdrawal by Parent/Guardian|0
7489405|NCT03780959|25959256|P2|Part 1|Withdrawal by Parent/Guardian|0
7489406|NCT03780959|25959257|P1|Part 1|Withdrawal by Parent/Guardian|1
7489407|NCT03780959|25959255|P3|Part 1|Withdrawal by Subject|0
7489408|NCT03780959|25959256|P2|Part 1|Withdrawal by Subject|0
7489409|NCT03780959|25959257|P1|Part 1|Withdrawal by Subject|1
7489410|NCT03780959|25959255|P3|Part 1|Adverse Event|0
7489411|NCT03780959|25959256|P2|Part 1|Adverse Event|0
7489412|NCT03780959|25959257|P1|Part 1|Adverse Event|1
7489413|NCT03780400|25959269|P1|Overall Study|Withdrawal by Subject|2
7489414|NCT03780400|25959269|P1|Overall Study|Lost to Follow-up|5
7489415|NCT03779503|25959359|P2|First Intervention|Withdrawal by Subject|0
7489416|NCT03779503|25959360|P1|First Intervention|Withdrawal by Subject|1
7489417|NCT03779503|25959359|P2|First Intervention|Adverse Event|1
7489418|NCT03779503|25959360|P1|First Intervention|Adverse Event|0
7489419|NCT03777059|25959399|P4|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
7489420|NCT03777059|25959400|P3|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
7489421|NCT03777059|25959401|P2|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
7489422|NCT03777059|25959402|P1|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
7489423|NCT03777059|25959399|P4|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
7489424|NCT03777059|25959400|P3|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
7489425|NCT03777059|25959401|P2|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
7489426|NCT03777059|25959402|P1|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
7489427|NCT03777059|25959399|P4|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
7489428|NCT03777059|25959400|P3|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
7489429|NCT03777059|25959401|P2|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
7489430|NCT03777059|25959402|P1|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
7489431|NCT03777059|25959399|P4|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
7489432|NCT03777059|25959400|P3|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
7489433|NCT03777059|25959401|P2|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
7489434|NCT03777059|25959402|P1|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
7489435|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
7489436|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
7489437|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
7489438|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
7489439|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
7489440|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
7489441|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
7489442|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
7489443|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Pregnancy|0
7489444|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Pregnancy|0
7489445|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Pregnancy|1
7489446|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Pregnancy|0
7489447|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
7489448|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
7489449|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
7489450|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
7489451|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
7489452|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
7489453|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
7489454|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
7489455|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
7489456|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
7489457|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
7489458|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
7489459|NCT03777059|25959399|P4|DB Treatment Period (Up to Week 12)|Adverse Event|6
7489460|NCT03777059|25959400|P3|DB Treatment Period (Up to Week 12)|Adverse Event|4
7489461|NCT03777059|25959401|P2|DB Treatment Period (Up to Week 12)|Adverse Event|9
7489462|NCT03777059|25959402|P1|DB Treatment Period (Up to Week 12)|Adverse Event|6
7489463|NCT03776175|25959481|P4|Follow-Up Period (35 Days)|Lost to Follow-up|2
7489464|NCT03776175|25959482|P3|Follow-Up Period (35 Days)|Lost to Follow-up|0
7489465|NCT03776175|25959483|P2|Follow-Up Period (35 Days)|Lost to Follow-up|0
7489466|NCT03776175|25959484|P1|Follow-Up Period (35 Days)|Lost to Follow-up|0
7489467|NCT03776175|25959481|P4|Treatment Period (42 Days)|Unable to attend study visits|0
7489468|NCT03776175|25959482|P3|Treatment Period (42 Days)|Unable to attend study visits|0
7489469|NCT03776175|25959483|P2|Treatment Period (42 Days)|Unable to attend study visits|2
7489470|NCT03776175|25959484|P1|Treatment Period (42 Days)|Unable to attend study visits|0
7489471|NCT03776175|25959481|P4|Treatment Period (42 Days)|Withdrawal by Subject|0
7489472|NCT03776175|25959482|P3|Treatment Period (42 Days)|Withdrawal by Subject|3
7489473|NCT03776175|25959483|P2|Treatment Period (42 Days)|Withdrawal by Subject|2
7489474|NCT03776175|25959484|P1|Treatment Period (42 Days)|Withdrawal by Subject|1
7489475|NCT03776175|25959481|P4|Treatment Period (42 Days)|Participants screened at other site|0
7489476|NCT03776175|25959482|P3|Treatment Period (42 Days)|Participants screened at other site|0
7489477|NCT03776175|25959483|P2|Treatment Period (42 Days)|Participants screened at other site|2
7489478|NCT03776175|25959484|P1|Treatment Period (42 Days)|Participants screened at other site|0
7489479|NCT03776175|25959481|P4|Treatment Period (42 Days)|Lost to Follow-up|2
7489480|NCT03776175|25959482|P3|Treatment Period (42 Days)|Lost to Follow-up|0
7489481|NCT03776175|25959483|P2|Treatment Period (42 Days)|Lost to Follow-up|0
7489482|NCT03776175|25959484|P1|Treatment Period (42 Days)|Lost to Follow-up|0
7489483|NCT03776175|25959481|P4|Treatment Period (42 Days)|Adverse Event|0
7489484|NCT03776175|25959482|P3|Treatment Period (42 Days)|Adverse Event|1
7489485|NCT03776175|25959483|P2|Treatment Period (42 Days)|Adverse Event|1
7489486|NCT03776175|25959484|P1|Treatment Period (42 Days)|Adverse Event|0
7489487|NCT03775681|25959535|P1|Overall Study|Physician Decision|3
7489488|NCT03774823|25959542|P2|Overall Study|Withdrawal by Subject|1
7489489|NCT03774823|25959543|P1|Overall Study|Withdrawal by Subject|1
7489490|NCT03774576|25959586|P1|Period 2|Adverse Event|1
7489491|NCT03774433|25959599|P1|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
7489492|NCT03773796|25959604|P1|Overall Study|Lack of Efficacy|1
7489493|NCT03773796|25959604|P1|Overall Study|Withdrawal by Subject|1
7489494|NCT03773796|25959604|P1|Overall Study|Adverse Event|1
7489495|NCT03773133|25959627|P1|Overall Study|Screen Failure|8
7489496|NCT03772522|25959634|P2|Post-intervention Follow-up|Lost to Follow-up|0
7489497|NCT03772522|25959635|P1|Post-intervention Follow-up|Lost to Follow-up|1
7489498|NCT03772522|25959634|P2|Intervention|Withdrawal by Subject|0
7489499|NCT03772522|25959635|P1|Intervention|Withdrawal by Subject|1
7489500|NCT03772522|25959634|P2|Pre-intervention|Withdrawal by Subject|4
7489501|NCT03772522|25959635|P1|Pre-intervention|Withdrawal by Subject|3
7489502|NCT03772327|25959658|P2|Overall Study|Withdrawal by Subject|3
7489503|NCT03772327|25959659|P1|Overall Study|Withdrawal by Subject|2
7489504|NCT03772327|25959658|P2|Overall Study|Lost to Follow-up|4
7489505|NCT03772327|25959659|P1|Overall Study|Lost to Follow-up|3
7489506|NCT03772041|25959677|P2|Overall Study|Physician Decision|3
7489507|NCT03772041|25959678|P1|Overall Study|Physician Decision|2
7489508|NCT03772041|25959677|P2|Overall Study|Protocol Violation|2
7489509|NCT03772041|25959678|P1|Overall Study|Protocol Violation|4
7489510|NCT03772041|25959677|P2|Overall Study|Withdrawal by Subject|2
7489511|NCT03772041|25959678|P1|Overall Study|Withdrawal by Subject|0
7489512|NCT03772041|25959677|P2|Overall Study|Adverse Event|3
7489513|NCT03772041|25959678|P1|Overall Study|Adverse Event|8
7489514|NCT03771963|25959692|P1|Overall Study|Withdrawal of Consent|10
7489515|NCT03771963|25959692|P1|Overall Study|Lost to Follow-up|22
7489516|NCT03771352|25959712|P1|Overall Study|Withdrawal by Subject|2
7489517|NCT03771352|25959712|P1|Overall Study|Screen failure|2
7489518|NCT03769896|25959752|P2|Open-label Phase|Withdrawal by Subject|0
7489519|NCT03769896|25959753|P1|Open-label Phase|Withdrawal by Subject|1
7489520|NCT03769896|25959752|P2|Open-label Phase|Adverse Event|0
7489521|NCT03769896|25959753|P1|Open-label Phase|Adverse Event|3
7489522|NCT03769896|25959752|P2|Open-label Phase|Lack of Efficacy|0
7489523|NCT03769896|25959753|P1|Open-label Phase|Lack of Efficacy|5
7489524|NCT03769649|25959802|P1|Overall Study|Lost to Follow-up|4
7489525|NCT03769194|25959833|P4|Overall Study|other|0
7489526|NCT03769194|25959834|P3|Overall Study|other|1
7489527|NCT03769194|25959835|P2|Overall Study|other|2
7489528|NCT03769194|25959836|P1|Overall Study|other|0
7489529|NCT03769194|25959833|P4|Overall Study|Lost to Follow-up|3
7489530|NCT03769194|25959834|P3|Overall Study|Lost to Follow-up|1
7489531|NCT03769194|25959835|P2|Overall Study|Lost to Follow-up|2
7489532|NCT03769194|25959836|P1|Overall Study|Lost to Follow-up|1
7489533|NCT03769194|25959833|P4|Overall Study|moved from study area|0
7489534|NCT03769194|25959834|P3|Overall Study|moved from study area|0
7489535|NCT03769194|25959835|P2|Overall Study|moved from study area|1
7489536|NCT03769194|25959836|P1|Overall Study|moved from study area|0
7489537|NCT03769194|25959833|P4|Overall Study|Withdrawal by Subject|0
7489538|NCT03769194|25959834|P3|Overall Study|Withdrawal by Subject|2
7489539|NCT03769194|25959835|P2|Overall Study|Withdrawal by Subject|5
7489540|NCT03769194|25959836|P1|Overall Study|Withdrawal by Subject|0
7489541|NCT03768726|25959857|P2|Follow-Up|Other|0
7489542|NCT03768726|25959858|P1|Follow-Up|Other|1
7489543|NCT03768726|25959857|P2|Follow-Up|Withdrawal by Subject|0
7489544|NCT03768726|25959858|P1|Follow-Up|Withdrawal by Subject|2
7489545|NCT03768726|25959857|P2|Follow-Up|Withdrawal By Parent/Guardian|1
7489546|NCT03768726|25959858|P1|Follow-Up|Withdrawal By Parent/Guardian|1
7489547|NCT03768726|25959857|P2|Follow-Up|Adverse Event|2
7489548|NCT03768726|25959858|P1|Follow-Up|Adverse Event|2
7489549|NCT03768726|25959857|P2|Treatment Phase|Withdrawal by Subject|1
7489550|NCT03768726|25959858|P1|Treatment Phase|Withdrawal by Subject|3
7489551|NCT03768726|25959857|P2|Treatment Phase|Withdrawal By Parent/Guardian|0
7489552|NCT03768726|25959858|P1|Treatment Phase|Withdrawal By Parent/Guardian|2
7489553|NCT03768726|25959857|P2|Treatment Phase|Lost to Follow-up|0
7489554|NCT03768726|25959858|P1|Treatment Phase|Lost to Follow-up|1
7489555|NCT03768726|25959857|P2|Treatment Phase|Adverse Event|2
7489556|NCT03768726|25959858|P1|Treatment Phase|Adverse Event|2
7489557|NCT03768206|25959902|P2|Overall Study|Withdrawal by Subject|1
7489558|NCT03768206|25959903|P1|Overall Study|Withdrawal by Subject|0
7489559|NCT03768206|25959902|P2|Overall Study|Lost to Follow-up|1
7489560|NCT03768206|25959903|P1|Overall Study|Lost to Follow-up|2
7489561|NCT03767894|25959912|P1|Overall Study|Withdrawal by Subject|1
7489562|NCT03766646|25959964|P2|Overall Study|Protocol Violation|3
7489563|NCT03766646|25959965|P1|Overall Study|Protocol Violation|0
7489564|NCT03766646|25959964|P2|Overall Study|Withdrawal by Subject|0
7489565|NCT03766646|25959965|P1|Overall Study|Withdrawal by Subject|1
7489566|NCT03765164|25960068|P2|Pre-intervention|Withdrawal by Subject|6
7489567|NCT03765164|25960069|P1|Pre-intervention|Withdrawal by Subject|5
7489568|NCT03765138|25960079|P1|Overall Study|Lost to Follow-up|1
7489569|NCT03764813|25960089|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
7489570|NCT03764813|25960090|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
7489571|NCT03764813|25960091|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
7489572|NCT03764813|25960092|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
7489573|NCT03762681|25960262|P8|Part 2a|Pandemic Travel Restrictions|1
7489574|NCT03762681|25960263|P7|Part 2a|Pandemic Travel Restrictions|0
7489575|NCT03762681|25960264|P6|Part 2a|Pandemic Travel Restrictions|0
7489576|NCT03762681|25960265|P5|Part 2a|Pandemic Travel Restrictions|0
7489577|NCT03762681|25960266|P4|Part 2a|Pandemic Travel Restrictions|0
7489578|NCT03762681|25960267|P3|Part 2a|Pandemic Travel Restrictions|0
7489579|NCT03762681|25960268|P2|Part 2a|Pandemic Travel Restrictions|0
7489580|NCT03762681|25960269|P1|Part 2a|Pandemic Travel Restrictions|0
7489581|NCT03762681|25960262|P8|Part 1|Withdrawal by Subject|0
7489582|NCT03762681|25960263|P7|Part 1|Withdrawal by Subject|0
7489583|NCT03762681|25960264|P6|Part 1|Withdrawal by Subject|0
7489584|NCT03762681|25960265|P5|Part 1|Withdrawal by Subject|0
7489585|NCT03762681|25960266|P4|Part 1|Withdrawal by Subject|1
7489586|NCT03762681|25960267|P3|Part 1|Withdrawal by Subject|0
7489587|NCT03762681|25960268|P2|Part 1|Withdrawal by Subject|0
7489588|NCT03762681|25960269|P1|Part 1|Withdrawal by Subject|0
7489589|NCT03762668|25960375|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
7489590|NCT03762668|25960376|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
7489591|NCT03762616|25960382|P1|Overall Study|Protocol Violation|2
7489592|NCT03762200|25960401|P1|Overall Study|Death|2
7489593|NCT03761147|25960427|P2|Overall Study|Adverse Event|3
7489594|NCT03761147|25960428|P1|Overall Study|Adverse Event|1
7489595|NCT03761147|25960427|P2|Overall Study|Withdrawal by Subject|1
7489596|NCT03761147|25960428|P1|Overall Study|Withdrawal by Subject|6
7489597|NCT03760510|25960707|P2|Overall Study|Not ventilated for 24 hours|97
7489598|NCT03760510|25960708|P1|Overall Study|Not ventilated for 24 hours|105
7489599|NCT03760250|25960720|P1|Overall Study|Physician Decision|1
7489600|NCT03760250|25960720|P1|Overall Study|Withdrawal by Subject|1
7489601|NCT03760146|25960731|P6|Overall Study|Withdrawal by Subject|0
7489602|NCT03760146|25960732|P5|Overall Study|Withdrawal by Subject|1
7489603|NCT03760146|25960733|P4|Overall Study|Withdrawal by Subject|0
7489604|NCT03760146|25960734|P3|Overall Study|Withdrawal by Subject|1
7489605|NCT03760146|25960735|P2|Overall Study|Withdrawal by Subject|20
7489606|NCT03760146|25960736|P1|Overall Study|Withdrawal by Subject|19
7489607|NCT03760146|25960731|P6|Overall Study|Protocol Violation|0
7489608|NCT03760146|25960732|P5|Overall Study|Protocol Violation|1
7489609|NCT03760146|25960733|P4|Overall Study|Protocol Violation|0
7489610|NCT03760146|25960734|P3|Overall Study|Protocol Violation|1
7489611|NCT03760146|25960735|P2|Overall Study|Protocol Violation|13
7489612|NCT03760146|25960736|P1|Overall Study|Protocol Violation|21
7489613|NCT03760146|25960731|P6|Overall Study|No longer met eligibility criteria|0
7489614|NCT03760146|25960732|P5|Overall Study|No longer met eligibility criteria|1
7489615|NCT03760146|25960733|P4|Overall Study|No longer met eligibility criteria|0
7489616|NCT03760146|25960734|P3|Overall Study|No longer met eligibility criteria|0
7489617|NCT03760146|25960735|P2|Overall Study|No longer met eligibility criteria|9
7489618|NCT03760146|25960736|P1|Overall Study|No longer met eligibility criteria|3
7489619|NCT03760146|25960731|P6|Overall Study|Lost to Follow-up|8
7489620|NCT03760146|25960732|P5|Overall Study|Lost to Follow-up|14
7489621|NCT03760146|25960733|P4|Overall Study|Lost to Follow-up|2
7489622|NCT03760146|25960734|P3|Overall Study|Lost to Follow-up|9
7489623|NCT03760146|25960735|P2|Overall Study|Lost to Follow-up|28
7489624|NCT03760146|25960736|P1|Overall Study|Lost to Follow-up|41
7489625|NCT03760146|25960731|P6|Overall Study|Death|0
7489626|NCT03760146|25960732|P5|Overall Study|Death|0
7489627|NCT03760146|25960733|P4|Overall Study|Death|0
7489628|NCT03760146|25960734|P3|Overall Study|Death|0
7489629|NCT03760146|25960735|P2|Overall Study|Death|0
7489630|NCT03760146|25960736|P1|Overall Study|Death|1
7489631|NCT03760146|25960731|P6|Overall Study|Adverse Event|0
7489632|NCT03760146|25960732|P5|Overall Study|Adverse Event|0
7489633|NCT03760146|25960733|P4|Overall Study|Adverse Event|0
7489634|NCT03760146|25960734|P3|Overall Study|Adverse Event|0
7489635|NCT03760146|25960735|P2|Overall Study|Adverse Event|8
7489636|NCT03760146|25960736|P1|Overall Study|Adverse Event|11
7489637|NCT03760068|25960802|P2|Overall Study|Subject Moved Out of State|0
7489638|NCT03760068|25960803|P1|Overall Study|Subject Moved Out of State|1
7489639|NCT03760068|25960802|P2|Overall Study|Lost to Follow-up|9
7489640|NCT03760068|25960803|P1|Overall Study|Lost to Follow-up|4
7489641|NCT03760068|25960802|P2|Overall Study|Physician Decision|2
7489642|NCT03760068|25960803|P1|Overall Study|Physician Decision|1
7489643|NCT03760068|25960802|P2|Overall Study|Administrative Decision by Sponsor|2
7489644|NCT03760068|25960803|P1|Overall Study|Administrative Decision by Sponsor|0
7489645|NCT03760068|25960802|P2|Overall Study|Adverse Event|2
7489646|NCT03760068|25960803|P1|Overall Study|Adverse Event|1
7489647|NCT03760068|25960802|P2|Overall Study|Withdrawal by Subject|8
7489648|NCT03760068|25960803|P1|Overall Study|Withdrawal by Subject|7
7489649|NCT03759600|25960821|P1|Overall Study|Progressive Disease|3
7489650|NCT03759600|25960821|P1|Overall Study|Adverse Event|1
7489651|NCT03759600|25960821|P1|Overall Study|Ongoing at Data Cut-off|16
7489652|NCT03759587|25960835|P1|Overall Study|Ongoing|19
7489653|NCT03759340|25960848|P1|Overall Study|Study Terminated by Sponsor|38
7489654|NCT03759340|25960848|P1|Overall Study|Withdrawal by Subject|15
7489655|NCT03759340|25960848|P1|Overall Study|Lost to Follow-up|1
7489656|NCT03759340|25960848|P1|Overall Study|Adverse Event|2
7489657|NCT03757988|25960889|P1|Overall Study|Withdrawal by Subject|1
7489658|NCT03757234|25960923|P5|Overall Study|Other|0
7489659|NCT03757234|25960924|P4|Overall Study|Other|0
7489660|NCT03757234|25960925|P3|Overall Study|Other|0
7489661|NCT03757234|25960926|P2|Overall Study|Other|1
7489662|NCT03757234|25960927|P1|Overall Study|Other|1
7489663|NCT03757234|25960923|P5|Overall Study|Withdrawal by Subject|2
7489664|NCT03757234|25960924|P4|Overall Study|Withdrawal by Subject|1
7489665|NCT03757234|25960925|P3|Overall Study|Withdrawal by Subject|0
7489666|NCT03757234|25960926|P2|Overall Study|Withdrawal by Subject|1
7489667|NCT03757234|25960927|P1|Overall Study|Withdrawal by Subject|1
7489668|NCT03757234|25960923|P5|Overall Study|Lost to Follow-up|1
7489669|NCT03757234|25960924|P4|Overall Study|Lost to Follow-up|0
7489670|NCT03757234|25960925|P3|Overall Study|Lost to Follow-up|0
7489671|NCT03757234|25960926|P2|Overall Study|Lost to Follow-up|0
7489672|NCT03757234|25960927|P1|Overall Study|Lost to Follow-up|1
7489673|NCT03757234|25960923|P5|Overall Study|Adverse Event|1
7489674|NCT03757234|25960924|P4|Overall Study|Adverse Event|0
7489675|NCT03757234|25960925|P3|Overall Study|Adverse Event|0
7489676|NCT03757234|25960926|P2|Overall Study|Adverse Event|0
7489677|NCT03757234|25960927|P1|Overall Study|Adverse Event|0
7489678|NCT03756883|25960975|P3|Overall Study|Other Reasons|0
7489679|NCT03756883|25960976|P2|Overall Study|Other Reasons|4
7489680|NCT03756883|25960977|P1|Overall Study|Other Reasons|2
7489681|NCT03756883|25960975|P3|Overall Study|Withdrawal by Subject|0
7489682|NCT03756883|25960976|P2|Overall Study|Withdrawal by Subject|1
7489683|NCT03756883|25960977|P1|Overall Study|Withdrawal by Subject|4
7489684|NCT03756883|25960975|P3|Overall Study|Significant Worsening of Condition requiring Therapy|2
7489685|NCT03756883|25960976|P2|Overall Study|Significant Worsening of Condition requiring Therapy|0
7489686|NCT03756883|25960977|P1|Overall Study|Significant Worsening of Condition requiring Therapy|0
7489687|NCT03756883|25960975|P3|Overall Study|Protocol Violation|1
7489688|NCT03756883|25960976|P2|Overall Study|Protocol Violation|0
7489689|NCT03756883|25960977|P1|Overall Study|Protocol Violation|2
7489690|NCT03756883|25960975|P3|Overall Study|Lost to Follow-up|0
7489691|NCT03756883|25960976|P2|Overall Study|Lost to Follow-up|3
7489692|NCT03756883|25960977|P1|Overall Study|Lost to Follow-up|3
7489693|NCT03756883|25960975|P3|Overall Study|Lack of Efficacy|2
7489694|NCT03756883|25960976|P2|Overall Study|Lack of Efficacy|1
7489695|NCT03756883|25960977|P1|Overall Study|Lack of Efficacy|0
7489696|NCT03756883|25960975|P3|Overall Study|Adverse Event|2
7489697|NCT03756883|25960976|P2|Overall Study|Adverse Event|2
7489698|NCT03756883|25960977|P1|Overall Study|Adverse Event|2
7489699|NCT03756571|25960994|P2|Overall Study|Lost to Follow-up|1
7489700|NCT03756571|25960995|P1|Overall Study|Lost to Follow-up|1
7489701|NCT03756285|25961036|P2|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
7489702|NCT03756285|25961037|P1|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
7489703|NCT03756285|25961036|P2|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
7489704|NCT03756285|25961037|P1|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
7489705|NCT03756285|25961036|P2|Overall Study|Lost to Follow-up|1
7489706|NCT03756285|25961037|P1|Overall Study|Lost to Follow-up|0
7489707|NCT03756129|25961053|P6|Overall Study|Physician Decision|1
7489708|NCT03756129|25961054|P5|Overall Study|Physician Decision|0
7489709|NCT03756129|25961055|P4|Overall Study|Physician Decision|0
7489710|NCT03756129|25961056|P3|Overall Study|Physician Decision|0
7489711|NCT03756129|25961057|P2|Overall Study|Physician Decision|0
7489712|NCT03756129|25961058|P1|Overall Study|Physician Decision|0
7489713|NCT03756129|25961053|P6|Overall Study|Lost to Follow-up|1
7489714|NCT03756129|25961054|P5|Overall Study|Lost to Follow-up|0
7489715|NCT03756129|25961055|P4|Overall Study|Lost to Follow-up|0
7489716|NCT03756129|25961056|P3|Overall Study|Lost to Follow-up|0
7489717|NCT03756129|25961057|P2|Overall Study|Lost to Follow-up|0
7489718|NCT03756129|25961058|P1|Overall Study|Lost to Follow-up|0
7489719|NCT03756129|25961053|P6|Overall Study|Withdrawal by Subject|3
7489720|NCT03756129|25961054|P5|Overall Study|Withdrawal by Subject|1
7489721|NCT03756129|25961055|P4|Overall Study|Withdrawal by Subject|1
7489722|NCT03756129|25961056|P3|Overall Study|Withdrawal by Subject|3
7489723|NCT03756129|25961057|P2|Overall Study|Withdrawal by Subject|1
7489724|NCT03756129|25961058|P1|Overall Study|Withdrawal by Subject|2
7489725|NCT03756129|25961053|P6|Overall Study|Adverse Event|0
7489726|NCT03756129|25961054|P5|Overall Study|Adverse Event|0
7489727|NCT03756129|25961055|P4|Overall Study|Adverse Event|2
7489728|NCT03756129|25961056|P3|Overall Study|Adverse Event|0
7489729|NCT03756129|25961057|P2|Overall Study|Adverse Event|1
7489730|NCT03756129|25961058|P1|Overall Study|Adverse Event|1
7489731|NCT03755882|25961180|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
7489732|NCT03755882|25961181|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
7489733|NCT03755882|25961180|P2|Period 1|Protocol Violation|0
7489734|NCT03755882|25961181|P1|Period 1|Protocol Violation|1
7489735|NCT03755661|25961189|P2|Overall Study|Lost to Follow-up|0
7489736|NCT03755661|25961190|P1|Overall Study|Lost to Follow-up|1
7489737|NCT03754582|25961204|P3|Follow-up Phase|Other|1
7489738|NCT03754582|25961205|P2|Follow-up Phase|Other|0
7489739|NCT03754582|25961206|P1|Follow-up Phase|Other|0
7489740|NCT03754582|25961204|P3|Treatment Phase|Adverse Event|0
7489741|NCT03754582|25961205|P2|Treatment Phase|Adverse Event|1
7489742|NCT03754582|25961206|P1|Treatment Phase|Adverse Event|0
7489743|NCT03753763|25961278|P2|Overall Study|clinical deterioration|0
7489744|NCT03753763|25961279|P1|Overall Study|clinical deterioration|1
7489745|NCT03753763|25961278|P2|Overall Study|Withdrawal by Subject|1
7489746|NCT03753763|25961279|P1|Overall Study|Withdrawal by Subject|3
7489747|NCT03753763|25961278|P2|Overall Study|Adverse Event|0
7489748|NCT03753763|25961279|P1|Overall Study|Adverse Event|2
7489749|NCT03752528|25961321|P1|Part B|Study terminated by sponsor|3
7489750|NCT03752528|25961321|P1|Part B|Protocol Violation|1
7489751|NCT03752528|25961321|P1|Part A|Protocol Violation|1
7489752|NCT03752528|25961321|P1|Part A|Lost to Follow-up|1
7489753|NCT03752151|25961381|P1|Overall Study|Protocol Violation|1
7489754|NCT03752151|25961381|P1|Overall Study|Withdrawal by Subject|1
7489755|NCT03751657|25961389|P2|Overall Study|Lost to Follow-up|1
7489756|NCT03751657|25961390|P1|Overall Study|Lost to Follow-up|2
7489757|NCT03751657|25961389|P2|Overall Study|Withdrawal by Subject|1
7489758|NCT03751657|25961390|P1|Overall Study|Withdrawal by Subject|1
7489759|NCT03751657|25961389|P2|Overall Study|Physician Decision|1
7489760|NCT03751657|25961390|P1|Overall Study|Physician Decision|0
7489761|NCT03751280|25961427|P2|Overall Study|Withdrawal by Subject|2
7489762|NCT03751280|25961428|P1|Overall Study|Withdrawal by Subject|5
7489763|NCT03751280|25961427|P2|Overall Study|Protocol Violation|2
7489764|NCT03751280|25961428|P1|Overall Study|Protocol Violation|0
7489765|NCT03751280|25961427|P2|Overall Study|Physician Decision|2
7489766|NCT03751280|25961428|P1|Overall Study|Physician Decision|0
7489767|NCT03751280|25961427|P2|Overall Study|Lost to Follow-up|5
7489768|NCT03751280|25961428|P1|Overall Study|Lost to Follow-up|3
7489769|NCT03751280|25961427|P2|Overall Study|Adverse Event|1
7489770|NCT03751280|25961428|P1|Overall Study|Adverse Event|0
7489771|NCT03751020|25961464|P3|Overall Study|Lost to Follow-up|10
7489772|NCT03751020|25961465|P2|Overall Study|Lost to Follow-up|4
7489773|NCT03751020|25961466|P1|Overall Study|Lost to Follow-up|7
7489774|NCT03751020|25961464|P3|Overall Study|Withdrawal by Subject|0
7489775|NCT03751020|25961465|P2|Overall Study|Withdrawal by Subject|0
7489776|NCT03751020|25961466|P1|Overall Study|Withdrawal by Subject|2
7489777|NCT03750955|25961563|P2|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
7489778|NCT03750955|25961564|P1|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
7489779|NCT03750955|25961563|P2|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
7489780|NCT03750955|25961564|P1|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
7489781|NCT03750695|25961580|P2|Overall Study|Lost to Follow-up|1
7489782|NCT03750695|25961581|P1|Overall Study|Lost to Follow-up|0
7489783|NCT03748706|25961727|P1|Overall Study|Lost to Follow-up|1
7489784|NCT03746405|25961783|P2|Overall Study|technical difficulties|2
7489785|NCT03746405|25961784|P1|Overall Study|technical difficulties|0
7489786|NCT03746405|25961783|P2|Overall Study|Withdrawal by Subject|0
7489787|NCT03746405|25961784|P1|Overall Study|Withdrawal by Subject|3
7489788|NCT03745937|25961794|P4|Overall Study|Not-specifed|1
7489789|NCT03745937|25961795|P3|Overall Study|Not-specifed|0
7489790|NCT03745937|25961796|P2|Overall Study|Not-specifed|1
7489791|NCT03745937|25961797|P1|Overall Study|Not-specifed|0
7489792|NCT03745937|25961794|P4|Overall Study|Withdrawal by Subject|1
7489793|NCT03745937|25961795|P3|Overall Study|Withdrawal by Subject|0
7489794|NCT03745937|25961796|P2|Overall Study|Withdrawal by Subject|0
7489795|NCT03745937|25961797|P1|Overall Study|Withdrawal by Subject|0
7489796|NCT03745222|25961911|P3|Overall Study|Withdrawal by Subject|0
7489797|NCT03745222|25961912|P2|Overall Study|Withdrawal by Subject|1
7489798|NCT03745222|25961913|P1|Overall Study|Withdrawal by Subject|0
7489799|NCT03743038|25962002|P1|Overall Study|Physician Decision|1
7489800|NCT03742271|25962048|P1|Overall Study|Protocol Violation|1
7489801|NCT03742271|25962048|P1|Overall Study|Failed Insertion & removal|3
7489802|NCT03742271|25962048|P1|Overall Study|Lost to Follow-up|4
7489803|NCT03742271|25962048|P1|Overall Study|Withdrawal by Subject|3
7489804|NCT03742271|25962048|P1|Overall Study|Unsatisfactory Visual Response|1
7489805|NCT03741062|25962119|P2|Overall Study|Protocol Violation|0
7489806|NCT03741062|25962120|P1|Overall Study|Protocol Violation|1
7489807|NCT03739866|25962174|P8|Overall Study|Enrolled but not treated|0
7489808|NCT03739866|25962175|P7|Overall Study|Enrolled but not treated|0
7489809|NCT03739866|25962176|P6|Overall Study|Enrolled but not treated|0
7489810|NCT03739866|25962177|P5|Overall Study|Enrolled but not treated|1
7489811|NCT03739866|25962178|P4|Overall Study|Enrolled but not treated|0
7489812|NCT03739866|25962179|P3|Overall Study|Enrolled but not treated|1
7489813|NCT03739866|25962180|P2|Overall Study|Enrolled but not treated|0
7489814|NCT03739866|25962181|P1|Overall Study|Enrolled but not treated|0
7489815|NCT03739866|25962174|P8|Overall Study|Lost to Follow-up|0
7489816|NCT03739866|25962175|P7|Overall Study|Lost to Follow-up|0
7489817|NCT03739866|25962176|P6|Overall Study|Lost to Follow-up|0
7489818|NCT03739866|25962177|P5|Overall Study|Lost to Follow-up|0
7489819|NCT03739866|25962178|P4|Overall Study|Lost to Follow-up|1
7489820|NCT03739866|25962179|P3|Overall Study|Lost to Follow-up|0
7489821|NCT03739866|25962180|P2|Overall Study|Lost to Follow-up|0
7489822|NCT03739866|25962181|P1|Overall Study|Lost to Follow-up|0
7489823|NCT03739528|25962288|P2|Overall Study|Treatment discontinued + study completed|3
7489824|NCT03739528|25962289|P1|Overall Study|Treatment discontinued + study completed|1
7489825|NCT03739528|25962288|P2|Overall Study|Treatment and study discontinued|2
7489826|NCT03739528|25962289|P1|Overall Study|Treatment and study discontinued|6
7489827|NCT03739528|25962288|P2|Overall Study|Not treated|12
7489828|NCT03739528|25962289|P1|Overall Study|Not treated|8
7489829|NCT03739242|25962321|P2|Overall Study|Protocol Violation|1
7489830|NCT03739242|25962322|P1|Overall Study|Protocol Violation|0
7489831|NCT03739242|25962321|P2|Overall Study|Withdrawal by Subject|1
7489832|NCT03739242|25962322|P1|Overall Study|Withdrawal by Subject|1
7489833|NCT03738865|25962360|P2|Overall Study|Physician Decision|1
7489834|NCT03738865|25962361|P1|Overall Study|Physician Decision|0
7489835|NCT03738865|25962360|P2|Overall Study|Adverse Event|0
7489836|NCT03738865|25962361|P1|Overall Study|Adverse Event|2
7489837|NCT03738865|25962360|P2|Overall Study|Withdrawal by Subject|3
7489838|NCT03738865|25962361|P1|Overall Study|Withdrawal by Subject|3
7489839|NCT03738475|25962392|P2|Overall Study|Participant Non-Compliance|0
7489840|NCT03738475|25962393|P1|Overall Study|Participant Non-Compliance|1
7489841|NCT03738241|25962440|P10|Overall Study|Adverse Event|0
7489842|NCT03738241|25962441|P9|Overall Study|Adverse Event|0
7489843|NCT03738241|25962442|P8|Overall Study|Adverse Event|0
7489844|NCT03738241|25962443|P7|Overall Study|Adverse Event|0
7489845|NCT03738241|25962444|P6|Overall Study|Adverse Event|0
7489846|NCT03738241|25962445|P5|Overall Study|Adverse Event|0
7489847|NCT03738241|25962446|P4|Overall Study|Adverse Event|0
7489848|NCT03738241|25962447|P3|Overall Study|Adverse Event|0
7489849|NCT03738241|25962448|P2|Overall Study|Adverse Event|0
7489850|NCT03738241|25962449|P1|Overall Study|Adverse Event|1
7489851|NCT03738241|25962440|P10|Overall Study|Physician Decision|0
7489852|NCT03738241|25962441|P9|Overall Study|Physician Decision|1
7489853|NCT03738241|25962442|P8|Overall Study|Physician Decision|0
7489854|NCT03738241|25962443|P7|Overall Study|Physician Decision|0
7489855|NCT03738241|25962444|P6|Overall Study|Physician Decision|0
7489856|NCT03738241|25962445|P5|Overall Study|Physician Decision|0
7489857|NCT03738241|25962446|P4|Overall Study|Physician Decision|0
7489858|NCT03738241|25962447|P3|Overall Study|Physician Decision|0
7489859|NCT03738241|25962448|P2|Overall Study|Physician Decision|0
7489860|NCT03738241|25962449|P1|Overall Study|Physician Decision|0
7489861|NCT03738241|25962440|P10|Overall Study|Withdrawal by Subject|1
7489862|NCT03738241|25962441|P9|Overall Study|Withdrawal by Subject|0
7489863|NCT03738241|25962442|P8|Overall Study|Withdrawal by Subject|0
7489864|NCT03738241|25962443|P7|Overall Study|Withdrawal by Subject|0
7489865|NCT03738241|25962444|P6|Overall Study|Withdrawal by Subject|0
7489866|NCT03738241|25962445|P5|Overall Study|Withdrawal by Subject|0
7489867|NCT03738241|25962446|P4|Overall Study|Withdrawal by Subject|0
7489868|NCT03738241|25962447|P3|Overall Study|Withdrawal by Subject|0
7489869|NCT03738241|25962448|P2|Overall Study|Withdrawal by Subject|0
7489870|NCT03738241|25962449|P1|Overall Study|Withdrawal by Subject|0
7489871|NCT03737110|25962781|P3|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7489872|NCT03737110|25962782|P2|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7489873|NCT03737110|25962783|P1|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7489874|NCT03737110|25962781|P3|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
7489875|NCT03737110|25962782|P2|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
7489876|NCT03737110|25962783|P1|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
7489877|NCT03737110|25962781|P3|Run-in (RI) Period|Adverse Event|0
7489878|NCT03737110|25962782|P2|Run-in (RI) Period|Adverse Event|0
7489879|NCT03737110|25962783|P1|Run-in (RI) Period|Adverse Event|4
7489880|NCT03737110|25962781|P3|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
7489881|NCT03737110|25962782|P2|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
7489882|NCT03737110|25962783|P1|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
7489883|NCT03737110|25962781|P3|Run-in (RI) Period|Lack of Efficacy|0
7489884|NCT03737110|25962782|P2|Run-in (RI) Period|Lack of Efficacy|0
7489885|NCT03737110|25962783|P1|Run-in (RI) Period|Lack of Efficacy|3
7489886|NCT03736785|25962918|P3|Overall Study|Withdrawal by Subject|4
7489887|NCT03736785|25962919|P2|Overall Study|Withdrawal by Subject|6
7489888|NCT03736785|25962920|P1|Overall Study|Withdrawal by Subject|9
7489889|NCT03736785|25962918|P3|Overall Study|Unknown/Missing data|1
7489890|NCT03736785|25962919|P2|Overall Study|Unknown/Missing data|2
7489891|NCT03736785|25962920|P1|Overall Study|Unknown/Missing data|3
7489892|NCT03736785|25962918|P3|Overall Study|Sponsor Decision|0
7489893|NCT03736785|25962919|P2|Overall Study|Sponsor Decision|0
7489894|NCT03736785|25962920|P1|Overall Study|Sponsor Decision|1
7489895|NCT03736785|25962918|P3|Overall Study|Protocol Violation|3
7489896|NCT03736785|25962919|P2|Overall Study|Protocol Violation|4
7489897|NCT03736785|25962920|P1|Overall Study|Protocol Violation|1
7489898|NCT03736785|25962918|P3|Overall Study|Physician Decision|1
7489899|NCT03736785|25962919|P2|Overall Study|Physician Decision|1
7489900|NCT03736785|25962920|P1|Overall Study|Physician Decision|0
7489901|NCT03736785|25962918|P3|Overall Study|Non compliance with study drug|0
7489902|NCT03736785|25962919|P2|Overall Study|Non compliance with study drug|1
7489903|NCT03736785|25962920|P1|Overall Study|Non compliance with study drug|1
7489904|NCT03736785|25962918|P3|Overall Study|Lost to Follow-up|3
7489905|NCT03736785|25962919|P2|Overall Study|Lost to Follow-up|2
7489906|NCT03736785|25962920|P1|Overall Study|Lost to Follow-up|0
7489907|NCT03736785|25962918|P3|Overall Study|Death|1
7489908|NCT03736785|25962919|P2|Overall Study|Death|0
7489909|NCT03736785|25962920|P1|Overall Study|Death|1
7489910|NCT03736785|25962918|P3|Overall Study|Adverse Event|1
7489911|NCT03736785|25962919|P2|Overall Study|Adverse Event|1
7489912|NCT03736785|25962920|P1|Overall Study|Adverse Event|1
7489913|NCT03736031|25962947|P2|Overall Study|Withdrawal by Subject|0
7489914|NCT03736031|25962948|P1|Overall Study|Withdrawal by Subject|9
7489915|NCT03736031|25962947|P2|Overall Study|Lost to Follow-up|2
7489916|NCT03736031|25962948|P1|Overall Study|Lost to Follow-up|21
7489917|NCT03736031|25962947|P2|Overall Study|Death|4
7489918|NCT03736031|25962948|P1|Overall Study|Death|2
7489919|NCT03734991|25962970|P2|Overall Study|Other|2
7489920|NCT03734991|25962971|P1|Overall Study|Other|2
7489921|NCT03734991|25962970|P2|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
7489922|NCT03734991|25962971|P1|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
7489923|NCT03734991|25962970|P2|Overall Study|Withdrawal by Subject|3
7489924|NCT03734991|25962971|P1|Overall Study|Withdrawal by Subject|6
7489925|NCT03734991|25962970|P2|Overall Study|Pregnancy|0
7489926|NCT03734991|25962971|P1|Overall Study|Pregnancy|1
7489927|NCT03734991|25962970|P2|Overall Study|Physician Decision|1
7489928|NCT03734991|25962971|P1|Overall Study|Physician Decision|0
7489929|NCT03734991|25962970|P2|Overall Study|Lost to Follow-up|0
7489930|NCT03734991|25962971|P1|Overall Study|Lost to Follow-up|4
7489931|NCT03734991|25962970|P2|Overall Study|Adverse Event|0
7489932|NCT03734991|25962971|P1|Overall Study|Adverse Event|4
7489933|NCT03733899|25962998|P6|Period 3|Withdrawal by Subject|0
7489934|NCT03733899|25962999|P5|Period 3|Withdrawal by Subject|0
7489935|NCT03733899|25963000|P4|Period 3|Withdrawal by Subject|0
7489936|NCT03733899|25963001|P3|Period 3|Withdrawal by Subject|0
7489937|NCT03733899|25963002|P2|Period 3|Withdrawal by Subject|0
7489938|NCT03733899|25963003|P1|Period 3|Withdrawal by Subject|1
7489939|NCT03733899|25962998|P6|Period 2|Unscuccessful Treatment|0
7489940|NCT03733899|25962999|P5|Period 2|Unscuccessful Treatment|0
7489941|NCT03733899|25963000|P4|Period 2|Unscuccessful Treatment|0
7489942|NCT03733899|25963001|P3|Period 2|Unscuccessful Treatment|0
7489943|NCT03733899|25963002|P2|Period 2|Unscuccessful Treatment|1
7489944|NCT03733899|25963003|P1|Period 2|Unscuccessful Treatment|0
7489945|NCT03733899|25962998|P6|Period 1|Protocol Violation|1
7489946|NCT03733899|25962999|P5|Period 1|Protocol Violation|0
7489947|NCT03733899|25963000|P4|Period 1|Protocol Violation|0
7489948|NCT03733899|25963001|P3|Period 1|Protocol Violation|0
7489949|NCT03733899|25963002|P2|Period 1|Protocol Violation|0
7489950|NCT03733899|25963003|P1|Period 1|Protocol Violation|0
7489951|NCT03733470|25963036|P2|Overall Study|PI Decision|1
7489952|NCT03733470|25963037|P1|Overall Study|PI Decision|1
7489953|NCT03733301|25963046|P3|Overall Study|Withdrawal by Subject|1
7489954|NCT03733301|25963047|P2|Overall Study|Withdrawal by Subject|5
7489955|NCT03733301|25963048|P1|Overall Study|Withdrawal by Subject|3
7489956|NCT03733301|25963046|P3|Overall Study|Adverse Event|3
7489957|NCT03733301|25963047|P2|Overall Study|Adverse Event|1
7489958|NCT03733301|25963048|P1|Overall Study|Adverse Event|0
7489959|NCT03733301|25963046|P3|Overall Study|Lack of Efficacy|0
7489960|NCT03733301|25963047|P2|Overall Study|Lack of Efficacy|3
7489961|NCT03733301|25963048|P1|Overall Study|Lack of Efficacy|2
7489962|NCT03733301|25963046|P3|Overall Study|Non-compliance|0
7489963|NCT03733301|25963047|P2|Overall Study|Non-compliance|0
7489964|NCT03733301|25963048|P1|Overall Study|Non-compliance|1
7489965|NCT03733301|25963046|P3|Overall Study|Screen Fail|0
7489966|NCT03733301|25963047|P2|Overall Study|Screen Fail|0
7489967|NCT03733301|25963048|P1|Overall Study|Screen Fail|1
7489968|NCT03732638|25963130|P2|Overall Study|Withdrawal by Subject|22
7489969|NCT03732638|25963131|P1|Overall Study|Withdrawal by Subject|11
7489970|NCT03732638|25963130|P2|Overall Study|Protocol deviation|5
7489971|NCT03732638|25963131|P1|Overall Study|Protocol deviation|4
7489972|NCT03732638|25963130|P2|Overall Study|Physician Decision|1
7489973|NCT03732638|25963131|P1|Overall Study|Physician Decision|0
7489974|NCT03732638|25963130|P2|Overall Study|Non-compliance|5
7489975|NCT03732638|25963131|P1|Overall Study|Non-compliance|6
7489976|NCT03732638|25963130|P2|Overall Study|Lost to Follow-up|12
7489977|NCT03732638|25963131|P1|Overall Study|Lost to Follow-up|19
7489978|NCT03732638|25963130|P2|Overall Study|Lack of Efficacy|1
7489979|NCT03732638|25963131|P1|Overall Study|Lack of Efficacy|1
7489980|NCT03732638|25963130|P2|Overall Study|Eligibility failure due to baseline laboratory values|13
7489981|NCT03732638|25963131|P1|Overall Study|Eligibility failure due to baseline laboratory values|8
7489982|NCT03732638|25963130|P2|Overall Study|Adverse Event|2
7489983|NCT03732638|25963131|P1|Overall Study|Adverse Event|5
7489984|NCT03732248|25963159|P2|Overall Study|Withdrawal by Subject|0
7489985|NCT03732248|25963160|P1|Overall Study|Withdrawal by Subject|1
7489986|NCT03731182|25963178|P2|Overall Study|Withdrawal By Parent/Guardian|0
7489987|NCT03731182|25963179|P1|Overall Study|Withdrawal By Parent/Guardian|2
7489988|NCT03731182|25963178|P2|Overall Study|Physician Decision|0
7489989|NCT03731182|25963179|P1|Overall Study|Physician Decision|1
7489990|NCT03731182|25963178|P2|Overall Study|Lost to Follow-up|0
7489991|NCT03731182|25963179|P1|Overall Study|Lost to Follow-up|2
7489992|NCT03730961|25963199|P2|Overall Study|Adverse Event|1
7489993|NCT03730961|25963200|P1|Overall Study|Adverse Event|0
7489994|NCT03730103|25963247|P2|Overall Study|Did not meet inclusion criteria|5
7489995|NCT03730103|25963248|P1|Overall Study|Did not meet inclusion criteria|0
7489996|NCT03728140|25963304|P2|Overall Study|Abnormal embryo transfer operation|7
7489997|NCT03728140|25963305|P1|Overall Study|Abnormal embryo transfer operation|10
7489998|NCT03727347|25963358|P1|Overall Study|Lost to Follow-up|1
7489999|NCT03727347|25963358|P1|Overall Study|Withdrawal by Subject|2
7490000|NCT03726996|25963380|P1|Overall Study|Study early termination|2
7490001|NCT03726996|25963380|P1|Overall Study|Parent's decision|2
7490002|NCT03725982|25963399|P2|First Intervention|Physician Decision|1
7490003|NCT03725982|25963400|P1|First Intervention|Physician Decision|1
7490004|NCT03725982|25963399|P2|First Intervention|Withdrawal by Subject|1
7490005|NCT03725982|25963400|P1|First Intervention|Withdrawal by Subject|0
7490006|NCT03725852|25963424|P2|Overall Study|Travel restrictions due to COVID-19|0
7490007|NCT03725852|25963425|P1|Overall Study|Travel restrictions due to COVID-19|2
7490008|NCT03725852|25963424|P2|Overall Study|Withdrawal by Subject|0
7490009|NCT03725852|25963425|P1|Overall Study|Withdrawal by Subject|1
7490010|NCT03725852|25963424|P2|Overall Study|Death|0
7490011|NCT03725852|25963425|P1|Overall Study|Death|1
7490012|NCT03725722|25963453|P5|Overall Study|COVID-19 situation|0
7490013|NCT03725722|25963454|P4|Overall Study|COVID-19 situation|0
7490014|NCT03725722|25963455|P3|Overall Study|COVID-19 situation|0
7490015|NCT03725722|25963456|P2|Overall Study|COVID-19 situation|1
7490016|NCT03725722|25963457|P1|Overall Study|COVID-19 situation|0
7490017|NCT03725722|25963453|P5|Overall Study|Personal reasons|1
7490018|NCT03725722|25963454|P4|Overall Study|Personal reasons|0
7490019|NCT03725722|25963455|P3|Overall Study|Personal reasons|1
7490020|NCT03725722|25963456|P2|Overall Study|Personal reasons|0
7490021|NCT03725722|25963457|P1|Overall Study|Personal reasons|0
7490022|NCT03725722|25963453|P5|Overall Study|Lost to Follow-up|1
7490023|NCT03725722|25963454|P4|Overall Study|Lost to Follow-up|2
7490024|NCT03725722|25963455|P3|Overall Study|Lost to Follow-up|2
7490025|NCT03725722|25963456|P2|Overall Study|Lost to Follow-up|1
7490026|NCT03725722|25963457|P1|Overall Study|Lost to Follow-up|3
7490027|NCT03725722|25963453|P5|Overall Study|Withdrawal by Subject|4
7490028|NCT03725722|25963454|P4|Overall Study|Withdrawal by Subject|4
7490029|NCT03725722|25963455|P3|Overall Study|Withdrawal by Subject|0
7490030|NCT03725722|25963456|P2|Overall Study|Withdrawal by Subject|1
7490031|NCT03725722|25963457|P1|Overall Study|Withdrawal by Subject|4
7490032|NCT03725722|25963453|P5|Overall Study|Adverse Event|6
7490033|NCT03725722|25963454|P4|Overall Study|Adverse Event|0
7490034|NCT03725722|25963455|P3|Overall Study|Adverse Event|1
7490035|NCT03725722|25963456|P2|Overall Study|Adverse Event|2
7490036|NCT03725722|25963457|P1|Overall Study|Adverse Event|2
7490037|NCT03725722|25963453|P5|Overall Study|Lack of Efficacy|2
7490038|NCT03725722|25963454|P4|Overall Study|Lack of Efficacy|0
7490039|NCT03725722|25963455|P3|Overall Study|Lack of Efficacy|2
7490040|NCT03725722|25963456|P2|Overall Study|Lack of Efficacy|1
7490041|NCT03725722|25963457|P1|Overall Study|Lack of Efficacy|2
7490042|NCT03725085|25963495|P1|Overall Study|Lost to Follow-up|2
7490043|NCT03724981|25963518|P2|First Device|Protocol Violation|1
7490044|NCT03724981|25963519|P1|First Device|Protocol Violation|1
7490045|NCT03724968|25963529|P2|Overall Study|Study closed|1
7490046|NCT03724968|25963530|P1|Overall Study|Study closed|0
7490047|NCT03724968|25963529|P2|Overall Study|Insurance issues|1
7490048|NCT03724968|25963530|P1|Overall Study|Insurance issues|0
7490049|NCT03724812|25963559|P1|Overall Study|Missed Visit|1
7490053|NCT03723070|25963701|P1|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
7490054|NCT03723070|25963701|P1|Overall Study|Physician Decision|1
7490055|NCT03723070|25963701|P1|Overall Study|Lost to Follow-up|2
7490056|NCT03722784|25963727|P2|Overall Study|Protocol Violation|1
7490057|NCT03722784|25963728|P1|Overall Study|Protocol Violation|0
7490058|NCT03722784|25963727|P2|Overall Study|Physician Decision|1
7490059|NCT03722784|25963728|P1|Overall Study|Physician Decision|1
7490060|NCT03722784|25963727|P2|Overall Study|Withdrawal by Subject|0
7490061|NCT03722784|25963728|P1|Overall Study|Withdrawal by Subject|1
7490062|NCT03722576|25963770|P1|Overall Study|Lost to Follow-up|1
7490063|NCT03722576|25963770|P1|Overall Study|Physician Decision|1
7490064|NCT03722576|25963770|P1|Overall Study|Adverse Event|2
7490065|NCT03722576|25963770|P1|Overall Study|Withdrawal by Subject|3
7490066|NCT03722524|25963778|P1|Overall Study|Patient's decision (refusal to continue participation)|3
7490067|NCT03722524|25963778|P1|Overall Study|Physician Decision|1
7490068|NCT03722524|25963778|P1|Overall Study|Reason is not stated|1
7490069|NCT03722524|25963778|P1|Overall Study|Lost to Follow-up|1
7490070|NCT03722524|25963778|P1|Overall Study|Adverse Event|7
7490071|NCT03722524|25963778|P1|Overall Study|Protocol Violation|86
7490072|NCT03722446|25963788|P2|Overall Study|Protocol Violation|2
7490073|NCT03722446|25963789|P1|Overall Study|Protocol Violation|15
7490074|NCT03722264|25963805|P1|Overall Study|Physician Decision|3
7490075|NCT03722238|25963817|P2|Overall Study|Did not qualify at re-screening and medical conditions|0
7490076|NCT03722238|25963818|P1|Overall Study|Did not qualify at re-screening and medical conditions|133
7490077|NCT03722238|25963817|P2|Overall Study|Not willing to purchase study medication|0
7490078|NCT03722238|25963818|P1|Overall Study|Not willing to purchase study medication|142
7490079|NCT03722238|25963817|P2|Overall Study|Other eligibility criteria not met pre-consent|0
7490080|NCT03722238|25963818|P1|Overall Study|Other eligibility criteria not met pre-consent|22
7490081|NCT03722238|25963817|P2|Overall Study|Did not sign consent|0
7490082|NCT03722238|25963818|P1|Overall Study|Did not sign consent|17
7490083|NCT03722238|25963817|P2|Overall Study|Did not meet risk classification group criteria|0
7490084|NCT03722238|25963818|P1|Overall Study|Did not meet risk classification group criteria|90
7490085|NCT03722238|25963817|P2|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
7490086|NCT03722238|25963818|P1|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
7490087|NCT03722238|25963817|P2|Overall Study|Other|0
7490088|NCT03722238|25963818|P1|Overall Study|Other|4
7490089|NCT03722238|25963817|P2|Overall Study|Withdrawal by Subject|0
7490090|NCT03722238|25963818|P1|Overall Study|Withdrawal by Subject|2
7490091|NCT03722238|25963817|P2|Overall Study|Partial missing data|1
7490092|NCT03722238|25963818|P1|Overall Study|Partial missing data|44
7490093|NCT03722238|25963817|P2|Overall Study|Lost to Follow-up|0
7490094|NCT03722238|25963818|P1|Overall Study|Lost to Follow-up|6
7490095|NCT03722238|25963817|P2|Overall Study|Death|0
7490096|NCT03722238|25963818|P1|Overall Study|Death|1
7490097|NCT03722238|25963817|P2|Overall Study|Physician Decision|0
7490098|NCT03722238|25963818|P1|Overall Study|Physician Decision|1
7490099|NCT03722238|25963817|P2|Overall Study|Protocol Violation|0
7490100|NCT03722238|25963818|P1|Overall Study|Protocol Violation|1
7490101|NCT03722030|25963904|P2|Overall Study|Withdrawal by Subject|0
7490102|NCT03722030|25963905|P1|Overall Study|Withdrawal by Subject|1
7490103|NCT03721172|25963984|P3|Apremilast Extension Phase|Other (Related to COVID-19)|7
7490104|NCT03721172|25963985|P2|Apremilast Extension Phase|Other (Related to COVID-19)|0
7490105|NCT03721172|25963986|P1|Apremilast Extension Phase|Other (Related to COVID-19)|0
7490106|NCT03721172|25963984|P3|Apremilast Extension Phase|Other|3
7490107|NCT03721172|25963985|P2|Apremilast Extension Phase|Other|0
7490108|NCT03721172|25963986|P1|Apremilast Extension Phase|Other|0
7490109|NCT03721172|25963984|P3|Apremilast Extension Phase|Withdrawal by Subject|21
7490110|NCT03721172|25963985|P2|Apremilast Extension Phase|Withdrawal by Subject|0
7490111|NCT03721172|25963986|P1|Apremilast Extension Phase|Withdrawal by Subject|0
7490112|NCT03721172|25963984|P3|Apremilast Extension Phase|Physician Decision|1
7490113|NCT03721172|25963985|P2|Apremilast Extension Phase|Physician Decision|0
7490114|NCT03721172|25963986|P1|Apremilast Extension Phase|Physician Decision|0
7490115|NCT03721172|25963984|P3|Apremilast Extension Phase|Protocol Violation|1
7490116|NCT03721172|25963985|P2|Apremilast Extension Phase|Protocol Violation|0
7490117|NCT03721172|25963986|P1|Apremilast Extension Phase|Protocol Violation|0
7490118|NCT03721172|25963984|P3|Apremilast Extension Phase|Lost to Follow-up|20
7490119|NCT03721172|25963985|P2|Apremilast Extension Phase|Lost to Follow-up|0
7490120|NCT03721172|25963986|P1|Apremilast Extension Phase|Lost to Follow-up|0
7490121|NCT03721172|25963984|P3|Apremilast Extension Phase|Non-compliance with study drug|1
7490122|NCT03721172|25963985|P2|Apremilast Extension Phase|Non-compliance with study drug|0
7490123|NCT03721172|25963986|P1|Apremilast Extension Phase|Non-compliance with study drug|0
7490124|NCT03721172|25963984|P3|Apremilast Extension Phase|Lack of Efficacy|2
7490125|NCT03721172|25963985|P2|Apremilast Extension Phase|Lack of Efficacy|0
7490126|NCT03721172|25963986|P1|Apremilast Extension Phase|Lack of Efficacy|0
7490127|NCT03721172|25963984|P3|Apremilast Extension Phase|Adverse Event|10
7490128|NCT03721172|25963985|P2|Apremilast Extension Phase|Adverse Event|0
7490129|NCT03721172|25963986|P1|Apremilast Extension Phase|Adverse Event|0
7490130|NCT03721172|25963984|P3|Placebo-controlled Phase|Other|0
7490131|NCT03721172|25963985|P2|Placebo-controlled Phase|Other|0
7490132|NCT03721172|25963986|P1|Placebo-controlled Phase|Other|3
7490133|NCT03721172|25963984|P3|Placebo-controlled Phase|Withdrawal by Subject|0
7490134|NCT03721172|25963985|P2|Placebo-controlled Phase|Withdrawal by Subject|18
7490135|NCT03721172|25963986|P1|Placebo-controlled Phase|Withdrawal by Subject|23
7490136|NCT03721172|25963984|P3|Placebo-controlled Phase|Lost to Follow-up|0
7490137|NCT03721172|25963985|P2|Placebo-controlled Phase|Lost to Follow-up|13
7490138|NCT03721172|25963986|P1|Placebo-controlled Phase|Lost to Follow-up|15
7490139|NCT03721172|25963984|P3|Placebo-controlled Phase|Non-compliance with study drug|0
7490140|NCT03721172|25963985|P2|Placebo-controlled Phase|Non-compliance with study drug|1
7490141|NCT03721172|25963986|P1|Placebo-controlled Phase|Non-compliance with study drug|0
7490142|NCT03721172|25963984|P3|Placebo-controlled Phase|Lack of Efficacy|0
7490143|NCT03721172|25963985|P2|Placebo-controlled Phase|Lack of Efficacy|0
7490144|NCT03721172|25963986|P1|Placebo-controlled Phase|Lack of Efficacy|4
7490145|NCT03721172|25963984|P3|Placebo-controlled Phase|Adverse Event|0
7490146|NCT03721172|25963985|P2|Placebo-controlled Phase|Adverse Event|7
7490147|NCT03721172|25963986|P1|Placebo-controlled Phase|Adverse Event|7
7490148|NCT03720847|25964057|P2|Washout|Physician Decision|2
7490149|NCT03720847|25964058|P1|Washout|Physician Decision|1
7490150|NCT03720652|25964078|P2|Overall Study|Lost to Follow-up|4
7490151|NCT03720652|25964079|P1|Overall Study|Lost to Follow-up|0
7490152|NCT03720652|25964078|P2|Overall Study|Withdrawal by Subject|7
7490153|NCT03720652|25964079|P1|Overall Study|Withdrawal by Subject|2
7490154|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Other|0
7490155|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Other|1
7490156|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Other|2
7490157|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Other|0
7490158|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Other|1
7490159|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Other|0
7490160|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7490161|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7490162|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7490163|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
7490164|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
7490165|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
7490166|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7490167|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7490168|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7490169|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Protocol Deviation|1
7490170|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7490171|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7490172|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Pregnancy|1
7490173|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Pregnancy|0
7490174|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Pregnancy|0
7490175|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Pregnancy|0
7490176|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Pregnancy|0
7490177|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Pregnancy|0
7490178|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
7490179|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7490180|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
7490181|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7490182|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7490183|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7490184|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7490185|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7490186|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7490187|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
7490188|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7490189|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7490190|NCT03720470|25964129|P6|Treatment Period: Final 4 Weeks|Adverse Event|1
7490191|NCT03720470|25964130|P5|Treatment Period: Final 4 Weeks|Adverse Event|1
7490192|NCT03720470|25964131|P4|Treatment Period: Final 4 Weeks|Adverse Event|2
7490193|NCT03720470|25964132|P3|Treatment Period: Final 4 Weeks|Adverse Event|0
7490194|NCT03720470|25964133|P2|Treatment Period: Final 4 Weeks|Adverse Event|0
7490195|NCT03720470|25964134|P1|Treatment Period: Final 4 Weeks|Adverse Event|0
7490196|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
7490197|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7490198|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7490199|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7490200|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7490201|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7490202|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Other|2
7490203|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Other|2
7490204|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Other|1
7490205|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Other|0
7490206|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Other|0
7490207|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Other|1
7490208|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7490209|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
7490210|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
7490211|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7490212|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7490213|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7490214|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
7490215|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
7490216|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
7490217|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
7490218|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
7490219|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
7490220|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Protocol deviation|1
7490221|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7490222|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7490223|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Protocol deviation|0
7490224|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Protocol deviation|0
7490225|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7490226|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Pregnancy|1
7490227|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Pregnancy|1
7490228|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Pregnancy|0
7490229|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Pregnancy|0
7490230|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Pregnancy|0
7490231|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Pregnancy|0
7490232|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
7490233|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
7490234|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
7490235|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
7490236|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
7490237|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
7490238|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
7490239|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7490240|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
7490241|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7490242|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7490243|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7490244|NCT03720470|25964129|P6|Treatment Period: First Part 16 Weeks|Adverse Event|6
7490245|NCT03720470|25964130|P5|Treatment Period: First Part 16 Weeks|Adverse Event|8
7490246|NCT03720470|25964131|P4|Treatment Period: First Part 16 Weeks|Adverse Event|5
7490247|NCT03720470|25964132|P3|Treatment Period: First Part 16 Weeks|Adverse Event|0
7490248|NCT03720470|25964133|P2|Treatment Period: First Part 16 Weeks|Adverse Event|0
7490249|NCT03720470|25964134|P1|Treatment Period: First Part 16 Weeks|Adverse Event|5
7490250|NCT03720210|25964278|P1|Overall Study|Lost to Follow-up|1
7490251|NCT03719586|25964327|P4|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
7490252|NCT03719586|25964328|P3|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
7490253|NCT03719586|25964329|P2|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
7490254|NCT03719586|25964330|P1|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
7490255|NCT03718143|25964437|P3|Overall Study|Withdrawal of Informed Consent|1
7490256|NCT03718143|25964438|P2|Overall Study|Withdrawal of Informed Consent|2
7490257|NCT03718143|25964439|P1|Overall Study|Withdrawal of Informed Consent|1
7490258|NCT03718143|25964437|P3|Overall Study|Progression of Disease|0
7490259|NCT03718143|25964438|P2|Overall Study|Progression of Disease|0
7490260|NCT03718143|25964439|P1|Overall Study|Progression of Disease|1
7490261|NCT03718143|25964437|P3|Overall Study|Death|0
7490262|NCT03718143|25964438|P2|Overall Study|Death|0
7490263|NCT03718143|25964439|P1|Overall Study|Death|1
7490264|NCT03718000|25964455|P2|Overall Study|Pregnancy|1
7490265|NCT03718000|25964456|P1|Overall Study|Pregnancy|0
7490266|NCT03718000|25964455|P2|Overall Study|Relocation|4
7490267|NCT03718000|25964456|P1|Overall Study|Relocation|2
7490268|NCT03717064|25964500|P1|Period 2|Adverse Event|1
7490269|NCT03717012|25964567|P2|Overall Study|Lung transplant|1
7490270|NCT03717012|25964568|P1|Overall Study|Lung transplant|0
7490271|NCT03717012|25964567|P2|Overall Study|Adverse Event|1
7490272|NCT03717012|25964568|P1|Overall Study|Adverse Event|0
7490273|NCT03717012|25964567|P2|Overall Study|Protocol Violation|2
7490274|NCT03717012|25964568|P1|Overall Study|Protocol Violation|0
7490275|NCT03717012|25964567|P2|Overall Study|Due to trial termination|2
7490276|NCT03717012|25964568|P1|Overall Study|Due to trial termination|1
7490277|NCT03716050|25964627|P8|Overall Study|Protocol Violation|2
7490278|NCT03716050|25964628|P7|Overall Study|Protocol Violation|0
7490279|NCT03716050|25964629|P6|Overall Study|Protocol Violation|0
7490280|NCT03716050|25964630|P5|Overall Study|Protocol Violation|0
7490281|NCT03716050|25964631|P4|Overall Study|Protocol Violation|1
7490282|NCT03716050|25964632|P3|Overall Study|Protocol Violation|0
7490283|NCT03716050|25964633|P2|Overall Study|Protocol Violation|0
7490284|NCT03716050|25964634|P1|Overall Study|Protocol Violation|0
7490285|NCT03716050|25964627|P8|Overall Study|Physician Decision|0
7490286|NCT03716050|25964628|P7|Overall Study|Physician Decision|0
7490287|NCT03716050|25964629|P6|Overall Study|Physician Decision|0
7490288|NCT03716050|25964630|P5|Overall Study|Physician Decision|0
7490289|NCT03716050|25964631|P4|Overall Study|Physician Decision|1
7490290|NCT03716050|25964632|P3|Overall Study|Physician Decision|0
7490291|NCT03716050|25964633|P2|Overall Study|Physician Decision|0
7490292|NCT03716050|25964634|P1|Overall Study|Physician Decision|0
7490293|NCT03716050|25964627|P8|Overall Study|Lost to Follow-up|0
7490294|NCT03716050|25964628|P7|Overall Study|Lost to Follow-up|0
7490295|NCT03716050|25964629|P6|Overall Study|Lost to Follow-up|0
7490296|NCT03716050|25964630|P5|Overall Study|Lost to Follow-up|0
7490297|NCT03716050|25964631|P4|Overall Study|Lost to Follow-up|0
7490298|NCT03716050|25964632|P3|Overall Study|Lost to Follow-up|1
7490299|NCT03716050|25964633|P2|Overall Study|Lost to Follow-up|0
7490300|NCT03716050|25964634|P1|Overall Study|Lost to Follow-up|0
7490301|NCT03716024|25964688|P2|Overall Study|Missing Reason|1
7490302|NCT03716024|25964689|P1|Overall Study|Missing Reason|0
7490303|NCT03716024|25964688|P2|Overall Study|Withdrawal by Subject|1
7490304|NCT03716024|25964689|P1|Overall Study|Withdrawal by Subject|0
7490305|NCT03716024|25964688|P2|Overall Study|Lost to Follow-up|6
7490306|NCT03716024|25964689|P1|Overall Study|Lost to Follow-up|2
7490307|NCT03716024|25964688|P2|Overall Study|Treatment Failure|0
7490308|NCT03716024|25964689|P1|Overall Study|Treatment Failure|1
7490309|NCT03716024|25964688|P2|Overall Study|Adverse Event|2
7490310|NCT03716024|25964689|P1|Overall Study|Adverse Event|1
7490311|NCT03716024|25964688|P2|Overall Study|Randomized, not Treated|8
7490312|NCT03716024|25964689|P1|Overall Study|Randomized, not Treated|7
7490313|NCT03715530|25964723|P3|Overall Study|Lost to Follow-up|2
7490314|NCT03715530|25964724|P2|Overall Study|Lost to Follow-up|1
7490315|NCT03715530|25964725|P1|Overall Study|Lost to Follow-up|3
7490316|NCT03714672|25964793|P4|Overall Study|Lost to Follow-up|0
7490317|NCT03714672|25964794|P3|Overall Study|Lost to Follow-up|0
7490318|NCT03714672|25964795|P2|Overall Study|Lost to Follow-up|1
7490319|NCT03714672|25964796|P1|Overall Study|Lost to Follow-up|1
7490320|NCT03714672|25964793|P4|Overall Study|Other Reason|1
7490321|NCT03714672|25964794|P3|Overall Study|Other Reason|1
7490322|NCT03714672|25964795|P2|Overall Study|Other Reason|2
7490323|NCT03714672|25964796|P1|Overall Study|Other Reason|1
7490324|NCT03714672|25964793|P4|Overall Study|Physician Decision|0
7490325|NCT03714672|25964794|P3|Overall Study|Physician Decision|0
7490326|NCT03714672|25964795|P2|Overall Study|Physician Decision|1
7490327|NCT03714672|25964796|P1|Overall Study|Physician Decision|0
7490328|NCT03714672|25964793|P4|Overall Study|Adverse Event|0
7490329|NCT03714672|25964794|P3|Overall Study|Adverse Event|3
7490330|NCT03714672|25964795|P2|Overall Study|Adverse Event|0
7490331|NCT03714672|25964796|P1|Overall Study|Adverse Event|0
7490332|NCT03714022|25964858|P2|Overall Study|Lost to Follow-up|2
7490333|NCT03714022|25964859|P1|Overall Study|Lost to Follow-up|3
7490334|NCT03714022|25964858|P2|Overall Study|Consent withdrawal|1
7490335|NCT03714022|25964859|P1|Overall Study|Consent withdrawal|0
7490336|NCT03714022|25964858|P2|Overall Study|Adverse Event|0
7490337|NCT03714022|25964859|P1|Overall Study|Adverse Event|1
7490338|NCT03712917|25964933|P3|Overall Study|Lost to Follow-up|5
7490339|NCT03712917|25964934|P2|Overall Study|Lost to Follow-up|4
7490340|NCT03712917|25964935|P1|Overall Study|Lost to Follow-up|9
7490341|NCT03712917|25964933|P3|Overall Study|Adverse Event|3
7490342|NCT03712917|25964934|P2|Overall Study|Adverse Event|4
7490343|NCT03712917|25964935|P1|Overall Study|Adverse Event|0
7490344|NCT03712917|25964933|P3|Overall Study|Pregnancy|1
7490345|NCT03712917|25964934|P2|Overall Study|Pregnancy|0
7490346|NCT03712917|25964935|P1|Overall Study|Pregnancy|0
7490347|NCT03712449|25964973|P2|Overall Study|Withdraw Consent|1
7490348|NCT03712449|25964974|P1|Overall Study|Withdraw Consent|0
7490349|NCT03712280|25965004|P4|Overall Study|Adverse Event|0
7490350|NCT03712280|25965005|P3|Overall Study|Adverse Event|1
7490351|NCT03712280|25965006|P2|Overall Study|Adverse Event|0
7490352|NCT03712280|25965007|P1|Overall Study|Adverse Event|0
7490353|NCT03712280|25965004|P4|Overall Study|Withdrawal by Participant or Caregiver|0
7490354|NCT03712280|25965005|P3|Overall Study|Withdrawal by Participant or Caregiver|0
7490355|NCT03712280|25965006|P2|Overall Study|Withdrawal by Participant or Caregiver|0
7490356|NCT03712280|25965007|P1|Overall Study|Withdrawal by Participant or Caregiver|1
7490357|NCT03712280|25965004|P4|Overall Study|Randomized, but not treated due to Adverse Event|1
7490358|NCT03712280|25965005|P3|Overall Study|Randomized, but not treated due to Adverse Event|0
7490359|NCT03712280|25965006|P2|Overall Study|Randomized, but not treated due to Adverse Event|1
7490360|NCT03712280|25965007|P1|Overall Study|Randomized, but not treated due to Adverse Event|0
7490361|NCT03710889|25965042|P1|Overall Study|Protocol Deviation|1
7490362|NCT03710889|25965042|P1|Overall Study|Adverse Event|2
7490363|NCT03710590|25965051|P2|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
7490364|NCT03710590|25965052|P1|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
7490365|NCT03710161|25965092|P2|Overall Study|Study halted due to COVID pandemic|2
7490366|NCT03710161|25965093|P1|Overall Study|Study halted due to COVID pandemic|3
7490367|NCT03710083|25965105|P1|Overall Study|Unsuccessful Procedure|1
7490368|NCT03710083|25965105|P1|Overall Study|Withdrawal by Subject|2
7490369|NCT03709823|25965118|P6|Overall Study|Other, Not Specified|0
7490370|NCT03709823|25965119|P5|Overall Study|Other, Not Specified|0
7490371|NCT03709823|25965120|P4|Overall Study|Other, Not Specified|1
7490372|NCT03709823|25965121|P3|Overall Study|Other, Not Specified|0
7490373|NCT03709823|25965122|P2|Overall Study|Other, Not Specified|0
7490374|NCT03709823|25965123|P1|Overall Study|Other, Not Specified|0
7490375|NCT03709823|25965118|P6|Overall Study|Withdrawal by Subject|0
7490376|NCT03709823|25965119|P5|Overall Study|Withdrawal by Subject|0
7490377|NCT03709823|25965120|P4|Overall Study|Withdrawal by Subject|0
7490378|NCT03709823|25965121|P3|Overall Study|Withdrawal by Subject|0
7490379|NCT03709823|25965122|P2|Overall Study|Withdrawal by Subject|3
7490380|NCT03709823|25965123|P1|Overall Study|Withdrawal by Subject|1
7490381|NCT03709823|25965118|P6|Overall Study|Lost to Follow-up|0
7490382|NCT03709823|25965119|P5|Overall Study|Lost to Follow-up|1
7490383|NCT03709823|25965120|P4|Overall Study|Lost to Follow-up|1
7490384|NCT03709823|25965121|P3|Overall Study|Lost to Follow-up|2
7490385|NCT03709823|25965122|P2|Overall Study|Lost to Follow-up|2
7490386|NCT03709823|25965123|P1|Overall Study|Lost to Follow-up|2
7490387|NCT03709823|25965118|P6|Overall Study|Adverse Event|0
7490388|NCT03709823|25965119|P5|Overall Study|Adverse Event|0
7490389|NCT03709823|25965120|P4|Overall Study|Adverse Event|0
7490390|NCT03709823|25965121|P3|Overall Study|Adverse Event|1
7490391|NCT03709823|25965122|P2|Overall Study|Adverse Event|0
7490392|NCT03709823|25965123|P1|Overall Study|Adverse Event|0
7490393|NCT03709654|25965160|P2|Overall Study|Adverse Event|0
7490394|NCT03709654|25965161|P1|Overall Study|Adverse Event|1
7490395|NCT03709654|25965160|P2|Overall Study|Withdrawal by Subject|1
7490396|NCT03709654|25965161|P1|Overall Study|Withdrawal by Subject|1
7490397|NCT03709654|25965160|P2|Overall Study|Lost to Follow-up|1
7490398|NCT03709654|25965161|P1|Overall Study|Lost to Follow-up|1
7490399|NCT03709576|25965198|P1|Overall Study|progression prior to enrollment|1
7490400|NCT03708744|25965221|P4|Overall Study|Withdrawal by Subject|0
7490401|NCT03708744|25965222|P3|Overall Study|Withdrawal by Subject|1
7490402|NCT03708744|25965223|P2|Overall Study|Withdrawal by Subject|0
7490403|NCT03708744|25965224|P1|Overall Study|Withdrawal by Subject|0
7490404|NCT03708211|25965295|P2|Overall Study|Other|0
7490405|NCT03708211|25965296|P1|Overall Study|Other|2
7490406|NCT03708211|25965295|P2|Overall Study|Withdrawal by Subject|1
7490407|NCT03708211|25965296|P1|Overall Study|Withdrawal by Subject|0
7490408|NCT03708211|25965295|P2|Overall Study|Progressive Disease|7
7490409|NCT03708211|25965296|P1|Overall Study|Progressive Disease|10
7490410|NCT03707912|25965328|P2|Overall Study|Violation of inclusion criteria|0
7490411|NCT03707912|25965329|P1|Overall Study|Violation of inclusion criteria|1
7490412|NCT03707821|25965349|P2|Overall Study|Unsatisfactory Lens Fitting|0
7490413|NCT03707821|25965350|P1|Overall Study|Unsatisfactory Lens Fitting|1
7490414|NCT03707821|25965349|P2|Overall Study|Unsatisfactory Visual Response|0
7490415|NCT03707821|25965350|P1|Overall Study|Unsatisfactory Visual Response|1
7490416|NCT03707821|25965349|P2|Overall Study|Protocol Violation|1
7490417|NCT03707821|25965350|P1|Overall Study|Protocol Violation|0
7490420|NCT03707522|25965387|P4|Overall Study|Lost to Follow-up|36
7490421|NCT03707522|25965388|P3|Overall Study|Lost to Follow-up|41
7490422|NCT03707522|25965389|P2|Overall Study|Lost to Follow-up|27
7490423|NCT03707522|25965390|P1|Overall Study|Lost to Follow-up|24
7490424|NCT03706456|25965491|P1|Overall Study|Ongoing|21
7490425|NCT03706456|25965491|P1|Overall Study|Lack of Efficacy|1
7490426|NCT03705793|25965535|P2|Overall Study|Withdrawal by Subject|1
7490427|NCT03705793|25965536|P1|Overall Study|Withdrawal by Subject|2
7490428|NCT03705793|25965535|P2|Overall Study|Lost to Follow-up|4
7490429|NCT03705793|25965536|P1|Overall Study|Lost to Follow-up|3
7490430|NCT03705494|25965548|P2|Overall Study|Withdrawal by Subject|2
7490431|NCT03705494|25965549|P1|Overall Study|Withdrawal by Subject|5
7490432|NCT03705494|25965548|P2|Overall Study|Lost to Follow-up|1
7490433|NCT03705494|25965549|P1|Overall Study|Lost to Follow-up|2
7490434|NCT03704636|25965570|P1|Overall Study|Inadequate Venous Flow|3
7490435|NCT03704194|25965639|P2|Overall Study|Withdrawal by Subject|1
7490436|NCT03704194|25965640|P1|Overall Study|Withdrawal by Subject|0
7490437|NCT03703817|25965667|P2|Overall Study|Not meeting eligibility criteria|4
7490438|NCT03703817|25965668|P1|Overall Study|Not meeting eligibility criteria|7
7490439|NCT03703466|25965690|P3|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
7490440|NCT03703466|25965691|P2|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
7490441|NCT03703466|25965692|P1|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
7490442|NCT03703466|25965690|P3|Overall Study|Withdrawal by Subject|0
7490443|NCT03703466|25965691|P2|Overall Study|Withdrawal by Subject|3
7490444|NCT03703466|25965692|P1|Overall Study|Withdrawal by Subject|0
7490445|NCT03703466|25965690|P3|Overall Study|Protocol Violation|0
7490446|NCT03703466|25965691|P2|Overall Study|Protocol Violation|0
7490447|NCT03703466|25965692|P1|Overall Study|Protocol Violation|1
7490448|NCT03703466|25965690|P3|Overall Study|Death|0
7490449|NCT03703466|25965691|P2|Overall Study|Death|1
7490450|NCT03703466|25965692|P1|Overall Study|Death|2
7490451|NCT03703336|25965726|P2|Overall Study|Lost to Follow-up|0
7490452|NCT03703336|25965727|P1|Overall Study|Lost to Follow-up|1
7490453|NCT03703336|25965726|P2|Overall Study|Adverse Event|2
7490454|NCT03703336|25965727|P1|Overall Study|Adverse Event|0
7490455|NCT03703336|25965726|P2|Overall Study|Physician Decision|0
7490456|NCT03703336|25965727|P1|Overall Study|Physician Decision|2
7490457|NCT03703336|25965726|P2|Overall Study|Protocol Violation|1
7490458|NCT03703336|25965727|P1|Overall Study|Protocol Violation|3
7490459|NCT03703336|25965726|P2|Overall Study|Migration|3
7490460|NCT03703336|25965727|P1|Overall Study|Migration|3
7490461|NCT03703336|25965726|P2|Overall Study|Parent withdrew consent|8
7490462|NCT03703336|25965727|P1|Overall Study|Parent withdrew consent|29
7490463|NCT03702166|25965750|P1|Overall Study|Withdrawal by Subject|1
7490464|NCT03702166|25965750|P1|Overall Study|Lost to Follow-up|1
7490465|NCT03702010|25965761|P2|Follow-up (30days)|Lack of Efficacy|2
7490466|NCT03702010|25965762|P1|Follow-up (30days)|Lack of Efficacy|2
7490467|NCT03701074|25965793|P2|Overall Study|Physician Decision|0
7490468|NCT03701074|25965794|P1|Overall Study|Physician Decision|1
7490469|NCT03700892|25965817|P3|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7490470|NCT03700892|25965818|P2|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
7490471|NCT03700892|25965819|P1|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7490472|NCT03700671|25965834|P2|Overall Study|Lack of Efficacy|2
7490473|NCT03700671|25965835|P1|Overall Study|Lack of Efficacy|1
7490474|NCT03700385|25965847|P1|Overall Study|Lost to Follow-up|1
7490475|NCT03700320|25965859|P2|Overall Study|Reason not Specified|1
7490476|NCT03700320|25965860|P1|Overall Study|Reason not Specified|0
7490477|NCT03700320|25965859|P2|Overall Study|Non-compliance with Study Drug|3
7490478|NCT03700320|25965860|P1|Overall Study|Non-compliance with Study Drug|1
7490479|NCT03700320|25965859|P2|Overall Study|Protocol Deviation|31
7490480|NCT03700320|25965860|P1|Overall Study|Protocol Deviation|7
7490481|NCT03700320|25965859|P2|Overall Study|Pregnancy|4
7490482|NCT03700320|25965860|P1|Overall Study|Pregnancy|2
7490483|NCT03700320|25965859|P2|Overall Study|Lost to Follow-up|23
7490484|NCT03700320|25965860|P1|Overall Study|Lost to Follow-up|16
7490485|NCT03700320|25965859|P2|Overall Study|Withdrawal by Subject|75
7490486|NCT03700320|25965860|P1|Overall Study|Withdrawal by Subject|29
7490487|NCT03700320|25965859|P2|Overall Study|Lack of Efficacy|5
7490488|NCT03700320|25965860|P1|Overall Study|Lack of Efficacy|2
7490489|NCT03700320|25965859|P2|Overall Study|Adverse Event|31
7490490|NCT03700320|25965860|P1|Overall Study|Adverse Event|5
7490491|NCT03699124|25965877|P3|Overall Study|Other reasons|10
7490492|NCT03699124|25965878|P2|Overall Study|Other reasons|3
7490493|NCT03699124|25965879|P1|Overall Study|Other reasons|5
7490494|NCT03699124|25965877|P3|Overall Study|Withdrawal by Subject|13
7490495|NCT03699124|25965878|P2|Overall Study|Withdrawal by Subject|14
7490496|NCT03699124|25965879|P1|Overall Study|Withdrawal by Subject|13
7490497|NCT03699124|25965877|P3|Overall Study|Protocol Violation|0
7490498|NCT03699124|25965878|P2|Overall Study|Protocol Violation|0
7490499|NCT03699124|25965879|P1|Overall Study|Protocol Violation|1
7490500|NCT03699124|25965877|P3|Overall Study|Lost to Follow-up|15
7490501|NCT03699124|25965878|P2|Overall Study|Lost to Follow-up|16
7490502|NCT03699124|25965879|P1|Overall Study|Lost to Follow-up|20
7490503|NCT03699124|25965877|P3|Overall Study|Death|0
7490504|NCT03699124|25965878|P2|Overall Study|Death|2
7490505|NCT03699124|25965879|P1|Overall Study|Death|0
7490506|NCT03699124|25965877|P3|Overall Study|Adverse Event|2
7490507|NCT03699124|25965878|P2|Overall Study|Adverse Event|5
7490508|NCT03699124|25965879|P1|Overall Study|Adverse Event|6
7490509|NCT03698591|25965925|P2|Overall Study|Could not establish TMS dosage|1
7490510|NCT03698591|25965926|P1|Overall Study|Could not establish TMS dosage|0
7490511|NCT03698591|25965925|P2|Overall Study|Equipment Error|0
7490512|NCT03698591|25965926|P1|Overall Study|Equipment Error|1
7490513|NCT03698591|25965925|P2|Overall Study|Ineligible for financial compensation|0
7490514|NCT03698591|25965926|P1|Overall Study|Ineligible for financial compensation|1
7490515|NCT03698591|25965925|P2|Overall Study|Failed health screen|1
7490516|NCT03698591|25965926|P1|Overall Study|Failed health screen|0
7490517|NCT03698591|25965925|P2|Overall Study|Failed drug screen|1
7490518|NCT03698591|25965926|P1|Overall Study|Failed drug screen|1
7490519|NCT03698591|25965925|P2|Overall Study|Withdrawal by Subject|2
7490520|NCT03698591|25965926|P1|Overall Study|Withdrawal by Subject|2
7490521|NCT03698331|25965940|P2|Overall Study|Non-compliance with study drug|0
7490522|NCT03698331|25965941|P1|Overall Study|Non-compliance with study drug|1
7490523|NCT03698331|25965940|P2|Overall Study|Lost to Follow-up|2
7490524|NCT03698331|25965941|P1|Overall Study|Lost to Follow-up|0
7490525|NCT03698331|25965940|P2|Overall Study|Withdrawal by Subject|1
7490526|NCT03698331|25965941|P1|Overall Study|Withdrawal by Subject|1
7490527|NCT03698331|25965940|P2|Overall Study|Adverse Event|3
7490528|NCT03698331|25965941|P1|Overall Study|Adverse Event|2
7490529|NCT03698279|25965963|P6|Overall Study|Lost to Follow-up|0
7490530|NCT03698279|25965964|P5|Overall Study|Lost to Follow-up|0
7490531|NCT03698279|25965965|P4|Overall Study|Lost to Follow-up|5
7490532|NCT03698279|25965966|P3|Overall Study|Lost to Follow-up|4
7490533|NCT03698279|25965967|P2|Overall Study|Lost to Follow-up|1
7490534|NCT03698279|25965968|P1|Overall Study|Lost to Follow-up|3
7490535|NCT03698279|25965963|P6|Overall Study|Withdrawal by Subject|0
7490536|NCT03698279|25965964|P5|Overall Study|Withdrawal by Subject|0
7490537|NCT03698279|25965965|P4|Overall Study|Withdrawal by Subject|0
7490538|NCT03698279|25965966|P3|Overall Study|Withdrawal by Subject|1
7490539|NCT03698279|25965967|P2|Overall Study|Withdrawal by Subject|0
7490540|NCT03698279|25965968|P1|Overall Study|Withdrawal by Subject|0
7490541|NCT03698279|25965963|P6|Overall Study|Protocol deviation|0
7490542|NCT03698279|25965964|P5|Overall Study|Protocol deviation|0
7490543|NCT03698279|25965965|P4|Overall Study|Protocol deviation|0
7490544|NCT03698279|25965966|P3|Overall Study|Protocol deviation|1
7490545|NCT03698279|25965967|P2|Overall Study|Protocol deviation|0
7490546|NCT03698279|25965968|P1|Overall Study|Protocol deviation|1
7490547|NCT03698279|25965963|P6|Overall Study|Withdrawal by parent/guardian|0
7490548|NCT03698279|25965964|P5|Overall Study|Withdrawal by parent/guardian|0
7490549|NCT03698279|25965965|P4|Overall Study|Withdrawal by parent/guardian|1
7490550|NCT03698279|25965966|P3|Overall Study|Withdrawal by parent/guardian|1
7490551|NCT03698279|25965967|P2|Overall Study|Withdrawal by parent/guardian|1
7490552|NCT03698279|25965968|P1|Overall Study|Withdrawal by parent/guardian|1
7490553|NCT03697993|25966064|P2|Overall Study|Initial Urine Culture Negative|1
7490554|NCT03697993|25966065|P1|Overall Study|Initial Urine Culture Negative|0
7490555|NCT03697993|25966064|P2|Overall Study|Physician Decision|0
7490556|NCT03697993|25966065|P1|Overall Study|Physician Decision|4
7490557|NCT03697993|25966064|P2|Overall Study|Lost to Follow-up|0
7490558|NCT03697993|25966065|P1|Overall Study|Lost to Follow-up|3
7490559|NCT03697993|25966064|P2|Overall Study|Enrolled but Treatment not Administered|1
7490560|NCT03697993|25966065|P1|Overall Study|Enrolled but Treatment not Administered|2
7490561|NCT03697993|25966064|P2|Overall Study|Became Ineligible after Enrollment|3
7490562|NCT03697993|25966065|P1|Overall Study|Became Ineligible after Enrollment|1
7490563|NCT03697460|25966089|P1|Overall Study|Withdrawal by Subject|3
7490564|NCT03697252|25966100|P2|Overall Study|Other|1
7490565|NCT03697252|25966101|P1|Overall Study|Other|0
7490566|NCT03697252|25966100|P2|Overall Study|Physician Decision|1
7490567|NCT03697252|25966101|P1|Overall Study|Physician Decision|1
7490568|NCT03697252|25966100|P2|Overall Study|Lost to Follow-up|1
7490569|NCT03697252|25966101|P1|Overall Study|Lost to Follow-up|0
7490570|NCT03697252|25966100|P2|Overall Study|Withdrawal by Subject|14
7490571|NCT03697252|25966101|P1|Overall Study|Withdrawal by Subject|14
7490572|NCT03697252|25966100|P2|Overall Study|Adverse Event|2
7490573|NCT03697252|25966101|P1|Overall Study|Adverse Event|3
7490574|NCT03696576|25966192|P2|Overall Study|Lost to Follow-up|4
7490575|NCT03696576|25966193|P1|Overall Study|Lost to Follow-up|2
7490576|NCT03696576|25966192|P2|Overall Study|Soreness of throat after therapy|1
7490577|NCT03696576|25966193|P1|Overall Study|Soreness of throat after therapy|1
7490578|NCT03696342|25966225|P2|Overall Study|Lost to Follow-up|0
7490579|NCT03696342|25966226|P1|Overall Study|Lost to Follow-up|1
7490580|NCT03695393|25966259|P2|Overall Study|Lost to Follow-up|1
7490581|NCT03695393|25966260|P1|Overall Study|Lost to Follow-up|0
7490582|NCT03695393|25966259|P2|Overall Study|Death|1
7490583|NCT03695393|25966260|P1|Overall Study|Death|3
7490592|NCT03695094|25966299|P2|Overall Study|Withdrawal by Subject|0
7490593|NCT03695094|25966300|P1|Overall Study|Withdrawal by Subject|1
7490594|NCT03695094|25966299|P2|Overall Study|Adverse Event|1
7490595|NCT03695094|25966300|P1|Overall Study|Adverse Event|1
7490596|NCT03694925|25966336|P3|Overall Study|Inadequate laboratory testing|0
7490597|NCT03694925|25966337|P2|Overall Study|Inadequate laboratory testing|3
7490598|NCT03694925|25966338|P1|Overall Study|Inadequate laboratory testing|0
7490599|NCT03694821|25966354|P3|Overall Study|Study terminated|4
7490600|NCT03694821|25966355|P2|Overall Study|Study terminated|8
7490601|NCT03694821|25966356|P1|Overall Study|Study terminated|4
7490602|NCT03694548|25966404|P3|Part B Yoga Program|Did not attend intervention|8
7490603|NCT03694548|25966405|P2|Part B Yoga Program|Did not attend intervention|0
7490604|NCT03694548|25966406|P1|Part B Yoga Program|Did not attend intervention|0
7490605|NCT03694548|25966404|P3|Part B Yoga Program|Protocol Violation|3
7490606|NCT03694548|25966405|P2|Part B Yoga Program|Protocol Violation|0
7490607|NCT03694548|25966406|P1|Part B Yoga Program|Protocol Violation|0
7490608|NCT03694548|25966404|P3|Part A Survey|Protocol Violation|0
7490609|NCT03694548|25966405|P2|Part A Survey|Protocol Violation|3
7490610|NCT03694548|25966406|P1|Part A Survey|Protocol Violation|3
7490611|NCT03694275|25966419|P2|Overall Study|Reason not Specified|1
7490612|NCT03694275|25966420|P1|Overall Study|Reason not Specified|0
7490613|NCT03694275|25966419|P2|Overall Study|Adverse Event|1
7490614|NCT03694275|25966420|P1|Overall Study|Adverse Event|0
7490615|NCT03694197|25966443|P1|Overall Study|Not disclosed|5
7490616|NCT03694197|25966443|P1|Overall Study|Related to IMP administration|1
7490617|NCT03694197|25966443|P1|Overall Study|Participant withdrew consent|10
7490618|NCT03694197|25966443|P1|Overall Study|Participant moved|5
7490619|NCT03694197|25966443|P1|Overall Study|Study terminated by sponsor|1350
7490620|NCT03694197|25966443|P1|Overall Study|Physician Decision|4
7490621|NCT03694197|25966443|P1|Overall Study|Protocol became inconvenient to participate|1
7490622|NCT03694197|25966443|P1|Overall Study|Adverse Event|9
7490623|NCT03693989|25966481|P2|Overall Study|Protocol Violation|4
7490624|NCT03693989|25966482|P1|Overall Study|Protocol Violation|3
7490625|NCT03693950|25966506|P2|Overall Study|Withdrawal by Subject|0
7490626|NCT03693950|25966507|P1|Overall Study|Withdrawal by Subject|1
7490627|NCT03693625|25966546|P2|Overall Study|Withdrawal by Subject|1
7490628|NCT03693625|25966547|P1|Overall Study|Withdrawal by Subject|1
7490629|NCT03693625|25966546|P2|Overall Study|Study Terminated By Sponsor|7
7490630|NCT03693625|25966547|P1|Overall Study|Study Terminated By Sponsor|20
7490631|NCT03693625|25966546|P2|Overall Study|Adverse Event|0
7490632|NCT03693625|25966547|P1|Overall Study|Adverse Event|2
7490633|NCT03692676|25966559|P4|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
7490634|NCT03692676|25966560|P3|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7490635|NCT03692676|25966561|P2|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7490636|NCT03692676|25966562|P1|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7490637|NCT03692676|25966559|P4|Overall Study|Other|277
7490638|NCT03692676|25966560|P3|Overall Study|Other|758
7490639|NCT03692676|25966561|P2|Overall Study|Other|805
7490640|NCT03692676|25966562|P1|Overall Study|Other|0
7490641|NCT03692676|25966559|P4|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
7490642|NCT03692676|25966560|P3|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7490643|NCT03692676|25966561|P2|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7490644|NCT03692676|25966562|P1|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7490645|NCT03692676|25966559|P4|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
7490646|NCT03692676|25966560|P3|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
7490647|NCT03692676|25966561|P2|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7490648|NCT03692676|25966562|P1|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7490649|NCT03692676|25966559|P4|Overall Study|exclude patients with prior use of same substances and device|0
7490650|NCT03692676|25966560|P3|Overall Study|exclude patients with prior use of same substances and device|3700
7490651|NCT03692676|25966561|P2|Overall Study|exclude patients with prior use of same substances and device|0
7490652|NCT03692676|25966562|P1|Overall Study|exclude patients with prior use of same substances and device|0
7490653|NCT03692676|25966559|P4|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
7490654|NCT03692676|25966560|P3|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
7490655|NCT03692676|25966561|P2|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7490656|NCT03692676|25966562|P1|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7490657|NCT03692676|25966559|P4|Overall Study|exclude patients with prior recorded COPD diagnosis|173
7490658|NCT03692676|25966560|P3|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
7490659|NCT03692676|25966561|P2|Overall Study|exclude patients with prior recorded COPD diagnosis|218
7490660|NCT03692676|25966562|P1|Overall Study|exclude patients with prior recorded COPD diagnosis|275
7490661|NCT03692676|25966559|P4|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
7490662|NCT03692676|25966560|P3|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
7490663|NCT03692676|25966561|P2|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
7490664|NCT03692676|25966562|P1|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
7490665|NCT03692676|25966559|P4|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
7490666|NCT03692676|25966560|P3|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
7490667|NCT03692676|25966561|P2|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
7490668|NCT03692676|25966562|P1|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
7490669|NCT03692676|25966559|P4|Overall Study|exclude patients less than 18 years of age on index date|193
7490670|NCT03692676|25966560|P3|Overall Study|exclude patients less than 18 years of age on index date|836
7490671|NCT03692676|25966561|P2|Overall Study|exclude patients less than 18 years of age on index date|613
7490672|NCT03692676|25966562|P1|Overall Study|exclude patients less than 18 years of age on index date|8
7490673|NCT03692676|25966559|P4|Overall Study|exclude patients without prior recorded asthma diagnosis|558
7490674|NCT03692676|25966560|P3|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
7490675|NCT03692676|25966561|P2|Overall Study|exclude patients without prior recorded asthma diagnosis|563
7490676|NCT03692676|25966562|P1|Overall Study|exclude patients without prior recorded asthma diagnosis|881
7490677|NCT03692676|25966559|P4|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7490678|NCT03692676|25966560|P3|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7490679|NCT03692676|25966561|P2|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
7490680|NCT03692676|25966562|P1|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
7490681|NCT03692676|25966559|P4|Overall Study|exclude patients with prior use|0
7490682|NCT03692676|25966560|P3|Overall Study|exclude patients with prior use|0
7490683|NCT03692676|25966561|P2|Overall Study|exclude patients with prior use|24726
7490684|NCT03692676|25966562|P1|Overall Study|exclude patients with prior use|4424
7490685|NCT03691948|25966578|P2|Overall Study|Lost to Follow-up|3
7490686|NCT03691948|25966579|P1|Overall Study|Lost to Follow-up|1
7490687|NCT03691831|25966666|P2|Overall Study|Investigator Decision|2
7490688|NCT03691831|25966667|P1|Overall Study|Investigator Decision|2
7490689|NCT03691831|25966666|P2|Overall Study|Withdrawal by Subject|17
7490690|NCT03691831|25966667|P1|Overall Study|Withdrawal by Subject|9
7490691|NCT03691831|25966666|P2|Overall Study|Lost to Follow-up|12
7490692|NCT03691831|25966667|P1|Overall Study|Lost to Follow-up|16
7490693|NCT03689452|25966717|P2|Overall Study|Lost to Follow-up|1
7490694|NCT03689452|25966718|P1|Overall Study|Lost to Follow-up|1
7490695|NCT03688880|25966736|P2|Overall Study|Other|16
7490696|NCT03688880|25966737|P1|Overall Study|Other|10
7490697|NCT03688880|25966736|P2|Overall Study|Device deficiencies|2
7490698|NCT03688880|25966737|P1|Overall Study|Device deficiencies|0
7490699|NCT03688880|25966736|P2|Overall Study|Adverse Event|2
7490700|NCT03688880|25966737|P1|Overall Study|Adverse Event|0
7490701|NCT03688880|25966736|P2|Overall Study|Lost to Follow-up|7
7490702|NCT03688880|25966737|P1|Overall Study|Lost to Follow-up|4
7490703|NCT03688880|25966736|P2|Overall Study|Use of non-permitted concurrent therapy|2
7490704|NCT03688880|25966737|P1|Overall Study|Use of non-permitted concurrent therapy|0
7490705|NCT03688880|25966736|P2|Overall Study|Withdrawal by Subject|2
7490706|NCT03688880|25966737|P1|Overall Study|Withdrawal by Subject|0
7490707|NCT03688711|25966763|P2|Overall Study|Withdrawal by Subject|1
7490708|NCT03688711|25966764|P1|Overall Study|Withdrawal by Subject|0
7490709|NCT03688620|25966795|P3|Overall Study|Withdrawal by Subject|6
7490710|NCT03688620|25966796|P2|Overall Study|Withdrawal by Subject|0
7490711|NCT03688620|25966797|P1|Overall Study|Withdrawal by Subject|0
7490712|NCT03688620|25966795|P3|Overall Study|Lost to Follow-up|1
7490713|NCT03688620|25966796|P2|Overall Study|Lost to Follow-up|0
7490714|NCT03688620|25966797|P1|Overall Study|Lost to Follow-up|16
7490715|NCT03688620|25966795|P3|Overall Study|Unwilling to attend the scheduled visit|0
7490716|NCT03688620|25966796|P2|Overall Study|Unwilling to attend the scheduled visit|1
7490717|NCT03688620|25966797|P1|Overall Study|Unwilling to attend the scheduled visit|0
7490718|NCT03688620|25966795|P3|Overall Study|Other|1
7490719|NCT03688620|25966796|P2|Overall Study|Other|0
7490720|NCT03688620|25966797|P1|Overall Study|Other|0
7490721|NCT03687970|25967309|P2|Overall Study|visit scheduling conflicts|0
7490722|NCT03687970|25967310|P1|Overall Study|visit scheduling conflicts|2
7490723|NCT03687827|25967320|P2|Treatment Period 2|Withdrawal by Subject|2
7490724|NCT03687827|25967321|P1|Treatment Period 2|Withdrawal by Subject|1
7490725|NCT03687827|25967320|P2|Treatment Period 2|Physician Decision|1
7490726|NCT03687827|25967321|P1|Treatment Period 2|Physician Decision|4
7490727|NCT03687827|25967320|P2|Treatment Period 1|Withdrawal by Subject|3
7490728|NCT03687827|25967321|P1|Treatment Period 1|Withdrawal by Subject|7
7490729|NCT03687827|25967320|P2|Treatment Period 1|Physician Decision|2
7490730|NCT03687827|25967321|P1|Treatment Period 1|Physician Decision|5
7490731|NCT03687827|25967320|P2|Treatment Period 1|Lost to Follow-up|2
7490732|NCT03687827|25967321|P1|Treatment Period 1|Lost to Follow-up|2
7490733|NCT03687827|25967320|P2|Treatment Period 1|Death|1
7490734|NCT03687827|25967321|P1|Treatment Period 1|Death|0
7490735|NCT03687736|25967337|P1|Overall Study|Withdrawal by Subject|3
7490736|NCT03687736|25967337|P1|Overall Study|Lost to Follow-up|7
7490737|NCT03687372|25967483|P2|Overall Study|Investigator Decision|1
7490738|NCT03687372|25967484|P1|Overall Study|Investigator Decision|1
7490739|NCT03687372|25967483|P2|Overall Study|Withdrawal by Subject|17
7490740|NCT03687372|25967484|P1|Overall Study|Withdrawal by Subject|4
7490741|NCT03687372|25967483|P2|Overall Study|Lost to Follow-up|21
7490742|NCT03687372|25967484|P1|Overall Study|Lost to Follow-up|12
7490743|NCT03687125|25967500|P2|Overall Study|Protocol Violation|0
7490744|NCT03687125|25967501|P1|Overall Study|Protocol Violation|1
7490745|NCT03687125|25967500|P2|Overall Study|Progressive Disease|1
7490746|NCT03687125|25967501|P1|Overall Study|Progressive Disease|2
7490747|NCT03686969|25967541|P2|Overall Study|Study terminated|0
7490748|NCT03686969|25967542|P1|Overall Study|Study terminated|1
7490749|NCT03686176|25967667|P3|Overall Study|VR Malfunction|0
7490750|NCT03686176|25967668|P2|Overall Study|VR Malfunction|0
7490751|NCT03686176|25967669|P1|Overall Study|VR Malfunction|1
7490752|NCT03686176|25967667|P3|Overall Study|Procedure cancelled|0
7490753|NCT03686176|25967668|P2|Overall Study|Procedure cancelled|0
7490754|NCT03686176|25967669|P1|Overall Study|Procedure cancelled|1
7490755|NCT03686033|25967708|P6|Treatment Period 2 (1 Day)|Adverse Event|0
7490756|NCT03686033|25967709|P5|Treatment Period 2 (1 Day)|Adverse Event|1
7490757|NCT03686033|25967710|P4|Treatment Period 2 (1 Day)|Adverse Event|0
7490758|NCT03686033|25967711|P3|Treatment Period 2 (1 Day)|Adverse Event|0
7490759|NCT03686033|25967712|P2|Treatment Period 2 (1 Day)|Adverse Event|0
7490760|NCT03686033|25967713|P1|Treatment Period 2 (1 Day)|Adverse Event|0
7490761|NCT03685643|25967789|P2|Overall Study|Lost to Follow-up|22
7490762|NCT03685643|25967790|P1|Overall Study|Lost to Follow-up|14
7490763|NCT03684928|25967815|P2|Second Intervention|Soft Tissue Injury|0
7490764|NCT03684928|25967816|P1|Second Intervention|Soft Tissue Injury|1
7490765|NCT03684928|25967815|P2|First Intervention|Withdrawal by Subject|2
7490766|NCT03684928|25967816|P1|First Intervention|Withdrawal by Subject|0
7490767|NCT03684928|25967815|P2|First Intervention|Lost to Follow-up|1
7490768|NCT03684928|25967816|P1|First Intervention|Lost to Follow-up|0
7490769|NCT03684044|25967845|P2|Overall Study|Withdrawal by Subject|9
7490770|NCT03684044|25967846|P1|Overall Study|Withdrawal by Subject|11
7490771|NCT03684044|25967845|P2|Overall Study|Physician Decision|0
7490772|NCT03684044|25967846|P1|Overall Study|Physician Decision|1
7490773|NCT03684044|25967845|P2|Overall Study|Patient Not Available|2
7490774|NCT03684044|25967846|P1|Overall Study|Patient Not Available|0
7490775|NCT03684044|25967845|P2|Overall Study|Lost to Follow-up|2
7490776|NCT03684044|25967846|P1|Overall Study|Lost to Follow-up|3
7490777|NCT03684044|25967845|P2|Overall Study|Death|7
7490778|NCT03684044|25967846|P1|Overall Study|Death|4
7490779|NCT03684044|25967845|P2|Overall Study|Adverse Event|0
7490780|NCT03684044|25967846|P1|Overall Study|Adverse Event|3
7490781|NCT03683758|25967914|P2|Overall Study|Adverse Event|0
7490782|NCT03683758|25967915|P1|Overall Study|Adverse Event|1
7490783|NCT03683758|25967914|P2|Overall Study|Illness preventing participation|0
7490784|NCT03683758|25967915|P1|Overall Study|Illness preventing participation|1
7490785|NCT03683758|25967914|P2|Overall Study|Non-study commitment conflict|3
7490786|NCT03683758|25967915|P1|Overall Study|Non-study commitment conflict|1
7490787|NCT03683719|25967932|P5|Overall Study|Other personal reasons|1
7490788|NCT03683719|25967933|P4|Overall Study|Other personal reasons|0
7490789|NCT03683719|25967934|P3|Overall Study|Other personal reasons|1
7490790|NCT03683719|25967935|P2|Overall Study|Other personal reasons|0
7490791|NCT03683719|25967936|P1|Overall Study|Other personal reasons|0
7490792|NCT03683719|25967932|P5|Overall Study|Lost to Follow-up|1
7490793|NCT03683719|25967933|P4|Overall Study|Lost to Follow-up|1
7490794|NCT03683719|25967934|P3|Overall Study|Lost to Follow-up|0
7490795|NCT03683719|25967935|P2|Overall Study|Lost to Follow-up|0
7490796|NCT03683719|25967936|P1|Overall Study|Lost to Follow-up|1
7490797|NCT03683719|25967932|P5|Overall Study|Withdrawal by Subject|5
7490798|NCT03683719|25967933|P4|Overall Study|Withdrawal by Subject|5
7490799|NCT03683719|25967934|P3|Overall Study|Withdrawal by Subject|3
7490800|NCT03683719|25967935|P2|Overall Study|Withdrawal by Subject|4
7490801|NCT03683719|25967936|P1|Overall Study|Withdrawal by Subject|4
7490802|NCT03683719|25967932|P5|Overall Study|Adverse Event|3
7490803|NCT03683719|25967933|P4|Overall Study|Adverse Event|1
7490804|NCT03683719|25967934|P3|Overall Study|Adverse Event|0
7490805|NCT03683719|25967935|P2|Overall Study|Adverse Event|6
7490806|NCT03683719|25967936|P1|Overall Study|Adverse Event|6
7490807|NCT03683719|25967932|P5|Overall Study|Lack of Efficacy|4
7490808|NCT03683719|25967933|P4|Overall Study|Lack of Efficacy|0
7490809|NCT03683719|25967934|P3|Overall Study|Lack of Efficacy|4
7490810|NCT03683719|25967935|P2|Overall Study|Lack of Efficacy|3
7490811|NCT03683719|25967936|P1|Overall Study|Lack of Efficacy|1
7490812|NCT03683576|25967962|P4|Overall Study|Protocol Violation|0
7490813|NCT03683576|25967963|P3|Overall Study|Protocol Violation|1
7490814|NCT03683576|25967964|P2|Overall Study|Protocol Violation|1
7490815|NCT03683576|25967965|P1|Overall Study|Protocol Violation|0
7490816|NCT03683576|25967962|P4|Overall Study|Other, Not Specified|0
7490817|NCT03683576|25967963|P3|Overall Study|Other, Not Specified|0
7490818|NCT03683576|25967964|P2|Overall Study|Other, Not Specified|2
7490819|NCT03683576|25967965|P1|Overall Study|Other, Not Specified|0
7490820|NCT03683576|25967962|P4|Overall Study|Lost to Follow-up|0
7490821|NCT03683576|25967963|P3|Overall Study|Lost to Follow-up|2
7490822|NCT03683576|25967964|P2|Overall Study|Lost to Follow-up|1
7490823|NCT03683576|25967965|P1|Overall Study|Lost to Follow-up|0
7490824|NCT03683576|25967962|P4|Overall Study|Lack of Efficacy|1
7490825|NCT03683576|25967963|P3|Overall Study|Lack of Efficacy|1
7490826|NCT03683576|25967964|P2|Overall Study|Lack of Efficacy|0
7490827|NCT03683576|25967965|P1|Overall Study|Lack of Efficacy|1
7490828|NCT03683576|25967962|P4|Overall Study|Adverse Event|4
7490829|NCT03683576|25967963|P3|Overall Study|Adverse Event|0
7490830|NCT03683576|25967964|P2|Overall Study|Adverse Event|0
7490831|NCT03683576|25967965|P1|Overall Study|Adverse Event|3
7490832|NCT03683576|25967962|P4|Overall Study|Withdrawal by Subject|3
7490833|NCT03683576|25967963|P3|Overall Study|Withdrawal by Subject|8
7490834|NCT03683576|25967964|P2|Overall Study|Withdrawal by Subject|0
7490835|NCT03683576|25967965|P1|Overall Study|Withdrawal by Subject|2
7490836|NCT03682705|25968049|P6|Overall Study|Lost to Follow-up|0
7490837|NCT03682705|25968050|P5|Overall Study|Lost to Follow-up|3
7490838|NCT03682705|25968051|P4|Overall Study|Lost to Follow-up|0
7490839|NCT03682705|25968052|P3|Overall Study|Lost to Follow-up|0
7490840|NCT03682705|25968053|P2|Overall Study|Lost to Follow-up|0
7490841|NCT03682705|25968054|P1|Overall Study|Lost to Follow-up|0
7490842|NCT03682705|25968049|P6|Overall Study|Other, not specified|0
7490843|NCT03682705|25968050|P5|Overall Study|Other, not specified|2
7490844|NCT03682705|25968051|P4|Overall Study|Other, not specified|1
7490845|NCT03682705|25968052|P3|Overall Study|Other, not specified|0
7490846|NCT03682705|25968053|P2|Overall Study|Other, not specified|0
7490847|NCT03682705|25968054|P1|Overall Study|Other, not specified|0
7490848|NCT03682705|25968049|P6|Overall Study|Withdrawal by Subject|1
7490849|NCT03682705|25968050|P5|Overall Study|Withdrawal by Subject|0
7490850|NCT03682705|25968051|P4|Overall Study|Withdrawal by Subject|4
7490851|NCT03682705|25968052|P3|Overall Study|Withdrawal by Subject|2
7490852|NCT03682705|25968053|P2|Overall Study|Withdrawal by Subject|3
7490853|NCT03682705|25968054|P1|Overall Study|Withdrawal by Subject|1
7490854|NCT03682705|25968049|P6|Overall Study|Adverse Event|1
7490855|NCT03682705|25968050|P5|Overall Study|Adverse Event|1
7490856|NCT03682705|25968051|P4|Overall Study|Adverse Event|0
7490857|NCT03682705|25968052|P3|Overall Study|Adverse Event|1
7490858|NCT03682705|25968053|P2|Overall Study|Adverse Event|1
7490859|NCT03682705|25968054|P1|Overall Study|Adverse Event|1
7490860|NCT03682367|25968196|P2|Overall Study|Closed Study Early|3
7490861|NCT03682367|25968197|P1|Overall Study|Closed Study Early|0
7490862|NCT03682367|25968196|P2|Overall Study|Protocol Violation|1
7490863|NCT03682367|25968197|P1|Overall Study|Protocol Violation|2
7490864|NCT03682302|25968221|P4|Overall Study|Study drug was not administered|1
7490865|NCT03682302|25968222|P3|Overall Study|Study drug was not administered|1
7490866|NCT03682302|25968223|P2|Overall Study|Study drug was not administered|0
7490867|NCT03682302|25968224|P1|Overall Study|Study drug was not administered|0
7490868|NCT03682302|25968221|P4|Overall Study|Lost to Follow-up|1
7490869|NCT03682302|25968222|P3|Overall Study|Lost to Follow-up|0
7490870|NCT03682302|25968223|P2|Overall Study|Lost to Follow-up|2
7490871|NCT03682302|25968224|P1|Overall Study|Lost to Follow-up|1
7490872|NCT03682120|25968258|P4|Overall Study|Enrolled but Treatment Not Administered|0
7490873|NCT03682120|25968259|P3|Overall Study|Enrolled but Treatment Not Administered|0
7490874|NCT03682120|25968260|P2|Overall Study|Enrolled but Treatment Not Administered|1
7490875|NCT03682120|25968261|P1|Overall Study|Enrolled but Treatment Not Administered|0
7490876|NCT03682120|25968258|P4|Overall Study|Death|0
7490877|NCT03682120|25968259|P3|Overall Study|Death|0
7490878|NCT03682120|25968260|P2|Overall Study|Death|1
7490879|NCT03682120|25968261|P1|Overall Study|Death|0
7490880|NCT03682120|25968258|P4|Overall Study|Withdrawal by Subject|0
7490881|NCT03682120|25968259|P3|Overall Study|Withdrawal by Subject|3
7490882|NCT03682120|25968260|P2|Overall Study|Withdrawal by Subject|2
7490883|NCT03682120|25968261|P1|Overall Study|Withdrawal by Subject|1
7490884|NCT03682120|25968258|P4|Overall Study|Physician Decision|0
7490885|NCT03682120|25968259|P3|Overall Study|Physician Decision|0
7490886|NCT03682120|25968260|P2|Overall Study|Physician Decision|0
7490887|NCT03682120|25968261|P1|Overall Study|Physician Decision|1
7490888|NCT03682120|25968258|P4|Overall Study|Lost to Follow-up|2
7490889|NCT03682120|25968259|P3|Overall Study|Lost to Follow-up|5
7490890|NCT03682120|25968260|P2|Overall Study|Lost to Follow-up|4
7490891|NCT03682120|25968261|P1|Overall Study|Lost to Follow-up|11
7490892|NCT03682107|25968436|P5|Overall Study|Withdrawal by Subject|0
7490893|NCT03682107|25968437|P4|Overall Study|Withdrawal by Subject|0
7490894|NCT03682107|25968438|P3|Overall Study|Withdrawal by Subject|0
7490895|NCT03682107|25968439|P2|Overall Study|Withdrawal by Subject|1
7490896|NCT03682107|25968440|P1|Overall Study|Withdrawal by Subject|0
7490897|NCT03681951|25968550|P8|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490898|NCT03681951|25968551|P7|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490899|NCT03681951|25968552|P6|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490900|NCT03681951|25968553|P5|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490901|NCT03681951|25968554|P4|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490902|NCT03681951|25968555|P3|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490903|NCT03681951|25968556|P2|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7490904|NCT03681951|25968557|P1|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
7490905|NCT03681951|25968550|P8|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490906|NCT03681951|25968551|P7|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490907|NCT03681951|25968552|P6|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490908|NCT03681951|25968553|P5|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490909|NCT03681951|25968554|P4|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490910|NCT03681951|25968555|P3|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490911|NCT03681951|25968556|P2|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7490912|NCT03681951|25968557|P1|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
7490913|NCT03681951|25968550|P8|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490914|NCT03681951|25968551|P7|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490915|NCT03681951|25968552|P6|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490916|NCT03681951|25968553|P5|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490917|NCT03681951|25968554|P4|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490918|NCT03681951|25968555|P3|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490919|NCT03681951|25968556|P2|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7490920|NCT03681951|25968557|P1|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
7490921|NCT03681405|25968798|P2|Overall Study|Found to be ineligible after randomized|0
7490922|NCT03681405|25968799|P1|Overall Study|Found to be ineligible after randomized|1
7490923|NCT03681353|25968821|P1|Overall Study|withdrawn by PI|2
7490924|NCT03681353|25968821|P1|Overall Study|Withdrawal by Subject|3
7490925|NCT03681353|25968821|P1|Overall Study|Lost to Follow-up|2
7490932|NCT03681119|25968860|P2|Overall Study|Sickness|0
7490933|NCT03681119|25968861|P1|Overall Study|Sickness|2
7490934|NCT03681119|25968860|P2|Overall Study|No specific reason|0
7490935|NCT03681119|25968861|P1|Overall Study|No specific reason|4
7490936|NCT03681093|25968868|P3|Overall Study|Subject decision|1
7490937|NCT03681093|25968869|P2|Overall Study|Subject decision|2
7490938|NCT03681093|25968870|P1|Overall Study|Subject decision|0
7490939|NCT03680911|25968889|P2|Visit 3 (4 Month Follow up)|Study Termination|1
7490940|NCT03680911|25968890|P1|Visit 3 (4 Month Follow up)|Study Termination|0
7490941|NCT03680911|25968889|P2|At Home Treatment|Withdrawal by Subject|2
7490942|NCT03680911|25968890|P1|At Home Treatment|Withdrawal by Subject|0
7490943|NCT03680911|25968889|P2|At Home Treatment|Lost to Follow-up|1
7490944|NCT03680911|25968890|P1|At Home Treatment|Lost to Follow-up|0
7490945|NCT03680911|25968889|P2|At Home Treatment|Study Termination|0
7490946|NCT03680911|25968890|P1|At Home Treatment|Study Termination|3
7490947|NCT03680742|25968898|P1|Overall Study|Unsuccessful Implant Attempt|2
7490948|NCT03680521|25968905|P2|Overall Study|Ongoing in long-term follow up|11
7490949|NCT03680521|25968906|P1|Overall Study|Ongoing in long-term follow up|7
7490950|NCT03679741|25968988|P2|Period 2|Withdrawal by Subject|1
7490951|NCT03679741|25968989|P1|Period 2|Withdrawal by Subject|1
7490952|NCT03679741|25968988|P2|Period 2|Adverse Event|1
7490953|NCT03679741|25968989|P1|Period 2|Adverse Event|2
7490954|NCT03679741|25968988|P2|Period 1|Withdrawal by Subject|1
7490955|NCT03679741|25968989|P1|Period 1|Withdrawal by Subject|0
7490956|NCT03679741|25968988|P2|Period 1|Adverse Event|1
7490957|NCT03679741|25968989|P1|Period 1|Adverse Event|1
7490958|NCT03679741|25968988|P2|Period 1|Lost to Follow-up|1
7490959|NCT03679741|25968989|P1|Period 1|Lost to Follow-up|0
7490960|NCT03679741|25968988|P2|Period 1|No longer meet eligibility criteria|0
7490961|NCT03679741|25968989|P1|Period 1|No longer meet eligibility criteria|1
7490962|NCT03678870|25969032|P2|Overall Study|Lost to Follow-up|2
7490963|NCT03678870|25969033|P1|Overall Study|Lost to Follow-up|3
7490964|NCT03678870|25969032|P2|Overall Study|prescribed non- protocol medications|6
7490965|NCT03678870|25969033|P1|Overall Study|prescribed non- protocol medications|10
7490966|NCT03678285|25969051|P1|Overall Study|Dehydrated prior to start of workout|1
7490967|NCT03678285|25969051|P1|Overall Study|Withdrawal by subject prior to start of workout|1
7490968|NCT03678285|25969051|P1|Overall Study|Adverse Event|2
7490969|NCT03678103|25969061|P1|Overall Study|Withdrawn prior to completion|4
7490970|NCT03677869|25969067|P1|Overall Study|Withdrawal by Subject|1
7490971|NCT03677401|25969080|P2|Overall Study|Reason Unspecified|0
7490972|NCT03677401|25969081|P1|Overall Study|Reason Unspecified|1
7490973|NCT03677401|25969080|P2|Overall Study|Sponsor decision|1
7490974|NCT03677401|25969081|P1|Overall Study|Sponsor decision|0
7490975|NCT03677401|25969080|P2|Overall Study|Withdrawal by Subject|2
7490976|NCT03677401|25969081|P1|Overall Study|Withdrawal by Subject|2
7490977|NCT03677401|25969080|P2|Overall Study|Lack of Efficacy|1
7490978|NCT03677401|25969081|P1|Overall Study|Lack of Efficacy|3
7490979|NCT03677401|25969080|P2|Overall Study|Adverse Event|14
7490980|NCT03677401|25969081|P1|Overall Study|Adverse Event|4
7490981|NCT03677375|25969105|P1|Overall Study|Physician Decision|1
7490982|NCT03677375|25969105|P1|Overall Study|Adverse Event|3
7490983|NCT03677375|25969105|P1|Overall Study|Incomplete procedure|8
7490984|NCT03675776|25969187|P3|Double Blind Treatment Period|Lack of Efficacy|0
7490985|NCT03675776|25969188|P2|Double Blind Treatment Period|Lack of Efficacy|0
7490986|NCT03675776|25969189|P1|Double Blind Treatment Period|Lack of Efficacy|1
7490987|NCT03675776|25969187|P3|Double Blind Treatment Period|Study Terminated by Sponsor|8
7490988|NCT03675776|25969188|P2|Double Blind Treatment Period|Study Terminated by Sponsor|6
7490989|NCT03675776|25969189|P1|Double Blind Treatment Period|Study Terminated by Sponsor|5
7490990|NCT03674281|25969282|P3|Overall Study|Withdrawal by Subject|3
7490991|NCT03674281|25969283|P2|Overall Study|Withdrawal by Subject|3
7490992|NCT03674281|25969284|P1|Overall Study|Withdrawal by Subject|1
7490993|NCT03674281|25969282|P3|Overall Study|screen failure|0
7490994|NCT03674281|25969283|P2|Overall Study|screen failure|0
7490995|NCT03674281|25969284|P1|Overall Study|screen failure|2
7490996|NCT03674177|25969308|P4|Overall Study|Lost to Follow-up|2
7490997|NCT03674177|25969309|P3|Overall Study|Lost to Follow-up|0
7490998|NCT03674177|25969310|P2|Overall Study|Lost to Follow-up|1
7490999|NCT03674177|25969311|P1|Overall Study|Lost to Follow-up|2
7491000|NCT03674112|25969379|P2|Overall Study|Ongoing in the Study|80
7491001|NCT03674112|25969380|P1|Overall Study|Ongoing in the Study|79
7491002|NCT03674112|25969379|P2|Overall Study|Adverse Event|0
7491003|NCT03674112|25969380|P1|Overall Study|Adverse Event|1
7491004|NCT03673670|25969457|P6|Treatment Period 3 (3 Days)|Adverse Event|0
7491005|NCT03673670|25969458|P5|Treatment Period 3 (3 Days)|Adverse Event|1
7491006|NCT03673670|25969459|P4|Treatment Period 3 (3 Days)|Adverse Event|0
7491007|NCT03673670|25969460|P3|Treatment Period 3 (3 Days)|Adverse Event|0
7491008|NCT03673670|25969461|P2|Treatment Period 3 (3 Days)|Adverse Event|0
7491009|NCT03673670|25969462|P1|Treatment Period 3 (3 Days)|Adverse Event|0
7491010|NCT03673670|25969457|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7491011|NCT03673670|25969458|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
7491012|NCT03673670|25969459|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7491013|NCT03673670|25969460|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7491014|NCT03673670|25969461|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7491015|NCT03673670|25969462|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7491016|NCT03673670|25969457|P6|Treatment Period 2 (3 Days)|Adverse Event|0
7491017|NCT03673670|25969458|P5|Treatment Period 2 (3 Days)|Adverse Event|1
7491018|NCT03673670|25969459|P4|Treatment Period 2 (3 Days)|Adverse Event|0
7491019|NCT03673670|25969460|P3|Treatment Period 2 (3 Days)|Adverse Event|1
7491020|NCT03673670|25969461|P2|Treatment Period 2 (3 Days)|Adverse Event|0
7491021|NCT03673670|25969462|P1|Treatment Period 2 (3 Days)|Adverse Event|0
7491022|NCT03673670|25969457|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
7491023|NCT03673670|25969458|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7491024|NCT03673670|25969459|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7491025|NCT03673670|25969460|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7491026|NCT03673670|25969461|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7491027|NCT03673670|25969462|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7491028|NCT03673670|25969457|P6|Treatment Period 1 (3 Days)|Adverse Event|1
7491029|NCT03673670|25969458|P5|Treatment Period 1 (3 Days)|Adverse Event|0
7491030|NCT03673670|25969459|P4|Treatment Period 1 (3 Days)|Adverse Event|0
7491031|NCT03673670|25969460|P3|Treatment Period 1 (3 Days)|Adverse Event|0
7491032|NCT03673670|25969461|P2|Treatment Period 1 (3 Days)|Adverse Event|0
7491033|NCT03673670|25969462|P1|Treatment Period 1 (3 Days)|Adverse Event|0
7491034|NCT03673670|25969457|P6|Treatment Period 1 (3 Days)|Physician Decision|0
7491035|NCT03673670|25969458|P5|Treatment Period 1 (3 Days)|Physician Decision|0
7491036|NCT03673670|25969459|P4|Treatment Period 1 (3 Days)|Physician Decision|0
7491037|NCT03673670|25969460|P3|Treatment Period 1 (3 Days)|Physician Decision|1
7491038|NCT03673670|25969461|P2|Treatment Period 1 (3 Days)|Physician Decision|0
7491039|NCT03673670|25969462|P1|Treatment Period 1 (3 Days)|Physician Decision|0
7491040|NCT03673670|25969457|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7491041|NCT03673670|25969458|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7491042|NCT03673670|25969459|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7491043|NCT03673670|25969460|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7491044|NCT03673670|25969461|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7491045|NCT03673670|25969462|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
7491046|NCT03672396|25969509|P1|Overall Study|Adverse Event|1
7491047|NCT03672396|25969509|P1|Overall Study|Physician Decision|1
7491048|NCT03672396|25969509|P1|Overall Study|Withdrawal by Subject|4
7491049|NCT03672006|25969554|P2|Overall Study|exclusion criteria met|1
7491050|NCT03672006|25969555|P1|Overall Study|exclusion criteria met|0
7491051|NCT03670810|25969572|P4|Overall Study|Continuing Study|10
7491052|NCT03670810|25969573|P3|Overall Study|Continuing Study|12
7491053|NCT03670810|25969574|P2|Overall Study|Continuing Study|29
7491054|NCT03670810|25969575|P1|Overall Study|Continuing Study|27
7491055|NCT03670810|25969572|P4|Overall Study|Withdrawal by Subject|9
7491056|NCT03670810|25969573|P3|Overall Study|Withdrawal by Subject|8
7491057|NCT03670810|25969574|P2|Overall Study|Withdrawal by Subject|20
7491058|NCT03670810|25969575|P1|Overall Study|Withdrawal by Subject|20
7491059|NCT03670810|25969572|P4|Overall Study|Protocol Violation|4
7491060|NCT03670810|25969573|P3|Overall Study|Protocol Violation|8
7491061|NCT03670810|25969574|P2|Overall Study|Protocol Violation|12
7491062|NCT03670810|25969575|P1|Overall Study|Protocol Violation|2
7491063|NCT03670810|25969572|P4|Overall Study|Pregnancy|0
7491064|NCT03670810|25969573|P3|Overall Study|Pregnancy|0
7491065|NCT03670810|25969574|P2|Overall Study|Pregnancy|1
7491066|NCT03670810|25969575|P1|Overall Study|Pregnancy|1
7491067|NCT03670810|25969572|P4|Overall Study|Physician Decision|0
7491068|NCT03670810|25969573|P3|Overall Study|Physician Decision|1
7491069|NCT03670810|25969574|P2|Overall Study|Physician Decision|0
7491070|NCT03670810|25969575|P1|Overall Study|Physician Decision|3
7491071|NCT03670810|25969572|P4|Overall Study|Missing|1
7491072|NCT03670810|25969573|P3|Overall Study|Missing|0
7491073|NCT03670810|25969574|P2|Overall Study|Missing|1
7491074|NCT03670810|25969575|P1|Overall Study|Missing|1
7491075|NCT03670810|25969572|P4|Overall Study|Non-compliance with Study Drug|0
7491076|NCT03670810|25969573|P3|Overall Study|Non-compliance with Study Drug|3
7491077|NCT03670810|25969574|P2|Overall Study|Non-compliance with Study Drug|2
7491078|NCT03670810|25969575|P1|Overall Study|Non-compliance with Study Drug|0
7491079|NCT03670810|25969572|P4|Overall Study|Lost to Follow-up|6
7491080|NCT03670810|25969573|P3|Overall Study|Lost to Follow-up|4
7491081|NCT03670810|25969574|P2|Overall Study|Lost to Follow-up|6
7491082|NCT03670810|25969575|P1|Overall Study|Lost to Follow-up|6
7491083|NCT03670810|25969572|P4|Overall Study|Lack of Efficacy|4
7491084|NCT03670810|25969573|P3|Overall Study|Lack of Efficacy|3
7491085|NCT03670810|25969574|P2|Overall Study|Lack of Efficacy|8
7491086|NCT03670810|25969575|P1|Overall Study|Lack of Efficacy|8
7491087|NCT03670810|25969572|P4|Overall Study|Adverse Event|4
7491088|NCT03670810|25969573|P3|Overall Study|Adverse Event|2
7491089|NCT03670810|25969574|P2|Overall Study|Adverse Event|38
7491090|NCT03670810|25969575|P1|Overall Study|Adverse Event|36
7491091|NCT03670641|25969646|P1|Overall Study|Lost to Follow-up|3
7491092|NCT03670537|25969655|P1|Overall Study|Protocol Violation|1
7491093|NCT03669861|25969677|P1|Overall Study|Lack of Efficacy|2
7491094|NCT03669861|25969677|P1|Overall Study|Disease Flare|5
7491095|NCT03669549|25969686|P1|Overall Study|Study terminated by the Sponsor|1
7491096|NCT03669549|25969686|P1|Overall Study|Withdrawal by Subject|1
7491097|NCT03669549|25969686|P1|Overall Study|Adverse Event|4
7491098|NCT03669081|25969721|P2|Overall Study|Data could not be validated|1
7491099|NCT03669081|25969722|P1|Overall Study|Data could not be validated|1
7491100|NCT03668613|25969740|P2|Overall Study|Lack of Efficacy|1
7491101|NCT03668613|25969741|P1|Overall Study|Lack of Efficacy|0
7491102|NCT03668613|25969740|P2|Overall Study|Adverse Event|2
7491103|NCT03668613|25969741|P1|Overall Study|Adverse Event|0
7491104|NCT03668600|25969751|P1|Overall Study|Adverse Event|1
7491105|NCT03668600|25969751|P1|Overall Study|Lack of Efficacy|7
7491106|NCT03668600|25969751|P1|Overall Study|Withdrawal by Subject|56
7491107|NCT03668600|25969751|P1|Overall Study|Lost to Follow-up|7
7491108|NCT03668600|25969751|P1|Overall Study|Pregnancy|1
7491109|NCT03668600|25969751|P1|Overall Study|Protocol Violation|1
7491110|NCT03668600|25969751|P1|Overall Study|Study Terminated by the Sponsor|157
7491111|NCT03667053|25969772|P3|Overall Study|Withdrawal by Subject|0
7491112|NCT03667053|25969773|P2|Overall Study|Withdrawal by Subject|0
7491113|NCT03667053|25969774|P1|Overall Study|Withdrawal by Subject|1
7491114|NCT03666858|25969823|P2|Cohort 2|Adverse Event|1
7491115|NCT03666858|25969824|P1|Cohort 2|Adverse Event|0
7491116|NCT03666858|25969823|P2|Cohort 1|Adverse Event|0
7491117|NCT03666858|25969824|P1|Cohort 1|Adverse Event|1
7491118|NCT03663582|25969914|P1|Overall Study|Physician Decision|1
7491119|NCT03663569|25969946|P1|Overall Study|Serious adverse event|1
7491120|NCT03663569|25969946|P1|Overall Study|Not meet inclusion / exclusion criterion|3
7491121|NCT03663569|25969946|P1|Overall Study|Not come to second visit|3
7491122|NCT03663569|25969946|P1|Overall Study|Adverse Event|4
7491123|NCT03663569|25969946|P1|Overall Study|Patient's request|11
7491124|NCT03663569|25969946|P1|Overall Study|Withdrawal of consent|5
7491125|NCT03663569|25969946|P1|Overall Study|Lost to Follow-up|18
7491126|NCT03663569|25969946|P1|Overall Study|Deceased patient|6
7491127|NCT03663569|25969946|P1|Overall Study|Never taken Spiolto® Respimat®|1
7491128|NCT03663569|25969946|P1|Overall Study|Discontinuation of study|11
7491129|NCT03663179|25969995|P2|Overall Study|Revealed exclusionary condition|0
7491130|NCT03663179|25969996|P1|Overall Study|Revealed exclusionary condition|1
7491131|NCT03663179|25969995|P2|Overall Study|Lost to Follow-up|1
7491132|NCT03663179|25969996|P1|Overall Study|Lost to Follow-up|1
7491133|NCT03663179|25969995|P2|Overall Study|Withdrawal by Subject|0
7491134|NCT03663179|25969996|P1|Overall Study|Withdrawal by Subject|2
7491135|NCT03662997|25970045|P4|Overall Study|Adverse Event|0
7491136|NCT03662997|25970046|P3|Overall Study|Adverse Event|0
7491137|NCT03662997|25970047|P2|Overall Study|Adverse Event|2
7491138|NCT03662997|25970048|P1|Overall Study|Adverse Event|0
7491139|NCT03662789|25970076|P2|Overall Study|Death|1
7491140|NCT03662789|25970077|P1|Overall Study|Death|0
7491141|NCT03662789|25970076|P2|Overall Study|Could not perform treadmill test|4
7491142|NCT03662789|25970077|P1|Overall Study|Could not perform treadmill test|4
7491143|NCT03662789|25970076|P2|Overall Study|Lost to Follow-up|2
7491144|NCT03662789|25970077|P1|Overall Study|Lost to Follow-up|1
7491145|NCT03662750|25970095|P1|Overall Study|Withdrawal by Subject|1
7491146|NCT03662334|25970113|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
7491147|NCT03662334|25970114|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
7491148|NCT03661983|25970173|P4|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7491149|NCT03661983|25970174|P3|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7491150|NCT03661983|25970175|P2|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7491151|NCT03661983|25970176|P1|Double-blind Randomized Phase|Study Terminated by Sponsor|0
7491152|NCT03661983|25970173|P4|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
7491153|NCT03661983|25970174|P3|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7491154|NCT03661983|25970175|P2|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7491155|NCT03661983|25970176|P1|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7491156|NCT03661983|25970173|P4|Double-blind Randomized Phase|Disease Relapse|6
7491157|NCT03661983|25970174|P3|Double-blind Randomized Phase|Disease Relapse|0
7491158|NCT03661983|25970175|P2|Double-blind Randomized Phase|Disease Relapse|0
7491159|NCT03661983|25970176|P1|Double-blind Randomized Phase|Disease Relapse|0
7491160|NCT03661983|25970173|P4|Double-blind Randomized Phase|Adverse Event|0
7491161|NCT03661983|25970174|P3|Double-blind Randomized Phase|Adverse Event|0
7491162|NCT03661983|25970175|P2|Double-blind Randomized Phase|Adverse Event|1
7491163|NCT03661983|25970176|P1|Double-blind Randomized Phase|Adverse Event|0
7491164|NCT03661983|25970173|P4|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7491165|NCT03661983|25970174|P3|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7491166|NCT03661983|25970175|P2|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7491167|NCT03661983|25970176|P1|Open Label Stabilization Phase|Study Terminated by Sponsor|3
7491168|NCT03661983|25970173|P4|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7491169|NCT03661983|25970174|P3|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7491170|NCT03661983|25970175|P2|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7491171|NCT03661983|25970176|P1|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
7491172|NCT03661983|25970173|P4|Open Label Stabilization Phase|Lack of Efficacy|0
7491173|NCT03661983|25970174|P3|Open Label Stabilization Phase|Lack of Efficacy|0
7491174|NCT03661983|25970175|P2|Open Label Stabilization Phase|Lack of Efficacy|0
7491175|NCT03661983|25970176|P1|Open Label Stabilization Phase|Lack of Efficacy|1
7491176|NCT03661983|25970173|P4|Open Label Stabilization Phase|Adverse Event|0
7491177|NCT03661983|25970174|P3|Open Label Stabilization Phase|Adverse Event|0
7491178|NCT03661983|25970175|P2|Open Label Stabilization Phase|Adverse Event|0
7491179|NCT03661983|25970176|P1|Open Label Stabilization Phase|Adverse Event|5
7491180|NCT03658889|25970434|P2|Overall Study|Protocol Violation|0
7491181|NCT03658889|25970435|P1|Overall Study|Protocol Violation|2
7491182|NCT03658876|25970466|P2|Overall Study|Transplantation/other operation|5
7491183|NCT03658876|25970467|P1|Overall Study|Transplantation/other operation|1
7491184|NCT03658876|25970466|P2|Overall Study|Intercurrent illness|4
7491185|NCT03658876|25970467|P1|Overall Study|Intercurrent illness|6
7491186|NCT03658876|25970466|P2|Overall Study|Death|1
7491187|NCT03658876|25970467|P1|Overall Study|Death|0
7491188|NCT03658876|25970466|P2|Overall Study|Withdrawal by Subject|0
7491189|NCT03658876|25970467|P1|Overall Study|Withdrawal by Subject|2
7491190|NCT03658876|25970466|P2|Overall Study|Protocol Violation|2
7491191|NCT03658876|25970467|P1|Overall Study|Protocol Violation|3
7491192|NCT03658811|25970473|P1|Overall Study|Lost to Follow-up|3
7491193|NCT03657277|25970495|P1|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
7491194|NCT03657277|25970495|P1|Overall Study|Lost to Follow-up|1
7491195|NCT03657277|25970495|P1|Overall Study|Physician Decision|2
7491196|NCT03657095|25970529|P2|Overall Study|Study Terminated by Sponsor|49
7491197|NCT03657095|25970530|P1|Overall Study|Study Terminated by Sponsor|58
7491198|NCT03657095|25970529|P2|Overall Study|Adverse Event|3
7491199|NCT03657095|25970530|P1|Overall Study|Adverse Event|0
7491200|NCT03657095|25970529|P2|Overall Study|Withdrawal by Subject|1
7491201|NCT03657095|25970530|P1|Overall Study|Withdrawal by Subject|1
7491202|NCT03656692|25970848|P1|Overall Study|Physician Decision|1
7491203|NCT03656692|25970848|P1|Overall Study|Worsening of disease activity|2
7491204|NCT03655951|25970857|P2|Overall Study|Withdrawal by Subject|1
7491205|NCT03655951|25970858|P1|Overall Study|Withdrawal by Subject|0
7491206|NCT03655951|25970857|P2|Overall Study|Lost to Follow-up|20
7491207|NCT03655951|25970858|P1|Overall Study|Lost to Follow-up|39
7491208|NCT03655405|25971037|P2|Overall Study|Protocol Violation|1
7491209|NCT03655405|25971038|P1|Overall Study|Protocol Violation|0
7491210|NCT03655405|25971037|P2|Overall Study|Died before initial data collection|2
7491211|NCT03655405|25971038|P1|Overall Study|Died before initial data collection|1
7491212|NCT03655405|25971037|P2|Overall Study|Death after initial data collection|2
7491213|NCT03655405|25971038|P1|Overall Study|Death after initial data collection|4
7491214|NCT03655106|25971082|P2|Overall Study|Protocol Violation|0
7491215|NCT03655106|25971083|P1|Overall Study|Protocol Violation|3
7491216|NCT03655106|25971082|P2|Overall Study|Duplicate Enrollment|1
7491217|NCT03655106|25971083|P1|Overall Study|Duplicate Enrollment|1
7491218|NCT03655106|25971082|P2|Overall Study|Lost to Follow-up|1
7491219|NCT03655106|25971083|P1|Overall Study|Lost to Follow-up|2
7491220|NCT03655106|25971082|P2|Overall Study|Withdrawal by Subject|2
7491221|NCT03655106|25971083|P1|Overall Study|Withdrawal by Subject|3
7491222|NCT03655054|25971093|P1|Overall Study|Lost to Follow-up|1
7491223|NCT03654560|25971102|P2|Overall Study|Lost to Follow-up|0
7491224|NCT03654560|25971103|P1|Overall Study|Lost to Follow-up|1
7491225|NCT03654560|25971102|P2|Overall Study|Death|1
7491226|NCT03654560|25971103|P1|Overall Study|Death|3
7491227|NCT03654326|25971144|P2|Overall Study|Lost to Follow-up|1
7491228|NCT03654326|25971145|P1|Overall Study|Lost to Follow-up|1
7491229|NCT03654326|25971144|P2|Overall Study|Unable to adhere to study schedule|1
7491230|NCT03654326|25971145|P1|Overall Study|Unable to adhere to study schedule|0
7491231|NCT03654326|25971144|P2|Overall Study|Physician Decision|1
7491232|NCT03654326|25971145|P1|Overall Study|Physician Decision|0
7491233|NCT03654326|25971144|P2|Overall Study|Withdrawal by Subject|3
7491234|NCT03654326|25971145|P1|Overall Study|Withdrawal by Subject|5
7491235|NCT03653429|25971161|P2|Overall Study|Physician Decision|10
7491236|NCT03653429|25971162|P1|Overall Study|Physician Decision|4
7491237|NCT03653416|25971176|P2|Overall Study|Protocol Violation|1
7491238|NCT03653416|25971177|P1|Overall Study|Protocol Violation|6
7491239|NCT03653208|25971213|P9|Overall Study|Withdrawal by Subject|1
7491240|NCT03653208|25971214|P8|Overall Study|Withdrawal by Subject|1
7491241|NCT03653208|25971215|P7|Overall Study|Withdrawal by Subject|0
7491242|NCT03653208|25971216|P6|Overall Study|Withdrawal by Subject|0
7491243|NCT03653208|25971217|P5|Overall Study|Withdrawal by Subject|1
7491244|NCT03653208|25971218|P4|Overall Study|Withdrawal by Subject|0
7491245|NCT03653208|25971219|P3|Overall Study|Withdrawal by Subject|0
7491246|NCT03653208|25971220|P2|Overall Study|Withdrawal by Subject|0
7491247|NCT03653208|25971221|P1|Overall Study|Withdrawal by Subject|0
7491248|NCT03652675|25971259|P2|Overall Study|Lost to Follow-up|4
7491249|NCT03652675|25971260|P1|Overall Study|Lost to Follow-up|4
7491250|NCT03652662|25971282|P2|Overall Study|Lost to Follow-up|0
7491251|NCT03652662|25971283|P1|Overall Study|Lost to Follow-up|1
7491252|NCT03652662|25971282|P2|Overall Study|Withdrawal by Subject|1
7491253|NCT03652662|25971283|P1|Overall Study|Withdrawal by Subject|2
7491254|NCT03652610|25971297|P2|Overall Study|Withdrawal by Subject|5
7491255|NCT03652610|25971298|P1|Overall Study|Withdrawal by Subject|3
7491256|NCT03652610|25971297|P2|Overall Study|Lost to Follow-up|0
7491257|NCT03652610|25971298|P1|Overall Study|Lost to Follow-up|1
7491258|NCT03650452|25971356|P2|Overall Study|Early Withdrawal from Study Treatment|0
7491259|NCT03650452|25971357|P1|Overall Study|Early Withdrawal from Study Treatment|3
7491260|NCT03650452|25971356|P2|Overall Study|Adverse Event|4
7491261|NCT03650452|25971357|P1|Overall Study|Adverse Event|3
7491262|NCT03650452|25971356|P2|Overall Study|Withdrawal by Parent/Guardian|1
7491263|NCT03650452|25971357|P1|Overall Study|Withdrawal by Parent/Guardian|3
7491264|NCT03650452|25971356|P2|Overall Study|Physician Decision|0
7491265|NCT03650452|25971357|P1|Overall Study|Physician Decision|1
7491266|NCT03650400|25971385|P2|Overall Study|Study terminated by sponsor|5
7491267|NCT03650400|25971386|P1|Overall Study|Study terminated by sponsor|0
7491268|NCT03650387|25971414|P1|Overall Study|Due to COVID-19 Pandemic|8
7491269|NCT03650387|25971414|P1|Overall Study|Adverse Event (Not related)|1
7491270|NCT03650387|25971414|P1|Overall Study|Lost to Follow-up|12
7491271|NCT03650387|25971414|P1|Overall Study|Withdrawal by Subject|13
7491272|NCT03649412|25971484|P2|Part B, Washout Period 5 (7 Days)|Adverse Event|1
7491273|NCT03649412|25971485|P1|Part B, Washout Period 5 (7 Days)|Adverse Event|0
7491274|NCT03649412|25971484|P2|Part B, Washout Period 1 (7 Days)|Adverse Event|1
7491275|NCT03649412|25971485|P1|Part B, Washout Period 1 (7 Days)|Adverse Event|0
7491276|NCT03649412|25971484|P2|Part A, Washout Period 5 (7 Days)|Adverse Event|0
7491277|NCT03649412|25971485|P1|Part A, Washout Period 5 (7 Days)|Adverse Event|1
7491278|NCT03649412|25971484|P2|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
7491279|NCT03649412|25971485|P1|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
7491280|NCT03649412|25971484|P2|Part A, Washout Period 4 (7 Days)|Adverse Event|0
7491281|NCT03649412|25971485|P1|Part A, Washout Period 4 (7 Days)|Adverse Event|1
7491282|NCT03649412|25971484|P2|Part A, Washout Period 1 (7 Days)|Physician Decision|0
7491283|NCT03649412|25971485|P1|Part A, Washout Period 1 (7 Days)|Physician Decision|1
7491284|NCT03648983|25971643|P1|Overall Study|Study was terminated due to PI departure|95
7491285|NCT03648879|25971649|P1|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
7491286|NCT03647709|25971659|P1|Overall Study|Withdrawal by Subject|3
7491287|NCT03647709|25971659|P1|Overall Study|Physician Decision|6
7491288|NCT03647709|25971659|P1|Overall Study|Lost to Follow-up|5
7491289|NCT03646656|25971708|P2|Overall Study|Withdrawal by Subject|0
7491290|NCT03646656|25971709|P1|Overall Study|Withdrawal by Subject|2
7491291|NCT03646656|25971708|P2|Overall Study|Lost to Follow-up|0
7491292|NCT03646656|25971709|P1|Overall Study|Lost to Follow-up|1
7491293|NCT03646305|25971730|P4|Overall Study|Withdrawal by Subject|1
7491294|NCT03646305|25971731|P3|Overall Study|Withdrawal by Subject|0
7491295|NCT03646305|25971732|P2|Overall Study|Withdrawal by Subject|0
7491296|NCT03646305|25971733|P1|Overall Study|Withdrawal by Subject|1
7491297|NCT03646305|25971730|P4|Overall Study|Lost to Follow-up|1
7491298|NCT03646305|25971731|P3|Overall Study|Lost to Follow-up|2
7491299|NCT03646305|25971732|P2|Overall Study|Lost to Follow-up|2
7491300|NCT03646305|25971733|P1|Overall Study|Lost to Follow-up|4
7491301|NCT03645863|25971855|P3|Overall Study|Withdrawal by Subject|0
7491302|NCT03645863|25971856|P2|Overall Study|Withdrawal by Subject|0
7491303|NCT03645863|25971857|P1|Overall Study|Withdrawal by Subject|1
7491304|NCT03645434|25971936|P6|Period 1|COPD exacerbation|0
7491305|NCT03645434|25971937|P5|Period 1|COPD exacerbation|1
7491306|NCT03645434|25971938|P4|Period 1|COPD exacerbation|0
7491307|NCT03645434|25971939|P3|Period 1|COPD exacerbation|0
7491308|NCT03645434|25971940|P2|Period 1|COPD exacerbation|0
7491309|NCT03645434|25971941|P1|Period 1|COPD exacerbation|0
7491310|NCT03645434|25971936|P6|Period 1|Adverse Event|0
7491311|NCT03645434|25971937|P5|Period 1|Adverse Event|0
7491312|NCT03645434|25971938|P4|Period 1|Adverse Event|1
7491313|NCT03645434|25971939|P3|Period 1|Adverse Event|0
7491314|NCT03645434|25971940|P2|Period 1|Adverse Event|0
7491315|NCT03645434|25971941|P1|Period 1|Adverse Event|0
7491316|NCT03645421|25971992|P4|Overall Study|Study specific withdrawal criteria|0
7491317|NCT03645421|25971993|P3|Overall Study|Study specific withdrawal criteria|1
7491318|NCT03645421|25971994|P2|Overall Study|Study specific withdrawal criteria|0
7491319|NCT03645421|25971995|P1|Overall Study|Study specific withdrawal criteria|0
7491320|NCT03645421|25971992|P4|Overall Study|Withdrawal by patient|3
7491321|NCT03645421|25971993|P3|Overall Study|Withdrawal by patient|0
7491322|NCT03645421|25971994|P2|Overall Study|Withdrawal by patient|0
7491323|NCT03645421|25971995|P1|Overall Study|Withdrawal by patient|0
7491324|NCT03645421|25971992|P4|Overall Study|Adverse Event|1
7491325|NCT03645421|25971993|P3|Overall Study|Adverse Event|4
7491326|NCT03645421|25971994|P2|Overall Study|Adverse Event|0
7491327|NCT03645421|25971995|P1|Overall Study|Adverse Event|0
7491328|NCT03644173|25972068|P1|Participants at the 3-month Follow up|Lost to Follow-up|2
7491329|NCT03644173|25972068|P1|Participants at the 1-month Follow up|Death|2
7491330|NCT03644173|25972068|P1|Participants at the 1-month Follow up|Lost to Follow-up|2
7491331|NCT03644173|25972068|P1|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
7491332|NCT03644017|25972122|P1|Overall Study|Kidney Transplant|2
7491333|NCT03644017|25972122|P1|Overall Study|Access Abandonment|5
7491334|NCT03643952|25972141|P1|Overall Study|Lack of Efficacy|1
7491335|NCT03643575|25972166|P6|Washout: 7 Days|Non compliance check in|0
7491336|NCT03643575|25972167|P5|Washout: 7 Days|Non compliance check in|0
7491337|NCT03643575|25972168|P4|Washout: 7 Days|Non compliance check in|0
7491338|NCT03643575|25972169|P3|Washout: 7 Days|Non compliance check in|0
7491339|NCT03643575|25972170|P2|Washout: 7 Days|Non compliance check in|1
7491340|NCT03643575|25972171|P1|Washout: 7 Days|Non compliance check in|0
7491341|NCT03643575|25972166|P6|Washout: 7 Days|Adverse Event|0
7491342|NCT03643575|25972167|P5|Washout: 7 Days|Adverse Event|0
7491343|NCT03643575|25972168|P4|Washout: 7 Days|Adverse Event|0
7491344|NCT03643575|25972169|P3|Washout: 7 Days|Adverse Event|0
7491345|NCT03643575|25972170|P2|Washout: 7 Days|Adverse Event|0
7491346|NCT03643575|25972171|P1|Washout: 7 Days|Adverse Event|1
7491347|NCT03643575|25972166|P6|Washout: 7 Days|Withdrew consent due to illness|0
7491348|NCT03643575|25972167|P5|Washout: 7 Days|Withdrew consent due to illness|0
7491349|NCT03643575|25972168|P4|Washout: 7 Days|Withdrew consent due to illness|1
7491350|NCT03643575|25972169|P3|Washout: 7 Days|Withdrew consent due to illness|0
7491351|NCT03643575|25972170|P2|Washout: 7 Days|Withdrew consent due to illness|0
7491352|NCT03643575|25972171|P1|Washout: 7 Days|Withdrew consent due to illness|0
7491353|NCT03643432|25972229|P2|Overall Study|Lost to Follow-up|0
7491354|NCT03643432|25972230|P1|Overall Study|Lost to Follow-up|1
7491355|NCT03643159|25972254|P1|Overall Study|Withdrawal by Subject|1
7491356|NCT03643159|25972254|P1|Overall Study|Adverse Event|1
7491357|NCT03642873|25972261|P6|Third Intervention (1 Day)|Screen failure|0
7491358|NCT03642873|25972262|P5|Third Intervention (1 Day)|Screen failure|1
7491359|NCT03642873|25972263|P4|Third Intervention (1 Day)|Screen failure|0
7491360|NCT03642873|25972264|P3|Third Intervention (1 Day)|Screen failure|0
7491361|NCT03642873|25972265|P2|Third Intervention (1 Day)|Screen failure|0
7491362|NCT03642873|25972266|P1|Third Intervention (1 Day)|Screen failure|0
7491363|NCT03642717|25972298|P1|Overall Study|Taken study drug prior to contract date|3
7491364|NCT03642717|25972298|P1|Overall Study|Inclusion/exclusion criteria violation|33
7491365|NCT03642717|25972298|P1|Overall Study|Lost to Follow-up|2
7491366|NCT03642262|25972333|P2|Period 1|Adverse Event|1
7491367|NCT03642262|25972334|P1|Period 1|Adverse Event|0
7491368|NCT03642262|25972333|P2|Period 1|Withdrawal by Subject|1
7491369|NCT03642262|25972334|P1|Period 1|Withdrawal by Subject|1
7491370|NCT03641508|25972361|P2|First Injection|Lost to Follow-up|0
7491371|NCT03641508|25972362|P1|First Injection|Lost to Follow-up|2
7491372|NCT03640559|25972389|P2|Overall Study|Withdrawal by Subject|0
7491373|NCT03640559|25972390|P1|Overall Study|Withdrawal by Subject|1
7491374|NCT03640559|25972389|P2|Overall Study|Physician Decision|1
7491375|NCT03640559|25972390|P1|Overall Study|Physician Decision|1
7491376|NCT03640507|25972399|P3|Overall Study|Withdrawal by Subject|1
7491377|NCT03640507|25972400|P2|Overall Study|Withdrawal by Subject|0
7491378|NCT03640507|25972401|P1|Overall Study|Withdrawal by Subject|0
7491379|NCT03640052|25972421|P5|Overall Study|Lost to Follow-up|0
7491380|NCT03640052|25972422|P4|Overall Study|Lost to Follow-up|0
7491381|NCT03640052|25972423|P3|Overall Study|Lost to Follow-up|0
7491382|NCT03640052|25972424|P2|Overall Study|Lost to Follow-up|1
7491383|NCT03640052|25972425|P1|Overall Study|Lost to Follow-up|0
7491384|NCT03639987|25972444|P2|Overall Study|Lost to Follow-up|1
7491385|NCT03639987|25972445|P1|Overall Study|Lost to Follow-up|0
7491386|NCT03639987|25972444|P2|Overall Study|Study terminated by sponsor|25
7491387|NCT03639987|25972445|P1|Overall Study|Study terminated by sponsor|26
7491388|NCT03639779|25972487|P1|Overall Study|Lost to Follow-up|1
7491389|NCT03639675|25972503|P1|Overall Study|Withdrawal by Subject|1
7491390|NCT03639311|25972510|P2|Overall Study|Adverse Event|0
7491391|NCT03639311|25972511|P1|Overall Study|Adverse Event|1
7491392|NCT03639311|25972510|P2|Overall Study|Lost to Follow-up|0
7491393|NCT03639311|25972511|P1|Overall Study|Lost to Follow-up|1
7491394|NCT03639311|25972510|P2|Overall Study|Ongoing at the time of analysis|0
7491395|NCT03639311|25972511|P1|Overall Study|Ongoing at the time of analysis|88
7491396|NCT03638635|25972610|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
7491397|NCT03638635|25972611|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
7491398|NCT03638635|25972610|P2|Initial Hospitalization|Withdrawal by study personnel|1
7491399|NCT03638635|25972611|P1|Initial Hospitalization|Withdrawal by study personnel|0
7491400|NCT03638635|25972610|P2|Initial Hospitalization|Study terminated prematurely|1
7491401|NCT03638635|25972611|P1|Initial Hospitalization|Study terminated prematurely|0
7491402|NCT03636893|25972774|P2|Overall Study|Adverse Event|1
7491403|NCT03636893|25972775|P1|Overall Study|Adverse Event|1
7491404|NCT03636893|25972774|P2|Overall Study|Early surgery (for acute bleeding)|0
7491405|NCT03636893|25972775|P1|Overall Study|Early surgery (for acute bleeding)|3
7491406|NCT03636893|25972774|P2|Overall Study|Refusal to surgery|3
7491407|NCT03636893|25972775|P1|Overall Study|Refusal to surgery|4
7491408|NCT03636893|25972774|P2|Overall Study|Withdrawal by Subject|2
7491409|NCT03636893|25972775|P1|Overall Study|Withdrawal by Subject|1
7491410|NCT03636893|25972774|P2|Overall Study|Protocol Violation|3
7491411|NCT03636893|25972775|P1|Overall Study|Protocol Violation|0
7491412|NCT03636893|25972774|P2|Overall Study|Death|1
7491413|NCT03636893|25972775|P1|Overall Study|Death|0
7491414|NCT03635957|25972792|P1|Pegloticase + IMM Period|Lack of Efficacy|3
7491415|NCT03635957|25972792|P1|Run-In Period|Lost to Follow-up|1
7491416|NCT03635775|25972807|P4|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
7491417|NCT03635775|25972808|P3|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7491418|NCT03635775|25972809|P2|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7491419|NCT03635775|25972810|P1|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7491423|NCT03635320|25972847|P2|Overall Study|Withdrawal by Subject|6
7491424|NCT03635320|25972848|P1|Overall Study|Withdrawal by Subject|11
7491425|NCT03635320|25972847|P2|Overall Study|not implanted the device|2
7491426|NCT03635320|25972848|P1|Overall Study|not implanted the device|1
7491427|NCT03634800|25972865|P1|Overall Study|Withdrawal by Subject|1
7491428|NCT03634800|25972865|P1|Overall Study|Disease Progression|4
7491429|NCT03634800|25972865|P1|Overall Study|Adverse Event|1
7491430|NCT03634579|25972871|P1|Overall Study|study termination|9
7491431|NCT03634085|25972969|P2|Overall Study|Withdrawal by Subject|2
7491432|NCT03634085|25972970|P1|Overall Study|Withdrawal by Subject|0
7491433|NCT03634085|25972969|P2|Overall Study|Adverse Event|0
7491434|NCT03634085|25972970|P1|Overall Study|Adverse Event|1
7491435|NCT03633929|25972983|P1|Overall Study|Did not login to software. Did not participate|3
7491436|NCT03633929|25972983|P1|Overall Study|Lost to Follow-up|1
7491437|NCT03633903|25972993|P2|Overall Study|Lost to Follow-up|5
7491438|NCT03633903|25972994|P1|Overall Study|Lost to Follow-up|5
7491439|NCT03633903|25972993|P2|Overall Study|Withdrawal by Subject|2
7491440|NCT03633903|25972994|P1|Overall Study|Withdrawal by Subject|1
7491441|NCT03633825|25973006|P2|Follow up|Lost to Follow-up|450
7491442|NCT03633825|25973007|P1|Follow up|Lost to Follow-up|478
7491443|NCT03633825|25973006|P2|Enrollment|Post not classified as crisis|13757
7491444|NCT03633825|25973007|P1|Enrollment|Post not classified as crisis|13967
7491445|NCT03633825|25973006|P2|Enrollment|Did not post on network|5080
7491446|NCT03633825|25973007|P1|Enrollment|Did not post on network|5066
7491447|NCT03633331|25973093|P1|Overall Study|Withdrawal by Subject|1
7491448|NCT03631732|25973252|P2|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
7491449|NCT03631732|25973253|P1|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
7491450|NCT03631732|25973252|P2|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
7491451|NCT03631732|25973253|P1|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
7491452|NCT03631732|25973252|P2|B/F/TAF Treatment Phase (After Week 24)|Death|0
7491453|NCT03631732|25973253|P1|B/F/TAF Treatment Phase (After Week 24)|Death|1
7491454|NCT03631732|25973252|P2|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
7491455|NCT03631732|25973253|P1|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
7491456|NCT03631732|25973252|P2|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7491457|NCT03631732|25973253|P1|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7491458|NCT03631732|25973252|P2|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
7491459|NCT03631732|25973253|P1|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
7491460|NCT03631732|25973252|P2|Randomized Phase Up to Week 24|Randomized but not treated|0
7491461|NCT03631732|25973253|P1|Randomized Phase Up to Week 24|Randomized but not treated|1
7491462|NCT03631732|25973252|P2|Randomized Phase Up to Week 24|Adverse Event|0
7491463|NCT03631732|25973253|P1|Randomized Phase Up to Week 24|Adverse Event|2
7491464|NCT03631732|25973252|P2|Randomized Phase Up to Week 24|Withdrew Consent|2
7491465|NCT03631732|25973253|P1|Randomized Phase Up to Week 24|Withdrew Consent|1
7491466|NCT03631732|25973252|P2|Randomized Phase Up to Week 24|Lost to Follow-up|0
7491467|NCT03631732|25973253|P1|Randomized Phase Up to Week 24|Lost to Follow-up|3
7491468|NCT03631355|25973292|P2|Overall Study|Lost to Follow-up|2
7491469|NCT03631355|25973293|P1|Overall Study|Lost to Follow-up|1
7491470|NCT03630302|25973320|P1|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
7491471|NCT03630302|25973320|P1|3 Month Visit|Adverse Event|2
7491472|NCT03630302|25973320|P1|Surgery|hardware issue prevented LFP recordings|1
7491473|NCT03630120|25973387|P4|Overall Study|Disease progression|1
7491474|NCT03630120|25973388|P3|Overall Study|Disease progression|1
7491475|NCT03630120|25973389|P2|Overall Study|Disease progression|1
7491476|NCT03630120|25973390|P1|Overall Study|Disease progression|0
7491477|NCT03630016|25973420|P1|Overall Study|Poor Sensor Placement|1
7491478|NCT03629886|25973445|P2|Overall Study|Refused vaccination step of the study|44
7491479|NCT03629886|25973446|P1|Overall Study|Refused vaccination step of the study|0
7491480|NCT03629886|25973445|P2|Overall Study|Didn't meet inclusion/exclusion criteria|28
7491481|NCT03629886|25973446|P1|Overall Study|Didn't meet inclusion/exclusion criteria|0
7491482|NCT03629886|25973445|P2|Overall Study|Study vaccine not administrated|3
7491483|NCT03629886|25973446|P1|Overall Study|Study vaccine not administrated|0
7491484|NCT03629886|25973445|P2|Overall Study|Consent withdrawal, not due to an AE|50
7491485|NCT03629886|25973446|P1|Overall Study|Consent withdrawal, not due to an AE|0
7491486|NCT03629886|25973445|P2|Overall Study|Migrated / moved from the study area|55
7491487|NCT03629886|25973446|P1|Overall Study|Migrated / moved from the study area|0
7491488|NCT03629249|25973470|P3|Overall Study|Physician Decision|0
7491489|NCT03629249|25973471|P2|Overall Study|Physician Decision|0
7491490|NCT03629249|25973472|P1|Overall Study|Physician Decision|1
7491491|NCT03629249|25973470|P3|Overall Study|Death|0
7491492|NCT03629249|25973471|P2|Overall Study|Death|0
7491493|NCT03629249|25973472|P1|Overall Study|Death|1
7491494|NCT03629249|25973470|P3|Overall Study|Adverse Event|0
7491495|NCT03629249|25973471|P2|Overall Study|Adverse Event|1
7491496|NCT03629249|25973472|P1|Overall Study|Adverse Event|1
7491497|NCT03629249|25973470|P3|Overall Study|Subject decision|3
7491498|NCT03629249|25973471|P2|Overall Study|Subject decision|1
7491499|NCT03629249|25973472|P1|Overall Study|Subject decision|1
7491500|NCT03629249|25973470|P3|Overall Study|Protocol deviation|5
7491501|NCT03629249|25973471|P2|Overall Study|Protocol deviation|2
7491502|NCT03629249|25973472|P1|Overall Study|Protocol deviation|0
7491503|NCT03629249|25973470|P3|Overall Study|Study terminated by sponsor|194
7491504|NCT03629249|25973471|P2|Overall Study|Study terminated by sponsor|197
7491505|NCT03629249|25973472|P1|Overall Study|Study terminated by sponsor|197
7491506|NCT03629184|25973506|P2|Overall Study|Physician Decision|0
7491507|NCT03629184|25973507|P1|Overall Study|Physician Decision|1
7491508|NCT03629184|25973506|P2|Overall Study|Withdrawal by Subject|1
7491509|NCT03629184|25973507|P1|Overall Study|Withdrawal by Subject|2
7491510|NCT03629054|25973557|P2|Period 2 (4 Days)|Not treated|1
7491511|NCT03629054|25973558|P1|Period 2 (4 Days)|Not treated|0
7491512|NCT03629041|25973582|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7491513|NCT03629041|25973583|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7491514|NCT03629041|25973584|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
7491515|NCT03629041|25973585|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7491516|NCT03629028|25973613|P2|Overall Study|intolerance to examination|0
7491517|NCT03629028|25973614|P1|Overall Study|intolerance to examination|2
7491518|NCT03629028|25973613|P2|Overall Study|Pregnancy|2
7491519|NCT03629028|25973614|P1|Overall Study|Pregnancy|4
7491520|NCT03629028|25973613|P2|Overall Study|Lost to Follow-up|23
7491521|NCT03629028|25973614|P1|Overall Study|Lost to Follow-up|26
7491522|NCT03628924|25973633|P7|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
7491523|NCT03628924|25973634|P6|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
7491524|NCT03628924|25973635|P5|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
7491525|NCT03628924|25973636|P4|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7491526|NCT03628924|25973637|P3|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7491527|NCT03628924|25973638|P2|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7491528|NCT03628924|25973639|P1|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7491529|NCT03628924|25973633|P7|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
7491530|NCT03628924|25973634|P6|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
7491531|NCT03628924|25973635|P5|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
7491532|NCT03628924|25973636|P4|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
7491533|NCT03628924|25973637|P3|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7491534|NCT03628924|25973638|P2|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7491535|NCT03628924|25973639|P1|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7491536|NCT03628924|25973633|P7|Active Treatment Period (Week 16-48)|Protocol Violation|1
7491537|NCT03628924|25973634|P6|Active Treatment Period (Week 16-48)|Protocol Violation|0
7491538|NCT03628924|25973635|P5|Active Treatment Period (Week 16-48)|Protocol Violation|1
7491539|NCT03628924|25973636|P4|Active Treatment Period (Week 16-48)|Protocol Violation|1
7491540|NCT03628924|25973637|P3|Active Treatment Period (Week 16-48)|Protocol Violation|0
7491541|NCT03628924|25973638|P2|Active Treatment Period (Week 16-48)|Protocol Violation|0
7491542|NCT03628924|25973639|P1|Active Treatment Period (Week 16-48)|Protocol Violation|0
7491543|NCT03628924|25973633|P7|Active Treatment Period (Week 16-48)|Adverse Event|4
7491544|NCT03628924|25973634|P6|Active Treatment Period (Week 16-48)|Adverse Event|2
7491545|NCT03628924|25973635|P5|Active Treatment Period (Week 16-48)|Adverse Event|0
7491546|NCT03628924|25973636|P4|Active Treatment Period (Week 16-48)|Adverse Event|1
7491547|NCT03628924|25973637|P3|Active Treatment Period (Week 16-48)|Adverse Event|0
7491548|NCT03628924|25973638|P2|Active Treatment Period (Week 16-48)|Adverse Event|0
7491549|NCT03628924|25973639|P1|Active Treatment Period (Week 16-48)|Adverse Event|0
7491550|NCT03628924|25973633|P7|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7491551|NCT03628924|25973634|P6|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
7491552|NCT03628924|25973635|P5|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7491553|NCT03628924|25973636|P4|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7491554|NCT03628924|25973637|P3|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7491555|NCT03628924|25973638|P2|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7491556|NCT03628924|25973639|P1|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7491557|NCT03628924|25973633|P7|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7491558|NCT03628924|25973634|P6|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7491559|NCT03628924|25973635|P5|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7491560|NCT03628924|25973636|P4|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7491561|NCT03628924|25973637|P3|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
7491562|NCT03628924|25973638|P2|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7491563|NCT03628924|25973639|P1|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
7491564|NCT03628924|25973633|P7|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7491565|NCT03628924|25973634|P6|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7491566|NCT03628924|25973635|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7491567|NCT03628924|25973636|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7491568|NCT03628924|25973637|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7491569|NCT03628924|25973638|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7491570|NCT03628924|25973639|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7491571|NCT03628924|25973633|P7|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7491572|NCT03628924|25973634|P6|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7491573|NCT03628924|25973635|P5|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7491574|NCT03628924|25973636|P4|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7491575|NCT03628924|25973637|P3|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7491576|NCT03628924|25973638|P2|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
7491577|NCT03628924|25973639|P1|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7491578|NCT03628924|25973633|P7|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7491579|NCT03628924|25973634|P6|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7491580|NCT03628924|25973635|P5|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7491581|NCT03628924|25973636|P4|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7491582|NCT03628924|25973637|P3|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7491583|NCT03628924|25973638|P2|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7491584|NCT03628924|25973639|P1|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7491585|NCT03628924|25973633|P7|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7491586|NCT03628924|25973634|P6|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7491587|NCT03628924|25973635|P5|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7491588|NCT03628924|25973636|P4|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7491589|NCT03628924|25973637|P3|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7491590|NCT03628924|25973638|P2|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7491591|NCT03628924|25973639|P1|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
7491592|NCT03628898|25973714|P1|Overall Study|Device deficiency|1
7491593|NCT03628599|25973735|P2|Overall Study|Adverse Event|1
7491594|NCT03628599|25973736|P1|Overall Study|Adverse Event|0
7491595|NCT03628508|25973746|P1|Overall Study|Lost to Follow-up|1
7491596|NCT03628417|25973771|P2|Overall Study|Death|1
7491597|NCT03628417|25973772|P1|Overall Study|Death|1
7491598|NCT03627832|25973784|P2|Overall Study|Withdrawal by Subject|1
7491599|NCT03627832|25973785|P1|Overall Study|Withdrawal by Subject|10
7491600|NCT03627767|25973810|P5|Open-label Rescue Period (12 Weeks)|Other|1
7491601|NCT03627767|25973811|P4|Open-label Rescue Period (12 Weeks)|Other|0
7491602|NCT03627767|25973812|P3|Open-label Rescue Period (12 Weeks)|Other|0
7491603|NCT03627767|25973813|P2|Open-label Rescue Period (12 Weeks)|Other|0
7491604|NCT03627767|25973814|P1|Open-label Rescue Period (12 Weeks)|Other|0
7491605|NCT03627767|25973810|P5|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
7491606|NCT03627767|25973811|P4|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7491607|NCT03627767|25973812|P3|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7491608|NCT03627767|25973813|P2|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7491609|NCT03627767|25973814|P1|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7491610|NCT03627767|25973810|P5|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
7491611|NCT03627767|25973811|P4|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7491612|NCT03627767|25973812|P3|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7491613|NCT03627767|25973813|P2|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7491614|NCT03627767|25973814|P1|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7491615|NCT03627767|25973810|P5|Open-label Rescue Period (12 Weeks)|Adverse Event|9
7491616|NCT03627767|25973811|P4|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7491617|NCT03627767|25973812|P3|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7491618|NCT03627767|25973813|P2|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7491619|NCT03627767|25973814|P1|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7491620|NCT03627767|25973810|P5|Double-blind Treatment Period (40 Weeks)|Other|0
7491621|NCT03627767|25973811|P4|Double-blind Treatment Period (40 Weeks)|Other|1
7491622|NCT03627767|25973812|P3|Double-blind Treatment Period (40 Weeks)|Other|1
7491623|NCT03627767|25973813|P2|Double-blind Treatment Period (40 Weeks)|Other|0
7491624|NCT03627767|25973814|P1|Double-blind Treatment Period (40 Weeks)|Other|0
7491625|NCT03627767|25973810|P5|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7491626|NCT03627767|25973811|P4|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7491627|NCT03627767|25973812|P3|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
7491628|NCT03627767|25973813|P2|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7491629|NCT03627767|25973814|P1|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7491630|NCT03627767|25973810|P5|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7491631|NCT03627767|25973811|P4|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
7491632|NCT03627767|25973812|P3|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
7491633|NCT03627767|25973813|P2|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
7491634|NCT03627767|25973814|P1|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7491635|NCT03627767|25973810|P5|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7491636|NCT03627767|25973811|P4|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
7491637|NCT03627767|25973812|P3|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
7491638|NCT03627767|25973813|P2|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
7491639|NCT03627767|25973814|P1|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7491640|NCT03627767|25973810|P5|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7491641|NCT03627767|25973811|P4|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
7491642|NCT03627767|25973812|P3|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
7491643|NCT03627767|25973813|P2|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7491644|NCT03627767|25973814|P1|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7491645|NCT03627767|25973810|P5|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7491646|NCT03627767|25973811|P4|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
7491647|NCT03627767|25973812|P3|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
7491648|NCT03627767|25973813|P2|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
7491649|NCT03627767|25973814|P1|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7491650|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7491651|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7491652|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7491653|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7491654|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
7491655|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7491656|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7491657|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7491658|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7491659|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Other|4
7491660|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7491661|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7491662|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7491663|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7491664|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
7491665|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7491666|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7491667|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7491668|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7491669|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
7491670|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7491671|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7491672|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7491673|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7491674|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
7491675|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7491676|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7491677|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7491678|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7491679|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
7491680|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7491681|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7491682|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7491683|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7491684|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
7491685|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7491686|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7491687|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7491688|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7491689|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
7491690|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7491691|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7491692|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7491693|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7491694|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Death|1
7491695|NCT03627767|25973810|P5|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7491696|NCT03627767|25973811|P4|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7491697|NCT03627767|25973812|P3|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7491698|NCT03627767|25973813|P2|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7491699|NCT03627767|25973814|P1|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
7491700|NCT03627494|25973903|P12|Part C Washout 1 (7 Days)|Adverse Event|1
7491701|NCT03627494|25973904|P11|Part C Washout 1 (7 Days)|Adverse Event|1
7491702|NCT03627494|25973905|P10|Part C Washout 1 (7 Days)|Adverse Event|0
7491703|NCT03627494|25973906|P9|Part C Washout 1 (7 Days)|Adverse Event|0
7491704|NCT03627494|25973907|P8|Part C Washout 1 (7 Days)|Adverse Event|0
7491705|NCT03627494|25973908|P7|Part C Washout 1 (7 Days)|Adverse Event|0
7491706|NCT03627494|25973909|P6|Part C Washout 1 (7 Days)|Adverse Event|0
7491707|NCT03627494|25973910|P5|Part C Washout 1 (7 Days)|Adverse Event|0
7491708|NCT03627494|25973911|P4|Part C Washout 1 (7 Days)|Adverse Event|0
7491709|NCT03627494|25973912|P3|Part C Washout 1 (7 Days)|Adverse Event|0
7491710|NCT03627494|25973913|P2|Part C Washout 1 (7 Days)|Adverse Event|0
7491711|NCT03627494|25973914|P1|Part C Washout 1 (7 Days)|Adverse Event|0
7491712|NCT03627494|25973903|P12|Part B (Maximum of 34 Days)|Adverse Event|0
7491713|NCT03627494|25973904|P11|Part B (Maximum of 34 Days)|Adverse Event|0
7491714|NCT03627494|25973905|P10|Part B (Maximum of 34 Days)|Adverse Event|0
7491715|NCT03627494|25973906|P9|Part B (Maximum of 34 Days)|Adverse Event|2
7491716|NCT03627494|25973907|P8|Part B (Maximum of 34 Days)|Adverse Event|0
7491717|NCT03627494|25973908|P7|Part B (Maximum of 34 Days)|Adverse Event|0
7491718|NCT03627494|25973909|P6|Part B (Maximum of 34 Days)|Adverse Event|0
7491719|NCT03627494|25973910|P5|Part B (Maximum of 34 Days)|Adverse Event|0
7491720|NCT03627494|25973911|P4|Part B (Maximum of 34 Days)|Adverse Event|0
7491721|NCT03627494|25973912|P3|Part B (Maximum of 34 Days)|Adverse Event|0
7491722|NCT03627494|25973913|P2|Part B (Maximum of 34 Days)|Adverse Event|0
7491723|NCT03627494|25973914|P1|Part B (Maximum of 34 Days)|Adverse Event|0
7491724|NCT03627494|25973903|P12|Part A Washout 2 (7 Days)|Adverse Event|0
7491725|NCT03627494|25973904|P11|Part A Washout 2 (7 Days)|Adverse Event|0
7491726|NCT03627494|25973905|P10|Part A Washout 2 (7 Days)|Adverse Event|0
7491727|NCT03627494|25973906|P9|Part A Washout 2 (7 Days)|Adverse Event|0
7491728|NCT03627494|25973907|P8|Part A Washout 2 (7 Days)|Adverse Event|0
7491729|NCT03627494|25973908|P7|Part A Washout 2 (7 Days)|Adverse Event|0
7491730|NCT03627494|25973909|P6|Part A Washout 2 (7 Days)|Adverse Event|0
7491731|NCT03627494|25973910|P5|Part A Washout 2 (7 Days)|Adverse Event|0
7491732|NCT03627494|25973911|P4|Part A Washout 2 (7 Days)|Adverse Event|0
7491733|NCT03627494|25973912|P3|Part A Washout 2 (7 Days)|Adverse Event|1
7491734|NCT03627494|25973913|P2|Part A Washout 2 (7 Days)|Adverse Event|0
7491735|NCT03627494|25973914|P1|Part A Washout 2 (7 Days)|Adverse Event|1
7491736|NCT03627416|25974112|P2|Overall Study|Adverse Event|1
7491737|NCT03627416|25974113|P1|Overall Study|Adverse Event|0
7491738|NCT03627195|25974145|P6|Overall Study|OTHER (LACK OF EFFICACY)|0
7491739|NCT03627195|25974146|P5|Overall Study|OTHER (LACK OF EFFICACY)|0
7491740|NCT03627195|25974147|P4|Overall Study|OTHER (LACK OF EFFICACY)|0
7491741|NCT03627195|25974148|P3|Overall Study|OTHER (LACK OF EFFICACY)|0
7491742|NCT03627195|25974149|P2|Overall Study|OTHER (LACK OF EFFICACY)|0
7491743|NCT03627195|25974150|P1|Overall Study|OTHER (LACK OF EFFICACY)|1
7491744|NCT03627065|25974176|P1|Overall Study|Withdrawal by Subject|2
7491745|NCT03627065|25974176|P1|Overall Study|Study Terminated by sponsor|1
7491746|NCT03624972|25974280|P3|Overall Study|Withdrawal by Subject|0
7491747|NCT03624972|25974281|P2|Overall Study|Withdrawal by Subject|2
7491748|NCT03624972|25974282|P1|Overall Study|Withdrawal by Subject|0
7491749|NCT03624972|25974280|P3|Overall Study|Lost to Follow-up|0
7491750|NCT03624972|25974281|P2|Overall Study|Lost to Follow-up|0
7491751|NCT03624972|25974282|P1|Overall Study|Lost to Follow-up|2
7491752|NCT03624946|25974337|P2|Overall Study|Lost to Follow-up|1
7491753|NCT03624946|25974338|P1|Overall Study|Lost to Follow-up|0
7491754|NCT03624504|25974392|P1|Overall Study|Unsuccessful Implant|1
7491755|NCT03624192|25974400|P2|Overall Study|Lost to Follow-up|1
7491756|NCT03624192|25974401|P1|Overall Study|Lost to Follow-up|1
7491757|NCT03622112|25974514|P7|Overall Study|Reason not specified|1
7491758|NCT03622112|25974515|P6|Overall Study|Reason not specified|2
7491759|NCT03622112|25974516|P5|Overall Study|Reason not specified|1
7491760|NCT03622112|25974517|P4|Overall Study|Reason not specified|1
7491761|NCT03622112|25974518|P3|Overall Study|Reason not specified|0
7491762|NCT03622112|25974519|P2|Overall Study|Reason not specified|1
7491763|NCT03622112|25974520|P1|Overall Study|Reason not specified|0
7491764|NCT03622112|25974514|P7|Overall Study|Adverse Event|2
7491765|NCT03622112|25974515|P6|Overall Study|Adverse Event|20
7491766|NCT03622112|25974516|P5|Overall Study|Adverse Event|4
7491767|NCT03622112|25974517|P4|Overall Study|Adverse Event|11
7491768|NCT03622112|25974518|P3|Overall Study|Adverse Event|4
7491769|NCT03622112|25974519|P2|Overall Study|Adverse Event|8
7491770|NCT03622112|25974520|P1|Overall Study|Adverse Event|6
7491771|NCT03622112|25974514|P7|Overall Study|Protocol Violation|0
7491772|NCT03622112|25974515|P6|Overall Study|Protocol Violation|0
7491773|NCT03622112|25974516|P5|Overall Study|Protocol Violation|0
7491774|NCT03622112|25974517|P4|Overall Study|Protocol Violation|1
7491775|NCT03622112|25974518|P3|Overall Study|Protocol Violation|1
7491776|NCT03622112|25974519|P2|Overall Study|Protocol Violation|0
7491777|NCT03622112|25974520|P1|Overall Study|Protocol Violation|2
7491778|NCT03622112|25974514|P7|Overall Study|Study-specific withdrawal criteria|4
7491779|NCT03622112|25974515|P6|Overall Study|Study-specific withdrawal criteria|18
7491780|NCT03622112|25974516|P5|Overall Study|Study-specific withdrawal criteria|4
7491781|NCT03622112|25974517|P4|Overall Study|Study-specific withdrawal criteria|6
7491782|NCT03622112|25974518|P3|Overall Study|Study-specific withdrawal criteria|7
7491783|NCT03622112|25974519|P2|Overall Study|Study-specific withdrawal criteria|8
7491784|NCT03622112|25974520|P1|Overall Study|Study-specific withdrawal criteria|10
7491785|NCT03622112|25974514|P7|Overall Study|Lost to Follow-up|0
7491786|NCT03622112|25974515|P6|Overall Study|Lost to Follow-up|0
7491787|NCT03622112|25974516|P5|Overall Study|Lost to Follow-up|0
7491788|NCT03622112|25974517|P4|Overall Study|Lost to Follow-up|0
7491789|NCT03622112|25974518|P3|Overall Study|Lost to Follow-up|0
7491790|NCT03622112|25974519|P2|Overall Study|Lost to Follow-up|1
7491791|NCT03622112|25974520|P1|Overall Study|Lost to Follow-up|1
7491792|NCT03622112|25974514|P7|Overall Study|Death|0
7491793|NCT03622112|25974515|P6|Overall Study|Death|0
7491794|NCT03622112|25974516|P5|Overall Study|Death|0
7491795|NCT03622112|25974517|P4|Overall Study|Death|1
7491796|NCT03622112|25974518|P3|Overall Study|Death|0
7491797|NCT03622112|25974519|P2|Overall Study|Death|0
7491798|NCT03622112|25974520|P1|Overall Study|Death|0
7491799|NCT03622112|25974514|P7|Overall Study|Withdrawal by Subject|2
7491800|NCT03622112|25974515|P6|Overall Study|Withdrawal by Subject|2
7491801|NCT03622112|25974516|P5|Overall Study|Withdrawal by Subject|1
7491802|NCT03622112|25974517|P4|Overall Study|Withdrawal by Subject|2
7491803|NCT03622112|25974518|P3|Overall Study|Withdrawal by Subject|4
7491804|NCT03622112|25974519|P2|Overall Study|Withdrawal by Subject|2
7491805|NCT03622112|25974520|P1|Overall Study|Withdrawal by Subject|6
7491806|NCT03621189|25974770|P2|Overall Study|Physician Decision|2
7491807|NCT03621189|25974771|P1|Overall Study|Physician Decision|0
7491808|NCT03621189|25974770|P2|Overall Study|Withdrawal by Subject|3
7491809|NCT03621189|25974771|P1|Overall Study|Withdrawal by Subject|0
7491810|NCT03620708|25974821|P3|Overall Study|Withdrawal by Subject|1
7491811|NCT03620708|25974822|P2|Overall Study|Withdrawal by Subject|0
7491812|NCT03620708|25974823|P1|Overall Study|Withdrawal by Subject|0
7491813|NCT03620708|25974821|P3|Overall Study|Lost to Follow-up|2
7491814|NCT03620708|25974822|P2|Overall Study|Lost to Follow-up|1
7491815|NCT03620708|25974823|P1|Overall Study|Lost to Follow-up|1
7491816|NCT03620162|25974857|P5|Overall Study|Consent withdrawn by parent/guardian|9
7491817|NCT03620162|25974858|P4|Overall Study|Consent withdrawn by parent/guardian|17
7491818|NCT03620162|25974859|P3|Overall Study|Consent withdrawn by parent/guardian|25
7491819|NCT03620162|25974860|P2|Overall Study|Consent withdrawn by parent/guardian|8
7491820|NCT03620162|25974861|P1|Overall Study|Consent withdrawn by parent/guardian|9
7491821|NCT03620162|25974857|P5|Overall Study|Lost to Follow-up|2
7491822|NCT03620162|25974858|P4|Overall Study|Lost to Follow-up|3
7491823|NCT03620162|25974859|P3|Overall Study|Lost to Follow-up|7
7491824|NCT03620162|25974860|P2|Overall Study|Lost to Follow-up|6
7491825|NCT03620162|25974861|P1|Overall Study|Lost to Follow-up|2
7491826|NCT03620162|25974857|P5|Overall Study|Physician Decision|2
7491827|NCT03620162|25974858|P4|Overall Study|Physician Decision|0
7491828|NCT03620162|25974859|P3|Overall Study|Physician Decision|1
7491829|NCT03620162|25974860|P2|Overall Study|Physician Decision|0
7491830|NCT03620162|25974861|P1|Overall Study|Physician Decision|4
7491831|NCT03619837|25974948|P1|Screening|excluded by the investigator due to non-compliance|1
7491832|NCT03619837|25974948|P1|Screening|developed exclusion criteria|2
7491833|NCT03619837|25974948|P1|Screening|never listed for HCV-viremic donor|1
7491834|NCT03619837|25974948|P1|Screening|withdrew consent|2
7491835|NCT03619837|25974948|P1|Screening|didn't meet eligibility criteria|3
7491836|NCT03619837|25974948|P1|Screening|remained on the wait list|40
7491837|NCT03619837|25974948|P1|Screening|died on the wait-list|2
7491838|NCT03619837|25974948|P1|Screening|received organs from HCV-negative donors|47
7491839|NCT03618628|25974982|P1|Overall Study|Lost to Follow-up|1
7491840|NCT03618628|25974982|P1|Overall Study|Death|1
7491841|NCT03617861|25975051|P4|Second Intervention (1 Day)|Adverse Event|0
7491842|NCT03617861|25975052|P3|Second Intervention (1 Day)|Adverse Event|1
7491843|NCT03617861|25975053|P2|Second Intervention (1 Day)|Adverse Event|0
7491844|NCT03617861|25975054|P1|Second Intervention (1 Day)|Adverse Event|0
7491845|NCT03617770|25975086|P2|Overall Study|Lost to Follow-up|0
7491846|NCT03617770|25975087|P1|Overall Study|Lost to Follow-up|1
7491847|NCT03617588|25975103|P2|Overall Study|Withdrawal by Subject|0
7491848|NCT03617588|25975104|P1|Overall Study|Withdrawal by Subject|1
7491849|NCT03616977|25975165|P2|Period 3|Adverse Event|1
7491850|NCT03616977|25975166|P1|Period 3|Adverse Event|1
7491851|NCT03616977|25975165|P2|Period 1|Physician Decision|1
7491852|NCT03616977|25975166|P1|Period 1|Physician Decision|0
7491853|NCT03616600|25975197|P2|Overall Study|Withdrawal by Subject|0
7491854|NCT03616600|25975198|P1|Overall Study|Withdrawal by Subject|1
7491855|NCT03616106|25975232|P2|Overall Study|Lost to Follow-up|0
7491856|NCT03616106|25975233|P1|Overall Study|Lost to Follow-up|7
7491857|NCT03616106|25975232|P2|Overall Study|Withdrawal by Subject|1
7491858|NCT03616106|25975233|P1|Overall Study|Withdrawal by Subject|1
7491859|NCT03616106|25975232|P2|Overall Study|Removed by PI|0
7491860|NCT03616106|25975233|P1|Overall Study|Removed by PI|6
7491861|NCT03615924|25975270|P2|Overall Study|Study termination by Sponsor|86
7491862|NCT03615924|25975271|P1|Overall Study|Study termination by Sponsor|94
7491863|NCT03615924|25975270|P2|Overall Study|Randomized in error|0
7491864|NCT03615924|25975271|P1|Overall Study|Randomized in error|1
7491865|NCT03615924|25975270|P2|Overall Study|Lost to Follow-up|0
7491866|NCT03615924|25975271|P1|Overall Study|Lost to Follow-up|1
7491867|NCT03615924|25975270|P2|Overall Study|Death|1
7491868|NCT03615924|25975271|P1|Overall Study|Death|3
7491869|NCT03615924|25975270|P2|Overall Study|Withdrawal by Subject|5
7491870|NCT03615924|25975271|P1|Overall Study|Withdrawal by Subject|2
7491871|NCT03615482|25975396|P2|Overall Study|Withdrawal by Subject|7
7491872|NCT03615482|25975397|P1|Overall Study|Withdrawal by Subject|7
7491873|NCT03615482|25975396|P2|Overall Study|Physician Decision|3
7491874|NCT03615482|25975397|P1|Overall Study|Physician Decision|2
7491875|NCT03615482|25975396|P2|Overall Study|Lost to Follow-up|7
7491876|NCT03615482|25975397|P1|Overall Study|Lost to Follow-up|7
7491877|NCT03615482|25975396|P2|Overall Study|Death|0
7491878|NCT03615482|25975397|P1|Overall Study|Death|1
7491879|NCT03615404|25975427|P1|Overall Study|vaccine did not pass quality assurance|1
7491880|NCT03615404|25975427|P1|Overall Study|Death|1
7491881|NCT03615144|25975499|P2|Overall Study|Participant no longer eligible for this protocol|0
7491882|NCT03615144|25975500|P1|Overall Study|Participant no longer eligible for this protocol|1
7491883|NCT03615066|25975509|P3|Overall Study|Still on Study|2
7491884|NCT03615066|25975510|P2|Overall Study|Still on Study|6
7491885|NCT03615066|25975511|P1|Overall Study|Still on Study|8
7491886|NCT03615066|25975509|P3|Overall Study|Lost to Follow-up|1
7491887|NCT03615066|25975510|P2|Overall Study|Lost to Follow-up|0
7491888|NCT03615066|25975511|P1|Overall Study|Lost to Follow-up|0
7491889|NCT03615066|25975509|P3|Overall Study|Withdrew Consent|1
7491890|NCT03615066|25975510|P2|Overall Study|Withdrew Consent|2
7491891|NCT03615066|25975511|P1|Overall Study|Withdrew Consent|0
7491892|NCT03615066|25975509|P3|Overall Study|Protocol Violation|0
7491893|NCT03615066|25975510|P2|Overall Study|Protocol Violation|0
7491894|NCT03615066|25975511|P1|Overall Study|Protocol Violation|1
7491895|NCT03614975|25975609|P2|Overall Study|Specimens not in lab batch shipment|1
7491896|NCT03614975|25975610|P1|Overall Study|Specimens not in lab batch shipment|1
7491897|NCT03614975|25975609|P2|Overall Study|Withdrawal by Subject|2
7491898|NCT03614975|25975610|P1|Overall Study|Withdrawal by Subject|2
7491899|NCT03614975|25975609|P2|Overall Study|Physician Decision|5
7491900|NCT03614975|25975610|P1|Overall Study|Physician Decision|7
7491901|NCT03614156|25975632|P4|Safety Follow-Up Period|Lost to Follow-up|1
7491902|NCT03614156|25975633|P3|Safety Follow-Up Period|Lost to Follow-up|0
7491903|NCT03614156|25975634|P2|Safety Follow-Up Period|Lost to Follow-up|0
7491904|NCT03614156|25975635|P1|Safety Follow-Up Period|Lost to Follow-up|1
7491905|NCT03614156|25975632|P4|Safety Follow-Up Period|Withdrawal by Subject|0
7491906|NCT03614156|25975633|P3|Safety Follow-Up Period|Withdrawal by Subject|1
7491907|NCT03614156|25975634|P2|Safety Follow-Up Period|Withdrawal by Subject|0
7491908|NCT03614156|25975635|P1|Safety Follow-Up Period|Withdrawal by Subject|0
7491909|NCT03614156|25975632|P4|Safety Follow-Up Period|Miscellaneous Reasons|0
7491910|NCT03614156|25975633|P3|Safety Follow-Up Period|Miscellaneous Reasons|0
7491911|NCT03614156|25975634|P2|Safety Follow-Up Period|Miscellaneous Reasons|0
7491912|NCT03614156|25975635|P1|Safety Follow-Up Period|Miscellaneous Reasons|2
7491913|NCT03614156|25975632|P4|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7491914|NCT03614156|25975633|P3|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7491915|NCT03614156|25975634|P2|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
7491916|NCT03614156|25975635|P1|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7491917|NCT03614156|25975632|P4|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
7491918|NCT03614156|25975633|P3|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
7491919|NCT03614156|25975634|P2|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
7491920|NCT03614156|25975635|P1|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
7491921|NCT03614156|25975632|P4|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7491922|NCT03614156|25975633|P3|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7491923|NCT03614156|25975634|P2|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7491924|NCT03614156|25975635|P1|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
7491925|NCT03614156|25975632|P4|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
7491926|NCT03614156|25975633|P3|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
7491927|NCT03614156|25975634|P2|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7491928|NCT03614156|25975635|P1|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7491929|NCT03614156|25975632|P4|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7491930|NCT03614156|25975633|P3|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7491931|NCT03614156|25975634|P2|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
7491932|NCT03614156|25975635|P1|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
7491933|NCT03614156|25975632|P4|Double-Blind Treatment Period (DBTP)|Adverse Event|1
7491934|NCT03614156|25975633|P3|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7491935|NCT03614156|25975634|P2|Double-Blind Treatment Period (DBTP)|Adverse Event|2
7491936|NCT03614156|25975635|P1|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7491937|NCT03614156|25975632|P4|Open-Label Treatment Period|Study terminated by sponsor|0
7491938|NCT03614156|25975633|P3|Open-Label Treatment Period|Study terminated by sponsor|0
7491939|NCT03614156|25975634|P2|Open-Label Treatment Period|Study terminated by sponsor|0
7491940|NCT03614156|25975635|P1|Open-Label Treatment Period|Study terminated by sponsor|74
7491941|NCT03614156|25975632|P4|Open-Label Treatment Period|Non-compliance with study drug|0
7491942|NCT03614156|25975633|P3|Open-Label Treatment Period|Non-compliance with study drug|0
7491943|NCT03614156|25975634|P2|Open-Label Treatment Period|Non-compliance with study drug|0
7491944|NCT03614156|25975635|P1|Open-Label Treatment Period|Non-compliance with study drug|1
7491945|NCT03614156|25975632|P4|Open-Label Treatment Period|Protocol Violation|0
7491946|NCT03614156|25975633|P3|Open-Label Treatment Period|Protocol Violation|0
7491947|NCT03614156|25975634|P2|Open-Label Treatment Period|Protocol Violation|0
7491948|NCT03614156|25975635|P1|Open-Label Treatment Period|Protocol Violation|2
7491949|NCT03614156|25975632|P4|Open-Label Treatment Period|Lost to Follow-up|0
7491950|NCT03614156|25975633|P3|Open-Label Treatment Period|Lost to Follow-up|0
7491951|NCT03614156|25975634|P2|Open-Label Treatment Period|Lost to Follow-up|0
7491952|NCT03614156|25975635|P1|Open-Label Treatment Period|Lost to Follow-up|10
7491953|NCT03614156|25975632|P4|Open-Label Treatment Period|Withdrawal by Subject|0
7491954|NCT03614156|25975633|P3|Open-Label Treatment Period|Withdrawal by Subject|0
7491955|NCT03614156|25975634|P2|Open-Label Treatment Period|Withdrawal by Subject|0
7491956|NCT03614156|25975635|P1|Open-Label Treatment Period|Withdrawal by Subject|36
7491957|NCT03614156|25975632|P4|Open-Label Treatment Period|Lack of Efficacy|0
7491958|NCT03614156|25975633|P3|Open-Label Treatment Period|Lack of Efficacy|0
7491959|NCT03614156|25975634|P2|Open-Label Treatment Period|Lack of Efficacy|0
7491960|NCT03614156|25975635|P1|Open-Label Treatment Period|Lack of Efficacy|18
7491961|NCT03614156|25975632|P4|Open-Label Treatment Period|Adverse Event|0
7491962|NCT03614156|25975633|P3|Open-Label Treatment Period|Adverse Event|0
7491963|NCT03614156|25975634|P2|Open-Label Treatment Period|Adverse Event|0
7491964|NCT03614156|25975635|P1|Open-Label Treatment Period|Adverse Event|7
7491965|NCT03614156|25975632|P4|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7491966|NCT03614156|25975633|P3|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7491967|NCT03614156|25975634|P2|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7491968|NCT03614156|25975635|P1|Open-Label Treatment Period|Protocol-specified withdrawal met|6
7491969|NCT03614078|25975658|P3|Overall Study|Dizziness and Rash|0
7491970|NCT03614078|25975659|P2|Overall Study|Dizziness and Rash|1
7491971|NCT03614078|25975660|P1|Overall Study|Dizziness and Rash|0
7491972|NCT03614078|25975658|P3|Overall Study|Adverse Event|0
7491973|NCT03614078|25975659|P2|Overall Study|Adverse Event|2
7491974|NCT03614078|25975660|P1|Overall Study|Adverse Event|0
7491975|NCT03614078|25975658|P3|Overall Study|Exacerbation of Psoriasis|0
7491976|NCT03614078|25975659|P2|Overall Study|Exacerbation of Psoriasis|1
7491977|NCT03614078|25975660|P1|Overall Study|Exacerbation of Psoriasis|0
7491978|NCT03614078|25975658|P3|Overall Study|Patient Did Not Meet Eligibility|0
7491979|NCT03614078|25975659|P2|Overall Study|Patient Did Not Meet Eligibility|0
7491980|NCT03614078|25975660|P1|Overall Study|Patient Did Not Meet Eligibility|1
7491981|NCT03614078|25975658|P3|Overall Study|High Neutrophils|2
7491982|NCT03614078|25975659|P2|Overall Study|High Neutrophils|0
7491983|NCT03614078|25975660|P1|Overall Study|High Neutrophils|0
7491984|NCT03614078|25975658|P3|Overall Study|Participant Did Not Return for Visit|0
7491985|NCT03614078|25975659|P2|Overall Study|Participant Did Not Return for Visit|1
7491986|NCT03614078|25975660|P1|Overall Study|Participant Did Not Return for Visit|0
7491987|NCT03614078|25975658|P3|Overall Study|Withdrawal by Subject|3
7491988|NCT03614078|25975659|P2|Overall Study|Withdrawal by Subject|2
7491989|NCT03614078|25975660|P1|Overall Study|Withdrawal by Subject|2
7491990|NCT03613649|25975708|P12|Fourth Treatment|Physician Decision|0
7491991|NCT03613649|25975709|P11|Fourth Treatment|Physician Decision|0
7491992|NCT03613649|25975710|P10|Fourth Treatment|Physician Decision|0
7491993|NCT03613649|25975711|P9|Fourth Treatment|Physician Decision|0
7491994|NCT03613649|25975712|P8|Fourth Treatment|Physician Decision|0
7491995|NCT03613649|25975713|P7|Fourth Treatment|Physician Decision|1
7491996|NCT03613649|25975714|P6|Fourth Treatment|Physician Decision|0
7491997|NCT03613649|25975715|P5|Fourth Treatment|Physician Decision|0
7491998|NCT03613649|25975716|P4|Fourth Treatment|Physician Decision|0
7491999|NCT03613649|25975717|P3|Fourth Treatment|Physician Decision|0
7492000|NCT03613649|25975718|P2|Fourth Treatment|Physician Decision|0
7492001|NCT03613649|25975719|P1|Fourth Treatment|Physician Decision|0
7492002|NCT03613649|25975708|P12|Fourth Treatment|Protocol Violation|0
7492003|NCT03613649|25975709|P11|Fourth Treatment|Protocol Violation|0
7492004|NCT03613649|25975710|P10|Fourth Treatment|Protocol Violation|0
7492005|NCT03613649|25975711|P9|Fourth Treatment|Protocol Violation|0
7492006|NCT03613649|25975712|P8|Fourth Treatment|Protocol Violation|0
7492007|NCT03613649|25975713|P7|Fourth Treatment|Protocol Violation|0
7492008|NCT03613649|25975714|P6|Fourth Treatment|Protocol Violation|0
7492009|NCT03613649|25975715|P5|Fourth Treatment|Protocol Violation|1
7492010|NCT03613649|25975716|P4|Fourth Treatment|Protocol Violation|0
7492011|NCT03613649|25975717|P3|Fourth Treatment|Protocol Violation|0
7492012|NCT03613649|25975718|P2|Fourth Treatment|Protocol Violation|0
7492013|NCT03613649|25975719|P1|Fourth Treatment|Protocol Violation|1
7492014|NCT03613649|25975708|P12|Third Treatment|Protocol Violation|1
7492015|NCT03613649|25975709|P11|Third Treatment|Protocol Violation|0
7492016|NCT03613649|25975710|P10|Third Treatment|Protocol Violation|0
7492017|NCT03613649|25975711|P9|Third Treatment|Protocol Violation|0
7492018|NCT03613649|25975712|P8|Third Treatment|Protocol Violation|0
7492019|NCT03613649|25975713|P7|Third Treatment|Protocol Violation|1
7492020|NCT03613649|25975714|P6|Third Treatment|Protocol Violation|0
7492021|NCT03613649|25975715|P5|Third Treatment|Protocol Violation|0
7492022|NCT03613649|25975716|P4|Third Treatment|Protocol Violation|0
7492023|NCT03613649|25975717|P3|Third Treatment|Protocol Violation|0
7492024|NCT03613649|25975718|P2|Third Treatment|Protocol Violation|0
7492025|NCT03613649|25975719|P1|Third Treatment|Protocol Violation|0
7492026|NCT03613649|25975708|P12|Third Treatment|Lost to Follow-up|1
7492027|NCT03613649|25975709|P11|Third Treatment|Lost to Follow-up|0
7492028|NCT03613649|25975710|P10|Third Treatment|Lost to Follow-up|0
7492029|NCT03613649|25975711|P9|Third Treatment|Lost to Follow-up|0
7492030|NCT03613649|25975712|P8|Third Treatment|Lost to Follow-up|0
7492031|NCT03613649|25975713|P7|Third Treatment|Lost to Follow-up|0
7492032|NCT03613649|25975714|P6|Third Treatment|Lost to Follow-up|0
7492033|NCT03613649|25975715|P5|Third Treatment|Lost to Follow-up|1
7492034|NCT03613649|25975716|P4|Third Treatment|Lost to Follow-up|0
7492035|NCT03613649|25975717|P3|Third Treatment|Lost to Follow-up|0
7492036|NCT03613649|25975718|P2|Third Treatment|Lost to Follow-up|0
7492037|NCT03613649|25975719|P1|Third Treatment|Lost to Follow-up|0
7492038|NCT03613649|25975708|P12|Second Treatment|Withdrawal by Subject|0
7492039|NCT03613649|25975709|P11|Second Treatment|Withdrawal by Subject|0
7492040|NCT03613649|25975710|P10|Second Treatment|Withdrawal by Subject|0
7492041|NCT03613649|25975711|P9|Second Treatment|Withdrawal by Subject|0
7492042|NCT03613649|25975712|P8|Second Treatment|Withdrawal by Subject|0
7492043|NCT03613649|25975713|P7|Second Treatment|Withdrawal by Subject|0
7492044|NCT03613649|25975714|P6|Second Treatment|Withdrawal by Subject|0
7492045|NCT03613649|25975715|P5|Second Treatment|Withdrawal by Subject|1
7492046|NCT03613649|25975716|P4|Second Treatment|Withdrawal by Subject|0
7492047|NCT03613649|25975717|P3|Second Treatment|Withdrawal by Subject|0
7492048|NCT03613649|25975718|P2|Second Treatment|Withdrawal by Subject|0
7492049|NCT03613649|25975719|P1|Second Treatment|Withdrawal by Subject|0
7492050|NCT03613649|25975708|P12|Second Treatment|Lost to Follow-up|0
7492051|NCT03613649|25975709|P11|Second Treatment|Lost to Follow-up|0
7492052|NCT03613649|25975710|P10|Second Treatment|Lost to Follow-up|0
7492053|NCT03613649|25975711|P9|Second Treatment|Lost to Follow-up|0
7492054|NCT03613649|25975712|P8|Second Treatment|Lost to Follow-up|0
7492055|NCT03613649|25975713|P7|Second Treatment|Lost to Follow-up|0
7492056|NCT03613649|25975714|P6|Second Treatment|Lost to Follow-up|0
7492057|NCT03613649|25975715|P5|Second Treatment|Lost to Follow-up|0
7492058|NCT03613649|25975716|P4|Second Treatment|Lost to Follow-up|0
7492059|NCT03613649|25975717|P3|Second Treatment|Lost to Follow-up|1
7492060|NCT03613649|25975718|P2|Second Treatment|Lost to Follow-up|0
7492061|NCT03613649|25975719|P1|Second Treatment|Lost to Follow-up|0
7492062|NCT03613454|25975862|P2|Overall Study|Protocol Violation|1
7492063|NCT03613454|25975863|P1|Overall Study|Protocol Violation|0
7492064|NCT03613454|25975862|P2|Overall Study|Protocol Violation|0
7492065|NCT03613454|25975863|P1|Overall Study|Protocol Violation|1
7492066|NCT03613129|25975883|P5|Pre-treatment Assessment|Withdrawal by Subject|0
7492067|NCT03613129|25975884|P4|Pre-treatment Assessment|Withdrawal by Subject|0
7492068|NCT03613129|25975885|P3|Pre-treatment Assessment|Withdrawal by Subject|0
7492069|NCT03613129|25975886|P2|Pre-treatment Assessment|Withdrawal by Subject|0
7492070|NCT03613129|25975887|P1|Pre-treatment Assessment|Withdrawal by Subject|1
7492071|NCT03613129|25975883|P5|Pre-treatment Assessment|Protocol Violation|0
7492072|NCT03613129|25975884|P4|Pre-treatment Assessment|Protocol Violation|0
7492073|NCT03613129|25975885|P3|Pre-treatment Assessment|Protocol Violation|0
7492074|NCT03613129|25975886|P2|Pre-treatment Assessment|Protocol Violation|0
7492075|NCT03613129|25975887|P1|Pre-treatment Assessment|Protocol Violation|2
7492076|NCT03612856|25975912|P3|Pre-dose Period|Withdrawal by Subject|0
7492077|NCT03612856|25975913|P2|Pre-dose Period|Withdrawal by Subject|1
7492078|NCT03612856|25975914|P1|Pre-dose Period|Withdrawal by Subject|0
7492079|NCT03612856|25975912|P3|Pre-dose Period|Physician Decision|1
7492080|NCT03612856|25975913|P2|Pre-dose Period|Physician Decision|1
7492081|NCT03612856|25975914|P1|Pre-dose Period|Physician Decision|0
7492082|NCT03611582|25976139|P2|Overall Study|other|16
7492083|NCT03611582|25976140|P1|Overall Study|other|17
7492084|NCT03611582|25976139|P2|Overall Study|Lost to Follow-up|7
7492085|NCT03611582|25976140|P1|Overall Study|Lost to Follow-up|18
7492086|NCT03611582|25976139|P2|Overall Study|Withdrawal by Subject|3
7492087|NCT03611582|25976140|P1|Overall Study|Withdrawal by Subject|4
7492088|NCT03611582|25976139|P2|Overall Study|Safety concern as judged by the investigator|2
7492089|NCT03611582|25976140|P1|Overall Study|Safety concern as judged by the investigator|1
7492090|NCT03611582|25976139|P2|Overall Study|At the discretion of the investigator|0
7492091|NCT03611582|25976140|P1|Overall Study|At the discretion of the investigator|1
7492092|NCT03611582|25976139|P2|Overall Study|Lack of Efficacy|1
7492093|NCT03611582|25976140|P1|Overall Study|Lack of Efficacy|0
7492094|NCT03611582|25976139|P2|Overall Study|Pregnancy|2
7492095|NCT03611582|25976140|P1|Overall Study|Pregnancy|1
7492096|NCT03611582|25976139|P2|Overall Study|Protocol Violation|1
7492097|NCT03611582|25976140|P1|Overall Study|Protocol Violation|0
7492098|NCT03611582|25976139|P2|Overall Study|Adverse Event|6
7492099|NCT03611582|25976140|P1|Overall Study|Adverse Event|26
7492100|NCT03611075|25976215|P9|Overall Study|Reason unknown|0
7492101|NCT03611075|25976216|P8|Overall Study|Reason unknown|0
7492102|NCT03611075|25976217|P7|Overall Study|Reason unknown|1
7492103|NCT03611075|25976218|P6|Overall Study|Reason unknown|0
7492104|NCT03611075|25976219|P5|Overall Study|Reason unknown|0
7492105|NCT03611075|25976220|P4|Overall Study|Reason unknown|1
7492106|NCT03611075|25976221|P3|Overall Study|Reason unknown|0
7492107|NCT03611075|25976222|P2|Overall Study|Reason unknown|0
7492108|NCT03611075|25976223|P1|Overall Study|Reason unknown|0
7492109|NCT03611075|25976215|P9|Overall Study|Withdrawal by Subject|0
7492110|NCT03611075|25976216|P8|Overall Study|Withdrawal by Subject|0
7492111|NCT03611075|25976217|P7|Overall Study|Withdrawal by Subject|1
7492112|NCT03611075|25976218|P6|Overall Study|Withdrawal by Subject|0
7492113|NCT03611075|25976219|P5|Overall Study|Withdrawal by Subject|0
7492114|NCT03611075|25976220|P4|Overall Study|Withdrawal by Subject|1
7492115|NCT03611075|25976221|P3|Overall Study|Withdrawal by Subject|1
7492116|NCT03611075|25976222|P2|Overall Study|Withdrawal by Subject|1
7492117|NCT03611075|25976223|P1|Overall Study|Withdrawal by Subject|0
7492118|NCT03611075|25976215|P9|Overall Study|Lost to Follow-up|0
7492119|NCT03611075|25976216|P8|Overall Study|Lost to Follow-up|0
7492120|NCT03611075|25976217|P7|Overall Study|Lost to Follow-up|0
7492121|NCT03611075|25976218|P6|Overall Study|Lost to Follow-up|0
7492122|NCT03611075|25976219|P5|Overall Study|Lost to Follow-up|0
7492123|NCT03611075|25976220|P4|Overall Study|Lost to Follow-up|2
7492124|NCT03611075|25976221|P3|Overall Study|Lost to Follow-up|0
7492125|NCT03611075|25976222|P2|Overall Study|Lost to Follow-up|0
7492126|NCT03611075|25976223|P1|Overall Study|Lost to Follow-up|1
7492127|NCT03611075|25976215|P9|Overall Study|Physician Decision|0
7492128|NCT03611075|25976216|P8|Overall Study|Physician Decision|0
7492129|NCT03611075|25976217|P7|Overall Study|Physician Decision|0
7492130|NCT03611075|25976218|P6|Overall Study|Physician Decision|0
7492131|NCT03611075|25976219|P5|Overall Study|Physician Decision|0
7492132|NCT03611075|25976220|P4|Overall Study|Physician Decision|0
7492133|NCT03611075|25976221|P3|Overall Study|Physician Decision|1
7492134|NCT03611075|25976222|P2|Overall Study|Physician Decision|1
7492135|NCT03611075|25976223|P1|Overall Study|Physician Decision|0
7492136|NCT03610269|25976398|P1|Overall Study|Screen fail|4
7492137|NCT03610269|25976398|P1|Overall Study|Unable to draw blood|1
7492138|NCT03610269|25976398|P1|Overall Study|Protocol Violation|1
7492139|NCT03610269|25976398|P1|Overall Study|Physician Decision|10
7492140|NCT03610165|25976404|P2|Overall Study|Device didn't work|1
7492141|NCT03610165|25976405|P1|Overall Study|Device didn't work|0
7492142|NCT03610048|25976427|P1|Overall Study|Pregnancy|1
7492143|NCT03610048|25976427|P1|Overall Study|Physician Decision|1
7492144|NCT03610048|25976427|P1|Overall Study|Other|4
7492145|NCT03610048|25976427|P1|Overall Study|Lost to Follow-up|8
7492146|NCT03610048|25976427|P1|Overall Study|Withdrawal by Subject|31
7492147|NCT03610048|25976427|P1|Overall Study|Adverse Event|32
7492148|NCT03610048|25976427|P1|Overall Study|Study terminated by sponsor|84
7492149|NCT03609619|25976456|P2|Overall Study|Lost to Follow-up|1
7492150|NCT03609619|25976457|P1|Overall Study|Lost to Follow-up|1
7492151|NCT03609619|25976456|P2|Overall Study|Withdrawal by Subject|3
7492152|NCT03609619|25976457|P1|Overall Study|Withdrawal by Subject|2
7492153|NCT03609619|25976456|P2|Overall Study|Protocol Violation|0
7492154|NCT03609619|25976457|P1|Overall Study|Protocol Violation|5
7492155|NCT03609619|25976456|P2|Overall Study|Lack of Efficacy|2
7492156|NCT03609619|25976457|P1|Overall Study|Lack of Efficacy|1
7492157|NCT03609619|25976456|P2|Overall Study|Adverse Event|0
7492158|NCT03609619|25976457|P1|Overall Study|Adverse Event|1
7492159|NCT03608774|25976495|P2|Overall Study|Health related event|1
7492160|NCT03608774|25976496|P1|Overall Study|Health related event|0
7492161|NCT03608774|25976495|P2|Overall Study|Not eligible at enrollment|1
7492162|NCT03608774|25976496|P1|Overall Study|Not eligible at enrollment|0
7492163|NCT03608774|25976495|P2|Overall Study|Protocol Violation|0
7492164|NCT03608774|25976496|P1|Overall Study|Protocol Violation|1
7492165|NCT03608774|25976495|P2|Overall Study|Withdrawal by Subject|0
7492166|NCT03608774|25976496|P1|Overall Study|Withdrawal by Subject|1
7492167|NCT03608774|25976495|P2|Overall Study|Lost to Follow-up|5
7492168|NCT03608774|25976496|P1|Overall Study|Lost to Follow-up|5
7492171|NCT03607682|25976568|P1|Overall Study|Disease progression|1
7492172|NCT03607682|25976568|P1|Overall Study|Withdrawal by Subject|1
7492173|NCT03607487|25976603|P4|Overall Study|Withdrawal by Subject|1
7492174|NCT03607487|25976604|P3|Overall Study|Withdrawal by Subject|0
7492175|NCT03607487|25976605|P2|Overall Study|Withdrawal by Subject|0
7492176|NCT03607487|25976606|P1|Overall Study|Withdrawal by Subject|2
7492177|NCT03606460|25976657|P2|Overall Study|Lost to Follow-up|8
7492178|NCT03606460|25976658|P1|Overall Study|Lost to Follow-up|1
7492179|NCT03605745|25976706|P1|Overall Study|Study was terminated for business reasons|47
7492180|NCT03605693|25976715|P2|Overall Study|Physician Decision|0
7492181|NCT03605693|25976716|P1|Overall Study|Physician Decision|1
7492182|NCT03605693|25976715|P2|Overall Study|Lost to Follow-up|0
7492183|NCT03605693|25976716|P1|Overall Study|Lost to Follow-up|4
7492184|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
7492185|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
7492186|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
7492187|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
7492188|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
7492189|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
7492190|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
7492191|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
7492192|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
7492193|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
7492194|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
7492195|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
7492196|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
7492197|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7492198|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7492199|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
7492200|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
7492201|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
7492202|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
7492203|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
7492204|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
7492205|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
7492206|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
7492207|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
7492208|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
7492209|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
7492210|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
7492211|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7492212|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7492213|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7492214|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7492215|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7492216|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
7492217|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
7492218|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
7492219|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
7492220|NCT03605680|25976734|P4|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
7492221|NCT03605680|25976735|P3|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
7492222|NCT03605680|25976736|P2|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
7492223|NCT03605680|25976737|P1|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
7492224|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7492225|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7492226|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7492227|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
7492228|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7492229|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7492230|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7492231|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Physician Decision|6
7492232|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
7492233|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
7492234|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
7492235|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|1
7492236|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7492237|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7492238|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7492239|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
7492240|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7492241|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7492242|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7492243|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
7492244|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7492245|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7492246|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7492247|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
7492248|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7492249|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7492250|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7492251|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
7492252|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7492253|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7492254|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7492255|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
7492256|NCT03605680|25976734|P4|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7492257|NCT03605680|25976735|P3|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7492258|NCT03605680|25976736|P2|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7492259|NCT03605680|25976737|P1|SB Placebo Run-in Period (1 Week)|Adverse Event|6
7492260|NCT03605303|25976749|P2|Period 1|Study Terminated|1
7492261|NCT03605303|25976750|P1|Period 1|Study Terminated|2
7492262|NCT03605212|25976763|P5|Treatment Period|Physician Decision|1
7492263|NCT03605212|25976764|P4|Treatment Period|Physician Decision|0
7492264|NCT03605212|25976765|P3|Treatment Period|Physician Decision|0
7492265|NCT03605212|25976766|P2|Treatment Period|Physician Decision|0
7492266|NCT03605212|25976767|P1|Treatment Period|Physician Decision|0
7492267|NCT03605212|25976763|P5|Treatment Period|Adverse Event|0
7492268|NCT03605212|25976764|P4|Treatment Period|Adverse Event|0
7492269|NCT03605212|25976765|P3|Treatment Period|Adverse Event|0
7492270|NCT03605212|25976766|P2|Treatment Period|Adverse Event|0
7492271|NCT03605212|25976767|P1|Treatment Period|Adverse Event|1
7492272|NCT03604523|25976849|P2|Overall Study|Physician Decision|0
7492273|NCT03604523|25976850|P1|Overall Study|Physician Decision|1
7492274|NCT03604497|25976862|P1|Overall Study|Protocol Violation|52
7492275|NCT03604341|25976872|P2|Overall Study|Protocol Violation|1
7492276|NCT03604341|25976873|P1|Overall Study|Protocol Violation|0
7492277|NCT03604341|25976872|P2|Overall Study|Adverse Event|0
7492278|NCT03604341|25976873|P1|Overall Study|Adverse Event|1
7492279|NCT03604341|25976872|P2|Overall Study|Withdrawal by Subject|1
7492280|NCT03604341|25976873|P1|Overall Study|Withdrawal by Subject|1
7492281|NCT03603652|25976883|P1|Overall Study|Death|2
7492282|NCT03603028|25976969|P1|Overall Study|Withdrawal by Subject|1
7492283|NCT03602482|25976976|P4|Overall Study|Withdrawal by Subject|0
7492284|NCT03602482|25976977|P3|Overall Study|Withdrawal by Subject|0
7492285|NCT03602482|25976978|P2|Overall Study|Withdrawal by Subject|7
7492286|NCT03602482|25976979|P1|Overall Study|Withdrawal by Subject|6
7492287|NCT03602339|25976996|P1|Overall Study|Other reason|4
7492288|NCT03602339|25976996|P1|Overall Study|Physician Decision|2
7492289|NCT03602339|25976996|P1|Overall Study|Withdrawal by Subject|9
7492290|NCT03602053|25977026|P3|Overall Study|Other|0
7492291|NCT03602053|25977027|P2|Overall Study|Other|0
7492292|NCT03602053|25977028|P1|Overall Study|Other|1
7492293|NCT03602053|25977026|P3|Overall Study|migration|0
7492294|NCT03602053|25977027|P2|Overall Study|migration|3
7492295|NCT03602053|25977028|P1|Overall Study|migration|2
7492296|NCT03602053|25977026|P3|Overall Study|Physician Decision|0
7492297|NCT03602053|25977027|P2|Overall Study|Physician Decision|0
7492298|NCT03602053|25977028|P1|Overall Study|Physician Decision|1
7492299|NCT03602053|25977026|P3|Overall Study|Protocol Violation|4
7492300|NCT03602053|25977027|P2|Overall Study|Protocol Violation|0
7492301|NCT03602053|25977028|P1|Overall Study|Protocol Violation|3
7492302|NCT03602053|25977026|P3|Overall Study|Lost to Follow-up|0
7492303|NCT03602053|25977027|P2|Overall Study|Lost to Follow-up|6
7492304|NCT03602053|25977028|P1|Overall Study|Lost to Follow-up|5
7492305|NCT03602053|25977026|P3|Overall Study|Withdrawal by Subject|7
7492306|NCT03602053|25977027|P2|Overall Study|Withdrawal by Subject|9
7492307|NCT03602053|25977028|P1|Overall Study|Withdrawal by Subject|7
7492308|NCT03601715|25977074|P3|Second Intervention|Lost to Follow-up|0
7492309|NCT03601715|25977075|P2|Second Intervention|Lost to Follow-up|1
7492310|NCT03601715|25977076|P1|Second Intervention|Lost to Follow-up|1
7492311|NCT03601052|25977127|P1|Overall Study|Lost to Follow-up|2
7492312|NCT03600740|25977146|P1|Overall Study|Surgical plan was altered-subject not eligible|1
7492313|NCT03600428|25977152|P2|Overall Study|Lost to Follow-up|4
7492314|NCT03600428|25977153|P1|Overall Study|Lost to Follow-up|5
7492315|NCT03600428|25977152|P2|Overall Study|Not eligible|1
7492316|NCT03600428|25977153|P1|Overall Study|Not eligible|0
7492317|NCT03600376|25977169|P2|Overall Study|Determined to be ineligible for study|1
7492318|NCT03600376|25977170|P1|Overall Study|Determined to be ineligible for study|0
7492319|NCT03600376|25977169|P2|Overall Study|Investigator Decision|4
7492320|NCT03600376|25977170|P1|Overall Study|Investigator Decision|0
7492321|NCT03600376|25977169|P2|Overall Study|Transferred to other facility|0
7492322|NCT03600376|25977170|P1|Overall Study|Transferred to other facility|1
7492323|NCT03600376|25977169|P2|Overall Study|Adverse Event|1
7492324|NCT03600376|25977170|P1|Overall Study|Adverse Event|1
7492325|NCT03599349|25977229|P1|Overall Study|Lost to Follow-up|1
7492326|NCT03599193|25977258|P2|Overall Study|Lost to Follow-up|1
7492327|NCT03599193|25977259|P1|Overall Study|Lost to Follow-up|0
7492328|NCT03599193|25977258|P2|Overall Study|Protocol Violation|0
7492329|NCT03599193|25977259|P1|Overall Study|Protocol Violation|1
7492330|NCT03599193|25977258|P2|Overall Study|Withdrawal by Subject|0
7492331|NCT03599193|25977259|P1|Overall Study|Withdrawal by Subject|1
7492332|NCT03599193|25977258|P2|Overall Study|Adverse Event|2
7492333|NCT03599193|25977259|P1|Overall Study|Adverse Event|0
7492334|NCT03599089|25977275|P4|Overall Study|Lack of Efficacy|2
7492335|NCT03599089|25977276|P3|Overall Study|Lack of Efficacy|1
7492336|NCT03599089|25977277|P2|Overall Study|Lack of Efficacy|0
7492337|NCT03599089|25977278|P1|Overall Study|Lack of Efficacy|0
7492338|NCT03599089|25977275|P4|Overall Study|Withdrawal by Subject|0
7492339|NCT03599089|25977276|P3|Overall Study|Withdrawal by Subject|0
7492340|NCT03599089|25977277|P2|Overall Study|Withdrawal by Subject|1
7492341|NCT03599089|25977278|P1|Overall Study|Withdrawal by Subject|2
7492342|NCT03599089|25977275|P4|Overall Study|Lost to Follow-up|0
7492343|NCT03599089|25977276|P3|Overall Study|Lost to Follow-up|0
7492344|NCT03599089|25977277|P2|Overall Study|Lost to Follow-up|0
7492345|NCT03599089|25977278|P1|Overall Study|Lost to Follow-up|1
7492346|NCT03598140|25977327|P2|Overall Study|enrolled but didn't start|0
7492347|NCT03598140|25977328|P1|Overall Study|enrolled but didn't start|1
7492348|NCT03598036|25977342|P2|Overall Study|Withdrawal by Subject|0
7492349|NCT03598036|25977343|P1|Overall Study|Withdrawal by Subject|1
7492350|NCT03597529|25977378|P2|Overall Study|Non-compliant with study activities|2
7492351|NCT03597529|25977379|P1|Overall Study|Non-compliant with study activities|1
7492352|NCT03597529|25977378|P2|Overall Study|Withdrawal by Subject|3
7492353|NCT03597529|25977379|P1|Overall Study|Withdrawal by Subject|6
7492354|NCT03597529|25977378|P2|Overall Study|Physician Decision|1
7492355|NCT03597529|25977379|P1|Overall Study|Physician Decision|3
7492356|NCT03597529|25977378|P2|Overall Study|Lost to Follow-up|12
7492357|NCT03597529|25977379|P1|Overall Study|Lost to Follow-up|10
7492367|NCT03597295|25977416|P1|Overall Study|Participants ongoing in the study|54
7492368|NCT03597295|25977416|P1|Overall Study|Lost to Follow-up|3
7492369|NCT03597295|25977416|P1|Overall Study|Death|37
7492370|NCT03597139|25977431|P2|Overall Study|Protocol Non-compliance|0
7492371|NCT03597139|25977432|P1|Overall Study|Protocol Non-compliance|1
7492372|NCT03597139|25977431|P2|Overall Study|Adverse Event|0
7492373|NCT03597139|25977432|P1|Overall Study|Adverse Event|3
7492374|NCT03597061|25977462|P2|Overall Study|Protocol Violation|1
7492375|NCT03597061|25977463|P1|Overall Study|Protocol Violation|0
7492376|NCT03597061|25977462|P2|Overall Study|Lost to Follow-up|0
7492377|NCT03597061|25977463|P1|Overall Study|Lost to Follow-up|1
7492378|NCT03597022|25977478|P3|Overall Study|Serious adverse event|0
7492379|NCT03597022|25977479|P2|Overall Study|Serious adverse event|1
7492380|NCT03597022|25977480|P1|Overall Study|Serious adverse event|1
7492381|NCT03597022|25977478|P3|Overall Study|Premature termination of the study|8
7492382|NCT03597022|25977479|P2|Overall Study|Premature termination of the study|7
7492383|NCT03597022|25977480|P1|Overall Study|Premature termination of the study|7
7492384|NCT03596177|25977520|P2|Double Blind Period|Death during safety follow-up|1
7492385|NCT03596177|25977521|P1|Double Blind Period|Death during safety follow-up|0
7492386|NCT03596177|25977520|P2|Double Blind Period|Other|4
7492387|NCT03596177|25977521|P1|Double Blind Period|Other|0
7492388|NCT03596177|25977520|P2|Double Blind Period|Withdrawal by Subject|1
7492389|NCT03596177|25977521|P1|Double Blind Period|Withdrawal by Subject|0
7492390|NCT03596177|25977520|P2|Single Blind Period|Other|0
7492391|NCT03596177|25977521|P1|Single Blind Period|Other|1
7492392|NCT03596177|25977520|P2|Single Blind Period|Withdrawal by Subject|1
7492393|NCT03596177|25977521|P1|Single Blind Period|Withdrawal by Subject|1
7492394|NCT03596151|25977571|P1|Overall Study|Withdrawal by Subject|1
7492395|NCT03595904|25977585|P2|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
7492396|NCT03595904|25977586|P1|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
7492397|NCT03595904|25977585|P2|Overall Study|Insurance complications|0
7492398|NCT03595904|25977586|P1|Overall Study|Insurance complications|1
7492399|NCT03595904|25977585|P2|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
7492400|NCT03595904|25977586|P1|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
7492401|NCT03595904|25977585|P2|Overall Study|Protocol Violation|1
7492402|NCT03595904|25977586|P1|Overall Study|Protocol Violation|3
7492403|NCT03595618|25977604|P4|Overall Study|Miscellaneous|6
7492404|NCT03595618|25977605|P3|Overall Study|Miscellaneous|10
7492405|NCT03595618|25977606|P2|Overall Study|Miscellaneous|5
7492406|NCT03595618|25977607|P1|Overall Study|Miscellaneous|7
7492407|NCT03595618|25977604|P4|Overall Study|Physician Decision|2
7492408|NCT03595618|25977605|P3|Overall Study|Physician Decision|1
7492409|NCT03595618|25977606|P2|Overall Study|Physician Decision|0
7492410|NCT03595618|25977607|P1|Overall Study|Physician Decision|0
7492411|NCT03595618|25977604|P4|Overall Study|Protocol Violation|2
7492412|NCT03595618|25977605|P3|Overall Study|Protocol Violation|6
7492413|NCT03595618|25977606|P2|Overall Study|Protocol Violation|0
7492414|NCT03595618|25977607|P1|Overall Study|Protocol Violation|2
7492415|NCT03595618|25977604|P4|Overall Study|Lost to Follow-up|6
7492416|NCT03595618|25977605|P3|Overall Study|Lost to Follow-up|5
7492417|NCT03595618|25977606|P2|Overall Study|Lost to Follow-up|4
7492418|NCT03595618|25977607|P1|Overall Study|Lost to Follow-up|6
7492419|NCT03595618|25977604|P4|Overall Study|Withdrawal by Subject|10
7492420|NCT03595618|25977605|P3|Overall Study|Withdrawal by Subject|14
7492421|NCT03595618|25977606|P2|Overall Study|Withdrawal by Subject|14
7492422|NCT03595618|25977607|P1|Overall Study|Withdrawal by Subject|12
7492423|NCT03595618|25977604|P4|Overall Study|Adverse Event|8
7492424|NCT03595618|25977605|P3|Overall Study|Adverse Event|20
7492425|NCT03595618|25977606|P2|Overall Study|Adverse Event|17
7492426|NCT03595618|25977607|P1|Overall Study|Adverse Event|16
7492427|NCT03595176|25977694|P2|Overall Study|Lost to Follow-up|1
7492428|NCT03595176|25977695|P1|Overall Study|Lost to Follow-up|0
7492429|NCT03595176|25977694|P2|Overall Study|Death|2
7492430|NCT03595176|25977695|P1|Overall Study|Death|0
7492431|NCT03594227|25977727|P4|Overall Study|Programmatic Analysis Non-completer|1
7492432|NCT03594227|25977728|P3|Overall Study|Programmatic Analysis Non-completer|1
7492433|NCT03594227|25977729|P2|Overall Study|Programmatic Analysis Non-completer|0
7492434|NCT03594227|25977730|P1|Overall Study|Programmatic Analysis Non-completer|1
7492435|NCT03594227|25977727|P4|Overall Study|Sponsor Decision|1
7492436|NCT03594227|25977728|P3|Overall Study|Sponsor Decision|0
7492437|NCT03594227|25977729|P2|Overall Study|Sponsor Decision|0
7492438|NCT03594227|25977730|P1|Overall Study|Sponsor Decision|0
7492439|NCT03594227|25977727|P4|Overall Study|Pregnancy|0
7492440|NCT03594227|25977728|P3|Overall Study|Pregnancy|0
7492441|NCT03594227|25977729|P2|Overall Study|Pregnancy|1
7492442|NCT03594227|25977730|P1|Overall Study|Pregnancy|0
7492443|NCT03594227|25977727|P4|Overall Study|Withdrawal by Subject|1
7492444|NCT03594227|25977728|P3|Overall Study|Withdrawal by Subject|1
7492445|NCT03594227|25977729|P2|Overall Study|Withdrawal by Subject|1
7492446|NCT03594227|25977730|P1|Overall Study|Withdrawal by Subject|1
7492447|NCT03594227|25977727|P4|Overall Study|Lost to Follow-up|0
7492448|NCT03594227|25977728|P3|Overall Study|Lost to Follow-up|1
7492449|NCT03594227|25977729|P2|Overall Study|Lost to Follow-up|1
7492450|NCT03594227|25977730|P1|Overall Study|Lost to Follow-up|1
7492451|NCT03594227|25977727|P4|Overall Study|Adverse Event|2
7492452|NCT03594227|25977728|P3|Overall Study|Adverse Event|0
7492453|NCT03594227|25977729|P2|Overall Study|Adverse Event|1
7492454|NCT03594227|25977730|P1|Overall Study|Adverse Event|2
7492455|NCT03594071|25977864|P1|Overall Study|Missed visit|2
7492456|NCT03594071|25977864|P1|Overall Study|Re-operation|3
7492457|NCT03593876|25977903|P1|Overall Study|Discharged home before intervention completion|2
7492458|NCT03593876|25977903|P1|Overall Study|Withdrawal by Subject|1
7492459|NCT03593681|25977909|P1|Overall Study|Physician Decision|1
7492460|NCT03593681|25977909|P1|Overall Study|Adverse Event|2
7492461|NCT03593681|25977909|P1|Overall Study|Procedure not attempted|3
7492462|NCT03593681|25977909|P1|Overall Study|Withdrawal by Subject|3
7492463|NCT03593681|25977909|P1|Overall Study|Protocol Violation|3
7492464|NCT03593681|25977909|P1|Overall Study|Hysteroscope attempted but unable to find ostia|11
7492465|NCT03593681|25977909|P1|Overall Study|Inadequate sample collected|12
7492466|NCT03592745|25977980|P2|Overall Study|study temporary closure due to covid-19 pandemic|1
7492467|NCT03592745|25977981|P1|Overall Study|study temporary closure due to covid-19 pandemic|1
7492468|NCT03592745|25977980|P2|Overall Study|Lost to Follow-up|0
7492469|NCT03592745|25977981|P1|Overall Study|Lost to Follow-up|2
7492470|NCT03592745|25977980|P2|Overall Study|Adverse Event|2
7492471|NCT03592745|25977981|P1|Overall Study|Adverse Event|0
7492472|NCT03592186|25977991|P2|Overall Study|Lost to Follow-up|11
7492473|NCT03592186|25977992|P1|Overall Study|Lost to Follow-up|16
7492474|NCT03592186|25977991|P2|Overall Study|Withdrawal by Subject|0
7492475|NCT03592186|25977992|P1|Overall Study|Withdrawal by Subject|1
7492476|NCT03591406|25978040|P2|Overall Study|Withdrawal by Subject|5
7492477|NCT03591406|25978041|P1|Overall Study|Withdrawal by Subject|0
7492478|NCT03591406|25978040|P2|Overall Study|Protocol Violation|1
7492479|NCT03591406|25978041|P1|Overall Study|Protocol Violation|2
7492480|NCT03591406|25978040|P2|Overall Study|Adverse Event|3
7492481|NCT03591406|25978041|P1|Overall Study|Adverse Event|5
7492482|NCT03591146|25978074|P5|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7492483|NCT03591146|25978075|P4|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7492484|NCT03591146|25978076|P3|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7492485|NCT03591146|25978077|P2|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7492486|NCT03591146|25978078|P1|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7492487|NCT03591146|25978074|P5|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
7492488|NCT03591146|25978075|P4|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7492489|NCT03591146|25978076|P3|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7492490|NCT03591146|25978077|P2|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7492491|NCT03591146|25978078|P1|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7492492|NCT03591146|25978074|P5|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7492493|NCT03591146|25978075|P4|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7492494|NCT03591146|25978076|P3|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7492495|NCT03591146|25978077|P2|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
7492496|NCT03591146|25978078|P1|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7492497|NCT03591146|25978074|P5|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
7492498|NCT03591146|25978075|P4|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7492499|NCT03591146|25978076|P3|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7492500|NCT03591146|25978077|P2|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7492501|NCT03591146|25978078|P1|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7492502|NCT03590743|25978108|P2|Overall Study|Withdrawal by Subject|1
7492503|NCT03590743|25978109|P1|Overall Study|Withdrawal by Subject|0
7492504|NCT03590613|25978121|P4|Period 2, 4 Days|Physician Decision|1
7492505|NCT03590613|25978122|P3|Period 2, 4 Days|Physician Decision|0
7492506|NCT03590613|25978123|P2|Period 2, 4 Days|Physician Decision|0
7492507|NCT03590613|25978124|P1|Period 2, 4 Days|Physician Decision|0
7492508|NCT03589885|25978245|P5|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7492509|NCT03589885|25978246|P4|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7492510|NCT03589885|25978247|P3|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7492511|NCT03589885|25978248|P2|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
7492512|NCT03589885|25978249|P1|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7492513|NCT03589885|25978245|P5|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7492514|NCT03589885|25978246|P4|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7492515|NCT03589885|25978247|P3|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7492516|NCT03589885|25978248|P2|Treatment Period 2-Randomized Set|Lost to Follow-up|3
7492517|NCT03589885|25978249|P1|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7492518|NCT03589885|25978245|P5|Treatment Period 2-Randomized Set|Pregnancy|0
7492519|NCT03589885|25978246|P4|Treatment Period 2-Randomized Set|Pregnancy|0
7492520|NCT03589885|25978247|P3|Treatment Period 2-Randomized Set|Pregnancy|0
7492521|NCT03589885|25978248|P2|Treatment Period 2-Randomized Set|Pregnancy|0
7492522|NCT03589885|25978249|P1|Treatment Period 2-Randomized Set|Pregnancy|1
7492523|NCT03589885|25978245|P5|Treatment Period 2-Randomized Set|Adverse Event|0
7492524|NCT03589885|25978246|P4|Treatment Period 2-Randomized Set|Adverse Event|0
7492525|NCT03589885|25978247|P3|Treatment Period 2-Randomized Set|Adverse Event|0
7492526|NCT03589885|25978248|P2|Treatment Period 2-Randomized Set|Adverse Event|1
7492527|NCT03589885|25978249|P1|Treatment Period 2-Randomized Set|Adverse Event|0
7492528|NCT03589885|25978245|P5|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7492529|NCT03589885|25978246|P4|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7492530|NCT03589885|25978247|P3|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
7492531|NCT03589885|25978248|P2|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7492532|NCT03589885|25978249|P1|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7492533|NCT03589885|25978245|P5|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7492534|NCT03589885|25978246|P4|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7492535|NCT03589885|25978247|P3|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7492536|NCT03589885|25978248|P2|Treatment Period 1-Randomized Set|Lost to Follow-up|1
7492537|NCT03589885|25978249|P1|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7492538|NCT03589885|25978245|P5|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7492539|NCT03589885|25978246|P4|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7492540|NCT03589885|25978247|P3|Treatment Period 1-Randomized Set|Lack of Efficacy|2
7492541|NCT03589885|25978248|P2|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7492542|NCT03589885|25978249|P1|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7492543|NCT03589885|25978245|P5|Treatment Period 1-Randomized Set|Adverse Event|0
7492544|NCT03589885|25978246|P4|Treatment Period 1-Randomized Set|Adverse Event|0
7492545|NCT03589885|25978247|P3|Treatment Period 1-Randomized Set|Adverse Event|0
7492546|NCT03589885|25978248|P2|Treatment Period 1-Randomized Set|Adverse Event|1
7492547|NCT03589885|25978249|P1|Treatment Period 1-Randomized Set|Adverse Event|0
7492548|NCT03589807|25978283|P6|Overall Study|Enrolled but treatment not administered|0
7492549|NCT03589807|25978284|P5|Overall Study|Enrolled but treatment not administered|1
7492550|NCT03589807|25978285|P4|Overall Study|Enrolled but treatment not administered|0
7492551|NCT03589807|25978286|P3|Overall Study|Enrolled but treatment not administered|0
7492552|NCT03589807|25978287|P2|Overall Study|Enrolled but treatment not administered|0
7492553|NCT03589807|25978288|P1|Overall Study|Enrolled but treatment not administered|0
7492554|NCT03589807|25978283|P6|Overall Study|Protocol Violation|0
7492555|NCT03589807|25978284|P5|Overall Study|Protocol Violation|0
7492556|NCT03589807|25978285|P4|Overall Study|Protocol Violation|1
7492557|NCT03589807|25978286|P3|Overall Study|Protocol Violation|0
7492558|NCT03589807|25978287|P2|Overall Study|Protocol Violation|0
7492559|NCT03589807|25978288|P1|Overall Study|Protocol Violation|0
7492560|NCT03589807|25978283|P6|Overall Study|Withdrawal by Subject|0
7492561|NCT03589807|25978284|P5|Overall Study|Withdrawal by Subject|0
7492562|NCT03589807|25978285|P4|Overall Study|Withdrawal by Subject|0
7492563|NCT03589807|25978286|P3|Overall Study|Withdrawal by Subject|0
7492564|NCT03589807|25978287|P2|Overall Study|Withdrawal by Subject|5
7492565|NCT03589807|25978288|P1|Overall Study|Withdrawal by Subject|0
7492566|NCT03589807|25978283|P6|Overall Study|Lost to Follow-up|1
7492567|NCT03589807|25978284|P5|Overall Study|Lost to Follow-up|1
7492568|NCT03589807|25978285|P4|Overall Study|Lost to Follow-up|3
7492569|NCT03589807|25978286|P3|Overall Study|Lost to Follow-up|2
7492570|NCT03589807|25978287|P2|Overall Study|Lost to Follow-up|2
7492571|NCT03589807|25978288|P1|Overall Study|Lost to Follow-up|0
7492572|NCT03589469|25978632|P1|Overall Study|Lost to Follow-up|3
7492573|NCT03589469|25978632|P1|Overall Study|Death|77
7492574|NCT03589469|25978632|P1|Overall Study|Physician Decision|1
7492575|NCT03589469|25978632|P1|Overall Study|Withdrawal by Subject|6
7492576|NCT03589469|25978632|P1|Overall Study|Ongoing in study|58
7492577|NCT03588910|25978658|P2|Overall Study|Did not complete Day 7 Survey|2
7492578|NCT03588910|25978659|P1|Overall Study|Did not complete Day 7 Survey|5
7492579|NCT03588910|25978658|P2|Overall Study|Did not complete Day 1 Survey|10
7492580|NCT03588910|25978659|P1|Overall Study|Did not complete Day 1 Survey|5
7492581|NCT03588910|25978658|P2|Overall Study|Protocol Violation|3
7492582|NCT03588910|25978659|P1|Overall Study|Protocol Violation|0
7492583|NCT03588910|25978658|P2|Overall Study|Allergy|0
7492584|NCT03588910|25978659|P1|Overall Study|Allergy|2
7492585|NCT03588910|25978658|P2|Overall Study|Withdrawal by Subject|0
7492586|NCT03588910|25978659|P1|Overall Study|Withdrawal by Subject|1
7492587|NCT03588741|25978684|P1|Overall Study|Withdrawal by Subject|1
7492588|NCT03588572|25978691|P2|Visitation 3|Withdrawal by Subject|0
7492589|NCT03588572|25978692|P1|Visitation 3|Withdrawal by Subject|1
7492590|NCT03588572|25978691|P2|Visitation 3|Physician Decision|1
7492591|NCT03588572|25978692|P1|Visitation 3|Physician Decision|1
7492592|NCT03588572|25978691|P2|Visitation 3|Lost to Follow-up|1
7492593|NCT03588572|25978692|P1|Visitation 3|Lost to Follow-up|1
7492594|NCT03588572|25978691|P2|Visitation 2|Withdrawal by Subject|0
7492595|NCT03588572|25978692|P1|Visitation 2|Withdrawal by Subject|1
7492596|NCT03588572|25978691|P2|Visitation 2|Lack of Efficacy|1
7492597|NCT03588572|25978692|P1|Visitation 2|Lack of Efficacy|0
7492598|NCT03588572|25978691|P2|Visitation 2|Lost to Follow-up|1
7492599|NCT03588572|25978692|P1|Visitation 2|Lost to Follow-up|1
7492600|NCT03588572|25978691|P2|Visitation 1|Lack of Efficacy|1
7492601|NCT03588572|25978692|P1|Visitation 1|Lack of Efficacy|1
7492602|NCT03587974|25978710|P2|Overall Study|Withdrawal by Subject|1
7492603|NCT03587974|25978711|P1|Overall Study|Withdrawal by Subject|2
7492604|NCT03587974|25978710|P2|Overall Study|caregiver demented, care recipient died|3
7492605|NCT03587974|25978711|P1|Overall Study|caregiver demented, care recipient died|3
7492606|NCT03586830|25978827|P4|Overall Study|Withdrawal by Subject|1
7492607|NCT03586830|25978828|P3|Overall Study|Withdrawal by Subject|3
7492608|NCT03586830|25978829|P2|Overall Study|Withdrawal by Subject|0
7492609|NCT03586830|25978830|P1|Overall Study|Withdrawal by Subject|1
7492610|NCT03586830|25978827|P4|Overall Study|Lost to Follow-up|1
7492611|NCT03586830|25978828|P3|Overall Study|Lost to Follow-up|2
7492612|NCT03586830|25978829|P2|Overall Study|Lost to Follow-up|2
7492613|NCT03586830|25978830|P1|Overall Study|Lost to Follow-up|0
7492614|NCT03586830|25978827|P4|Overall Study|Site terminated by Sponsor|3
7492615|NCT03586830|25978828|P3|Overall Study|Site terminated by Sponsor|3
7492616|NCT03586830|25978829|P2|Overall Study|Site terminated by Sponsor|4
7492617|NCT03586830|25978830|P1|Overall Study|Site terminated by Sponsor|1
7492618|NCT03586726|25978852|P1|Overall Study|Withdrawal by Subject|1
7492619|NCT03586648|25978869|P2|Period 2|Adverse Event|0
7492620|NCT03586648|25978870|P1|Period 2|Adverse Event|1
7492621|NCT03586648|25978869|P2|Period 1|Physician Decision|1
7492622|NCT03586648|25978870|P1|Period 1|Physician Decision|0
7492623|NCT03586648|25978869|P2|Period 1|Study related symptoms or complaints|1
7492624|NCT03586648|25978870|P1|Period 1|Study related symptoms or complaints|2
7492625|NCT03586648|25978869|P2|Period 1|Adverse Event|0
7492626|NCT03586648|25978870|P1|Period 1|Adverse Event|1
7492627|NCT03586648|25978869|P2|Period 1|Lost to Follow-up|1
7492628|NCT03586648|25978870|P1|Period 1|Lost to Follow-up|1
7492629|NCT03586648|25978869|P2|Period 1|Withdrawal by Subject|1
7492630|NCT03586648|25978870|P1|Period 1|Withdrawal by Subject|0
7492631|NCT03586544|25978885|P2|Second Intervention|Withdrawal by Subject|1
7492632|NCT03586544|25978886|P1|Second Intervention|Withdrawal by Subject|0
7492633|NCT03586544|25978885|P2|First Intervention|Adverse Event|1
7492634|NCT03586544|25978886|P1|First Intervention|Adverse Event|0
7492635|NCT03586167|25978894|P2|Overall Study|Other|0
7492636|NCT03586167|25978895|P1|Overall Study|Other|1
7492637|NCT03585959|25978906|P1|Overall Study|Unsuccessful Procedure|2
7492638|NCT03585959|25978906|P1|Overall Study|Physician Decision|1
7492639|NCT03585712|25978936|P3|Treatment Periods 2 and 3|Physician Decision|2
7492640|NCT03585712|25978937|P2|Treatment Periods 2 and 3|Physician Decision|0
7492641|NCT03585712|25978938|P1|Treatment Periods 2 and 3|Physician Decision|0
7492642|NCT03585712|25978936|P3|Treatment Periods 2 and 3|Withdrawal by Subject|0
7492643|NCT03585712|25978937|P2|Treatment Periods 2 and 3|Withdrawal by Subject|2
7492644|NCT03585712|25978938|P1|Treatment Periods 2 and 3|Withdrawal by Subject|0
7492645|NCT03585712|25978936|P3|Treatment Periods 2 and 3|Protocol Violation|1
7492646|NCT03585712|25978937|P2|Treatment Periods 2 and 3|Protocol Violation|1
7492647|NCT03585712|25978938|P1|Treatment Periods 2 and 3|Protocol Violation|0
7492648|NCT03585712|25978936|P3|Treatment Period 1|Protocol Violation|0
7492649|NCT03585712|25978937|P2|Treatment Period 1|Protocol Violation|0
7492650|NCT03585712|25978938|P1|Treatment Period 1|Protocol Violation|1
7492651|NCT03585504|25978981|P2|Overall Study|Lost to Follow-up|29
7492652|NCT03585504|25978982|P1|Overall Study|Lost to Follow-up|26
7492653|NCT03585296|25978992|P1|Overall Study|Withdrawal by Subject|2
7492654|NCT03585296|25978992|P1|Overall Study|Lost to Follow-up|2
7492655|NCT03585296|25978992|P1|Overall Study|Adverse Event|1
7492656|NCT03585244|25978996|P1|Overall Study|Withdrawal by Subject|15
7492657|NCT03584009|25979010|P2|Overall Study|Ongoing in study|40
7492658|NCT03584009|25979011|P1|Overall Study|Ongoing in study|29
7492659|NCT03584009|25979010|P2|Overall Study|Withdrawal by Subject|1
7492660|NCT03584009|25979011|P1|Overall Study|Withdrawal by Subject|3
7492661|NCT03584009|25979010|P2|Overall Study|Physician Decision|1
7492662|NCT03584009|25979011|P1|Overall Study|Physician Decision|1
7492663|NCT03584009|25979010|P2|Overall Study|Lost to Follow-up|1
7492664|NCT03584009|25979011|P1|Overall Study|Lost to Follow-up|0
7492665|NCT03584009|25979010|P2|Overall Study|Death|9
7492666|NCT03584009|25979011|P1|Overall Study|Death|18
7492667|NCT03583606|25979026|P3|Overall Study|Ineligible at baseline|0
7492668|NCT03583606|25979027|P2|Overall Study|Ineligible at baseline|0
7492669|NCT03583606|25979028|P1|Overall Study|Ineligible at baseline|1
7492670|NCT03583606|25979026|P3|Overall Study|Lost to Follow-up|0
7492671|NCT03583606|25979027|P2|Overall Study|Lost to Follow-up|1
7492672|NCT03583606|25979028|P1|Overall Study|Lost to Follow-up|0
7492673|NCT03583450|25979131|P2|Overall Study|hardware malfunction (battery depletion)|0
7492674|NCT03583450|25979132|P1|Overall Study|hardware malfunction (battery depletion)|1
7492675|NCT03583385|25979154|P2|Treatment Period 2|Adverse Event|0
7492676|NCT03583385|25979155|P1|Treatment Period 2|Adverse Event|1
7492677|NCT03583385|25979154|P2|Treatment Period 1|Withdrawal by Subject|1
7492678|NCT03583385|25979155|P1|Treatment Period 1|Withdrawal by Subject|1
7492679|NCT03583372|25979175|P4|Overall Study|Captured as Other in the Database|1
7492680|NCT03583372|25979176|P3|Overall Study|Captured as Other in the Database|4
7492681|NCT03583372|25979177|P2|Overall Study|Captured as Other in the Database|2
7492682|NCT03583372|25979178|P1|Overall Study|Captured as Other in the Database|1
7492683|NCT03583372|25979175|P4|Overall Study|Did Not Receive Study Drug|0
7492684|NCT03583372|25979176|P3|Overall Study|Did Not Receive Study Drug|0
7492685|NCT03583372|25979177|P2|Overall Study|Did Not Receive Study Drug|1
7492686|NCT03583372|25979178|P1|Overall Study|Did Not Receive Study Drug|0
7492687|NCT03583372|25979175|P4|Overall Study|Subject Withdrawn due to Sponsor|1
7492688|NCT03583372|25979176|P3|Overall Study|Subject Withdrawn due to Sponsor|0
7492689|NCT03583372|25979177|P2|Overall Study|Subject Withdrawn due to Sponsor|0
7492690|NCT03583372|25979178|P1|Overall Study|Subject Withdrawn due to Sponsor|0
7492691|NCT03583372|25979175|P4|Overall Study|Protocol Violation|0
7492692|NCT03583372|25979176|P3|Overall Study|Protocol Violation|0
7492693|NCT03583372|25979177|P2|Overall Study|Protocol Violation|1
7492694|NCT03583372|25979178|P1|Overall Study|Protocol Violation|0
7492695|NCT03583372|25979175|P4|Overall Study|Death|0
7492696|NCT03583372|25979176|P3|Overall Study|Death|0
7492697|NCT03583372|25979177|P2|Overall Study|Death|0
7492698|NCT03583372|25979178|P1|Overall Study|Death|1
7492699|NCT03583372|25979175|P4|Overall Study|Lack of Efficacy|1
7492700|NCT03583372|25979176|P3|Overall Study|Lack of Efficacy|0
7492701|NCT03583372|25979177|P2|Overall Study|Lack of Efficacy|1
7492702|NCT03583372|25979178|P1|Overall Study|Lack of Efficacy|0
7492703|NCT03583372|25979175|P4|Overall Study|Physician Decision|1
7492704|NCT03583372|25979176|P3|Overall Study|Physician Decision|1
7492705|NCT03583372|25979177|P2|Overall Study|Physician Decision|1
7492706|NCT03583372|25979178|P1|Overall Study|Physician Decision|0
7492707|NCT03583372|25979175|P4|Overall Study|Adverse Event|4
7492708|NCT03583372|25979176|P3|Overall Study|Adverse Event|4
7492709|NCT03583372|25979177|P2|Overall Study|Adverse Event|3
7492710|NCT03583372|25979178|P1|Overall Study|Adverse Event|1
7492711|NCT03583372|25979175|P4|Overall Study|Lost to Follow-up|2
7492712|NCT03583372|25979176|P3|Overall Study|Lost to Follow-up|3
7492713|NCT03583372|25979177|P2|Overall Study|Lost to Follow-up|6
7492714|NCT03583372|25979178|P1|Overall Study|Lost to Follow-up|4
7492715|NCT03583372|25979175|P4|Overall Study|Withdrawal by Subject|8
7492716|NCT03583372|25979176|P3|Overall Study|Withdrawal by Subject|7
7492717|NCT03583372|25979177|P2|Overall Study|Withdrawal by Subject|11
7492718|NCT03583372|25979178|P1|Overall Study|Withdrawal by Subject|6
7492719|NCT03582943|25979194|P2|Analyzed|Protocol Violation|1
7492720|NCT03582943|25979195|P1|Analyzed|Protocol Violation|4
7492721|NCT03582943|25979194|P2|Intervention and Follow up|Withdrawal by Subject|2
7492722|NCT03582943|25979195|P1|Intervention and Follow up|Withdrawal by Subject|4
7492723|NCT03582943|25979194|P2|Allocated to Groups|Withdrawal by Subject|1
7492724|NCT03582943|25979195|P1|Allocated to Groups|Withdrawal by Subject|1
7492725|NCT03582826|25979203|P2|Overall Study|Withdrawal by Subject|0
7492726|NCT03582826|25979204|P1|Overall Study|Withdrawal by Subject|2
7492727|NCT03582826|25979203|P2|Overall Study|Lost to Follow-up|0
7492728|NCT03582826|25979204|P1|Overall Study|Lost to Follow-up|39
7492729|NCT03582813|25979221|P2|Overall Study|Withdrawal by Subject|0
7492730|NCT03582813|25979222|P1|Overall Study|Withdrawal by Subject|1
7492731|NCT03582813|25979221|P2|Overall Study|Lost to Follow-up|21
7492732|NCT03582813|25979222|P1|Overall Study|Lost to Follow-up|18
7492733|NCT03582215|25979289|P8|Overall Study|Adverse Event|2
7492734|NCT03582215|25979290|P7|Overall Study|Adverse Event|2
7492735|NCT03582215|25979291|P6|Overall Study|Adverse Event|0
7492736|NCT03582215|25979292|P5|Overall Study|Adverse Event|0
7492737|NCT03582215|25979293|P4|Overall Study|Adverse Event|0
7492738|NCT03582215|25979294|P3|Overall Study|Adverse Event|0
7492739|NCT03582215|25979295|P2|Overall Study|Adverse Event|0
7492740|NCT03582215|25979296|P1|Overall Study|Adverse Event|1
7492741|NCT03581825|25979337|P2|Period 2|Unsatisfactory Vision to Test|1
7492742|NCT03581825|25979338|P1|Period 2|Unsatisfactory Vision to Test|0
7492743|NCT03581825|25979337|P2|Period 1|Lens Discomfort|0
7492744|NCT03581825|25979338|P1|Period 1|Lens Discomfort|1
7492745|NCT03580382|25979374|P2|Overall Study|Early Termination of Study|3
7492746|NCT03580382|25979375|P1|Overall Study|Early Termination of Study|0
7492747|NCT03579940|25979397|P11|Period 2|Withdrawal by Subject|0
7492748|NCT03579940|25979398|P10|Period 2|Withdrawal by Subject|0
7492749|NCT03579940|25979399|P9|Period 2|Withdrawal by Subject|0
7492750|NCT03579940|25979400|P8|Period 2|Withdrawal by Subject|0
7492751|NCT03579940|25979401|P7|Period 2|Withdrawal by Subject|0
7492752|NCT03579940|25979402|P6|Period 2|Withdrawal by Subject|0
7492753|NCT03579940|25979403|P5|Period 2|Withdrawal by Subject|0
7492754|NCT03579940|25979404|P4|Period 2|Withdrawal by Subject|0
7492755|NCT03579940|25979405|P3|Period 2|Withdrawal by Subject|1
7492756|NCT03579940|25979406|P2|Period 2|Withdrawal by Subject|0
7492757|NCT03579940|25979407|P1|Period 2|Withdrawal by Subject|0
7492758|NCT03579719|25979447|P1|Overall Study|Protocol deviation, pre-existent disease|1
7492759|NCT03579290|25979472|P1|Overall Study|Lost to Follow-up|9
7492760|NCT03578146|25979510|P6|Overall Study|Lost to Follow-up|1
7492761|NCT03578146|25979511|P5|Overall Study|Lost to Follow-up|0
7492762|NCT03578146|25979512|P4|Overall Study|Lost to Follow-up|0
7492763|NCT03578146|25979513|P3|Overall Study|Lost to Follow-up|1
7492764|NCT03578146|25979514|P2|Overall Study|Lost to Follow-up|1
7492765|NCT03578146|25979515|P1|Overall Study|Lost to Follow-up|0
7492766|NCT03578146|25979510|P6|Overall Study|Did Not Receive Treatment|2
7492767|NCT03578146|25979511|P5|Overall Study|Did Not Receive Treatment|0
7492768|NCT03578146|25979512|P4|Overall Study|Did Not Receive Treatment|0
7492769|NCT03578146|25979513|P3|Overall Study|Did Not Receive Treatment|0
7492770|NCT03578146|25979514|P2|Overall Study|Did Not Receive Treatment|0
7492771|NCT03578146|25979515|P1|Overall Study|Did Not Receive Treatment|1
7492772|NCT03577730|25979579|P2|Overall Study|Did not receive allocated intervention|0
7492773|NCT03577730|25979580|P1|Overall Study|Did not receive allocated intervention|1
7492774|NCT03577730|25979579|P2|Overall Study|Physician Decision|1
7492775|NCT03577730|25979580|P1|Overall Study|Physician Decision|3
7492776|NCT03576768|25979669|P4|Overall Study|Lost to Follow-up|0
7492777|NCT03576768|25979670|P3|Overall Study|Lost to Follow-up|0
7492778|NCT03576768|25979671|P2|Overall Study|Lost to Follow-up|3
7492779|NCT03576768|25979672|P1|Overall Study|Lost to Follow-up|3
7492780|NCT03576716|25979692|P2|Overall Study|Withdrawal by Subject|1
7492781|NCT03576716|25979693|P1|Overall Study|Withdrawal by Subject|0
7492782|NCT03576066|25979746|P2|Overall Study|Noncompliance with study drug|1
7492783|NCT03576066|25979747|P1|Overall Study|Noncompliance with study drug|0
7492784|NCT03575975|25979782|P3|Overall Study|Lost to Follow-up|0
7492785|NCT03575975|25979783|P2|Overall Study|Lost to Follow-up|0
7492786|NCT03575975|25979784|P1|Overall Study|Lost to Follow-up|1
7492787|NCT03575897|25979835|P2|Overall Study|Lost to Follow-up|13
7492788|NCT03575897|25979836|P1|Overall Study|Lost to Follow-up|12
7492789|NCT03575871|25979855|P3|Overall Study|Other than specified|0
7492790|NCT03575871|25979856|P2|Overall Study|Other than specified|2
7492791|NCT03575871|25979857|P1|Overall Study|Other than specified|2
7492792|NCT03575871|25979855|P3|Overall Study|Withdrawal by Subject|9
7492793|NCT03575871|25979856|P2|Overall Study|Withdrawal by Subject|1
7492794|NCT03575871|25979857|P1|Overall Study|Withdrawal by Subject|6
7492795|NCT03575871|25979855|P3|Overall Study|Protocol Deviation|1
7492796|NCT03575871|25979856|P2|Overall Study|Protocol Deviation|1
7492797|NCT03575871|25979857|P1|Overall Study|Protocol Deviation|1
7492798|NCT03575871|25979855|P3|Overall Study|Lost to Follow-up|1
7492799|NCT03575871|25979856|P2|Overall Study|Lost to Follow-up|1
7492800|NCT03575871|25979857|P1|Overall Study|Lost to Follow-up|1
7492801|NCT03575871|25979855|P3|Overall Study|Lack of Efficacy|7
7492802|NCT03575871|25979856|P2|Overall Study|Lack of Efficacy|4
7492803|NCT03575871|25979857|P1|Overall Study|Lack of Efficacy|5
7492804|NCT03575871|25979855|P3|Overall Study|Death|0
7492805|NCT03575871|25979856|P2|Overall Study|Death|0
7492806|NCT03575871|25979857|P1|Overall Study|Death|1
7492807|NCT03575871|25979855|P3|Overall Study|Adverse Event|8
7492808|NCT03575871|25979856|P2|Overall Study|Adverse Event|5
7492809|NCT03575871|25979857|P1|Overall Study|Adverse Event|5
7492810|NCT03575806|25979921|P2|Overall Study|Protocol Violation|2
7492811|NCT03575806|25979922|P1|Overall Study|Protocol Violation|0
7492812|NCT03575806|25979921|P2|Overall Study|Withdrawal by Subject|2
7492813|NCT03575806|25979922|P1|Overall Study|Withdrawal by Subject|0
7492814|NCT03575702|25979947|P2|Overall Study|Patient non compliance|0
7492815|NCT03575702|25979948|P1|Overall Study|Patient non compliance|4
7492816|NCT03575702|25979947|P2|Overall Study|Protocol Violation|1
7492817|NCT03575702|25979948|P1|Overall Study|Protocol Violation|0
7492818|NCT03575702|25979947|P2|Overall Study|Lost to Follow-up|2
7492819|NCT03575702|25979948|P1|Overall Study|Lost to Follow-up|1
7492820|NCT03575702|25979947|P2|Overall Study|Withdrawal by Subject|1
7492821|NCT03575702|25979948|P1|Overall Study|Withdrawal by Subject|1
7492825|NCT03573908|25980019|P5|Randomized Withdrawal Period|Other, Not Specified|0
7492826|NCT03573908|25980020|P4|Randomized Withdrawal Period|Other, Not Specified|2
7492827|NCT03573908|25980021|P3|Randomized Withdrawal Period|Other, Not Specified|4
7492828|NCT03573908|25980022|P2|Randomized Withdrawal Period|Other, Not Specified|0
7492829|NCT03573908|25980023|P1|Randomized Withdrawal Period|Other, Not Specified|0
7492830|NCT03573908|25980019|P5|Randomized Withdrawal Period|Lost to Follow-up|0
7492831|NCT03573908|25980020|P4|Randomized Withdrawal Period|Lost to Follow-up|0
7492832|NCT03573908|25980021|P3|Randomized Withdrawal Period|Lost to Follow-up|1
7492833|NCT03573908|25980022|P2|Randomized Withdrawal Period|Lost to Follow-up|0
7492834|NCT03573908|25980023|P1|Randomized Withdrawal Period|Lost to Follow-up|0
7492835|NCT03573908|25980019|P5|Randomized Withdrawal Period|Withdrawal by Subject|2
7492836|NCT03573908|25980020|P4|Randomized Withdrawal Period|Withdrawal by Subject|0
7492837|NCT03573908|25980021|P3|Randomized Withdrawal Period|Withdrawal by Subject|0
7492838|NCT03573908|25980022|P2|Randomized Withdrawal Period|Withdrawal by Subject|0
7492839|NCT03573908|25980023|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
7492840|NCT03573908|25980019|P5|Randomized Withdrawal Period|Adverse Event|0
7492841|NCT03573908|25980020|P4|Randomized Withdrawal Period|Adverse Event|0
7492842|NCT03573908|25980021|P3|Randomized Withdrawal Period|Adverse Event|3
7492843|NCT03573908|25980022|P2|Randomized Withdrawal Period|Adverse Event|0
7492844|NCT03573908|25980023|P1|Randomized Withdrawal Period|Adverse Event|0
7492845|NCT03573908|25980019|P5|Treatment Period|Other, Not Specified|0
7492846|NCT03573908|25980020|P4|Treatment Period|Other, Not Specified|0
7492847|NCT03573908|25980021|P3|Treatment Period|Other, Not Specified|0
7492848|NCT03573908|25980022|P2|Treatment Period|Other, Not Specified|6
7492849|NCT03573908|25980023|P1|Treatment Period|Other, Not Specified|4
7492850|NCT03573908|25980019|P5|Treatment Period|Pregnancy|0
7492851|NCT03573908|25980020|P4|Treatment Period|Pregnancy|0
7492852|NCT03573908|25980021|P3|Treatment Period|Pregnancy|0
7492853|NCT03573908|25980022|P2|Treatment Period|Pregnancy|0
7492854|NCT03573908|25980023|P1|Treatment Period|Pregnancy|1
7492855|NCT03573908|25980019|P5|Treatment Period|Lost to Follow-up|0
7492856|NCT03573908|25980020|P4|Treatment Period|Lost to Follow-up|0
7492857|NCT03573908|25980021|P3|Treatment Period|Lost to Follow-up|0
7492858|NCT03573908|25980022|P2|Treatment Period|Lost to Follow-up|6
7492859|NCT03573908|25980023|P1|Treatment Period|Lost to Follow-up|7
7492860|NCT03573908|25980019|P5|Treatment Period|Withdrawal by Subject|0
7492861|NCT03573908|25980020|P4|Treatment Period|Withdrawal by Subject|0
7492862|NCT03573908|25980021|P3|Treatment Period|Withdrawal by Subject|0
7492863|NCT03573908|25980022|P2|Treatment Period|Withdrawal by Subject|5
7492864|NCT03573908|25980023|P1|Treatment Period|Withdrawal by Subject|7
7492865|NCT03573908|25980019|P5|Treatment Period|Protocol Violation|0
7492866|NCT03573908|25980020|P4|Treatment Period|Protocol Violation|0
7492867|NCT03573908|25980021|P3|Treatment Period|Protocol Violation|0
7492868|NCT03573908|25980022|P2|Treatment Period|Protocol Violation|0
7492869|NCT03573908|25980023|P1|Treatment Period|Protocol Violation|1
7492870|NCT03573908|25980019|P5|Treatment Period|Adverse Event|0
7492871|NCT03573908|25980020|P4|Treatment Period|Adverse Event|0
7492872|NCT03573908|25980021|P3|Treatment Period|Adverse Event|0
7492873|NCT03573908|25980022|P2|Treatment Period|Adverse Event|9
7492874|NCT03573908|25980023|P1|Treatment Period|Adverse Event|4
7492875|NCT03573830|25980040|P2|Overall Study|Lost to Follow-up|0
7492876|NCT03573830|25980041|P1|Overall Study|Lost to Follow-up|4
7492877|NCT03573830|25980040|P2|Overall Study|Dropped without completing treatment|7
7492878|NCT03573830|25980041|P1|Overall Study|Dropped without completing treatment|0
7492879|NCT03573817|25980064|P2|Overall Study|Withdrawal by Subject|1
7492880|NCT03573817|25980065|P1|Overall Study|Withdrawal by Subject|1
7492881|NCT03573817|25980064|P2|Overall Study|Protocol Violation|1
7492882|NCT03573817|25980065|P1|Overall Study|Protocol Violation|0
7492883|NCT03573817|25980064|P2|Overall Study|Adverse Event|2
7492884|NCT03573817|25980065|P1|Overall Study|Adverse Event|0
7492885|NCT03573804|25980091|P1|Overall Study|claustrophobia or MRI table problems|10
7492886|NCT03573505|25980107|P2|Overall Study|Death|4
7492887|NCT03573505|25980108|P1|Overall Study|Death|0
7492888|NCT03573505|25980107|P2|Overall Study|Reason not specified|1
7492889|NCT03573505|25980108|P1|Overall Study|Reason not specified|0
7492890|NCT03573505|25980107|P2|Overall Study|Study terminated by sponsor|45
7492891|NCT03573505|25980108|P1|Overall Study|Study terminated by sponsor|50
7492892|NCT03573505|25980107|P2|Overall Study|Site Terminated by Sponsor|1
7492893|NCT03573505|25980108|P1|Overall Study|Site Terminated by Sponsor|1
7492894|NCT03573505|25980107|P2|Overall Study|Disease progression|1
7492895|NCT03573505|25980108|P1|Overall Study|Disease progression|0
7492896|NCT03573505|25980107|P2|Overall Study|Consent withdrawn|1
7492897|NCT03573505|25980108|P1|Overall Study|Consent withdrawn|0
7492898|NCT03573505|25980107|P2|Overall Study|Adverse Event|1
7492899|NCT03573505|25980108|P1|Overall Study|Adverse Event|1
7492900|NCT03573336|25980154|P3|Overall Study|Study terminated|2
7492901|NCT03573336|25980155|P2|Overall Study|Study terminated|4
7492902|NCT03573336|25980156|P1|Overall Study|Study terminated|2
7492903|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
7492904|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
7492905|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
7492906|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
7492907|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
7492908|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
7492909|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
7492910|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
7492911|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
7492912|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
7492913|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
7492914|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
7492915|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
7492916|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
7492917|NCT03573323|25980175|P2|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
7492918|NCT03573323|25980176|P1|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
7492919|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
7492920|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
7492921|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
7492922|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
7492923|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
7492924|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
7492925|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
7492926|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
7492927|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
7492928|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
7492929|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
7492930|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
7492931|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
7492932|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
7492933|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
7492934|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
7492935|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
7492936|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
7492937|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
7492938|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
7492939|NCT03573323|25980175|P2|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7492940|NCT03573323|25980176|P1|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7492941|NCT03572218|25980354|P2|Overall Study|No longer interested|2
7492942|NCT03572218|25980355|P1|Overall Study|No longer interested|1
7492943|NCT03572218|25980354|P2|Overall Study|No longer available for study visits|1
7492944|NCT03572218|25980355|P1|Overall Study|No longer available for study visits|2
7492945|NCT03572218|25980354|P2|Overall Study|Lost to Follow-up|2
7492946|NCT03572218|25980355|P1|Overall Study|Lost to Follow-up|3
7492947|NCT03572062|25980479|P10|Overall Study|Randomized But Not Treated|0
7492948|NCT03572062|25980480|P9|Overall Study|Randomized But Not Treated|0
7492949|NCT03572062|25980481|P8|Overall Study|Randomized But Not Treated|1
7492950|NCT03572062|25980482|P7|Overall Study|Randomized But Not Treated|0
7492951|NCT03572062|25980483|P6|Overall Study|Randomized But Not Treated|2
7492952|NCT03572062|25980484|P5|Overall Study|Randomized But Not Treated|1
7492953|NCT03572062|25980485|P4|Overall Study|Randomized But Not Treated|0
7492954|NCT03572062|25980486|P3|Overall Study|Randomized But Not Treated|0
7492955|NCT03572062|25980487|P2|Overall Study|Randomized But Not Treated|0
7492956|NCT03572062|25980488|P1|Overall Study|Randomized But Not Treated|0
7492957|NCT03572062|25980479|P10|Overall Study|Withdrawal by Subject|1
7492958|NCT03572062|25980480|P9|Overall Study|Withdrawal by Subject|0
7492959|NCT03572062|25980481|P8|Overall Study|Withdrawal by Subject|0
7492960|NCT03572062|25980482|P7|Overall Study|Withdrawal by Subject|0
7492961|NCT03572062|25980483|P6|Overall Study|Withdrawal by Subject|0
7492962|NCT03572062|25980484|P5|Overall Study|Withdrawal by Subject|0
7492963|NCT03572062|25980485|P4|Overall Study|Withdrawal by Subject|0
7492964|NCT03572062|25980486|P3|Overall Study|Withdrawal by Subject|0
7492965|NCT03572062|25980487|P2|Overall Study|Withdrawal by Subject|0
7492966|NCT03572062|25980488|P1|Overall Study|Withdrawal by Subject|0
7492967|NCT03572062|25980479|P10|Overall Study|Physician Decision|0
7492968|NCT03572062|25980480|P9|Overall Study|Physician Decision|1
7492969|NCT03572062|25980481|P8|Overall Study|Physician Decision|0
7492970|NCT03572062|25980482|P7|Overall Study|Physician Decision|0
7492971|NCT03572062|25980483|P6|Overall Study|Physician Decision|0
7492972|NCT03572062|25980484|P5|Overall Study|Physician Decision|0
7492973|NCT03572062|25980485|P4|Overall Study|Physician Decision|0
7492974|NCT03572062|25980486|P3|Overall Study|Physician Decision|0
7492975|NCT03572062|25980487|P2|Overall Study|Physician Decision|0
7492976|NCT03572062|25980488|P1|Overall Study|Physician Decision|0
7492977|NCT03572062|25980479|P10|Overall Study|Study Terminated By Sponsor|27
7492978|NCT03572062|25980480|P9|Overall Study|Study Terminated By Sponsor|29
7492979|NCT03572062|25980481|P8|Overall Study|Study Terminated By Sponsor|0
7492980|NCT03572062|25980482|P7|Overall Study|Study Terminated By Sponsor|0
7492981|NCT03572062|25980483|P6|Overall Study|Study Terminated By Sponsor|0
7492982|NCT03572062|25980484|P5|Overall Study|Study Terminated By Sponsor|0
7492983|NCT03572062|25980485|P4|Overall Study|Study Terminated By Sponsor|0
7492984|NCT03572062|25980486|P3|Overall Study|Study Terminated By Sponsor|0
7492985|NCT03572062|25980487|P2|Overall Study|Study Terminated By Sponsor|0
7492986|NCT03572062|25980488|P1|Overall Study|Study Terminated By Sponsor|0
7492987|NCT03572062|25980479|P10|Overall Study|No Longer Meets Eligibility Criteria|0
7492988|NCT03572062|25980480|P9|Overall Study|No Longer Meets Eligibility Criteria|1
7492989|NCT03572062|25980481|P8|Overall Study|No Longer Meets Eligibility Criteria|0
7492990|NCT03572062|25980482|P7|Overall Study|No Longer Meets Eligibility Criteria|0
7492991|NCT03572062|25980483|P6|Overall Study|No Longer Meets Eligibility Criteria|0
7492992|NCT03572062|25980484|P5|Overall Study|No Longer Meets Eligibility Criteria|0
7492993|NCT03572062|25980485|P4|Overall Study|No Longer Meets Eligibility Criteria|0
7492994|NCT03572062|25980486|P3|Overall Study|No Longer Meets Eligibility Criteria|0
7492995|NCT03572062|25980487|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7492996|NCT03572062|25980488|P1|Overall Study|No Longer Meets Eligibility Criteria|0
7492997|NCT03572062|25980479|P10|Overall Study|Lost to Follow-up|0
7492998|NCT03572062|25980480|P9|Overall Study|Lost to Follow-up|0
7492999|NCT03572062|25980481|P8|Overall Study|Lost to Follow-up|0
7493000|NCT03572062|25980482|P7|Overall Study|Lost to Follow-up|1
7493001|NCT03572062|25980483|P6|Overall Study|Lost to Follow-up|1
7493002|NCT03572062|25980484|P5|Overall Study|Lost to Follow-up|0
7493003|NCT03572062|25980485|P4|Overall Study|Lost to Follow-up|0
7493004|NCT03572062|25980486|P3|Overall Study|Lost to Follow-up|0
7493005|NCT03572062|25980487|P2|Overall Study|Lost to Follow-up|0
7493006|NCT03572062|25980488|P1|Overall Study|Lost to Follow-up|0
7493007|NCT03572062|25980479|P10|Overall Study|Death|0
7493008|NCT03572062|25980480|P9|Overall Study|Death|0
7493009|NCT03572062|25980481|P8|Overall Study|Death|0
7493010|NCT03572062|25980482|P7|Overall Study|Death|0
7493011|NCT03572062|25980483|P6|Overall Study|Death|1
7493012|NCT03572062|25980484|P5|Overall Study|Death|0
7493013|NCT03572062|25980485|P4|Overall Study|Death|0
7493014|NCT03572062|25980486|P3|Overall Study|Death|0
7493015|NCT03572062|25980487|P2|Overall Study|Death|0
7493016|NCT03572062|25980488|P1|Overall Study|Death|0
7493017|NCT03572062|25980479|P10|Overall Study|Adverse Event|3
7493018|NCT03572062|25980480|P9|Overall Study|Adverse Event|1
7493019|NCT03572062|25980481|P8|Overall Study|Adverse Event|0
7493020|NCT03572062|25980482|P7|Overall Study|Adverse Event|0
7493021|NCT03572062|25980483|P6|Overall Study|Adverse Event|0
7493022|NCT03572062|25980484|P5|Overall Study|Adverse Event|0
7493023|NCT03572062|25980485|P4|Overall Study|Adverse Event|0
7493024|NCT03572062|25980486|P3|Overall Study|Adverse Event|0
7493025|NCT03572062|25980487|P2|Overall Study|Adverse Event|0
7493026|NCT03572062|25980488|P1|Overall Study|Adverse Event|0
7493027|NCT03571646|25980687|P2|Overall Study|Withdrawal by Subject|1
7493028|NCT03571646|25980688|P1|Overall Study|Withdrawal by Subject|1
7493029|NCT03571646|25980687|P2|Overall Study|Adverse Event|0
7493030|NCT03571646|25980688|P1|Overall Study|Adverse Event|1
7493031|NCT03571516|25980724|P2|Overall Study|Withdrawal by Subject|1
7493032|NCT03571516|25980725|P1|Overall Study|Withdrawal by Subject|0
7493033|NCT03571516|25980724|P2|Overall Study|Severe diarrhea|0
7493034|NCT03571516|25980725|P1|Overall Study|Severe diarrhea|1
7493035|NCT03571256|25980776|P3|Overall Study|Protocol Violation|1
7493036|NCT03571256|25980777|P2|Overall Study|Protocol Violation|1
7493037|NCT03571256|25980778|P1|Overall Study|Protocol Violation|0
7493038|NCT03571256|25980776|P3|Overall Study|Other than specified|1
7493039|NCT03571256|25980777|P2|Overall Study|Other than specified|1
7493040|NCT03571256|25980778|P1|Overall Study|Other than specified|0
7493041|NCT03571256|25980776|P3|Overall Study|Withdrawal by Subject|1
7493042|NCT03571256|25980777|P2|Overall Study|Withdrawal by Subject|1
7493043|NCT03571256|25980778|P1|Overall Study|Withdrawal by Subject|3
7493044|NCT03571256|25980776|P3|Overall Study|Adverse Event|1
7493045|NCT03571256|25980777|P2|Overall Study|Adverse Event|0
7493046|NCT03571256|25980778|P1|Overall Study|Adverse Event|3
7493047|NCT03570554|25980866|P4|Overall Study|Adverse Event|1
7493048|NCT03570554|25980867|P3|Overall Study|Adverse Event|0
7493049|NCT03570554|25980868|P2|Overall Study|Adverse Event|0
7493050|NCT03570554|25980869|P1|Overall Study|Adverse Event|0
7493051|NCT03570554|25980866|P4|Overall Study|Non-compliance with study drug|0
7493052|NCT03570554|25980867|P3|Overall Study|Non-compliance with study drug|1
7493053|NCT03570554|25980868|P2|Overall Study|Non-compliance with study drug|0
7493054|NCT03570554|25980869|P1|Overall Study|Non-compliance with study drug|0
7493055|NCT03569371|25981010|P1|Overall Study|Adverse Event|1
7493056|NCT03569371|25981010|P1|Overall Study|Lost to Follow-up|1
7493057|NCT03569371|25981010|P1|Overall Study|Lack of Efficacy|1
7493058|NCT03569202|25981031|P2|Part 3|Other|1
7493059|NCT03569202|25981032|P1|Part 3|Other|1
7493060|NCT03569202|25981031|P2|Part 3|Physician Decision|0
7493061|NCT03569202|25981032|P1|Part 3|Physician Decision|1
7493062|NCT03569098|25981065|P3|Open-Label Treatment Cycle 3|Lost to Follow-up|1
7493063|NCT03569098|25981066|P2|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7493064|NCT03569098|25981067|P1|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7493065|NCT03569098|25981065|P3|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7493066|NCT03569098|25981066|P2|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7493067|NCT03569098|25981067|P1|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
7493068|NCT03569098|25981065|P3|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
7493069|NCT03569098|25981066|P2|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7493070|NCT03569098|25981067|P1|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7493071|NCT03569098|25981065|P3|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7493072|NCT03569098|25981066|P2|Open-Label Treatment Cycle 2|Lost to Follow-up|3
7493073|NCT03569098|25981067|P1|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7493074|NCT03569098|25981065|P3|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7493075|NCT03569098|25981066|P2|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
7493076|NCT03569098|25981067|P1|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7493077|NCT03569098|25981065|P3|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7493078|NCT03569098|25981066|P2|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
7493079|NCT03569098|25981067|P1|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7493080|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Other|1
7493081|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Other|0
7493082|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Other|1
7493083|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Protocol deviation|0
7493084|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Protocol deviation|1
7493085|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Protocol deviation|0
7493086|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Physician Decision|0
7493087|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Physician Decision|0
7493088|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Physician Decision|1
7493089|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Technical problems|2
7493090|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Technical problems|0
7493091|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Technical problems|0
7493092|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
7493093|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7493094|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7493095|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
7493096|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
7493097|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
7493098|NCT03569098|25981065|P3|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7493099|NCT03569098|25981066|P2|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
7493100|NCT03569098|25981067|P1|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7493101|NCT03568942|25981159|P1|Overall Study|Lost to Follow-up|1
7493102|NCT03568942|25981159|P1|Overall Study|Family emergency|1
7493103|NCT03568500|25981216|P3|Overall Study|Participant Noncompliance|0
7493104|NCT03568500|25981217|P2|Overall Study|Participant Noncompliance|1
7493105|NCT03568500|25981218|P1|Overall Study|Participant Noncompliance|1
7493106|NCT03568500|25981216|P3|Overall Study|Technical Problems|0
7493107|NCT03568500|25981217|P2|Overall Study|Technical Problems|1
7493108|NCT03568500|25981218|P1|Overall Study|Technical Problems|2
7493109|NCT03568500|25981216|P3|Overall Study|Withdrawal by Subject|0
7493110|NCT03568500|25981217|P2|Overall Study|Withdrawal by Subject|2
7493111|NCT03568500|25981218|P1|Overall Study|Withdrawal by Subject|4
7493112|NCT03568500|25981216|P3|Overall Study|Physician Decision|0
7493113|NCT03568500|25981217|P2|Overall Study|Physician Decision|0
7493114|NCT03568500|25981218|P1|Overall Study|Physician Decision|1
7493115|NCT03568500|25981216|P3|Overall Study|Adverse Event|2
7493116|NCT03568500|25981217|P2|Overall Study|Adverse Event|1
7493117|NCT03568500|25981218|P1|Overall Study|Adverse Event|1
7493118|NCT03568500|25981216|P3|Overall Study|Lost to Follow-up|2
7493119|NCT03568500|25981217|P2|Overall Study|Lost to Follow-up|1
7493120|NCT03568500|25981218|P1|Overall Study|Lost to Follow-up|1
7493121|NCT03567616|25981234|P1|Overall Study|Adverse Event|1
7493122|NCT03567616|25981234|P1|Overall Study|Death|1
7493123|NCT03567616|25981234|P1|Overall Study|Physician Decision|1
7493124|NCT03567616|25981234|P1|Overall Study|Withdrawal by Subject|1
7493125|NCT03567616|25981234|P1|Overall Study|Disease progression|4
7493126|NCT03567382|25981254|P4|Overall Study|Withdrawal by Subject|12
7493127|NCT03567382|25981255|P3|Overall Study|Withdrawal by Subject|1
7493128|NCT03567382|25981256|P2|Overall Study|Withdrawal by Subject|14
7493129|NCT03567382|25981257|P1|Overall Study|Withdrawal by Subject|2
7493130|NCT03567382|25981254|P4|Overall Study|Lost to Follow-up|21
7493131|NCT03567382|25981255|P3|Overall Study|Lost to Follow-up|1
7493132|NCT03567382|25981256|P2|Overall Study|Lost to Follow-up|21
7493133|NCT03567382|25981257|P1|Overall Study|Lost to Follow-up|1
7493134|NCT03567291|25981272|P4|Period III|Missing or unknown|8
7493135|NCT03567291|25981273|P3|Period III|Missing or unknown|0
7493136|NCT03567291|25981274|P2|Period III|Missing or unknown|0
7493137|NCT03567291|25981275|P1|Period III|Missing or unknown|0
7493138|NCT03567291|25981272|P4|Period III|Terminated by sponsor|68
7493139|NCT03567291|25981273|P3|Period III|Terminated by sponsor|0
7493140|NCT03567291|25981274|P2|Period III|Terminated by sponsor|0
7493141|NCT03567291|25981275|P1|Period III|Terminated by sponsor|0
7493142|NCT03567291|25981272|P4|Period III|Lost to Follow-up|1
7493143|NCT03567291|25981273|P3|Period III|Lost to Follow-up|0
7493144|NCT03567291|25981274|P2|Period III|Lost to Follow-up|0
7493145|NCT03567291|25981275|P1|Period III|Lost to Follow-up|0
7493146|NCT03567291|25981272|P4|Period III|Withdrawal by Subject|4
7493147|NCT03567291|25981273|P3|Period III|Withdrawal by Subject|0
7493148|NCT03567291|25981274|P2|Period III|Withdrawal by Subject|0
7493149|NCT03567291|25981275|P1|Period III|Withdrawal by Subject|0
7493150|NCT03567291|25981272|P4|Period III|Adverse Event|4
7493151|NCT03567291|25981273|P3|Period III|Adverse Event|0
7493152|NCT03567291|25981274|P2|Period III|Adverse Event|0
7493153|NCT03567291|25981275|P1|Period III|Adverse Event|0
7493154|NCT03567291|25981272|P4|Period II|Missing or unknown|0
7493155|NCT03567291|25981273|P3|Period II|Missing or unknown|1
7493156|NCT03567291|25981274|P2|Period II|Missing or unknown|2
7493157|NCT03567291|25981275|P1|Period II|Missing or unknown|0
7493158|NCT03567291|25981272|P4|Period II|Adverse Event|0
7493159|NCT03567291|25981273|P3|Period II|Adverse Event|0
7493160|NCT03567291|25981274|P2|Period II|Adverse Event|1
7493161|NCT03567291|25981275|P1|Period II|Adverse Event|0
7493162|NCT03567291|25981272|P4|Period I|Missing or unknown|0
7493163|NCT03567291|25981273|P3|Period I|Missing or unknown|0
7493164|NCT03567291|25981274|P2|Period I|Missing or unknown|0
7493165|NCT03567291|25981275|P1|Period I|Missing or unknown|7
7493166|NCT03567291|25981272|P4|Period I|Terminated by sponsor|0
7493167|NCT03567291|25981273|P3|Period I|Terminated by sponsor|0
7493168|NCT03567291|25981274|P2|Period I|Terminated by sponsor|0
7493169|NCT03567291|25981275|P1|Period I|Terminated by sponsor|44
7493170|NCT03567291|25981272|P4|Period I|Lost to Follow-up|0
7493171|NCT03567291|25981273|P3|Period I|Lost to Follow-up|0
7493172|NCT03567291|25981274|P2|Period I|Lost to Follow-up|0
7493173|NCT03567291|25981275|P1|Period I|Lost to Follow-up|2
7493174|NCT03567291|25981272|P4|Period I|Withdrawal by Subject|0
7493175|NCT03567291|25981273|P3|Period I|Withdrawal by Subject|0
7493176|NCT03567291|25981274|P2|Period I|Withdrawal by Subject|0
7493177|NCT03567291|25981275|P1|Period I|Withdrawal by Subject|23
7493178|NCT03567291|25981272|P4|Period I|Protocol Violation|0
7493179|NCT03567291|25981273|P3|Period I|Protocol Violation|0
7493180|NCT03567291|25981274|P2|Period I|Protocol Violation|0
7493181|NCT03567291|25981275|P1|Period I|Protocol Violation|1
7493182|NCT03567291|25981272|P4|Period I|Adverse Event|0
7493183|NCT03567291|25981273|P3|Period I|Adverse Event|0
7493184|NCT03567291|25981274|P2|Period I|Adverse Event|0
7493185|NCT03567291|25981275|P1|Period I|Adverse Event|14
7493186|NCT03566979|25981360|P4|Overall Study|Adverse Event|0
7493187|NCT03566979|25981361|P3|Overall Study|Adverse Event|0
7493188|NCT03566979|25981362|P2|Overall Study|Adverse Event|0
7493189|NCT03566979|25981363|P1|Overall Study|Adverse Event|1
7493190|NCT03566979|25981360|P4|Overall Study|Lost to Follow-up|5
7493191|NCT03566979|25981361|P3|Overall Study|Lost to Follow-up|9
7493192|NCT03566979|25981362|P2|Overall Study|Lost to Follow-up|7
7493193|NCT03566979|25981363|P1|Overall Study|Lost to Follow-up|2
7493194|NCT03566979|25981360|P4|Overall Study|Withdrawal by Subject|1
7493195|NCT03566979|25981361|P3|Overall Study|Withdrawal by Subject|1
7493196|NCT03566979|25981362|P2|Overall Study|Withdrawal by Subject|0
7493197|NCT03566979|25981363|P1|Overall Study|Withdrawal by Subject|2
7493198|NCT03566823|25981378|P3|Overall Study|Adverse Event|2
7493199|NCT03566823|25981379|P2|Overall Study|Adverse Event|0
7493200|NCT03566823|25981380|P1|Overall Study|Adverse Event|1
7493201|NCT03566823|25981378|P3|Overall Study|Withdrawal by Subject|0
7493202|NCT03566823|25981379|P2|Overall Study|Withdrawal by Subject|2
7493203|NCT03566823|25981380|P1|Overall Study|Withdrawal by Subject|1
7493204|NCT03566823|25981378|P3|Overall Study|Lack of Efficacy|0
7493205|NCT03566823|25981379|P2|Overall Study|Lack of Efficacy|1
7493206|NCT03566823|25981380|P1|Overall Study|Lack of Efficacy|0
7493207|NCT03566810|25981443|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7493208|NCT03566810|25981444|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7493209|NCT03566810|25981445|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
7493210|NCT03566810|25981446|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7493211|NCT03566680|25981508|P1|Overall Study|Withdrawal by Subject|3
7493212|NCT03566680|25981508|P1|Overall Study|Lost to Follow-up|13
7493213|NCT03566680|25981508|P1|Overall Study|Pregnancy|1
7493214|NCT03566550|25981519|P2|Overall Study|Withdrawal by Subject|1
7493215|NCT03566550|25981520|P1|Overall Study|Withdrawal by Subject|0
7493216|NCT03566485|25981536|P2|Overall Study|Toxicity|2
7493217|NCT03566485|25981537|P1|Overall Study|Toxicity|0
7493218|NCT03566485|25981536|P2|Overall Study|Clinical progression|1
7493219|NCT03566485|25981537|P1|Overall Study|Clinical progression|0
7493220|NCT03566485|25981536|P2|Overall Study|Disease progression|4
7493221|NCT03566485|25981537|P1|Overall Study|Disease progression|5
7493222|NCT03566238|25981553|P3|Overall Study|Other|0
7493223|NCT03566238|25981554|P2|Overall Study|Other|0
7493224|NCT03566238|25981555|P1|Overall Study|Other|1
7493225|NCT03566238|25981553|P3|Overall Study|Lack of Efficacy|5
7493226|NCT03566238|25981554|P2|Overall Study|Lack of Efficacy|2
7493227|NCT03566238|25981555|P1|Overall Study|Lack of Efficacy|4
7493228|NCT03566238|25981553|P3|Overall Study|Adverse Event|0
7493229|NCT03566238|25981554|P2|Overall Study|Adverse Event|1
7493230|NCT03566238|25981555|P1|Overall Study|Adverse Event|0
7493231|NCT03565887|25981568|P2|Overall Study|Withdrawal by Subject|2
7493232|NCT03565887|25981569|P1|Overall Study|Withdrawal by Subject|0
7493233|NCT03565887|25981568|P2|Overall Study|Adverse Event|0
7493234|NCT03565887|25981569|P1|Overall Study|Adverse Event|1
7493235|NCT03565315|25981648|P4|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
7493236|NCT03565315|25981649|P3|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7493237|NCT03565315|25981650|P2|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7493238|NCT03565315|25981651|P1|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7493239|NCT03565211|25981688|P1|Overall Study|Personal issues|1
7493240|NCT03565211|25981688|P1|Overall Study|Adverse Event|44
7493241|NCT03565211|25981688|P1|Overall Study|Lost to Follow-up|1
7493242|NCT03565211|25981688|P1|Overall Study|Withdrawal by Subject|2
7493243|NCT03565068|25981720|P9|Overall Study|Lost to Follow-up|0
7493244|NCT03565068|25981721|P8|Overall Study|Lost to Follow-up|1
7493245|NCT03565068|25981722|P7|Overall Study|Lost to Follow-up|0
7493246|NCT03565068|25981723|P6|Overall Study|Lost to Follow-up|0
7493247|NCT03565068|25981724|P5|Overall Study|Lost to Follow-up|0
7493248|NCT03565068|25981725|P4|Overall Study|Lost to Follow-up|0
7493249|NCT03565068|25981726|P3|Overall Study|Lost to Follow-up|0
7493250|NCT03565068|25981727|P2|Overall Study|Lost to Follow-up|0
7493251|NCT03565068|25981728|P1|Overall Study|Lost to Follow-up|0
7493252|NCT03565068|25981720|P9|Overall Study|Physician Decision|0
7493253|NCT03565068|25981721|P8|Overall Study|Physician Decision|1
7493254|NCT03565068|25981722|P7|Overall Study|Physician Decision|0
7493255|NCT03565068|25981723|P6|Overall Study|Physician Decision|0
7493256|NCT03565068|25981724|P5|Overall Study|Physician Decision|0
7493257|NCT03565068|25981725|P4|Overall Study|Physician Decision|0
7493258|NCT03565068|25981726|P3|Overall Study|Physician Decision|0
7493259|NCT03565068|25981727|P2|Overall Study|Physician Decision|0
7493260|NCT03565068|25981728|P1|Overall Study|Physician Decision|0
7493261|NCT03565068|25981720|P9|Overall Study|Withdrawal by Subject|1
7493262|NCT03565068|25981721|P8|Overall Study|Withdrawal by Subject|5
7493263|NCT03565068|25981722|P7|Overall Study|Withdrawal by Subject|1
7493264|NCT03565068|25981723|P6|Overall Study|Withdrawal by Subject|0
7493265|NCT03565068|25981724|P5|Overall Study|Withdrawal by Subject|2
7493266|NCT03565068|25981725|P4|Overall Study|Withdrawal by Subject|0
7493267|NCT03565068|25981726|P3|Overall Study|Withdrawal by Subject|1
7493268|NCT03565068|25981727|P2|Overall Study|Withdrawal by Subject|0
7493269|NCT03565068|25981728|P1|Overall Study|Withdrawal by Subject|0
7493270|NCT03565068|25981720|P9|Overall Study|Sponsor decision|0
7493271|NCT03565068|25981721|P8|Overall Study|Sponsor decision|0
7493272|NCT03565068|25981722|P7|Overall Study|Sponsor decision|0
7493273|NCT03565068|25981723|P6|Overall Study|Sponsor decision|1
7493274|NCT03565068|25981724|P5|Overall Study|Sponsor decision|1
7493275|NCT03565068|25981725|P4|Overall Study|Sponsor decision|0
7493276|NCT03565068|25981726|P3|Overall Study|Sponsor decision|0
7493277|NCT03565068|25981727|P2|Overall Study|Sponsor decision|0
7493278|NCT03565068|25981728|P1|Overall Study|Sponsor decision|0
7493279|NCT03565068|25981720|P9|Overall Study|Protocol Violation|0
7493280|NCT03565068|25981721|P8|Overall Study|Protocol Violation|1
7493281|NCT03565068|25981722|P7|Overall Study|Protocol Violation|0
7493282|NCT03565068|25981723|P6|Overall Study|Protocol Violation|0
7493283|NCT03565068|25981724|P5|Overall Study|Protocol Violation|1
7493284|NCT03565068|25981725|P4|Overall Study|Protocol Violation|0
7493285|NCT03565068|25981726|P3|Overall Study|Protocol Violation|0
7493286|NCT03565068|25981727|P2|Overall Study|Protocol Violation|0
7493287|NCT03565068|25981728|P1|Overall Study|Protocol Violation|0
7493288|NCT03563716|25982051|P2|Overall Study|Still on Study|50
7493289|NCT03563716|25982052|P1|Overall Study|Still on Study|45
7493290|NCT03563716|25982051|P2|Overall Study|Withdrawal by Subject|3
7493291|NCT03563716|25982052|P1|Overall Study|Withdrawal by Subject|3
7493292|NCT03563716|25982051|P2|Overall Study|Death|14
7493293|NCT03563716|25982052|P1|Overall Study|Death|20
7493294|NCT03562481|25982332|P2|First Intervention|Lost to Follow-up|0
7493295|NCT03562481|25982333|P1|First Intervention|Lost to Follow-up|1
7493296|NCT03562117|25982377|P3|Part 1, Up to 3 Days|Adverse Event|0
7493297|NCT03562117|25982378|P2|Part 1, Up to 3 Days|Adverse Event|0
7493298|NCT03562117|25982379|P1|Part 1, Up to 3 Days|Adverse Event|1
7493299|NCT03561883|25982467|P2|Overall Study|Other, Not Specified|2
7493300|NCT03561883|25982468|P1|Overall Study|Other, Not Specified|3
7493301|NCT03561883|25982467|P2|Overall Study|Randomized by Mistake|0
7493302|NCT03561883|25982468|P1|Overall Study|Randomized by Mistake|1
7493303|NCT03561883|25982467|P2|Overall Study|Physician Decision|0
7493304|NCT03561883|25982468|P1|Overall Study|Physician Decision|1
7493305|NCT03561883|25982467|P2|Overall Study|Study Terminated by Sponsor|11
7493306|NCT03561883|25982468|P1|Overall Study|Study Terminated by Sponsor|12
7493307|NCT03561883|25982467|P2|Overall Study|Lost to Follow-up|6
7493308|NCT03561883|25982468|P1|Overall Study|Lost to Follow-up|2
7493309|NCT03561883|25982467|P2|Overall Study|Withdrawal by Subject|6
7493310|NCT03561883|25982468|P1|Overall Study|Withdrawal by Subject|14
7493311|NCT03561883|25982467|P2|Overall Study|Protocol Violation|3
7493312|NCT03561883|25982468|P1|Overall Study|Protocol Violation|2
7493313|NCT03561883|25982467|P2|Overall Study|Non-Compliance With Study Drug|2
7493314|NCT03561883|25982468|P1|Overall Study|Non-Compliance With Study Drug|1
7493315|NCT03561883|25982467|P2|Overall Study|Adverse Event|13
7493316|NCT03561883|25982468|P1|Overall Study|Adverse Event|10
7493317|NCT03561090|25982482|P2|Overall Study|Other Not Specified|2
7493318|NCT03561090|25982483|P1|Overall Study|Other Not Specified|0
7493319|NCT03561090|25982482|P2|Overall Study|Randomized by Mistake|1
7493320|NCT03561090|25982483|P1|Overall Study|Randomized by Mistake|1
7493321|NCT03561090|25982482|P2|Overall Study|Study Terminated by Sponsor|15
7493322|NCT03561090|25982483|P1|Overall Study|Study Terminated by Sponsor|10
7493323|NCT03561090|25982482|P2|Overall Study|Lost to Follow-up|2
7493324|NCT03561090|25982483|P1|Overall Study|Lost to Follow-up|7
7493325|NCT03561090|25982482|P2|Overall Study|Withdrawal by Subject|7
7493326|NCT03561090|25982483|P1|Overall Study|Withdrawal by Subject|7
7493327|NCT03561090|25982482|P2|Overall Study|Protocol Violation|2
7493328|NCT03561090|25982483|P1|Overall Study|Protocol Violation|2
7493329|NCT03561090|25982482|P2|Overall Study|Non-Compliance With Study Drug|0
7493330|NCT03561090|25982483|P1|Overall Study|Non-Compliance With Study Drug|2
7493331|NCT03561090|25982482|P2|Overall Study|Adverse Event|7
7493332|NCT03561090|25982483|P1|Overall Study|Adverse Event|11
7493333|NCT03560986|25982497|P2|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7493334|NCT03560986|25982498|P1|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7493335|NCT03560986|25982497|P2|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
7493336|NCT03560986|25982498|P1|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
7493337|NCT03560986|25982497|P2|Treatment Period B/Follow-up Period 2|Adverse Event|0
7493338|NCT03560986|25982498|P1|Treatment Period B/Follow-up Period 2|Adverse Event|1
7493339|NCT03560986|25982497|P2|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
7493340|NCT03560986|25982498|P1|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
7493341|NCT03560986|25982497|P2|Treatment Period A/Follow-up Period 1|Protocol Violation|1
7493342|NCT03560986|25982498|P1|Treatment Period A/Follow-up Period 1|Protocol Violation|0
7493343|NCT03560986|25982497|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7493344|NCT03560986|25982498|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7493345|NCT03560986|25982497|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7493346|NCT03560986|25982498|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7493347|NCT03560869|25982520|P2|Overall Study|Withdrawal by PI|1
7493348|NCT03560869|25982521|P1|Overall Study|Withdrawal by PI|0
7493349|NCT03560869|25982520|P2|Overall Study|Screening failure|4
7493350|NCT03560869|25982521|P1|Overall Study|Screening failure|4
7493351|NCT03560869|25982520|P2|Overall Study|Withdrawal by Subject|4
7493352|NCT03560869|25982521|P1|Overall Study|Withdrawal by Subject|3
7493353|NCT03560739|25982533|P4|Overall Study|Adverse Event|0
7493354|NCT03560739|25982534|P3|Overall Study|Adverse Event|0
7493355|NCT03560739|25982535|P2|Overall Study|Adverse Event|1
7493356|NCT03560739|25982536|P1|Overall Study|Adverse Event|0
7493357|NCT03560518|25982565|P3|Double Blind Treatment Period|Adverse Event|1
7493358|NCT03560518|25982566|P2|Double Blind Treatment Period|Adverse Event|3
7493359|NCT03560518|25982567|P1|Double Blind Treatment Period|Adverse Event|0
7493360|NCT03560518|25982565|P3|Double Blind Treatment Period|Lack of Efficacy|1
7493361|NCT03560518|25982566|P2|Double Blind Treatment Period|Lack of Efficacy|1
7493362|NCT03560518|25982567|P1|Double Blind Treatment Period|Lack of Efficacy|2
7493363|NCT03560518|25982565|P3|Double Blind Treatment Period|Withdrawal by Subject|5
7493364|NCT03560518|25982566|P2|Double Blind Treatment Period|Withdrawal by Subject|6
7493365|NCT03560518|25982567|P1|Double Blind Treatment Period|Withdrawal by Subject|10
7493366|NCT03560518|25982565|P3|Double Blind Treatment Period|Lost to Follow-up|6
7493367|NCT03560518|25982566|P2|Double Blind Treatment Period|Lost to Follow-up|6
7493368|NCT03560518|25982567|P1|Double Blind Treatment Period|Lost to Follow-up|5
7493369|NCT03560518|25982565|P3|Double Blind Treatment Period|Pregnancy|0
7493370|NCT03560518|25982566|P2|Double Blind Treatment Period|Pregnancy|2
7493371|NCT03560518|25982567|P1|Double Blind Treatment Period|Pregnancy|0
7493372|NCT03560518|25982565|P3|Double Blind Treatment Period|Protocol Violation|0
7493373|NCT03560518|25982566|P2|Double Blind Treatment Period|Protocol Violation|2
7493374|NCT03560518|25982567|P1|Double Blind Treatment Period|Protocol Violation|1
7493375|NCT03560518|25982565|P3|Double Blind Treatment Period|Study Terminated by the Sponsor|10
7493376|NCT03560518|25982566|P2|Double Blind Treatment Period|Study Terminated by the Sponsor|9
7493377|NCT03560518|25982567|P1|Double Blind Treatment Period|Study Terminated by the Sponsor|6
7493378|NCT03560518|25982565|P3|Double Blind Treatment Period|Miscellaneous Reasons|0
7493379|NCT03560518|25982566|P2|Double Blind Treatment Period|Miscellaneous Reasons|0
7493380|NCT03560518|25982567|P1|Double Blind Treatment Period|Miscellaneous Reasons|1
7493381|NCT03560245|25982580|P2|Overall Study|Other|1
7493382|NCT03560245|25982581|P1|Overall Study|Other|0
7493383|NCT03560245|25982580|P2|Overall Study|Physician Decision|1
7493384|NCT03560245|25982581|P1|Overall Study|Physician Decision|0
7493385|NCT03560245|25982580|P2|Overall Study|Lost to Follow-up|1
7493386|NCT03560245|25982581|P1|Overall Study|Lost to Follow-up|0
7493387|NCT03560245|25982580|P2|Overall Study|Death|1
7493388|NCT03560245|25982581|P1|Overall Study|Death|0
7493389|NCT03560245|25982580|P2|Overall Study|Protocol Violation|0
7493390|NCT03560245|25982581|P1|Overall Study|Protocol Violation|1
7493391|NCT03560245|25982580|P2|Overall Study|Adverse Event|1
7493392|NCT03560245|25982581|P1|Overall Study|Adverse Event|1
7493393|NCT03560245|25982580|P2|Overall Study|Withdrawal by Subject|2
7493394|NCT03560245|25982581|P1|Overall Study|Withdrawal by Subject|3
7493395|NCT03559530|25982652|P2|Overall Study|contamination / colonization|0
7493396|NCT03559530|25982653|P1|Overall Study|contamination / colonization|3
7493397|NCT03559530|25982652|P2|Overall Study|other species of Acinetobacte|0
7493398|NCT03559530|25982653|P1|Overall Study|other species of Acinetobacte|7
7493399|NCT03559530|25982652|P2|Overall Study|duplicate cases|0
7493400|NCT03559530|25982653|P1|Overall Study|duplicate cases|8
7493401|NCT03559530|25982652|P2|Overall Study|culture results not considered for treat|0
7493402|NCT03559530|25982653|P1|Overall Study|culture results not considered for treat|29
7493403|NCT03559530|25982652|P2|Overall Study|non-location of medical records|0
7493404|NCT03559530|25982653|P1|Overall Study|non-location of medical records|44
7493405|NCT03559517|25982661|P3|Overall Study|Withdrawal by Subject|0
7493406|NCT03559517|25982662|P2|Overall Study|Withdrawal by Subject|0
7493407|NCT03559517|25982663|P1|Overall Study|Withdrawal by Subject|1
7493408|NCT03559257|25982724|P2|Open-label Treatment Period|Physician Decision|1
7493409|NCT03559257|25982725|P1|Open-label Treatment Period|Physician Decision|0
7493410|NCT03559257|25982724|P2|Open-label Treatment Period|Lost to Follow-up|0
7493411|NCT03559257|25982725|P1|Open-label Treatment Period|Lost to Follow-up|1
7493412|NCT03559257|25982724|P2|Open-label Treatment Period|Protocol Violation|0
7493413|NCT03559257|25982725|P1|Open-label Treatment Period|Protocol Violation|2
7493414|NCT03559257|25982724|P2|Open-label Treatment Period|Withdrawal by Subject|0
7493415|NCT03559257|25982725|P1|Open-label Treatment Period|Withdrawal by Subject|3
7493416|NCT03559257|25982724|P2|Open-label Treatment Period|Lack of Efficacy|2
7493417|NCT03559257|25982725|P1|Open-label Treatment Period|Lack of Efficacy|3
7493418|NCT03559257|25982724|P2|Open-label Treatment Period|Adverse Event|4
7493419|NCT03559257|25982725|P1|Open-label Treatment Period|Adverse Event|1
7493420|NCT03559257|25982724|P2|Double Blind Treatment Period|Screen Failure|1
7493421|NCT03559257|25982725|P1|Double Blind Treatment Period|Screen Failure|0
7493422|NCT03559257|25982724|P2|Double Blind Treatment Period|Adverse Event|1
7493423|NCT03559257|25982725|P1|Double Blind Treatment Period|Adverse Event|0
7493424|NCT03559257|25982724|P2|Double Blind Treatment Period|Lack of Efficacy|1
7493425|NCT03559257|25982725|P1|Double Blind Treatment Period|Lack of Efficacy|1
7493426|NCT03559257|25982724|P2|Double Blind Treatment Period|Protocol Violation|4
7493427|NCT03559257|25982725|P1|Double Blind Treatment Period|Protocol Violation|1
7493428|NCT03559257|25982724|P2|Double Blind Treatment Period|Withdrawal by Subject|1
7493429|NCT03559257|25982725|P1|Double Blind Treatment Period|Withdrawal by Subject|2
7493430|NCT03559218|25982771|P2|Overall Study|Withdrawal by Subject|0
7493431|NCT03559218|25982772|P1|Overall Study|Withdrawal by Subject|1
7493432|NCT03559062|25982808|P3|Overall Study|Other|0
7493433|NCT03559062|25982809|P2|Overall Study|Other|1
7493434|NCT03559062|25982810|P1|Overall Study|Other|0
7493435|NCT03558997|25982825|P4|Overall Study|Lost to Follow-up|0
7493436|NCT03558997|25982826|P3|Overall Study|Lost to Follow-up|1
7493437|NCT03558997|25982827|P2|Overall Study|Lost to Follow-up|0
7493438|NCT03558997|25982828|P1|Overall Study|Lost to Follow-up|0
7493439|NCT03558997|25982825|P4|Overall Study|Withdrawal by Subject|1
7493440|NCT03558997|25982826|P3|Overall Study|Withdrawal by Subject|1
7493441|NCT03558997|25982827|P2|Overall Study|Withdrawal by Subject|0
7493442|NCT03558997|25982828|P1|Overall Study|Withdrawal by Subject|1
7493443|NCT03558997|25982825|P4|Overall Study|Physician Decision|0
7493444|NCT03558997|25982826|P3|Overall Study|Physician Decision|1
7493445|NCT03558997|25982827|P2|Overall Study|Physician Decision|0
7493446|NCT03558997|25982828|P1|Overall Study|Physician Decision|0
7493447|NCT03558997|25982825|P4|Overall Study|Adverse Event|1
7493448|NCT03558997|25982826|P3|Overall Study|Adverse Event|5
7493449|NCT03558997|25982827|P2|Overall Study|Adverse Event|2
7493450|NCT03558997|25982828|P1|Overall Study|Adverse Event|0
7493451|NCT03558672|25982860|P1|Overall Study|Study Early Termination|10
7493452|NCT03558555|25982872|P2|Overall Study|Lost to Follow-up|1
7493453|NCT03558555|25982873|P1|Overall Study|Lost to Follow-up|2
7493454|NCT03558516|25982891|P2|Overall Study|Protocol Violation|2
7493455|NCT03558516|25982892|P1|Overall Study|Protocol Violation|2
7493456|NCT03557931|25982932|P3|Overall Study|Miscellaneous|3
7493457|NCT03557931|25982933|P2|Overall Study|Miscellaneous|5
7493458|NCT03557931|25982934|P1|Overall Study|Miscellaneous|8
7493459|NCT03557931|25982932|P3|Overall Study|Withdrawal by Subject|7
7493460|NCT03557931|25982933|P2|Overall Study|Withdrawal by Subject|0
7493461|NCT03557931|25982934|P1|Overall Study|Withdrawal by Subject|14
7493462|NCT03557931|25982932|P3|Overall Study|Protocol Violation|1
7493463|NCT03557931|25982933|P2|Overall Study|Protocol Violation|4
7493464|NCT03557931|25982934|P1|Overall Study|Protocol Violation|1
7493465|NCT03557931|25982932|P3|Overall Study|Lost to Follow-up|1
7493466|NCT03557931|25982933|P2|Overall Study|Lost to Follow-up|4
7493467|NCT03557931|25982934|P1|Overall Study|Lost to Follow-up|4
7493468|NCT03557931|25982932|P3|Overall Study|Adverse Event|1
7493469|NCT03557931|25982933|P2|Overall Study|Adverse Event|6
7493470|NCT03557931|25982934|P1|Overall Study|Adverse Event|4
7493471|NCT03557801|25982965|P3|Overall Study|Lost to Follow-up|0
7493472|NCT03557801|25982966|P2|Overall Study|Lost to Follow-up|1
7493473|NCT03557801|25982967|P1|Overall Study|Lost to Follow-up|0
7493474|NCT03557801|25982965|P3|Overall Study|Withdrawal by Subject|3
7493475|NCT03557801|25982966|P2|Overall Study|Withdrawal by Subject|0
7493476|NCT03557801|25982967|P1|Overall Study|Withdrawal by Subject|1
7493477|NCT03557801|25982965|P3|Overall Study|Protocol Violation|0
7493478|NCT03557801|25982966|P2|Overall Study|Protocol Violation|0
7493479|NCT03557801|25982967|P1|Overall Study|Protocol Violation|1
7493480|NCT03557775|25982984|P3|Overall Study|Physician Decision|0
7493481|NCT03557775|25982985|P2|Overall Study|Physician Decision|1
7493482|NCT03557775|25982986|P1|Overall Study|Physician Decision|0
7493483|NCT03557775|25982984|P3|Overall Study|Withdrawal by Subject|4
7493484|NCT03557775|25982985|P2|Overall Study|Withdrawal by Subject|2
7493485|NCT03557775|25982986|P1|Overall Study|Withdrawal by Subject|1
7493486|NCT03557034|25983119|P2|Overall Study|Withdrawal by Subject|0
7493487|NCT03557034|25983120|P1|Overall Study|Withdrawal by Subject|1
7493488|NCT03556891|25983136|P1|Overall Study|Protocol Violation|1
7493489|NCT03556891|25983136|P1|Overall Study|Missing due to COVID|1
7493490|NCT03556891|25983136|P1|Overall Study|Missing at random|1
7493491|NCT03556891|25983136|P1|Overall Study|Lost to Follow-up|1
7493492|NCT03556891|25983136|P1|Overall Study|Death|1
7493493|NCT03556891|25983136|P1|Overall Study|Device Failure|1
7493494|NCT03556891|25983136|P1|Overall Study|MRI Need|3
7493495|NCT03556891|25983136|P1|Overall Study|Adverse Event|4
7493496|NCT03555890|25983197|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7493497|NCT03555890|25983198|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7493498|NCT03555890|25983199|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7493499|NCT03555890|25983200|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7493500|NCT03555565|25983334|P1|Overall Study|Protocol Deviation|13
7493501|NCT03555565|25983334|P1|Overall Study|Case Report Forms Uncollected|2
7493502|NCT03555435|25983344|P3|Overall Study|Lost to Follow-up|8
7493503|NCT03555435|25983345|P2|Overall Study|Lost to Follow-up|19
7493504|NCT03555435|25983346|P1|Overall Study|Lost to Follow-up|17
7493505|NCT03555305|25983377|P2|Period 1|Adverse Event|1
7493506|NCT03555305|25983378|P1|Period 1|Adverse Event|0
7493507|NCT03555305|25983377|P2|Period 1|Physician Decision|1
7493508|NCT03555305|25983378|P1|Period 1|Physician Decision|0
7493509|NCT03554772|25983445|P4|Overall Study|Lost to Follow-up|2
7493510|NCT03554772|25983446|P3|Overall Study|Lost to Follow-up|0
7493511|NCT03554772|25983447|P2|Overall Study|Lost to Follow-up|0
7493512|NCT03554772|25983448|P1|Overall Study|Lost to Follow-up|0
7493513|NCT03554629|25983477|P1|Overall Study|Inadequate data|6
7493514|NCT03554486|25983507|P3|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7493515|NCT03554486|25983508|P2|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7493516|NCT03554486|25983509|P1|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
7493517|NCT03554486|25983507|P3|Run-in Period (2 Weeks)|Lost to Follow-up|0
7493518|NCT03554486|25983508|P2|Run-in Period (2 Weeks)|Lost to Follow-up|0
7493519|NCT03554486|25983509|P1|Run-in Period (2 Weeks)|Lost to Follow-up|2
7493520|NCT03554486|25983507|P3|Run-in Period (2 Weeks)|Need for steroid injection|0
7493521|NCT03554486|25983508|P2|Run-in Period (2 Weeks)|Need for steroid injection|0
7493522|NCT03554486|25983509|P1|Run-in Period (2 Weeks)|Need for steroid injection|1
7493523|NCT03554018|25983522|P2|Overall Study|Lost to Follow-up|7
7493524|NCT03554018|25983523|P1|Overall Study|Lost to Follow-up|3
7493525|NCT03554005|25983539|P6|Overall Study|Other|1
7493526|NCT03554005|25983540|P5|Overall Study|Other|0
7493527|NCT03554005|25983541|P4|Overall Study|Other|0
7493528|NCT03554005|25983542|P3|Overall Study|Other|0
7493529|NCT03554005|25983543|P2|Overall Study|Other|0
7493530|NCT03554005|25983544|P1|Overall Study|Other|0
7493531|NCT03554005|25983539|P6|Overall Study|Physician Decision|0
7493532|NCT03554005|25983540|P5|Overall Study|Physician Decision|1
7493533|NCT03554005|25983541|P4|Overall Study|Physician Decision|0
7493534|NCT03554005|25983542|P3|Overall Study|Physician Decision|0
7493535|NCT03554005|25983543|P2|Overall Study|Physician Decision|0
7493536|NCT03554005|25983544|P1|Overall Study|Physician Decision|0
7493537|NCT03554005|25983539|P6|Overall Study|Adverse Event|3
7493538|NCT03554005|25983540|P5|Overall Study|Adverse Event|0
7493539|NCT03554005|25983541|P4|Overall Study|Adverse Event|0
7493540|NCT03554005|25983542|P3|Overall Study|Adverse Event|0
7493541|NCT03554005|25983543|P2|Overall Study|Adverse Event|0
7493542|NCT03554005|25983544|P1|Overall Study|Adverse Event|0
7493543|NCT03554005|25983539|P6|Overall Study|Disease Progression|6
7493544|NCT03554005|25983540|P5|Overall Study|Disease Progression|5
7493545|NCT03554005|25983541|P4|Overall Study|Disease Progression|1
7493546|NCT03554005|25983542|P3|Overall Study|Disease Progression|1
7493547|NCT03554005|25983543|P2|Overall Study|Disease Progression|1
7493548|NCT03554005|25983544|P1|Overall Study|Disease Progression|1
7493549|NCT03554005|25983539|P6|Overall Study|Not in participant's best interest|1
7493550|NCT03554005|25983540|P5|Overall Study|Not in participant's best interest|0
7493551|NCT03554005|25983541|P4|Overall Study|Not in participant's best interest|0
7493552|NCT03554005|25983542|P3|Overall Study|Not in participant's best interest|0
7493553|NCT03554005|25983543|P2|Overall Study|Not in participant's best interest|0
7493554|NCT03554005|25983544|P1|Overall Study|Not in participant's best interest|0
7493555|NCT03553823|25983572|P2|Overall Study|Physician Decision|1
7493556|NCT03553823|25983573|P1|Overall Study|Physician Decision|0
7493557|NCT03553758|25983579|P1|Overall Study|Lost to Follow-up|1
7493558|NCT03552757|25983588|P3|Overall Study|Death|1
7493559|NCT03552757|25983589|P2|Overall Study|Death|1
7493560|NCT03552757|25983590|P1|Overall Study|Death|1
7493561|NCT03552757|25983588|P3|Overall Study|Lost to Follow-up|7
7493562|NCT03552757|25983589|P2|Overall Study|Lost to Follow-up|7
7493563|NCT03552757|25983590|P1|Overall Study|Lost to Follow-up|2
7493564|NCT03552757|25983588|P3|Overall Study|Withdrawal by Subject|12
7493565|NCT03552757|25983589|P2|Overall Study|Withdrawal by Subject|5
7493566|NCT03552757|25983590|P1|Overall Study|Withdrawal by Subject|10
7493567|NCT03552549|25983709|P2|Overall Study|Administrative|14
7493568|NCT03552549|25983710|P1|Overall Study|Administrative|0
7493569|NCT03552549|25983709|P2|Overall Study|Did not meet eligibility criteria|0
7493570|NCT03552549|25983710|P1|Overall Study|Did not meet eligibility criteria|1
7493571|NCT03552549|25983709|P2|Overall Study|Did not complete study treatment|3
7493572|NCT03552549|25983710|P1|Overall Study|Did not complete study treatment|2
7493573|NCT03552549|25983709|P2|Overall Study|Not in participant's best interest|1
7493574|NCT03552549|25983710|P1|Overall Study|Not in participant's best interest|2
7493575|NCT03552549|25983709|P2|Overall Study|Unknown (no reason provided)|2
7493576|NCT03552549|25983710|P1|Overall Study|Unknown (no reason provided)|4
7493577|NCT03552549|25983709|P2|Overall Study|Withdrawal by Subject|7
7493578|NCT03552549|25983710|P1|Overall Study|Withdrawal by Subject|7
7493579|NCT03552549|25983709|P2|Overall Study|Adverse event in first 12 months|8
7493580|NCT03552549|25983710|P1|Overall Study|Adverse event in first 12 months|12
7493581|NCT03552549|25983709|P2|Overall Study|Disease progression|17
7493582|NCT03552549|25983710|P1|Overall Study|Disease progression|25
7493583|NCT03552523|25983748|P2|Overall Study|Withdrawal by Subject|1
7493584|NCT03552523|25983749|P1|Overall Study|Withdrawal by Subject|1
7493585|NCT03551743|25983775|P4|Overall Study|Withdrawal by Subject|0
7493586|NCT03551743|25983776|P3|Overall Study|Withdrawal by Subject|0
7493587|NCT03551743|25983777|P2|Overall Study|Withdrawal by Subject|0
7493588|NCT03551743|25983778|P1|Overall Study|Withdrawal by Subject|1
7493589|NCT03551743|25983775|P4|Overall Study|Adverse Event|0
7493590|NCT03551743|25983776|P3|Overall Study|Adverse Event|0
7493591|NCT03551743|25983777|P2|Overall Study|Adverse Event|0
7493592|NCT03551743|25983778|P1|Overall Study|Adverse Event|1
7493593|NCT03551730|25983824|P4|Overall Study|Adverse Event|0
7493594|NCT03551730|25983825|P3|Overall Study|Adverse Event|0
7493595|NCT03551730|25983826|P2|Overall Study|Adverse Event|0
7493596|NCT03551730|25983827|P1|Overall Study|Adverse Event|1
7493597|NCT03550378|25983949|P2|Overall Study|Death|1
7493598|NCT03550378|25983950|P1|Overall Study|Death|0
7493599|NCT03550209|25983992|P4|Overall Study|Excluded due to ineligibility after randomization|2
7493600|NCT03550209|25983993|P3|Overall Study|Excluded due to ineligibility after randomization|0
7493601|NCT03550209|25983994|P2|Overall Study|Excluded due to ineligibility after randomization|0
7493602|NCT03550209|25983995|P1|Overall Study|Excluded due to ineligibility after randomization|0
7493603|NCT03550209|25983992|P4|Overall Study|Withdrawal by Subject|2
7493604|NCT03550209|25983993|P3|Overall Study|Withdrawal by Subject|1
7493605|NCT03550209|25983994|P2|Overall Study|Withdrawal by Subject|3
7493606|NCT03550209|25983995|P1|Overall Study|Withdrawal by Subject|0
7493607|NCT03550209|25983992|P4|Overall Study|Lost to Follow-up|0
7493608|NCT03550209|25983993|P3|Overall Study|Lost to Follow-up|1
7493609|NCT03550209|25983994|P2|Overall Study|Lost to Follow-up|0
7493610|NCT03550209|25983995|P1|Overall Study|Lost to Follow-up|1
7493611|NCT03549429|25984038|P2|Overall Study|Protocol Violation|3
7493612|NCT03549429|25984039|P1|Overall Study|Protocol Violation|5
7493613|NCT03549338|25984052|P3|Overall Study|Clinical Progression|0
7493614|NCT03549338|25984053|P2|Overall Study|Clinical Progression|1
7493615|NCT03549338|25984054|P1|Overall Study|Clinical Progression|0
7493616|NCT03549338|25984052|P3|Overall Study|Progressive Disease|0
7493617|NCT03549338|25984053|P2|Overall Study|Progressive Disease|0
7493618|NCT03549338|25984054|P1|Overall Study|Progressive Disease|1
7493619|NCT03549130|25984081|P2|Overall Study|Lost to Follow-up|1
7493620|NCT03549130|25984082|P1|Overall Study|Lost to Follow-up|0
7493621|NCT03549130|25984081|P2|Overall Study|Adverse Event|1
7493622|NCT03549130|25984082|P1|Overall Study|Adverse Event|0
7493623|NCT03549117|25984100|P2|Overall Study|Withdrawal by Subject|0
7493624|NCT03549117|25984101|P1|Overall Study|Withdrawal by Subject|1
7493625|NCT03548987|25984129|P2|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
7493626|NCT03548987|25984130|P1|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
7493627|NCT03548987|25984129|P2|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
7493628|NCT03548987|25984130|P1|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
7493629|NCT03548987|25984129|P2|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
7493630|NCT03548987|25984130|P1|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
7493631|NCT03548987|25984129|P2|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
7493632|NCT03548987|25984130|P1|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
7493633|NCT03548987|25984129|P2|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
7493634|NCT03548987|25984130|P1|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
7493635|NCT03548987|25984129|P2|Maintenance Period (Week 20 to Week 68)|other|23
7493636|NCT03548987|25984130|P1|Maintenance Period (Week 20 to Week 68)|other|12
7493637|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Adverse Event|0
7493638|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Adverse Event|48
7493639|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
7493640|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
7493641|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Pregnancy|0
7493642|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Pregnancy|1
7493643|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Run-in failure|0
7493644|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Run-in failure|19
7493645|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
7493646|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
7493647|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
7493648|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
7493649|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
7493650|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
7493651|NCT03548987|25984129|P2|Run-in Period (Week 0 to Week 20)|Other|0
7493652|NCT03548987|25984130|P1|Run-in Period (Week 0 to Week 20)|Other|9
7493653|NCT03548935|25984211|P2|Overall Study|Death|1
7493654|NCT03548935|25984212|P1|Overall Study|Death|1
7493655|NCT03548935|25984211|P2|Overall Study|Lost to Follow-up|28
7493656|NCT03548935|25984212|P1|Overall Study|Lost to Follow-up|39
7493657|NCT03548935|25984211|P2|Overall Study|Withdrawal by Subject|17
7493658|NCT03548935|25984212|P1|Overall Study|Withdrawal by Subject|26
7493659|NCT03548337|25984302|P2|Toddler Dose|Withdrawal by parent/guardian|1
7493660|NCT03548337|25984303|P1|Toddler Dose|Withdrawal by parent/guardian|1
7493661|NCT03548337|25984302|P2|Infant Series|Randomized but Not Vaccinated|0
7493662|NCT03548337|25984303|P1|Infant Series|Randomized but Not Vaccinated|1
7493663|NCT03548337|25984302|P2|Infant Series|Adverse Event|2
7493664|NCT03548337|25984303|P1|Infant Series|Adverse Event|0
7493665|NCT03548337|25984302|P2|Infant Series|Lost to Follow-up|1
7493666|NCT03548337|25984303|P1|Infant Series|Lost to Follow-up|2
7493667|NCT03548337|25984302|P2|Infant Series|No Longer Met Eligibility Criteria|0
7493668|NCT03548337|25984303|P1|Infant Series|No Longer Met Eligibility Criteria|1
7493669|NCT03548337|25984302|P2|Infant Series|Withdrawal by Parent/Guardian|8
7493670|NCT03548337|25984303|P1|Infant Series|Withdrawal by Parent/Guardian|8
7493671|NCT03547687|25984351|P1|Overall Study|Death|1
7493672|NCT03547687|25984351|P1|Overall Study|Withdrawal by Subject|1
7493673|NCT03547635|25984362|P3|Overall Study|Withdrawal by Subject|0
7493674|NCT03547635|25984363|P2|Overall Study|Withdrawal by Subject|0
7493675|NCT03547635|25984364|P1|Overall Study|Withdrawal by Subject|1
7493676|NCT03547635|25984362|P3|Overall Study|Errant Randomization before Treatment|0
7493677|NCT03547635|25984363|P2|Overall Study|Errant Randomization before Treatment|1
7493678|NCT03547635|25984364|P1|Overall Study|Errant Randomization before Treatment|0
7493679|NCT03547635|25984362|P3|Overall Study|Withdrawal by Sponsor|1
7493680|NCT03547635|25984363|P2|Overall Study|Withdrawal by Sponsor|0
7493681|NCT03547635|25984364|P1|Overall Study|Withdrawal by Sponsor|0
7493682|NCT03547635|25984362|P3|Overall Study|Withdrawal By PI|0
7493683|NCT03547635|25984363|P2|Overall Study|Withdrawal By PI|1
7493684|NCT03547635|25984364|P1|Overall Study|Withdrawal By PI|0
7493685|NCT03547635|25984362|P3|Overall Study|Withdrawal by Subject|0
7493686|NCT03547635|25984363|P2|Overall Study|Withdrawal by Subject|0
7493687|NCT03547635|25984364|P1|Overall Study|Withdrawal by Subject|1
7493688|NCT03547635|25984362|P3|Overall Study|Lost to Follow-up|4
7493689|NCT03547635|25984363|P2|Overall Study|Lost to Follow-up|3
7493690|NCT03547635|25984364|P1|Overall Study|Lost to Follow-up|1
7493691|NCT03547635|25984362|P3|Overall Study|Adverse Event|3
7493692|NCT03547635|25984363|P2|Overall Study|Adverse Event|2
7493693|NCT03547635|25984364|P1|Overall Study|Adverse Event|5
7493694|NCT03547583|25984375|P3|Overall Study|Other|3
7493695|NCT03547583|25984376|P2|Overall Study|Other|2
7493696|NCT03547583|25984377|P1|Overall Study|Other|2
7493697|NCT03547583|25984375|P3|Overall Study|Withdrawal by Subject|10
7493698|NCT03547583|25984376|P2|Overall Study|Withdrawal by Subject|19
7493699|NCT03547583|25984377|P1|Overall Study|Withdrawal by Subject|12
7493700|NCT03547583|25984375|P3|Overall Study|Protocol Violation|1
7493701|NCT03547583|25984376|P2|Overall Study|Protocol Violation|1
7493702|NCT03547583|25984377|P1|Overall Study|Protocol Violation|2
7493703|NCT03547583|25984375|P3|Overall Study|Physician Decision|3
7493704|NCT03547583|25984376|P2|Overall Study|Physician Decision|0
7493705|NCT03547583|25984377|P1|Overall Study|Physician Decision|1
7493706|NCT03547583|25984375|P3|Overall Study|Non-compliance with study drug|1
7493707|NCT03547583|25984376|P2|Overall Study|Non-compliance with study drug|0
7493708|NCT03547583|25984377|P1|Overall Study|Non-compliance with study drug|0
7493709|NCT03547583|25984375|P3|Overall Study|Lost to Follow-up|0
7493710|NCT03547583|25984376|P2|Overall Study|Lost to Follow-up|0
7493711|NCT03547583|25984377|P1|Overall Study|Lost to Follow-up|1
7493712|NCT03547583|25984375|P3|Overall Study|Death|4
7493713|NCT03547583|25984376|P2|Overall Study|Death|7
7493714|NCT03547583|25984377|P1|Overall Study|Death|11
7493715|NCT03547583|25984375|P3|Overall Study|Adverse Event|10
7493716|NCT03547583|25984376|P2|Overall Study|Adverse Event|11
7493717|NCT03547583|25984377|P1|Overall Study|Adverse Event|16
7493718|NCT03547531|25984393|P2|Overall Study|having family occasion|2
7493719|NCT03547531|25984394|P1|Overall Study|having family occasion|0
7493720|NCT03547531|25984393|P2|Overall Study|not coming in data collection : sick|2
7493721|NCT03547531|25984394|P1|Overall Study|not coming in data collection : sick|2
7493722|NCT03547167|25984408|P2|Overall Study|Death|2
7493723|NCT03547167|25984409|P1|Overall Study|Death|4
7493724|NCT03547167|25984408|P2|Overall Study|Lost to Follow-up|15
7493725|NCT03547167|25984409|P1|Overall Study|Lost to Follow-up|59
7493726|NCT03547167|25984408|P2|Overall Study|Screen Failure|1
7493727|NCT03547167|25984409|P1|Overall Study|Screen Failure|0
7493728|NCT03547167|25984408|P2|Overall Study|Withdrawal by Subject|12
7493729|NCT03547167|25984409|P1|Overall Study|Withdrawal by Subject|34
7493730|NCT03547154|25984461|P2|Overall Study|Continued treatment beyond 12 mo.|50
7493731|NCT03547154|25984462|P1|Overall Study|Continued treatment beyond 12 mo.|58
7493732|NCT03547154|25984461|P2|Overall Study|Not Selected|1
7493733|NCT03547154|25984462|P1|Overall Study|Not Selected|0
7493734|NCT03547154|25984461|P2|Overall Study|Withdrawal by Subject|6
7493735|NCT03547154|25984462|P1|Overall Study|Withdrawal by Subject|10
7493736|NCT03547154|25984461|P2|Overall Study|Insufficient Therapeutic Response|10
7493737|NCT03547154|25984462|P1|Overall Study|Insufficient Therapeutic Response|13
7493738|NCT03547154|25984461|P2|Overall Study|Physician Decision|3
7493739|NCT03547154|25984462|P1|Overall Study|Physician Decision|4
7493740|NCT03547154|25984461|P2|Overall Study|Protocol Violation|1
7493741|NCT03547154|25984462|P1|Overall Study|Protocol Violation|6
7493742|NCT03547154|25984461|P2|Overall Study|Adverse Event|31
7493743|NCT03547154|25984462|P1|Overall Study|Adverse Event|26
7493744|NCT03547154|25984461|P2|Overall Study|Disease Progression/Recurrence|14
7493745|NCT03547154|25984462|P1|Overall Study|Disease Progression/Recurrence|6
7493746|NCT03546842|25984474|P1|Overall Study|Withdrawal by Subject|2
7493747|NCT03546842|25984474|P1|Overall Study|Protocol Violation|1
7493748|NCT03546816|25984485|P2|Overall Study|Lost to Follow-up|2
7493749|NCT03546816|25984486|P1|Overall Study|Lost to Follow-up|3
7493750|NCT03546816|25984485|P2|Overall Study|Withdrawal by Subject|10
7493751|NCT03546816|25984486|P1|Overall Study|Withdrawal by Subject|8
7493752|NCT03546816|25984485|P2|Overall Study|Physician Decision|0
7493753|NCT03546816|25984486|P1|Overall Study|Physician Decision|2
7493754|NCT03546816|25984485|P2|Overall Study|Pregnancy|0
7493755|NCT03546816|25984486|P1|Overall Study|Pregnancy|1
7493756|NCT03546816|25984485|P2|Overall Study|Lack of Efficacy|4
7493757|NCT03546816|25984486|P1|Overall Study|Lack of Efficacy|2
7493758|NCT03546816|25984485|P2|Overall Study|Adverse Event|3
7493759|NCT03546816|25984486|P1|Overall Study|Adverse Event|5
7493760|NCT03546647|25984510|P2|Overall Study|Adverse Event|0
7493761|NCT03546647|25984511|P1|Overall Study|Adverse Event|1
7493762|NCT03546621|25984521|P4|Overall Study|Progressive disease|1
7493763|NCT03546621|25984522|P3|Overall Study|Progressive disease|0
7493764|NCT03546621|25984523|P2|Overall Study|Progressive disease|0
7493765|NCT03546621|25984524|P1|Overall Study|Progressive disease|0
7493766|NCT03546621|25984521|P4|Overall Study|Adverse Event|1
7493767|NCT03546621|25984522|P3|Overall Study|Adverse Event|0
7493768|NCT03546621|25984523|P2|Overall Study|Adverse Event|1
7493769|NCT03546621|25984524|P1|Overall Study|Adverse Event|0
7493770|NCT03546621|25984521|P4|Overall Study|Lost to Follow-up|0
7493771|NCT03546621|25984522|P3|Overall Study|Lost to Follow-up|0
7493772|NCT03546621|25984523|P2|Overall Study|Lost to Follow-up|1
7493773|NCT03546621|25984524|P1|Overall Study|Lost to Follow-up|0
7493774|NCT03546621|25984521|P4|Overall Study|Withdrawal by Subject|1
7493775|NCT03546621|25984522|P3|Overall Study|Withdrawal by Subject|2
7493776|NCT03546621|25984523|P2|Overall Study|Withdrawal by Subject|1
7493777|NCT03546621|25984524|P1|Overall Study|Withdrawal by Subject|0
7493778|NCT03545984|25984618|P2|Overall Study|CSF cases not present during rotation|9
7493779|NCT03545984|25984619|P1|Overall Study|CSF cases not present during rotation|11
7493780|NCT03544333|25984690|P2|Overall Study|Withdrawal by Subject|0
7493781|NCT03544333|25984691|P1|Overall Study|Withdrawal by Subject|1
7493782|NCT03543358|25984772|P2|Overall Study|Parent Study Closure|0
7493783|NCT03543358|25984773|P1|Overall Study|Parent Study Closure|1
7493784|NCT03543358|25984772|P2|Overall Study|Disease Progression|0
7493785|NCT03543358|25984773|P1|Overall Study|Disease Progression|1
7493786|NCT03543358|25984772|P2|Overall Study|Death|0
7493787|NCT03543358|25984773|P1|Overall Study|Death|1
7493788|NCT03543137|25984822|P2|Study Period 2: Up to Day 8|Adverse Event|1
7493789|NCT03543137|25984823|P1|Study Period 2: Up to Day 8|Adverse Event|0
7493790|NCT03543137|25984822|P2|Study Period 2: Up to Day 8|Protocol Violation|0
7493791|NCT03543137|25984823|P1|Study Period 2: Up to Day 8|Protocol Violation|1
7493792|NCT03543137|25984822|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7493793|NCT03543137|25984823|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7493794|NCT03542266|25984914|P1|Treatment Phase|PD|1
7493795|NCT03542266|25984914|P1|Treatment Phase|Adverse Event|1
7493796|NCT03542266|25984914|P1|Treatment Phase|Withdrawal by Subject|1
7493797|NCT03541317|25985062|P6|Stage 2 of the Implementation|Withdrawal by Subject|0
7493798|NCT03541317|25985063|P5|Stage 2 of the Implementation|Withdrawal by Subject|0
7493799|NCT03541317|25985064|P4|Stage 2 of the Implementation|Withdrawal by Subject|0
7493800|NCT03541317|25985065|P3|Stage 2 of the Implementation|Withdrawal by Subject|0
7493801|NCT03541317|25985066|P2|Stage 2 of the Implementation|Withdrawal by Subject|0
7493802|NCT03541317|25985067|P1|Stage 2 of the Implementation|Withdrawal by Subject|1
7493803|NCT03541044|25985083|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7493804|NCT03541044|25985084|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7493805|NCT03541044|25985083|P2|Study Period 2: Up to Day 8|Protocol Violation|0
7493806|NCT03541044|25985084|P1|Study Period 2: Up to Day 8|Protocol Violation|1
7493807|NCT03540160|25985104|P1|Overall Study|Sponsor decision|191
7493808|NCT03540160|25985104|P1|Overall Study|Lost to Follow-up|18
7493809|NCT03540160|25985104|P1|Overall Study|Study Closure|10
7493810|NCT03540160|25985104|P1|Overall Study|COVID-19|2
7493811|NCT03540160|25985104|P1|Overall Study|Withdrawal by Subject|68
7493812|NCT03540160|25985104|P1|Overall Study|Adverse Event|20
7493813|NCT03540160|25985104|P1|Overall Study|Pregnancy|1
7493814|NCT03540160|25985104|P1|Overall Study|Lack of Efficacy|60
7493815|NCT03540160|25985104|P1|Overall Study|Physician Decision|8
7493816|NCT03540160|25985104|P1|Overall Study|Protocol Violation|1
7493817|NCT03540030|25985135|P2|Overall Study|never had surgery after signing consent|1
7493818|NCT03540030|25985136|P1|Overall Study|never had surgery after signing consent|9
7493819|NCT03540030|25985135|P2|Overall Study|screen fail|1
7493820|NCT03540030|25985136|P1|Overall Study|screen fail|7
7493821|NCT03540030|25985135|P2|Overall Study|Withdrawal by Subject|1
7493822|NCT03540030|25985136|P1|Overall Study|Withdrawal by Subject|2
7493823|NCT03539549|25985172|P1|Overall Study|Reason not Specified|1
7493824|NCT03539549|25985172|P1|Overall Study|Progressive Disease|1
7493825|NCT03539549|25985172|P1|Overall Study|Death|2
7493826|NCT03539549|25985172|P1|Overall Study|Lost to Follow-up|1
7493827|NCT03539549|25985172|P1|Overall Study|Adverse Event|12
7493828|NCT03539484|25985187|P7|Overall Study|Study Terminated by Sponsor|1
7493829|NCT03539484|25985188|P6|Overall Study|Study Terminated by Sponsor|2
7493830|NCT03539484|25985189|P5|Overall Study|Study Terminated by Sponsor|2
7493831|NCT03539484|25985190|P4|Overall Study|Study Terminated by Sponsor|1
7493832|NCT03539484|25985191|P3|Overall Study|Study Terminated by Sponsor|1
7493833|NCT03539484|25985192|P2|Overall Study|Study Terminated by Sponsor|0
7493834|NCT03539484|25985193|P1|Overall Study|Study Terminated by Sponsor|0
7493835|NCT03539484|25985187|P7|Overall Study|Withdrawal by Subject|1
7493836|NCT03539484|25985188|P6|Overall Study|Withdrawal by Subject|0
7493837|NCT03539484|25985189|P5|Overall Study|Withdrawal by Subject|2
7493838|NCT03539484|25985190|P4|Overall Study|Withdrawal by Subject|0
7493839|NCT03539484|25985191|P3|Overall Study|Withdrawal by Subject|0
7493840|NCT03539484|25985192|P2|Overall Study|Withdrawal by Subject|0
7493841|NCT03539484|25985193|P1|Overall Study|Withdrawal by Subject|0
7493842|NCT03539484|25985187|P7|Overall Study|Lost to Follow-up|0
7493843|NCT03539484|25985188|P6|Overall Study|Lost to Follow-up|0
7493844|NCT03539484|25985189|P5|Overall Study|Lost to Follow-up|1
7493845|NCT03539484|25985190|P4|Overall Study|Lost to Follow-up|0
7493846|NCT03539484|25985191|P3|Overall Study|Lost to Follow-up|0
7493847|NCT03539484|25985192|P2|Overall Study|Lost to Follow-up|1
7493848|NCT03539484|25985193|P1|Overall Study|Lost to Follow-up|0
7493849|NCT03539484|25985187|P7|Overall Study|Death|0
7493850|NCT03539484|25985188|P6|Overall Study|Death|3
7493851|NCT03539484|25985189|P5|Overall Study|Death|8
7493852|NCT03539484|25985190|P4|Overall Study|Death|2
7493853|NCT03539484|25985191|P3|Overall Study|Death|0
7493854|NCT03539484|25985192|P2|Overall Study|Death|0
7493855|NCT03539484|25985193|P1|Overall Study|Death|1
7493856|NCT03539458|25985327|P1|Overall Study|Death|1
7493857|NCT03538743|25985382|P9|Overall Study|Withdrawal by Subject|0
7493858|NCT03538743|25985383|P8|Overall Study|Withdrawal by Subject|0
7493859|NCT03538743|25985384|P7|Overall Study|Withdrawal by Subject|0
7493860|NCT03538743|25985385|P6|Overall Study|Withdrawal by Subject|0
7493861|NCT03538743|25985386|P5|Overall Study|Withdrawal by Subject|0
7493862|NCT03538743|25985387|P4|Overall Study|Withdrawal by Subject|1
7493863|NCT03538743|25985388|P3|Overall Study|Withdrawal by Subject|0
7493864|NCT03538743|25985389|P2|Overall Study|Withdrawal by Subject|0
7493865|NCT03538743|25985390|P1|Overall Study|Withdrawal by Subject|0
7493866|NCT03538743|25985382|P9|Overall Study|Non-Treatment-Related Reasons|3
7493867|NCT03538743|25985383|P8|Overall Study|Non-Treatment-Related Reasons|0
7493868|NCT03538743|25985384|P7|Overall Study|Non-Treatment-Related Reasons|0
7493869|NCT03538743|25985385|P6|Overall Study|Non-Treatment-Related Reasons|0
7493870|NCT03538743|25985386|P5|Overall Study|Non-Treatment-Related Reasons|0
7493871|NCT03538743|25985387|P4|Overall Study|Non-Treatment-Related Reasons|0
7493872|NCT03538743|25985388|P3|Overall Study|Non-Treatment-Related Reasons|0
7493873|NCT03538743|25985389|P2|Overall Study|Non-Treatment-Related Reasons|0
7493874|NCT03538743|25985390|P1|Overall Study|Non-Treatment-Related Reasons|0
7493875|NCT03538743|25985382|P9|Overall Study|Adverse Event|0
7493876|NCT03538743|25985383|P8|Overall Study|Adverse Event|0
7493877|NCT03538743|25985384|P7|Overall Study|Adverse Event|0
7493878|NCT03538743|25985385|P6|Overall Study|Adverse Event|0
7493879|NCT03538743|25985386|P5|Overall Study|Adverse Event|0
7493880|NCT03538743|25985387|P4|Overall Study|Adverse Event|1
7493881|NCT03538743|25985388|P3|Overall Study|Adverse Event|1
7493882|NCT03538743|25985389|P2|Overall Study|Adverse Event|0
7493883|NCT03538743|25985390|P1|Overall Study|Adverse Event|0
7493884|NCT03538431|25985570|P2|Overall Study|Withdrawal by Subject|0
7493885|NCT03538431|25985571|P1|Overall Study|Withdrawal by Subject|1
7493886|NCT03538431|25985570|P2|Overall Study|Physician Decision|1
7493887|NCT03538431|25985571|P1|Overall Study|Physician Decision|0
7493888|NCT03537261|25985691|P2|Overall Study|Did not return study questionnaires|1
7493889|NCT03537261|25985692|P1|Overall Study|Did not return study questionnaires|0
7493890|NCT03537261|25985691|P2|Overall Study|Withdrawal by Subject|6
7493891|NCT03537261|25985692|P1|Overall Study|Withdrawal by Subject|4
7493892|NCT03537261|25985691|P2|Overall Study|Lost to Follow-up|5
7493893|NCT03537261|25985692|P1|Overall Study|Lost to Follow-up|4
7493894|NCT03536949|25985722|P2|Overall Study|Non-compliance|1
7493895|NCT03536949|25985723|P1|Overall Study|Non-compliance|2
7493896|NCT03536949|25985722|P2|Overall Study|Withdrawal by Subject|0
7493897|NCT03536949|25985723|P1|Overall Study|Withdrawal by Subject|6
7493898|NCT03536949|25985722|P2|Overall Study|Lost to Follow-up|1
7493899|NCT03536949|25985723|P1|Overall Study|Lost to Follow-up|2
7493900|NCT03536949|25985722|P2|Overall Study|Adverse Event|0
7493901|NCT03536949|25985723|P1|Overall Study|Adverse Event|4
7493902|NCT03536663|25985786|P1|Endexo|Protocol Violation|1
7493903|NCT03535974|25985804|P3|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
7493904|NCT03535974|25985805|P2|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
7493905|NCT03535974|25985806|P1|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
7493906|NCT03535974|25985804|P3|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7493907|NCT03535974|25985805|P2|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
7493908|NCT03535974|25985806|P1|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7493909|NCT03535844|25985816|P2|Overall Study|Withdrawal by Subject|1
7493910|NCT03535844|25985817|P1|Overall Study|Withdrawal by Subject|0
7493911|NCT03535194|25985896|P5|Post-Treatment Followup Period|Withdrawal by Subject|0
7493912|NCT03535194|25985897|P4|Post-Treatment Followup Period|Withdrawal by Subject|6
7493913|NCT03535194|25985898|P3|Post-Treatment Followup Period|Withdrawal by Subject|3
7493914|NCT03535194|25985899|P2|Post-Treatment Followup Period|Withdrawal by Subject|2
7493915|NCT03535194|25985900|P1|Post-Treatment Followup Period|Withdrawal by Subject|2
7493916|NCT03535194|25985896|P5|Post-Treatment Followup Period|Physician Decision|0
7493917|NCT03535194|25985897|P4|Post-Treatment Followup Period|Physician Decision|1
7493918|NCT03535194|25985898|P3|Post-Treatment Followup Period|Physician Decision|1
7493919|NCT03535194|25985899|P2|Post-Treatment Followup Period|Physician Decision|2
7493920|NCT03535194|25985900|P1|Post-Treatment Followup Period|Physician Decision|0
7493921|NCT03535194|25985896|P5|Post-Treatment Followup Period|Other|0
7493922|NCT03535194|25985897|P4|Post-Treatment Followup Period|Other|5
7493923|NCT03535194|25985898|P3|Post-Treatment Followup Period|Other|0
7493924|NCT03535194|25985899|P2|Post-Treatment Followup Period|Other|0
7493925|NCT03535194|25985900|P1|Post-Treatment Followup Period|Other|1
7493926|NCT03535194|25985896|P5|Post-Treatment Followup Period|Lost to Follow-up|0
7493927|NCT03535194|25985897|P4|Post-Treatment Followup Period|Lost to Follow-up|0
7493928|NCT03535194|25985898|P3|Post-Treatment Followup Period|Lost to Follow-up|1
7493929|NCT03535194|25985899|P2|Post-Treatment Followup Period|Lost to Follow-up|1
7493930|NCT03535194|25985900|P1|Post-Treatment Followup Period|Lost to Follow-up|1
7493931|NCT03535194|25985896|P5|Post-Treatment Followup Period|Lack of Efficacy|0
7493932|NCT03535194|25985897|P4|Post-Treatment Followup Period|Lack of Efficacy|4
7493933|NCT03535194|25985898|P3|Post-Treatment Followup Period|Lack of Efficacy|5
7493934|NCT03535194|25985899|P2|Post-Treatment Followup Period|Lack of Efficacy|4
7493935|NCT03535194|25985900|P1|Post-Treatment Followup Period|Lack of Efficacy|3
7493936|NCT03535194|25985896|P5|Post-Treatment Followup Period|Adverse Event|0
7493937|NCT03535194|25985897|P4|Post-Treatment Followup Period|Adverse Event|8
7493938|NCT03535194|25985898|P3|Post-Treatment Followup Period|Adverse Event|1
7493939|NCT03535194|25985899|P2|Post-Treatment Followup Period|Adverse Event|5
7493940|NCT03535194|25985900|P1|Post-Treatment Followup Period|Adverse Event|4
7493941|NCT03535194|25985896|P5|Maintenance Period|Withdrawal by Subject|0
7493942|NCT03535194|25985897|P4|Maintenance Period|Withdrawal by Subject|8
7493943|NCT03535194|25985898|P3|Maintenance Period|Withdrawal by Subject|1
7493944|NCT03535194|25985899|P2|Maintenance Period|Withdrawal by Subject|2
7493945|NCT03535194|25985900|P1|Maintenance Period|Withdrawal by Subject|7
7493946|NCT03535194|25985896|P5|Maintenance Period|Protocol Violation|0
7493947|NCT03535194|25985897|P4|Maintenance Period|Protocol Violation|0
7493948|NCT03535194|25985898|P3|Maintenance Period|Protocol Violation|0
7493949|NCT03535194|25985899|P2|Maintenance Period|Protocol Violation|1
7493950|NCT03535194|25985900|P1|Maintenance Period|Protocol Violation|0
7493951|NCT03535194|25985896|P5|Maintenance Period|Pregnancy|0
7493952|NCT03535194|25985897|P4|Maintenance Period|Pregnancy|2
7493953|NCT03535194|25985898|P3|Maintenance Period|Pregnancy|0
7493954|NCT03535194|25985899|P2|Maintenance Period|Pregnancy|0
7493955|NCT03535194|25985900|P1|Maintenance Period|Pregnancy|0
7493956|NCT03535194|25985896|P5|Maintenance Period|Physician Decision|0
7493957|NCT03535194|25985897|P4|Maintenance Period|Physician Decision|2
7493958|NCT03535194|25985898|P3|Maintenance Period|Physician Decision|0
7493959|NCT03535194|25985899|P2|Maintenance Period|Physician Decision|2
7493960|NCT03535194|25985900|P1|Maintenance Period|Physician Decision|1
7493961|NCT03535194|25985896|P5|Maintenance Period|Other|0
7493962|NCT03535194|25985897|P4|Maintenance Period|Other|0
7493963|NCT03535194|25985898|P3|Maintenance Period|Other|0
7493964|NCT03535194|25985899|P2|Maintenance Period|Other|2
7493965|NCT03535194|25985900|P1|Maintenance Period|Other|1
7493966|NCT03535194|25985896|P5|Maintenance Period|Lost to Follow-up|2
7493967|NCT03535194|25985897|P4|Maintenance Period|Lost to Follow-up|5
7493968|NCT03535194|25985898|P3|Maintenance Period|Lost to Follow-up|1
7493969|NCT03535194|25985899|P2|Maintenance Period|Lost to Follow-up|2
7493970|NCT03535194|25985900|P1|Maintenance Period|Lost to Follow-up|4
7493971|NCT03535194|25985896|P5|Maintenance Period|Lack of Efficacy|0
7493972|NCT03535194|25985897|P4|Maintenance Period|Lack of Efficacy|9
7493973|NCT03535194|25985898|P3|Maintenance Period|Lack of Efficacy|5
7493974|NCT03535194|25985899|P2|Maintenance Period|Lack of Efficacy|2
7493975|NCT03535194|25985900|P1|Maintenance Period|Lack of Efficacy|3
7493976|NCT03535194|25985896|P5|Maintenance Period|Adverse Event|4
7493977|NCT03535194|25985897|P4|Maintenance Period|Adverse Event|11
7493978|NCT03535194|25985898|P3|Maintenance Period|Adverse Event|1
7493979|NCT03535194|25985899|P2|Maintenance Period|Adverse Event|5
7493980|NCT03535194|25985900|P1|Maintenance Period|Adverse Event|6
7493981|NCT03535194|25985896|P5|Induction Period|Withdrawal by Subject|0
7493982|NCT03535194|25985897|P4|Induction Period|Withdrawal by Subject|2
7493983|NCT03535194|25985898|P3|Induction Period|Withdrawal by Subject|3
7493984|NCT03535194|25985899|P2|Induction Period|Withdrawal by Subject|4
7493985|NCT03535194|25985900|P1|Induction Period|Withdrawal by Subject|3
7493986|NCT03535194|25985896|P5|Induction Period|Screen Failure|0
7493987|NCT03535194|25985897|P4|Induction Period|Screen Failure|0
7493988|NCT03535194|25985898|P3|Induction Period|Screen Failure|0
7493989|NCT03535194|25985899|P2|Induction Period|Screen Failure|1
7493990|NCT03535194|25985900|P1|Induction Period|Screen Failure|0
7493991|NCT03535194|25985896|P5|Induction Period|Protocol Violation|0
7493992|NCT03535194|25985897|P4|Induction Period|Protocol Violation|1
7493993|NCT03535194|25985898|P3|Induction Period|Protocol Violation|0
7493994|NCT03535194|25985899|P2|Induction Period|Protocol Violation|0
7493995|NCT03535194|25985900|P1|Induction Period|Protocol Violation|1
7493996|NCT03535194|25985896|P5|Induction Period|Physician Decision|0
7493997|NCT03535194|25985897|P4|Induction Period|Physician Decision|0
7493998|NCT03535194|25985898|P3|Induction Period|Physician Decision|0
7493999|NCT03535194|25985899|P2|Induction Period|Physician Decision|1
7494000|NCT03535194|25985900|P1|Induction Period|Physician Decision|1
7494001|NCT03535194|25985896|P5|Induction Period|Lost to Follow-up|0
7494002|NCT03535194|25985897|P4|Induction Period|Lost to Follow-up|3
7494003|NCT03535194|25985898|P3|Induction Period|Lost to Follow-up|2
7494004|NCT03535194|25985899|P2|Induction Period|Lost to Follow-up|5
7494005|NCT03535194|25985900|P1|Induction Period|Lost to Follow-up|3
7494006|NCT03535194|25985896|P5|Induction Period|Lack of Efficacy|0
7494007|NCT03535194|25985897|P4|Induction Period|Lack of Efficacy|2
7494008|NCT03535194|25985898|P3|Induction Period|Lack of Efficacy|2
7494009|NCT03535194|25985899|P2|Induction Period|Lack of Efficacy|3
7494010|NCT03535194|25985900|P1|Induction Period|Lack of Efficacy|1
7494011|NCT03535194|25985896|P5|Induction Period|Death|0
7494012|NCT03535194|25985897|P4|Induction Period|Death|0
7494013|NCT03535194|25985898|P3|Induction Period|Death|0
7494014|NCT03535194|25985899|P2|Induction Period|Death|1
7494015|NCT03535194|25985900|P1|Induction Period|Death|0
7494016|NCT03535194|25985896|P5|Induction Period|Adverse Event|0
7494017|NCT03535194|25985897|P4|Induction Period|Adverse Event|3
7494018|NCT03535194|25985898|P3|Induction Period|Adverse Event|1
7494019|NCT03535194|25985899|P2|Induction Period|Adverse Event|2
7494020|NCT03535194|25985900|P1|Induction Period|Adverse Event|2
7494021|NCT03533608|25986139|P1|Overall Study|Physician Decision|2
7494022|NCT03533608|25986139|P1|Overall Study|Withdrawal by Subject|3
7494023|NCT03532451|25986207|P2|Overall Study|Progression prior to the surgery|0
7494024|NCT03532451|25986208|P1|Overall Study|Progression prior to the surgery|1
7494025|NCT03532451|25986207|P2|Overall Study|Withdrawal by Subject|1
7494026|NCT03532451|25986208|P1|Overall Study|Withdrawal by Subject|0
7494027|NCT03532048|25986237|P2|Overall Study|Withdrawal by Subject|0
7494028|NCT03532048|25986238|P1|Overall Study|Withdrawal by Subject|7
7494029|NCT03532048|25986237|P2|Overall Study|Lost to Follow-up|17
7494030|NCT03532048|25986238|P1|Overall Study|Lost to Follow-up|12
7494031|NCT03532009|25986254|P2|Overall Study|Withdrawal by Patient|2
7494032|NCT03532009|25986255|P1|Overall Study|Withdrawal by Patient|0
7494033|NCT03532009|25986254|P2|Overall Study|Death|1
7494034|NCT03532009|25986255|P1|Overall Study|Death|1
7494035|NCT03532009|25986254|P2|Overall Study|Other|1
7494036|NCT03532009|25986255|P1|Overall Study|Other|1
7494037|NCT03531905|25986276|P3|Overall Study|Could not speak with the participant|0
7494038|NCT03531905|25986277|P2|Overall Study|Could not speak with the participant|0
7494039|NCT03531905|25986278|P1|Overall Study|Could not speak with the participant|1
7494040|NCT03531905|25986276|P3|Overall Study|Participant was out of town|0
7494041|NCT03531905|25986277|P2|Overall Study|Participant was out of town|0
7494042|NCT03531905|25986278|P1|Overall Study|Participant was out of town|1
7494043|NCT03531905|25986276|P3|Overall Study|Lost to Follow-up|1
7494044|NCT03531905|25986277|P2|Overall Study|Lost to Follow-up|2
7494045|NCT03531905|25986278|P1|Overall Study|Lost to Follow-up|2
7494046|NCT03531905|25986276|P3|Overall Study|Withdrawal by Subject|2
7494047|NCT03531905|25986277|P2|Overall Study|Withdrawal by Subject|3
7494048|NCT03531905|25986278|P1|Overall Study|Withdrawal by Subject|3
7494049|NCT03531840|25986334|P4|Overall Study|Death during follow up|1
7494050|NCT03531840|25986335|P3|Overall Study|Death during follow up|4
7494051|NCT03531840|25986336|P2|Overall Study|Death during follow up|3
7494052|NCT03531840|25986337|P1|Overall Study|Death during follow up|2
7494053|NCT03531840|25986334|P4|Overall Study|Death on study|2
7494054|NCT03531840|25986335|P3|Overall Study|Death on study|1
7494055|NCT03531840|25986336|P2|Overall Study|Death on study|2
7494056|NCT03531840|25986337|P1|Overall Study|Death on study|3
7494057|NCT03530995|25986409|P2|Overall Study|Physician Decision|0
7494058|NCT03530995|25986410|P1|Overall Study|Physician Decision|2
7494059|NCT03530995|25986409|P2|Overall Study|Withdrawal by Subject|0
7494060|NCT03530995|25986410|P1|Overall Study|Withdrawal by Subject|3
7494061|NCT03530345|25986547|P2|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
7494062|NCT03530345|25986548|P1|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
7494063|NCT03530345|25986547|P2|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
7494064|NCT03530345|25986548|P1|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
7494065|NCT03530345|25986547|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7494066|NCT03530345|25986548|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7494067|NCT03530345|25986547|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
7494068|NCT03530345|25986548|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7494069|NCT03529942|25986581|P1|Overall Study|Personal reasons|1
7494070|NCT03529942|25986581|P1|Overall Study|Needle inserted but no drug administered|1
7494071|NCT03529942|25986581|P1|Overall Study|Lost to Follow-up|7
7494072|NCT03529942|25986581|P1|Overall Study|Physician Decision|1
7494073|NCT03529942|25986581|P1|Overall Study|Withdrawal by Subject|13
7494074|NCT03529773|25986633|P40|Overall Study|Withdrawal by Subject|0
7494075|NCT03529773|25986634|P39|Overall Study|Withdrawal by Subject|0
7494076|NCT03529773|25986635|P38|Overall Study|Withdrawal by Subject|1
7494077|NCT03529773|25986636|P37|Overall Study|Withdrawal by Subject|0
7494078|NCT03529773|25986637|P36|Overall Study|Withdrawal by Subject|1
7494079|NCT03529773|25986638|P35|Overall Study|Withdrawal by Subject|1
7494080|NCT03529773|25986639|P34|Overall Study|Withdrawal by Subject|0
7494081|NCT03529773|25986640|P33|Overall Study|Withdrawal by Subject|0
7494082|NCT03529773|25986641|P32|Overall Study|Withdrawal by Subject|0
7494083|NCT03529773|25986642|P31|Overall Study|Withdrawal by Subject|0
7494084|NCT03529773|25986643|P30|Overall Study|Withdrawal by Subject|0
7494085|NCT03529773|25986644|P29|Overall Study|Withdrawal by Subject|1
7494086|NCT03529773|25986645|P28|Overall Study|Withdrawal by Subject|1
7494087|NCT03529773|25986646|P27|Overall Study|Withdrawal by Subject|2
7494088|NCT03529773|25986647|P26|Overall Study|Withdrawal by Subject|4
7494089|NCT03529773|25986648|P25|Overall Study|Withdrawal by Subject|2
7494090|NCT03529773|25986649|P24|Overall Study|Withdrawal by Subject|1
7494091|NCT03529773|25986650|P23|Overall Study|Withdrawal by Subject|1
7494092|NCT03529773|25986651|P22|Overall Study|Withdrawal by Subject|1
7494093|NCT03529773|25986652|P21|Overall Study|Withdrawal by Subject|3
7494094|NCT03529773|25986653|P20|Overall Study|Withdrawal by Subject|1
7494095|NCT03529773|25986654|P19|Overall Study|Withdrawal by Subject|3
7494096|NCT03529773|25986655|P18|Overall Study|Withdrawal by Subject|3
7494097|NCT03529773|25986656|P17|Overall Study|Withdrawal by Subject|0
7494098|NCT03529773|25986657|P16|Overall Study|Withdrawal by Subject|3
7494099|NCT03529773|25986658|P15|Overall Study|Withdrawal by Subject|0
7494100|NCT03529773|25986659|P14|Overall Study|Withdrawal by Subject|0
7494101|NCT03529773|25986660|P13|Overall Study|Withdrawal by Subject|0
7494102|NCT03529773|25986661|P12|Overall Study|Withdrawal by Subject|0
7494103|NCT03529773|25986662|P11|Overall Study|Withdrawal by Subject|1
7494104|NCT03529773|25986663|P10|Overall Study|Withdrawal by Subject|1
7494105|NCT03529773|25986664|P9|Overall Study|Withdrawal by Subject|0
7494106|NCT03529773|25986665|P8|Overall Study|Withdrawal by Subject|1
7494107|NCT03529773|25986666|P7|Overall Study|Withdrawal by Subject|0
7494108|NCT03529773|25986667|P6|Overall Study|Withdrawal by Subject|0
7494109|NCT03529773|25986668|P5|Overall Study|Withdrawal by Subject|0
7494110|NCT03529773|25986669|P4|Overall Study|Withdrawal by Subject|0
7494111|NCT03529773|25986670|P3|Overall Study|Withdrawal by Subject|0
7494112|NCT03529773|25986671|P2|Overall Study|Withdrawal by Subject|0
7494113|NCT03529773|25986672|P1|Overall Study|Withdrawal by Subject|0
7494114|NCT03529773|25986633|P40|Overall Study|Protocol Violation|0
7494115|NCT03529773|25986634|P39|Overall Study|Protocol Violation|0
7494116|NCT03529773|25986635|P38|Overall Study|Protocol Violation|0
7494117|NCT03529773|25986636|P37|Overall Study|Protocol Violation|0
7494118|NCT03529773|25986637|P36|Overall Study|Protocol Violation|0
7494119|NCT03529773|25986638|P35|Overall Study|Protocol Violation|0
7494120|NCT03529773|25986639|P34|Overall Study|Protocol Violation|0
7494121|NCT03529773|25986640|P33|Overall Study|Protocol Violation|0
7494122|NCT03529773|25986641|P32|Overall Study|Protocol Violation|0
7494123|NCT03529773|25986642|P31|Overall Study|Protocol Violation|1
7494124|NCT03529773|25986643|P30|Overall Study|Protocol Violation|0
7494125|NCT03529773|25986644|P29|Overall Study|Protocol Violation|0
7494126|NCT03529773|25986645|P28|Overall Study|Protocol Violation|0
7494127|NCT03529773|25986646|P27|Overall Study|Protocol Violation|0
7494128|NCT03529773|25986647|P26|Overall Study|Protocol Violation|0
7494129|NCT03529773|25986648|P25|Overall Study|Protocol Violation|0
7494130|NCT03529773|25986649|P24|Overall Study|Protocol Violation|0
7494131|NCT03529773|25986650|P23|Overall Study|Protocol Violation|0
7494132|NCT03529773|25986651|P22|Overall Study|Protocol Violation|0
7494133|NCT03529773|25986652|P21|Overall Study|Protocol Violation|0
7494134|NCT03529773|25986653|P20|Overall Study|Protocol Violation|0
7494135|NCT03529773|25986654|P19|Overall Study|Protocol Violation|0
7494136|NCT03529773|25986655|P18|Overall Study|Protocol Violation|0
7494137|NCT03529773|25986656|P17|Overall Study|Protocol Violation|0
7494138|NCT03529773|25986657|P16|Overall Study|Protocol Violation|0
7494139|NCT03529773|25986658|P15|Overall Study|Protocol Violation|0
7494140|NCT03529773|25986659|P14|Overall Study|Protocol Violation|0
7494141|NCT03529773|25986660|P13|Overall Study|Protocol Violation|0
7494142|NCT03529773|25986661|P12|Overall Study|Protocol Violation|0
7494143|NCT03529773|25986662|P11|Overall Study|Protocol Violation|0
7494144|NCT03529773|25986663|P10|Overall Study|Protocol Violation|0
7494145|NCT03529773|25986664|P9|Overall Study|Protocol Violation|0
7494146|NCT03529773|25986665|P8|Overall Study|Protocol Violation|0
7494147|NCT03529773|25986666|P7|Overall Study|Protocol Violation|0
7494148|NCT03529773|25986667|P6|Overall Study|Protocol Violation|0
7494149|NCT03529773|25986668|P5|Overall Study|Protocol Violation|0
7494150|NCT03529773|25986669|P4|Overall Study|Protocol Violation|0
7494151|NCT03529773|25986670|P3|Overall Study|Protocol Violation|0
7494152|NCT03529773|25986671|P2|Overall Study|Protocol Violation|0
7494153|NCT03529773|25986672|P1|Overall Study|Protocol Violation|0
7494154|NCT03529773|25986633|P40|Overall Study|Physician Decision|0
7494155|NCT03529773|25986634|P39|Overall Study|Physician Decision|0
7494156|NCT03529773|25986635|P38|Overall Study|Physician Decision|0
7494157|NCT03529773|25986636|P37|Overall Study|Physician Decision|0
7494158|NCT03529773|25986637|P36|Overall Study|Physician Decision|0
7494159|NCT03529773|25986638|P35|Overall Study|Physician Decision|0
7494160|NCT03529773|25986639|P34|Overall Study|Physician Decision|0
7494161|NCT03529773|25986640|P33|Overall Study|Physician Decision|0
7494162|NCT03529773|25986641|P32|Overall Study|Physician Decision|0
7494163|NCT03529773|25986642|P31|Overall Study|Physician Decision|0
7494164|NCT03529773|25986643|P30|Overall Study|Physician Decision|0
7494165|NCT03529773|25986644|P29|Overall Study|Physician Decision|0
7494166|NCT03529773|25986645|P28|Overall Study|Physician Decision|0
7494167|NCT03529773|25986646|P27|Overall Study|Physician Decision|0
7494168|NCT03529773|25986647|P26|Overall Study|Physician Decision|0
7494169|NCT03529773|25986648|P25|Overall Study|Physician Decision|0
7494170|NCT03529773|25986649|P24|Overall Study|Physician Decision|0
7494171|NCT03529773|25986650|P23|Overall Study|Physician Decision|0
7494172|NCT03529773|25986651|P22|Overall Study|Physician Decision|0
7494173|NCT03529773|25986652|P21|Overall Study|Physician Decision|1
7494174|NCT03529773|25986653|P20|Overall Study|Physician Decision|1
7494175|NCT03529773|25986654|P19|Overall Study|Physician Decision|0
7494176|NCT03529773|25986655|P18|Overall Study|Physician Decision|0
7494177|NCT03529773|25986656|P17|Overall Study|Physician Decision|0
7494178|NCT03529773|25986657|P16|Overall Study|Physician Decision|0
7494179|NCT03529773|25986658|P15|Overall Study|Physician Decision|0
7494180|NCT03529773|25986659|P14|Overall Study|Physician Decision|0
7494181|NCT03529773|25986660|P13|Overall Study|Physician Decision|0
7494182|NCT03529773|25986661|P12|Overall Study|Physician Decision|0
7494183|NCT03529773|25986662|P11|Overall Study|Physician Decision|0
7494184|NCT03529773|25986663|P10|Overall Study|Physician Decision|0
7494185|NCT03529773|25986664|P9|Overall Study|Physician Decision|0
7494186|NCT03529773|25986665|P8|Overall Study|Physician Decision|0
7494187|NCT03529773|25986666|P7|Overall Study|Physician Decision|0
7494188|NCT03529773|25986667|P6|Overall Study|Physician Decision|0
7494189|NCT03529773|25986668|P5|Overall Study|Physician Decision|0
7494190|NCT03529773|25986669|P4|Overall Study|Physician Decision|0
7494191|NCT03529773|25986670|P3|Overall Study|Physician Decision|0
7494192|NCT03529773|25986671|P2|Overall Study|Physician Decision|0
7494193|NCT03529773|25986672|P1|Overall Study|Physician Decision|0
7494194|NCT03529773|25986633|P40|Overall Study|Other|0
7494195|NCT03529773|25986634|P39|Overall Study|Other|0
7494196|NCT03529773|25986635|P38|Overall Study|Other|0
7494197|NCT03529773|25986636|P37|Overall Study|Other|0
7494198|NCT03529773|25986637|P36|Overall Study|Other|1
7494199|NCT03529773|25986638|P35|Overall Study|Other|1
7494200|NCT03529773|25986639|P34|Overall Study|Other|0
7494201|NCT03529773|25986640|P33|Overall Study|Other|0
7494202|NCT03529773|25986641|P32|Overall Study|Other|0
7494203|NCT03529773|25986642|P31|Overall Study|Other|0
7494204|NCT03529773|25986643|P30|Overall Study|Other|0
7494205|NCT03529773|25986644|P29|Overall Study|Other|0
7494206|NCT03529773|25986645|P28|Overall Study|Other|0
7494207|NCT03529773|25986646|P27|Overall Study|Other|1
7494208|NCT03529773|25986647|P26|Overall Study|Other|2
7494209|NCT03529773|25986648|P25|Overall Study|Other|2
7494210|NCT03529773|25986649|P24|Overall Study|Other|0
7494211|NCT03529773|25986650|P23|Overall Study|Other|1
7494212|NCT03529773|25986651|P22|Overall Study|Other|0
7494213|NCT03529773|25986652|P21|Overall Study|Other|1
7494214|NCT03529773|25986653|P20|Overall Study|Other|0
7494215|NCT03529773|25986654|P19|Overall Study|Other|0
7494216|NCT03529773|25986655|P18|Overall Study|Other|2
7494217|NCT03529773|25986656|P17|Overall Study|Other|0
7494218|NCT03529773|25986657|P16|Overall Study|Other|0
7494219|NCT03529773|25986658|P15|Overall Study|Other|2
7494220|NCT03529773|25986659|P14|Overall Study|Other|0
7494221|NCT03529773|25986660|P13|Overall Study|Other|1
7494222|NCT03529773|25986661|P12|Overall Study|Other|0
7494223|NCT03529773|25986662|P11|Overall Study|Other|0
7494224|NCT03529773|25986663|P10|Overall Study|Other|0
7494225|NCT03529773|25986664|P9|Overall Study|Other|0
7494226|NCT03529773|25986665|P8|Overall Study|Other|0
7494227|NCT03529773|25986666|P7|Overall Study|Other|0
7494228|NCT03529773|25986667|P6|Overall Study|Other|0
7494229|NCT03529773|25986668|P5|Overall Study|Other|0
7494230|NCT03529773|25986669|P4|Overall Study|Other|0
7494231|NCT03529773|25986670|P3|Overall Study|Other|0
7494232|NCT03529773|25986671|P2|Overall Study|Other|0
7494233|NCT03529773|25986672|P1|Overall Study|Other|0
7494234|NCT03529773|25986633|P40|Overall Study|No longer meets eligibility criteria|0
7494235|NCT03529773|25986634|P39|Overall Study|No longer meets eligibility criteria|0
7494236|NCT03529773|25986635|P38|Overall Study|No longer meets eligibility criteria|0
7494237|NCT03529773|25986636|P37|Overall Study|No longer meets eligibility criteria|0
7494238|NCT03529773|25986637|P36|Overall Study|No longer meets eligibility criteria|0
7494239|NCT03529773|25986638|P35|Overall Study|No longer meets eligibility criteria|0
7494240|NCT03529773|25986639|P34|Overall Study|No longer meets eligibility criteria|0
7494241|NCT03529773|25986640|P33|Overall Study|No longer meets eligibility criteria|0
7494242|NCT03529773|25986641|P32|Overall Study|No longer meets eligibility criteria|0
7494243|NCT03529773|25986642|P31|Overall Study|No longer meets eligibility criteria|0
7494244|NCT03529773|25986643|P30|Overall Study|No longer meets eligibility criteria|0
7494245|NCT03529773|25986644|P29|Overall Study|No longer meets eligibility criteria|0
7494246|NCT03529773|25986645|P28|Overall Study|No longer meets eligibility criteria|0
7494247|NCT03529773|25986646|P27|Overall Study|No longer meets eligibility criteria|0
7494248|NCT03529773|25986647|P26|Overall Study|No longer meets eligibility criteria|0
7494249|NCT03529773|25986648|P25|Overall Study|No longer meets eligibility criteria|0
7494250|NCT03529773|25986649|P24|Overall Study|No longer meets eligibility criteria|0
7494251|NCT03529773|25986650|P23|Overall Study|No longer meets eligibility criteria|1
7494252|NCT03529773|25986651|P22|Overall Study|No longer meets eligibility criteria|0
7494253|NCT03529773|25986652|P21|Overall Study|No longer meets eligibility criteria|0
7494254|NCT03529773|25986653|P20|Overall Study|No longer meets eligibility criteria|0
7494255|NCT03529773|25986654|P19|Overall Study|No longer meets eligibility criteria|0
7494256|NCT03529773|25986655|P18|Overall Study|No longer meets eligibility criteria|0
7494257|NCT03529773|25986656|P17|Overall Study|No longer meets eligibility criteria|0
7494258|NCT03529773|25986657|P16|Overall Study|No longer meets eligibility criteria|0
7494259|NCT03529773|25986658|P15|Overall Study|No longer meets eligibility criteria|0
7494260|NCT03529773|25986659|P14|Overall Study|No longer meets eligibility criteria|0
7494261|NCT03529773|25986660|P13|Overall Study|No longer meets eligibility criteria|0
7494262|NCT03529773|25986661|P12|Overall Study|No longer meets eligibility criteria|0
7494263|NCT03529773|25986662|P11|Overall Study|No longer meets eligibility criteria|0
7494264|NCT03529773|25986663|P10|Overall Study|No longer meets eligibility criteria|0
7494265|NCT03529773|25986664|P9|Overall Study|No longer meets eligibility criteria|0
7494266|NCT03529773|25986665|P8|Overall Study|No longer meets eligibility criteria|0
7494267|NCT03529773|25986666|P7|Overall Study|No longer meets eligibility criteria|0
7494268|NCT03529773|25986667|P6|Overall Study|No longer meets eligibility criteria|0
7494269|NCT03529773|25986668|P5|Overall Study|No longer meets eligibility criteria|0
7494270|NCT03529773|25986669|P4|Overall Study|No longer meets eligibility criteria|0
7494271|NCT03529773|25986670|P3|Overall Study|No longer meets eligibility criteria|0
7494272|NCT03529773|25986671|P2|Overall Study|No longer meets eligibility criteria|0
7494273|NCT03529773|25986672|P1|Overall Study|No longer meets eligibility criteria|0
7494274|NCT03529773|25986633|P40|Overall Study|Lost to Follow-up|1
7494275|NCT03529773|25986634|P39|Overall Study|Lost to Follow-up|0
7494276|NCT03529773|25986635|P38|Overall Study|Lost to Follow-up|0
7494277|NCT03529773|25986636|P37|Overall Study|Lost to Follow-up|0
7494278|NCT03529773|25986637|P36|Overall Study|Lost to Follow-up|0
7494279|NCT03529773|25986638|P35|Overall Study|Lost to Follow-up|1
7494280|NCT03529773|25986639|P34|Overall Study|Lost to Follow-up|1
7494281|NCT03529773|25986640|P33|Overall Study|Lost to Follow-up|0
7494282|NCT03529773|25986641|P32|Overall Study|Lost to Follow-up|0
7494283|NCT03529773|25986642|P31|Overall Study|Lost to Follow-up|1
7494284|NCT03529773|25986643|P30|Overall Study|Lost to Follow-up|0
7494285|NCT03529773|25986644|P29|Overall Study|Lost to Follow-up|0
7494286|NCT03529773|25986645|P28|Overall Study|Lost to Follow-up|0
7494287|NCT03529773|25986646|P27|Overall Study|Lost to Follow-up|5
7494288|NCT03529773|25986647|P26|Overall Study|Lost to Follow-up|4
7494289|NCT03529773|25986648|P25|Overall Study|Lost to Follow-up|3
7494290|NCT03529773|25986649|P24|Overall Study|Lost to Follow-up|4
7494291|NCT03529773|25986650|P23|Overall Study|Lost to Follow-up|1
7494292|NCT03529773|25986651|P22|Overall Study|Lost to Follow-up|4
7494293|NCT03529773|25986652|P21|Overall Study|Lost to Follow-up|2
7494294|NCT03529773|25986653|P20|Overall Study|Lost to Follow-up|1
7494295|NCT03529773|25986654|P19|Overall Study|Lost to Follow-up|1
7494296|NCT03529773|25986655|P18|Overall Study|Lost to Follow-up|0
7494297|NCT03529773|25986656|P17|Overall Study|Lost to Follow-up|1
7494298|NCT03529773|25986657|P16|Overall Study|Lost to Follow-up|1
7494299|NCT03529773|25986658|P15|Overall Study|Lost to Follow-up|4
7494300|NCT03529773|25986659|P14|Overall Study|Lost to Follow-up|1
7494301|NCT03529773|25986660|P13|Overall Study|Lost to Follow-up|0
7494302|NCT03529773|25986661|P12|Overall Study|Lost to Follow-up|0
7494303|NCT03529773|25986662|P11|Overall Study|Lost to Follow-up|0
7494304|NCT03529773|25986663|P10|Overall Study|Lost to Follow-up|0
7494305|NCT03529773|25986664|P9|Overall Study|Lost to Follow-up|0
7494306|NCT03529773|25986665|P8|Overall Study|Lost to Follow-up|0
7494307|NCT03529773|25986666|P7|Overall Study|Lost to Follow-up|0
7494308|NCT03529773|25986667|P6|Overall Study|Lost to Follow-up|1
7494309|NCT03529773|25986668|P5|Overall Study|Lost to Follow-up|1
7494310|NCT03529773|25986669|P4|Overall Study|Lost to Follow-up|0
7494311|NCT03529773|25986670|P3|Overall Study|Lost to Follow-up|1
7494312|NCT03529773|25986671|P2|Overall Study|Lost to Follow-up|0
7494313|NCT03529773|25986672|P1|Overall Study|Lost to Follow-up|0
7494314|NCT03529773|25986633|P40|Overall Study|Death|0
7494315|NCT03529773|25986634|P39|Overall Study|Death|0
7494316|NCT03529773|25986635|P38|Overall Study|Death|0
7494317|NCT03529773|25986636|P37|Overall Study|Death|1
7494318|NCT03529773|25986637|P36|Overall Study|Death|0
7494319|NCT03529773|25986638|P35|Overall Study|Death|1
7494320|NCT03529773|25986639|P34|Overall Study|Death|1
7494321|NCT03529773|25986640|P33|Overall Study|Death|0
7494322|NCT03529773|25986641|P32|Overall Study|Death|0
7494323|NCT03529773|25986642|P31|Overall Study|Death|0
7494324|NCT03529773|25986643|P30|Overall Study|Death|0
7494325|NCT03529773|25986644|P29|Overall Study|Death|0
7494326|NCT03529773|25986645|P28|Overall Study|Death|0
7494327|NCT03529773|25986646|P27|Overall Study|Death|0
7494328|NCT03529773|25986647|P26|Overall Study|Death|0
7494329|NCT03529773|25986648|P25|Overall Study|Death|0
7494330|NCT03529773|25986649|P24|Overall Study|Death|0
7494331|NCT03529773|25986650|P23|Overall Study|Death|1
7494332|NCT03529773|25986651|P22|Overall Study|Death|0
7494333|NCT03529773|25986652|P21|Overall Study|Death|0
7494334|NCT03529773|25986653|P20|Overall Study|Death|1
7494335|NCT03529773|25986654|P19|Overall Study|Death|0
7494336|NCT03529773|25986655|P18|Overall Study|Death|0
7494337|NCT03529773|25986656|P17|Overall Study|Death|0
7494338|NCT03529773|25986657|P16|Overall Study|Death|0
7494339|NCT03529773|25986658|P15|Overall Study|Death|0
7494340|NCT03529773|25986659|P14|Overall Study|Death|0
7494341|NCT03529773|25986660|P13|Overall Study|Death|1
7494342|NCT03529773|25986661|P12|Overall Study|Death|0
7494343|NCT03529773|25986662|P11|Overall Study|Death|0
7494344|NCT03529773|25986663|P10|Overall Study|Death|0
7494345|NCT03529773|25986664|P9|Overall Study|Death|0
7494346|NCT03529773|25986665|P8|Overall Study|Death|0
7494347|NCT03529773|25986666|P7|Overall Study|Death|0
7494348|NCT03529773|25986667|P6|Overall Study|Death|0
7494349|NCT03529773|25986668|P5|Overall Study|Death|0
7494350|NCT03529773|25986669|P4|Overall Study|Death|0
7494351|NCT03529773|25986670|P3|Overall Study|Death|0
7494352|NCT03529773|25986671|P2|Overall Study|Death|0
7494353|NCT03529773|25986672|P1|Overall Study|Death|0
7494354|NCT03529773|25986633|P40|Overall Study|Adverse Event|1
7494355|NCT03529773|25986634|P39|Overall Study|Adverse Event|0
7494356|NCT03529773|25986635|P38|Overall Study|Adverse Event|0
7494357|NCT03529773|25986636|P37|Overall Study|Adverse Event|0
7494358|NCT03529773|25986637|P36|Overall Study|Adverse Event|1
7494359|NCT03529773|25986638|P35|Overall Study|Adverse Event|0
7494360|NCT03529773|25986639|P34|Overall Study|Adverse Event|0
7494361|NCT03529773|25986640|P33|Overall Study|Adverse Event|0
7494362|NCT03529773|25986641|P32|Overall Study|Adverse Event|0
7494363|NCT03529773|25986642|P31|Overall Study|Adverse Event|1
7494364|NCT03529773|25986643|P30|Overall Study|Adverse Event|0
7494365|NCT03529773|25986644|P29|Overall Study|Adverse Event|0
7494366|NCT03529773|25986645|P28|Overall Study|Adverse Event|0
7494367|NCT03529773|25986646|P27|Overall Study|Adverse Event|0
7494368|NCT03529773|25986647|P26|Overall Study|Adverse Event|0
7494369|NCT03529773|25986648|P25|Overall Study|Adverse Event|0
7494370|NCT03529773|25986649|P24|Overall Study|Adverse Event|0
7494371|NCT03529773|25986650|P23|Overall Study|Adverse Event|0
7494372|NCT03529773|25986651|P22|Overall Study|Adverse Event|0
7494373|NCT03529773|25986652|P21|Overall Study|Adverse Event|0
7494374|NCT03529773|25986653|P20|Overall Study|Adverse Event|0
7494375|NCT03529773|25986654|P19|Overall Study|Adverse Event|0
7494376|NCT03529773|25986655|P18|Overall Study|Adverse Event|0
7494377|NCT03529773|25986656|P17|Overall Study|Adverse Event|0
7494378|NCT03529773|25986657|P16|Overall Study|Adverse Event|0
7494379|NCT03529773|25986658|P15|Overall Study|Adverse Event|0
7494380|NCT03529773|25986659|P14|Overall Study|Adverse Event|0
7494381|NCT03529773|25986660|P13|Overall Study|Adverse Event|0
7494382|NCT03529773|25986661|P12|Overall Study|Adverse Event|0
7494383|NCT03529773|25986662|P11|Overall Study|Adverse Event|0
7494384|NCT03529773|25986663|P10|Overall Study|Adverse Event|0
7494385|NCT03529773|25986664|P9|Overall Study|Adverse Event|0
7494386|NCT03529773|25986665|P8|Overall Study|Adverse Event|0
7494387|NCT03529773|25986666|P7|Overall Study|Adverse Event|0
7494388|NCT03529773|25986667|P6|Overall Study|Adverse Event|0
7494389|NCT03529773|25986668|P5|Overall Study|Adverse Event|0
7494390|NCT03529773|25986669|P4|Overall Study|Adverse Event|0
7494391|NCT03529773|25986670|P3|Overall Study|Adverse Event|0
7494392|NCT03529773|25986671|P2|Overall Study|Adverse Event|0
7494393|NCT03529773|25986672|P1|Overall Study|Adverse Event|0
7494394|NCT03529409|25986981|P3|Follow-up Assessment|Withdrawal by Subject|0
7494395|NCT03529409|25986982|P2|Follow-up Assessment|Withdrawal by Subject|1
7494396|NCT03529409|25986983|P1|Follow-up Assessment|Withdrawal by Subject|0
7494397|NCT03529409|25986981|P3|Follow-up Assessment|Death|0
7494398|NCT03529409|25986982|P2|Follow-up Assessment|Death|0
7494399|NCT03529409|25986983|P1|Follow-up Assessment|Death|1
7494400|NCT03529409|25986981|P3|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
7494401|NCT03529409|25986982|P2|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
7494402|NCT03529409|25986983|P1|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
7494403|NCT03529409|25986981|P3|Post-treatment Assessment|Lost to Follow-up|0
7494404|NCT03529409|25986982|P2|Post-treatment Assessment|Lost to Follow-up|1
7494405|NCT03529409|25986983|P1|Post-treatment Assessment|Lost to Follow-up|1
7494406|NCT03529409|25986981|P3|Post-treatment Assessment|Death|0
7494407|NCT03529409|25986982|P2|Post-treatment Assessment|Death|0
7494408|NCT03529409|25986983|P1|Post-treatment Assessment|Death|1
7494409|NCT03529409|25986981|P3|Randomized|Excluded|1
7494410|NCT03529409|25986982|P2|Randomized|Excluded|0
7494411|NCT03529409|25986983|P1|Randomized|Excluded|0
7494412|NCT03529409|25986981|P3|Randomized|Lost to Follow-up|4
7494413|NCT03529409|25986982|P2|Randomized|Lost to Follow-up|0
7494414|NCT03529409|25986983|P1|Randomized|Lost to Follow-up|0
7494415|NCT03529162|25987014|P2|Overall Study|Lost to Follow-up|2
7494416|NCT03529162|25987015|P1|Overall Study|Lost to Follow-up|2
7494417|NCT03528577|25987029|P1|Sequence 4|Adverse Event|1
7494418|NCT03528577|25987029|P1|Sequence 4|Failed Spirometry|2
7494419|NCT03528577|25987029|P1|Sequence 3|Failed Spirometry|1
7494420|NCT03528577|25987029|P1|Sequence 2|Failed Spirometry|1
7494421|NCT03528577|25987029|P1|Sequence 2|Withdrawal by Subject|1
7494422|NCT03528577|25987029|P1|Sequence 2|Adverse Event|1
7494423|NCT03528577|25987029|P1|Sequence 1|Restricted medication|1
7494424|NCT03528577|25987029|P1|Sequence 1|Failed Spirometry|1
7494425|NCT03528369|25987058|P3|Overall Study|Adverse Event|0
7494426|NCT03528369|25987059|P2|Overall Study|Adverse Event|1
7494427|NCT03528369|25987060|P1|Overall Study|Adverse Event|0
7494428|NCT03528369|25987058|P3|Overall Study|Lost to Follow-up|0
7494429|NCT03528369|25987059|P2|Overall Study|Lost to Follow-up|0
7494430|NCT03528369|25987060|P1|Overall Study|Lost to Follow-up|1
7494431|NCT03528369|25987058|P3|Overall Study|Withdrawal by Subject|0
7494432|NCT03528369|25987059|P2|Overall Study|Withdrawal by Subject|0
7494433|NCT03528369|25987060|P1|Overall Study|Withdrawal by Subject|2
7494434|NCT03528174|25987089|P1|Overall Study|sensors dislodged|1
7494435|NCT03528174|25987089|P1|Overall Study|Adverse Event|1
7494436|NCT03527966|25987109|P2|Overall Study|Lost to Follow-up|0
7494437|NCT03527966|25987110|P1|Overall Study|Lost to Follow-up|3
7494438|NCT03527745|25987148|P26|Overall Study|Lost to Follow-up|3
7494439|NCT03527745|25987149|P25|Overall Study|Lost to Follow-up|1
7494440|NCT03527745|25987150|P24|Overall Study|Lost to Follow-up|8
7494441|NCT03527745|25987151|P23|Overall Study|Lost to Follow-up|6
7494442|NCT03527745|25987152|P22|Overall Study|Lost to Follow-up|5
7494443|NCT03527745|25987153|P21|Overall Study|Lost to Follow-up|1
7494444|NCT03527745|25987154|P20|Overall Study|Lost to Follow-up|1
7494445|NCT03527745|25987155|P19|Overall Study|Lost to Follow-up|0
7494446|NCT03527745|25987156|P18|Overall Study|Lost to Follow-up|0
7494447|NCT03527745|25987157|P17|Overall Study|Lost to Follow-up|1
7494448|NCT03527745|25987158|P16|Overall Study|Lost to Follow-up|0
7494449|NCT03527745|25987159|P15|Overall Study|Lost to Follow-up|0
7494450|NCT03527745|25987160|P14|Overall Study|Lost to Follow-up|0
7494451|NCT03527745|25987161|P13|Overall Study|Lost to Follow-up|0
7494452|NCT03527745|25987162|P12|Overall Study|Lost to Follow-up|1
7494453|NCT03527745|25987163|P11|Overall Study|Lost to Follow-up|1
7494454|NCT03527745|25987164|P10|Overall Study|Lost to Follow-up|2
7494455|NCT03527745|25987165|P9|Overall Study|Lost to Follow-up|3
7494456|NCT03527745|25987166|P8|Overall Study|Lost to Follow-up|2
7494457|NCT03527745|25987167|P7|Overall Study|Lost to Follow-up|3
7494458|NCT03527745|25987168|P6|Overall Study|Lost to Follow-up|2
7494459|NCT03527745|25987169|P5|Overall Study|Lost to Follow-up|0
7494460|NCT03527745|25987170|P4|Overall Study|Lost to Follow-up|9
7494461|NCT03527745|25987171|P3|Overall Study|Lost to Follow-up|7
7494462|NCT03527745|25987172|P2|Overall Study|Lost to Follow-up|6
7494463|NCT03527745|25987173|P1|Overall Study|Lost to Follow-up|3
7494464|NCT03527550|25987255|P2|Overall Study|Participant reported exclusion criterion after study enrollment.|0
7494465|NCT03527550|25987256|P1|Overall Study|Participant reported exclusion criterion after study enrollment.|1
7494466|NCT03527550|25987255|P2|Overall Study|Withdrawal by Subject|1
7494467|NCT03527550|25987256|P1|Overall Study|Withdrawal by Subject|4
7494468|NCT03527550|25987255|P2|Overall Study|Lost to Follow-up|2
7494469|NCT03527550|25987256|P1|Overall Study|Lost to Follow-up|4
7494470|NCT03527173|25987274|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7494471|NCT03527173|25987275|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7494472|NCT03527173|25987274|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7494473|NCT03527173|25987275|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7494474|NCT03527173|25987274|P2|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
7494475|NCT03527173|25987275|P1|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
7494476|NCT03527173|25987274|P2|Overall Study|Lost to Follow-up|2
7494477|NCT03527173|25987275|P1|Overall Study|Lost to Follow-up|4
7494478|NCT03527160|25987319|P1|Overall Study|Did not meet inclusion|2
7494479|NCT03527160|25987319|P1|Overall Study|No clinical serum creatinine collected|6
7494480|NCT03527160|25987319|P1|Overall Study|No urine collected|13
7494481|NCT03526458|25987328|P2|Overall Study|Lack of equipment|1
7494482|NCT03526458|25987329|P1|Overall Study|Lack of equipment|1
7494483|NCT03526458|25987328|P2|Overall Study|Physician Decision|1
7494484|NCT03526458|25987329|P1|Overall Study|Physician Decision|2
7494485|NCT03526458|25987328|P2|Overall Study|Withdrawal by Subject|0
7494486|NCT03526458|25987329|P1|Overall Study|Withdrawal by Subject|1
7494487|NCT03526458|25987328|P2|Overall Study|Stone passed, surgery cancelled|1
7494488|NCT03526458|25987329|P1|Overall Study|Stone passed, surgery cancelled|2
7494489|NCT03526458|25987328|P2|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7494490|NCT03526458|25987329|P1|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7494491|NCT03525834|25987362|P1|Overall Study|Progressive disease|1
7494492|NCT03525678|25987373|P3|Overall Study|Death|4
7494493|NCT03525678|25987374|P2|Overall Study|Death|31
7494494|NCT03525678|25987375|P1|Overall Study|Death|32
7494495|NCT03525678|25987373|P3|Overall Study|Lost to Follow-up|0
7494496|NCT03525678|25987374|P2|Overall Study|Lost to Follow-up|0
7494497|NCT03525678|25987375|P1|Overall Study|Lost to Follow-up|1
7494498|NCT03525678|25987373|P3|Overall Study|Physician Decision|0
7494499|NCT03525678|25987374|P2|Overall Study|Physician Decision|2
7494500|NCT03525678|25987375|P1|Overall Study|Physician Decision|1
7494501|NCT03525678|25987373|P3|Overall Study|Withdrawal by Subject|0
7494502|NCT03525678|25987374|P2|Overall Study|Withdrawal by Subject|1
7494503|NCT03525678|25987375|P1|Overall Study|Withdrawal by Subject|3
7494504|NCT03525678|25987373|P3|Overall Study|Ongoing at the time of interim analysis|21
7494505|NCT03525678|25987374|P2|Overall Study|Ongoing at the time of interim analysis|65
7494506|NCT03525678|25987375|P1|Overall Study|Ongoing at the time of interim analysis|60
7494507|NCT03525444|25987577|P2|Overall Study|Other|1
7494508|NCT03525444|25987578|P1|Overall Study|Other|0
7494509|NCT03525444|25987577|P2|Overall Study|Withdrawal of consent (not due to AE)|1
7494510|NCT03525444|25987578|P1|Overall Study|Withdrawal of consent (not due to AE)|0
7494511|NCT03525444|25987577|P2|Overall Study|Adverse Event|1
7494512|NCT03525444|25987578|P1|Overall Study|Adverse Event|0
7494513|NCT03525119|25987621|P3|Overall Study|Randomized but not Vaccinated|2
7494514|NCT03525119|25987622|P2|Overall Study|Randomized but not Vaccinated|0
7494515|NCT03525119|25987623|P1|Overall Study|Randomized but not Vaccinated|1
7494516|NCT03525119|25987621|P3|Overall Study|Reason not Specified|2
7494517|NCT03525119|25987622|P2|Overall Study|Reason not Specified|1
7494518|NCT03525119|25987623|P1|Overall Study|Reason not Specified|2
7494519|NCT03525119|25987621|P3|Overall Study|Withdrawal by Subject|2
7494520|NCT03525119|25987622|P2|Overall Study|Withdrawal by Subject|4
7494521|NCT03525119|25987623|P1|Overall Study|Withdrawal by Subject|5
7494522|NCT03525119|25987621|P3|Overall Study|Lost to Follow-up|37
7494523|NCT03525119|25987622|P2|Overall Study|Lost to Follow-up|33
7494524|NCT03525119|25987623|P1|Overall Study|Lost to Follow-up|32
7494525|NCT03525119|25987621|P3|Overall Study|Adverse Event|0
7494526|NCT03525119|25987622|P2|Overall Study|Adverse Event|1
7494527|NCT03525119|25987623|P1|Overall Study|Adverse Event|0
7494528|NCT03524157|25987658|P3|Overall Study|cytology not readable|1
7494529|NCT03524157|25987659|P2|Overall Study|cytology not readable|0
7494530|NCT03524157|25987660|P1|Overall Study|cytology not readable|0
7494531|NCT03523871|25987714|P1|Overall Study|Death|1
7494532|NCT03523715|25987721|P2|Overall Study|Internally inconsistent reporting|2
7494533|NCT03523715|25987722|P1|Overall Study|Internally inconsistent reporting|0
7494534|NCT03523715|25987721|P2|Overall Study|Did not meet inclusion criteria|0
7494535|NCT03523715|25987722|P1|Overall Study|Did not meet inclusion criteria|1
7494536|NCT03523715|25987721|P2|Overall Study|Lost to Follow-up|14
7494537|NCT03523715|25987722|P1|Overall Study|Lost to Follow-up|11
7494538|NCT03522948|25987740|P1|Overall Study|Lost to Follow-up|1
7494539|NCT03522675|25987748|P1|Overall Study|Non-reactive to histamine|1
7494540|NCT03522675|25987748|P1|Overall Study|Screen fail|1
7494541|NCT03522506|25987766|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
7494542|NCT03522506|25987767|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7494543|NCT03522506|25987768|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7494544|NCT03522506|25987769|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7494545|NCT03522506|25987766|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7494546|NCT03522506|25987767|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7494547|NCT03522506|25987768|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7494548|NCT03522506|25987769|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7494549|NCT03521817|25987847|P2|Overall Study|Protocol Violation|1
7494550|NCT03521817|25987848|P1|Overall Study|Protocol Violation|0
7494551|NCT03521791|25987856|P2|Overall Study|Protocol Violation|17
7494552|NCT03521791|25987857|P1|Overall Study|Protocol Violation|7
7494553|NCT03521635|25987883|P2|Overall Study|Patient not taken study medicine|1
7494554|NCT03521635|25987884|P1|Overall Study|Patient not taken study medicine|0
7494555|NCT03521635|25987883|P2|Overall Study|Meet exclusion criteria|1
7494556|NCT03521635|25987884|P1|Overall Study|Meet exclusion criteria|0
7494557|NCT03521635|25987883|P2|Overall Study|Lost to Follow-up|1
7494558|NCT03521635|25987884|P1|Overall Study|Lost to Follow-up|0
7494559|NCT03521635|25987883|P2|Overall Study|Refused to continue trial medication|2
7494560|NCT03521635|25987884|P1|Overall Study|Refused to continue trial medication|2
7494561|NCT03521635|25987883|P2|Overall Study|Refused to complete study visit|0
7494562|NCT03521635|25987884|P1|Overall Study|Refused to complete study visit|1
7494563|NCT03521635|25987883|P2|Overall Study|Adverse Event|1
7494564|NCT03521635|25987884|P1|Overall Study|Adverse Event|1
7494565|NCT03521141|25987949|P3|Overall Study|Death|1
7494566|NCT03521141|25987950|P2|Overall Study|Death|0
7494567|NCT03521141|25987951|P1|Overall Study|Death|1
7494568|NCT03521115|25987976|P2|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
7494569|NCT03521115|25987977|P1|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
7494570|NCT03521115|25987976|P2|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
7494571|NCT03521115|25987977|P1|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
7494572|NCT03520959|25988058|P2|Overall Study|Study terminated by Sponsor|1
7494573|NCT03520959|25988059|P1|Overall Study|Study terminated by Sponsor|0
7494574|NCT03520400|25988081|P2|Overall Study|Physician Decision|7
7494575|NCT03520400|25988082|P1|Overall Study|Physician Decision|15
7494576|NCT03520387|25988093|P5|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7494577|NCT03520387|25988094|P4|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7494578|NCT03520387|25988095|P3|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7494579|NCT03520387|25988096|P2|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7494580|NCT03520387|25988097|P1|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
7494581|NCT03520387|25988093|P5|Pre-Randomization|Withdrawal by Subject|0
7494582|NCT03520387|25988094|P4|Pre-Randomization|Withdrawal by Subject|0
7494583|NCT03520387|25988095|P3|Pre-Randomization|Withdrawal by Subject|0
7494584|NCT03520387|25988096|P2|Pre-Randomization|Withdrawal by Subject|0
7494585|NCT03520387|25988097|P1|Pre-Randomization|Withdrawal by Subject|1
7494586|NCT03519932|25988190|P2|First Intervention|Adverse Event|3
7494587|NCT03519932|25988191|P1|First Intervention|Adverse Event|1
7494588|NCT03519919|25988217|P1|Overall Study|Screen Failure|1
7494589|NCT03519919|25988217|P1|Overall Study|Lack of Efficacy|1
7494590|NCT03519919|25988217|P1|Overall Study|Withdrawal by Subject|1
7494591|NCT03519867|25988269|P10|Overall Study|Reason not provided|0
7494592|NCT03519867|25988270|P9|Overall Study|Reason not provided|1
7494593|NCT03519867|25988271|P8|Overall Study|Reason not provided|1
7494594|NCT03519867|25988272|P7|Overall Study|Reason not provided|0
7494595|NCT03519867|25988273|P6|Overall Study|Reason not provided|1
7494596|NCT03519867|25988274|P5|Overall Study|Reason not provided|0
7494597|NCT03519867|25988275|P4|Overall Study|Reason not provided|1
7494598|NCT03519867|25988276|P3|Overall Study|Reason not provided|1
7494599|NCT03519867|25988277|P2|Overall Study|Reason not provided|1
7494600|NCT03519867|25988278|P1|Overall Study|Reason not provided|1
7494601|NCT03519867|25988269|P10|Overall Study|Admin. of other reversal agent|0
7494602|NCT03519867|25988270|P9|Overall Study|Admin. of other reversal agent|0
7494603|NCT03519867|25988271|P8|Overall Study|Admin. of other reversal agent|0
7494604|NCT03519867|25988272|P7|Overall Study|Admin. of other reversal agent|0
7494605|NCT03519867|25988273|P6|Overall Study|Admin. of other reversal agent|1
7494606|NCT03519867|25988274|P5|Overall Study|Admin. of other reversal agent|0
7494607|NCT03519867|25988275|P4|Overall Study|Admin. of other reversal agent|0
7494608|NCT03519867|25988276|P3|Overall Study|Admin. of other reversal agent|0
7494609|NCT03519867|25988277|P2|Overall Study|Admin. of other reversal agent|1
7494610|NCT03519867|25988278|P1|Overall Study|Admin. of other reversal agent|1
7494611|NCT03519867|25988269|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
7494612|NCT03519867|25988270|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
7494613|NCT03519867|25988271|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
7494614|NCT03519867|25988272|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
7494615|NCT03519867|25988273|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
7494616|NCT03519867|25988274|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
7494617|NCT03519867|25988275|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
7494618|NCT03519867|25988276|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
7494619|NCT03519867|25988277|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
7494620|NCT03519867|25988278|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
7494621|NCT03519867|25988269|P10|Overall Study|Protocol Violation|0
7494622|NCT03519867|25988270|P9|Overall Study|Protocol Violation|0
7494623|NCT03519867|25988271|P8|Overall Study|Protocol Violation|0
7494624|NCT03519867|25988272|P7|Overall Study|Protocol Violation|0
7494625|NCT03519867|25988273|P6|Overall Study|Protocol Violation|1
7494626|NCT03519867|25988274|P5|Overall Study|Protocol Violation|0
7494627|NCT03519867|25988275|P4|Overall Study|Protocol Violation|0
7494628|NCT03519867|25988276|P3|Overall Study|Protocol Violation|0
7494629|NCT03519867|25988277|P2|Overall Study|Protocol Violation|0
7494630|NCT03519867|25988278|P1|Overall Study|Protocol Violation|0
7494631|NCT03519867|25988269|P10|Overall Study|Adverse Event|0
7494632|NCT03519867|25988270|P9|Overall Study|Adverse Event|0
7494633|NCT03519867|25988271|P8|Overall Study|Adverse Event|0
7494634|NCT03519867|25988272|P7|Overall Study|Adverse Event|0
7494635|NCT03519867|25988273|P6|Overall Study|Adverse Event|0
7494636|NCT03519867|25988274|P5|Overall Study|Adverse Event|0
7494637|NCT03519867|25988275|P4|Overall Study|Adverse Event|0
7494638|NCT03519867|25988276|P3|Overall Study|Adverse Event|0
7494639|NCT03519867|25988277|P2|Overall Study|Adverse Event|1
7494640|NCT03519867|25988278|P1|Overall Study|Adverse Event|1
7494641|NCT03519854|25988328|P18|Overall Study|Technical Error|0
7494642|NCT03519854|25988329|P17|Overall Study|Technical Error|0
7494643|NCT03519854|25988330|P16|Overall Study|Technical Error|0
7494644|NCT03519854|25988331|P15|Overall Study|Technical Error|0
7494645|NCT03519854|25988332|P14|Overall Study|Technical Error|0
7494646|NCT03519854|25988333|P13|Overall Study|Technical Error|0
7494647|NCT03519854|25988334|P12|Overall Study|Technical Error|0
7494648|NCT03519854|25988335|P11|Overall Study|Technical Error|0
7494649|NCT03519854|25988336|P10|Overall Study|Technical Error|0
7494650|NCT03519854|25988337|P9|Overall Study|Technical Error|0
7494651|NCT03519854|25988338|P8|Overall Study|Technical Error|0
7494652|NCT03519854|25988339|P7|Overall Study|Technical Error|0
7494653|NCT03519854|25988340|P6|Overall Study|Technical Error|0
7494654|NCT03519854|25988341|P5|Overall Study|Technical Error|0
7494655|NCT03519854|25988342|P4|Overall Study|Technical Error|0
7494656|NCT03519854|25988343|P3|Overall Study|Technical Error|1
7494657|NCT03519854|25988344|P2|Overall Study|Technical Error|0
7494658|NCT03519854|25988345|P1|Overall Study|Technical Error|0
7494659|NCT03519516|25988511|P2|Overall Study|Adverse Event|1
7494660|NCT03519516|25988512|P1|Overall Study|Adverse Event|0
7494661|NCT03519204|25988586|P2|Overall Study|Other Miscellaneous Reasons|0
7494662|NCT03519204|25988587|P1|Overall Study|Other Miscellaneous Reasons|1
7494663|NCT03519204|25988586|P2|Overall Study|Withdrawal by Subject|7
7494664|NCT03519204|25988587|P1|Overall Study|Withdrawal by Subject|9
7494665|NCT03519204|25988586|P2|Overall Study|Lost to Follow-up|8
7494666|NCT03519204|25988587|P1|Overall Study|Lost to Follow-up|3
7494667|NCT03519087|25988606|P5|Laboratory Testing|Protocol Violation|0
7494668|NCT03519087|25988607|P4|Laboratory Testing|Protocol Violation|1
7494669|NCT03519087|25988608|P3|Laboratory Testing|Protocol Violation|0
7494670|NCT03519087|25988609|P2|Laboratory Testing|Protocol Violation|0
7494671|NCT03519087|25988610|P1|Laboratory Testing|Protocol Violation|0
7494672|NCT03519087|25988606|P5|Laboratory Testing|Lost to Follow-up|6
7494673|NCT03519087|25988607|P4|Laboratory Testing|Lost to Follow-up|3
7494674|NCT03519087|25988608|P3|Laboratory Testing|Lost to Follow-up|2
7494675|NCT03519087|25988609|P2|Laboratory Testing|Lost to Follow-up|0
7494676|NCT03519087|25988610|P1|Laboratory Testing|Lost to Follow-up|0
7494677|NCT03519087|25988606|P5|Re-randomization for Treatment|Not appropriate|0
7494678|NCT03519087|25988607|P4|Re-randomization for Treatment|Not appropriate|0
7494679|NCT03519087|25988608|P3|Re-randomization for Treatment|Not appropriate|0
7494680|NCT03519087|25988609|P2|Re-randomization for Treatment|Not appropriate|3
7494681|NCT03519087|25988610|P1|Re-randomization for Treatment|Not appropriate|2
7494682|NCT03519087|25988606|P5|Re-randomization for Treatment|Withdrawal by Subject|0
7494683|NCT03519087|25988607|P4|Re-randomization for Treatment|Withdrawal by Subject|0
7494684|NCT03519087|25988608|P3|Re-randomization for Treatment|Withdrawal by Subject|0
7494685|NCT03519087|25988609|P2|Re-randomization for Treatment|Withdrawal by Subject|29
7494686|NCT03519087|25988610|P1|Re-randomization for Treatment|Withdrawal by Subject|25
7494687|NCT03519087|25988606|P5|Clinic Evaluation|Protocol Violation|0
7494688|NCT03519087|25988607|P4|Clinic Evaluation|Protocol Violation|0
7494689|NCT03519087|25988608|P3|Clinic Evaluation|Protocol Violation|0
7494690|NCT03519087|25988609|P2|Clinic Evaluation|Protocol Violation|0
7494691|NCT03519087|25988610|P1|Clinic Evaluation|Protocol Violation|1
7494692|NCT03519087|25988606|P5|Clinic Evaluation|Physician Decision|0
7494693|NCT03519087|25988607|P4|Clinic Evaluation|Physician Decision|0
7494694|NCT03519087|25988608|P3|Clinic Evaluation|Physician Decision|0
7494695|NCT03519087|25988609|P2|Clinic Evaluation|Physician Decision|18
7494696|NCT03519087|25988610|P1|Clinic Evaluation|Physician Decision|15
7494697|NCT03518840|25988646|P1|Overall Study|Lost to Follow-up|6
7494698|NCT03518658|25988655|P2|Overall Study|Other|0
7494699|NCT03518658|25988656|P1|Overall Study|Other|51
7494700|NCT03518125|25988670|P6|Overall Study|Missed Day 394 Visit|0
7494701|NCT03518125|25988671|P5|Overall Study|Missed Day 394 Visit|0
7494702|NCT03518125|25988672|P4|Overall Study|Missed Day 394 Visit|0
7494703|NCT03518125|25988673|P3|Overall Study|Missed Day 394 Visit|0
7494704|NCT03518125|25988674|P2|Overall Study|Missed Day 394 Visit|0
7494705|NCT03518125|25988675|P1|Overall Study|Missed Day 394 Visit|1
7494706|NCT03518125|25988670|P6|Overall Study|Withdrawal by Subject|3
7494707|NCT03518125|25988671|P5|Overall Study|Withdrawal by Subject|1
7494708|NCT03518125|25988672|P4|Overall Study|Withdrawal by Subject|1
7494709|NCT03518125|25988673|P3|Overall Study|Withdrawal by Subject|0
7494710|NCT03518125|25988674|P2|Overall Study|Withdrawal by Subject|1
7494711|NCT03518125|25988675|P1|Overall Study|Withdrawal by Subject|1
7494712|NCT03518125|25988670|P6|Overall Study|Physician Decision|0
7494713|NCT03518125|25988671|P5|Overall Study|Physician Decision|0
7494714|NCT03518125|25988672|P4|Overall Study|Physician Decision|0
7494715|NCT03518125|25988673|P3|Overall Study|Physician Decision|0
7494716|NCT03518125|25988674|P2|Overall Study|Physician Decision|1
7494717|NCT03518125|25988675|P1|Overall Study|Physician Decision|0
7494718|NCT03518125|25988670|P6|Overall Study|Lost to Follow-up|5
7494719|NCT03518125|25988671|P5|Overall Study|Lost to Follow-up|3
7494720|NCT03518125|25988672|P4|Overall Study|Lost to Follow-up|0
7494721|NCT03518125|25988673|P3|Overall Study|Lost to Follow-up|0
7494722|NCT03518125|25988674|P2|Overall Study|Lost to Follow-up|2
7494723|NCT03518125|25988675|P1|Overall Study|Lost to Follow-up|0
7494724|NCT03518008|25988773|P2|Period 2, Second Week of Wear|Family emergency|1
7494725|NCT03518008|25988774|P1|Period 2, Second Week of Wear|Family emergency|0
7494726|NCT03517566|25988785|P5|Overall Study|Subject Decision /Guardian Decision|8
7494727|NCT03517566|25988786|P4|Overall Study|Subject Decision /Guardian Decision|8
7494728|NCT03517566|25988787|P3|Overall Study|Subject Decision /Guardian Decision|5
7494729|NCT03517566|25988788|P2|Overall Study|Subject Decision /Guardian Decision|8
7494730|NCT03517566|25988789|P1|Overall Study|Subject Decision /Guardian Decision|9
7494731|NCT03517566|25988785|P5|Overall Study|Study terminated by Sponsor|12
7494732|NCT03517566|25988786|P4|Overall Study|Study terminated by Sponsor|14
7494733|NCT03517566|25988787|P3|Overall Study|Study terminated by Sponsor|6
7494734|NCT03517566|25988788|P2|Overall Study|Study terminated by Sponsor|5
7494735|NCT03517566|25988789|P1|Overall Study|Study terminated by Sponsor|11
7494736|NCT03517566|25988785|P5|Overall Study|Protocol Deviation|1
7494737|NCT03517566|25988786|P4|Overall Study|Protocol Deviation|1
7494738|NCT03517566|25988787|P3|Overall Study|Protocol Deviation|0
7494739|NCT03517566|25988788|P2|Overall Study|Protocol Deviation|1
7494740|NCT03517566|25988789|P1|Overall Study|Protocol Deviation|0
7494741|NCT03517566|25988785|P5|Overall Study|Pregnancy|0
7494742|NCT03517566|25988786|P4|Overall Study|Pregnancy|0
7494743|NCT03517566|25988787|P3|Overall Study|Pregnancy|0
7494744|NCT03517566|25988788|P2|Overall Study|Pregnancy|1
7494745|NCT03517566|25988789|P1|Overall Study|Pregnancy|0
7494746|NCT03517566|25988785|P5|Overall Study|Physician Decision|0
7494747|NCT03517566|25988786|P4|Overall Study|Physician Decision|1
7494748|NCT03517566|25988787|P3|Overall Study|Physician Decision|0
7494749|NCT03517566|25988788|P2|Overall Study|Physician Decision|1
7494750|NCT03517566|25988789|P1|Overall Study|Physician Decision|1
7494751|NCT03517566|25988785|P5|Overall Study|Lost to Follow-up|0
7494752|NCT03517566|25988786|P4|Overall Study|Lost to Follow-up|1
7494753|NCT03517566|25988787|P3|Overall Study|Lost to Follow-up|1
7494754|NCT03517566|25988788|P2|Overall Study|Lost to Follow-up|1
7494755|NCT03517566|25988789|P1|Overall Study|Lost to Follow-up|3
7494756|NCT03517566|25988785|P5|Overall Study|Lack of Efficacy|4
7494757|NCT03517566|25988786|P4|Overall Study|Lack of Efficacy|1
7494758|NCT03517566|25988787|P3|Overall Study|Lack of Efficacy|1
7494759|NCT03517566|25988788|P2|Overall Study|Lack of Efficacy|2
7494760|NCT03517566|25988789|P1|Overall Study|Lack of Efficacy|3
7494761|NCT03517566|25988785|P5|Overall Study|Adverse Event|7
7494762|NCT03517566|25988786|P4|Overall Study|Adverse Event|8
7494763|NCT03517566|25988787|P3|Overall Study|Adverse Event|2
7494764|NCT03517566|25988788|P2|Overall Study|Adverse Event|2
7494765|NCT03517566|25988789|P1|Overall Study|Adverse Event|5
7494766|NCT03517436|25988832|P1|Overall Study|Did not receive study valve.|1
7494767|NCT03517436|25988832|P1|Overall Study|Withdrawal by Subject|4
7494768|NCT03517436|25988832|P1|Overall Study|Death|3
7494769|NCT03515941|25988855|P2|Overall Study|Adverse Event|0
7494770|NCT03515941|25988856|P1|Overall Study|Adverse Event|1
7494771|NCT03515824|25988867|P4|Overall Study|Status not recorded|0
7494772|NCT03515824|25988868|P3|Overall Study|Status not recorded|2
7494773|NCT03515824|25988869|P2|Overall Study|Status not recorded|0
7494774|NCT03515824|25988870|P1|Overall Study|Status not recorded|0
7494775|NCT03515824|25988867|P4|Overall Study|Study terminated by sponsor|0
7494776|NCT03515824|25988868|P3|Overall Study|Study terminated by sponsor|6
7494777|NCT03515824|25988869|P2|Overall Study|Study terminated by sponsor|1
7494778|NCT03515824|25988870|P1|Overall Study|Study terminated by sponsor|0
7494779|NCT03515824|25988867|P4|Overall Study|Lost to Follow-up|0
7494780|NCT03515824|25988868|P3|Overall Study|Lost to Follow-up|1
7494781|NCT03515824|25988869|P2|Overall Study|Lost to Follow-up|1
7494782|NCT03515824|25988870|P1|Overall Study|Lost to Follow-up|0
7494783|NCT03515824|25988867|P4|Overall Study|Death|0
7494784|NCT03515824|25988868|P3|Overall Study|Death|6
7494785|NCT03515824|25988869|P2|Overall Study|Death|2
7494786|NCT03515824|25988870|P1|Overall Study|Death|3
7494787|NCT03514641|25988940|P4|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7494788|NCT03514641|25988941|P3|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7494789|NCT03514641|25988942|P2|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7494790|NCT03514641|25988943|P1|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7494791|NCT03514641|25988940|P4|603B: 24-36 Week Study Period|Lost to Follow-up|6
7494792|NCT03514641|25988941|P3|603B: 24-36 Week Study Period|Lost to Follow-up|6
7494793|NCT03514641|25988942|P2|603B: 24-36 Week Study Period|Lost to Follow-up|0
7494794|NCT03514641|25988943|P1|603B: 24-36 Week Study Period|Lost to Follow-up|0
7494795|NCT03514641|25988940|P4|603B: 24-36 Week Study Period|Withdrawal by Subject|3
7494796|NCT03514641|25988941|P3|603B: 24-36 Week Study Period|Withdrawal by Subject|2
7494797|NCT03514641|25988942|P2|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7494798|NCT03514641|25988943|P1|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7494799|NCT03514641|25988940|P4|603B: 24-36 Week Study Period|Adverse Event|1
7494800|NCT03514641|25988941|P3|603B: 24-36 Week Study Period|Adverse Event|3
7494801|NCT03514641|25988942|P2|603B: 24-36 Week Study Period|Adverse Event|0
7494802|NCT03514641|25988943|P1|603B: 24-36 Week Study Period|Adverse Event|0
7494803|NCT03514641|25988940|P4|603B: 24-36 Week Study Period|Protocol Violation|2
7494804|NCT03514641|25988941|P3|603B: 24-36 Week Study Period|Protocol Violation|0
7494805|NCT03514641|25988942|P2|603B: 24-36 Week Study Period|Protocol Violation|0
7494806|NCT03514641|25988943|P1|603B: 24-36 Week Study Period|Protocol Violation|0
7494807|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7494808|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7494809|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
7494810|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7494811|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|Lack of Efficacy|0
7494812|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|Lack of Efficacy|0
7494813|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|Lack of Efficacy|0
7494814|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|Lack of Efficacy|1
7494815|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|Physician Decision|0
7494816|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|Physician Decision|0
7494817|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|Physician Decision|0
7494818|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|Physician Decision|1
7494819|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|Lost to Follow-up|0
7494820|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|Lost to Follow-up|0
7494821|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|Lost to Follow-up|9
7494822|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|Lost to Follow-up|10
7494823|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7494824|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7494825|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|Withdrawal by Subject|5
7494826|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|Withdrawal by Subject|7
7494827|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|Adverse Event|0
7494828|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|Adverse Event|0
7494829|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|Adverse Event|2
7494830|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|Adverse Event|5
7494831|NCT03514641|25988940|P4|603A: 0-12 Week Study Period|Protocol Violation|0
7494832|NCT03514641|25988941|P3|603A: 0-12 Week Study Period|Protocol Violation|0
7494833|NCT03514641|25988942|P2|603A: 0-12 Week Study Period|Protocol Violation|3
7494834|NCT03514641|25988943|P1|603A: 0-12 Week Study Period|Protocol Violation|3
7494835|NCT03513588|25989096|P3|Overall Study|Death|1
7494836|NCT03513588|25989097|P2|Overall Study|Death|0
7494837|NCT03513588|25989098|P1|Overall Study|Death|0
7494838|NCT03513588|25989096|P3|Overall Study|Study dosing paused by sponsor|0
7494839|NCT03513588|25989097|P2|Overall Study|Study dosing paused by sponsor|1
7494840|NCT03513588|25989098|P1|Overall Study|Study dosing paused by sponsor|1
7494841|NCT03513588|25989096|P3|Overall Study|Lost to Follow-up|1
7494842|NCT03513588|25989097|P2|Overall Study|Lost to Follow-up|1
7494843|NCT03513588|25989098|P1|Overall Study|Lost to Follow-up|0
7494844|NCT03512353|25989141|P1|Overall Study|Death|1
7494845|NCT03512353|25989141|P1|Overall Study|Sponsor Decision|3
7494846|NCT03512288|25989169|P2|Overall Study|Randomized but not treated|1
7494847|NCT03512288|25989170|P1|Overall Study|Randomized but not treated|1
7494848|NCT03512288|25989169|P2|Overall Study|Other|1
7494849|NCT03512288|25989170|P1|Overall Study|Other|1
7494850|NCT03512288|25989169|P2|Overall Study|Withdrawal by parent/guardian|18
7494851|NCT03512288|25989170|P1|Overall Study|Withdrawal by parent/guardian|14
7494852|NCT03512288|25989169|P2|Overall Study|No longer met eligibility criteria|2
7494853|NCT03512288|25989170|P1|Overall Study|No longer met eligibility criteria|5
7494854|NCT03512288|25989169|P2|Overall Study|Medication error without associated adverse event|0
7494855|NCT03512288|25989170|P1|Overall Study|Medication error without associated adverse event|1
7494856|NCT03512288|25989169|P2|Overall Study|Protocol Violation|4
7494857|NCT03512288|25989170|P1|Overall Study|Protocol Violation|6
7494858|NCT03512288|25989169|P2|Overall Study|Physician Decision|2
7494859|NCT03512288|25989170|P1|Overall Study|Physician Decision|0
7494860|NCT03512288|25989169|P2|Overall Study|Lost to Follow-up|15
7494861|NCT03512288|25989170|P1|Overall Study|Lost to Follow-up|12
7494862|NCT03512288|25989169|P2|Overall Study|Adverse Event|0
7494863|NCT03512288|25989170|P1|Overall Study|Adverse Event|1
7494864|NCT03512210|25989204|P1|Overall Study|Protocol Violation|1
7494865|NCT03512210|25989204|P1|Overall Study|Lost to Follow-up|3
7494866|NCT03512028|25989244|P2|Overall Study|Protocol Violation|0
7494867|NCT03512028|25989245|P1|Overall Study|Protocol Violation|2
7494868|NCT03512028|25989244|P2|Overall Study|Withdrawal by Subject|0
7494869|NCT03512028|25989245|P1|Overall Study|Withdrawal by Subject|2
7494870|NCT03511378|25989317|P2|Overall Study|Patient not coming or schedule visit|0
7494871|NCT03511378|25989318|P1|Overall Study|Patient not coming or schedule visit|1
7494872|NCT03511378|25989317|P2|Overall Study|Withdrawal by Subject|2
7494873|NCT03511378|25989318|P1|Overall Study|Withdrawal by Subject|2
7494874|NCT03511326|25989330|P1|Overall Study|Withdrawal by Subject|1
7494875|NCT03511105|25989337|P2|Overall Study|Withdrew consent|0
7494876|NCT03511105|25989338|P1|Overall Study|Withdrew consent|1
7494877|NCT03511105|25989337|P2|Overall Study|Adverse Event|0
7494878|NCT03511105|25989338|P1|Overall Study|Adverse Event|1
7494879|NCT03511053|25989392|P1|Overall Study|Withdrawal by Subject|1
7494880|NCT03510910|25989423|P2|Overall Study|Incomplete Survey|3
7494881|NCT03510910|25989424|P1|Overall Study|Incomplete Survey|2
7494882|NCT03510715|25989440|P2|Overall Study|Adverse Event|0
7494883|NCT03510715|25989441|P1|Overall Study|Adverse Event|1
7494884|NCT03510663|25989467|P8|Overall Study|Withdrawal by Subject|0
7494885|NCT03510663|25989468|P7|Overall Study|Withdrawal by Subject|0
7494886|NCT03510663|25989469|P6|Overall Study|Withdrawal by Subject|0
7494887|NCT03510663|25989470|P5|Overall Study|Withdrawal by Subject|0
7494888|NCT03510663|25989471|P4|Overall Study|Withdrawal by Subject|0
7494889|NCT03510663|25989472|P3|Overall Study|Withdrawal by Subject|0
7494890|NCT03510663|25989473|P2|Overall Study|Withdrawal by Subject|1
7494891|NCT03510663|25989474|P1|Overall Study|Withdrawal by Subject|0
7494892|NCT03510455|25989505|P1|Overall Study|Physician Decision|1
7494893|NCT03510273|25989528|P1|Overall Study|Moved away from study area|4
7494894|NCT03510273|25989528|P1|Overall Study|Care outside study, ineligible to cont.|3
7494895|NCT03510273|25989528|P1|Overall Study|Withdrawal by Subject|2
7494896|NCT03510182|25989551|P1|Overall Study|Withdrawal by Subject|2
7494897|NCT03509948|25989561|P2|Overall Study|Protocol Violation|1
7494898|NCT03509948|25989562|P1|Overall Study|Protocol Violation|0
7494899|NCT03509675|25989630|P2|Second Intervention )7 Days)|Lost Rinse B|0
7494900|NCT03509675|25989631|P1|Second Intervention )7 Days)|Lost Rinse B|1
7494901|NCT03509675|25989630|P2|Second Intervention )7 Days)|Withdrawal by Subject|0
7494902|NCT03509675|25989631|P1|Second Intervention )7 Days)|Withdrawal by Subject|1
7494903|NCT03509675|25989630|P2|First Intervention (7 Days)|Lack of Efficacy|1
7494904|NCT03509675|25989631|P1|First Intervention (7 Days)|Lack of Efficacy|2
7494905|NCT03509675|25989630|P2|First Intervention (7 Days)|Lost to Follow-up|3
7494906|NCT03509675|25989631|P1|First Intervention (7 Days)|Lost to Follow-up|3
7494907|NCT03509350|25989639|P2|Overall Study|Withdrawal by Subject|2
7494908|NCT03509350|25989640|P1|Overall Study|Withdrawal by Subject|0
7494909|NCT03509207|25989682|P1|Overall Study|Death|2
7494910|NCT03508843|25989687|P1|Overall Study|technical difficulties|2
7494911|NCT03508843|25989687|P1|Overall Study|Withdrawal by Subject|1
7494912|NCT03508830|25989695|P2|Overall Study|Physician Decision|2
7494913|NCT03508830|25989696|P1|Overall Study|Physician Decision|2
7494914|NCT03508830|25989695|P2|Overall Study|Withdrawal by Subject|4
7494915|NCT03508830|25989696|P1|Overall Study|Withdrawal by Subject|3
7494916|NCT03508609|25989767|P1|Overall Study|Withdrawal by Subject|1
7494917|NCT03508050|25989779|P2|Overall Study|Sustained desaturation|1
7494918|NCT03508050|25989780|P1|Overall Study|Sustained desaturation|0
7494919|NCT03508050|25989779|P2|Overall Study|Negative biopsy, surgery cancelled|1
7494920|NCT03508050|25989780|P1|Overall Study|Negative biopsy, surgery cancelled|3
7494921|NCT03508050|25989779|P2|Overall Study|Mucus plug|0
7494922|NCT03508050|25989780|P1|Overall Study|Mucus plug|1
7494923|NCT03508050|25989779|P2|Overall Study|Pleural adhesions|0
7494924|NCT03508050|25989780|P1|Overall Study|Pleural adhesions|1
7494925|NCT03506477|25989870|P2|Overall Study|Withdrawal by Subject|0
7494926|NCT03506477|25989871|P1|Overall Study|Withdrawal by Subject|1
7494927|NCT03506425|25989900|P3|Overall Study|Withdrawal by Subject|1
7494928|NCT03506425|25989901|P2|Overall Study|Withdrawal by Subject|0
7494929|NCT03506425|25989902|P1|Overall Study|Withdrawal by Subject|0
7494930|NCT03506425|25989900|P3|Overall Study|Death|0
7494931|NCT03506425|25989901|P2|Overall Study|Death|0
7494932|NCT03506425|25989902|P1|Overall Study|Death|1
7494933|NCT03506425|25989900|P3|Overall Study|Adverse Event|0
7494934|NCT03506425|25989901|P2|Overall Study|Adverse Event|3
7494935|NCT03506425|25989902|P1|Overall Study|Adverse Event|1
7494936|NCT03505749|25989946|P2|Overall Study|Discharged from treatment|6
7494937|NCT03505749|25989947|P1|Overall Study|Discharged from treatment|3
7494938|NCT03505749|25989946|P2|Overall Study|Withdrawal by Subject|0
7494939|NCT03505749|25989947|P1|Overall Study|Withdrawal by Subject|6
7494940|NCT03505749|25989946|P2|Overall Study|Lost to Follow-up|11
7494941|NCT03505749|25989947|P1|Overall Study|Lost to Follow-up|7
7494942|NCT03505593|25989967|P1|Overall Study|Obstruction by Endotracheal tube|1
7494943|NCT03505593|25989967|P1|Overall Study|Unable to pass through esophagus|1
7494944|NCT03505593|25989967|P1|Overall Study|Anatomical abnormality|1
7494945|NCT03505593|25989967|P1|Overall Study|Died before procedure|1
7494946|NCT03505593|25989967|P1|Overall Study|Withdrawal by Subject|1
7494947|NCT03505021|25990066|P2|Overall Study|Personal reason|12
7494948|NCT03505021|25990067|P1|Overall Study|Personal reason|21
7494949|NCT03505021|25990066|P2|Overall Study|Other|5
7494950|NCT03505021|25990067|P1|Overall Study|Other|11
7494951|NCT03505021|25990066|P2|Overall Study|Disease progression|17
7494952|NCT03505021|25990067|P1|Overall Study|Disease progression|33
7494953|NCT03505021|25990066|P2|Overall Study|Adverse Event|9
7494954|NCT03505021|25990067|P1|Overall Study|Adverse Event|26
7494955|NCT03505021|25990066|P2|Overall Study|Lost to Follow-up|3
7494956|NCT03505021|25990067|P1|Overall Study|Lost to Follow-up|5
7494957|NCT03505021|25990066|P2|Overall Study|Consent withdrawn by subject|1
7494958|NCT03505021|25990067|P1|Overall Study|Consent withdrawn by subject|6
7494959|NCT03505021|25990066|P2|Overall Study|Death|8
7494960|NCT03505021|25990067|P1|Overall Study|Death|9
7494961|NCT03505021|25990066|P2|Overall Study|Protocol Violation|0
7494962|NCT03505021|25990067|P1|Overall Study|Protocol Violation|1
7494995|NCT03504852|25990121|P3|Overall Study|Adverse Event|2
7494996|NCT03504852|25990122|P2|Overall Study|Adverse Event|8
7494997|NCT03504852|25990123|P1|Overall Study|Adverse Event|4
7494998|NCT03504852|25990121|P3|Overall Study|Death|0
7494999|NCT03504852|25990122|P2|Overall Study|Death|1
7495000|NCT03504852|25990123|P1|Overall Study|Death|0
7495001|NCT03504852|25990121|P3|Overall Study|Lack of Efficacy|0
7495002|NCT03504852|25990122|P2|Overall Study|Lack of Efficacy|2
7495003|NCT03504852|25990123|P1|Overall Study|Lack of Efficacy|1
7495004|NCT03504852|25990121|P3|Overall Study|New therapy for study indication|0
7495005|NCT03504852|25990122|P2|Overall Study|New therapy for study indication|0
7495006|NCT03504852|25990123|P1|Overall Study|New therapy for study indication|1
7495007|NCT03504852|25990121|P3|Overall Study|Lost to Follow-up|0
7495008|NCT03504852|25990122|P2|Overall Study|Lost to Follow-up|1
7495009|NCT03504852|25990123|P1|Overall Study|Lost to Follow-up|4
7495010|NCT03504852|25990121|P3|Overall Study|Withdrawal by Subject|1
7495011|NCT03504852|25990122|P2|Overall Study|Withdrawal by Subject|5
7495012|NCT03504852|25990123|P1|Overall Study|Withdrawal by Subject|5
7495013|NCT03504852|25990121|P3|Overall Study|Withdrawal of informed consent|0
7495014|NCT03504852|25990122|P2|Overall Study|Withdrawal of informed consent|1
7495015|NCT03504852|25990123|P1|Overall Study|Withdrawal of informed consent|2
7495016|NCT03504189|25990146|P1|Overall Study|Device Failure|2
7495017|NCT03504189|25990146|P1|Overall Study|Screening Failure|1
7495018|NCT03504189|25990146|P1|Overall Study|Withdrawal by Subject|1
7495019|NCT03503188|25990181|P2|Overall Study|Non eligible in the sub study|1
7495020|NCT03503188|25990182|P1|Overall Study|Non eligible in the sub study|0
7495021|NCT03503162|25990198|P1|Overall Study|did not meet eligibility|1
7495022|NCT03502798|25990221|P2|Overall Study|equipment failure|7
7495023|NCT03502798|25990222|P1|Overall Study|equipment failure|0
7495024|NCT03502681|25990234|P2|Overall Study|Disease Progression|1
7495025|NCT03502681|25990235|P1|Overall Study|Disease Progression|2
7495026|NCT03502681|25990234|P2|Overall Study|Adverse Event|1
7495027|NCT03502681|25990235|P1|Overall Study|Adverse Event|1
7495028|NCT03502616|25990256|P2|Week 16 to Week 48|Lost to Follow-up|0
7495029|NCT03502616|25990257|P1|Week 16 to Week 48|Lost to Follow-up|1
7495030|NCT03502616|25990256|P2|Week 16 to Week 48|Withdrawal by Subject|6
7495031|NCT03502616|25990257|P1|Week 16 to Week 48|Withdrawal by Subject|6
7495032|NCT03502616|25990256|P2|Up to Week 16|Randomized, but not treated|0
7495033|NCT03502616|25990257|P1|Up to Week 16|Randomized, but not treated|1
7495034|NCT03502616|25990256|P2|Up to Week 16|Lost to Follow-up|1
7495035|NCT03502616|25990257|P1|Up to Week 16|Lost to Follow-up|0
7495036|NCT03502616|25990256|P2|Up to Week 16|Withdrawal by Subject|2
7495037|NCT03502616|25990257|P1|Up to Week 16|Withdrawal by Subject|1
7495038|NCT03502070|25990351|P1|Overall Study|Screen Failure|1
7495039|NCT03502070|25990351|P1|Overall Study|Withdrawal by Subject|1
7495040|NCT03501277|25990378|P4|Intervention Period 3 (4 Days)|Adverse Event|1
7495041|NCT03501277|25990379|P3|Intervention Period 3 (4 Days)|Adverse Event|0
7495042|NCT03501277|25990380|P2|Intervention Period 3 (4 Days)|Adverse Event|0
7495043|NCT03501277|25990381|P1|Intervention Period 3 (4 Days)|Adverse Event|0
7495044|NCT03501277|25990378|P4|Intervention Period 2 (4 Days)|Adverse Event|1
7495045|NCT03501277|25990379|P3|Intervention Period 2 (4 Days)|Adverse Event|0
7495046|NCT03501277|25990380|P2|Intervention Period 2 (4 Days)|Adverse Event|0
7495047|NCT03501277|25990381|P1|Intervention Period 2 (4 Days)|Adverse Event|0
7495048|NCT03501277|25990378|P4|Intervention Period 1 (4 Days)|Adverse Event|1
7495049|NCT03501277|25990379|P3|Intervention Period 1 (4 Days)|Adverse Event|0
7495050|NCT03501277|25990380|P2|Intervention Period 1 (4 Days)|Adverse Event|0
7495051|NCT03501277|25990381|P1|Intervention Period 1 (4 Days)|Adverse Event|0
7495052|NCT03501277|25990378|P4|Intervention Period 1 (4 Days)|Other|0
7495053|NCT03501277|25990379|P3|Intervention Period 1 (4 Days)|Other|1
7495054|NCT03501277|25990380|P2|Intervention Period 1 (4 Days)|Other|0
7495055|NCT03501277|25990381|P1|Intervention Period 1 (4 Days)|Other|0
7495056|NCT03500692|25990506|P1|Overall Study|Termination Reasons|3
7495057|NCT03500692|25990506|P1|Overall Study|Missed visit|30
7495058|NCT03500692|25990506|P1|Overall Study|Death|76
7495059|NCT03500679|25990513|P2|Overall Study|Withdrawal by Subject|0
7495060|NCT03500679|25990514|P1|Overall Study|Withdrawal by Subject|3
7495061|NCT03500679|25990513|P2|Overall Study|Lost to Follow-up|3
7495062|NCT03500679|25990514|P1|Overall Study|Lost to Follow-up|6
7495063|NCT03500341|25990581|P1|Overall Study|Withdrawn prior to Completion|2
7495064|NCT03500224|25990609|P1|Overall Study|Withdrawal by Subject|2
7495065|NCT03500211|25990648|P2|Overall Study|Withdrawal by Subject|1
7495066|NCT03500211|25990649|P1|Overall Study|Withdrawal by Subject|1
7495067|NCT03500198|25990665|P2|Overall Study|Lost to Follow-up|1
7495068|NCT03500198|25990666|P1|Overall Study|Lost to Follow-up|0
7495069|NCT03500159|25990682|P2|Overall Study|Study Terminated|1
7495070|NCT03500159|25990683|P1|Overall Study|Study Terminated|2
7495071|NCT03499873|25990692|P3|Overall Study|Investigational Product (IP) Missed dose compliance|0
7495072|NCT03499873|25990693|P2|Overall Study|Investigational Product (IP) Missed dose compliance|1
7495073|NCT03499873|25990694|P1|Overall Study|Investigational Product (IP) Missed dose compliance|1
7495074|NCT03499873|25990692|P3|Overall Study|Miscellaneous|2
7495075|NCT03499873|25990693|P2|Overall Study|Miscellaneous|2
7495076|NCT03499873|25990694|P1|Overall Study|Miscellaneous|1
7495077|NCT03499873|25990692|P3|Overall Study|Concomitant therapy|7
7495078|NCT03499873|25990693|P2|Overall Study|Concomitant therapy|4
7495079|NCT03499873|25990694|P1|Overall Study|Concomitant therapy|5
7495080|NCT03499873|25990692|P3|Overall Study|Administrative reasons|0
7495081|NCT03499873|25990693|P2|Overall Study|Administrative reasons|1
7495082|NCT03499873|25990694|P1|Overall Study|Administrative reasons|0
7495083|NCT03499873|25990692|P3|Overall Study|Physician Decision|0
7495084|NCT03499873|25990693|P2|Overall Study|Physician Decision|0
7495085|NCT03499873|25990694|P1|Overall Study|Physician Decision|1
7495086|NCT03499873|25990692|P3|Overall Study|Adverse Event|6
7495087|NCT03499873|25990693|P2|Overall Study|Adverse Event|3
7495088|NCT03499873|25990694|P1|Overall Study|Adverse Event|8
7495089|NCT03499873|25990692|P3|Overall Study|Subjects condition worsened|11
7495090|NCT03499873|25990693|P2|Overall Study|Subjects condition worsened|3
7495091|NCT03499873|25990694|P1|Overall Study|Subjects condition worsened|0
7495092|NCT03499873|25990692|P3|Overall Study|Withdrawal by Subject|1
7495093|NCT03499873|25990693|P2|Overall Study|Withdrawal by Subject|6
7495094|NCT03499873|25990694|P1|Overall Study|Withdrawal by Subject|4
7495095|NCT03499067|25990702|P2|First Intervention|Withdrawal by Subject|6
7495096|NCT03499067|25990703|P1|First Intervention|Withdrawal by Subject|3
7495097|NCT03499067|25990702|P2|First Intervention|Physician Decision|1
7495098|NCT03499067|25990703|P1|First Intervention|Physician Decision|2
7495099|NCT03499028|25990745|P2|Overall Study|Unplanned SNF discharge|8
7495100|NCT03499028|25990746|P1|Overall Study|Unplanned SNF discharge|5
7495101|NCT03499028|25990745|P2|Overall Study|Withdrawal by Subject|8
7495102|NCT03499028|25990746|P1|Overall Study|Withdrawal by Subject|5
7495103|NCT03499028|25990745|P2|Overall Study|Lost to Follow-up|9
7495104|NCT03499028|25990746|P1|Overall Study|Lost to Follow-up|12
7495105|NCT03498560|25990770|P1|Overall Study|Death|1
7495106|NCT03498560|25990770|P1|Overall Study|Lost to Follow-up|4
7495107|NCT03498560|25990770|P1|Overall Study|Withdrawal by Subject|14
7495108|NCT03498560|25990770|P1|Overall Study|Found Ineligible|2
7495109|NCT03498287|25990787|P2|Overall Study|Adverse Event|1
7495110|NCT03498287|25990788|P1|Overall Study|Adverse Event|0
7495111|NCT03498287|25990787|P2|Overall Study|Protocol Violation|4
7495112|NCT03498287|25990788|P1|Overall Study|Protocol Violation|0
7495113|NCT03498287|25990787|P2|Overall Study|Withdrawal by Subject|0
7495114|NCT03498287|25990788|P1|Overall Study|Withdrawal by Subject|3
7495115|NCT03497130|25990913|P2|Overall Study|Lost to Follow-up|1
7495116|NCT03497130|25990914|P1|Overall Study|Lost to Follow-up|1
7495117|NCT03497039|25990926|P2|Overall Study|Protocol Violation|1
7495118|NCT03497039|25990927|P1|Overall Study|Protocol Violation|0
7495119|NCT03497039|25990926|P2|Overall Study|Withdrawal by Subject|0
7495120|NCT03497039|25990927|P1|Overall Study|Withdrawal by Subject|1
7495121|NCT03496298|25991090|P3|Overall Study|Randomized and not treated|1
7495122|NCT03496298|25991091|P2|Overall Study|Randomized and not treated|1
7495123|NCT03496298|25991092|P1|Overall Study|Randomized and not treated|1
7495124|NCT03496298|25991090|P3|Overall Study|Other|23
7495125|NCT03496298|25991091|P2|Overall Study|Other|20
7495126|NCT03496298|25991092|P1|Overall Study|Other|29
7495127|NCT03496298|25991090|P3|Overall Study|Withdrawal by Subject|151
7495128|NCT03496298|25991091|P2|Overall Study|Withdrawal by Subject|154
7495129|NCT03496298|25991092|P1|Overall Study|Withdrawal by Subject|176
7495130|NCT03496298|25991090|P3|Overall Study|Physician decision (other than Adverse event)|10
7495131|NCT03496298|25991091|P2|Overall Study|Physician decision (other than Adverse event)|17
7495132|NCT03496298|25991092|P1|Overall Study|Physician decision (other than Adverse event)|12
7495133|NCT03496298|25991090|P3|Overall Study|Study terminated by Sponsor|1071
7495134|NCT03496298|25991091|P2|Overall Study|Study terminated by Sponsor|1063
7495135|NCT03496298|25991092|P1|Overall Study|Study terminated by Sponsor|1050
7495136|NCT03496298|25991090|P3|Overall Study|Adverse Event|79
7495137|NCT03496298|25991091|P2|Overall Study|Adverse Event|68
7495138|NCT03496298|25991092|P1|Overall Study|Adverse Event|49
7495139|NCT03495908|25991117|P2|Overall Study|No documented reason|2
7495140|NCT03495908|25991118|P1|Overall Study|No documented reason|0
7495141|NCT03495908|25991117|P2|Overall Study|Physician Decision|4
7495142|NCT03495908|25991118|P1|Overall Study|Physician Decision|5
7495143|NCT03495908|25991117|P2|Overall Study|Death|0
7495144|NCT03495908|25991118|P1|Overall Study|Death|1
7495145|NCT03495908|25991117|P2|Overall Study|Adverse Event|2
7495146|NCT03495908|25991118|P1|Overall Study|Adverse Event|0
7495147|NCT03495908|25991117|P2|Overall Study|Lost to Follow-up|4
7495148|NCT03495908|25991118|P1|Overall Study|Lost to Follow-up|1
7495149|NCT03495908|25991117|P2|Overall Study|Withdrawal by Subject|1
7495150|NCT03495908|25991118|P1|Overall Study|Withdrawal by Subject|3
7495151|NCT03495869|25991140|P4|Overall Study|Dropped from study|4
7495152|NCT03495869|25991141|P3|Overall Study|Dropped from study|2
7495153|NCT03495869|25991142|P2|Overall Study|Dropped from study|7
7495154|NCT03495869|25991143|P1|Overall Study|Dropped from study|0
7495155|NCT03495869|25991140|P4|Overall Study|Withdrawal by Subject|3
7495156|NCT03495869|25991141|P3|Overall Study|Withdrawal by Subject|0
7495157|NCT03495869|25991142|P2|Overall Study|Withdrawal by Subject|3
7495158|NCT03495869|25991143|P1|Overall Study|Withdrawal by Subject|0
7495159|NCT03495869|25991140|P4|Overall Study|Lost to Follow-up|14
7495160|NCT03495869|25991141|P3|Overall Study|Lost to Follow-up|8
7495161|NCT03495869|25991142|P2|Overall Study|Lost to Follow-up|17
7495162|NCT03495869|25991143|P1|Overall Study|Lost to Follow-up|4
7495163|NCT03495817|25991179|P1|26 Week Extension|Lost to Follow-up|2
7495164|NCT03495817|25991179|P1|26 Week Open Label|Lost to Follow-up|1
7495165|NCT03495817|25991179|P1|26 Week Open Label|Withdrawal by Subject|4
7495166|NCT03495817|25991179|P1|26 Week Open Label|Adverse Event|3
7495167|NCT03495102|25991197|P3|Overall Study|Participant was in Rehabilitation|0
7495168|NCT03495102|25991198|P2|Overall Study|Participant was in Rehabilitation|0
7495169|NCT03495102|25991199|P1|Overall Study|Participant was in Rehabilitation|1
7495170|NCT03495102|25991197|P3|Overall Study|Relocated to Another Country|0
7495171|NCT03495102|25991198|P2|Overall Study|Relocated to Another Country|1
7495172|NCT03495102|25991199|P1|Overall Study|Relocated to Another Country|0
7495173|NCT03495102|25991197|P3|Overall Study|Primary Care Physician Recommendation|0
7495174|NCT03495102|25991198|P2|Overall Study|Primary Care Physician Recommendation|1
7495175|NCT03495102|25991199|P1|Overall Study|Primary Care Physician Recommendation|0
7495176|NCT03495102|25991197|P3|Overall Study|Participant Duplicated at Another Site|1
7495177|NCT03495102|25991198|P2|Overall Study|Participant Duplicated at Another Site|0
7495178|NCT03495102|25991199|P1|Overall Study|Participant Duplicated at Another Site|0
7495179|NCT03495102|25991197|P3|Overall Study|Non-compliance|0
7495180|NCT03495102|25991198|P2|Overall Study|Non-compliance|0
7495181|NCT03495102|25991199|P1|Overall Study|Non-compliance|1
7495182|NCT03495102|25991197|P3|Overall Study|Site Closure|2
7495183|NCT03495102|25991198|P2|Overall Study|Site Closure|1
7495184|NCT03495102|25991199|P1|Overall Study|Site Closure|3
7495185|NCT03495102|25991197|P3|Overall Study|Protocol Violation|0
7495186|NCT03495102|25991198|P2|Overall Study|Protocol Violation|1
7495187|NCT03495102|25991199|P1|Overall Study|Protocol Violation|1
7495188|NCT03495102|25991197|P3|Overall Study|Withdrawal by Subject|18
7495189|NCT03495102|25991198|P2|Overall Study|Withdrawal by Subject|36
7495190|NCT03495102|25991199|P1|Overall Study|Withdrawal by Subject|25
7495191|NCT03495102|25991197|P3|Overall Study|Physician Decision|2
7495192|NCT03495102|25991198|P2|Overall Study|Physician Decision|0
7495193|NCT03495102|25991199|P1|Overall Study|Physician Decision|2
7495194|NCT03495102|25991197|P3|Overall Study|Lost to Follow-up|17
7495195|NCT03495102|25991198|P2|Overall Study|Lost to Follow-up|16
7495196|NCT03495102|25991199|P1|Overall Study|Lost to Follow-up|15
7495197|NCT03495102|25991197|P3|Overall Study|Death|4
7495198|NCT03495102|25991198|P2|Overall Study|Death|4
7495199|NCT03495102|25991199|P1|Overall Study|Death|3
7495200|NCT03495102|25991197|P3|Overall Study|Adverse Event|10
7495201|NCT03495102|25991198|P2|Overall Study|Adverse Event|7
7495202|NCT03495102|25991199|P1|Overall Study|Adverse Event|5
7495203|NCT03494985|25991229|P4|Overall Study|Other (Not specified)|0
7495204|NCT03494985|25991230|P3|Overall Study|Other (Not specified)|1
7495205|NCT03494985|25991231|P2|Overall Study|Other (Not specified)|1
7495206|NCT03494985|25991232|P1|Overall Study|Other (Not specified)|0
7495207|NCT03494985|25991229|P4|Overall Study|Other (Withdrawal of consent)|5
7495208|NCT03494985|25991230|P3|Overall Study|Other (Withdrawal of consent)|2
7495209|NCT03494985|25991231|P2|Overall Study|Other (Withdrawal of consent)|3
7495210|NCT03494985|25991232|P1|Overall Study|Other (Withdrawal of consent)|2
7495211|NCT03494985|25991229|P4|Overall Study|Adverse Event|0
7495212|NCT03494985|25991230|P3|Overall Study|Adverse Event|3
7495213|NCT03494985|25991231|P2|Overall Study|Adverse Event|2
7495214|NCT03494985|25991232|P1|Overall Study|Adverse Event|3
7495215|NCT03494816|25991266|P1|Overall Study|Adverse Event|1
7495216|NCT03494816|25991266|P1|Overall Study|Did not start trial treatment|1
7495217|NCT03494816|25991266|P1|Overall Study|Physician Decision|2
7495218|NCT03494816|25991266|P1|Overall Study|Protocol Violation|2
7495219|NCT03494725|25991276|P2|Overall Study|Antibiotic use|0
7495220|NCT03494725|25991277|P1|Overall Study|Antibiotic use|1
7495221|NCT03494725|25991276|P2|Overall Study|Withdrawal by Subject|2
7495222|NCT03494725|25991277|P1|Overall Study|Withdrawal by Subject|0
7495223|NCT03493854|25991349|P2|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
7495224|NCT03493854|25991350|P1|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
7495225|NCT03493854|25991349|P2|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
7495226|NCT03493854|25991350|P1|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
7495227|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
7495228|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
7495229|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
7495230|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
7495231|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
7495232|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
7495233|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
7495234|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
7495235|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
7495236|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
7495237|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
7495238|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
7495239|NCT03493854|25991349|P2|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
7495240|NCT03493854|25991350|P1|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
7495241|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
7495242|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
7495243|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
7495244|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
7495245|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
7495246|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
7495247|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
7495248|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
7495249|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
7495250|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
7495251|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
7495252|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
7495253|NCT03493854|25991349|P2|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
7495254|NCT03493854|25991350|P1|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
7495255|NCT03493698|25991396|P1|Treatment Period C|Withdrawal by Subject|1
7495256|NCT03493698|25991396|P1|Treatment Period C|Adverse Event|1
7495257|NCT03493542|25991425|P2|Overall Study|Withdrawal by Subject|6
7495258|NCT03493542|25991426|P1|Overall Study|Withdrawal by Subject|2
7495259|NCT03493542|25991425|P2|Overall Study|Withdrawal by parent or guardian|0
7495260|NCT03493542|25991426|P1|Overall Study|Withdrawal by parent or guardian|3
7495261|NCT03493542|25991425|P2|Overall Study|Ongoing|3
7495262|NCT03493542|25991426|P1|Overall Study|Ongoing|2
7495263|NCT03493386|25991450|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7495264|NCT03493386|25991451|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7495265|NCT03493386|25991452|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7495266|NCT03493386|25991453|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7495267|NCT03492554|25991573|P2|Overall Study|Protocol Violation|14
7495268|NCT03492554|25991574|P1|Overall Study|Protocol Violation|0
7495269|NCT03492281|25991626|P3|Overall Study|Captured as Other in Database|3
7495270|NCT03492281|25991627|P2|Overall Study|Captured as Other in Database|6
7495271|NCT03492281|25991628|P1|Overall Study|Captured as Other in Database|8
7495272|NCT03492281|25991626|P3|Overall Study|Death|1
7495273|NCT03492281|25991627|P2|Overall Study|Death|0
7495274|NCT03492281|25991628|P1|Overall Study|Death|0
7495275|NCT03492281|25991626|P3|Overall Study|Withdrawn Due to Sponsor|1
7495276|NCT03492281|25991627|P2|Overall Study|Withdrawn Due to Sponsor|0
7495277|NCT03492281|25991628|P1|Overall Study|Withdrawn Due to Sponsor|1
7495278|NCT03492281|25991626|P3|Overall Study|Protocol Violation|1
7495279|NCT03492281|25991627|P2|Overall Study|Protocol Violation|2
7495280|NCT03492281|25991628|P1|Overall Study|Protocol Violation|0
7495281|NCT03492281|25991626|P3|Overall Study|Physician Decision|3
7495282|NCT03492281|25991627|P2|Overall Study|Physician Decision|0
7495283|NCT03492281|25991628|P1|Overall Study|Physician Decision|1
7495284|NCT03492281|25991626|P3|Overall Study|Lack of Efficacy|1
7495285|NCT03492281|25991627|P2|Overall Study|Lack of Efficacy|0
7495286|NCT03492281|25991628|P1|Overall Study|Lack of Efficacy|3
7495287|NCT03492281|25991626|P3|Overall Study|Adverse Event|13
7495288|NCT03492281|25991627|P2|Overall Study|Adverse Event|8
7495289|NCT03492281|25991628|P1|Overall Study|Adverse Event|6
7495290|NCT03492281|25991626|P3|Overall Study|Lost to Follow-up|10
7495291|NCT03492281|25991627|P2|Overall Study|Lost to Follow-up|15
7495292|NCT03492281|25991628|P1|Overall Study|Lost to Follow-up|14
7495293|NCT03492281|25991626|P3|Overall Study|Withdrawal by Subject|13
7495294|NCT03492281|25991627|P2|Overall Study|Withdrawal by Subject|14
7495295|NCT03492281|25991628|P1|Overall Study|Withdrawal by Subject|21
7495296|NCT03491553|25991742|P6|Main Study (Up to Week 48)|Withdrew Consent|0
7495297|NCT03491553|25991743|P5|Main Study (Up to Week 48)|Withdrew Consent|0
7495298|NCT03491553|25991744|P4|Main Study (Up to Week 48)|Withdrew Consent|0
7495299|NCT03491553|25991745|P3|Main Study (Up to Week 48)|Withdrew Consent|0
7495300|NCT03491553|25991746|P2|Main Study (Up to Week 48)|Withdrew Consent|1
7495301|NCT03491553|25991747|P1|Main Study (Up to Week 48)|Withdrew Consent|1
7495302|NCT03491553|25991742|P6|Main Study (Up to Week 48)|Adverse Event|0
7495303|NCT03491553|25991743|P5|Main Study (Up to Week 48)|Adverse Event|0
7495304|NCT03491553|25991744|P4|Main Study (Up to Week 48)|Adverse Event|1
7495305|NCT03491553|25991745|P3|Main Study (Up to Week 48)|Adverse Event|0
7495306|NCT03491553|25991746|P2|Main Study (Up to Week 48)|Adverse Event|0
7495307|NCT03491553|25991747|P1|Main Study (Up to Week 48)|Adverse Event|0
7495308|NCT03491150|25991862|P2|Overall Study|Withdrawal by Subject|2
7495309|NCT03491150|25991863|P1|Overall Study|Withdrawal by Subject|1
7495310|NCT03491150|25991862|P2|Overall Study|Other|1
7495311|NCT03491150|25991863|P1|Overall Study|Other|0
7495312|NCT03491150|25991862|P2|Overall Study|Study Terminated by Sponsor|70
7495313|NCT03491150|25991863|P1|Overall Study|Study Terminated by Sponsor|74
7495314|NCT03491150|25991862|P2|Overall Study|Adverse Event|0
7495315|NCT03491150|25991863|P1|Overall Study|Adverse Event|1
7495316|NCT03490981|25991873|P2|Overall Study|Lost to Follow-up|2
7495317|NCT03490981|25991874|P1|Overall Study|Lost to Follow-up|1
7495318|NCT03490032|25991947|P3|Overall Study|family issue (child custody)|0
7495319|NCT03490032|25991948|P2|Overall Study|family issue (child custody)|0
7495320|NCT03490032|25991949|P1|Overall Study|family issue (child custody)|1
7495321|NCT03489863|25992000|P2|Overall Study|Withdrawal by Subject|1
7495322|NCT03489863|25992001|P1|Overall Study|Withdrawal by Subject|0
7495323|NCT03489720|25992024|P2|Overall Study|Withdrawal by Subject|0
7495324|NCT03489720|25992025|P1|Overall Study|Withdrawal by Subject|2
7495325|NCT03489551|25992050|P1|Overall Study|Withdrawal by Subject|2
7495326|NCT03489369|25992058|P4|Overall Study|Clinical Progression (Worsening of Clini|0
7495327|NCT03489369|25992059|P3|Overall Study|Clinical Progression (Worsening of Clini|0
7495328|NCT03489369|25992060|P2|Overall Study|Clinical Progression (Worsening of Clini|1
7495329|NCT03489369|25992061|P1|Overall Study|Clinical Progression (Worsening of Clini|0
7495330|NCT03489369|25992058|P4|Overall Study|Documented Progressive Disease|6
7495331|NCT03489369|25992059|P3|Overall Study|Documented Progressive Disease|3
7495332|NCT03489369|25992060|P2|Overall Study|Documented Progressive Disease|2
7495333|NCT03489369|25992061|P1|Overall Study|Documented Progressive Disease|3
7495334|NCT03489343|25992114|P7|Overall Study|Clinical progression|1
7495335|NCT03489343|25992115|P6|Overall Study|Clinical progression|0
7495336|NCT03489343|25992116|P5|Overall Study|Clinical progression|0
7495337|NCT03489343|25992117|P4|Overall Study|Clinical progression|1
7495338|NCT03489343|25992118|P3|Overall Study|Clinical progression|0
7495339|NCT03489343|25992119|P2|Overall Study|Clinical progression|0
7495340|NCT03489343|25992120|P1|Overall Study|Clinical progression|0
7495341|NCT03489343|25992114|P7|Overall Study|Withdrawal by Subject|1
7495342|NCT03489343|25992115|P6|Overall Study|Withdrawal by Subject|1
7495343|NCT03489343|25992116|P5|Overall Study|Withdrawal by Subject|0
7495344|NCT03489343|25992117|P4|Overall Study|Withdrawal by Subject|1
7495345|NCT03489343|25992118|P3|Overall Study|Withdrawal by Subject|0
7495346|NCT03489343|25992119|P2|Overall Study|Withdrawal by Subject|0
7495347|NCT03489343|25992120|P1|Overall Study|Withdrawal by Subject|0
7495348|NCT03489343|25992114|P7|Overall Study|Adverse Event|0
7495349|NCT03489343|25992115|P6|Overall Study|Adverse Event|1
7495350|NCT03489343|25992116|P5|Overall Study|Adverse Event|0
7495351|NCT03489343|25992117|P4|Overall Study|Adverse Event|0
7495352|NCT03489343|25992118|P3|Overall Study|Adverse Event|0
7495353|NCT03489343|25992119|P2|Overall Study|Adverse Event|1
7495354|NCT03489343|25992120|P1|Overall Study|Adverse Event|0
7495355|NCT03489343|25992114|P7|Overall Study|Documented progressive disease|4
7495356|NCT03489343|25992115|P6|Overall Study|Documented progressive disease|5
7495357|NCT03489343|25992116|P5|Overall Study|Documented progressive disease|3
7495358|NCT03489343|25992117|P4|Overall Study|Documented progressive disease|1
7495359|NCT03489343|25992118|P3|Overall Study|Documented progressive disease|3
7495360|NCT03489343|25992119|P2|Overall Study|Documented progressive disease|0
7495361|NCT03489343|25992120|P1|Overall Study|Documented progressive disease|1
7495362|NCT03489304|25992213|P1|Overall Study|Lost to Follow-up|4
7495363|NCT03488927|25992222|P3|Overall Study|Withdrawal by Subject|217
7495364|NCT03488927|25992223|P2|Overall Study|Withdrawal by Subject|118
7495365|NCT03488927|25992224|P1|Overall Study|Withdrawal by Subject|44
7495366|NCT03488238|25992235|P1|Overall Study|Adverse Event|1
7495367|NCT03488238|25992235|P1|Overall Study|Equipment malfunction|1
7495368|NCT03488225|25992241|P1|Overall Study|Stem Cell Transplant|2
7495369|NCT03488225|25992241|P1|Overall Study|Off Protocol Therapy|2
7495370|NCT03488108|25992251|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7495371|NCT03488108|25992252|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7495372|NCT03488108|25992251|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
7495373|NCT03488108|25992252|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
7495374|NCT03487848|25992319|P1|Overall Study|Lost to Follow-up|1
7495375|NCT03487549|25992350|P2|Overall Study|Withdrawal by Subject|0
7495376|NCT03487549|25992351|P1|Overall Study|Withdrawal by Subject|2
7495377|NCT03487549|25992350|P2|Overall Study|Lost to Follow-up|1
7495378|NCT03487549|25992351|P1|Overall Study|Lost to Follow-up|2
7495379|NCT03487549|25992350|P2|Overall Study|Protocol Violation|1
7495380|NCT03487549|25992351|P1|Overall Study|Protocol Violation|0
7495381|NCT03487445|25992378|P2|Randomization|Not treated for administrative reasons|0
7495382|NCT03487445|25992379|P1|Randomization|Not treated for administrative reasons|1
7495383|NCT03486392|25992670|P5|Overall Study|Death|1
7495384|NCT03486392|25992671|P4|Overall Study|Death|0
7495385|NCT03486392|25992672|P3|Overall Study|Death|0
7495386|NCT03486392|25992673|P2|Overall Study|Death|0
7495387|NCT03486392|25992674|P1|Overall Study|Death|0
7495388|NCT03486392|25992670|P5|Overall Study|Withdrawal by Subject|1
7495389|NCT03486392|25992671|P4|Overall Study|Withdrawal by Subject|4
7495390|NCT03486392|25992672|P3|Overall Study|Withdrawal by Subject|6
7495391|NCT03486392|25992673|P2|Overall Study|Withdrawal by Subject|0
7495392|NCT03486392|25992674|P1|Overall Study|Withdrawal by Subject|3
7495393|NCT03486392|25992670|P5|Overall Study|Lost to Follow-up|2
7495394|NCT03486392|25992671|P4|Overall Study|Lost to Follow-up|5
7495395|NCT03486392|25992672|P3|Overall Study|Lost to Follow-up|8
7495396|NCT03486392|25992673|P2|Overall Study|Lost to Follow-up|0
7495397|NCT03486392|25992674|P1|Overall Study|Lost to Follow-up|0
7495398|NCT03485950|25992714|P2|Overall Study|Withdrawal by Subject|0
7495399|NCT03485950|25992715|P1|Overall Study|Withdrawal by Subject|3
7495400|NCT03485950|25992714|P2|Overall Study|Death|2
7495401|NCT03485950|25992715|P1|Overall Study|Death|3
7495402|NCT03485950|25992714|P2|Overall Study|Adverse Event|0
7495403|NCT03485950|25992715|P1|Overall Study|Adverse Event|1
7495404|NCT03485911|25992770|P3|Overall Study|High frequency of HAE attacks|1
7495405|NCT03485911|25992771|P2|Overall Study|High frequency of HAE attacks|0
7495406|NCT03485911|25992772|P1|Overall Study|High frequency of HAE attacks|0
7495407|NCT03485911|25992770|P3|Overall Study|Adverse Event|1
7495408|NCT03485911|25992771|P2|Overall Study|Adverse Event|0
7495409|NCT03485911|25992772|P1|Overall Study|Adverse Event|1
7495410|NCT03485911|25992770|P3|Overall Study|Withdrawal by Subject|2
7495411|NCT03485911|25992771|P2|Overall Study|Withdrawal by Subject|2
7495412|NCT03485911|25992772|P1|Overall Study|Withdrawal by Subject|0
7495413|NCT03485495|25992791|P2|Overall Study|Non-compliance with inclusion criteria|0
7495414|NCT03485495|25992792|P1|Overall Study|Non-compliance with inclusion criteria|1
7495415|NCT03485222|25992819|P2|Overall Study|Lost to Follow-up|1
7495416|NCT03485222|25992820|P1|Overall Study|Lost to Follow-up|2
7495417|NCT03485222|25992819|P2|Overall Study|Death|1
7495418|NCT03485222|25992820|P1|Overall Study|Death|0
7495419|NCT03484429|25992838|P2|Overall Study|Adverse Event|0
7495420|NCT03484429|25992839|P1|Overall Study|Adverse Event|2
7495421|NCT03484429|25992838|P2|Overall Study|Withdrawal by Subject|0
7495422|NCT03484429|25992839|P1|Overall Study|Withdrawal by Subject|1
7495425|NCT03483623|25992959|P1|Overall Study|43 complete sets achieved|1
7495426|NCT03482882|25993032|P1|Overall Study|Not further specified|1
7495427|NCT03482882|25993032|P1|Overall Study|Protocol Violation|2
7495428|NCT03482882|25993032|P1|Overall Study|Lost to Follow-up|1
7495429|NCT03482882|25993032|P1|Overall Study|Adverse Event|3
7495430|NCT03482635|25993062|P4|Overall Study|Not treated|1
7495431|NCT03482635|25993063|P3|Overall Study|Not treated|0
7495432|NCT03482635|25993064|P2|Overall Study|Not treated|0
7495433|NCT03482635|25993065|P1|Overall Study|Not treated|0
7495434|NCT03482635|25993062|P4|Overall Study|Withdrawn by Principle Investigator|0
7495435|NCT03482635|25993063|P3|Overall Study|Withdrawn by Principle Investigator|0
7495436|NCT03482635|25993064|P2|Overall Study|Withdrawn by Principle Investigator|0
7495437|NCT03482635|25993065|P1|Overall Study|Withdrawn by Principle Investigator|1
7495438|NCT03482635|25993062|P4|Overall Study|Withdrawal by Subject|1
7495439|NCT03482635|25993063|P3|Overall Study|Withdrawal by Subject|0
7495440|NCT03482635|25993064|P2|Overall Study|Withdrawal by Subject|1
7495441|NCT03482635|25993065|P1|Overall Study|Withdrawal by Subject|2
7495442|NCT03482635|25993062|P4|Overall Study|Adverse Event|3
7495443|NCT03482635|25993063|P3|Overall Study|Adverse Event|0
7495444|NCT03482635|25993064|P2|Overall Study|Adverse Event|2
7495445|NCT03482635|25993065|P1|Overall Study|Adverse Event|2
7495446|NCT03482635|25993062|P4|Overall Study|Lack of Efficacy|3
7495447|NCT03482635|25993063|P3|Overall Study|Lack of Efficacy|1
7495448|NCT03482635|25993064|P2|Overall Study|Lack of Efficacy|0
7495449|NCT03482635|25993065|P1|Overall Study|Lack of Efficacy|0
7495450|NCT03482453|25993126|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495451|NCT03482453|25993127|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
7495452|NCT03482453|25993128|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495453|NCT03482453|25993129|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495454|NCT03482453|25993130|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495455|NCT03482453|25993131|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495456|NCT03482453|25993132|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495457|NCT03482453|25993133|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495458|NCT03482453|25993134|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495459|NCT03482453|25993135|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495460|NCT03482453|25993136|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495461|NCT03482453|25993137|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7495462|NCT03482011|25993256|P8|Follow-up Period (12 Weeks)|Lost to Follow-up|1
7495463|NCT03482011|25993257|P7|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495464|NCT03482011|25993258|P6|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495465|NCT03482011|25993259|P5|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495466|NCT03482011|25993260|P4|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495467|NCT03482011|25993261|P3|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495468|NCT03482011|25993262|P2|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495469|NCT03482011|25993263|P1|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7495470|NCT03482011|25993256|P8|Follow-up Period (12 Weeks)|Physician Decision|1
7495471|NCT03482011|25993257|P7|Follow-up Period (12 Weeks)|Physician Decision|0
7495472|NCT03482011|25993258|P6|Follow-up Period (12 Weeks)|Physician Decision|0
7495473|NCT03482011|25993259|P5|Follow-up Period (12 Weeks)|Physician Decision|0
7495474|NCT03482011|25993260|P4|Follow-up Period (12 Weeks)|Physician Decision|0
7495475|NCT03482011|25993261|P3|Follow-up Period (12 Weeks)|Physician Decision|0
7495476|NCT03482011|25993262|P2|Follow-up Period (12 Weeks)|Physician Decision|0
7495477|NCT03482011|25993263|P1|Follow-up Period (12 Weeks)|Physician Decision|0
7495478|NCT03482011|25993256|P8|Follow-up Period (12 Weeks)|Lack of Efficacy|6
7495479|NCT03482011|25993257|P7|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7495480|NCT03482011|25993258|P6|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7495481|NCT03482011|25993259|P5|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7495482|NCT03482011|25993260|P4|Follow-up Period (12 Weeks)|Lack of Efficacy|3
7495483|NCT03482011|25993261|P3|Follow-up Period (12 Weeks)|Lack of Efficacy|1
7495484|NCT03482011|25993262|P2|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7495485|NCT03482011|25993263|P1|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7495486|NCT03482011|25993256|P8|Follow-up Period (12 Weeks)|Adverse Event|4
7495487|NCT03482011|25993257|P7|Follow-up Period (12 Weeks)|Adverse Event|1
7495488|NCT03482011|25993258|P6|Follow-up Period (12 Weeks)|Adverse Event|0
7495489|NCT03482011|25993259|P5|Follow-up Period (12 Weeks)|Adverse Event|0
7495490|NCT03482011|25993260|P4|Follow-up Period (12 Weeks)|Adverse Event|0
7495491|NCT03482011|25993261|P3|Follow-up Period (12 Weeks)|Adverse Event|0
7495492|NCT03482011|25993262|P2|Follow-up Period (12 Weeks)|Adverse Event|0
7495493|NCT03482011|25993263|P1|Follow-up Period (12 Weeks)|Adverse Event|0
7495494|NCT03482011|25993256|P8|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
7495495|NCT03482011|25993257|P7|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7495496|NCT03482011|25993258|P6|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7495497|NCT03482011|25993259|P5|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7495498|NCT03482011|25993260|P4|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
7495499|NCT03482011|25993261|P3|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7495500|NCT03482011|25993262|P2|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7495501|NCT03482011|25993263|P1|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7495502|NCT03482011|25993256|P8|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7495503|NCT03482011|25993257|P7|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7495504|NCT03482011|25993258|P6|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7495505|NCT03482011|25993259|P5|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7495506|NCT03482011|25993260|P4|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7495507|NCT03482011|25993261|P3|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7495508|NCT03482011|25993262|P2|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7495509|NCT03482011|25993263|P1|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7495510|NCT03482011|25993256|P8|Maintenance Period (36 Weeks)|Physician Decision|1
7495511|NCT03482011|25993257|P7|Maintenance Period (36 Weeks)|Physician Decision|1
7495512|NCT03482011|25993258|P6|Maintenance Period (36 Weeks)|Physician Decision|1
7495513|NCT03482011|25993259|P5|Maintenance Period (36 Weeks)|Physician Decision|0
7495514|NCT03482011|25993260|P4|Maintenance Period (36 Weeks)|Physician Decision|1
7495515|NCT03482011|25993261|P3|Maintenance Period (36 Weeks)|Physician Decision|0
7495516|NCT03482011|25993262|P2|Maintenance Period (36 Weeks)|Physician Decision|0
7495517|NCT03482011|25993263|P1|Maintenance Period (36 Weeks)|Physician Decision|0
7495518|NCT03482011|25993256|P8|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7495519|NCT03482011|25993257|P7|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7495520|NCT03482011|25993258|P6|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7495521|NCT03482011|25993259|P5|Maintenance Period (36 Weeks)|Lost to Follow-up|2
7495522|NCT03482011|25993260|P4|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7495523|NCT03482011|25993261|P3|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7495524|NCT03482011|25993262|P2|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7495525|NCT03482011|25993263|P1|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7495526|NCT03482011|25993256|P8|Maintenance Period (36 Weeks)|Lack of Efficacy|9
7495527|NCT03482011|25993257|P7|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7495528|NCT03482011|25993258|P6|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7495529|NCT03482011|25993259|P5|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7495530|NCT03482011|25993260|P4|Maintenance Period (36 Weeks)|Lack of Efficacy|2
7495531|NCT03482011|25993261|P3|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7495532|NCT03482011|25993262|P2|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7495533|NCT03482011|25993263|P1|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7495534|NCT03482011|25993256|P8|Maintenance Period (36 Weeks)|Adverse Event|4
7495535|NCT03482011|25993257|P7|Maintenance Period (36 Weeks)|Adverse Event|1
7495536|NCT03482011|25993258|P6|Maintenance Period (36 Weeks)|Adverse Event|1
7495537|NCT03482011|25993259|P5|Maintenance Period (36 Weeks)|Adverse Event|0
7495538|NCT03482011|25993260|P4|Maintenance Period (36 Weeks)|Adverse Event|0
7495539|NCT03482011|25993261|P3|Maintenance Period (36 Weeks)|Adverse Event|0
7495540|NCT03482011|25993262|P2|Maintenance Period (36 Weeks)|Adverse Event|0
7495541|NCT03482011|25993263|P1|Maintenance Period (36 Weeks)|Adverse Event|0
7495542|NCT03482011|25993256|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
7495543|NCT03482011|25993257|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
7495544|NCT03482011|25993258|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
7495545|NCT03482011|25993259|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
7495546|NCT03482011|25993260|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
7495547|NCT03482011|25993261|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
7495548|NCT03482011|25993262|P2|Induction Period (16 Weeks)|Withdrawal by Subject|5
7495549|NCT03482011|25993263|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
7495550|NCT03482011|25993256|P8|Induction Period (16 Weeks)|Screen Failure|0
7495551|NCT03482011|25993257|P7|Induction Period (16 Weeks)|Screen Failure|0
7495552|NCT03482011|25993258|P6|Induction Period (16 Weeks)|Screen Failure|0
7495553|NCT03482011|25993259|P5|Induction Period (16 Weeks)|Screen Failure|0
7495554|NCT03482011|25993260|P4|Induction Period (16 Weeks)|Screen Failure|0
7495555|NCT03482011|25993261|P3|Induction Period (16 Weeks)|Screen Failure|0
7495556|NCT03482011|25993262|P2|Induction Period (16 Weeks)|Screen Failure|1
7495557|NCT03482011|25993263|P1|Induction Period (16 Weeks)|Screen Failure|0
7495558|NCT03482011|25993256|P8|Induction Period (16 Weeks)|Lost to Follow-up|0
7495559|NCT03482011|25993257|P7|Induction Period (16 Weeks)|Lost to Follow-up|0
7495560|NCT03482011|25993258|P6|Induction Period (16 Weeks)|Lost to Follow-up|0
7495561|NCT03482011|25993259|P5|Induction Period (16 Weeks)|Lost to Follow-up|0
7495562|NCT03482011|25993260|P4|Induction Period (16 Weeks)|Lost to Follow-up|0
7495563|NCT03482011|25993261|P3|Induction Period (16 Weeks)|Lost to Follow-up|0
7495564|NCT03482011|25993262|P2|Induction Period (16 Weeks)|Lost to Follow-up|1
7495565|NCT03482011|25993263|P1|Induction Period (16 Weeks)|Lost to Follow-up|0
7495566|NCT03482011|25993256|P8|Induction Period (16 Weeks)|Lack of Efficacy|0
7495567|NCT03482011|25993257|P7|Induction Period (16 Weeks)|Lack of Efficacy|0
7495568|NCT03482011|25993258|P6|Induction Period (16 Weeks)|Lack of Efficacy|0
7495569|NCT03482011|25993259|P5|Induction Period (16 Weeks)|Lack of Efficacy|0
7495570|NCT03482011|25993260|P4|Induction Period (16 Weeks)|Lack of Efficacy|0
7495571|NCT03482011|25993261|P3|Induction Period (16 Weeks)|Lack of Efficacy|0
7495572|NCT03482011|25993262|P2|Induction Period (16 Weeks)|Lack of Efficacy|1
7495573|NCT03482011|25993263|P1|Induction Period (16 Weeks)|Lack of Efficacy|3
7495574|NCT03482011|25993256|P8|Induction Period (16 Weeks)|Adverse Event|0
7495575|NCT03482011|25993257|P7|Induction Period (16 Weeks)|Adverse Event|0
7495576|NCT03482011|25993258|P6|Induction Period (16 Weeks)|Adverse Event|0
7495577|NCT03482011|25993259|P5|Induction Period (16 Weeks)|Adverse Event|0
7495578|NCT03482011|25993260|P4|Induction Period (16 Weeks)|Adverse Event|0
7495579|NCT03482011|25993261|P3|Induction Period (16 Weeks)|Adverse Event|0
7495580|NCT03482011|25993262|P2|Induction Period (16 Weeks)|Adverse Event|3
7495581|NCT03482011|25993263|P1|Induction Period (16 Weeks)|Adverse Event|1
7495582|NCT03481816|25993322|P2|Dose Expansion|Physician Decision|5
7495583|NCT03481816|25993323|P1|Dose Expansion|Physician Decision|0
7495584|NCT03481816|25993322|P2|Dose Expansion|Withdrawal by Subject|2
7495585|NCT03481816|25993323|P1|Dose Expansion|Withdrawal by Subject|0
7495586|NCT03481816|25993322|P2|Dose Expansion|Off treatment due to progressive disease|5
7495587|NCT03481816|25993323|P1|Dose Expansion|Off treatment due to progressive disease|0
7495588|NCT03481816|25993322|P2|Starting Dose|Refused further vaccines after 1 dose|0
7495589|NCT03481816|25993323|P1|Starting Dose|Refused further vaccines after 1 dose|1
7495590|NCT03481725|25993346|P2|Overall Study|Withdrawal by Subject|0
7495591|NCT03481725|25993347|P1|Overall Study|Withdrawal by Subject|1
7495592|NCT03481309|25993375|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
7495593|NCT03481309|25993376|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
7495594|NCT03481309|25993377|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
7495595|NCT03481309|25993378|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
7495596|NCT03481309|25993379|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
7495597|NCT03481309|25993380|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
7495598|NCT03480932|25993406|P3|Overall Study|Incarcerated|2
7495599|NCT03480932|25993407|P2|Overall Study|Incarcerated|2
7495600|NCT03480932|25993408|P1|Overall Study|Incarcerated|2
7495601|NCT03480932|25993406|P3|Overall Study|Lost to Follow-up|3
7495602|NCT03480932|25993407|P2|Overall Study|Lost to Follow-up|2
7495603|NCT03480932|25993408|P1|Overall Study|Lost to Follow-up|0
7495604|NCT03480932|25993406|P3|Overall Study|Death|0
7495605|NCT03480932|25993407|P2|Overall Study|Death|1
7495606|NCT03480932|25993408|P1|Overall Study|Death|1
7495607|NCT03480841|25993441|P1|Overall Study|Lost to Follow-up|2
7495608|NCT03480802|25993452|P2|Overall Study|Relocated|1
7495609|NCT03480802|25993453|P1|Overall Study|Relocated|0
7495610|NCT03480802|25993452|P2|Overall Study|Withdrawal by Subject|1
7495611|NCT03480802|25993453|P1|Overall Study|Withdrawal by Subject|2
7495612|NCT03480802|25993452|P2|Overall Study|Lost to Follow-up|1
7495613|NCT03480802|25993453|P1|Overall Study|Lost to Follow-up|5
7495614|NCT03480763|25993481|P2|Overall Study|pain with vaccination|0
7495615|NCT03480763|25993482|P1|Overall Study|pain with vaccination|1
7495616|NCT03480763|25993481|P2|Overall Study|oncological treatment|2
7495617|NCT03480763|25993482|P1|Overall Study|oncological treatment|0
7495618|NCT03480763|25993481|P2|Overall Study|non-study pneumococcal vaccine|0
7495619|NCT03480763|25993482|P1|Overall Study|non-study pneumococcal vaccine|1
7495620|NCT03480763|25993481|P2|Overall Study|Lost to Follow-up|7
7495621|NCT03480763|25993482|P1|Overall Study|Lost to Follow-up|4
7495622|NCT03480763|25993481|P2|Overall Study|Withdrawal by Subject|10
7495623|NCT03480763|25993482|P1|Overall Study|Withdrawal by Subject|18
7495624|NCT03480750|25993550|P6|Overall Study|The interruption in Trientine shippment|1
7495625|NCT03480750|25993551|P5|Overall Study|The interruption in Trientine shippment|0
7495626|NCT03480750|25993552|P4|Overall Study|The interruption in Trientine shippment|0
7495627|NCT03480750|25993553|P3|Overall Study|The interruption in Trientine shippment|0
7495628|NCT03480750|25993554|P2|Overall Study|The interruption in Trientine shippment|0
7495629|NCT03480750|25993555|P1|Overall Study|The interruption in Trientine shippment|0
7495630|NCT03480750|25993550|P6|Overall Study|Withdrawal by Subject|0
7495631|NCT03480750|25993551|P5|Overall Study|Withdrawal by Subject|0
7495632|NCT03480750|25993552|P4|Overall Study|Withdrawal by Subject|0
7495633|NCT03480750|25993553|P3|Overall Study|Withdrawal by Subject|0
7495634|NCT03480750|25993554|P2|Overall Study|Withdrawal by Subject|1
7495635|NCT03480750|25993555|P1|Overall Study|Withdrawal by Subject|0
7495636|NCT03480425|25993599|P1|Overall Study|Force transducer technical failure|1
7495637|NCT03480243|25993603|P1|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
7495638|NCT03480243|25993603|P1|Padsevonil (Period 2)|Consent withdrawal by subject|1
7495639|NCT03480152|25993697|P3|Phase I|Signed consent. Died before treatment.|0
7495640|NCT03480152|25993698|P2|Phase I|Signed consent. Died before treatment.|0
7495641|NCT03480152|25993699|P1|Phase I|Signed consent. Died before treatment.|1
7495642|NCT03480022|25993727|P2|Overall Study|Family member COVID exposure|1
7495643|NCT03480022|25993728|P1|Overall Study|Family member COVID exposure|0
7495644|NCT03480022|25993727|P2|Overall Study|Medication concerns|0
7495645|NCT03480022|25993728|P1|Overall Study|Medication concerns|1
7495646|NCT03480022|25993727|P2|Overall Study|Withdrawal by Subject|0
7495647|NCT03480022|25993728|P1|Overall Study|Withdrawal by Subject|2
7495648|NCT03480022|25993727|P2|Overall Study|Physician Decision|1
7495649|NCT03480022|25993728|P1|Overall Study|Physician Decision|0
7495650|NCT03480022|25993727|P2|Overall Study|Lack of Efficacy|2
7495651|NCT03480022|25993728|P1|Overall Study|Lack of Efficacy|0
7495652|NCT03480022|25993727|P2|Overall Study|Adverse Event|0
7495653|NCT03480022|25993728|P1|Overall Study|Adverse Event|6
7495654|NCT03480022|25993727|P2|Overall Study|Pregnancy|0
7495655|NCT03480022|25993728|P1|Overall Study|Pregnancy|2
7495656|NCT03480009|25993794|P4|Overall Study|Lost to Follow-up|0
7495657|NCT03480009|25993795|P3|Overall Study|Lost to Follow-up|4
7495658|NCT03480009|25993796|P2|Overall Study|Lost to Follow-up|5
7495659|NCT03480009|25993797|P1|Overall Study|Lost to Follow-up|4
7495660|NCT03479216|25993832|P2|Overall Study|Physician Decision|3
7495661|NCT03479216|25993833|P1|Overall Study|Physician Decision|2
7495662|NCT03479216|25993832|P2|Overall Study|Withdrawal by Subject|2
7495663|NCT03479216|25993833|P1|Overall Study|Withdrawal by Subject|3
7495664|NCT03478969|25993883|P3|Overall Study|Lost to Follow-up|1
7495665|NCT03478969|25993884|P2|Overall Study|Lost to Follow-up|0
7495666|NCT03478969|25993885|P1|Overall Study|Lost to Follow-up|0
7495667|NCT03478969|25993883|P3|Overall Study|Eligibility Criteria|5
7495668|NCT03478969|25993884|P2|Overall Study|Eligibility Criteria|0
7495669|NCT03478969|25993885|P1|Overall Study|Eligibility Criteria|0
7495670|NCT03478969|25993883|P3|Overall Study|Multiple Reasons|1
7495671|NCT03478969|25993884|P2|Overall Study|Multiple Reasons|1
7495672|NCT03478969|25993885|P1|Overall Study|Multiple Reasons|0
7495673|NCT03478969|25993883|P3|Overall Study|Covid-19|3
7495674|NCT03478969|25993884|P2|Overall Study|Covid-19|4
7495675|NCT03478969|25993885|P1|Overall Study|Covid-19|1
7495676|NCT03478969|25993883|P3|Overall Study|Personal Reasons|1
7495677|NCT03478969|25993884|P2|Overall Study|Personal Reasons|0
7495678|NCT03478969|25993885|P1|Overall Study|Personal Reasons|1
7495679|NCT03478969|25993883|P3|Overall Study|Pregnancy|0
7495680|NCT03478969|25993884|P2|Overall Study|Pregnancy|0
7495681|NCT03478969|25993885|P1|Overall Study|Pregnancy|1
7495682|NCT03478969|25993883|P3|Overall Study|Adverse Event|1
7495683|NCT03478969|25993884|P2|Overall Study|Adverse Event|0
7495684|NCT03478969|25993885|P1|Overall Study|Adverse Event|2
7495685|NCT03478969|25993883|P3|Overall Study|Withdrawal by Subject|6
7495686|NCT03478969|25993884|P2|Overall Study|Withdrawal by Subject|7
7495687|NCT03478969|25993885|P1|Overall Study|Withdrawal by Subject|4
7495688|NCT03478956|25993954|P2|Overall Study|Ongoing in the Study|11
7495689|NCT03478956|25993955|P1|Overall Study|Ongoing in the Study|11
7495690|NCT03478956|25993954|P2|Overall Study|Withdrawal by Subject|1
7495691|NCT03478956|25993955|P1|Overall Study|Withdrawal by Subject|0
7495692|NCT03478956|25993954|P2|Overall Study|Adverse Event|0
7495693|NCT03478956|25993955|P1|Overall Study|Adverse Event|1
7495694|NCT03478930|25993983|P2|Overall Study|Withdrawal by Subject|5
7495695|NCT03478930|25993984|P1|Overall Study|Withdrawal by Subject|6
7495696|NCT03478930|25993983|P2|Overall Study|Lack of Efficacy|3
7495697|NCT03478930|25993984|P1|Overall Study|Lack of Efficacy|3
7495698|NCT03478930|25993983|P2|Overall Study|Adverse Event|1
7495699|NCT03478930|25993984|P1|Overall Study|Adverse Event|0
7495700|NCT03478891|25994037|P3|Overall Study|Lost to Follow-up|1
7495701|NCT03478891|25994038|P2|Overall Study|Lost to Follow-up|0
7495702|NCT03478891|25994039|P1|Overall Study|Lost to Follow-up|1
7495703|NCT03478891|25994037|P3|Overall Study|Moved from area|1
7495704|NCT03478891|25994038|P2|Overall Study|Moved from area|0
7495705|NCT03478891|25994039|P1|Overall Study|Moved from area|0
7495706|NCT03478891|25994037|P3|Overall Study|Enrolled, but product never administered|1
7495707|NCT03478891|25994038|P2|Overall Study|Enrolled, but product never administered|0
7495708|NCT03478891|25994039|P1|Overall Study|Enrolled, but product never administered|0
7495709|NCT03478787|25994090|P2|Overall Study|Other, Not Specified|0
7495710|NCT03478787|25994091|P1|Overall Study|Other, Not Specified|3
7495711|NCT03478787|25994090|P2|Overall Study|Withdrawal by Subject|6
7495712|NCT03478787|25994091|P1|Overall Study|Withdrawal by Subject|2
7495713|NCT03478787|25994090|P2|Overall Study|Lost to Follow-up|5
7495714|NCT03478787|25994091|P1|Overall Study|Lost to Follow-up|9
7495715|NCT03478787|25994090|P2|Overall Study|Lack of Efficacy|1
7495716|NCT03478787|25994091|P1|Overall Study|Lack of Efficacy|7
7495717|NCT03478787|25994090|P2|Overall Study|Protocol Violation|0
7495718|NCT03478787|25994091|P1|Overall Study|Protocol Violation|3
7495719|NCT03478787|25994090|P2|Overall Study|Adverse Event|1
7495720|NCT03478787|25994091|P1|Overall Study|Adverse Event|5
7495721|NCT03478696|25994107|P2|Overall Study|Withdrawal by Subject|4
7495722|NCT03478696|25994108|P1|Overall Study|Withdrawal by Subject|9
7495723|NCT03478696|25994107|P2|Overall Study|Physician Decision|3
7495724|NCT03478696|25994108|P1|Overall Study|Physician Decision|6
7495725|NCT03478696|25994107|P2|Overall Study|Lost to Follow-up|0
7495726|NCT03478696|25994108|P1|Overall Study|Lost to Follow-up|1
7495727|NCT03478696|25994107|P2|Overall Study|Adverse Event|5
7495728|NCT03478696|25994108|P1|Overall Study|Adverse Event|1
7495729|NCT03478683|25994122|P2|Overall Study|Withdrawal by Subject|7
7495730|NCT03478683|25994123|P1|Overall Study|Withdrawal by Subject|7
7495731|NCT03478683|25994122|P2|Overall Study|Physician Decision|3
7495732|NCT03478683|25994123|P1|Overall Study|Physician Decision|1
7495733|NCT03478683|25994122|P2|Overall Study|Lost to Follow-up|5
7495734|NCT03478683|25994123|P1|Overall Study|Lost to Follow-up|0
7495735|NCT03478683|25994122|P2|Overall Study|Adverse Event|3
7495736|NCT03478683|25994123|P1|Overall Study|Adverse Event|5
7495737|NCT03478657|25994137|P2|Overall Study|Withdrawal by Subject|1
7495738|NCT03478657|25994138|P1|Overall Study|Withdrawal by Subject|0
7495739|NCT03478644|25994153|P2|Phase 2|Lost to Follow-up|0
7495740|NCT03478644|25994154|P1|Phase 2|Lost to Follow-up|1
7495741|NCT03478644|25994153|P2|Phase 2|Withdrawal by Subject|1
7495742|NCT03478644|25994154|P1|Phase 2|Withdrawal by Subject|2
7495743|NCT03478371|25994166|P1|Overall Study|Lost to Follow-up|4
7495744|NCT03478371|25994166|P1|Overall Study|non-compliance|1
7495745|NCT03477903|25994223|P1|Overall Study|Study Terminated by Sponsor|1
7495746|NCT03477838|25994234|P1|Overall Study|Lost to Follow-up|14
7495747|NCT03476798|25994304|P1|Overall Study|Protocol Violation|2
7495748|NCT03476798|25994304|P1|Overall Study|Withdrawal by Subject|2
7495749|NCT03476798|25994304|P1|Overall Study|Death|1
7495750|NCT03476239|25994358|P1|Overall Study|Did not receive study drug|1
7495751|NCT03476239|25994358|P1|Overall Study|Data Not Available|15
7495752|NCT03476239|25994358|P1|Overall Study|Lost to Follow-up|2
7495753|NCT03476239|25994358|P1|Overall Study|Death|39
7495754|NCT03476239|25994358|P1|Overall Study|Withdrawal by Subject|6
7495755|NCT03476239|25994358|P1|Overall Study|Continuing study|43
7495756|NCT03475875|25994424|P2|Period 2|Protocol Violation|1
7495757|NCT03475875|25994425|P1|Period 2|Protocol Violation|0
7495758|NCT03475875|25994424|P2|Period 2|Adverse Event|0
7495759|NCT03475875|25994425|P1|Period 2|Adverse Event|3
7495760|NCT03475875|25994424|P2|Period 1|Adverse Event|1
7495761|NCT03475875|25994425|P1|Period 1|Adverse Event|2
7495762|NCT03475875|25994424|P2|Period 1|Lost to Follow-up|0
7495763|NCT03475875|25994425|P1|Period 1|Lost to Follow-up|1
7495764|NCT03475316|25994435|P2|9 Months|Study stopped due to COVID pandemic|4
7495765|NCT03475316|25994436|P1|9 Months|Study stopped due to COVID pandemic|3
7495766|NCT03475316|25994435|P2|6 Month Intervention|Study stopped due to COVID pandemic|3
7495767|NCT03475316|25994436|P1|6 Month Intervention|Study stopped due to COVID pandemic|1
7495768|NCT03475316|25994435|P2|6 Month Intervention|Withdrawal by Subject|0
7495769|NCT03475316|25994436|P1|6 Month Intervention|Withdrawal by Subject|2
7495770|NCT03475316|25994435|P2|6 Month Intervention|Adverse Event|1
7495771|NCT03475316|25994436|P1|6 Month Intervention|Adverse Event|2
7495772|NCT03475056|25994456|P2|Overall Study|Moved from Area|2
7495773|NCT03475056|25994457|P1|Overall Study|Moved from Area|0
7495774|NCT03475056|25994456|P2|Overall Study|Lost to Follow-up|1
7495775|NCT03475056|25994457|P1|Overall Study|Lost to Follow-up|0
7495792|NCT03474081|25994556|P2|Overall Study|Investigator site closed|0
7495793|NCT03474081|25994557|P1|Overall Study|Investigator site closed|1
7495794|NCT03474081|25994556|P2|Overall Study|Withdrawal by Subject|7
7495795|NCT03474081|25994557|P1|Overall Study|Withdrawal by Subject|5
7495796|NCT03474081|25994556|P2|Overall Study|Physician Decision|2
7495797|NCT03474081|25994557|P1|Overall Study|Physician Decision|3
7495798|NCT03474081|25994556|P2|Overall Study|Lost to Follow-up|1
7495799|NCT03474081|25994557|P1|Overall Study|Lost to Follow-up|2
7495800|NCT03474081|25994556|P2|Overall Study|Adverse Event|3
7495801|NCT03474081|25994557|P1|Overall Study|Adverse Event|6
7495802|NCT03473808|25994619|P1|Overall Study|Withdrawal by Subject|1
7495803|NCT03473301|25994644|P3|Overall Study|Missed study visit due to pandemic restrictions|6
7495804|NCT03473301|25994645|P2|Overall Study|Missed study visit due to pandemic restrictions|5
7495805|NCT03473301|25994646|P1|Overall Study|Missed study visit due to pandemic restrictions|7
7495806|NCT03473301|25994644|P3|Overall Study|Withdrawal by Subject|0
7495807|NCT03473301|25994645|P2|Overall Study|Withdrawal by Subject|1
7495808|NCT03473301|25994646|P1|Overall Study|Withdrawal by Subject|0
7495809|NCT03473301|25994644|P3|Overall Study|Protocol Violation|0
7495810|NCT03473301|25994645|P2|Overall Study|Protocol Violation|0
7495811|NCT03473301|25994646|P1|Overall Study|Protocol Violation|4
7495812|NCT03473236|25994670|P10|Overall Study|Withdrawal by Subject|0
7495813|NCT03473236|25994671|P9|Overall Study|Withdrawal by Subject|1
7495814|NCT03473236|25994672|P8|Overall Study|Withdrawal by Subject|0
7495815|NCT03473236|25994673|P7|Overall Study|Withdrawal by Subject|0
7495816|NCT03473236|25994674|P6|Overall Study|Withdrawal by Subject|1
7495817|NCT03473236|25994675|P5|Overall Study|Withdrawal by Subject|0
7495818|NCT03473236|25994676|P4|Overall Study|Withdrawal by Subject|0
7495819|NCT03473236|25994677|P3|Overall Study|Withdrawal by Subject|0
7495820|NCT03473236|25994678|P2|Overall Study|Withdrawal by Subject|0
7495821|NCT03473236|25994679|P1|Overall Study|Withdrawal by Subject|0
7495822|NCT03473197|25994846|P1|Overall Study|Withdrawal by Subject|5
7495823|NCT03473197|25994846|P1|Overall Study|Lost to Follow-up|1
7495824|NCT03473197|25994846|P1|Overall Study|Adverse Event|4
7495825|NCT03472885|25994858|P1|Overall Study|Adverse Event|1
7495826|NCT03472547|25994866|P1|Overall Study|Withdrawal by Subject|30
7495827|NCT03472534|25994870|P1|Overall Study|Adverse Event|2
7495828|NCT03472534|25994870|P1|Overall Study|Withdrawal by Subject|9
7495829|NCT03472326|25994907|P4|Part 2: Combination Therapy|Pregnancy|1
7495830|NCT03472326|25994908|P3|Part 2: Combination Therapy|Pregnancy|0
7495831|NCT03472326|25994909|P2|Part 2: Combination Therapy|Pregnancy|0
7495832|NCT03472326|25994910|P1|Part 2: Combination Therapy|Pregnancy|0
7495833|NCT03472326|25994907|P4|Part 2: Combination Therapy|Study Terminated by Sponsor|2
7495834|NCT03472326|25994908|P3|Part 2: Combination Therapy|Study Terminated by Sponsor|1
7495835|NCT03472326|25994909|P2|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7495836|NCT03472326|25994910|P1|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7495837|NCT03472014|25994939|P1|Overall Study|Lost to Follow-up|4
7495838|NCT03471871|25994961|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7495839|NCT03471871|25994962|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
7495840|NCT03471871|25994963|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7495841|NCT03471871|25994964|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7495842|NCT03471871|25994965|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7495843|NCT03471871|25994961|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
7495844|NCT03471871|25994962|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7495845|NCT03471871|25994963|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7495846|NCT03471871|25994964|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7495847|NCT03471871|25994965|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7495848|NCT03471871|25994961|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
7495849|NCT03471871|25994962|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7495850|NCT03471871|25994963|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7495851|NCT03471871|25994964|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7495852|NCT03471871|25994965|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7495853|NCT03471871|25994961|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7495854|NCT03471871|25994962|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7495855|NCT03471871|25994963|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7495856|NCT03471871|25994964|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7495857|NCT03471871|25994965|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7495858|NCT03471871|25994961|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7495859|NCT03471871|25994962|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7495860|NCT03471871|25994963|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
7495861|NCT03471871|25994964|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7495862|NCT03471871|25994965|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7495863|NCT03470545|25995081|P2|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
7495864|NCT03470545|25995082|P1|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
7495865|NCT03470545|25995081|P2|Overall Study|Withdrawal by Subject|1
7495866|NCT03470545|25995082|P1|Overall Study|Withdrawal by Subject|1
7495867|NCT03470545|25995081|P2|Overall Study|Adverse Event|0
7495868|NCT03470545|25995082|P1|Overall Study|Adverse Event|2
7495869|NCT03470545|25995081|P2|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
7495870|NCT03470545|25995082|P1|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
7495871|NCT03470545|25995081|P2|Overall Study|Death|1
7495872|NCT03470545|25995082|P1|Overall Study|Death|0
7495873|NCT03470194|25995107|P2|Overall Study|Lost to Follow-up|17
7495874|NCT03470194|25995108|P1|Overall Study|Lost to Follow-up|11
7495875|NCT03469349|25995120|P2|Overall Study|Adverse Event|4
7495876|NCT03469349|25995121|P1|Overall Study|Adverse Event|2
7495877|NCT03469349|25995120|P2|Overall Study|Lost to Follow-up|2
7495878|NCT03469349|25995121|P1|Overall Study|Lost to Follow-up|2
7495879|NCT03469349|25995120|P2|Overall Study|Progressive Disease|1
7495880|NCT03469349|25995121|P1|Overall Study|Progressive Disease|0
7495881|NCT03469349|25995120|P2|Overall Study|Withdrawal by Subject|3
7495882|NCT03469349|25995121|P1|Overall Study|Withdrawal by Subject|1
7495883|NCT03469336|25995137|P1|Overall Study|Adverse Event|1
7495884|NCT03469258|25995160|P1|Overall Study|Upon surgery, did not meet criteria|4
7495885|NCT03468855|25995206|P1|Overall Study|Inclusion/Exclusion Enrollment Violator|1
7495886|NCT03468855|25995206|P1|Overall Study|Withdrawal by Subject|3
7495887|NCT03468855|25995206|P1|Overall Study|Lost to Follow-up|5
7495888|NCT03468855|25995206|P1|Overall Study|Adverse Event|2
7495889|NCT03468543|25995260|P1|Overall Study|Protocol stopping rules met|3
7495890|NCT03467971|25995279|P2|Treatment Period 2|Withdrawal by Subject|1
7495891|NCT03467971|25995280|P1|Treatment Period 2|Withdrawal by Subject|0
7495892|NCT03467945|25995304|P4|Treatment Period 3|Withdrawal by Subject|1
7495893|NCT03467945|25995305|P3|Treatment Period 3|Withdrawal by Subject|2
7495894|NCT03467945|25995306|P2|Treatment Period 3|Withdrawal by Subject|0
7495895|NCT03467945|25995307|P1|Treatment Period 3|Withdrawal by Subject|1
7495896|NCT03467945|25995304|P4|Treatment Period 2|Withdrawal by Subject|0
7495897|NCT03467945|25995305|P3|Treatment Period 2|Withdrawal by Subject|0
7495898|NCT03467945|25995306|P2|Treatment Period 2|Withdrawal by Subject|1
7495899|NCT03467945|25995307|P1|Treatment Period 2|Withdrawal by Subject|0
7495900|NCT03467763|25995359|P1|Overall Study|Protocol Violation|2
7495901|NCT03467763|25995359|P1|Overall Study|Lost to Follow-up|1
7495902|NCT03467425|25995389|P2|Overall Study|Withdrawal by Subject|17
7495903|NCT03467425|25995390|P1|Overall Study|Withdrawal by Subject|15
7495904|NCT03467425|25995389|P2|Overall Study|Physician Decision|1
7495905|NCT03467425|25995390|P1|Overall Study|Physician Decision|2
7495906|NCT03467425|25995389|P2|Overall Study|Lost to Follow-up|25
7495907|NCT03467425|25995390|P1|Overall Study|Lost to Follow-up|18
7495908|NCT03467425|25995389|P2|Overall Study|Protocol Violation|1
7495909|NCT03467425|25995390|P1|Overall Study|Protocol Violation|0
7495910|NCT03467425|25995389|P2|Overall Study|Lack of Efficacy|1
7495911|NCT03467425|25995390|P1|Overall Study|Lack of Efficacy|3
7495912|NCT03467425|25995389|P2|Overall Study|Adverse Event|9
7495913|NCT03467425|25995390|P1|Overall Study|Adverse Event|9
7495914|NCT03466658|25995457|P1|Overall Study|Withdrawal by Subject|3
7495915|NCT03466099|25995466|P3|Overall Study|Worsening disease|1
7495916|NCT03466099|25995467|P2|Overall Study|Worsening disease|0
7495917|NCT03466099|25995468|P1|Overall Study|Worsening disease|0
7495918|NCT03466099|25995466|P3|Overall Study|Subject compliance|0
7495919|NCT03466099|25995467|P2|Overall Study|Subject compliance|0
7495920|NCT03466099|25995468|P1|Overall Study|Subject compliance|2
7495921|NCT03466099|25995466|P3|Overall Study|Rescued without meeting criteria|1
7495922|NCT03466099|25995467|P2|Overall Study|Rescued without meeting criteria|1
7495923|NCT03466099|25995468|P1|Overall Study|Rescued without meeting criteria|4
7495924|NCT03466099|25995466|P3|Overall Study|Use of rescue medication|13
7495925|NCT03466099|25995467|P2|Overall Study|Use of rescue medication|9
7495926|NCT03466099|25995468|P1|Overall Study|Use of rescue medication|8
7495927|NCT03466099|25995466|P3|Overall Study|Withdrawal by Subject|1
7495928|NCT03466099|25995467|P2|Overall Study|Withdrawal by Subject|3
7495929|NCT03466099|25995468|P1|Overall Study|Withdrawal by Subject|2
7495930|NCT03466099|25995466|P3|Overall Study|Adverse Event|1
7495931|NCT03466099|25995467|P2|Overall Study|Adverse Event|1
7495932|NCT03466099|25995468|P1|Overall Study|Adverse Event|1
7495933|NCT03466086|25995482|P2|Period 1|Withdrawal by Subject|0
7495934|NCT03466086|25995483|P1|Period 1|Withdrawal by Subject|1
7495935|NCT03466086|25995482|P2|Period 1|Sponsor decision due to study timeline|0
7495936|NCT03466086|25995483|P1|Period 1|Sponsor decision due to study timeline|1
7495937|NCT03466073|25995497|P6|Overall Study|Death|1
7495938|NCT03466073|25995498|P5|Overall Study|Death|0
7495939|NCT03466073|25995499|P4|Overall Study|Death|0
7495940|NCT03466073|25995500|P3|Overall Study|Death|0
7495941|NCT03466073|25995501|P2|Overall Study|Death|0
7495942|NCT03466073|25995502|P1|Overall Study|Death|1
7495943|NCT03466060|25995535|P6|Period 2|Lens Handling Difficulties|0
7495944|NCT03466060|25995536|P5|Period 2|Lens Handling Difficulties|0
7495945|NCT03466060|25995537|P4|Period 2|Lens Handling Difficulties|0
7495946|NCT03466060|25995538|P3|Period 2|Lens Handling Difficulties|1
7495947|NCT03466060|25995539|P2|Period 2|Lens Handling Difficulties|0
7495948|NCT03466060|25995540|P1|Period 2|Lens Handling Difficulties|0
7495949|NCT03466060|25995535|P6|Period 1|Grade 2 Conjunctivitis|0
7495950|NCT03466060|25995536|P5|Period 1|Grade 2 Conjunctivitis|0
7495951|NCT03466060|25995537|P4|Period 1|Grade 2 Conjunctivitis|0
7495952|NCT03466060|25995538|P3|Period 1|Grade 2 Conjunctivitis|1
7495953|NCT03466060|25995539|P2|Period 1|Grade 2 Conjunctivitis|0
7495954|NCT03466060|25995540|P1|Period 1|Grade 2 Conjunctivitis|0
7495955|NCT03466060|25995535|P6|Period 1|Lost to Follow-up|0
7495956|NCT03466060|25995536|P5|Period 1|Lost to Follow-up|0
7495957|NCT03466060|25995537|P4|Period 1|Lost to Follow-up|1
7495958|NCT03466060|25995538|P3|Period 1|Lost to Follow-up|0
7495959|NCT03466060|25995539|P2|Period 1|Lost to Follow-up|0
7495960|NCT03466060|25995540|P1|Period 1|Lost to Follow-up|0
7495961|NCT03466060|25995535|P6|Period 1|Withdrawal by Subject|0
7495962|NCT03466060|25995536|P5|Period 1|Withdrawal by Subject|0
7495963|NCT03466060|25995537|P4|Period 1|Withdrawal by Subject|0
7495964|NCT03466060|25995538|P3|Period 1|Withdrawal by Subject|2
7495965|NCT03466060|25995539|P2|Period 1|Withdrawal by Subject|0
7495966|NCT03466060|25995540|P1|Period 1|Withdrawal by Subject|0
7495967|NCT03466060|25995535|P6|Period 1|Test Lens Damage|0
7495968|NCT03466060|25995536|P5|Period 1|Test Lens Damage|0
7495969|NCT03466060|25995537|P4|Period 1|Test Lens Damage|0
7495970|NCT03466060|25995538|P3|Period 1|Test Lens Damage|0
7495971|NCT03466060|25995539|P2|Period 1|Test Lens Damage|2
7495972|NCT03466060|25995540|P1|Period 1|Test Lens Damage|0
7495973|NCT03465904|25995582|P2|Overall Study|Ineligible for mITT analysis|47
7495974|NCT03465904|25995583|P1|Overall Study|Ineligible for mITT analysis|62
7495975|NCT03465904|25995582|P2|Overall Study|Protocol Violation|5
7495976|NCT03465904|25995583|P1|Overall Study|Protocol Violation|8
7495977|NCT03465904|25995582|P2|Overall Study|Lost to Follow-up|9
7495978|NCT03465904|25995583|P1|Overall Study|Lost to Follow-up|10
7495979|NCT03465904|25995582|P2|Overall Study|Withdrawal by Subject|5
7495980|NCT03465904|25995583|P1|Overall Study|Withdrawal by Subject|9
7495981|NCT03465891|25995603|P2|Overall Study|Disease progression|0
7495982|NCT03465891|25995604|P1|Overall Study|Disease progression|1
7495983|NCT03465891|25995603|P2|Overall Study|Withdrawal by Subject|1
7495984|NCT03465891|25995604|P1|Overall Study|Withdrawal by Subject|0
7495985|NCT03465878|25995612|P4|Period 1-Part B First Intervention Day 1|Physician Decision|1
7495986|NCT03465878|25995613|P3|Period 1-Part B First Intervention Day 1|Physician Decision|0
7495987|NCT03465878|25995614|P2|Period 1-Part B First Intervention Day 1|Physician Decision|0
7495988|NCT03465878|25995615|P1|Period 1-Part B First Intervention Day 1|Physician Decision|0
7495989|NCT03465878|25995612|P4|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
7495990|NCT03465878|25995613|P3|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7495991|NCT03465878|25995614|P2|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7495992|NCT03465878|25995615|P1|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7495993|NCT03465878|25995612|P4|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7495994|NCT03465878|25995613|P3|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7495995|NCT03465878|25995614|P2|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
7495996|NCT03465878|25995615|P1|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7496027|NCT03465709|25995677|P1|Overall Study|Withdrawal by Subject|3
7496028|NCT03465709|25995677|P1|Overall Study|Study/Site Terminated by Sponsor|14
7496029|NCT03465436|25995689|P4|Period 4|Protocol Violation|0
7496030|NCT03465436|25995690|P3|Period 4|Protocol Violation|1
7496031|NCT03465436|25995691|P2|Period 4|Protocol Violation|0
7496032|NCT03465436|25995692|P1|Period 4|Protocol Violation|0
7496033|NCT03465436|25995689|P4|Period 3|Protocol Violation|0
7496034|NCT03465436|25995690|P3|Period 3|Protocol Violation|0
7496035|NCT03465436|25995691|P2|Period 3|Protocol Violation|1
7496036|NCT03465436|25995692|P1|Period 3|Protocol Violation|1
7496037|NCT03465436|25995689|P4|Period 2|Protocol Violation|0
7496038|NCT03465436|25995690|P3|Period 2|Protocol Violation|0
7496039|NCT03465436|25995691|P2|Period 2|Protocol Violation|1
7496040|NCT03465436|25995692|P1|Period 2|Protocol Violation|0
7496041|NCT03465436|25995689|P4|Period 1|Protocol Violation|0
7496042|NCT03465436|25995690|P3|Period 1|Protocol Violation|1
7496043|NCT03465436|25995691|P2|Period 1|Protocol Violation|0
7496044|NCT03465436|25995692|P1|Period 1|Protocol Violation|0
7496045|NCT03464422|25995726|P1|Overall Study|Withdrawal by Subject|2
7496046|NCT03464422|25995726|P1|Overall Study|Lost to Follow-up|2
7496047|NCT03464383|25995745|P3|Overall Study|Withdrawal by Subject|0
7496048|NCT03464383|25995746|P2|Overall Study|Withdrawal by Subject|1
7496049|NCT03464383|25995747|P1|Overall Study|Withdrawal by Subject|0
7496050|NCT03464383|25995745|P3|Overall Study|Lost to Follow-up|0
7496051|NCT03464383|25995746|P2|Overall Study|Lost to Follow-up|0
7496052|NCT03464383|25995747|P1|Overall Study|Lost to Follow-up|1
7496053|NCT03463031|25995833|P2|Overall Study|Use of prohibited medication by subject|0
7496054|NCT03463031|25995834|P1|Overall Study|Use of prohibited medication by subject|1
7496055|NCT03463031|25995833|P2|Overall Study|Adverse Event|1
7496056|NCT03463031|25995834|P1|Overall Study|Adverse Event|4
7496057|NCT03463031|25995833|P2|Overall Study|Lost to Follow-up|1
7496058|NCT03463031|25995834|P1|Overall Study|Lost to Follow-up|1
7496059|NCT03463031|25995833|P2|Overall Study|Investigator/Sponsor Decision|1
7496060|NCT03463031|25995834|P1|Overall Study|Investigator/Sponsor Decision|0
7496061|NCT03463031|25995833|P2|Overall Study|Withdrawal by Subject|2
7496062|NCT03463031|25995834|P1|Overall Study|Withdrawal by Subject|4
7496063|NCT03462576|25995885|P3|Overall Study|Device Malfunction|1
7496064|NCT03462576|25995886|P2|Overall Study|Device Malfunction|0
7496065|NCT03462576|25995887|P1|Overall Study|Device Malfunction|0
7496066|NCT03462576|25995885|P3|Overall Study|Protocol Violation|7
7496067|NCT03462576|25995886|P2|Overall Study|Protocol Violation|11
7496068|NCT03462576|25995887|P1|Overall Study|Protocol Violation|5
7496069|NCT03462082|25995898|P8|Open Label Phase|Symptom worsening (Treatment failure)|2
7496070|NCT03462082|25995899|P7|Open Label Phase|Symptom worsening (Treatment failure)|1
7496071|NCT03462082|25995900|P6|Open Label Phase|Symptom worsening (Treatment failure)|0
7496072|NCT03462082|25995901|P5|Open Label Phase|Symptom worsening (Treatment failure)|0
7496073|NCT03462082|25995902|P4|Open Label Phase|Symptom worsening (Treatment failure)|0
7496074|NCT03462082|25995903|P3|Open Label Phase|Symptom worsening (Treatment failure)|0
7496075|NCT03462082|25995904|P2|Open Label Phase|Symptom worsening (Treatment failure)|0
7496076|NCT03462082|25995905|P1|Open Label Phase|Symptom worsening (Treatment failure)|0
7496077|NCT03461757|25995973|P2|Overall Study|Other Reasons|4
7496078|NCT03461757|25995974|P1|Overall Study|Other Reasons|1
7496079|NCT03461757|25995973|P2|Overall Study|Withdrawal by Subject|7
7496080|NCT03461757|25995974|P1|Overall Study|Withdrawal by Subject|7
7496081|NCT03461757|25995973|P2|Overall Study|Protocol Violation|1
7496082|NCT03461757|25995974|P1|Overall Study|Protocol Violation|1
7496083|NCT03461757|25995973|P2|Overall Study|Pregnancy|0
7496084|NCT03461757|25995974|P1|Overall Study|Pregnancy|2
7496085|NCT03461757|25995973|P2|Overall Study|Non-compliance with study treatment|1
7496086|NCT03461757|25995974|P1|Overall Study|Non-compliance with study treatment|0
7496087|NCT03461757|25995973|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
7496088|NCT03461757|25995974|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
7496089|NCT03461757|25995973|P2|Overall Study|Lost to Follow-up|7
7496090|NCT03461757|25995974|P1|Overall Study|Lost to Follow-up|13
7496091|NCT03461757|25995973|P2|Overall Study|Adverse Event|0
7496092|NCT03461757|25995974|P1|Overall Study|Adverse Event|1
7496093|NCT03461289|25996035|P1|Overall Study|Death|1
7496094|NCT03461211|25996042|P2|Overall Study|Lack of Efficacy|1
7496095|NCT03461211|25996043|P1|Overall Study|Lack of Efficacy|0
7496096|NCT03461211|25996042|P2|Overall Study|Adverse Event|1
7496097|NCT03461211|25996043|P1|Overall Study|Adverse Event|1
7496098|NCT03461146|25996059|P1|Overall Study|Physician Decision|1
7496099|NCT03461146|25996059|P1|Overall Study|Adverse Event|2
7496100|NCT03459196|25996187|P1|Overall Study|Subject didn't receive study catheter|2
7496101|NCT03459040|25996201|P1|Overall Study|Withdrawal by Subject|1
7496102|NCT03459040|25996201|P1|Overall Study|Death|8
7496103|NCT03458702|25996243|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
7496104|NCT03458702|25996244|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
7496105|NCT03458702|25996243|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
7496106|NCT03458702|25996244|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
7496107|NCT03457727|25996282|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
7496108|NCT03457727|25996283|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7496109|NCT03457727|25996284|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7496110|NCT03457727|25996285|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7496111|NCT03457636|25996482|P1|Overall Study|Lost to Follow-up|2
7496112|NCT03457103|25996491|P2|Overall Study|financial/ insurance issues|1
7496113|NCT03457103|25996492|P1|Overall Study|financial/ insurance issues|1
7496114|NCT03457103|25996491|P2|Overall Study|Withdrawal by Subject|2
7496115|NCT03457103|25996492|P1|Overall Study|Withdrawal by Subject|1
7496116|NCT03457103|25996491|P2|Overall Study|Lost to Follow-up|1
7496117|NCT03457103|25996492|P1|Overall Study|Lost to Follow-up|2
7496118|NCT03457103|25996491|P2|Overall Study|illness/hospitalization|2
7496119|NCT03457103|25996492|P1|Overall Study|illness/hospitalization|4
7496120|NCT03456960|25996516|P6|Period 2 (1 Day)|Adverse Event|0
7496121|NCT03456960|25996517|P5|Period 2 (1 Day)|Adverse Event|0
7496122|NCT03456960|25996518|P4|Period 2 (1 Day)|Adverse Event|1
7496123|NCT03456960|25996519|P3|Period 2 (1 Day)|Adverse Event|0
7496124|NCT03456960|25996520|P2|Period 2 (1 Day)|Adverse Event|0
7496125|NCT03456960|25996521|P1|Period 2 (1 Day)|Adverse Event|1
7496126|NCT03456960|25996516|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7496127|NCT03456960|25996517|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7496128|NCT03456960|25996518|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
7496129|NCT03456960|25996519|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7496130|NCT03456960|25996520|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7496131|NCT03456960|25996521|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7496134|NCT03456700|25996617|P1|Overall Study|Withdrawal by Subject|1
7496135|NCT03455543|25996649|P3|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
7496136|NCT03455543|25996650|P2|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7496137|NCT03455543|25996651|P1|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7496138|NCT03455543|25996649|P3|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
7496139|NCT03455543|25996650|P2|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7496140|NCT03455543|25996651|P1|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7496141|NCT03455543|25996649|P3|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
7496142|NCT03455543|25996650|P2|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7496143|NCT03455543|25996651|P1|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7496144|NCT03455543|25996649|P3|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
7496145|NCT03455543|25996650|P2|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7496146|NCT03455543|25996651|P1|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7496147|NCT03455543|25996649|P3|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
7496148|NCT03455543|25996650|P2|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7496149|NCT03455543|25996651|P1|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7496150|NCT03455543|25996649|P3|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
7496151|NCT03455543|25996650|P2|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7496152|NCT03455543|25996651|P1|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7496153|NCT03455543|25996649|P3|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7496154|NCT03455543|25996650|P2|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7496155|NCT03455543|25996651|P1|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
7496156|NCT03455543|25996649|P3|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
7496157|NCT03455543|25996650|P2|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
7496158|NCT03455543|25996651|P1|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
7496159|NCT03455543|25996649|P3|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
7496160|NCT03455543|25996650|P2|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
7496246|NCT03449446|25997396|P3|Overall Study|Non Compliance with Study Drug|0
7496161|NCT03455543|25996651|P1|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
7496162|NCT03454412|25996784|P1|Baseline Assesment|Physician Decision|12
7496163|NCT03453151|25996850|P1|Overall Study|Physician Decision|3
7496164|NCT03453151|25996850|P1|Overall Study|Withdrawal by Subject|1
7496165|NCT03452943|25997087|P2|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
7496166|NCT03452943|25997088|P1|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
7496167|NCT03452943|25997087|P2|Maintenance Period (5 Weeks)|Adverse Event|0
7496168|NCT03452943|25997088|P1|Maintenance Period (5 Weeks)|Adverse Event|1
7496169|NCT03452943|25997087|P2|Titration Period (7 Weeks)|Lost to Follow-up|0
7496170|NCT03452943|25997088|P1|Titration Period (7 Weeks)|Lost to Follow-up|1
7496171|NCT03452943|25997087|P2|Titration Period (7 Weeks)|Withdrawal by Subject|2
7496172|NCT03452943|25997088|P1|Titration Period (7 Weeks)|Withdrawal by Subject|3
7496173|NCT03452943|25997087|P2|Titration Period (7 Weeks)|Protocol Violation|1
7496174|NCT03452943|25997088|P1|Titration Period (7 Weeks)|Protocol Violation|0
7496175|NCT03452943|25997087|P2|Titration Period (7 Weeks)|Adverse Event|1
7496176|NCT03452943|25997088|P1|Titration Period (7 Weeks)|Adverse Event|1
7496177|NCT03452527|25997104|P2|Overall Study|Study Terminated|3
7496178|NCT03452527|25997105|P1|Overall Study|Study Terminated|2
7496179|NCT03452527|25997104|P2|Overall Study|Withdrawal by Subject|1
7496180|NCT03452527|25997105|P1|Overall Study|Withdrawal by Subject|1
7496181|NCT03452189|25997132|P2|First Intervention (3 Months)|insufficient samples of plasma and stool|0
7496182|NCT03452189|25997133|P1|First Intervention (3 Months)|insufficient samples of plasma and stool|4
7496183|NCT03452189|25997132|P2|First Intervention (3 Months)|Adverse Event|0
7496184|NCT03452189|25997133|P1|First Intervention (3 Months)|Adverse Event|1
7496185|NCT03451773|25997183|P2|Overall Study|Death during follow-up period|1
7496186|NCT03451773|25997184|P1|Overall Study|Death during follow-up period|0
7496187|NCT03451773|25997183|P2|Overall Study|Death on study|5
7496188|NCT03451773|25997184|P1|Overall Study|Death on study|1
7496189|NCT03451721|25997206|P1|Overall Study|Death|1
7496190|NCT03451084|25997219|P4|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
7496191|NCT03451084|25997220|P3|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7496192|NCT03451084|25997221|P2|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7496193|NCT03451084|25997222|P1|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
7496194|NCT03451084|25997219|P4|Overall Study|Physician Decision|2
7496195|NCT03451084|25997220|P3|Overall Study|Physician Decision|2
7496196|NCT03451084|25997221|P2|Overall Study|Physician Decision|0
7496197|NCT03451084|25997222|P1|Overall Study|Physician Decision|0
7496198|NCT03451084|25997219|P4|Overall Study|Death|0
7496199|NCT03451084|25997220|P3|Overall Study|Death|2
7496200|NCT03451084|25997221|P2|Overall Study|Death|0
7496201|NCT03451084|25997222|P1|Overall Study|Death|1
7496202|NCT03451084|25997219|P4|Overall Study|Lack of Efficacy|1
7496203|NCT03451084|25997220|P3|Overall Study|Lack of Efficacy|0
7496204|NCT03451084|25997221|P2|Overall Study|Lack of Efficacy|3
7496205|NCT03451084|25997222|P1|Overall Study|Lack of Efficacy|0
7496206|NCT03451084|25997219|P4|Overall Study|Disease recurrence|0
7496207|NCT03451084|25997220|P3|Overall Study|Disease recurrence|0
7496208|NCT03451084|25997221|P2|Overall Study|Disease recurrence|2
7496209|NCT03451084|25997222|P1|Overall Study|Disease recurrence|0
7496210|NCT03451084|25997219|P4|Overall Study|Withdrawal by Subject|1
7496211|NCT03451084|25997220|P3|Overall Study|Withdrawal by Subject|2
7496212|NCT03451084|25997221|P2|Overall Study|Withdrawal by Subject|1
7496213|NCT03451084|25997222|P1|Overall Study|Withdrawal by Subject|2
7496214|NCT03451071|25997252|P1|Final Questionnaire and Blood Draw|Lost to Follow-up|4
7496215|NCT03451071|25997252|P1|Third Vaccine|Lost to Follow-up|22
7496216|NCT03451071|25997252|P1|Second Vaccine|Lost to Follow-up|19
7496217|NCT03451071|25997252|P1|First Vaccine|Withdrawal by Subject|1
7496218|NCT03450070|25997331|P1|Overall Study|Withdrawal by Subject|8
7496219|NCT03449979|25997339|P4|Overall Study|Technical difficulty|1
7496220|NCT03449979|25997340|P3|Overall Study|Technical difficulty|0
7496221|NCT03449979|25997341|P2|Overall Study|Technical difficulty|0
7496222|NCT03449979|25997342|P1|Overall Study|Technical difficulty|0
7496223|NCT03449758|25997352|P1|Overall Study|Other unspecified reason|3
7496224|NCT03449758|25997352|P1|Overall Study|Consent withdrawal|1
7496225|NCT03449758|25997352|P1|Overall Study|Adverse Event|9
7496226|NCT03449758|25997352|P1|Overall Study|Treatment inefficacy|5
7496227|NCT03449758|25997352|P1|Overall Study|Major protocol deviation|1
7496228|NCT03449446|25997392|P7|Overall Study|Death|0
7496229|NCT03449446|25997393|P6|Overall Study|Death|0
7496230|NCT03449446|25997394|P5|Overall Study|Death|1
7496231|NCT03449446|25997395|P4|Overall Study|Death|0
7496232|NCT03449446|25997396|P3|Overall Study|Death|0
7496233|NCT03449446|25997397|P2|Overall Study|Death|0
7496234|NCT03449446|25997398|P1|Overall Study|Death|0
7496235|NCT03449446|25997392|P7|Overall Study|Protocol Violation|0
7496236|NCT03449446|25997393|P6|Overall Study|Protocol Violation|1
7496237|NCT03449446|25997394|P5|Overall Study|Protocol Violation|1
7496238|NCT03449446|25997395|P4|Overall Study|Protocol Violation|0
7496239|NCT03449446|25997396|P3|Overall Study|Protocol Violation|0
7496240|NCT03449446|25997397|P2|Overall Study|Protocol Violation|0
7496241|NCT03449446|25997398|P1|Overall Study|Protocol Violation|0
7496242|NCT03449446|25997392|P7|Overall Study|Non Compliance with Study Drug|0
7496243|NCT03449446|25997393|P6|Overall Study|Non Compliance with Study Drug|0
7496244|NCT03449446|25997394|P5|Overall Study|Non Compliance with Study Drug|0
7496245|NCT03449446|25997395|P4|Overall Study|Non Compliance with Study Drug|0
7496247|NCT03449446|25997397|P2|Overall Study|Non Compliance with Study Drug|0
7496248|NCT03449446|25997398|P1|Overall Study|Non Compliance with Study Drug|1
7496249|NCT03449446|25997392|P7|Overall Study|Investigator's Discretion|0
7496250|NCT03449446|25997393|P6|Overall Study|Investigator's Discretion|0
7496251|NCT03449446|25997394|P5|Overall Study|Investigator's Discretion|0
7496252|NCT03449446|25997395|P4|Overall Study|Investigator's Discretion|2
7496253|NCT03449446|25997396|P3|Overall Study|Investigator's Discretion|1
7496254|NCT03449446|25997397|P2|Overall Study|Investigator's Discretion|1
7496255|NCT03449446|25997398|P1|Overall Study|Investigator's Discretion|0
7496256|NCT03449446|25997392|P7|Overall Study|Lost to Follow-up|0
7496257|NCT03449446|25997393|P6|Overall Study|Lost to Follow-up|0
7496258|NCT03449446|25997394|P5|Overall Study|Lost to Follow-up|3
7496259|NCT03449446|25997395|P4|Overall Study|Lost to Follow-up|1
7496260|NCT03449446|25997396|P3|Overall Study|Lost to Follow-up|2
7496261|NCT03449446|25997397|P2|Overall Study|Lost to Follow-up|0
7496262|NCT03449446|25997398|P1|Overall Study|Lost to Follow-up|0
7496263|NCT03449446|25997392|P7|Overall Study|Adverse Event|0
7496264|NCT03449446|25997393|P6|Overall Study|Adverse Event|2
7496265|NCT03449446|25997394|P5|Overall Study|Adverse Event|0
7496266|NCT03449446|25997395|P4|Overall Study|Adverse Event|0
7496267|NCT03449446|25997396|P3|Overall Study|Adverse Event|1
7496268|NCT03449446|25997397|P2|Overall Study|Adverse Event|2
7496269|NCT03449446|25997398|P1|Overall Study|Adverse Event|1
7496270|NCT03449446|25997392|P7|Overall Study|Withdrew Consent|1
7496271|NCT03449446|25997393|P6|Overall Study|Withdrew Consent|4
7496272|NCT03449446|25997394|P5|Overall Study|Withdrew Consent|4
7496273|NCT03449446|25997395|P4|Overall Study|Withdrew Consent|4
7496274|NCT03449446|25997396|P3|Overall Study|Withdrew Consent|1
7496275|NCT03449446|25997397|P2|Overall Study|Withdrew Consent|3
7496276|NCT03449446|25997398|P1|Overall Study|Withdrew Consent|1
7496277|NCT03449446|25997392|P7|Overall Study|Unknown Reason|0
7496278|NCT03449446|25997393|P6|Overall Study|Unknown Reason|2
7496279|NCT03449446|25997394|P5|Overall Study|Unknown Reason|2
7496280|NCT03449446|25997395|P4|Overall Study|Unknown Reason|1
7496281|NCT03449446|25997396|P3|Overall Study|Unknown Reason|1
7496282|NCT03449446|25997397|P2|Overall Study|Unknown Reason|1
7496283|NCT03449446|25997398|P1|Overall Study|Unknown Reason|33
7496284|NCT03449446|25997392|P7|Overall Study|Randomized but Never Treated|0
7496285|NCT03449446|25997393|P6|Overall Study|Randomized but Never Treated|0
7496286|NCT03449446|25997394|P5|Overall Study|Randomized but Never Treated|1
7496287|NCT03449446|25997395|P4|Overall Study|Randomized but Never Treated|1
7496288|NCT03449446|25997396|P3|Overall Study|Randomized but Never Treated|1
7496289|NCT03449446|25997397|P2|Overall Study|Randomized but Never Treated|0
7496290|NCT03449446|25997398|P1|Overall Study|Randomized but Never Treated|0
7496291|NCT03449147|25997470|P3|12-Week Off-Treatment Durability Period|Other|0
7496292|NCT03449147|25997471|P2|12-Week Off-Treatment Durability Period|Other|1
7496293|NCT03449147|25997472|P1|12-Week Off-Treatment Durability Period|Other|0
7496294|NCT03449147|25997470|P3|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7496295|NCT03449147|25997471|P2|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7496296|NCT03449147|25997472|P1|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
7496297|NCT03449147|25997470|P3|52-week Treatment Period|Withdrawal by Subject|74
7496298|NCT03449147|25997471|P2|52-week Treatment Period|Withdrawal by Subject|68
7496299|NCT03449147|25997472|P1|52-week Treatment Period|Withdrawal by Subject|46
7496300|NCT03449147|25997470|P3|52-week Treatment Period|Screen Failure|0
7496301|NCT03449147|25997471|P2|52-week Treatment Period|Screen Failure|2
7496302|NCT03449147|25997472|P1|52-week Treatment Period|Screen Failure|1
7496303|NCT03449147|25997470|P3|52-week Treatment Period|Physician Decision|3
7496304|NCT03449147|25997471|P2|52-week Treatment Period|Physician Decision|0
7496305|NCT03449147|25997472|P1|52-week Treatment Period|Physician Decision|1
7496306|NCT03449147|25997470|P3|52-week Treatment Period|Other|2
7496307|NCT03449147|25997471|P2|52-week Treatment Period|Other|1
7496308|NCT03449147|25997472|P1|52-week Treatment Period|Other|0
7496309|NCT03449147|25997470|P3|52-week Treatment Period|Lost to Follow-up|5
7496310|NCT03449147|25997471|P2|52-week Treatment Period|Lost to Follow-up|2
7496311|NCT03449147|25997472|P1|52-week Treatment Period|Lost to Follow-up|6
7496312|NCT03449147|25997470|P3|52-week Treatment Period|Death|0
7496313|NCT03449147|25997471|P2|52-week Treatment Period|Death|1
7496314|NCT03449147|25997472|P1|52-week Treatment Period|Death|0
7496315|NCT03449134|25997510|P3|52-Week Treatment Period|Site Closure|0
7496316|NCT03449134|25997511|P2|52-Week Treatment Period|Site Closure|0
7496317|NCT03449134|25997512|P1|52-Week Treatment Period|Site Closure|1
7496318|NCT03449134|25997510|P3|52-Week Treatment Period|Withdrawal by Subject|55
7496319|NCT03449134|25997511|P2|52-Week Treatment Period|Withdrawal by Subject|39
7496320|NCT03449134|25997512|P1|52-Week Treatment Period|Withdrawal by Subject|37
7496321|NCT03449134|25997510|P3|52-Week Treatment Period|Screen Failure|1
7496322|NCT03449134|25997511|P2|52-Week Treatment Period|Screen Failure|0
7496323|NCT03449134|25997512|P1|52-Week Treatment Period|Screen Failure|1
7496324|NCT03449134|25997510|P3|52-Week Treatment Period|Physician Decision|3
7496325|NCT03449134|25997511|P2|52-Week Treatment Period|Physician Decision|3
7496326|NCT03449134|25997512|P1|52-Week Treatment Period|Physician Decision|2
7496327|NCT03449134|25997510|P3|52-Week Treatment Period|Lost to Follow-up|1
7496328|NCT03449134|25997511|P2|52-Week Treatment Period|Lost to Follow-up|1
7496329|NCT03449134|25997512|P1|52-Week Treatment Period|Lost to Follow-up|2
7496330|NCT03449134|25997510|P3|52-Week Treatment Period|Death|0
7496331|NCT03449134|25997511|P2|52-Week Treatment Period|Death|1
7496332|NCT03449134|25997512|P1|52-Week Treatment Period|Death|2
7496333|NCT03449030|25997557|P10|Overall Study|Death|0
7496334|NCT03449030|25997558|P9|Overall Study|Death|0
7496335|NCT03449030|25997559|P8|Overall Study|Death|0
7496336|NCT03449030|25997560|P7|Overall Study|Death|0
7496337|NCT03449030|25997561|P6|Overall Study|Death|0
7496338|NCT03449030|25997562|P5|Overall Study|Death|1
7496339|NCT03449030|25997563|P4|Overall Study|Death|0
7496340|NCT03449030|25997564|P3|Overall Study|Death|0
7496341|NCT03449030|25997565|P2|Overall Study|Death|0
7496342|NCT03449030|25997566|P1|Overall Study|Death|0
7496343|NCT03449030|25997557|P10|Overall Study|Adverse Event|0
7496344|NCT03449030|25997558|P9|Overall Study|Adverse Event|0
7496345|NCT03449030|25997559|P8|Overall Study|Adverse Event|0
7496346|NCT03449030|25997560|P7|Overall Study|Adverse Event|0
7496347|NCT03449030|25997561|P6|Overall Study|Adverse Event|2
7496348|NCT03449030|25997562|P5|Overall Study|Adverse Event|0
7496349|NCT03449030|25997563|P4|Overall Study|Adverse Event|0
7496350|NCT03449030|25997564|P3|Overall Study|Adverse Event|0
7496351|NCT03449030|25997565|P2|Overall Study|Adverse Event|0
7496352|NCT03449030|25997566|P1|Overall Study|Adverse Event|0
7496353|NCT03449030|25997557|P10|Overall Study|Progressive Disease|1
7496354|NCT03449030|25997558|P9|Overall Study|Progressive Disease|1
7496355|NCT03449030|25997559|P8|Overall Study|Progressive Disease|1
7496356|NCT03449030|25997560|P7|Overall Study|Progressive Disease|0
7496357|NCT03449030|25997561|P6|Overall Study|Progressive Disease|3
7496358|NCT03449030|25997562|P5|Overall Study|Progressive Disease|5
7496359|NCT03449030|25997563|P4|Overall Study|Progressive Disease|4
7496360|NCT03449030|25997564|P3|Overall Study|Progressive Disease|1
7496361|NCT03449030|25997565|P2|Overall Study|Progressive Disease|0
7496362|NCT03449030|25997566|P1|Overall Study|Progressive Disease|1
7496363|NCT03449030|25997557|P10|Overall Study|Symptomatic Deterioration|0
7496364|NCT03449030|25997558|P9|Overall Study|Symptomatic Deterioration|2
7496365|NCT03449030|25997559|P8|Overall Study|Symptomatic Deterioration|0
7496366|NCT03449030|25997560|P7|Overall Study|Symptomatic Deterioration|1
7496367|NCT03449030|25997561|P6|Overall Study|Symptomatic Deterioration|1
7496368|NCT03449030|25997562|P5|Overall Study|Symptomatic Deterioration|0
7496369|NCT03449030|25997563|P4|Overall Study|Symptomatic Deterioration|0
7496370|NCT03449030|25997564|P3|Overall Study|Symptomatic Deterioration|0
7496371|NCT03449030|25997565|P2|Overall Study|Symptomatic Deterioration|1
7496372|NCT03449030|25997566|P1|Overall Study|Symptomatic Deterioration|0
7496373|NCT03449030|25997557|P10|Overall Study|Withdrawal by Subject|0
7496374|NCT03449030|25997558|P9|Overall Study|Withdrawal by Subject|0
7496375|NCT03449030|25997559|P8|Overall Study|Withdrawal by Subject|2
7496376|NCT03449030|25997560|P7|Overall Study|Withdrawal by Subject|1
7496377|NCT03449030|25997561|P6|Overall Study|Withdrawal by Subject|1
7496378|NCT03449030|25997562|P5|Overall Study|Withdrawal by Subject|1
7496379|NCT03449030|25997563|P4|Overall Study|Withdrawal by Subject|1
7496380|NCT03449030|25997564|P3|Overall Study|Withdrawal by Subject|0
7496381|NCT03449030|25997565|P2|Overall Study|Withdrawal by Subject|0
7496382|NCT03449030|25997566|P1|Overall Study|Withdrawal by Subject|0
7496383|NCT03448536|25997741|P2|Overall Study|Physician Decision|0
7496384|NCT03448536|25997742|P1|Overall Study|Physician Decision|1
7496385|NCT03448536|25997741|P2|Overall Study|Other|0
7496386|NCT03448536|25997742|P1|Overall Study|Other|3
7496387|NCT03448536|25997741|P2|Overall Study|Inadequate pain reporter|0
7496388|NCT03448536|25997742|P1|Overall Study|Inadequate pain reporter|1
7496389|NCT03448536|25997741|P2|Overall Study|Lost to Follow-up|2
7496390|NCT03448536|25997742|P1|Overall Study|Lost to Follow-up|3
7496391|NCT03448536|25997741|P2|Overall Study|Withdrawal by Subject|2
7496392|NCT03448536|25997742|P1|Overall Study|Withdrawal by Subject|1
7496393|NCT03448536|25997741|P2|Overall Study|Pregnancy|0
7496394|NCT03448536|25997742|P1|Overall Study|Pregnancy|1
7496395|NCT03448536|25997741|P2|Overall Study|Protocol Violation|0
7496396|NCT03448536|25997742|P1|Overall Study|Protocol Violation|2
7496397|NCT03448419|25997768|P2|Overall Study|Withdrawn by Sponsor|1
7496398|NCT03448419|25997769|P1|Overall Study|Withdrawn by Sponsor|0
7496399|NCT03448419|25997768|P2|Overall Study|Patient did not attend all visits|2
7496400|NCT03448419|25997769|P1|Overall Study|Patient did not attend all visits|0
7496401|NCT03448419|25997768|P2|Overall Study|Not treated|1
7496402|NCT03448419|25997769|P1|Overall Study|Not treated|0
7496403|NCT03448419|25997768|P2|Overall Study|Withdrawal by Subject|1
7496404|NCT03448419|25997769|P1|Overall Study|Withdrawal by Subject|3
7496405|NCT03448419|25997768|P2|Overall Study|Lost to Follow-up|2
7496406|NCT03448419|25997769|P1|Overall Study|Lost to Follow-up|0
7496407|NCT03448419|25997768|P2|Overall Study|Adverse Event|9
7496408|NCT03448419|25997769|P1|Overall Study|Adverse Event|10
7496409|NCT03448406|25997795|P2|Overall Study|Adverse Event|9
7496410|NCT03448406|25997796|P1|Overall Study|Adverse Event|8
7496411|NCT03448406|25997795|P2|Overall Study|Protocol Violation|0
7496412|NCT03448406|25997796|P1|Overall Study|Protocol Violation|1
7496413|NCT03448406|25997795|P2|Overall Study|Withdrawal by Subject|2
7496414|NCT03448406|25997796|P1|Overall Study|Withdrawal by Subject|1
7496415|NCT03448406|25997795|P2|Overall Study|Noncompliance of scheduled visits|2
7496416|NCT03448406|25997796|P1|Overall Study|Noncompliance of scheduled visits|1
7496417|NCT03448224|25997822|P2|Overall Study|Provided same answer to every question|0
7496418|NCT03448224|25997823|P1|Overall Study|Provided same answer to every question|1
7496419|NCT03447821|25997863|P3|Overall Study|Lost to Follow-up|1
7496420|NCT03447821|25997864|P2|Overall Study|Lost to Follow-up|0
7496421|NCT03447821|25997865|P1|Overall Study|Lost to Follow-up|0
7496422|NCT03447821|25997863|P3|Overall Study|Withdrawal by Subject|0
7496423|NCT03447821|25997864|P2|Overall Study|Withdrawal by Subject|1
7496424|NCT03447821|25997865|P1|Overall Study|Withdrawal by Subject|1
7496425|NCT03447730|25997891|P3|Overall Study|Adverse Event|0
7496426|NCT03447730|25997892|P2|Overall Study|Adverse Event|2
7496427|NCT03447730|25997893|P1|Overall Study|Adverse Event|0
7496428|NCT03447353|25997920|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
7496429|NCT03447353|25997920|P1|Overall Study|Scheduling Conflicts|3
7496430|NCT03447353|25997920|P1|Overall Study|Lost to Follow-up|4
7496431|NCT03447353|25997920|P1|Overall Study|Failure at Screening Visit|2
7496432|NCT03447314|25997952|P18|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496433|NCT03447314|25997953|P17|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496434|NCT03447314|25997954|P16|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496435|NCT03447314|25997955|P15|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496436|NCT03447314|25997956|P14|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496437|NCT03447314|25997957|P13|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496438|NCT03447314|25997958|P12|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496439|NCT03447314|25997959|P11|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496440|NCT03447314|25997960|P10|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496441|NCT03447314|25997961|P9|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496442|NCT03447314|25997962|P8|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496443|NCT03447314|25997963|P7|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496444|NCT03447314|25997964|P6|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496445|NCT03447314|25997965|P5|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496446|NCT03447314|25997966|P4|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496447|NCT03447314|25997967|P3|Part 1 (Up to 27 Months)|Lost to Follow-up|1
7496448|NCT03447314|25997968|P2|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496449|NCT03447314|25997969|P1|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7496450|NCT03447314|25997952|P18|Part 1 (Up to 27 Months)|Disease progression|0
7496451|NCT03447314|25997953|P17|Part 1 (Up to 27 Months)|Disease progression|0
7496452|NCT03447314|25997954|P16|Part 1 (Up to 27 Months)|Disease progression|0
7496453|NCT03447314|25997955|P15|Part 1 (Up to 27 Months)|Disease progression|0
7496454|NCT03447314|25997956|P14|Part 1 (Up to 27 Months)|Disease progression|0
7496455|NCT03447314|25997957|P13|Part 1 (Up to 27 Months)|Disease progression|0
7496456|NCT03447314|25997958|P12|Part 1 (Up to 27 Months)|Disease progression|0
7496457|NCT03447314|25997959|P11|Part 1 (Up to 27 Months)|Disease progression|0
7496458|NCT03447314|25997960|P10|Part 1 (Up to 27 Months)|Disease progression|0
7496459|NCT03447314|25997961|P9|Part 1 (Up to 27 Months)|Disease progression|0
7496460|NCT03447314|25997962|P8|Part 1 (Up to 27 Months)|Disease progression|0
7496461|NCT03447314|25997963|P7|Part 1 (Up to 27 Months)|Disease progression|0
7496462|NCT03447314|25997964|P6|Part 1 (Up to 27 Months)|Disease progression|0
7496463|NCT03447314|25997965|P5|Part 1 (Up to 27 Months)|Disease progression|0
7496464|NCT03447314|25997966|P4|Part 1 (Up to 27 Months)|Disease progression|0
7496465|NCT03447314|25997967|P3|Part 1 (Up to 27 Months)|Disease progression|1
7496466|NCT03447314|25997968|P2|Part 1 (Up to 27 Months)|Disease progression|0
7496467|NCT03447314|25997969|P1|Part 1 (Up to 27 Months)|Disease progression|0
7496468|NCT03447314|25997952|P18|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496469|NCT03447314|25997953|P17|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496470|NCT03447314|25997954|P16|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496471|NCT03447314|25997955|P15|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496472|NCT03447314|25997956|P14|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496473|NCT03447314|25997957|P13|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496474|NCT03447314|25997958|P12|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496475|NCT03447314|25997959|P11|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496476|NCT03447314|25997960|P10|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496477|NCT03447314|25997961|P9|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496478|NCT03447314|25997962|P8|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496479|NCT03447314|25997963|P7|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496480|NCT03447314|25997964|P6|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7496481|NCT03447314|25997965|P5|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496482|NCT03447314|25997966|P4|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496483|NCT03447314|25997967|P3|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7496484|NCT03447314|25997968|P2|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7496485|NCT03447314|25997969|P1|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7496486|NCT03447314|25997952|P18|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496487|NCT03447314|25997953|P17|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496488|NCT03447314|25997954|P16|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496489|NCT03447314|25997955|P15|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496490|NCT03447314|25997956|P14|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496491|NCT03447314|25997957|P13|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496492|NCT03447314|25997958|P12|Part 1 (Up to 27 Months)|Ongoing in the study|4
7496493|NCT03447314|25997959|P11|Part 1 (Up to 27 Months)|Ongoing in the study|3
7496494|NCT03447314|25997960|P10|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496495|NCT03447314|25997961|P9|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496496|NCT03447314|25997962|P8|Part 1 (Up to 27 Months)|Ongoing in the study|0
7496497|NCT03447314|25997963|P7|Part 1 (Up to 27 Months)|Ongoing in the study|2
7496498|NCT03447314|25997964|P6|Part 1 (Up to 27 Months)|Ongoing in the study|1
7496499|NCT03447314|25997965|P5|Part 1 (Up to 27 Months)|Ongoing in the study|2
7496500|NCT03447314|25997966|P4|Part 1 (Up to 27 Months)|Ongoing in the study|1
7496501|NCT03447314|25997967|P3|Part 1 (Up to 27 Months)|Ongoing in the study|3
7496502|NCT03447314|25997968|P2|Part 1 (Up to 27 Months)|Ongoing in the study|1
7496503|NCT03447314|25997969|P1|Part 1 (Up to 27 Months)|Ongoing in the study|2
7496504|NCT03447314|25997952|P18|Part 1 (Up to 27 Months)|Death|0
7496505|NCT03447314|25997953|P17|Part 1 (Up to 27 Months)|Death|0
7496506|NCT03447314|25997954|P16|Part 1 (Up to 27 Months)|Death|0
7496507|NCT03447314|25997955|P15|Part 1 (Up to 27 Months)|Death|0
7496508|NCT03447314|25997956|P14|Part 1 (Up to 27 Months)|Death|0
7496509|NCT03447314|25997957|P13|Part 1 (Up to 27 Months)|Death|0
7496510|NCT03447314|25997958|P12|Part 1 (Up to 27 Months)|Death|2
7496511|NCT03447314|25997959|P11|Part 1 (Up to 27 Months)|Death|4
7496512|NCT03447314|25997960|P10|Part 1 (Up to 27 Months)|Death|0
7496513|NCT03447314|25997961|P9|Part 1 (Up to 27 Months)|Death|0
7496514|NCT03447314|25997962|P8|Part 1 (Up to 27 Months)|Death|0
7496515|NCT03447314|25997963|P7|Part 1 (Up to 27 Months)|Death|3
7496516|NCT03447314|25997964|P6|Part 1 (Up to 27 Months)|Death|4
7496517|NCT03447314|25997965|P5|Part 1 (Up to 27 Months)|Death|0
7496518|NCT03447314|25997966|P4|Part 1 (Up to 27 Months)|Death|3
7496519|NCT03447314|25997967|P3|Part 1 (Up to 27 Months)|Death|3
7496520|NCT03447314|25997968|P2|Part 1 (Up to 27 Months)|Death|5
7496521|NCT03447314|25997969|P1|Part 1 (Up to 27 Months)|Death|6
7496522|NCT03447249|25998345|P2|Overall Study|Other|0
7496523|NCT03447249|25998346|P1|Overall Study|Other|3
7496524|NCT03447249|25998345|P2|Overall Study|Withdrawal of consent (not due to AE)|0
7496525|NCT03447249|25998346|P1|Overall Study|Withdrawal of consent (not due to AE)|1
7496526|NCT03447249|25998345|P2|Overall Study|Adverse Event|0
7496527|NCT03447249|25998346|P1|Overall Study|Adverse Event|1
7496528|NCT03446885|25998394|P2|Overall Study|Did not complete entire visit|0
7496529|NCT03446885|25998395|P1|Overall Study|Did not complete entire visit|1
7496530|NCT03446885|25998394|P2|Overall Study|Lost to Follow-up|0
7496531|NCT03446885|25998395|P1|Overall Study|Lost to Follow-up|1
7496532|NCT03446781|25998431|P2|Overall Study|Protocol Violation|3
7496533|NCT03446781|25998432|P1|Overall Study|Protocol Violation|0
7496534|NCT03446781|25998431|P2|Overall Study|Adverse Event|2
7496535|NCT03446781|25998432|P1|Overall Study|Adverse Event|8
7496536|NCT03446781|25998431|P2|Overall Study|Withdrawal by Subject|7
7496537|NCT03446781|25998432|P1|Overall Study|Withdrawal by Subject|9
7496538|NCT03446781|25998431|P2|Overall Study|Lost to Follow-up|5
7496539|NCT03446781|25998432|P1|Overall Study|Lost to Follow-up|11
7496540|NCT03446612|25998490|P2|Overall Study|Protocol defined stopping criteria|1
7496541|NCT03446612|25998491|P1|Overall Study|Protocol defined stopping criteria|0
7496556|NCT03445065|25998781|P4|Overall Study|Other|1
7496557|NCT03445065|25998782|P3|Overall Study|Other|3
7496558|NCT03445065|25998783|P2|Overall Study|Other|3
7496559|NCT03445065|25998784|P1|Overall Study|Other|4
7496560|NCT03445065|25998781|P4|Overall Study|Withdrawal by Subject|2
7496561|NCT03445065|25998782|P3|Overall Study|Withdrawal by Subject|2
7496562|NCT03445065|25998783|P2|Overall Study|Withdrawal by Subject|6
7496563|NCT03445065|25998784|P1|Overall Study|Withdrawal by Subject|3
7496564|NCT03444766|25998954|P1|Overall Study|Disease Progression|49
7496565|NCT03444766|25998954|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
7496566|NCT03444766|25998954|P1|Overall Study|Death|2
7496567|NCT03444766|25998954|P1|Overall Study|Lost to Follow-up|2
7496568|NCT03444766|25998954|P1|Overall Study|Participant Withdrew Consent|5
7496569|NCT03444766|25998954|P1|Overall Study|Other Reasons|2
7496570|NCT03444584|25998963|P2|Overall Study|Other|1
7496571|NCT03444584|25998964|P1|Overall Study|Other|0
7496572|NCT03444584|25998963|P2|Overall Study|Withdrawal by Subject|1
7496573|NCT03444584|25998964|P1|Overall Study|Withdrawal by Subject|0
7496574|NCT03444155|25999022|P2|First Intervention (6 Weeks)|Adverse Event|0
7496575|NCT03444155|25999023|P1|First Intervention (6 Weeks)|Adverse Event|1
7496576|NCT03443713|25999061|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
7496577|NCT03443713|25999062|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7496578|NCT03443713|25999063|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7496579|NCT03443427|25999094|P2|Overall Study|Other|6
7496580|NCT03443427|25999095|P1|Overall Study|Other|4
7496581|NCT03443427|25999094|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7496582|NCT03443427|25999095|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7496583|NCT03443427|25999094|P2|Overall Study|Adverse Event|3
7496584|NCT03443427|25999095|P1|Overall Study|Adverse Event|2
7496585|NCT03443414|25999136|P5|Overall Study|Reason not specified|1
7496586|NCT03443414|25999137|P4|Overall Study|Reason not specified|0
7496587|NCT03443414|25999138|P3|Overall Study|Reason not specified|0
7496588|NCT03443414|25999139|P2|Overall Study|Reason not specified|0
7496589|NCT03443414|25999140|P1|Overall Study|Reason not specified|2
7496590|NCT03443414|25999136|P5|Overall Study|Death|0
7496591|NCT03443414|25999137|P4|Overall Study|Death|1
7496592|NCT03443414|25999138|P3|Overall Study|Death|0
7496593|NCT03443414|25999139|P2|Overall Study|Death|1
7496594|NCT03443414|25999140|P1|Overall Study|Death|0
7496595|NCT03443414|25999136|P5|Overall Study|Withdrawal by Subject|1
7496596|NCT03443414|25999137|P4|Overall Study|Withdrawal by Subject|2
7496597|NCT03443414|25999138|P3|Overall Study|Withdrawal by Subject|2
7496598|NCT03443414|25999139|P2|Overall Study|Withdrawal by Subject|2
7496599|NCT03443414|25999140|P1|Overall Study|Withdrawal by Subject|3
7496600|NCT03443414|25999136|P5|Overall Study|Adverse Event|3
7496601|NCT03443414|25999137|P4|Overall Study|Adverse Event|2
7496602|NCT03443414|25999138|P3|Overall Study|Adverse Event|4
7496603|NCT03443414|25999139|P2|Overall Study|Adverse Event|0
7496604|NCT03443414|25999140|P1|Overall Study|Adverse Event|6
7496605|NCT03443024|25999234|P4|Overall Study|Protocol Deviation|2
7496606|NCT03443024|25999235|P3|Overall Study|Protocol Deviation|0
7496607|NCT03443024|25999236|P2|Overall Study|Protocol Deviation|0
7496608|NCT03443024|25999237|P1|Overall Study|Protocol Deviation|0
7496609|NCT03443024|25999234|P4|Overall Study|Sponsor Decision|0
7496610|NCT03443024|25999235|P3|Overall Study|Sponsor Decision|0
7496611|NCT03443024|25999236|P2|Overall Study|Sponsor Decision|1
7496612|NCT03443024|25999237|P1|Overall Study|Sponsor Decision|1
7496613|NCT03443024|25999234|P4|Overall Study|Physician Decision|1
7496614|NCT03443024|25999235|P3|Overall Study|Physician Decision|0
7496615|NCT03443024|25999236|P2|Overall Study|Physician Decision|2
7496616|NCT03443024|25999237|P1|Overall Study|Physician Decision|1
7496617|NCT03443024|25999234|P4|Overall Study|Withdrawal by Subject|23
7496618|NCT03443024|25999235|P3|Overall Study|Withdrawal by Subject|9
7496619|NCT03443024|25999236|P2|Overall Study|Withdrawal by Subject|15
7496620|NCT03443024|25999237|P1|Overall Study|Withdrawal by Subject|8
7496621|NCT03443024|25999234|P4|Overall Study|Lost to Follow-up|5
7496622|NCT03443024|25999235|P3|Overall Study|Lost to Follow-up|7
7496623|NCT03443024|25999236|P2|Overall Study|Lost to Follow-up|9
7496624|NCT03443024|25999237|P1|Overall Study|Lost to Follow-up|9
7496625|NCT03443024|25999234|P4|Overall Study|Adverse Event|1
7496626|NCT03443024|25999235|P3|Overall Study|Adverse Event|3
7496627|NCT03443024|25999236|P2|Overall Study|Adverse Event|4
7496628|NCT03443024|25999237|P1|Overall Study|Adverse Event|2
7496629|NCT03442829|25999312|P2|Overall Study|Illness unrelated to study|1
7496630|NCT03442829|25999313|P1|Overall Study|Illness unrelated to study|1
7496631|NCT03442829|25999312|P2|Overall Study|Scheduling clash|1
7496632|NCT03442829|25999313|P1|Overall Study|Scheduling clash|3
7496633|NCT03442777|25999330|P3|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
7496634|NCT03442777|25999331|P2|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
7496635|NCT03442777|25999332|P1|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
7496636|NCT03442595|25999389|P2|Overall Study|Lost to Follow-up|0
7496637|NCT03442595|25999390|P1|Overall Study|Lost to Follow-up|94
7496638|NCT03442296|25999409|P2|12 Month Follow-up|Incomplete measurement|1
7496639|NCT03442296|25999410|P1|12 Month Follow-up|Incomplete measurement|1
7496640|NCT03442296|25999409|P2|3 Month Follow-up|Obtained Hearing Aids|1
7496641|NCT03442296|25999410|P1|3 Month Follow-up|Obtained Hearing Aids|0
7496642|NCT03442296|25999409|P2|3 Month Follow-up|Withdrawal by Subject|0
7496643|NCT03442296|25999410|P1|3 Month Follow-up|Withdrawal by Subject|1
7496644|NCT03442296|25999409|P2|3 Month Follow-up|Lost to Follow-up|1
7496645|NCT03442296|25999410|P1|3 Month Follow-up|Lost to Follow-up|1
7496646|NCT03442296|25999409|P2|3 Month Follow-up|Death|1
7496647|NCT03442296|25999410|P1|3 Month Follow-up|Death|3
7496648|NCT03441984|25999463|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496649|NCT03441984|25999464|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496650|NCT03441984|25999465|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496651|NCT03441984|25999466|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496652|NCT03441984|25999467|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496653|NCT03441984|25999468|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496654|NCT03441984|25999469|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496655|NCT03441984|25999470|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496656|NCT03441984|25999471|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496657|NCT03441984|25999472|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
7496658|NCT03441984|25999473|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496659|NCT03441984|25999474|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7496660|NCT03441789|25999835|P2|Overall Study|Lost to Follow-up|1
7496661|NCT03441789|25999836|P1|Overall Study|Lost to Follow-up|0
7496662|NCT03441789|25999835|P2|Overall Study|Protocol Violation|1
7496663|NCT03441789|25999836|P1|Overall Study|Protocol Violation|0
7496664|NCT03441789|25999835|P2|Overall Study|Adverse Event|1
7496665|NCT03441789|25999836|P1|Overall Study|Adverse Event|0
7496666|NCT03441789|25999835|P2|Overall Study|Withdrawal by Subject|1
7496667|NCT03441789|25999836|P1|Overall Study|Withdrawal by Subject|1
7496668|NCT03440944|26000102|P2|Overall Study|No Acceptable Vasculature|1
7496669|NCT03440944|26000103|P1|Overall Study|No Acceptable Vasculature|0
7496670|NCT03440944|26000102|P2|Overall Study|Physician Decision|0
7496671|NCT03440944|26000103|P1|Overall Study|Physician Decision|1
7496672|NCT03440918|26000119|P2|Overall Study|Protocol Violation|16
7496673|NCT03440918|26000120|P1|Overall Study|Protocol Violation|0
7496674|NCT03440411|26000232|P4|Overall Study|Closed study by sponsor|1
7496675|NCT03440411|26000233|P3|Overall Study|Closed study by sponsor|0
7496676|NCT03440411|26000234|P2|Overall Study|Closed study by sponsor|0
7496677|NCT03440411|26000235|P1|Overall Study|Closed study by sponsor|0
7496678|NCT03440411|26000232|P4|Overall Study|Withdrawal by Subject|0
7496679|NCT03440411|26000233|P3|Overall Study|Withdrawal by Subject|0
7496680|NCT03440411|26000234|P2|Overall Study|Withdrawal by Subject|0
7496681|NCT03440411|26000235|P1|Overall Study|Withdrawal by Subject|1
7496682|NCT03440411|26000232|P4|Overall Study|PD|1
7496683|NCT03440411|26000233|P3|Overall Study|PD|1
7496684|NCT03440411|26000234|P2|Overall Study|PD|1
7496685|NCT03440411|26000235|P1|Overall Study|PD|2
7496686|NCT03440411|26000232|P4|Overall Study|Adverse Event|0
7496687|NCT03440411|26000233|P3|Overall Study|Adverse Event|1
7496688|NCT03440411|26000234|P2|Overall Study|Adverse Event|0
7496689|NCT03440411|26000235|P1|Overall Study|Adverse Event|0
7496690|NCT03440320|26000271|P2|Overall Study|Withdrawal by Subject|1
7496691|NCT03440320|26000272|P1|Overall Study|Withdrawal by Subject|0
7496692|NCT03439657|26000301|P2|Overall Study|Consent withdrawal, not due to an Adverse Event|0
7496693|NCT03439657|26000302|P1|Overall Study|Consent withdrawal, not due to an Adverse Event|3
7496694|NCT03439657|26000301|P2|Overall Study|Protocol Violation|1
7496695|NCT03439657|26000302|P1|Overall Study|Protocol Violation|1
7496696|NCT03439657|26000301|P2|Overall Study|Lost to Follow-up|0
7496697|NCT03439657|26000302|P1|Overall Study|Lost to Follow-up|1
7496698|NCT03439657|26000301|P2|Overall Study|Adverse Event|3
7496699|NCT03439657|26000302|P1|Overall Study|Adverse Event|2
7496700|NCT03439189|26000335|P1|Overall Study|Lack of Efficacy|63
7496701|NCT03439189|26000335|P1|Overall Study|Protocol Violation|19
7496702|NCT03439137|26000342|P2|Overall Study|Initiation of a renal transplant|2
7496703|NCT03439137|26000343|P1|Overall Study|Initiation of a renal transplant|0
7496704|NCT03439137|26000342|P2|Overall Study|Difficult to control Hb|2
7496705|NCT03439137|26000343|P1|Overall Study|Difficult to control Hb|10
7496706|NCT03439137|26000342|P2|Overall Study|Conducting rescue therapy|1
7496707|NCT03439137|26000343|P1|Overall Study|Conducting rescue therapy|2
7496708|NCT03439137|26000342|P2|Overall Study|Withdrawal by Subject|4
7496709|NCT03439137|26000343|P1|Overall Study|Withdrawal by Subject|14
7496710|NCT03439137|26000342|P2|Overall Study|Physician Decision|5
7496711|NCT03439137|26000343|P1|Overall Study|Physician Decision|0
7496712|NCT03439137|26000342|P2|Overall Study|Adverse Event|12
7496713|NCT03439137|26000343|P1|Overall Study|Adverse Event|16
7496714|NCT03439124|26000357|P2|Overall Study|Other reasons|0
7496715|NCT03439124|26000358|P1|Overall Study|Other reasons|1
7496716|NCT03439124|26000357|P2|Overall Study|Lost to Follow-up|0
7496717|NCT03439124|26000358|P1|Overall Study|Lost to Follow-up|1
7496718|NCT03439124|26000357|P2|Overall Study|Adverse Event|0
7496719|NCT03439124|26000358|P1|Overall Study|Adverse Event|2
7496720|NCT03439072|26000372|P2|Overall Study|Physician Decision|1
7496721|NCT03439072|26000373|P1|Overall Study|Physician Decision|0
7496722|NCT03439072|26000372|P2|Overall Study|Withdrawal by Subject|3
7496723|NCT03439072|26000373|P1|Overall Study|Withdrawal by Subject|2
7496724|NCT03438539|26000424|P6|Overall Study|Lost to Follow-up|8
7496725|NCT03438539|26000425|P5|Overall Study|Lost to Follow-up|3
7496726|NCT03438539|26000426|P4|Overall Study|Lost to Follow-up|9
7496727|NCT03438539|26000427|P3|Overall Study|Lost to Follow-up|10
7496728|NCT03438539|26000428|P2|Overall Study|Lost to Follow-up|4
7496729|NCT03438539|26000429|P1|Overall Study|Lost to Follow-up|8
7496730|NCT03438383|26000457|P2|Overall Study|Protocol Violation|3
7496731|NCT03438383|26000458|P1|Overall Study|Protocol Violation|9
7496732|NCT03438006|26000494|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
7496733|NCT03438006|26000494|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
7496734|NCT03438006|26000494|P1|Overall Study|Lost to Follow-up|67
7496735|NCT03438006|26000494|P1|Overall Study|Adverse Event|1
7496736|NCT03437733|26000503|P2|Overall Study|Eligibility criteria not met|3
7496737|NCT03437733|26000504|P1|Overall Study|Eligibility criteria not met|0
7496738|NCT03437577|26000528|P3|Post-Randomization|Physician Decision|0
7496739|NCT03437577|26000529|P2|Post-Randomization|Physician Decision|2
7496740|NCT03437577|26000530|P1|Post-Randomization|Physician Decision|0
7496741|NCT03437577|26000528|P3|Pre-Randomization|Withdrawal by Subject|10
7496742|NCT03437577|26000529|P2|Pre-Randomization|Withdrawal by Subject|0
7496743|NCT03437577|26000530|P1|Pre-Randomization|Withdrawal by Subject|0
7496744|NCT03437512|26000569|P2|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
7496745|NCT03437512|26000570|P1|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
7496746|NCT03437512|26000569|P2|Randomized|Withdrawal by Subject|2
7496747|NCT03437512|26000570|P1|Randomized|Withdrawal by Subject|0
7496748|NCT03437447|26000583|P3|Treatment Period 1|Withdrawal by Subject|1
7496749|NCT03437447|26000584|P2|Treatment Period 1|Withdrawal by Subject|0
7496750|NCT03437447|26000585|P1|Treatment Period 1|Withdrawal by Subject|0
7496751|NCT03437278|26000641|P3|Overall Study|Physician Decision|1
7496752|NCT03437278|26000642|P2|Overall Study|Physician Decision|0
7496753|NCT03437278|26000643|P1|Overall Study|Physician Decision|1
7496754|NCT03437278|26000641|P3|Overall Study|Progressive disease|0
7496755|NCT03437278|26000642|P2|Overall Study|Progressive disease|0
7496756|NCT03437278|26000643|P1|Overall Study|Progressive disease|1
7496757|NCT03437278|26000641|P3|Overall Study|Adverse Event|1
7496758|NCT03437278|26000642|P2|Overall Study|Adverse Event|0
7496759|NCT03437278|26000643|P1|Overall Study|Adverse Event|0
7496760|NCT03436732|26000717|P2|Overall Study|Death|1
7496761|NCT03436732|26000718|P1|Overall Study|Death|0
7496762|NCT03436732|26000717|P2|Overall Study|Adverse Event|0
7496763|NCT03436732|26000718|P1|Overall Study|Adverse Event|2
7496764|NCT03436732|26000717|P2|Overall Study|Off study after cycle 1|0
7496765|NCT03436732|26000718|P1|Overall Study|Off study after cycle 1|1
7496766|NCT03436732|26000717|P2|Overall Study|Not treated-enrolled in different study|0
7496767|NCT03436732|26000718|P1|Overall Study|Not treated-enrolled in different study|1
7496768|NCT03436420|26000731|P1|Overall Study|Lack of Efficacy|3
7496769|NCT03436082|26000787|P2|Overall Study|Did not undergo procedure|0
7496770|NCT03436082|26000788|P1|Overall Study|Did not undergo procedure|1
7496771|NCT03435497|26000907|P2|Overall Study|Wrong survey administered|2
7496772|NCT03435497|26000908|P1|Overall Study|Wrong survey administered|0
7496773|NCT03435497|26000907|P2|Overall Study|Withdrawal by Subject|4
7496774|NCT03435497|26000908|P1|Overall Study|Withdrawal by Subject|0
7496775|NCT03435497|26000907|P2|Overall Study|Death|0
7496776|NCT03435497|26000908|P1|Overall Study|Death|1
7496777|NCT03435497|26000907|P2|Overall Study|Lost to Follow-up|0
7496778|NCT03435497|26000908|P1|Overall Study|Lost to Follow-up|1
7496779|NCT03435224|26000922|P1|Overall Study|Unable to achieve a minimum desaturation level|4
7496780|NCT03435211|26000926|P1|Overall Study|Unable to achieve minimum desaturation level|1
7496781|NCT03435081|26000944|P3|Overall Study|Withdrawal Due to Caregiver Circumstance|1
7496782|NCT03435081|26000945|P2|Overall Study|Withdrawal Due to Caregiver Circumstance|0
7496783|NCT03435081|26000946|P1|Overall Study|Withdrawal Due to Caregiver Circumstance|0
7496784|NCT03435081|26000944|P3|Overall Study|Inadequate Response|0
7496785|NCT03435081|26000945|P2|Overall Study|Inadequate Response|1
7496786|NCT03435081|26000946|P1|Overall Study|Inadequate Response|0
7496787|NCT03435081|26000944|P3|Overall Study|Non-compliance|2
7496788|NCT03435081|26000945|P2|Overall Study|Non-compliance|0
7496789|NCT03435081|26000946|P1|Overall Study|Non-compliance|1
7496790|NCT03435081|26000944|P3|Overall Study|Pregnancy|0
7496791|NCT03435081|26000945|P2|Overall Study|Pregnancy|0
7496792|NCT03435081|26000946|P1|Overall Study|Pregnancy|1
7496793|NCT03435081|26000944|P3|Overall Study|Lost to Follow-up|4
7496794|NCT03435081|26000945|P2|Overall Study|Lost to Follow-up|1
7496795|NCT03435081|26000946|P1|Overall Study|Lost to Follow-up|3
7496796|NCT03435081|26000944|P3|Overall Study|Withdrawal by Subject|10
7496797|NCT03435081|26000945|P2|Overall Study|Withdrawal by Subject|7
7496798|NCT03435081|26000946|P1|Overall Study|Withdrawal by Subject|8
7496799|NCT03435081|26000944|P3|Overall Study|Adverse Event|2
7496800|NCT03435081|26000945|P2|Overall Study|Adverse Event|2
7496801|NCT03435081|26000946|P1|Overall Study|Adverse Event|2
7496802|NCT03435081|26000944|P3|Overall Study|Lack of Efficacy|0
7496803|NCT03435081|26000945|P2|Overall Study|Lack of Efficacy|5
7496804|NCT03435081|26000946|P1|Overall Study|Lack of Efficacy|6
7496805|NCT03435055|26001021|P1|Received Intervention|Did not complete nitrous administration|3
7496806|NCT03435055|26001021|P1|Screening|Physician Decision|2
7496807|NCT03434977|26001032|P2|Washout Period (at Least 6 Days)|Adverse Event|1
7496808|NCT03434977|26001033|P1|Washout Period (at Least 6 Days)|Adverse Event|0
7496809|NCT03434834|26001067|P1|Overall Study|unable to swallow OCT probe|16
7496810|NCT03434249|26001106|P2|Overall Study|Difficulties in completing daily diary|1
7496811|NCT03434249|26001107|P1|Overall Study|Difficulties in completing daily diary|2
7496812|NCT03434249|26001106|P2|Overall Study|Non-compliance of family|1
7496813|NCT03434249|26001107|P1|Overall Study|Non-compliance of family|2
7496814|NCT03434249|26001106|P2|Overall Study|Lost to Follow-up|1
7496815|NCT03434249|26001107|P1|Overall Study|Lost to Follow-up|0
7496816|NCT03434249|26001106|P2|Overall Study|Adverse Event|0
7496817|NCT03434249|26001107|P1|Overall Study|Adverse Event|1
7496818|NCT03434119|26001141|P2|Overall Study|Other than specified|5
7496819|NCT03434119|26001142|P1|Overall Study|Other than specified|7
7496820|NCT03434119|26001141|P2|Overall Study|Withdrawal by Subject|5
7496821|NCT03434119|26001142|P1|Overall Study|Withdrawal by Subject|7
7496822|NCT03434119|26001141|P2|Overall Study|Study Terminated by Sponsor|102
7496823|NCT03434119|26001142|P1|Overall Study|Study Terminated by Sponsor|91
7496824|NCT03434119|26001141|P2|Overall Study|Poor Compliance to Protocol|1
7496825|NCT03434119|26001142|P1|Overall Study|Poor Compliance to Protocol|0
7496826|NCT03434119|26001141|P2|Overall Study|Adverse Event|0
7496827|NCT03434119|26001142|P1|Overall Study|Adverse Event|1
7496828|NCT03434119|26001141|P2|Overall Study|Randomized but not treated|0
7496829|NCT03434119|26001142|P1|Overall Study|Randomized but not treated|1
7496830|NCT03433755|26001180|P4|Overall Study|Decision by Sponsor|0
7496831|NCT03433755|26001181|P3|Overall Study|Decision by Sponsor|0
7496832|NCT03433755|26001182|P2|Overall Study|Decision by Sponsor|0
7496833|NCT03433755|26001183|P1|Overall Study|Decision by Sponsor|1
7496834|NCT03433755|26001180|P4|Overall Study|Lost to Follow-up|0
7496835|NCT03433755|26001181|P3|Overall Study|Lost to Follow-up|0
7496836|NCT03433755|26001182|P2|Overall Study|Lost to Follow-up|0
7496837|NCT03433755|26001183|P1|Overall Study|Lost to Follow-up|1
7496838|NCT03433703|26001277|P1|Overall Study|Study terminated by Sponsor|2
7496839|NCT03433677|26001286|P2|Period 2|Withdrawal by Subject|1
7496840|NCT03433677|26001287|P1|Period 2|Withdrawal by Subject|1
7496841|NCT03433677|26001286|P2|Period 1|Protocol Violation|0
7496842|NCT03433677|26001287|P1|Period 1|Protocol Violation|1
7496843|NCT03433482|26001309|P4|Overall Study|Unknown reason|0
7496844|NCT03433482|26001310|P3|Overall Study|Unknown reason|2
7496845|NCT03433482|26001311|P2|Overall Study|Unknown reason|0
7496846|NCT03433482|26001312|P1|Overall Study|Unknown reason|0
7496847|NCT03433482|26001309|P4|Overall Study|Withdrawal by Subject|0
7496848|NCT03433482|26001310|P3|Overall Study|Withdrawal by Subject|1
7496849|NCT03433482|26001311|P2|Overall Study|Withdrawal by Subject|0
7496850|NCT03433482|26001312|P1|Overall Study|Withdrawal by Subject|0
7496851|NCT03433482|26001309|P4|Overall Study|Lost to Follow-up|1
7496852|NCT03433482|26001310|P3|Overall Study|Lost to Follow-up|1
7496853|NCT03433482|26001311|P2|Overall Study|Lost to Follow-up|0
7496854|NCT03433482|26001312|P1|Overall Study|Lost to Follow-up|1
7496855|NCT03432819|26001364|P2|Overall Study|Withdrawal by Subject|3
7496856|NCT03432819|26001365|P1|Overall Study|Withdrawal by Subject|5
7496857|NCT03432819|26001364|P2|Overall Study|Lost to Follow-up|2
7496858|NCT03432819|26001365|P1|Overall Study|Lost to Follow-up|2
7496859|NCT03432533|26001391|P2|Overall Study|Withdrawal by Subject|9
7496860|NCT03432533|26001392|P1|Overall Study|Withdrawal by Subject|14
7496861|NCT03432533|26001391|P2|Overall Study|Lost to Follow-up|2
7496862|NCT03432533|26001392|P1|Overall Study|Lost to Follow-up|1
7496863|NCT03432390|26001408|P2|Apnea Period|Protocol Violation|2
7496864|NCT03432390|26001409|P1|Apnea Period|Protocol Violation|2
7496865|NCT03431441|26001419|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
7496866|NCT03431441|26001419|P1|Overall Study|Adverse Event|2
7496867|NCT03431441|26001419|P1|Overall Study|Withdrawal by Subject|2
7496868|NCT03431337|26001425|P2|Overall Study|Withdrawal by Subject|3
7496869|NCT03431337|26001426|P1|Overall Study|Withdrawal by Subject|8
7496870|NCT03431337|26001425|P2|Overall Study|Lost to Follow-up|19
7496871|NCT03431337|26001426|P1|Overall Study|Lost to Follow-up|21
7496872|NCT03430986|26001489|P2|24-week Post-Control Period|Withdrawal by Participant|1
7496873|NCT03430986|26001490|P1|24-week Post-Control Period|Withdrawal by Participant|0
7496874|NCT03430986|26001489|P2|24-week Post-Control Period|Lost to Follow-up|1
7496875|NCT03430986|26001490|P1|24-week Post-Control Period|Lost to Follow-up|1
7496876|NCT03430986|26001489|P2|24-week Control Period|Protocol Deviation|2
7496877|NCT03430986|26001490|P1|24-week Control Period|Protocol Deviation|0
7496878|NCT03430986|26001489|P2|24-week Control Period|Withdrawal by Participant|0
7496879|NCT03430986|26001490|P1|24-week Control Period|Withdrawal by Participant|5
7496880|NCT03430986|26001489|P2|24-week Control Period|Lost to Follow-up|2
7496881|NCT03430986|26001490|P1|24-week Control Period|Lost to Follow-up|2
7496882|NCT03430986|26001489|P2|24-week Control Period|Adverse Event|0
7496883|NCT03430986|26001490|P1|24-week Control Period|Adverse Event|1
7496884|NCT03430856|26001507|P3|Overall Study|Voluntary withdrawal of consent|1
7496885|NCT03430856|26001508|P2|Overall Study|Voluntary withdrawal of consent|1
7496886|NCT03430856|26001509|P1|Overall Study|Voluntary withdrawal of consent|1
7496887|NCT03430856|26001507|P3|Overall Study|Rescue criteria|0
7496888|NCT03430856|26001508|P2|Overall Study|Rescue criteria|1
7496889|NCT03430856|26001509|P1|Overall Study|Rescue criteria|1
7496890|NCT03430856|26001507|P3|Overall Study|Adverse Event|0
7496891|NCT03430856|26001508|P2|Overall Study|Adverse Event|1
7496892|NCT03430856|26001509|P1|Overall Study|Adverse Event|0
7496893|NCT03430245|26001578|P1|Overall Study|Lost to Follow-up|1
7496894|NCT03430245|26001578|P1|Overall Study|Withdrawal by Subject|6
7496895|NCT03429556|26001625|P4|Overall Study|Lost to Follow-up|0
7496896|NCT03429556|26001626|P3|Overall Study|Lost to Follow-up|0
7496897|NCT03429556|26001627|P2|Overall Study|Lost to Follow-up|1
7496898|NCT03429556|26001628|P1|Overall Study|Lost to Follow-up|0
7496899|NCT03428997|26001690|P1|Overall Study|Lost to Follow-up|4
7496900|NCT03428997|26001690|P1|Overall Study|Withdrawal by Subject|3
7496901|NCT03428997|26001690|P1|Overall Study|Sponsor decision.|1
7496902|NCT03428815|26001698|P2|Overall Study|Intermittent fitting issues that affected reliability of data|1
7496903|NCT03428815|26001699|P1|Overall Study|Intermittent fitting issues that affected reliability of data|3
7496904|NCT03428815|26001698|P2|Overall Study|suspension of study activities due to Covid-19 pandemic|2
7496905|NCT03428815|26001699|P1|Overall Study|suspension of study activities due to Covid-19 pandemic|5
7496906|NCT03428815|26001698|P2|Overall Study|Lost to Follow-up|2
7496907|NCT03428815|26001699|P1|Overall Study|Lost to Follow-up|2
7496908|NCT03428750|26001709|P2|Overall Study|Administrative|1
7496909|NCT03428750|26001710|P1|Overall Study|Administrative|0
7496910|NCT03428750|26001709|P2|Overall Study|Protocol Violation|0
7496911|NCT03428750|26001710|P1|Overall Study|Protocol Violation|1
7496912|NCT03428750|26001709|P2|Overall Study|Adverse Event|1
7496913|NCT03428750|26001710|P1|Overall Study|Adverse Event|9
7496914|NCT03428750|26001709|P2|Overall Study|Lost to Follow-up|9
7496915|NCT03428750|26001710|P1|Overall Study|Lost to Follow-up|3
7496916|NCT03428750|26001709|P2|Overall Study|Withdrawal by Subject|10
7496917|NCT03428750|26001710|P1|Overall Study|Withdrawal by Subject|11
7496918|NCT03428360|26001757|P1|Overall Study|Not on antiepileptic drug|1
7496919|NCT03428360|26001757|P1|Overall Study|Adverse Event|1
7496920|NCT03428360|26001757|P1|Overall Study|Death|3
7496921|NCT03428360|26001757|P1|Overall Study|Non-compliant with study drug|3
7496922|NCT03428360|26001757|P1|Overall Study|Non-compliant with study|1
7496923|NCT03428360|26001757|P1|Overall Study|Study terminated by sponsor|10
7496924|NCT03428360|26001757|P1|Overall Study|Informed consent withdrawn|5
7496925|NCT03428360|26001757|P1|Overall Study|Physician Decision|2
7496926|NCT03428360|26001757|P1|Overall Study|Lost to Follow-up|5
7496927|NCT03428360|26001757|P1|Overall Study|Withdrawal by Subject|4
7496928|NCT03428360|26001757|P1|Overall Study|Informed consent withdrawn|5
7496929|NCT03428152|26001876|P2|Overall Study|Lack of Efficacy|4
7496930|NCT03428152|26001877|P1|Overall Study|Lack of Efficacy|0
7496931|NCT03428152|26001876|P2|Overall Study|Protocol Violation|5
7496932|NCT03428152|26001877|P1|Overall Study|Protocol Violation|3
7496933|NCT03428152|26001876|P2|Overall Study|Physician Decision|2
7496934|NCT03428152|26001877|P1|Overall Study|Physician Decision|4
7496935|NCT03428100|26001897|P4|Overall Study|Physician Decision|0
7496936|NCT03428100|26001898|P3|Overall Study|Physician Decision|0
7496937|NCT03428100|26001899|P2|Overall Study|Physician Decision|1
7496938|NCT03428100|26001900|P1|Overall Study|Physician Decision|0
7496939|NCT03428100|26001897|P4|Overall Study|Withdrawal by Subject|0
7496940|NCT03428100|26001898|P3|Overall Study|Withdrawal by Subject|0
7496941|NCT03428100|26001899|P2|Overall Study|Withdrawal by Subject|0
7496942|NCT03428100|26001900|P1|Overall Study|Withdrawal by Subject|4
7496943|NCT03428100|26001897|P4|Overall Study|Protocol Deviation|0
7496944|NCT03428100|26001898|P3|Overall Study|Protocol Deviation|2
7496945|NCT03428100|26001899|P2|Overall Study|Protocol Deviation|2
7496946|NCT03428100|26001900|P1|Overall Study|Protocol Deviation|0
7496947|NCT03428100|26001897|P4|Overall Study|Lack of Efficacy|6
7496948|NCT03428100|26001898|P3|Overall Study|Lack of Efficacy|7
7496949|NCT03428100|26001899|P2|Overall Study|Lack of Efficacy|10
7496950|NCT03428100|26001900|P1|Overall Study|Lack of Efficacy|16
7496951|NCT03428100|26001897|P4|Overall Study|Adverse Event|1
7496952|NCT03428100|26001898|P3|Overall Study|Adverse Event|3
7496953|NCT03428100|26001899|P2|Overall Study|Adverse Event|0
7496954|NCT03428100|26001900|P1|Overall Study|Adverse Event|1
7496955|NCT03427892|26002020|P1|Overall Study|Lost to Follow-up|2
7496956|NCT03427268|26002036|P1|Overall Study|Adverse Event|3
7496957|NCT03427268|26002036|P1|Overall Study|Withdrawal by Subject|1
7496958|NCT03427268|26002036|P1|Overall Study|Compassionate use|1
7496959|NCT03427268|26002036|P1|Overall Study|Never treated|2
7496960|NCT03427268|26002036|P1|Overall Study|Progressive disease|25
7496961|NCT03427073|26002068|P8|Overall Study|Physician Decision|1
7496962|NCT03427073|26002069|P7|Overall Study|Physician Decision|1
7496963|NCT03427073|26002070|P6|Overall Study|Physician Decision|0
7496964|NCT03427073|26002071|P5|Overall Study|Physician Decision|0
7496965|NCT03427073|26002072|P4|Overall Study|Physician Decision|0
7496966|NCT03427073|26002073|P3|Overall Study|Physician Decision|0
7496967|NCT03427073|26002074|P2|Overall Study|Physician Decision|0
7496968|NCT03427073|26002075|P1|Overall Study|Physician Decision|0
7496969|NCT03427073|26002068|P8|Overall Study|Disease Progression|3
7496970|NCT03427073|26002069|P7|Overall Study|Disease Progression|2
7496971|NCT03427073|26002070|P6|Overall Study|Disease Progression|4
7496972|NCT03427073|26002071|P5|Overall Study|Disease Progression|3
7496973|NCT03427073|26002072|P4|Overall Study|Disease Progression|3
7496974|NCT03427073|26002073|P3|Overall Study|Disease Progression|1
7496975|NCT03427073|26002074|P2|Overall Study|Disease Progression|1
7496976|NCT03427073|26002075|P1|Overall Study|Disease Progression|1
7496977|NCT03426995|26002144|P19|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496978|NCT03426995|26002145|P18|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496979|NCT03426995|26002146|P17|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496980|NCT03426995|26002147|P16|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
7496981|NCT03426995|26002148|P15|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
7496982|NCT03426995|26002149|P14|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496983|NCT03426995|26002150|P13|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496984|NCT03426995|26002151|P12|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496985|NCT03426995|26002152|P11|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496986|NCT03426995|26002153|P10|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496987|NCT03426995|26002154|P9|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496988|NCT03426995|26002155|P8|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496989|NCT03426995|26002156|P7|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496990|NCT03426995|26002157|P6|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496991|NCT03426995|26002158|P5|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496992|NCT03426995|26002159|P4|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496993|NCT03426995|26002160|P3|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496994|NCT03426995|26002161|P2|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496995|NCT03426995|26002162|P1|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7496996|NCT03426995|26002144|P19|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7496997|NCT03426995|26002145|P18|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7496998|NCT03426995|26002146|P17|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7496999|NCT03426995|26002147|P16|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
7497000|NCT03426995|26002148|P15|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
7497001|NCT03426995|26002149|P14|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497002|NCT03426995|26002150|P13|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497003|NCT03426995|26002151|P12|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497004|NCT03426995|26002152|P11|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497005|NCT03426995|26002153|P10|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497006|NCT03426995|26002154|P9|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497007|NCT03426995|26002155|P8|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497008|NCT03426995|26002156|P7|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497009|NCT03426995|26002157|P6|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497010|NCT03426995|26002158|P5|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497011|NCT03426995|26002159|P4|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497012|NCT03426995|26002160|P3|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497013|NCT03426995|26002161|P2|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497014|NCT03426995|26002162|P1|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7497015|NCT03426995|26002144|P19|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497016|NCT03426995|26002145|P18|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497017|NCT03426995|26002146|P17|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497018|NCT03426995|26002147|P16|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497019|NCT03426995|26002148|P15|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497020|NCT03426995|26002149|P14|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497021|NCT03426995|26002150|P13|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497022|NCT03426995|26002151|P12|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497023|NCT03426995|26002152|P11|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497024|NCT03426995|26002153|P10|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497025|NCT03426995|26002154|P9|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497026|NCT03426995|26002155|P8|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
7497027|NCT03426995|26002156|P7|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497028|NCT03426995|26002157|P6|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497029|NCT03426995|26002158|P5|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497030|NCT03426995|26002159|P4|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497031|NCT03426995|26002160|P3|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497032|NCT03426995|26002161|P2|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497033|NCT03426995|26002162|P1|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7497034|NCT03426995|26002144|P19|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497035|NCT03426995|26002145|P18|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497036|NCT03426995|26002146|P17|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497037|NCT03426995|26002147|P16|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497038|NCT03426995|26002148|P15|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497039|NCT03426995|26002149|P14|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497040|NCT03426995|26002150|P13|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497041|NCT03426995|26002151|P12|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497042|NCT03426995|26002152|P11|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
7497043|NCT03426995|26002153|P10|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497044|NCT03426995|26002154|P9|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497045|NCT03426995|26002155|P8|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497046|NCT03426995|26002156|P7|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497047|NCT03426995|26002157|P6|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497048|NCT03426995|26002158|P5|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497049|NCT03426995|26002159|P4|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497050|NCT03426995|26002160|P3|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497051|NCT03426995|26002161|P2|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497052|NCT03426995|26002162|P1|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7497053|NCT03426995|26002144|P19|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497054|NCT03426995|26002145|P18|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497055|NCT03426995|26002146|P17|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497056|NCT03426995|26002147|P16|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497057|NCT03426995|26002148|P15|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497058|NCT03426995|26002149|P14|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497059|NCT03426995|26002150|P13|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497060|NCT03426995|26002151|P12|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497061|NCT03426995|26002152|P11|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497062|NCT03426995|26002153|P10|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497063|NCT03426995|26002154|P9|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497064|NCT03426995|26002155|P8|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497065|NCT03426995|26002156|P7|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497066|NCT03426995|26002157|P6|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7497067|NCT03426995|26002158|P5|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7497068|NCT03426995|26002159|P4|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497069|NCT03426995|26002160|P3|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497070|NCT03426995|26002161|P2|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497071|NCT03426995|26002162|P1|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7497072|NCT03426995|26002144|P19|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497073|NCT03426995|26002145|P18|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497074|NCT03426995|26002146|P17|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497075|NCT03426995|26002147|P16|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497076|NCT03426995|26002148|P15|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497077|NCT03426995|26002149|P14|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497078|NCT03426995|26002150|P13|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497079|NCT03426995|26002151|P12|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497080|NCT03426995|26002152|P11|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497081|NCT03426995|26002153|P10|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497082|NCT03426995|26002154|P9|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497083|NCT03426995|26002155|P8|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497084|NCT03426995|26002156|P7|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497085|NCT03426995|26002157|P6|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
7497086|NCT03426995|26002158|P5|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497087|NCT03426995|26002159|P4|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497088|NCT03426995|26002160|P3|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497089|NCT03426995|26002161|P2|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497090|NCT03426995|26002162|P1|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7497091|NCT03426995|26002144|P19|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497092|NCT03426995|26002145|P18|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497093|NCT03426995|26002146|P17|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497094|NCT03426995|26002147|P16|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497095|NCT03426995|26002148|P15|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497096|NCT03426995|26002149|P14|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497097|NCT03426995|26002150|P13|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497098|NCT03426995|26002151|P12|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497099|NCT03426995|26002152|P11|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497100|NCT03426995|26002153|P10|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497101|NCT03426995|26002154|P9|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497102|NCT03426995|26002155|P8|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497103|NCT03426995|26002156|P7|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497104|NCT03426995|26002157|P6|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497105|NCT03426995|26002158|P5|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497106|NCT03426995|26002159|P4|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497107|NCT03426995|26002160|P3|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
7497108|NCT03426995|26002161|P2|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497109|NCT03426995|26002162|P1|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7497110|NCT03426787|26002509|P1|Overall Study|Unrelated to intervention death|1
7497111|NCT03426787|26002509|P1|Overall Study|Lost to Follow-up|7
7497112|NCT03426787|26002509|P1|Overall Study|Withdrawal by Subject|6
7497113|NCT03426631|26002519|P2|Overall Study|Lost to Follow-up|1
7497114|NCT03426631|26002520|P1|Overall Study|Lost to Follow-up|0
7497115|NCT03426436|26002532|P1|Overall Study|ECGs not saved|4
7497116|NCT03426436|26002532|P1|Overall Study|Consent issue|1
7497117|NCT03426436|26002532|P1|Overall Study|Withdrawal by Subject|2
7497118|NCT03426436|26002532|P1|Overall Study|Incorrect lead placement|12
7497119|NCT03426345|26002539|P2|Overall Study|Missing Completion Status|0
7497120|NCT03426345|26002540|P1|Overall Study|Missing Completion Status|1
7497121|NCT03426345|26002539|P2|Overall Study|Reason Not Specified|2
7497122|NCT03426345|26002540|P1|Overall Study|Reason Not Specified|1
7497123|NCT03426345|26002539|P2|Overall Study|Protocol Deviation|4
7497124|NCT03426345|26002540|P1|Overall Study|Protocol Deviation|3
7497125|NCT03426345|26002539|P2|Overall Study|Lost to Follow-up|1
7497126|NCT03426345|26002540|P1|Overall Study|Lost to Follow-up|3
7497127|NCT03426345|26002539|P2|Overall Study|Withdrawal by Subject|6
7497128|NCT03426345|26002540|P1|Overall Study|Withdrawal by Subject|5
7497129|NCT03426345|26002539|P2|Overall Study|Lack of Efficacy|0
7497130|NCT03426345|26002540|P1|Overall Study|Lack of Efficacy|1
7497131|NCT03426345|26002539|P2|Overall Study|Adverse Event|4
7497132|NCT03426345|26002540|P1|Overall Study|Adverse Event|4
7497133|NCT03426267|26002569|P2|Overall Study|other|0
7497134|NCT03426267|26002570|P1|Overall Study|other|3
7497135|NCT03426267|26002569|P2|Overall Study|Lack of Efficacy|25
7497136|NCT03426267|26002570|P1|Overall Study|Lack of Efficacy|0
7497137|NCT03426267|26002569|P2|Overall Study|Prohibited Treatment Intake|3
7497138|NCT03426267|26002570|P1|Overall Study|Prohibited Treatment Intake|2
7497139|NCT03426267|26002569|P2|Overall Study|Adverse Event|27
7497140|NCT03426267|26002570|P1|Overall Study|Adverse Event|9
7497141|NCT03426267|26002569|P2|Overall Study|Protocol Violation|3
7497142|NCT03426267|26002570|P1|Overall Study|Protocol Violation|1
7497143|NCT03426267|26002569|P2|Overall Study|Withdrawal by Subject|10
7497144|NCT03426267|26002570|P1|Overall Study|Withdrawal by Subject|4
7497145|NCT03426267|26002569|P2|Overall Study|Lost to Follow-up|0
7497146|NCT03426267|26002570|P1|Overall Study|Lost to Follow-up|1
7497147|NCT03426267|26002569|P2|Overall Study|Physician Decision|4
7497148|NCT03426267|26002570|P1|Overall Study|Physician Decision|1
7497149|NCT03425396|26002626|P5|Overall Study|Other|1
7497150|NCT03425396|26002627|P4|Overall Study|Other|0
7497151|NCT03425396|26002628|P3|Overall Study|Other|1
7497152|NCT03425396|26002629|P2|Overall Study|Other|1
7497153|NCT03425396|26002630|P1|Overall Study|Other|0
7497154|NCT03425396|26002626|P5|Overall Study|Withdrawal by Subject|0
7497155|NCT03425396|26002627|P4|Overall Study|Withdrawal by Subject|1
7497156|NCT03425396|26002628|P3|Overall Study|Withdrawal by Subject|0
7497157|NCT03425396|26002629|P2|Overall Study|Withdrawal by Subject|1
7497158|NCT03425396|26002630|P1|Overall Study|Withdrawal by Subject|0
7497159|NCT03425396|26002626|P5|Overall Study|Lost to Follow-up|0
7497160|NCT03425396|26002627|P4|Overall Study|Lost to Follow-up|0
7497161|NCT03425396|26002628|P3|Overall Study|Lost to Follow-up|2
7497162|NCT03425396|26002629|P2|Overall Study|Lost to Follow-up|5
7497163|NCT03425396|26002630|P1|Overall Study|Lost to Follow-up|2
7497164|NCT03425253|26002712|P1|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
7497165|NCT03425253|26002712|P1|Overall Study|Withdrew Consent|6
7497166|NCT03425253|26002712|P1|Overall Study|Lost to Follow-up|3
7497167|NCT03425253|26002712|P1|Overall Study|Adverse Event|2
7497168|NCT03425188|26002724|P1|Overall Study|Withdrawal by Subject|1
7497169|NCT03424265|26002814|P2|Overall Study|Withdrawal by Subject|2
7497170|NCT03424265|26002815|P1|Overall Study|Withdrawal by Subject|0
7497171|NCT03424265|26002814|P2|Overall Study|screening failure|0
7497172|NCT03424265|26002815|P1|Overall Study|screening failure|1
7497173|NCT03424239|26002821|P1|Overall Study|Withdrawal by Subject|2
7497174|NCT03424044|26002859|P9|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497175|NCT03424044|26002860|P8|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497176|NCT03424044|26002861|P7|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497177|NCT03424044|26002862|P6|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497178|NCT03424044|26002863|P5|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497179|NCT03424044|26002864|P4|Third Intervention (76 Hours)|Withdrawal by Subject|1
7497180|NCT03424044|26002865|P3|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497181|NCT03424044|26002866|P2|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497182|NCT03424044|26002867|P1|Third Intervention (76 Hours)|Withdrawal by Subject|0
7497183|NCT03424044|26002859|P9|Third Intervention (76 Hours)|Adverse Event|0
7497184|NCT03424044|26002860|P8|Third Intervention (76 Hours)|Adverse Event|0
7497185|NCT03424044|26002861|P7|Third Intervention (76 Hours)|Adverse Event|1
7497186|NCT03424044|26002862|P6|Third Intervention (76 Hours)|Adverse Event|0
7497187|NCT03424044|26002863|P5|Third Intervention (76 Hours)|Adverse Event|0
7497188|NCT03424044|26002864|P4|Third Intervention (76 Hours)|Adverse Event|0
7497189|NCT03424044|26002865|P3|Third Intervention (76 Hours)|Adverse Event|0
7497190|NCT03424044|26002866|P2|Third Intervention (76 Hours)|Adverse Event|0
7497191|NCT03424044|26002867|P1|Third Intervention (76 Hours)|Adverse Event|1
7497192|NCT03424044|26002859|P9|First Intervention (76 Hours)|device issues|1
7497193|NCT03424044|26002860|P8|First Intervention (76 Hours)|device issues|1
7497194|NCT03424044|26002861|P7|First Intervention (76 Hours)|device issues|1
7497195|NCT03424044|26002862|P6|First Intervention (76 Hours)|device issues|0
7497196|NCT03424044|26002863|P5|First Intervention (76 Hours)|device issues|0
7497197|NCT03424044|26002864|P4|First Intervention (76 Hours)|device issues|0
7497198|NCT03424044|26002865|P3|First Intervention (76 Hours)|device issues|0
7497199|NCT03424044|26002866|P2|First Intervention (76 Hours)|device issues|0
7497200|NCT03424044|26002867|P1|First Intervention (76 Hours)|device issues|0
7497201|NCT03424044|26002859|P9|First Intervention (76 Hours)|Adverse Event|0
7497202|NCT03424044|26002860|P8|First Intervention (76 Hours)|Adverse Event|0
7497203|NCT03424044|26002861|P7|First Intervention (76 Hours)|Adverse Event|0
7497204|NCT03424044|26002862|P6|First Intervention (76 Hours)|Adverse Event|0
7497205|NCT03424044|26002863|P5|First Intervention (76 Hours)|Adverse Event|1
7497206|NCT03424044|26002864|P4|First Intervention (76 Hours)|Adverse Event|0
7497207|NCT03424044|26002865|P3|First Intervention (76 Hours)|Adverse Event|0
7497208|NCT03424044|26002866|P2|First Intervention (76 Hours)|Adverse Event|0
7497209|NCT03424044|26002867|P1|First Intervention (76 Hours)|Adverse Event|0
7497210|NCT03424044|26002859|P9|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497211|NCT03424044|26002860|P8|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497212|NCT03424044|26002861|P7|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497213|NCT03424044|26002862|P6|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497214|NCT03424044|26002863|P5|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497215|NCT03424044|26002864|P4|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497216|NCT03424044|26002865|P3|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
7497217|NCT03424044|26002866|P2|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497218|NCT03424044|26002867|P1|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7497219|NCT03423173|26002990|P4|Overall Study|Reason not Specified|1
7497220|NCT03423173|26002991|P3|Overall Study|Reason not Specified|3
7497221|NCT03423173|26002992|P2|Overall Study|Reason not Specified|5
7497222|NCT03423173|26002993|P1|Overall Study|Reason not Specified|2
7497223|NCT03423173|26002990|P4|Overall Study|Death|0
7497224|NCT03423173|26002991|P3|Overall Study|Death|0
7497225|NCT03423173|26002992|P2|Overall Study|Death|0
7497226|NCT03423173|26002993|P1|Overall Study|Death|1
7497227|NCT03423173|26002990|P4|Overall Study|Withdrawal of consent|5
7497228|NCT03423173|26002991|P3|Overall Study|Withdrawal of consent|4
7497229|NCT03423173|26002992|P2|Overall Study|Withdrawal of consent|10
7497230|NCT03423173|26002993|P1|Overall Study|Withdrawal of consent|4
7497231|NCT03423173|26002990|P4|Overall Study|Lost to Follow-up|22
7497232|NCT03423173|26002991|P3|Overall Study|Lost to Follow-up|17
7497233|NCT03423173|26002992|P2|Overall Study|Lost to Follow-up|19
7497234|NCT03423173|26002993|P1|Overall Study|Lost to Follow-up|10
7497235|NCT03423173|26002990|P4|Overall Study|Adverse Event|1
7497236|NCT03423173|26002991|P3|Overall Study|Adverse Event|1
7497237|NCT03423173|26002992|P2|Overall Study|Adverse Event|1
7497238|NCT03423173|26002993|P1|Overall Study|Adverse Event|1
7497239|NCT03423173|26002990|P4|Overall Study|Randomized but not vaccinated|1
7497240|NCT03423173|26002991|P3|Overall Study|Randomized but not vaccinated|2
7497241|NCT03423173|26002992|P2|Overall Study|Randomized but not vaccinated|0
7497242|NCT03423173|26002993|P1|Overall Study|Randomized but not vaccinated|1
7497243|NCT03422250|26003042|P4|Follow-up|Adverse Event|1
7497244|NCT03422250|26003043|P3|Follow-up|Adverse Event|0
7497245|NCT03422250|26003044|P2|Follow-up|Adverse Event|0
7497246|NCT03422250|26003045|P1|Follow-up|Adverse Event|0
7497247|NCT03422250|26003042|P4|Follow-up|Withdrawal by Subject|1
7497248|NCT03422250|26003043|P3|Follow-up|Withdrawal by Subject|0
7497249|NCT03422250|26003044|P2|Follow-up|Withdrawal by Subject|0
7497250|NCT03422250|26003045|P1|Follow-up|Withdrawal by Subject|0
7497251|NCT03422250|26003042|P4|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7497252|NCT03422250|26003043|P3|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
7497253|NCT03422250|26003044|P2|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7497254|NCT03422250|26003045|P1|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
7497255|NCT03422250|26003042|P4|Intervention|Adverse Event|1
7497256|NCT03422250|26003043|P3|Intervention|Adverse Event|0
7497257|NCT03422250|26003044|P2|Intervention|Adverse Event|1
7497258|NCT03422250|26003045|P1|Intervention|Adverse Event|0
7497259|NCT03422172|26003097|P1|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
7497260|NCT03422172|26003097|P1|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
7497261|NCT03422172|26003097|P1|Oral lead-in Phase (4 Weeks)|Adverse Event|1
7497262|NCT03422159|26003142|P2|Overall Study|Exclusion due to terminal disease|1
7497263|NCT03422159|26003143|P1|Overall Study|Exclusion due to terminal disease|2
7497264|NCT03421730|26003172|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497265|NCT03421730|26003173|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497266|NCT03421730|26003174|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497267|NCT03421730|26003175|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497268|NCT03421730|26003176|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497269|NCT03421730|26003177|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497270|NCT03421730|26003178|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497271|NCT03421730|26003179|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
7497272|NCT03421730|26003180|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497273|NCT03421730|26003181|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497274|NCT03421730|26003182|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497275|NCT03421730|26003183|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7497276|NCT03421730|26003172|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497277|NCT03421730|26003173|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497278|NCT03421730|26003174|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497279|NCT03421730|26003175|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497280|NCT03421730|26003176|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497281|NCT03421730|26003177|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497282|NCT03421730|26003178|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497283|NCT03421730|26003179|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497284|NCT03421730|26003180|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497285|NCT03421730|26003181|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497286|NCT03421730|26003182|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
7497287|NCT03421730|26003183|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7497288|NCT03421431|26003257|P3|Overall Study|Participant met Stopping Rules|0
7497289|NCT03421431|26003258|P2|Overall Study|Participant met Stopping Rules|1
7497290|NCT03421431|26003259|P1|Overall Study|Participant met Stopping Rules|0
7497291|NCT03421431|26003257|P3|Overall Study|Protocol Violation|0
7497292|NCT03421431|26003258|P2|Overall Study|Protocol Violation|1
7497293|NCT03421431|26003259|P1|Overall Study|Protocol Violation|0
7497294|NCT03421431|26003257|P3|Overall Study|Withdrawal by Subject|1
7497295|NCT03421431|26003258|P2|Overall Study|Withdrawal by Subject|2
7497296|NCT03421431|26003259|P1|Overall Study|Withdrawal by Subject|3
7497297|NCT03421431|26003257|P3|Overall Study|Lost to Follow-up|1
7497298|NCT03421431|26003258|P2|Overall Study|Lost to Follow-up|1
7497299|NCT03421431|26003259|P1|Overall Study|Lost to Follow-up|1
7497300|NCT03421431|26003257|P3|Overall Study|Adverse Event|12
7497301|NCT03421431|26003258|P2|Overall Study|Adverse Event|1
7497302|NCT03421431|26003259|P1|Overall Study|Adverse Event|2
7497303|NCT03421379|26003362|P2|Period 1|Did not receive treatment|2
7497304|NCT03421379|26003363|P1|Period 1|Did not receive treatment|1
7497305|NCT03421379|26003362|P2|Period 1|Physician Decision|1
7497306|NCT03421379|26003363|P1|Period 1|Physician Decision|1
7497307|NCT03421379|26003362|P2|Period 1|Withdrawal by Subject|1
7497308|NCT03421379|26003363|P1|Period 1|Withdrawal by Subject|0
7497309|NCT03420300|26003436|P1|Overall Study|Death|2
7497310|NCT03419962|26003445|P1|Overall Study|Missing completion data|31
7497311|NCT03419962|26003445|P1|Overall Study|Difficulty in inhaling the doses|1
7497312|NCT03419962|26003445|P1|Overall Study|Lost to Follow-up|3
7497313|NCT03419962|26003445|P1|Overall Study|Refusal of continuing with trial drug|1
7497314|NCT03419962|26003445|P1|Overall Study|Change to other medication|1
7497315|NCT03419598|26003476|P1|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
7497316|NCT03419403|26003486|P4|Overall Study|Left study due to COVID-19 restrictions|0
7497317|NCT03419403|26003487|P3|Overall Study|Left study due to COVID-19 restrictions|0
7497318|NCT03419403|26003488|P2|Overall Study|Left study due to COVID-19 restrictions|1
7497319|NCT03419403|26003489|P1|Overall Study|Left study due to COVID-19 restrictions|1
7497320|NCT03419403|26003486|P4|Overall Study|Other, not specified|1
7497321|NCT03419403|26003487|P3|Overall Study|Other, not specified|5
7497322|NCT03419403|26003488|P2|Overall Study|Other, not specified|4
7497323|NCT03419403|26003489|P1|Overall Study|Other, not specified|6
7497324|NCT03419403|26003486|P4|Overall Study|Progressive disease (per protocol)|0
7497325|NCT03419403|26003487|P3|Overall Study|Progressive disease (per protocol)|2
7497326|NCT03419403|26003488|P2|Overall Study|Progressive disease (per protocol)|2
7497327|NCT03419403|26003489|P1|Overall Study|Progressive disease (per protocol)|0
7497328|NCT03419403|26003486|P4|Overall Study|Withdrawal by Subject|1
7497329|NCT03419403|26003487|P3|Overall Study|Withdrawal by Subject|5
7497330|NCT03419403|26003488|P2|Overall Study|Withdrawal by Subject|2
7497331|NCT03419403|26003489|P1|Overall Study|Withdrawal by Subject|5
7497332|NCT03418571|26003587|P2|Overall Study|Consent withdrawn by legal guardian|0
7497333|NCT03418571|26003588|P1|Overall Study|Consent withdrawn by legal guardian|1
7497334|NCT03418376|26003600|P4|Overall Study|Exacerbation|0
7497335|NCT03418376|26003601|P3|Overall Study|Exacerbation|0
7497336|NCT03418376|26003602|P2|Overall Study|Exacerbation|1
7497337|NCT03418376|26003603|P1|Overall Study|Exacerbation|0
7497338|NCT03418376|26003600|P4|Overall Study|Personal reasons|1
7497339|NCT03418376|26003601|P3|Overall Study|Personal reasons|2
7497340|NCT03418376|26003602|P2|Overall Study|Personal reasons|2
7497341|NCT03418376|26003603|P1|Overall Study|Personal reasons|0
7497342|NCT03418376|26003600|P4|Overall Study|Musculoskeletal injury|0
7497343|NCT03418376|26003601|P3|Overall Study|Musculoskeletal injury|1
7497344|NCT03418376|26003602|P2|Overall Study|Musculoskeletal injury|2
7497345|NCT03418376|26003603|P1|Overall Study|Musculoskeletal injury|1
7497346|NCT03418324|26003631|P2|Overall Study|Physician Decision|1
7497347|NCT03418324|26003632|P1|Overall Study|Physician Decision|1
7497348|NCT03418324|26003631|P2|Overall Study|Death|1
7497349|NCT03418324|26003632|P1|Overall Study|Death|0
7497350|NCT03417830|26003794|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
7497351|NCT03417830|26003795|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
7497352|NCT03417505|26003957|P2|First Lens Type (30 Days)|Lost to Follow-up|1
7497353|NCT03417505|26003958|P1|First Lens Type (30 Days)|Lost to Follow-up|1
7497354|NCT03417219|26003989|P2|Overall Study|Lost to Follow-up|3
7497355|NCT03417219|26003990|P1|Overall Study|Lost to Follow-up|0
7497356|NCT03417141|26004000|P1|Overall Study|Protocol Violation|3
7497357|NCT03417141|26004000|P1|Overall Study|Withdrawal by Subject|1
7497358|NCT03417024|26004007|P1|Overall Study|Physician Decision|2
7497359|NCT03417024|26004007|P1|Overall Study|Study Termination prior to follow-up|11
7497360|NCT03416179|26004081|P4|Overall Study|Other|0
7497361|NCT03416179|26004082|P3|Overall Study|Other|0
7497362|NCT03416179|26004083|P2|Overall Study|Other|1
7497363|NCT03416179|26004084|P1|Overall Study|Other|0
7497364|NCT03416179|26004081|P4|Overall Study|Lost to Follow-up|2
7497365|NCT03416179|26004082|P3|Overall Study|Lost to Follow-up|0
7497366|NCT03416179|26004083|P2|Overall Study|Lost to Follow-up|0
7497367|NCT03416179|26004084|P1|Overall Study|Lost to Follow-up|0
7497368|NCT03416179|26004081|P4|Overall Study|Ongoing|66
7497369|NCT03416179|26004082|P3|Overall Study|Ongoing|62
7497370|NCT03416179|26004083|P2|Overall Study|Ongoing|123
7497371|NCT03416179|26004084|P1|Overall Study|Ongoing|121
7497372|NCT03416179|26004081|P4|Overall Study|Withdrawal by Subject|6
7497373|NCT03416179|26004082|P3|Overall Study|Withdrawal by Subject|5
7497374|NCT03416179|26004083|P2|Overall Study|Withdrawal by Subject|19
7497375|NCT03416179|26004084|P1|Overall Study|Withdrawal by Subject|13
7497376|NCT03416179|26004081|P4|Overall Study|Death|88
7497377|NCT03416179|26004082|P3|Overall Study|Death|96
7497378|NCT03416179|26004083|P2|Overall Study|Death|60
7497379|NCT03416179|26004084|P1|Overall Study|Death|67
7497380|NCT03416127|26004097|P3|Overall Study|Withdrawal by Subject|1
7497381|NCT03416127|26004098|P2|Overall Study|Withdrawal by Subject|1
7497382|NCT03416127|26004099|P1|Overall Study|Withdrawal by Subject|0
7497383|NCT03415178|26004254|P2|Single Arm Period (up to Week 16)|Adverse Event|1
7497384|NCT03415178|26004255|P1|Single Arm Period (up to Week 16)|Adverse Event|0
7497385|NCT03415178|26004254|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
7497386|NCT03415178|26004255|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
7497387|NCT03415022|26004309|P2|Overall Study|Lost to Follow-up|0
7497388|NCT03415022|26004310|P1|Overall Study|Lost to Follow-up|2
7497389|NCT03415022|26004309|P2|Overall Study|COVID-19 Suspension|3
7497390|NCT03415022|26004310|P1|Overall Study|COVID-19 Suspension|2
7497391|NCT03415022|26004309|P2|Overall Study|Withdrawal by Subject|2
7497392|NCT03415022|26004310|P1|Overall Study|Withdrawal by Subject|1
7497393|NCT03414359|26004320|P2|Overall Study|Protocol Violation|1
7497394|NCT03414359|26004321|P1|Overall Study|Protocol Violation|0
7497395|NCT03414359|26004320|P2|Overall Study|Lack of Efficacy|1
7497396|NCT03414359|26004321|P1|Overall Study|Lack of Efficacy|1
7497405|NCT03412929|26004396|P1|Overall Study|Protocol Violation|3
7497406|NCT03412734|26004407|P2|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
7497407|NCT03412734|26004408|P1|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
7497408|NCT03412734|26004407|P2|Overall Study|Incorrect labeling of samples|0
7497409|NCT03412734|26004408|P1|Overall Study|Incorrect labeling of samples|2
7497410|NCT03412604|26004414|P1|Overall Study|Withdrawal by Subject|1
7497411|NCT03412084|26004424|P2|Overall Study|Lost to Follow-up|1
7497412|NCT03412084|26004425|P1|Overall Study|Lost to Follow-up|1
7497413|NCT03412084|26004424|P2|Overall Study|Participant moved|0
7497414|NCT03412084|26004425|P1|Overall Study|Participant moved|1
7497415|NCT03412084|26004424|P2|Overall Study|Withdrawal by Subject|0
7497416|NCT03412084|26004425|P1|Overall Study|Withdrawal by Subject|2
7497417|NCT03412019|26004435|P2|Overall Study|Withdrawal by Subject|1
7497418|NCT03412019|26004436|P1|Overall Study|Withdrawal by Subject|1
7497419|NCT03411902|26004448|P2|Overall Study|Lost to Follow-up|0
7497420|NCT03411902|26004449|P1|Overall Study|Lost to Follow-up|3
7497421|NCT03410056|26004508|P7|Overall Study|Withdrawal by Subject|0
7497422|NCT03410056|26004509|P6|Overall Study|Withdrawal by Subject|0
7497423|NCT03410056|26004510|P5|Overall Study|Withdrawal by Subject|0
7497424|NCT03410056|26004511|P4|Overall Study|Withdrawal by Subject|5
7497425|NCT03410056|26004512|P3|Overall Study|Withdrawal by Subject|5
7497426|NCT03410056|26004513|P2|Overall Study|Withdrawal by Subject|2
7497427|NCT03410056|26004514|P1|Overall Study|Withdrawal by Subject|0
7497428|NCT03410056|26004508|P7|Overall Study|Decision by Sponsor|0
7497429|NCT03410056|26004509|P6|Overall Study|Decision by Sponsor|0
7497430|NCT03410056|26004510|P5|Overall Study|Decision by Sponsor|0
7497431|NCT03410056|26004511|P4|Overall Study|Decision by Sponsor|0
7497432|NCT03410056|26004512|P3|Overall Study|Decision by Sponsor|3
7497433|NCT03410056|26004513|P2|Overall Study|Decision by Sponsor|0
7497434|NCT03410056|26004514|P1|Overall Study|Decision by Sponsor|0
7497435|NCT03409796|26004580|P2|Overall Study|Other|1
7497436|NCT03409796|26004581|P1|Overall Study|Other|0
7497437|NCT03409796|26004580|P2|Overall Study|Adverse Event|0
7497438|NCT03409796|26004581|P1|Overall Study|Adverse Event|2
7497439|NCT03409731|26004593|P1|Overall Study|Death|2
7497440|NCT03409731|26004593|P1|Overall Study|Withdrawal by Subject|1
7497441|NCT03408639|26004702|P2|Overall Study|Physician Decision|6
7497442|NCT03408639|26004703|P1|Overall Study|Physician Decision|3
7497443|NCT03408639|26004702|P2|Overall Study|Withdrawal by Subject|7
7497444|NCT03408639|26004703|P1|Overall Study|Withdrawal by Subject|2
7497445|NCT03408639|26004702|P2|Overall Study|Lost to Follow-up|4
7497446|NCT03408639|26004703|P1|Overall Study|Lost to Follow-up|1
7497447|NCT03408639|26004702|P2|Overall Study|Death|5
7497448|NCT03408639|26004703|P1|Overall Study|Death|5
7497449|NCT03408483|26004733|P2|Overall Study|Lost to Follow-up|0
7497450|NCT03408483|26004734|P1|Overall Study|Lost to Follow-up|3
7497451|NCT03408483|26004733|P2|Overall Study|Physician Decision|3
7497452|NCT03408483|26004734|P1|Overall Study|Physician Decision|3
7497453|NCT03407482|26004947|P1|Overall Study|Data Entry Error|1
7497454|NCT03407482|26004947|P1|Overall Study|Withdrawal by Subject|6
7497455|NCT03407482|26004947|P1|Overall Study|Study Terminated By Sponsor|106
7497456|NCT03407482|26004947|P1|Overall Study|Protocol Violation|1
7497457|NCT03407482|26004947|P1|Overall Study|Pregnancy|2
7497458|NCT03407482|26004947|P1|Overall Study|Non-Compliance With Study Drug|1
7497459|NCT03407482|26004947|P1|Overall Study|Lost to Follow-up|1
7497460|NCT03407482|26004947|P1|Overall Study|Disease Relapse|1
7497461|NCT03407482|26004947|P1|Overall Study|Adverse Event|12
7497462|NCT03407430|26004958|P2|Washout|Protocol Violation|0
7497463|NCT03407430|26004959|P1|Washout|Protocol Violation|1
7497464|NCT03407170|26004997|P1|Overall Study|Adverse Event|1
7497465|NCT03407118|26005010|P2|Period 2|Withdrawal by Subject|0
7497466|NCT03407118|26005011|P1|Period 2|Withdrawal by Subject|1
7497467|NCT03406260|26005116|P6|Period 1|Adverse Event|0
7497468|NCT03406260|26005117|P5|Period 1|Adverse Event|1
7497469|NCT03406260|26005118|P4|Period 1|Adverse Event|0
7497470|NCT03406260|26005119|P3|Period 1|Adverse Event|0
7497471|NCT03406260|26005120|P2|Period 1|Adverse Event|0
7497472|NCT03406260|26005121|P1|Period 1|Adverse Event|0
7497473|NCT03405935|26005133|P1|Overall Study|Lost to Follow-up|2
7497474|NCT03405935|26005133|P1|Overall Study|Withdrawal by Subject|1
7497475|NCT03405935|26005133|P1|Overall Study|Death|2
7497476|NCT03405935|26005133|P1|Overall Study|Adverse Event|3
7497477|NCT03405818|26005160|P1|Overall Study|Lost to Follow-up|4
7497478|NCT03405818|26005160|P1|Overall Study|Withdrawal by Subject|4
7497479|NCT03404843|26005233|P2|Overall Study|Study difficulties unrelated to Tx|1
7497480|NCT03404843|26005234|P1|Overall Study|Study difficulties unrelated to Tx|4
7497481|NCT03404674|26005266|P6|Overall Study|Started a Medication that Precluded Eligibility|1
7497482|NCT03404674|26005267|P5|Overall Study|Started a Medication that Precluded Eligibility|0
7497483|NCT03404674|26005268|P4|Overall Study|Started a Medication that Precluded Eligibility|1
7497484|NCT03404674|26005269|P3|Overall Study|Started a Medication that Precluded Eligibility|0
7497485|NCT03404674|26005270|P2|Overall Study|Started a Medication that Precluded Eligibility|0
7497486|NCT03404674|26005271|P1|Overall Study|Started a Medication that Precluded Eligibility|0
7497487|NCT03404674|26005266|P6|Overall Study|Behavioral Problems|0
7497488|NCT03404674|26005267|P5|Overall Study|Behavioral Problems|0
7497489|NCT03404674|26005268|P4|Overall Study|Behavioral Problems|0
7497490|NCT03404674|26005269|P3|Overall Study|Behavioral Problems|1
7497491|NCT03404674|26005270|P2|Overall Study|Behavioral Problems|0
7497492|NCT03404674|26005271|P1|Overall Study|Behavioral Problems|0
7497493|NCT03404674|26005266|P6|Overall Study|Inability to Attend Future Visits|0
7497494|NCT03404674|26005267|P5|Overall Study|Inability to Attend Future Visits|0
7497495|NCT03404674|26005268|P4|Overall Study|Inability to Attend Future Visits|0
7497496|NCT03404674|26005269|P3|Overall Study|Inability to Attend Future Visits|1
7497497|NCT03404674|26005270|P2|Overall Study|Inability to Attend Future Visits|1
7497498|NCT03404674|26005271|P1|Overall Study|Inability to Attend Future Visits|0
7497499|NCT03404206|26005413|P3|Overall Study|Lost to Follow-up|0
7497500|NCT03404206|26005414|P2|Overall Study|Lost to Follow-up|1
7497501|NCT03404206|26005415|P1|Overall Study|Lost to Follow-up|3
7497502|NCT03404206|26005413|P3|Overall Study|Withdrawal by Subject|0
7497503|NCT03404206|26005414|P2|Overall Study|Withdrawal by Subject|1
7497504|NCT03404206|26005415|P1|Overall Study|Withdrawal by Subject|1
7497505|NCT03403751|26005466|P2|Overall Study|Discontinuation (includes missing from Day 29)|2
7497506|NCT03403751|26005467|P1|Overall Study|Discontinuation (includes missing from Day 29)|2
7497507|NCT03403751|26005466|P2|Overall Study|Death|6
7497508|NCT03403751|26005467|P1|Overall Study|Death|5
7497509|NCT03403426|26005768|P1|Overall Study|Lost to Follow-up|2
7497510|NCT03403426|26005768|P1|Overall Study|Death|1
7497511|NCT03403413|26005781|P1|Overall Study|Lack of Efficacy|2
7497512|NCT03403400|26005799|P3|Overall Study|Benign Paroxysmal Positional Vertigo|1
7497513|NCT03403400|26005800|P2|Overall Study|Benign Paroxysmal Positional Vertigo|0
7497514|NCT03403400|26005801|P1|Overall Study|Benign Paroxysmal Positional Vertigo|0
7497515|NCT03403400|26005799|P3|Overall Study|Hospitalization|0
7497516|NCT03403400|26005800|P2|Overall Study|Hospitalization|0
7497517|NCT03403400|26005801|P1|Overall Study|Hospitalization|1
7497518|NCT03403400|26005799|P3|Overall Study|Lost to Follow-up|1
7497519|NCT03403400|26005800|P2|Overall Study|Lost to Follow-up|0
7497520|NCT03403400|26005801|P1|Overall Study|Lost to Follow-up|1
7497521|NCT03403374|26005833|P1|Overall Study|Lost to Follow-up|1
7497522|NCT03403192|26006037|P4|Overall Study|Incomplete|6
7497523|NCT03403192|26006038|P3|Overall Study|Incomplete|3
7497524|NCT03403192|26006039|P2|Overall Study|Incomplete|1
7497525|NCT03403192|26006040|P1|Overall Study|Incomplete|3
7497526|NCT03403192|26006037|P4|Overall Study|Unable to respond|0
7497527|NCT03403192|26006038|P3|Overall Study|Unable to respond|0
7497528|NCT03403192|26006039|P2|Overall Study|Unable to respond|1
7497529|NCT03403192|26006040|P1|Overall Study|Unable to respond|0
7497530|NCT03403192|26006037|P4|Overall Study|Lost to Follow-up|0
7497531|NCT03403192|26006038|P3|Overall Study|Lost to Follow-up|0
7497532|NCT03403192|26006039|P2|Overall Study|Lost to Follow-up|2
7497533|NCT03403192|26006040|P1|Overall Study|Lost to Follow-up|1
7497534|NCT03403036|26006062|P1|Overall Study|Lack of Efficacy|5
7497535|NCT03402893|26006089|P1|Overall Study|Withdrawal by Subject|1
7497536|NCT03402841|26006098|P1|Overall Study|Death|85
7497537|NCT03402841|26006098|P1|Overall Study|Lost to Follow-up|3
7497538|NCT03402841|26006098|P1|Overall Study|Withdrawal by Subject|4
7497539|NCT03402750|26006110|P2|Overall Study|Lost to Follow-up|1
7497540|NCT03402750|26006111|P1|Overall Study|Lost to Follow-up|2
7497541|NCT03402386|26006131|P1|Overall Study|Difficult to control Hb|2
7497542|NCT03402386|26006131|P1|Overall Study|Physician Decision|1
7497543|NCT03402386|26006131|P1|Overall Study|Adverse Event|3
7497544|NCT03401450|26006210|P2|Overall Study|Cancelled surgery|2
7497545|NCT03401450|26006211|P1|Overall Study|Cancelled surgery|0
7497546|NCT03401450|26006210|P2|Overall Study|post surgery medication change|1
7497547|NCT03401450|26006211|P1|Overall Study|post surgery medication change|2
7497548|NCT03401450|26006210|P2|Overall Study|Did not complete medication diary|2
7497549|NCT03401450|26006211|P1|Overall Study|Did not complete medication diary|4
7497550|NCT03401450|26006210|P2|Overall Study|Anesthesia plan changed|2
7497551|NCT03401450|26006211|P1|Overall Study|Anesthesia plan changed|2
7497552|NCT03401450|26006210|P2|Overall Study|Lost to Follow-up|6
7497553|NCT03401450|26006211|P1|Overall Study|Lost to Follow-up|4
7497554|NCT03401229|26006223|P2|Overall Study|COVID-19|1
7497555|NCT03401229|26006224|P1|Overall Study|COVID-19|0
7497556|NCT03401229|26006223|P2|Overall Study|Withdrawal by Subject|26
7497557|NCT03401229|26006224|P1|Overall Study|Withdrawal by Subject|29
7497558|NCT03401229|26006223|P2|Overall Study|Adverse Event|6
7497559|NCT03401229|26006224|P1|Overall Study|Adverse Event|8
7497560|NCT03401229|26006223|P2|Overall Study|Other|3
7497561|NCT03401229|26006224|P1|Overall Study|Other|1
7497562|NCT03401229|26006223|P2|Overall Study|Lost to Follow-up|1
7497563|NCT03401229|26006224|P1|Overall Study|Lost to Follow-up|2
7497564|NCT03400956|26006301|P3|Follow-up Period|Other|1
7497565|NCT03400956|26006302|P2|Follow-up Period|Other|0
7497566|NCT03400956|26006303|P1|Follow-up Period|Other|0
7497567|NCT03400956|26006301|P3|Follow-up Period|Withdrawal by Subject|1
7497568|NCT03400956|26006302|P2|Follow-up Period|Withdrawal by Subject|0
7497569|NCT03400956|26006303|P1|Follow-up Period|Withdrawal by Subject|0
7497570|NCT03400956|26006301|P3|Treatment Period 2|Other|0
7497571|NCT03400956|26006302|P2|Treatment Period 2|Other|1
7497572|NCT03400956|26006303|P1|Treatment Period 2|Other|1
7497573|NCT03400956|26006301|P3|Treatment Period 2|Withdrawal by Subject|3
7497574|NCT03400956|26006302|P2|Treatment Period 2|Withdrawal by Subject|0
7497575|NCT03400956|26006303|P1|Treatment Period 2|Withdrawal by Subject|0
7497576|NCT03400956|26006301|P3|Treatment Period 2|Lost to Follow-up|0
7497577|NCT03400956|26006302|P2|Treatment Period 2|Lost to Follow-up|1
7497578|NCT03400956|26006303|P1|Treatment Period 2|Lost to Follow-up|1
7497579|NCT03400956|26006301|P3|Treatment Period 2|Adverse Event|1
7497580|NCT03400956|26006302|P2|Treatment Period 2|Adverse Event|1
7497581|NCT03400956|26006303|P1|Treatment Period 2|Adverse Event|2
7497582|NCT03400956|26006301|P3|Post-treatment Period 1|Other|4
7497583|NCT03400956|26006302|P2|Post-treatment Period 1|Other|3
7497584|NCT03400956|26006303|P1|Post-treatment Period 1|Other|4
7497585|NCT03400956|26006301|P3|Post-treatment Period 1|Withdrawal by Subject|0
7497586|NCT03400956|26006302|P2|Post-treatment Period 1|Withdrawal by Subject|0
7497587|NCT03400956|26006303|P1|Post-treatment Period 1|Withdrawal by Subject|5
7497588|NCT03400956|26006301|P3|Post-treatment Period 1|Study terminated by sponsor|11
7497589|NCT03400956|26006302|P2|Post-treatment Period 1|Study terminated by sponsor|10
7497590|NCT03400956|26006303|P1|Post-treatment Period 1|Study terminated by sponsor|11
7497591|NCT03400956|26006301|P3|Post-treatment Period 1|Physician Decision|0
7497592|NCT03400956|26006302|P2|Post-treatment Period 1|Physician Decision|3
7497593|NCT03400956|26006303|P1|Post-treatment Period 1|Physician Decision|2
7497594|NCT03400956|26006301|P3|Post-treatment Period 1|Adverse Event|1
7497595|NCT03400956|26006302|P2|Post-treatment Period 1|Adverse Event|0
7497596|NCT03400956|26006303|P1|Post-treatment Period 1|Adverse Event|0
7497597|NCT03400956|26006301|P3|Treatment Period 1|Other|3
7497598|NCT03400956|26006302|P2|Treatment Period 1|Other|2
7497599|NCT03400956|26006303|P1|Treatment Period 1|Other|1
7497600|NCT03400956|26006301|P3|Treatment Period 1|Withdrawal by Subject|4
7497601|NCT03400956|26006302|P2|Treatment Period 1|Withdrawal by Subject|2
7497602|NCT03400956|26006303|P1|Treatment Period 1|Withdrawal by Subject|0
7497603|NCT03400956|26006301|P3|Treatment Period 1|Study terminated by sponsor|1
7497604|NCT03400956|26006302|P2|Treatment Period 1|Study terminated by sponsor|1
7497605|NCT03400956|26006303|P1|Treatment Period 1|Study terminated by sponsor|3
7497606|NCT03400956|26006301|P3|Treatment Period 1|Protocol Violation|0
7497607|NCT03400956|26006302|P2|Treatment Period 1|Protocol Violation|2
7497608|NCT03400956|26006303|P1|Treatment Period 1|Protocol Violation|0
7497609|NCT03400956|26006301|P3|Treatment Period 1|Lost to Follow-up|1
7497610|NCT03400956|26006302|P2|Treatment Period 1|Lost to Follow-up|0
7497611|NCT03400956|26006303|P1|Treatment Period 1|Lost to Follow-up|0
7497612|NCT03400956|26006301|P3|Treatment Period 1|Adverse Event|0
7497613|NCT03400956|26006302|P2|Treatment Period 1|Adverse Event|1
7497614|NCT03400956|26006303|P1|Treatment Period 1|Adverse Event|0
7497675|NCT03400852|26006363|P3|Open Label Period|Study terminated by sponsor|21
7497676|NCT03400852|26006364|P2|Open Label Period|Study terminated by sponsor|0
7497677|NCT03400852|26006365|P1|Open Label Period|Study terminated by sponsor|0
7497678|NCT03400852|26006363|P3|Open Label Period|Physician Decision|1
7497679|NCT03400852|26006364|P2|Open Label Period|Physician Decision|0
7497680|NCT03400852|26006365|P1|Open Label Period|Physician Decision|0
7497681|NCT03400852|26006363|P3|Blinded Treatment Period|Study terminated by sponsor|0
7497682|NCT03400852|26006364|P2|Blinded Treatment Period|Study terminated by sponsor|4
7497683|NCT03400852|26006365|P1|Blinded Treatment Period|Study terminated by sponsor|8
7497684|NCT03400852|26006363|P3|Blinded Treatment Period|Adverse Event|0
7497685|NCT03400852|26006364|P2|Blinded Treatment Period|Adverse Event|1
7497686|NCT03400852|26006365|P1|Blinded Treatment Period|Adverse Event|1
7497687|NCT03400852|26006363|P3|Blinded Treatment Period|Physician Decision|0
7497688|NCT03400852|26006364|P2|Blinded Treatment Period|Physician Decision|1
7497689|NCT03400852|26006365|P1|Blinded Treatment Period|Physician Decision|0
7497690|NCT03400787|26006410|P2|Overall Study|Unblinded before 3-month follow-upa-|6
7497691|NCT03400787|26006411|P1|Overall Study|Unblinded before 3-month follow-upa-|0
7497692|NCT03400787|26006410|P2|Overall Study|Protocol Violation|2
7497693|NCT03400787|26006411|P1|Overall Study|Protocol Violation|0
7497694|NCT03400787|26006410|P2|Overall Study|Death|0
7497695|NCT03400787|26006411|P1|Overall Study|Death|1
7497696|NCT03400787|26006410|P2|Overall Study|Lost to Follow-up|0
7497697|NCT03400787|26006411|P1|Overall Study|Lost to Follow-up|1
7497698|NCT03400033|26006524|P2|Overall Study|Withdrawal by Subject|2
7497699|NCT03400033|26006525|P1|Overall Study|Withdrawal by Subject|1
7497700|NCT03399786|26006571|P4|Open-label Treatment Period (OLTP)|Pregnancy|1
7497701|NCT03399786|26006572|P3|Open-label Treatment Period (OLTP)|Pregnancy|0
7497702|NCT03399786|26006573|P2|Open-label Treatment Period (OLTP)|Pregnancy|0
7497703|NCT03399786|26006574|P1|Open-label Treatment Period (OLTP)|Pregnancy|0
7497704|NCT03399786|26006571|P4|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7497705|NCT03399786|26006572|P3|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
7497706|NCT03399786|26006573|P2|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7497707|NCT03399786|26006574|P1|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7497708|NCT03399786|26006571|P4|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7497709|NCT03399786|26006572|P3|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7497710|NCT03399786|26006573|P2|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7497711|NCT03399786|26006574|P1|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
7497712|NCT03398356|26006770|P3|After 6 Weeks of Treatment|Physician Decision|0
7497713|NCT03398356|26006771|P2|After 6 Weeks of Treatment|Physician Decision|2
7497714|NCT03398356|26006772|P1|After 6 Weeks of Treatment|Physician Decision|0
7497715|NCT03398356|26006770|P3|Before Treatment|Physician Decision|11
7497716|NCT03398356|26006771|P2|Before Treatment|Physician Decision|0
7497717|NCT03398356|26006772|P1|Before Treatment|Physician Decision|0
7497718|NCT03398356|26006770|P3|Before Treatment|Withdrawal by Subject|0
7497719|NCT03398356|26006771|P2|Before Treatment|Withdrawal by Subject|5
7497720|NCT03398356|26006772|P1|Before Treatment|Withdrawal by Subject|0
7497721|NCT03398356|26006770|P3|Before Treatment|drug intolerance|0
7497722|NCT03398356|26006771|P2|Before Treatment|drug intolerance|1
7497723|NCT03398356|26006772|P1|Before Treatment|drug intolerance|2
7497724|NCT03398356|26006770|P3|Before Treatment|Lost to Follow-up|0
7497725|NCT03398356|26006771|P2|Before Treatment|Lost to Follow-up|2
7497726|NCT03398356|26006772|P1|Before Treatment|Lost to Follow-up|1
7497727|NCT03397771|26006902|P2|Overall Study|Adverse Event|1
7497728|NCT03397771|26006903|P1|Overall Study|Adverse Event|2
7497729|NCT03397771|26006902|P2|Overall Study|Protocol Violation|2
7497730|NCT03397771|26006903|P1|Overall Study|Protocol Violation|2
7497731|NCT03397771|26006902|P2|Overall Study|Withdrawal by Subject|3
7497732|NCT03397771|26006903|P1|Overall Study|Withdrawal by Subject|1
7497733|NCT03397771|26006902|P2|Overall Study|2 erroneously randomized, never treated|1
7497734|NCT03397771|26006903|P1|Overall Study|2 erroneously randomized, never treated|3
7497735|NCT03396913|26006969|P2|Overall Study|Lost to Follow-up|6
7497736|NCT03396913|26006970|P1|Overall Study|Lost to Follow-up|0
7497737|NCT03396835|26006980|P1|Overall Study|Did not meet criteria for data analysis|1
7497738|NCT03396835|26006980|P1|Overall Study|Withdrawn prior to completion|1
7497739|NCT03395353|26007019|P1|Overall Study|Early termination of overall study|33
7497740|NCT03395353|26007019|P1|Overall Study|Physician Decision|4
7497741|NCT03395353|26007019|P1|Overall Study|Refrain from visit due to COVID-19|1
7497742|NCT03395353|26007019|P1|Overall Study|Discontinued visit|1
7497743|NCT03395353|26007019|P1|Overall Study|Withdrawal by Subject|24
7497744|NCT03395353|26007019|P1|Overall Study|Lack of Efficacy|3
7497745|NCT03395353|26007019|P1|Overall Study|Protocol Violation|1
7497746|NCT03395353|26007019|P1|Overall Study|Adverse Event|20
7497747|NCT03394924|26007032|P3|Overall Study|Did not meet all inclusion criteria|0
7497748|NCT03394924|26007033|P2|Overall Study|Did not meet all inclusion criteria|0
7497749|NCT03394924|26007034|P1|Overall Study|Did not meet all inclusion criteria|1
7497750|NCT03394924|26007032|P3|Overall Study|Lost to Follow-up|0
7497751|NCT03394924|26007033|P2|Overall Study|Lost to Follow-up|1
7497752|NCT03394924|26007034|P1|Overall Study|Lost to Follow-up|0
7497753|NCT03394924|26007032|P3|Overall Study|Withdrawal by Subject|0
7497754|NCT03394924|26007033|P2|Overall Study|Withdrawal by Subject|0
7497755|NCT03394924|26007034|P1|Overall Study|Withdrawal by Subject|2
7497756|NCT03394924|26007032|P3|Overall Study|Adverse Event|0
7497757|NCT03394924|26007033|P2|Overall Study|Adverse Event|5
7497758|NCT03394924|26007034|P1|Overall Study|Adverse Event|0
7497759|NCT03394885|26007099|P1|Overall Study|Alternative Therapy|1
7497760|NCT03394885|26007099|P1|Overall Study|Withdrawal by Subject|8
7497761|NCT03394885|26007099|P1|Overall Study|Physician Decision|1
7497762|NCT03394885|26007099|P1|Overall Study|Lack of Efficacy|1
7497763|NCT03394885|26007099|P1|Overall Study|Adverse Event|4
7497764|NCT03394508|26007117|P2|Overall Study|Lost to Follow-up|0
7497765|NCT03394508|26007118|P1|Overall Study|Lost to Follow-up|1
7497766|NCT03394508|26007117|P2|Overall Study|Protocol Violation|3
7497767|NCT03394508|26007118|P1|Overall Study|Protocol Violation|0
7497768|NCT03394391|26007144|P2|Overall Study|Lost to Follow-up|2
7497769|NCT03394391|26007145|P1|Overall Study|Lost to Follow-up|1
7497770|NCT03393806|26007163|P2|Overall Study|Physician Decision|0
7497771|NCT03393806|26007164|P1|Overall Study|Physician Decision|1
7497772|NCT03393000|26007297|P1|Overall Study|Physician Decision|1
7497773|NCT03393000|26007297|P1|Overall Study|Withdrawal by Subject|2
7497774|NCT03393000|26007297|P1|Overall Study|Death|11
7497775|NCT03392194|26007324|P2|Overall Study|Conflicts with personal schedule|0
7497776|NCT03392194|26007325|P1|Overall Study|Conflicts with personal schedule|1
7497777|NCT03392194|26007324|P2|Overall Study|Withdrawal by Subject|2
7497778|NCT03392194|26007325|P1|Overall Study|Withdrawal by Subject|1
7497779|NCT03392168|26007335|P4|Period 2: Cohort 2|Other|0
7497780|NCT03392168|26007336|P3|Period 2: Cohort 2|Other|0
7497781|NCT03392168|26007337|P2|Period 2: Cohort 2|Other|1
7497782|NCT03392168|26007338|P1|Period 2: Cohort 2|Other|0
7497783|NCT03392168|26007335|P4|Period 2: Cohort 2|Lost to Follow-up|1
7497784|NCT03392168|26007336|P3|Period 2: Cohort 2|Lost to Follow-up|1
7497785|NCT03392168|26007337|P2|Period 2: Cohort 2|Lost to Follow-up|1
7497786|NCT03392168|26007338|P1|Period 2: Cohort 2|Lost to Follow-up|0
7497787|NCT03391765|26007376|P4|Overall Study|Other, not specified|16
7497788|NCT03391765|26007377|P3|Overall Study|Other, not specified|21
7497789|NCT03391765|26007378|P2|Overall Study|Other, not specified|38
7497790|NCT03391765|26007379|P1|Overall Study|Other, not specified|44
7497791|NCT03391765|26007376|P4|Overall Study|Withdrew consent|5
7497792|NCT03391765|26007377|P3|Overall Study|Withdrew consent|2
7497793|NCT03391765|26007378|P2|Overall Study|Withdrew consent|7
7497794|NCT03391765|26007379|P1|Overall Study|Withdrew consent|5
7497795|NCT03391765|26007376|P4|Overall Study|Adverse Event|2
7497796|NCT03391765|26007377|P3|Overall Study|Adverse Event|0
7497797|NCT03391765|26007378|P2|Overall Study|Adverse Event|0
7497798|NCT03391765|26007379|P1|Overall Study|Adverse Event|2
7497799|NCT03390426|26007430|P2|Overall Study|Protocol Violation|1
7497800|NCT03390426|26007431|P1|Overall Study|Protocol Violation|0
7497801|NCT03390166|26007451|P2|Overall Study|Move to work oversea|1
7497802|NCT03390166|26007452|P1|Overall Study|Move to work oversea|0
7497803|NCT03390166|26007451|P2|Overall Study|To drug therapy course|1
7497804|NCT03390166|26007452|P1|Overall Study|To drug therapy course|0
7497805|NCT03390166|26007451|P2|Overall Study|To militarycamp for conscript|0
7497806|NCT03390166|26007452|P1|Overall Study|To militarycamp for conscript|1
7497807|NCT03390166|26007451|P2|Overall Study|Move from study area|2
7497808|NCT03390166|26007452|P1|Overall Study|Move from study area|3
7497809|NCT03390166|26007451|P2|Overall Study|Physician Decision|1
7497810|NCT03390166|26007452|P1|Overall Study|Physician Decision|2
7497811|NCT03390166|26007451|P2|Overall Study|Lost to Follow-up|4
7497812|NCT03390166|26007452|P1|Overall Study|Lost to Follow-up|6
7497813|NCT03390166|26007451|P2|Overall Study|Death|1
7497814|NCT03390166|26007452|P1|Overall Study|Death|0
7497815|NCT03390101|26007476|P3|Weeks 12-54|Adverse Event|1
7497816|NCT03390101|26007477|P2|Weeks 12-54|Adverse Event|1
7497817|NCT03390101|26007478|P1|Weeks 12-54|Adverse Event|2
7497818|NCT03390101|26007476|P3|Weeks 12-54|Pregnancy|0
7497819|NCT03390101|26007477|P2|Weeks 12-54|Pregnancy|0
7497820|NCT03390101|26007478|P1|Weeks 12-54|Pregnancy|1
7497821|NCT03390101|26007476|P3|Weeks 12-54|Withdrawal by Subject|1
7497822|NCT03390101|26007477|P2|Weeks 12-54|Withdrawal by Subject|3
7497823|NCT03390101|26007478|P1|Weeks 12-54|Withdrawal by Subject|0
7497824|NCT03390101|26007476|P3|Weeks 0-12|Lost to Follow-up|0
7497825|NCT03390101|26007477|P2|Weeks 0-12|Lost to Follow-up|1
7497826|NCT03390101|26007478|P1|Weeks 0-12|Lost to Follow-up|0
7497827|NCT03390101|26007476|P3|Weeks 0-12|Withdrawal by Subject|1
7497828|NCT03390101|26007477|P2|Weeks 0-12|Withdrawal by Subject|1
7497829|NCT03390101|26007478|P1|Weeks 0-12|Withdrawal by Subject|0
7497830|NCT03389893|26007488|P4|Open Label Extension and Follow-Up|Participant Moved|0
7497831|NCT03389893|26007489|P3|Open Label Extension and Follow-Up|Participant Moved|1
7497832|NCT03389893|26007490|P2|Open Label Extension and Follow-Up|Participant Moved|0
7497833|NCT03389893|26007491|P1|Open Label Extension and Follow-Up|Participant Moved|0
7497834|NCT03389893|26007488|P4|Open Label Extension and Follow-Up|Physician Decision|0
7497835|NCT03389893|26007489|P3|Open Label Extension and Follow-Up|Physician Decision|1
7497836|NCT03389893|26007490|P2|Open Label Extension and Follow-Up|Physician Decision|0
7497837|NCT03389893|26007491|P1|Open Label Extension and Follow-Up|Physician Decision|0
7497838|NCT03389893|26007488|P4|Open Label Extension and Follow-Up|Lost to Follow-up|1
7497839|NCT03389893|26007489|P3|Open Label Extension and Follow-Up|Lost to Follow-up|2
7497840|NCT03389893|26007490|P2|Open Label Extension and Follow-Up|Lost to Follow-up|0
7497841|NCT03389893|26007491|P1|Open Label Extension and Follow-Up|Lost to Follow-up|0
7497842|NCT03389893|26007488|P4|Randomized Double Blind Period|Withdrawal by Subject|0
7497843|NCT03389893|26007489|P3|Randomized Double Blind Period|Withdrawal by Subject|0
7497844|NCT03389893|26007490|P2|Randomized Double Blind Period|Withdrawal by Subject|0
7497845|NCT03389893|26007491|P1|Randomized Double Blind Period|Withdrawal by Subject|1
7497846|NCT03389555|26007559|P2|Overall Study|Death|0
7497847|NCT03389555|26007560|P1|Overall Study|Death|1
7497848|NCT03389555|26007559|P2|Overall Study|Protocol Violation|3
7497849|NCT03389555|26007560|P1|Overall Study|Protocol Violation|1
7497850|NCT03389308|26007584|P1|Overall Study|Sponsor Request|2
7497851|NCT03389308|26007584|P1|Overall Study|Adverse Event|2
7497852|NCT03389308|26007584|P1|Overall Study|Lost to Follow-up|3
7497853|NCT03389308|26007584|P1|Overall Study|Withdrawal by Subject|5
7497854|NCT03388164|26007624|P2|Overall Study|Withdrawal by Subject|1
7497855|NCT03388164|26007625|P1|Overall Study|Withdrawal by Subject|3
7497856|NCT03388138|26007635|P2|Overall Study|Protocol Violation|0
7497857|NCT03388138|26007636|P1|Overall Study|Protocol Violation|1
7497858|NCT03387683|26007650|P2|Overall Study|Did not receive treatment|0
7497859|NCT03387683|26007651|P1|Overall Study|Did not receive treatment|1
7497860|NCT03387683|26007650|P2|Overall Study|In receipt of disallowed medication|0
7497861|NCT03387683|26007651|P1|Overall Study|In receipt of disallowed medication|1
7497863|NCT03387059|26007698|P2|Overall Study|Study termination|4
7497864|NCT03387059|26007699|P1|Overall Study|Study termination|5
7497865|NCT03387046|26007713|P2|Overall Study|Adverse Event|1
7497866|NCT03387046|26007714|P1|Overall Study|Adverse Event|1
7497867|NCT03387020|26007748|P3|Overall Study|Withdrawal by Subject|0
7497868|NCT03387020|26007749|P2|Overall Study|Withdrawal by Subject|0
7497869|NCT03387020|26007750|P1|Overall Study|Withdrawal by Subject|2
7497870|NCT03387020|26007748|P3|Overall Study|Adverse Event|0
7497871|NCT03387020|26007749|P2|Overall Study|Adverse Event|2
7497872|NCT03387020|26007750|P1|Overall Study|Adverse Event|0
7497873|NCT03386994|26007780|P1|Overall Study|Death|16
7497874|NCT03386994|26007780|P1|Overall Study|Withdrawal by Subject|3
7497875|NCT03386994|26007780|P1|Overall Study|Lost to Follow-up|4
7497876|NCT03386994|26007780|P1|Overall Study|Adverse Event|14
7497877|NCT03386994|26007780|P1|Overall Study|Lung transplant|1
7497878|NCT03386474|26007840|P2|Overall Study|Adverse Event|1
7497879|NCT03386474|26007841|P1|Overall Study|Adverse Event|0
7497880|NCT03386474|26007840|P2|Overall Study|Death|0
7497881|NCT03386474|26007841|P1|Overall Study|Death|1
7497882|NCT03386448|26007863|P2|Overall Study|Adverse Event|2
7497883|NCT03386448|26007864|P1|Overall Study|Adverse Event|0
7497884|NCT03386435|26007872|P2|Overall Study|Protocol Violation|7
7497885|NCT03386435|26007873|P1|Overall Study|Protocol Violation|5
7497886|NCT03386344|26007888|P3|Overall Study|Reason not Specified|0
7497887|NCT03386344|26007889|P2|Overall Study|Reason not Specified|1
7497888|NCT03386344|26007890|P1|Overall Study|Reason not Specified|0
7497889|NCT03386344|26007888|P3|Overall Study|At the Participant's own Request|8
7497890|NCT03386344|26007889|P2|Overall Study|At the Participant's own Request|7
7497891|NCT03386344|26007890|P1|Overall Study|At the Participant's own Request|7
7497892|NCT03386344|26007888|P3|Overall Study|Lost to Follow-up|1
7497893|NCT03386344|26007889|P2|Overall Study|Lost to Follow-up|2
7497894|NCT03386344|26007890|P1|Overall Study|Lost to Follow-up|3
7497895|NCT03386344|26007888|P3|Overall Study|Study Terminated by Sponsor|106
7497896|NCT03386344|26007889|P2|Overall Study|Study Terminated by Sponsor|102
7497897|NCT03386344|26007890|P1|Overall Study|Study Terminated by Sponsor|101
7497898|NCT03386344|26007888|P3|Overall Study|Poor Compliance to Protocol|0
7497899|NCT03386344|26007889|P2|Overall Study|Poor Compliance to Protocol|1
7497900|NCT03386344|26007890|P1|Overall Study|Poor Compliance to Protocol|0
7497901|NCT03386344|26007888|P3|Overall Study|Adverse Event|1
7497902|NCT03386344|26007889|P2|Overall Study|Adverse Event|3
7497903|NCT03386344|26007890|P1|Overall Study|Adverse Event|6
7497904|NCT03386032|26007938|P3|Overall Study|Lost to Follow-up|0
7497905|NCT03386032|26007939|P2|Overall Study|Lost to Follow-up|3
7497906|NCT03386032|26007940|P1|Overall Study|Lost to Follow-up|9
7497907|NCT03386032|26007938|P3|Overall Study|Withdrawal by Subject|0
7497908|NCT03386032|26007939|P2|Overall Study|Withdrawal by Subject|0
7497909|NCT03386032|26007940|P1|Overall Study|Withdrawal by Subject|1
7497910|NCT03386032|26007938|P3|Overall Study|Adverse Event|0
7497911|NCT03386032|26007939|P2|Overall Study|Adverse Event|2
7497912|NCT03386032|26007940|P1|Overall Study|Adverse Event|2
7497913|NCT03386032|26007938|P3|Overall Study|Lack of Efficacy|0
7497914|NCT03386032|26007939|P2|Overall Study|Lack of Efficacy|2
7497915|NCT03386032|26007940|P1|Overall Study|Lack of Efficacy|6
7497916|NCT03384966|26007954|P3|Follow-up Period|Adverse Event|0
7497917|NCT03384966|26007955|P2|Follow-up Period|Adverse Event|0
7497918|NCT03384966|26007956|P1|Follow-up Period|Adverse Event|1
7497919|NCT03384966|26007954|P3|Randomized at End of Screening Period|Physician decision due to adverse event|0
7497920|NCT03384966|26007955|P2|Randomized at End of Screening Period|Physician decision due to adverse event|0
7497921|NCT03384966|26007956|P1|Randomized at End of Screening Period|Physician decision due to adverse event|1
7497943|NCT03384745|26008062|P6|Response Assess/Dose Hold (W24-W48)|Death|0
7497944|NCT03384745|26008063|P5|Response Assess/Dose Hold (W24-W48)|Death|0
7497945|NCT03384745|26008064|P4|Response Assess/Dose Hold (W24-W48)|Death|0
7497946|NCT03384745|26008065|P3|Response Assess/Dose Hold (W24-W48)|Death|0
7497947|NCT03384745|26008066|P2|Response Assess/Dose Hold (W24-W48)|Death|1
7497948|NCT03384745|26008067|P1|Response Assess/Dose Hold (W24-W48)|Death|0
7497949|NCT03384745|26008062|P6|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7497950|NCT03384745|26008063|P5|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7497951|NCT03384745|26008064|P4|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
7497952|NCT03384745|26008065|P3|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7497953|NCT03384745|26008066|P2|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7497954|NCT03384745|26008067|P1|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7497955|NCT03384745|26008062|P6|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7497956|NCT03384745|26008063|P5|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7497957|NCT03384745|26008064|P4|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7497958|NCT03384745|26008065|P3|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7497959|NCT03384745|26008066|P2|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7497960|NCT03384745|26008067|P1|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7497961|NCT03384745|26008062|P6|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7497962|NCT03384745|26008063|P5|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7497963|NCT03384745|26008064|P4|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7497964|NCT03384745|26008065|P3|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
7497965|NCT03384745|26008066|P2|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7497966|NCT03384745|26008067|P1|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7497967|NCT03384745|26008062|P6|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7497968|NCT03384745|26008063|P5|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7497969|NCT03384745|26008064|P4|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7497970|NCT03384745|26008065|P3|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7497971|NCT03384745|26008066|P2|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7497972|NCT03384745|26008067|P1|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7497973|NCT03384745|26008062|P6|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7497974|NCT03384745|26008063|P5|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
7497975|NCT03384745|26008064|P4|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7497976|NCT03384745|26008065|P3|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7497977|NCT03384745|26008066|P2|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7497978|NCT03384745|26008067|P1|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7497979|NCT03384745|26008062|P6|Maintenance/Escalation (W12-W24)|Adverse Event|0
7497980|NCT03384745|26008063|P5|Maintenance/Escalation (W12-W24)|Adverse Event|1
7497981|NCT03384745|26008064|P4|Maintenance/Escalation (W12-W24)|Adverse Event|1
7497982|NCT03384745|26008065|P3|Maintenance/Escalation (W12-W24)|Adverse Event|0
7497983|NCT03384745|26008066|P2|Maintenance/Escalation (W12-W24)|Adverse Event|0
7497984|NCT03384745|26008067|P1|Maintenance/Escalation (W12-W24)|Adverse Event|0
7497985|NCT03384745|26008062|P6|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7497986|NCT03384745|26008063|P5|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7497987|NCT03384745|26008064|P4|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7497988|NCT03384745|26008065|P3|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
7497989|NCT03384745|26008066|P2|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7497990|NCT03384745|26008067|P1|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7497991|NCT03384745|26008062|P6|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7497992|NCT03384745|26008063|P5|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7497993|NCT03384745|26008064|P4|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7497994|NCT03384745|26008065|P3|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7497995|NCT03384745|26008066|P2|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7497996|NCT03384745|26008067|P1|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7497997|NCT03384745|26008062|P6|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
7497998|NCT03384745|26008063|P5|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
7497999|NCT03384745|26008064|P4|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7498000|NCT03384745|26008065|P3|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7498001|NCT03384745|26008066|P2|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7498002|NCT03384745|26008067|P1|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7498003|NCT03384745|26008062|P6|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7498004|NCT03384745|26008063|P5|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7498005|NCT03384745|26008064|P4|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
7498006|NCT03384745|26008065|P3|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
7498007|NCT03384745|26008066|P2|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7498008|NCT03384745|26008067|P1|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7498009|NCT03384693|26008102|P1|Overall Study|Adverse Event|3
7498010|NCT03384316|26008127|P2|Overall Study|Screen failure|1
7498011|NCT03384316|26008128|P1|Overall Study|Screen failure|0
7498012|NCT03383887|26008167|P2|Overall Study|Lost to Follow-up|1
7498013|NCT03383887|26008168|P1|Overall Study|Lost to Follow-up|0
7498014|NCT03383783|26008176|P1|Overall Study|Withdrawal by Subject|2
7498015|NCT03383692|26008248|P2|Overall Study|Adverse Event|0
7498016|NCT03383692|26008249|P1|Overall Study|Adverse Event|3
7498017|NCT03383692|26008248|P2|Overall Study|Clinical progression|1
7498018|NCT03383692|26008249|P1|Overall Study|Clinical progression|0
7498019|NCT03383692|26008248|P2|Overall Study|Progressive disease as per RECIST|3
7498020|NCT03383692|26008249|P1|Overall Study|Progressive disease as per RECIST|3
7498021|NCT03383614|26008281|P4|Overall Study|Withdrawal by Subject|0
7498022|NCT03383614|26008282|P3|Overall Study|Withdrawal by Subject|0
7498023|NCT03383614|26008283|P2|Overall Study|Withdrawal by Subject|1
7498024|NCT03383614|26008284|P1|Overall Study|Withdrawal by Subject|0
7498025|NCT03382912|26008575|P2|Overall Study|Withdrawal by Subject|5
7498026|NCT03382912|26008576|P1|Overall Study|Withdrawal by Subject|0
7498027|NCT03382912|26008575|P2|Overall Study|Sponsor Decision|6
7498028|NCT03382912|26008576|P1|Overall Study|Sponsor Decision|6
7498029|NCT03382912|26008575|P2|Overall Study|Physician Decision|1
7498030|NCT03382912|26008576|P1|Overall Study|Physician Decision|0
7498031|NCT03382899|26008592|P2|Overall Study|Withdrawal by Subject|5
7498032|NCT03382899|26008593|P1|Overall Study|Withdrawal by Subject|0
7498033|NCT03382899|26008592|P2|Overall Study|Sponsor's decision|28
7498034|NCT03382899|26008593|P1|Overall Study|Sponsor's decision|31
7498035|NCT03382899|26008592|P2|Overall Study|Lost to Follow-up|1
7498036|NCT03382899|26008593|P1|Overall Study|Lost to Follow-up|0
7498037|NCT03382899|26008592|P2|Overall Study|Ineligibility Determined|1
7498038|NCT03382899|26008593|P1|Overall Study|Ineligibility Determined|0
7498039|NCT03382834|26008613|P2|Overall Study|Withdrawal by Subject|1
7498040|NCT03382834|26008614|P1|Overall Study|Withdrawal by Subject|0
7498041|NCT03382834|26008613|P2|Overall Study|Lost to Follow-up|0
7498042|NCT03382834|26008614|P1|Overall Study|Lost to Follow-up|1
7498043|NCT03382821|26008628|P2|Overall Study|Did not receive allocated intervention.|3
7498044|NCT03382821|26008629|P1|Overall Study|Did not receive allocated intervention.|0
7498045|NCT03382418|26008671|P3|Overall Study|Lost to Follow-up|0
7498046|NCT03382418|26008672|P2|Overall Study|Lost to Follow-up|3
7498047|NCT03382418|26008673|P1|Overall Study|Lost to Follow-up|2
7498048|NCT03382418|26008671|P3|Overall Study|Withdrawal by Subject|0
7498049|NCT03382418|26008672|P2|Overall Study|Withdrawal by Subject|0
7498050|NCT03382418|26008673|P1|Overall Study|Withdrawal by Subject|1
7498051|NCT03382262|26008766|P4|Overall Study|Withdrawal by Subject|1
7498052|NCT03382262|26008767|P3|Overall Study|Withdrawal by Subject|0
7498053|NCT03382262|26008768|P2|Overall Study|Withdrawal by Subject|0
7498054|NCT03382262|26008769|P1|Overall Study|Withdrawal by Subject|0
7498055|NCT03382262|26008766|P4|Overall Study|Physician Decision|0
7498056|NCT03382262|26008767|P3|Overall Study|Physician Decision|1
7498057|NCT03382262|26008768|P2|Overall Study|Physician Decision|0
7498058|NCT03382262|26008769|P1|Overall Study|Physician Decision|0
7498059|NCT03381339|26008827|P2|Overall Study|Lost to Follow-up|1
7498060|NCT03381339|26008828|P1|Overall Study|Lost to Follow-up|0
7498061|NCT03381339|26008827|P2|Overall Study|Protocol Violation|3
7498062|NCT03381339|26008828|P1|Overall Study|Protocol Violation|4
7498063|NCT03381248|26008836|P2|Overall Study|Protocol Violation|1
7498064|NCT03381248|26008837|P1|Overall Study|Protocol Violation|2
7498065|NCT03381248|26008836|P2|Overall Study|Adverse Event|0
7498066|NCT03381248|26008837|P1|Overall Study|Adverse Event|2
7498067|NCT03381248|26008836|P2|Overall Study|Lack of Efficacy|0
7498068|NCT03381248|26008837|P1|Overall Study|Lack of Efficacy|1
7498069|NCT03381248|26008836|P2|Overall Study|Lost to Follow-up|2
7498070|NCT03381248|26008837|P1|Overall Study|Lost to Follow-up|3
7498071|NCT03381248|26008836|P2|Overall Study|Withdrawal by Subject|3
7498072|NCT03381248|26008837|P1|Overall Study|Withdrawal by Subject|5
7498073|NCT03381196|26008853|P2|Overall Study|Randomized, not treated|6
7498074|NCT03381196|26008854|P1|Overall Study|Randomized, not treated|3
7498075|NCT03381196|26008853|P2|Overall Study|Adverse Event|0
7498076|NCT03381196|26008854|P1|Overall Study|Adverse Event|1
7498077|NCT03381196|26008853|P2|Overall Study|Death|1
7498078|NCT03381196|26008854|P1|Overall Study|Death|0
7498079|NCT03381196|26008853|P2|Overall Study|Lost to Follow-up|4
7498080|NCT03381196|26008854|P1|Overall Study|Lost to Follow-up|5
7498081|NCT03381196|26008853|P2|Overall Study|Other|1
7498082|NCT03381196|26008854|P1|Overall Study|Other|0
7498083|NCT03381196|26008853|P2|Overall Study|Withdrawal by Subject|7
7498084|NCT03381196|26008854|P1|Overall Study|Withdrawal by Subject|7
7498085|NCT03380429|26008975|P5|Overall Study|Adverse Event|0
7498086|NCT03380429|26008976|P4|Overall Study|Adverse Event|2
7498087|NCT03380429|26008977|P3|Overall Study|Adverse Event|1
7498088|NCT03380429|26008978|P2|Overall Study|Adverse Event|1
7498089|NCT03380429|26008979|P1|Overall Study|Adverse Event|1
7498090|NCT03380429|26008975|P5|Overall Study|Lack of Efficacy|1
7498091|NCT03380429|26008976|P4|Overall Study|Lack of Efficacy|2
7498092|NCT03380429|26008977|P3|Overall Study|Lack of Efficacy|0
7498093|NCT03380429|26008978|P2|Overall Study|Lack of Efficacy|0
7498094|NCT03380429|26008979|P1|Overall Study|Lack of Efficacy|0
7498095|NCT03380429|26008975|P5|Overall Study|Protocol Violation|1
7498096|NCT03380429|26008976|P4|Overall Study|Protocol Violation|0
7498097|NCT03380429|26008977|P3|Overall Study|Protocol Violation|1
7498098|NCT03380429|26008978|P2|Overall Study|Protocol Violation|0
7498099|NCT03380429|26008979|P1|Overall Study|Protocol Violation|1
7498100|NCT03380429|26008975|P5|Overall Study|Lost to Follow-up|1
7498101|NCT03380429|26008976|P4|Overall Study|Lost to Follow-up|3
7498102|NCT03380429|26008977|P3|Overall Study|Lost to Follow-up|4
7498103|NCT03380429|26008978|P2|Overall Study|Lost to Follow-up|2
7498104|NCT03380429|26008979|P1|Overall Study|Lost to Follow-up|0
7498105|NCT03380429|26008975|P5|Overall Study|Withdrawal by Subject|1
7498106|NCT03380429|26008976|P4|Overall Study|Withdrawal by Subject|2
7498107|NCT03380429|26008977|P3|Overall Study|Withdrawal by Subject|5
7498108|NCT03380429|26008978|P2|Overall Study|Withdrawal by Subject|3
7498109|NCT03380429|26008979|P1|Overall Study|Withdrawal by Subject|3
7498110|NCT03380429|26008975|P5|Overall Study|Physician Decision|1
7498111|NCT03380429|26008976|P4|Overall Study|Physician Decision|1
7498112|NCT03380429|26008977|P3|Overall Study|Physician Decision|0
7498113|NCT03380429|26008978|P2|Overall Study|Physician Decision|1
7498114|NCT03380429|26008979|P1|Overall Study|Physician Decision|0
7498115|NCT03380390|26009032|P1|Overall Study|Adverse Event|3
7498116|NCT03380091|26009040|P2|Overall Study|Withdrawal by Subject|1
7498117|NCT03380091|26009041|P1|Overall Study|Withdrawal by Subject|2
7498118|NCT03379753|26009066|P2|Overall Study|No primary outcome|22
7498119|NCT03379753|26009067|P1|Overall Study|No primary outcome|12
7498120|NCT03379753|26009066|P2|Overall Study|not having correct procedure|2
7498121|NCT03379753|26009067|P1|Overall Study|not having correct procedure|1
7498122|NCT03379753|26009066|P2|Overall Study|Withdrawal by Subject|1
7498123|NCT03379753|26009067|P1|Overall Study|Withdrawal by Subject|2
7498124|NCT03379376|26009225|P1|Overall Study|Death|1
7498125|NCT03379376|26009225|P1|Overall Study|Overwhelmed, didn't want to continue|1
7498126|NCT03379376|26009225|P1|Overall Study|Did not wish to complete follow up|1
7498127|NCT03379376|26009225|P1|Overall Study|Lost to Follow-up|2
7498128|NCT03379233|26009235|P2|Overall Study|Technical issues with Concept 2 inhalers|6
7498129|NCT03379233|26009236|P1|Overall Study|Technical issues with Concept 2 inhalers|1
7498130|NCT03378635|26009269|P3|Overall Study|Withdrawal by Subject|0
7498131|NCT03378635|26009270|P2|Overall Study|Withdrawal by Subject|0
7498132|NCT03378635|26009271|P1|Overall Study|Withdrawal by Subject|1
7498133|NCT03378635|26009269|P3|Overall Study|Adverse Event|0
7498134|NCT03378635|26009270|P2|Overall Study|Adverse Event|0
7498135|NCT03378635|26009271|P1|Overall Study|Adverse Event|1
7498136|NCT03377634|26009320|P2|Study Period|Withdrawal by Subject|0
7498137|NCT03377634|26009321|P1|Study Period|Withdrawal by Subject|1
7498138|NCT03377634|26009320|P2|Study Period|Adverse Event|0
7498139|NCT03377634|26009321|P1|Study Period|Adverse Event|1
7498140|NCT03377556|26009343|P1|Overall Study|Death|3
7498141|NCT03377556|26009343|P1|Overall Study|Progression/relapse|38
7498142|NCT03377556|26009343|P1|Overall Study|Refusal unrelated to adverse events|1
7498143|NCT03377556|26009343|P1|Overall Study|Adverse Event|5
7498144|NCT03376516|26009444|P1|Overall Study|Consent withdrawn|1
7498145|NCT03376516|26009444|P1|Overall Study|Not treated|1
7498146|NCT03376321|26009476|P2|Overall Study|Randomized, not treated|3
7498147|NCT03376321|26009477|P1|Overall Study|Randomized, not treated|5
7498148|NCT03376321|26009476|P2|Overall Study|Death|0
7498149|NCT03376321|26009477|P1|Overall Study|Death|4
7498150|NCT03376321|26009476|P2|Overall Study|Lost to Follow-up|7
7498151|NCT03376321|26009477|P1|Overall Study|Lost to Follow-up|1
7498152|NCT03376321|26009476|P2|Overall Study|Withdrawal by Subject|14
7498153|NCT03376321|26009477|P1|Overall Study|Withdrawal by Subject|8
7498154|NCT03376321|26009476|P2|Overall Study|Other|1
7498155|NCT03376321|26009477|P1|Overall Study|Other|5
7498156|NCT03374995|26009551|P2|Overall Study|Withdrawal by Subject|1
7498157|NCT03374995|26009552|P1|Overall Study|Withdrawal by Subject|0
7498158|NCT03374488|26009582|P2|Overall Study|On-going at clinical cut off date|28
7498159|NCT03374488|26009583|P1|Overall Study|On-going at clinical cut off date|30
7498160|NCT03374488|26009582|P2|Overall Study|Withdrawal by Subject|1
7498161|NCT03374488|26009583|P1|Overall Study|Withdrawal by Subject|1
7498162|NCT03374488|26009582|P2|Overall Study|Death|8
7498163|NCT03374488|26009583|P1|Overall Study|Death|10
7498164|NCT03374358|26009595|P2|Overall Study|Withdrawal by Subject|2
7498165|NCT03374358|26009596|P1|Overall Study|Withdrawal by Subject|0
7498166|NCT03374189|26009618|P2|Overall Study|Lost to Follow-up|0
7498167|NCT03374189|26009619|P1|Overall Study|Lost to Follow-up|1
7498168|NCT03373383|26009714|P5|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7498169|NCT03373383|26009715|P4|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7498170|NCT03373383|26009716|P3|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7498171|NCT03373383|26009717|P2|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7498253|NCT03371355|26010104|P1|Overall Study|Investigator judgment|0
7498172|NCT03373383|26009718|P1|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
7498173|NCT03373383|26009714|P5|Treatment Period: Wk0-16|Sponsor decision|0
7498174|NCT03373383|26009715|P4|Treatment Period: Wk0-16|Sponsor decision|1
7498175|NCT03373383|26009716|P3|Treatment Period: Wk0-16|Sponsor decision|0
7498176|NCT03373383|26009717|P2|Treatment Period: Wk0-16|Sponsor decision|0
7498177|NCT03373383|26009718|P1|Treatment Period: Wk0-16|Sponsor decision|0
7498178|NCT03373383|26009714|P5|Treatment Period: Wk0-16|By opinion of investigator|0
7498179|NCT03373383|26009715|P4|Treatment Period: Wk0-16|By opinion of investigator|1
7498180|NCT03373383|26009716|P3|Treatment Period: Wk0-16|By opinion of investigator|0
7498181|NCT03373383|26009717|P2|Treatment Period: Wk0-16|By opinion of investigator|0
7498182|NCT03373383|26009718|P1|Treatment Period: Wk0-16|By opinion of investigator|0
7498183|NCT03373383|26009714|P5|Treatment Period: Wk0-16|As advised by the sponsor|0
7498184|NCT03373383|26009715|P4|Treatment Period: Wk0-16|As advised by the sponsor|0
7498185|NCT03373383|26009716|P3|Treatment Period: Wk0-16|As advised by the sponsor|0
7498186|NCT03373383|26009717|P2|Treatment Period: Wk0-16|As advised by the sponsor|1
7498187|NCT03373383|26009718|P1|Treatment Period: Wk0-16|As advised by the sponsor|0
7498188|NCT03373383|26009714|P5|Treatment Period: Wk0-16|Withdrawal by Subject|3
7498189|NCT03373383|26009715|P4|Treatment Period: Wk0-16|Withdrawal by Subject|3
7498190|NCT03373383|26009716|P3|Treatment Period: Wk0-16|Withdrawal by Subject|2
7498191|NCT03373383|26009717|P2|Treatment Period: Wk0-16|Withdrawal by Subject|3
7498192|NCT03373383|26009718|P1|Treatment Period: Wk0-16|Withdrawal by Subject|2
7498193|NCT03373383|26009714|P5|Treatment Period: Wk0-16|Lost to Follow-up|0
7498194|NCT03373383|26009715|P4|Treatment Period: Wk0-16|Lost to Follow-up|0
7498195|NCT03373383|26009716|P3|Treatment Period: Wk0-16|Lost to Follow-up|0
7498196|NCT03373383|26009717|P2|Treatment Period: Wk0-16|Lost to Follow-up|0
7498197|NCT03373383|26009718|P1|Treatment Period: Wk0-16|Lost to Follow-up|2
7498198|NCT03373383|26009714|P5|Treatment Period: Wk0-16|Protocol Violation|0
7498199|NCT03373383|26009715|P4|Treatment Period: Wk0-16|Protocol Violation|1
7498200|NCT03373383|26009716|P3|Treatment Period: Wk0-16|Protocol Violation|2
7498201|NCT03373383|26009717|P2|Treatment Period: Wk0-16|Protocol Violation|4
7498202|NCT03373383|26009718|P1|Treatment Period: Wk0-16|Protocol Violation|0
7498203|NCT03373383|26009714|P5|Treatment Period: Wk0-16|Lack of Efficacy|0
7498204|NCT03373383|26009715|P4|Treatment Period: Wk0-16|Lack of Efficacy|0
7498205|NCT03373383|26009716|P3|Treatment Period: Wk0-16|Lack of Efficacy|0
7498206|NCT03373383|26009717|P2|Treatment Period: Wk0-16|Lack of Efficacy|1
7498207|NCT03373383|26009718|P1|Treatment Period: Wk0-16|Lack of Efficacy|2
7498208|NCT03373383|26009714|P5|Treatment Period: Wk0-16|Adverse Event|21
7498209|NCT03373383|26009715|P4|Treatment Period: Wk0-16|Adverse Event|15
7498210|NCT03373383|26009716|P3|Treatment Period: Wk0-16|Adverse Event|11
7498211|NCT03373383|26009717|P2|Treatment Period: Wk0-16|Adverse Event|6
7498212|NCT03373383|26009718|P1|Treatment Period: Wk0-16|Adverse Event|7
7498213|NCT03372603|26009872|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
7498214|NCT03372603|26009873|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
7498215|NCT03372603|26009872|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
7498216|NCT03372603|26009873|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
7498217|NCT03372551|26009915|P2|First Intervention (1 Week)|Withdrawal by Subject|0
7498218|NCT03372551|26009916|P1|First Intervention (1 Week)|Withdrawal by Subject|1
7498219|NCT03372369|26009959|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
7498220|NCT03372369|26009960|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
7498221|NCT03372369|26009959|P2|Qualification Period|Inconsistent Eligibility Results|9
7498222|NCT03372369|26009960|P1|Qualification Period|Inconsistent Eligibility Results|10
7498223|NCT03372369|26009959|P2|Qualification Period|Withdrawal by Subject|13
7498224|NCT03372369|26009960|P1|Qualification Period|Withdrawal by Subject|16
7498225|NCT03372096|26009972|P1|Overall Study|Study Closed|8
7498226|NCT03372083|26009983|P1|Overall Study|Withdrawal by Subject|1
7498227|NCT03372083|26009983|P1|Overall Study|Physician Decision|1
7498228|NCT03372083|26009983|P1|Overall Study|Adverse Event|3
7498229|NCT03371732|26010021|P2|Overall Study|Refusal to continue|4
7498230|NCT03371732|26010022|P1|Overall Study|Refusal to continue|3
7498231|NCT03371732|26010021|P2|Overall Study|Withdrawal by Subject|3
7498232|NCT03371732|26010022|P1|Overall Study|Withdrawal by Subject|9
7498233|NCT03371459|26010076|P2|Washout|Lost to Follow-up|1
7498234|NCT03371459|26010077|P1|Washout|Lost to Follow-up|0
7498235|NCT03371381|26010085|P1|Overall Study|Other|4
7498236|NCT03371381|26010085|P1|Overall Study|Study terminated by sponsor|3
7498237|NCT03371381|26010085|P1|Overall Study|Death|5
7498238|NCT03371355|26010101|P4|Overall Study|Reason not Specified|1
7498239|NCT03371355|26010102|P3|Overall Study|Reason not Specified|0
7498240|NCT03371355|26010103|P2|Overall Study|Reason not Specified|1
7498241|NCT03371355|26010104|P1|Overall Study|Reason not Specified|0
7498242|NCT03371355|26010101|P4|Overall Study|Adverse Event|3
7498243|NCT03371355|26010102|P3|Overall Study|Adverse Event|2
7498244|NCT03371355|26010103|P2|Overall Study|Adverse Event|1
7498245|NCT03371355|26010104|P1|Overall Study|Adverse Event|0
7498246|NCT03371355|26010101|P4|Overall Study|Voluntary withdrawal|2
7498247|NCT03371355|26010102|P3|Overall Study|Voluntary withdrawal|1
7498248|NCT03371355|26010103|P2|Overall Study|Voluntary withdrawal|0
7498249|NCT03371355|26010104|P1|Overall Study|Voluntary withdrawal|1
7498250|NCT03371355|26010101|P4|Overall Study|Investigator judgment|1
7498251|NCT03371355|26010102|P3|Overall Study|Investigator judgment|1
7498252|NCT03371355|26010103|P2|Overall Study|Investigator judgment|0
7498254|NCT03370770|26010218|P1|Overall Study|Death|5
7498255|NCT03370770|26010218|P1|Overall Study|Adverse Event|2
7498256|NCT03370770|26010218|P1|Overall Study|Progressive Disease|98
7498257|NCT03370770|26010218|P1|Overall Study|Patient was followed in another hospital center|1
7498258|NCT03370471|26010234|P2|Overall Study|Screen fail|0
7498259|NCT03370471|26010235|P1|Overall Study|Screen fail|1
7498260|NCT03370471|26010234|P2|Overall Study|Unable to access veins for blood draw|1
7498261|NCT03370471|26010235|P1|Overall Study|Unable to access veins for blood draw|0
7498262|NCT03370471|26010234|P2|Overall Study|Withdrawal by Subject|1
7498263|NCT03370471|26010235|P1|Overall Study|Withdrawal by Subject|6
7498264|NCT03370419|26010247|P1|Overall Study|Lost to Follow-up|16
7498265|NCT03370302|26010257|P6|Dose Expansion Phase|Progressive Disease|0
7498266|NCT03370302|26010258|P5|Dose Expansion Phase|Progressive Disease|0
7498267|NCT03370302|26010259|P4|Dose Expansion Phase|Progressive Disease|6
7498268|NCT03370302|26010260|P3|Dose Expansion Phase|Progressive Disease|0
7498269|NCT03370302|26010261|P2|Dose Expansion Phase|Progressive Disease|0
7498270|NCT03370302|26010262|P1|Dose Expansion Phase|Progressive Disease|0
7498271|NCT03370302|26010257|P6|Dose Escalation Phase|Progressive Disease|1
7498272|NCT03370302|26010258|P5|Dose Escalation Phase|Progressive Disease|3
7498273|NCT03370302|26010259|P4|Dose Escalation Phase|Progressive Disease|0
7498274|NCT03370302|26010260|P3|Dose Escalation Phase|Progressive Disease|2
7498275|NCT03370302|26010261|P2|Dose Escalation Phase|Progressive Disease|4
7498276|NCT03370302|26010262|P1|Dose Escalation Phase|Progressive Disease|2
7498277|NCT03370302|26010257|P6|Dose Escalation Phase|Adverse Event|0
7498278|NCT03370302|26010258|P5|Dose Escalation Phase|Adverse Event|0
7498279|NCT03370302|26010259|P4|Dose Escalation Phase|Adverse Event|0
7498280|NCT03370302|26010260|P3|Dose Escalation Phase|Adverse Event|2
7498281|NCT03370302|26010261|P2|Dose Escalation Phase|Adverse Event|0
7498282|NCT03370302|26010262|P1|Dose Escalation Phase|Adverse Event|1
7498283|NCT03370302|26010257|P6|Dose Escalation Phase|Withdrawal by Subject|2
7498284|NCT03370302|26010258|P5|Dose Escalation Phase|Withdrawal by Subject|0
7498285|NCT03370302|26010259|P4|Dose Escalation Phase|Withdrawal by Subject|0
7498286|NCT03370302|26010260|P3|Dose Escalation Phase|Withdrawal by Subject|2
7498287|NCT03370302|26010261|P2|Dose Escalation Phase|Withdrawal by Subject|1
7498288|NCT03370302|26010262|P1|Dose Escalation Phase|Withdrawal by Subject|0
7498289|NCT03370302|26010257|P6|Dose Escalation Phase|Other|0
7498290|NCT03370302|26010258|P5|Dose Escalation Phase|Other|0
7498291|NCT03370302|26010259|P4|Dose Escalation Phase|Other|0
7498292|NCT03370302|26010260|P3|Dose Escalation Phase|Other|1
7498293|NCT03370302|26010261|P2|Dose Escalation Phase|Other|1
7498294|NCT03370302|26010262|P1|Dose Escalation Phase|Other|0
7498295|NCT03370289|26010359|P1|Overall Study|Sample Size Sufficient|4
7498296|NCT03370289|26010359|P1|Overall Study|Screen Failure|1
7498297|NCT03369951|26010393|P1|Overall Study|Protocol Violation|1
7498298|NCT03369951|26010393|P1|Overall Study|Lost to Follow-up|1
7498299|NCT03369951|26010393|P1|Overall Study|Death|1
7498300|NCT03369951|26010393|P1|Overall Study|Withdrawal by Subject|3
7498301|NCT03369704|26010428|P2|Follow-up Epoch|Lost to Follow-up|0
7498302|NCT03369704|26010429|P1|Follow-up Epoch|Lost to Follow-up|1
7498303|NCT03369704|26010428|P2|Treatment Epoch|Adverse Event|0
7498304|NCT03369704|26010429|P1|Treatment Epoch|Adverse Event|2
7498305|NCT03369704|26010428|P2|Treatment Epoch|Lack of Efficacy|2
7498306|NCT03369704|26010429|P1|Treatment Epoch|Lack of Efficacy|0
7498307|NCT03369704|26010428|P2|Treatment Epoch|Lost to Follow-up|1
7498308|NCT03369704|26010429|P1|Treatment Epoch|Lost to Follow-up|0
7498309|NCT03369704|26010428|P2|Treatment Epoch|Protocol Violation|0
7498310|NCT03369704|26010429|P1|Treatment Epoch|Protocol Violation|1
7498311|NCT03369704|26010428|P2|Treatment Epoch|technical problems|0
7498312|NCT03369704|26010429|P1|Treatment Epoch|technical problems|1
7498313|NCT03369418|26010464|P2|Overall Study|Withdrawal by Subject|3
7498314|NCT03369418|26010465|P1|Overall Study|Withdrawal by Subject|3
7498315|NCT03368859|26010623|P2|Overall Study|Other|1
7498316|NCT03368859|26010624|P1|Overall Study|Other|1
7498317|NCT03368859|26010623|P2|Overall Study|Study terminated by Sponsor|23
7498318|NCT03368859|26010624|P1|Overall Study|Study terminated by Sponsor|18
7498319|NCT03368859|26010623|P2|Overall Study|Death|6
7498320|NCT03368859|26010624|P1|Overall Study|Death|12
7498321|NCT03368859|26010623|P2|Overall Study|Withdrew Consent|4
7498322|NCT03368859|26010624|P1|Overall Study|Withdrew Consent|5
7498323|NCT03368807|26010634|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
7498324|NCT03368807|26010634|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
7498325|NCT03368807|26010634|P1|Period 1 (Blinded CGM)|Protocol Violation|1
7498326|NCT03368807|26010634|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
7498327|NCT03368170|26010695|P2|Overall Study|Adverse Event|1
7498328|NCT03368170|26010696|P1|Overall Study|Adverse Event|2
7498329|NCT03366428|26010723|P1|Overall Study|Withdrawal by Subject|1
7498330|NCT03366428|26010723|P1|Overall Study|Clinical progression|1
7498331|NCT03366428|26010723|P1|Overall Study|Adverse Event|2
7498332|NCT03366428|26010723|P1|Overall Study|Progressive disease per RECIST v1.1|15
7498333|NCT03365934|26010759|P1|Overall Study|Withdrawal by Subject|1
7498334|NCT03365934|26010759|P1|Overall Study|Adverse Event|1
7498335|NCT03365791|26011032|P1|Overall Study|Subject/guardian decision|5
7498336|NCT03365791|26011032|P1|Overall Study|Progressive disease|51
7498337|NCT03365791|26011032|P1|Overall Study|Physician Decision|9
7498338|NCT03365791|26011032|P1|Overall Study|Lost to Follow-up|1
7498339|NCT03365791|26011032|P1|Overall Study|Death|1
7498340|NCT03365791|26011032|P1|Overall Study|Adverse Event|5
7498341|NCT03365011|26011069|P2|Overall Study|Withdrawal by Subject|2
7498342|NCT03365011|26011070|P1|Overall Study|Withdrawal by Subject|1
7498343|NCT03364751|26011084|P4|Overall Study|Lost to Follow-up|0
7498344|NCT03364751|26011085|P3|Overall Study|Lost to Follow-up|0
7498345|NCT03364751|26011086|P2|Overall Study|Lost to Follow-up|1
7498346|NCT03364751|26011087|P1|Overall Study|Lost to Follow-up|0
7498347|NCT03364751|26011084|P4|Overall Study|Withdrawal by Subject|0
7498348|NCT03364751|26011085|P3|Overall Study|Withdrawal by Subject|0
7498349|NCT03364751|26011086|P2|Overall Study|Withdrawal by Subject|0
7498350|NCT03364751|26011087|P1|Overall Study|Withdrawal by Subject|1
7498351|NCT03364738|26011162|P1|Overall Study|Adverse Event|1
7498352|NCT03364738|26011162|P1|Overall Study|Withdrawal by Subject|1
7498353|NCT03364738|26011162|P1|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6
7498354|NCT03364673|26011186|P1|Overall Study|Injury unrelated to study|3
7498355|NCT03364673|26011186|P1|Overall Study|Withdrawal by Subject|2
7498356|NCT03364608|26011194|P1|Overall Study|Lost to Follow-up|2
7498357|NCT03364608|26011194|P1|Overall Study|Protocol Violation|2
7498358|NCT03364608|26011194|P1|Overall Study|Withdrawal by Subject|4
7498359|NCT03364335|26011221|P5|Overall Study|Lost to Follow-up|11
7498360|NCT03364335|26011222|P4|Overall Study|Lost to Follow-up|11
7498361|NCT03364335|26011223|P3|Overall Study|Lost to Follow-up|10
7498362|NCT03364335|26011224|P2|Overall Study|Lost to Follow-up|7
7498363|NCT03364335|26011225|P1|Overall Study|Lost to Follow-up|7
7498364|NCT03364335|26011221|P5|Overall Study|Adverse Event|0
7498365|NCT03364335|26011222|P4|Overall Study|Adverse Event|2
7498366|NCT03364335|26011223|P3|Overall Study|Adverse Event|1
7498367|NCT03364335|26011224|P2|Overall Study|Adverse Event|4
7498368|NCT03364335|26011225|P1|Overall Study|Adverse Event|3
7498369|NCT03364309|26011300|P19|Post-Treatment Followup Period|Miscellaneous|0
7498370|NCT03364309|26011301|P18|Post-Treatment Followup Period|Miscellaneous|4
7498371|NCT03364309|26011302|P17|Post-Treatment Followup Period|Miscellaneous|0
7498372|NCT03364309|26011303|P16|Post-Treatment Followup Period|Miscellaneous|0
7498373|NCT03364309|26011304|P15|Post-Treatment Followup Period|Miscellaneous|0
7498374|NCT03364309|26011305|P14|Post-Treatment Followup Period|Miscellaneous|0
7498375|NCT03364309|26011306|P13|Post-Treatment Followup Period|Miscellaneous|0
7498376|NCT03364309|26011307|P12|Post-Treatment Followup Period|Miscellaneous|0
7498377|NCT03364309|26011308|P11|Post-Treatment Followup Period|Miscellaneous|0
7498378|NCT03364309|26011309|P10|Post-Treatment Followup Period|Miscellaneous|0
7498379|NCT03364309|26011310|P9|Post-Treatment Followup Period|Miscellaneous|0
7498380|NCT03364309|26011311|P8|Post-Treatment Followup Period|Miscellaneous|0
7498381|NCT03364309|26011312|P7|Post-Treatment Followup Period|Miscellaneous|0
7498382|NCT03364309|26011313|P6|Post-Treatment Followup Period|Miscellaneous|0
7498383|NCT03364309|26011314|P5|Post-Treatment Followup Period|Miscellaneous|0
7498384|NCT03364309|26011315|P4|Post-Treatment Followup Period|Miscellaneous|0
7498385|NCT03364309|26011316|P3|Post-Treatment Followup Period|Miscellaneous|0
7498386|NCT03364309|26011317|P2|Post-Treatment Followup Period|Miscellaneous|0
7498387|NCT03364309|26011318|P1|Post-Treatment Followup Period|Miscellaneous|0
7498388|NCT03364309|26011300|P19|Post-Treatment Followup Period|Lost to Follow-up|0
7498389|NCT03364309|26011301|P18|Post-Treatment Followup Period|Lost to Follow-up|2
7498390|NCT03364309|26011302|P17|Post-Treatment Followup Period|Lost to Follow-up|0
7498391|NCT03364309|26011303|P16|Post-Treatment Followup Period|Lost to Follow-up|0
7498392|NCT03364309|26011304|P15|Post-Treatment Followup Period|Lost to Follow-up|0
7498393|NCT03364309|26011305|P14|Post-Treatment Followup Period|Lost to Follow-up|0
7498394|NCT03364309|26011306|P13|Post-Treatment Followup Period|Lost to Follow-up|0
7498395|NCT03364309|26011307|P12|Post-Treatment Followup Period|Lost to Follow-up|0
7498396|NCT03364309|26011308|P11|Post-Treatment Followup Period|Lost to Follow-up|0
7498397|NCT03364309|26011309|P10|Post-Treatment Followup Period|Lost to Follow-up|0
7498398|NCT03364309|26011310|P9|Post-Treatment Followup Period|Lost to Follow-up|0
7498399|NCT03364309|26011311|P8|Post-Treatment Followup Period|Lost to Follow-up|0
7498400|NCT03364309|26011312|P7|Post-Treatment Followup Period|Lost to Follow-up|0
7498401|NCT03364309|26011313|P6|Post-Treatment Followup Period|Lost to Follow-up|0
7498402|NCT03364309|26011314|P5|Post-Treatment Followup Period|Lost to Follow-up|0
7498403|NCT03364309|26011315|P4|Post-Treatment Followup Period|Lost to Follow-up|0
7498404|NCT03364309|26011316|P3|Post-Treatment Followup Period|Lost to Follow-up|0
7498405|NCT03364309|26011317|P2|Post-Treatment Followup Period|Lost to Follow-up|0
7498406|NCT03364309|26011318|P1|Post-Treatment Followup Period|Lost to Follow-up|0
7498407|NCT03364309|26011300|P19|Post-Treatment Followup Period|Adverse Event|1
7498408|NCT03364309|26011301|P18|Post-Treatment Followup Period|Adverse Event|6
7498409|NCT03364309|26011302|P17|Post-Treatment Followup Period|Adverse Event|2
7498410|NCT03364309|26011303|P16|Post-Treatment Followup Period|Adverse Event|0
7498411|NCT03364309|26011304|P15|Post-Treatment Followup Period|Adverse Event|0
7498412|NCT03364309|26011305|P14|Post-Treatment Followup Period|Adverse Event|0
7498413|NCT03364309|26011306|P13|Post-Treatment Followup Period|Adverse Event|0
7498414|NCT03364309|26011307|P12|Post-Treatment Followup Period|Adverse Event|0
7498415|NCT03364309|26011308|P11|Post-Treatment Followup Period|Adverse Event|0
7498416|NCT03364309|26011309|P10|Post-Treatment Followup Period|Adverse Event|0
7498417|NCT03364309|26011310|P9|Post-Treatment Followup Period|Adverse Event|0
7498418|NCT03364309|26011311|P8|Post-Treatment Followup Period|Adverse Event|0
7498419|NCT03364309|26011312|P7|Post-Treatment Followup Period|Adverse Event|0
7498420|NCT03364309|26011313|P6|Post-Treatment Followup Period|Adverse Event|0
7498421|NCT03364309|26011314|P5|Post-Treatment Followup Period|Adverse Event|0
7498422|NCT03364309|26011315|P4|Post-Treatment Followup Period|Adverse Event|0
7498423|NCT03364309|26011316|P3|Post-Treatment Followup Period|Adverse Event|0
7498424|NCT03364309|26011317|P2|Post-Treatment Followup Period|Adverse Event|0
7498425|NCT03364309|26011318|P1|Post-Treatment Followup Period|Adverse Event|0
7498426|NCT03364309|26011300|P19|Post-Treatment Followup Period|Withdrawal by Subject|1
7498427|NCT03364309|26011301|P18|Post-Treatment Followup Period|Withdrawal by Subject|19
7498428|NCT03364309|26011302|P17|Post-Treatment Followup Period|Withdrawal by Subject|3
7498429|NCT03364309|26011303|P16|Post-Treatment Followup Period|Withdrawal by Subject|0
7498430|NCT03364309|26011304|P15|Post-Treatment Followup Period|Withdrawal by Subject|0
7498431|NCT03364309|26011305|P14|Post-Treatment Followup Period|Withdrawal by Subject|0
7498432|NCT03364309|26011306|P13|Post-Treatment Followup Period|Withdrawal by Subject|0
7498433|NCT03364309|26011307|P12|Post-Treatment Followup Period|Withdrawal by Subject|0
7498434|NCT03364309|26011308|P11|Post-Treatment Followup Period|Withdrawal by Subject|0
7498435|NCT03364309|26011309|P10|Post-Treatment Followup Period|Withdrawal by Subject|0
7498436|NCT03364309|26011310|P9|Post-Treatment Followup Period|Withdrawal by Subject|0
7498437|NCT03364309|26011311|P8|Post-Treatment Followup Period|Withdrawal by Subject|0
7498438|NCT03364309|26011312|P7|Post-Treatment Followup Period|Withdrawal by Subject|0
7498439|NCT03364309|26011313|P6|Post-Treatment Followup Period|Withdrawal by Subject|0
7498440|NCT03364309|26011314|P5|Post-Treatment Followup Period|Withdrawal by Subject|0
7498441|NCT03364309|26011315|P4|Post-Treatment Followup Period|Withdrawal by Subject|0
7498442|NCT03364309|26011316|P3|Post-Treatment Followup Period|Withdrawal by Subject|0
7498443|NCT03364309|26011317|P2|Post-Treatment Followup Period|Withdrawal by Subject|0
7498444|NCT03364309|26011318|P1|Post-Treatment Followup Period|Withdrawal by Subject|0
7498445|NCT03364309|26011300|P19|Re-treatment (Maintenance) Period|Relapse|0
7498446|NCT03364309|26011301|P18|Re-treatment (Maintenance) Period|Relapse|0
7498447|NCT03364309|26011302|P17|Re-treatment (Maintenance) Period|Relapse|0
7498448|NCT03364309|26011303|P16|Re-treatment (Maintenance) Period|Relapse|1
7498449|NCT03364309|26011304|P15|Re-treatment (Maintenance) Period|Relapse|0
7498450|NCT03364309|26011305|P14|Re-treatment (Maintenance) Period|Relapse|0
7498451|NCT03364309|26011306|P13|Re-treatment (Maintenance) Period|Relapse|1
7498452|NCT03364309|26011307|P12|Re-treatment (Maintenance) Period|Relapse|0
7498453|NCT03364309|26011308|P11|Re-treatment (Maintenance) Period|Relapse|0
7498454|NCT03364309|26011309|P10|Re-treatment (Maintenance) Period|Relapse|0
7498455|NCT03364309|26011310|P9|Re-treatment (Maintenance) Period|Relapse|0
7498456|NCT03364309|26011311|P8|Re-treatment (Maintenance) Period|Relapse|0
7498457|NCT03364309|26011312|P7|Re-treatment (Maintenance) Period|Relapse|0
7498458|NCT03364309|26011313|P6|Re-treatment (Maintenance) Period|Relapse|0
7498459|NCT03364309|26011314|P5|Re-treatment (Maintenance) Period|Relapse|0
7498460|NCT03364309|26011315|P4|Re-treatment (Maintenance) Period|Relapse|0
7498461|NCT03364309|26011316|P3|Re-treatment (Maintenance) Period|Relapse|0
7498462|NCT03364309|26011317|P2|Re-treatment (Maintenance) Period|Relapse|0
7498463|NCT03364309|26011318|P1|Re-treatment (Maintenance) Period|Relapse|0
7498464|NCT03364309|26011300|P19|Re-treatment (Maintenance) Period|Adverse Event|0
7498465|NCT03364309|26011301|P18|Re-treatment (Maintenance) Period|Adverse Event|0
7498466|NCT03364309|26011302|P17|Re-treatment (Maintenance) Period|Adverse Event|0
7498467|NCT03364309|26011303|P16|Re-treatment (Maintenance) Period|Adverse Event|0
7498468|NCT03364309|26011304|P15|Re-treatment (Maintenance) Period|Adverse Event|1
7498469|NCT03364309|26011305|P14|Re-treatment (Maintenance) Period|Adverse Event|0
7498470|NCT03364309|26011306|P13|Re-treatment (Maintenance) Period|Adverse Event|0
7498471|NCT03364309|26011307|P12|Re-treatment (Maintenance) Period|Adverse Event|0
7498472|NCT03364309|26011308|P11|Re-treatment (Maintenance) Period|Adverse Event|0
7498473|NCT03364309|26011309|P10|Re-treatment (Maintenance) Period|Adverse Event|0
7498474|NCT03364309|26011310|P9|Re-treatment (Maintenance) Period|Adverse Event|0
7498475|NCT03364309|26011311|P8|Re-treatment (Maintenance) Period|Adverse Event|0
7498476|NCT03364309|26011312|P7|Re-treatment (Maintenance) Period|Adverse Event|0
7498477|NCT03364309|26011313|P6|Re-treatment (Maintenance) Period|Adverse Event|0
7498478|NCT03364309|26011314|P5|Re-treatment (Maintenance) Period|Adverse Event|0
7498479|NCT03364309|26011315|P4|Re-treatment (Maintenance) Period|Adverse Event|0
7498480|NCT03364309|26011316|P3|Re-treatment (Maintenance) Period|Adverse Event|0
7498481|NCT03364309|26011317|P2|Re-treatment (Maintenance) Period|Adverse Event|0
7498482|NCT03364309|26011318|P1|Re-treatment (Maintenance) Period|Adverse Event|0
7498483|NCT03364309|26011300|P19|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498484|NCT03364309|26011301|P18|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498485|NCT03364309|26011302|P17|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498486|NCT03364309|26011303|P16|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7498487|NCT03364309|26011304|P15|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7498488|NCT03364309|26011305|P14|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7498489|NCT03364309|26011306|P13|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498490|NCT03364309|26011307|P12|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498491|NCT03364309|26011308|P11|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498492|NCT03364309|26011309|P10|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498493|NCT03364309|26011310|P9|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498494|NCT03364309|26011311|P8|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498495|NCT03364309|26011312|P7|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498496|NCT03364309|26011313|P6|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498497|NCT03364309|26011314|P5|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498498|NCT03364309|26011315|P4|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498499|NCT03364309|26011316|P3|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498500|NCT03364309|26011317|P2|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498501|NCT03364309|26011318|P1|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7498502|NCT03364309|26011300|P19|Maintenance Period|Miscellaneous|0
7498503|NCT03364309|26011301|P18|Maintenance Period|Miscellaneous|0
7498504|NCT03364309|26011302|P17|Maintenance Period|Miscellaneous|0
7498505|NCT03364309|26011303|P16|Maintenance Period|Miscellaneous|0
7498506|NCT03364309|26011304|P15|Maintenance Period|Miscellaneous|0
7498507|NCT03364309|26011305|P14|Maintenance Period|Miscellaneous|0
7498508|NCT03364309|26011306|P13|Maintenance Period|Miscellaneous|0
7498509|NCT03364309|26011307|P12|Maintenance Period|Miscellaneous|0
7498510|NCT03364309|26011308|P11|Maintenance Period|Miscellaneous|0
7498511|NCT03364309|26011309|P10|Maintenance Period|Miscellaneous|0
7498512|NCT03364309|26011310|P9|Maintenance Period|Miscellaneous|1
7498513|NCT03364309|26011311|P8|Maintenance Period|Miscellaneous|0
7498514|NCT03364309|26011312|P7|Maintenance Period|Miscellaneous|0
7498515|NCT03364309|26011313|P6|Maintenance Period|Miscellaneous|0
7498516|NCT03364309|26011314|P5|Maintenance Period|Miscellaneous|0
7498517|NCT03364309|26011315|P4|Maintenance Period|Miscellaneous|0
7498518|NCT03364309|26011316|P3|Maintenance Period|Miscellaneous|0
7498519|NCT03364309|26011317|P2|Maintenance Period|Miscellaneous|0
7498520|NCT03364309|26011318|P1|Maintenance Period|Miscellaneous|0
7498521|NCT03364309|26011300|P19|Maintenance Period|Lost to Follow-up|0
7498522|NCT03364309|26011301|P18|Maintenance Period|Lost to Follow-up|0
7498523|NCT03364309|26011302|P17|Maintenance Period|Lost to Follow-up|0
7498524|NCT03364309|26011303|P16|Maintenance Period|Lost to Follow-up|0
7498525|NCT03364309|26011304|P15|Maintenance Period|Lost to Follow-up|0
7498526|NCT03364309|26011305|P14|Maintenance Period|Lost to Follow-up|0
7498527|NCT03364309|26011306|P13|Maintenance Period|Lost to Follow-up|0
7498528|NCT03364309|26011307|P12|Maintenance Period|Lost to Follow-up|0
7498529|NCT03364309|26011308|P11|Maintenance Period|Lost to Follow-up|0
7498530|NCT03364309|26011309|P10|Maintenance Period|Lost to Follow-up|0
7498531|NCT03364309|26011310|P9|Maintenance Period|Lost to Follow-up|1
7498532|NCT03364309|26011311|P8|Maintenance Period|Lost to Follow-up|0
7498533|NCT03364309|26011312|P7|Maintenance Period|Lost to Follow-up|0
7498534|NCT03364309|26011313|P6|Maintenance Period|Lost to Follow-up|0
7498535|NCT03364309|26011314|P5|Maintenance Period|Lost to Follow-up|0
7498536|NCT03364309|26011315|P4|Maintenance Period|Lost to Follow-up|0
7498537|NCT03364309|26011316|P3|Maintenance Period|Lost to Follow-up|0
7498538|NCT03364309|26011317|P2|Maintenance Period|Lost to Follow-up|0
7498539|NCT03364309|26011318|P1|Maintenance Period|Lost to Follow-up|0
7498540|NCT03364309|26011300|P19|Maintenance Period|Death|0
7498541|NCT03364309|26011301|P18|Maintenance Period|Death|0
7498542|NCT03364309|26011302|P17|Maintenance Period|Death|0
7498543|NCT03364309|26011303|P16|Maintenance Period|Death|0
7498544|NCT03364309|26011304|P15|Maintenance Period|Death|0
7498545|NCT03364309|26011305|P14|Maintenance Period|Death|0
7498546|NCT03364309|26011306|P13|Maintenance Period|Death|0
7498547|NCT03364309|26011307|P12|Maintenance Period|Death|0
7498548|NCT03364309|26011308|P11|Maintenance Period|Death|0
7498549|NCT03364309|26011309|P10|Maintenance Period|Death|0
7498550|NCT03364309|26011310|P9|Maintenance Period|Death|1
7498551|NCT03364309|26011311|P8|Maintenance Period|Death|0
7498552|NCT03364309|26011312|P7|Maintenance Period|Death|0
7498553|NCT03364309|26011313|P6|Maintenance Period|Death|0
7498554|NCT03364309|26011314|P5|Maintenance Period|Death|0
7498555|NCT03364309|26011315|P4|Maintenance Period|Death|0
7498556|NCT03364309|26011316|P3|Maintenance Period|Death|0
7498557|NCT03364309|26011317|P2|Maintenance Period|Death|0
7498558|NCT03364309|26011318|P1|Maintenance Period|Death|0
7498559|NCT03364309|26011300|P19|Maintenance Period|Lack of Efficacy|0
7498560|NCT03364309|26011301|P18|Maintenance Period|Lack of Efficacy|0
7498561|NCT03364309|26011302|P17|Maintenance Period|Lack of Efficacy|0
7498562|NCT03364309|26011303|P16|Maintenance Period|Lack of Efficacy|0
7498563|NCT03364309|26011304|P15|Maintenance Period|Lack of Efficacy|0
7498564|NCT03364309|26011305|P14|Maintenance Period|Lack of Efficacy|0
7498565|NCT03364309|26011306|P13|Maintenance Period|Lack of Efficacy|0
7498566|NCT03364309|26011307|P12|Maintenance Period|Lack of Efficacy|0
7498567|NCT03364309|26011308|P11|Maintenance Period|Lack of Efficacy|2
7498568|NCT03364309|26011309|P10|Maintenance Period|Lack of Efficacy|3
7498569|NCT03364309|26011310|P9|Maintenance Period|Lack of Efficacy|1
7498570|NCT03364309|26011311|P8|Maintenance Period|Lack of Efficacy|0
7498571|NCT03364309|26011312|P7|Maintenance Period|Lack of Efficacy|0
7498572|NCT03364309|26011313|P6|Maintenance Period|Lack of Efficacy|0
7498573|NCT03364309|26011314|P5|Maintenance Period|Lack of Efficacy|0
7498574|NCT03364309|26011315|P4|Maintenance Period|Lack of Efficacy|0
7498575|NCT03364309|26011316|P3|Maintenance Period|Lack of Efficacy|0
7498576|NCT03364309|26011317|P2|Maintenance Period|Lack of Efficacy|0
7498577|NCT03364309|26011318|P1|Maintenance Period|Lack of Efficacy|0
7498578|NCT03364309|26011300|P19|Maintenance Period|Relapsed|0
7498579|NCT03364309|26011301|P18|Maintenance Period|Relapsed|0
7498580|NCT03364309|26011302|P17|Maintenance Period|Relapsed|0
7498581|NCT03364309|26011303|P16|Maintenance Period|Relapsed|0
7498582|NCT03364309|26011304|P15|Maintenance Period|Relapsed|0
7498583|NCT03364309|26011305|P14|Maintenance Period|Relapsed|0
7498584|NCT03364309|26011306|P13|Maintenance Period|Relapsed|0
7498585|NCT03364309|26011307|P12|Maintenance Period|Relapsed|0
7498586|NCT03364309|26011308|P11|Maintenance Period|Relapsed|0
7498587|NCT03364309|26011309|P10|Maintenance Period|Relapsed|0
7498588|NCT03364309|26011310|P9|Maintenance Period|Relapsed|0
7498589|NCT03364309|26011311|P8|Maintenance Period|Relapsed|2
7498590|NCT03364309|26011312|P7|Maintenance Period|Relapsed|10
7498591|NCT03364309|26011313|P6|Maintenance Period|Relapsed|45
7498592|NCT03364309|26011314|P5|Maintenance Period|Relapsed|7
7498593|NCT03364309|26011315|P4|Maintenance Period|Relapsed|43
7498594|NCT03364309|26011316|P3|Maintenance Period|Relapsed|0
7498595|NCT03364309|26011317|P2|Maintenance Period|Relapsed|0
7498596|NCT03364309|26011318|P1|Maintenance Period|Relapsed|0
7498597|NCT03364309|26011300|P19|Maintenance Period|Adverse Event|0
7498598|NCT03364309|26011301|P18|Maintenance Period|Adverse Event|0
7498599|NCT03364309|26011302|P17|Maintenance Period|Adverse Event|0
7498600|NCT03364309|26011303|P16|Maintenance Period|Adverse Event|0
7498601|NCT03364309|26011304|P15|Maintenance Period|Adverse Event|0
7498602|NCT03364309|26011305|P14|Maintenance Period|Adverse Event|0
7498603|NCT03364309|26011306|P13|Maintenance Period|Adverse Event|0
7498604|NCT03364309|26011307|P12|Maintenance Period|Adverse Event|0
7498605|NCT03364309|26011308|P11|Maintenance Period|Adverse Event|2
7498606|NCT03364309|26011309|P10|Maintenance Period|Adverse Event|0
7498607|NCT03364309|26011310|P9|Maintenance Period|Adverse Event|1
7498608|NCT03364309|26011311|P8|Maintenance Period|Adverse Event|0
7498609|NCT03364309|26011312|P7|Maintenance Period|Adverse Event|3
7498610|NCT03364309|26011313|P6|Maintenance Period|Adverse Event|0
7498611|NCT03364309|26011314|P5|Maintenance Period|Adverse Event|2
7498612|NCT03364309|26011315|P4|Maintenance Period|Adverse Event|0
7498613|NCT03364309|26011316|P3|Maintenance Period|Adverse Event|0
7498614|NCT03364309|26011317|P2|Maintenance Period|Adverse Event|0
7498615|NCT03364309|26011318|P1|Maintenance Period|Adverse Event|0
7498616|NCT03364309|26011300|P19|Maintenance Period|Withdrawal by Subject|0
7498617|NCT03364309|26011301|P18|Maintenance Period|Withdrawal by Subject|0
7498618|NCT03364309|26011302|P17|Maintenance Period|Withdrawal by Subject|0
7498619|NCT03364309|26011303|P16|Maintenance Period|Withdrawal by Subject|0
7498620|NCT03364309|26011304|P15|Maintenance Period|Withdrawal by Subject|0
7498621|NCT03364309|26011305|P14|Maintenance Period|Withdrawal by Subject|0
7498622|NCT03364309|26011306|P13|Maintenance Period|Withdrawal by Subject|0
7498623|NCT03364309|26011307|P12|Maintenance Period|Withdrawal by Subject|0
7498624|NCT03364309|26011308|P11|Maintenance Period|Withdrawal by Subject|2
7498625|NCT03364309|26011309|P10|Maintenance Period|Withdrawal by Subject|1
7498626|NCT03364309|26011310|P9|Maintenance Period|Withdrawal by Subject|1
7498627|NCT03364309|26011311|P8|Maintenance Period|Withdrawal by Subject|0
7498628|NCT03364309|26011312|P7|Maintenance Period|Withdrawal by Subject|3
7498629|NCT03364309|26011313|P6|Maintenance Period|Withdrawal by Subject|1
7498630|NCT03364309|26011314|P5|Maintenance Period|Withdrawal by Subject|3
7498631|NCT03364309|26011315|P4|Maintenance Period|Withdrawal by Subject|1
7498632|NCT03364309|26011316|P3|Maintenance Period|Withdrawal by Subject|0
7498633|NCT03364309|26011317|P2|Maintenance Period|Withdrawal by Subject|0
7498634|NCT03364309|26011318|P1|Maintenance Period|Withdrawal by Subject|0
7498635|NCT03364309|26011300|P19|Induction Period|Physician Decision|0
7498636|NCT03364309|26011301|P18|Induction Period|Physician Decision|0
7498637|NCT03364309|26011302|P17|Induction Period|Physician Decision|0
7498638|NCT03364309|26011303|P16|Induction Period|Physician Decision|0
7498639|NCT03364309|26011304|P15|Induction Period|Physician Decision|0
7498640|NCT03364309|26011305|P14|Induction Period|Physician Decision|0
7498641|NCT03364309|26011306|P13|Induction Period|Physician Decision|0
7498642|NCT03364309|26011307|P12|Induction Period|Physician Decision|0
7498643|NCT03364309|26011308|P11|Induction Period|Physician Decision|0
7498644|NCT03364309|26011309|P10|Induction Period|Physician Decision|0
7498645|NCT03364309|26011310|P9|Induction Period|Physician Decision|0
7498646|NCT03364309|26011311|P8|Induction Period|Physician Decision|0
7498647|NCT03364309|26011312|P7|Induction Period|Physician Decision|0
7498648|NCT03364309|26011313|P6|Induction Period|Physician Decision|0
7498649|NCT03364309|26011314|P5|Induction Period|Physician Decision|0
7498650|NCT03364309|26011315|P4|Induction Period|Physician Decision|0
7498651|NCT03364309|26011316|P3|Induction Period|Physician Decision|0
7498652|NCT03364309|26011317|P2|Induction Period|Physician Decision|1
7498653|NCT03364309|26011318|P1|Induction Period|Physician Decision|0
7498654|NCT03364309|26011300|P19|Induction Period|Lost to Follow-up|0
7498655|NCT03364309|26011301|P18|Induction Period|Lost to Follow-up|0
7498656|NCT03364309|26011302|P17|Induction Period|Lost to Follow-up|0
7498657|NCT03364309|26011303|P16|Induction Period|Lost to Follow-up|0
7498658|NCT03364309|26011304|P15|Induction Period|Lost to Follow-up|0
7498659|NCT03364309|26011305|P14|Induction Period|Lost to Follow-up|0
7498660|NCT03364309|26011306|P13|Induction Period|Lost to Follow-up|0
7498661|NCT03364309|26011307|P12|Induction Period|Lost to Follow-up|0
7498662|NCT03364309|26011308|P11|Induction Period|Lost to Follow-up|0
7498663|NCT03364309|26011309|P10|Induction Period|Lost to Follow-up|0
7498664|NCT03364309|26011310|P9|Induction Period|Lost to Follow-up|0
7498665|NCT03364309|26011311|P8|Induction Period|Lost to Follow-up|0
7498666|NCT03364309|26011312|P7|Induction Period|Lost to Follow-up|0
7498667|NCT03364309|26011313|P6|Induction Period|Lost to Follow-up|0
7498668|NCT03364309|26011314|P5|Induction Period|Lost to Follow-up|0
7498669|NCT03364309|26011315|P4|Induction Period|Lost to Follow-up|0
7498670|NCT03364309|26011316|P3|Induction Period|Lost to Follow-up|0
7498671|NCT03364309|26011317|P2|Induction Period|Lost to Follow-up|0
7498672|NCT03364309|26011318|P1|Induction Period|Lost to Follow-up|1
7498673|NCT03364309|26011300|P19|Induction Period|Withdrawal by Subject|0
7498674|NCT03364309|26011301|P18|Induction Period|Withdrawal by Subject|0
7498675|NCT03364309|26011302|P17|Induction Period|Withdrawal by Subject|0
7498676|NCT03364309|26011303|P16|Induction Period|Withdrawal by Subject|0
7498677|NCT03364309|26011304|P15|Induction Period|Withdrawal by Subject|0
7498678|NCT03364309|26011305|P14|Induction Period|Withdrawal by Subject|0
7498679|NCT03364309|26011306|P13|Induction Period|Withdrawal by Subject|0
7498680|NCT03364309|26011307|P12|Induction Period|Withdrawal by Subject|0
7498681|NCT03364309|26011308|P11|Induction Period|Withdrawal by Subject|0
7498682|NCT03364309|26011309|P10|Induction Period|Withdrawal by Subject|0
7498683|NCT03364309|26011310|P9|Induction Period|Withdrawal by Subject|0
7498684|NCT03364309|26011311|P8|Induction Period|Withdrawal by Subject|0
7498685|NCT03364309|26011312|P7|Induction Period|Withdrawal by Subject|0
7498686|NCT03364309|26011313|P6|Induction Period|Withdrawal by Subject|0
7498687|NCT03364309|26011314|P5|Induction Period|Withdrawal by Subject|0
7498688|NCT03364309|26011315|P4|Induction Period|Withdrawal by Subject|0
7498689|NCT03364309|26011316|P3|Induction Period|Withdrawal by Subject|0
7498690|NCT03364309|26011317|P2|Induction Period|Withdrawal by Subject|3
7498691|NCT03364309|26011318|P1|Induction Period|Withdrawal by Subject|1
7498692|NCT03364309|26011300|P19|Induction Period|Adverse Event|0
7498693|NCT03364309|26011301|P18|Induction Period|Adverse Event|0
7498694|NCT03364309|26011302|P17|Induction Period|Adverse Event|0
7498695|NCT03364309|26011303|P16|Induction Period|Adverse Event|0
7498696|NCT03364309|26011304|P15|Induction Period|Adverse Event|0
7498697|NCT03364309|26011305|P14|Induction Period|Adverse Event|0
7498698|NCT03364309|26011306|P13|Induction Period|Adverse Event|0
7498699|NCT03364309|26011307|P12|Induction Period|Adverse Event|0
7498700|NCT03364309|26011308|P11|Induction Period|Adverse Event|0
7498701|NCT03364309|26011309|P10|Induction Period|Adverse Event|0
7498702|NCT03364309|26011310|P9|Induction Period|Adverse Event|0
7498703|NCT03364309|26011311|P8|Induction Period|Adverse Event|0
7498704|NCT03364309|26011312|P7|Induction Period|Adverse Event|0
7498705|NCT03364309|26011313|P6|Induction Period|Adverse Event|0
7498706|NCT03364309|26011314|P5|Induction Period|Adverse Event|0
7498707|NCT03364309|26011315|P4|Induction Period|Adverse Event|0
7498708|NCT03364309|26011316|P3|Induction Period|Adverse Event|1
7498709|NCT03364309|26011317|P2|Induction Period|Adverse Event|0
7498710|NCT03364309|26011318|P1|Induction Period|Adverse Event|4
7498711|NCT03364192|26011387|P1|Overall Study|Lost to Follow-up|1
7498712|NCT03364192|26011387|P1|Overall Study|Withdrawal by Subject|5
7498713|NCT03364192|26011387|P1|Overall Study|Ineligible|10
7498714|NCT03364036|26011394|P1|Overall Study|Other|2
7498715|NCT03364036|26011394|P1|Overall Study|Protocol Non-Compliance|1
7498716|NCT03364036|26011394|P1|Overall Study|Withdrew Consent|1
7498717|NCT03364036|26011394|P1|Overall Study|Lost to Follow-up|1
7498718|NCT03364036|26011394|P1|Overall Study|Adverse Event|1
7498719|NCT03364023|26011400|P1|Overall Study|Death|14
7498720|NCT03364023|26011400|P1|Overall Study|Lost to Follow-up|3
7498721|NCT03363906|26011407|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
7498722|NCT03363906|26011408|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
7498723|NCT03363906|26011407|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
7498724|NCT03363906|26011408|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
7498725|NCT03363906|26011407|P2|Period 2 (Test or Reference)|Adverse Event|0
7498726|NCT03363906|26011408|P1|Period 2 (Test or Reference)|Adverse Event|2
7498727|NCT03363906|26011407|P2|Period 1 (Reference or Test)|Adverse Event|2
7498728|NCT03363906|26011408|P1|Period 1 (Reference or Test)|Adverse Event|1
7498729|NCT03363776|26011481|P3|Overall Study|Death|0
7498730|NCT03363776|26011482|P2|Overall Study|Death|0
7498731|NCT03363776|26011483|P1|Overall Study|Death|1
7498732|NCT03363776|26011481|P3|Overall Study|Study drug toxicity|1
7498733|NCT03363776|26011482|P2|Overall Study|Study drug toxicity|0
7498734|NCT03363776|26011483|P1|Overall Study|Study drug toxicity|0
7498735|NCT03363776|26011481|P3|Overall Study|Progressive disease|1
7498736|NCT03363776|26011482|P2|Overall Study|Progressive disease|3
7498737|NCT03363776|26011483|P1|Overall Study|Progressive disease|2
7498738|NCT03363321|26011588|P5|Overall Study|Withdrawal by Subject|0
7498739|NCT03363321|26011589|P4|Overall Study|Withdrawal by Subject|1
7498740|NCT03363321|26011590|P3|Overall Study|Withdrawal by Subject|0
7498741|NCT03363321|26011591|P2|Overall Study|Withdrawal by Subject|1
7498742|NCT03363321|26011592|P1|Overall Study|Withdrawal by Subject|0
7498743|NCT03361865|26011716|P2|Overall Study|On-going at clinical cut off date|39
7498744|NCT03361865|26011717|P1|Overall Study|On-going at clinical cut off date|29
7498745|NCT03361865|26011716|P2|Overall Study|Physician Decision|0
7498746|NCT03361865|26011717|P1|Overall Study|Physician Decision|1
7498747|NCT03361865|26011716|P2|Overall Study|Death|10
7498748|NCT03361865|26011717|P1|Overall Study|Death|13
7498749|NCT03361605|26011727|P1|Overall Study|Analyzable data not available|3
7498750|NCT03361423|26011734|P2|Overall Study|Missing data|1
7498751|NCT03361423|26011735|P1|Overall Study|Missing data|4
7498752|NCT03361423|26011734|P2|Overall Study|Started >60 minutes from migraine onset|1
7498753|NCT03361423|26011735|P1|Overall Study|Started >60 minutes from migraine onset|0
7498754|NCT03361423|26011734|P2|Overall Study|Did not treat|18
7498755|NCT03361423|26011735|P1|Overall Study|Did not treat|19
7498756|NCT03361423|26011734|P2|Overall Study|Withdrawal by Subject|3
7498757|NCT03361423|26011735|P1|Overall Study|Withdrawal by Subject|4
7498758|NCT03361293|26011757|P2|Overall Study|Withdrawal by Subject|3
7498759|NCT03361293|26011758|P1|Overall Study|Withdrawal by Subject|1
7498760|NCT03361293|26011757|P2|Overall Study|Lost to Follow-up|2
7498761|NCT03361293|26011758|P1|Overall Study|Lost to Follow-up|0
7498762|NCT03361228|26011780|P2|Overall Study|Death|0
7498763|NCT03361228|26011781|P1|Overall Study|Death|3
7498764|NCT03361228|26011780|P2|Overall Study|Other|1
7498765|NCT03361228|26011781|P1|Overall Study|Other|1
7498766|NCT03361176|26011803|P2|Overall Study|Withdrawal by Subject|1
7498767|NCT03361176|26011804|P1|Overall Study|Withdrawal by Subject|0
7498768|NCT03361176|26011803|P2|Overall Study|Adverse Event|2
7498769|NCT03361176|26011804|P1|Overall Study|Adverse Event|0
7498770|NCT03361176|26011803|P2|Overall Study|Lost to Follow-up|2
7498771|NCT03361176|26011804|P1|Overall Study|Lost to Follow-up|1
7498772|NCT03361137|26011819|P5|Overall Study|Reason not specified|0
7498773|NCT03361137|26011820|P4|Overall Study|Reason not specified|0
7498774|NCT03361137|26011821|P3|Overall Study|Reason not specified|0
7498775|NCT03361137|26011822|P2|Overall Study|Reason not specified|0
7498776|NCT03361137|26011823|P1|Overall Study|Reason not specified|1
7498777|NCT03360747|26011883|P1|Overall Study|Voluntary Withdrawal|1
7498778|NCT03360344|26011899|P3|Overall Study|Withdrawal by Subject|1
7498779|NCT03360344|26011900|P2|Overall Study|Withdrawal by Subject|1
7498780|NCT03360344|26011901|P1|Overall Study|Withdrawal by Subject|0
7498781|NCT03360071|26011964|P2|Overall Study|Lost to Follow-up|0
7498782|NCT03360071|26011965|P1|Overall Study|Lost to Follow-up|1
7498783|NCT03359850|26011984|P2|Extension Phase (Up to 28 Months)|Disease Progression|0
7498784|NCT03359850|26011985|P1|Extension Phase (Up to 28 Months)|Disease Progression|5
7498785|NCT03359850|26011984|P2|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
7498786|NCT03359850|26011985|P1|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
7498787|NCT03359850|26011984|P2|Extension Phase (Up to 28 Months)|Death|4
7498788|NCT03359850|26011985|P1|Extension Phase (Up to 28 Months)|Death|2
7498789|NCT03359850|26011984|P2|PK Phase (Up to Day 8)|Adverse Event|0
7498790|NCT03359850|26011985|P1|PK Phase (Up to Day 8)|Adverse Event|1
7498791|NCT03359850|26011984|P2|PK Phase (Up to Day 8)|Physician Decision|1
7498792|NCT03359850|26011985|P1|PK Phase (Up to Day 8)|Physician Decision|0
7498793|NCT03359590|26012064|P2|First Intervention|Protocol Violation|1
7498794|NCT03359590|26012065|P1|First Intervention|Protocol Violation|0
7498795|NCT03359590|26012064|P2|First Intervention|Withdrawal by Subject|1
7498796|NCT03359590|26012065|P1|First Intervention|Withdrawal by Subject|1
7498797|NCT03359473|26012075|P4|Overall Study|Protocol-defined stopping criteria|1
7498798|NCT03359473|26012076|P3|Overall Study|Protocol-defined stopping criteria|0
7498799|NCT03359473|26012077|P2|Overall Study|Protocol-defined stopping criteria|0
7498800|NCT03359473|26012078|P1|Overall Study|Protocol-defined stopping criteria|1
7498801|NCT03359473|26012075|P4|Overall Study|Withdrawal by Subject|0
7498802|NCT03359473|26012076|P3|Overall Study|Withdrawal by Subject|1
7498803|NCT03359473|26012077|P2|Overall Study|Withdrawal by Subject|2
7498804|NCT03359473|26012078|P1|Overall Study|Withdrawal by Subject|1
7498805|NCT03359473|26012075|P4|Overall Study|Physician Decision|1
7498806|NCT03359473|26012076|P3|Overall Study|Physician Decision|0
7498807|NCT03359473|26012077|P2|Overall Study|Physician Decision|1
7498808|NCT03359473|26012078|P1|Overall Study|Physician Decision|0
7498809|NCT03359473|26012075|P4|Overall Study|Lost to Follow-up|0
7498810|NCT03359473|26012076|P3|Overall Study|Lost to Follow-up|0
7498811|NCT03359473|26012077|P2|Overall Study|Lost to Follow-up|1
7498812|NCT03359473|26012078|P1|Overall Study|Lost to Follow-up|0
7498813|NCT03359473|26012075|P4|Overall Study|Adverse Event|3
7498814|NCT03359473|26012076|P3|Overall Study|Adverse Event|5
7498815|NCT03359473|26012077|P2|Overall Study|Adverse Event|2
7498816|NCT03359473|26012078|P1|Overall Study|Adverse Event|0
7498817|NCT03359395|26012290|P2|Second Intervention B/A|Lost to Follow-up|2
7498818|NCT03359395|26012291|P1|Second Intervention B/A|Lost to Follow-up|3
7498819|NCT03359395|26012290|P2|Second Intervention B/A|Exclusion criteria|1
7498820|NCT03359395|26012291|P1|Second Intervention B/A|Exclusion criteria|0
7498821|NCT03359395|26012290|P2|First Intervention A / B|Lost to Follow-up|3
7498822|NCT03359395|26012291|P1|First Intervention A / B|Lost to Follow-up|2
7498823|NCT03359395|26012290|P2|First Intervention A / B|Withdrawal by Subject|0
7498824|NCT03359395|26012291|P1|First Intervention A / B|Withdrawal by Subject|1
7498825|NCT03359174|26012319|P1|Overall Study|Adverse Event|1
7498826|NCT03358472|26012343|P3|Overall Study|On-going at clinical cut off date|5
7498827|NCT03358472|26012344|P2|Overall Study|On-going at clinical cut off date|6
7498828|NCT03358472|26012345|P1|Overall Study|On-going at clinical cut off date|9
7498829|NCT03358472|26012343|P3|Overall Study|Withdrawal by Subject|1
7498830|NCT03358472|26012344|P2|Overall Study|Withdrawal by Subject|0
7498831|NCT03358472|26012345|P1|Overall Study|Withdrawal by Subject|0
7498832|NCT03358472|26012343|P3|Overall Study|Physician Decision|0
7498833|NCT03358472|26012344|P2|Overall Study|Physician Decision|1
7498834|NCT03358472|26012345|P1|Overall Study|Physician Decision|0
7498835|NCT03358472|26012343|P3|Overall Study|Death|10
7498836|NCT03358472|26012344|P2|Overall Study|Death|3
7498837|NCT03358472|26012345|P1|Overall Study|Death|6
7498838|NCT03358407|26012369|P10|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498839|NCT03358407|26012370|P9|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498840|NCT03358407|26012371|P8|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
7498841|NCT03358407|26012372|P7|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7498842|NCT03358407|26012373|P6|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7498843|NCT03358407|26012374|P5|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498844|NCT03358407|26012375|P4|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498845|NCT03358407|26012376|P3|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498846|NCT03358407|26012377|P2|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498847|NCT03358407|26012378|P1|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7498848|NCT03358407|26012369|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498849|NCT03358407|26012370|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498850|NCT03358407|26012371|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498851|NCT03358407|26012372|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7498852|NCT03358407|26012373|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7498853|NCT03358407|26012374|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498854|NCT03358407|26012375|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498855|NCT03358407|26012376|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498856|NCT03358407|26012377|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498857|NCT03358407|26012378|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7498858|NCT03358407|26012369|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498859|NCT03358407|26012370|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498860|NCT03358407|26012371|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7498861|NCT03358407|26012372|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498862|NCT03358407|26012373|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7498863|NCT03358407|26012374|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498864|NCT03358407|26012375|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498865|NCT03358407|26012376|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498866|NCT03358407|26012377|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498867|NCT03358407|26012378|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7498868|NCT03358407|26012369|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498869|NCT03358407|26012370|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498870|NCT03358407|26012371|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
7498871|NCT03358407|26012372|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498872|NCT03358407|26012373|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
7498873|NCT03358407|26012374|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498874|NCT03358407|26012375|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498875|NCT03358407|26012376|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498876|NCT03358407|26012377|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498877|NCT03358407|26012378|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7498878|NCT03358407|26012369|P10|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498879|NCT03358407|26012370|P9|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498880|NCT03358407|26012371|P8|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498881|NCT03358407|26012372|P7|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498882|NCT03358407|26012373|P6|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498883|NCT03358407|26012374|P5|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
7498884|NCT03358407|26012375|P4|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498885|NCT03358407|26012376|P3|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498886|NCT03358407|26012377|P2|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498887|NCT03358407|26012378|P1|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7498888|NCT03358407|26012369|P10|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498889|NCT03358407|26012370|P9|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498890|NCT03358407|26012371|P8|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498891|NCT03358407|26012372|P7|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498892|NCT03358407|26012373|P6|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498893|NCT03358407|26012374|P5|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498894|NCT03358407|26012375|P4|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498895|NCT03358407|26012376|P3|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
7498896|NCT03358407|26012377|P2|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498897|NCT03358407|26012378|P1|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7498898|NCT03358329|26012655|P1|Overall Study|Withdrawal by Subject|2
7498899|NCT03358329|26012655|P1|Overall Study|Lost to Follow-up|2
7498900|NCT03358290|26012666|P5|Overall Study|Withdrawal by Subject|1
7498901|NCT03358290|26012667|P4|Overall Study|Withdrawal by Subject|0
7498902|NCT03358290|26012668|P3|Overall Study|Withdrawal by Subject|0
7498903|NCT03358290|26012669|P2|Overall Study|Withdrawal by Subject|0
7498904|NCT03358290|26012670|P1|Overall Study|Withdrawal by Subject|0
7498905|NCT03358290|26012666|P5|Overall Study|Adverse Event|0
7498906|NCT03358290|26012667|P4|Overall Study|Adverse Event|2
7498907|NCT03358290|26012668|P3|Overall Study|Adverse Event|1
7498908|NCT03358290|26012669|P2|Overall Study|Adverse Event|0
7498909|NCT03358290|26012670|P1|Overall Study|Adverse Event|0
7498910|NCT03358290|26012666|P5|Overall Study|Study discontinued by Sponsor|0
7498911|NCT03358290|26012667|P4|Overall Study|Study discontinued by Sponsor|0
7498912|NCT03358290|26012668|P3|Overall Study|Study discontinued by Sponsor|1
7498913|NCT03358290|26012669|P2|Overall Study|Study discontinued by Sponsor|1
7498914|NCT03358290|26012670|P1|Overall Study|Study discontinued by Sponsor|0
7498915|NCT03358238|26012771|P2|Overall Study|Withdrawal by Subject|1
7498916|NCT03358238|26012772|P1|Overall Study|Withdrawal by Subject|0
7498917|NCT03358147|26012792|P5|Overall Study|Lack of Efficacy|0
7498918|NCT03358147|26012793|P4|Overall Study|Lack of Efficacy|0
7498919|NCT03358147|26012794|P3|Overall Study|Lack of Efficacy|1
7498920|NCT03358147|26012795|P2|Overall Study|Lack of Efficacy|1
7498921|NCT03358147|26012796|P1|Overall Study|Lack of Efficacy|0
7498922|NCT03358147|26012792|P5|Overall Study|Administrative reasons|0
7498923|NCT03358147|26012793|P4|Overall Study|Administrative reasons|3
7498924|NCT03358147|26012794|P3|Overall Study|Administrative reasons|0
7498925|NCT03358147|26012795|P2|Overall Study|Administrative reasons|1
7498926|NCT03358147|26012796|P1|Overall Study|Administrative reasons|0
7498927|NCT03358147|26012792|P5|Overall Study|Physician Decision|1
7498928|NCT03358147|26012793|P4|Overall Study|Physician Decision|6
7498929|NCT03358147|26012794|P3|Overall Study|Physician Decision|1
7498930|NCT03358147|26012795|P2|Overall Study|Physician Decision|0
7498931|NCT03358147|26012796|P1|Overall Study|Physician Decision|1
7498932|NCT03358147|26012792|P5|Overall Study|Protocol specified criteria|1
7498933|NCT03358147|26012793|P4|Overall Study|Protocol specified criteria|3
7498934|NCT03358147|26012794|P3|Overall Study|Protocol specified criteria|0
7498935|NCT03358147|26012795|P2|Overall Study|Protocol specified criteria|3
7498936|NCT03358147|26012796|P1|Overall Study|Protocol specified criteria|2
7498937|NCT03358147|26012792|P5|Overall Study|Major Protocol Deviation|1
7498938|NCT03358147|26012793|P4|Overall Study|Major Protocol Deviation|3
7498939|NCT03358147|26012794|P3|Overall Study|Major Protocol Deviation|2
7498940|NCT03358147|26012795|P2|Overall Study|Major Protocol Deviation|3
7498941|NCT03358147|26012796|P1|Overall Study|Major Protocol Deviation|11
7498942|NCT03358147|26012792|P5|Overall Study|Lost to Follow-up|4
7498943|NCT03358147|26012793|P4|Overall Study|Lost to Follow-up|6
7498944|NCT03358147|26012794|P3|Overall Study|Lost to Follow-up|7
7498945|NCT03358147|26012795|P2|Overall Study|Lost to Follow-up|3
7498946|NCT03358147|26012796|P1|Overall Study|Lost to Follow-up|4
7498947|NCT03358147|26012792|P5|Overall Study|Adverse Event|2
7498948|NCT03358147|26012793|P4|Overall Study|Adverse Event|5
7498949|NCT03358147|26012794|P3|Overall Study|Adverse Event|7
7498950|NCT03358147|26012795|P2|Overall Study|Adverse Event|9
7498951|NCT03358147|26012796|P1|Overall Study|Adverse Event|3
7498952|NCT03358147|26012792|P5|Overall Study|Withdrawal by Subject|5
7498953|NCT03358147|26012793|P4|Overall Study|Withdrawal by Subject|10
7498954|NCT03358147|26012794|P3|Overall Study|Withdrawal by Subject|16
7498955|NCT03358147|26012795|P2|Overall Study|Withdrawal by Subject|19
7498956|NCT03358147|26012796|P1|Overall Study|Withdrawal by Subject|13
7498957|NCT03357952|26012835|P2|Overall Study|Sponsor Decision|0
7498958|NCT03357952|26012836|P1|Overall Study|Sponsor Decision|9
7498959|NCT03357952|26012835|P2|Overall Study|Withdrawal by Subject|1
7498960|NCT03357952|26012836|P1|Overall Study|Withdrawal by Subject|0
7498961|NCT03357731|26012843|P6|Overall Study|Lost to Follow-up|0
7498962|NCT03357731|26012844|P5|Overall Study|Lost to Follow-up|0
7498963|NCT03357731|26012845|P4|Overall Study|Lost to Follow-up|1
7498964|NCT03357731|26012846|P3|Overall Study|Lost to Follow-up|0
7498965|NCT03357731|26012847|P2|Overall Study|Lost to Follow-up|0
7498966|NCT03357731|26012848|P1|Overall Study|Lost to Follow-up|0
7498967|NCT03357731|26012843|P6|Overall Study|Hypotension|0
7498968|NCT03357731|26012844|P5|Overall Study|Hypotension|0
7498969|NCT03357731|26012845|P4|Overall Study|Hypotension|1
7498970|NCT03357731|26012846|P3|Overall Study|Hypotension|1
7498971|NCT03357731|26012847|P2|Overall Study|Hypotension|0
7498972|NCT03357731|26012848|P1|Overall Study|Hypotension|0
7498973|NCT03357731|26012843|P6|Overall Study|Adverse Event|1
7498974|NCT03357731|26012844|P5|Overall Study|Adverse Event|0
7498975|NCT03357731|26012845|P4|Overall Study|Adverse Event|0
7498976|NCT03357731|26012846|P3|Overall Study|Adverse Event|0
7498977|NCT03357731|26012847|P2|Overall Study|Adverse Event|0
7498978|NCT03357731|26012848|P1|Overall Study|Adverse Event|0
7498979|NCT03357731|26012843|P6|Overall Study|Acute bradycardia and hypotension|0
7498980|NCT03357731|26012844|P5|Overall Study|Acute bradycardia and hypotension|0
7498981|NCT03357731|26012845|P4|Overall Study|Acute bradycardia and hypotension|1
7498982|NCT03357731|26012846|P3|Overall Study|Acute bradycardia and hypotension|0
7498983|NCT03357731|26012847|P2|Overall Study|Acute bradycardia and hypotension|0
7498984|NCT03357731|26012848|P1|Overall Study|Acute bradycardia and hypotension|0
7498985|NCT03357731|26012843|P6|Overall Study|Withdrew consent due to personal reasons|0
7498986|NCT03357731|26012844|P5|Overall Study|Withdrew consent due to personal reasons|1
7498987|NCT03357731|26012845|P4|Overall Study|Withdrew consent due to personal reasons|0
7498988|NCT03357731|26012846|P3|Overall Study|Withdrew consent due to personal reasons|0
7498989|NCT03357731|26012847|P2|Overall Study|Withdrew consent due to personal reasons|0
7498990|NCT03357731|26012848|P1|Overall Study|Withdrew consent due to personal reasons|0
7498991|NCT03357471|26012887|P2|Overall Study|Lost to Follow-up|0
7498992|NCT03357471|26012888|P1|Overall Study|Lost to Follow-up|1
7498993|NCT03357471|26012887|P2|Overall Study|Adverse Event|0
7498994|NCT03357471|26012888|P1|Overall Study|Adverse Event|1
7498995|NCT03357341|26012945|P2|Overall Study|Death|1
7498996|NCT03357341|26012946|P1|Overall Study|Death|0
7498997|NCT03357341|26012945|P2|Overall Study|Lost to Follow-up|5
7498998|NCT03357341|26012946|P1|Overall Study|Lost to Follow-up|4
7498999|NCT03357341|26012945|P2|Overall Study|Withdrawal by Subject|6
7499000|NCT03357341|26012946|P1|Overall Study|Withdrawal by Subject|3
7499001|NCT03356977|26012986|P1|Overall Study|Withdrawal by parent/guardian|2
7499002|NCT03356977|26012986|P1|Overall Study|Lost to Follow-up|3
7499003|NCT03355742|26013009|P1|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
7499004|NCT03355742|26013009|P1|Overall Study|Death|55
7499005|NCT03355742|26013009|P1|Overall Study|Physician Decision|6
7499006|NCT03355742|26013009|P1|Overall Study|Withdrawal by Subject|29
7499007|NCT03355742|26013009|P1|Overall Study|Lost to Follow-up|4
7499008|NCT03355326|26013050|P2|Overall Study|Protocol Violation|3
7499009|NCT03355326|26013051|P1|Overall Study|Protocol Violation|3
7499010|NCT03354663|26013094|P1|Completed 30-day Visit|Missed Visit|1
7499011|NCT03354663|26013094|P1|Completed 30-day Visit|Withdrawal by Subject|1
7499012|NCT03354663|26013094|P1|Enrollment to Catheter Insertion|Adverse Event|1
7499013|NCT03354663|26013094|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
7499014|NCT03354637|26013121|P3|Open Label Extension|Physician Decision|1
7499015|NCT03354637|26013122|P2|Open Label Extension|Physician Decision|0
7499016|NCT03354637|26013123|P1|Open Label Extension|Physician Decision|0
7499017|NCT03354637|26013121|P3|Open Label Extension|Lack of Efficacy|1
7499018|NCT03354637|26013122|P2|Open Label Extension|Lack of Efficacy|0
7499019|NCT03354637|26013123|P1|Open Label Extension|Lack of Efficacy|0
7499020|NCT03354637|26013121|P3|Open Label Extension|Subject Noncompliance|1
7499021|NCT03354637|26013122|P2|Open Label Extension|Subject Noncompliance|0
7499022|NCT03354637|26013123|P1|Open Label Extension|Subject Noncompliance|0
7499023|NCT03354637|26013121|P3|Open Label Extension|Study Terminated by Sponsor|17
7499024|NCT03354637|26013122|P2|Open Label Extension|Study Terminated by Sponsor|0
7499025|NCT03354637|26013123|P1|Open Label Extension|Study Terminated by Sponsor|0
7499026|NCT03354637|26013121|P3|Open Label Extension|Withdrawal by Subject|5
7499027|NCT03354637|26013122|P2|Open Label Extension|Withdrawal by Subject|0
7499028|NCT03354637|26013123|P1|Open Label Extension|Withdrawal by Subject|0
7499029|NCT03354637|26013121|P3|Open Label Extension|Lost to Follow-up|2
7499030|NCT03354637|26013122|P2|Open Label Extension|Lost to Follow-up|0
7499031|NCT03354637|26013123|P1|Open Label Extension|Lost to Follow-up|0
7499032|NCT03354637|26013121|P3|Open Label Extension|Adverse Event|1
7499033|NCT03354637|26013122|P2|Open Label Extension|Adverse Event|0
7499034|NCT03354637|26013123|P1|Open Label Extension|Adverse Event|0
7499035|NCT03354637|26013121|P3|Double-blind Period|Incomplete Efficacy Data Collection|0
7499036|NCT03354637|26013122|P2|Double-blind Period|Incomplete Efficacy Data Collection|1
7499037|NCT03354637|26013123|P1|Double-blind Period|Incomplete Efficacy Data Collection|1
7499038|NCT03354637|26013121|P3|Double-blind Period|Withdrawal by Subject|4
7499039|NCT03354637|26013122|P2|Double-blind Period|Withdrawal by Subject|6
7499040|NCT03354637|26013123|P1|Double-blind Period|Withdrawal by Subject|10
7499041|NCT03354637|26013121|P3|Double-blind Period|Lost to Follow-up|3
7499042|NCT03354637|26013122|P2|Double-blind Period|Lost to Follow-up|4
7499043|NCT03354637|26013123|P1|Double-blind Period|Lost to Follow-up|3
7499044|NCT03354637|26013121|P3|Double-blind Period|Adverse Event|0
7499045|NCT03354637|26013122|P2|Double-blind Period|Adverse Event|2
7499046|NCT03354637|26013123|P1|Double-blind Period|Adverse Event|1
7499047|NCT03354637|26013121|P3|Double-blind Period|Protocol Violation|0
7499048|NCT03354637|26013122|P2|Double-blind Period|Protocol Violation|0
7499049|NCT03354637|26013123|P1|Double-blind Period|Protocol Violation|2
7499050|NCT03354429|26013197|P2|Overall Study|Lost to Follow-up|0
7499051|NCT03354429|26013198|P1|Overall Study|Lost to Follow-up|1
7499052|NCT03354429|26013197|P2|Overall Study|Withdrawal by Subject|7
7499053|NCT03354429|26013198|P1|Overall Study|Withdrawal by Subject|8
7499054|NCT03353922|26013249|P6|Overall Study|Adverse Event|0
7499055|NCT03353922|26013250|P5|Overall Study|Adverse Event|0
7499056|NCT03353922|26013251|P4|Overall Study|Adverse Event|0
7499057|NCT03353922|26013252|P3|Overall Study|Adverse Event|0
7499058|NCT03353922|26013253|P2|Overall Study|Adverse Event|1
7499059|NCT03353922|26013254|P1|Overall Study|Adverse Event|0
7499060|NCT03353922|26013249|P6|Overall Study|Withdrawal by Subject|0
7499061|NCT03353922|26013250|P5|Overall Study|Withdrawal by Subject|0
7499062|NCT03353922|26013251|P4|Overall Study|Withdrawal by Subject|1
7499063|NCT03353922|26013252|P3|Overall Study|Withdrawal by Subject|1
7499064|NCT03353922|26013253|P2|Overall Study|Withdrawal by Subject|0
7499065|NCT03353922|26013254|P1|Overall Study|Withdrawal by Subject|1
7499066|NCT03353220|26013309|P2|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
7499067|NCT03353220|26013310|P1|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
7499068|NCT03352713|26013336|P1|Overall Study|Device incompatible/stolen|5
7499069|NCT03352713|26013336|P1|Overall Study|Completed 0 EMAs|8
7499070|NCT03352713|26013336|P1|Overall Study|Withdrawn by investigator|5
7499071|NCT03352713|26013336|P1|Overall Study|Lost to Follow-up|8
7499072|NCT03352453|26013357|P2|Overall Study|Adverse Event|9
7499073|NCT03352453|26013358|P1|Overall Study|Adverse Event|2
7499074|NCT03352453|26013357|P2|Overall Study|Lost to Follow-up|6
7499075|NCT03352453|26013358|P1|Overall Study|Lost to Follow-up|7
7499076|NCT03352453|26013357|P2|Overall Study|Protocol Deviation|0
7499077|NCT03352453|26013358|P1|Overall Study|Protocol Deviation|1
7499078|NCT03352453|26013357|P2|Overall Study|Study Terminated by Sponsor|1
7499079|NCT03352453|26013358|P1|Overall Study|Study Terminated by Sponsor|2
7499080|NCT03352453|26013357|P2|Overall Study|Withdrawal by Subject|14
7499081|NCT03352453|26013358|P1|Overall Study|Withdrawal by Subject|8
7499082|NCT03352453|26013357|P2|Overall Study|Lack of Efficacy|0
7499083|NCT03352453|26013358|P1|Overall Study|Lack of Efficacy|1
7499084|NCT03352453|26013357|P2|Overall Study|Miscellaneous Reasons|2
7499085|NCT03352453|26013358|P1|Overall Study|Miscellaneous Reasons|1
7499086|NCT03352414|26013372|P2|Overall Study|Ineligible by operative criteria|10
7499087|NCT03352414|26013373|P1|Overall Study|Ineligible by operative criteria|12
7499088|NCT03351738|26013462|P6|Overall Study|Withdrawal by Subject|0
7499089|NCT03351738|26013463|P5|Overall Study|Withdrawal by Subject|0
7499090|NCT03351738|26013464|P4|Overall Study|Withdrawal by Subject|1
7499091|NCT03351738|26013465|P3|Overall Study|Withdrawal by Subject|0
7499092|NCT03351738|26013466|P2|Overall Study|Withdrawal by Subject|1
7499093|NCT03351738|26013467|P1|Overall Study|Withdrawal by Subject|0
7499094|NCT03351608|26013621|P5|Overall Study|Other|0
7499095|NCT03351608|26013622|P4|Overall Study|Other|3
7499096|NCT03351608|26013623|P3|Overall Study|Other|1
7499097|NCT03351608|26013624|P2|Overall Study|Other|1
7499098|NCT03351608|26013625|P1|Overall Study|Other|0
7499099|NCT03351608|26013621|P5|Overall Study|Withdrawal by parent/guardian|0
7499100|NCT03351608|26013622|P4|Overall Study|Withdrawal by parent/guardian|1
7499101|NCT03351608|26013623|P3|Overall Study|Withdrawal by parent/guardian|1
7499102|NCT03351608|26013624|P2|Overall Study|Withdrawal by parent/guardian|0
7499103|NCT03351608|26013625|P1|Overall Study|Withdrawal by parent/guardian|0
7499104|NCT03351608|26013621|P5|Overall Study|Randomized by mistake, no treatment given|0
7499105|NCT03351608|26013622|P4|Overall Study|Randomized by mistake, no treatment given|1
7499106|NCT03351608|26013623|P3|Overall Study|Randomized by mistake, no treatment given|0
7499107|NCT03351608|26013624|P2|Overall Study|Randomized by mistake, no treatment given|0
7499108|NCT03351608|26013625|P1|Overall Study|Randomized by mistake, no treatment given|0
7499109|NCT03351608|26013621|P5|Overall Study|Physician Decision|1
7499110|NCT03351608|26013622|P4|Overall Study|Physician Decision|2
7499111|NCT03351608|26013623|P3|Overall Study|Physician Decision|0
7499112|NCT03351608|26013624|P2|Overall Study|Physician Decision|0
7499113|NCT03351608|26013625|P1|Overall Study|Physician Decision|1
7499114|NCT03351608|26013621|P5|Overall Study|Lost to Follow-up|1
7499115|NCT03351608|26013622|P4|Overall Study|Lost to Follow-up|1
7499116|NCT03351608|26013623|P3|Overall Study|Lost to Follow-up|1
7499117|NCT03351608|26013624|P2|Overall Study|Lost to Follow-up|1
7499118|NCT03351608|26013625|P1|Overall Study|Lost to Follow-up|0
7499119|NCT03351478|26013681|P3|Overall Study|Lost to Follow-up|1
7499120|NCT03351478|26013682|P2|Overall Study|Lost to Follow-up|0
7499121|NCT03351478|26013683|P1|Overall Study|Lost to Follow-up|0
7499122|NCT03351478|26013681|P3|Overall Study|Reason not Specified|0
7499123|NCT03351478|26013682|P2|Overall Study|Reason not Specified|3
7499124|NCT03351478|26013683|P1|Overall Study|Reason not Specified|1
7499125|NCT03351478|26013681|P3|Overall Study|Poor compliance to protocol|0
7499126|NCT03351478|26013682|P2|Overall Study|Poor compliance to protocol|0
7499127|NCT03351478|26013683|P1|Overall Study|Poor compliance to protocol|1
7499128|NCT03351478|26013681|P3|Overall Study|Adverse Event|1
7499129|NCT03351478|26013682|P2|Overall Study|Adverse Event|2
7499130|NCT03351478|26013683|P1|Overall Study|Adverse Event|1
7499131|NCT03351478|26013681|P3|Overall Study|At the subject's own request|5
7499132|NCT03351478|26013682|P2|Overall Study|At the subject's own request|12
7499133|NCT03351478|26013683|P1|Overall Study|At the subject's own request|11
7499134|NCT03351335|26013715|P3|Overall Study|Failure to maintain inclusion/exclusion|4
7499135|NCT03351335|26013716|P2|Overall Study|Failure to maintain inclusion/exclusion|0
7499136|NCT03351335|26013717|P1|Overall Study|Failure to maintain inclusion/exclusion|0
7499137|NCT03351231|26013737|P1|Safety Follow-Up Period|Other reason|2
7499138|NCT03351231|26013737|P1|Safety Follow-Up Period|Participant withdrew consent|1
7499139|NCT03351231|26013737|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
7499140|NCT03351231|26013737|P1|Combination Therapy Period|Study drug toxicity|1
7499141|NCT03351231|26013737|P1|Combination Therapy Period|Disease progression|2
7499142|NCT03351231|26013737|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
7499143|NCT03351114|26013759|P1|Overall Study|Withdrawal by Subject|1
7499144|NCT03350984|26013780|P2|Overall Study|Physician Decision|0
7499145|NCT03350984|26013781|P1|Overall Study|Physician Decision|1
7499146|NCT03350984|26013780|P2|Overall Study|Protocol Violation|2
7499147|NCT03350984|26013781|P1|Overall Study|Protocol Violation|1
7499148|NCT03350984|26013780|P2|Overall Study|Lost to Follow-up|6
7499149|NCT03350984|26013781|P1|Overall Study|Lost to Follow-up|5
7499150|NCT03350984|26013780|P2|Overall Study|Death|0
7499151|NCT03350984|26013781|P1|Overall Study|Death|1
7499152|NCT03350672|26013862|P3|Overall Study|Withdrawal by Subject|0
7499153|NCT03350672|26013863|P2|Overall Study|Withdrawal by Subject|0
7499154|NCT03350672|26013864|P1|Overall Study|Withdrawal by Subject|7
7499155|NCT03350503|26013889|P1|Overall Study|Subject Wishes|2
7499156|NCT03350503|26013889|P1|Overall Study|Hospital Transfer or Removal|2
7499157|NCT03350503|26013889|P1|Overall Study|Adverse Event|1
7499158|NCT03350256|26013893|P1|Overall Study|Lack of Efficacy|2
7499159|NCT03350256|26013893|P1|Overall Study|Lost to Follow-up|1
7499160|NCT03350256|26013893|P1|Overall Study|Subject moving out of state|1
7499161|NCT03350256|26013893|P1|Overall Study|Withdrawal by Subject|3
7499162|NCT03350256|26013893|P1|Overall Study|Did not proceed to permanent implant|3
7499163|NCT03350256|26013893|P1|Overall Study|Trial failure|12
7499164|NCT03350256|26013893|P1|Overall Study|Adverse Event|2
7499165|NCT03350256|26013893|P1|Overall Study|Denial by insurance|1
7499166|NCT03350256|26013893|P1|Overall Study|Non compliance|2
7499167|NCT03350256|26013893|P1|Overall Study|Protocol Violation|3
7499168|NCT03350256|26013893|P1|Overall Study|Recommended for other therapies|2
7499169|NCT03350256|26013893|P1|Overall Study|Inclusion/exclusion violation|4
7499170|NCT03349710|26013950|P4|Treatment Period|participant withdrew consent|0
7499171|NCT03349710|26013951|P3|Treatment Period|participant withdrew consent|0
7499172|NCT03349710|26013952|P2|Treatment Period|participant withdrew consent|0
7499173|NCT03349710|26013953|P1|Treatment Period|participant withdrew consent|1
7499174|NCT03349710|26013950|P4|Treatment Period|participant request to discontinue|0
7499175|NCT03349710|26013951|P3|Treatment Period|participant request to discontinue|4
7499176|NCT03349710|26013952|P2|Treatment Period|participant request to discontinue|0
7499177|NCT03349710|26013953|P1|Treatment Period|participant request to discontinue|0
7499178|NCT03349710|26013950|P4|Treatment Period|completed|1
7499179|NCT03349710|26013951|P3|Treatment Period|completed|18
7499180|NCT03349710|26013952|P2|Treatment Period|completed|0
7499181|NCT03349710|26013953|P1|Treatment Period|completed|6
7499182|NCT03349710|26013950|P4|Treatment Period|Other Reason|1
7499183|NCT03349710|26013951|P3|Treatment Period|Other Reason|2
7499184|NCT03349710|26013952|P2|Treatment Period|Other Reason|0
7499185|NCT03349710|26013953|P1|Treatment Period|Other Reason|2
7499186|NCT03349710|26013950|P4|Treatment Period|admin reason by sponsor|19
7499187|NCT03349710|26013951|P3|Treatment Period|admin reason by sponsor|0
7499188|NCT03349710|26013952|P2|Treatment Period|admin reason by sponsor|7
7499189|NCT03349710|26013953|P1|Treatment Period|admin reason by sponsor|0
7499190|NCT03349710|26013950|P4|Treatment Period|Adverse event unrelated to Study Drug|1
7499191|NCT03349710|26013951|P3|Treatment Period|Adverse event unrelated to Study Drug|1
7499192|NCT03349710|26013952|P2|Treatment Period|Adverse event unrelated to Study Drug|1
7499193|NCT03349710|26013953|P1|Treatment Period|Adverse event unrelated to Study Drug|2
7499194|NCT03349710|26013950|P4|Treatment Period|Study Drug Toxicity|1
7499195|NCT03349710|26013951|P3|Treatment Period|Study Drug Toxicity|1
7499196|NCT03349710|26013952|P2|Treatment Period|Study Drug Toxicity|0
7499197|NCT03349710|26013953|P1|Treatment Period|Study Drug Toxicity|1
7499198|NCT03349710|26013950|P4|Treatment Period|Disease Progression|1
7499199|NCT03349710|26013951|P3|Treatment Period|Disease Progression|0
7499200|NCT03349710|26013952|P2|Treatment Period|Disease Progression|2
7499201|NCT03349710|26013953|P1|Treatment Period|Disease Progression|0
7499202|NCT03349710|26013950|P4|Treatment Period|Death|0
7499203|NCT03349710|26013951|P3|Treatment Period|Death|1
7499204|NCT03349710|26013952|P2|Treatment Period|Death|0
7499205|NCT03349710|26013953|P1|Treatment Period|Death|0
7499206|NCT03349515|26014045|P2|Overall Study|Physician Decision|1
7499207|NCT03349515|26014046|P1|Overall Study|Physician Decision|3
7499208|NCT03349515|26014045|P2|Overall Study|Lack of Efficacy|0
7499209|NCT03349515|26014046|P1|Overall Study|Lack of Efficacy|2
7499210|NCT03349437|26014052|P3|Screening|Withdrawn|0
7499211|NCT03349437|26014053|P2|Screening|Withdrawn|0
7499212|NCT03349437|26014054|P1|Screening|Withdrawn|1
7499213|NCT03349437|26014052|P3|Screening|Screen Fail|0
7499214|NCT03349437|26014053|P2|Screening|Screen Fail|0
7499215|NCT03349437|26014054|P1|Screening|Screen Fail|4
7499216|NCT03349333|26014061|P1|Overall Study|Patients in treatment less than 24 month|8
7499217|NCT03349333|26014061|P1|Overall Study|3-week lapse between pralatrexate doses|1
7499218|NCT03349333|26014061|P1|Overall Study|Physician Decision|2
7499219|NCT03349333|26014061|P1|Overall Study|Conditions interfere with participation|2
7499220|NCT03349333|26014061|P1|Overall Study|Withdrawal by Subject|5
7499221|NCT03349333|26014061|P1|Overall Study|Other|6
7499222|NCT03349333|26014061|P1|Overall Study|Adverse Event|11
7499223|NCT03349333|26014061|P1|Overall Study|Progression of Disease|36
7499224|NCT03349099|26014084|P2|Overall Study|Stone migrated from the kidney|0
7499225|NCT03349099|26014085|P1|Overall Study|Stone migrated from the kidney|1
7499226|NCT03349099|26014084|P2|Overall Study|Physician Decision|4
7499227|NCT03349099|26014085|P1|Overall Study|Physician Decision|3
7499228|NCT03349060|26014098|P3|Overall Study|Other|0
7499229|NCT03349060|26014099|P2|Overall Study|Other|1
7499230|NCT03349060|26014100|P1|Overall Study|Other|2
7499231|NCT03349060|26014098|P3|Overall Study|Withdrawal By Parent/Guardian|0
7499232|NCT03349060|26014099|P2|Overall Study|Withdrawal By Parent/Guardian|1
7499233|NCT03349060|26014100|P1|Overall Study|Withdrawal By Parent/Guardian|0
7499234|NCT03349060|26014098|P3|Overall Study|Medication error,no linked adverse event|1
7499235|NCT03349060|26014099|P2|Overall Study|Medication error,no linked adverse event|0
7499236|NCT03349060|26014100|P1|Overall Study|Medication error,no linked adverse event|0
7499237|NCT03349060|26014098|P3|Overall Study|Withdrawal by Subject|4
7499238|NCT03349060|26014099|P2|Overall Study|Withdrawal by Subject|3
7499239|NCT03349060|26014100|P1|Overall Study|Withdrawal by Subject|5
7499240|NCT03349060|26014098|P3|Overall Study|Protocol Violation|1
7499241|NCT03349060|26014099|P2|Overall Study|Protocol Violation|2
7499242|NCT03349060|26014100|P1|Overall Study|Protocol Violation|2
7499243|NCT03349060|26014098|P3|Overall Study|Lost to Follow-up|1
7499244|NCT03349060|26014099|P2|Overall Study|Lost to Follow-up|1
7499245|NCT03349060|26014100|P1|Overall Study|Lost to Follow-up|2
7499246|NCT03349060|26014098|P3|Overall Study|Lack of Efficacy|2
7499247|NCT03349060|26014099|P2|Overall Study|Lack of Efficacy|0
7499248|NCT03349060|26014100|P1|Overall Study|Lack of Efficacy|1
7499249|NCT03349060|26014098|P3|Overall Study|Adverse Event|7
7499250|NCT03349060|26014099|P2|Overall Study|Adverse Event|9
7499251|NCT03349060|26014100|P1|Overall Study|Adverse Event|9
7499252|NCT03349034|26014241|P2|Overall Study|Other|1
7499253|NCT03349034|26014242|P1|Overall Study|Other|0
7499254|NCT03349034|26014241|P2|Overall Study|soft tissue flap used|0
7499255|NCT03349034|26014242|P1|Overall Study|soft tissue flap used|1
7499256|NCT03349034|26014241|P2|Overall Study|intubated for >48 hrs following surgery|1
7499257|NCT03349034|26014242|P1|Overall Study|intubated for >48 hrs following surgery|1
7499258|NCT03349034|26014241|P2|Overall Study|catheters dislodged during transport|0
7499259|NCT03349034|26014242|P1|Overall Study|catheters dislodged during transport|2
7499260|NCT03348904|26014263|P3|Overall Study|Administrative reason by the sponsor|0
7499261|NCT03348904|26014264|P2|Overall Study|Administrative reason by the sponsor|1
7499262|NCT03348904|26014265|P1|Overall Study|Administrative reason by the sponsor|0
7499263|NCT03347188|26014309|P2|Open-label (OL) Period (12 Weeks)|Other than specified|1
7499264|NCT03347188|26014310|P1|Open-label (OL) Period (12 Weeks)|Other than specified|0
7499265|NCT03347188|26014309|P2|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
7499266|NCT03347188|26014310|P1|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
7499267|NCT03347188|26014309|P2|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
7499268|NCT03347188|26014310|P1|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
7499269|NCT03347188|26014309|P2|Double-blind (DB) Period (12 Weeks)|Other than specified|2
7499270|NCT03347188|26014310|P1|Double-blind (DB) Period (12 Weeks)|Other than specified|1
7499271|NCT03347188|26014309|P2|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7499272|NCT03347188|26014310|P1|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7499273|NCT03347188|26014309|P2|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
7499274|NCT03347188|26014310|P1|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
7499275|NCT03347188|26014309|P2|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
7499276|NCT03347188|26014310|P1|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
7499277|NCT03347188|26014309|P2|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7499278|NCT03347188|26014310|P1|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7499279|NCT03346759|26014378|P2|Second Menstrual Cycle|Lost to Follow-up|0
7499280|NCT03346759|26014379|P1|Second Menstrual Cycle|Lost to Follow-up|1
7499281|NCT03346759|26014378|P2|First Menstrual Cycle|Withdrawal by Subject|0
7499282|NCT03346759|26014379|P1|First Menstrual Cycle|Withdrawal by Subject|1
7499283|NCT03346759|26014378|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
7499284|NCT03346759|26014379|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
7499285|NCT03346070|26014424|P5|Overall Study|Screen Failure|1
7499286|NCT03346070|26014425|P4|Overall Study|Screen Failure|1
7499287|NCT03346070|26014426|P3|Overall Study|Screen Failure|0
7499288|NCT03346070|26014427|P2|Overall Study|Screen Failure|0
7499289|NCT03346070|26014428|P1|Overall Study|Screen Failure|0
7499290|NCT03346070|26014424|P5|Overall Study|Study medication not received as planned|2
7499291|NCT03346070|26014425|P4|Overall Study|Study medication not received as planned|3
7499292|NCT03346070|26014426|P3|Overall Study|Study medication not received as planned|2
7499293|NCT03346070|26014427|P2|Overall Study|Study medication not received as planned|3
7499294|NCT03346070|26014428|P1|Overall Study|Study medication not received as planned|2
7499295|NCT03346070|26014424|P5|Overall Study|Withdrawal by Subject|0
7499296|NCT03346070|26014425|P4|Overall Study|Withdrawal by Subject|1
7499297|NCT03346070|26014426|P3|Overall Study|Withdrawal by Subject|0
7499298|NCT03346070|26014427|P2|Overall Study|Withdrawal by Subject|0
7499299|NCT03346070|26014428|P1|Overall Study|Withdrawal by Subject|1
7499300|NCT03346070|26014424|P5|Overall Study|Physician Decision|1
7499301|NCT03346070|26014425|P4|Overall Study|Physician Decision|1
7499302|NCT03346070|26014426|P3|Overall Study|Physician Decision|0
7499303|NCT03346070|26014427|P2|Overall Study|Physician Decision|0
7499304|NCT03346070|26014428|P1|Overall Study|Physician Decision|0
7499305|NCT03346070|26014424|P5|Overall Study|Lost to Follow-up|0
7499306|NCT03346070|26014425|P4|Overall Study|Lost to Follow-up|0
7499307|NCT03346070|26014426|P3|Overall Study|Lost to Follow-up|2
7499308|NCT03346070|26014427|P2|Overall Study|Lost to Follow-up|1
7499309|NCT03346070|26014428|P1|Overall Study|Lost to Follow-up|0
7499310|NCT03346070|26014424|P5|Overall Study|Death|1
7499311|NCT03346070|26014425|P4|Overall Study|Death|0
7499312|NCT03346070|26014426|P3|Overall Study|Death|0
7499313|NCT03346070|26014427|P2|Overall Study|Death|0
7499314|NCT03346070|26014428|P1|Overall Study|Death|0
7499315|NCT03346057|26014516|P4|Overall Study|Withdrawal by Subject|0
7499316|NCT03346057|26014517|P3|Overall Study|Withdrawal by Subject|0
7499317|NCT03346057|26014518|P2|Overall Study|Withdrawal by Subject|0
7499318|NCT03346057|26014519|P1|Overall Study|Withdrawal by Subject|1
7499319|NCT03346057|26014516|P4|Overall Study|Randomization Mistake - Not Treated|0
7499320|NCT03346057|26014517|P3|Overall Study|Randomization Mistake - Not Treated|0
7499321|NCT03346057|26014518|P2|Overall Study|Randomization Mistake - Not Treated|1
7499322|NCT03346057|26014519|P1|Overall Study|Randomization Mistake - Not Treated|1
7499323|NCT03346057|26014516|P4|Overall Study|Physician Decision|2
7499324|NCT03346057|26014517|P3|Overall Study|Physician Decision|0
7499325|NCT03346057|26014518|P2|Overall Study|Physician Decision|2
7499326|NCT03346057|26014519|P1|Overall Study|Physician Decision|3
7499327|NCT03346057|26014516|P4|Overall Study|Renal Insufficiency - Not Treated|0
7499328|NCT03346057|26014517|P3|Overall Study|Renal Insufficiency - Not Treated|0
7499329|NCT03346057|26014518|P2|Overall Study|Renal Insufficiency - Not Treated|0
7499330|NCT03346057|26014519|P1|Overall Study|Renal Insufficiency - Not Treated|1
7499331|NCT03346057|26014516|P4|Overall Study|Ineligible For Study - Not Treated|0
7499332|NCT03346057|26014517|P3|Overall Study|Ineligible For Study - Not Treated|0
7499333|NCT03346057|26014518|P2|Overall Study|Ineligible For Study - Not Treated|1
7499334|NCT03346057|26014519|P1|Overall Study|Ineligible For Study - Not Treated|0
7499335|NCT03346057|26014516|P4|Overall Study|Lost to Follow-up|0
7499336|NCT03346057|26014517|P3|Overall Study|Lost to Follow-up|1
7499337|NCT03346057|26014518|P2|Overall Study|Lost to Follow-up|2
7499338|NCT03346057|26014519|P1|Overall Study|Lost to Follow-up|0
7499339|NCT03346057|26014516|P4|Overall Study|Death|0
7499340|NCT03346057|26014517|P3|Overall Study|Death|0
7499341|NCT03346057|26014518|P2|Overall Study|Death|2
7499342|NCT03346057|26014519|P1|Overall Study|Death|1
7499343|NCT03345979|26014551|P2|Overall Study|Physician Decision|2
7499344|NCT03345979|26014552|P1|Overall Study|Physician Decision|0
7499345|NCT03345979|26014551|P2|Overall Study|Protocol Violation|3
7499346|NCT03345979|26014552|P1|Overall Study|Protocol Violation|1
7499347|NCT03345979|26014551|P2|Overall Study|Lack of Efficacy|2
7499348|NCT03345979|26014552|P1|Overall Study|Lack of Efficacy|4
7499349|NCT03345979|26014551|P2|Overall Study|Lost to Follow-up|9
7499350|NCT03345979|26014552|P1|Overall Study|Lost to Follow-up|8
7499351|NCT03345979|26014551|P2|Overall Study|Adverse Event|11
7499352|NCT03345979|26014552|P1|Overall Study|Adverse Event|10
7499353|NCT03345979|26014551|P2|Overall Study|Withdrawal by Subject|31
7499354|NCT03345979|26014552|P1|Overall Study|Withdrawal by Subject|20
7499355|NCT03345914|26014573|P3|Overall Study|Ongoing|1
7499356|NCT03345914|26014574|P2|Overall Study|Ongoing|0
7499357|NCT03345914|26014575|P1|Overall Study|Ongoing|0
7499358|NCT03345914|26014573|P3|Overall Study|Other|1
7499359|NCT03345914|26014574|P2|Overall Study|Other|1
7499360|NCT03345914|26014575|P1|Overall Study|Other|1
7499361|NCT03345914|26014573|P3|Overall Study|Withdrawal by Subject|2
7499362|NCT03345914|26014574|P2|Overall Study|Withdrawal by Subject|1
7499363|NCT03345914|26014575|P1|Overall Study|Withdrawal by Subject|5
7499364|NCT03345914|26014573|P3|Overall Study|Physician Decision|1
7499365|NCT03345914|26014574|P2|Overall Study|Physician Decision|1
7499366|NCT03345914|26014575|P1|Overall Study|Physician Decision|0
7499367|NCT03345914|26014573|P3|Overall Study|Transition to OLE during follow-up|39
7499368|NCT03345914|26014574|P2|Overall Study|Transition to OLE during follow-up|33
7499369|NCT03345914|26014575|P1|Overall Study|Transition to OLE during follow-up|37
7499370|NCT03345914|26014573|P3|Overall Study|Transition to another study at week 16|78
7499371|NCT03345914|26014574|P2|Overall Study|Transition to another study at week 16|86
7499372|NCT03345914|26014575|P1|Overall Study|Transition to another study at week 16|80
7499373|NCT03345901|26014646|P1|Overall Study|The study was terminated|18
7499374|NCT03345472|26014651|P1|3 Months to 12 Months|Death|1
7499375|NCT03345472|26014651|P1|3 Months to 12 Months|Adverse Event|1
7499376|NCT03345472|26014651|P1|3 Months to 12 Months|Withdrawal by Subject|1
7499377|NCT03345472|26014651|P1|3 Months to 12 Months|Lost to Follow-up|2
7499378|NCT03345472|26014651|P1|3 Months to 12 Months|Physician Decision|3
7499379|NCT03345472|26014651|P1|Implant to 3 Months|Adverse Event|1
7499380|NCT03345472|26014651|P1|Implant to 3 Months|Physician Decision|1
7499381|NCT03345472|26014651|P1|Implant to 3 Months|Withdrawal by Subject|2
7499382|NCT03345407|26014665|P7|Overall Study|Adverse Event|16
7499383|NCT03345407|26014666|P6|Overall Study|Adverse Event|5
7499384|NCT03345407|26014667|P5|Overall Study|Adverse Event|6
7499385|NCT03345407|26014668|P4|Overall Study|Adverse Event|4
7499386|NCT03345407|26014669|P3|Overall Study|Adverse Event|5
7499387|NCT03345407|26014670|P2|Overall Study|Adverse Event|0
7499388|NCT03345407|26014671|P1|Overall Study|Adverse Event|4
7499389|NCT03345407|26014665|P7|Overall Study|Lack of Efficacy|3
7499390|NCT03345407|26014666|P6|Overall Study|Lack of Efficacy|0
7499391|NCT03345407|26014667|P5|Overall Study|Lack of Efficacy|1
7499392|NCT03345407|26014668|P4|Overall Study|Lack of Efficacy|1
7499393|NCT03345407|26014669|P3|Overall Study|Lack of Efficacy|1
7499394|NCT03345407|26014670|P2|Overall Study|Lack of Efficacy|1
7499395|NCT03345407|26014671|P1|Overall Study|Lack of Efficacy|1
7499396|NCT03345407|26014665|P7|Overall Study|Protocol Violation|3
7499397|NCT03345407|26014666|P6|Overall Study|Protocol Violation|0
7499398|NCT03345407|26014667|P5|Overall Study|Protocol Violation|1
7499399|NCT03345407|26014668|P4|Overall Study|Protocol Violation|0
7499400|NCT03345407|26014669|P3|Overall Study|Protocol Violation|0
7499401|NCT03345407|26014670|P2|Overall Study|Protocol Violation|0
7499402|NCT03345407|26014671|P1|Overall Study|Protocol Violation|2
7499403|NCT03345407|26014665|P7|Overall Study|Protocol-defined stopping criteria|1
7499404|NCT03345407|26014666|P6|Overall Study|Protocol-defined stopping criteria|1
7499405|NCT03345407|26014667|P5|Overall Study|Protocol-defined stopping criteria|2
7499406|NCT03345407|26014668|P4|Overall Study|Protocol-defined stopping criteria|0
7499407|NCT03345407|26014669|P3|Overall Study|Protocol-defined stopping criteria|0
7499408|NCT03345407|26014670|P2|Overall Study|Protocol-defined stopping criteria|0
7499409|NCT03345407|26014671|P1|Overall Study|Protocol-defined stopping criteria|9
7499410|NCT03345407|26014665|P7|Overall Study|Lost to Follow-up|3
7499411|NCT03345407|26014666|P6|Overall Study|Lost to Follow-up|2
7499412|NCT03345407|26014667|P5|Overall Study|Lost to Follow-up|1
7499413|NCT03345407|26014668|P4|Overall Study|Lost to Follow-up|0
7499414|NCT03345407|26014669|P3|Overall Study|Lost to Follow-up|1
7499415|NCT03345407|26014670|P2|Overall Study|Lost to Follow-up|0
7499416|NCT03345407|26014671|P1|Overall Study|Lost to Follow-up|2
7499417|NCT03345407|26014665|P7|Overall Study|Physician Decision|3
7499418|NCT03345407|26014666|P6|Overall Study|Physician Decision|2
7499419|NCT03345407|26014667|P5|Overall Study|Physician Decision|1
7499420|NCT03345407|26014668|P4|Overall Study|Physician Decision|0
7499421|NCT03345407|26014669|P3|Overall Study|Physician Decision|0
7499422|NCT03345407|26014670|P2|Overall Study|Physician Decision|1
7499423|NCT03345407|26014671|P1|Overall Study|Physician Decision|3
7499424|NCT03345407|26014665|P7|Overall Study|Withdrawal by Subject|16
7499425|NCT03345407|26014666|P6|Overall Study|Withdrawal by Subject|6
7499426|NCT03345407|26014667|P5|Overall Study|Withdrawal by Subject|3
7499427|NCT03345407|26014668|P4|Overall Study|Withdrawal by Subject|6
7499428|NCT03345407|26014669|P3|Overall Study|Withdrawal by Subject|5
7499429|NCT03345407|26014670|P2|Overall Study|Withdrawal by Subject|1
7499430|NCT03345407|26014671|P1|Overall Study|Withdrawal by Subject|11
7499431|NCT03344640|26014913|P2|Follow-up Epoch|Withdrawal by Subject|2
7499432|NCT03344640|26014914|P1|Follow-up Epoch|Withdrawal by Subject|0
7499433|NCT03344640|26014913|P2|Overall Study|Withdrawal by Subject|2
7499434|NCT03344640|26014914|P1|Overall Study|Withdrawal by Subject|1
7499435|NCT03344640|26014913|P2|Overall Study|Physician Decision|1
7499436|NCT03344640|26014914|P1|Overall Study|Physician Decision|1
7499437|NCT03344640|26014913|P2|Overall Study|Adverse Event|0
7499438|NCT03344640|26014914|P1|Overall Study|Adverse Event|1
7499439|NCT03344562|26014943|P2|Overall Study|Withdrawal by Subject|0
7499440|NCT03344562|26014944|P1|Overall Study|Withdrawal by Subject|2
7499441|NCT03344172|26014964|P2|Overall Study|Received <1 dose of treatment|0
7499442|NCT03344172|26014965|P1|Overall Study|Received <1 dose of treatment|1
7499443|NCT03343704|26014983|P2|Overall Study|Reluctant to collect blood and received telephone follow up|0
7499444|NCT03343704|26014984|P1|Overall Study|Reluctant to collect blood and received telephone follow up|1
7499445|NCT03343704|26014983|P2|Overall Study|Death|1
7499446|NCT03343704|26014984|P1|Overall Study|Death|0
7499447|NCT03343704|26014983|P2|Overall Study|Refused to complete follow up|1
7499448|NCT03343704|26014984|P1|Overall Study|Refused to complete follow up|0
7499449|NCT03343639|26015026|P2|Overall Study|Protocol Violation|1
7499450|NCT03343639|26015027|P1|Overall Study|Protocol Violation|0
7499451|NCT03343639|26015026|P2|Overall Study|Lost to Follow-up|5
7499452|NCT03343639|26015027|P1|Overall Study|Lost to Follow-up|4
7499453|NCT03343639|26015026|P2|Overall Study|Withdrawal by Subject|6
7499454|NCT03343639|26015027|P1|Overall Study|Withdrawal by Subject|10
7499455|NCT03343067|26015055|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
7499456|NCT03343067|26015056|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
7499457|NCT03343067|26015057|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
7499458|NCT03342963|26015186|P4|Overall Study|Withdrawal by Subject|0
7499459|NCT03342963|26015187|P3|Overall Study|Withdrawal by Subject|0
7499460|NCT03342963|26015188|P2|Overall Study|Withdrawal by Subject|0
7499461|NCT03342963|26015189|P1|Overall Study|Withdrawal by Subject|1
7499462|NCT03342963|26015186|P4|Overall Study|Adverse Event|0
7499463|NCT03342963|26015187|P3|Overall Study|Adverse Event|0
7499464|NCT03342963|26015188|P2|Overall Study|Adverse Event|2
7499465|NCT03342963|26015189|P1|Overall Study|Adverse Event|1
7499466|NCT03342898|26015206|P3|Overall Study|Reason not Specified|0
7499467|NCT03342898|26015207|P2|Overall Study|Reason not Specified|2
7499468|NCT03342898|26015208|P1|Overall Study|Reason not Specified|2
7499469|NCT03342898|26015206|P3|Overall Study|Death|1
7499470|NCT03342898|26015207|P2|Overall Study|Death|1
7499471|NCT03342898|26015208|P1|Overall Study|Death|0
7499472|NCT03342898|26015206|P3|Overall Study|Withdrawal of Consent|11
7499473|NCT03342898|26015207|P2|Overall Study|Withdrawal of Consent|9
7499474|NCT03342898|26015208|P1|Overall Study|Withdrawal of Consent|5
7499475|NCT03342898|26015206|P3|Overall Study|Lost to Follow-up|42
7499476|NCT03342898|26015207|P2|Overall Study|Lost to Follow-up|40
7499477|NCT03342898|26015208|P1|Overall Study|Lost to Follow-up|44
7499478|NCT03342898|26015206|P3|Overall Study|Adverse Event|0
7499479|NCT03342898|26015207|P2|Overall Study|Adverse Event|1
7499480|NCT03342898|26015208|P1|Overall Study|Adverse Event|3
7499481|NCT03342690|26015249|P1|Overall Study|Protocol Violation|16
7499482|NCT03342690|26015249|P1|Overall Study|Missing Information|9
7499483|NCT03342638|26015260|P2|Overall Study|Physician Decision|1
7499484|NCT03342638|26015261|P1|Overall Study|Physician Decision|0
7499485|NCT03342638|26015260|P2|Overall Study|Withdrawal by Subject|0
7499486|NCT03342638|26015261|P1|Overall Study|Withdrawal by Subject|1
7499487|NCT03342560|26015267|P1|Overall Study|Lost to Follow-up|2
7499488|NCT03342469|26015277|P4|Overall Study|Withdrawal by Subject|0
7499489|NCT03342469|26015278|P3|Overall Study|Withdrawal by Subject|0
7499490|NCT03342469|26015279|P2|Overall Study|Withdrawal by Subject|1
7499491|NCT03342469|26015280|P1|Overall Study|Withdrawal by Subject|0
7499492|NCT03342053|26015311|P2|Overall Study|Withdrawal by Subject|1
7499493|NCT03342053|26015312|P1|Overall Study|Withdrawal by Subject|0
7499494|NCT03342053|26015311|P2|Overall Study|Adverse Event|0
7499495|NCT03342053|26015312|P1|Overall Study|Adverse Event|2
7499496|NCT03342001|26015330|P1|Overall Study|Lost to Follow-up|1
7499497|NCT03342001|26015330|P1|Overall Study|Adverse Event|1
7499498|NCT03341923|26015343|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
7499499|NCT03341923|26015344|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
7499500|NCT03341637|26015388|P2|Overall Study|Reason not Specified|1
7499501|NCT03341637|26015389|P1|Overall Study|Reason not Specified|1
7499502|NCT03341637|26015388|P2|Overall Study|Withdrawal by Subject|3
7499503|NCT03341637|26015389|P1|Overall Study|Withdrawal by Subject|3
7499504|NCT03341637|26015388|P2|Overall Study|Lost to Follow-up|0
7499505|NCT03341637|26015389|P1|Overall Study|Lost to Follow-up|1
7499506|NCT03341533|26015417|P2|Overall Study|Not eligible after randomization|1
7499507|NCT03341533|26015418|P1|Overall Study|Not eligible after randomization|2
7499508|NCT03341533|26015417|P2|Overall Study|Withdrawal by Subject|1
7499509|NCT03341533|26015418|P1|Overall Study|Withdrawal by Subject|1
7499510|NCT03341507|26015430|P1|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
7499511|NCT03341312|26015437|P4|Period 1|Withdrawal by Subject|0
7499512|NCT03341312|26015438|P3|Period 1|Withdrawal by Subject|0
7499513|NCT03341312|26015439|P2|Period 1|Withdrawal by Subject|1
7499514|NCT03341312|26015440|P1|Period 1|Withdrawal by Subject|0
7499515|NCT03341299|26015452|P4|Washout (A Minimum of 21 Hours)|Adverse Event|0
7499516|NCT03341299|26015453|P3|Washout (A Minimum of 21 Hours)|Adverse Event|1
7499517|NCT03341299|26015454|P2|Washout (A Minimum of 21 Hours)|Adverse Event|0
7499518|NCT03341299|26015455|P1|Washout (A Minimum of 21 Hours)|Adverse Event|0
7499519|NCT03341273|26015469|P2|Overall Study|Participant incarcerated|0
7499520|NCT03341273|26015470|P1|Overall Study|Participant incarcerated|1
7499521|NCT03341273|26015469|P2|Overall Study|Not Eligible at Enrollment|1
7499522|NCT03341273|26015470|P1|Overall Study|Not Eligible at Enrollment|0
7499523|NCT03341273|26015469|P2|Overall Study|Became ineligible after enrollment|0
7499524|NCT03341273|26015470|P1|Overall Study|Became ineligible after enrollment|1
7499525|NCT03341273|26015469|P2|Overall Study|Enrolled but Treatment Not Administered|1
7499526|NCT03341273|26015470|P1|Overall Study|Enrolled but Treatment Not Administered|6
7499527|NCT03341273|26015469|P2|Overall Study|Protocol Violation|1
7499528|NCT03341273|26015470|P1|Overall Study|Protocol Violation|0
7499529|NCT03341273|26015469|P2|Overall Study|Physician Decision|0
7499530|NCT03341273|26015470|P1|Overall Study|Physician Decision|1
7499531|NCT03341273|26015469|P2|Overall Study|Withdrawal by Subject|2
7499532|NCT03341273|26015470|P1|Overall Study|Withdrawal by Subject|4
7499533|NCT03341273|26015469|P2|Overall Study|Lost to Follow-up|7
7499534|NCT03341273|26015470|P1|Overall Study|Lost to Follow-up|7
7499535|NCT03340961|26015516|P4|Overall Study|Lack of Efficacy|1
7499536|NCT03340961|26015517|P3|Overall Study|Lack of Efficacy|0
7499537|NCT03340961|26015518|P2|Overall Study|Lack of Efficacy|0
7499538|NCT03340961|26015519|P1|Overall Study|Lack of Efficacy|0
7499539|NCT03340961|26015516|P4|Overall Study|Adverse Event|0
7499540|NCT03340961|26015517|P3|Overall Study|Adverse Event|0
7499541|NCT03340961|26015518|P2|Overall Study|Adverse Event|1
7499542|NCT03340961|26015519|P1|Overall Study|Adverse Event|1
7499543|NCT03340961|26015516|P4|Overall Study|Protocol Violation|0
7499544|NCT03340961|26015517|P3|Overall Study|Protocol Violation|1
7499545|NCT03340961|26015518|P2|Overall Study|Protocol Violation|0
7499546|NCT03340961|26015519|P1|Overall Study|Protocol Violation|1
7499547|NCT03340961|26015516|P4|Overall Study|Subject developed an exclusion criterion|0
7499548|NCT03340961|26015517|P3|Overall Study|Subject developed an exclusion criterion|0
7499549|NCT03340961|26015518|P2|Overall Study|Subject developed an exclusion criterion|1
7499550|NCT03340961|26015519|P1|Overall Study|Subject developed an exclusion criterion|0
7499551|NCT03340961|26015516|P4|Overall Study|Wrongful enrollment (I/E criteria not me|1
7499552|NCT03340961|26015517|P3|Overall Study|Wrongful enrollment (I/E criteria not me|0
7499553|NCT03340961|26015518|P2|Overall Study|Wrongful enrollment (I/E criteria not me|1
7499554|NCT03340961|26015519|P1|Overall Study|Wrongful enrollment (I/E criteria not me|0
7499555|NCT03340961|26015516|P4|Overall Study|Use of prohibited treatment|4
7499556|NCT03340961|26015517|P3|Overall Study|Use of prohibited treatment|2
7499557|NCT03340961|26015518|P2|Overall Study|Use of prohibited treatment|3
7499558|NCT03340961|26015519|P1|Overall Study|Use of prohibited treatment|0
7499559|NCT03340961|26015516|P4|Overall Study|Withdrawal by Subject|7
7499560|NCT03340961|26015517|P3|Overall Study|Withdrawal by Subject|4
7499561|NCT03340961|26015518|P2|Overall Study|Withdrawal by Subject|2
7499562|NCT03340961|26015519|P1|Overall Study|Withdrawal by Subject|3
7499563|NCT03340961|26015516|P4|Overall Study|Lost to Follow-up|1
7499564|NCT03340961|26015517|P3|Overall Study|Lost to Follow-up|0
7499565|NCT03340961|26015518|P2|Overall Study|Lost to Follow-up|1
7499566|NCT03340961|26015519|P1|Overall Study|Lost to Follow-up|0
7499567|NCT03340961|26015516|P4|Overall Study|Adverse Event|4
7499568|NCT03340961|26015517|P3|Overall Study|Adverse Event|2
7499569|NCT03340961|26015518|P2|Overall Study|Adverse Event|3
7499570|NCT03340961|26015519|P1|Overall Study|Adverse Event|1
7499571|NCT03340025|26015686|P2|Overall Study|Lost to Follow-up|2
7499572|NCT03340025|26015687|P1|Overall Study|Lost to Follow-up|2
7499573|NCT03339999|26015697|P4|Overall Study|Study Terminated by Sponsor|3
7499574|NCT03339999|26015698|P3|Overall Study|Study Terminated by Sponsor|4
7499575|NCT03339999|26015699|P2|Overall Study|Study Terminated by Sponsor|3
7499576|NCT03339999|26015700|P1|Overall Study|Study Terminated by Sponsor|6
7499577|NCT03339999|26015697|P4|Overall Study|Lost to Follow-up|1
7499578|NCT03339999|26015698|P3|Overall Study|Lost to Follow-up|0
7499579|NCT03339999|26015699|P2|Overall Study|Lost to Follow-up|0
7499580|NCT03339999|26015700|P1|Overall Study|Lost to Follow-up|0
7499581|NCT03339999|26015697|P4|Overall Study|Lack of Efficacy|0
7499582|NCT03339999|26015698|P3|Overall Study|Lack of Efficacy|0
7499583|NCT03339999|26015699|P2|Overall Study|Lack of Efficacy|1
7499584|NCT03339999|26015700|P1|Overall Study|Lack of Efficacy|0
7499585|NCT03339999|26015697|P4|Overall Study|Adverse Event|1
7499586|NCT03339999|26015698|P3|Overall Study|Adverse Event|2
7499587|NCT03339999|26015699|P2|Overall Study|Adverse Event|2
7499588|NCT03339999|26015700|P1|Overall Study|Adverse Event|1
7499589|NCT03339726|26015744|P3|Overall Study|Lost to Follow-up|0
7499590|NCT03339726|26015745|P2|Overall Study|Lost to Follow-up|1
7499591|NCT03339726|26015746|P1|Overall Study|Lost to Follow-up|0
7499592|NCT03339726|26015744|P3|Overall Study|Withdrawal by Subject|0
7499593|NCT03339726|26015745|P2|Overall Study|Withdrawal by Subject|0
7499594|NCT03339726|26015746|P1|Overall Study|Withdrawal by Subject|1
7499595|NCT03339713|26015804|P2|Overall Study|Withdrawal by Subject|1
7499596|NCT03339713|26015805|P1|Overall Study|Withdrawal by Subject|1
7499597|NCT03339713|26015804|P2|Overall Study|Protocol Violation|0
7499598|NCT03339713|26015805|P1|Overall Study|Protocol Violation|1
7499599|NCT03339713|26015804|P2|Overall Study|Lost to Follow-up|1
7499600|NCT03339713|26015805|P1|Overall Study|Lost to Follow-up|2
7499601|NCT03339583|26015833|P2|Follow-up (14 Days)|Physician Decision|3
7499602|NCT03339583|26015834|P1|Follow-up (14 Days)|Physician Decision|6
7499603|NCT03339583|26015833|P2|Second Intervention (14 Days)|Adverse Event|1
7499604|NCT03339583|26015834|P1|Second Intervention (14 Days)|Adverse Event|0
7499605|NCT03339583|26015833|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
7499606|NCT03339583|26015834|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
7499607|NCT03339583|26015833|P2|First Intervention (14 Days)|Adverse Event|0
7499608|NCT03339583|26015834|P1|First Intervention (14 Days)|Adverse Event|1
7499609|NCT03339453|26015872|P2|First Visit of Glucagon Treatment|Adverse Event|1
7499610|NCT03339453|26015873|P1|First Visit of Glucagon Treatment|Adverse Event|0
7499611|NCT03339401|26015891|P2|Overall Study|Investigator Decision|0
7499612|NCT03339401|26015892|P1|Overall Study|Investigator Decision|1
7499613|NCT03339401|26015891|P2|Overall Study|Study terminated|3
7499614|NCT03339401|26015892|P1|Overall Study|Study terminated|4
7499615|NCT03339401|26015891|P2|Overall Study|Withdrawal by Subject|0
7499616|NCT03339401|26015892|P1|Overall Study|Withdrawal by Subject|2
7499617|NCT03339401|26015891|P2|Overall Study|Death|1
7499618|NCT03339401|26015892|P1|Overall Study|Death|2
7499619|NCT03339297|26015900|P2|Overall Study|Patient Was Not Eligible|0
7499620|NCT03339297|26015901|P1|Overall Study|Patient Was Not Eligible|1
7499621|NCT03339297|26015900|P2|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
7499622|NCT03339297|26015901|P1|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
7499623|NCT03339297|26015900|P2|Overall Study|Adverse Event, Non-fatal|0
7499624|NCT03339297|26015901|P1|Overall Study|Adverse Event, Non-fatal|1
7499625|NCT03339297|26015900|P2|Overall Study|Early Termination, Did Not Proceed to Transplant|0
7499626|NCT03339297|26015901|P1|Overall Study|Early Termination, Did Not Proceed to Transplant|1
7499627|NCT03339297|26015900|P2|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
7499628|NCT03339297|26015901|P1|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
7499629|NCT03339297|26015900|P2|Overall Study|Relapse of Disease New Transplant Performed|0
7499630|NCT03339297|26015901|P1|Overall Study|Relapse of Disease New Transplant Performed|1
7499631|NCT03339297|26015900|P2|Overall Study|Physician Decision|1
7499632|NCT03339297|26015901|P1|Overall Study|Physician Decision|1
7499633|NCT03339297|26015900|P2|Overall Study|Disease Relapse|0
7499634|NCT03339297|26015901|P1|Overall Study|Disease Relapse|2
7499635|NCT03339297|26015900|P2|Overall Study|Consent Withdrawn by Participant|3
7499636|NCT03339297|26015901|P1|Overall Study|Consent Withdrawn by Participant|3
7499637|NCT03339297|26015900|P2|Overall Study|Adverse Event, Serious Fatal|2
7499638|NCT03339297|26015901|P1|Overall Study|Adverse Event, Serious Fatal|0
7499639|NCT03339297|26015900|P2|Overall Study|Hepatic Candidosis|0
7499640|NCT03339297|26015901|P1|Overall Study|Hepatic Candidosis|1
7499641|NCT03339297|26015900|P2|Overall Study|Death|7
7499642|NCT03339297|26015901|P1|Overall Study|Death|10
7499643|NCT03339297|26015900|P2|Overall Study|Relapse of Hematologic Disease|0
7499644|NCT03339297|26015901|P1|Overall Study|Relapse of Hematologic Disease|1
7499645|NCT03339245|26015959|P2|Overall Study|Withdrawal by Subject|0
7499646|NCT03339245|26015960|P1|Overall Study|Withdrawal by Subject|1
7499647|NCT03339245|26015959|P2|Overall Study|Adverse Event|1
7499648|NCT03339245|26015960|P1|Overall Study|Adverse Event|1
7499649|NCT03339219|26015966|P1|Overall Study|Withdrawal by Subject|1
7499650|NCT03339219|26015966|P1|Overall Study|Site Terminated by Sponsor|22
7499651|NCT03339219|26015966|P1|Overall Study|Death|12
7499652|NCT03338998|26016028|P2|Safety Follow-Up Period|Lost to Follow-up|0
7499653|NCT03338998|26016029|P1|Safety Follow-Up Period|Lost to Follow-up|1
7499654|NCT03338998|26016028|P2|Safety Follow-Up Period|Protocol deviation|0
7499655|NCT03338998|26016029|P1|Safety Follow-Up Period|Protocol deviation|1
7499656|NCT03338998|26016028|P2|Safety Follow-Up Period|Adverse Event|1
7499657|NCT03338998|26016029|P1|Safety Follow-Up Period|Adverse Event|0
7499658|NCT03338998|26016028|P2|Treatment Period|Subject failed swallow test|0
7499659|NCT03338998|26016029|P1|Treatment Period|Subject failed swallow test|4
7499660|NCT03338998|26016028|P2|Treatment Period|Physician Decision|0
7499661|NCT03338998|26016029|P1|Treatment Period|Physician Decision|2
7499662|NCT03338998|26016028|P2|Treatment Period|Protocol deviation|0
7499663|NCT03338998|26016029|P1|Treatment Period|Protocol deviation|1
7499664|NCT03338998|26016028|P2|Treatment Period|Adverse Event|2
7499665|NCT03338998|26016029|P1|Treatment Period|Adverse Event|0
7499666|NCT03338998|26016028|P2|Treatment Period|Withdrawal by Subject|1
7499667|NCT03338998|26016029|P1|Treatment Period|Withdrawal by Subject|1
7499668|NCT03338894|26016036|P1|Overall Study|not able able to attend 9 or more classes|10
7499669|NCT03338855|26016043|P2|Overall Study|Withdrawn as birth control pill stopped|0
7499670|NCT03338855|26016044|P1|Overall Study|Withdrawn as birth control pill stopped|1
7499671|NCT03338816|26016066|P2|Open-Label Extension Period|Ongoing in Study|47
7499672|NCT03338816|26016067|P1|Open-Label Extension Period|Ongoing in Study|46
7499673|NCT03338816|26016066|P2|6-Month Double-blind Period|Adverse Event|1
7499674|NCT03338816|26016067|P1|6-Month Double-blind Period|Adverse Event|0
7499675|NCT03338673|26016120|P2|Overall Study|Lost to Follow-up|1
7499676|NCT03338673|26016121|P1|Overall Study|Lost to Follow-up|1
7499677|NCT03338569|26016131|P2|Overall Study|Lost to Follow-up|1
7499678|NCT03338569|26016132|P1|Overall Study|Lost to Follow-up|0
7499679|NCT03338569|26016131|P2|Overall Study|Withdrawal by Subject|1
7499680|NCT03338569|26016132|P1|Overall Study|Withdrawal by Subject|0
7499681|NCT03338569|26016131|P2|Overall Study|Physician Decision|3
7499682|NCT03338569|26016132|P1|Overall Study|Physician Decision|8
7499683|NCT03338400|26016187|P2|Overall Study|Lost to Follow-up|2
7499684|NCT03338400|26016188|P1|Overall Study|Lost to Follow-up|1
7499685|NCT03338296|26016204|P2|Overall Study|Missing|1
7499686|NCT03338296|26016205|P1|Overall Study|Missing|0
7499687|NCT03338296|26016204|P2|Overall Study|Other|7
7499688|NCT03338296|26016205|P1|Overall Study|Other|2
7499689|NCT03338296|26016204|P2|Overall Study|Study Terminated by Sponsor|76
7499690|NCT03338296|26016205|P1|Overall Study|Study Terminated by Sponsor|77
7499691|NCT03338296|26016204|P2|Overall Study|Lost to Follow-up|10
7499692|NCT03338296|26016205|P1|Overall Study|Lost to Follow-up|10
7499693|NCT03338296|26016204|P2|Overall Study|Withdrawal by Subject|13
7499694|NCT03338296|26016205|P1|Overall Study|Withdrawal by Subject|14
7499695|NCT03338296|26016204|P2|Overall Study|Adverse Event|1
7499696|NCT03338296|26016205|P1|Overall Study|Adverse Event|0
7499697|NCT03338062|26016259|P2|Overall Study|Alternative Therapy|0
7499698|NCT03338062|26016260|P1|Overall Study|Alternative Therapy|1
7499699|NCT03338023|26016312|P2|Overall Study|Physician Decision|2
7499700|NCT03338023|26016313|P1|Overall Study|Physician Decision|1
7499701|NCT03338023|26016312|P2|Overall Study|Lost to Follow-up|1
7499702|NCT03338023|26016313|P1|Overall Study|Lost to Follow-up|2
7499703|NCT03338023|26016312|P2|Overall Study|Protocol Violation|3
7499704|NCT03338023|26016313|P1|Overall Study|Protocol Violation|3
7499705|NCT03338023|26016312|P2|Overall Study|Withdrawal by Subject|4
7499706|NCT03338023|26016313|P1|Overall Study|Withdrawal by Subject|3
7499707|NCT03338010|26016345|P2|Overall Study|Protocol Violation|1
7499708|NCT03338010|26016346|P1|Overall Study|Protocol Violation|0
7499709|NCT03338010|26016345|P2|Overall Study|Non-Compliance with Study Drug|3
7499710|NCT03338010|26016346|P1|Overall Study|Non-Compliance with Study Drug|0
7499711|NCT03338010|26016345|P2|Overall Study|Physician Decision|2
7499712|NCT03338010|26016346|P1|Overall Study|Physician Decision|2
7499713|NCT03338010|26016345|P2|Overall Study|Adverse Event|2
7499714|NCT03338010|26016346|P1|Overall Study|Adverse Event|3
7499715|NCT03338010|26016345|P2|Overall Study|Lost to Follow-up|2
7499716|NCT03338010|26016346|P1|Overall Study|Lost to Follow-up|4
7499717|NCT03338010|26016345|P2|Overall Study|Withdrawal by Subject|8
7499718|NCT03338010|26016346|P1|Overall Study|Withdrawal by Subject|14
7499719|NCT03337490|26016377|P3|Overall Study|Lost to Follow-up|0
7499720|NCT03337490|26016378|P2|Overall Study|Lost to Follow-up|1
7499721|NCT03337490|26016379|P1|Overall Study|Lost to Follow-up|0
7499722|NCT03337490|26016377|P3|Overall Study|Physician Decision|0
7499723|NCT03337490|26016378|P2|Overall Study|Physician Decision|1
7499724|NCT03337490|26016379|P1|Overall Study|Physician Decision|0
7499725|NCT03337490|26016377|P3|Overall Study|Lack of Efficacy|35
7499726|NCT03337490|26016378|P2|Overall Study|Lack of Efficacy|12
7499727|NCT03337490|26016379|P1|Overall Study|Lack of Efficacy|10
7499728|NCT03337490|26016377|P3|Overall Study|Withdrawal by Subject|0
7499729|NCT03337490|26016378|P2|Overall Study|Withdrawal by Subject|0
7499730|NCT03337490|26016379|P1|Overall Study|Withdrawal by Subject|1
7499731|NCT03337477|26016392|P2|Overall Study|Lost to Follow-up|2
7499732|NCT03337477|26016393|P1|Overall Study|Lost to Follow-up|0
7499733|NCT03337477|26016392|P2|Overall Study|Death|1
7499734|NCT03337477|26016393|P1|Overall Study|Death|0
7499735|NCT03337477|26016392|P2|Overall Study|Withdrawal by Subject|1
7499736|NCT03337477|26016393|P1|Overall Study|Withdrawal by Subject|0
7499737|NCT03337477|26016392|P2|Overall Study|not categorized into the listed ones|9
7499738|NCT03337477|26016393|P1|Overall Study|not categorized into the listed ones|11
7499739|NCT03337308|26016417|P4|Overall Study|Protocol Violation|0
7499740|NCT03337308|26016418|P3|Overall Study|Protocol Violation|0
7499741|NCT03337308|26016419|P2|Overall Study|Protocol Violation|1
7499742|NCT03337308|26016420|P1|Overall Study|Protocol Violation|0
7499743|NCT03337308|26016417|P4|Overall Study|Withdrawal by Subject|1
7499744|NCT03337308|26016418|P3|Overall Study|Withdrawal by Subject|2
7499745|NCT03337308|26016419|P2|Overall Study|Withdrawal by Subject|1
7499746|NCT03337308|26016420|P1|Overall Study|Withdrawal by Subject|2
7499747|NCT03337308|26016417|P4|Overall Study|Lost to Follow-up|0
7499748|NCT03337308|26016418|P3|Overall Study|Lost to Follow-up|0
7499749|NCT03337308|26016419|P2|Overall Study|Lost to Follow-up|2
7499750|NCT03337308|26016420|P1|Overall Study|Lost to Follow-up|1
7499751|NCT03337308|26016417|P4|Overall Study|Adverse Event|1
7499752|NCT03337308|26016418|P3|Overall Study|Adverse Event|3
7499753|NCT03337308|26016419|P2|Overall Study|Adverse Event|3
7499754|NCT03337308|26016420|P1|Overall Study|Adverse Event|2
7499755|NCT03337139|26016456|P2|Phase I|Withdrawal by Subject|0
7499756|NCT03337139|26016457|P1|Phase I|Withdrawal by Subject|10
7499757|NCT03336502|26016508|P2|Overall Study|Adverse Event|5
7499758|NCT03336502|26016509|P1|Overall Study|Adverse Event|2
7499759|NCT03336502|26016508|P2|Overall Study|Death|2
7499760|NCT03336502|26016509|P1|Overall Study|Death|1
7499761|NCT03336502|26016508|P2|Overall Study|Prohibited Drugs|1
7499762|NCT03336502|26016509|P1|Overall Study|Prohibited Drugs|1
7499763|NCT03336502|26016508|P2|Overall Study|Physician Decision|1
7499764|NCT03336502|26016509|P1|Overall Study|Physician Decision|0
7499765|NCT03335566|26016579|P2|Overall Study|Other than specified above|2
7499766|NCT03335566|26016580|P1|Overall Study|Other than specified above|1
7499767|NCT03335566|26016579|P2|Overall Study|Protocol Violation|0
7499768|NCT03335566|26016580|P1|Overall Study|Protocol Violation|1
7499769|NCT03335566|26016579|P2|Overall Study|Technical Problems|0
7499770|NCT03335566|26016580|P1|Overall Study|Technical Problems|1
7499771|NCT03335566|26016579|P2|Overall Study|Lost to Follow-up|0
7499772|NCT03335566|26016580|P1|Overall Study|Lost to Follow-up|1
7499773|NCT03335566|26016579|P2|Overall Study|Adverse Event|1
7499774|NCT03335566|26016580|P1|Overall Study|Adverse Event|0
7499775|NCT03335150|26016662|P2|Overall Study|Adverse Event|1
7499776|NCT03335150|26016663|P1|Overall Study|Adverse Event|0
7499777|NCT03335150|26016662|P2|Overall Study|Withdrawal by Subject|4
7499778|NCT03335150|26016663|P1|Overall Study|Withdrawal by Subject|10
7499779|NCT03334903|26016687|P2|Overall Study|Withdrawal by Subject|1
7499780|NCT03334903|26016688|P1|Overall Study|Withdrawal by Subject|0
7499781|NCT03334903|26016687|P2|Overall Study|Adverse Event|1
7499782|NCT03334903|26016688|P1|Overall Study|Adverse Event|1
7499783|NCT03334903|26016687|P2|Overall Study|Surgery postponed|0
7499784|NCT03334903|26016688|P1|Overall Study|Surgery postponed|1
7499785|NCT03334903|26016687|P2|Overall Study|Protocol Violation|3
7499786|NCT03334903|26016688|P1|Overall Study|Protocol Violation|1
7499787|NCT03334903|26016687|P2|Overall Study|Use of medical marijuana - determined ineligible later in study|0
7499788|NCT03334903|26016688|P1|Overall Study|Use of medical marijuana - determined ineligible later in study|1
7499789|NCT03334747|26016755|P9|Follow-Up Phase|Subject/guardian decision|1
7499790|NCT03334747|26016756|P8|Follow-Up Phase|Subject/guardian decision|0
7499791|NCT03334747|26016757|P7|Follow-Up Phase|Subject/guardian decision|1
7499792|NCT03334747|26016758|P6|Follow-Up Phase|Subject/guardian decision|0
7499793|NCT03334747|26016759|P5|Follow-Up Phase|Subject/guardian decision|0
7499794|NCT03334747|26016760|P4|Follow-Up Phase|Subject/guardian decision|0
7499795|NCT03334747|26016761|P3|Follow-Up Phase|Subject/guardian decision|0
7499796|NCT03334747|26016762|P2|Follow-Up Phase|Subject/guardian decision|0
7499797|NCT03334747|26016763|P1|Follow-Up Phase|Subject/guardian decision|0
7499798|NCT03334747|26016755|P9|Treatment Phase|Subject/guardian decision|0
7499799|NCT03334747|26016756|P8|Treatment Phase|Subject/guardian decision|0
7499800|NCT03334747|26016757|P7|Treatment Phase|Subject/guardian decision|0
7499801|NCT03334747|26016758|P6|Treatment Phase|Subject/guardian decision|1
7499802|NCT03334747|26016759|P5|Treatment Phase|Subject/guardian decision|0
7499803|NCT03334747|26016760|P4|Treatment Phase|Subject/guardian decision|0
7499804|NCT03334747|26016761|P3|Treatment Phase|Subject/guardian decision|0
7499805|NCT03334747|26016762|P2|Treatment Phase|Subject/guardian decision|0
7499806|NCT03334747|26016763|P1|Treatment Phase|Subject/guardian decision|1
7499807|NCT03334747|26016755|P9|Treatment Phase|Technical problems|0
7499808|NCT03334747|26016756|P8|Treatment Phase|Technical problems|0
7499809|NCT03334747|26016757|P7|Treatment Phase|Technical problems|0
7499810|NCT03334747|26016758|P6|Treatment Phase|Technical problems|0
7499811|NCT03334747|26016759|P5|Treatment Phase|Technical problems|1
7499812|NCT03334747|26016760|P4|Treatment Phase|Technical problems|0
7499813|NCT03334747|26016761|P3|Treatment Phase|Technical problems|0
7499814|NCT03334747|26016762|P2|Treatment Phase|Technical problems|0
7499815|NCT03334747|26016763|P1|Treatment Phase|Technical problems|0
7499816|NCT03334721|26016953|P2|Overall Study|No longer met inclusion/exclusion criter|0
7499817|NCT03334721|26016954|P1|Overall Study|No longer met inclusion/exclusion criter|1
7499818|NCT03334721|26016953|P2|Overall Study|Withdrawal by Subject|0
7499819|NCT03334721|26016954|P1|Overall Study|Withdrawal by Subject|1
7499820|NCT03334695|26016962|P2|Overall Study|Protocol Violation|1
7499821|NCT03334695|26016963|P1|Overall Study|Protocol Violation|0
7499822|NCT03334695|26016962|P2|Overall Study|Physician Decision|2
7499823|NCT03334695|26016963|P1|Overall Study|Physician Decision|1
7499824|NCT03334695|26016962|P2|Overall Study|Lost to Follow-up|3
7499825|NCT03334695|26016963|P1|Overall Study|Lost to Follow-up|3
7499826|NCT03334630|26016999|P2|Overall Study|Subject unable to complete 12-month follow-up visit|1
7499827|NCT03334630|26017000|P1|Overall Study|Subject unable to complete 12-month follow-up visit|1
7499828|NCT03334630|26016999|P2|Overall Study|Subject not treated with study ablation due to technical difficulties|1
7499829|NCT03334630|26017000|P1|Overall Study|Subject not treated with study ablation due to technical difficulties|0
7499830|NCT03334630|26016999|P2|Overall Study|Enrollment closed|1
7499831|NCT03334630|26017000|P1|Overall Study|Enrollment closed|2
7499832|NCT03334630|26016999|P2|Overall Study|Physician Decision|1
7499833|NCT03334630|26017000|P1|Overall Study|Physician Decision|1
7499834|NCT03334630|26016999|P2|Overall Study|Adverse Event|1
7499835|NCT03334630|26017000|P1|Overall Study|Adverse Event|0
7499836|NCT03334630|26016999|P2|Overall Study|Lost to Follow-up|1
7499837|NCT03334630|26017000|P1|Overall Study|Lost to Follow-up|3
7499838|NCT03334630|26016999|P2|Overall Study|Withdrawal by Subject|7
7499839|NCT03334630|26017000|P1|Overall Study|Withdrawal by Subject|7
7499840|NCT03334448|26017042|P4|Washout|Protocol Violation|1
7499841|NCT03334448|26017043|P3|Washout|Protocol Violation|0
7499842|NCT03334448|26017044|P2|Washout|Protocol Violation|0
7499843|NCT03334448|26017045|P1|Washout|Protocol Violation|0
7499844|NCT03334448|26017042|P4|Washout|Personal Reason|0
7499845|NCT03334448|26017043|P3|Washout|Personal Reason|0
7499846|NCT03334448|26017044|P2|Washout|Personal Reason|1
7499847|NCT03334448|26017045|P1|Washout|Personal Reason|0
7499848|NCT03334422|26017057|P4|Overall Study|Pregnancy|0
7499849|NCT03334422|26017058|P3|Overall Study|Pregnancy|0
7499850|NCT03334422|26017059|P2|Overall Study|Pregnancy|1
7499851|NCT03334422|26017060|P1|Overall Study|Pregnancy|0
7499852|NCT03334422|26017057|P4|Overall Study|Inability to obtain laboratory samples|0
7499853|NCT03334422|26017058|P3|Overall Study|Inability to obtain laboratory samples|0
7499854|NCT03334422|26017059|P2|Overall Study|Inability to obtain laboratory samples|1
7499855|NCT03334422|26017060|P1|Overall Study|Inability to obtain laboratory samples|0
7499856|NCT03334422|26017057|P4|Overall Study|Lost to Follow-up|1
7499857|NCT03334422|26017058|P3|Overall Study|Lost to Follow-up|0
7499858|NCT03334422|26017059|P2|Overall Study|Lost to Follow-up|0
7499859|NCT03334422|26017060|P1|Overall Study|Lost to Follow-up|0
7499860|NCT03334422|26017057|P4|Overall Study|Withdrawal by Subject|0
7499861|NCT03334422|26017058|P3|Overall Study|Withdrawal by Subject|1
7499862|NCT03334422|26017059|P2|Overall Study|Withdrawal by Subject|3
7499863|NCT03334422|26017060|P1|Overall Study|Withdrawal by Subject|8
7499864|NCT03334422|26017057|P4|Overall Study|Lack of Efficacy|3
7499865|NCT03334422|26017058|P3|Overall Study|Lack of Efficacy|7
7499866|NCT03334422|26017059|P2|Overall Study|Lack of Efficacy|2
7499867|NCT03334422|26017060|P1|Overall Study|Lack of Efficacy|10
7499868|NCT03334422|26017057|P4|Overall Study|Adverse Event|2
7499869|NCT03334422|26017058|P3|Overall Study|Adverse Event|2
7499870|NCT03334422|26017059|P2|Overall Study|Adverse Event|3
7499871|NCT03334422|26017060|P1|Overall Study|Adverse Event|1
7499872|NCT03334396|26017167|P8|Overall Study|Started New Job|0
7499873|NCT03334396|26017168|P7|Overall Study|Started New Job|0
7499874|NCT03334396|26017169|P6|Overall Study|Started New Job|0
7499875|NCT03334396|26017170|P5|Overall Study|Started New Job|0
7499876|NCT03334396|26017171|P4|Overall Study|Started New Job|0
7499877|NCT03334396|26017172|P3|Overall Study|Started New Job|0
7499878|NCT03334396|26017173|P2|Overall Study|Started New Job|0
7499879|NCT03334396|26017174|P1|Overall Study|Started New Job|1
7499880|NCT03334396|26017167|P8|Overall Study|Ineligible|0
7499881|NCT03334396|26017168|P7|Overall Study|Ineligible|0
7499882|NCT03334396|26017169|P6|Overall Study|Ineligible|0
7499883|NCT03334396|26017170|P5|Overall Study|Ineligible|0
7499884|NCT03334396|26017171|P4|Overall Study|Ineligible|0
7499885|NCT03334396|26017172|P3|Overall Study|Ineligible|0
7499886|NCT03334396|26017173|P2|Overall Study|Ineligible|1
7499887|NCT03334396|26017174|P1|Overall Study|Ineligible|0
7499888|NCT03334396|26017167|P8|Overall Study|Pregnancy|0
7499889|NCT03334396|26017168|P7|Overall Study|Pregnancy|0
7499890|NCT03334396|26017169|P6|Overall Study|Pregnancy|0
7499891|NCT03334396|26017170|P5|Overall Study|Pregnancy|0
7499892|NCT03334396|26017171|P4|Overall Study|Pregnancy|0
7499893|NCT03334396|26017172|P3|Overall Study|Pregnancy|0
7499894|NCT03334396|26017173|P2|Overall Study|Pregnancy|1
7499895|NCT03334396|26017174|P1|Overall Study|Pregnancy|0
7499896|NCT03334396|26017167|P8|Overall Study|Withdrawal by Subject|0
7499897|NCT03334396|26017168|P7|Overall Study|Withdrawal by Subject|2
7499898|NCT03334396|26017169|P6|Overall Study|Withdrawal by Subject|1
7499899|NCT03334396|26017170|P5|Overall Study|Withdrawal by Subject|2
7499900|NCT03334396|26017171|P4|Overall Study|Withdrawal by Subject|2
7499901|NCT03334396|26017172|P3|Overall Study|Withdrawal by Subject|7
7499902|NCT03334396|26017173|P2|Overall Study|Withdrawal by Subject|5
7499903|NCT03334396|26017174|P1|Overall Study|Withdrawal by Subject|10
7499904|NCT03334396|26017167|P8|Overall Study|Physician Decision|0
7499905|NCT03334396|26017168|P7|Overall Study|Physician Decision|0
7499906|NCT03334396|26017169|P6|Overall Study|Physician Decision|0
7499907|NCT03334396|26017170|P5|Overall Study|Physician Decision|0
7499908|NCT03334396|26017171|P4|Overall Study|Physician Decision|0
7499909|NCT03334396|26017172|P3|Overall Study|Physician Decision|0
7499910|NCT03334396|26017173|P2|Overall Study|Physician Decision|0
7499911|NCT03334396|26017174|P1|Overall Study|Physician Decision|1
7499912|NCT03334396|26017167|P8|Overall Study|Lost to Follow-up|0
7499913|NCT03334396|26017168|P7|Overall Study|Lost to Follow-up|1
7499914|NCT03334396|26017169|P6|Overall Study|Lost to Follow-up|0
7499915|NCT03334396|26017170|P5|Overall Study|Lost to Follow-up|0
7499916|NCT03334396|26017171|P4|Overall Study|Lost to Follow-up|0
7499917|NCT03334396|26017172|P3|Overall Study|Lost to Follow-up|1
7499918|NCT03334396|26017173|P2|Overall Study|Lost to Follow-up|0
7499919|NCT03334396|26017174|P1|Overall Study|Lost to Follow-up|0
7499920|NCT03334396|26017167|P8|Overall Study|Lack of Efficacy|1
7499921|NCT03334396|26017168|P7|Overall Study|Lack of Efficacy|0
7499922|NCT03334396|26017169|P6|Overall Study|Lack of Efficacy|0
7499923|NCT03334396|26017170|P5|Overall Study|Lack of Efficacy|1
7499924|NCT03334396|26017171|P4|Overall Study|Lack of Efficacy|3
7499925|NCT03334396|26017172|P3|Overall Study|Lack of Efficacy|1
7499926|NCT03334396|26017173|P2|Overall Study|Lack of Efficacy|4
7499927|NCT03334396|26017174|P1|Overall Study|Lack of Efficacy|10
7499928|NCT03334396|26017167|P8|Overall Study|Adverse Event|0
7499929|NCT03334396|26017168|P7|Overall Study|Adverse Event|0
7499930|NCT03334396|26017169|P6|Overall Study|Adverse Event|0
7499931|NCT03334396|26017170|P5|Overall Study|Adverse Event|0
7499932|NCT03334396|26017171|P4|Overall Study|Adverse Event|0
7499933|NCT03334396|26017172|P3|Overall Study|Adverse Event|1
7499934|NCT03334396|26017173|P2|Overall Study|Adverse Event|0
7499935|NCT03334396|26017174|P1|Overall Study|Adverse Event|1
7499936|NCT03334214|26017279|P2|Overall Study|Other|0
7499937|NCT03334214|26017280|P1|Overall Study|Other|1
7499938|NCT03334214|26017279|P2|Overall Study|Withdrawal by Subject|1
7499939|NCT03334214|26017280|P1|Overall Study|Withdrawal by Subject|0
7499940|NCT03334214|26017279|P2|Overall Study|Adverse Event or Serious Adverse Event|1
7499941|NCT03334214|26017280|P1|Overall Study|Adverse Event or Serious Adverse Event|0
7499942|NCT03334188|26017306|P2|Overall Study|Never had qualifying clinic visit|7
7499943|NCT03334188|26017307|P1|Overall Study|Never had qualifying clinic visit|7
7499944|NCT03334188|26017306|P2|Overall Study|Death|0
7499945|NCT03334188|26017307|P1|Overall Study|Death|1
7499946|NCT03334188|26017306|P2|Overall Study|Withdrawal by Subject|1
7499947|NCT03334188|26017307|P1|Overall Study|Withdrawal by Subject|0
7499948|NCT03334175|26017322|P2|Overall Study|Lost to Follow-up|1
7499949|NCT03334175|26017323|P1|Overall Study|Lost to Follow-up|0
7499950|NCT03333941|26017343|P1|Overall Study|Adverse Event|1
7499951|NCT03333941|26017343|P1|Overall Study|Death|2
7499952|NCT03333941|26017343|P1|Overall Study|Lost to Follow-up|10
7499953|NCT03333876|26017349|P1|Mandibular Advancement|Product Damage|2
7499954|NCT03333876|26017349|P1|Mandibular Advancement|Adverse Event|2
7499955|NCT03333876|26017349|P1|Nasal Dilator|Bed Partner Lost to follow up|6
7499956|NCT03333876|26017349|P1|Screening Period|Screen Failure|4
7499957|NCT03333109|26017512|P3|Safety Follow-up Period|Withdrawal by Subject|12
7499958|NCT03333109|26017513|P2|Safety Follow-up Period|Withdrawal by Subject|2
7499959|NCT03333109|26017514|P1|Safety Follow-up Period|Withdrawal by Subject|7
7499960|NCT03333109|26017512|P3|Safety Follow-up Period|Lost to Follow-up|1
7499961|NCT03333109|26017513|P2|Safety Follow-up Period|Lost to Follow-up|2
7499962|NCT03333109|26017514|P1|Safety Follow-up Period|Lost to Follow-up|6
7499963|NCT03333109|26017512|P3|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7499964|NCT03333109|26017513|P2|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
7499965|NCT03333109|26017514|P1|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7499966|NCT03333109|26017512|P3|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
7499967|NCT03333109|26017513|P2|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
7499968|NCT03333109|26017514|P1|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
7499969|NCT03333109|26017512|P3|Double-blind Treatment Period (DBTP)|Pregnancy|0
7499970|NCT03333109|26017513|P2|Double-blind Treatment Period (DBTP)|Pregnancy|0
7499971|NCT03333109|26017514|P1|Double-blind Treatment Period (DBTP)|Pregnancy|1
7499972|NCT03333109|26017512|P3|Double-blind Treatment Period (DBTP)|Physician Decision|1
7499973|NCT03333109|26017513|P2|Double-blind Treatment Period (DBTP)|Physician Decision|0
7499974|NCT03333109|26017514|P1|Double-blind Treatment Period (DBTP)|Physician Decision|4
7499975|NCT03333109|26017512|P3|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
7499976|NCT03333109|26017513|P2|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7499977|NCT03333109|26017514|P1|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7499978|NCT03333109|26017512|P3|Double-blind Treatment Period (DBTP)|Adverse Event|2
7499979|NCT03333109|26017513|P2|Double-blind Treatment Period (DBTP)|Adverse Event|0
7499980|NCT03333109|26017514|P1|Double-blind Treatment Period (DBTP)|Adverse Event|0
7499981|NCT03332784|26017575|P20|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499982|NCT03332784|26017576|P19|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499983|NCT03332784|26017577|P18|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499984|NCT03332784|26017578|P17|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499985|NCT03332784|26017579|P16|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499986|NCT03332784|26017580|P15|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7499987|NCT03332784|26017581|P14|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499988|NCT03332784|26017582|P13|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499989|NCT03332784|26017583|P12|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499990|NCT03332784|26017584|P11|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499991|NCT03332784|26017585|P10|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499992|NCT03332784|26017586|P9|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499993|NCT03332784|26017587|P8|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499994|NCT03332784|26017588|P7|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499995|NCT03332784|26017589|P6|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499996|NCT03332784|26017590|P5|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499997|NCT03332784|26017591|P4|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499998|NCT03332784|26017592|P3|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7499999|NCT03332784|26017593|P2|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7500000|NCT03332784|26017594|P1|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7500001|NCT03332771|26017854|P4|Overall Study|Reason Not Specified|19
7500002|NCT03332771|26017855|P3|Overall Study|Reason Not Specified|16
7500003|NCT03332771|26017856|P2|Overall Study|Reason Not Specified|18
7500004|NCT03332771|26017857|P1|Overall Study|Reason Not Specified|6
7500005|NCT03332771|26017854|P4|Overall Study|At the Participant's own request|23
7500006|NCT03332771|26017855|P3|Overall Study|At the Participant's own request|14
7500007|NCT03332771|26017856|P2|Overall Study|At the Participant's own request|26
7500008|NCT03332771|26017857|P1|Overall Study|At the Participant's own request|20
7500009|NCT03332771|26017854|P4|Overall Study|Lost to Follow-up|2
7500010|NCT03332771|26017855|P3|Overall Study|Lost to Follow-up|1
7500011|NCT03332771|26017856|P2|Overall Study|Lost to Follow-up|2
7500012|NCT03332771|26017857|P1|Overall Study|Lost to Follow-up|2
7500013|NCT03332771|26017854|P4|Overall Study|Poor Compliance to Protocol|1
7500014|NCT03332771|26017855|P3|Overall Study|Poor Compliance to Protocol|0
7500015|NCT03332771|26017856|P2|Overall Study|Poor Compliance to Protocol|1
7500016|NCT03332771|26017857|P1|Overall Study|Poor Compliance to Protocol|0
7500017|NCT03332771|26017854|P4|Overall Study|Adverse Event|3
7500018|NCT03332771|26017855|P3|Overall Study|Adverse Event|1
7500019|NCT03332771|26017856|P2|Overall Study|Adverse Event|4
7500020|NCT03332771|26017857|P1|Overall Study|Adverse Event|6
7500021|NCT03332628|26017895|P1|Overall Study|Physician Decision|2
7500022|NCT03332498|26017905|P3|Overall Study|Severe illness prior to Day 1 of treatment|2
7500023|NCT03332498|26017906|P2|Overall Study|Severe illness prior to Day 1 of treatment|0
7500024|NCT03332498|26017907|P1|Overall Study|Severe illness prior to Day 1 of treatment|0
7500025|NCT03332212|26017952|P4|Overall Study|worsening of disease under study|0
7500026|NCT03332212|26017953|P3|Overall Study|worsening of disease under study|0
7500027|NCT03332212|26017954|P2|Overall Study|worsening of disease under study|1
7500028|NCT03332212|26017955|P1|Overall Study|worsening of disease under study|1
7500029|NCT03332212|26017952|P4|Overall Study|Adverse Event|1
7500030|NCT03332212|26017953|P3|Overall Study|Adverse Event|0
7500031|NCT03332212|26017954|P2|Overall Study|Adverse Event|0
7500032|NCT03332212|26017955|P1|Overall Study|Adverse Event|0
7500033|NCT03332212|26017952|P4|Overall Study|Not treated|0
7500034|NCT03332212|26017953|P3|Overall Study|Not treated|0
7500035|NCT03332212|26017954|P2|Overall Study|Not treated|1
7500036|NCT03332212|26017955|P1|Overall Study|Not treated|0
7500037|NCT03332160|26017965|P2|Overall Study|Non-adherence to treatment|2
7500038|NCT03332160|26017966|P1|Overall Study|Non-adherence to treatment|0
7500039|NCT03332160|26017965|P2|Overall Study|Developed Exclusion Criteria|1
7500040|NCT03332160|26017966|P1|Overall Study|Developed Exclusion Criteria|0
7500041|NCT03332160|26017965|P2|Overall Study|Adverse Event|1
7500042|NCT03332160|26017966|P1|Overall Study|Adverse Event|0
7500043|NCT03332160|26017965|P2|Overall Study|Withdrawal by Subject|1
7500044|NCT03332160|26017966|P1|Overall Study|Withdrawal by Subject|1
7500045|NCT03331666|26018050|P2|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7500046|NCT03331666|26018051|P1|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7500047|NCT03331315|26018061|P2|Overall Study|Physician Decision|14
7500048|NCT03331315|26018062|P1|Overall Study|Physician Decision|18
7500049|NCT03331042|26018099|P4|Overall Study|Lost to Follow-up|1
7500050|NCT03331042|26018100|P3|Overall Study|Lost to Follow-up|0
7500051|NCT03331042|26018101|P2|Overall Study|Lost to Follow-up|0
7500052|NCT03331042|26018102|P1|Overall Study|Lost to Follow-up|0
7500053|NCT03331042|26018099|P4|Overall Study|Physician Decision|0
7500054|NCT03331042|26018100|P3|Overall Study|Physician Decision|1
7500055|NCT03331042|26018101|P2|Overall Study|Physician Decision|0
7500056|NCT03331042|26018102|P1|Overall Study|Physician Decision|0
7500057|NCT03331042|26018099|P4|Overall Study|Protocol Violation|0
7500058|NCT03331042|26018100|P3|Overall Study|Protocol Violation|0
7500059|NCT03331042|26018101|P2|Overall Study|Protocol Violation|0
7500060|NCT03331042|26018102|P1|Overall Study|Protocol Violation|1
7500061|NCT03330288|26018177|P2|Overall Study|Lost to Follow-up|7
7500062|NCT03330288|26018178|P1|Overall Study|Lost to Follow-up|26
7500063|NCT03330288|26018177|P2|Overall Study|Withdrawal by Subject|0
7500064|NCT03330288|26018178|P1|Overall Study|Withdrawal by Subject|1
7500065|NCT03330288|26018177|P2|Overall Study|Adverse Event|0
7500066|NCT03330288|26018178|P1|Overall Study|Adverse Event|1
7500067|NCT03330288|26018177|P2|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
7500068|NCT03330288|26018178|P1|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
7500069|NCT03330288|26018177|P2|Overall Study|Other reason|1
7500070|NCT03330288|26018178|P1|Overall Study|Other reason|1
7500071|NCT03330236|26018250|P2|Overall Study|Surgery aborted/converted to open|52
7500072|NCT03330236|26018251|P1|Overall Study|Surgery aborted/converted to open|60
7500073|NCT03330236|26018250|P2|Overall Study|Volatile anesthetics used|8
7500074|NCT03330236|26018251|P1|Overall Study|Volatile anesthetics used|11
7500075|NCT03330236|26018250|P2|Overall Study|SedLine malfunction/blinding|14
7500076|NCT03330236|26018251|P1|Overall Study|SedLine malfunction/blinding|19
7500077|NCT03330236|26018250|P2|Overall Study|Protocol Violation|3
7500078|NCT03330236|26018251|P1|Overall Study|Protocol Violation|4
7500079|NCT03330236|26018250|P2|Overall Study|Physician Decision|0
7500080|NCT03330236|26018251|P1|Overall Study|Physician Decision|2
7500081|NCT03330236|26018250|P2|Overall Study|Lost to Follow-up|2
7500082|NCT03330236|26018251|P1|Overall Study|Lost to Follow-up|0
7500083|NCT03330236|26018250|P2|Overall Study|Withdrawal by Subject|4
7500084|NCT03330236|26018251|P1|Overall Study|Withdrawal by Subject|2
7500085|NCT03330236|26018250|P2|Overall Study|Death|1
7500086|NCT03330236|26018251|P1|Overall Study|Death|2
7500087|NCT03330119|26018277|P2|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
7500088|NCT03330119|26018278|P1|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
7500089|NCT03330002|26018294|P1|Overall Study|Death|7
7500090|NCT03330002|26018294|P1|Overall Study|Lost to Follow-up|15
7500091|NCT03329989|26018300|P1|Overall Study|Protocol Violation|1
7500092|NCT03329989|26018300|P1|Overall Study|Adverse Event|5
7500093|NCT03329989|26018300|P1|Overall Study|Lost to Follow-up|8
7500094|NCT03329989|26018300|P1|Overall Study|Withdrawal by Subject|9
7500095|NCT03329885|26018336|P9|Overall Study|Sponsor discontinued the study early|0
7500096|NCT03329885|26018337|P8|Overall Study|Sponsor discontinued the study early|1
7500097|NCT03329885|26018338|P7|Overall Study|Sponsor discontinued the study early|1
7500098|NCT03329885|26018339|P6|Overall Study|Sponsor discontinued the study early|0
7500099|NCT03329885|26018340|P5|Overall Study|Sponsor discontinued the study early|0
7500100|NCT03329885|26018341|P4|Overall Study|Sponsor discontinued the study early|0
7500101|NCT03329885|26018342|P3|Overall Study|Sponsor discontinued the study early|0
7500102|NCT03329885|26018343|P2|Overall Study|Sponsor discontinued the study early|0
7500103|NCT03329885|26018344|P1|Overall Study|Sponsor discontinued the study early|0
7500104|NCT03329846|26018510|P2|Overall Study|Other reasons|2
7500105|NCT03329846|26018511|P1|Overall Study|Other reasons|2
7500106|NCT03329846|26018510|P2|Overall Study|Participant withdrew consent|0
7500107|NCT03329846|26018511|P1|Overall Study|Participant withdrew consent|1
7500108|NCT03329846|26018510|P2|Overall Study|Participant request to discontinue treatment|1
7500109|NCT03329846|26018511|P1|Overall Study|Participant request to discontinue treatment|0
7500110|NCT03329846|26018510|P2|Overall Study|Study drug toxicity|0
7500111|NCT03329846|26018511|P1|Overall Study|Study drug toxicity|1
7500112|NCT03329846|26018510|P2|Overall Study|Disease progression|6
7500113|NCT03329846|26018511|P1|Overall Study|Disease progression|4
7500114|NCT03329690|26018522|P5|Overall Study|Did not receive treatment|0
7500115|NCT03329690|26018523|P4|Overall Study|Did not receive treatment|1
7500116|NCT03329690|26018524|P3|Overall Study|Did not receive treatment|0
7500117|NCT03329690|26018525|P2|Overall Study|Did not receive treatment|0
7500118|NCT03329690|26018526|P1|Overall Study|Did not receive treatment|1
7500119|NCT03329690|26018522|P5|Overall Study|Physician Decision|1
7500120|NCT03329690|26018523|P4|Overall Study|Physician Decision|0
7500121|NCT03329690|26018524|P3|Overall Study|Physician Decision|0
7500122|NCT03329690|26018525|P2|Overall Study|Physician Decision|0
7500123|NCT03329690|26018526|P1|Overall Study|Physician Decision|1
7500124|NCT03329690|26018522|P5|Overall Study|Withdrawal by Subject|0
7500125|NCT03329690|26018523|P4|Overall Study|Withdrawal by Subject|1
7500126|NCT03329690|26018524|P3|Overall Study|Withdrawal by Subject|0
7500127|NCT03329690|26018525|P2|Overall Study|Withdrawal by Subject|3
7500128|NCT03329690|26018526|P1|Overall Study|Withdrawal by Subject|2
7500129|NCT03329690|26018522|P5|Overall Study|Death|0
7500130|NCT03329690|26018523|P4|Overall Study|Death|1
7500131|NCT03329690|26018524|P3|Overall Study|Death|0
7500132|NCT03329690|26018525|P2|Overall Study|Death|0
7500133|NCT03329690|26018526|P1|Overall Study|Death|2
7500134|NCT03329690|26018522|P5|Overall Study|Adverse Event|2
7500135|NCT03329690|26018523|P4|Overall Study|Adverse Event|1
7500136|NCT03329690|26018524|P3|Overall Study|Adverse Event|0
7500137|NCT03329690|26018525|P2|Overall Study|Adverse Event|4
7500138|NCT03329690|26018526|P1|Overall Study|Adverse Event|19
7500139|NCT03329690|26018522|P5|Overall Study|Clinical progression|0
7500140|NCT03329690|26018523|P4|Overall Study|Clinical progression|1
7500141|NCT03329690|26018524|P3|Overall Study|Clinical progression|1
7500142|NCT03329690|26018525|P2|Overall Study|Clinical progression|4
7500143|NCT03329690|26018526|P1|Overall Study|Clinical progression|6
7500144|NCT03329690|26018522|P5|Overall Study|Progressive disease per RECIST|19
7500145|NCT03329690|26018523|P4|Overall Study|Progressive disease per RECIST|16
7500146|NCT03329690|26018524|P3|Overall Study|Progressive disease per RECIST|5
7500147|NCT03329690|26018525|P2|Overall Study|Progressive disease per RECIST|42
7500148|NCT03329690|26018526|P1|Overall Study|Progressive disease per RECIST|67
7500149|NCT03329573|26018608|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7500150|NCT03329573|26018609|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7500151|NCT03329573|26018610|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
7500152|NCT03329573|26018611|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7500153|NCT03329573|26018608|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7500154|NCT03329573|26018609|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7500155|NCT03329573|26018610|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7500156|NCT03329573|26018611|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
7500157|NCT03329573|26018608|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7500158|NCT03329573|26018609|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7500159|NCT03329573|26018610|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
7500160|NCT03329573|26018611|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
7500161|NCT03329573|26018608|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7500162|NCT03329573|26018609|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7500163|NCT03329573|26018610|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
7500164|NCT03329573|26018611|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7500165|NCT03329404|26018679|P2|Overall Study|The study was suspended.|4
7500166|NCT03329404|26018680|P1|Overall Study|The study was suspended.|1
7500167|NCT03329196|26018706|P2|Overall Study|Dialysis or renal transplant|15
7500168|NCT03329196|26018707|P1|Overall Study|Dialysis or renal transplant|13
7500169|NCT03329196|26018706|P2|Overall Study|Difficult to control Hb|3
7500170|NCT03329196|26018707|P1|Overall Study|Difficult to control Hb|2
7500171|NCT03329196|26018706|P2|Overall Study|Conducting rescue therapy before Week 24|1
7500172|NCT03329196|26018707|P1|Overall Study|Conducting rescue therapy before Week 24|2
7500173|NCT03329196|26018706|P2|Overall Study|Hepatic function abnormalities|1
7500174|NCT03329196|26018707|P1|Overall Study|Hepatic function abnormalities|0
7500175|NCT03329196|26018706|P2|Overall Study|Withdrawal by Subject|3
7500176|NCT03329196|26018707|P1|Overall Study|Withdrawal by Subject|11
7500177|NCT03329196|26018706|P2|Overall Study|Physician Decision|2
7500178|NCT03329196|26018707|P1|Overall Study|Physician Decision|2
7500179|NCT03329196|26018706|P2|Overall Study|Adverse Event|5
7500180|NCT03329196|26018707|P1|Overall Study|Adverse Event|10
7500181|NCT03328897|26018733|P3|Follow-up Epoch|Patient/guardian decision|0
7500182|NCT03328897|26018734|P2|Follow-up Epoch|Patient/guardian decision|1
7500183|NCT03328897|26018735|P1|Follow-up Epoch|Patient/guardian decision|2
7500184|NCT03328897|26018733|P3|Follow-up Epoch|Pregnancy|0
7500185|NCT03328897|26018734|P2|Follow-up Epoch|Pregnancy|0
7500186|NCT03328897|26018735|P1|Follow-up Epoch|Pregnancy|1
7500187|NCT03328897|26018733|P3|Follow-up Epoch|Lost to Follow-up|0
7500188|NCT03328897|26018734|P2|Follow-up Epoch|Lost to Follow-up|1
7500189|NCT03328897|26018735|P1|Follow-up Epoch|Lost to Follow-up|0
7500190|NCT03328897|26018733|P3|Follow-up Epoch|Lack of Efficacy|1
7500191|NCT03328897|26018734|P2|Follow-up Epoch|Lack of Efficacy|1
7500192|NCT03328897|26018735|P1|Follow-up Epoch|Lack of Efficacy|1
7500193|NCT03328897|26018733|P3|Follow-up Epoch|Adverse Event|1
7500194|NCT03328897|26018734|P2|Follow-up Epoch|Adverse Event|0
7500195|NCT03328897|26018735|P1|Follow-up Epoch|Adverse Event|4
7500196|NCT03328897|26018733|P3|Randomized-treatment Epoch|Lack of Efficacy|0
7500197|NCT03328897|26018734|P2|Randomized-treatment Epoch|Lack of Efficacy|0
7500198|NCT03328897|26018735|P1|Randomized-treatment Epoch|Lack of Efficacy|1
7500199|NCT03328897|26018733|P3|Randomized-treatment Epoch|Patient/guardian decision|1
7500200|NCT03328897|26018734|P2|Randomized-treatment Epoch|Patient/guardian decision|3
7500201|NCT03328897|26018735|P1|Randomized-treatment Epoch|Patient/guardian decision|8
7500202|NCT03328897|26018733|P3|Randomized-treatment Epoch|Pregnancy|0
7500203|NCT03328897|26018734|P2|Randomized-treatment Epoch|Pregnancy|0
7500204|NCT03328897|26018735|P1|Randomized-treatment Epoch|Pregnancy|3
7500205|NCT03328897|26018733|P3|Randomized-treatment Epoch|Lost to Follow-up|0
7500206|NCT03328897|26018734|P2|Randomized-treatment Epoch|Lost to Follow-up|1
7500207|NCT03328897|26018735|P1|Randomized-treatment Epoch|Lost to Follow-up|0
7500208|NCT03328897|26018733|P3|Randomized-treatment Epoch|Adverse Event|1
7500209|NCT03328897|26018734|P2|Randomized-treatment Epoch|Adverse Event|1
7500210|NCT03328897|26018735|P1|Randomized-treatment Epoch|Adverse Event|4
7500211|NCT03328832|26018766|P2|Overall Study|Lost to Follow-up|1
7500212|NCT03328832|26018767|P1|Overall Study|Lost to Follow-up|0
7500213|NCT03328325|26018781|P1|Overall Study|Early Study Termination due to COVID-19 pandemic|3
7500214|NCT03328325|26018781|P1|Overall Study|Withdrawal by Subject|3
7500215|NCT03328325|26018781|P1|Overall Study|Physician Decision|1
7500216|NCT03328325|26018781|P1|Overall Study|Lost to Follow-up|4
7500217|NCT03328182|26018819|P1|Overall Study|No Product Evaluated|1
7500218|NCT03328182|26018819|P1|Overall Study|Protocol Violation|2
7500219|NCT03328182|26018819|P1|Overall Study|Withdrawal by Subject|1
7500220|NCT03327402|26018905|P1|Overall Study|Other (Visit Out-Of-Window)|1
7500221|NCT03327402|26018905|P1|Overall Study|Withdrawal by Subject|1
7500222|NCT03327220|26018940|P2|Overall Study|Missing|0
7500223|NCT03327220|26018941|P1|Overall Study|Missing|1
7500224|NCT03327220|26018940|P2|Overall Study|Discharged to Rehabilitation|1
7500225|NCT03327220|26018941|P1|Overall Study|Discharged to Rehabilitation|0
7500226|NCT03327220|26018940|P2|Overall Study|Fungal infection|0
7500227|NCT03327220|26018941|P1|Overall Study|Fungal infection|1
7500228|NCT03327220|26018940|P2|Overall Study|Missed Visit 6 (Week 6 Visit)|1
7500229|NCT03327220|26018941|P1|Overall Study|Missed Visit 6 (Week 6 Visit)|0
7500230|NCT03327220|26018940|P2|Overall Study|Investigator Decision|0
7500231|NCT03327220|26018941|P1|Overall Study|Investigator Decision|2
7500232|NCT03327220|26018940|P2|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
7500233|NCT03327220|26018941|P1|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
7500234|NCT03326869|26019239|P2|Overall Study|Study data has been lost to natural disa|1
7500235|NCT03326869|26019240|P1|Overall Study|Study data has been lost to natural disa|1
7500236|NCT03326856|26019253|P5|Overall Study|Lost to Follow-up|0
7500237|NCT03326856|26019254|P4|Overall Study|Lost to Follow-up|0
7500238|NCT03326856|26019255|P3|Overall Study|Lost to Follow-up|0
7500239|NCT03326856|26019256|P2|Overall Study|Lost to Follow-up|1
7500240|NCT03326856|26019257|P1|Overall Study|Lost to Follow-up|1
7500241|NCT03326518|26019287|P3|Overall Study|Lost to Follow-up|1
7500242|NCT03326518|26019288|P2|Overall Study|Lost to Follow-up|0
7500243|NCT03326518|26019289|P1|Overall Study|Lost to Follow-up|1
7500244|NCT03326518|26019287|P3|Overall Study|Withdrawal by Subject|0
7500245|NCT03326518|26019288|P2|Overall Study|Withdrawal by Subject|0
7500246|NCT03326518|26019289|P1|Overall Study|Withdrawal by Subject|1
7500247|NCT03326518|26019287|P3|Overall Study|Protocol Violation|0
7500248|NCT03326518|26019288|P2|Overall Study|Protocol Violation|0
7500249|NCT03326518|26019289|P1|Overall Study|Protocol Violation|1
7500250|NCT03326323|26019324|P1|Overall Study|Unable to receive ANH protocol|3
7500251|NCT03325894|26019331|P2|Overall Study|Other (Not received Treatment)|0
7500252|NCT03325894|26019332|P1|Overall Study|Other (Not received Treatment)|1
7500253|NCT03325894|26019331|P2|Overall Study|Study Terminated by Sponsor|43
7500254|NCT03325894|26019332|P1|Overall Study|Study Terminated by Sponsor|38
7500255|NCT03325894|26019331|P2|Overall Study|Lack of Efficacy|14
7500256|NCT03325894|26019332|P1|Overall Study|Lack of Efficacy|8
7500257|NCT03325894|26019331|P2|Overall Study|Lost to Follow-up|9
7500258|NCT03325894|26019332|P1|Overall Study|Lost to Follow-up|4
7500259|NCT03325894|26019331|P2|Overall Study|Withdrawal by Subject|6
7500260|NCT03325894|26019332|P1|Overall Study|Withdrawal by Subject|10
7500261|NCT03325894|26019331|P2|Overall Study|Protocol Violation|2
7500262|NCT03325894|26019332|P1|Overall Study|Protocol Violation|1
7500263|NCT03325894|26019331|P2|Overall Study|Adverse Event|3
7500264|NCT03325894|26019332|P1|Overall Study|Adverse Event|2
7500265|NCT03325881|26019400|P2|Overall Study|Not treated|0
7500266|NCT03325881|26019401|P1|Overall Study|Not treated|1
7500267|NCT03325881|26019400|P2|Overall Study|Lack of Efficacy|0
7500268|NCT03325881|26019401|P1|Overall Study|Lack of Efficacy|2
7500269|NCT03325881|26019400|P2|Overall Study|Withdrawal by Subject|2
7500270|NCT03325881|26019401|P1|Overall Study|Withdrawal by Subject|0
7500271|NCT03325881|26019400|P2|Overall Study|Protocol Violation|1
7500272|NCT03325881|26019401|P1|Overall Study|Protocol Violation|0
7500273|NCT03325673|26019444|P2|Overall Study|Adverse Event|0
7500274|NCT03325673|26019445|P1|Overall Study|Adverse Event|4
7500275|NCT03325556|26019457|P3|Double-blind Period|Administrative discont. at study termination|31
7500276|NCT03325556|26019458|P2|Double-blind Period|Administrative discont. at study termination|35
7500277|NCT03325556|26019459|P1|Double-blind Period|Administrative discont. at study termination|0
7500278|NCT03325556|26019457|P3|Double-blind Period|Not otherwise specified|5
7500279|NCT03325556|26019458|P2|Double-blind Period|Not otherwise specified|1
7500280|NCT03325556|26019459|P1|Double-blind Period|Not otherwise specified|0
7500281|NCT03325556|26019457|P3|Double-blind Period|Withdrawal by Subject|4
7500282|NCT03325556|26019458|P2|Double-blind Period|Withdrawal by Subject|6
7500283|NCT03325556|26019459|P1|Double-blind Period|Withdrawal by Subject|0
7500284|NCT03325556|26019457|P3|Double-blind Period|Physician Decision|1
7500285|NCT03325556|26019458|P2|Double-blind Period|Physician Decision|0
7500286|NCT03325556|26019459|P1|Double-blind Period|Physician Decision|0
7500287|NCT03325556|26019457|P3|Double-blind Period|Use of prohibited medication|0
7500288|NCT03325556|26019458|P2|Double-blind Period|Use of prohibited medication|1
7500289|NCT03325556|26019459|P1|Double-blind Period|Use of prohibited medication|0
7500290|NCT03325556|26019457|P3|Double-blind Period|Noncompliance with study drug|1
7500291|NCT03325556|26019458|P2|Double-blind Period|Noncompliance with study drug|0
7500292|NCT03325556|26019459|P1|Double-blind Period|Noncompliance with study drug|0
7500293|NCT03325556|26019457|P3|Double-blind Period|Adverse Event|1
7500294|NCT03325556|26019458|P2|Double-blind Period|Adverse Event|3
7500295|NCT03325556|26019459|P1|Double-blind Period|Adverse Event|0
7500296|NCT03325556|26019457|P3|Double-blind Period|Relapse|34
7500297|NCT03325556|26019458|P2|Double-blind Period|Relapse|15
7500298|NCT03325556|26019459|P1|Double-blind Period|Relapse|0
7500299|NCT03325556|26019457|P3|Open-label Period|Administrative discont. at study termination|0
7500300|NCT03325556|26019458|P2|Open-label Period|Administrative discont. at study termination|0
7500301|NCT03325556|26019459|P1|Open-label Period|Administrative discont. at study termination|41
7500302|NCT03325556|26019457|P3|Open-label Period|Not otherwise specified|0
7500303|NCT03325556|26019458|P2|Open-label Period|Not otherwise specified|0
7500304|NCT03325556|26019459|P1|Open-label Period|Not otherwise specified|8
7500305|NCT03325556|26019457|P3|Open-label Period|Withdrawal by Subject|0
7500306|NCT03325556|26019458|P2|Open-label Period|Withdrawal by Subject|0
7500307|NCT03325556|26019459|P1|Open-label Period|Withdrawal by Subject|17
7500308|NCT03325556|26019457|P3|Open-label Period|Protocol Violation|0
7500309|NCT03325556|26019458|P2|Open-label Period|Protocol Violation|0
7500310|NCT03325556|26019459|P1|Open-label Period|Protocol Violation|4
7500311|NCT03325556|26019457|P3|Open-label Period|Use of prohibited medication|0
7500312|NCT03325556|26019458|P2|Open-label Period|Use of prohibited medication|0
7500313|NCT03325556|26019459|P1|Open-label Period|Use of prohibited medication|1
7500314|NCT03325556|26019457|P3|Open-label Period|Non-compliance with study drug|0
7500315|NCT03325556|26019458|P2|Open-label Period|Non-compliance with study drug|0
7500316|NCT03325556|26019459|P1|Open-label Period|Non-compliance with study drug|5
7500317|NCT03325556|26019457|P3|Open-label Period|Lost to Follow-up|0
7500318|NCT03325556|26019458|P2|Open-label Period|Lost to Follow-up|0
7500319|NCT03325556|26019459|P1|Open-label Period|Lost to Follow-up|1
7500320|NCT03325556|26019457|P3|Open-label Period|Death|0
7500321|NCT03325556|26019458|P2|Open-label Period|Death|0
7500322|NCT03325556|26019459|P1|Open-label Period|Death|1
7500323|NCT03325556|26019457|P3|Open-label Period|Adverse Event|0
7500324|NCT03325556|26019458|P2|Open-label Period|Adverse Event|0
7500325|NCT03325556|26019459|P1|Open-label Period|Adverse Event|27
7500326|NCT03325556|26019457|P3|Open-label Period|Lack of Response in OL period|0
7500327|NCT03325556|26019458|P2|Open-label Period|Lack of Response in OL period|0
7500328|NCT03325556|26019459|P1|Open-label Period|Lack of Response in OL period|70
7500329|NCT03325010|26019477|P2|Overall Study|Lack of Efficacy|0
7500330|NCT03325010|26019478|P1|Overall Study|Lack of Efficacy|2
7500331|NCT03325010|26019477|P2|Overall Study|Physician Decision|1
7500332|NCT03325010|26019478|P1|Overall Study|Physician Decision|1
7500333|NCT03325010|26019477|P2|Overall Study|Lost to Follow-up|0
7500334|NCT03325010|26019478|P1|Overall Study|Lost to Follow-up|1
7500335|NCT03325010|26019477|P2|Overall Study|Withdrawal by Subject|3
7500336|NCT03325010|26019478|P1|Overall Study|Withdrawal by Subject|1
7500337|NCT03325010|26019477|P2|Overall Study|Protocol Violation|8
7500338|NCT03325010|26019478|P1|Overall Study|Protocol Violation|1
7500339|NCT03325010|26019477|P2|Overall Study|Adverse Event|8
7500340|NCT03325010|26019478|P1|Overall Study|Adverse Event|3
7500341|NCT03323749|26019533|P2|Open-Label Period|Withdrawal by Subject|5
7500342|NCT03323749|26019534|P1|Open-Label Period|Withdrawal by Subject|7
7500343|NCT03323749|26019533|P2|Open-Label Period|Adverse Event|10
7500344|NCT03323749|26019534|P1|Open-Label Period|Adverse Event|3
7500345|NCT03323749|26019533|P2|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
7500346|NCT03323749|26019534|P1|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
7500347|NCT03323749|26019533|P2|Double-blind Period|Adverse Event|1
7500348|NCT03323749|26019534|P1|Double-blind Period|Adverse Event|3
7500349|NCT03323749|26019533|P2|Double-blind Period|Lost to Follow-up|5
7500350|NCT03323749|26019534|P1|Double-blind Period|Lost to Follow-up|4
7500351|NCT03323736|26019555|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
7500352|NCT03323736|26019556|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
7500353|NCT03323736|26019557|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
7500354|NCT03323736|26019555|P3|Overall Study|Withdrawal Before Treatment|1
7500355|NCT03323736|26019556|P2|Overall Study|Withdrawal Before Treatment|1
7500356|NCT03323736|26019557|P1|Overall Study|Withdrawal Before Treatment|3
7500357|NCT03323736|26019555|P3|Overall Study|Screen Failure|1
7500358|NCT03323736|26019556|P2|Overall Study|Screen Failure|9
7500359|NCT03323736|26019557|P1|Overall Study|Screen Failure|14
7500360|NCT03323164|26019584|P2|Overall Study|Poor quality imaging/scans|2
7500361|NCT03323164|26019585|P1|Overall Study|Poor quality imaging/scans|2
7500362|NCT03323086|26019611|P2|Overall Study|Lost to Follow-up|2
7500363|NCT03323086|26019612|P1|Overall Study|Lost to Follow-up|3
7500364|NCT03322566|26019651|P3|Overall Study|On-going at clinical cut off date|36
7500365|NCT03322566|26019652|P2|Overall Study|On-going at clinical cut off date|74
7500366|NCT03322566|26019653|P1|Overall Study|On-going at clinical cut off date|68
7500367|NCT03322566|26019651|P3|Overall Study|Withdrawal by Subject|5
7500368|NCT03322566|26019652|P2|Overall Study|Withdrawal by Subject|1
7500369|NCT03322566|26019653|P1|Overall Study|Withdrawal by Subject|3
7500370|NCT03322566|26019651|P3|Overall Study|Physician Decision|1
7500371|NCT03322566|26019652|P2|Overall Study|Physician Decision|0
7500372|NCT03322566|26019653|P1|Overall Study|Physician Decision|0
7500373|NCT03322566|26019651|P3|Overall Study|Death|13
7500374|NCT03322566|26019652|P2|Overall Study|Death|12
7500375|NCT03322566|26019653|P1|Overall Study|Death|20
7500376|NCT03322540|26019672|P2|Overall Study|Participants Ongoing|59
7500377|NCT03322540|26019673|P1|Overall Study|Participants Ongoing|63
7500378|NCT03322540|26019672|P2|Overall Study|Withdrawal by Subject|1
7500379|NCT03322540|26019673|P1|Overall Study|Withdrawal by Subject|2
7500380|NCT03322540|26019672|P2|Overall Study|Physician Decision|1
7500381|NCT03322540|26019673|P1|Overall Study|Physician Decision|0
7500382|NCT03322540|26019672|P2|Overall Study|Lost to Follow-up|1
7500383|NCT03322540|26019673|P1|Overall Study|Lost to Follow-up|0
7500384|NCT03322540|26019672|P2|Overall Study|Death|15
7500385|NCT03322540|26019673|P1|Overall Study|Death|12
7500386|NCT03322514|26019681|P2|Overall Study|Withdrawal by Subject|1
7500387|NCT03322514|26019682|P1|Overall Study|Withdrawal by Subject|1
7500388|NCT03322462|26019692|P1|Overall Study|Other|1
7500389|NCT03322462|26019692|P1|Overall Study|Technical difficulties|2
7500390|NCT03322423|26019701|P2|Period 2|Subject not eligible for Pytergiumectomy|1
7500391|NCT03322423|26019702|P1|Period 2|Subject not eligible for Pytergiumectomy|0
7500392|NCT03322423|26019701|P2|Period 2|Protocol Violation|0
7500393|NCT03322423|26019702|P1|Period 2|Protocol Violation|1
7500394|NCT03322423|26019701|P2|Period 2|Dispensed incorrect lens in left eye|1
7500395|NCT03322423|26019702|P1|Period 2|Dispensed incorrect lens in left eye|0
7500396|NCT03322423|26019701|P2|Period 1|Unsatisfactory Lens Fitting|0
7500397|NCT03322423|26019702|P1|Period 1|Unsatisfactory Lens Fitting|1
7500398|NCT03322423|26019701|P2|Period 1|Incorrect Lens Dispensed|0
7500399|NCT03322423|26019702|P1|Period 1|Incorrect Lens Dispensed|1
7500400|NCT03322423|26019701|P2|Period 1|Withdrawal by Subject|1
7500401|NCT03322423|26019702|P1|Period 1|Withdrawal by Subject|0
7500402|NCT03322423|26019701|P2|Period 1|Subject no longer eligible|1
7500403|NCT03322423|26019702|P1|Period 1|Subject no longer eligible|0
7500404|NCT03322293|26019715|P3|Overall Study|Lost to Follow-up|1
7500405|NCT03322293|26019716|P2|Overall Study|Lost to Follow-up|0
7500406|NCT03322293|26019717|P1|Overall Study|Lost to Follow-up|0
7500407|NCT03321721|26019740|P3|Overall Study|Lost to Follow-up|11
7500408|NCT03321721|26019741|P2|Overall Study|Lost to Follow-up|8
7500409|NCT03321721|26019742|P1|Overall Study|Lost to Follow-up|4
7500410|NCT03321396|26019759|P1|Overall Study|Physician Decision|1
7500411|NCT03321006|26019794|P2|Overall Study|Lack of Efficacy|0
7500412|NCT03321006|26019795|P1|Overall Study|Lack of Efficacy|1
7500413|NCT03321006|26019794|P2|Overall Study|Death|0
7500414|NCT03321006|26019795|P1|Overall Study|Death|1
7500415|NCT03320941|26019810|P5|Overall Study|subject/guardian decision|0
7500416|NCT03320941|26019811|P4|Overall Study|subject/guardian decision|1
7500417|NCT03320941|26019812|P3|Overall Study|subject/guardian decision|0
7500418|NCT03320941|26019813|P2|Overall Study|subject/guardian decision|0
7500419|NCT03320941|26019814|P1|Overall Study|subject/guardian decision|0
7500420|NCT03320850|26019925|P10|Overall Study|Reason Not Specified|1
7500421|NCT03320850|26019926|P9|Overall Study|Reason Not Specified|0
7500422|NCT03320850|26019927|P8|Overall Study|Reason Not Specified|0
7500423|NCT03320850|26019928|P7|Overall Study|Reason Not Specified|0
7500424|NCT03320850|26019929|P6|Overall Study|Reason Not Specified|1
7500425|NCT03320850|26019930|P5|Overall Study|Reason Not Specified|0
7500426|NCT03320850|26019931|P4|Overall Study|Reason Not Specified|0
7500427|NCT03320850|26019932|P3|Overall Study|Reason Not Specified|0
7500428|NCT03320850|26019933|P2|Overall Study|Reason Not Specified|0
7500429|NCT03320850|26019934|P1|Overall Study|Reason Not Specified|0
7500430|NCT03320850|26019925|P10|Overall Study|Adverse Event|0
7500431|NCT03320850|26019926|P9|Overall Study|Adverse Event|2
7500432|NCT03320850|26019927|P8|Overall Study|Adverse Event|0
7500433|NCT03320850|26019928|P7|Overall Study|Adverse Event|1
7500434|NCT03320850|26019929|P6|Overall Study|Adverse Event|2
7500435|NCT03320850|26019930|P5|Overall Study|Adverse Event|0
7500436|NCT03320850|26019931|P4|Overall Study|Adverse Event|0
7500437|NCT03320850|26019932|P3|Overall Study|Adverse Event|0
7500438|NCT03320850|26019933|P2|Overall Study|Adverse Event|0
7500439|NCT03320850|26019934|P1|Overall Study|Adverse Event|0
7500440|NCT03320850|26019925|P10|Overall Study|Failure to Meet Randomization Criteria|0
7500441|NCT03320850|26019926|P9|Overall Study|Failure to Meet Randomization Criteria|0
7500442|NCT03320850|26019927|P8|Overall Study|Failure to Meet Randomization Criteria|0
7500443|NCT03320850|26019928|P7|Overall Study|Failure to Meet Randomization Criteria|0
7500444|NCT03320850|26019929|P6|Overall Study|Failure to Meet Randomization Criteria|1
7500445|NCT03320850|26019930|P5|Overall Study|Failure to Meet Randomization Criteria|0
7500446|NCT03320850|26019931|P4|Overall Study|Failure to Meet Randomization Criteria|0
7500447|NCT03320850|26019932|P3|Overall Study|Failure to Meet Randomization Criteria|0
7500448|NCT03320850|26019933|P2|Overall Study|Failure to Meet Randomization Criteria|0
7500449|NCT03320850|26019934|P1|Overall Study|Failure to Meet Randomization Criteria|0
7500450|NCT03320850|26019925|P10|Overall Study|Lack of Efficacy|3
7500451|NCT03320850|26019926|P9|Overall Study|Lack of Efficacy|0
7500452|NCT03320850|26019927|P8|Overall Study|Lack of Efficacy|2
7500453|NCT03320850|26019928|P7|Overall Study|Lack of Efficacy|0
7500454|NCT03320850|26019929|P6|Overall Study|Lack of Efficacy|1
7500455|NCT03320850|26019930|P5|Overall Study|Lack of Efficacy|0
7500456|NCT03320850|26019931|P4|Overall Study|Lack of Efficacy|1
7500457|NCT03320850|26019932|P3|Overall Study|Lack of Efficacy|0
7500458|NCT03320850|26019933|P2|Overall Study|Lack of Efficacy|0
7500459|NCT03320850|26019934|P1|Overall Study|Lack of Efficacy|0
7500460|NCT03320850|26019925|P10|Overall Study|Withdrawal by Subject|1
7500461|NCT03320850|26019926|P9|Overall Study|Withdrawal by Subject|2
7500462|NCT03320850|26019927|P8|Overall Study|Withdrawal by Subject|5
7500463|NCT03320850|26019928|P7|Overall Study|Withdrawal by Subject|4
7500464|NCT03320850|26019929|P6|Overall Study|Withdrawal by Subject|2
7500465|NCT03320850|26019930|P5|Overall Study|Withdrawal by Subject|1
7500466|NCT03320850|26019931|P4|Overall Study|Withdrawal by Subject|0
7500467|NCT03320850|26019932|P3|Overall Study|Withdrawal by Subject|0
7500468|NCT03320850|26019933|P2|Overall Study|Withdrawal by Subject|0
7500469|NCT03320850|26019934|P1|Overall Study|Withdrawal by Subject|0
7500470|NCT03320850|26019925|P10|Overall Study|Lost to Follow-up|4
7500471|NCT03320850|26019926|P9|Overall Study|Lost to Follow-up|6
7500472|NCT03320850|26019927|P8|Overall Study|Lost to Follow-up|0
7500473|NCT03320850|26019928|P7|Overall Study|Lost to Follow-up|2
7500474|NCT03320850|26019929|P6|Overall Study|Lost to Follow-up|2
7500475|NCT03320850|26019930|P5|Overall Study|Lost to Follow-up|1
7500476|NCT03320850|26019931|P4|Overall Study|Lost to Follow-up|0
7500477|NCT03320850|26019932|P3|Overall Study|Lost to Follow-up|0
7500478|NCT03320850|26019933|P2|Overall Study|Lost to Follow-up|0
7500479|NCT03320850|26019934|P1|Overall Study|Lost to Follow-up|0
7500480|NCT03320824|26019973|P2|Overall Study|could not complete final visit|1
7500481|NCT03320824|26019974|P1|Overall Study|could not complete final visit|0
7500482|NCT03320824|26019973|P2|Overall Study|moved out of state|1
7500483|NCT03320824|26019974|P1|Overall Study|moved out of state|0
7500484|NCT03320824|26019973|P2|Overall Study|Lost to Follow-up|1
7500485|NCT03320824|26019974|P1|Overall Study|Lost to Follow-up|10
7500486|NCT03320824|26019973|P2|Overall Study|Withdrawal by Subject|1
7500487|NCT03320824|26019974|P1|Overall Study|Withdrawal by Subject|8
7500488|NCT03320564|26019990|P1|Overall Study|Protocol Violation|1
7500489|NCT03320369|26019994|P1|Overall Study|Withdrawal by Subject|2
7500490|NCT03320369|26019994|P1|Overall Study|Adverse Event|1
7500491|NCT03320057|26020010|P2|Overall Study|Did not take mifepristone or misoprostol|0
7500492|NCT03320057|26020011|P1|Overall Study|Did not take mifepristone or misoprostol|2
7500493|NCT03320057|26020010|P2|Overall Study|Lost to Follow-up|17
7500494|NCT03320057|26020011|P1|Overall Study|Lost to Follow-up|4
7500495|NCT03319953|26020025|P4|Period 2 (Day 49 to 154)|Reason not Specified|1
7500496|NCT03319953|26020026|P3|Period 2 (Day 49 to 154)|Reason not Specified|1
7500497|NCT03319953|26020027|P2|Period 2 (Day 49 to 154)|Reason not Specified|0
7500498|NCT03319953|26020028|P1|Period 2 (Day 49 to 154)|Reason not Specified|0
7500499|NCT03319953|26020025|P4|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7500500|NCT03319953|26020026|P3|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7500501|NCT03319953|26020027|P2|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7500502|NCT03319953|26020028|P1|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
7500503|NCT03319719|26020059|P1|Overall Study|Lost to Follow-up|1
7500504|NCT03319212|26020092|P2|Overall Study|Physician Decision|0
7500505|NCT03319212|26020093|P1|Overall Study|Physician Decision|1
7500506|NCT03319212|26020092|P2|Overall Study|Lost to Follow-up|1
7500507|NCT03319212|26020093|P1|Overall Study|Lost to Follow-up|0
7500508|NCT03319212|26020092|P2|Overall Study|Withdrawal by Subject|1
7500509|NCT03319212|26020093|P1|Overall Study|Withdrawal by Subject|0
7500510|NCT03319212|26020092|P2|Overall Study|Adverse Event|2
7500511|NCT03319212|26020093|P1|Overall Study|Adverse Event|2
7500512|NCT03319212|26020092|P2|Overall Study|Discontinued as moving out of local area|1
7500513|NCT03319212|26020093|P1|Overall Study|Discontinued as moving out of local area|0
7500529|NCT03318783|26020246|P2|Overall Study|Death|1
7500530|NCT03318783|26020247|P1|Overall Study|Death|0
7500531|NCT03318783|26020246|P2|Overall Study|Withdrawal by Subject|1
7500532|NCT03318783|26020247|P1|Overall Study|Withdrawal by Subject|0
7500533|NCT03318315|26020287|P3|Overall Study|Withdrawal by Subject|2
7500534|NCT03318315|26020288|P2|Overall Study|Withdrawal by Subject|0
7500535|NCT03318315|26020289|P1|Overall Study|Withdrawal by Subject|0
7500536|NCT03318315|26020287|P3|Overall Study|Protocol Violation|1
7500537|NCT03318315|26020288|P2|Overall Study|Protocol Violation|1
7500538|NCT03318315|26020289|P1|Overall Study|Protocol Violation|1
7500539|NCT03318315|26020287|P3|Overall Study|Lost to Follow-up|1
7500540|NCT03318315|26020288|P2|Overall Study|Lost to Follow-up|2
7500541|NCT03318315|26020289|P1|Overall Study|Lost to Follow-up|3
7500542|NCT03317379|26020402|P3|Overall Study|Lost to Follow-up|2
7500543|NCT03317379|26020403|P2|Overall Study|Lost to Follow-up|3
7500544|NCT03317379|26020404|P1|Overall Study|Lost to Follow-up|0
7500545|NCT03316911|26020514|P2|Overall Study|Lost to Follow-up|29
7500546|NCT03316911|26020515|P1|Overall Study|Lost to Follow-up|33
7500547|NCT03316547|26020582|P2|Overall Study|Transfer to another hospital|4
7500548|NCT03316547|26020583|P1|Overall Study|Transfer to another hospital|6
7500549|NCT03316547|26020582|P2|Overall Study|Withdrawal by Subject|2
7500550|NCT03316547|26020583|P1|Overall Study|Withdrawal by Subject|3
7500551|NCT03316547|26020582|P2|Overall Study|Lost to Follow-up|6
7500552|NCT03316547|26020583|P1|Overall Study|Lost to Follow-up|6
7500553|NCT03316547|26020582|P2|Overall Study|Death|1
7500554|NCT03316547|26020583|P1|Overall Study|Death|3
7500555|NCT03316170|26020626|P2|Overall Study|Lost to Follow-up|7
7500556|NCT03316170|26020627|P1|Overall Study|Lost to Follow-up|6
7500557|NCT03316170|26020626|P2|Overall Study|Death|0
7500558|NCT03316170|26020627|P1|Overall Study|Death|1
7500559|NCT03316131|26020636|P2|Treatment Period 2|Protocol deviation|0
7500560|NCT03316131|26020637|P1|Treatment Period 2|Protocol deviation|1
7500561|NCT03315793|26020675|P2|Overall Study|Difficult for regular visit|1
7500562|NCT03315793|26020676|P1|Overall Study|Difficult for regular visit|0
7500563|NCT03315793|26020675|P2|Overall Study|Protocol Deviation|0
7500564|NCT03315793|26020676|P1|Overall Study|Protocol Deviation|1
7500565|NCT03315793|26020675|P2|Overall Study|Adverse Event|2
7500566|NCT03315793|26020676|P1|Overall Study|Adverse Event|4
7500567|NCT03315689|26020720|P2|Open Label Extension = 52 Weeks|Lost to Follow-up|1
7500568|NCT03315689|26020721|P1|Open Label Extension = 52 Weeks|Lost to Follow-up|0
7500569|NCT03315689|26020720|P2|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
7500570|NCT03315689|26020721|P1|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
7500571|NCT03315689|26020720|P2|Double-blind Period = 28 Days|Withdrawal by Subject|0
7500572|NCT03315689|26020721|P1|Double-blind Period = 28 Days|Withdrawal by Subject|1
7500573|NCT03315286|26020815|P2|Overall Study|Protocol Violation|1
7500574|NCT03315286|26020816|P1|Overall Study|Protocol Violation|0
7500575|NCT03315286|26020815|P2|Overall Study|Withdrawal by Subject|0
7500576|NCT03315286|26020816|P1|Overall Study|Withdrawal by Subject|1
7500577|NCT03315286|26020815|P2|Overall Study|Lost to Follow-up|3
7500578|NCT03315286|26020816|P1|Overall Study|Lost to Follow-up|0
7500579|NCT03315208|26020834|P2|Overall Study|Withdrawal by Subject|0
7500580|NCT03315208|26020835|P1|Overall Study|Withdrawal by Subject|2
7500581|NCT03315208|26020834|P2|Overall Study|Lost to Follow-up|6
7500582|NCT03315208|26020835|P1|Overall Study|Lost to Follow-up|11
7500583|NCT03314857|26020882|P1|Overall Study|Physician Decision|1
7500584|NCT03314857|26020882|P1|Overall Study|Death|4
7500585|NCT03314662|26020916|P3|Overall Study|Death|0
7500586|NCT03314662|26020917|P2|Overall Study|Death|0
7500587|NCT03314662|26020918|P1|Overall Study|Death|2
7500588|NCT03314662|26020916|P3|Overall Study|Lost to Follow-up|4
7500589|NCT03314662|26020917|P2|Overall Study|Lost to Follow-up|4
7500590|NCT03314662|26020918|P1|Overall Study|Lost to Follow-up|5
7500591|NCT03314662|26020916|P3|Overall Study|Withdrawal by Subject|1
7500592|NCT03314662|26020917|P2|Overall Study|Withdrawal by Subject|1
7500593|NCT03314662|26020918|P1|Overall Study|Withdrawal by Subject|1
7500594|NCT03314519|26020963|P2|Overall Study|Protocol Violation|2
7500595|NCT03314519|26020964|P1|Overall Study|Protocol Violation|3
7500596|NCT03314233|26020974|P1|Overall Study|No longer eligible at time of delivery|1
7500597|NCT03313310|26020987|P2|Phase 3|Lost to Follow-up|1
7500598|NCT03313310|26020988|P1|Phase 3|Lost to Follow-up|0
7500599|NCT03313310|26020987|P2|Phase 2|Lost to Follow-up|0
7500600|NCT03313310|26020988|P1|Phase 2|Lost to Follow-up|4
7500601|NCT03313076|26021030|P4|Overall Study|Lost to Follow-up|2
7500602|NCT03313076|26021031|P3|Overall Study|Lost to Follow-up|2
7500603|NCT03313076|26021032|P2|Overall Study|Lost to Follow-up|2
7500604|NCT03313076|26021033|P1|Overall Study|Lost to Follow-up|0
7500605|NCT03313076|26021030|P4|Overall Study|Withdrawal by Subject|0
7500606|NCT03313076|26021031|P3|Overall Study|Withdrawal by Subject|0
7500607|NCT03313076|26021032|P2|Overall Study|Withdrawal by Subject|0
7500608|NCT03313076|26021033|P1|Overall Study|Withdrawal by Subject|2
7500609|NCT03313050|26021071|P4|Stage 2: 12 Months|Other|1
7500610|NCT03313050|26021072|P3|Stage 2: 12 Months|Other|0
7500611|NCT03313050|26021073|P2|Stage 2: 12 Months|Other|0
7500612|NCT03313050|26021074|P1|Stage 2: 12 Months|Other|0
7500613|NCT03313050|26021071|P4|Stage 2: 12 Months|Withdrawal by Subject|3
7500614|NCT03313050|26021072|P3|Stage 2: 12 Months|Withdrawal by Subject|0
7500615|NCT03313050|26021073|P2|Stage 2: 12 Months|Withdrawal by Subject|0
7500616|NCT03313050|26021074|P1|Stage 2: 12 Months|Withdrawal by Subject|0
7500617|NCT03313050|26021071|P4|Stage 2: 12 Months|Protocol deviation|7
7500618|NCT03313050|26021072|P3|Stage 2: 12 Months|Protocol deviation|7
7500619|NCT03313050|26021073|P2|Stage 2: 12 Months|Protocol deviation|0
7500620|NCT03313050|26021074|P1|Stage 2: 12 Months|Protocol deviation|0
7500621|NCT03313050|26021071|P4|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
7500622|NCT03313050|26021072|P3|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7500623|NCT03313050|26021073|P2|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7500624|NCT03313050|26021074|P1|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7500625|NCT03313050|26021071|P4|Stage 2: 12 Months|Lost to Follow-up|5
7500626|NCT03313050|26021072|P3|Stage 2: 12 Months|Lost to Follow-up|1
7500627|NCT03313050|26021073|P2|Stage 2: 12 Months|Lost to Follow-up|0
7500628|NCT03313050|26021074|P1|Stage 2: 12 Months|Lost to Follow-up|0
7500629|NCT03313050|26021071|P4|Stage 2: 12 Months|Death|0
7500630|NCT03313050|26021072|P3|Stage 2: 12 Months|Death|3
7500631|NCT03313050|26021073|P2|Stage 2: 12 Months|Death|0
7500632|NCT03313050|26021074|P1|Stage 2: 12 Months|Death|0
7500633|NCT03313050|26021071|P4|Stage 2: 12 Months|Adverse Event|1
7500634|NCT03313050|26021072|P3|Stage 2: 12 Months|Adverse Event|0
7500635|NCT03313050|26021073|P2|Stage 2: 12 Months|Adverse Event|0
7500636|NCT03313050|26021074|P1|Stage 2: 12 Months|Adverse Event|0
7500637|NCT03313037|26021114|P2|Overall Study|Randomized but not treated|0
7500638|NCT03313037|26021115|P1|Overall Study|Randomized but not treated|1
7500639|NCT03313037|26021114|P2|Overall Study|Lost to Follow-up|8
7500640|NCT03313037|26021115|P1|Overall Study|Lost to Follow-up|9
7500641|NCT03313037|26021114|P2|Overall Study|No longer meets eligibility criteria|7
7500642|NCT03313037|26021115|P1|Overall Study|No longer meets eligibility criteria|1
7500643|NCT03313037|26021114|P2|Overall Study|Withdrawal by Subject|3
7500644|NCT03313037|26021115|P1|Overall Study|Withdrawal by Subject|4
7500645|NCT03313037|26021114|P2|Overall Study|Other|1
7500646|NCT03313037|26021115|P1|Overall Study|Other|1
7500647|NCT03313037|26021114|P2|Overall Study|Protocol Violation|1
7500648|NCT03313037|26021115|P1|Overall Study|Protocol Violation|4
7500649|NCT03312933|26021137|P1|Overall Study|Withdrawal by Subject|3
7500650|NCT03312933|26021137|P1|Overall Study|Lost to Follow-up|36
7500651|NCT03312933|26021137|P1|Overall Study|Protocol Violation|15
7500652|NCT03312543|26021149|P2|Regression (Week 12 to Week 24)|Death|1
7500653|NCT03312543|26021150|P1|Regression (Week 12 to Week 24)|Death|0
7500654|NCT03312543|26021149|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
7500655|NCT03312543|26021150|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
7500656|NCT03312543|26021149|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
7500657|NCT03312543|26021150|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
7500658|NCT03312543|26021149|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
7500659|NCT03312543|26021150|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
7500660|NCT03312543|26021149|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
7500661|NCT03312543|26021150|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
7500662|NCT03312543|26021149|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
7500663|NCT03312543|26021150|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
7500664|NCT03312231|26021246|P5|Overall Study|Study Vaccination not Received|0
7500665|NCT03312231|26021247|P4|Overall Study|Study Vaccination not Received|0
7500666|NCT03312231|26021248|P3|Overall Study|Study Vaccination not Received|1
7500667|NCT03312231|26021249|P2|Overall Study|Study Vaccination not Received|1
7500668|NCT03312231|26021250|P1|Overall Study|Study Vaccination not Received|1
7500669|NCT03312231|26021246|P5|Overall Study|Death|0
7500670|NCT03312231|26021247|P4|Overall Study|Death|0
7500671|NCT03312231|26021248|P3|Overall Study|Death|1
7500672|NCT03312231|26021249|P2|Overall Study|Death|1
7500673|NCT03312231|26021250|P1|Overall Study|Death|0
7500674|NCT03312231|26021246|P5|Overall Study|Withdrawal by Subject|0
7500675|NCT03312231|26021247|P4|Overall Study|Withdrawal by Subject|0
7500676|NCT03312231|26021248|P3|Overall Study|Withdrawal by Subject|1
7500677|NCT03312231|26021249|P2|Overall Study|Withdrawal by Subject|3
7500678|NCT03312231|26021250|P1|Overall Study|Withdrawal by Subject|0
7500679|NCT03312231|26021246|P5|Overall Study|Lost to Follow-up|1
7500680|NCT03312231|26021247|P4|Overall Study|Lost to Follow-up|3
7500681|NCT03312231|26021248|P3|Overall Study|Lost to Follow-up|1
7500682|NCT03312231|26021249|P2|Overall Study|Lost to Follow-up|6
7500683|NCT03312231|26021250|P1|Overall Study|Lost to Follow-up|2
7500684|NCT03312218|26021454|P2|Overall Study|Never signed in to access the app|58
7500685|NCT03312218|26021455|P1|Overall Study|Never signed in to access the app|54
7500686|NCT03312114|26021461|P1|Overall Study|All the five enrolled dropped out of the|5
7500687|NCT03311841|26021496|P5|14-day Wash-out|Non-Compliance With Study Drug|0
7500688|NCT03311841|26021497|P4|14-day Wash-out|Non-Compliance With Study Drug|1
7500689|NCT03311841|26021498|P3|14-day Wash-out|Non-Compliance With Study Drug|0
7500690|NCT03311841|26021499|P2|14-day Wash-out|Non-Compliance With Study Drug|0
7500691|NCT03311841|26021500|P1|14-day Wash-out|Non-Compliance With Study Drug|0
7500692|NCT03311841|26021496|P5|14-day Wash-out|Adverse Event|0
7500693|NCT03311841|26021497|P4|14-day Wash-out|Adverse Event|0
7500694|NCT03311841|26021498|P3|14-day Wash-out|Adverse Event|0
7500695|NCT03311841|26021499|P2|14-day Wash-out|Adverse Event|1
7500696|NCT03311841|26021500|P1|14-day Wash-out|Adverse Event|0
7500697|NCT03311724|26021605|P4|Overall Study|Sponsor Decision|0
7500698|NCT03311724|26021606|P3|Overall Study|Sponsor Decision|1
7500699|NCT03311724|26021607|P2|Overall Study|Sponsor Decision|0
7500700|NCT03311724|26021608|P1|Overall Study|Sponsor Decision|0
7500701|NCT03311724|26021605|P4|Overall Study|Lost to Follow-up|0
7500702|NCT03311724|26021606|P3|Overall Study|Lost to Follow-up|0
7500703|NCT03311724|26021607|P2|Overall Study|Lost to Follow-up|0
7500704|NCT03311724|26021608|P1|Overall Study|Lost to Follow-up|1
7500705|NCT03311724|26021605|P4|Overall Study|Withdrawal by Subject|0
7500706|NCT03311724|26021606|P3|Overall Study|Withdrawal by Subject|0
7500707|NCT03311724|26021607|P2|Overall Study|Withdrawal by Subject|1
7500708|NCT03311724|26021608|P1|Overall Study|Withdrawal by Subject|1
7500709|NCT03311724|26021605|P4|Overall Study|Protocol Violation|0
7500710|NCT03311724|26021606|P3|Overall Study|Protocol Violation|1
7500711|NCT03311724|26021607|P2|Overall Study|Protocol Violation|0
7500712|NCT03311724|26021608|P1|Overall Study|Protocol Violation|1
7500713|NCT03311724|26021605|P4|Overall Study|Physician Decision|1
7500714|NCT03311724|26021606|P3|Overall Study|Physician Decision|0
7500715|NCT03311724|26021607|P2|Overall Study|Physician Decision|0
7500716|NCT03311724|26021608|P1|Overall Study|Physician Decision|0
7500717|NCT03311659|26021645|P1|Overall Study|Protocol Violation|1
7500718|NCT03311646|26021660|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
7500719|NCT03311646|26021660|P1|Overall Study|Lost to Follow-up|5
7500720|NCT03311646|26021660|P1|Overall Study|Withdrawal by Subject|5
7500721|NCT03311646|26021660|P1|Overall Study|Physician Decision|1
7500722|NCT03311373|26021667|P1|Overall Study|Withdrawal by Subject|3
7500723|NCT03311373|26021667|P1|Overall Study|Physician Decision|1
7500724|NCT03311373|26021667|P1|Overall Study|Lost to Follow-up|1
7500725|NCT03311373|26021667|P1|Overall Study|Protocol Discontinuation Criteria|3
7500726|NCT03311373|26021667|P1|Overall Study|Adverse Event|1
7500727|NCT03311230|26021725|P4|Overall Study|Unrelated injury|0
7500728|NCT03311230|26021726|P3|Overall Study|Unrelated injury|0
7500729|NCT03311230|26021727|P2|Overall Study|Unrelated injury|1
7500730|NCT03311230|26021728|P1|Overall Study|Unrelated injury|0
7500731|NCT03311230|26021725|P4|Overall Study|Withdrawal by Subject|7
7500732|NCT03311230|26021726|P3|Overall Study|Withdrawal by Subject|2
7500733|NCT03311230|26021727|P2|Overall Study|Withdrawal by Subject|4
7500734|NCT03311230|26021728|P1|Overall Study|Withdrawal by Subject|1
7500735|NCT03310775|26021752|P2|Overall Study|aggravation of depression|1
7500736|NCT03310775|26021753|P1|Overall Study|aggravation of depression|0
7500737|NCT03310775|26021752|P2|Overall Study|Lost to Follow-up|3
7500738|NCT03310775|26021753|P1|Overall Study|Lost to Follow-up|2
7500739|NCT03310723|26021771|P2|Overall Study|Protocol Violation|2
7500740|NCT03310723|26021772|P1|Overall Study|Protocol Violation|0
7500741|NCT03310723|26021771|P2|Overall Study|Withdrawal by Subject|1
7500742|NCT03310723|26021772|P1|Overall Study|Withdrawal by Subject|0
7500743|NCT03310580|26021783|P3|Overall Study|Adverse Event|0
7500744|NCT03310580|26021784|P2|Overall Study|Adverse Event|1
7500745|NCT03310580|26021785|P1|Overall Study|Adverse Event|0
7500746|NCT03310411|26021818|P4|Period 1|Adverse Event|1
7500747|NCT03310411|26021819|P3|Period 1|Adverse Event|0
7500748|NCT03310411|26021820|P2|Period 1|Adverse Event|0
7500749|NCT03310411|26021821|P1|Period 1|Adverse Event|0
7500750|NCT03310268|26021842|P3|Overall Study|(Not specified)|0
7500751|NCT03310268|26021843|P2|Overall Study|(Not specified)|5
7500752|NCT03310268|26021844|P1|Overall Study|(Not specified)|1
7500753|NCT03310021|26021875|P20|Overall Study|Lost to Follow-up|0
7500754|NCT03310021|26021876|P19|Overall Study|Lost to Follow-up|0
7500755|NCT03310021|26021877|P18|Overall Study|Lost to Follow-up|0
7500756|NCT03310021|26021878|P17|Overall Study|Lost to Follow-up|0
7500757|NCT03310021|26021879|P16|Overall Study|Lost to Follow-up|0
7500758|NCT03310021|26021880|P15|Overall Study|Lost to Follow-up|0
7500759|NCT03310021|26021881|P14|Overall Study|Lost to Follow-up|0
7500760|NCT03310021|26021882|P13|Overall Study|Lost to Follow-up|0
7500761|NCT03310021|26021883|P12|Overall Study|Lost to Follow-up|0
7500762|NCT03310021|26021884|P11|Overall Study|Lost to Follow-up|1
7500763|NCT03310021|26021885|P10|Overall Study|Lost to Follow-up|0
7500764|NCT03310021|26021886|P9|Overall Study|Lost to Follow-up|0
7500765|NCT03310021|26021887|P8|Overall Study|Lost to Follow-up|0
7500766|NCT03310021|26021888|P7|Overall Study|Lost to Follow-up|0
7500767|NCT03310021|26021889|P6|Overall Study|Lost to Follow-up|0
7500768|NCT03310021|26021890|P5|Overall Study|Lost to Follow-up|0
7500769|NCT03310021|26021891|P4|Overall Study|Lost to Follow-up|0
7500770|NCT03310021|26021892|P3|Overall Study|Lost to Follow-up|0
7500771|NCT03310021|26021893|P2|Overall Study|Lost to Follow-up|0
7500772|NCT03310021|26021894|P1|Overall Study|Lost to Follow-up|0
7500773|NCT03310021|26021875|P20|Overall Study|Withdrawal by Subject|0
7500774|NCT03310021|26021876|P19|Overall Study|Withdrawal by Subject|0
7500775|NCT03310021|26021877|P18|Overall Study|Withdrawal by Subject|0
7500776|NCT03310021|26021878|P17|Overall Study|Withdrawal by Subject|0
7500777|NCT03310021|26021879|P16|Overall Study|Withdrawal by Subject|0
7500778|NCT03310021|26021880|P15|Overall Study|Withdrawal by Subject|0
7500779|NCT03310021|26021881|P14|Overall Study|Withdrawal by Subject|0
7500780|NCT03310021|26021882|P13|Overall Study|Withdrawal by Subject|0
7500781|NCT03310021|26021883|P12|Overall Study|Withdrawal by Subject|0
7500782|NCT03310021|26021884|P11|Overall Study|Withdrawal by Subject|0
7500783|NCT03310021|26021885|P10|Overall Study|Withdrawal by Subject|0
7500784|NCT03310021|26021886|P9|Overall Study|Withdrawal by Subject|0
7500785|NCT03310021|26021887|P8|Overall Study|Withdrawal by Subject|0
7500786|NCT03310021|26021888|P7|Overall Study|Withdrawal by Subject|1
7500787|NCT03310021|26021889|P6|Overall Study|Withdrawal by Subject|0
7500788|NCT03310021|26021890|P5|Overall Study|Withdrawal by Subject|0
7500789|NCT03310021|26021891|P4|Overall Study|Withdrawal by Subject|0
7500790|NCT03310021|26021892|P3|Overall Study|Withdrawal by Subject|0
7500791|NCT03310021|26021893|P2|Overall Study|Withdrawal by Subject|0
7500792|NCT03310021|26021894|P1|Overall Study|Withdrawal by Subject|0
7500793|NCT03309943|26022038|P2|Overall Study|Inappropriate behavior towards staff|1
7500794|NCT03309943|26022039|P1|Overall Study|Inappropriate behavior towards staff|0
7500795|NCT03309943|26022038|P2|Overall Study|Withdrawal by Subject|1
7500796|NCT03309943|26022039|P1|Overall Study|Withdrawal by Subject|0
7500797|NCT03309696|26022102|P4|Overall Study|Analysis of TEP data could not be completed|0
7500798|NCT03309696|26022103|P3|Overall Study|Analysis of TEP data could not be completed|0
7500799|NCT03309696|26022104|P2|Overall Study|Analysis of TEP data could not be completed|5
7500800|NCT03309696|26022105|P1|Overall Study|Analysis of TEP data could not be completed|0
7500801|NCT03309605|26022128|P8|Overall Study|Withdrawal by Subject|1
7500802|NCT03309605|26022129|P7|Overall Study|Withdrawal by Subject|1
7500803|NCT03309605|26022130|P6|Overall Study|Withdrawal by Subject|0
7500804|NCT03309605|26022131|P5|Overall Study|Withdrawal by Subject|1
7500805|NCT03309605|26022132|P4|Overall Study|Withdrawal by Subject|0
7500806|NCT03309605|26022133|P3|Overall Study|Withdrawal by Subject|0
7500807|NCT03309605|26022134|P2|Overall Study|Withdrawal by Subject|0
7500808|NCT03309605|26022135|P1|Overall Study|Withdrawal by Subject|0
7500809|NCT03309605|26022128|P8|Overall Study|Adverse Event|1
7500810|NCT03309605|26022129|P7|Overall Study|Adverse Event|2
7500811|NCT03309605|26022130|P6|Overall Study|Adverse Event|0
7500812|NCT03309605|26022131|P5|Overall Study|Adverse Event|0
7500813|NCT03309605|26022132|P4|Overall Study|Adverse Event|1
7500814|NCT03309605|26022133|P3|Overall Study|Adverse Event|0
7500815|NCT03309605|26022134|P2|Overall Study|Adverse Event|0
7500816|NCT03309605|26022135|P1|Overall Study|Adverse Event|0
7500817|NCT03309202|26022243|P4|Overall Study|Lost to Follow-up|0
7500818|NCT03309202|26022244|P3|Overall Study|Lost to Follow-up|0
7500819|NCT03309202|26022245|P2|Overall Study|Lost to Follow-up|0
7500820|NCT03309202|26022246|P1|Overall Study|Lost to Follow-up|1
7500821|NCT03309020|26022339|P2|Overall Study|Did not undergo surgery|1
7500822|NCT03309020|26022340|P1|Overall Study|Did not undergo surgery|2
7500823|NCT03309020|26022339|P2|Overall Study|Death|0
7500824|NCT03309020|26022340|P1|Overall Study|Death|1
7500825|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
7500826|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
7500827|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
7500828|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7500829|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7500830|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
7500831|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
7500832|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7500833|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7500834|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
7500835|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
7500836|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
7500837|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
7500838|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7500839|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7500840|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Adverse Event|1
7500841|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Adverse Event|1
7500842|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Adverse Event|4
7500843|NCT03308968|26022366|P3|Open-Label Period (12 Weeks)|Other than specified|1
7500844|NCT03308968|26022367|P2|Open-Label Period (12 Weeks)|Other than specified|2
7500845|NCT03308968|26022368|P1|Open-Label Period (12 Weeks)|Other than specified|1
7500846|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Other than specified|2
7500847|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Other than specified|0
7500848|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Other than specified|1
7500849|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
7500850|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7500851|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7500852|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7500853|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7500854|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
7500855|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
7500856|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7500857|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7500858|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
7500859|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
7500860|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
7500861|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
7500862|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7500863|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7500864|NCT03308968|26022366|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
7500865|NCT03308968|26022367|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
7500866|NCT03308968|26022368|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
7500897|NCT03308825|26022502|P4|Overall Study|Protocol Violation|0
7500898|NCT03308825|26022503|P3|Overall Study|Protocol Violation|0
7500899|NCT03308825|26022504|P2|Overall Study|Protocol Violation|2
7500900|NCT03308825|26022505|P1|Overall Study|Protocol Violation|0
7500901|NCT03308825|26022502|P4|Overall Study|Lost to Follow-up|0
7500902|NCT03308825|26022503|P3|Overall Study|Lost to Follow-up|1
7500903|NCT03308825|26022504|P2|Overall Study|Lost to Follow-up|2
7500904|NCT03308825|26022505|P1|Overall Study|Lost to Follow-up|2
7500905|NCT03307837|26022615|P6|Overall Study|Lost to Follow-up|1
7500906|NCT03307837|26022616|P5|Overall Study|Lost to Follow-up|0
7500907|NCT03307837|26022617|P4|Overall Study|Lost to Follow-up|0
7500908|NCT03307837|26022618|P3|Overall Study|Lost to Follow-up|0
7500909|NCT03307837|26022619|P2|Overall Study|Lost to Follow-up|1
7500910|NCT03307837|26022620|P1|Overall Study|Lost to Follow-up|1
7500911|NCT03307837|26022615|P6|Overall Study|Withdrawal by Subject|1
7500912|NCT03307837|26022616|P5|Overall Study|Withdrawal by Subject|0
7500913|NCT03307837|26022617|P4|Overall Study|Withdrawal by Subject|0
7500914|NCT03307837|26022618|P3|Overall Study|Withdrawal by Subject|1
7500915|NCT03307837|26022619|P2|Overall Study|Withdrawal by Subject|0
7500916|NCT03307837|26022620|P1|Overall Study|Withdrawal by Subject|0
7500917|NCT03307785|26022663|P11|Part F: Up to 3.5 Months|Physician Decision|0
7500918|NCT03307785|26022664|P10|Part F: Up to 3.5 Months|Physician Decision|0
7500919|NCT03307785|26022665|P9|Part F: Up to 3.5 Months|Physician Decision|0
7500920|NCT03307785|26022666|P8|Part F: Up to 3.5 Months|Physician Decision|1
7500921|NCT03307785|26022667|P7|Part F: Up to 3.5 Months|Physician Decision|0
7500922|NCT03307785|26022668|P6|Part F: Up to 3.5 Months|Physician Decision|0
7500923|NCT03307785|26022669|P5|Part F: Up to 3.5 Months|Physician Decision|0
7500924|NCT03307785|26022670|P4|Part F: Up to 3.5 Months|Physician Decision|0
7500925|NCT03307785|26022671|P3|Part F: Up to 3.5 Months|Physician Decision|0
7500926|NCT03307785|26022672|P2|Part F: Up to 3.5 Months|Physician Decision|0
7500927|NCT03307785|26022673|P1|Part F: Up to 3.5 Months|Physician Decision|0
7500928|NCT03307785|26022663|P11|Part E: Up to 4.4 Months|Physician Decision|0
7500929|NCT03307785|26022664|P10|Part E: Up to 4.4 Months|Physician Decision|0
7500930|NCT03307785|26022665|P9|Part E: Up to 4.4 Months|Physician Decision|0
7500931|NCT03307785|26022666|P8|Part E: Up to 4.4 Months|Physician Decision|0
7500932|NCT03307785|26022667|P7|Part E: Up to 4.4 Months|Physician Decision|1
7500933|NCT03307785|26022668|P6|Part E: Up to 4.4 Months|Physician Decision|0
7500934|NCT03307785|26022669|P5|Part E: Up to 4.4 Months|Physician Decision|0
7500935|NCT03307785|26022670|P4|Part E: Up to 4.4 Months|Physician Decision|0
7500936|NCT03307785|26022671|P3|Part E: Up to 4.4 Months|Physician Decision|0
7500937|NCT03307785|26022672|P2|Part E: Up to 4.4 Months|Physician Decision|0
7500938|NCT03307785|26022673|P1|Part E: Up to 4.4 Months|Physician Decision|0
7500939|NCT03307785|26022663|P11|Part E: Up to 4.4 Months|Death|0
7500940|NCT03307785|26022664|P10|Part E: Up to 4.4 Months|Death|0
7500941|NCT03307785|26022665|P9|Part E: Up to 4.4 Months|Death|0
7500942|NCT03307785|26022666|P8|Part E: Up to 4.4 Months|Death|0
7500943|NCT03307785|26022667|P7|Part E: Up to 4.4 Months|Death|1
7500944|NCT03307785|26022668|P6|Part E: Up to 4.4 Months|Death|0
7500945|NCT03307785|26022669|P5|Part E: Up to 4.4 Months|Death|0
7500946|NCT03307785|26022670|P4|Part E: Up to 4.4 Months|Death|0
7500947|NCT03307785|26022671|P3|Part E: Up to 4.4 Months|Death|0
7500948|NCT03307785|26022672|P2|Part E: Up to 4.4 Months|Death|0
7500949|NCT03307785|26022673|P1|Part E: Up to 4.4 Months|Death|0
7500950|NCT03307785|26022663|P11|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500951|NCT03307785|26022664|P10|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500952|NCT03307785|26022665|P9|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500953|NCT03307785|26022666|P8|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500954|NCT03307785|26022667|P7|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500955|NCT03307785|26022668|P6|Part D: Up to 9.5 Months|Withdrawal by Subject|1
7500956|NCT03307785|26022669|P5|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500957|NCT03307785|26022670|P4|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500958|NCT03307785|26022671|P3|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500959|NCT03307785|26022672|P2|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500960|NCT03307785|26022673|P1|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7500961|NCT03307785|26022663|P11|Part D: Up to 9.5 Months|Death|0
7500962|NCT03307785|26022664|P10|Part D: Up to 9.5 Months|Death|0
7500963|NCT03307785|26022665|P9|Part D: Up to 9.5 Months|Death|0
7500964|NCT03307785|26022666|P8|Part D: Up to 9.5 Months|Death|0
7500965|NCT03307785|26022667|P7|Part D: Up to 9.5 Months|Death|0
7500966|NCT03307785|26022668|P6|Part D: Up to 9.5 Months|Death|1
7500967|NCT03307785|26022669|P5|Part D: Up to 9.5 Months|Death|0
7500968|NCT03307785|26022670|P4|Part D: Up to 9.5 Months|Death|0
7500969|NCT03307785|26022671|P3|Part D: Up to 9.5 Months|Death|0
7500970|NCT03307785|26022672|P2|Part D: Up to 9.5 Months|Death|0
7500971|NCT03307785|26022673|P1|Part D: Up to 9.5 Months|Death|0
7500972|NCT03307785|26022663|P11|Part D: Up to 9.5 Months|Physician Decision|0
7500973|NCT03307785|26022664|P10|Part D: Up to 9.5 Months|Physician Decision|0
7500974|NCT03307785|26022665|P9|Part D: Up to 9.5 Months|Physician Decision|0
7500975|NCT03307785|26022666|P8|Part D: Up to 9.5 Months|Physician Decision|0
7500976|NCT03307785|26022667|P7|Part D: Up to 9.5 Months|Physician Decision|0
7500977|NCT03307785|26022668|P6|Part D: Up to 9.5 Months|Physician Decision|1
7500978|NCT03307785|26022669|P5|Part D: Up to 9.5 Months|Physician Decision|0
7500979|NCT03307785|26022670|P4|Part D: Up to 9.5 Months|Physician Decision|0
7500980|NCT03307785|26022671|P3|Part D: Up to 9.5 Months|Physician Decision|0
7500981|NCT03307785|26022672|P2|Part D: Up to 9.5 Months|Physician Decision|0
7500982|NCT03307785|26022673|P1|Part D: Up to 9.5 Months|Physician Decision|0
7500983|NCT03307785|26022663|P11|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500984|NCT03307785|26022664|P10|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500985|NCT03307785|26022665|P9|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500986|NCT03307785|26022666|P8|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500987|NCT03307785|26022667|P7|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500988|NCT03307785|26022668|P6|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500989|NCT03307785|26022669|P5|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
7500990|NCT03307785|26022670|P4|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
7500991|NCT03307785|26022671|P3|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500992|NCT03307785|26022672|P2|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500993|NCT03307785|26022673|P1|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7500994|NCT03307785|26022663|P11|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7500995|NCT03307785|26022664|P10|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7500996|NCT03307785|26022665|P9|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7500997|NCT03307785|26022666|P8|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7500998|NCT03307785|26022667|P7|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7500999|NCT03307785|26022668|P6|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7501000|NCT03307785|26022669|P5|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7501001|NCT03307785|26022670|P4|Part C: Up to 22.5 Months|Withdrawal by Subject|1
7501002|NCT03307785|26022671|P3|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7501003|NCT03307785|26022672|P2|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7501004|NCT03307785|26022673|P1|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7501005|NCT03307785|26022663|P11|Part C: Up to 22.5 Months|Death|0
7501006|NCT03307785|26022664|P10|Part C: Up to 22.5 Months|Death|0
7501007|NCT03307785|26022665|P9|Part C: Up to 22.5 Months|Death|0
7501008|NCT03307785|26022666|P8|Part C: Up to 22.5 Months|Death|0
7501009|NCT03307785|26022667|P7|Part C: Up to 22.5 Months|Death|0
7501010|NCT03307785|26022668|P6|Part C: Up to 22.5 Months|Death|0
7501011|NCT03307785|26022669|P5|Part C: Up to 22.5 Months|Death|4
7501012|NCT03307785|26022670|P4|Part C: Up to 22.5 Months|Death|1
7501013|NCT03307785|26022671|P3|Part C: Up to 22.5 Months|Death|0
7501014|NCT03307785|26022672|P2|Part C: Up to 22.5 Months|Death|0
7501015|NCT03307785|26022673|P1|Part C: Up to 22.5 Months|Death|0
7501016|NCT03307785|26022663|P11|Part C: Up to 22.5 Months|Physician Decision|0
7501017|NCT03307785|26022664|P10|Part C: Up to 22.5 Months|Physician Decision|0
7501018|NCT03307785|26022665|P9|Part C: Up to 22.5 Months|Physician Decision|0
7501019|NCT03307785|26022666|P8|Part C: Up to 22.5 Months|Physician Decision|0
7501020|NCT03307785|26022667|P7|Part C: Up to 22.5 Months|Physician Decision|0
7501021|NCT03307785|26022668|P6|Part C: Up to 22.5 Months|Physician Decision|0
7501022|NCT03307785|26022669|P5|Part C: Up to 22.5 Months|Physician Decision|1
7501023|NCT03307785|26022670|P4|Part C: Up to 22.5 Months|Physician Decision|3
7501024|NCT03307785|26022671|P3|Part C: Up to 22.5 Months|Physician Decision|0
7501025|NCT03307785|26022672|P2|Part C: Up to 22.5 Months|Physician Decision|0
7501026|NCT03307785|26022673|P1|Part C: Up to 22.5 Months|Physician Decision|0
7501027|NCT03307785|26022663|P11|Part C: Up to 22.5 Months|Disease progression|0
7501028|NCT03307785|26022664|P10|Part C: Up to 22.5 Months|Disease progression|0
7501029|NCT03307785|26022665|P9|Part C: Up to 22.5 Months|Disease progression|0
7501030|NCT03307785|26022666|P8|Part C: Up to 22.5 Months|Disease progression|0
7501031|NCT03307785|26022667|P7|Part C: Up to 22.5 Months|Disease progression|0
7501032|NCT03307785|26022668|P6|Part C: Up to 22.5 Months|Disease progression|0
7501033|NCT03307785|26022669|P5|Part C: Up to 22.5 Months|Disease progression|1
7501034|NCT03307785|26022670|P4|Part C: Up to 22.5 Months|Disease progression|0
7501035|NCT03307785|26022671|P3|Part C: Up to 22.5 Months|Disease progression|0
7501036|NCT03307785|26022672|P2|Part C: Up to 22.5 Months|Disease progression|0
7501037|NCT03307785|26022673|P1|Part C: Up to 22.5 Months|Disease progression|0
7501038|NCT03307785|26022663|P11|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501039|NCT03307785|26022664|P10|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501040|NCT03307785|26022665|P9|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501041|NCT03307785|26022666|P8|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501042|NCT03307785|26022667|P7|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501043|NCT03307785|26022668|P6|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501044|NCT03307785|26022669|P5|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501045|NCT03307785|26022670|P4|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501046|NCT03307785|26022671|P3|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4
7501047|NCT03307785|26022672|P2|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501048|NCT03307785|26022673|P1|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7501049|NCT03307785|26022663|P11|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501050|NCT03307785|26022664|P10|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501051|NCT03307785|26022665|P9|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501052|NCT03307785|26022666|P8|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501053|NCT03307785|26022667|P7|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501054|NCT03307785|26022668|P6|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501055|NCT03307785|26022669|P5|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501056|NCT03307785|26022670|P4|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501057|NCT03307785|26022671|P3|Part B: Up to 28.5 Months|Withdrawal by Subject|1
7501058|NCT03307785|26022672|P2|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501059|NCT03307785|26022673|P1|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7501060|NCT03307785|26022663|P11|Part B: Up to 28.5 Months|Death|0
7501061|NCT03307785|26022664|P10|Part B: Up to 28.5 Months|Death|0
7501062|NCT03307785|26022665|P9|Part B: Up to 28.5 Months|Death|0
7501063|NCT03307785|26022666|P8|Part B: Up to 28.5 Months|Death|0
7501064|NCT03307785|26022667|P7|Part B: Up to 28.5 Months|Death|0
7501065|NCT03307785|26022668|P6|Part B: Up to 28.5 Months|Death|0
7501066|NCT03307785|26022669|P5|Part B: Up to 28.5 Months|Death|0
7501067|NCT03307785|26022670|P4|Part B: Up to 28.5 Months|Death|0
7501068|NCT03307785|26022671|P3|Part B: Up to 28.5 Months|Death|7
7501069|NCT03307785|26022672|P2|Part B: Up to 28.5 Months|Death|0
7501070|NCT03307785|26022673|P1|Part B: Up to 28.5 Months|Death|0
7501071|NCT03307785|26022663|P11|Part B: Up to 28.5 Months|Physician Decision|0
7501072|NCT03307785|26022664|P10|Part B: Up to 28.5 Months|Physician Decision|0
7501073|NCT03307785|26022665|P9|Part B: Up to 28.5 Months|Physician Decision|0
7501074|NCT03307785|26022666|P8|Part B: Up to 28.5 Months|Physician Decision|0
7501075|NCT03307785|26022667|P7|Part B: Up to 28.5 Months|Physician Decision|0
7501076|NCT03307785|26022668|P6|Part B: Up to 28.5 Months|Physician Decision|0
7501077|NCT03307785|26022669|P5|Part B: Up to 28.5 Months|Physician Decision|0
7501078|NCT03307785|26022670|P4|Part B: Up to 28.5 Months|Physician Decision|0
7501079|NCT03307785|26022671|P3|Part B: Up to 28.5 Months|Physician Decision|1
7501080|NCT03307785|26022672|P2|Part B: Up to 28.5 Months|Physician Decision|0
7501081|NCT03307785|26022673|P1|Part B: Up to 28.5 Months|Physician Decision|0
7501082|NCT03307785|26022663|P11|Part B: Up to 28.5 Months|Disease progression|0
7501083|NCT03307785|26022664|P10|Part B: Up to 28.5 Months|Disease progression|0
7501084|NCT03307785|26022665|P9|Part B: Up to 28.5 Months|Disease progression|0
7501085|NCT03307785|26022666|P8|Part B: Up to 28.5 Months|Disease progression|0
7501086|NCT03307785|26022667|P7|Part B: Up to 28.5 Months|Disease progression|0
7501087|NCT03307785|26022668|P6|Part B: Up to 28.5 Months|Disease progression|0
7501088|NCT03307785|26022669|P5|Part B: Up to 28.5 Months|Disease progression|0
7501089|NCT03307785|26022670|P4|Part B: Up to 28.5 Months|Disease progression|0
7501090|NCT03307785|26022671|P3|Part B: Up to 28.5 Months|Disease progression|1
7501091|NCT03307785|26022672|P2|Part B: Up to 28.5 Months|Disease progression|0
7501092|NCT03307785|26022673|P1|Part B: Up to 28.5 Months|Disease progression|0
7501093|NCT03307785|26022663|P11|Part A: Up to 28.5 Months|Physician Decision|0
7501094|NCT03307785|26022664|P10|Part A: Up to 28.5 Months|Physician Decision|0
7501095|NCT03307785|26022665|P9|Part A: Up to 28.5 Months|Physician Decision|0
7501096|NCT03307785|26022666|P8|Part A: Up to 28.5 Months|Physician Decision|0
7501097|NCT03307785|26022667|P7|Part A: Up to 28.5 Months|Physician Decision|0
7501098|NCT03307785|26022668|P6|Part A: Up to 28.5 Months|Physician Decision|0
7501099|NCT03307785|26022669|P5|Part A: Up to 28.5 Months|Physician Decision|0
7501100|NCT03307785|26022670|P4|Part A: Up to 28.5 Months|Physician Decision|0
7501101|NCT03307785|26022671|P3|Part A: Up to 28.5 Months|Physician Decision|0
7501102|NCT03307785|26022672|P2|Part A: Up to 28.5 Months|Physician Decision|1
7501103|NCT03307785|26022673|P1|Part A: Up to 28.5 Months|Physician Decision|3
7501104|NCT03307785|26022663|P11|Part A: Up to 28.5 Months|Death|0
7501105|NCT03307785|26022664|P10|Part A: Up to 28.5 Months|Death|0
7501106|NCT03307785|26022665|P9|Part A: Up to 28.5 Months|Death|0
7501107|NCT03307785|26022666|P8|Part A: Up to 28.5 Months|Death|0
7501108|NCT03307785|26022667|P7|Part A: Up to 28.5 Months|Death|0
7501109|NCT03307785|26022668|P6|Part A: Up to 28.5 Months|Death|0
7501110|NCT03307785|26022669|P5|Part A: Up to 28.5 Months|Death|0
7501111|NCT03307785|26022670|P4|Part A: Up to 28.5 Months|Death|0
7501112|NCT03307785|26022671|P3|Part A: Up to 28.5 Months|Death|0
7501113|NCT03307785|26022672|P2|Part A: Up to 28.5 Months|Death|4
7501114|NCT03307785|26022673|P1|Part A: Up to 28.5 Months|Death|4
7501115|NCT03307785|26022663|P11|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501116|NCT03307785|26022664|P10|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501117|NCT03307785|26022665|P9|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501118|NCT03307785|26022666|P8|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501119|NCT03307785|26022667|P7|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501120|NCT03307785|26022668|P6|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501121|NCT03307785|26022669|P5|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501122|NCT03307785|26022670|P4|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501123|NCT03307785|26022671|P3|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7501124|NCT03307785|26022672|P2|Part A: Up to 28.5 Months|Withdrawal by Subject|1
7501125|NCT03307785|26022673|P1|Part A: Up to 28.5 Months|Withdrawal by Subject|7
7501126|NCT03307785|26022663|P11|Part A: Up to 28.5 Months|Disease progression|0
7501127|NCT03307785|26022664|P10|Part A: Up to 28.5 Months|Disease progression|0
7501128|NCT03307785|26022665|P9|Part A: Up to 28.5 Months|Disease progression|0
7501129|NCT03307785|26022666|P8|Part A: Up to 28.5 Months|Disease progression|0
7501130|NCT03307785|26022667|P7|Part A: Up to 28.5 Months|Disease progression|0
7501131|NCT03307785|26022668|P6|Part A: Up to 28.5 Months|Disease progression|0
7501132|NCT03307785|26022669|P5|Part A: Up to 28.5 Months|Disease progression|0
7501133|NCT03307785|26022670|P4|Part A: Up to 28.5 Months|Disease progression|0
7501134|NCT03307785|26022671|P3|Part A: Up to 28.5 Months|Disease progression|0
7501135|NCT03307785|26022672|P2|Part A: Up to 28.5 Months|Disease progression|0
7501136|NCT03307785|26022673|P1|Part A: Up to 28.5 Months|Disease progression|2
7501137|NCT03307252|26022982|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
7501138|NCT03307252|26022983|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501139|NCT03307252|26022984|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501140|NCT03307252|26022985|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501141|NCT03307252|26022986|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501142|NCT03307252|26022987|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501143|NCT03307252|26022988|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501144|NCT03307252|26022989|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501145|NCT03307252|26022990|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501146|NCT03307252|26022991|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501147|NCT03307252|26022992|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7501148|NCT03307252|26022982|P11|Part 2, Period 4|Other than listed|0
7501149|NCT03307252|26022983|P10|Part 2, Period 4|Other than listed|0
7501150|NCT03307252|26022984|P9|Part 2, Period 4|Other than listed|0
7501151|NCT03307252|26022985|P8|Part 2, Period 4|Other than listed|0
7501152|NCT03307252|26022986|P7|Part 2, Period 4|Other than listed|1
7501153|NCT03307252|26022987|P6|Part 2, Period 4|Other than listed|0
7501154|NCT03307252|26022988|P5|Part 2, Period 4|Other than listed|0
7501155|NCT03307252|26022989|P4|Part 2, Period 4|Other than listed|0
7501156|NCT03307252|26022990|P3|Part 2, Period 4|Other than listed|0
7501157|NCT03307252|26022991|P2|Part 2, Period 4|Other than listed|0
7501158|NCT03307252|26022992|P1|Part 2, Period 4|Other than listed|0
7501159|NCT03307252|26022982|P11|Part 2, Period 3|Other than listed|0
7501160|NCT03307252|26022983|P10|Part 2, Period 3|Other than listed|0
7501161|NCT03307252|26022984|P9|Part 2, Period 3|Other than listed|0
7501162|NCT03307252|26022985|P8|Part 2, Period 3|Other than listed|0
7501163|NCT03307252|26022986|P7|Part 2, Period 3|Other than listed|0
7501164|NCT03307252|26022987|P6|Part 2, Period 3|Other than listed|0
7501165|NCT03307252|26022988|P5|Part 2, Period 3|Other than listed|1
7501166|NCT03307252|26022989|P4|Part 2, Period 3|Other than listed|0
7501167|NCT03307252|26022990|P3|Part 2, Period 3|Other than listed|0
7501168|NCT03307252|26022991|P2|Part 2, Period 3|Other than listed|0
7501169|NCT03307252|26022992|P1|Part 2, Period 3|Other than listed|0
7501170|NCT03307252|26022982|P11|Part 2, Period 1|Treatment not received|0
7501171|NCT03307252|26022983|P10|Part 2, Period 1|Treatment not received|0
7501172|NCT03307252|26022984|P9|Part 2, Period 1|Treatment not received|0
7501173|NCT03307252|26022985|P8|Part 2, Period 1|Treatment not received|0
7501174|NCT03307252|26022986|P7|Part 2, Period 1|Treatment not received|0
7501175|NCT03307252|26022987|P6|Part 2, Period 1|Treatment not received|1
7501176|NCT03307252|26022988|P5|Part 2, Period 1|Treatment not received|0
7501177|NCT03307252|26022989|P4|Part 2, Period 1|Treatment not received|0
7501178|NCT03307252|26022990|P3|Part 2, Period 1|Treatment not received|0
7501179|NCT03307252|26022991|P2|Part 2, Period 1|Treatment not received|0
7501180|NCT03307252|26022992|P1|Part 2, Period 1|Treatment not received|0
7501181|NCT03307174|26023029|P2|Overall Study|Intrathecal catheter placement|1
7501182|NCT03307174|26023030|P1|Overall Study|Intrathecal catheter placement|0
7501183|NCT03307174|26023029|P2|Overall Study|Planned epidural removal|0
7501184|NCT03307174|26023030|P1|Overall Study|Planned epidural removal|1
7501185|NCT03307174|26023029|P2|Overall Study|Nonfunctional epidural|1
7501186|NCT03307174|26023030|P1|Overall Study|Nonfunctional epidural|1
7501187|NCT03307174|26023029|P2|Overall Study|Hypotension|0
7501188|NCT03307174|26023030|P1|Overall Study|Hypotension|6
7501189|NCT03307174|26023029|P2|Overall Study|Aborted Surgery|2
7501190|NCT03307174|26023030|P1|Overall Study|Aborted Surgery|1
7501191|NCT03307174|26023029|P2|Overall Study|Unplanned ICU Administrion|3
7501192|NCT03307174|26023030|P1|Overall Study|Unplanned ICU Administrion|5
7501193|NCT03306433|26023190|P1|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
7501194|NCT03306433|26023190|P1|Overall Study|Patient did not have teeth extracted|1
7501195|NCT03306433|26023190|P1|Overall Study|Lost to Follow-up|3
7501196|NCT03306277|26023322|P1|Overall Study|Withdrawal by Subject|1
7501197|NCT03306277|26023322|P1|Overall Study|Adverse Event|1
7501198|NCT03306277|26023322|P1|Overall Study|Death|1
7501199|NCT03306043|26023333|P1|Overall Study|Withdrawal by Subject|2
7501200|NCT03306043|26023333|P1|Overall Study|Lost to Follow-up|1
7501201|NCT03306043|26023333|P1|Overall Study|Adverse Event|1
7501202|NCT03305809|26023361|P4|Overall Study|Withdrawal due to Caregiver Circumstances|1
7501203|NCT03305809|26023362|P3|Overall Study|Withdrawal due to Caregiver Circumstances|1
7501204|NCT03305809|26023363|P2|Overall Study|Withdrawal due to Caregiver Circumstances|0
7501205|NCT03305809|26023364|P1|Overall Study|Withdrawal due to Caregiver Circumstances|0
7501206|NCT03305809|26023361|P4|Overall Study|Withdrawal by Subject|2
7501207|NCT03305809|26023362|P3|Overall Study|Withdrawal by Subject|5
7501208|NCT03305809|26023363|P2|Overall Study|Withdrawal by Subject|4
7501209|NCT03305809|26023364|P1|Overall Study|Withdrawal by Subject|2
7501210|NCT03305809|26023361|P4|Overall Study|Withdrawal due to Assessment Committee Decision|2
7501211|NCT03305809|26023362|P3|Overall Study|Withdrawal due to Assessment Committee Decision|0
7501212|NCT03305809|26023363|P2|Overall Study|Withdrawal due to Assessment Committee Decision|0
7501213|NCT03305809|26023364|P1|Overall Study|Withdrawal due to Assessment Committee Decision|0
7501214|NCT03305809|26023361|P4|Overall Study|Protocol Violation|3
7501215|NCT03305809|26023362|P3|Overall Study|Protocol Violation|2
7501216|NCT03305809|26023363|P2|Overall Study|Protocol Violation|0
7501217|NCT03305809|26023364|P1|Overall Study|Protocol Violation|1
7501218|NCT03305809|26023361|P4|Overall Study|Progressive Disease|0
7501219|NCT03305809|26023362|P3|Overall Study|Progressive Disease|1
7501220|NCT03305809|26023363|P2|Overall Study|Progressive Disease|0
7501221|NCT03305809|26023364|P1|Overall Study|Progressive Disease|0
7501222|NCT03305809|26023361|P4|Overall Study|Physician Decision|4
7501223|NCT03305809|26023362|P3|Overall Study|Physician Decision|2
7501224|NCT03305809|26023363|P2|Overall Study|Physician Decision|0
7501225|NCT03305809|26023364|P1|Overall Study|Physician Decision|0
7501226|NCT03305809|26023361|P4|Overall Study|Sponsor Decision|8
7501227|NCT03305809|26023362|P3|Overall Study|Sponsor Decision|1
7501228|NCT03305809|26023363|P2|Overall Study|Sponsor Decision|0
7501229|NCT03305809|26023364|P1|Overall Study|Sponsor Decision|1
7501230|NCT03305809|26023361|P4|Overall Study|Lost to Follow-up|0
7501231|NCT03305809|26023362|P3|Overall Study|Lost to Follow-up|0
7501232|NCT03305809|26023363|P2|Overall Study|Lost to Follow-up|2
7501233|NCT03305809|26023364|P1|Overall Study|Lost to Follow-up|1
7501234|NCT03305809|26023361|P4|Overall Study|Death|1
7501235|NCT03305809|26023362|P3|Overall Study|Death|1
7501236|NCT03305809|26023363|P2|Overall Study|Death|0
7501237|NCT03305809|26023364|P1|Overall Study|Death|0
7501238|NCT03305809|26023361|P4|Overall Study|Adverse Event|6
7501239|NCT03305809|26023362|P3|Overall Study|Adverse Event|6
7501240|NCT03305809|26023363|P2|Overall Study|Adverse Event|2
7501241|NCT03305809|26023364|P1|Overall Study|Adverse Event|2
7501242|NCT03305770|26023451|P2|Overall Study|Subject moved|0
7501243|NCT03305770|26023452|P1|Overall Study|Subject moved|1
7501244|NCT03305770|26023451|P2|Overall Study|Physician Decision - prior to dispense|1
7501245|NCT03305770|26023452|P1|Overall Study|Physician Decision - prior to dispense|0
7501246|NCT03305731|26023460|P1|Overall Study|Protocol Violation|1
7501247|NCT03305666|26023471|P2|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
7501248|NCT03305666|26023472|P1|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
7501249|NCT03305575|26023488|P2|Overall Study|Physician Decision|0
7501250|NCT03305575|26023489|P1|Overall Study|Physician Decision|1
7501251|NCT03305419|26023509|P8|Part B (14 Days)|Physician Decision|0
7501252|NCT03305419|26023510|P7|Part B (14 Days)|Physician Decision|1
7501253|NCT03305419|26023511|P6|Part B (14 Days)|Physician Decision|8
7501254|NCT03305419|26023512|P5|Part B (14 Days)|Physician Decision|2
7501255|NCT03305419|26023513|P4|Part B (14 Days)|Physician Decision|0
7501256|NCT03305419|26023514|P3|Part B (14 Days)|Physician Decision|0
7501257|NCT03305419|26023515|P2|Part B (14 Days)|Physician Decision|0
7501258|NCT03305419|26023516|P1|Part B (14 Days)|Physician Decision|0
7501259|NCT03305419|26023509|P8|Part B (14 Days)|Adverse Event|0
7501260|NCT03305419|26023510|P7|Part B (14 Days)|Adverse Event|4
7501261|NCT03305419|26023511|P6|Part B (14 Days)|Adverse Event|2
7501262|NCT03305419|26023512|P5|Part B (14 Days)|Adverse Event|1
7501263|NCT03305419|26023513|P4|Part B (14 Days)|Adverse Event|0
7501264|NCT03305419|26023514|P3|Part B (14 Days)|Adverse Event|0
7501265|NCT03305419|26023515|P2|Part B (14 Days)|Adverse Event|0
7501266|NCT03305419|26023516|P1|Part B (14 Days)|Adverse Event|0
7501267|NCT03305419|26023509|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501268|NCT03305419|26023510|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501269|NCT03305419|26023511|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501270|NCT03305419|26023512|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501271|NCT03305419|26023513|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501272|NCT03305419|26023514|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501273|NCT03305419|26023515|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7501274|NCT03305419|26023516|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
7501275|NCT03305419|26023509|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501276|NCT03305419|26023510|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501277|NCT03305419|26023511|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501278|NCT03305419|26023512|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501279|NCT03305419|26023513|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501280|NCT03305419|26023514|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501281|NCT03305419|26023515|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7501282|NCT03305419|26023516|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
7501283|NCT03305419|26023509|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501284|NCT03305419|26023510|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501285|NCT03305419|26023511|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501286|NCT03305419|26023512|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501287|NCT03305419|26023513|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501288|NCT03305419|26023514|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501289|NCT03305419|26023515|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
7501290|NCT03305419|26023516|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7501291|NCT03305081|26023657|P2|Overall Study|Lost to Follow-up|15
7501292|NCT03305081|26023658|P1|Overall Study|Lost to Follow-up|10
7501293|NCT03305055|26023668|P2|Overall Study|Adverse Event|1
7501294|NCT03305055|26023669|P1|Overall Study|Adverse Event|1
7501295|NCT03305055|26023668|P2|Overall Study|Withdrawal by Subject|1
7501296|NCT03305055|26023669|P1|Overall Study|Withdrawal by Subject|0
7501297|NCT03304873|26023687|P2|Overall Study|Lost to Follow-up|8
7501298|NCT03304873|26023688|P1|Overall Study|Lost to Follow-up|1
7501299|NCT03304626|26023698|P2|Overall Study|Lack of Efficacy|1
7501300|NCT03304626|26023699|P1|Overall Study|Lack of Efficacy|1
7501301|NCT03304626|26023698|P2|Overall Study|Adverse Event|0
7501302|NCT03304626|26023699|P1|Overall Study|Adverse Event|1
7501303|NCT03304184|26023713|P2|Overall Study|Withdrawal by Subject|2
7501304|NCT03304184|26023714|P1|Overall Study|Withdrawal by Subject|1
7501305|NCT03303521|26023850|P2|Overall Study|Adverse Event|0
7501306|NCT03303521|26023851|P1|Overall Study|Adverse Event|1
7501307|NCT03303521|26023850|P2|Overall Study|Non-comliance to study protocol|1
7501308|NCT03303521|26023851|P1|Overall Study|Non-comliance to study protocol|0
7501309|NCT03303521|26023850|P2|Overall Study|Transferred to non-study dialysis center|0
7501310|NCT03303521|26023851|P1|Overall Study|Transferred to non-study dialysis center|1
7501311|NCT03303521|26023850|P2|Overall Study|Investigational product discontinuation|1
7501312|NCT03303521|26023851|P1|Overall Study|Investigational product discontinuation|0
7501313|NCT03303521|26023850|P2|Overall Study|Kidney transplantation|1
7501314|NCT03303521|26023851|P1|Overall Study|Kidney transplantation|0
7501315|NCT03303521|26023850|P2|Overall Study|Death|0
7501316|NCT03303521|26023851|P1|Overall Study|Death|1
7501317|NCT03303521|26023850|P2|Overall Study|Withdrawal by Subject|0
7501318|NCT03303521|26023851|P1|Overall Study|Withdrawal by Subject|2
7501319|NCT03303469|26023861|P1|Overall Study|Lost to Follow-up|2
7501320|NCT03303417|26023867|P2|Overall Study|Withdrawal by Subject|1
7501321|NCT03303417|26023868|P1|Overall Study|Withdrawal by Subject|1
7501322|NCT03303105|26023911|P2|Overall Study|Withdrawal by Subject|2
7501323|NCT03303105|26023912|P1|Overall Study|Withdrawal by Subject|0
7501324|NCT03303105|26023911|P2|Overall Study|Protocol Violation|0
7501325|NCT03303105|26023912|P1|Overall Study|Protocol Violation|1
7501326|NCT03303105|26023911|P2|Overall Study|Lack of Efficacy|0
7501327|NCT03303105|26023912|P1|Overall Study|Lack of Efficacy|1
7501328|NCT03303105|26023911|P2|Overall Study|Adverse Event|2
7501329|NCT03303105|26023912|P1|Overall Study|Adverse Event|0
7501330|NCT03303092|26023925|P3|Overall Study|Withdrawal by Subject|3
7501331|NCT03303092|26023926|P2|Overall Study|Withdrawal by Subject|1
7501332|NCT03303092|26023927|P1|Overall Study|Withdrawal by Subject|1
7501333|NCT03303092|26023925|P3|Overall Study|Protocol Violation|1
7501334|NCT03303092|26023926|P2|Overall Study|Protocol Violation|5
7501335|NCT03303092|26023927|P1|Overall Study|Protocol Violation|1
7501336|NCT03303092|26023925|P3|Overall Study|Adverse Event|1
7501337|NCT03303092|26023926|P2|Overall Study|Adverse Event|0
7501338|NCT03303092|26023927|P1|Overall Study|Adverse Event|1
7501339|NCT03303079|26023950|P3|Overall Study|Other than specified|0
7501340|NCT03303079|26023951|P2|Overall Study|Other than specified|2
7501341|NCT03303079|26023952|P1|Overall Study|Other than specified|0
7501342|NCT03303079|26023950|P3|Overall Study|Withdrawal by Subject|2
7501343|NCT03303079|26023951|P2|Overall Study|Withdrawal by Subject|4
7501344|NCT03303079|26023952|P1|Overall Study|Withdrawal by Subject|2
7501345|NCT03303079|26023950|P3|Overall Study|Protocol Violation|7
7501346|NCT03303079|26023951|P2|Overall Study|Protocol Violation|4
7501347|NCT03303079|26023952|P1|Overall Study|Protocol Violation|5
7501348|NCT03303079|26023950|P3|Overall Study|Adverse Event|3
7501349|NCT03303079|26023951|P2|Overall Study|Adverse Event|1
7501350|NCT03303079|26023952|P1|Overall Study|Adverse Event|0
7501351|NCT03302975|26023975|P1|Overall Study|Lost to Follow-up|4
7501352|NCT03302936|26023983|P2|Overall Study|Protocol Violation|4
7501353|NCT03302936|26023984|P1|Overall Study|Protocol Violation|3
7501354|NCT03302559|26024041|P1|Overall Study|Withdrew Consent|3
7501355|NCT03302559|26024041|P1|Overall Study|Lost to Follow-up|1
7501356|NCT03302559|26024041|P1|Overall Study|Adverse Event|2
7501357|NCT03302247|26024059|P1|Overall Study|Death|1
7501358|NCT03302247|26024059|P1|Overall Study|the study has closed prematurely|2
7501359|NCT03302234|26024066|P2|Overall Study|Laryngeal carcinoma|1
7501360|NCT03302234|26024067|P1|Overall Study|Laryngeal carcinoma|0
7501361|NCT03302234|26024066|P2|Overall Study|Withdrawal by Subject|1
7501362|NCT03302234|26024067|P1|Overall Study|Withdrawal by Subject|1
7501363|NCT03302234|26024066|P2|Overall Study|Death|135
7501364|NCT03302234|26024067|P1|Overall Study|Death|137
7501365|NCT03301844|26024109|P2|Overall Study|suspected colon cancer|1
7501366|NCT03301844|26024110|P1|Overall Study|suspected colon cancer|1
7501367|NCT03301740|26024137|P2|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
7501368|NCT03301740|26024138|P1|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
7501369|NCT03301740|26024137|P2|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
7501370|NCT03301740|26024138|P1|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
7501371|NCT03301714|26024181|P3|Overall Study|Did not receive allocated intervention|3
7501372|NCT03301714|26024182|P2|Overall Study|Did not receive allocated intervention|2
7501373|NCT03301714|26024183|P1|Overall Study|Did not receive allocated intervention|0
7501374|NCT03301714|26024181|P3|Overall Study|Lost to Follow-up|4
7501375|NCT03301714|26024182|P2|Overall Study|Lost to Follow-up|4
7501376|NCT03301714|26024183|P1|Overall Study|Lost to Follow-up|10
7501377|NCT03301649|26024200|P3|Overall Study|Other than specified|0
7501378|NCT03301649|26024201|P2|Overall Study|Other than specified|3
7501379|NCT03301649|26024202|P1|Overall Study|Other than specified|5
7501380|NCT03301649|26024200|P3|Overall Study|Withdrawal by Subject|0
7501381|NCT03301649|26024201|P2|Overall Study|Withdrawal by Subject|4
7501382|NCT03301649|26024202|P1|Overall Study|Withdrawal by Subject|10
7501383|NCT03301649|26024200|P3|Overall Study|Protocol Violation|1
7501384|NCT03301649|26024201|P2|Overall Study|Protocol Violation|1
7501385|NCT03301649|26024202|P1|Overall Study|Protocol Violation|0
7501386|NCT03301649|26024200|P3|Overall Study|Lost to Follow-up|3
7501387|NCT03301649|26024201|P2|Overall Study|Lost to Follow-up|11
7501388|NCT03301649|26024202|P1|Overall Study|Lost to Follow-up|11
7501389|NCT03301649|26024200|P3|Overall Study|Need alternate therapy due to live lice|81
7501390|NCT03301649|26024201|P2|Overall Study|Need alternate therapy due to live lice|25
7501391|NCT03301649|26024202|P1|Overall Study|Need alternate therapy due to live lice|17
7501392|NCT03301623|26024219|P2|Overall Study|Lost to Follow-up|1
7501393|NCT03301623|26024220|P1|Overall Study|Lost to Follow-up|3
7501394|NCT03301623|26024219|P2|Overall Study|Withdrawal by Subject|13
7501395|NCT03301623|26024220|P1|Overall Study|Withdrawal by Subject|11
7501396|NCT03301623|26024219|P2|Overall Study|Death|1
7501397|NCT03301623|26024220|P1|Overall Study|Death|3
7501398|NCT03301155|26024304|P2|Overall Study|Сompliance with exclusion criteria|7
7501399|NCT03301155|26024305|P1|Overall Study|Сompliance with exclusion criteria|8
7501400|NCT03300570|26024353|P2|Overall Study|Inadequate bowel prep|0
7501401|NCT03300570|26024354|P1|Overall Study|Inadequate bowel prep|1
7501402|NCT03300570|26024353|P2|Overall Study|Withdrawal by Subject|0
7501403|NCT03300570|26024354|P1|Overall Study|Withdrawal by Subject|1
7501404|NCT03300570|26024353|P2|Overall Study|Adverse Event|1
7501405|NCT03300570|26024354|P1|Overall Study|Adverse Event|0
7501406|NCT03300050|26024411|P5|Overall Study|Not Eligible at Randomization|0
7501407|NCT03300050|26024412|P4|Overall Study|Not Eligible at Randomization|1
7501408|NCT03300050|26024413|P3|Overall Study|Not Eligible at Randomization|1
7501409|NCT03300050|26024414|P2|Overall Study|Not Eligible at Randomization|0
7501410|NCT03300050|26024415|P1|Overall Study|Not Eligible at Randomization|0
7501411|NCT03300050|26024411|P5|Overall Study|Death|0
7501412|NCT03300050|26024412|P4|Overall Study|Death|0
7501413|NCT03300050|26024413|P3|Overall Study|Death|1
7501414|NCT03300050|26024414|P2|Overall Study|Death|0
7501415|NCT03300050|26024415|P1|Overall Study|Death|0
7501416|NCT03300050|26024411|P5|Overall Study|Withdrawal by Subject|0
7501417|NCT03300050|26024412|P4|Overall Study|Withdrawal by Subject|0
7501418|NCT03300050|26024413|P3|Overall Study|Withdrawal by Subject|1
7501419|NCT03300050|26024414|P2|Overall Study|Withdrawal by Subject|1
7501420|NCT03300050|26024415|P1|Overall Study|Withdrawal by Subject|1
7501421|NCT03300050|26024411|P5|Overall Study|Lost to Follow-up|1
7501422|NCT03300050|26024412|P4|Overall Study|Lost to Follow-up|0
7501423|NCT03300050|26024413|P3|Overall Study|Lost to Follow-up|0
7501424|NCT03300050|26024414|P2|Overall Study|Lost to Follow-up|1
7501425|NCT03300050|26024415|P1|Overall Study|Lost to Follow-up|2
7501426|NCT03300024|26024785|P2|Overall Study|Physician Decision|6
7501427|NCT03300024|26024786|P1|Overall Study|Physician Decision|4
7501428|NCT03299686|26024840|P2|Follow-up Epoch|Subject/Guardian Decision|1
7501429|NCT03299686|26024841|P1|Follow-up Epoch|Subject/Guardian Decision|0
7501430|NCT03299686|26024840|P2|Treatment Epoch|Adverse Event|4
7501431|NCT03299686|26024841|P1|Treatment Epoch|Adverse Event|8
7501432|NCT03299686|26024840|P2|Treatment Epoch|Physician Decision|0
7501433|NCT03299686|26024841|P1|Treatment Epoch|Physician Decision|1
7501434|NCT03299686|26024840|P2|Treatment Epoch|Subject/Guardian Decision|0
7501435|NCT03299686|26024841|P1|Treatment Epoch|Subject/Guardian Decision|2
7501436|NCT03299244|26024859|P2|Overall Study|Death|4
7501437|NCT03299244|26024860|P1|Overall Study|Death|9
7501438|NCT03299244|26024859|P2|Overall Study|Decision by Sponsor|5
7501439|NCT03299244|26024860|P1|Overall Study|Decision by Sponsor|4
7501440|NCT03299244|26024859|P2|Overall Study|Withdrawal by Subject|29
7501441|NCT03299244|26024860|P1|Overall Study|Withdrawal by Subject|34
7501442|NCT03299101|26024885|P1|Overall Study|Not enough time to complete prehab|1
7501443|NCT03299101|26024885|P1|Overall Study|Surgery was changed|3
7501444|NCT03299101|26024885|P1|Overall Study|Withdrawal by Subject|5
7501445|NCT03299101|26024885|P1|Overall Study|Lost to Follow-up|1
7501446|NCT03299049|26024908|P2|Overall Study|Adverse Event|13
7501447|NCT03299049|26024909|P1|Overall Study|Adverse Event|12
7501448|NCT03299049|26024908|P2|Overall Study|Lack of Efficacy|3
7501449|NCT03299049|26024909|P1|Overall Study|Lack of Efficacy|9
7501450|NCT03299049|26024908|P2|Overall Study|Protocol Violation|1
7501451|NCT03299049|26024909|P1|Overall Study|Protocol Violation|1
7501452|NCT03299049|26024908|P2|Overall Study|Pregnancy|3
7501453|NCT03299049|26024909|P1|Overall Study|Pregnancy|1
7501454|NCT03299049|26024908|P2|Overall Study|Lost to Follow-up|0
7501455|NCT03299049|26024909|P1|Overall Study|Lost to Follow-up|2
7501456|NCT03299049|26024908|P2|Overall Study|Physician Decision|1
7501457|NCT03299049|26024909|P1|Overall Study|Physician Decision|5
7501458|NCT03299049|26024908|P2|Overall Study|Withdrawal by Subject|21
7501459|NCT03299049|26024909|P1|Overall Study|Withdrawal by Subject|6
7501460|NCT03299049|26024908|P2|Overall Study|On-going|481
7501461|NCT03299049|26024909|P1|Overall Study|On-going|486
7501462|NCT03298984|26025010|P4|Overall Study|Insurance Company Decision|1
7501463|NCT03298984|26025011|P3|Overall Study|Insurance Company Decision|0
7501464|NCT03298984|26025012|P2|Overall Study|Insurance Company Decision|0
7501465|NCT03298984|26025013|P1|Overall Study|Insurance Company Decision|0
7501466|NCT03298984|26025010|P4|Overall Study|Death|2
7501467|NCT03298984|26025011|P3|Overall Study|Death|0
7501468|NCT03298984|26025012|P2|Overall Study|Death|0
7501469|NCT03298984|26025013|P1|Overall Study|Death|0
7501470|NCT03298984|26025010|P4|Overall Study|Adverse Event|1
7501471|NCT03298984|26025011|P3|Overall Study|Adverse Event|0
7501472|NCT03298984|26025012|P2|Overall Study|Adverse Event|0
7501473|NCT03298984|26025013|P1|Overall Study|Adverse Event|0
7501474|NCT03298984|26025010|P4|Overall Study|Relapsed disease (following remission)|1
7501475|NCT03298984|26025011|P3|Overall Study|Relapsed disease (following remission)|1
7501476|NCT03298984|26025012|P2|Overall Study|Relapsed disease (following remission)|0
7501477|NCT03298984|26025013|P1|Overall Study|Relapsed disease (following remission)|0
7501478|NCT03298984|26025010|P4|Overall Study|Lack of Efficacy|4
7501479|NCT03298984|26025011|P3|Overall Study|Lack of Efficacy|1
7501480|NCT03298984|26025012|P2|Overall Study|Lack of Efficacy|1
7501481|NCT03298984|26025013|P1|Overall Study|Lack of Efficacy|0
7501482|NCT03298984|26025010|P4|Overall Study|Physician Decision|6
7501483|NCT03298984|26025011|P3|Overall Study|Physician Decision|0
7501484|NCT03298984|26025012|P2|Overall Study|Physician Decision|0
7501485|NCT03298984|26025013|P1|Overall Study|Physician Decision|1
7501486|NCT03298867|26025046|P2|Overall Study|Continued in the Follow-Up Period|1
7501487|NCT03298867|26025047|P1|Overall Study|Continued in the Follow-Up Period|0
7501488|NCT03298867|26025046|P2|Overall Study|Did not Continue in the Follow-Up Period|1
7501489|NCT03298867|26025047|P1|Overall Study|Did not Continue in the Follow-Up Period|2
7501490|NCT03298412|26025073|P1|Run-in Period|Decision by Sponsor|6
7501491|NCT03298412|26025073|P1|Run-in Period|Ineligibility Determined|1
7501492|NCT03298412|26025073|P1|Run-in Period|Disease Progression|1
7501493|NCT03298412|26025073|P1|Run-in Period|Other, Not Specified|1
7501494|NCT03297398|26025185|P3|Overall Study|Lost to Follow-up|1
7501495|NCT03297398|26025186|P2|Overall Study|Lost to Follow-up|0
7501496|NCT03297398|26025187|P1|Overall Study|Lost to Follow-up|0
7501497|NCT03297398|26025185|P3|Overall Study|Physician Decision|1
7501498|NCT03297398|26025186|P2|Overall Study|Physician Decision|0
7501499|NCT03297398|26025187|P1|Overall Study|Physician Decision|0
7501500|NCT03297398|26025185|P3|Overall Study|Protocol Violation|0
7501501|NCT03297398|26025186|P2|Overall Study|Protocol Violation|2
7501502|NCT03297398|26025187|P1|Overall Study|Protocol Violation|0
7501503|NCT03297398|26025185|P3|Overall Study|Withdrawal by Subject|2
7501504|NCT03297398|26025186|P2|Overall Study|Withdrawal by Subject|2
7501505|NCT03297398|26025187|P1|Overall Study|Withdrawal by Subject|1
7501506|NCT03297398|26025185|P3|Overall Study|Adverse Event|4
7501507|NCT03297398|26025186|P2|Overall Study|Adverse Event|4
7501508|NCT03297398|26025187|P1|Overall Study|Adverse Event|1
7501509|NCT03297398|26025185|P3|Overall Study|Sponsor's decision|7
7501510|NCT03297398|26025186|P2|Overall Study|Sponsor's decision|9
7501511|NCT03297398|26025187|P1|Overall Study|Sponsor's decision|6
7501512|NCT03297294|26025215|P5|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7501513|NCT03297294|26025216|P4|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
7501514|NCT03297294|26025217|P3|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7501515|NCT03297294|26025218|P2|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7501516|NCT03297294|26025219|P1|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7501517|NCT03297294|26025215|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
7501518|NCT03297294|26025216|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
7501519|NCT03297294|26025217|P3|Double-Blind Treatment Period (DB)|Physician Decision|0
7501520|NCT03297294|26025218|P2|Double-Blind Treatment Period (DB)|Physician Decision|1
7501521|NCT03297294|26025219|P1|Double-Blind Treatment Period (DB)|Physician Decision|1
7501522|NCT03297294|26025215|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
7501523|NCT03297294|26025216|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
7501524|NCT03297294|26025217|P3|Double-Blind Treatment Period (DB)|Adverse Event|0
7501525|NCT03297294|26025218|P2|Double-Blind Treatment Period (DB)|Adverse Event|1
7501526|NCT03297294|26025219|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
7501527|NCT03297294|26025215|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7501528|NCT03297294|26025216|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7501529|NCT03297294|26025217|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7501530|NCT03297294|26025218|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7501531|NCT03297294|26025219|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7501532|NCT03297294|26025215|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7501533|NCT03297294|26025216|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7501534|NCT03297294|26025217|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7501535|NCT03297294|26025218|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
7501536|NCT03297294|26025219|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
7501537|NCT03297216|26025255|P2|Overall Study|Lost to Follow-up|2
7501538|NCT03297216|26025256|P1|Overall Study|Lost to Follow-up|3
7501539|NCT03297216|26025255|P2|Overall Study|Miscarriage|2
7501540|NCT03297216|26025256|P1|Overall Study|Miscarriage|0
7501541|NCT03297216|26025255|P2|Overall Study|Death|1
7501542|NCT03297216|26025256|P1|Overall Study|Death|0
7501543|NCT03297021|26025298|P3|Overall Study|Missing Post-Op Data|1
7501544|NCT03297021|26025299|P2|Overall Study|Missing Post-Op Data|2
7501545|NCT03297021|26025300|P1|Overall Study|Missing Post-Op Data|1
7501546|NCT03297021|26025298|P3|Overall Study|Incomplete/illegible data sheet|3
7501547|NCT03297021|26025299|P2|Overall Study|Incomplete/illegible data sheet|2
7501548|NCT03297021|26025300|P1|Overall Study|Incomplete/illegible data sheet|4
7501549|NCT03296566|26025401|P2|Overall Study|Withdrawal by Subject|3
7501550|NCT03296566|26025402|P1|Overall Study|Withdrawal by Subject|0
7501551|NCT03296566|26025401|P2|Overall Study|Lost to Follow-up|46
7501552|NCT03296566|26025402|P1|Overall Study|Lost to Follow-up|19
7501553|NCT03296527|26025418|P2|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
7501554|NCT03296527|26025419|P1|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
7501555|NCT03296527|26025418|P2|Overall Study|Discontinuation due to liquid in uterus|0
7501556|NCT03296527|26025419|P1|Overall Study|Discontinuation due to liquid in uterus|1
7501557|NCT03296527|26025418|P2|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
7501558|NCT03296527|26025419|P1|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
7501559|NCT03296527|26025418|P2|Overall Study|Discontinuations due to withdrawal from trial|3
7501560|NCT03296527|26025419|P1|Overall Study|Discontinuations due to withdrawal from trial|2
7501561|NCT03296527|26025418|P2|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
7501562|NCT03296527|26025419|P1|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
7501563|NCT03296527|26025418|P2|Overall Study|Subject withdrew consent|1
7501564|NCT03296527|26025419|P1|Overall Study|Subject withdrew consent|3
7501565|NCT03296527|26025418|P2|Overall Study|Protocol Deviation|0
7501566|NCT03296527|26025419|P1|Overall Study|Protocol Deviation|4
7501567|NCT03296527|26025418|P2|Overall Study|Adverse Event|33
7501568|NCT03296527|26025419|P1|Overall Study|Adverse Event|15
7501569|NCT03295318|26025631|P3|Overall Study|Subject discontinued due to travel|0
7501570|NCT03295318|26025632|P2|Overall Study|Subject discontinued due to travel|1
7501571|NCT03295318|26025633|P1|Overall Study|Subject discontinued due to travel|0
7501572|NCT03295318|26025631|P3|Overall Study|Withdrawal by Subject|1
7501573|NCT03295318|26025632|P2|Overall Study|Withdrawal by Subject|0
7501574|NCT03295318|26025633|P1|Overall Study|Withdrawal by Subject|0
7501575|NCT03295318|26025631|P3|Overall Study|Protocol Violation|3
7501576|NCT03295318|26025632|P2|Overall Study|Protocol Violation|3
7501577|NCT03295318|26025633|P1|Overall Study|Protocol Violation|4
7501578|NCT03295318|26025631|P3|Overall Study|Death|1
7501579|NCT03295318|26025632|P2|Overall Study|Death|1
7501580|NCT03295318|26025633|P1|Overall Study|Death|1
7501581|NCT03295318|26025631|P3|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7501582|NCT03295318|26025632|P2|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7501583|NCT03295318|26025633|P1|Overall Study|Withdrawal by Subject prior to initial vaccination|1
7501584|NCT03295201|26025707|P2|Overall Study|Hospital admission|1
7501585|NCT03295201|26025708|P1|Overall Study|Hospital admission|0
7501586|NCT03295201|26025707|P2|Overall Study|Lost to Follow-up|1
7501587|NCT03295201|26025708|P1|Overall Study|Lost to Follow-up|1
7501588|NCT03294941|26025762|P2|Overall Study|Withdrawal by Subject|2
7501589|NCT03294941|26025763|P1|Overall Study|Withdrawal by Subject|0
7501590|NCT03294681|26025783|P1|Overall Study|Withdrawal by Subject|1
7501591|NCT03294538|26025821|P3|Overall Study|Outside of Visit Window|1
7501592|NCT03294538|26025822|P2|Overall Study|Outside of Visit Window|4
7501593|NCT03294538|26025823|P1|Overall Study|Outside of Visit Window|4
7501594|NCT03294538|26025821|P3|Overall Study|Lost to Follow-up|0
7501595|NCT03294538|26025822|P2|Overall Study|Lost to Follow-up|0
7501596|NCT03294538|26025823|P1|Overall Study|Lost to Follow-up|1
7501597|NCT03294538|26025821|P3|Overall Study|Adverse Event|1
7501598|NCT03294538|26025822|P2|Overall Study|Adverse Event|1
7501599|NCT03294538|26025823|P1|Overall Study|Adverse Event|0
7501600|NCT03294317|26025838|P1|Overall Study|Exited after lead revision|2
7501601|NCT03294317|26025838|P1|Overall Study|Received CRT instead|1
7501602|NCT03294317|26025838|P1|Overall Study|Failed HB lead implant|8
7501603|NCT03294317|26025838|P1|Overall Study|Did not meet inclusion/exclusion criteria|1
7501604|NCT03294317|26025838|P1|Overall Study|Lost to Follow-up|1
7501605|NCT03294317|26025838|P1|Overall Study|Withdrawal by Subject|6
7501606|NCT03294317|26025838|P1|Overall Study|Physician Decision|1
7501607|NCT03293654|26025858|P3|Overall Study|Lost to Follow-up|0
7501608|NCT03293654|26025859|P2|Overall Study|Lost to Follow-up|1
7501609|NCT03293654|26025860|P1|Overall Study|Lost to Follow-up|0
7501610|NCT03293485|26025898|P1|Overall Study|Withdrawal by Subject|2
7501611|NCT03293485|26025898|P1|Overall Study|Screen Failure|2
7501612|NCT03293485|26025898|P1|Overall Study|Death|1
7501613|NCT03293394|26025909|P2|Follow-up (6 Months)|Adverse Event|2
7501614|NCT03293394|26025910|P1|Follow-up (6 Months)|Adverse Event|4
7501615|NCT03292653|26025997|P3|Overall Study|Did not Receive Treatment|0
7501616|NCT03292653|26025998|P2|Overall Study|Did not Receive Treatment|0
7501617|NCT03292653|26025999|P1|Overall Study|Did not Receive Treatment|1
7501618|NCT03292653|26025997|P3|Overall Study|Adverse Event|1
7501619|NCT03292653|26025998|P2|Overall Study|Adverse Event|0
7501620|NCT03292653|26025999|P1|Overall Study|Adverse Event|0
7501621|NCT03292640|26026030|P2|Overall Study|Lost to Follow-up|24
7501622|NCT03292640|26026031|P1|Overall Study|Lost to Follow-up|24
7501623|NCT03292640|26026030|P2|Overall Study|Adverse Event|2
7501624|NCT03292640|26026031|P1|Overall Study|Adverse Event|20
7501625|NCT03292640|26026030|P2|Overall Study|Withdrawal by Subject|16
7501626|NCT03292640|26026031|P1|Overall Study|Withdrawal by Subject|17
7501627|NCT03292432|26026070|P2|Overall Study|Site closed before any data collected|0
7501628|NCT03292432|26026071|P1|Overall Study|Site closed before any data collected|1
7501629|NCT03292432|26026070|P2|Overall Study|Withdrawal by Subject|2
7501630|NCT03292432|26026071|P1|Overall Study|Withdrawal by Subject|1
7501631|NCT03292432|26026070|P2|Overall Study|Death|1
7501632|NCT03292432|26026071|P1|Overall Study|Death|2
7501633|NCT03292432|26026070|P2|Overall Study|Lost to Follow-up|8
7501634|NCT03292432|26026071|P1|Overall Study|Lost to Follow-up|11
7501635|NCT03292406|26026098|P3|Overall Study|Other|2
7501636|NCT03292406|26026099|P2|Overall Study|Other|1
7501637|NCT03292406|26026100|P1|Overall Study|Other|0
7501638|NCT03292406|26026098|P3|Overall Study|Protocol Violation|1
7501639|NCT03292406|26026099|P2|Overall Study|Protocol Violation|1
7501640|NCT03292406|26026100|P1|Overall Study|Protocol Violation|0
7501641|NCT03292406|26026098|P3|Overall Study|Withdrawal by Subject|2
7501642|NCT03292406|26026099|P2|Overall Study|Withdrawal by Subject|7
7501643|NCT03292406|26026100|P1|Overall Study|Withdrawal by Subject|0
7501644|NCT03292406|26026098|P3|Overall Study|Adverse Event|4
7501645|NCT03292406|26026099|P2|Overall Study|Adverse Event|1
7501646|NCT03292406|26026100|P1|Overall Study|Adverse Event|7
7501647|NCT03292406|26026098|P3|Overall Study|Progressive Disease|4
7501648|NCT03292406|26026099|P2|Overall Study|Progressive Disease|3
7501649|NCT03292406|26026100|P1|Overall Study|Progressive Disease|6
7501650|NCT03292016|26026129|P6|Second Washout|Adverse Event|0
7501651|NCT03292016|26026130|P5|Second Washout|Adverse Event|0
7501652|NCT03292016|26026131|P4|Second Washout|Adverse Event|0
7501653|NCT03292016|26026132|P3|Second Washout|Adverse Event|0
7501654|NCT03292016|26026133|P2|Second Washout|Adverse Event|1
7501655|NCT03292016|26026134|P1|Second Washout|Adverse Event|0
7501656|NCT03291288|26026188|P2|Pexidartinib Only|Ongoing|2
7501657|NCT03291288|26026189|P1|Pexidartinib Only|Ongoing|0
7501658|NCT03291288|26026188|P2|Drug-drug Interaction Phase|Other|0
7501659|NCT03291288|26026189|P1|Drug-drug Interaction Phase|Other|3
7501660|NCT03291288|26026188|P2|Drug-drug Interaction Phase|Disease progression|0
7501661|NCT03291288|26026189|P1|Drug-drug Interaction Phase|Disease progression|1
7501662|NCT03291288|26026188|P2|Drug-drug Interaction Phase|Adverse Event|0
7501663|NCT03291288|26026189|P1|Drug-drug Interaction Phase|Adverse Event|2
7501664|NCT03290300|26026263|P1|Overall Study|Lost to Follow-up|3
7501665|NCT03289676|26026296|P2|Overall Study|Lost to Follow-up|1
7501666|NCT03289676|26026297|P1|Overall Study|Lost to Follow-up|0
7501667|NCT03289676|26026296|P2|Overall Study|Protocol Violation|0
7501668|NCT03289676|26026297|P1|Overall Study|Protocol Violation|2
7501669|NCT03289676|26026296|P2|Overall Study|Withdrawal by Subject|0
7501670|NCT03289676|26026297|P1|Overall Study|Withdrawal by Subject|2
7501671|NCT03289533|26026307|P1|Overall Study|Terminated from study by sponsor|10
7501672|NCT03289533|26026307|P1|Overall Study|Death|12
7501673|NCT03289455|26026346|P3|Overall Study|Progressive disease|5
7501674|NCT03289455|26026347|P2|Overall Study|Progressive disease|4
7501675|NCT03289455|26026348|P1|Overall Study|Progressive disease|3
7501676|NCT03289455|26026346|P3|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
7501677|NCT03289455|26026347|P2|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7501678|NCT03289455|26026348|P1|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7501679|NCT03289455|26026346|P3|Overall Study|Sponsor decision due to covid19 restrictions|0
7501680|NCT03289455|26026347|P2|Overall Study|Sponsor decision due to covid19 restrictions|1
7501681|NCT03289455|26026348|P1|Overall Study|Sponsor decision due to covid19 restrictions|0
7501682|NCT03289455|26026346|P3|Overall Study|Death|0
7501683|NCT03289455|26026347|P2|Overall Study|Death|0
7501684|NCT03289455|26026348|P1|Overall Study|Death|1
7501685|NCT03289208|26026409|P3|Overall Study|Adverse Event|0
7501686|NCT03289208|26026410|P2|Overall Study|Adverse Event|0
7501687|NCT03289208|26026411|P1|Overall Study|Adverse Event|1
7501688|NCT03288987|26026443|P2|Overall Study|Protocol Violation|4
7501689|NCT03288987|26026444|P1|Overall Study|Protocol Violation|10
7501690|NCT03288779|26026460|P1|Overall Study|Withdrawal by Subject|3
7501691|NCT03288714|26026467|P2|Overall Study|Adverse Event|0
7501692|NCT03288714|26026468|P1|Overall Study|Adverse Event|1
7501693|NCT03288714|26026467|P2|Overall Study|Clinical Worsening|1
7501694|NCT03288714|26026468|P1|Overall Study|Clinical Worsening|2
7501695|NCT03288714|26026467|P2|Overall Study|Withdrawal by Subject|1
7501696|NCT03288714|26026468|P1|Overall Study|Withdrawal by Subject|3
7501697|NCT03288714|26026467|P2|Overall Study|Non-compliance with study schedule|0
7501698|NCT03288714|26026468|P1|Overall Study|Non-compliance with study schedule|2
7501699|NCT03288714|26026467|P2|Overall Study|Lost to Follow-up|1
7501700|NCT03288714|26026468|P1|Overall Study|Lost to Follow-up|2
7501701|NCT03287869|26026493|P2|Overall Study|Reason not Specified|3
7501702|NCT03287869|26026494|P1|Overall Study|Reason not Specified|6
7501703|NCT03287869|26026493|P2|Overall Study|Physician Decision|5
7501704|NCT03287869|26026494|P1|Overall Study|Physician Decision|5
7501705|NCT03287869|26026493|P2|Overall Study|Early Closure of the Site|1
7501706|NCT03287869|26026494|P1|Overall Study|Early Closure of the Site|0
7501707|NCT03287869|26026493|P2|Overall Study|Withdrawal by Subject|43
7501708|NCT03287869|26026494|P1|Overall Study|Withdrawal by Subject|36
7501709|NCT03287869|26026493|P2|Overall Study|Protocol Deviation|1
7501710|NCT03287869|26026494|P1|Overall Study|Protocol Deviation|2
7501711|NCT03287869|26026493|P2|Overall Study|Progressive Disease|0
7501712|NCT03287869|26026494|P1|Overall Study|Progressive Disease|1
7501713|NCT03287869|26026493|P2|Overall Study|Non-Compliance With Study Drug|9
7501714|NCT03287869|26026494|P1|Overall Study|Non-Compliance With Study Drug|5
7501715|NCT03287869|26026493|P2|Overall Study|Lost to Follow-up|19
7501716|NCT03287869|26026494|P1|Overall Study|Lost to Follow-up|13
7501717|NCT03287869|26026493|P2|Overall Study|Lack of Efficacy|0
7501718|NCT03287869|26026494|P1|Overall Study|Lack of Efficacy|1
7501719|NCT03287869|26026493|P2|Overall Study|Adverse Event|12
7501720|NCT03287869|26026494|P1|Overall Study|Adverse Event|14
7501721|NCT03287804|26026515|P1|Overall Study|Progressive disease|8
7501722|NCT03287804|26026515|P1|Overall Study|Physician Decision|2
7501723|NCT03287804|26026515|P1|Overall Study|Death|1
7501724|NCT03287791|26026531|P3|Overall Study|Did not meet inclusion criteria|0
7501725|NCT03287791|26026532|P2|Overall Study|Did not meet inclusion criteria|0
7501726|NCT03287791|26026533|P1|Overall Study|Did not meet inclusion criteria|1
7501727|NCT03287791|26026531|P3|Overall Study|Non-compliance|0
7501728|NCT03287791|26026532|P2|Overall Study|Non-compliance|1
7501729|NCT03287791|26026533|P1|Overall Study|Non-compliance|0
7501730|NCT03287791|26026531|P3|Overall Study|Too much time between 2 visits|0
7501731|NCT03287791|26026532|P2|Overall Study|Too much time between 2 visits|1
7501732|NCT03287791|26026533|P1|Overall Study|Too much time between 2 visits|0
7501733|NCT03287791|26026531|P3|Overall Study|Participant was enrolled at 2 sites|1
7501734|NCT03287791|26026532|P2|Overall Study|Participant was enrolled at 2 sites|0
7501735|NCT03287791|26026533|P1|Overall Study|Participant was enrolled at 2 sites|1
7501736|NCT03287791|26026531|P3|Overall Study|Protocol Violation|1
7501737|NCT03287791|26026532|P2|Overall Study|Protocol Violation|2
7501738|NCT03287791|26026533|P1|Overall Study|Protocol Violation|7
7501739|NCT03287791|26026531|P3|Overall Study|Lost to Follow-up|11
7501740|NCT03287791|26026532|P2|Overall Study|Lost to Follow-up|14
7501741|NCT03287791|26026533|P1|Overall Study|Lost to Follow-up|8
7501742|NCT03287791|26026531|P3|Overall Study|Missed more than 6 consecutive doses|2
7501743|NCT03287791|26026532|P2|Overall Study|Missed more than 6 consecutive doses|2
7501744|NCT03287791|26026533|P1|Overall Study|Missed more than 6 consecutive doses|3
7501745|NCT03287791|26026531|P3|Overall Study|Withdrawal by Subject|17
7501746|NCT03287791|26026532|P2|Overall Study|Withdrawal by Subject|12
7501747|NCT03287791|26026533|P1|Overall Study|Withdrawal by Subject|12
7501748|NCT03287791|26026531|P3|Overall Study|Adverse Event|3
7501749|NCT03287791|26026532|P2|Overall Study|Adverse Event|4
7501750|NCT03287791|26026533|P1|Overall Study|Adverse Event|0
7501751|NCT03287791|26026531|P3|Overall Study|Insufficient Therapeutic Response|1
7501752|NCT03287791|26026532|P2|Overall Study|Insufficient Therapeutic Response|0
7501753|NCT03287791|26026533|P1|Overall Study|Insufficient Therapeutic Response|0
7501754|NCT03287635|26026552|P1|Overall Study|Physician Decision|1
7501755|NCT03287635|26026552|P1|Overall Study|Withdrawal by Subject|1
7501756|NCT03287635|26026552|P1|Overall Study|Lost to Follow-up|5
7501757|NCT03287622|26026560|P2|Overall Study|surgery related|2
7501758|NCT03287622|26026561|P1|Overall Study|surgery related|0
7501759|NCT03287622|26026560|P2|Overall Study|prolonged Length of stay|0
7501760|NCT03287622|26026561|P1|Overall Study|prolonged Length of stay|2
7501761|NCT03287622|26026560|P2|Overall Study|No prescripion after surgery|31
7501762|NCT03287622|26026561|P1|Overall Study|No prescripion after surgery|28
7501763|NCT03287622|26026560|P2|Overall Study|Lost to Follow-up|15
7501764|NCT03287622|26026561|P1|Overall Study|Lost to Follow-up|27
7501765|NCT03287622|26026560|P2|Overall Study|Withdrawal by Subject|0
7501766|NCT03287622|26026561|P1|Overall Study|Withdrawal by Subject|1
7501783|NCT03287219|26026948|P2|Overall Study|Protocol Violation|2
7501784|NCT03287219|26026949|P1|Overall Study|Protocol Violation|0
7501785|NCT03287089|26026996|P2|Overall Study|Withdrawal by Subject|2
7501786|NCT03287089|26026997|P1|Overall Study|Withdrawal by Subject|0
7501787|NCT03287089|26026996|P2|Overall Study|Physician Decision|2
7501788|NCT03287089|26026997|P1|Overall Study|Physician Decision|0
7501789|NCT03287089|26026996|P2|Overall Study|Lost to Follow-up|2
7501790|NCT03287089|26026997|P1|Overall Study|Lost to Follow-up|0
7501791|NCT03286751|26027032|P6|Washout Period 5|Adverse Event|0
7501792|NCT03286751|26027033|P5|Washout Period 5|Adverse Event|1
7501793|NCT03286751|26027034|P4|Washout Period 5|Adverse Event|0
7501794|NCT03286751|26027035|P3|Washout Period 5|Adverse Event|0
7501795|NCT03286751|26027036|P2|Washout Period 5|Adverse Event|0
7501796|NCT03286751|26027037|P1|Washout Period 5|Adverse Event|0
7501797|NCT03286751|26027032|P6|Washout Period 2|Personal Reasons|0
7501798|NCT03286751|26027033|P5|Washout Period 2|Personal Reasons|0
7501799|NCT03286751|26027034|P4|Washout Period 2|Personal Reasons|0
7501800|NCT03286751|26027035|P3|Washout Period 2|Personal Reasons|0
7501801|NCT03286751|26027036|P2|Washout Period 2|Personal Reasons|1
7501802|NCT03286751|26027037|P1|Washout Period 2|Personal Reasons|0
7501803|NCT03286751|26027032|P6|Washout Period 1|Withdrawal by Subject|0
7501804|NCT03286751|26027033|P5|Washout Period 1|Withdrawal by Subject|1
7501805|NCT03286751|26027034|P4|Washout Period 1|Withdrawal by Subject|0
7501806|NCT03286751|26027035|P3|Washout Period 1|Withdrawal by Subject|0
7501807|NCT03286751|26027036|P2|Washout Period 1|Withdrawal by Subject|0
7501808|NCT03286751|26027037|P1|Washout Period 1|Withdrawal by Subject|0
7501809|NCT03286543|26027059|P3|Study Enrollment|Withdrawn from study|6
7501810|NCT03286543|26027060|P2|Study Enrollment|Withdrawn from study|6
7501811|NCT03286543|26027061|P1|Study Enrollment|Withdrawn from study|0
7501812|NCT03286543|26027059|P3|Study Enrollment|TKA cancelled after enrollment|1
7501813|NCT03286543|26027060|P2|Study Enrollment|TKA cancelled after enrollment|0
7501814|NCT03286543|26027061|P1|Study Enrollment|TKA cancelled after enrollment|0
7501815|NCT03286543|26027059|P3|Consented|Withdrawn from study|0
7501816|NCT03286543|26027060|P2|Consented|Withdrawn from study|0
7501817|NCT03286543|26027061|P1|Consented|Withdrawn from study|12
7501818|NCT03286543|26027059|P3|Consented|TKA cancelled after enrollment|0
7501819|NCT03286543|26027060|P2|Consented|TKA cancelled after enrollment|0
7501820|NCT03286543|26027061|P1|Consented|TKA cancelled after enrollment|1
7501821|NCT03286543|26027059|P3|Consented|Screen failure before enrollment|0
7501822|NCT03286543|26027060|P2|Consented|Screen failure before enrollment|0
7501823|NCT03286543|26027061|P1|Consented|Screen failure before enrollment|4
7501824|NCT03286543|26027059|P3|Consented|Screen failure before randomization|0
7501825|NCT03286543|26027060|P2|Consented|Screen failure before randomization|0
7501826|NCT03286543|26027061|P1|Consented|Screen failure before randomization|2
7501827|NCT03286400|26027121|P1|Overall Study|Scheduling difficulty|4
7501828|NCT03286400|26027121|P1|Overall Study|Physician Decision|1
7501829|NCT03286400|26027121|P1|Overall Study|Lost to Follow-up|10
7501830|NCT03286400|26027121|P1|Overall Study|Death|10
7501831|NCT03286218|26027150|P12|Treatment Phase Period 4|Withdrawal by Subject|1
7501832|NCT03286218|26027151|P11|Treatment Phase Period 4|Withdrawal by Subject|0
7501833|NCT03286218|26027152|P10|Treatment Phase Period 4|Withdrawal by Subject|0
7501834|NCT03286218|26027153|P9|Treatment Phase Period 4|Withdrawal by Subject|0
7501835|NCT03286218|26027154|P8|Treatment Phase Period 4|Withdrawal by Subject|0
7501836|NCT03286218|26027155|P7|Treatment Phase Period 4|Withdrawal by Subject|0
7501837|NCT03286218|26027156|P6|Treatment Phase Period 4|Withdrawal by Subject|0
7501838|NCT03286218|26027157|P5|Treatment Phase Period 4|Withdrawal by Subject|0
7501839|NCT03286218|26027158|P4|Treatment Phase Period 4|Withdrawal by Subject|0
7501840|NCT03286218|26027159|P3|Treatment Phase Period 4|Withdrawal by Subject|0
7501841|NCT03286218|26027160|P2|Treatment Phase Period 4|Withdrawal by Subject|0
7501842|NCT03286218|26027161|P1|Treatment Phase Period 4|Withdrawal by Subject|0
7501843|NCT03286218|26027150|P12|Treatment Phase Period 1|Withdrawal by Subject|1
7501844|NCT03286218|26027151|P11|Treatment Phase Period 1|Withdrawal by Subject|0
7501845|NCT03286218|26027152|P10|Treatment Phase Period 1|Withdrawal by Subject|0
7501846|NCT03286218|26027153|P9|Treatment Phase Period 1|Withdrawal by Subject|0
7501847|NCT03286218|26027154|P8|Treatment Phase Period 1|Withdrawal by Subject|0
7501848|NCT03286218|26027155|P7|Treatment Phase Period 1|Withdrawal by Subject|0
7501849|NCT03286218|26027156|P6|Treatment Phase Period 1|Withdrawal by Subject|1
7501850|NCT03286218|26027157|P5|Treatment Phase Period 1|Withdrawal by Subject|0
7501851|NCT03286218|26027158|P4|Treatment Phase Period 1|Withdrawal by Subject|1
7501852|NCT03286218|26027159|P3|Treatment Phase Period 1|Withdrawal by Subject|1
7501853|NCT03286218|26027160|P2|Treatment Phase Period 1|Withdrawal by Subject|0
7501854|NCT03286218|26027161|P1|Treatment Phase Period 1|Withdrawal by Subject|0
7501855|NCT03286218|26027150|P12|Qualification Phase Period 2|Withdrawal by Subject|0
7501856|NCT03286218|26027151|P11|Qualification Phase Period 2|Withdrawal by Subject|0
7501857|NCT03286218|26027152|P10|Qualification Phase Period 2|Withdrawal by Subject|0
7501858|NCT03286218|26027153|P9|Qualification Phase Period 2|Withdrawal by Subject|0
7501859|NCT03286218|26027154|P8|Qualification Phase Period 2|Withdrawal by Subject|0
7501860|NCT03286218|26027155|P7|Qualification Phase Period 2|Withdrawal by Subject|0
7501861|NCT03286218|26027156|P6|Qualification Phase Period 2|Withdrawal by Subject|0
7501862|NCT03286218|26027157|P5|Qualification Phase Period 2|Withdrawal by Subject|0
7501863|NCT03286218|26027158|P4|Qualification Phase Period 2|Withdrawal by Subject|0
7501864|NCT03286218|26027159|P3|Qualification Phase Period 2|Withdrawal by Subject|0
7501865|NCT03286218|26027160|P2|Qualification Phase Period 2|Withdrawal by Subject|2
7501866|NCT03286218|26027161|P1|Qualification Phase Period 2|Withdrawal by Subject|1
7501867|NCT03286218|26027150|P12|Qualification Phase Period 2|Protocol Violation|0
7501868|NCT03286218|26027151|P11|Qualification Phase Period 2|Protocol Violation|0
7501869|NCT03286218|26027152|P10|Qualification Phase Period 2|Protocol Violation|0
7501870|NCT03286218|26027153|P9|Qualification Phase Period 2|Protocol Violation|0
7501871|NCT03286218|26027154|P8|Qualification Phase Period 2|Protocol Violation|0
7501872|NCT03286218|26027155|P7|Qualification Phase Period 2|Protocol Violation|0
7501873|NCT03286218|26027156|P6|Qualification Phase Period 2|Protocol Violation|0
7501874|NCT03286218|26027157|P5|Qualification Phase Period 2|Protocol Violation|0
7501875|NCT03286218|26027158|P4|Qualification Phase Period 2|Protocol Violation|0
7501876|NCT03286218|26027159|P3|Qualification Phase Period 2|Protocol Violation|0
7501877|NCT03286218|26027160|P2|Qualification Phase Period 2|Protocol Violation|0
7501878|NCT03286218|26027161|P1|Qualification Phase Period 2|Protocol Violation|2
7501879|NCT03286218|26027150|P12|Qualification Phase Period 2|Lost to Follow-up|0
7501880|NCT03286218|26027151|P11|Qualification Phase Period 2|Lost to Follow-up|0
7501881|NCT03286218|26027152|P10|Qualification Phase Period 2|Lost to Follow-up|0
7501882|NCT03286218|26027153|P9|Qualification Phase Period 2|Lost to Follow-up|0
7501883|NCT03286218|26027154|P8|Qualification Phase Period 2|Lost to Follow-up|0
7501884|NCT03286218|26027155|P7|Qualification Phase Period 2|Lost to Follow-up|0
7501885|NCT03286218|26027156|P6|Qualification Phase Period 2|Lost to Follow-up|0
7501886|NCT03286218|26027157|P5|Qualification Phase Period 2|Lost to Follow-up|0
7501887|NCT03286218|26027158|P4|Qualification Phase Period 2|Lost to Follow-up|0
7501888|NCT03286218|26027159|P3|Qualification Phase Period 2|Lost to Follow-up|0
7501889|NCT03286218|26027160|P2|Qualification Phase Period 2|Lost to Follow-up|1
7501890|NCT03286218|26027161|P1|Qualification Phase Period 2|Lost to Follow-up|0
7501891|NCT03286218|26027150|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501892|NCT03286218|26027151|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501893|NCT03286218|26027152|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501894|NCT03286218|26027153|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501895|NCT03286218|26027154|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501896|NCT03286218|26027155|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501897|NCT03286218|26027156|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501898|NCT03286218|26027157|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501899|NCT03286218|26027158|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501900|NCT03286218|26027159|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
7501901|NCT03286218|26027160|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
7501902|NCT03286218|26027161|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
7501903|NCT03286218|26027150|P12|Qualification Phase Period 2|Adverse Event|0
7501904|NCT03286218|26027151|P11|Qualification Phase Period 2|Adverse Event|0
7501905|NCT03286218|26027152|P10|Qualification Phase Period 2|Adverse Event|0
7501906|NCT03286218|26027153|P9|Qualification Phase Period 2|Adverse Event|0
7501907|NCT03286218|26027154|P8|Qualification Phase Period 2|Adverse Event|0
7501908|NCT03286218|26027155|P7|Qualification Phase Period 2|Adverse Event|0
7501909|NCT03286218|26027156|P6|Qualification Phase Period 2|Adverse Event|0
7501910|NCT03286218|26027157|P5|Qualification Phase Period 2|Adverse Event|0
7501911|NCT03286218|26027158|P4|Qualification Phase Period 2|Adverse Event|0
7501912|NCT03286218|26027159|P3|Qualification Phase Period 2|Adverse Event|0
7501913|NCT03286218|26027160|P2|Qualification Phase Period 2|Adverse Event|1
7501914|NCT03286218|26027161|P1|Qualification Phase Period 2|Adverse Event|0
7501915|NCT03286218|26027150|P12|Qualification Phase Period 1|Withdrawal by Subject|0
7501916|NCT03286218|26027151|P11|Qualification Phase Period 1|Withdrawal by Subject|0
7501917|NCT03286218|26027152|P10|Qualification Phase Period 1|Withdrawal by Subject|0
7501918|NCT03286218|26027153|P9|Qualification Phase Period 1|Withdrawal by Subject|0
7501919|NCT03286218|26027154|P8|Qualification Phase Period 1|Withdrawal by Subject|0
7501920|NCT03286218|26027155|P7|Qualification Phase Period 1|Withdrawal by Subject|0
7501921|NCT03286218|26027156|P6|Qualification Phase Period 1|Withdrawal by Subject|0
7501922|NCT03286218|26027157|P5|Qualification Phase Period 1|Withdrawal by Subject|0
7501923|NCT03286218|26027158|P4|Qualification Phase Period 1|Withdrawal by Subject|0
7501924|NCT03286218|26027159|P3|Qualification Phase Period 1|Withdrawal by Subject|0
7501925|NCT03286218|26027160|P2|Qualification Phase Period 1|Withdrawal by Subject|1
7501926|NCT03286218|26027161|P1|Qualification Phase Period 1|Withdrawal by Subject|0
7501927|NCT03286218|26027150|P12|Qualification Phase Period 1|Adverse Event|0
7501928|NCT03286218|26027151|P11|Qualification Phase Period 1|Adverse Event|0
7501929|NCT03286218|26027152|P10|Qualification Phase Period 1|Adverse Event|0
7501930|NCT03286218|26027153|P9|Qualification Phase Period 1|Adverse Event|0
7501931|NCT03286218|26027154|P8|Qualification Phase Period 1|Adverse Event|0
7501932|NCT03286218|26027155|P7|Qualification Phase Period 1|Adverse Event|0
7501933|NCT03286218|26027156|P6|Qualification Phase Period 1|Adverse Event|0
7501934|NCT03286218|26027157|P5|Qualification Phase Period 1|Adverse Event|0
7501935|NCT03286218|26027158|P4|Qualification Phase Period 1|Adverse Event|0
7501936|NCT03286218|26027159|P3|Qualification Phase Period 1|Adverse Event|0
7501937|NCT03286218|26027160|P2|Qualification Phase Period 1|Adverse Event|0
7501938|NCT03286218|26027161|P1|Qualification Phase Period 1|Adverse Event|1
7501939|NCT03285958|26027217|P2|Overall Study|Not able to attend required orientation|0
7501940|NCT03285958|26027218|P1|Overall Study|Not able to attend required orientation|3
7501941|NCT03285958|26027217|P2|Overall Study|Withdrawal by Subject|0
7501942|NCT03285958|26027218|P1|Overall Study|Withdrawal by Subject|1
7501943|NCT03285958|26027217|P2|Overall Study|Lost to Follow-up|1
7501944|NCT03285958|26027218|P1|Overall Study|Lost to Follow-up|1
7501945|NCT03285711|26027242|P4|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7501946|NCT03285711|26027243|P3|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7501947|NCT03285711|26027244|P2|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
7501948|NCT03285711|26027245|P1|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7501949|NCT03285711|26027242|P4|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7501950|NCT03285711|26027243|P3|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
7501951|NCT03285711|26027244|P2|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7501952|NCT03285711|26027245|P1|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7501953|NCT03285711|26027242|P4|Blinded Phase (Up to Week 16)|Protocol Violation|0
7501954|NCT03285711|26027243|P3|Blinded Phase (Up to Week 16)|Protocol Violation|0
7501955|NCT03285711|26027244|P2|Blinded Phase (Up to Week 16)|Protocol Violation|0
7501956|NCT03285711|26027245|P1|Blinded Phase (Up to Week 16)|Protocol Violation|1
7501957|NCT03285711|26027242|P4|Blinded Phase (Up to Week 16)|Adverse Event|0
7501958|NCT03285711|26027243|P3|Blinded Phase (Up to Week 16)|Adverse Event|0
7501959|NCT03285711|26027244|P2|Blinded Phase (Up to Week 16)|Adverse Event|1
7501960|NCT03285711|26027245|P1|Blinded Phase (Up to Week 16)|Adverse Event|2
7501961|NCT03285646|26027267|P2|Overall Study|Investigator/Sponsor Decision|1
7501962|NCT03285646|26027268|P1|Overall Study|Investigator/Sponsor Decision|0
7501963|NCT03285646|26027267|P2|Overall Study|Lost to Follow-up|1
7501964|NCT03285646|26027268|P1|Overall Study|Lost to Follow-up|2
7501965|NCT03285646|26027267|P2|Overall Study|Withdrawal by Subject|2
7501966|NCT03285646|26027268|P1|Overall Study|Withdrawal by Subject|10
7501967|NCT03285646|26027267|P2|Overall Study|Adverse Event|0
7501968|NCT03285646|26027268|P1|Overall Study|Adverse Event|1
7501969|NCT03285594|26027302|P3|Overall Study|Reason Not Specified|8
7501970|NCT03285594|26027303|P2|Overall Study|Reason Not Specified|4
7501971|NCT03285594|26027304|P1|Overall Study|Reason Not Specified|3
7501972|NCT03285594|26027302|P3|Overall Study|Lost to Follow-up|1
7501973|NCT03285594|26027303|P2|Overall Study|Lost to Follow-up|0
7501974|NCT03285594|26027304|P1|Overall Study|Lost to Follow-up|0
7501975|NCT03285594|26027302|P3|Overall Study|Poor Compliance to Protocol|1
7501976|NCT03285594|26027303|P2|Overall Study|Poor Compliance to Protocol|0
7501977|NCT03285594|26027304|P1|Overall Study|Poor Compliance to Protocol|0
7501978|NCT03285594|26027302|P3|Overall Study|Adverse Event|6
7501979|NCT03285594|26027303|P2|Overall Study|Adverse Event|2
7501980|NCT03285594|26027304|P1|Overall Study|Adverse Event|2
7501981|NCT03285594|26027302|P3|Overall Study|At the Participant's Own Request|21
7501982|NCT03285594|26027303|P2|Overall Study|At the Participant's Own Request|5
7501983|NCT03285594|26027304|P1|Overall Study|At the Participant's Own Request|10
7501984|NCT03285490|26027373|P2|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
7501985|NCT03285490|26027374|P1|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
7501986|NCT03285490|26027373|P2|Recurrence Follow-up Period|Withdrawal by Subject|1
7501987|NCT03285490|26027374|P1|Recurrence Follow-up Period|Withdrawal by Subject|0
7501988|NCT03285477|26027403|P2|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
7501989|NCT03285477|26027404|P1|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
7501990|NCT03285477|26027403|P2|Recurrence Follow-up Period|Withdrawal of consent|3
7501991|NCT03285477|26027404|P1|Recurrence Follow-up Period|Withdrawal of consent|1
7501992|NCT03285477|26027403|P2|Recurrence Follow-up Period|Lost to Follow-up|1
7501993|NCT03285477|26027404|P1|Recurrence Follow-up Period|Lost to Follow-up|0
7501994|NCT03285477|26027403|P2|Treatment and Response Assessment Period|Withdrawn of Consent|0
7501995|NCT03285477|26027404|P1|Treatment and Response Assessment Period|Withdrawn of Consent|1
7501996|NCT03285477|26027403|P2|Treatment and Response Assessment Period|Death|0
7501997|NCT03285477|26027404|P1|Treatment and Response Assessment Period|Death|1
7501998|NCT03285308|26027481|P2|Overall Study|Reason not Specified|1
7501999|NCT03285308|26027482|P1|Overall Study|Reason not Specified|0
7502000|NCT03285308|26027481|P2|Overall Study|Protocol Deviation|5
7502001|NCT03285308|26027482|P1|Overall Study|Protocol Deviation|6
7502002|NCT03285308|26027481|P2|Overall Study|Lost to Follow-up|1
7502003|NCT03285308|26027482|P1|Overall Study|Lost to Follow-up|3
7502004|NCT03285308|26027481|P2|Overall Study|Withdrawal by Subject|9
7502005|NCT03285308|26027482|P1|Overall Study|Withdrawal by Subject|8
7502006|NCT03285308|26027481|P2|Overall Study|Adverse Event|7
7502007|NCT03285308|26027482|P1|Overall Study|Adverse Event|3
7502008|NCT03285295|26027514|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7502009|NCT03285295|26027515|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7502010|NCT03285295|26027516|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7502011|NCT03285295|26027517|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7502012|NCT03285295|26027518|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
7502013|NCT03285295|26027514|P5|Alinity s Chagas|No Results Generated|0
7502014|NCT03285295|26027515|P4|Alinity s Chagas|No Results Generated|0
7502015|NCT03285295|26027516|P3|Alinity s Chagas|No Results Generated|0
7502016|NCT03285295|26027517|P2|Alinity s Chagas|No Results Generated|0
7502017|NCT03285295|26027518|P1|Alinity s Chagas|No Results Generated|105
7502018|NCT03285295|26027514|P5|Alinity s Chagas|No Results on Comparator Assay|0
7502019|NCT03285295|26027515|P4|Alinity s Chagas|No Results on Comparator Assay|0
7502020|NCT03285295|26027516|P3|Alinity s Chagas|No Results on Comparator Assay|0
7502021|NCT03285295|26027517|P2|Alinity s Chagas|No Results on Comparator Assay|0
7502022|NCT03285295|26027518|P1|Alinity s Chagas|No Results on Comparator Assay|38
7502023|NCT03285295|26027514|P5|Alinity s Chagas|Protocol Violation|0
7502024|NCT03285295|26027515|P4|Alinity s Chagas|Protocol Violation|0
7502025|NCT03285295|26027516|P3|Alinity s Chagas|Protocol Violation|0
7502026|NCT03285295|26027517|P2|Alinity s Chagas|Protocol Violation|0
7502027|NCT03285295|26027518|P1|Alinity s Chagas|Protocol Violation|76
7502028|NCT03285295|26027514|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7502029|NCT03285295|26027515|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7502030|NCT03285295|26027516|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7502031|NCT03285295|26027517|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7502032|NCT03285295|26027518|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
7502033|NCT03285295|26027514|P5|Alinity s Anti-HBc|No Results Generated|0
7502034|NCT03285295|26027515|P4|Alinity s Anti-HBc|No Results Generated|0
7502035|NCT03285295|26027516|P3|Alinity s Anti-HBc|No Results Generated|0
7502036|NCT03285295|26027517|P2|Alinity s Anti-HBc|No Results Generated|0
7502037|NCT03285295|26027518|P1|Alinity s Anti-HBc|No Results Generated|70
7502038|NCT03285295|26027514|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
7502039|NCT03285295|26027515|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
7502040|NCT03285295|26027516|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
7502041|NCT03285295|26027517|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
7502042|NCT03285295|26027518|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
7502043|NCT03285295|26027514|P5|Alinity s Anti-HBc|Protocol Violation|0
7502044|NCT03285295|26027515|P4|Alinity s Anti-HBc|Protocol Violation|0
7502045|NCT03285295|26027516|P3|Alinity s Anti-HBc|Protocol Violation|0
7502046|NCT03285295|26027517|P2|Alinity s Anti-HBc|Protocol Violation|0
7502047|NCT03285295|26027518|P1|Alinity s Anti-HBc|Protocol Violation|8
7502048|NCT03285295|26027514|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7502049|NCT03285295|26027515|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7502050|NCT03285295|26027516|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7502051|NCT03285295|26027517|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7502052|NCT03285295|26027518|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
7502053|NCT03285295|26027514|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7502054|NCT03285295|26027515|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7502055|NCT03285295|26027516|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7502056|NCT03285295|26027517|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7502057|NCT03285295|26027518|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
7502058|NCT03285295|26027514|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7502059|NCT03285295|26027515|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7502060|NCT03285295|26027516|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7502061|NCT03285295|26027517|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7502062|NCT03285295|26027518|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
7502063|NCT03285295|26027514|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7502064|NCT03285295|26027515|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7502065|NCT03285295|26027516|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7502066|NCT03285295|26027517|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7502067|NCT03285295|26027518|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
7502068|NCT03285295|26027514|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7502069|NCT03285295|26027515|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7502070|NCT03285295|26027516|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7502071|NCT03285295|26027517|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7502072|NCT03285295|26027518|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
7502073|NCT03285295|26027514|P5|Alinity s Anti-HCV|No Results Generated|0
7502074|NCT03285295|26027515|P4|Alinity s Anti-HCV|No Results Generated|0
7502075|NCT03285295|26027516|P3|Alinity s Anti-HCV|No Results Generated|0
7502076|NCT03285295|26027517|P2|Alinity s Anti-HCV|No Results Generated|0
7502077|NCT03285295|26027518|P1|Alinity s Anti-HCV|No Results Generated|71
7502078|NCT03285295|26027514|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
7502079|NCT03285295|26027515|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
7502080|NCT03285295|26027516|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
7502081|NCT03285295|26027517|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
7502082|NCT03285295|26027518|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
7502083|NCT03285295|26027514|P5|Alinity s Anti-HCV|Protocol Violation|0
7502084|NCT03285295|26027515|P4|Alinity s Anti-HCV|Protocol Violation|0
7502085|NCT03285295|26027516|P3|Alinity s Anti-HCV|Protocol Violation|0
7502086|NCT03285295|26027517|P2|Alinity s Anti-HCV|Protocol Violation|0
7502087|NCT03285295|26027518|P1|Alinity s Anti-HCV|Protocol Violation|12
7502088|NCT03285295|26027514|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7502089|NCT03285295|26027515|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7502090|NCT03285295|26027516|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7502091|NCT03285295|26027517|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7502092|NCT03285295|26027518|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
7502093|NCT03285295|26027514|P5|Alinity s HTLV I/II|No Results Generated|0
7502094|NCT03285295|26027515|P4|Alinity s HTLV I/II|No Results Generated|0
7502095|NCT03285295|26027516|P3|Alinity s HTLV I/II|No Results Generated|0
7502096|NCT03285295|26027517|P2|Alinity s HTLV I/II|No Results Generated|0
7502097|NCT03285295|26027518|P1|Alinity s HTLV I/II|No Results Generated|70
7502098|NCT03285295|26027514|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
7502099|NCT03285295|26027515|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
7502100|NCT03285295|26027516|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
7502101|NCT03285295|26027517|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
7502102|NCT03285295|26027518|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
7502103|NCT03285295|26027514|P5|Alinity s HTLV I/II|Protocol Violation|0
7502104|NCT03285295|26027515|P4|Alinity s HTLV I/II|Protocol Violation|0
7502105|NCT03285295|26027516|P3|Alinity s HTLV I/II|Protocol Violation|0
7502106|NCT03285295|26027517|P2|Alinity s HTLV I/II|Protocol Violation|0
7502107|NCT03285295|26027518|P1|Alinity s HTLV I/II|Protocol Violation|6
7502108|NCT03285295|26027514|P5|Alinity s HBsAg|No Results Generated|0
7502109|NCT03285295|26027515|P4|Alinity s HBsAg|No Results Generated|0
7502110|NCT03285295|26027516|P3|Alinity s HBsAg|No Results Generated|0
7502111|NCT03285295|26027517|P2|Alinity s HBsAg|No Results Generated|6
7502112|NCT03285295|26027518|P1|Alinity s HBsAg|No Results Generated|74
7502113|NCT03285295|26027514|P5|Alinity s HBsAg|No Result on Comparator Assay|0
7502114|NCT03285295|26027515|P4|Alinity s HBsAg|No Result on Comparator Assay|0
7502115|NCT03285295|26027516|P3|Alinity s HBsAg|No Result on Comparator Assay|0
7502116|NCT03285295|26027517|P2|Alinity s HBsAg|No Result on Comparator Assay|0
7502117|NCT03285295|26027518|P1|Alinity s HBsAg|No Result on Comparator Assay|17
7502118|NCT03285295|26027514|P5|Alinity s HBsAg|Protocol Violation|0
7502119|NCT03285295|26027515|P4|Alinity s HBsAg|Protocol Violation|0
7502120|NCT03285295|26027516|P3|Alinity s HBsAg|Protocol Violation|0
7502121|NCT03285295|26027517|P2|Alinity s HBsAg|Protocol Violation|0
7502122|NCT03285295|26027518|P1|Alinity s HBsAg|Protocol Violation|11
7502123|NCT03285113|26027547|P1|Overall Study|Unable to implant leads|2
7502124|NCT03284710|26027567|P4|Overall Study|HIV Infection|1
7502125|NCT03284710|26027568|P3|Overall Study|HIV Infection|2
7502126|NCT03284710|26027569|P2|Overall Study|HIV Infection|2
7502127|NCT03284710|26027570|P1|Overall Study|HIV Infection|0
7502128|NCT03284710|26027567|P4|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7502129|NCT03284710|26027568|P3|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7502130|NCT03284710|26027569|P2|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7502131|NCT03284710|26027570|P1|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7502132|NCT03284710|26027567|P4|Overall Study|Physician Decision|0
7502133|NCT03284710|26027568|P3|Overall Study|Physician Decision|0
7502134|NCT03284710|26027569|P2|Overall Study|Physician Decision|0
7502135|NCT03284710|26027570|P1|Overall Study|Physician Decision|1
7502136|NCT03284710|26027567|P4|Overall Study|Lost to Follow-up|0
7502137|NCT03284710|26027568|P3|Overall Study|Lost to Follow-up|1
7502138|NCT03284710|26027569|P2|Overall Study|Lost to Follow-up|3
7502139|NCT03284710|26027570|P1|Overall Study|Lost to Follow-up|3
7502140|NCT03284710|26027567|P4|Overall Study|Withdrawal by Subject|6
7502141|NCT03284710|26027568|P3|Overall Study|Withdrawal by Subject|1
7502142|NCT03284710|26027569|P2|Overall Study|Withdrawal by Subject|0
7502143|NCT03284710|26027570|P1|Overall Study|Withdrawal by Subject|1
7502144|NCT03284229|26027731|P1|Overall Study|Lost to Follow-up|3
7502145|NCT03283709|26027765|P2|Overall Study|trial terminated|1
7502146|NCT03283709|26027766|P1|Overall Study|trial terminated|0
7502147|NCT03283696|26027798|P2|Overall Study|Withdrawal by Subject|0
7502148|NCT03283696|26027799|P1|Overall Study|Withdrawal by Subject|2
7502149|NCT03283696|26027798|P2|Overall Study|Physician Decision|6
7502150|NCT03283696|26027799|P1|Overall Study|Physician Decision|5
7502151|NCT03283553|26027827|P2|Care Partner Participant Flow|Discontinued because patient death|11
7502152|NCT03283553|26027828|P1|Care Partner Participant Flow|Discontinued because patient death|5
7502153|NCT03283553|26027827|P2|Care Partner Participant Flow|Lost to Follow-up|1
7502154|NCT03283553|26027828|P1|Care Partner Participant Flow|Lost to Follow-up|1
7502155|NCT03283553|26027827|P2|Care Partner Participant Flow|Withdrawal by Subject|3
7502156|NCT03283553|26027828|P1|Care Partner Participant Flow|Withdrawal by Subject|4
7502157|NCT03283553|26027827|P2|Patient Participant Flow|Lost to Follow-up|1
7502158|NCT03283553|26027828|P1|Patient Participant Flow|Lost to Follow-up|1
7502159|NCT03283553|26027827|P2|Patient Participant Flow|Withdrawal by Subject|2
7502160|NCT03283553|26027828|P1|Patient Participant Flow|Withdrawal by Subject|4
7502161|NCT03283553|26027827|P2|Patient Participant Flow|Death|10
7502162|NCT03283553|26027828|P1|Patient Participant Flow|Death|5
7502163|NCT03283371|26027873|P2|Overall Study|Participants Did Not Receive Study Drug|1
7502164|NCT03283371|26027874|P1|Overall Study|Participants Did Not Receive Study Drug|0
7502165|NCT03283371|26027873|P2|Overall Study|Withdrawal by Subject|1
7502166|NCT03283371|26027874|P1|Overall Study|Withdrawal by Subject|1
7502167|NCT03283371|26027873|P2|Overall Study|Lack of Efficacy|0
7502168|NCT03283371|26027874|P1|Overall Study|Lack of Efficacy|1
7502169|NCT03283371|26027873|P2|Overall Study|Adverse Event|1
7502170|NCT03283371|26027874|P1|Overall Study|Adverse Event|1
7502171|NCT03283319|26027894|P6|Overall Study|BARDA regulatory agency or IRB decision|0
7502172|NCT03283319|26027895|P5|Overall Study|BARDA regulatory agency or IRB decision|0
7502173|NCT03283319|26027896|P4|Overall Study|BARDA regulatory agency or IRB decision|1
7502174|NCT03283319|26027897|P3|Overall Study|BARDA regulatory agency or IRB decision|0
7502175|NCT03283319|26027898|P2|Overall Study|BARDA regulatory agency or IRB decision|0
7502176|NCT03283319|26027899|P1|Overall Study|BARDA regulatory agency or IRB decision|0
7502177|NCT03283319|26027894|P6|Overall Study|Withdrawal by Subject|1
7502178|NCT03283319|26027895|P5|Overall Study|Withdrawal by Subject|0
7502179|NCT03283319|26027896|P4|Overall Study|Withdrawal by Subject|1
7502180|NCT03283319|26027897|P3|Overall Study|Withdrawal by Subject|2
7502181|NCT03283319|26027898|P2|Overall Study|Withdrawal by Subject|2
7502182|NCT03283319|26027899|P1|Overall Study|Withdrawal by Subject|2
7502183|NCT03283319|26027894|P6|Overall Study|Lost to Follow-up|3
7502184|NCT03283319|26027895|P5|Overall Study|Lost to Follow-up|4
7502185|NCT03283319|26027896|P4|Overall Study|Lost to Follow-up|5
7502186|NCT03283319|26027897|P3|Overall Study|Lost to Follow-up|5
7502187|NCT03283319|26027898|P2|Overall Study|Lost to Follow-up|4
7502188|NCT03283319|26027899|P1|Overall Study|Lost to Follow-up|5
7502189|NCT03283098|26028041|P2|Overall Study|Withdrawal by Subject|1
7502190|NCT03283098|26028042|P1|Overall Study|Withdrawal by Subject|0
7502191|NCT03282357|26028159|P1|Overall Study|Other|9
7502192|NCT03282357|26028159|P1|Overall Study|Adverse Event|1
7502193|NCT03282357|26028159|P1|Overall Study|Withdrawal by Subject|4
7502194|NCT03282357|26028159|P1|Overall Study|Lost to Follow-up|3
7502195|NCT03282240|26028169|P3|Overall Study|Withdrawal by Subject|1
7502196|NCT03282240|26028170|P2|Overall Study|Withdrawal by Subject|0
7502197|NCT03282240|26028171|P1|Overall Study|Withdrawal by Subject|1
7502198|NCT03282240|26028169|P3|Overall Study|Protocol Deviation|2
7502199|NCT03282240|26028170|P2|Overall Study|Protocol Deviation|1
7502200|NCT03282240|26028171|P1|Overall Study|Protocol Deviation|4
7502201|NCT03282240|26028169|P3|Overall Study|Lost to Follow-up|0
7502202|NCT03282240|26028170|P2|Overall Study|Lost to Follow-up|0
7502203|NCT03282240|26028171|P1|Overall Study|Lost to Follow-up|3
7502204|NCT03282240|26028169|P3|Overall Study|Adverse Event|0
7502205|NCT03282240|26028170|P2|Overall Study|Adverse Event|2
7502206|NCT03282240|26028171|P1|Overall Study|Adverse Event|2
7502207|NCT03282227|26028223|P1|Overall Study|Other|1
7502208|NCT03282227|26028223|P1|Overall Study|Pregnancy|2
7502209|NCT03282227|26028223|P1|Overall Study|Physician Decision|2
7502210|NCT03282227|26028223|P1|Overall Study|Sponsor decision|3
7502211|NCT03282227|26028223|P1|Overall Study|Lack of Efficacy|12
7502212|NCT03282227|26028223|P1|Overall Study|Withdrawal by Subject|20
7502213|NCT03282227|26028223|P1|Overall Study|Lost to Follow-up|21
7502214|NCT03282227|26028223|P1|Overall Study|Adverse Event|15
7502215|NCT03282227|26028223|P1|Overall Study|Non-compliance w/ protocol requirements|79
7502216|NCT03282227|26028223|P1|Overall Study|Exposure Goals Achieved|60
7502217|NCT03282123|26028233|P1|Overall Study|Withdrawal by Subject|5
7502218|NCT03281876|26028264|P2|Overall Study|OTHER|5
7502219|NCT03281876|26028265|P1|Overall Study|OTHER|5
7502220|NCT03281876|26028264|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502221|NCT03281876|26028265|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7502222|NCT03281876|26028264|P2|Overall Study|Withdrawal by Subject|15
7502223|NCT03281876|26028265|P1|Overall Study|Withdrawal by Subject|11
7502224|NCT03281876|26028264|P2|Overall Study|Lost to Follow-up|4
7502225|NCT03281876|26028265|P1|Overall Study|Lost to Follow-up|1
7502226|NCT03281876|26028264|P2|Overall Study|Adverse Event|15
7502227|NCT03281876|26028265|P1|Overall Study|Adverse Event|4
7502228|NCT03281668|26028335|P1|Overall Study|Lost to Follow-up|1
7502229|NCT03281668|26028335|P1|Overall Study|Withdrawal by Subject|4
7502230|NCT03281668|26028335|P1|Overall Study|scheduling conflict, family circumstance|2
7502231|NCT03281668|26028335|P1|Overall Study|Physician Decision|1
7502232|NCT03281577|26028363|P4|Overall Study|Withdrawal by Subject|0
7502233|NCT03281577|26028364|P3|Overall Study|Withdrawal by Subject|0
7502234|NCT03281577|26028365|P2|Overall Study|Withdrawal by Subject|0
7502235|NCT03281577|26028366|P1|Overall Study|Withdrawal by Subject|1
7502236|NCT03281577|26028363|P4|Overall Study|Adverse Event|1
7502237|NCT03281577|26028364|P3|Overall Study|Adverse Event|0
7502238|NCT03281577|26028365|P2|Overall Study|Adverse Event|0
7502239|NCT03281577|26028366|P1|Overall Study|Adverse Event|0
7502240|NCT03281304|26028403|P2|Overall Study|Withdrawal by Subject|10
7502241|NCT03281304|26028404|P1|Overall Study|Withdrawal by Subject|5
7502242|NCT03281304|26028403|P2|Overall Study|Pregnancy|0
7502243|NCT03281304|26028404|P1|Overall Study|Pregnancy|1
7502244|NCT03281304|26028403|P2|Overall Study|Lack of Efficacy|0
7502245|NCT03281304|26028404|P1|Overall Study|Lack of Efficacy|2
7502246|NCT03281304|26028403|P2|Overall Study|Adverse Event|2
7502247|NCT03281304|26028404|P1|Overall Study|Adverse Event|5
7502248|NCT03280615|26028470|P2|Overall Study|Withdrawal by Subject|2
7502249|NCT03280615|26028471|P1|Overall Study|Withdrawal by Subject|2
7502250|NCT03280615|26028470|P2|Overall Study|Adverse Event|1
7502251|NCT03280615|26028471|P1|Overall Study|Adverse Event|1
7502252|NCT03280615|26028470|P2|Overall Study|Lost to Follow-up|2
7502253|NCT03280615|26028471|P1|Overall Study|Lost to Follow-up|1
7502254|NCT03280550|26028483|P2|Overall Study|Physician Decision|1
7502255|NCT03280550|26028484|P1|Overall Study|Physician Decision|0
7502256|NCT03280550|26028483|P2|Overall Study|Withdrawal by Subject|2
7502257|NCT03280550|26028484|P1|Overall Study|Withdrawal by Subject|2
7502258|NCT03280537|26028536|P2|Overall Study|Withdrawal by Subject|4
7502259|NCT03280537|26028537|P1|Overall Study|Withdrawal by Subject|2
7502260|NCT03280381|26028589|P2|Overall Study|Physician Decision|2
7502261|NCT03280381|26028590|P1|Overall Study|Physician Decision|0
7502262|NCT03280264|26028598|P1|Overall Study|Withdrawal by Subject|1
7502263|NCT03280264|26028598|P1|Overall Study|Physician Decision|1
7502264|NCT03280264|26028598|P1|Overall Study|Adverse Event|1
7502265|NCT03280121|26028606|P1|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
7502266|NCT03280121|26028606|P1|Overall Study|Lost to Follow-up|1
7502267|NCT03280121|26028606|P1|Overall Study|Physician Decision|1
7502268|NCT03280108|26028614|P2|Overall Study|Lost to Follow-up|0
7502269|NCT03280108|26028615|P1|Overall Study|Lost to Follow-up|2
7502270|NCT03278613|26028699|P2|Overall Study|Lost to Follow-up|1
7502271|NCT03278613|26028700|P1|Overall Study|Lost to Follow-up|3
7502273|NCT03278028|26029253|P2|Overall Study|Pregnancy|1
7502274|NCT03278028|26029254|P1|Overall Study|Pregnancy|0
7502275|NCT03278028|26029253|P2|Overall Study|Withdrawal by Subject|1
7502276|NCT03278028|26029254|P1|Overall Study|Withdrawal by Subject|3
7502277|NCT03278028|26029253|P2|Overall Study|Lost to Follow-up|0
7502278|NCT03278028|26029254|P1|Overall Study|Lost to Follow-up|1
7502279|NCT03277846|26029262|P2|Overall Study|Inpatient stay too brief|11
7502280|NCT03277846|26029263|P1|Overall Study|Inpatient stay too brief|12
7502281|NCT03277794|26029271|P2|Overall Study|Withdrew due to high acuity|0
7502282|NCT03277794|26029272|P1|Overall Study|Withdrew due to high acuity|1
7502283|NCT03277794|26029271|P2|Overall Study|Lost to Follow-up|4
7502284|NCT03277794|26029272|P1|Overall Study|Lost to Follow-up|2
7502285|NCT03277352|26029355|P1|Overall Study|Death|4
7502286|NCT03277352|26029355|P1|Overall Study|Withdrawal by Subject|4
7502287|NCT03277352|26029355|P1|Overall Study|Study Terminated By Sponsor|2
7502288|NCT03277105|26029418|P2|Overall Study|Ongoing|175
7502289|NCT03277105|26029419|P1|Overall Study|Ongoing|171
7502290|NCT03277105|26029418|P2|Overall Study|Other|3
7502291|NCT03277105|26029419|P1|Overall Study|Other|1
7502292|NCT03277105|26029418|P2|Overall Study|Withdrawal by Subject|9
7502293|NCT03277105|26029419|P1|Overall Study|Withdrawal by Subject|10
7502294|NCT03277105|26029418|P2|Overall Study|Lost to Follow-up|3
7502295|NCT03277105|26029419|P1|Overall Study|Lost to Follow-up|0
7502296|NCT03277105|26029418|P2|Overall Study|Death|73
7502297|NCT03277105|26029419|P1|Overall Study|Death|77
7502298|NCT03276975|26029451|P2|Overall Study|Withdrawal by Subject|0
7502299|NCT03276975|26029452|P1|Overall Study|Withdrawal by Subject|1
7502300|NCT03276936|26029472|P2|Overall Study|Not mentioned|3
7502301|NCT03276936|26029473|P1|Overall Study|Not mentioned|6
7502302|NCT03276936|26029472|P2|Overall Study|Withdrawal by Subject|20
7502303|NCT03276936|26029473|P1|Overall Study|Withdrawal by Subject|30
7502304|NCT03276936|26029472|P2|Overall Study|Lost to Follow-up|13
7502305|NCT03276936|26029473|P1|Overall Study|Lost to Follow-up|16
7502306|NCT03276936|26029472|P2|Overall Study|Adverse Event|2
7502307|NCT03276936|26029473|P1|Overall Study|Adverse Event|4
7502308|NCT03276078|26029519|P1|Overall Study|Adverse Event|1
7502309|NCT03276026|26029548|P2|Overall Study|Protocol Violation|0
7502310|NCT03276026|26029549|P1|Overall Study|Protocol Violation|1
7502311|NCT03275389|26029602|P10|Overall Study|Other|0
7502312|NCT03275389|26029603|P9|Overall Study|Other|1
7502313|NCT03275389|26029604|P8|Overall Study|Other|0
7502314|NCT03275389|26029605|P7|Overall Study|Other|0
7502315|NCT03275389|26029606|P6|Overall Study|Other|2
7502316|NCT03275389|26029607|P5|Overall Study|Other|2
7502317|NCT03275389|26029608|P4|Overall Study|Other|2
7502318|NCT03275389|26029609|P3|Overall Study|Other|3
7502319|NCT03275389|26029610|P2|Overall Study|Other|4
7502320|NCT03275389|26029611|P1|Overall Study|Other|0
7502321|NCT03275389|26029602|P10|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7502322|NCT03275389|26029603|P9|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502323|NCT03275389|26029604|P8|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502324|NCT03275389|26029605|P7|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502325|NCT03275389|26029606|P6|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502326|NCT03275389|26029607|P5|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502327|NCT03275389|26029608|P4|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502328|NCT03275389|26029609|P3|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7502329|NCT03275389|26029610|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502330|NCT03275389|26029611|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7502331|NCT03275389|26029602|P10|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502332|NCT03275389|26029603|P9|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502333|NCT03275389|26029604|P8|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502334|NCT03275389|26029605|P7|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7502335|NCT03275389|26029606|P6|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502336|NCT03275389|26029607|P5|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502337|NCT03275389|26029608|P4|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7502338|NCT03275389|26029609|P3|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502339|NCT03275389|26029610|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7502340|NCT03275389|26029611|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7502341|NCT03275389|26029602|P10|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7502342|NCT03275389|26029603|P9|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7502343|NCT03275389|26029604|P8|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7502344|NCT03275389|26029605|P7|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7502345|NCT03275389|26029606|P6|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7502346|NCT03275389|26029607|P5|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7502347|NCT03275389|26029608|P4|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7502348|NCT03275389|26029609|P3|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7502349|NCT03275389|26029610|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7502350|NCT03275389|26029611|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7502351|NCT03275389|26029602|P10|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7502352|NCT03275389|26029603|P9|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502353|NCT03275389|26029604|P8|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502354|NCT03275389|26029605|P7|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502355|NCT03275389|26029606|P6|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7502356|NCT03275389|26029607|P5|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502357|NCT03275389|26029608|P4|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502358|NCT03275389|26029609|P3|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502359|NCT03275389|26029610|P2|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502360|NCT03275389|26029611|P1|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7502361|NCT03275389|26029602|P10|Overall Study|Lost to Follow-up|14
7502362|NCT03275389|26029603|P9|Overall Study|Lost to Follow-up|12
7502363|NCT03275389|26029604|P8|Overall Study|Lost to Follow-up|15
7502364|NCT03275389|26029605|P7|Overall Study|Lost to Follow-up|21
7502365|NCT03275389|26029606|P6|Overall Study|Lost to Follow-up|12
7502366|NCT03275389|26029607|P5|Overall Study|Lost to Follow-up|11
7502367|NCT03275389|26029608|P4|Overall Study|Lost to Follow-up|12
7502368|NCT03275389|26029609|P3|Overall Study|Lost to Follow-up|19
7502369|NCT03275389|26029610|P2|Overall Study|Lost to Follow-up|10
7502370|NCT03275389|26029611|P1|Overall Study|Lost to Follow-up|10
7502371|NCT03275246|26030173|P1|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
7502372|NCT03275246|26030173|P1|Overall Study|Protocol Violation|5
7502373|NCT03274986|26030199|P2|Overall Study|Lost to Follow-up|1
7502374|NCT03274986|26030200|P1|Overall Study|Lost to Follow-up|0
7502375|NCT03274986|26030199|P2|Overall Study|Withdrawal by Subject|1
7502376|NCT03274986|26030200|P1|Overall Study|Withdrawal by Subject|0
7502377|NCT03274466|26030274|P2|Overall Study|Protocol Violation|3
7502378|NCT03274466|26030275|P1|Overall Study|Protocol Violation|3
7502379|NCT03274466|26030274|P2|Overall Study|Physician Decision|1
7502380|NCT03274466|26030275|P1|Overall Study|Physician Decision|0
7502381|NCT03274466|26030274|P2|Overall Study|Adverse Event|3
7502382|NCT03274466|26030275|P1|Overall Study|Adverse Event|3
7502383|NCT03274466|26030274|P2|Overall Study|Subject Non-compliance|1
7502384|NCT03274466|26030275|P1|Overall Study|Subject Non-compliance|0
7502385|NCT03274466|26030274|P2|Overall Study|Lost to Follow-up|7
7502386|NCT03274466|26030275|P1|Overall Study|Lost to Follow-up|5
7502387|NCT03274466|26030274|P2|Overall Study|Protocol Specified Withdrawal|11
7502388|NCT03274466|26030275|P1|Overall Study|Protocol Specified Withdrawal|5
7502389|NCT03274466|26030274|P2|Overall Study|Withdrawal by Subject|3
7502390|NCT03274466|26030275|P1|Overall Study|Withdrawal by Subject|7
7502391|NCT03274453|26030291|P4|Overall Study|Surgery Cancelled|0
7502392|NCT03274453|26030292|P3|Overall Study|Surgery Cancelled|0
7502393|NCT03274453|26030293|P2|Overall Study|Surgery Cancelled|1
7502394|NCT03274453|26030294|P1|Overall Study|Surgery Cancelled|0
7502395|NCT03274453|26030291|P4|Overall Study|Physician Decision|3
7502396|NCT03274453|26030292|P3|Overall Study|Physician Decision|0
7502397|NCT03274453|26030293|P2|Overall Study|Physician Decision|0
7502398|NCT03274453|26030294|P1|Overall Study|Physician Decision|2
7502399|NCT03274453|26030291|P4|Overall Study|Lost to Follow-up|1
7502400|NCT03274453|26030292|P3|Overall Study|Lost to Follow-up|4
7502401|NCT03274453|26030293|P2|Overall Study|Lost to Follow-up|5
7502402|NCT03274453|26030294|P1|Overall Study|Lost to Follow-up|2
7502403|NCT03274440|26030304|P6|Overall Study|Time commitment too great|0
7502404|NCT03274440|26030305|P5|Overall Study|Time commitment too great|0
7502405|NCT03274440|26030306|P4|Overall Study|Time commitment too great|1
7502406|NCT03274440|26030307|P3|Overall Study|Time commitment too great|0
7502407|NCT03274440|26030308|P2|Overall Study|Time commitment too great|0
7502408|NCT03274440|26030309|P1|Overall Study|Time commitment too great|1
7502409|NCT03274076|26030322|P4|24 Weeks Open Label|Withdrawal by Subject|1
7502410|NCT03274076|26030323|P3|24 Weeks Open Label|Withdrawal by Subject|0
7502411|NCT03274076|26030324|P2|24 Weeks Open Label|Withdrawal by Subject|0
7502412|NCT03274076|26030325|P1|24 Weeks Open Label|Withdrawal by Subject|0
7502413|NCT03274076|26030322|P4|24 Weeks Open Label|Adverse Event|0
7502414|NCT03274076|26030323|P3|24 Weeks Open Label|Adverse Event|2
7502415|NCT03274076|26030324|P2|24 Weeks Open Label|Adverse Event|0
7502416|NCT03274076|26030325|P1|24 Weeks Open Label|Adverse Event|0
7502417|NCT03274076|26030322|P4|24 Weeks Double Blind|Withdrawal by Subject|0
7502418|NCT03274076|26030323|P3|24 Weeks Double Blind|Withdrawal by Subject|0
7502419|NCT03274076|26030324|P2|24 Weeks Double Blind|Withdrawal by Subject|1
7502420|NCT03274076|26030325|P1|24 Weeks Double Blind|Withdrawal by Subject|0
7502421|NCT03273946|26030353|P1|Overall Study|Participant relative refused to use drug|1
7502422|NCT03273946|26030353|P1|Overall Study|Participant refused to use the drug|2
7502423|NCT03273946|26030353|P1|Overall Study|Unwillingness of the guardian|1
7502424|NCT03273946|26030353|P1|Overall Study|Withdrawal by Subject|5
7502425|NCT03273387|26030401|P2|Overall Study|Withdrawal by Subject|1
7502426|NCT03273387|26030402|P1|Overall Study|Withdrawal by Subject|1
7502427|NCT03273387|26030401|P2|Overall Study|Death|2
7502428|NCT03273387|26030402|P1|Overall Study|Death|2
7502429|NCT03273257|26030438|P2|Overall Study|Study terminated|2
7502430|NCT03273257|26030439|P1|Overall Study|Study terminated|3
7502431|NCT03273257|26030438|P2|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7502432|NCT03273257|26030439|P1|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7502433|NCT03273257|26030438|P2|Overall Study|Death|1
7502434|NCT03273257|26030439|P1|Overall Study|Death|0
7502435|NCT03273166|26030463|P1|Overall Study|Withdrawn prior to Completion|31
7502436|NCT03273153|26030470|P2|Overall Study|Other|1
7502437|NCT03273153|26030471|P1|Overall Study|Other|0
7502438|NCT03273153|26030470|P2|Overall Study|Symptomatic Deterioration|1
7502439|NCT03273153|26030471|P1|Overall Study|Symptomatic Deterioration|0
7502440|NCT03273153|26030470|P2|Overall Study|Withdrawal by Subject|13
7502441|NCT03273153|26030471|P1|Overall Study|Withdrawal by Subject|16
7502442|NCT03273153|26030470|P2|Overall Study|Protocol Violation|0
7502443|NCT03273153|26030471|P1|Overall Study|Protocol Violation|3
7502444|NCT03273153|26030470|P2|Overall Study|Lost to Follow-up|3
7502445|NCT03273153|26030471|P1|Overall Study|Lost to Follow-up|3
7502446|NCT03273153|26030470|P2|Overall Study|Death|45
7502447|NCT03273153|26030471|P1|Overall Study|Death|41
7502448|NCT03273153|26030470|P2|Overall Study|Remain on Study|159
7502449|NCT03273153|26030471|P1|Overall Study|Remain on Study|161
7502450|NCT03271528|26030519|P2|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
7502451|NCT03271528|26030520|P1|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
7502452|NCT03271528|26030519|P2|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
7502453|NCT03271528|26030520|P1|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
7502454|NCT03271528|26030519|P2|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7502455|NCT03271528|26030520|P1|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7502456|NCT03271528|26030519|P2|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
7502457|NCT03271528|26030520|P1|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
7502458|NCT03271528|26030519|P2|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
7502459|NCT03271528|26030520|P1|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
7502460|NCT03271528|26030519|P2|Medication Dispense/Exposure Period 1|Protocol Violation|0
7502461|NCT03271528|26030520|P1|Medication Dispense/Exposure Period 1|Protocol Violation|1
7502462|NCT03271528|26030519|P2|Medication Dispense/Exposure Period 1|Adverse Event|0
7502463|NCT03271528|26030520|P1|Medication Dispense/Exposure Period 1|Adverse Event|1
7502464|NCT03271307|26030586|P5|Overall Study|Lost to Follow-up|91
7502465|NCT03271307|26030587|P4|Overall Study|Lost to Follow-up|28
7502466|NCT03271307|26030588|P3|Overall Study|Lost to Follow-up|0
7502467|NCT03271307|26030589|P2|Overall Study|Lost to Follow-up|0
7502468|NCT03271307|26030590|P1|Overall Study|Lost to Follow-up|0
7502469|NCT03271021|26030646|P2|Overall Study|Miscellaneous|8
7502470|NCT03271021|26030647|P1|Overall Study|Miscellaneous|9
7502471|NCT03271021|26030646|P2|Overall Study|Abnormal Lab Results|0
7502472|NCT03271021|26030647|P1|Overall Study|Abnormal Lab Results|1
7502473|NCT03271021|26030646|P2|Overall Study|Protocol Violation|4
7502474|NCT03271021|26030647|P1|Overall Study|Protocol Violation|6
7502475|NCT03271021|26030646|P2|Overall Study|Lost to Follow-up|39
7502476|NCT03271021|26030647|P1|Overall Study|Lost to Follow-up|34
7502477|NCT03271021|26030646|P2|Overall Study|Withdrawal by Subject|53
7502478|NCT03271021|26030647|P1|Overall Study|Withdrawal by Subject|36
7502479|NCT03271021|26030646|P2|Overall Study|Adverse Event|2
7502480|NCT03271021|26030647|P1|Overall Study|Adverse Event|3
7502481|NCT03270657|26030686|P1|Overall Study|Withdrawal by Subject|1
7502482|NCT03270644|26030692|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
7502483|NCT03270644|26030692|P1|Day 1 Lasmiditan Reference|Physician Decision|1
7502484|NCT03270085|26030800|P2|Overall Study|Withdrawal by Subject|0
7502485|NCT03270085|26030801|P1|Overall Study|Withdrawal by Subject|1
7502486|NCT03269552|26030822|P1|Overall Study|Adverse Event|2
7502487|NCT03268941|26030846|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
7502488|NCT03268941|26030847|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
7502489|NCT03268941|26030848|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
7502490|NCT03268941|26030849|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
7502491|NCT03268941|26030850|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
7502492|NCT03268941|26030851|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
7502493|NCT03268941|26030852|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
7502494|NCT03268941|26030846|P7|Part 2: Days 17 to 25|Reason not specified|1
7502495|NCT03268941|26030847|P6|Part 2: Days 17 to 25|Reason not specified|0
7502496|NCT03268941|26030848|P5|Part 2: Days 17 to 25|Reason not specified|0
7502497|NCT03268941|26030849|P4|Part 2: Days 17 to 25|Reason not specified|0
7502498|NCT03268941|26030850|P3|Part 2: Days 17 to 25|Reason not specified|0
7502499|NCT03268941|26030851|P2|Part 2: Days 17 to 25|Reason not specified|0
7502500|NCT03268941|26030852|P1|Part 2: Days 17 to 25|Reason not specified|0
7502501|NCT03268941|26030846|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
7502502|NCT03268941|26030847|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
7502503|NCT03268941|26030848|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
7502504|NCT03268941|26030849|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
7502505|NCT03268941|26030850|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
7502506|NCT03268941|26030851|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
7502507|NCT03268941|26030852|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
7502508|NCT03268941|26030846|P7|Part 1 (Days 1 to 9)|Adverse Event|0
7502509|NCT03268941|26030847|P6|Part 1 (Days 1 to 9)|Adverse Event|0
7502510|NCT03268941|26030848|P5|Part 1 (Days 1 to 9)|Adverse Event|0
7502511|NCT03268941|26030849|P4|Part 1 (Days 1 to 9)|Adverse Event|1
7502512|NCT03268941|26030850|P3|Part 1 (Days 1 to 9)|Adverse Event|0
7502513|NCT03268941|26030851|P2|Part 1 (Days 1 to 9)|Adverse Event|0
7502514|NCT03268941|26030852|P1|Part 1 (Days 1 to 9)|Adverse Event|0
7502515|NCT03268941|26030846|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7502516|NCT03268941|26030847|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7502517|NCT03268941|26030848|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7502518|NCT03268941|26030849|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
7502519|NCT03268941|26030850|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7502520|NCT03268941|26030851|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7502521|NCT03268941|26030852|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7502522|NCT03268746|26030914|P1|Overall Study|Withdrawal by Subject|1
7502523|NCT03268590|26030936|P1|Overall Study|Previously unknown exclusion criteria|1
7502524|NCT03268005|26030971|P2|Overall Study|Withdrawal by Subject|11
7502525|NCT03268005|26030972|P1|Overall Study|Withdrawal by Subject|11
7502526|NCT03268005|26030971|P2|Overall Study|Lost to Follow-up|2
7502527|NCT03268005|26030972|P1|Overall Study|Lost to Follow-up|2
7502528|NCT03268005|26030971|P2|Overall Study|Death|1
7502529|NCT03268005|26030972|P1|Overall Study|Death|2
7502530|NCT03267940|26031086|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
7502531|NCT03267940|26031087|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
7502532|NCT03267940|26031088|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
7502533|NCT03267940|26031089|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
7502534|NCT03267940|26031090|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
7502535|NCT03267940|26031091|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
7502536|NCT03267940|26031086|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
7502537|NCT03267940|26031087|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
7502538|NCT03267940|26031088|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
7502539|NCT03267940|26031089|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
7502540|NCT03267940|26031090|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7502541|NCT03267940|26031091|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7502542|NCT03267940|26031086|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7502543|NCT03267940|26031087|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7502544|NCT03267940|26031088|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7502545|NCT03267940|26031089|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
7502546|NCT03267940|26031090|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7502547|NCT03267940|26031091|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7502548|NCT03267940|26031086|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7502549|NCT03267940|26031087|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7502550|NCT03267940|26031088|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
7502551|NCT03267940|26031089|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7502552|NCT03267940|26031090|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7502553|NCT03267940|26031091|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7502554|NCT03267940|26031086|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7502555|NCT03267940|26031087|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
7502556|NCT03267940|26031088|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
7502557|NCT03267940|26031089|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7502558|NCT03267940|26031090|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7502559|NCT03267940|26031091|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7502560|NCT03267940|26031086|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7502561|NCT03267940|26031087|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7502562|NCT03267940|26031088|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7502563|NCT03267940|26031089|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7502564|NCT03267940|26031090|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
7502565|NCT03267940|26031091|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
7502566|NCT03267940|26031086|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7502567|NCT03267940|26031087|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7502568|NCT03267940|26031088|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7502569|NCT03267940|26031089|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7502570|NCT03267940|26031090|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
7502571|NCT03267940|26031091|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7502572|NCT03267940|26031086|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7502573|NCT03267940|26031087|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7502574|NCT03267940|26031088|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7502575|NCT03267940|26031089|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7502576|NCT03267940|26031090|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
7502577|NCT03267940|26031091|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7502578|NCT03267940|26031086|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7502579|NCT03267940|26031087|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7502580|NCT03267940|26031088|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7502581|NCT03267940|26031089|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7502582|NCT03267940|26031090|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
7502583|NCT03267940|26031091|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
7502584|NCT03267576|26031193|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
7502585|NCT03267576|26031194|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
7502586|NCT03267576|26031193|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
7502587|NCT03267576|26031194|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
7502588|NCT03267511|26031232|P4|Overall Study|Lost to Follow-up|1
7502589|NCT03267511|26031233|P3|Overall Study|Lost to Follow-up|0
7502590|NCT03267511|26031234|P2|Overall Study|Lost to Follow-up|0
7502591|NCT03267511|26031235|P1|Overall Study|Lost to Follow-up|0
7502592|NCT03267264|26031251|P4|Overall Study|Withdrawal by Subject|4
7502593|NCT03267264|26031252|P3|Overall Study|Withdrawal by Subject|2
7502594|NCT03267264|26031253|P2|Overall Study|Withdrawal by Subject|0
7502595|NCT03267264|26031254|P1|Overall Study|Withdrawal by Subject|1
7502596|NCT03267212|26031271|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
7502597|NCT03267212|26031272|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
7502598|NCT03267212|26031271|P2|First Intervention|Withdrawal by Subject|1
7502599|NCT03267212|26031272|P1|First Intervention|Withdrawal by Subject|1
7502600|NCT03267212|26031271|P2|First Intervention|Lost to Follow-up|2
7502601|NCT03267212|26031272|P1|First Intervention|Lost to Follow-up|0
7502602|NCT03266588|26031287|P3|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7502603|NCT03266588|26031288|P2|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
7502604|NCT03266588|26031289|P1|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7502605|NCT03266588|26031287|P3|Long-term Treatment Period|Other Reasons|0
7502606|NCT03266588|26031288|P2|Long-term Treatment Period|Other Reasons|0
7502607|NCT03266588|26031289|P1|Long-term Treatment Period|Other Reasons|5
7502608|NCT03266588|26031287|P3|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
7502609|NCT03266588|26031288|P2|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
7502610|NCT03266588|26031289|P1|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
7502611|NCT03266588|26031287|P3|Long-term Treatment Period|Withdrawal by Subject|16
7502612|NCT03266588|26031288|P2|Long-term Treatment Period|Withdrawal by Subject|63
7502613|NCT03266588|26031289|P1|Long-term Treatment Period|Withdrawal by Subject|100
7502614|NCT03266588|26031287|P3|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7502615|NCT03266588|26031288|P2|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7502616|NCT03266588|26031289|P1|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
7502617|NCT03266588|26031287|P3|Long-term Treatment Period|Protocol Deviation|4
7502618|NCT03266588|26031288|P2|Long-term Treatment Period|Protocol Deviation|10
7502619|NCT03266588|26031289|P1|Long-term Treatment Period|Protocol Deviation|17
7502620|NCT03266588|26031287|P3|Long-term Treatment Period|Pregnancy|0
7502621|NCT03266588|26031288|P2|Long-term Treatment Period|Pregnancy|5
7502622|NCT03266588|26031289|P1|Long-term Treatment Period|Pregnancy|11
7502623|NCT03266588|26031287|P3|Long-term Treatment Period|Non-Compliance|7
7502624|NCT03266588|26031288|P2|Long-term Treatment Period|Non-Compliance|57
7502625|NCT03266588|26031289|P1|Long-term Treatment Period|Non-Compliance|126
7502626|NCT03266588|26031287|P3|Long-term Treatment Period|Lost to Follow-up|8
7502627|NCT03266588|26031288|P2|Long-term Treatment Period|Lost to Follow-up|37
7502628|NCT03266588|26031289|P1|Long-term Treatment Period|Lost to Follow-up|39
7502629|NCT03266588|26031287|P3|Long-term Treatment Period|Lack of Efficacy|5
7502630|NCT03266588|26031288|P2|Long-term Treatment Period|Lack of Efficacy|31
7502631|NCT03266588|26031289|P1|Long-term Treatment Period|Lack of Efficacy|41
7502632|NCT03266588|26031287|P3|Long-term Treatment Period|Adverse Event|8
7502633|NCT03266588|26031288|P2|Long-term Treatment Period|Adverse Event|17
7502634|NCT03266588|26031289|P1|Long-term Treatment Period|Adverse Event|33
7502635|NCT03266588|26031287|P3|Observational Period|Other Reasons|1
7502636|NCT03266588|26031288|P2|Observational Period|Other Reasons|0
7502637|NCT03266588|26031289|P1|Observational Period|Other Reasons|3
7502638|NCT03266588|26031287|P3|Observational Period|Protocol Deviation|0
7502639|NCT03266588|26031288|P2|Observational Period|Protocol Deviation|0
7502640|NCT03266588|26031289|P1|Observational Period|Protocol Deviation|1
7502641|NCT03266588|26031287|P3|Observational Period|Eligibility Failure- Baseline Lab Values|0
7502642|NCT03266588|26031288|P2|Observational Period|Eligibility Failure- Baseline Lab Values|1
7502643|NCT03266588|26031289|P1|Observational Period|Eligibility Failure- Baseline Lab Values|3
7502644|NCT03266588|26031287|P3|Observational Period|Lost to Follow-up|4
7502645|NCT03266588|26031288|P2|Observational Period|Lost to Follow-up|12
7502646|NCT03266588|26031289|P1|Observational Period|Lost to Follow-up|8
7502647|NCT03266588|26031287|P3|Observational Period|Non-compliance|10
7502648|NCT03266588|26031288|P2|Observational Period|Non-compliance|12
7502649|NCT03266588|26031289|P1|Observational Period|Non-compliance|18
7502650|NCT03266588|26031287|P3|Observational Period|Withdrawal by Subject|13
7502651|NCT03266588|26031288|P2|Observational Period|Withdrawal by Subject|22
7502652|NCT03266588|26031289|P1|Observational Period|Withdrawal by Subject|44
7502653|NCT03266588|26031287|P3|Observational Period|Screen Failure: Eligibility Criteria|140
7502654|NCT03266588|26031288|P2|Observational Period|Screen Failure: Eligibility Criteria|228
7502655|NCT03266588|26031289|P1|Observational Period|Screen Failure: Eligibility Criteria|439
7502656|NCT03266172|26031320|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7502657|NCT03266172|26031321|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7502658|NCT03266172|26031322|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7502659|NCT03266172|26031320|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7502660|NCT03266172|26031321|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7502661|NCT03266172|26031322|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7502662|NCT03266172|26031320|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
7502663|NCT03266172|26031321|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
7502664|NCT03266172|26031322|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
7502665|NCT03266172|26031320|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7502666|NCT03266172|26031321|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7502667|NCT03266172|26031322|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
7502668|NCT03266172|26031320|P3|Part A: Washout Period (7 Days)|Adverse Event|0
7502669|NCT03266172|26031321|P2|Part A: Washout Period (7 Days)|Adverse Event|0
7502670|NCT03266172|26031322|P1|Part A: Washout Period (7 Days)|Adverse Event|1
7502671|NCT03266172|26031320|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7502672|NCT03266172|26031321|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7502673|NCT03266172|26031322|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
7502674|NCT03266107|26031567|P1|12-Month Follow-up Visit|Lost to Follow-up|1
7502675|NCT03266107|26031567|P1|3-Month Follow-up Visit|Lost to Follow-up|1
7502676|NCT03266107|26031567|P1|Enrollment to Procedure|Study stopped prior to Procedure|2
7502677|NCT03266107|26031567|P1|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
7502678|NCT03266094|26031579|P1|Overall Study|Withdrawal by Subject|1
7502679|NCT03266094|26031579|P1|Overall Study|Lost to Follow-up|1
7502680|NCT03265938|26031597|P1|Overall Study|friable mass|6
7502681|NCT03265938|26031597|P1|Overall Study|Physician Decision|1
7502682|NCT03265938|26031597|P1|Overall Study|Withdrawal by Subject|1
7502683|NCT03265600|26031610|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
7502684|NCT03265600|26031611|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
7502685|NCT03265600|26031610|P2|Overall Study|Withdrawal by Subject|2
7502686|NCT03265600|26031611|P1|Overall Study|Withdrawal by Subject|4
7502687|NCT03265600|26031610|P2|Overall Study|Lost to Follow-up|5
7502688|NCT03265600|26031611|P1|Overall Study|Lost to Follow-up|17
7502689|NCT03265132|26031637|P2|Overall Study|Withdrawal by Subject|1
7502690|NCT03265132|26031638|P1|Overall Study|Withdrawal by Subject|0
7502691|NCT03265132|26031637|P2|Overall Study|Progressive disease|2
7502692|NCT03265132|26031638|P1|Overall Study|Progressive disease|0
7502693|NCT03265132|26031637|P2|Overall Study|Lack of Efficacy|2
7502694|NCT03265132|26031638|P1|Overall Study|Lack of Efficacy|0
7502695|NCT03265132|26031637|P2|Overall Study|Adverse Event|1
7502696|NCT03265132|26031638|P1|Overall Study|Adverse Event|0
7502697|NCT03265119|26031744|P2|Overall Study|Lack of Compliance|0
7502698|NCT03265119|26031745|P1|Overall Study|Lack of Compliance|1
7502699|NCT03265119|26031744|P2|Overall Study|Lost to Follow-up|0
7502700|NCT03265119|26031745|P1|Overall Study|Lost to Follow-up|1
7502701|NCT03265119|26031744|P2|Overall Study|Withdrawal by Subject|4
7502702|NCT03265119|26031745|P1|Overall Study|Withdrawal by Subject|2
7502703|NCT03265119|26031744|P2|Overall Study|Protocol Violation|2
7502704|NCT03265119|26031745|P1|Overall Study|Protocol Violation|1
7502705|NCT03265119|26031744|P2|Overall Study|Lack of Efficacy|0
7502706|NCT03265119|26031745|P1|Overall Study|Lack of Efficacy|3
7502707|NCT03265119|26031744|P2|Overall Study|Adverse Event|1
7502708|NCT03265119|26031745|P1|Overall Study|Adverse Event|2
7502709|NCT03264456|26031753|P1|Overall Study|Lost to Follow-up|1
7502710|NCT03264456|26031753|P1|Overall Study|Withdrawal by Subject|3
7502711|NCT03264066|26031811|P6|Overall Study|Withdrawal by Subject|0
7502712|NCT03264066|26031812|P5|Overall Study|Withdrawal by Subject|0
7502713|NCT03264066|26031813|P4|Overall Study|Withdrawal by Subject|5
7502714|NCT03264066|26031814|P3|Overall Study|Withdrawal by Subject|0
7502715|NCT03264066|26031815|P2|Overall Study|Withdrawal by Subject|0
7502716|NCT03264066|26031816|P1|Overall Study|Withdrawal by Subject|1
7502717|NCT03264066|26031811|P6|Overall Study|Study Terminated by Sponsor|2
7502718|NCT03264066|26031812|P5|Overall Study|Study Terminated by Sponsor|1
7502719|NCT03264066|26031813|P4|Overall Study|Study Terminated by Sponsor|5
7502720|NCT03264066|26031814|P3|Overall Study|Study Terminated by Sponsor|8
7502721|NCT03264066|26031815|P2|Overall Study|Study Terminated by Sponsor|5
7502722|NCT03264066|26031816|P1|Overall Study|Study Terminated by Sponsor|5
7502723|NCT03264066|26031811|P6|Overall Study|Progressive Disease|0
7502724|NCT03264066|26031812|P5|Overall Study|Progressive Disease|0
7502725|NCT03264066|26031813|P4|Overall Study|Progressive Disease|0
7502726|NCT03264066|26031814|P3|Overall Study|Progressive Disease|1
7502727|NCT03264066|26031815|P2|Overall Study|Progressive Disease|2
7502728|NCT03264066|26031816|P1|Overall Study|Progressive Disease|0
7502729|NCT03264066|26031811|P6|Overall Study|Lost to Follow-up|0
7502730|NCT03264066|26031812|P5|Overall Study|Lost to Follow-up|0
7502731|NCT03264066|26031813|P4|Overall Study|Lost to Follow-up|0
7502732|NCT03264066|26031814|P3|Overall Study|Lost to Follow-up|0
7502733|NCT03264066|26031815|P2|Overall Study|Lost to Follow-up|0
7502734|NCT03264066|26031816|P1|Overall Study|Lost to Follow-up|1
7502735|NCT03264066|26031811|P6|Overall Study|Death|1
7502736|NCT03264066|26031812|P5|Overall Study|Death|6
7502737|NCT03264066|26031813|P4|Overall Study|Death|10
7502738|NCT03264066|26031814|P3|Overall Study|Death|8
7502739|NCT03264066|26031815|P2|Overall Study|Death|12
7502740|NCT03264066|26031816|P1|Overall Study|Death|12
7502741|NCT03264066|26031811|P6|Overall Study|Adverse Event|0
7502742|NCT03264066|26031812|P5|Overall Study|Adverse Event|0
7502743|NCT03264066|26031813|P4|Overall Study|Adverse Event|0
7502744|NCT03264066|26031814|P3|Overall Study|Adverse Event|0
7502745|NCT03264066|26031815|P2|Overall Study|Adverse Event|1
7502746|NCT03264066|26031816|P1|Overall Study|Adverse Event|1
7502747|NCT03263806|26031872|P2|Overall Study|Study Termination|6
7502748|NCT03263806|26031873|P1|Overall Study|Study Termination|5
7502749|NCT03263806|26031872|P2|Overall Study|Withdrawal by Subject|1
7502750|NCT03263806|26031873|P1|Overall Study|Withdrawal by Subject|0
7502751|NCT03263806|26031872|P2|Overall Study|Elevated Troponin (failed screen)|0
7502752|NCT03263806|26031873|P1|Overall Study|Elevated Troponin (failed screen)|1
7502753|NCT03263780|26031885|P1|Overall Study|Ineligible (incomplete post-HIFU)|7
7502754|NCT03263780|26031885|P1|Overall Study|Withdrawal by Subject|3
7502755|NCT03263702|26031894|P2|Overall Study|Withdrawal by Subject|2
7502756|NCT03263702|26031895|P1|Overall Study|Withdrawal by Subject|1
7502757|NCT03263702|26031894|P2|Overall Study|Lost to Follow-up|2
7502758|NCT03263702|26031895|P1|Overall Study|Lost to Follow-up|2
7502771|NCT03262441|26031966|P1|Overall Study|Withdrawal by Subject|1
7502772|NCT03262389|26031974|P1|Overall Study|opted out of PET/MR|1
7502773|NCT03262389|26031974|P1|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
7502774|NCT03262389|26031974|P1|Overall Study|Machine malfunction Day 1, no return Day 2|1
7502775|NCT03262233|26031983|P4|Overall Study|data collection artifact|0
7502776|NCT03262233|26031984|P3|Overall Study|data collection artifact|0
7502777|NCT03262233|26031985|P2|Overall Study|data collection artifact|1
7502778|NCT03262233|26031986|P1|Overall Study|data collection artifact|0
7502779|NCT03262233|26031983|P4|Overall Study|Protocol Violation|13
7502780|NCT03262233|26031984|P3|Overall Study|Protocol Violation|2
7502781|NCT03262233|26031985|P2|Overall Study|Protocol Violation|10
7502782|NCT03262233|26031986|P1|Overall Study|Protocol Violation|5
7502783|NCT03262233|26031983|P4|Overall Study|Declined due to shock|3
7502784|NCT03262233|26031984|P3|Overall Study|Declined due to shock|2
7502785|NCT03262233|26031985|P2|Overall Study|Declined due to shock|2
7502786|NCT03262233|26031986|P1|Overall Study|Declined due to shock|1
7502787|NCT03262233|26031983|P4|Overall Study|Withdrawal by Subject|13
7502788|NCT03262233|26031984|P3|Overall Study|Withdrawal by Subject|21
7502789|NCT03262233|26031985|P2|Overall Study|Withdrawal by Subject|8
7502790|NCT03262233|26031986|P1|Overall Study|Withdrawal by Subject|12
7502791|NCT03262038|26032010|P2|Overall Study|Withdrawal by Subject|1
7502792|NCT03262038|26032011|P1|Overall Study|Withdrawal by Subject|0
7502793|NCT03262012|26032027|P4|Overall Study|Protocol Discontinuation Criteria|0
7502794|NCT03262012|26032028|P3|Overall Study|Protocol Discontinuation Criteria|0
7502795|NCT03262012|26032029|P2|Overall Study|Protocol Discontinuation Criteria|1
7502796|NCT03262012|26032030|P1|Overall Study|Protocol Discontinuation Criteria|0
7502797|NCT03262012|26032027|P4|Overall Study|Lack of Efficacy|2
7502798|NCT03262012|26032028|P3|Overall Study|Lack of Efficacy|1
7502799|NCT03262012|26032029|P2|Overall Study|Lack of Efficacy|5
7502800|NCT03262012|26032030|P1|Overall Study|Lack of Efficacy|0
7502801|NCT03262012|26032027|P4|Overall Study|Physician Decision|0
7502802|NCT03262012|26032028|P3|Overall Study|Physician Decision|1
7502803|NCT03262012|26032029|P2|Overall Study|Physician Decision|5
7502804|NCT03262012|26032030|P1|Overall Study|Physician Decision|2
7502805|NCT03262012|26032027|P4|Overall Study|Adverse Event|6
7502806|NCT03262012|26032028|P3|Overall Study|Adverse Event|4
7502807|NCT03262012|26032029|P2|Overall Study|Adverse Event|12
7502808|NCT03262012|26032030|P1|Overall Study|Adverse Event|10
7502809|NCT03262012|26032027|P4|Overall Study|Withdrawal by Subject|7
7502810|NCT03262012|26032028|P3|Overall Study|Withdrawal by Subject|8
7502811|NCT03262012|26032029|P2|Overall Study|Withdrawal by Subject|13
7502812|NCT03262012|26032030|P1|Overall Study|Withdrawal by Subject|15
7502813|NCT03261947|26032085|P5|Overall Study|Reason not Specified|3
7502814|NCT03261947|26032086|P4|Overall Study|Reason not Specified|1
7502815|NCT03261947|26032087|P3|Overall Study|Reason not Specified|4
7502816|NCT03261947|26032088|P2|Overall Study|Reason not Specified|0
7502817|NCT03261947|26032089|P1|Overall Study|Reason not Specified|2
7502818|NCT03261947|26032085|P5|Overall Study|Site Terminated by Sponsor|5
7502819|NCT03261947|26032086|P4|Overall Study|Site Terminated by Sponsor|7
7502820|NCT03261947|26032087|P3|Overall Study|Site Terminated by Sponsor|4
7502821|NCT03261947|26032088|P2|Overall Study|Site Terminated by Sponsor|0
7502822|NCT03261947|26032089|P1|Overall Study|Site Terminated by Sponsor|0
7502823|NCT03261947|26032085|P5|Overall Study|Withdrawal by Subject|1
7502824|NCT03261947|26032086|P4|Overall Study|Withdrawal by Subject|0
7502825|NCT03261947|26032087|P3|Overall Study|Withdrawal by Subject|3
7502826|NCT03261947|26032088|P2|Overall Study|Withdrawal by Subject|0
7502827|NCT03261947|26032089|P1|Overall Study|Withdrawal by Subject|0
7502828|NCT03261947|26032085|P5|Overall Study|Lost to Follow-up|0
7502829|NCT03261947|26032086|P4|Overall Study|Lost to Follow-up|1
7502830|NCT03261947|26032087|P3|Overall Study|Lost to Follow-up|2
7502831|NCT03261947|26032088|P2|Overall Study|Lost to Follow-up|0
7502832|NCT03261947|26032089|P1|Overall Study|Lost to Follow-up|0
7502833|NCT03261947|26032085|P5|Overall Study|Death|8
7502834|NCT03261947|26032086|P4|Overall Study|Death|12
7502835|NCT03261947|26032087|P3|Overall Study|Death|17
7502836|NCT03261947|26032088|P2|Overall Study|Death|13
7502837|NCT03261947|26032089|P1|Overall Study|Death|10
7502838|NCT03261531|26032155|P1|Overall Study|Withdrawal by Subject|4
7502839|NCT03261336|26032171|P1|Overall Study|Adverse Event|1
7502840|NCT03261167|26032179|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7502841|NCT03261167|26032180|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7502842|NCT03261167|26032179|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
7502843|NCT03261167|26032180|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
7502844|NCT03261167|26032179|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
7502845|NCT03261167|26032180|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
7502846|NCT03261167|26032179|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
7502847|NCT03261167|26032180|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
7502848|NCT03261167|26032179|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
7502849|NCT03261167|26032180|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
7502850|NCT03261037|26032220|P4|Overall Study|Participant was too weak to continue in study|0
7502851|NCT03261037|26032221|P3|Overall Study|Participant was too weak to continue in study|0
7502852|NCT03261037|26032222|P2|Overall Study|Participant was too weak to continue in study|0
7502853|NCT03261037|26032223|P1|Overall Study|Participant was too weak to continue in study|1
7502854|NCT03261037|26032220|P4|Overall Study|End of study for participant and no follow up|1
7502855|NCT03261037|26032221|P3|Overall Study|End of study for participant and no follow up|0
7502856|NCT03261037|26032222|P2|Overall Study|End of study for participant and no follow up|0
7502857|NCT03261037|26032223|P1|Overall Study|End of study for participant and no follow up|0
7502858|NCT03261037|26032220|P4|Overall Study|Equipment failed to work|1
7502859|NCT03261037|26032221|P3|Overall Study|Equipment failed to work|0
7502860|NCT03261037|26032222|P2|Overall Study|Equipment failed to work|0
7502861|NCT03261037|26032223|P1|Overall Study|Equipment failed to work|0
7502862|NCT03261037|26032220|P4|Overall Study|Technical difficulties|1
7502863|NCT03261037|26032221|P3|Overall Study|Technical difficulties|0
7502864|NCT03261037|26032222|P2|Overall Study|Technical difficulties|0
7502865|NCT03261037|26032223|P1|Overall Study|Technical difficulties|0
7502866|NCT03261037|26032220|P4|Overall Study|Participant presented clinical improvement|0
7502867|NCT03261037|26032221|P3|Overall Study|Participant presented clinical improvement|0
7502868|NCT03261037|26032222|P2|Overall Study|Participant presented clinical improvement|2
7502869|NCT03261037|26032223|P1|Overall Study|Participant presented clinical improvement|0
7502870|NCT03261037|26032220|P4|Overall Study|Participant did not want to continue the diagnostic procedures|1
7502871|NCT03261037|26032221|P3|Overall Study|Participant did not want to continue the diagnostic procedures|0
7502872|NCT03261037|26032222|P2|Overall Study|Participant did not want to continue the diagnostic procedures|0
7502873|NCT03261037|26032223|P1|Overall Study|Participant did not want to continue the diagnostic procedures|0
7502874|NCT03261037|26032220|P4|Overall Study|Participant did not want to continue the study|0
7502875|NCT03261037|26032221|P3|Overall Study|Participant did not want to continue the study|0
7502876|NCT03261037|26032222|P2|Overall Study|Participant did not want to continue the study|1
7502877|NCT03261037|26032223|P1|Overall Study|Participant did not want to continue the study|0
7502878|NCT03261037|26032220|P4|Overall Study|Diagnosed but protocol deviation|0
7502879|NCT03261037|26032221|P3|Overall Study|Diagnosed but protocol deviation|0
7502880|NCT03261037|26032222|P2|Overall Study|Diagnosed but protocol deviation|0
7502881|NCT03261037|26032223|P1|Overall Study|Diagnosed but protocol deviation|1
7502882|NCT03261037|26032220|P4|Overall Study|Participant came out of study due to investigator discretion|0
7502883|NCT03261037|26032221|P3|Overall Study|Participant came out of study due to investigator discretion|0
7502884|NCT03261037|26032222|P2|Overall Study|Participant came out of study due to investigator discretion|2
7502885|NCT03261037|26032223|P1|Overall Study|Participant came out of study due to investigator discretion|0
7502886|NCT03261037|26032220|P4|Overall Study|Participant moving away and can no longer be in study|0
7502887|NCT03261037|26032221|P3|Overall Study|Participant moving away and can no longer be in study|0
7502888|NCT03261037|26032222|P2|Overall Study|Participant moving away and can no longer be in study|1
7502889|NCT03261037|26032223|P1|Overall Study|Participant moving away and can no longer be in study|0
7502890|NCT03261037|26032220|P4|Overall Study|Non-compliance with study procedures|6
7502891|NCT03261037|26032221|P3|Overall Study|Non-compliance with study procedures|0
7502892|NCT03261037|26032222|P2|Overall Study|Non-compliance with study procedures|2
7502893|NCT03261037|26032223|P1|Overall Study|Non-compliance with study procedures|0
7502894|NCT03261037|26032220|P4|Overall Study|Withdrawal by Subject|18
7502895|NCT03261037|26032221|P3|Overall Study|Withdrawal by Subject|0
7502896|NCT03261037|26032222|P2|Overall Study|Withdrawal by Subject|13
7502897|NCT03261037|26032223|P1|Overall Study|Withdrawal by Subject|2
7502898|NCT03260894|26032299|P2|Overall Study|On-going at clinical cut off date|31
7502899|NCT03260894|26032300|P1|Overall Study|On-going at clinical cut off date|36
7502900|NCT03260894|26032299|P2|Overall Study|Withdrawal by Subject|11
7502901|NCT03260894|26032300|P1|Overall Study|Withdrawal by Subject|4
7502902|NCT03260894|26032299|P2|Overall Study|Death|8
7502903|NCT03260894|26032300|P1|Overall Study|Death|6
7502904|NCT03260868|26032312|P2|Overall Study|Other than specified above|0
7502905|NCT03260868|26032313|P1|Overall Study|Other than specified above|1
7502906|NCT03260868|26032312|P2|Overall Study|Study Terminated By Sponsor|1
7502907|NCT03260868|26032313|P1|Overall Study|Study Terminated By Sponsor|2
7502908|NCT03260868|26032312|P2|Overall Study|Poor Compliance to Protocol|2
7502909|NCT03260868|26032313|P1|Overall Study|Poor Compliance to Protocol|0
7502910|NCT03260205|26032435|P5|Overall Study|Participant Who Did Not Received AnyDose|1
7502911|NCT03260205|26032436|P4|Overall Study|Participant Who Did Not Received AnyDose|3
7502912|NCT03260205|26032437|P3|Overall Study|Participant Who Did Not Received AnyDose|2
7502913|NCT03260205|26032438|P2|Overall Study|Participant Who Did Not Received AnyDose|1
7502914|NCT03260205|26032439|P1|Overall Study|Participant Who Did Not Received AnyDose|1
7502915|NCT03260205|26032435|P5|Overall Study|Other: Unspecified|1
7502916|NCT03260205|26032436|P4|Overall Study|Other: Unspecified|1
7502917|NCT03260205|26032437|P3|Overall Study|Other: Unspecified|3
7502918|NCT03260205|26032438|P2|Overall Study|Other: Unspecified|0
7502919|NCT03260205|26032439|P1|Overall Study|Other: Unspecified|0
7502920|NCT03260205|26032435|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
7502921|NCT03260205|26032436|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
7502922|NCT03260205|26032437|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
7502923|NCT03260205|26032438|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
7502924|NCT03260205|26032439|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
7502925|NCT03260205|26032435|P5|Overall Study|Protocol Violation|1
7502926|NCT03260205|26032436|P4|Overall Study|Protocol Violation|0
7502927|NCT03260205|26032437|P3|Overall Study|Protocol Violation|2
7502928|NCT03260205|26032438|P2|Overall Study|Protocol Violation|0
7502929|NCT03260205|26032439|P1|Overall Study|Protocol Violation|0
7502930|NCT03260205|26032435|P5|Overall Study|Lost to Follow-up|5
7502931|NCT03260205|26032436|P4|Overall Study|Lost to Follow-up|1
7502932|NCT03260205|26032437|P3|Overall Study|Lost to Follow-up|1
7502933|NCT03260205|26032438|P2|Overall Study|Lost to Follow-up|2
7502934|NCT03260205|26032439|P1|Overall Study|Lost to Follow-up|2
7502935|NCT03260205|26032435|P5|Overall Study|Adverse Event|4
7502936|NCT03260205|26032436|P4|Overall Study|Adverse Event|2
7502937|NCT03260205|26032437|P3|Overall Study|Adverse Event|2
7502938|NCT03260205|26032438|P2|Overall Study|Adverse Event|0
7502939|NCT03260205|26032439|P1|Overall Study|Adverse Event|2
7502940|NCT03259789|26032503|P3|Overall Study|Physician Decision|0
7502941|NCT03259789|26032504|P2|Overall Study|Physician Decision|1
7502942|NCT03259789|26032505|P1|Overall Study|Physician Decision|0
7502943|NCT03259789|26032503|P3|Overall Study|Lost to Follow-up|4
7502944|NCT03259789|26032504|P2|Overall Study|Lost to Follow-up|9
7502945|NCT03259789|26032505|P1|Overall Study|Lost to Follow-up|5
7502946|NCT03259789|26032503|P3|Overall Study|Withdrawal by Subject|1
7502947|NCT03259789|26032504|P2|Overall Study|Withdrawal by Subject|5
7502948|NCT03259789|26032505|P1|Overall Study|Withdrawal by Subject|9
7502949|NCT03259789|26032503|P3|Overall Study|Adverse Event|1
7502950|NCT03259789|26032504|P2|Overall Study|Adverse Event|2
7502951|NCT03259789|26032505|P1|Overall Study|Adverse Event|3
7502952|NCT03259555|26032530|P2|Overall Study|Other|0
7502953|NCT03259555|26032531|P1|Overall Study|Other|1
7502954|NCT03259555|26032530|P2|Overall Study|Physician Decision|2
7502955|NCT03259555|26032531|P1|Overall Study|Physician Decision|1
7502956|NCT03259555|26032530|P2|Overall Study|Withdrawal by Subject|16
7502957|NCT03259555|26032531|P1|Overall Study|Withdrawal by Subject|19
7502958|NCT03259555|26032530|P2|Overall Study|Progressive Disease|2
7502959|NCT03259555|26032531|P1|Overall Study|Progressive Disease|0
7502960|NCT03259555|26032530|P2|Overall Study|Non-Compliance With Study Drug|0
7502961|NCT03259555|26032531|P1|Overall Study|Non-Compliance With Study Drug|1
7502962|NCT03259555|26032530|P2|Overall Study|Lost to Follow-up|2
7502963|NCT03259555|26032531|P1|Overall Study|Lost to Follow-up|0
7502964|NCT03259555|26032530|P2|Overall Study|Lack of Efficacy|4
7502965|NCT03259555|26032531|P1|Overall Study|Lack of Efficacy|6
7502966|NCT03259555|26032530|P2|Overall Study|Adverse Event|4
7502967|NCT03259555|26032531|P1|Overall Study|Adverse Event|6
7502968|NCT03259490|26032541|P2|Period 2|Protocol Violation|0
7502969|NCT03259490|26032542|P1|Period 2|Protocol Violation|1
7502970|NCT03259490|26032541|P2|Period 1|Withdrawal by Subject|1
7502971|NCT03259490|26032542|P1|Period 1|Withdrawal by Subject|0
7502972|NCT03259334|26032571|P3|Overall Study|Randomized but never treated|0
7502973|NCT03259334|26032572|P2|Overall Study|Randomized but never treated|2
7502974|NCT03259334|26032573|P1|Overall Study|Randomized but never treated|0
7502975|NCT03259334|26032571|P3|Overall Study|Lack of Efficacy|1
7502976|NCT03259334|26032572|P2|Overall Study|Lack of Efficacy|0
7502977|NCT03259334|26032573|P1|Overall Study|Lack of Efficacy|2
7502978|NCT03259334|26032571|P3|Overall Study|Protocol Deviation|2
7502979|NCT03259334|26032572|P2|Overall Study|Protocol Deviation|3
7502980|NCT03259334|26032573|P1|Overall Study|Protocol Deviation|0
7502981|NCT03259334|26032571|P3|Overall Study|Lost to Follow-up|1
7502982|NCT03259334|26032572|P2|Overall Study|Lost to Follow-up|2
7502983|NCT03259334|26032573|P1|Overall Study|Lost to Follow-up|0
7502984|NCT03259334|26032571|P3|Overall Study|Physician Decision|0
7502985|NCT03259334|26032572|P2|Overall Study|Physician Decision|0
7502986|NCT03259334|26032573|P1|Overall Study|Physician Decision|1
7502987|NCT03259334|26032571|P3|Overall Study|Withdrawal by Subject|4
7502988|NCT03259334|26032572|P2|Overall Study|Withdrawal by Subject|2
7502989|NCT03259334|26032573|P1|Overall Study|Withdrawal by Subject|4
7502990|NCT03259334|26032571|P3|Overall Study|Adverse Event|5
7502991|NCT03259334|26032572|P2|Overall Study|Adverse Event|8
7502992|NCT03259334|26032573|P1|Overall Study|Adverse Event|3
7502993|NCT03259308|26032653|P3|Overall Study|Lack of Efficacy|1
7502994|NCT03259308|26032654|P2|Overall Study|Lack of Efficacy|0
7502995|NCT03259308|26032655|P1|Overall Study|Lack of Efficacy|0
7502996|NCT03259308|26032653|P3|Overall Study|Protocol Deviation|0
7502997|NCT03259308|26032654|P2|Overall Study|Protocol Deviation|3
7502998|NCT03259308|26032655|P1|Overall Study|Protocol Deviation|0
7502999|NCT03259308|26032653|P3|Overall Study|Pregnancy|1
7503000|NCT03259308|26032654|P2|Overall Study|Pregnancy|0
7503001|NCT03259308|26032655|P1|Overall Study|Pregnancy|0
7503002|NCT03259308|26032653|P3|Overall Study|Lost to Follow-up|1
7503003|NCT03259308|26032654|P2|Overall Study|Lost to Follow-up|0
7503004|NCT03259308|26032655|P1|Overall Study|Lost to Follow-up|0
7503005|NCT03259308|26032653|P3|Overall Study|Withdrawal by Subject|3
7503006|NCT03259308|26032654|P2|Overall Study|Withdrawal by Subject|1
7503007|NCT03259308|26032655|P1|Overall Study|Withdrawal by Subject|2
7503008|NCT03259308|26032653|P3|Overall Study|Adverse Event|1
7503009|NCT03259308|26032654|P2|Overall Study|Adverse Event|4
7503010|NCT03259308|26032655|P1|Overall Study|Adverse Event|5
7503011|NCT03259087|26032774|P5|Period 2 of Part 2|Adverse Event|1
7503012|NCT03259087|26032775|P4|Period 2 of Part 2|Adverse Event|0
7503013|NCT03259087|26032776|P3|Period 2 of Part 2|Adverse Event|0
7503014|NCT03259087|26032777|P2|Period 2 of Part 2|Adverse Event|0
7503015|NCT03259087|26032778|P1|Period 2 of Part 2|Adverse Event|0
7503016|NCT03259087|26032774|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
7503017|NCT03259087|26032775|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
7503018|NCT03259087|26032776|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
7503019|NCT03259087|26032777|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
7503020|NCT03259087|26032778|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
7503021|NCT03258814|26032906|P3|Overall Study|Early Termination|10
7503022|NCT03258814|26032907|P2|Overall Study|Early Termination|3
7503023|NCT03258814|26032908|P1|Overall Study|Early Termination|4
7503024|NCT03258762|26032963|P2|Overall Study|Lost to Follow-up|1
7503025|NCT03258762|26032964|P1|Overall Study|Lost to Follow-up|0
7503026|NCT03258710|26033024|P1|Overall Study|Physician Decision|1
7503027|NCT03258710|26033024|P1|Overall Study|Protocol-defined stopping criteria|1
7503028|NCT03258710|26033024|P1|Overall Study|Adverse Event|1
7503029|NCT03257995|26033118|P6|Overall Study|Protocol deviation|2
7503030|NCT03257995|26033119|P5|Overall Study|Protocol deviation|0
7503031|NCT03257995|26033120|P4|Overall Study|Protocol deviation|0
7503032|NCT03257995|26033121|P3|Overall Study|Protocol deviation|0
7503033|NCT03257995|26033122|P2|Overall Study|Protocol deviation|0
7503034|NCT03257995|26033123|P1|Overall Study|Protocol deviation|0
7503035|NCT03257995|26033118|P6|Overall Study|Adverse Event|0
7503036|NCT03257995|26033119|P5|Overall Study|Adverse Event|0
7503037|NCT03257995|26033120|P4|Overall Study|Adverse Event|0
7503038|NCT03257995|26033121|P3|Overall Study|Adverse Event|0
7503039|NCT03257995|26033122|P2|Overall Study|Adverse Event|1
7503040|NCT03257995|26033123|P1|Overall Study|Adverse Event|0
7503041|NCT03257865|26033173|P2|Overall Study|Lost to Follow-up|4
7503042|NCT03257865|26033174|P1|Overall Study|Lost to Follow-up|4
7503043|NCT03257865|26033173|P2|Overall Study|Other|1
7503044|NCT03257865|26033174|P1|Overall Study|Other|0
7503045|NCT03257865|26033173|P2|Overall Study|Physician Decision|1
7503046|NCT03257865|26033174|P1|Overall Study|Physician Decision|3
7503047|NCT03257865|26033173|P2|Overall Study|Withdrawal by Subject|17
7503048|NCT03257865|26033174|P1|Overall Study|Withdrawal by Subject|23
7503049|NCT03257865|26033173|P2|Overall Study|Non-compliance with Study Drug|2
7503050|NCT03257865|26033174|P1|Overall Study|Non-compliance with Study Drug|0
7503051|NCT03257865|26033173|P2|Overall Study|Lack of Efficacy|2
7503052|NCT03257865|26033174|P1|Overall Study|Lack of Efficacy|1
7503053|NCT03257865|26033173|P2|Overall Study|Adverse Event|8
7503054|NCT03257865|26033174|P1|Overall Study|Adverse Event|4
7503055|NCT03257813|26033184|P2|Overall Study|Protocol Violation|3
7503056|NCT03257813|26033185|P1|Overall Study|Protocol Violation|6
7503057|NCT03257657|26033207|P2|Overall Study|Noted not eligible right after enrolled|1
7503058|NCT03257657|26033208|P1|Overall Study|Noted not eligible right after enrolled|0
7503059|NCT03257657|26033207|P2|Overall Study|Withdrawn|1
7503060|NCT03257657|26033208|P1|Overall Study|Withdrawn|0
7503061|NCT03257657|26033207|P2|Overall Study|Lost to Follow-up|3
7503062|NCT03257657|26033208|P1|Overall Study|Lost to Follow-up|0
7503063|NCT03257631|26033239|P4|Overall Study|Still on Study|4
7503064|NCT03257631|26033240|P3|Overall Study|Still on Study|4
7503065|NCT03257631|26033241|P2|Overall Study|Still on Study|2
7503066|NCT03257631|26033242|P1|Overall Study|Still on Study|3
7503067|NCT03257631|26033239|P4|Overall Study|Lost to Follow-up|0
7503068|NCT03257631|26033240|P3|Overall Study|Lost to Follow-up|1
7503069|NCT03257631|26033241|P2|Overall Study|Lost to Follow-up|0
7503070|NCT03257631|26033242|P1|Overall Study|Lost to Follow-up|0
7503071|NCT03257631|26033239|P4|Overall Study|Withdrawal by Parent/Guardian|1
7503072|NCT03257631|26033240|P3|Overall Study|Withdrawal by Parent/Guardian|4
7503073|NCT03257631|26033241|P2|Overall Study|Withdrawal by Parent/Guardian|2
7503074|NCT03257631|26033242|P1|Overall Study|Withdrawal by Parent/Guardian|0
7503075|NCT03257631|26033239|P4|Overall Study|Progressive Disease|0
7503076|NCT03257631|26033240|P3|Overall Study|Progressive Disease|1
7503077|NCT03257631|26033241|P2|Overall Study|Progressive Disease|0
7503078|NCT03257631|26033242|P1|Overall Study|Progressive Disease|0
7503079|NCT03257631|26033239|P4|Overall Study|Death|5
7503080|NCT03257631|26033240|P3|Overall Study|Death|13
7503081|NCT03257631|26033241|P2|Overall Study|Death|5
7503082|NCT03257631|26033242|P1|Overall Study|Death|8
7503083|NCT03257410|26033278|P2|Overall Study|Other|1
7503084|NCT03257410|26033279|P1|Overall Study|Other|0
7503085|NCT03257410|26033278|P2|Overall Study|Miscellaneous|2
7503086|NCT03257410|26033279|P1|Overall Study|Miscellaneous|2
7503087|NCT03257410|26033278|P2|Overall Study|Missing 3 consecutive study treatments|6
7503088|NCT03257410|26033279|P1|Overall Study|Missing 3 consecutive study treatments|5
7503089|NCT03257410|26033278|P2|Overall Study|Change to another dialysis center|2
7503090|NCT03257410|26033279|P1|Overall Study|Change to another dialysis center|2
7503091|NCT03257410|26033278|P2|Overall Study|Death|2
7503092|NCT03257410|26033279|P1|Overall Study|Death|3
7503093|NCT03257410|26033278|P2|Overall Study|Switch to peritoneal dialysis|0
7503094|NCT03257410|26033279|P1|Overall Study|Switch to peritoneal dialysis|1
7503095|NCT03257410|26033278|P2|Overall Study|Renal transplantation|0
7503096|NCT03257410|26033279|P1|Overall Study|Renal transplantation|2
7503097|NCT03257410|26033278|P2|Overall Study|Physician Decision|1
7503098|NCT03257410|26033279|P1|Overall Study|Physician Decision|1
7503099|NCT03257410|26033278|P2|Overall Study|Withdrawal by Subject|2
7503100|NCT03257410|26033279|P1|Overall Study|Withdrawal by Subject|1
7503101|NCT03257410|26033278|P2|Overall Study|Lost to Follow-up|0
7503102|NCT03257410|26033279|P1|Overall Study|Lost to Follow-up|1
7503103|NCT03257410|26033278|P2|Overall Study|Protocol Violation|2
7503104|NCT03257410|26033279|P1|Overall Study|Protocol Violation|1
7503105|NCT03257410|26033278|P2|Overall Study|Adverse Event|3
7503106|NCT03257410|26033279|P1|Overall Study|Adverse Event|2
7503107|NCT03257371|26033419|P1|Overall Study|Lost to Follow-up|1
7503108|NCT03257358|26033428|P2|Overall Study|No longer requires treatment|1
7503109|NCT03257358|26033429|P1|Overall Study|No longer requires treatment|0
7503110|NCT03257358|26033428|P2|Overall Study|New therapy for study indication|0
7503111|NCT03257358|26033429|P1|Overall Study|New therapy for study indication|1
7503112|NCT03257358|26033428|P2|Overall Study|Withdrawal of informed consent|5
7503113|NCT03257358|26033429|P1|Overall Study|Withdrawal of informed consent|9
7503114|NCT03257358|26033428|P2|Overall Study|Withdrawal by Subject|3
7503115|NCT03257358|26033429|P1|Overall Study|Withdrawal by Subject|8
7503116|NCT03257358|26033428|P2|Overall Study|Technical problems|1
7503117|NCT03257358|26033429|P1|Overall Study|Technical problems|4
7503118|NCT03257358|26033428|P2|Overall Study|Protocol Violation|3
7503119|NCT03257358|26033429|P1|Overall Study|Protocol Violation|5
7503120|NCT03257358|26033428|P2|Overall Study|Physician Decision|2
7503121|NCT03257358|26033429|P1|Overall Study|Physician Decision|2
7503122|NCT03257358|26033428|P2|Overall Study|Non-compliance with fingolimod treatment|2
7503123|NCT03257358|26033429|P1|Overall Study|Non-compliance with fingolimod treatment|4
7503124|NCT03257358|26033428|P2|Overall Study|Lost to Follow-up|4
7503125|NCT03257358|26033429|P1|Overall Study|Lost to Follow-up|12
7503126|NCT03257358|26033428|P2|Overall Study|Lack of Efficacy|1
7503127|NCT03257358|26033429|P1|Overall Study|Lack of Efficacy|1
7503128|NCT03257358|26033428|P2|Overall Study|Adverse Event|12
7503129|NCT03257358|26033429|P1|Overall Study|Adverse Event|25
7503130|NCT03256851|26033557|P2|Overall Study|Withdrawal by Subject|0
7503131|NCT03256851|26033558|P1|Overall Study|Withdrawal by Subject|1
7503132|NCT03256695|26033570|P1|Overall Study|Other than specified|3
7503133|NCT03256695|26033570|P1|Overall Study|Protocol Violation|5
7503134|NCT03256695|26033570|P1|Overall Study|Lack of Efficacy|3
7503135|NCT03256695|26033570|P1|Overall Study|Lost to Follow-up|3
7503136|NCT03256695|26033570|P1|Overall Study|Non-compliance with study drug|1
7503137|NCT03256695|26033570|P1|Overall Study|Withdrawal by Subject|14
7503138|NCT03256695|26033570|P1|Overall Study|Death|2
7503139|NCT03256695|26033570|P1|Overall Study|Adverse Event|8
7503140|NCT03256578|26033580|P2|Overall Study|Excluded Post Randomization|56
7503141|NCT03256578|26033581|P1|Overall Study|Excluded Post Randomization|66
7503142|NCT03256552|26033637|P1|Overall Study|Withdrawal by Subject|2
7503143|NCT03256552|26033637|P1|Overall Study|Adverse Event|1
7503144|NCT03256552|26033637|P1|Overall Study|Physician Decision|1
7503145|NCT03256552|26033637|P1|Overall Study|Protocol Violation|1
7503146|NCT03256526|26033662|P3|Overall Study|Lost to Follow-up|2
7503147|NCT03256526|26033663|P2|Overall Study|Lost to Follow-up|0
7503148|NCT03256526|26033664|P1|Overall Study|Lost to Follow-up|1
7503149|NCT03256526|26033662|P3|Overall Study|Adverse Event|1
7503150|NCT03256526|26033663|P2|Overall Study|Adverse Event|0
7503151|NCT03256526|26033664|P1|Overall Study|Adverse Event|1
7503152|NCT03256344|26033686|P2|Overall Study|Withdrawal by Subject|3
7503153|NCT03256344|26033687|P1|Overall Study|Withdrawal by Subject|3
7503154|NCT03256344|26033686|P2|Overall Study|Death|19
7503155|NCT03256344|26033687|P1|Overall Study|Death|5
7503156|NCT03256344|26033686|P2|Overall Study|Ongoing on study|3
7503157|NCT03256344|26033687|P1|Overall Study|Ongoing on study|3
7503158|NCT03255980|26033773|P4|Overall Study|Withdrawal by Subject|3
7503159|NCT03255980|26033774|P3|Overall Study|Withdrawal by Subject|0
7503160|NCT03255980|26033775|P2|Overall Study|Withdrawal by Subject|1
7503161|NCT03255980|26033776|P1|Overall Study|Withdrawal by Subject|0
7503162|NCT03255980|26033773|P4|Overall Study|Lost to Follow-up|3
7503163|NCT03255980|26033774|P3|Overall Study|Lost to Follow-up|0
7503164|NCT03255980|26033775|P2|Overall Study|Lost to Follow-up|1
7503165|NCT03255980|26033776|P1|Overall Study|Lost to Follow-up|1
7503166|NCT03255980|26033773|P4|Overall Study|Lack of compliance to study or assessmen|0
7503167|NCT03255980|26033774|P3|Overall Study|Lack of compliance to study or assessmen|0
7503168|NCT03255980|26033775|P2|Overall Study|Lack of compliance to study or assessmen|1
7503169|NCT03255980|26033776|P1|Overall Study|Lack of compliance to study or assessmen|0
7503170|NCT03255980|26033773|P4|Overall Study|Adverse Event|1
7503171|NCT03255980|26033774|P3|Overall Study|Adverse Event|0
7503172|NCT03255980|26033775|P2|Overall Study|Adverse Event|1
7503173|NCT03255980|26033776|P1|Overall Study|Adverse Event|1
7503174|NCT03255980|26033773|P4|Overall Study|Grade =>3 Skin Toxicity|5
7503175|NCT03255980|26033774|P3|Overall Study|Grade =>3 Skin Toxicity|6
7503176|NCT03255980|26033775|P2|Overall Study|Grade =>3 Skin Toxicity|4
7503177|NCT03255980|26033776|P1|Overall Study|Grade =>3 Skin Toxicity|1
7503178|NCT03255941|26033790|P4|Overall Study|Did not complete exit interview|0
7503179|NCT03255941|26033791|P3|Overall Study|Did not complete exit interview|0
7503180|NCT03255941|26033792|P2|Overall Study|Did not complete exit interview|2
7503181|NCT03255941|26033793|P1|Overall Study|Did not complete exit interview|1
7503182|NCT03255941|26033790|P4|Overall Study|Not eligible or refused injection|6
7503183|NCT03255941|26033791|P3|Overall Study|Not eligible or refused injection|5
7503184|NCT03255941|26033792|P2|Overall Study|Not eligible or refused injection|44
7503185|NCT03255941|26033793|P1|Overall Study|Not eligible or refused injection|37
7503186|NCT03255824|26033822|P2|Overall Study|Under-sedation|1
7503187|NCT03255824|26033823|P1|Overall Study|Under-sedation|2
7503188|NCT03255733|26033851|P1|Overall Study|Lost to Follow-up|4
7503189|NCT03255655|26033858|P2|Overall Study|Lost to Follow-up|4
7503190|NCT03255655|26033859|P1|Overall Study|Lost to Follow-up|7
7503191|NCT03255382|26033869|P2|Overall Study|Other|0
7503192|NCT03255382|26033870|P1|Overall Study|Other|6
7503193|NCT03255382|26033869|P2|Overall Study|Withdrawal by Subject|0
7503194|NCT03255382|26033870|P1|Overall Study|Withdrawal by Subject|2
7503195|NCT03255382|26033869|P2|Overall Study|Lost to Follow-up|0
7503196|NCT03255382|26033870|P1|Overall Study|Lost to Follow-up|2
7503197|NCT03255382|26033869|P2|Overall Study|Adverse Event|0
7503198|NCT03255382|26033870|P1|Overall Study|Adverse Event|3
7503199|NCT03255291|26034044|P6|Overall Study|Baseline data collection issues|0
7503200|NCT03255291|26034045|P5|Overall Study|Baseline data collection issues|2
7503201|NCT03255291|26034046|P4|Overall Study|Baseline data collection issues|0
7503202|NCT03255291|26034047|P3|Overall Study|Baseline data collection issues|0
7503203|NCT03255291|26034048|P2|Overall Study|Baseline data collection issues|0
7503204|NCT03255291|26034049|P1|Overall Study|Baseline data collection issues|3
7503205|NCT03255291|26034044|P6|Overall Study|Determined to be ineligible|10
7503206|NCT03255291|26034045|P5|Overall Study|Determined to be ineligible|5
7503207|NCT03255291|26034046|P4|Overall Study|Determined to be ineligible|6
7503208|NCT03255291|26034047|P3|Overall Study|Determined to be ineligible|6
7503209|NCT03255291|26034048|P2|Overall Study|Determined to be ineligible|12
7503210|NCT03255291|26034049|P1|Overall Study|Determined to be ineligible|10
7503211|NCT03255187|26034082|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
7503212|NCT03255187|26034083|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
7503213|NCT03255187|26034082|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
7503214|NCT03255187|26034083|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
7503215|NCT03254602|26034142|P1|Overall Study|Lost to Follow-up|4
7503216|NCT03254459|26034150|P2|Overall Study|Miscellaneous|1
7503217|NCT03254459|26034151|P1|Overall Study|Miscellaneous|0
7503218|NCT03254459|26034150|P2|Overall Study|Lost to Follow-up|1
7503219|NCT03254459|26034151|P1|Overall Study|Lost to Follow-up|0
7503220|NCT03254459|26034150|P2|Overall Study|Withdrawal by Subject Consent|1
7503221|NCT03254459|26034151|P1|Overall Study|Withdrawal by Subject Consent|3
7503222|NCT03254459|26034150|P2|Overall Study|Adverse Event|20
7503223|NCT03254459|26034151|P1|Overall Study|Adverse Event|7
7503224|NCT03254134|26034176|P2|Overall Study|Not eligible patients|3630
7503225|NCT03254134|26034177|P1|Overall Study|Not eligible patients|599
7503226|NCT03254108|26034190|P5|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
7503227|NCT03254108|26034191|P4|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7503228|NCT03254108|26034192|P3|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7503229|NCT03254108|26034193|P2|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7503230|NCT03254108|26034194|P1|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7503231|NCT03254108|26034190|P5|Overall Study|Adverse Event|1
7503232|NCT03254108|26034191|P4|Overall Study|Adverse Event|1
7503233|NCT03254108|26034192|P3|Overall Study|Adverse Event|0
7503234|NCT03254108|26034193|P2|Overall Study|Adverse Event|2
7503235|NCT03254108|26034194|P1|Overall Study|Adverse Event|0
7503236|NCT03253094|26034217|P6|Overall Study|Other|0
7503237|NCT03253094|26034218|P5|Overall Study|Other|0
7503238|NCT03253094|26034219|P4|Overall Study|Other|1
7503239|NCT03253094|26034220|P3|Overall Study|Other|2
7503240|NCT03253094|26034221|P2|Overall Study|Other|1
7503241|NCT03253094|26034222|P1|Overall Study|Other|0
7503242|NCT03253094|26034217|P6|Overall Study|Withdrawal by Subject|0
7503243|NCT03253094|26034218|P5|Overall Study|Withdrawal by Subject|3
7503244|NCT03253094|26034219|P4|Overall Study|Withdrawal by Subject|0
7503245|NCT03253094|26034220|P3|Overall Study|Withdrawal by Subject|1
7503246|NCT03253094|26034221|P2|Overall Study|Withdrawal by Subject|2
7503247|NCT03253094|26034222|P1|Overall Study|Withdrawal by Subject|1
7503248|NCT03253094|26034217|P6|Overall Study|Physician Decision|2
7503249|NCT03253094|26034218|P5|Overall Study|Physician Decision|0
7503250|NCT03253094|26034219|P4|Overall Study|Physician Decision|1
7503251|NCT03253094|26034220|P3|Overall Study|Physician Decision|0
7503252|NCT03253094|26034221|P2|Overall Study|Physician Decision|0
7503253|NCT03253094|26034222|P1|Overall Study|Physician Decision|1
7503254|NCT03253094|26034217|P6|Overall Study|Lost to Follow-up|1
7503255|NCT03253094|26034218|P5|Overall Study|Lost to Follow-up|0
7503256|NCT03253094|26034219|P4|Overall Study|Lost to Follow-up|1
7503257|NCT03253094|26034220|P3|Overall Study|Lost to Follow-up|1
7503258|NCT03253094|26034221|P2|Overall Study|Lost to Follow-up|0
7503259|NCT03253094|26034222|P1|Overall Study|Lost to Follow-up|0
7503260|NCT03253094|26034217|P6|Overall Study|Lack of Efficacy|1
7503261|NCT03253094|26034218|P5|Overall Study|Lack of Efficacy|2
7503262|NCT03253094|26034219|P4|Overall Study|Lack of Efficacy|1
7503263|NCT03253094|26034220|P3|Overall Study|Lack of Efficacy|2
7503264|NCT03253094|26034221|P2|Overall Study|Lack of Efficacy|0
7503265|NCT03253094|26034222|P1|Overall Study|Lack of Efficacy|0
7503266|NCT03253094|26034217|P6|Overall Study|Adverse Event|0
7503267|NCT03253094|26034218|P5|Overall Study|Adverse Event|0
7503268|NCT03253094|26034219|P4|Overall Study|Adverse Event|0
7503269|NCT03253094|26034220|P3|Overall Study|Adverse Event|0
7503270|NCT03253094|26034221|P2|Overall Study|Adverse Event|0
7503271|NCT03253094|26034222|P1|Overall Study|Adverse Event|2
7503272|NCT03252145|26034298|P2|Overall Study|Complicating Disease|2
7503273|NCT03252145|26034299|P1|Overall Study|Complicating Disease|1
7503274|NCT03252145|26034298|P2|Overall Study|Withdrawal by Subject|0
7503275|NCT03252145|26034299|P1|Overall Study|Withdrawal by Subject|1
7503276|NCT03252015|26034367|P4|Overall Study|Adverse Event|1
7503277|NCT03252015|26034368|P3|Overall Study|Adverse Event|0
7503278|NCT03252015|26034369|P2|Overall Study|Adverse Event|0
7503279|NCT03252015|26034370|P1|Overall Study|Adverse Event|1
7503280|NCT03252015|26034367|P4|Overall Study|Withdrawal by Subject|0
7503281|NCT03252015|26034368|P3|Overall Study|Withdrawal by Subject|1
7503282|NCT03252015|26034369|P2|Overall Study|Withdrawal by Subject|1
7503283|NCT03252015|26034370|P1|Overall Study|Withdrawal by Subject|0
7503284|NCT03251963|26034408|P2|Overall Study|bled prior to Xa level|2
7503285|NCT03251963|26034409|P1|Overall Study|bled prior to Xa level|1
7503286|NCT03251963|26034408|P2|Overall Study|no peak Xa level drawn|0
7503287|NCT03251963|26034409|P1|Overall Study|no peak Xa level drawn|2
7503288|NCT03251963|26034408|P2|Overall Study|inappropriate Xa level timing|3
7503289|NCT03251963|26034409|P1|Overall Study|inappropriate Xa level timing|6
7503290|NCT03251482|26034428|P5|Overall Study|Withdrawal by Subject|0
7503291|NCT03251482|26034429|P4|Overall Study|Withdrawal by Subject|0
7503292|NCT03251482|26034430|P3|Overall Study|Withdrawal by Subject|0
7503293|NCT03251482|26034431|P2|Overall Study|Withdrawal by Subject|1
7503294|NCT03251482|26034432|P1|Overall Study|Withdrawal by Subject|0
7503295|NCT03250182|26034600|P1|Overall Study|Withdrawal by Subject|1
7503296|NCT03249935|26034624|P1|Overall Study|Protocol Violation|5
7503297|NCT03249935|26034624|P1|Overall Study|Negative for chlamydia at enrollment|4
7503298|NCT03249935|26034624|P1|Overall Study|Discharged from facility early|36
7503299|NCT03249909|26034633|P3|Overall Study|Lost to Follow-up|0
7503300|NCT03249909|26034634|P2|Overall Study|Lost to Follow-up|1
7503301|NCT03249909|26034635|P1|Overall Study|Lost to Follow-up|0
7503302|NCT03249909|26034633|P3|Overall Study|Adverse Event|0
7503303|NCT03249909|26034634|P2|Overall Study|Adverse Event|0
7503304|NCT03249909|26034635|P1|Overall Study|Adverse Event|3
7503305|NCT03249909|26034633|P3|Overall Study|Withdrawal by Subject|0
7503306|NCT03249909|26034634|P2|Overall Study|Withdrawal by Subject|0
7503307|NCT03249909|26034635|P1|Overall Study|Withdrawal by Subject|3
7503308|NCT03249454|26034683|P11|Overall Study|Withdrawal by Subject|1
7503309|NCT03249454|26034684|P10|Overall Study|Withdrawal by Subject|1
7503310|NCT03249454|26034685|P9|Overall Study|Withdrawal by Subject|0
7503311|NCT03249454|26034686|P8|Overall Study|Withdrawal by Subject|0
7503312|NCT03249454|26034687|P7|Overall Study|Withdrawal by Subject|0
7503313|NCT03249454|26034688|P6|Overall Study|Withdrawal by Subject|0
7503314|NCT03249454|26034689|P5|Overall Study|Withdrawal by Subject|0
7503315|NCT03249454|26034690|P4|Overall Study|Withdrawal by Subject|0
7503316|NCT03249454|26034691|P3|Overall Study|Withdrawal by Subject|0
7503317|NCT03249454|26034692|P2|Overall Study|Withdrawal by Subject|0
7503318|NCT03249454|26034693|P1|Overall Study|Withdrawal by Subject|0
7503319|NCT03248882|26034781|P5|Overall Study|Withdrawal by Subject|2
7503320|NCT03248882|26034782|P4|Overall Study|Withdrawal by Subject|4
7503321|NCT03248882|26034783|P3|Overall Study|Withdrawal by Subject|3
7503322|NCT03248882|26034784|P2|Overall Study|Withdrawal by Subject|2
7503323|NCT03248882|26034785|P1|Overall Study|Withdrawal by Subject|2
7503324|NCT03248882|26034781|P5|Overall Study|Protocol Violation|1
7503325|NCT03248882|26034782|P4|Overall Study|Protocol Violation|0
7503326|NCT03248882|26034783|P3|Overall Study|Protocol Violation|2
7503327|NCT03248882|26034784|P2|Overall Study|Protocol Violation|0
7503328|NCT03248882|26034785|P1|Overall Study|Protocol Violation|2
7503329|NCT03248882|26034781|P5|Overall Study|Lost to Follow-up|1
7503330|NCT03248882|26034782|P4|Overall Study|Lost to Follow-up|0
7503331|NCT03248882|26034783|P3|Overall Study|Lost to Follow-up|0
7503332|NCT03248882|26034784|P2|Overall Study|Lost to Follow-up|0
7503333|NCT03248882|26034785|P1|Overall Study|Lost to Follow-up|0
7503334|NCT03248882|26034781|P5|Overall Study|Adverse Event|9
7503335|NCT03248882|26034782|P4|Overall Study|Adverse Event|6
7503336|NCT03248882|26034783|P3|Overall Study|Adverse Event|2
7503337|NCT03248882|26034784|P2|Overall Study|Adverse Event|3
7503338|NCT03248882|26034785|P1|Overall Study|Adverse Event|3
7503374|NCT03248037|26034893|P2|Overall Study|Adverse Event|0
7503375|NCT03248037|26034894|P1|Overall Study|Adverse Event|15
7503376|NCT03248037|26034893|P2|Overall Study|Withdrawal by Subject|9
7503377|NCT03248037|26034894|P1|Overall Study|Withdrawal by Subject|6
7503378|NCT03247816|26034917|P1|Overall Study|Missing Feraccru stop date|3
7503379|NCT03247816|26034917|P1|Overall Study|Lost to Follow-up|10
7503380|NCT03247816|26034917|P1|Overall Study|Lack of Efficacy|1
7503381|NCT03247816|26034917|P1|Overall Study|Physician Decision|3
7503382|NCT03247816|26034917|P1|Overall Study|Adverse Event|12
7503383|NCT03247686|26034972|P2|Overall Study|Withdrawal by Subject|2
7503384|NCT03247686|26034973|P1|Overall Study|Withdrawal by Subject|1
7503385|NCT03247673|26034986|P3|Overall Study|Lost to Follow-up|1
7503386|NCT03247673|26034987|P2|Overall Study|Lost to Follow-up|0
7503387|NCT03247673|26034988|P1|Overall Study|Lost to Follow-up|0
7503388|NCT03247673|26034986|P3|Overall Study|Withdrawal by Subject|3
7503389|NCT03247673|26034987|P2|Overall Study|Withdrawal by Subject|0
7503390|NCT03247673|26034988|P1|Overall Study|Withdrawal by Subject|1
7503391|NCT03247556|26035011|P3|Overall Study|Subject did not meet inclusion criteria|1
7503392|NCT03247556|26035012|P2|Overall Study|Subject did not meet inclusion criteria|0
7503393|NCT03247556|26035013|P1|Overall Study|Subject did not meet inclusion criteria|0
7503394|NCT03247556|26035011|P3|Overall Study|Protocol Violation|1
7503395|NCT03247556|26035012|P2|Overall Study|Protocol Violation|0
7503396|NCT03247556|26035013|P1|Overall Study|Protocol Violation|2
7503397|NCT03247556|26035011|P3|Overall Study|Assent/consent Withdrawn by Subject|2
7503398|NCT03247556|26035012|P2|Overall Study|Assent/consent Withdrawn by Subject|2
7503399|NCT03247556|26035013|P1|Overall Study|Assent/consent Withdrawn by Subject|0
7503400|NCT03247556|26035011|P3|Overall Study|Consent Withdrawn by Caregiver|5
7503401|NCT03247556|26035012|P2|Overall Study|Consent Withdrawn by Caregiver|1
7503402|NCT03247556|26035013|P1|Overall Study|Consent Withdrawn by Caregiver|4
7503403|NCT03247556|26035011|P3|Overall Study|Lost to Follow-up|4
7503404|NCT03247556|26035012|P2|Overall Study|Lost to Follow-up|5
7503405|NCT03247556|26035013|P1|Overall Study|Lost to Follow-up|5
7503406|NCT03247556|26035011|P3|Overall Study|Adverse Event|5
7503407|NCT03247556|26035012|P2|Overall Study|Adverse Event|4
7503408|NCT03247556|26035013|P1|Overall Study|Adverse Event|1
7503409|NCT03247543|26035048|P3|Overall Study|Non-compliance with study visits|0
7503410|NCT03247543|26035049|P2|Overall Study|Non-compliance with study visits|1
7503411|NCT03247543|26035050|P1|Overall Study|Non-compliance with study visits|0
7503412|NCT03247543|26035048|P3|Overall Study|Lack of Efficacy|0
7503413|NCT03247543|26035049|P2|Overall Study|Lack of Efficacy|0
7503414|NCT03247543|26035050|P1|Overall Study|Lack of Efficacy|1
7503415|NCT03247543|26035048|P3|Overall Study|Failure to Follow study procedures|1
7503416|NCT03247543|26035049|P2|Overall Study|Failure to Follow study procedures|3
7503417|NCT03247543|26035050|P1|Overall Study|Failure to Follow study procedures|1
7503418|NCT03247543|26035048|P3|Overall Study|Withdrawal by Subject|1
7503419|NCT03247543|26035049|P2|Overall Study|Withdrawal by Subject|0
7503420|NCT03247543|26035050|P1|Overall Study|Withdrawal by Subject|0
7503421|NCT03247543|26035048|P3|Overall Study|Consent withdrawn by caregiver|9
7503422|NCT03247543|26035049|P2|Overall Study|Consent withdrawn by caregiver|2
7503423|NCT03247543|26035050|P1|Overall Study|Consent withdrawn by caregiver|2
7503424|NCT03247543|26035048|P3|Overall Study|Lost to Follow-up|8
7503425|NCT03247543|26035049|P2|Overall Study|Lost to Follow-up|7
7503426|NCT03247543|26035050|P1|Overall Study|Lost to Follow-up|10
7503427|NCT03247543|26035048|P3|Overall Study|Adverse Event|4
7503428|NCT03247543|26035049|P2|Overall Study|Adverse Event|6
7503429|NCT03247543|26035050|P1|Overall Study|Adverse Event|3
7503430|NCT03247530|26035085|P3|Overall Study|Other, multiple categories|1
7503431|NCT03247530|26035086|P2|Overall Study|Other, multiple categories|3
7503432|NCT03247530|26035087|P1|Overall Study|Other, multiple categories|1
7503433|NCT03247530|26035085|P3|Overall Study|Study medication misuse|0
7503434|NCT03247530|26035086|P2|Overall Study|Study medication misuse|1
7503435|NCT03247530|26035087|P1|Overall Study|Study medication misuse|0
7503436|NCT03247530|26035085|P3|Overall Study|Withdrawal by Subject|0
7503437|NCT03247530|26035086|P2|Overall Study|Withdrawal by Subject|1
7503438|NCT03247530|26035087|P1|Overall Study|Withdrawal by Subject|1
7503439|NCT03247530|26035085|P3|Overall Study|Failure to follow procedure|1
7503440|NCT03247530|26035086|P2|Overall Study|Failure to follow procedure|1
7503441|NCT03247530|26035087|P1|Overall Study|Failure to follow procedure|1
7503442|NCT03247530|26035085|P3|Overall Study|Adverse Event|2
7503443|NCT03247530|26035086|P2|Overall Study|Adverse Event|5
7503444|NCT03247530|26035087|P1|Overall Study|Adverse Event|2
7503445|NCT03247530|26035085|P3|Overall Study|Lost to Follow-up|6
7503446|NCT03247530|26035086|P2|Overall Study|Lost to Follow-up|9
7503447|NCT03247530|26035087|P1|Overall Study|Lost to Follow-up|3
7503448|NCT03247530|26035085|P3|Overall Study|Withdrawal by caregiver|10
7503449|NCT03247530|26035086|P2|Overall Study|Withdrawal by caregiver|8
7503450|NCT03247530|26035087|P1|Overall Study|Withdrawal by caregiver|19
7503451|NCT03247517|26035122|P3|Overall Study|Multiple reasons|0
7503452|NCT03247517|26035123|P2|Overall Study|Multiple reasons|1
7503453|NCT03247517|26035124|P1|Overall Study|Multiple reasons|3
7503454|NCT03247517|26035122|P3|Overall Study|Protocol Violation|0
7503455|NCT03247517|26035123|P2|Overall Study|Protocol Violation|2
7503456|NCT03247517|26035124|P1|Overall Study|Protocol Violation|0
7503457|NCT03247517|26035122|P3|Overall Study|Assent/consent withdrawn by subject|1
7503458|NCT03247517|26035123|P2|Overall Study|Assent/consent withdrawn by subject|3
7503459|NCT03247517|26035124|P1|Overall Study|Assent/consent withdrawn by subject|2
7503460|NCT03247517|26035122|P3|Overall Study|Consent withdrawn by caregiver|7
7503461|NCT03247517|26035123|P2|Overall Study|Consent withdrawn by caregiver|4
7503462|NCT03247517|26035124|P1|Overall Study|Consent withdrawn by caregiver|1
7503463|NCT03247517|26035122|P3|Overall Study|Lost to Follow-up|4
7503464|NCT03247517|26035123|P2|Overall Study|Lost to Follow-up|6
7503465|NCT03247517|26035124|P1|Overall Study|Lost to Follow-up|2
7503466|NCT03247517|26035122|P3|Overall Study|Adverse Event|2
7503467|NCT03247517|26035123|P2|Overall Study|Adverse Event|4
7503468|NCT03247517|26035124|P1|Overall Study|Adverse Event|0
7503469|NCT03246724|26035179|P4|Overall Study|Re-consented to participate|1
7503470|NCT03246724|26035180|P3|Overall Study|Re-consented to participate|0
7503471|NCT03246724|26035181|P2|Overall Study|Re-consented to participate|0
7503472|NCT03246724|26035182|P1|Overall Study|Re-consented to participate|0
7503473|NCT03246724|26035179|P4|Overall Study|Unable to obtain medication timely|1
7503474|NCT03246724|26035180|P3|Overall Study|Unable to obtain medication timely|2
7503475|NCT03246724|26035181|P2|Overall Study|Unable to obtain medication timely|2
7503476|NCT03246724|26035182|P1|Overall Study|Unable to obtain medication timely|0
7503477|NCT03246724|26035179|P4|Overall Study|Transferred to other arm|0
7503478|NCT03246724|26035180|P3|Overall Study|Transferred to other arm|1
7503479|NCT03246724|26035181|P2|Overall Study|Transferred to other arm|0
7503480|NCT03246724|26035182|P1|Overall Study|Transferred to other arm|0
7503481|NCT03246724|26035179|P4|Overall Study|Study completed before surgical date|1
7503482|NCT03246724|26035180|P3|Overall Study|Study completed before surgical date|8
7503483|NCT03246724|26035181|P2|Overall Study|Study completed before surgical date|1
7503484|NCT03246724|26035182|P1|Overall Study|Study completed before surgical date|2
7503485|NCT03246724|26035179|P4|Overall Study|Ineligible on day of surgery|3
7503486|NCT03246724|26035180|P3|Overall Study|Ineligible on day of surgery|0
7503487|NCT03246724|26035181|P2|Overall Study|Ineligible on day of surgery|2
7503488|NCT03246724|26035182|P1|Overall Study|Ineligible on day of surgery|7
7503489|NCT03246724|26035179|P4|Overall Study|Withdrawal by Subject|2
7503490|NCT03246724|26035180|P3|Overall Study|Withdrawal by Subject|4
7503491|NCT03246724|26035181|P2|Overall Study|Withdrawal by Subject|2
7503492|NCT03246724|26035182|P1|Overall Study|Withdrawal by Subject|5
7503493|NCT03246672|26035208|P1|Overall Study|Lost to Follow-up|2
7503494|NCT03246646|26035216|P2|Overall Study|Lost to Follow-up|0
7503495|NCT03246646|26035217|P1|Overall Study|Lost to Follow-up|7
7503496|NCT03246646|26035216|P2|Overall Study|Withdrawal by Subject|0
7503497|NCT03246646|26035217|P1|Overall Study|Withdrawal by Subject|3
7503498|NCT03246646|26035216|P2|Overall Study|deemed ineligible and administratively withdrawn|0
7503499|NCT03246646|26035217|P1|Overall Study|deemed ineligible and administratively withdrawn|1
7503500|NCT03246152|26035223|P1|Overall Study|Protocol Violation|1
7503501|NCT03246152|26035223|P1|Overall Study|Lost to Follow-up|2
7503502|NCT03246061|26035231|P2|Overall Study|Still in follow-up|21
7503503|NCT03246061|26035232|P1|Overall Study|Still in follow-up|15
7503504|NCT03245723|26035251|P2|Overall Study|Image acquisition/reconstruction failure|1
7503505|NCT03245723|26035252|P1|Overall Study|Image acquisition/reconstruction failure|1
7503506|NCT03245723|26035251|P2|Overall Study|Having to abruptly stop the scan to use the restroom|0
7503507|NCT03245723|26035252|P1|Overall Study|Having to abruptly stop the scan to use the restroom|2
7503508|NCT03245723|26035251|P2|Overall Study|Claustrophobia from wearing the mask|0
7503509|NCT03245723|26035252|P1|Overall Study|Claustrophobia from wearing the mask|1
7503510|NCT03245723|26035251|P2|Overall Study|Bigeminy precluding hypoxia exposure|0
7503511|NCT03245723|26035252|P1|Overall Study|Bigeminy precluding hypoxia exposure|1
7503512|NCT03245619|26035277|P17|Part A (Up to Day 22)|Physician Decision|0
7503513|NCT03245619|26035278|P16|Part A (Up to Day 22)|Physician Decision|0
7503514|NCT03245619|26035279|P15|Part A (Up to Day 22)|Physician Decision|0
7503515|NCT03245619|26035280|P14|Part A (Up to Day 22)|Physician Decision|0
7503516|NCT03245619|26035281|P13|Part A (Up to Day 22)|Physician Decision|0
7503517|NCT03245619|26035282|P12|Part A (Up to Day 22)|Physician Decision|0
7503518|NCT03245619|26035283|P11|Part A (Up to Day 22)|Physician Decision|0
7503519|NCT03245619|26035284|P10|Part A (Up to Day 22)|Physician Decision|0
7503520|NCT03245619|26035285|P9|Part A (Up to Day 22)|Physician Decision|0
7503521|NCT03245619|26035286|P8|Part A (Up to Day 22)|Physician Decision|0
7503522|NCT03245619|26035287|P7|Part A (Up to Day 22)|Physician Decision|0
7503523|NCT03245619|26035288|P6|Part A (Up to Day 22)|Physician Decision|0
7503524|NCT03245619|26035289|P5|Part A (Up to Day 22)|Physician Decision|0
7503525|NCT03245619|26035290|P4|Part A (Up to Day 22)|Physician Decision|0
7503526|NCT03245619|26035291|P3|Part A (Up to Day 22)|Physician Decision|6
7503527|NCT03245619|26035292|P2|Part A (Up to Day 22)|Physician Decision|6
7503528|NCT03245619|26035293|P1|Part A (Up to Day 22)|Physician Decision|4
7503529|NCT03245398|26035567|P2|Overall Study|Travelled to another island|0
7503530|NCT03245398|26035568|P1|Overall Study|Travelled to another island|1
7503531|NCT03244917|26035592|P2|Overall Study|Lost to Follow-up|2
7503532|NCT03244917|26035593|P1|Overall Study|Lost to Follow-up|2
7503533|NCT03244800|26035613|P4|Overall Study|Withdrew treatment|1
7503534|NCT03244800|26035614|P3|Overall Study|Withdrew treatment|0
7503535|NCT03244800|26035615|P2|Overall Study|Withdrew treatment|0
7503536|NCT03244800|26035616|P1|Overall Study|Withdrew treatment|0
7503537|NCT03244800|26035613|P4|Overall Study|Adverse Event|1
7503538|NCT03244800|26035614|P3|Overall Study|Adverse Event|0
7503539|NCT03244800|26035615|P2|Overall Study|Adverse Event|1
7503540|NCT03244800|26035616|P1|Overall Study|Adverse Event|0
7503541|NCT03244618|26035676|P2|Overall Study|Withdrawal by Subject|2
7503542|NCT03244618|26035677|P1|Overall Study|Withdrawal by Subject|0
7503543|NCT03244618|26035676|P2|Overall Study|Protocol Violation|3
7503544|NCT03244618|26035677|P1|Overall Study|Protocol Violation|4
7503545|NCT03244618|26035676|P2|Overall Study|Lost to Follow-up|4
7503546|NCT03244618|26035677|P1|Overall Study|Lost to Follow-up|3
7503547|NCT03243630|26035712|P1|Overall Study|Physician Decision|1
7503548|NCT03243630|26035712|P1|Overall Study|Protocol Violation|1
7503549|NCT03243305|26035720|P1|Overall Study|Early terminations|267
7503550|NCT03243305|26035720|P1|Overall Study|Study Terminated by Sponsor|1
7503551|NCT03243305|26035720|P1|Overall Study|Study method no longer primary method|12
7503552|NCT03243305|26035720|P1|Overall Study|Protocol Violation|22
7503553|NCT03243305|26035720|P1|Overall Study|Physician Decision|22
7503554|NCT03243305|26035720|P1|Overall Study|No sexually active|26
7503555|NCT03243305|26035720|P1|Overall Study|Adverse Event|23
7503556|NCT03243305|26035720|P1|Overall Study|Non-Compliance with Study Drug|38
7503557|NCT03243305|26035720|P1|Overall Study|Pregnancy|104
7503558|NCT03243305|26035720|P1|Overall Study|Withdrawal by Subject|170
7503559|NCT03243305|26035720|P1|Overall Study|Lost to Follow-up|250
7503560|NCT03243084|26035727|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
7503561|NCT03243084|26035728|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
7503562|NCT03242928|26035767|P2|Overall Study|Withdrawal by Subject|3
7503563|NCT03242928|26035768|P1|Overall Study|Withdrawal by Subject|5
7503564|NCT03242928|26035767|P2|Overall Study|Physician Decision|1
7503565|NCT03242928|26035768|P1|Overall Study|Physician Decision|0
7503566|NCT03242928|26035767|P2|Overall Study|Lost to Follow-up|0
7503567|NCT03242928|26035768|P1|Overall Study|Lost to Follow-up|2
7503568|NCT03242928|26035767|P2|Overall Study|Adverse Event|1
7503569|NCT03242928|26035768|P1|Overall Study|Adverse Event|2
7503570|NCT03242863|26035779|P6|Study Week 1|Withdrawal by Subject|0
7503571|NCT03242863|26035780|P5|Study Week 1|Withdrawal by Subject|3
7503572|NCT03242863|26035781|P4|Study Week 1|Withdrawal by Subject|0
7503573|NCT03242863|26035782|P3|Study Week 1|Withdrawal by Subject|0
7503574|NCT03242863|26035783|P2|Study Week 1|Withdrawal by Subject|1
7503575|NCT03242863|26035784|P1|Study Week 1|Withdrawal by Subject|0
7503576|NCT03242759|26035803|P2|Overall Study|Change visit schedule|1
7503577|NCT03242759|26035804|P1|Overall Study|Change visit schedule|0
7503578|NCT03242759|26035803|P2|Overall Study|Death|0
7503579|NCT03242759|26035804|P1|Overall Study|Death|22
7503580|NCT03242759|26035803|P2|Overall Study|Administrative problems|1
7503581|NCT03242759|26035804|P1|Overall Study|Administrative problems|1
7503582|NCT03242759|26035803|P2|Overall Study|Lost to Follow-up|1
7503583|NCT03242759|26035804|P1|Overall Study|Lost to Follow-up|3
7503584|NCT03242759|26035803|P2|Overall Study|Withdrawal by Subject|3
7503585|NCT03242759|26035804|P1|Overall Study|Withdrawal by Subject|4
7503586|NCT03242759|26035803|P2|Overall Study|Adverse Event|1
7503587|NCT03242759|26035804|P1|Overall Study|Adverse Event|5
7503588|NCT03242434|26035852|P2|Overall Study|Death|2
7503589|NCT03242434|26035853|P1|Overall Study|Death|0
7503590|NCT03242252|26035868|P3|Overall Study|Lost to Follow-up|4
7503591|NCT03242252|26035869|P2|Overall Study|Lost to Follow-up|1
7503592|NCT03242252|26035870|P1|Overall Study|Lost to Follow-up|5
7503593|NCT03242252|26035868|P3|Overall Study|Reason not Specified|1
7503594|NCT03242252|26035869|P2|Overall Study|Reason not Specified|4
7503595|NCT03242252|26035870|P1|Overall Study|Reason not Specified|4
7503596|NCT03242252|26035868|P3|Overall Study|Study Terminated by Sponsor|0
7503597|NCT03242252|26035869|P2|Overall Study|Study Terminated by Sponsor|0
7503598|NCT03242252|26035870|P1|Overall Study|Study Terminated by Sponsor|1
7503599|NCT03242252|26035868|P3|Overall Study|Poor Compliance to Protocol|3
7503600|NCT03242252|26035869|P2|Overall Study|Poor Compliance to Protocol|2
7503601|NCT03242252|26035870|P1|Overall Study|Poor Compliance to Protocol|0
7503602|NCT03242252|26035868|P3|Overall Study|Adverse Event|9
7503603|NCT03242252|26035869|P2|Overall Study|Adverse Event|6
7503604|NCT03242252|26035870|P1|Overall Study|Adverse Event|8
7503605|NCT03242252|26035868|P3|Overall Study|At the Participant's own Request|15
7503606|NCT03242252|26035869|P2|Overall Study|At the Participant's own Request|10
7503607|NCT03242252|26035870|P1|Overall Study|At the Participant's own Request|18
7503608|NCT03242018|26035916|P3|Overall Study|Study Terminated by Sponsor|1
7503609|NCT03242018|26035917|P2|Overall Study|Study Terminated by Sponsor|0
7503610|NCT03242018|26035918|P1|Overall Study|Study Terminated by Sponsor|1
7503611|NCT03242018|26035916|P3|Overall Study|Reason Not Specified|1
7503612|NCT03242018|26035917|P2|Overall Study|Reason Not Specified|4
7503613|NCT03242018|26035918|P1|Overall Study|Reason Not Specified|3
7503614|NCT03242018|26035916|P3|Overall Study|At the Participant's Own Request|4
7503615|NCT03242018|26035917|P2|Overall Study|At the Participant's Own Request|1
7503616|NCT03242018|26035918|P1|Overall Study|At the Participant's Own Request|5
7503617|NCT03242018|26035916|P3|Overall Study|Lost to Follow-up|2
7503618|NCT03242018|26035917|P2|Overall Study|Lost to Follow-up|2
7503619|NCT03242018|26035918|P1|Overall Study|Lost to Follow-up|2
7503620|NCT03242018|26035916|P3|Overall Study|Adverse Event|6
7503621|NCT03242018|26035917|P2|Overall Study|Adverse Event|7
7503622|NCT03242018|26035918|P1|Overall Study|Adverse Event|7
7503623|NCT03241927|26035954|P2|Overall Study|study terminated|0
7503624|NCT03241927|26035955|P1|Overall Study|study terminated|1
7503625|NCT03241368|26036001|P1|Overall Study|Protocol Violation|1
7503626|NCT03241368|26036001|P1|Overall Study|Withdrawal by Subject|6
7503627|NCT03241368|26036001|P1|Overall Study|Physician Decision|6
7503628|NCT03241368|26036001|P1|Overall Study|Lost to Follow-up|1
7503629|NCT03241368|26036001|P1|Overall Study|MRE Stricture or Patency Capsule Failure|25
7503630|NCT03241342|26036011|P3|Overall Study|not reported|19
7503631|NCT03241342|26036012|P2|Overall Study|not reported|21
7503632|NCT03241342|26036013|P1|Overall Study|not reported|15
7503633|NCT03241342|26036011|P3|Overall Study|sponsor decision|2
7503634|NCT03241342|26036012|P2|Overall Study|sponsor decision|1
7503635|NCT03241342|26036013|P1|Overall Study|sponsor decision|0
7503636|NCT03241342|26036011|P3|Overall Study|noncompliance with study drug|1
7503637|NCT03241342|26036012|P2|Overall Study|noncompliance with study drug|1
7503638|NCT03241342|26036013|P1|Overall Study|noncompliance with study drug|2
7503639|NCT03241342|26036011|P3|Overall Study|Lack of Efficacy|1
7503640|NCT03241342|26036012|P2|Overall Study|Lack of Efficacy|0
7503641|NCT03241342|26036013|P1|Overall Study|Lack of Efficacy|0
7503642|NCT03241342|26036011|P3|Overall Study|Adverse Event|4
7503643|NCT03241342|26036012|P2|Overall Study|Adverse Event|8
7503644|NCT03241342|26036013|P1|Overall Study|Adverse Event|5
7503645|NCT03240575|26036025|P4|Overall Study|Other|0
7503646|NCT03240575|26036026|P3|Overall Study|Other|0
7503647|NCT03240575|26036027|P2|Overall Study|Other|1
7503648|NCT03240575|26036028|P1|Overall Study|Other|0
7503649|NCT03240575|26036025|P4|Overall Study|Withdrawal by Subject|1
7503650|NCT03240575|26036026|P3|Overall Study|Withdrawal by Subject|0
7503651|NCT03240575|26036027|P2|Overall Study|Withdrawal by Subject|11
7503652|NCT03240575|26036028|P1|Overall Study|Withdrawal by Subject|2
7503653|NCT03240575|26036025|P4|Overall Study|Adverse Event|1
7503654|NCT03240575|26036026|P3|Overall Study|Adverse Event|0
7503655|NCT03240575|26036027|P2|Overall Study|Adverse Event|2
7503656|NCT03240575|26036028|P1|Overall Study|Adverse Event|0
7503657|NCT03240133|26036051|P3|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
7503658|NCT03240133|26036052|P2|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7503659|NCT03240133|26036053|P1|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7503660|NCT03240133|26036051|P3|Overall Study|Intercurrent illness.|0
7503661|NCT03240133|26036052|P2|Overall Study|Intercurrent illness.|1
7503662|NCT03240133|26036053|P1|Overall Study|Intercurrent illness.|0
7503663|NCT03240133|26036051|P3|Overall Study|sponsor closure/completion of Part 1 of the study|0
7503664|NCT03240133|26036052|P2|Overall Study|sponsor closure/completion of Part 1 of the study|0
7503665|NCT03240133|26036053|P1|Overall Study|sponsor closure/completion of Part 1 of the study|1
7503666|NCT03240133|26036051|P3|Overall Study|Rash|0
7503667|NCT03240133|26036052|P2|Overall Study|Rash|0
7503668|NCT03240133|26036053|P1|Overall Study|Rash|1
7503669|NCT03240133|26036051|P3|Overall Study|Adverse Event|0
7503670|NCT03240133|26036052|P2|Overall Study|Adverse Event|1
7503671|NCT03240133|26036053|P1|Overall Study|Adverse Event|1
7503672|NCT03240133|26036051|P3|Overall Study|Withdrawal by Subject|0
7503673|NCT03240133|26036052|P2|Overall Study|Withdrawal by Subject|1
7503674|NCT03240133|26036053|P1|Overall Study|Withdrawal by Subject|0
7503675|NCT03240081|26036079|P2|Overall Study|Lost to Follow-up|1
7503676|NCT03240081|26036080|P1|Overall Study|Lost to Follow-up|0
7503677|NCT03240081|26036079|P2|Overall Study|Withdrawal by Subject|2
7503678|NCT03240081|26036080|P1|Overall Study|Withdrawal by Subject|0
7503679|NCT03239873|26036090|P2|Overall Study|Protocol Violation|0
7503680|NCT03239873|26036091|P1|Overall Study|Protocol Violation|1
7503681|NCT03239873|26036090|P2|Overall Study|Contraindication to study medication|0
7503682|NCT03239873|26036091|P1|Overall Study|Contraindication to study medication|1
7503683|NCT03239873|26036090|P2|Overall Study|Withdrawal by Subject|0
7503684|NCT03239873|26036091|P1|Overall Study|Withdrawal by Subject|2
7503685|NCT03239873|26036090|P2|Overall Study|Withdrawal by Parent/Guardian|11
7503686|NCT03239873|26036091|P1|Overall Study|Withdrawal by Parent/Guardian|12
7503687|NCT03239873|26036090|P2|Overall Study|Physician Decision|0
7503688|NCT03239873|26036091|P1|Overall Study|Physician Decision|1
7503689|NCT03239873|26036090|P2|Overall Study|Lost to Follow-up|16
7503690|NCT03239873|26036091|P1|Overall Study|Lost to Follow-up|15
7503695|NCT03238963|26036311|P2|Overall Study|Adverse Event|0
7503696|NCT03238963|26036312|P1|Overall Study|Adverse Event|1
7503697|NCT03238963|26036311|P2|Overall Study|Protocol Violation|1
7503698|NCT03238963|26036312|P1|Overall Study|Protocol Violation|1
7503699|NCT03238963|26036311|P2|Overall Study|Lost to Follow-up|0
7503700|NCT03238963|26036312|P1|Overall Study|Lost to Follow-up|1
7503701|NCT03238963|26036311|P2|Overall Study|Withdrawal by Subject|1
7503702|NCT03238963|26036312|P1|Overall Study|Withdrawal by Subject|1
7503703|NCT03238963|26036311|P2|Overall Study|Prohibited medication given due to hospital stay|0
7503704|NCT03238963|26036312|P1|Overall Study|Prohibited medication given due to hospital stay|1
7503705|NCT03238924|26036324|P2|Overall Study|Withdrawal by Subject|2
7503706|NCT03238924|26036325|P1|Overall Study|Withdrawal by Subject|2
7503707|NCT03238911|26036337|P2|Overall Study|Lost to Follow-up|1
7503708|NCT03238911|26036338|P1|Overall Study|Lost to Follow-up|2
7503709|NCT03238911|26036337|P2|Overall Study|Withdrawal by Subject|2
7503710|NCT03238911|26036338|P1|Overall Study|Withdrawal by Subject|1
7503711|NCT03238781|26036381|P3|Overall Study|Decision by sponsor|0
7503712|NCT03238781|26036382|P2|Overall Study|Decision by sponsor|1
7503713|NCT03238781|26036383|P1|Overall Study|Decision by sponsor|0
7503714|NCT03238781|26036381|P3|Overall Study|Withdrawal by Subject|16
7503715|NCT03238781|26036382|P2|Overall Study|Withdrawal by Subject|14
7503716|NCT03238781|26036383|P1|Overall Study|Withdrawal by Subject|23
7503717|NCT03238781|26036381|P3|Overall Study|Lost to Follow-up|2
7503718|NCT03238781|26036382|P2|Overall Study|Lost to Follow-up|1
7503719|NCT03238781|26036383|P1|Overall Study|Lost to Follow-up|2
7503720|NCT03238781|26036381|P3|Overall Study|Adverse Event|2
7503721|NCT03238781|26036382|P2|Overall Study|Adverse Event|1
7503722|NCT03238781|26036383|P1|Overall Study|Adverse Event|1
7503723|NCT03238651|26036435|P5|Overall Study|Adverse Event|0
7503724|NCT03238651|26036436|P4|Overall Study|Adverse Event|0
7503725|NCT03238651|26036437|P3|Overall Study|Adverse Event|2
7503726|NCT03238651|26036438|P2|Overall Study|Adverse Event|3
7503727|NCT03238651|26036439|P1|Overall Study|Adverse Event|1
7503728|NCT03238651|26036435|P5|Overall Study|Withdrawal by Subject|0
7503729|NCT03238651|26036436|P4|Overall Study|Withdrawal by Subject|1
7503730|NCT03238651|26036437|P3|Overall Study|Withdrawal by Subject|0
7503731|NCT03238651|26036438|P2|Overall Study|Withdrawal by Subject|1
7503732|NCT03238651|26036439|P1|Overall Study|Withdrawal by Subject|0
7503733|NCT03238651|26036435|P5|Overall Study|Progressive Disease|0
7503734|NCT03238651|26036436|P4|Overall Study|Progressive Disease|2
7503735|NCT03238651|26036437|P3|Overall Study|Progressive Disease|2
7503736|NCT03238651|26036438|P2|Overall Study|Progressive Disease|2
7503737|NCT03238651|26036439|P1|Overall Study|Progressive Disease|2
7503738|NCT03238651|26036435|P5|Overall Study|Other|1
7503739|NCT03238651|26036436|P4|Overall Study|Other|0
7503740|NCT03238651|26036437|P3|Overall Study|Other|0
7503741|NCT03238651|26036438|P2|Overall Study|Other|0
7503742|NCT03238651|26036439|P1|Overall Study|Other|0
7503743|NCT03238417|26036508|P2|24-month|partial completion|31
7503744|NCT03238417|26036509|P1|24-month|partial completion|8
7503745|NCT03238417|26036508|P2|24-month|non-response|594
7503746|NCT03238417|26036509|P1|24-month|non-response|287
7503747|NCT03238417|26036508|P2|12-month|partial completion|37
7503748|NCT03238417|26036509|P1|12-month|partial completion|23
7503749|NCT03238417|26036508|P2|12-month|non-response|669
7503750|NCT03238417|26036509|P1|12-month|non-response|296
7503751|NCT03238417|26036508|P2|Baseline|non-response|669
7503752|NCT03238417|26036509|P1|Baseline|non-response|372
7503753|NCT03238417|26036508|P2|Baseline|Partial completion|48
7503754|NCT03238417|26036509|P1|Baseline|Partial completion|17
7503755|NCT03238417|26036508|P2|Overall|partial completion|68
7503756|NCT03238417|26036509|P1|Overall|partial completion|48
7503757|NCT03238417|26036508|P2|Overall|non-response|1920
7503758|NCT03238417|26036509|P1|Overall|non-response|955
7503759|NCT03238352|26036552|P3|Overall Study|Withdrawal by Subject|0
7503760|NCT03238352|26036553|P2|Overall Study|Withdrawal by Subject|1
7503761|NCT03238352|26036554|P1|Overall Study|Withdrawal by Subject|0
7503762|NCT03238352|26036552|P3|Overall Study|Lost to Follow-up|1
7503763|NCT03238352|26036553|P2|Overall Study|Lost to Follow-up|2
7503764|NCT03238352|26036554|P1|Overall Study|Lost to Follow-up|0
7503765|NCT03238001|26036565|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
7503766|NCT03238001|26036565|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
7503767|NCT03238001|26036565|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
7503768|NCT03238001|26036565|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
7503769|NCT03238001|26036565|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
7503770|NCT03238001|26036565|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
7503771|NCT03238001|26036565|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
7503772|NCT03238001|26036565|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
7503773|NCT03237845|26036596|P2|Overall Study|Other Reasons|0
7503774|NCT03237845|26036597|P1|Overall Study|Other Reasons|4
7503775|NCT03237845|26036596|P2|Overall Study|Withdrawal by Subject|3
7503776|NCT03237845|26036597|P1|Overall Study|Withdrawal by Subject|3
7503777|NCT03237845|26036596|P2|Overall Study|Technical Problems|1
7503778|NCT03237845|26036597|P1|Overall Study|Technical Problems|8
7503779|NCT03237845|26036596|P2|Overall Study|Protocol Deviation|1
7503780|NCT03237845|26036597|P1|Overall Study|Protocol Deviation|0
7503781|NCT03237845|26036596|P2|Overall Study|Pregnancy|0
7503782|NCT03237845|26036597|P1|Overall Study|Pregnancy|1
7503783|NCT03237845|26036596|P2|Overall Study|Physician Decision|2
7503784|NCT03237845|26036597|P1|Overall Study|Physician Decision|1
7503785|NCT03237845|26036596|P2|Overall Study|Non-Compliance With Study Treatment|1
7503786|NCT03237845|26036597|P1|Overall Study|Non-Compliance With Study Treatment|0
7503787|NCT03237845|26036596|P2|Overall Study|Not Experienced Moderate/Severe Migraine|31
7503788|NCT03237845|26036597|P1|Overall Study|Not Experienced Moderate/Severe Migraine|26
7503789|NCT03237845|26036596|P2|Overall Study|Lost to Follow-up|10
7503790|NCT03237845|26036597|P1|Overall Study|Lost to Follow-up|13
7503791|NCT03237845|26036596|P2|Overall Study|Adverse Event|1
7503792|NCT03237845|26036597|P1|Overall Study|Adverse Event|0
7503793|NCT03237065|26036758|P2|Overall Study|Unable to obtain venous access|1
7503794|NCT03237065|26036759|P1|Overall Study|Unable to obtain venous access|0
7503795|NCT03237065|26036758|P2|Overall Study|Lost to Follow-up|0
7503796|NCT03237065|26036759|P1|Overall Study|Lost to Follow-up|1
7503797|NCT03237065|26036758|P2|Overall Study|Withdrawal by Subject|0
7503798|NCT03237065|26036759|P1|Overall Study|Withdrawal by Subject|3
7503799|NCT03237065|26036758|P2|Overall Study|Protocol Violation|1
7503800|NCT03237065|26036759|P1|Overall Study|Protocol Violation|0
7503801|NCT03237065|26036758|P2|Overall Study|Adverse Event|2
7503802|NCT03237065|26036759|P1|Overall Study|Adverse Event|0
7503803|NCT03237013|26036802|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
7503804|NCT03237013|26036803|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
7503805|NCT03237013|26036804|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
7503806|NCT03236779|26036853|P2|Overall Study|Lost to Follow-up|21
7503807|NCT03236779|26036854|P1|Overall Study|Lost to Follow-up|13
7503808|NCT03236311|26036883|P2|Overall Study|Adverse Event|1
7503809|NCT03236311|26036884|P1|Overall Study|Adverse Event|0
7503810|NCT03236311|26036883|P2|Overall Study|Study terminated by sponsor|2
7503811|NCT03236311|26036884|P1|Overall Study|Study terminated by sponsor|0
7503812|NCT03236246|26036896|P2|24-Week Dose Maintenance Period|Adverse Event|1
7503813|NCT03236246|26036897|P1|24-Week Dose Maintenance Period|Adverse Event|0
7503814|NCT03236246|26036896|P2|24-Week Dose Maintenance Period|Death|1
7503815|NCT03236246|26036897|P1|24-Week Dose Maintenance Period|Death|0
7503816|NCT03236246|26036896|P2|24-Week Dose Maintenance Period|Prohibited Therapy|0
7503817|NCT03236246|26036897|P1|24-Week Dose Maintenance Period|Prohibited Therapy|1
7503818|NCT03236246|26036896|P2|24-Week Dose Maintenance Period|Lost to Follow-up|1
7503819|NCT03236246|26036897|P1|24-Week Dose Maintenance Period|Lost to Follow-up|1
7503820|NCT03236246|26036896|P2|24-Week Dose Maintenance Period|Withdrawal by Subject|3
7503821|NCT03236246|26036897|P1|24-Week Dose Maintenance Period|Withdrawal by Subject|1
7503822|NCT03236246|26036896|P2|24-Week Dose Titration Period|Captured as Other|2
7503823|NCT03236246|26036897|P1|24-Week Dose Titration Period|Captured as Other|1
7503824|NCT03236246|26036896|P2|24-Week Dose Titration Period|Adverse Event|8
7503825|NCT03236246|26036897|P1|24-Week Dose Titration Period|Adverse Event|7
7503826|NCT03236246|26036896|P2|24-Week Dose Titration Period|Protocol Violation|2
7503827|NCT03236246|26036897|P1|24-Week Dose Titration Period|Protocol Violation|0
7503828|NCT03236246|26036896|P2|24-Week Dose Titration Period|Death|1
7503829|NCT03236246|26036897|P1|24-Week Dose Titration Period|Death|3
7503830|NCT03236246|26036896|P2|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
7503831|NCT03236246|26036897|P1|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
7503832|NCT03236246|26036896|P2|24-Week Dose Titration Period|Prohibited Therapy|1
7503833|NCT03236246|26036897|P1|24-Week Dose Titration Period|Prohibited Therapy|1
7503834|NCT03236246|26036896|P2|24-Week Dose Titration Period|Investigator Judgement|1
7503835|NCT03236246|26036897|P1|24-Week Dose Titration Period|Investigator Judgement|1
7503836|NCT03236246|26036896|P2|24-Week Dose Titration Period|Study Drug Non-Compliance|2
7503837|NCT03236246|26036897|P1|24-Week Dose Titration Period|Study Drug Non-Compliance|3
7503838|NCT03236246|26036896|P2|24-Week Dose Titration Period|Lost to Follow-up|2
7503839|NCT03236246|26036897|P1|24-Week Dose Titration Period|Lost to Follow-up|0
7503840|NCT03236246|26036896|P2|24-Week Dose Titration Period|Withdrawal by Subject|7
7503841|NCT03236246|26036897|P1|24-Week Dose Titration Period|Withdrawal by Subject|8
7503842|NCT03235726|26036991|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503843|NCT03235726|26036992|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503844|NCT03235726|26036993|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503845|NCT03235726|26036994|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503846|NCT03235726|26036995|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503847|NCT03235726|26036996|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
7503848|NCT03235726|26036997|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503849|NCT03235726|26036998|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503850|NCT03235726|26036999|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503851|NCT03235726|26037000|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7503852|NCT03235726|26036991|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503853|NCT03235726|26036992|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503854|NCT03235726|26036993|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503855|NCT03235726|26036994|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503856|NCT03235726|26036995|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503857|NCT03235726|26036996|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
7503858|NCT03235726|26036997|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503859|NCT03235726|26036998|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503860|NCT03235726|26036999|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503861|NCT03235726|26037000|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7503862|NCT03235479|26037154|P2|Overall Study|Other Reasons|5
7503863|NCT03235479|26037155|P1|Overall Study|Other Reasons|3
7503864|NCT03235479|26037154|P2|Overall Study|Withdrawal by Subject|2
7503865|NCT03235479|26037155|P1|Overall Study|Withdrawal by Subject|2
7503866|NCT03235479|26037154|P2|Overall Study|Technical Problems|2
7503867|NCT03235479|26037155|P1|Overall Study|Technical Problems|3
7503868|NCT03235479|26037154|P2|Overall Study|Protocol Deviation|3
7503869|NCT03235479|26037155|P1|Overall Study|Protocol Deviation|1
7503870|NCT03235479|26037154|P2|Overall Study|Pregnancy|0
7503871|NCT03235479|26037155|P1|Overall Study|Pregnancy|1
7503872|NCT03235479|26037154|P2|Overall Study|Not Experienced Moderate/Severe Migraine|17
7503873|NCT03235479|26037155|P1|Overall Study|Not Experienced Moderate/Severe Migraine|23
7503874|NCT03235479|26037154|P2|Overall Study|Lost to Follow-up|11
7503875|NCT03235479|26037155|P1|Overall Study|Lost to Follow-up|8
7503876|NCT03235349|26037192|P1|Overall Study|Other|1
7503877|NCT03235349|26037192|P1|Overall Study|Adverse Event|1
7503878|NCT03235284|26037202|P3|Overall Study|Adverse Event|1
7503879|NCT03235284|26037203|P2|Overall Study|Adverse Event|2
7503880|NCT03235284|26037204|P1|Overall Study|Adverse Event|1
7503881|NCT03235154|26037221|P1|Overall Study|Lost to Follow-up|2
7503882|NCT03235154|26037221|P1|Overall Study|Adverse Event|1
7503883|NCT03235154|26037221|P1|Overall Study|Withdrawal by Subject|1
7503884|NCT03235115|26037227|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
7503885|NCT03235115|26037228|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7503886|NCT03235115|26037229|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7503887|NCT03235115|26037230|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7503888|NCT03235115|26037231|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7503889|NCT03235115|26037232|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7503890|NCT03235089|26037252|P2|Overall Study|Physician Decision|2
7503891|NCT03235089|26037253|P1|Overall Study|Physician Decision|2
7503892|NCT03235089|26037252|P2|Overall Study|Lost to Follow-up|1
7503893|NCT03235089|26037253|P1|Overall Study|Lost to Follow-up|1
7503894|NCT03235050|26037294|P5|Overall Study|Other reasons|2
7503895|NCT03235050|26037295|P4|Overall Study|Other reasons|1
7503896|NCT03235050|26037296|P3|Overall Study|Other reasons|0
7503897|NCT03235050|26037297|P2|Overall Study|Other reasons|1
7503898|NCT03235050|26037298|P1|Overall Study|Other reasons|0
7503899|NCT03235050|26037294|P5|Overall Study|Withdrawal by Subject|7
7503900|NCT03235050|26037295|P4|Overall Study|Withdrawal by Subject|5
7503901|NCT03235050|26037296|P3|Overall Study|Withdrawal by Subject|2
7503902|NCT03235050|26037297|P2|Overall Study|Withdrawal by Subject|2
7503903|NCT03235050|26037298|P1|Overall Study|Withdrawal by Subject|3
7503904|NCT03235050|26037294|P5|Overall Study|Lost to Follow-up|0
7503905|NCT03235050|26037295|P4|Overall Study|Lost to Follow-up|2
7503906|NCT03235050|26037296|P3|Overall Study|Lost to Follow-up|1
7503907|NCT03235050|26037297|P2|Overall Study|Lost to Follow-up|2
7503908|NCT03235050|26037298|P1|Overall Study|Lost to Follow-up|1
7503909|NCT03235050|26037294|P5|Overall Study|Death|1
7503910|NCT03235050|26037295|P4|Overall Study|Death|2
7503911|NCT03235050|26037296|P3|Overall Study|Death|0
7503912|NCT03235050|26037297|P2|Overall Study|Death|0
7503913|NCT03235050|26037298|P1|Overall Study|Death|0
7503914|NCT03235050|26037294|P5|Overall Study|Adverse Event|1
7503915|NCT03235050|26037295|P4|Overall Study|Adverse Event|4
7503916|NCT03235050|26037296|P3|Overall Study|Adverse Event|1
7503917|NCT03235050|26037297|P2|Overall Study|Adverse Event|0
7503918|NCT03235050|26037298|P1|Overall Study|Adverse Event|0
7503919|NCT03234465|26037359|P2|Overall Study|Other|8
7503920|NCT03234465|26037360|P1|Overall Study|Other|14
7503921|NCT03234465|26037359|P2|Overall Study|Non-compliance|0
7503922|NCT03234465|26037360|P1|Overall Study|Non-compliance|2
7503923|NCT03234465|26037359|P2|Overall Study|Symptomatic deterioration|1
7503924|NCT03234465|26037360|P1|Overall Study|Symptomatic deterioration|0
7503925|NCT03234465|26037359|P2|Overall Study|Withdrawal by Subject|27
7503926|NCT03234465|26037360|P1|Overall Study|Withdrawal by Subject|12
7503927|NCT03234465|26037359|P2|Overall Study|Lost to Follow-up|1
7503928|NCT03234465|26037360|P1|Overall Study|Lost to Follow-up|1
7503929|NCT03234465|26037359|P2|Overall Study|Death|1
7503930|NCT03234465|26037360|P1|Overall Study|Death|0
7503931|NCT03234465|26037359|P2|Overall Study|Adverse Event|2
7503932|NCT03234465|26037360|P1|Overall Study|Adverse Event|4
7503933|NCT03234036|26037392|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7504025|NCT03231943|26038080|P2|Part 2|Adverse Event|0
7503934|NCT03234036|26037393|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7503935|NCT03234036|26037394|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7503936|NCT03234036|26037395|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7503937|NCT03233529|26037566|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
7503938|NCT03233529|26037566|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
7503939|NCT03233438|26037610|P2|Overall Study|No recording of dalbavancin|1
7503940|NCT03233438|26037611|P1|Overall Study|No recording of dalbavancin|0
7503941|NCT03233438|26037610|P2|Overall Study|Withdrawal by Subject|1
7503942|NCT03233438|26037611|P1|Overall Study|Withdrawal by Subject|2
7503943|NCT03233438|26037610|P2|Overall Study|Lost to Follow-up|9
7503944|NCT03233438|26037611|P1|Overall Study|Lost to Follow-up|4
7503945|NCT03233308|26037677|P1|Overall Study|Protocol Violation|1
7503946|NCT03233308|26037677|P1|Overall Study|Adverse Event|1
7503947|NCT03233230|26037693|P4|Overall Study|Lost to Follow-up|0
7503948|NCT03233230|26037694|P3|Overall Study|Lost to Follow-up|0
7503949|NCT03233230|26037695|P2|Overall Study|Lost to Follow-up|3
7503950|NCT03233230|26037696|P1|Overall Study|Lost to Follow-up|0
7503951|NCT03233230|26037693|P4|Overall Study|Withdrawal by Subject|1
7503952|NCT03233230|26037694|P3|Overall Study|Withdrawal by Subject|0
7503953|NCT03233230|26037695|P2|Overall Study|Withdrawal by Subject|2
7503954|NCT03233230|26037696|P1|Overall Study|Withdrawal by Subject|2
7503955|NCT03233230|26037693|P4|Overall Study|Other|3
7503956|NCT03233230|26037694|P3|Overall Study|Other|5
7503957|NCT03233230|26037695|P2|Overall Study|Other|5
7503958|NCT03233230|26037696|P1|Overall Study|Other|5
7503959|NCT03233230|26037693|P4|Overall Study|Lack of Efficacy|0
7503960|NCT03233230|26037694|P3|Overall Study|Lack of Efficacy|0
7503961|NCT03233230|26037695|P2|Overall Study|Lack of Efficacy|0
7503962|NCT03233230|26037696|P1|Overall Study|Lack of Efficacy|1
7503963|NCT03233230|26037693|P4|Overall Study|Protocol Violation|1
7503964|NCT03233230|26037694|P3|Overall Study|Protocol Violation|1
7503965|NCT03233230|26037695|P2|Overall Study|Protocol Violation|2
7503966|NCT03233230|26037696|P1|Overall Study|Protocol Violation|1
7503967|NCT03233230|26037693|P4|Overall Study|Adverse Event|3
7503968|NCT03233230|26037694|P3|Overall Study|Adverse Event|6
7503969|NCT03233230|26037695|P2|Overall Study|Adverse Event|3
7503970|NCT03233230|26037696|P1|Overall Study|Adverse Event|6
7503971|NCT03233009|26037888|P1|Overall Study|Lost to Follow-up|1
7503972|NCT03232983|26037931|P4|Period 4|Withdrawal by Subject|0
7503973|NCT03232983|26037932|P3|Period 4|Withdrawal by Subject|0
7503974|NCT03232983|26037933|P2|Period 4|Withdrawal by Subject|0
7503975|NCT03232983|26037934|P1|Period 4|Withdrawal by Subject|1
7503976|NCT03232983|26037931|P4|Washout Period 2|Withdrawal by Subject|1
7503977|NCT03232983|26037932|P3|Washout Period 2|Withdrawal by Subject|0
7503978|NCT03232983|26037933|P2|Washout Period 2|Withdrawal by Subject|0
7503979|NCT03232983|26037934|P1|Washout Period 2|Withdrawal by Subject|0
7503980|NCT03232983|26037931|P4|Washout Period 2|Physician Decision|0
7503981|NCT03232983|26037932|P3|Washout Period 2|Physician Decision|1
7503982|NCT03232983|26037933|P2|Washout Period 2|Physician Decision|0
7503983|NCT03232983|26037934|P1|Washout Period 2|Physician Decision|0
7503984|NCT03232983|26037931|P4|Period 1|Physician Decision|0
7503985|NCT03232983|26037932|P3|Period 1|Physician Decision|1
7503986|NCT03232983|26037933|P2|Period 1|Physician Decision|0
7503987|NCT03232983|26037934|P1|Period 1|Physician Decision|0
7503988|NCT03232567|26038004|P4|Overall Study|Withdrawal by Subject|0
7503989|NCT03232567|26038005|P3|Overall Study|Withdrawal by Subject|0
7503990|NCT03232567|26038006|P2|Overall Study|Withdrawal by Subject|1
7503991|NCT03232567|26038007|P1|Overall Study|Withdrawal by Subject|0
7503992|NCT03232333|26038029|P1|Overall Study|Withdrawal by Subject|2
7503993|NCT03232333|26038029|P1|Overall Study|Lost to Follow-up|4
7503994|NCT03232333|26038029|P1|Overall Study|Infection or Osteomyelitis|9
7503995|NCT03232281|26038041|P2|Overall Study|Protocol Deviation|1
7503996|NCT03232281|26038042|P1|Overall Study|Protocol Deviation|1
7503997|NCT03232281|26038041|P2|Overall Study|Withdrawal by Subject|4
7503998|NCT03232281|26038042|P1|Overall Study|Withdrawal by Subject|5
7503999|NCT03232281|26038041|P2|Overall Study|Adverse Event|1
7504000|NCT03232281|26038042|P1|Overall Study|Adverse Event|1
7504001|NCT03231943|26038069|P13|Part 2|Withdrawal by Subject|0
7504002|NCT03231943|26038070|P12|Part 2|Withdrawal by Subject|1
7504003|NCT03231943|26038071|P11|Part 2|Withdrawal by Subject|0
7504004|NCT03231943|26038072|P10|Part 2|Withdrawal by Subject|0
7504005|NCT03231943|26038073|P9|Part 2|Withdrawal by Subject|0
7504006|NCT03231943|26038074|P8|Part 2|Withdrawal by Subject|0
7504007|NCT03231943|26038075|P7|Part 2|Withdrawal by Subject|0
7504008|NCT03231943|26038076|P6|Part 2|Withdrawal by Subject|0
7504009|NCT03231943|26038077|P5|Part 2|Withdrawal by Subject|0
7504010|NCT03231943|26038078|P4|Part 2|Withdrawal by Subject|0
7504011|NCT03231943|26038079|P3|Part 2|Withdrawal by Subject|0
7504012|NCT03231943|26038080|P2|Part 2|Withdrawal by Subject|0
7504013|NCT03231943|26038081|P1|Part 2|Withdrawal by Subject|0
7504014|NCT03231943|26038069|P13|Part 2|Adverse Event|0
7504015|NCT03231943|26038070|P12|Part 2|Adverse Event|0
7504016|NCT03231943|26038071|P11|Part 2|Adverse Event|1
7504017|NCT03231943|26038072|P10|Part 2|Adverse Event|0
7504018|NCT03231943|26038073|P9|Part 2|Adverse Event|0
7504019|NCT03231943|26038074|P8|Part 2|Adverse Event|0
7504020|NCT03231943|26038075|P7|Part 2|Adverse Event|0
7504021|NCT03231943|26038076|P6|Part 2|Adverse Event|0
7504022|NCT03231943|26038077|P5|Part 2|Adverse Event|0
7504023|NCT03231943|26038078|P4|Part 2|Adverse Event|0
7504024|NCT03231943|26038079|P3|Part 2|Adverse Event|0
7504026|NCT03231943|26038081|P1|Part 2|Adverse Event|0
7504027|NCT03231943|26038069|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504028|NCT03231943|26038070|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504029|NCT03231943|26038071|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504030|NCT03231943|26038072|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504031|NCT03231943|26038073|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504032|NCT03231943|26038074|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504033|NCT03231943|26038075|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504034|NCT03231943|26038076|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504035|NCT03231943|26038077|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504036|NCT03231943|26038078|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504037|NCT03231943|26038079|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504038|NCT03231943|26038080|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7504039|NCT03231943|26038081|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
7504040|NCT03231943|26038069|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504041|NCT03231943|26038070|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504042|NCT03231943|26038071|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504043|NCT03231943|26038072|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504044|NCT03231943|26038073|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504045|NCT03231943|26038074|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504046|NCT03231943|26038075|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504047|NCT03231943|26038076|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504048|NCT03231943|26038077|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504049|NCT03231943|26038078|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504050|NCT03231943|26038079|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504051|NCT03231943|26038080|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
7504052|NCT03231943|26038081|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7504053|NCT03231943|26038069|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504054|NCT03231943|26038070|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504055|NCT03231943|26038071|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504056|NCT03231943|26038072|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504057|NCT03231943|26038073|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504058|NCT03231943|26038074|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504059|NCT03231943|26038075|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504060|NCT03231943|26038076|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504061|NCT03231943|26038077|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504062|NCT03231943|26038078|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504063|NCT03231943|26038079|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7504064|NCT03231943|26038080|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7504065|NCT03231943|26038081|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7504066|NCT03231800|26038544|P2|Overall Study|reason not provided|0
7504067|NCT03231800|26038545|P1|Overall Study|reason not provided|2
7504068|NCT03231800|26038544|P2|Overall Study|Protocol Violation|1
7504069|NCT03231800|26038545|P1|Overall Study|Protocol Violation|1
7504070|NCT03231800|26038544|P2|Overall Study|Lost to Follow-up|2
7504071|NCT03231800|26038545|P1|Overall Study|Lost to Follow-up|0
7504072|NCT03231709|26038561|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
7504073|NCT03231709|26038562|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
7504074|NCT03231709|26038561|P2|Treatment Period 1|Reason not Specified|1
7504075|NCT03231709|26038562|P1|Treatment Period 1|Reason not Specified|0
7504076|NCT03231371|26038605|P1|Overall Study|chose or were ineligible to have MRI|12
7504077|NCT03231371|26038605|P1|Overall Study|Withdrawal by Subject|1
7504078|NCT03231228|26038618|P2|Overall Study|Physician Decision|0
7504079|NCT03231228|26038619|P1|Overall Study|Physician Decision|1
7504080|NCT03231228|26038618|P2|Overall Study|Lost to Follow-up|0
7504081|NCT03231228|26038619|P1|Overall Study|Lost to Follow-up|2
7504082|NCT03230864|26038630|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7504083|NCT03230864|26038631|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
7504084|NCT03230864|26038632|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7504085|NCT03230864|26038633|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7504086|NCT03230864|26038630|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
7504087|NCT03230864|26038631|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
7504088|NCT03230864|26038632|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7504089|NCT03230864|26038633|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7504090|NCT03230864|26038630|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
7504091|NCT03230864|26038631|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
7504092|NCT03230864|26038632|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
7504093|NCT03230864|26038633|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
7504094|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7504095|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7504096|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7504097|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
7504098|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
7504099|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
7504100|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
7504101|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
7504102|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7504103|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7504104|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
7504105|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
7504106|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7504107|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7504108|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
7504109|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
7504110|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
7504111|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
7504112|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
7504113|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
7504114|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7504115|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7504116|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7504117|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7504118|NCT03230864|26038630|P4|Prospective Confirmation (PC) Period|Adverse Event|0
7504119|NCT03230864|26038631|P3|Prospective Confirmation (PC) Period|Adverse Event|0
7504120|NCT03230864|26038632|P2|Prospective Confirmation (PC) Period|Adverse Event|0
7504121|NCT03230864|26038633|P1|Prospective Confirmation (PC) Period|Adverse Event|3
7504122|NCT03229759|26038655|P1|Overall Study|Screen Failure|30
7504123|NCT03229486|26038663|P2|Overall Study|Protocol Violation|1
7504124|NCT03229486|26038664|P1|Overall Study|Protocol Violation|0
7504125|NCT03229109|26038705|P4|Overall Study|Withdrawal by Subject|1
7504126|NCT03229109|26038706|P3|Overall Study|Withdrawal by Subject|0
7504127|NCT03229109|26038707|P2|Overall Study|Withdrawal by Subject|0
7504128|NCT03229109|26038708|P1|Overall Study|Withdrawal by Subject|0
7504129|NCT03228836|26038727|P1|Overall Study|Other|4
7504130|NCT03228836|26038727|P1|Overall Study|Disease Progression|7
7504131|NCT03228836|26038727|P1|Overall Study|Physician Decision|1
7504132|NCT03228836|26038727|P1|Overall Study|Death|1
7504133|NCT03228836|26038727|P1|Overall Study|Withdrawal by Subject|1
7504134|NCT03228836|26038727|P1|Overall Study|Adverse Event|3
7504135|NCT03228680|26038735|P2|Overall Study|Other|16
7504136|NCT03228680|26038736|P1|Overall Study|Other|9
7504137|NCT03228680|26038735|P2|Overall Study|Withdrawal by Subject|0
7504138|NCT03228680|26038736|P1|Overall Study|Withdrawal by Subject|1
7504139|NCT03228680|26038735|P2|Overall Study|Randomization failure|1
7504140|NCT03228680|26038736|P1|Overall Study|Randomization failure|0
7504141|NCT03228680|26038735|P2|Overall Study|Adverse Event|18
7504142|NCT03228680|26038736|P1|Overall Study|Adverse Event|13
7504143|NCT03228433|26038822|P6|Overall Study|Positive alcohol test|0
7504144|NCT03228433|26038823|P5|Overall Study|Positive alcohol test|0
7504145|NCT03228433|26038824|P4|Overall Study|Positive alcohol test|1
7504146|NCT03228433|26038825|P3|Overall Study|Positive alcohol test|0
7504147|NCT03228433|26038826|P2|Overall Study|Positive alcohol test|0
7504148|NCT03228433|26038827|P1|Overall Study|Positive alcohol test|0
7504149|NCT03228433|26038822|P6|Overall Study|Lost to Follow-up|0
7504150|NCT03228433|26038823|P5|Overall Study|Lost to Follow-up|0
7504151|NCT03228433|26038824|P4|Overall Study|Lost to Follow-up|0
7504152|NCT03228433|26038825|P3|Overall Study|Lost to Follow-up|0
7504153|NCT03228433|26038826|P2|Overall Study|Lost to Follow-up|0
7504154|NCT03228433|26038827|P1|Overall Study|Lost to Follow-up|1
7504155|NCT03228420|26038904|P2|Overall Study|Adverse Event|2
7504156|NCT03228420|26038905|P1|Overall Study|Adverse Event|5
7504157|NCT03228420|26038904|P2|Overall Study|Withdrawal by Subject|0
7504158|NCT03228420|26038905|P1|Overall Study|Withdrawal by Subject|10
7504159|NCT03228420|26038904|P2|Overall Study|Lost to Follow-up|3
7504160|NCT03228420|26038905|P1|Overall Study|Lost to Follow-up|5
7504161|NCT03228212|26038911|P2|Period 2|Lost to Follow-up|0
7504162|NCT03228212|26038912|P1|Period 2|Lost to Follow-up|1
7504163|NCT03228212|26038911|P2|Period 1|no longer meets eligibility criteria|1
7504164|NCT03228212|26038912|P1|Period 1|no longer meets eligibility criteria|0
7504165|NCT03228212|26038911|P2|Period 1|Adverse Event|0
7504166|NCT03228212|26038912|P1|Period 1|Adverse Event|1
7504167|NCT03227861|26038943|P1|Extension Period (Week 48 to Week 96)|Other|2
7504168|NCT03227861|26038943|P1|Extension Period (Week 48 to Week 96)|Adverse Event|1
7504169|NCT03227861|26038943|P1|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
7504170|NCT03227861|26038943|P1|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
7504171|NCT03227861|26038943|P1|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
7504172|NCT03227861|26038943|P1|Main Study Period (Week 0 to Week 48)|Other|5
7504173|NCT03227861|26038943|P1|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
7504174|NCT03227861|26038943|P1|Main Study Period (Week 0 to Week 48)|Adverse Event|1
7504175|NCT03227861|26038943|P1|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
7504176|NCT03227861|26038943|P1|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
7504177|NCT03227692|26038975|P2|Overall Study|Adverse Event|2
7504178|NCT03227692|26038976|P1|Overall Study|Adverse Event|0
7504179|NCT03227692|26038975|P2|Overall Study|Lost to Follow-up|2
7504180|NCT03227692|26038976|P1|Overall Study|Lost to Follow-up|4
7504181|NCT03227692|26038975|P2|Overall Study|Protocol Violation|1
7504182|NCT03227692|26038976|P1|Overall Study|Protocol Violation|1
7504183|NCT03227445|26039004|P4|Period 2 (28 Days)|Withdrawal by Subject|1
7504184|NCT03227445|26039005|P3|Period 2 (28 Days)|Withdrawal by Subject|0
7504185|NCT03227445|26039006|P2|Period 2 (28 Days)|Withdrawal by Subject|1
7504186|NCT03227445|26039007|P1|Period 2 (28 Days)|Withdrawal by Subject|0
7504187|NCT03227445|26039004|P4|Period 2 (28 Days)|Protocol Violation|1
7504188|NCT03227445|26039005|P3|Period 2 (28 Days)|Protocol Violation|0
7504189|NCT03227445|26039006|P2|Period 2 (28 Days)|Protocol Violation|0
7504190|NCT03227445|26039007|P1|Period 2 (28 Days)|Protocol Violation|0
7504191|NCT03227445|26039004|P4|Period 2 (28 Days)|Adverse Event|1
7504192|NCT03227445|26039005|P3|Period 2 (28 Days)|Adverse Event|2
7504193|NCT03227445|26039006|P2|Period 2 (28 Days)|Adverse Event|0
7504194|NCT03227445|26039007|P1|Period 2 (28 Days)|Adverse Event|1
7504195|NCT03227445|26039004|P4|Period 1 (28 Days)|Withdrawal by Subject|1
7504196|NCT03227445|26039005|P3|Period 1 (28 Days)|Withdrawal by Subject|1
7504197|NCT03227445|26039006|P2|Period 1 (28 Days)|Withdrawal by Subject|0
7504198|NCT03227445|26039007|P1|Period 1 (28 Days)|Withdrawal by Subject|0
7504199|NCT03227445|26039004|P4|Period 1 (28 Days)|Protocol Violation|0
7504200|NCT03227445|26039005|P3|Period 1 (28 Days)|Protocol Violation|0
7504201|NCT03227445|26039006|P2|Period 1 (28 Days)|Protocol Violation|0
7504202|NCT03227445|26039007|P1|Period 1 (28 Days)|Protocol Violation|1
7504203|NCT03227445|26039004|P4|Period 1 (28 Days)|Adverse Event|1
7504204|NCT03227445|26039005|P3|Period 1 (28 Days)|Adverse Event|0
7504205|NCT03227445|26039006|P2|Period 1 (28 Days)|Adverse Event|2
7504206|NCT03227445|26039007|P1|Period 1 (28 Days)|Adverse Event|1
7504207|NCT03227029|26039034|P3|Overall Study|Unable to receive treatment in time (no treatment)|1
7504208|NCT03227029|26039035|P2|Overall Study|Unable to receive treatment in time (no treatment)|0
7504209|NCT03227029|26039036|P1|Overall Study|Unable to receive treatment in time (no treatment)|0
7504210|NCT03227029|26039034|P3|Overall Study|Withdrawal by Subject|0
7504211|NCT03227029|26039035|P2|Overall Study|Withdrawal by Subject|0
7504212|NCT03227029|26039036|P1|Overall Study|Withdrawal by Subject|1
7504213|NCT03227029|26039034|P3|Overall Study|Not able to get to clinic|1
7504214|NCT03227029|26039035|P2|Overall Study|Not able to get to clinic|0
7504215|NCT03227029|26039036|P1|Overall Study|Not able to get to clinic|0
7504216|NCT03227029|26039034|P3|Overall Study|No post RSV season visit due to COVID|2
7504217|NCT03227029|26039035|P2|Overall Study|No post RSV season visit due to COVID|3
7504218|NCT03227029|26039036|P1|Overall Study|No post RSV season visit due to COVID|3
7504219|NCT03227029|26039034|P3|Overall Study|Child Wheezed (no treatment)|0
7504220|NCT03227029|26039035|P2|Overall Study|Child Wheezed (no treatment)|1
7504221|NCT03227029|26039036|P1|Overall Study|Child Wheezed (no treatment)|0
7504222|NCT03226769|26039079|P2|Overall Study|Withdrawal by Subject|1
7504223|NCT03226769|26039080|P1|Overall Study|Withdrawal by Subject|0
7504224|NCT03226392|26039117|P2|Overall Study|Subject/Guardian Decision|6
7504225|NCT03226392|26039118|P1|Overall Study|Subject/Guardian Decision|7
7504226|NCT03226392|26039117|P2|Overall Study|Technical Problems|2
7504227|NCT03226392|26039118|P1|Overall Study|Technical Problems|0
7504228|NCT03226392|26039117|P2|Overall Study|Adverse Event|0
7504229|NCT03226392|26039118|P1|Overall Study|Adverse Event|1
7504230|NCT03226392|26039117|P2|Overall Study|Lost to Follow-up|0
7504231|NCT03226392|26039118|P1|Overall Study|Lost to Follow-up|1
7504232|NCT03226392|26039117|P2|Overall Study|Physician Decision|0
7504233|NCT03226392|26039118|P1|Overall Study|Physician Decision|1
7504234|NCT03226392|26039117|P2|Overall Study|Protocol Deviation|0
7504235|NCT03226392|26039118|P1|Overall Study|Protocol Deviation|1
7504236|NCT03226353|26039159|P1|Overall Study|Screen Failure|5
7504237|NCT03226353|26039159|P1|Overall Study|Withdrawal by Subject|1
7504238|NCT03226275|26039183|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
7504239|NCT03226275|26039184|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7504240|NCT03226275|26039185|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7504241|NCT03226275|26039186|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7504242|NCT03226275|26039183|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7504243|NCT03226275|26039184|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
7504244|NCT03226275|26039185|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7504245|NCT03226275|26039186|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7504246|NCT03226249|26039232|P1|Survival Follow-up|Patients still in follow-up.|30
7504247|NCT03226249|26039232|P1|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
7504248|NCT03226249|26039232|P1|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
7504249|NCT03224598|26039314|P3|Overall Study|Other|0
7504250|NCT03224598|26039315|P2|Overall Study|Other|1
7504251|NCT03224598|26039316|P1|Overall Study|Other|0
7504252|NCT03224598|26039314|P3|Overall Study|Lost to Follow-up|0
7504253|NCT03224598|26039315|P2|Overall Study|Lost to Follow-up|2
7504254|NCT03224598|26039316|P1|Overall Study|Lost to Follow-up|0
7504255|NCT03224325|26039516|P7|Overall Study|Withdrawal by Subject|0
7504256|NCT03224325|26039517|P6|Overall Study|Withdrawal by Subject|0
7504257|NCT03224325|26039518|P5|Overall Study|Withdrawal by Subject|0
7504258|NCT03224325|26039519|P4|Overall Study|Withdrawal by Subject|1
7504259|NCT03224325|26039520|P3|Overall Study|Withdrawal by Subject|0
7504260|NCT03224325|26039521|P2|Overall Study|Withdrawal by Subject|0
7504261|NCT03224325|26039522|P1|Overall Study|Withdrawal by Subject|0
7504262|NCT03224325|26039516|P7|Overall Study|Adverse Event|1
7504263|NCT03224325|26039517|P6|Overall Study|Adverse Event|0
7504264|NCT03224325|26039518|P5|Overall Study|Adverse Event|0
7504265|NCT03224325|26039519|P4|Overall Study|Adverse Event|0
7504266|NCT03224325|26039520|P3|Overall Study|Adverse Event|0
7504267|NCT03224325|26039521|P2|Overall Study|Adverse Event|0
7504268|NCT03224325|26039522|P1|Overall Study|Adverse Event|1
7504269|NCT03224234|26039602|P2|Main Study|Lost to Follow-up|5
7504270|NCT03224234|26039603|P1|Main Study|Lost to Follow-up|5
7504271|NCT03224182|26039651|P2|Overall Study|Other|0
7504272|NCT03224182|26039652|P1|Overall Study|Other|1
7504273|NCT03224182|26039651|P2|Overall Study|Reason not Specified|3
7504274|NCT03224182|26039652|P1|Overall Study|Reason not Specified|3
7504275|NCT03224182|26039651|P2|Overall Study|Death|1
7504276|NCT03224182|26039652|P1|Overall Study|Death|0
7504277|NCT03224182|26039651|P2|Overall Study|Participant Had Recurrence|5
7504278|NCT03224182|26039652|P1|Overall Study|Participant Had Recurrence|11
7504279|NCT03224182|26039651|P2|Overall Study|Lost to Follow-up|0
7504280|NCT03224182|26039652|P1|Overall Study|Lost to Follow-up|1
7504281|NCT03224182|26039651|P2|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
7504282|NCT03224182|26039652|P1|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
7504283|NCT03224182|26039651|P2|Overall Study|Sponsor Decision|12
7504284|NCT03224182|26039652|P1|Overall Study|Sponsor Decision|26
7504285|NCT03224182|26039651|P2|Overall Study|Investigator Decision|1
7504286|NCT03224182|26039652|P1|Overall Study|Investigator Decision|3
7504287|NCT03224182|26039651|P2|Overall Study|Withdrew of Consent|2
7504288|NCT03224182|26039652|P1|Overall Study|Withdrew of Consent|4
7504289|NCT03224182|26039651|P2|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
7504290|NCT03224182|26039652|P1|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
7504291|NCT03224182|26039651|P2|Overall Study|Study Drug Not Instilled|1
7504292|NCT03224182|26039652|P1|Overall Study|Study Drug Not Instilled|6
7504293|NCT03224130|26039666|P2|Overall Study|consent issue|1
7504294|NCT03224130|26039667|P1|Overall Study|consent issue|0
7504295|NCT03223909|26039688|P3|Overall Study|Protocol Violation|16
7504296|NCT03223909|26039689|P2|Overall Study|Protocol Violation|45
7504297|NCT03223909|26039690|P1|Overall Study|Protocol Violation|48
7504298|NCT03223662|26039719|P1|Overall Study|Study closure|1
7504299|NCT03223662|26039719|P1|Overall Study|Physician Decision|1
7504300|NCT03222583|26039850|P2|Overall Study|Other|3
7504301|NCT03222583|26039851|P1|Overall Study|Other|1
7504302|NCT03222583|26039850|P2|Overall Study|Lost to Follow-up|0
7504303|NCT03222583|26039851|P1|Overall Study|Lost to Follow-up|1
7504304|NCT03222583|26039850|P2|Overall Study|Withdrawal by Subject|3
7504305|NCT03222583|26039851|P1|Overall Study|Withdrawal by Subject|3
7504306|NCT03222349|26039901|P2|Overall Study|Study terminated by sponsor|0
7504307|NCT03222349|26039902|P1|Overall Study|Study terminated by sponsor|1
7504308|NCT03222349|26039901|P2|Overall Study|Treatment A not done|5
7504309|NCT03222349|26039902|P1|Overall Study|Treatment A not done|0
7504310|NCT03222349|26039901|P2|Overall Study|Withdrawal by Subject|0
7504311|NCT03222349|26039902|P1|Overall Study|Withdrawal by Subject|1
7504312|NCT03222349|26039901|P2|Overall Study|Lost to Follow-up|2
7504313|NCT03222349|26039902|P1|Overall Study|Lost to Follow-up|1
7504314|NCT03222349|26039901|P2|Overall Study|Treatment B not done|0
7504315|NCT03222349|26039902|P1|Overall Study|Treatment B not done|5
7504316|NCT03222141|26039926|P1|Overall Study|Lost to Follow-up|3
7504317|NCT03222141|26039926|P1|Overall Study|Death|15
7504318|NCT03221387|26039986|P1|Overall Study|Lung transplant|1
7504319|NCT03221387|26039986|P1|Overall Study|Lost to Follow-up|1
7504320|NCT03220737|26040079|P7|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7504321|NCT03220737|26040080|P6|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7504322|NCT03220737|26040081|P5|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7504323|NCT03220737|26040082|P4|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7504324|NCT03220737|26040083|P3|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7504325|NCT03220737|26040084|P2|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7504326|NCT03220737|26040085|P1|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
7504327|NCT03220737|26040079|P7|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7504328|NCT03220737|26040080|P6|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7504329|NCT03220737|26040081|P5|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7504330|NCT03220737|26040082|P4|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7504331|NCT03220737|26040083|P3|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7504332|NCT03220737|26040084|P2|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7504333|NCT03220737|26040085|P1|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
7504334|NCT03220737|26040079|P7|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7504335|NCT03220737|26040080|P6|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7504336|NCT03220737|26040081|P5|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7504337|NCT03220737|26040082|P4|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7504338|NCT03220737|26040083|P3|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7504339|NCT03220737|26040084|P2|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7504340|NCT03220737|26040085|P1|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
7504341|NCT03220737|26040079|P7|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7504342|NCT03220737|26040080|P6|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7504343|NCT03220737|26040081|P5|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
7504344|NCT03220737|26040082|P4|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7504345|NCT03220737|26040083|P3|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7504346|NCT03220737|26040084|P2|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7504347|NCT03220737|26040085|P1|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7504348|NCT03220737|26040079|P7|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7504349|NCT03220737|26040080|P6|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7504350|NCT03220737|26040081|P5|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7504351|NCT03220737|26040082|P4|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7504352|NCT03220737|26040083|P3|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
7504353|NCT03220737|26040084|P2|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7504354|NCT03220737|26040085|P1|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7504355|NCT03220737|26040079|P7|Main Study (Day 1 - 181)|Protocol Violation|1
7504356|NCT03220737|26040080|P6|Main Study (Day 1 - 181)|Protocol Violation|0
7504357|NCT03220737|26040081|P5|Main Study (Day 1 - 181)|Protocol Violation|3
7504358|NCT03220737|26040082|P4|Main Study (Day 1 - 181)|Protocol Violation|1
7504359|NCT03220737|26040083|P3|Main Study (Day 1 - 181)|Protocol Violation|1
7504360|NCT03220737|26040084|P2|Main Study (Day 1 - 181)|Protocol Violation|0
7504361|NCT03220737|26040085|P1|Main Study (Day 1 - 181)|Protocol Violation|0
7504362|NCT03220737|26040079|P7|Main Study (Day 1 - 181)|Lost to Follow-up|0
7504363|NCT03220737|26040080|P6|Main Study (Day 1 - 181)|Lost to Follow-up|1
7504364|NCT03220737|26040081|P5|Main Study (Day 1 - 181)|Lost to Follow-up|13
7504365|NCT03220737|26040082|P4|Main Study (Day 1 - 181)|Lost to Follow-up|1
7504366|NCT03220737|26040083|P3|Main Study (Day 1 - 181)|Lost to Follow-up|6
7504367|NCT03220737|26040084|P2|Main Study (Day 1 - 181)|Lost to Follow-up|1
7504368|NCT03220737|26040085|P1|Main Study (Day 1 - 181)|Lost to Follow-up|2
7504369|NCT03220737|26040079|P7|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7504370|NCT03220737|26040080|P6|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7504371|NCT03220737|26040081|P5|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7504372|NCT03220737|26040082|P4|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7504373|NCT03220737|26040083|P3|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7504374|NCT03220737|26040084|P2|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7504375|NCT03220737|26040085|P1|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7504376|NCT03220581|26040126|P2|Overall Study|Lost to Follow-up|6
7504377|NCT03220581|26040127|P1|Overall Study|Lost to Follow-up|3
7504378|NCT03220581|26040126|P2|Overall Study|Withdrawal by Subject|1
7504379|NCT03220581|26040127|P1|Overall Study|Withdrawal by Subject|0
7504380|NCT03220217|26040164|P3|Overall Study|Subject Missed Procedure|1
7504381|NCT03220217|26040165|P2|Overall Study|Subject Missed Procedure|0
7504382|NCT03220217|26040166|P1|Overall Study|Subject Missed Procedure|0
7504383|NCT03220217|26040164|P3|Overall Study|Withdrawal by Subject|0
7504384|NCT03220217|26040165|P2|Overall Study|Withdrawal by Subject|1
7504385|NCT03220217|26040166|P1|Overall Study|Withdrawal by Subject|0
7504386|NCT03219723|26040376|P1|Overall Study|Protocol Deviation|4
7504387|NCT03219723|26040376|P1|Overall Study|Case Report Forms Uncollected|6
7504388|NCT03219372|26040383|P2|Overall Study|Withdrawal by Subject|0
7504389|NCT03219372|26040384|P1|Overall Study|Withdrawal by Subject|1
7504390|NCT03219216|26040442|P2|Overall Study|Lost to Follow-up|1
7504391|NCT03219216|26040443|P1|Overall Study|Lost to Follow-up|0
7504392|NCT03218397|26040489|P2|Overall Study|Randomized during laboratory off hours|1
7504393|NCT03218397|26040490|P1|Overall Study|Randomized during laboratory off hours|2
7504394|NCT03218397|26040489|P2|Overall Study|No gram-negative bacilli (GNB)|2
7504395|NCT03218397|26040490|P1|Overall Study|No gram-negative bacilli (GNB)|0
7504396|NCT03218397|26040489|P2|Overall Study|Inaccessible hospital records|5
7504397|NCT03218397|26040490|P1|Overall Study|Inaccessible hospital records|2
7504398|NCT03218397|26040489|P2|Overall Study|Mixed culture|2
7504399|NCT03218397|26040490|P1|Overall Study|Mixed culture|2
7504400|NCT03218397|26040489|P2|Overall Study|Comfort care and mixed culture|1
7504401|NCT03218397|26040490|P1|Overall Study|Comfort care and mixed culture|0
7504402|NCT03218397|26040489|P2|Overall Study|Comfort care and positive blood culture|0
7504403|NCT03218397|26040490|P1|Overall Study|Comfort care and positive blood culture|1
7504404|NCT03218397|26040489|P2|Overall Study|Comfort care|5
7504405|NCT03218397|26040490|P1|Overall Study|Comfort care|8
7504406|NCT03218397|26040489|P2|Overall Study|Prior positive blood culture|13
7504407|NCT03218397|26040490|P1|Overall Study|Prior positive blood culture|8
7504408|NCT03217968|26040522|P1|Overall Study|Protocol Violation|6
7504409|NCT03217968|26040522|P1|Overall Study|Lost to Follow-up|1
7504410|NCT03217968|26040522|P1|Overall Study|Withdrawal by Subject|4
7504411|NCT03217175|26040531|P2|Overall Study|Physician Decision|1
7504412|NCT03217175|26040532|P1|Overall Study|Physician Decision|4
7504413|NCT03216954|26040546|P5|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7504414|NCT03216954|26040547|P4|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7504415|NCT03216954|26040548|P3|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7504416|NCT03216954|26040549|P2|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
7504417|NCT03216954|26040550|P1|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7504418|NCT03216954|26040546|P5|Overall Study|Withdrawal by Subject|0
7504419|NCT03216954|26040547|P4|Overall Study|Withdrawal by Subject|0
7504420|NCT03216954|26040548|P3|Overall Study|Withdrawal by Subject|0
7504421|NCT03216954|26040549|P2|Overall Study|Withdrawal by Subject|0
7504422|NCT03216954|26040550|P1|Overall Study|Withdrawal by Subject|2
7504423|NCT03216954|26040546|P5|Overall Study|Adverse Event|1
7504424|NCT03216954|26040547|P4|Overall Study|Adverse Event|0
7504425|NCT03216954|26040548|P3|Overall Study|Adverse Event|1
7504426|NCT03216954|26040549|P2|Overall Study|Adverse Event|0
7504427|NCT03216954|26040550|P1|Overall Study|Adverse Event|0
7504428|NCT03216850|26040639|P1|Overall Study|Pre-analytical error|6
7504429|NCT03216746|26040647|P4|Overall Study|Lost to Follow-up|6
7504430|NCT03216746|26040648|P3|Overall Study|Lost to Follow-up|5
7504431|NCT03216746|26040649|P2|Overall Study|Lost to Follow-up|8
7504432|NCT03216746|26040650|P1|Overall Study|Lost to Follow-up|6
7504433|NCT03216265|26040720|P3|Overall Study|Withdrawal by Subject|1
7504434|NCT03216265|26040721|P2|Overall Study|Withdrawal by Subject|0
7504435|NCT03216265|26040722|P1|Overall Study|Withdrawal by Subject|0
7504436|NCT03216265|26040720|P3|Overall Study|Lost to Follow-up|0
7504437|NCT03216265|26040721|P2|Overall Study|Lost to Follow-up|1
7504438|NCT03216265|26040722|P1|Overall Study|Lost to Follow-up|0
7504439|NCT03216265|26040720|P3|Overall Study|Adverse Event|2
7504440|NCT03216265|26040721|P2|Overall Study|Adverse Event|0
7504441|NCT03216265|26040722|P1|Overall Study|Adverse Event|2
7504442|NCT03216226|26040774|P2|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
7504443|NCT03216226|26040775|P1|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
7504444|NCT03216226|26040774|P2|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
7504445|NCT03216226|26040775|P1|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
7504446|NCT03216226|26040774|P2|Overall Study|Patient unable to take time off work to come in for the third injection|0
7504447|NCT03216226|26040775|P1|Overall Study|Patient unable to take time off work to come in for the third injection|1
7504448|NCT03216226|26040774|P2|Overall Study|Protocol Violation|3
7504449|NCT03216226|26040775|P1|Overall Study|Protocol Violation|1
7504450|NCT03216226|26040774|P2|Overall Study|Adverse Event|0
7504451|NCT03216226|26040775|P1|Overall Study|Adverse Event|3
7504452|NCT03215771|26040852|P1|Overall Study|Physician Decision|1
7504453|NCT03215771|26040852|P1|Overall Study|Withdrawal by Subject|2
7504454|NCT03215758|26040862|P2|Overall Study|Subject/Guardian Decision|3
7504455|NCT03215758|26040863|P1|Overall Study|Subject/Guardian Decision|3
7504456|NCT03215758|26040862|P2|Overall Study|Adverse Event|2
7504457|NCT03215758|26040863|P1|Overall Study|Adverse Event|1
7504458|NCT03215758|26040862|P2|Overall Study|Death|1
7504459|NCT03215758|26040863|P1|Overall Study|Death|0
7504460|NCT03215758|26040862|P2|Overall Study|Physician Decision|1
7504461|NCT03215758|26040863|P1|Overall Study|Physician Decision|0
7504462|NCT03215758|26040862|P2|Overall Study|Protocol deviation|1
7504463|NCT03215758|26040863|P1|Overall Study|Protocol deviation|0
7504464|NCT03215758|26040862|P2|Overall Study|Technical Problems|0
7504465|NCT03215758|26040863|P1|Overall Study|Technical Problems|1
7504466|NCT03215706|26040877|P2|Treatment Period|Ongoing in the treatment period|43
7504467|NCT03215706|26040878|P1|Treatment Period|Ongoing in the treatment period|105
7504468|NCT03215706|26040877|P2|Treatment Period|Other Reasons|5
7504469|NCT03215706|26040878|P1|Treatment Period|Other Reasons|4
7504470|NCT03215706|26040877|P2|Treatment Period|Lost to Follow-up|1
7504471|NCT03215706|26040878|P1|Treatment Period|Lost to Follow-up|0
7504472|NCT03215706|26040877|P2|Treatment Period|Participant withdrew consent|4
7504473|NCT03215706|26040878|P1|Treatment Period|Participant withdrew consent|3
7504474|NCT03215706|26040877|P2|Treatment Period|Request to D/C treatment|6
7504475|NCT03215706|26040878|P1|Treatment Period|Request to D/C treatment|1
7504476|NCT03215706|26040877|P2|Treatment Period|Adverse event unrelated to study drug|23
7504477|NCT03215706|26040878|P1|Treatment Period|Adverse event unrelated to study drug|24
7504478|NCT03215706|26040877|P2|Treatment Period|Death|1
7504479|NCT03215706|26040878|P1|Treatment Period|Death|2
7504480|NCT03215706|26040877|P2|Treatment Period|Study Drug Toxicity|21
7504481|NCT03215706|26040878|P1|Treatment Period|Study Drug Toxicity|53
7504482|NCT03215706|26040877|P2|Treatment Period|Disease Progression|142
7504483|NCT03215706|26040878|P1|Treatment Period|Disease Progression|150
7504484|NCT03215706|26040877|P2|Randomization|other reasons|2
7504485|NCT03215706|26040878|P1|Randomization|other reasons|0
7504486|NCT03215706|26040877|P2|Randomization|no longer meets study criteria|4
7504487|NCT03215706|26040878|P1|Randomization|no longer meets study criteria|1
7504488|NCT03215706|26040877|P2|Randomization|participant withdrew consent|3
7504489|NCT03215706|26040878|P1|Randomization|participant withdrew consent|1
7504490|NCT03215706|26040877|P2|Randomization|Adverse Event unrelated to study drug|0
7504491|NCT03215706|26040878|P1|Randomization|Adverse Event unrelated to study drug|1
7504492|NCT03215667|26040898|P1|Overall Study|Physician Decision|4
7504493|NCT03214952|26040903|P1|Overall Study|Case Report Forms Uncollected|13
7504494|NCT03214952|26040903|P1|Overall Study|Protocol Deviation|45
7504495|NCT03214640|26040919|P4|Overall Study|Protocol Violation|4
7504496|NCT03214640|26040920|P3|Overall Study|Protocol Violation|1
7504497|NCT03214640|26040921|P2|Overall Study|Protocol Violation|2
7504498|NCT03214640|26040922|P1|Overall Study|Protocol Violation|1
7504499|NCT03214588|26040943|P3|Overall Study|Reason Not Specified|0
7504500|NCT03214588|26040944|P2|Overall Study|Reason Not Specified|1
7504501|NCT03214588|26040945|P1|Overall Study|Reason Not Specified|0
7504502|NCT03214588|26040943|P3|Overall Study|Adverse Event|2
7504503|NCT03214588|26040944|P2|Overall Study|Adverse Event|0
7504504|NCT03214588|26040945|P1|Overall Study|Adverse Event|1
7504505|NCT03214406|26041012|P2|Overall Study|Lost to Follow-up|2
7504506|NCT03214406|26041013|P1|Overall Study|Lost to Follow-up|0
7504507|NCT03214406|26041012|P2|Overall Study|Withdrawal by Subject|0
7504508|NCT03214406|26041013|P1|Overall Study|Withdrawal by Subject|1
7504509|NCT03214406|26041012|P2|Overall Study|did not meet enrollment criteria|13
7504510|NCT03214406|26041013|P1|Overall Study|did not meet enrollment criteria|9
7504511|NCT03214380|26041027|P6|Treatment Period|Treatment Interruption|0
7504512|NCT03214380|26041028|P5|Treatment Period|Treatment Interruption|0
7504513|NCT03214380|26041029|P4|Treatment Period|Treatment Interruption|0
7504514|NCT03214380|26041030|P3|Treatment Period|Treatment Interruption|1
7504515|NCT03214380|26041031|P2|Treatment Period|Treatment Interruption|0
7504516|NCT03214380|26041032|P1|Treatment Period|Treatment Interruption|0
7504517|NCT03214380|26041027|P6|Treatment Period|Participant schedule|0
7504518|NCT03214380|26041028|P5|Treatment Period|Participant schedule|0
7504519|NCT03214380|26041029|P4|Treatment Period|Participant schedule|0
7504520|NCT03214380|26041030|P3|Treatment Period|Participant schedule|1
7504521|NCT03214380|26041031|P2|Treatment Period|Participant schedule|0
7504522|NCT03214380|26041032|P1|Treatment Period|Participant schedule|0
7504523|NCT03214380|26041027|P6|Treatment Period|Lost to Follow-up|0
7504524|NCT03214380|26041028|P5|Treatment Period|Lost to Follow-up|0
7504525|NCT03214380|26041029|P4|Treatment Period|Lost to Follow-up|0
7504526|NCT03214380|26041030|P3|Treatment Period|Lost to Follow-up|3
7504527|NCT03214380|26041031|P2|Treatment Period|Lost to Follow-up|6
7504528|NCT03214380|26041032|P1|Treatment Period|Lost to Follow-up|0
7504529|NCT03214380|26041027|P6|Treatment Period|Death|0
7504530|NCT03214380|26041028|P5|Treatment Period|Death|0
7504531|NCT03214380|26041029|P4|Treatment Period|Death|0
7504532|NCT03214380|26041030|P3|Treatment Period|Death|2
7504533|NCT03214380|26041031|P2|Treatment Period|Death|1
7504534|NCT03214380|26041032|P1|Treatment Period|Death|0
7504535|NCT03214380|26041027|P6|Treatment Period|Withdrawal by Subject|11
7504536|NCT03214380|26041028|P5|Treatment Period|Withdrawal by Subject|7
7504537|NCT03214380|26041029|P4|Treatment Period|Withdrawal by Subject|0
7504538|NCT03214380|26041030|P3|Treatment Period|Withdrawal by Subject|8
7504539|NCT03214380|26041031|P2|Treatment Period|Withdrawal by Subject|10
7504540|NCT03214380|26041032|P1|Treatment Period|Withdrawal by Subject|0
7504541|NCT03214380|26041027|P6|Treatment Period|Non-Compliance with Study Drug|0
7504542|NCT03214380|26041028|P5|Treatment Period|Non-Compliance with Study Drug|1
7504543|NCT03214380|26041029|P4|Treatment Period|Non-Compliance with Study Drug|0
7504544|NCT03214380|26041030|P3|Treatment Period|Non-Compliance with Study Drug|0
7504545|NCT03214380|26041031|P2|Treatment Period|Non-Compliance with Study Drug|0
7504546|NCT03214380|26041032|P1|Treatment Period|Non-Compliance with Study Drug|0
7504547|NCT03214380|26041027|P6|Treatment Period|Adverse Event|0
7504548|NCT03214380|26041028|P5|Treatment Period|Adverse Event|1
7504549|NCT03214380|26041029|P4|Treatment Period|Adverse Event|0
7504550|NCT03214380|26041030|P3|Treatment Period|Adverse Event|1
7504551|NCT03214380|26041031|P2|Treatment Period|Adverse Event|1
7504552|NCT03214380|26041032|P1|Treatment Period|Adverse Event|0
7504553|NCT03214380|26041027|P6|Lead-in|Participant Schedule|0
7504554|NCT03214380|26041028|P5|Lead-in|Participant Schedule|0
7504555|NCT03214380|26041029|P4|Lead-in|Participant Schedule|0
7504556|NCT03214380|26041030|P3|Lead-in|Participant Schedule|0
7504557|NCT03214380|26041031|P2|Lead-in|Participant Schedule|0
7504558|NCT03214380|26041032|P1|Lead-in|Participant Schedule|2
7504559|NCT03214380|26041027|P6|Lead-in|Non Compliance|0
7504560|NCT03214380|26041028|P5|Lead-in|Non Compliance|0
7504561|NCT03214380|26041029|P4|Lead-in|Non Compliance|0
7504562|NCT03214380|26041030|P3|Lead-in|Non Compliance|0
7504563|NCT03214380|26041031|P2|Lead-in|Non Compliance|0
7504564|NCT03214380|26041032|P1|Lead-in|Non Compliance|1
7504565|NCT03214380|26041027|P6|Lead-in|Natural Disaster|0
7504566|NCT03214380|26041028|P5|Lead-in|Natural Disaster|0
7504567|NCT03214380|26041029|P4|Lead-in|Natural Disaster|0
7504568|NCT03214380|26041030|P3|Lead-in|Natural Disaster|0
7504569|NCT03214380|26041031|P2|Lead-in|Natural Disaster|0
7504570|NCT03214380|26041032|P1|Lead-in|Natural Disaster|9
7504571|NCT03214380|26041027|P6|Lead-in|Family Emergency|0
7504572|NCT03214380|26041028|P5|Lead-in|Family Emergency|0
7504573|NCT03214380|26041029|P4|Lead-in|Family Emergency|0
7504574|NCT03214380|26041030|P3|Lead-in|Family Emergency|0
7504575|NCT03214380|26041031|P2|Lead-in|Family Emergency|0
7504576|NCT03214380|26041032|P1|Lead-in|Family Emergency|1
7504577|NCT03214380|26041027|P6|Lead-in|Withdrawal by Subject|0
7504578|NCT03214380|26041028|P5|Lead-in|Withdrawal by Subject|0
7504579|NCT03214380|26041029|P4|Lead-in|Withdrawal by Subject|14
7504580|NCT03214380|26041030|P3|Lead-in|Withdrawal by Subject|0
7504581|NCT03214380|26041031|P2|Lead-in|Withdrawal by Subject|0
7504582|NCT03214380|26041032|P1|Lead-in|Withdrawal by Subject|41
7504583|NCT03214380|26041027|P6|Lead-in|Protocol Deviation|0
7504584|NCT03214380|26041028|P5|Lead-in|Protocol Deviation|0
7504585|NCT03214380|26041029|P4|Lead-in|Protocol Deviation|3
7504586|NCT03214380|26041030|P3|Lead-in|Protocol Deviation|0
7504587|NCT03214380|26041031|P2|Lead-in|Protocol Deviation|0
7504588|NCT03214380|26041032|P1|Lead-in|Protocol Deviation|7
7504589|NCT03214380|26041027|P6|Lead-in|Physician Decision|0
7504590|NCT03214380|26041028|P5|Lead-in|Physician Decision|0
7504591|NCT03214380|26041029|P4|Lead-in|Physician Decision|0
7504592|NCT03214380|26041030|P3|Lead-in|Physician Decision|0
7504593|NCT03214380|26041031|P2|Lead-in|Physician Decision|0
7504594|NCT03214380|26041032|P1|Lead-in|Physician Decision|6
7504595|NCT03214380|26041027|P6|Lead-in|Eligibility Criteria|0
7504596|NCT03214380|26041028|P5|Lead-in|Eligibility Criteria|0
7504597|NCT03214380|26041029|P4|Lead-in|Eligibility Criteria|0
7504598|NCT03214380|26041030|P3|Lead-in|Eligibility Criteria|0
7504599|NCT03214380|26041031|P2|Lead-in|Eligibility Criteria|0
7504600|NCT03214380|26041032|P1|Lead-in|Eligibility Criteria|3
7504601|NCT03214380|26041027|P6|Lead-in|Lost to Follow-up|0
7504602|NCT03214380|26041028|P5|Lead-in|Lost to Follow-up|0
7504603|NCT03214380|26041029|P4|Lead-in|Lost to Follow-up|1
7504604|NCT03214380|26041030|P3|Lead-in|Lost to Follow-up|0
7504605|NCT03214380|26041031|P2|Lead-in|Lost to Follow-up|0
7504606|NCT03214380|26041032|P1|Lead-in|Lost to Follow-up|4
7504607|NCT03214380|26041027|P6|Lead-in|Adverse Event|0
7504608|NCT03214380|26041028|P5|Lead-in|Adverse Event|0
7504609|NCT03214380|26041029|P4|Lead-in|Adverse Event|1
7504610|NCT03214380|26041030|P3|Lead-in|Adverse Event|0
7504611|NCT03214380|26041031|P2|Lead-in|Adverse Event|0
7504612|NCT03214380|26041032|P1|Lead-in|Adverse Event|3
7504613|NCT03214367|26041068|P8|Treatment Period|Withdrawal by Subject|1
7504614|NCT03214367|26041069|P7|Treatment Period|Withdrawal by Subject|1
7504615|NCT03214367|26041070|P6|Treatment Period|Withdrawal by Subject|1
7504616|NCT03214367|26041071|P5|Treatment Period|Withdrawal by Subject|0
7504617|NCT03214367|26041072|P4|Treatment Period|Withdrawal by Subject|14
7504618|NCT03214367|26041073|P3|Treatment Period|Withdrawal by Subject|23
7504619|NCT03214367|26041074|P2|Treatment Period|Withdrawal by Subject|20
7504620|NCT03214367|26041075|P1|Treatment Period|Withdrawal by Subject|0
7504621|NCT03214367|26041068|P8|Treatment Period|Protocol Violation|0
7504622|NCT03214367|26041069|P7|Treatment Period|Protocol Violation|0
7504623|NCT03214367|26041070|P6|Treatment Period|Protocol Violation|0
7504624|NCT03214367|26041071|P5|Treatment Period|Protocol Violation|0
7504625|NCT03214367|26041072|P4|Treatment Period|Protocol Violation|0
7504626|NCT03214367|26041073|P3|Treatment Period|Protocol Violation|0
7504627|NCT03214367|26041074|P2|Treatment Period|Protocol Violation|3
7504628|NCT03214367|26041075|P1|Treatment Period|Protocol Violation|0
7504629|NCT03214367|26041068|P8|Treatment Period|Physician Decision|0
7504630|NCT03214367|26041069|P7|Treatment Period|Physician Decision|0
7504631|NCT03214367|26041070|P6|Treatment Period|Physician Decision|0
7504632|NCT03214367|26041071|P5|Treatment Period|Physician Decision|0
7504633|NCT03214367|26041072|P4|Treatment Period|Physician Decision|0
7504634|NCT03214367|26041073|P3|Treatment Period|Physician Decision|2
7504635|NCT03214367|26041074|P2|Treatment Period|Physician Decision|1
7504636|NCT03214367|26041075|P1|Treatment Period|Physician Decision|0
7504637|NCT03214367|26041068|P8|Treatment Period|Sponsor Decision|0
7504638|NCT03214367|26041069|P7|Treatment Period|Sponsor Decision|0
7504639|NCT03214367|26041070|P6|Treatment Period|Sponsor Decision|0
7504640|NCT03214367|26041071|P5|Treatment Period|Sponsor Decision|0
7504641|NCT03214367|26041072|P4|Treatment Period|Sponsor Decision|0
7504642|NCT03214367|26041073|P3|Treatment Period|Sponsor Decision|0
7504643|NCT03214367|26041074|P2|Treatment Period|Sponsor Decision|3
7504644|NCT03214367|26041075|P1|Treatment Period|Sponsor Decision|0
7504645|NCT03214367|26041068|P8|Treatment Period|Lost to Follow-up|0
7504646|NCT03214367|26041069|P7|Treatment Period|Lost to Follow-up|1
7504647|NCT03214367|26041070|P6|Treatment Period|Lost to Follow-up|2
7504648|NCT03214367|26041071|P5|Treatment Period|Lost to Follow-up|0
7504649|NCT03214367|26041072|P4|Treatment Period|Lost to Follow-up|2
7504650|NCT03214367|26041073|P3|Treatment Period|Lost to Follow-up|3
7504651|NCT03214367|26041074|P2|Treatment Period|Lost to Follow-up|5
7504652|NCT03214367|26041075|P1|Treatment Period|Lost to Follow-up|0
7504653|NCT03214367|26041068|P8|Treatment Period|Death|0
7504654|NCT03214367|26041069|P7|Treatment Period|Death|0
7504655|NCT03214367|26041070|P6|Treatment Period|Death|0
7504656|NCT03214367|26041071|P5|Treatment Period|Death|0
7504657|NCT03214367|26041072|P4|Treatment Period|Death|1
7504658|NCT03214367|26041073|P3|Treatment Period|Death|1
7504659|NCT03214367|26041074|P2|Treatment Period|Death|1
7504660|NCT03214367|26041075|P1|Treatment Period|Death|0
7504661|NCT03214367|26041068|P8|Treatment Period|Adverse Event|0
7504662|NCT03214367|26041069|P7|Treatment Period|Adverse Event|0
7504663|NCT03214367|26041070|P6|Treatment Period|Adverse Event|0
7504664|NCT03214367|26041071|P5|Treatment Period|Adverse Event|0
7504665|NCT03214367|26041072|P4|Treatment Period|Adverse Event|2
7504666|NCT03214367|26041073|P3|Treatment Period|Adverse Event|4
7504667|NCT03214367|26041074|P2|Treatment Period|Adverse Event|1
7504668|NCT03214367|26041075|P1|Treatment Period|Adverse Event|0
7504669|NCT03214367|26041068|P8|Lead-in Period|Treatment Interruption|0
7504670|NCT03214367|26041069|P7|Lead-in Period|Treatment Interruption|0
7504671|NCT03214367|26041070|P6|Lead-in Period|Treatment Interruption|0
7504672|NCT03214367|26041071|P5|Lead-in Period|Treatment Interruption|0
7504673|NCT03214367|26041072|P4|Lead-in Period|Treatment Interruption|0
7504674|NCT03214367|26041073|P3|Lead-in Period|Treatment Interruption|0
7504675|NCT03214367|26041074|P2|Lead-in Period|Treatment Interruption|0
7504676|NCT03214367|26041075|P1|Lead-in Period|Treatment Interruption|1
7504677|NCT03214367|26041068|P8|Lead-in Period|Protocol Violation|0
7504678|NCT03214367|26041069|P7|Lead-in Period|Protocol Violation|0
7504679|NCT03214367|26041070|P6|Lead-in Period|Protocol Violation|0
7504680|NCT03214367|26041071|P5|Lead-in Period|Protocol Violation|0
7504681|NCT03214367|26041072|P4|Lead-in Period|Protocol Violation|0
7504682|NCT03214367|26041073|P3|Lead-in Period|Protocol Violation|0
7504683|NCT03214367|26041074|P2|Lead-in Period|Protocol Violation|0
7504684|NCT03214367|26041075|P1|Lead-in Period|Protocol Violation|5
7504685|NCT03214367|26041068|P8|Lead-in Period|Physician Decision|0
7504686|NCT03214367|26041069|P7|Lead-in Period|Physician Decision|0
7504687|NCT03214367|26041070|P6|Lead-in Period|Physician Decision|0
7504688|NCT03214367|26041071|P5|Lead-in Period|Physician Decision|0
7504689|NCT03214367|26041072|P4|Lead-in Period|Physician Decision|0
7504690|NCT03214367|26041073|P3|Lead-in Period|Physician Decision|0
7504691|NCT03214367|26041074|P2|Lead-in Period|Physician Decision|0
7504692|NCT03214367|26041075|P1|Lead-in Period|Physician Decision|12
7504693|NCT03214367|26041068|P8|Lead-in Period|Sponsor Decision|0
7504694|NCT03214367|26041069|P7|Lead-in Period|Sponsor Decision|0
7504695|NCT03214367|26041070|P6|Lead-in Period|Sponsor Decision|0
7504696|NCT03214367|26041071|P5|Lead-in Period|Sponsor Decision|0
7504697|NCT03214367|26041072|P4|Lead-in Period|Sponsor Decision|0
7504698|NCT03214367|26041073|P3|Lead-in Period|Sponsor Decision|0
7504699|NCT03214367|26041074|P2|Lead-in Period|Sponsor Decision|0
7504700|NCT03214367|26041075|P1|Lead-in Period|Sponsor Decision|11
7504701|NCT03214367|26041068|P8|Lead-in Period|Lost to Follow-up|0
7504702|NCT03214367|26041069|P7|Lead-in Period|Lost to Follow-up|0
7504703|NCT03214367|26041070|P6|Lead-in Period|Lost to Follow-up|0
7504704|NCT03214367|26041071|P5|Lead-in Period|Lost to Follow-up|0
7504705|NCT03214367|26041072|P4|Lead-in Period|Lost to Follow-up|0
7504706|NCT03214367|26041073|P3|Lead-in Period|Lost to Follow-up|0
7504707|NCT03214367|26041074|P2|Lead-in Period|Lost to Follow-up|0
7504708|NCT03214367|26041075|P1|Lead-in Period|Lost to Follow-up|12
7504709|NCT03214367|26041068|P8|Lead-in Period|Adverse Event|0
7504710|NCT03214367|26041069|P7|Lead-in Period|Adverse Event|0
7504711|NCT03214367|26041070|P6|Lead-in Period|Adverse Event|0
7504712|NCT03214367|26041071|P5|Lead-in Period|Adverse Event|0
7504713|NCT03214367|26041072|P4|Lead-in Period|Adverse Event|0
7504714|NCT03214367|26041073|P3|Lead-in Period|Adverse Event|0
7504715|NCT03214367|26041074|P2|Lead-in Period|Adverse Event|0
7504716|NCT03214367|26041075|P1|Lead-in Period|Adverse Event|3
7504717|NCT03214367|26041068|P8|Lead-in Period|Withdrawal by Subject|0
7504718|NCT03214367|26041069|P7|Lead-in Period|Withdrawal by Subject|0
7504719|NCT03214367|26041070|P6|Lead-in Period|Withdrawal by Subject|0
7504720|NCT03214367|26041071|P5|Lead-in Period|Withdrawal by Subject|2
7504721|NCT03214367|26041072|P4|Lead-in Period|Withdrawal by Subject|0
7504722|NCT03214367|26041073|P3|Lead-in Period|Withdrawal by Subject|0
7504723|NCT03214367|26041074|P2|Lead-in Period|Withdrawal by Subject|0
7504724|NCT03214367|26041075|P1|Lead-in Period|Withdrawal by Subject|50
7504725|NCT03214224|26041120|P1|Overall Study|Practice controls or therapists|6
7504726|NCT03214224|26041120|P1|Overall Study|Withdrawal by Subject|2
7504727|NCT03214224|26041120|P1|Overall Study|Protocol Violation|1
7504728|NCT03214198|26041129|P1|Overall Study|Protocol Deviation|18
7504729|NCT03214198|26041129|P1|Overall Study|Case Report Forms Uncollected|18
7504730|NCT03214094|26041137|P1|Overall Study|Protocol Deviation|46
7504731|NCT03214094|26041137|P1|Overall Study|Case Report Forms Uncollected|14
7504732|NCT03214081|26041145|P1|Overall Study|Protocol Deviation|54
7504733|NCT03214081|26041145|P1|Overall Study|Case Report Forms Uncollected|9
7504734|NCT03213938|26041162|P2|Overall Study|Without reason|5
7504735|NCT03213938|26041163|P1|Overall Study|Without reason|4
7504736|NCT03213938|26041162|P2|Overall Study|Decline to participate|4
7504737|NCT03213938|26041163|P1|Overall Study|Decline to participate|5
7504738|NCT03213938|26041162|P2|Overall Study|Lack of Efficacy|0
7504739|NCT03213938|26041163|P1|Overall Study|Lack of Efficacy|1
7504740|NCT03213938|26041162|P2|Overall Study|Lost to Follow-up|3
7504741|NCT03213938|26041163|P1|Overall Study|Lost to Follow-up|4
7504742|NCT03213626|26041191|P1|Overall Study|Progressive Disease|6
7504743|NCT03213626|26041191|P1|Overall Study|Adverse Event|1
7504744|NCT03213509|26041201|P2|Overall Study|Did not consent for verbal autopsy|5
7504745|NCT03213509|26041202|P1|Overall Study|Did not consent for verbal autopsy|4
7504746|NCT03213457|26041216|P3|Overall Study|Other, Not Specified|26
7504747|NCT03213457|26041217|P2|Overall Study|Other, Not Specified|3
7504748|NCT03213457|26041218|P1|Overall Study|Other, Not Specified|11
7504749|NCT03213457|26041216|P3|Overall Study|Lack of Efficacy|9
7504750|NCT03213457|26041217|P2|Overall Study|Lack of Efficacy|2
7504751|NCT03213457|26041218|P1|Overall Study|Lack of Efficacy|12
7504752|NCT03213457|26041216|P3|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
7504753|NCT03213457|26041217|P2|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
7504754|NCT03213457|26041218|P1|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
7504755|NCT03213457|26041216|P3|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
7504756|NCT03213457|26041217|P2|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
7504757|NCT03213457|26041218|P1|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
7504758|NCT03213457|26041216|P3|Overall Study|Protocol Violation|6
7504759|NCT03213457|26041217|P2|Overall Study|Protocol Violation|1
7504760|NCT03213457|26041218|P1|Overall Study|Protocol Violation|1
7504761|NCT03213457|26041216|P3|Overall Study|Pregnancy|7
7504762|NCT03213457|26041217|P2|Overall Study|Pregnancy|0
7504763|NCT03213457|26041218|P1|Overall Study|Pregnancy|11
7504764|NCT03213457|26041216|P3|Overall Study|Lost to Follow-up|33
7504765|NCT03213457|26041217|P2|Overall Study|Lost to Follow-up|12
7504766|NCT03213457|26041218|P1|Overall Study|Lost to Follow-up|12
7504767|NCT03213457|26041216|P3|Overall Study|Withdrawal by Subject|35
7504768|NCT03213457|26041217|P2|Overall Study|Withdrawal by Subject|7
7504769|NCT03213457|26041218|P1|Overall Study|Withdrawal by Subject|18
7504770|NCT03213457|26041216|P3|Overall Study|Non-Compliance Other, Not Specified|5
7504771|NCT03213457|26041217|P2|Overall Study|Non-Compliance Other, Not Specified|1
7504772|NCT03213457|26041218|P1|Overall Study|Non-Compliance Other, Not Specified|0
7504773|NCT03213457|26041216|P3|Overall Study|Non-Compliance With Study Drug|7
7504774|NCT03213457|26041217|P2|Overall Study|Non-Compliance With Study Drug|2
7504775|NCT03213457|26041218|P1|Overall Study|Non-Compliance With Study Drug|1
7504776|NCT03213457|26041216|P3|Overall Study|Adverse Event|41
7504777|NCT03213457|26041217|P2|Overall Study|Adverse Event|9
7504778|NCT03213457|26041218|P1|Overall Study|Adverse Event|16
7504779|NCT03213457|26041216|P3|Overall Study|Not Treated|0
7504780|NCT03213457|26041217|P2|Overall Study|Not Treated|1
7504781|NCT03213457|26041218|P1|Overall Study|Not Treated|1
7504782|NCT03213366|26041274|P2|Overall Study|Lost to Follow-up|4
7504783|NCT03213366|26041275|P1|Overall Study|Lost to Follow-up|9
7504784|NCT03213210|26041301|P1|Overall Study|Study termination|3
7504785|NCT03213210|26041301|P1|Overall Study|Lost to Follow-up|2
7504786|NCT03212690|26041309|P1|Overall Study|Protocol Violation|1
7504787|NCT03212521|26041357|P1|Overall Study|Other|1
7504788|NCT03212521|26041357|P1|Overall Study|Withdrawal by Subject|1
7504789|NCT03212521|26041357|P1|Overall Study|Lost to Follow-up|4
7504790|NCT03212521|26041357|P1|Overall Study|Adverse Event|1
7504791|NCT03212365|26041366|P2|Overall Study|developed acute renal failure|1
7504792|NCT03212365|26041367|P1|Overall Study|developed acute renal failure|0
7504793|NCT03212365|26041366|P2|Overall Study|Withdrawal by Subject|1
7504794|NCT03212365|26041367|P1|Overall Study|Withdrawal by Subject|0
7504795|NCT03212365|26041366|P2|Overall Study|Required epidural placement|0
7504796|NCT03212365|26041367|P1|Overall Study|Required epidural placement|1
7504797|NCT03212365|26041366|P2|Overall Study|Medication distribution error|0
7504798|NCT03212365|26041367|P1|Overall Study|Medication distribution error|1
7504799|NCT03212365|26041366|P2|Overall Study|Unexpected return to OR|1
7504800|NCT03212365|26041367|P1|Overall Study|Unexpected return to OR|1
7504801|NCT03212365|26041366|P2|Overall Study|Initiated heparin infusion on floor|1
7504802|NCT03212365|26041367|P1|Overall Study|Initiated heparin infusion on floor|1
7504803|NCT03212365|26041366|P2|Overall Study|Refused study medication|0
7504804|NCT03212365|26041367|P1|Overall Study|Refused study medication|3
7504805|NCT03212365|26041366|P2|Overall Study|Bled requiring enoxaparin cessation|2
7504806|NCT03212365|26041367|P1|Overall Study|Bled requiring enoxaparin cessation|4
7504807|NCT03212365|26041366|P2|Overall Study|Discharged prior to Xa level|8
7504808|NCT03212365|26041367|P1|Overall Study|Discharged prior to Xa level|12
7504809|NCT03212326|26041379|P1|Overall Study|Physician Decision|4
7504810|NCT03212261|26041384|P1|Overall Study|Too busy/ No time|5
7504811|NCT03212261|26041384|P1|Overall Study|Family Emergency|1
7504812|NCT03212261|26041384|P1|Overall Study|Lost to Follow-up|7
7504813|NCT03212261|26041384|P1|Overall Study|Tech Trouble- No first study visit|1
7504814|NCT03212261|26041384|P1|Overall Study|Became ineligible d/t tech|2
7504815|NCT03212144|26041392|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
7504816|NCT03212144|26041393|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
7504817|NCT03212144|26041392|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
7504818|NCT03212144|26041393|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
7504819|NCT03211858|26041401|P2|Overall Study|Other than specified above|21
7504820|NCT03211858|26041402|P1|Overall Study|Other than specified above|22
7504821|NCT03211858|26041401|P2|Overall Study|Non-serious Hypoglycemia|0
7504822|NCT03211858|26041402|P1|Overall Study|Non-serious Hypoglycemia|1
7504823|NCT03211858|26041401|P2|Overall Study|Poor compliance to protocol|2
7504824|NCT03211858|26041402|P1|Overall Study|Poor compliance to protocol|6
7504825|NCT03211858|26041401|P2|Overall Study|Lack of Efficacy|4
7504826|NCT03211858|26041402|P1|Overall Study|Lack of Efficacy|0
7504827|NCT03211858|26041401|P2|Overall Study|Adverse Event|6
7504828|NCT03211858|26041402|P1|Overall Study|Adverse Event|8
7504829|NCT03211156|26041467|P2|Overall Study|Adverse Event|0
7504830|NCT03211156|26041468|P1|Overall Study|Adverse Event|1
7504831|NCT03211156|26041467|P2|Overall Study|Lost to Follow-up|1
7504832|NCT03211156|26041468|P1|Overall Study|Lost to Follow-up|1
7504833|NCT03211156|26041467|P2|Overall Study|Withdrawal by Subject|2
7504834|NCT03211156|26041468|P1|Overall Study|Withdrawal by Subject|0
7504835|NCT03210961|26041499|P15|Overall Study|Other|0
7504836|NCT03210961|26041500|P14|Overall Study|Other|2
7504837|NCT03210961|26041501|P13|Overall Study|Other|2
7504838|NCT03210961|26041502|P12|Overall Study|Other|0
7504839|NCT03210961|26041503|P11|Overall Study|Other|1
7504840|NCT03210961|26041504|P10|Overall Study|Other|0
7504841|NCT03210961|26041505|P9|Overall Study|Other|0
7504842|NCT03210961|26041506|P8|Overall Study|Other|0
7504843|NCT03210961|26041507|P7|Overall Study|Other|1
7504844|NCT03210961|26041508|P6|Overall Study|Other|0
7504845|NCT03210961|26041509|P5|Overall Study|Other|0
7504846|NCT03210961|26041510|P4|Overall Study|Other|1
7504847|NCT03210961|26041511|P3|Overall Study|Other|0
7504848|NCT03210961|26041512|P2|Overall Study|Other|0
7504849|NCT03210961|26041513|P1|Overall Study|Other|0
7504850|NCT03210961|26041499|P15|Overall Study|No Longer Meets Eligibility Criteria|0
7504851|NCT03210961|26041500|P14|Overall Study|No Longer Meets Eligibility Criteria|1
7504852|NCT03210961|26041501|P13|Overall Study|No Longer Meets Eligibility Criteria|0
7504853|NCT03210961|26041502|P12|Overall Study|No Longer Meets Eligibility Criteria|0
7504854|NCT03210961|26041503|P11|Overall Study|No Longer Meets Eligibility Criteria|0
7504855|NCT03210961|26041504|P10|Overall Study|No Longer Meets Eligibility Criteria|0
7504856|NCT03210961|26041505|P9|Overall Study|No Longer Meets Eligibility Criteria|0
7504857|NCT03210961|26041506|P8|Overall Study|No Longer Meets Eligibility Criteria|0
7504858|NCT03210961|26041507|P7|Overall Study|No Longer Meets Eligibility Criteria|0
7504859|NCT03210961|26041508|P6|Overall Study|No Longer Meets Eligibility Criteria|0
7504860|NCT03210961|26041509|P5|Overall Study|No Longer Meets Eligibility Criteria|0
7504861|NCT03210961|26041510|P4|Overall Study|No Longer Meets Eligibility Criteria|0
7504862|NCT03210961|26041511|P3|Overall Study|No Longer Meets Eligibility Criteria|0
7504863|NCT03210961|26041512|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7504864|NCT03210961|26041513|P1|Overall Study|No Longer Meets Eligibility Criteria|0
7504865|NCT03210961|26041499|P15|Overall Study|Withdrawal by Subject|1
7504866|NCT03210961|26041500|P14|Overall Study|Withdrawal by Subject|0
7504867|NCT03210961|26041501|P13|Overall Study|Withdrawal by Subject|0
7504868|NCT03210961|26041502|P12|Overall Study|Withdrawal by Subject|0
7504869|NCT03210961|26041503|P11|Overall Study|Withdrawal by Subject|0
7504870|NCT03210961|26041504|P10|Overall Study|Withdrawal by Subject|0
7504871|NCT03210961|26041505|P9|Overall Study|Withdrawal by Subject|0
7504872|NCT03210961|26041506|P8|Overall Study|Withdrawal by Subject|0
7504873|NCT03210961|26041507|P7|Overall Study|Withdrawal by Subject|0
7504874|NCT03210961|26041508|P6|Overall Study|Withdrawal by Subject|0
7504875|NCT03210961|26041509|P5|Overall Study|Withdrawal by Subject|0
7504876|NCT03210961|26041510|P4|Overall Study|Withdrawal by Subject|0
7504877|NCT03210961|26041511|P3|Overall Study|Withdrawal by Subject|0
7504878|NCT03210961|26041512|P2|Overall Study|Withdrawal by Subject|0
7504879|NCT03210961|26041513|P1|Overall Study|Withdrawal by Subject|0
7504880|NCT03210961|26041499|P15|Overall Study|Lost to Follow-up|1
7504881|NCT03210961|26041500|P14|Overall Study|Lost to Follow-up|0
7504882|NCT03210961|26041501|P13|Overall Study|Lost to Follow-up|0
7504883|NCT03210961|26041502|P12|Overall Study|Lost to Follow-up|0
7504884|NCT03210961|26041503|P11|Overall Study|Lost to Follow-up|0
7504885|NCT03210961|26041504|P10|Overall Study|Lost to Follow-up|0
7504886|NCT03210961|26041505|P9|Overall Study|Lost to Follow-up|0
7504887|NCT03210961|26041506|P8|Overall Study|Lost to Follow-up|0
7504888|NCT03210961|26041507|P7|Overall Study|Lost to Follow-up|0
7504889|NCT03210961|26041508|P6|Overall Study|Lost to Follow-up|0
7504890|NCT03210961|26041509|P5|Overall Study|Lost to Follow-up|0
7504891|NCT03210961|26041510|P4|Overall Study|Lost to Follow-up|0
7504892|NCT03210961|26041511|P3|Overall Study|Lost to Follow-up|0
7504893|NCT03210961|26041512|P2|Overall Study|Lost to Follow-up|0
7504894|NCT03210961|26041513|P1|Overall Study|Lost to Follow-up|0
7504895|NCT03210961|26041499|P15|Overall Study|Adverse Event|0
7504896|NCT03210961|26041500|P14|Overall Study|Adverse Event|1
7504897|NCT03210961|26041501|P13|Overall Study|Adverse Event|0
7504898|NCT03210961|26041502|P12|Overall Study|Adverse Event|0
7504899|NCT03210961|26041503|P11|Overall Study|Adverse Event|0
7504900|NCT03210961|26041504|P10|Overall Study|Adverse Event|0
7504901|NCT03210961|26041505|P9|Overall Study|Adverse Event|0
7504902|NCT03210961|26041506|P8|Overall Study|Adverse Event|0
7504903|NCT03210961|26041507|P7|Overall Study|Adverse Event|0
7504904|NCT03210961|26041508|P6|Overall Study|Adverse Event|0
7504905|NCT03210961|26041509|P5|Overall Study|Adverse Event|0
7504906|NCT03210961|26041510|P4|Overall Study|Adverse Event|0
7504907|NCT03210961|26041511|P3|Overall Study|Adverse Event|0
7504908|NCT03210961|26041512|P2|Overall Study|Adverse Event|0
7504909|NCT03210961|26041513|P1|Overall Study|Adverse Event|0
7504910|NCT03210519|26041872|P2|Overall Study|Adverse Event|0
7504911|NCT03210519|26041873|P1|Overall Study|Adverse Event|2
7504912|NCT03210259|26041929|P3|48-Week Randomized Responder Period|Adverse Event|1
7504913|NCT03210259|26041930|P2|48-Week Randomized Responder Period|Adverse Event|1
7504914|NCT03210259|26041931|P1|48-Week Randomized Responder Period|Adverse Event|0
7504915|NCT03210259|26041929|P3|48-Week Randomized Responder Period|Withdrawal by Subject|17
7504916|NCT03210259|26041930|P2|48-Week Randomized Responder Period|Withdrawal by Subject|5
7504917|NCT03210259|26041931|P1|48-Week Randomized Responder Period|Withdrawal by Subject|0
7504918|NCT03210259|26041929|P3|48-Week Randomized Responder Period|Physician Decision|1
7504919|NCT03210259|26041930|P2|48-Week Randomized Responder Period|Physician Decision|0
7504920|NCT03210259|26041931|P1|48-Week Randomized Responder Period|Physician Decision|0
7504921|NCT03210259|26041929|P3|48-Week Randomized Responder Period|Pregnancy|0
7504922|NCT03210259|26041930|P2|48-Week Randomized Responder Period|Pregnancy|1
7504923|NCT03210259|26041931|P1|48-Week Randomized Responder Period|Pregnancy|0
7504924|NCT03210259|26041929|P3|48-Week Randomized Responder Period|Lost to Follow-up|8
7504925|NCT03210259|26041930|P2|48-Week Randomized Responder Period|Lost to Follow-up|3
7504926|NCT03210259|26041931|P1|48-Week Randomized Responder Period|Lost to Follow-up|0
7504927|NCT03210259|26041929|P3|48-Week Randomized Responder Period|Missed study visit|2
7504928|NCT03210259|26041930|P2|48-Week Randomized Responder Period|Missed study visit|1
7504929|NCT03210259|26041931|P1|48-Week Randomized Responder Period|Missed study visit|0
7504930|NCT03210259|26041929|P3|12-Week Run-in Period|Lack of Efficacy|0
7504931|NCT03210259|26041930|P2|12-Week Run-in Period|Lack of Efficacy|0
7504932|NCT03210259|26041931|P1|12-Week Run-in Period|Lack of Efficacy|6
7504933|NCT03210259|26041929|P3|12-Week Run-in Period|Lost to Follow-up|0
7504934|NCT03210259|26041930|P2|12-Week Run-in Period|Lost to Follow-up|0
7504935|NCT03210259|26041931|P1|12-Week Run-in Period|Lost to Follow-up|4
7504936|NCT03210259|26041929|P3|12-Week Run-in Period|Withdrawal by Subject|0
7504937|NCT03210259|26041930|P2|12-Week Run-in Period|Withdrawal by Subject|0
7504938|NCT03210259|26041931|P1|12-Week Run-in Period|Withdrawal by Subject|9
7504939|NCT03210259|26041929|P3|12-Week Run-in Period|Death|0
7504940|NCT03210259|26041930|P2|12-Week Run-in Period|Death|0
7504941|NCT03210259|26041931|P1|12-Week Run-in Period|Death|1
7504942|NCT03210259|26041929|P3|12-Week Run-in Period|Adverse Event|0
7504943|NCT03210259|26041930|P2|12-Week Run-in Period|Adverse Event|0
7504944|NCT03210259|26041931|P1|12-Week Run-in Period|Adverse Event|1
7504945|NCT03210220|26041960|P2|Overall Study|Physician Decision|0
7504946|NCT03210220|26041961|P1|Overall Study|Physician Decision|1
7504947|NCT03209973|26041984|P1|Overall Study|Death|1
7504948|NCT03209973|26041984|P1|Overall Study|Patient withdrew consent|3
7504949|NCT03209570|26042005|P2|Overall Study|Withdrawal by Subject|3
7504950|NCT03209570|26042006|P1|Overall Study|Withdrawal by Subject|0
7504951|NCT03209570|26042005|P2|Overall Study|Protocol Violation|0
7504952|NCT03209570|26042006|P1|Overall Study|Protocol Violation|1
7504953|NCT03209570|26042005|P2|Overall Study|Incomplete Data|10
7504954|NCT03209570|26042006|P1|Overall Study|Incomplete Data|8
7504955|NCT03209570|26042005|P2|Overall Study|Death|0
7504956|NCT03209570|26042006|P1|Overall Study|Death|1
7504957|NCT03209518|26042016|P1|Overall Study|Protocol Deviation|1
7504958|NCT03209518|26042016|P1|Overall Study|Case Report Forms Uncollected|1
7504959|NCT03209492|26042030|P1|Overall Study|Case Report Forms Uncollected|5
7504960|NCT03209362|26042037|P2|Overall Study|Other|1
7504961|NCT03209362|26042038|P1|Overall Study|Other|0
7504962|NCT03209362|26042037|P2|Overall Study|Withdrawal by Subject|0
7504963|NCT03209362|26042038|P1|Overall Study|Withdrawal by Subject|2
7504964|NCT03209362|26042037|P2|Overall Study|Lost to Follow-up|1
7504965|NCT03209362|26042038|P1|Overall Study|Lost to Follow-up|0
7504966|NCT03209362|26042037|P2|Overall Study|Adverse Event|1
7504967|NCT03209362|26042038|P1|Overall Study|Adverse Event|0
7504968|NCT03208933|26042057|P1|Overall Study|Protocol Violation|1
7504969|NCT03208933|26042057|P1|Overall Study|Physician Decision|3
7504970|NCT03208933|26042057|P1|Overall Study|Lost to Follow-up|2
7504971|NCT03208933|26042057|P1|Overall Study|Adverse Event|1
7504972|NCT03208933|26042057|P1|Overall Study|Withdrawal by Subject|3
7504973|NCT03208933|26042057|P1|Overall Study|Death|3
7504974|NCT03208088|26042113|P10|Period 4|Unsatisfactory Test Article|0
7504975|NCT03208088|26042114|P9|Period 4|Unsatisfactory Test Article|0
7504976|NCT03208088|26042115|P8|Period 4|Unsatisfactory Test Article|0
7504977|NCT03208088|26042116|P7|Period 4|Unsatisfactory Test Article|0
7504978|NCT03208088|26042117|P6|Period 4|Unsatisfactory Test Article|0
7504979|NCT03208088|26042118|P5|Period 4|Unsatisfactory Test Article|0
7504980|NCT03208088|26042119|P4|Period 4|Unsatisfactory Test Article|1
7504981|NCT03208088|26042120|P3|Period 4|Unsatisfactory Test Article|0
7504982|NCT03208088|26042121|P2|Period 4|Unsatisfactory Test Article|0
7504983|NCT03208088|26042122|P1|Period 4|Unsatisfactory Test Article|0
7504984|NCT03208088|26042113|P10|Period 3|Unsatisfactory Test Article|0
7504985|NCT03208088|26042114|P9|Period 3|Unsatisfactory Test Article|0
7504986|NCT03208088|26042115|P8|Period 3|Unsatisfactory Test Article|0
7504987|NCT03208088|26042116|P7|Period 3|Unsatisfactory Test Article|0
7504988|NCT03208088|26042117|P6|Period 3|Unsatisfactory Test Article|0
7504989|NCT03208088|26042118|P5|Period 3|Unsatisfactory Test Article|0
7504990|NCT03208088|26042119|P4|Period 3|Unsatisfactory Test Article|1
7504991|NCT03208088|26042120|P3|Period 3|Unsatisfactory Test Article|0
7504992|NCT03208088|26042121|P2|Period 3|Unsatisfactory Test Article|0
7504993|NCT03208088|26042122|P1|Period 3|Unsatisfactory Test Article|0
7504994|NCT03208088|26042113|P10|Period 2|Withdrawal by Subject|0
7504995|NCT03208088|26042114|P9|Period 2|Withdrawal by Subject|1
7504996|NCT03208088|26042115|P8|Period 2|Withdrawal by Subject|0
7504997|NCT03208088|26042116|P7|Period 2|Withdrawal by Subject|0
7504998|NCT03208088|26042117|P6|Period 2|Withdrawal by Subject|0
7504999|NCT03208088|26042118|P5|Period 2|Withdrawal by Subject|0
7505000|NCT03208088|26042119|P4|Period 2|Withdrawal by Subject|0
7505001|NCT03208088|26042120|P3|Period 2|Withdrawal by Subject|0
7505002|NCT03208088|26042121|P2|Period 2|Withdrawal by Subject|0
7505003|NCT03208088|26042122|P1|Period 2|Withdrawal by Subject|0
7505004|NCT03207763|26042152|P2|Overall Study|Lost to Follow-up|0
7505005|NCT03207763|26042153|P1|Overall Study|Lost to Follow-up|1
7505006|NCT03207750|26042179|P2|Overall Study|OTHER, NOT SPECIFIED|4
7505007|NCT03207750|26042180|P1|Overall Study|OTHER, NOT SPECIFIED|5
7505008|NCT03207750|26042179|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
7505009|NCT03207750|26042180|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
7505010|NCT03207750|26042179|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
7505011|NCT03207750|26042180|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
7505012|NCT03207750|26042179|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
7505013|NCT03207750|26042180|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
7505014|NCT03207750|26042179|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
7505015|NCT03207750|26042180|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
7505016|NCT03207750|26042179|P2|Overall Study|Protocol Violation|1
7505017|NCT03207750|26042180|P1|Overall Study|Protocol Violation|0
7505018|NCT03207750|26042179|P2|Overall Study|Lost to Follow-up|29
7505019|NCT03207750|26042180|P1|Overall Study|Lost to Follow-up|21
7505020|NCT03207750|26042179|P2|Overall Study|Adverse Event|2
7505021|NCT03207750|26042180|P1|Overall Study|Adverse Event|3
7505022|NCT03207243|26042260|P2|Overall Study|Protocol Violation|3
7505023|NCT03207243|26042261|P1|Overall Study|Protocol Violation|0
7505024|NCT03207243|26042260|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
7505025|NCT03207243|26042261|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
7505026|NCT03207243|26042260|P2|Overall Study|Lost to Follow-up|1
7505027|NCT03207243|26042261|P1|Overall Study|Lost to Follow-up|0
7505028|NCT03207243|26042260|P2|Overall Study|Physician Decision|1
7505029|NCT03207243|26042261|P1|Overall Study|Physician Decision|1
7505030|NCT03207243|26042260|P2|Overall Study|Withdrawal by Subject|4
7505031|NCT03207243|26042261|P1|Overall Study|Withdrawal by Subject|2
7505032|NCT03207243|26042260|P2|Overall Study|Loss of Asthma Control|31
7505033|NCT03207243|26042261|P1|Overall Study|Loss of Asthma Control|47
7505034|NCT03207243|26042260|P2|Overall Study|Adverse Event|2
7505035|NCT03207243|26042261|P1|Overall Study|Adverse Event|2
7505036|NCT03206970|26042385|P1|Overall Study|Lost to Follow-up|3
7505037|NCT03206970|26042385|P1|Overall Study|Withdrawal by Subject|9
7505038|NCT03206970|26042385|P1|Overall Study|Death|14
7505039|NCT03206918|26042389|P1|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
7505040|NCT03206918|26042389|P1|Overall Study|Lost to Follow-up|3
7505041|NCT03206918|26042389|P1|Overall Study|Study terminated by sponsor|12
7505042|NCT03206918|26042389|P1|Overall Study|Withdrawal by Subject|5
7505043|NCT03206918|26042389|P1|Overall Study|Death|11
7505044|NCT03206788|26042400|P2|Overall Study|Physician Decision|1
7505045|NCT03206788|26042401|P1|Overall Study|Physician Decision|0
7505046|NCT03206788|26042400|P2|Overall Study|Adverse Event|1
7505047|NCT03206788|26042401|P1|Overall Study|Adverse Event|0
7505048|NCT03206788|26042400|P2|Overall Study|Withdrawal by Subject|1
7505049|NCT03206788|26042401|P1|Overall Study|Withdrawal by Subject|0
7505050|NCT03206749|26042440|P3|Overall Study|Lost to Follow-up|1
7505051|NCT03206749|26042441|P2|Overall Study|Lost to Follow-up|0
7505052|NCT03206749|26042442|P1|Overall Study|Lost to Follow-up|0
7505053|NCT03206749|26042440|P3|Overall Study|Withdrawal of consent|6
7505054|NCT03206749|26042441|P2|Overall Study|Withdrawal of consent|3
7505055|NCT03206749|26042442|P1|Overall Study|Withdrawal of consent|5
7505056|NCT03206216|26042471|P2|Overall Study|Withdrawal by Subject|1
7505057|NCT03206216|26042472|P1|Overall Study|Withdrawal by Subject|0
7505058|NCT03205566|26042482|P2|Phase 1|Protocol Violation|1
7505059|NCT03205566|26042483|P1|Phase 1|Protocol Violation|1
7505060|NCT03205488|26042499|P3|Overall Study|Protocol Violation|1
7505061|NCT03205488|26042500|P2|Overall Study|Protocol Violation|0
7505062|NCT03205488|26042501|P1|Overall Study|Protocol Violation|0
7505063|NCT03205488|26042499|P3|Overall Study|Adverse Event|4
7505064|NCT03205488|26042500|P2|Overall Study|Adverse Event|2
7505065|NCT03205488|26042501|P1|Overall Study|Adverse Event|1
7505066|NCT03205371|26042527|P12|Overall Study|Adverse Event|0
7505067|NCT03205371|26042528|P11|Overall Study|Adverse Event|0
7505068|NCT03205371|26042529|P10|Overall Study|Adverse Event|0
7505069|NCT03205371|26042530|P9|Overall Study|Adverse Event|0
7505070|NCT03205371|26042531|P8|Overall Study|Adverse Event|1
7505071|NCT03205371|26042532|P7|Overall Study|Adverse Event|0
7505072|NCT03205371|26042533|P6|Overall Study|Adverse Event|0
7505073|NCT03205371|26042534|P5|Overall Study|Adverse Event|0
7505074|NCT03205371|26042535|P4|Overall Study|Adverse Event|0
7505075|NCT03205371|26042536|P3|Overall Study|Adverse Event|0
7505076|NCT03205371|26042537|P2|Overall Study|Adverse Event|0
7505077|NCT03205371|26042538|P1|Overall Study|Adverse Event|0
7505078|NCT03205371|26042527|P12|Overall Study|Protocol Violation|0
7505079|NCT03205371|26042528|P11|Overall Study|Protocol Violation|0
7505080|NCT03205371|26042529|P10|Overall Study|Protocol Violation|0
7505081|NCT03205371|26042530|P9|Overall Study|Protocol Violation|0
7505082|NCT03205371|26042531|P8|Overall Study|Protocol Violation|0
7505083|NCT03205371|26042532|P7|Overall Study|Protocol Violation|1
7505084|NCT03205371|26042533|P6|Overall Study|Protocol Violation|0
7505085|NCT03205371|26042534|P5|Overall Study|Protocol Violation|0
7505086|NCT03205371|26042535|P4|Overall Study|Protocol Violation|0
7505087|NCT03205371|26042536|P3|Overall Study|Protocol Violation|0
7505088|NCT03205371|26042537|P2|Overall Study|Protocol Violation|0
7505089|NCT03205371|26042538|P1|Overall Study|Protocol Violation|0
7505090|NCT03205371|26042527|P12|Overall Study|Lost to Follow-up|0
7505091|NCT03205371|26042528|P11|Overall Study|Lost to Follow-up|0
7505092|NCT03205371|26042529|P10|Overall Study|Lost to Follow-up|0
7505093|NCT03205371|26042530|P9|Overall Study|Lost to Follow-up|3
7505094|NCT03205371|26042531|P8|Overall Study|Lost to Follow-up|2
7505095|NCT03205371|26042532|P7|Overall Study|Lost to Follow-up|5
7505096|NCT03205371|26042533|P6|Overall Study|Lost to Follow-up|0
7505097|NCT03205371|26042534|P5|Overall Study|Lost to Follow-up|0
7505098|NCT03205371|26042535|P4|Overall Study|Lost to Follow-up|0
7505099|NCT03205371|26042536|P3|Overall Study|Lost to Follow-up|0
7505100|NCT03205371|26042537|P2|Overall Study|Lost to Follow-up|0
7505101|NCT03205371|26042538|P1|Overall Study|Lost to Follow-up|0
7505102|NCT03205371|26042527|P12|Overall Study|Withdrawal by Subject|1
7505103|NCT03205371|26042528|P11|Overall Study|Withdrawal by Subject|0
7505104|NCT03205371|26042529|P10|Overall Study|Withdrawal by Subject|0
7505105|NCT03205371|26042530|P9|Overall Study|Withdrawal by Subject|2
7505106|NCT03205371|26042531|P8|Overall Study|Withdrawal by Subject|0
7505107|NCT03205371|26042532|P7|Overall Study|Withdrawal by Subject|4
7505108|NCT03205371|26042533|P6|Overall Study|Withdrawal by Subject|0
7505109|NCT03205371|26042534|P5|Overall Study|Withdrawal by Subject|0
7505110|NCT03205371|26042535|P4|Overall Study|Withdrawal by Subject|0
7505111|NCT03205371|26042536|P3|Overall Study|Withdrawal by Subject|0
7505112|NCT03205371|26042537|P2|Overall Study|Withdrawal by Subject|1
7505113|NCT03205371|26042538|P1|Overall Study|Withdrawal by Subject|4
7505114|NCT03205163|26042627|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
7505115|NCT03205163|26042628|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
7505116|NCT03205150|26042679|P3|Overall Study|Lost to Follow-up|1
7505117|NCT03205150|26042680|P2|Overall Study|Lost to Follow-up|0
7505118|NCT03205150|26042681|P1|Overall Study|Lost to Follow-up|0
7505119|NCT03205150|26042679|P3|Overall Study|Adverse Event|1
7505120|NCT03205150|26042680|P2|Overall Study|Adverse Event|1
7505121|NCT03205150|26042681|P1|Overall Study|Adverse Event|1
7505122|NCT03205150|26042679|P3|Overall Study|Patient/guardian decision|0
7505123|NCT03205150|26042680|P2|Overall Study|Patient/guardian decision|3
7505124|NCT03205150|26042681|P1|Overall Study|Patient/guardian decision|0
7505125|NCT03205150|26042679|P3|Overall Study|Protocol deviation|0
7505126|NCT03205150|26042680|P2|Overall Study|Protocol deviation|3
7505127|NCT03205150|26042681|P1|Overall Study|Protocol deviation|1
7505128|NCT03205046|26042719|P2|Overall Study|Study terminated by sponsor|1
7505129|NCT03205046|26042720|P1|Overall Study|Study terminated by sponsor|2
7505130|NCT03205046|26042719|P2|Overall Study|Lost to Follow-up|1
7505131|NCT03205046|26042720|P1|Overall Study|Lost to Follow-up|0
7505132|NCT03205046|26042719|P2|Overall Study|Withdrawal by Subject|2
7505133|NCT03205046|26042720|P1|Overall Study|Withdrawal by Subject|1
7505134|NCT03205046|26042719|P2|Overall Study|Death|6
7505135|NCT03205046|26042720|P1|Overall Study|Death|10
7505136|NCT03204981|26042726|P1|Overall Study|Screen failures (no inducible VT or PVCs)|4
7505137|NCT03204981|26042726|P1|Overall Study|Physician Decision|2
7505138|NCT03204539|26042785|P2|Overall Study|Loss of funding|1
7505139|NCT03204539|26042786|P1|Overall Study|Loss of funding|0
7505140|NCT03204279|26042817|P2|Overall Study|Withdrawal by Subject|1
7505141|NCT03204279|26042818|P1|Overall Study|Withdrawal by Subject|0
7505142|NCT03203447|26042956|P2|Overall Study|Includes premature discontinuation due to study termination and unknown|152
7505143|NCT03203447|26042957|P1|Overall Study|Includes premature discontinuation due to study termination and unknown|159
7505144|NCT03203447|26042956|P2|Overall Study|Lost to Follow-up|10
7505145|NCT03203447|26042957|P1|Overall Study|Lost to Follow-up|1
7505146|NCT03203447|26042956|P2|Overall Study|Withdrawal by Subject|1
7505147|NCT03203447|26042957|P1|Overall Study|Withdrawal by Subject|2
7505148|NCT03203291|26042967|P1|Overall Study|Withdrawal by Subject|1
7505149|NCT03202511|26043002|P2|Overall Study|Withdrawal by Subject|0
7505150|NCT03202511|26043003|P1|Overall Study|Withdrawal by Subject|1
7505151|NCT03201965|26043050|P3|Overall Study|Ongoing|164
7505152|NCT03201965|26043051|P2|Overall Study|Ongoing|152
7505153|NCT03201965|26043052|P1|Overall Study|Ongoing|20
7505154|NCT03201965|26043050|P3|Overall Study|Withdrawal by Subject|4
7505155|NCT03201965|26043051|P2|Overall Study|Withdrawal by Subject|13
7505156|NCT03201965|26043052|P1|Overall Study|Withdrawal by Subject|3
7505157|NCT03201965|26043050|P3|Overall Study|Lost to Follow-up|0
7505158|NCT03201965|26043051|P2|Overall Study|Lost to Follow-up|1
7505159|NCT03201965|26043052|P1|Overall Study|Lost to Follow-up|0
7505160|NCT03201965|26043050|P3|Overall Study|Death|27
7505161|NCT03201965|26043051|P2|Overall Study|Death|27
7505162|NCT03201965|26043052|P1|Overall Study|Death|5
7505163|NCT03201900|26043059|P1|Extension Phase (From Week 63 to 156)|Other|1
7505164|NCT03201900|26043059|P1|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
7505165|NCT03201900|26043059|P1|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
7505166|NCT03201900|26043059|P1|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
7505167|NCT03201900|26043059|P1|Extension Phase (From Week 63 to 156)|Pregnancy|1
7505168|NCT03201900|26043059|P1|Extension Phase (From Week 63 to 156)|Subject choice|1
7505169|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
7505170|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
7505171|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
7505172|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
7505173|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
7505174|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
7505175|NCT03201900|26043059|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
7505176|NCT03201809|26043073|P2|Overall Study|Lost to Follow-up|0
7505177|NCT03201809|26043074|P1|Overall Study|Lost to Follow-up|2
7505178|NCT03201562|26043087|P3|Overall Study|Lost to Follow-up|2
7505179|NCT03201562|26043088|P2|Overall Study|Lost to Follow-up|1
7505180|NCT03201562|26043089|P1|Overall Study|Lost to Follow-up|0
7505181|NCT03201562|26043087|P3|Overall Study|Adverse Event|1
7505182|NCT03201562|26043088|P2|Overall Study|Adverse Event|0
7505183|NCT03201562|26043089|P1|Overall Study|Adverse Event|0
7505184|NCT03201562|26043087|P3|Overall Study|Physician Decision|1
7505185|NCT03201562|26043088|P2|Overall Study|Physician Decision|0
7505186|NCT03201562|26043089|P1|Overall Study|Physician Decision|0
7505187|NCT03201419|26043106|P9|Overall Study|Other|0
7505188|NCT03201419|26043107|P8|Overall Study|Other|0
7505189|NCT03201419|26043108|P7|Overall Study|Other|0
7505190|NCT03201419|26043109|P6|Overall Study|Other|0
7505191|NCT03201419|26043110|P5|Overall Study|Other|0
7505192|NCT03201419|26043111|P4|Overall Study|Other|0
7505193|NCT03201419|26043112|P3|Overall Study|Other|1
7505194|NCT03201419|26043113|P2|Overall Study|Other|0
7505195|NCT03201419|26043114|P1|Overall Study|Other|0
7505196|NCT03201419|26043106|P9|Overall Study|Withdrawal by Subject|2
7505197|NCT03201419|26043107|P8|Overall Study|Withdrawal by Subject|1
7505198|NCT03201419|26043108|P7|Overall Study|Withdrawal by Subject|0
7505199|NCT03201419|26043109|P6|Overall Study|Withdrawal by Subject|0
7505200|NCT03201419|26043110|P5|Overall Study|Withdrawal by Subject|0
7505201|NCT03201419|26043111|P4|Overall Study|Withdrawal by Subject|0
7505202|NCT03201419|26043112|P3|Overall Study|Withdrawal by Subject|1
7505203|NCT03201419|26043113|P2|Overall Study|Withdrawal by Subject|2
7505204|NCT03201419|26043114|P1|Overall Study|Withdrawal by Subject|4
7505205|NCT03201419|26043106|P9|Overall Study|Protocol Deviation|0
7505206|NCT03201419|26043107|P8|Overall Study|Protocol Deviation|0
7505207|NCT03201419|26043108|P7|Overall Study|Protocol Deviation|1
7505208|NCT03201419|26043109|P6|Overall Study|Protocol Deviation|0
7505209|NCT03201419|26043110|P5|Overall Study|Protocol Deviation|0
7505210|NCT03201419|26043111|P4|Overall Study|Protocol Deviation|0
7505211|NCT03201419|26043112|P3|Overall Study|Protocol Deviation|0
7505212|NCT03201419|26043113|P2|Overall Study|Protocol Deviation|0
7505213|NCT03201419|26043114|P1|Overall Study|Protocol Deviation|0
7505214|NCT03201419|26043106|P9|Overall Study|Lost to Follow-up|0
7505215|NCT03201419|26043107|P8|Overall Study|Lost to Follow-up|0
7505216|NCT03201419|26043108|P7|Overall Study|Lost to Follow-up|0
7505217|NCT03201419|26043109|P6|Overall Study|Lost to Follow-up|0
7505218|NCT03201419|26043110|P5|Overall Study|Lost to Follow-up|0
7505219|NCT03201419|26043111|P4|Overall Study|Lost to Follow-up|0
7505220|NCT03201419|26043112|P3|Overall Study|Lost to Follow-up|0
7505221|NCT03201419|26043113|P2|Overall Study|Lost to Follow-up|0
7505222|NCT03201419|26043114|P1|Overall Study|Lost to Follow-up|1
7505223|NCT03201419|26043106|P9|Overall Study|Adverse Event|0
7505224|NCT03201419|26043107|P8|Overall Study|Adverse Event|0
7505225|NCT03201419|26043108|P7|Overall Study|Adverse Event|5
7505226|NCT03201419|26043109|P6|Overall Study|Adverse Event|1
7505227|NCT03201419|26043110|P5|Overall Study|Adverse Event|1
7505228|NCT03201419|26043111|P4|Overall Study|Adverse Event|0
7505229|NCT03201419|26043112|P3|Overall Study|Adverse Event|0
7505230|NCT03201419|26043113|P2|Overall Study|Adverse Event|1
7505231|NCT03201419|26043114|P1|Overall Study|Adverse Event|3
7505232|NCT03201211|26043451|P3|Overall Study|OTHER unknown reasons|0
7505233|NCT03201211|26043452|P2|Overall Study|OTHER unknown reasons|1
7505234|NCT03201211|26043453|P1|Overall Study|OTHER unknown reasons|0
7505235|NCT03201211|26043451|P3|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7505236|NCT03201211|26043452|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7505237|NCT03201211|26043453|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7505238|NCT03201211|26043451|P3|Overall Study|Protocol Violation|0
7505239|NCT03201211|26043452|P2|Overall Study|Protocol Violation|0
7505240|NCT03201211|26043453|P1|Overall Study|Protocol Violation|1
7505241|NCT03201211|26043451|P3|Overall Study|Adverse Event|0
7505242|NCT03201211|26043452|P2|Overall Study|Adverse Event|0
7505243|NCT03201211|26043453|P1|Overall Study|Adverse Event|1
7505244|NCT03201003|26043538|P2|Overall Study|Protocol Violation|0
7505245|NCT03201003|26043539|P1|Overall Study|Protocol Violation|1
7505246|NCT03201003|26043538|P2|Overall Study|Lost to Follow-up|0
7505247|NCT03201003|26043539|P1|Overall Study|Lost to Follow-up|2
7505248|NCT03201003|26043538|P2|Overall Study|Withdrawal by Subject|1
7505249|NCT03201003|26043539|P1|Overall Study|Withdrawal by Subject|4
7505250|NCT03201003|26043538|P2|Overall Study|Other reasons|1
7505251|NCT03201003|26043539|P1|Overall Study|Other reasons|5
7505252|NCT03201003|26043538|P2|Overall Study|Adverse Event|1
7505253|NCT03201003|26043539|P1|Overall Study|Adverse Event|14
7505254|NCT03200912|26043567|P3|Overall Study|Non-compliance with study drug|0
7505255|NCT03200912|26043568|P2|Overall Study|Non-compliance with study drug|1
7505256|NCT03200912|26043569|P1|Overall Study|Non-compliance with study drug|0
7505257|NCT03200912|26043567|P3|Overall Study|Withdrawal by Subject|4
7505258|NCT03200912|26043568|P2|Overall Study|Withdrawal by Subject|2
7505259|NCT03200912|26043569|P1|Overall Study|Withdrawal by Subject|1
7505260|NCT03200912|26043567|P3|Overall Study|Adverse Event|0
7505261|NCT03200912|26043568|P2|Overall Study|Adverse Event|0
7505262|NCT03200912|26043569|P1|Overall Study|Adverse Event|3
7505263|NCT03200860|26043579|P2|Overall Study|Withdrawal by Subject|0
7505264|NCT03200860|26043580|P1|Overall Study|Withdrawal by Subject|1
7505265|NCT03200366|26043624|P3|9 Month Post-Baseline Interview|Refused interview|0
7505266|NCT03200366|26043625|P2|9 Month Post-Baseline Interview|Refused interview|2
7505267|NCT03200366|26043626|P1|9 Month Post-Baseline Interview|Refused interview|0
7505268|NCT03200366|26043624|P3|9 Month Post-Baseline Interview|Withdrawal by PI|1
7505269|NCT03200366|26043625|P2|9 Month Post-Baseline Interview|Withdrawal by PI|0
7505270|NCT03200366|26043626|P1|9 Month Post-Baseline Interview|Withdrawal by PI|0
7505271|NCT03200366|26043624|P3|9 Month Post-Baseline Interview|Lost to Follow-up|9
7505272|NCT03200366|26043625|P2|9 Month Post-Baseline Interview|Lost to Follow-up|18
7505273|NCT03200366|26043626|P1|9 Month Post-Baseline Interview|Lost to Follow-up|23
7505274|NCT03200366|26043624|P3|9 Month Post-Baseline Interview|Death|1
7505275|NCT03200366|26043625|P2|9 Month Post-Baseline Interview|Death|1
7505276|NCT03200366|26043626|P1|9 Month Post-Baseline Interview|Death|1
7505277|NCT03200366|26043624|P3|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
7505278|NCT03200366|26043625|P2|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7505279|NCT03200366|26043626|P1|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7505280|NCT03200366|26043624|P3|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7505281|NCT03200366|26043625|P2|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7505282|NCT03200366|26043626|P1|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
7505283|NCT03200366|26043624|P3|6 Month Post-Baseline Interview|Withdrawal by Subject|0
7505284|NCT03200366|26043625|P2|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7505285|NCT03200366|26043626|P1|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7505286|NCT03200366|26043624|P3|6 Month Post-Baseline Interview|Lost to Follow-up|17
7505287|NCT03200366|26043625|P2|6 Month Post-Baseline Interview|Lost to Follow-up|21
7505288|NCT03200366|26043626|P1|6 Month Post-Baseline Interview|Lost to Follow-up|27
7505289|NCT03200366|26043624|P3|6 Month Post-Baseline Interview|Death|1
7505290|NCT03200366|26043625|P2|6 Month Post-Baseline Interview|Death|1
7505291|NCT03200366|26043626|P1|6 Month Post-Baseline Interview|Death|1
7505292|NCT03200366|26043624|P3|Patient Navigation Intervention Given|Declined navigation intervention|0
7505293|NCT03200366|26043625|P2|Patient Navigation Intervention Given|Declined navigation intervention|1
7505294|NCT03200366|26043626|P1|Patient Navigation Intervention Given|Declined navigation intervention|0
7505295|NCT03200366|26043624|P3|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7505296|NCT03200366|26043625|P2|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
7505297|NCT03200366|26043626|P1|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7505298|NCT03200366|26043624|P3|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7505299|NCT03200366|26043625|P2|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
7505300|NCT03200366|26043626|P1|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7505301|NCT03200366|26043624|P3|Patient Navigation Intervention Given|Lost to Follow-up|0
7505302|NCT03200366|26043625|P2|Patient Navigation Intervention Given|Lost to Follow-up|25
7505303|NCT03200366|26043626|P1|Patient Navigation Intervention Given|Lost to Follow-up|0
7505304|NCT03200366|26043624|P3|Patient Navigation Intervention Given|Death|0
7505305|NCT03200366|26043625|P2|Patient Navigation Intervention Given|Death|2
7505306|NCT03200366|26043626|P1|Patient Navigation Intervention Given|Death|0
7505307|NCT03199911|26043690|P2|Overall Study|Did not proceed with surgery|1
7505308|NCT03199911|26043691|P1|Overall Study|Did not proceed with surgery|2
7505309|NCT03199911|26043690|P2|Overall Study|Lost to Follow-up|5
7505310|NCT03199911|26043691|P1|Overall Study|Lost to Follow-up|5
7505311|NCT03198767|26043802|P7|Overall Study|Protocol Violation|0
7505312|NCT03198767|26043803|P6|Overall Study|Protocol Violation|0
7505313|NCT03198767|26043804|P5|Overall Study|Protocol Violation|0
7505314|NCT03198767|26043805|P4|Overall Study|Protocol Violation|6
7505315|NCT03198767|26043806|P3|Overall Study|Protocol Violation|0
7505316|NCT03198767|26043807|P2|Overall Study|Protocol Violation|0
7505317|NCT03198767|26043808|P1|Overall Study|Protocol Violation|0
7505318|NCT03198754|26043849|P2|Overall Study|Ineligible|1
7505319|NCT03198754|26043850|P1|Overall Study|Ineligible|2
7505320|NCT03198754|26043849|P2|Overall Study|Lost to Follow-up|3
7505321|NCT03198754|26043850|P1|Overall Study|Lost to Follow-up|4
7505322|NCT03198754|26043849|P2|Overall Study|Withdrawal by Subject|4
7505323|NCT03198754|26043850|P1|Overall Study|Withdrawal by Subject|5
7505324|NCT03198715|26043893|P5|Overall Study|Other|0
7505325|NCT03198715|26043894|P4|Overall Study|Other|0
7505326|NCT03198715|26043895|P3|Overall Study|Other|1
7505327|NCT03198715|26043896|P2|Overall Study|Other|1
7505328|NCT03198715|26043897|P1|Overall Study|Other|0
7505329|NCT03198715|26043893|P5|Overall Study|Death|2
7505330|NCT03198715|26043894|P4|Overall Study|Death|0
7505331|NCT03198715|26043895|P3|Overall Study|Death|1
7505332|NCT03198715|26043896|P2|Overall Study|Death|0
7505333|NCT03198715|26043897|P1|Overall Study|Death|0
7505334|NCT03198520|26043949|P1|Overall Study|Study Ended|1
7505335|NCT03198520|26043949|P1|Overall Study|Withdrawal by Subject|1
7505336|NCT03198520|26043949|P1|Overall Study|Protocol Violation|2
7505337|NCT03198520|26043949|P1|Overall Study|Physician Decision|2
7505338|NCT03198507|26043972|P2|Overall Study|Withdrawal by Subject|0
7505339|NCT03198507|26043973|P1|Overall Study|Withdrawal by Subject|1
7505340|NCT03197935|26044120|P2|Overall Study|Did not receive any study treatment|1
7505341|NCT03197935|26044121|P1|Overall Study|Did not receive any study treatment|1
7505342|NCT03197935|26044120|P2|Overall Study|On-Going in Study|146
7505343|NCT03197935|26044121|P1|Overall Study|On-Going in Study|147
7505344|NCT03197935|26044120|P2|Overall Study|Withdrawal by Subject|7
7505345|NCT03197935|26044121|P1|Overall Study|Withdrawal by Subject|11
7505346|NCT03197935|26044120|P2|Overall Study|Physician Decision|1
7505347|NCT03197935|26044121|P1|Overall Study|Physician Decision|0
7505348|NCT03197935|26044120|P2|Overall Study|Lost to Follow-up|3
7505349|NCT03197935|26044121|P1|Overall Study|Lost to Follow-up|0
7505350|NCT03197935|26044120|P2|Overall Study|Death due to any cause|7
7505351|NCT03197935|26044121|P1|Overall Study|Death due to any cause|9
7505352|NCT03197883|26044134|P2|Overall Study|Other (Not Specified)|5
7505353|NCT03197883|26044135|P1|Overall Study|Other (Not Specified)|0
7505354|NCT03197883|26044134|P2|Overall Study|Protocol Violation|0
7505355|NCT03197883|26044135|P1|Overall Study|Protocol Violation|1
7505356|NCT03197883|26044134|P2|Overall Study|Lost to Follow-up|0
7505357|NCT03197883|26044135|P1|Overall Study|Lost to Follow-up|1
7505358|NCT03197883|26044134|P2|Overall Study|Adverse Event|1
7505359|NCT03197883|26044135|P1|Overall Study|Adverse Event|1
7505360|NCT03197558|26044165|P1|Overall Study|Tubes not placed|1
7505361|NCT03197376|26044198|P4|Immune Persistence Phase|Not vaccine related|1
7505362|NCT03197376|26044199|P3|Immune Persistence Phase|Not vaccine related|1
7505363|NCT03197376|26044200|P2|Immune Persistence Phase|Not vaccine related|0
7505364|NCT03197376|26044201|P1|Immune Persistence Phase|Not vaccine related|1
7505365|NCT03197376|26044198|P4|Immune Persistence Phase|Withdrawal by subject's parents|3
7505366|NCT03197376|26044199|P3|Immune Persistence Phase|Withdrawal by subject's parents|2
7505367|NCT03197376|26044200|P2|Immune Persistence Phase|Withdrawal by subject's parents|4
7505368|NCT03197376|26044201|P1|Immune Persistence Phase|Withdrawal by subject's parents|4
7505369|NCT03197376|26044198|P4|Immune Persistence Phase|Lost to Follow-up|1
7505370|NCT03197376|26044199|P3|Immune Persistence Phase|Lost to Follow-up|2
7505371|NCT03197376|26044200|P2|Immune Persistence Phase|Lost to Follow-up|0
7505372|NCT03197376|26044201|P1|Immune Persistence Phase|Lost to Follow-up|0
7505373|NCT03197376|26044198|P4|Primary and Booster Phase|Not vaccine related|6
7505374|NCT03197376|26044199|P3|Primary and Booster Phase|Not vaccine related|0
7505375|NCT03197376|26044200|P2|Primary and Booster Phase|Not vaccine related|2
7505376|NCT03197376|26044201|P1|Primary and Booster Phase|Not vaccine related|1
7505377|NCT03197376|26044198|P4|Primary and Booster Phase|Ineligibility criteria|2
7505378|NCT03197376|26044199|P3|Primary and Booster Phase|Ineligibility criteria|4
7505379|NCT03197376|26044200|P2|Primary and Booster Phase|Ineligibility criteria|1
7505380|NCT03197376|26044201|P1|Primary and Booster Phase|Ineligibility criteria|1
7505381|NCT03197376|26044198|P4|Primary and Booster Phase|Withdrawal by subject's parents|11
7505382|NCT03197376|26044199|P3|Primary and Booster Phase|Withdrawal by subject's parents|14
7505383|NCT03197376|26044200|P2|Primary and Booster Phase|Withdrawal by subject's parents|10
7505384|NCT03197376|26044201|P1|Primary and Booster Phase|Withdrawal by subject's parents|11
7505385|NCT03197376|26044198|P4|Primary and Booster Phase|Physician Decision|3
7505386|NCT03197376|26044199|P3|Primary and Booster Phase|Physician Decision|1
7505387|NCT03197376|26044200|P2|Primary and Booster Phase|Physician Decision|0
7505388|NCT03197376|26044201|P1|Primary and Booster Phase|Physician Decision|1
7505389|NCT03197376|26044198|P4|Primary and Booster Phase|Lost to Follow-up|0
7505390|NCT03197376|26044199|P3|Primary and Booster Phase|Lost to Follow-up|1
7505391|NCT03197376|26044200|P2|Primary and Booster Phase|Lost to Follow-up|0
7505392|NCT03197376|26044201|P1|Primary and Booster Phase|Lost to Follow-up|0
7505393|NCT03197376|26044198|P4|Primary and Booster Phase|Death|2
7505394|NCT03197376|26044199|P3|Primary and Booster Phase|Death|0
7505395|NCT03197376|26044200|P2|Primary and Booster Phase|Death|0
7505396|NCT03197376|26044201|P1|Primary and Booster Phase|Death|1
7505397|NCT03197376|26044198|P4|Primary and Booster Phase|Adverse Event|1
7505398|NCT03197376|26044199|P3|Primary and Booster Phase|Adverse Event|0
7505399|NCT03197376|26044200|P2|Primary and Booster Phase|Adverse Event|0
7505400|NCT03197376|26044201|P1|Primary and Booster Phase|Adverse Event|0
7505401|NCT03197324|26044270|P2|Overall Study|Adverse Event|1
7505402|NCT03197324|26044271|P1|Overall Study|Adverse Event|0
7505403|NCT03196973|26044332|P3|Overall Study|Administration of a wrong kit of study medication|0
7505404|NCT03196973|26044333|P2|Overall Study|Administration of a wrong kit of study medication|1
7505405|NCT03196973|26044334|P1|Overall Study|Administration of a wrong kit of study medication|0
7505406|NCT03196973|26044332|P3|Overall Study|Consent withdrawn|0
7505407|NCT03196973|26044333|P2|Overall Study|Consent withdrawn|1
7505408|NCT03196973|26044334|P1|Overall Study|Consent withdrawn|2
7505409|NCT03196973|26044332|P3|Overall Study|Lost to Follow-up|2
7505410|NCT03196973|26044333|P2|Overall Study|Lost to Follow-up|3
7505411|NCT03196973|26044334|P1|Overall Study|Lost to Follow-up|4
7505412|NCT03196973|26044332|P3|Overall Study|Lack of Efficacy|1
7505413|NCT03196973|26044333|P2|Overall Study|Lack of Efficacy|6
7505414|NCT03196973|26044334|P1|Overall Study|Lack of Efficacy|2
7505415|NCT03196973|26044332|P3|Overall Study|Adverse Event|2
7505416|NCT03196973|26044333|P2|Overall Study|Adverse Event|1
7505417|NCT03196973|26044334|P1|Overall Study|Adverse Event|1
7505418|NCT03196791|26044347|P2|Overall Study|Withdrawal by Subject|2
7505419|NCT03196791|26044348|P1|Overall Study|Withdrawal by Subject|3
7505420|NCT03196791|26044347|P2|Overall Study|Protocol Violation|3
7505421|NCT03196791|26044348|P1|Overall Study|Protocol Violation|7
7505422|NCT03196635|26044360|P1|Overall Study|Withdrawal by Subject|1
7505423|NCT03196505|26044380|P2|Overall Study|Physician Decision|26
7505424|NCT03196505|26044381|P1|Overall Study|Physician Decision|26
7505425|NCT03196349|26044392|P3|Overall Study|Study Terminated early|11
7505426|NCT03196349|26044393|P2|Overall Study|Study Terminated early|9
7505427|NCT03196349|26044394|P1|Overall Study|Study Terminated early|15
7505428|NCT03196349|26044392|P3|Overall Study|No data entered|0
7505429|NCT03196349|26044393|P2|Overall Study|No data entered|4
7505430|NCT03196349|26044394|P1|Overall Study|No data entered|2
7505431|NCT03196349|26044392|P3|Overall Study|Did not receive study drug|2
7505432|NCT03196349|26044393|P2|Overall Study|Did not receive study drug|1
7505433|NCT03196349|26044394|P1|Overall Study|Did not receive study drug|0
7505434|NCT03196297|26044420|P1|Extension Period|Lack of Efficacy|2
7505435|NCT03196297|26044420|P1|Extension Period|Withdrawal by Subject|1
7505436|NCT03196297|26044420|P1|Main Period|Withdrawal by Subject|4
7505437|NCT03196193|26044525|P2|Overall Study|Computed Tomography (CT) data missing|0
7505438|NCT03196193|26044526|P1|Overall Study|Computed Tomography (CT) data missing|2
7505439|NCT03196193|26044525|P2|Overall Study|Adverse Event|0
7505440|NCT03196193|26044526|P1|Overall Study|Adverse Event|1
7505441|NCT03195660|26044551|P1|Overall Study|The study was terminated|2
7505490|NCT03194490|26044696|P2|Overall Study|participant developed specific neck pain|0
7505491|NCT03194490|26044697|P1|Overall Study|participant developed specific neck pain|1
7505492|NCT03194490|26044696|P2|Overall Study|Lost to Follow-up|3
7505493|NCT03194490|26044697|P1|Overall Study|Lost to Follow-up|1
7505494|NCT03194464|26044739|P1|Overall Study|data not usable|2
7505495|NCT03194217|26044833|P4|Overall Study|Other|0
7505496|NCT03194217|26044834|P3|Overall Study|Other|1
7505497|NCT03194217|26044835|P2|Overall Study|Other|1
7505498|NCT03194217|26044836|P1|Overall Study|Other|0
7505499|NCT03194217|26044833|P4|Overall Study|Failure to meet randomisation criteria|1
7505500|NCT03194217|26044834|P3|Overall Study|Failure to meet randomisation criteria|0
7505501|NCT03194217|26044835|P2|Overall Study|Failure to meet randomisation criteria|0
7505502|NCT03194217|26044836|P1|Overall Study|Failure to meet randomisation criteria|0
7505503|NCT03194217|26044833|P4|Overall Study|Adverse Event|3
7505504|NCT03194217|26044834|P3|Overall Study|Adverse Event|3
7505505|NCT03194217|26044835|P2|Overall Study|Adverse Event|2
7505506|NCT03194217|26044836|P1|Overall Study|Adverse Event|0
7505507|NCT03193736|26044846|P1|Overall Study|implant not received|1
7505508|NCT03193736|26044846|P1|Overall Study|Lost to Follow-up|1
7505509|NCT03193736|26044846|P1|Overall Study|Withdrawal by Subject|1
7505510|NCT03193736|26044846|P1|Overall Study|Death|2
7505511|NCT03193047|26044900|P2|Overall Study|Participant Left State|0
7505512|NCT03193047|26044901|P1|Overall Study|Participant Left State|1
7505513|NCT03193047|26044900|P2|Overall Study|Physician Decision|0
7505514|NCT03193047|26044901|P1|Overall Study|Physician Decision|1
7505515|NCT03193021|26044921|P2|Overall Study|Lost to Follow-up|1
7505516|NCT03193021|26044922|P1|Overall Study|Lost to Follow-up|1
7505517|NCT03192904|26044947|P2|Overall Study|Lost to Follow-up|1
7505518|NCT03192904|26044948|P1|Overall Study|Lost to Follow-up|0
7505519|NCT03192904|26044947|P2|Overall Study|Physician Decision|1
7505520|NCT03192904|26044948|P1|Overall Study|Physician Decision|3
7505521|NCT03192488|26045004|P6|Third Intervention (d1)|Adverse Event|0
7505522|NCT03192488|26045005|P5|Third Intervention (d1)|Adverse Event|1
7505523|NCT03192488|26045006|P4|Third Intervention (d1)|Adverse Event|0
7505524|NCT03192488|26045007|P3|Third Intervention (d1)|Adverse Event|0
7505525|NCT03192488|26045008|P2|Third Intervention (d1)|Adverse Event|0
7505526|NCT03192488|26045009|P1|Third Intervention (d1)|Adverse Event|0
7505527|NCT03192488|26045004|P6|First Washout (>6d)|Withdrawal by Subject|1
7505528|NCT03192488|26045005|P5|First Washout (>6d)|Withdrawal by Subject|0
7505529|NCT03192488|26045006|P4|First Washout (>6d)|Withdrawal by Subject|0
7505530|NCT03192488|26045007|P3|First Washout (>6d)|Withdrawal by Subject|1
7505531|NCT03192488|26045008|P2|First Washout (>6d)|Withdrawal by Subject|0
7505532|NCT03192488|26045009|P1|First Washout (>6d)|Withdrawal by Subject|0
7505533|NCT03192475|26045025|P2|Overall Study|Lost to Follow-up|8
7505534|NCT03192475|26045026|P1|Overall Study|Lost to Follow-up|13
7505535|NCT03192475|26045025|P2|Overall Study|Death|1
7505536|NCT03192475|26045026|P1|Overall Study|Death|0
7505537|NCT03192306|26045062|P2|Overall Study|Protocol Violation|1
7505538|NCT03192306|26045063|P1|Overall Study|Protocol Violation|1
7505539|NCT03192306|26045062|P2|Overall Study|Lost to Follow-up|0
7505540|NCT03192306|26045063|P1|Overall Study|Lost to Follow-up|1
7505541|NCT03192306|26045062|P2|Overall Study|Withdrawal by Subject|1
7505542|NCT03192306|26045063|P1|Overall Study|Withdrawal by Subject|1
7505543|NCT03192306|26045062|P2|Overall Study|Did not treat cold sore during study|143
7505544|NCT03192306|26045063|P1|Overall Study|Did not treat cold sore during study|149
7505545|NCT03192176|26045089|P8|Overall Study|Miscellaneous|1
7505546|NCT03192176|26045090|P7|Overall Study|Miscellaneous|0
7505547|NCT03192176|26045091|P6|Overall Study|Miscellaneous|2
7505548|NCT03192176|26045092|P5|Overall Study|Miscellaneous|1
7505549|NCT03192176|26045093|P4|Overall Study|Miscellaneous|1
7505550|NCT03192176|26045094|P3|Overall Study|Miscellaneous|1
7505551|NCT03192176|26045095|P2|Overall Study|Miscellaneous|0
7505552|NCT03192176|26045096|P1|Overall Study|Miscellaneous|1
7505553|NCT03192176|26045089|P8|Overall Study|Withdrawal by Subject|2
7505554|NCT03192176|26045090|P7|Overall Study|Withdrawal by Subject|4
7505555|NCT03192176|26045091|P6|Overall Study|Withdrawal by Subject|4
7505556|NCT03192176|26045092|P5|Overall Study|Withdrawal by Subject|3
7505557|NCT03192176|26045093|P4|Overall Study|Withdrawal by Subject|4
7505558|NCT03192176|26045094|P3|Overall Study|Withdrawal by Subject|0
7505559|NCT03192176|26045095|P2|Overall Study|Withdrawal by Subject|4
7505560|NCT03192176|26045096|P1|Overall Study|Withdrawal by Subject|3
7505561|NCT03192176|26045089|P8|Overall Study|Protocol Deviation|0
7505562|NCT03192176|26045090|P7|Overall Study|Protocol Deviation|0
7505563|NCT03192176|26045091|P6|Overall Study|Protocol Deviation|0
7505564|NCT03192176|26045092|P5|Overall Study|Protocol Deviation|2
7505565|NCT03192176|26045093|P4|Overall Study|Protocol Deviation|0
7505566|NCT03192176|26045094|P3|Overall Study|Protocol Deviation|0
7505567|NCT03192176|26045095|P2|Overall Study|Protocol Deviation|1
7505568|NCT03192176|26045096|P1|Overall Study|Protocol Deviation|1
7505569|NCT03192176|26045089|P8|Overall Study|Physician Decision|0
7505570|NCT03192176|26045090|P7|Overall Study|Physician Decision|1
7505571|NCT03192176|26045091|P6|Overall Study|Physician Decision|2
7505572|NCT03192176|26045092|P5|Overall Study|Physician Decision|0
7505573|NCT03192176|26045093|P4|Overall Study|Physician Decision|0
7505574|NCT03192176|26045094|P3|Overall Study|Physician Decision|0
7505575|NCT03192176|26045095|P2|Overall Study|Physician Decision|0
7505576|NCT03192176|26045096|P1|Overall Study|Physician Decision|1
7505577|NCT03192176|26045089|P8|Overall Study|Lost to Follow-up|1
7505578|NCT03192176|26045090|P7|Overall Study|Lost to Follow-up|1
7505579|NCT03192176|26045091|P6|Overall Study|Lost to Follow-up|1
7505580|NCT03192176|26045092|P5|Overall Study|Lost to Follow-up|3
7505581|NCT03192176|26045093|P4|Overall Study|Lost to Follow-up|2
7505582|NCT03192176|26045094|P3|Overall Study|Lost to Follow-up|1
7505583|NCT03192176|26045095|P2|Overall Study|Lost to Follow-up|0
7505584|NCT03192176|26045096|P1|Overall Study|Lost to Follow-up|0
7505585|NCT03192176|26045089|P8|Overall Study|Adverse Event|3
7505586|NCT03192176|26045090|P7|Overall Study|Adverse Event|3
7505587|NCT03192176|26045091|P6|Overall Study|Adverse Event|2
7505588|NCT03192176|26045092|P5|Overall Study|Adverse Event|3
7505589|NCT03192176|26045093|P4|Overall Study|Adverse Event|5
7505590|NCT03192176|26045094|P3|Overall Study|Adverse Event|4
7505591|NCT03192176|26045095|P2|Overall Study|Adverse Event|0
7505592|NCT03192176|26045096|P1|Overall Study|Adverse Event|1
7505593|NCT03192150|26045396|P2|Overall Study|Other-Various Administrative Reasons|5
7505594|NCT03192150|26045397|P1|Overall Study|Other-Various Administrative Reasons|2
7505595|NCT03192150|26045396|P2|Overall Study|Surgery Canceled|2
7505596|NCT03192150|26045397|P1|Overall Study|Surgery Canceled|6
7505597|NCT03192150|26045396|P2|Overall Study|Protocol Violation|2
7505598|NCT03192150|26045397|P1|Overall Study|Protocol Violation|5
7505599|NCT03192150|26045396|P2|Overall Study|Withdrawal by Subject|2
7505600|NCT03192150|26045397|P1|Overall Study|Withdrawal by Subject|4
7505601|NCT03192150|26045396|P2|Overall Study|Lost to Follow-up|1
7505602|NCT03192150|26045397|P1|Overall Study|Lost to Follow-up|1
7505603|NCT03192150|26045396|P2|Overall Study|Lack of Efficacy|30
7505604|NCT03192150|26045397|P1|Overall Study|Lack of Efficacy|23
7505605|NCT03192150|26045396|P2|Overall Study|Adverse Event|12
7505606|NCT03192150|26045397|P1|Overall Study|Adverse Event|14
7505607|NCT03192137|26045407|P2|Overall Study|Other - Various Administrative Reasons|3
7505608|NCT03192137|26045408|P1|Overall Study|Other - Various Administrative Reasons|8
7505609|NCT03192137|26045407|P2|Overall Study|Surgery Cancelled|1
7505610|NCT03192137|26045408|P1|Overall Study|Surgery Cancelled|4
7505611|NCT03192137|26045407|P2|Overall Study|Protocol Violation|3
7505612|NCT03192137|26045408|P1|Overall Study|Protocol Violation|4
7505613|NCT03192137|26045407|P2|Overall Study|Withdrawal by Subject|3
7505614|NCT03192137|26045408|P1|Overall Study|Withdrawal by Subject|3
7505615|NCT03192137|26045407|P2|Overall Study|Lack of Efficacy|37
7505616|NCT03192137|26045408|P1|Overall Study|Lack of Efficacy|20
7505617|NCT03192137|26045407|P2|Overall Study|Physician Decision|0
7505618|NCT03192137|26045408|P1|Overall Study|Physician Decision|1
7505619|NCT03192137|26045407|P2|Overall Study|Adverse Event|11
7505620|NCT03192137|26045408|P1|Overall Study|Adverse Event|10
7505621|NCT03191799|26045416|P1|Overall Study|Death|2
7505622|NCT03191799|26045416|P1|Overall Study|Lost to Follow-up|1
7505623|NCT03191799|26045416|P1|Overall Study|Physician Decision|2
7505624|NCT03191799|26045416|P1|Overall Study|Withdrawal by Subject|4
7505625|NCT03191630|26045469|P2|Overall Study|Lost to Follow-up|7
7505626|NCT03191630|26045470|P1|Overall Study|Lost to Follow-up|7
7505627|NCT03191552|26045493|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
7505628|NCT03191552|26045494|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
7505629|NCT03191552|26045495|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
7505630|NCT03191552|26045493|P3|Overall Study|Lost to Follow-up|0
7505631|NCT03191552|26045494|P2|Overall Study|Lost to Follow-up|0
7505632|NCT03191552|26045495|P1|Overall Study|Lost to Follow-up|1
7505633|NCT03191396|26045548|P2|Overall Study|Withdrawal by Subject|2
7505634|NCT03191396|26045549|P1|Overall Study|Withdrawal by Subject|3
7505635|NCT03191396|26045548|P2|Overall Study|Lost to Follow-up|3
7505636|NCT03191396|26045549|P1|Overall Study|Lost to Follow-up|0
7505637|NCT03190369|26045655|P2|Overall Study|Randomized but not treated|2
7505638|NCT03190369|26045656|P1|Overall Study|Randomized but not treated|0
7505639|NCT03190369|26045655|P2|Overall Study|Withdraw before treatment|5
7505640|NCT03190369|26045656|P1|Overall Study|Withdraw before treatment|1
7505641|NCT03190369|26045655|P2|Overall Study|Poor compliance to protocol|1
7505642|NCT03190369|26045656|P1|Overall Study|Poor compliance to protocol|0
7505643|NCT03189745|26045717|P2|Overall Study|Conflict in work schedule of participant|1
7505644|NCT03189745|26045718|P1|Overall Study|Conflict in work schedule of participant|1
7505645|NCT03189719|26045746|P2|Overall Study|Ongoing in Study|65
7505646|NCT03189719|26045747|P1|Overall Study|Ongoing in Study|108
7505647|NCT03189719|26045746|P2|Overall Study|Withdrawal by Subject|3
7505648|NCT03189719|26045747|P1|Overall Study|Withdrawal by Subject|5
7505649|NCT03189719|26045746|P2|Overall Study|Death|308
7505650|NCT03189719|26045747|P1|Overall Study|Death|260
7505651|NCT03189446|26045828|P1|Overall Study|Physician Decision|1
7505652|NCT03189446|26045828|P1|Overall Study|Withdrawal by Subject|2
7505653|NCT03189446|26045828|P1|Overall Study|Adverse Event|2
7505654|NCT03188991|26045854|P4|Overall Study|Withdrawal by Subject|1
7505655|NCT03188991|26045855|P3|Overall Study|Withdrawal by Subject|0
7505656|NCT03188991|26045856|P2|Overall Study|Withdrawal by Subject|0
7505657|NCT03188991|26045857|P1|Overall Study|Withdrawal by Subject|0
7505658|NCT03188718|26045871|P1|Overall Study|Device failure|3
7505659|NCT03188718|26045871|P1|Overall Study|Withdrawal by Subject|1
7505660|NCT03188718|26045871|P1|Overall Study|Participant noncompliance|4
7505661|NCT03188536|26045883|P1|Overall Study|Not participated/met inclusion criteria|1
7505662|NCT03188536|26045883|P1|Overall Study|No relapse/refractoriness(last 6 months)|5
7505663|NCT03188263|26045952|P2|Overall Study|Physician Decision|0
7505664|NCT03188263|26045953|P1|Overall Study|Physician Decision|1
7505665|NCT03188263|26045952|P2|Overall Study|Withdrawal by Subject|0
7505666|NCT03188263|26045953|P1|Overall Study|Withdrawal by Subject|3
7505667|NCT03188185|26045963|P4|Stage 2|Withdrawal by Subject|1
7505668|NCT03188185|26045964|P3|Stage 2|Withdrawal by Subject|3
7505669|NCT03188185|26045965|P2|Stage 2|Withdrawal by Subject|0
7505670|NCT03188185|26045966|P1|Stage 2|Withdrawal by Subject|0
7505671|NCT03188185|26045963|P4|Stage 2|Physician Decision|1
7505672|NCT03188185|26045964|P3|Stage 2|Physician Decision|0
7505673|NCT03188185|26045965|P2|Stage 2|Physician Decision|0
7505674|NCT03188185|26045966|P1|Stage 2|Physician Decision|0
7505675|NCT03188185|26045963|P4|Stage 2|Lost to Follow-up|0
7505676|NCT03188185|26045964|P3|Stage 2|Lost to Follow-up|1
7505677|NCT03188185|26045965|P2|Stage 2|Lost to Follow-up|0
7505678|NCT03188185|26045966|P1|Stage 2|Lost to Follow-up|0
7505679|NCT03188185|26045963|P4|Stage 2|Lack of Efficacy|0
7505680|NCT03188185|26045964|P3|Stage 2|Lack of Efficacy|3
7505681|NCT03188185|26045965|P2|Stage 2|Lack of Efficacy|0
7505682|NCT03188185|26045966|P1|Stage 2|Lack of Efficacy|0
7505683|NCT03188185|26045963|P4|Stage 2|Adverse Event|4
7505684|NCT03188185|26045964|P3|Stage 2|Adverse Event|2
7505685|NCT03188185|26045965|P2|Stage 2|Adverse Event|0
7505686|NCT03188185|26045966|P1|Stage 2|Adverse Event|0
7505687|NCT03188185|26045963|P4|Stage 1|Identified as a professional patient|0
7505688|NCT03188185|26045964|P3|Stage 1|Identified as a professional patient|0
7505689|NCT03188185|26045965|P2|Stage 1|Identified as a professional patient|1
7505690|NCT03188185|26045966|P1|Stage 1|Identified as a professional patient|0
7505691|NCT03188185|26045963|P4|Stage 1|Withdrawal by Subject|0
7505692|NCT03188185|26045964|P3|Stage 1|Withdrawal by Subject|0
7505693|NCT03188185|26045965|P2|Stage 1|Withdrawal by Subject|0
7505694|NCT03188185|26045966|P1|Stage 1|Withdrawal by Subject|9
7505695|NCT03188185|26045963|P4|Stage 1|Lost to Follow-up|0
7505696|NCT03188185|26045964|P3|Stage 1|Lost to Follow-up|0
7505697|NCT03188185|26045965|P2|Stage 1|Lost to Follow-up|1
7505698|NCT03188185|26045966|P1|Stage 1|Lost to Follow-up|6
7505699|NCT03188185|26045963|P4|Stage 1|Lack of Efficacy|0
7505700|NCT03188185|26045964|P3|Stage 1|Lack of Efficacy|0
7505701|NCT03188185|26045965|P2|Stage 1|Lack of Efficacy|2
7505702|NCT03188185|26045966|P1|Stage 1|Lack of Efficacy|0
7505703|NCT03188185|26045963|P4|Stage 1|Adverse Event|0
7505704|NCT03188185|26045964|P3|Stage 1|Adverse Event|0
7505705|NCT03188185|26045965|P2|Stage 1|Adverse Event|12
7505706|NCT03188185|26045966|P1|Stage 1|Adverse Event|4
7505707|NCT03188120|26045984|P1|Overall Study|No visit after the first visit|13
7505708|NCT03188120|26045984|P1|Overall Study|Other than specified|3
7505709|NCT03188120|26045984|P1|Overall Study|Lost to Follow-up|7
7505710|NCT03188120|26045984|P1|Overall Study|Improved|12
7505711|NCT03188120|26045984|P1|Overall Study|Insufficient Effectiveness|8
7505712|NCT03188120|26045984|P1|Overall Study|Adverse Event|4
7505713|NCT03188055|26045991|P6|Overall Study|Withdrawal by Subject|0
7505714|NCT03188055|26045992|P5|Overall Study|Withdrawal by Subject|0
7505715|NCT03188055|26045993|P4|Overall Study|Withdrawal by Subject|1
7505716|NCT03188055|26045994|P3|Overall Study|Withdrawal by Subject|0
7505717|NCT03188055|26045995|P2|Overall Study|Withdrawal by Subject|1
7505718|NCT03188055|26045996|P1|Overall Study|Withdrawal by Subject|0
7505719|NCT03188055|26045991|P6|Overall Study|Lost to Follow-up|0
7505720|NCT03188055|26045992|P5|Overall Study|Lost to Follow-up|0
7505721|NCT03188055|26045993|P4|Overall Study|Lost to Follow-up|11
7505722|NCT03188055|26045994|P3|Overall Study|Lost to Follow-up|0
7505723|NCT03188055|26045995|P2|Overall Study|Lost to Follow-up|18
7505724|NCT03188055|26045996|P1|Overall Study|Lost to Follow-up|0
7505725|NCT03188055|26045991|P6|Overall Study|Unavailable for training|0
7505726|NCT03188055|26045992|P5|Overall Study|Unavailable for training|0
7505727|NCT03188055|26045993|P4|Overall Study|Unavailable for training|0
7505728|NCT03188055|26045994|P3|Overall Study|Unavailable for training|19
7505729|NCT03188055|26045995|P2|Overall Study|Unavailable for training|0
7505730|NCT03188055|26045996|P1|Overall Study|Unavailable for training|0
7505731|NCT03187756|26046022|P1|Overall Study|Termination of study|4
7505732|NCT03187301|26046065|P7|Pre-Intervention|Withdrawal by Subject|0
7505733|NCT03187301|26046066|P6|Pre-Intervention|Withdrawal by Subject|0
7505734|NCT03187301|26046067|P5|Pre-Intervention|Withdrawal by Subject|0
7505735|NCT03187301|26046068|P4|Pre-Intervention|Withdrawal by Subject|0
7505736|NCT03187301|26046069|P3|Pre-Intervention|Withdrawal by Subject|0
7505737|NCT03187301|26046070|P2|Pre-Intervention|Withdrawal by Subject|0
7505738|NCT03187301|26046071|P1|Pre-Intervention|Withdrawal by Subject|1
7505739|NCT03187301|26046065|P7|Titration Period|Exclusion Criteria Met|1
7505740|NCT03187301|26046066|P6|Titration Period|Exclusion Criteria Met|0
7505741|NCT03187301|26046067|P5|Titration Period|Exclusion Criteria Met|0
7505742|NCT03187301|26046068|P4|Titration Period|Exclusion Criteria Met|0
7505743|NCT03187301|26046069|P3|Titration Period|Exclusion Criteria Met|0
7505744|NCT03187301|26046070|P2|Titration Period|Exclusion Criteria Met|0
7505745|NCT03187301|26046071|P1|Titration Period|Exclusion Criteria Met|0
7505746|NCT03187301|26046065|P7|Titration Period|Withdrawal by Subject|1
7505747|NCT03187301|26046066|P6|Titration Period|Withdrawal by Subject|0
7505748|NCT03187301|26046067|P5|Titration Period|Withdrawal by Subject|0
7505749|NCT03187301|26046068|P4|Titration Period|Withdrawal by Subject|0
7505750|NCT03187301|26046069|P3|Titration Period|Withdrawal by Subject|0
7505751|NCT03187301|26046070|P2|Titration Period|Withdrawal by Subject|0
7505752|NCT03187301|26046071|P1|Titration Period|Withdrawal by Subject|0
7505753|NCT03187301|26046065|P7|Titration Period|Adverse Event|5
7505754|NCT03187301|26046066|P6|Titration Period|Adverse Event|0
7505755|NCT03187301|26046067|P5|Titration Period|Adverse Event|0
7505756|NCT03187301|26046068|P4|Titration Period|Adverse Event|0
7505757|NCT03187301|26046069|P3|Titration Period|Adverse Event|0
7505758|NCT03187301|26046070|P2|Titration Period|Adverse Event|0
7505759|NCT03187301|26046071|P1|Titration Period|Adverse Event|0
7505760|NCT03187262|26046120|P1|Consolidation|Progressive Disease|5
7505761|NCT03187262|26046120|P1|Induction|Progressive Disease|4
7505762|NCT03187262|26046120|P1|Induction|Lack of Efficacy|2
7505763|NCT03187197|26046132|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
7505764|NCT03187197|26046133|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
7505765|NCT03187197|26046134|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
7505766|NCT03187197|26046132|P3|Overall Study|Status missing|3
7505767|NCT03187197|26046133|P2|Overall Study|Status missing|33
7505768|NCT03187197|26046134|P1|Overall Study|Status missing|2
7505769|NCT03187197|26046132|P3|Overall Study|Missing|3
7505770|NCT03187197|26046133|P2|Overall Study|Missing|32
7505771|NCT03187197|26046134|P1|Overall Study|Missing|1
7505772|NCT03187197|26046132|P3|Overall Study|Reason not listed|1
7505773|NCT03187197|26046133|P2|Overall Study|Reason not listed|54
7505774|NCT03187197|26046134|P1|Overall Study|Reason not listed|2
7505775|NCT03187197|26046132|P3|Overall Study|Administrative problem|0
7505776|NCT03187197|26046133|P2|Overall Study|Administrative problem|1
7505777|NCT03187197|26046134|P1|Overall Study|Administrative problem|1
7505778|NCT03187197|26046132|P3|Overall Study|Death|0
7505779|NCT03187197|26046133|P2|Overall Study|Death|11
7505780|NCT03187197|26046134|P1|Overall Study|Death|0
7505781|NCT03187197|26046132|P3|Overall Study|Adverse Event|0
7505782|NCT03187197|26046133|P2|Overall Study|Adverse Event|29
7505783|NCT03187197|26046134|P1|Overall Study|Adverse Event|6
7505784|NCT03187197|26046132|P3|Overall Study|Lost to Follow-up|7
7505785|NCT03187197|26046133|P2|Overall Study|Lost to Follow-up|60
7505786|NCT03187197|26046134|P1|Overall Study|Lost to Follow-up|1
7505787|NCT03187197|26046132|P3|Overall Study|Withdrawal by Subject|4
7505788|NCT03187197|26046133|P2|Overall Study|Withdrawal by Subject|63
7505789|NCT03187197|26046134|P1|Overall Study|Withdrawal by Subject|8
7505790|NCT03187197|26046132|P3|Overall Study|Stopped Pradaxa®/VKA|4
7505791|NCT03187197|26046133|P2|Overall Study|Stopped Pradaxa®/VKA|65
7505792|NCT03187197|26046134|P1|Overall Study|Stopped Pradaxa®/VKA|11
7505793|NCT03187132|26046147|P2|Pain Clinic Only, Fully Remote|EMR|1
7505794|NCT03187132|26046148|P1|Pain Clinic Only, Fully Remote|EMR|0
7505795|NCT03187132|26046147|P2|Pain Clinic Only, Fully Remote|Language barrier|1
7505796|NCT03187132|26046148|P1|Pain Clinic Only, Fully Remote|Language barrier|0
7505797|NCT03187132|26046147|P2|Pain Clinic Only, Fully Remote|Disease burden|5
7505798|NCT03187132|26046148|P1|Pain Clinic Only, Fully Remote|Disease burden|6
7505799|NCT03187132|26046147|P2|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
7505800|NCT03187132|26046148|P1|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
7505801|NCT03187132|26046147|P2|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
7505802|NCT03187132|26046148|P1|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
7505803|NCT03187132|26046147|P2|Inpatient Trauma+Pain Clinic|Disease burden|0
7505804|NCT03187132|26046148|P1|Inpatient Trauma+Pain Clinic|Disease burden|1
7505805|NCT03187132|26046147|P2|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
7505806|NCT03187132|26046148|P1|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
7505807|NCT03187132|26046147|P2|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
7505808|NCT03187132|26046148|P1|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
7505809|NCT03187132|26046147|P2|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
7505810|NCT03187132|26046148|P1|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
7505811|NCT03187132|26046147|P2|Inpatient Trauma Only|socioeconomic burden|0
7505812|NCT03187132|26046148|P1|Inpatient Trauma Only|socioeconomic burden|1
7505813|NCT03187132|26046147|P2|Inpatient Trauma Only|Lost to Follow-up|12
7505814|NCT03187132|26046148|P1|Inpatient Trauma Only|Lost to Follow-up|3
7505815|NCT03186781|26046189|P6|Overall Study|Withdrawal by Subject|0
7505816|NCT03186781|26046190|P5|Overall Study|Withdrawal by Subject|1
7505817|NCT03186781|26046191|P4|Overall Study|Withdrawal by Subject|0
7505818|NCT03186781|26046192|P3|Overall Study|Withdrawal by Subject|0
7505819|NCT03186781|26046193|P2|Overall Study|Withdrawal by Subject|0
7505820|NCT03186781|26046194|P1|Overall Study|Withdrawal by Subject|0
7505821|NCT03186781|26046189|P6|Overall Study|Moved from Area|0
7505822|NCT03186781|26046190|P5|Overall Study|Moved from Area|1
7505823|NCT03186781|26046191|P4|Overall Study|Moved from Area|0
7505824|NCT03186781|26046192|P3|Overall Study|Moved from Area|0
7505825|NCT03186781|26046193|P2|Overall Study|Moved from Area|0
7505826|NCT03186781|26046194|P1|Overall Study|Moved from Area|0
7505827|NCT03186781|26046189|P6|Overall Study|Lost to Follow-up|0
7505828|NCT03186781|26046190|P5|Overall Study|Lost to Follow-up|1
7505829|NCT03186781|26046191|P4|Overall Study|Lost to Follow-up|0
7505830|NCT03186781|26046192|P3|Overall Study|Lost to Follow-up|1
7505831|NCT03186781|26046193|P2|Overall Study|Lost to Follow-up|0
7505832|NCT03186781|26046194|P1|Overall Study|Lost to Follow-up|0
7505833|NCT03186378|26046293|P2|Overall Study|Lost to Follow-up|0
7505834|NCT03186378|26046294|P1|Overall Study|Lost to Follow-up|1
7505835|NCT03185481|26046370|P1|Overall Study|Study Terminated by Sponsor|4
7505836|NCT03185481|26046370|P1|Overall Study|Adverse Event|1
7505837|NCT03184987|26046441|P3|Overall Study|Adverse Event|1
7505838|NCT03184987|26046442|P2|Overall Study|Adverse Event|0
7505839|NCT03184987|26046443|P1|Overall Study|Adverse Event|1
7505840|NCT03184987|26046441|P3|Overall Study|Physician Decision|1
7505841|NCT03184987|26046442|P2|Overall Study|Physician Decision|0
7505842|NCT03184987|26046443|P1|Overall Study|Physician Decision|0
7505843|NCT03184987|26046441|P3|Overall Study|Withdrawal by Subject|2
7505844|NCT03184987|26046442|P2|Overall Study|Withdrawal by Subject|1
7505845|NCT03184987|26046443|P1|Overall Study|Withdrawal by Subject|0
7505846|NCT03184701|26046508|P1|Overall Study|Lost to Follow-up|5
7505847|NCT03184701|26046508|P1|Overall Study|Withdrawal by Subject|6
7505848|NCT03184701|26046508|P1|Overall Study|Physician Decision|3
7505849|NCT03184701|26046508|P1|Overall Study|Death|3
7505850|NCT03184519|26046512|P1|Overall Study|Physician Decision|21
7505851|NCT03184519|26046512|P1|Overall Study|Lost to Follow-up|6
7505852|NCT03184441|26046516|P1|Overall Study|Withdrawal by Subject|1
7505853|NCT03184077|26046542|P2|Overall Study|Lost to Follow-up|21
7505854|NCT03184077|26046543|P1|Overall Study|Lost to Follow-up|21
7505855|NCT03183908|26046555|P2|Overall Study|Missing Symptom Diary Data|2
7505856|NCT03183908|26046556|P1|Overall Study|Missing Symptom Diary Data|0
7505857|NCT03183518|26046625|P1|Overall Study|Other (Withdrawal of consent)|1
7505858|NCT03183518|26046625|P1|Overall Study|Other (Not specified)|2
7505859|NCT03183063|26046659|P3|Overall Study|Physician Decision|4
7505860|NCT03183063|26046660|P2|Overall Study|Physician Decision|4
7505861|NCT03183063|26046661|P1|Overall Study|Physician Decision|3
7505862|NCT03183063|26046659|P3|Overall Study|Withdrawal by Subject|0
7505863|NCT03183063|26046660|P2|Overall Study|Withdrawal by Subject|0
7505864|NCT03183063|26046661|P1|Overall Study|Withdrawal by Subject|2
7505865|NCT03182868|26046719|P5|Overall Study|Protocol Violation|8
7505866|NCT03182868|26046720|P4|Overall Study|Protocol Violation|1
7505867|NCT03182868|26046721|P3|Overall Study|Protocol Violation|4
7505868|NCT03182868|26046722|P2|Overall Study|Protocol Violation|0
7505869|NCT03182868|26046723|P1|Overall Study|Protocol Violation|3
7505870|NCT03182829|26046757|P2|Overall Study|Other|3
7505871|NCT03182829|26046758|P1|Overall Study|Other|4
7505872|NCT03182829|26046757|P2|Overall Study|Protocol Violation|12
7505873|NCT03182829|26046758|P1|Overall Study|Protocol Violation|12
7505874|NCT03182738|26046766|P2|Overall Study|Withdrawal by Subject|1
7505875|NCT03182738|26046767|P1|Overall Study|Withdrawal by Subject|0
7505876|NCT03182738|26046766|P2|Overall Study|Pregnancy|1
7505877|NCT03182738|26046767|P1|Overall Study|Pregnancy|0
7505878|NCT03182738|26046766|P2|Overall Study|Lost to Follow-up|3
7505879|NCT03182738|26046767|P1|Overall Study|Lost to Follow-up|9
7505880|NCT03181958|26046811|P3|Overall Study|Lost to Follow-up|15
7505881|NCT03181958|26046812|P2|Overall Study|Lost to Follow-up|21
7505882|NCT03181958|26046813|P1|Overall Study|Lost to Follow-up|17
7505883|NCT03181789|26046861|P4|Overall Study|Participant unable to adhere to visit|0
7505884|NCT03181789|26046862|P3|Overall Study|Participant unable to adhere to visit|0
7505885|NCT03181789|26046863|P2|Overall Study|Participant unable to adhere to visit|1
7505886|NCT03181789|26046864|P1|Overall Study|Participant unable to adhere to visit|0
7505887|NCT03181789|26046861|P4|Overall Study|Lost to Follow-up|0
7505888|NCT03181789|26046862|P3|Overall Study|Lost to Follow-up|0
7505889|NCT03181789|26046863|P2|Overall Study|Lost to Follow-up|1
7505890|NCT03181789|26046864|P1|Overall Study|Lost to Follow-up|7
7505891|NCT03181789|26046861|P4|Overall Study|Withdrawal by Subject|0
7505892|NCT03181789|26046862|P3|Overall Study|Withdrawal by Subject|1
7505893|NCT03181789|26046863|P2|Overall Study|Withdrawal by Subject|1
7505894|NCT03181789|26046864|P1|Overall Study|Withdrawal by Subject|0
7505895|NCT03181594|26046937|P1|Long-term Extension (15-24 Month FU)|Death|2
7505896|NCT03181594|26046937|P1|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
7505897|NCT03181594|26046937|P1|Initial Study Protocol (12-month FU)|Death|1
7505898|NCT03181594|26046937|P1|Initial Study Protocol (12-month FU)|Physician Decision|1
7505899|NCT03181594|26046937|P1|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
7505900|NCT03181594|26046937|P1|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
7505901|NCT03181503|26046946|P2|Overall Study|Lost to Follow-up|1
7505902|NCT03181503|26046947|P1|Overall Study|Lost to Follow-up|1
7505903|NCT03181503|26046946|P2|Overall Study|Withdrawal by Subject|0
7505904|NCT03181503|26046947|P1|Overall Study|Withdrawal by Subject|3
7505905|NCT03181503|26046946|P2|Overall Study|Protocol Violation|0
7505906|NCT03181503|26046947|P1|Overall Study|Protocol Violation|1
7505907|NCT03181503|26046946|P2|Overall Study|Adverse Event|2
7505908|NCT03181503|26046947|P1|Overall Study|Adverse Event|2
7505909|NCT03181451|26046986|P3|Overall Study|Withdrawal by Subject|0
7505910|NCT03181451|26046987|P2|Overall Study|Withdrawal by Subject|1
7505911|NCT03181451|26046988|P1|Overall Study|Withdrawal by Subject|0
7505912|NCT03181451|26046986|P3|Overall Study|Adverse Event|0
7505913|NCT03181451|26046987|P2|Overall Study|Adverse Event|1
7505914|NCT03181451|26046988|P1|Overall Study|Adverse Event|0
7505915|NCT03180801|26047175|P3|Overall Study|Lost to Follow-up|3
7505916|NCT03180801|26047176|P2|Overall Study|Lost to Follow-up|2
7505917|NCT03180801|26047177|P1|Overall Study|Lost to Follow-up|0
7505918|NCT03180801|26047175|P3|Overall Study|Withdrawal by Subject|1
7505919|NCT03180801|26047176|P2|Overall Study|Withdrawal by Subject|2
7505920|NCT03180801|26047177|P1|Overall Study|Withdrawal by Subject|2
7505921|NCT03180801|26047175|P3|Overall Study|Adverse Event|2
7505922|NCT03180801|26047176|P2|Overall Study|Adverse Event|0
7505923|NCT03180801|26047177|P1|Overall Study|Adverse Event|1
7505924|NCT03180801|26047175|P3|Overall Study|Inoculation Target Reached|3
7505925|NCT03180801|26047176|P2|Overall Study|Inoculation Target Reached|1
7505926|NCT03180801|26047177|P1|Overall Study|Inoculation Target Reached|1
7505927|NCT03180801|26047175|P3|Overall Study|Non-compliance|0
7505928|NCT03180801|26047176|P2|Overall Study|Non-compliance|4
7505929|NCT03180801|26047177|P1|Overall Study|Non-compliance|1
7505930|NCT03180801|26047175|P3|Overall Study|Physician Decision|1
7505931|NCT03180801|26047176|P2|Overall Study|Physician Decision|3
7505932|NCT03180801|26047177|P1|Overall Study|Physician Decision|3
7505933|NCT03180645|26047221|P3|Overall Study|Adverse Event|2
7505934|NCT03180645|26047222|P2|Overall Study|Adverse Event|1
7505935|NCT03180645|26047223|P1|Overall Study|Adverse Event|0
7505936|NCT03180619|26047265|P3|Overall Study|Investigator's discretion|1
7505937|NCT03180619|26047266|P2|Overall Study|Investigator's discretion|0
7505938|NCT03180619|26047267|P1|Overall Study|Investigator's discretion|2
7505939|NCT03180619|26047265|P3|Overall Study|Adverse Event|1
7505940|NCT03180619|26047266|P2|Overall Study|Adverse Event|0
7505941|NCT03180619|26047267|P1|Overall Study|Adverse Event|2
7505942|NCT03180619|26047265|P3|Overall Study|Death|2
7505943|NCT03180619|26047266|P2|Overall Study|Death|1
7505944|NCT03180619|26047267|P1|Overall Study|Death|2
7505945|NCT03180619|26047265|P3|Overall Study|Withdrew Consent|2
7505946|NCT03180619|26047266|P2|Overall Study|Withdrew Consent|0
7505947|NCT03180619|26047267|P1|Overall Study|Withdrew Consent|5
7505948|NCT03180528|26047410|P1|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
7505949|NCT03180528|26047410|P1|Overall Study|Withdrawal by Subject|1
7505950|NCT03180528|26047410|P1|Overall Study|Adverse Event|1
7505951|NCT03180138|26047523|P3|Overall Study|Found to be >24 mon after randomization|3
7505952|NCT03180138|26047524|P2|Overall Study|Found to be >24 mon after randomization|0
7505953|NCT03180138|26047525|P1|Overall Study|Found to be >24 mon after randomization|3
7505954|NCT03180138|26047523|P3|Overall Study|No prior immunization records|6
7505955|NCT03180138|26047524|P2|Overall Study|No prior immunization records|0
7505956|NCT03180138|26047525|P1|Overall Study|No prior immunization records|17
7505957|NCT03180138|26047523|P3|Overall Study|Mobile-phone could not be verified|15
7505958|NCT03180138|26047524|P2|Overall Study|Mobile-phone could not be verified|13
7505959|NCT03180138|26047525|P1|Overall Study|Mobile-phone could not be verified|2
7505960|NCT03179891|26047536|P2|First Intervention|Protocol Violation|1
7505961|NCT03179891|26047537|P1|First Intervention|Protocol Violation|0
7505962|NCT03179891|26047536|P2|First Intervention|Unspecified reason|0
7505963|NCT03179891|26047537|P1|First Intervention|Unspecified reason|1
7505964|NCT03179891|26047536|P2|First Intervention|Withdrawal by Subject|1
7505965|NCT03179891|26047537|P1|First Intervention|Withdrawal by Subject|1
7505966|NCT03179787|26047557|P1|Overall Study|Treatment not administered|1
7505967|NCT03179787|26047557|P1|Overall Study|Case report failures|2
7505968|NCT03179787|26047557|P1|Overall Study|Lost to Follow-up|15
7505969|NCT03179462|26047564|P3|Overall Study|screening failure|0
7505970|NCT03179462|26047565|P2|Overall Study|screening failure|2
7505971|NCT03179462|26047566|P1|Overall Study|screening failure|1
7505972|NCT03179319|26047641|P2|Overall Study|Lost to Follow-up|0
7505973|NCT03179319|26047642|P1|Overall Study|Lost to Follow-up|6
7505974|NCT03178942|26047657|P2|Overall Study|Lost to Follow-up|2
7505975|NCT03178942|26047658|P1|Overall Study|Lost to Follow-up|1
7505976|NCT03178942|26047657|P2|Overall Study|Withdrawal by Subject|0
7505977|NCT03178942|26047658|P1|Overall Study|Withdrawal by Subject|2
7505978|NCT03178851|26047673|P3|Overall Study|Study Termination by Sponsor|26
7505979|NCT03178851|26047674|P2|Overall Study|Study Termination by Sponsor|7
7505980|NCT03178851|26047675|P1|Overall Study|Study Termination by Sponsor|31
7505981|NCT03178851|26047673|P3|Overall Study|Adverse Event|1
7505982|NCT03178851|26047674|P2|Overall Study|Adverse Event|0
7505983|NCT03178851|26047675|P1|Overall Study|Adverse Event|0
7505984|NCT03178851|26047673|P3|Overall Study|Lost to Follow-up|0
7505985|NCT03178851|26047674|P2|Overall Study|Lost to Follow-up|2
7505986|NCT03178851|26047675|P1|Overall Study|Lost to Follow-up|5
7505987|NCT03178851|26047673|P3|Overall Study|Withdrawal by Subject|0
7505988|NCT03178851|26047674|P2|Overall Study|Withdrawal by Subject|0
7505989|NCT03178851|26047675|P1|Overall Study|Withdrawal by Subject|8
7505990|NCT03178851|26047673|P3|Overall Study|Death|25
7505991|NCT03178851|26047674|P2|Overall Study|Death|2
7505992|NCT03178851|26047675|P1|Overall Study|Death|48
7505993|NCT03178773|26047712|P2|Overall Study|Withdrawal by Subject|14
7505994|NCT03178773|26047713|P1|Overall Study|Withdrawal by Subject|10
7505995|NCT03178773|26047712|P2|Overall Study|Lost to Follow-up|25
7505996|NCT03178773|26047713|P1|Overall Study|Lost to Follow-up|29
7505997|NCT03178773|26047712|P2|Overall Study|Death|1
7505998|NCT03178773|26047713|P1|Overall Study|Death|0
7505999|NCT03178669|26047825|P5|Overall Study|Lost to Follow-up|0
7506000|NCT03178669|26047826|P4|Overall Study|Lost to Follow-up|1
7506001|NCT03178669|26047827|P3|Overall Study|Lost to Follow-up|0
7506002|NCT03178669|26047828|P2|Overall Study|Lost to Follow-up|0
7506003|NCT03178669|26047829|P1|Overall Study|Lost to Follow-up|0
7506004|NCT03178669|26047825|P5|Overall Study|Withdrawal by Subject|0
7506005|NCT03178669|26047826|P4|Overall Study|Withdrawal by Subject|1
7506006|NCT03178669|26047827|P3|Overall Study|Withdrawal by Subject|1
7506007|NCT03178669|26047828|P2|Overall Study|Withdrawal by Subject|0
7506008|NCT03178669|26047829|P1|Overall Study|Withdrawal by Subject|1
7506009|NCT03178669|26047825|P5|Overall Study|Physician Decision|1
7506010|NCT03178669|26047826|P4|Overall Study|Physician Decision|0
7506011|NCT03178669|26047827|P3|Overall Study|Physician Decision|0
7506012|NCT03178669|26047828|P2|Overall Study|Physician Decision|0
7506013|NCT03178669|26047829|P1|Overall Study|Physician Decision|0
7506014|NCT03178669|26047825|P5|Overall Study|Lack of Efficacy|1
7506015|NCT03178669|26047826|P4|Overall Study|Lack of Efficacy|0
7506016|NCT03178669|26047827|P3|Overall Study|Lack of Efficacy|2
7506017|NCT03178669|26047828|P2|Overall Study|Lack of Efficacy|0
7506018|NCT03178669|26047829|P1|Overall Study|Lack of Efficacy|0
7506019|NCT03178669|26047825|P5|Overall Study|Adverse Event|2
7506020|NCT03178669|26047826|P4|Overall Study|Adverse Event|2
7506021|NCT03178669|26047827|P3|Overall Study|Adverse Event|4
7506022|NCT03178669|26047828|P2|Overall Study|Adverse Event|1
7506023|NCT03178669|26047829|P1|Overall Study|Adverse Event|4
7506024|NCT03178487|26047868|P2|Overall Study|Other|2
7506025|NCT03178487|26047869|P1|Overall Study|Other|0
7506026|NCT03178487|26047868|P2|Overall Study|Lost to Follow-up|0
7506027|NCT03178487|26047869|P1|Overall Study|Lost to Follow-up|1
7506028|NCT03178487|26047868|P2|Overall Study|Withdrawal by Subject|1
7506029|NCT03178487|26047869|P1|Overall Study|Withdrawal by Subject|2
7506030|NCT03178487|26047868|P2|Overall Study|Adverse Event|1
7506031|NCT03178487|26047869|P1|Overall Study|Adverse Event|1
7506032|NCT03178266|26047920|P2|Overall Study|Withdrawal by Subject|2
7506033|NCT03178266|26047921|P1|Overall Study|Withdrawal by Subject|0
7506034|NCT03178266|26047920|P2|Overall Study|Disont. Early|1
7506035|NCT03178266|26047921|P1|Overall Study|Disont. Early|0
7506036|NCT03178266|26047920|P2|Overall Study|Death|1
7506037|NCT03178266|26047921|P1|Overall Study|Death|0
7506038|NCT03178201|26047929|P1|Overall Study|Off study|5
7506039|NCT03178045|26047940|P2|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
7506040|NCT03178045|26047941|P1|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
7506041|NCT03178045|26047940|P2|Overall Study|Surgery Cancelled/Relocated|30
7506042|NCT03178045|26047941|P1|Overall Study|Surgery Cancelled/Relocated|34
7506043|NCT03178045|26047940|P2|Overall Study|Withdrawal by Subject|7
7506044|NCT03178045|26047941|P1|Overall Study|Withdrawal by Subject|5
7506045|NCT03176784|26048284|P4|Overall Study|Withdrawal by Subject|21
7506046|NCT03176784|26048285|P3|Overall Study|Withdrawal by Subject|34
7506047|NCT03176784|26048286|P2|Overall Study|Withdrawal by Subject|34
7506048|NCT03176784|26048287|P1|Overall Study|Withdrawal by Subject|28
7506049|NCT03176784|26048284|P4|Overall Study|Lost to Follow-up|49
7506050|NCT03176784|26048285|P3|Overall Study|Lost to Follow-up|79
7506051|NCT03176784|26048286|P2|Overall Study|Lost to Follow-up|79
7506052|NCT03176784|26048287|P1|Overall Study|Lost to Follow-up|77
7506053|NCT03176459|26048334|P2|Overall Study|Lost to Follow-up|7
7506054|NCT03176459|26048335|P1|Overall Study|Lost to Follow-up|5
7506055|NCT03176407|26048357|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
7506056|NCT03176407|26048357|P1|Overall Study|human failure|1
7506057|NCT03176407|26048357|P1|Overall Study|Protocol Violation|1
7506058|NCT03176238|26048367|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
7506059|NCT03176238|26048368|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
7506060|NCT03176238|26048367|P2|Overall Study|Changes in the patient's condition|1
7506061|NCT03176238|26048368|P1|Overall Study|Changes in the patient's condition|2
7506062|NCT03176238|26048367|P2|Overall Study|Protocol Violation|0
7506063|NCT03176238|26048368|P1|Overall Study|Protocol Violation|1
7506064|NCT03176238|26048367|P2|Overall Study|Patient is switched to commercial drug|1
7506065|NCT03176238|26048368|P1|Overall Study|Patient is switched to commercial drug|16
7506066|NCT03176238|26048367|P2|Overall Study|Tx duration completed per EAP|1
7506067|NCT03176238|26048368|P1|Overall Study|Tx duration completed per EAP|0
7506068|NCT03176238|26048367|P2|Overall Study|Disease Progression|22
7506069|NCT03176238|26048368|P1|Overall Study|Disease Progression|133
7506070|NCT03176238|26048367|P2|Overall Study|Death|0
7506071|NCT03176238|26048368|P1|Overall Study|Death|3
7506072|NCT03176238|26048367|P2|Overall Study|Administrative problems|0
7506073|NCT03176238|26048368|P1|Overall Study|Administrative problems|1
7506074|NCT03176238|26048367|P2|Overall Study|Lost to Follow-up|0
7506075|NCT03176238|26048368|P1|Overall Study|Lost to Follow-up|3
7506076|NCT03176238|26048367|P2|Overall Study|Consent withdrawal|2
7506077|NCT03176238|26048368|P1|Overall Study|Consent withdrawal|14
7506078|NCT03176238|26048367|P2|Overall Study|Inter-current illness|1
7506079|NCT03176238|26048368|P1|Overall Study|Inter-current illness|0
7506080|NCT03176238|26048367|P2|Overall Study|Abnormal lab value(s)|0
7506081|NCT03176238|26048368|P1|Overall Study|Abnormal lab value(s)|2
7506082|NCT03176238|26048367|P2|Overall Study|Unacceptable AEs|8
7506083|NCT03176238|26048368|P1|Overall Study|Unacceptable AEs|15
7506084|NCT03175562|26048400|P1|Overall Study|Other (Not Specified)|5
7506085|NCT03175562|26048400|P1|Overall Study|Withdrawal by Subject|7
7506086|NCT03175562|26048400|P1|Overall Study|Lost to Follow-up|3
7506087|NCT03175562|26048400|P1|Overall Study|Adverse Event|1
7506088|NCT03175172|26048425|P1|Overall Study|Study Terminated by Sponsor|3
7506089|NCT03175172|26048425|P1|Overall Study|Lost to Follow-up|1
7506090|NCT03175172|26048425|P1|Overall Study|Withdrawal by Subject|3
7506091|NCT03175172|26048425|P1|Overall Study|Death|3
7506092|NCT03175120|26048435|P2|Overall Study|Other|3
7506093|NCT03175120|26048436|P1|Overall Study|Other|2
7506094|NCT03175120|26048435|P2|Overall Study|Withdrawal by Subject|5
7506095|NCT03175120|26048436|P1|Overall Study|Withdrawal by Subject|2
7506096|NCT03175120|26048435|P2|Overall Study|Lost to Follow-up|0
7506097|NCT03175120|26048436|P1|Overall Study|Lost to Follow-up|1
7506098|NCT03175120|26048435|P2|Overall Study|Protocol Violation|2
7506099|NCT03175120|26048436|P1|Overall Study|Protocol Violation|5
7506100|NCT03175120|26048435|P2|Overall Study|Adverse Event|2
7506101|NCT03175120|26048436|P1|Overall Study|Adverse Event|2
7506102|NCT03174925|26048558|P1|Overall Study|Elastography image not interpretable|1
7506103|NCT03174925|26048558|P1|Overall Study|Elastographic images not retrievable|2
7506114|NCT03173547|26048648|P2|Overall Study|Withdrawal by Subject|2
7506115|NCT03173547|26048649|P1|Overall Study|Withdrawal by Subject|2
7506116|NCT03173547|26048648|P2|Overall Study|Adverse Event|0
7506117|NCT03173547|26048649|P1|Overall Study|Adverse Event|2
7506118|NCT03173313|26048659|P2|Overall Study|Bone Fracture|0
7506119|NCT03173313|26048660|P1|Overall Study|Bone Fracture|1
7506120|NCT03173313|26048659|P2|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
7506121|NCT03173313|26048660|P1|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
7506122|NCT03173313|26048659|P2|Overall Study|Physician Decision|0
7506123|NCT03173313|26048660|P1|Overall Study|Physician Decision|1
7506124|NCT03173313|26048659|P2|Overall Study|Death|0
7506125|NCT03173313|26048660|P1|Overall Study|Death|5
7506126|NCT03173313|26048659|P2|Overall Study|Withdrawal by Subject|1
7506127|NCT03173313|26048660|P1|Overall Study|Withdrawal by Subject|0
7506128|NCT03173313|26048659|P2|Overall Study|Lost to Follow-up|3
7506129|NCT03173313|26048660|P1|Overall Study|Lost to Follow-up|2
7506130|NCT03172702|26048733|P1|Overall Study|Other|2
7506131|NCT03172702|26048733|P1|Overall Study|Withdrawal by Subject|5
7506132|NCT03172702|26048733|P1|Overall Study|Study-specific Withdrawal Criteria|10
7506133|NCT03172702|26048733|P1|Overall Study|Death|2
7506134|NCT03172702|26048733|P1|Overall Study|Adverse Event|9
7506135|NCT03172494|26048761|P3|Overall Study|Non-compliance towards treatment|0
7506136|NCT03172494|26048762|P2|Overall Study|Non-compliance towards treatment|0
7506137|NCT03172494|26048763|P1|Overall Study|Non-compliance towards treatment|2
7506138|NCT03172494|26048761|P3|Overall Study|Severe hypoglycaemic episode|1
7506139|NCT03172494|26048762|P2|Overall Study|Severe hypoglycaemic episode|0
7506140|NCT03172494|26048763|P1|Overall Study|Severe hypoglycaemic episode|0
7506141|NCT03172494|26048761|P3|Overall Study|Withdrawal by Subject|8
7506142|NCT03172494|26048762|P2|Overall Study|Withdrawal by Subject|8
7506143|NCT03172494|26048763|P1|Overall Study|Withdrawal by Subject|10
7506144|NCT03172494|26048761|P3|Overall Study|Pregnancy|0
7506145|NCT03172494|26048762|P2|Overall Study|Pregnancy|1
7506146|NCT03172494|26048763|P1|Overall Study|Pregnancy|0
7506147|NCT03172494|26048761|P3|Overall Study|Lack of Efficacy|4
7506148|NCT03172494|26048762|P2|Overall Study|Lack of Efficacy|0
7506149|NCT03172494|26048763|P1|Overall Study|Lack of Efficacy|0
7506150|NCT03172494|26048761|P3|Overall Study|Protocol Violation|1
7506151|NCT03172494|26048762|P2|Overall Study|Protocol Violation|2
7506152|NCT03172494|26048763|P1|Overall Study|Protocol Violation|3
7506153|NCT03172494|26048761|P3|Overall Study|Adverse Event|15
7506154|NCT03172494|26048762|P2|Overall Study|Adverse Event|1
7506155|NCT03172494|26048763|P1|Overall Study|Adverse Event|5
7506156|NCT03172481|26048946|P2|Double-blind|Withdrawal by Subject|0
7506157|NCT03172481|26048947|P1|Double-blind|Withdrawal by Subject|1
7506158|NCT03172364|26048955|P2|Overall Study|Protocol Violation|0
7506159|NCT03172364|26048956|P1|Overall Study|Protocol Violation|1
7506160|NCT03172364|26048955|P2|Overall Study|Adverse Event|1
7506161|NCT03172364|26048956|P1|Overall Study|Adverse Event|1
7506162|NCT03172325|26048974|P2|Overall Study|Poor Compliance|1
7506163|NCT03172325|26048975|P1|Overall Study|Poor Compliance|1
7506164|NCT03172325|26048974|P2|Overall Study|Positive PPD|0
7506165|NCT03172325|26048975|P1|Overall Study|Positive PPD|1
7506166|NCT03172325|26048974|P2|Overall Study|Adverse Event|3
7506167|NCT03172325|26048975|P1|Overall Study|Adverse Event|2
7506168|NCT03172130|26048991|P2|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
7506169|NCT03172130|26048992|P1|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
7506170|NCT03172026|26049014|P2|Overall Study|COVID restrictions|0
7506171|NCT03172026|26049015|P1|Overall Study|COVID restrictions|1
7506172|NCT03172026|26049014|P2|Overall Study|Withdrawal by Subject|0
7506173|NCT03172026|26049015|P1|Overall Study|Withdrawal by Subject|1
7506174|NCT03171415|26049046|P5|Overall Study|Lost to Follow-up|2
7506175|NCT03171415|26049047|P4|Overall Study|Lost to Follow-up|0
7506176|NCT03171415|26049048|P3|Overall Study|Lost to Follow-up|0
7506177|NCT03171415|26049049|P2|Overall Study|Lost to Follow-up|0
7506178|NCT03171415|26049050|P1|Overall Study|Lost to Follow-up|0
7506179|NCT03170609|26049142|P7|Overall Study|Other|0
7506180|NCT03170609|26049143|P6|Overall Study|Other|1
7506181|NCT03170609|26049144|P5|Overall Study|Other|0
7506182|NCT03170609|26049145|P4|Overall Study|Other|0
7506183|NCT03170609|26049146|P3|Overall Study|Other|0
7506184|NCT03170609|26049147|P2|Overall Study|Other|0
7506185|NCT03170609|26049148|P1|Overall Study|Other|1
7506186|NCT03170609|26049142|P7|Overall Study|Lost to Follow-up|0
7506187|NCT03170609|26049143|P6|Overall Study|Lost to Follow-up|1
7506188|NCT03170609|26049144|P5|Overall Study|Lost to Follow-up|1
7506189|NCT03170609|26049145|P4|Overall Study|Lost to Follow-up|2
7506190|NCT03170609|26049146|P3|Overall Study|Lost to Follow-up|5
7506191|NCT03170609|26049147|P2|Overall Study|Lost to Follow-up|0
7506192|NCT03170609|26049148|P1|Overall Study|Lost to Follow-up|1
7506193|NCT03170609|26049142|P7|Overall Study|Withdrawal by Subject|1
7506194|NCT03170609|26049143|P6|Overall Study|Withdrawal by Subject|0
7506195|NCT03170609|26049144|P5|Overall Study|Withdrawal by Subject|0
7506196|NCT03170609|26049145|P4|Overall Study|Withdrawal by Subject|0
7506197|NCT03170609|26049146|P3|Overall Study|Withdrawal by Subject|0
7506198|NCT03170609|26049147|P2|Overall Study|Withdrawal by Subject|2
7506199|NCT03170609|26049148|P1|Overall Study|Withdrawal by Subject|1
7506200|NCT03170609|26049142|P7|Overall Study|Death|0
7506201|NCT03170609|26049143|P6|Overall Study|Death|0
7506202|NCT03170609|26049144|P5|Overall Study|Death|0
7506203|NCT03170609|26049145|P4|Overall Study|Death|0
7506204|NCT03170609|26049146|P3|Overall Study|Death|1
7506205|NCT03170609|26049147|P2|Overall Study|Death|0
7506206|NCT03170609|26049148|P1|Overall Study|Death|0
7506207|NCT03170544|26049218|P12|Part 1|Not treated|0
7506208|NCT03170544|26049219|P11|Part 1|Not treated|0
7506209|NCT03170544|26049220|P10|Part 1|Not treated|0
7506210|NCT03170544|26049221|P9|Part 1|Not treated|0
7506211|NCT03170544|26049222|P8|Part 1|Not treated|0
7506212|NCT03170544|26049223|P7|Part 1|Not treated|0
7506213|NCT03170544|26049224|P6|Part 1|Not treated|0
7506214|NCT03170544|26049225|P5|Part 1|Not treated|0
7506215|NCT03170544|26049226|P4|Part 1|Not treated|1
7506216|NCT03170544|26049227|P3|Part 1|Not treated|0
7506217|NCT03170544|26049228|P2|Part 1|Not treated|0
7506218|NCT03170544|26049229|P1|Part 1|Not treated|0
7506219|NCT03170544|26049218|P12|Part 1|Lost to Follow-up|0
7506220|NCT03170544|26049219|P11|Part 1|Lost to Follow-up|0
7506221|NCT03170544|26049220|P10|Part 1|Lost to Follow-up|0
7506222|NCT03170544|26049221|P9|Part 1|Lost to Follow-up|0
7506223|NCT03170544|26049222|P8|Part 1|Lost to Follow-up|0
7506224|NCT03170544|26049223|P7|Part 1|Lost to Follow-up|0
7506225|NCT03170544|26049224|P6|Part 1|Lost to Follow-up|0
7506226|NCT03170544|26049225|P5|Part 1|Lost to Follow-up|0
7506227|NCT03170544|26049226|P4|Part 1|Lost to Follow-up|0
7506228|NCT03170544|26049227|P3|Part 1|Lost to Follow-up|0
7506229|NCT03170544|26049228|P2|Part 1|Lost to Follow-up|0
7506230|NCT03170544|26049229|P1|Part 1|Lost to Follow-up|1
7506231|NCT03170271|26049393|P2|Overall Study|Randomized in error|0
7506232|NCT03170271|26049394|P1|Overall Study|Randomized in error|4
7506233|NCT03170271|26049393|P2|Overall Study|Other|2
7506234|NCT03170271|26049394|P1|Overall Study|Other|2
7506235|NCT03170271|26049393|P2|Overall Study|Withdrawal by Subject|5
7506236|NCT03170271|26049394|P1|Overall Study|Withdrawal by Subject|17
7506237|NCT03170271|26049393|P2|Overall Study|Protocol-specified withdrawal criterion|1
7506238|NCT03170271|26049394|P1|Overall Study|Protocol-specified withdrawal criterion|2
7506239|NCT03170271|26049393|P2|Overall Study|Physician Decision|0
7506240|NCT03170271|26049394|P1|Overall Study|Physician Decision|1
7506241|NCT03170271|26049393|P2|Overall Study|Lost to Follow-up|1
7506242|NCT03170271|26049394|P1|Overall Study|Lost to Follow-up|0
7506243|NCT03170271|26049393|P2|Overall Study|Adverse Event|2
7506244|NCT03170271|26049394|P1|Overall Study|Adverse Event|7
7506245|NCT03170232|26049422|P2|Overall Study|Withdrawal by Subject|1
7506246|NCT03170232|26049423|P1|Overall Study|Withdrawal by Subject|0
7506247|NCT03170232|26049422|P2|Overall Study|Lost to Follow-up|0
7506248|NCT03170232|26049423|P1|Overall Study|Lost to Follow-up|1
7506249|NCT03170232|26049422|P2|Overall Study|Study closed/terminated|23
7506250|NCT03170232|26049423|P1|Overall Study|Study closed/terminated|26
7506251|NCT03170232|26049422|P2|Overall Study|Lack of Efficacy|1
7506252|NCT03170232|26049423|P1|Overall Study|Lack of Efficacy|0
7506253|NCT03170232|26049422|P2|Overall Study|Protocol Violation|1
7506254|NCT03170232|26049423|P1|Overall Study|Protocol Violation|0
7506255|NCT03170232|26049422|P2|Overall Study|Adverse Event|1
7506256|NCT03170232|26049423|P1|Overall Study|Adverse Event|0
7506257|NCT03170193|26049501|P7|Overall Study|Lost to Follow-up|0
7506258|NCT03170193|26049502|P6|Overall Study|Lost to Follow-up|0
7506259|NCT03170193|26049503|P5|Overall Study|Lost to Follow-up|0
7506260|NCT03170193|26049504|P4|Overall Study|Lost to Follow-up|0
7506261|NCT03170193|26049505|P3|Overall Study|Lost to Follow-up|0
7506262|NCT03170193|26049506|P2|Overall Study|Lost to Follow-up|1
7506263|NCT03170193|26049507|P1|Overall Study|Lost to Follow-up|1
7506264|NCT03170193|26049501|P7|Overall Study|Withdrawal by Subject|0
7506265|NCT03170193|26049502|P6|Overall Study|Withdrawal by Subject|0
7506266|NCT03170193|26049503|P5|Overall Study|Withdrawal by Subject|0
7506267|NCT03170193|26049504|P4|Overall Study|Withdrawal by Subject|1
7506268|NCT03170193|26049505|P3|Overall Study|Withdrawal by Subject|0
7506269|NCT03170193|26049506|P2|Overall Study|Withdrawal by Subject|0
7506270|NCT03170193|26049507|P1|Overall Study|Withdrawal by Subject|0
7506271|NCT03170154|26049576|P1|Overall Study|Withdrawal by Subject|2
7506272|NCT03170154|26049576|P1|Overall Study|Death|2
7506273|NCT03170154|26049576|P1|Overall Study|Lost to Follow-up|4
7506274|NCT03169530|26049600|P2|Overall Study|Study ended by NIH|17
7506275|NCT03169530|26049601|P1|Overall Study|Study ended by NIH|15
7506276|NCT03169244|26049621|P2|Overall Study|Physician Decision|0
7506277|NCT03169244|26049622|P1|Overall Study|Physician Decision|1
7506278|NCT03169244|26049621|P2|Overall Study|Withdrawal by Subject|2
7506279|NCT03169244|26049622|P1|Overall Study|Withdrawal by Subject|2
7506280|NCT03169244|26049621|P2|Overall Study|Adverse Event|0
7506281|NCT03169244|26049622|P1|Overall Study|Adverse Event|1
7506282|NCT03169244|26049621|P2|Overall Study|Lost to Follow-up|2
7506283|NCT03169244|26049622|P1|Overall Study|Lost to Follow-up|1
7506284|NCT03169153|26049632|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
7506285|NCT03169153|26049633|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
7506286|NCT03169153|26049632|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
7506287|NCT03169153|26049633|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
7506288|NCT03169153|26049632|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
7506289|NCT03169153|26049633|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
7506290|NCT03169153|26049632|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7506291|NCT03169153|26049633|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7506292|NCT03168919|26049644|P1|Overall Study|Withdrawal by Subject|2
7506293|NCT03168906|26049654|P2|Overall Study|Lack of Efficacy|6
7506294|NCT03168906|26049655|P1|Overall Study|Lack of Efficacy|6
7506295|NCT03168711|26049684|P2|Overall Study|Death|1
7506296|NCT03168711|26049685|P1|Overall Study|Death|0
7506297|NCT03168711|26049684|P2|Overall Study|Withdrawal by Subject|1
7506298|NCT03168711|26049685|P1|Overall Study|Withdrawal by Subject|0
7506299|NCT03168711|26049684|P2|Overall Study|Adverse Event|0
7506300|NCT03168711|26049685|P1|Overall Study|Adverse Event|2
7506301|NCT03168425|26049712|P2|Overall Study|unable to confirm post op opioids|3
7506302|NCT03168425|26049713|P1|Overall Study|unable to confirm post op opioids|2
7506303|NCT03168425|26049712|P2|Overall Study|Lost to Follow-up|8
7506304|NCT03168425|26049713|P1|Overall Study|Lost to Follow-up|5
7506305|NCT03167411|26049827|P2|Overall Study|Adverse Event|1
7506306|NCT03167411|26049828|P1|Overall Study|Adverse Event|0
7506307|NCT03167359|26049842|P1|Overall Study|Lost to Follow-up|1
7506308|NCT03167359|26049842|P1|Overall Study|Physician Decision|1
7506309|NCT03167151|26049868|P3|Overall Study|No evidence of tumour at surgery|1
7506310|NCT03167151|26049869|P2|Overall Study|No evidence of tumour at surgery|1
7506311|NCT03167151|26049870|P1|Overall Study|No evidence of tumour at surgery|0
7506312|NCT03167151|26049868|P3|Overall Study|Withdrawal by Subject|0
7506313|NCT03167151|26049869|P2|Overall Study|Withdrawal by Subject|0
7506314|NCT03167151|26049870|P1|Overall Study|Withdrawal by Subject|1
7506315|NCT03167073|26049880|P2|Overall Study|Stillbirth|0
7506316|NCT03167073|26049881|P1|Overall Study|Stillbirth|1
7506317|NCT03166735|26049910|P5|Overall Study|Lost to Follow-up|1
7506318|NCT03166735|26049911|P4|Overall Study|Lost to Follow-up|0
7506319|NCT03166735|26049912|P3|Overall Study|Lost to Follow-up|1
7506320|NCT03166735|26049913|P2|Overall Study|Lost to Follow-up|2
7506321|NCT03166735|26049914|P1|Overall Study|Lost to Follow-up|0
7506322|NCT03166735|26049910|P5|Overall Study|Withdrawal by Subject|2
7506323|NCT03166735|26049911|P4|Overall Study|Withdrawal by Subject|1
7506324|NCT03166735|26049912|P3|Overall Study|Withdrawal by Subject|1
7506325|NCT03166735|26049913|P2|Overall Study|Withdrawal by Subject|0
7506326|NCT03166735|26049914|P1|Overall Study|Withdrawal by Subject|0
7506327|NCT03166735|26049910|P5|Overall Study|follow-up not completed as planned|1
7506328|NCT03166735|26049911|P4|Overall Study|follow-up not completed as planned|0
7506329|NCT03166735|26049912|P3|Overall Study|follow-up not completed as planned|1
7506330|NCT03166735|26049913|P2|Overall Study|follow-up not completed as planned|1
7506331|NCT03166735|26049914|P1|Overall Study|follow-up not completed as planned|0
7506332|NCT03166735|26049910|P5|Overall Study|Not Treated|0
7506333|NCT03166735|26049911|P4|Overall Study|Not Treated|0
7506334|NCT03166735|26049912|P3|Overall Study|Not Treated|0
7506335|NCT03166735|26049913|P2|Overall Study|Not Treated|0
7506336|NCT03166735|26049914|P1|Overall Study|Not Treated|1
7506337|NCT03166618|26049964|P2|Overall Study|Study was Terminated|1
7506338|NCT03166618|26049965|P1|Overall Study|Study was Terminated|0
7506339|NCT03166215|26049977|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
7506340|NCT03166215|26049978|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7506341|NCT03166215|26049979|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7506342|NCT03166215|26049977|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7506343|NCT03166215|26049978|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
7506344|NCT03166215|26049979|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7506345|NCT03166124|26050019|P4|Wash-out Period|Adverse Event|0
7506346|NCT03166124|26050020|P3|Wash-out Period|Adverse Event|1
7506347|NCT03166124|26050021|P2|Wash-out Period|Adverse Event|1
7506348|NCT03166124|26050022|P1|Wash-out Period|Adverse Event|0
7506349|NCT03166124|26050019|P4|Wash-out Period|Withdrawal by Subject|1
7506350|NCT03166124|26050020|P3|Wash-out Period|Withdrawal by Subject|0
7506351|NCT03166124|26050021|P2|Wash-out Period|Withdrawal by Subject|1
7506352|NCT03166124|26050022|P1|Wash-out Period|Withdrawal by Subject|0
7506353|NCT03166124|26050019|P4|Treatment Period 1|Adverse Event|0
7506354|NCT03166124|26050020|P3|Treatment Period 1|Adverse Event|1
7506355|NCT03166124|26050021|P2|Treatment Period 1|Adverse Event|0
7506356|NCT03166124|26050022|P1|Treatment Period 1|Adverse Event|0
7506357|NCT03165955|26050067|P1|Treatment|Progressive disease|3
7506358|NCT03165955|26050067|P1|Treatment|Adverse Event|1
7506359|NCT03165955|26050067|P1|Treatment|Death|1
7506360|NCT03165955|26050067|P1|Treatment|Withdrawal by Subject|3
7506361|NCT03165721|26050127|P3|Overall Study|Physician Decision|0
7506362|NCT03165721|26050128|P2|Overall Study|Physician Decision|0
7506363|NCT03165721|26050129|P1|Overall Study|Physician Decision|1
7506364|NCT03165721|26050127|P3|Overall Study|Refused further treatment|0
7506365|NCT03165721|26050128|P2|Overall Study|Refused further treatment|0
7506366|NCT03165721|26050129|P1|Overall Study|Refused further treatment|3
7506367|NCT03165110|26050237|P1|Overall Study|Anroid phone software incompatibility|1
7506368|NCT03165045|26050259|P1|Visit 2|Available total CCQ score at vist 2 only|44
7506369|NCT03165045|26050259|P1|Visit 2|No available total CCQ score at all|29
7506370|NCT03165045|26050259|P1|Visit 2|Available CCQ score at visit 1 only|109
7506371|NCT03165045|26050259|P1|Visit 1|No visit 1|10
7506372|NCT03165045|26050259|P1|Visit 1|No treatment documented|10
7506373|NCT03165045|26050259|P1|Visit 1|No registration after visit 1|9
7506374|NCT03164551|26050279|P2|Overall Study|Other|2
7506375|NCT03164551|26050280|P1|Overall Study|Other|8
7506376|NCT03164551|26050279|P2|Overall Study|Cancellation of Fresh Embryo Transfer|14
7506377|NCT03164551|26050280|P1|Overall Study|Cancellation of Fresh Embryo Transfer|12
7506378|NCT03164551|26050279|P2|Overall Study|Participant was non-compliant|0
7506379|NCT03164551|26050280|P1|Overall Study|Participant was non-compliant|1
7506380|NCT03164551|26050279|P2|Overall Study|Imaging discontinued prior completion|0
7506381|NCT03164551|26050280|P1|Overall Study|Imaging discontinued prior completion|8
7506382|NCT03163446|26050392|P2|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
7506383|NCT03163446|26050393|P1|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
7506384|NCT03163446|26050392|P2|Overall Study|Physician Decision|1
7506385|NCT03163446|26050393|P1|Overall Study|Physician Decision|1
7506386|NCT03163446|26050392|P2|Overall Study|Lost to Follow-up|5
7506387|NCT03163446|26050393|P1|Overall Study|Lost to Follow-up|6
7506388|NCT03163446|26050392|P2|Overall Study|Death|5
7506389|NCT03163446|26050393|P1|Overall Study|Death|16
7506390|NCT03163446|26050392|P2|Overall Study|Withdrawal by Subject|6
7506391|NCT03163446|26050393|P1|Overall Study|Withdrawal by Subject|2
7506392|NCT03163446|26050392|P2|Overall Study|Unable to return for Day 180 visit|0
7506393|NCT03163446|26050393|P1|Overall Study|Unable to return for Day 180 visit|2
7506394|NCT03162796|26050497|P3|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7506395|NCT03162796|26050498|P2|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
7506396|NCT03162796|26050499|P1|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7506397|NCT03162796|26050497|P3|Active Treatment Period: Week 24 - 52|Adverse Event|0
7506398|NCT03162796|26050498|P2|Active Treatment Period: Week 24 - 52|Adverse Event|2
7506399|NCT03162796|26050499|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
7506400|NCT03162796|26050497|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
7506401|NCT03162796|26050498|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7506402|NCT03162796|26050499|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7506403|NCT03162796|26050497|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7506404|NCT03162796|26050498|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7506405|NCT03162796|26050499|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7506406|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
7506407|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
7506408|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
7506409|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7506410|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7506411|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
7506412|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
7506413|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
7506414|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
7506415|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7506416|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7506417|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
7506418|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Death|0
7506419|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Death|0
7506420|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Death|1
7506589|NCT03160885|26051218|P2|Open-label Treatment|Discontinued IMP|0
7506421|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7506422|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7506423|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
7506424|NCT03162796|26050497|P3|Placebo Controlled Period: Week 0 - 24|Other|1
7506425|NCT03162796|26050498|P2|Placebo Controlled Period: Week 0 - 24|Other|1
7506426|NCT03162796|26050499|P1|Placebo Controlled Period: Week 0 - 24|Other|0
7506427|NCT03162614|26050809|P6|Overall Study|Missed vaccination, exclusion criteria|0
7506428|NCT03162614|26050810|P5|Overall Study|Missed vaccination, exclusion criteria|3
7506429|NCT03162614|26050811|P4|Overall Study|Missed vaccination, exclusion criteria|4
7506430|NCT03162614|26050812|P3|Overall Study|Missed vaccination, exclusion criteria|2
7506431|NCT03162614|26050813|P2|Overall Study|Missed vaccination, exclusion criteria|2
7506432|NCT03162614|26050814|P1|Overall Study|Missed vaccination, exclusion criteria|2
7506433|NCT03162614|26050809|P6|Overall Study|Withdrawal by Subject|0
7506434|NCT03162614|26050810|P5|Overall Study|Withdrawal by Subject|0
7506435|NCT03162614|26050811|P4|Overall Study|Withdrawal by Subject|1
7506436|NCT03162614|26050812|P3|Overall Study|Withdrawal by Subject|1
7506437|NCT03162614|26050813|P2|Overall Study|Withdrawal by Subject|1
7506438|NCT03162614|26050814|P1|Overall Study|Withdrawal by Subject|2
7506439|NCT03162614|26050809|P6|Overall Study|Protocol Violation|0
7506440|NCT03162614|26050810|P5|Overall Study|Protocol Violation|0
7506441|NCT03162614|26050811|P4|Overall Study|Protocol Violation|1
7506442|NCT03162614|26050812|P3|Overall Study|Protocol Violation|0
7506443|NCT03162614|26050813|P2|Overall Study|Protocol Violation|1
7506444|NCT03162614|26050814|P1|Overall Study|Protocol Violation|0
7506445|NCT03162614|26050809|P6|Overall Study|Lost to Follow-up|0
7506446|NCT03162614|26050810|P5|Overall Study|Lost to Follow-up|2
7506447|NCT03162614|26050811|P4|Overall Study|Lost to Follow-up|1
7506448|NCT03162614|26050812|P3|Overall Study|Lost to Follow-up|1
7506449|NCT03162614|26050813|P2|Overall Study|Lost to Follow-up|1
7506450|NCT03162614|26050814|P1|Overall Study|Lost to Follow-up|2
7506451|NCT03162328|26050967|P3|Study Period|Withdrawal by Subject|1
7506452|NCT03162328|26050968|P2|Study Period|Withdrawal by Subject|0
7506453|NCT03162328|26050969|P1|Study Period|Withdrawal by Subject|0
7506454|NCT03162328|26050967|P3|Screening Period|Withdrawal by Subject|0
7506455|NCT03162328|26050968|P2|Screening Period|Withdrawal by Subject|0
7506456|NCT03162328|26050969|P1|Screening Period|Withdrawal by Subject|1
7506457|NCT03162328|26050967|P3|Screening Period|Did not meet inclusion/exclusion|0
7506458|NCT03162328|26050968|P2|Screening Period|Did not meet inclusion/exclusion|0
7506459|NCT03162328|26050969|P1|Screening Period|Did not meet inclusion/exclusion|21
7506460|NCT03162055|26050998|P2|Overall Study|Other|15
7506461|NCT03162055|26050999|P1|Overall Study|Other|8
7506462|NCT03162055|26050998|P2|Overall Study|Incorrect randomization|3
7506463|NCT03162055|26050999|P1|Overall Study|Incorrect randomization|4
7506464|NCT03162055|26050998|P2|Overall Study|Did not receive treatment|0
7506465|NCT03162055|26050999|P1|Overall Study|Did not receive treatment|2
7506466|NCT03162055|26050998|P2|Overall Study|Withdrawal by Subject|2
7506467|NCT03162055|26050999|P1|Overall Study|Withdrawal by Subject|17
7506468|NCT03162055|26050998|P2|Overall Study|Study-specific withdrawal criteria|14
7506469|NCT03162055|26050999|P1|Overall Study|Study-specific withdrawal criteria|22
7506470|NCT03162055|26050998|P2|Overall Study|Lost to Follow-up|1
7506471|NCT03162055|26050999|P1|Overall Study|Lost to Follow-up|0
7506472|NCT03162055|26050998|P2|Overall Study|Death|3
7506473|NCT03162055|26050999|P1|Overall Study|Death|3
7506474|NCT03162055|26050998|P2|Overall Study|Adverse Event|5
7506475|NCT03162055|26050999|P1|Overall Study|Adverse Event|6
7506476|NCT03161483|26051095|P4|Overall Study|Other reasons|1
7506477|NCT03161483|26051096|P3|Overall Study|Other reasons|0
7506478|NCT03161483|26051097|P2|Overall Study|Other reasons|0
7506479|NCT03161483|26051098|P1|Overall Study|Other reasons|1
7506480|NCT03161483|26051095|P4|Overall Study|Protocol Violation|0
7506481|NCT03161483|26051096|P3|Overall Study|Protocol Violation|1
7506482|NCT03161483|26051097|P2|Overall Study|Protocol Violation|0
7506483|NCT03161483|26051098|P1|Overall Study|Protocol Violation|0
7506484|NCT03161483|26051095|P4|Overall Study|Lost to Follow-up|0
7506485|NCT03161483|26051096|P3|Overall Study|Lost to Follow-up|1
7506486|NCT03161483|26051097|P2|Overall Study|Lost to Follow-up|0
7506487|NCT03161483|26051098|P1|Overall Study|Lost to Follow-up|0
7506488|NCT03161483|26051095|P4|Overall Study|Withdrawal by Subject|5
7506489|NCT03161483|26051096|P3|Overall Study|Withdrawal by Subject|6
7506490|NCT03161483|26051097|P2|Overall Study|Withdrawal by Subject|2
7506491|NCT03161483|26051098|P1|Overall Study|Withdrawal by Subject|2
7506492|NCT03161483|26051095|P4|Overall Study|Lack of Efficacy|0
7506493|NCT03161483|26051096|P3|Overall Study|Lack of Efficacy|1
7506494|NCT03161483|26051097|P2|Overall Study|Lack of Efficacy|0
7506495|NCT03161483|26051098|P1|Overall Study|Lack of Efficacy|0
7506496|NCT03161483|26051095|P4|Overall Study|Pregnancy|0
7506497|NCT03161483|26051096|P3|Overall Study|Pregnancy|0
7506498|NCT03161483|26051097|P2|Overall Study|Pregnancy|0
7506499|NCT03161483|26051098|P1|Overall Study|Pregnancy|1
7506500|NCT03161483|26051095|P4|Overall Study|Adverse Event|2
7506501|NCT03161483|26051096|P3|Overall Study|Adverse Event|11
7506502|NCT03161483|26051097|P2|Overall Study|Adverse Event|1
7506503|NCT03161483|26051098|P1|Overall Study|Adverse Event|5
7506504|NCT03161483|26051095|P4|Overall Study|Death|0
7506505|NCT03161483|26051096|P3|Overall Study|Death|0
7506506|NCT03161483|26051097|P2|Overall Study|Death|0
7506507|NCT03161483|26051098|P1|Overall Study|Death|1
7506508|NCT03161405|26051156|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
7506509|NCT03160898|26051187|P4|Overall Study|Other|2
7506510|NCT03160898|26051188|P3|Overall Study|Other|2
7506511|NCT03160898|26051189|P2|Overall Study|Other|0
7506512|NCT03160898|26051190|P1|Overall Study|Other|2
7506513|NCT03160898|26051187|P4|Overall Study|Withdrawal by Subject|1
7506514|NCT03160898|26051188|P3|Overall Study|Withdrawal by Subject|2
7506515|NCT03160898|26051189|P2|Overall Study|Withdrawal by Subject|3
7506516|NCT03160898|26051190|P1|Overall Study|Withdrawal by Subject|1
7506517|NCT03160898|26051187|P4|Overall Study|Sponsor Discretion|0
7506518|NCT03160898|26051188|P3|Overall Study|Sponsor Discretion|0
7506519|NCT03160898|26051189|P2|Overall Study|Sponsor Discretion|0
7506520|NCT03160898|26051190|P1|Overall Study|Sponsor Discretion|2
7506521|NCT03160898|26051187|P4|Overall Study|Protocol Violation|0
7506522|NCT03160898|26051188|P3|Overall Study|Protocol Violation|2
7506523|NCT03160898|26051189|P2|Overall Study|Protocol Violation|0
7506524|NCT03160898|26051190|P1|Overall Study|Protocol Violation|1
7506525|NCT03160898|26051187|P4|Overall Study|Progressive Disease|1
7506526|NCT03160898|26051188|P3|Overall Study|Progressive Disease|2
7506527|NCT03160898|26051189|P2|Overall Study|Progressive Disease|1
7506528|NCT03160898|26051190|P1|Overall Study|Progressive Disease|4
7506529|NCT03160898|26051187|P4|Overall Study|Physician Decision|1
7506530|NCT03160898|26051188|P3|Overall Study|Physician Decision|0
7506531|NCT03160898|26051189|P2|Overall Study|Physician Decision|0
7506532|NCT03160898|26051190|P1|Overall Study|Physician Decision|1
7506533|NCT03160898|26051187|P4|Overall Study|Lost to Follow-up|2
7506534|NCT03160898|26051188|P3|Overall Study|Lost to Follow-up|1
7506535|NCT03160898|26051189|P2|Overall Study|Lost to Follow-up|1
7506536|NCT03160898|26051190|P1|Overall Study|Lost to Follow-up|1
7506537|NCT03160898|26051187|P4|Overall Study|Difficulty Traveling to Clinic Visits|1
7506538|NCT03160898|26051188|P3|Overall Study|Difficulty Traveling to Clinic Visits|0
7506539|NCT03160898|26051189|P2|Overall Study|Difficulty Traveling to Clinic Visits|0
7506540|NCT03160898|26051190|P1|Overall Study|Difficulty Traveling to Clinic Visits|3
7506541|NCT03160898|26051187|P4|Overall Study|Death|1
7506542|NCT03160898|26051188|P3|Overall Study|Death|0
7506543|NCT03160898|26051189|P2|Overall Study|Death|0
7506544|NCT03160898|26051190|P1|Overall Study|Death|1
7506545|NCT03160898|26051187|P4|Overall Study|Adverse Event|10
7506546|NCT03160898|26051188|P3|Overall Study|Adverse Event|7
7506547|NCT03160898|26051189|P2|Overall Study|Adverse Event|8
7506548|NCT03160898|26051190|P1|Overall Study|Adverse Event|4
7506549|NCT03160885|26051213|P7|Maintenance Treatment Period|Completed Week 50|0
7506550|NCT03160885|26051214|P6|Maintenance Treatment Period|Completed Week 50|0
7506551|NCT03160885|26051215|P5|Maintenance Treatment Period|Completed Week 50|0
7506552|NCT03160885|26051216|P4|Maintenance Treatment Period|Completed Week 50|0
7506553|NCT03160885|26051217|P3|Maintenance Treatment Period|Completed Week 50|1
7506554|NCT03160885|26051218|P2|Maintenance Treatment Period|Completed Week 50|0
7506555|NCT03160885|26051219|P1|Maintenance Treatment Period|Completed Week 50|0
7506556|NCT03160885|26051213|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
7506557|NCT03160885|26051214|P6|Maintenance Treatment Period|Transfer to open-label treatment|8
7506558|NCT03160885|26051215|P5|Maintenance Treatment Period|Transfer to open-label treatment|26
7506559|NCT03160885|26051216|P4|Maintenance Treatment Period|Transfer to open-label treatment|26
7506560|NCT03160885|26051217|P3|Maintenance Treatment Period|Transfer to open-label treatment|29
7506561|NCT03160885|26051218|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
7506562|NCT03160885|26051219|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
7506563|NCT03160885|26051213|P7|Maintenance Treatment Period|Discontinued IMP|0
7506564|NCT03160885|26051214|P6|Maintenance Treatment Period|Discontinued IMP|7
7506565|NCT03160885|26051215|P5|Maintenance Treatment Period|Discontinued IMP|5
7506566|NCT03160885|26051216|P4|Maintenance Treatment Period|Discontinued IMP|13
7506567|NCT03160885|26051217|P3|Maintenance Treatment Period|Discontinued IMP|9
7506568|NCT03160885|26051218|P2|Maintenance Treatment Period|Discontinued IMP|0
7506569|NCT03160885|26051219|P1|Maintenance Treatment Period|Discontinued IMP|0
7506570|NCT03160885|26051213|P7|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7506571|NCT03160885|26051214|P6|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7506572|NCT03160885|26051215|P5|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7506573|NCT03160885|26051216|P4|Maintenance Treatment Period|Not dosed - transfer to open-label|1
7506574|NCT03160885|26051217|P3|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7506575|NCT03160885|26051218|P2|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7506576|NCT03160885|26051219|P1|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7506577|NCT03160885|26051213|P7|Open-label Treatment|Completed Week 50|4
7506578|NCT03160885|26051214|P6|Open-label Treatment|Completed Week 50|0
7506579|NCT03160885|26051215|P5|Open-label Treatment|Completed Week 50|0
7506580|NCT03160885|26051216|P4|Open-label Treatment|Completed Week 50|0
7506581|NCT03160885|26051217|P3|Open-label Treatment|Completed Week 50|0
7506582|NCT03160885|26051218|P2|Open-label Treatment|Completed Week 50|0
7506583|NCT03160885|26051219|P1|Open-label Treatment|Completed Week 50|0
7506584|NCT03160885|26051213|P7|Open-label Treatment|Discontinued IMP|131
7506585|NCT03160885|26051214|P6|Open-label Treatment|Discontinued IMP|0
7506586|NCT03160885|26051215|P5|Open-label Treatment|Discontinued IMP|0
7506587|NCT03160885|26051216|P4|Open-label Treatment|Discontinued IMP|0
7506588|NCT03160885|26051217|P3|Open-label Treatment|Discontinued IMP|0
7506590|NCT03160885|26051219|P1|Open-label Treatment|Discontinued IMP|0
7506591|NCT03160885|26051213|P7|Open-label Treatment|Not dosed|2
7506592|NCT03160885|26051214|P6|Open-label Treatment|Not dosed|0
7506593|NCT03160885|26051215|P5|Open-label Treatment|Not dosed|0
7506594|NCT03160885|26051216|P4|Open-label Treatment|Not dosed|0
7506595|NCT03160885|26051217|P3|Open-label Treatment|Not dosed|0
7506596|NCT03160885|26051218|P2|Open-label Treatment|Not dosed|0
7506597|NCT03160885|26051219|P1|Open-label Treatment|Not dosed|0
7506598|NCT03160885|26051213|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
7506599|NCT03160885|26051214|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
7506600|NCT03160885|26051215|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
7506601|NCT03160885|26051216|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
7506602|NCT03160885|26051217|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
7506603|NCT03160885|26051218|P2|Initial Treatment Period|Discontinued IMP before Week 16|22
7506604|NCT03160885|26051219|P1|Initial Treatment Period|Discontinued IMP before Week 16|33
7506605|NCT03160885|26051213|P7|Initial Treatment Period|Not dosed|0
7506606|NCT03160885|26051214|P6|Initial Treatment Period|Not dosed|0
7506607|NCT03160885|26051215|P5|Initial Treatment Period|Not dosed|0
7506608|NCT03160885|26051216|P4|Initial Treatment Period|Not dosed|0
7506609|NCT03160885|26051217|P3|Initial Treatment Period|Not dosed|0
7506610|NCT03160885|26051218|P2|Initial Treatment Period|Not dosed|0
7506611|NCT03160885|26051219|P1|Initial Treatment Period|Not dosed|2
7506612|NCT03160716|26051265|P1|Overall Study|Lost to Follow-up|1
7506613|NCT03160703|26051276|P4|Overall Study|Withdrawal by Subject|1
7506614|NCT03160703|26051277|P3|Overall Study|Withdrawal by Subject|0
7506615|NCT03160703|26051278|P2|Overall Study|Withdrawal by Subject|0
7506616|NCT03160703|26051279|P1|Overall Study|Withdrawal by Subject|0
7506617|NCT03160573|26051293|P4|First Sequence (3 Weeks)|Withdrawal by Subject|2
7506618|NCT03160573|26051294|P3|First Sequence (3 Weeks)|Withdrawal by Subject|2
7506619|NCT03160573|26051295|P2|First Sequence (3 Weeks)|Withdrawal by Subject|3
7506620|NCT03160573|26051296|P1|First Sequence (3 Weeks)|Withdrawal by Subject|1
7506621|NCT03160560|26051310|P4|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7506622|NCT03160560|26051311|P3|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7506623|NCT03160560|26051312|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7506624|NCT03160560|26051313|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7506625|NCT03160560|26051310|P4|First Intervention (3 Weeks)|Withdrawal by Subject|0
7506626|NCT03160560|26051311|P3|First Intervention (3 Weeks)|Withdrawal by Subject|1
7506627|NCT03160560|26051312|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
7506628|NCT03160560|26051313|P1|First Intervention (3 Weeks)|Withdrawal by Subject|2
7506629|NCT03159611|26051399|P2|Overall Study|Inability to perform procedures|0
7506630|NCT03159611|26051400|P1|Overall Study|Inability to perform procedures|1
7506631|NCT03159611|26051399|P2|Overall Study|Non-compliance with protocol requirement|2
7506632|NCT03159611|26051400|P1|Overall Study|Non-compliance with protocol requirement|3
7506633|NCT03159611|26051399|P2|Overall Study|Withdrawal by Subject|1
7506634|NCT03159611|26051400|P1|Overall Study|Withdrawal by Subject|1
7506635|NCT03159611|26051399|P2|Overall Study|Adverse Event|0
7506636|NCT03159611|26051400|P1|Overall Study|Adverse Event|1
7506637|NCT03159611|26051399|P2|Overall Study|Protocol Violation|4
7506638|NCT03159611|26051400|P1|Overall Study|Protocol Violation|7
7506639|NCT03159611|26051399|P2|Overall Study|Did Not Meet Exclusion Criteria|3
7506640|NCT03159611|26051400|P1|Overall Study|Did Not Meet Exclusion Criteria|1
7506641|NCT03159611|26051399|P2|Overall Study|Did Not Meet Inclusion Criteria|5
7506642|NCT03159611|26051400|P1|Overall Study|Did Not Meet Inclusion Criteria|9
7506643|NCT03159468|26051420|P6|Overall Study|Withdrawal by Subject|0
7506644|NCT03159468|26051421|P5|Overall Study|Withdrawal by Subject|0
7506645|NCT03159468|26051422|P4|Overall Study|Withdrawal by Subject|0
7506646|NCT03159468|26051423|P3|Overall Study|Withdrawal by Subject|3
7506647|NCT03159468|26051424|P2|Overall Study|Withdrawal by Subject|0
7506648|NCT03159468|26051425|P1|Overall Study|Withdrawal by Subject|0
7506649|NCT03159455|26051445|P6|Overall Study|Adverse Event|1
7506650|NCT03159455|26051446|P5|Overall Study|Adverse Event|0
7506651|NCT03159455|26051447|P4|Overall Study|Adverse Event|0
7506652|NCT03159455|26051448|P3|Overall Study|Adverse Event|0
7506653|NCT03159455|26051449|P2|Overall Study|Adverse Event|0
7506654|NCT03159455|26051450|P1|Overall Study|Adverse Event|0
7506655|NCT03159091|26051534|P2|Overall Study|Patient has taken no dose of study drug|1
7506656|NCT03159091|26051535|P1|Overall Study|Patient has taken no dose of study drug|0
7506657|NCT03159091|26051534|P2|Overall Study|Incorrect inclusion ineligible patient|3
7506658|NCT03159091|26051535|P1|Overall Study|Incorrect inclusion ineligible patient|5
7506669|NCT03158311|26051604|P3|Overall Study|Randomized in error|1
7506670|NCT03158311|26051605|P2|Overall Study|Randomized in error|0
7506671|NCT03158311|26051606|P1|Overall Study|Randomized in error|0
7506672|NCT03158311|26051604|P3|Overall Study|Pregnancy|0
7506673|NCT03158311|26051605|P2|Overall Study|Pregnancy|2
7506674|NCT03158311|26051606|P1|Overall Study|Pregnancy|0
7506675|NCT03158311|26051604|P3|Overall Study|Sponsor decision|0
7506676|NCT03158311|26051605|P2|Overall Study|Sponsor decision|0
7506677|NCT03158311|26051606|P1|Overall Study|Sponsor decision|1
7506678|NCT03158311|26051604|P3|Overall Study|Lost to Follow-up|1
7506679|NCT03158311|26051605|P2|Overall Study|Lost to Follow-up|1
7506680|NCT03158311|26051606|P1|Overall Study|Lost to Follow-up|1
7506681|NCT03158311|26051604|P3|Overall Study|Physician Decision|7
7506682|NCT03158311|26051605|P2|Overall Study|Physician Decision|3
7506683|NCT03158311|26051606|P1|Overall Study|Physician Decision|2
7506684|NCT03158311|26051604|P3|Overall Study|Techinical Problems|5
7506685|NCT03158311|26051605|P2|Overall Study|Techinical Problems|1
7506686|NCT03158311|26051606|P1|Overall Study|Techinical Problems|3
7506687|NCT03158311|26051604|P3|Overall Study|Adverse Event|3
7506688|NCT03158311|26051605|P2|Overall Study|Adverse Event|3
7506689|NCT03158311|26051606|P1|Overall Study|Adverse Event|5
7506690|NCT03158311|26051604|P3|Overall Study|Subject/Guardian Decision|11
7506691|NCT03158311|26051605|P2|Overall Study|Subject/Guardian Decision|6
7506692|NCT03158311|26051606|P1|Overall Study|Subject/Guardian Decision|10
7506693|NCT03158285|26051638|P3|Active Treatment Period: Week 24 - 52|Other|0
7506694|NCT03158285|26051639|P2|Active Treatment Period: Week 24 - 52|Other|1
7506695|NCT03158285|26051640|P1|Active Treatment Period: Week 24 - 52|Other|1
7506696|NCT03158285|26051638|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
7506697|NCT03158285|26051639|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7506698|NCT03158285|26051640|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
7506699|NCT03158285|26051638|P3|Active Treatment Period: Week 24 - 52|Pregnancy|1
7506700|NCT03158285|26051639|P2|Active Treatment Period: Week 24 - 52|Pregnancy|0
7506701|NCT03158285|26051640|P1|Active Treatment Period: Week 24 - 52|Pregnancy|0
7506702|NCT03158285|26051638|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7506703|NCT03158285|26051639|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7506704|NCT03158285|26051640|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
7506705|NCT03158285|26051638|P3|Active Treatment Period: Week 24 - 52|Adverse Event|1
7506706|NCT03158285|26051639|P2|Active Treatment Period: Week 24 - 52|Adverse Event|0
7506707|NCT03158285|26051640|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
7506708|NCT03158285|26051638|P3|Placebo-controlled Period: Week 0 - 24|Other|0
7506709|NCT03158285|26051639|P2|Placebo-controlled Period: Week 0 - 24|Other|1
7506710|NCT03158285|26051640|P1|Placebo-controlled Period: Week 0 - 24|Other|1
7506711|NCT03158285|26051638|P3|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
7506712|NCT03158285|26051639|P2|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
7506713|NCT03158285|26051640|P1|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
7506714|NCT03158285|26051638|P3|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
7506715|NCT03158285|26051639|P2|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
7506716|NCT03158285|26051640|P1|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
7506717|NCT03158285|26051638|P3|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
7506718|NCT03158285|26051639|P2|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
7506719|NCT03158285|26051640|P1|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
7506720|NCT03158285|26051638|P3|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
7506721|NCT03158285|26051639|P2|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
7506722|NCT03158285|26051640|P1|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
7506723|NCT03158272|26051856|P4|Overall Study|Adverse event unrelated to the drug|0
7506724|NCT03158272|26051857|P3|Overall Study|Adverse event unrelated to the drug|0
7506725|NCT03158272|26051858|P2|Overall Study|Adverse event unrelated to the drug|1
7506726|NCT03158272|26051859|P1|Overall Study|Adverse event unrelated to the drug|0
7506727|NCT03158272|26051856|P4|Overall Study|Other reasons|0
7506728|NCT03158272|26051857|P3|Overall Study|Other reasons|1
7506729|NCT03158272|26051858|P2|Overall Study|Other reasons|0
7506730|NCT03158272|26051859|P1|Overall Study|Other reasons|0
7506731|NCT03158272|26051856|P4|Overall Study|Death|0
7506732|NCT03158272|26051857|P3|Overall Study|Death|1
7506733|NCT03158272|26051858|P2|Overall Study|Death|0
7506734|NCT03158272|26051859|P1|Overall Study|Death|0
7506735|NCT03158272|26051856|P4|Overall Study|Disease progression|6
7506736|NCT03158272|26051857|P3|Overall Study|Disease progression|4
7506737|NCT03158272|26051858|P2|Overall Study|Disease progression|3
7506738|NCT03158272|26051859|P1|Overall Study|Disease progression|3
7506739|NCT03158220|26051929|P2|Overall Study|Physician Decision|0
7506740|NCT03158220|26051930|P1|Overall Study|Physician Decision|1
7506741|NCT03158220|26051929|P2|Overall Study|Lost to Follow-up|5
7506742|NCT03158220|26051930|P1|Overall Study|Lost to Follow-up|8
7506743|NCT03158220|26051929|P2|Overall Study|Status unknown|1
7506744|NCT03158220|26051930|P1|Overall Study|Status unknown|0
7506745|NCT03158220|26051929|P2|Overall Study|Withdrawal by Subject|9
7506746|NCT03158220|26051930|P1|Overall Study|Withdrawal by Subject|8
7506747|NCT03158220|26051929|P2|Overall Study|Screen Failure|1
7506748|NCT03158220|26051930|P1|Overall Study|Screen Failure|0
7506749|NCT03158012|26051975|P2|Overall Study|Withdrawal by Subject|1
7506750|NCT03158012|26051976|P1|Overall Study|Withdrawal by Subject|0
7506751|NCT03157583|26051982|P1|Overall Study|Other (did not meet study criteria)|1
7506752|NCT03157531|26052000|P1|Overall Study|Lost to Follow-up|4
7506753|NCT03157531|26052000|P1|Overall Study|Death|2
7506754|NCT03157089|26052021|P2|Overall Study|Progressive disease|8
7506755|NCT03157089|26052022|P1|Overall Study|Progressive disease|6
7506756|NCT03157089|26052021|P2|Overall Study|Adverse Event|4
7506757|NCT03157089|26052022|P1|Overall Study|Adverse Event|5
7506758|NCT03157089|26052021|P2|Overall Study|Treated only with pembrolizumab|0
7506759|NCT03157089|26052022|P1|Overall Study|Treated only with pembrolizumab|1
7506760|NCT03156621|26052041|P2|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
7506761|NCT03156621|26052042|P1|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
7506762|NCT03156621|26052041|P2|Open-Label Treatment Period (OLTP)|Adverse Event|2
7506763|NCT03156621|26052042|P1|Open-Label Treatment Period (OLTP)|Adverse Event|0
7506764|NCT03156543|26052097|P2|Overall Study|Withdrawal by Subject|0
7506765|NCT03156543|26052098|P1|Overall Study|Withdrawal by Subject|1
7506766|NCT03156270|26052106|P1|Overall Study|Lost to Follow-up|1
7506767|NCT03156270|26052106|P1|Overall Study|Failed pre-treatment screening|1
7506768|NCT03155997|26052115|P2|Overall Study|On study treatment|2074
7506769|NCT03155997|26052116|P1|Overall Study|On study treatment|2027
7506770|NCT03155997|26052115|P2|Overall Study|Missing disposition data|1
7506771|NCT03155997|26052116|P1|Overall Study|Missing disposition data|0
7506772|NCT03155997|26052115|P2|Overall Study|Lost to Follow-up|13
7506773|NCT03155997|26052116|P1|Overall Study|Lost to Follow-up|12
7506774|NCT03155997|26052115|P2|Overall Study|Withdrawal by Subject|134
7506775|NCT03155997|26052116|P1|Overall Study|Withdrawal by Subject|119
7506776|NCT03155724|26052125|P1|Overall Study|Study closure|7
7506777|NCT03155724|26052125|P1|Overall Study|Physician Decision|1
7506778|NCT03155724|26052125|P1|Overall Study|Death|3
7506779|NCT03155269|26052134|P2|Overall Study|Lost to Follow-up|2
7506780|NCT03155269|26052135|P1|Overall Study|Lost to Follow-up|1
7506781|NCT03155269|26052134|P2|Overall Study|Withdrawal by Subject|5
7506782|NCT03155269|26052135|P1|Overall Study|Withdrawal by Subject|4
7506783|NCT03155178|26052181|P4|Overall Study|Did not meet treatment day baseline|7
7506784|NCT03155178|26052182|P3|Overall Study|Did not meet treatment day baseline|7
7506785|NCT03155178|26052183|P2|Overall Study|Did not meet treatment day baseline|7
7506786|NCT03155178|26052184|P1|Overall Study|Did not meet treatment day baseline|7
7506787|NCT03154476|26052234|P2|Overall Study|Lost to Follow-up|4
7506788|NCT03154476|26052235|P1|Overall Study|Lost to Follow-up|4
7506789|NCT03154086|26052267|P15|Part B (Up to 25 Days)|Adverse Event|0
7506790|NCT03154086|26052268|P14|Part B (Up to 25 Days)|Adverse Event|0
7506791|NCT03154086|26052269|P13|Part B (Up to 25 Days)|Adverse Event|0
7506792|NCT03154086|26052270|P12|Part B (Up to 25 Days)|Adverse Event|0
7506793|NCT03154086|26052271|P11|Part B (Up to 25 Days)|Adverse Event|1
7506794|NCT03154086|26052272|P10|Part B (Up to 25 Days)|Adverse Event|0
7506795|NCT03154086|26052273|P9|Part B (Up to 25 Days)|Adverse Event|0
7506796|NCT03154086|26052274|P8|Part B (Up to 25 Days)|Adverse Event|0
7506797|NCT03154086|26052275|P7|Part B (Up to 25 Days)|Adverse Event|0
7506798|NCT03154086|26052276|P6|Part B (Up to 25 Days)|Adverse Event|0
7506799|NCT03154086|26052277|P5|Part B (Up to 25 Days)|Adverse Event|0
7506800|NCT03154086|26052278|P4|Part B (Up to 25 Days)|Adverse Event|0
7506801|NCT03154086|26052279|P3|Part B (Up to 25 Days)|Adverse Event|0
7506802|NCT03154086|26052280|P2|Part B (Up to 25 Days)|Adverse Event|0
7506803|NCT03154086|26052281|P1|Part B (Up to 25 Days)|Adverse Event|0
7506804|NCT03154086|26052267|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506805|NCT03154086|26052268|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506806|NCT03154086|26052269|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506807|NCT03154086|26052270|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506808|NCT03154086|26052271|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506809|NCT03154086|26052272|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506810|NCT03154086|26052273|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506811|NCT03154086|26052274|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
7506812|NCT03154086|26052275|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506813|NCT03154086|26052276|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506814|NCT03154086|26052277|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506815|NCT03154086|26052278|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506816|NCT03154086|26052279|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506817|NCT03154086|26052280|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506818|NCT03154086|26052281|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7506819|NCT03154086|26052267|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506820|NCT03154086|26052268|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506821|NCT03154086|26052269|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506822|NCT03154086|26052270|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506823|NCT03154086|26052271|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506824|NCT03154086|26052272|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506825|NCT03154086|26052273|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
7506826|NCT03154086|26052274|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506827|NCT03154086|26052275|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506828|NCT03154086|26052276|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506829|NCT03154086|26052277|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506830|NCT03154086|26052278|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506831|NCT03154086|26052279|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506832|NCT03154086|26052280|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506833|NCT03154086|26052281|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7506834|NCT03154086|26052267|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506835|NCT03154086|26052268|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506836|NCT03154086|26052269|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506837|NCT03154086|26052270|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506838|NCT03154086|26052271|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506839|NCT03154086|26052272|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506840|NCT03154086|26052273|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506841|NCT03154086|26052274|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506842|NCT03154086|26052275|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506843|NCT03154086|26052276|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506844|NCT03154086|26052277|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506845|NCT03154086|26052278|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506846|NCT03154086|26052279|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506847|NCT03154086|26052280|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7506848|NCT03154086|26052281|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
7506849|NCT03154086|26052267|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506850|NCT03154086|26052268|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506851|NCT03154086|26052269|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506852|NCT03154086|26052270|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506853|NCT03154086|26052271|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506854|NCT03154086|26052272|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506855|NCT03154086|26052273|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506856|NCT03154086|26052274|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506857|NCT03154086|26052275|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506858|NCT03154086|26052276|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506859|NCT03154086|26052277|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506860|NCT03154086|26052278|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506861|NCT03154086|26052279|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
7506862|NCT03154086|26052280|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506863|NCT03154086|26052281|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7506864|NCT03154086|26052267|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506865|NCT03154086|26052268|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506866|NCT03154086|26052269|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506867|NCT03154086|26052270|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506868|NCT03154086|26052271|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506869|NCT03154086|26052272|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506870|NCT03154086|26052273|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506871|NCT03154086|26052274|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506872|NCT03154086|26052275|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506873|NCT03154086|26052276|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506874|NCT03154086|26052277|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506875|NCT03154086|26052278|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506876|NCT03154086|26052279|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506877|NCT03154086|26052280|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
7506878|NCT03154086|26052281|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7506879|NCT03154086|26052267|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506880|NCT03154086|26052268|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506881|NCT03154086|26052269|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506882|NCT03154086|26052270|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506883|NCT03154086|26052271|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506884|NCT03154086|26052272|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506885|NCT03154086|26052273|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506886|NCT03154086|26052274|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506887|NCT03154086|26052275|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506888|NCT03154086|26052276|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506889|NCT03154086|26052277|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506890|NCT03154086|26052278|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
7506891|NCT03154086|26052279|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506892|NCT03154086|26052280|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506893|NCT03154086|26052281|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7506894|NCT03154047|26052681|P1|Overall Study|Withdrawal by Subject|3
7506895|NCT03154047|26052681|P1|Overall Study|Study terminated by sponsor|76
7506896|NCT03154047|26052681|P1|Overall Study|Death|1
7506897|NCT03152552|26052728|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
7506898|NCT03152552|26052729|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7506899|NCT03152552|26052730|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7506900|NCT03152552|26052731|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
7506901|NCT03152552|26052732|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
7506902|NCT03152552|26052728|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7506903|NCT03152552|26052729|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
7506904|NCT03152552|26052730|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7506905|NCT03152552|26052731|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7506906|NCT03152552|26052732|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7506907|NCT03152552|26052728|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
7506908|NCT03152552|26052729|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
7506909|NCT03152552|26052730|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
7506910|NCT03152552|26052731|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
7506911|NCT03152552|26052732|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
7506912|NCT03152552|26052728|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7506913|NCT03152552|26052729|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7506914|NCT03152552|26052730|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7506915|NCT03152552|26052731|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7506916|NCT03152552|26052732|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7506917|NCT03152552|26052728|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
7506918|NCT03152552|26052729|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7506919|NCT03152552|26052730|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7506920|NCT03152552|26052731|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
7506921|NCT03152552|26052732|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
7506922|NCT03152552|26052728|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7506923|NCT03152552|26052729|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7506924|NCT03152552|26052730|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7506925|NCT03152552|26052731|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
7506926|NCT03152552|26052732|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7506927|NCT03152552|26052728|P5|Treatment Period 1 (12 Weeks)|Death|1
7506928|NCT03152552|26052729|P4|Treatment Period 1 (12 Weeks)|Death|0
7506929|NCT03152552|26052730|P3|Treatment Period 1 (12 Weeks)|Death|0
7506930|NCT03152552|26052731|P2|Treatment Period 1 (12 Weeks)|Death|1
7506931|NCT03152552|26052732|P1|Treatment Period 1 (12 Weeks)|Death|0
7506932|NCT03152526|26052865|P2|Overall Study|Withdrawal by Subject|1
7506933|NCT03152526|26052866|P1|Overall Study|Withdrawal by Subject|0
7506934|NCT03152110|26052886|P1|Overall Study|Withdrawal by Subject|3
7506935|NCT03152019|26052942|P2|Overall Study|Adverse Event|1
7506936|NCT03152019|26052943|P1|Overall Study|Adverse Event|0
7506937|NCT03151551|26052951|P2|Post-Treatment Follow-Up Period|Physician Decision|1
7506938|NCT03151551|26052952|P1|Post-Treatment Follow-Up Period|Physician Decision|0
7506939|NCT03151551|26052951|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
7506940|NCT03151551|26052952|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
7506941|NCT03151551|26052951|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7506942|NCT03151551|26052952|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7506943|NCT03151551|26052951|P2|Post-Treatment Follow-Up Period|Adverse Event|3
7506944|NCT03151551|26052952|P1|Post-Treatment Follow-Up Period|Adverse Event|1
7506945|NCT03151551|26052951|P2|Open-Label Treatment Period|Protocol Deviation|2
7506946|NCT03151551|26052952|P1|Open-Label Treatment Period|Protocol Deviation|1
7506947|NCT03151551|26052951|P2|Open-Label Treatment Period|Physician Decision|0
7506948|NCT03151551|26052952|P1|Open-Label Treatment Period|Physician Decision|3
7506949|NCT03151551|26052951|P2|Open-Label Treatment Period|Lack of Efficacy|1
7506950|NCT03151551|26052952|P1|Open-Label Treatment Period|Lack of Efficacy|1
7506951|NCT03151551|26052951|P2|Open-Label Treatment Period|Withdrawal by Subject|18
7506952|NCT03151551|26052952|P1|Open-Label Treatment Period|Withdrawal by Subject|12
7506953|NCT03151551|26052951|P2|Open-Label Treatment Period|Lost to Follow-up|1
7506954|NCT03151551|26052952|P1|Open-Label Treatment Period|Lost to Follow-up|1
7506955|NCT03151551|26052951|P2|Open-Label Treatment Period|Adverse Event|2
7506956|NCT03151551|26052952|P1|Open-Label Treatment Period|Adverse Event|0
7506957|NCT03151395|26053047|P1|Overall Study|Unspecified reason|4
7506958|NCT03151395|26053047|P1|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
7506959|NCT03151395|26053047|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7506960|NCT03151395|26053047|P1|Overall Study|Adverse Event|2
7506961|NCT03151226|26053095|P1|Overall Study|not wear device correctly|1
7506962|NCT03151226|26053095|P1|Overall Study|Withdrawal by Subject|2
7506963|NCT03151148|26053101|P2|Overall Study|Withdrawal by Subject|0
7506964|NCT03151148|26053102|P1|Overall Study|Withdrawal by Subject|1
7506965|NCT03151148|26053101|P2|Overall Study|Lost to Follow-up|0
7506966|NCT03151148|26053102|P1|Overall Study|Lost to Follow-up|1
7506967|NCT03150719|26053193|P2|Overall Study|Other|0
7506968|NCT03150719|26053194|P1|Overall Study|Other|1
7506969|NCT03150719|26053193|P2|Overall Study|Death|1
7506970|NCT03150719|26053194|P1|Overall Study|Death|0
7506971|NCT03150719|26053193|P2|Overall Study|Adverse Event|1
7506972|NCT03150719|26053194|P1|Overall Study|Adverse Event|0
7506973|NCT03150589|26053212|P2|Overall Study|IP non-compliance and other reasons|3
7506974|NCT03150589|26053213|P1|Overall Study|IP non-compliance and other reasons|12
7506975|NCT03150589|26053212|P2|Overall Study|Death|3
7506976|NCT03150589|26053213|P1|Overall Study|Death|2
7506977|NCT03150589|26053212|P2|Overall Study|Lost to Follow-up|3
7506978|NCT03150589|26053213|P1|Overall Study|Lost to Follow-up|3
7506979|NCT03150589|26053212|P2|Overall Study|Protocol Violation|3
7506980|NCT03150589|26053213|P1|Overall Study|Protocol Violation|4
7506981|NCT03150589|26053212|P2|Overall Study|Adverse Event|6
7506982|NCT03150589|26053213|P1|Overall Study|Adverse Event|7
7506983|NCT03150589|26053212|P2|Overall Study|Withdrawal by Subject|9
7506984|NCT03150589|26053213|P1|Overall Study|Withdrawal by Subject|16
7506985|NCT03150485|26053221|P6|Overall Study|Unsatisfactory Lens Fitting|0
7506986|NCT03150485|26053222|P5|Overall Study|Unsatisfactory Lens Fitting|0
7506987|NCT03150485|26053223|P4|Overall Study|Unsatisfactory Lens Fitting|0
7506988|NCT03150485|26053224|P3|Overall Study|Unsatisfactory Lens Fitting|0
7506989|NCT03150485|26053225|P2|Overall Study|Unsatisfactory Lens Fitting|1
7506990|NCT03150485|26053226|P1|Overall Study|Unsatisfactory Lens Fitting|0
7506991|NCT03150082|26053403|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7506992|NCT03150082|26053404|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
7507017|NCT03149848|26053666|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
7507018|NCT03149848|26053666|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
7507019|NCT03149328|26053705|P2|Overall Study|Language Barrier|0
7507020|NCT03149328|26053706|P1|Overall Study|Language Barrier|1
7507021|NCT03149328|26053705|P2|Overall Study|Left Study Site|2
7507022|NCT03149328|26053706|P1|Overall Study|Left Study Site|1
7507023|NCT03149328|26053705|P2|Overall Study|Lost to Follow-up|16
7507024|NCT03149328|26053706|P1|Overall Study|Lost to Follow-up|25
7507025|NCT03149328|26053705|P2|Overall Study|Transplant|1
7507026|NCT03149328|26053706|P1|Overall Study|Transplant|9
7507027|NCT03149328|26053705|P2|Overall Study|Changed Dialysis Modality|1
7507028|NCT03149328|26053706|P1|Overall Study|Changed Dialysis Modality|18
7507029|NCT03149328|26053705|P2|Overall Study|Withdrawal by Subject|26
7507030|NCT03149328|26053706|P1|Overall Study|Withdrawal by Subject|30
7507031|NCT03149055|26053738|P1|Overall Study|Not treated|4
7507032|NCT03149042|26053743|P1|Overall Study|Invasive FFR Measurement cancelled|1
7507033|NCT03149042|26053743|P1|Overall Study|Poor CT Image Quality|1
7507034|NCT03149042|26053743|P1|Overall Study|Invasive FFR not performed|21
7507035|NCT03148795|26053755|P1|Overall Study|Ongoing|30
7507036|NCT03148795|26053755|P1|Overall Study|Progressive Disease|62
7507037|NCT03148795|26053755|P1|Overall Study|Withdrawal by Subject|2
7507038|NCT03148795|26053755|P1|Overall Study|Global Deterioration Of Health Status|6
7507039|NCT03148795|26053755|P1|Overall Study|No Longer Clinically Benefitting|2
7507040|NCT03148795|26053755|P1|Overall Study|Other|15
7507041|NCT03148795|26053755|P1|Overall Study|Adverse Event|5
7507042|NCT03148795|26053755|P1|Overall Study|Death|6
7507043|NCT03148756|26053772|P2|Overall Study|Study Terminated|1
7507044|NCT03148756|26053773|P1|Overall Study|Study Terminated|0
7507045|NCT03148691|26053806|P3|Overall Study|Withdrawal by Subject|0
7507046|NCT03148691|26053807|P2|Overall Study|Withdrawal by Subject|0
7507047|NCT03148691|26053808|P1|Overall Study|Withdrawal by Subject|1
7507048|NCT03148691|26053806|P3|Overall Study|Other|0
7507049|NCT03148691|26053807|P2|Overall Study|Other|0
7507050|NCT03148691|26053808|P1|Overall Study|Other|1
7507051|NCT03148691|26053806|P3|Overall Study|Lost to Follow-up|1
7507052|NCT03148691|26053807|P2|Overall Study|Lost to Follow-up|0
7507053|NCT03148691|26053808|P1|Overall Study|Lost to Follow-up|0
7507054|NCT03148691|26053806|P3|Overall Study|Protocol Violation|7
7507055|NCT03148691|26053807|P2|Overall Study|Protocol Violation|2
7507056|NCT03148691|26053808|P1|Overall Study|Protocol Violation|1
7507057|NCT03148067|26053871|P1|Overall Study|Death|1
7507058|NCT03148067|26053871|P1|Overall Study|Lost to Follow-up|3
7507059|NCT03147495|26053900|P2|Overall Study|Physician Decision|6
7507060|NCT03147495|26053901|P1|Overall Study|Physician Decision|0
7507061|NCT03147248|26053923|P6|Overall Study|Prolonged Dosing Interval|1
7507062|NCT03147248|26053924|P5|Overall Study|Prolonged Dosing Interval|1
7507063|NCT03147248|26053925|P4|Overall Study|Prolonged Dosing Interval|0
7507064|NCT03147248|26053926|P3|Overall Study|Prolonged Dosing Interval|0
7507065|NCT03147248|26053927|P2|Overall Study|Prolonged Dosing Interval|0
7507066|NCT03147248|26053928|P1|Overall Study|Prolonged Dosing Interval|0
7507067|NCT03147248|26053923|P6|Overall Study|Physician Decision|4
7507068|NCT03147248|26053924|P5|Overall Study|Physician Decision|2
7507069|NCT03147248|26053925|P4|Overall Study|Physician Decision|0
7507070|NCT03147248|26053926|P3|Overall Study|Physician Decision|0
7507071|NCT03147248|26053927|P2|Overall Study|Physician Decision|0
7507072|NCT03147248|26053928|P1|Overall Study|Physician Decision|0
7507073|NCT03147248|26053923|P6|Overall Study|Death|4
7507074|NCT03147248|26053924|P5|Overall Study|Death|0
7507075|NCT03147248|26053925|P4|Overall Study|Death|0
7507076|NCT03147248|26053926|P3|Overall Study|Death|0
7507077|NCT03147248|26053927|P2|Overall Study|Death|0
7507078|NCT03147248|26053928|P1|Overall Study|Death|0
7507079|NCT03147248|26053923|P6|Overall Study|Pregnancy|0
7507080|NCT03147248|26053924|P5|Overall Study|Pregnancy|1
7507081|NCT03147248|26053925|P4|Overall Study|Pregnancy|0
7507082|NCT03147248|26053926|P3|Overall Study|Pregnancy|0
7507083|NCT03147248|26053927|P2|Overall Study|Pregnancy|0
7507084|NCT03147248|26053928|P1|Overall Study|Pregnancy|0
7507085|NCT03147248|26053923|P6|Overall Study|Lost to Follow-up|0
7507086|NCT03147248|26053924|P5|Overall Study|Lost to Follow-up|2
7507087|NCT03147248|26053925|P4|Overall Study|Lost to Follow-up|0
7507088|NCT03147248|26053926|P3|Overall Study|Lost to Follow-up|0
7507089|NCT03147248|26053927|P2|Overall Study|Lost to Follow-up|0
7507090|NCT03147248|26053928|P1|Overall Study|Lost to Follow-up|0
7507091|NCT03147248|26053923|P6|Overall Study|Protocol Violation|0
7507092|NCT03147248|26053924|P5|Overall Study|Protocol Violation|2
7507093|NCT03147248|26053925|P4|Overall Study|Protocol Violation|0
7507094|NCT03147248|26053926|P3|Overall Study|Protocol Violation|0
7507095|NCT03147248|26053927|P2|Overall Study|Protocol Violation|0
7507096|NCT03147248|26053928|P1|Overall Study|Protocol Violation|0
7507097|NCT03147248|26053923|P6|Overall Study|Withdrawal by Subject|9
7507098|NCT03147248|26053924|P5|Overall Study|Withdrawal by Subject|12
7507099|NCT03147248|26053925|P4|Overall Study|Withdrawal by Subject|0
7507100|NCT03147248|26053926|P3|Overall Study|Withdrawal by Subject|0
7507101|NCT03147248|26053927|P2|Overall Study|Withdrawal by Subject|0
7507102|NCT03147248|26053928|P1|Overall Study|Withdrawal by Subject|0
7507103|NCT03147248|26053923|P6|Overall Study|Disease progression|2
7507104|NCT03147248|26053924|P5|Overall Study|Disease progression|0
7507105|NCT03147248|26053925|P4|Overall Study|Disease progression|0
7507106|NCT03147248|26053926|P3|Overall Study|Disease progression|0
7507107|NCT03147248|26053927|P2|Overall Study|Disease progression|0
7507108|NCT03147248|26053928|P1|Overall Study|Disease progression|1
7507109|NCT03147248|26053923|P6|Overall Study|Adverse Event|11
7507110|NCT03147248|26053924|P5|Overall Study|Adverse Event|6
7507111|NCT03147248|26053925|P4|Overall Study|Adverse Event|2
7507112|NCT03147248|26053926|P3|Overall Study|Adverse Event|2
7507113|NCT03147248|26053927|P2|Overall Study|Adverse Event|2
7507114|NCT03147248|26053928|P1|Overall Study|Adverse Event|0
7507115|NCT03146741|26054048|P1|Overall Study|Awaiting txp|2
7507116|NCT03146741|26054048|P1|Overall Study|Physician Decision|2
7507117|NCT03146741|26054048|P1|Overall Study|Listeted for MOT|2
7507118|NCT03146741|26054048|P1|Overall Study|Txp with non-HCV+ heart|4
7507119|NCT03146663|26054055|P2|Overall Study|Did not receive study treatment|1
7507120|NCT03146663|26054056|P1|Overall Study|Did not receive study treatment|1
7507121|NCT03146403|26054079|P2|Overall Study|Lost to Follow-up|0
7507122|NCT03146403|26054080|P1|Overall Study|Lost to Follow-up|2
7507123|NCT03146403|26054079|P2|Overall Study|Withdrawal by Subject|3
7507124|NCT03146403|26054080|P1|Overall Study|Withdrawal by Subject|0
7507125|NCT03145766|26054114|P5|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7507126|NCT03145766|26054115|P4|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7507127|NCT03145766|26054116|P3|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7507128|NCT03145766|26054117|P2|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7507129|NCT03145766|26054118|P1|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7507130|NCT03145766|26054114|P5|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
7507131|NCT03145766|26054115|P4|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
7507132|NCT03145766|26054116|P3|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7507133|NCT03145766|26054117|P2|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
7507134|NCT03145766|26054118|P1|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7507135|NCT03145766|26054114|P5|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7507136|NCT03145766|26054115|P4|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
7507137|NCT03145766|26054116|P3|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7507138|NCT03145766|26054117|P2|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7507139|NCT03145766|26054118|P1|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
7507140|NCT03145766|26054114|P5|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
7507141|NCT03145766|26054115|P4|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7507142|NCT03145766|26054116|P3|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7507143|NCT03145766|26054117|P2|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7507144|NCT03145766|26054118|P1|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
7507145|NCT03145766|26054114|P5|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7507146|NCT03145766|26054115|P4|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
7507147|NCT03145766|26054116|P3|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7507148|NCT03145766|26054117|P2|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7507149|NCT03145766|26054118|P1|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7507150|NCT03145766|26054114|P5|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7507151|NCT03145766|26054115|P4|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
7507152|NCT03145766|26054116|P3|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7507153|NCT03145766|26054117|P2|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7507154|NCT03145766|26054118|P1|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7507155|NCT03145766|26054114|P5|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
7507156|NCT03145766|26054115|P4|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7507157|NCT03145766|26054116|P3|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
7507158|NCT03145766|26054117|P2|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7507159|NCT03145766|26054118|P1|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7507160|NCT03145207|26054252|P1|Overall Study|baseline blood pressure high|1
7507161|NCT03145207|26054252|P1|Overall Study|volunteer started taking allergy shots|1
7507162|NCT03144804|26054267|P1|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
7507163|NCT03144687|26054274|P2|Overall Study|Participants With Ongoing Treatment|2
7507164|NCT03144687|26054275|P1|Overall Study|Participants With Ongoing Treatment|3
7507165|NCT03144687|26054274|P2|Overall Study|Withdrawal by Subject|3
7507166|NCT03144687|26054275|P1|Overall Study|Withdrawal by Subject|1
7507167|NCT03144687|26054274|P2|Overall Study|Physician Decision|2
7507168|NCT03144687|26054275|P1|Overall Study|Physician Decision|5
7507169|NCT03144687|26054274|P2|Overall Study|Lost to Follow-up|1
7507170|NCT03144687|26054275|P1|Overall Study|Lost to Follow-up|0
7507171|NCT03144687|26054274|P2|Overall Study|Death|2
7507172|NCT03144687|26054275|P1|Overall Study|Death|0
7507173|NCT03144687|26054274|P2|Overall Study|Progressive disease|0
7507174|NCT03144687|26054275|P1|Overall Study|Progressive disease|3
7507175|NCT03144687|26054274|P2|Overall Study|Adverse Event|0
7507176|NCT03144687|26054275|P1|Overall Study|Adverse Event|1
7507177|NCT03144180|26054353|P2|Overall Study|Scrub tech removed tube cap|1
7507178|NCT03144180|26054354|P1|Overall Study|Scrub tech removed tube cap|0
7507179|NCT03144180|26054353|P2|Overall Study|Provider forgot to use the Q-cup|1
7507180|NCT03144180|26054354|P1|Overall Study|Provider forgot to use the Q-cup|0
7507181|NCT03144180|26054353|P2|Overall Study|Provider forgot to fill out forms|3
7507182|NCT03144180|26054354|P1|Overall Study|Provider forgot to fill out forms|1
7507183|NCT03144180|26054353|P2|Overall Study|STAT Delivery|1
7507184|NCT03144180|26054354|P1|Overall Study|STAT Delivery|1
7507185|NCT03143855|26054392|P2|Overall Study|Participant experienced withdrawal|1
7507186|NCT03143855|26054393|P1|Overall Study|Participant experienced withdrawal|0
7507187|NCT03143855|26054392|P2|Overall Study|Protocol Violation|0
7507188|NCT03143855|26054393|P1|Overall Study|Protocol Violation|1
7507189|NCT03143855|26054392|P2|Overall Study|Withdrawal by Subject|3
7507190|NCT03143855|26054393|P1|Overall Study|Withdrawal by Subject|4
7507191|NCT03143166|26054424|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
7507192|NCT03143101|26054443|P3|Overall Study|Lost to Follow-up|0
7507193|NCT03143101|26054444|P2|Overall Study|Lost to Follow-up|2
7507194|NCT03143101|26054445|P1|Overall Study|Lost to Follow-up|2
7507195|NCT03143101|26054443|P3|Overall Study|Withdrawal by Subject|0
7507196|NCT03143101|26054444|P2|Overall Study|Withdrawal by Subject|1
7507197|NCT03143101|26054445|P1|Overall Study|Withdrawal by Subject|0
7507198|NCT03142932|26054500|P2|Overall Study|Lost to Follow-up|11
7507199|NCT03142932|26054501|P1|Overall Study|Lost to Follow-up|2
7507200|NCT03142750|26054517|P2|Overall Study|Lost to Follow-up|1
7507201|NCT03142750|26054518|P1|Overall Study|Lost to Follow-up|4
7507202|NCT03142451|26054531|P2|Overall Study|Other|1
7507203|NCT03142451|26054532|P1|Overall Study|Other|1
7507204|NCT03142451|26054531|P2|Overall Study|Protocol Violation|1
7507205|NCT03142451|26054532|P1|Overall Study|Protocol Violation|3
7507206|NCT03142451|26054531|P2|Overall Study|Participant request|12
7507207|NCT03142451|26054532|P1|Overall Study|Participant request|24
7507208|NCT03142451|26054531|P2|Overall Study|Lost to Follow-up|8
7507209|NCT03142451|26054532|P1|Overall Study|Lost to Follow-up|25
7507210|NCT03142451|26054531|P2|Overall Study|Adverse Event|2
7507211|NCT03142451|26054532|P1|Overall Study|Adverse Event|5
7507212|NCT03141905|26054584|P2|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
7507213|NCT03141905|26054585|P1|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
7507214|NCT03141905|26054584|P2|Overall Study|Lost to Follow-up|7
7507215|NCT03141905|26054585|P1|Overall Study|Lost to Follow-up|3
7507216|NCT03141905|26054584|P2|Overall Study|Withdrawal by Subject|0
7507217|NCT03141905|26054585|P1|Overall Study|Withdrawal by Subject|1
7507218|NCT03141905|26054584|P2|Overall Study|Death|2
7507219|NCT03141905|26054585|P1|Overall Study|Death|3
7507220|NCT03141788|26054598|P1|Overall Study|Withdrawal by Subject|4
7507221|NCT03141788|26054598|P1|Overall Study|Protocol Violation|3
7507222|NCT03141788|26054598|P1|Overall Study|Lost to Follow-up|1
7507223|NCT03141307|26054679|P2|Follow-Up|Lost to Follow-up|54
7507224|NCT03141307|26054680|P1|Follow-Up|Lost to Follow-up|97
7507225|NCT03141307|26054679|P2|In-Hospital|Protocol Violation|0
7507226|NCT03141307|26054680|P1|In-Hospital|Protocol Violation|4
7507227|NCT03141307|26054679|P2|In-Hospital|Withdrawal by Subject|2
7507228|NCT03141307|26054680|P1|In-Hospital|Withdrawal by Subject|0
7507229|NCT03141151|26054865|P2|Overall Study|Withdrawal by Subject|2
7507230|NCT03141151|26054866|P1|Overall Study|Withdrawal by Subject|3
7507231|NCT03141151|26054865|P2|Overall Study|Lost to Follow-up|2
7507232|NCT03141151|26054866|P1|Overall Study|Lost to Follow-up|3
7507233|NCT03141086|26054884|P2|Overall Study|Adverse Event|2
7507234|NCT03141086|26054885|P1|Overall Study|Adverse Event|0
7507235|NCT03141086|26054884|P2|Overall Study|Protocol Violation|1
7507236|NCT03141086|26054885|P1|Overall Study|Protocol Violation|0
7507237|NCT03141086|26054884|P2|Overall Study|Withdrawal by Subject|1
7507238|NCT03141086|26054885|P1|Overall Study|Withdrawal by Subject|0
7507239|NCT03141086|26054884|P2|Overall Study|Study Terminated By Sponsor|1
7507240|NCT03141086|26054885|P1|Overall Study|Study Terminated By Sponsor|1
7507241|NCT03139604|26054967|P2|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
7507242|NCT03139604|26054968|P1|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
7507243|NCT03139604|26054967|P2|Overall Study|Study Terminated by Sponsor|127
7507244|NCT03139604|26054968|P1|Overall Study|Study Terminated by Sponsor|122
7507245|NCT03139604|26054967|P2|Overall Study|Death|67
7507246|NCT03139604|26054968|P1|Overall Study|Death|65
7507247|NCT03139604|26054967|P2|Overall Study|Lost to Follow-up|1
7507248|NCT03139604|26054968|P1|Overall Study|Lost to Follow-up|3
7507249|NCT03139604|26054967|P2|Overall Study|Physician Decision|2
7507250|NCT03139604|26054968|P1|Overall Study|Physician Decision|1
7507251|NCT03139604|26054967|P2|Overall Study|Withdrawal by Subject|17
7507252|NCT03139604|26054968|P1|Overall Study|Withdrawal by Subject|16
7507253|NCT03139604|26054967|P2|Overall Study|Other|3
7507254|NCT03139604|26054968|P1|Overall Study|Other|7
7507255|NCT03139552|26055045|P1|Overall Study|unable to attend tasting due to schedule|3
7507256|NCT03139448|26055088|P2|Overall Study|Physician Decision|2
7507257|NCT03139448|26055089|P1|Overall Study|Physician Decision|0
7507258|NCT03139448|26055088|P2|Overall Study|Screen fail|3
7507259|NCT03139448|26055089|P1|Overall Study|Screen fail|1
7507260|NCT03139448|26055088|P2|Overall Study|Withdrawal by Subject|6
7507261|NCT03139448|26055089|P1|Overall Study|Withdrawal by Subject|3
7507262|NCT03139448|26055088|P2|Overall Study|Location of procedure changed|8
7507263|NCT03139448|26055089|P1|Overall Study|Location of procedure changed|2
7507264|NCT03139448|26055088|P2|Overall Study|Lack of Efficacy|7
7507265|NCT03139448|26055089|P1|Overall Study|Lack of Efficacy|6
7507266|NCT03139279|26055113|P2|Overall Study|Withdrawal by Subject|2
7507267|NCT03139279|26055114|P1|Overall Study|Withdrawal by Subject|0
7507268|NCT03139279|26055113|P2|Overall Study|Protocol Violation|4
7507269|NCT03139279|26055114|P1|Overall Study|Protocol Violation|5
7507270|NCT03139279|26055113|P2|Overall Study|Physician Decision|0
7507271|NCT03139279|26055114|P1|Overall Study|Physician Decision|2
7507272|NCT03139240|26055132|P4|Overall Study|Lost to Follow-up|0
7507273|NCT03139240|26055133|P3|Overall Study|Lost to Follow-up|1
7507274|NCT03139240|26055134|P2|Overall Study|Lost to Follow-up|1
7507275|NCT03139240|26055135|P1|Overall Study|Lost to Follow-up|0
7507276|NCT03138967|26055167|P2|Overall Study|Physician Decision|3
7507277|NCT03138967|26055168|P1|Overall Study|Physician Decision|1
7507278|NCT03138967|26055167|P2|Overall Study|Death|1
7507279|NCT03138967|26055168|P1|Overall Study|Death|0
7507280|NCT03138655|26055219|P8|Overall Study|Reason not Specified|0
7507281|NCT03138655|26055220|P7|Overall Study|Reason not Specified|0
7507282|NCT03138655|26055221|P6|Overall Study|Reason not Specified|1
7507283|NCT03138655|26055222|P5|Overall Study|Reason not Specified|1
7507284|NCT03138655|26055223|P4|Overall Study|Reason not Specified|2
7507285|NCT03138655|26055224|P3|Overall Study|Reason not Specified|0
7507286|NCT03138655|26055225|P2|Overall Study|Reason not Specified|0
7507287|NCT03138655|26055226|P1|Overall Study|Reason not Specified|1
7507288|NCT03138655|26055219|P8|Overall Study|Withdrawal by Subject|0
7507289|NCT03138655|26055220|P7|Overall Study|Withdrawal by Subject|1
7507290|NCT03138655|26055221|P6|Overall Study|Withdrawal by Subject|0
7507291|NCT03138655|26055222|P5|Overall Study|Withdrawal by Subject|0
7507292|NCT03138655|26055223|P4|Overall Study|Withdrawal by Subject|0
7507293|NCT03138655|26055224|P3|Overall Study|Withdrawal by Subject|0
7507294|NCT03138655|26055225|P2|Overall Study|Withdrawal by Subject|1
7507295|NCT03138655|26055226|P1|Overall Study|Withdrawal by Subject|0
7507296|NCT03138655|26055219|P8|Overall Study|Adverse Event|2
7507297|NCT03138655|26055220|P7|Overall Study|Adverse Event|2
7507298|NCT03138655|26055221|P6|Overall Study|Adverse Event|4
7507299|NCT03138655|26055222|P5|Overall Study|Adverse Event|1
7507300|NCT03138655|26055223|P4|Overall Study|Adverse Event|1
7507301|NCT03138655|26055224|P3|Overall Study|Adverse Event|2
7507302|NCT03138655|26055225|P2|Overall Study|Adverse Event|1
7507303|NCT03138655|26055226|P1|Overall Study|Adverse Event|2
7507304|NCT03137992|26055347|P6|Part 2 (Open-label Extension)|Prohibited Medication|1
7507305|NCT03137992|26055348|P5|Part 2 (Open-label Extension)|Prohibited Medication|0
7507306|NCT03137992|26055349|P4|Part 2 (Open-label Extension)|Prohibited Medication|0
7507307|NCT03137992|26055350|P3|Part 2 (Open-label Extension)|Prohibited Medication|0
7507308|NCT03137992|26055351|P2|Part 2 (Open-label Extension)|Prohibited Medication|0
7507309|NCT03137992|26055352|P1|Part 2 (Open-label Extension)|Prohibited Medication|0
7507310|NCT03137992|26055347|P6|Part 2 (Open-label Extension)|Per study team|0
7507311|NCT03137992|26055348|P5|Part 2 (Open-label Extension)|Per study team|0
7507312|NCT03137992|26055349|P4|Part 2 (Open-label Extension)|Per study team|0
7507313|NCT03137992|26055350|P3|Part 2 (Open-label Extension)|Per study team|0
7507314|NCT03137992|26055351|P2|Part 2 (Open-label Extension)|Per study team|0
7507315|NCT03137992|26055352|P1|Part 2 (Open-label Extension)|Per study team|1
7507316|NCT03137992|26055347|P6|Part 2 (Open-label Extension)|COPD exacerbation|0
7507317|NCT03137992|26055348|P5|Part 2 (Open-label Extension)|COPD exacerbation|0
7507318|NCT03137992|26055349|P4|Part 2 (Open-label Extension)|COPD exacerbation|1
7507319|NCT03137992|26055350|P3|Part 2 (Open-label Extension)|COPD exacerbation|0
7507320|NCT03137992|26055351|P2|Part 2 (Open-label Extension)|COPD exacerbation|0
7507403|NCT03137992|26055350|P3|Washout Period 1|Subject Noncompliance|0
7507321|NCT03137992|26055352|P1|Part 2 (Open-label Extension)|COPD exacerbation|0
7507322|NCT03137992|26055347|P6|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7507323|NCT03137992|26055348|P5|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7507324|NCT03137992|26055349|P4|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7507325|NCT03137992|26055350|P3|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7507326|NCT03137992|26055351|P2|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7507327|NCT03137992|26055352|P1|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7507328|NCT03137992|26055347|P6|Period 3 (Visit 04)|Withdrawal by Subject|0
7507329|NCT03137992|26055348|P5|Period 3 (Visit 04)|Withdrawal by Subject|1
7507330|NCT03137992|26055349|P4|Period 3 (Visit 04)|Withdrawal by Subject|0
7507331|NCT03137992|26055350|P3|Period 3 (Visit 04)|Withdrawal by Subject|1
7507332|NCT03137992|26055351|P2|Period 3 (Visit 04)|Withdrawal by Subject|2
7507333|NCT03137992|26055352|P1|Period 3 (Visit 04)|Withdrawal by Subject|0
7507334|NCT03137992|26055347|P6|Period 3 (Visit 04)|Did not meet continuation criteria|3
7507335|NCT03137992|26055348|P5|Period 3 (Visit 04)|Did not meet continuation criteria|2
7507336|NCT03137992|26055349|P4|Period 3 (Visit 04)|Did not meet continuation criteria|0
7507337|NCT03137992|26055350|P3|Period 3 (Visit 04)|Did not meet continuation criteria|2
7507338|NCT03137992|26055351|P2|Period 3 (Visit 04)|Did not meet continuation criteria|0
7507339|NCT03137992|26055352|P1|Period 3 (Visit 04)|Did not meet continuation criteria|6
7507340|NCT03137992|26055347|P6|Washout Period 2|Sponsor Decision|1
7507341|NCT03137992|26055348|P5|Washout Period 2|Sponsor Decision|0
7507342|NCT03137992|26055349|P4|Washout Period 2|Sponsor Decision|0
7507343|NCT03137992|26055350|P3|Washout Period 2|Sponsor Decision|0
7507344|NCT03137992|26055351|P2|Washout Period 2|Sponsor Decision|0
7507345|NCT03137992|26055352|P1|Washout Period 2|Sponsor Decision|0
7507346|NCT03137992|26055347|P6|Washout Period 2|Withdrawal by Subject|0
7507347|NCT03137992|26055348|P5|Washout Period 2|Withdrawal by Subject|1
7507348|NCT03137992|26055349|P4|Washout Period 2|Withdrawal by Subject|0
7507349|NCT03137992|26055350|P3|Washout Period 2|Withdrawal by Subject|0
7507350|NCT03137992|26055351|P2|Washout Period 2|Withdrawal by Subject|0
7507351|NCT03137992|26055352|P1|Washout Period 2|Withdrawal by Subject|1
7507352|NCT03137992|26055347|P6|Washout Period 2|Adverse Event|0
7507353|NCT03137992|26055348|P5|Washout Period 2|Adverse Event|1
7507354|NCT03137992|26055349|P4|Washout Period 2|Adverse Event|1
7507355|NCT03137992|26055350|P3|Washout Period 2|Adverse Event|0
7507356|NCT03137992|26055351|P2|Washout Period 2|Adverse Event|0
7507357|NCT03137992|26055352|P1|Washout Period 2|Adverse Event|0
7507358|NCT03137992|26055347|P6|Washout Period 2|Subject Non-compliance|0
7507359|NCT03137992|26055348|P5|Washout Period 2|Subject Non-compliance|0
7507360|NCT03137992|26055349|P4|Washout Period 2|Subject Non-compliance|0
7507361|NCT03137992|26055350|P3|Washout Period 2|Subject Non-compliance|0
7507362|NCT03137992|26055351|P2|Washout Period 2|Subject Non-compliance|1
7507363|NCT03137992|26055352|P1|Washout Period 2|Subject Non-compliance|0
7507364|NCT03137992|26055347|P6|Washout Period 2|COPD Exacerbation|0
7507365|NCT03137992|26055348|P5|Washout Period 2|COPD Exacerbation|1
7507366|NCT03137992|26055349|P4|Washout Period 2|COPD Exacerbation|0
7507367|NCT03137992|26055350|P3|Washout Period 2|COPD Exacerbation|0
7507368|NCT03137992|26055351|P2|Washout Period 2|COPD Exacerbation|1
7507369|NCT03137992|26055352|P1|Washout Period 2|COPD Exacerbation|1
7507370|NCT03137992|26055347|P6|Period 2 (Visit 3)|Withdrawal by Subject|0
7507371|NCT03137992|26055348|P5|Period 2 (Visit 3)|Withdrawal by Subject|1
7507372|NCT03137992|26055349|P4|Period 2 (Visit 3)|Withdrawal by Subject|0
7507373|NCT03137992|26055350|P3|Period 2 (Visit 3)|Withdrawal by Subject|0
7507374|NCT03137992|26055351|P2|Period 2 (Visit 3)|Withdrawal by Subject|2
7507375|NCT03137992|26055352|P1|Period 2 (Visit 3)|Withdrawal by Subject|0
7507376|NCT03137992|26055347|P6|Period 2 (Visit 3)|Lost to Follow-up|0
7507377|NCT03137992|26055348|P5|Period 2 (Visit 3)|Lost to Follow-up|0
7507378|NCT03137992|26055349|P4|Period 2 (Visit 3)|Lost to Follow-up|1
7507379|NCT03137992|26055350|P3|Period 2 (Visit 3)|Lost to Follow-up|0
7507380|NCT03137992|26055351|P2|Period 2 (Visit 3)|Lost to Follow-up|0
7507381|NCT03137992|26055352|P1|Period 2 (Visit 3)|Lost to Follow-up|0
7507382|NCT03137992|26055347|P6|Period 2 (Visit 3)|Adverse Event|0
7507383|NCT03137992|26055348|P5|Period 2 (Visit 3)|Adverse Event|0
7507384|NCT03137992|26055349|P4|Period 2 (Visit 3)|Adverse Event|0
7507385|NCT03137992|26055350|P3|Period 2 (Visit 3)|Adverse Event|0
7507386|NCT03137992|26055351|P2|Period 2 (Visit 3)|Adverse Event|1
7507387|NCT03137992|26055352|P1|Period 2 (Visit 3)|Adverse Event|0
7507388|NCT03137992|26055347|P6|Period 2 (Visit 3)|Did not meet continuation criteria|7
7507389|NCT03137992|26055348|P5|Period 2 (Visit 3)|Did not meet continuation criteria|3
7507390|NCT03137992|26055349|P4|Period 2 (Visit 3)|Did not meet continuation criteria|4
7507391|NCT03137992|26055350|P3|Period 2 (Visit 3)|Did not meet continuation criteria|3
7507392|NCT03137992|26055351|P2|Period 2 (Visit 3)|Did not meet continuation criteria|3
7507393|NCT03137992|26055352|P1|Period 2 (Visit 3)|Did not meet continuation criteria|2
7507394|NCT03137992|26055347|P6|Period 2 (Visit 3)|COPD Exacerbation|1
7507395|NCT03137992|26055348|P5|Period 2 (Visit 3)|COPD Exacerbation|0
7507396|NCT03137992|26055349|P4|Period 2 (Visit 3)|COPD Exacerbation|0
7507397|NCT03137992|26055350|P3|Period 2 (Visit 3)|COPD Exacerbation|0
7507398|NCT03137992|26055351|P2|Period 2 (Visit 3)|COPD Exacerbation|1
7507399|NCT03137992|26055352|P1|Period 2 (Visit 3)|COPD Exacerbation|1
7507400|NCT03137992|26055347|P6|Washout Period 1|Subject Noncompliance|0
7507401|NCT03137992|26055348|P5|Washout Period 1|Subject Noncompliance|1
7507402|NCT03137992|26055349|P4|Washout Period 1|Subject Noncompliance|0
7507404|NCT03137992|26055351|P2|Washout Period 1|Subject Noncompliance|0
7507405|NCT03137992|26055352|P1|Washout Period 1|Subject Noncompliance|1
7507406|NCT03137992|26055347|P6|Washout Period 1|COPD Exacerbation|1
7507407|NCT03137992|26055348|P5|Washout Period 1|COPD Exacerbation|1
7507408|NCT03137992|26055349|P4|Washout Period 1|COPD Exacerbation|0
7507409|NCT03137992|26055350|P3|Washout Period 1|COPD Exacerbation|1
7507410|NCT03137992|26055351|P2|Washout Period 1|COPD Exacerbation|1
7507411|NCT03137992|26055352|P1|Washout Period 1|COPD Exacerbation|1
7507412|NCT03137992|26055347|P6|Washout Period 1|Principal Investigator Discretion|0
7507413|NCT03137992|26055348|P5|Washout Period 1|Principal Investigator Discretion|0
7507414|NCT03137992|26055349|P4|Washout Period 1|Principal Investigator Discretion|0
7507415|NCT03137992|26055350|P3|Washout Period 1|Principal Investigator Discretion|0
7507416|NCT03137992|26055351|P2|Washout Period 1|Principal Investigator Discretion|1
7507417|NCT03137992|26055352|P1|Washout Period 1|Principal Investigator Discretion|0
7507418|NCT03137992|26055347|P6|Washout Period 1|Withdrawal by Subject|0
7507419|NCT03137992|26055348|P5|Washout Period 1|Withdrawal by Subject|0
7507420|NCT03137992|26055349|P4|Washout Period 1|Withdrawal by Subject|0
7507421|NCT03137992|26055350|P3|Washout Period 1|Withdrawal by Subject|1
7507422|NCT03137992|26055351|P2|Washout Period 1|Withdrawal by Subject|1
7507423|NCT03137992|26055352|P1|Washout Period 1|Withdrawal by Subject|0
7507424|NCT03137992|26055347|P6|Washout Period 1|Adverse Event|1
7507425|NCT03137992|26055348|P5|Washout Period 1|Adverse Event|0
7507426|NCT03137992|26055349|P4|Washout Period 1|Adverse Event|0
7507427|NCT03137992|26055350|P3|Washout Period 1|Adverse Event|0
7507428|NCT03137992|26055351|P2|Washout Period 1|Adverse Event|1
7507429|NCT03137992|26055352|P1|Washout Period 1|Adverse Event|1
7507430|NCT03137784|26055362|P6|Overall Study|Non-compliance with study treatment|0
7507431|NCT03137784|26055363|P5|Overall Study|Non-compliance with study treatment|1
7507432|NCT03137784|26055364|P4|Overall Study|Non-compliance with study treatment|0
7507433|NCT03137784|26055365|P3|Overall Study|Non-compliance with study treatment|0
7507434|NCT03137784|26055366|P2|Overall Study|Non-compliance with study treatment|0
7507435|NCT03137784|26055367|P1|Overall Study|Non-compliance with study treatment|0
7507436|NCT03137784|26055362|P6|Overall Study|Subject/guardian decision|0
7507437|NCT03137784|26055363|P5|Overall Study|Subject/guardian decision|0
7507438|NCT03137784|26055364|P4|Overall Study|Subject/guardian decision|0
7507439|NCT03137784|26055365|P3|Overall Study|Subject/guardian decision|0
7507440|NCT03137784|26055366|P2|Overall Study|Subject/guardian decision|0
7507441|NCT03137784|26055367|P1|Overall Study|Subject/guardian decision|1
7507442|NCT03137784|26055362|P6|Overall Study|Adverse Event|0
7507443|NCT03137784|26055363|P5|Overall Study|Adverse Event|0
7507444|NCT03137784|26055364|P4|Overall Study|Adverse Event|0
7507445|NCT03137784|26055365|P3|Overall Study|Adverse Event|0
7507446|NCT03137784|26055366|P2|Overall Study|Adverse Event|1
7507447|NCT03137784|26055367|P1|Overall Study|Adverse Event|1
7507448|NCT03137459|26055408|P2|6-months|Acutely ill|1
7507449|NCT03137459|26055409|P1|6-months|Acutely ill|1
7507450|NCT03137459|26055408|P2|6-months|Refused assessment|3
7507451|NCT03137459|26055409|P1|6-months|Refused assessment|6
7507452|NCT03137459|26055408|P2|6-months|Death|2
7507453|NCT03137459|26055409|P1|6-months|Death|0
7507454|NCT03137459|26055408|P2|6-months|Lost to Follow-up|11
7507455|NCT03137459|26055409|P1|6-months|Lost to Follow-up|14
7507456|NCT03137459|26055408|P2|4-month Assessment|Acutely ill|3
7507457|NCT03137459|26055409|P1|4-month Assessment|Acutely ill|2
7507458|NCT03137459|26055408|P2|4-month Assessment|Refused assessment|10
7507459|NCT03137459|26055409|P1|4-month Assessment|Refused assessment|24
7507460|NCT03137459|26055408|P2|4-month Assessment|Unable to reach|29
7507461|NCT03137459|26055409|P1|4-month Assessment|Unable to reach|44
7507462|NCT03137459|26055408|P2|4-month Assessment|Withdrawal by Subject|2
7507463|NCT03137459|26055409|P1|4-month Assessment|Withdrawal by Subject|4
7507464|NCT03137459|26055408|P2|4-month Assessment|Death|2
7507465|NCT03137459|26055409|P1|4-month Assessment|Death|4
7507466|NCT03137459|26055408|P2|2-month Assessment|Acutely ill|2
7507467|NCT03137459|26055409|P1|2-month Assessment|Acutely ill|6
7507468|NCT03137459|26055408|P2|2-month Assessment|Refused assessment|5
7507469|NCT03137459|26055409|P1|2-month Assessment|Refused assessment|7
7507470|NCT03137459|26055408|P2|2-month Assessment|Unable to reach|32
7507471|NCT03137459|26055409|P1|2-month Assessment|Unable to reach|42
7507472|NCT03137459|26055408|P2|2-month Assessment|Withdrawal by Subject|3
7507473|NCT03137459|26055409|P1|2-month Assessment|Withdrawal by Subject|13
7507474|NCT03137303|26055423|P2|T4: 12-month Follow-up|Lost to Follow-up|4
7507475|NCT03137303|26055424|P1|T4: 12-month Follow-up|Lost to Follow-up|7
7507476|NCT03137303|26055423|P2|T4: 12-month Follow-up|Withdrawal by Subject|1
7507477|NCT03137303|26055424|P1|T4: 12-month Follow-up|Withdrawal by Subject|0
7507478|NCT03137303|26055423|P2|T3: 9-month Follow-up|Lost to Follow-up|4
7507479|NCT03137303|26055424|P1|T3: 9-month Follow-up|Lost to Follow-up|4
7507480|NCT03137303|26055423|P2|T3: 9-month Follow-up|Death|0
7507481|NCT03137303|26055424|P1|T3: 9-month Follow-up|Death|1
7507482|NCT03137303|26055423|P2|T2: 6-month Follow-up|Lost to Follow-up|5
7507483|NCT03137303|26055424|P1|T2: 6-month Follow-up|Lost to Follow-up|5
7507484|NCT03137303|26055423|P2|T1: 3-month Follow-up|Lost to Follow-up|6
7507485|NCT03137303|26055424|P1|T1: 3-month Follow-up|Lost to Follow-up|5
7507486|NCT03137303|26055423|P2|T1: 3-month Follow-up|Withdrawal by Subject|4
7507487|NCT03137303|26055424|P1|T1: 3-month Follow-up|Withdrawal by Subject|1
7507488|NCT03137173|26055449|P2|Overall Study|Other reasons|2
7507489|NCT03137173|26055450|P1|Overall Study|Other reasons|3
7507490|NCT03137173|26055449|P2|Overall Study|Lost to Follow-up|18
7507491|NCT03137173|26055450|P1|Overall Study|Lost to Follow-up|13
7507492|NCT03137173|26055449|P2|Overall Study|Physician Decision|0
7507493|NCT03137173|26055450|P1|Overall Study|Physician Decision|1
7507494|NCT03137173|26055449|P2|Overall Study|Death|3
7507495|NCT03137173|26055450|P1|Overall Study|Death|1
7507496|NCT03137173|26055449|P2|Overall Study|Withdrawal by Subject|13
7507497|NCT03137173|26055450|P1|Overall Study|Withdrawal by Subject|8
7507498|NCT03137121|26055462|P2|Overall Study|Withdrawal by Subject|1
7507499|NCT03137121|26055463|P1|Overall Study|Withdrawal by Subject|0
7507500|NCT03137069|26055479|P6|Overall Study|Data Entry Error|0
7507501|NCT03137069|26055480|P5|Overall Study|Data Entry Error|0
7507502|NCT03137069|26055481|P4|Overall Study|Data Entry Error|1
7507503|NCT03137069|26055482|P3|Overall Study|Data Entry Error|0
7507504|NCT03137069|26055483|P2|Overall Study|Data Entry Error|0
7507505|NCT03137069|26055484|P1|Overall Study|Data Entry Error|0
7507506|NCT03137069|26055479|P6|Overall Study|Study Terminated by Sponsor|0
7507507|NCT03137069|26055480|P5|Overall Study|Study Terminated by Sponsor|1
7507508|NCT03137069|26055481|P4|Overall Study|Study Terminated by Sponsor|0
7507509|NCT03137069|26055482|P3|Overall Study|Study Terminated by Sponsor|0
7507510|NCT03137069|26055483|P2|Overall Study|Study Terminated by Sponsor|0
7507511|NCT03137069|26055484|P1|Overall Study|Study Terminated by Sponsor|0
7507512|NCT03137069|26055479|P6|Overall Study|Physician Decision|0
7507513|NCT03137069|26055480|P5|Overall Study|Physician Decision|0
7507514|NCT03137069|26055481|P4|Overall Study|Physician Decision|1
7507515|NCT03137069|26055482|P3|Overall Study|Physician Decision|0
7507516|NCT03137069|26055483|P2|Overall Study|Physician Decision|0
7507517|NCT03137069|26055484|P1|Overall Study|Physician Decision|0
7507518|NCT03137069|26055479|P6|Overall Study|Protocol Violation|1
7507519|NCT03137069|26055480|P5|Overall Study|Protocol Violation|1
7507520|NCT03137069|26055481|P4|Overall Study|Protocol Violation|1
7507521|NCT03137069|26055482|P3|Overall Study|Protocol Violation|0
7507522|NCT03137069|26055483|P2|Overall Study|Protocol Violation|1
7507523|NCT03137069|26055484|P1|Overall Study|Protocol Violation|0
7507524|NCT03137069|26055479|P6|Overall Study|Adverse Event|1
7507525|NCT03137069|26055480|P5|Overall Study|Adverse Event|0
7507526|NCT03137069|26055481|P4|Overall Study|Adverse Event|1
7507527|NCT03137069|26055482|P3|Overall Study|Adverse Event|1
7507528|NCT03137069|26055483|P2|Overall Study|Adverse Event|3
7507529|NCT03137069|26055484|P1|Overall Study|Adverse Event|0
7507530|NCT03137069|26055479|P6|Overall Study|Withdrawal by Subject|0
7507531|NCT03137069|26055480|P5|Overall Study|Withdrawal by Subject|0
7507532|NCT03137069|26055481|P4|Overall Study|Withdrawal by Subject|2
7507533|NCT03137069|26055482|P3|Overall Study|Withdrawal by Subject|2
7507534|NCT03137069|26055483|P2|Overall Study|Withdrawal by Subject|2
7507535|NCT03137069|26055484|P1|Overall Study|Withdrawal by Subject|1
7507536|NCT03136861|26055536|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7507537|NCT03136861|26055537|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7507538|NCT03136861|26055538|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7507539|NCT03136861|26055539|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7507540|NCT03136861|26055540|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
7507541|NCT03136861|26055541|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7507542|NCT03136861|26055542|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7507543|NCT03136861|26055536|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7507544|NCT03136861|26055537|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7507545|NCT03136861|26055538|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7507546|NCT03136861|26055539|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7507547|NCT03136861|26055540|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
7507548|NCT03136861|26055541|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7507549|NCT03136861|26055542|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7507550|NCT03136861|26055536|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7507551|NCT03136861|26055537|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7507552|NCT03136861|26055538|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
7507553|NCT03136861|26055539|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7507554|NCT03136861|26055540|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7507555|NCT03136861|26055541|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7507556|NCT03136861|26055542|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7507557|NCT03136861|26055536|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7507558|NCT03136861|26055537|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7507559|NCT03136861|26055538|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7507560|NCT03136861|26055539|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7507561|NCT03136861|26055540|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7507562|NCT03136861|26055541|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7507563|NCT03136861|26055542|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7507564|NCT03136861|26055536|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7507565|NCT03136861|26055537|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7507566|NCT03136861|26055538|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7507567|NCT03136861|26055539|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7507568|NCT03136861|26055540|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7507569|NCT03136861|26055541|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
7507570|NCT03136861|26055542|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7507571|NCT03136861|26055536|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7507572|NCT03136861|26055537|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7507573|NCT03136861|26055538|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7507574|NCT03136861|26055539|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7507575|NCT03136861|26055540|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7507576|NCT03136861|26055541|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
7507577|NCT03136861|26055542|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
7507578|NCT03136861|26055536|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7507579|NCT03136861|26055537|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7507580|NCT03136861|26055538|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7507581|NCT03136861|26055539|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7507582|NCT03136861|26055540|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7507583|NCT03136861|26055541|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7507584|NCT03136861|26055542|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7507585|NCT03136861|26055536|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7507586|NCT03136861|26055537|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7507587|NCT03136861|26055538|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7507588|NCT03136861|26055539|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7507589|NCT03136861|26055540|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7507590|NCT03136861|26055541|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
7507591|NCT03136861|26055542|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
7507592|NCT03136484|26055557|P2|Overall Study|Death|0
7507593|NCT03136484|26055558|P1|Overall Study|Death|1
7507594|NCT03136484|26055557|P2|Overall Study|Lost to Follow-up|8
7507595|NCT03136484|26055558|P1|Overall Study|Lost to Follow-up|7
7507596|NCT03136484|26055557|P2|Overall Study|Withdrawal by Subject|14
7507597|NCT03136484|26055558|P1|Overall Study|Withdrawal by Subject|19
7507598|NCT03136380|26055686|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7507599|NCT03136380|26055687|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7507600|NCT03136380|26055688|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7507601|NCT03136380|26055689|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
7507602|NCT03136380|26055690|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7507603|NCT03136367|26055866|P3|T5 1 Year After Surgery|logistical issues prevented contact|2
7507604|NCT03136367|26055867|P2|T5 1 Year After Surgery|logistical issues prevented contact|4
7507605|NCT03136367|26055868|P1|T5 1 Year After Surgery|logistical issues prevented contact|0
7507606|NCT03136367|26055866|P3|T5 1 Year After Surgery|study ended before due|110
7507607|NCT03136367|26055867|P2|T5 1 Year After Surgery|study ended before due|103
7507608|NCT03136367|26055868|P1|T5 1 Year After Surgery|study ended before due|31
7507609|NCT03136367|26055866|P3|T5 1 Year After Surgery|Lost to Follow-up|15
7507610|NCT03136367|26055867|P2|T5 1 Year After Surgery|Lost to Follow-up|22
7507611|NCT03136367|26055868|P1|T5 1 Year After Surgery|Lost to Follow-up|2
7507612|NCT03136367|26055866|P3|T5 1 Year After Surgery|Discontinued lost contact|0
7507613|NCT03136367|26055867|P2|T5 1 Year After Surgery|Discontinued lost contact|6
7507614|NCT03136367|26055868|P1|T5 1 Year After Surgery|Discontinued lost contact|1
7507615|NCT03136367|26055866|P3|T5 1 Year After Surgery|Death|1
7507616|NCT03136367|26055867|P2|T5 1 Year After Surgery|Death|0
7507617|NCT03136367|26055868|P1|T5 1 Year After Surgery|Death|0
7507618|NCT03136367|26055866|P3|T5 1 Year After Surgery|Withdrawal by Subject|0
7507619|NCT03136367|26055867|P2|T5 1 Year After Surgery|Withdrawal by Subject|0
7507620|NCT03136367|26055868|P1|T5 1 Year After Surgery|Withdrawal by Subject|1
7507621|NCT03136367|26055866|P3|T5 1 Year After Surgery|discontinued mistakenly included|1
7507622|NCT03136367|26055867|P2|T5 1 Year After Surgery|discontinued mistakenly included|1
7507623|NCT03136367|26055868|P1|T5 1 Year After Surgery|discontinued mistakenly included|1
7507624|NCT03136367|26055866|P3|T4 12 Weeks After Surgery|discontinued mistakenly included|1
7507625|NCT03136367|26055867|P2|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7507626|NCT03136367|26055868|P1|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7507627|NCT03136367|26055866|P3|T4 12 Weeks After Surgery|discontinued transferred care|5
7507628|NCT03136367|26055867|P2|T4 12 Weeks After Surgery|discontinued transferred care|1
7507629|NCT03136367|26055868|P1|T4 12 Weeks After Surgery|discontinued transferred care|0
7507630|NCT03136367|26055866|P3|T4 12 Weeks After Surgery|discontinued lost contact|0
7507631|NCT03136367|26055867|P2|T4 12 Weeks After Surgery|discontinued lost contact|0
7507632|NCT03136367|26055868|P1|T4 12 Weeks After Surgery|discontinued lost contact|1
7507633|NCT03136367|26055866|P3|T4 12 Weeks After Surgery|Death|3
7507634|NCT03136367|26055867|P2|T4 12 Weeks After Surgery|Death|1
7507635|NCT03136367|26055868|P1|T4 12 Weeks After Surgery|Death|0
7507636|NCT03136367|26055866|P3|T4 12 Weeks After Surgery|Withdrawal by Subject|0
7507637|NCT03136367|26055867|P2|T4 12 Weeks After Surgery|Withdrawal by Subject|3
7507638|NCT03136367|26055868|P1|T4 12 Weeks After Surgery|Withdrawal by Subject|1
7507639|NCT03136367|26055866|P3|T3 1 Week After Surgery|Discontinued lost contact|4
7507640|NCT03136367|26055867|P2|T3 1 Week After Surgery|Discontinued lost contact|2
7507641|NCT03136367|26055868|P1|T3 1 Week After Surgery|Discontinued lost contact|1
7507642|NCT03136367|26055866|P3|T3 1 Week After Surgery|Withdrawal by Subject|2
7507643|NCT03136367|26055867|P2|T3 1 Week After Surgery|Withdrawal by Subject|6
7507644|NCT03136367|26055868|P1|T3 1 Week After Surgery|Withdrawal by Subject|0
7507645|NCT03136367|26055866|P3|T3 1 Week After Surgery|other discontinued|3
7507646|NCT03136367|26055867|P2|T3 1 Week After Surgery|other discontinued|4
7507647|NCT03136367|26055868|P1|T3 1 Week After Surgery|other discontinued|2
7507648|NCT03136367|26055866|P3|T3 1 Week After Surgery|Discontinued transferred care|14
7507649|NCT03136367|26055867|P2|T3 1 Week After Surgery|Discontinued transferred care|11
7507650|NCT03136367|26055868|P1|T3 1 Week After Surgery|Discontinued transferred care|2
7507651|NCT03136367|26055866|P3|T3 1 Week After Surgery|Discontinued mistakenly included|8
7507652|NCT03136367|26055867|P2|T3 1 Week After Surgery|Discontinued mistakenly included|9
7507653|NCT03136367|26055868|P1|T3 1 Week After Surgery|Discontinued mistakenly included|5
7507654|NCT03136367|26055866|P3|T2 Post-consultation|Discontinued lost contact|0
7507655|NCT03136367|26055867|P2|T2 Post-consultation|Discontinued lost contact|1
7507656|NCT03136367|26055868|P1|T2 Post-consultation|Discontinued lost contact|0
7507657|NCT03136367|26055866|P3|T2 Post-consultation|Discontinued transferred care|3
7507658|NCT03136367|26055867|P2|T2 Post-consultation|Discontinued transferred care|0
7507659|NCT03136367|26055868|P1|T2 Post-consultation|Discontinued transferred care|0
7507660|NCT03136367|26055866|P3|T2 Post-consultation|Discontinued other|6
7507661|NCT03136367|26055867|P2|T2 Post-consultation|Discontinued other|2
7507662|NCT03136367|26055868|P1|T2 Post-consultation|Discontinued other|0
7507663|NCT03136367|26055866|P3|T2 Post-consultation|discontinued mistakenly included|17
7507664|NCT03136367|26055867|P2|T2 Post-consultation|discontinued mistakenly included|2
7507665|NCT03136367|26055868|P1|T2 Post-consultation|discontinued mistakenly included|2
7507666|NCT03136367|26055866|P3|T2 Post-consultation|Withdrawal by Subject|5
7507667|NCT03136367|26055867|P2|T2 Post-consultation|Withdrawal by Subject|1
7507668|NCT03136367|26055868|P1|T2 Post-consultation|Withdrawal by Subject|1
7507669|NCT03136367|26055866|P3|T1 Consultation|Discontinued other|0
7507670|NCT03136367|26055867|P2|T1 Consultation|Discontinued other|1
7507671|NCT03136367|26055868|P1|T1 Consultation|Discontinued other|0
7507672|NCT03136367|26055866|P3|T1 Consultation|discontinued mistakenly included|1
7507673|NCT03136367|26055867|P2|T1 Consultation|discontinued mistakenly included|6
7507674|NCT03136367|26055868|P1|T1 Consultation|discontinued mistakenly included|2
7507675|NCT03136198|26055913|P2|Overall Study|Withdrawal by Subject|1
7507676|NCT03136198|26055914|P1|Overall Study|Withdrawal by Subject|0
7507677|NCT03136159|26055922|P2|Overall Study|never got dressing placed|0
7507678|NCT03136159|26055923|P1|Overall Study|never got dressing placed|1
7507679|NCT03136159|26055922|P2|Overall Study|additional dressing|0
7507680|NCT03136159|26055923|P1|Overall Study|additional dressing|1
7507681|NCT03136159|26055922|P2|Overall Study|vertical skin incision|0
7507682|NCT03136159|26055923|P1|Overall Study|vertical skin incision|1
7507683|NCT03136159|26055922|P2|Overall Study|chorioamnionitis|0
7507684|NCT03136159|26055923|P1|Overall Study|chorioamnionitis|2
7507685|NCT03136107|26055929|P1|Overall Study|Other (Not specified)|1
7507686|NCT03136068|26055939|P2|Overall Study|Protocol Violation|0
7507687|NCT03136068|26055940|P1|Overall Study|Protocol Violation|1
7507688|NCT03136068|26055939|P2|Overall Study|Lost to Follow-up|1
7507689|NCT03136068|26055940|P1|Overall Study|Lost to Follow-up|1
7507690|NCT03135899|26055962|P8|Overall Study|Withdrawal by Subject|0
7507691|NCT03135899|26055963|P7|Overall Study|Withdrawal by Subject|0
7507692|NCT03135899|26055964|P6|Overall Study|Withdrawal by Subject|2
7507693|NCT03135899|26055965|P5|Overall Study|Withdrawal by Subject|0
7507694|NCT03135899|26055966|P4|Overall Study|Withdrawal by Subject|0
7507695|NCT03135899|26055967|P3|Overall Study|Withdrawal by Subject|0
7507696|NCT03135899|26055968|P2|Overall Study|Withdrawal by Subject|0
7507697|NCT03135899|26055969|P1|Overall Study|Withdrawal by Subject|0
7507698|NCT03135899|26055962|P8|Overall Study|Failed spirometry,unable to repeat visit|0
7507699|NCT03135899|26055963|P7|Overall Study|Failed spirometry,unable to repeat visit|1
7507700|NCT03135899|26055964|P6|Overall Study|Failed spirometry,unable to repeat visit|0
7507701|NCT03135899|26055965|P5|Overall Study|Failed spirometry,unable to repeat visit|0
7507702|NCT03135899|26055966|P4|Overall Study|Failed spirometry,unable to repeat visit|0
7507703|NCT03135899|26055967|P3|Overall Study|Failed spirometry,unable to repeat visit|0
7507704|NCT03135899|26055968|P2|Overall Study|Failed spirometry,unable to repeat visit|0
7507705|NCT03135899|26055969|P1|Overall Study|Failed spirometry,unable to repeat visit|0
7507706|NCT03135548|26056002|P3|Overall Study|Other than listed|2
7507707|NCT03135548|26056003|P2|Overall Study|Other than listed|2
7507708|NCT03135548|26056004|P1|Overall Study|Other than listed|0
7507709|NCT03135548|26056002|P3|Overall Study|Withdrawal by Subject|1
7507710|NCT03135548|26056003|P2|Overall Study|Withdrawal by Subject|2
7507711|NCT03135548|26056004|P1|Overall Study|Withdrawal by Subject|2
7507712|NCT03135548|26056002|P3|Overall Study|Lost to Follow-up|0
7507713|NCT03135548|26056003|P2|Overall Study|Lost to Follow-up|0
7507714|NCT03135548|26056004|P1|Overall Study|Lost to Follow-up|3
7507715|NCT03135522|26056034|P2|Overall Study|Adverse Event|0
7507716|NCT03135522|26056035|P1|Overall Study|Adverse Event|1
7507717|NCT03135431|26056049|P2|Overall Study|Study Surgeon not available|0
7507718|NCT03135431|26056050|P1|Overall Study|Study Surgeon not available|2
7507719|NCT03135262|26056076|P5|Overall Study|Study terminated by sponsor|0
7507720|NCT03135262|26056077|P4|Overall Study|Study terminated by sponsor|3
7507721|NCT03135262|26056078|P3|Overall Study|Study terminated by sponsor|4
7507722|NCT03135262|26056079|P2|Overall Study|Study terminated by sponsor|4
7507723|NCT03135262|26056080|P1|Overall Study|Study terminated by sponsor|2
7507724|NCT03135262|26056076|P5|Overall Study|Withdrawal by Subject|1
7507725|NCT03135262|26056077|P4|Overall Study|Withdrawal by Subject|0
7507726|NCT03135262|26056078|P3|Overall Study|Withdrawal by Subject|1
7507727|NCT03135262|26056079|P2|Overall Study|Withdrawal by Subject|0
7507728|NCT03135262|26056080|P1|Overall Study|Withdrawal by Subject|0
7507729|NCT03135262|26056076|P5|Overall Study|Death|0
7507730|NCT03135262|26056077|P4|Overall Study|Death|2
7507731|NCT03135262|26056078|P3|Overall Study|Death|2
7507732|NCT03135262|26056079|P2|Overall Study|Death|2
7507733|NCT03135262|26056080|P1|Overall Study|Death|6
7507734|NCT03135262|26056076|P5|Overall Study|Progression of disease|0
7507735|NCT03135262|26056077|P4|Overall Study|Progression of disease|1
7507736|NCT03135262|26056078|P3|Overall Study|Progression of disease|0
7507737|NCT03135262|26056079|P2|Overall Study|Progression of disease|0
7507738|NCT03135262|26056080|P1|Overall Study|Progression of disease|0
7507739|NCT03135262|26056076|P5|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7507740|NCT03135262|26056077|P4|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7507741|NCT03135262|26056078|P3|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7507742|NCT03135262|26056079|P2|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7507743|NCT03135262|26056080|P1|Overall Study|discontinued due to worsening of pre-existing medical condition|1
7507744|NCT03135210|26056190|P2|Overall Study|Death|1
7507745|NCT03135210|26056191|P1|Overall Study|Death|0
7507746|NCT03135028|26056197|P1|Overall Study|Withdrew Consent|1
7507747|NCT03135028|26056197|P1|Overall Study|Study Terminated by Sponsor|2
7507748|NCT03135028|26056197|P1|Overall Study|Death|6
7507749|NCT03134911|26056349|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
7507750|NCT03134911|26056349|P1|Overall Study|Screen failure|31
7507751|NCT03134599|26056411|P6|Week 3|Lost to Follow-up|1
7507752|NCT03134599|26056412|P5|Week 3|Lost to Follow-up|0
7507753|NCT03134599|26056413|P4|Week 3|Lost to Follow-up|1
7507754|NCT03134599|26056414|P3|Week 3|Lost to Follow-up|0
7507755|NCT03134599|26056415|P2|Week 3|Lost to Follow-up|0
7507756|NCT03134599|26056416|P1|Week 3|Lost to Follow-up|0
7507757|NCT03134599|26056411|P6|Week 2|Lost to Follow-up|0
7507758|NCT03134599|26056412|P5|Week 2|Lost to Follow-up|1
7507759|NCT03134599|26056413|P4|Week 2|Lost to Follow-up|1
7507760|NCT03134599|26056414|P3|Week 2|Lost to Follow-up|0
7507761|NCT03134599|26056415|P2|Week 2|Lost to Follow-up|0
7507762|NCT03134599|26056416|P1|Week 2|Lost to Follow-up|1
7507763|NCT03134599|26056411|P6|Week 1|Lost to Follow-up|0
7507764|NCT03134599|26056412|P5|Week 1|Lost to Follow-up|1
7507765|NCT03134599|26056413|P4|Week 1|Lost to Follow-up|0
7507766|NCT03134599|26056414|P3|Week 1|Lost to Follow-up|0
7507767|NCT03134599|26056415|P2|Week 1|Lost to Follow-up|0
7507768|NCT03134599|26056416|P1|Week 1|Lost to Follow-up|0
7507769|NCT03134222|26056456|P5|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7507770|NCT03134222|26056457|P4|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7507771|NCT03134222|26056458|P3|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7507772|NCT03134222|26056459|P2|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
7507773|NCT03134222|26056460|P1|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7507774|NCT03134222|26056456|P5|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7507775|NCT03134222|26056457|P4|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
7507776|NCT03134222|26056458|P3|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7507777|NCT03134222|26056459|P2|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7507778|NCT03134222|26056460|P1|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7507779|NCT03134222|26056456|P5|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7507780|NCT03134222|26056457|P4|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7507781|NCT03134222|26056458|P3|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7507782|NCT03134222|26056459|P2|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7507783|NCT03134222|26056460|P1|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
7507784|NCT03134222|26056456|P5|Treatment Period (Week 12 to 48)|Withdrew Consent|1
7507785|NCT03134222|26056457|P4|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7507786|NCT03134222|26056458|P3|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7507787|NCT03134222|26056459|P2|Treatment Period (Week 12 to 48)|Withdrew Consent|2
7507788|NCT03134222|26056460|P1|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7507789|NCT03134222|26056456|P5|Treatment Period (Up to Week 12)|Randomized but not treated|0
7507790|NCT03134222|26056457|P4|Treatment Period (Up to Week 12)|Randomized but not treated|0
7507791|NCT03134222|26056458|P3|Treatment Period (Up to Week 12)|Randomized but not treated|1
7507792|NCT03134222|26056459|P2|Treatment Period (Up to Week 12)|Randomized but not treated|1
7507793|NCT03134222|26056460|P1|Treatment Period (Up to Week 12)|Randomized but not treated|0
7507794|NCT03134222|26056456|P5|Treatment Period (Up to Week 12)|Withdrew Consent|0
7507795|NCT03134222|26056457|P4|Treatment Period (Up to Week 12)|Withdrew Consent|0
7507796|NCT03134222|26056458|P3|Treatment Period (Up to Week 12)|Withdrew Consent|0
7507797|NCT03134222|26056459|P2|Treatment Period (Up to Week 12)|Withdrew Consent|1
7507798|NCT03134222|26056460|P1|Treatment Period (Up to Week 12)|Withdrew Consent|0
7507799|NCT03134222|26056456|P5|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7507800|NCT03134222|26056457|P4|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7507801|NCT03134222|26056458|P3|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7507802|NCT03134222|26056459|P2|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7507803|NCT03134222|26056460|P1|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7507804|NCT03134222|26056456|P5|Treatment Period (Up to Week 12)|Adverse Event|0
7507805|NCT03134222|26056457|P4|Treatment Period (Up to Week 12)|Adverse Event|0
7507806|NCT03134222|26056458|P3|Treatment Period (Up to Week 12)|Adverse Event|0
7507807|NCT03134222|26056459|P2|Treatment Period (Up to Week 12)|Adverse Event|1
7507808|NCT03134222|26056460|P1|Treatment Period (Up to Week 12)|Adverse Event|4
7507809|NCT03134183|26056495|P2|Overall Study|Withdrawal by Subject|1
7507810|NCT03134183|26056496|P1|Overall Study|Withdrawal by Subject|1
7507811|NCT03133767|26056547|P2|Overall Study|Protocol Violation|1
7507812|NCT03133767|26056548|P1|Overall Study|Protocol Violation|0
7507813|NCT03133767|26056547|P2|Overall Study|Lost to Follow-up|24
7507814|NCT03133767|26056548|P1|Overall Study|Lost to Follow-up|38
7507815|NCT03133481|26056713|P2|Overall Study|FC Catheter fell out post operative day1|4
7507816|NCT03133481|26056714|P1|Overall Study|FC Catheter fell out post operative day1|0
7507817|NCT03132753|26056744|P2|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
7507818|NCT03132753|26056745|P1|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
7507819|NCT03132753|26056744|P2|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
7507820|NCT03132753|26056745|P1|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
7507821|NCT03132220|26056890|P2|Overall Study|Withdrawal by Subject|4
7507822|NCT03132220|26056891|P1|Overall Study|Withdrawal by Subject|1
7507823|NCT03132220|26056890|P2|Overall Study|Lost to Follow-up|8
7507824|NCT03132220|26056891|P1|Overall Study|Lost to Follow-up|17
7507825|NCT03131999|26056919|P2|Overall Study|Withdrawal by Subject|1
7507826|NCT03131999|26056920|P1|Overall Study|Withdrawal by Subject|0
7507827|NCT03131960|26056930|P2|Overall Study|Adverse Event|1
7507828|NCT03131960|26056931|P1|Overall Study|Adverse Event|0
7507829|NCT03131895|26056947|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7507830|NCT03131895|26056948|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7507831|NCT03131895|26056949|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7507832|NCT03131895|26056950|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
7507833|NCT03131895|26056947|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7507834|NCT03131895|26056948|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7507835|NCT03131895|26056949|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
7507836|NCT03131895|26056950|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7507837|NCT03131895|26056947|P4|Washout Period (at Least 5 Days)|Other|0
7507838|NCT03131895|26056948|P3|Washout Period (at Least 5 Days)|Other|2
7507839|NCT03131895|26056949|P2|Washout Period (at Least 5 Days)|Other|0
7507840|NCT03131895|26056950|P1|Washout Period (at Least 5 Days)|Other|0
7507841|NCT03131895|26056947|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7507842|NCT03131895|26056948|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7507843|NCT03131895|26056949|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
7507844|NCT03131895|26056950|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7507845|NCT03131895|26056947|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7507846|NCT03131895|26056948|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
7507847|NCT03131895|26056949|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7507848|NCT03131895|26056950|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7507849|NCT03131895|26056947|P4|Washout Period (at Least 5 Days)|Adverse Event|1
7507850|NCT03131895|26056948|P3|Washout Period (at Least 5 Days)|Adverse Event|0
7507851|NCT03131895|26056949|P2|Washout Period (at Least 5 Days)|Adverse Event|0
7507852|NCT03131895|26056950|P1|Washout Period (at Least 5 Days)|Adverse Event|1
7507853|NCT03131713|26056970|P2|Overall Study|Lost to Follow-up|0
7507854|NCT03131713|26056971|P1|Overall Study|Lost to Follow-up|5
7507855|NCT03131687|26056995|P6|Overall Study|Inadvertent Enrollment|0
7507856|NCT03131687|26056996|P5|Overall Study|Inadvertent Enrollment|0
7507857|NCT03131687|26056997|P4|Overall Study|Inadvertent Enrollment|1
7507858|NCT03131687|26056998|P3|Overall Study|Inadvertent Enrollment|0
7507859|NCT03131687|26056999|P2|Overall Study|Inadvertent Enrollment|0
7507860|NCT03131687|26057000|P1|Overall Study|Inadvertent Enrollment|0
7507861|NCT03131687|26056995|P6|Overall Study|Principle Investigator Decision|0
7507862|NCT03131687|26056996|P5|Overall Study|Principle Investigator Decision|0
7507863|NCT03131687|26056997|P4|Overall Study|Principle Investigator Decision|0
7507864|NCT03131687|26056998|P3|Overall Study|Principle Investigator Decision|0
7507865|NCT03131687|26056999|P2|Overall Study|Principle Investigator Decision|1
7507866|NCT03131687|26057000|P1|Overall Study|Principle Investigator Decision|0
7507867|NCT03131687|26056995|P6|Overall Study|Participant Started New Diabetic Drug|0
7507868|NCT03131687|26056996|P5|Overall Study|Participant Started New Diabetic Drug|0
7507869|NCT03131687|26056997|P4|Overall Study|Participant Started New Diabetic Drug|0
7507870|NCT03131687|26056998|P3|Overall Study|Participant Started New Diabetic Drug|0
7507871|NCT03131687|26056999|P2|Overall Study|Participant Started New Diabetic Drug|0
7507872|NCT03131687|26057000|P1|Overall Study|Participant Started New Diabetic Drug|1
7507873|NCT03131687|26056995|P6|Overall Study|Lost to Follow-up|2
7507874|NCT03131687|26056996|P5|Overall Study|Lost to Follow-up|4
7507875|NCT03131687|26056997|P4|Overall Study|Lost to Follow-up|1
7507876|NCT03131687|26056998|P3|Overall Study|Lost to Follow-up|0
7507877|NCT03131687|26056999|P2|Overall Study|Lost to Follow-up|4
7507878|NCT03131687|26057000|P1|Overall Study|Lost to Follow-up|1
7507879|NCT03131687|26056995|P6|Overall Study|Withdrawal by Subject|1
7507880|NCT03131687|26056996|P5|Overall Study|Withdrawal by Subject|2
7507881|NCT03131687|26056997|P4|Overall Study|Withdrawal by Subject|1
7507882|NCT03131687|26056998|P3|Overall Study|Withdrawal by Subject|3
7507883|NCT03131687|26056999|P2|Overall Study|Withdrawal by Subject|3
7507884|NCT03131687|26057000|P1|Overall Study|Withdrawal by Subject|3
7507885|NCT03131687|26056995|P6|Overall Study|Death|0
7507886|NCT03131687|26056996|P5|Overall Study|Death|0
7507887|NCT03131687|26056997|P4|Overall Study|Death|0
7507888|NCT03131687|26056998|P3|Overall Study|Death|0
7507889|NCT03131687|26056999|P2|Overall Study|Death|0
7507890|NCT03131687|26057000|P1|Overall Study|Death|1
7507891|NCT03131687|26056995|P6|Overall Study|Adverse Event|2
7507892|NCT03131687|26056996|P5|Overall Study|Adverse Event|2
7507893|NCT03131687|26056997|P4|Overall Study|Adverse Event|1
7507894|NCT03131687|26056998|P3|Overall Study|Adverse Event|0
7507895|NCT03131687|26056999|P2|Overall Study|Adverse Event|1
7507896|NCT03131687|26057000|P1|Overall Study|Adverse Event|0
7507897|NCT03131648|26057110|P8|Open-label (Short Term Extension)|Discontinued IMP|3
7507898|NCT03131648|26057111|P7|Open-label (Short Term Extension)|Discontinued IMP|0
7507899|NCT03131648|26057112|P6|Open-label (Short Term Extension)|Discontinued IMP|0
7507900|NCT03131648|26057113|P5|Open-label (Short Term Extension)|Discontinued IMP|0
7507901|NCT03131648|26057114|P4|Open-label (Short Term Extension)|Discontinued IMP|0
7507902|NCT03131648|26057115|P3|Open-label (Short Term Extension)|Discontinued IMP|0
7507903|NCT03131648|26057116|P2|Open-label (Short Term Extension)|Discontinued IMP|0
7507904|NCT03131648|26057117|P1|Open-label (Short Term Extension)|Discontinued IMP|0
7507905|NCT03131648|26057110|P8|Maintenance Treatment Period|Completed Week 50|0
7507906|NCT03131648|26057111|P7|Maintenance Treatment Period|Completed Week 50|0
7507907|NCT03131648|26057112|P6|Maintenance Treatment Period|Completed Week 50|0
7507908|NCT03131648|26057113|P5|Maintenance Treatment Period|Completed Week 50|1
7507909|NCT03131648|26057114|P4|Maintenance Treatment Period|Completed Week 50|0
7507910|NCT03131648|26057115|P3|Maintenance Treatment Period|Completed Week 50|0
7507911|NCT03131648|26057116|P2|Maintenance Treatment Period|Completed Week 50|0
7507912|NCT03131648|26057117|P1|Maintenance Treatment Period|Completed Week 50|0
7507913|NCT03131648|26057110|P8|Maintenance Treatment Period|Transfer to open-label treatment|0
7507914|NCT03131648|26057111|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
7507915|NCT03131648|26057112|P6|Maintenance Treatment Period|Transfer to open-label treatment|10
7507916|NCT03131648|26057113|P5|Maintenance Treatment Period|Transfer to open-label treatment|9
7507917|NCT03131648|26057114|P4|Maintenance Treatment Period|Transfer to open-label treatment|18
7507918|NCT03131648|26057115|P3|Maintenance Treatment Period|Transfer to open-label treatment|21
7507919|NCT03131648|26057116|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
7507920|NCT03131648|26057117|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
7507921|NCT03131648|26057110|P8|Maintenance Treatment Period|Discontinued IMP|0
7507922|NCT03131648|26057111|P7|Maintenance Treatment Period|Discontinued IMP|0
7507923|NCT03131648|26057112|P6|Maintenance Treatment Period|Discontinued IMP|4
7507924|NCT03131648|26057113|P5|Maintenance Treatment Period|Discontinued IMP|4
7507925|NCT03131648|26057114|P4|Maintenance Treatment Period|Discontinued IMP|5
7507926|NCT03131648|26057115|P3|Maintenance Treatment Period|Discontinued IMP|3
7507927|NCT03131648|26057116|P2|Maintenance Treatment Period|Discontinued IMP|0
7507928|NCT03131648|26057117|P1|Maintenance Treatment Period|Discontinued IMP|0
7507929|NCT03131648|26057110|P8|Maintenance Treatment Period|Not dosed|0
7507930|NCT03131648|26057111|P7|Maintenance Treatment Period|Not dosed|0
7507931|NCT03131648|26057112|P6|Maintenance Treatment Period|Not dosed|0
7507932|NCT03131648|26057113|P5|Maintenance Treatment Period|Not dosed|1
7507933|NCT03131648|26057114|P4|Maintenance Treatment Period|Not dosed|2
7507934|NCT03131648|26057115|P3|Maintenance Treatment Period|Not dosed|3
7507935|NCT03131648|26057116|P2|Maintenance Treatment Period|Not dosed|0
7507936|NCT03131648|26057117|P1|Maintenance Treatment Period|Not dosed|0
7507937|NCT03131648|26057110|P8|Open-label Treatment|Completed Week 50|0
7507938|NCT03131648|26057111|P7|Open-label Treatment|Completed Week 50|6
7507939|NCT03131648|26057112|P6|Open-label Treatment|Completed Week 50|0
7507940|NCT03131648|26057113|P5|Open-label Treatment|Completed Week 50|0
7507941|NCT03131648|26057114|P4|Open-label Treatment|Completed Week 50|0
7507942|NCT03131648|26057115|P3|Open-label Treatment|Completed Week 50|0
7507943|NCT03131648|26057116|P2|Open-label Treatment|Completed Week 50|0
7507944|NCT03131648|26057117|P1|Open-label Treatment|Completed Week 50|0
7507945|NCT03131648|26057110|P8|Open-label Treatment|Discontinued IMP|0
7507946|NCT03131648|26057111|P7|Open-label Treatment|Discontinued IMP|112
7507947|NCT03131648|26057112|P6|Open-label Treatment|Discontinued IMP|0
7507948|NCT03131648|26057113|P5|Open-label Treatment|Discontinued IMP|0
7507949|NCT03131648|26057114|P4|Open-label Treatment|Discontinued IMP|0
7507950|NCT03131648|26057115|P3|Open-label Treatment|Discontinued IMP|0
7507951|NCT03131648|26057116|P2|Open-label Treatment|Discontinued IMP|0
7507952|NCT03131648|26057117|P1|Open-label Treatment|Discontinued IMP|0
7507953|NCT03131648|26057110|P8|Initial Treatment Period|Discontinued IMP before Week 16|0
7507954|NCT03131648|26057111|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
7507955|NCT03131648|26057112|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
7507956|NCT03131648|26057113|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
7507957|NCT03131648|26057114|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
7507958|NCT03131648|26057115|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
7507959|NCT03131648|26057116|P2|Initial Treatment Period|Discontinued IMP before Week 16|18
7507960|NCT03131648|26057117|P1|Initial Treatment Period|Discontinued IMP before Week 16|51
7507961|NCT03131648|26057110|P8|Initial Treatment Period|Not dosed|0
7507962|NCT03131648|26057111|P7|Initial Treatment Period|Not dosed|0
7507963|NCT03131648|26057112|P6|Initial Treatment Period|Not dosed|0
7507964|NCT03131648|26057113|P5|Initial Treatment Period|Not dosed|0
7507965|NCT03131648|26057114|P4|Initial Treatment Period|Not dosed|0
7507966|NCT03131648|26057115|P3|Initial Treatment Period|Not dosed|0
7507967|NCT03131648|26057116|P2|Initial Treatment Period|Not dosed|2
7507968|NCT03131648|26057117|P1|Initial Treatment Period|Not dosed|2
7507969|NCT03131596|26057165|P2|Overall Study|Lost to Follow-up|0
7507970|NCT03131596|26057166|P1|Overall Study|Lost to Follow-up|3
7507971|NCT03131596|26057165|P2|Overall Study|Protocol Violation|3
7507972|NCT03131596|26057166|P1|Overall Study|Protocol Violation|3
7507973|NCT03131479|26057183|P5|Overall Study|Subject/Guardian Decision|0
7507974|NCT03131479|26057184|P4|Overall Study|Subject/Guardian Decision|1
7507975|NCT03131479|26057185|P3|Overall Study|Subject/Guardian Decision|0
7507976|NCT03131479|26057186|P2|Overall Study|Subject/Guardian Decision|0
7507977|NCT03131479|26057187|P1|Overall Study|Subject/Guardian Decision|0
7507978|NCT03131479|26057183|P5|Overall Study|Adverse Event|0
7507979|NCT03131479|26057184|P4|Overall Study|Adverse Event|1
7507980|NCT03131479|26057185|P3|Overall Study|Adverse Event|1
7507981|NCT03131479|26057186|P2|Overall Study|Adverse Event|0
7507982|NCT03131479|26057187|P1|Overall Study|Adverse Event|0
7507983|NCT03131453|26057247|P3|Overall Study|Protocol deviation|0
7507984|NCT03131453|26057248|P2|Overall Study|Protocol deviation|1
7507985|NCT03131453|26057249|P1|Overall Study|Protocol deviation|0
7507986|NCT03131453|26057247|P3|Overall Study|Technical problems|0
7507987|NCT03131453|26057248|P2|Overall Study|Technical problems|0
7507988|NCT03131453|26057249|P1|Overall Study|Technical problems|1
7507989|NCT03131453|26057247|P3|Overall Study|Non-compliance with study treatment|0
7507990|NCT03131453|26057248|P2|Overall Study|Non-compliance with study treatment|0
7507991|NCT03131453|26057249|P1|Overall Study|Non-compliance with study treatment|1
7507992|NCT03131453|26057247|P3|Overall Study|Physician Decision|1
7507993|NCT03131453|26057248|P2|Overall Study|Physician Decision|0
7507994|NCT03131453|26057249|P1|Overall Study|Physician Decision|1
7507995|NCT03131453|26057247|P3|Overall Study|Lost to Follow-up|1
7507996|NCT03131453|26057248|P2|Overall Study|Lost to Follow-up|0
7507997|NCT03131453|26057249|P1|Overall Study|Lost to Follow-up|1
7507998|NCT03131453|26057247|P3|Overall Study|Adverse Event|3
7507999|NCT03131453|26057248|P2|Overall Study|Adverse Event|3
7508000|NCT03131453|26057249|P1|Overall Study|Adverse Event|10
7508001|NCT03131453|26057247|P3|Overall Study|Withdrawal by Subject|13
7508002|NCT03131453|26057248|P2|Overall Study|Withdrawal by Subject|7
7508003|NCT03131453|26057249|P1|Overall Study|Withdrawal by Subject|18
7508004|NCT03131453|26057247|P3|Overall Study|Study terminated by Sponsor|438
7508005|NCT03131453|26057248|P2|Overall Study|Study terminated by Sponsor|222
7508006|NCT03131453|26057249|P1|Overall Study|Study terminated by Sponsor|424
7508007|NCT03131219|26057301|P2|Initial Evaluation Period|Deemed ineligible post treatment|0
7508008|NCT03131219|26057302|P1|Initial Evaluation Period|Deemed ineligible post treatment|2
7508009|NCT03131219|26057301|P2|Initial Evaluation Period|Protocol Violation|0
7508010|NCT03131219|26057302|P1|Initial Evaluation Period|Protocol Violation|1
7508011|NCT03131219|26057301|P2|Initial Evaluation Period|Adverse Event|0
7508012|NCT03131219|26057302|P1|Initial Evaluation Period|Adverse Event|1
7508013|NCT03131167|26057378|P13|Overall Study|Other (Unspecified)|0
7508014|NCT03131167|26057379|P12|Overall Study|Other (Unspecified)|0
7508015|NCT03131167|26057380|P11|Overall Study|Other (Unspecified)|0
7508016|NCT03131167|26057381|P10|Overall Study|Other (Unspecified)|0
7508017|NCT03131167|26057382|P9|Overall Study|Other (Unspecified)|0
7508018|NCT03131167|26057383|P8|Overall Study|Other (Unspecified)|0
7508019|NCT03131167|26057384|P7|Overall Study|Other (Unspecified)|0
7508020|NCT03131167|26057385|P6|Overall Study|Other (Unspecified)|1
7508021|NCT03131167|26057386|P5|Overall Study|Other (Unspecified)|0
7508022|NCT03131167|26057387|P4|Overall Study|Other (Unspecified)|0
7508023|NCT03131167|26057388|P3|Overall Study|Other (Unspecified)|0
7508024|NCT03131167|26057389|P2|Overall Study|Other (Unspecified)|0
7508025|NCT03131167|26057390|P1|Overall Study|Other (Unspecified)|0
7508026|NCT03130959|26057441|P10|Follow-up Period|Other reasons|2
7508027|NCT03130959|26057442|P9|Follow-up Period|Other reasons|0
7508028|NCT03130959|26057443|P8|Follow-up Period|Other reasons|0
7508029|NCT03130959|26057444|P7|Follow-up Period|Other reasons|0
7508030|NCT03130959|26057445|P6|Follow-up Period|Other reasons|0
7508031|NCT03130959|26057446|P5|Follow-up Period|Other reasons|0
7508032|NCT03130959|26057447|P4|Follow-up Period|Other reasons|1
7508033|NCT03130959|26057448|P3|Follow-up Period|Other reasons|0
7508034|NCT03130959|26057449|P2|Follow-up Period|Other reasons|1
7508035|NCT03130959|26057450|P1|Follow-up Period|Other reasons|0
7508036|NCT03130959|26057441|P10|Follow-up Period|Lost to Follow-up|1
7508037|NCT03130959|26057442|P9|Follow-up Period|Lost to Follow-up|0
7508038|NCT03130959|26057443|P8|Follow-up Period|Lost to Follow-up|0
7508039|NCT03130959|26057444|P7|Follow-up Period|Lost to Follow-up|0
7508040|NCT03130959|26057445|P6|Follow-up Period|Lost to Follow-up|2
7508041|NCT03130959|26057446|P5|Follow-up Period|Lost to Follow-up|0
7508042|NCT03130959|26057447|P4|Follow-up Period|Lost to Follow-up|0
7508043|NCT03130959|26057448|P3|Follow-up Period|Lost to Follow-up|0
7508044|NCT03130959|26057449|P2|Follow-up Period|Lost to Follow-up|1
7508045|NCT03130959|26057450|P1|Follow-up Period|Lost to Follow-up|1
7508046|NCT03130959|26057441|P10|Follow-up Period|Participant withdrew consent|3
7508047|NCT03130959|26057442|P9|Follow-up Period|Participant withdrew consent|1
7508048|NCT03130959|26057443|P8|Follow-up Period|Participant withdrew consent|1
7508049|NCT03130959|26057444|P7|Follow-up Period|Participant withdrew consent|0
7508050|NCT03130959|26057445|P6|Follow-up Period|Participant withdrew consent|0
7508051|NCT03130959|26057446|P5|Follow-up Period|Participant withdrew consent|3
7508052|NCT03130959|26057447|P4|Follow-up Period|Participant withdrew consent|3
7508053|NCT03130959|26057448|P3|Follow-up Period|Participant withdrew consent|0
7508054|NCT03130959|26057449|P2|Follow-up Period|Participant withdrew consent|1
7508055|NCT03130959|26057450|P1|Follow-up Period|Participant withdrew consent|3
7508056|NCT03130959|26057441|P10|Follow-up Period|Death|10
7508057|NCT03130959|26057442|P9|Follow-up Period|Death|17
7508058|NCT03130959|26057443|P8|Follow-up Period|Death|7
7508059|NCT03130959|26057444|P7|Follow-up Period|Death|9
7508060|NCT03130959|26057445|P6|Follow-up Period|Death|8
7508061|NCT03130959|26057446|P5|Follow-up Period|Death|11
7508062|NCT03130959|26057447|P4|Follow-up Period|Death|10
7508063|NCT03130959|26057448|P3|Follow-up Period|Death|12
7508064|NCT03130959|26057449|P2|Follow-up Period|Death|17
7508065|NCT03130959|26057450|P1|Follow-up Period|Death|16
7508066|NCT03130959|26057441|P10|Treatment Period|Participant withdrew consent|2
7508067|NCT03130959|26057442|P9|Treatment Period|Participant withdrew consent|0
7508068|NCT03130959|26057443|P8|Treatment Period|Participant withdrew consent|0
7508069|NCT03130959|26057444|P7|Treatment Period|Participant withdrew consent|0
7508070|NCT03130959|26057445|P6|Treatment Period|Participant withdrew consent|0
7508071|NCT03130959|26057446|P5|Treatment Period|Participant withdrew consent|1
7508072|NCT03130959|26057447|P4|Treatment Period|Participant withdrew consent|2
7508073|NCT03130959|26057448|P3|Treatment Period|Participant withdrew consent|0
7508074|NCT03130959|26057449|P2|Treatment Period|Participant withdrew consent|0
7508075|NCT03130959|26057450|P1|Treatment Period|Participant withdrew consent|0
7508076|NCT03130959|26057441|P10|Treatment Period|Adverse Event unrelated to drug|1
7508077|NCT03130959|26057442|P9|Treatment Period|Adverse Event unrelated to drug|1
7508078|NCT03130959|26057443|P8|Treatment Period|Adverse Event unrelated to drug|0
7508079|NCT03130959|26057444|P7|Treatment Period|Adverse Event unrelated to drug|1
7508080|NCT03130959|26057445|P6|Treatment Period|Adverse Event unrelated to drug|0
7508081|NCT03130959|26057446|P5|Treatment Period|Adverse Event unrelated to drug|1
7508082|NCT03130959|26057447|P4|Treatment Period|Adverse Event unrelated to drug|1
7508083|NCT03130959|26057448|P3|Treatment Period|Adverse Event unrelated to drug|1
7508084|NCT03130959|26057449|P2|Treatment Period|Adverse Event unrelated to drug|0
7508085|NCT03130959|26057450|P1|Treatment Period|Adverse Event unrelated to drug|0
7508086|NCT03130959|26057441|P10|Treatment Period|Not reported|2
7508087|NCT03130959|26057442|P9|Treatment Period|Not reported|0
7508088|NCT03130959|26057443|P8|Treatment Period|Not reported|0
7508089|NCT03130959|26057444|P7|Treatment Period|Not reported|0
7508090|NCT03130959|26057445|P6|Treatment Period|Not reported|2
7508091|NCT03130959|26057446|P5|Treatment Period|Not reported|0
7508092|NCT03130959|26057447|P4|Treatment Period|Not reported|1
7508093|NCT03130959|26057448|P3|Treatment Period|Not reported|0
7508094|NCT03130959|26057449|P2|Treatment Period|Not reported|2
7508095|NCT03130959|26057450|P1|Treatment Period|Not reported|0
7508096|NCT03130959|26057441|P10|Treatment Period|Participant request to stop therapy|0
7508097|NCT03130959|26057442|P9|Treatment Period|Participant request to stop therapy|0
7508098|NCT03130959|26057443|P8|Treatment Period|Participant request to stop therapy|1
7508099|NCT03130959|26057444|P7|Treatment Period|Participant request to stop therapy|1
7508100|NCT03130959|26057445|P6|Treatment Period|Participant request to stop therapy|0
7508101|NCT03130959|26057446|P5|Treatment Period|Participant request to stop therapy|0
7508102|NCT03130959|26057447|P4|Treatment Period|Participant request to stop therapy|1
7508103|NCT03130959|26057448|P3|Treatment Period|Participant request to stop therapy|1
7508104|NCT03130959|26057449|P2|Treatment Period|Participant request to stop therapy|1
7508105|NCT03130959|26057450|P1|Treatment Period|Participant request to stop therapy|0
7508106|NCT03130959|26057441|P10|Treatment Period|Other reasons|0
7508107|NCT03130959|26057442|P9|Treatment Period|Other reasons|0
7508108|NCT03130959|26057443|P8|Treatment Period|Other reasons|0
7508109|NCT03130959|26057444|P7|Treatment Period|Other reasons|1
7508110|NCT03130959|26057445|P6|Treatment Period|Other reasons|0
7508111|NCT03130959|26057446|P5|Treatment Period|Other reasons|0
7508112|NCT03130959|26057447|P4|Treatment Period|Other reasons|0
7508113|NCT03130959|26057448|P3|Treatment Period|Other reasons|0
7508114|NCT03130959|26057449|P2|Treatment Period|Other reasons|0
7508115|NCT03130959|26057450|P1|Treatment Period|Other reasons|1
7508116|NCT03130959|26057441|P10|Treatment Period|Study drug toxicity|4
7508117|NCT03130959|26057442|P9|Treatment Period|Study drug toxicity|3
7508118|NCT03130959|26057443|P8|Treatment Period|Study drug toxicity|0
7508119|NCT03130959|26057444|P7|Treatment Period|Study drug toxicity|3
7508120|NCT03130959|26057445|P6|Treatment Period|Study drug toxicity|2
7508121|NCT03130959|26057446|P5|Treatment Period|Study drug toxicity|1
7508122|NCT03130959|26057447|P4|Treatment Period|Study drug toxicity|2
7508123|NCT03130959|26057448|P3|Treatment Period|Study drug toxicity|1
7508124|NCT03130959|26057449|P2|Treatment Period|Study drug toxicity|3
7508125|NCT03130959|26057450|P1|Treatment Period|Study drug toxicity|2
7508126|NCT03130959|26057441|P10|Treatment Period|Disease progression|9
7508127|NCT03130959|26057442|P9|Treatment Period|Disease progression|15
7508128|NCT03130959|26057443|P8|Treatment Period|Disease progression|9
7508129|NCT03130959|26057444|P7|Treatment Period|Disease progression|6
7508130|NCT03130959|26057445|P6|Treatment Period|Disease progression|11
7508131|NCT03130959|26057446|P5|Treatment Period|Disease progression|12
7508132|NCT03130959|26057447|P4|Treatment Period|Disease progression|8
7508133|NCT03130959|26057448|P3|Treatment Period|Disease progression|12
7508134|NCT03130959|26057449|P2|Treatment Period|Disease progression|15
7508135|NCT03130959|26057450|P1|Treatment Period|Disease progression|18
7508136|NCT03130257|26057596|P3|Overall Study|Withdrawal by Subject|2
7508137|NCT03130257|26057597|P2|Overall Study|Withdrawal by Subject|0
7508138|NCT03130257|26057598|P1|Overall Study|Withdrawal by Subject|1
7508139|NCT03129100|26057657|P11|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508140|NCT03129100|26057658|P10|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
7508141|NCT03129100|26057659|P9|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508142|NCT03129100|26057660|P8|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508143|NCT03129100|26057661|P7|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508144|NCT03129100|26057662|P6|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508145|NCT03129100|26057663|P5|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508146|NCT03129100|26057664|P4|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508147|NCT03129100|26057665|P3|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508148|NCT03129100|26057666|P2|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508149|NCT03129100|26057667|P1|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7508150|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508151|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508152|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508153|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508154|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Experienced Flare|19
7508155|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Experienced Flare|6
7508156|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Experienced Flare|5
7508157|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508158|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508159|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508160|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Experienced Flare|0
7508161|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508162|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508163|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508164|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508165|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508166|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508167|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508168|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508169|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
7508170|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508171|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7508172|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508173|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508174|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508175|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508176|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508177|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508178|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508179|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508180|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
7508181|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508182|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7508183|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Physician Decision|0
7508184|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Physician Decision|0
7508185|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Physician Decision|0
7508186|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Physician Decision|0
7508187|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Physician Decision|0
7508188|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Physician Decision|0
7508189|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Physician Decision|0
7508190|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Physician Decision|0
7508191|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Physician Decision|1
7508192|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Physician Decision|0
7508193|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Physician Decision|0
7508194|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7508195|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7508196|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7508197|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7508198|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
7508199|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
7508200|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
7508201|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
7508202|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
7508203|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7508204|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7508205|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Death|0
7508206|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Death|0
7508207|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Death|0
7508208|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Death|0
7508209|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Death|0
7508210|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Death|0
7508211|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Death|0
7508212|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Death|0
7508213|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Death|1
7508214|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Death|0
7508215|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Death|0
7508216|NCT03129100|26057657|P11|Period2 Extension Period (Group A and B)|Adverse Event|0
7508217|NCT03129100|26057658|P10|Period2 Extension Period (Group A and B)|Adverse Event|0
7508218|NCT03129100|26057659|P9|Period2 Extension Period (Group A and B)|Adverse Event|0
7508219|NCT03129100|26057660|P8|Period2 Extension Period (Group A and B)|Adverse Event|0
7508220|NCT03129100|26057661|P7|Period2 Extension Period (Group A and B)|Adverse Event|0
7508221|NCT03129100|26057662|P6|Period2 Extension Period (Group A and B)|Adverse Event|2
7508222|NCT03129100|26057663|P5|Period2 Extension Period (Group A and B)|Adverse Event|0
7508223|NCT03129100|26057664|P4|Period2 Extension Period (Group A and B)|Adverse Event|1
7508224|NCT03129100|26057665|P3|Period2 Extension Period (Group A and B)|Adverse Event|2
7508225|NCT03129100|26057666|P2|Period2 Extension Period (Group A and B)|Adverse Event|0
7508226|NCT03129100|26057667|P1|Period2 Extension Period (Group A and B)|Adverse Event|0
7508227|NCT03129100|26057657|P11|Lead-In Period (Period 1)|Surgery Programmed|0
7508228|NCT03129100|26057658|P10|Lead-In Period (Period 1)|Surgery Programmed|0
7508229|NCT03129100|26057659|P9|Lead-In Period (Period 1)|Surgery Programmed|0
7508230|NCT03129100|26057660|P8|Lead-In Period (Period 1)|Surgery Programmed|0
7508231|NCT03129100|26057661|P7|Lead-In Period (Period 1)|Surgery Programmed|0
7508232|NCT03129100|26057662|P6|Lead-In Period (Period 1)|Surgery Programmed|0
7508233|NCT03129100|26057663|P5|Lead-In Period (Period 1)|Surgery Programmed|0
7508234|NCT03129100|26057664|P4|Lead-In Period (Period 1)|Surgery Programmed|0
7508235|NCT03129100|26057665|P3|Lead-In Period (Period 1)|Surgery Programmed|0
7508236|NCT03129100|26057666|P2|Lead-In Period (Period 1)|Surgery Programmed|1
7508237|NCT03129100|26057667|P1|Lead-In Period (Period 1)|Surgery Programmed|0
7508238|NCT03129100|26057657|P11|Lead-In Period (Period 1)|Lack of Efficacy|0
7508239|NCT03129100|26057658|P10|Lead-In Period (Period 1)|Lack of Efficacy|0
7508240|NCT03129100|26057659|P9|Lead-In Period (Period 1)|Lack of Efficacy|0
7508241|NCT03129100|26057660|P8|Lead-In Period (Period 1)|Lack of Efficacy|0
7508242|NCT03129100|26057661|P7|Lead-In Period (Period 1)|Lack of Efficacy|0
7508243|NCT03129100|26057662|P6|Lead-In Period (Period 1)|Lack of Efficacy|0
7508244|NCT03129100|26057663|P5|Lead-In Period (Period 1)|Lack of Efficacy|0
7508245|NCT03129100|26057664|P4|Lead-In Period (Period 1)|Lack of Efficacy|0
7508246|NCT03129100|26057665|P3|Lead-In Period (Period 1)|Lack of Efficacy|0
7508247|NCT03129100|26057666|P2|Lead-In Period (Period 1)|Lack of Efficacy|2
7508248|NCT03129100|26057667|P1|Lead-In Period (Period 1)|Lack of Efficacy|3
7508249|NCT03129100|26057657|P11|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508250|NCT03129100|26057658|P10|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508251|NCT03129100|26057659|P9|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508252|NCT03129100|26057660|P8|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508253|NCT03129100|26057661|P7|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508254|NCT03129100|26057662|P6|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508255|NCT03129100|26057663|P5|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508256|NCT03129100|26057664|P4|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508257|NCT03129100|26057665|P3|Lead-In Period (Period 1)|Withdrawal by Subject|0
7508258|NCT03129100|26057666|P2|Lead-In Period (Period 1)|Withdrawal by Subject|8
7508259|NCT03129100|26057667|P1|Lead-In Period (Period 1)|Withdrawal by Subject|8
7508260|NCT03129100|26057657|P11|Lead-In Period (Period 1)|Lost to Follow-up|0
7508261|NCT03129100|26057658|P10|Lead-In Period (Period 1)|Lost to Follow-up|0
7508262|NCT03129100|26057659|P9|Lead-In Period (Period 1)|Lost to Follow-up|0
7508263|NCT03129100|26057660|P8|Lead-In Period (Period 1)|Lost to Follow-up|0
7508264|NCT03129100|26057661|P7|Lead-In Period (Period 1)|Lost to Follow-up|0
7508265|NCT03129100|26057662|P6|Lead-In Period (Period 1)|Lost to Follow-up|0
7508266|NCT03129100|26057663|P5|Lead-In Period (Period 1)|Lost to Follow-up|0
7508267|NCT03129100|26057664|P4|Lead-In Period (Period 1)|Lost to Follow-up|0
7508268|NCT03129100|26057665|P3|Lead-In Period (Period 1)|Lost to Follow-up|0
7508269|NCT03129100|26057666|P2|Lead-In Period (Period 1)|Lost to Follow-up|0
7508270|NCT03129100|26057667|P1|Lead-In Period (Period 1)|Lost to Follow-up|2
7508271|NCT03129100|26057657|P11|Lead-In Period (Period 1)|Adverse Event|0
7508272|NCT03129100|26057658|P10|Lead-In Period (Period 1)|Adverse Event|0
7508273|NCT03129100|26057659|P9|Lead-In Period (Period 1)|Adverse Event|0
7508274|NCT03129100|26057660|P8|Lead-In Period (Period 1)|Adverse Event|0
7508275|NCT03129100|26057661|P7|Lead-In Period (Period 1)|Adverse Event|0
7508276|NCT03129100|26057662|P6|Lead-In Period (Period 1)|Adverse Event|0
7508277|NCT03129100|26057663|P5|Lead-In Period (Period 1)|Adverse Event|0
7508278|NCT03129100|26057664|P4|Lead-In Period (Period 1)|Adverse Event|0
7508279|NCT03129100|26057665|P3|Lead-In Period (Period 1)|Adverse Event|0
7508280|NCT03129100|26057666|P2|Lead-In Period (Period 1)|Adverse Event|6
7508281|NCT03129100|26057667|P1|Lead-In Period (Period 1)|Adverse Event|2
7508282|NCT03128931|26057762|P1|Overall Study|Equipment Issues|3
7508283|NCT03128931|26057762|P1|Overall Study|Physician Decision|1
7508284|NCT03128892|26057766|P1|Overall Study|Physician Decision|1
7508285|NCT03128892|26057766|P1|Overall Study|Withdrawal by Subject|2
7508286|NCT03128723|26057772|P1|Overall Study|Withdrawal by Subject|2
7508287|NCT03128411|26057787|P1|Long Term Follow-up Phase|Ongoing|18
7508288|NCT03128411|26057787|P1|Long Term Follow-up Phase|Death|1
7508289|NCT03128411|26057787|P1|Treatment Phase|Ongoing|41
7508290|NCT03128411|26057787|P1|Treatment Phase|Physician Decision|1
7508291|NCT03128411|26057787|P1|Treatment Phase|Adverse Event|18
7508292|NCT03128307|26057830|P1|Overall Study|Withdrawal by Subject|5
7508293|NCT03128307|26057830|P1|Overall Study|Lost to Follow-up|29
7508294|NCT03128099|26057838|P3|Overall Study|Did not complete all the assessments|1
7508295|NCT03128099|26057839|P2|Overall Study|Did not complete all the assessments|0
7508296|NCT03128099|26057840|P1|Overall Study|Did not complete all the assessments|0
7508297|NCT03128099|26057838|P3|Overall Study|Became homeless and lost contact|0
7508298|NCT03128099|26057839|P2|Overall Study|Became homeless and lost contact|0
7508299|NCT03128099|26057840|P1|Overall Study|Became homeless and lost contact|1
7508300|NCT03128099|26057838|P3|Overall Study|Participant got a full time job.|0
7508301|NCT03128099|26057839|P2|Overall Study|Participant got a full time job.|0
7508302|NCT03128099|26057840|P1|Overall Study|Participant got a full time job.|1
7508303|NCT03128099|26057838|P3|Overall Study|High dose task was too long|0
7508304|NCT03128099|26057839|P2|Overall Study|High dose task was too long|4
7508305|NCT03128099|26057840|P1|Overall Study|High dose task was too long|0
7508306|NCT03127644|26057893|P3|Overall Study|Study-specific withdrawal criteria|2
7508307|NCT03127644|26057894|P2|Overall Study|Study-specific withdrawal criteria|0
7508308|NCT03127644|26057895|P1|Overall Study|Study-specific withdrawal criteria|0
7508309|NCT03127384|26057948|P1|Overall Study|Subject request|2
7508310|NCT03127384|26057948|P1|Overall Study|Lost to Follow-up|4
7508311|NCT03126786|26057990|P2|Overall Study|Withdrawal by Subject|1
7508312|NCT03126786|26057991|P1|Overall Study|Withdrawal by Subject|3
7508313|NCT03126786|26057990|P2|Overall Study|Lost to Follow-up|1
7508314|NCT03126786|26057991|P1|Overall Study|Lost to Follow-up|0
7508315|NCT03126786|26057990|P2|Overall Study|Adverse Event|0
7508316|NCT03126786|26057991|P1|Overall Study|Adverse Event|3
7508317|NCT03126539|26058023|P5|Overall Study|Lost to Follow-up|0
7508318|NCT03126539|26058024|P4|Overall Study|Lost to Follow-up|0
7508319|NCT03126539|26058025|P3|Overall Study|Lost to Follow-up|1
7508320|NCT03126539|26058026|P2|Overall Study|Lost to Follow-up|1
7508321|NCT03126539|26058027|P1|Overall Study|Lost to Follow-up|1
7508322|NCT03126344|26058079|P3|Overall Study|Lost to Follow-up|5
7508323|NCT03126344|26058080|P2|Overall Study|Lost to Follow-up|0
7508324|NCT03126344|26058081|P1|Overall Study|Lost to Follow-up|0
7508325|NCT03125941|26058097|P2|Overall Study|did not receive intervention|2
7508326|NCT03125941|26058098|P1|Overall Study|did not receive intervention|1
7508327|NCT03125915|26058134|P4|6 Month Follow-up|Lost to Follow-up|3
7508328|NCT03125915|26058135|P3|6 Month Follow-up|Lost to Follow-up|6
7508329|NCT03125915|26058136|P2|6 Month Follow-up|Lost to Follow-up|3
7508330|NCT03125915|26058137|P1|6 Month Follow-up|Lost to Follow-up|7
7508331|NCT03125915|26058134|P4|3 Month Follow-up|Lost to Follow-up|2
7508332|NCT03125915|26058135|P3|3 Month Follow-up|Lost to Follow-up|4
7508333|NCT03125915|26058136|P2|3 Month Follow-up|Lost to Follow-up|4
7508334|NCT03125915|26058137|P1|3 Month Follow-up|Lost to Follow-up|6
7508335|NCT03125915|26058134|P4|1 Month Follow up|Lost to Follow-up|3
7508336|NCT03125915|26058135|P3|1 Month Follow up|Lost to Follow-up|2
7508337|NCT03125915|26058136|P2|1 Month Follow up|Lost to Follow-up|3
7508338|NCT03125915|26058137|P1|1 Month Follow up|Lost to Follow-up|3
7508351|NCT03125629|26058203|P1|Overall Study|Equipment malfunction|1
7508352|NCT03125629|26058203|P1|Overall Study|Withdrawal by Subject|2
7508353|NCT03125395|26058215|P1|Overall Study|Commercial drug is available|5
7508354|NCT03125395|26058215|P1|Overall Study|Physician Decision|2
7508355|NCT03125395|26058215|P1|Overall Study|Withdrawal of consent (not due to AE)|1
7508356|NCT03125395|26058215|P1|Overall Study|Adverse Event|2
7508357|NCT03125200|26058250|P7|Overall Study|Consent Withdrawn by Subject|1
7508358|NCT03125200|26058251|P6|Overall Study|Consent Withdrawn by Subject|0
7508359|NCT03125200|26058252|P5|Overall Study|Consent Withdrawn by Subject|1
7508360|NCT03125200|26058253|P4|Overall Study|Consent Withdrawn by Subject|0
7508361|NCT03125200|26058254|P3|Overall Study|Consent Withdrawn by Subject|0
7508362|NCT03125200|26058255|P2|Overall Study|Consent Withdrawn by Subject|1
7508363|NCT03125200|26058256|P1|Overall Study|Consent Withdrawn by Subject|0
7508364|NCT03125200|26058250|P7|Overall Study|Toxicity|0
7508365|NCT03125200|26058251|P6|Overall Study|Toxicity|0
7508366|NCT03125200|26058252|P5|Overall Study|Toxicity|0
7508367|NCT03125200|26058253|P4|Overall Study|Toxicity|1
7508368|NCT03125200|26058254|P3|Overall Study|Toxicity|0
7508369|NCT03125200|26058255|P2|Overall Study|Toxicity|0
7508370|NCT03125200|26058256|P1|Overall Study|Toxicity|0
7508371|NCT03125200|26058250|P7|Overall Study|Lack of Efficacy|0
7508372|NCT03125200|26058251|P6|Overall Study|Lack of Efficacy|0
7508373|NCT03125200|26058252|P5|Overall Study|Lack of Efficacy|0
7508374|NCT03125200|26058253|P4|Overall Study|Lack of Efficacy|1
7508375|NCT03125200|26058254|P3|Overall Study|Lack of Efficacy|0
7508376|NCT03125200|26058255|P2|Overall Study|Lack of Efficacy|0
7508377|NCT03125200|26058256|P1|Overall Study|Lack of Efficacy|0
7508378|NCT03125200|26058250|P7|Overall Study|Progressive Disease|1
7508379|NCT03125200|26058251|P6|Overall Study|Progressive Disease|0
7508380|NCT03125200|26058252|P5|Overall Study|Progressive Disease|2
7508381|NCT03125200|26058253|P4|Overall Study|Progressive Disease|1
7508382|NCT03125200|26058254|P3|Overall Study|Progressive Disease|2
7508383|NCT03125200|26058255|P2|Overall Study|Progressive Disease|1
7508384|NCT03125200|26058256|P1|Overall Study|Progressive Disease|2
7508385|NCT03125200|26058250|P7|Overall Study|Clinical Progression|0
7508386|NCT03125200|26058251|P6|Overall Study|Clinical Progression|1
7508387|NCT03125200|26058252|P5|Overall Study|Clinical Progression|0
7508388|NCT03125200|26058253|P4|Overall Study|Clinical Progression|1
7508389|NCT03125200|26058254|P3|Overall Study|Clinical Progression|0
7508390|NCT03125200|26058255|P2|Overall Study|Clinical Progression|0
7508391|NCT03125200|26058256|P1|Overall Study|Clinical Progression|0
7508392|NCT03125200|26058250|P7|Overall Study|Study Termination|1
7508393|NCT03125200|26058251|P6|Overall Study|Study Termination|2
7508394|NCT03125200|26058252|P5|Overall Study|Study Termination|1
7508395|NCT03125200|26058253|P4|Overall Study|Study Termination|1
7508396|NCT03125200|26058254|P3|Overall Study|Study Termination|0
7508397|NCT03125200|26058255|P2|Overall Study|Study Termination|0
7508398|NCT03125200|26058256|P1|Overall Study|Study Termination|0
7508399|NCT03124784|26058496|P1|Overall Study|Computer/Equip Malfunction|1
7508400|NCT03124784|26058496|P1|Overall Study|Adverse Event|1
7508401|NCT03124563|26058518|P2|Overall Study|Withdrawal by Subject|1
7508402|NCT03124563|26058519|P1|Overall Study|Withdrawal by Subject|1
7508403|NCT03124563|26058518|P2|Overall Study|Lost to Follow-up|1
7508404|NCT03124563|26058519|P1|Overall Study|Lost to Follow-up|1
7508405|NCT03124537|26058544|P2|Overall Study|App Crash, Incomplete Data|8
7508406|NCT03124537|26058545|P1|Overall Study|App Crash, Incomplete Data|7
7508407|NCT03124537|26058544|P2|Overall Study|Lost to Follow-up|5
7508408|NCT03124537|26058545|P1|Overall Study|Lost to Follow-up|3
7508409|NCT03124459|26058571|P6|Part 2- Open Label ACE-083|Withdrawal by Subject|1
7508410|NCT03124459|26058572|P5|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7508411|NCT03124459|26058573|P4|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7508412|NCT03124459|26058574|P3|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7508413|NCT03124459|26058575|P2|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7508414|NCT03124459|26058576|P1|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7508415|NCT03124459|26058571|P6|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
7508416|NCT03124459|26058572|P5|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7508417|NCT03124459|26058573|P4|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7508418|NCT03124459|26058574|P3|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7508419|NCT03124459|26058575|P2|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7508420|NCT03124459|26058576|P1|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7508421|NCT03124459|26058571|P6|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7508422|NCT03124459|26058572|P5|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
7508423|NCT03124459|26058573|P4|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
7508424|NCT03124459|26058574|P3|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7508425|NCT03124459|26058575|P2|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7508426|NCT03124459|26058576|P1|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7508427|NCT03124459|26058571|P6|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7508428|NCT03124459|26058572|P5|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
7508429|NCT03124459|26058573|P4|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
7508430|NCT03124459|26058574|P3|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7508431|NCT03124459|26058575|P2|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7508432|NCT03124459|26058576|P1|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7508433|NCT03124459|26058571|P6|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7508434|NCT03124459|26058572|P5|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
7508435|NCT03124459|26058573|P4|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7508436|NCT03124459|26058574|P3|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7508437|NCT03124459|26058575|P2|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7508438|NCT03124459|26058576|P1|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7508439|NCT03124459|26058571|P6|Phase 2- Randomized Doubled-blind|Adverse Event|0
7508440|NCT03124459|26058572|P5|Phase 2- Randomized Doubled-blind|Adverse Event|2
7508441|NCT03124459|26058573|P4|Phase 2- Randomized Doubled-blind|Adverse Event|0
7508442|NCT03124459|26058574|P3|Phase 2- Randomized Doubled-blind|Adverse Event|0
7508528|NCT03122860|26059167|P6|Overall Study|Lost to Follow-up|4
7508443|NCT03124459|26058575|P2|Phase 2- Randomized Doubled-blind|Adverse Event|0
7508444|NCT03124459|26058576|P1|Phase 2- Randomized Doubled-blind|Adverse Event|0
7508445|NCT03124407|26058611|P4|Overall Study|Adverse Event|0
7508446|NCT03124407|26058612|P3|Overall Study|Adverse Event|1
7508447|NCT03124407|26058613|P2|Overall Study|Adverse Event|0
7508448|NCT03124407|26058614|P1|Overall Study|Adverse Event|0
7508449|NCT03124407|26058611|P4|Overall Study|Lost to Follow-up|0
7508450|NCT03124407|26058612|P3|Overall Study|Lost to Follow-up|0
7508451|NCT03124407|26058613|P2|Overall Study|Lost to Follow-up|0
7508452|NCT03124407|26058614|P1|Overall Study|Lost to Follow-up|1
7508453|NCT03124381|26058634|P2|Overall Study|Non-Compliance with Study Treatment|0
7508454|NCT03124381|26058635|P1|Overall Study|Non-Compliance with Study Treatment|1
7508455|NCT03124381|26058634|P2|Overall Study|Adverse Event|1
7508456|NCT03124381|26058635|P1|Overall Study|Adverse Event|1
7508457|NCT03124381|26058634|P2|Overall Study|Protocol Violation|1
7508458|NCT03124381|26058635|P1|Overall Study|Protocol Violation|0
7508459|NCT03124381|26058634|P2|Overall Study|Withdrawal by Subject|3
7508460|NCT03124381|26058635|P1|Overall Study|Withdrawal by Subject|6
7508461|NCT03124381|26058634|P2|Overall Study|Lost to Follow-up|1
7508462|NCT03124381|26058635|P1|Overall Study|Lost to Follow-up|1
7508463|NCT03124199|26058782|P1|Overall Study|Lost to Follow-up|4
7508464|NCT03124108|26058814|P3|Overall Study|Adverse Event|0
7508465|NCT03124108|26058815|P2|Overall Study|Adverse Event|1
7508466|NCT03124108|26058816|P1|Overall Study|Adverse Event|0
7508467|NCT03123939|26058957|P1|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
7508468|NCT03123939|26058957|P1|Overall Study|Discontinued prior to CTL019 infusion due to death|4
7508469|NCT03123939|26058957|P1|Overall Study|Progressive disease|18
7508470|NCT03123939|26058957|P1|Overall Study|Protocol deviation|1
7508471|NCT03123939|26058957|P1|Overall Study|New therapy for study indication|1
7508472|NCT03123939|26058957|P1|Overall Study|Lost to Follow-up|1
7508473|NCT03123939|26058957|P1|Overall Study|Subject/guardian decision|2
7508474|NCT03123939|26058957|P1|Overall Study|Physician Decision|2
7508475|NCT03123939|26058957|P1|Overall Study|Death|5
7508476|NCT03123939|26058957|P1|Overall Study|Lack of Efficacy|6
7508477|NCT03123861|26058999|P2|Overall Study|Withdrawal by Subject|2
7508478|NCT03123861|26059000|P1|Overall Study|Withdrawal by Subject|2
7508479|NCT03123861|26058999|P2|Overall Study|Protocol Violation|1
7508480|NCT03123861|26059000|P1|Overall Study|Protocol Violation|1
7508481|NCT03123471|26059051|P2|Apremilast Extension Phase|Withdrawal by Subject|7
7508482|NCT03123471|26059052|P1|Apremilast Extension Phase|Withdrawal by Subject|3
7508483|NCT03123471|26059051|P2|Apremilast Extension Phase|Lack of Efficacy|8
7508484|NCT03123471|26059052|P1|Apremilast Extension Phase|Lack of Efficacy|2
7508485|NCT03123471|26059051|P2|Apremilast Extension Phase|Adverse Event|5
7508486|NCT03123471|26059052|P1|Apremilast Extension Phase|Adverse Event|1
7508487|NCT03123471|26059051|P2|Apremilast Extension Phase|Lost to Follow-up|5
7508488|NCT03123471|26059052|P1|Apremilast Extension Phase|Lost to Follow-up|2
7508489|NCT03123471|26059051|P2|Placebo-controlled Phase|Miscellaneous|1
7508490|NCT03123471|26059052|P1|Placebo-controlled Phase|Miscellaneous|0
7508491|NCT03123471|26059051|P2|Placebo-controlled Phase|Protocol Deviation|1
7508492|NCT03123471|26059052|P1|Placebo-controlled Phase|Protocol Deviation|2
7508493|NCT03123471|26059051|P2|Placebo-controlled Phase|Lost to Follow-up|3
7508494|NCT03123471|26059052|P1|Placebo-controlled Phase|Lost to Follow-up|1
7508495|NCT03123471|26059051|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
7508496|NCT03123471|26059052|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
7508497|NCT03123471|26059051|P2|Placebo-controlled Phase|Withdrawal by Subject|16
7508498|NCT03123471|26059052|P1|Placebo-controlled Phase|Withdrawal by Subject|6
7508499|NCT03123471|26059051|P2|Placebo-controlled Phase|Lack of Efficacy|4
7508500|NCT03123471|26059052|P1|Placebo-controlled Phase|Lack of Efficacy|3
7508501|NCT03123471|26059051|P2|Placebo-controlled Phase|Adverse Event|8
7508502|NCT03123471|26059052|P1|Placebo-controlled Phase|Adverse Event|3
7508503|NCT03123393|26059079|P2|Overall Study|Reason not Specified|13
7508504|NCT03123393|26059080|P1|Overall Study|Reason not Specified|13
7508505|NCT03123393|26059079|P2|Overall Study|Withdrawal by Subject|1
7508506|NCT03123393|26059080|P1|Overall Study|Withdrawal by Subject|2
7508507|NCT03123393|26059079|P2|Overall Study|Study Terminated by Sponsor|9
7508508|NCT03123393|26059080|P1|Overall Study|Study Terminated by Sponsor|6
7508509|NCT03123354|26059108|P1|Overall Study|Physician Decision|6
7508510|NCT03123120|26059125|P2|Overall Study|Withdrawal by Subject|1
7508511|NCT03123120|26059126|P1|Overall Study|Withdrawal by Subject|0
7508512|NCT03123120|26059125|P2|Overall Study|Lost to Follow-up|1
7508513|NCT03123120|26059126|P1|Overall Study|Lost to Follow-up|0
7508514|NCT03122886|26059154|P2|Overall Study|Withdrawal by Subject|2
7508515|NCT03122886|26059155|P1|Overall Study|Withdrawal by Subject|1
7508516|NCT03122860|26059167|P6|Overall Study|Withdrawal by Subject|8
7508517|NCT03122860|26059168|P5|Overall Study|Withdrawal by Subject|9
7508518|NCT03122860|26059169|P4|Overall Study|Withdrawal by Subject|7
7508519|NCT03122860|26059170|P3|Overall Study|Withdrawal by Subject|5
7508520|NCT03122860|26059171|P2|Overall Study|Withdrawal by Subject|2
7508521|NCT03122860|26059172|P1|Overall Study|Withdrawal by Subject|3
7508522|NCT03122860|26059167|P6|Overall Study|Subject Non-Compliance|0
7508523|NCT03122860|26059168|P5|Overall Study|Subject Non-Compliance|0
7508524|NCT03122860|26059169|P4|Overall Study|Subject Non-Compliance|0
7508525|NCT03122860|26059170|P3|Overall Study|Subject Non-Compliance|1
7508526|NCT03122860|26059171|P2|Overall Study|Subject Non-Compliance|0
7508527|NCT03122860|26059172|P1|Overall Study|Subject Non-Compliance|0
7508529|NCT03122860|26059168|P5|Overall Study|Lost to Follow-up|5
7508530|NCT03122860|26059169|P4|Overall Study|Lost to Follow-up|3
7508531|NCT03122860|26059170|P3|Overall Study|Lost to Follow-up|3
7508532|NCT03122860|26059171|P2|Overall Study|Lost to Follow-up|2
7508533|NCT03122860|26059172|P1|Overall Study|Lost to Follow-up|5
7508534|NCT03122860|26059167|P6|Overall Study|Adverse Event|0
7508535|NCT03122860|26059168|P5|Overall Study|Adverse Event|0
7508536|NCT03122860|26059169|P4|Overall Study|Adverse Event|1
7508537|NCT03122860|26059170|P3|Overall Study|Adverse Event|1
7508538|NCT03122860|26059171|P2|Overall Study|Adverse Event|0
7508539|NCT03122860|26059172|P1|Overall Study|Adverse Event|1
7508540|NCT03122860|26059167|P6|Overall Study|Discontinued Before Treatment|0
7508541|NCT03122860|26059168|P5|Overall Study|Discontinued Before Treatment|1
7508542|NCT03122860|26059169|P4|Overall Study|Discontinued Before Treatment|0
7508543|NCT03122860|26059170|P3|Overall Study|Discontinued Before Treatment|2
7508544|NCT03122860|26059171|P2|Overall Study|Discontinued Before Treatment|1
7508545|NCT03122860|26059172|P1|Overall Study|Discontinued Before Treatment|1
7508546|NCT03122548|26059251|P1|Overall Study|Study Terminated by Sponsor|2
7508547|NCT03122548|26059251|P1|Overall Study|Progression - subject went into hospice|1
7508548|NCT03122548|26059251|P1|Overall Study|Death|2
7508549|NCT03122535|26059259|P2|Overall Study|Withdrawal by Subject|2
7508550|NCT03122535|26059260|P1|Overall Study|Withdrawal by Subject|2
7508551|NCT03122535|26059259|P2|Overall Study|Physician Decision|3
7508552|NCT03122535|26059260|P1|Overall Study|Physician Decision|3
7508553|NCT03122535|26059259|P2|Overall Study|Lost to Follow-up|68
7508554|NCT03122535|26059260|P1|Overall Study|Lost to Follow-up|68
7508555|NCT03122457|26059268|P1|Overall Study|Withdrawal by Subject|6
7508556|NCT03122223|26059277|P4|Overall Study|Participant unable to adhere|0
7508557|NCT03122223|26059278|P3|Overall Study|Participant unable to adhere|1
7508558|NCT03122223|26059279|P2|Overall Study|Participant unable to adhere|1
7508559|NCT03122223|26059280|P1|Overall Study|Participant unable to adhere|1
7508560|NCT03122223|26059277|P4|Overall Study|Lost to Follow-up|0
7508561|NCT03122223|26059278|P3|Overall Study|Lost to Follow-up|2
7508562|NCT03122223|26059279|P2|Overall Study|Lost to Follow-up|2
7508563|NCT03122223|26059280|P1|Overall Study|Lost to Follow-up|0
7508564|NCT03122223|26059277|P4|Overall Study|Withdrawal by Subject|0
7508565|NCT03122223|26059278|P3|Overall Study|Withdrawal by Subject|1
7508566|NCT03122223|26059279|P2|Overall Study|Withdrawal by Subject|2
7508567|NCT03122223|26059280|P1|Overall Study|Withdrawal by Subject|2
7508568|NCT03122184|26059336|P2|Overall Study|Terminated due to cognitive problem|0
7508569|NCT03122184|26059337|P1|Overall Study|Terminated due to cognitive problem|1
7508570|NCT03122184|26059336|P2|Overall Study|Withdrawal by Subject|0
7508571|NCT03122184|26059337|P1|Overall Study|Withdrawal by Subject|3
7508572|NCT03122184|26059336|P2|Overall Study|Lost to Follow-up|6
7508573|NCT03122184|26059337|P1|Overall Study|Lost to Follow-up|4
7508574|NCT03122171|26059374|P1|Overall Study|Withdrawal by Subject|1
7508575|NCT03122145|26059383|P2|Overall Study|Concurrent respiratory disease|0
7508576|NCT03122145|26059384|P1|Overall Study|Concurrent respiratory disease|3
7508577|NCT03121950|26059394|P2|Overall Study|Withdrawal by Subject|2
7508578|NCT03121950|26059395|P1|Overall Study|Withdrawal by Subject|11
7508579|NCT03120676|26059496|P1|Overall Study|Not treated|1
7508580|NCT03120520|26059504|P4|Overall Study|Other|0
7508581|NCT03120520|26059505|P3|Overall Study|Other|0
7508582|NCT03120520|26059506|P2|Overall Study|Other|1
7508583|NCT03120520|26059507|P1|Overall Study|Other|0
7508584|NCT03120520|26059504|P4|Overall Study|Withdrawal by Subject|2
7508585|NCT03120520|26059505|P3|Overall Study|Withdrawal by Subject|3
7508586|NCT03120520|26059506|P2|Overall Study|Withdrawal by Subject|2
7508587|NCT03120520|26059507|P1|Overall Study|Withdrawal by Subject|3
7508588|NCT03120520|26059504|P4|Overall Study|Lost to Follow-up|1
7508589|NCT03120520|26059505|P3|Overall Study|Lost to Follow-up|1
7508590|NCT03120520|26059506|P2|Overall Study|Lost to Follow-up|1
7508591|NCT03120520|26059507|P1|Overall Study|Lost to Follow-up|1
7508592|NCT03120351|26059531|P2|Overall Study|Physician Decision|1
7508593|NCT03120351|26059532|P1|Overall Study|Physician Decision|1
7508594|NCT03120013|26059538|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
7508595|NCT03120013|26059539|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
7508596|NCT03119701|26059583|P2|Mid-term (Final) Follow-up at D90|Death|1
7508597|NCT03119701|26059584|P1|Mid-term (Final) Follow-up at D90|Death|3
7508598|NCT03119701|26059583|P2|6-day Dosing|Withdrawal by Subject|1
7508599|NCT03119701|26059584|P1|6-day Dosing|Withdrawal by Subject|0
7508600|NCT03119701|26059583|P2|6-day Dosing|Physician Decision|1
7508601|NCT03119701|26059584|P1|6-day Dosing|Physician Decision|0
7508602|NCT03119701|26059583|P2|6-day Dosing|Adverse Event|0
7508603|NCT03119701|26059584|P1|6-day Dosing|Adverse Event|3
7508604|NCT03119701|26059583|P2|6-day Dosing|Death|1
7508605|NCT03119701|26059584|P1|6-day Dosing|Death|4
7508606|NCT03119688|26059616|P1|Overall Study|Adverse Event|4
7508607|NCT03119662|26059649|P2|Overall Study|Withdrawal by Subject|1
7508608|NCT03119662|26059650|P1|Overall Study|Withdrawal by Subject|0
7508613|NCT03118947|26059808|P1|Overall Study|Lost to Follow-up|2
7508614|NCT03118947|26059808|P1|Overall Study|Change in patient's living situation|4
7508615|NCT03118947|26059808|P1|Overall Study|Withdrawal by caregiver|3
7508616|NCT03118947|26059808|P1|Overall Study|Withdrawal by Subject|3
7508617|NCT03118947|26059808|P1|Overall Study|Protocol Violation|2
7508618|NCT03118947|26059808|P1|Overall Study|Non-compliance with study drug|1
7508619|NCT03118947|26059808|P1|Overall Study|Lack of Efficacy|4
7508620|NCT03118947|26059808|P1|Overall Study|Death|3
7508621|NCT03118947|26059808|P1|Overall Study|Adverse Event|7
7508622|NCT03118934|26059815|P6|Overall Study|Discontinued prior to exposure|0
7508623|NCT03118934|26059816|P5|Overall Study|Discontinued prior to exposure|2
7508624|NCT03118934|26059817|P4|Overall Study|Discontinued prior to exposure|1
7508625|NCT03118934|26059818|P3|Overall Study|Discontinued prior to exposure|1
7508626|NCT03118934|26059819|P2|Overall Study|Discontinued prior to exposure|1
7508627|NCT03118934|26059820|P1|Overall Study|Discontinued prior to exposure|0
7508628|NCT03118934|26059815|P6|Overall Study|Physician Decision|1
7508629|NCT03118934|26059816|P5|Overall Study|Physician Decision|0
7508630|NCT03118934|26059817|P4|Overall Study|Physician Decision|0
7508631|NCT03118934|26059818|P3|Overall Study|Physician Decision|0
7508632|NCT03118934|26059819|P2|Overall Study|Physician Decision|0
7508633|NCT03118934|26059820|P1|Overall Study|Physician Decision|0
7508634|NCT03118934|26059815|P6|Overall Study|Adverse Event|1
7508635|NCT03118934|26059816|P5|Overall Study|Adverse Event|0
7508636|NCT03118934|26059817|P4|Overall Study|Adverse Event|0
7508637|NCT03118934|26059818|P3|Overall Study|Adverse Event|0
7508638|NCT03118934|26059819|P2|Overall Study|Adverse Event|0
7508639|NCT03118934|26059820|P1|Overall Study|Adverse Event|0
7508640|NCT03118765|26059844|P5|Overall Study|Sponsor Decision|1
7508641|NCT03118765|26059845|P4|Overall Study|Sponsor Decision|0
7508642|NCT03118765|26059846|P3|Overall Study|Sponsor Decision|1
7508643|NCT03118765|26059847|P2|Overall Study|Sponsor Decision|0
7508644|NCT03118765|26059848|P1|Overall Study|Sponsor Decision|1
7508645|NCT03118765|26059844|P5|Overall Study|Lost to Follow-up|0
7508646|NCT03118765|26059845|P4|Overall Study|Lost to Follow-up|0
7508647|NCT03118765|26059846|P3|Overall Study|Lost to Follow-up|1
7508648|NCT03118765|26059847|P2|Overall Study|Lost to Follow-up|0
7508649|NCT03118765|26059848|P1|Overall Study|Lost to Follow-up|1
7508650|NCT03118765|26059844|P5|Overall Study|COPD Exacerbation|0
7508651|NCT03118765|26059845|P4|Overall Study|COPD Exacerbation|1
7508652|NCT03118765|26059846|P3|Overall Study|COPD Exacerbation|0
7508653|NCT03118765|26059847|P2|Overall Study|COPD Exacerbation|0
7508654|NCT03118765|26059848|P1|Overall Study|COPD Exacerbation|1
7508655|NCT03118765|26059844|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7508656|NCT03118765|26059845|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7508657|NCT03118765|26059846|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7508658|NCT03118765|26059847|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7508659|NCT03118765|26059848|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7508660|NCT03118765|26059844|P5|Overall Study|Non compliance with Study Procedures|0
7508661|NCT03118765|26059845|P4|Overall Study|Non compliance with Study Procedures|1
7508662|NCT03118765|26059846|P3|Overall Study|Non compliance with Study Procedures|0
7508663|NCT03118765|26059847|P2|Overall Study|Non compliance with Study Procedures|0
7508664|NCT03118765|26059848|P1|Overall Study|Non compliance with Study Procedures|0
7508665|NCT03118765|26059844|P5|Overall Study|Adverse Event|1
7508666|NCT03118765|26059845|P4|Overall Study|Adverse Event|1
7508667|NCT03118765|26059846|P3|Overall Study|Adverse Event|1
7508668|NCT03118765|26059847|P2|Overall Study|Adverse Event|1
7508669|NCT03118765|26059848|P1|Overall Study|Adverse Event|1
7508670|NCT03118765|26059844|P5|Overall Study|Withdrawal by Subject|0
7508671|NCT03118765|26059845|P4|Overall Study|Withdrawal by Subject|0
7508672|NCT03118765|26059846|P3|Overall Study|Withdrawal by Subject|1
7508673|NCT03118765|26059847|P2|Overall Study|Withdrawal by Subject|0
7508674|NCT03118765|26059848|P1|Overall Study|Withdrawal by Subject|0
7508675|NCT03118739|26059944|P2|Overall Study|Lost to Follow-up|0
7508676|NCT03118739|26059945|P1|Overall Study|Lost to Follow-up|2
7508677|NCT03118739|26059944|P2|Overall Study|Withdrawal by Subject|3
7508678|NCT03118739|26059945|P1|Overall Study|Withdrawal by Subject|5
7508679|NCT03118739|26059944|P2|Overall Study|Physician Decision|1
7508680|NCT03118739|26059945|P1|Overall Study|Physician Decision|0
7508681|NCT03118518|26060058|P2|Overall Study|Early Exit after randomization but prior to treatment|3
7508682|NCT03118518|26060059|P1|Overall Study|Early Exit after randomization but prior to treatment|4
7508683|NCT03118518|26060058|P2|Overall Study|Early Exit after treatment|8
7508684|NCT03118518|26060059|P1|Overall Study|Early Exit after treatment|2
7508685|NCT03118297|26060080|P2|Overall Study|Lost to Follow-up|2
7508686|NCT03118297|26060081|P1|Overall Study|Lost to Follow-up|0
7508687|NCT03117738|26060097|P2|Overall Study|Lost to Follow-up|4
7508688|NCT03117738|26060098|P1|Overall Study|Lost to Follow-up|1
7508689|NCT03117738|26060097|P2|Overall Study|Withdrawal by Subject|1
7508690|NCT03117738|26060098|P1|Overall Study|Withdrawal by Subject|3
7508691|NCT03117361|26060171|P1|Overall Study|Treatment-related adverse event|1
7508692|NCT03117361|26060171|P1|Overall Study|On study treatment at the end of study|1
7508693|NCT03117361|26060171|P1|Overall Study|Physician Decision|2
7508694|NCT03117361|26060171|P1|Overall Study|Death|1
7508695|NCT03117361|26060171|P1|Overall Study|Progressive disease|5
7508696|NCT03116828|26060286|P2|Overall Study|OTHER|3
7508697|NCT03116828|26060287|P1|Overall Study|OTHER|3
7508698|NCT03116828|26060286|P2|Overall Study|Withdrawal by Subject|8
7508699|NCT03116828|26060287|P1|Overall Study|Withdrawal by Subject|4
7508700|NCT03116828|26060286|P2|Overall Study|Adverse Event|10
7508701|NCT03116828|26060287|P1|Overall Study|Adverse Event|1
7508702|NCT03116698|26060297|P4|Overall Study|Death|0
7508703|NCT03116698|26060298|P3|Overall Study|Death|2
7508704|NCT03116698|26060299|P2|Overall Study|Death|0
7508705|NCT03116698|26060300|P1|Overall Study|Death|0
7508706|NCT03116698|26060297|P4|Overall Study|Protocol Violation|0
7508707|NCT03116698|26060298|P3|Overall Study|Protocol Violation|0
7508708|NCT03116698|26060299|P2|Overall Study|Protocol Violation|0
7508709|NCT03116698|26060300|P1|Overall Study|Protocol Violation|1
7508710|NCT03116698|26060297|P4|Overall Study|Physician Decision|0
7508711|NCT03116698|26060298|P3|Overall Study|Physician Decision|0
7508712|NCT03116698|26060299|P2|Overall Study|Physician Decision|1
7508713|NCT03116698|26060300|P1|Overall Study|Physician Decision|1
7508714|NCT03116698|26060297|P4|Overall Study|Lost to Follow-up|0
7508715|NCT03116698|26060298|P3|Overall Study|Lost to Follow-up|0
7508716|NCT03116698|26060299|P2|Overall Study|Lost to Follow-up|0
7508717|NCT03116698|26060300|P1|Overall Study|Lost to Follow-up|2
7508718|NCT03116698|26060297|P4|Overall Study|Withdrawal by Subject|2
7508719|NCT03116698|26060298|P3|Overall Study|Withdrawal by Subject|5
7508720|NCT03116698|26060299|P2|Overall Study|Withdrawal by Subject|4
7508721|NCT03116698|26060300|P1|Overall Study|Withdrawal by Subject|1
7508722|NCT03116698|26060297|P4|Overall Study|Adverse Event|0
7508723|NCT03116698|26060298|P3|Overall Study|Adverse Event|1
7508724|NCT03116698|26060299|P2|Overall Study|Adverse Event|1
7508725|NCT03116698|26060300|P1|Overall Study|Adverse Event|1
7508726|NCT03116152|26060329|P2|Overall Study|other|34
7508727|NCT03116152|26060330|P1|Overall Study|other|11
7508728|NCT03116152|26060329|P2|Overall Study|Physician Decision|2
7508729|NCT03116152|26060330|P1|Overall Study|Physician Decision|3
7508730|NCT03116152|26060329|P2|Overall Study|Withdrawal by Subject|1
7508731|NCT03116152|26060330|P1|Overall Study|Withdrawal by Subject|0
7508732|NCT03116152|26060329|P2|Overall Study|Protocol Violation|2
7508733|NCT03116152|26060330|P1|Overall Study|Protocol Violation|2
7508734|NCT03116152|26060329|P2|Overall Study|Adverse Event|7
7508735|NCT03116152|26060330|P1|Overall Study|Adverse Event|21
7508736|NCT03116152|26060329|P2|Overall Study|Death|2
7508737|NCT03116152|26060330|P1|Overall Study|Death|5
7508738|NCT03116152|26060329|P2|Overall Study|Disease Progression|47
7508739|NCT03116152|26060330|P1|Overall Study|Disease Progression|49
7508740|NCT03115476|26060407|P3|LP0084-1369|Trial terminated by Sponsor|160
7508741|NCT03115476|26060408|P2|LP0084-1369|Trial terminated by Sponsor|210
7508742|NCT03115476|26060409|P1|LP0084-1369|Trial terminated by Sponsor|190
7508743|NCT03115476|26060407|P3|LP0084-1369|Death|2
7508744|NCT03115476|26060408|P2|LP0084-1369|Death|0
7508745|NCT03115476|26060409|P1|LP0084-1369|Death|1
7508746|NCT03115112|26060435|P2|Overall Study|Site closure|1
7508747|NCT03115112|26060436|P1|Overall Study|Site closure|1
7508748|NCT03115112|26060435|P2|Overall Study|Pregnancy|0
7508749|NCT03115112|26060436|P1|Overall Study|Pregnancy|1
7508750|NCT03115112|26060435|P2|Overall Study|Death|0
7508751|NCT03115112|26060436|P1|Overall Study|Death|1
7508752|NCT03115112|26060435|P2|Overall Study|Lost to Follow-up|1
7508753|NCT03115112|26060436|P1|Overall Study|Lost to Follow-up|0
7508754|NCT03115112|26060435|P2|Overall Study|Withdrawal by Subject|2
7508755|NCT03115112|26060436|P1|Overall Study|Withdrawal by Subject|4
7508756|NCT03115112|26060435|P2|Overall Study|Adverse Event|1
7508757|NCT03115112|26060436|P1|Overall Study|Adverse Event|5
7508758|NCT03114969|26060473|P9|Overall Study|Adverse Event|2
7508759|NCT03114969|26060474|P8|Overall Study|Adverse Event|0
7508760|NCT03114969|26060475|P7|Overall Study|Adverse Event|1
7508761|NCT03114969|26060476|P6|Overall Study|Adverse Event|1
7508762|NCT03114969|26060477|P5|Overall Study|Adverse Event|0
7508763|NCT03114969|26060478|P4|Overall Study|Adverse Event|0
7508764|NCT03114969|26060479|P3|Overall Study|Adverse Event|1
7508765|NCT03114969|26060480|P2|Overall Study|Adverse Event|0
7508766|NCT03114969|26060481|P1|Overall Study|Adverse Event|0
7508767|NCT03114969|26060473|P9|Overall Study|Lost to Follow-up|0
7508768|NCT03114969|26060474|P8|Overall Study|Lost to Follow-up|0
7508769|NCT03114969|26060475|P7|Overall Study|Lost to Follow-up|0
7508770|NCT03114969|26060476|P6|Overall Study|Lost to Follow-up|0
7508771|NCT03114969|26060477|P5|Overall Study|Lost to Follow-up|0
7508772|NCT03114969|26060478|P4|Overall Study|Lost to Follow-up|2
7508773|NCT03114969|26060479|P3|Overall Study|Lost to Follow-up|3
7508774|NCT03114969|26060480|P2|Overall Study|Lost to Follow-up|0
7508775|NCT03114969|26060481|P1|Overall Study|Lost to Follow-up|0
7508776|NCT03114657|26060582|P2|Overall Study|Withdrawal by Subject|22
7508777|NCT03114657|26060583|P1|Overall Study|Withdrawal by Subject|28
7508778|NCT03114657|26060582|P2|Overall Study|Symptomatic Deterioration|1
7508779|NCT03114657|26060583|P1|Overall Study|Symptomatic Deterioration|0
7508780|NCT03114657|26060582|P2|Overall Study|Study Terminated By Sponsor|374
7508781|NCT03114657|26060583|P1|Overall Study|Study Terminated By Sponsor|355
7508782|NCT03114657|26060582|P2|Overall Study|Physician Decision|2
7508783|NCT03114657|26060583|P1|Overall Study|Physician Decision|2
7508784|NCT03114657|26060582|P2|Overall Study|Multiple Reasons|2
7508785|NCT03114657|26060583|P1|Overall Study|Multiple Reasons|1
7508786|NCT03114657|26060582|P2|Overall Study|Death|0
7508787|NCT03114657|26060583|P1|Overall Study|Death|4
7508788|NCT03114657|26060582|P2|Overall Study|Adverse Event|6
7508789|NCT03114657|26060583|P1|Overall Study|Adverse Event|9
7508790|NCT03114488|26060628|P2|Time Period 2|Withdrawal by Subject|3
7508791|NCT03114488|26060629|P1|Time Period 2|Withdrawal by Subject|1
7508792|NCT03113916|26060663|P2|Overall Study|Lost to Follow-up|2
7508793|NCT03113916|26060664|P1|Overall Study|Lost to Follow-up|1
7508794|NCT03113916|26060663|P2|Overall Study|Pregnancy|3
7508795|NCT03113916|26060664|P1|Overall Study|Pregnancy|1
7508796|NCT03113916|26060663|P2|Overall Study|Withdrawal by Subject|7
7508797|NCT03113916|26060664|P1|Overall Study|Withdrawal by Subject|9
7508798|NCT03113071|26060704|P2|Overall Study|Withdrawal by Subject|0
7508799|NCT03113071|26060705|P1|Overall Study|Withdrawal by Subject|1
7508800|NCT03111732|26060837|P1|Overall Study|Withdrawal by Subject|1
7508801|NCT03111732|26060837|P1|Overall Study|Progressive disease|3
7508802|NCT03111732|26060837|P1|Overall Study|Enrolled in different study|1
7508803|NCT03111108|26060921|P2|Overall Study|Withdrawal by Subject|0
7508804|NCT03111108|26060922|P1|Overall Study|Withdrawal by Subject|1
7508805|NCT03111108|26060921|P2|Overall Study|Death|1
7508806|NCT03111108|26060922|P1|Overall Study|Death|0
7508807|NCT03110900|26060940|P2|Overall Study|Sponsor withdrew|1
7508808|NCT03110900|26060941|P1|Overall Study|Sponsor withdrew|1
7508809|NCT03110770|26060952|P5|Overall Study|Illness/Injury unrelated to product|1
7508810|NCT03110770|26060953|P4|Overall Study|Illness/Injury unrelated to product|0
7508811|NCT03110770|26060954|P3|Overall Study|Illness/Injury unrelated to product|0
7508812|NCT03110770|26060955|P2|Overall Study|Illness/Injury unrelated to product|0
7508813|NCT03110770|26060956|P1|Overall Study|Illness/Injury unrelated to product|0
7508814|NCT03110770|26060952|P5|Overall Study|Moved from area|43
7508815|NCT03110770|26060953|P4|Overall Study|Moved from area|42
7508816|NCT03110770|26060954|P3|Overall Study|Moved from area|2
7508817|NCT03110770|26060955|P2|Overall Study|Moved from area|0
7508818|NCT03110770|26060956|P1|Overall Study|Moved from area|5
7508819|NCT03110770|26060952|P5|Overall Study|Withdrawal by Subject|24
7508820|NCT03110770|26060953|P4|Overall Study|Withdrawal by Subject|24
7508821|NCT03110770|26060954|P3|Overall Study|Withdrawal by Subject|0
7508822|NCT03110770|26060955|P2|Overall Study|Withdrawal by Subject|0
7508823|NCT03110770|26060956|P1|Overall Study|Withdrawal by Subject|0
7508824|NCT03110770|26060952|P5|Overall Study|Investigator Decision|3
7508825|NCT03110770|26060953|P4|Overall Study|Investigator Decision|5
7508826|NCT03110770|26060954|P3|Overall Study|Investigator Decision|0
7508827|NCT03110770|26060955|P2|Overall Study|Investigator Decision|0
7508828|NCT03110770|26060956|P1|Overall Study|Investigator Decision|0
7508829|NCT03110770|26060952|P5|Overall Study|Lost to Follow-up|45
7508830|NCT03110770|26060953|P4|Overall Study|Lost to Follow-up|53
7508831|NCT03110770|26060954|P3|Overall Study|Lost to Follow-up|0
7508832|NCT03110770|26060955|P2|Overall Study|Lost to Follow-up|0
7508833|NCT03110770|26060956|P1|Overall Study|Lost to Follow-up|0
7508834|NCT03110770|26060952|P5|Overall Study|Enrolled but did not receive product|7
7508835|NCT03110770|26060953|P4|Overall Study|Enrolled but did not receive product|8
7508836|NCT03110770|26060954|P3|Overall Study|Enrolled but did not receive product|0
7508837|NCT03110770|26060955|P2|Overall Study|Enrolled but did not receive product|0
7508838|NCT03110770|26060956|P1|Overall Study|Enrolled but did not receive product|0
7508839|NCT03110770|26060952|P5|Overall Study|Death|0
7508840|NCT03110770|26060953|P4|Overall Study|Death|1
7508841|NCT03110770|26060954|P3|Overall Study|Death|0
7508842|NCT03110770|26060955|P2|Overall Study|Death|0
7508843|NCT03110770|26060956|P1|Overall Study|Death|1
7508844|NCT03110562|26061021|P2|Overall Study|Ongoing|101
7508845|NCT03110562|26061022|P1|Overall Study|Ongoing|102
7508846|NCT03110562|26061021|P2|Overall Study|Randomized but never treated|3
7508847|NCT03110562|26061022|P1|Overall Study|Randomized but never treated|0
7508848|NCT03110562|26061021|P2|Overall Study|Other|1
7508849|NCT03110562|26061022|P1|Overall Study|Other|2
7508850|NCT03110562|26061021|P2|Overall Study|Lost to Follow-up|6
7508851|NCT03110562|26061022|P1|Overall Study|Lost to Follow-up|7
7508852|NCT03110562|26061021|P2|Overall Study|Death|61
7508853|NCT03110562|26061022|P1|Overall Study|Death|47
7508854|NCT03110562|26061021|P2|Overall Study|Withdrawal by Subject|35
7508855|NCT03110562|26061022|P1|Overall Study|Withdrawal by Subject|37
7508856|NCT03110380|26061073|P2|Overall Study|Lost to Follow-up|1
7508857|NCT03110380|26061074|P1|Overall Study|Lost to Follow-up|4
7508858|NCT03110380|26061073|P2|Overall Study|Withdrew Consent|16
7508859|NCT03110380|26061074|P1|Overall Study|Withdrew Consent|9
7508860|NCT03110380|26061073|P2|Overall Study|Protocol Violation|1
7508861|NCT03110380|26061074|P1|Overall Study|Protocol Violation|0
7508862|NCT03110380|26061073|P2|Overall Study|Non-Compliance with Study Drug|1
7508863|NCT03110380|26061074|P1|Overall Study|Non-Compliance with Study Drug|1
7508864|NCT03110380|26061073|P2|Overall Study|Investigator's Discretion|2
7508865|NCT03110380|26061074|P1|Overall Study|Investigator's Discretion|1
7508866|NCT03110380|26061073|P2|Overall Study|Death|1
7508867|NCT03110380|26061074|P1|Overall Study|Death|2
7508868|NCT03110380|26061073|P2|Overall Study|Adverse Event|3
7508869|NCT03110380|26061074|P1|Overall Study|Adverse Event|3
7508870|NCT03110380|26061073|P2|Overall Study|Still in Study|256
7508871|NCT03110380|26061074|P1|Overall Study|Still in Study|264
7508872|NCT03110380|26061073|P2|Overall Study|Randomized and Never Treated|2
7508873|NCT03110380|26061074|P1|Overall Study|Randomized and Never Treated|0
7508874|NCT03110185|26061086|P2|Overall Study|Patient Refusal|1
7508875|NCT03110185|26061087|P1|Overall Study|Patient Refusal|0
7508876|NCT03110185|26061086|P2|Overall Study|MRI Incompatible|0
7508877|NCT03110185|26061087|P1|Overall Study|MRI Incompatible|2
7508878|NCT03110185|26061086|P2|Overall Study|Protocol Violation|4
7508879|NCT03110185|26061087|P1|Overall Study|Protocol Violation|1
7508880|NCT03110185|26061086|P2|Overall Study|Conflict with care|12
7508881|NCT03110185|26061087|P1|Overall Study|Conflict with care|5
7508882|NCT03110185|26061086|P2|Overall Study|Time Constraints|6
7508883|NCT03110185|26061087|P1|Overall Study|Time Constraints|0
7508884|NCT03110185|26061086|P2|Overall Study|Withdrawal by Subject|7
7508885|NCT03110185|26061087|P1|Overall Study|Withdrawal by Subject|2
7508886|NCT03110185|26061086|P2|Overall Study|Death|1
7508887|NCT03110185|26061087|P1|Overall Study|Death|0
7508888|NCT03110029|26061099|P2|Overall Study|Withdrawal by Subject|1
7508889|NCT03110029|26061100|P1|Overall Study|Withdrawal by Subject|1
7508890|NCT03109184|26061180|P2|Overall Study|Withdrawal by Subject|1
7508891|NCT03109184|26061181|P1|Overall Study|Withdrawal by Subject|1
7508892|NCT03109184|26061180|P2|Overall Study|Lost to Follow-up|6
7508893|NCT03109184|26061181|P1|Overall Study|Lost to Follow-up|6
7508894|NCT03108521|26061335|P2|Overall Study|Adverse Event|0
7508895|NCT03108521|26061336|P1|Overall Study|Adverse Event|3
7508896|NCT03108521|26061335|P2|Overall Study|Physician Decision|0
7508897|NCT03108521|26061336|P1|Overall Study|Physician Decision|4
7508898|NCT03108521|26061335|P2|Overall Study|Lack of Efficacy|0
7508899|NCT03108521|26061336|P1|Overall Study|Lack of Efficacy|2
7508900|NCT03108521|26061335|P2|Overall Study|Lost to Follow-up|0
7508901|NCT03108521|26061336|P1|Overall Study|Lost to Follow-up|3
7508902|NCT03108157|26061388|P2|Overall Study|Protocol Violation|4
7508903|NCT03108157|26061389|P1|Overall Study|Protocol Violation|15
7508904|NCT03108027|26061399|P6|Period 3|Adverse Event|0
7508905|NCT03108027|26061400|P5|Period 3|Adverse Event|0
7508906|NCT03108027|26061401|P4|Period 3|Adverse Event|0
7508907|NCT03108027|26061402|P3|Period 3|Adverse Event|0
7508908|NCT03108027|26061403|P2|Period 3|Adverse Event|1
7508909|NCT03108027|26061404|P1|Period 3|Adverse Event|0
7508910|NCT03108027|26061399|P6|Period 1|Subject/Guardian Decision|0
7508911|NCT03108027|26061400|P5|Period 1|Subject/Guardian Decision|0
7508912|NCT03108027|26061401|P4|Period 1|Subject/Guardian Decision|2
7508913|NCT03108027|26061402|P3|Period 1|Subject/Guardian Decision|0
7508914|NCT03108027|26061403|P2|Period 1|Subject/Guardian Decision|0
7508915|NCT03108027|26061404|P1|Period 1|Subject/Guardian Decision|0
7508916|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
7508917|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7508918|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7508919|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Progressive Disease|1
7508920|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Progressive Disease|0
7508921|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Progressive Disease|0
7508922|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Disease Relapse|1
7508923|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Disease Relapse|2
7508924|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Disease Relapse|0
7508925|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Pregnancy|1
7508926|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Pregnancy|1
7508927|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Pregnancy|0
7508928|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Physician Decision|2
7508929|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Physician Decision|1
7508930|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Physician Decision|0
7508931|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
7508932|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
7508933|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
7508934|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7508935|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Lost to Follow-up|1
7508936|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7508937|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Lack of Efficacy|8
7508938|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Lack of Efficacy|21
7508939|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Lack of Efficacy|0
7508940|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Death|0
7508941|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Death|2
7508942|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Death|0
7508943|NCT03107793|26061418|P3|Maintenance Period (16-48 Week)|Adverse Event|10
7508944|NCT03107793|26061419|P2|Maintenance Period (16-48 Week)|Adverse Event|6
7508945|NCT03107793|26061420|P1|Maintenance Period (16-48 Week)|Adverse Event|0
7508946|NCT03107793|26061418|P3|Induction Period (16 Weeks)|Progressive Disease|0
7508947|NCT03107793|26061419|P2|Induction Period (16 Weeks)|Progressive Disease|0
7508948|NCT03107793|26061420|P1|Induction Period (16 Weeks)|Progressive Disease|1
7508949|NCT03107793|26061418|P3|Induction Period (16 Weeks)|Physician Decision|0
7508950|NCT03107793|26061419|P2|Induction Period (16 Weeks)|Physician Decision|0
7508951|NCT03107793|26061420|P1|Induction Period (16 Weeks)|Physician Decision|1
7508952|NCT03107793|26061418|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
7508953|NCT03107793|26061419|P2|Induction Period (16 Weeks)|Withdrawal by Subject|0
7508954|NCT03107793|26061420|P1|Induction Period (16 Weeks)|Withdrawal by Subject|3
7508955|NCT03107793|26061418|P3|Induction Period (16 Weeks)|Adverse Event|0
7508956|NCT03107793|26061419|P2|Induction Period (16 Weeks)|Adverse Event|0
7508957|NCT03107793|26061420|P1|Induction Period (16 Weeks)|Adverse Event|5
7508958|NCT03107715|26061448|P2|Overall Study|infant stillborn|1
7508959|NCT03107715|26061449|P1|Overall Study|infant stillborn|0
7508960|NCT03107715|26061448|P2|Overall Study|did not deliver at the home hospital|6
7508961|NCT03107715|26061449|P1|Overall Study|did not deliver at the home hospital|4
7508962|NCT03107611|26061464|P3|Overall Study|Worsening signs/symptoms|2
7508963|NCT03107611|26061465|P2|Overall Study|Worsening signs/symptoms|1
7508964|NCT03107611|26061466|P1|Overall Study|Worsening signs/symptoms|2
7508965|NCT03107611|26061464|P3|Overall Study|Withdrawal by Subject|1
7508966|NCT03107611|26061465|P2|Overall Study|Withdrawal by Subject|0
7508967|NCT03107611|26061466|P1|Overall Study|Withdrawal by Subject|1
7508968|NCT03107611|26061464|P3|Overall Study|Protocol Violation|1
7508969|NCT03107611|26061465|P2|Overall Study|Protocol Violation|0
7508970|NCT03107611|26061466|P1|Overall Study|Protocol Violation|0
7508971|NCT03107611|26061464|P3|Overall Study|Lost to Follow-up|3
7508972|NCT03107611|26061465|P2|Overall Study|Lost to Follow-up|3
7508973|NCT03107611|26061466|P1|Overall Study|Lost to Follow-up|3
7508974|NCT03107611|26061464|P3|Overall Study|Adverse Event|2
7508975|NCT03107611|26061465|P2|Overall Study|Adverse Event|0
7508976|NCT03107611|26061466|P1|Overall Study|Adverse Event|1
7508977|NCT03107377|26061485|P2|Overall Study|Other reason not specified|15
7508978|NCT03107377|26061486|P1|Overall Study|Other reason not specified|16
7508979|NCT03107377|26061485|P2|Overall Study|Lost to Follow-up|34
7508980|NCT03107377|26061486|P1|Overall Study|Lost to Follow-up|37
7508981|NCT03107377|26061485|P2|Overall Study|Withdrawal by Subject|22
7508982|NCT03107377|26061486|P1|Overall Study|Withdrawal by Subject|16
7508983|NCT03107377|26061485|P2|Overall Study|Pregnancy|7
7508984|NCT03107377|26061486|P1|Overall Study|Pregnancy|7
7508985|NCT03107377|26061485|P2|Overall Study|Physician Decision|6
7508986|NCT03107377|26061486|P1|Overall Study|Physician Decision|3
7508987|NCT03107377|26061485|P2|Overall Study|Protocol Violation|12
7508988|NCT03107377|26061486|P1|Overall Study|Protocol Violation|9
7508989|NCT03107377|26061485|P2|Overall Study|Adverse Event|3
7508990|NCT03107377|26061486|P1|Overall Study|Adverse Event|3
7508991|NCT03107091|26061508|P1|Overall Study|Physician Decision|1
7508992|NCT03107052|26061517|P3|Overall Study|Study terminated due to futility|23
7508993|NCT03107052|26061518|P2|Overall Study|Study terminated due to futility|31
7508994|NCT03107052|26061519|P1|Overall Study|Study terminated due to futility|67
7508995|NCT03107052|26061517|P3|Overall Study|Other than specified|0
7508996|NCT03107052|26061518|P2|Overall Study|Other than specified|2
7508997|NCT03107052|26061519|P1|Overall Study|Other than specified|4
7508998|NCT03107052|26061517|P3|Overall Study|Lack of Efficacy|4
7508999|NCT03107052|26061518|P2|Overall Study|Lack of Efficacy|7
7509000|NCT03107052|26061519|P1|Overall Study|Lack of Efficacy|23
7509001|NCT03107052|26061517|P3|Overall Study|Lost to Follow-up|1
7509002|NCT03107052|26061518|P2|Overall Study|Lost to Follow-up|0
7509003|NCT03107052|26061519|P1|Overall Study|Lost to Follow-up|4
7509004|NCT03107052|26061517|P3|Overall Study|Protocol Violation|3
7509005|NCT03107052|26061518|P2|Overall Study|Protocol Violation|0
7509006|NCT03107052|26061519|P1|Overall Study|Protocol Violation|6
7509007|NCT03107052|26061517|P3|Overall Study|Withdrawal by Subject|8
7509008|NCT03107052|26061518|P2|Overall Study|Withdrawal by Subject|5
7509009|NCT03107052|26061519|P1|Overall Study|Withdrawal by Subject|9
7509010|NCT03107052|26061517|P3|Overall Study|Adverse Event|2
7509011|NCT03107052|26061518|P2|Overall Study|Adverse Event|1
7509012|NCT03107052|26061519|P1|Overall Study|Adverse Event|6
7509013|NCT03107026|26061563|P3|Overall Study|Physician Decision|0
7509014|NCT03107026|26061564|P2|Overall Study|Physician Decision|1
7509015|NCT03107026|26061565|P1|Overall Study|Physician Decision|0
7509016|NCT03107026|26061563|P3|Overall Study|non-compliance with study drug|3
7509017|NCT03107026|26061564|P2|Overall Study|non-compliance with study drug|2
7509018|NCT03107026|26061565|P1|Overall Study|non-compliance with study drug|2
7509019|NCT03107026|26061563|P3|Overall Study|non compliance with study visits|0
7509020|NCT03107026|26061564|P2|Overall Study|non compliance with study visits|2
7509021|NCT03107026|26061565|P1|Overall Study|non compliance with study visits|1
7509022|NCT03107026|26061563|P3|Overall Study|Withdrawal by Subject|17
7509023|NCT03107026|26061564|P2|Overall Study|Withdrawal by Subject|5
7509024|NCT03107026|26061565|P1|Overall Study|Withdrawal by Subject|13
7509025|NCT03107026|26061563|P3|Overall Study|Pregnancy|0
7509026|NCT03107026|26061564|P2|Overall Study|Pregnancy|0
7509027|NCT03107026|26061565|P1|Overall Study|Pregnancy|1
7509028|NCT03107026|26061563|P3|Overall Study|Protocol Violation|0
7509029|NCT03107026|26061564|P2|Overall Study|Protocol Violation|2
7509030|NCT03107026|26061565|P1|Overall Study|Protocol Violation|1
7509031|NCT03107026|26061563|P3|Overall Study|Lost to Follow-up|13
7509032|NCT03107026|26061564|P2|Overall Study|Lost to Follow-up|12
7509033|NCT03107026|26061565|P1|Overall Study|Lost to Follow-up|12
7509034|NCT03107026|26061563|P3|Overall Study|Adverse Event|23
7509035|NCT03107026|26061564|P2|Overall Study|Adverse Event|14
7509036|NCT03107026|26061565|P1|Overall Study|Adverse Event|2
7509037|NCT03106753|26061632|P2|Overall Study|Withdrawal by Subject|1
7509038|NCT03106753|26061633|P1|Overall Study|Withdrawal by Subject|0
7509039|NCT03106077|26061699|P2|Overall Study|Screen Failure|0
7509040|NCT03106077|26061700|P1|Overall Study|Screen Failure|94
7509041|NCT03105362|26061744|P1|Overall Study|Lost to Follow-up|1
7509042|NCT03105362|26061744|P1|Overall Study|Withdrawal by Subject|1
7509043|NCT03105297|26061751|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
7509044|NCT03105297|26061751|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
7509045|NCT03105297|26061751|P1|Baseline Phase (Day 1)|Other|21
7509046|NCT03104816|26061795|P3|Overall Study|Protocol Violation|2
7509047|NCT03104816|26061796|P2|Overall Study|Protocol Violation|0
7509048|NCT03104816|26061797|P1|Overall Study|Protocol Violation|2
7509049|NCT03104816|26061795|P3|Overall Study|Lack of Efficacy|0
7509050|NCT03104816|26061796|P2|Overall Study|Lack of Efficacy|2
7509051|NCT03104816|26061797|P1|Overall Study|Lack of Efficacy|0
7509052|NCT03103919|26061918|P2|Overall Study|Adverse Event|2
7509053|NCT03103919|26061919|P1|Overall Study|Adverse Event|2
7509054|NCT03103906|26061955|P2|Overall Study|Other|0
7509055|NCT03103906|26061956|P1|Overall Study|Other|2
7509056|NCT03103906|26061955|P2|Overall Study|Adverse Event|3
7509057|NCT03103906|26061956|P1|Overall Study|Adverse Event|2
7509058|NCT03103763|26061979|P3|Overall Study|Withdrawal by Subject|2
7509059|NCT03103763|26061980|P2|Overall Study|Withdrawal by Subject|3
7509060|NCT03103763|26061981|P1|Overall Study|Withdrawal by Subject|0
7509061|NCT03103763|26061979|P3|Overall Study|Death|5
7509062|NCT03103763|26061980|P2|Overall Study|Death|5
7509063|NCT03103763|26061981|P1|Overall Study|Death|15
7509064|NCT03103503|26062010|P1|Overall Study|Study Closure|757
7509065|NCT03103503|26062010|P1|Overall Study|Lost to Follow-up|3
7509066|NCT03103503|26062010|P1|Overall Study|Plexa Lead or Pulse Generator Extraction|10
7509067|NCT03103503|26062010|P1|Overall Study|Withdrawal by Subject|10
7509068|NCT03103503|26062010|P1|Overall Study|Physician Decision|57
7509069|NCT03103503|26062010|P1|Overall Study|Death|64
7509070|NCT03103100|26062064|P3|Overall Study|Physician Decision|2
7509071|NCT03103100|26062065|P2|Overall Study|Physician Decision|0
7509072|NCT03103100|26062066|P1|Overall Study|Physician Decision|1
7509073|NCT03103100|26062064|P3|Overall Study|Adverse Event|0
7509074|NCT03103100|26062065|P2|Overall Study|Adverse Event|0
7509075|NCT03103100|26062066|P1|Overall Study|Adverse Event|1
7509076|NCT03102918|26062090|P2|Overall Study|Protocol Violation|0
7509077|NCT03102918|26062091|P1|Overall Study|Protocol Violation|1
7509078|NCT03102762|26062117|P2|Overall Study|Lost to Follow-up|0
7509079|NCT03102762|26062118|P1|Overall Study|Lost to Follow-up|1
7509080|NCT03102710|26062162|P3|Overall Study|Subject unable to attend final session|0
7509081|NCT03102710|26062163|P2|Overall Study|Subject unable to attend final session|1
7509082|NCT03102710|26062164|P1|Overall Study|Subject unable to attend final session|0
7509083|NCT03102710|26062162|P3|Overall Study|Nausea during MRI scan|0
7509084|NCT03102710|26062163|P2|Overall Study|Nausea during MRI scan|1
7509085|NCT03102710|26062164|P1|Overall Study|Nausea during MRI scan|0
7509086|NCT03102710|26062162|P3|Overall Study|Technical issues during final MRI scan|0
7509087|NCT03102710|26062163|P2|Overall Study|Technical issues during final MRI scan|1
7509088|NCT03102710|26062164|P1|Overall Study|Technical issues during final MRI scan|0
7509089|NCT03102710|26062162|P3|Overall Study|Dental metal affected MRI scan quality|0
7509090|NCT03102710|26062163|P2|Overall Study|Dental metal affected MRI scan quality|0
7509091|NCT03102710|26062164|P1|Overall Study|Dental metal affected MRI scan quality|1
7509092|NCT03102034|26062200|P2|Overall Study|Withdrawal by Subject|0
7509093|NCT03102034|26062201|P1|Overall Study|Withdrawal by Subject|1
7509094|NCT03101592|26062230|P3|Overall Study|participant files could not be located|118
7509095|NCT03101592|26062231|P2|Overall Study|participant files could not be located|170
7509096|NCT03101592|26062232|P1|Overall Study|participant files could not be located|111
7509097|NCT03101514|26062258|P1|Overall Study|patient's information was incomplete|1
7509098|NCT03101514|26062258|P1|Overall Study|Protocol Violation|2
7509099|NCT03101514|26062258|P1|Overall Study|Withdrawal by Subject|4
7509100|NCT03101462|26062269|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
7509101|NCT03101462|26062270|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
7509102|NCT03101371|26062286|P2|Overall Study|Did not meet eligibility criteria|1
7509103|NCT03101371|26062287|P1|Overall Study|Did not meet eligibility criteria|2
7509104|NCT03101371|26062286|P2|Overall Study|Lost to Follow-up|4
7509105|NCT03101371|26062287|P1|Overall Study|Lost to Follow-up|1
7509106|NCT03101371|26062286|P2|Overall Study|Physician Decision|1
7509107|NCT03101371|26062287|P1|Overall Study|Physician Decision|0
7509108|NCT03101293|26062307|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
7509109|NCT03101293|26062308|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
7509110|NCT03101267|26062323|P3|Primary Study Period|Miscellaneous|0
7509111|NCT03101267|26062324|P2|Primary Study Period|Miscellaneous|0
7509112|NCT03101267|26062325|P1|Primary Study Period|Miscellaneous|2
7509113|NCT03101267|26062323|P3|Primary Study Period|Withdrawal by Subject|3
7509114|NCT03101267|26062324|P2|Primary Study Period|Withdrawal by Subject|2
7509115|NCT03101267|26062325|P1|Primary Study Period|Withdrawal by Subject|1
7509116|NCT03101150|26062380|P2|Overall Study|Miscarriage|6
7509117|NCT03101150|26062381|P1|Overall Study|Miscarriage|3
7509118|NCT03101150|26062380|P2|Overall Study|Lost to Follow-up|4
7509119|NCT03101150|26062381|P1|Overall Study|Lost to Follow-up|2
7509120|NCT03101020|26062433|P2|Overall Study|Withdrawal by Subject|2
7509121|NCT03101020|26062434|P1|Overall Study|Withdrawal by Subject|0
7509122|NCT03101020|26062433|P2|Overall Study|Ran over by a car|1
7509123|NCT03101020|26062434|P1|Overall Study|Ran over by a car|0
7509124|NCT03101020|26062433|P2|Overall Study|Lack of time to participate|0
7509125|NCT03101020|26062434|P1|Overall Study|Lack of time to participate|1
7509126|NCT03100942|26062469|P7|Placebo Arm Re-Randomized|Withdrew Consent|1
7509127|NCT03100942|26062470|P6|Placebo Arm Re-Randomized|Withdrew Consent|0
7509128|NCT03100942|26062471|P5|Placebo Arm Re-Randomized|Withdrew Consent|0
7509129|NCT03100942|26062472|P4|Placebo Arm Re-Randomized|Withdrew Consent|0
7509130|NCT03100942|26062473|P3|Placebo Arm Re-Randomized|Withdrew Consent|0
7509131|NCT03100942|26062474|P2|Placebo Arm Re-Randomized|Withdrew Consent|0
7509132|NCT03100942|26062475|P1|Placebo Arm Re-Randomized|Withdrew Consent|0
7509133|NCT03100942|26062469|P7|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7509134|NCT03100942|26062470|P6|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7509135|NCT03100942|26062471|P5|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7509136|NCT03100942|26062472|P4|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7509137|NCT03100942|26062473|P3|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7509138|NCT03100942|26062474|P2|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7509139|NCT03100942|26062475|P1|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7509140|NCT03100942|26062469|P7|Randomized Treatment Period|Lost to Follow-up|0
7509141|NCT03100942|26062470|P6|Randomized Treatment Period|Lost to Follow-up|0
7509142|NCT03100942|26062471|P5|Randomized Treatment Period|Lost to Follow-up|0
7509143|NCT03100942|26062472|P4|Randomized Treatment Period|Lost to Follow-up|0
7509144|NCT03100942|26062473|P3|Randomized Treatment Period|Lost to Follow-up|1
7509145|NCT03100942|26062474|P2|Randomized Treatment Period|Lost to Follow-up|0
7509146|NCT03100942|26062475|P1|Randomized Treatment Period|Lost to Follow-up|0
7509147|NCT03100942|26062469|P7|Randomized Treatment Period|Protocol Violation|0
7509148|NCT03100942|26062470|P6|Randomized Treatment Period|Protocol Violation|0
7509149|NCT03100942|26062471|P5|Randomized Treatment Period|Protocol Violation|0
7509150|NCT03100942|26062472|P4|Randomized Treatment Period|Protocol Violation|1
7509151|NCT03100942|26062473|P3|Randomized Treatment Period|Protocol Violation|1
7509152|NCT03100942|26062474|P2|Randomized Treatment Period|Protocol Violation|1
7509153|NCT03100942|26062475|P1|Randomized Treatment Period|Protocol Violation|0
7509154|NCT03100942|26062469|P7|Randomized Treatment Period|Investigator's Discretion|0
7509155|NCT03100942|26062470|P6|Randomized Treatment Period|Investigator's Discretion|0
7509156|NCT03100942|26062471|P5|Randomized Treatment Period|Investigator's Discretion|0
7509157|NCT03100942|26062472|P4|Randomized Treatment Period|Investigator's Discretion|0
7509158|NCT03100942|26062473|P3|Randomized Treatment Period|Investigator's Discretion|0
7509159|NCT03100942|26062474|P2|Randomized Treatment Period|Investigator's Discretion|1
7509160|NCT03100942|26062475|P1|Randomized Treatment Period|Investigator's Discretion|2
7509161|NCT03100942|26062469|P7|Randomized Treatment Period|Adverse Event|0
7509162|NCT03100942|26062470|P6|Randomized Treatment Period|Adverse Event|0
7509163|NCT03100942|26062471|P5|Randomized Treatment Period|Adverse Event|0
7509164|NCT03100942|26062472|P4|Randomized Treatment Period|Adverse Event|0
7509165|NCT03100942|26062473|P3|Randomized Treatment Period|Adverse Event|1
7509166|NCT03100942|26062474|P2|Randomized Treatment Period|Adverse Event|2
7509167|NCT03100942|26062475|P1|Randomized Treatment Period|Adverse Event|5
7509168|NCT03100942|26062469|P7|Randomized Treatment Period|Withdrew Consent|0
7509169|NCT03100942|26062470|P6|Randomized Treatment Period|Withdrew Consent|0
7509170|NCT03100942|26062471|P5|Randomized Treatment Period|Withdrew Consent|0
7509171|NCT03100942|26062472|P4|Randomized Treatment Period|Withdrew Consent|3
7509172|NCT03100942|26062473|P3|Randomized Treatment Period|Withdrew Consent|3
7509173|NCT03100942|26062474|P2|Randomized Treatment Period|Withdrew Consent|5
7509174|NCT03100942|26062475|P1|Randomized Treatment Period|Withdrew Consent|4
7509175|NCT03100838|26062513|P4|Overall Study|Lost to Follow-up|0
7509176|NCT03100838|26062514|P3|Overall Study|Lost to Follow-up|1
7509177|NCT03100838|26062515|P2|Overall Study|Lost to Follow-up|0
7509178|NCT03100838|26062516|P1|Overall Study|Lost to Follow-up|0
7509179|NCT03100838|26062513|P4|Overall Study|Pregnancy|0
7509180|NCT03100838|26062514|P3|Overall Study|Pregnancy|0
7509181|NCT03100838|26062515|P2|Overall Study|Pregnancy|1
7509182|NCT03100838|26062516|P1|Overall Study|Pregnancy|0
7509183|NCT03100838|26062513|P4|Overall Study|Physician Decision|1
7509184|NCT03100838|26062514|P3|Overall Study|Physician Decision|1
7509185|NCT03100838|26062515|P2|Overall Study|Physician Decision|1
7509186|NCT03100838|26062516|P1|Overall Study|Physician Decision|1
7509187|NCT03100838|26062513|P4|Overall Study|Adverse Event|0
7509188|NCT03100838|26062514|P3|Overall Study|Adverse Event|0
7509189|NCT03100838|26062515|P2|Overall Study|Adverse Event|0
7509190|NCT03100838|26062516|P1|Overall Study|Adverse Event|1
7509191|NCT03100825|26062542|P1|Overall Study|Physician Decision|1
7509192|NCT03100825|26062542|P1|Overall Study|Participant/Guardian Decision|7
7509193|NCT03100344|26062569|P4|Overall Study|Lost to Follow-up|1
7509194|NCT03100344|26062570|P3|Overall Study|Lost to Follow-up|1
7509195|NCT03100344|26062571|P2|Overall Study|Lost to Follow-up|1
7509196|NCT03100344|26062572|P1|Overall Study|Lost to Follow-up|1
7509197|NCT03100344|26062569|P4|Overall Study|Withdrawal by Subject|8
7509198|NCT03100344|26062570|P3|Overall Study|Withdrawal by Subject|4
7509199|NCT03100344|26062571|P2|Overall Study|Withdrawal by Subject|7
7509200|NCT03100344|26062572|P1|Overall Study|Withdrawal by Subject|10
7509201|NCT03100344|26062569|P4|Overall Study|Protocol Violation|0
7509202|NCT03100344|26062570|P3|Overall Study|Protocol Violation|0
7509203|NCT03100344|26062571|P2|Overall Study|Protocol Violation|0
7509204|NCT03100344|26062572|P1|Overall Study|Protocol Violation|1
7509205|NCT03100344|26062569|P4|Overall Study|Lack of Efficacy|0
7509206|NCT03100344|26062570|P3|Overall Study|Lack of Efficacy|0
7509207|NCT03100344|26062571|P2|Overall Study|Lack of Efficacy|0
7509208|NCT03100344|26062572|P1|Overall Study|Lack of Efficacy|2
7509209|NCT03100344|26062569|P4|Overall Study|Adverse Event|3
7509210|NCT03100344|26062570|P3|Overall Study|Adverse Event|2
7509211|NCT03100344|26062571|P2|Overall Study|Adverse Event|3
7509212|NCT03100344|26062572|P1|Overall Study|Adverse Event|0
7509222|NCT03100058|26062715|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509223|NCT03100058|26062716|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509224|NCT03100058|26062717|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509225|NCT03100058|26062718|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
7509226|NCT03100058|26062719|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509227|NCT03100058|26062720|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509228|NCT03100058|26062721|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509229|NCT03100058|26062722|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509230|NCT03100058|26062723|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509231|NCT03100058|26062724|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509232|NCT03100058|26062725|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509233|NCT03100058|26062726|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509234|NCT03100058|26062727|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7509235|NCT03100058|26062715|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
7509236|NCT03100058|26062716|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509237|NCT03100058|26062717|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509238|NCT03100058|26062718|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509239|NCT03100058|26062719|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509240|NCT03100058|26062720|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509241|NCT03100058|26062721|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509242|NCT03100058|26062722|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509243|NCT03100058|26062723|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509244|NCT03100058|26062724|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509245|NCT03100058|26062725|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509246|NCT03100058|26062726|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509247|NCT03100058|26062727|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7509248|NCT03100058|26062715|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509249|NCT03100058|26062716|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509250|NCT03100058|26062717|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
7509251|NCT03100058|26062718|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509252|NCT03100058|26062719|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509253|NCT03100058|26062720|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509254|NCT03100058|26062721|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509255|NCT03100058|26062722|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509256|NCT03100058|26062723|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509257|NCT03100058|26062724|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509258|NCT03100058|26062725|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509259|NCT03100058|26062726|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509260|NCT03100058|26062727|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7509261|NCT03100058|26062715|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
7509262|NCT03100058|26062716|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509263|NCT03100058|26062717|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
7509264|NCT03100058|26062718|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
7509265|NCT03100058|26062719|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509266|NCT03100058|26062720|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509267|NCT03100058|26062721|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509268|NCT03100058|26062722|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509269|NCT03100058|26062723|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509270|NCT03100058|26062724|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509271|NCT03100058|26062725|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509272|NCT03100058|26062726|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509273|NCT03100058|26062727|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7509274|NCT03100058|26062715|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509275|NCT03100058|26062716|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
7509276|NCT03100058|26062717|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
7509277|NCT03100058|26062718|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509278|NCT03100058|26062719|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509279|NCT03100058|26062720|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509280|NCT03100058|26062721|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509281|NCT03100058|26062722|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509282|NCT03100058|26062723|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509283|NCT03100058|26062724|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509284|NCT03100058|26062725|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509285|NCT03100058|26062726|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509286|NCT03100058|26062727|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7509287|NCT03100058|26062715|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
7509288|NCT03100058|26062716|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
7509289|NCT03100058|26062717|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
7509290|NCT03100058|26062718|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509291|NCT03100058|26062719|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509292|NCT03100058|26062720|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509293|NCT03100058|26062721|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509294|NCT03100058|26062722|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509295|NCT03100058|26062723|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509296|NCT03100058|26062724|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509297|NCT03100058|26062725|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509298|NCT03100058|26062726|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509299|NCT03100058|26062727|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7509300|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509301|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509302|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509303|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509304|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509305|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509306|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
7509307|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509308|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509309|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509310|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509311|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509312|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7509313|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509314|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509315|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509316|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509317|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509318|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509319|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509320|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509321|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509322|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509323|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509324|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7509325|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
7509326|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
7509327|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
7509328|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
7509329|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
7509330|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
7509331|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
7509332|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
7509333|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
7509334|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
7509335|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
7509336|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
7509337|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
7509338|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
7509339|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509340|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509341|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509342|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509343|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509344|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509345|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7509346|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509347|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509348|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7509349|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509350|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509351|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7509352|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509353|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509354|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509355|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509356|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509357|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7509358|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509359|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509360|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509361|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7509362|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509363|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509364|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7509365|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509366|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509367|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509368|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509369|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7509370|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509371|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7509372|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509373|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509374|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509375|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7509376|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7509377|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7509378|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509379|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509380|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509381|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509382|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509383|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509384|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7509385|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7509386|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509387|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509388|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7509389|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7509390|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7509391|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7509392|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7509393|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7509394|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7509395|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7509396|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7509397|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7509398|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7509399|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7509400|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7509401|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
7509402|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7509403|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7509404|NCT03100058|26062715|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509405|NCT03100058|26062716|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509406|NCT03100058|26062717|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509407|NCT03100058|26062718|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509408|NCT03100058|26062719|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
7509409|NCT03100058|26062720|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
7509410|NCT03100058|26062721|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
7509411|NCT03100058|26062722|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509412|NCT03100058|26062723|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
7509413|NCT03100058|26062724|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
7509414|NCT03100058|26062725|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
7509415|NCT03100058|26062726|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509416|NCT03100058|26062727|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7509417|NCT03099694|26062934|P2|Overall Study|Lost to Follow-up|5
7509418|NCT03099694|26062935|P1|Overall Study|Lost to Follow-up|9
7509419|NCT03099694|26062934|P2|Overall Study|Withdrawal by Subject|13
7509420|NCT03099694|26062935|P1|Overall Study|Withdrawal by Subject|11
7509421|NCT03099538|26062974|P1|Overall Study|Lack of Efficacy|3
7509422|NCT03099187|26062999|P4|12-month Safety Follow-up|Due to hospitalization|1
7509423|NCT03099187|26063000|P3|12-month Safety Follow-up|Due to hospitalization|0
7509424|NCT03099187|26063001|P2|12-month Safety Follow-up|Due to hospitalization|0
7509425|NCT03099187|26063002|P1|12-month Safety Follow-up|Due to hospitalization|0
7509426|NCT03099187|26062999|P4|12-month Safety Follow-up|Withdrawal by Subject|2
7509427|NCT03099187|26063000|P3|12-month Safety Follow-up|Withdrawal by Subject|3
7509428|NCT03099187|26063001|P2|12-month Safety Follow-up|Withdrawal by Subject|0
7509429|NCT03099187|26063002|P1|12-month Safety Follow-up|Withdrawal by Subject|0
7509430|NCT03099187|26062999|P4|12-month Safety Follow-up|Symptomatic deterioration|1
7509431|NCT03099187|26063000|P3|12-month Safety Follow-up|Symptomatic deterioration|1
7509432|NCT03099187|26063001|P2|12-month Safety Follow-up|Symptomatic deterioration|0
7509433|NCT03099187|26063002|P1|12-month Safety Follow-up|Symptomatic deterioration|0
7509434|NCT03099187|26062999|P4|12-month Safety Follow-up|Lost to Follow-up|0
7509435|NCT03099187|26063000|P3|12-month Safety Follow-up|Lost to Follow-up|1
7509436|NCT03099187|26063001|P2|12-month Safety Follow-up|Lost to Follow-up|0
7509437|NCT03099187|26063002|P1|12-month Safety Follow-up|Lost to Follow-up|0
7509438|NCT03099187|26062999|P4|12-month Safety Follow-up|Lung transplantation|1
7509439|NCT03099187|26063000|P3|12-month Safety Follow-up|Lung transplantation|2
7509440|NCT03099187|26063001|P2|12-month Safety Follow-up|Lung transplantation|0
7509441|NCT03099187|26063002|P1|12-month Safety Follow-up|Lung transplantation|0
7509442|NCT03099187|26062999|P4|12-month Safety Follow-up|Death|9
7509443|NCT03099187|26063000|P3|12-month Safety Follow-up|Death|7
7509444|NCT03099187|26063001|P2|12-month Safety Follow-up|Death|0
7509445|NCT03099187|26063002|P1|12-month Safety Follow-up|Death|0
7509446|NCT03099187|26062999|P4|12-month Safety Follow-up|Adverse Event|12
7509447|NCT03099187|26063000|P3|12-month Safety Follow-up|Adverse Event|5
7509448|NCT03099187|26063001|P2|12-month Safety Follow-up|Adverse Event|0
7509449|NCT03099187|26063002|P1|12-month Safety Follow-up|Adverse Event|0
7509450|NCT03099187|26062999|P4|Double-blind Treatment|Non-compliance with Protocol procedure|0
7509451|NCT03099187|26063000|P3|Double-blind Treatment|Non-compliance with Protocol procedure|0
7509452|NCT03099187|26063001|P2|Double-blind Treatment|Non-compliance with Protocol procedure|1
7509453|NCT03099187|26063002|P1|Double-blind Treatment|Non-compliance with Protocol procedure|1
7509454|NCT03099187|26062999|P4|Double-blind Treatment|Randomization error|0
7509455|NCT03099187|26063000|P3|Double-blind Treatment|Randomization error|0
7509456|NCT03099187|26063001|P2|Double-blind Treatment|Randomization error|2
7509457|NCT03099187|26063002|P1|Double-blind Treatment|Randomization error|0
7509458|NCT03099187|26062999|P4|Double-blind Treatment|Disease progression|0
7509459|NCT03099187|26063000|P3|Double-blind Treatment|Disease progression|0
7509460|NCT03099187|26063001|P2|Double-blind Treatment|Disease progression|1
7509461|NCT03099187|26063002|P1|Double-blind Treatment|Disease progression|0
7509462|NCT03099187|26062999|P4|Double-blind Treatment|Non-compliance with study drug|0
7509463|NCT03099187|26063000|P3|Double-blind Treatment|Non-compliance with study drug|0
7509464|NCT03099187|26063001|P2|Double-blind Treatment|Non-compliance with study drug|2
7509465|NCT03099187|26063002|P1|Double-blind Treatment|Non-compliance with study drug|0
7509466|NCT03099187|26062999|P4|Double-blind Treatment|Lung transplantation|0
7509467|NCT03099187|26063000|P3|Double-blind Treatment|Lung transplantation|0
7509468|NCT03099187|26063001|P2|Double-blind Treatment|Lung transplantation|1
7509469|NCT03099187|26063002|P1|Double-blind Treatment|Lung transplantation|0
7509470|NCT03099187|26062999|P4|Double-blind Treatment|Withdrawal by Subject|0
7509471|NCT03099187|26063000|P3|Double-blind Treatment|Withdrawal by Subject|0
7509472|NCT03099187|26063001|P2|Double-blind Treatment|Withdrawal by Subject|4
7509473|NCT03099187|26063002|P1|Double-blind Treatment|Withdrawal by Subject|9
7509474|NCT03099187|26062999|P4|Double-blind Treatment|Physician Decision|0
7509475|NCT03099187|26063000|P3|Double-blind Treatment|Physician Decision|0
7509476|NCT03099187|26063001|P2|Double-blind Treatment|Physician Decision|1
7509477|NCT03099187|26063002|P1|Double-blind Treatment|Physician Decision|2
7509478|NCT03099187|26062999|P4|Double-blind Treatment|Lack of Efficacy|0
7509479|NCT03099187|26063000|P3|Double-blind Treatment|Lack of Efficacy|0
7509480|NCT03099187|26063001|P2|Double-blind Treatment|Lack of Efficacy|0
7509481|NCT03099187|26063002|P1|Double-blind Treatment|Lack of Efficacy|1
7509482|NCT03099187|26062999|P4|Double-blind Treatment|Death|0
7509483|NCT03099187|26063000|P3|Double-blind Treatment|Death|0
7509484|NCT03099187|26063001|P2|Double-blind Treatment|Death|3
7509485|NCT03099187|26063002|P1|Double-blind Treatment|Death|1
7509486|NCT03099187|26062999|P4|Double-blind Treatment|Adverse Event|0
7509487|NCT03099187|26063000|P3|Double-blind Treatment|Adverse Event|0
7509488|NCT03099187|26063001|P2|Double-blind Treatment|Adverse Event|1
7509489|NCT03099187|26063002|P1|Double-blind Treatment|Adverse Event|19
7509490|NCT03099161|26063057|P3|Overall Study|Progressive Disease|1
7509491|NCT03099161|26063058|P2|Overall Study|Progressive Disease|4
7509492|NCT03099161|26063059|P1|Overall Study|Progressive Disease|1
7509493|NCT03099161|26063057|P3|Overall Study|Physician Decision|0
7509494|NCT03099161|26063058|P2|Overall Study|Physician Decision|0
7509495|NCT03099161|26063059|P1|Overall Study|Physician Decision|2
7509496|NCT03099161|26063057|P3|Overall Study|Adverse Event|2
7509497|NCT03099161|26063058|P2|Overall Study|Adverse Event|0
7509498|NCT03099161|26063059|P1|Overall Study|Adverse Event|0
7509499|NCT03099096|26063076|P1|Overall Study|Physician Decision|1
7509500|NCT03099096|26063076|P1|Overall Study|Adverse Event|1
7509501|NCT03098979|26063089|P6|Overall Study|Protocol Violation|1
7509502|NCT03098979|26063090|P5|Overall Study|Protocol Violation|0
7509503|NCT03098979|26063091|P4|Overall Study|Protocol Violation|0
7509504|NCT03098979|26063092|P3|Overall Study|Protocol Violation|0
7509505|NCT03098979|26063093|P2|Overall Study|Protocol Violation|0
7509506|NCT03098979|26063094|P1|Overall Study|Protocol Violation|0
7509507|NCT03098979|26063089|P6|Overall Study|Non-compliance|1
7509508|NCT03098979|26063090|P5|Overall Study|Non-compliance|0
7509509|NCT03098979|26063091|P4|Overall Study|Non-compliance|0
7509510|NCT03098979|26063092|P3|Overall Study|Non-compliance|0
7509511|NCT03098979|26063093|P2|Overall Study|Non-compliance|0
7509512|NCT03098979|26063094|P1|Overall Study|Non-compliance|0
7509513|NCT03098979|26063089|P6|Overall Study|Physician Decision|0
7509514|NCT03098979|26063090|P5|Overall Study|Physician Decision|0
7509515|NCT03098979|26063091|P4|Overall Study|Physician Decision|0
7509516|NCT03098979|26063092|P3|Overall Study|Physician Decision|0
7509517|NCT03098979|26063093|P2|Overall Study|Physician Decision|1
7509518|NCT03098979|26063094|P1|Overall Study|Physician Decision|2
7509519|NCT03098979|26063089|P6|Overall Study|Death|0
7509520|NCT03098979|26063090|P5|Overall Study|Death|1
7509521|NCT03098979|26063091|P4|Overall Study|Death|0
7509522|NCT03098979|26063092|P3|Overall Study|Death|2
7509523|NCT03098979|26063093|P2|Overall Study|Death|0
7509524|NCT03098979|26063094|P1|Overall Study|Death|1
7509525|NCT03098979|26063089|P6|Overall Study|Withdrawal by Subject|1
7509526|NCT03098979|26063090|P5|Overall Study|Withdrawal by Subject|2
7509527|NCT03098979|26063091|P4|Overall Study|Withdrawal by Subject|1
7509528|NCT03098979|26063092|P3|Overall Study|Withdrawal by Subject|1
7509529|NCT03098979|26063093|P2|Overall Study|Withdrawal by Subject|1
7509530|NCT03098979|26063094|P1|Overall Study|Withdrawal by Subject|2
7509531|NCT03098979|26063089|P6|Overall Study|Adverse Event|1
7509532|NCT03098979|26063090|P5|Overall Study|Adverse Event|6
7509533|NCT03098979|26063091|P4|Overall Study|Adverse Event|4
7509534|NCT03098979|26063092|P3|Overall Study|Adverse Event|1
7509535|NCT03098979|26063093|P2|Overall Study|Adverse Event|0
7509536|NCT03098979|26063094|P1|Overall Study|Adverse Event|1
7509537|NCT03098550|26063205|P3|Overall Study|Other reasons|0
7509538|NCT03098550|26063206|P2|Overall Study|Other reasons|0
7509539|NCT03098550|26063207|P1|Overall Study|Other reasons|2
7509540|NCT03098550|26063205|P3|Overall Study|Administrative reason by sponsor|1
7509541|NCT03098550|26063206|P2|Overall Study|Administrative reason by sponsor|0
7509542|NCT03098550|26063207|P1|Overall Study|Administrative reason by sponsor|0
7509543|NCT03098550|26063205|P3|Overall Study|Adverse Event unrelated to Study Drug|1
7509544|NCT03098550|26063206|P2|Overall Study|Adverse Event unrelated to Study Drug|0
7509545|NCT03098550|26063207|P1|Overall Study|Adverse Event unrelated to Study Drug|6
7509546|NCT03098550|26063205|P3|Overall Study|Death|0
7509547|NCT03098550|26063206|P2|Overall Study|Death|0
7509548|NCT03098550|26063207|P1|Overall Study|Death|1
7509549|NCT03098550|26063205|P3|Overall Study|Study Drug Toxicity|0
7509550|NCT03098550|26063206|P2|Overall Study|Study Drug Toxicity|1
7509551|NCT03098550|26063207|P1|Overall Study|Study Drug Toxicity|2
7509552|NCT03098550|26063205|P3|Overall Study|Disease Progression|41
7509553|NCT03098550|26063206|P2|Overall Study|Disease Progression|19
7509554|NCT03098550|26063207|P1|Overall Study|Disease Progression|30
7509555|NCT03098433|26063248|P1|Overall Study|Withdrawal by Subject|10
7509556|NCT03098030|26063307|P4|Overall Study|Lost to Follow-up|1
7509557|NCT03098030|26063308|P3|Overall Study|Lost to Follow-up|2
7509558|NCT03098030|26063309|P2|Overall Study|Lost to Follow-up|0
7509559|NCT03098030|26063310|P1|Overall Study|Lost to Follow-up|0
7509560|NCT03098030|26063307|P4|Overall Study|Withdrawal by Subject|2
7509561|NCT03098030|26063308|P3|Overall Study|Withdrawal by Subject|8
7509562|NCT03098030|26063309|P2|Overall Study|Withdrawal by Subject|7
7509563|NCT03098030|26063310|P1|Overall Study|Withdrawal by Subject|0
7509564|NCT03098030|26063307|P4|Overall Study|Death|82
7509565|NCT03098030|26063308|P3|Overall Study|Death|156
7509566|NCT03098030|26063309|P2|Overall Study|Death|156
7509567|NCT03098030|26063310|P1|Overall Study|Death|10
7509568|NCT03097861|26063331|P3|Overall Study|Reason not provided|1
7509569|NCT03097861|26063332|P2|Overall Study|Reason not provided|1
7509570|NCT03097861|26063333|P1|Overall Study|Reason not provided|3
7509571|NCT03097861|26063331|P3|Overall Study|Withdrawal by Subject|3
7509572|NCT03097861|26063332|P2|Overall Study|Withdrawal by Subject|5
7509573|NCT03097861|26063333|P1|Overall Study|Withdrawal by Subject|1
7509574|NCT03097861|26063331|P3|Overall Study|Lost to Follow-up|1
7509575|NCT03097861|26063332|P2|Overall Study|Lost to Follow-up|7
7509576|NCT03097861|26063333|P1|Overall Study|Lost to Follow-up|0
7509577|NCT03097861|26063331|P3|Overall Study|Investigator Decision|0
7509578|NCT03097861|26063332|P2|Overall Study|Investigator Decision|1
7509579|NCT03097861|26063333|P1|Overall Study|Investigator Decision|0
7509580|NCT03097861|26063331|P3|Overall Study|Adverse Event|4
7509581|NCT03097861|26063332|P2|Overall Study|Adverse Event|8
7509582|NCT03097861|26063333|P1|Overall Study|Adverse Event|3
7509583|NCT03097614|26063383|P1|Overall Study|Adverse Event|3
7509584|NCT03097588|26063387|P1|Overall Study|Adverse Event|1
7509585|NCT03097315|26063499|P1|Overall Study|Withdrawal by Subject|1
7509586|NCT03097289|26063507|P1|Overall Study|Collected platelet product unusable|3
7509587|NCT03097289|26063507|P1|Overall Study|Equipment failure|2
7509588|NCT03097289|26063507|P1|Overall Study|Adverse Event|1
7509589|NCT03097133|26063516|P2|Overall Study|Adverse Event|0
7509590|NCT03097133|26063517|P1|Overall Study|Adverse Event|1
7509591|NCT03097133|26063516|P2|Overall Study|Other|2
7509592|NCT03097133|26063517|P1|Overall Study|Other|3
7509593|NCT03097133|26063516|P2|Overall Study|Discontinued DB, not entered FU Phase|25
7509594|NCT03097133|26063517|P1|Overall Study|Discontinued DB, not entered FU Phase|21
7509595|NCT03097133|26063516|P2|Overall Study|Withdrawal by Subject|5
7509596|NCT03097133|26063517|P1|Overall Study|Withdrawal by Subject|2
7509597|NCT03097133|26063516|P2|Overall Study|Lost to Follow-up|2
7509598|NCT03097133|26063517|P1|Overall Study|Lost to Follow-up|3
7509599|NCT03097029|26063567|P1|Overall Study|Withdrawal by Subject|1
7509600|NCT03096847|26063614|P3|Overall Study|New therapy for study indication|1
7509601|NCT03096847|26063615|P2|Overall Study|New therapy for study indication|0
7509602|NCT03096847|26063616|P1|Overall Study|New therapy for study indication|1
7509603|NCT03096847|26063614|P3|Overall Study|Non-compliance with study medication|0
7509604|NCT03096847|26063615|P2|Overall Study|Non-compliance with study medication|0
7509605|NCT03096847|26063616|P1|Overall Study|Non-compliance with study medication|1
7509606|NCT03096847|26063614|P3|Overall Study|Progressive disease|78
7509607|NCT03096847|26063615|P2|Overall Study|Progressive disease|10
7509608|NCT03096847|26063616|P1|Overall Study|Progressive disease|97
7509609|NCT03096847|26063614|P3|Overall Study|Adverse Event|28
7509610|NCT03096847|26063615|P2|Overall Study|Adverse Event|6
7509611|NCT03096847|26063616|P1|Overall Study|Adverse Event|72
7509612|NCT03096847|26063614|P3|Overall Study|Withdrawal by Subject|12
7509613|NCT03096847|26063615|P2|Overall Study|Withdrawal by Subject|1
7509614|NCT03096847|26063616|P1|Overall Study|Withdrawal by Subject|24
7509615|NCT03096847|26063614|P3|Overall Study|Physician Decision|8
7509616|NCT03096847|26063615|P2|Overall Study|Physician Decision|2
7509617|NCT03096847|26063616|P1|Overall Study|Physician Decision|12
7509618|NCT03096847|26063614|P3|Overall Study|Protocol Violation|6
7509619|NCT03096847|26063615|P2|Overall Study|Protocol Violation|0
7509620|NCT03096847|26063616|P1|Overall Study|Protocol Violation|3
7509621|NCT03096847|26063614|P3|Overall Study|Death|2
7509622|NCT03096847|26063615|P2|Overall Study|Death|0
7509623|NCT03096847|26063616|P1|Overall Study|Death|6
7509624|NCT03096847|26063614|P3|Overall Study|Lost to Follow-up|1
7509625|NCT03096847|26063615|P2|Overall Study|Lost to Follow-up|0
7509626|NCT03096847|26063616|P1|Overall Study|Lost to Follow-up|1
7509627|NCT03096847|26063614|P3|Overall Study|Other|2
7509628|NCT03096847|26063615|P2|Overall Study|Other|1
7509629|NCT03096847|26063616|P1|Overall Study|Other|2
7509630|NCT03096483|26063685|P1|Overall Study|Withdrawal by site|1
7509631|NCT03096314|26063749|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
7509632|NCT03096314|26063750|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
7509633|NCT03095651|26063817|P8|Overall Study|Withdrawal by Subject|0
7509634|NCT03095651|26063818|P7|Overall Study|Withdrawal by Subject|0
7509635|NCT03095651|26063819|P6|Overall Study|Withdrawal by Subject|1
7509636|NCT03095651|26063820|P5|Overall Study|Withdrawal by Subject|0
7509637|NCT03095651|26063821|P4|Overall Study|Withdrawal by Subject|0
7509638|NCT03095651|26063822|P3|Overall Study|Withdrawal by Subject|0
7509639|NCT03095651|26063823|P2|Overall Study|Withdrawal by Subject|0
7509640|NCT03095651|26063824|P1|Overall Study|Withdrawal by Subject|0
7509641|NCT03095651|26063817|P8|Overall Study|Lost to Follow-up|0
7509642|NCT03095651|26063818|P7|Overall Study|Lost to Follow-up|0
7509643|NCT03095651|26063819|P6|Overall Study|Lost to Follow-up|0
7509644|NCT03095651|26063820|P5|Overall Study|Lost to Follow-up|0
7509645|NCT03095651|26063821|P4|Overall Study|Lost to Follow-up|1
7509646|NCT03095651|26063822|P3|Overall Study|Lost to Follow-up|0
7509647|NCT03095651|26063823|P2|Overall Study|Lost to Follow-up|1
7509648|NCT03095651|26063824|P1|Overall Study|Lost to Follow-up|1
7509649|NCT03095599|26064103|P2|Overall Study|Withdrawal prior to vaccination|0
7509650|NCT03095599|26064104|P1|Overall Study|Withdrawal prior to vaccination|1
7509651|NCT03095599|26064103|P2|Overall Study|Lost to Follow-up|0
7509652|NCT03095599|26064104|P1|Overall Study|Lost to Follow-up|1
7509653|NCT03095599|26064103|P2|Overall Study|Withdrawal by Subject|0
7509654|NCT03095599|26064104|P1|Overall Study|Withdrawal by Subject|1
7509655|NCT03095521|26064140|P2|Overall Study|Lost to Follow-up|1
7509656|NCT03095521|26064141|P1|Overall Study|Lost to Follow-up|0
7509657|NCT03095521|26064140|P2|Overall Study|Withdrawal by Subject|1
7509658|NCT03095521|26064141|P1|Overall Study|Withdrawal by Subject|0
7509659|NCT03095508|26064159|P2|Overall Study|Adverse Event|1
7509660|NCT03095508|26064160|P1|Overall Study|Adverse Event|0
7509661|NCT03095118|26064195|P1|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
7509662|NCT03095118|26064195|P1|Overall Study|Adverse Event|1
7509663|NCT03095027|26064220|P2|Period 2, Second Week of Wear|Adverse Event|0
7509664|NCT03095027|26064221|P1|Period 2, Second Week of Wear|Adverse Event|1
7509665|NCT03094611|26064261|P1|Overall Study|Stem Cell Transplant|1
7509666|NCT03094611|26064261|P1|Overall Study|Lack of Efficacy|1
7509667|NCT03094195|26064278|P8|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7509668|NCT03094195|26064279|P7|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7509669|NCT03094195|26064280|P6|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7509670|NCT03094195|26064281|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7509671|NCT03094195|26064282|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7509672|NCT03094195|26064283|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7509673|NCT03094195|26064284|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7509674|NCT03094195|26064285|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7509675|NCT03094195|26064278|P8|Double-Blind Treatment Period (DB)|Physician Decision|0
7509676|NCT03094195|26064279|P7|Double-Blind Treatment Period (DB)|Physician Decision|0
7509677|NCT03094195|26064280|P6|Double-Blind Treatment Period (DB)|Physician Decision|0
7509678|NCT03094195|26064281|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
7509679|NCT03094195|26064282|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
7509680|NCT03094195|26064283|P3|Double-Blind Treatment Period (DB)|Physician Decision|1
7509681|NCT03094195|26064284|P2|Double-Blind Treatment Period (DB)|Physician Decision|0
7509682|NCT03094195|26064285|P1|Double-Blind Treatment Period (DB)|Physician Decision|0
7509683|NCT03094195|26064278|P8|Double-Blind Treatment Period (DB)|Adverse Event|0
7509684|NCT03094195|26064279|P7|Double-Blind Treatment Period (DB)|Adverse Event|0
7509685|NCT03094195|26064280|P6|Double-Blind Treatment Period (DB)|Adverse Event|0
7509686|NCT03094195|26064281|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
7509687|NCT03094195|26064282|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
7509688|NCT03094195|26064283|P3|Double-Blind Treatment Period (DB)|Adverse Event|1
7509689|NCT03094195|26064284|P2|Double-Blind Treatment Period (DB)|Adverse Event|2
7509690|NCT03094195|26064285|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
7509691|NCT03094195|26064278|P8|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7509692|NCT03094195|26064279|P7|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7509693|NCT03094195|26064280|P6|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7509694|NCT03094195|26064281|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7509695|NCT03094195|26064282|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7509696|NCT03094195|26064283|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
7509697|NCT03094195|26064284|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
7509698|NCT03094195|26064285|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
7509699|NCT03093870|26064334|P3|Overall Study|Lost to Follow-up|1
7509700|NCT03093870|26064335|P2|Overall Study|Lost to Follow-up|0
7509701|NCT03093870|26064336|P1|Overall Study|Lost to Follow-up|0
7509702|NCT03093870|26064334|P3|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7509703|NCT03093870|26064335|P2|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7509704|NCT03093870|26064336|P1|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
7509705|NCT03093870|26064334|P3|Overall Study|Adverse Event|0
7509706|NCT03093870|26064335|P2|Overall Study|Adverse Event|0
7509707|NCT03093870|26064336|P1|Overall Study|Adverse Event|7
7509708|NCT03093870|26064334|P3|Overall Study|Physician Decision|0
7509709|NCT03093870|26064335|P2|Overall Study|Physician Decision|0
7509710|NCT03093870|26064336|P1|Overall Study|Physician Decision|2
7509711|NCT03093870|26064334|P3|Overall Study|Clinical disease progression|0
7509712|NCT03093870|26064335|P2|Overall Study|Clinical disease progression|0
7509713|NCT03093870|26064336|P1|Overall Study|Clinical disease progression|1
7509714|NCT03093870|26064334|P3|Overall Study|Radiographic disease progression|0
7509715|NCT03093870|26064335|P2|Overall Study|Radiographic disease progression|0
7509716|NCT03093870|26064336|P1|Overall Study|Radiographic disease progression|10
7509717|NCT03093870|26064334|P3|Overall Study|Death|35
7509718|NCT03093870|26064335|P2|Overall Study|Death|35
7509719|NCT03093870|26064336|P1|Overall Study|Death|1
7509720|NCT03093870|26064334|P3|Overall Study|Withdrawal by Subject|5
7509721|NCT03093870|26064335|P2|Overall Study|Withdrawal by Subject|6
7509722|NCT03093870|26064336|P1|Overall Study|Withdrawal by Subject|2
7509723|NCT03093454|26064392|P2|Overall Study|Physician Decision|1
7509724|NCT03093454|26064393|P1|Overall Study|Physician Decision|2
7509725|NCT03093454|26064392|P2|Overall Study|Scheduling conflict|1
7509726|NCT03093454|26064393|P1|Overall Study|Scheduling conflict|3
7509727|NCT03093454|26064392|P2|Overall Study|Withdrawal by Subject|1
7509728|NCT03093454|26064393|P1|Overall Study|Withdrawal by Subject|1
7509729|NCT03093415|26064406|P3|Enrollment to SVR12 Results|Lost to Follow-up|3
7509730|NCT03093415|26064407|P2|Enrollment to SVR12 Results|Lost to Follow-up|8
7509731|NCT03093415|26064408|P1|Enrollment to SVR12 Results|Lost to Follow-up|1
7509732|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
7509733|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
7509734|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
7509735|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
7509736|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
7509737|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
7509738|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
7509739|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
7509740|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
7509741|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
7509742|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
7509743|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
7509744|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
7509745|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7509746|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7509747|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
7509748|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
7509749|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
7509750|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7509751|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
7509752|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7509753|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
7509754|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
7509755|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
7509756|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7509757|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7509758|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
7509759|NCT03093415|26064406|P3|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
7509760|NCT03093415|26064407|P2|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
7509761|NCT03093415|26064408|P1|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
7509762|NCT03093350|26064431|P1|Overall Study|Signed consent, never began treartment|1
7509763|NCT03093350|26064431|P1|Overall Study|Death|1
7509764|NCT03093324|26064439|P2|Overall Study|Withdrawal by Subject|2
7509765|NCT03093324|26064440|P1|Overall Study|Withdrawal by Subject|2
7509766|NCT03093324|26064439|P2|Overall Study|Protocol Deviation|2
7509767|NCT03093324|26064440|P1|Overall Study|Protocol Deviation|2
7509768|NCT03093324|26064439|P2|Overall Study|Lost to Follow-up|0
7509769|NCT03093324|26064440|P1|Overall Study|Lost to Follow-up|1
7509770|NCT03093324|26064439|P2|Overall Study|Adverse Event|15
7509771|NCT03093324|26064440|P1|Overall Study|Adverse Event|4
7509772|NCT03093181|26064500|P3|Overall Study|Other (Protocol violation)|1
7509773|NCT03093181|26064501|P2|Overall Study|Other (Protocol violation)|0
7509774|NCT03093181|26064502|P1|Overall Study|Other (Protocol violation)|0
7509775|NCT03093181|26064500|P3|Overall Study|Adverse Event|0
7509776|NCT03093181|26064501|P2|Overall Study|Adverse Event|1
7509777|NCT03093181|26064502|P1|Overall Study|Adverse Event|0
7509778|NCT03093181|26064500|P3|Overall Study|Other (Not specified)|0
7509779|NCT03093181|26064501|P2|Overall Study|Other (Not specified)|0
7509780|NCT03093181|26064502|P1|Overall Study|Other (Not specified)|1
7509781|NCT03093181|26064500|P3|Overall Study|Withdrawal by Subject|2
7509782|NCT03093181|26064501|P2|Overall Study|Withdrawal by Subject|1
7509783|NCT03093181|26064502|P1|Overall Study|Withdrawal by Subject|2
7509784|NCT03092791|26064598|P8|Overall Study|Reason Not Specified|0
7509785|NCT03092791|26064599|P7|Overall Study|Reason Not Specified|0
7509786|NCT03092791|26064600|P6|Overall Study|Reason Not Specified|1
7509787|NCT03092791|26064601|P5|Overall Study|Reason Not Specified|1
7509788|NCT03092791|26064602|P4|Overall Study|Reason Not Specified|0
7509789|NCT03092791|26064603|P3|Overall Study|Reason Not Specified|0
7509790|NCT03092791|26064604|P2|Overall Study|Reason Not Specified|0
7509791|NCT03092791|26064605|P1|Overall Study|Reason Not Specified|0
7509792|NCT03092791|26064598|P8|Overall Study|Death|1
7509793|NCT03092791|26064599|P7|Overall Study|Death|0
7509794|NCT03092791|26064600|P6|Overall Study|Death|1
7509795|NCT03092791|26064601|P5|Overall Study|Death|0
7509796|NCT03092791|26064602|P4|Overall Study|Death|0
7509797|NCT03092791|26064603|P3|Overall Study|Death|0
7509798|NCT03092791|26064604|P2|Overall Study|Death|0
7509799|NCT03092791|26064605|P1|Overall Study|Death|0
7509800|NCT03092791|26064598|P8|Overall Study|Study Termination|55
7509801|NCT03092791|26064599|P7|Overall Study|Study Termination|53
7509802|NCT03092791|26064600|P6|Overall Study|Study Termination|46
7509803|NCT03092791|26064601|P5|Overall Study|Study Termination|55
7509804|NCT03092791|26064602|P4|Overall Study|Study Termination|0
7509805|NCT03092791|26064603|P3|Overall Study|Study Termination|0
7509806|NCT03092791|26064604|P2|Overall Study|Study Termination|0
7509807|NCT03092791|26064605|P1|Overall Study|Study Termination|0
7509808|NCT03092791|26064598|P8|Overall Study|Withdrawal of Consent|4
7509809|NCT03092791|26064599|P7|Overall Study|Withdrawal of Consent|6
7509810|NCT03092791|26064600|P6|Overall Study|Withdrawal of Consent|12
7509811|NCT03092791|26064601|P5|Overall Study|Withdrawal of Consent|4
7509812|NCT03092791|26064602|P4|Overall Study|Withdrawal of Consent|0
7509813|NCT03092791|26064603|P3|Overall Study|Withdrawal of Consent|0
7509814|NCT03092791|26064604|P2|Overall Study|Withdrawal of Consent|0
7509815|NCT03092791|26064605|P1|Overall Study|Withdrawal of Consent|0
7509816|NCT03092791|26064598|P8|Overall Study|Lost to Follow-up|0
7509817|NCT03092791|26064599|P7|Overall Study|Lost to Follow-up|1
7509818|NCT03092791|26064600|P6|Overall Study|Lost to Follow-up|0
7509819|NCT03092791|26064601|P5|Overall Study|Lost to Follow-up|0
7509820|NCT03092791|26064602|P4|Overall Study|Lost to Follow-up|0
7509821|NCT03092791|26064603|P3|Overall Study|Lost to Follow-up|0
7509822|NCT03092791|26064604|P2|Overall Study|Lost to Follow-up|0
7509823|NCT03092791|26064605|P1|Overall Study|Lost to Follow-up|0
7509824|NCT03092752|26064720|P1|Overall Study|<6 month history|245900
7509825|NCT03092752|26064720|P1|Overall Study|Average hospital visit interval >92 days|10779
7509826|NCT03092752|26064720|P1|Overall Study|Having no claim of study drugs|29282
7509827|NCT03092752|26064720|P1|Overall Study|At least one claim with T2DM|61299
7509828|NCT03092752|26064720|P1|Overall Study|Aged <40 years|14209
7509829|NCT03092726|26064785|P2|Overall Study|Withdrawal by Subject|3
7509830|NCT03092726|26064786|P1|Overall Study|Withdrawal by Subject|5
7509831|NCT03092726|26064785|P2|Overall Study|Lost to Follow-up|0
7509832|NCT03092726|26064786|P1|Overall Study|Lost to Follow-up|1
7509833|NCT03092726|26064785|P2|Overall Study|Lack of Efficacy|1
7509834|NCT03092726|26064786|P1|Overall Study|Lack of Efficacy|0
7509835|NCT03092726|26064785|P2|Overall Study|Adverse Event|10
7509836|NCT03092726|26064786|P1|Overall Study|Adverse Event|3
7509837|NCT03092479|26064812|P2|Overall Study|Withdrawal by Subject|0
7509838|NCT03092479|26064813|P1|Overall Study|Withdrawal by Subject|4
7509839|NCT03092479|26064812|P2|Overall Study|Lost to Follow-up|2
7509840|NCT03092479|26064813|P1|Overall Study|Lost to Follow-up|3
7509841|NCT03092375|26064835|P4|Overall Study|Lack of Efficacy|0
7509842|NCT03092375|26064836|P3|Overall Study|Lack of Efficacy|1
7509843|NCT03092375|26064837|P2|Overall Study|Lack of Efficacy|1
7509844|NCT03092375|26064838|P1|Overall Study|Lack of Efficacy|0
7509845|NCT03092219|26064866|P2|Overall Study|Protocol Violation|4
7509846|NCT03092219|26064867|P1|Overall Study|Protocol Violation|7
7509847|NCT03091920|26064952|P3|Overall Study|Adverse Event|0
7509848|NCT03091920|26064953|P2|Overall Study|Adverse Event|1
7509849|NCT03091920|26064954|P1|Overall Study|Adverse Event|0
7509850|NCT03091777|26065101|P3|Overall Study|Abnormal Laboratory Value|12
7509851|NCT03091777|26065102|P2|Overall Study|Abnormal Laboratory Value|11
7509852|NCT03091777|26065103|P1|Overall Study|Abnormal Laboratory Value|7
7509853|NCT03091777|26065101|P3|Overall Study|Physician Decision|1
7509854|NCT03091777|26065102|P2|Overall Study|Physician Decision|0
7509855|NCT03091777|26065103|P1|Overall Study|Physician Decision|1
7509856|NCT03091777|26065101|P3|Overall Study|Noncompliance with study drug|1
7509857|NCT03091777|26065102|P2|Overall Study|Noncompliance with study drug|3
7509858|NCT03091777|26065103|P1|Overall Study|Noncompliance with study drug|2
7509859|NCT03091777|26065101|P3|Overall Study|Lack of Efficacy|5
7509860|NCT03091777|26065102|P2|Overall Study|Lack of Efficacy|0
7509861|NCT03091777|26065103|P1|Overall Study|Lack of Efficacy|0
7509862|NCT03091777|26065101|P3|Overall Study|Lost to Follow-up|7
7509863|NCT03091777|26065102|P2|Overall Study|Lost to Follow-up|14
7509864|NCT03091777|26065103|P1|Overall Study|Lost to Follow-up|12
7509865|NCT03091777|26065101|P3|Overall Study|Protocol Violation|1
7509866|NCT03091777|26065102|P2|Overall Study|Protocol Violation|1
7509867|NCT03091777|26065103|P1|Overall Study|Protocol Violation|2
7509868|NCT03091777|26065101|P3|Overall Study|Withdrawal by Subject|6
7509869|NCT03091777|26065102|P2|Overall Study|Withdrawal by Subject|2
7509870|NCT03091777|26065103|P1|Overall Study|Withdrawal by Subject|4
7509871|NCT03091777|26065101|P3|Overall Study|Adverse Event|4
7509872|NCT03091777|26065102|P2|Overall Study|Adverse Event|1
7509873|NCT03091777|26065103|P1|Overall Study|Adverse Event|2
7509874|NCT03091777|26065101|P3|Overall Study|Pregnancy|0
7509875|NCT03091777|26065102|P2|Overall Study|Pregnancy|1
7509876|NCT03091777|26065103|P1|Overall Study|Pregnancy|2
7509877|NCT03091738|26065119|P1|Overall Study|Lost to Follow-up|1
7509878|NCT03091738|26065119|P1|Overall Study|Adverse Event|1
7509879|NCT03091439|26065157|P2|Overall Study|Study Terminated by the Sponsor|0
7509880|NCT03091439|26065158|P1|Overall Study|Study Terminated by the Sponsor|1
7509881|NCT03091400|26065182|P2|Washout - 2 Weeks|Withdrawal by Subject|0
7509882|NCT03091400|26065183|P1|Washout - 2 Weeks|Withdrawal by Subject|1
7509883|NCT03091348|26065205|P2|Overall Study|Lost to Follow-up|1
7509884|NCT03091348|26065206|P1|Overall Study|Lost to Follow-up|2
7509885|NCT03091192|26065232|P2|Overall Study|Lost to Follow-up|0
7509886|NCT03091192|26065233|P1|Overall Study|Lost to Follow-up|1
7509887|NCT03091192|26065232|P2|Overall Study|Withdrawal by Subject|0
7509888|NCT03091192|26065233|P1|Overall Study|Withdrawal by Subject|2
7509889|NCT03091192|26065232|P2|Overall Study|Death|13
7509890|NCT03091192|26065233|P1|Overall Study|Death|9
7509891|NCT03091192|26065232|P2|Overall Study|Study terminated by sponsor|14
7509892|NCT03091192|26065233|P1|Overall Study|Study terminated by sponsor|21
7509893|NCT03090100|26065322|P2|Overall Study|Other|2
7509894|NCT03090100|26065323|P1|Overall Study|Other|2
7509895|NCT03090100|26065322|P2|Overall Study|Non-compliance|0
7509896|NCT03090100|26065323|P1|Overall Study|Non-compliance|2
7509897|NCT03090100|26065322|P2|Overall Study|Protocol Violation|6
7509898|NCT03090100|26065323|P1|Overall Study|Protocol Violation|2
7509899|NCT03090100|26065322|P2|Overall Study|Withdrawal by Subject|19
7509900|NCT03090100|26065323|P1|Overall Study|Withdrawal by Subject|7
7509901|NCT03090100|26065322|P2|Overall Study|Lost to Follow-up|2
7509902|NCT03090100|26065323|P1|Overall Study|Lost to Follow-up|2
7509903|NCT03090100|26065322|P2|Overall Study|Lack of Efficacy|7
7509904|NCT03090100|26065323|P1|Overall Study|Lack of Efficacy|2
7509905|NCT03090100|26065322|P2|Overall Study|Pregnancy|1
7509906|NCT03090100|26065323|P1|Overall Study|Pregnancy|1
7509907|NCT03090100|26065322|P2|Overall Study|Adverse Event|11
7509908|NCT03090100|26065323|P1|Overall Study|Adverse Event|9
7509909|NCT03089944|26065363|P1|Overall Study|Other|1
7509910|NCT03089944|26065363|P1|Overall Study|Adverse Event|1
7509911|NCT03089944|26065363|P1|Overall Study|Withdrew Consent|2
7509912|NCT03089944|26065363|P1|Overall Study|Lost to Follow-up|8
7509913|NCT03089853|26065410|P2|Overall Study|Lost to Follow-up|1
7509914|NCT03089853|26065411|P1|Overall Study|Lost to Follow-up|2
7509915|NCT03089697|26065435|P2|Overall Study|Withdrawal by Subject|0
7509916|NCT03089697|26065436|P1|Overall Study|Withdrawal by Subject|1
7509917|NCT03089697|26065435|P2|Overall Study|Adverse Event|2
7509918|NCT03089697|26065436|P1|Overall Study|Adverse Event|1
7509919|NCT03089580|26065448|P1|Overall Study|Lost to Follow-up|2
7509920|NCT03089216|26065459|P4|Overall Study|Adverse Event|1
7509921|NCT03089216|26065460|P3|Overall Study|Adverse Event|0
7509922|NCT03089216|26065461|P2|Overall Study|Adverse Event|0
7509923|NCT03089216|26065462|P1|Overall Study|Adverse Event|0
7509924|NCT03089047|26065478|P2|Overall Study|Lost to Follow-up|0
7509925|NCT03089047|26065479|P1|Overall Study|Lost to Follow-up|1
7509926|NCT03088917|26065489|P1|Overall Study|Moved outside study region|50
7509927|NCT03088917|26065489|P1|Overall Study|Severe comorbidity/short life expectancy|5
7509928|NCT03088917|26065489|P1|Overall Study|Contact not established|13
7509929|NCT03088917|26065489|P1|Overall Study|Refuse re-evaluation|13
7509930|NCT03088917|26065489|P1|Overall Study|In care/cured elsewhere|15
7509931|NCT03087851|26065600|P3|Overall Study|Withdraw on medical grounds|2
7509932|NCT03087851|26065601|P2|Overall Study|Withdraw on medical grounds|1
7509933|NCT03087851|26065602|P1|Overall Study|Withdraw on medical grounds|0
7509934|NCT03087786|26065633|P2|Overall Study|Withdrawal by Subject|0
7509935|NCT03087786|26065634|P1|Overall Study|Withdrawal by Subject|2
7509936|NCT03087643|26065670|P2|Overall Study|Death|2
7509937|NCT03087643|26065671|P1|Overall Study|Death|2
7509938|NCT03087643|26065670|P2|Overall Study|Withdrawal by Subject|4
7509939|NCT03087643|26065671|P1|Overall Study|Withdrawal by Subject|2
7509940|NCT03087513|26065698|P1|Second Intervention After 3 hr Washout|Equipment malfunction|2
7509941|NCT03086551|26065764|P2|Washout|Withdrawal by Subject|1
7509942|NCT03086551|26065765|P1|Washout|Withdrawal by Subject|2
7509943|NCT03086551|26065764|P2|Washout|Lost to Follow-up|2
7509944|NCT03086551|26065765|P1|Washout|Lost to Follow-up|1
7509945|NCT03086551|26065764|P2|First Intervention|Lost to Follow-up|1
7509946|NCT03086551|26065765|P1|First Intervention|Lost to Follow-up|0
7509947|NCT03086551|26065764|P2|First Intervention|Failure to meet inclusion criterion|0
7509948|NCT03086551|26065765|P1|First Intervention|Failure to meet inclusion criterion|1
7509949|NCT03086460|26065779|P1|Treatment E|Withdrawal by Subject|3
7509950|NCT03086460|26065779|P1|Treatment E|Lost to Follow-up|1
7509951|NCT03086460|26065779|P1|Treatment C|Withdrawal by Subject|2
7509952|NCT03086460|26065779|P1|Treatment A|Withdrawal by Subject|2
7509953|NCT03086460|26065779|P1|Treatment A|Protocol Violation|1
7509954|NCT03086460|26065779|P1|Treatment A|Lost to Follow-up|1
7509955|NCT03086460|26065779|P1|Study Participants|Withdrawal by Subject|6
7509956|NCT03086460|26065779|P1|Study Participants|Protocol Violation|1
7509957|NCT03086460|26065779|P1|Study Participants|Lost to Follow-up|2
7509958|NCT03086447|26065933|P2|Overall Study|Lens Discomfort|1
7509959|NCT03086447|26065934|P1|Overall Study|Lens Discomfort|2
7509960|NCT03086447|26065933|P2|Overall Study|Adverse Event|0
7509961|NCT03086447|26065934|P1|Overall Study|Adverse Event|3
7509962|NCT03086447|26065933|P2|Overall Study|Lost to Follow-up|1
7509963|NCT03086447|26065934|P1|Overall Study|Lost to Follow-up|0
7509964|NCT03086447|26065933|P2|Overall Study|Protocol Violation|4
7509965|NCT03086447|26065934|P1|Overall Study|Protocol Violation|2
7509966|NCT03086447|26065933|P2|Overall Study|Test Article No Longer Available|0
7509967|NCT03086447|26065934|P1|Overall Study|Test Article No Longer Available|1
7509968|NCT03086447|26065933|P2|Overall Study|Unsatisfactory Lens Fitting|1
7509969|NCT03086447|26065934|P1|Overall Study|Unsatisfactory Lens Fitting|0
7509970|NCT03086447|26065933|P2|Overall Study|Lens Damage|6
7509971|NCT03086447|26065934|P1|Overall Study|Lens Damage|1
7509972|NCT03086447|26065933|P2|Overall Study|Product quality complaint|1
7509973|NCT03086447|26065934|P1|Overall Study|Product quality complaint|0
7509974|NCT03086447|26065933|P2|Overall Study|Lost Lens|5
7509975|NCT03086447|26065934|P1|Overall Study|Lost Lens|2
7509976|NCT03086447|26065933|P2|Overall Study|No Longer Meets Eligibility Criteria|1
7509977|NCT03086447|26065934|P1|Overall Study|No Longer Meets Eligibility Criteria|0
7509978|NCT03086343|26065992|P2|Overall Study|Missing|1
7509979|NCT03086343|26065993|P1|Overall Study|Missing|0
7509980|NCT03086343|26065992|P2|Overall Study|Other, not specified|4
7509981|NCT03086343|26065993|P1|Overall Study|Other, not specified|8
7509982|NCT03086343|26065992|P2|Overall Study|Lack of Efficacy|6
7509983|NCT03086343|26065993|P1|Overall Study|Lack of Efficacy|4
7509984|NCT03086343|26065992|P2|Overall Study|Lost to Follow-up|1
7509985|NCT03086343|26065993|P1|Overall Study|Lost to Follow-up|3
7509986|NCT03086343|26065992|P2|Overall Study|Withdrawal by Subject|6
7509987|NCT03086343|26065993|P1|Overall Study|Withdrawal by Subject|10
7509988|NCT03086343|26065992|P2|Overall Study|Adverse Event|7
7509989|NCT03086343|26065993|P1|Overall Study|Adverse Event|7
7509990|NCT03086330|26066005|P2|Overall Study|Lost to Follow-up|2
7509991|NCT03086330|26066006|P1|Overall Study|Lost to Follow-up|1
7509992|NCT03086330|26066005|P2|Overall Study|Withdrawal by Subject|2
7509993|NCT03086330|26066006|P1|Overall Study|Withdrawal by Subject|3
7509994|NCT03086135|26066203|P1|Overall Study|Lost to Follow-up|2
7509995|NCT03086135|26066203|P1|Overall Study|Adverse Event|1
7509996|NCT03086057|26066234|P4|Stage 2: PrEP Adherence|Lost to Follow-up|2
7509997|NCT03086057|26066235|P3|Stage 2: PrEP Adherence|Lost to Follow-up|3
7509998|NCT03086057|26066236|P2|Stage 2: PrEP Adherence|Lost to Follow-up|0
7509999|NCT03086057|26066237|P1|Stage 2: PrEP Adherence|Lost to Follow-up|0
7510000|NCT03086057|26066234|P4|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7510001|NCT03086057|26066235|P3|Stage 2: PrEP Adherence|Withdrawal by Subject|1
7510002|NCT03086057|26066236|P2|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7510003|NCT03086057|26066237|P1|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7510004|NCT03086057|26066234|P4|Stage 2: PrEP Adherence|Incarcerated|0
7510005|NCT03086057|26066235|P3|Stage 2: PrEP Adherence|Incarcerated|2
7510006|NCT03086057|26066236|P2|Stage 2: PrEP Adherence|Incarcerated|0
7510007|NCT03086057|26066237|P1|Stage 2: PrEP Adherence|Incarcerated|0
7510008|NCT03086057|26066234|P4|Stage 1: PrEP Uptake|Death|0
7510009|NCT03086057|26066235|P3|Stage 1: PrEP Uptake|Death|0
7510010|NCT03086057|26066236|P2|Stage 1: PrEP Uptake|Death|0
7510011|NCT03086057|26066237|P1|Stage 1: PrEP Uptake|Death|1
7510012|NCT03086057|26066234|P4|Stage 1: PrEP Uptake|Lost to Follow-up|0
7510013|NCT03086057|26066235|P3|Stage 1: PrEP Uptake|Lost to Follow-up|0
7510014|NCT03086057|26066236|P2|Stage 1: PrEP Uptake|Lost to Follow-up|5
7510015|NCT03086057|26066237|P1|Stage 1: PrEP Uptake|Lost to Follow-up|6
7510016|NCT03086057|26066234|P4|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7510017|NCT03086057|26066235|P3|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7510018|NCT03086057|26066236|P2|Stage 1: PrEP Uptake|Withdrawal by Subject|4
7510019|NCT03086057|26066237|P1|Stage 1: PrEP Uptake|Withdrawal by Subject|1
7510020|NCT03086057|26066234|P4|Stage 1: PrEP Uptake|Incarcerated|0
7510021|NCT03086057|26066235|P3|Stage 1: PrEP Uptake|Incarcerated|0
7510022|NCT03086057|26066236|P2|Stage 1: PrEP Uptake|Incarcerated|1
7510023|NCT03086057|26066237|P1|Stage 1: PrEP Uptake|Incarcerated|3
7510024|NCT03086018|26066249|P1|Final Testing for End of Trial|Withdrawal by Subject|1
7510025|NCT03086018|26066249|P1|Final Testing for End of Trial|Adverse Event|1
7510026|NCT03085914|26066264|P7|Overall Study|Study Terminated by the Sponsor|0
7510027|NCT03085914|26066265|P6|Overall Study|Study Terminated by the Sponsor|1
7510028|NCT03085914|26066266|P5|Overall Study|Study Terminated by the Sponsor|2
7510029|NCT03085914|26066267|P4|Overall Study|Study Terminated by the Sponsor|1
7510030|NCT03085914|26066268|P3|Overall Study|Study Terminated by the Sponsor|0
7510031|NCT03085914|26066269|P2|Overall Study|Study Terminated by the Sponsor|0
7510032|NCT03085914|26066270|P1|Overall Study|Study Terminated by the Sponsor|0
7510033|NCT03085914|26066264|P7|Overall Study|Progressive Disease|1
7510034|NCT03085914|26066265|P6|Overall Study|Progressive Disease|1
7510035|NCT03085914|26066266|P5|Overall Study|Progressive Disease|1
7510036|NCT03085914|26066267|P4|Overall Study|Progressive Disease|2
7510037|NCT03085914|26066268|P3|Overall Study|Progressive Disease|2
7510038|NCT03085914|26066269|P2|Overall Study|Progressive Disease|0
7510039|NCT03085914|26066270|P1|Overall Study|Progressive Disease|0
7510040|NCT03085914|26066264|P7|Overall Study|Reason was not specified,|6
7510041|NCT03085914|26066265|P6|Overall Study|Reason was not specified,|3
7510042|NCT03085914|26066266|P5|Overall Study|Reason was not specified,|3
7510043|NCT03085914|26066267|P4|Overall Study|Reason was not specified,|3
7510044|NCT03085914|26066268|P3|Overall Study|Reason was not specified,|2
7510045|NCT03085914|26066269|P2|Overall Study|Reason was not specified,|2
7510046|NCT03085914|26066270|P1|Overall Study|Reason was not specified,|2
7510047|NCT03085914|26066264|P7|Overall Study|Lost to Follow-up|1
7510048|NCT03085914|26066265|P6|Overall Study|Lost to Follow-up|1
7510049|NCT03085914|26066266|P5|Overall Study|Lost to Follow-up|0
7510050|NCT03085914|26066267|P4|Overall Study|Lost to Follow-up|0
7510051|NCT03085914|26066268|P3|Overall Study|Lost to Follow-up|1
7510052|NCT03085914|26066269|P2|Overall Study|Lost to Follow-up|0
7510053|NCT03085914|26066270|P1|Overall Study|Lost to Follow-up|0
7510054|NCT03085914|26066264|P7|Overall Study|Withdrawal by Subject|1
7510055|NCT03085914|26066265|P6|Overall Study|Withdrawal by Subject|0
7510056|NCT03085914|26066266|P5|Overall Study|Withdrawal by Subject|2
7510057|NCT03085914|26066267|P4|Overall Study|Withdrawal by Subject|2
7510058|NCT03085914|26066268|P3|Overall Study|Withdrawal by Subject|2
7510059|NCT03085914|26066269|P2|Overall Study|Withdrawal by Subject|1
7510060|NCT03085914|26066270|P1|Overall Study|Withdrawal by Subject|1
7510061|NCT03085914|26066264|P7|Overall Study|Death|2
7510062|NCT03085914|26066265|P6|Overall Study|Death|2
7510063|NCT03085914|26066266|P5|Overall Study|Death|5
7510064|NCT03085914|26066267|P4|Overall Study|Death|1
7510065|NCT03085914|26066268|P3|Overall Study|Death|4
7510066|NCT03085914|26066269|P2|Overall Study|Death|6
7510067|NCT03085914|26066270|P1|Overall Study|Death|6
7510068|NCT03085797|26066355|P2|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
7510069|NCT03085797|26066356|P1|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
7510070|NCT03085797|26066355|P2|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
7510071|NCT03085797|26066356|P1|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
7510072|NCT03085797|26066355|P2|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
7510073|NCT03085797|26066356|P1|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
7510074|NCT03085758|26066381|P3|Overall Study|Pt seen by doctor in digestive surgery|0
7510075|NCT03085758|26066382|P2|Overall Study|Pt seen by doctor in digestive surgery|1
7510076|NCT03085758|26066383|P1|Overall Study|Pt seen by doctor in digestive surgery|0
7510077|NCT03085758|26066381|P3|Overall Study|Refusal to recall it up to day 90|1
7510078|NCT03085758|26066382|P2|Overall Study|Refusal to recall it up to day 90|0
7510079|NCT03085758|26066383|P1|Overall Study|Refusal to recall it up to day 90|0
7510080|NCT03085758|26066381|P3|Overall Study|Withdrawal by Subject|1
7510081|NCT03085758|26066382|P2|Overall Study|Withdrawal by Subject|2
7510082|NCT03085758|26066383|P1|Overall Study|Withdrawal by Subject|2
7510083|NCT03085758|26066381|P3|Overall Study|Lost to Follow-up|1
7510084|NCT03085758|26066382|P2|Overall Study|Lost to Follow-up|1
7510085|NCT03085758|26066383|P1|Overall Study|Lost to Follow-up|1
7510086|NCT03085758|26066381|P3|Overall Study|Death|53
7510087|NCT03085758|26066382|P2|Overall Study|Death|24
7510088|NCT03085758|26066383|P1|Overall Study|Death|26
7510089|NCT03085238|26066536|P1|Overall Study|Death|2
7510090|NCT03085238|26066536|P1|Overall Study|Adverse Event|2
7510091|NCT03085095|26066563|P2|Overall Study|Dosing Interruption (Logistical Reason)|0
7510092|NCT03085095|26066564|P1|Overall Study|Dosing Interruption (Logistical Reason)|1
7510093|NCT03085095|26066563|P2|Overall Study|Did not Receive Study Drug|2
7510094|NCT03085095|26066564|P1|Overall Study|Did not Receive Study Drug|2
7510095|NCT03085095|26066563|P2|Overall Study|Testosterone Suppression Level Not Met|13
7510096|NCT03085095|26066564|P1|Overall Study|Testosterone Suppression Level Not Met|7
7510097|NCT03085095|26066563|P2|Overall Study|Physician Decision|3
7510098|NCT03085095|26066564|P1|Overall Study|Physician Decision|9
7510099|NCT03085095|26066563|P2|Overall Study|Withdrawal by Subject|6
7510100|NCT03085095|26066564|P1|Overall Study|Withdrawal by Subject|17
7510101|NCT03085095|26066563|P2|Overall Study|Lost to Follow-up|1
7510102|NCT03085095|26066564|P1|Overall Study|Lost to Follow-up|2
7510103|NCT03085095|26066563|P2|Overall Study|Protocol Violation|1
7510104|NCT03085095|26066564|P1|Overall Study|Protocol Violation|0
7510105|NCT03085095|26066563|P2|Overall Study|Adverse Event|8
7510106|NCT03085095|26066564|P1|Overall Study|Adverse Event|23
7510107|NCT03085017|26066624|P2|Overall Study|Death|3
7510108|NCT03085017|26066625|P1|Overall Study|Death|0
7510109|NCT03084796|26066655|P6|Overall Study|Randomization error|0
7510110|NCT03084796|26066656|P5|Overall Study|Randomization error|0
7510111|NCT03084796|26066657|P4|Overall Study|Randomization error|0
7510112|NCT03084796|26066658|P3|Overall Study|Randomization error|1
7510113|NCT03084796|26066659|P2|Overall Study|Randomization error|0
7510114|NCT03084796|26066660|P1|Overall Study|Randomization error|0
7510115|NCT03084796|26066655|P6|Overall Study|Lost to Follow-up|1
7510116|NCT03084796|26066656|P5|Overall Study|Lost to Follow-up|3
7510117|NCT03084796|26066657|P4|Overall Study|Lost to Follow-up|1
7510118|NCT03084796|26066658|P3|Overall Study|Lost to Follow-up|1
7510119|NCT03084796|26066659|P2|Overall Study|Lost to Follow-up|0
7510120|NCT03084796|26066660|P1|Overall Study|Lost to Follow-up|0
7510121|NCT03084796|26066655|P6|Overall Study|Lack of Efficacy|0
7510122|NCT03084796|26066656|P5|Overall Study|Lack of Efficacy|1
7510123|NCT03084796|26066657|P4|Overall Study|Lack of Efficacy|0
7510124|NCT03084796|26066658|P3|Overall Study|Lack of Efficacy|1
7510125|NCT03084796|26066659|P2|Overall Study|Lack of Efficacy|0
7510126|NCT03084796|26066660|P1|Overall Study|Lack of Efficacy|0
7510127|NCT03084796|26066655|P6|Overall Study|Protocol Violation|1
7510128|NCT03084796|26066656|P5|Overall Study|Protocol Violation|1
7510129|NCT03084796|26066657|P4|Overall Study|Protocol Violation|0
7510130|NCT03084796|26066658|P3|Overall Study|Protocol Violation|1
7510131|NCT03084796|26066659|P2|Overall Study|Protocol Violation|0
7510132|NCT03084796|26066660|P1|Overall Study|Protocol Violation|0
7510133|NCT03084796|26066655|P6|Overall Study|Withdrawal by Subject|0
7510134|NCT03084796|26066656|P5|Overall Study|Withdrawal by Subject|3
7510135|NCT03084796|26066657|P4|Overall Study|Withdrawal by Subject|1
7510136|NCT03084796|26066658|P3|Overall Study|Withdrawal by Subject|2
7510137|NCT03084796|26066659|P2|Overall Study|Withdrawal by Subject|5
7510138|NCT03084796|26066660|P1|Overall Study|Withdrawal by Subject|3
7510139|NCT03084796|26066655|P6|Overall Study|Adverse Event|5
7510140|NCT03084796|26066656|P5|Overall Study|Adverse Event|3
7510141|NCT03084796|26066657|P4|Overall Study|Adverse Event|2
7510142|NCT03084796|26066658|P3|Overall Study|Adverse Event|6
7510143|NCT03084796|26066659|P2|Overall Study|Adverse Event|5
7510144|NCT03084796|26066660|P1|Overall Study|Adverse Event|4
7510155|NCT03084315|26066822|P2|Overall Study|Withdrawal by Subject|2
7510156|NCT03084315|26066823|P1|Overall Study|Withdrawal by Subject|2
7510157|NCT03084315|26066822|P2|Overall Study|Lost to Follow-up|7
7510158|NCT03084315|26066823|P1|Overall Study|Lost to Follow-up|8
7510159|NCT03084302|26066833|P1|Overall Study|No valid objective monitor data|6
7510160|NCT03084302|26066833|P1|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
7510161|NCT03083990|26066842|P2|Overall Study|Adverse Event|0
7510162|NCT03083990|26066843|P1|Overall Study|Adverse Event|1
7510163|NCT03083847|26066881|P10|Main|Withdrawal by Subject|0
7510164|NCT03083847|26066882|P9|Main|Withdrawal by Subject|0
7510165|NCT03083847|26066883|P8|Main|Withdrawal by Subject|1
7510166|NCT03083847|26066884|P7|Main|Withdrawal by Subject|1
7510167|NCT03083847|26066885|P6|Main|Withdrawal by Subject|0
7510168|NCT03083847|26066886|P5|Main|Withdrawal by Subject|0
7510169|NCT03083847|26066887|P4|Main|Withdrawal by Subject|0
7510170|NCT03083847|26066888|P3|Main|Withdrawal by Subject|0
7510171|NCT03083847|26066889|P2|Main|Withdrawal by Subject|0
7510172|NCT03083847|26066890|P1|Main|Withdrawal by Subject|0
7510173|NCT03083847|26066881|P10|Main|Adverse Event|0
7510174|NCT03083847|26066882|P9|Main|Adverse Event|0
7510175|NCT03083847|26066883|P8|Main|Adverse Event|2
7510176|NCT03083847|26066884|P7|Main|Adverse Event|0
7510177|NCT03083847|26066885|P6|Main|Adverse Event|0
7510178|NCT03083847|26066886|P5|Main|Adverse Event|0
7510179|NCT03083847|26066887|P4|Main|Adverse Event|0
7510180|NCT03083847|26066888|P3|Main|Adverse Event|0
7510181|NCT03083847|26066889|P2|Main|Adverse Event|0
7510182|NCT03083847|26066890|P1|Main|Adverse Event|0
7510183|NCT03083847|26066881|P10|Main|Pregnancy|0
7510184|NCT03083847|26066882|P9|Main|Pregnancy|0
7510185|NCT03083847|26066883|P8|Main|Pregnancy|1
7510186|NCT03083847|26066884|P7|Main|Pregnancy|0
7510187|NCT03083847|26066885|P6|Main|Pregnancy|0
7510188|NCT03083847|26066886|P5|Main|Pregnancy|0
7510189|NCT03083847|26066887|P4|Main|Pregnancy|0
7510190|NCT03083847|26066888|P3|Main|Pregnancy|0
7510191|NCT03083847|26066889|P2|Main|Pregnancy|0
7510192|NCT03083847|26066890|P1|Main|Pregnancy|0
7510193|NCT03083847|26066881|P10|Main|Physician Decision|0
7510194|NCT03083847|26066882|P9|Main|Physician Decision|0
7510195|NCT03083847|26066883|P8|Main|Physician Decision|0
7510196|NCT03083847|26066884|P7|Main|Physician Decision|0
7510197|NCT03083847|26066885|P6|Main|Physician Decision|1
7510198|NCT03083847|26066886|P5|Main|Physician Decision|0
7510199|NCT03083847|26066887|P4|Main|Physician Decision|0
7510200|NCT03083847|26066888|P3|Main|Physician Decision|0
7510201|NCT03083847|26066889|P2|Main|Physician Decision|0
7510202|NCT03083847|26066890|P1|Main|Physician Decision|0
7510203|NCT03083639|26066941|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
7510204|NCT03083639|26066942|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
7510205|NCT03083639|26066941|P2|Washout Period (at Least 6 Days)|Pregnancy|1
7510206|NCT03083639|26066942|P1|Washout Period (at Least 6 Days)|Pregnancy|0
7510207|NCT03083483|26066955|P3|Overall Study|technological issues|1
7510208|NCT03083483|26066956|P2|Overall Study|technological issues|0
7510209|NCT03083483|26066957|P1|Overall Study|technological issues|1
7510210|NCT03083483|26066955|P3|Overall Study|Lost to Follow-up|1
7510211|NCT03083483|26066956|P2|Overall Study|Lost to Follow-up|1
7510212|NCT03083483|26066957|P1|Overall Study|Lost to Follow-up|2
7510213|NCT03083483|26066955|P3|Overall Study|Adverse Event|1
7510214|NCT03083483|26066956|P2|Overall Study|Adverse Event|1
7510215|NCT03083483|26066957|P1|Overall Study|Adverse Event|1
7510216|NCT03083470|26066976|P5|Overall Study|Withdrawal by Subject|1
7510217|NCT03083470|26066977|P4|Overall Study|Withdrawal by Subject|0
7510218|NCT03083470|26066978|P3|Overall Study|Withdrawal by Subject|0
7510219|NCT03083470|26066979|P2|Overall Study|Withdrawal by Subject|0
7510220|NCT03083470|26066980|P1|Overall Study|Withdrawal by Subject|0
7510221|NCT03083470|26066976|P5|Overall Study|Lost to Follow-up|1
7510222|NCT03083470|26066977|P4|Overall Study|Lost to Follow-up|0
7510223|NCT03083470|26066978|P3|Overall Study|Lost to Follow-up|0
7510224|NCT03083470|26066979|P2|Overall Study|Lost to Follow-up|0
7510225|NCT03083470|26066980|P1|Overall Study|Lost to Follow-up|0
7510226|NCT03082599|26067037|P2|Overall Study|Lost to Follow-up|0
7510227|NCT03082599|26067038|P1|Overall Study|Lost to Follow-up|1
7510228|NCT03082261|26067095|P1|Overall Study|Unsuccessful trial evaluation period|19
7510229|NCT03082261|26067095|P1|Overall Study|Unable to place lead(s)|2
7510230|NCT03082261|26067095|P1|Overall Study|System explant|19
7510231|NCT03082261|26067095|P1|Overall Study|Subject participation terminated by sponsor|4
7510232|NCT03082261|26067095|P1|Overall Study|Subject participation terminated by investigator|9
7510233|NCT03082261|26067095|P1|Overall Study|Subject non-compliance|2
7510234|NCT03082261|26067095|P1|Overall Study|Subject moved to a different state|1
7510235|NCT03082261|26067095|P1|Overall Study|Lost to Follow-up|14
7510236|NCT03082261|26067095|P1|Overall Study|Subject implanted with device other than study device|1
7510237|NCT03082261|26067095|P1|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
7510238|NCT03082261|26067095|P1|Overall Study|Withdrawal by Subject|40
7510239|NCT03082261|26067095|P1|Overall Study|Peripheral lead added|1
7510240|NCT03082261|26067095|P1|Overall Study|Insurance denial|1
7510241|NCT03082261|26067095|P1|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
7510242|NCT03082261|26067095|P1|Overall Study|Death|4
7510243|NCT03081884|26067186|P1|Overall Study|metastasis managed with systemic therapy|3
7510244|NCT03081884|26067186|P1|Overall Study|deferred prostate cancer treatment|1
7510245|NCT03080961|26067227|P1|Overall Study|Withdrawal by Subject|3
7510246|NCT03080493|26067238|P2|Overall Study|Randomization error (parity group)|1
7510247|NCT03080493|26067239|P1|Overall Study|Randomization error (parity group)|0
7510248|NCT03080493|26067238|P2|Overall Study|Adverse Event|1
7510249|NCT03080493|26067239|P1|Overall Study|Adverse Event|0
7510250|NCT03080493|26067238|P2|Overall Study|Did not provide NRS pain results|0
7510251|NCT03080493|26067239|P1|Overall Study|Did not provide NRS pain results|1
7510252|NCT03080454|26067255|P1|Anodal FU (7 Days)|Lost to Follow-up|4
7510253|NCT03080454|26067255|P1|Anodal Doublestim (5 Days)|Adverse Event|1
7510254|NCT03080454|26067255|P1|Baseline|Adverse Event|2
7510255|NCT03078907|26067333|P2|Overall Study|Protocol Violation|1
7510256|NCT03078907|26067334|P1|Overall Study|Protocol Violation|0
7510257|NCT03078907|26067333|P2|Overall Study|Other|0
7510258|NCT03078907|26067334|P1|Overall Study|Other|1
7510259|NCT03078907|26067333|P2|Overall Study|Adverse Event|0
7510260|NCT03078907|26067334|P1|Overall Study|Adverse Event|2
7510261|NCT03078868|26067368|P1|Overall Study|Physician Decision|3
7510262|NCT03078816|26067372|P1|Overall Study|Withdrawal by Subject|1
7510263|NCT03078751|26067389|P2|Overall Study|Untreated|4
7510264|NCT03078751|26067390|P1|Overall Study|Untreated|0
7510265|NCT03078751|26067389|P2|Overall Study|Subject/guardian decision|1
7510266|NCT03078751|26067390|P1|Overall Study|Subject/guardian decision|8
7510267|NCT03078751|26067389|P2|Overall Study|Terminated by Sponsor = early terminated recruitment|23
7510268|NCT03078751|26067390|P1|Overall Study|Terminated by Sponsor = early terminated recruitment|0
7510269|NCT03078751|26067389|P2|Overall Study|Physician Decision|0
7510270|NCT03078751|26067390|P1|Overall Study|Physician Decision|1
7510271|NCT03078751|26067389|P2|Overall Study|Adverse Event|0
7510272|NCT03078751|26067390|P1|Overall Study|Adverse Event|4
7510273|NCT03078582|26067433|P2|Overall Study|Adverse Event|8
7510274|NCT03078582|26067434|P1|Overall Study|Adverse Event|0
7510275|NCT03078556|26067454|P4|Washout Period 1 (7 Days)|Physician Decision|0
7510276|NCT03078556|26067455|P3|Washout Period 1 (7 Days)|Physician Decision|0
7510277|NCT03078556|26067456|P2|Washout Period 1 (7 Days)|Physician Decision|1
7510278|NCT03078556|26067457|P1|Washout Period 1 (7 Days)|Physician Decision|0
7510279|NCT03078556|26067454|P4|Washout Period 1 (7 Days)|Adverse Event|1
7510280|NCT03078556|26067455|P3|Washout Period 1 (7 Days)|Adverse Event|0
7510281|NCT03078556|26067456|P2|Washout Period 1 (7 Days)|Adverse Event|1
7510282|NCT03078556|26067457|P1|Washout Period 1 (7 Days)|Adverse Event|0
7510283|NCT03078556|26067454|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
7510284|NCT03078556|26067455|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
7510285|NCT03078556|26067456|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
7510286|NCT03078556|26067457|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
7510287|NCT03078556|26067454|P4|Treatment Period 1 (4 Days)|Adverse Event|0
7510288|NCT03078556|26067455|P3|Treatment Period 1 (4 Days)|Adverse Event|0
7510289|NCT03078556|26067456|P2|Treatment Period 1 (4 Days)|Adverse Event|1
7510290|NCT03078556|26067457|P1|Treatment Period 1 (4 Days)|Adverse Event|0
7510291|NCT03078478|26067601|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
7510292|NCT03078478|26067602|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
7510293|NCT03078478|26067601|P2|Maintencance Period 2 (36 Weeks)|Death|6
7510294|NCT03078478|26067602|P1|Maintencance Period 2 (36 Weeks)|Death|4
7510295|NCT03078478|26067601|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
7510296|NCT03078478|26067602|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
7510297|NCT03078478|26067601|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
7510298|NCT03078478|26067602|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
7510299|NCT03078478|26067601|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
7510300|NCT03078478|26067602|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
7510301|NCT03078478|26067601|P2|Maintenance Period 1 (36 Weeks)|Death|3
7510302|NCT03078478|26067602|P1|Maintenance Period 1 (36 Weeks)|Death|3
7510303|NCT03078478|26067601|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
7510304|NCT03078478|26067602|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
7510305|NCT03078478|26067601|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
7510306|NCT03078478|26067602|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
7510307|NCT03077919|26067776|P2|Overall Study|Lost to Follow-up|1
7510308|NCT03077919|26067777|P1|Overall Study|Lost to Follow-up|4
7510309|NCT03077724|26067837|P2|Overall Study|Withdrawal by Subject|1
7510310|NCT03077724|26067838|P1|Overall Study|Withdrawal by Subject|3
7510311|NCT03077724|26067837|P2|Overall Study|Lost to Follow-up|1
7510312|NCT03077724|26067838|P1|Overall Study|Lost to Follow-up|5
7510313|NCT03077711|26067850|P2|Overall Study|noncompliant taking medication|0
7510314|NCT03077711|26067851|P1|Overall Study|noncompliant taking medication|2
7510315|NCT03077711|26067850|P2|Overall Study|Lost to Follow-up|2
7510316|NCT03077711|26067851|P1|Overall Study|Lost to Follow-up|2
7510317|NCT03077659|26067870|P3|Overall Study|Withdrawal by Subject|1
7510318|NCT03077659|26067871|P2|Overall Study|Withdrawal by Subject|0
7510319|NCT03077659|26067872|P1|Overall Study|Withdrawal by Subject|0
7510320|NCT03077646|26067904|P3|Overall Study|Lost to Follow-up|31
7510321|NCT03077646|26067905|P2|Overall Study|Lost to Follow-up|30
7510322|NCT03077646|26067906|P1|Overall Study|Lost to Follow-up|29
7510323|NCT03077607|26067919|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7510324|NCT03077607|26067920|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7510325|NCT03077607|26067919|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
7510326|NCT03077607|26067920|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
7510327|NCT03077607|26067919|P2|Period 1 (15 Days)|Death|0
7510328|NCT03077607|26067920|P1|Period 1 (15 Days)|Death|1
7510329|NCT03077607|26067919|P2|Period 1 (15 Days)|Adverse Event|0
7510330|NCT03077607|26067920|P1|Period 1 (15 Days)|Adverse Event|1
7510331|NCT03077438|26067988|P2|Overall Study|Lost to Follow-up|3
7510332|NCT03077438|26067989|P1|Overall Study|Lost to Follow-up|6
7510333|NCT03077438|26067988|P2|Overall Study|Withdrawal by Subject|6
7510334|NCT03077438|26067989|P1|Overall Study|Withdrawal by Subject|3
7510335|NCT03077438|26067988|P2|Overall Study|Protocol Violation|5
7510336|NCT03077438|26067989|P1|Overall Study|Protocol Violation|3
7510337|NCT03076996|26068030|P1|Overall Study|Literacy precluded participation|1
7510338|NCT03076996|26068030|P1|Overall Study|Lost to Follow-up|3
7510339|NCT03076996|26068030|P1|Overall Study|Withdrawal by Subject|2
7510340|NCT03076970|26068056|P6|Period 3|Failure to meet I/E criteria|0
7510341|NCT03076970|26068057|P5|Period 3|Failure to meet I/E criteria|1
7510342|NCT03076970|26068058|P4|Period 3|Failure to meet I/E criteria|0
7510343|NCT03076970|26068059|P3|Period 3|Failure to meet I/E criteria|0
7510344|NCT03076970|26068060|P2|Period 3|Failure to meet I/E criteria|0
7510345|NCT03076970|26068061|P1|Period 3|Failure to meet I/E criteria|0
7510346|NCT03076970|26068056|P6|Period 3|Withdrawal by Subject|1
7510347|NCT03076970|26068057|P5|Period 3|Withdrawal by Subject|0
7510348|NCT03076970|26068058|P4|Period 3|Withdrawal by Subject|0
7510349|NCT03076970|26068059|P3|Period 3|Withdrawal by Subject|0
7510350|NCT03076970|26068060|P2|Period 3|Withdrawal by Subject|0
7510351|NCT03076970|26068061|P1|Period 3|Withdrawal by Subject|0
7510352|NCT03076970|26068056|P6|Washout Period 2|Adverse Event|0
7510353|NCT03076970|26068057|P5|Washout Period 2|Adverse Event|1
7510354|NCT03076970|26068058|P4|Washout Period 2|Adverse Event|0
7510355|NCT03076970|26068059|P3|Washout Period 2|Adverse Event|0
7510356|NCT03076970|26068060|P2|Washout Period 2|Adverse Event|0
7510357|NCT03076970|26068061|P1|Washout Period 2|Adverse Event|0
7510358|NCT03076515|26068113|P2|Overall Study|DMC decision based on interim analysis|29
7510359|NCT03076515|26068114|P1|Overall Study|DMC decision based on interim analysis|25
7510360|NCT03076190|26068138|P2|Overall Study|Excluded from Analysis (zero duration ev|7
7510361|NCT03076190|26068139|P1|Overall Study|Excluded from Analysis (zero duration ev|9
7510362|NCT03076190|26068138|P2|Overall Study|Lost to Follow-up|34
7510363|NCT03076190|26068139|P1|Overall Study|Lost to Follow-up|9
7510364|NCT03075904|26068152|P1|Overall Study|Need for Medication not Permitted|1
7510365|NCT03075904|26068152|P1|Overall Study|Physician Decision|3
7510366|NCT03075891|26068162|P2|Overall Study|Adverse event, non-fatal|4
7510367|NCT03075891|26068163|P1|Overall Study|Adverse event, non-fatal|1
7510368|NCT03075891|26068162|P2|Overall Study|Participant requiring study withdrawal|1
7510369|NCT03075891|26068163|P1|Overall Study|Participant requiring study withdrawal|0
7510370|NCT03075891|26068162|P2|Overall Study|Drug abuse relapse issue|1
7510371|NCT03075891|26068163|P1|Overall Study|Drug abuse relapse issue|0
7510372|NCT03075891|26068162|P2|Overall Study|visits not performed (no time)|0
7510373|NCT03075891|26068163|P1|Overall Study|visits not performed (no time)|1
7510374|NCT03075891|26068162|P2|Overall Study|Pregnancy|1
7510375|NCT03075891|26068163|P1|Overall Study|Pregnancy|3
7510376|NCT03075891|26068162|P2|Overall Study|Lost to Follow-up|0
7510377|NCT03075891|26068163|P1|Overall Study|Lost to Follow-up|1
7510378|NCT03075891|26068162|P2|Overall Study|Withdrawal by Subject|6
7510379|NCT03075891|26068163|P1|Overall Study|Withdrawal by Subject|3
7510380|NCT03075878|26068217|P1|Overall Study|Physician Decision|1
7510381|NCT03075839|26068225|P1|Overall Study|Lost to Follow-up|4
7510382|NCT03075761|26068233|P2|Overall Study|Lost to Follow-up|6
7510383|NCT03075761|26068234|P1|Overall Study|Lost to Follow-up|1
7510384|NCT03075644|26068262|P2|Overall Study|Withdrawal by Subject|1
7510385|NCT03075644|26068263|P1|Overall Study|Withdrawal by Subject|1
7510386|NCT03075527|26068333|P1|Overall Study|Ongoing treatment|2
7510387|NCT03075501|26068339|P2|Overall Study|Scheduling difficulties|9
7510388|NCT03075501|26068340|P1|Overall Study|Scheduling difficulties|15
7510389|NCT03075410|26068368|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510390|NCT03075410|26068369|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510391|NCT03075410|26068370|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510392|NCT03075410|26068371|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510393|NCT03075410|26068372|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510394|NCT03075410|26068373|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510395|NCT03075410|26068374|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510396|NCT03075410|26068375|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7510397|NCT03075410|26068376|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
7510398|NCT03075410|26068368|P9|Part A-Period 2 (14 Days)|Personal reasons|0
7510399|NCT03075410|26068369|P8|Part A-Period 2 (14 Days)|Personal reasons|0
7510400|NCT03075410|26068370|P7|Part A-Period 2 (14 Days)|Personal reasons|0
7510401|NCT03075410|26068371|P6|Part A-Period 2 (14 Days)|Personal reasons|0
7510402|NCT03075410|26068372|P5|Part A-Period 2 (14 Days)|Personal reasons|0
7510403|NCT03075410|26068373|P4|Part A-Period 2 (14 Days)|Personal reasons|0
7510404|NCT03075410|26068374|P3|Part A-Period 2 (14 Days)|Personal reasons|1
7510405|NCT03075410|26068375|P2|Part A-Period 2 (14 Days)|Personal reasons|0
7510406|NCT03075410|26068376|P1|Part A-Period 2 (14 Days)|Personal reasons|1
7510407|NCT03075267|26068543|P3|Overall Study|Protocol Violation|0
7510408|NCT03075267|26068544|P2|Overall Study|Protocol Violation|0
7510409|NCT03075267|26068545|P1|Overall Study|Protocol Violation|1
7510410|NCT03075163|26068679|P2|Overall Study|not eligible for treatment limb|138
7510411|NCT03075163|26068680|P1|Overall Study|not eligible for treatment limb|138
7510412|NCT03074500|26068736|P3|Overall Study|Adverse Event|1
7510413|NCT03074500|26068737|P2|Overall Study|Adverse Event|0
7510414|NCT03074500|26068738|P1|Overall Study|Adverse Event|0
7510415|NCT03074500|26068736|P3|Overall Study|Lack of Efficacy|0
7510416|NCT03074500|26068737|P2|Overall Study|Lack of Efficacy|1
7510417|NCT03074500|26068738|P1|Overall Study|Lack of Efficacy|0
7510418|NCT03074500|26068736|P3|Overall Study|Lost to Follow-up|0
7510419|NCT03074500|26068737|P2|Overall Study|Lost to Follow-up|0
7510420|NCT03074500|26068738|P1|Overall Study|Lost to Follow-up|1
7510421|NCT03074331|26068775|P1|Overall Study|Withdrew Consent|1
7510422|NCT03074331|26068775|P1|Overall Study|Lost to Follow-up|5
7510423|NCT03074331|26068775|P1|Overall Study|Enrolled but Not Treated|1
7510424|NCT03074162|26068787|P6|Period 3|Withdrawal by Subject|0
7510425|NCT03074162|26068788|P5|Period 3|Withdrawal by Subject|1
7510426|NCT03074162|26068789|P4|Period 3|Withdrawal by Subject|0
7510427|NCT03074162|26068790|P3|Period 3|Withdrawal by Subject|0
7510428|NCT03074162|26068791|P2|Period 3|Withdrawal by Subject|0
7510429|NCT03074162|26068792|P1|Period 3|Withdrawal by Subject|1
7510430|NCT03074162|26068787|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
7510431|NCT03074162|26068788|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
7510432|NCT03074162|26068789|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
7510433|NCT03074162|26068790|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
7510434|NCT03074162|26068791|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
7510435|NCT03074162|26068792|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
7510436|NCT03074162|26068787|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
7510437|NCT03074162|26068788|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
7510438|NCT03074162|26068789|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
7510439|NCT03074162|26068790|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
7510440|NCT03074162|26068791|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
7510441|NCT03074162|26068792|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
7510442|NCT03073798|26068854|P1|Overall Study|Withdrawal by Subject|1
7510443|NCT03073798|26068854|P1|Overall Study|Adverse Event|1
7510444|NCT03073213|26068892|P3|Multiple Dose Period|Protocol Violation|1
7510445|NCT03073213|26068893|P2|Multiple Dose Period|Protocol Violation|0
7510446|NCT03073213|26068894|P1|Multiple Dose Period|Protocol Violation|0
7510447|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510448|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
7510449|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510450|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510451|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510452|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510453|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510454|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510455|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510456|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510457|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510458|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510459|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510460|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510461|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7510462|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510463|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
7510464|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510465|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510466|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510467|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510468|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510469|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510470|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510471|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510472|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510473|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510474|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510475|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510476|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7510477|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510478|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
7510479|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510480|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510481|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510482|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510483|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510484|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510485|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510486|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510487|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510488|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510489|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510490|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510491|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7510492|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
7510493|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510494|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510495|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510496|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510497|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510498|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510499|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510500|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510501|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510502|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510503|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510504|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510505|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510506|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7510507|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Protocol Violation|0
7510508|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
7510509|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
7510510|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
7510511|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
7510512|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
7510513|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
7510514|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
7510515|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
7510516|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
7510517|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
7510518|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
7510519|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
7510520|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
7510521|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
7510522|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510523|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Participant moved to another city|1
7510524|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510525|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510526|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510527|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510528|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510529|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510530|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510531|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510532|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510533|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510534|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510535|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510536|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Participant moved to another city|0
7510537|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510538|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7510539|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510540|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510541|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510542|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510543|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510544|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510545|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510546|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510547|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510548|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510549|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510550|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510551|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7510552|NCT03073200|26068909|P15|Post-Treatment Follow-Up Period|Adverse Event|0
7510553|NCT03073200|26068910|P14|Post-Treatment Follow-Up Period|Adverse Event|2
7510554|NCT03073200|26068911|P13|Post-Treatment Follow-Up Period|Adverse Event|0
7510555|NCT03073200|26068912|P12|Post-Treatment Follow-Up Period|Adverse Event|0
7510556|NCT03073200|26068913|P11|Post-Treatment Follow-Up Period|Adverse Event|0
7510557|NCT03073200|26068914|P10|Post-Treatment Follow-Up Period|Adverse Event|0
7510558|NCT03073200|26068915|P9|Post-Treatment Follow-Up Period|Adverse Event|0
7510559|NCT03073200|26068916|P8|Post-Treatment Follow-Up Period|Adverse Event|0
7510560|NCT03073200|26068917|P7|Post-Treatment Follow-Up Period|Adverse Event|0
7510561|NCT03073200|26068918|P6|Post-Treatment Follow-Up Period|Adverse Event|0
7510562|NCT03073200|26068919|P5|Post-Treatment Follow-Up Period|Adverse Event|0
7510563|NCT03073200|26068920|P4|Post-Treatment Follow-Up Period|Adverse Event|0
7510564|NCT03073200|26068921|P3|Post-Treatment Follow-Up Period|Adverse Event|0
7510565|NCT03073200|26068922|P2|Post-Treatment Follow-Up Period|Adverse Event|0
7510566|NCT03073200|26068923|P1|Post-Treatment Follow-Up Period|Adverse Event|0
7510567|NCT03073200|26068909|P15|Randomized Withdrawal Period|Adverse Event|0
7510568|NCT03073200|26068910|P14|Randomized Withdrawal Period|Adverse Event|0
7510569|NCT03073200|26068911|P13|Randomized Withdrawal Period|Adverse Event|0
7510570|NCT03073200|26068912|P12|Randomized Withdrawal Period|Adverse Event|0
7510571|NCT03073200|26068913|P11|Randomized Withdrawal Period|Adverse Event|1
7510572|NCT03073200|26068914|P10|Randomized Withdrawal Period|Adverse Event|0
7510573|NCT03073200|26068915|P9|Randomized Withdrawal Period|Adverse Event|0
7510574|NCT03073200|26068916|P8|Randomized Withdrawal Period|Adverse Event|0
7510575|NCT03073200|26068917|P7|Randomized Withdrawal Period|Adverse Event|0
7510576|NCT03073200|26068918|P6|Randomized Withdrawal Period|Adverse Event|0
7510577|NCT03073200|26068919|P5|Randomized Withdrawal Period|Adverse Event|0
7510578|NCT03073200|26068920|P4|Randomized Withdrawal Period|Adverse Event|0
7510579|NCT03073200|26068921|P3|Randomized Withdrawal Period|Adverse Event|0
7510580|NCT03073200|26068922|P2|Randomized Withdrawal Period|Adverse Event|0
7510581|NCT03073200|26068923|P1|Randomized Withdrawal Period|Adverse Event|0
7510582|NCT03073200|26068909|P15|Randomized Withdrawal Period|Withdrawal by Subject|0
7510583|NCT03073200|26068910|P14|Randomized Withdrawal Period|Withdrawal by Subject|0
7510584|NCT03073200|26068911|P13|Randomized Withdrawal Period|Withdrawal by Subject|0
7510585|NCT03073200|26068912|P12|Randomized Withdrawal Period|Withdrawal by Subject|1
7510586|NCT03073200|26068913|P11|Randomized Withdrawal Period|Withdrawal by Subject|1
7510587|NCT03073200|26068914|P10|Randomized Withdrawal Period|Withdrawal by Subject|0
7510588|NCT03073200|26068915|P9|Randomized Withdrawal Period|Withdrawal by Subject|0
7510589|NCT03073200|26068916|P8|Randomized Withdrawal Period|Withdrawal by Subject|0
7510590|NCT03073200|26068917|P7|Randomized Withdrawal Period|Withdrawal by Subject|0
7510591|NCT03073200|26068918|P6|Randomized Withdrawal Period|Withdrawal by Subject|0
7510592|NCT03073200|26068919|P5|Randomized Withdrawal Period|Withdrawal by Subject|0
7510593|NCT03073200|26068920|P4|Randomized Withdrawal Period|Withdrawal by Subject|0
7510594|NCT03073200|26068921|P3|Randomized Withdrawal Period|Withdrawal by Subject|0
7510595|NCT03073200|26068922|P2|Randomized Withdrawal Period|Withdrawal by Subject|0
7510596|NCT03073200|26068923|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
7510597|NCT03073200|26068909|P15|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510598|NCT03073200|26068910|P14|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510599|NCT03073200|26068911|P13|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510600|NCT03073200|26068912|P12|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
7510601|NCT03073200|26068913|P11|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510681|NCT03073200|26068918|P6|Extension Period|Lost to Follow-up|0
7510602|NCT03073200|26068914|P10|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510603|NCT03073200|26068915|P9|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510604|NCT03073200|26068916|P8|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510605|NCT03073200|26068917|P7|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510606|NCT03073200|26068918|P6|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510607|NCT03073200|26068919|P5|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510608|NCT03073200|26068920|P4|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510609|NCT03073200|26068921|P3|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510610|NCT03073200|26068922|P2|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510611|NCT03073200|26068923|P1|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7510612|NCT03073200|26068909|P15|Randomized Withdrawal Period|Lost to Follow-up|0
7510613|NCT03073200|26068910|P14|Randomized Withdrawal Period|Lost to Follow-up|0
7510614|NCT03073200|26068911|P13|Randomized Withdrawal Period|Lost to Follow-up|0
7510615|NCT03073200|26068912|P12|Randomized Withdrawal Period|Lost to Follow-up|1
7510616|NCT03073200|26068913|P11|Randomized Withdrawal Period|Lost to Follow-up|0
7510617|NCT03073200|26068914|P10|Randomized Withdrawal Period|Lost to Follow-up|0
7510618|NCT03073200|26068915|P9|Randomized Withdrawal Period|Lost to Follow-up|0
7510619|NCT03073200|26068916|P8|Randomized Withdrawal Period|Lost to Follow-up|0
7510620|NCT03073200|26068917|P7|Randomized Withdrawal Period|Lost to Follow-up|0
7510621|NCT03073200|26068918|P6|Randomized Withdrawal Period|Lost to Follow-up|0
7510622|NCT03073200|26068919|P5|Randomized Withdrawal Period|Lost to Follow-up|0
7510623|NCT03073200|26068920|P4|Randomized Withdrawal Period|Lost to Follow-up|0
7510624|NCT03073200|26068921|P3|Randomized Withdrawal Period|Lost to Follow-up|0
7510625|NCT03073200|26068922|P2|Randomized Withdrawal Period|Lost to Follow-up|0
7510626|NCT03073200|26068923|P1|Randomized Withdrawal Period|Lost to Follow-up|0
7510627|NCT03073200|26068909|P15|Extension Period|Withdrawal by Subject|0
7510628|NCT03073200|26068910|P14|Extension Period|Withdrawal by Subject|0
7510629|NCT03073200|26068911|P13|Extension Period|Withdrawal by Subject|0
7510630|NCT03073200|26068912|P12|Extension Period|Withdrawal by Subject|0
7510631|NCT03073200|26068913|P11|Extension Period|Withdrawal by Subject|0
7510632|NCT03073200|26068914|P10|Extension Period|Withdrawal by Subject|0
7510633|NCT03073200|26068915|P9|Extension Period|Withdrawal by Subject|0
7510634|NCT03073200|26068916|P8|Extension Period|Withdrawal by Subject|2
7510635|NCT03073200|26068917|P7|Extension Period|Withdrawal by Subject|1
7510636|NCT03073200|26068918|P6|Extension Period|Withdrawal by Subject|0
7510637|NCT03073200|26068919|P5|Extension Period|Withdrawal by Subject|0
7510638|NCT03073200|26068920|P4|Extension Period|Withdrawal by Subject|0
7510639|NCT03073200|26068921|P3|Extension Period|Withdrawal by Subject|0
7510640|NCT03073200|26068922|P2|Extension Period|Withdrawal by Subject|0
7510641|NCT03073200|26068923|P1|Extension Period|Withdrawal by Subject|0
7510642|NCT03073200|26068909|P15|Extension Period|Withdrawal by Parent/Guardian|0
7510643|NCT03073200|26068910|P14|Extension Period|Withdrawal by Parent/Guardian|0
7510644|NCT03073200|26068911|P13|Extension Period|Withdrawal by Parent/Guardian|0
7510645|NCT03073200|26068912|P12|Extension Period|Withdrawal by Parent/Guardian|0
7510646|NCT03073200|26068913|P11|Extension Period|Withdrawal by Parent/Guardian|0
7510647|NCT03073200|26068914|P10|Extension Period|Withdrawal by Parent/Guardian|0
7510648|NCT03073200|26068915|P9|Extension Period|Withdrawal by Parent/Guardian|1
7510649|NCT03073200|26068916|P8|Extension Period|Withdrawal by Parent/Guardian|3
7510650|NCT03073200|26068917|P7|Extension Period|Withdrawal by Parent/Guardian|1
7510651|NCT03073200|26068918|P6|Extension Period|Withdrawal by Parent/Guardian|0
7510652|NCT03073200|26068919|P5|Extension Period|Withdrawal by Parent/Guardian|0
7510653|NCT03073200|26068920|P4|Extension Period|Withdrawal by Parent/Guardian|0
7510654|NCT03073200|26068921|P3|Extension Period|Withdrawal by Parent/Guardian|0
7510655|NCT03073200|26068922|P2|Extension Period|Withdrawal by Parent/Guardian|0
7510656|NCT03073200|26068923|P1|Extension Period|Withdrawal by Parent/Guardian|0
7510657|NCT03073200|26068909|P15|Extension Period|Sponsor Decision|0
7510658|NCT03073200|26068910|P14|Extension Period|Sponsor Decision|0
7510659|NCT03073200|26068911|P13|Extension Period|Sponsor Decision|0
7510660|NCT03073200|26068912|P12|Extension Period|Sponsor Decision|0
7510661|NCT03073200|26068913|P11|Extension Period|Sponsor Decision|0
7510662|NCT03073200|26068914|P10|Extension Period|Sponsor Decision|0
7510663|NCT03073200|26068915|P9|Extension Period|Sponsor Decision|1
7510664|NCT03073200|26068916|P8|Extension Period|Sponsor Decision|0
7510665|NCT03073200|26068917|P7|Extension Period|Sponsor Decision|0
7510666|NCT03073200|26068918|P6|Extension Period|Sponsor Decision|0
7510667|NCT03073200|26068919|P5|Extension Period|Sponsor Decision|0
7510668|NCT03073200|26068920|P4|Extension Period|Sponsor Decision|0
7510669|NCT03073200|26068921|P3|Extension Period|Sponsor Decision|0
7510670|NCT03073200|26068922|P2|Extension Period|Sponsor Decision|0
7510671|NCT03073200|26068923|P1|Extension Period|Sponsor Decision|0
7510672|NCT03073200|26068909|P15|Extension Period|Lost to Follow-up|0
7510673|NCT03073200|26068910|P14|Extension Period|Lost to Follow-up|0
7510674|NCT03073200|26068911|P13|Extension Period|Lost to Follow-up|0
7510675|NCT03073200|26068912|P12|Extension Period|Lost to Follow-up|0
7510676|NCT03073200|26068913|P11|Extension Period|Lost to Follow-up|0
7510677|NCT03073200|26068914|P10|Extension Period|Lost to Follow-up|0
7510678|NCT03073200|26068915|P9|Extension Period|Lost to Follow-up|0
7510679|NCT03073200|26068916|P8|Extension Period|Lost to Follow-up|1
7510680|NCT03073200|26068917|P7|Extension Period|Lost to Follow-up|1
7510682|NCT03073200|26068919|P5|Extension Period|Lost to Follow-up|0
7510683|NCT03073200|26068920|P4|Extension Period|Lost to Follow-up|0
7510684|NCT03073200|26068921|P3|Extension Period|Lost to Follow-up|0
7510685|NCT03073200|26068922|P2|Extension Period|Lost to Follow-up|0
7510686|NCT03073200|26068923|P1|Extension Period|Lost to Follow-up|0
7510687|NCT03073200|26068909|P15|Open-Label Maintenance Period|Withdrawal by Subject|0
7510688|NCT03073200|26068910|P14|Open-Label Maintenance Period|Withdrawal by Subject|0
7510689|NCT03073200|26068911|P13|Open-Label Maintenance Period|Withdrawal by Subject|0
7510690|NCT03073200|26068912|P12|Open-Label Maintenance Period|Withdrawal by Subject|0
7510691|NCT03073200|26068913|P11|Open-Label Maintenance Period|Withdrawal by Subject|0
7510692|NCT03073200|26068914|P10|Open-Label Maintenance Period|Withdrawal by Subject|0
7510693|NCT03073200|26068915|P9|Open-Label Maintenance Period|Withdrawal by Subject|0
7510694|NCT03073200|26068916|P8|Open-Label Maintenance Period|Withdrawal by Subject|0
7510695|NCT03073200|26068917|P7|Open-Label Maintenance Period|Withdrawal by Subject|0
7510696|NCT03073200|26068918|P6|Open-Label Maintenance Period|Withdrawal by Subject|0
7510697|NCT03073200|26068919|P5|Open-Label Maintenance Period|Withdrawal by Subject|1
7510698|NCT03073200|26068920|P4|Open-Label Maintenance Period|Withdrawal by Subject|2
7510699|NCT03073200|26068921|P3|Open-Label Maintenance Period|Withdrawal by Subject|0
7510700|NCT03073200|26068922|P2|Open-Label Maintenance Period|Withdrawal by Subject|0
7510701|NCT03073200|26068923|P1|Open-Label Maintenance Period|Withdrawal by Subject|0
7510702|NCT03073200|26068909|P15|Open-Label Maintenance Period|Lack of Efficacy|0
7510703|NCT03073200|26068910|P14|Open-Label Maintenance Period|Lack of Efficacy|0
7510704|NCT03073200|26068911|P13|Open-Label Maintenance Period|Lack of Efficacy|0
7510705|NCT03073200|26068912|P12|Open-Label Maintenance Period|Lack of Efficacy|0
7510706|NCT03073200|26068913|P11|Open-Label Maintenance Period|Lack of Efficacy|0
7510707|NCT03073200|26068914|P10|Open-Label Maintenance Period|Lack of Efficacy|0
7510708|NCT03073200|26068915|P9|Open-Label Maintenance Period|Lack of Efficacy|0
7510709|NCT03073200|26068916|P8|Open-Label Maintenance Period|Lack of Efficacy|0
7510710|NCT03073200|26068917|P7|Open-Label Maintenance Period|Lack of Efficacy|0
7510711|NCT03073200|26068918|P6|Open-Label Maintenance Period|Lack of Efficacy|0
7510712|NCT03073200|26068919|P5|Open-Label Maintenance Period|Lack of Efficacy|1
7510713|NCT03073200|26068920|P4|Open-Label Maintenance Period|Lack of Efficacy|0
7510714|NCT03073200|26068921|P3|Open-Label Maintenance Period|Lack of Efficacy|0
7510715|NCT03073200|26068922|P2|Open-Label Maintenance Period|Lack of Efficacy|0
7510716|NCT03073200|26068923|P1|Open-Label Maintenance Period|Lack of Efficacy|0
7510717|NCT03073200|26068909|P15|Open-Label Maintenance Period|Participant moved to another city|0
7510718|NCT03073200|26068910|P14|Open-Label Maintenance Period|Participant moved to another city|0
7510719|NCT03073200|26068911|P13|Open-Label Maintenance Period|Participant moved to another city|0
7510720|NCT03073200|26068912|P12|Open-Label Maintenance Period|Participant moved to another city|0
7510721|NCT03073200|26068913|P11|Open-Label Maintenance Period|Participant moved to another city|0
7510722|NCT03073200|26068914|P10|Open-Label Maintenance Period|Participant moved to another city|0
7510723|NCT03073200|26068915|P9|Open-Label Maintenance Period|Participant moved to another city|0
7510724|NCT03073200|26068916|P8|Open-Label Maintenance Period|Participant moved to another city|0
7510725|NCT03073200|26068917|P7|Open-Label Maintenance Period|Participant moved to another city|0
7510726|NCT03073200|26068918|P6|Open-Label Maintenance Period|Participant moved to another city|0
7510727|NCT03073200|26068919|P5|Open-Label Maintenance Period|Participant moved to another city|0
7510728|NCT03073200|26068920|P4|Open-Label Maintenance Period|Participant moved to another city|1
7510729|NCT03073200|26068921|P3|Open-Label Maintenance Period|Participant moved to another city|0
7510730|NCT03073200|26068922|P2|Open-Label Maintenance Period|Participant moved to another city|0
7510731|NCT03073200|26068923|P1|Open-Label Maintenance Period|Participant moved to another city|0
7510732|NCT03073200|26068909|P15|Open-Label Maintenance Period|Lost to Follow-up|0
7510733|NCT03073200|26068910|P14|Open-Label Maintenance Period|Lost to Follow-up|0
7510734|NCT03073200|26068911|P13|Open-Label Maintenance Period|Lost to Follow-up|0
7510735|NCT03073200|26068912|P12|Open-Label Maintenance Period|Lost to Follow-up|0
7510736|NCT03073200|26068913|P11|Open-Label Maintenance Period|Lost to Follow-up|0
7510737|NCT03073200|26068914|P10|Open-Label Maintenance Period|Lost to Follow-up|0
7510738|NCT03073200|26068915|P9|Open-Label Maintenance Period|Lost to Follow-up|0
7510739|NCT03073200|26068916|P8|Open-Label Maintenance Period|Lost to Follow-up|0
7510740|NCT03073200|26068917|P7|Open-Label Maintenance Period|Lost to Follow-up|0
7510741|NCT03073200|26068918|P6|Open-Label Maintenance Period|Lost to Follow-up|0
7510742|NCT03073200|26068919|P5|Open-Label Maintenance Period|Lost to Follow-up|2
7510743|NCT03073200|26068920|P4|Open-Label Maintenance Period|Lost to Follow-up|1
7510744|NCT03073200|26068921|P3|Open-Label Maintenance Period|Lost to Follow-up|0
7510745|NCT03073200|26068922|P2|Open-Label Maintenance Period|Lost to Follow-up|0
7510746|NCT03073200|26068923|P1|Open-Label Maintenance Period|Lost to Follow-up|0
7510747|NCT03073200|26068909|P15|Double Blind Treatment Period|Withdrawal by Subject|0
7510748|NCT03073200|26068910|P14|Double Blind Treatment Period|Withdrawal by Subject|0
7510749|NCT03073200|26068911|P13|Double Blind Treatment Period|Withdrawal by Subject|0
7510750|NCT03073200|26068912|P12|Double Blind Treatment Period|Withdrawal by Subject|0
7510751|NCT03073200|26068913|P11|Double Blind Treatment Period|Withdrawal by Subject|0
7510752|NCT03073200|26068914|P10|Double Blind Treatment Period|Withdrawal by Subject|0
7510753|NCT03073200|26068915|P9|Double Blind Treatment Period|Withdrawal by Subject|0
7510754|NCT03073200|26068916|P8|Double Blind Treatment Period|Withdrawal by Subject|0
7510755|NCT03073200|26068917|P7|Double Blind Treatment Period|Withdrawal by Subject|0
7510756|NCT03073200|26068918|P6|Double Blind Treatment Period|Withdrawal by Subject|0
7510757|NCT03073200|26068919|P5|Double Blind Treatment Period|Withdrawal by Subject|0
7510758|NCT03073200|26068920|P4|Double Blind Treatment Period|Withdrawal by Subject|0
7510759|NCT03073200|26068921|P3|Double Blind Treatment Period|Withdrawal by Subject|0
7510760|NCT03073200|26068922|P2|Double Blind Treatment Period|Withdrawal by Subject|0
7510761|NCT03073200|26068923|P1|Double Blind Treatment Period|Withdrawal by Subject|1
7510762|NCT03073200|26068909|P15|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510763|NCT03073200|26068910|P14|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510764|NCT03073200|26068911|P13|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510765|NCT03073200|26068912|P12|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510766|NCT03073200|26068913|P11|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510767|NCT03073200|26068914|P10|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510768|NCT03073200|26068915|P9|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510769|NCT03073200|26068916|P8|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510770|NCT03073200|26068917|P7|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510771|NCT03073200|26068918|P6|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510772|NCT03073200|26068919|P5|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510773|NCT03073200|26068920|P4|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510774|NCT03073200|26068921|P3|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510775|NCT03073200|26068922|P2|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
7510776|NCT03073200|26068923|P1|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7510777|NCT03073200|26068909|P15|Double Blind Treatment Period|Protocol Violation|0
7510778|NCT03073200|26068910|P14|Double Blind Treatment Period|Protocol Violation|0
7510779|NCT03073200|26068911|P13|Double Blind Treatment Period|Protocol Violation|0
7510780|NCT03073200|26068912|P12|Double Blind Treatment Period|Protocol Violation|0
7510781|NCT03073200|26068913|P11|Double Blind Treatment Period|Protocol Violation|0
7510782|NCT03073200|26068914|P10|Double Blind Treatment Period|Protocol Violation|0
7510783|NCT03073200|26068915|P9|Double Blind Treatment Period|Protocol Violation|0
7510784|NCT03073200|26068916|P8|Double Blind Treatment Period|Protocol Violation|0
7510785|NCT03073200|26068917|P7|Double Blind Treatment Period|Protocol Violation|0
7510786|NCT03073200|26068918|P6|Double Blind Treatment Period|Protocol Violation|0
7510787|NCT03073200|26068919|P5|Double Blind Treatment Period|Protocol Violation|0
7510788|NCT03073200|26068920|P4|Double Blind Treatment Period|Protocol Violation|0
7510789|NCT03073200|26068921|P3|Double Blind Treatment Period|Protocol Violation|0
7510790|NCT03073200|26068922|P2|Double Blind Treatment Period|Protocol Violation|0
7510791|NCT03073200|26068923|P1|Double Blind Treatment Period|Protocol Violation|1
7510792|NCT03073109|26068998|P2|Overall Study|Lost to Follow-up|1
7510793|NCT03073109|26068999|P1|Overall Study|Lost to Follow-up|8
7510794|NCT03073109|26068998|P2|Overall Study|Other|0
7510795|NCT03073109|26068999|P1|Overall Study|Other|2
7510796|NCT03073109|26068998|P2|Overall Study|Adverse Event|1
7510797|NCT03073109|26068999|P1|Overall Study|Adverse Event|0
7510798|NCT03073005|26069031|P4|Overall Study|Withdrawal by Subject|4
7510799|NCT03073005|26069032|P3|Overall Study|Withdrawal by Subject|4
7510800|NCT03073005|26069033|P2|Overall Study|Withdrawal by Subject|4
7510801|NCT03073005|26069034|P1|Overall Study|Withdrawal by Subject|0
7510802|NCT03073005|26069031|P4|Overall Study|Lost to Follow-up|2
7510803|NCT03073005|26069032|P3|Overall Study|Lost to Follow-up|1
7510804|NCT03073005|26069033|P2|Overall Study|Lost to Follow-up|2
7510805|NCT03073005|26069034|P1|Overall Study|Lost to Follow-up|2
7510806|NCT03073005|26069031|P4|Overall Study|caregiver withdrew bc of pt death|7
7510807|NCT03073005|26069032|P3|Overall Study|caregiver withdrew bc of pt death|0
7510808|NCT03073005|26069033|P2|Overall Study|caregiver withdrew bc of pt death|6
7510809|NCT03073005|26069034|P1|Overall Study|caregiver withdrew bc of pt death|0
7510810|NCT03073005|26069031|P4|Overall Study|Death|0
7510811|NCT03073005|26069032|P3|Overall Study|Death|7
7510812|NCT03073005|26069033|P2|Overall Study|Death|0
7510813|NCT03073005|26069034|P1|Overall Study|Death|6
7510814|NCT03072875|26069062|P1|Overall Study|Lost to Follow-up|1
7510815|NCT03072719|26069078|P2|Overall Study|Adverse Event|1
7510816|NCT03072719|26069079|P1|Overall Study|Adverse Event|1
7510817|NCT03072160|26069115|P2|Overall Study|No contact|1
7510818|NCT03072160|26069116|P1|Overall Study|No contact|0
7510819|NCT03072160|26069115|P2|Overall Study|Disease progression on study|1
7510820|NCT03072160|26069116|P1|Overall Study|Disease progression on study|1
7510821|NCT03072160|26069115|P2|Overall Study|Physician Decision|0
7510822|NCT03072160|26069116|P1|Overall Study|Physician Decision|1
7510823|NCT03072160|26069115|P2|Overall Study|Refused further treatment|1
7510824|NCT03072160|26069116|P1|Overall Study|Refused further treatment|6
7510825|NCT03072160|26069115|P2|Overall Study|Adverse Event|1
7510826|NCT03072160|26069116|P1|Overall Study|Adverse Event|3
7510827|NCT03072043|26069169|P3|Overall Study|Withdrawal by Subject|4
7510828|NCT03072043|26069170|P2|Overall Study|Withdrawal by Subject|0
7510829|NCT03072043|26069171|P1|Overall Study|Withdrawal by Subject|0
7510830|NCT03072043|26069169|P3|Overall Study|Adverse Event|2
7510831|NCT03072043|26069170|P2|Overall Study|Adverse Event|0
7510832|NCT03072043|26069171|P1|Overall Study|Adverse Event|0
7510833|NCT03072043|26069169|P3|Overall Study|Death|3
7510834|NCT03072043|26069170|P2|Overall Study|Death|0
7510835|NCT03072043|26069171|P1|Overall Study|Death|0
7510836|NCT03071276|26069194|P1|Overall Study|Lack of Efficacy|14
7510837|NCT03071276|26069194|P1|Overall Study|Adverse Event|1
7510838|NCT03071263|26069202|P2|Overall Study|Participant moved to another city|1
7510839|NCT03071263|26069203|P1|Overall Study|Participant moved to another city|0
7510840|NCT03071263|26069202|P2|Overall Study|Physician Decision|0
7510841|NCT03071263|26069203|P1|Overall Study|Physician Decision|1
7510842|NCT03071263|26069202|P2|Overall Study|Withdrawal by Subject|3
7510843|NCT03071263|26069203|P1|Overall Study|Withdrawal by Subject|1
7510844|NCT03071263|26069202|P2|Overall Study|Adverse Event|3
7510845|NCT03071263|26069203|P1|Overall Study|Adverse Event|1
7510846|NCT03070964|26069227|P1|Overall Study|Adverse Event|1
7510847|NCT03070964|26069227|P1|Overall Study|Withdrawal by Subject|1
7510848|NCT03070964|26069227|P1|Overall Study|Physician Decision|1
7510849|NCT03070964|26069227|P1|Overall Study|Never treated|1
7510850|NCT03070964|26069227|P1|Overall Study|Treatment-unrelated adverse event|2
7510851|NCT03070964|26069227|P1|Overall Study|Progressive disease|8
7510852|NCT03070782|26069238|P6|Overall Study|Investigator Judgement|0
7510853|NCT03070782|26069239|P5|Overall Study|Investigator Judgement|0
7510854|NCT03070782|26069240|P4|Overall Study|Investigator Judgement|1
7510855|NCT03070782|26069241|P3|Overall Study|Investigator Judgement|0
7510856|NCT03070782|26069242|P2|Overall Study|Investigator Judgement|0
7510857|NCT03070782|26069243|P1|Overall Study|Investigator Judgement|0
7510858|NCT03070782|26069238|P6|Overall Study|Pregnancy|0
7510859|NCT03070782|26069239|P5|Overall Study|Pregnancy|0
7510860|NCT03070782|26069240|P4|Overall Study|Pregnancy|1
7510861|NCT03070782|26069241|P3|Overall Study|Pregnancy|0
7510862|NCT03070782|26069242|P2|Overall Study|Pregnancy|0
7510863|NCT03070782|26069243|P1|Overall Study|Pregnancy|0
7510864|NCT03070782|26069238|P6|Overall Study|Ineligibility|1
7510865|NCT03070782|26069239|P5|Overall Study|Ineligibility|0
7510866|NCT03070782|26069240|P4|Overall Study|Ineligibility|1
7510867|NCT03070782|26069241|P3|Overall Study|Ineligibility|0
7510868|NCT03070782|26069242|P2|Overall Study|Ineligibility|0
7510869|NCT03070782|26069243|P1|Overall Study|Ineligibility|0
7510870|NCT03070782|26069238|P6|Overall Study|Reason Not Specified|1
7510871|NCT03070782|26069239|P5|Overall Study|Reason Not Specified|2
7510872|NCT03070782|26069240|P4|Overall Study|Reason Not Specified|1
7510873|NCT03070782|26069241|P3|Overall Study|Reason Not Specified|0
7510874|NCT03070782|26069242|P2|Overall Study|Reason Not Specified|0
7510875|NCT03070782|26069243|P1|Overall Study|Reason Not Specified|2
7510876|NCT03070782|26069238|P6|Overall Study|Withdrawal by Subject|3
7510877|NCT03070782|26069239|P5|Overall Study|Withdrawal by Subject|4
7510878|NCT03070782|26069240|P4|Overall Study|Withdrawal by Subject|0
7510879|NCT03070782|26069241|P3|Overall Study|Withdrawal by Subject|1
7510880|NCT03070782|26069242|P2|Overall Study|Withdrawal by Subject|1
7510881|NCT03070782|26069243|P1|Overall Study|Withdrawal by Subject|2
7510882|NCT03070782|26069238|P6|Overall Study|Adverse Event|2
7510883|NCT03070782|26069239|P5|Overall Study|Adverse Event|6
7510884|NCT03070782|26069240|P4|Overall Study|Adverse Event|1
7510885|NCT03070782|26069241|P3|Overall Study|Adverse Event|3
7510886|NCT03070782|26069242|P2|Overall Study|Adverse Event|0
7510887|NCT03070782|26069243|P1|Overall Study|Adverse Event|3
7510888|NCT03070483|26069483|P1|Overall Study|Lost to Follow-up|2
7510889|NCT03070431|26069530|P1|Overall Study|Lost to Follow-up|2
7510890|NCT03070431|26069530|P1|Overall Study|Withdrawal by Subject|2
7510891|NCT03070392|26069545|P4|Overall Study|Ongoing|11
7510892|NCT03070392|26069546|P3|Overall Study|Ongoing|0
7510893|NCT03070392|26069547|P2|Overall Study|Ongoing|0
7510894|NCT03070392|26069548|P1|Overall Study|Ongoing|73
7510895|NCT03070392|26069545|P4|Overall Study|Alternate anticancer treatment|1
7510896|NCT03070392|26069546|P3|Overall Study|Alternate anticancer treatment|0
7510897|NCT03070392|26069547|P2|Overall Study|Alternate anticancer treatment|0
7510898|NCT03070392|26069548|P1|Overall Study|Alternate anticancer treatment|1
7510899|NCT03070392|26069545|P4|Overall Study|Adverse Event|3
7510900|NCT03070392|26069546|P3|Overall Study|Adverse Event|1
7510901|NCT03070392|26069547|P2|Overall Study|Adverse Event|1
7510902|NCT03070392|26069548|P1|Overall Study|Adverse Event|6
7510903|NCT03070392|26069545|P4|Overall Study|Progressive Disease|70
7510904|NCT03070392|26069546|P3|Overall Study|Progressive Disease|2
7510905|NCT03070392|26069547|P2|Overall Study|Progressive Disease|6
7510906|NCT03070392|26069548|P1|Overall Study|Progressive Disease|154
7510907|NCT03070392|26069545|P4|Overall Study|Physician Decision|2
7510908|NCT03070392|26069546|P3|Overall Study|Physician Decision|0
7510909|NCT03070392|26069547|P2|Overall Study|Physician Decision|0
7510910|NCT03070392|26069548|P1|Overall Study|Physician Decision|1
7510911|NCT03070392|26069545|P4|Overall Study|Withdrawal by Subject|3
7510912|NCT03070392|26069546|P3|Overall Study|Withdrawal by Subject|0
7510913|NCT03070392|26069547|P2|Overall Study|Withdrawal by Subject|0
7510914|NCT03070392|26069548|P1|Overall Study|Withdrawal by Subject|7
7510915|NCT03070392|26069545|P4|Overall Study|Death|1
7510916|NCT03070392|26069546|P3|Overall Study|Death|0
7510917|NCT03070392|26069547|P2|Overall Study|Death|0
7510918|NCT03070392|26069548|P1|Overall Study|Death|3
7510919|NCT03070392|26069545|P4|Overall Study|Not Treated|12
7510920|NCT03070392|26069546|P3|Overall Study|Not Treated|3
7510921|NCT03070392|26069547|P2|Overall Study|Not Treated|0
7510922|NCT03070392|26069548|P1|Overall Study|Not Treated|7
7510923|NCT03070171|26069574|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
7510924|NCT03070171|26069575|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
7510925|NCT03070171|26069574|P2|Treatment Period 2 + Washout|Other Adverse Event|1
7510926|NCT03070171|26069575|P1|Treatment Period 2 + Washout|Other Adverse Event|0
7510927|NCT03070002|26069591|P1|Follow up for 2 Years|Death|1
7510928|NCT03069989|26069599|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
7510929|NCT03069989|26069600|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
7510930|NCT03069716|26069688|P3|Randomized Treatment|Withdrawal by Subject|0
7510931|NCT03069716|26069689|P2|Randomized Treatment|Withdrawal by Subject|2
7510932|NCT03069716|26069690|P1|Randomized Treatment|Withdrawal by Subject|0
7510933|NCT03069716|26069688|P3|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7510934|NCT03069716|26069689|P2|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7510935|NCT03069716|26069690|P1|Run-in Period (2 Weeks)|Withdrawal by Subject|5
7510936|NCT03069716|26069688|P3|Run-in Period (2 Weeks)|Protocol Violation|0
7510937|NCT03069716|26069689|P2|Run-in Period (2 Weeks)|Protocol Violation|0
7510938|NCT03069716|26069690|P1|Run-in Period (2 Weeks)|Protocol Violation|1
7510939|NCT03069716|26069688|P3|Run-in Period (2 Weeks)|Adverse Event|0
7510940|NCT03069716|26069689|P2|Run-in Period (2 Weeks)|Adverse Event|0
7510941|NCT03069716|26069690|P1|Run-in Period (2 Weeks)|Adverse Event|1
7510942|NCT03069482|26069745|P2|Overall Study|Physician Decision|0
7510943|NCT03069482|26069746|P1|Overall Study|Physician Decision|1
7510944|NCT03069482|26069745|P2|Overall Study|Lost to Follow-up|1
7510945|NCT03069482|26069746|P1|Overall Study|Lost to Follow-up|0
7510946|NCT03069365|26069856|P1|Overall Study|Adverse Event|1
7510947|NCT03069352|26069864|P2|Overall Study|Ongoing|40
7510948|NCT03069352|26069865|P1|Overall Study|Ongoing|12
7510949|NCT03069313|26069907|P1|Overall Study|Adverse Event|5
7510950|NCT03068767|26069945|P2|Overall Study|Protocol Violation|0
7510951|NCT03068767|26069946|P1|Overall Study|Protocol Violation|3
7510952|NCT03068767|26069945|P2|Overall Study|Lost to Follow-up|3
7510953|NCT03068767|26069946|P1|Overall Study|Lost to Follow-up|7
7510954|NCT03068754|26069956|P4|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
7510955|NCT03068754|26069957|P3|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
7510956|NCT03068754|26069958|P2|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7510957|NCT03068754|26069959|P1|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7510958|NCT03068754|26069956|P4|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7510959|NCT03068754|26069957|P3|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
7510960|NCT03068754|26069958|P2|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7510961|NCT03068754|26069959|P1|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7510962|NCT03068754|26069956|P4|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7510963|NCT03068754|26069957|P3|Open Label Extension Period (OLE)|Withdrawal by Subject|5
7510964|NCT03068754|26069958|P2|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7510965|NCT03068754|26069959|P1|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7510966|NCT03068754|26069956|P4|Open Label Extension Period (OLE)|Disease progression|1
7510967|NCT03068754|26069957|P3|Open Label Extension Period (OLE)|Disease progression|3
7510968|NCT03068754|26069958|P2|Open Label Extension Period (OLE)|Disease progression|0
7510969|NCT03068754|26069959|P1|Open Label Extension Period (OLE)|Disease progression|0
7510970|NCT03068754|26069956|P4|Open Label Extension Period (OLE)|Death|1
7510971|NCT03068754|26069957|P3|Open Label Extension Period (OLE)|Death|0
7510972|NCT03068754|26069958|P2|Open Label Extension Period (OLE)|Death|0
7510973|NCT03068754|26069959|P1|Open Label Extension Period (OLE)|Death|0
7510974|NCT03068754|26069956|P4|Open Label Extension Period (OLE)|Adverse Event|1
7510975|NCT03068754|26069957|P3|Open Label Extension Period (OLE)|Adverse Event|0
7510976|NCT03068754|26069958|P2|Open Label Extension Period (OLE)|Adverse Event|0
7510977|NCT03068754|26069959|P1|Open Label Extension Period (OLE)|Adverse Event|0
7510978|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7510979|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7510980|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
7510981|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
7510982|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7510983|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7510984|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
7510985|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7510986|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7510987|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7510988|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7510989|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Discontinued by Physician|1
7510990|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7510991|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7510992|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
7510993|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
7510994|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7510995|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7510996|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7510997|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Lost to Follow-up|1
7510998|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Disease progression|0
7510999|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Disease progression|0
7511000|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Disease progression|2
7511001|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Disease progression|1
7511002|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Death|0
7511003|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Death|0
7511004|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Death|2
7511005|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Death|2
7511006|NCT03068754|26069956|P4|Randomized Treatment Period (RTP)|Adverse Event|0
7511007|NCT03068754|26069957|P3|Randomized Treatment Period (RTP)|Adverse Event|0
7511008|NCT03068754|26069958|P2|Randomized Treatment Period (RTP)|Adverse Event|3
7511009|NCT03068754|26069959|P1|Randomized Treatment Period (RTP)|Adverse Event|1
7511010|NCT03068715|26069979|P2|Overall Study|No longer met inclusion criteria|0
7511011|NCT03068715|26069980|P1|Overall Study|No longer met inclusion criteria|1
7511012|NCT03068468|26070019|P4|Open-Label Extension Period|Reason not Specified|4
7511013|NCT03068468|26070020|P3|Open-Label Extension Period|Reason not Specified|1
7511014|NCT03068468|26070021|P2|Open-Label Extension Period|Reason not Specified|0
7511015|NCT03068468|26070022|P1|Open-Label Extension Period|Reason not Specified|0
7511016|NCT03068468|26070019|P4|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
7511017|NCT03068468|26070020|P3|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7511018|NCT03068468|26070021|P2|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7511019|NCT03068468|26070022|P1|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7511020|NCT03068468|26070019|P4|Open-Label Extension Period|Withdrawal by Sponsor|228
7511021|NCT03068468|26070020|P3|Open-Label Extension Period|Withdrawal by Sponsor|115
7511022|NCT03068468|26070021|P2|Open-Label Extension Period|Withdrawal by Sponsor|0
7511023|NCT03068468|26070022|P1|Open-Label Extension Period|Withdrawal by Sponsor|0
7511024|NCT03068468|26070019|P4|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7511025|NCT03068468|26070020|P3|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
7511026|NCT03068468|26070021|P2|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7511027|NCT03068468|26070022|P1|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7511028|NCT03068468|26070019|P4|Open-Label Extension Period|Lost to Follow-up|0
7511029|NCT03068468|26070020|P3|Open-Label Extension Period|Lost to Follow-up|1
7511030|NCT03068468|26070021|P2|Open-Label Extension Period|Lost to Follow-up|0
7511031|NCT03068468|26070022|P1|Open-Label Extension Period|Lost to Follow-up|0
7511032|NCT03068468|26070019|P4|Open-Label Extension Period|Death|1
7511033|NCT03068468|26070020|P3|Open-Label Extension Period|Death|0
7511034|NCT03068468|26070021|P2|Open-Label Extension Period|Death|0
7511035|NCT03068468|26070022|P1|Open-Label Extension Period|Death|0
7511036|NCT03068468|26070019|P4|Open-Label Extension Period|Withdrawal by Subject|20
7511037|NCT03068468|26070020|P3|Open-Label Extension Period|Withdrawal by Subject|7
7511038|NCT03068468|26070021|P2|Open-Label Extension Period|Withdrawal by Subject|0
7511039|NCT03068468|26070022|P1|Open-Label Extension Period|Withdrawal by Subject|0
7511040|NCT03068468|26070019|P4|Open-Label Extension Period|Adverse Event|17
7511041|NCT03068468|26070020|P3|Open-Label Extension Period|Adverse Event|13
7511042|NCT03068468|26070021|P2|Open-Label Extension Period|Adverse Event|0
7511043|NCT03068468|26070022|P1|Open-Label Extension Period|Adverse Event|0
7511044|NCT03068468|26070019|P4|Open-Label Extension Period|Lack of Efficacy|2
7511045|NCT03068468|26070020|P3|Open-Label Extension Period|Lack of Efficacy|1
7511046|NCT03068468|26070021|P2|Open-Label Extension Period|Lack of Efficacy|0
7511047|NCT03068468|26070022|P1|Open-Label Extension Period|Lack of Efficacy|0
7511048|NCT03068468|26070019|P4|Placebo-Controlled Period|Death|0
7511049|NCT03068468|26070020|P3|Placebo-Controlled Period|Death|0
7511050|NCT03068468|26070021|P2|Placebo-Controlled Period|Death|1
7511051|NCT03068468|26070022|P1|Placebo-Controlled Period|Death|0
7511052|NCT03068468|26070019|P4|Placebo-Controlled Period|Reason Not Specified|0
7511053|NCT03068468|26070020|P3|Placebo-Controlled Period|Reason Not Specified|0
7511054|NCT03068468|26070021|P2|Placebo-Controlled Period|Reason Not Specified|6
7511055|NCT03068468|26070022|P1|Placebo-Controlled Period|Reason Not Specified|1
7511056|NCT03068468|26070019|P4|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7511057|NCT03068468|26070020|P3|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7511058|NCT03068468|26070021|P2|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
7511059|NCT03068468|26070022|P1|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7511060|NCT03068468|26070019|P4|Placebo-Controlled Period|Withdrawal by Subject|0
7511061|NCT03068468|26070020|P3|Placebo-Controlled Period|Withdrawal by Subject|0
7511062|NCT03068468|26070021|P2|Placebo-Controlled Period|Withdrawal by Subject|11
7511063|NCT03068468|26070022|P1|Placebo-Controlled Period|Withdrawal by Subject|3
7511064|NCT03068468|26070019|P4|Placebo-Controlled Period|Adverse Event|0
7511065|NCT03068468|26070020|P3|Placebo-Controlled Period|Adverse Event|0
7511066|NCT03068468|26070021|P2|Placebo-Controlled Period|Adverse Event|21
7511067|NCT03068468|26070022|P1|Placebo-Controlled Period|Adverse Event|16
7511068|NCT03068468|26070019|P4|Placebo-Controlled Period|Lack of Efficacy|0
7511069|NCT03068468|26070020|P3|Placebo-Controlled Period|Lack of Efficacy|0
7511070|NCT03068468|26070021|P2|Placebo-Controlled Period|Lack of Efficacy|1
7511071|NCT03068468|26070022|P1|Placebo-Controlled Period|Lack of Efficacy|0
7511072|NCT03068468|26070019|P4|Placebo-Controlled Period|Randomized but not Treated|0
7511073|NCT03068468|26070020|P3|Placebo-Controlled Period|Randomized but not Treated|0
7511074|NCT03068468|26070021|P2|Placebo-Controlled Period|Randomized but not Treated|3
7511075|NCT03068468|26070022|P1|Placebo-Controlled Period|Randomized but not Treated|1
7511076|NCT03068455|26070060|P2|Treatment Period|Other reasons|4
7511077|NCT03068455|26070061|P1|Treatment Period|Other reasons|12
7511078|NCT03068455|26070060|P2|Treatment Period|Participant no longer meets study criteria|3
7511079|NCT03068455|26070061|P1|Treatment Period|Participant no longer meets study criteria|1
7511080|NCT03068455|26070060|P2|Treatment Period|Poor/non-compliance|0
7511081|NCT03068455|26070061|P1|Treatment Period|Poor/non-compliance|3
7511082|NCT03068455|26070060|P2|Treatment Period|Participant withdrew consent|10
7511083|NCT03068455|26070061|P1|Treatment Period|Participant withdrew consent|5
7511084|NCT03068455|26070060|P2|Treatment Period|Participant request to stop therapy|20
7511085|NCT03068455|26070061|P1|Treatment Period|Participant request to stop therapy|33
7511086|NCT03068455|26070060|P2|Treatment Period|Adverse Event unrelated to study drug|7
7511087|NCT03068455|26070061|P1|Treatment Period|Adverse Event unrelated to study drug|15
7511088|NCT03068455|26070060|P2|Treatment Period|Study drug toxicity|104
7511089|NCT03068455|26070061|P1|Treatment Period|Study drug toxicity|317
7511090|NCT03068455|26070060|P2|Treatment Period|Disease progression|208
7511091|NCT03068455|26070061|P1|Treatment Period|Disease progression|166
7511092|NCT03068455|26070060|P2|Pre-treatment Period|Not reported|1
7511093|NCT03068455|26070061|P1|Pre-treatment Period|Not reported|2
7511094|NCT03068455|26070060|P2|Pre-treatment Period|Participant no longer meets study criteria|3
7511095|NCT03068455|26070061|P1|Pre-treatment Period|Participant no longer meets study criteria|1
7511096|NCT03068455|26070060|P2|Pre-treatment Period|Poor/non-compliance|1
7511097|NCT03068455|26070061|P1|Pre-treatment Period|Poor/non-compliance|0
7511098|NCT03068455|26070060|P2|Pre-treatment Period|Participant withdrew consent|1
7511099|NCT03068455|26070061|P1|Pre-treatment Period|Participant withdrew consent|1
7511100|NCT03068455|26070060|P2|Pre-treatment Period|Disease progression|1
7511101|NCT03068455|26070061|P1|Pre-treatment Period|Disease progression|0
7511102|NCT03067987|26070103|P2|Overall Study|Withdrawal by Subject|1
7511103|NCT03067987|26070104|P1|Overall Study|Withdrawal by Subject|2
7511104|NCT03067987|26070103|P2|Overall Study|Protocol Violation|2
7511105|NCT03067987|26070104|P1|Overall Study|Protocol Violation|1
7511106|NCT03067987|26070103|P2|Overall Study|Lost to Follow-up|10
7511107|NCT03067987|26070104|P1|Overall Study|Lost to Follow-up|7
7511108|NCT03067441|26070130|P2|Overall Study|Other|1
7511109|NCT03067441|26070131|P1|Overall Study|Other|1
7511110|NCT03067441|26070130|P2|Overall Study|Physician Decision|3
7511111|NCT03067441|26070131|P1|Overall Study|Physician Decision|1
7511112|NCT03067441|26070130|P2|Overall Study|Study Terminated by Sponsor or Investigator|0
7511113|NCT03067441|26070131|P1|Overall Study|Study Terminated by Sponsor or Investigator|1
7511114|NCT03067441|26070130|P2|Overall Study|Adverse Event|14
7511115|NCT03067441|26070131|P1|Overall Study|Adverse Event|7
7511116|NCT03067441|26070130|P2|Overall Study|Lost to Follow-up|5
7511117|NCT03067441|26070131|P1|Overall Study|Lost to Follow-up|7
7511118|NCT03067441|26070130|P2|Overall Study|Withdrawal by Subject|34
7511119|NCT03067441|26070131|P1|Overall Study|Withdrawal by Subject|16
7511120|NCT03067311|26070189|P2|Overall Study|Moved away|1
7511121|NCT03067311|26070190|P1|Overall Study|Moved away|1
7511122|NCT03067311|26070189|P2|Overall Study|Lost to Follow-up|1
7511123|NCT03067311|26070190|P1|Overall Study|Lost to Follow-up|1
7511124|NCT03067129|26070222|P4|Overall Study|Partially dosed; refused to swallow entire dose|1
7511125|NCT03067129|26070223|P3|Overall Study|Partially dosed; refused to swallow entire dose|0
7511126|NCT03067129|26070224|P2|Overall Study|Partially dosed; refused to swallow entire dose|0
7511127|NCT03067129|26070225|P1|Overall Study|Partially dosed; refused to swallow entire dose|0
7511128|NCT03067129|26070222|P4|Overall Study|Ongoing|23
7511129|NCT03067129|26070223|P3|Overall Study|Ongoing|27
7511130|NCT03067129|26070224|P2|Overall Study|Ongoing|28
7511131|NCT03067129|26070225|P1|Overall Study|Ongoing|45
7511132|NCT03066999|26070307|P2|Overall Study|abnormal urethraBladder neck contracture|2
7511133|NCT03066999|26070308|P1|Overall Study|abnormal urethraBladder neck contracture|0
7511134|NCT03066830|26070337|P2|Overall Study|Lost to Follow-up|3
7511135|NCT03066830|26070338|P1|Overall Study|Lost to Follow-up|11
7511136|NCT03066830|26070337|P2|Overall Study|Adverse Event|2
7511137|NCT03066830|26070338|P1|Overall Study|Adverse Event|2
7511138|NCT03066830|26070337|P2|Overall Study|Poor Compliance to Protocol|0
7511139|NCT03066830|26070338|P1|Overall Study|Poor Compliance to Protocol|1
7511140|NCT03066830|26070337|P2|Overall Study|Other|0
7511141|NCT03066830|26070338|P1|Overall Study|Other|3
7511142|NCT03066830|26070337|P2|Overall Study|At the Participant's own Request|17
7511143|NCT03066830|26070338|P1|Overall Study|At the Participant's own Request|16
7511144|NCT03066804|26070360|P2|Overall Study|Technical problems|1
7511145|NCT03066804|26070361|P1|Overall Study|Technical problems|5
7511146|NCT03066804|26070360|P2|Overall Study|Adverse Event|3
7511147|NCT03066804|26070361|P1|Overall Study|Adverse Event|2
7511148|NCT03066804|26070360|P2|Overall Study|Lost to Follow-up|0
7511149|NCT03066804|26070361|P1|Overall Study|Lost to Follow-up|2
7511150|NCT03066804|26070360|P2|Overall Study|Withdrawal by Subject|25
7511151|NCT03066804|26070361|P1|Overall Study|Withdrawal by Subject|19
7511152|NCT03066804|26070360|P2|Overall Study|Death|17
7511153|NCT03066804|26070361|P1|Overall Study|Death|23
7511154|NCT03066804|26070360|P2|Overall Study|Physician Decision|4
7511155|NCT03066804|26070361|P1|Overall Study|Physician Decision|0
7511162|NCT03066622|26070411|P2|Overall Study|Withdrawal by Subject|1
7511163|NCT03066622|26070412|P1|Overall Study|Withdrawal by Subject|2
7511164|NCT03066622|26070411|P2|Overall Study|Lost to Follow-up|25
7511165|NCT03066622|26070412|P1|Overall Study|Lost to Follow-up|24
7511166|NCT03066609|26070425|P4|OVERALL STUDY|discontinued follow up|0
7511167|NCT03066609|26070426|P3|OVERALL STUDY|discontinued follow up|0
7511168|NCT03066609|26070427|P2|OVERALL STUDY|discontinued follow up|2
7511169|NCT03066609|26070428|P1|OVERALL STUDY|discontinued follow up|0
7511170|NCT03066609|26070425|P4|OVERALL STUDY|Lack of Efficacy|1
7511171|NCT03066609|26070426|P3|OVERALL STUDY|Lack of Efficacy|1
7511172|NCT03066609|26070427|P2|OVERALL STUDY|Lack of Efficacy|1
7511173|NCT03066609|26070428|P1|OVERALL STUDY|Lack of Efficacy|2
7511174|NCT03066609|26070425|P4|OVERALL STUDY|Pregnancy|0
7511175|NCT03066609|26070426|P3|OVERALL STUDY|Pregnancy|1
7511176|NCT03066609|26070427|P2|OVERALL STUDY|Pregnancy|0
7511177|NCT03066609|26070428|P1|OVERALL STUDY|Pregnancy|1
7511178|NCT03066609|26070425|P4|OVERALL STUDY|Lost to Follow-up|1
7511179|NCT03066609|26070426|P3|OVERALL STUDY|Lost to Follow-up|1
7511180|NCT03066609|26070427|P2|OVERALL STUDY|Lost to Follow-up|1
7511181|NCT03066609|26070428|P1|OVERALL STUDY|Lost to Follow-up|1
7511182|NCT03066609|26070425|P4|OVERALL STUDY|Withdrawal by Subject|2
7511183|NCT03066609|26070426|P3|OVERALL STUDY|Withdrawal by Subject|1
7511184|NCT03066609|26070427|P2|OVERALL STUDY|Withdrawal by Subject|2
7511185|NCT03066609|26070428|P1|OVERALL STUDY|Withdrawal by Subject|4
7511186|NCT03066609|26070425|P4|OVERALL STUDY|Adverse Event|1
7511187|NCT03066609|26070426|P3|OVERALL STUDY|Adverse Event|0
7511188|NCT03066609|26070427|P2|OVERALL STUDY|Adverse Event|2
7511189|NCT03066609|26070428|P1|OVERALL STUDY|Adverse Event|2
7511190|NCT03066609|26070425|P4|MAINTENANCE|Lack of Efficacy|1
7511191|NCT03066609|26070426|P3|MAINTENANCE|Lack of Efficacy|0
7511192|NCT03066609|26070427|P2|MAINTENANCE|Lack of Efficacy|1
7511193|NCT03066609|26070428|P1|MAINTENANCE|Lack of Efficacy|2
7511194|NCT03066609|26070425|P4|MAINTENANCE|Pregnancy|0
7511195|NCT03066609|26070426|P3|MAINTENANCE|Pregnancy|0
7511196|NCT03066609|26070427|P2|MAINTENANCE|Pregnancy|0
7511197|NCT03066609|26070428|P1|MAINTENANCE|Pregnancy|1
7511198|NCT03066609|26070425|P4|MAINTENANCE|Lost to Follow-up|0
7511199|NCT03066609|26070426|P3|MAINTENANCE|Lost to Follow-up|1
7511200|NCT03066609|26070427|P2|MAINTENANCE|Lost to Follow-up|1
7511201|NCT03066609|26070428|P1|MAINTENANCE|Lost to Follow-up|0
7511202|NCT03066609|26070425|P4|MAINTENANCE|Withdrawal by Subject|1
7511203|NCT03066609|26070426|P3|MAINTENANCE|Withdrawal by Subject|1
7511204|NCT03066609|26070427|P2|MAINTENANCE|Withdrawal by Subject|2
7511205|NCT03066609|26070428|P1|MAINTENANCE|Withdrawal by Subject|4
7511206|NCT03066609|26070425|P4|MAINTENANCE|Adverse Event|1
7511207|NCT03066609|26070426|P3|MAINTENANCE|Adverse Event|0
7511208|NCT03066609|26070427|P2|MAINTENANCE|Adverse Event|0
7511209|NCT03066609|26070428|P1|MAINTENANCE|Adverse Event|0
7511210|NCT03066609|26070425|P4|INDUCTION|Adverse Event|0
7511211|NCT03066609|26070426|P3|INDUCTION|Adverse Event|0
7511212|NCT03066609|26070427|P2|INDUCTION|Adverse Event|2
7511213|NCT03066609|26070428|P1|INDUCTION|Adverse Event|2
7511214|NCT03066609|26070425|P4|INDUCTION|Lack of Efficacy|0
7511215|NCT03066609|26070426|P3|INDUCTION|Lack of Efficacy|1
7511216|NCT03066609|26070427|P2|INDUCTION|Lack of Efficacy|0
7511217|NCT03066609|26070428|P1|INDUCTION|Lack of Efficacy|0
7511218|NCT03066609|26070425|P4|INDUCTION|Pregnancy|0
7511219|NCT03066609|26070426|P3|INDUCTION|Pregnancy|1
7511220|NCT03066609|26070427|P2|INDUCTION|Pregnancy|0
7511221|NCT03066609|26070428|P1|INDUCTION|Pregnancy|0
7511222|NCT03066193|26070458|P1|Overall Study|Withdrawal by Subject|1
7511223|NCT03065933|26070471|P1|Overall Study|study terminated|5
7511224|NCT03065530|26070490|P4|Overall Study|Protocol Violation|1
7511225|NCT03065530|26070491|P3|Overall Study|Protocol Violation|1
7511226|NCT03065530|26070492|P2|Overall Study|Protocol Violation|0
7511227|NCT03065530|26070493|P1|Overall Study|Protocol Violation|1
7511228|NCT03065530|26070490|P4|Overall Study|Lack of Efficacy|1
7511229|NCT03065530|26070491|P3|Overall Study|Lack of Efficacy|0
7511230|NCT03065530|26070492|P2|Overall Study|Lack of Efficacy|1
7511231|NCT03065530|26070493|P1|Overall Study|Lack of Efficacy|1
7511232|NCT03065400|26070570|P1|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
7511233|NCT03065400|26070570|P1|Overall Study|Withdrawal by Subject|1
7511234|NCT03065400|26070570|P1|Overall Study|Physician Decision|3
7511235|NCT03065400|26070570|P1|Overall Study|Adverse Event|1
7511236|NCT03065023|26070612|P5|Overall Study|Withdrawal by Subject|0
7511237|NCT03065023|26070613|P4|Overall Study|Withdrawal by Subject|1
7511238|NCT03065023|26070614|P3|Overall Study|Withdrawal by Subject|0
7511239|NCT03065023|26070615|P2|Overall Study|Withdrawal by Subject|0
7511240|NCT03065023|26070616|P1|Overall Study|Withdrawal by Subject|0
7511241|NCT03065023|26070612|P5|Overall Study|Participant Decision|0
7511242|NCT03065023|26070613|P4|Overall Study|Participant Decision|1
7511243|NCT03065023|26070614|P3|Overall Study|Participant Decision|0
7511244|NCT03065023|26070615|P2|Overall Study|Participant Decision|0
7511245|NCT03065023|26070616|P1|Overall Study|Participant Decision|0
7511246|NCT03065023|26070612|P5|Overall Study|Lost to Follow-up|0
7511247|NCT03065023|26070613|P4|Overall Study|Lost to Follow-up|0
7511248|NCT03065023|26070614|P3|Overall Study|Lost to Follow-up|0
7511249|NCT03065023|26070615|P2|Overall Study|Lost to Follow-up|1
7511250|NCT03065023|26070616|P1|Overall Study|Lost to Follow-up|0
7511251|NCT03065023|26070612|P5|Overall Study|Death|0
7511252|NCT03065023|26070613|P4|Overall Study|Death|1
7511253|NCT03065023|26070614|P3|Overall Study|Death|1
7511254|NCT03065023|26070615|P2|Overall Study|Death|0
7511255|NCT03065023|26070616|P1|Overall Study|Death|2
7511256|NCT03065023|26070612|P5|Overall Study|Progressive Disease|0
7511257|NCT03065023|26070613|P4|Overall Study|Progressive Disease|0
7511258|NCT03065023|26070614|P3|Overall Study|Progressive Disease|0
7511259|NCT03065023|26070615|P2|Overall Study|Progressive Disease|1
7511260|NCT03065023|26070616|P1|Overall Study|Progressive Disease|0
7511261|NCT03064841|26070682|P1|Overall Study|Screen failure|2
7511262|NCT03064841|26070682|P1|Overall Study|No glycated haemoglobinA1c measurement|11
7511263|NCT03064841|26070682|P1|Overall Study|Inclusion/exclusion criteria violation|4
7511264|NCT03064763|26070697|P1|Overall Study|Death|8
7511265|NCT03064763|26070697|P1|Overall Study|Ongoing in study|10
7511266|NCT03064451|26070702|P1|Overall Study|Withdrew consent: 3-month FU visit|1
7511267|NCT03064451|26070702|P1|Overall Study|Exited prior to procedure|8
7511268|NCT03064451|26070702|P1|Overall Study|Mapping Failure|4
7511269|NCT03064451|26070702|P1|Overall Study|Lost to Follow-up|1
7511270|NCT03064438|26070718|P2|Overall Study|Withdrawal by Subject|1
7511271|NCT03064438|26070719|P1|Overall Study|Withdrawal by Subject|0
7511272|NCT03064438|26070718|P2|Overall Study|Lost to Follow-up|0
7511273|NCT03064438|26070719|P1|Overall Study|Lost to Follow-up|1
7511294|NCT03063086|26070929|P6|Overall Study|Physician Decision|0
7511295|NCT03063086|26070930|P5|Overall Study|Physician Decision|0
7511296|NCT03063086|26070931|P4|Overall Study|Physician Decision|1
7511297|NCT03063086|26070932|P3|Overall Study|Physician Decision|0
7511298|NCT03063086|26070933|P2|Overall Study|Physician Decision|0
7511299|NCT03063086|26070934|P1|Overall Study|Physician Decision|0
7511300|NCT03063086|26070929|P6|Overall Study|Non-compliance with study treatment|1
7511301|NCT03063086|26070930|P5|Overall Study|Non-compliance with study treatment|0
7511302|NCT03063086|26070931|P4|Overall Study|Non-compliance with study treatment|1
7511303|NCT03063086|26070932|P3|Overall Study|Non-compliance with study treatment|0
7511304|NCT03063086|26070933|P2|Overall Study|Non-compliance with study treatment|0
7511305|NCT03063086|26070934|P1|Overall Study|Non-compliance with study treatment|0
7511306|NCT03063086|26070929|P6|Overall Study|subject/guardian decision|0
7511307|NCT03063086|26070930|P5|Overall Study|subject/guardian decision|0
7511308|NCT03063086|26070931|P4|Overall Study|subject/guardian decision|0
7511309|NCT03063086|26070932|P3|Overall Study|subject/guardian decision|0
7511310|NCT03063086|26070933|P2|Overall Study|subject/guardian decision|0
7511311|NCT03063086|26070934|P1|Overall Study|subject/guardian decision|1
7511312|NCT03063086|26070929|P6|Overall Study|Adverse Event|0
7511313|NCT03063086|26070930|P5|Overall Study|Adverse Event|0
7511314|NCT03063086|26070931|P4|Overall Study|Adverse Event|1
7511315|NCT03063086|26070932|P3|Overall Study|Adverse Event|1
7511316|NCT03063086|26070933|P2|Overall Study|Adverse Event|1
7511317|NCT03063086|26070934|P1|Overall Study|Adverse Event|1
7511318|NCT03063086|26070929|P6|Overall Study|technical problems|0
7511319|NCT03063086|26070930|P5|Overall Study|technical problems|0
7511320|NCT03063086|26070931|P4|Overall Study|technical problems|0
7511321|NCT03063086|26070932|P3|Overall Study|technical problems|0
7511322|NCT03063086|26070933|P2|Overall Study|technical problems|0
7511323|NCT03063086|26070934|P1|Overall Study|technical problems|1
7511324|NCT03062891|26070980|P2|Overall Study|Lost to Follow-up|38
7511325|NCT03062891|26070981|P1|Overall Study|Lost to Follow-up|50
7511326|NCT03062891|26070980|P2|Overall Study|Withdrawal by Subject|0
7511327|NCT03062891|26070981|P1|Overall Study|Withdrawal by Subject|2
7511328|NCT03061331|26071110|P2|Washout Period (8 Weeks)|Adverse Event|1
7511329|NCT03061331|26071111|P1|Washout Period (8 Weeks)|Adverse Event|2
7511330|NCT03061214|26071141|P3|Overall Study|Death|0
7511331|NCT03061214|26071142|P2|Overall Study|Death|1
7511332|NCT03061214|26071143|P1|Overall Study|Death|1
7511333|NCT03061214|26071141|P3|Overall Study|Lost to Follow-up|1
7511334|NCT03061214|26071142|P2|Overall Study|Lost to Follow-up|1
7511335|NCT03061214|26071143|P1|Overall Study|Lost to Follow-up|3
7511336|NCT03061214|26071141|P3|Overall Study|Withdrawal by Subject|9
7511337|NCT03061214|26071142|P2|Overall Study|Withdrawal by Subject|26
7511338|NCT03061214|26071143|P1|Overall Study|Withdrawal by Subject|21
7511339|NCT03061188|26071369|P4|On Follow-up for 3 Years|Still in follow-up|3
7511340|NCT03061188|26071370|P3|On Follow-up for 3 Years|Still in follow-up|0
7511341|NCT03061188|26071371|P2|On Follow-up for 3 Years|Still in follow-up|0
7511342|NCT03061188|26071372|P1|On Follow-up for 3 Years|Still in follow-up|0
7511343|NCT03061188|26071369|P4|On Follow-up for 3 Years|Death|2
7511344|NCT03061188|26071370|P3|On Follow-up for 3 Years|Death|5
7511345|NCT03061188|26071371|P2|On Follow-up for 3 Years|Death|3
7511346|NCT03061188|26071372|P1|On Follow-up for 3 Years|Death|0
7511347|NCT03061188|26071369|P4|Went on to Cycle 2 and Beyond|Adverse Event|1
7511348|NCT03061188|26071370|P3|Went on to Cycle 2 and Beyond|Adverse Event|1
7511349|NCT03061188|26071371|P2|Went on to Cycle 2 and Beyond|Adverse Event|0
7511350|NCT03061188|26071372|P1|Went on to Cycle 2 and Beyond|Adverse Event|0
7511351|NCT03061175|26071394|P2|Followup 2 at 6 Months|Lost to Follow-up|7
7511352|NCT03061175|26071395|P1|Followup 2 at 6 Months|Lost to Follow-up|4
7511353|NCT03061175|26071394|P2|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
7511354|NCT03061175|26071395|P1|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
7511355|NCT03061175|26071394|P2|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
7511356|NCT03061175|26071395|P1|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
7511357|NCT03061175|26071394|P2|Baseline|Participant was deemed ineligible|0
7511358|NCT03061175|26071395|P1|Baseline|Participant was deemed ineligible|1
7511359|NCT03061097|26071419|P2|Overall Study|Withdrawal by Subject|3
7511360|NCT03061097|26071420|P1|Overall Study|Withdrawal by Subject|0
7511361|NCT03060551|26071441|P1|Overall Study|Adverse Event|1
7511362|NCT03060551|26071441|P1|Overall Study|Withdrawal by Subject|1
7511363|NCT03060512|26071462|P2|Overall Study|Non-compliance with study medication|2
7511364|NCT03060512|26071463|P1|Overall Study|Non-compliance with study medication|1
7511365|NCT03060512|26071462|P2|Overall Study|Withdrawal by Subject|0
7511366|NCT03060512|26071463|P1|Overall Study|Withdrawal by Subject|1
7511367|NCT03060512|26071462|P2|Overall Study|Lost to Follow-up|1
7511368|NCT03060512|26071463|P1|Overall Study|Lost to Follow-up|1
7511369|NCT03060512|26071462|P2|Overall Study|Adverse Event|6
7511370|NCT03060512|26071463|P1|Overall Study|Adverse Event|4
7511371|NCT03060447|26071486|P2|Overall Study|Withdrawal by Subject|0
7511372|NCT03060447|26071487|P1|Overall Study|Withdrawal by Subject|2
7511373|NCT03058991|26071532|P3|Overall Study|Withdrawal by Subject|0
7511374|NCT03058991|26071533|P2|Overall Study|Withdrawal by Subject|0
7511375|NCT03058991|26071534|P1|Overall Study|Withdrawal by Subject|1
7511376|NCT03058991|26071532|P3|Overall Study|Lost to Follow-up|12
7511377|NCT03058991|26071533|P2|Overall Study|Lost to Follow-up|12
7511378|NCT03058991|26071534|P1|Overall Study|Lost to Follow-up|17
7511379|NCT03058705|26071560|P1|Overall Study|Physician Decision|2
7511380|NCT03058705|26071560|P1|Overall Study|Withdrawal by Subject|2
7511381|NCT03058692|26071566|P2|Overall Study|Withdrawal by Subject|1
7511382|NCT03058692|26071567|P1|Overall Study|Withdrawal by Subject|1
7511383|NCT03058692|26071566|P2|Overall Study|Lost to Follow-up|1
7511384|NCT03058692|26071567|P1|Overall Study|Lost to Follow-up|2
7511385|NCT03058679|26071681|P2|Week 6 to Week 12|Difficulty following the assigned diet|3
7511386|NCT03058679|26071682|P1|Week 6 to Week 12|Difficulty following the assigned diet|2
7511387|NCT03058679|26071681|P2|Week 6 to Week 12|Withdrawal by Subject|4
7511388|NCT03058679|26071682|P1|Week 6 to Week 12|Withdrawal by Subject|9
7511389|NCT03058679|26071681|P2|Week 6 to Week 12|Adverse Event|3
7511390|NCT03058679|26071682|P1|Week 6 to Week 12|Adverse Event|4
7511391|NCT03058679|26071681|P2|Week 6 to Week 12|Change in medication|7
7511392|NCT03058679|26071682|P1|Week 6 to Week 12|Change in medication|5
7511393|NCT03058679|26071681|P2|Baseline to Week 6|Physician Decision|0
7511394|NCT03058679|26071682|P1|Baseline to Week 6|Physician Decision|1
7511395|NCT03058679|26071681|P2|Baseline to Week 6|Difficulty following the diet|2
7511396|NCT03058679|26071682|P1|Baseline to Week 6|Difficulty following the diet|0
7511397|NCT03058679|26071681|P2|Baseline to Week 6|Withdrawal by Subject|3
7511398|NCT03058679|26071682|P1|Baseline to Week 6|Withdrawal by Subject|4
7511399|NCT03058679|26071681|P2|Baseline to Week 6|Adverse Event|6
7511400|NCT03058679|26071682|P1|Baseline to Week 6|Adverse Event|6
7511401|NCT03058679|26071681|P2|Baseline to Week 6|Change in Crohn's disease medication|2
7511402|NCT03058679|26071682|P1|Baseline to Week 6|Change in Crohn's disease medication|4
7511403|NCT03058679|26071681|P2|Baseline to Week 6|Lost to Follow-up|2
7511404|NCT03058679|26071682|P1|Baseline to Week 6|Lost to Follow-up|3
7511405|NCT03057977|26071696|P2|Discontinuation From Trial|Withdrawal by Subject|11
7511406|NCT03057977|26071697|P1|Discontinuation From Trial|Withdrawal by Subject|9
7511407|NCT03057977|26071696|P2|Discontinuation From Trial|Limited follow-up agreed|2
7511408|NCT03057977|26071697|P1|Discontinuation From Trial|Limited follow-up agreed|2
7511409|NCT03057977|26071696|P2|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7511410|NCT03057977|26071697|P1|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7511411|NCT03057977|26071696|P2|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
7511412|NCT03057977|26071697|P1|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
7511413|NCT03057977|26071696|P2|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
7511414|NCT03057977|26071697|P1|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
7511415|NCT03057977|26071696|P2|Discontinuation From Treatment|Not attending study visit|10
7511416|NCT03057977|26071697|P1|Discontinuation From Treatment|Not attending study visit|3
7511417|NCT03057977|26071696|P2|Discontinuation From Treatment|Unable to continue treatment|1
7511418|NCT03057977|26071697|P1|Discontinuation From Treatment|Unable to continue treatment|4
7511419|NCT03057977|26071696|P2|Discontinuation From Treatment|Patient moved away/being abroad|3
7511420|NCT03057977|26071697|P1|Discontinuation From Treatment|Patient moved away/being abroad|4
7511421|NCT03057977|26071696|P2|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
7511422|NCT03057977|26071697|P1|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
7511423|NCT03057977|26071696|P2|Discontinuation From Treatment|Principle Investigator Decision|0
7511424|NCT03057977|26071697|P1|Discontinuation From Treatment|Principle Investigator Decision|2
7511425|NCT03057977|26071696|P2|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7511426|NCT03057977|26071697|P1|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7511427|NCT03057977|26071696|P2|Discontinuation From Treatment|Unblinded medication|0
7511428|NCT03057977|26071697|P1|Discontinuation From Treatment|Unblinded medication|1
7511429|NCT03057977|26071696|P2|Discontinuation From Treatment|Personal Reasons|1
7511430|NCT03057977|26071697|P1|Discontinuation From Treatment|Personal Reasons|1
7511431|NCT03057977|26071696|P2|Discontinuation From Treatment|Reason Unknown|1
7511432|NCT03057977|26071697|P1|Discontinuation From Treatment|Reason Unknown|0
7511433|NCT03057977|26071696|P2|Discontinuation From Treatment|Adverse Event|337
7511434|NCT03057977|26071697|P1|Discontinuation From Treatment|Adverse Event|343
7511435|NCT03057977|26071696|P2|Discontinuation From Treatment|Not treated|0
7511436|NCT03057977|26071697|P1|Discontinuation From Treatment|Not treated|4
7511437|NCT03057977|26071696|P2|Discontinuation From Treatment|Protocol Violation|5
7511438|NCT03057977|26071697|P1|Discontinuation From Treatment|Protocol Violation|6
7511439|NCT03057977|26071696|P2|Discontinuation From Treatment|Lost to Follow-up|17
7511440|NCT03057977|26071697|P1|Discontinuation From Treatment|Lost to Follow-up|11
7511441|NCT03057977|26071696|P2|Discontinuation From Treatment|Withdrawal by Subject|92
7511442|NCT03057977|26071697|P1|Discontinuation From Treatment|Withdrawal by Subject|124
7511443|NCT03057496|26071738|P1|Overall Study|Device failure|2
7511444|NCT03057496|26071738|P1|Overall Study|Did not use device during home trial|3
7511445|NCT03057496|26071738|P1|Overall Study|Lost to Follow-up|5
7511446|NCT03057496|26071738|P1|Overall Study|Withdrawal by Subject|8
7511447|NCT03056690|26071778|P2|Overall Study|Miscellaneous|2
7511448|NCT03056690|26071779|P1|Overall Study|Miscellaneous|1
7511449|NCT03056690|26071778|P2|Overall Study|Non-compliance with Study Drug|0
7511450|NCT03056690|26071779|P1|Overall Study|Non-compliance with Study Drug|1
7511451|NCT03056690|26071778|P2|Overall Study|Withdrawal by Subject|6
7511452|NCT03056690|26071779|P1|Overall Study|Withdrawal by Subject|3
7511453|NCT03056690|26071778|P2|Overall Study|Protocol Violation|2
7511454|NCT03056690|26071779|P1|Overall Study|Protocol Violation|2
7511455|NCT03056690|26071778|P2|Overall Study|Lost to Follow-up|2
7511456|NCT03056690|26071779|P1|Overall Study|Lost to Follow-up|3
7511457|NCT03056690|26071778|P2|Overall Study|Lack of Efficacy|2
7511458|NCT03056690|26071779|P1|Overall Study|Lack of Efficacy|1
7511459|NCT03056690|26071778|P2|Overall Study|Adverse Event|2
7511460|NCT03056690|26071779|P1|Overall Study|Adverse Event|3
7511461|NCT03056573|26071813|P2|Overall Study|Lost to Follow-up|1
7511462|NCT03056573|26071814|P1|Overall Study|Lost to Follow-up|1
7511463|NCT03056573|26071813|P2|Overall Study|Withdrawal by Subject|0
7511464|NCT03056573|26071814|P1|Overall Study|Withdrawal by Subject|2
7511465|NCT03056573|26071813|P2|Overall Study|Death|4
7511466|NCT03056573|26071814|P1|Overall Study|Death|2
7511467|NCT03056352|26071874|P1|Overall Study|Lost to Follow-up|1
7511468|NCT03056300|26071880|P1|Overall Study|Surgical reason per study protocol|3
7511469|NCT03056040|26071897|P2|Primary Evaluation Period|Pregnancy|1
7511470|NCT03056040|26071898|P1|Primary Evaluation Period|Pregnancy|0
7511471|NCT03056040|26071897|P2|Primary Evaluation Period|Lack of Efficacy|1
7511472|NCT03056040|26071898|P1|Primary Evaluation Period|Lack of Efficacy|0
7511473|NCT03056040|26071897|P2|Primary Evaluation Period|Withdrawal by Subject|1
7511474|NCT03056040|26071898|P1|Primary Evaluation Period|Withdrawal by Subject|1
7511475|NCT03055988|26071912|P2|Period 2|Other than listed|1
7511476|NCT03055988|26071913|P1|Period 2|Other than listed|1
7511477|NCT03055988|26071912|P2|Period 2|Adverse Event|1
7511478|NCT03055988|26071913|P1|Period 2|Adverse Event|0
7511479|NCT03055988|26071912|P2|Period 1|Withdrawal by Subject|4
7511480|NCT03055988|26071913|P1|Period 1|Withdrawal by Subject|0
7511481|NCT03055988|26071912|P2|Period 1|Lost to Follow-up|0
7511482|NCT03055988|26071913|P1|Period 1|Lost to Follow-up|1
7511483|NCT03055988|26071912|P2|Period 1|Adverse Event|1
7511484|NCT03055988|26071913|P1|Period 1|Adverse Event|0
7511485|NCT03055936|26071939|P4|Overall Study|Personal reason|0
7511486|NCT03055936|26071940|P3|Overall Study|Personal reason|1
7511487|NCT03055936|26071941|P2|Overall Study|Personal reason|0
7511488|NCT03055936|26071942|P1|Overall Study|Personal reason|2
7511489|NCT03055936|26071939|P4|Overall Study|Adverse Event|1
7511490|NCT03055936|26071940|P3|Overall Study|Adverse Event|1
7511491|NCT03055936|26071941|P2|Overall Study|Adverse Event|1
7511492|NCT03055936|26071942|P1|Overall Study|Adverse Event|0
7511493|NCT03055858|26072012|P1|Overall Study|Adverse Event|1
7511494|NCT03055858|26072012|P1|Overall Study|Death|5
7511495|NCT03055832|26072020|P2|Week 2|Withdrawal by Subject|0
7511496|NCT03055832|26072021|P1|Week 2|Withdrawal by Subject|1
7511497|NCT03055806|26072081|P4|Overall Study|Partner not willing to try intercourse|0
7511498|NCT03055806|26072082|P3|Overall Study|Partner not willing to try intercourse|0
7511499|NCT03055806|26072083|P2|Overall Study|Partner not willing to try intercourse|0
7511500|NCT03055806|26072084|P1|Overall Study|Partner not willing to try intercourse|1
7511501|NCT03055806|26072081|P4|Overall Study|Withdrawal of consent to continue study|6
7511502|NCT03055806|26072082|P3|Overall Study|Withdrawal of consent to continue study|4
7511503|NCT03055806|26072083|P2|Overall Study|Withdrawal of consent to continue study|3
7511504|NCT03055806|26072084|P1|Overall Study|Withdrawal of consent to continue study|2
7511505|NCT03055806|26072081|P4|Overall Study|Withdrawal of consent to continue drug|0
7511506|NCT03055806|26072082|P3|Overall Study|Withdrawal of consent to continue drug|2
7511507|NCT03055806|26072083|P2|Overall Study|Withdrawal of consent to continue drug|1
7511508|NCT03055806|26072084|P1|Overall Study|Withdrawal of consent to continue drug|1
7511509|NCT03055806|26072081|P4|Overall Study|Protocol Violation|0
7511510|NCT03055806|26072082|P3|Overall Study|Protocol Violation|0
7511511|NCT03055806|26072083|P2|Overall Study|Protocol Violation|0
7511512|NCT03055806|26072084|P1|Overall Study|Protocol Violation|1
7511513|NCT03055806|26072081|P4|Overall Study|Physician Decision|1
7511514|NCT03055806|26072082|P3|Overall Study|Physician Decision|0
7511515|NCT03055806|26072083|P2|Overall Study|Physician Decision|0
7511516|NCT03055806|26072084|P1|Overall Study|Physician Decision|1
7511517|NCT03055806|26072081|P4|Overall Study|Lost to Follow-up|7
7511518|NCT03055806|26072082|P3|Overall Study|Lost to Follow-up|6
7511519|NCT03055806|26072083|P2|Overall Study|Lost to Follow-up|3
7511520|NCT03055806|26072084|P1|Overall Study|Lost to Follow-up|0
7511521|NCT03055806|26072081|P4|Overall Study|Adverse Event|1
7511522|NCT03055806|26072082|P3|Overall Study|Adverse Event|1
7511523|NCT03055806|26072083|P2|Overall Study|Adverse Event|0
7511524|NCT03055806|26072084|P1|Overall Study|Adverse Event|0
7511525|NCT03055624|26072133|P1|Overall Study|Study closed|9
7511526|NCT03055494|26072144|P2|Overall Study|Non-compliance with study treatment|0
7511527|NCT03055494|26072145|P1|Overall Study|Non-compliance with study treatment|1
7511528|NCT03055494|26072144|P2|Overall Study|Adverse Event|1
7511529|NCT03055494|26072145|P1|Overall Study|Adverse Event|0
7511530|NCT03055494|26072144|P2|Overall Study|Withdrawal by Subject|0
7511531|NCT03055494|26072145|P1|Overall Study|Withdrawal by Subject|1
7511532|NCT03055494|26072144|P2|Overall Study|Physician Decision|0
7511533|NCT03055494|26072145|P1|Overall Study|Physician Decision|2
7511534|NCT03055494|26072144|P2|Overall Study|Lost to Follow-up|0
7511535|NCT03055494|26072145|P1|Overall Study|Lost to Follow-up|6
7511536|NCT03055338|26072176|P3|Overall Study|Withdrawal by Subject|7
7511537|NCT03055338|26072177|P2|Overall Study|Withdrawal by Subject|8
7511538|NCT03055338|26072178|P1|Overall Study|Withdrawal by Subject|9
7511539|NCT03055338|26072176|P3|Overall Study|Physician Decision|2
7511540|NCT03055338|26072177|P2|Overall Study|Physician Decision|0
7511541|NCT03055338|26072178|P1|Overall Study|Physician Decision|0
7511542|NCT03055338|26072176|P3|Overall Study|No Post-treatment Protocol Contact|0
7511543|NCT03055338|26072177|P2|Overall Study|No Post-treatment Protocol Contact|1
7511544|NCT03055338|26072178|P1|Overall Study|No Post-treatment Protocol Contact|0
7511545|NCT03055338|26072176|P3|Overall Study|Lost to Follow-up|3
7511546|NCT03055338|26072177|P2|Overall Study|Lost to Follow-up|2
7511547|NCT03055338|26072178|P1|Overall Study|Lost to Follow-up|9
7511548|NCT03055260|26072197|P2|Overall Study|Withdrawal by Subject|0
7511549|NCT03055260|26072198|P1|Overall Study|Withdrawal by Subject|1
7511550|NCT03055221|26072206|P1|Overall Study|Study terminated by Sponsor|3
7511551|NCT03055221|26072206|P1|Overall Study|Physician Decision|1
7511552|NCT03055221|26072206|P1|Overall Study|Death|6
7511553|NCT03055221|26072206|P1|Overall Study|Withdrawal by Subject|4
7511554|NCT03055221|26072206|P1|Overall Study|Adverse Event|2
7511555|NCT03055195|26072213|P2|Overall Study|Physician Decision|0
7511556|NCT03055195|26072214|P1|Overall Study|Physician Decision|1
7511557|NCT03055195|26072213|P2|Overall Study|Protocol Violation|1
7511558|NCT03055195|26072214|P1|Overall Study|Protocol Violation|2
7511559|NCT03055195|26072213|P2|Overall Study|Study Terminated by Sponsor|6
7511560|NCT03055195|26072214|P1|Overall Study|Study Terminated by Sponsor|2
7511561|NCT03055195|26072213|P2|Overall Study|Withdrawal by Subject|7
7511562|NCT03055195|26072214|P1|Overall Study|Withdrawal by Subject|6
7511563|NCT03055195|26072213|P2|Overall Study|Lack of Efficacy|0
7511564|NCT03055195|26072214|P1|Overall Study|Lack of Efficacy|1
7511565|NCT03054870|26072416|P1|Day of Ventilation Imaging|Lost to Follow-up|1
7511566|NCT03054870|26072416|P1|Day of Ventilation Imaging|Protocol Violation|4
7511567|NCT03054428|26072601|P3|Overall Study|Lost to Follow-up|1
7511568|NCT03054428|26072602|P2|Overall Study|Lost to Follow-up|0
7511569|NCT03054428|26072603|P1|Overall Study|Lost to Follow-up|0
7511570|NCT03054428|26072601|P3|Overall Study|Withdrawal by Subject|3
7511571|NCT03054428|26072602|P2|Overall Study|Withdrawal by Subject|2
7511572|NCT03054428|26072603|P1|Overall Study|Withdrawal by Subject|3
7511573|NCT03054428|26072601|P3|Overall Study|Transitioned to OLE study|73
7511574|NCT03054428|26072602|P2|Overall Study|Transitioned to OLE study|76
7511575|NCT03054428|26072603|P1|Overall Study|Transitioned to OLE study|76
7511576|NCT03054428|26072601|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7511577|NCT03054428|26072602|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7511578|NCT03054428|26072603|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
7511579|NCT03054428|26072601|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
7511580|NCT03054428|26072602|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
7511581|NCT03054428|26072603|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
7511582|NCT03054428|26072601|P3|Overall Study|Lack of Efficacy|0
7511583|NCT03054428|26072602|P2|Overall Study|Lack of Efficacy|1
7511584|NCT03054428|26072603|P1|Overall Study|Lack of Efficacy|3
7511585|NCT03054428|26072601|P3|Overall Study|Physician Decision|1
7511586|NCT03054428|26072602|P2|Overall Study|Physician Decision|1
7511587|NCT03054428|26072603|P1|Overall Study|Physician Decision|0
7511588|NCT03054350|26072674|P6|Dose Adjustment and Maintenance Period|Captured as Other|0
7511589|NCT03054350|26072675|P5|Dose Adjustment and Maintenance Period|Captured as Other|0
7511590|NCT03054350|26072676|P4|Dose Adjustment and Maintenance Period|Captured as Other|0
7511591|NCT03054350|26072677|P3|Dose Adjustment and Maintenance Period|Captured as Other|1
7511592|NCT03054350|26072678|P2|Dose Adjustment and Maintenance Period|Captured as Other|0
7511593|NCT03054350|26072679|P1|Dose Adjustment and Maintenance Period|Captured as Other|0
7511594|NCT03054350|26072674|P6|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7511595|NCT03054350|26072675|P5|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7511596|NCT03054350|26072676|P4|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7511597|NCT03054350|26072677|P3|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7511598|NCT03054350|26072678|P2|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7511599|NCT03054350|26072679|P1|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7511600|NCT03054350|26072674|P6|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7511601|NCT03054350|26072675|P5|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7511602|NCT03054350|26072676|P4|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7511603|NCT03054350|26072677|P3|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
7511604|NCT03054350|26072678|P2|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7511605|NCT03054350|26072679|P1|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7511606|NCT03054350|26072674|P6|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
7511607|NCT03054350|26072675|P5|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7511608|NCT03054350|26072676|P4|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7511609|NCT03054350|26072677|P3|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
7511610|NCT03054350|26072678|P2|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7511611|NCT03054350|26072679|P1|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7511612|NCT03054337|26072821|P6|Dose Adjustment and Maintenance Period|Investigator discretion|1
7511613|NCT03054337|26072822|P5|Dose Adjustment and Maintenance Period|Investigator discretion|0
7511614|NCT03054337|26072823|P4|Dose Adjustment and Maintenance Period|Investigator discretion|0
7511615|NCT03054337|26072824|P3|Dose Adjustment and Maintenance Period|Investigator discretion|1
7511616|NCT03054337|26072825|P2|Dose Adjustment and Maintenance Period|Investigator discretion|2
7511617|NCT03054337|26072826|P1|Dose Adjustment and Maintenance Period|Investigator discretion|1
7511618|NCT03054064|26073003|P1|Overall Study|Change in Status|1
7511619|NCT03054064|26073003|P1|Overall Study|High Blood Pressure|1
7511620|NCT03054064|26073003|P1|Overall Study|Bladder Issue|1
7511621|NCT03054064|26073003|P1|Overall Study|Investigator Decision|2
7511622|NCT03054064|26073003|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
7511623|NCT03053518|26073048|P1|Overall Study|Ineligible|5
7511624|NCT03053518|26073048|P1|Overall Study|Lost to Follow-up|2
7511625|NCT03053518|26073048|P1|Overall Study|Withdrawal by Subject|3
7511626|NCT03053492|26073054|P2|Overall Study|Withdrawal by Subject|5
7511627|NCT03053492|26073055|P1|Overall Study|Withdrawal by Subject|7
7511628|NCT03053492|26073054|P2|Overall Study|Adverse Event|1
7511629|NCT03053492|26073055|P1|Overall Study|Adverse Event|1
7511630|NCT03053427|26073069|P2|Overall Study|Miscellaneous|1
7511631|NCT03053427|26073070|P1|Overall Study|Miscellaneous|0
7511632|NCT03053427|26073069|P2|Overall Study|Withdrawal by Subject|2
7511633|NCT03053427|26073070|P1|Overall Study|Withdrawal by Subject|3
7511634|NCT03053427|26073069|P2|Overall Study|Protocol Deviation|3
7511635|NCT03053427|26073070|P1|Overall Study|Protocol Deviation|3
7511636|NCT03053427|26073069|P2|Overall Study|Worsening of the target disease|1
7511637|NCT03053427|26073070|P1|Overall Study|Worsening of the target disease|0
7511638|NCT03053427|26073069|P2|Overall Study|Lost to Follow-up|2
7511639|NCT03053427|26073070|P1|Overall Study|Lost to Follow-up|2
7511640|NCT03053427|26073069|P2|Overall Study|Lack of Efficacy|3
7511641|NCT03053427|26073070|P1|Overall Study|Lack of Efficacy|1
7511642|NCT03053427|26073069|P2|Overall Study|Adverse Event|4
7511643|NCT03053427|26073070|P1|Overall Study|Adverse Event|4
7511644|NCT03053271|26073105|P1|Overall Study|Withdrawal by Subject|1
7511645|NCT03053271|26073105|P1|Overall Study|Did not meet randomization criteria|3
7511646|NCT03053180|26073113|P1|Overall Study|Failure to Return|1
7511647|NCT03053102|26073122|P1|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
7511648|NCT03053102|26073122|P1|Study Part 2: 84-Day Treatment|Adverse Event|1
7511649|NCT03053063|26073137|P4|Open-Label Phase|Investigator's discretion|2
7511650|NCT03053063|26073138|P3|Open-Label Phase|Investigator's discretion|0
7511651|NCT03053063|26073139|P2|Open-Label Phase|Investigator's discretion|0
7511652|NCT03053063|26073140|P1|Open-Label Phase|Investigator's discretion|0
7511653|NCT03053063|26073137|P4|Open-Label Phase|Death|2
7511654|NCT03053063|26073138|P3|Open-Label Phase|Death|0
7511655|NCT03053063|26073139|P2|Open-Label Phase|Death|0
7511656|NCT03053063|26073140|P1|Open-Label Phase|Death|0
7511657|NCT03053063|26073137|P4|Open-Label Phase|Study Terminated by Sponsor|19
7511658|NCT03053063|26073138|P3|Open-Label Phase|Study Terminated by Sponsor|0
7511659|NCT03053063|26073139|P2|Open-Label Phase|Study Terminated by Sponsor|0
7511660|NCT03053063|26073140|P1|Open-Label Phase|Study Terminated by Sponsor|0
7511661|NCT03053063|26073137|P4|Randomized Phase|Entered the Open-Label Phase|0
7511662|NCT03053063|26073138|P3|Randomized Phase|Entered the Open-Label Phase|3
7511663|NCT03053063|26073139|P2|Randomized Phase|Entered the Open-Label Phase|11
7511664|NCT03053063|26073140|P1|Randomized Phase|Entered the Open-Label Phase|9
7511665|NCT03053063|26073137|P4|Randomized Phase|Randomized but Never Treated|0
7511666|NCT03053063|26073138|P3|Randomized Phase|Randomized but Never Treated|2
7511667|NCT03053063|26073139|P2|Randomized Phase|Randomized but Never Treated|3
7511668|NCT03053063|26073140|P1|Randomized Phase|Randomized but Never Treated|1
7511669|NCT03053063|26073137|P4|Randomized Phase|Adverse Event|0
7511670|NCT03053063|26073138|P3|Randomized Phase|Adverse Event|0
7511671|NCT03053063|26073139|P2|Randomized Phase|Adverse Event|1
7511672|NCT03053063|26073140|P1|Randomized Phase|Adverse Event|0
7511673|NCT03053063|26073137|P4|Randomized Phase|Lost to Follow-up|0
7511674|NCT03053063|26073138|P3|Randomized Phase|Lost to Follow-up|1
7511675|NCT03053063|26073139|P2|Randomized Phase|Lost to Follow-up|5
7511676|NCT03053063|26073140|P1|Randomized Phase|Lost to Follow-up|3
7511677|NCT03053063|26073137|P4|Randomized Phase|Investigator's Discretion|0
7511678|NCT03053063|26073138|P3|Randomized Phase|Investigator's Discretion|2
7511679|NCT03053063|26073139|P2|Randomized Phase|Investigator's Discretion|6
7511680|NCT03053063|26073140|P1|Randomized Phase|Investigator's Discretion|8
7511681|NCT03053063|26073137|P4|Randomized Phase|Withdrew consent|0
7511682|NCT03053063|26073138|P3|Randomized Phase|Withdrew consent|5
7511683|NCT03053063|26073139|P2|Randomized Phase|Withdrew consent|11
7511684|NCT03053063|26073140|P1|Randomized Phase|Withdrew consent|8
7511685|NCT03053063|26073137|P4|Randomized Phase|Study Terminated by Sponsor|0
7511686|NCT03053063|26073138|P3|Randomized Phase|Study Terminated by Sponsor|161
7511687|NCT03053063|26073139|P2|Randomized Phase|Study Terminated by Sponsor|317
7511688|NCT03053063|26073140|P1|Randomized Phase|Study Terminated by Sponsor|326
7511689|NCT03053050|26073170|P4|Open-label Phase|Investigator's Discretion|4
7511690|NCT03053050|26073171|P3|Open-label Phase|Investigator's Discretion|0
7511691|NCT03053050|26073172|P2|Open-label Phase|Investigator's Discretion|0
7511692|NCT03053050|26073173|P1|Open-label Phase|Investigator's Discretion|0
7511693|NCT03053050|26073170|P4|Open-label Phase|Withdrew Consent|6
7511694|NCT03053050|26073171|P3|Open-label Phase|Withdrew Consent|0
7511695|NCT03053050|26073172|P2|Open-label Phase|Withdrew Consent|0
7511696|NCT03053050|26073173|P1|Open-label Phase|Withdrew Consent|0
7511697|NCT03053050|26073170|P4|Open-label Phase|Study Terminated by Sponsor|89
7511698|NCT03053050|26073171|P3|Open-label Phase|Study Terminated by Sponsor|0
7511699|NCT03053050|26073172|P2|Open-label Phase|Study Terminated by Sponsor|0
7511700|NCT03053050|26073173|P1|Open-label Phase|Study Terminated by Sponsor|0
7511701|NCT03053050|26073170|P4|Randomized Phase|Entered the Open-Label Phase|0
7511702|NCT03053050|26073171|P3|Randomized Phase|Entered the Open-Label Phase|18
7511703|NCT03053050|26073172|P2|Randomized Phase|Entered the Open-Label Phase|45
7511704|NCT03053050|26073173|P1|Randomized Phase|Entered the Open-Label Phase|36
7511705|NCT03053050|26073170|P4|Randomized Phase|Randomized but Never Treated|0
7511706|NCT03053050|26073171|P3|Randomized Phase|Randomized but Never Treated|2
7511707|NCT03053050|26073172|P2|Randomized Phase|Randomized but Never Treated|2
7511708|NCT03053050|26073173|P1|Randomized Phase|Randomized but Never Treated|2
7511709|NCT03053050|26073170|P4|Randomized Phase|Adverse Event|0
7511710|NCT03053050|26073171|P3|Randomized Phase|Adverse Event|0
7511711|NCT03053050|26073172|P2|Randomized Phase|Adverse Event|1
7511712|NCT03053050|26073173|P1|Randomized Phase|Adverse Event|0
7511713|NCT03053050|26073170|P4|Randomized Phase|Lost to Follow-up|0
7511714|NCT03053050|26073171|P3|Randomized Phase|Lost to Follow-up|1
7511715|NCT03053050|26073172|P2|Randomized Phase|Lost to Follow-up|1
7511716|NCT03053050|26073173|P1|Randomized Phase|Lost to Follow-up|5
7511717|NCT03053050|26073170|P4|Randomized Phase|Investigator's Discretion|0
7511718|NCT03053050|26073171|P3|Randomized Phase|Investigator's Discretion|3
7511719|NCT03053050|26073172|P2|Randomized Phase|Investigator's Discretion|6
7511720|NCT03053050|26073173|P1|Randomized Phase|Investigator's Discretion|6
7511721|NCT03053050|26073170|P4|Randomized Phase|Withdrew Consent|0
7511722|NCT03053050|26073171|P3|Randomized Phase|Withdrew Consent|9
7511723|NCT03053050|26073172|P2|Randomized Phase|Withdrew Consent|8
7511724|NCT03053050|26073173|P1|Randomized Phase|Withdrew Consent|16
7511725|NCT03053050|26073170|P4|Randomized Phase|Study Terminated by Sponsor|0
7511726|NCT03053050|26073171|P3|Randomized Phase|Study Terminated by Sponsor|128
7511727|NCT03053050|26073172|P2|Randomized Phase|Study Terminated by Sponsor|260
7511728|NCT03053050|26073173|P1|Randomized Phase|Study Terminated by Sponsor|259
7511729|NCT03052816|26073217|P2|Overall Study|Desired opioids|0
7511730|NCT03052816|26073218|P1|Overall Study|Desired opioids|2
7511731|NCT03052816|26073217|P2|Overall Study|Withdrawal by Subject|0
7511732|NCT03052816|26073218|P1|Overall Study|Withdrawal by Subject|1
7511733|NCT03052764|26073244|P2|Double-Blind Treatment Period|Reason not Specified|1
7511734|NCT03052764|26073245|P1|Double-Blind Treatment Period|Reason not Specified|2
7511735|NCT03052764|26073244|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
7511736|NCT03052764|26073245|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
7511737|NCT03052764|26073244|P2|Double-Blind Treatment Period|Protocol Violation|1
7511738|NCT03052764|26073245|P1|Double-Blind Treatment Period|Protocol Violation|2
7511739|NCT03052764|26073244|P2|Double-Blind Treatment Period|Lack of Efficacy|0
7511740|NCT03052764|26073245|P1|Double-Blind Treatment Period|Lack of Efficacy|1
7511741|NCT03052764|26073244|P2|Double-Blind Treatment Period|Adverse Event|0
7511742|NCT03052764|26073245|P1|Double-Blind Treatment Period|Adverse Event|2
7511743|NCT03052751|26073265|P6|Observation Period|Adverse Event|0
7511744|NCT03052751|26073266|P5|Observation Period|Adverse Event|1
7511745|NCT03052751|26073267|P4|Observation Period|Adverse Event|0
7511746|NCT03052751|26073268|P3|Observation Period|Adverse Event|0
7511747|NCT03052751|26073269|P2|Observation Period|Adverse Event|0
7511748|NCT03052751|26073270|P1|Observation Period|Adverse Event|0
7511749|NCT03052751|26073265|P6|Dosing Period 2|Adverse Event|0
7511750|NCT03052751|26073266|P5|Dosing Period 2|Adverse Event|0
7511751|NCT03052751|26073267|P4|Dosing Period 2|Adverse Event|0
7511752|NCT03052751|26073268|P3|Dosing Period 2|Adverse Event|3
7511753|NCT03052751|26073269|P2|Dosing Period 2|Adverse Event|0
7511754|NCT03052751|26073270|P1|Dosing Period 2|Adverse Event|0
7511755|NCT03052751|26073265|P6|Dosing Period 1|Adverse Event|0
7511756|NCT03052751|26073266|P5|Dosing Period 1|Adverse Event|0
7511757|NCT03052751|26073267|P4|Dosing Period 1|Adverse Event|0
7511758|NCT03052751|26073268|P3|Dosing Period 1|Adverse Event|0
7511759|NCT03052751|26073269|P2|Dosing Period 1|Adverse Event|1
7511760|NCT03052751|26073270|P1|Dosing Period 1|Adverse Event|0
7511761|NCT03052725|26073286|P2|Overall Study|Study terminated by sponsor|144
7511762|NCT03052725|26073287|P1|Overall Study|Study terminated by sponsor|143
7511763|NCT03052725|26073286|P2|Overall Study|Site closure|1
7511764|NCT03052725|26073287|P1|Overall Study|Site closure|0
7511765|NCT03052725|26073286|P2|Overall Study|Pregnancy|1
7511766|NCT03052725|26073287|P1|Overall Study|Pregnancy|0
7511767|NCT03052725|26073286|P2|Overall Study|Withdrawal by Subject|4
7511768|NCT03052725|26073287|P1|Overall Study|Withdrawal by Subject|3
7511769|NCT03052725|26073286|P2|Overall Study|Adverse Event|0
7511770|NCT03052725|26073287|P1|Overall Study|Adverse Event|2
7511771|NCT03052608|26073326|P2|Long-Term Follow-up Phase|Ongoing|99
7511772|NCT03052608|26073327|P1|Long-Term Follow-up Phase|Ongoing|122
7511773|NCT03052608|26073326|P2|Long-Term Follow-up Phase|Withdrawal by Subject|18
7511774|NCT03052608|26073327|P1|Long-Term Follow-up Phase|Withdrawal by Subject|4
7511775|NCT03052608|26073326|P2|Long-Term Follow-up Phase|Lost to Follow-up|2
7511776|NCT03052608|26073327|P1|Long-Term Follow-up Phase|Lost to Follow-up|0
7511777|NCT03052608|26073326|P2|Long-Term Follow-up Phase|Death|28
7511778|NCT03052608|26073327|P1|Long-Term Follow-up Phase|Death|23
7511779|NCT03052608|26073326|P2|Treatment Phase|Ongoing|31
7511780|NCT03052608|26073327|P1|Treatment Phase|Ongoing|103
7511781|NCT03052608|26073326|P2|Treatment Phase|Subject didn't receive study treatment.|1
7511782|NCT03052608|26073327|P1|Treatment Phase|Subject didn't receive study treatment.|0
7511783|NCT03052608|26073326|P2|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
7511784|NCT03052608|26073327|P1|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
7511785|NCT03052608|26073326|P2|Treatment Phase|Global Deterioration of Health Status|3
7511786|NCT03052608|26073327|P1|Treatment Phase|Global Deterioration of Health Status|0
7511787|NCT03052608|26073326|P2|Treatment Phase|Withdrawal by Subject|12
7511788|NCT03052608|26073327|P1|Treatment Phase|Withdrawal by Subject|4
7511789|NCT03052608|26073326|P2|Treatment Phase|Death|4
7511790|NCT03052608|26073327|P1|Treatment Phase|Death|6
7511791|NCT03052608|26073326|P2|Treatment Phase|Adverse Event|12
7511792|NCT03052608|26073327|P1|Treatment Phase|Adverse Event|10
7511793|NCT03052517|26073395|P3|Overall Study|Technical Problems|0
7511794|NCT03052517|26073396|P2|Overall Study|Technical Problems|1
7511795|NCT03052517|26073397|P1|Overall Study|Technical Problems|0
7511796|NCT03052517|26073395|P3|Overall Study|Non-Compliance With Study Treatment|0
7511797|NCT03052517|26073396|P2|Overall Study|Non-Compliance With Study Treatment|2
7511798|NCT03052517|26073397|P1|Overall Study|Non-Compliance With Study Treatment|0
7511799|NCT03052517|26073395|P3|Overall Study|Pregnancy|1
7511800|NCT03052517|26073396|P2|Overall Study|Pregnancy|0
7511801|NCT03052517|26073397|P1|Overall Study|Pregnancy|1
7511802|NCT03052517|26073395|P3|Overall Study|Lost to Follow-up|0
7511803|NCT03052517|26073396|P2|Overall Study|Lost to Follow-up|4
7511804|NCT03052517|26073397|P1|Overall Study|Lost to Follow-up|2
7511805|NCT03052517|26073395|P3|Overall Study|Death|1
7511806|NCT03052517|26073396|P2|Overall Study|Death|0
7511807|NCT03052517|26073397|P1|Overall Study|Death|3
7511808|NCT03052517|26073395|P3|Overall Study|Physician Decision|1
7511809|NCT03052517|26073396|P2|Overall Study|Physician Decision|5
7511810|NCT03052517|26073397|P1|Overall Study|Physician Decision|4
7511811|NCT03052517|26073395|P3|Overall Study|Adverse Event|0
7511812|NCT03052517|26073396|P2|Overall Study|Adverse Event|5
7511813|NCT03052517|26073397|P1|Overall Study|Adverse Event|6
7511814|NCT03052517|26073395|P3|Overall Study|Lack of Efficacy|7
7511815|NCT03052517|26073396|P2|Overall Study|Lack of Efficacy|14
7511816|NCT03052517|26073397|P1|Overall Study|Lack of Efficacy|23
7511817|NCT03052517|26073395|P3|Overall Study|Subject/Guardian Decision|22
7511818|NCT03052517|26073396|P2|Overall Study|Subject/Guardian Decision|45
7511819|NCT03052517|26073397|P1|Overall Study|Subject/Guardian Decision|50
7511820|NCT03052517|26073395|P3|Overall Study|Study Terminated By Sponsor|296
7511821|NCT03052517|26073396|P2|Overall Study|Study Terminated By Sponsor|938
7511822|NCT03052517|26073397|P1|Overall Study|Study Terminated By Sponsor|928
7511823|NCT03052426|26073441|P3|Overall Study|Lost to Follow-up|1
7511824|NCT03052426|26073442|P2|Overall Study|Lost to Follow-up|0
7511825|NCT03052426|26073443|P1|Overall Study|Lost to Follow-up|2
7511826|NCT03052426|26073441|P3|Overall Study|Withdrawal by Subject|0
7511827|NCT03052426|26073442|P2|Overall Study|Withdrawal by Subject|1
7511828|NCT03052426|26073443|P1|Overall Study|Withdrawal by Subject|0
7511829|NCT03052322|26073458|P2|Overall Study|Adverse Event|13
7511830|NCT03052322|26073459|P1|Overall Study|Adverse Event|6
7511831|NCT03052322|26073458|P2|Overall Study|Lost to Follow-up|4
7511832|NCT03052322|26073459|P1|Overall Study|Lost to Follow-up|2
7511833|NCT03052322|26073458|P2|Overall Study|Protocol Violation|0
7511834|NCT03052322|26073459|P1|Overall Study|Protocol Violation|1
7511835|NCT03052322|26073458|P2|Overall Study|Lack of Efficacy|2
7511836|NCT03052322|26073459|P1|Overall Study|Lack of Efficacy|1
7511837|NCT03052322|26073458|P2|Overall Study|Death|2
7511838|NCT03052322|26073459|P1|Overall Study|Death|0
7511839|NCT03052322|26073458|P2|Overall Study|Withdrawal by Subject|9
7511840|NCT03052322|26073459|P1|Overall Study|Withdrawal by Subject|10
7511841|NCT03052322|26073458|P2|Overall Study|Other un-specified|2
7511842|NCT03052322|26073459|P1|Overall Study|Other un-specified|1
7511843|NCT03051620|26073549|P1|Overall Study|n=124 enrolled in extension (all completed)|12
7511844|NCT03051620|26073549|P1|Overall Study|Lost to Follow-up|6
7511845|NCT03051607|26073557|P1|Overall Study|Adverse Event|66
7511846|NCT03051217|26073620|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7511847|NCT03051217|26073621|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
7511848|NCT03051217|26073622|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7511849|NCT03051217|26073623|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7511850|NCT03051217|26073624|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7511851|NCT03051217|26073625|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7511852|NCT03051217|26073626|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7511853|NCT03051217|26073620|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7511854|NCT03051217|26073621|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7511855|NCT03051217|26073622|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
7511856|NCT03051217|26073623|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7511857|NCT03051217|26073624|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7511858|NCT03051217|26073625|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7511859|NCT03051217|26073626|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7511860|NCT03051217|26073620|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7511861|NCT03051217|26073621|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7511862|NCT03051217|26073622|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7511863|NCT03051217|26073623|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
7511864|NCT03051217|26073624|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7511865|NCT03051217|26073625|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7511866|NCT03051217|26073626|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7511867|NCT03051217|26073620|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7511868|NCT03051217|26073621|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7511869|NCT03051217|26073622|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7511870|NCT03051217|26073623|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
7511871|NCT03051217|26073624|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7511872|NCT03051217|26073625|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7511873|NCT03051217|26073626|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7511874|NCT03051217|26073620|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7511875|NCT03051217|26073621|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7511876|NCT03051217|26073622|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
7511877|NCT03051217|26073623|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7511878|NCT03051217|26073624|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7511879|NCT03051217|26073625|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7511880|NCT03051217|26073626|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7511881|NCT03051217|26073620|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7511882|NCT03051217|26073621|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7511883|NCT03051217|26073622|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7511884|NCT03051217|26073623|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7511885|NCT03051217|26073624|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7511886|NCT03051217|26073625|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7511887|NCT03051217|26073626|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7511888|NCT03051217|26073620|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7511889|NCT03051217|26073621|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7511890|NCT03051217|26073622|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7511891|NCT03051217|26073623|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7511892|NCT03051217|26073624|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7511893|NCT03051217|26073625|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
7511894|NCT03051217|26073626|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7511895|NCT03051217|26073620|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
7511896|NCT03051217|26073621|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
7511897|NCT03051217|26073622|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
7511898|NCT03051217|26073623|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
7511899|NCT03051217|26073624|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
7511900|NCT03051217|26073625|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
7511901|NCT03051217|26073626|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
7511902|NCT03051165|26073655|P1|Overall Study|Early termination of study|12
7511903|NCT03051165|26073655|P1|Overall Study|Withdrawal by Subject|1
7511904|NCT03051100|26073669|P2|Overall Study|Withdrawal by Subject|0
7511905|NCT03051100|26073670|P1|Overall Study|Withdrawal by Subject|1
7511906|NCT03050801|26073713|P6|Experiment 2|Discomfort during stimulation|2
7511907|NCT03050801|26073714|P5|Experiment 2|Discomfort during stimulation|0
7511908|NCT03050801|26073715|P4|Experiment 2|Discomfort during stimulation|0
7511909|NCT03050801|26073716|P3|Experiment 2|Discomfort during stimulation|0
7511910|NCT03050801|26073717|P2|Experiment 2|Discomfort during stimulation|0
7511911|NCT03050801|26073718|P1|Experiment 2|Discomfort during stimulation|0
7511912|NCT03050801|26073713|P6|Experiment 2|Poor data quality|0
7511913|NCT03050801|26073714|P5|Experiment 2|Poor data quality|1
7511914|NCT03050801|26073715|P4|Experiment 2|Poor data quality|4
7511915|NCT03050801|26073716|P3|Experiment 2|Poor data quality|0
7511916|NCT03050801|26073717|P2|Experiment 2|Poor data quality|0
7511917|NCT03050801|26073718|P1|Experiment 2|Poor data quality|0
7511918|NCT03050801|26073713|P6|Experiment 2|Withdrawal by Subject|0
7511919|NCT03050801|26073714|P5|Experiment 2|Withdrawal by Subject|0
7511920|NCT03050801|26073715|P4|Experiment 2|Withdrawal by Subject|1
7511921|NCT03050801|26073716|P3|Experiment 2|Withdrawal by Subject|0
7511922|NCT03050801|26073717|P2|Experiment 2|Withdrawal by Subject|0
7511923|NCT03050801|26073718|P1|Experiment 2|Withdrawal by Subject|0
7511924|NCT03050801|26073713|P6|Experiment 2|Pregnancy|0
7511925|NCT03050801|26073714|P5|Experiment 2|Pregnancy|1
7511926|NCT03050801|26073715|P4|Experiment 2|Pregnancy|0
7511927|NCT03050801|26073716|P3|Experiment 2|Pregnancy|0
7511928|NCT03050801|26073717|P2|Experiment 2|Pregnancy|0
7511929|NCT03050801|26073718|P1|Experiment 2|Pregnancy|0
7511930|NCT03050801|26073713|P6|Experiment 2|Physician Decision|0
7511931|NCT03050801|26073714|P5|Experiment 2|Physician Decision|1
7511932|NCT03050801|26073715|P4|Experiment 2|Physician Decision|0
7511933|NCT03050801|26073716|P3|Experiment 2|Physician Decision|0
7511934|NCT03050801|26073717|P2|Experiment 2|Physician Decision|0
7511935|NCT03050801|26073718|P1|Experiment 2|Physician Decision|0
7511936|NCT03050801|26073713|P6|Experiment 2|Lost to Follow-up|0
7511937|NCT03050801|26073714|P5|Experiment 2|Lost to Follow-up|1
7511938|NCT03050801|26073715|P4|Experiment 2|Lost to Follow-up|1
7511939|NCT03050801|26073716|P3|Experiment 2|Lost to Follow-up|0
7511940|NCT03050801|26073717|P2|Experiment 2|Lost to Follow-up|0
7511941|NCT03050801|26073718|P1|Experiment 2|Lost to Follow-up|0
7511942|NCT03050801|26073713|P6|Experiment 1|Unable to obtain critical rTMS measure|0
7511943|NCT03050801|26073714|P5|Experiment 1|Unable to obtain critical rTMS measure|0
7511944|NCT03050801|26073715|P4|Experiment 1|Unable to obtain critical rTMS measure|0
7511945|NCT03050801|26073716|P3|Experiment 1|Unable to obtain critical rTMS measure|2
7511946|NCT03050801|26073717|P2|Experiment 1|Unable to obtain critical rTMS measure|0
7511947|NCT03050801|26073718|P1|Experiment 1|Unable to obtain critical rTMS measure|0
7511948|NCT03050801|26073713|P6|Experiment 1|Change of experimental design|0
7511949|NCT03050801|26073714|P5|Experiment 1|Change of experimental design|0
7511950|NCT03050801|26073715|P4|Experiment 1|Change of experimental design|0
7511951|NCT03050801|26073716|P3|Experiment 1|Change of experimental design|0
7511952|NCT03050801|26073717|P2|Experiment 1|Change of experimental design|3
7511953|NCT03050801|26073718|P1|Experiment 1|Change of experimental design|0
7511954|NCT03050801|26073713|P6|Experiment 1|Physician Decision|0
7511955|NCT03050801|26073714|P5|Experiment 1|Physician Decision|0
7511956|NCT03050801|26073715|P4|Experiment 1|Physician Decision|0
7511957|NCT03050801|26073716|P3|Experiment 1|Physician Decision|0
7511958|NCT03050801|26073717|P2|Experiment 1|Physician Decision|3
7511959|NCT03050801|26073718|P1|Experiment 1|Physician Decision|0
7511960|NCT03050801|26073713|P6|Experiment 1|Lost to Follow-up|0
7511961|NCT03050801|26073714|P5|Experiment 1|Lost to Follow-up|0
7511962|NCT03050801|26073715|P4|Experiment 1|Lost to Follow-up|0
7511963|NCT03050801|26073716|P3|Experiment 1|Lost to Follow-up|0
7511964|NCT03050801|26073717|P2|Experiment 1|Lost to Follow-up|1
7511965|NCT03050801|26073718|P1|Experiment 1|Lost to Follow-up|0
7511966|NCT03050450|26073956|P5|Overall Study|Physician Decision|0
7511967|NCT03050450|26073957|P4|Overall Study|Physician Decision|0
7511968|NCT03050450|26073958|P3|Overall Study|Physician Decision|0
7511969|NCT03050450|26073959|P2|Overall Study|Physician Decision|0
7511970|NCT03050450|26073960|P1|Overall Study|Physician Decision|1
7511971|NCT03050398|26073987|P1|Overall Study|Study terminated by sponsor|8
7511972|NCT03050372|26073992|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
7511973|NCT03050372|26073993|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
7511974|NCT03050372|26073992|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
7511975|NCT03050372|26073993|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
7511976|NCT03050359|26074016|P2|Overall Study|Reason Not Specified|0
7511977|NCT03050359|26074017|P1|Overall Study|Reason Not Specified|1
7511978|NCT03050359|26074016|P2|Overall Study|Pregnancy|0
7511979|NCT03050359|26074017|P1|Overall Study|Pregnancy|1
7511980|NCT03050359|26074016|P2|Overall Study|Voluntary Withdrawal|6
7511981|NCT03050359|26074017|P1|Overall Study|Voluntary Withdrawal|4
7511982|NCT03050359|26074016|P2|Overall Study|Lost to Follow-up|1
7511983|NCT03050359|26074017|P1|Overall Study|Lost to Follow-up|2
7511984|NCT03050359|26074016|P2|Overall Study|Significant Protocol Deviation|3
7511985|NCT03050359|26074017|P1|Overall Study|Significant Protocol Deviation|2
7511986|NCT03050359|26074016|P2|Overall Study|Pretreatment Event/Adverse Event|10
7511987|NCT03050359|26074017|P1|Overall Study|Pretreatment Event/Adverse Event|5
7511988|NCT03050359|26074016|P2|Overall Study|Randomized But Not Treated|0
7511989|NCT03050359|26074017|P1|Overall Study|Randomized But Not Treated|2
7511990|NCT03050307|26074064|P2|Overall Study|Reason not Specified|1
7511991|NCT03050307|26074065|P1|Overall Study|Reason not Specified|1
7511992|NCT03050307|26074064|P2|Overall Study|Voluntary Withdrawal|4
7511993|NCT03050307|26074065|P1|Overall Study|Voluntary Withdrawal|3
7511994|NCT03050307|26074064|P2|Overall Study|Lost to Follow-up|1
7511995|NCT03050307|26074065|P1|Overall Study|Lost to Follow-up|0
7511996|NCT03050307|26074064|P2|Overall Study|Significant Protocol Deviation|1
7511997|NCT03050307|26074065|P1|Overall Study|Significant Protocol Deviation|0
7511998|NCT03050307|26074064|P2|Overall Study|Adverse Event|2
7511999|NCT03050307|26074065|P1|Overall Study|Adverse Event|4
7512000|NCT03049852|26074190|P3|Overall Study|Lost to Follow-up|0
7512001|NCT03049852|26074191|P2|Overall Study|Lost to Follow-up|1
7512002|NCT03049852|26074192|P1|Overall Study|Lost to Follow-up|0
7512003|NCT03049748|26074204|P2|Overall Study|Moved out of state (relocation)|1
7512004|NCT03049748|26074205|P1|Overall Study|Moved out of state (relocation)|0
7512005|NCT03049748|26074204|P2|Overall Study|Protocol Violation|2
7512006|NCT03049748|26074205|P1|Overall Study|Protocol Violation|0
7512007|NCT03049748|26074204|P2|Overall Study|Withdrawal by Subject|3
7512008|NCT03049748|26074205|P1|Overall Study|Withdrawal by Subject|0
7512009|NCT03049748|26074204|P2|Overall Study|Death|0
7512010|NCT03049748|26074205|P1|Overall Study|Death|3
7512011|NCT03049748|26074204|P2|Overall Study|Lost to Follow-up|0
7512012|NCT03049748|26074205|P1|Overall Study|Lost to Follow-up|1
7512013|NCT03049488|26074246|P6|Overall Study|Withdrawal by Subject|0
7512014|NCT03049488|26074247|P5|Overall Study|Withdrawal by Subject|1
7512015|NCT03049488|26074248|P4|Overall Study|Withdrawal by Subject|1
7512016|NCT03049488|26074249|P3|Overall Study|Withdrawal by Subject|0
7512017|NCT03049488|26074250|P2|Overall Study|Withdrawal by Subject|0
7512018|NCT03049488|26074251|P1|Overall Study|Withdrawal by Subject|0
7512019|NCT03049488|26074246|P6|Overall Study|Physician Decision|0
7512020|NCT03049488|26074247|P5|Overall Study|Physician Decision|0
7512021|NCT03049488|26074248|P4|Overall Study|Physician Decision|0
7512022|NCT03049488|26074249|P3|Overall Study|Physician Decision|0
7512023|NCT03049488|26074250|P2|Overall Study|Physician Decision|1
7512024|NCT03049488|26074251|P1|Overall Study|Physician Decision|0
7512025|NCT03049488|26074246|P6|Overall Study|Moved from Area|0
7512026|NCT03049488|26074247|P5|Overall Study|Moved from Area|1
7512027|NCT03049488|26074248|P4|Overall Study|Moved from Area|1
7512028|NCT03049488|26074249|P3|Overall Study|Moved from Area|0
7512029|NCT03049488|26074250|P2|Overall Study|Moved from Area|0
7512030|NCT03049488|26074251|P1|Overall Study|Moved from Area|1
7512031|NCT03049488|26074246|P6|Overall Study|Lost to Follow-up|0
7512032|NCT03049488|26074247|P5|Overall Study|Lost to Follow-up|0
7512033|NCT03049488|26074248|P4|Overall Study|Lost to Follow-up|0
7512034|NCT03049488|26074249|P3|Overall Study|Lost to Follow-up|0
7512035|NCT03049488|26074250|P2|Overall Study|Lost to Follow-up|1
7512036|NCT03049488|26074251|P1|Overall Study|Lost to Follow-up|1
7512037|NCT03049280|26074334|P1|Overall Study|Physician Decision|1
7512038|NCT03048747|26074359|P1|Overall Study|Physician Decision|1
7512039|NCT03048747|26074359|P1|Overall Study|Participant Met Withdrawal Criteria|2
7512040|NCT03048747|26074359|P1|Overall Study|Adverse Event|2
7512041|NCT03048500|26074364|P1|Follow up for 3 Years|Death|12
7512042|NCT03048500|26074364|P1|Follow up for 3 Years|Currently in Follow-up|4
7512043|NCT03048500|26074364|P1|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
7512044|NCT03048500|26074364|P1|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
7512045|NCT03048500|26074364|P1|Reached 1st Response/Continued Treatment|Death|1
7512046|NCT03048500|26074364|P1|Reached 1st Response/Continued Treatment|Progressive Disease|4
7512047|NCT03048500|26074364|P1|2 Cycles of Treatment|Withdrawal by Subject|1
7512048|NCT03048058|26074387|P2|Overall Study|Withdrawal by Subject|4
7512049|NCT03048058|26074388|P1|Overall Study|Withdrawal by Subject|0
7512050|NCT03048058|26074387|P2|Overall Study|Lost to Follow-up|0
7512051|NCT03048058|26074388|P1|Overall Study|Lost to Follow-up|4
7512052|NCT03047720|26074414|P2|First Intervention (6weeks)|Participant data entry insufficient|0
7512053|NCT03047720|26074415|P1|First Intervention (6weeks)|Participant data entry insufficient|7
7512054|NCT03047551|26074429|P2|Overall Study|Ineligible|1
7512055|NCT03047551|26074430|P1|Overall Study|Ineligible|0
7512056|NCT03047551|26074429|P2|Overall Study|Probe malfunction|1
7512057|NCT03047551|26074430|P1|Overall Study|Probe malfunction|0
7512058|NCT03047551|26074429|P2|Overall Study|Withdrawal by Subject|1
7512059|NCT03047551|26074430|P1|Overall Study|Withdrawal by Subject|0
7512060|NCT03047551|26074429|P2|Overall Study|Physician Decision|0
7512061|NCT03047551|26074430|P1|Overall Study|Physician Decision|1
7512062|NCT03047551|26074429|P2|Overall Study|Did not receive TAS|0
7512063|NCT03047551|26074430|P1|Overall Study|Did not receive TAS|1
7512064|NCT03046446|26074522|P1|Overall Study|Non OA related knee surgery|1
7512065|NCT03046446|26074522|P1|Overall Study|Disease Progression (see caveats)|25
7512066|NCT03046446|26074522|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
7512067|NCT03046446|26074522|P1|Overall Study|Withdrawal by Subject|14
7512068|NCT03046446|26074522|P1|Overall Study|Lost to Follow-up|3
7512069|NCT03046446|26074522|P1|Overall Study|Adverse Event|6
7512070|NCT03046446|26074522|P1|Overall Study|Lack of Efficacy|7
7512071|NCT03046056|26074559|P3|Overall Study|Withdrew Consent|0
7512072|NCT03046056|26074560|P2|Overall Study|Withdrew Consent|0
7512073|NCT03046056|26074561|P1|Overall Study|Withdrew Consent|1
7512074|NCT03046056|26074559|P3|Overall Study|Investigator's Discretion|0
7512075|NCT03046056|26074560|P2|Overall Study|Investigator's Discretion|1
7512076|NCT03046056|26074561|P1|Overall Study|Investigator's Discretion|0
7512077|NCT03046056|26074559|P3|Overall Study|Protocol Violation|0
7512078|NCT03046056|26074560|P2|Overall Study|Protocol Violation|1
7512079|NCT03046056|26074561|P1|Overall Study|Protocol Violation|1
7512080|NCT03046056|26074559|P3|Overall Study|Non-compliance With Study Drug|2
7512081|NCT03046056|26074560|P2|Overall Study|Non-compliance With Study Drug|0
7512082|NCT03046056|26074561|P1|Overall Study|Non-compliance With Study Drug|0
7512083|NCT03046056|26074559|P3|Overall Study|Adverse Event|0
7512084|NCT03046056|26074560|P2|Overall Study|Adverse Event|5
7512085|NCT03046056|26074561|P1|Overall Study|Adverse Event|1
7512086|NCT03046056|26074559|P3|Overall Study|Protocol-specified Disease Worsening|1
7512087|NCT03046056|26074560|P2|Overall Study|Protocol-specified Disease Worsening|3
7512088|NCT03046056|26074561|P1|Overall Study|Protocol-specified Disease Worsening|3
7512089|NCT03046056|26074559|P3|Overall Study|Non-responder at Week 10|4
7512090|NCT03046056|26074560|P2|Overall Study|Non-responder at Week 10|6
7512091|NCT03046056|26074561|P1|Overall Study|Non-responder at Week 10|6
7512092|NCT03045887|26074640|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512093|NCT03045887|26074641|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512094|NCT03045887|26074642|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512095|NCT03045887|26074643|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512096|NCT03045887|26074644|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512097|NCT03045887|26074645|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512098|NCT03045887|26074646|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
7512099|NCT03045887|26074647|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512100|NCT03045887|26074648|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512101|NCT03045887|26074649|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7512102|NCT03045887|26074640|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512103|NCT03045887|26074641|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512104|NCT03045887|26074642|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512105|NCT03045887|26074643|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512106|NCT03045887|26074644|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512107|NCT03045887|26074645|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512108|NCT03045887|26074646|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7512109|NCT03045887|26074647|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7512110|NCT03045887|26074648|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512111|NCT03045887|26074649|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7512112|NCT03045887|26074640|P10|Part A, Period 2 (1 Day)|Adverse Event|0
7512113|NCT03045887|26074641|P9|Part A, Period 2 (1 Day)|Adverse Event|0
7512114|NCT03045887|26074642|P8|Part A, Period 2 (1 Day)|Adverse Event|0
7512115|NCT03045887|26074643|P7|Part A, Period 2 (1 Day)|Adverse Event|0
7512116|NCT03045887|26074644|P6|Part A, Period 2 (1 Day)|Adverse Event|0
7512117|NCT03045887|26074645|P5|Part A, Period 2 (1 Day)|Adverse Event|0
7512118|NCT03045887|26074646|P4|Part A, Period 2 (1 Day)|Adverse Event|0
7512119|NCT03045887|26074647|P3|Part A, Period 2 (1 Day)|Adverse Event|0
7512120|NCT03045887|26074648|P2|Part A, Period 2 (1 Day)|Adverse Event|0
7512121|NCT03045887|26074649|P1|Part A, Period 2 (1 Day)|Adverse Event|1
7512122|NCT03045887|26074640|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512123|NCT03045887|26074641|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512124|NCT03045887|26074642|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512125|NCT03045887|26074643|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512126|NCT03045887|26074644|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512127|NCT03045887|26074645|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512128|NCT03045887|26074646|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
7512129|NCT03045887|26074647|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512130|NCT03045887|26074648|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512131|NCT03045887|26074649|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7512132|NCT03045887|26074640|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512133|NCT03045887|26074641|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512134|NCT03045887|26074642|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512135|NCT03045887|26074643|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512136|NCT03045887|26074644|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512137|NCT03045887|26074645|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512138|NCT03045887|26074646|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512139|NCT03045887|26074647|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512140|NCT03045887|26074648|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7512141|NCT03045887|26074649|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
7512142|NCT03045328|26074931|P1|Overall Study|Withdrawal by Subject|2
7512143|NCT03045302|26074942|P1|Overall Study|Pre-treatment adverse event|1
7512144|NCT03045081|26074948|P2|Overall Study|Withdrawal by Subject|11
7512145|NCT03045081|26074949|P1|Overall Study|Withdrawal by Subject|6
7512146|NCT03044886|26074968|P3|Overall Study|Lost to Follow-up|12
7512147|NCT03044886|26074969|P2|Overall Study|Lost to Follow-up|10
7512148|NCT03044886|26074970|P1|Overall Study|Lost to Follow-up|15
7512149|NCT03044730|26075011|P1|On Follow-up for 2 Years|Death|17
7512150|NCT03044730|26075011|P1|On Follow-up for 2 Years|Lost to Follow-up|1
7512151|NCT03044730|26075011|P1|On Follow-up for 2 Years|Still in follow-up|7
7512152|NCT03044730|26075011|P1|Cycles 4 and Beyond|Adverse Event|1
7512153|NCT03044730|26075011|P1|Cycles 4 and Beyond|Progressive Disease|9
7512154|NCT03044730|26075011|P1|3 Cycles of Pembro + Capecitab|Adverse Event|1
7512155|NCT03044730|26075011|P1|3 Cycles of Pembro + Capecitab|Death|1
7512156|NCT03044730|26075011|P1|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
7512157|NCT03044730|26075011|P1|3 Cycles of Pembro + Capecitab|Progressive Disease|1
7512158|NCT03044574|26075031|P2|Overall Study|Lost to Follow-up|45
7512159|NCT03044574|26075032|P1|Overall Study|Lost to Follow-up|37
7512160|NCT03044431|26075058|P1|Overall Study|Lost to Follow-up|59
7512161|NCT03044353|26075075|P3|Overall Study|Adverse Event|0
7512162|NCT03044353|26075076|P2|Overall Study|Adverse Event|1
7512163|NCT03044353|26075077|P1|Overall Study|Adverse Event|0
7512164|NCT03044249|26075160|P2|Overall Study|Withdrawal by Subject|5
7512165|NCT03044249|26075161|P1|Overall Study|Withdrawal by Subject|2
7512166|NCT03044249|26075160|P2|Overall Study|Study Terminated by Sponsor|0
7512167|NCT03044249|26075161|P1|Overall Study|Study Terminated by Sponsor|2
7512168|NCT03044249|26075160|P2|Overall Study|Non-compliance with Study Drug|0
7512169|NCT03044249|26075161|P1|Overall Study|Non-compliance with Study Drug|1
7512170|NCT03044249|26075160|P2|Overall Study|Lost to Follow-up|0
7512171|NCT03044249|26075161|P1|Overall Study|Lost to Follow-up|1
7512172|NCT03044249|26075160|P2|Overall Study|Adverse Event|9
7512173|NCT03044249|26075161|P1|Overall Study|Adverse Event|4
7512174|NCT03044197|26075185|P2|Overall Study|Withdrawal by Subject|1
7512175|NCT03044197|26075186|P1|Overall Study|Withdrawal by Subject|3
7512176|NCT03044106|26075196|P2|Washout (1 Week)|Withdrawal by Subject|2
7512177|NCT03044106|26075197|P1|Washout (1 Week)|Withdrawal by Subject|0
7512178|NCT03043872|26075272|P3|Overall Study|Death|225
7512179|NCT03043872|26075273|P2|Overall Study|Death|207
7512180|NCT03043872|26075274|P1|Overall Study|Death|204
7512181|NCT03043872|26075272|P3|Overall Study|Lost to Follow-up|1
7512182|NCT03043872|26075273|P2|Overall Study|Lost to Follow-up|1
7512183|NCT03043872|26075274|P1|Overall Study|Lost to Follow-up|2
7512184|NCT03043872|26075272|P3|Overall Study|Withdrawal by Subject|12
7512185|NCT03043872|26075273|P2|Overall Study|Withdrawal by Subject|4
7512186|NCT03043872|26075274|P1|Overall Study|Withdrawal by Subject|6
7512187|NCT03043651|26075317|P1|Overall Study|Study Terminated by Sponsor|39
7512188|NCT03043651|26075317|P1|Overall Study|Withdrawal by Subject|4
7512189|NCT03043651|26075317|P1|Overall Study|Adverse Event|2
7512190|NCT03043651|26075317|P1|Overall Study|Progressive Disease|2
7512191|NCT03043651|26075317|P1|Overall Study|Death|1
7512192|NCT03043560|26075329|P2|Overall Study|Lost to Follow-up|1
7512193|NCT03043560|26075330|P1|Overall Study|Lost to Follow-up|0
7512194|NCT03043560|26075329|P2|Overall Study|Discontinued Intervention|2
7512195|NCT03043560|26075330|P1|Overall Study|Discontinued Intervention|1
7512196|NCT03043365|26075371|P2|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
7512197|NCT03043365|26075372|P1|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
7512198|NCT03043365|26075371|P2|Weeks 0 to Week 8|Lost to Follow-up|0
7512199|NCT03043365|26075372|P1|Weeks 0 to Week 8|Lost to Follow-up|2
7512200|NCT03043365|26075371|P2|Weeks 0 to Week 8|Adverse Event|3
7512201|NCT03043365|26075372|P1|Weeks 0 to Week 8|Adverse Event|1
7512202|NCT03042910|26075426|P1|Overall Study|Enrolled but not treated|1
7512203|NCT03042910|26075426|P1|Overall Study|Withdrawal by Subject|3
7512204|NCT03042910|26075426|P1|Overall Study|Disease Progression|2
7512205|NCT03042910|26075426|P1|Overall Study|Adverse Event|1
7512206|NCT03042767|26075457|P2|Overall Study|Lost to Follow-up|2
7512207|NCT03042767|26075458|P1|Overall Study|Lost to Follow-up|1
7512208|NCT03042559|26075509|P2|Overall Study|drop out|1
7512209|NCT03042559|26075510|P1|Overall Study|drop out|1
7512210|NCT03042312|26075572|P2|Overall Study|Withdrawal by Subject|5
7512211|NCT03042312|26075573|P1|Overall Study|Withdrawal by Subject|4
7512212|NCT03042312|26075572|P2|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
7512213|NCT03042312|26075573|P1|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
7512214|NCT03042312|26075572|P2|Overall Study|Lost to Follow-up|3
7512215|NCT03042312|26075573|P1|Overall Study|Lost to Follow-up|1
7512216|NCT03042312|26075572|P2|Overall Study|Adverse Event|1
7512217|NCT03042312|26075573|P1|Overall Study|Adverse Event|0
7512218|NCT03042312|26075572|P2|Overall Study|Administrative Reason|1
7512219|NCT03042312|26075573|P1|Overall Study|Administrative Reason|1
7512220|NCT03041792|26075672|P2|Overall Study|Randomized but not treated|1
7512221|NCT03041792|26075673|P1|Overall Study|Randomized but not treated|0
7512222|NCT03041792|26075672|P2|Overall Study|Death in the family|2
7512223|NCT03041792|26075673|P1|Overall Study|Death in the family|0
7512224|NCT03041792|26075672|P2|Overall Study|Adverse Event|0
7512225|NCT03041792|26075673|P1|Overall Study|Adverse Event|4
7512226|NCT03041181|26075753|P2|Overall Study|Disease Progression|2
7512227|NCT03041181|26075754|P1|Overall Study|Disease Progression|1
7512228|NCT03041116|26075770|P2|Open-label|Withdrawal by Subject|0
7512229|NCT03041116|26075771|P1|Open-label|Withdrawal by Subject|1
7512230|NCT03041116|26075770|P2|Open-label|Termination of the study by Sponsor|37
7512231|NCT03041116|26075771|P1|Open-label|Termination of the study by Sponsor|39
7512232|NCT03041116|26075770|P2|Open-label|Death|0
7512233|NCT03041116|26075771|P1|Open-label|Death|1
7512234|NCT03041116|26075770|P2|Double-blind|Withdrawal by Subject|4
7512235|NCT03041116|26075771|P1|Double-blind|Withdrawal by Subject|0
7512236|NCT03041116|26075770|P2|Double-blind|Death|2
7512237|NCT03041116|26075771|P1|Double-blind|Death|0
7512238|NCT03041090|26075787|P2|Overall Study|technical error|3
7512239|NCT03041090|26075788|P1|Overall Study|technical error|0
7512240|NCT03041038|26075800|P2|Overall Study|Protocol Violation|1
7512241|NCT03041038|26075801|P1|Overall Study|Protocol Violation|1
7512242|NCT03041038|26075800|P2|Overall Study|Lost to Follow-up|1
7512243|NCT03041038|26075801|P1|Overall Study|Lost to Follow-up|1
7512244|NCT03041038|26075800|P2|Overall Study|Withdrawal by Subject|0
7512245|NCT03041038|26075801|P1|Overall Study|Withdrawal by Subject|4
7512246|NCT03041025|26075814|P3|Overall Study|Withdrawal by Subject|1
7512247|NCT03041025|26075815|P2|Overall Study|Withdrawal by Subject|0
7512248|NCT03041025|26075816|P1|Overall Study|Withdrawal by Subject|0
7512249|NCT03041025|26075814|P3|Overall Study|Lost to Follow-up|0
7512250|NCT03041025|26075815|P2|Overall Study|Lost to Follow-up|0
7512251|NCT03041025|26075816|P1|Overall Study|Lost to Follow-up|1
7512252|NCT03041025|26075814|P3|Overall Study|Adverse Event|1
7512253|NCT03041025|26075815|P2|Overall Study|Adverse Event|0
7512254|NCT03041025|26075816|P1|Overall Study|Adverse Event|0
7512255|NCT03040986|26075901|P2|Overall Study|Disease progression on study|1
7512256|NCT03040986|26075902|P1|Overall Study|Disease progression on study|3
7512257|NCT03040986|26075901|P2|Overall Study|Adverse Event|1
7512258|NCT03040986|26075902|P1|Overall Study|Adverse Event|2
7512259|NCT03040986|26075901|P2|Overall Study|Hospice|0
7512260|NCT03040986|26075902|P1|Overall Study|Hospice|1
7512261|NCT03040713|26075941|P1|Overall Study|Positive amyloid scan|3
7512262|NCT03040687|26075949|P3|Overall Study|Withdrawal by Subject|0
7512263|NCT03040687|26075950|P2|Overall Study|Withdrawal by Subject|0
7512264|NCT03040687|26075951|P1|Overall Study|Withdrawal by Subject|1
7512265|NCT03040674|26075962|P1|Overall Study|Death|23
7512266|NCT03040674|26075962|P1|Overall Study|Lost to Follow-up|225
7512267|NCT03040336|26076072|P2|Overall Study|Withdrawal by Subject|3
7512268|NCT03040336|26076073|P1|Overall Study|Withdrawal by Subject|2
7512269|NCT03040336|26076072|P2|Overall Study|Death|0
7512270|NCT03040336|26076073|P1|Overall Study|Death|1
7512271|NCT03040024|26076126|P3|Overall Study|Physician Decision|1
7512272|NCT03040024|26076127|P2|Overall Study|Physician Decision|0
7512273|NCT03040024|26076128|P1|Overall Study|Physician Decision|0
7512274|NCT03040024|26076126|P3|Overall Study|Death|0
7512275|NCT03040024|26076127|P2|Overall Study|Death|1
7512276|NCT03040024|26076128|P1|Overall Study|Death|0
7512277|NCT03040024|26076126|P3|Overall Study|Adverse Event|0
7512278|NCT03040024|26076127|P2|Overall Study|Adverse Event|1
7512279|NCT03040024|26076128|P1|Overall Study|Adverse Event|0
7512280|NCT03039738|26076229|P2|Overall Study|Incomplete data sets|0
7512281|NCT03039738|26076230|P1|Overall Study|Incomplete data sets|54
7512282|NCT03039699|26076252|P2|Overall Study|Bacterial infection|28
7512283|NCT03039699|26076253|P1|Overall Study|Bacterial infection|12
7512284|NCT03039699|26076252|P2|Overall Study|Lack of data to assess study endpoint|3
7512285|NCT03039699|26076253|P1|Overall Study|Lack of data to assess study endpoint|5
7512286|NCT03039699|26076252|P2|Overall Study|Incorrect inclusion|4
7512287|NCT03039699|26076253|P1|Overall Study|Incorrect inclusion|5
7512288|NCT03039686|26076276|P3|Open Label Period|Withdrawal by Subject|1
7512289|NCT03039686|26076277|P2|Open Label Period|Withdrawal by Subject|3
7512290|NCT03039686|26076278|P1|Open Label Period|Withdrawal by Subject|0
7512291|NCT03039686|26076276|P3|Open Label Period|Subject Request to Discontinue Study Treatment|0
7512292|NCT03039686|26076277|P2|Open Label Period|Subject Request to Discontinue Study Treatment|1
7512293|NCT03039686|26076278|P1|Open Label Period|Subject Request to Discontinue Study Treatment|0
7512294|NCT03039686|26076276|P3|Open Label Period|Administrative Reason by Sponsor|41
7512295|NCT03039686|26076277|P2|Open Label Period|Administrative Reason by Sponsor|34
7512296|NCT03039686|26076278|P1|Open Label Period|Administrative Reason by Sponsor|0
7512297|NCT03039686|26076276|P3|Double-blind Period|Death|1
7512298|NCT03039686|26076277|P2|Double-blind Period|Death|0
7512299|NCT03039686|26076278|P1|Double-blind Period|Death|0
7512300|NCT03039686|26076276|P3|Double-blind Period|Withdrawal by Subject|1
7512301|NCT03039686|26076277|P2|Double-blind Period|Withdrawal by Subject|2
7512302|NCT03039686|26076278|P1|Double-blind Period|Withdrawal by Subject|2
7512303|NCT03039686|26076276|P3|Double-blind Period|Subject Request to Discontinue Study Treatment|0
7512304|NCT03039686|26076277|P2|Double-blind Period|Subject Request to Discontinue Study Treatment|2
7512305|NCT03039686|26076278|P1|Double-blind Period|Subject Request to Discontinue Study Treatment|1
7512306|NCT03039686|26076276|P3|Double-blind Period|Administrative Reason by Sponsor|21
7512307|NCT03039686|26076277|P2|Double-blind Period|Administrative Reason by Sponsor|25
7512308|NCT03039686|26076278|P1|Double-blind Period|Administrative Reason by Sponsor|24
7512309|NCT03039621|26076344|P2|Overall Study|Violation of non-inclusion criteria|2
7512310|NCT03039621|26076345|P1|Overall Study|Violation of non-inclusion criteria|1
7512311|NCT03039621|26076344|P2|Overall Study|Necessity to use drugs forbidden by pro|7
7512312|NCT03039621|26076345|P1|Overall Study|Necessity to use drugs forbidden by pro|4
7512313|NCT03039621|26076344|P2|Overall Study|Non-compliance with protocol requirement|5
7512314|NCT03039621|26076345|P1|Overall Study|Non-compliance with protocol requirement|4
7512315|NCT03039621|26076344|P2|Overall Study|Violation of inclusion criteria|2
7512316|NCT03039621|26076345|P1|Overall Study|Violation of inclusion criteria|3
7512317|NCT03039569|26076369|P2|Overall Study|Lost to Follow-up|4
7512318|NCT03039569|26076370|P1|Overall Study|Lost to Follow-up|5
7512319|NCT03039283|26076415|P1|Overall Study|Protocol Violation|2
7512320|NCT03039192|26076426|P2|Overall Study|Other|2
7512321|NCT03039192|26076427|P1|Overall Study|Other|3
7512322|NCT03039192|26076426|P2|Overall Study|Discontinued from treatment phase|12
7512323|NCT03039192|26076427|P1|Overall Study|Discontinued from treatment phase|19
7512324|NCT03039192|26076426|P2|Overall Study|Withdrawal by Subject|9
7512325|NCT03039192|26076427|P1|Overall Study|Withdrawal by Subject|6
7512326|NCT03039192|26076426|P2|Overall Study|Adverse event, non-fatal|2
7512327|NCT03039192|26076427|P1|Overall Study|Adverse event, non-fatal|0
7512328|NCT03039192|26076426|P2|Overall Study|Adverse event, serious fatal|1
7512329|NCT03039192|26076427|P1|Overall Study|Adverse event, serious fatal|0
7512330|NCT03039192|26076426|P2|Overall Study|Lost to Follow-up|4
7512331|NCT03039192|26076427|P1|Overall Study|Lost to Follow-up|4
7512332|NCT03039023|26076502|P5|Overall Study|Physician Decision|0
7512333|NCT03039023|26076503|P4|Overall Study|Physician Decision|1
7512334|NCT03039023|26076504|P3|Overall Study|Physician Decision|0
7512335|NCT03039023|26076505|P2|Overall Study|Physician Decision|0
7512336|NCT03039023|26076506|P1|Overall Study|Physician Decision|0
7512337|NCT03039023|26076502|P5|Overall Study|Withdrawal by Subject|0
7512338|NCT03039023|26076503|P4|Overall Study|Withdrawal by Subject|1
7512339|NCT03039023|26076504|P3|Overall Study|Withdrawal by Subject|1
7512340|NCT03039023|26076505|P2|Overall Study|Withdrawal by Subject|0
7512341|NCT03039023|26076506|P1|Overall Study|Withdrawal by Subject|1
7512342|NCT03038880|26076566|P3|Overall Study|Physician Decision|0
7512343|NCT03038880|26076567|P2|Overall Study|Physician Decision|1
7512344|NCT03038880|26076568|P1|Overall Study|Physician Decision|2
7512345|NCT03038880|26076566|P3|Overall Study|Death|0
7512346|NCT03038880|26076567|P2|Overall Study|Death|2
7512347|NCT03038880|26076568|P1|Overall Study|Death|1
7512348|NCT03038438|26076759|P1|Overall Study|Subject Incarcerated|1
7512349|NCT03038438|26076759|P1|Overall Study|Lost to Follow-up|1
7512350|NCT03038438|26076759|P1|Overall Study|Death|2
7512351|NCT03038126|26076810|P2|Overall Study|Too Ill to Participate|2
7512352|NCT03038126|26076811|P1|Overall Study|Too Ill to Participate|1
7512353|NCT03038126|26076810|P2|Overall Study|Long Term Hospitalization|0
7512354|NCT03038126|26076811|P1|Overall Study|Long Term Hospitalization|2
7512355|NCT03038126|26076810|P2|Overall Study|Lost to Follow-up|1
7512356|NCT03038126|26076811|P1|Overall Study|Lost to Follow-up|0
7512357|NCT03038126|26076810|P2|Overall Study|Withdrawal by Subject|0
7512358|NCT03038126|26076811|P1|Overall Study|Withdrawal by Subject|5
7512359|NCT03038126|26076810|P2|Overall Study|Death|1
7512360|NCT03038126|26076811|P1|Overall Study|Death|1
7512361|NCT03038113|26076835|P14|Overall Study|Lost to Follow-up|0
7512362|NCT03038113|26076836|P13|Overall Study|Lost to Follow-up|0
7512363|NCT03038113|26076837|P12|Overall Study|Lost to Follow-up|0
7512364|NCT03038113|26076838|P11|Overall Study|Lost to Follow-up|0
7512365|NCT03038113|26076839|P10|Overall Study|Lost to Follow-up|0
7512366|NCT03038113|26076840|P9|Overall Study|Lost to Follow-up|0
7512367|NCT03038113|26076841|P8|Overall Study|Lost to Follow-up|0
7512368|NCT03038113|26076842|P7|Overall Study|Lost to Follow-up|1
7512369|NCT03038113|26076843|P6|Overall Study|Lost to Follow-up|0
7512370|NCT03038113|26076844|P5|Overall Study|Lost to Follow-up|0
7512371|NCT03038113|26076845|P4|Overall Study|Lost to Follow-up|0
7512372|NCT03038113|26076846|P3|Overall Study|Lost to Follow-up|0
7512373|NCT03038113|26076847|P2|Overall Study|Lost to Follow-up|0
7512374|NCT03038113|26076848|P1|Overall Study|Lost to Follow-up|0
7512375|NCT03038113|26076835|P14|Overall Study|Withdrawal by Subject|1
7512376|NCT03038113|26076836|P13|Overall Study|Withdrawal by Subject|0
7512377|NCT03038113|26076837|P12|Overall Study|Withdrawal by Subject|0
7512378|NCT03038113|26076838|P11|Overall Study|Withdrawal by Subject|0
7512379|NCT03038113|26076839|P10|Overall Study|Withdrawal by Subject|0
7512380|NCT03038113|26076840|P9|Overall Study|Withdrawal by Subject|0
7512381|NCT03038113|26076841|P8|Overall Study|Withdrawal by Subject|0
7512382|NCT03038113|26076842|P7|Overall Study|Withdrawal by Subject|0
7512383|NCT03038113|26076843|P6|Overall Study|Withdrawal by Subject|0
7512384|NCT03038113|26076844|P5|Overall Study|Withdrawal by Subject|0
7512385|NCT03038113|26076845|P4|Overall Study|Withdrawal by Subject|0
7512386|NCT03038113|26076846|P3|Overall Study|Withdrawal by Subject|1
7512387|NCT03038113|26076847|P2|Overall Study|Withdrawal by Subject|0
7512388|NCT03038113|26076848|P1|Overall Study|Withdrawal by Subject|0
7512389|NCT03038087|26077057|P1|Overall Study|lost data|1
7512390|NCT03037619|26077095|P2|Overall Study|Lost to Follow-up|1
7512391|NCT03037619|26077096|P1|Overall Study|Lost to Follow-up|0
7512392|NCT03037580|26077110|P2|Overall Study|Death|1
7512393|NCT03037580|26077111|P1|Overall Study|Death|0
7512394|NCT03037580|26077110|P2|Overall Study|Study Terminated by Sponsor|15
7512395|NCT03037580|26077111|P1|Overall Study|Study Terminated by Sponsor|12
7512396|NCT03037580|26077110|P2|Overall Study|Adverse Event|0
7512397|NCT03037580|26077111|P1|Overall Study|Adverse Event|1
7512398|NCT03037580|26077110|P2|Overall Study|Withdrawal by Subject|0
7512399|NCT03037580|26077111|P1|Overall Study|Withdrawal by Subject|3
7512400|NCT03037489|26077136|P2|Overall Study|Withdrawal by Subject|0
7512401|NCT03037489|26077137|P1|Overall Study|Withdrawal by Subject|3
7512402|NCT03037489|26077136|P2|Overall Study|Adverse Event|0
7512403|NCT03037489|26077137|P1|Overall Study|Adverse Event|4
7512404|NCT03037307|26077143|P6|Period 1|Did Not Meet Study Criteria|0
7512405|NCT03037307|26077144|P5|Period 1|Did Not Meet Study Criteria|0
7512406|NCT03037307|26077145|P4|Period 1|Did Not Meet Study Criteria|1
7512407|NCT03037307|26077146|P3|Period 1|Did Not Meet Study Criteria|0
7512408|NCT03037307|26077147|P2|Period 1|Did Not Meet Study Criteria|0
7512409|NCT03037307|26077148|P1|Period 1|Did Not Meet Study Criteria|0
7512410|NCT03036852|26077208|P1|Overall Study|Lost to Follow-up|1
7512411|NCT03036852|26077208|P1|Overall Study|Adverse Event|1
7512412|NCT03036852|26077208|P1|Overall Study|Lack of Efficacy|2
7512413|NCT03036852|26077208|P1|Overall Study|Death|2
7512414|NCT03036839|26077265|P3|Overall Study|Withdrew Consent|1
7512415|NCT03036839|26077266|P2|Overall Study|Withdrew Consent|0
7512416|NCT03036839|26077267|P1|Overall Study|Withdrew Consent|0
7512417|NCT03036839|26077265|P3|Overall Study|Death|3
7512418|NCT03036839|26077266|P2|Overall Study|Death|0
7512419|NCT03036839|26077267|P1|Overall Study|Death|3
7512420|NCT03036839|26077265|P3|Overall Study|Adverse Event|1
7512421|NCT03036839|26077266|P2|Overall Study|Adverse Event|0
7512422|NCT03036839|26077267|P1|Overall Study|Adverse Event|0
7512423|NCT03036813|26077320|P3|Overall Study|Other|5
7512424|NCT03036813|26077321|P2|Overall Study|Other|3
7512425|NCT03036813|26077322|P1|Overall Study|Other|0
7512426|NCT03036813|26077320|P3|Overall Study|Pregnancy|1
7512427|NCT03036813|26077321|P2|Overall Study|Pregnancy|0
7512428|NCT03036813|26077322|P1|Overall Study|Pregnancy|0
7512429|NCT03036813|26077320|P3|Overall Study|Non-Compliance|3
7512430|NCT03036813|26077321|P2|Overall Study|Non-Compliance|5
7512431|NCT03036813|26077322|P1|Overall Study|Non-Compliance|1
7512432|NCT03036813|26077320|P3|Overall Study|Physician Decision|1
7512433|NCT03036813|26077321|P2|Overall Study|Physician Decision|1
7512434|NCT03036813|26077322|P1|Overall Study|Physician Decision|2
7512435|NCT03036813|26077320|P3|Overall Study|Lost to Follow-up|0
7512436|NCT03036813|26077321|P2|Overall Study|Lost to Follow-up|1
7512437|NCT03036813|26077322|P1|Overall Study|Lost to Follow-up|1
7512438|NCT03036813|26077320|P3|Overall Study|Withdrawal by Subject|10
7512439|NCT03036813|26077321|P2|Overall Study|Withdrawal by Subject|6
7512440|NCT03036813|26077322|P1|Overall Study|Withdrawal by Subject|12
7512441|NCT03036813|26077320|P3|Overall Study|Adverse Event|6
7512442|NCT03036813|26077321|P2|Overall Study|Adverse Event|11
7512443|NCT03036813|26077322|P1|Overall Study|Adverse Event|6
7512444|NCT03036150|26077554|P2|Overall Study|Lost to Follow-up|2
7512445|NCT03036150|26077555|P1|Overall Study|Lost to Follow-up|2
7512446|NCT03036150|26077554|P2|Overall Study|Withdrawal by Subject|3
7512447|NCT03036150|26077555|P1|Overall Study|Withdrawal by Subject|8
7512448|NCT03036124|26077569|P2|Overall Study|Withdrawal by Subject|4
7512449|NCT03036124|26077570|P1|Overall Study|Withdrawal by Subject|5
7512450|NCT03036124|26077569|P2|Overall Study|Lost to Follow-up|2
7512451|NCT03036124|26077570|P1|Overall Study|Lost to Follow-up|0
7512452|NCT03036072|26077588|P2|Overall Study|Physician Decision|1
7512453|NCT03036072|26077589|P1|Overall Study|Physician Decision|0
7512454|NCT03036072|26077588|P2|Overall Study|Withdrawal by Subject|1
7512455|NCT03036072|26077589|P1|Overall Study|Withdrawal by Subject|0
7512456|NCT03036072|26077588|P2|Overall Study|Death|1
7512457|NCT03036072|26077589|P1|Overall Study|Death|0
7512458|NCT03035942|26077609|P3|Overall Study|Adverse Event|5
7512459|NCT03035942|26077610|P2|Overall Study|Adverse Event|4
7512460|NCT03035942|26077611|P1|Overall Study|Adverse Event|8
7512461|NCT03035916|26077640|P3|Overall Study|Puncture failed|0
7512462|NCT03035916|26077641|P2|Overall Study|Puncture failed|2
7512463|NCT03035916|26077642|P1|Overall Study|Puncture failed|0
7512464|NCT03035864|26077691|P2|Follow-up Period|Other|2
7512465|NCT03035864|26077692|P1|Follow-up Period|Other|3
7512466|NCT03035864|26077691|P2|Follow-up Period|Physician Decision|0
7512467|NCT03035864|26077692|P1|Follow-up Period|Physician Decision|1
7512468|NCT03035864|26077691|P2|Follow-up Period|Lost to Follow-up|2
7512469|NCT03035864|26077692|P1|Follow-up Period|Lost to Follow-up|6
7512470|NCT03035864|26077691|P2|Follow-up Period|Adverse Event|0
7512471|NCT03035864|26077692|P1|Follow-up Period|Adverse Event|1
7512472|NCT03035864|26077691|P2|Treatment Period|Other|1
7512473|NCT03035864|26077692|P1|Treatment Period|Other|3
7512474|NCT03035864|26077691|P2|Treatment Period|Adverse Event|0
7512475|NCT03035864|26077692|P1|Treatment Period|Adverse Event|1
7512476|NCT03035032|26077797|P1|Overall Study|Physician Decision|5
7512477|NCT03035032|26077797|P1|Overall Study|Withdrawal by Subject|2
7512478|NCT03035032|26077797|P1|Overall Study|Protocol Violation|2
7512479|NCT03035032|26077797|P1|Overall Study|Progressive Disease|22
7512480|NCT03035032|26077797|P1|Overall Study|Lost to Follow-up|1
7512481|NCT03035032|26077797|P1|Overall Study|Death|9
7512482|NCT03035032|26077797|P1|Overall Study|Adverse Event|2
7512483|NCT03034967|26077818|P6|Overall Study|Adverse Event, Serious Fatal|1
7512484|NCT03034967|26077819|P5|Overall Study|Adverse Event, Serious Fatal|1
7512485|NCT03034967|26077820|P4|Overall Study|Adverse Event, Serious Fatal|2
7512486|NCT03034967|26077821|P3|Overall Study|Adverse Event, Serious Fatal|1
7512487|NCT03034967|26077822|P2|Overall Study|Adverse Event, Serious Fatal|1
7512488|NCT03034967|26077823|P1|Overall Study|Adverse Event, Serious Fatal|0
7512489|NCT03034967|26077818|P6|Overall Study|Adverse Event, non-fatal|8
7512490|NCT03034967|26077819|P5|Overall Study|Adverse Event, non-fatal|2
7512491|NCT03034967|26077820|P4|Overall Study|Adverse Event, non-fatal|0
7512492|NCT03034967|26077821|P3|Overall Study|Adverse Event, non-fatal|2
7512493|NCT03034967|26077822|P2|Overall Study|Adverse Event, non-fatal|1
7512494|NCT03034967|26077823|P1|Overall Study|Adverse Event, non-fatal|3
7512495|NCT03034967|26077818|P6|Overall Study|Lack of Efficacy|0
7512496|NCT03034967|26077819|P5|Overall Study|Lack of Efficacy|1
7512497|NCT03034967|26077820|P4|Overall Study|Lack of Efficacy|1
7512498|NCT03034967|26077821|P3|Overall Study|Lack of Efficacy|2
7512499|NCT03034967|26077822|P2|Overall Study|Lack of Efficacy|1
7512500|NCT03034967|26077823|P1|Overall Study|Lack of Efficacy|0
7512501|NCT03034967|26077818|P6|Overall Study|Protocol Violation|2
7512502|NCT03034967|26077819|P5|Overall Study|Protocol Violation|0
7512503|NCT03034967|26077820|P4|Overall Study|Protocol Violation|0
7512504|NCT03034967|26077821|P3|Overall Study|Protocol Violation|0
7512505|NCT03034967|26077822|P2|Overall Study|Protocol Violation|0
7512506|NCT03034967|26077823|P1|Overall Study|Protocol Violation|1
7512507|NCT03034967|26077818|P6|Overall Study|Liver function test abnormality|0
7512508|NCT03034967|26077819|P5|Overall Study|Liver function test abnormality|0
7512509|NCT03034967|26077820|P4|Overall Study|Liver function test abnormality|0
7512510|NCT03034967|26077821|P3|Overall Study|Liver function test abnormality|1
7512511|NCT03034967|26077822|P2|Overall Study|Liver function test abnormality|0
7512512|NCT03034967|26077823|P1|Overall Study|Liver function test abnormality|0
7512513|NCT03034967|26077818|P6|Overall Study|Lost to Follow-up|2
7512514|NCT03034967|26077819|P5|Overall Study|Lost to Follow-up|0
7512515|NCT03034967|26077820|P4|Overall Study|Lost to Follow-up|1
7512516|NCT03034967|26077821|P3|Overall Study|Lost to Follow-up|0
7512517|NCT03034967|26077822|P2|Overall Study|Lost to Follow-up|0
7512518|NCT03034967|26077823|P1|Overall Study|Lost to Follow-up|0
7512519|NCT03034967|26077818|P6|Overall Study|Physician Decision|0
7512520|NCT03034967|26077819|P5|Overall Study|Physician Decision|1
7512521|NCT03034967|26077820|P4|Overall Study|Physician Decision|1
7512522|NCT03034967|26077821|P3|Overall Study|Physician Decision|1
7512523|NCT03034967|26077822|P2|Overall Study|Physician Decision|0
7512524|NCT03034967|26077823|P1|Overall Study|Physician Decision|1
7512525|NCT03034967|26077818|P6|Overall Study|Withdrawal by Subject|2
7512526|NCT03034967|26077819|P5|Overall Study|Withdrawal by Subject|9
7512527|NCT03034967|26077820|P4|Overall Study|Withdrawal by Subject|6
7512528|NCT03034967|26077821|P3|Overall Study|Withdrawal by Subject|6
7512529|NCT03034967|26077822|P2|Overall Study|Withdrawal by Subject|2
7512530|NCT03034967|26077823|P1|Overall Study|Withdrawal by Subject|9
7512531|NCT03034954|26078021|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
7512532|NCT03034954|26078022|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
7512533|NCT03034915|26078089|P3|Overall Study|Physician Decision|2
7512534|NCT03034915|26078090|P2|Overall Study|Physician Decision|5
7512535|NCT03034915|26078091|P1|Overall Study|Physician Decision|1
7512536|NCT03034915|26078089|P3|Overall Study|Protocol-defined withdrawal criteria met|29
7512537|NCT03034915|26078090|P2|Overall Study|Protocol-defined withdrawal criteria met|26
7512538|NCT03034915|26078091|P1|Overall Study|Protocol-defined withdrawal criteria met|19
7512539|NCT03034915|26078089|P3|Overall Study|Site closed|4
7512540|NCT03034915|26078090|P2|Overall Study|Site closed|2
7512541|NCT03034915|26078091|P1|Overall Study|Site closed|2
7512542|NCT03034915|26078089|P3|Overall Study|Lack of Efficacy|18
7512543|NCT03034915|26078090|P2|Overall Study|Lack of Efficacy|16
7512544|NCT03034915|26078091|P1|Overall Study|Lack of Efficacy|8
7512545|NCT03034915|26078089|P3|Overall Study|Protocol Deviation|7
7512546|NCT03034915|26078090|P2|Overall Study|Protocol Deviation|14
7512547|NCT03034915|26078091|P1|Overall Study|Protocol Deviation|2
7512548|NCT03034915|26078089|P3|Overall Study|Withdrawal by Subject|41
7512549|NCT03034915|26078090|P2|Overall Study|Withdrawal by Subject|46
7512550|NCT03034915|26078091|P1|Overall Study|Withdrawal by Subject|29
7512551|NCT03034915|26078089|P3|Overall Study|Lost to Follow-up|3
7512552|NCT03034915|26078090|P2|Overall Study|Lost to Follow-up|13
7512553|NCT03034915|26078091|P1|Overall Study|Lost to Follow-up|5
7512554|NCT03034915|26078089|P3|Overall Study|Adverse Event|22
7512555|NCT03034915|26078090|P2|Overall Study|Adverse Event|32
7512556|NCT03034915|26078091|P1|Overall Study|Adverse Event|29
7512557|NCT03034772|26078131|P2|Overall Study|Withdrawal by Subject|1
7512558|NCT03034772|26078132|P1|Overall Study|Withdrawal by Subject|0
7512559|NCT03034772|26078131|P2|Overall Study|Adverse Event|1
7512560|NCT03034772|26078132|P1|Overall Study|Adverse Event|0
7512561|NCT03034577|26078148|P2|Overall Study|Lost to Follow-up|26
7512562|NCT03034577|26078149|P1|Overall Study|Lost to Follow-up|25
7512563|NCT03034577|26078148|P2|Overall Study|Withdrawal by Subject|9
7512564|NCT03034577|26078149|P1|Overall Study|Withdrawal by Subject|6
7512565|NCT03034460|26078167|P2|Overall Study|Personal Reasons|0
7512566|NCT03034460|26078168|P1|Overall Study|Personal Reasons|1
7512567|NCT03034460|26078167|P2|Overall Study|Withdrawal by Subject|2
7512568|NCT03034460|26078168|P1|Overall Study|Withdrawal by Subject|2
7512569|NCT03034460|26078167|P2|Overall Study|Adverse Event|1
7512570|NCT03034460|26078168|P1|Overall Study|Adverse Event|0
7512571|NCT03034135|26078210|P1|Overall Study|Withdrawal by Subject|2
7512572|NCT03034057|26078219|P1|Overall Study|Medication error without associated AE|1
7512573|NCT03034057|26078219|P1|Overall Study|Adverse Event|22
7512574|NCT03034057|26078219|P1|Overall Study|Lost to Follow-up|19
7512575|NCT03034057|26078219|P1|Overall Study|Not defined|2
7512576|NCT03034057|26078219|P1|Overall Study|Protocol Violation|1
7512577|NCT03034057|26078219|P1|Overall Study|Withdrawal by Subject|10
7512578|NCT03034044|26078225|P1|Overall Study|Enrolled, but not received Xyntha|1
7512579|NCT03033784|26078247|P13|Overall Study|Withdrawal by Subject|2
7512580|NCT03033784|26078248|P12|Overall Study|Withdrawal by Subject|0
7512581|NCT03033784|26078249|P11|Overall Study|Withdrawal by Subject|0
7512582|NCT03033784|26078250|P10|Overall Study|Withdrawal by Subject|0
7512583|NCT03033784|26078251|P9|Overall Study|Withdrawal by Subject|0
7512584|NCT03033784|26078252|P8|Overall Study|Withdrawal by Subject|0
7512585|NCT03033784|26078253|P7|Overall Study|Withdrawal by Subject|0
7512586|NCT03033784|26078254|P6|Overall Study|Withdrawal by Subject|0
7512587|NCT03033784|26078255|P5|Overall Study|Withdrawal by Subject|0
7512588|NCT03033784|26078256|P4|Overall Study|Withdrawal by Subject|0
7512589|NCT03033784|26078257|P3|Overall Study|Withdrawal by Subject|0
7512590|NCT03033784|26078258|P2|Overall Study|Withdrawal by Subject|0
7512591|NCT03033784|26078259|P1|Overall Study|Withdrawal by Subject|0
7512592|NCT03033784|26078247|P13|Overall Study|Anxiety related to MRI scanner|0
7512593|NCT03033784|26078248|P12|Overall Study|Anxiety related to MRI scanner|0
7512594|NCT03033784|26078249|P11|Overall Study|Anxiety related to MRI scanner|0
7512595|NCT03033784|26078250|P10|Overall Study|Anxiety related to MRI scanner|0
7512596|NCT03033784|26078251|P9|Overall Study|Anxiety related to MRI scanner|0
7512597|NCT03033784|26078252|P8|Overall Study|Anxiety related to MRI scanner|0
7512598|NCT03033784|26078253|P7|Overall Study|Anxiety related to MRI scanner|0
7512599|NCT03033784|26078254|P6|Overall Study|Anxiety related to MRI scanner|0
7512600|NCT03033784|26078255|P5|Overall Study|Anxiety related to MRI scanner|0
7512601|NCT03033784|26078256|P4|Overall Study|Anxiety related to MRI scanner|0
7512602|NCT03033784|26078257|P3|Overall Study|Anxiety related to MRI scanner|0
7512603|NCT03033784|26078258|P2|Overall Study|Anxiety related to MRI scanner|1
7512604|NCT03033784|26078259|P1|Overall Study|Anxiety related to MRI scanner|0
7512605|NCT03033745|26078300|P3|Overall Study|Withdrawal by Subject|0
7512606|NCT03033745|26078301|P2|Overall Study|Withdrawal by Subject|1
7512607|NCT03033745|26078302|P1|Overall Study|Withdrawal by Subject|0
7512608|NCT03033745|26078300|P3|Overall Study|Adverse Event|1
7512609|NCT03033745|26078301|P2|Overall Study|Adverse Event|0
7512610|NCT03033745|26078302|P1|Overall Study|Adverse Event|1
7512611|NCT03033745|26078300|P3|Overall Study|Protocol Violation|1
7512612|NCT03033745|26078301|P2|Overall Study|Protocol Violation|0
7512613|NCT03033745|26078302|P1|Overall Study|Protocol Violation|0
7512614|NCT03033394|26078348|P1|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
7512615|NCT03033394|26078348|P1|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
7512616|NCT03033394|26078348|P1|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
7512617|NCT03033394|26078348|P1|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
7512618|NCT03033394|26078348|P1|Completed Pharmacokinetic Analysis|Missing data|1
7512619|NCT03032523|26078423|P2|Overall Study|Physician Decision|0
7512620|NCT03032523|26078424|P1|Overall Study|Physician Decision|1
7512621|NCT03032523|26078423|P2|Overall Study|Withdrawal by Subject|2
7512622|NCT03032523|26078424|P1|Overall Study|Withdrawal by Subject|2
7512623|NCT03032510|26078436|P2|Overall Study|Physician Decision|0
7512624|NCT03032510|26078437|P1|Overall Study|Physician Decision|2
7512625|NCT03032510|26078436|P2|Overall Study|Subject noncompliance|2
7512626|NCT03032510|26078437|P1|Overall Study|Subject noncompliance|4
7512627|NCT03032510|26078436|P2|Overall Study|Withdrawal by Subject|7
7512628|NCT03032510|26078437|P1|Overall Study|Withdrawal by Subject|8
7512629|NCT03032510|26078436|P2|Overall Study|Lost to Follow-up|7
7512630|NCT03032510|26078437|P1|Overall Study|Lost to Follow-up|8
7512631|NCT03032510|26078436|P2|Overall Study|Adverse Event|2
7512632|NCT03032510|26078437|P1|Overall Study|Adverse Event|5
7512633|NCT03032380|26078458|P2|Overall Study|Other - Miscellaneous|1
7512634|NCT03032380|26078459|P1|Overall Study|Other - Miscellaneous|0
7512635|NCT03032380|26078458|P2|Overall Study|Death|34
7512636|NCT03032380|26078459|P1|Overall Study|Death|39
7512637|NCT03032380|26078458|P2|Overall Study|Recovery|1
7512638|NCT03032380|26078459|P1|Overall Study|Recovery|0
7512639|NCT03032380|26078458|P2|Overall Study|Withdrawal by Subject|3
7512640|NCT03032380|26078459|P1|Overall Study|Withdrawal by Subject|2
7512641|NCT03032380|26078458|P2|Overall Study|Lack of Efficacy|0
7512642|NCT03032380|26078459|P1|Overall Study|Lack of Efficacy|1
7512643|NCT03032380|26078458|P2|Overall Study|Adverse Event|1
7512644|NCT03032380|26078459|P1|Overall Study|Adverse Event|0
7512645|NCT03031938|26078531|P2|Overall Study|Death|0
7512646|NCT03031938|26078532|P1|Overall Study|Death|1
7512647|NCT03031899|26078688|P1|Overall Study|lesion disappeared after stopping habit|1
7512648|NCT03031899|26078688|P1|Overall Study|Protocol Violation|1
7512649|NCT03031678|26078705|P1|Overall Study|Study closed prior to completion|1
7512650|NCT03031496|26078714|P2|Period 1|Withdrawal by Subject|2
7512651|NCT03031496|26078715|P1|Period 1|Withdrawal by Subject|0
7512652|NCT03031496|26078714|P2|Period 1|Adverse Event|0
7512653|NCT03031496|26078715|P1|Period 1|Adverse Event|2
7512654|NCT03031431|26078751|P1|Overall Study|Infant removed by maternal request|1
7512655|NCT03030989|26078779|P2|Overall Study|No longer interested|3
7512656|NCT03030989|26078780|P1|Overall Study|No longer interested|5
7512657|NCT03030989|26078779|P2|Overall Study|Line Removed|2
7512658|NCT03030989|26078780|P1|Overall Study|Line Removed|0
7512659|NCT03030989|26078779|P2|Overall Study|Positive Blood Cultures|1
7512660|NCT03030989|26078780|P1|Overall Study|Positive Blood Cultures|2
7512661|NCT03030989|26078779|P2|Overall Study|Fatigue/Overwhelmed|5
7512662|NCT03030989|26078780|P1|Overall Study|Fatigue/Overwhelmed|1
7512663|NCT03030989|26078779|P2|Overall Study|Rash|1
7512664|NCT03030989|26078780|P1|Overall Study|Rash|2
7512665|NCT03030989|26078779|P2|Overall Study|Fever|2
7512666|NCT03030989|26078780|P1|Overall Study|Fever|2
7512667|NCT03030599|26078833|P3|Open-label Extension|Other Reason|0
7512668|NCT03030599|26078834|P2|Open-label Extension|Other Reason|0
7512669|NCT03030599|26078835|P1|Open-label Extension|Other Reason|1
7512670|NCT03030599|26078833|P3|Open-label Extension|Lack of Efficacy|0
7512671|NCT03030599|26078834|P2|Open-label Extension|Lack of Efficacy|0
7512672|NCT03030599|26078835|P1|Open-label Extension|Lack of Efficacy|1
7512673|NCT03030599|26078833|P3|Open-label Extension|Lost to Follow-up|0
7512674|NCT03030599|26078834|P2|Open-label Extension|Lost to Follow-up|0
7512675|NCT03030599|26078835|P1|Open-label Extension|Lost to Follow-up|2
7512676|NCT03030599|26078833|P3|Open-label Extension|Adverse Event|0
7512677|NCT03030599|26078834|P2|Open-label Extension|Adverse Event|0
7512678|NCT03030599|26078835|P1|Open-label Extension|Adverse Event|3
7512679|NCT03030599|26078833|P3|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
7512680|NCT03030599|26078834|P2|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7512681|NCT03030599|26078835|P1|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7512682|NCT03030599|26078833|P3|Double Blind Randomized Withdrawal|Randomized in error|2
7512683|NCT03030599|26078834|P2|Double Blind Randomized Withdrawal|Randomized in error|0
7512684|NCT03030599|26078835|P1|Double Blind Randomized Withdrawal|Randomized in error|0
7512685|NCT03030599|26078833|P3|Double Blind Randomized Withdrawal|Adverse Event|3
7512686|NCT03030599|26078834|P2|Double Blind Randomized Withdrawal|Adverse Event|0
7512687|NCT03030599|26078835|P1|Double Blind Randomized Withdrawal|Adverse Event|0
7512688|NCT03030599|26078833|P3|Double Blind Randomized Withdrawal|Lack of Efficacy|2
7512689|NCT03030599|26078834|P2|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7512690|NCT03030599|26078835|P1|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7512691|NCT03030599|26078833|P3|Stable Dose|Lost to Follow-up|0
7512692|NCT03030599|26078834|P2|Stable Dose|Lost to Follow-up|0
7512693|NCT03030599|26078835|P1|Stable Dose|Lost to Follow-up|1
7512694|NCT03030599|26078833|P3|Stable Dose|Adverse Event|0
7512695|NCT03030599|26078834|P2|Stable Dose|Adverse Event|0
7512696|NCT03030599|26078835|P1|Stable Dose|Adverse Event|1
7512697|NCT03030599|26078833|P3|Stable Dose|Protocol deviation|0
7512698|NCT03030599|26078834|P2|Stable Dose|Protocol deviation|0
7512699|NCT03030599|26078835|P1|Stable Dose|Protocol deviation|3
7512700|NCT03030599|26078833|P3|Open Label Treatment and Titration|Lost to Follow-up|0
7512701|NCT03030599|26078834|P2|Open Label Treatment and Titration|Lost to Follow-up|0
7512702|NCT03030599|26078835|P1|Open Label Treatment and Titration|Lost to Follow-up|3
7512703|NCT03030599|26078833|P3|Open Label Treatment and Titration|Sponsor decision|0
7512704|NCT03030599|26078834|P2|Open Label Treatment and Titration|Sponsor decision|0
7512705|NCT03030599|26078835|P1|Open Label Treatment and Titration|Sponsor decision|2
7512706|NCT03030599|26078833|P3|Open Label Treatment and Titration|Withdrawal by Subject|0
7512707|NCT03030599|26078834|P2|Open Label Treatment and Titration|Withdrawal by Subject|0
7512708|NCT03030599|26078835|P1|Open Label Treatment and Titration|Withdrawal by Subject|6
7512709|NCT03030599|26078833|P3|Open Label Treatment and Titration|Adverse Event|0
7512710|NCT03030599|26078834|P2|Open Label Treatment and Titration|Adverse Event|0
7512711|NCT03030599|26078835|P1|Open Label Treatment and Titration|Adverse Event|18
7512712|NCT03030599|26078833|P3|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7512713|NCT03030599|26078834|P2|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7512714|NCT03030599|26078835|P1|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
7512715|NCT03030599|26078833|P3|Open Label Treatment and Titration|Lack of Efficacy|0
7512716|NCT03030599|26078834|P2|Open Label Treatment and Titration|Lack of Efficacy|0
7512717|NCT03030599|26078835|P1|Open Label Treatment and Titration|Lack of Efficacy|1
7512718|NCT03030599|26078833|P3|Open Label Treatment and Titration|Physician Decision|0
7512719|NCT03030599|26078834|P2|Open Label Treatment and Titration|Physician Decision|0
7512720|NCT03030599|26078835|P1|Open Label Treatment and Titration|Physician Decision|3
7512721|NCT03030599|26078833|P3|Open Label Treatment and Titration|Other|0
7512722|NCT03030599|26078834|P2|Open Label Treatment and Titration|Other|0
7512723|NCT03030599|26078835|P1|Open Label Treatment and Titration|Other|1
7512724|NCT03030599|26078833|P3|Open Label Treatment and Titration|Protocol deviation|0
7512725|NCT03030599|26078834|P2|Open Label Treatment and Titration|Protocol deviation|0
7512726|NCT03030599|26078835|P1|Open Label Treatment and Titration|Protocol deviation|8
7512727|NCT03029832|26078868|P2|Overall Study|Study Terminated By Sponsor|1
7512728|NCT03029832|26078869|P1|Overall Study|Study Terminated By Sponsor|1
7512729|NCT03029832|26078868|P2|Overall Study|Death due to Disease Progression|0
7512730|NCT03029832|26078869|P1|Overall Study|Death due to Disease Progression|1
7512731|NCT03029832|26078868|P2|Overall Study|Safety Follow-Up Completed|0
7512732|NCT03029832|26078869|P1|Overall Study|Safety Follow-Up Completed|2
7512733|NCT03029819|26078899|P2|Overall Study|Removed due to disruptive behavior|1
7512734|NCT03029819|26078900|P1|Overall Study|Removed due to disruptive behavior|0
7512735|NCT03029819|26078899|P2|Overall Study|Lost to Follow-up|5
7512736|NCT03029819|26078900|P1|Overall Study|Lost to Follow-up|3
7512737|NCT03029780|26078914|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
7512738|NCT03029780|26078915|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
7512739|NCT03029780|26078914|P2|Overall Study|Study Drug Toxicity|5
7512740|NCT03029780|26078915|P1|Overall Study|Study Drug Toxicity|5
7512741|NCT03029780|26078914|P2|Overall Study|Disease Progression|3
7512742|NCT03029780|26078915|P1|Overall Study|Disease Progression|1
7512743|NCT03029650|26078938|P2|Washout (1 Week)|Physician Decision|1
7512744|NCT03029650|26078939|P1|Washout (1 Week)|Physician Decision|0
7512745|NCT03029650|26078938|P2|Washout (1 Week)|Withdrawal by Subject|1
7512746|NCT03029650|26078939|P1|Washout (1 Week)|Withdrawal by Subject|1
7512747|NCT03029624|26078954|P1|Overall Study|MRI need|2
7512748|NCT03029624|26078954|P1|Overall Study|Lack of Efficacy|1
7512749|NCT03029624|26078954|P1|Overall Study|Withdrawal by Subject|1
7512750|NCT03029624|26078954|P1|Overall Study|Adverse Event|1
7512751|NCT03029585|26078963|P2|Overall Study|Withdrawal by Subject|0
7512752|NCT03029585|26078964|P1|Overall Study|Withdrawal by Subject|1
7512753|NCT03029585|26078963|P2|Overall Study|Death|1
7512754|NCT03029585|26078964|P1|Overall Study|Death|1
7512755|NCT03029247|26078976|P2|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7512756|NCT03029247|26078977|P1|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7512916|NCT03026257|26079816|P2|Overall Study|Lost to Follow-up|0
7512757|NCT03029247|26078976|P2|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
7512758|NCT03029247|26078977|P1|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
7512759|NCT03029247|26078976|P2|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7512760|NCT03029247|26078977|P1|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7512761|NCT03029247|26078976|P2|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
7512762|NCT03029247|26078977|P1|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
7512763|NCT03029234|26079084|P1|Overall Study|Death|61
7512764|NCT03029234|26079084|P1|Overall Study|Withdrawal by Subject|5
7512765|NCT03029234|26079084|P1|Overall Study|Sponsor Decision|1
7512766|NCT03028870|26079207|P4|Overall Study|Administrative|4
7512767|NCT03028870|26079208|P3|Overall Study|Administrative|12
7512768|NCT03028870|26079209|P2|Overall Study|Administrative|5
7512769|NCT03028870|26079210|P1|Overall Study|Administrative|5
7512770|NCT03028870|26079207|P4|Overall Study|Lack of Efficacy|0
7512771|NCT03028870|26079208|P3|Overall Study|Lack of Efficacy|0
7512772|NCT03028870|26079209|P2|Overall Study|Lack of Efficacy|0
7512773|NCT03028870|26079210|P1|Overall Study|Lack of Efficacy|3
7512774|NCT03028870|26079207|P4|Overall Study|Lost to Follow-up|0
7512775|NCT03028870|26079208|P3|Overall Study|Lost to Follow-up|0
7512776|NCT03028870|26079209|P2|Overall Study|Lost to Follow-up|0
7512777|NCT03028870|26079210|P1|Overall Study|Lost to Follow-up|1
7512778|NCT03028870|26079207|P4|Overall Study|Withdrawal by Subject|2
7512779|NCT03028870|26079208|P3|Overall Study|Withdrawal by Subject|1
7512780|NCT03028870|26079209|P2|Overall Study|Withdrawal by Subject|1
7512781|NCT03028870|26079210|P1|Overall Study|Withdrawal by Subject|1
7512782|NCT03028870|26079207|P4|Overall Study|Adverse Event|3
7512783|NCT03028870|26079208|P3|Overall Study|Adverse Event|3
7512784|NCT03028870|26079209|P2|Overall Study|Adverse Event|4
7512785|NCT03028870|26079210|P1|Overall Study|Adverse Event|7
7512786|NCT03028415|26079368|P2|Overall Study|Discontinued due to COVID-19|0
7512787|NCT03028415|26079369|P1|Overall Study|Discontinued due to COVID-19|1
7512788|NCT03028415|26079368|P2|Overall Study|Withdrawal by Subject|0
7512789|NCT03028415|26079369|P1|Overall Study|Withdrawal by Subject|1
7512790|NCT03028415|26079368|P2|Overall Study|Lost to Follow-up|3
7512791|NCT03028415|26079369|P1|Overall Study|Lost to Follow-up|6
7512792|NCT03028142|26079455|P6|Overall Study|Withdrawal by Subject|0
7512793|NCT03028142|26079456|P5|Overall Study|Withdrawal by Subject|1
7512794|NCT03028142|26079457|P4|Overall Study|Withdrawal by Subject|0
7512795|NCT03028142|26079458|P3|Overall Study|Withdrawal by Subject|0
7512796|NCT03028142|26079459|P2|Overall Study|Withdrawal by Subject|0
7512797|NCT03028142|26079460|P1|Overall Study|Withdrawal by Subject|0
7512798|NCT03028142|26079455|P6|Overall Study|Adverse Event|1
7512799|NCT03028142|26079456|P5|Overall Study|Adverse Event|0
7512800|NCT03028142|26079457|P4|Overall Study|Adverse Event|0
7512801|NCT03028142|26079458|P3|Overall Study|Adverse Event|0
7512802|NCT03028142|26079459|P2|Overall Study|Adverse Event|1
7512803|NCT03028142|26079460|P1|Overall Study|Adverse Event|1
7512804|NCT03028129|26079479|P2|Overall Study|Withdrawal by Subject|45
7512805|NCT03028129|26079480|P1|Overall Study|Withdrawal by Subject|62
7512806|NCT03028129|26079479|P2|Overall Study|Protocol Violation|1
7512807|NCT03028129|26079480|P1|Overall Study|Protocol Violation|1
7512808|NCT03028129|26079479|P2|Overall Study|Physician Decision|1
7512809|NCT03028129|26079480|P1|Overall Study|Physician Decision|0
7512810|NCT03028129|26079479|P2|Overall Study|Lost to Follow-up|38
7512811|NCT03028129|26079480|P1|Overall Study|Lost to Follow-up|50
7512812|NCT03028129|26079479|P2|Overall Study|Adverse Event|2
7512813|NCT03028129|26079480|P1|Overall Study|Adverse Event|13
7512814|NCT03028012|26079528|P3|Overall Study|Lost to Follow-up|3
7512815|NCT03028012|26079529|P2|Overall Study|Lost to Follow-up|3
7512816|NCT03028012|26079530|P1|Overall Study|Lost to Follow-up|2
7512817|NCT03027557|26079558|P3|Overall Study|Adverse Event|0
7512818|NCT03027557|26079559|P2|Overall Study|Adverse Event|0
7512819|NCT03027557|26079560|P1|Overall Study|Adverse Event|1
7512820|NCT03027466|26079665|P4|Overall Study|Opting out of the app|1821
7512821|NCT03027466|26079666|P3|Overall Study|Opting out of the app|1743
7512822|NCT03027466|26079667|P2|Overall Study|Opting out of the app|1819
7512823|NCT03027466|26079668|P1|Overall Study|Opting out of the app|1869
7512824|NCT03026530|26079775|P2|Overall Study|Protocol Violation|5
7512825|NCT03026530|26079776|P1|Overall Study|Protocol Violation|2
7512826|NCT03026530|26079775|P2|Overall Study|Lost to Follow-up|24
7512827|NCT03026530|26079776|P1|Overall Study|Lost to Follow-up|19
7512828|NCT03026283|26079784|P8|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7512829|NCT03026283|26079785|P7|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7512830|NCT03026283|26079786|P6|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
7512831|NCT03026283|26079787|P5|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
7512832|NCT03026283|26079788|P4|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7512833|NCT03026283|26079789|P3|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7512834|NCT03026283|26079790|P2|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7512835|NCT03026283|26079791|P1|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7512836|NCT03026283|26079784|P8|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512837|NCT03026283|26079785|P7|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512838|NCT03026283|26079786|P6|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512839|NCT03026283|26079787|P5|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512840|NCT03026283|26079788|P4|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
7512841|NCT03026283|26079789|P3|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512842|NCT03026283|26079790|P2|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512843|NCT03026283|26079791|P1|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7512844|NCT03026283|26079784|P8|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7512845|NCT03026283|26079785|P7|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7512846|NCT03026283|26079786|P6|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
7512847|NCT03026283|26079787|P5|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7512848|NCT03026283|26079788|P4|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
7512849|NCT03026283|26079789|P3|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7512850|NCT03026283|26079790|P2|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7512851|NCT03026283|26079791|P1|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7512852|NCT03026283|26079784|P8|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7512853|NCT03026283|26079785|P7|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7512854|NCT03026283|26079786|P6|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7512855|NCT03026283|26079787|P5|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7512856|NCT03026283|26079788|P4|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
7512857|NCT03026283|26079789|P3|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7512858|NCT03026283|26079790|P2|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7512859|NCT03026283|26079791|P1|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7512860|NCT03026283|26079784|P8|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7512861|NCT03026283|26079785|P7|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7512862|NCT03026283|26079786|P6|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7512863|NCT03026283|26079787|P5|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
7512864|NCT03026283|26079788|P4|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
7512865|NCT03026283|26079789|P3|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7512866|NCT03026283|26079790|P2|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7512867|NCT03026283|26079791|P1|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7512868|NCT03026283|26079784|P8|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512869|NCT03026283|26079785|P7|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512870|NCT03026283|26079786|P6|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512871|NCT03026283|26079787|P5|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512872|NCT03026283|26079788|P4|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512873|NCT03026283|26079789|P3|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
7512874|NCT03026283|26079790|P2|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512875|NCT03026283|26079791|P1|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7512876|NCT03026283|26079784|P8|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512877|NCT03026283|26079785|P7|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512878|NCT03026283|26079786|P6|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512879|NCT03026283|26079787|P5|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512880|NCT03026283|26079788|P4|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512881|NCT03026283|26079789|P3|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512882|NCT03026283|26079790|P2|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
7512883|NCT03026283|26079791|P1|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7512884|NCT03026283|26079784|P8|CCTA Diagnosis|Withdrawal by Subject|0
7512885|NCT03026283|26079785|P7|CCTA Diagnosis|Withdrawal by Subject|0
7512886|NCT03026283|26079786|P6|CCTA Diagnosis|Withdrawal by Subject|0
7512887|NCT03026283|26079787|P5|CCTA Diagnosis|Withdrawal by Subject|0
7512888|NCT03026283|26079788|P4|CCTA Diagnosis|Withdrawal by Subject|0
7512889|NCT03026283|26079789|P3|CCTA Diagnosis|Withdrawal by Subject|0
7512890|NCT03026283|26079790|P2|CCTA Diagnosis|Withdrawal by Subject|0
7512891|NCT03026283|26079791|P1|CCTA Diagnosis|Withdrawal by Subject|5
7512892|NCT03026283|26079784|P8|CCTA Diagnosis|CCTA not performed as planned|0
7512893|NCT03026283|26079785|P7|CCTA Diagnosis|CCTA not performed as planned|0
7512894|NCT03026283|26079786|P6|CCTA Diagnosis|CCTA not performed as planned|0
7512895|NCT03026283|26079787|P5|CCTA Diagnosis|CCTA not performed as planned|0
7512896|NCT03026283|26079788|P4|CCTA Diagnosis|CCTA not performed as planned|0
7512897|NCT03026283|26079789|P3|CCTA Diagnosis|CCTA not performed as planned|0
7512898|NCT03026283|26079790|P2|CCTA Diagnosis|CCTA not performed as planned|0
7512899|NCT03026283|26079791|P1|CCTA Diagnosis|CCTA not performed as planned|9
7512900|NCT03026257|26079812|P6|Overall Study|Withdrawal by Subject|0
7512901|NCT03026257|26079813|P5|Overall Study|Withdrawal by Subject|0
7512902|NCT03026257|26079814|P4|Overall Study|Withdrawal by Subject|0
7512903|NCT03026257|26079815|P3|Overall Study|Withdrawal by Subject|0
7512904|NCT03026257|26079816|P2|Overall Study|Withdrawal by Subject|1
7512905|NCT03026257|26079817|P1|Overall Study|Withdrawal by Subject|1
7512906|NCT03026257|26079812|P6|Overall Study|Protocol Violation|0
7512907|NCT03026257|26079813|P5|Overall Study|Protocol Violation|1
7512908|NCT03026257|26079814|P4|Overall Study|Protocol Violation|1
7512909|NCT03026257|26079815|P3|Overall Study|Protocol Violation|0
7512910|NCT03026257|26079816|P2|Overall Study|Protocol Violation|0
7512911|NCT03026257|26079817|P1|Overall Study|Protocol Violation|1
7512912|NCT03026257|26079812|P6|Overall Study|Lost to Follow-up|0
7512913|NCT03026257|26079813|P5|Overall Study|Lost to Follow-up|0
7512914|NCT03026257|26079814|P4|Overall Study|Lost to Follow-up|0
7512915|NCT03026257|26079815|P3|Overall Study|Lost to Follow-up|0
7512917|NCT03026257|26079817|P1|Overall Study|Lost to Follow-up|1
7512918|NCT03026257|26079812|P6|Overall Study|Adverse Event|0
7512919|NCT03026257|26079813|P5|Overall Study|Adverse Event|0
7512920|NCT03026257|26079814|P4|Overall Study|Adverse Event|0
7512921|NCT03026257|26079815|P3|Overall Study|Adverse Event|0
7512922|NCT03026257|26079816|P2|Overall Study|Adverse Event|0
7512923|NCT03026257|26079817|P1|Overall Study|Adverse Event|3
7512924|NCT03026166|26079833|P2|Overall Study|Other|0
7512925|NCT03026166|26079834|P1|Overall Study|Other|1
7512926|NCT03026166|26079833|P2|Overall Study|Study Terminated by Sponsor|3
7512927|NCT03026166|26079834|P1|Overall Study|Study Terminated by Sponsor|3
7512928|NCT03026166|26079833|P2|Overall Study|Lost to Follow-up|0
7512929|NCT03026166|26079834|P1|Overall Study|Lost to Follow-up|1
7512930|NCT03026166|26079833|P2|Overall Study|Withdrawal by Subject|2
7512931|NCT03026166|26079834|P1|Overall Study|Withdrawal by Subject|1
7512932|NCT03026166|26079833|P2|Overall Study|Physician Decision|0
7512933|NCT03026166|26079834|P1|Overall Study|Physician Decision|2
7512934|NCT03026166|26079833|P2|Overall Study|Death|7
7512935|NCT03026166|26079834|P1|Overall Study|Death|22
7512936|NCT03026088|26079850|P1|Overall Study|Study termination|20
7512937|NCT03026075|26079874|P1|Overall Study|Physician Decision|1
7512938|NCT03025542|26079889|P2|Overall Study|Withdrawal by Subject|0
7512939|NCT03025542|26079890|P1|Overall Study|Withdrawal by Subject|1
7512940|NCT03025542|26079889|P2|Overall Study|Lost to Follow-up|0
7512941|NCT03025542|26079890|P1|Overall Study|Lost to Follow-up|1
7512942|NCT03025542|26079889|P2|Overall Study|Adverse Event|2
7512943|NCT03025542|26079890|P1|Overall Study|Adverse Event|0
7512944|NCT03025217|26079930|P1|Overall Study|Not eligible, poor English|2
7512945|NCT03025217|26079930|P1|Overall Study|Lost to Follow-up|1
7512946|NCT03025217|26079930|P1|Overall Study|Pregnancy|1
7512947|NCT03024970|26079935|P2|Second Intervention|Lost to Follow-up|0
7512948|NCT03024970|26079936|P1|Second Intervention|Lost to Follow-up|1
7512949|NCT03024970|26079935|P2|First Intervention|Adverse Event|0
7512950|NCT03024970|26079936|P1|First Intervention|Adverse Event|1
7512951|NCT03024606|26080014|P2|Overall Study|Withdrawal by Subject|10
7512952|NCT03024606|26080015|P1|Overall Study|Withdrawal by Subject|9
7512953|NCT03023878|26080043|P1|Long Term Follow-Up Period|Death|2
7512954|NCT03023878|26080043|P1|Treatment Period|Adverse Event|1
7512955|NCT03023878|26080043|P1|Treatment Period|Withdrawal by Subject|1
7512956|NCT03023878|26080043|P1|Treatment Period|Disease Progression|1
7512957|NCT03023878|26080043|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
7512958|NCT03023878|26080043|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
7512959|NCT03023878|26080043|P1|Pre-Study Run-In Period|Death|1
7512960|NCT03023878|26080043|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
7512961|NCT03023826|26080056|P6|Period 1|Withdrawal by Subject|0
7512962|NCT03023826|26080057|P5|Period 1|Withdrawal by Subject|1
7512963|NCT03023826|26080058|P4|Period 1|Withdrawal by Subject|0
7512964|NCT03023826|26080059|P3|Period 1|Withdrawal by Subject|0
7512965|NCT03023826|26080060|P2|Period 1|Withdrawal by Subject|0
7512966|NCT03023826|26080061|P1|Period 1|Withdrawal by Subject|0
7512967|NCT03023813|26080078|P3|Overall Study|Lost to Follow-up|0
7512968|NCT03023813|26080079|P2|Overall Study|Lost to Follow-up|2
7512969|NCT03023813|26080080|P1|Overall Study|Lost to Follow-up|1
7512971|NCT03023423|26080164|P3|Overall Study|Ongoing|24
7512972|NCT03023423|26080165|P2|Overall Study|Ongoing|32
7512973|NCT03023423|26080166|P1|Overall Study|Ongoing|2
7512974|NCT03023423|26080164|P3|Overall Study|Other|2
7512975|NCT03023423|26080165|P2|Overall Study|Other|2
7512976|NCT03023423|26080166|P1|Overall Study|Other|0
7512977|NCT03023423|26080164|P3|Overall Study|Death|20
7512978|NCT03023423|26080165|P2|Overall Study|Death|12
7512979|NCT03023423|26080166|P1|Overall Study|Death|5
7512980|NCT03023397|26080199|P3|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7512981|NCT03023397|26080200|P2|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7512982|NCT03023397|26080201|P1|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
7512983|NCT03023397|26080199|P3|Run-In|Failed screening allergen challenge|0
7512984|NCT03023397|26080200|P2|Run-In|Failed screening allergen challenge|0
7512985|NCT03023397|26080201|P1|Run-In|Failed screening allergen challenge|1
7512986|NCT03023137|26080234|P2|Overall Study|Lost the baby in a car accident|0
7512987|NCT03023137|26080235|P1|Overall Study|Lost the baby in a car accident|1
7512988|NCT03023137|26080234|P2|Overall Study|Protocol Violation|4
7512989|NCT03023137|26080235|P1|Overall Study|Protocol Violation|0
7512990|NCT03023137|26080234|P2|Overall Study|Lost to Follow-up|1
7512991|NCT03023137|26080235|P1|Overall Study|Lost to Follow-up|1
7512992|NCT03023137|26080234|P2|Overall Study|Multiple pregnancy|4
7512993|NCT03023137|26080235|P1|Overall Study|Multiple pregnancy|2
7512994|NCT03022981|26080264|P3|Overall Study|Withdrew Assent By Parent/Guardian|1
7512995|NCT03022981|26080265|P2|Overall Study|Withdrew Assent By Parent/Guardian|0
7512996|NCT03022981|26080266|P1|Overall Study|Withdrew Assent By Parent/Guardian|0
7512997|NCT03022981|26080264|P3|Overall Study|Non-Compliance With Study Drug|2
7512998|NCT03022981|26080265|P2|Overall Study|Non-Compliance With Study Drug|0
7512999|NCT03022981|26080266|P1|Overall Study|Non-Compliance With Study Drug|0
7513000|NCT03022981|26080264|P3|Overall Study|Lost to Follow-up|1
7513001|NCT03022981|26080265|P2|Overall Study|Lost to Follow-up|2
7513002|NCT03022981|26080266|P1|Overall Study|Lost to Follow-up|6
7513003|NCT03022981|26080264|P3|Overall Study|Investigator's Discretion|2
7513004|NCT03022981|26080265|P2|Overall Study|Investigator's Discretion|1
7513005|NCT03022981|26080266|P1|Overall Study|Investigator's Discretion|0
7513006|NCT03022981|26080264|P3|Overall Study|Adverse Event|0
7513007|NCT03022981|26080265|P2|Overall Study|Adverse Event|1
7513008|NCT03022981|26080266|P1|Overall Study|Adverse Event|0
7513009|NCT03022799|26080365|P13|Overall Study|Adverse Event|0
7513010|NCT03022799|26080366|P12|Overall Study|Adverse Event|0
7513011|NCT03022799|26080367|P11|Overall Study|Adverse Event|1
7513012|NCT03022799|26080368|P10|Overall Study|Adverse Event|1
7513013|NCT03022799|26080369|P9|Overall Study|Adverse Event|0
7513014|NCT03022799|26080370|P8|Overall Study|Adverse Event|0
7513015|NCT03022799|26080371|P7|Overall Study|Adverse Event|0
7513016|NCT03022799|26080372|P6|Overall Study|Adverse Event|0
7513017|NCT03022799|26080373|P5|Overall Study|Adverse Event|0
7513018|NCT03022799|26080374|P4|Overall Study|Adverse Event|0
7513019|NCT03022799|26080375|P3|Overall Study|Adverse Event|0
7513020|NCT03022799|26080376|P2|Overall Study|Adverse Event|0
7513021|NCT03022799|26080377|P1|Overall Study|Adverse Event|0
7513022|NCT03022630|26080574|P2|Overall Study|Withdrawal by Subject|5
7513023|NCT03022630|26080575|P1|Overall Study|Withdrawal by Subject|0
7513024|NCT03022630|26080574|P2|Overall Study|Death|7
7513025|NCT03022630|26080575|P1|Overall Study|Death|9
7513026|NCT03022422|26080696|P6|Overall Study|3 subjects consented but not vaccinated|0
7513027|NCT03022422|26080697|P5|Overall Study|3 subjects consented but not vaccinated|0
7513028|NCT03022422|26080698|P4|Overall Study|3 subjects consented but not vaccinated|0
7513029|NCT03022422|26080699|P3|Overall Study|3 subjects consented but not vaccinated|3
7513030|NCT03022422|26080700|P2|Overall Study|3 subjects consented but not vaccinated|0
7513031|NCT03022422|26080701|P1|Overall Study|3 subjects consented but not vaccinated|0
7513032|NCT03022370|26080756|P2|Overall Study|Lost to Follow-up|109
7513033|NCT03022370|26080757|P1|Overall Study|Lost to Follow-up|174
7513034|NCT03022370|26080756|P2|Overall Study|Death|12
7513035|NCT03022370|26080757|P1|Overall Study|Death|6
7513036|NCT03022084|26080833|P2|Overall Study|Lost to Follow-up|3
7513037|NCT03022084|26080834|P1|Overall Study|Lost to Follow-up|2
7513038|NCT03022045|26080842|P2|Overall Study|Withdrawal by Subject|1
7513039|NCT03022045|26080843|P1|Overall Study|Withdrawal by Subject|1
7513040|NCT03022045|26080842|P2|Overall Study|Adverse Event|1
7513041|NCT03022045|26080843|P1|Overall Study|Adverse Event|0
7513042|NCT03021668|26080872|P2|Overall Study|Physician Decision|1
7513043|NCT03021668|26080873|P1|Overall Study|Physician Decision|0
7513044|NCT03021642|26080885|P2|Washout Period (21 Days)|Adverse Event|1
7513045|NCT03021642|26080886|P1|Washout Period (21 Days)|Adverse Event|1
7513046|NCT03021564|26080926|P2|Overall Study|Lost to Follow-up|2
7513047|NCT03021564|26080927|P1|Overall Study|Lost to Follow-up|0
7513048|NCT03021564|26080926|P2|Overall Study|Death|466
7513049|NCT03021564|26080927|P1|Overall Study|Death|84
7513050|NCT03021499|26080962|P2|Overall Study|Adverse Event (AE) Prior to First Dose|0
7513051|NCT03021499|26080963|P1|Overall Study|Adverse Event (AE) Prior to First Dose|1
7513052|NCT03021499|26080962|P2|Overall Study|None of the above|4
7513053|NCT03021499|26080963|P1|Overall Study|None of the above|0
7513054|NCT03021499|26080962|P2|Overall Study|Protocol non-compliance|1
7513055|NCT03021499|26080963|P1|Overall Study|Protocol non-compliance|1
7513056|NCT03021499|26080962|P2|Overall Study|Prohibited medication required|0
7513057|NCT03021499|26080963|P1|Overall Study|Prohibited medication required|1
7513058|NCT03021499|26080962|P2|Overall Study|Withdrawal by Subject|14
7513059|NCT03021499|26080963|P1|Overall Study|Withdrawal by Subject|7
7513060|NCT03021499|26080962|P2|Overall Study|Pregnancy|0
7513061|NCT03021499|26080963|P1|Overall Study|Pregnancy|1
7513062|NCT03021499|26080962|P2|Overall Study|Physician Decision|3
7513063|NCT03021499|26080963|P1|Overall Study|Physician Decision|2
7513064|NCT03021499|26080962|P2|Overall Study|Lost to Follow-up|3
7513065|NCT03021499|26080963|P1|Overall Study|Lost to Follow-up|1
7513066|NCT03021499|26080962|P2|Overall Study|Lack of Efficacy|1
7513067|NCT03021499|26080963|P1|Overall Study|Lack of Efficacy|0
7513068|NCT03021499|26080962|P2|Overall Study|Death|5
7513069|NCT03021499|26080963|P1|Overall Study|Death|1
7513070|NCT03021499|26080962|P2|Overall Study|Adverse Event|0
7513071|NCT03021499|26080963|P1|Overall Study|Adverse Event|1
7513072|NCT03021304|26081006|P1|Overall Study|Lack of Efficacy|1
7513073|NCT03021265|26081011|P1|Overall Study|No visit since the first visit|4
7513074|NCT03021265|26081011|P1|Overall Study|No reason given|2
7513075|NCT03021265|26081011|P1|Overall Study|Lost to Follow-up|67
7513076|NCT03021265|26081011|P1|Overall Study|Improved|17
7513077|NCT03021265|26081011|P1|Overall Study|Lack of Efficacy|3
7513078|NCT03021265|26081011|P1|Overall Study|Adverse Event|29
7513079|NCT03021187|26081021|P4|Overall Study|Lost to Follow-up|4
7513080|NCT03021187|26081022|P3|Overall Study|Lost to Follow-up|1
7513081|NCT03021187|26081023|P2|Overall Study|Lost to Follow-up|3
7513082|NCT03021187|26081024|P1|Overall Study|Lost to Follow-up|10
7513083|NCT03021187|26081021|P4|Overall Study|Withdrawal by Subject|5
7513084|NCT03021187|26081022|P3|Overall Study|Withdrawal by Subject|2
7513085|NCT03021187|26081023|P2|Overall Study|Withdrawal by Subject|6
7513086|NCT03021187|26081024|P1|Overall Study|Withdrawal by Subject|0
7513087|NCT03021187|26081021|P4|Overall Study|Death|0
7513088|NCT03021187|26081022|P3|Overall Study|Death|3
7513089|NCT03021187|26081023|P2|Overall Study|Death|0
7513090|NCT03021187|26081024|P1|Overall Study|Death|0
7513091|NCT03021018|26081180|P3|Overall Study|Fall with subsequent nasal fracture|0
7513092|NCT03021018|26081181|P2|Overall Study|Fall with subsequent nasal fracture|0
7513093|NCT03021018|26081182|P1|Overall Study|Fall with subsequent nasal fracture|1
7513094|NCT03021018|26081180|P3|Overall Study|Adverse Event|0
7513095|NCT03021018|26081181|P2|Overall Study|Adverse Event|0
7513096|NCT03021018|26081182|P1|Overall Study|Adverse Event|1
7513097|NCT03021005|26081213|P2|Overall Study|Lost to Follow-up|26
7513098|NCT03021005|26081214|P1|Overall Study|Lost to Follow-up|39
7513099|NCT03020992|26081220|P1|Overall Study|Withdrawal by Subject|1
7513100|NCT03020992|26081220|P1|Overall Study|Adverse Event|5
7513101|NCT03020966|26081257|P2|Overall Study|Withdrawal by Subject|0
7513102|NCT03020966|26081258|P1|Overall Study|Withdrawal by Subject|2
7513103|NCT03020888|26081268|P1|Overall Study|Lost to Follow-up|1
7513104|NCT03020888|26081268|P1|Overall Study|Insurance coverage|2
7513105|NCT03020888|26081268|P1|Overall Study|Withdrawal by Subject|6
7513106|NCT03020888|26081268|P1|Overall Study|Physician Decision|4
7513107|NCT03020745|26081287|P10|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513108|NCT03020745|26081288|P9|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
7513109|NCT03020745|26081289|P8|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513110|NCT03020745|26081290|P7|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513111|NCT03020745|26081291|P6|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513112|NCT03020745|26081292|P5|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513113|NCT03020745|26081293|P4|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513114|NCT03020745|26081294|P3|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513115|NCT03020745|26081295|P2|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513116|NCT03020745|26081296|P1|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7513117|NCT03020745|26081287|P10|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513118|NCT03020745|26081288|P9|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7513119|NCT03020745|26081289|P8|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513120|NCT03020745|26081290|P7|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513121|NCT03020745|26081291|P6|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7513122|NCT03020745|26081292|P5|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513123|NCT03020745|26081293|P4|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513124|NCT03020745|26081294|P3|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513125|NCT03020745|26081295|P2|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513126|NCT03020745|26081296|P1|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7513127|NCT03020745|26081287|P10|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513128|NCT03020745|26081288|P9|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513129|NCT03020745|26081289|P8|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
7513130|NCT03020745|26081290|P7|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513131|NCT03020745|26081291|P6|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513132|NCT03020745|26081292|P5|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513133|NCT03020745|26081293|P4|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513134|NCT03020745|26081294|P3|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513135|NCT03020745|26081295|P2|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513136|NCT03020745|26081296|P1|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7513137|NCT03020745|26081287|P10|Part 2 (Up to 169 Days)|Adverse Event|0
7513138|NCT03020745|26081288|P9|Part 2 (Up to 169 Days)|Adverse Event|1
7513139|NCT03020745|26081289|P8|Part 2 (Up to 169 Days)|Adverse Event|0
7513140|NCT03020745|26081290|P7|Part 2 (Up to 169 Days)|Adverse Event|0
7513141|NCT03020745|26081291|P6|Part 2 (Up to 169 Days)|Adverse Event|0
7513142|NCT03020745|26081292|P5|Part 2 (Up to 169 Days)|Adverse Event|0
7513143|NCT03020745|26081293|P4|Part 2 (Up to 169 Days)|Adverse Event|0
7513144|NCT03020745|26081294|P3|Part 2 (Up to 169 Days)|Adverse Event|0
7513145|NCT03020745|26081295|P2|Part 2 (Up to 169 Days)|Adverse Event|0
7513146|NCT03020745|26081296|P1|Part 2 (Up to 169 Days)|Adverse Event|0
7513147|NCT03020641|26081657|P2|Overall Study|for surgery not performed|1
7513148|NCT03020641|26081658|P1|Overall Study|for surgery not performed|0
7513149|NCT03020641|26081657|P2|Overall Study|Converted to open surgery|1
7513150|NCT03020641|26081658|P1|Overall Study|Converted to open surgery|2
7513151|NCT03020641|26081657|P2|Overall Study|Lost to Follow-up|1
7513152|NCT03020641|26081658|P1|Overall Study|Lost to Follow-up|0
7513153|NCT03020615|26081673|P3|Overall Study|Lost to Follow-up|0
7513154|NCT03020615|26081674|P2|Overall Study|Lost to Follow-up|1
7513155|NCT03020615|26081675|P1|Overall Study|Lost to Follow-up|0
7513156|NCT03020615|26081673|P3|Overall Study|Death|0
7513157|NCT03020615|26081674|P2|Overall Study|Death|0
7513158|NCT03020615|26081675|P1|Overall Study|Death|1
7513159|NCT03020615|26081673|P3|Overall Study|Screen failure|1
7513160|NCT03020615|26081674|P2|Overall Study|Screen failure|0
7513161|NCT03020615|26081675|P1|Overall Study|Screen failure|0
7513162|NCT03020615|26081673|P3|Overall Study|Parent/guardian/patient choice|4
7513163|NCT03020615|26081674|P2|Overall Study|Parent/guardian/patient choice|0
7513164|NCT03020615|26081675|P1|Overall Study|Parent/guardian/patient choice|3
7513165|NCT03020615|26081673|P3|Overall Study|Physician Decision|2
7513166|NCT03020615|26081674|P2|Overall Study|Physician Decision|1
7513167|NCT03020615|26081675|P1|Overall Study|Physician Decision|3
7513168|NCT03020576|26081775|P2|Overall Study|Withdrawal by Subject|2
7513169|NCT03020576|26081776|P1|Overall Study|Withdrawal by Subject|1
7513170|NCT03020407|26081867|P2|Overall Study|Protocol Violation|1
7513171|NCT03020407|26081868|P1|Overall Study|Protocol Violation|0
7513172|NCT03020407|26081867|P2|Overall Study|Lost to Follow-up|3
7513173|NCT03020407|26081868|P1|Overall Study|Lost to Follow-up|2
7513174|NCT03020407|26081867|P2|Overall Study|Withdrawal by Subject|1
7513175|NCT03020407|26081868|P1|Overall Study|Withdrawal by Subject|2
7513176|NCT03020160|26081884|P2|Overall Study|Continuing to receive emicizumab|41
7513177|NCT03020160|26081885|P1|Overall Study|Continuing to receive emicizumab|7
7513178|NCT03020069|26081948|P2|Overall Study|Lost to Follow-up|1
7513179|NCT03020069|26081949|P1|Overall Study|Lost to Follow-up|0
7513180|NCT03019965|26081967|P2|Overall Study|Physician Decision|1
7513181|NCT03019965|26081968|P1|Overall Study|Physician Decision|1
7513182|NCT03019965|26081967|P2|Overall Study|acute liver failure in the first 24 hours of randomization|5
7513183|NCT03019965|26081968|P1|Overall Study|acute liver failure in the first 24 hours of randomization|4
7513184|NCT03019965|26081967|P2|Overall Study|viral or fungal infection|4
7513185|NCT03019965|26081968|P1|Overall Study|viral or fungal infection|3
7513186|NCT03019965|26081967|P2|Overall Study|Protocol Violation|3
7513187|NCT03019965|26081968|P1|Overall Study|Protocol Violation|1
7513188|NCT03019965|26081967|P2|Overall Study|Withdrawal by Subject|0
7513189|NCT03019965|26081968|P1|Overall Study|Withdrawal by Subject|1
7513190|NCT03019627|26082041|P2|Overall Study|Other|2
7513191|NCT03019627|26082042|P1|Overall Study|Other|2
7513192|NCT03019627|26082041|P2|Overall Study|not compliance|2
7513193|NCT03019627|26082042|P1|Overall Study|not compliance|2
7513194|NCT03019627|26082041|P2|Overall Study|Lost to Follow-up|1
7513195|NCT03019627|26082042|P1|Overall Study|Lost to Follow-up|2
7513196|NCT03019627|26082041|P2|Overall Study|Unrelated to adverse event|3
7513197|NCT03019627|26082042|P1|Overall Study|Unrelated to adverse event|1
7513198|NCT03019627|26082041|P2|Overall Study|Adverse Event|0
7513199|NCT03019627|26082042|P1|Overall Study|Adverse Event|8
7513200|NCT03019549|26082078|P1|Period 2|Withdrawal by Subject|1
7513201|NCT03019549|26082078|P1|Period 2|Physician Decision|2
7513202|NCT03019549|26082078|P1|Period 2|Adverse Event|2
7513203|NCT03019549|26082078|P1|Washout|DId not meet genotype criteria|11
7513204|NCT03019458|26082091|P2|Overall Study|Death|1
7513205|NCT03019458|26082092|P1|Overall Study|Death|0
7513206|NCT03018938|26082123|P2|Overall Study|Not recorded|2
7513207|NCT03018938|26082124|P1|Overall Study|Not recorded|0
7513208|NCT03018938|26082123|P2|Overall Study|Screen failure-After randomization|2
7513209|NCT03018938|26082124|P1|Overall Study|Screen failure-After randomization|4
7513210|NCT03018938|26082123|P2|Overall Study|Sponsor Decision|1
7513211|NCT03018938|26082124|P1|Overall Study|Sponsor Decision|0
7513212|NCT03018938|26082123|P2|Overall Study|Physician Decision|2
7513213|NCT03018938|26082124|P1|Overall Study|Physician Decision|3
7513214|NCT03018938|26082123|P2|Overall Study|Withdrawal by Subject|45
7513215|NCT03018938|26082124|P1|Overall Study|Withdrawal by Subject|38
7513216|NCT03018938|26082123|P2|Overall Study|Lost to Follow-up|32
7513217|NCT03018938|26082124|P1|Overall Study|Lost to Follow-up|21
7513218|NCT03018938|26082123|P2|Overall Study|Death|1
7513219|NCT03018938|26082124|P1|Overall Study|Death|0
7513220|NCT03018691|26082188|P3|Overall Study|Withdrawal by parent/guardian|1
7513221|NCT03018691|26082189|P2|Overall Study|Withdrawal by parent/guardian|0
7513222|NCT03018691|26082190|P1|Overall Study|Withdrawal by parent/guardian|1
7513223|NCT03018691|26082188|P3|Overall Study|Withdrawal by Subject|1
7513224|NCT03018691|26082189|P2|Overall Study|Withdrawal by Subject|0
7513225|NCT03018691|26082190|P1|Overall Study|Withdrawal by Subject|0
7513226|NCT03018691|26082188|P3|Overall Study|Lack of Efficacy|1
7513227|NCT03018691|26082189|P2|Overall Study|Lack of Efficacy|0
7513228|NCT03018691|26082190|P1|Overall Study|Lack of Efficacy|0
7513229|NCT03018691|26082188|P3|Overall Study|Adverse Event|4
7513230|NCT03018691|26082189|P2|Overall Study|Adverse Event|1
7513231|NCT03018691|26082190|P1|Overall Study|Adverse Event|1
7513232|NCT03018340|26082226|P2|Overall Study|Not further specified|1
7513233|NCT03018340|26082227|P1|Overall Study|Not further specified|0
7513234|NCT03018340|26082226|P2|Overall Study|Protocol Violation|7
7513235|NCT03018340|26082227|P1|Overall Study|Protocol Violation|3
7513236|NCT03018340|26082226|P2|Overall Study|Lost to Follow-up|7
7513237|NCT03018340|26082227|P1|Overall Study|Lost to Follow-up|1
7513238|NCT03018340|26082226|P2|Overall Study|Non-compliance with study drug/procedure|4
7513239|NCT03018340|26082227|P1|Overall Study|Non-compliance with study drug/procedure|3
7513240|NCT03018340|26082226|P2|Overall Study|Lack of Efficacy|1
7513241|NCT03018340|26082227|P1|Overall Study|Lack of Efficacy|0
7513242|NCT03018340|26082226|P2|Overall Study|Withdrawal by Subject|8
7513243|NCT03018340|26082227|P1|Overall Study|Withdrawal by Subject|0
7513244|NCT03018340|26082226|P2|Overall Study|Adverse Event|2
7513245|NCT03018340|26082227|P1|Overall Study|Adverse Event|1
7513246|NCT03018249|26082279|P2|Overall Study|Withdrawal by Subject|2
7513247|NCT03018249|26082280|P1|Overall Study|Withdrawal by Subject|2
7513248|NCT03018106|26082301|P2|Overall Study|Lost to Follow-up|1
7513249|NCT03018106|26082302|P1|Overall Study|Lost to Follow-up|0
7513250|NCT03018028|26082315|P5|Overall Study|Withdrawal by Subject|0
7513251|NCT03018028|26082316|P4|Overall Study|Withdrawal by Subject|2
7513252|NCT03018028|26082317|P3|Overall Study|Withdrawal by Subject|1
7513253|NCT03018028|26082318|P2|Overall Study|Withdrawal by Subject|0
7513254|NCT03018028|26082319|P1|Overall Study|Withdrawal by Subject|3
7513255|NCT03017846|26082584|P1|Overall Study|Adverse Event|2
7513256|NCT03017846|26082584|P1|Overall Study|Lost to Follow-up|3
7513257|NCT03017612|26082592|P1|Overall Study|Adverse Event|2
7513258|NCT03017235|26082646|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
7513259|NCT03017235|26082647|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
7513260|NCT03017235|26082646|P2|Overall Study|Protocol Violation|1
7513261|NCT03017235|26082647|P1|Overall Study|Protocol Violation|2
7513262|NCT03017235|26082646|P2|Overall Study|Adverse Event|1
7513263|NCT03017235|26082647|P1|Overall Study|Adverse Event|0
7513264|NCT03017235|26082646|P2|Overall Study|Lost to Follow-up|7
7513265|NCT03017235|26082647|P1|Overall Study|Lost to Follow-up|2
7513266|NCT03017235|26082646|P2|Overall Study|Withdrawal by Subject|3
7513267|NCT03017235|26082647|P1|Overall Study|Withdrawal by Subject|4
7513268|NCT03016598|26082710|P2|Overall Study|Lost to Follow-up|2
7513269|NCT03016598|26082711|P1|Overall Study|Lost to Follow-up|0
7513270|NCT03016403|26082741|P4|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
7513271|NCT03016403|26082742|P3|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7513272|NCT03016403|26082743|P2|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7513273|NCT03016403|26082744|P1|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7513274|NCT03016403|26082741|P4|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7513275|NCT03016403|26082742|P3|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
7513276|NCT03016403|26082743|P2|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
7513277|NCT03016403|26082744|P1|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7513278|NCT03016403|26082741|P4|3-month Follow-up and 6-month Follow-up|Death|0
7513279|NCT03016403|26082742|P3|3-month Follow-up and 6-month Follow-up|Death|0
7513280|NCT03016403|26082743|P2|3-month Follow-up and 6-month Follow-up|Death|4
7513281|NCT03016403|26082744|P1|3-month Follow-up and 6-month Follow-up|Death|6
7513282|NCT03016403|26082741|P4|6-week Follow-up|Withdrawal by Subject|1
7513283|NCT03016403|26082742|P3|6-week Follow-up|Withdrawal by Subject|0
7513284|NCT03016403|26082743|P2|6-week Follow-up|Withdrawal by Subject|2
7513285|NCT03016403|26082744|P1|6-week Follow-up|Withdrawal by Subject|0
7513286|NCT03016403|26082741|P4|6-week Follow-up|Lost to Follow-up|8
7513287|NCT03016403|26082742|P3|6-week Follow-up|Lost to Follow-up|4
7513288|NCT03016403|26082743|P2|6-week Follow-up|Lost to Follow-up|7
7513289|NCT03016403|26082744|P1|6-week Follow-up|Lost to Follow-up|2
7513290|NCT03016403|26082741|P4|6-week Follow-up|Death|0
7513291|NCT03016403|26082742|P3|6-week Follow-up|Death|0
7513292|NCT03016403|26082743|P2|6-week Follow-up|Death|4
7513293|NCT03016403|26082744|P1|6-week Follow-up|Death|1
7513294|NCT03016403|26082741|P4|Baseline|Lost to Follow-up|24
7513295|NCT03016403|26082742|P3|Baseline|Lost to Follow-up|6
7513296|NCT03016403|26082743|P2|Baseline|Lost to Follow-up|11
7513297|NCT03016403|26082744|P1|Baseline|Lost to Follow-up|9
7513298|NCT03016403|26082741|P4|Baseline|Withdrawal by Subject|10
7513299|NCT03016403|26082742|P3|Baseline|Withdrawal by Subject|4
7513300|NCT03016403|26082743|P2|Baseline|Withdrawal by Subject|8
7513301|NCT03016403|26082744|P1|Baseline|Withdrawal by Subject|2
7513302|NCT03016403|26082741|P4|Baseline|Death|0
7513303|NCT03016403|26082742|P3|Baseline|Death|1
7513304|NCT03016403|26082743|P2|Baseline|Death|8
7513305|NCT03016403|26082744|P1|Baseline|Death|5
7513306|NCT03016325|26082778|P8|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
7513307|NCT03016325|26082779|P7|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
7513308|NCT03016325|26082780|P6|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
7513309|NCT03016325|26082781|P5|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7513310|NCT03016325|26082782|P4|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7513311|NCT03016325|26082783|P3|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7513312|NCT03016325|26082784|P2|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7513313|NCT03016325|26082785|P1|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7513314|NCT03016325|26082778|P8|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513315|NCT03016325|26082779|P7|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513316|NCT03016325|26082780|P6|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513317|NCT03016325|26082781|P5|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513318|NCT03016325|26082782|P4|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513319|NCT03016325|26082783|P3|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513320|NCT03016325|26082784|P2|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
7513321|NCT03016325|26082785|P1|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7513322|NCT03016325|26082778|P8|182-Day Follow-Up Period|Vital status collected via EMR|0
7513323|NCT03016325|26082779|P7|182-Day Follow-Up Period|Vital status collected via EMR|0
7513324|NCT03016325|26082780|P6|182-Day Follow-Up Period|Vital status collected via EMR|0
7513325|NCT03016325|26082781|P5|182-Day Follow-Up Period|Vital status collected via EMR|0
7513326|NCT03016325|26082782|P4|182-Day Follow-Up Period|Vital status collected via EMR|1
7513327|NCT03016325|26082783|P3|182-Day Follow-Up Period|Vital status collected via EMR|0
7513328|NCT03016325|26082784|P2|182-Day Follow-Up Period|Vital status collected via EMR|0
7513329|NCT03016325|26082785|P1|182-Day Follow-Up Period|Vital status collected via EMR|0
7513330|NCT03016325|26082778|P8|182-Day Follow-Up Period|Alive, per civil unit|0
7513331|NCT03016325|26082779|P7|182-Day Follow-Up Period|Alive, per civil unit|0
7513332|NCT03016325|26082780|P6|182-Day Follow-Up Period|Alive, per civil unit|0
7513333|NCT03016325|26082781|P5|182-Day Follow-Up Period|Alive, per civil unit|1
7513334|NCT03016325|26082782|P4|182-Day Follow-Up Period|Alive, per civil unit|0
7513335|NCT03016325|26082783|P3|182-Day Follow-Up Period|Alive, per civil unit|0
7513336|NCT03016325|26082784|P2|182-Day Follow-Up Period|Alive, per civil unit|0
7513337|NCT03016325|26082785|P1|182-Day Follow-Up Period|Alive, per civil unit|0
7513338|NCT03016325|26082778|P8|182-Day Follow-Up Period|Alive, per Family doctor|0
7513339|NCT03016325|26082779|P7|182-Day Follow-Up Period|Alive, per Family doctor|0
7513340|NCT03016325|26082780|P6|182-Day Follow-Up Period|Alive, per Family doctor|0
7513341|NCT03016325|26082781|P5|182-Day Follow-Up Period|Alive, per Family doctor|1
7513342|NCT03016325|26082782|P4|182-Day Follow-Up Period|Alive, per Family doctor|0
7513343|NCT03016325|26082783|P3|182-Day Follow-Up Period|Alive, per Family doctor|0
7513344|NCT03016325|26082784|P2|182-Day Follow-Up Period|Alive, per Family doctor|0
7513345|NCT03016325|26082785|P1|182-Day Follow-Up Period|Alive, per Family doctor|0
7513346|NCT03016325|26082778|P8|182-Day Follow-Up Period|Participant withdrew consent|0
7513347|NCT03016325|26082779|P7|182-Day Follow-Up Period|Participant withdrew consent|1
7513348|NCT03016325|26082780|P6|182-Day Follow-Up Period|Participant withdrew consent|0
7513349|NCT03016325|26082781|P5|182-Day Follow-Up Period|Participant withdrew consent|1
7513350|NCT03016325|26082782|P4|182-Day Follow-Up Period|Participant withdrew consent|0
7513351|NCT03016325|26082783|P3|182-Day Follow-Up Period|Participant withdrew consent|0
7513352|NCT03016325|26082784|P2|182-Day Follow-Up Period|Participant withdrew consent|0
7513353|NCT03016325|26082785|P1|182-Day Follow-Up Period|Participant withdrew consent|0
7513354|NCT03016325|26082778|P8|182-Day Follow-Up Period|Alive, per national insurance system|0
7513355|NCT03016325|26082779|P7|182-Day Follow-Up Period|Alive, per national insurance system|0
7513356|NCT03016325|26082780|P6|182-Day Follow-Up Period|Alive, per national insurance system|0
7513357|NCT03016325|26082781|P5|182-Day Follow-Up Period|Alive, per national insurance system|0
7513358|NCT03016325|26082782|P4|182-Day Follow-Up Period|Alive, per national insurance system|0
7513359|NCT03016325|26082783|P3|182-Day Follow-Up Period|Alive, per national insurance system|0
7513360|NCT03016325|26082784|P2|182-Day Follow-Up Period|Alive, per national insurance system|0
7513361|NCT03016325|26082785|P1|182-Day Follow-Up Period|Alive, per national insurance system|1
7513362|NCT03016325|26082778|P8|182-Day Follow-Up Period|Death|1
7513363|NCT03016325|26082779|P7|182-Day Follow-Up Period|Death|0
7513364|NCT03016325|26082780|P6|182-Day Follow-Up Period|Death|0
7513365|NCT03016325|26082781|P5|182-Day Follow-Up Period|Death|9
7513366|NCT03016325|26082782|P4|182-Day Follow-Up Period|Death|12
7513367|NCT03016325|26082783|P3|182-Day Follow-Up Period|Death|11
7513368|NCT03016325|26082784|P2|182-Day Follow-Up Period|Death|3
7513369|NCT03016325|26082785|P1|182-Day Follow-Up Period|Death|3
7513370|NCT03016325|26082778|P8|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513371|NCT03016325|26082779|P7|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513372|NCT03016325|26082780|P6|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513373|NCT03016325|26082781|P5|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513374|NCT03016325|26082782|P4|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513375|NCT03016325|26082783|P3|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513376|NCT03016325|26082784|P2|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
7513377|NCT03016325|26082785|P1|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7513378|NCT03016325|26082778|P8|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513379|NCT03016325|26082779|P7|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513380|NCT03016325|26082780|P6|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513381|NCT03016325|26082781|P5|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513382|NCT03016325|26082782|P4|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513383|NCT03016325|26082783|P3|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
7513384|NCT03016325|26082784|P2|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513385|NCT03016325|26082785|P1|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7513386|NCT03016325|26082778|P8|32-Day Follow-Up Period|Participant withdrew consent|0
7513387|NCT03016325|26082779|P7|32-Day Follow-Up Period|Participant withdrew consent|1
7513388|NCT03016325|26082780|P6|32-Day Follow-Up Period|Participant withdrew consent|0
7513389|NCT03016325|26082781|P5|32-Day Follow-Up Period|Participant withdrew consent|2
7513390|NCT03016325|26082782|P4|32-Day Follow-Up Period|Participant withdrew consent|0
7513391|NCT03016325|26082783|P3|32-Day Follow-Up Period|Participant withdrew consent|0
7513392|NCT03016325|26082784|P2|32-Day Follow-Up Period|Participant withdrew consent|0
7513393|NCT03016325|26082785|P1|32-Day Follow-Up Period|Participant withdrew consent|0
7513394|NCT03016325|26082778|P8|32-Day Follow-Up Period|Participant refused to visit|0
7513395|NCT03016325|26082779|P7|32-Day Follow-Up Period|Participant refused to visit|0
7513396|NCT03016325|26082780|P6|32-Day Follow-Up Period|Participant refused to visit|0
7513397|NCT03016325|26082781|P5|32-Day Follow-Up Period|Participant refused to visit|2
7513398|NCT03016325|26082782|P4|32-Day Follow-Up Period|Participant refused to visit|0
7513399|NCT03016325|26082783|P3|32-Day Follow-Up Period|Participant refused to visit|2
7513400|NCT03016325|26082784|P2|32-Day Follow-Up Period|Participant refused to visit|1
7513401|NCT03016325|26082785|P1|32-Day Follow-Up Period|Participant refused to visit|0
7513402|NCT03016325|26082778|P8|32-Day Follow-Up Period|Poor/non-compliance|0
7513403|NCT03016325|26082779|P7|32-Day Follow-Up Period|Poor/non-compliance|0
7513404|NCT03016325|26082780|P6|32-Day Follow-Up Period|Poor/non-compliance|0
7513405|NCT03016325|26082781|P5|32-Day Follow-Up Period|Poor/non-compliance|1
7513406|NCT03016325|26082782|P4|32-Day Follow-Up Period|Poor/non-compliance|1
7513407|NCT03016325|26082783|P3|32-Day Follow-Up Period|Poor/non-compliance|0
7513408|NCT03016325|26082784|P2|32-Day Follow-Up Period|Poor/non-compliance|0
7513409|NCT03016325|26082785|P1|32-Day Follow-Up Period|Poor/non-compliance|1
7513410|NCT03016325|26082778|P8|32-Day Follow-Up Period|Lost to Follow-up|0
7513411|NCT03016325|26082779|P7|32-Day Follow-Up Period|Lost to Follow-up|0
7513412|NCT03016325|26082780|P6|32-Day Follow-Up Period|Lost to Follow-up|0
7513413|NCT03016325|26082781|P5|32-Day Follow-Up Period|Lost to Follow-up|0
7513414|NCT03016325|26082782|P4|32-Day Follow-Up Period|Lost to Follow-up|1
7513415|NCT03016325|26082783|P3|32-Day Follow-Up Period|Lost to Follow-up|1
7513416|NCT03016325|26082784|P2|32-Day Follow-Up Period|Lost to Follow-up|0
7513417|NCT03016325|26082785|P1|32-Day Follow-Up Period|Lost to Follow-up|1
7513418|NCT03016325|26082778|P8|32-Day Follow-Up Period|Death|0
7513419|NCT03016325|26082779|P7|32-Day Follow-Up Period|Death|0
7513420|NCT03016325|26082780|P6|32-Day Follow-Up Period|Death|0
7513421|NCT03016325|26082781|P5|32-Day Follow-Up Period|Death|3
7513422|NCT03016325|26082782|P4|32-Day Follow-Up Period|Death|6
7513423|NCT03016325|26082783|P3|32-Day Follow-Up Period|Death|5
7513424|NCT03016325|26082784|P2|32-Day Follow-Up Period|Death|0
7513425|NCT03016325|26082785|P1|32-Day Follow-Up Period|Death|2
7513426|NCT03016325|26082778|P8|Treatment Period|Participant refuses assessments|0
7513427|NCT03016325|26082779|P7|Treatment Period|Participant refuses assessments|0
7513428|NCT03016325|26082780|P6|Treatment Period|Participant refuses assessments|0
7513429|NCT03016325|26082781|P5|Treatment Period|Participant refuses assessments|0
7513430|NCT03016325|26082782|P4|Treatment Period|Participant refuses assessments|0
7513431|NCT03016325|26082783|P3|Treatment Period|Participant refuses assessments|1
7513432|NCT03016325|26082784|P2|Treatment Period|Participant refuses assessments|0
7513433|NCT03016325|26082785|P1|Treatment Period|Participant refuses assessments|0
7513434|NCT03016325|26082778|P8|Treatment Period|Death|0
7513435|NCT03016325|26082779|P7|Treatment Period|Death|0
7513436|NCT03016325|26082780|P6|Treatment Period|Death|0
7513437|NCT03016325|26082781|P5|Treatment Period|Death|2
7513438|NCT03016325|26082782|P4|Treatment Period|Death|0
7513439|NCT03016325|26082783|P3|Treatment Period|Death|0
7513440|NCT03016325|26082784|P2|Treatment Period|Death|0
7513441|NCT03016325|26082785|P1|Treatment Period|Death|0
7513442|NCT03016325|26082778|P8|Treatment Period|Participant withdrew consent|0
7513443|NCT03016325|26082779|P7|Treatment Period|Participant withdrew consent|0
7513444|NCT03016325|26082780|P6|Treatment Period|Participant withdrew consent|0
7513445|NCT03016325|26082781|P5|Treatment Period|Participant withdrew consent|0
7513446|NCT03016325|26082782|P4|Treatment Period|Participant withdrew consent|0
7513447|NCT03016325|26082783|P3|Treatment Period|Participant withdrew consent|0
7513448|NCT03016325|26082784|P2|Treatment Period|Participant withdrew consent|1
7513449|NCT03016325|26082785|P1|Treatment Period|Participant withdrew consent|0
7513460|NCT03016078|26083031|P1|Overall Study|Protocol Violation|1
7513461|NCT03016078|26083031|P1|Overall Study|Protocol Violation|1
7513462|NCT03015363|26083061|P1|Overall Study|Withdrawal by Subject|3
7513463|NCT03015363|26083061|P1|Overall Study|Physician Decision|14
7513464|NCT03015220|26083072|P4|Overall Study|Lost to Follow-up|0
7513465|NCT03015220|26083073|P3|Overall Study|Lost to Follow-up|1
7513466|NCT03015220|26083074|P2|Overall Study|Lost to Follow-up|0
7513467|NCT03015220|26083075|P1|Overall Study|Lost to Follow-up|0
7513468|NCT03015220|26083072|P4|Overall Study|Withdrawal by Subject|2
7513469|NCT03015220|26083073|P3|Overall Study|Withdrawal by Subject|2
7513470|NCT03015220|26083074|P2|Overall Study|Withdrawal by Subject|2
7513471|NCT03015220|26083075|P1|Overall Study|Withdrawal by Subject|3
7513472|NCT03015194|26083213|P1|Overall Study|Withdrawal by Subject|2
7513473|NCT03015194|26083213|P1|Overall Study|Death|10
7513474|NCT03015181|26083225|P7|Overall Study|Physician Decision|1
7513475|NCT03015181|26083226|P6|Overall Study|Physician Decision|0
7513476|NCT03015181|26083227|P5|Overall Study|Physician Decision|0
7513477|NCT03015181|26083228|P4|Overall Study|Physician Decision|0
7513478|NCT03015181|26083229|P3|Overall Study|Physician Decision|0
7513479|NCT03015181|26083230|P2|Overall Study|Physician Decision|0
7513480|NCT03015181|26083231|P1|Overall Study|Physician Decision|0
7513481|NCT03015181|26083225|P7|Overall Study|Withdrawal by Subject|0
7513482|NCT03015181|26083226|P6|Overall Study|Withdrawal by Subject|1
7513483|NCT03015181|26083227|P5|Overall Study|Withdrawal by Subject|0
7513484|NCT03015181|26083228|P4|Overall Study|Withdrawal by Subject|0
7513485|NCT03015181|26083229|P3|Overall Study|Withdrawal by Subject|0
7513486|NCT03015181|26083230|P2|Overall Study|Withdrawal by Subject|0
7513487|NCT03015181|26083231|P1|Overall Study|Withdrawal by Subject|0
7513488|NCT03015181|26083225|P7|Overall Study|Enrolled, but product never administered|0
7513489|NCT03015181|26083226|P6|Overall Study|Enrolled, but product never administered|0
7513490|NCT03015181|26083227|P5|Overall Study|Enrolled, but product never administered|0
7513491|NCT03015181|26083228|P4|Overall Study|Enrolled, but product never administered|0
7513492|NCT03015181|26083229|P3|Overall Study|Enrolled, but product never administered|0
7513493|NCT03015181|26083230|P2|Overall Study|Enrolled, but product never administered|0
7513494|NCT03015181|26083231|P1|Overall Study|Enrolled, but product never administered|1
7513495|NCT03015116|26083358|P3|Overall Study|Physician Decision|0
7513496|NCT03015116|26083359|P2|Overall Study|Physician Decision|1
7513497|NCT03015116|26083360|P1|Overall Study|Physician Decision|0
7513498|NCT03015116|26083358|P3|Overall Study|Subject has New Medical Status|0
7513499|NCT03015116|26083359|P2|Overall Study|Subject has New Medical Status|0
7513500|NCT03015116|26083360|P1|Overall Study|Subject has New Medical Status|1
7513501|NCT03015116|26083358|P3|Overall Study|Withdrawal by Subject|0
7513502|NCT03015116|26083359|P2|Overall Study|Withdrawal by Subject|1
7513503|NCT03015116|26083360|P1|Overall Study|Withdrawal by Subject|3
7513504|NCT03015116|26083358|P3|Overall Study|Lost to Follow-up|2
7513505|NCT03015116|26083359|P2|Overall Study|Lost to Follow-up|0
7513506|NCT03015116|26083360|P1|Overall Study|Lost to Follow-up|3
7513507|NCT03014674|26083400|P3|Overall Study|Withdrawal by Subject|0
7513508|NCT03014674|26083401|P2|Overall Study|Withdrawal by Subject|0
7513509|NCT03014674|26083402|P1|Overall Study|Withdrawal by Subject|1
7513510|NCT03014479|26083477|P2|Overall Study|Unacceptable Inability of Site Visit|1
7513511|NCT03014479|26083478|P1|Overall Study|Unacceptable Inability of Site Visit|0
7513512|NCT03014479|26083477|P2|Overall Study|Voluntary Withdrawal|2
7513513|NCT03014479|26083478|P1|Overall Study|Voluntary Withdrawal|0
7513514|NCT03014479|26083477|P2|Overall Study|Adverse Event|1
7513515|NCT03014479|26083478|P1|Overall Study|Adverse Event|0
7513516|NCT03014453|26083524|P1|Overall Study|Refused to take part in|37
7513517|NCT03014453|26083524|P1|Overall Study|Excluded|19
7513518|NCT03014453|26083524|P1|Overall Study|Discontinued GER|3
7513519|NCT03014453|26083524|P1|Overall Study|Lost to Follow-up|12
7513520|NCT03014206|26083528|P1|Overall Study|Registration Violation|12
7513521|NCT03014180|26083532|P1|Overall Study|Protocol Violation|2
7513522|NCT03014011|26083541|P2|Washout|Withdrawal by Subject|0
7513523|NCT03014011|26083542|P1|Washout|Withdrawal by Subject|1
7513524|NCT03014011|26083541|P2|First Intervention|Withdrawal by Subject|0
7513525|NCT03014011|26083542|P1|First Intervention|Withdrawal by Subject|1
7513526|NCT03013985|26083550|P2|Overall Study|Withdrawal by Subject|17
7513527|NCT03013985|26083551|P1|Overall Study|Withdrawal by Subject|14
7513528|NCT03013985|26083550|P2|Overall Study|Protocol Violation|2
7513529|NCT03013985|26083551|P1|Overall Study|Protocol Violation|2
7513530|NCT03012841|26083583|P2|Overall Study|Insurance change|1
7513531|NCT03012841|26083584|P1|Overall Study|Insurance change|0
7513532|NCT03012841|26083583|P2|Overall Study|Study reached n=165 treated subject cap|5
7513533|NCT03012841|26083584|P1|Overall Study|Study reached n=165 treated subject cap|0
7513534|NCT03012841|26083583|P2|Overall Study|No ablation performed|2
7513535|NCT03012841|26083584|P1|Overall Study|No ablation performed|0
7513536|NCT03012841|26083583|P2|Overall Study|Physician Decision|2
7513537|NCT03012841|26083584|P1|Overall Study|Physician Decision|0
7513538|NCT03012841|26083583|P2|Overall Study|Seasonal winter travel|0
7513539|NCT03012841|26083584|P1|Overall Study|Seasonal winter travel|1
7513540|NCT03012841|26083583|P2|Overall Study|Subject relocation|0
7513541|NCT03012841|26083584|P1|Overall Study|Subject relocation|1
7513542|NCT03012841|26083583|P2|Overall Study|Unable to complete 12 month visit|0
7513543|NCT03012841|26083584|P1|Overall Study|Unable to complete 12 month visit|6
7513544|NCT03012841|26083583|P2|Overall Study|Withdrawal by Subject|0
7513545|NCT03012841|26083584|P1|Overall Study|Withdrawal by Subject|6
7513546|NCT03012841|26083583|P2|Overall Study|Lost to Follow-up|1
7513547|NCT03012841|26083584|P1|Overall Study|Lost to Follow-up|6
7513548|NCT03012841|26083583|P2|Overall Study|Protocol Violation|10
7513549|NCT03012841|26083584|P1|Overall Study|Protocol Violation|0
7513550|NCT03012828|26083598|P6|Overall Study|Delay to last visit would delay DBL|1
7513551|NCT03012828|26083599|P5|Overall Study|Delay to last visit would delay DBL|0
7513552|NCT03012828|26083600|P4|Overall Study|Delay to last visit would delay DBL|0
7513553|NCT03012828|26083601|P3|Overall Study|Delay to last visit would delay DBL|0
7513554|NCT03012828|26083602|P2|Overall Study|Delay to last visit would delay DBL|0
7513555|NCT03012828|26083603|P1|Overall Study|Delay to last visit would delay DBL|0
7513556|NCT03012828|26083598|P6|Overall Study|Non-compliance with protocol|0
7513557|NCT03012828|26083599|P5|Overall Study|Non-compliance with protocol|1
7513558|NCT03012828|26083600|P4|Overall Study|Non-compliance with protocol|0
7513559|NCT03012828|26083601|P3|Overall Study|Non-compliance with protocol|0
7513560|NCT03012828|26083602|P2|Overall Study|Non-compliance with protocol|0
7513561|NCT03012828|26083603|P1|Overall Study|Non-compliance with protocol|0
7513562|NCT03012828|26083598|P6|Overall Study|Withdrawal by Subject|1
7513563|NCT03012828|26083599|P5|Overall Study|Withdrawal by Subject|0
7513564|NCT03012828|26083600|P4|Overall Study|Withdrawal by Subject|0
7513565|NCT03012828|26083601|P3|Overall Study|Withdrawal by Subject|1
7513566|NCT03012828|26083602|P2|Overall Study|Withdrawal by Subject|0
7513567|NCT03012828|26083603|P1|Overall Study|Withdrawal by Subject|0
7513568|NCT03012828|26083598|P6|Overall Study|Lost to Follow-up|0
7513569|NCT03012828|26083599|P5|Overall Study|Lost to Follow-up|1
7513570|NCT03012828|26083600|P4|Overall Study|Lost to Follow-up|0
7513571|NCT03012828|26083601|P3|Overall Study|Lost to Follow-up|1
7513572|NCT03012828|26083602|P2|Overall Study|Lost to Follow-up|0
7513573|NCT03012828|26083603|P1|Overall Study|Lost to Follow-up|1
7513574|NCT03012334|26083651|P10|Period 4|Adverse Event|0
7513575|NCT03012334|26083652|P9|Period 4|Adverse Event|1
7513576|NCT03012334|26083653|P8|Period 4|Adverse Event|0
7513577|NCT03012334|26083654|P7|Period 4|Adverse Event|0
7513578|NCT03012334|26083655|P6|Period 4|Adverse Event|0
7513579|NCT03012334|26083656|P5|Period 4|Adverse Event|0
7513580|NCT03012334|26083657|P4|Period 4|Adverse Event|0
7513581|NCT03012334|26083658|P3|Period 4|Adverse Event|0
7513582|NCT03012334|26083659|P2|Period 4|Adverse Event|0
7513583|NCT03012334|26083660|P1|Period 4|Adverse Event|0
7513584|NCT03012334|26083651|P10|Period 4|Non-Compliance|0
7513585|NCT03012334|26083652|P9|Period 4|Non-Compliance|0
7513586|NCT03012334|26083653|P8|Period 4|Non-Compliance|0
7513587|NCT03012334|26083654|P7|Period 4|Non-Compliance|1
7513588|NCT03012334|26083655|P6|Period 4|Non-Compliance|0
7513589|NCT03012334|26083656|P5|Period 4|Non-Compliance|0
7513590|NCT03012334|26083657|P4|Period 4|Non-Compliance|0
7513591|NCT03012334|26083658|P3|Period 4|Non-Compliance|0
7513592|NCT03012334|26083659|P2|Period 4|Non-Compliance|0
7513593|NCT03012334|26083660|P1|Period 4|Non-Compliance|0
7513594|NCT03012334|26083651|P10|Period 2|Protocol Violation|0
7513595|NCT03012334|26083652|P9|Period 2|Protocol Violation|0
7513596|NCT03012334|26083653|P8|Period 2|Protocol Violation|1
7513597|NCT03012334|26083654|P7|Period 2|Protocol Violation|0
7513598|NCT03012334|26083655|P6|Period 2|Protocol Violation|0
7513599|NCT03012334|26083656|P5|Period 2|Protocol Violation|0
7513600|NCT03012334|26083657|P4|Period 2|Protocol Violation|0
7513601|NCT03012334|26083658|P3|Period 2|Protocol Violation|1
7513602|NCT03012334|26083659|P2|Period 2|Protocol Violation|0
7513603|NCT03012334|26083660|P1|Period 2|Protocol Violation|0
7513604|NCT03012334|26083651|P10|Period 2|Withdrawal by Subject|0
7513605|NCT03012334|26083652|P9|Period 2|Withdrawal by Subject|0
7513606|NCT03012334|26083653|P8|Period 2|Withdrawal by Subject|0
7513607|NCT03012334|26083654|P7|Period 2|Withdrawal by Subject|0
7513608|NCT03012334|26083655|P6|Period 2|Withdrawal by Subject|0
7513609|NCT03012334|26083656|P5|Period 2|Withdrawal by Subject|0
7513610|NCT03012334|26083657|P4|Period 2|Withdrawal by Subject|0
7513611|NCT03012334|26083658|P3|Period 2|Withdrawal by Subject|0
7513612|NCT03012334|26083659|P2|Period 2|Withdrawal by Subject|1
7513613|NCT03012334|26083660|P1|Period 2|Withdrawal by Subject|0
7513614|NCT03012334|26083651|P10|Period 1|Withdrawal by Subject|1
7513615|NCT03012334|26083652|P9|Period 1|Withdrawal by Subject|0
7513616|NCT03012334|26083653|P8|Period 1|Withdrawal by Subject|0
7513617|NCT03012334|26083654|P7|Period 1|Withdrawal by Subject|0
7513618|NCT03012334|26083655|P6|Period 1|Withdrawal by Subject|0
7513619|NCT03012334|26083656|P5|Period 1|Withdrawal by Subject|0
7513620|NCT03012334|26083657|P4|Period 1|Withdrawal by Subject|0
7513621|NCT03012334|26083658|P3|Period 1|Withdrawal by Subject|0
7513622|NCT03012334|26083659|P2|Period 1|Withdrawal by Subject|0
7513623|NCT03012334|26083660|P1|Period 1|Withdrawal by Subject|0
7513624|NCT03012061|26083730|P3|Overall Study|Adverse Event|0
7513625|NCT03012061|26083731|P2|Overall Study|Adverse Event|0
7513626|NCT03012061|26083732|P1|Overall Study|Adverse Event|2
7513627|NCT03012061|26083730|P3|Overall Study|Lack of Efficacy|0
7513628|NCT03012061|26083731|P2|Overall Study|Lack of Efficacy|1
7513629|NCT03012061|26083732|P1|Overall Study|Lack of Efficacy|0
7513630|NCT03012061|26083730|P3|Overall Study|Protocol Violation|2
7513631|NCT03012061|26083731|P2|Overall Study|Protocol Violation|0
7513632|NCT03012061|26083732|P1|Overall Study|Protocol Violation|0
7513633|NCT03012061|26083730|P3|Overall Study|Met Protocol Withdrawal Criterion|1
7513634|NCT03012061|26083731|P2|Overall Study|Met Protocol Withdrawal Criterion|0
7513635|NCT03012061|26083732|P1|Overall Study|Met Protocol Withdrawal Criterion|0
7513636|NCT03012061|26083730|P3|Overall Study|Study closed/ Terminated|1
7513637|NCT03012061|26083731|P2|Overall Study|Study closed/ Terminated|0
7513638|NCT03012061|26083732|P1|Overall Study|Study closed/ Terminated|0
7513639|NCT03012061|26083730|P3|Overall Study|Lost to Follow-up|0
7513640|NCT03012061|26083731|P2|Overall Study|Lost to Follow-up|1
7513641|NCT03012061|26083732|P1|Overall Study|Lost to Follow-up|2
7513642|NCT03012061|26083730|P3|Overall Study|Investigator Site Closed|0
7513643|NCT03012061|26083731|P2|Overall Study|Investigator Site Closed|2
7513644|NCT03012061|26083732|P1|Overall Study|Investigator Site Closed|1
7513645|NCT03012061|26083730|P3|Overall Study|Withdrawal by Subject|4
7513646|NCT03012061|26083731|P2|Overall Study|Withdrawal by Subject|5
7513647|NCT03012061|26083732|P1|Overall Study|Withdrawal by Subject|1
7513648|NCT03011892|26083761|P12|Open Label (OL) Period|Reason not specified|0
7513649|NCT03011892|26083762|P11|Open Label (OL) Period|Reason not specified|0
7513650|NCT03011892|26083763|P10|Open Label (OL) Period|Reason not specified|0
7513651|NCT03011892|26083764|P9|Open Label (OL) Period|Reason not specified|0
7513652|NCT03011892|26083765|P8|Open Label (OL) Period|Reason not specified|1
7513653|NCT03011892|26083766|P7|Open Label (OL) Period|Reason not specified|0
7513654|NCT03011892|26083767|P6|Open Label (OL) Period|Reason not specified|0
7513655|NCT03011892|26083768|P5|Open Label (OL) Period|Reason not specified|0
7513656|NCT03011892|26083769|P4|Open Label (OL) Period|Reason not specified|0
7513657|NCT03011892|26083770|P3|Open Label (OL) Period|Reason not specified|0
7513658|NCT03011892|26083771|P2|Open Label (OL) Period|Reason not specified|0
7513659|NCT03011892|26083772|P1|Open Label (OL) Period|Reason not specified|0
7513660|NCT03011892|26083761|P12|Open Label (OL) Period|Withdrawal by Subject|2
7513661|NCT03011892|26083762|P11|Open Label (OL) Period|Withdrawal by Subject|1
7513662|NCT03011892|26083763|P10|Open Label (OL) Period|Withdrawal by Subject|0
7513663|NCT03011892|26083764|P9|Open Label (OL) Period|Withdrawal by Subject|1
7513664|NCT03011892|26083765|P8|Open Label (OL) Period|Withdrawal by Subject|0
7513665|NCT03011892|26083766|P7|Open Label (OL) Period|Withdrawal by Subject|3
7513666|NCT03011892|26083767|P6|Open Label (OL) Period|Withdrawal by Subject|0
7513667|NCT03011892|26083768|P5|Open Label (OL) Period|Withdrawal by Subject|0
7513668|NCT03011892|26083769|P4|Open Label (OL) Period|Withdrawal by Subject|0
7513669|NCT03011892|26083770|P3|Open Label (OL) Period|Withdrawal by Subject|0
7513670|NCT03011892|26083771|P2|Open Label (OL) Period|Withdrawal by Subject|0
7513671|NCT03011892|26083772|P1|Open Label (OL) Period|Withdrawal by Subject|0
7513672|NCT03011892|26083761|P12|Open Label (OL) Period|Lost to Follow-up|1
7513673|NCT03011892|26083762|P11|Open Label (OL) Period|Lost to Follow-up|1
7513674|NCT03011892|26083763|P10|Open Label (OL) Period|Lost to Follow-up|0
7513675|NCT03011892|26083764|P9|Open Label (OL) Period|Lost to Follow-up|1
7513676|NCT03011892|26083765|P8|Open Label (OL) Period|Lost to Follow-up|2
7513677|NCT03011892|26083766|P7|Open Label (OL) Period|Lost to Follow-up|4
7513678|NCT03011892|26083767|P6|Open Label (OL) Period|Lost to Follow-up|0
7513679|NCT03011892|26083768|P5|Open Label (OL) Period|Lost to Follow-up|0
7513680|NCT03011892|26083769|P4|Open Label (OL) Period|Lost to Follow-up|0
7513681|NCT03011892|26083770|P3|Open Label (OL) Period|Lost to Follow-up|0
7513682|NCT03011892|26083771|P2|Open Label (OL) Period|Lost to Follow-up|0
7513683|NCT03011892|26083772|P1|Open Label (OL) Period|Lost to Follow-up|0
7513684|NCT03011892|26083761|P12|Double Blind (DB) Period|Randomized but not treated|0
7513685|NCT03011892|26083762|P11|Double Blind (DB) Period|Randomized but not treated|0
7513686|NCT03011892|26083763|P10|Double Blind (DB) Period|Randomized but not treated|0
7513687|NCT03011892|26083764|P9|Double Blind (DB) Period|Randomized but not treated|0
7513688|NCT03011892|26083765|P8|Double Blind (DB) Period|Randomized but not treated|0
7513689|NCT03011892|26083766|P7|Double Blind (DB) Period|Randomized but not treated|0
7513690|NCT03011892|26083767|P6|Double Blind (DB) Period|Randomized but not treated|0
7513691|NCT03011892|26083768|P5|Double Blind (DB) Period|Randomized but not treated|1
7513692|NCT03011892|26083769|P4|Double Blind (DB) Period|Randomized but not treated|0
7513693|NCT03011892|26083770|P3|Double Blind (DB) Period|Randomized but not treated|0
7513694|NCT03011892|26083771|P2|Double Blind (DB) Period|Randomized but not treated|0
7513695|NCT03011892|26083772|P1|Double Blind (DB) Period|Randomized but not treated|0
7513696|NCT03011892|26083761|P12|Double Blind (DB) Period|Withdrawal by Subject|0
7513697|NCT03011892|26083762|P11|Double Blind (DB) Period|Withdrawal by Subject|0
7513698|NCT03011892|26083763|P10|Double Blind (DB) Period|Withdrawal by Subject|0
7513699|NCT03011892|26083764|P9|Double Blind (DB) Period|Withdrawal by Subject|0
7513700|NCT03011892|26083765|P8|Double Blind (DB) Period|Withdrawal by Subject|0
7513701|NCT03011892|26083766|P7|Double Blind (DB) Period|Withdrawal by Subject|0
7513702|NCT03011892|26083767|P6|Double Blind (DB) Period|Withdrawal by Subject|3
7513703|NCT03011892|26083768|P5|Double Blind (DB) Period|Withdrawal by Subject|4
7513704|NCT03011892|26083769|P4|Double Blind (DB) Period|Withdrawal by Subject|2
7513705|NCT03011892|26083770|P3|Double Blind (DB) Period|Withdrawal by Subject|1
7513706|NCT03011892|26083771|P2|Double Blind (DB) Period|Withdrawal by Subject|5
7513707|NCT03011892|26083772|P1|Double Blind (DB) Period|Withdrawal by Subject|7
7513708|NCT03011892|26083761|P12|Double Blind (DB) Period|Protocol Violation|0
7513709|NCT03011892|26083762|P11|Double Blind (DB) Period|Protocol Violation|0
7513710|NCT03011892|26083763|P10|Double Blind (DB) Period|Protocol Violation|0
7513711|NCT03011892|26083764|P9|Double Blind (DB) Period|Protocol Violation|0
7513712|NCT03011892|26083765|P8|Double Blind (DB) Period|Protocol Violation|0
7513713|NCT03011892|26083766|P7|Double Blind (DB) Period|Protocol Violation|0
7513714|NCT03011892|26083767|P6|Double Blind (DB) Period|Protocol Violation|0
7513715|NCT03011892|26083768|P5|Double Blind (DB) Period|Protocol Violation|0
7513716|NCT03011892|26083769|P4|Double Blind (DB) Period|Protocol Violation|0
7513717|NCT03011892|26083770|P3|Double Blind (DB) Period|Protocol Violation|0
7513718|NCT03011892|26083771|P2|Double Blind (DB) Period|Protocol Violation|0
7513719|NCT03011892|26083772|P1|Double Blind (DB) Period|Protocol Violation|1
7513720|NCT03011892|26083761|P12|Double Blind (DB) Period|Pregnancy|0
7513721|NCT03011892|26083762|P11|Double Blind (DB) Period|Pregnancy|0
7513722|NCT03011892|26083763|P10|Double Blind (DB) Period|Pregnancy|0
7513723|NCT03011892|26083764|P9|Double Blind (DB) Period|Pregnancy|0
7513724|NCT03011892|26083765|P8|Double Blind (DB) Period|Pregnancy|0
7513725|NCT03011892|26083766|P7|Double Blind (DB) Period|Pregnancy|0
7513726|NCT03011892|26083767|P6|Double Blind (DB) Period|Pregnancy|0
7513727|NCT03011892|26083768|P5|Double Blind (DB) Period|Pregnancy|1
7513728|NCT03011892|26083769|P4|Double Blind (DB) Period|Pregnancy|0
7513729|NCT03011892|26083770|P3|Double Blind (DB) Period|Pregnancy|0
7513730|NCT03011892|26083771|P2|Double Blind (DB) Period|Pregnancy|0
7513731|NCT03011892|26083772|P1|Double Blind (DB) Period|Pregnancy|0
7513732|NCT03011892|26083761|P12|Double Blind (DB) Period|Physician Decision|0
7513733|NCT03011892|26083762|P11|Double Blind (DB) Period|Physician Decision|0
7513734|NCT03011892|26083763|P10|Double Blind (DB) Period|Physician Decision|0
7513735|NCT03011892|26083764|P9|Double Blind (DB) Period|Physician Decision|0
7513736|NCT03011892|26083765|P8|Double Blind (DB) Period|Physician Decision|0
7513737|NCT03011892|26083766|P7|Double Blind (DB) Period|Physician Decision|0
7513738|NCT03011892|26083767|P6|Double Blind (DB) Period|Physician Decision|0
7513739|NCT03011892|26083768|P5|Double Blind (DB) Period|Physician Decision|0
7513740|NCT03011892|26083769|P4|Double Blind (DB) Period|Physician Decision|0
7513741|NCT03011892|26083770|P3|Double Blind (DB) Period|Physician Decision|1
7513742|NCT03011892|26083771|P2|Double Blind (DB) Period|Physician Decision|0
7513743|NCT03011892|26083772|P1|Double Blind (DB) Period|Physician Decision|1
7513744|NCT03011892|26083761|P12|Double Blind (DB) Period|Other|0
7513745|NCT03011892|26083762|P11|Double Blind (DB) Period|Other|0
7513746|NCT03011892|26083763|P10|Double Blind (DB) Period|Other|0
7513747|NCT03011892|26083764|P9|Double Blind (DB) Period|Other|0
7513748|NCT03011892|26083765|P8|Double Blind (DB) Period|Other|0
7513749|NCT03011892|26083766|P7|Double Blind (DB) Period|Other|0
7513750|NCT03011892|26083767|P6|Double Blind (DB) Period|Other|0
7513751|NCT03011892|26083768|P5|Double Blind (DB) Period|Other|1
7513752|NCT03011892|26083769|P4|Double Blind (DB) Period|Other|0
7513753|NCT03011892|26083770|P3|Double Blind (DB) Period|Other|1
7513754|NCT03011892|26083771|P2|Double Blind (DB) Period|Other|1
7513755|NCT03011892|26083772|P1|Double Blind (DB) Period|Other|1
7513756|NCT03011892|26083761|P12|Double Blind (DB) Period|Lost to Follow-up|0
7513757|NCT03011892|26083762|P11|Double Blind (DB) Period|Lost to Follow-up|0
7513758|NCT03011892|26083763|P10|Double Blind (DB) Period|Lost to Follow-up|0
7513759|NCT03011892|26083764|P9|Double Blind (DB) Period|Lost to Follow-up|0
7513760|NCT03011892|26083765|P8|Double Blind (DB) Period|Lost to Follow-up|0
7513761|NCT03011892|26083766|P7|Double Blind (DB) Period|Lost to Follow-up|0
7513762|NCT03011892|26083767|P6|Double Blind (DB) Period|Lost to Follow-up|2
7513763|NCT03011892|26083768|P5|Double Blind (DB) Period|Lost to Follow-up|0
7513764|NCT03011892|26083769|P4|Double Blind (DB) Period|Lost to Follow-up|5
7513765|NCT03011892|26083770|P3|Double Blind (DB) Period|Lost to Follow-up|2
7513766|NCT03011892|26083771|P2|Double Blind (DB) Period|Lost to Follow-up|3
7513767|NCT03011892|26083772|P1|Double Blind (DB) Period|Lost to Follow-up|0
7513768|NCT03011892|26083761|P12|Double Blind (DB) Period|Lack of Efficacy|0
7513769|NCT03011892|26083762|P11|Double Blind (DB) Period|Lack of Efficacy|0
7513770|NCT03011892|26083763|P10|Double Blind (DB) Period|Lack of Efficacy|0
7513771|NCT03011892|26083764|P9|Double Blind (DB) Period|Lack of Efficacy|0
7513772|NCT03011892|26083765|P8|Double Blind (DB) Period|Lack of Efficacy|0
7513773|NCT03011892|26083766|P7|Double Blind (DB) Period|Lack of Efficacy|0
7513774|NCT03011892|26083767|P6|Double Blind (DB) Period|Lack of Efficacy|0
7513775|NCT03011892|26083768|P5|Double Blind (DB) Period|Lack of Efficacy|0
7513776|NCT03011892|26083769|P4|Double Blind (DB) Period|Lack of Efficacy|0
7513777|NCT03011892|26083770|P3|Double Blind (DB) Period|Lack of Efficacy|0
7513778|NCT03011892|26083771|P2|Double Blind (DB) Period|Lack of Efficacy|0
7513779|NCT03011892|26083772|P1|Double Blind (DB) Period|Lack of Efficacy|1
7513780|NCT03011892|26083761|P12|Double Blind (DB) Period|Adverse Event|0
7513781|NCT03011892|26083762|P11|Double Blind (DB) Period|Adverse Event|0
7513782|NCT03011892|26083763|P10|Double Blind (DB) Period|Adverse Event|0
7513783|NCT03011892|26083764|P9|Double Blind (DB) Period|Adverse Event|0
7513784|NCT03011892|26083765|P8|Double Blind (DB) Period|Adverse Event|0
7513785|NCT03011892|26083766|P7|Double Blind (DB) Period|Adverse Event|0
7513786|NCT03011892|26083767|P6|Double Blind (DB) Period|Adverse Event|0
7513787|NCT03011892|26083768|P5|Double Blind (DB) Period|Adverse Event|0
7513788|NCT03011892|26083769|P4|Double Blind (DB) Period|Adverse Event|0
7513789|NCT03011892|26083770|P3|Double Blind (DB) Period|Adverse Event|1
7513790|NCT03011892|26083771|P2|Double Blind (DB) Period|Adverse Event|1
7513791|NCT03011892|26083772|P1|Double Blind (DB) Period|Adverse Event|0
7513792|NCT03011840|26083841|P2|Overall Study|Not received PIL in post PIL phase|21
7513793|NCT03011840|26083842|P1|Overall Study|Not received PIL in post PIL phase|0
7513794|NCT03011099|26083852|P2|Overall Study|Withdrawal by Subject|2
7513795|NCT03011099|26083853|P1|Overall Study|Withdrawal by Subject|0
7513796|NCT03011034|26083879|P2|Overall Study|Adverse Event|0
7513797|NCT03011034|26083880|P1|Overall Study|Adverse Event|1
7513798|NCT03010501|26083961|P6|Study Week 3|Withdrawal by Subject|0
7513799|NCT03010501|26083962|P5|Study Week 3|Withdrawal by Subject|0
7513800|NCT03010501|26083963|P4|Study Week 3|Withdrawal by Subject|1
7513801|NCT03010501|26083964|P3|Study Week 3|Withdrawal by Subject|0
7513802|NCT03010501|26083965|P2|Study Week 3|Withdrawal by Subject|0
7513803|NCT03010501|26083966|P1|Study Week 3|Withdrawal by Subject|0
7513804|NCT03010501|26083961|P6|Study Week 1|Withdrawal by Subject|0
7513805|NCT03010501|26083962|P5|Study Week 1|Withdrawal by Subject|0
7513806|NCT03010501|26083963|P4|Study Week 1|Withdrawal by Subject|2
7513807|NCT03010501|26083964|P3|Study Week 1|Withdrawal by Subject|0
7513808|NCT03010501|26083965|P2|Study Week 1|Withdrawal by Subject|1
7513809|NCT03010501|26083966|P1|Study Week 1|Withdrawal by Subject|2
7513810|NCT03010462|26083993|P2|Overall Study|Withdrawal by Subject|1
7513811|NCT03010462|26083994|P1|Overall Study|Withdrawal by Subject|3
7513812|NCT03010423|26084008|P1|Overall Study|Study termination|8
7513813|NCT03010254|26084021|P2|Overall Study|Other|3
7513814|NCT03010254|26084022|P1|Overall Study|Other|2
7513815|NCT03010254|26084021|P2|Overall Study|Withdrawal by Subject|1
7513816|NCT03010254|26084022|P1|Overall Study|Withdrawal by Subject|1
7513817|NCT03010254|26084021|P2|Overall Study|Lost to Follow-up|0
7513818|NCT03010254|26084022|P1|Overall Study|Lost to Follow-up|4
7513819|NCT03010254|26084021|P2|Overall Study|Adverse Event|1
7513820|NCT03010254|26084022|P1|Overall Study|Adverse Event|0
7513821|NCT03008915|26084108|P2|Treatment 1|Withdrawal by Subject|1
7513822|NCT03008915|26084109|P1|Treatment 1|Withdrawal by Subject|0
7513823|NCT03008460|26084220|P2|Overall Study|Lost to Follow-up|3
7513824|NCT03008460|26084221|P1|Overall Study|Lost to Follow-up|1
7513825|NCT03008460|26084220|P2|Overall Study|End of study visit outside permitted time window|1
7513826|NCT03008460|26084221|P1|Overall Study|End of study visit outside permitted time window|0
7513827|NCT03008460|26084220|P2|Overall Study|COVID-19 pandemic - consent withdrawn|0
7513828|NCT03008460|26084221|P1|Overall Study|COVID-19 pandemic - consent withdrawn|1
7513829|NCT03008460|26084220|P2|Overall Study|Withdrawal by Subject|6
7513830|NCT03008460|26084221|P1|Overall Study|Withdrawal by Subject|5
7513831|NCT03008460|26084220|P2|Overall Study|Adverse Event|1
7513832|NCT03008460|26084221|P1|Overall Study|Adverse Event|0
7513833|NCT03008460|26084220|P2|Overall Study|Study drug not dispensed|1
7513834|NCT03008460|26084221|P1|Overall Study|Study drug not dispensed|0
7513835|NCT03008460|26084220|P2|Overall Study|Protocol deviation|2
7513836|NCT03008460|26084221|P1|Overall Study|Protocol deviation|0
7513837|NCT03008070|26084295|P3|Overall Study|Use of prohibited drug|2
7513838|NCT03008070|26084296|P2|Overall Study|Use of prohibited drug|0
7513839|NCT03008070|26084297|P1|Overall Study|Use of prohibited drug|0
7513840|NCT03008070|26084295|P3|Overall Study|Withdrawal by Subject|1
7513841|NCT03008070|26084296|P2|Overall Study|Withdrawal by Subject|0
7513842|NCT03008070|26084297|P1|Overall Study|Withdrawal by Subject|2
7513843|NCT03008070|26084295|P3|Overall Study|Withdrawal by patient and adverse event non fatal|0
7513844|NCT03008070|26084296|P2|Overall Study|Withdrawal by patient and adverse event non fatal|1
7513845|NCT03008070|26084297|P1|Overall Study|Withdrawal by patient and adverse event non fatal|0
7513846|NCT03008070|26084295|P3|Overall Study|Non compliance|1
7513847|NCT03008070|26084296|P2|Overall Study|Non compliance|1
7513848|NCT03008070|26084297|P1|Overall Study|Non compliance|0
7513849|NCT03008070|26084295|P3|Overall Study|Lost to Follow-up|0
7513850|NCT03008070|26084296|P2|Overall Study|Lost to Follow-up|1
7513851|NCT03008070|26084297|P1|Overall Study|Lost to Follow-up|1
7513852|NCT03008070|26084295|P3|Overall Study|Adverse Event|3
7513853|NCT03008070|26084296|P2|Overall Study|Adverse Event|3
7513854|NCT03008070|26084297|P1|Overall Study|Adverse Event|3
7513855|NCT03007979|26084386|P1|Overall Study|Deemed not eligible prior to starting palbociclib|1
7513856|NCT03007966|26084392|P2|Overall Study|Did not meeting inclusion/exclusion|0
7513857|NCT03007966|26084393|P1|Overall Study|Did not meeting inclusion/exclusion|1
7513858|NCT03007953|26084425|P2|Overall Study|Enrolled in Hospice|2
7513859|NCT03007953|26084426|P1|Overall Study|Enrolled in Hospice|3
7513860|NCT03007953|26084425|P2|Overall Study|Lost to Follow-up|2
7513861|NCT03007953|26084426|P1|Overall Study|Lost to Follow-up|3
7513862|NCT03007953|26084425|P2|Overall Study|Death|7
7513863|NCT03007953|26084426|P1|Overall Study|Death|5
7513864|NCT03007953|26084425|P2|Overall Study|Withdrawal by Subject|2
7513865|NCT03007953|26084426|P1|Overall Study|Withdrawal by Subject|5
7513866|NCT03007472|26084445|P1|Overall Study|Loss to Follow Up|1
7513867|NCT03007472|26084445|P1|Overall Study|Death|2
7513868|NCT03007472|26084445|P1|Overall Study|Did not have aidable contralateral thresholds at the time|2
7513879|NCT03006887|26084492|P1|Overall Study|Adverse Event|1
7513880|NCT03006848|26084518|P1|Overall Study|Lack of Efficacy|16
7513881|NCT03006848|26084518|P1|Overall Study|Physician Decision|1
7513882|NCT03006848|26084518|P1|Overall Study|Adverse Event|1
7513883|NCT03006562|26084531|P2|Overall Study|Lost to Follow-up|1
7513884|NCT03006562|26084532|P1|Overall Study|Lost to Follow-up|0
7513885|NCT03006458|26084623|P2|First Intervention|Unsatisfied Vision|3
7513886|NCT03006458|26084624|P1|First Intervention|Unsatisfied Vision|0
7513887|NCT03006341|26084666|P4|Overall Study|Not linked in the EMR|10685
7513888|NCT03006341|26084667|P3|Overall Study|Not linked in the EMR|30993
7513889|NCT03006341|26084668|P2|Overall Study|Not linked in the EMR|67505
7513890|NCT03006341|26084669|P1|Overall Study|Not linked in the EMR|25069
7513891|NCT03005288|26084713|P2|Overall Study|Physician Decision|1
7513892|NCT03005288|26084714|P1|Overall Study|Physician Decision|0
7513893|NCT03005288|26084713|P2|Overall Study|Protocol deviation|1
7513894|NCT03005288|26084714|P1|Overall Study|Protocol deviation|0
7513895|NCT03005288|26084713|P2|Overall Study|Adverse Event|0
7513896|NCT03005288|26084714|P1|Overall Study|Adverse Event|5
7513897|NCT03005288|26084713|P2|Overall Study|Lost to Follow-up|1
7513898|NCT03005288|26084714|P1|Overall Study|Lost to Follow-up|0
7513899|NCT03005288|26084713|P2|Overall Study|Withdrawal by Subject|5
7513900|NCT03005288|26084714|P1|Overall Study|Withdrawal by Subject|7
7513901|NCT03005106|26084744|P1|Overall Study|Death|2
7513902|NCT03005106|26084744|P1|Overall Study|Physician Decision|1
7513903|NCT03005106|26084744|P1|Overall Study|Adverse Event|1
7513904|NCT03005106|26084744|P1|Overall Study|Lost to Follow-up|16
7513905|NCT03005067|26084753|P2|Overall Study|Protocol Violation|1
7513906|NCT03005067|26084754|P1|Overall Study|Protocol Violation|0
7513907|NCT03005067|26084753|P2|Overall Study|Other (reason not specified)|1
7513908|NCT03005067|26084754|P1|Overall Study|Other (reason not specified)|3
7513909|NCT03005067|26084753|P2|Overall Study|Adverse Event|3
7513910|NCT03005067|26084754|P1|Overall Study|Adverse Event|4
7513911|NCT03005067|26084753|P2|Overall Study|Withdrawal by Subject|2
7513912|NCT03005067|26084754|P1|Overall Study|Withdrawal by Subject|3
7513913|NCT03004924|26084793|P3|Overall Study|HSV1 Positive|0
7513914|NCT03004924|26084794|P2|Overall Study|HSV1 Positive|0
7513915|NCT03004924|26084795|P1|Overall Study|HSV1 Positive|1
7513916|NCT03004924|26084793|P3|Overall Study|Missed Study Visit|2
7513917|NCT03004924|26084794|P2|Overall Study|Missed Study Visit|0
7513918|NCT03004924|26084795|P1|Overall Study|Missed Study Visit|0
7513919|NCT03004924|26084793|P3|Overall Study|Terminated by Sponsor|1
7513920|NCT03004924|26084794|P2|Overall Study|Terminated by Sponsor|0
7513921|NCT03004924|26084795|P1|Overall Study|Terminated by Sponsor|0
7513922|NCT03004924|26084793|P3|Overall Study|Pregnancy|0
7513923|NCT03004924|26084794|P2|Overall Study|Pregnancy|1
7513924|NCT03004924|26084795|P1|Overall Study|Pregnancy|0
7513925|NCT03004924|26084793|P3|Overall Study|Screen Failure|0
7513926|NCT03004924|26084794|P2|Overall Study|Screen Failure|0
7513927|NCT03004924|26084795|P1|Overall Study|Screen Failure|1
7513928|NCT03004924|26084793|P3|Overall Study|Withdrawal by parent/guardian|2
7513929|NCT03004924|26084794|P2|Overall Study|Withdrawal by parent/guardian|0
7513930|NCT03004924|26084795|P1|Overall Study|Withdrawal by parent/guardian|1
7513931|NCT03004924|26084793|P3|Overall Study|Physician Decision|1
7513932|NCT03004924|26084794|P2|Overall Study|Physician Decision|0
7513933|NCT03004924|26084795|P1|Overall Study|Physician Decision|1
7513934|NCT03004924|26084793|P3|Overall Study|Lack of Efficacy|2
7513935|NCT03004924|26084794|P2|Overall Study|Lack of Efficacy|4
7513936|NCT03004924|26084795|P1|Overall Study|Lack of Efficacy|2
7513937|NCT03004924|26084793|P3|Overall Study|Lost to Follow-up|4
7513938|NCT03004924|26084794|P2|Overall Study|Lost to Follow-up|1
7513939|NCT03004924|26084795|P1|Overall Study|Lost to Follow-up|6
7513940|NCT03004924|26084793|P3|Overall Study|Withdrawal by Subject|5
7513941|NCT03004924|26084794|P2|Overall Study|Withdrawal by Subject|3
7513942|NCT03004924|26084795|P1|Overall Study|Withdrawal by Subject|5
7513943|NCT03004924|26084793|P3|Overall Study|Protocol Violation|1
7513944|NCT03004924|26084794|P2|Overall Study|Protocol Violation|0
7513945|NCT03004924|26084795|P1|Overall Study|Protocol Violation|4
7513946|NCT03004924|26084793|P3|Overall Study|Adverse Event|10
7513947|NCT03004924|26084794|P2|Overall Study|Adverse Event|5
7513948|NCT03004924|26084795|P1|Overall Study|Adverse Event|6
7513949|NCT03004469|26085039|P3|Overall Study|Other unspecified reason|1
7513950|NCT03004469|26085040|P2|Overall Study|Other unspecified reason|4
7513951|NCT03004469|26085041|P1|Overall Study|Other unspecified reason|0
7513952|NCT03004469|26085039|P3|Overall Study|Withdrawal by Subject|10
7513953|NCT03004469|26085040|P2|Overall Study|Withdrawal by Subject|27
7513954|NCT03004469|26085041|P1|Overall Study|Withdrawal by Subject|29
7513955|NCT03004469|26085039|P3|Overall Study|Protocol Violation|1
7513956|NCT03004469|26085040|P2|Overall Study|Protocol Violation|0
7513957|NCT03004469|26085041|P1|Overall Study|Protocol Violation|0
7513958|NCT03004469|26085039|P3|Overall Study|Non-Compliance with Study Drug|0
7513959|NCT03004469|26085040|P2|Overall Study|Non-Compliance with Study Drug|0
7513960|NCT03004469|26085041|P1|Overall Study|Non-Compliance with Study Drug|2
7513961|NCT03004469|26085039|P3|Overall Study|Lost to Follow-up|6
7513962|NCT03004469|26085040|P2|Overall Study|Lost to Follow-up|14
7513963|NCT03004469|26085041|P1|Overall Study|Lost to Follow-up|23
7513964|NCT03004469|26085039|P3|Overall Study|Lack of Efficacy|1
7513965|NCT03004469|26085040|P2|Overall Study|Lack of Efficacy|0
7513966|NCT03004469|26085041|P1|Overall Study|Lack of Efficacy|1
7513967|NCT03004469|26085039|P3|Overall Study|Adverse Event|6
7513968|NCT03004469|26085040|P2|Overall Study|Adverse Event|4
7513969|NCT03004469|26085041|P1|Overall Study|Adverse Event|6
7513970|NCT03003676|26085099|P1|Overall Study|Other: Hepatitis B infection.|1
7513971|NCT03003676|26085099|P1|Overall Study|Withdrawal by Subject|1
7513972|NCT03003676|26085099|P1|Overall Study|Lack of Efficacy|12
7513973|NCT03003520|26085105|P2|Follow-up|Withdrawal by Subject|0
7513974|NCT03003520|26085106|P1|Follow-up|Withdrawal by Subject|1
7513975|NCT03003520|26085105|P2|Follow-up|Ongoing|2
7513976|NCT03003520|26085106|P1|Follow-up|Ongoing|12
7513977|NCT03003520|26085105|P2|Follow-up|Death|1
7513978|NCT03003520|26085106|P1|Follow-up|Death|1
7513979|NCT03003520|26085105|P2|Consolidation|Withdrawal by Subject|0
7513980|NCT03003520|26085106|P1|Consolidation|Withdrawal by Subject|1
7513981|NCT03003520|26085105|P2|Consolidation|Progressive disease|1
7513982|NCT03003520|26085106|P1|Consolidation|Progressive disease|3
7513983|NCT03003520|26085105|P2|Consolidation|Adverse Event|0
7513984|NCT03003520|26085106|P1|Consolidation|Adverse Event|2
7513985|NCT03003520|26085105|P2|Consolidation|Ongoing|0
7513986|NCT03003520|26085106|P1|Consolidation|Ongoing|18
7513987|NCT03003520|26085105|P2|Induction|Progressive disease|0
7513988|NCT03003520|26085106|P1|Induction|Progressive disease|1
7513989|NCT03003520|26085105|P2|Induction|Withdrawal by Subject|0
7513990|NCT03003520|26085106|P1|Induction|Withdrawal by Subject|3
7513991|NCT03003520|26085105|P2|Induction|Physician Decision|0
7513992|NCT03003520|26085106|P1|Induction|Physician Decision|2
7513993|NCT03003520|26085105|P2|Induction|Palliative care|0
7513994|NCT03003520|26085106|P1|Induction|Palliative care|1
7513995|NCT03003520|26085105|P2|Induction|Death|0
7513996|NCT03003520|26085106|P1|Induction|Death|1
7513997|NCT03003520|26085105|P2|Induction|Adverse Event|0
7513998|NCT03003520|26085106|P1|Induction|Adverse Event|4
7513999|NCT03003520|26085105|P2|Induction|Ongoing|0
7514000|NCT03003520|26085106|P1|Induction|Ongoing|1
7514001|NCT03003494|26085124|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
7514002|NCT03003390|26085135|P2|Overall Study|Parent refused intervention|0
7514003|NCT03003390|26085136|P1|Overall Study|Parent refused intervention|2
7514004|NCT03003390|26085135|P2|Overall Study|Physician Decision|0
7514005|NCT03003390|26085136|P1|Overall Study|Physician Decision|2
7514006|NCT03003000|26085173|P3|Overall Study|Other than listed|1
7514007|NCT03003000|26085174|P2|Overall Study|Other than listed|1
7514008|NCT03003000|26085175|P1|Overall Study|Other than listed|1
7514009|NCT03003000|26085173|P3|Overall Study|Refused to continue medication|0
7514010|NCT03003000|26085174|P2|Overall Study|Refused to continue medication|0
7514011|NCT03003000|26085175|P1|Overall Study|Refused to continue medication|2
7514012|NCT03003000|26085173|P3|Overall Study|Non-compliant with protocol|1
7514013|NCT03003000|26085174|P2|Overall Study|Non-compliant with protocol|1
7514014|NCT03003000|26085175|P1|Overall Study|Non-compliant with protocol|0
7514015|NCT03003000|26085173|P3|Overall Study|Lack of Efficacy|0
7514016|NCT03003000|26085174|P2|Overall Study|Lack of Efficacy|0
7514017|NCT03003000|26085175|P1|Overall Study|Lack of Efficacy|1
7514018|NCT03003000|26085173|P3|Overall Study|Adverse Event|3
7514019|NCT03003000|26085174|P2|Overall Study|Adverse Event|2
7514020|NCT03003000|26085175|P1|Overall Study|Adverse Event|1
7514021|NCT03002818|26085277|P1|Overall Study|Decision of the investigator|1
7514022|NCT03002623|26085303|P2|Overall Study|Physician Decision|1
7514023|NCT03002623|26085304|P1|Overall Study|Physician Decision|1
7514024|NCT03002623|26085303|P2|Overall Study|Lost to Follow-up|0
7514025|NCT03002623|26085304|P1|Overall Study|Lost to Follow-up|1
7514026|NCT03002610|26085321|P3|Overall Study|Withdrawal by Subject|13
7514027|NCT03002610|26085322|P2|Overall Study|Withdrawal by Subject|25
7514028|NCT03002610|26085323|P1|Overall Study|Withdrawal by Subject|6
7514029|NCT03002311|26085351|P2|Overall Study|Physician Decision|1
7514030|NCT03002311|26085352|P1|Overall Study|Physician Decision|3
7514031|NCT03002311|26085351|P2|Overall Study|Referral provider called to schedule app|3
7514032|NCT03002311|26085352|P1|Overall Study|Referral provider called to schedule app|3
7514033|NCT03002311|26085351|P2|Overall Study|Lost to Follow-up|26
7514034|NCT03002311|26085352|P1|Overall Study|Lost to Follow-up|13
7514035|NCT03002194|26085360|P1|Overall Study|Withdrawal by Subject|2
7514036|NCT03002194|26085360|P1|Overall Study|Lack of Efficacy|1
7514037|NCT03002194|26085360|P1|Overall Study|Adverse Event|1
7514038|NCT03002194|26085360|P1|Overall Study|Lost to Follow-up|6
7514039|NCT03002077|26085366|P1|Overall Study|Protocol Violation|21
7514040|NCT03002077|26085366|P1|Overall Study|Pregnancy|4
7514041|NCT03002077|26085366|P1|Overall Study|Lost to Follow-up|21
7514042|NCT03002077|26085366|P1|Overall Study|Withdrawal by Subject|72
7514043|NCT03002077|26085366|P1|Overall Study|Lack of Efficacy|20
7514044|NCT03002077|26085366|P1|Overall Study|Adverse Event|23
7514045|NCT03002077|26085366|P1|Overall Study|Miscellaneous Reasons|10
7514046|NCT03002077|26085366|P1|Overall Study|Site Terminated by Sponsor|5
7514047|NCT03002077|26085366|P1|Overall Study|Study Terminated by Sponsor|257
7514048|NCT03002077|26085366|P1|Overall Study|Non-compliance w/Background ADT|1
7514049|NCT03002077|26085366|P1|Overall Study|Non-compliance with Study Drug|4
7514050|NCT03002038|26085374|P2|Overall Study|Immigration to another region|2
7514051|NCT03002038|26085375|P1|Overall Study|Immigration to another region|0
7514052|NCT03002038|26085374|P2|Overall Study|Withdrawal by Subject|4
7514053|NCT03002038|26085375|P1|Overall Study|Withdrawal by Subject|8
7514054|NCT03002038|26085374|P2|Overall Study|Adverse Event|1
7514055|NCT03002038|26085375|P1|Overall Study|Adverse Event|3
7514056|NCT03001557|26085442|P8|Extension Phase|Others|0
7514057|NCT03001557|26085443|P7|Extension Phase|Others|3
7514058|NCT03001557|26085444|P6|Extension Phase|Others|1
7514059|NCT03001557|26085445|P5|Extension Phase|Others|0
7514060|NCT03001557|26085446|P4|Extension Phase|Others|0
7514061|NCT03001557|26085447|P3|Extension Phase|Others|0
7514062|NCT03001557|26085448|P2|Extension Phase|Others|0
7514063|NCT03001557|26085449|P1|Extension Phase|Others|0
7514064|NCT03001557|26085442|P8|Extension Phase|Loss of caregiver|0
7514065|NCT03001557|26085443|P7|Extension Phase|Loss of caregiver|1
7514066|NCT03001557|26085444|P6|Extension Phase|Loss of caregiver|0
7514067|NCT03001557|26085445|P5|Extension Phase|Loss of caregiver|0
7514068|NCT03001557|26085446|P4|Extension Phase|Loss of caregiver|0
7514069|NCT03001557|26085447|P3|Extension Phase|Loss of caregiver|0
7514070|NCT03001557|26085448|P2|Extension Phase|Loss of caregiver|0
7514071|NCT03001557|26085449|P1|Extension Phase|Loss of caregiver|0
7514072|NCT03001557|26085442|P8|Extension Phase|Administrative Reason|3
7514073|NCT03001557|26085443|P7|Extension Phase|Administrative Reason|3
7514074|NCT03001557|26085444|P6|Extension Phase|Administrative Reason|1
7514075|NCT03001557|26085445|P5|Extension Phase|Administrative Reason|0
7514076|NCT03001557|26085446|P4|Extension Phase|Administrative Reason|0
7514077|NCT03001557|26085447|P3|Extension Phase|Administrative Reason|0
7514078|NCT03001557|26085448|P2|Extension Phase|Administrative Reason|0
7514079|NCT03001557|26085449|P1|Extension Phase|Administrative Reason|0
7514080|NCT03001557|26085442|P8|Extension Phase|Lost to Follow-up|1
7514081|NCT03001557|26085443|P7|Extension Phase|Lost to Follow-up|2
7514082|NCT03001557|26085444|P6|Extension Phase|Lost to Follow-up|0
7514083|NCT03001557|26085445|P5|Extension Phase|Lost to Follow-up|0
7514084|NCT03001557|26085446|P4|Extension Phase|Lost to Follow-up|0
7514085|NCT03001557|26085447|P3|Extension Phase|Lost to Follow-up|0
7514086|NCT03001557|26085448|P2|Extension Phase|Lost to Follow-up|0
7514087|NCT03001557|26085449|P1|Extension Phase|Lost to Follow-up|0
7514088|NCT03001557|26085442|P8|Extension Phase|Withdrawal by Subject|2
7514089|NCT03001557|26085443|P7|Extension Phase|Withdrawal by Subject|5
7514090|NCT03001557|26085444|P6|Extension Phase|Withdrawal by Subject|1
7514091|NCT03001557|26085445|P5|Extension Phase|Withdrawal by Subject|0
7514092|NCT03001557|26085446|P4|Extension Phase|Withdrawal by Subject|0
7514093|NCT03001557|26085447|P3|Extension Phase|Withdrawal by Subject|0
7514094|NCT03001557|26085448|P2|Extension Phase|Withdrawal by Subject|0
7514095|NCT03001557|26085449|P1|Extension Phase|Withdrawal by Subject|0
7514096|NCT03001557|26085442|P8|Extension Phase|Adverse Event|0
7514097|NCT03001557|26085443|P7|Extension Phase|Adverse Event|0
7514098|NCT03001557|26085444|P6|Extension Phase|Adverse Event|2
7514099|NCT03001557|26085445|P5|Extension Phase|Adverse Event|0
7514100|NCT03001557|26085446|P4|Extension Phase|Adverse Event|0
7514101|NCT03001557|26085447|P3|Extension Phase|Adverse Event|0
7514102|NCT03001557|26085448|P2|Extension Phase|Adverse Event|0
7514103|NCT03001557|26085449|P1|Extension Phase|Adverse Event|0
7514104|NCT03001557|26085442|P8|Core Phase|Randomized but not treated|0
7514105|NCT03001557|26085443|P7|Core Phase|Randomized but not treated|0
7514106|NCT03001557|26085444|P6|Core Phase|Randomized but not treated|0
7514107|NCT03001557|26085445|P5|Core Phase|Randomized but not treated|0
7514108|NCT03001557|26085446|P4|Core Phase|Randomized but not treated|0
7514109|NCT03001557|26085447|P3|Core Phase|Randomized but not treated|1
7514110|NCT03001557|26085448|P2|Core Phase|Randomized but not treated|0
7514111|NCT03001557|26085449|P1|Core Phase|Randomized but not treated|0
7514112|NCT03001219|26085757|P2|Extension Period Analysis|Withdrawal by Subject|5
7514113|NCT03001219|26085758|P1|Extension Period Analysis|Withdrawal by Subject|4
7514114|NCT03001219|26085757|P2|Extension Period Analysis|Protocol Deviation|1
7514115|NCT03001219|26085758|P1|Extension Period Analysis|Protocol Deviation|0
7514116|NCT03001219|26085757|P2|Extension Period Analysis|Adverse Event|1
7514117|NCT03001219|26085758|P1|Extension Period Analysis|Adverse Event|1
7514118|NCT03001219|26085757|P2|Extension Period Analysis|Physician Decision|1
7514119|NCT03001219|26085758|P1|Extension Period Analysis|Physician Decision|0
7514120|NCT03001219|26085757|P2|Extension Period Analysis|Participant Non-Compliance|1
7514121|NCT03001219|26085758|P1|Extension Period Analysis|Participant Non-Compliance|0
7514122|NCT03001219|26085757|P2|Extension Period Analysis|Study Termination by Sponsor|36
7514123|NCT03001219|26085758|P1|Extension Period Analysis|Study Termination by Sponsor|0
7514124|NCT03001219|26085757|P2|Proof of Concept|Physician Decision|0
7514125|NCT03001219|26085758|P1|Proof of Concept|Physician Decision|1
7514126|NCT03001219|26085757|P2|Proof of Concept|Adverse Event|1
7514127|NCT03001219|26085758|P1|Proof of Concept|Adverse Event|1
7514128|NCT03001219|26085757|P2|Proof of Concept|Protocol Deviation|1
7514129|NCT03001219|26085758|P1|Proof of Concept|Protocol Deviation|0
7514130|NCT03001219|26085757|P2|Proof of Concept|Withdrawal by Subject|4
7514131|NCT03001219|26085758|P1|Proof of Concept|Withdrawal by Subject|0
7514132|NCT03001219|26085757|P2|Proof of Concept|Study Termination by Sponsor|1
7514133|NCT03001219|26085758|P1|Proof of Concept|Study Termination by Sponsor|0
7514134|NCT03001076|26085819|P2|Overall Study|Lost to Follow-up|2
7514135|NCT03001076|26085820|P1|Overall Study|Lost to Follow-up|0
7514136|NCT03001076|26085819|P2|Overall Study|Sponsor decision|0
7514137|NCT03001076|26085820|P1|Overall Study|Sponsor decision|1
7514138|NCT03001076|26085819|P2|Overall Study|Adverse Event|3
7514139|NCT03001076|26085820|P1|Overall Study|Adverse Event|3
7514140|NCT03001076|26085819|P2|Overall Study|Other|0
7514141|NCT03001076|26085820|P1|Overall Study|Other|1
7514142|NCT03001076|26085819|P2|Overall Study|Withdrawal by patient|0
7514143|NCT03001076|26085820|P1|Overall Study|Withdrawal by patient|2
7514144|NCT03001011|26085854|P2|Overall Study|Other than specified above|8
7514145|NCT03001011|26085855|P1|Overall Study|Other than specified above|3
7514146|NCT03001011|26085854|P2|Overall Study|Chronic kidney disease lead to dialysis|10
7514147|NCT03001011|26085855|P1|Overall Study|Chronic kidney disease lead to dialysis|15
7514148|NCT03001011|26085854|P2|Overall Study|Adverse Event|3
7514149|NCT03001011|26085855|P1|Overall Study|Adverse Event|9
7514150|NCT03000686|26085889|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
7514151|NCT03000686|26085890|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
7514152|NCT03000686|26085891|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
7514153|NCT03000686|26085892|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
7514154|NCT03000673|26085962|P4|Overall Study|Withdrawal by Subject|0
7514155|NCT03000673|26085963|P3|Overall Study|Withdrawal by Subject|0
7514156|NCT03000673|26085964|P2|Overall Study|Withdrawal by Subject|0
7514157|NCT03000673|26085965|P1|Overall Study|Withdrawal by Subject|1
7514158|NCT03000569|26086058|P2|Overall Study|Withdrawal by Subject|0
7514159|NCT03000569|26086059|P1|Overall Study|Withdrawal by Subject|1
7514160|NCT03000530|26086194|P3|Overall Study|Withdrawal by Subject|1
7514161|NCT03000530|26086195|P2|Overall Study|Withdrawal by Subject|2
7514162|NCT03000530|26086196|P1|Overall Study|Withdrawal by Subject|0
7514163|NCT03000530|26086194|P3|Overall Study|Lost to Follow-up|1
7514164|NCT03000530|26086195|P2|Overall Study|Lost to Follow-up|3
7514165|NCT03000530|26086196|P1|Overall Study|Lost to Follow-up|0
7514166|NCT03000530|26086194|P3|Overall Study|Adverse Event|2
7514167|NCT03000530|26086195|P2|Overall Study|Adverse Event|0
7514168|NCT03000530|26086196|P1|Overall Study|Adverse Event|0
7514169|NCT03000452|26086394|P1|Follow-Up Period|Withdrawal by Subject|3
7514170|NCT03000452|26086394|P1|Follow-Up Period|Death|3
7514171|NCT03000452|26086394|P1|Follow-Up Period|Study Terminated by Sponsor|1
7514172|NCT03000452|26086394|P1|Treatment Period|Miscellaneous|2
7514173|NCT03000452|26086394|P1|Treatment Period|Physician Decision|1
7514174|NCT03000452|26086394|P1|Treatment Period|Progressive Disease (PD)|14
7514175|NCT03000452|26086394|P1|Treatment Period|Death|1
7514176|NCT03000348|26086416|P6|Overall Study|Dosing|0
7514177|NCT03000348|26086417|P5|Overall Study|Dosing|1
7514178|NCT03000348|26086418|P4|Overall Study|Dosing|0
7514179|NCT03000348|26086419|P3|Overall Study|Dosing|0
7514180|NCT03000348|26086420|P2|Overall Study|Dosing|0
7514181|NCT03000348|26086421|P1|Overall Study|Dosing|0
7514182|NCT03000348|26086416|P6|Overall Study|Patient had no transport|0
7514183|NCT03000348|26086417|P5|Overall Study|Patient had no transport|0
7514184|NCT03000348|26086418|P4|Overall Study|Patient had no transport|1
7514185|NCT03000348|26086419|P3|Overall Study|Patient had no transport|0
7514186|NCT03000348|26086420|P2|Overall Study|Patient had no transport|0
7514187|NCT03000348|26086421|P1|Overall Study|Patient had no transport|0
7514188|NCT03000348|26086416|P6|Overall Study|No gram negative|1
7514189|NCT03000348|26086417|P5|Overall Study|No gram negative|1
7514190|NCT03000348|26086418|P4|Overall Study|No gram negative|1
7514191|NCT03000348|26086419|P3|Overall Study|No gram negative|1
7514192|NCT03000348|26086420|P2|Overall Study|No gram negative|2
7514193|NCT03000348|26086421|P1|Overall Study|No gram negative|1
7514194|NCT03000348|26086416|P6|Overall Study|Failure to expectorate sputum|0
7514195|NCT03000348|26086417|P5|Overall Study|Failure to expectorate sputum|1
7514196|NCT03000348|26086418|P4|Overall Study|Failure to expectorate sputum|0
7514197|NCT03000348|26086419|P3|Overall Study|Failure to expectorate sputum|1
7514198|NCT03000348|26086420|P2|Overall Study|Failure to expectorate sputum|0
7514199|NCT03000348|26086421|P1|Overall Study|Failure to expectorate sputum|1
7514200|NCT03000348|26086416|P6|Overall Study|Consent|0
7514201|NCT03000348|26086417|P5|Overall Study|Consent|1
7514202|NCT03000348|26086418|P4|Overall Study|Consent|0
7514203|NCT03000348|26086419|P3|Overall Study|Consent|0
7514204|NCT03000348|26086420|P2|Overall Study|Consent|0
7514205|NCT03000348|26086421|P1|Overall Study|Consent|0
7514206|NCT03000348|26086416|P6|Overall Study|Withdrawal by Subject|0
7514207|NCT03000348|26086417|P5|Overall Study|Withdrawal by Subject|0
7514208|NCT03000348|26086418|P4|Overall Study|Withdrawal by Subject|0
7514209|NCT03000348|26086419|P3|Overall Study|Withdrawal by Subject|0
7514210|NCT03000348|26086420|P2|Overall Study|Withdrawal by Subject|1
7514211|NCT03000348|26086421|P1|Overall Study|Withdrawal by Subject|0
7514212|NCT03000348|26086416|P6|Overall Study|Lost to Follow-up|0
7514213|NCT03000348|26086417|P5|Overall Study|Lost to Follow-up|0
7514214|NCT03000348|26086418|P4|Overall Study|Lost to Follow-up|0
7514215|NCT03000348|26086419|P3|Overall Study|Lost to Follow-up|1
7514216|NCT03000348|26086420|P2|Overall Study|Lost to Follow-up|0
7514217|NCT03000348|26086421|P1|Overall Study|Lost to Follow-up|0
7514218|NCT03000348|26086416|P6|Overall Study|Adverse Event|1
7514219|NCT03000348|26086417|P5|Overall Study|Adverse Event|1
7514220|NCT03000348|26086418|P4|Overall Study|Adverse Event|1
7514221|NCT03000348|26086419|P3|Overall Study|Adverse Event|1
7514222|NCT03000348|26086420|P2|Overall Study|Adverse Event|1
7514223|NCT03000348|26086421|P1|Overall Study|Adverse Event|1
7514224|NCT03000075|26086569|P7|Part B|Adverse Event|0
7514225|NCT03000075|26086570|P6|Part B|Adverse Event|0
7514226|NCT03000075|26086571|P5|Part B|Adverse Event|1
7514227|NCT03000075|26086572|P4|Part B|Adverse Event|0
7514228|NCT03000075|26086573|P3|Part B|Adverse Event|0
7514229|NCT03000075|26086574|P2|Part B|Adverse Event|0
7514230|NCT03000075|26086575|P1|Part B|Adverse Event|0
7514231|NCT03000075|26086569|P7|Part B|Not dosed due to AE|1
7514232|NCT03000075|26086570|P6|Part B|Not dosed due to AE|2
7514233|NCT03000075|26086571|P5|Part B|Not dosed due to AE|0
7514234|NCT03000075|26086572|P4|Part B|Not dosed due to AE|0
7514235|NCT03000075|26086573|P3|Part B|Not dosed due to AE|0
7514236|NCT03000075|26086574|P2|Part B|Not dosed due to AE|0
7514237|NCT03000075|26086575|P1|Part B|Not dosed due to AE|0
7514238|NCT03000075|26086569|P7|Part A|Adverse Event|0
7514239|NCT03000075|26086570|P6|Part A|Adverse Event|0
7514240|NCT03000075|26086571|P5|Part A|Adverse Event|0
7514241|NCT03000075|26086572|P4|Part A|Adverse Event|0
7514242|NCT03000075|26086573|P3|Part A|Adverse Event|0
7514243|NCT03000075|26086574|P2|Part A|Adverse Event|0
7514244|NCT03000075|26086575|P1|Part A|Adverse Event|4
7514245|NCT02999672|26086637|P2|Overall Study|Adverse Event|0
7514246|NCT02999672|26086638|P1|Overall Study|Adverse Event|4
7514247|NCT02999672|26086637|P2|Overall Study|Progressive Disease|5
7514248|NCT02999672|26086638|P1|Overall Study|Progressive Disease|9
7514249|NCT02999672|26086637|P2|Overall Study|Study Terminated by Sponsor|1
7514250|NCT02999672|26086638|P1|Overall Study|Study Terminated by Sponsor|0
7514251|NCT02999672|26086637|P2|Overall Study|Death|1
7514252|NCT02999672|26086638|P1|Overall Study|Death|0
7514253|NCT02999633|26086654|P1|Overall Study|Progressive disease|12
7514254|NCT02999633|26086654|P1|Overall Study|Adverse Event|2
7514255|NCT02999191|26086665|P3|Wash-out Period 1 [21 Days]|Adverse Event|0
7514256|NCT02999191|26086666|P2|Wash-out Period 1 [21 Days]|Adverse Event|1
7514257|NCT02999191|26086667|P1|Wash-out Period 1 [21 Days]|Adverse Event|0
7514258|NCT02999178|26086680|P2|Overall Study|Other reason not defined above|13
7514259|NCT02999178|26086681|P1|Overall Study|Other reason not defined above|7
7514260|NCT02999178|26086680|P2|Overall Study|Withdrawal by Subject|21
7514261|NCT02999178|26086681|P1|Overall Study|Withdrawal by Subject|21
7514262|NCT02999178|26086680|P2|Overall Study|Lost to Follow-up|2
7514263|NCT02999178|26086681|P1|Overall Study|Lost to Follow-up|0
7514264|NCT02999178|26086680|P2|Overall Study|Protocol Violation|2
7514265|NCT02999178|26086681|P1|Overall Study|Protocol Violation|1
7514266|NCT02999178|26086680|P2|Overall Study|Adverse Event|62
7514267|NCT02999178|26086681|P1|Overall Study|Adverse Event|85
7514268|NCT02999100|26086731|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7514269|NCT02999100|26086732|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7514270|NCT02999100|26086733|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7514271|NCT02999100|26086734|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
7514272|NCT02999100|26086735|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7514273|NCT02999100|26086736|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7514274|NCT02999100|26086731|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
7514275|NCT02999100|26086732|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7514276|NCT02999100|26086733|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7514277|NCT02999100|26086734|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7514278|NCT02999100|26086735|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7514279|NCT02999100|26086736|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7514280|NCT02999100|26086731|P6|Part 1 (up to 15 Days)|Adverse Event|0
7514281|NCT02999100|26086732|P5|Part 1 (up to 15 Days)|Adverse Event|0
7514282|NCT02999100|26086733|P4|Part 1 (up to 15 Days)|Adverse Event|0
7514283|NCT02999100|26086734|P3|Part 1 (up to 15 Days)|Adverse Event|0
7514284|NCT02999100|26086735|P2|Part 1 (up to 15 Days)|Adverse Event|1
7514285|NCT02999100|26086736|P1|Part 1 (up to 15 Days)|Adverse Event|0
7514286|NCT02998996|26086904|P6|Overall Study|Family reasons|0
7514287|NCT02998996|26086905|P5|Overall Study|Family reasons|1
7514288|NCT02998996|26086906|P4|Overall Study|Family reasons|0
7514289|NCT02998996|26086907|P3|Overall Study|Family reasons|0
7514290|NCT02998996|26086908|P2|Overall Study|Family reasons|0
7514291|NCT02998996|26086909|P1|Overall Study|Family reasons|0
7514292|NCT02998996|26086904|P6|Overall Study|Pregnancy|0
7514293|NCT02998996|26086905|P5|Overall Study|Pregnancy|0
7514294|NCT02998996|26086906|P4|Overall Study|Pregnancy|0
7514295|NCT02998996|26086907|P3|Overall Study|Pregnancy|0
7514296|NCT02998996|26086908|P2|Overall Study|Pregnancy|1
7514297|NCT02998996|26086909|P1|Overall Study|Pregnancy|0
7514298|NCT02998996|26086904|P6|Overall Study|Lost to Follow-up|0
7514299|NCT02998996|26086905|P5|Overall Study|Lost to Follow-up|0
7514300|NCT02998996|26086906|P4|Overall Study|Lost to Follow-up|0
7514301|NCT02998996|26086907|P3|Overall Study|Lost to Follow-up|1
7514302|NCT02998996|26086908|P2|Overall Study|Lost to Follow-up|0
7514303|NCT02998996|26086909|P1|Overall Study|Lost to Follow-up|0
7514304|NCT02998671|26086943|P5|Period 2|Lost to Follow-up|0
7514305|NCT02998671|26086944|P4|Period 2|Lost to Follow-up|1
7514306|NCT02998671|26086945|P3|Period 2|Lost to Follow-up|0
7514307|NCT02998671|26086946|P2|Period 2|Lost to Follow-up|0
7514308|NCT02998671|26086947|P1|Period 2|Lost to Follow-up|0
7514309|NCT02998671|26086943|P5|Period 2|Withdrawal by Subject|0
7514310|NCT02998671|26086944|P4|Period 2|Withdrawal by Subject|0
7514311|NCT02998671|26086945|P3|Period 2|Withdrawal by Subject|0
7514312|NCT02998671|26086946|P2|Period 2|Withdrawal by Subject|1
7514313|NCT02998671|26086947|P1|Period 2|Withdrawal by Subject|0
7514314|NCT02998671|26086943|P5|Period 2|Study Terminated By Sponsor|0
7514315|NCT02998671|26086944|P4|Period 2|Study Terminated By Sponsor|3
7514316|NCT02998671|26086945|P3|Period 2|Study Terminated By Sponsor|1
7514317|NCT02998671|26086946|P2|Period 2|Study Terminated By Sponsor|5
7514318|NCT02998671|26086947|P1|Period 2|Study Terminated By Sponsor|3
7514319|NCT02998671|26086943|P5|Period 2|Adverse Event|0
7514320|NCT02998671|26086944|P4|Period 2|Adverse Event|0
7514321|NCT02998671|26086945|P3|Period 2|Adverse Event|0
7514322|NCT02998671|26086946|P2|Period 2|Adverse Event|1
7514323|NCT02998671|26086947|P1|Period 2|Adverse Event|0
7514324|NCT02998671|26086943|P5|Period 1|Adverse Event|1
7514325|NCT02998671|26086944|P4|Period 1|Adverse Event|0
7514326|NCT02998671|26086945|P3|Period 1|Adverse Event|0
7514327|NCT02998671|26086946|P2|Period 1|Adverse Event|0
7514328|NCT02998671|26086947|P1|Period 1|Adverse Event|0
7514329|NCT02998671|26086943|P5|Period 1|Pregnancy|0
7514330|NCT02998671|26086944|P4|Period 1|Pregnancy|0
7514331|NCT02998671|26086945|P3|Period 1|Pregnancy|0
7514332|NCT02998671|26086946|P2|Period 1|Pregnancy|0
7514333|NCT02998671|26086947|P1|Period 1|Pregnancy|1
7514334|NCT02998671|26086943|P5|Period 1|Withdrawal by Subject|2
7514335|NCT02998671|26086944|P4|Period 1|Withdrawal by Subject|0
7514336|NCT02998671|26086945|P3|Period 1|Withdrawal by Subject|0
7514337|NCT02998671|26086946|P2|Period 1|Withdrawal by Subject|2
7514338|NCT02998671|26086947|P1|Period 1|Withdrawal by Subject|1
7514339|NCT02998671|26086943|P5|Period 1|Study Terminated By Sponsor|1
7514340|NCT02998671|26086944|P4|Period 1|Study Terminated By Sponsor|0
7514341|NCT02998671|26086945|P3|Period 1|Study Terminated By Sponsor|0
7514342|NCT02998671|26086946|P2|Period 1|Study Terminated By Sponsor|1
7514343|NCT02998671|26086947|P1|Period 1|Study Terminated By Sponsor|2
7514344|NCT02998554|26086992|P2|Overall Study|Lack of Efficacy|1
7514345|NCT02998554|26086993|P1|Overall Study|Lack of Efficacy|0
7514346|NCT02998554|26086992|P2|Overall Study|Lost to Follow-up|1
7514347|NCT02998554|26086993|P1|Overall Study|Lost to Follow-up|0
7514348|NCT02998554|26086992|P2|Overall Study|Withdrawal by Subject|6
7514349|NCT02998554|26086993|P1|Overall Study|Withdrawal by Subject|2
7514350|NCT02998554|26086992|P2|Overall Study|Protocol deviation|0
7514351|NCT02998554|26086993|P1|Overall Study|Protocol deviation|1
7514352|NCT02998554|26086992|P2|Overall Study|Adverse Event|3
7514353|NCT02998554|26086993|P1|Overall Study|Adverse Event|8
7514354|NCT02998541|26087024|P3|Overall Study|Withdrawal by Parent/Guardian|1
7514355|NCT02998541|26087025|P2|Overall Study|Withdrawal by Parent/Guardian|0
7514356|NCT02998541|26087026|P1|Overall Study|Withdrawal by Parent/Guardian|0
7514357|NCT02998541|26087024|P3|Overall Study|Physician Decision|3
7514358|NCT02998541|26087025|P2|Overall Study|Physician Decision|0
7514359|NCT02998541|26087026|P1|Overall Study|Physician Decision|0
7514360|NCT02998541|26087024|P3|Overall Study|Lost to Follow-up|1
7514361|NCT02998541|26087025|P2|Overall Study|Lost to Follow-up|3
7514362|NCT02998541|26087026|P1|Overall Study|Lost to Follow-up|0
7514363|NCT02998541|26087024|P3|Overall Study|Withdrawal by Subject|0
7514364|NCT02998541|26087025|P2|Overall Study|Withdrawal by Subject|1
7514365|NCT02998541|26087026|P1|Overall Study|Withdrawal by Subject|3
7514366|NCT02998541|26087024|P3|Overall Study|Protocol Violation|0
7514367|NCT02998541|26087025|P2|Overall Study|Protocol Violation|0
7514368|NCT02998541|26087026|P1|Overall Study|Protocol Violation|1
7514369|NCT02998541|26087024|P3|Overall Study|Adverse Event|1
7514370|NCT02998541|26087025|P2|Overall Study|Adverse Event|5
7514371|NCT02998541|26087026|P1|Overall Study|Adverse Event|4
7514372|NCT02998476|26087081|P2|Overall Study|Death|2
7514373|NCT02998476|26087082|P1|Overall Study|Death|32
7514374|NCT02998476|26087081|P2|Overall Study|Withdrawal by Subject|2
7514375|NCT02998476|26087082|P1|Overall Study|Withdrawal by Subject|1
7514376|NCT02998476|26087081|P2|Overall Study|Disease Progression|0
7514377|NCT02998476|26087082|P1|Overall Study|Disease Progression|1
7514378|NCT02998476|26087081|P2|Overall Study|Ongoing in study|1
7514379|NCT02998476|26087082|P1|Overall Study|Ongoing in study|21
7514380|NCT02998021|26087092|P2|Overall Study|unsafe home|1
7514381|NCT02998021|26087093|P1|Overall Study|unsafe home|0
7514382|NCT02998021|26087092|P2|Overall Study|Withdrawal by Subject|1
7514383|NCT02998021|26087093|P1|Overall Study|Withdrawal by Subject|3
7514384|NCT02997176|26087168|P4|Overall Study|Withdrawal by Subject|1
7514385|NCT02997176|26087169|P3|Overall Study|Withdrawal by Subject|0
7514386|NCT02997176|26087170|P2|Overall Study|Withdrawal by Subject|2
7514387|NCT02997176|26087171|P1|Overall Study|Withdrawal by Subject|0
7514388|NCT02997176|26087168|P4|Overall Study|Death|1
7514389|NCT02997176|26087169|P3|Overall Study|Death|1
7514390|NCT02997176|26087170|P2|Overall Study|Death|0
7514391|NCT02997176|26087171|P1|Overall Study|Death|0
7514392|NCT02997176|26087168|P4|Overall Study|Progressive Disease|1
7514393|NCT02997176|26087169|P3|Overall Study|Progressive Disease|1
7514394|NCT02997176|26087170|P2|Overall Study|Progressive Disease|0
7514395|NCT02997176|26087171|P1|Overall Study|Progressive Disease|1
7514396|NCT02997176|26087168|P4|Overall Study|Adverse Event|8
7514397|NCT02997176|26087169|P3|Overall Study|Adverse Event|0
7514398|NCT02997176|26087170|P2|Overall Study|Adverse Event|0
7514399|NCT02997176|26087171|P1|Overall Study|Adverse Event|0
7514400|NCT02997163|26087309|P4|Overall Study|Adverse Event|1
7514401|NCT02997163|26087310|P3|Overall Study|Adverse Event|0
7514402|NCT02997163|26087311|P2|Overall Study|Adverse Event|0
7514403|NCT02997163|26087312|P1|Overall Study|Adverse Event|1
7514404|NCT02996968|26087468|P2|Overall Study|Withdrawal by Subject|0
7514405|NCT02996968|26087469|P1|Overall Study|Withdrawal by Subject|1
7514406|NCT02996682|26087508|P2|Overall Study|Death|3
7514407|NCT02996682|26087509|P1|Overall Study|Death|0
7514408|NCT02996500|26087588|P6|Overall Study|Withdrawal by Subject|0
7514409|NCT02996500|26087589|P5|Overall Study|Withdrawal by Subject|2
7514410|NCT02996500|26087590|P4|Overall Study|Withdrawal by Subject|0
7514411|NCT02996500|26087591|P3|Overall Study|Withdrawal by Subject|3
7514412|NCT02996500|26087592|P2|Overall Study|Withdrawal by Subject|0
7514413|NCT02996500|26087593|P1|Overall Study|Withdrawal by Subject|3
7514414|NCT02996500|26087588|P6|Overall Study|Protocol Violation|0
7514415|NCT02996500|26087589|P5|Overall Study|Protocol Violation|0
7514416|NCT02996500|26087590|P4|Overall Study|Protocol Violation|1
7514417|NCT02996500|26087591|P3|Overall Study|Protocol Violation|0
7514418|NCT02996500|26087592|P2|Overall Study|Protocol Violation|0
7514419|NCT02996500|26087593|P1|Overall Study|Protocol Violation|0
7514420|NCT02996500|26087588|P6|Overall Study|Other|0
7514421|NCT02996500|26087589|P5|Overall Study|Other|0
7514422|NCT02996500|26087590|P4|Overall Study|Other|0
7514423|NCT02996500|26087591|P3|Overall Study|Other|2
7514424|NCT02996500|26087592|P2|Overall Study|Other|0
7514425|NCT02996500|26087593|P1|Overall Study|Other|2
7514426|NCT02996500|26087588|P6|Overall Study|Progressive Disease|0
7514427|NCT02996500|26087589|P5|Overall Study|Progressive Disease|0
7514428|NCT02996500|26087590|P4|Overall Study|Progressive Disease|0
7514429|NCT02996500|26087591|P3|Overall Study|Progressive Disease|0
7514430|NCT02996500|26087592|P2|Overall Study|Progressive Disease|0
7514431|NCT02996500|26087593|P1|Overall Study|Progressive Disease|1
7514432|NCT02996500|26087588|P6|Overall Study|Non-Compliance With Study Drug|1
7514433|NCT02996500|26087589|P5|Overall Study|Non-Compliance With Study Drug|0
7514434|NCT02996500|26087590|P4|Overall Study|Non-Compliance With Study Drug|0
7514435|NCT02996500|26087591|P3|Overall Study|Non-Compliance With Study Drug|0
7514436|NCT02996500|26087592|P2|Overall Study|Non-Compliance With Study Drug|0
7514437|NCT02996500|26087593|P1|Overall Study|Non-Compliance With Study Drug|0
7514438|NCT02996500|26087588|P6|Overall Study|No Longer Meets Eligibility Criteria|0
7514439|NCT02996500|26087589|P5|Overall Study|No Longer Meets Eligibility Criteria|0
7514440|NCT02996500|26087590|P4|Overall Study|No Longer Meets Eligibility Criteria|0
7514441|NCT02996500|26087591|P3|Overall Study|No Longer Meets Eligibility Criteria|1
7514442|NCT02996500|26087592|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7514443|NCT02996500|26087593|P1|Overall Study|No Longer Meets Eligibility Criteria|0
7514444|NCT02996500|26087588|P6|Overall Study|Lost to Follow-up|1
7514445|NCT02996500|26087589|P5|Overall Study|Lost to Follow-up|0
7514446|NCT02996500|26087590|P4|Overall Study|Lost to Follow-up|0
7514447|NCT02996500|26087591|P3|Overall Study|Lost to Follow-up|0
7514448|NCT02996500|26087592|P2|Overall Study|Lost to Follow-up|0
7514449|NCT02996500|26087593|P1|Overall Study|Lost to Follow-up|1
7514450|NCT02996500|26087588|P6|Overall Study|Lack of Efficacy|0
7514451|NCT02996500|26087589|P5|Overall Study|Lack of Efficacy|2
7514452|NCT02996500|26087590|P4|Overall Study|Lack of Efficacy|0
7514453|NCT02996500|26087591|P3|Overall Study|Lack of Efficacy|0
7514454|NCT02996500|26087592|P2|Overall Study|Lack of Efficacy|0
7514455|NCT02996500|26087593|P1|Overall Study|Lack of Efficacy|0
7514456|NCT02996500|26087588|P6|Overall Study|Adverse Event|2
7514457|NCT02996500|26087589|P5|Overall Study|Adverse Event|1
7514458|NCT02996500|26087590|P4|Overall Study|Adverse Event|3
7514459|NCT02996500|26087591|P3|Overall Study|Adverse Event|4
7514460|NCT02996500|26087592|P2|Overall Study|Adverse Event|1
7514461|NCT02996500|26087593|P1|Overall Study|Adverse Event|1
7514462|NCT02996474|26087776|P1|Overall Study|Physician Decision|5
7514463|NCT02996448|26087780|P1|Overall Study|Study terminated due to adverse effects|3
7514464|NCT02996097|26087786|P2|Overall Study|Lost to Follow-up|11
7514465|NCT02996097|26087787|P1|Overall Study|Lost to Follow-up|11
7514466|NCT02995980|26087794|P1|Overall Study|Lost to Follow-up|14
7514467|NCT02994940|26087906|P2|Overall Study|Did not receive study medications: red dye allergy|1
7514468|NCT02994940|26087907|P1|Overall Study|Did not receive study medications: red dye allergy|0
7514469|NCT02994940|26087906|P2|Overall Study|Did not receive study medications: vomited after ingestion|0
7514470|NCT02994940|26087907|P1|Overall Study|Did not receive study medications: vomited after ingestion|1
7514471|NCT02994940|26087906|P2|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
7514472|NCT02994940|26087907|P1|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
7514473|NCT02994654|26087933|P1|Overall Study|Lost to Follow-up|1
7514474|NCT02994394|26087942|P6|Period 2 (Days 4 to 6)|Adverse Event|0
7514475|NCT02994394|26087943|P5|Period 2 (Days 4 to 6)|Adverse Event|1
7514476|NCT02994394|26087944|P4|Period 2 (Days 4 to 6)|Adverse Event|0
7514477|NCT02994394|26087945|P3|Period 2 (Days 4 to 6)|Adverse Event|0
7514478|NCT02994394|26087946|P2|Period 2 (Days 4 to 6)|Adverse Event|1
7514479|NCT02994394|26087947|P1|Period 2 (Days 4 to 6)|Adverse Event|0
7514480|NCT02994394|26087942|P6|Period 1 (Days 1 to 3)|Adverse Event|0
7514481|NCT02994394|26087943|P5|Period 1 (Days 1 to 3)|Adverse Event|0
7514482|NCT02994394|26087944|P4|Period 1 (Days 1 to 3)|Adverse Event|0
7514483|NCT02994394|26087945|P3|Period 1 (Days 1 to 3)|Adverse Event|1
7514484|NCT02994394|26087946|P2|Period 1 (Days 1 to 3)|Adverse Event|0
7514485|NCT02994394|26087947|P1|Period 1 (Days 1 to 3)|Adverse Event|0
7514486|NCT02994108|26087996|P2|Phase 2 Assessment|Withdrawal by Subject|0
7514487|NCT02994108|26087997|P1|Phase 2 Assessment|Withdrawal by Subject|1
7514488|NCT02994108|26087996|P2|Phase 2 Assessment|Lost to Follow-up|7
7514489|NCT02994108|26087997|P1|Phase 2 Assessment|Lost to Follow-up|8
7514490|NCT02994108|26087996|P2|Phase 1 Assessment|Lost to Follow-up|3
7514491|NCT02994108|26087997|P1|Phase 1 Assessment|Lost to Follow-up|5
7514492|NCT02994108|26087996|P2|Intervention Messages|Withdrawal by Subject|0
7514493|NCT02994108|26087997|P1|Intervention Messages|Withdrawal by Subject|2
7514494|NCT02994056|26088029|P1|Overall Study|Withdrew Consent|1
7514495|NCT02994056|26088029|P1|Overall Study|Death|8
7514496|NCT02993926|26088063|P3|Enantone Treatment Phase|Reason Not Specified|0
7514497|NCT02993926|26088064|P2|Enantone Treatment Phase|Reason Not Specified|0
7514498|NCT02993926|26088065|P1|Enantone Treatment Phase|Reason Not Specified|4
7514499|NCT02993926|26088063|P3|Enantone Treatment Phase|Investigator Judgment|0
7514500|NCT02993926|26088064|P2|Enantone Treatment Phase|Investigator Judgment|0
7514501|NCT02993926|26088065|P1|Enantone Treatment Phase|Investigator Judgment|1
7514502|NCT02993926|26088063|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
7514503|NCT02993926|26088064|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
7514504|NCT02993926|26088065|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
7514505|NCT02993926|26088063|P3|Enantone Treatment Phase|Adverse Event|0
7514506|NCT02993926|26088064|P2|Enantone Treatment Phase|Adverse Event|0
7514507|NCT02993926|26088065|P1|Enantone Treatment Phase|Adverse Event|1
7514508|NCT02993783|26088097|P2|Overall Study|Reason not Specified|9
7514509|NCT02993783|26088098|P1|Overall Study|Reason not Specified|6
7514510|NCT02993757|26088130|P2|Overall Study|Voluntary withdraw not due adverse event|8
7514511|NCT02993757|26088131|P1|Overall Study|Voluntary withdraw not due adverse event|8
7514512|NCT02993757|26088130|P2|Overall Study|Lost to Follow-up|0
7514513|NCT02993757|26088131|P1|Overall Study|Lost to Follow-up|1
7514514|NCT02993757|26088130|P2|Overall Study|Non compliance with the protocol|170
7514515|NCT02993757|26088131|P1|Overall Study|Non compliance with the protocol|155
7514516|NCT02993731|26088165|P2|Overall Study|Study Termination|105
7514517|NCT02993731|26088166|P1|Overall Study|Study Termination|101
7514518|NCT02993471|26088190|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
7514519|NCT02993471|26088190|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
7514520|NCT02993250|26088252|P2|Overall Study|Lost to Follow-up|1
7514521|NCT02993250|26088253|P1|Overall Study|Lost to Follow-up|0
7514522|NCT02993224|26088273|P1|Extension Phase|Deferasirox FCT locally reimbursed|27
7514523|NCT02993224|26088273|P1|Extension Phase|Lost to Follow-up|2
7514524|NCT02993224|26088273|P1|Extension Phase|Withdrawal by Subject|3
7514525|NCT02993224|26088273|P1|Extension Phase|Adverse Event|3
7514526|NCT02993224|26088273|P1|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1
7514527|NCT02993224|26088273|P1|Core Phase- Period 2|Allogenic stem cell transplantation|1
7514528|NCT02993224|26088273|P1|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2
7514529|NCT02993224|26088273|P1|Core Phase- Period 2|Adverse Event|1
7514530|NCT02993224|26088273|P1|Core Phase - Period 1|Lost to Follow-up|3
7514531|NCT02993224|26088273|P1|Core Phase - Period 1|Withdrawal by Subject|1
7514532|NCT02993224|26088273|P1|Core Phase - Period 1|Adverse Event|4
7514533|NCT02992899|26088292|P2|Overall Study|Lost to Follow-up|3
7514534|NCT02992899|26088293|P1|Overall Study|Lost to Follow-up|1
7514535|NCT02992899|26088292|P2|Overall Study|Withdrawal by Subject|0
7514536|NCT02992899|26088293|P1|Overall Study|Withdrawal by Subject|1
7514537|NCT02992691|26088343|P1|Overall Study|Withdrawal by Subject|1
7514538|NCT02992691|26088343|P1|Overall Study|Adverse Event|2
7514539|NCT02992418|26088362|P2|Overall Study|Lost to Follow-up|22
7514540|NCT02992418|26088363|P1|Overall Study|Lost to Follow-up|27
7514541|NCT02992418|26088362|P2|Overall Study|Non-compliance with the protocol|308
7514542|NCT02992418|26088363|P1|Overall Study|Non-compliance with the protocol|308
7514543|NCT02992418|26088362|P2|Overall Study|Withdrawal by Subject|12
7514544|NCT02992418|26088363|P1|Overall Study|Withdrawal by Subject|11
7514545|NCT02992288|26088403|P6|Overall Study|Withdrawal by Subject|4
7514546|NCT02992288|26088404|P5|Overall Study|Withdrawal by Subject|3
7514547|NCT02992288|26088405|P4|Overall Study|Withdrawal by Subject|5
7514548|NCT02992288|26088406|P3|Overall Study|Withdrawal by Subject|1
7514549|NCT02992288|26088407|P2|Overall Study|Withdrawal by Subject|2
7514550|NCT02992288|26088408|P1|Overall Study|Withdrawal by Subject|4
7514551|NCT02992288|26088403|P6|Overall Study|Protocol Violation|1
7514552|NCT02992288|26088404|P5|Overall Study|Protocol Violation|0
7514553|NCT02992288|26088405|P4|Overall Study|Protocol Violation|0
7514554|NCT02992288|26088406|P3|Overall Study|Protocol Violation|0
7514555|NCT02992288|26088407|P2|Overall Study|Protocol Violation|0
7514556|NCT02992288|26088408|P1|Overall Study|Protocol Violation|0
7514557|NCT02992288|26088403|P6|Overall Study|Lost to Follow-up|0
7514558|NCT02992288|26088404|P5|Overall Study|Lost to Follow-up|0
7514559|NCT02992288|26088405|P4|Overall Study|Lost to Follow-up|1
7514560|NCT02992288|26088406|P3|Overall Study|Lost to Follow-up|0
7514561|NCT02992288|26088407|P2|Overall Study|Lost to Follow-up|0
7514562|NCT02992288|26088408|P1|Overall Study|Lost to Follow-up|0
7514563|NCT02992288|26088403|P6|Overall Study|Death|0
7514564|NCT02992288|26088404|P5|Overall Study|Death|2
7514565|NCT02992288|26088405|P4|Overall Study|Death|1
7514566|NCT02992288|26088406|P3|Overall Study|Death|2
7514567|NCT02992288|26088407|P2|Overall Study|Death|0
7514568|NCT02992288|26088408|P1|Overall Study|Death|2
7514569|NCT02992288|26088403|P6|Overall Study|Physician Decision|1
7514570|NCT02992288|26088404|P5|Overall Study|Physician Decision|0
7514571|NCT02992288|26088405|P4|Overall Study|Physician Decision|0
7514572|NCT02992288|26088406|P3|Overall Study|Physician Decision|1
7514573|NCT02992288|26088407|P2|Overall Study|Physician Decision|0
7514574|NCT02992288|26088408|P1|Overall Study|Physician Decision|3
7514575|NCT02992288|26088403|P6|Overall Study|Non-compliance with study drug|0
7514576|NCT02992288|26088404|P5|Overall Study|Non-compliance with study drug|1
7514577|NCT02992288|26088405|P4|Overall Study|Non-compliance with study drug|0
7514578|NCT02992288|26088406|P3|Overall Study|Non-compliance with study drug|1
7514579|NCT02992288|26088407|P2|Overall Study|Non-compliance with study drug|1
7514580|NCT02992288|26088408|P1|Overall Study|Non-compliance with study drug|0
7514581|NCT02992288|26088403|P6|Overall Study|Adverse Event|7
7514582|NCT02992288|26088404|P5|Overall Study|Adverse Event|2
7514583|NCT02992288|26088405|P4|Overall Study|Adverse Event|2
7514584|NCT02992288|26088406|P3|Overall Study|Adverse Event|2
7514585|NCT02992288|26088407|P2|Overall Study|Adverse Event|2
7514586|NCT02992288|26088408|P1|Overall Study|Adverse Event|8
7514587|NCT02992132|26088493|P3|Overall Study|Physician Decision|1
7514588|NCT02992132|26088494|P2|Overall Study|Physician Decision|0
7514589|NCT02992132|26088495|P1|Overall Study|Physician Decision|0
7514590|NCT02992132|26088493|P3|Overall Study|Withdrawal by Subject|1
7514591|NCT02992132|26088494|P2|Overall Study|Withdrawal by Subject|2
7514592|NCT02992132|26088495|P1|Overall Study|Withdrawal by Subject|0
7514593|NCT02992132|26088493|P3|Overall Study|Caregiver withdrew consent|2
7514594|NCT02992132|26088494|P2|Overall Study|Caregiver withdrew consent|3
7514595|NCT02992132|26088495|P1|Overall Study|Caregiver withdrew consent|2
7514596|NCT02992132|26088493|P3|Overall Study|Protocol Violation|0
7514597|NCT02992132|26088494|P2|Overall Study|Protocol Violation|2
7514598|NCT02992132|26088495|P1|Overall Study|Protocol Violation|2
7514599|NCT02992132|26088493|P3|Overall Study|Progressive disease|0
7514600|NCT02992132|26088494|P2|Overall Study|Progressive disease|0
7514601|NCT02992132|26088495|P1|Overall Study|Progressive disease|1
7514602|NCT02992132|26088493|P3|Overall Study|Non-compliance with study drug|0
7514603|NCT02992132|26088494|P2|Overall Study|Non-compliance with study drug|0
7514604|NCT02992132|26088495|P1|Overall Study|Non-compliance with study drug|2
7514605|NCT02992132|26088493|P3|Overall Study|Lack of Efficacy|0
7514606|NCT02992132|26088494|P2|Overall Study|Lack of Efficacy|0
7514607|NCT02992132|26088495|P1|Overall Study|Lack of Efficacy|2
7514608|NCT02992132|26088493|P3|Overall Study|Adverse Event|3
7514609|NCT02992132|26088494|P2|Overall Study|Adverse Event|1
7514610|NCT02992132|26088495|P1|Overall Study|Adverse Event|4
7514611|NCT02991859|26088608|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514612|NCT02991859|26088609|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514613|NCT02991859|26088610|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514614|NCT02991859|26088611|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514615|NCT02991859|26088612|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514616|NCT02991859|26088613|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514617|NCT02991859|26088614|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514618|NCT02991859|26088615|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514619|NCT02991859|26088616|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
7514620|NCT02991859|26088617|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514621|NCT02991859|26088618|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514622|NCT02991859|26088619|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514623|NCT02991859|26088620|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514624|NCT02991859|26088621|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514625|NCT02991859|26088622|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514626|NCT02991859|26088623|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514627|NCT02991859|26088624|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7514628|NCT02991859|26088608|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
7514629|NCT02991859|26088609|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
7514630|NCT02991859|26088610|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
7514631|NCT02991859|26088611|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
7514632|NCT02991859|26088612|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
7514633|NCT02991859|26088613|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
7514634|NCT02991859|26088614|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
7514635|NCT02991859|26088615|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
7514636|NCT02991859|26088616|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
7514637|NCT02991859|26088617|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
7514638|NCT02991859|26088618|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
7514639|NCT02991859|26088619|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
7514640|NCT02991859|26088620|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
7514641|NCT02991859|26088621|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
7514642|NCT02991859|26088622|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
7514643|NCT02991859|26088623|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
7514644|NCT02991859|26088624|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
7514645|NCT02991859|26088608|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514646|NCT02991859|26088609|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514647|NCT02991859|26088610|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514648|NCT02991859|26088611|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514649|NCT02991859|26088612|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514650|NCT02991859|26088613|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514651|NCT02991859|26088614|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514652|NCT02991859|26088615|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514653|NCT02991859|26088616|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514654|NCT02991859|26088617|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514655|NCT02991859|26088618|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514656|NCT02991859|26088619|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
7514657|NCT02991859|26088620|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514658|NCT02991859|26088621|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514659|NCT02991859|26088622|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514660|NCT02991859|26088623|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514661|NCT02991859|26088624|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
7514662|NCT02991859|26088608|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514663|NCT02991859|26088609|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514664|NCT02991859|26088610|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514665|NCT02991859|26088611|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7514666|NCT02991859|26088612|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7514667|NCT02991859|26088613|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514668|NCT02991859|26088614|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514669|NCT02991859|26088615|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514670|NCT02991859|26088616|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514671|NCT02991859|26088617|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514672|NCT02991859|26088618|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514673|NCT02991859|26088619|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514674|NCT02991859|26088620|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514675|NCT02991859|26088621|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514676|NCT02991859|26088622|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514677|NCT02991859|26088623|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514678|NCT02991859|26088624|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7514679|NCT02991859|26088608|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514680|NCT02991859|26088609|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514681|NCT02991859|26088610|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514682|NCT02991859|26088611|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514683|NCT02991859|26088612|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514684|NCT02991859|26088613|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514685|NCT02991859|26088614|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514686|NCT02991859|26088615|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514687|NCT02991859|26088616|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514688|NCT02991859|26088617|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514689|NCT02991859|26088618|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514690|NCT02991859|26088619|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514691|NCT02991859|26088620|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7514780|NCT02988622|26089384|P1|Overall Study|Lost to Follow-up|17
7514692|NCT02991859|26088621|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514693|NCT02991859|26088622|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514694|NCT02991859|26088623|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7514695|NCT02991859|26088624|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7514696|NCT02991430|26088919|P3|Post-treatment Observation Period|Study Termination|5
7514697|NCT02991430|26088920|P2|Post-treatment Observation Period|Study Termination|6
7514698|NCT02991430|26088921|P1|Post-treatment Observation Period|Study Termination|3
7514699|NCT02991430|26088919|P3|Treatment Period 2|Lost to Follow-up|1
7514700|NCT02991430|26088920|P2|Treatment Period 2|Lost to Follow-up|0
7514701|NCT02991430|26088921|P1|Treatment Period 2|Lost to Follow-up|0
7514702|NCT02991430|26088919|P3|Treatment Period 2|Study Termination|3
7514703|NCT02991430|26088920|P2|Treatment Period 2|Study Termination|3
7514704|NCT02991430|26088921|P1|Treatment Period 2|Study Termination|6
7514705|NCT02991430|26088919|P3|Treatment Period 1|Withdrawal by Subject|0
7514706|NCT02991430|26088920|P2|Treatment Period 1|Withdrawal by Subject|4
7514707|NCT02991430|26088921|P1|Treatment Period 1|Withdrawal by Subject|0
7514708|NCT02991430|26088919|P3|Treatment Period 1|Adverse Event|2
7514709|NCT02991430|26088920|P2|Treatment Period 1|Adverse Event|0
7514710|NCT02991430|26088921|P1|Treatment Period 1|Adverse Event|1
7514711|NCT02991118|26088958|P2|Overall Study|Lost to Follow-up|9
7514712|NCT02991118|26088959|P1|Overall Study|Lost to Follow-up|1
7514713|NCT02991118|26088958|P2|Overall Study|Could not attend study visits|1
7514714|NCT02991118|26088959|P1|Overall Study|Could not attend study visits|0
7514715|NCT02991118|26088958|P2|Overall Study|Withdrawal by Subject|7
7514716|NCT02991118|26088959|P1|Overall Study|Withdrawal by Subject|1
7514717|NCT02991118|26088958|P2|Overall Study|Adverse Event|2
7514718|NCT02991118|26088959|P1|Overall Study|Adverse Event|2
7514719|NCT02991118|26088958|P2|Overall Study|Moved out of the country|1
7514720|NCT02991118|26088959|P1|Overall Study|Moved out of the country|0
7514721|NCT02991118|26088958|P2|Overall Study|Physician Decision|1
7514722|NCT02991118|26088959|P1|Overall Study|Physician Decision|0
7514723|NCT02991118|26088958|P2|Overall Study|Protocol Violation|3
7514724|NCT02991118|26088959|P1|Overall Study|Protocol Violation|0
7514725|NCT02991118|26088958|P2|Overall Study|Death|8
7514726|NCT02991118|26088959|P1|Overall Study|Death|3
7514727|NCT02991040|26089003|P1|Overall Study|Lost to Follow-up|2
7514728|NCT02991040|26089003|P1|Overall Study|Withdrawal by Subject|2
7514729|NCT02990910|26089018|P2|Overall Study|Lack of Efficacy|10
7514730|NCT02990910|26089019|P1|Overall Study|Lack of Efficacy|6
7514743|NCT02990000|26089078|P2|Overall Study|Failed to provide data beyond baseline|34
7514744|NCT02990000|26089079|P1|Overall Study|Failed to provide data beyond baseline|36
7514745|NCT02989805|26089099|P2|Overall Study|invalid consent|4
7514746|NCT02989805|26089100|P1|Overall Study|invalid consent|6
7514747|NCT02989649|26089203|P1|Overall Study|Reason Not Specified|13
7514748|NCT02989649|26089203|P1|Overall Study|Lost For Observation During Study|3
7514749|NCT02989649|26089203|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
7514750|NCT02989649|26089203|P1|Overall Study|Patient/Investigator's Decision to Stop|403
7514751|NCT02989610|26089215|P1|Overall Study|Withdrawal/Other reasons|39
7514752|NCT02989389|26089256|P10|Period 1|Physician Decision|0
7514753|NCT02989389|26089257|P9|Period 1|Physician Decision|1
7514754|NCT02989389|26089258|P8|Period 1|Physician Decision|0
7514755|NCT02989389|26089259|P7|Period 1|Physician Decision|0
7514756|NCT02989389|26089260|P6|Period 1|Physician Decision|0
7514757|NCT02989389|26089261|P5|Period 1|Physician Decision|0
7514758|NCT02989389|26089262|P4|Period 1|Physician Decision|0
7514759|NCT02989389|26089263|P3|Period 1|Physician Decision|0
7514760|NCT02989389|26089264|P2|Period 1|Physician Decision|0
7514761|NCT02989389|26089265|P1|Period 1|Physician Decision|0
7514762|NCT02989389|26089256|P10|Period 1|Lost to Follow-up|0
7514763|NCT02989389|26089257|P9|Period 1|Lost to Follow-up|0
7514764|NCT02989389|26089258|P8|Period 1|Lost to Follow-up|0
7514765|NCT02989389|26089259|P7|Period 1|Lost to Follow-up|0
7514766|NCT02989389|26089260|P6|Period 1|Lost to Follow-up|0
7514767|NCT02989389|26089261|P5|Period 1|Lost to Follow-up|0
7514768|NCT02989389|26089262|P4|Period 1|Lost to Follow-up|0
7514769|NCT02989389|26089263|P3|Period 1|Lost to Follow-up|0
7514770|NCT02989389|26089264|P2|Period 1|Lost to Follow-up|1
7514771|NCT02989389|26089265|P1|Period 1|Lost to Follow-up|0
7514772|NCT02989168|26089331|P2|Overall Study|Sponsor stopped study.|0
7514773|NCT02989168|26089332|P1|Overall Study|Sponsor stopped study.|1
7514774|NCT02989168|26089331|P2|Overall Study|Adverse Event|2
7514775|NCT02989168|26089332|P1|Overall Study|Adverse Event|1
7514776|NCT02989168|26089331|P2|Overall Study|Physician Decision|1
7514777|NCT02989168|26089332|P1|Overall Study|Physician Decision|0
7514778|NCT02989168|26089331|P2|Overall Study|Withdrawal by Subject|0
7514779|NCT02989168|26089332|P1|Overall Study|Withdrawal by Subject|2
7514781|NCT02988219|26089419|P2|Overall Study|Withdrawal by Subject|2
7514782|NCT02988219|26089420|P1|Overall Study|Withdrawal by Subject|0
7514783|NCT02988219|26089419|P2|Overall Study|Lack of Efficacy|1
7514784|NCT02988219|26089420|P1|Overall Study|Lack of Efficacy|1
7514785|NCT02988115|26089439|P2|Overall Study|Lost to Follow-up|0
7514786|NCT02988115|26089440|P1|Overall Study|Lost to Follow-up|1
7514787|NCT02988115|26089439|P2|Overall Study|Withdrawn by Mistake|0
7514788|NCT02988115|26089440|P1|Overall Study|Withdrawn by Mistake|1
7514789|NCT02988115|26089439|P2|Overall Study|Withdrawal by Subject|1
7514790|NCT02988115|26089440|P1|Overall Study|Withdrawal by Subject|1
7514791|NCT02988115|26089439|P2|Overall Study|Sponsor Decision|2
7514792|NCT02988115|26089440|P1|Overall Study|Sponsor Decision|5
7514793|NCT02988115|26089439|P2|Overall Study|Adverse Event|1
7514794|NCT02988115|26089440|P1|Overall Study|Adverse Event|6
7514795|NCT02987972|26089466|P3|Overall Study|Withdrawal by Subject|21
7514796|NCT02987972|26089467|P2|Overall Study|Withdrawal by Subject|17
7514797|NCT02987972|26089468|P1|Overall Study|Withdrawal by Subject|22
7514798|NCT02987972|26089466|P3|Overall Study|Protocol Violation|5
7514799|NCT02987972|26089467|P2|Overall Study|Protocol Violation|1
7514800|NCT02987972|26089468|P1|Overall Study|Protocol Violation|2
7514801|NCT02987972|26089466|P3|Overall Study|Physician Decision|0
7514802|NCT02987972|26089467|P2|Overall Study|Physician Decision|6
7514803|NCT02987972|26089468|P1|Overall Study|Physician Decision|1
7514804|NCT02987972|26089466|P3|Overall Study|Lost to Follow-up|4
7514805|NCT02987972|26089467|P2|Overall Study|Lost to Follow-up|8
7514806|NCT02987972|26089468|P1|Overall Study|Lost to Follow-up|7
7514807|NCT02987972|26089466|P3|Overall Study|Lack of Efficacy|12
7514808|NCT02987972|26089467|P2|Overall Study|Lack of Efficacy|12
7514809|NCT02987972|26089468|P1|Overall Study|Lack of Efficacy|9
7514810|NCT02987972|26089466|P3|Overall Study|Death|0
7514811|NCT02987972|26089467|P2|Overall Study|Death|0
7514812|NCT02987972|26089468|P1|Overall Study|Death|1
7514813|NCT02987972|26089466|P3|Overall Study|Adverse Event|0
7514814|NCT02987972|26089467|P2|Overall Study|Adverse Event|1
7514815|NCT02987972|26089468|P1|Overall Study|Adverse Event|1
7514816|NCT02987959|26089497|P1|Overall Study|Grantor stopped supply of drugs|6
7514817|NCT02987660|26089569|P2|Overall Study|Study terminated by sponsor|10
7514818|NCT02987660|26089570|P1|Overall Study|Study terminated by sponsor|10
7514819|NCT02987543|26089594|P4|Overall Study|Disease progression|1
7514820|NCT02987543|26089595|P3|Overall Study|Disease progression|0
7514821|NCT02987543|26089596|P2|Overall Study|Disease progression|0
7514822|NCT02987543|26089597|P1|Overall Study|Disease progression|0
7514823|NCT02987543|26089594|P4|Overall Study|Investigator decision|0
7514824|NCT02987543|26089595|P3|Overall Study|Investigator decision|0
7514825|NCT02987543|26089596|P2|Overall Study|Investigator decision|1
7514826|NCT02987543|26089597|P1|Overall Study|Investigator decision|0
7514827|NCT02987543|26089594|P4|Overall Study|Study terminated by sponsor|0
7514828|NCT02987543|26089595|P3|Overall Study|Study terminated by sponsor|0
7514829|NCT02987543|26089596|P2|Overall Study|Study terminated by sponsor|0
7514830|NCT02987543|26089597|P1|Overall Study|Study terminated by sponsor|1
7514831|NCT02987543|26089594|P4|Overall Study|Withdrawal by Subject|6
7514832|NCT02987543|26089595|P3|Overall Study|Withdrawal by Subject|7
7514833|NCT02987543|26089596|P2|Overall Study|Withdrawal by Subject|7
7514834|NCT02987543|26089597|P1|Overall Study|Withdrawal by Subject|21
7514835|NCT02987543|26089594|P4|Overall Study|Screen failure|1
7514836|NCT02987543|26089595|P3|Overall Study|Screen failure|0
7514837|NCT02987543|26089596|P2|Overall Study|Screen failure|0
7514838|NCT02987543|26089597|P1|Overall Study|Screen failure|0
7514839|NCT02987543|26089594|P4|Overall Study|Lost to Follow-up|0
7514840|NCT02987543|26089595|P3|Overall Study|Lost to Follow-up|1
7514841|NCT02987543|26089596|P2|Overall Study|Lost to Follow-up|0
7514842|NCT02987543|26089597|P1|Overall Study|Lost to Follow-up|3
7514843|NCT02987543|26089594|P4|Overall Study|Death|28
7514844|NCT02987543|26089595|P3|Overall Study|Death|67
7514845|NCT02987543|26089596|P2|Overall Study|Death|54
7514846|NCT02987543|26089597|P1|Overall Study|Death|88
7514847|NCT02987543|26089594|P4|Overall Study|Ongoing study at data cut off|12
7514848|NCT02987543|26089595|P3|Overall Study|Ongoing study at data cut off|19
7514849|NCT02987543|26089596|P2|Overall Study|Ongoing study at data cut off|21
7514850|NCT02987543|26089597|P1|Overall Study|Ongoing study at data cut off|49
7514851|NCT02987205|26089627|P1|Overall Study|Withdrawal by Subject|3
7514852|NCT02987205|26089627|P1|Overall Study|Adverse Event|1
7514853|NCT02986854|26089661|P3|Overall Study|Lost to Follow-up|2
7514854|NCT02986854|26089662|P2|Overall Study|Lost to Follow-up|11
7514855|NCT02986854|26089663|P1|Overall Study|Lost to Follow-up|3
7514856|NCT02986854|26089661|P3|Overall Study|Withdrawal by Subject|1
7514857|NCT02986854|26089662|P2|Overall Study|Withdrawal by Subject|1
7514858|NCT02986854|26089663|P1|Overall Study|Withdrawal by Subject|0
7514859|NCT02986373|26089768|P1|Overall Study|Other|24
7514860|NCT02986373|26089768|P1|Overall Study|Withdrawal by Subject|10
7514861|NCT02986373|26089768|P1|Overall Study|Lost to Follow-up|1
7514862|NCT02986373|26089768|P1|Overall Study|Adverse Event|4
7514863|NCT02986139|26089810|P2|Overall Study|Lost to Follow-up|1
7514864|NCT02986139|26089811|P1|Overall Study|Lost to Follow-up|0
7514865|NCT02986139|26089810|P2|Overall Study|Withdrawal by Subject|1
7514866|NCT02986139|26089811|P1|Overall Study|Withdrawal by Subject|0
7514867|NCT02986139|26089810|P2|Overall Study|Sponsor Decision|2
7514868|NCT02986139|26089811|P1|Overall Study|Sponsor Decision|1
7514869|NCT02986074|26089823|P4|Follow up Period|Physician Decision|1
7514870|NCT02986074|26089824|P3|Follow up Period|Physician Decision|0
7514871|NCT02986074|26089825|P2|Follow up Period|Physician Decision|0
7514872|NCT02986074|26089826|P1|Follow up Period|Physician Decision|0
7514873|NCT02986074|26089823|P4|Follow up Period|system explant|2
7514874|NCT02986074|26089824|P3|Follow up Period|system explant|1
7514875|NCT02986074|26089825|P2|Follow up Period|system explant|0
7514876|NCT02986074|26089826|P1|Follow up Period|system explant|0
7514877|NCT02986074|26089823|P4|First Trial Period|Adverse Event|0
7514878|NCT02986074|26089824|P3|First Trial Period|Adverse Event|0
7514879|NCT02986074|26089825|P2|First Trial Period|Adverse Event|0
7514880|NCT02986074|26089826|P1|First Trial Period|Adverse Event|1
7514881|NCT02985996|26089864|P5|Overall Study|Protocol Violation|0
7514882|NCT02985996|26089865|P4|Overall Study|Protocol Violation|0
7514883|NCT02985996|26089866|P3|Overall Study|Protocol Violation|0
7514884|NCT02985996|26089867|P2|Overall Study|Protocol Violation|1
7514885|NCT02985996|26089868|P1|Overall Study|Protocol Violation|0
7514886|NCT02985996|26089864|P5|Overall Study|Withdrawal by Subject|0
7514887|NCT02985996|26089865|P4|Overall Study|Withdrawal by Subject|0
7514888|NCT02985996|26089866|P3|Overall Study|Withdrawal by Subject|1
7514889|NCT02985996|26089867|P2|Overall Study|Withdrawal by Subject|0
7514890|NCT02985996|26089868|P1|Overall Study|Withdrawal by Subject|0
7514891|NCT02985879|26089983|P3|Overall Study|Other, not specified|58
7514892|NCT02985879|26089984|P2|Overall Study|Other, not specified|58
7514893|NCT02985879|26089985|P1|Overall Study|Other, not specified|62
7514894|NCT02985879|26089983|P3|Overall Study|Lost to Follow-up|2
7514895|NCT02985879|26089984|P2|Overall Study|Lost to Follow-up|0
7514896|NCT02985879|26089985|P1|Overall Study|Lost to Follow-up|1
7514897|NCT02985879|26089983|P3|Overall Study|Withdrew consent|10
7514898|NCT02985879|26089984|P2|Overall Study|Withdrew consent|8
7514899|NCT02985879|26089985|P1|Overall Study|Withdrew consent|6
7514900|NCT02985879|26089983|P3|Overall Study|Adverse Event|7
7514901|NCT02985879|26089984|P2|Overall Study|Adverse Event|9
7514902|NCT02985879|26089985|P1|Overall Study|Adverse Event|7
7514903|NCT02985684|26090099|P1|6-Month Closure Success Evaluation|Device Removal|3
7514904|NCT02985684|26090099|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
7514905|NCT02985684|26090099|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
7514906|NCT02985398|26090110|P1|Overall Study|Study Burden|9
7514907|NCT02985398|26090110|P1|Overall Study|Withdrawal by Subject|8
7514908|NCT02985398|26090110|P1|Overall Study|Lost to Follow-up|4
7514909|NCT02985398|26090110|P1|Overall Study|Adverse Event|1
7514910|NCT02985021|26090126|P1|Overall Study|Inability to comply with study procedures|1
7514911|NCT02984995|26090132|P2|Overall Study|Adverse Event|0
7514912|NCT02984995|26090133|P1|Overall Study|Adverse Event|1
7514913|NCT02984995|26090132|P2|Overall Study|Progressive disease|1
7514914|NCT02984995|26090133|P1|Overall Study|Progressive disease|11
7514915|NCT02984995|26090132|P2|Overall Study|Required stem cell transplant|2
7514916|NCT02984995|26090133|P1|Overall Study|Required stem cell transplant|13
7514917|NCT02984982|26090180|P2|Overall Study|Randomized but not treated|1
7514918|NCT02984982|26090181|P1|Overall Study|Randomized but not treated|0
7514919|NCT02984982|26090180|P2|Overall Study|Withdrawal by Subject|0
7514920|NCT02984982|26090181|P1|Overall Study|Withdrawal by Subject|2
7514921|NCT02984982|26090180|P2|Overall Study|Poor Compliance to Protocol|4
7514922|NCT02984982|26090181|P1|Overall Study|Poor Compliance to Protocol|4
7514923|NCT02984982|26090180|P2|Overall Study|Adverse Event|5
7514924|NCT02984982|26090181|P1|Overall Study|Adverse Event|2
7514925|NCT02984943|26090233|P1|Overall Study|Physician Decision|1
7514926|NCT02984943|26090233|P1|Overall Study|Withdrawal by Subject|3
7514927|NCT02984683|26090316|P2|Overall Study|Disease progression|9
7514928|NCT02984683|26090317|P1|Overall Study|Disease progression|7
7514929|NCT02984683|26090316|P2|Overall Study|Withdrawal by Subject|0
7514930|NCT02984683|26090317|P1|Overall Study|Withdrawal by Subject|1
7514931|NCT02984683|26090316|P2|Overall Study|Adverse Event|3
7514932|NCT02984683|26090317|P1|Overall Study|Adverse Event|3
7514933|NCT02984267|26090372|P2|Overall Study|Withdrawal by Subject|1
7514934|NCT02984267|26090373|P1|Overall Study|Withdrawal by Subject|0
7514935|NCT02984267|26090372|P2|Overall Study|Protocol Violation|0
7514936|NCT02984267|26090373|P1|Overall Study|Protocol Violation|1
7514937|NCT02983617|26090418|P2|Overall Study|Still on Study|28
7514938|NCT02983617|26090419|P1|Overall Study|Still on Study|6
7514939|NCT02983617|26090418|P2|Overall Study|Death|1
7514940|NCT02983617|26090419|P1|Overall Study|Death|0
7514941|NCT02983617|26090418|P2|Overall Study|Adverse Event|1
7514942|NCT02983617|26090419|P1|Overall Study|Adverse Event|0
7514943|NCT02983604|26090437|P4|Overall Study|Enrolled but not Treated|0
7514944|NCT02983604|26090438|P3|Overall Study|Enrolled but not Treated|1
7514945|NCT02983604|26090439|P2|Overall Study|Enrolled but not Treated|0
7514946|NCT02983604|26090440|P1|Overall Study|Enrolled but not Treated|0
7514947|NCT02983305|26090638|P2|Overall Study|incomplete data|0
7514948|NCT02983305|26090639|P1|Overall Study|incomplete data|2
7514949|NCT02983227|26090649|P2|Overall Study|Withdrawal by Subject|8
7514950|NCT02983227|26090650|P1|Overall Study|Withdrawal by Subject|19
7514951|NCT02983227|26090649|P2|Overall Study|Physician Decision|1
7514952|NCT02983227|26090650|P1|Overall Study|Physician Decision|3
7514953|NCT02983227|26090649|P2|Overall Study|Multiple Reasons|1
7514954|NCT02983227|26090650|P1|Overall Study|Multiple Reasons|2
7514955|NCT02983227|26090649|P2|Overall Study|Lost to Follow-up|0
7514956|NCT02983227|26090650|P1|Overall Study|Lost to Follow-up|3
7514957|NCT02983227|26090649|P2|Overall Study|Lack of Efficacy|1
7514958|NCT02983227|26090650|P1|Overall Study|Lack of Efficacy|8
7514959|NCT02983227|26090649|P2|Overall Study|Death|0
7514960|NCT02983227|26090650|P1|Overall Study|Death|3
7514961|NCT02983227|26090649|P2|Overall Study|Adverse Event|3
7514962|NCT02983227|26090650|P1|Overall Study|Adverse Event|21
7514963|NCT02982954|26090725|P4|Continuing in Study|other reasons|0
7514964|NCT02982954|26090726|P3|Continuing in Study|other reasons|0
7514965|NCT02982954|26090727|P2|Continuing in Study|other reasons|1
7514966|NCT02982954|26090728|P1|Continuing in Study|other reasons|0
7514967|NCT02982954|26090725|P4|Continuing in Study|Lost to Follow-up|0
7514968|NCT02982954|26090726|P3|Continuing in Study|Lost to Follow-up|0
7514969|NCT02982954|26090727|P2|Continuing in Study|Lost to Follow-up|0
7514970|NCT02982954|26090728|P1|Continuing in Study|Lost to Follow-up|1
7514971|NCT02982954|26090725|P4|Continuing in Study|participant withdrew consent|1
7514972|NCT02982954|26090726|P3|Continuing in Study|participant withdrew consent|1
7514973|NCT02982954|26090727|P2|Continuing in Study|participant withdrew consent|5
7514974|NCT02982954|26090728|P1|Continuing in Study|participant withdrew consent|9
7514975|NCT02982954|26090725|P4|Continuing in Study|Death|17
7514976|NCT02982954|26090726|P3|Continuing in Study|Death|10
7514977|NCT02982954|26090727|P2|Continuing in Study|Death|27
7514978|NCT02982954|26090728|P1|Continuing in Study|Death|44
7514979|NCT02982954|26090725|P4|Treatment Period|other reasons|5
7514980|NCT02982954|26090726|P3|Treatment Period|other reasons|4
7514981|NCT02982954|26090727|P2|Treatment Period|other reasons|8
7514982|NCT02982954|26090728|P1|Treatment Period|other reasons|12
7514983|NCT02982954|26090725|P4|Treatment Period|Admin reason by sponsor|0
7514984|NCT02982954|26090726|P3|Treatment Period|Admin reason by sponsor|0
7514985|NCT02982954|26090727|P2|Treatment Period|Admin reason by sponsor|0
7514986|NCT02982954|26090728|P1|Treatment Period|Admin reason by sponsor|3
7514987|NCT02982954|26090725|P4|Treatment Period|no longer meets study criteria|0
7514988|NCT02982954|26090726|P3|Treatment Period|no longer meets study criteria|0
7514989|NCT02982954|26090727|P2|Treatment Period|no longer meets study criteria|1
7514990|NCT02982954|26090728|P1|Treatment Period|no longer meets study criteria|0
7514991|NCT02982954|26090725|P4|Treatment Period|maximum clinical benefit|0
7514992|NCT02982954|26090726|P3|Treatment Period|maximum clinical benefit|0
7514993|NCT02982954|26090727|P2|Treatment Period|maximum clinical benefit|0
7514994|NCT02982954|26090728|P1|Treatment Period|maximum clinical benefit|1
7514995|NCT02982954|26090725|P4|Treatment Period|participant withdrew consent|1
7514996|NCT02982954|26090726|P3|Treatment Period|participant withdrew consent|0
7514997|NCT02982954|26090727|P2|Treatment Period|participant withdrew consent|1
7514998|NCT02982954|26090728|P1|Treatment Period|participant withdrew consent|1
7514999|NCT02982954|26090725|P4|Treatment Period|participant request to discontinue|2
7515000|NCT02982954|26090726|P3|Treatment Period|participant request to discontinue|1
7515001|NCT02982954|26090727|P2|Treatment Period|participant request to discontinue|2
7515002|NCT02982954|26090728|P1|Treatment Period|participant request to discontinue|2
7515003|NCT02982954|26090725|P4|Treatment Period|Adverse events unrelated to study drug|3
7515004|NCT02982954|26090726|P3|Treatment Period|Adverse events unrelated to study drug|1
7515005|NCT02982954|26090727|P2|Treatment Period|Adverse events unrelated to study drug|1
7515006|NCT02982954|26090728|P1|Treatment Period|Adverse events unrelated to study drug|4
7515007|NCT02982954|26090725|P4|Treatment Period|Death|4
7515008|NCT02982954|26090726|P3|Treatment Period|Death|2
7515009|NCT02982954|26090727|P2|Treatment Period|Death|3
7515010|NCT02982954|26090728|P1|Treatment Period|Death|1
7515011|NCT02982954|26090725|P4|Treatment Period|study drug toxicity|0
7515012|NCT02982954|26090726|P3|Treatment Period|study drug toxicity|8
7515013|NCT02982954|26090727|P2|Treatment Period|study drug toxicity|10
7515014|NCT02982954|26090728|P1|Treatment Period|study drug toxicity|20
7515015|NCT02982954|26090725|P4|Treatment Period|Disease progression|10
7515016|NCT02982954|26090726|P3|Treatment Period|Disease progression|12
7515017|NCT02982954|26090727|P2|Treatment Period|Disease progression|26
7515018|NCT02982954|26090728|P1|Treatment Period|Disease progression|62
7515019|NCT02982863|26090787|P5|Overall Study|Not eligible patients|492
7515020|NCT02982863|26090788|P4|Overall Study|Not eligible patients|1400
7515021|NCT02982863|26090789|P3|Overall Study|Not eligible patients|1852
7515022|NCT02982863|26090790|P2|Overall Study|Not eligible patients|4261
7515023|NCT02982863|26090791|P1|Overall Study|Not eligible patients|809
7515024|NCT02982772|26090850|P2|12M Follow-Up|Lost to Follow-up|5
7515025|NCT02982772|26090851|P1|12M Follow-Up|Lost to Follow-up|11
7515026|NCT02982772|26090850|P2|6M Follow-Up|Lost to Follow-up|9
7515027|NCT02982772|26090851|P1|6M Follow-Up|Lost to Follow-up|11
7515028|NCT02982772|26090850|P2|3M Follow-Up|Lost to Follow-up|11
7515029|NCT02982772|26090851|P1|3M Follow-Up|Lost to Follow-up|17
7515030|NCT02982772|26090850|P2|1M Follow-Up|Lost to Follow-up|18
7515031|NCT02982772|26090851|P1|1M Follow-Up|Lost to Follow-up|21
7515032|NCT02982772|26090850|P2|Intervention|Lost to Follow-up|13
7515033|NCT02982772|26090851|P1|Intervention|Lost to Follow-up|19
7515034|NCT02982720|26090875|P1|Overall Study|Death|1
7515035|NCT02982720|26090875|P1|Overall Study|Adverse Event|3
7515036|NCT02982590|26090885|P2|Overall Study|Death|0
7515037|NCT02982590|26090886|P1|Overall Study|Death|4
7515038|NCT02982590|26090885|P2|Overall Study|Lost to Follow-up|1
7515039|NCT02982590|26090886|P1|Overall Study|Lost to Follow-up|0
7515040|NCT02982239|26090900|P2|Overall Study|Lost to Follow-up|2
7515041|NCT02982239|26090901|P1|Overall Study|Lost to Follow-up|3
7515042|NCT02982213|26090917|P2|Overall Study|Did not complete follow up questionnaire|1
7515043|NCT02982213|26090918|P1|Overall Study|Did not complete follow up questionnaire|5
7515044|NCT02982187|26090934|P8|Overall Study|Withdrawal by Subject|0
7515045|NCT02982187|26090935|P7|Overall Study|Withdrawal by Subject|1
7515046|NCT02982187|26090936|P6|Overall Study|Withdrawal by Subject|0
7515047|NCT02982187|26090937|P5|Overall Study|Withdrawal by Subject|0
7515048|NCT02982187|26090938|P4|Overall Study|Withdrawal by Subject|0
7515049|NCT02982187|26090939|P3|Overall Study|Withdrawal by Subject|0
7515050|NCT02982187|26090940|P2|Overall Study|Withdrawal by Subject|0
7515051|NCT02982187|26090941|P1|Overall Study|Withdrawal by Subject|0
7515052|NCT02982018|26090991|P2|Overall Study|Withdrawal by Subject|1
7515053|NCT02982018|26090992|P1|Overall Study|Withdrawal by Subject|0
7515054|NCT02982018|26090991|P2|Overall Study|Lens Discomfort|0
7515055|NCT02982018|26090992|P1|Overall Study|Lens Discomfort|2
7515056|NCT02982018|26090991|P2|Overall Study|Adverse Event|1
7515057|NCT02982018|26090992|P1|Overall Study|Adverse Event|1
7515058|NCT02982018|26090991|P2|Overall Study|Protocol Violation|1
7515059|NCT02982018|26090992|P1|Overall Study|Protocol Violation|1
7515060|NCT02982018|26090991|P2|Overall Study|Incorrect Lens Dispensed|0
7515061|NCT02982018|26090992|P1|Overall Study|Incorrect Lens Dispensed|1
7515062|NCT02981953|26091006|P1|Overall Study|Withdrawal to non-compliance|1
7515063|NCT02981953|26091006|P1|Overall Study|Withdrawal by Subject|1
7515064|NCT02981953|26091006|P1|Overall Study|Death|9
7515065|NCT02981602|26091042|P5|Overall Study|Adverse Event|0
7515066|NCT02981602|26091043|P4|Overall Study|Adverse Event|1
7515067|NCT02981602|26091044|P3|Overall Study|Adverse Event|0
7515068|NCT02981602|26091045|P2|Overall Study|Adverse Event|0
7515069|NCT02981602|26091046|P1|Overall Study|Adverse Event|0
7515070|NCT02981524|26091226|P1|Overall Study|Withdrawal by Subject|1
7515071|NCT02981524|26091226|P1|Overall Study|Treatment Related Toxicity|1
7515072|NCT02981524|26091226|P1|Overall Study|Death (unrelated)|1
7515073|NCT02981524|26091226|P1|Overall Study|Progressive Disease|14
7515074|NCT02981342|26091291|P4|Overall Study|Lost to Follow-up|0
7515075|NCT02981342|26091292|P3|Overall Study|Lost to Follow-up|0
7515076|NCT02981342|26091293|P2|Overall Study|Lost to Follow-up|1
7515077|NCT02981342|26091294|P1|Overall Study|Lost to Follow-up|0
7515078|NCT02981342|26091291|P4|Overall Study|Randomized, Never Treated|7
7515079|NCT02981342|26091292|P3|Overall Study|Randomized, Never Treated|0
7515080|NCT02981342|26091293|P2|Overall Study|Randomized, Never Treated|1
7515081|NCT02981342|26091294|P1|Overall Study|Randomized, Never Treated|0
7515082|NCT02981342|26091291|P4|Overall Study|Study closed by sponsor|1
7515083|NCT02981342|26091292|P3|Overall Study|Study closed by sponsor|1
7515084|NCT02981342|26091293|P2|Overall Study|Study closed by sponsor|0
7515085|NCT02981342|26091294|P1|Overall Study|Study closed by sponsor|0
7515086|NCT02981342|26091291|P4|Overall Study|Withdrawal by Subject|1
7515087|NCT02981342|26091292|P3|Overall Study|Withdrawal by Subject|3
7515088|NCT02981342|26091293|P2|Overall Study|Withdrawal by Subject|0
7515089|NCT02981342|26091294|P1|Overall Study|Withdrawal by Subject|0
7515090|NCT02981342|26091291|P4|Overall Study|Death|4
7515091|NCT02981342|26091292|P3|Overall Study|Death|9
7515092|NCT02981342|26091293|P2|Overall Study|Death|9
7515093|NCT02981342|26091294|P1|Overall Study|Death|0
7515094|NCT02981342|26091291|P4|Overall Study|Adverse Event|1
7515095|NCT02981342|26091292|P3|Overall Study|Adverse Event|0
7515096|NCT02981342|26091293|P2|Overall Study|Adverse Event|0
7515097|NCT02981342|26091294|P1|Overall Study|Adverse Event|0
7515098|NCT02980874|26091354|P2|Overall Study|Unknown study completion status|0
7515099|NCT02980874|26091355|P1|Overall Study|Unknown study completion status|1
7515100|NCT02980874|26091354|P2|Overall Study|Includes premature discontinuation due to study termination.|88
7515101|NCT02980874|26091355|P1|Overall Study|Includes premature discontinuation due to study termination.|88
7515102|NCT02980874|26091354|P2|Overall Study|Lost to Follow-up|5
7515103|NCT02980874|26091355|P1|Overall Study|Lost to Follow-up|5
7515104|NCT02980874|26091354|P2|Overall Study|Withdrawal by Subject|2
7515105|NCT02980874|26091355|P1|Overall Study|Withdrawal by Subject|7
7515106|NCT02980874|26091354|P2|Overall Study|Adverse Event|7
7515107|NCT02980874|26091355|P1|Overall Study|Adverse Event|2
7515108|NCT02980783|26091365|P1|Overall Study|Lost to Follow-up|1
7515109|NCT02980705|26091378|P2|Overall Study|Lost to Follow-up|0
7515110|NCT02980705|26091379|P1|Overall Study|Lost to Follow-up|2
7515111|NCT02980705|26091378|P2|Overall Study|withdrew participation|1
7515112|NCT02980705|26091379|P1|Overall Study|withdrew participation|0
7515113|NCT02980705|26091378|P2|Overall Study|Withdrawal by Subject|9
7515114|NCT02980705|26091379|P1|Overall Study|Withdrawal by Subject|6
7515115|NCT02980705|26091378|P2|Overall Study|Adverse Event|1
7515116|NCT02980705|26091379|P1|Overall Study|Adverse Event|0
7515117|NCT02980692|26091393|P5|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
7515118|NCT02980692|26091394|P4|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7515119|NCT02980692|26091395|P3|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7515120|NCT02980692|26091396|P2|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7515121|NCT02980692|26091397|P1|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7515122|NCT02980692|26091393|P5|Overall Study|RELOCATION|1
7515123|NCT02980692|26091394|P4|Overall Study|RELOCATION|0
7515124|NCT02980692|26091395|P3|Overall Study|RELOCATION|0
7515125|NCT02980692|26091396|P2|Overall Study|RELOCATION|0
7515126|NCT02980692|26091397|P1|Overall Study|RELOCATION|0
7515127|NCT02980692|26091393|P5|Overall Study|Lack of Efficacy|0
7515128|NCT02980692|26091394|P4|Overall Study|Lack of Efficacy|1
7515129|NCT02980692|26091395|P3|Overall Study|Lack of Efficacy|0
7515130|NCT02980692|26091396|P2|Overall Study|Lack of Efficacy|0
7515131|NCT02980692|26091397|P1|Overall Study|Lack of Efficacy|0
7515132|NCT02980692|26091393|P5|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7515133|NCT02980692|26091394|P4|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7515134|NCT02980692|26091395|P3|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
7515135|NCT02980692|26091396|P2|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7515136|NCT02980692|26091397|P1|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7515137|NCT02980692|26091393|P5|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7515138|NCT02980692|26091394|P4|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7515139|NCT02980692|26091395|P3|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7515140|NCT02980692|26091396|P2|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
7515141|NCT02980692|26091397|P1|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7515142|NCT02980692|26091393|P5|Overall Study|NON COMPLIANCE|0
7515143|NCT02980692|26091394|P4|Overall Study|NON COMPLIANCE|0
7515144|NCT02980692|26091395|P3|Overall Study|NON COMPLIANCE|0
7515145|NCT02980692|26091396|P2|Overall Study|NON COMPLIANCE|0
7515146|NCT02980692|26091397|P1|Overall Study|NON COMPLIANCE|1
7515147|NCT02980692|26091393|P5|Overall Study|Physician Decision|0
7515148|NCT02980692|26091394|P4|Overall Study|Physician Decision|1
7515149|NCT02980692|26091395|P3|Overall Study|Physician Decision|1
7515150|NCT02980692|26091396|P2|Overall Study|Physician Decision|0
7515151|NCT02980692|26091397|P1|Overall Study|Physician Decision|0
7515152|NCT02980692|26091393|P5|Overall Study|Death|0
7515153|NCT02980692|26091394|P4|Overall Study|Death|0
7515154|NCT02980692|26091395|P3|Overall Study|Death|0
7515155|NCT02980692|26091396|P2|Overall Study|Death|0
7515156|NCT02980692|26091397|P1|Overall Study|Death|1
7515157|NCT02980692|26091393|P5|Overall Study|Lost to Follow-up|1
7515158|NCT02980692|26091394|P4|Overall Study|Lost to Follow-up|1
7515159|NCT02980692|26091395|P3|Overall Study|Lost to Follow-up|4
7515160|NCT02980692|26091396|P2|Overall Study|Lost to Follow-up|0
7515161|NCT02980692|26091397|P1|Overall Study|Lost to Follow-up|3
7515162|NCT02980692|26091393|P5|Overall Study|Withdrawal by Subject|7
7515163|NCT02980692|26091394|P4|Overall Study|Withdrawal by Subject|6
7515164|NCT02980692|26091395|P3|Overall Study|Withdrawal by Subject|6
7515165|NCT02980692|26091396|P2|Overall Study|Withdrawal by Subject|3
7515166|NCT02980692|26091397|P1|Overall Study|Withdrawal by Subject|4
7515167|NCT02980692|26091393|P5|Overall Study|Adverse Event|1
7515168|NCT02980692|26091394|P4|Overall Study|Adverse Event|0
7515169|NCT02980692|26091395|P3|Overall Study|Adverse Event|0
7515170|NCT02980692|26091396|P2|Overall Study|Adverse Event|2
7515171|NCT02980692|26091397|P1|Overall Study|Adverse Event|0
7515172|NCT02980601|26091581|P2|Overall Study|Failed to sign consent|0
7515173|NCT02980601|26091582|P1|Overall Study|Failed to sign consent|2
7515174|NCT02980601|26091581|P2|Overall Study|Graft loss|0
7515175|NCT02980601|26091582|P1|Overall Study|Graft loss|1
7515176|NCT02980601|26091581|P2|Overall Study|Death|1
7515177|NCT02980601|26091582|P1|Overall Study|Death|0
7515178|NCT02980601|26091581|P2|Overall Study|Lost to Follow-up|2
7515179|NCT02980601|26091582|P1|Overall Study|Lost to Follow-up|2
7515180|NCT02980523|26091675|P5|Overall Study|Did not receive intervention|0
7515181|NCT02980523|26091676|P4|Overall Study|Did not receive intervention|1
7515182|NCT02980523|26091677|P3|Overall Study|Did not receive intervention|0
7515183|NCT02980523|26091678|P2|Overall Study|Did not receive intervention|0
7515184|NCT02980523|26091679|P1|Overall Study|Did not receive intervention|0
7515185|NCT02980523|26091675|P5|Overall Study|Lack of Efficacy|8
7515186|NCT02980523|26091676|P4|Overall Study|Lack of Efficacy|5
7515187|NCT02980523|26091677|P3|Overall Study|Lack of Efficacy|4
7515188|NCT02980523|26091678|P2|Overall Study|Lack of Efficacy|4
7515189|NCT02980523|26091679|P1|Overall Study|Lack of Efficacy|1
7515190|NCT02980523|26091675|P5|Overall Study|Excluded from analysis|1
7515191|NCT02980523|26091676|P4|Overall Study|Excluded from analysis|1
7515192|NCT02980523|26091677|P3|Overall Study|Excluded from analysis|1
7515193|NCT02980523|26091678|P2|Overall Study|Excluded from analysis|3
7515194|NCT02980523|26091679|P1|Overall Study|Excluded from analysis|1
7515195|NCT02980523|26091675|P5|Overall Study|Lost to Follow-up|1
7515196|NCT02980523|26091676|P4|Overall Study|Lost to Follow-up|2
7515197|NCT02980523|26091677|P3|Overall Study|Lost to Follow-up|1
7515198|NCT02980523|26091678|P2|Overall Study|Lost to Follow-up|4
7515199|NCT02980523|26091679|P1|Overall Study|Lost to Follow-up|1
7515200|NCT02980224|26091723|P2|Overall Study|Withdrawal by Subject|2
7515201|NCT02980224|26091724|P1|Overall Study|Withdrawal by Subject|0
7515202|NCT02980224|26091723|P2|Overall Study|Adverse Event|1
7515203|NCT02980224|26091724|P1|Overall Study|Adverse Event|4
7515204|NCT02980133|26091742|P4|Overall Study|Withdrawal by Subject|0
7515205|NCT02980133|26091743|P3|Overall Study|Withdrawal by Subject|1
7515206|NCT02980133|26091744|P2|Overall Study|Withdrawal by Subject|0
7515207|NCT02980133|26091745|P1|Overall Study|Withdrawal by Subject|0
7515208|NCT02980133|26091742|P4|Overall Study|Withdrawal by parent/guardian|1
7515209|NCT02980133|26091743|P3|Overall Study|Withdrawal by parent/guardian|3
7515210|NCT02980133|26091744|P2|Overall Study|Withdrawal by parent/guardian|3
7515211|NCT02980133|26091745|P1|Overall Study|Withdrawal by parent/guardian|6
7515212|NCT02980133|26091742|P4|Overall Study|Protocol Violation|0
7515213|NCT02980133|26091743|P3|Overall Study|Protocol Violation|0
7515214|NCT02980133|26091744|P2|Overall Study|Protocol Violation|1
7515215|NCT02980133|26091745|P1|Overall Study|Protocol Violation|0
7515216|NCT02980133|26091742|P4|Overall Study|Lost to Follow-up|3
7515217|NCT02980133|26091743|P3|Overall Study|Lost to Follow-up|1
7515218|NCT02980133|26091744|P2|Overall Study|Lost to Follow-up|0
7515219|NCT02980133|26091745|P1|Overall Study|Lost to Follow-up|0
7515220|NCT02980133|26091742|P4|Overall Study|Other than specified|2
7515221|NCT02980133|26091743|P3|Overall Study|Other than specified|2
7515222|NCT02980133|26091744|P2|Overall Study|Other than specified|1
7515223|NCT02980133|26091745|P1|Overall Study|Other than specified|1
7515224|NCT02980107|26091783|P2|Overall Study|Withdrawal by Subject|62
7515225|NCT02980107|26091784|P1|Overall Study|Withdrawal by Subject|51
7515226|NCT02980042|26091798|P2|Overall Study|Insurance issues/treatment plan changes|0
7515227|NCT02980042|26091799|P1|Overall Study|Insurance issues/treatment plan changes|2
7515228|NCT02980042|26091798|P2|Overall Study|Lost to Follow-up|0
7515229|NCT02980042|26091799|P1|Overall Study|Lost to Follow-up|5
7515230|NCT02979639|26091916|P1|Overall Study|Adverse Event|2
7515231|NCT02979639|26091916|P1|Overall Study|Withdrawal by Subject|3
7515232|NCT02979639|26091916|P1|Overall Study|Lost to Follow-up|8
7515233|NCT02979639|26091916|P1|Overall Study|Withdrawal based on medical judgement|1
7515234|NCT02979613|26091971|P2|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
7515235|NCT02979613|26091972|P1|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
7515236|NCT02979613|26091971|P2|Open-Label Extension (OLE) Phase|Death|1
7515237|NCT02979613|26091972|P1|Open-Label Extension (OLE) Phase|Death|0
7515238|NCT02979613|26091971|P2|Open-Label Extension (OLE) Phase|Adverse Event|0
7515239|NCT02979613|26091972|P1|Open-Label Extension (OLE) Phase|Adverse Event|1
7515240|NCT02979613|26091971|P2|Open-Label Extension (OLE) Phase|Withdrew Consent|4
7515241|NCT02979613|26091972|P1|Open-Label Extension (OLE) Phase|Withdrew Consent|2
7515242|NCT02979613|26091971|P2|Double-Blind Phase|Randomized but Never Treated|0
7515243|NCT02979613|26091972|P1|Double-Blind Phase|Randomized but Never Treated|2
7515244|NCT02979613|26091971|P2|Double-Blind Phase|Protocol Violation|1
7515245|NCT02979613|26091972|P1|Double-Blind Phase|Protocol Violation|1
7515246|NCT02979613|26091971|P2|Double-Blind Phase|Lost to Follow-up|1
7515247|NCT02979613|26091972|P1|Double-Blind Phase|Lost to Follow-up|1
7515248|NCT02979613|26091971|P2|Double-Blind Phase|Adverse Event|0
7515249|NCT02979613|26091972|P1|Double-Blind Phase|Adverse Event|2
7515250|NCT02979613|26091971|P2|Double-Blind Phase|Pregnancy|2
7515251|NCT02979613|26091972|P1|Double-Blind Phase|Pregnancy|2
7515252|NCT02979613|26091971|P2|Double-Blind Phase|Withdrew Consent|4
7515253|NCT02979613|26091972|P1|Double-Blind Phase|Withdrew Consent|2
7515254|NCT02979535|26092032|P2|Overall Study|Lost to Follow-up|1
7515255|NCT02979535|26092033|P1|Overall Study|Lost to Follow-up|6
7515256|NCT02979535|26092032|P2|Overall Study|Consent withdrawn by participant|18
7515257|NCT02979535|26092033|P1|Overall Study|Consent withdrawn by participant|11
7515258|NCT02979535|26092032|P2|Overall Study|Non compliance with the protocol|82
7515259|NCT02979535|26092033|P1|Overall Study|Non compliance with the protocol|78
7515260|NCT02979431|26092111|P4|Overall Study|Subject left country after Day14|0
7515261|NCT02979431|26092112|P3|Overall Study|Subject left country after Day14|0
7515262|NCT02979431|26092113|P2|Overall Study|Subject left country after Day14|0
7515263|NCT02979431|26092114|P1|Overall Study|Subject left country after Day14|1
7515264|NCT02979431|26092111|P4|Overall Study|Adverse Event|0
7515265|NCT02979431|26092112|P3|Overall Study|Adverse Event|1
7515266|NCT02979431|26092113|P2|Overall Study|Adverse Event|0
7515267|NCT02979431|26092114|P1|Overall Study|Adverse Event|0
7515268|NCT02979431|26092111|P4|Overall Study|Randomized but received no study drug|0
7515269|NCT02979431|26092112|P3|Overall Study|Randomized but received no study drug|0
7515270|NCT02979431|26092113|P2|Overall Study|Randomized but received no study drug|1
7515271|NCT02979431|26092114|P1|Overall Study|Randomized but received no study drug|1
7515272|NCT02979431|26092111|P4|Overall Study|Parent/guardian withdrew consent|1
7515273|NCT02979431|26092112|P3|Overall Study|Parent/guardian withdrew consent|1
7515274|NCT02979431|26092113|P2|Overall Study|Parent/guardian withdrew consent|1
7515275|NCT02979431|26092114|P1|Overall Study|Parent/guardian withdrew consent|2
7515276|NCT02979249|26092192|P1|Overall Study|Withdrawal by Subject|4
7515277|NCT02979249|26092192|P1|Overall Study|Lost to Follow-up|2
7515278|NCT02979197|26092200|P3|Overall Study|Subject unable to commit to study dates|0
7515279|NCT02979197|26092201|P2|Overall Study|Subject unable to commit to study dates|1
7515280|NCT02979197|26092202|P1|Overall Study|Subject unable to commit to study dates|0
7515281|NCT02979197|26092200|P3|Overall Study|Protocol Violation|0
7515282|NCT02979197|26092201|P2|Overall Study|Protocol Violation|1
7515283|NCT02979197|26092202|P1|Overall Study|Protocol Violation|0
7515284|NCT02979197|26092200|P3|Overall Study|Adverse Event|0
7515285|NCT02979197|26092201|P2|Overall Study|Adverse Event|2
7515286|NCT02979197|26092202|P1|Overall Study|Adverse Event|4
7515287|NCT02978833|26092268|P2|Overall Study|Study terminated|1
7515288|NCT02978833|26092269|P1|Overall Study|Study terminated|1
7515289|NCT02978781|26092288|P5|Part C|Tremor not improved due to Topamax discontinuation|1
7515290|NCT02978781|26092289|P4|Part C|Tremor not improved due to Topamax discontinuation|0
7515291|NCT02978781|26092290|P3|Part C|Tremor not improved due to Topamax discontinuation|0
7515292|NCT02978781|26092291|P2|Part C|Tremor not improved due to Topamax discontinuation|0
7515293|NCT02978781|26092292|P1|Part C|Tremor not improved due to Topamax discontinuation|0
7515294|NCT02978781|26092288|P5|Part C|Withdrawal by Subject|1
7515295|NCT02978781|26092289|P4|Part C|Withdrawal by Subject|0
7515296|NCT02978781|26092290|P3|Part C|Withdrawal by Subject|0
7515297|NCT02978781|26092291|P2|Part C|Withdrawal by Subject|0
7515298|NCT02978781|26092292|P1|Part C|Withdrawal by Subject|0
7515299|NCT02978781|26092288|P5|Part C|Adverse Event|2
7515300|NCT02978781|26092289|P4|Part C|Adverse Event|0
7515301|NCT02978781|26092290|P3|Part C|Adverse Event|0
7515302|NCT02978781|26092291|P2|Part C|Adverse Event|0
7515303|NCT02978781|26092292|P1|Part C|Adverse Event|0
7515304|NCT02978781|26092288|P5|Part B|Withdrawal by Subject|0
7515305|NCT02978781|26092289|P4|Part B|Withdrawal by Subject|1
7515306|NCT02978781|26092290|P3|Part B|Withdrawal by Subject|0
7515307|NCT02978781|26092291|P2|Part B|Withdrawal by Subject|0
7515308|NCT02978781|26092292|P1|Part B|Withdrawal by Subject|0
7515309|NCT02978781|26092288|P5|Part A|Withdrawal by Subject|0
7515310|NCT02978781|26092289|P4|Part A|Withdrawal by Subject|0
7515311|NCT02978781|26092290|P3|Part A|Withdrawal by Subject|0
7515312|NCT02978781|26092291|P2|Part A|Withdrawal by Subject|1
7515313|NCT02978781|26092292|P1|Part A|Withdrawal by Subject|0
7515314|NCT02978781|26092288|P5|Part A|Adverse Event|0
7515315|NCT02978781|26092289|P4|Part A|Adverse Event|0
7515316|NCT02978781|26092290|P3|Part A|Adverse Event|0
7515317|NCT02978781|26092291|P2|Part A|Adverse Event|1
7515318|NCT02978781|26092292|P1|Part A|Adverse Event|1
7515319|NCT02978417|26092373|P2|Overall Study|Lost to Follow-up|2
7515320|NCT02978417|26092374|P1|Overall Study|Lost to Follow-up|2
7515321|NCT02977572|26092460|P2|Overall Study|Exclusion criterion|2
7515322|NCT02977572|26092461|P1|Overall Study|Exclusion criterion|2
7515323|NCT02977507|26092483|P2|Overall Study|Lost to Follow-up|0
7515324|NCT02977507|26092484|P1|Overall Study|Lost to Follow-up|1
7515325|NCT02977507|26092483|P2|Overall Study|Protocol Deviation|0
7515326|NCT02977507|26092484|P1|Overall Study|Protocol Deviation|1
7515327|NCT02976519|26092514|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
7515328|NCT02976519|26092515|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7515329|NCT02976519|26092516|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7515330|NCT02976519|26092517|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7515331|NCT02976519|26092518|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7515332|NCT02976519|26092519|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7515333|NCT02976519|26092520|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7515334|NCT02976519|26092514|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
7515335|NCT02976519|26092515|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7515336|NCT02976519|26092516|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7515337|NCT02976519|26092517|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7515338|NCT02976519|26092518|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7515339|NCT02976519|26092519|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7515340|NCT02976519|26092520|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7515341|NCT02976519|26092514|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
7515342|NCT02976519|26092515|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
7515343|NCT02976519|26092516|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
7515344|NCT02976519|26092517|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
7515345|NCT02976519|26092518|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
7515346|NCT02976519|26092519|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
7515347|NCT02976519|26092520|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
7515348|NCT02976519|26092514|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7515349|NCT02976519|26092515|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7515350|NCT02976519|26092516|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7515351|NCT02976519|26092517|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
7515352|NCT02976519|26092518|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7515353|NCT02976519|26092519|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7515354|NCT02976519|26092520|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7515355|NCT02976519|26092514|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7515356|NCT02976519|26092515|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7515357|NCT02976519|26092516|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7515358|NCT02976519|26092517|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7515359|NCT02976519|26092518|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7515360|NCT02976519|26092519|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
7515361|NCT02976519|26092520|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7515362|NCT02976103|26092551|P2|Overall Study|Lost to Follow-up|8
7515363|NCT02976103|26092552|P1|Overall Study|Lost to Follow-up|12
7515364|NCT02976103|26092551|P2|Overall Study|Withdrawal by Subject|0
7515365|NCT02976103|26092552|P1|Overall Study|Withdrawal by Subject|1
7515366|NCT02975973|26092607|P4|Overall Study|Adverse Event|0
7515367|NCT02975973|26092608|P3|Overall Study|Adverse Event|1
7515368|NCT02975973|26092609|P2|Overall Study|Adverse Event|1
7515369|NCT02975973|26092610|P1|Overall Study|Adverse Event|1
7515370|NCT02975700|26092673|P1|Overall Study|Failed screening criteria|2
7515371|NCT02975700|26092673|P1|Overall Study|Progressive disease|3
7515372|NCT02975700|26092673|P1|Overall Study|Adverse Event|1
7515373|NCT02975349|26092709|P6|Blinded Extension Period (24 Weeks)|Un-specified|0
7515374|NCT02975349|26092710|P5|Blinded Extension Period (24 Weeks)|Un-specified|0
7515375|NCT02975349|26092711|P4|Blinded Extension Period (24 Weeks)|Un-specified|1
7515376|NCT02975349|26092712|P3|Blinded Extension Period (24 Weeks)|Un-specified|0
7515377|NCT02975349|26092713|P2|Blinded Extension Period (24 Weeks)|Un-specified|0
7515378|NCT02975349|26092714|P1|Blinded Extension Period (24 Weeks)|Un-specified|0
7515379|NCT02975349|26092709|P6|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7515380|NCT02975349|26092710|P5|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7515381|NCT02975349|26092711|P4|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7515382|NCT02975349|26092712|P3|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7515383|NCT02975349|26092713|P2|Blinded Extension Period (24 Weeks)|Progressive Disease|1
7515384|NCT02975349|26092714|P1|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7515385|NCT02975349|26092709|P6|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7515386|NCT02975349|26092710|P5|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7515387|NCT02975349|26092711|P4|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7515388|NCT02975349|26092712|P3|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
7515389|NCT02975349|26092713|P2|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7515390|NCT02975349|26092714|P1|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7515391|NCT02975349|26092709|P6|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7515392|NCT02975349|26092710|P5|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7515393|NCT02975349|26092711|P4|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7515394|NCT02975349|26092712|P3|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
7515395|NCT02975349|26092713|P2|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
7515396|NCT02975349|26092714|P1|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7515397|NCT02975349|26092709|P6|Blinded Extension Period (24 Weeks)|Adverse Event|0
7515398|NCT02975349|26092710|P5|Blinded Extension Period (24 Weeks)|Adverse Event|1
7515399|NCT02975349|26092711|P4|Blinded Extension Period (24 Weeks)|Adverse Event|2
7515400|NCT02975349|26092712|P3|Blinded Extension Period (24 Weeks)|Adverse Event|1
7515401|NCT02975349|26092713|P2|Blinded Extension Period (24 Weeks)|Adverse Event|1
7515402|NCT02975349|26092714|P1|Blinded Extension Period (24 Weeks)|Adverse Event|0
7515403|NCT02975349|26092709|P6|Active Treatment Period (24 Weeks)|Un-specified|0
7515404|NCT02975349|26092710|P5|Active Treatment Period (24 Weeks)|Un-specified|0
7515405|NCT02975349|26092711|P4|Active Treatment Period (24 Weeks)|Un-specified|0
7515406|NCT02975349|26092712|P3|Active Treatment Period (24 Weeks)|Un-specified|1
7515407|NCT02975349|26092713|P2|Active Treatment Period (24 Weeks)|Un-specified|0
7515408|NCT02975349|26092714|P1|Active Treatment Period (24 Weeks)|Un-specified|0
7515409|NCT02975349|26092709|P6|Active Treatment Period (24 Weeks)|Adverse Event|2
7515410|NCT02975349|26092710|P5|Active Treatment Period (24 Weeks)|Adverse Event|6
7515411|NCT02975349|26092711|P4|Active Treatment Period (24 Weeks)|Adverse Event|2
7515412|NCT02975349|26092712|P3|Active Treatment Period (24 Weeks)|Adverse Event|1
7515413|NCT02975349|26092713|P2|Active Treatment Period (24 Weeks)|Adverse Event|0
7515414|NCT02975349|26092714|P1|Active Treatment Period (24 Weeks)|Adverse Event|4
7515415|NCT02975349|26092709|P6|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7515416|NCT02975349|26092710|P5|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7515417|NCT02975349|26092711|P4|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7515418|NCT02975349|26092712|P3|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7515419|NCT02975349|26092713|P2|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7515420|NCT02975349|26092714|P1|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
7515421|NCT02975349|26092709|P6|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7515422|NCT02975349|26092710|P5|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7515423|NCT02975349|26092711|P4|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7515424|NCT02975349|26092712|P3|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7515425|NCT02975349|26092713|P2|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7515426|NCT02975349|26092714|P1|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7515427|NCT02975336|26092849|P8|LTE (104 Weeks)|Other|72
7515428|NCT02975336|26092850|P7|LTE (104 Weeks)|Other|76
7515429|NCT02975336|26092851|P6|LTE (104 Weeks)|Other|63
7515430|NCT02975336|26092852|P5|LTE (104 Weeks)|Other|55
7515431|NCT02975336|26092853|P4|LTE (104 Weeks)|Other|0
7515432|NCT02975336|26092854|P3|LTE (104 Weeks)|Other|0
7515433|NCT02975336|26092855|P2|LTE (104 Weeks)|Other|0
7515434|NCT02975336|26092856|P1|LTE (104 Weeks)|Other|0
7515435|NCT02975336|26092849|P8|LTE (104 Weeks)|Lack of Efficacy|0
7515436|NCT02975336|26092850|P7|LTE (104 Weeks)|Lack of Efficacy|2
7515437|NCT02975336|26092851|P6|LTE (104 Weeks)|Lack of Efficacy|1
7515438|NCT02975336|26092852|P5|LTE (104 Weeks)|Lack of Efficacy|0
7515439|NCT02975336|26092853|P4|LTE (104 Weeks)|Lack of Efficacy|0
7515440|NCT02975336|26092854|P3|LTE (104 Weeks)|Lack of Efficacy|0
7515441|NCT02975336|26092855|P2|LTE (104 Weeks)|Lack of Efficacy|0
7515442|NCT02975336|26092856|P1|LTE (104 Weeks)|Lack of Efficacy|0
7515443|NCT02975336|26092849|P8|LTE (104 Weeks)|Lost to Follow-up|0
7515444|NCT02975336|26092850|P7|LTE (104 Weeks)|Lost to Follow-up|0
7515445|NCT02975336|26092851|P6|LTE (104 Weeks)|Lost to Follow-up|1
7515446|NCT02975336|26092852|P5|LTE (104 Weeks)|Lost to Follow-up|0
7515447|NCT02975336|26092853|P4|LTE (104 Weeks)|Lost to Follow-up|0
7515448|NCT02975336|26092854|P3|LTE (104 Weeks)|Lost to Follow-up|0
7515449|NCT02975336|26092855|P2|LTE (104 Weeks)|Lost to Follow-up|0
7515450|NCT02975336|26092856|P1|LTE (104 Weeks)|Lost to Follow-up|0
7515451|NCT02975336|26092849|P8|LTE (104 Weeks)|Adverse Event|0
7515452|NCT02975336|26092850|P7|LTE (104 Weeks)|Adverse Event|2
7515453|NCT02975336|26092851|P6|LTE (104 Weeks)|Adverse Event|4
7515454|NCT02975336|26092852|P5|LTE (104 Weeks)|Adverse Event|7
7515455|NCT02975336|26092853|P4|LTE (104 Weeks)|Adverse Event|0
7515456|NCT02975336|26092854|P3|LTE (104 Weeks)|Adverse Event|0
7515457|NCT02975336|26092855|P2|LTE (104 Weeks)|Adverse Event|0
7515458|NCT02975336|26092856|P1|LTE (104 Weeks)|Adverse Event|0
7515459|NCT02975336|26092849|P8|DBPC (52 Weeks)|Premature termination of the study|0
7515460|NCT02975336|26092850|P7|DBPC (52 Weeks)|Premature termination of the study|0
7515461|NCT02975336|26092851|P6|DBPC (52 Weeks)|Premature termination of the study|0
7515462|NCT02975336|26092852|P5|DBPC (52 Weeks)|Premature termination of the study|0
7515463|NCT02975336|26092853|P4|DBPC (52 Weeks)|Premature termination of the study|4
7515464|NCT02975336|26092854|P3|DBPC (52 Weeks)|Premature termination of the study|6
7515465|NCT02975336|26092855|P2|DBPC (52 Weeks)|Premature termination of the study|6
7515466|NCT02975336|26092856|P1|DBPC (52 Weeks)|Premature termination of the study|5
7515467|NCT02975336|26092849|P8|DBPC (52 Weeks)|Withdrawal by Subject|0
7515468|NCT02975336|26092850|P7|DBPC (52 Weeks)|Withdrawal by Subject|0
7515469|NCT02975336|26092851|P6|DBPC (52 Weeks)|Withdrawal by Subject|0
7515470|NCT02975336|26092852|P5|DBPC (52 Weeks)|Withdrawal by Subject|0
7515471|NCT02975336|26092853|P4|DBPC (52 Weeks)|Withdrawal by Subject|3
7515472|NCT02975336|26092854|P3|DBPC (52 Weeks)|Withdrawal by Subject|1
7515473|NCT02975336|26092855|P2|DBPC (52 Weeks)|Withdrawal by Subject|0
7515474|NCT02975336|26092856|P1|DBPC (52 Weeks)|Withdrawal by Subject|1
7515475|NCT02975336|26092849|P8|DBPC (52 Weeks)|Lack of Efficacy|0
7515476|NCT02975336|26092850|P7|DBPC (52 Weeks)|Lack of Efficacy|0
7515477|NCT02975336|26092851|P6|DBPC (52 Weeks)|Lack of Efficacy|0
7515478|NCT02975336|26092852|P5|DBPC (52 Weeks)|Lack of Efficacy|0
7515479|NCT02975336|26092853|P4|DBPC (52 Weeks)|Lack of Efficacy|3
7515480|NCT02975336|26092854|P3|DBPC (52 Weeks)|Lack of Efficacy|2
7515481|NCT02975336|26092855|P2|DBPC (52 Weeks)|Lack of Efficacy|4
7515482|NCT02975336|26092856|P1|DBPC (52 Weeks)|Lack of Efficacy|4
7515483|NCT02975336|26092849|P8|DBPC (52 Weeks)|Protocol Violation|0
7515484|NCT02975336|26092850|P7|DBPC (52 Weeks)|Protocol Violation|0
7515485|NCT02975336|26092851|P6|DBPC (52 Weeks)|Protocol Violation|0
7515486|NCT02975336|26092852|P5|DBPC (52 Weeks)|Protocol Violation|0
7515487|NCT02975336|26092853|P4|DBPC (52 Weeks)|Protocol Violation|1
7515488|NCT02975336|26092854|P3|DBPC (52 Weeks)|Protocol Violation|3
7515489|NCT02975336|26092855|P2|DBPC (52 Weeks)|Protocol Violation|1
7515490|NCT02975336|26092856|P1|DBPC (52 Weeks)|Protocol Violation|4
7515491|NCT02975336|26092849|P8|DBPC (52 Weeks)|Lost to Follow-up|0
7515492|NCT02975336|26092850|P7|DBPC (52 Weeks)|Lost to Follow-up|0
7515493|NCT02975336|26092851|P6|DBPC (52 Weeks)|Lost to Follow-up|0
7515494|NCT02975336|26092852|P5|DBPC (52 Weeks)|Lost to Follow-up|0
7515495|NCT02975336|26092853|P4|DBPC (52 Weeks)|Lost to Follow-up|4
7515496|NCT02975336|26092854|P3|DBPC (52 Weeks)|Lost to Follow-up|2
7515497|NCT02975336|26092855|P2|DBPC (52 Weeks)|Lost to Follow-up|1
7515498|NCT02975336|26092856|P1|DBPC (52 Weeks)|Lost to Follow-up|2
7515499|NCT02975336|26092849|P8|DBPC (52 Weeks)|Adverse Event|0
7515500|NCT02975336|26092850|P7|DBPC (52 Weeks)|Adverse Event|0
7515501|NCT02975336|26092851|P6|DBPC (52 Weeks)|Adverse Event|0
7515502|NCT02975336|26092852|P5|DBPC (52 Weeks)|Adverse Event|0
7515503|NCT02975336|26092853|P4|DBPC (52 Weeks)|Adverse Event|18
7515504|NCT02975336|26092854|P3|DBPC (52 Weeks)|Adverse Event|13
7515505|NCT02975336|26092855|P2|DBPC (52 Weeks)|Adverse Event|17
7515506|NCT02975336|26092856|P1|DBPC (52 Weeks)|Adverse Event|16
7515507|NCT02975206|26093118|P3|Overall Study|Other (e.g., lost to follow up)|6
7515508|NCT02975206|26093119|P2|Overall Study|Other (e.g., lost to follow up)|6
7515509|NCT02975206|26093120|P1|Overall Study|Other (e.g., lost to follow up)|13
7515510|NCT02975206|26093118|P3|Overall Study|Withdrawal by Subject|11
7515511|NCT02975206|26093119|P2|Overall Study|Withdrawal by Subject|11
7515512|NCT02975206|26093120|P1|Overall Study|Withdrawal by Subject|14
7515513|NCT02974868|26093137|P4|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
7515514|NCT02974868|26093138|P3|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
7515515|NCT02974868|26093139|P2|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
7515516|NCT02974868|26093140|P1|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
7515517|NCT02974868|26093137|P4|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
7515518|NCT02974868|26093138|P3|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
7515519|NCT02974868|26093139|P2|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
7515520|NCT02974868|26093140|P1|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
7515521|NCT02974868|26093137|P4|Initial 24-Week Treatment Period (TP)|others|8
7515522|NCT02974868|26093138|P3|Initial 24-Week Treatment Period (TP)|others|1
7515523|NCT02974868|26093139|P2|Initial 24-Week Treatment Period (TP)|others|8
7515524|NCT02974868|26093140|P1|Initial 24-Week Treatment Period (TP)|others|3
7515525|NCT02974868|26093137|P4|Initial 24-Week Treatment Period (TP)|Adverse Event|4
7515526|NCT02974868|26093138|P3|Initial 24-Week Treatment Period (TP)|Adverse Event|2
7515527|NCT02974868|26093139|P2|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7515528|NCT02974868|26093140|P1|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7515529|NCT02974855|26093262|P4|Overall Study|Adverse Event|1
7515530|NCT02974855|26093263|P3|Overall Study|Adverse Event|0
7515531|NCT02974855|26093264|P2|Overall Study|Adverse Event|1
7515532|NCT02974855|26093265|P1|Overall Study|Adverse Event|0
7515533|NCT02974842|26093451|P1|Overall Study|Screen failures|4
7515534|NCT02974842|26093451|P1|Overall Study|Withdrawal by Subject|4
7515535|NCT02974634|26093479|P2|Overall Study|Death|11
7515536|NCT02974634|26093480|P1|Overall Study|Death|8
7515537|NCT02974634|26093479|P2|Overall Study|intervention technology related issues|0
7515538|NCT02974634|26093480|P1|Overall Study|intervention technology related issues|5
7515539|NCT02974634|26093479|P2|Overall Study|Noncompliance|7
7515540|NCT02974634|26093480|P1|Overall Study|Noncompliance|3
7515541|NCT02974634|26093479|P2|Overall Study|Advanced disease|3
7515542|NCT02974634|26093480|P1|Overall Study|Advanced disease|12
7515543|NCT02974543|26093490|P2|Overall Study|Withdrawal by Subject|0
7515544|NCT02974543|26093491|P1|Overall Study|Withdrawal by Subject|1
7515545|NCT02974153|26093525|P3|Overall Study|Other|7
7515546|NCT02974153|26093526|P2|Overall Study|Other|8
7515547|NCT02974153|26093527|P1|Overall Study|Other|14
7515548|NCT02974153|26093525|P3|Overall Study|Study Burden|3
7515549|NCT02974153|26093526|P2|Overall Study|Study Burden|7
7515550|NCT02974153|26093527|P1|Overall Study|Study Burden|8
7515551|NCT02974153|26093525|P3|Overall Study|Withdrawal by Subject|11
7515552|NCT02974153|26093526|P2|Overall Study|Withdrawal by Subject|16
7515553|NCT02974153|26093527|P1|Overall Study|Withdrawal by Subject|9
7515554|NCT02974153|26093525|P3|Overall Study|Physician Decision|1
7515555|NCT02974153|26093526|P2|Overall Study|Physician Decision|2
7515556|NCT02974153|26093527|P1|Overall Study|Physician Decision|0
7515557|NCT02974153|26093525|P3|Overall Study|Lost to Follow-up|17
7515558|NCT02974153|26093526|P2|Overall Study|Lost to Follow-up|10
7515559|NCT02974153|26093527|P1|Overall Study|Lost to Follow-up|9
7515560|NCT02974153|26093525|P3|Overall Study|Lack of Efficacy|10
7515561|NCT02974153|26093526|P2|Overall Study|Lack of Efficacy|5
7515562|NCT02974153|26093527|P1|Overall Study|Lack of Efficacy|6
7515563|NCT02974153|26093525|P3|Overall Study|Adverse Event|1
7515564|NCT02974153|26093526|P2|Overall Study|Adverse Event|0
7515565|NCT02974153|26093527|P1|Overall Study|Adverse Event|6
7515566|NCT02974140|26093613|P1|Overall Study|Study Terminated by Sponsor|36
7515567|NCT02974140|26093613|P1|Overall Study|Lost to Follow-up|1
7515568|NCT02974140|26093613|P1|Overall Study|Adverse Event|2
7515569|NCT02974114|26093629|P3|Overall Study|Other (Not specified)|2
7515570|NCT02974114|26093630|P2|Overall Study|Other (Not specified)|1
7515571|NCT02974114|26093631|P1|Overall Study|Other (Not specified)|0
7515572|NCT02974088|26093674|P2|Overall Study|Adverse Event|1
7515573|NCT02974088|26093675|P1|Overall Study|Adverse Event|0
7515574|NCT02974088|26093674|P2|Overall Study|Lost to Follow-up|2
7515575|NCT02974088|26093675|P1|Overall Study|Lost to Follow-up|0
7515576|NCT02974010|26093685|P4|Overall Study|Lack of Efficacy|0
7515577|NCT02974010|26093686|P3|Overall Study|Lack of Efficacy|1
7515578|NCT02974010|26093687|P2|Overall Study|Lack of Efficacy|0
7515579|NCT02974010|26093688|P1|Overall Study|Lack of Efficacy|0
7515580|NCT02974010|26093685|P4|Overall Study|Completed day 42 but did not return for day 70|0
7515581|NCT02974010|26093686|P3|Overall Study|Completed day 42 but did not return for day 70|1
7515582|NCT02974010|26093687|P2|Overall Study|Completed day 42 but did not return for day 70|0
7515583|NCT02974010|26093688|P1|Overall Study|Completed day 42 but did not return for day 70|1
7515584|NCT02974010|26093685|P4|Overall Study|Adverse Event|0
7515585|NCT02974010|26093686|P3|Overall Study|Adverse Event|0
7515586|NCT02974010|26093687|P2|Overall Study|Adverse Event|1
7515587|NCT02974010|26093688|P1|Overall Study|Adverse Event|0
7515588|NCT02974010|26093685|P4|Overall Study|Withdrawal by Subject|0
7515589|NCT02974010|26093686|P3|Overall Study|Withdrawal by Subject|0
7515590|NCT02974010|26093687|P2|Overall Study|Withdrawal by Subject|1
7515591|NCT02974010|26093688|P1|Overall Study|Withdrawal by Subject|2
7515592|NCT02974010|26093685|P4|Overall Study|Lost to Follow-up|0
7515593|NCT02974010|26093686|P3|Overall Study|Lost to Follow-up|0
7515594|NCT02974010|26093687|P2|Overall Study|Lost to Follow-up|1
7515595|NCT02974010|26093688|P1|Overall Study|Lost to Follow-up|3
7515596|NCT02973802|26093698|P1|Overall Study|Withdrawal by Subject|1
7515597|NCT02973802|26093698|P1|Overall Study|Lost to Follow-up|1
7515598|NCT02973477|26093734|P2|Second Intervention|Lost to Follow-up|0
7515599|NCT02973477|26093735|P1|Second Intervention|Lost to Follow-up|1
7515600|NCT02973477|26093734|P2|Washout|Withdrawal by Subject|0
7515601|NCT02973477|26093735|P1|Washout|Withdrawal by Subject|1
7515602|NCT02973477|26093734|P2|First Intervention|Lost to Follow-up|2
7515603|NCT02973477|26093735|P1|First Intervention|Lost to Follow-up|0
7515604|NCT02973321|26093774|P5|Overall Study|Adverse Event|3
7515605|NCT02973321|26093775|P4|Overall Study|Adverse Event|13
7515606|NCT02973321|26093776|P3|Overall Study|Adverse Event|11
7515607|NCT02973321|26093777|P2|Overall Study|Adverse Event|10
7515608|NCT02973321|26093778|P1|Overall Study|Adverse Event|1
7515609|NCT02973321|26093774|P5|Overall Study|Lack of Efficacy|1
7515610|NCT02973321|26093775|P4|Overall Study|Lack of Efficacy|0
7515611|NCT02973321|26093776|P3|Overall Study|Lack of Efficacy|0
7515612|NCT02973321|26093777|P2|Overall Study|Lack of Efficacy|0
7515613|NCT02973321|26093778|P1|Overall Study|Lack of Efficacy|0
7515614|NCT02973321|26093774|P5|Overall Study|Other than specified|1
7515615|NCT02973321|26093775|P4|Overall Study|Other than specified|3
7515616|NCT02973321|26093776|P3|Overall Study|Other than specified|3
7515617|NCT02973321|26093777|P2|Overall Study|Other than specified|5
7515618|NCT02973321|26093778|P1|Overall Study|Other than specified|0
7515619|NCT02973100|26093840|P4|Overall Study|Failed to attend Safety followup period|0
7515620|NCT02973100|26093841|P3|Overall Study|Failed to attend Safety followup period|1
7515621|NCT02973100|26093842|P2|Overall Study|Failed to attend Safety followup period|0
7515622|NCT02973100|26093843|P1|Overall Study|Failed to attend Safety followup period|0
7515623|NCT02973100|26093840|P4|Overall Study|Notification of change in address|1
7515624|NCT02973100|26093841|P3|Overall Study|Notification of change in address|0
7515625|NCT02973100|26093842|P2|Overall Study|Notification of change in address|0
7515626|NCT02973100|26093843|P1|Overall Study|Notification of change in address|0
7515627|NCT02973100|26093840|P4|Overall Study|Withdrawal by Subject|4
7515628|NCT02973100|26093841|P3|Overall Study|Withdrawal by Subject|1
7515629|NCT02973100|26093842|P2|Overall Study|Withdrawal by Subject|5
7515630|NCT02973100|26093843|P1|Overall Study|Withdrawal by Subject|3
7515631|NCT02973100|26093840|P4|Overall Study|Lost to Follow-up|0
7515632|NCT02973100|26093841|P3|Overall Study|Lost to Follow-up|1
7515633|NCT02973100|26093842|P2|Overall Study|Lost to Follow-up|1
7515634|NCT02973100|26093843|P1|Overall Study|Lost to Follow-up|3
7515635|NCT02973100|26093840|P4|Overall Study|Adverse Event|2
7515636|NCT02973100|26093841|P3|Overall Study|Adverse Event|1
7515637|NCT02973100|26093842|P2|Overall Study|Adverse Event|2
7515638|NCT02973100|26093843|P1|Overall Study|Adverse Event|1
7515639|NCT02973087|26093881|P2|Overall Study|other|1
7515640|NCT02973087|26093882|P1|Overall Study|other|1
7515641|NCT02973087|26093881|P2|Overall Study|Adverse Event|0
7515642|NCT02973087|26093882|P1|Overall Study|Adverse Event|1
7515643|NCT02973087|26093881|P2|Overall Study|Withdrawal by Subject|1
7515644|NCT02973087|26093882|P1|Overall Study|Withdrawal by Subject|2
7515645|NCT02973048|26093986|P2|Overall Study|Withdrawal by Subject|3
7515646|NCT02973048|26093987|P1|Overall Study|Withdrawal by Subject|0
7515647|NCT02973048|26093986|P2|Overall Study|Epidural catheter insertion failure|0
7515648|NCT02973048|26093987|P1|Overall Study|Epidural catheter insertion failure|1
7515649|NCT02972658|26094039|P4|Overall Study|Sponsor Decision|119
7515650|NCT02972658|26094040|P3|Overall Study|Sponsor Decision|72
7515651|NCT02972658|26094041|P2|Overall Study|Sponsor Decision|127
7515652|NCT02972658|26094042|P1|Overall Study|Sponsor Decision|70
7515653|NCT02972658|26094039|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
7515654|NCT02972658|26094040|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
7515655|NCT02972658|26094041|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
7515656|NCT02972658|26094042|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
7515657|NCT02972658|26094039|P4|Overall Study|Withdrawal by Subject|6
7515658|NCT02972658|26094040|P3|Overall Study|Withdrawal by Subject|1
7515659|NCT02972658|26094041|P2|Overall Study|Withdrawal by Subject|4
7515660|NCT02972658|26094042|P1|Overall Study|Withdrawal by Subject|4
7515661|NCT02972658|26094039|P4|Overall Study|Progressive Disease|1
7515662|NCT02972658|26094040|P3|Overall Study|Progressive Disease|0
7515663|NCT02972658|26094041|P2|Overall Study|Progressive Disease|1
7515664|NCT02972658|26094042|P1|Overall Study|Progressive Disease|0
7515665|NCT02972658|26094039|P4|Overall Study|Lost to Follow-up|2
7515666|NCT02972658|26094040|P3|Overall Study|Lost to Follow-up|1
7515667|NCT02972658|26094041|P2|Overall Study|Lost to Follow-up|1
7515668|NCT02972658|26094042|P1|Overall Study|Lost to Follow-up|0
7515669|NCT02972658|26094039|P4|Overall Study|Death|1
7515670|NCT02972658|26094040|P3|Overall Study|Death|0
7515671|NCT02972658|26094041|P2|Overall Study|Death|0
7515672|NCT02972658|26094042|P1|Overall Study|Death|0
7515673|NCT02972658|26094039|P4|Overall Study|Other-determined by Investigator|0
7515674|NCT02972658|26094040|P3|Overall Study|Other-determined by Investigator|0
7515675|NCT02972658|26094041|P2|Overall Study|Other-determined by Investigator|1
7515676|NCT02972658|26094042|P1|Overall Study|Other-determined by Investigator|1
7515677|NCT02972658|26094039|P4|Overall Study|Adverse Event|2
7515678|NCT02972658|26094040|P3|Overall Study|Adverse Event|0
7515679|NCT02972658|26094041|P2|Overall Study|Adverse Event|3
7515680|NCT02972658|26094042|P1|Overall Study|Adverse Event|0
7515681|NCT02972632|26094072|P1|Overall Study|Voluntary Withdrawal|10
7515682|NCT02972632|26094072|P1|Overall Study|Lost to Follow-up|4
7515683|NCT02972632|26094072|P1|Overall Study|Pretreatment Event/Adverse Event|3
7515684|NCT02972515|26094102|P1|Overall Study|Lost to Follow-up|78
7515685|NCT02972502|26094111|P2|Overall Study|Withdrawal by Subject|1
7515686|NCT02972502|26094112|P1|Overall Study|Withdrawal by Subject|1
7515687|NCT02972502|26094111|P2|Overall Study|Lost to Follow-up|1
7515688|NCT02972502|26094112|P1|Overall Study|Lost to Follow-up|3
7515689|NCT02972359|26094122|P1|Overall Study|Missing|1
7515690|NCT02972359|26094122|P1|Overall Study|Other reasons|5
7515691|NCT02972359|26094122|P1|Overall Study|Lost to Follow-up|26
7515692|NCT02972359|26094122|P1|Overall Study|Protocol Violation|1
7515693|NCT02972359|26094122|P1|Overall Study|Withdrawal by Subject|30
7515694|NCT02972359|26094122|P1|Overall Study|Death|1
7515695|NCT02972359|26094122|P1|Overall Study|Adverse Event|4
7515696|NCT02972359|26094122|P1|Overall Study|Lack of Efficacy|1
7515697|NCT02972359|26094122|P1|Overall Study|Incl. criteria not met/Exclusion met|2
7515698|NCT02972242|26094135|P2|Overall Study|Withdrawal by Subject|0
7515699|NCT02972242|26094136|P1|Overall Study|Withdrawal by Subject|1
7515700|NCT02971800|26094189|P1|Overall Study|Number evaluable participant already reached|4
7515701|NCT02971800|26094189|P1|Overall Study|Exclusion criteria prior intervention|1
7515702|NCT02971800|26094189|P1|Overall Study|Withdrawal by Subject|1
7515703|NCT02971800|26094189|P1|Overall Study|Protocol Violation|1
7515704|NCT02971683|26094218|P2|Overall Study|Lack of Efficacy|2
7515705|NCT02971683|26094219|P1|Overall Study|Lack of Efficacy|2
7515706|NCT02971683|26094218|P2|Overall Study|Adverse Event|2
7515707|NCT02971683|26094219|P1|Overall Study|Adverse Event|1
7515708|NCT02971683|26094218|P2|Overall Study|Participant request to discontinue study treatment|1
7515709|NCT02971683|26094219|P1|Overall Study|Participant request to discontinue study treatment|1
7515710|NCT02971683|26094218|P2|Overall Study|Participant withdrew consent|1
7515711|NCT02971683|26094219|P1|Overall Study|Participant withdrew consent|1
7515712|NCT02971683|26094218|P2|Overall Study|Lost to Follow-up|0
7515713|NCT02971683|26094219|P1|Overall Study|Lost to Follow-up|1
7515714|NCT02971683|26094218|P2|Overall Study|Poor/Non-Compliance|1
7515715|NCT02971683|26094219|P1|Overall Study|Poor/Non-Compliance|0
7515716|NCT02971683|26094218|P2|Overall Study|Other reasons|1
7515717|NCT02971683|26094219|P1|Overall Study|Other reasons|0
7515718|NCT02971670|26094245|P4|Overall Study|Withdrawal by Subject|2
7515719|NCT02971670|26094246|P3|Overall Study|Withdrawal by Subject|1
7515720|NCT02971670|26094247|P2|Overall Study|Withdrawal by Subject|1
7515721|NCT02971670|26094248|P1|Overall Study|Withdrawal by Subject|4
7515722|NCT02971605|26094287|P1|Overall Study|Withdrawal by Subject|1
7515723|NCT02971228|26094398|P5|Overall Study|Logistical challenges|0
7515724|NCT02971228|26094399|P4|Overall Study|Logistical challenges|0
7515725|NCT02971228|26094400|P3|Overall Study|Logistical challenges|0
7515726|NCT02971228|26094401|P2|Overall Study|Logistical challenges|1
7515727|NCT02971228|26094402|P1|Overall Study|Logistical challenges|0
7515728|NCT02971228|26094398|P5|Overall Study|Withdrawal by Subject|0
7515729|NCT02971228|26094399|P4|Overall Study|Withdrawal by Subject|0
7515730|NCT02971228|26094400|P3|Overall Study|Withdrawal by Subject|0
7515731|NCT02971228|26094401|P2|Overall Study|Withdrawal by Subject|1
7515732|NCT02971228|26094402|P1|Overall Study|Withdrawal by Subject|1
7515733|NCT02971202|26094447|P3|Overall Study|screen fail after consent|1
7515734|NCT02971202|26094448|P2|Overall Study|screen fail after consent|0
7515735|NCT02971202|26094449|P1|Overall Study|screen fail after consent|1
7515736|NCT02971202|26094447|P3|Overall Study|Pregnancy|0
7515737|NCT02971202|26094448|P2|Overall Study|Pregnancy|0
7515738|NCT02971202|26094449|P1|Overall Study|Pregnancy|1
7515739|NCT02971163|26094465|P2|Overall Study|Lost to Follow-up|2
7515740|NCT02971163|26094466|P1|Overall Study|Lost to Follow-up|4
7515741|NCT02971007|26094489|P3|Overall Study|Patient discontinued study drug|0
7515742|NCT02971007|26094490|P2|Overall Study|Patient discontinued study drug|1
7515743|NCT02971007|26094491|P1|Overall Study|Patient discontinued study drug|0
7515744|NCT02971007|26094489|P3|Overall Study|Patient had yeast at Day 5 visit|0
7515745|NCT02971007|26094490|P2|Overall Study|Patient had yeast at Day 5 visit|0
7515746|NCT02971007|26094491|P1|Overall Study|Patient had yeast at Day 5 visit|1
7515747|NCT02971007|26094489|P3|Overall Study|Withdrawal by Subject|0
7515748|NCT02971007|26094490|P2|Overall Study|Withdrawal by Subject|1
7515749|NCT02971007|26094491|P1|Overall Study|Withdrawal by Subject|0
7515750|NCT02971007|26094489|P3|Overall Study|Lost to Follow-up|1
7515751|NCT02971007|26094490|P2|Overall Study|Lost to Follow-up|1
7515752|NCT02971007|26094491|P1|Overall Study|Lost to Follow-up|0
7515753|NCT02971007|26094489|P3|Overall Study|Adverse Event|0
7515754|NCT02971007|26094490|P2|Overall Study|Adverse Event|0
7515755|NCT02971007|26094491|P1|Overall Study|Adverse Event|1
7515756|NCT02970942|26094516|P4|Overall Study|Withdrawal by Subject|2
7515757|NCT02970942|26094517|P3|Overall Study|Withdrawal by Subject|3
7515758|NCT02970942|26094518|P2|Overall Study|Withdrawal by Subject|5
7515759|NCT02970942|26094519|P1|Overall Study|Withdrawal by Subject|3
7515760|NCT02970942|26094516|P4|Overall Study|Lost to Follow-up|1
7515761|NCT02970942|26094517|P3|Overall Study|Lost to Follow-up|2
7515762|NCT02970942|26094518|P2|Overall Study|Lost to Follow-up|0
7515763|NCT02970942|26094519|P1|Overall Study|Lost to Follow-up|1
7515764|NCT02970942|26094516|P4|Overall Study|Death|0
7515765|NCT02970942|26094517|P3|Overall Study|Death|0
7515766|NCT02970942|26094518|P2|Overall Study|Death|1
7515767|NCT02970942|26094519|P1|Overall Study|Death|0
7515768|NCT02970669|26094884|P2|Open-label Period|Physician Decision|0
7515769|NCT02970669|26094885|P1|Open-label Period|Physician Decision|1
7515770|NCT02970669|26094884|P2|Open-label Period|Adverse Event|0
7515771|NCT02970669|26094885|P1|Open-label Period|Adverse Event|1
7515772|NCT02970669|26094884|P2|Open-label Period|Withdrawal by Subject|2
7515773|NCT02970669|26094885|P1|Open-label Period|Withdrawal by Subject|2
7515774|NCT02970669|26094884|P2|Double-blind Period|Withdrawal by Subject|2
7515775|NCT02970669|26094885|P1|Double-blind Period|Withdrawal by Subject|2
7515776|NCT02970669|26094884|P2|Double-blind Period|Physician Decision|2
7515777|NCT02970669|26094885|P1|Double-blind Period|Physician Decision|0
7515778|NCT02970669|26094884|P2|Double-blind Period|Study terminated by sponsor|2
7515779|NCT02970669|26094885|P1|Double-blind Period|Study terminated by sponsor|1
7515780|NCT02970669|26094884|P2|Double-blind Period|Death|0
7515781|NCT02970669|26094885|P1|Double-blind Period|Death|1
7515782|NCT02970669|26094884|P2|Double-blind Period|Adverse Event|0
7515783|NCT02970669|26094885|P1|Double-blind Period|Adverse Event|4
7515784|NCT02970305|26095039|P2|Overall Study|Lost to Follow-up|2
7515785|NCT02970305|26095040|P1|Overall Study|Lost to Follow-up|1
7515786|NCT02970305|26095039|P2|Overall Study|Not further specified|2
7515787|NCT02970305|26095040|P1|Overall Study|Not further specified|1
7515788|NCT02970305|26095039|P2|Overall Study|Withdrawal by Subject|11
7515789|NCT02970305|26095040|P1|Overall Study|Withdrawal by Subject|12
7515790|NCT02970305|26095039|P2|Overall Study|Protocol Violation|2
7515791|NCT02970305|26095040|P1|Overall Study|Protocol Violation|2
7515792|NCT02970305|26095039|P2|Overall Study|Noncompliance with study drug|4
7515793|NCT02970305|26095040|P1|Overall Study|Noncompliance with study drug|2
7515794|NCT02970305|26095039|P2|Overall Study|Lack of Efficacy|1
7515795|NCT02970305|26095040|P1|Overall Study|Lack of Efficacy|1
7515796|NCT02970305|26095039|P2|Overall Study|Adverse Event|6
7515797|NCT02970305|26095040|P1|Overall Study|Adverse Event|10
7515798|NCT02970292|26095072|P2|Overall Study|Other|0
7515799|NCT02970292|26095073|P1|Overall Study|Other|1
7515800|NCT02970292|26095072|P2|Overall Study|Protocol Violation|0
7515801|NCT02970292|26095073|P1|Overall Study|Protocol Violation|2
7515802|NCT02970292|26095072|P2|Overall Study|Lost to Follow-up|0
7515803|NCT02970292|26095073|P1|Overall Study|Lost to Follow-up|1
7515804|NCT02970292|26095072|P2|Overall Study|Lack of Efficacy|0
7515805|NCT02970292|26095073|P1|Overall Study|Lack of Efficacy|1
7515806|NCT02970292|26095072|P2|Overall Study|Adverse Event|0
7515807|NCT02970292|26095073|P1|Overall Study|Adverse Event|5
7515808|NCT02970292|26095072|P2|Overall Study|Noncompliance with study drug|2
7515809|NCT02970292|26095073|P1|Overall Study|Noncompliance with study drug|2
7515810|NCT02970292|26095072|P2|Overall Study|Withdrawal by Subject|5
7515811|NCT02970292|26095073|P1|Overall Study|Withdrawal by Subject|11
7515812|NCT02970292|26095072|P2|Overall Study|Physician Decision|1
7515813|NCT02970292|26095073|P1|Overall Study|Physician Decision|1
7515814|NCT02969863|26095144|P6|Overall Study|Physician Decision|0
7515815|NCT02969863|26095145|P5|Overall Study|Physician Decision|0
7515816|NCT02969863|26095146|P4|Overall Study|Physician Decision|0
7515817|NCT02969863|26095147|P3|Overall Study|Physician Decision|0
7515818|NCT02969863|26095148|P2|Overall Study|Physician Decision|0
7515819|NCT02969863|26095149|P1|Overall Study|Physician Decision|1
7515820|NCT02969707|26095165|P2|Overall Study|Withdrawal by Subject|4
7515821|NCT02969707|26095166|P1|Overall Study|Withdrawal by Subject|3
7515822|NCT02969707|26095165|P2|Overall Study|Protocol Violation|1
7515823|NCT02969707|26095166|P1|Overall Study|Protocol Violation|1
7515824|NCT02969707|26095165|P2|Overall Study|Physician Decision|1
7515825|NCT02969707|26095166|P1|Overall Study|Physician Decision|0
7515826|NCT02969707|26095165|P2|Overall Study|Lost to Follow-up|0
7515827|NCT02969707|26095166|P1|Overall Study|Lost to Follow-up|3
7515828|NCT02969707|26095165|P2|Overall Study|Adverse Event|2
7515829|NCT02969707|26095166|P1|Overall Study|Adverse Event|1
7515830|NCT02969655|26095206|P2|Overall Study|Adverse Event|8
7515831|NCT02969655|26095207|P1|Overall Study|Adverse Event|10
7515832|NCT02969655|26095206|P2|Overall Study|Protocol-specified withdrawal criteria|2
7515833|NCT02969655|26095207|P1|Overall Study|Protocol-specified withdrawal criteria|4
7515834|NCT02969655|26095206|P2|Overall Study|Physician Decision|3
7515835|NCT02969655|26095207|P1|Overall Study|Physician Decision|4
7515836|NCT02969655|26095206|P2|Overall Study|Withdrawal by Subject|2
7515837|NCT02969655|26095207|P1|Overall Study|Withdrawal by Subject|3
7515838|NCT02969590|26095242|P3|Screening Period|Hormones not suppressed post Lupron|0
7515839|NCT02969590|26095243|P2|Screening Period|Hormones not suppressed post Lupron|0
7515840|NCT02969590|26095244|P1|Screening Period|Hormones not suppressed post Lupron|1
7515841|NCT02969525|26095267|P12|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515842|NCT02969525|26095268|P11|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
7515843|NCT02969525|26095269|P10|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515844|NCT02969525|26095270|P9|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515845|NCT02969525|26095271|P8|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515846|NCT02969525|26095272|P7|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515847|NCT02969525|26095273|P6|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515848|NCT02969525|26095274|P5|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515849|NCT02969525|26095275|P4|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515850|NCT02969525|26095276|P3|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515851|NCT02969525|26095277|P2|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515852|NCT02969525|26095278|P1|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7515853|NCT02969525|26095267|P12|Dose-Blind Period|Non-cooperating patient|1
7515854|NCT02969525|26095268|P11|Dose-Blind Period|Non-cooperating patient|0
7515855|NCT02969525|26095269|P10|Dose-Blind Period|Non-cooperating patient|0
7515856|NCT02969525|26095270|P9|Dose-Blind Period|Non-cooperating patient|0
7515857|NCT02969525|26095271|P8|Dose-Blind Period|Non-cooperating patient|0
7515858|NCT02969525|26095272|P7|Dose-Blind Period|Non-cooperating patient|0
7515859|NCT02969525|26095273|P6|Dose-Blind Period|Non-cooperating patient|0
7515860|NCT02969525|26095274|P5|Dose-Blind Period|Non-cooperating patient|0
7515861|NCT02969525|26095275|P4|Dose-Blind Period|Non-cooperating patient|0
7515862|NCT02969525|26095276|P3|Dose-Blind Period|Non-cooperating patient|0
7515863|NCT02969525|26095277|P2|Dose-Blind Period|Non-cooperating patient|0
7515864|NCT02969525|26095278|P1|Dose-Blind Period|Non-cooperating patient|0
7515865|NCT02969525|26095267|P12|Dose-Blind Period|Withdrawal by Subject|0
7515866|NCT02969525|26095268|P11|Dose-Blind Period|Withdrawal by Subject|0
7515867|NCT02969525|26095269|P10|Dose-Blind Period|Withdrawal by Subject|2
7515868|NCT02969525|26095270|P9|Dose-Blind Period|Withdrawal by Subject|1
7515869|NCT02969525|26095271|P8|Dose-Blind Period|Withdrawal by Subject|0
7515870|NCT02969525|26095272|P7|Dose-Blind Period|Withdrawal by Subject|2
7515871|NCT02969525|26095273|P6|Dose-Blind Period|Withdrawal by Subject|0
7515872|NCT02969525|26095274|P5|Dose-Blind Period|Withdrawal by Subject|0
7515873|NCT02969525|26095275|P4|Dose-Blind Period|Withdrawal by Subject|0
7515874|NCT02969525|26095276|P3|Dose-Blind Period|Withdrawal by Subject|0
7515875|NCT02969525|26095277|P2|Dose-Blind Period|Withdrawal by Subject|0
7515876|NCT02969525|26095278|P1|Dose-Blind Period|Withdrawal by Subject|0
7515877|NCT02969525|26095267|P12|Dose-Blind Period|Adverse Event|1
7515878|NCT02969525|26095268|P11|Dose-Blind Period|Adverse Event|1
7515879|NCT02969525|26095269|P10|Dose-Blind Period|Adverse Event|1
7515880|NCT02969525|26095270|P9|Dose-Blind Period|Adverse Event|0
7515881|NCT02969525|26095271|P8|Dose-Blind Period|Adverse Event|0
7515882|NCT02969525|26095272|P7|Dose-Blind Period|Adverse Event|0
7515883|NCT02969525|26095273|P6|Dose-Blind Period|Adverse Event|0
7515884|NCT02969525|26095274|P5|Dose-Blind Period|Adverse Event|0
7515885|NCT02969525|26095275|P4|Dose-Blind Period|Adverse Event|0
7515886|NCT02969525|26095276|P3|Dose-Blind Period|Adverse Event|0
7515887|NCT02969525|26095277|P2|Dose-Blind Period|Adverse Event|0
7515888|NCT02969525|26095278|P1|Dose-Blind Period|Adverse Event|0
7515889|NCT02969525|26095267|P12|Double-Blind Period|Study medication discontinued prior Wk12|0
7515890|NCT02969525|26095268|P11|Double-Blind Period|Study medication discontinued prior Wk12|0
7515891|NCT02969525|26095269|P10|Double-Blind Period|Study medication discontinued prior Wk12|0
7515892|NCT02969525|26095270|P9|Double-Blind Period|Study medication discontinued prior Wk12|0
7515893|NCT02969525|26095271|P8|Double-Blind Period|Study medication discontinued prior Wk12|0
7515894|NCT02969525|26095272|P7|Double-Blind Period|Study medication discontinued prior Wk12|0
7515895|NCT02969525|26095273|P6|Double-Blind Period|Study medication discontinued prior Wk12|0
7515896|NCT02969525|26095274|P5|Double-Blind Period|Study medication discontinued prior Wk12|0
7515897|NCT02969525|26095275|P4|Double-Blind Period|Study medication discontinued prior Wk12|2
7515898|NCT02969525|26095276|P3|Double-Blind Period|Study medication discontinued prior Wk12|0
7515899|NCT02969525|26095277|P2|Double-Blind Period|Study medication discontinued prior Wk12|0
7515900|NCT02969525|26095278|P1|Double-Blind Period|Study medication discontinued prior Wk12|2
7515901|NCT02969525|26095267|P12|Double-Blind Period|LOW EGFR|0
7515902|NCT02969525|26095268|P11|Double-Blind Period|LOW EGFR|0
7515903|NCT02969525|26095269|P10|Double-Blind Period|LOW EGFR|0
7515904|NCT02969525|26095270|P9|Double-Blind Period|LOW EGFR|0
7515905|NCT02969525|26095271|P8|Double-Blind Period|LOW EGFR|0
7515906|NCT02969525|26095272|P7|Double-Blind Period|LOW EGFR|0
7515907|NCT02969525|26095273|P6|Double-Blind Period|LOW EGFR|0
7515908|NCT02969525|26095274|P5|Double-Blind Period|LOW EGFR|0
7515909|NCT02969525|26095275|P4|Double-Blind Period|LOW EGFR|1
7515910|NCT02969525|26095276|P3|Double-Blind Period|LOW EGFR|0
7515911|NCT02969525|26095277|P2|Double-Blind Period|LOW EGFR|0
7515912|NCT02969525|26095278|P1|Double-Blind Period|LOW EGFR|0
7515913|NCT02969525|26095267|P12|Double-Blind Period|Adverse Event|0
7515914|NCT02969525|26095268|P11|Double-Blind Period|Adverse Event|0
7515915|NCT02969525|26095269|P10|Double-Blind Period|Adverse Event|0
7515916|NCT02969525|26095270|P9|Double-Blind Period|Adverse Event|0
7515917|NCT02969525|26095271|P8|Double-Blind Period|Adverse Event|0
7515918|NCT02969525|26095272|P7|Double-Blind Period|Adverse Event|0
7515919|NCT02969525|26095273|P6|Double-Blind Period|Adverse Event|0
7515920|NCT02969525|26095274|P5|Double-Blind Period|Adverse Event|0
7515921|NCT02969525|26095275|P4|Double-Blind Period|Adverse Event|1
7515922|NCT02969525|26095276|P3|Double-Blind Period|Adverse Event|1
7515923|NCT02969525|26095277|P2|Double-Blind Period|Adverse Event|0
7515924|NCT02969525|26095278|P1|Double-Blind Period|Adverse Event|0
7515925|NCT02969408|26095437|P1|Overall Study|Other than specified|1
7515926|NCT02969408|26095437|P1|Overall Study|Protocol Violation|1
7515927|NCT02969408|26095437|P1|Overall Study|Lost to Follow-up|4
7515928|NCT02969408|26095437|P1|Overall Study|Withdrawal by Subject|8
7515929|NCT02969408|26095437|P1|Overall Study|Adverse Event|2
7515930|NCT02969382|26095447|P2|Overall Study|Withdrawal by Subject|9
7515931|NCT02969382|26095448|P1|Overall Study|Withdrawal by Subject|14
7515932|NCT02969382|26095447|P2|Overall Study|PROTOCOL DEVIATION|1
7515933|NCT02969382|26095448|P1|Overall Study|PROTOCOL DEVIATION|0
7515934|NCT02969382|26095447|P2|Overall Study|Death|1
7515935|NCT02969382|26095448|P1|Overall Study|Death|0
7515936|NCT02969382|26095447|P2|Overall Study|Lack of Efficacy|5
7515937|NCT02969382|26095448|P1|Overall Study|Lack of Efficacy|4
7515938|NCT02969382|26095447|P2|Overall Study|Adverse Event|10
7515939|NCT02969382|26095448|P1|Overall Study|Adverse Event|8
7515940|NCT02969356|26095476|P1|Overall Study|Personal reasons|5
7515941|NCT02969356|26095476|P1|Overall Study|Did not need to be reinjected|6
7515942|NCT02969356|26095476|P1|Overall Study|Lost to Follow-up|3
7515943|NCT02969356|26095476|P1|Overall Study|Consent withdrawn|2
7515944|NCT02969356|26095476|P1|Overall Study|Adverse Event|7
7515945|NCT02969187|26095519|P2|Overall Study|Physician Decision|13
7515946|NCT02969187|26095520|P1|Overall Study|Physician Decision|12
7515947|NCT02969044|26095532|P2|Overall Study|Adverse Event|0
7515948|NCT02969044|26095533|P1|Overall Study|Adverse Event|3
7515949|NCT02969044|26095532|P2|Overall Study|Withdrawal by Subject|6
7515950|NCT02969044|26095533|P1|Overall Study|Withdrawal by Subject|2
7515951|NCT02969018|26095592|P8|Overall Study|Withdrawal by Subject|3
7515952|NCT02969018|26095593|P7|Overall Study|Withdrawal by Subject|4
7515953|NCT02969018|26095594|P6|Overall Study|Withdrawal by Subject|4
7515954|NCT02969018|26095595|P5|Overall Study|Withdrawal by Subject|0
7515955|NCT02969018|26095596|P4|Overall Study|Withdrawal by Subject|1
7515956|NCT02969018|26095597|P3|Overall Study|Withdrawal by Subject|2
7515957|NCT02969018|26095598|P2|Overall Study|Withdrawal by Subject|1
7515958|NCT02969018|26095599|P1|Overall Study|Withdrawal by Subject|0
7515959|NCT02969018|26095592|P8|Overall Study|Protocol Violation|0
7515960|NCT02969018|26095593|P7|Overall Study|Protocol Violation|0
7515961|NCT02969018|26095594|P6|Overall Study|Protocol Violation|0
7515962|NCT02969018|26095595|P5|Overall Study|Protocol Violation|0
7515963|NCT02969018|26095596|P4|Overall Study|Protocol Violation|1
7515964|NCT02969018|26095597|P3|Overall Study|Protocol Violation|1
7515965|NCT02969018|26095598|P2|Overall Study|Protocol Violation|0
7515966|NCT02969018|26095599|P1|Overall Study|Protocol Violation|0
7515967|NCT02969018|26095592|P8|Overall Study|Pregnancy|0
7515968|NCT02969018|26095593|P7|Overall Study|Pregnancy|0
7515969|NCT02969018|26095594|P6|Overall Study|Pregnancy|1
7515970|NCT02969018|26095595|P5|Overall Study|Pregnancy|0
7515971|NCT02969018|26095596|P4|Overall Study|Pregnancy|0
7515972|NCT02969018|26095597|P3|Overall Study|Pregnancy|0
7515973|NCT02969018|26095598|P2|Overall Study|Pregnancy|0
7515974|NCT02969018|26095599|P1|Overall Study|Pregnancy|0
7515975|NCT02969018|26095592|P8|Overall Study|Other|2
7515976|NCT02969018|26095593|P7|Overall Study|Other|0
7515977|NCT02969018|26095594|P6|Overall Study|Other|0
7515978|NCT02969018|26095595|P5|Overall Study|Other|0
7515979|NCT02969018|26095596|P4|Overall Study|Other|1
7515980|NCT02969018|26095597|P3|Overall Study|Other|0
7515981|NCT02969018|26095598|P2|Overall Study|Other|0
7515982|NCT02969018|26095599|P1|Overall Study|Other|0
7515983|NCT02969018|26095592|P8|Overall Study|Non-Compliance With Study Drug|0
7515984|NCT02969018|26095593|P7|Overall Study|Non-Compliance With Study Drug|0
7515985|NCT02969018|26095594|P6|Overall Study|Non-Compliance With Study Drug|0
7515986|NCT02969018|26095595|P5|Overall Study|Non-Compliance With Study Drug|0
7515987|NCT02969018|26095596|P4|Overall Study|Non-Compliance With Study Drug|0
7515988|NCT02969018|26095597|P3|Overall Study|Non-Compliance With Study Drug|0
7515989|NCT02969018|26095598|P2|Overall Study|Non-Compliance With Study Drug|0
7515990|NCT02969018|26095599|P1|Overall Study|Non-Compliance With Study Drug|1
7515991|NCT02969018|26095592|P8|Overall Study|No Longer Meets Eligibility Criteria|0
7515992|NCT02969018|26095593|P7|Overall Study|No Longer Meets Eligibility Criteria|1
7515993|NCT02969018|26095594|P6|Overall Study|No Longer Meets Eligibility Criteria|0
7515994|NCT02969018|26095595|P5|Overall Study|No Longer Meets Eligibility Criteria|0
7515995|NCT02969018|26095596|P4|Overall Study|No Longer Meets Eligibility Criteria|0
7515996|NCT02969018|26095597|P3|Overall Study|No Longer Meets Eligibility Criteria|0
7515997|NCT02969018|26095598|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7515998|NCT02969018|26095599|P1|Overall Study|No Longer Meets Eligibility Criteria|0
7515999|NCT02969018|26095592|P8|Overall Study|Lost to Follow-up|1
7516000|NCT02969018|26095593|P7|Overall Study|Lost to Follow-up|0
7516001|NCT02969018|26095594|P6|Overall Study|Lost to Follow-up|1
7516002|NCT02969018|26095595|P5|Overall Study|Lost to Follow-up|1
7516003|NCT02969018|26095596|P4|Overall Study|Lost to Follow-up|0
7516004|NCT02969018|26095597|P3|Overall Study|Lost to Follow-up|2
7516005|NCT02969018|26095598|P2|Overall Study|Lost to Follow-up|2
7516006|NCT02969018|26095599|P1|Overall Study|Lost to Follow-up|1
7516007|NCT02969018|26095592|P8|Overall Study|Lack of Efficacy|1
7516008|NCT02969018|26095593|P7|Overall Study|Lack of Efficacy|1
7516009|NCT02969018|26095594|P6|Overall Study|Lack of Efficacy|1
7516010|NCT02969018|26095595|P5|Overall Study|Lack of Efficacy|1
7516011|NCT02969018|26095596|P4|Overall Study|Lack of Efficacy|0
7516012|NCT02969018|26095597|P3|Overall Study|Lack of Efficacy|0
7516013|NCT02969018|26095598|P2|Overall Study|Lack of Efficacy|1
7516014|NCT02969018|26095599|P1|Overall Study|Lack of Efficacy|0
7516015|NCT02969018|26095592|P8|Overall Study|Adverse Event|0
7516016|NCT02969018|26095593|P7|Overall Study|Adverse Event|2
7516017|NCT02969018|26095594|P6|Overall Study|Adverse Event|1
7516018|NCT02969018|26095595|P5|Overall Study|Adverse Event|0
7516019|NCT02969018|26095596|P4|Overall Study|Adverse Event|2
7516020|NCT02969018|26095597|P3|Overall Study|Adverse Event|1
7516021|NCT02969018|26095598|P2|Overall Study|Adverse Event|4
7516022|NCT02969018|26095599|P1|Overall Study|Adverse Event|2
7516023|NCT02968979|26095739|P1|Overall Study|Withdrawal by Subject|1
7516024|NCT02968979|26095739|P1|Overall Study|Protocol Violation|7
7516025|NCT02968576|26095864|P2|Overall Study|Pregnancy|1
7516026|NCT02968576|26095865|P1|Overall Study|Pregnancy|0
7516027|NCT02968563|26095872|P2|Overall Study|Still on Study|17
7516028|NCT02968563|26095873|P1|Overall Study|Still on Study|0
7516029|NCT02968563|26095872|P2|Overall Study|Death|1
7516030|NCT02968563|26095873|P1|Overall Study|Death|1
7516031|NCT02968563|26095872|P2|Overall Study|Adverse Event|5
7516032|NCT02968563|26095873|P1|Overall Study|Adverse Event|0
7516033|NCT02968433|26095887|P1|Overall Study|Withdrawal by Subject|1
7516034|NCT02968173|26096012|P1|Overall Study|Withdrawal by Subject|1
7516035|NCT02968004|26096031|P2|Overall Study|Withdrawal by Subject|1
7516036|NCT02968004|26096032|P1|Overall Study|Withdrawal by Subject|0
7516037|NCT02968004|26096031|P2|Overall Study|Adverse Event|0
7516038|NCT02968004|26096032|P1|Overall Study|Adverse Event|1
7516039|NCT02967679|26096067|P1|Overall Study|Adverse Event|1
7516040|NCT02967562|26096088|P2|Overall Study|High leak precluding analysis|1
7516041|NCT02967562|26096089|P1|Overall Study|High leak precluding analysis|1
7516042|NCT02967562|26096088|P2|Overall Study|Consent not obtained|0
7516043|NCT02967562|26096089|P1|Overall Study|Consent not obtained|1
7516044|NCT02967055|26096315|P1|Overall Study|Stopped due to drug cost|1
7516045|NCT02967055|26096315|P1|Overall Study|Stopped due to side effects|3
7516046|NCT02967055|26096315|P1|Overall Study|Lost to Follow-up|2
7516047|NCT02967055|26096315|P1|Overall Study|Screen fail|3
7516048|NCT02967055|26096315|P1|Overall Study|Excluded|40
7516049|NCT02966834|26096340|P6|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7516050|NCT02966834|26096341|P5|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7516051|NCT02966834|26096342|P4|Follow-up (Up to 4 Weeks)|Protocol Violation|1
7516052|NCT02966834|26096343|P3|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7516053|NCT02966834|26096344|P2|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7516054|NCT02966834|26096345|P1|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7516055|NCT02966834|26096340|P6|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7516056|NCT02966834|26096341|P5|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7516057|NCT02966834|26096342|P4|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
7516058|NCT02966834|26096343|P3|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7516059|NCT02966834|26096344|P2|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7516060|NCT02966834|26096345|P1|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7516061|NCT02966834|26096340|P6|Follow-up (Up to 4 Weeks)|Adverse Event|1
7516062|NCT02966834|26096341|P5|Follow-up (Up to 4 Weeks)|Adverse Event|0
7516063|NCT02966834|26096342|P4|Follow-up (Up to 4 Weeks)|Adverse Event|2
7516064|NCT02966834|26096343|P3|Follow-up (Up to 4 Weeks)|Adverse Event|1
7516065|NCT02966834|26096344|P2|Follow-up (Up to 4 Weeks)|Adverse Event|0
7516066|NCT02966834|26096345|P1|Follow-up (Up to 4 Weeks)|Adverse Event|0
7516067|NCT02966834|26096340|P6|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
7516068|NCT02966834|26096341|P5|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7516069|NCT02966834|26096342|P4|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
7516070|NCT02966834|26096343|P3|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
7516071|NCT02966834|26096344|P2|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7516072|NCT02966834|26096345|P1|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7516073|NCT02966834|26096340|P6|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7516074|NCT02966834|26096341|P5|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7516075|NCT02966834|26096342|P4|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7516076|NCT02966834|26096343|P3|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7516077|NCT02966834|26096344|P2|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7516078|NCT02966834|26096345|P1|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
7516079|NCT02966834|26096340|P6|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7516080|NCT02966834|26096341|P5|Main Study Period (Up to 12 Weeks)|Adverse Event|1
7516081|NCT02966834|26096342|P4|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7516082|NCT02966834|26096343|P3|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7516083|NCT02966834|26096344|P2|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7516084|NCT02966834|26096345|P1|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7516085|NCT02966795|26096576|P2|Overall Study|Patient Left the Country|1
7516086|NCT02966795|26096577|P1|Overall Study|Patient Left the Country|0
7516087|NCT02966509|26096588|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
7516088|NCT02966509|26096589|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
7516089|NCT02966509|26096588|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
7516090|NCT02966509|26096589|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
7516091|NCT02966509|26096588|P2|6 Month Satisfaction Survey|Refused to Answer|11
7516092|NCT02966509|26096589|P1|6 Month Satisfaction Survey|Refused to Answer|8
7516093|NCT02966509|26096588|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
7516094|NCT02966509|26096589|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
7516095|NCT02966509|26096588|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
7516096|NCT02966509|26096589|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
7516097|NCT02966509|26096588|P2|6 Month Satisfaction Survey|Death|33
7516098|NCT02966509|26096589|P1|6 Month Satisfaction Survey|Death|36
7516099|NCT02966509|26096588|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
7516100|NCT02966509|26096589|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
7516101|NCT02966509|26096588|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7516102|NCT02966509|26096589|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7516103|NCT02966509|26096588|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
7516104|NCT02966509|26096589|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
7516105|NCT02966509|26096588|P2|6 Month Satisfaction Decision Survey|Death|25
7516106|NCT02966509|26096589|P1|6 Month Satisfaction Decision Survey|Death|22
7516107|NCT02966509|26096588|P2|Baseline Satisfaction Survey|Refused to Answer|2
7516108|NCT02966509|26096589|P1|Baseline Satisfaction Survey|Refused to Answer|1
7516109|NCT02966509|26096588|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
7516110|NCT02966509|26096589|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
7516111|NCT02966509|26096588|P2|Baseline Satisfaction Survey|Death|1
7516112|NCT02966509|26096589|P1|Baseline Satisfaction Survey|Death|0
7516113|NCT02966509|26096588|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
7516114|NCT02966509|26096589|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
7516115|NCT02966353|26096613|P1|Overall Study|Protocol deviation|2
7516116|NCT02966353|26096613|P1|Overall Study|Progressive disease|2
7516117|NCT02966353|26096613|P1|Overall Study|Physician Decision|3
7516118|NCT02966353|26096613|P1|Overall Study|Death|4
7516119|NCT02966353|26096613|P1|Overall Study|Adverse Event|4
7516120|NCT02966353|26096613|P1|Overall Study|Withdrawal by Subject|7
7516121|NCT02966340|26096622|P2|Overall Study|startle non-responder|1
7516122|NCT02966340|26096623|P1|Overall Study|startle non-responder|1
7516123|NCT02966340|26096622|P2|Overall Study|data acquisition error|0
7516124|NCT02966340|26096623|P1|Overall Study|data acquisition error|1
7516125|NCT02966340|26096622|P2|Overall Study|Withdrawal by Subject|0
7516126|NCT02966340|26096623|P1|Overall Study|Withdrawal by Subject|1
7516127|NCT02966340|26096622|P2|Overall Study|Lost to Follow-up|1
7516128|NCT02966340|26096623|P1|Overall Study|Lost to Follow-up|0
7516129|NCT02966340|26096622|P2|Overall Study|Adverse Event|1
7516130|NCT02966340|26096623|P1|Overall Study|Adverse Event|0
7516131|NCT02966223|26096666|P1|Overall Study|Lost to Follow-up|1
7516132|NCT02966223|26096666|P1|Overall Study|Withdrawal by Subject|11
7516133|NCT02966223|26096666|P1|Overall Study|Physician Decision|3
7516134|NCT02966028|26096684|P3|Overall Study|Kidney transplant Changed dialysis units|14
7516135|NCT02966028|26096685|P2|Overall Study|Kidney transplant Changed dialysis units|16
7516136|NCT02966028|26096686|P1|Overall Study|Kidney transplant Changed dialysis units|9
7516137|NCT02966028|26096684|P3|Overall Study|Withdrawal by Subject|5
7516138|NCT02966028|26096685|P2|Overall Study|Withdrawal by Subject|5
7516139|NCT02966028|26096686|P1|Overall Study|Withdrawal by Subject|7
7516140|NCT02966028|26096684|P3|Overall Study|Physician Decision|2
7516141|NCT02966028|26096685|P2|Overall Study|Physician Decision|0
7516142|NCT02966028|26096686|P1|Overall Study|Physician Decision|1
7516143|NCT02966028|26096684|P3|Overall Study|Adverse Event|10
7516144|NCT02966028|26096685|P2|Overall Study|Adverse Event|13
7516145|NCT02966028|26096686|P1|Overall Study|Adverse Event|7
7516146|NCT02966015|26096734|P2|Inclusion Visit|did not answer questionnaire|3
7516147|NCT02966015|26096735|P1|Inclusion Visit|did not answer questionnaire|8
7516148|NCT02966002|26096741|P1|Overall Study|Lost to Follow-up|1
7516149|NCT02966002|26096741|P1|Overall Study|Adverse Event|1
7516150|NCT02966002|26096741|P1|Overall Study|Withdrawal by Subject|2
7516151|NCT02965846|26096771|P3|Overall Study|Participants not randomized|33
7516152|NCT02965846|26096772|P2|Overall Study|Participants not randomized|0
7516153|NCT02965846|26096773|P1|Overall Study|Participants not randomized|0
7516154|NCT02965846|26096771|P3|Overall Study|Study Terminated By Sponsor|0
7516155|NCT02965846|26096772|P2|Overall Study|Study Terminated By Sponsor|4
7516156|NCT02965846|26096773|P1|Overall Study|Study Terminated By Sponsor|4
7516157|NCT02965846|26096771|P3|Overall Study|Withdrawal by Subject|0
7516158|NCT02965846|26096772|P2|Overall Study|Withdrawal by Subject|1
7516159|NCT02965846|26096773|P1|Overall Study|Withdrawal by Subject|0
7516160|NCT02965846|26096771|P3|Overall Study|Lost to Follow-up|0
7516161|NCT02965846|26096772|P2|Overall Study|Lost to Follow-up|0
7516162|NCT02965846|26096773|P1|Overall Study|Lost to Follow-up|1
7516163|NCT02965833|26096781|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
7516164|NCT02965833|26096782|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
7516165|NCT02965833|26096781|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7516166|NCT02965833|26096782|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7516167|NCT02965833|26096781|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
7516168|NCT02965833|26096782|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
7516169|NCT02965833|26096781|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7516170|NCT02965833|26096782|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7516171|NCT02965833|26096781|P2|Period 1, First 30 Days of Wear|Adverse Event|1
7516172|NCT02965833|26096782|P1|Period 1, First 30 Days of Wear|Adverse Event|0
7516173|NCT02965820|26096788|P2|Period 2, Second 30 Days|Adverse Event|1
7516174|NCT02965820|26096789|P1|Period 2, Second 30 Days|Adverse Event|1
7516175|NCT02965599|26096828|P2|Overall Study|Protocol-defined stop criteria reached|0
7516176|NCT02965599|26096829|P1|Overall Study|Protocol-defined stop criteria reached|1
7516177|NCT02965573|26096893|P2|Overall Study|Lack of Efficacy|0
7516178|NCT02965573|26096894|P1|Overall Study|Lack of Efficacy|1
7516179|NCT02965456|26096955|P2|Overall Study|Participant ran out of study drug|1
7516180|NCT02965456|26096956|P1|Overall Study|Participant ran out of study drug|0
7516181|NCT02965456|26096955|P2|Overall Study|Protocol Violation|1
7516182|NCT02965456|26096956|P1|Overall Study|Protocol Violation|0
7516183|NCT02965456|26096955|P2|Overall Study|Pregnancy|0
7516184|NCT02965456|26096956|P1|Overall Study|Pregnancy|1
7516185|NCT02965456|26096955|P2|Overall Study|Physician Decision|1
7516186|NCT02965456|26096956|P1|Overall Study|Physician Decision|0
7516187|NCT02965456|26096955|P2|Overall Study|Lack of Efficacy|0
7516188|NCT02965456|26096956|P1|Overall Study|Lack of Efficacy|1
7516189|NCT02965456|26096955|P2|Overall Study|Worsening Condition|2
7516190|NCT02965456|26096956|P1|Overall Study|Worsening Condition|0
7516191|NCT02965456|26096955|P2|Overall Study|Noncompliance with Study Drug|1
7516192|NCT02965456|26096956|P1|Overall Study|Noncompliance with Study Drug|1
7516193|NCT02965456|26096955|P2|Overall Study|Adverse Event|0
7516194|NCT02965456|26096956|P1|Overall Study|Adverse Event|3
7516195|NCT02965456|26096955|P2|Overall Study|Withdrawal by Parent or Guardian|6
7516196|NCT02965456|26096956|P1|Overall Study|Withdrawal by Parent or Guardian|3
7516197|NCT02965456|26096955|P2|Overall Study|Subject Request|13
7516198|NCT02965456|26096956|P1|Overall Study|Subject Request|22
7516199|NCT02965456|26096955|P2|Overall Study|Lost to Follow-up|18
7516200|NCT02965456|26096956|P1|Overall Study|Lost to Follow-up|40
7516201|NCT02965378|26096972|P2|Overall Study|Not protocol specified|2
7516202|NCT02965378|26096973|P1|Overall Study|Not protocol specified|0
7516203|NCT02965378|26096972|P2|Overall Study|Refusal|1
7516204|NCT02965378|26096973|P1|Overall Study|Refusal|2
7516205|NCT02965378|26096972|P2|Overall Study|Death|0
7516206|NCT02965378|26096973|P1|Overall Study|Death|2
7516207|NCT02965378|26096972|P2|Overall Study|Adverse Event|2
7516208|NCT02965378|26096973|P1|Overall Study|Adverse Event|5
7516209|NCT02965378|26096972|P2|Overall Study|Progression|4
7516210|NCT02965378|26096973|P1|Overall Study|Progression|16
7516211|NCT02964338|26097072|P3|Overall Study|Did not meet criteria|0
7516212|NCT02964338|26097073|P2|Overall Study|Did not meet criteria|0
7516213|NCT02964338|26097074|P1|Overall Study|Did not meet criteria|1
7516214|NCT02964338|26097072|P3|Overall Study|Non-compliant with e-diary|0
7516215|NCT02964338|26097073|P2|Overall Study|Non-compliant with e-diary|1
7516216|NCT02964338|26097074|P1|Overall Study|Non-compliant with e-diary|0
7516217|NCT02964338|26097072|P3|Overall Study|Adverse Event|1
7516218|NCT02964338|26097073|P2|Overall Study|Adverse Event|1
7516219|NCT02964338|26097074|P1|Overall Study|Adverse Event|2
7516220|NCT02964338|26097072|P3|Overall Study|Withdrawal by Subject|1
7516221|NCT02964338|26097073|P2|Overall Study|Withdrawal by Subject|3
7516222|NCT02964338|26097074|P1|Overall Study|Withdrawal by Subject|1
7516223|NCT02964338|26097072|P3|Overall Study|Protocol Violation|0
7516224|NCT02964338|26097073|P2|Overall Study|Protocol Violation|1
7516225|NCT02964338|26097074|P1|Overall Study|Protocol Violation|0
7516226|NCT02964338|26097072|P3|Overall Study|Lost to Follow-up|3
7516227|NCT02964338|26097073|P2|Overall Study|Lost to Follow-up|0
7516228|NCT02964338|26097074|P1|Overall Study|Lost to Follow-up|1
7516229|NCT02964338|26097072|P3|Overall Study|Lack of Efficacy|0
7516230|NCT02964338|26097073|P2|Overall Study|Lack of Efficacy|3
7516231|NCT02964338|26097074|P1|Overall Study|Lack of Efficacy|0
7516232|NCT02964338|26097072|P3|Overall Study|Sponsor terminated study for futility|14
7516233|NCT02964338|26097073|P2|Overall Study|Sponsor terminated study for futility|15
7516234|NCT02964338|26097074|P1|Overall Study|Sponsor terminated study for futility|12
7516235|NCT02964325|26097120|P2|Overall Study|Did not require PLT transfusion, had HLA positive|12
7516236|NCT02964325|26097121|P1|Overall Study|Did not require PLT transfusion, had HLA positive|10
7516237|NCT02964325|26097120|P2|Overall Study|Withdrawal by Subject|1
7516238|NCT02964325|26097121|P1|Overall Study|Withdrawal by Subject|2
7516239|NCT02964325|26097120|P2|Overall Study|Death|3
7516240|NCT02964325|26097121|P1|Overall Study|Death|1
7516241|NCT02964325|26097120|P2|Overall Study|Physician Decision|4
7516242|NCT02964325|26097121|P1|Overall Study|Physician Decision|5
7516243|NCT02964325|26097120|P2|Overall Study|Lost to Follow-up|3
7516244|NCT02964325|26097121|P1|Overall Study|Lost to Follow-up|3
7516245|NCT02964312|26097141|P1|Overall Study|Death|1
7516246|NCT02964312|26097141|P1|Overall Study|Did not consent to long-term FU|14
7516247|NCT02964312|26097141|P1|Overall Study|Lack of Efficacy|10
7516248|NCT02964312|26097141|P1|Overall Study|Withdrawal by Subject|11
7516249|NCT02964312|26097141|P1|Overall Study|Lost to Follow-up|28
7516250|NCT02964247|26097152|P2|Overall Study|Withdrawal by Subject|2
7516251|NCT02964247|26097153|P1|Overall Study|Withdrawal by Subject|1
7516252|NCT02964247|26097152|P2|Overall Study|Lost to Follow-up|0
7516253|NCT02964247|26097153|P1|Overall Study|Lost to Follow-up|2
7516254|NCT02964234|26097211|P2|Overall Study|Lost to Follow-up|13
7516255|NCT02964234|26097212|P1|Overall Study|Lost to Follow-up|22
7516256|NCT02964039|26097231|P3|Overall Study|Lost to Follow-up|1
7516257|NCT02964039|26097232|P2|Overall Study|Lost to Follow-up|0
7516258|NCT02964039|26097233|P1|Overall Study|Lost to Follow-up|1
7516259|NCT02964039|26097231|P3|Overall Study|Withdrawal by Subject|0
7516260|NCT02964039|26097232|P2|Overall Study|Withdrawal by Subject|1
7516261|NCT02964039|26097233|P1|Overall Study|Withdrawal by Subject|0
7516262|NCT02964039|26097231|P3|Overall Study|Research shutdown due to pandemic|1
7516263|NCT02964039|26097232|P2|Overall Study|Research shutdown due to pandemic|0
7516264|NCT02964039|26097233|P1|Overall Study|Research shutdown due to pandemic|2
7516265|NCT02964039|26097231|P3|Overall Study|Medical reason unrelated to study participation|3
7516266|NCT02964039|26097232|P2|Overall Study|Medical reason unrelated to study participation|0
7516267|NCT02964039|26097233|P1|Overall Study|Medical reason unrelated to study participation|1
7516268|NCT02963935|26097283|P2|Overall Study|Unclassified|22
7516269|NCT02963935|26097284|P1|Overall Study|Unclassified|13
7516270|NCT02963935|26097283|P2|Overall Study|Lost to Follow-up|6
7516271|NCT02963935|26097284|P1|Overall Study|Lost to Follow-up|1
7516272|NCT02963935|26097283|P2|Overall Study|Lack of Efficacy|2
7516273|NCT02963935|26097284|P1|Overall Study|Lack of Efficacy|0
7516274|NCT02963935|26097283|P2|Overall Study|Protocol Violation|1
7516275|NCT02963935|26097284|P1|Overall Study|Protocol Violation|2
7516276|NCT02963935|26097283|P2|Overall Study|Adverse Event|6
7516277|NCT02963935|26097284|P1|Overall Study|Adverse Event|12
7516278|NCT02963922|26097392|P2|Overall Study|Other|14
7516279|NCT02963922|26097393|P1|Overall Study|Other|8
7516280|NCT02963922|26097392|P2|Overall Study|Lost to Follow-up|3
7516281|NCT02963922|26097393|P1|Overall Study|Lost to Follow-up|2
7516282|NCT02963922|26097392|P2|Overall Study|Lack of Efficacy|1
7516283|NCT02963922|26097393|P1|Overall Study|Lack of Efficacy|1
7516284|NCT02963922|26097392|P2|Overall Study|Protocol deviation|6
7516285|NCT02963922|26097393|P1|Overall Study|Protocol deviation|6
7516286|NCT02963922|26097392|P2|Overall Study|Adverse Event|6
7516287|NCT02963922|26097393|P1|Overall Study|Adverse Event|15
7516288|NCT02963701|26097491|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
7516289|NCT02963701|26097492|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
7516290|NCT02963506|26097552|P13|Dose-Blind Period|Meeting exclusion criteria 9|1
7516291|NCT02963506|26097553|P12|Dose-Blind Period|Meeting exclusion criteria 9|0
7516292|NCT02963506|26097554|P11|Dose-Blind Period|Meeting exclusion criteria 9|0
7516293|NCT02963506|26097555|P10|Dose-Blind Period|Meeting exclusion criteria 9|0
7516294|NCT02963506|26097556|P9|Dose-Blind Period|Meeting exclusion criteria 9|0
7516295|NCT02963506|26097557|P8|Dose-Blind Period|Meeting exclusion criteria 9|0
7516296|NCT02963506|26097558|P7|Dose-Blind Period|Meeting exclusion criteria 9|0
7516297|NCT02963506|26097559|P6|Dose-Blind Period|Meeting exclusion criteria 9|0
7516298|NCT02963506|26097560|P5|Dose-Blind Period|Meeting exclusion criteria 9|0
7516299|NCT02963506|26097561|P4|Dose-Blind Period|Meeting exclusion criteria 9|0
7516300|NCT02963506|26097562|P3|Dose-Blind Period|Meeting exclusion criteria 9|0
7516301|NCT02963506|26097563|P2|Dose-Blind Period|Meeting exclusion criteria 9|0
7516302|NCT02963506|26097564|P1|Dose-Blind Period|Meeting exclusion criteria 9|0
7516303|NCT02963506|26097552|P13|Dose-Blind Period|Sponsor decision|0
7516304|NCT02963506|26097553|P12|Dose-Blind Period|Sponsor decision|0
7516305|NCT02963506|26097554|P11|Dose-Blind Period|Sponsor decision|0
7516306|NCT02963506|26097555|P10|Dose-Blind Period|Sponsor decision|0
7516307|NCT02963506|26097556|P9|Dose-Blind Period|Sponsor decision|0
7516308|NCT02963506|26097557|P8|Dose-Blind Period|Sponsor decision|0
7516309|NCT02963506|26097558|P7|Dose-Blind Period|Sponsor decision|0
7516310|NCT02963506|26097559|P6|Dose-Blind Period|Sponsor decision|1
7516311|NCT02963506|26097560|P5|Dose-Blind Period|Sponsor decision|0
7516312|NCT02963506|26097561|P4|Dose-Blind Period|Sponsor decision|0
7516313|NCT02963506|26097562|P3|Dose-Blind Period|Sponsor decision|0
7516314|NCT02963506|26097563|P2|Dose-Blind Period|Sponsor decision|0
7516315|NCT02963506|26097564|P1|Dose-Blind Period|Sponsor decision|0
7516316|NCT02963506|26097552|P13|Dose-Blind Period|Withdrawal by Subject|0
7516317|NCT02963506|26097553|P12|Dose-Blind Period|Withdrawal by Subject|0
7516318|NCT02963506|26097554|P11|Dose-Blind Period|Withdrawal by Subject|0
7516319|NCT02963506|26097555|P10|Dose-Blind Period|Withdrawal by Subject|1
7516320|NCT02963506|26097556|P9|Dose-Blind Period|Withdrawal by Subject|0
7516321|NCT02963506|26097557|P8|Dose-Blind Period|Withdrawal by Subject|2
7516322|NCT02963506|26097558|P7|Dose-Blind Period|Withdrawal by Subject|2
7516323|NCT02963506|26097559|P6|Dose-Blind Period|Withdrawal by Subject|1
7516324|NCT02963506|26097560|P5|Dose-Blind Period|Withdrawal by Subject|0
7516325|NCT02963506|26097561|P4|Dose-Blind Period|Withdrawal by Subject|0
7516326|NCT02963506|26097562|P3|Dose-Blind Period|Withdrawal by Subject|0
7516327|NCT02963506|26097563|P2|Dose-Blind Period|Withdrawal by Subject|0
7516328|NCT02963506|26097564|P1|Dose-Blind Period|Withdrawal by Subject|0
7516329|NCT02963506|26097552|P13|Dose-Blind Period|Lost to Follow-up|0
7516330|NCT02963506|26097553|P12|Dose-Blind Period|Lost to Follow-up|1
7516331|NCT02963506|26097554|P11|Dose-Blind Period|Lost to Follow-up|0
7516332|NCT02963506|26097555|P10|Dose-Blind Period|Lost to Follow-up|0
7516333|NCT02963506|26097556|P9|Dose-Blind Period|Lost to Follow-up|1
7516334|NCT02963506|26097557|P8|Dose-Blind Period|Lost to Follow-up|0
7516335|NCT02963506|26097558|P7|Dose-Blind Period|Lost to Follow-up|0
7516336|NCT02963506|26097559|P6|Dose-Blind Period|Lost to Follow-up|1
7516337|NCT02963506|26097560|P5|Dose-Blind Period|Lost to Follow-up|0
7516338|NCT02963506|26097561|P4|Dose-Blind Period|Lost to Follow-up|0
7516339|NCT02963506|26097562|P3|Dose-Blind Period|Lost to Follow-up|0
7516340|NCT02963506|26097563|P2|Dose-Blind Period|Lost to Follow-up|0
7516341|NCT02963506|26097564|P1|Dose-Blind Period|Lost to Follow-up|0
7516342|NCT02963506|26097552|P13|Dose-Blind Period|Lack of Efficacy|0
7516343|NCT02963506|26097553|P12|Dose-Blind Period|Lack of Efficacy|0
7516344|NCT02963506|26097554|P11|Dose-Blind Period|Lack of Efficacy|0
7516345|NCT02963506|26097555|P10|Dose-Blind Period|Lack of Efficacy|1
7516346|NCT02963506|26097556|P9|Dose-Blind Period|Lack of Efficacy|0
7516347|NCT02963506|26097557|P8|Dose-Blind Period|Lack of Efficacy|1
7516348|NCT02963506|26097558|P7|Dose-Blind Period|Lack of Efficacy|0
7516349|NCT02963506|26097559|P6|Dose-Blind Period|Lack of Efficacy|0
7516350|NCT02963506|26097560|P5|Dose-Blind Period|Lack of Efficacy|0
7516351|NCT02963506|26097561|P4|Dose-Blind Period|Lack of Efficacy|0
7516352|NCT02963506|26097562|P3|Dose-Blind Period|Lack of Efficacy|0
7516353|NCT02963506|26097563|P2|Dose-Blind Period|Lack of Efficacy|0
7516354|NCT02963506|26097564|P1|Dose-Blind Period|Lack of Efficacy|0
7516355|NCT02963506|26097552|P13|Dose-Blind Period|Adverse Event|6
7516356|NCT02963506|26097553|P12|Dose-Blind Period|Adverse Event|1
7516357|NCT02963506|26097554|P11|Dose-Blind Period|Adverse Event|1
7516358|NCT02963506|26097555|P10|Dose-Blind Period|Adverse Event|2
7516359|NCT02963506|26097556|P9|Dose-Blind Period|Adverse Event|2
7516360|NCT02963506|26097557|P8|Dose-Blind Period|Adverse Event|2
7516361|NCT02963506|26097558|P7|Dose-Blind Period|Adverse Event|3
7516362|NCT02963506|26097559|P6|Dose-Blind Period|Adverse Event|1
7516363|NCT02963506|26097560|P5|Dose-Blind Period|Adverse Event|0
7516364|NCT02963506|26097561|P4|Dose-Blind Period|Adverse Event|0
7516365|NCT02963506|26097562|P3|Dose-Blind Period|Adverse Event|0
7516366|NCT02963506|26097563|P2|Dose-Blind Period|Adverse Event|0
7516367|NCT02963506|26097564|P1|Dose-Blind Period|Adverse Event|0
7516368|NCT02963506|26097552|P13|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516369|NCT02963506|26097553|P12|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516370|NCT02963506|26097554|P11|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516371|NCT02963506|26097555|P10|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516372|NCT02963506|26097556|P9|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516373|NCT02963506|26097557|P8|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516374|NCT02963506|26097558|P7|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516375|NCT02963506|26097559|P6|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516376|NCT02963506|26097560|P5|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516377|NCT02963506|26097561|P4|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516378|NCT02963506|26097562|P3|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516379|NCT02963506|26097563|P2|Double-Blind Period|Adverse event, non fatal after Wk12|1
7516380|NCT02963506|26097564|P1|Double-Blind Period|Adverse event, non fatal after Wk12|0
7516381|NCT02963506|26097552|P13|Double-Blind Period|No compliance|0
7516382|NCT02963506|26097553|P12|Double-Blind Period|No compliance|0
7516383|NCT02963506|26097554|P11|Double-Blind Period|No compliance|0
7516384|NCT02963506|26097555|P10|Double-Blind Period|No compliance|0
7516385|NCT02963506|26097556|P9|Double-Blind Period|No compliance|0
7516386|NCT02963506|26097557|P8|Double-Blind Period|No compliance|0
7516387|NCT02963506|26097558|P7|Double-Blind Period|No compliance|0
7516388|NCT02963506|26097559|P6|Double-Blind Period|No compliance|0
7516389|NCT02963506|26097560|P5|Double-Blind Period|No compliance|0
7516390|NCT02963506|26097561|P4|Double-Blind Period|No compliance|0
7516391|NCT02963506|26097562|P3|Double-Blind Period|No compliance|0
7516392|NCT02963506|26097563|P2|Double-Blind Period|No compliance|1
7516393|NCT02963506|26097564|P1|Double-Blind Period|No compliance|0
7516394|NCT02963506|26097552|P13|Double-Blind Period|Withdrawal by Subject|0
7516395|NCT02963506|26097553|P12|Double-Blind Period|Withdrawal by Subject|0
7516396|NCT02963506|26097554|P11|Double-Blind Period|Withdrawal by Subject|0
7516397|NCT02963506|26097555|P10|Double-Blind Period|Withdrawal by Subject|0
7516398|NCT02963506|26097556|P9|Double-Blind Period|Withdrawal by Subject|0
7516399|NCT02963506|26097557|P8|Double-Blind Period|Withdrawal by Subject|0
7516400|NCT02963506|26097558|P7|Double-Blind Period|Withdrawal by Subject|0
7516401|NCT02963506|26097559|P6|Double-Blind Period|Withdrawal by Subject|0
7516402|NCT02963506|26097560|P5|Double-Blind Period|Withdrawal by Subject|0
7516403|NCT02963506|26097561|P4|Double-Blind Period|Withdrawal by Subject|1
7516404|NCT02963506|26097562|P3|Double-Blind Period|Withdrawal by Subject|1
7516405|NCT02963506|26097563|P2|Double-Blind Period|Withdrawal by Subject|0
7516406|NCT02963506|26097564|P1|Double-Blind Period|Withdrawal by Subject|0
7516407|NCT02963506|26097552|P13|Double-Blind Period|Lost to Follow-up|0
7516408|NCT02963506|26097553|P12|Double-Blind Period|Lost to Follow-up|0
7516409|NCT02963506|26097554|P11|Double-Blind Period|Lost to Follow-up|0
7516410|NCT02963506|26097555|P10|Double-Blind Period|Lost to Follow-up|0
7516411|NCT02963506|26097556|P9|Double-Blind Period|Lost to Follow-up|0
7516412|NCT02963506|26097557|P8|Double-Blind Period|Lost to Follow-up|0
7516413|NCT02963506|26097558|P7|Double-Blind Period|Lost to Follow-up|0
7516414|NCT02963506|26097559|P6|Double-Blind Period|Lost to Follow-up|0
7516415|NCT02963506|26097560|P5|Double-Blind Period|Lost to Follow-up|0
7516416|NCT02963506|26097561|P4|Double-Blind Period|Lost to Follow-up|0
7516417|NCT02963506|26097562|P3|Double-Blind Period|Lost to Follow-up|0
7516418|NCT02963506|26097563|P2|Double-Blind Period|Lost to Follow-up|1
7516419|NCT02963506|26097564|P1|Double-Blind Period|Lost to Follow-up|0
7516420|NCT02963506|26097552|P13|Double-Blind Period|Death|0
7516421|NCT02963506|26097553|P12|Double-Blind Period|Death|0
7516422|NCT02963506|26097554|P11|Double-Blind Period|Death|0
7516423|NCT02963506|26097555|P10|Double-Blind Period|Death|0
7516424|NCT02963506|26097556|P9|Double-Blind Period|Death|0
7516425|NCT02963506|26097557|P8|Double-Blind Period|Death|0
7516426|NCT02963506|26097558|P7|Double-Blind Period|Death|0
7516427|NCT02963506|26097559|P6|Double-Blind Period|Death|0
7516428|NCT02963506|26097560|P5|Double-Blind Period|Death|0
7516429|NCT02963506|26097561|P4|Double-Blind Period|Death|1
7516430|NCT02963506|26097562|P3|Double-Blind Period|Death|0
7516431|NCT02963506|26097563|P2|Double-Blind Period|Death|0
7516432|NCT02963506|26097564|P1|Double-Blind Period|Death|0
7516433|NCT02963506|26097552|P13|Double-Blind Period|Adverse Event|0
7516434|NCT02963506|26097553|P12|Double-Blind Period|Adverse Event|0
7516435|NCT02963506|26097554|P11|Double-Blind Period|Adverse Event|0
7516436|NCT02963506|26097555|P10|Double-Blind Period|Adverse Event|0
7516437|NCT02963506|26097556|P9|Double-Blind Period|Adverse Event|0
7516438|NCT02963506|26097557|P8|Double-Blind Period|Adverse Event|0
7516439|NCT02963506|26097558|P7|Double-Blind Period|Adverse Event|0
7516440|NCT02963506|26097559|P6|Double-Blind Period|Adverse Event|0
7516441|NCT02963506|26097560|P5|Double-Blind Period|Adverse Event|0
7516442|NCT02963506|26097561|P4|Double-Blind Period|Adverse Event|0
7516443|NCT02963506|26097562|P3|Double-Blind Period|Adverse Event|1
7516444|NCT02963506|26097563|P2|Double-Blind Period|Adverse Event|0
7516445|NCT02963506|26097564|P1|Double-Blind Period|Adverse Event|0
7516446|NCT02963441|26097616|P1|Overall Study|IDx-DR insufficient quality|33
7516447|NCT02963441|26097616|P1|Overall Study|Ungradeable by FPRC or IDx|40
7516448|NCT02963441|26097616|P1|Overall Study|Protocol violation or withdrawn|8
7516449|NCT02963311|26097656|P1|Overall Study|Screen Failure|4
7516450|NCT02963311|26097656|P1|Overall Study|Withdrawal by Subject|1
7516451|NCT02962960|26097683|P3|Overall Study|Protocol Violation|0
7516452|NCT02962960|26097684|P2|Overall Study|Protocol Violation|0
7516453|NCT02962960|26097685|P1|Overall Study|Protocol Violation|1
7516454|NCT02962960|26097683|P3|Overall Study|Adverse Event|0
7516455|NCT02962960|26097684|P2|Overall Study|Adverse Event|1
7516456|NCT02962960|26097685|P1|Overall Study|Adverse Event|1
7516457|NCT02962960|26097683|P3|Overall Study|Withdrawal by Subject|0
7516458|NCT02962960|26097684|P2|Overall Study|Withdrawal by Subject|1
7516459|NCT02962960|26097685|P1|Overall Study|Withdrawal by Subject|1
7516460|NCT02962908|26097769|P4|Overall Study|Physician Decision|0
7516461|NCT02962908|26097770|P3|Overall Study|Physician Decision|0
7516462|NCT02962908|26097771|P2|Overall Study|Physician Decision|1
7516463|NCT02962908|26097772|P1|Overall Study|Physician Decision|0
7516464|NCT02962908|26097769|P4|Overall Study|Protocol Violation|0
7516465|NCT02962908|26097770|P3|Overall Study|Protocol Violation|0
7516466|NCT02962908|26097771|P2|Overall Study|Protocol Violation|1
7516467|NCT02962908|26097772|P1|Overall Study|Protocol Violation|0
7516468|NCT02962908|26097769|P4|Overall Study|Withdrawal by Subject|2
7516469|NCT02962908|26097770|P3|Overall Study|Withdrawal by Subject|0
7516470|NCT02962908|26097771|P2|Overall Study|Withdrawal by Subject|3
7516471|NCT02962908|26097772|P1|Overall Study|Withdrawal by Subject|0
7516472|NCT02962908|26097769|P4|Overall Study|Lost to Follow-up|1
7516473|NCT02962908|26097770|P3|Overall Study|Lost to Follow-up|0
7516474|NCT02962908|26097771|P2|Overall Study|Lost to Follow-up|3
7516475|NCT02962908|26097772|P1|Overall Study|Lost to Follow-up|0
7516476|NCT02962882|26097836|P1|Overall Study|Transfer from ICU|32
7516477|NCT02962882|26097836|P1|Overall Study|Withdrawal by Subject|2
7516478|NCT02962882|26097836|P1|Overall Study|Adverse Event|2
7516484|NCT02962739|26097856|P6|Overall Study|Protocol Violation|0
7516485|NCT02962739|26097857|P5|Overall Study|Protocol Violation|1
7516486|NCT02962739|26097858|P4|Overall Study|Protocol Violation|0
7516487|NCT02962739|26097859|P3|Overall Study|Protocol Violation|1
7516488|NCT02962739|26097860|P2|Overall Study|Protocol Violation|0
7516489|NCT02962739|26097861|P1|Overall Study|Protocol Violation|0
7516490|NCT02962739|26097856|P6|Overall Study|Withdrawal by Subject|0
7516491|NCT02962739|26097857|P5|Overall Study|Withdrawal by Subject|0
7516492|NCT02962739|26097858|P4|Overall Study|Withdrawal by Subject|0
7516493|NCT02962739|26097859|P3|Overall Study|Withdrawal by Subject|0
7516494|NCT02962739|26097860|P2|Overall Study|Withdrawal by Subject|1
7516495|NCT02962739|26097861|P1|Overall Study|Withdrawal by Subject|0
7516496|NCT02962674|26097894|P1|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
7516497|NCT02962648|26097911|P1|Overall Study|Subject had problems with transportation|2
7516498|NCT02962648|26097911|P1|Overall Study|Physician Decision|1
7516499|NCT02962648|26097911|P1|Overall Study|Lost to Follow-up|3
7516500|NCT02962648|26097911|P1|Overall Study|Withdrawal by Subject|3
7516501|NCT02962284|26097949|P2|Overall Study|Withdrawal by Subject|0
7516502|NCT02962284|26097950|P1|Overall Study|Withdrawal by Subject|1
7516503|NCT02962284|26097949|P2|Overall Study|Progressive disease|3
7516504|NCT02962284|26097950|P1|Overall Study|Progressive disease|2
7516505|NCT02962284|26097949|P2|Overall Study|Death|0
7516506|NCT02962284|26097950|P1|Overall Study|Death|2
7516507|NCT02961920|26097981|P2|Overall Study|did not achive stydy protocol schedule|1
7516508|NCT02961920|26097982|P1|Overall Study|did not achive stydy protocol schedule|1
7516509|NCT02961790|26098010|P4|Overall Study|without post baseline data|1
7516510|NCT02961790|26098011|P3|Overall Study|without post baseline data|4
7516511|NCT02961790|26098012|P2|Overall Study|without post baseline data|6
7516512|NCT02961790|26098013|P1|Overall Study|without post baseline data|7
7516513|NCT02961790|26098010|P4|Overall Study|without baseline data|0
7516514|NCT02961790|26098011|P3|Overall Study|without baseline data|1
7516515|NCT02961790|26098012|P2|Overall Study|without baseline data|0
7516516|NCT02961790|26098013|P1|Overall Study|without baseline data|4
7516517|NCT02961790|26098010|P4|Overall Study|Canceled|4
7516518|NCT02961790|26098011|P3|Overall Study|Canceled|1
7516519|NCT02961790|26098012|P2|Overall Study|Canceled|5
7516520|NCT02961790|26098013|P1|Overall Study|Canceled|4
7516521|NCT02961764|26098036|P2|Overall Study|Withdrawal by Subject|0
7516522|NCT02961764|26098037|P1|Overall Study|Withdrawal by Subject|2
7516523|NCT02961764|26098036|P2|Overall Study|Lost to Follow-up|24
7516524|NCT02961764|26098037|P1|Overall Study|Lost to Follow-up|35
7516525|NCT02961764|26098036|P2|Overall Study|Death|0
7516526|NCT02961764|26098037|P1|Overall Study|Death|2
7516527|NCT02961764|26098036|P2|Overall Study|Protocol Violation|1
7516528|NCT02961764|26098037|P1|Overall Study|Protocol Violation|0
7516529|NCT02961751|26098111|P1|Overall Study|Protocol Violation|1
7516530|NCT02961751|26098111|P1|Overall Study|Not Eligible at Enrollment|1
7516531|NCT02961751|26098111|P1|Overall Study|Physician Decision|2
7516532|NCT02961751|26098111|P1|Overall Study|Lost to Follow-up|11
7516533|NCT02961374|26098122|P1|Overall Study|Adverse Event|4
7516534|NCT02961244|26098136|P2|Overall Study|İnadequate data|2
7516535|NCT02961244|26098137|P1|Overall Study|İnadequate data|0
7516536|NCT02961244|26098136|P2|Overall Study|Lost to Follow-up|2
7516537|NCT02961244|26098137|P1|Overall Study|Lost to Follow-up|0
7516538|NCT02961244|26098136|P2|Overall Study|Surgery plan change after study approval|2
7516539|NCT02961244|26098137|P1|Overall Study|Surgery plan change after study approval|0
7516540|NCT02961244|26098136|P2|Overall Study|Withdrawal by Subject|2
7516541|NCT02961244|26098137|P1|Overall Study|Withdrawal by Subject|1
7516542|NCT02961244|26098136|P2|Overall Study|Protocol Violation|1
7516543|NCT02961244|26098137|P1|Overall Study|Protocol Violation|0
7516544|NCT02961218|26098147|P2|Overall Study|Subject/Guardian Decision|1
7516545|NCT02961218|26098148|P1|Overall Study|Subject/Guardian Decision|3
7516546|NCT02961218|26098147|P2|Overall Study|Physician Decision|2
7516547|NCT02961218|26098148|P1|Overall Study|Physician Decision|0
7516548|NCT02961218|26098147|P2|Overall Study|Lost to Follow-up|2
7516549|NCT02961218|26098148|P1|Overall Study|Lost to Follow-up|0
7516550|NCT02960893|26098228|P2|Extension Phase (48-week)|Sponsors Decision|0
7516551|NCT02960893|26098229|P1|Extension Phase (48-week)|Sponsors Decision|1
7516552|NCT02960893|26098228|P2|Extension Phase (48-week)|Lost to Follow-up|1
7516553|NCT02960893|26098229|P1|Extension Phase (48-week)|Lost to Follow-up|1
7516554|NCT02960893|26098228|P2|Extension Phase (48-week)|Other Reason|1
7516555|NCT02960893|26098229|P1|Extension Phase (48-week)|Other Reason|2
7516556|NCT02960893|26098228|P2|Extension Phase (48-week)|Withdrawal by Subject|8
7516557|NCT02960893|26098229|P1|Extension Phase (48-week)|Withdrawal by Subject|8
7516558|NCT02960893|26098228|P2|Extension Phase (48-week)|Adverse Event|3
7516559|NCT02960893|26098229|P1|Extension Phase (48-week)|Adverse Event|2
7516560|NCT02960893|26098228|P2|Randomization Phase (8-week)|Reason Not Specified|1
7516561|NCT02960893|26098229|P1|Randomization Phase (8-week)|Reason Not Specified|0
7516562|NCT02960893|26098228|P2|Randomization Phase (8-week)|Withdrawal by Subject|1
7516563|NCT02960893|26098229|P1|Randomization Phase (8-week)|Withdrawal by Subject|2
7516564|NCT02960893|26098228|P2|Randomization Phase (8-week)|Adverse Event|0
7516565|NCT02960893|26098229|P1|Randomization Phase (8-week)|Adverse Event|5
7516566|NCT02960854|26098247|P2|Overall Study|Death|6
7516567|NCT02960854|26098248|P1|Overall Study|Death|4
7516568|NCT02960854|26098247|P2|Overall Study|Subject Withdrew Consent|1
7516569|NCT02960854|26098248|P1|Overall Study|Subject Withdrew Consent|0
7516570|NCT02960854|26098247|P2|Overall Study|Subject No Longer Meets Study Criteria|0
7516571|NCT02960854|26098248|P1|Overall Study|Subject No Longer Meets Study Criteria|1
7516572|NCT02960854|26098247|P2|Overall Study|Not Disclosed|2
7516573|NCT02960854|26098248|P1|Overall Study|Not Disclosed|2
7516574|NCT02960490|26098280|P10|Extension Phase(Open-label): 80 Weeks|Other|0
7516575|NCT02960490|26098281|P9|Extension Phase(Open-label): 80 Weeks|Other|0
7516576|NCT02960490|26098282|P8|Extension Phase(Open-label): 80 Weeks|Other|1
7516577|NCT02960490|26098283|P7|Extension Phase(Open-label): 80 Weeks|Other|0
7516578|NCT02960490|26098284|P6|Extension Phase(Open-label): 80 Weeks|Other|0
7516579|NCT02960490|26098285|P5|Extension Phase(Open-label): 80 Weeks|Other|0
7516580|NCT02960490|26098286|P4|Extension Phase(Open-label): 80 Weeks|Other|0
7516581|NCT02960490|26098287|P3|Extension Phase(Open-label): 80 Weeks|Other|0
7516582|NCT02960490|26098288|P2|Extension Phase(Open-label): 80 Weeks|Other|0
7516583|NCT02960490|26098289|P1|Extension Phase(Open-label): 80 Weeks|Other|0
7516584|NCT02960490|26098280|P10|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516585|NCT02960490|26098281|P9|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516586|NCT02960490|26098282|P8|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516587|NCT02960490|26098283|P7|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
7516588|NCT02960490|26098284|P6|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516589|NCT02960490|26098285|P5|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516590|NCT02960490|26098286|P4|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516591|NCT02960490|26098287|P3|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516592|NCT02960490|26098288|P2|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516593|NCT02960490|26098289|P1|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7516594|NCT02960490|26098280|P10|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
7516595|NCT02960490|26098281|P9|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7516596|NCT02960490|26098282|P8|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7516597|NCT02960490|26098283|P7|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
7516598|NCT02960490|26098284|P6|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7516599|NCT02960490|26098285|P5|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7516600|NCT02960490|26098286|P4|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7516601|NCT02960490|26098287|P3|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7516602|NCT02960490|26098288|P2|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7516603|NCT02960490|26098289|P1|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7516604|NCT02960490|26098280|P10|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516605|NCT02960490|26098281|P9|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516606|NCT02960490|26098282|P8|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
7516607|NCT02960490|26098283|P7|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516608|NCT02960490|26098284|P6|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516609|NCT02960490|26098285|P5|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516610|NCT02960490|26098286|P4|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516611|NCT02960490|26098287|P3|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516612|NCT02960490|26098288|P2|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516613|NCT02960490|26098289|P1|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7516614|NCT02960490|26098280|P10|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516615|NCT02960490|26098281|P9|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7516616|NCT02960490|26098282|P8|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7516617|NCT02960490|26098283|P7|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
7516618|NCT02960490|26098284|P6|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516619|NCT02960490|26098285|P5|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516620|NCT02960490|26098286|P4|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516621|NCT02960490|26098287|P3|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516622|NCT02960490|26098288|P2|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516623|NCT02960490|26098289|P1|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7516624|NCT02960490|26098280|P10|Re-randomized Participants: 12 Weeks|Other|0
7516625|NCT02960490|26098281|P9|Re-randomized Participants: 12 Weeks|Other|0
7516626|NCT02960490|26098282|P8|Re-randomized Participants: 12 Weeks|Other|0
7516627|NCT02960490|26098283|P7|Re-randomized Participants: 12 Weeks|Other|0
7516628|NCT02960490|26098284|P6|Re-randomized Participants: 12 Weeks|Other|0
7516629|NCT02960490|26098285|P5|Re-randomized Participants: 12 Weeks|Other|0
7516630|NCT02960490|26098286|P4|Re-randomized Participants: 12 Weeks|Other|1
7516631|NCT02960490|26098287|P3|Re-randomized Participants: 12 Weeks|Other|0
7516632|NCT02960490|26098288|P2|Re-randomized Participants: 12 Weeks|Other|0
7516633|NCT02960490|26098289|P1|Re-randomized Participants: 12 Weeks|Other|0
7516634|NCT02960490|26098280|P10|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516635|NCT02960490|26098281|P9|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516636|NCT02960490|26098282|P8|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516637|NCT02960490|26098283|P7|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516638|NCT02960490|26098284|P6|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516639|NCT02960490|26098285|P5|Re-randomized Participants: 12 Weeks|Adverse Event|1
7516640|NCT02960490|26098286|P4|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516641|NCT02960490|26098287|P3|Re-randomized Participants: 12 Weeks|Adverse Event|1
7516642|NCT02960490|26098288|P2|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516643|NCT02960490|26098289|P1|Re-randomized Participants: 12 Weeks|Adverse Event|0
7516644|NCT02960490|26098280|P10|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516645|NCT02960490|26098281|P9|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516646|NCT02960490|26098282|P8|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516647|NCT02960490|26098283|P7|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516648|NCT02960490|26098284|P6|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
7516649|NCT02960490|26098285|P5|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516650|NCT02960490|26098286|P4|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7516651|NCT02960490|26098287|P3|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7516652|NCT02960490|26098288|P2|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516653|NCT02960490|26098289|P1|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7516654|NCT02960490|26098280|P10|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516655|NCT02960490|26098281|P9|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516656|NCT02960490|26098282|P8|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516657|NCT02960490|26098283|P7|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516658|NCT02960490|26098284|P6|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516659|NCT02960490|26098285|P5|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516660|NCT02960490|26098286|P4|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516661|NCT02960490|26098287|P3|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7516662|NCT02960490|26098288|P2|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7516663|NCT02960490|26098289|P1|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7516664|NCT02960490|26098280|P10|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516665|NCT02960490|26098281|P9|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516666|NCT02960490|26098282|P8|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516667|NCT02960490|26098283|P7|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516668|NCT02960490|26098284|P6|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516669|NCT02960490|26098285|P5|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516670|NCT02960490|26098286|P4|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516671|NCT02960490|26098287|P3|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7516672|NCT02960490|26098288|P2|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
7516673|NCT02960490|26098289|P1|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
7516674|NCT02960490|26098280|P10|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516675|NCT02960490|26098281|P9|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516676|NCT02960490|26098282|P8|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516677|NCT02960490|26098283|P7|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516678|NCT02960490|26098284|P6|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516679|NCT02960490|26098285|P5|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516680|NCT02960490|26098286|P4|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516681|NCT02960490|26098287|P3|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516682|NCT02960490|26098288|P2|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
7516683|NCT02960490|26098289|P1|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7516684|NCT02960490|26098280|P10|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516685|NCT02960490|26098281|P9|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516686|NCT02960490|26098282|P8|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516687|NCT02960490|26098283|P7|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516688|NCT02960490|26098284|P6|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516689|NCT02960490|26098285|P5|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516690|NCT02960490|26098286|P4|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516691|NCT02960490|26098287|P3|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7516692|NCT02960490|26098288|P2|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
7516693|NCT02960490|26098289|P1|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
7516694|NCT02960438|26098467|P4|Extension Phase (Open-label): 80 Weeks|Other|1
7516695|NCT02960438|26098468|P3|Extension Phase (Open-label): 80 Weeks|Other|1
7516696|NCT02960438|26098469|P2|Extension Phase (Open-label): 80 Weeks|Other|0
7516697|NCT02960438|26098470|P1|Extension Phase (Open-label): 80 Weeks|Other|0
7516698|NCT02960438|26098467|P4|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7516699|NCT02960438|26098468|P3|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7516700|NCT02960438|26098469|P2|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7516701|NCT02960438|26098470|P1|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7516702|NCT02960438|26098467|P4|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
7516703|NCT02960438|26098468|P3|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7516704|NCT02960438|26098469|P2|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
7516705|NCT02960438|26098470|P1|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7516706|NCT02960438|26098467|P4|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7516707|NCT02960438|26098468|P3|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
7516708|NCT02960438|26098469|P2|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7516709|NCT02960438|26098470|P1|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7516710|NCT02960438|26098467|P4|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7516711|NCT02960438|26098468|P3|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
7516712|NCT02960438|26098469|P2|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7516713|NCT02960438|26098470|P1|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7516714|NCT02960438|26098467|P4|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7516715|NCT02960438|26098468|P3|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
7516716|NCT02960438|26098469|P2|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
7516717|NCT02960438|26098470|P1|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7516718|NCT02960438|26098467|P4|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7516719|NCT02960438|26098468|P3|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
7516720|NCT02960438|26098469|P2|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7516721|NCT02960438|26098470|P1|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
7516722|NCT02960438|26098467|P4|Treatment Phase (Double-blind): 24 Weeks|Other|0
7516723|NCT02960438|26098468|P3|Treatment Phase (Double-blind): 24 Weeks|Other|1
7516724|NCT02960438|26098469|P2|Treatment Phase (Double-blind): 24 Weeks|Other|0
7516725|NCT02960438|26098470|P1|Treatment Phase (Double-blind): 24 Weeks|Other|0
7516726|NCT02960438|26098467|P4|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7516727|NCT02960438|26098468|P3|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7516728|NCT02960438|26098469|P2|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7516729|NCT02960438|26098470|P1|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7516730|NCT02960438|26098467|P4|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7516731|NCT02960438|26098468|P3|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7516732|NCT02960438|26098469|P2|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7516733|NCT02960438|26098470|P1|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
7516734|NCT02960438|26098467|P4|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
7516735|NCT02960438|26098468|P3|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
7516736|NCT02960438|26098469|P2|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
7516737|NCT02960438|26098470|P1|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
7516738|NCT02960438|26098467|P4|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
7516739|NCT02960438|26098468|P3|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7516740|NCT02960438|26098469|P2|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
7516741|NCT02960438|26098470|P1|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7516742|NCT02960217|26098649|P2|Open-Label Extension Phase|Other, Not Specified|1
7516743|NCT02960217|26098650|P1|Open-Label Extension Phase|Other, Not Specified|0
7516744|NCT02960217|26098649|P2|Open-Label Extension Phase|Lack of Efficacy|1
7516745|NCT02960217|26098650|P1|Open-Label Extension Phase|Lack of Efficacy|1
7516746|NCT02960217|26098649|P2|Open-Label Extension Phase|Sponsor Decision|11
7516747|NCT02960217|26098650|P1|Open-Label Extension Phase|Sponsor Decision|18
7516748|NCT02960217|26098649|P2|Open-Label Extension Phase|Adverse Event|0
7516749|NCT02960217|26098650|P1|Open-Label Extension Phase|Adverse Event|1
7516750|NCT02960217|26098649|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
7516751|NCT02960217|26098650|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
7516752|NCT02960217|26098649|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
7516753|NCT02960217|26098650|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
7516754|NCT02960217|26098649|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
7516755|NCT02960217|26098650|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
7516756|NCT02960217|26098649|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
7516757|NCT02960217|26098650|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
7516758|NCT02960217|26098649|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
7516759|NCT02960217|26098650|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
7516760|NCT02959983|26098729|P2|Overall Study|Withdrawal by Subject|12
7516761|NCT02959983|26098730|P1|Overall Study|Withdrawal by Subject|7
7516762|NCT02959983|26098729|P2|Overall Study|Adverse Event|1
7516763|NCT02959983|26098730|P1|Overall Study|Adverse Event|5
7516764|NCT02959983|26098729|P2|Overall Study|Physician Decision|0
7516765|NCT02959983|26098730|P1|Overall Study|Physician Decision|1
7516766|NCT02959983|26098729|P2|Overall Study|Other|1
7516767|NCT02959983|26098730|P1|Overall Study|Other|1
7516768|NCT02959983|26098729|P2|Overall Study|Lost to Follow-up|9
7516769|NCT02959983|26098730|P1|Overall Study|Lost to Follow-up|12
7516770|NCT02959983|26098729|P2|Overall Study|Lack of Efficacy|1
7516771|NCT02959983|26098730|P1|Overall Study|Lack of Efficacy|0
7516772|NCT02959983|26098729|P2|Overall Study|Protocol Violation|1
7516773|NCT02959983|26098730|P1|Overall Study|Protocol Violation|0
7516774|NCT02959970|26098744|P2|Overall Study|Lost to Follow-up|5
7516775|NCT02959970|26098745|P1|Overall Study|Lost to Follow-up|1
7516776|NCT02959970|26098744|P2|Overall Study|Withdrawal by Subject|2
7516777|NCT02959970|26098745|P1|Overall Study|Withdrawal by Subject|0
7516778|NCT02959970|26098744|P2|Overall Study|Adverse Event|0
7516779|NCT02959970|26098745|P1|Overall Study|Adverse Event|1
7516780|NCT02959892|26098804|P2|Overall Study|Study termination|1
7516781|NCT02959892|26098805|P1|Overall Study|Study termination|0
7516782|NCT02959892|26098804|P2|Overall Study|PET tracer synthesis failure|0
7516783|NCT02959892|26098805|P1|Overall Study|PET tracer synthesis failure|1
7516784|NCT02959866|26098813|P1|Overall Study|Withdrawal by Subject|1
7516785|NCT02959814|26098902|P1|Overall Study|Excluded by FFR core-lab|24
7516786|NCT02959814|26098902|P1|Overall Study|In-procedure QFR not computed|6
7516787|NCT02959814|26098902|P1|Overall Study|FFR not measured|2
7516788|NCT02959814|26098902|P1|Overall Study|Protocol Violation|7
7516789|NCT02959814|26098902|P1|Overall Study|Excluded based on anatomical criteria|2
7516790|NCT02959814|26098902|P1|Overall Study|Excluded based on diagnostic angiography|16
7516791|NCT02959671|26098921|P1|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
7516792|NCT02959671|26098921|P1|Overall Study|Adverse Event|2
7516793|NCT02959437|26098933|P4|Overall Study|Other Unspecified|0
7516794|NCT02959437|26098934|P3|Overall Study|Other Unspecified|0
7516795|NCT02959437|26098935|P2|Overall Study|Other Unspecified|0
7516796|NCT02959437|26098936|P1|Overall Study|Other Unspecified|2
7516797|NCT02959437|26098933|P4|Overall Study|Study Terminated by Sponsor|0
7516798|NCT02959437|26098934|P3|Overall Study|Study Terminated by Sponsor|0
7516799|NCT02959437|26098935|P2|Overall Study|Study Terminated by Sponsor|0
7516800|NCT02959437|26098936|P1|Overall Study|Study Terminated by Sponsor|4
7516801|NCT02959437|26098933|P4|Overall Study|Progressive Disease|0
7516802|NCT02959437|26098934|P3|Overall Study|Progressive Disease|0
7516803|NCT02959437|26098935|P2|Overall Study|Progressive Disease|1
7516804|NCT02959437|26098936|P1|Overall Study|Progressive Disease|9
7516805|NCT02959437|26098933|P4|Overall Study|Withdrawal by Subject|0
7516806|NCT02959437|26098934|P3|Overall Study|Withdrawal by Subject|0
7516807|NCT02959437|26098935|P2|Overall Study|Withdrawal by Subject|3
7516808|NCT02959437|26098936|P1|Overall Study|Withdrawal by Subject|11
7516809|NCT02959437|26098933|P4|Overall Study|Lost to Follow-up|0
7516810|NCT02959437|26098934|P3|Overall Study|Lost to Follow-up|0
7516811|NCT02959437|26098935|P2|Overall Study|Lost to Follow-up|1
7516812|NCT02959437|26098936|P1|Overall Study|Lost to Follow-up|3
7516813|NCT02959437|26098933|P4|Overall Study|Death|0
7516814|NCT02959437|26098934|P3|Overall Study|Death|0
7516815|NCT02959437|26098935|P2|Overall Study|Death|3
7516816|NCT02959437|26098936|P1|Overall Study|Death|33
7516817|NCT02959190|26098980|P4|Post Treatment Follow Up|Withdrawal by Subject|0
7516818|NCT02959190|26098981|P3|Post Treatment Follow Up|Withdrawal by Subject|1
7516819|NCT02959190|26098982|P2|Post Treatment Follow Up|Withdrawal by Subject|0
7516820|NCT02959190|26098983|P1|Post Treatment Follow Up|Withdrawal by Subject|2
7516821|NCT02959190|26098980|P4|Post Treatment Follow Up|Adverse Event|0
7516822|NCT02959190|26098981|P3|Post Treatment Follow Up|Adverse Event|0
7516823|NCT02959190|26098982|P2|Post Treatment Follow Up|Adverse Event|1
7516824|NCT02959190|26098983|P1|Post Treatment Follow Up|Adverse Event|1
7516825|NCT02959190|26098980|P4|Open Label|Protocol Violation|2
7516826|NCT02959190|26098981|P3|Open Label|Protocol Violation|0
7516827|NCT02959190|26098982|P2|Open Label|Protocol Violation|0
7516828|NCT02959190|26098983|P1|Open Label|Protocol Violation|0
7516829|NCT02959190|26098980|P4|Open Label|Physician Decision|0
7516830|NCT02959190|26098981|P3|Open Label|Physician Decision|1
7516831|NCT02959190|26098982|P2|Open Label|Physician Decision|0
7516832|NCT02959190|26098983|P1|Open Label|Physician Decision|0
7516833|NCT02959190|26098980|P4|Open Label|Withdrawal by Subject|0
7516834|NCT02959190|26098981|P3|Open Label|Withdrawal by Subject|0
7516835|NCT02959190|26098982|P2|Open Label|Withdrawal by Subject|8
7516836|NCT02959190|26098983|P1|Open Label|Withdrawal by Subject|2
7516837|NCT02959190|26098980|P4|Open Label|Pregnancy|0
7516838|NCT02959190|26098981|P3|Open Label|Pregnancy|0
7516839|NCT02959190|26098982|P2|Open Label|Pregnancy|1
7516840|NCT02959190|26098983|P1|Open Label|Pregnancy|0
7516841|NCT02959190|26098980|P4|Open Label|Adverse Event|4
7516842|NCT02959190|26098981|P3|Open Label|Adverse Event|3
7516843|NCT02959190|26098982|P2|Open Label|Adverse Event|7
7516844|NCT02959190|26098983|P1|Open Label|Adverse Event|5
7516845|NCT02959177|26099076|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
7516846|NCT02959177|26099077|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7516847|NCT02959177|26099078|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7516848|NCT02959177|26099076|P3|Follow-up Post Treatment Phase|Adverse Event|0
7516849|NCT02959177|26099077|P2|Follow-up Post Treatment Phase|Adverse Event|1
7516850|NCT02959177|26099078|P1|Follow-up Post Treatment Phase|Adverse Event|0
7516851|NCT02959177|26099076|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
7516852|NCT02959177|26099077|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
7516853|NCT02959177|26099078|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
7516854|NCT02959177|26099076|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
7516855|NCT02959177|26099077|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
7516856|NCT02959177|26099078|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
7516857|NCT02959177|26099076|P3|Double-Blind Treatment Phase|Protocol Violation|0
7516858|NCT02959177|26099077|P2|Double-Blind Treatment Phase|Protocol Violation|1
7516859|NCT02959177|26099078|P1|Double-Blind Treatment Phase|Protocol Violation|0
7516860|NCT02959177|26099076|P3|Double-Blind Treatment Phase|Physician Decision|0
7516861|NCT02959177|26099077|P2|Double-Blind Treatment Phase|Physician Decision|0
7516862|NCT02959177|26099078|P1|Double-Blind Treatment Phase|Physician Decision|1
7516863|NCT02959177|26099076|P3|Double-Blind Treatment Phase|Adverse Event|0
7516864|NCT02959177|26099077|P2|Double-Blind Treatment Phase|Adverse Event|2
7516865|NCT02959177|26099078|P1|Double-Blind Treatment Phase|Adverse Event|5
7516866|NCT02959138|26099133|P3|Overall Study|Enrolled but Never Treated|0
7516867|NCT02959138|26099134|P2|Overall Study|Enrolled but Never Treated|1
7516868|NCT02959138|26099135|P1|Overall Study|Enrolled but Never Treated|0
7516869|NCT02958553|26099276|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
7516870|NCT02958553|26099276|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
7516871|NCT02958527|26099297|P1|Overall Study|Not collected CRFs|12
7516872|NCT02958267|26099325|P2|Follow-up Visits|Additional treatment pursued|1
7516873|NCT02958267|26099326|P1|Follow-up Visits|Additional treatment pursued|2
7516874|NCT02958267|26099325|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
7516875|NCT02958267|26099326|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
7516876|NCT02958267|26099325|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
7516877|NCT02958267|26099326|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
7516878|NCT02957942|26099338|P2|Overall Study|Practicing experiment protocol|6
7516879|NCT02957942|26099339|P1|Overall Study|Practicing experiment protocol|0
7516880|NCT02957942|26099338|P2|Overall Study|Withdrawal by Subject|1
7516881|NCT02957942|26099339|P1|Overall Study|Withdrawal by Subject|0
7516882|NCT02957747|26099355|P2|Overall Study|Lost to Follow-up|5
7516883|NCT02957747|26099356|P1|Overall Study|Lost to Follow-up|10
7516884|NCT02957747|26099355|P2|Overall Study|Withdrawal by Subject|3
7516885|NCT02957747|26099356|P1|Overall Study|Withdrawal by Subject|0
7516886|NCT02957682|26099392|P2|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
7516887|NCT02957682|26099393|P1|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
7516888|NCT02957682|26099392|P2|Overall Study|Non-disclosed|12
7516889|NCT02957682|26099393|P1|Overall Study|Non-disclosed|16
7516890|NCT02957682|26099392|P2|Overall Study|Related to IMP Administration|6
7516891|NCT02957682|26099393|P1|Overall Study|Related to IMP Administration|3
7516892|NCT02957682|26099392|P2|Overall Study|Withdrawal by Subject|33
7516893|NCT02957682|26099393|P1|Overall Study|Withdrawal by Subject|64
7516894|NCT02957682|26099392|P2|Overall Study|Subject Moved|16
7516895|NCT02957682|26099393|P1|Overall Study|Subject Moved|10
7516896|NCT02957682|26099392|P2|Overall Study|Study Terminated by Sponsor|3
7516897|NCT02957682|26099393|P1|Overall Study|Study Terminated by Sponsor|4
7516898|NCT02957682|26099392|P2|Overall Study|Physician Decision|4
7516899|NCT02957682|26099393|P1|Overall Study|Physician Decision|4
7516900|NCT02957682|26099392|P2|Overall Study|Poor Compliance to Protocol|26
7516901|NCT02957682|26099393|P1|Overall Study|Poor Compliance to Protocol|30
7516902|NCT02957682|26099392|P2|Overall Study|Adverse Event|67
7516903|NCT02957682|26099393|P1|Overall Study|Adverse Event|64
7516904|NCT02957331|26099425|P2|Overall Study|Protocol Violation|0
7516905|NCT02957331|26099426|P1|Overall Study|Protocol Violation|1
7516906|NCT02957136|26099449|P2|Overall Study|Withdrawal by Subject|1
7516907|NCT02957136|26099450|P1|Overall Study|Withdrawal by Subject|2
7516908|NCT02956967|26099480|P1|Overall Study|Termination of Nivestim administration|29
7516909|NCT02956967|26099480|P1|Overall Study|Missing|1
7516910|NCT02956967|26099480|P1|Overall Study|Lost to Follow-up|5
7516911|NCT02956967|26099480|P1|Overall Study|Reason non-related to neutropenia|10
7516912|NCT02956967|26099480|P1|Overall Study|Adverse Event|3
7516913|NCT02956837|26099507|P4|Overall Study|Lost to Follow-up|0
7516914|NCT02956837|26099508|P3|Overall Study|Lost to Follow-up|2
7516915|NCT02956837|26099509|P2|Overall Study|Lost to Follow-up|1
7516916|NCT02956837|26099510|P1|Overall Study|Lost to Follow-up|0
7516917|NCT02956837|26099507|P4|Overall Study|Withdrawal by Subject|3
7516918|NCT02956837|26099508|P3|Overall Study|Withdrawal by Subject|0
7516919|NCT02956837|26099509|P2|Overall Study|Withdrawal by Subject|1
7516920|NCT02956837|26099510|P1|Overall Study|Withdrawal by Subject|0
7516921|NCT02956837|26099507|P4|Overall Study|Serious Adverse Events|0
7516922|NCT02956837|26099508|P3|Overall Study|Serious Adverse Events|0
7516923|NCT02956837|26099509|P2|Overall Study|Serious Adverse Events|1
7516924|NCT02956837|26099510|P1|Overall Study|Serious Adverse Events|0
7516925|NCT02956629|26099645|P6|Overall Study|Withdrawal by Subject|0
7516926|NCT02956629|26099646|P5|Overall Study|Withdrawal by Subject|0
7516927|NCT02956629|26099647|P4|Overall Study|Withdrawal by Subject|0
7516928|NCT02956629|26099648|P3|Overall Study|Withdrawal by Subject|0
7516929|NCT02956629|26099649|P2|Overall Study|Withdrawal by Subject|1
7516930|NCT02956629|26099650|P1|Overall Study|Withdrawal by Subject|3
7516931|NCT02956629|26099645|P6|Overall Study|Lost to Follow-up|1
7516932|NCT02956629|26099646|P5|Overall Study|Lost to Follow-up|0
7516933|NCT02956629|26099647|P4|Overall Study|Lost to Follow-up|1
7516934|NCT02956629|26099648|P3|Overall Study|Lost to Follow-up|3
7516935|NCT02956629|26099649|P2|Overall Study|Lost to Follow-up|5
7516936|NCT02956629|26099650|P1|Overall Study|Lost to Follow-up|2
7516937|NCT02956629|26099645|P6|Overall Study|Adverse Event|0
7516938|NCT02956629|26099646|P5|Overall Study|Adverse Event|0
7516939|NCT02956629|26099647|P4|Overall Study|Adverse Event|0
7516940|NCT02956629|26099648|P3|Overall Study|Adverse Event|1
7516941|NCT02956629|26099649|P2|Overall Study|Adverse Event|0
7516942|NCT02956629|26099650|P1|Overall Study|Adverse Event|0
7516943|NCT02956486|26099729|P3|Extension Phase|Not Treated|1
7516944|NCT02956486|26099730|P2|Extension Phase|Not Treated|0
7516945|NCT02956486|26099731|P1|Extension Phase|Not Treated|0
7516946|NCT02956486|26099729|P3|Extension Phase|Study terminated by sponsor|16
7516947|NCT02956486|26099730|P2|Extension Phase|Study terminated by sponsor|0
7516948|NCT02956486|26099731|P1|Extension Phase|Study terminated by sponsor|0
7516949|NCT02956486|26099729|P3|Extension Phase|Adverse Event|2
7516950|NCT02956486|26099730|P2|Extension Phase|Adverse Event|0
7516951|NCT02956486|26099731|P1|Extension Phase|Adverse Event|0
7516952|NCT02956486|26099729|P3|Core Phase|Not treated|0
7516953|NCT02956486|26099730|P2|Core Phase|Not treated|3
7516954|NCT02956486|26099731|P1|Core Phase|Not treated|0
7516955|NCT02956486|26099729|P3|Core Phase|Other|0
7516956|NCT02956486|26099730|P2|Core Phase|Other|18
7516957|NCT02956486|26099731|P1|Core Phase|Other|27
7516958|NCT02956486|26099729|P3|Core Phase|Study terminated by sponsor|0
7516959|NCT02956486|26099730|P2|Core Phase|Study terminated by sponsor|848
7516960|NCT02956486|26099731|P1|Core Phase|Study terminated by sponsor|888
7516961|NCT02956486|26099729|P3|Core Phase|Withdrawal by Subject|0
7516962|NCT02956486|26099730|P2|Core Phase|Withdrawal by Subject|104
7516963|NCT02956486|26099731|P1|Core Phase|Withdrawal by Subject|101
7516964|NCT02956486|26099729|P3|Core Phase|Inadequate therapeutic effect|0
7516965|NCT02956486|26099730|P2|Core Phase|Inadequate therapeutic effect|5
7516966|NCT02956486|26099731|P1|Core Phase|Inadequate therapeutic effect|4
7516967|NCT02956486|26099729|P3|Core Phase|Lost to Follow-up|0
7516968|NCT02956486|26099730|P2|Core Phase|Lost to Follow-up|6
7516969|NCT02956486|26099731|P1|Core Phase|Lost to Follow-up|8
7516970|NCT02956486|26099729|P3|Core Phase|Adverse Event|0
7516971|NCT02956486|26099730|P2|Core Phase|Adverse Event|88
7516972|NCT02956486|26099731|P1|Core Phase|Adverse Event|51
7516973|NCT02956460|26099784|P2|Lens 1|Lost to Follow-up|0
7516974|NCT02956460|26099785|P1|Lens 1|Lost to Follow-up|1
7516975|NCT02956278|26099829|P3|Overall Study|Withdrawal by Subject|0
7516976|NCT02956278|26099830|P2|Overall Study|Withdrawal by Subject|2
7516977|NCT02956278|26099831|P1|Overall Study|Withdrawal by Subject|6
7516978|NCT02956057|26099915|P6|Overall Study|Lost to Follow-up|0
7516979|NCT02956057|26099916|P5|Overall Study|Lost to Follow-up|1
7516980|NCT02956057|26099917|P4|Overall Study|Lost to Follow-up|1
7516981|NCT02956057|26099918|P3|Overall Study|Lost to Follow-up|1
7516982|NCT02956057|26099919|P2|Overall Study|Lost to Follow-up|2
7516983|NCT02956057|26099920|P1|Overall Study|Lost to Follow-up|0
7516984|NCT02956057|26099915|P6|Overall Study|Discontinued intervention|17
7516985|NCT02956057|26099916|P5|Overall Study|Discontinued intervention|4
7516986|NCT02956057|26099917|P4|Overall Study|Discontinued intervention|14
7516987|NCT02956057|26099918|P3|Overall Study|Discontinued intervention|7
7516988|NCT02956057|26099919|P2|Overall Study|Discontinued intervention|10
7516989|NCT02956057|26099920|P1|Overall Study|Discontinued intervention|14
7516990|NCT02956005|26100001|P1|Overall Study|Physician Decision|12
7516991|NCT02956005|26100001|P1|Overall Study|Withdrawal by Subject|3
7516992|NCT02956005|26100001|P1|Overall Study|Not eligible|1
7516993|NCT02955797|26100010|P4|Overall Study|Lost to Follow-up|0
7516994|NCT02955797|26100011|P3|Overall Study|Lost to Follow-up|0
7516995|NCT02955797|26100012|P2|Overall Study|Lost to Follow-up|1
7516996|NCT02955797|26100013|P1|Overall Study|Lost to Follow-up|0
7516997|NCT02955797|26100010|P4|Overall Study|Withdrawal by Subject|1
7516998|NCT02955797|26100011|P3|Overall Study|Withdrawal by Subject|0
7516999|NCT02955797|26100012|P2|Overall Study|Withdrawal by Subject|2
7517000|NCT02955797|26100013|P1|Overall Study|Withdrawal by Subject|2
7517001|NCT02955797|26100010|P4|Overall Study|Protocol Violation|1
7517002|NCT02955797|26100011|P3|Overall Study|Protocol Violation|0
7517003|NCT02955797|26100012|P2|Overall Study|Protocol Violation|0
7517004|NCT02955797|26100013|P1|Overall Study|Protocol Violation|1
7517005|NCT02955212|26100069|P2|Period 2: Open-label Extension|Other|4
7517006|NCT02955212|26100070|P1|Period 2: Open-label Extension|Other|2
7517007|NCT02955212|26100069|P2|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
7517008|NCT02955212|26100070|P1|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
7517009|NCT02955212|26100069|P2|Period 2: Open-label Extension|Lack of Efficacy|2
7517010|NCT02955212|26100070|P1|Period 2: Open-label Extension|Lack of Efficacy|3
7517011|NCT02955212|26100069|P2|Period 2: Open-label Extension|Withdrawal by Subject|4
7517012|NCT02955212|26100070|P1|Period 2: Open-label Extension|Withdrawal by Subject|1
7517013|NCT02955212|26100069|P2|Period 2: Open-label Extension|Adverse Event|7
7517014|NCT02955212|26100070|P1|Period 2: Open-label Extension|Adverse Event|11
7517015|NCT02955212|26100069|P2|Period 1: Double-blind Treatment Period|Other|2
7517016|NCT02955212|26100070|P1|Period 1: Double-blind Treatment Period|Other|3
7517017|NCT02955212|26100069|P2|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
7517018|NCT02955212|26100070|P1|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
7517019|NCT02955212|26100069|P2|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
7517020|NCT02955212|26100070|P1|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
7517021|NCT02955212|26100069|P2|Period 1: Double-blind Treatment Period|Adverse Event|7
7517022|NCT02955212|26100070|P1|Period 1: Double-blind Treatment Period|Adverse Event|4
7517023|NCT02955186|26100097|P2|Overall Study|Protocol Violation|0
7517024|NCT02955186|26100098|P1|Overall Study|Protocol Violation|1
7517025|NCT02955186|26100097|P2|Overall Study|Withdrawal by Subject|2
7517026|NCT02955186|26100098|P1|Overall Study|Withdrawal by Subject|6
7517027|NCT02955069|26100119|P2|Overall Study|Subject/Guardian decision|1
7517028|NCT02955069|26100120|P1|Overall Study|Subject/Guardian decision|3
7517029|NCT02955069|26100119|P2|Overall Study|Study terminated by sponsor|0
7517030|NCT02955069|26100120|P1|Overall Study|Study terminated by sponsor|4
7517031|NCT02955069|26100119|P2|Overall Study|Progressive disease|13
7517032|NCT02955069|26100120|P1|Overall Study|Progressive disease|64
7517033|NCT02955069|26100119|P2|Overall Study|Physician Decision|2
7517034|NCT02955069|26100120|P1|Overall Study|Physician Decision|10
7517035|NCT02955069|26100119|P2|Overall Study|Death|3
7517036|NCT02955069|26100120|P1|Overall Study|Death|7
7517037|NCT02955069|26100119|P2|Overall Study|Adverse Event|2
7517038|NCT02955069|26100120|P1|Overall Study|Adverse Event|7
7517039|NCT02954952|26100166|P3|Overall Study|No data collected|0
7517040|NCT02954952|26100167|P2|Overall Study|No data collected|1
7517041|NCT02954952|26100168|P1|Overall Study|No data collected|0
7517042|NCT02954952|26100166|P3|Overall Study|Withdrawal by Subject|0
7517043|NCT02954952|26100167|P2|Overall Study|Withdrawal by Subject|0
7517044|NCT02954952|26100168|P1|Overall Study|Withdrawal by Subject|1
7517045|NCT02954887|26100176|P1|Overall Study|Other|1
7517046|NCT02954887|26100176|P1|Overall Study|Lack of Efficacy|3
7517047|NCT02954887|26100176|P1|Overall Study|Withdrawal by Subject|3
7517048|NCT02954848|26100205|P2|Overall Study|Withdrawal by Participant|1
7517049|NCT02954848|26100206|P1|Overall Study|Withdrawal by Participant|0
7517050|NCT02954848|26100205|P2|Overall Study|Adverse Event|3
7517051|NCT02954848|26100206|P1|Overall Study|Adverse Event|2
7517052|NCT02954848|26100205|P2|Overall Study|Randomized but Not Treated|1
7517053|NCT02954848|26100206|P1|Overall Study|Randomized but Not Treated|0
7517054|NCT02954653|26100266|P9|Overall Study|Treatment failure and consent withdrawal|0
7517055|NCT02954653|26100267|P8|Overall Study|Treatment failure and consent withdrawal|0
7517056|NCT02954653|26100268|P7|Overall Study|Treatment failure and consent withdrawal|0
7517057|NCT02954653|26100269|P6|Overall Study|Treatment failure and consent withdrawal|0
7517058|NCT02954653|26100270|P5|Overall Study|Treatment failure and consent withdrawal|0
7517059|NCT02954653|26100271|P4|Overall Study|Treatment failure and consent withdrawal|0
7517060|NCT02954653|26100272|P3|Overall Study|Treatment failure and consent withdrawal|0
7517061|NCT02954653|26100273|P2|Overall Study|Treatment failure and consent withdrawal|1
7517062|NCT02954653|26100274|P1|Overall Study|Treatment failure and consent withdrawal|0
7517063|NCT02954653|26100266|P9|Overall Study|Started another anti-cancer therapy|0
7517064|NCT02954653|26100267|P8|Overall Study|Started another anti-cancer therapy|0
7517065|NCT02954653|26100268|P7|Overall Study|Started another anti-cancer therapy|0
7517066|NCT02954653|26100269|P6|Overall Study|Started another anti-cancer therapy|0
7517067|NCT02954653|26100270|P5|Overall Study|Started another anti-cancer therapy|0
7517068|NCT02954653|26100271|P4|Overall Study|Started another anti-cancer therapy|0
7517069|NCT02954653|26100272|P3|Overall Study|Started another anti-cancer therapy|0
7517070|NCT02954653|26100273|P2|Overall Study|Started another anti-cancer therapy|1
7517071|NCT02954653|26100274|P1|Overall Study|Started another anti-cancer therapy|0
7517072|NCT02954653|26100266|P9|Overall Study|Randomized but did not receive treatment|0
7517073|NCT02954653|26100267|P8|Overall Study|Randomized but did not receive treatment|0
7517074|NCT02954653|26100268|P7|Overall Study|Randomized but did not receive treatment|0
7517075|NCT02954653|26100269|P6|Overall Study|Randomized but did not receive treatment|0
7517076|NCT02954653|26100270|P5|Overall Study|Randomized but did not receive treatment|0
7517077|NCT02954653|26100271|P4|Overall Study|Randomized but did not receive treatment|0
7517078|NCT02954653|26100272|P3|Overall Study|Randomized but did not receive treatment|0
7517079|NCT02954653|26100273|P2|Overall Study|Randomized but did not receive treatment|0
7517080|NCT02954653|26100274|P1|Overall Study|Randomized but did not receive treatment|1
7517081|NCT02954653|26100266|P9|Overall Study|Death|0
7517082|NCT02954653|26100267|P8|Overall Study|Death|0
7517083|NCT02954653|26100268|P7|Overall Study|Death|0
7517084|NCT02954653|26100269|P6|Overall Study|Death|0
7517085|NCT02954653|26100270|P5|Overall Study|Death|0
7517086|NCT02954653|26100271|P4|Overall Study|Death|0
7517087|NCT02954653|26100272|P3|Overall Study|Death|0
7517088|NCT02954653|26100273|P2|Overall Study|Death|1
7517089|NCT02954653|26100274|P1|Overall Study|Death|3
7517090|NCT02954601|26100393|P4|First Intervention (Five Days)|Withdrawal by Subject|0
7517091|NCT02954601|26100394|P3|First Intervention (Five Days)|Withdrawal by Subject|1
7517092|NCT02954601|26100395|P2|First Intervention (Five Days)|Withdrawal by Subject|0
7517093|NCT02954601|26100396|P1|First Intervention (Five Days)|Withdrawal by Subject|0
7517094|NCT02954575|26100418|P1|Overall Study|Adverse Event|1
7517095|NCT02954575|26100418|P1|Overall Study|Withdrawal by Subject|2
7517096|NCT02954458|26100439|P4|Overall Study|Other|7
7517097|NCT02954458|26100440|P3|Overall Study|Other|0
7517098|NCT02954458|26100441|P2|Overall Study|Other|0
7517099|NCT02954458|26100442|P1|Overall Study|Other|0
7517100|NCT02954458|26100439|P4|Overall Study|Death|1
7517101|NCT02954458|26100440|P3|Overall Study|Death|0
7517102|NCT02954458|26100441|P2|Overall Study|Death|0
7517103|NCT02954458|26100442|P1|Overall Study|Death|0
7517104|NCT02954458|26100439|P4|Overall Study|Lost to Follow-up|1
7517105|NCT02954458|26100440|P3|Overall Study|Lost to Follow-up|0
7517106|NCT02954458|26100441|P2|Overall Study|Lost to Follow-up|0
7517107|NCT02954458|26100442|P1|Overall Study|Lost to Follow-up|1
7517108|NCT02954458|26100439|P4|Overall Study|Physician Decision|1
7517109|NCT02954458|26100440|P3|Overall Study|Physician Decision|1
7517110|NCT02954458|26100441|P2|Overall Study|Physician Decision|0
7517111|NCT02954458|26100442|P1|Overall Study|Physician Decision|0
7517112|NCT02954458|26100439|P4|Overall Study|Withdrawal by Subject|1
7517113|NCT02954458|26100440|P3|Overall Study|Withdrawal by Subject|0
7517114|NCT02954458|26100441|P2|Overall Study|Withdrawal by Subject|0
7517115|NCT02954458|26100442|P1|Overall Study|Withdrawal by Subject|0
7517116|NCT02954458|26100439|P4|Overall Study|Adverse Event|1
7517117|NCT02954458|26100440|P3|Overall Study|Adverse Event|0
7517118|NCT02954458|26100441|P2|Overall Study|Adverse Event|0
7517119|NCT02954458|26100442|P1|Overall Study|Adverse Event|0
7517120|NCT02954354|26100568|P3|Overall Study|Miscellaneous|1
7517121|NCT02954354|26100569|P2|Overall Study|Miscellaneous|2
7517122|NCT02954354|26100570|P1|Overall Study|Miscellaneous|2
7517123|NCT02954354|26100568|P3|Overall Study|Lost to Follow-up|0
7517124|NCT02954354|26100569|P2|Overall Study|Lost to Follow-up|5
7517125|NCT02954354|26100570|P1|Overall Study|Lost to Follow-up|12
7517126|NCT02954354|26100568|P3|Overall Study|Withdrawal by Subject|11
7517127|NCT02954354|26100569|P2|Overall Study|Withdrawal by Subject|9
7517128|NCT02954354|26100570|P1|Overall Study|Withdrawal by Subject|17
7517129|NCT02954354|26100568|P3|Overall Study|Lack of Efficacy|0
7517130|NCT02954354|26100569|P2|Overall Study|Lack of Efficacy|2
7517131|NCT02954354|26100570|P1|Overall Study|Lack of Efficacy|0
7517132|NCT02954354|26100568|P3|Overall Study|Failure to Meet Eligibility Criteria|0
7517133|NCT02954354|26100569|P2|Overall Study|Failure to Meet Eligibility Criteria|0
7517134|NCT02954354|26100570|P1|Overall Study|Failure to Meet Eligibility Criteria|1
7517135|NCT02954354|26100568|P3|Overall Study|Adverse Event|4
7517136|NCT02954354|26100569|P2|Overall Study|Adverse Event|2
7517137|NCT02954354|26100570|P1|Overall Study|Adverse Event|2
7517138|NCT02954172|26100671|P2|Overall Study|non-measurable lesions at baseline|2
7517139|NCT02954172|26100672|P1|Overall Study|non-measurable lesions at baseline|1
7517140|NCT02954172|26100671|P2|Overall Study|allergic reaction|1
7517141|NCT02954172|26100672|P1|Overall Study|allergic reaction|2
7517142|NCT02954172|26100671|P2|Overall Study|Protocol Violation|0
7517143|NCT02954172|26100672|P1|Overall Study|Protocol Violation|3
7517144|NCT02954159|26100684|P2|Overall Study|Withdrawal by Subject|1
7517145|NCT02954159|26100685|P1|Overall Study|Withdrawal by Subject|0
7517146|NCT02954159|26100684|P2|Overall Study|Study ended prematurely due to low enrol|0
7517147|NCT02954159|26100685|P1|Overall Study|Study ended prematurely due to low enrol|1
7517148|NCT02953938|26100699|P2|Overall Study|Withdrawal by Subject|1
7517149|NCT02953938|26100700|P1|Overall Study|Withdrawal by Subject|1
7517150|NCT02953938|26100699|P2|Overall Study|Adverse Event|1
7517151|NCT02953938|26100700|P1|Overall Study|Adverse Event|0
7517152|NCT02953821|26100737|P2|Overall Study|Refused follow-up visit|1
7517153|NCT02953821|26100738|P1|Overall Study|Refused follow-up visit|2
7517154|NCT02953821|26100737|P2|Overall Study|No improvement|1
7517155|NCT02953821|26100738|P1|Overall Study|No improvement|0
7517156|NCT02953821|26100737|P2|Overall Study|Out of state for indeterminate time|1
7517157|NCT02953821|26100738|P1|Overall Study|Out of state for indeterminate time|0
7517158|NCT02953821|26100737|P2|Overall Study|Lack of Efficacy|0
7517159|NCT02953821|26100738|P1|Overall Study|Lack of Efficacy|1
7517160|NCT02953821|26100737|P2|Overall Study|Change of address|1
7517161|NCT02953821|26100738|P1|Overall Study|Change of address|0
7517162|NCT02953821|26100737|P2|Overall Study|Withdrawal by Subject|3
7517163|NCT02953821|26100738|P1|Overall Study|Withdrawal by Subject|3
7517164|NCT02953821|26100737|P2|Overall Study|Physician Decision|1
7517165|NCT02953821|26100738|P1|Overall Study|Physician Decision|1
7517166|NCT02953821|26100737|P2|Overall Study|Lost to Follow-up|0
7517167|NCT02953821|26100738|P1|Overall Study|Lost to Follow-up|2
7517168|NCT02953821|26100737|P2|Overall Study|Progressive Disease|1
7517169|NCT02953821|26100738|P1|Overall Study|Progressive Disease|5
7517170|NCT02953821|26100737|P2|Overall Study|Death|0
7517171|NCT02953821|26100738|P1|Overall Study|Death|1
7517172|NCT02953821|26100737|P2|Overall Study|Adverse Event|4
7517173|NCT02953821|26100738|P1|Overall Study|Adverse Event|0
7517174|NCT02953782|26100764|P8|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517175|NCT02953782|26100765|P7|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
7517176|NCT02953782|26100766|P6|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517177|NCT02953782|26100767|P5|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517178|NCT02953782|26100768|P4|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517179|NCT02953782|26100769|P3|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517180|NCT02953782|26100770|P2|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517181|NCT02953782|26100771|P1|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7517182|NCT02953782|26100764|P8|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
7517183|NCT02953782|26100765|P7|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7517184|NCT02953782|26100766|P6|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7517185|NCT02953782|26100767|P5|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7517186|NCT02953782|26100768|P4|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7517187|NCT02953782|26100769|P3|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7517188|NCT02953782|26100770|P2|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7517189|NCT02953782|26100771|P1|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7517190|NCT02953782|26100764|P8|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
7517191|NCT02953782|26100765|P7|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
7517192|NCT02953782|26100766|P6|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
7517193|NCT02953782|26100767|P5|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7517194|NCT02953782|26100768|P4|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7517195|NCT02953782|26100769|P3|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7517196|NCT02953782|26100770|P2|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7517197|NCT02953782|26100771|P1|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7517198|NCT02953782|26100764|P8|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
7517199|NCT02953782|26100765|P7|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
7517200|NCT02953782|26100766|P6|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
7517201|NCT02953782|26100767|P5|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7517202|NCT02953782|26100768|P4|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7517203|NCT02953782|26100769|P3|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7517204|NCT02953782|26100770|P2|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7517205|NCT02953782|26100771|P1|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7517206|NCT02953782|26100764|P8|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7517207|NCT02953782|26100765|P7|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7517208|NCT02953782|26100766|P6|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7517209|NCT02953782|26100767|P5|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7517210|NCT02953782|26100768|P4|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7517211|NCT02953782|26100769|P3|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7517212|NCT02953782|26100770|P2|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7517213|NCT02953782|26100771|P1|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7517214|NCT02953782|26100764|P8|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7517215|NCT02953782|26100765|P7|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7517216|NCT02953782|26100766|P6|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7517217|NCT02953782|26100767|P5|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7517218|NCT02953782|26100768|P4|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7517219|NCT02953782|26100769|P3|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7517220|NCT02953782|26100770|P2|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7517221|NCT02953782|26100771|P1|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7517222|NCT02953782|26100764|P8|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7517223|NCT02953782|26100765|P7|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7517224|NCT02953782|26100766|P6|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7517225|NCT02953782|26100767|P5|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7517226|NCT02953782|26100768|P4|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7517227|NCT02953782|26100769|P3|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
7517228|NCT02953782|26100770|P2|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7517229|NCT02953782|26100771|P1|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7517230|NCT02953782|26100764|P8|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7517231|NCT02953782|26100765|P7|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7517232|NCT02953782|26100766|P6|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7517233|NCT02953782|26100767|P5|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
7517234|NCT02953782|26100768|P4|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7517235|NCT02953782|26100769|P3|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7517236|NCT02953782|26100770|P2|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
7517237|NCT02953782|26100771|P1|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
7517238|NCT02953678|26100843|P1|Overall Study|Reason unspecified|2
7517239|NCT02953678|26100843|P1|Overall Study|Withdrawal by Subject|3
7517240|NCT02953678|26100843|P1|Overall Study|Relapse of Underlying Malignancy|2
7517241|NCT02953678|26100843|P1|Overall Study|Progressive Disease of GVHD|6
7517242|NCT02953678|26100843|P1|Overall Study|Physician Decision|20
7517243|NCT02953678|26100843|P1|Overall Study|Death|7
7517244|NCT02953678|26100843|P1|Overall Study|Adverse Event|20
7517245|NCT02953639|26100855|P3|Overall Study|Completed or Discontinued information is missing|0
7517246|NCT02953639|26100856|P2|Overall Study|Completed or Discontinued information is missing|0
7517247|NCT02953639|26100857|P1|Overall Study|Completed or Discontinued information is missing|1
7517248|NCT02953639|26100855|P3|Overall Study|Withdrawal by Subject|10
7517249|NCT02953639|26100856|P2|Overall Study|Withdrawal by Subject|8
7517250|NCT02953639|26100857|P1|Overall Study|Withdrawal by Subject|7
7517251|NCT02953639|26100855|P3|Overall Study|Physician Decision|0
7517252|NCT02953639|26100856|P2|Overall Study|Physician Decision|0
7517253|NCT02953639|26100857|P1|Overall Study|Physician Decision|1
7517254|NCT02953639|26100855|P3|Overall Study|Multiple Reasons|1
7517255|NCT02953639|26100856|P2|Overall Study|Multiple Reasons|0
7517256|NCT02953639|26100857|P1|Overall Study|Multiple Reasons|1
7517257|NCT02953639|26100855|P3|Overall Study|Non-Compliance With Study Drug|1
7517258|NCT02953639|26100856|P2|Overall Study|Non-Compliance With Study Drug|2
7517259|NCT02953639|26100857|P1|Overall Study|Non-Compliance With Study Drug|0
7517260|NCT02953639|26100855|P3|Overall Study|Lost to Follow-up|3
7517261|NCT02953639|26100856|P2|Overall Study|Lost to Follow-up|4
7517262|NCT02953639|26100857|P1|Overall Study|Lost to Follow-up|8
7517263|NCT02953639|26100855|P3|Overall Study|Adverse Event|1
7517264|NCT02953639|26100856|P2|Overall Study|Adverse Event|0
7517265|NCT02953639|26100857|P1|Overall Study|Adverse Event|2
7517266|NCT02953314|26100932|P2|Overall Study|Withdrawal of consent (not due to AE)|2
7517267|NCT02953314|26100933|P1|Overall Study|Withdrawal of consent (not due to AE)|0
7517268|NCT02953314|26100932|P2|Overall Study|Adverse Event|1
7517269|NCT02953314|26100933|P1|Overall Study|Adverse Event|0
7517270|NCT02953262|26100960|P4|Overall Study|Used portal during 6 months prior to randomization|3
7517271|NCT02953262|26100961|P3|Overall Study|Used portal during 6 months prior to randomization|3
7517272|NCT02953262|26100962|P2|Overall Study|Used portal during 6 months prior to randomization|6
7517273|NCT02953262|26100963|P1|Overall Study|Used portal during 6 months prior to randomization|3
7517274|NCT02952898|26100988|P3|Overall Study|Non-compliance with study drug|2
7517275|NCT02952898|26100989|P2|Overall Study|Non-compliance with study drug|1
7517276|NCT02952898|26100990|P1|Overall Study|Non-compliance with study drug|1
7517277|NCT02952898|26100988|P3|Overall Study|Lost to Follow-up|2
7517278|NCT02952898|26100989|P2|Overall Study|Lost to Follow-up|2
7517279|NCT02952898|26100990|P1|Overall Study|Lost to Follow-up|3
7517280|NCT02952898|26100988|P3|Overall Study|Adverse Event|3
7517281|NCT02952898|26100989|P2|Overall Study|Adverse Event|8
7517282|NCT02952898|26100990|P1|Overall Study|Adverse Event|8
7517283|NCT02952898|26100988|P3|Overall Study|Withdrawal by Subject|8
7517284|NCT02952898|26100989|P2|Overall Study|Withdrawal by Subject|8
7517285|NCT02952898|26100990|P1|Overall Study|Withdrawal by Subject|10
7517286|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Not treated|1
7517287|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Not treated|0
7517288|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Not treated|0
7517289|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Other than specified|2
7517290|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Other than specified|6
7517291|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Other than specified|0
7517292|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
7517293|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
7517294|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
7517295|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
7517296|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
7517297|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
7517298|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Subject choice|7
7517299|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Subject choice|10
7517300|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Subject choice|0
7517301|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
7517302|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
7517303|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
7517304|NCT02952820|26101114|P3|Active Treatment Period (6 Months)|Adverse Event|5
7517305|NCT02952820|26101115|P2|Active Treatment Period (6 Months)|Adverse Event|6
7517306|NCT02952820|26101116|P1|Active Treatment Period (6 Months)|Adverse Event|0
7517307|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
7517308|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
7517309|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
7517310|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
7517311|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
7517312|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
7517313|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
7517314|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
7517315|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
7517316|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
7517317|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
7517318|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
7517319|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
7517320|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
7517321|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
7517322|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
7517323|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7517324|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7517325|NCT02952820|26101114|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
7517326|NCT02952820|26101115|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
7517327|NCT02952820|26101116|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
7517328|NCT02952586|26101178|P2|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
7517329|NCT02952586|26101179|P1|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
7517330|NCT02952586|26101178|P2|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
7517331|NCT02952586|26101179|P1|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
7517332|NCT02952586|26101178|P2|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
7517333|NCT02952586|26101179|P1|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
7517334|NCT02952586|26101178|P2|LT Follow-up (up to 45 Months)|Death|31
7517335|NCT02952586|26101179|P1|LT Follow-up (up to 45 Months)|Death|51
7517336|NCT02952586|26101178|P2|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
7517337|NCT02952586|26101179|P1|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
7517338|NCT02952586|26101178|P2|Follow-Up Phase (90 Days)|Other|5
7517339|NCT02952586|26101179|P1|Follow-Up Phase (90 Days)|Other|7
7517340|NCT02952586|26101178|P2|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7517341|NCT02952586|26101179|P1|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7517342|NCT02952586|26101178|P2|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
7517343|NCT02952586|26101179|P1|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
7517344|NCT02952586|26101178|P2|Follow-Up Phase (90 Days)|Death|10
7517345|NCT02952586|26101179|P1|Follow-Up Phase (90 Days)|Death|12
7517346|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
7517347|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
7517348|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Other|1
7517349|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Other|2
7517350|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Lost to Follow-up|2
7517351|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Lost to Follow-up|1
7517352|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Withdrawal by Subject|25
7517353|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Withdrawal by Subject|31
7517354|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
7517355|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
7517356|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Physician Decision|1
7517357|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Physician Decision|1
7517358|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7517359|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7517360|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Adverse Event|21
7517361|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Adverse Event|24
7517362|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Progressive disease|54
7517363|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Progressive disease|60
7517364|NCT02952586|26101178|P2|Maintenance Phase (12 Months)|Death|11
7517365|NCT02952586|26101179|P1|Maintenance Phase (12 Months)|Death|17
7517366|NCT02952586|26101178|P2|CRT for IMRT (63 Days)|Other|0
7517367|NCT02952586|26101179|P1|CRT for IMRT (63 Days)|Other|1
7517368|NCT02952586|26101178|P2|CRT for IMRT (63 Days)|Lost to Follow-up|1
7517369|NCT02952586|26101179|P1|CRT for IMRT (63 Days)|Lost to Follow-up|1
7517370|NCT02952586|26101178|P2|CRT for IMRT (63 Days)|Withdrawal by Subject|6
7517371|NCT02952586|26101179|P1|CRT for IMRT (63 Days)|Withdrawal by Subject|10
7517372|NCT02952586|26101178|P2|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
7517373|NCT02952586|26101179|P1|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
7517374|NCT02952586|26101178|P2|CRT for IMRT (63 Days)|Adverse Event|5
7517375|NCT02952586|26101179|P1|CRT for IMRT (63 Days)|Adverse Event|5
7517376|NCT02952586|26101178|P2|CRT for IMRT (63 Days)|Death|8
7517377|NCT02952586|26101179|P1|CRT for IMRT (63 Days)|Death|5
7517378|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Other|1
7517379|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Other|1
7517380|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7517381|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7517382|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
7517383|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
7517384|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
7517385|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
7517386|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Physician Decision|10
7517387|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Physician Decision|12
7517388|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Adverse Event|81
7517389|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Adverse Event|82
7517390|NCT02952586|26101178|P2|CRT for Cisplatin (63 Days)|Death|8
7517391|NCT02952586|26101179|P1|CRT for Cisplatin (63 Days)|Death|3
7517392|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Other|1
7517393|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Other|2
7517394|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7517395|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7517396|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
7517397|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
7517398|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
7517399|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
7517400|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
7517401|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
7517402|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7517403|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7517404|NCT02952586|26101178|P2|CRT for Avelumab or Placebo (63 Days)|Death|8
7517405|NCT02952586|26101179|P1|CRT for Avelumab or Placebo (63 Days)|Death|5
7517406|NCT02952586|26101178|P2|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7517407|NCT02952586|26101179|P1|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7517408|NCT02952586|26101178|P2|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
7517409|NCT02952586|26101179|P1|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
7517410|NCT02952586|26101178|P2|Lead-In Phase (7 Days)|Adverse Event|0
7517411|NCT02952586|26101179|P1|Lead-In Phase (7 Days)|Adverse Event|3
7517412|NCT02952586|26101178|P2|Lead-In Phase (7 Days)|Death|1
7517413|NCT02952586|26101179|P1|Lead-In Phase (7 Days)|Death|0
7517414|NCT02952313|26101230|P1|Long-term Follow-up|Death|1
7517415|NCT02952313|26101230|P1|Long-term Follow-up|Physician Decision|1
7517416|NCT02952313|26101230|P1|Long-term Follow-up|Withdrawal by Subject|5
7517417|NCT02952313|26101230|P1|Long-term Follow-up|Lack of Efficacy|6
7517418|NCT02952313|26101230|P1|Long-term Follow-up|Did not reconsent for long-term FU|7
7517419|NCT02952313|26101230|P1|Long-term Follow-up|Lost to Follow-up|12
7517420|NCT02952313|26101230|P1|Primary Endpoint|Missed visit|1
7517421|NCT02952313|26101230|P1|Primary Endpoint|Lack of Efficacy|1
7517422|NCT02952313|26101230|P1|Primary Endpoint|Withdrawal by Subject|1
7517423|NCT02952313|26101230|P1|Primary Endpoint|Lost to Follow-up|4
7517424|NCT02952261|26101241|P2|Overall Study|Protocol Violation|0
7517425|NCT02952261|26101242|P1|Overall Study|Protocol Violation|1
7517426|NCT02952261|26101241|P2|Overall Study|Withdrawal by Subject|5
7517427|NCT02952261|26101242|P1|Overall Study|Withdrawal by Subject|4
7517428|NCT02952001|26101256|P2|Overall Study|Due to Posterior Capsular Opacity|0
7517429|NCT02952001|26101257|P1|Overall Study|Due to Posterior Capsular Opacity|1
7517430|NCT02952001|26101256|P2|Overall Study|Prohibited therapy|3
7517431|NCT02952001|26101257|P1|Overall Study|Prohibited therapy|10
7517432|NCT02952001|26101256|P2|Overall Study|Adverse Event|0
7517433|NCT02952001|26101257|P1|Overall Study|Adverse Event|3
7517434|NCT02951988|26101272|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
7517435|NCT02951988|26101273|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
7517436|NCT02951988|26101274|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
7517437|NCT02951988|26101275|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
7517438|NCT02951988|26101272|P4|Double-Blind Treatment Period|Adverse Event|6
7517439|NCT02951988|26101273|P3|Double-Blind Treatment Period|Adverse Event|3
7517440|NCT02951988|26101274|P2|Double-Blind Treatment Period|Adverse Event|8
7517441|NCT02951988|26101275|P1|Double-Blind Treatment Period|Adverse Event|0
7517442|NCT02951988|26101272|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
7517443|NCT02951988|26101273|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
7517444|NCT02951988|26101274|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
7517445|NCT02951988|26101275|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7517446|NCT02951988|26101272|P4|Double-Blind Treatment Period|Lost to Follow-up|3
7517447|NCT02951988|26101273|P3|Double-Blind Treatment Period|Lost to Follow-up|12
7517448|NCT02951988|26101274|P2|Double-Blind Treatment Period|Lost to Follow-up|4
7517449|NCT02951988|26101275|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7517450|NCT02951988|26101272|P4|Double-Blind Treatment Period|Pregnancy|0
7517451|NCT02951988|26101273|P3|Double-Blind Treatment Period|Pregnancy|1
7517452|NCT02951988|26101274|P2|Double-Blind Treatment Period|Pregnancy|1
7517453|NCT02951988|26101275|P1|Double-Blind Treatment Period|Pregnancy|0
7517454|NCT02951988|26101272|P4|Double-Blind Treatment Period|Protocol Violation|8
7517455|NCT02951988|26101273|P3|Double-Blind Treatment Period|Protocol Violation|4
7517456|NCT02951988|26101274|P2|Double-Blind Treatment Period|Protocol Violation|4
7517457|NCT02951988|26101275|P1|Double-Blind Treatment Period|Protocol Violation|0
7517458|NCT02951988|26101272|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
7517459|NCT02951988|26101273|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
7517460|NCT02951988|26101274|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
7517461|NCT02951988|26101275|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
7517462|NCT02951988|26101272|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
7517463|NCT02951988|26101273|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
7517464|NCT02951988|26101274|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
7517465|NCT02951988|26101275|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
7517466|NCT02951988|26101272|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
7517467|NCT02951988|26101273|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
7517468|NCT02951988|26101274|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
7517469|NCT02951988|26101275|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
7517470|NCT02951988|26101272|P4|Open-Label Treatment Period|Adverse Event|0
7517471|NCT02951988|26101273|P3|Open-Label Treatment Period|Adverse Event|0
7517472|NCT02951988|26101274|P2|Open-Label Treatment Period|Adverse Event|0
7517473|NCT02951988|26101275|P1|Open-Label Treatment Period|Adverse Event|45
7517474|NCT02951988|26101272|P4|Open-Label Treatment Period|Lack of Efficacy|0
7517475|NCT02951988|26101273|P3|Open-Label Treatment Period|Lack of Efficacy|0
7517476|NCT02951988|26101274|P2|Open-Label Treatment Period|Lack of Efficacy|0
7517477|NCT02951988|26101275|P1|Open-Label Treatment Period|Lack of Efficacy|49
7517478|NCT02951988|26101272|P4|Open-Label Treatment Period|Withdrawal by Subject|0
7517479|NCT02951988|26101273|P3|Open-Label Treatment Period|Withdrawal by Subject|0
7517480|NCT02951988|26101274|P2|Open-Label Treatment Period|Withdrawal by Subject|0
7517481|NCT02951988|26101275|P1|Open-Label Treatment Period|Withdrawal by Subject|78
7517482|NCT02951988|26101272|P4|Open-Label Treatment Period|Lost to Follow-up|0
7517483|NCT02951988|26101273|P3|Open-Label Treatment Period|Lost to Follow-up|0
7517484|NCT02951988|26101274|P2|Open-Label Treatment Period|Lost to Follow-up|0
7517485|NCT02951988|26101275|P1|Open-Label Treatment Period|Lost to Follow-up|28
7517486|NCT02951988|26101272|P4|Open-Label Treatment Period|Pregnancy|0
7517487|NCT02951988|26101273|P3|Open-Label Treatment Period|Pregnancy|0
7517488|NCT02951988|26101274|P2|Open-Label Treatment Period|Pregnancy|0
7517489|NCT02951988|26101275|P1|Open-Label Treatment Period|Pregnancy|2
7517490|NCT02951988|26101272|P4|Open-Label Treatment Period|Protocol Violation|0
7517491|NCT02951988|26101273|P3|Open-Label Treatment Period|Protocol Violation|0
7517492|NCT02951988|26101274|P2|Open-Label Treatment Period|Protocol Violation|0
7517493|NCT02951988|26101275|P1|Open-Label Treatment Period|Protocol Violation|22
7517494|NCT02951988|26101272|P4|Open-Label Treatment Period|Non-compliance with study drug|0
7517495|NCT02951988|26101273|P3|Open-Label Treatment Period|Non-compliance with study drug|0
7517496|NCT02951988|26101274|P2|Open-Label Treatment Period|Non-compliance with study drug|0
7517497|NCT02951988|26101275|P1|Open-Label Treatment Period|Non-compliance with study drug|5
7517498|NCT02951988|26101272|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
7517499|NCT02951988|26101273|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
7517500|NCT02951988|26101274|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
7517501|NCT02951988|26101275|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
7517502|NCT02951988|26101272|P4|Open-Label Treatment Period|Study terminated by sponsor|0
7517503|NCT02951988|26101273|P3|Open-Label Treatment Period|Study terminated by sponsor|0
7517504|NCT02951988|26101274|P2|Open-Label Treatment Period|Study terminated by sponsor|0
7517505|NCT02951988|26101275|P1|Open-Label Treatment Period|Study terminated by sponsor|9
7517506|NCT02951988|26101272|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
7517507|NCT02951988|26101273|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
7517508|NCT02951988|26101274|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
7517509|NCT02951988|26101275|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
7517510|NCT02951819|26101308|P2|Overall Study|Other|0
7517511|NCT02951819|26101309|P1|Overall Study|Other|9
7517512|NCT02951819|26101308|P2|Overall Study|Progressive Disease|0
7517513|NCT02951819|26101309|P1|Overall Study|Progressive Disease|1
7517514|NCT02951819|26101308|P2|Overall Study|Lost to Follow-up|0
7517515|NCT02951819|26101309|P1|Overall Study|Lost to Follow-up|1
7517516|NCT02951819|26101308|P2|Overall Study|Lack of Efficacy|0
7517517|NCT02951819|26101309|P1|Overall Study|Lack of Efficacy|4
7517518|NCT02951819|26101308|P2|Overall Study|Adverse Event|0
7517519|NCT02951819|26101309|P1|Overall Study|Adverse Event|1
7517520|NCT02951819|26101308|P2|Overall Study|Withdrawal by Subject|0
7517521|NCT02951819|26101309|P1|Overall Study|Withdrawal by Subject|3
7517522|NCT02951819|26101308|P2|Overall Study|Death|7
7517523|NCT02951819|26101309|P1|Overall Study|Death|9
7517524|NCT02951780|26101340|P9|Period 2|Scheduling Conflicts|0
7517525|NCT02951780|26101341|P8|Period 2|Scheduling Conflicts|1
7517526|NCT02951780|26101342|P7|Period 2|Scheduling Conflicts|0
7517527|NCT02951780|26101343|P6|Period 2|Scheduling Conflicts|0
7517528|NCT02951780|26101344|P5|Period 2|Scheduling Conflicts|0
7517529|NCT02951780|26101345|P4|Period 2|Scheduling Conflicts|0
7517530|NCT02951780|26101346|P3|Period 2|Scheduling Conflicts|0
7517531|NCT02951780|26101347|P2|Period 2|Scheduling Conflicts|0
7517532|NCT02951780|26101348|P1|Period 2|Scheduling Conflicts|0
7517533|NCT02951780|26101340|P9|Period 1|Scheduling Conflicts|0
7517534|NCT02951780|26101341|P8|Period 1|Scheduling Conflicts|1
7517535|NCT02951780|26101342|P7|Period 1|Scheduling Conflicts|0
7517536|NCT02951780|26101343|P6|Period 1|Scheduling Conflicts|0
7517537|NCT02951780|26101344|P5|Period 1|Scheduling Conflicts|0
7517538|NCT02951780|26101345|P4|Period 1|Scheduling Conflicts|0
7517539|NCT02951780|26101346|P3|Period 1|Scheduling Conflicts|0
7517540|NCT02951780|26101347|P2|Period 1|Scheduling Conflicts|0
7517541|NCT02951780|26101348|P1|Period 1|Scheduling Conflicts|0
7517542|NCT02951780|26101340|P9|Period 1|Adverse Event|0
7517543|NCT02951780|26101341|P8|Period 1|Adverse Event|0
7517544|NCT02951780|26101342|P7|Period 1|Adverse Event|0
7517545|NCT02951780|26101343|P6|Period 1|Adverse Event|0
7517546|NCT02951780|26101344|P5|Period 1|Adverse Event|0
7517547|NCT02951780|26101345|P4|Period 1|Adverse Event|1
7517548|NCT02951780|26101346|P3|Period 1|Adverse Event|0
7517549|NCT02951780|26101347|P2|Period 1|Adverse Event|0
7517550|NCT02951780|26101348|P1|Period 1|Adverse Event|0
7517551|NCT02951767|26101413|P1|Overall Study|Lost to Follow-up|1
7517552|NCT02951767|26101413|P1|Overall Study|Death|59
7517553|NCT02951767|26101413|P1|Overall Study|Withdrawal by Subject|5
7517554|NCT02951767|26101413|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
7517555|NCT02951533|26101445|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7517556|NCT02951533|26101446|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
7517557|NCT02951533|26101447|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7517558|NCT02951533|26101445|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7517559|NCT02951533|26101446|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7517560|NCT02951533|26101447|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
7517561|NCT02951533|26101445|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7517562|NCT02951533|26101446|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7517563|NCT02951533|26101447|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
7517564|NCT02951533|26101445|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
7517565|NCT02951533|26101446|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
7517566|NCT02951533|26101447|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
7517567|NCT02951533|26101445|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7517568|NCT02951533|26101446|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
7517569|NCT02951533|26101447|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7517570|NCT02951533|26101445|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7517571|NCT02951533|26101446|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7517572|NCT02951533|26101447|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
7517573|NCT02951533|26101445|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7517574|NCT02951533|26101446|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
7517575|NCT02951533|26101447|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7517576|NCT02951533|26101445|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7517577|NCT02951533|26101446|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
7517578|NCT02951533|26101447|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7517579|NCT02951533|26101445|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
7517580|NCT02951533|26101446|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
7517581|NCT02951533|26101447|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
7517582|NCT02951533|26101445|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
7517583|NCT02951533|26101446|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7517584|NCT02951533|26101447|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7517585|NCT02951533|26101445|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
7517586|NCT02951533|26101446|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
7517587|NCT02951533|26101447|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
7517588|NCT02951429|26101569|P2|Overall Study|Participant ongoing in the study|17
7517589|NCT02951429|26101570|P1|Overall Study|Participant ongoing in the study|23
7517590|NCT02951429|26101569|P2|Overall Study|Withdrawal by Subject|11
7517591|NCT02951429|26101570|P1|Overall Study|Withdrawal by Subject|7
7517592|NCT02951429|26101569|P2|Overall Study|Progressive Disease|1
7517593|NCT02951429|26101570|P1|Overall Study|Progressive Disease|1
7517594|NCT02951429|26101569|P2|Overall Study|Other|3
7517595|NCT02951429|26101570|P1|Overall Study|Other|1
7517596|NCT02951429|26101569|P2|Overall Study|Lung Transplantation|6
7517597|NCT02951429|26101570|P1|Overall Study|Lung Transplantation|9
7517598|NCT02951429|26101569|P2|Overall Study|Lost to Follow-up|1
7517599|NCT02951429|26101570|P1|Overall Study|Lost to Follow-up|0
7517600|NCT02951429|26101569|P2|Overall Study|Lack of Efficacy|1
7517601|NCT02951429|26101570|P1|Overall Study|Lack of Efficacy|0
7517602|NCT02951429|26101569|P2|Overall Study|Death|36
7517603|NCT02951429|26101570|P1|Overall Study|Death|28
7517604|NCT02951429|26101569|P2|Overall Study|Adverse Event|7
7517605|NCT02951429|26101570|P1|Overall Study|Adverse Event|3
7517606|NCT02951156|26101918|P3|Overall Study|Other|2
7517607|NCT02951156|26101919|P2|Overall Study|Other|1
7517608|NCT02951156|26101920|P1|Overall Study|Other|5
7517609|NCT02951156|26101918|P3|Overall Study|Study terminated by sponsor|1
7517610|NCT02951156|26101919|P2|Overall Study|Study terminated by sponsor|0
7517611|NCT02951156|26101920|P1|Overall Study|Study terminated by sponsor|0
7517612|NCT02951156|26101918|P3|Overall Study|Withdrawal by Subject|1
7517613|NCT02951156|26101919|P2|Overall Study|Withdrawal by Subject|0
7517614|NCT02951156|26101920|P1|Overall Study|Withdrawal by Subject|0
7517615|NCT02951156|26101918|P3|Overall Study|Progressive disease|1
7517616|NCT02951156|26101919|P2|Overall Study|Progressive disease|0
7517617|NCT02951156|26101920|P1|Overall Study|Progressive disease|1
7517618|NCT02951156|26101918|P3|Overall Study|Death|5
7517619|NCT02951156|26101919|P2|Overall Study|Death|8
7517620|NCT02951156|26101920|P1|Overall Study|Death|3
7517621|NCT02951052|26102017|P2|Overall Study|Ongoing|0
7517622|NCT02951052|26102018|P1|Overall Study|Ongoing|1
7517623|NCT02951052|26102017|P2|Overall Study|Lack of Efficacy|4
7517624|NCT02951052|26102018|P1|Overall Study|Lack of Efficacy|3
7517625|NCT02951052|26102017|P2|Overall Study|Protocol Violation|3
7517626|NCT02951052|26102018|P1|Overall Study|Protocol Violation|5
7517627|NCT02951052|26102017|P2|Overall Study|Protocol-specified withdrawal criterion|0
7517628|NCT02951052|26102018|P1|Overall Study|Protocol-specified withdrawal criterion|1
7517629|NCT02951052|26102017|P2|Overall Study|Lost to Follow-up|1
7517630|NCT02951052|26102018|P1|Overall Study|Lost to Follow-up|1
7517631|NCT02951052|26102017|P2|Overall Study|Physician Decision|0
7517632|NCT02951052|26102018|P1|Overall Study|Physician Decision|2
7517633|NCT02951052|26102017|P2|Overall Study|Withdrawal by Subject|5
7517634|NCT02951052|26102018|P1|Overall Study|Withdrawal by Subject|1
7517635|NCT02951052|26102017|P2|Overall Study|Adverse Event|5
7517636|NCT02951052|26102018|P1|Overall Study|Adverse Event|13
7517637|NCT02950831|26102186|P1|Overall Study|stimulation trail failure|5
7517638|NCT02950831|26102186|P1|Overall Study|Withdrawal by Subject|3
7517639|NCT02950831|26102186|P1|Overall Study|Lost to Follow-up|1
7517640|NCT02950558|26102224|P2|Overall Study|Lost to Follow-up|0
7517641|NCT02950558|26102225|P1|Overall Study|Lost to Follow-up|2
7517642|NCT02950545|26102245|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
7517643|NCT02950545|26102246|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
7517644|NCT02950545|26102247|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
7517645|NCT02950545|26102248|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
7517646|NCT02950545|26102249|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
7517647|NCT02950545|26102250|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
7517648|NCT02950545|26102245|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7517649|NCT02950545|26102246|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7517650|NCT02950545|26102247|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7517651|NCT02950545|26102248|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7517652|NCT02950545|26102249|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7517653|NCT02950545|26102250|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
7517654|NCT02950545|26102245|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
7517655|NCT02950545|26102246|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
7517656|NCT02950545|26102247|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
7517657|NCT02950545|26102248|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
7517658|NCT02950545|26102249|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
7517659|NCT02950545|26102250|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
7517660|NCT02950545|26102245|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7517661|NCT02950545|26102246|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7517662|NCT02950545|26102247|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7517663|NCT02950545|26102248|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7517664|NCT02950545|26102249|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7517665|NCT02950545|26102250|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7517666|NCT02950545|26102245|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
7517667|NCT02950545|26102246|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
7517668|NCT02950545|26102247|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
7517669|NCT02950545|26102248|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
7517670|NCT02950545|26102249|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
7517671|NCT02950545|26102250|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
7517672|NCT02950480|26102259|P2|Overall Study|Withdrawal by Subject|0
7517673|NCT02950480|26102260|P1|Overall Study|Withdrawal by Subject|1
7517674|NCT02949973|26102319|P1|Overall Study|Physician Decision|1
7517675|NCT02949947|26102330|P2|Overall Study|Insurance change|0
7517676|NCT02949947|26102331|P1|Overall Study|Insurance change|1
7517677|NCT02949947|26102330|P2|Overall Study|Non Compliance|1
7517678|NCT02949947|26102331|P1|Overall Study|Non Compliance|0
7517679|NCT02949908|26102364|P1|Overall Study|Study termination|2
7517680|NCT02949362|26102428|P4|Prospective Period|Other|4
7517681|NCT02949362|26102429|P3|Prospective Period|Other|0
7517682|NCT02949362|26102430|P2|Prospective Period|Other|0
7517683|NCT02949362|26102431|P1|Prospective Period|Other|0
7517684|NCT02949362|26102428|P4|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7517685|NCT02949362|26102429|P3|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1
7517686|NCT02949362|26102430|P2|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7517687|NCT02949362|26102431|P1|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7517688|NCT02949362|26102428|P4|Retrospective Period|Inform consent not signed by participant|0
7517689|NCT02949362|26102429|P3|Retrospective Period|Inform consent not signed by participant|0
7517690|NCT02949362|26102430|P2|Retrospective Period|Inform consent not signed by participant|1
7517691|NCT02949362|26102431|P1|Retrospective Period|Inform consent not signed by participant|4
7517692|NCT02949271|26102491|P2|Overall Study|Outside the window for cervical dilation|3
7517693|NCT02949271|26102492|P1|Overall Study|Outside the window for cervical dilation|2
7517694|NCT02949271|26102491|P2|Overall Study|Delivered prior to intervention|9
7517695|NCT02949271|26102492|P1|Overall Study|Delivered prior to intervention|7
7517696|NCT02949271|26102491|P2|Overall Study|Withdrawal by Subject|0
7517697|NCT02949271|26102492|P1|Overall Study|Withdrawal by Subject|1
7517698|NCT02949271|26102491|P2|Overall Study|Protocol Violation|3
7517699|NCT02949271|26102492|P1|Overall Study|Protocol Violation|6
7517700|NCT02949271|26102491|P2|Overall Study|Physician Decision|5
7517701|NCT02949271|26102492|P1|Overall Study|Physician Decision|5
7517702|NCT02949271|26102491|P2|Overall Study|Lost to Follow-up|6
7517703|NCT02949271|26102492|P1|Overall Study|Lost to Follow-up|3
7517704|NCT02949271|26102491|P2|Overall Study|Lack of Efficacy|4
7517705|NCT02949271|26102492|P1|Overall Study|Lack of Efficacy|5
7517706|NCT02949219|26102518|P1|Overall Study|Withdrawal by Subject|1
7517707|NCT02949128|26102532|P1|Extension Period|Withdrawal by Subject|1
7517708|NCT02949128|26102532|P1|Extension Period|Physician Decision|1
7517709|NCT02949128|26102532|P1|Initial Evaluation Period|Protocol Violation|1
7517710|NCT02949128|26102532|P1|Initial Evaluation Period|Physician Decision|1
7517711|NCT02949128|26102532|P1|Initial Evaluation Period|Death|2
7517712|NCT02949128|26102532|P1|Initial Evaluation Period|Adverse Event|3
7517713|NCT02949128|26102532|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
7517714|NCT02949024|26102548|P2|Overall Study|Withdrawal by Subject|1
7517715|NCT02949024|26102549|P1|Overall Study|Withdrawal by Subject|0
7517716|NCT02949011|26102566|P3|Overall Study|Miscellaneous|6
7517717|NCT02949011|26102567|P2|Overall Study|Miscellaneous|4
7517718|NCT02949011|26102568|P1|Overall Study|Miscellaneous|2
7517719|NCT02949011|26102566|P3|Overall Study|Death|1
7517720|NCT02949011|26102567|P2|Overall Study|Death|0
7517721|NCT02949011|26102568|P1|Overall Study|Death|0
7517722|NCT02949011|26102566|P3|Overall Study|Lost to Follow-up|5
7517723|NCT02949011|26102567|P2|Overall Study|Lost to Follow-up|5
7517724|NCT02949011|26102568|P1|Overall Study|Lost to Follow-up|7
7517725|NCT02949011|26102566|P3|Overall Study|Withdrawal by Subject|21
7517726|NCT02949011|26102567|P2|Overall Study|Withdrawal by Subject|13
7517727|NCT02949011|26102568|P1|Overall Study|Withdrawal by Subject|13
7517728|NCT02949011|26102566|P3|Overall Study|Lack of Efficacy|0
7517729|NCT02949011|26102567|P2|Overall Study|Lack of Efficacy|2
7517730|NCT02949011|26102568|P1|Overall Study|Lack of Efficacy|0
7517731|NCT02949011|26102566|P3|Overall Study|Protocol Deviation|3
7517732|NCT02949011|26102567|P2|Overall Study|Protocol Deviation|3
7517733|NCT02949011|26102568|P1|Overall Study|Protocol Deviation|5
7517734|NCT02949011|26102566|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
7517735|NCT02949011|26102567|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
7517736|NCT02949011|26102568|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
7517737|NCT02949011|26102566|P3|Overall Study|Adverse Event|3
7517738|NCT02949011|26102567|P2|Overall Study|Adverse Event|7
7517739|NCT02949011|26102568|P1|Overall Study|Adverse Event|6
7517740|NCT02948829|26102636|P1|Overall Study|Non-Compliance with Study Procedures|1
7517741|NCT02948829|26102636|P1|Overall Study|Ongoing (at data cut-off date: 29 May 2018)|195
7517742|NCT02948829|26102636|P1|Overall Study|Withdrawal by Subject|4
7517744|NCT02948634|26102698|P2|Overall Study|Lack of efficacy and study suspended|2
7517745|NCT02948634|26102699|P1|Overall Study|Lack of efficacy and study suspended|10
7517746|NCT02948582|26102709|P6|Washout Period 4|Adverse Event|0
7517747|NCT02948582|26102710|P5|Washout Period 4|Adverse Event|0
7517748|NCT02948582|26102711|P4|Washout Period 4|Adverse Event|0
7517749|NCT02948582|26102712|P3|Washout Period 4|Adverse Event|1
7517750|NCT02948582|26102713|P2|Washout Period 4|Adverse Event|0
7517751|NCT02948582|26102714|P1|Washout Period 4|Adverse Event|1
7517752|NCT02948582|26102709|P6|Washout Period 2|personal reasons|0
7517753|NCT02948582|26102710|P5|Washout Period 2|personal reasons|0
7517754|NCT02948582|26102711|P4|Washout Period 2|personal reasons|1
7517755|NCT02948582|26102712|P3|Washout Period 2|personal reasons|0
7517756|NCT02948582|26102713|P2|Washout Period 2|personal reasons|0
7517757|NCT02948582|26102714|P1|Washout Period 2|personal reasons|0
7517758|NCT02948582|26102709|P6|Washout Period 2|Adverse Event|0
7517759|NCT02948582|26102710|P5|Washout Period 2|Adverse Event|0
7517760|NCT02948582|26102711|P4|Washout Period 2|Adverse Event|0
7517761|NCT02948582|26102712|P3|Washout Period 2|Adverse Event|0
7517762|NCT02948582|26102713|P2|Washout Period 2|Adverse Event|1
7517763|NCT02948582|26102714|P1|Washout Period 2|Adverse Event|0
7517764|NCT02948582|26102709|P6|Washout Period 1|Protocol Violation|1
7517765|NCT02948582|26102710|P5|Washout Period 1|Protocol Violation|0
7517766|NCT02948582|26102711|P4|Washout Period 1|Protocol Violation|0
7517767|NCT02948582|26102712|P3|Washout Period 1|Protocol Violation|0
7517768|NCT02948582|26102713|P2|Washout Period 1|Protocol Violation|0
7517769|NCT02948582|26102714|P1|Washout Period 1|Protocol Violation|0
7517770|NCT02948582|26102709|P6|Washout Period 1|Adverse Event|0
7517771|NCT02948582|26102710|P5|Washout Period 1|Adverse Event|0
7517772|NCT02948582|26102711|P4|Washout Period 1|Adverse Event|0
7517773|NCT02948582|26102712|P3|Washout Period 1|Adverse Event|0
7517774|NCT02948582|26102713|P2|Washout Period 1|Adverse Event|2
7517775|NCT02948582|26102714|P1|Washout Period 1|Adverse Event|0
7517776|NCT02947100|26102868|P1|Overall Study|did not meet inclusion criteria|1
7517777|NCT02947100|26102868|P1|Overall Study|study terminated early|3
7517778|NCT02947022|26102876|P1|Overall Study|Study Stopped|1
7517779|NCT02946918|26102897|P2|Overall Study|Ran out of study medication|1
7517780|NCT02946918|26102898|P1|Overall Study|Ran out of study medication|0
7517781|NCT02946918|26102897|P2|Overall Study|Physician Decision|2
7517782|NCT02946918|26102898|P1|Overall Study|Physician Decision|0
7517783|NCT02946918|26102897|P2|Overall Study|Patient unblinded himself|0
7517784|NCT02946918|26102898|P1|Overall Study|Patient unblinded himself|1
7517785|NCT02946580|26102923|P2|Overall Study|Did not undergo posterior spinal fusion|1
7517786|NCT02946580|26102924|P1|Overall Study|Did not undergo posterior spinal fusion|0
7517787|NCT02946580|26102923|P2|Overall Study|Adverse Event|2
7517788|NCT02946580|26102924|P1|Overall Study|Adverse Event|0
7517789|NCT02946580|26102923|P2|Overall Study|Withdrawal by Subject|2
7517790|NCT02946580|26102924|P1|Overall Study|Withdrawal by Subject|1
7517791|NCT02946515|26102942|P2|Overall Study|Lost to Follow-up|1
7517792|NCT02946515|26102943|P1|Overall Study|Lost to Follow-up|2
7517793|NCT02946463|26102956|P2|Primary Evaluation Period|Withdrawal by Subject|1
7517794|NCT02946463|26102957|P1|Primary Evaluation Period|Withdrawal by Subject|0
7517795|NCT02946463|26102956|P2|Primary Evaluation Period|Physician Decision|1
7517796|NCT02946463|26102957|P1|Primary Evaluation Period|Physician Decision|0
7517797|NCT02946385|26102979|P6|Overall Study|Lost to Follow-up|1
7517798|NCT02946385|26102980|P5|Overall Study|Lost to Follow-up|2
7517799|NCT02946385|26102981|P4|Overall Study|Lost to Follow-up|0
7517800|NCT02946385|26102982|P3|Overall Study|Lost to Follow-up|3
7517801|NCT02946385|26102983|P2|Overall Study|Lost to Follow-up|0
7517802|NCT02946385|26102984|P1|Overall Study|Lost to Follow-up|0
7517803|NCT02945657|26103161|P1|Overall Study|Withdrawal by Parent/Guardian|3
7517804|NCT02945657|26103161|P1|Overall Study|Adverse Event|1
7517805|NCT02945410|26103203|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
7517806|NCT02945410|26103204|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
7517807|NCT02945410|26103205|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
7517808|NCT02945410|26103206|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
7517809|NCT02945410|26103207|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
7517810|NCT02945410|26103208|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
7517811|NCT02945410|26103203|P6|Intervention 1 (5 Days)|Adverse Event|1
7517812|NCT02945410|26103204|P5|Intervention 1 (5 Days)|Adverse Event|0
7517813|NCT02945410|26103205|P4|Intervention 1 (5 Days)|Adverse Event|0
7517814|NCT02945410|26103206|P3|Intervention 1 (5 Days)|Adverse Event|0
7517815|NCT02945410|26103207|P2|Intervention 1 (5 Days)|Adverse Event|0
7517816|NCT02945410|26103208|P1|Intervention 1 (5 Days)|Adverse Event|1
7517817|NCT02945410|26103203|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
7517818|NCT02945410|26103204|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
7517819|NCT02945410|26103205|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
7517820|NCT02945410|26103206|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
7517821|NCT02945410|26103207|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
7517822|NCT02945410|26103208|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
7517823|NCT02945254|26103239|P2|Overall Study|Withdrawal by Subject|0
7517824|NCT02945254|26103240|P1|Overall Study|Withdrawal by Subject|1
7517825|NCT02945254|26103239|P2|Overall Study|Lost to Follow-up|0
7517826|NCT02945254|26103240|P1|Overall Study|Lost to Follow-up|1
7517827|NCT02945046|26103256|P3|Overall Study|Other than specified|7
7517828|NCT02945046|26103257|P2|Overall Study|Other than specified|4
7517829|NCT02945046|26103258|P1|Overall Study|Other than specified|5
7517830|NCT02945046|26103256|P3|Overall Study|Lack of Efficacy|1
7517831|NCT02945046|26103257|P2|Overall Study|Lack of Efficacy|2
7517832|NCT02945046|26103258|P1|Overall Study|Lack of Efficacy|1
7517833|NCT02945046|26103256|P3|Overall Study|Lost to Follow-up|0
7517834|NCT02945046|26103257|P2|Overall Study|Lost to Follow-up|1
7517835|NCT02945046|26103258|P1|Overall Study|Lost to Follow-up|1
7517836|NCT02945046|26103256|P3|Overall Study|Protocol Violation|2
7517837|NCT02945046|26103257|P2|Overall Study|Protocol Violation|3
7517838|NCT02945046|26103258|P1|Overall Study|Protocol Violation|2
7517839|NCT02945046|26103256|P3|Overall Study|Withdrawal by Subject|3
7517840|NCT02945046|26103257|P2|Overall Study|Withdrawal by Subject|3
7517841|NCT02945046|26103258|P1|Overall Study|Withdrawal by Subject|3
7517842|NCT02945046|26103256|P3|Overall Study|Adverse Event|2
7517843|NCT02945046|26103257|P2|Overall Study|Adverse Event|0
7517844|NCT02945046|26103258|P1|Overall Study|Adverse Event|1
7517845|NCT02944968|26103311|P1|Overall Study|Subject didn't meet eligibility criteria|2
7517846|NCT02944968|26103311|P1|Overall Study|Subject excluded before study procedure|1
7517847|NCT02944656|26103318|P2|Overall Study|Lost to Follow-up|10
7517848|NCT02944656|26103319|P1|Overall Study|Lost to Follow-up|7
7517849|NCT02944656|26103318|P2|Overall Study|No longer eligible|0
7517850|NCT02944656|26103319|P1|Overall Study|No longer eligible|3
7517851|NCT02944513|26103355|P2|Overall Study|Withdrawal by Subject|1
7517852|NCT02944513|26103356|P1|Overall Study|Withdrawal by Subject|4
7517853|NCT02944448|26103381|P2|Overall Study|Abnormal laboratory values|0
7517854|NCT02944448|26103382|P1|Overall Study|Abnormal laboratory values|1
7517855|NCT02944448|26103381|P2|Overall Study|Noncompliant with dosing|0
7517856|NCT02944448|26103382|P1|Overall Study|Noncompliant with dosing|1
7517857|NCT02944448|26103381|P2|Overall Study|Sponsor did not supply drug in time|1
7517858|NCT02944448|26103382|P1|Overall Study|Sponsor did not supply drug in time|0
7517859|NCT02944448|26103381|P2|Overall Study|Withdrawal by Subject|4
7517860|NCT02944448|26103382|P1|Overall Study|Withdrawal by Subject|14
7517861|NCT02944448|26103381|P2|Overall Study|Protocol Violation|7
7517862|NCT02944448|26103382|P1|Overall Study|Protocol Violation|25
7517863|NCT02944448|26103381|P2|Overall Study|Lost to Follow-up|1
7517864|NCT02944448|26103382|P1|Overall Study|Lost to Follow-up|3
7517865|NCT02944448|26103381|P2|Overall Study|Lack of Efficacy|5
7517866|NCT02944448|26103382|P1|Overall Study|Lack of Efficacy|8
7517867|NCT02944448|26103381|P2|Overall Study|Adverse Event|6
7517868|NCT02944448|26103382|P1|Overall Study|Adverse Event|37
7517869|NCT02944383|26103409|P3|Overall Study|Withdrawal by Subject|0
7517870|NCT02944383|26103410|P2|Overall Study|Withdrawal by Subject|0
7517871|NCT02944383|26103411|P1|Overall Study|Withdrawal by Subject|1
7517872|NCT02944383|26103409|P3|Overall Study|Lost to Follow-up|1
7517873|NCT02944383|26103410|P2|Overall Study|Lost to Follow-up|0
7517874|NCT02944383|26103411|P1|Overall Study|Lost to Follow-up|0
7517875|NCT02943668|26103572|P1|Overall Study|Disease Progression|1
7517876|NCT02943577|26103583|P2|Overall Study|Pregnancy|0
7517877|NCT02943577|26103584|P1|Overall Study|Pregnancy|1
7517878|NCT02943577|26103583|P2|Overall Study|Withdrawal by Subject|1
7517879|NCT02943577|26103584|P1|Overall Study|Withdrawal by Subject|1
7517880|NCT02943577|26103583|P2|Overall Study|Lost to Follow-up|1
7517881|NCT02943577|26103584|P1|Overall Study|Lost to Follow-up|0
7517882|NCT02943577|26103583|P2|Overall Study|Adverse Event|2
7517883|NCT02943577|26103584|P1|Overall Study|Adverse Event|3
7517884|NCT02943577|26103583|P2|Overall Study|Protocol Violation|1
7517885|NCT02943577|26103584|P1|Overall Study|Protocol Violation|0
7517886|NCT02943564|26103599|P3|Overall Study|Lack of Efficacy|0
7517887|NCT02943564|26103600|P2|Overall Study|Lack of Efficacy|1
7517888|NCT02943564|26103601|P1|Overall Study|Lack of Efficacy|0
7517889|NCT02943564|26103599|P3|Overall Study|Adverse Event|1
7517890|NCT02943564|26103600|P2|Overall Study|Adverse Event|2
7517891|NCT02943564|26103601|P1|Overall Study|Adverse Event|1
7517892|NCT02943564|26103599|P3|Overall Study|Withdrawal by Subject|2
7517893|NCT02943564|26103600|P2|Overall Study|Withdrawal by Subject|5
7517894|NCT02943564|26103601|P1|Overall Study|Withdrawal by Subject|6
7517895|NCT02943564|26103599|P3|Overall Study|Lost to Follow-up|0
7517896|NCT02943564|26103600|P2|Overall Study|Lost to Follow-up|0
7517897|NCT02943564|26103601|P1|Overall Study|Lost to Follow-up|1
7517898|NCT02943564|26103599|P3|Overall Study|Protocol Violation|2
7517899|NCT02943564|26103600|P2|Overall Study|Protocol Violation|2
7517900|NCT02943564|26103601|P1|Overall Study|Protocol Violation|2
7517901|NCT02943564|26103599|P3|Overall Study|Pregnancy|1
7517902|NCT02943564|26103600|P2|Overall Study|Pregnancy|1
7517903|NCT02943564|26103601|P1|Overall Study|Pregnancy|0
7517904|NCT02943564|26103599|P3|Overall Study|Non-compliance with study drug|0
7517905|NCT02943564|26103600|P2|Overall Study|Non-compliance with study drug|1
7517906|NCT02943564|26103601|P1|Overall Study|Non-compliance with study drug|0
7517907|NCT02943564|26103599|P3|Overall Study|Site terminated by sponsor|0
7517908|NCT02943564|26103600|P2|Overall Study|Site terminated by sponsor|1
7517909|NCT02943564|26103601|P1|Overall Study|Site terminated by sponsor|0
7517910|NCT02943564|26103599|P3|Overall Study|Miscellaneous Reasons|3
7517911|NCT02943564|26103600|P2|Overall Study|Miscellaneous Reasons|0
7517912|NCT02943564|26103601|P1|Overall Study|Miscellaneous Reasons|0
7517913|NCT02943473|26103621|P1|Overall Study|Physician Decision|4
7517914|NCT02943473|26103621|P1|Overall Study|screen failure|1
7517915|NCT02943473|26103621|P1|Overall Study|enrolled but not dosed|1
7517916|NCT02943460|26103628|P3|Open Label Extension (OLE) Phase|Investigator's Discretion|0
7517917|NCT02943460|26103629|P2|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7517918|NCT02943460|26103630|P1|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7517919|NCT02943460|26103628|P3|Open Label Extension (OLE) Phase|Withdrew Consent|0
7517920|NCT02943460|26103629|P2|Open Label Extension (OLE) Phase|Withdrew Consent|1
7517921|NCT02943460|26103630|P1|Open Label Extension (OLE) Phase|Withdrew Consent|2
7517922|NCT02943460|26103628|P3|Open Label Extension (OLE) Phase|Adverse Event|2
7517923|NCT02943460|26103629|P2|Open Label Extension (OLE) Phase|Adverse Event|5
7517924|NCT02943460|26103630|P1|Open Label Extension (OLE) Phase|Adverse Event|2
7517925|NCT02943460|26103628|P3|Blinded Study Phase|Withdrew Consent|0
7517926|NCT02943460|26103629|P2|Blinded Study Phase|Withdrew Consent|1
7517927|NCT02943460|26103630|P1|Blinded Study Phase|Withdrew Consent|0
7517928|NCT02943460|26103628|P3|Blinded Study Phase|Adverse Event|0
7517929|NCT02943460|26103629|P2|Blinded Study Phase|Adverse Event|0
7517930|NCT02943460|26103630|P1|Blinded Study Phase|Adverse Event|3
7517931|NCT02943447|26103648|P3|Open-Label Extension Phase|Lost to Follow-up|0
7517932|NCT02943447|26103649|P2|Open-Label Extension Phase|Lost to Follow-up|1
7517933|NCT02943447|26103650|P1|Open-Label Extension Phase|Lost to Follow-up|0
7517934|NCT02943447|26103648|P3|Open-Label Extension Phase|Withdrew consent|1
7517935|NCT02943447|26103649|P2|Open-Label Extension Phase|Withdrew consent|1
7517936|NCT02943447|26103650|P1|Open-Label Extension Phase|Withdrew consent|1
7517937|NCT02943447|26103648|P3|Open-Label Extension Phase|Lack of Efficacy|0
7517938|NCT02943447|26103649|P2|Open-Label Extension Phase|Lack of Efficacy|4
7517939|NCT02943447|26103650|P1|Open-Label Extension Phase|Lack of Efficacy|3
7517940|NCT02943447|26103648|P3|Open-Label Extension Phase|Adverse Event|3
7517941|NCT02943447|26103649|P2|Open-Label Extension Phase|Adverse Event|7
7517942|NCT02943447|26103650|P1|Open-Label Extension Phase|Adverse Event|4
7517943|NCT02943447|26103648|P3|Open-Label Extension Phase|Study terminated by sponsor|6
7517944|NCT02943447|26103649|P2|Open-Label Extension Phase|Study terminated by sponsor|12
7517945|NCT02943447|26103650|P1|Open-Label Extension Phase|Study terminated by sponsor|10
7517946|NCT02943447|26103648|P3|Blinded Study Phase|Investigator's discretion|0
7517947|NCT02943447|26103649|P2|Blinded Study Phase|Investigator's discretion|0
7517948|NCT02943447|26103650|P1|Blinded Study Phase|Investigator's discretion|1
7517949|NCT02943447|26103648|P3|Blinded Study Phase|Adverse Event|0
7517950|NCT02943447|26103649|P2|Blinded Study Phase|Adverse Event|0
7517951|NCT02943447|26103650|P1|Blinded Study Phase|Adverse Event|3
7517952|NCT02943447|26103648|P3|Blinded Study Phase|Withdrew Consent|1
7517953|NCT02943447|26103649|P2|Blinded Study Phase|Withdrew Consent|2
7517954|NCT02943447|26103650|P1|Blinded Study Phase|Withdrew Consent|1
7517955|NCT02943096|26103719|P2|Overall Study|Lack of Efficacy|1
7517956|NCT02943096|26103720|P1|Overall Study|Lack of Efficacy|0
7517957|NCT02943070|26103734|P1|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
7517958|NCT02943070|26103734|P1|Overall Study|Retreatment or TURP|13
7517959|NCT02943070|26103734|P1|Overall Study|Lost to Follow-up|4
7517960|NCT02943070|26103734|P1|Overall Study|Withdrawal by Subject|3
7517961|NCT02943070|26103734|P1|Overall Study|Death|2
7517962|NCT02943070|26103734|P1|Overall Study|Adverse Event|2
7517963|NCT02943070|26103734|P1|Overall Study|Physician Decision|1
7517964|NCT02942771|26103778|P5|Overall Study|Withdrawal by Subject|2
7517965|NCT02942771|26103779|P4|Overall Study|Withdrawal by Subject|0
7517966|NCT02942771|26103780|P3|Overall Study|Withdrawal by Subject|0
7517967|NCT02942771|26103781|P2|Overall Study|Withdrawal by Subject|0
7517968|NCT02942771|26103782|P1|Overall Study|Withdrawal by Subject|1
7517969|NCT02942771|26103778|P5|Overall Study|Lost to Follow-up|0
7517970|NCT02942771|26103779|P4|Overall Study|Lost to Follow-up|0
7517971|NCT02942771|26103780|P3|Overall Study|Lost to Follow-up|0
7517972|NCT02942771|26103781|P2|Overall Study|Lost to Follow-up|0
7517973|NCT02942771|26103782|P1|Overall Study|Lost to Follow-up|1
7517974|NCT02942771|26103778|P5|Overall Study|Adverse Event|2
7517975|NCT02942771|26103779|P4|Overall Study|Adverse Event|0
7517976|NCT02942771|26103780|P3|Overall Study|Adverse Event|0
7517977|NCT02942771|26103781|P2|Overall Study|Adverse Event|0
7517978|NCT02942771|26103782|P1|Overall Study|Adverse Event|1
7517979|NCT02942576|26103835|P2|Overall Study|Other|8
7517980|NCT02942576|26103836|P1|Overall Study|Other|10
7517981|NCT02942576|26103835|P2|Overall Study|Physician Decision|4
7517982|NCT02942576|26103836|P1|Overall Study|Physician Decision|1
7517983|NCT02942576|26103835|P2|Overall Study|Withdrawal by Subject|5
7517984|NCT02942576|26103836|P1|Overall Study|Withdrawal by Subject|7
7517985|NCT02942576|26103835|P2|Overall Study|Adverse Event|6
7517986|NCT02942576|26103836|P1|Overall Study|Adverse Event|28
7517987|NCT02942485|26103850|P2|Overall Study|Lost to Follow-up|0
7517988|NCT02942485|26103851|P1|Overall Study|Lost to Follow-up|1
7517989|NCT02942407|26103863|P2|Overall Study|Death|13
7517990|NCT02942407|26103864|P1|Overall Study|Death|16
7517991|NCT02942407|26103863|P2|Overall Study|Withdrawal by Subject|9
7517992|NCT02942407|26103864|P1|Overall Study|Withdrawal by Subject|7
7517993|NCT02942407|26103863|P2|Overall Study|Lost to Follow-up|2
7517994|NCT02942407|26103864|P1|Overall Study|Lost to Follow-up|3
7517995|NCT02942264|26103901|P9|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
7517996|NCT02942264|26103902|P8|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7517997|NCT02942264|26103903|P7|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7517998|NCT02942264|26103904|P6|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7517999|NCT02942264|26103905|P5|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7518000|NCT02942264|26103906|P4|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7518001|NCT02942264|26103907|P3|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7518002|NCT02942264|26103908|P2|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7518003|NCT02942264|26103909|P1|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7518004|NCT02942264|26103901|P9|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518005|NCT02942264|26103902|P8|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518006|NCT02942264|26103903|P7|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7518007|NCT02942264|26103904|P6|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518008|NCT02942264|26103905|P5|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518009|NCT02942264|26103906|P4|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518010|NCT02942264|26103907|P3|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518011|NCT02942264|26103908|P2|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7518012|NCT02942264|26103909|P1|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7518013|NCT02942017|26103977|P2|Overall Study|Randomized but not dosed|3
7518014|NCT02942017|26103978|P1|Overall Study|Randomized but not dosed|1
7518015|NCT02942017|26103977|P2|Overall Study|Lost to Follow-up|1
7518016|NCT02942017|26103978|P1|Overall Study|Lost to Follow-up|1
7518017|NCT02942017|26103977|P2|Overall Study|Withdrawal by Subject|1
7518018|NCT02942017|26103978|P1|Overall Study|Withdrawal by Subject|0
7518019|NCT02942017|26103977|P2|Overall Study|Adverse Event|1
7518020|NCT02942017|26103978|P1|Overall Study|Adverse Event|0
7518021|NCT02942004|26104009|P3|Overall Study|Randomized but not dosed|4
7518022|NCT02942004|26104010|P2|Overall Study|Randomized but not dosed|9
7518023|NCT02942004|26104011|P1|Overall Study|Randomized but not dosed|3
7518024|NCT02942004|26104009|P3|Overall Study|Lost to Follow-up|2
7518025|NCT02942004|26104010|P2|Overall Study|Lost to Follow-up|1
7518026|NCT02942004|26104011|P1|Overall Study|Lost to Follow-up|1
7518027|NCT02942004|26104009|P3|Overall Study|Withdrawal by Subject|3
7518028|NCT02942004|26104010|P2|Overall Study|Withdrawal by Subject|2
7518029|NCT02942004|26104011|P1|Overall Study|Withdrawal by Subject|0
7518030|NCT02941523|26104125|P2|Carboplatin Combination Therapy|Withdrawal by Subject|1
7518031|NCT02941523|26104126|P1|Carboplatin Combination Therapy|Withdrawal by Subject|2
7518032|NCT02941523|26104125|P2|Carboplatin Combination Therapy|Disease progression|0
7518033|NCT02941523|26104126|P1|Carboplatin Combination Therapy|Disease progression|2
7518034|NCT02941523|26104125|P2|Carboplatin Combination Therapy|Death|2
7518035|NCT02941523|26104126|P1|Carboplatin Combination Therapy|Death|1
7518036|NCT02941523|26104125|P2|Carboplatin Combination Therapy|Adverse Event|1
7518037|NCT02941523|26104126|P1|Carboplatin Combination Therapy|Adverse Event|0
7518038|NCT02941523|26104125|P2|Monotherapy|Withdrawal by Subject|1
7518039|NCT02941523|26104126|P1|Monotherapy|Withdrawal by Subject|0
7518040|NCT02940886|26104156|P2|Overall Study|Enrolment error|1
7518041|NCT02940886|26104157|P1|Overall Study|Enrolment error|0
7518042|NCT02940886|26104156|P2|Overall Study|No treatment|2
7518043|NCT02940886|26104157|P1|Overall Study|No treatment|7
7518044|NCT02940886|26104156|P2|Overall Study|Sponsor decision|1
7518045|NCT02940886|26104157|P1|Overall Study|Sponsor decision|0
7518046|NCT02940886|26104156|P2|Overall Study|Physician Decision|4
7518047|NCT02940886|26104157|P1|Overall Study|Physician Decision|9
7518048|NCT02940886|26104156|P2|Overall Study|Lost to Follow-up|21
7518049|NCT02940886|26104157|P1|Overall Study|Lost to Follow-up|49
7518050|NCT02940886|26104156|P2|Overall Study|Lack of Efficacy|0
7518051|NCT02940886|26104157|P1|Overall Study|Lack of Efficacy|1
7518052|NCT02940886|26104156|P2|Overall Study|Death|0
7518053|NCT02940886|26104157|P1|Overall Study|Death|1
7518054|NCT02940886|26104156|P2|Overall Study|Withdrawal by Subject|20
7518055|NCT02940886|26104157|P1|Overall Study|Withdrawal by Subject|28
7518056|NCT02940886|26104156|P2|Overall Study|Protocol Violation|2
7518057|NCT02940886|26104157|P1|Overall Study|Protocol Violation|0
7518058|NCT02940886|26104156|P2|Overall Study|Adverse Event|3
7518059|NCT02940886|26104157|P1|Overall Study|Adverse Event|7
7518060|NCT02940860|26104203|P2|Overall Study|Not treated|2
7518061|NCT02940860|26104204|P1|Overall Study|Not treated|2
7518062|NCT02940860|26104203|P2|Overall Study|Moved, poor venous access, transport|4
7518063|NCT02940860|26104204|P1|Overall Study|Moved, poor venous access, transport|6
7518064|NCT02940860|26104203|P2|Overall Study|Death|2
7518065|NCT02940860|26104204|P1|Overall Study|Death|3
7518066|NCT02940860|26104203|P2|Overall Study|Protocol Violation|2
7518067|NCT02940860|26104204|P1|Overall Study|Protocol Violation|0
7518068|NCT02940860|26104203|P2|Overall Study|Sponsor Decision|1
7518069|NCT02940860|26104204|P1|Overall Study|Sponsor Decision|0
7518070|NCT02940860|26104203|P2|Overall Study|Physician Decision|3
7518071|NCT02940860|26104204|P1|Overall Study|Physician Decision|5
7518072|NCT02940860|26104203|P2|Overall Study|Lost to Follow-up|7
7518073|NCT02940860|26104204|P1|Overall Study|Lost to Follow-up|13
7518074|NCT02940860|26104203|P2|Overall Study|Withdrawal by Subject|9
7518075|NCT02940860|26104204|P1|Overall Study|Withdrawal by Subject|19
7518076|NCT02940860|26104203|P2|Overall Study|Serious AE|3
7518077|NCT02940860|26104204|P1|Overall Study|Serious AE|7
7518078|NCT02940860|26104203|P2|Overall Study|Non-serious AE|2
7518079|NCT02940860|26104204|P1|Overall Study|Non-serious AE|1
7518080|NCT02940730|26104250|P2|Intervention 2|Physician Decision|0
7518081|NCT02940730|26104251|P1|Intervention 2|Physician Decision|7
7518082|NCT02940691|26104265|P1|Overall Study|Incarceration|1
7518083|NCT02940691|26104265|P1|Overall Study|Lost to Follow-up|5
7518084|NCT02940626|26104274|P2|Overall Study|Prohibited Concomitant Medication|1
7518085|NCT02940626|26104275|P1|Overall Study|Prohibited Concomitant Medication|0
7518086|NCT02940626|26104274|P2|Overall Study|Transfer to Hospice Care|0
7518087|NCT02940626|26104275|P1|Overall Study|Transfer to Hospice Care|1
7518088|NCT02940626|26104274|P2|Overall Study|Withdrawal by Subject|0
7518089|NCT02940626|26104275|P1|Overall Study|Withdrawal by Subject|1
7518090|NCT02940626|26104274|P2|Overall Study|Lost to Follow-up|2
7518091|NCT02940626|26104275|P1|Overall Study|Lost to Follow-up|5
7518092|NCT02940626|26104274|P2|Overall Study|Death|32
7518093|NCT02940626|26104275|P1|Overall Study|Death|40
7518094|NCT02940574|26104297|P2|1-year Follow-up|Lost to Follow-up|4
7518095|NCT02940574|26104298|P1|1-year Follow-up|Lost to Follow-up|3
7518096|NCT02940574|26104297|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
7518097|NCT02940574|26104298|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
7518098|NCT02940522|26104336|P2|Overall Study|Withdrawal by Subject|0
7518099|NCT02940522|26104337|P1|Overall Study|Withdrawal by Subject|1
7518100|NCT02940522|26104336|P2|Overall Study|Lost to Follow-up|2
7518101|NCT02940522|26104337|P1|Overall Study|Lost to Follow-up|1
7518102|NCT02940392|26104353|P1|Overall Study|Death|2
7518103|NCT02940392|26104353|P1|Overall Study|Retreatment|3
7518104|NCT02940392|26104353|P1|Overall Study|Lost to Follow-up|3
7518105|NCT02940223|26104438|P2|Overall Study|Failed Requirement|0
7518106|NCT02940223|26104439|P1|Overall Study|Failed Requirement|2
7518107|NCT02939950|26104451|P2|Overall Study|Ineligible at Baseline|8
7518108|NCT02939950|26104452|P1|Overall Study|Ineligible at Baseline|2
7518109|NCT02939950|26104451|P2|Overall Study|Randomized, not dispensed|0
7518110|NCT02939950|26104452|P1|Overall Study|Randomized, not dispensed|1
7518111|NCT02939950|26104451|P2|Overall Study|Adverse Event|3
7518112|NCT02939950|26104452|P1|Overall Study|Adverse Event|7
7518113|NCT02939950|26104451|P2|Overall Study|Withdrawal by Subject|28
7518114|NCT02939950|26104452|P1|Overall Study|Withdrawal by Subject|12
7518115|NCT02939950|26104451|P2|Overall Study|Pregnancy|7
7518116|NCT02939950|26104452|P1|Overall Study|Pregnancy|6
7518117|NCT02939950|26104451|P2|Overall Study|Physician Decision|0
7518118|NCT02939950|26104452|P1|Overall Study|Physician Decision|2
7518119|NCT02939950|26104451|P2|Overall Study|Protocol Violation|3
7518120|NCT02939950|26104452|P1|Overall Study|Protocol Violation|6
7518121|NCT02939950|26104451|P2|Overall Study|Unacceptable lens movement|0
7518122|NCT02939950|26104452|P1|Overall Study|Unacceptable lens movement|2
7518123|NCT02939950|26104451|P2|Overall Study|Study related symptoms|8
7518124|NCT02939950|26104452|P1|Overall Study|Study related symptoms|8
7518125|NCT02939950|26104451|P2|Overall Study|Participant Relocated|3
7518126|NCT02939950|26104452|P1|Overall Study|Participant Relocated|5
7518127|NCT02939950|26104451|P2|Overall Study|Military orders|0
7518128|NCT02939950|26104452|P1|Overall Study|Military orders|1
7518129|NCT02939950|26104451|P2|Overall Study|Unacceptable distance lens visual acuity|1
7518130|NCT02939950|26104452|P1|Overall Study|Unacceptable distance lens visual acuity|1
7518131|NCT02939950|26104451|P2|Overall Study|Lack of motivation|2
7518132|NCT02939950|26104452|P1|Overall Study|Lack of motivation|0
7518133|NCT02939950|26104451|P2|Overall Study|Chalazion upper lid|1
7518134|NCT02939950|26104452|P1|Overall Study|Chalazion upper lid|0
7518135|NCT02939950|26104451|P2|Overall Study|Positive slit lamp findings|1
7518136|NCT02939950|26104452|P1|Overall Study|Positive slit lamp findings|0
7518137|NCT02939950|26104451|P2|Overall Study|Lost to Follow-up|16
7518138|NCT02939950|26104452|P1|Overall Study|Lost to Follow-up|13
7518139|NCT02939937|26104462|P2|Overall Study|Lost to Follow-up|3
7518140|NCT02939937|26104463|P1|Overall Study|Lost to Follow-up|1
7518141|NCT02939937|26104462|P2|Overall Study|Adverse Event|0
7518142|NCT02939937|26104463|P1|Overall Study|Adverse Event|5
7518143|NCT02939781|26104477|P1|Overall Study|Withdrawal by Subject|1
7518144|NCT02939781|26104477|P1|Overall Study|Protocol Violation|8
7518145|NCT02939716|26104482|P6|Overall Study|scanner failure|1
7518146|NCT02939716|26104483|P5|Overall Study|scanner failure|1
7518147|NCT02939716|26104484|P4|Overall Study|scanner failure|1
7518148|NCT02939716|26104485|P3|Overall Study|scanner failure|0
7518149|NCT02939716|26104486|P2|Overall Study|scanner failure|0
7518150|NCT02939716|26104487|P1|Overall Study|scanner failure|0
7518151|NCT02939599|26104519|P2|Overall Study|Study Terminated By Sponsor|2
7518152|NCT02939599|26104520|P1|Overall Study|Study Terminated By Sponsor|2
7518153|NCT02939599|26104519|P2|Overall Study|Adverse Event|0
7518154|NCT02939599|26104520|P1|Overall Study|Adverse Event|1
7518155|NCT02939560|26104534|P1|Overall Study|Protocol Violation|1
7518156|NCT02939560|26104534|P1|Overall Study|Withdrawal by Subject|2
7518157|NCT02939131|26104592|P2|Overall Study|not willing to adhere to protocol|0
7518158|NCT02939131|26104593|P1|Overall Study|not willing to adhere to protocol|2
7518159|NCT02939131|26104592|P2|Overall Study|Other|1
7518160|NCT02939131|26104593|P1|Overall Study|Other|0
7518161|NCT02939131|26104592|P2|Overall Study|severe debilitation|0
7518162|NCT02939131|26104593|P1|Overall Study|severe debilitation|1
7518163|NCT02939131|26104592|P2|Overall Study|Lost to Follow-up|4
7518164|NCT02939131|26104593|P1|Overall Study|Lost to Follow-up|2
7518165|NCT02939131|26104592|P2|Overall Study|Unable to get to clinic|4
7518166|NCT02939131|26104593|P1|Overall Study|Unable to get to clinic|6
7518167|NCT02939079|26104694|P2|Overall Study|relapse during the study|1
7518168|NCT02939079|26104695|P1|Overall Study|relapse during the study|1
7518169|NCT02939079|26104694|P2|Overall Study|Withdrawal by Subject|1
7518170|NCT02939079|26104695|P1|Overall Study|Withdrawal by Subject|0
7518171|NCT02939079|26104694|P2|Overall Study|Protocol Violation|0
7518172|NCT02939079|26104695|P1|Overall Study|Protocol Violation|1
7518173|NCT02939079|26104694|P2|Overall Study|Lost to Follow-up|2
7518174|NCT02939079|26104695|P1|Overall Study|Lost to Follow-up|0
7518175|NCT02939079|26104694|P2|Overall Study|Adverse Event|1
7518176|NCT02939079|26104695|P1|Overall Study|Adverse Event|2
7518177|NCT02939014|26104725|P2|Overall Study|Death|3
7518178|NCT02939014|26104726|P1|Overall Study|Death|4
7518179|NCT02939014|26104725|P2|Overall Study|Lost to Follow-up|0
7518180|NCT02939014|26104726|P1|Overall Study|Lost to Follow-up|1
7518181|NCT02938585|26104776|P4|Overall Study|Withdrawal by Subject|5
7518182|NCT02938585|26104777|P3|Overall Study|Withdrawal by Subject|0
7518183|NCT02938585|26104778|P2|Overall Study|Withdrawal by Subject|0
7518184|NCT02938585|26104779|P1|Overall Study|Withdrawal by Subject|0
7518185|NCT02938585|26104776|P4|Overall Study|Withdrawal by parent or guardian|0
7518186|NCT02938585|26104777|P3|Overall Study|Withdrawal by parent or guardian|0
7518187|NCT02938585|26104778|P2|Overall Study|Withdrawal by parent or guardian|1
7518188|NCT02938585|26104779|P1|Overall Study|Withdrawal by parent or guardian|0
7518189|NCT02938520|26104943|P2|Overall Study|Adverse Event|4
7518190|NCT02938520|26104944|P1|Overall Study|Adverse Event|9
7518191|NCT02938520|26104943|P2|Overall Study|Lack of Efficacy|3
7518192|NCT02938520|26104944|P1|Overall Study|Lack of Efficacy|5
7518193|NCT02938520|26104943|P2|Overall Study|Protocol Violation|1
7518194|NCT02938520|26104944|P1|Overall Study|Protocol Violation|0
7518195|NCT02938520|26104943|P2|Overall Study|Withdrawal by Subject|7
7518196|NCT02938520|26104944|P1|Overall Study|Withdrawal by Subject|7
7518197|NCT02938520|26104943|P2|Overall Study|Lost to Follow-up|2
7518198|NCT02938520|26104944|P1|Overall Study|Lost to Follow-up|2
7518199|NCT02938520|26104943|P2|Overall Study|Physician Decision|5
7518200|NCT02938520|26104944|P1|Overall Study|Physician Decision|2
7518201|NCT02938520|26104943|P2|Overall Study|On-going at the time of analysis|261
7518202|NCT02938520|26104944|P1|Overall Study|On-going at the time of analysis|258
7518203|NCT02937870|26105166|P1|Overall Study|Protocol Deviation|2
7518204|NCT02937870|26105166|P1|Overall Study|Adverse Event|1
7518205|NCT02937818|26105186|P4|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
7518206|NCT02937818|26105187|P3|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7518207|NCT02937818|26105188|P2|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7518208|NCT02937818|26105189|P1|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7518209|NCT02937818|26105186|P4|Overall Study|Condition under investigation worsened|0
7518210|NCT02937818|26105187|P3|Overall Study|Condition under investigation worsened|1
7518211|NCT02937818|26105188|P2|Overall Study|Condition under investigation worsened|0
7518212|NCT02937818|26105189|P1|Overall Study|Condition under investigation worsened|0
7518213|NCT02937818|26105186|P4|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
7518214|NCT02937818|26105187|P3|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
7518215|NCT02937818|26105188|P2|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
7518216|NCT02937818|26105189|P1|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
7518217|NCT02937818|26105186|P4|Overall Study|Disease progression|18
7518218|NCT02937818|26105187|P3|Overall Study|Disease progression|7
7518219|NCT02937818|26105188|P2|Overall Study|Disease progression|14
7518220|NCT02937818|26105189|P1|Overall Study|Disease progression|17
7518221|NCT02937818|26105186|P4|Overall Study|Adverse Event|1
7518222|NCT02937818|26105187|P3|Overall Study|Adverse Event|1
7518223|NCT02937818|26105188|P2|Overall Study|Adverse Event|4
7518224|NCT02937818|26105189|P1|Overall Study|Adverse Event|2
7518225|NCT02937818|26105186|P4|Overall Study|Participants decision|1
7518226|NCT02937818|26105187|P3|Overall Study|Participants decision|1
7518227|NCT02937818|26105188|P2|Overall Study|Participants decision|0
7518228|NCT02937818|26105189|P1|Overall Study|Participants decision|1
7518229|NCT02937740|26105258|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
7518230|NCT02937740|26105259|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
7518231|NCT02937740|26105258|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
7518232|NCT02937740|26105259|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
7518233|NCT02937740|26105258|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
7518234|NCT02937740|26105259|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
7518235|NCT02937740|26105258|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
7518236|NCT02937740|26105259|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
7518237|NCT02937740|26105258|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
7518238|NCT02937740|26105259|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
7518239|NCT02937740|26105258|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
7518240|NCT02937740|26105259|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
7518241|NCT02937701|26105275|P5|Week 22 to Week 50|Other|1
7518242|NCT02937701|26105276|P4|Week 22 to Week 50|Other|0
7518243|NCT02937701|26105277|P3|Week 22 to Week 50|Other|0
7518244|NCT02937701|26105278|P2|Week 22 to Week 50|Other|0
7518245|NCT02937701|26105279|P1|Week 22 to Week 50|Other|0
7518246|NCT02937701|26105275|P5|Week 22 to Week 50|Physician Decision|1
7518247|NCT02937701|26105276|P4|Week 22 to Week 50|Physician Decision|0
7518248|NCT02937701|26105277|P3|Week 22 to Week 50|Physician Decision|2
7518249|NCT02937701|26105278|P2|Week 22 to Week 50|Physician Decision|0
7518250|NCT02937701|26105279|P1|Week 22 to Week 50|Physician Decision|0
7518251|NCT02937701|26105275|P5|Week 22 to Week 50|Lost to Follow-up|1
7518252|NCT02937701|26105276|P4|Week 22 to Week 50|Lost to Follow-up|0
7518253|NCT02937701|26105277|P3|Week 22 to Week 50|Lost to Follow-up|2
7518254|NCT02937701|26105278|P2|Week 22 to Week 50|Lost to Follow-up|0
7518255|NCT02937701|26105279|P1|Week 22 to Week 50|Lost to Follow-up|0
7518256|NCT02937701|26105275|P5|Week 22 to Week 50|Withdrawal by Subject|1
7518257|NCT02937701|26105276|P4|Week 22 to Week 50|Withdrawal by Subject|2
7518258|NCT02937701|26105277|P3|Week 22 to Week 50|Withdrawal by Subject|8
7518259|NCT02937701|26105278|P2|Week 22 to Week 50|Withdrawal by Subject|0
7518260|NCT02937701|26105279|P1|Week 22 to Week 50|Withdrawal by Subject|0
7518261|NCT02937701|26105275|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
7518262|NCT02937701|26105276|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
7518263|NCT02937701|26105277|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
7518264|NCT02937701|26105278|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7518265|NCT02937701|26105279|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7518266|NCT02937701|26105275|P5|Week 22 to Week 50|Adverse Event|3
7518267|NCT02937701|26105276|P4|Week 22 to Week 50|Adverse Event|3
7518268|NCT02937701|26105277|P3|Week 22 to Week 50|Adverse Event|10
7518269|NCT02937701|26105278|P2|Week 22 to Week 50|Adverse Event|0
7518270|NCT02937701|26105279|P1|Week 22 to Week 50|Adverse Event|0
7518271|NCT02937701|26105275|P5|Day 1 to Week 22|Other|0
7518272|NCT02937701|26105276|P4|Day 1 to Week 22|Other|0
7518273|NCT02937701|26105277|P3|Day 1 to Week 22|Other|0
7518274|NCT02937701|26105278|P2|Day 1 to Week 22|Other|0
7518275|NCT02937701|26105279|P1|Day 1 to Week 22|Other|1
7518276|NCT02937701|26105275|P5|Day 1 to Week 22|Physician Decision|0
7518277|NCT02937701|26105276|P4|Day 1 to Week 22|Physician Decision|0
7518278|NCT02937701|26105277|P3|Day 1 to Week 22|Physician Decision|0
7518279|NCT02937701|26105278|P2|Day 1 to Week 22|Physician Decision|0
7518280|NCT02937701|26105279|P1|Day 1 to Week 22|Physician Decision|2
7518281|NCT02937701|26105275|P5|Day 1 to Week 22|Lost to Follow-up|0
7518282|NCT02937701|26105276|P4|Day 1 to Week 22|Lost to Follow-up|0
7518283|NCT02937701|26105277|P3|Day 1 to Week 22|Lost to Follow-up|0
7518284|NCT02937701|26105278|P2|Day 1 to Week 22|Lost to Follow-up|1
7518285|NCT02937701|26105279|P1|Day 1 to Week 22|Lost to Follow-up|1
7518286|NCT02937701|26105275|P5|Day 1 to Week 22|Protocol Violation|0
7518287|NCT02937701|26105276|P4|Day 1 to Week 22|Protocol Violation|0
7518288|NCT02937701|26105277|P3|Day 1 to Week 22|Protocol Violation|0
7518289|NCT02937701|26105278|P2|Day 1 to Week 22|Protocol Violation|1
7518290|NCT02937701|26105279|P1|Day 1 to Week 22|Protocol Violation|1
7518291|NCT02937701|26105275|P5|Day 1 to Week 22|Death|0
7518292|NCT02937701|26105276|P4|Day 1 to Week 22|Death|0
7518293|NCT02937701|26105277|P3|Day 1 to Week 22|Death|0
7518294|NCT02937701|26105278|P2|Day 1 to Week 22|Death|1
7518295|NCT02937701|26105279|P1|Day 1 to Week 22|Death|1
7518296|NCT02937701|26105275|P5|Day 1 to Week 22|Withdrawal by Subject|0
7518297|NCT02937701|26105276|P4|Day 1 to Week 22|Withdrawal by Subject|0
7518298|NCT02937701|26105277|P3|Day 1 to Week 22|Withdrawal by Subject|0
7518299|NCT02937701|26105278|P2|Day 1 to Week 22|Withdrawal by Subject|6
7518300|NCT02937701|26105279|P1|Day 1 to Week 22|Withdrawal by Subject|6
7518301|NCT02937701|26105275|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7518302|NCT02937701|26105276|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7518303|NCT02937701|26105277|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7518304|NCT02937701|26105278|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
7518305|NCT02937701|26105279|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
7518306|NCT02937701|26105275|P5|Day 1 to Week 22|Protocol Specified Criteria|0
7518307|NCT02937701|26105276|P4|Day 1 to Week 22|Protocol Specified Criteria|0
7518308|NCT02937701|26105277|P3|Day 1 to Week 22|Protocol Specified Criteria|0
7518309|NCT02937701|26105278|P2|Day 1 to Week 22|Protocol Specified Criteria|7
7518310|NCT02937701|26105279|P1|Day 1 to Week 22|Protocol Specified Criteria|7
7518311|NCT02937701|26105275|P5|Day 1 to Week 22|Adverse Event|0
7518312|NCT02937701|26105276|P4|Day 1 to Week 22|Adverse Event|0
7518313|NCT02937701|26105277|P3|Day 1 to Week 22|Adverse Event|0
7518314|NCT02937701|26105278|P2|Day 1 to Week 22|Adverse Event|14
7518315|NCT02937701|26105279|P1|Day 1 to Week 22|Adverse Event|11
7518316|NCT02937636|26105310|P2|Overall Study|Other (Not specified)|2
7518317|NCT02937636|26105311|P1|Overall Study|Other (Not specified)|3
7518318|NCT02937584|26105338|P2|Washout|Adverse Event|1
7518319|NCT02937584|26105339|P1|Washout|Adverse Event|0
7518320|NCT02937584|26105338|P2|Period 1|Adverse Event|2
7518321|NCT02937584|26105339|P1|Period 1|Adverse Event|1
7518322|NCT02937545|26105373|P4|Overall Study|Lost to Follow-up|0
7518323|NCT02937545|26105374|P3|Overall Study|Lost to Follow-up|0
7518324|NCT02937545|26105375|P2|Overall Study|Lost to Follow-up|0
7518325|NCT02937545|26105376|P1|Overall Study|Lost to Follow-up|1
7518326|NCT02937545|26105373|P4|Overall Study|Withdrawal by Subject|7
7518327|NCT02937545|26105374|P3|Overall Study|Withdrawal by Subject|6
7518328|NCT02937545|26105375|P2|Overall Study|Withdrawal by Subject|2
7518329|NCT02937545|26105376|P1|Overall Study|Withdrawal by Subject|1
7518330|NCT02937454|26105413|P2|Overall Study|Other|5
7518331|NCT02937454|26105414|P1|Overall Study|Other|8
7518332|NCT02937454|26105413|P2|Overall Study|Withdrawal by Subject|15
7518333|NCT02937454|26105414|P1|Overall Study|Withdrawal by Subject|27
7518334|NCT02937454|26105413|P2|Overall Study|Protocol Violation|10
7518335|NCT02937454|26105414|P1|Overall Study|Protocol Violation|6
7518336|NCT02937454|26105413|P2|Overall Study|Physician Decision|1
7518337|NCT02937454|26105414|P1|Overall Study|Physician Decision|0
7518338|NCT02937454|26105413|P2|Overall Study|Lost to Follow-up|1
7518339|NCT02937454|26105414|P1|Overall Study|Lost to Follow-up|1
7518340|NCT02937454|26105413|P2|Overall Study|Death|95
7518341|NCT02937454|26105414|P1|Overall Study|Death|98
7518342|NCT02937454|26105413|P2|Overall Study|Adverse Event|1
7518343|NCT02937454|26105414|P1|Overall Study|Adverse Event|0
7518344|NCT02937350|26105445|P3|Overall Study|Withdrawal by Subject|0
7518345|NCT02937350|26105446|P2|Overall Study|Withdrawal by Subject|1
7518346|NCT02937350|26105447|P1|Overall Study|Withdrawal by Subject|0
7518347|NCT02936869|26105717|P2|Overall Study|Protocol Violation|0
7518348|NCT02936869|26105718|P1|Overall Study|Protocol Violation|1
7518349|NCT02936869|26105717|P2|Overall Study|Legal Case|1
7518350|NCT02936869|26105718|P1|Overall Study|Legal Case|0
7518351|NCT02936869|26105717|P2|Overall Study|Death|1
7518352|NCT02936869|26105718|P1|Overall Study|Death|0
7518353|NCT02936869|26105717|P2|Overall Study|Lost to Follow-up|3
7518354|NCT02936869|26105718|P1|Overall Study|Lost to Follow-up|1
7518355|NCT02936635|26105732|P2|Overall Study|Lack of effect/Entry into other study|65
7518356|NCT02936635|26105733|P1|Overall Study|Lack of effect/Entry into other study|31
7518357|NCT02936635|26105732|P2|Overall Study|Protocol Violation|0
7518358|NCT02936635|26105733|P1|Overall Study|Protocol Violation|1
7518359|NCT02936635|26105732|P2|Overall Study|Lost to Follow-up|2
7518360|NCT02936635|26105733|P1|Overall Study|Lost to Follow-up|1
7518361|NCT02936635|26105732|P2|Overall Study|Physician Decision|9
7518362|NCT02936635|26105733|P1|Overall Study|Physician Decision|2
7518363|NCT02936635|26105732|P2|Overall Study|Withdrawal by Subject|15
7518364|NCT02936635|26105733|P1|Overall Study|Withdrawal by Subject|8
7518365|NCT02936635|26105732|P2|Overall Study|Death|15
7518366|NCT02936635|26105733|P1|Overall Study|Death|9
7518367|NCT02936635|26105732|P2|Overall Study|Sponsor Discretion|16
7518368|NCT02936635|26105733|P1|Overall Study|Sponsor Discretion|10
7518369|NCT02936635|26105732|P2|Overall Study|Progressive Disease|18
7518370|NCT02936635|26105733|P1|Overall Study|Progressive Disease|10
7518371|NCT02936635|26105732|P2|Overall Study|Adverse Event|25
7518372|NCT02936635|26105733|P1|Overall Study|Adverse Event|43
7518373|NCT02936037|26105789|P2|Open Label Extension|Withdrawal by Subject|4
7518374|NCT02936037|26105790|P1|Open Label Extension|Withdrawal by Subject|0
7518375|NCT02936037|26105789|P2|Open Label Extension|Other|3
7518376|NCT02936037|26105790|P1|Open Label Extension|Other|0
7518377|NCT02936037|26105789|P2|Open Label Extension|Adverse Event|3
7518378|NCT02936037|26105790|P1|Open Label Extension|Adverse Event|0
7518379|NCT02936037|26105789|P2|Double-Blind Treatment Period|Lost to Follow-up|1
7518380|NCT02936037|26105790|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7518381|NCT02936037|26105789|P2|Double-Blind Treatment Period|Withdrawal by Subject|28
7518382|NCT02936037|26105790|P1|Double-Blind Treatment Period|Withdrawal by Subject|31
7518383|NCT02936037|26105789|P2|Double-Blind Treatment Period|Adverse Event|11
7518384|NCT02936037|26105790|P1|Double-Blind Treatment Period|Adverse Event|11
7518385|NCT02936037|26105789|P2|Double-Blind Treatment Period|Death|1
7518386|NCT02936037|26105790|P1|Double-Blind Treatment Period|Death|0
7518387|NCT02936037|26105789|P2|Double-Blind Treatment Period|Lack of Efficacy|12
7518388|NCT02936037|26105790|P1|Double-Blind Treatment Period|Lack of Efficacy|4
7518389|NCT02936037|26105789|P2|Double-Blind Treatment Period|Suicidal risk, etc.|8
7518390|NCT02936037|26105790|P1|Double-Blind Treatment Period|Suicidal risk, etc.|2
7518391|NCT02936037|26105789|P2|Double-Blind Treatment Period|Protocol Violation|4
7518392|NCT02936037|26105790|P1|Double-Blind Treatment Period|Protocol Violation|1
7518393|NCT02935894|26105796|P1|Overall Study|Subject dismissed|1
7518394|NCT02935842|26105811|P4|Testing and Therapy Period 3|Withdrawal by Subject|0
7518395|NCT02935842|26105812|P3|Testing and Therapy Period 3|Withdrawal by Subject|3
7518396|NCT02935842|26105813|P2|Testing and Therapy Period 3|Withdrawal by Subject|0
7518397|NCT02935842|26105814|P1|Testing and Therapy Period 3|Withdrawal by Subject|0
7518398|NCT02935842|26105811|P4|Testing and Therapy Period 3|Lost to Follow-up|1
7518399|NCT02935842|26105812|P3|Testing and Therapy Period 3|Lost to Follow-up|0
7518400|NCT02935842|26105813|P2|Testing and Therapy Period 3|Lost to Follow-up|0
7518401|NCT02935842|26105814|P1|Testing and Therapy Period 3|Lost to Follow-up|0
7518402|NCT02935842|26105811|P4|Testing and Therapy Period 3|Accident prior to treatment|0
7518403|NCT02935842|26105812|P3|Testing and Therapy Period 3|Accident prior to treatment|0
7518404|NCT02935842|26105813|P2|Testing and Therapy Period 3|Accident prior to treatment|2
7518405|NCT02935842|26105814|P1|Testing and Therapy Period 3|Accident prior to treatment|2
7518406|NCT02935842|26105811|P4|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
7518407|NCT02935842|26105812|P3|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7518408|NCT02935842|26105813|P2|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7518409|NCT02935842|26105814|P1|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
7518410|NCT02935842|26105811|P4|Testing and Therapy Period 2|Withdrawal by Subject|0
7518411|NCT02935842|26105812|P3|Testing and Therapy Period 2|Withdrawal by Subject|0
7518412|NCT02935842|26105813|P2|Testing and Therapy Period 2|Withdrawal by Subject|0
7518413|NCT02935842|26105814|P1|Testing and Therapy Period 2|Withdrawal by Subject|2
7518414|NCT02935673|26105883|P3|Overall Study|Withdrawal by Subject|0
7518415|NCT02935673|26105884|P2|Overall Study|Withdrawal by Subject|2
7518416|NCT02935673|26105885|P1|Overall Study|Withdrawal by Subject|1
7518417|NCT02935673|26105883|P3|Overall Study|Adverse Event|0
7518418|NCT02935673|26105884|P2|Overall Study|Adverse Event|1
7518419|NCT02935673|26105885|P1|Overall Study|Adverse Event|0
7518420|NCT02935452|26106030|P2|Overall Study|work and life commintment|1
7518421|NCT02935452|26106031|P1|Overall Study|work and life commintment|3
7518422|NCT02935192|26106045|P2|Overall Study|Withdrawal by Subject|4
7518423|NCT02935192|26106046|P1|Overall Study|Withdrawal by Subject|8
7518424|NCT02934178|26106182|P2|Received Vaccination 3|Withdrawal by Subject|0
7518425|NCT02934178|26106183|P1|Received Vaccination 3|Withdrawal by Subject|1
7518426|NCT02934178|26106182|P2|Received Vaccination 2|Death|1
7518427|NCT02934178|26106183|P1|Received Vaccination 2|Death|0
7518428|NCT02933528|26106323|P1|Overall Study|Lost to Follow-up|2
7518429|NCT02933489|26106333|P2|Overall Study|Unable to complete exams (other)|7
7518430|NCT02933489|26106334|P1|Overall Study|Unable to complete exams (other)|14
7518431|NCT02933489|26106333|P2|Overall Study|Withdrawal by Subject|18
7518432|NCT02933489|26106334|P1|Overall Study|Withdrawal by Subject|27
7518433|NCT02933489|26106333|P2|Overall Study|Ineligible|3
7518434|NCT02933489|26106334|P1|Overall Study|Ineligible|3
7518435|NCT02933060|26106435|P2|Overall Study|Withdrawal by Subject|1
7518436|NCT02933060|26106436|P1|Overall Study|Withdrawal by Subject|0
7518437|NCT02932943|26106477|P2|Overall Study|Withdrawal by Subject|3
7518438|NCT02932943|26106478|P1|Overall Study|Withdrawal by Subject|3
7518439|NCT02932943|26106477|P2|Overall Study|Adverse Event|2
7518440|NCT02932943|26106478|P1|Overall Study|Adverse Event|2
7518441|NCT02932943|26106477|P2|Overall Study|Lost to Follow-up|2
7518442|NCT02932943|26106478|P1|Overall Study|Lost to Follow-up|0
7518443|NCT02932904|26106494|P4|Overall Study|Randomized But Not Treated|2
7518444|NCT02932904|26106495|P3|Overall Study|Randomized But Not Treated|0
7518445|NCT02932904|26106496|P2|Overall Study|Randomized But Not Treated|1
7518446|NCT02932904|26106497|P1|Overall Study|Randomized But Not Treated|1
7518447|NCT02932904|26106494|P4|Overall Study|Pretreatment Event/Adverse Event|3
7518448|NCT02932904|26106495|P3|Overall Study|Pretreatment Event/Adverse Event|1
7518449|NCT02932904|26106496|P2|Overall Study|Pretreatment Event/Adverse Event|5
7518450|NCT02932904|26106497|P1|Overall Study|Pretreatment Event/Adverse Event|3
7518451|NCT02932904|26106494|P4|Overall Study|Significant Protocol Deviation|1
7518452|NCT02932904|26106495|P3|Overall Study|Significant Protocol Deviation|6
7518453|NCT02932904|26106496|P2|Overall Study|Significant Protocol Deviation|3
7518454|NCT02932904|26106497|P1|Overall Study|Significant Protocol Deviation|2
7518455|NCT02932904|26106494|P4|Overall Study|Lost to Follow-up|0
7518456|NCT02932904|26106495|P3|Overall Study|Lost to Follow-up|6
7518457|NCT02932904|26106496|P2|Overall Study|Lost to Follow-up|3
7518458|NCT02932904|26106497|P1|Overall Study|Lost to Follow-up|5
7518459|NCT02932904|26106494|P4|Overall Study|Voluntary Withdrawal|2
7518460|NCT02932904|26106495|P3|Overall Study|Voluntary Withdrawal|4
7518461|NCT02932904|26106496|P2|Overall Study|Voluntary Withdrawal|1
7518462|NCT02932904|26106497|P1|Overall Study|Voluntary Withdrawal|2
7518463|NCT02932904|26106494|P4|Overall Study|Study Termination|0
7518464|NCT02932904|26106495|P3|Overall Study|Study Termination|0
7518465|NCT02932904|26106496|P2|Overall Study|Study Termination|1
7518466|NCT02932904|26106497|P1|Overall Study|Study Termination|0
7518467|NCT02932904|26106494|P4|Overall Study|Pregnancy|0
7518468|NCT02932904|26106495|P3|Overall Study|Pregnancy|1
7518469|NCT02932904|26106496|P2|Overall Study|Pregnancy|1
7518470|NCT02932904|26106497|P1|Overall Study|Pregnancy|0
7518471|NCT02932904|26106494|P4|Overall Study|Noncompliance with Study Drug|4
7518472|NCT02932904|26106495|P3|Overall Study|Noncompliance with Study Drug|3
7518473|NCT02932904|26106496|P2|Overall Study|Noncompliance with Study Drug|3
7518474|NCT02932904|26106497|P1|Overall Study|Noncompliance with Study Drug|2
7518475|NCT02932904|26106494|P4|Overall Study|Reason not Specified|2
7518476|NCT02932904|26106495|P3|Overall Study|Reason not Specified|2
7518477|NCT02932904|26106496|P2|Overall Study|Reason not Specified|0
7518478|NCT02932904|26106497|P1|Overall Study|Reason not Specified|1
7518479|NCT02932891|26106532|P1|Overall Study|HPA Suppress|2
7518480|NCT02932891|26106532|P1|Overall Study|Lost to Follow-up|2
7518481|NCT02932878|26106538|P2|Overall Study|Due to Lab Results|1
7518482|NCT02932878|26106539|P1|Overall Study|Due to Lab Results|2
7518483|NCT02932462|26106560|P2|Overall Study|Progressive Disease|0
7518484|NCT02932462|26106561|P1|Overall Study|Progressive Disease|1
7518485|NCT02932462|26106560|P2|Overall Study|Non-Compliance With Study Drug|1
7518486|NCT02932462|26106561|P1|Overall Study|Non-Compliance With Study Drug|0
7518487|NCT02932462|26106560|P2|Overall Study|Withdrawal by Subject|4
7518488|NCT02932462|26106561|P1|Overall Study|Withdrawal by Subject|1
7518489|NCT02932462|26106560|P2|Overall Study|Protocol Violation|5
7518490|NCT02932462|26106561|P1|Overall Study|Protocol Violation|0
7518491|NCT02932462|26106560|P2|Overall Study|Lost to Follow-up|1
7518492|NCT02932462|26106561|P1|Overall Study|Lost to Follow-up|4
7518493|NCT02932462|26106560|P2|Overall Study|Adverse Event|2
7518494|NCT02932462|26106561|P1|Overall Study|Adverse Event|1
7518495|NCT02932332|26106575|P4|Overall Study|Not Dyspneic cough|0
7518496|NCT02932332|26106576|P3|Overall Study|Not Dyspneic cough|1
7518497|NCT02932332|26106577|P2|Overall Study|Not Dyspneic cough|2
7518498|NCT02932332|26106578|P1|Overall Study|Not Dyspneic cough|1
7518499|NCT02932332|26106575|P4|Overall Study|Chest pain|1
7518500|NCT02932332|26106576|P3|Overall Study|Chest pain|0
7518501|NCT02932332|26106577|P2|Overall Study|Chest pain|0
7518502|NCT02932332|26106578|P1|Overall Study|Chest pain|0
7518503|NCT02932332|26106575|P4|Overall Study|Withdrawal by Subject|1
7518504|NCT02932332|26106576|P3|Overall Study|Withdrawal by Subject|0
7518505|NCT02932332|26106577|P2|Overall Study|Withdrawal by Subject|1
7518506|NCT02932332|26106578|P1|Overall Study|Withdrawal by Subject|1
7518507|NCT02932306|26106598|P2|Overall Study|Withdrew due to burning,itching,stinging|0
7518508|NCT02932306|26106599|P1|Overall Study|Withdrew due to burning,itching,stinging|1
7518509|NCT02932306|26106598|P2|Overall Study|Worsening condition|0
7518510|NCT02932306|26106599|P1|Overall Study|Worsening condition|2
7518511|NCT02932306|26106598|P2|Overall Study|Lack of Efficacy|2
7518512|NCT02932306|26106599|P1|Overall Study|Lack of Efficacy|0
7518513|NCT02932306|26106598|P2|Overall Study|Withdrawal by Parent or Guardian|8
7518514|NCT02932306|26106599|P1|Overall Study|Withdrawal by Parent or Guardian|6
7518515|NCT02932306|26106598|P2|Overall Study|Lost to Follow-up|40
7518516|NCT02932306|26106599|P1|Overall Study|Lost to Follow-up|36
7518517|NCT02932306|26106598|P2|Overall Study|Noncompliance with Study Drug|1
7518518|NCT02932306|26106599|P1|Overall Study|Noncompliance with Study Drug|1
7518519|NCT02932306|26106598|P2|Overall Study|Protocol Violation|1
7518520|NCT02932306|26106599|P1|Overall Study|Protocol Violation|1
7518521|NCT02932306|26106598|P2|Overall Study|Pregnancy|0
7518522|NCT02932306|26106599|P1|Overall Study|Pregnancy|2
7518523|NCT02932306|26106598|P2|Overall Study|Adverse Event|0
7518524|NCT02932306|26106599|P1|Overall Study|Adverse Event|3
7518525|NCT02932306|26106598|P2|Overall Study|Withdrawal by Subject|25
7518526|NCT02932306|26106599|P1|Overall Study|Withdrawal by Subject|16
7518527|NCT02932267|26106613|P1|Overall Study|Pregnancy|1
7518528|NCT02932267|26106613|P1|Overall Study|Lost to Follow-up|4
7518529|NCT02932267|26106613|P1|Overall Study|Withdrawal by Subject|3
7518530|NCT02932228|26106619|P2|Overall Study|not eligible upon chart review|5
7518531|NCT02932228|26106620|P1|Overall Study|not eligible upon chart review|2
7518532|NCT02932228|26106619|P2|Overall Study|Death|23
7518533|NCT02932228|26106620|P1|Overall Study|Death|8
7518534|NCT02931838|26106645|P6|Overall Study|Adverse Event|1
7518535|NCT02931838|26106646|P5|Overall Study|Adverse Event|3
7518536|NCT02931838|26106647|P4|Overall Study|Adverse Event|1
7518537|NCT02931838|26106648|P3|Overall Study|Adverse Event|2
7518538|NCT02931838|26106649|P2|Overall Study|Adverse Event|1
7518539|NCT02931838|26106650|P1|Overall Study|Adverse Event|2
7518540|NCT02931838|26106645|P6|Overall Study|Withdrawal by Subject|0
7518541|NCT02931838|26106646|P5|Overall Study|Withdrawal by Subject|0
7518542|NCT02931838|26106647|P4|Overall Study|Withdrawal by Subject|1
7518543|NCT02931838|26106648|P3|Overall Study|Withdrawal by Subject|0
7518544|NCT02931838|26106649|P2|Overall Study|Withdrawal by Subject|2
7518545|NCT02931838|26106650|P1|Overall Study|Withdrawal by Subject|1
7518546|NCT02931838|26106645|P6|Overall Study|Subject request to discontinue treatment|0
7518547|NCT02931838|26106646|P5|Overall Study|Subject request to discontinue treatment|1
7518548|NCT02931838|26106647|P4|Overall Study|Subject request to discontinue treatment|0
7518549|NCT02931838|26106648|P3|Overall Study|Subject request to discontinue treatment|3
7518550|NCT02931838|26106649|P2|Overall Study|Subject request to discontinue treatment|3
7518551|NCT02931838|26106650|P1|Overall Study|Subject request to discontinue treatment|4
7518552|NCT02931838|26106645|P6|Overall Study|Lost to Follow-up|0
7518553|NCT02931838|26106646|P5|Overall Study|Lost to Follow-up|2
7518554|NCT02931838|26106647|P4|Overall Study|Lost to Follow-up|1
7518555|NCT02931838|26106648|P3|Overall Study|Lost to Follow-up|1
7518556|NCT02931838|26106649|P2|Overall Study|Lost to Follow-up|0
7518557|NCT02931838|26106650|P1|Overall Study|Lost to Follow-up|1
7518558|NCT02931838|26106645|P6|Overall Study|Lack of Efficacy|1
7518559|NCT02931838|26106646|P5|Overall Study|Lack of Efficacy|0
7518560|NCT02931838|26106647|P4|Overall Study|Lack of Efficacy|0
7518561|NCT02931838|26106648|P3|Overall Study|Lack of Efficacy|0
7518562|NCT02931838|26106649|P2|Overall Study|Lack of Efficacy|4
7518563|NCT02931838|26106650|P1|Overall Study|Lack of Efficacy|5
7518564|NCT02931838|26106645|P6|Overall Study|Poor/non-compliance|0
7518565|NCT02931838|26106646|P5|Overall Study|Poor/non-compliance|0
7518566|NCT02931838|26106647|P4|Overall Study|Poor/non-compliance|0
7518567|NCT02931838|26106648|P3|Overall Study|Poor/non-compliance|1
7518568|NCT02931838|26106649|P2|Overall Study|Poor/non-compliance|0
7518569|NCT02931838|26106650|P1|Overall Study|Poor/non-compliance|0
7518570|NCT02931838|26106645|P6|Overall Study|Reason not provided by investigator|0
7518571|NCT02931838|26106646|P5|Overall Study|Reason not provided by investigator|0
7518572|NCT02931838|26106647|P4|Overall Study|Reason not provided by investigator|0
7518573|NCT02931838|26106648|P3|Overall Study|Reason not provided by investigator|1
7518574|NCT02931838|26106649|P2|Overall Study|Reason not provided by investigator|0
7518575|NCT02931838|26106650|P1|Overall Study|Reason not provided by investigator|1
7518576|NCT02931539|26106725|P3|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
7518577|NCT02931539|26106726|P2|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7518578|NCT02931539|26106727|P1|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7518579|NCT02931539|26106725|P3|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7518580|NCT02931539|26106726|P2|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7518581|NCT02931539|26106727|P1|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
7518582|NCT02931539|26106725|P3|Period 1: Treatment Phase|Protocol Violation|0
7518583|NCT02931539|26106726|P2|Period 1: Treatment Phase|Protocol Violation|0
7518584|NCT02931539|26106727|P1|Period 1: Treatment Phase|Protocol Violation|6
7518585|NCT02931539|26106725|P3|Period 1: Treatment Phase|Withdrawal by Subject|0
7518586|NCT02931539|26106726|P2|Period 1: Treatment Phase|Withdrawal by Subject|8
7518587|NCT02931539|26106727|P1|Period 1: Treatment Phase|Withdrawal by Subject|16
7518588|NCT02931539|26106725|P3|Period 1: Treatment Phase|Death|0
7518589|NCT02931539|26106726|P2|Period 1: Treatment Phase|Death|24
7518590|NCT02931539|26106727|P1|Period 1: Treatment Phase|Death|8
7518591|NCT02931539|26106725|P3|Period 1: Treatment Phase|Lost to Follow-up|0
7518592|NCT02931539|26106726|P2|Period 1: Treatment Phase|Lost to Follow-up|2
7518593|NCT02931539|26106727|P1|Period 1: Treatment Phase|Lost to Follow-up|1
7518594|NCT02931539|26106725|P3|Period 1: Treatment Phase|Adverse Event|0
7518595|NCT02931539|26106726|P2|Period 1: Treatment Phase|Adverse Event|1
7518596|NCT02931539|26106727|P1|Period 1: Treatment Phase|Adverse Event|5
7518597|NCT02931539|26106725|P3|Period 1: Treatment Phase|Investigator discretion|0
7518598|NCT02931539|26106726|P2|Period 1: Treatment Phase|Investigator discretion|1
7518599|NCT02931539|26106727|P1|Period 1: Treatment Phase|Investigator discretion|1
7518600|NCT02931396|26106790|P2|Overall Study|Withdrawal by Subject|0
7518601|NCT02931396|26106791|P1|Overall Study|Withdrawal by Subject|2
7518602|NCT02931396|26106790|P2|Overall Study|Lost to Follow-up|0
7518603|NCT02931396|26106791|P1|Overall Study|Lost to Follow-up|3
7518604|NCT02930837|26106837|P1|Overall Study|Withdrawal by Subject|1
7518605|NCT02930837|26106837|P1|Overall Study|Lost to Follow-up|5
7518606|NCT02930837|26106837|P1|Overall Study|Adverse Event|6
7518607|NCT02930343|26107162|P2|Overall Study|Lost to Follow-up|7
7518608|NCT02930343|26107163|P1|Overall Study|Lost to Follow-up|9
7518609|NCT02930226|26107181|P6|Overall Study|Technical Problems: Leak in plasma bag|0
7518610|NCT02930226|26107182|P5|Overall Study|Technical Problems: Leak in plasma bag|1
7518611|NCT02930226|26107183|P4|Overall Study|Technical Problems: Leak in plasma bag|0
7518612|NCT02930226|26107184|P3|Overall Study|Technical Problems: Leak in plasma bag|0
7518613|NCT02930226|26107185|P2|Overall Study|Technical Problems: Leak in plasma bag|0
7518614|NCT02930226|26107186|P1|Overall Study|Technical Problems: Leak in plasma bag|0
7518615|NCT02930018|26107240|P2|Overall Study|Withdrawal by Subject|2
7518616|NCT02930018|26107241|P1|Overall Study|Withdrawal by Subject|5
7518617|NCT02930018|26107240|P2|Overall Study|Lost to Follow-up|1
7518618|NCT02930018|26107241|P1|Overall Study|Lost to Follow-up|1
7518619|NCT02930005|26107265|P2|Overall Study|Lost to Follow-up|5
7518620|NCT02930005|26107266|P1|Overall Study|Lost to Follow-up|1
7518621|NCT02929498|26107333|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7518622|NCT02929498|26107334|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7518623|NCT02929498|26107335|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
7518624|NCT02929498|26107333|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7518625|NCT02929498|26107334|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7518626|NCT02929498|26107335|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
7518627|NCT02929407|26107429|P1|Overall Study|Adverse Event|1
7518628|NCT02929329|26107446|P2|Overall Study|Death|1051
7518629|NCT02929329|26107447|P1|Overall Study|Death|1054
7518630|NCT02929329|26107446|P2|Overall Study|Lost to Follow-up|20
7518631|NCT02929329|26107447|P1|Overall Study|Lost to Follow-up|26
7518632|NCT02929329|26107446|P2|Overall Study|Withdrawal by Subject|21
7518633|NCT02929329|26107447|P1|Overall Study|Withdrawal by Subject|24
7518634|NCT02928952|26107465|P2|Overall Study|Physician Decision|1
7518635|NCT02928952|26107466|P1|Overall Study|Physician Decision|0
7518636|NCT02928952|26107465|P2|Overall Study|Withdrawal by Subject|1
7518637|NCT02928952|26107466|P1|Overall Study|Withdrawal by Subject|5
7518638|NCT02928952|26107465|P2|Overall Study|Lost to Follow-up|5
7518639|NCT02928952|26107466|P1|Overall Study|Lost to Follow-up|5
7518640|NCT02928848|26107508|P2|Arm 2|Withdrawal by Subject|0
7518641|NCT02928848|26107509|P1|Arm 2|Withdrawal by Subject|1
7518642|NCT02928770|26107517|P1|Overall Study|Withdrawal by Subject|2
7518643|NCT02928224|26107557|P4|Overall Study|not listed|0
7518644|NCT02928224|26107558|P3|Overall Study|not listed|1
7518645|NCT02928224|26107559|P2|Overall Study|not listed|3
7518646|NCT02928224|26107560|P1|Overall Study|not listed|0
7518647|NCT02928224|26107557|P4|Overall Study|Physician Decision|2
7518648|NCT02928224|26107558|P3|Overall Study|Physician Decision|4
7518649|NCT02928224|26107559|P2|Overall Study|Physician Decision|2
7518650|NCT02928224|26107560|P1|Overall Study|Physician Decision|0
7518651|NCT02928224|26107557|P4|Overall Study|Patient Decision to Discontinue Drug|4
7518652|NCT02928224|26107558|P3|Overall Study|Patient Decision to Discontinue Drug|2
7518653|NCT02928224|26107559|P2|Overall Study|Patient Decision to Discontinue Drug|2
7518654|NCT02928224|26107560|P1|Overall Study|Patient Decision to Discontinue Drug|0
7518655|NCT02928224|26107557|P4|Overall Study|Dose Interruptions>28|4
7518656|NCT02928224|26107558|P3|Overall Study|Dose Interruptions>28|2
7518657|NCT02928224|26107559|P2|Overall Study|Dose Interruptions>28|2
7518658|NCT02928224|26107560|P1|Overall Study|Dose Interruptions>28|1
7518659|NCT02928224|26107557|P4|Overall Study|Withdrawal by Subject|9
7518660|NCT02928224|26107558|P3|Overall Study|Withdrawal by Subject|3
7518661|NCT02928224|26107559|P2|Overall Study|Withdrawal by Subject|4
7518662|NCT02928224|26107560|P1|Overall Study|Withdrawal by Subject|1
7518663|NCT02928224|26107557|P4|Overall Study|Death|11
7518664|NCT02928224|26107558|P3|Overall Study|Death|5
7518665|NCT02928224|26107559|P2|Overall Study|Death|7
7518666|NCT02928224|26107560|P1|Overall Study|Death|1
7518667|NCT02928224|26107557|P4|Overall Study|Changes in Patient's Condition|13
7518668|NCT02928224|26107558|P3|Overall Study|Changes in Patient's Condition|9
7518669|NCT02928224|26107559|P2|Overall Study|Changes in Patient's Condition|9
7518670|NCT02928224|26107560|P1|Overall Study|Changes in Patient's Condition|3
7518671|NCT02928224|26107557|P4|Overall Study|Adverse Event|10
7518672|NCT02928224|26107558|P3|Overall Study|Adverse Event|11
7518673|NCT02928224|26107559|P2|Overall Study|Adverse Event|11
7518674|NCT02928224|26107560|P1|Overall Study|Adverse Event|2
7518675|NCT02928224|26107557|P4|Overall Study|Progressive Disease|103
7518676|NCT02928224|26107558|P3|Overall Study|Progressive Disease|101
7518677|NCT02928224|26107559|P2|Overall Study|Progressive Disease|104
7518678|NCT02928224|26107560|P1|Overall Study|Progressive Disease|23
7518679|NCT02928224|26107557|P4|Overall Study|Treatment Ongoing|37
7518680|NCT02928224|26107558|P3|Overall Study|Treatment Ongoing|78
7518681|NCT02928224|26107559|P2|Overall Study|Treatment Ongoing|78
7518682|NCT02928224|26107560|P1|Overall Study|Treatment Ongoing|6
7518683|NCT02928224|26107557|P4|Overall Study|Randomized, Not Treated|28
7518684|NCT02928224|26107558|P3|Overall Study|Randomized, Not Treated|4
7518685|NCT02928224|26107559|P2|Overall Study|Randomized, Not Treated|2
7518686|NCT02928224|26107560|P1|Overall Study|Randomized, Not Treated|0
7518687|NCT02928029|26107677|P2|Overall Study|AE not related to clinical progression|1
7518688|NCT02928029|26107678|P1|Overall Study|AE not related to clinical progression|1
7518689|NCT02928029|26107677|P2|Overall Study|Clinical progression|2
7518690|NCT02928029|26107678|P1|Overall Study|Clinical progression|1
7518691|NCT02928029|26107677|P2|Overall Study|Radiological progression|0
7518692|NCT02928029|26107678|P1|Overall Study|Radiological progression|1
7518693|NCT02928029|26107677|P2|Overall Study|Withdrawal by Subject|1
7518694|NCT02928029|26107678|P1|Overall Study|Withdrawal by Subject|0
7518695|NCT02927938|26107692|P4|Overall Study|Early Study Termination|3
7518696|NCT02927938|26107693|P3|Overall Study|Early Study Termination|4
7518697|NCT02927938|26107694|P2|Overall Study|Early Study Termination|5
7518698|NCT02927938|26107695|P1|Overall Study|Early Study Termination|1
7518699|NCT02927938|26107692|P4|Overall Study|Death|4
7518700|NCT02927938|26107693|P3|Overall Study|Death|0
7518701|NCT02927938|26107694|P2|Overall Study|Death|1
7518702|NCT02927938|26107695|P1|Overall Study|Death|0
7518703|NCT02927925|26107703|P1|Overall Study|Disease progression at clinical cutoff|1
7518704|NCT02927925|26107703|P1|Overall Study|Other|3
7518705|NCT02927925|26107703|P1|Overall Study|Withdrawal by Subject|11
7518706|NCT02927925|26107703|P1|Overall Study|Physician Decision|1
7518707|NCT02927925|26107703|P1|Overall Study|Death|16
7518708|NCT02927834|26107720|P3|Overall Study|Lost to Follow-up|2
7518709|NCT02927834|26107721|P2|Overall Study|Lost to Follow-up|2
7518710|NCT02927834|26107722|P1|Overall Study|Lost to Follow-up|1
7518711|NCT02927795|26107736|P1|Overall Study|Not Treated|4
7518712|NCT02927795|26107736|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
7518713|NCT02927431|26107792|P3|Overall Study|Withdrawal by Subject|1
7518714|NCT02927431|26107793|P2|Overall Study|Withdrawal by Subject|0
7518715|NCT02927431|26107794|P1|Overall Study|Withdrawal by Subject|0
7518716|NCT02927366|26107872|P2|Overall Study|Patient schedule|0
7518717|NCT02927366|26107873|P1|Overall Study|Patient schedule|1
7518718|NCT02927366|26107872|P2|Overall Study|Adverse Event|0
7518719|NCT02927366|26107873|P1|Overall Study|Adverse Event|1
7518720|NCT02927301|26107920|P1|Overall Study|Physician Decision|2
7518721|NCT02927301|26107920|P1|Overall Study|Withdrawal by Subject|1
7518722|NCT02927301|26107920|P1|Overall Study|Adverse Event|7
7518723|NCT02927171|26107934|P2|Overall Study|Lost to Follow-up|1
7518724|NCT02927171|26107935|P1|Overall Study|Lost to Follow-up|0
7518725|NCT02927080|26107955|P10|Overall Study|Other|0
7518726|NCT02927080|26107956|P9|Overall Study|Other|1
7518727|NCT02927080|26107957|P8|Overall Study|Other|0
7518728|NCT02927080|26107958|P7|Overall Study|Other|1
7518729|NCT02927080|26107959|P6|Overall Study|Other|0
7518730|NCT02927080|26107960|P5|Overall Study|Other|0
7518731|NCT02927080|26107961|P4|Overall Study|Other|0
7518732|NCT02927080|26107962|P3|Overall Study|Other|0
7518733|NCT02927080|26107963|P2|Overall Study|Other|0
7518734|NCT02927080|26107964|P1|Overall Study|Other|0
7518735|NCT02927080|26107955|P10|Overall Study|Adverse Event|1
7518736|NCT02927080|26107956|P9|Overall Study|Adverse Event|0
7518737|NCT02927080|26107957|P8|Overall Study|Adverse Event|1
7518738|NCT02927080|26107958|P7|Overall Study|Adverse Event|0
7518739|NCT02927080|26107959|P6|Overall Study|Adverse Event|0
7518740|NCT02927080|26107960|P5|Overall Study|Adverse Event|0
7518741|NCT02927080|26107961|P4|Overall Study|Adverse Event|0
7518742|NCT02927080|26107962|P3|Overall Study|Adverse Event|0
7518743|NCT02927080|26107963|P2|Overall Study|Adverse Event|1
7518744|NCT02927080|26107964|P1|Overall Study|Adverse Event|0
7518745|NCT02927080|26107955|P10|Overall Study|Study terminated by Sponsor|3
7518746|NCT02927080|26107956|P9|Overall Study|Study terminated by Sponsor|2
7518747|NCT02927080|26107957|P8|Overall Study|Study terminated by Sponsor|7
7518748|NCT02927080|26107958|P7|Overall Study|Study terminated by Sponsor|6
7518749|NCT02927080|26107959|P6|Overall Study|Study terminated by Sponsor|0
7518750|NCT02927080|26107960|P5|Overall Study|Study terminated by Sponsor|0
7518751|NCT02927080|26107961|P4|Overall Study|Study terminated by Sponsor|0
7518752|NCT02927080|26107962|P3|Overall Study|Study terminated by Sponsor|0
7518753|NCT02927080|26107963|P2|Overall Study|Study terminated by Sponsor|0
7518754|NCT02927080|26107964|P1|Overall Study|Study terminated by Sponsor|0
7518755|NCT02927080|26107955|P10|Overall Study|Willingness to comply with protocol|1
7518756|NCT02927080|26107956|P9|Overall Study|Willingness to comply with protocol|0
7518757|NCT02927080|26107957|P8|Overall Study|Willingness to comply with protocol|0
7518758|NCT02927080|26107958|P7|Overall Study|Willingness to comply with protocol|0
7518759|NCT02927080|26107959|P6|Overall Study|Willingness to comply with protocol|0
7518760|NCT02927080|26107960|P5|Overall Study|Willingness to comply with protocol|0
7518761|NCT02927080|26107961|P4|Overall Study|Willingness to comply with protocol|0
7518762|NCT02927080|26107962|P3|Overall Study|Willingness to comply with protocol|0
7518763|NCT02927080|26107963|P2|Overall Study|Willingness to comply with protocol|0
7518764|NCT02927080|26107964|P1|Overall Study|Willingness to comply with protocol|0
7518765|NCT02927080|26107955|P10|Overall Study|Withdrawal by Subject|2
7518766|NCT02927080|26107956|P9|Overall Study|Withdrawal by Subject|0
7518767|NCT02927080|26107957|P8|Overall Study|Withdrawal by Subject|1
7518768|NCT02927080|26107958|P7|Overall Study|Withdrawal by Subject|1
7518769|NCT02927080|26107959|P6|Overall Study|Withdrawal by Subject|0
7518770|NCT02927080|26107960|P5|Overall Study|Withdrawal by Subject|1
7518771|NCT02927080|26107961|P4|Overall Study|Withdrawal by Subject|0
7518772|NCT02927080|26107962|P3|Overall Study|Withdrawal by Subject|0
7518773|NCT02927080|26107963|P2|Overall Study|Withdrawal by Subject|0
7518774|NCT02927080|26107964|P1|Overall Study|Withdrawal by Subject|0
7518775|NCT02926950|26108046|P2|Overall Study|Lost to Follow-up|8
7518776|NCT02926950|26108047|P1|Overall Study|Lost to Follow-up|7
7518777|NCT02926950|26108046|P2|Overall Study|Reason not Specified|9
7518778|NCT02926950|26108047|P1|Overall Study|Reason not Specified|17
7518779|NCT02926950|26108046|P2|Overall Study|At the participant's own request|25
7518780|NCT02926950|26108047|P1|Overall Study|At the participant's own request|21
7518781|NCT02926950|26108046|P2|Overall Study|Adverse Event|6
7518782|NCT02926950|26108047|P1|Overall Study|Adverse Event|4
7518783|NCT02926937|26108072|P3|Overall Study|Reason not Specified|2
7518784|NCT02926937|26108073|P2|Overall Study|Reason not Specified|4
7518785|NCT02926937|26108074|P1|Overall Study|Reason not Specified|3
7518786|NCT02926937|26108072|P3|Overall Study|At the Participant's own Request|8
7518787|NCT02926937|26108073|P2|Overall Study|At the Participant's own Request|5
7518788|NCT02926937|26108074|P1|Overall Study|At the Participant's own Request|11
7518789|NCT02926937|26108072|P3|Overall Study|Lost to Follow-up|0
7518790|NCT02926937|26108073|P2|Overall Study|Lost to Follow-up|5
7518791|NCT02926937|26108074|P1|Overall Study|Lost to Follow-up|4
7518792|NCT02926937|26108072|P3|Overall Study|Poor Compliance to Protocol|0
7518793|NCT02926937|26108073|P2|Overall Study|Poor Compliance to Protocol|0
7518794|NCT02926937|26108074|P1|Overall Study|Poor Compliance to Protocol|1
7518795|NCT02926937|26108072|P3|Overall Study|Adverse Event|1
7518796|NCT02926937|26108073|P2|Overall Study|Adverse Event|1
7518797|NCT02926937|26108074|P1|Overall Study|Adverse Event|0
7518798|NCT02926833|26108111|P4|Overall Study|Adverse Event|0
7518799|NCT02926833|26108112|P3|Overall Study|Adverse Event|1
7518800|NCT02926833|26108113|P2|Overall Study|Adverse Event|0
7518801|NCT02926833|26108114|P1|Overall Study|Adverse Event|0
7518802|NCT02926833|26108111|P4|Overall Study|Still on study|14
7518803|NCT02926833|26108112|P3|Overall Study|Still on study|5
7518804|NCT02926833|26108113|P2|Overall Study|Still on study|3
7518805|NCT02926833|26108114|P1|Overall Study|Still on study|2
7518806|NCT02926833|26108111|P4|Overall Study|Death|7
7518807|NCT02926833|26108112|P3|Overall Study|Death|1
7518808|NCT02926833|26108113|P2|Overall Study|Death|1
7518809|NCT02926833|26108114|P1|Overall Study|Death|1
7518810|NCT02926833|26108111|P4|Overall Study|Full Consent Withdrawal|2
7518811|NCT02926833|26108112|P3|Overall Study|Full Consent Withdrawal|0
7518812|NCT02926833|26108113|P2|Overall Study|Full Consent Withdrawal|0
7518813|NCT02926833|26108114|P1|Overall Study|Full Consent Withdrawal|0
7518814|NCT02926638|26108195|P2|Overall Study|Not protocol specified|0
7518815|NCT02926638|26108196|P1|Overall Study|Not protocol specified|1
7518816|NCT02926638|26108195|P2|Overall Study|Ineligible|0
7518817|NCT02926638|26108196|P1|Overall Study|Ineligible|1
7518818|NCT02926638|26108195|P2|Overall Study|Progression|5
7518819|NCT02926638|26108196|P1|Overall Study|Progression|2
7518820|NCT02926573|26108210|P2|Overall Study|Delirium|1
7518821|NCT02926573|26108211|P1|Overall Study|Delirium|0
7518822|NCT02926573|26108210|P2|Overall Study|Return to operating room|2
7518823|NCT02926573|26108211|P1|Overall Study|Return to operating room|0
7518824|NCT02926573|26108210|P2|Overall Study|Withdrawal by Subject|2
7518825|NCT02926573|26108211|P1|Overall Study|Withdrawal by Subject|0
7518826|NCT02926573|26108210|P2|Overall Study|Change to outpatient status|1
7518827|NCT02926573|26108211|P1|Overall Study|Change to outpatient status|5
7518828|NCT02926573|26108210|P2|Overall Study|Change in surgery plan|1
7518829|NCT02926573|26108211|P1|Overall Study|Change in surgery plan|3
7518830|NCT02926573|26108210|P2|Overall Study|Remain intubated|2
7518831|NCT02926573|26108211|P1|Overall Study|Remain intubated|2
7518832|NCT02926573|26108210|P2|Overall Study|Nausea|0
7518833|NCT02926573|26108211|P1|Overall Study|Nausea|1
7518834|NCT02926209|26108229|P2|Study Cohort|Poor Bowel Preparation|0
7518835|NCT02926209|26108230|P1|Study Cohort|Poor Bowel Preparation|1
7518836|NCT02925923|26108243|P2|Overall Study|blood samples hemolyzed|2
7518837|NCT02925923|26108244|P1|Overall Study|blood samples hemolyzed|0
7518838|NCT02925741|26108301|P2|Overall Study|Withdrawal by Subject|0
7518839|NCT02925741|26108302|P1|Overall Study|Withdrawal by Subject|11
7518840|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Adverse Event|1
7518841|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Adverse Event|0
7518842|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Adverse Event|0
7518843|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Adverse Event|0
7518844|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Non-Compliance|2
7518845|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
7518846|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
7518847|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
7518848|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Pregnancy|2
7518849|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Pregnancy|1
7518850|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Pregnancy|0
7518851|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Pregnancy|1
7518852|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
7518853|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7518854|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7518855|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
7518856|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Other|6
7518857|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Other|3
7518858|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Other|4
7518859|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Other|1
7518860|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|10
7518861|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|9
7518862|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7518863|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7518864|NCT02925494|26108335|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
7518865|NCT02925494|26108336|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7518866|NCT02925494|26108337|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7518867|NCT02925494|26108338|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7518868|NCT02925455|26108366|P2|Overall Study|Withdrawal by Subject|0
7518869|NCT02925455|26108367|P1|Overall Study|Withdrawal by Subject|2
7518870|NCT02925403|26108383|P2|Overall Study|Lost to Follow-up|1
7518871|NCT02925403|26108384|P1|Overall Study|Lost to Follow-up|0
7518872|NCT02925312|26108398|P2|Overall Study|Adverse Event|0
7518873|NCT02925312|26108399|P1|Overall Study|Adverse Event|2
7518874|NCT02925312|26108398|P2|Overall Study|Lost to Follow-up|0
7518875|NCT02925312|26108399|P1|Overall Study|Lost to Follow-up|25
7518876|NCT02925117|26108425|P12|Period 2 (Weeks 16 - 88)|Other|0
7518877|NCT02925117|26108426|P11|Period 2 (Weeks 16 - 88)|Other|3
7518878|NCT02925117|26108427|P10|Period 2 (Weeks 16 - 88)|Other|4
7518879|NCT02925117|26108428|P9|Period 2 (Weeks 16 - 88)|Other|3
7518880|NCT02925117|26108429|P8|Period 2 (Weeks 16 - 88)|Other|1
7518881|NCT02925117|26108430|P7|Period 2 (Weeks 16 - 88)|Other|1
7518882|NCT02925117|26108431|P6|Period 2 (Weeks 16 - 88)|Other|1
7518883|NCT02925117|26108432|P5|Period 2 (Weeks 16 - 88)|Other|1
7518884|NCT02925117|26108433|P4|Period 2 (Weeks 16 - 88)|Other|0
7518885|NCT02925117|26108434|P3|Period 2 (Weeks 16 - 88)|Other|0
7518886|NCT02925117|26108435|P2|Period 2 (Weeks 16 - 88)|Other|0
7518887|NCT02925117|26108436|P1|Period 2 (Weeks 16 - 88)|Other|0
7518888|NCT02925117|26108425|P12|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7518889|NCT02925117|26108426|P11|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7518890|NCT02925117|26108427|P10|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7518891|NCT02925117|26108428|P9|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7518892|NCT02925117|26108429|P8|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7518893|NCT02925117|26108430|P7|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7518894|NCT02925117|26108431|P6|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
7518895|NCT02925117|26108432|P5|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7518896|NCT02925117|26108433|P4|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7518897|NCT02925117|26108434|P3|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7518898|NCT02925117|26108435|P2|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7518899|NCT02925117|26108436|P1|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7518900|NCT02925117|26108425|P12|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7518901|NCT02925117|26108426|P11|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7518902|NCT02925117|26108427|P10|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7518903|NCT02925117|26108428|P9|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7518904|NCT02925117|26108429|P8|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
7518905|NCT02925117|26108430|P7|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
7518906|NCT02925117|26108431|P6|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
7518907|NCT02925117|26108432|P5|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7518908|NCT02925117|26108433|P4|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7518909|NCT02925117|26108434|P3|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7518910|NCT02925117|26108435|P2|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7518911|NCT02925117|26108436|P1|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7518912|NCT02925117|26108425|P12|Period 2 (Weeks 16 - 88)|Adverse Event|2
7518913|NCT02925117|26108426|P11|Period 2 (Weeks 16 - 88)|Adverse Event|3
7518914|NCT02925117|26108427|P10|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518915|NCT02925117|26108428|P9|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518916|NCT02925117|26108429|P8|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518917|NCT02925117|26108430|P7|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518918|NCT02925117|26108431|P6|Period 2 (Weeks 16 - 88)|Adverse Event|1
7518919|NCT02925117|26108432|P5|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518920|NCT02925117|26108433|P4|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518921|NCT02925117|26108434|P3|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518922|NCT02925117|26108435|P2|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518923|NCT02925117|26108436|P1|Period 2 (Weeks 16 - 88)|Adverse Event|0
7518924|NCT02925117|26108425|P12|Period 1 (Weeks 0 - 16)|Other|0
7518925|NCT02925117|26108426|P11|Period 1 (Weeks 0 - 16)|Other|0
7518926|NCT02925117|26108427|P10|Period 1 (Weeks 0 - 16)|Other|0
7518927|NCT02925117|26108428|P9|Period 1 (Weeks 0 - 16)|Other|0
7518928|NCT02925117|26108429|P8|Period 1 (Weeks 0 - 16)|Other|0
7518929|NCT02925117|26108430|P7|Period 1 (Weeks 0 - 16)|Other|0
7518930|NCT02925117|26108431|P6|Period 1 (Weeks 0 - 16)|Other|0
7518931|NCT02925117|26108432|P5|Period 1 (Weeks 0 - 16)|Other|0
7518932|NCT02925117|26108433|P4|Period 1 (Weeks 0 - 16)|Other|1
7518933|NCT02925117|26108434|P3|Period 1 (Weeks 0 - 16)|Other|1
7518934|NCT02925117|26108435|P2|Period 1 (Weeks 0 - 16)|Other|4
7518935|NCT02925117|26108436|P1|Period 1 (Weeks 0 - 16)|Other|5
7518936|NCT02925117|26108425|P12|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518937|NCT02925117|26108426|P11|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518938|NCT02925117|26108427|P10|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518939|NCT02925117|26108428|P9|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518940|NCT02925117|26108429|P8|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518941|NCT02925117|26108430|P7|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518942|NCT02925117|26108431|P6|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518943|NCT02925117|26108432|P5|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518944|NCT02925117|26108433|P4|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518945|NCT02925117|26108434|P3|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7518946|NCT02925117|26108435|P2|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
7518947|NCT02925117|26108436|P1|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
7518948|NCT02925117|26108425|P12|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518949|NCT02925117|26108426|P11|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518950|NCT02925117|26108427|P10|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518951|NCT02925117|26108428|P9|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518952|NCT02925117|26108429|P8|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518953|NCT02925117|26108430|P7|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518954|NCT02925117|26108431|P6|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518955|NCT02925117|26108432|P5|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518956|NCT02925117|26108433|P4|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7518957|NCT02925117|26108434|P3|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7518958|NCT02925117|26108435|P2|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7518959|NCT02925117|26108436|P1|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
7518960|NCT02925117|26108425|P12|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518961|NCT02925117|26108426|P11|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518962|NCT02925117|26108427|P10|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518963|NCT02925117|26108428|P9|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518964|NCT02925117|26108429|P8|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518965|NCT02925117|26108430|P7|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518966|NCT02925117|26108431|P6|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518967|NCT02925117|26108432|P5|Period 1 (Weeks 0 - 16)|Adverse Event|0
7518968|NCT02925117|26108433|P4|Period 1 (Weeks 0 - 16)|Adverse Event|2
7518969|NCT02925117|26108434|P3|Period 1 (Weeks 0 - 16)|Adverse Event|1
7518970|NCT02925117|26108435|P2|Period 1 (Weeks 0 - 16)|Adverse Event|3
7518971|NCT02925117|26108436|P1|Period 1 (Weeks 0 - 16)|Adverse Event|1
7518972|NCT02924883|26108547|P2|Overall Study|Study Terminated by Sponsor|32
7518973|NCT02924883|26108548|P1|Overall Study|Study Terminated by Sponsor|69
7518974|NCT02924883|26108547|P2|Overall Study|Progressive Disease|0
7518975|NCT02924883|26108548|P1|Overall Study|Progressive Disease|1
7518976|NCT02924883|26108547|P2|Overall Study|Withdrawal by Subject|16
7518977|NCT02924883|26108548|P1|Overall Study|Withdrawal by Subject|22
7518978|NCT02924883|26108547|P2|Overall Study|Protocol Violation|0
7518979|NCT02924883|26108548|P1|Overall Study|Protocol Violation|1
7518980|NCT02924883|26108547|P2|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
7518981|NCT02924883|26108548|P1|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
7518982|NCT02924883|26108547|P2|Overall Study|Lost to Follow-up|0
7518983|NCT02924883|26108548|P1|Overall Study|Lost to Follow-up|1
7518984|NCT02924883|26108547|P2|Overall Study|Death|20
7518985|NCT02924883|26108548|P1|Overall Study|Death|39
7518986|NCT02924688|26108578|P6|Overall Study|Withdrawal by Subject|14
7518987|NCT02924688|26108579|P5|Overall Study|Withdrawal by Subject|13
7518988|NCT02924688|26108580|P4|Overall Study|Withdrawal by Subject|12
7518989|NCT02924688|26108581|P3|Overall Study|Withdrawal by Subject|9
7518990|NCT02924688|26108582|P2|Overall Study|Withdrawal by Subject|13
7518991|NCT02924688|26108583|P1|Overall Study|Withdrawal by Subject|14
7518992|NCT02924688|26108578|P6|Overall Study|Physician Decision|1
7518993|NCT02924688|26108579|P5|Overall Study|Physician Decision|1
7518994|NCT02924688|26108580|P4|Overall Study|Physician Decision|1
7518995|NCT02924688|26108581|P3|Overall Study|Physician Decision|0
7518996|NCT02924688|26108582|P2|Overall Study|Physician Decision|1
7518997|NCT02924688|26108583|P1|Overall Study|Physician Decision|2
7518998|NCT02924688|26108578|P6|Overall Study|Lost to Follow-up|4
7518999|NCT02924688|26108579|P5|Overall Study|Lost to Follow-up|2
7519000|NCT02924688|26108580|P4|Overall Study|Lost to Follow-up|4
7519001|NCT02924688|26108581|P3|Overall Study|Lost to Follow-up|2
7519002|NCT02924688|26108582|P2|Overall Study|Lost to Follow-up|4
7519003|NCT02924688|26108583|P1|Overall Study|Lost to Follow-up|2
7519004|NCT02924688|26108578|P6|Overall Study|Protocol defined withdrawal criteria met|0
7519005|NCT02924688|26108579|P5|Overall Study|Protocol defined withdrawal criteria met|1
7519006|NCT02924688|26108580|P4|Overall Study|Protocol defined withdrawal criteria met|1
7519007|NCT02924688|26108581|P3|Overall Study|Protocol defined withdrawal criteria met|1
7519008|NCT02924688|26108582|P2|Overall Study|Protocol defined withdrawal criteria met|0
7519009|NCT02924688|26108583|P1|Overall Study|Protocol defined withdrawal criteria met|1
7519010|NCT02924688|26108578|P6|Overall Study|Protocol Violation|2
7519011|NCT02924688|26108579|P5|Overall Study|Protocol Violation|2
7519012|NCT02924688|26108580|P4|Overall Study|Protocol Violation|6
7519013|NCT02924688|26108581|P3|Overall Study|Protocol Violation|5
7519014|NCT02924688|26108582|P2|Overall Study|Protocol Violation|7
7519015|NCT02924688|26108583|P1|Overall Study|Protocol Violation|3
7519016|NCT02924688|26108578|P6|Overall Study|Lack of Efficacy|1
7519017|NCT02924688|26108579|P5|Overall Study|Lack of Efficacy|1
7519018|NCT02924688|26108580|P4|Overall Study|Lack of Efficacy|2
7519019|NCT02924688|26108581|P3|Overall Study|Lack of Efficacy|4
7519020|NCT02924688|26108582|P2|Overall Study|Lack of Efficacy|3
7519021|NCT02924688|26108583|P1|Overall Study|Lack of Efficacy|2
7519022|NCT02924688|26108578|P6|Overall Study|Adverse Event|2
7519023|NCT02924688|26108579|P5|Overall Study|Adverse Event|3
7519024|NCT02924688|26108580|P4|Overall Study|Adverse Event|2
7519025|NCT02924688|26108581|P3|Overall Study|Adverse Event|2
7519026|NCT02924688|26108582|P2|Overall Study|Adverse Event|3
7519027|NCT02924688|26108583|P1|Overall Study|Adverse Event|9
7519028|NCT02924428|26108653|P2|Overall Study|Pregnancy|1
7519029|NCT02924428|26108654|P1|Overall Study|Pregnancy|0
7519030|NCT02924428|26108653|P2|Overall Study|Lost to Follow-up|4
7519031|NCT02924428|26108654|P1|Overall Study|Lost to Follow-up|2
7519032|NCT02924428|26108653|P2|Overall Study|Physician Decision|0
7519033|NCT02924428|26108654|P1|Overall Study|Physician Decision|1
7519034|NCT02924428|26108653|P2|Overall Study|Adverse Event|0
7519035|NCT02924428|26108654|P1|Overall Study|Adverse Event|1
7519044|NCT02924051|26108698|P2|Overall Study|Withdrawal by Subject|9
7519045|NCT02924051|26108699|P1|Overall Study|Withdrawal by Subject|1
7519046|NCT02923921|26108711|P2|Overall Study|Unknown, Not Collected|6
7519047|NCT02923921|26108712|P1|Overall Study|Unknown, Not Collected|7
7519048|NCT02923921|26108711|P2|Overall Study|Withdrawal by Subject|13
7519049|NCT02923921|26108712|P1|Overall Study|Withdrawal by Subject|6
7519050|NCT02923921|26108711|P2|Overall Study|Lost to Follow-up|0
7519051|NCT02923921|26108712|P1|Overall Study|Lost to Follow-up|1
7519052|NCT02923921|26108711|P2|Overall Study|Sponsor Decision|38
7519053|NCT02923921|26108712|P1|Overall Study|Sponsor Decision|39
7519054|NCT02923830|26108745|P2|Overall Study|Physician Decision|15
7519055|NCT02923830|26108746|P1|Overall Study|Physician Decision|13
7519056|NCT02923427|26108766|P2|Overall Study|can not replace LMA|0
7519057|NCT02923427|26108767|P1|Overall Study|can not replace LMA|1
7519058|NCT02923427|26108766|P2|Overall Study|destaturation|0
7519059|NCT02923427|26108767|P1|Overall Study|destaturation|1
7519060|NCT02923427|26108766|P2|Overall Study|convert to laparatomy|2
7519061|NCT02923427|26108767|P1|Overall Study|convert to laparatomy|2
7519062|NCT02923349|26108794|P7|Overall Study|Death|0
7519063|NCT02923349|26108795|P6|Overall Study|Death|3
7519064|NCT02923349|26108796|P5|Overall Study|Death|2
7519065|NCT02923349|26108797|P4|Overall Study|Death|4
7519066|NCT02923349|26108798|P3|Overall Study|Death|2
7519067|NCT02923349|26108799|P2|Overall Study|Death|0
7519068|NCT02923349|26108800|P1|Overall Study|Death|1
7519069|NCT02923349|26108794|P7|Overall Study|Lost to Follow-up|0
7519070|NCT02923349|26108795|P6|Overall Study|Lost to Follow-up|1
7519071|NCT02923349|26108796|P5|Overall Study|Lost to Follow-up|1
7519072|NCT02923349|26108797|P4|Overall Study|Lost to Follow-up|0
7519073|NCT02923349|26108798|P3|Overall Study|Lost to Follow-up|3
7519074|NCT02923349|26108799|P2|Overall Study|Lost to Follow-up|0
7519075|NCT02923349|26108800|P1|Overall Study|Lost to Follow-up|0
7519076|NCT02923349|26108794|P7|Overall Study|Physician Decision|2
7519077|NCT02923349|26108795|P6|Overall Study|Physician Decision|0
7519078|NCT02923349|26108796|P5|Overall Study|Physician Decision|1
7519079|NCT02923349|26108797|P4|Overall Study|Physician Decision|1
7519080|NCT02923349|26108798|P3|Overall Study|Physician Decision|0
7519081|NCT02923349|26108799|P2|Overall Study|Physician Decision|0
7519082|NCT02923349|26108800|P1|Overall Study|Physician Decision|0
7519083|NCT02923349|26108794|P7|Overall Study|Withdrawal by Subject|0
7519084|NCT02923349|26108795|P6|Overall Study|Withdrawal by Subject|3
7519085|NCT02923349|26108796|P5|Overall Study|Withdrawal by Subject|12
7519086|NCT02923349|26108797|P4|Overall Study|Withdrawal by Subject|10
7519087|NCT02923349|26108798|P3|Overall Study|Withdrawal by Subject|8
7519088|NCT02923349|26108799|P2|Overall Study|Withdrawal by Subject|2
7519089|NCT02923349|26108800|P1|Overall Study|Withdrawal by Subject|2
7519090|NCT02923349|26108794|P7|Overall Study|Other|1
7519091|NCT02923349|26108795|P6|Overall Study|Other|0
7519092|NCT02923349|26108796|P5|Overall Study|Other|3
7519093|NCT02923349|26108797|P4|Overall Study|Other|1
7519094|NCT02923349|26108798|P3|Overall Study|Other|4
7519095|NCT02923349|26108799|P2|Overall Study|Other|2
7519096|NCT02923349|26108800|P1|Overall Study|Other|1
7519097|NCT02923245|26108885|P2|Overall Study|ultrasound order was cancelled|1
7519098|NCT02923245|26108886|P1|Overall Study|ultrasound order was cancelled|2
7519099|NCT02923180|26108903|P1|Overall Study|Remaining in Long Term Follow Up for PSA|13
7519100|NCT02923180|26108903|P1|Overall Study|Off Study Due to Detectable PSA|13
7519101|NCT02923115|26108930|P6|Overall Study|Randomized, but not dosed|0
7519102|NCT02923115|26108931|P5|Overall Study|Randomized, but not dosed|5
7519103|NCT02923115|26108932|P4|Overall Study|Randomized, but not dosed|1
7519104|NCT02923115|26108933|P3|Overall Study|Randomized, but not dosed|3
7519105|NCT02923115|26108934|P2|Overall Study|Randomized, but not dosed|0
7519106|NCT02923115|26108935|P1|Overall Study|Randomized, but not dosed|0
7519107|NCT02923115|26108930|P6|Overall Study|Withdrawal by Subject|0
7519108|NCT02923115|26108931|P5|Overall Study|Withdrawal by Subject|0
7519109|NCT02923115|26108932|P4|Overall Study|Withdrawal by Subject|0
7519110|NCT02923115|26108933|P3|Overall Study|Withdrawal by Subject|0
7519111|NCT02923115|26108934|P2|Overall Study|Withdrawal by Subject|1
7519112|NCT02923115|26108935|P1|Overall Study|Withdrawal by Subject|0
7519113|NCT02923115|26108930|P6|Overall Study|Lost to Follow-up|0
7519114|NCT02923115|26108931|P5|Overall Study|Lost to Follow-up|0
7519115|NCT02923115|26108932|P4|Overall Study|Lost to Follow-up|1
7519116|NCT02923115|26108933|P3|Overall Study|Lost to Follow-up|0
7519117|NCT02923115|26108934|P2|Overall Study|Lost to Follow-up|0
7519118|NCT02923115|26108935|P1|Overall Study|Lost to Follow-up|0
7519119|NCT02922634|26109050|P1|Overall Study|Did not have their surgery|5
7519120|NCT02922634|26109050|P1|Overall Study|Withdrawal by Subject|5
7519121|NCT02922153|26109150|P2|Overall Study|Physician Decision|1
7519122|NCT02922153|26109151|P1|Overall Study|Physician Decision|1
7519123|NCT02922153|26109150|P2|Overall Study|Lost to Follow-up|0
7519124|NCT02922153|26109151|P1|Overall Study|Lost to Follow-up|1
7519125|NCT02922153|26109150|P2|Overall Study|Death|1
7519126|NCT02922153|26109151|P1|Overall Study|Death|8
7519127|NCT02921750|26109210|P2|Overall Study|Serious Adverse Event|2
7519128|NCT02921750|26109211|P1|Overall Study|Serious Adverse Event|1
7519129|NCT02921750|26109210|P2|Overall Study|Wound healed|3
7519130|NCT02921750|26109211|P1|Overall Study|Wound healed|3
7519131|NCT02921750|26109210|P2|Overall Study|Lost to Follow-up|3
7519132|NCT02921750|26109211|P1|Overall Study|Lost to Follow-up|3
7519133|NCT02921750|26109210|P2|Overall Study|Withdrawal by Subject|1
7519134|NCT02921750|26109211|P1|Overall Study|Withdrawal by Subject|1
7519135|NCT02921750|26109210|P2|Overall Study|Adverse Event|2
7519136|NCT02921750|26109211|P1|Overall Study|Adverse Event|1
7519137|NCT02921425|26109250|P1|Overall Study|Protocol Violation|9
7519138|NCT02921087|26109322|P2|Overall Study|Withdrawal by Subject|1
7519139|NCT02921087|26109323|P1|Overall Study|Withdrawal by Subject|0
7519140|NCT02920983|26109352|P6|Dispense 3|Unacceptable Lens Fit|0
7519141|NCT02920983|26109353|P5|Dispense 3|Unacceptable Lens Fit|1
7519142|NCT02920983|26109354|P4|Dispense 3|Unacceptable Lens Fit|0
7519143|NCT02920983|26109355|P3|Dispense 3|Unacceptable Lens Fit|0
7519144|NCT02920983|26109356|P2|Dispense 3|Unacceptable Lens Fit|1
7519145|NCT02920983|26109357|P1|Dispense 3|Unacceptable Lens Fit|1
7519146|NCT02920983|26109352|P6|Dispense 2|Unscceptable lens fit|0
7519147|NCT02920983|26109353|P5|Dispense 2|Unscceptable lens fit|1
7519148|NCT02920983|26109354|P4|Dispense 2|Unscceptable lens fit|0
7519149|NCT02920983|26109355|P3|Dispense 2|Unscceptable lens fit|0
7519150|NCT02920983|26109356|P2|Dispense 2|Unscceptable lens fit|0
7519151|NCT02920983|26109357|P1|Dispense 2|Unscceptable lens fit|1
7519152|NCT02920983|26109352|P6|Dispense 1|Unacceptable Lens Fit|0
7519153|NCT02920983|26109353|P5|Dispense 1|Unacceptable Lens Fit|1
7519154|NCT02920983|26109354|P4|Dispense 1|Unacceptable Lens Fit|0
7519155|NCT02920983|26109355|P3|Dispense 1|Unacceptable Lens Fit|0
7519156|NCT02920983|26109356|P2|Dispense 1|Unacceptable Lens Fit|0
7519157|NCT02920983|26109357|P1|Dispense 1|Unacceptable Lens Fit|0
7519158|NCT02920970|26109386|P2|Second Intervention|Poor Lens Fit|0
7519159|NCT02920970|26109387|P1|Second Intervention|Poor Lens Fit|1
7519160|NCT02920970|26109386|P2|First Intervention|Adverse Event|1
7519161|NCT02920970|26109387|P1|First Intervention|Adverse Event|0
7519162|NCT02920970|26109386|P2|First Intervention|Protocol Violation|1
7519163|NCT02920970|26109387|P1|First Intervention|Protocol Violation|0
7519164|NCT02920957|26109413|P2|Second Intervention: 1 Month|Lost to Follow-up|1
7519165|NCT02920957|26109414|P1|Second Intervention: 1 Month|Lost to Follow-up|0
7519166|NCT02920957|26109413|P2|First Intervention : 1 Month|Adverse Event|0
7519167|NCT02920957|26109414|P1|First Intervention : 1 Month|Adverse Event|1
7519168|NCT02920957|26109413|P2|First Intervention : 1 Month|Lost to Follow-up|0
7519169|NCT02920957|26109414|P1|First Intervention : 1 Month|Lost to Follow-up|1
7519170|NCT02920957|26109413|P2|First Intervention : 1 Month|Withdrawal by Subject|0
7519171|NCT02920957|26109414|P1|First Intervention : 1 Month|Withdrawal by Subject|2
7519172|NCT02920528|26109501|P3|Overall Study|Did not meet inclusion criteria|1
7519173|NCT02920528|26109502|P2|Overall Study|Did not meet inclusion criteria|0
7519174|NCT02920528|26109503|P1|Overall Study|Did not meet inclusion criteria|2
7519175|NCT02920528|26109501|P3|Overall Study|Adverse Event|3
7519176|NCT02920528|26109502|P2|Overall Study|Adverse Event|0
7519177|NCT02920528|26109503|P1|Overall Study|Adverse Event|0
7519178|NCT02920528|26109501|P3|Overall Study|Incomplete Data|1
7519179|NCT02920528|26109502|P2|Overall Study|Incomplete Data|1
7519180|NCT02920528|26109503|P1|Overall Study|Incomplete Data|1
7519181|NCT02920450|26109522|P4|Overall Study|Withdrawal by Subject|0
7519182|NCT02920450|26109523|P3|Overall Study|Withdrawal by Subject|0
7519183|NCT02920450|26109524|P2|Overall Study|Withdrawal by Subject|0
7519184|NCT02920450|26109525|P1|Overall Study|Withdrawal by Subject|1
7519185|NCT02920450|26109522|P4|Overall Study|Death|0
7519186|NCT02920450|26109523|P3|Overall Study|Death|0
7519187|NCT02920450|26109524|P2|Overall Study|Death|0
7519188|NCT02920450|26109525|P1|Overall Study|Death|1
7519189|NCT02920242|26109536|P3|Overall Study|Did not meet inc./exc. criteria|0
7519190|NCT02920242|26109537|P2|Overall Study|Did not meet inc./exc. criteria|0
7519191|NCT02920242|26109538|P1|Overall Study|Did not meet inc./exc. criteria|1
7519192|NCT02920242|26109536|P3|Overall Study|Withdrawal by Subject|1
7519193|NCT02920242|26109537|P2|Overall Study|Withdrawal by Subject|0
7519194|NCT02920242|26109538|P1|Overall Study|Withdrawal by Subject|1
7519195|NCT02920177|26109566|P2|Overall Study|Lost to Follow-up|1
7519196|NCT02920177|26109567|P1|Overall Study|Lost to Follow-up|0
7519197|NCT02920177|26109566|P2|Overall Study|Physician Decision|0
7519198|NCT02920177|26109567|P1|Overall Study|Physician Decision|1
7519199|NCT02920177|26109566|P2|Overall Study|Withdrawal by Subject|1
7519200|NCT02920177|26109567|P1|Overall Study|Withdrawal by Subject|1
7519201|NCT02919995|26109587|P6|Overall Study|Adverse Event|1
7519202|NCT02919995|26109588|P5|Overall Study|Adverse Event|0
7519203|NCT02919995|26109589|P4|Overall Study|Adverse Event|0
7519204|NCT02919995|26109590|P3|Overall Study|Adverse Event|0
7519205|NCT02919995|26109591|P2|Overall Study|Adverse Event|0
7519206|NCT02919995|26109592|P1|Overall Study|Adverse Event|0
7519207|NCT02919761|26109655|P3|Part 2: Double-blind|Discontinued exclusion 16|2
7519208|NCT02919761|26109656|P2|Part 2: Double-blind|Discontinued exclusion 16|0
7519209|NCT02919761|26109657|P1|Part 2: Double-blind|Discontinued exclusion 16|0
7519210|NCT02919761|26109655|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
7519211|NCT02919761|26109656|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
7519212|NCT02919761|26109657|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
7519213|NCT02919761|26109655|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
7519214|NCT02919761|26109656|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
7519215|NCT02919761|26109657|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
7519216|NCT02919761|26109655|P3|Part 2: Double-blind|Worsening of disease activity|10
7519217|NCT02919761|26109656|P2|Part 2: Double-blind|Worsening of disease activity|4
7519218|NCT02919761|26109657|P1|Part 2: Double-blind|Worsening of disease activity|0
7519219|NCT02919761|26109655|P3|Part 2: Double-blind|Met withdrawal criteria|2
7519220|NCT02919761|26109656|P2|Part 2: Double-blind|Met withdrawal criteria|1
7519221|NCT02919761|26109657|P1|Part 2: Double-blind|Met withdrawal criteria|0
7519222|NCT02919761|26109655|P3|Part 2: Double-blind|Lost to Follow-up|3
7519223|NCT02919761|26109656|P2|Part 2: Double-blind|Lost to Follow-up|0
7519224|NCT02919761|26109657|P1|Part 2: Double-blind|Lost to Follow-up|0
7519225|NCT02919761|26109655|P3|Part 2: Double-blind|Adverse Event|0
7519226|NCT02919761|26109656|P2|Part 2: Double-blind|Adverse Event|1
7519227|NCT02919761|26109657|P1|Part 2: Double-blind|Adverse Event|0
7519228|NCT02919761|26109655|P3|Part 2: Double-blind|Withdrawal by Subject|2
7519229|NCT02919761|26109656|P2|Part 2: Double-blind|Withdrawal by Subject|0
7519230|NCT02919761|26109657|P1|Part 2: Double-blind|Withdrawal by Subject|0
7519231|NCT02919761|26109655|P3|Part 1: Open Label|Termination by Sponsor|0
7519232|NCT02919761|26109656|P2|Part 1: Open Label|Termination by Sponsor|0
7519233|NCT02919761|26109657|P1|Part 1: Open Label|Termination by Sponsor|1
7519234|NCT02919761|26109655|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
7519235|NCT02919761|26109656|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
7519236|NCT02919761|26109657|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
7519237|NCT02919761|26109655|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7519238|NCT02919761|26109656|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7519239|NCT02919761|26109657|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
7519240|NCT02919761|26109655|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7519241|NCT02919761|26109656|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7519242|NCT02919761|26109657|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
7519243|NCT02919761|26109655|P3|Part 1: Open Label|Met withdrawal criteria|0
7519244|NCT02919761|26109656|P2|Part 1: Open Label|Met withdrawal criteria|0
7519245|NCT02919761|26109657|P1|Part 1: Open Label|Met withdrawal criteria|5
7519246|NCT02919761|26109655|P3|Part 1: Open Label|Lost to Follow-up|0
7519247|NCT02919761|26109656|P2|Part 1: Open Label|Lost to Follow-up|0
7519248|NCT02919761|26109657|P1|Part 1: Open Label|Lost to Follow-up|1
7519249|NCT02919761|26109655|P3|Part 1: Open Label|Adverse Event|0
7519250|NCT02919761|26109656|P2|Part 1: Open Label|Adverse Event|0
7519251|NCT02919761|26109657|P1|Part 1: Open Label|Adverse Event|1
7519252|NCT02919761|26109655|P3|Part 1: Open Label|Withdrawal by Subject|0
7519253|NCT02919761|26109656|P2|Part 1: Open Label|Withdrawal by Subject|0
7519254|NCT02919761|26109657|P1|Part 1: Open Label|Withdrawal by Subject|12
7519255|NCT02919696|26109685|P2|Overall Study|Never Treated|1
7519256|NCT02919696|26109686|P1|Overall Study|Never Treated|0
7519257|NCT02919696|26109685|P2|Overall Study|Sponsor Decision|1
7519258|NCT02919696|26109686|P1|Overall Study|Sponsor Decision|1
7519259|NCT02919696|26109685|P2|Overall Study|Withdrawal by Subject|1
7519260|NCT02919696|26109686|P1|Overall Study|Withdrawal by Subject|2
7519261|NCT02919696|26109685|P2|Overall Study|Adverse Event|2
7519262|NCT02919696|26109686|P1|Overall Study|Adverse Event|1
7519263|NCT02919683|26109708|P2|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
7519264|NCT02919683|26109709|P1|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
7519265|NCT02919683|26109708|P2|Post-Surgery Follow-Up|Death|2
7519266|NCT02919683|26109709|P1|Post-Surgery Follow-Up|Death|2
7519267|NCT02919618|26109730|P1|Overall Study|Death|1
7519268|NCT02919475|26109752|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7519269|NCT02919475|26109753|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7519270|NCT02919475|26109754|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7519271|NCT02919475|26109755|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7519272|NCT02919475|26109756|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7519273|NCT02919475|26109752|P5|Overall Study|Withdrawal by Subject|2
7519274|NCT02919475|26109753|P4|Overall Study|Withdrawal by Subject|2
7519275|NCT02919475|26109754|P3|Overall Study|Withdrawal by Subject|1
7519276|NCT02919475|26109755|P2|Overall Study|Withdrawal by Subject|3
7519277|NCT02919475|26109756|P1|Overall Study|Withdrawal by Subject|2
7519278|NCT02919475|26109752|P5|Overall Study|Lost to Follow-up|0
7519279|NCT02919475|26109753|P4|Overall Study|Lost to Follow-up|1
7519280|NCT02919475|26109754|P3|Overall Study|Lost to Follow-up|0
7519281|NCT02919475|26109755|P2|Overall Study|Lost to Follow-up|0
7519282|NCT02919475|26109756|P1|Overall Study|Lost to Follow-up|0
7519283|NCT02919475|26109752|P5|Overall Study|Death|0
7519284|NCT02919475|26109753|P4|Overall Study|Death|0
7519285|NCT02919475|26109754|P3|Overall Study|Death|0
7519286|NCT02919475|26109755|P2|Overall Study|Death|1
7519287|NCT02919475|26109756|P1|Overall Study|Death|0
7519288|NCT02919475|26109752|P5|Overall Study|Adverse Event|2
7519289|NCT02919475|26109753|P4|Overall Study|Adverse Event|9
7519290|NCT02919475|26109754|P3|Overall Study|Adverse Event|3
7519291|NCT02919475|26109755|P2|Overall Study|Adverse Event|3
7519292|NCT02919475|26109756|P1|Overall Study|Adverse Event|3
7519293|NCT02919267|26109825|P4|Overall Study|Protocol Violation|4
7519294|NCT02919267|26109826|P3|Overall Study|Protocol Violation|3
7519295|NCT02919267|26109827|P2|Overall Study|Protocol Violation|3
7519296|NCT02919267|26109828|P1|Overall Study|Protocol Violation|0
7519297|NCT02918968|26109864|P2|2nd Line AAT|Death|1
7519298|NCT02918968|26109865|P1|2nd Line AAT|Death|0
7519299|NCT02918968|26109864|P2|2nd Line AAT|Withdrawal by Subject|2
7519300|NCT02918968|26109865|P1|2nd Line AAT|Withdrawal by Subject|2
7519301|NCT02918968|26109864|P2|2nd Line AAT|Physician Decision|1
7519302|NCT02918968|26109865|P1|2nd Line AAT|Physician Decision|0
7519303|NCT02918968|26109864|P2|2nd Line AAT|Adverse Event|5
7519304|NCT02918968|26109865|P1|2nd Line AAT|Adverse Event|2
7519305|NCT02918968|26109864|P2|2nd Line AAT|Progressive disease|3
7519306|NCT02918968|26109865|P1|2nd Line AAT|Progressive disease|21
7519307|NCT02918968|26109864|P2|1st Line AAT|Miscellaneous|0
7519308|NCT02918968|26109865|P1|1st Line AAT|Miscellaneous|1
7519309|NCT02918968|26109864|P2|1st Line AAT|Death|0
7519310|NCT02918968|26109865|P1|1st Line AAT|Death|1
7519311|NCT02918968|26109864|P2|1st Line AAT|Lost to Follow-up|1
7519312|NCT02918968|26109865|P1|1st Line AAT|Lost to Follow-up|0
7519313|NCT02918968|26109864|P2|1st Line AAT|Withdrawal by Subject|1
7519314|NCT02918968|26109865|P1|1st Line AAT|Withdrawal by Subject|2
7519315|NCT02918968|26109864|P2|1st Line AAT|Physician Decision|2
7519316|NCT02918968|26109865|P1|1st Line AAT|Physician Decision|4
7519317|NCT02918968|26109864|P2|1st Line AAT|Adverse Event|3
7519318|NCT02918968|26109865|P1|1st Line AAT|Adverse Event|12
7519319|NCT02918968|26109864|P2|1st Line AAT|Progressive disease|4
7519320|NCT02918968|26109865|P1|1st Line AAT|Progressive disease|9
7519321|NCT02918877|26109889|P2|Overall Study|Unsafe to perform BAL|1
7519322|NCT02918877|26109890|P1|Overall Study|Unsafe to perform BAL|0
7519323|NCT02918877|26109889|P2|Overall Study|Unable to obtain lab samples|0
7519324|NCT02918877|26109890|P1|Overall Study|Unable to obtain lab samples|1
7519325|NCT02918877|26109889|P2|Overall Study|Received intraoperative steroids|0
7519326|NCT02918877|26109890|P1|Overall Study|Received intraoperative steroids|1
7519327|NCT02918877|26109889|P2|Overall Study|Physician Decision|0
7519328|NCT02918877|26109890|P1|Overall Study|Physician Decision|1
7519329|NCT02918877|26109889|P2|Overall Study|Surgery cancelled|0
7519330|NCT02918877|26109890|P1|Overall Study|Surgery cancelled|1
7519331|NCT02918877|26109889|P2|Overall Study|Withdrawal by Subject|2
7519332|NCT02918877|26109890|P1|Overall Study|Withdrawal by Subject|2
7519333|NCT02918552|26110055|P2|Overall Study|Lost to Follow-up|1
7519334|NCT02918552|26110056|P1|Overall Study|Lost to Follow-up|0
7519335|NCT02918552|26110055|P2|Overall Study|Withdrawal by Subject|1
7519336|NCT02918552|26110056|P1|Overall Study|Withdrawal by Subject|0
7519337|NCT02918552|26110055|P2|Overall Study|Failed Pharmacokinetics|0
7519338|NCT02918552|26110056|P1|Overall Study|Failed Pharmacokinetics|1
7519339|NCT02918318|26110132|P5|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
7519340|NCT02918318|26110133|P4|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7519341|NCT02918318|26110134|P3|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7519342|NCT02918318|26110135|P2|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7519343|NCT02918318|26110136|P1|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7519344|NCT02918318|26110132|P5|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
7519345|NCT02918318|26110133|P4|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7519346|NCT02918318|26110134|P3|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7519347|NCT02918318|26110135|P2|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7519348|NCT02918318|26110136|P1|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7519349|NCT02918318|26110132|P5|Posttreatment Phase: Up to 24 Weeks|Other|0
7519350|NCT02918318|26110133|P4|Posttreatment Phase: Up to 24 Weeks|Other|1
7519351|NCT02918318|26110134|P3|Posttreatment Phase: Up to 24 Weeks|Other|1
7519352|NCT02918318|26110135|P2|Posttreatment Phase: Up to 24 Weeks|Other|3
7519353|NCT02918318|26110136|P1|Posttreatment Phase: Up to 24 Weeks|Other|0
7519354|NCT02918318|26110132|P5|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7519355|NCT02918318|26110133|P4|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7519356|NCT02918318|26110134|P3|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7519357|NCT02918318|26110135|P2|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7519358|NCT02918318|26110136|P1|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7519359|NCT02918318|26110132|P5|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7519360|NCT02918318|26110133|P4|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7519361|NCT02918318|26110134|P3|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7519362|NCT02918318|26110135|P2|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7519363|NCT02918318|26110136|P1|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7519364|NCT02918318|26110132|P5|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7519365|NCT02918318|26110133|P4|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
7519366|NCT02918318|26110134|P3|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7519367|NCT02918318|26110135|P2|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7519368|NCT02918318|26110136|P1|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7519369|NCT02918318|26110132|P5|Double-blind Induction Phase: 4 Weeks|Other|0
7519370|NCT02918318|26110133|P4|Double-blind Induction Phase: 4 Weeks|Other|1
7519371|NCT02918318|26110134|P3|Double-blind Induction Phase: 4 Weeks|Other|0
7519372|NCT02918318|26110135|P2|Double-blind Induction Phase: 4 Weeks|Other|2
7519373|NCT02918318|26110136|P1|Double-blind Induction Phase: 4 Weeks|Other|0
7519374|NCT02918318|26110132|P5|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7519375|NCT02918318|26110133|P4|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
7519376|NCT02918318|26110134|P3|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7519377|NCT02918318|26110135|P2|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7519378|NCT02918318|26110136|P1|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7519379|NCT02918318|26110132|P5|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7519380|NCT02918318|26110133|P4|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7519381|NCT02918318|26110134|P3|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7519382|NCT02918318|26110135|P2|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7519383|NCT02918318|26110136|P1|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7519384|NCT02918318|26110132|P5|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7519385|NCT02918318|26110133|P4|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
7519386|NCT02918318|26110134|P3|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7519387|NCT02918318|26110135|P2|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7519388|NCT02918318|26110136|P1|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7519389|NCT02918318|26110132|P5|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7519390|NCT02918318|26110133|P4|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
7519391|NCT02918318|26110134|P3|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7519392|NCT02918318|26110135|P2|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7519393|NCT02918318|26110136|P1|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7519394|NCT02918318|26110132|P5|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
7519395|NCT02918318|26110133|P4|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
7519396|NCT02918318|26110134|P3|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
7519397|NCT02918318|26110135|P2|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
7519398|NCT02918318|26110136|P1|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
7519399|NCT02918279|26110197|P2|Overall Study|Other|1
7519400|NCT02918279|26110198|P1|Overall Study|Other|3
7519401|NCT02918279|26110197|P2|Overall Study|Withdrawal by parent/guardian|1
7519402|NCT02918279|26110198|P1|Overall Study|Withdrawal by parent/guardian|2
7519403|NCT02918279|26110197|P2|Overall Study|Withdrawal by Subject|15
7519404|NCT02918279|26110198|P1|Overall Study|Withdrawal by Subject|5
7519405|NCT02918279|26110197|P2|Overall Study|Lost to Follow-up|6
7519406|NCT02918279|26110198|P1|Overall Study|Lost to Follow-up|3
7519407|NCT02918266|26110334|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519408|NCT02918266|26110335|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519409|NCT02918266|26110336|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7519410|NCT02918266|26110337|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519411|NCT02918266|26110338|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7519412|NCT02918266|26110339|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519413|NCT02918266|26110340|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519414|NCT02918266|26110341|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519415|NCT02918266|26110342|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519416|NCT02918266|26110343|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7519417|NCT02918266|26110344|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
7519418|NCT02918071|26110449|P1|Overall Study|Lost to Follow-up|1
7519419|NCT02918071|26110449|P1|Overall Study|Withdrawal by Subject|2
7519420|NCT02917941|26110459|P1|Survival Follow-up Period|Withdrawal by Subject|4
7519421|NCT02917941|26110459|P1|Survival Follow-up Period|Lost to Follow-up|1
7519422|NCT02917941|26110459|P1|Treatment Period|Reason not Specified|2
7519423|NCT02917941|26110459|P1|Treatment Period|Progressive Disease|11
7519424|NCT02917941|26110459|P1|Treatment Period|Adverse Event|11
7519425|NCT02917265|26110553|P2|Overall Study|Withdrawal by Subject|0
7519426|NCT02917265|26110554|P1|Overall Study|Withdrawal by Subject|1
7519427|NCT02917265|26110553|P2|Overall Study|Physician Decision|0
7519428|NCT02917265|26110554|P1|Overall Study|Physician Decision|1
7519429|NCT02917031|26110571|P3|Overall Study|Death|4
7519430|NCT02917031|26110572|P2|Overall Study|Death|3
7519431|NCT02917031|26110573|P1|Overall Study|Death|2
7519432|NCT02917031|26110571|P3|Overall Study|Adverse Event|5
7519433|NCT02917031|26110572|P2|Overall Study|Adverse Event|1
7519434|NCT02917031|26110573|P1|Overall Study|Adverse Event|4
7519435|NCT02917031|26110571|P3|Overall Study|Physician Decision|0
7519436|NCT02917031|26110572|P2|Overall Study|Physician Decision|0
7519437|NCT02917031|26110573|P1|Overall Study|Physician Decision|1
7519438|NCT02917031|26110571|P3|Overall Study|Withdrawal by Subject|0
7519439|NCT02917031|26110572|P2|Overall Study|Withdrawal by Subject|3
7519440|NCT02917031|26110573|P1|Overall Study|Withdrawal by Subject|3
7519441|NCT02917031|26110571|P3|Overall Study|Development of study-specific withdrawal criteria|0
7519442|NCT02917031|26110572|P2|Overall Study|Development of study-specific withdrawal criteria|1
7519443|NCT02917031|26110573|P1|Overall Study|Development of study-specific withdrawal criteria|1
7519444|NCT02917031|26110571|P3|Overall Study|Reason not specified|6
7519445|NCT02917031|26110572|P2|Overall Study|Reason not specified|5
7519446|NCT02917031|26110573|P1|Overall Study|Reason not specified|7
7519447|NCT02916927|26110593|P2|Overall Study|Withdrawal before first time point|0
7519448|NCT02916927|26110594|P1|Overall Study|Withdrawal before first time point|1
7519449|NCT02916927|26110593|P2|Overall Study|At radiology for 45 & 60 min time points|1
7519450|NCT02916927|26110594|P1|Overall Study|At radiology for 45 & 60 min time points|0
7519451|NCT02916927|26110593|P2|Overall Study|Discharged prior to study drug receipt|2
7519452|NCT02916927|26110594|P1|Overall Study|Discharged prior to study drug receipt|0
7519453|NCT02916693|26110638|P1|Overall Study|Lost to Follow-up|7
7519454|NCT02916433|26110666|P2|Overall Study|Physician Decision|0
7519455|NCT02916433|26110667|P1|Overall Study|Physician Decision|1
7519456|NCT02916433|26110666|P2|Overall Study|Withdrawal by Subject|0
7519457|NCT02916433|26110667|P1|Overall Study|Withdrawal by Subject|1
7519458|NCT02916056|26110687|P1|Overall Study|Study Terminated by Sponsor|269
7519459|NCT02916056|26110687|P1|Overall Study|Withdrawal by Subject|8
7519460|NCT02916056|26110687|P1|Overall Study|Protocol Violation|1
7519461|NCT02916056|26110687|P1|Overall Study|Other|12
7519462|NCT02916056|26110687|P1|Overall Study|Lost to Follow-up|1
7519463|NCT02916056|26110687|P1|Overall Study|Adverse Event|6
7519464|NCT02915978|26110694|P3|Overall Study|Adverse Event|0
7519465|NCT02915978|26110695|P2|Overall Study|Adverse Event|1
7519466|NCT02915978|26110696|P1|Overall Study|Adverse Event|2
7519467|NCT02915874|26110748|P2|Overall Study|Started New Anxiety Medication|1
7519468|NCT02915874|26110749|P1|Overall Study|Started New Anxiety Medication|0
7519469|NCT02915874|26110748|P2|Overall Study|Withdrawal by Subject|1
7519470|NCT02915874|26110749|P1|Overall Study|Withdrawal by Subject|1
7519471|NCT02915874|26110748|P2|Overall Study|Lost to Follow-up|4
7519472|NCT02915874|26110749|P1|Overall Study|Lost to Follow-up|5
7519473|NCT02915835|26110769|P2|Overall Study|Withdrawal by Subject|1
7519474|NCT02915835|26110770|P1|Overall Study|Withdrawal by Subject|0
7519475|NCT02915835|26110769|P2|Overall Study|Physician Decision|0
7519476|NCT02915835|26110770|P1|Overall Study|Physician Decision|1
7519477|NCT02915783|26110894|P1|Overall Study|Ongoing: In Survival Follow Up|8
7519478|NCT02915783|26110894|P1|Overall Study|Ongoing: Receiving Treatment|6
7519479|NCT02915302|26111017|P2|Overall Study|Other|0
7519480|NCT02915302|26111018|P1|Overall Study|Other|1
7519481|NCT02915302|26111017|P2|Overall Study|Withdrawal by Subject|29
7519482|NCT02915302|26111018|P1|Overall Study|Withdrawal by Subject|22
7519483|NCT02915302|26111017|P2|Overall Study|Lost to Follow-up|22
7519484|NCT02915302|26111018|P1|Overall Study|Lost to Follow-up|19
7519485|NCT02915302|26111017|P2|Overall Study|Protocol Violation|27
7519486|NCT02915302|26111018|P1|Overall Study|Protocol Violation|20
7519487|NCT02915302|26111017|P2|Overall Study|Adverse Event|0
7519488|NCT02915302|26111018|P1|Overall Study|Adverse Event|3
7519489|NCT02915159|26111030|P2|Overall Study|Lack of Efficacy|3
7519490|NCT02915159|26111031|P1|Overall Study|Lack of Efficacy|0
7519491|NCT02915159|26111030|P2|Overall Study|Adverse Event|2
7519492|NCT02915159|26111031|P1|Overall Study|Adverse Event|2
7519493|NCT02915159|26111030|P2|Overall Study|Request to discontinue treatment|2
7519494|NCT02915159|26111031|P1|Overall Study|Request to discontinue treatment|1
7519495|NCT02915159|26111030|P2|Overall Study|Participant withdrew consent|1
7519496|NCT02915159|26111031|P1|Overall Study|Participant withdrew consent|5
7519497|NCT02915159|26111030|P2|Overall Study|poor/non-compliance|0
7519498|NCT02915159|26111031|P1|Overall Study|poor/non-compliance|1
7519499|NCT02915159|26111030|P2|Overall Study|Participant no longer meets criteria|0
7519500|NCT02915159|26111031|P1|Overall Study|Participant no longer meets criteria|2
7519501|NCT02915016|26111170|P8|Overall Study|Participant unable to adhere|1
7519502|NCT02915016|26111171|P7|Overall Study|Participant unable to adhere|0
7519503|NCT02915016|26111172|P6|Overall Study|Participant unable to adhere|0
7519504|NCT02915016|26111173|P5|Overall Study|Participant unable to adhere|0
7519505|NCT02915016|26111174|P4|Overall Study|Participant unable to adhere|0
7519506|NCT02915016|26111175|P3|Overall Study|Participant unable to adhere|0
7519507|NCT02915016|26111176|P2|Overall Study|Participant unable to adhere|0
7519508|NCT02915016|26111177|P1|Overall Study|Participant unable to adhere|0
7519509|NCT02915016|26111170|P8|Overall Study|HIV infection|0
7519510|NCT02915016|26111171|P7|Overall Study|HIV infection|0
7519511|NCT02915016|26111172|P6|Overall Study|HIV infection|0
7519512|NCT02915016|26111173|P5|Overall Study|HIV infection|1
7519513|NCT02915016|26111174|P4|Overall Study|HIV infection|0
7519514|NCT02915016|26111175|P3|Overall Study|HIV infection|1
7519515|NCT02915016|26111176|P2|Overall Study|HIV infection|1
7519516|NCT02915016|26111177|P1|Overall Study|HIV infection|1
7519517|NCT02915016|26111170|P8|Overall Study|Elected not to continue|0
7519518|NCT02915016|26111171|P7|Overall Study|Elected not to continue|1
7519519|NCT02915016|26111172|P6|Overall Study|Elected not to continue|0
7519520|NCT02915016|26111173|P5|Overall Study|Elected not to continue|0
7519521|NCT02915016|26111174|P4|Overall Study|Elected not to continue|1
7519522|NCT02915016|26111175|P3|Overall Study|Elected not to continue|0
7519523|NCT02915016|26111176|P2|Overall Study|Elected not to continue|0
7519524|NCT02915016|26111177|P1|Overall Study|Elected not to continue|0
7519525|NCT02915016|26111170|P8|Overall Study|Withdrawal by Subject|1
7519526|NCT02915016|26111171|P7|Overall Study|Withdrawal by Subject|1
7519527|NCT02915016|26111172|P6|Overall Study|Withdrawal by Subject|3
7519528|NCT02915016|26111173|P5|Overall Study|Withdrawal by Subject|1
7519529|NCT02915016|26111174|P4|Overall Study|Withdrawal by Subject|0
7519530|NCT02915016|26111175|P3|Overall Study|Withdrawal by Subject|1
7519531|NCT02915016|26111176|P2|Overall Study|Withdrawal by Subject|0
7519532|NCT02915016|26111177|P1|Overall Study|Withdrawal by Subject|2
7519533|NCT02915016|26111170|P8|Overall Study|Physician Decision|0
7519534|NCT02915016|26111171|P7|Overall Study|Physician Decision|2
7519535|NCT02915016|26111172|P6|Overall Study|Physician Decision|1
7519536|NCT02915016|26111173|P5|Overall Study|Physician Decision|0
7519537|NCT02915016|26111174|P4|Overall Study|Physician Decision|0
7519538|NCT02915016|26111175|P3|Overall Study|Physician Decision|1
7519539|NCT02915016|26111176|P2|Overall Study|Physician Decision|0
7519540|NCT02915016|26111177|P1|Overall Study|Physician Decision|0
7519541|NCT02915016|26111170|P8|Overall Study|Lost to Follow-up|2
7519542|NCT02915016|26111171|P7|Overall Study|Lost to Follow-up|8
7519543|NCT02915016|26111172|P6|Overall Study|Lost to Follow-up|2
7519544|NCT02915016|26111173|P5|Overall Study|Lost to Follow-up|5
7519545|NCT02915016|26111174|P4|Overall Study|Lost to Follow-up|3
7519546|NCT02915016|26111175|P3|Overall Study|Lost to Follow-up|5
7519547|NCT02915016|26111176|P2|Overall Study|Lost to Follow-up|2
7519548|NCT02915016|26111177|P1|Overall Study|Lost to Follow-up|4
7519549|NCT02914834|26111389|P2|Overall Study|1 subject withdrew|1
7519550|NCT02914834|26111390|P1|Overall Study|1 subject withdrew|0
7519551|NCT02914834|26111389|P2|Overall Study|Study halted due to COVID|1
7519552|NCT02914834|26111390|P1|Overall Study|Study halted due to COVID|1
7519553|NCT02914548|26111420|P3|Overall Study|>40% of body surface area|1
7519554|NCT02914548|26111421|P2|Overall Study|>40% of body surface area|1
7519555|NCT02914548|26111422|P1|Overall Study|>40% of body surface area|0
7519556|NCT02914548|26111420|P3|Overall Study|Withdrawal by Subject|4
7519557|NCT02914548|26111421|P2|Overall Study|Withdrawal by Subject|4
7519558|NCT02914548|26111422|P1|Overall Study|Withdrawal by Subject|3
7519559|NCT02914548|26111420|P3|Overall Study|Protocol Violation|0
7519560|NCT02914548|26111421|P2|Overall Study|Protocol Violation|0
7519561|NCT02914548|26111422|P1|Overall Study|Protocol Violation|1
7519562|NCT02914548|26111420|P3|Overall Study|Physician Decision|0
7519563|NCT02914548|26111421|P2|Overall Study|Physician Decision|2
7519564|NCT02914548|26111422|P1|Overall Study|Physician Decision|2
7519565|NCT02914548|26111420|P3|Overall Study|Adverse Event|15
7519566|NCT02914548|26111421|P2|Overall Study|Adverse Event|7
7519567|NCT02914548|26111422|P1|Overall Study|Adverse Event|15
7519568|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519569|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
7519570|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519571|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519572|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519573|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519574|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519575|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519576|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519577|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519578|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7519579|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519580|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Pregnancy|2
7519581|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Pregnancy|1
7519582|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519583|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519584|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519585|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519586|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519587|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519588|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519589|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7519590|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519591|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519592|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
7519593|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
7519594|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519595|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519596|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519597|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519598|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519599|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519600|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7519601|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Death|0
7519602|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Death|0
7519603|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Death|0
7519604|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Death|0
7519605|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Death|2
7519606|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Death|0
7519607|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Death|0
7519608|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Death|0
7519609|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Death|0
7519610|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Death|0
7519611|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Death|0
7519612|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7519613|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
7519614|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
7519615|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
7519616|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7519617|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7519618|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7519619|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7519620|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7519621|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7519622|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7519623|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
7519624|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519625|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
7519626|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7519627|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7519628|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519629|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519630|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519631|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519632|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519633|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7519634|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Adverse Event|3
7519635|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Adverse Event|4
7519636|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Adverse Event|10
7519637|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Adverse Event|2
7519638|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Adverse Event|7
7519639|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7519640|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7519641|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7519642|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7519643|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7519644|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7519645|NCT02914522|26111459|P11|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
7519646|NCT02914522|26111460|P10|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
7519647|NCT02914522|26111461|P9|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
7519648|NCT02914522|26111462|P8|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
7519649|NCT02914522|26111463|P7|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
7519650|NCT02914522|26111464|P6|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7519651|NCT02914522|26111465|P5|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7519652|NCT02914522|26111466|P4|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7519653|NCT02914522|26111467|P3|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7519654|NCT02914522|26111468|P2|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7519655|NCT02914522|26111469|P1|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7519656|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519657|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519658|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519659|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519660|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519661|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7519662|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7519663|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519664|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519665|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7519666|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7519667|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Pregnancy|0
7519668|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Pregnancy|0
7519669|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Pregnancy|0
7519670|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Pregnancy|0
7519671|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Pregnancy|0
7519672|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Pregnancy|0
7519673|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Pregnancy|1
7519674|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Pregnancy|0
7519675|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Pregnancy|0
7519676|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Pregnancy|0
7519677|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Pregnancy|0
7519678|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519679|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519680|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519681|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519682|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519683|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519684|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519685|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519686|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519687|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7519688|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
7519689|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Investigator's Discretion|0
7519690|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Investigator's Discretion|0
7519691|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Investigator's Discretion|0
7519692|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Investigator's Discretion|0
7519693|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Investigator's Discretion|0
7519694|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Investigator's Discretion|0
7519695|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Investigator's Discretion|1
7519696|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Investigator's Discretion|0
7519697|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Investigator's Discretion|0
7519698|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Investigator's Discretion|0
7519699|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Investigator's Discretion|0
7519700|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Lost to Follow-up|0
7519701|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Lost to Follow-up|0
7519702|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Lost to Follow-up|0
7519703|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Lost to Follow-up|0
7519704|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Lost to Follow-up|0
7519705|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Lost to Follow-up|0
7519706|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Lost to Follow-up|0
7519707|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Lost to Follow-up|1
7519708|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Lost to Follow-up|1
7519709|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Lost to Follow-up|2
7519710|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Lost to Follow-up|0
7519711|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Protocol Violation|0
7519712|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Protocol Violation|0
7519713|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Protocol Violation|0
7519714|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Protocol Violation|0
7519715|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Protocol Violation|0
7519716|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Protocol Violation|2
7519717|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Protocol Violation|4
7519718|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Protocol Violation|3
7519719|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Protocol Violation|1
7519720|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Protocol Violation|2
7519721|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Protocol Violation|0
7519722|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Withdrew Consent|0
7519723|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Withdrew Consent|0
7519724|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Withdrew Consent|0
7519725|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Withdrew Consent|0
7519726|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Withdrew Consent|0
7519727|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Withdrew Consent|3
7519728|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Withdrew Consent|3
7519729|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Withdrew Consent|6
7519730|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Withdrew Consent|4
7519731|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Withdrew Consent|11
7519732|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Withdrew Consent|4
7519733|NCT02914522|26111459|P11|Induction Study: Up to Week 11|Adverse Event|0
7519734|NCT02914522|26111460|P10|Induction Study: Up to Week 11|Adverse Event|0
7519735|NCT02914522|26111461|P9|Induction Study: Up to Week 11|Adverse Event|0
7519736|NCT02914522|26111462|P8|Induction Study: Up to Week 11|Adverse Event|0
7519737|NCT02914522|26111463|P7|Induction Study: Up to Week 11|Adverse Event|0
7519738|NCT02914522|26111464|P6|Induction Study: Up to Week 11|Adverse Event|10
7519739|NCT02914522|26111465|P5|Induction Study: Up to Week 11|Adverse Event|14
7519740|NCT02914522|26111466|P4|Induction Study: Up to Week 11|Adverse Event|18
7519741|NCT02914522|26111467|P3|Induction Study: Up to Week 11|Adverse Event|4
7519742|NCT02914522|26111468|P2|Induction Study: Up to Week 11|Adverse Event|6
7519743|NCT02914522|26111469|P1|Induction Study: Up to Week 11|Adverse Event|5
7519744|NCT02914457|26111577|P1|Overall Study|Protocol Violation|1
7519745|NCT02914457|26111577|P1|Overall Study|ECG acquisition error due to sweating|1
7519746|NCT02914457|26111577|P1|Overall Study|Electrical instability of patient|1
7519747|NCT02914457|26111577|P1|Overall Study|No veins available for lead placement|1
7519748|NCT02914457|26111577|P1|Overall Study|Physician Decision|1
7519749|NCT02914457|26111577|P1|Overall Study|Withdrawal by Subject|1
7519750|NCT02914275|26111587|P2|Overall Study|Excluded due to invalid informed consent|0
7519751|NCT02914275|26111588|P1|Overall Study|Excluded due to invalid informed consent|3
7519752|NCT02914275|26111587|P2|Overall Study|Other|1
7519753|NCT02914275|26111588|P1|Overall Study|Other|4
7519754|NCT02914275|26111587|P2|Overall Study|Physician Decision|1
7519755|NCT02914275|26111588|P1|Overall Study|Physician Decision|3
7519756|NCT02914275|26111587|P2|Overall Study|Protocol Violation|1
7519757|NCT02914275|26111588|P1|Overall Study|Protocol Violation|1
7519758|NCT02914275|26111587|P2|Overall Study|Withdrawal by Subject|10
7519759|NCT02914275|26111588|P1|Overall Study|Withdrawal by Subject|26
7519760|NCT02914275|26111587|P2|Overall Study|Lost to Follow-up|29
7519761|NCT02914275|26111588|P1|Overall Study|Lost to Follow-up|84
7519762|NCT02914236|26111620|P1|Overall Study|Lost to Follow-up|1
7519763|NCT02914184|26111666|P4|Overall Study|Migrated/moved from the study area|1
7519764|NCT02914184|26111667|P3|Overall Study|Migrated/moved from the study area|2
7519765|NCT02914184|26111668|P2|Overall Study|Migrated/moved from the study area|1
7519766|NCT02914184|26111669|P1|Overall Study|Migrated/moved from the study area|2
7519767|NCT02914184|26111666|P4|Overall Study|Other|0
7519768|NCT02914184|26111667|P3|Overall Study|Other|0
7519769|NCT02914184|26111668|P2|Overall Study|Other|0
7519770|NCT02914184|26111669|P1|Overall Study|Other|1
7519771|NCT02914184|26111666|P4|Overall Study|Withdrawal by Subject|3
7519772|NCT02914184|26111667|P3|Overall Study|Withdrawal by Subject|7
7519773|NCT02914184|26111668|P2|Overall Study|Withdrawal by Subject|2
7519774|NCT02914184|26111669|P1|Overall Study|Withdrawal by Subject|4
7519775|NCT02914184|26111666|P4|Overall Study|Lost to Follow-up|7
7519776|NCT02914184|26111667|P3|Overall Study|Lost to Follow-up|8
7519777|NCT02914184|26111668|P2|Overall Study|Lost to Follow-up|10
7519778|NCT02914184|26111669|P1|Overall Study|Lost to Follow-up|7
7519779|NCT02913482|26111754|P3|Overall Study|Progressive Disease|1
7519780|NCT02913482|26111755|P2|Overall Study|Progressive Disease|1
7519781|NCT02913482|26111756|P1|Overall Study|Progressive Disease|0
7519782|NCT02913482|26111754|P3|Overall Study|Death|2
7519783|NCT02913482|26111755|P2|Overall Study|Death|1
7519784|NCT02913482|26111756|P1|Overall Study|Death|1
7519785|NCT02913326|26111789|P2|Overall Study|Adverse Event|0
7519786|NCT02913326|26111790|P1|Overall Study|Adverse Event|1
7519787|NCT02913326|26111789|P2|Overall Study|Lost to Follow-up|1
7519788|NCT02913326|26111790|P1|Overall Study|Lost to Follow-up|0
7519789|NCT02913326|26111789|P2|Overall Study|Reason not listed|1
7519790|NCT02913326|26111790|P1|Overall Study|Reason not listed|0
7519791|NCT02913105|26111838|P3|Overall Study|Withdrawal by Subject|1
7519792|NCT02913105|26111839|P2|Overall Study|Withdrawal by Subject|3
7519793|NCT02913105|26111840|P1|Overall Study|Withdrawal by Subject|0
7519794|NCT02913105|26111838|P3|Overall Study|Physician Decision|0
7519795|NCT02913105|26111839|P2|Overall Study|Physician Decision|1
7519796|NCT02913105|26111840|P1|Overall Study|Physician Decision|1
7519797|NCT02913105|26111838|P3|Overall Study|Reason Not Specified|1
7519798|NCT02913105|26111839|P2|Overall Study|Reason Not Specified|1
7519799|NCT02913105|26111840|P1|Overall Study|Reason Not Specified|3
7519800|NCT02913105|26111838|P3|Overall Study|Non-Compliance With Study Drug|1
7519801|NCT02913105|26111839|P2|Overall Study|Non-Compliance With Study Drug|0
7519802|NCT02913105|26111840|P1|Overall Study|Non-Compliance With Study Drug|0
7519803|NCT02913105|26111838|P3|Overall Study|Adverse Event|4
7519804|NCT02913105|26111839|P2|Overall Study|Adverse Event|0
7519805|NCT02913105|26111840|P1|Overall Study|Adverse Event|11
7519806|NCT02912650|26111893|P4|Overall Study|Adverse Event|0
7519807|NCT02912650|26111894|P3|Overall Study|Adverse Event|1
7519808|NCT02912650|26111895|P2|Overall Study|Adverse Event|0
7519809|NCT02912650|26111896|P1|Overall Study|Adverse Event|0
7519810|NCT02912650|26111893|P4|Overall Study|Withdrawal by Subject|5
7519811|NCT02912650|26111894|P3|Overall Study|Withdrawal by Subject|1
7519812|NCT02912650|26111895|P2|Overall Study|Withdrawal by Subject|0
7519813|NCT02912650|26111896|P1|Overall Study|Withdrawal by Subject|1
7519814|NCT02912468|26111980|P2|Overall Study|Randomized and not treated|1
7519815|NCT02912468|26111981|P1|Overall Study|Randomized and not treated|0
7519816|NCT02912468|26111980|P2|Overall Study|Withdrawal by Subject|2
7519817|NCT02912468|26111981|P1|Overall Study|Withdrawal by Subject|6
7519818|NCT02912468|26111980|P2|Overall Study|Adverse Event|2
7519819|NCT02912468|26111981|P1|Overall Study|Adverse Event|3
7519820|NCT02912455|26112060|P2|Overall Study|Lost to Follow-up|1
7519821|NCT02912455|26112061|P1|Overall Study|Lost to Follow-up|2
7519822|NCT02912455|26112060|P2|Overall Study|Lack of Efficacy|1
7519823|NCT02912455|26112061|P1|Overall Study|Lack of Efficacy|0
7519824|NCT02912455|26112060|P2|Overall Study|Withdrawal by Subject|1
7519825|NCT02912455|26112061|P1|Overall Study|Withdrawal by Subject|0
7519826|NCT02911948|26112156|P2|Overall Study|Unclassified|3
7519827|NCT02911948|26112157|P1|Overall Study|Unclassified|0
7519828|NCT02911948|26112156|P2|Overall Study|Lack of Efficacy|1
7519829|NCT02911948|26112157|P1|Overall Study|Lack of Efficacy|0
7519830|NCT02911948|26112156|P2|Overall Study|Withdrawal by Subject|2
7519831|NCT02911948|26112157|P1|Overall Study|Withdrawal by Subject|0
7519832|NCT02911948|26112156|P2|Overall Study|Protocol Violation|1
7519833|NCT02911948|26112157|P1|Overall Study|Protocol Violation|0
7519834|NCT02911688|26112419|P2|Washout|Withdrawal by Subject|1
7519835|NCT02911688|26112420|P1|Washout|Withdrawal by Subject|0
7519836|NCT02911688|26112419|P2|Washout|Lost to Follow-up|1
7519837|NCT02911688|26112420|P1|Washout|Lost to Follow-up|1
7519838|NCT02911519|26112444|P2|Overall Study|Death|2
7519839|NCT02911519|26112445|P1|Overall Study|Death|0
7519840|NCT02911519|26112444|P2|Overall Study|Lost to Follow-up|2
7519841|NCT02911519|26112445|P1|Overall Study|Lost to Follow-up|2
7519842|NCT02911285|26112477|P2|Overall Study|Participant got a job and no longer had time to participate.|0
7519843|NCT02911285|26112478|P1|Overall Study|Participant got a job and no longer had time to participate.|1
7519844|NCT02911285|26112477|P2|Overall Study|Lost to Follow-up|5
7519845|NCT02911285|26112478|P1|Overall Study|Lost to Follow-up|8
7519846|NCT02911116|26112492|P2|Overall Study|Lost to Follow-up|1
7519847|NCT02911116|26112493|P1|Overall Study|Lost to Follow-up|0
7519848|NCT02911116|26112492|P2|Overall Study|Insufficient Therapeutic Response|0
7519849|NCT02911116|26112493|P1|Overall Study|Insufficient Therapeutic Response|1
7519850|NCT02911025|26112541|P1|Overall Study|Lost to Follow-up|3
7519851|NCT02910739|26112548|P4|Overall Study|Adverse Event|0
7519852|NCT02910739|26112549|P3|Overall Study|Adverse Event|0
7519853|NCT02910739|26112550|P2|Overall Study|Adverse Event|0
7519854|NCT02910739|26112551|P1|Overall Study|Adverse Event|1
7519855|NCT02910713|26112577|P1|Overall Study|Investigator Discretion|1
7519856|NCT02910713|26112577|P1|Overall Study|Enrollment cap|7
7519857|NCT02910713|26112577|P1|Overall Study|Received Neither Application|18
7519858|NCT02910713|26112577|P1|Overall Study|Received One Application|10
7519859|NCT02910713|26112577|P1|Overall Study|Subject Choice|4
7519860|NCT02910713|26112577|P1|Overall Study|Protocol Violation|2
7519861|NCT02910466|26112591|P1|Overall Study|Participant didn't meet inclusion criteria|1
7519862|NCT02910466|26112591|P1|Overall Study|Due to Food and Drug Administration (FDA) recall|29
7519863|NCT02910466|26112591|P1|Overall Study|Lost to Follow-up|5
7519864|NCT02910466|26112591|P1|Overall Study|Withdrawal by Subject|3
7519865|NCT02910466|26112591|P1|Overall Study|Adverse Event|1
7519866|NCT02910167|26112629|P1|Overall Study|Lost to Follow-up|18
7519867|NCT02910167|26112629|P1|Overall Study|Adverse Event|1
7519868|NCT02910089|26112654|P2|Overall Study|Lost insurance eligibility|16
7519869|NCT02910089|26112655|P1|Overall Study|Lost insurance eligibility|22
7519870|NCT02910063|26112667|P3|Phase 2|Death|0
7519871|NCT02910063|26112668|P2|Phase 2|Death|0
7519872|NCT02910063|26112669|P1|Phase 2|Death|24
7519873|NCT02910063|26112667|P3|Phase 2|Lost to Follow-up|0
7519874|NCT02910063|26112668|P2|Phase 2|Lost to Follow-up|0
7519875|NCT02910063|26112669|P1|Phase 2|Lost to Follow-up|1
7519876|NCT02910063|26112667|P3|Phase 2|Withdrawal by Subject|0
7519877|NCT02910063|26112668|P2|Phase 2|Withdrawal by Subject|0
7519878|NCT02910063|26112669|P1|Phase 2|Withdrawal by Subject|3
7519879|NCT02910037|26112710|P1|Overall Study|Lost to Follow-up|6
7519880|NCT02910037|26112710|P1|Overall Study|Withdrawal by Subject|4
7519881|NCT02910011|26112731|P1|Overall Study|Physician Decision|2
7519882|NCT02909907|26112840|P2|Overall Study|Withdrawal by Subject|1
7519883|NCT02909907|26112841|P1|Overall Study|Withdrawal by Subject|0
7519884|NCT02909504|26112882|P1|Overall Study|Lost to Follow-up|1
7519885|NCT02909504|26112882|P1|Overall Study|Subject moved|1
7519886|NCT02909504|26112882|P1|Overall Study|Pregnancy|1
7519887|NCT02909504|26112882|P1|Overall Study|Withdrawal by Subject|4
7519888|NCT02909504|26112882|P1|Overall Study|Lack of Efficacy|3
7519889|NCT02909504|26112882|P1|Overall Study|Adverse Event|2
7519890|NCT02909153|26112919|P5|Overall Study|Withdrawal by Subject|0
7519891|NCT02909153|26112920|P4|Overall Study|Withdrawal by Subject|0
7519892|NCT02909153|26112921|P3|Overall Study|Withdrawal by Subject|0
7519893|NCT02909153|26112922|P2|Overall Study|Withdrawal by Subject|1
7519894|NCT02909153|26112923|P1|Overall Study|Withdrawal by Subject|0
7519895|NCT02909101|26113013|P2|Overall Study|Lost to Follow-up|1
7519896|NCT02909101|26113014|P1|Overall Study|Lost to Follow-up|1
7519897|NCT02908880|26113032|P1|Overall Study|Death|5
7519898|NCT02908880|26113032|P1|Overall Study|Withdrawal by Subject|17
7519899|NCT02908880|26113032|P1|Overall Study|Explantation of the device|1
7519900|NCT02908880|26113032|P1|Overall Study|Lost to Follow-up|4
7519901|NCT02908841|26113042|P2|Overall Study|Physician Decision|0
7519902|NCT02908841|26113043|P1|Overall Study|Physician Decision|4
7519903|NCT02908685|26113071|P12|Part 2 Confirmatory|Changed to other treatment|0
7519904|NCT02908685|26113072|P11|Part 2 Confirmatory|Changed to other treatment|1
7519905|NCT02908685|26113073|P10|Part 2 Confirmatory|Changed to other treatment|0
7519906|NCT02908685|26113074|P9|Part 2 Confirmatory|Changed to other treatment|0
7519907|NCT02908685|26113075|P8|Part 2 Confirmatory|Changed to other treatment|0
7519908|NCT02908685|26113076|P7|Part 2 Confirmatory|Changed to other treatment|0
7519909|NCT02908685|26113077|P6|Part 2 Confirmatory|Changed to other treatment|0
7519910|NCT02908685|26113078|P5|Part 2 Confirmatory|Changed to other treatment|0
7519911|NCT02908685|26113079|P4|Part 2 Confirmatory|Changed to other treatment|0
7519912|NCT02908685|26113080|P3|Part 2 Confirmatory|Changed to other treatment|0
7519913|NCT02908685|26113081|P2|Part 2 Confirmatory|Changed to other treatment|0
7519914|NCT02908685|26113082|P1|Part 2 Confirmatory|Changed to other treatment|0
7519915|NCT02908685|26113071|P12|Part 2 Confirmatory|Changed to Spinraza|1
7519916|NCT02908685|26113072|P11|Part 2 Confirmatory|Changed to Spinraza|2
7519917|NCT02908685|26113073|P10|Part 2 Confirmatory|Changed to Spinraza|0
7519918|NCT02908685|26113074|P9|Part 2 Confirmatory|Changed to Spinraza|0
7519919|NCT02908685|26113075|P8|Part 2 Confirmatory|Changed to Spinraza|0
7519920|NCT02908685|26113076|P7|Part 2 Confirmatory|Changed to Spinraza|0
7519921|NCT02908685|26113077|P6|Part 2 Confirmatory|Changed to Spinraza|0
7519922|NCT02908685|26113078|P5|Part 2 Confirmatory|Changed to Spinraza|0
7519923|NCT02908685|26113079|P4|Part 2 Confirmatory|Changed to Spinraza|0
7519924|NCT02908685|26113080|P3|Part 2 Confirmatory|Changed to Spinraza|0
7519925|NCT02908685|26113081|P2|Part 2 Confirmatory|Changed to Spinraza|0
7519926|NCT02908685|26113082|P1|Part 2 Confirmatory|Changed to Spinraza|0
7519927|NCT02908685|26113071|P12|Part 1 Exploratory|Withdrawal by Subject|0
7519928|NCT02908685|26113072|P11|Part 1 Exploratory|Withdrawal by Subject|0
7519929|NCT02908685|26113073|P10|Part 1 Exploratory|Withdrawal by Subject|0
7519930|NCT02908685|26113074|P9|Part 1 Exploratory|Withdrawal by Subject|0
7519931|NCT02908685|26113075|P8|Part 1 Exploratory|Withdrawal by Subject|0
7519932|NCT02908685|26113076|P7|Part 1 Exploratory|Withdrawal by Subject|0
7519933|NCT02908685|26113077|P6|Part 1 Exploratory|Withdrawal by Subject|0
7519934|NCT02908685|26113078|P5|Part 1 Exploratory|Withdrawal by Subject|0
7519935|NCT02908685|26113079|P4|Part 1 Exploratory|Withdrawal by Subject|0
7519936|NCT02908685|26113080|P3|Part 1 Exploratory|Withdrawal by Subject|0
7519937|NCT02908685|26113081|P2|Part 1 Exploratory|Withdrawal by Subject|1
7519938|NCT02908685|26113082|P1|Part 1 Exploratory|Withdrawal by Subject|0
7519939|NCT02908672|26113154|P2|Overall Study|Discontinued the study during run-in|0
7519940|NCT02908672|26113155|P1|Overall Study|Discontinued the study during run-in|3
7519941|NCT02908672|26113154|P2|Overall Study|Study is ongoing|141
7519942|NCT02908672|26113155|P1|Overall Study|Study is ongoing|124
7519943|NCT02908672|26113154|P2|Overall Study|Withdrawal by Subject|18
7519944|NCT02908672|26113155|P1|Overall Study|Withdrawal by Subject|13
7519945|NCT02908672|26113154|P2|Overall Study|Protocol Violation|1
7519946|NCT02908672|26113155|P1|Overall Study|Protocol Violation|1
7519947|NCT02908672|26113154|P2|Overall Study|Other|0
7519948|NCT02908672|26113155|P1|Overall Study|Other|2
7519949|NCT02908672|26113154|P2|Overall Study|Lost to Follow-up|3
7519950|NCT02908672|26113155|P1|Overall Study|Lost to Follow-up|3
7519951|NCT02908672|26113154|P2|Overall Study|Death|93
7519952|NCT02908672|26113155|P1|Overall Study|Death|112
7519953|NCT02908529|26113228|P2|Overall Study|Lost to Follow-up|2
7519954|NCT02908529|26113229|P1|Overall Study|Lost to Follow-up|0
7519955|NCT02908516|26113239|P2|Overall Study|Study Terminated|3
7519956|NCT02908516|26113240|P1|Overall Study|Study Terminated|3
7519957|NCT02908464|26113293|P2|Overall Study|Found ineligible after randomization|2
7519958|NCT02908464|26113294|P1|Overall Study|Found ineligible after randomization|0
7519959|NCT02908464|26113293|P2|Overall Study|Withdrawal by Subject|1
7519960|NCT02908464|26113294|P1|Overall Study|Withdrawal by Subject|2
7519961|NCT02908347|26113315|P2|Overall Study|Lost to Follow-up|0
7519962|NCT02908347|26113316|P1|Overall Study|Lost to Follow-up|1
7519963|NCT02908347|26113315|P2|Overall Study|Adverse Event|1
7519964|NCT02908347|26113316|P1|Overall Study|Adverse Event|0
7519965|NCT02908100|26113412|P3|Overall Study|Randomised in Error|0
7519966|NCT02908100|26113413|P2|Overall Study|Randomised in Error|0
7519967|NCT02908100|26113414|P1|Overall Study|Randomised in Error|1
7519968|NCT02908100|26113412|P3|Overall Study|Withdrawal by Subject|5
7519969|NCT02908100|26113413|P2|Overall Study|Withdrawal by Subject|7
7519970|NCT02908100|26113414|P1|Overall Study|Withdrawal by Subject|8
7519971|NCT02908100|26113412|P3|Overall Study|Pregnancy|0
7519972|NCT02908100|26113413|P2|Overall Study|Pregnancy|2
7519973|NCT02908100|26113414|P1|Overall Study|Pregnancy|1
7519974|NCT02908100|26113412|P3|Overall Study|Physician Decision|0
7519975|NCT02908100|26113413|P2|Overall Study|Physician Decision|1
7519976|NCT02908100|26113414|P1|Overall Study|Physician Decision|0
7519977|NCT02908100|26113412|P3|Overall Study|Non-Compliance With Contraceptive Method|0
7519978|NCT02908100|26113413|P2|Overall Study|Non-Compliance With Contraceptive Method|0
7519979|NCT02908100|26113414|P1|Overall Study|Non-Compliance With Contraceptive Method|1
7519980|NCT02908100|26113412|P3|Overall Study|Non-Compliance With Study Drug|2
7519981|NCT02908100|26113413|P2|Overall Study|Non-Compliance With Study Drug|1
7519982|NCT02908100|26113414|P1|Overall Study|Non-Compliance With Study Drug|1
7519983|NCT02908100|26113412|P3|Overall Study|Lost to Follow-up|2
7519984|NCT02908100|26113413|P2|Overall Study|Lost to Follow-up|1
7519985|NCT02908100|26113414|P1|Overall Study|Lost to Follow-up|0
7519986|NCT02908100|26113412|P3|Overall Study|Lack of Efficacy|3
7519987|NCT02908100|26113413|P2|Overall Study|Lack of Efficacy|3
7519988|NCT02908100|26113414|P1|Overall Study|Lack of Efficacy|2
7519989|NCT02908100|26113412|P3|Overall Study|Death|0
7519990|NCT02908100|26113413|P2|Overall Study|Death|0
7519991|NCT02908100|26113414|P1|Overall Study|Death|2
7519992|NCT02908100|26113412|P3|Overall Study|Adverse Event|9
7519993|NCT02908100|26113413|P2|Overall Study|Adverse Event|6
7519994|NCT02908100|26113414|P1|Overall Study|Adverse Event|7
7519995|NCT02907892|26113458|P2|Overall Study|Lost to Follow-up|40
7519996|NCT02907892|26113459|P1|Overall Study|Lost to Follow-up|27
7519997|NCT02907619|26113479|P3|Overall Study|Other|0
7519998|NCT02907619|26113480|P2|Overall Study|Other|1
7519999|NCT02907619|26113481|P1|Overall Study|Other|0
7520000|NCT02907619|26113479|P3|Overall Study|Withdrawal by Subject|0
7520001|NCT02907619|26113480|P2|Overall Study|Withdrawal by Subject|1
7520002|NCT02907619|26113481|P1|Overall Study|Withdrawal by Subject|1
7520003|NCT02907619|26113479|P3|Overall Study|Death|1
7520004|NCT02907619|26113480|P2|Overall Study|Death|0
7520005|NCT02907619|26113481|P1|Overall Study|Death|0
7520006|NCT02907619|26113479|P3|Overall Study|Study terminated by sponsor|19
7520007|NCT02907619|26113480|P2|Overall Study|Study terminated by sponsor|18
7520008|NCT02907619|26113481|P1|Overall Study|Study terminated by sponsor|18
7520009|NCT02907463|26113697|P1|Overall Study|Missing Exit Form|1
7520010|NCT02907463|26113697|P1|Overall Study|Device Explanted|1
7520011|NCT02907463|26113697|P1|Overall Study|Not Implanted with Study Device|2
7520012|NCT02907463|26113697|P1|Overall Study|MIS Approach was not used|2
7520013|NCT02907463|26113697|P1|Overall Study|Withdrawal by Subject|4
7520014|NCT02907463|26113697|P1|Overall Study|Death|10
7520015|NCT02907463|26113697|P1|Overall Study|Lost to Follow-up|17
7520016|NCT02907216|26113779|P2|Overall Study|Withdrawal by Subject|0
7520017|NCT02907216|26113780|P1|Overall Study|Withdrawal by Subject|1
7520018|NCT02907216|26113779|P2|Overall Study|No benefit to be obtained by continuing|1
7520019|NCT02907216|26113780|P1|Overall Study|No benefit to be obtained by continuing|0
7520020|NCT02907177|26113814|P2|Overall Study|Sponsor's Decision|57
7520021|NCT02907177|26113815|P1|Overall Study|Sponsor's Decision|50
7520022|NCT02907177|26113814|P2|Overall Study|Withdrawal by Subject|7
7520023|NCT02907177|26113815|P1|Overall Study|Withdrawal by Subject|15
7520024|NCT02907177|26113814|P2|Overall Study|Physician Decision|3
7520025|NCT02907177|26113815|P1|Overall Study|Physician Decision|3
7520026|NCT02907177|26113814|P2|Overall Study|Death|1
7520027|NCT02907177|26113815|P1|Overall Study|Death|0
7520028|NCT02906930|26113847|P4|Overall Study|Other|2
7520029|NCT02906930|26113848|P3|Overall Study|Other|1
7520030|NCT02906930|26113849|P2|Overall Study|Other|2
7520031|NCT02906930|26113850|P1|Overall Study|Other|1
7520032|NCT02906930|26113847|P4|Overall Study|Death|0
7520033|NCT02906930|26113848|P3|Overall Study|Death|1
7520034|NCT02906930|26113849|P2|Overall Study|Death|0
7520035|NCT02906930|26113850|P1|Overall Study|Death|0
7520036|NCT02906930|26113847|P4|Overall Study|Lost to Follow-up|2
7520037|NCT02906930|26113848|P3|Overall Study|Lost to Follow-up|5
7520038|NCT02906930|26113849|P2|Overall Study|Lost to Follow-up|7
7520039|NCT02906930|26113850|P1|Overall Study|Lost to Follow-up|5
7520040|NCT02906930|26113847|P4|Overall Study|Withdrawal by Subject|4
7520041|NCT02906930|26113848|P3|Overall Study|Withdrawal by Subject|5
7520042|NCT02906930|26113849|P2|Overall Study|Withdrawal by Subject|5
7520043|NCT02906930|26113850|P1|Overall Study|Withdrawal by Subject|0
7520044|NCT02906917|26114043|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
7520045|NCT02906917|26114044|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
7520046|NCT02906917|26114043|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
7520047|NCT02906917|26114044|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
7520048|NCT02906917|26114043|P2|Intensification Period (Week 26-38)|Adverse Event|2
7520049|NCT02906917|26114044|P1|Intensification Period (Week 26-38)|Adverse Event|0
7520050|NCT02906917|26114043|P2|Intensification Period (Week 26-38)|Unclassified|2
7520051|NCT02906917|26114044|P1|Intensification Period (Week 26-38)|Unclassified|3
7520052|NCT02906917|26114043|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
7520053|NCT02906917|26114044|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
7520054|NCT02906917|26114043|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
7520055|NCT02906917|26114044|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
7520056|NCT02906917|26114043|P2|Initiation Period (Week 0-26)|Adverse Event|0
7520057|NCT02906917|26114044|P1|Initiation Period (Week 0-26)|Adverse Event|1
7520058|NCT02906917|26114043|P2|Initiation Period (Week 0-26)|Unclassified|3
7520059|NCT02906917|26114044|P1|Initiation Period (Week 0-26)|Unclassified|1
7520060|NCT02906709|26114105|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
7520061|NCT02906709|26114106|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
7520062|NCT02906709|26114105|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
7520063|NCT02906709|26114106|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
7520064|NCT02906709|26114105|P2|Phase A (Week 0 to Week 16)|Death|1
7520065|NCT02906709|26114106|P1|Phase A (Week 0 to Week 16)|Death|0
7520066|NCT02906709|26114105|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
7520067|NCT02906709|26114106|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
7520068|NCT02906670|26114160|P10|Cohort 5P, QW|Radiological Progression|0
7520069|NCT02906670|26114161|P9|Cohort 5P, QW|Radiological Progression|0
7520070|NCT02906670|26114162|P8|Cohort 5P, QW|Radiological Progression|0
7520071|NCT02906670|26114163|P7|Cohort 5P, QW|Radiological Progression|0
7520072|NCT02906670|26114164|P6|Cohort 5P, QW|Radiological Progression|0
7520073|NCT02906670|26114165|P5|Cohort 5P, QW|Radiological Progression|3
7520074|NCT02906670|26114166|P4|Cohort 5P, QW|Radiological Progression|0
7520075|NCT02906670|26114167|P3|Cohort 5P, QW|Radiological Progression|0
7520076|NCT02906670|26114168|P2|Cohort 5P, QW|Radiological Progression|0
7520077|NCT02906670|26114169|P1|Cohort 5P, QW|Radiological Progression|0
7520078|NCT02906670|26114160|P10|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
7520079|NCT02906670|26114161|P9|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520080|NCT02906670|26114162|P8|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520081|NCT02906670|26114163|P7|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520082|NCT02906670|26114164|P6|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520083|NCT02906670|26114165|P5|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520084|NCT02906670|26114166|P4|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520085|NCT02906670|26114167|P3|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520086|NCT02906670|26114168|P2|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520087|NCT02906670|26114169|P1|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7520088|NCT02906670|26114160|P10|Cohort 7P, Q2W|Physician Decision|1
7520089|NCT02906670|26114161|P9|Cohort 7P, Q2W|Physician Decision|0
7520090|NCT02906670|26114162|P8|Cohort 7P, Q2W|Physician Decision|0
7520091|NCT02906670|26114163|P7|Cohort 7P, Q2W|Physician Decision|0
7520092|NCT02906670|26114164|P6|Cohort 7P, Q2W|Physician Decision|0
7520093|NCT02906670|26114165|P5|Cohort 7P, Q2W|Physician Decision|0
7520094|NCT02906670|26114166|P4|Cohort 7P, Q2W|Physician Decision|0
7520095|NCT02906670|26114167|P3|Cohort 7P, Q2W|Physician Decision|0
7520096|NCT02906670|26114168|P2|Cohort 7P, Q2W|Physician Decision|0
7520097|NCT02906670|26114169|P1|Cohort 7P, Q2W|Physician Decision|0
7520098|NCT02906670|26114160|P10|Cohort 7P, Q2W|Adverse Event|1
7520099|NCT02906670|26114161|P9|Cohort 7P, Q2W|Adverse Event|0
7520100|NCT02906670|26114162|P8|Cohort 7P, Q2W|Adverse Event|0
7520101|NCT02906670|26114163|P7|Cohort 7P, Q2W|Adverse Event|0
7520102|NCT02906670|26114164|P6|Cohort 7P, Q2W|Adverse Event|0
7520103|NCT02906670|26114165|P5|Cohort 7P, Q2W|Adverse Event|0
7520104|NCT02906670|26114166|P4|Cohort 7P, Q2W|Adverse Event|0
7520105|NCT02906670|26114167|P3|Cohort 7P, Q2W|Adverse Event|0
7520106|NCT02906670|26114168|P2|Cohort 7P, Q2W|Adverse Event|0
7520107|NCT02906670|26114169|P1|Cohort 7P, Q2W|Adverse Event|0
7520108|NCT02906670|26114160|P10|Cohort 4P, QW|Radiological Progression|0
7520109|NCT02906670|26114161|P9|Cohort 4P, QW|Radiological Progression|0
7520110|NCT02906670|26114162|P8|Cohort 4P, QW|Radiological Progression|0
7520111|NCT02906670|26114163|P7|Cohort 4P, QW|Radiological Progression|0
7520112|NCT02906670|26114164|P6|Cohort 4P, QW|Radiological Progression|0
7520113|NCT02906670|26114165|P5|Cohort 4P, QW|Radiological Progression|0
7520114|NCT02906670|26114166|P4|Cohort 4P, QW|Radiological Progression|3
7520115|NCT02906670|26114167|P3|Cohort 4P, QW|Radiological Progression|0
7520116|NCT02906670|26114168|P2|Cohort 4P, QW|Radiological Progression|0
7520117|NCT02906670|26114169|P1|Cohort 4P, QW|Radiological Progression|0
7520118|NCT02906670|26114160|P10|Cohort 6P, Q2W|Clinical Progression|0
7520119|NCT02906670|26114161|P9|Cohort 6P, Q2W|Clinical Progression|3
7520120|NCT02906670|26114162|P8|Cohort 6P, Q2W|Clinical Progression|0
7520121|NCT02906670|26114163|P7|Cohort 6P, Q2W|Clinical Progression|0
7520122|NCT02906670|26114164|P6|Cohort 6P, Q2W|Clinical Progression|0
7520123|NCT02906670|26114165|P5|Cohort 6P, Q2W|Clinical Progression|0
7520124|NCT02906670|26114166|P4|Cohort 6P, Q2W|Clinical Progression|0
7520125|NCT02906670|26114167|P3|Cohort 6P, Q2W|Clinical Progression|0
7520126|NCT02906670|26114168|P2|Cohort 6P, Q2W|Clinical Progression|0
7520127|NCT02906670|26114169|P1|Cohort 6P, Q2W|Clinical Progression|0
7520128|NCT02906670|26114160|P10|Cohort 6P, Q2W|Radiological Progression|0
7520129|NCT02906670|26114161|P9|Cohort 6P, Q2W|Radiological Progression|1
7520130|NCT02906670|26114162|P8|Cohort 6P, Q2W|Radiological Progression|0
7520131|NCT02906670|26114163|P7|Cohort 6P, Q2W|Radiological Progression|0
7520132|NCT02906670|26114164|P6|Cohort 6P, Q2W|Radiological Progression|0
7520133|NCT02906670|26114165|P5|Cohort 6P, Q2W|Radiological Progression|0
7520134|NCT02906670|26114166|P4|Cohort 6P, Q2W|Radiological Progression|0
7520135|NCT02906670|26114167|P3|Cohort 6P, Q2W|Radiological Progression|0
7520136|NCT02906670|26114168|P2|Cohort 6P, Q2W|Radiological Progression|0
7520137|NCT02906670|26114169|P1|Cohort 6P, Q2W|Radiological Progression|0
7520138|NCT02906670|26114160|P10|Cohort 5P, Q2W|Adverse Event|0
7520139|NCT02906670|26114161|P9|Cohort 5P, Q2W|Adverse Event|0
7520140|NCT02906670|26114162|P8|Cohort 5P, Q2W|Adverse Event|1
7520141|NCT02906670|26114163|P7|Cohort 5P, Q2W|Adverse Event|0
7520142|NCT02906670|26114164|P6|Cohort 5P, Q2W|Adverse Event|0
7520143|NCT02906670|26114165|P5|Cohort 5P, Q2W|Adverse Event|0
7520144|NCT02906670|26114166|P4|Cohort 5P, Q2W|Adverse Event|0
7520145|NCT02906670|26114167|P3|Cohort 5P, Q2W|Adverse Event|0
7520146|NCT02906670|26114168|P2|Cohort 5P, Q2W|Adverse Event|0
7520147|NCT02906670|26114169|P1|Cohort 5P, Q2W|Adverse Event|0
7520148|NCT02906670|26114160|P10|Cohort 5P, Q2W|Radiological Progression|0
7520149|NCT02906670|26114161|P9|Cohort 5P, Q2W|Radiological Progression|0
7520150|NCT02906670|26114162|P8|Cohort 5P, Q2W|Radiological Progression|2
7520151|NCT02906670|26114163|P7|Cohort 5P, Q2W|Radiological Progression|0
7520152|NCT02906670|26114164|P6|Cohort 5P, Q2W|Radiological Progression|0
7520153|NCT02906670|26114165|P5|Cohort 5P, Q2W|Radiological Progression|0
7520154|NCT02906670|26114166|P4|Cohort 5P, Q2W|Radiological Progression|0
7520155|NCT02906670|26114167|P3|Cohort 5P, Q2W|Radiological Progression|0
7520156|NCT02906670|26114168|P2|Cohort 5P, Q2W|Radiological Progression|0
7520157|NCT02906670|26114169|P1|Cohort 5P, Q2W|Radiological Progression|0
7520158|NCT02906670|26114160|P10|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520159|NCT02906670|26114161|P9|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520160|NCT02906670|26114162|P8|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520161|NCT02906670|26114163|P7|Cohort 5, Q2W|Lack of Clinical Benefit|1
7520162|NCT02906670|26114164|P6|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520163|NCT02906670|26114165|P5|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520164|NCT02906670|26114166|P4|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520165|NCT02906670|26114167|P3|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520166|NCT02906670|26114168|P2|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520167|NCT02906670|26114169|P1|Cohort 5, Q2W|Lack of Clinical Benefit|0
7520168|NCT02906670|26114160|P10|Cohort 5, Q2W|Adverse Event|0
7520169|NCT02906670|26114161|P9|Cohort 5, Q2W|Adverse Event|0
7520170|NCT02906670|26114162|P8|Cohort 5, Q2W|Adverse Event|0
7520171|NCT02906670|26114163|P7|Cohort 5, Q2W|Adverse Event|1
7520172|NCT02906670|26114164|P6|Cohort 5, Q2W|Adverse Event|0
7520173|NCT02906670|26114165|P5|Cohort 5, Q2W|Adverse Event|0
7520174|NCT02906670|26114166|P4|Cohort 5, Q2W|Adverse Event|0
7520175|NCT02906670|26114167|P3|Cohort 5, Q2W|Adverse Event|0
7520176|NCT02906670|26114168|P2|Cohort 5, Q2W|Adverse Event|0
7520177|NCT02906670|26114169|P1|Cohort 5, Q2W|Adverse Event|0
7520178|NCT02906670|26114160|P10|Cohort 5, Q2W|Clinical Progression|0
7520179|NCT02906670|26114161|P9|Cohort 5, Q2W|Clinical Progression|0
7520180|NCT02906670|26114162|P8|Cohort 5, Q2W|Clinical Progression|0
7520181|NCT02906670|26114163|P7|Cohort 5, Q2W|Clinical Progression|1
7520182|NCT02906670|26114164|P6|Cohort 5, Q2W|Clinical Progression|0
7520183|NCT02906670|26114165|P5|Cohort 5, Q2W|Clinical Progression|0
7520184|NCT02906670|26114166|P4|Cohort 5, Q2W|Clinical Progression|0
7520185|NCT02906670|26114167|P3|Cohort 5, Q2W|Clinical Progression|0
7520186|NCT02906670|26114168|P2|Cohort 5, Q2W|Clinical Progression|0
7520187|NCT02906670|26114169|P1|Cohort 5, Q2W|Clinical Progression|0
7520188|NCT02906670|26114160|P10|Cohort 5, Q2W|Radiological Progression|0
7520189|NCT02906670|26114161|P9|Cohort 5, Q2W|Radiological Progression|0
7520190|NCT02906670|26114162|P8|Cohort 5, Q2W|Radiological Progression|0
7520191|NCT02906670|26114163|P7|Cohort 5, Q2W|Radiological Progression|4
7520192|NCT02906670|26114164|P6|Cohort 5, Q2W|Radiological Progression|0
7520193|NCT02906670|26114165|P5|Cohort 5, Q2W|Radiological Progression|0
7520194|NCT02906670|26114166|P4|Cohort 5, Q2W|Radiological Progression|0
7520195|NCT02906670|26114167|P3|Cohort 5, Q2W|Radiological Progression|0
7520196|NCT02906670|26114168|P2|Cohort 5, Q2W|Radiological Progression|0
7520197|NCT02906670|26114169|P1|Cohort 5, Q2W|Radiological Progression|0
7520198|NCT02906670|26114160|P10|Cohort 4, Q2W|Clinical Progression|0
7520199|NCT02906670|26114161|P9|Cohort 4, Q2W|Clinical Progression|0
7520200|NCT02906670|26114162|P8|Cohort 4, Q2W|Clinical Progression|0
7520201|NCT02906670|26114163|P7|Cohort 4, Q2W|Clinical Progression|0
7520202|NCT02906670|26114164|P6|Cohort 4, Q2W|Clinical Progression|2
7520203|NCT02906670|26114165|P5|Cohort 4, Q2W|Clinical Progression|0
7520204|NCT02906670|26114166|P4|Cohort 4, Q2W|Clinical Progression|0
7520205|NCT02906670|26114167|P3|Cohort 4, Q2W|Clinical Progression|0
7520206|NCT02906670|26114168|P2|Cohort 4, Q2W|Clinical Progression|0
7520207|NCT02906670|26114169|P1|Cohort 4, Q2W|Clinical Progression|0
7520208|NCT02906670|26114160|P10|Cohort 4, Q2W|Radiological Progression|0
7520209|NCT02906670|26114161|P9|Cohort 4, Q2W|Radiological Progression|0
7520210|NCT02906670|26114162|P8|Cohort 4, Q2W|Radiological Progression|0
7520211|NCT02906670|26114163|P7|Cohort 4, Q2W|Radiological Progression|0
7520212|NCT02906670|26114164|P6|Cohort 4, Q2W|Radiological Progression|1
7520213|NCT02906670|26114165|P5|Cohort 4, Q2W|Radiological Progression|0
7520214|NCT02906670|26114166|P4|Cohort 4, Q2W|Radiological Progression|0
7520215|NCT02906670|26114167|P3|Cohort 4, Q2W|Radiological Progression|0
7520216|NCT02906670|26114168|P2|Cohort 4, Q2W|Radiological Progression|0
7520217|NCT02906670|26114169|P1|Cohort 4, Q2W|Radiological Progression|0
7520218|NCT02906670|26114160|P10|Cohort 3, QW|Lack of Clinical Benefit|0
7520219|NCT02906670|26114161|P9|Cohort 3, QW|Lack of Clinical Benefit|0
7520220|NCT02906670|26114162|P8|Cohort 3, QW|Lack of Clinical Benefit|0
7520221|NCT02906670|26114163|P7|Cohort 3, QW|Lack of Clinical Benefit|0
7520222|NCT02906670|26114164|P6|Cohort 3, QW|Lack of Clinical Benefit|0
7520223|NCT02906670|26114165|P5|Cohort 3, QW|Lack of Clinical Benefit|0
7520224|NCT02906670|26114166|P4|Cohort 3, QW|Lack of Clinical Benefit|0
7520225|NCT02906670|26114167|P3|Cohort 3, QW|Lack of Clinical Benefit|2
7520226|NCT02906670|26114168|P2|Cohort 3, QW|Lack of Clinical Benefit|0
7520227|NCT02906670|26114169|P1|Cohort 3, QW|Lack of Clinical Benefit|0
7520228|NCT02906670|26114160|P10|Cohort 3, QW|Radiological Progression|0
7520229|NCT02906670|26114161|P9|Cohort 3, QW|Radiological Progression|0
7520230|NCT02906670|26114162|P8|Cohort 3, QW|Radiological Progression|0
7520231|NCT02906670|26114163|P7|Cohort 3, QW|Radiological Progression|0
7520232|NCT02906670|26114164|P6|Cohort 3, QW|Radiological Progression|0
7520233|NCT02906670|26114165|P5|Cohort 3, QW|Radiological Progression|0
7520234|NCT02906670|26114166|P4|Cohort 3, QW|Radiological Progression|0
7520235|NCT02906670|26114167|P3|Cohort 3, QW|Radiological Progression|2
7520236|NCT02906670|26114168|P2|Cohort 3, QW|Radiological Progression|0
7520237|NCT02906670|26114169|P1|Cohort 3, QW|Radiological Progression|0
7520238|NCT02906670|26114160|P10|Cohort 2, QW|Radiological Progression|0
7520239|NCT02906670|26114161|P9|Cohort 2, QW|Radiological Progression|0
7520240|NCT02906670|26114162|P8|Cohort 2, QW|Radiological Progression|0
7520241|NCT02906670|26114163|P7|Cohort 2, QW|Radiological Progression|0
7520242|NCT02906670|26114164|P6|Cohort 2, QW|Radiological Progression|0
7520243|NCT02906670|26114165|P5|Cohort 2, QW|Radiological Progression|0
7520244|NCT02906670|26114166|P4|Cohort 2, QW|Radiological Progression|0
7520245|NCT02906670|26114167|P3|Cohort 2, QW|Radiological Progression|0
7520246|NCT02906670|26114168|P2|Cohort 2, QW|Radiological Progression|1
7520247|NCT02906670|26114169|P1|Cohort 2, QW|Radiological Progression|0
7520248|NCT02906670|26114160|P10|Cohort 1, QW|Radiological Progression|0
7520249|NCT02906670|26114161|P9|Cohort 1, QW|Radiological Progression|0
7520250|NCT02906670|26114162|P8|Cohort 1, QW|Radiological Progression|0
7520251|NCT02906670|26114163|P7|Cohort 1, QW|Radiological Progression|0
7520252|NCT02906670|26114164|P6|Cohort 1, QW|Radiological Progression|0
7520253|NCT02906670|26114165|P5|Cohort 1, QW|Radiological Progression|0
7520254|NCT02906670|26114166|P4|Cohort 1, QW|Radiological Progression|0
7520255|NCT02906670|26114167|P3|Cohort 1, QW|Radiological Progression|0
7520256|NCT02906670|26114168|P2|Cohort 1, QW|Radiological Progression|0
7520257|NCT02906670|26114169|P1|Cohort 1, QW|Radiological Progression|1
7520258|NCT02906644|26114286|P2|Weeks 3 to 14|Lost to Follow-up|4
7520259|NCT02906644|26114287|P1|Weeks 3 to 14|Lost to Follow-up|3
7520260|NCT02906644|26114286|P2|Weeks 3 to 14|Withdrawal by Subject|7
7520261|NCT02906644|26114287|P1|Weeks 3 to 14|Withdrawal by Subject|13
7520262|NCT02906644|26114286|P2|First 2 Weeks|Physician Decision|1
7520263|NCT02906644|26114287|P1|First 2 Weeks|Physician Decision|1
7520264|NCT02906644|26114286|P2|First 2 Weeks|Withdrawal by Subject|2
7520265|NCT02906644|26114287|P1|First 2 Weeks|Withdrawal by Subject|0
7520266|NCT02906579|26114303|P1|Overall Study|Physician Decision|1
7520267|NCT02906579|26114303|P1|Overall Study|Adverse Event|1
7520268|NCT02906358|26114507|P2|Overall Study|Lost to Follow-up|15
7520269|NCT02906358|26114508|P1|Overall Study|Lost to Follow-up|12
7520270|NCT02906358|26114507|P2|Overall Study|Withdrawal by Subject|7
7520271|NCT02906358|26114508|P1|Overall Study|Withdrawal by Subject|10
7520272|NCT02905825|26114542|P1|Overall Study|Device Malfunction|1
7520273|NCT02905825|26114542|P1|Overall Study|Protocol Violation|11
7520274|NCT02905435|26114548|P1|Overall Study|Lost to Follow-up|4
7520275|NCT02905435|26114548|P1|Overall Study|Physician Decision|1
7520276|NCT02905435|26114548|P1|Overall Study|Death|2
7520277|NCT02905331|26114569|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7520278|NCT02905331|26114570|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
7520279|NCT02905331|26114571|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7520280|NCT02905331|26114569|P3|Active Treatment and Follow up (wk16-40)|Other|0
7520281|NCT02905331|26114570|P2|Active Treatment and Follow up (wk16-40)|Other|6
7520282|NCT02905331|26114571|P1|Active Treatment and Follow up (wk16-40)|Other|0
7520283|NCT02905331|26114569|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7520284|NCT02905331|26114570|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
7520285|NCT02905331|26114571|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7520286|NCT02905331|26114569|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7520287|NCT02905331|26114570|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7520288|NCT02905331|26114571|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
7520289|NCT02905331|26114569|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7520290|NCT02905331|26114570|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7520291|NCT02905331|26114571|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
7520292|NCT02905266|26114599|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|2
7520293|NCT02905266|26114600|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
7520294|NCT02905266|26114599|P2|Maintenance Phase Part 2|Study Drug Toxicity|4
7520295|NCT02905266|26114600|P1|Maintenance Phase Part 2|Study Drug Toxicity|3
7520296|NCT02905266|26114599|P2|Maintenance Phase Part 2|Disease Progression|2
7520297|NCT02905266|26114600|P1|Maintenance Phase Part 2|Disease Progression|9
7520298|NCT02905266|26114599|P2|Transition From Part 1 to Part 2|Adverse Event|1
7520299|NCT02905266|26114600|P1|Transition From Part 1 to Part 2|Adverse Event|1
7520300|NCT02905266|26114599|P2|Transition From Part 1 to Part 2|Participant withdrew consent|1
7520301|NCT02905266|26114600|P1|Transition From Part 1 to Part 2|Participant withdrew consent|0
7520302|NCT02905266|26114599|P2|Transition From Part 1 to Part 2|Death|1
7520303|NCT02905266|26114600|P1|Transition From Part 1 to Part 2|Death|0
7520304|NCT02905266|26114599|P2|Transition From Part 1 to Part 2|Study drug toxicity|4
7520305|NCT02905266|26114600|P1|Transition From Part 1 to Part 2|Study drug toxicity|0
7520306|NCT02905266|26114599|P2|Transition From Part 1 to Part 2|Disease progression|1
7520307|NCT02905266|26114600|P1|Transition From Part 1 to Part 2|Disease progression|2
7520308|NCT02905266|26114599|P2|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
7520309|NCT02905266|26114600|P1|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
7520310|NCT02905266|26114599|P2|Treatment Phase Part 1|Study Drug Toxicity|16
7520311|NCT02905266|26114600|P1|Treatment Phase Part 1|Study Drug Toxicity|22
7520312|NCT02905266|26114599|P2|Treatment Phase Part 1|Disease Progression|7
7520313|NCT02905266|26114600|P1|Treatment Phase Part 1|Disease Progression|6
7520314|NCT02905266|26114599|P2|Treatment Phase Part 1|Participant Withdrew Consent|0
7520315|NCT02905266|26114600|P1|Treatment Phase Part 1|Participant Withdrew Consent|1
7520316|NCT02905149|26114628|P2|Overall Study|Lost to Follow-up|0
7520317|NCT02905149|26114629|P1|Overall Study|Lost to Follow-up|2
7520318|NCT02905006|26114647|P6|Overall Study|Patient randomized by mistake|1
7520319|NCT02905006|26114648|P5|Overall Study|Patient randomized by mistake|0
7520320|NCT02905006|26114649|P4|Overall Study|Patient randomized by mistake|0
7520321|NCT02905006|26114650|P3|Overall Study|Patient randomized by mistake|0
7520322|NCT02905006|26114651|P2|Overall Study|Patient randomized by mistake|0
7520323|NCT02905006|26114652|P1|Overall Study|Patient randomized by mistake|0
7520324|NCT02905006|26114647|P6|Overall Study|Patient moved abroad|0
7520325|NCT02905006|26114648|P5|Overall Study|Patient moved abroad|0
7520326|NCT02905006|26114649|P4|Overall Study|Patient moved abroad|1
7520327|NCT02905006|26114650|P3|Overall Study|Patient moved abroad|0
7520328|NCT02905006|26114651|P2|Overall Study|Patient moved abroad|0
7520329|NCT02905006|26114652|P1|Overall Study|Patient moved abroad|0
7520330|NCT02905006|26114647|P6|Overall Study|Subject positive for Hep B|0
7520331|NCT02905006|26114648|P5|Overall Study|Subject positive for Hep B|0
7520332|NCT02905006|26114649|P4|Overall Study|Subject positive for Hep B|0
7520333|NCT02905006|26114650|P3|Overall Study|Subject positive for Hep B|1
7520334|NCT02905006|26114651|P2|Overall Study|Subject positive for Hep B|0
7520335|NCT02905006|26114652|P1|Overall Study|Subject positive for Hep B|0
7520336|NCT02905006|26114647|P6|Overall Study|Positive for Tuberculosis|0
7520337|NCT02905006|26114648|P5|Overall Study|Positive for Tuberculosis|0
7520338|NCT02905006|26114649|P4|Overall Study|Positive for Tuberculosis|0
7520339|NCT02905006|26114650|P3|Overall Study|Positive for Tuberculosis|0
7520340|NCT02905006|26114651|P2|Overall Study|Positive for Tuberculosis|1
7520341|NCT02905006|26114652|P1|Overall Study|Positive for Tuberculosis|0
7520342|NCT02905006|26114647|P6|Overall Study|Lab withdrawal criterion met|1
7520343|NCT02905006|26114648|P5|Overall Study|Lab withdrawal criterion met|2
7520344|NCT02905006|26114649|P4|Overall Study|Lab withdrawal criterion met|2
7520345|NCT02905006|26114650|P3|Overall Study|Lab withdrawal criterion met|2
7520346|NCT02905006|26114651|P2|Overall Study|Lab withdrawal criterion met|1
7520347|NCT02905006|26114652|P1|Overall Study|Lab withdrawal criterion met|0
7520348|NCT02905006|26114647|P6|Overall Study|Screening exclusion criteria met|0
7520349|NCT02905006|26114648|P5|Overall Study|Screening exclusion criteria met|0
7520350|NCT02905006|26114649|P4|Overall Study|Screening exclusion criteria met|0
7520351|NCT02905006|26114650|P3|Overall Study|Screening exclusion criteria met|0
7520352|NCT02905006|26114651|P2|Overall Study|Screening exclusion criteria met|0
7520353|NCT02905006|26114652|P1|Overall Study|Screening exclusion criteria met|1
7520354|NCT02905006|26114647|P6|Overall Study|Withdrawal by Subject|1
7520355|NCT02905006|26114648|P5|Overall Study|Withdrawal by Subject|0
7520356|NCT02905006|26114649|P4|Overall Study|Withdrawal by Subject|1
7520357|NCT02905006|26114650|P3|Overall Study|Withdrawal by Subject|1
7520358|NCT02905006|26114651|P2|Overall Study|Withdrawal by Subject|0
7520359|NCT02905006|26114652|P1|Overall Study|Withdrawal by Subject|0
7520360|NCT02905006|26114647|P6|Overall Study|Lost to Follow-up|0
7520361|NCT02905006|26114648|P5|Overall Study|Lost to Follow-up|1
7520362|NCT02905006|26114649|P4|Overall Study|Lost to Follow-up|1
7520363|NCT02905006|26114650|P3|Overall Study|Lost to Follow-up|0
7520364|NCT02905006|26114651|P2|Overall Study|Lost to Follow-up|0
7520365|NCT02905006|26114652|P1|Overall Study|Lost to Follow-up|0
7520366|NCT02905006|26114647|P6|Overall Study|Protocol Violation|0
7520367|NCT02905006|26114648|P5|Overall Study|Protocol Violation|0
7520368|NCT02905006|26114649|P4|Overall Study|Protocol Violation|0
7520369|NCT02905006|26114650|P3|Overall Study|Protocol Violation|0
7520370|NCT02905006|26114651|P2|Overall Study|Protocol Violation|0
7520371|NCT02905006|26114652|P1|Overall Study|Protocol Violation|2
7520372|NCT02905006|26114647|P6|Overall Study|Lack of Efficacy|0
7520373|NCT02905006|26114648|P5|Overall Study|Lack of Efficacy|0
7520374|NCT02905006|26114649|P4|Overall Study|Lack of Efficacy|0
7520375|NCT02905006|26114650|P3|Overall Study|Lack of Efficacy|0
7520376|NCT02905006|26114651|P2|Overall Study|Lack of Efficacy|0
7520377|NCT02905006|26114652|P1|Overall Study|Lack of Efficacy|1
7520378|NCT02905006|26114647|P6|Overall Study|Adverse Event|1
7520379|NCT02905006|26114648|P5|Overall Study|Adverse Event|0
7520380|NCT02905006|26114649|P4|Overall Study|Adverse Event|1
7520381|NCT02905006|26114650|P3|Overall Study|Adverse Event|1
7520382|NCT02905006|26114651|P2|Overall Study|Adverse Event|1
7520383|NCT02905006|26114652|P1|Overall Study|Adverse Event|1
7520384|NCT02904954|26114868|P2|Adjuvant Durvalumab|Currently on treatment|3
7520385|NCT02904954|26114869|P1|Adjuvant Durvalumab|Currently on treatment|1
7520386|NCT02904954|26114868|P2|Adjuvant Durvalumab|Prostate cancer|0
7520387|NCT02904954|26114869|P1|Adjuvant Durvalumab|Prostate cancer|1
7520388|NCT02904954|26114868|P2|Adjuvant Durvalumab|Death|1
7520389|NCT02904954|26114869|P1|Adjuvant Durvalumab|Death|0
7520390|NCT02904954|26114868|P2|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
7520391|NCT02904954|26114869|P1|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
7520392|NCT02904954|26114868|P2|Adjuvant Durvalumab|Physician Decision|1
7520393|NCT02904954|26114869|P1|Adjuvant Durvalumab|Physician Decision|2
7520394|NCT02904954|26114868|P2|Adjuvant Durvalumab|Participant wishes|5
7520395|NCT02904954|26114869|P1|Adjuvant Durvalumab|Participant wishes|12
7520396|NCT02904954|26114868|P2|Adjuvant Durvalumab|Adverse Event|6
7520397|NCT02904954|26114869|P1|Adjuvant Durvalumab|Adverse Event|2
7520398|NCT02904954|26114868|P2|Adjuvant Durvalumab|Recurrence|0
7520399|NCT02904954|26114869|P1|Adjuvant Durvalumab|Recurrence|2
7520400|NCT02904954|26114868|P2|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
7520401|NCT02904954|26114869|P1|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
7520402|NCT02904954|26114868|P2|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
7520403|NCT02904954|26114869|P1|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
7520404|NCT02904954|26114868|P2|Neoadjuvant (Preoperative) to Surgery|Death|1
7520405|NCT02904954|26114869|P1|Neoadjuvant (Preoperative) to Surgery|Death|1
7520406|NCT02904902|26114890|P1|Overall Study|Withdrawal by Subject|1
7520407|NCT02904512|26114899|P2|Overall Study|Minor Bleeding at site of device insertion|0
7520408|NCT02904512|26114900|P1|Overall Study|Minor Bleeding at site of device insertion|1
7520409|NCT02904512|26114899|P2|Overall Study|Transferred to ICU|0
7520410|NCT02904512|26114900|P1|Overall Study|Transferred to ICU|1
7520411|NCT02904512|26114899|P2|Overall Study|Withdrawal by Subject|0
7520412|NCT02904512|26114900|P1|Overall Study|Withdrawal by Subject|1
7520413|NCT02904265|26114916|P2|Overall Study|Physician Decision|2
7520414|NCT02904265|26114917|P1|Overall Study|Physician Decision|1
7520415|NCT02904200|26115038|P2|Overall Study|Withdrawal by Subject|0
7520416|NCT02904200|26115039|P1|Overall Study|Withdrawal by Subject|1
7520417|NCT02904096|26115046|P2|Overall Study|Sponsor instructed|0
7520418|NCT02904096|26115047|P1|Overall Study|Sponsor instructed|1
7520419|NCT02904096|26115046|P2|Overall Study|Non-compliant|1
7520420|NCT02904096|26115047|P1|Overall Study|Non-compliant|3
7520421|NCT02904096|26115046|P2|Overall Study|Lost to Follow-up|17
7520422|NCT02904096|26115047|P1|Overall Study|Lost to Follow-up|10
7520423|NCT02904096|26115046|P2|Overall Study|Withdrawal by Subject|3
7520424|NCT02904096|26115047|P1|Overall Study|Withdrawal by Subject|4
7520425|NCT02904096|26115046|P2|Overall Study|Adverse Event|0
7520426|NCT02904096|26115047|P1|Overall Study|Adverse Event|1
7520427|NCT02903966|26115083|P2|Part B (Day 44 to 112)|Withdrawal by Subject|1
7520428|NCT02903966|26115084|P1|Part B (Day 44 to 112)|Withdrawal by Subject|0
7520429|NCT02903966|26115083|P2|Part B (Day 44 to 112)|Lack of Efficacy|1
7520430|NCT02903966|26115084|P1|Part B (Day 44 to 112)|Lack of Efficacy|0
7520431|NCT02903966|26115083|P2|Part A (Day 1 to 43)|Adverse Event|0
7520432|NCT02903966|26115084|P1|Part A (Day 1 to 43)|Adverse Event|1
7520505|NCT02903823|26115201|P1|Overall Study|Catheter dislodgement|1
7520506|NCT02903823|26115201|P1|Overall Study|Could not advance catheter|1
7520507|NCT02903823|26115201|P1|Overall Study|Physician Decision|5
7520508|NCT02903511|26115208|P2|Overall Study|Lost to Follow-up|2
7520509|NCT02903511|26115209|P1|Overall Study|Lost to Follow-up|3
7520510|NCT02903511|26115208|P2|Overall Study|Withdrawal by Subject|0
7520511|NCT02903511|26115209|P1|Overall Study|Withdrawal by Subject|1
7520512|NCT02903420|26115240|P1|Overall Study|Death|3
7520513|NCT02903368|26115294|P2|Overall Study|Not sprcified|0
7520514|NCT02903368|26115295|P1|Overall Study|Not sprcified|4
7520515|NCT02903238|26115311|P1|Overall Study|Lost to Follow-up|4
7520516|NCT02903030|26115337|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
7520517|NCT02903030|26115338|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
7520518|NCT02902965|26115356|P1|Overall Study|Withdrawal by Subject|10
7520519|NCT02902809|26115374|P1|Overall Study|Discontinuation of asthma program|28
7520521|NCT02901431|26115471|P13|Open Label Part|Withdrawal by Subject|1
7520522|NCT02901431|26115472|P12|Open Label Part|Withdrawal by Subject|3
7520523|NCT02901431|26115473|P11|Open Label Part|Withdrawal by Subject|7
7520524|NCT02901431|26115474|P10|Open Label Part|Withdrawal by Subject|5
7520525|NCT02901431|26115475|P9|Open Label Part|Withdrawal by Subject|6
7520526|NCT02901431|26115476|P8|Open Label Part|Withdrawal by Subject|0
7520527|NCT02901431|26115477|P7|Open Label Part|Withdrawal by Subject|0
7520528|NCT02901431|26115478|P6|Open Label Part|Withdrawal by Subject|0
7520529|NCT02901431|26115479|P5|Open Label Part|Withdrawal by Subject|0
7520530|NCT02901431|26115480|P4|Open Label Part|Withdrawal by Subject|0
7520531|NCT02901431|26115481|P3|Open Label Part|Withdrawal by Subject|0
7520532|NCT02901431|26115482|P2|Open Label Part|Withdrawal by Subject|0
7520533|NCT02901431|26115483|P1|Open Label Part|Withdrawal by Subject|0
7520534|NCT02901431|26115471|P13|Open Label Part|Study Terminated By Sponsor|0
7520535|NCT02901431|26115472|P12|Open Label Part|Study Terminated By Sponsor|31
7520536|NCT02901431|26115473|P11|Open Label Part|Study Terminated By Sponsor|21
7520537|NCT02901431|26115474|P10|Open Label Part|Study Terminated By Sponsor|12
7520538|NCT02901431|26115475|P9|Open Label Part|Study Terminated By Sponsor|35
7520539|NCT02901431|26115476|P8|Open Label Part|Study Terminated By Sponsor|0
7520540|NCT02901431|26115477|P7|Open Label Part|Study Terminated By Sponsor|0
7520541|NCT02901431|26115478|P6|Open Label Part|Study Terminated By Sponsor|0
7520542|NCT02901431|26115479|P5|Open Label Part|Study Terminated By Sponsor|0
7520543|NCT02901431|26115480|P4|Open Label Part|Study Terminated By Sponsor|0
7520544|NCT02901431|26115481|P3|Open Label Part|Study Terminated By Sponsor|0
7520545|NCT02901431|26115482|P2|Open Label Part|Study Terminated By Sponsor|0
7520546|NCT02901431|26115483|P1|Open Label Part|Study Terminated By Sponsor|0
7520547|NCT02901431|26115471|P13|Open Label Part|Physician Decision|0
7520548|NCT02901431|26115472|P12|Open Label Part|Physician Decision|0
7520549|NCT02901431|26115473|P11|Open Label Part|Physician Decision|0
7520550|NCT02901431|26115474|P10|Open Label Part|Physician Decision|1
7520551|NCT02901431|26115475|P9|Open Label Part|Physician Decision|1
7520552|NCT02901431|26115476|P8|Open Label Part|Physician Decision|0
7520553|NCT02901431|26115477|P7|Open Label Part|Physician Decision|0
7520554|NCT02901431|26115478|P6|Open Label Part|Physician Decision|0
7520555|NCT02901431|26115479|P5|Open Label Part|Physician Decision|0
7520556|NCT02901431|26115480|P4|Open Label Part|Physician Decision|0
7520557|NCT02901431|26115481|P3|Open Label Part|Physician Decision|0
7520558|NCT02901431|26115482|P2|Open Label Part|Physician Decision|0
7520559|NCT02901431|26115483|P1|Open Label Part|Physician Decision|0
7520560|NCT02901431|26115471|P13|Open Label Part|Lost to Follow-up|1
7520561|NCT02901431|26115472|P12|Open Label Part|Lost to Follow-up|1
7520562|NCT02901431|26115473|P11|Open Label Part|Lost to Follow-up|1
7520563|NCT02901431|26115474|P10|Open Label Part|Lost to Follow-up|2
7520564|NCT02901431|26115475|P9|Open Label Part|Lost to Follow-up|2
7520565|NCT02901431|26115476|P8|Open Label Part|Lost to Follow-up|0
7520566|NCT02901431|26115477|P7|Open Label Part|Lost to Follow-up|0
7520567|NCT02901431|26115478|P6|Open Label Part|Lost to Follow-up|0
7520568|NCT02901431|26115479|P5|Open Label Part|Lost to Follow-up|0
7520569|NCT02901431|26115480|P4|Open Label Part|Lost to Follow-up|0
7520570|NCT02901431|26115481|P3|Open Label Part|Lost to Follow-up|0
7520571|NCT02901431|26115482|P2|Open Label Part|Lost to Follow-up|0
7520572|NCT02901431|26115483|P1|Open Label Part|Lost to Follow-up|0
7520573|NCT02901431|26115471|P13|Open Label Part|Adverse Event|1
7520574|NCT02901431|26115472|P12|Open Label Part|Adverse Event|4
7520575|NCT02901431|26115473|P11|Open Label Part|Adverse Event|0
7520576|NCT02901431|26115474|P10|Open Label Part|Adverse Event|4
7520577|NCT02901431|26115475|P9|Open Label Part|Adverse Event|4
7520578|NCT02901431|26115476|P8|Open Label Part|Adverse Event|0
7520579|NCT02901431|26115477|P7|Open Label Part|Adverse Event|0
7520580|NCT02901431|26115478|P6|Open Label Part|Adverse Event|0
7520581|NCT02901431|26115479|P5|Open Label Part|Adverse Event|0
7520582|NCT02901431|26115480|P4|Open Label Part|Adverse Event|0
7520583|NCT02901431|26115481|P3|Open Label Part|Adverse Event|0
7520584|NCT02901431|26115482|P2|Open Label Part|Adverse Event|0
7520585|NCT02901431|26115483|P1|Open Label Part|Adverse Event|0
7520586|NCT02901431|26115471|P13|Main Treatment Part|Withdrawal by Subject|0
7520587|NCT02901431|26115472|P12|Main Treatment Part|Withdrawal by Subject|0
7520588|NCT02901431|26115473|P11|Main Treatment Part|Withdrawal by Subject|0
7520589|NCT02901431|26115474|P10|Main Treatment Part|Withdrawal by Subject|0
7520590|NCT02901431|26115475|P9|Main Treatment Part|Withdrawal by Subject|0
7520591|NCT02901431|26115476|P8|Main Treatment Part|Withdrawal by Subject|0
7520592|NCT02901431|26115477|P7|Main Treatment Part|Withdrawal by Subject|6
7520593|NCT02901431|26115478|P6|Main Treatment Part|Withdrawal by Subject|5
7520594|NCT02901431|26115479|P5|Main Treatment Part|Withdrawal by Subject|3
7520595|NCT02901431|26115480|P4|Main Treatment Part|Withdrawal by Subject|18
7520596|NCT02901431|26115481|P3|Main Treatment Part|Withdrawal by Subject|0
7520597|NCT02901431|26115482|P2|Main Treatment Part|Withdrawal by Subject|0
7520598|NCT02901431|26115483|P1|Main Treatment Part|Withdrawal by Subject|0
7520599|NCT02901431|26115471|P13|Main Treatment Part|Physician Decision|0
7520600|NCT02901431|26115472|P12|Main Treatment Part|Physician Decision|0
7520601|NCT02901431|26115473|P11|Main Treatment Part|Physician Decision|0
7520602|NCT02901431|26115474|P10|Main Treatment Part|Physician Decision|0
7520603|NCT02901431|26115475|P9|Main Treatment Part|Physician Decision|0
7520604|NCT02901431|26115476|P8|Main Treatment Part|Physician Decision|0
7520605|NCT02901431|26115477|P7|Main Treatment Part|Physician Decision|1
7520606|NCT02901431|26115478|P6|Main Treatment Part|Physician Decision|0
7520607|NCT02901431|26115479|P5|Main Treatment Part|Physician Decision|0
7520608|NCT02901431|26115480|P4|Main Treatment Part|Physician Decision|1
7520609|NCT02901431|26115481|P3|Main Treatment Part|Physician Decision|0
7520610|NCT02901431|26115482|P2|Main Treatment Part|Physician Decision|0
7520611|NCT02901431|26115483|P1|Main Treatment Part|Physician Decision|0
7520612|NCT02901431|26115471|P13|Main Treatment Part|Withdrawal by Caregiver|0
7520613|NCT02901431|26115472|P12|Main Treatment Part|Withdrawal by Caregiver|0
7520614|NCT02901431|26115473|P11|Main Treatment Part|Withdrawal by Caregiver|0
7520615|NCT02901431|26115474|P10|Main Treatment Part|Withdrawal by Caregiver|0
7520616|NCT02901431|26115475|P9|Main Treatment Part|Withdrawal by Caregiver|0
7520617|NCT02901431|26115476|P8|Main Treatment Part|Withdrawal by Caregiver|0
7520618|NCT02901431|26115477|P7|Main Treatment Part|Withdrawal by Caregiver|0
7520619|NCT02901431|26115478|P6|Main Treatment Part|Withdrawal by Caregiver|1
7520620|NCT02901431|26115479|P5|Main Treatment Part|Withdrawal by Caregiver|0
7520621|NCT02901431|26115480|P4|Main Treatment Part|Withdrawal by Caregiver|0
7520622|NCT02901431|26115481|P3|Main Treatment Part|Withdrawal by Caregiver|0
7520623|NCT02901431|26115482|P2|Main Treatment Part|Withdrawal by Caregiver|0
7520624|NCT02901431|26115483|P1|Main Treatment Part|Withdrawal by Caregiver|0
7520625|NCT02901431|26115471|P13|Main Treatment Part|Lost to Follow-up|0
7520626|NCT02901431|26115472|P12|Main Treatment Part|Lost to Follow-up|0
7520627|NCT02901431|26115473|P11|Main Treatment Part|Lost to Follow-up|0
7520628|NCT02901431|26115474|P10|Main Treatment Part|Lost to Follow-up|0
7520629|NCT02901431|26115475|P9|Main Treatment Part|Lost to Follow-up|0
7520630|NCT02901431|26115476|P8|Main Treatment Part|Lost to Follow-up|0
7520631|NCT02901431|26115477|P7|Main Treatment Part|Lost to Follow-up|3
7520632|NCT02901431|26115478|P6|Main Treatment Part|Lost to Follow-up|2
7520633|NCT02901431|26115479|P5|Main Treatment Part|Lost to Follow-up|1
7520634|NCT02901431|26115480|P4|Main Treatment Part|Lost to Follow-up|3
7520635|NCT02901431|26115481|P3|Main Treatment Part|Lost to Follow-up|0
7520636|NCT02901431|26115482|P2|Main Treatment Part|Lost to Follow-up|0
7520637|NCT02901431|26115483|P1|Main Treatment Part|Lost to Follow-up|0
7520638|NCT02901431|26115471|P13|Main Treatment Part|Lack of Efficacy|0
7520639|NCT02901431|26115472|P12|Main Treatment Part|Lack of Efficacy|0
7520640|NCT02901431|26115473|P11|Main Treatment Part|Lack of Efficacy|0
7520641|NCT02901431|26115474|P10|Main Treatment Part|Lack of Efficacy|0
7520642|NCT02901431|26115475|P9|Main Treatment Part|Lack of Efficacy|0
7520643|NCT02901431|26115476|P8|Main Treatment Part|Lack of Efficacy|0
7520644|NCT02901431|26115477|P7|Main Treatment Part|Lack of Efficacy|0
7520645|NCT02901431|26115478|P6|Main Treatment Part|Lack of Efficacy|0
7520646|NCT02901431|26115479|P5|Main Treatment Part|Lack of Efficacy|0
7520647|NCT02901431|26115480|P4|Main Treatment Part|Lack of Efficacy|1
7520648|NCT02901431|26115481|P3|Main Treatment Part|Lack of Efficacy|0
7520649|NCT02901431|26115482|P2|Main Treatment Part|Lack of Efficacy|0
7520650|NCT02901431|26115483|P1|Main Treatment Part|Lack of Efficacy|0
7520651|NCT02901431|26115471|P13|Main Treatment Part|Adverse Event|0
7520652|NCT02901431|26115472|P12|Main Treatment Part|Adverse Event|0
7520653|NCT02901431|26115473|P11|Main Treatment Part|Adverse Event|0
7520654|NCT02901431|26115474|P10|Main Treatment Part|Adverse Event|0
7520655|NCT02901431|26115475|P9|Main Treatment Part|Adverse Event|0
7520656|NCT02901431|26115476|P8|Main Treatment Part|Adverse Event|0
7520657|NCT02901431|26115477|P7|Main Treatment Part|Adverse Event|1
7520658|NCT02901431|26115478|P6|Main Treatment Part|Adverse Event|4
7520659|NCT02901431|26115479|P5|Main Treatment Part|Adverse Event|3
7520660|NCT02901431|26115480|P4|Main Treatment Part|Adverse Event|3
7520661|NCT02901431|26115481|P3|Main Treatment Part|Adverse Event|0
7520662|NCT02901431|26115482|P2|Main Treatment Part|Adverse Event|0
7520663|NCT02901431|26115483|P1|Main Treatment Part|Adverse Event|0
7520664|NCT02901431|26115471|P13|PK Part|Withdrawal by Subject|0
7520665|NCT02901431|26115472|P12|PK Part|Withdrawal by Subject|0
7520666|NCT02901431|26115473|P11|PK Part|Withdrawal by Subject|0
7520667|NCT02901431|26115474|P10|PK Part|Withdrawal by Subject|0
7520668|NCT02901431|26115475|P9|PK Part|Withdrawal by Subject|0
7520669|NCT02901431|26115476|P8|PK Part|Withdrawal by Subject|0
7520670|NCT02901431|26115477|P7|PK Part|Withdrawal by Subject|0
7520671|NCT02901431|26115478|P6|PK Part|Withdrawal by Subject|0
7520672|NCT02901431|26115479|P5|PK Part|Withdrawal by Subject|0
7520673|NCT02901431|26115480|P4|PK Part|Withdrawal by Subject|0
7520674|NCT02901431|26115481|P3|PK Part|Withdrawal by Subject|3
7520675|NCT02901431|26115482|P2|PK Part|Withdrawal by Subject|1
7520676|NCT02901431|26115483|P1|PK Part|Withdrawal by Subject|1
7520677|NCT02901431|26115471|P13|PK Part|Discontinued per Sponsor|0
7520678|NCT02901431|26115472|P12|PK Part|Discontinued per Sponsor|0
7520679|NCT02901431|26115473|P11|PK Part|Discontinued per Sponsor|0
7520680|NCT02901431|26115474|P10|PK Part|Discontinued per Sponsor|0
7520681|NCT02901431|26115475|P9|PK Part|Discontinued per Sponsor|0
7520682|NCT02901431|26115476|P8|PK Part|Discontinued per Sponsor|0
7520683|NCT02901431|26115477|P7|PK Part|Discontinued per Sponsor|0
7520684|NCT02901431|26115478|P6|PK Part|Discontinued per Sponsor|0
7520685|NCT02901431|26115479|P5|PK Part|Discontinued per Sponsor|0
7520686|NCT02901431|26115480|P4|PK Part|Discontinued per Sponsor|0
7520687|NCT02901431|26115481|P3|PK Part|Discontinued per Sponsor|0
7520688|NCT02901431|26115482|P2|PK Part|Discontinued per Sponsor|3
7520689|NCT02901431|26115483|P1|PK Part|Discontinued per Sponsor|0
7520690|NCT02901431|26115471|P13|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520691|NCT02901431|26115472|P12|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520692|NCT02901431|26115473|P11|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520693|NCT02901431|26115474|P10|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520694|NCT02901431|26115475|P9|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520695|NCT02901431|26115476|P8|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520696|NCT02901431|26115477|P7|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520697|NCT02901431|26115478|P6|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520698|NCT02901431|26115479|P5|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520699|NCT02901431|26115480|P4|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520700|NCT02901431|26115481|P3|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
7520701|NCT02901431|26115482|P2|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7520702|NCT02901431|26115483|P1|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
7520703|NCT02901431|26115471|P13|PK Part|Stopped treatment after 8 weeks|0
7520704|NCT02901431|26115472|P12|PK Part|Stopped treatment after 8 weeks|0
7520705|NCT02901431|26115473|P11|PK Part|Stopped treatment after 8 weeks|0
7520706|NCT02901431|26115474|P10|PK Part|Stopped treatment after 8 weeks|0
7520707|NCT02901431|26115475|P9|PK Part|Stopped treatment after 8 weeks|0
7520708|NCT02901431|26115476|P8|PK Part|Stopped treatment after 8 weeks|0
7520709|NCT02901431|26115477|P7|PK Part|Stopped treatment after 8 weeks|0
7520710|NCT02901431|26115478|P6|PK Part|Stopped treatment after 8 weeks|0
7520711|NCT02901431|26115479|P5|PK Part|Stopped treatment after 8 weeks|0
7520712|NCT02901431|26115480|P4|PK Part|Stopped treatment after 8 weeks|0
7520713|NCT02901431|26115481|P3|PK Part|Stopped treatment after 8 weeks|1
7520714|NCT02901431|26115482|P2|PK Part|Stopped treatment after 8 weeks|0
7520715|NCT02901431|26115483|P1|PK Part|Stopped treatment after 8 weeks|1
7520716|NCT02901431|26115471|P13|PK Part|8 weeks of treatment ran out|0
7520717|NCT02901431|26115472|P12|PK Part|8 weeks of treatment ran out|0
7520718|NCT02901431|26115473|P11|PK Part|8 weeks of treatment ran out|0
7520719|NCT02901431|26115474|P10|PK Part|8 weeks of treatment ran out|0
7520720|NCT02901431|26115475|P9|PK Part|8 weeks of treatment ran out|0
7520721|NCT02901431|26115476|P8|PK Part|8 weeks of treatment ran out|0
7520722|NCT02901431|26115477|P7|PK Part|8 weeks of treatment ran out|0
7520723|NCT02901431|26115478|P6|PK Part|8 weeks of treatment ran out|0
7520724|NCT02901431|26115479|P5|PK Part|8 weeks of treatment ran out|0
7520725|NCT02901431|26115480|P4|PK Part|8 weeks of treatment ran out|0
7520726|NCT02901431|26115481|P3|PK Part|8 weeks of treatment ran out|0
7520727|NCT02901431|26115482|P2|PK Part|8 weeks of treatment ran out|0
7520728|NCT02901431|26115483|P1|PK Part|8 weeks of treatment ran out|2
7520729|NCT02901431|26115471|P13|PK Part|Pending dose confirmation|0
7520730|NCT02901431|26115472|P12|PK Part|Pending dose confirmation|0
7520731|NCT02901431|26115473|P11|PK Part|Pending dose confirmation|0
7520732|NCT02901431|26115474|P10|PK Part|Pending dose confirmation|0
7520733|NCT02901431|26115475|P9|PK Part|Pending dose confirmation|0
7520734|NCT02901431|26115476|P8|PK Part|Pending dose confirmation|0
7520735|NCT02901431|26115477|P7|PK Part|Pending dose confirmation|0
7520736|NCT02901431|26115478|P6|PK Part|Pending dose confirmation|0
7520737|NCT02901431|26115479|P5|PK Part|Pending dose confirmation|0
7520738|NCT02901431|26115480|P4|PK Part|Pending dose confirmation|0
7520739|NCT02901431|26115481|P3|PK Part|Pending dose confirmation|0
7520740|NCT02901431|26115482|P2|PK Part|Pending dose confirmation|1
7520741|NCT02901431|26115483|P1|PK Part|Pending dose confirmation|0
7520742|NCT02901431|26115471|P13|PK Part|Pending IMC/SOC Dose Confirmation|0
7520743|NCT02901431|26115472|P12|PK Part|Pending IMC/SOC Dose Confirmation|0
7520744|NCT02901431|26115473|P11|PK Part|Pending IMC/SOC Dose Confirmation|0
7520745|NCT02901431|26115474|P10|PK Part|Pending IMC/SOC Dose Confirmation|0
7520746|NCT02901431|26115475|P9|PK Part|Pending IMC/SOC Dose Confirmation|0
7520747|NCT02901431|26115476|P8|PK Part|Pending IMC/SOC Dose Confirmation|0
7520748|NCT02901431|26115477|P7|PK Part|Pending IMC/SOC Dose Confirmation|0
7520749|NCT02901431|26115478|P6|PK Part|Pending IMC/SOC Dose Confirmation|0
7520750|NCT02901431|26115479|P5|PK Part|Pending IMC/SOC Dose Confirmation|0
7520751|NCT02901431|26115480|P4|PK Part|Pending IMC/SOC Dose Confirmation|0
7520752|NCT02901431|26115481|P3|PK Part|Pending IMC/SOC Dose Confirmation|0
7520753|NCT02901431|26115482|P2|PK Part|Pending IMC/SOC Dose Confirmation|0
7520754|NCT02901431|26115483|P1|PK Part|Pending IMC/SOC Dose Confirmation|2
7520755|NCT02901431|26115471|P13|PK Part|Lost to Follow-up|0
7520756|NCT02901431|26115472|P12|PK Part|Lost to Follow-up|0
7520757|NCT02901431|26115473|P11|PK Part|Lost to Follow-up|0
7520758|NCT02901431|26115474|P10|PK Part|Lost to Follow-up|0
7520759|NCT02901431|26115475|P9|PK Part|Lost to Follow-up|0
7520760|NCT02901431|26115476|P8|PK Part|Lost to Follow-up|0
7520761|NCT02901431|26115477|P7|PK Part|Lost to Follow-up|0
7520762|NCT02901431|26115478|P6|PK Part|Lost to Follow-up|0
7520763|NCT02901431|26115479|P5|PK Part|Lost to Follow-up|0
7520764|NCT02901431|26115480|P4|PK Part|Lost to Follow-up|0
7520765|NCT02901431|26115481|P3|PK Part|Lost to Follow-up|1
7520766|NCT02901431|26115482|P2|PK Part|Lost to Follow-up|0
7520767|NCT02901431|26115483|P1|PK Part|Lost to Follow-up|0
7520768|NCT02901431|26115471|P13|PK Part|Adverse Event|0
7520769|NCT02901431|26115472|P12|PK Part|Adverse Event|0
7520770|NCT02901431|26115473|P11|PK Part|Adverse Event|0
7520771|NCT02901431|26115474|P10|PK Part|Adverse Event|0
7520772|NCT02901431|26115475|P9|PK Part|Adverse Event|0
7520773|NCT02901431|26115476|P8|PK Part|Adverse Event|0
7520774|NCT02901431|26115477|P7|PK Part|Adverse Event|0
7520775|NCT02901431|26115478|P6|PK Part|Adverse Event|0
7520776|NCT02901431|26115479|P5|PK Part|Adverse Event|0
7520777|NCT02901431|26115480|P4|PK Part|Adverse Event|0
7520778|NCT02901431|26115481|P3|PK Part|Adverse Event|0
7520779|NCT02901431|26115482|P2|PK Part|Adverse Event|1
7520780|NCT02901431|26115483|P1|PK Part|Adverse Event|0
7520781|NCT02901054|26115563|P1|Overall Study|Withdrawal by Subject|3
7520782|NCT02901054|26115563|P1|Overall Study|Physician Decision|1
7520783|NCT02900378|26115578|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
7520784|NCT02900378|26115579|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
7520785|NCT02900378|26115578|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
7520786|NCT02900378|26115579|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
7520787|NCT02900378|26115578|P2|Randomization (Visit 2)|Protocol Deviation|7
7520788|NCT02900378|26115579|P1|Randomization (Visit 2)|Protocol Deviation|1
7520789|NCT02900378|26115578|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
7520790|NCT02900378|26115579|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
7520791|NCT02900378|26115578|P2|Randomization (Visit 2)|Lost to Follow-up|0
7520792|NCT02900378|26115579|P1|Randomization (Visit 2)|Lost to Follow-up|1
7520793|NCT02900378|26115578|P2|Randomization (Visit 2)|Death|4
7520794|NCT02900378|26115579|P1|Randomization (Visit 2)|Death|1
7520795|NCT02900378|26115578|P2|Randomization (Visit 2)|Adverse Event|11
7520796|NCT02900378|26115579|P1|Randomization (Visit 2)|Adverse Event|14
7520797|NCT02900170|26115623|P1|Overall Study|Lost to Follow-up|8
7520798|NCT02900092|26115627|P1|Overall Study|Adverse Event|1
7520799|NCT02899988|26115635|P11|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7520800|NCT02899988|26115636|P10|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7520801|NCT02899988|26115637|P9|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7520802|NCT02899988|26115638|P8|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7520803|NCT02899988|26115639|P7|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
7520804|NCT02899988|26115640|P6|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7520805|NCT02899988|26115641|P5|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7520806|NCT02899988|26115642|P4|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7520807|NCT02899988|26115643|P3|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7520808|NCT02899988|26115644|P2|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7520809|NCT02899988|26115645|P1|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7520810|NCT02899988|26115635|P11|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520811|NCT02899988|26115636|P10|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520812|NCT02899988|26115637|P9|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520813|NCT02899988|26115638|P8|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7520814|NCT02899988|26115639|P7|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520815|NCT02899988|26115640|P6|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7520816|NCT02899988|26115641|P5|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520817|NCT02899988|26115642|P4|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520818|NCT02899988|26115643|P3|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520819|NCT02899988|26115644|P2|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520820|NCT02899988|26115645|P1|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7520821|NCT02899988|26115635|P11|Maintenance Period (88 Weeks)|Adverse Event|1
7520822|NCT02899988|26115636|P10|Maintenance Period (88 Weeks)|Adverse Event|2
7520823|NCT02899988|26115637|P9|Maintenance Period (88 Weeks)|Adverse Event|2
7520824|NCT02899988|26115638|P8|Maintenance Period (88 Weeks)|Adverse Event|2
7520825|NCT02899988|26115639|P7|Maintenance Period (88 Weeks)|Adverse Event|1
7520826|NCT02899988|26115640|P6|Maintenance Period (88 Weeks)|Adverse Event|2
7520827|NCT02899988|26115641|P5|Maintenance Period (88 Weeks)|Adverse Event|1
7520828|NCT02899988|26115642|P4|Maintenance Period (88 Weeks)|Adverse Event|0
7520829|NCT02899988|26115643|P3|Maintenance Period (88 Weeks)|Adverse Event|0
7520830|NCT02899988|26115644|P2|Maintenance Period (88 Weeks)|Adverse Event|0
7520831|NCT02899988|26115645|P1|Maintenance Period (88 Weeks)|Adverse Event|0
7520832|NCT02899988|26115635|P11|Induction Period (16 Weeks)|Physician Decision|0
7520833|NCT02899988|26115636|P10|Induction Period (16 Weeks)|Physician Decision|0
7520834|NCT02899988|26115637|P9|Induction Period (16 Weeks)|Physician Decision|0
7520835|NCT02899988|26115638|P8|Induction Period (16 Weeks)|Physician Decision|0
7520836|NCT02899988|26115639|P7|Induction Period (16 Weeks)|Physician Decision|0
7520837|NCT02899988|26115640|P6|Induction Period (16 Weeks)|Physician Decision|0
7520838|NCT02899988|26115641|P5|Induction Period (16 Weeks)|Physician Decision|0
7520839|NCT02899988|26115642|P4|Induction Period (16 Weeks)|Physician Decision|0
7520840|NCT02899988|26115643|P3|Induction Period (16 Weeks)|Physician Decision|0
7520841|NCT02899988|26115644|P2|Induction Period (16 Weeks)|Physician Decision|1
7520842|NCT02899988|26115645|P1|Induction Period (16 Weeks)|Physician Decision|0
7520843|NCT02899988|26115635|P11|Induction Period (16 Weeks)|Adverse Event|0
7520844|NCT02899988|26115636|P10|Induction Period (16 Weeks)|Adverse Event|0
7520845|NCT02899988|26115637|P9|Induction Period (16 Weeks)|Adverse Event|0
7520846|NCT02899988|26115638|P8|Induction Period (16 Weeks)|Adverse Event|0
7520847|NCT02899988|26115639|P7|Induction Period (16 Weeks)|Adverse Event|0
7520848|NCT02899988|26115640|P6|Induction Period (16 Weeks)|Adverse Event|0
7520849|NCT02899988|26115641|P5|Induction Period (16 Weeks)|Adverse Event|0
7520850|NCT02899988|26115642|P4|Induction Period (16 Weeks)|Adverse Event|2
7520851|NCT02899988|26115643|P3|Induction Period (16 Weeks)|Adverse Event|0
7520852|NCT02899988|26115644|P2|Induction Period (16 Weeks)|Adverse Event|0
7520853|NCT02899988|26115645|P1|Induction Period (16 Weeks)|Adverse Event|0
7520854|NCT02899988|26115635|P11|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520855|NCT02899988|26115636|P10|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520856|NCT02899988|26115637|P9|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520857|NCT02899988|26115638|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520858|NCT02899988|26115639|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520859|NCT02899988|26115640|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520860|NCT02899988|26115641|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520861|NCT02899988|26115642|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520862|NCT02899988|26115643|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
7520863|NCT02899988|26115644|P2|Induction Period (16 Weeks)|Withdrawal by Subject|1
7520864|NCT02899988|26115645|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
7520865|NCT02899962|26115704|P3|Maintenance Phase|Withdrawal by Subject|36
7520866|NCT02899962|26115705|P2|Maintenance Phase|Withdrawal by Subject|30
7520867|NCT02899962|26115706|P1|Maintenance Phase|Withdrawal by Subject|0
7520868|NCT02899962|26115704|P3|Maintenance Phase|Not clear/almost clear after rescue med|70
7520869|NCT02899962|26115705|P2|Maintenance Phase|Not clear/almost clear after rescue med|65
7520870|NCT02899962|26115706|P1|Maintenance Phase|Not clear/almost clear after rescue med|0
7520871|NCT02899962|26115704|P3|Maintenance Phase|Not achieve treatment success after Wk 4|2
7520872|NCT02899962|26115705|P2|Maintenance Phase|Not achieve treatment success after Wk 4|3
7520873|NCT02899962|26115706|P1|Maintenance Phase|Not achieve treatment success after Wk 4|0
7520874|NCT02899962|26115704|P3|Maintenance Phase|Other reasons|13
7520875|NCT02899962|26115705|P2|Maintenance Phase|Other reasons|9
7520876|NCT02899962|26115706|P1|Maintenance Phase|Other reasons|0
7520877|NCT02899962|26115704|P3|Maintenance Phase|Lost to Follow-up|14
7520878|NCT02899962|26115705|P2|Maintenance Phase|Lost to Follow-up|12
7520879|NCT02899962|26115706|P1|Maintenance Phase|Lost to Follow-up|0
7520880|NCT02899962|26115704|P3|Maintenance Phase|Lack of Efficacy|16
7520881|NCT02899962|26115705|P2|Maintenance Phase|Lack of Efficacy|20
7520882|NCT02899962|26115706|P1|Maintenance Phase|Lack of Efficacy|0
7520883|NCT02899962|26115704|P3|Maintenance Phase|Death|1
7520884|NCT02899962|26115705|P2|Maintenance Phase|Death|0
7520885|NCT02899962|26115706|P1|Maintenance Phase|Death|0
7520886|NCT02899962|26115704|P3|Maintenance Phase|Adverse Event|1
7520887|NCT02899962|26115705|P2|Maintenance Phase|Adverse Event|2
7520888|NCT02899962|26115706|P1|Maintenance Phase|Adverse Event|0
7520889|NCT02899962|26115704|P3|Open-label Phase|Withdrawal by Subject|0
7520890|NCT02899962|26115705|P2|Open-label Phase|Withdrawal by Subject|0
7520891|NCT02899962|26115706|P1|Open-label Phase|Withdrawal by Subject|7
7520892|NCT02899962|26115704|P3|Open-label Phase|Other reasons|0
7520893|NCT02899962|26115705|P2|Open-label Phase|Other reasons|0
7520894|NCT02899962|26115706|P1|Open-label Phase|Other reasons|9
7520895|NCT02899962|26115704|P3|Open-label Phase|Lost to Follow-up|0
7520896|NCT02899962|26115705|P2|Open-label Phase|Lost to Follow-up|0
7520897|NCT02899962|26115706|P1|Open-label Phase|Lost to Follow-up|9
7520898|NCT02899962|26115704|P3|Open-label Phase|Adverse Event|0
7520899|NCT02899962|26115705|P2|Open-label Phase|Adverse Event|0
7520900|NCT02899962|26115706|P1|Open-label Phase|Adverse Event|2
7520901|NCT02899728|26115731|P2|Overall Study|Withdrawal by Subject|1
7520902|NCT02899728|26115732|P1|Overall Study|Withdrawal by Subject|1
7520903|NCT02899377|26115789|P2|Overall Study|Adverse Event|0
7520904|NCT02899377|26115790|P1|Overall Study|Adverse Event|1
7520905|NCT02899338|26115823|P2|Overall Study|Withdrawal by Subject|0
7520906|NCT02899338|26115824|P1|Overall Study|Withdrawal by Subject|2
7520907|NCT02899338|26115823|P2|Overall Study|Adverse Event|2
7520908|NCT02899338|26115824|P1|Overall Study|Adverse Event|1
7520909|NCT02899299|26115838|P2|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
7520910|NCT02899299|26115839|P1|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
7520911|NCT02899299|26115838|P2|Treatment|Other reasons|2
7520912|NCT02899299|26115839|P1|Treatment|Other reasons|11
7520913|NCT02899299|26115838|P2|Treatment|Administrative reason by Sponsor|0
7520914|NCT02899299|26115839|P1|Treatment|Administrative reason by Sponsor|2
7520915|NCT02899299|26115838|P2|Treatment|Participant no longer meets Study criteria|0
7520916|NCT02899299|26115839|P1|Treatment|Participant no longer meets Study criteria|4
7520917|NCT02899299|26115838|P2|Treatment|Poor/Non-compliance|0
7520918|NCT02899299|26115839|P1|Treatment|Poor/Non-compliance|1
7520919|NCT02899299|26115838|P2|Treatment|Maximum Clinical Benefit|2
7520920|NCT02899299|26115839|P1|Treatment|Maximum Clinical Benefit|10
7520921|NCT02899299|26115838|P2|Treatment|Lost to Follow-up|1
7520922|NCT02899299|26115839|P1|Treatment|Lost to Follow-up|0
7520923|NCT02899299|26115838|P2|Treatment|Participant withdrew consent|3
7520924|NCT02899299|26115839|P1|Treatment|Participant withdrew consent|6
7520925|NCT02899299|26115838|P2|Treatment|Participant request to discontinue Study treatment|10
7520926|NCT02899299|26115839|P1|Treatment|Participant request to discontinue Study treatment|4
7520927|NCT02899299|26115838|P2|Treatment|Adverse Event unrelated to Study Drug|9
7520928|NCT02899299|26115839|P1|Treatment|Adverse Event unrelated to Study Drug|12
7520929|NCT02899299|26115838|P2|Treatment|Study Drug Toxicity|24
7520930|NCT02899299|26115839|P1|Treatment|Study Drug Toxicity|59
7520931|NCT02899299|26115838|P2|Treatment|Disease Progression|44
7520932|NCT02899299|26115839|P1|Treatment|Disease Progression|182
7520933|NCT02899299|26115838|P2|Pre-treatment|Not reported|1
7520934|NCT02899299|26115839|P1|Pre-treatment|Not reported|0
7520935|NCT02899299|26115838|P2|Pre-treatment|Participant no longer meets study criteria|3
7520936|NCT02899299|26115839|P1|Pre-treatment|Participant no longer meets study criteria|2
7520937|NCT02899299|26115838|P2|Pre-treatment|Participant withdrew consent|11
7520938|NCT02899299|26115839|P1|Pre-treatment|Participant withdrew consent|1
7520939|NCT02899299|26115838|P2|Pre-treatment|Participant request to discontinue study treatment|3
7520940|NCT02899299|26115839|P1|Pre-treatment|Participant request to discontinue study treatment|0
7520941|NCT02899195|26115857|P1|Maintenance Durvalumab|Progressive Disease|31
7520942|NCT02899195|26115857|P1|Maintenance Durvalumab|Withdrawal by Subject|1
7520943|NCT02899195|26115857|P1|Maintenance Durvalumab|Physician Decision|1
7520944|NCT02899195|26115857|P1|Maintenance Durvalumab|Adverse Event|1
7520945|NCT02899195|26115857|P1|Concurrent Durvalumab|Progressive Disease|5
7520946|NCT02899195|26115857|P1|Concurrent Durvalumab|Withdrawal by Subject|1
7520947|NCT02899195|26115857|P1|Concurrent Durvalumab|Physician Decision|1
7520948|NCT02899195|26115857|P1|Concurrent Durvalumab|Adverse Event|4
7520949|NCT02899156|26115867|P2|Overall Study|Physician Decision|1
7520950|NCT02899156|26115868|P1|Overall Study|Physician Decision|0
7520951|NCT02899156|26115867|P2|Overall Study|Death|0
7520952|NCT02899156|26115868|P1|Overall Study|Death|1
7520953|NCT02898662|26115910|P2|Overall Study|Other|1
7520954|NCT02898662|26115911|P1|Overall Study|Other|0
7520955|NCT02898662|26115910|P2|Overall Study|Subject decision|0
7520956|NCT02898662|26115911|P1|Overall Study|Subject decision|1
7520957|NCT02898662|26115910|P2|Overall Study|Randomized in error|1
7520958|NCT02898662|26115911|P1|Overall Study|Randomized in error|0
7520959|NCT02898662|26115910|P2|Overall Study|Technical issue|1
7520960|NCT02898662|26115911|P1|Overall Study|Technical issue|0
7520961|NCT02898662|26115910|P2|Overall Study|Withdrawal by Subject|1
7520962|NCT02898662|26115911|P1|Overall Study|Withdrawal by Subject|4
7520963|NCT02898662|26115910|P2|Overall Study|Loss of asthma control|24
7520964|NCT02898662|26115911|P1|Overall Study|Loss of asthma control|23
7520965|NCT02898662|26115910|P2|Overall Study|Adverse Event|0
7520966|NCT02898662|26115911|P1|Overall Study|Adverse Event|1
7520967|NCT02898597|26115935|P2|Overall Study|Death|1
7520968|NCT02898597|26115936|P1|Overall Study|Death|0
7520969|NCT02898597|26115935|P2|Overall Study|Lost to Follow-up|9
7520970|NCT02898597|26115936|P1|Overall Study|Lost to Follow-up|0
7520971|NCT02898597|26115935|P2|Overall Study|Protocol Violation|2
7520972|NCT02898597|26115936|P1|Overall Study|Protocol Violation|4
7520973|NCT02898454|26115945|P3|Overall Study|Did Not Met Eligibility Criteria|0
7520974|NCT02898454|26115946|P2|Overall Study|Did Not Met Eligibility Criteria|0
7520975|NCT02898454|26115947|P1|Overall Study|Did Not Met Eligibility Criteria|1
7520976|NCT02898454|26115945|P3|Overall Study|Lost to Follow-up|0
7520977|NCT02898454|26115946|P2|Overall Study|Lost to Follow-up|0
7520978|NCT02898454|26115947|P1|Overall Study|Lost to Follow-up|1
7520979|NCT02898454|26115945|P3|Overall Study|Withdrawal by Subject|3
7520980|NCT02898454|26115946|P2|Overall Study|Withdrawal by Subject|3
7520981|NCT02898454|26115947|P1|Overall Study|Withdrawal by Subject|6
7520982|NCT02898454|26115945|P3|Overall Study|Lack of Efficacy|0
7520983|NCT02898454|26115946|P2|Overall Study|Lack of Efficacy|1
7520984|NCT02898454|26115947|P1|Overall Study|Lack of Efficacy|4
7520985|NCT02898454|26115945|P3|Overall Study|Protocol Violation|1
7520986|NCT02898454|26115946|P2|Overall Study|Protocol Violation|0
7520987|NCT02898454|26115947|P1|Overall Study|Protocol Violation|1
7520988|NCT02898454|26115945|P3|Overall Study|Adverse Event|2
7520989|NCT02898454|26115946|P2|Overall Study|Adverse Event|1
7520990|NCT02898454|26115947|P1|Overall Study|Adverse Event|4
7520991|NCT02898259|26116065|P5|Overall Study|Transformation before study began|0
7520992|NCT02898259|26116066|P4|Overall Study|Transformation before study began|1
7520993|NCT02898259|26116067|P3|Overall Study|Transformation before study began|0
7520994|NCT02898259|26116068|P2|Overall Study|Transformation before study began|0
7520995|NCT02898259|26116069|P1|Overall Study|Transformation before study began|0
7520996|NCT02898259|26116065|P5|Overall Study|Lost to Follow-up|0
7520997|NCT02898259|26116066|P4|Overall Study|Lost to Follow-up|0
7520998|NCT02898259|26116067|P3|Overall Study|Lost to Follow-up|1
7520999|NCT02898259|26116068|P2|Overall Study|Lost to Follow-up|0
7521000|NCT02898259|26116069|P1|Overall Study|Lost to Follow-up|0
7521001|NCT02898259|26116065|P5|Overall Study|Lack of Efficacy|0
7521002|NCT02898259|26116066|P4|Overall Study|Lack of Efficacy|0
7521003|NCT02898259|26116067|P3|Overall Study|Lack of Efficacy|3
7521004|NCT02898259|26116068|P2|Overall Study|Lack of Efficacy|1
7521005|NCT02898259|26116069|P1|Overall Study|Lack of Efficacy|1
7521006|NCT02898259|26116065|P5|Overall Study|Adverse Event|0
7521007|NCT02898259|26116066|P4|Overall Study|Adverse Event|0
7521008|NCT02898259|26116067|P3|Overall Study|Adverse Event|1
7521009|NCT02898259|26116068|P2|Overall Study|Adverse Event|0
7521010|NCT02898259|26116069|P1|Overall Study|Adverse Event|0
7521011|NCT02898116|26116077|P1|Overall Study|Progressive disease|1
7521012|NCT02898116|26116077|P1|Overall Study|Adverse Event|1
7521013|NCT02898077|26116106|P2|Overall Study|On Study Treatment|3
7521014|NCT02898077|26116107|P1|Overall Study|On Study Treatment|5
7521015|NCT02898077|26116106|P2|Overall Study|Protocol Deviation|0
7521016|NCT02898077|26116107|P1|Overall Study|Protocol Deviation|3
7521017|NCT02898077|26116106|P2|Overall Study|Non-compliance With Study Drug|2
7521018|NCT02898077|26116107|P1|Overall Study|Non-compliance With Study Drug|3
7521019|NCT02898077|26116106|P2|Overall Study|Physician Decision|4
7521020|NCT02898077|26116107|P1|Overall Study|Physician Decision|12
7521021|NCT02898077|26116106|P2|Overall Study|Withdrawal by Subject|14
7521022|NCT02898077|26116107|P1|Overall Study|Withdrawal by Subject|51
7521023|NCT02898077|26116106|P2|Overall Study|Adverse Event|7
7521024|NCT02898077|26116107|P1|Overall Study|Adverse Event|21
7521025|NCT02897349|26116131|P2|Overall Study|Other than listed above|1
7521026|NCT02897349|26116132|P1|Overall Study|Other than listed above|0
7521027|NCT02897349|26116131|P2|Overall Study|Adverse Event|3
7521028|NCT02897349|26116132|P1|Overall Study|Adverse Event|3
7521029|NCT02897349|26116131|P2|Overall Study|Lost to Follow-up|2
7521030|NCT02897349|26116132|P1|Overall Study|Lost to Follow-up|2
7521031|NCT02897115|26116174|P2|Overall Study|Early termination of study by sponsor|8
7521032|NCT02897115|26116175|P1|Overall Study|Early termination of study by sponsor|11
7521033|NCT02896855|26116252|P2|Overall Study|Withdrawal by Subject|1
7521034|NCT02896855|26116253|P1|Overall Study|Withdrawal by Subject|1
7521035|NCT02896855|26116252|P2|Overall Study|Lost to Follow-up|0
7521036|NCT02896855|26116253|P1|Overall Study|Lost to Follow-up|5
7521037|NCT02896855|26116252|P2|Overall Study|Death|12
7521038|NCT02896855|26116253|P1|Overall Study|Death|13
7521039|NCT02896855|26116252|P2|Overall Study|In Follow-Up|49
7521040|NCT02896855|26116253|P1|Overall Study|In Follow-Up|61
7521041|NCT02896855|26116252|P2|Overall Study|On Study Treatment|60
7521042|NCT02896855|26116253|P1|Overall Study|On Study Treatment|41
7521043|NCT02896569|26116336|P2|Overall Study|Withdrawal by Subject|0
7521044|NCT02896569|26116337|P1|Overall Study|Withdrawal by Subject|1
7521045|NCT02896569|26116336|P2|Overall Study|Adverse Event|1
7521046|NCT02896569|26116337|P1|Overall Study|Adverse Event|0
7521047|NCT02896569|26116336|P2|Overall Study|Physician Decision|3
7521048|NCT02896569|26116337|P1|Overall Study|Physician Decision|1
7521049|NCT02896569|26116336|P2|Overall Study|Lost to Follow-up|1
7521050|NCT02896569|26116337|P1|Overall Study|Lost to Follow-up|2
7521051|NCT02896400|26116371|P16|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
7521052|NCT02896400|26116372|P15|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7521053|NCT02896400|26116373|P14|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7521054|NCT02896400|26116374|P13|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7521055|NCT02896400|26116375|P12|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
7521056|NCT02896400|26116376|P11|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
7521057|NCT02896400|26116377|P10|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7521058|NCT02896400|26116378|P9|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
7521059|NCT02896400|26116379|P8|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
7521060|NCT02896400|26116380|P7|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7521061|NCT02896400|26116381|P6|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7521062|NCT02896400|26116382|P5|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7521063|NCT02896400|26116383|P4|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
7521064|NCT02896400|26116384|P3|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
7521065|NCT02896400|26116385|P2|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7521066|NCT02896400|26116386|P1|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7521067|NCT02896400|26116371|P16|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521068|NCT02896400|26116372|P15|Biochemical Verification at 3 Months|Lost to Follow-up|3
7521069|NCT02896400|26116373|P14|Biochemical Verification at 3 Months|Lost to Follow-up|0
7521070|NCT02896400|26116374|P13|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521071|NCT02896400|26116375|P12|Biochemical Verification at 3 Months|Lost to Follow-up|0
7521072|NCT02896400|26116376|P11|Biochemical Verification at 3 Months|Lost to Follow-up|0
7521073|NCT02896400|26116377|P10|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521074|NCT02896400|26116378|P9|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521075|NCT02896400|26116379|P8|Biochemical Verification at 3 Months|Lost to Follow-up|2
7521076|NCT02896400|26116380|P7|Biochemical Verification at 3 Months|Lost to Follow-up|3
7521077|NCT02896400|26116381|P6|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521078|NCT02896400|26116382|P5|Biochemical Verification at 3 Months|Lost to Follow-up|0
7521079|NCT02896400|26116383|P4|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521080|NCT02896400|26116384|P3|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521081|NCT02896400|26116385|P2|Biochemical Verification at 3 Months|Lost to Follow-up|0
7521082|NCT02896400|26116386|P1|Biochemical Verification at 3 Months|Lost to Follow-up|1
7521083|NCT02896400|26116371|P16|3 Month Follow-up|Death|0
7521084|NCT02896400|26116372|P15|3 Month Follow-up|Death|1
7521085|NCT02896400|26116373|P14|3 Month Follow-up|Death|1
7521086|NCT02896400|26116374|P13|3 Month Follow-up|Death|0
7521087|NCT02896400|26116375|P12|3 Month Follow-up|Death|0
7521088|NCT02896400|26116376|P11|3 Month Follow-up|Death|0
7521089|NCT02896400|26116377|P10|3 Month Follow-up|Death|0
7521090|NCT02896400|26116378|P9|3 Month Follow-up|Death|0
7521091|NCT02896400|26116379|P8|3 Month Follow-up|Death|0
7521092|NCT02896400|26116380|P7|3 Month Follow-up|Death|0
7521093|NCT02896400|26116381|P6|3 Month Follow-up|Death|0
7521094|NCT02896400|26116382|P5|3 Month Follow-up|Death|0
7521095|NCT02896400|26116383|P4|3 Month Follow-up|Death|0
7521096|NCT02896400|26116384|P3|3 Month Follow-up|Death|0
7521097|NCT02896400|26116385|P2|3 Month Follow-up|Death|0
7521098|NCT02896400|26116386|P1|3 Month Follow-up|Death|0
7521099|NCT02896400|26116371|P16|3 Month Follow-up|Lost to Follow-up|2
7521100|NCT02896400|26116372|P15|3 Month Follow-up|Lost to Follow-up|3
7521101|NCT02896400|26116373|P14|3 Month Follow-up|Lost to Follow-up|5
7521102|NCT02896400|26116374|P13|3 Month Follow-up|Lost to Follow-up|3
7521103|NCT02896400|26116375|P12|3 Month Follow-up|Lost to Follow-up|6
7521104|NCT02896400|26116376|P11|3 Month Follow-up|Lost to Follow-up|6
7521105|NCT02896400|26116377|P10|3 Month Follow-up|Lost to Follow-up|5
7521106|NCT02896400|26116378|P9|3 Month Follow-up|Lost to Follow-up|6
7521107|NCT02896400|26116379|P8|3 Month Follow-up|Lost to Follow-up|3
7521108|NCT02896400|26116380|P7|3 Month Follow-up|Lost to Follow-up|4
7521109|NCT02896400|26116381|P6|3 Month Follow-up|Lost to Follow-up|6
7521110|NCT02896400|26116382|P5|3 Month Follow-up|Lost to Follow-up|12
7521111|NCT02896400|26116383|P4|3 Month Follow-up|Lost to Follow-up|11
7521112|NCT02896400|26116384|P3|3 Month Follow-up|Lost to Follow-up|6
7521113|NCT02896400|26116385|P2|3 Month Follow-up|Lost to Follow-up|3
7521114|NCT02896400|26116386|P1|3 Month Follow-up|Lost to Follow-up|6
7521115|NCT02896400|26116371|P16|1 Month Follow-up|Death|1
7521116|NCT02896400|26116372|P15|1 Month Follow-up|Death|0
7521117|NCT02896400|26116373|P14|1 Month Follow-up|Death|0
7521118|NCT02896400|26116374|P13|1 Month Follow-up|Death|0
7521119|NCT02896400|26116375|P12|1 Month Follow-up|Death|0
7521120|NCT02896400|26116376|P11|1 Month Follow-up|Death|0
7521121|NCT02896400|26116377|P10|1 Month Follow-up|Death|0
7521122|NCT02896400|26116378|P9|1 Month Follow-up|Death|0
7521123|NCT02896400|26116379|P8|1 Month Follow-up|Death|0
7521124|NCT02896400|26116380|P7|1 Month Follow-up|Death|0
7521125|NCT02896400|26116381|P6|1 Month Follow-up|Death|0
7521126|NCT02896400|26116382|P5|1 Month Follow-up|Death|0
7521127|NCT02896400|26116383|P4|1 Month Follow-up|Death|0
7521128|NCT02896400|26116384|P3|1 Month Follow-up|Death|0
7521129|NCT02896400|26116385|P2|1 Month Follow-up|Death|0
7521130|NCT02896400|26116386|P1|1 Month Follow-up|Death|0
7521131|NCT02896400|26116371|P16|1 Month Follow-up|Lost to Follow-up|2
7521132|NCT02896400|26116372|P15|1 Month Follow-up|Lost to Follow-up|1
7521133|NCT02896400|26116373|P14|1 Month Follow-up|Lost to Follow-up|4
7521134|NCT02896400|26116374|P13|1 Month Follow-up|Lost to Follow-up|3
7521135|NCT02896400|26116375|P12|1 Month Follow-up|Lost to Follow-up|5
7521136|NCT02896400|26116376|P11|1 Month Follow-up|Lost to Follow-up|5
7521137|NCT02896400|26116377|P10|1 Month Follow-up|Lost to Follow-up|7
7521138|NCT02896400|26116378|P9|1 Month Follow-up|Lost to Follow-up|4
7521139|NCT02896400|26116379|P8|1 Month Follow-up|Lost to Follow-up|6
7521140|NCT02896400|26116380|P7|1 Month Follow-up|Lost to Follow-up|5
7521141|NCT02896400|26116381|P6|1 Month Follow-up|Lost to Follow-up|6
7521142|NCT02896400|26116382|P5|1 Month Follow-up|Lost to Follow-up|9
7521143|NCT02896400|26116383|P4|1 Month Follow-up|Lost to Follow-up|8
7521144|NCT02896400|26116384|P3|1 Month Follow-up|Lost to Follow-up|5
7521145|NCT02896400|26116385|P2|1 Month Follow-up|Lost to Follow-up|7
7521146|NCT02896400|26116386|P1|1 Month Follow-up|Lost to Follow-up|7
7521147|NCT02896361|26116412|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7521148|NCT02896361|26116413|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
7521149|NCT02896361|26116414|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7521150|NCT02896361|26116412|P3|Third Intervention (2 Weeks)|Protocol Violation|0
7521151|NCT02896361|26116413|P2|Third Intervention (2 Weeks)|Protocol Violation|0
7521152|NCT02896361|26116414|P1|Third Intervention (2 Weeks)|Protocol Violation|1
7521153|NCT02896296|26116432|P1|Overall Study|Relocation|1
7521154|NCT02896296|26116432|P1|Overall Study|Incarceration|1
7521155|NCT02896296|26116432|P1|Overall Study|Site closing|7
7521156|NCT02896296|26116432|P1|Overall Study|Withdrawal by Subject|10
7521157|NCT02896296|26116432|P1|Overall Study|Physician Decision|2
7521158|NCT02896296|26116432|P1|Overall Study|Pregnancy|1
7521159|NCT02896296|26116432|P1|Overall Study|Lost to Follow-up|19
7521160|NCT02896296|26116432|P1|Overall Study|Adverse Event|1
7521161|NCT02896127|26116440|P2|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
7521162|NCT02896127|26116441|P1|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
7521163|NCT02896127|26116440|P2|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
7521164|NCT02896127|26116441|P1|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
7521165|NCT02896127|26116440|P2|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
7521166|NCT02896127|26116441|P1|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
7521167|NCT02896127|26116440|P2|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
7521168|NCT02896127|26116441|P1|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
7521169|NCT02896127|26116440|P2|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
7521170|NCT02896127|26116441|P1|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
7521171|NCT02896127|26116440|P2|COMPLETED WEEK 52|Technical problems|0
7521172|NCT02896127|26116441|P1|COMPLETED WEEK 52|Technical problems|1
7521173|NCT02896127|26116440|P2|COMPLETED WEEK 52|Withdrawal by Subject|4
7521174|NCT02896127|26116441|P1|COMPLETED WEEK 52|Withdrawal by Subject|12
7521175|NCT02896127|26116440|P2|COMPLETED WEEK 52|Pregnancy|0
7521176|NCT02896127|26116441|P1|COMPLETED WEEK 52|Pregnancy|2
7521177|NCT02896127|26116440|P2|COMPLETED WEEK 52|Physician Decision|1
7521178|NCT02896127|26116441|P1|COMPLETED WEEK 52|Physician Decision|1
7521179|NCT02896127|26116440|P2|COMPLETED WEEK 52|Lost to Follow-up|1
7521180|NCT02896127|26116441|P1|COMPLETED WEEK 52|Lost to Follow-up|0
7521181|NCT02896127|26116440|P2|COMPLETED WEEK 52|Lack of Efficacy|3
7521182|NCT02896127|26116441|P1|COMPLETED WEEK 52|Lack of Efficacy|2
7521183|NCT02896127|26116440|P2|COMPLETED WEEK 52|Adverse Event|2
7521184|NCT02896127|26116441|P1|COMPLETED WEEK 52|Adverse Event|9
7521185|NCT02895360|26116476|P6|Phase 2a|Progressive disease|11
7521186|NCT02895360|26116477|P5|Phase 2a|Progressive disease|11
7521187|NCT02895360|26116478|P4|Phase 2a|Progressive disease|0
7521188|NCT02895360|26116479|P3|Phase 2a|Progressive disease|0
7521189|NCT02895360|26116480|P2|Phase 2a|Progressive disease|0
7521190|NCT02895360|26116481|P1|Phase 2a|Progressive disease|0
7521191|NCT02895360|26116476|P6|Phase 2a|Adverse Event|1
7521192|NCT02895360|26116477|P5|Phase 2a|Adverse Event|0
7521193|NCT02895360|26116478|P4|Phase 2a|Adverse Event|0
7521194|NCT02895360|26116479|P3|Phase 2a|Adverse Event|0
7521195|NCT02895360|26116480|P2|Phase 2a|Adverse Event|0
7521196|NCT02895360|26116481|P1|Phase 2a|Adverse Event|0
7521197|NCT02895360|26116476|P6|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7521198|NCT02895360|26116477|P5|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7521199|NCT02895360|26116478|P4|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
7521200|NCT02895360|26116479|P3|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7521201|NCT02895360|26116480|P2|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7521202|NCT02895360|26116481|P1|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7521203|NCT02895360|26116476|P6|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7521204|NCT02895360|26116477|P5|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7521205|NCT02895360|26116478|P4|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7521206|NCT02895360|26116479|P3|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
7521207|NCT02895360|26116480|P2|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7521208|NCT02895360|26116481|P1|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7521209|NCT02895360|26116476|P6|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7521210|NCT02895360|26116477|P5|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7521211|NCT02895360|26116478|P4|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7521212|NCT02895360|26116479|P3|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
7521213|NCT02895360|26116480|P2|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7521214|NCT02895360|26116481|P1|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7521215|NCT02895360|26116476|P6|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7521216|NCT02895360|26116477|P5|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7521217|NCT02895360|26116478|P4|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7521218|NCT02895360|26116479|P3|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7521219|NCT02895360|26116480|P2|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
7521220|NCT02895360|26116481|P1|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7521221|NCT02895360|26116476|P6|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7521222|NCT02895360|26116477|P5|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7521223|NCT02895360|26116478|P4|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7521224|NCT02895360|26116479|P3|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7521225|NCT02895360|26116480|P2|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7521226|NCT02895360|26116481|P1|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
7521227|NCT02895347|26116531|P2|Overall Study|Withdrawal by Subject|1
7521228|NCT02895347|26116532|P1|Overall Study|Withdrawal by Subject|3
7521229|NCT02895295|26116544|P3|Overall Study|Survey Non-response|92
7521230|NCT02895295|26116545|P2|Overall Study|Survey Non-response|94
7521231|NCT02895295|26116546|P1|Overall Study|Survey Non-response|71
7521232|NCT02894840|26116597|P4|Overall Study|Lost to Follow-up|0
7521233|NCT02894840|26116598|P3|Overall Study|Lost to Follow-up|3
7521234|NCT02894840|26116599|P2|Overall Study|Lost to Follow-up|0
7521235|NCT02894840|26116600|P1|Overall Study|Lost to Follow-up|1
7521236|NCT02894502|26116625|P3|Third Follow up|Death|0
7521237|NCT02894502|26116626|P2|Third Follow up|Death|1
7521238|NCT02894502|26116627|P1|Third Follow up|Death|1
7521239|NCT02894502|26116625|P3|Third Follow up|Withdrawal by Subject|3
7521240|NCT02894502|26116626|P2|Third Follow up|Withdrawal by Subject|6
7521241|NCT02894502|26116627|P1|Third Follow up|Withdrawal by Subject|5
7521242|NCT02894502|26116625|P3|Second Follow up|Death|1
7521243|NCT02894502|26116626|P2|Second Follow up|Death|3
7521244|NCT02894502|26116627|P1|Second Follow up|Death|2
7521245|NCT02894502|26116625|P3|Second Follow up|Withdrawal by Subject|13
7521246|NCT02894502|26116626|P2|Second Follow up|Withdrawal by Subject|15
7521247|NCT02894502|26116627|P1|Second Follow up|Withdrawal by Subject|13
7521248|NCT02894502|26116625|P3|First Follow up|Death|3
7521249|NCT02894502|26116626|P2|First Follow up|Death|2
7521250|NCT02894502|26116627|P1|First Follow up|Death|2
7521251|NCT02894502|26116625|P3|First Follow up|Withdrawal by Subject|37
7521252|NCT02894502|26116626|P2|First Follow up|Withdrawal by Subject|29
7521253|NCT02894502|26116627|P1|First Follow up|Withdrawal by Subject|32
7521254|NCT02894502|26116625|P3|Baseline|Death|9
7521255|NCT02894502|26116626|P2|Baseline|Death|1
7521256|NCT02894502|26116627|P1|Baseline|Death|3
7521257|NCT02894502|26116625|P3|Baseline|Withdrawal by Subject|36
7521258|NCT02894502|26116626|P2|Baseline|Withdrawal by Subject|31
7521259|NCT02894502|26116627|P1|Baseline|Withdrawal by Subject|24
7521260|NCT02892734|26116891|P1|Follow up for 2 Years|Study closed early|1
7521261|NCT02892734|26116891|P1|Follow up for 2 Years|Death|2
7521262|NCT02892734|26116891|P1|Treatment on Study|Progressive Disease|2
7521263|NCT02892513|26116901|P2|Overall Study|Withdrawal by Subject|1
7521264|NCT02892513|26116902|P1|Overall Study|Withdrawal by Subject|0
7521265|NCT02892448|26116922|P3|Overall Study|Screening failure|1
7521266|NCT02892448|26116923|P2|Overall Study|Screening failure|2
7521267|NCT02892448|26116924|P1|Overall Study|Screening failure|2
7521268|NCT02892422|26116944|P1|Overall Study|Investigator decision|1
7521269|NCT02892422|26116944|P1|Overall Study|patient decision|7
7521270|NCT02892422|26116944|P1|Overall Study|patient legally incapable|1
7521271|NCT02892422|26116944|P1|Overall Study|non-compliance|10
7521272|NCT02892422|26116944|P1|Overall Study|moving elsewhere|4
7521273|NCT02892422|26116944|P1|Overall Study|exclusion criteria met|3
7521274|NCT02892422|26116944|P1|Overall Study|withdrawal of consent|13
7521275|NCT02892422|26116944|P1|Overall Study|sponsor information 16159A results|21
7521276|NCT02892422|26116944|P1|Overall Study|Lost to Follow-up|5
7521277|NCT02892422|26116944|P1|Overall Study|Withdrawal by Subject|56
7521278|NCT02892422|26116944|P1|Overall Study|Protocol Violation|4
7521279|NCT02892422|26116944|P1|Overall Study|Non-compliance with study drug|11
7521280|NCT02892422|26116944|P1|Overall Study|Lack of Efficacy|32
7521281|NCT02892422|26116944|P1|Overall Study|Adverse Event|38
7521282|NCT02892422|26116944|P1|Overall Study|Enrolled not treated|4
7521283|NCT02892409|26116950|P2|Overall Study|Withdrawal by Subject|1
7521284|NCT02892409|26116951|P1|Overall Study|Withdrawal by Subject|2
7521285|NCT02892409|26116950|P2|Overall Study|Adverse Event|0
7521286|NCT02892409|26116951|P1|Overall Study|Adverse Event|1
7521287|NCT02892344|26116973|P2|Overall Study|Technical problems|1
7521288|NCT02892344|26116974|P1|Overall Study|Technical problems|0
7521289|NCT02892344|26116973|P2|Overall Study|Subject/guardian decision|4
7521290|NCT02892344|26116974|P1|Overall Study|Subject/guardian decision|0
7521291|NCT02892344|26116973|P2|Overall Study|Physician Decision|2
7521292|NCT02892344|26116974|P1|Overall Study|Physician Decision|0
7521293|NCT02892344|26116973|P2|Overall Study|Non-compliance with study treatment|1
7521294|NCT02892344|26116974|P1|Overall Study|Non-compliance with study treatment|0
7521295|NCT02892344|26116973|P2|Overall Study|Lost to Follow-up|1
7521296|NCT02892344|26116974|P1|Overall Study|Lost to Follow-up|0
7521297|NCT02892344|26116973|P2|Overall Study|Adverse Event|8
7521298|NCT02892344|26116974|P1|Overall Study|Adverse Event|1
7521299|NCT02892344|26116973|P2|Overall Study|Protocol deviation|4
7521300|NCT02892344|26116974|P1|Overall Study|Protocol deviation|3
7521301|NCT02892019|26117023|P2|Overall Study|Adverse Event|1
7521302|NCT02892019|26117024|P1|Overall Study|Adverse Event|1
7521303|NCT02892019|26117023|P2|Overall Study|Withdrawal by Subject|1
7521304|NCT02892019|26117024|P1|Overall Study|Withdrawal by Subject|0
7521305|NCT02892019|26117023|P2|Overall Study|randomized but not treated|1
7521306|NCT02892019|26117024|P1|Overall Study|randomized but not treated|0
7521307|NCT02891915|26117048|P2|Overall Study|Physician Decision|0
7521308|NCT02891915|26117049|P1|Overall Study|Physician Decision|1
7521309|NCT02891915|26117048|P2|Overall Study|Lost to Follow-up|4
7521310|NCT02891915|26117049|P1|Overall Study|Lost to Follow-up|1
7521311|NCT02891915|26117048|P2|Overall Study|Became Ineligible After Enrollment|1
7521312|NCT02891915|26117049|P1|Overall Study|Became Ineligible After Enrollment|2
7521313|NCT02891915|26117048|P2|Overall Study|Withdrawal by Subject|3
7521314|NCT02891915|26117049|P1|Overall Study|Withdrawal by Subject|3
7521315|NCT02891915|26117048|P2|Overall Study|Enrolled but Treatment Not Administered|4
7521316|NCT02891915|26117049|P1|Overall Study|Enrolled but Treatment Not Administered|6
7521317|NCT02891850|26117084|P2|Overall Study|Withdrawal by Subject|3
7521318|NCT02891850|26117085|P1|Overall Study|Withdrawal by Subject|2
7521319|NCT02891850|26117084|P2|Overall Study|Pregnancy|0
7521320|NCT02891850|26117085|P1|Overall Study|Pregnancy|1
7521321|NCT02891850|26117084|P2|Overall Study|Physician Decision|0
7521322|NCT02891850|26117085|P1|Overall Study|Physician Decision|1
7521323|NCT02891850|26117084|P2|Overall Study|Death|4
7521324|NCT02891850|26117085|P1|Overall Study|Death|0
7521325|NCT02891850|26117084|P2|Overall Study|Adverse Event|0
7521326|NCT02891850|26117085|P1|Overall Study|Adverse Event|3
7521327|NCT02891681|26117102|P3|Overall Study|Taken off study after first imaging appointment|0
7521328|NCT02891681|26117103|P2|Overall Study|Taken off study after first imaging appointment|0
7521329|NCT02891681|26117104|P1|Overall Study|Taken off study after first imaging appointment|1
7521330|NCT02891681|26117102|P3|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7521331|NCT02891681|26117103|P2|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7521332|NCT02891681|26117104|P1|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
7521333|NCT02891681|26117102|P3|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
7521334|NCT02891681|26117103|P2|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7521335|NCT02891681|26117104|P1|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7521336|NCT02891408|26117130|P7|Overall Study|Lost to Follow-up|0
7521337|NCT02891408|26117131|P6|Overall Study|Lost to Follow-up|0
7521338|NCT02891408|26117132|P5|Overall Study|Lost to Follow-up|0
7521339|NCT02891408|26117133|P4|Overall Study|Lost to Follow-up|0
7521340|NCT02891408|26117134|P3|Overall Study|Lost to Follow-up|1
7521341|NCT02891408|26117135|P2|Overall Study|Lost to Follow-up|0
7521342|NCT02891408|26117136|P1|Overall Study|Lost to Follow-up|0
7521343|NCT02891200|26117249|P2|Overall Study|Withdrawal by Subject|4
7521344|NCT02891200|26117250|P1|Overall Study|Withdrawal by Subject|1
7521345|NCT02891200|26117249|P2|Overall Study|Death|9
7521346|NCT02891200|26117250|P1|Overall Study|Death|10
7521347|NCT02891200|26117249|P2|Overall Study|Lost to Follow-up|36
7521348|NCT02891200|26117250|P1|Overall Study|Lost to Follow-up|31
7521349|NCT02891174|26117278|P2|Second Intervention (24 Hours)|Protocol Violation|1
7521350|NCT02891174|26117279|P1|Second Intervention (24 Hours)|Protocol Violation|0
7521351|NCT02891174|26117278|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
7521352|NCT02891174|26117279|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
7521353|NCT02891174|26117278|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
7521354|NCT02891174|26117279|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
7521355|NCT02891174|26117278|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
7521356|NCT02891174|26117279|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
7521357|NCT02891174|26117278|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
7521358|NCT02891174|26117279|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
7521359|NCT02891174|26117278|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
7521360|NCT02891174|26117279|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
7521361|NCT02891174|26117278|P2|First Intervention (24 Hours)|Declined any study medication|5
7521362|NCT02891174|26117279|P1|First Intervention (24 Hours)|Declined any study medication|1
7521363|NCT02891070|26117293|P2|Overall Study|Death|0
7521364|NCT02891070|26117294|P1|Overall Study|Death|3
7521365|NCT02891070|26117293|P2|Overall Study|Withdrawal by Subject|2
7521366|NCT02891070|26117294|P1|Overall Study|Withdrawal by Subject|1
7521367|NCT02891070|26117293|P2|Overall Study|Protocol Violation|1
7521368|NCT02891070|26117294|P1|Overall Study|Protocol Violation|0
7521369|NCT02891070|26117293|P2|Overall Study|Other|0
7521370|NCT02891070|26117294|P1|Overall Study|Other|1
7521371|NCT02891070|26117293|P2|Overall Study|Lost to Follow-up|4
7521372|NCT02891070|26117294|P1|Overall Study|Lost to Follow-up|4
7521373|NCT02891070|26117293|P2|Overall Study|Physician Decision|1
7521374|NCT02891070|26117294|P1|Overall Study|Physician Decision|0
7521375|NCT02891070|26117293|P2|Overall Study|Adverse Event|0
7521376|NCT02891070|26117294|P1|Overall Study|Adverse Event|1
7521377|NCT02890992|26117320|P8|130 Weeks Open-Label Extension Period|Other than specified|0
7521378|NCT02890992|26117321|P7|130 Weeks Open-Label Extension Period|Other than specified|0
7521379|NCT02890992|26117322|P6|130 Weeks Open-Label Extension Period|Other than specified|0
7521380|NCT02890992|26117323|P5|130 Weeks Open-Label Extension Period|Other than specified|0
7521381|NCT02890992|26117324|P4|130 Weeks Open-Label Extension Period|Other than specified|0
7521382|NCT02890992|26117325|P3|130 Weeks Open-Label Extension Period|Other than specified|0
7521383|NCT02890992|26117326|P2|130 Weeks Open-Label Extension Period|Other than specified|2
7521384|NCT02890992|26117327|P1|130 Weeks Open-Label Extension Period|Other than specified|0
7521385|NCT02890992|26117320|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
7521386|NCT02890992|26117321|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
7521387|NCT02890992|26117322|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
7521388|NCT02890992|26117323|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
7521389|NCT02890992|26117324|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
7521390|NCT02890992|26117325|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
7521391|NCT02890992|26117326|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
7521392|NCT02890992|26117327|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
7521393|NCT02890992|26117320|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
7521394|NCT02890992|26117321|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
7521395|NCT02890992|26117322|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
7521396|NCT02890992|26117323|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
7521397|NCT02890992|26117324|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
7521398|NCT02890992|26117325|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
7521399|NCT02890992|26117326|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
7521400|NCT02890992|26117327|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
7521401|NCT02890355|26117524|P2|Overall Study|Not protocol specified|4
7521402|NCT02890355|26117525|P1|Overall Study|Not protocol specified|3
7521403|NCT02890355|26117524|P2|Overall Study|Progression/relapse|39
7521404|NCT02890355|26117525|P1|Overall Study|Progression/relapse|46
7521405|NCT02890355|26117524|P2|Overall Study|Refusal unrelated to adverse event|10
7521406|NCT02890355|26117525|P1|Overall Study|Refusal unrelated to adverse event|5
7521407|NCT02890355|26117524|P2|Overall Study|Adverse Event|5
7521408|NCT02890355|26117525|P1|Overall Study|Adverse Event|5
7521409|NCT02889900|26117545|P1|Overall Study|Not treated|2
7521410|NCT02889900|26117545|P1|Overall Study|Withdrawal by Subject|7
7521411|NCT02889900|26117545|P1|Overall Study|Other|5
7521412|NCT02889900|26117545|P1|Overall Study|Condition under investigation worsened|32
7521413|NCT02889900|26117545|P1|Overall Study|Adverse Event|11
7521414|NCT02889861|26117557|P1|Overall Study|Ongoing in Survival Follow-up|2
7521415|NCT02889796|26117582|P6|Overall Study|Randomized but not Dosed|2
7521416|NCT02889796|26117583|P5|Overall Study|Randomized but not Dosed|0
7521417|NCT02889796|26117584|P4|Overall Study|Randomized but not Dosed|0
7521418|NCT02889796|26117585|P3|Overall Study|Randomized but not Dosed|0
7521419|NCT02889796|26117586|P2|Overall Study|Randomized but not Dosed|0
7521420|NCT02889796|26117587|P1|Overall Study|Randomized but not Dosed|2
7521421|NCT02889796|26117582|P6|Overall Study|Pregnancy|0
7521422|NCT02889796|26117583|P5|Overall Study|Pregnancy|0
7521423|NCT02889796|26117584|P4|Overall Study|Pregnancy|0
7521424|NCT02889796|26117585|P3|Overall Study|Pregnancy|1
7521425|NCT02889796|26117586|P2|Overall Study|Pregnancy|1
7521426|NCT02889796|26117587|P1|Overall Study|Pregnancy|0
7521427|NCT02889796|26117582|P6|Overall Study|Death|1
7521428|NCT02889796|26117583|P5|Overall Study|Death|0
7521429|NCT02889796|26117584|P4|Overall Study|Death|1
7521430|NCT02889796|26117585|P3|Overall Study|Death|0
7521431|NCT02889796|26117586|P2|Overall Study|Death|1
7521432|NCT02889796|26117587|P1|Overall Study|Death|1
7521433|NCT02889796|26117582|P6|Overall Study|Non-compliance With Study Drug|2
7521434|NCT02889796|26117583|P5|Overall Study|Non-compliance With Study Drug|1
7521435|NCT02889796|26117584|P4|Overall Study|Non-compliance With Study Drug|0
7521436|NCT02889796|26117585|P3|Overall Study|Non-compliance With Study Drug|0
7521437|NCT02889796|26117586|P2|Overall Study|Non-compliance With Study Drug|2
7521438|NCT02889796|26117587|P1|Overall Study|Non-compliance With Study Drug|0
7521439|NCT02889796|26117582|P6|Overall Study|Protocol Violation|4
7521440|NCT02889796|26117583|P5|Overall Study|Protocol Violation|0
7521441|NCT02889796|26117584|P4|Overall Study|Protocol Violation|0
7521442|NCT02889796|26117585|P3|Overall Study|Protocol Violation|3
7521443|NCT02889796|26117586|P2|Overall Study|Protocol Violation|1
7521444|NCT02889796|26117587|P1|Overall Study|Protocol Violation|0
7521445|NCT02889796|26117582|P6|Overall Study|Lost to Follow-up|6
7521446|NCT02889796|26117583|P5|Overall Study|Lost to Follow-up|2
7521447|NCT02889796|26117584|P4|Overall Study|Lost to Follow-up|0
7521448|NCT02889796|26117585|P3|Overall Study|Lost to Follow-up|2
7521449|NCT02889796|26117586|P2|Overall Study|Lost to Follow-up|7
7521450|NCT02889796|26117587|P1|Overall Study|Lost to Follow-up|5
7521451|NCT02889796|26117582|P6|Overall Study|Adverse Event|7
7521452|NCT02889796|26117583|P5|Overall Study|Adverse Event|1
7521453|NCT02889796|26117584|P4|Overall Study|Adverse Event|4
7521454|NCT02889796|26117585|P3|Overall Study|Adverse Event|8
7521455|NCT02889796|26117586|P2|Overall Study|Adverse Event|8
7521456|NCT02889796|26117587|P1|Overall Study|Adverse Event|17
7521457|NCT02889796|26117582|P6|Overall Study|Investigator's Discretion|15
7521458|NCT02889796|26117583|P5|Overall Study|Investigator's Discretion|0
7521459|NCT02889796|26117584|P4|Overall Study|Investigator's Discretion|3
7521460|NCT02889796|26117585|P3|Overall Study|Investigator's Discretion|10
7521461|NCT02889796|26117586|P2|Overall Study|Investigator's Discretion|9
7521462|NCT02889796|26117587|P1|Overall Study|Investigator's Discretion|10
7521463|NCT02889796|26117582|P6|Overall Study|Withdrew Consent|35
7521464|NCT02889796|26117583|P5|Overall Study|Withdrew Consent|2
7521465|NCT02889796|26117584|P4|Overall Study|Withdrew Consent|1
7521466|NCT02889796|26117585|P3|Overall Study|Withdrew Consent|20
7521467|NCT02889796|26117586|P2|Overall Study|Withdrew Consent|29
7521468|NCT02889796|26117587|P1|Overall Study|Withdrew Consent|18
7521469|NCT02889562|26117954|P2|Overall Study|Withdrawal by Subject|1
7521470|NCT02889562|26117955|P1|Overall Study|Withdrawal by Subject|0
7521471|NCT02889562|26117954|P2|Overall Study|Physician Decision|1
7521472|NCT02889562|26117955|P1|Overall Study|Physician Decision|0
7521473|NCT02888756|26118026|P3|Analytical Treatment Interruption|Physician Decision|5
7521474|NCT02888756|26118027|P2|Analytical Treatment Interruption|Physician Decision|6
7521475|NCT02888756|26118028|P1|Analytical Treatment Interruption|Physician Decision|10
7521476|NCT02888171|26118185|P2|Overall Study|Adverse Event|1
7521477|NCT02888171|26118186|P1|Overall Study|Adverse Event|0
7521478|NCT02888171|26118185|P2|Overall Study|Withdrawal by Subject|2
7521479|NCT02888171|26118186|P1|Overall Study|Withdrawal by Subject|3
7521480|NCT02888171|26118185|P2|Overall Study|Lost to Follow-up|1
7521481|NCT02888171|26118186|P1|Overall Study|Lost to Follow-up|2
7521482|NCT02888106|26118206|P6|Overall Study|Pregnancy|0
7521483|NCT02888106|26118207|P5|Overall Study|Pregnancy|0
7521484|NCT02888106|26118208|P4|Overall Study|Pregnancy|0
7521485|NCT02888106|26118209|P3|Overall Study|Pregnancy|0
7521486|NCT02888106|26118210|P2|Overall Study|Pregnancy|0
7521487|NCT02888106|26118211|P1|Overall Study|Pregnancy|1
7521488|NCT02888106|26118206|P6|Overall Study|Withdrawal of consent|0
7521489|NCT02888106|26118207|P5|Overall Study|Withdrawal of consent|1
7521490|NCT02888106|26118208|P4|Overall Study|Withdrawal of consent|0
7521491|NCT02888106|26118209|P3|Overall Study|Withdrawal of consent|0
7521492|NCT02888106|26118210|P2|Overall Study|Withdrawal of consent|0
7521493|NCT02888106|26118211|P1|Overall Study|Withdrawal of consent|0
7521494|NCT02888106|26118206|P6|Overall Study|Adverse Event|0
7521495|NCT02888106|26118207|P5|Overall Study|Adverse Event|0
7521496|NCT02888106|26118208|P4|Overall Study|Adverse Event|0
7521497|NCT02888106|26118209|P3|Overall Study|Adverse Event|0
7521498|NCT02888106|26118210|P2|Overall Study|Adverse Event|0
7521499|NCT02888106|26118211|P1|Overall Study|Adverse Event|2
7521500|NCT02888106|26118206|P6|Overall Study|Lost to Follow-up|1
7521501|NCT02888106|26118207|P5|Overall Study|Lost to Follow-up|0
7521502|NCT02888106|26118208|P4|Overall Study|Lost to Follow-up|1
7521503|NCT02888106|26118209|P3|Overall Study|Lost to Follow-up|0
7521504|NCT02888106|26118210|P2|Overall Study|Lost to Follow-up|0
7521505|NCT02888106|26118211|P1|Overall Study|Lost to Follow-up|1
7521506|NCT02888106|26118206|P6|Overall Study|Withdrawal by Subject|0
7521507|NCT02888106|26118207|P5|Overall Study|Withdrawal by Subject|0
7521508|NCT02888106|26118208|P4|Overall Study|Withdrawal by Subject|1
7521509|NCT02888106|26118209|P3|Overall Study|Withdrawal by Subject|0
7521510|NCT02888106|26118210|P2|Overall Study|Withdrawal by Subject|2
7521511|NCT02888106|26118211|P1|Overall Study|Withdrawal by Subject|1
7521512|NCT02888080|26118312|P2|Overall Study|Adverse Event|1
7521513|NCT02888080|26118313|P1|Overall Study|Adverse Event|0
7521514|NCT02888080|26118312|P2|Overall Study|Lack of Efficacy|1
7521515|NCT02888080|26118313|P1|Overall Study|Lack of Efficacy|0
7521516|NCT02888080|26118312|P2|Overall Study|New Therapy for study indication|0
7521517|NCT02888080|26118313|P1|Overall Study|New Therapy for study indication|1
7521518|NCT02888080|26118312|P2|Overall Study|Subject / Guardian decision|3
7521519|NCT02888080|26118313|P1|Overall Study|Subject / Guardian decision|1
7521520|NCT02887989|26118339|P2|Overall Study|Death|0
7521521|NCT02887989|26118340|P1|Overall Study|Death|1
7521522|NCT02887989|26118339|P2|Overall Study|Withdrawal by Subject|11
7521523|NCT02887989|26118340|P1|Overall Study|Withdrawal by Subject|8
7521524|NCT02887521|26118352|P2|Overall Study|Withdrawal by Subject|3
7521525|NCT02887521|26118353|P1|Overall Study|Withdrawal by Subject|0
7521526|NCT02887183|26118416|P1|Overall Study|Withdrawal by Subject|35
7521527|NCT02887183|26118416|P1|Overall Study|Physician Decision|10
7521528|NCT02887183|26118416|P1|Overall Study|Lost to Follow-up|13
7521529|NCT02887183|26118416|P1|Overall Study|Technical Problems|2
7521530|NCT02887183|26118416|P1|Overall Study|Protocol Violation|6
7521531|NCT02887183|26118416|P1|Overall Study|Pregnancy|1
7521532|NCT02887183|26118416|P1|Overall Study|Death|30
7521533|NCT02887183|26118416|P1|Overall Study|Adverse Event|44
7521534|NCT02886728|26118444|P4|Overall Study|Randomized but Not Dosed|2
7521535|NCT02886728|26118445|P3|Overall Study|Randomized but Not Dosed|0
7521536|NCT02886728|26118446|P2|Overall Study|Randomized but Not Dosed|0
7521537|NCT02886728|26118447|P1|Overall Study|Randomized but Not Dosed|1
7521538|NCT02886728|26118444|P4|Overall Study|Pregnancy|0
7521539|NCT02886728|26118445|P3|Overall Study|Pregnancy|1
7521540|NCT02886728|26118446|P2|Overall Study|Pregnancy|0
7521541|NCT02886728|26118447|P1|Overall Study|Pregnancy|0
7521542|NCT02886728|26118444|P4|Overall Study|Non-Compliance with Study Drug|0
7521543|NCT02886728|26118445|P3|Overall Study|Non-Compliance with Study Drug|1
7521544|NCT02886728|26118446|P2|Overall Study|Non-Compliance with Study Drug|0
7521545|NCT02886728|26118447|P1|Overall Study|Non-Compliance with Study Drug|1
7521546|NCT02886728|26118444|P4|Overall Study|Protocol Violation|4
7521547|NCT02886728|26118445|P3|Overall Study|Protocol Violation|0
7521548|NCT02886728|26118446|P2|Overall Study|Protocol Violation|0
7521549|NCT02886728|26118447|P1|Overall Study|Protocol Violation|0
7521550|NCT02886728|26118444|P4|Overall Study|Death|0
7521551|NCT02886728|26118445|P3|Overall Study|Death|0
7521552|NCT02886728|26118446|P2|Overall Study|Death|1
7521553|NCT02886728|26118447|P1|Overall Study|Death|3
7521554|NCT02886728|26118444|P4|Overall Study|Investigator's Discretion|11
7521555|NCT02886728|26118445|P3|Overall Study|Investigator's Discretion|5
7521556|NCT02886728|26118446|P2|Overall Study|Investigator's Discretion|7
7521557|NCT02886728|26118447|P1|Overall Study|Investigator's Discretion|11
7521558|NCT02886728|26118444|P4|Overall Study|Adverse Event|11
7521559|NCT02886728|26118445|P3|Overall Study|Adverse Event|5
7521560|NCT02886728|26118446|P2|Overall Study|Adverse Event|5
7521561|NCT02886728|26118447|P1|Overall Study|Adverse Event|13
7521562|NCT02886728|26118444|P4|Overall Study|Lost to Follow-up|12
7521563|NCT02886728|26118445|P3|Overall Study|Lost to Follow-up|13
7521564|NCT02886728|26118446|P2|Overall Study|Lost to Follow-up|6
7521565|NCT02886728|26118447|P1|Overall Study|Lost to Follow-up|12
7521566|NCT02886728|26118444|P4|Overall Study|Withdrew Consent|47
7521567|NCT02886728|26118445|P3|Overall Study|Withdrew Consent|11
7521568|NCT02886728|26118446|P2|Overall Study|Withdrew Consent|13
7521569|NCT02886728|26118447|P1|Overall Study|Withdrew Consent|31
7521570|NCT02886715|26118628|P3|Overall Study|missing|2
7521571|NCT02886715|26118629|P2|Overall Study|missing|2
7521572|NCT02886715|26118630|P1|Overall Study|missing|7
7521573|NCT02886715|26118628|P3|Overall Study|Withdrawal by Subject|5
7521574|NCT02886715|26118629|P2|Overall Study|Withdrawal by Subject|18
7521575|NCT02886715|26118630|P1|Overall Study|Withdrawal by Subject|20
7521576|NCT02886715|26118628|P3|Overall Study|Protocol Violation|1
7521577|NCT02886715|26118629|P2|Overall Study|Protocol Violation|2
7521578|NCT02886715|26118630|P1|Overall Study|Protocol Violation|3
7521579|NCT02886715|26118628|P3|Overall Study|Pregnancy|1
7521580|NCT02886715|26118629|P2|Overall Study|Pregnancy|1
7521581|NCT02886715|26118630|P1|Overall Study|Pregnancy|1
7521582|NCT02886715|26118628|P3|Overall Study|Lost to Follow-up|10
7521583|NCT02886715|26118629|P2|Overall Study|Lost to Follow-up|26
7521584|NCT02886715|26118630|P1|Overall Study|Lost to Follow-up|29
7521585|NCT02886715|26118628|P3|Overall Study|Lack of Efficacy|1
7521586|NCT02886715|26118629|P2|Overall Study|Lack of Efficacy|2
7521587|NCT02886715|26118630|P1|Overall Study|Lack of Efficacy|0
7521588|NCT02886715|26118628|P3|Overall Study|Adverse Event|0
7521589|NCT02886715|26118629|P2|Overall Study|Adverse Event|2
7521590|NCT02886715|26118630|P1|Overall Study|Adverse Event|4
7521591|NCT02886715|26118628|P3|Overall Study|Non-Compliance With Study Drug|0
7521592|NCT02886715|26118629|P2|Overall Study|Non-Compliance With Study Drug|2
7521593|NCT02886715|26118630|P1|Overall Study|Non-Compliance With Study Drug|0
7521594|NCT02886702|26118647|P3|Overall Study|Administrative Reasons|1
7521595|NCT02886702|26118648|P2|Overall Study|Administrative Reasons|0
7521596|NCT02886702|26118649|P1|Overall Study|Administrative Reasons|0
7521597|NCT02886702|26118647|P3|Overall Study|Adverse Event|3
7521598|NCT02886702|26118648|P2|Overall Study|Adverse Event|9
7521599|NCT02886702|26118649|P1|Overall Study|Adverse Event|4
7521600|NCT02886702|26118647|P3|Overall Study|Lack of Efficacy|5
7521601|NCT02886702|26118648|P2|Overall Study|Lack of Efficacy|4
7521602|NCT02886702|26118649|P1|Overall Study|Lack of Efficacy|3
7521603|NCT02886702|26118647|P3|Overall Study|Lost to Follow-up|8
7521604|NCT02886702|26118648|P2|Overall Study|Lost to Follow-up|13
7521605|NCT02886702|26118649|P1|Overall Study|Lost to Follow-up|11
7521606|NCT02886702|26118647|P3|Overall Study|Non-Compliance With Study Drug|4
7521607|NCT02886702|26118648|P2|Overall Study|Non-Compliance With Study Drug|1
7521608|NCT02886702|26118649|P1|Overall Study|Non-Compliance With Study Drug|0
7521609|NCT02886702|26118647|P3|Overall Study|Protocol Violation|1
7521610|NCT02886702|26118648|P2|Overall Study|Protocol Violation|2
7521611|NCT02886702|26118649|P1|Overall Study|Protocol Violation|2
7521612|NCT02886702|26118647|P3|Overall Study|Significant Worsening of Condition|0
7521613|NCT02886702|26118648|P2|Overall Study|Significant Worsening of Condition|1
7521614|NCT02886702|26118649|P1|Overall Study|Significant Worsening of Condition|0
7521615|NCT02886702|26118647|P3|Overall Study|Withdrawal by Subject|22
7521616|NCT02886702|26118648|P2|Overall Study|Withdrawal by Subject|18
7521617|NCT02886702|26118649|P1|Overall Study|Withdrawal by Subject|24
7521618|NCT02886702|26118647|P3|Overall Study|Other|9
7521619|NCT02886702|26118648|P2|Overall Study|Other|3
7521620|NCT02886702|26118649|P1|Overall Study|Other|4
7521621|NCT02886624|26118663|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
7521622|NCT02886624|26118663|P1|12-week Post Treatment Follow-up|Death|1
7521623|NCT02886494|26118674|P2|Overall Study|Protocol Violation|1
7521624|NCT02886494|26118675|P1|Overall Study|Protocol Violation|4
7521625|NCT02886494|26118674|P2|Overall Study|Withdrawal by Subject|3
7521626|NCT02886494|26118675|P1|Overall Study|Withdrawal by Subject|12
7521627|NCT02886494|26118674|P2|Overall Study|Adverse Event|0
7521628|NCT02886494|26118675|P1|Overall Study|Adverse Event|1
7521629|NCT02886338|26118703|P1|Overall Study|Withdrawal by Subject|1
7521630|NCT02885181|26118913|P4|Overall Study|Withdrawal by Subject|1
7521631|NCT02885181|26118914|P3|Overall Study|Withdrawal by Subject|0
7521632|NCT02885181|26118915|P2|Overall Study|Withdrawal by Subject|0
7521633|NCT02885181|26118916|P1|Overall Study|Withdrawal by Subject|0
7521634|NCT02885181|26118913|P4|Overall Study|Adverse Event|1
7521635|NCT02885181|26118914|P3|Overall Study|Adverse Event|0
7521636|NCT02885181|26118915|P2|Overall Study|Adverse Event|0
7521637|NCT02885181|26118916|P1|Overall Study|Adverse Event|0
7521638|NCT02885181|26118913|P4|Overall Study|Investigator's Discretion|1
7521639|NCT02885181|26118914|P3|Overall Study|Investigator's Discretion|0
7521640|NCT02885181|26118915|P2|Overall Study|Investigator's Discretion|1
7521641|NCT02885181|26118916|P1|Overall Study|Investigator's Discretion|0
7521642|NCT02884089|26119032|P4|Follow-up Visit|Withdrawal by Subject|1
7521643|NCT02884089|26119033|P3|Follow-up Visit|Withdrawal by Subject|0
7521644|NCT02884089|26119034|P2|Follow-up Visit|Withdrawal by Subject|0
7521645|NCT02884089|26119035|P1|Follow-up Visit|Withdrawal by Subject|1
7521646|NCT02884089|26119032|P4|Period 4|Lost to Follow-up|0
7521647|NCT02884089|26119033|P3|Period 4|Lost to Follow-up|0
7521648|NCT02884089|26119034|P2|Period 4|Lost to Follow-up|0
7521649|NCT02884089|26119035|P1|Period 4|Lost to Follow-up|1
7521650|NCT02884089|26119032|P4|Period 4|Withdrawal by Subject|0
7521651|NCT02884089|26119033|P3|Period 4|Withdrawal by Subject|0
7521652|NCT02884089|26119034|P2|Period 4|Withdrawal by Subject|1
7521653|NCT02884089|26119035|P1|Period 4|Withdrawal by Subject|0
7521654|NCT02884089|26119032|P4|Washout Period 3|Lost to Follow-up|1
7521655|NCT02884089|26119033|P3|Washout Period 3|Lost to Follow-up|0
7521656|NCT02884089|26119034|P2|Washout Period 3|Lost to Follow-up|0
7521657|NCT02884089|26119035|P1|Washout Period 3|Lost to Follow-up|0
7521658|NCT02884089|26119032|P4|Washout Period 3|Withdrawal by Subject|0
7521659|NCT02884089|26119033|P3|Washout Period 3|Withdrawal by Subject|1
7521660|NCT02884089|26119034|P2|Washout Period 3|Withdrawal by Subject|0
7521661|NCT02884089|26119035|P1|Washout Period 3|Withdrawal by Subject|0
7521662|NCT02884089|26119032|P4|Period 3|Withdrawal by Subject|0
7521663|NCT02884089|26119033|P3|Period 3|Withdrawal by Subject|1
7521664|NCT02884089|26119034|P2|Period 3|Withdrawal by Subject|0
7521665|NCT02884089|26119035|P1|Period 3|Withdrawal by Subject|0
7521666|NCT02884089|26119032|P4|Period 2|Adverse Event|0
7521667|NCT02884089|26119033|P3|Period 2|Adverse Event|0
7521668|NCT02884089|26119034|P2|Period 2|Adverse Event|0
7521669|NCT02884089|26119035|P1|Period 2|Adverse Event|1
7521670|NCT02884089|26119032|P4|Washout Period 1|Withdrawal by Subject|0
7521671|NCT02884089|26119033|P3|Washout Period 1|Withdrawal by Subject|0
7521672|NCT02884089|26119034|P2|Washout Period 1|Withdrawal by Subject|1
7521673|NCT02884089|26119035|P1|Washout Period 1|Withdrawal by Subject|0
7521674|NCT02884089|26119032|P4|Washout Period 1|Lost to Follow-up|1
7521675|NCT02884089|26119033|P3|Washout Period 1|Lost to Follow-up|0
7521676|NCT02884089|26119034|P2|Washout Period 1|Lost to Follow-up|1
7521677|NCT02884089|26119035|P1|Washout Period 1|Lost to Follow-up|0
7521678|NCT02884089|26119032|P4|Period 1|Dosing error|0
7521679|NCT02884089|26119033|P3|Period 1|Dosing error|0
7521680|NCT02884089|26119034|P2|Period 1|Dosing error|2
7521681|NCT02884089|26119035|P1|Period 1|Dosing error|2
7521682|NCT02883452|26119055|P6|Overall Study|Other|1
7521683|NCT02883452|26119056|P5|Overall Study|Other|0
7521684|NCT02883452|26119057|P4|Overall Study|Other|0
7521685|NCT02883452|26119058|P3|Overall Study|Other|0
7521686|NCT02883452|26119059|P2|Overall Study|Other|0
7521687|NCT02883452|26119060|P1|Overall Study|Other|0
7521688|NCT02883452|26119055|P6|Overall Study|Death|0
7521689|NCT02883452|26119056|P5|Overall Study|Death|0
7521690|NCT02883452|26119057|P4|Overall Study|Death|0
7521691|NCT02883452|26119058|P3|Overall Study|Death|1
7521692|NCT02883452|26119059|P2|Overall Study|Death|0
7521693|NCT02883452|26119060|P1|Overall Study|Death|1
7521694|NCT02883452|26119055|P6|Overall Study|Physician Decision|1
7521695|NCT02883452|26119056|P5|Overall Study|Physician Decision|4
7521696|NCT02883452|26119057|P4|Overall Study|Physician Decision|0
7521697|NCT02883452|26119058|P3|Overall Study|Physician Decision|0
7521698|NCT02883452|26119059|P2|Overall Study|Physician Decision|0
7521699|NCT02883452|26119060|P1|Overall Study|Physician Decision|0
7521700|NCT02883452|26119055|P6|Overall Study|Adverse Event|3
7521701|NCT02883452|26119056|P5|Overall Study|Adverse Event|1
7521702|NCT02883452|26119057|P4|Overall Study|Adverse Event|1
7521703|NCT02883452|26119058|P3|Overall Study|Adverse Event|1
7521704|NCT02883452|26119059|P2|Overall Study|Adverse Event|1
7521705|NCT02883452|26119060|P1|Overall Study|Adverse Event|2
7521706|NCT02883452|26119055|P6|Overall Study|Disease progression|5
7521707|NCT02883452|26119056|P5|Overall Study|Disease progression|4
7521708|NCT02883452|26119057|P4|Overall Study|Disease progression|1
7521709|NCT02883452|26119058|P3|Overall Study|Disease progression|0
7521710|NCT02883452|26119059|P2|Overall Study|Disease progression|0
7521711|NCT02883452|26119060|P1|Overall Study|Disease progression|1
7521712|NCT02883452|26119055|P6|Overall Study|Withdrawal by Subject|5
7521713|NCT02883452|26119056|P5|Overall Study|Withdrawal by Subject|2
7521714|NCT02883452|26119057|P4|Overall Study|Withdrawal by Subject|0
7521715|NCT02883452|26119058|P3|Overall Study|Withdrawal by Subject|3
7521716|NCT02883452|26119059|P2|Overall Study|Withdrawal by Subject|1
7521717|NCT02883452|26119060|P1|Overall Study|Withdrawal by Subject|1
7521718|NCT02883244|26119097|P2|Overall Study|Lost to Follow-up|1
7521719|NCT02883244|26119098|P1|Overall Study|Lost to Follow-up|0
7521720|NCT02882854|26119116|P2|Overall Study|Physician Decision|1
7521721|NCT02882854|26119117|P1|Overall Study|Physician Decision|0
7521722|NCT02882854|26119116|P2|Overall Study|Lost to Follow-up|2
7521723|NCT02882854|26119117|P1|Overall Study|Lost to Follow-up|1
7521724|NCT02882152|26119164|P2|Overall Study|Lost to Follow-up|0
7521725|NCT02882152|26119165|P1|Overall Study|Lost to Follow-up|1
7521726|NCT02881957|26119186|P2|Overall Study|Protocol Violation|0
7521727|NCT02881957|26119187|P1|Overall Study|Protocol Violation|1
7521728|NCT02881957|26119186|P2|Overall Study|Withdrawal by Subject|1
7521729|NCT02881957|26119187|P1|Overall Study|Withdrawal by Subject|2
7521730|NCT02881957|26119186|P2|Overall Study|Discharged within 48 hours|1
7521731|NCT02881957|26119187|P1|Overall Study|Discharged within 48 hours|0
7521732|NCT02881957|26119186|P2|Overall Study|Concurrent trial enrollment|1
7521733|NCT02881957|26119187|P1|Overall Study|Concurrent trial enrollment|0
7521734|NCT02881957|26119186|P2|Overall Study|Comfort care|1
7521735|NCT02881957|26119187|P1|Overall Study|Comfort care|0
7521736|NCT02881567|26119273|P1|Overall Study|Reason not Specified|3
7521737|NCT02881567|26119273|P1|Overall Study|Study terminated by sponsor|9
7521738|NCT02881567|26119273|P1|Overall Study|Investigator decision|1
7521739|NCT02881567|26119273|P1|Overall Study|Consent withdrawn|1
7521740|NCT02881567|26119273|P1|Overall Study|Lost to Follow-up|3
7521741|NCT02881567|26119273|P1|Overall Study|Adverse Event|1
7521742|NCT02881047|26119289|P1|Overall Study|Withdrawal by Subject|1
7521743|NCT02881047|26119289|P1|Overall Study|Adverse Event|1
7521744|NCT02880865|26119341|P2|Overall Study|Physician Decision|1
7521745|NCT02880865|26119342|P1|Overall Study|Physician Decision|0
7521746|NCT02880865|26119341|P2|Overall Study|Withdrawal by Subject|2
7521747|NCT02880865|26119342|P1|Overall Study|Withdrawal by Subject|0
7521748|NCT02880865|26119341|P2|Overall Study|Adverse Event|0
7521749|NCT02880865|26119342|P1|Overall Study|Adverse Event|1
7521750|NCT02880761|26119425|P2|Overall Study|Lost to Follow-up|4
7521751|NCT02880761|26119426|P1|Overall Study|Lost to Follow-up|3
7521752|NCT02880761|26119425|P2|Overall Study|Protocol Violation|3
7521753|NCT02880761|26119426|P1|Overall Study|Protocol Violation|4
7521754|NCT02880761|26119425|P2|Overall Study|Withdrawal by Subject|6
7521755|NCT02880761|26119426|P1|Overall Study|Withdrawal by Subject|3
7521756|NCT02880761|26119425|P2|Overall Study|Death|8
7521757|NCT02880761|26119426|P1|Overall Study|Death|6
7521758|NCT02879994|26119622|P1|Overall Study|Death|2
7521759|NCT02879994|26119622|P1|Overall Study|Adverse Event|2
7521760|NCT02879994|26119622|P1|Overall Study|off treatment early|7
7521761|NCT02879578|26119672|P3|Overall Study|Physician Decision|4
7521762|NCT02879578|26119673|P2|Overall Study|Physician Decision|0
7521763|NCT02879578|26119674|P1|Overall Study|Physician Decision|0
7521764|NCT02879578|26119672|P3|Overall Study|Lost to Follow-up|4
7521765|NCT02879578|26119673|P2|Overall Study|Lost to Follow-up|0
7521766|NCT02879578|26119674|P1|Overall Study|Lost to Follow-up|1
7521767|NCT02879578|26119672|P3|Overall Study|Withdrawal by Subject|9
7521768|NCT02879578|26119673|P2|Overall Study|Withdrawal by Subject|6
7521769|NCT02879578|26119674|P1|Overall Study|Withdrawal by Subject|8
7521770|NCT02879578|26119672|P3|Overall Study|Protocol Violation|1
7521771|NCT02879578|26119673|P2|Overall Study|Protocol Violation|1
7521772|NCT02879578|26119674|P1|Overall Study|Protocol Violation|0
7521773|NCT02879578|26119672|P3|Overall Study|Adverse Event|14
7521774|NCT02879578|26119673|P2|Overall Study|Adverse Event|2
7521775|NCT02879578|26119674|P1|Overall Study|Adverse Event|1
7521776|NCT02879383|26119686|P4|First 24 Weeks|Physician Decision|0
7521777|NCT02879383|26119687|P3|First 24 Weeks|Physician Decision|0
7521778|NCT02879383|26119688|P2|First 24 Weeks|Physician Decision|1
7521779|NCT02879383|26119689|P1|First 24 Weeks|Physician Decision|0
7521780|NCT02878590|26119724|P1|Overall Study|Withdrawal by Subject|2
7521781|NCT02878330|26119762|P2|Overall Study|Other|7
7521782|NCT02878330|26119763|P1|Overall Study|Other|4
7521783|NCT02878330|26119762|P2|Overall Study|Withdrawal by Subject|21
7521784|NCT02878330|26119763|P1|Overall Study|Withdrawal by Subject|11
7521785|NCT02878330|26119762|P2|Overall Study|Lost to Follow-up|26
7521786|NCT02878330|26119763|P1|Overall Study|Lost to Follow-up|11
7521787|NCT02878330|26119762|P2|Overall Study|Death|2
7521788|NCT02878330|26119763|P1|Overall Study|Death|3
7521789|NCT02878213|26119779|P1|Overall Study|Adverse Event|1
7521790|NCT02878213|26119779|P1|Overall Study|Withdrawal by Subject|2
7521791|NCT02877927|26119794|P2|Overall Study|Missed EOT/PTE Visit|6
7521792|NCT02877927|26119795|P1|Overall Study|Missed EOT/PTE Visit|5
7521793|NCT02877927|26119794|P2|Overall Study|Physician Decision|1
7521794|NCT02877927|26119795|P1|Overall Study|Physician Decision|0
7521795|NCT02877927|26119794|P2|Overall Study|Withdrawal by Subject|12
7521796|NCT02877927|26119795|P1|Overall Study|Withdrawal by Subject|11
7521797|NCT02877927|26119794|P2|Overall Study|Lost to Follow-up|38
7521798|NCT02877927|26119795|P1|Overall Study|Lost to Follow-up|37
7521799|NCT02877927|26119794|P2|Overall Study|Adverse Event|0
7521800|NCT02877927|26119795|P1|Overall Study|Adverse Event|1
7521801|NCT02877680|26119826|P2|Overall Study|Lost to Follow-up|1
7521802|NCT02877680|26119827|P1|Overall Study|Lost to Follow-up|1
7521803|NCT02877082|26119885|P1|Overall Study|Trial was closed early|5
7521804|NCT02877004|26119896|P3|Overall Study|Pregnancy|1
7521805|NCT02877004|26119897|P2|Overall Study|Pregnancy|0
7521806|NCT02877004|26119898|P1|Overall Study|Pregnancy|0
7521807|NCT02876601|26119982|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7521808|NCT02876601|26119983|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
7521809|NCT02876601|26119984|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7521810|NCT02876601|26119985|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7521811|NCT02875977|26120112|P2|Overall Study|Lost to Follow-up|29
7521812|NCT02875977|26120113|P1|Overall Study|Lost to Follow-up|42
7521813|NCT02875834|26120131|P4|Randomized Treatment Phase|(Not collected)|9
7521814|NCT02875834|26120132|P3|Randomized Treatment Phase|(Not collected)|10
7521815|NCT02875834|26120133|P2|Randomized Treatment Phase|(Not collected)|9
7521816|NCT02875834|26120134|P1|Randomized Treatment Phase|(Not collected)|0
7521817|NCT02875834|26120131|P4|Randomized Treatment Phase|Protocol Violation|0
7521818|NCT02875834|26120132|P3|Randomized Treatment Phase|Protocol Violation|0
7521819|NCT02875834|26120133|P2|Randomized Treatment Phase|Protocol Violation|2
7521820|NCT02875834|26120134|P1|Randomized Treatment Phase|Protocol Violation|0
7521821|NCT02875834|26120131|P4|Randomized Treatment Phase|Withdrawal by Subject|0
7521822|NCT02875834|26120132|P3|Randomized Treatment Phase|Withdrawal by Subject|1
7521823|NCT02875834|26120133|P2|Randomized Treatment Phase|Withdrawal by Subject|3
7521824|NCT02875834|26120134|P1|Randomized Treatment Phase|Withdrawal by Subject|0
7521825|NCT02875834|26120131|P4|Open-label Phase|(Not collected)|0
7521826|NCT02875834|26120132|P3|Open-label Phase|(Not collected)|0
7521827|NCT02875834|26120133|P2|Open-label Phase|(Not collected)|0
7521828|NCT02875834|26120134|P1|Open-label Phase|(Not collected)|4
7521829|NCT02875834|26120131|P4|Open-label Phase|Withdrawal by Subject|0
7521830|NCT02875834|26120132|P3|Open-label Phase|Withdrawal by Subject|0
7521831|NCT02875834|26120133|P2|Open-label Phase|Withdrawal by Subject|0
7521832|NCT02875834|26120134|P1|Open-label Phase|Withdrawal by Subject|3
7521833|NCT02875613|26120192|P1|Overall Study|Withdrawal by Subject|1
7521834|NCT02875392|26120198|P2|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
7521835|NCT02875392|26120199|P1|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
7521836|NCT02875366|26120211|P2|Overall Study|Noncompliance|1
7521837|NCT02875366|26120212|P1|Overall Study|Noncompliance|0
7521838|NCT02875366|26120211|P2|Overall Study|Adverse Event|2
7521839|NCT02875366|26120212|P1|Overall Study|Adverse Event|0
7521840|NCT02875340|26120264|P1|Overall Study|Adverse Event|1
7521841|NCT02875340|26120264|P1|Overall Study|Physician Decision|3
7521842|NCT02875340|26120264|P1|Overall Study|Withdrawal by Subject|2
7521843|NCT02875340|26120264|P1|Overall Study|Death|2
7521844|NCT02875080|26120289|P3|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7521845|NCT02875080|26120290|P2|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7521846|NCT02875080|26120291|P1|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
7521847|NCT02875067|26120302|P1|Overall Study|Withdrawal by Termination of Study|5
7521848|NCT02875067|26120302|P1|Overall Study|Withdrawal by Subject|1
7521849|NCT02875028|26120317|P2|Washout Period|Withdrawal by Subject|1
7521850|NCT02875028|26120318|P1|Washout Period|Withdrawal by Subject|0
7521851|NCT02874924|26120349|P3|Overall Study|Withdrawal by Subject|0
7521852|NCT02874924|26120350|P2|Overall Study|Withdrawal by Subject|0
7521853|NCT02874924|26120351|P1|Overall Study|Withdrawal by Subject|1
7521854|NCT02874924|26120349|P3|Overall Study|Adverse Event|0
7521855|NCT02874924|26120350|P2|Overall Study|Adverse Event|0
7521856|NCT02874924|26120351|P1|Overall Study|Adverse Event|2
7521857|NCT02874794|26120384|P2|Overall Study|Death|1
7521858|NCT02874794|26120385|P1|Overall Study|Death|2
7521859|NCT02874794|26120384|P2|Overall Study|Withdrawal by Subject|8
7521860|NCT02874794|26120385|P1|Overall Study|Withdrawal by Subject|2
7521861|NCT02874794|26120384|P2|Overall Study|Physician Decision|2
7521862|NCT02874794|26120385|P1|Overall Study|Physician Decision|3
7521863|NCT02874742|26120417|P3|Overall Study|Ongoing|15
7521864|NCT02874742|26120418|P2|Overall Study|Ongoing|98
7521865|NCT02874742|26120419|P1|Overall Study|Ongoing|87
7521866|NCT02874742|26120417|P3|Overall Study|Other|0
7521867|NCT02874742|26120418|P2|Overall Study|Other|1
7521868|NCT02874742|26120419|P1|Overall Study|Other|3
7521869|NCT02874742|26120417|P3|Overall Study|Withdrawal by Subject|0
7521870|NCT02874742|26120418|P2|Overall Study|Withdrawal by Subject|4
7521871|NCT02874742|26120419|P1|Overall Study|Withdrawal by Subject|8
7521872|NCT02874742|26120417|P3|Overall Study|Lost to Follow-up|0
7521873|NCT02874742|26120418|P2|Overall Study|Lost to Follow-up|0
7521874|NCT02874742|26120419|P1|Overall Study|Lost to Follow-up|2
7521875|NCT02874742|26120417|P3|Overall Study|Death|1
7521876|NCT02874742|26120418|P2|Overall Study|Death|1
7521877|NCT02874742|26120419|P1|Overall Study|Death|3
7521878|NCT02874534|26120473|P2|Overall Study|Ongoing in study|1
7521879|NCT02874534|26120474|P1|Overall Study|Ongoing in study|1
7521880|NCT02874534|26120473|P2|Overall Study|Lost to Follow-up|2
7521881|NCT02874534|26120474|P1|Overall Study|Lost to Follow-up|2
7521882|NCT02874534|26120473|P2|Overall Study|Withdrawal by Subject|8
7521883|NCT02874534|26120474|P1|Overall Study|Withdrawal by Subject|5
7521884|NCT02873936|26120499|P3|Overall Study|Randomized but not Dosed|0
7521885|NCT02873936|26120500|P2|Overall Study|Randomized but not Dosed|0
7521886|NCT02873936|26120501|P1|Overall Study|Randomized but not Dosed|1
7521887|NCT02873936|26120499|P3|Overall Study|Non-compliance With Study Drug|1
7521888|NCT02873936|26120500|P2|Overall Study|Non-compliance With Study Drug|0
7521889|NCT02873936|26120501|P1|Overall Study|Non-compliance With Study Drug|1
7521890|NCT02873936|26120499|P3|Overall Study|Lost to Follow-up|1
7521891|NCT02873936|26120500|P2|Overall Study|Lost to Follow-up|1
7521892|NCT02873936|26120501|P1|Overall Study|Lost to Follow-up|1
7521893|NCT02873936|26120499|P3|Overall Study|Protocol Violation|3
7521894|NCT02873936|26120500|P2|Overall Study|Protocol Violation|1
7521895|NCT02873936|26120501|P1|Overall Study|Protocol Violation|0
7521896|NCT02873936|26120499|P3|Overall Study|Adverse Event|3
7521897|NCT02873936|26120500|P2|Overall Study|Adverse Event|5
7521898|NCT02873936|26120501|P1|Overall Study|Adverse Event|3
7521899|NCT02873936|26120499|P3|Overall Study|Investigator's Discretion|4
7521900|NCT02873936|26120500|P2|Overall Study|Investigator's Discretion|5
7521901|NCT02873936|26120501|P1|Overall Study|Investigator's Discretion|3
7521902|NCT02873936|26120499|P3|Overall Study|Withdrew Consent|20
7521903|NCT02873936|26120500|P2|Overall Study|Withdrew Consent|11
7521904|NCT02873936|26120501|P1|Overall Study|Withdrew Consent|4
7521905|NCT02873754|26120636|P1|Overall Study|Couldn't complete study procedures|1
7521906|NCT02873754|26120636|P1|Overall Study|Lost to Follow-up|5
7521907|NCT02873702|26120653|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
7521908|NCT02873702|26120654|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
7521909|NCT02873702|26120655|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7521910|NCT02873702|26120656|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7521911|NCT02873702|26120653|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
7521912|NCT02873702|26120654|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
7521913|NCT02873702|26120655|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
7521914|NCT02873702|26120656|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
7521915|NCT02873702|26120653|P4|Maintenance Period (up to Month 6)|Adverse Event|0
7521916|NCT02873702|26120654|P3|Maintenance Period (up to Month 6)|Adverse Event|1
7521917|NCT02873702|26120655|P2|Maintenance Period (up to Month 6)|Adverse Event|0
7521918|NCT02873702|26120656|P1|Maintenance Period (up to Month 6)|Adverse Event|0
7521919|NCT02873702|26120653|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
7521920|NCT02873702|26120654|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
7521921|NCT02873702|26120655|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
7521922|NCT02873702|26120656|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
7521923|NCT02873702|26120653|P4|Healing Period (up to Week 8)|Adverse Event|0
7521924|NCT02873702|26120654|P3|Healing Period (up to Week 8)|Adverse Event|0
7521925|NCT02873702|26120655|P2|Healing Period (up to Week 8)|Adverse Event|0
7521926|NCT02873702|26120656|P1|Healing Period (up to Week 8)|Adverse Event|1
7521927|NCT02873689|26120668|P2|Overall Study|Randomized but not Treated|1
7521928|NCT02873689|26120669|P1|Overall Study|Randomized but not Treated|1
7521929|NCT02873689|26120668|P2|Overall Study|Adverse Event|2
7521930|NCT02873689|26120669|P1|Overall Study|Adverse Event|2
7521931|NCT02873689|26120668|P2|Overall Study|Protocol Violation|0
7521932|NCT02873689|26120669|P1|Overall Study|Protocol Violation|1
7521933|NCT02873689|26120668|P2|Overall Study|Withdrawal by Subject|2
7521934|NCT02873689|26120669|P1|Overall Study|Withdrawal by Subject|2
7521935|NCT02873689|26120668|P2|Overall Study|Lack of Efficacy|0
7521936|NCT02873689|26120669|P1|Overall Study|Lack of Efficacy|1
7521937|NCT02873429|26120710|P2|16 Weeks|Lost to Follow-up|0
7521938|NCT02873429|26120711|P1|16 Weeks|Lost to Follow-up|3
7521939|NCT02873429|26120710|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
7521940|NCT02873429|26120711|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
7521941|NCT02873429|26120710|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
7521942|NCT02873429|26120711|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
7521943|NCT02873377|26120723|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
7521944|NCT02873377|26120724|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
7521945|NCT02873377|26120723|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7521946|NCT02873377|26120724|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7521947|NCT02873221|26120982|P3|Safety Follow-up Period|Withdrawal of Consent|8
7521948|NCT02873221|26120983|P2|Safety Follow-up Period|Withdrawal of Consent|10
7521949|NCT02873221|26120984|P1|Safety Follow-up Period|Withdrawal of Consent|4
7521950|NCT02873221|26120982|P3|Safety Follow-up Period|Lost to Follow-up|5
7521951|NCT02873221|26120983|P2|Safety Follow-up Period|Lost to Follow-up|5
7521952|NCT02873221|26120984|P1|Safety Follow-up Period|Lost to Follow-up|3
7521953|NCT02873221|26120982|P3|Safety Follow-up Period|Protocol Violation|1
7521954|NCT02873221|26120983|P2|Safety Follow-up Period|Protocol Violation|0
7521955|NCT02873221|26120984|P1|Safety Follow-up Period|Protocol Violation|0
7521956|NCT02873221|26120982|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
7521957|NCT02873221|26120983|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
7521958|NCT02873221|26120984|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
7521959|NCT02873221|26120982|P3|Treatment Period|Lost to Follow-up|26
7521960|NCT02873221|26120983|P2|Treatment Period|Lost to Follow-up|30
7521961|NCT02873221|26120984|P1|Treatment Period|Lost to Follow-up|26
7521962|NCT02873221|26120982|P3|Treatment Period|Adverse Event|11
7521963|NCT02873221|26120983|P2|Treatment Period|Adverse Event|9
7521964|NCT02873221|26120984|P1|Treatment Period|Adverse Event|4
7521965|NCT02873221|26120982|P3|Treatment Period|Lack of Efficacy|12
7521966|NCT02873221|26120983|P2|Treatment Period|Lack of Efficacy|17
7521967|NCT02873221|26120984|P1|Treatment Period|Lack of Efficacy|0
7521968|NCT02873221|26120982|P3|Treatment Period|Withdrawal of Consent|41
7521969|NCT02873221|26120983|P2|Treatment Period|Withdrawal of Consent|51
7521970|NCT02873221|26120984|P1|Treatment Period|Withdrawal of Consent|52
7521971|NCT02873221|26120982|P3|Treatment Period|Lack of Qualifying Event|1
7521972|NCT02873221|26120983|P2|Treatment Period|Lack of Qualifying Event|3
7521973|NCT02873221|26120984|P1|Treatment Period|Lack of Qualifying Event|0
7521974|NCT02873221|26120982|P3|Treatment Period|Pregnancy|3
7521975|NCT02873221|26120983|P2|Treatment Period|Pregnancy|6
7521976|NCT02873221|26120984|P1|Treatment Period|Pregnancy|4
7521977|NCT02873221|26120982|P3|Treatment Period|Protocol Violation|8
7521978|NCT02873221|26120983|P2|Treatment Period|Protocol Violation|5
7521979|NCT02873221|26120984|P1|Treatment Period|Protocol Violation|2
7521980|NCT02873221|26120982|P3|Treatment Period|Non-Compliance with Study Drug|2
7521981|NCT02873221|26120983|P2|Treatment Period|Non-Compliance with Study Drug|3
7521982|NCT02873221|26120984|P1|Treatment Period|Non-Compliance with Study Drug|0
7521983|NCT02873221|26120982|P3|Treatment Period|Other Miscellaneous Reasons|1
7521984|NCT02873221|26120983|P2|Treatment Period|Other Miscellaneous Reasons|2
7521985|NCT02873221|26120984|P1|Treatment Period|Other Miscellaneous Reasons|0
7521986|NCT02873208|26121004|P1|Overall Study|Physician Decision|1
7521987|NCT02873208|26121004|P1|Overall Study|Lack of Efficacy|1
7521988|NCT02873208|26121004|P1|Overall Study|Incarceration|1
7521989|NCT02873208|26121004|P1|Overall Study|Pregnancy|2
7521990|NCT02873208|26121004|P1|Overall Study|Protocol Violation|8
7521991|NCT02873208|26121004|P1|Overall Study|Non-compliance with study drug|12
7521992|NCT02873208|26121004|P1|Overall Study|Adverse Event|15
7521993|NCT02873208|26121004|P1|Overall Study|Lost to Follow-up|22
7521994|NCT02873208|26121004|P1|Overall Study|Withdrawal by Subject|36
7521995|NCT02873195|26121010|P2|Overall Study|Ineligible|0
7521996|NCT02873195|26121011|P1|Overall Study|Ineligible|5
7521997|NCT02872935|26121040|P2|Overall Study|Other|1
7521998|NCT02872935|26121041|P1|Overall Study|Other|0
7521999|NCT02872311|26121090|P5|Overall Study|Protocol Violation|0
7522000|NCT02872311|26121091|P4|Overall Study|Protocol Violation|0
7522001|NCT02872311|26121092|P3|Overall Study|Protocol Violation|1
7522002|NCT02872311|26121093|P2|Overall Study|Protocol Violation|2
7522003|NCT02872311|26121094|P1|Overall Study|Protocol Violation|0
7522004|NCT02872311|26121090|P5|Overall Study|Lost to Follow-up|0
7522005|NCT02872311|26121091|P4|Overall Study|Lost to Follow-up|0
7522006|NCT02872311|26121092|P3|Overall Study|Lost to Follow-up|0
7522007|NCT02872311|26121093|P2|Overall Study|Lost to Follow-up|0
7522008|NCT02872311|26121094|P1|Overall Study|Lost to Follow-up|2
7522009|NCT02872311|26121090|P5|Overall Study|Death|0
7522010|NCT02872311|26121091|P4|Overall Study|Death|0
7522011|NCT02872311|26121092|P3|Overall Study|Death|0
7522012|NCT02872311|26121093|P2|Overall Study|Death|0
7522013|NCT02872311|26121094|P1|Overall Study|Death|2
7522014|NCT02872285|26121155|P2|Overall Study|Discontinued due to back surgery|0
7522015|NCT02872285|26121156|P1|Overall Study|Discontinued due to back surgery|1
7522016|NCT02872285|26121155|P2|Overall Study|Lost to Follow-up|2
7522017|NCT02872285|26121156|P1|Overall Study|Lost to Follow-up|2
7522018|NCT02872285|26121155|P2|Overall Study|Withdrawal by Subject|0
7522019|NCT02872285|26121156|P1|Overall Study|Withdrawal by Subject|2
7522020|NCT02872142|26121170|P1|Overall Study|Participant Decision|3
7522021|NCT02872142|26121170|P1|Overall Study|Death|1
7522022|NCT02872142|26121170|P1|Overall Study|Adverse Event|2
7522023|NCT02872012|26121222|P5|Overall Study|Withdrawal by Subject|0
7522024|NCT02872012|26121223|P4|Overall Study|Withdrawal by Subject|0
7522025|NCT02872012|26121224|P3|Overall Study|Withdrawal by Subject|0
7522026|NCT02872012|26121225|P2|Overall Study|Withdrawal by Subject|0
7522027|NCT02872012|26121226|P1|Overall Study|Withdrawal by Subject|1
7522028|NCT02871739|26121244|P4|Overall Study|Lost to Follow-up|2
7522029|NCT02871739|26121245|P3|Overall Study|Lost to Follow-up|0
7522030|NCT02871739|26121246|P2|Overall Study|Lost to Follow-up|2
7522031|NCT02871739|26121247|P1|Overall Study|Lost to Follow-up|3
7522032|NCT02871635|26121259|P2|Overall Study|Secondary lack of efficacy|1
7522033|NCT02871635|26121260|P1|Overall Study|Secondary lack of efficacy|2
7522034|NCT02871635|26121259|P2|Overall Study|Adverse Event|4
7522035|NCT02871635|26121260|P1|Overall Study|Adverse Event|4
7522036|NCT02871635|26121259|P2|Overall Study|Withdrawal by Subject|4
7522037|NCT02871635|26121260|P1|Overall Study|Withdrawal by Subject|3
7522038|NCT02871635|26121259|P2|Overall Study|Physician Decision|1
7522039|NCT02871635|26121260|P1|Overall Study|Physician Decision|1
7522040|NCT02871635|26121259|P2|Overall Study|Pregnancy|2
7522041|NCT02871635|26121260|P1|Overall Study|Pregnancy|0
7522042|NCT02871635|26121259|P2|Overall Study|Lost to Follow-up|2
7522043|NCT02871635|26121260|P1|Overall Study|Lost to Follow-up|1
7522044|NCT02871635|26121259|P2|Overall Study|Protocol Violation|1
7522045|NCT02871635|26121260|P1|Overall Study|Protocol Violation|3
7522046|NCT02871635|26121259|P2|Overall Study|Primary lack of efficacy|4
7522047|NCT02871635|26121260|P1|Overall Study|Primary lack of efficacy|4
7522048|NCT02871492|26121318|P3|Overall Study|Withdrawal by Subject|1
7522049|NCT02871492|26121319|P2|Overall Study|Withdrawal by Subject|0
7522050|NCT02871492|26121320|P1|Overall Study|Withdrawal by Subject|0
7522051|NCT02871492|26121318|P3|Overall Study|Lost to Follow-up|5
7522052|NCT02871492|26121319|P2|Overall Study|Lost to Follow-up|3
7522053|NCT02871492|26121320|P1|Overall Study|Lost to Follow-up|6
7522054|NCT02871375|26121363|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
7522055|NCT02871375|26121364|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
7522056|NCT02870972|26121413|P5|Overall Study|Adverse Event|0
7522057|NCT02870972|26121414|P4|Overall Study|Adverse Event|0
7522058|NCT02870972|26121415|P3|Overall Study|Adverse Event|0
7522059|NCT02870972|26121416|P2|Overall Study|Adverse Event|0
7522060|NCT02870972|26121417|P1|Overall Study|Adverse Event|1
7522061|NCT02870933|26121471|P2|Overall Study|Withdrawal by Subject|1
7522062|NCT02870933|26121472|P1|Overall Study|Withdrawal by Subject|0
7522063|NCT02870933|26121471|P2|Overall Study|Death|1
7522064|NCT02870933|26121472|P1|Overall Study|Death|2
7522065|NCT02869893|26121567|P1|Overall Study|participant fear of MRI scanner|2
7522066|NCT02869893|26121567|P1|Overall Study|participant aversion to IV|5
7522067|NCT02869438|26121597|P2|Overall Study|Withdrawal by Subject|2
7522068|NCT02869438|26121598|P1|Overall Study|Withdrawal by Subject|1
7522069|NCT02869438|26121597|P2|Overall Study|Adverse Event|0
7522070|NCT02869438|26121598|P1|Overall Study|Adverse Event|1
7522071|NCT02869438|26121597|P2|Overall Study|Lost to Follow-up|0
7522072|NCT02869438|26121598|P1|Overall Study|Lost to Follow-up|1
7522073|NCT02868892|26121689|P1|Overall Study|Investigator left site and no follow-up|6
7522074|NCT02868554|26121698|P3|Overall Study|Lost to Follow-up|1
7522075|NCT02868554|26121699|P2|Overall Study|Lost to Follow-up|0
7522076|NCT02868554|26121700|P1|Overall Study|Lost to Follow-up|3
7522077|NCT02868281|26121725|P2|Overall Study|Long journey/moving away|1
7522078|NCT02868281|26121726|P1|Overall Study|Long journey/moving away|1
7522079|NCT02868281|26121725|P2|Overall Study|Inclusion/exclusion criteria violation|2
7522080|NCT02868281|26121726|P1|Overall Study|Inclusion/exclusion criteria violation|3
7522081|NCT02868281|26121725|P2|Overall Study|Had protocol-defined asthma exacerbation|8
7522082|NCT02868281|26121726|P1|Overall Study|Had protocol-defined asthma exacerbation|8
7522083|NCT02868281|26121725|P2|Overall Study|Physician Decision|0
7522084|NCT02868281|26121726|P1|Overall Study|Physician Decision|2
7522085|NCT02868281|26121725|P2|Overall Study|Withdrawal by Subject|15
7522086|NCT02868281|26121726|P1|Overall Study|Withdrawal by Subject|11
7522087|NCT02868281|26121725|P2|Overall Study|Lost to Follow-up|6
7522088|NCT02868281|26121726|P1|Overall Study|Lost to Follow-up|3
7522089|NCT02868281|26121725|P2|Overall Study|Protocol Violation|10
7522090|NCT02868281|26121726|P1|Overall Study|Protocol Violation|13
7522091|NCT02868281|26121725|P2|Overall Study|Adverse Event|2
7522092|NCT02868281|26121726|P1|Overall Study|Adverse Event|2
7522093|NCT02868229|26121762|P4|Overall Study|Missed dose|3
7522094|NCT02868229|26121763|P3|Overall Study|Missed dose|0
7522095|NCT02868229|26121764|P2|Overall Study|Missed dose|0
7522096|NCT02868229|26121765|P1|Overall Study|Missed dose|0
7522097|NCT02868229|26121762|P4|Overall Study|Death|1
7522098|NCT02868229|26121763|P3|Overall Study|Death|1
7522099|NCT02868229|26121764|P2|Overall Study|Death|0
7522100|NCT02868229|26121765|P1|Overall Study|Death|0
7522101|NCT02868229|26121762|P4|Overall Study|Adverse Event|1
7522102|NCT02868229|26121763|P3|Overall Study|Adverse Event|0
7522103|NCT02868229|26121764|P2|Overall Study|Adverse Event|0
7522104|NCT02868229|26121765|P1|Overall Study|Adverse Event|1
7522105|NCT02868216|26122302|P2|Overall Study|Withdrawal by Subject|5
7522106|NCT02868216|26122303|P1|Overall Study|Withdrawal by Subject|7
7522107|NCT02868216|26122302|P2|Overall Study|coronary artery bypass|0
7522108|NCT02868216|26122303|P1|Overall Study|coronary artery bypass|1
7522109|NCT02868216|26122302|P2|Overall Study|Death|1
7522110|NCT02868216|26122303|P1|Overall Study|Death|0
7522111|NCT02867995|26122311|P2|Overall Study|Lost to Follow-up|2
7522112|NCT02867995|26122312|P1|Overall Study|Lost to Follow-up|0
7522113|NCT02867995|26122311|P2|Overall Study|Withdrawal by Subject|1
7522114|NCT02867995|26122312|P1|Overall Study|Withdrawal by Subject|0
7522115|NCT02867709|26122331|P3|Safety Follow-up Period|Protocol Violation|1
7522116|NCT02867709|26122332|P2|Safety Follow-up Period|Protocol Violation|1
7522117|NCT02867709|26122333|P1|Safety Follow-up Period|Protocol Violation|0
7522118|NCT02867709|26122331|P3|Safety Follow-up Period|Pregnancy|0
7522119|NCT02867709|26122332|P2|Safety Follow-up Period|Pregnancy|1
7522120|NCT02867709|26122333|P1|Safety Follow-up Period|Pregnancy|0
7522121|NCT02867709|26122331|P3|Safety Follow-up Period|Lost to Follow-up|7
7522122|NCT02867709|26122332|P2|Safety Follow-up Period|Lost to Follow-up|5
7522123|NCT02867709|26122333|P1|Safety Follow-up Period|Lost to Follow-up|10
7522124|NCT02867709|26122331|P3|Safety Follow-up Period|Withdrawal of Consent|6
7522125|NCT02867709|26122332|P2|Safety Follow-up Period|Withdrawal of Consent|8
7522126|NCT02867709|26122333|P1|Safety Follow-up Period|Withdrawal of Consent|1
7522127|NCT02867709|26122331|P3|Treatment Period|Protocol Violation|3
7522128|NCT02867709|26122332|P2|Treatment Period|Protocol Violation|2
7522129|NCT02867709|26122333|P1|Treatment Period|Protocol Violation|3
7522130|NCT02867709|26122331|P3|Treatment Period|Lack of Qualifying Event|42
7522131|NCT02867709|26122332|P2|Treatment Period|Lack of Qualifying Event|55
7522132|NCT02867709|26122333|P1|Treatment Period|Lack of Qualifying Event|42
7522133|NCT02867709|26122331|P3|Treatment Period|Lost to Follow-up|20
7522134|NCT02867709|26122332|P2|Treatment Period|Lost to Follow-up|20
7522135|NCT02867709|26122333|P1|Treatment Period|Lost to Follow-up|17
7522136|NCT02867709|26122331|P3|Treatment Period|Withdrawal of Consent|8
7522137|NCT02867709|26122332|P2|Treatment Period|Withdrawal of Consent|9
7522138|NCT02867709|26122333|P1|Treatment Period|Withdrawal of Consent|7
7522139|NCT02867709|26122331|P3|Treatment Period|Adverse Event|2
7522140|NCT02867709|26122332|P2|Treatment Period|Adverse Event|1
7522141|NCT02867709|26122333|P1|Treatment Period|Adverse Event|1
7522142|NCT02866942|26122445|P1|Overall Study|Invalid consent|1
7522143|NCT02866695|26122450|P1|Overall Study|Lost to Follow-up|1
7522144|NCT02866695|26122450|P1|Overall Study|Adverse Event|1
7522145|NCT02866175|26122467|P2|Overall Study|Did not receive treatment|15
7522146|NCT02866175|26122468|P1|Overall Study|Did not receive treatment|5
7522147|NCT02866175|26122467|P2|Overall Study|Physician Decision|15
7522148|NCT02866175|26122468|P1|Overall Study|Physician Decision|3
7522149|NCT02866175|26122467|P2|Overall Study|Lack of Efficacy|1
7522150|NCT02866175|26122468|P1|Overall Study|Lack of Efficacy|0
7522151|NCT02866175|26122467|P2|Overall Study|Lost to Follow-up|0
7522152|NCT02866175|26122468|P1|Overall Study|Lost to Follow-up|2
7522153|NCT02866175|26122467|P2|Overall Study|Progressive disease|1
7522154|NCT02866175|26122468|P1|Overall Study|Progressive disease|1
7522155|NCT02866175|26122467|P2|Overall Study|Other|14
7522156|NCT02866175|26122468|P1|Overall Study|Other|7
7522157|NCT02866175|26122467|P2|Overall Study|Death|23
7522158|NCT02866175|26122468|P1|Overall Study|Death|30
7522159|NCT02866175|26122467|P2|Overall Study|Withdrawal by Subject|52
7522160|NCT02866175|26122468|P1|Overall Study|Withdrawal by Subject|31
7522161|NCT02866175|26122467|P2|Overall Study|Adverse Event|54
7522162|NCT02866175|26122468|P1|Overall Study|Adverse Event|56
7522163|NCT02865915|26122488|P2|Overall Study|Dosing group discontinued|5
7522164|NCT02865915|26122489|P1|Overall Study|Dosing group discontinued|0
7522165|NCT02865915|26122488|P2|Overall Study|Study terminated by sponsor|18
7522166|NCT02865915|26122489|P1|Overall Study|Study terminated by sponsor|23
7522167|NCT02865915|26122488|P2|Overall Study|Protocol Violation|1
7522168|NCT02865915|26122489|P1|Overall Study|Protocol Violation|0
7522169|NCT02865915|26122488|P2|Overall Study|Lost to Follow-up|1
7522170|NCT02865915|26122489|P1|Overall Study|Lost to Follow-up|0
7522171|NCT02865915|26122488|P2|Overall Study|Adverse Event|4
7522172|NCT02865915|26122489|P1|Overall Study|Adverse Event|0
7522173|NCT02865915|26122488|P2|Overall Study|Withdrawal by Subject|1
7522174|NCT02865915|26122489|P1|Overall Study|Withdrawal by Subject|1
7522175|NCT02865915|26122488|P2|Overall Study|Pregnancy|0
7522176|NCT02865915|26122489|P1|Overall Study|Pregnancy|1
7522177|NCT02865538|26122546|P5|Overall Study|Lost to Follow-up|0
7522178|NCT02865538|26122547|P4|Overall Study|Lost to Follow-up|0
7522179|NCT02865538|26122548|P3|Overall Study|Lost to Follow-up|0
7522180|NCT02865538|26122549|P2|Overall Study|Lost to Follow-up|0
7522181|NCT02865538|26122550|P1|Overall Study|Lost to Follow-up|1
7522182|NCT02865538|26122546|P5|Overall Study|Withdrawal by Subject|0
7522183|NCT02865538|26122547|P4|Overall Study|Withdrawal by Subject|0
7522184|NCT02865538|26122548|P3|Overall Study|Withdrawal by Subject|1
7522185|NCT02865538|26122549|P2|Overall Study|Withdrawal by Subject|0
7522186|NCT02865538|26122550|P1|Overall Study|Withdrawal by Subject|0
7522187|NCT02865499|26122832|P1|Baseline|Withdrawal by Subject|1
7522188|NCT02865499|26122832|P1|Baseline|Adverse Event|1
7522189|NCT02865395|26123018|P3|Overall Study|Physician Decision|7
7522190|NCT02865395|26123019|P2|Overall Study|Physician Decision|10
7522191|NCT02865395|26123020|P1|Overall Study|Physician Decision|6
7522192|NCT02865187|26123046|P2|Overall Study|Adverse Event|0
7522193|NCT02865187|26123047|P1|Overall Study|Adverse Event|1
7522194|NCT02865187|26123046|P2|Overall Study|Lost to Follow-up|7
7522195|NCT02865187|26123047|P1|Overall Study|Lost to Follow-up|12
7522196|NCT02865122|26123058|P3|Overall Study|Adverse Event|0
7522197|NCT02865122|26123059|P2|Overall Study|Adverse Event|0
7522198|NCT02865122|26123060|P1|Overall Study|Adverse Event|1
7522199|NCT02865083|26123070|P2|Overall Study|Early Termination|1
7522200|NCT02865083|26123071|P1|Overall Study|Early Termination|3
7522201|NCT02864394|26123132|P2|Overall Study|Ongoing In Study|53
7522202|NCT02864394|26123133|P1|Overall Study|Ongoing In Study|77
7522203|NCT02864394|26123132|P2|Overall Study|Withdrawal by Subject|9
7522204|NCT02864394|26123133|P1|Overall Study|Withdrawal by Subject|1
7522205|NCT02864394|26123132|P2|Overall Study|Death|150
7522206|NCT02864394|26123133|P1|Overall Study|Death|135
7522207|NCT02864381|26123159|P2|Overall Study|Protocol Violation|1
7522208|NCT02864381|26123160|P1|Overall Study|Protocol Violation|0
7522209|NCT02864381|26123159|P2|Overall Study|Investigator's Discretion|0
7522210|NCT02864381|26123160|P1|Overall Study|Investigator's Discretion|1
7522211|NCT02864381|26123159|P2|Overall Study|Lost to Follow-up|1
7522212|NCT02864381|26123160|P1|Overall Study|Lost to Follow-up|1
7522213|NCT02864381|26123159|P2|Overall Study|Reason Unknown|3
7522214|NCT02864381|26123160|P1|Overall Study|Reason Unknown|7
7522215|NCT02864381|26123159|P2|Overall Study|Withdrew Consent|6
7522216|NCT02864381|26123160|P1|Overall Study|Withdrew Consent|5
7522217|NCT02864381|26123159|P2|Overall Study|Death|61
7522218|NCT02864381|26123160|P1|Overall Study|Death|58
7522219|NCT02864342|26123197|P2|Overall Study|Adverse Event|0
7522220|NCT02864342|26123198|P1|Overall Study|Adverse Event|1
7522221|NCT02864342|26123197|P2|Overall Study|Lost Device|0
7522222|NCT02864342|26123198|P1|Overall Study|Lost Device|1
7522223|NCT02864342|26123197|P2|Overall Study|Lost to Follow-up|5
7522224|NCT02864342|26123198|P1|Overall Study|Lost to Follow-up|1
7522225|NCT02864342|26123197|P2|Overall Study|Did Not Start Treatment with Symbicort|1
7522226|NCT02864342|26123198|P1|Overall Study|Did Not Start Treatment with Symbicort|0
7522227|NCT02864342|26123197|P2|Overall Study|Death|1
7522228|NCT02864342|26123198|P1|Overall Study|Death|0
7522229|NCT02864342|26123197|P2|Overall Study|Device Technology Issue|7
7522230|NCT02864342|26123198|P1|Overall Study|Device Technology Issue|6
7522231|NCT02864342|26123197|P2|Overall Study|Withdrawal by Subject|2
7522232|NCT02864342|26123198|P1|Overall Study|Withdrawal by Subject|4
7522233|NCT02864342|26123197|P2|Overall Study|Eligibility Criteria Deviation|3
7522234|NCT02864342|26123198|P1|Overall Study|Eligibility Criteria Deviation|2
7522235|NCT02864316|26123215|P2|Overall Study|Adverse Event|1
7522236|NCT02864316|26123216|P1|Overall Study|Adverse Event|0
7522237|NCT02864316|26123215|P2|Overall Study|Progressive Disease|1
7522238|NCT02864316|26123216|P1|Overall Study|Progressive Disease|2
7522239|NCT02864082|26123234|P2|Overall Study|Withdrawal by Subject|2
7522240|NCT02864082|26123235|P1|Overall Study|Withdrawal by Subject|2
7522241|NCT02864082|26123234|P2|Overall Study|Lost to Follow-up|1
7522242|NCT02864082|26123235|P1|Overall Study|Lost to Follow-up|0
7522243|NCT02864082|26123234|P2|Overall Study|Adverse Event|1
7522244|NCT02864082|26123235|P1|Overall Study|Adverse Event|1
7522245|NCT02863575|26123281|P3|Overall Study|Adverse Event|0
7522246|NCT02863575|26123282|P2|Overall Study|Adverse Event|1
7522247|NCT02863575|26123283|P1|Overall Study|Adverse Event|0
7522248|NCT02863575|26123281|P3|Overall Study|Withdrawal by Subject|1
7522249|NCT02863575|26123282|P2|Overall Study|Withdrawal by Subject|1
7522250|NCT02863575|26123283|P1|Overall Study|Withdrawal by Subject|0
7522251|NCT02863575|26123281|P3|Overall Study|Participants Unable To Swallow Capsule|0
7522252|NCT02863575|26123282|P2|Overall Study|Participants Unable To Swallow Capsule|0
7522253|NCT02863575|26123283|P1|Overall Study|Participants Unable To Swallow Capsule|1
7522254|NCT02863419|26123335|P3|Overall Study|Died|1
7522255|NCT02863419|26123336|P2|Overall Study|Died|4
7522256|NCT02863419|26123337|P1|Overall Study|Died|3
7522257|NCT02863419|26123335|P3|Overall Study|Withdrawal by Subject|3
7522258|NCT02863419|26123336|P2|Overall Study|Withdrawal by Subject|5
7522259|NCT02863419|26123337|P1|Overall Study|Withdrawal by Subject|5
7522260|NCT02863419|26123335|P3|Overall Study|Lost to Follow-up|4
7522261|NCT02863419|26123336|P2|Overall Study|Lost to Follow-up|1
7522262|NCT02863419|26123337|P1|Overall Study|Lost to Follow-up|0
7522263|NCT02863354|26123454|P2|Year 2|Lost to Follow-up|2
7522264|NCT02863354|26123455|P1|Year 2|Lost to Follow-up|2
7522265|NCT02863354|26123454|P2|Year 1|Death|1
7522266|NCT02863354|26123455|P1|Year 1|Death|0
7522267|NCT02863354|26123454|P2|Year 1|Withdrawal by Subject|0
7522268|NCT02863354|26123455|P1|Year 1|Withdrawal by Subject|3
7522269|NCT02863354|26123454|P2|Year 1|Lost to Follow-up|1
7522270|NCT02863354|26123455|P1|Year 1|Lost to Follow-up|1
7522271|NCT02863328|26123485|P2|Overall Study|Died|1
7522272|NCT02863328|26123486|P1|Overall Study|Died|0
7522273|NCT02863328|26123485|P2|Overall Study|Withdrawal by Subject|12
7522274|NCT02863328|26123486|P1|Overall Study|Withdrawal by Subject|7
7522275|NCT02863328|26123485|P2|Overall Study|Lost to Follow-up|10
7522276|NCT02863328|26123486|P1|Overall Study|Lost to Follow-up|4
7522277|NCT02862730|26123643|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7522278|NCT02862730|26123644|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7522279|NCT02862730|26123645|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7522280|NCT02862730|26123646|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
7522281|NCT02862730|26123647|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7522282|NCT02862730|26123648|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7522283|NCT02862730|26123649|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7522284|NCT02862730|26123643|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7522285|NCT02862730|26123644|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7522286|NCT02862730|26123645|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7522287|NCT02862730|26123646|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7522288|NCT02862730|26123647|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7522289|NCT02862730|26123648|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7522290|NCT02862730|26123649|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7522291|NCT02862730|26123643|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
7522292|NCT02862730|26123644|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
7522293|NCT02862730|26123645|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
7522294|NCT02862730|26123646|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
7522295|NCT02862730|26123647|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
7522296|NCT02862730|26123648|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
7522297|NCT02862730|26123649|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
7522298|NCT02862730|26123643|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7522299|NCT02862730|26123644|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7522300|NCT02862730|26123645|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7522301|NCT02862730|26123646|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7522302|NCT02862730|26123647|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
7522303|NCT02862730|26123648|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7522304|NCT02862730|26123649|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7522305|NCT02862600|26123704|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
7522306|NCT02862600|26123704|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
7522307|NCT02862600|26123704|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
7522308|NCT02862600|26123704|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
7522309|NCT02862574|26123714|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
7522310|NCT02862574|26123715|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
7522311|NCT02862574|26123716|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
7522312|NCT02862574|26123714|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
7522313|NCT02862574|26123715|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
7522314|NCT02862574|26123716|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
7522315|NCT02862574|26123714|P3|Double-Blind Treatment Period|Adverse Event|0
7522316|NCT02862574|26123715|P2|Double-Blind Treatment Period|Adverse Event|1
7522317|NCT02862574|26123716|P1|Double-Blind Treatment Period|Adverse Event|0
7522318|NCT02862548|26123736|P2|Open-Label Extension Phase|Still on Study|24
7522319|NCT02862548|26123737|P1|Open-Label Extension Phase|Still on Study|26
7522320|NCT02862548|26123736|P2|Open-Label Phase|Death|1
7522321|NCT02862548|26123737|P1|Open-Label Phase|Death|0
7522322|NCT02862535|26123765|P4|Overall Study|Enrolled, not Treated|1
7522323|NCT02862535|26123766|P3|Overall Study|Enrolled, not Treated|0
7522324|NCT02862535|26123767|P2|Overall Study|Enrolled, not Treated|0
7522325|NCT02862535|26123768|P1|Overall Study|Enrolled, not Treated|1
7522326|NCT02862535|26123765|P4|Overall Study|Study Terminated by Sponsor|5
7522327|NCT02862535|26123766|P3|Overall Study|Study Terminated by Sponsor|8
7522328|NCT02862535|26123767|P2|Overall Study|Study Terminated by Sponsor|3
7522329|NCT02862535|26123768|P1|Overall Study|Study Terminated by Sponsor|1
7522330|NCT02862535|26123765|P4|Overall Study|Death|5
7522331|NCT02862535|26123766|P3|Overall Study|Death|2
7522332|NCT02862535|26123767|P2|Overall Study|Death|3
7522333|NCT02862535|26123768|P1|Overall Study|Death|7
7522334|NCT02862106|26123796|P2|Overall Study|Subjects moved to other city|0
7522335|NCT02862106|26123797|P1|Overall Study|Subjects moved to other city|1
7522336|NCT02862106|26123796|P2|Overall Study|Withdrawal by Subject|0
7522337|NCT02862106|26123797|P1|Overall Study|Withdrawal by Subject|2
7522338|NCT02862106|26123796|P2|Overall Study|Lost to Follow-up|5
7522339|NCT02862106|26123797|P1|Overall Study|Lost to Follow-up|15
7522340|NCT02862106|26123796|P2|Overall Study|Protocol Violation|1
7522341|NCT02862106|26123797|P1|Overall Study|Protocol Violation|16
7522342|NCT02862106|26123796|P2|Overall Study|Adverse Event|0
7522343|NCT02862106|26123797|P1|Overall Study|Adverse Event|4
7522344|NCT02861807|26123918|P2|Overall Study|Withdrawal by Subject|8
7522345|NCT02861807|26123919|P1|Overall Study|Withdrawal by Subject|5
7522346|NCT02861807|26123918|P2|Overall Study|Lost to Follow-up|6
7522347|NCT02861807|26123919|P1|Overall Study|Lost to Follow-up|7
7522348|NCT02861664|26123935|P2|Overall Study|Withdrawal of Consent|1
7522349|NCT02861664|26123936|P1|Overall Study|Withdrawal of Consent|0
7522374|NCT02861534|26124049|P2|Overall Study|Withdrawal by Subject|18
7522375|NCT02861534|26124050|P1|Overall Study|Withdrawal by Subject|15
7522376|NCT02861534|26124049|P2|Overall Study|Site Terminated by Sponsor|3
7522377|NCT02861534|26124050|P1|Overall Study|Site Terminated by Sponsor|4
7522378|NCT02861534|26124049|P2|Overall Study|Lost to Follow-up|14
7522379|NCT02861534|26124050|P1|Overall Study|Lost to Follow-up|14
7522380|NCT02861534|26124049|P2|Overall Study|Death|552
7522381|NCT02861534|26124050|P1|Overall Study|Death|541
7522382|NCT02861014|26124108|P1|Overall Study|Commercial ocrelizumab|3
7522383|NCT02861014|26124108|P1|Overall Study|Withdrawal by Subject|14
7522384|NCT02861014|26124108|P1|Overall Study|Study Terminated By Sponsor|3
7522385|NCT02861014|26124108|P1|Overall Study|Protocol Violation|2
7522386|NCT02861014|26124108|P1|Overall Study|Pregnancy|4
7522387|NCT02861014|26124108|P1|Overall Study|Physician Decision|2
7522388|NCT02861014|26124108|P1|Overall Study|Lack of Efficacy|3
7522389|NCT02861014|26124108|P1|Overall Study|Death|1
7522390|NCT02861014|26124108|P1|Overall Study|Adverse Event|7
7522391|NCT02860546|26124178|P1|Overall Study|Radiological Progression|12
7522392|NCT02860546|26124178|P1|Overall Study|Clinical Progression|6
7522393|NCT02860169|26124229|P1|Part C|Other (Screening failure)|1
7522394|NCT02860169|26124229|P1|Part B|Withdrawal by Subject|1
7522395|NCT02860169|26124229|P1|Part B|Other (Screening failure)|10
7522396|NCT02860169|26124229|P1|Part A|Other (did not completed consent)|1
7522397|NCT02860169|26124229|P1|Part A|Other (Survey not completed)|3
7522398|NCT02860169|26124229|P1|Part A|Other (Screening failure)|6
7522399|NCT02860169|26124229|P1|Part A|Withdrawal by Subject|1
7522400|NCT02860130|26124247|P2|Overall Study|Other|1
7522401|NCT02860130|26124248|P1|Overall Study|Other|2
7522402|NCT02860130|26124247|P2|Overall Study|Physician Decision|2
7522403|NCT02860130|26124248|P1|Overall Study|Physician Decision|2
7522404|NCT02860130|26124247|P2|Overall Study|Withdrawal by Subject|2
7522405|NCT02860130|26124248|P1|Overall Study|Withdrawal by Subject|0
7522406|NCT02860130|26124247|P2|Overall Study|Protocol Violation|1
7522407|NCT02860130|26124248|P1|Overall Study|Protocol Violation|1
7522408|NCT02860130|26124247|P2|Overall Study|Adverse Event|3
7522409|NCT02860130|26124248|P1|Overall Study|Adverse Event|2
7522410|NCT02859454|26124313|P1|Overall Study|PI discretion/off study prior to trtmt|1
7522411|NCT02859324|26124372|P3|Overall Study|Other reasons|0
7522412|NCT02859324|26124373|P2|Overall Study|Other reasons|3
7522413|NCT02859324|26124374|P1|Overall Study|Other reasons|3
7522414|NCT02859324|26124372|P3|Overall Study|Death|5
7522415|NCT02859324|26124373|P2|Overall Study|Death|6
7522416|NCT02859324|26124374|P1|Overall Study|Death|4
7522417|NCT02859246|26124418|P1|Overall Study|Withdrawal by Subject|1
7522418|NCT02859246|26124418|P1|Overall Study|Adverse Event|1
7522419|NCT02859246|26124418|P1|Overall Study|Screen fails|3
7522420|NCT02859142|26124425|P2|Overall Study|Scheduling difficulties|3
7522421|NCT02859142|26124426|P1|Overall Study|Scheduling difficulties|0
7522422|NCT02859142|26124425|P2|Overall Study|Withdrawal by Subject|0
7522423|NCT02859142|26124426|P1|Overall Study|Withdrawal by Subject|2
7522424|NCT02859142|26124425|P2|Overall Study|Lost to Follow-up|4
7522425|NCT02859142|26124426|P1|Overall Study|Lost to Follow-up|1
7522426|NCT02859142|26124425|P2|Overall Study|Adverse Event|2
7522427|NCT02859142|26124426|P1|Overall Study|Adverse Event|1
7522428|NCT02858726|26124446|P4|Overall Study|Noncompliance|0
7522429|NCT02858726|26124447|P3|Overall Study|Noncompliance|0
7522430|NCT02858726|26124448|P2|Overall Study|Noncompliance|1
7522431|NCT02858726|26124449|P1|Overall Study|Noncompliance|0
7522432|NCT02858726|26124446|P4|Overall Study|Withdrawal by Subject|0
7522433|NCT02858726|26124447|P3|Overall Study|Withdrawal by Subject|1
7522434|NCT02858726|26124448|P2|Overall Study|Withdrawal by Subject|2
7522435|NCT02858726|26124449|P1|Overall Study|Withdrawal by Subject|1
7522436|NCT02858726|26124446|P4|Overall Study|Study Terminated by Sponsor|1
7522437|NCT02858726|26124447|P3|Overall Study|Study Terminated by Sponsor|0
7522438|NCT02858726|26124448|P2|Overall Study|Study Terminated by Sponsor|0
7522439|NCT02858726|26124449|P1|Overall Study|Study Terminated by Sponsor|0
7522440|NCT02858726|26124446|P4|Overall Study|Protocol Violation|1
7522441|NCT02858726|26124447|P3|Overall Study|Protocol Violation|0
7522442|NCT02858726|26124448|P2|Overall Study|Protocol Violation|0
7522443|NCT02858726|26124449|P1|Overall Study|Protocol Violation|0
7522444|NCT02858726|26124446|P4|Overall Study|Physician Decision|0
7522445|NCT02858726|26124447|P3|Overall Study|Physician Decision|1
7522446|NCT02858726|26124448|P2|Overall Study|Physician Decision|0
7522447|NCT02858726|26124449|P1|Overall Study|Physician Decision|0
7522448|NCT02858726|26124446|P4|Overall Study|Adverse Event|1
7522449|NCT02858726|26124447|P3|Overall Study|Adverse Event|9
7522450|NCT02858726|26124448|P2|Overall Study|Adverse Event|4
7522451|NCT02858726|26124449|P1|Overall Study|Adverse Event|4
7522452|NCT02858492|26124480|P4|Overall Study|Protocol defined stopping criteria|1
7522453|NCT02858492|26124481|P3|Overall Study|Protocol defined stopping criteria|0
7522454|NCT02858492|26124482|P2|Overall Study|Protocol defined stopping criteria|0
7522455|NCT02858492|26124483|P1|Overall Study|Protocol defined stopping criteria|0
7522456|NCT02858492|26124480|P4|Overall Study|Lack of Efficacy|1
7522457|NCT02858492|26124481|P3|Overall Study|Lack of Efficacy|0
7522458|NCT02858492|26124482|P2|Overall Study|Lack of Efficacy|0
7522459|NCT02858492|26124483|P1|Overall Study|Lack of Efficacy|0
7522460|NCT02858492|26124480|P4|Overall Study|Adverse Event|3
7522461|NCT02858492|26124481|P3|Overall Study|Adverse Event|0
7522462|NCT02858492|26124482|P2|Overall Study|Adverse Event|0
7522463|NCT02858492|26124483|P1|Overall Study|Adverse Event|0
7522464|NCT02858492|26124480|P4|Overall Study|Withdrawal by Subject|1
7522465|NCT02858492|26124481|P3|Overall Study|Withdrawal by Subject|0
7522466|NCT02858492|26124482|P2|Overall Study|Withdrawal by Subject|1
7522467|NCT02858492|26124483|P1|Overall Study|Withdrawal by Subject|0
7522468|NCT02858440|26124659|P1|Overall Study|Migrated/moved from study area|4
7522469|NCT02858440|26124659|P1|Overall Study|Consent withdrawal|3
7522470|NCT02858440|26124659|P1|Overall Study|Protocol Violation|2
7522471|NCT02858440|26124659|P1|Overall Study|Lost to Follow-up|3
7522472|NCT02858401|26124692|P7|Overall Study|Lost to Follow-up|0
7522473|NCT02858401|26124693|P6|Overall Study|Lost to Follow-up|0
7522474|NCT02858401|26124694|P5|Overall Study|Lost to Follow-up|0
7522475|NCT02858401|26124695|P4|Overall Study|Lost to Follow-up|0
7522476|NCT02858401|26124696|P3|Overall Study|Lost to Follow-up|0
7522477|NCT02858401|26124697|P2|Overall Study|Lost to Follow-up|1
7522478|NCT02858401|26124698|P1|Overall Study|Lost to Follow-up|0
7522479|NCT02858401|26124692|P7|Overall Study|Withdrew Consent|0
7522480|NCT02858401|26124693|P6|Overall Study|Withdrew Consent|1
7522481|NCT02858401|26124694|P5|Overall Study|Withdrew Consent|0
7522482|NCT02858401|26124695|P4|Overall Study|Withdrew Consent|0
7522483|NCT02858401|26124696|P3|Overall Study|Withdrew Consent|0
7522484|NCT02858401|26124697|P2|Overall Study|Withdrew Consent|0
7522485|NCT02858401|26124698|P1|Overall Study|Withdrew Consent|0
7522486|NCT02858362|26125109|P3|Overall Study|Lost to Follow-up|0
7522487|NCT02858362|26125110|P2|Overall Study|Lost to Follow-up|0
7522488|NCT02858362|26125111|P1|Overall Study|Lost to Follow-up|1
7522489|NCT02858362|26125109|P3|Overall Study|Early Study Termination|3
7522490|NCT02858362|26125110|P2|Overall Study|Early Study Termination|0
7522491|NCT02858362|26125111|P1|Overall Study|Early Study Termination|0
7522492|NCT02858362|26125109|P3|Overall Study|Withdrawal by Subject|0
7522493|NCT02858362|26125110|P2|Overall Study|Withdrawal by Subject|0
7522494|NCT02858362|26125111|P1|Overall Study|Withdrawal by Subject|1
7522495|NCT02858362|26125109|P3|Overall Study|Protocol Violation|0
7522496|NCT02858362|26125110|P2|Overall Study|Protocol Violation|1
7522497|NCT02858362|26125111|P1|Overall Study|Protocol Violation|0
7522498|NCT02858180|26125152|P2|Overall Study|Lost to Follow-up|2
7522499|NCT02858180|26125153|P1|Overall Study|Lost to Follow-up|0
7522500|NCT02858076|26125172|P2|Overall Study|Completed Out of Window|3
7522501|NCT02858076|26125173|P1|Overall Study|Completed Out of Window|1
7522502|NCT02858076|26125172|P2|Overall Study|Lost to Follow-up|7
7522503|NCT02858076|26125173|P1|Overall Study|Lost to Follow-up|2
7522504|NCT02858076|26125172|P2|Overall Study|Withdrawal by Subject|5
7522505|NCT02858076|26125173|P1|Overall Study|Withdrawal by Subject|1
7522506|NCT02858076|26125172|P2|Overall Study|Death|3
7522507|NCT02858076|26125173|P1|Overall Study|Death|6
7522508|NCT02857816|26125218|P1|Overall Study|Lost to Follow-up|1
7522509|NCT02857816|26125218|P1|Overall Study|Withdrawal by Subject|4
7522510|NCT02857816|26125218|P1|Overall Study|Screen Failure|33
7522511|NCT02857426|26125226|P2|Follow-up|other reason|0
7522512|NCT02857426|26125227|P1|Follow-up|other reason|1
7522513|NCT02857426|26125226|P2|Follow-up|Participant withdrew consent|4
7522514|NCT02857426|26125227|P1|Follow-up|Participant withdrew consent|3
7522515|NCT02857426|26125226|P2|Follow-up|Death|2
7522516|NCT02857426|26125227|P1|Follow-up|Death|6
7522517|NCT02857426|26125226|P2|Treatment|Maximum clinical benefit|0
7522518|NCT02857426|26125227|P1|Treatment|Maximum clinical benefit|1
7522519|NCT02857426|26125226|P2|Treatment|Participant withdrew consent|1
7522520|NCT02857426|26125227|P1|Treatment|Participant withdrew consent|1
7522521|NCT02857426|26125226|P2|Treatment|Adverse event unrelated to study drug|2
7522522|NCT02857426|26125227|P1|Treatment|Adverse event unrelated to study drug|6
7522523|NCT02857426|26125226|P2|Treatment|Death|0
7522524|NCT02857426|26125227|P1|Treatment|Death|1
7522525|NCT02857426|26125226|P2|Treatment|Study drug toxicity|1
7522526|NCT02857426|26125227|P1|Treatment|Study drug toxicity|4
7522527|NCT02857426|26125226|P2|Treatment|Disease progression|13
7522528|NCT02857426|26125227|P1|Treatment|Disease progression|33
7522529|NCT02857283|26125243|P2|First Exposure|Withdrawal by Subject|0
7522530|NCT02857283|26125244|P1|First Exposure|Withdrawal by Subject|1
7522531|NCT02856880|26125278|P1|Overall Study|Withdrawal of consent|1
7522532|NCT02856802|26125321|P2|Double-Blind Treatment Period 2|Lost to Follow-up|0
7522533|NCT02856802|26125322|P1|Double-Blind Treatment Period 2|Lost to Follow-up|1
7522534|NCT02856802|26125321|P2|Double-Blind Treatment Period 1|Lack of diary compliance|2
7522535|NCT02856802|26125322|P1|Double-Blind Treatment Period 1|Lack of diary compliance|0
7522536|NCT02856802|26125321|P2|Double-Blind Treatment Period 1|Sponsor terminated|0
7522537|NCT02856802|26125322|P1|Double-Blind Treatment Period 1|Sponsor terminated|1
7522538|NCT02856802|26125321|P2|Double-Blind Treatment Period 1|Protocol Violation|1
7522539|NCT02856802|26125322|P1|Double-Blind Treatment Period 1|Protocol Violation|0
7522540|NCT02856802|26125321|P2|Double-Blind Treatment Period 1|Lost to Follow-up|0
7522541|NCT02856802|26125322|P1|Double-Blind Treatment Period 1|Lost to Follow-up|1
7522542|NCT02856802|26125321|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|2
7522543|NCT02856802|26125322|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7522544|NCT02856555|26125337|P3|Overall Study|Randomized but Never Treated|0
7522545|NCT02856555|26125338|P2|Overall Study|Randomized but Never Treated|1
7522546|NCT02856555|26125339|P1|Overall Study|Randomized but Never Treated|0
7522547|NCT02856555|26125337|P3|Overall Study|Withdrawal by Subject|0
7522548|NCT02856555|26125338|P2|Overall Study|Withdrawal by Subject|0
7522549|NCT02856555|26125339|P1|Overall Study|Withdrawal by Subject|3
7522550|NCT02856555|26125337|P3|Overall Study|Lost to Follow-up|0
7522551|NCT02856555|26125338|P2|Overall Study|Lost to Follow-up|3
7522552|NCT02856555|26125339|P1|Overall Study|Lost to Follow-up|1
7522553|NCT02856555|26125337|P3|Overall Study|Adverse Event|0
7522554|NCT02856555|26125338|P2|Overall Study|Adverse Event|0
7522555|NCT02856555|26125339|P1|Overall Study|Adverse Event|1
7522556|NCT02856282|26125347|P1|Overall Study|Withdrawal by Subject|1
7522557|NCT02855541|26125379|P1|Overall Study|Withdrawal by Subject|2
7522558|NCT02855541|26125379|P1|Overall Study|Change in health status|2
7522559|NCT02855450|26125392|P2|Overall Study|Lost to Follow-up|0
7522560|NCT02855450|26125393|P1|Overall Study|Lost to Follow-up|4
7522561|NCT02855450|26125392|P2|Overall Study|Adverse Event|0
7522562|NCT02855450|26125393|P1|Overall Study|Adverse Event|1
7522563|NCT02855411|26125410|P1|Overall Study|Does not meet entrance criteria|14
7522564|NCT02855411|26125410|P1|Overall Study|Study terminated by sponsor|21
7522565|NCT02855359|26125432|P4|Overall Study|Study Termination by Sponsor|0
7522566|NCT02855359|26125433|P3|Overall Study|Study Termination by Sponsor|0
7522567|NCT02855359|26125434|P2|Overall Study|Study Termination by Sponsor|11
7522568|NCT02855359|26125435|P1|Overall Study|Study Termination by Sponsor|9
7522569|NCT02855359|26125432|P4|Overall Study|Death|0
7522570|NCT02855359|26125433|P3|Overall Study|Death|0
7522571|NCT02855359|26125434|P2|Overall Study|Death|2
7522572|NCT02855359|26125435|P1|Overall Study|Death|2
7522573|NCT02855164|26125485|P8|Part C (Randomized Set)|Withdrawal by Subject|3
7522574|NCT02855164|26125486|P7|Part C (Randomized Set)|Withdrawal by Subject|4
7522575|NCT02855164|26125487|P6|Part C (Randomized Set)|Withdrawal by Subject|5
7522576|NCT02855164|26125488|P5|Part C (Randomized Set)|Withdrawal by Subject|0
7522577|NCT02855164|26125489|P4|Part C (Randomized Set)|Withdrawal by Subject|0
7522578|NCT02855164|26125490|P3|Part C (Randomized Set)|Withdrawal by Subject|0
7522579|NCT02855164|26125491|P2|Part C (Randomized Set)|Withdrawal by Subject|0
7522580|NCT02855164|26125492|P1|Part C (Randomized Set)|Withdrawal by Subject|0
7522581|NCT02855164|26125485|P8|Part C (Randomized Set)|Physician Decision|1
7522582|NCT02855164|26125486|P7|Part C (Randomized Set)|Physician Decision|0
7522583|NCT02855164|26125487|P6|Part C (Randomized Set)|Physician Decision|1
7522584|NCT02855164|26125488|P5|Part C (Randomized Set)|Physician Decision|0
7522585|NCT02855164|26125489|P4|Part C (Randomized Set)|Physician Decision|0
7522586|NCT02855164|26125490|P3|Part C (Randomized Set)|Physician Decision|0
7522587|NCT02855164|26125491|P2|Part C (Randomized Set)|Physician Decision|0
7522588|NCT02855164|26125492|P1|Part C (Randomized Set)|Physician Decision|0
7522589|NCT02855164|26125485|P8|Part C (Randomized Set)|Lost to Follow-up|1
7522590|NCT02855164|26125486|P7|Part C (Randomized Set)|Lost to Follow-up|1
7522591|NCT02855164|26125487|P6|Part C (Randomized Set)|Lost to Follow-up|1
7522592|NCT02855164|26125488|P5|Part C (Randomized Set)|Lost to Follow-up|0
7522593|NCT02855164|26125489|P4|Part C (Randomized Set)|Lost to Follow-up|0
7522594|NCT02855164|26125490|P3|Part C (Randomized Set)|Lost to Follow-up|0
7522595|NCT02855164|26125491|P2|Part C (Randomized Set)|Lost to Follow-up|0
7522596|NCT02855164|26125492|P1|Part C (Randomized Set)|Lost to Follow-up|0
7522597|NCT02855164|26125485|P8|Part C (Randomized Set)|Adverse Event|2
7522598|NCT02855164|26125486|P7|Part C (Randomized Set)|Adverse Event|9
7522599|NCT02855164|26125487|P6|Part C (Randomized Set)|Adverse Event|5
7522600|NCT02855164|26125488|P5|Part C (Randomized Set)|Adverse Event|0
7522601|NCT02855164|26125489|P4|Part C (Randomized Set)|Adverse Event|0
7522602|NCT02855164|26125490|P3|Part C (Randomized Set)|Adverse Event|0
7522603|NCT02855164|26125491|P2|Part C (Randomized Set)|Adverse Event|0
7522604|NCT02855164|26125492|P1|Part C (Randomized Set)|Adverse Event|0
7522605|NCT02855164|26125485|P8|Parts A + B (Randomized Set)|Adverse Event|0
7522606|NCT02855164|26125486|P7|Parts A + B (Randomized Set)|Adverse Event|0
7522607|NCT02855164|26125487|P6|Parts A + B (Randomized Set)|Adverse Event|0
7522608|NCT02855164|26125488|P5|Parts A + B (Randomized Set)|Adverse Event|0
7522609|NCT02855164|26125489|P4|Parts A + B (Randomized Set)|Adverse Event|4
7522610|NCT02855164|26125490|P3|Parts A + B (Randomized Set)|Adverse Event|0
7522611|NCT02855164|26125491|P2|Parts A + B (Randomized Set)|Adverse Event|0
7522612|NCT02855164|26125492|P1|Parts A + B (Randomized Set)|Adverse Event|0
7522613|NCT02855164|26125485|P8|Parts A + B (Randomized Set)|Physician Decision|0
7522614|NCT02855164|26125486|P7|Parts A + B (Randomized Set)|Physician Decision|0
7522615|NCT02855164|26125487|P6|Parts A + B (Randomized Set)|Physician Decision|0
7522616|NCT02855164|26125488|P5|Parts A + B (Randomized Set)|Physician Decision|0
7522617|NCT02855164|26125489|P4|Parts A + B (Randomized Set)|Physician Decision|2
7522618|NCT02855164|26125490|P3|Parts A + B (Randomized Set)|Physician Decision|0
7522619|NCT02855164|26125491|P2|Parts A + B (Randomized Set)|Physician Decision|0
7522620|NCT02855164|26125492|P1|Parts A + B (Randomized Set)|Physician Decision|0
7522621|NCT02855164|26125485|P8|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7522622|NCT02855164|26125486|P7|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7522623|NCT02855164|26125487|P6|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7522624|NCT02855164|26125488|P5|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7522625|NCT02855164|26125489|P4|Parts A + B (Randomized Set)|Withdrawal by Subject|2
7522626|NCT02855164|26125490|P3|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7522627|NCT02855164|26125491|P2|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7522628|NCT02855164|26125492|P1|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7522629|NCT02854800|26125677|P3|Overall Study|Withdrawal by Subject|3
7522630|NCT02854800|26125678|P2|Overall Study|Withdrawal by Subject|2
7522631|NCT02854800|26125679|P1|Overall Study|Withdrawal by Subject|4
7522632|NCT02854800|26125677|P3|Overall Study|Protocol Violation|3
7522633|NCT02854800|26125678|P2|Overall Study|Protocol Violation|11
7522634|NCT02854800|26125679|P1|Overall Study|Protocol Violation|16
7522635|NCT02854631|26125719|P2|Overall Study|Lost to Follow-up|2
7522636|NCT02854631|26125720|P1|Overall Study|Lost to Follow-up|4
7522637|NCT02854631|26125719|P2|Overall Study|Subjects Randomized but Never Treated|0
7522638|NCT02854631|26125720|P1|Overall Study|Subjects Randomized but Never Treated|2
7522639|NCT02854631|26125719|P2|Overall Study|Protocol Violation|1
7522640|NCT02854631|26125720|P1|Overall Study|Protocol Violation|0
7522641|NCT02854631|26125719|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
7522642|NCT02854631|26125720|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
7522643|NCT02854631|26125719|P2|Overall Study|Death|8
7522644|NCT02854631|26125720|P1|Overall Study|Death|12
7522645|NCT02854631|26125719|P2|Overall Study|Investigator's Discretion|0
7522646|NCT02854631|26125720|P1|Overall Study|Investigator's Discretion|2
7522647|NCT02854631|26125719|P2|Overall Study|Withdrew Consent|2
7522648|NCT02854631|26125720|P1|Overall Study|Withdrew Consent|3
7522649|NCT02854631|26125719|P2|Overall Study|Adverse Event|2
7522650|NCT02854631|26125720|P1|Overall Study|Adverse Event|1
7522651|NCT02854605|26125781|P3|Overall Study|Protocol Violation|1
7522652|NCT02854605|26125782|P2|Overall Study|Protocol Violation|0
7522653|NCT02854605|26125783|P1|Overall Study|Protocol Violation|0
7522654|NCT02854605|26125781|P3|Overall Study|Investigator's Discretion|0
7522655|NCT02854605|26125782|P2|Overall Study|Investigator's Discretion|0
7522656|NCT02854605|26125783|P1|Overall Study|Investigator's Discretion|1
7522657|NCT02854605|26125781|P3|Overall Study|Withdrew Consent|1
7522658|NCT02854605|26125782|P2|Overall Study|Withdrew Consent|0
7522659|NCT02854605|26125783|P1|Overall Study|Withdrew Consent|1
7522660|NCT02854605|26125781|P3|Overall Study|Lost to Follow-up|0
7522661|NCT02854605|26125782|P2|Overall Study|Lost to Follow-up|2
7522662|NCT02854605|26125783|P1|Overall Study|Lost to Follow-up|0
7522663|NCT02854605|26125781|P3|Overall Study|Adverse Event|2
7522664|NCT02854605|26125782|P2|Overall Study|Adverse Event|5
7522665|NCT02854605|26125783|P1|Overall Study|Adverse Event|1
7522666|NCT02854527|26125813|P10|Overall Study|Lost to Follow-up|0
7522667|NCT02854527|26125814|P9|Overall Study|Lost to Follow-up|0
7522668|NCT02854527|26125815|P8|Overall Study|Lost to Follow-up|0
7522669|NCT02854527|26125816|P7|Overall Study|Lost to Follow-up|0
7522670|NCT02854527|26125817|P6|Overall Study|Lost to Follow-up|0
7522671|NCT02854527|26125818|P5|Overall Study|Lost to Follow-up|0
7522672|NCT02854527|26125819|P4|Overall Study|Lost to Follow-up|1
7522673|NCT02854527|26125820|P3|Overall Study|Lost to Follow-up|0
7522674|NCT02854527|26125821|P2|Overall Study|Lost to Follow-up|0
7522675|NCT02854527|26125822|P1|Overall Study|Lost to Follow-up|0
7522676|NCT02854527|26125813|P10|Overall Study|Adverse Event|0
7522677|NCT02854527|26125814|P9|Overall Study|Adverse Event|0
7522678|NCT02854527|26125815|P8|Overall Study|Adverse Event|0
7522679|NCT02854527|26125816|P7|Overall Study|Adverse Event|0
7522680|NCT02854527|26125817|P6|Overall Study|Adverse Event|0
7522681|NCT02854527|26125818|P5|Overall Study|Adverse Event|1
7522682|NCT02854527|26125819|P4|Overall Study|Adverse Event|0
7522683|NCT02854527|26125820|P3|Overall Study|Adverse Event|0
7522684|NCT02854527|26125821|P2|Overall Study|Adverse Event|0
7522685|NCT02854527|26125822|P1|Overall Study|Adverse Event|0
7522686|NCT02853929|26125880|P2|Overall Study|Subjects enrolled but not vaccinated|4
7522687|NCT02853929|26125881|P1|Overall Study|Subjects enrolled but not vaccinated|7
7522688|NCT02853929|26125880|P2|Overall Study|Withdrawal by Subject|0
7522689|NCT02853929|26125881|P1|Overall Study|Withdrawal by Subject|1
7522690|NCT02853929|26125880|P2|Overall Study|Lost to Follow-up|0
7522691|NCT02853929|26125881|P1|Overall Study|Lost to Follow-up|3
7522692|NCT02853760|26125919|P6|Washout (1 Week)|acute illness (not connected with the study)|2
7522693|NCT02853760|26125920|P5|Washout (1 Week)|acute illness (not connected with the study)|0
7522694|NCT02853760|26125921|P4|Washout (1 Week)|acute illness (not connected with the study)|2
7522695|NCT02853760|26125922|P3|Washout (1 Week)|acute illness (not connected with the study)|1
7522696|NCT02853760|26125923|P2|Washout (1 Week)|acute illness (not connected with the study)|0
7522697|NCT02853760|26125924|P1|Washout (1 Week)|acute illness (not connected with the study)|0
7522698|NCT02853435|26125950|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7522699|NCT02853435|26125951|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
7522700|NCT02853435|26125952|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7522701|NCT02853435|26125953|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7522702|NCT02853435|26125954|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7522703|NCT02853435|26125955|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7522704|NCT02853331|26126265|P2|Overall Study|Ongoing in study|325
7522705|NCT02853331|26126266|P1|Overall Study|Ongoing in study|368
7522706|NCT02853331|26126265|P2|Overall Study|Withdrawal by Subject|9
7522707|NCT02853331|26126266|P1|Overall Study|Withdrawal by Subject|5
7522708|NCT02853331|26126265|P2|Overall Study|Death|95
7522709|NCT02853331|26126266|P1|Overall Study|Death|59
7522710|NCT02853318|26126298|P1|Overall Study|Withdrawal by Subject|1
7522711|NCT02853305|26126309|P3|Overall Study|Ongoing in Trial|87
7522712|NCT02853305|26126310|P2|Overall Study|Ongoing in Trial|96
7522713|NCT02853305|26126311|P1|Overall Study|Ongoing in Trial|105
7522714|NCT02853305|26126309|P3|Overall Study|Withdrawal by Subject|2
7522715|NCT02853305|26126310|P2|Overall Study|Withdrawal by Subject|4
7522716|NCT02853305|26126311|P1|Overall Study|Withdrawal by Subject|2
7522717|NCT02853305|26126309|P3|Overall Study|Death|263
7522718|NCT02853305|26126310|P2|Overall Study|Death|207
7522719|NCT02853305|26126311|P1|Overall Study|Death|244
7522720|NCT02853123|26126376|P2|Washout Period|Adverse Event|0
7522721|NCT02853123|26126377|P1|Washout Period|Adverse Event|1
7522722|NCT02853123|26126376|P2|Washout Period|Worsening of COPD|3
7522723|NCT02853123|26126377|P1|Washout Period|Worsening of COPD|0
7522724|NCT02853123|26126376|P2|Treatment Period 1|Adverse Event|3
7522725|NCT02853123|26126377|P1|Treatment Period 1|Adverse Event|0
7522726|NCT02853032|26126400|P2|Overall Study|Requested to withdraw from all treatment|2
7522727|NCT02853032|26126401|P1|Overall Study|Requested to withdraw from all treatment|2
7522728|NCT02853032|26126400|P2|Overall Study|Withdrawal by Subject|1
7522729|NCT02853032|26126401|P1|Overall Study|Withdrawal by Subject|3
7522730|NCT02853032|26126400|P2|Overall Study|Adverse Event|0
7522731|NCT02853032|26126401|P1|Overall Study|Adverse Event|4
7522787|NCT02852434|26126541|P2|Overall Study|Unsuccessful Dilator Procedure|0
7522788|NCT02852434|26126542|P1|Overall Study|Unsuccessful Dilator Procedure|2
7522789|NCT02852434|26126541|P2|Overall Study|Withdrawal by Subject|1
7522790|NCT02852434|26126542|P1|Overall Study|Withdrawal by Subject|0
7522791|NCT02852265|26126562|P2|3-month Follow-up|Lost to Follow-up|1
7522792|NCT02852265|26126563|P1|3-month Follow-up|Lost to Follow-up|1
7522793|NCT02852005|26126584|P5|Overall Study|Withdrawal by Subject|0
7522794|NCT02852005|26126585|P4|Overall Study|Withdrawal by Subject|0
7522795|NCT02852005|26126586|P3|Overall Study|Withdrawal by Subject|0
7522796|NCT02852005|26126587|P2|Overall Study|Withdrawal by Subject|0
7522797|NCT02852005|26126588|P1|Overall Study|Withdrawal by Subject|1
7522798|NCT02852005|26126584|P5|Overall Study|Lost to Follow-up|1
7522799|NCT02852005|26126585|P4|Overall Study|Lost to Follow-up|0
7522800|NCT02852005|26126586|P3|Overall Study|Lost to Follow-up|0
7522801|NCT02852005|26126587|P2|Overall Study|Lost to Follow-up|0
7522802|NCT02852005|26126588|P1|Overall Study|Lost to Follow-up|0
7522803|NCT02851615|26126743|P2|Overall Study|Lost to Follow-up|4
7522804|NCT02851615|26126744|P1|Overall Study|Lost to Follow-up|0
7522805|NCT02851615|26126743|P2|Overall Study|Cognitive Issue|0
7522806|NCT02851615|26126744|P1|Overall Study|Cognitive Issue|1
7522807|NCT02851069|26126762|P1|Overall Study|Other|3
7522808|NCT02851069|26126762|P1|Overall Study|Failure to Return|3
7522809|NCT02850978|26126784|P1|Overall Study|Reason not listed|88
7522810|NCT02850978|26126784|P1|Overall Study|Lost to Follow-up|121
7522811|NCT02850978|26126784|P1|Overall Study|Improvement in condition|34
7522812|NCT02850978|26126784|P1|Overall Study|Lack of Efficacy|40
7522813|NCT02850978|26126784|P1|Overall Study|Adverse Event|81
7522814|NCT02850978|26126784|P1|Overall Study|No visit since the first visit|35
7522815|NCT02850978|26126784|P1|Overall Study|Uncollectable CRF|27
7522816|NCT02850965|26126791|P2|Overall Study|Randomized but not treated|1
7522817|NCT02850965|26126792|P1|Overall Study|Randomized but not treated|0
7522818|NCT02850965|26126791|P2|Overall Study|Physician Decision|1
7522819|NCT02850965|26126792|P1|Overall Study|Physician Decision|0
7522820|NCT02850965|26126791|P2|Overall Study|Withdrawal by Subject|4
7522821|NCT02850965|26126792|P1|Overall Study|Withdrawal by Subject|3
7522822|NCT02850965|26126791|P2|Overall Study|Adverse Event|2
7522823|NCT02850965|26126792|P1|Overall Study|Adverse Event|3
7522824|NCT02850965|26126791|P2|Overall Study|Lack of Efficacy|8
7522825|NCT02850965|26126792|P1|Overall Study|Lack of Efficacy|4
7522826|NCT02850965|26126791|P2|Overall Study|Lost to Follow-up|3
7522827|NCT02850965|26126792|P1|Overall Study|Lost to Follow-up|5
7522828|NCT02850965|26126791|P2|Overall Study|Protocol Violation|2
7522829|NCT02850965|26126792|P1|Overall Study|Protocol Violation|0
7522830|NCT02850965|26126791|P2|Overall Study|Other than listed|4
7522831|NCT02850965|26126792|P1|Overall Study|Other than listed|3
7522832|NCT02850276|26126817|P1|Overall Study|Lost to Follow-up|2
7522833|NCT02850276|26126817|P1|Overall Study|Physician Decision|2
7522834|NCT02850276|26126817|P1|Overall Study|Withdrawal by Subject|14
7522835|NCT02850276|26126817|P1|Overall Study|screen failure|43
7522836|NCT02849990|26126844|P1|Overall Study|Withdrawal by Subject|1
7522837|NCT02849990|26126844|P1|Overall Study|Adverse Event|1
7522838|NCT02849704|26126869|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
7522839|NCT02849704|26126870|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
7522840|NCT02849704|26126869|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
7522841|NCT02849704|26126870|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
7522842|NCT02849704|26126869|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
7522843|NCT02849704|26126870|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
7522844|NCT02849678|26126885|P2|Overall Study|Protocol Violation|6
7522845|NCT02849678|26126886|P1|Overall Study|Protocol Violation|3
7522846|NCT02849626|26126906|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
7522927|NCT02848326|26127404|P5|Safety Follow-up Period|Lost to Follow-up|1
7522847|NCT02849626|26126907|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
7522848|NCT02849626|26126906|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
7522849|NCT02849626|26126907|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
7522850|NCT02849626|26126906|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
7522851|NCT02849626|26126907|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
7522852|NCT02849626|26126906|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
7522853|NCT02849626|26126907|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
7522854|NCT02849626|26126906|P2|Core Phase (up to 23 Weeks)|Non-specified|0
7522855|NCT02849626|26126907|P1|Core Phase (up to 23 Weeks)|Non-specified|3
7522856|NCT02849626|26126906|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
7522857|NCT02849626|26126907|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
7522858|NCT02849626|26126906|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
7522859|NCT02849626|26126907|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
7522860|NCT02849626|26126906|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
7522861|NCT02849626|26126907|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
7522862|NCT02849509|26126970|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
7522863|NCT02849509|26126971|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
7522864|NCT02849509|26126972|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
7522865|NCT02849509|26126970|P3|Overall Study|Other, reason not specified|25
7522866|NCT02849509|26126971|P2|Overall Study|Other, reason not specified|29
7522867|NCT02849509|26126972|P1|Overall Study|Other, reason not specified|14
7522868|NCT02849509|26126970|P3|Overall Study|Lost to Follow-up|36
7522869|NCT02849509|26126971|P2|Overall Study|Lost to Follow-up|67
7522870|NCT02849509|26126972|P1|Overall Study|Lost to Follow-up|27
7522871|NCT02849509|26126970|P3|Overall Study|Withdrawal by Subject|12
7522872|NCT02849509|26126971|P2|Overall Study|Withdrawal by Subject|17
7522873|NCT02849509|26126972|P1|Overall Study|Withdrawal by Subject|6
7522874|NCT02849509|26126970|P3|Overall Study|Other adverse event|8
7522875|NCT02849509|26126971|P2|Overall Study|Other adverse event|41
7522876|NCT02849509|26126972|P1|Overall Study|Other adverse event|36
7522877|NCT02849509|26126970|P3|Overall Study|Worsening of other pre-existing disease|2
7522878|NCT02849509|26126971|P2|Overall Study|Worsening of other pre-existing disease|1
7522879|NCT02849509|26126972|P1|Overall Study|Worsening of other pre-existing disease|0
7522880|NCT02849509|26126970|P3|Overall Study|Worsening of disease under study|1
7522881|NCT02849509|26126971|P2|Overall Study|Worsening of disease under study|1
7522882|NCT02849509|26126972|P1|Overall Study|Worsening of disease under study|1
7522883|NCT02849080|26127179|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7522884|NCT02849080|26127180|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7522885|NCT02849080|26127181|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7522886|NCT02849080|26127182|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
7522887|NCT02849080|26127179|P4|Extension Phase: 53 - 104 Weeks|Other|0
7522888|NCT02849080|26127180|P3|Extension Phase: 53 - 104 Weeks|Other|1
7522889|NCT02849080|26127181|P2|Extension Phase: 53 - 104 Weeks|Other|0
7522890|NCT02849080|26127182|P1|Extension Phase: 53 - 104 Weeks|Other|0
7522891|NCT02849080|26127179|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7522892|NCT02849080|26127180|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7522893|NCT02849080|26127181|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7522894|NCT02849080|26127182|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
7522895|NCT02849080|26127179|P4|Main Phase: 0 - 52 Weeks|Death|0
7522896|NCT02849080|26127180|P3|Main Phase: 0 - 52 Weeks|Death|0
7522897|NCT02849080|26127181|P2|Main Phase: 0 - 52 Weeks|Death|2
7522898|NCT02849080|26127182|P1|Main Phase: 0 - 52 Weeks|Death|0
7522899|NCT02849080|26127179|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7522900|NCT02849080|26127180|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7522901|NCT02849080|26127181|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
7522902|NCT02849080|26127182|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
7522903|NCT02849080|26127179|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7522904|NCT02849080|26127180|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7522905|NCT02849080|26127181|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
7522906|NCT02849080|26127182|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
7522907|NCT02848833|26127307|P1|Overall Study|Protocol Violation|119
7522908|NCT02848833|26127307|P1|Overall Study|follow-up failure|6
7522909|NCT02848833|26127307|P1|Overall Study|have not taken the study drug|11
7522910|NCT02848833|26127307|P1|Overall Study|subject who are duplicated|1
7522911|NCT02848729|26127325|P2|Overall Study|Emesis|11
7522912|NCT02848729|26127326|P1|Overall Study|Emesis|15
7522913|NCT02848729|26127325|P2|Overall Study|Withdrawal by Subject|0
7522914|NCT02848729|26127326|P1|Overall Study|Withdrawal by Subject|1
7522915|NCT02848664|26127343|P1|Overall Study|no assistance for device training|1
7522916|NCT02848664|26127343|P1|Overall Study|Adverse Event|1
7522917|NCT02848664|26127343|P1|Overall Study|Withdrawal by Subject|2
7522918|NCT02848651|26127351|P1|Overall Study|Withdrawal by Subject|14
7522919|NCT02848651|26127351|P1|Overall Study|Physician Decision|4
7522920|NCT02848651|26127351|P1|Overall Study|Symptomatic Deterioration|1
7522921|NCT02848651|26127351|P1|Overall Study|Non-Compliance|1
7522922|NCT02848651|26127351|P1|Overall Study|Lost to Follow-up|1
7522923|NCT02848651|26127351|P1|Overall Study|Death|85
7522924|NCT02848599|26127380|P2|Overall Study|Protocol Violation|9
7522925|NCT02848599|26127381|P1|Overall Study|Protocol Violation|7
7522926|NCT02848326|26127403|P6|Safety Follow-up Period|Lost to Follow-up|3
7522928|NCT02848326|26127405|P4|Safety Follow-up Period|Lost to Follow-up|0
7522929|NCT02848326|26127406|P3|Safety Follow-up Period|Lost to Follow-up|2
7522930|NCT02848326|26127407|P2|Safety Follow-up Period|Lost to Follow-up|0
7522931|NCT02848326|26127408|P1|Safety Follow-up Period|Lost to Follow-up|4
7522932|NCT02848326|26127403|P6|Safety Follow-up Period|Withdrawal of Consent|2
7522933|NCT02848326|26127404|P5|Safety Follow-up Period|Withdrawal of Consent|0
7522934|NCT02848326|26127405|P4|Safety Follow-up Period|Withdrawal of Consent|0
7522935|NCT02848326|26127406|P3|Safety Follow-up Period|Withdrawal of Consent|1
7522936|NCT02848326|26127407|P2|Safety Follow-up Period|Withdrawal of Consent|1
7522937|NCT02848326|26127408|P1|Safety Follow-up Period|Withdrawal of Consent|0
7522938|NCT02848326|26127403|P6|Treatment Period|Non-compliance with Study Drug|0
7522939|NCT02848326|26127404|P5|Treatment Period|Non-compliance with Study Drug|0
7522940|NCT02848326|26127405|P4|Treatment Period|Non-compliance with Study Drug|1
7522941|NCT02848326|26127406|P3|Treatment Period|Non-compliance with Study Drug|0
7522942|NCT02848326|26127407|P2|Treatment Period|Non-compliance with Study Drug|0
7522943|NCT02848326|26127408|P1|Treatment Period|Non-compliance with Study Drug|4
7522944|NCT02848326|26127403|P6|Treatment Period|Protocol Violation|3
7522945|NCT02848326|26127404|P5|Treatment Period|Protocol Violation|3
7522946|NCT02848326|26127405|P4|Treatment Period|Protocol Violation|2
7522947|NCT02848326|26127406|P3|Treatment Period|Protocol Violation|4
7522948|NCT02848326|26127407|P2|Treatment Period|Protocol Violation|3
7522949|NCT02848326|26127408|P1|Treatment Period|Protocol Violation|4
7522950|NCT02848326|26127403|P6|Treatment Period|Pregnancy|1
7522951|NCT02848326|26127404|P5|Treatment Period|Pregnancy|0
7522952|NCT02848326|26127405|P4|Treatment Period|Pregnancy|1
7522953|NCT02848326|26127406|P3|Treatment Period|Pregnancy|1
7522954|NCT02848326|26127407|P2|Treatment Period|Pregnancy|0
7522955|NCT02848326|26127408|P1|Treatment Period|Pregnancy|0
7522956|NCT02848326|26127403|P6|Treatment Period|Lost to Follow-up|3
7522957|NCT02848326|26127404|P5|Treatment Period|Lost to Follow-up|2
7522958|NCT02848326|26127405|P4|Treatment Period|Lost to Follow-up|7
7522959|NCT02848326|26127406|P3|Treatment Period|Lost to Follow-up|11
7522960|NCT02848326|26127407|P2|Treatment Period|Lost to Follow-up|1
7522961|NCT02848326|26127408|P1|Treatment Period|Lost to Follow-up|5
7522962|NCT02848326|26127403|P6|Treatment Period|Withdrawal of Consent|6
7522963|NCT02848326|26127404|P5|Treatment Period|Withdrawal of Consent|9
7522964|NCT02848326|26127405|P4|Treatment Period|Withdrawal of Consent|6
7522965|NCT02848326|26127406|P3|Treatment Period|Withdrawal of Consent|9
7522966|NCT02848326|26127407|P2|Treatment Period|Withdrawal of Consent|6
7522967|NCT02848326|26127408|P1|Treatment Period|Withdrawal of Consent|20
7522968|NCT02848326|26127403|P6|Treatment Period|Adverse Event|7
7522969|NCT02848326|26127404|P5|Treatment Period|Adverse Event|5
7522970|NCT02848326|26127405|P4|Treatment Period|Adverse Event|6
7522971|NCT02848326|26127406|P3|Treatment Period|Adverse Event|11
7522972|NCT02848326|26127407|P2|Treatment Period|Adverse Event|4
7522973|NCT02848326|26127408|P1|Treatment Period|Adverse Event|5
7522974|NCT02848313|26127442|P2|Overall Study|Lost to follow up|0
7522975|NCT02848313|26127443|P1|Overall Study|Lost to follow up|1
7522976|NCT02848313|26127442|P2|Overall Study|Withdrawal by Subject|1
7522977|NCT02848313|26127443|P1|Overall Study|Withdrawal by Subject|1
7522978|NCT02848313|26127442|P2|Overall Study|Lack of Efficacy|1
7522979|NCT02848313|26127443|P1|Overall Study|Lack of Efficacy|0
7522980|NCT02848313|26127442|P2|Overall Study|Adverse Event|2
7522981|NCT02848313|26127443|P1|Overall Study|Adverse Event|1
7522982|NCT02847858|26127496|P2|Overall Study|Lost to Follow-up|269
7522983|NCT02847858|26127497|P1|Overall Study|Lost to Follow-up|401
7522984|NCT02847650|26127523|P2|Overall Study|Withdrawal by Subject|1
7522985|NCT02847650|26127524|P1|Overall Study|Withdrawal by Subject|1
7522986|NCT02847650|26127523|P2|Overall Study|Protocol Violation|1
7522987|NCT02847650|26127524|P1|Overall Study|Protocol Violation|0
7522988|NCT02847650|26127523|P2|Overall Study|Lost to Follow-up|0
7522989|NCT02847650|26127524|P1|Overall Study|Lost to Follow-up|1
7522990|NCT02847650|26127523|P2|Overall Study|Adverse Event|4
7522991|NCT02847650|26127524|P1|Overall Study|Adverse Event|2
7522992|NCT02847637|26127548|P4|Overall Study|First emicizumab dose delayed|0
7522993|NCT02847637|26127549|P3|Overall Study|First emicizumab dose delayed|0
7522994|NCT02847637|26127550|P2|Overall Study|First emicizumab dose delayed|0
7522995|NCT02847637|26127551|P1|Overall Study|First emicizumab dose delayed|1
7522996|NCT02847637|26127548|P4|Overall Study|Ongoing treatment with emicizumab|63
7522997|NCT02847637|26127549|P3|Overall Study|Ongoing treatment with emicizumab|34
7522998|NCT02847637|26127550|P2|Overall Study|Ongoing treatment with emicizumab|35
7522999|NCT02847637|26127551|P1|Overall Study|Ongoing treatment with emicizumab|16
7523000|NCT02847637|26127548|P4|Overall Study|Withdrew from treatment due to AE|0
7523001|NCT02847637|26127549|P3|Overall Study|Withdrew from treatment due to AE|1
7523002|NCT02847637|26127550|P2|Overall Study|Withdrew from treatment due to AE|0
7523003|NCT02847637|26127551|P1|Overall Study|Withdrew from treatment due to AE|0
7523004|NCT02847494|26127665|P2|Overall Study|Lost to Follow-up|5
7523005|NCT02847494|26127666|P1|Overall Study|Lost to Follow-up|8
7523006|NCT02847260|26127676|P1|Overall Study|Physician Decision|1
7523007|NCT02847260|26127676|P1|Overall Study|Clinical Deterioration|1
7523008|NCT02847260|26127676|P1|Overall Study|Withdrawal by Subject|2
7523009|NCT02847260|26127676|P1|Overall Study|Adverse Event|3
7523010|NCT02847182|26127690|P2|Overall Study|Withdrawal by Subject|1
7523011|NCT02847182|26127691|P1|Overall Study|Withdrawal by Subject|0
7523012|NCT02846779|26127815|P3|Overall Study|Less than 31 days of follow-up|52
7523013|NCT02846779|26127816|P2|Overall Study|Less than 31 days of follow-up|45
7523014|NCT02846779|26127817|P1|Overall Study|Less than 31 days of follow-up|56
7523015|NCT02846779|26127815|P3|Overall Study|Lost Enrollment|86
7523016|NCT02846779|26127816|P2|Overall Study|Lost Enrollment|82
7523017|NCT02846779|26127817|P1|Overall Study|Lost Enrollment|83
7523018|NCT02846558|26127873|P4|Overall Study|Lost to Follow-up|0
7523019|NCT02846558|26127874|P3|Overall Study|Lost to Follow-up|0
7523020|NCT02846558|26127875|P2|Overall Study|Lost to Follow-up|0
7523021|NCT02846558|26127876|P1|Overall Study|Lost to Follow-up|2
7523022|NCT02846558|26127873|P4|Overall Study|Withdrawal by Subject|2
7523023|NCT02846558|26127874|P3|Overall Study|Withdrawal by Subject|2
7523024|NCT02846558|26127875|P2|Overall Study|Withdrawal by Subject|4
7523025|NCT02846558|26127876|P1|Overall Study|Withdrawal by Subject|5
7523026|NCT02846558|26127873|P4|Overall Study|Adverse Event|0
7523027|NCT02846558|26127874|P3|Overall Study|Adverse Event|0
7523028|NCT02846558|26127875|P2|Overall Study|Adverse Event|0
7523029|NCT02846558|26127876|P1|Overall Study|Adverse Event|1
7523030|NCT02846415|26127914|P2|Overall Study|Withdrawal by Subject|1
7523031|NCT02846415|26127915|P1|Overall Study|Withdrawal by Subject|1
7523032|NCT02846415|26127914|P2|Overall Study|Lost to Follow-up|0
7523033|NCT02846415|26127915|P1|Overall Study|Lost to Follow-up|2
7523034|NCT02846324|26127929|P4|Overall Study|Withdrawal by Subject|0
7523035|NCT02846324|26127930|P3|Overall Study|Withdrawal by Subject|4
7523036|NCT02846324|26127931|P2|Overall Study|Withdrawal by Subject|0
7523037|NCT02846324|26127932|P1|Overall Study|Withdrawal by Subject|1
7523038|NCT02846324|26127929|P4|Overall Study|Other|0
7523039|NCT02846324|26127930|P3|Overall Study|Other|0
7523040|NCT02846324|26127931|P2|Overall Study|Other|0
7523041|NCT02846324|26127932|P1|Overall Study|Other|1
7523042|NCT02845375|26128049|P3|Overall Study|upper airway obstruction|1
7523043|NCT02845375|26128050|P2|Overall Study|upper airway obstruction|2
7523044|NCT02845375|26128051|P1|Overall Study|upper airway obstruction|1
7523045|NCT02845336|26128064|P2|Overall Study|Inability to get medication|0
7523046|NCT02845336|26128065|P1|Overall Study|Inability to get medication|2
7523047|NCT02845336|26128064|P2|Overall Study|Lost to Follow-up|1
7523048|NCT02845336|26128065|P1|Overall Study|Lost to Follow-up|3
7523049|NCT02844946|26128107|P2|Overall Study|Lost to Follow-up|0
7523050|NCT02844946|26128108|P1|Overall Study|Lost to Follow-up|7
7523051|NCT02844920|26128126|P1|Overall Study|Lost to Follow-up|2
7523052|NCT02844543|26128152|P1|Overall Study|Did not meet eligibility criteria|1
7523053|NCT02844543|26128152|P1|Overall Study|Withdrawal by Subject|4
7523054|NCT02844439|26128159|P1|Overall Study|Other|5
7523055|NCT02844439|26128159|P1|Overall Study|Death|28
7523056|NCT02844439|26128159|P1|Overall Study|Termination by Sponsor|4
7523057|NCT02844439|26128159|P1|Overall Study|Lost to Follow-up|2
7523058|NCT02844439|26128159|P1|Overall Study|Withdrawal by Subject|1
7523059|NCT02843659|26128197|P3|Overall Study|Adverse Event|0
7523060|NCT02843659|26128198|P2|Overall Study|Adverse Event|1
7523061|NCT02843659|26128199|P1|Overall Study|Adverse Event|0
7523062|NCT02843659|26128197|P3|Overall Study|Administrative Reason by Sponsor|4
7523063|NCT02843659|26128198|P2|Overall Study|Administrative Reason by Sponsor|5
7523064|NCT02843659|26128199|P1|Overall Study|Administrative Reason by Sponsor|4
7523065|NCT02843659|26128197|P3|Overall Study|Subject Withdrew Consent|1
7523066|NCT02843659|26128198|P2|Overall Study|Subject Withdrew Consent|0
7523067|NCT02843659|26128199|P1|Overall Study|Subject Withdrew Consent|0
7523068|NCT02843178|26128277|P4|Overall Study|Withdrawal by Subject|1
7523069|NCT02843178|26128278|P3|Overall Study|Withdrawal by Subject|1
7523070|NCT02843178|26128279|P2|Overall Study|Withdrawal by Subject|0
7523071|NCT02843178|26128280|P1|Overall Study|Withdrawal by Subject|0
7523072|NCT02843178|26128277|P4|Overall Study|Lost to Follow-up|3
7523073|NCT02843178|26128278|P3|Overall Study|Lost to Follow-up|6
7523074|NCT02843178|26128279|P2|Overall Study|Lost to Follow-up|8
7523075|NCT02843178|26128280|P1|Overall Study|Lost to Follow-up|8
7523076|NCT02842866|26128320|P2|Overall Study|Withdrawal by Subject|0
7523077|NCT02842866|26128321|P1|Overall Study|Withdrawal by Subject|1
7523078|NCT02842866|26128320|P2|Overall Study|Lost to Follow-up|0
7523079|NCT02842866|26128321|P1|Overall Study|Lost to Follow-up|2
7523080|NCT02842866|26128320|P2|Overall Study|Protocol Violation|2
7523081|NCT02842866|26128321|P1|Overall Study|Protocol Violation|4
7523082|NCT02842866|26128320|P2|Overall Study|Serious Adverse Event|1
7523083|NCT02842866|26128321|P1|Overall Study|Serious Adverse Event|0
7523084|NCT02842853|26128333|P4|Overall Study|Lost to Follow-up|11
7523085|NCT02842853|26128334|P3|Overall Study|Lost to Follow-up|10
7523086|NCT02842853|26128335|P2|Overall Study|Lost to Follow-up|13
7523087|NCT02842853|26128336|P1|Overall Study|Lost to Follow-up|9
7523088|NCT02842853|26128333|P4|Overall Study|Withdrawal by Subject|8
7523089|NCT02842853|26128334|P3|Overall Study|Withdrawal by Subject|9
7523090|NCT02842853|26128335|P2|Overall Study|Withdrawal by Subject|13
7523091|NCT02842853|26128336|P1|Overall Study|Withdrawal by Subject|11
7523092|NCT02842853|26128333|P4|Overall Study|Subject met exclusion criteria|0
7523093|NCT02842853|26128334|P3|Overall Study|Subject met exclusion criteria|0
7523094|NCT02842853|26128335|P2|Overall Study|Subject met exclusion criteria|1
7523095|NCT02842853|26128336|P1|Overall Study|Subject met exclusion criteria|0
7523096|NCT02842853|26128333|P4|Overall Study|Non-compliance with the protocol|5
7523097|NCT02842853|26128334|P3|Overall Study|Non-compliance with the protocol|2
7523098|NCT02842853|26128335|P2|Overall Study|Non-compliance with the protocol|7
7523099|NCT02842853|26128336|P1|Overall Study|Non-compliance with the protocol|3
7523100|NCT02842736|26128356|P1|Overall Study|IUD: Mirena|1
7523101|NCT02842736|26128356|P1|Overall Study|Hysterectomy for uterine prolapse|1
7523102|NCT02842736|26128356|P1|Overall Study|Hysterectomy for fibroids|2
7523103|NCT02842736|26128356|P1|Overall Study|Pregnancy|3
7523104|NCT02842736|26128356|P1|Overall Study|Withdrawal by Subject|4
7523105|NCT02842736|26128356|P1|Overall Study|Intervention for menstrual bleeding|17
7523106|NCT02842736|26128356|P1|Overall Study|Lost to Follow-up|13
7523107|NCT02842151|26128399|P1|Overall Study|Subject moved too far away|1
7523108|NCT02842151|26128399|P1|Overall Study|Adverse Event|1
7523109|NCT02842086|26128407|P2|Overall Study|HIV-1 Infection|6
7523110|NCT02842086|26128408|P1|Overall Study|HIV-1 Infection|5
7523111|NCT02842086|26128407|P2|Overall Study|Lost to Follow-up|236
7523112|NCT02842086|26128408|P1|Overall Study|Lost to Follow-up|274
7523113|NCT02842086|26128407|P2|Overall Study|Withdrew Consent|194
7523114|NCT02842086|26128408|P1|Overall Study|Withdrew Consent|205
7523115|NCT02842086|26128407|P2|Overall Study|Protocol Violation|4
7523116|NCT02842086|26128408|P1|Overall Study|Protocol Violation|8
7523117|NCT02842086|26128407|P2|Overall Study|Non-Compliance with Study Drug|8
7523118|NCT02842086|26128408|P1|Overall Study|Non-Compliance with Study Drug|9
7523119|NCT02842086|26128407|P2|Overall Study|Investigator's Discretion|13
7523120|NCT02842086|26128408|P1|Overall Study|Investigator's Discretion|9
7523121|NCT02842086|26128407|P2|Overall Study|Death|3
7523122|NCT02842086|26128408|P1|Overall Study|Death|3
7523123|NCT02842086|26128407|P2|Overall Study|Adverse Event|20
7523124|NCT02842086|26128408|P1|Overall Study|Adverse Event|18
7523125|NCT02842086|26128407|P2|Overall Study|Still in Double-Blind Phase|3
7523126|NCT02842086|26128408|P1|Overall Study|Still in Double-Blind Phase|7
7523127|NCT02842086|26128407|P2|Overall Study|Randomized but Never Treated|6
7523128|NCT02842086|26128408|P1|Overall Study|Randomized but Never Treated|6
7523129|NCT02842073|26128444|P1|Overall Study|Withdrawal by Subject|1
7523130|NCT02841787|26128470|P3|Overall Study|Withdrawal by Subject|0
7523131|NCT02841787|26128471|P2|Overall Study|Withdrawal by Subject|4
7523132|NCT02841787|26128472|P1|Overall Study|Withdrawal by Subject|1
7523133|NCT02841787|26128470|P3|Overall Study|Symptoms dropped below threshold|0
7523134|NCT02841787|26128471|P2|Overall Study|Symptoms dropped below threshold|0
7523135|NCT02841787|26128472|P1|Overall Study|Symptoms dropped below threshold|1
7523136|NCT02841787|26128470|P3|Overall Study|Lost to Follow-up|0
7523137|NCT02841787|26128471|P2|Overall Study|Lost to Follow-up|0
7523138|NCT02841787|26128472|P1|Overall Study|Lost to Follow-up|1
7523139|NCT02841709|26128486|P5|5th Intervention|Adverse Event|2
7523140|NCT02841709|26128487|P4|5th Intervention|Adverse Event|0
7523141|NCT02841709|26128488|P3|5th Intervention|Adverse Event|0
7523142|NCT02841709|26128489|P2|5th Intervention|Adverse Event|0
7523143|NCT02841709|26128490|P1|5th Intervention|Adverse Event|2
7523144|NCT02840721|26128640|P1|Follow-Up|Withdrawal of Consent|2
7523145|NCT02840721|26128640|P1|Follow-Up|Withdrawal by Subject|4
7523146|NCT02840721|26128640|P1|Follow-Up|Lack of Efficacy|1
7523147|NCT02840721|26128640|P1|Treatment Period|Adverse Event|1
7523148|NCT02840474|26128661|P2|Overall Study|Lost to Follow-up|0
7523149|NCT02840474|26128662|P1|Overall Study|Lost to Follow-up|1
7523150|NCT02840461|26128701|P3|Overall Study|Worsening of Symptom & Kit Error|2
7523151|NCT02840461|26128702|P2|Overall Study|Worsening of Symptom & Kit Error|0
7523152|NCT02840461|26128703|P1|Overall Study|Worsening of Symptom & Kit Error|0
7523153|NCT02840461|26128701|P3|Overall Study|Withdrawal by Subject|2
7523154|NCT02840461|26128702|P2|Overall Study|Withdrawal by Subject|6
7523155|NCT02840461|26128703|P1|Overall Study|Withdrawal by Subject|10
7523156|NCT02840461|26128701|P3|Overall Study|Protocol Violation|1
7523157|NCT02840461|26128702|P2|Overall Study|Protocol Violation|3
7523158|NCT02840461|26128703|P1|Overall Study|Protocol Violation|2
7523159|NCT02840461|26128701|P3|Overall Study|Non-Comliance with Dosing Requirements|0
7523160|NCT02840461|26128702|P2|Overall Study|Non-Comliance with Dosing Requirements|1
7523161|NCT02840461|26128703|P1|Overall Study|Non-Comliance with Dosing Requirements|0
7523162|NCT02840461|26128701|P3|Overall Study|Lost to Follow-up|6
7523163|NCT02840461|26128702|P2|Overall Study|Lost to Follow-up|7
7523164|NCT02840461|26128703|P1|Overall Study|Lost to Follow-up|10
7523165|NCT02840461|26128701|P3|Overall Study|Adverse Event|3
7523166|NCT02840461|26128702|P2|Overall Study|Adverse Event|5
7523167|NCT02840461|26128703|P1|Overall Study|Adverse Event|1
7523168|NCT02840253|26128714|P1|Overall Study|Unsuccessful block|4
7523169|NCT02839876|26128836|P2|Overall Study|Protocol Violation|11
7523170|NCT02839876|26128837|P1|Overall Study|Protocol Violation|10
7523171|NCT02839798|26128899|P1|Overall Study|Withdrawal by Subject|2
7523172|NCT02839746|26128945|P1|Overall Study|Not met selection criteria|12
7523173|NCT02839681|26128959|P1|Overall Study|Death|2
7523174|NCT02839330|26128972|P4|Overall Study|Other reason, not specified|6
7523175|NCT02839330|26128973|P3|Overall Study|Other reason, not specified|3
7523176|NCT02839330|26128974|P2|Overall Study|Other reason, not specified|3
7523177|NCT02839330|26128975|P1|Overall Study|Other reason, not specified|4
7523178|NCT02839330|26128972|P4|Overall Study|Protocol Violation|3
7523179|NCT02839330|26128973|P3|Overall Study|Protocol Violation|2
7523180|NCT02839330|26128974|P2|Overall Study|Protocol Violation|2
7523181|NCT02839330|26128975|P1|Overall Study|Protocol Violation|1
7523182|NCT02839330|26128972|P4|Overall Study|Administrative Reason|1
7523183|NCT02839330|26128973|P3|Overall Study|Administrative Reason|0
7523184|NCT02839330|26128974|P2|Overall Study|Administrative Reason|0
7523185|NCT02839330|26128975|P1|Overall Study|Administrative Reason|0
7523186|NCT02839330|26128972|P4|Overall Study|Lost to Follow-up|25
7523187|NCT02839330|26128973|P3|Overall Study|Lost to Follow-up|29
7523188|NCT02839330|26128974|P2|Overall Study|Lost to Follow-up|27
7523189|NCT02839330|26128975|P1|Overall Study|Lost to Follow-up|22
7523190|NCT02839330|26128972|P4|Overall Study|Withdrawal by Subject|13
7523191|NCT02839330|26128973|P3|Overall Study|Withdrawal by Subject|11
7523192|NCT02839330|26128974|P2|Overall Study|Withdrawal by Subject|19
7523193|NCT02839330|26128975|P1|Overall Study|Withdrawal by Subject|27
7523194|NCT02839330|26128972|P4|Overall Study|Death|1
7523195|NCT02839330|26128973|P3|Overall Study|Death|1
7523196|NCT02839330|26128974|P2|Overall Study|Death|6
7523197|NCT02839330|26128975|P1|Overall Study|Death|4
7523198|NCT02839330|26128972|P4|Overall Study|Adverse Event|2
7523199|NCT02839330|26128973|P3|Overall Study|Adverse Event|2
7523200|NCT02839330|26128974|P2|Overall Study|Adverse Event|1
7523201|NCT02839330|26128975|P1|Overall Study|Adverse Event|0
7523202|NCT02839200|26129010|P6|Overall Study|Randomized in error|0
7523203|NCT02839200|26129011|P5|Overall Study|Randomized in error|0
7523204|NCT02839200|26129012|P4|Overall Study|Randomized in error|0
7523205|NCT02839200|26129013|P3|Overall Study|Randomized in error|0
7523206|NCT02839200|26129014|P2|Overall Study|Randomized in error|1
7523207|NCT02839200|26129015|P1|Overall Study|Randomized in error|0
7523208|NCT02839200|26129010|P6|Overall Study|Adverse Event|0
7523209|NCT02839200|26129011|P5|Overall Study|Adverse Event|1
7523210|NCT02839200|26129012|P4|Overall Study|Adverse Event|0
7523211|NCT02839200|26129013|P3|Overall Study|Adverse Event|0
7523212|NCT02839200|26129014|P2|Overall Study|Adverse Event|0
7523213|NCT02839200|26129015|P1|Overall Study|Adverse Event|0
7523214|NCT02839200|26129010|P6|Overall Study|Lost to Follow-up|0
7523215|NCT02839200|26129011|P5|Overall Study|Lost to Follow-up|1
7523216|NCT02839200|26129012|P4|Overall Study|Lost to Follow-up|0
7523217|NCT02839200|26129013|P3|Overall Study|Lost to Follow-up|0
7523218|NCT02839200|26129014|P2|Overall Study|Lost to Follow-up|0
7523219|NCT02839200|26129015|P1|Overall Study|Lost to Follow-up|2
7523220|NCT02839200|26129010|P6|Overall Study|Withdrawal by Subject|1
7523221|NCT02839200|26129011|P5|Overall Study|Withdrawal by Subject|0
7523222|NCT02839200|26129012|P4|Overall Study|Withdrawal by Subject|0
7523223|NCT02839200|26129013|P3|Overall Study|Withdrawal by Subject|1
7523224|NCT02839200|26129014|P2|Overall Study|Withdrawal by Subject|0
7523225|NCT02839200|26129015|P1|Overall Study|Withdrawal by Subject|2
7523226|NCT02838901|26129049|P2|Overall Study|Lost to Follow-up|1
7523227|NCT02838901|26129050|P1|Overall Study|Lost to Follow-up|1
7523228|NCT02838901|26129049|P2|Overall Study|Withdrawal by Subject|1
7523229|NCT02838901|26129050|P1|Overall Study|Withdrawal by Subject|1
7523230|NCT02838628|26129080|P2|Recurrence Follow-up Period|Other un-specified|1
7523231|NCT02838628|26129081|P1|Recurrence Follow-up Period|Other un-specified|1
7523232|NCT02838628|26129080|P2|Recurrence Follow-up Period|Withdrawal by Subject|2
7523233|NCT02838628|26129081|P1|Recurrence Follow-up Period|Withdrawal by Subject|0
7523234|NCT02838628|26129080|P2|Recurrence Follow-up Period|Non-compliance|1
7523235|NCT02838628|26129081|P1|Recurrence Follow-up Period|Non-compliance|0
7523236|NCT02838628|26129080|P2|Recurrence Follow-up Period|Adverse Event|0
7523237|NCT02838628|26129081|P1|Recurrence Follow-up Period|Adverse Event|1
7523238|NCT02838628|26129080|P2|Recurrence Follow-up Period|AK Recurrence|13
7523239|NCT02838628|26129081|P1|Recurrence Follow-up Period|AK Recurrence|18
7523240|NCT02838420|26129115|P2|Overall Study|Death|13
7523241|NCT02838420|26129116|P1|Overall Study|Death|8
7523242|NCT02838420|26129115|P2|Overall Study|Withdrawal by Subject|4
7523243|NCT02838420|26129116|P1|Overall Study|Withdrawal by Subject|3
7523244|NCT02838420|26129115|P2|Overall Study|Lost to Follow-up|0
7523245|NCT02838420|26129116|P1|Overall Study|Lost to Follow-up|1
7523246|NCT02838420|26129115|P2|Overall Study|Ongoing in Study|45
7523247|NCT02838420|26129116|P1|Overall Study|Ongoing in Study|113
7523248|NCT02838134|26129179|P2|Overall Study|logistic problems|1
7523249|NCT02838134|26129180|P1|Overall Study|logistic problems|1
7523250|NCT02838134|26129179|P2|Overall Study|Lost to Follow-up|2
7523251|NCT02838134|26129180|P1|Overall Study|Lost to Follow-up|1
7523252|NCT02838017|26129212|P2|Overall Study|Lost to Follow-up|11
7523253|NCT02838017|26129213|P1|Overall Study|Lost to Follow-up|14
7523254|NCT02837952|26129231|P2|Overall Study|Medication Error|0
7523255|NCT02837952|26129232|P1|Overall Study|Medication Error|1
7523256|NCT02837952|26129231|P2|Overall Study|Withdrawal by Subject|5
7523257|NCT02837952|26129232|P1|Overall Study|Withdrawal by Subject|4
7523258|NCT02837952|26129231|P2|Overall Study|Adverse Event|1
7523259|NCT02837952|26129232|P1|Overall Study|Adverse Event|0
7523260|NCT02837731|26129278|P2|Allocation|Known aortic abnormalities|1
7523261|NCT02837731|26129279|P1|Allocation|Known aortic abnormalities|0
7523262|NCT02837731|26129278|P2|Allocation|Did not meet sepsis criteria|2
7523263|NCT02837731|26129279|P1|Allocation|Did not meet sepsis criteria|1
7523264|NCT02837731|26129278|P2|Allocation|Moribund/Do not resuscitate|0
7523265|NCT02837731|26129279|P1|Allocation|Moribund/Do not resuscitate|2
7523266|NCT02837731|26129278|P2|Allocation|Protocol not implemented|0
7523267|NCT02837731|26129279|P1|Allocation|Protocol not implemented|7
7523268|NCT02837731|26129278|P2|Allocation|Device not available|0
7523269|NCT02837731|26129279|P1|Allocation|Device not available|1
7523270|NCT02837731|26129278|P2|Allocation|Withdrawal by Subject|0
7523271|NCT02837731|26129279|P1|Allocation|Withdrawal by Subject|2
7523272|NCT02837731|26129278|P2|Allocation|Diabetic Ketoacidosis/withdrew|0
7523273|NCT02837731|26129279|P1|Allocation|Diabetic Ketoacidosis/withdrew|1
7523274|NCT02837731|26129278|P2|Allocation|Immediate surgery/withdrew|0
7523275|NCT02837731|26129279|P1|Allocation|Immediate surgery/withdrew|2
7523276|NCT02837731|26129278|P2|Allocation|Admitted to General Floor|4
7523277|NCT02837731|26129279|P1|Allocation|Admitted to General Floor|3
7523278|NCT02837029|26129327|P3|2 Year Follow-up|Death|0
7523279|NCT02837029|26129328|P2|2 Year Follow-up|Death|7
7523280|NCT02837029|26129329|P1|2 Year Follow-up|Death|6
7523281|NCT02837029|26129327|P3|Cycle 2 and Beyond|Adverse Event|0
7523282|NCT02837029|26129328|P2|Cycle 2 and Beyond|Adverse Event|0
7523283|NCT02837029|26129329|P1|Cycle 2 and Beyond|Adverse Event|1
7523284|NCT02837029|26129327|P3|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
7523285|NCT02837029|26129328|P2|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
7523286|NCT02837029|26129329|P1|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
7523287|NCT02837029|26129327|P3|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
7523288|NCT02837029|26129328|P2|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
7523289|NCT02837029|26129329|P1|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
7523290|NCT02837029|26129327|P3|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
7523291|NCT02837029|26129328|P2|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
7523292|NCT02837029|26129329|P1|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
7523293|NCT02837029|26129327|P3|Screening|Failed to meet screening requirements.|0
7523294|NCT02837029|26129328|P2|Screening|Failed to meet screening requirements.|3
7523295|NCT02837029|26129329|P1|Screening|Failed to meet screening requirements.|7
7523296|NCT02836873|26129359|P2|Overall Study|Other|0
7523297|NCT02836873|26129360|P1|Overall Study|Other|1
7523298|NCT02836873|26129359|P2|Overall Study|Physician Decision|1
7523299|NCT02836873|26129360|P1|Overall Study|Physician Decision|0
7523300|NCT02836873|26129359|P2|Overall Study|Lost to Follow-up|3
7523301|NCT02836873|26129360|P1|Overall Study|Lost to Follow-up|1
7523302|NCT02836873|26129359|P2|Overall Study|Withdrawal by Subject|2
7523303|NCT02836873|26129360|P1|Overall Study|Withdrawal by Subject|2
7523304|NCT02836873|26129359|P2|Overall Study|Adverse Event|4
7523305|NCT02836873|26129360|P1|Overall Study|Adverse Event|1
7523306|NCT02836873|26129359|P2|Overall Study|Protocol Violation|1
7523307|NCT02836873|26129360|P1|Overall Study|Protocol Violation|0
7523308|NCT02836769|26129374|P1|Overall Study|Withdrawal by Subject|3
7523309|NCT02836769|26129374|P1|Overall Study|Medical withdrawal|2
7523310|NCT02836769|26129374|P1|Overall Study|Lost to Follow-up|10
7523311|NCT02836652|26129382|P2|Overall Study|Not on treatment regimen post-op day 15|3
7523312|NCT02836652|26129383|P1|Overall Study|Not on treatment regimen post-op day 15|3
7523313|NCT02836652|26129382|P2|Overall Study|Withdrawn|9
7523314|NCT02836652|26129383|P1|Overall Study|Withdrawn|9
7523315|NCT02836652|26129382|P2|Overall Study|Transplant/Explant|4
7523316|NCT02836652|26129383|P1|Overall Study|Transplant/Explant|3
7523317|NCT02836652|26129382|P2|Overall Study|Death|3
7523318|NCT02836652|26129383|P1|Overall Study|Death|3
7523319|NCT02836613|26129397|P2|Overall Study|Withdrawal by Subject|2
7523320|NCT02836613|26129398|P1|Overall Study|Withdrawal by Subject|0
7523321|NCT02836613|26129397|P2|Overall Study|Lost to Follow-up|1
7523322|NCT02836613|26129398|P1|Overall Study|Lost to Follow-up|0
7523323|NCT02836613|26129397|P2|Overall Study|Accidental drowning|0
7523324|NCT02836613|26129398|P1|Overall Study|Accidental drowning|1
7523325|NCT02836496|26129412|P2|Overall Study|Withdrawal by Subject|1
7523326|NCT02836496|26129413|P1|Overall Study|Withdrawal by Subject|0
7523327|NCT02836496|26129412|P2|Overall Study|Adverse Event|1
7523328|NCT02836496|26129413|P1|Overall Study|Adverse Event|2
7523329|NCT02836249|26129429|P2|Overall Study|Still on Study|55
7523330|NCT02836249|26129430|P1|Overall Study|Still on Study|121
7523331|NCT02836249|26129429|P2|Overall Study|Lost to Follow-up|1
7523332|NCT02836249|26129430|P1|Overall Study|Lost to Follow-up|0
7523333|NCT02836249|26129429|P2|Overall Study|Withdrew Consent|1
7523334|NCT02836249|26129430|P1|Overall Study|Withdrew Consent|0
7523335|NCT02836249|26129429|P2|Overall Study|Pregnancy|0
7523336|NCT02836249|26129430|P1|Overall Study|Pregnancy|2
7523337|NCT02836249|26129429|P2|Overall Study|Randomized but Never Treated|1
7523338|NCT02836249|26129430|P1|Overall Study|Randomized but Never Treated|0
7523339|NCT02836236|26129448|P2|Overall Study|Still on Study|49
7523340|NCT02836236|26129449|P1|Overall Study|Still on Study|101
7523341|NCT02836236|26129448|P2|Overall Study|Investigator's Discretion|0
7523342|NCT02836236|26129449|P1|Overall Study|Investigator's Discretion|1
7523343|NCT02836236|26129448|P2|Overall Study|Adverse Event|1
7523344|NCT02836236|26129449|P1|Overall Study|Adverse Event|0
7523345|NCT02836236|26129448|P2|Overall Study|Withdrew Consent|0
7523346|NCT02836236|26129449|P1|Overall Study|Withdrew Consent|2
7523347|NCT02836236|26129448|P2|Overall Study|Randomized but Never Treated|0
7523348|NCT02836236|26129449|P1|Overall Study|Randomized but Never Treated|1
7523349|NCT02835820|26129473|P2|Overall Study|Baseline Screen Failure|3
7523350|NCT02835820|26129474|P1|Overall Study|Baseline Screen Failure|0
7523351|NCT02835690|26129521|P3|Overall Study|Not Treated|0
7523352|NCT02835690|26129522|P2|Overall Study|Not Treated|2
7523353|NCT02835690|26129523|P1|Overall Study|Not Treated|0
7523354|NCT02835690|26129521|P3|Overall Study|Ongoing in Study (Follow-up)|9
7523355|NCT02835690|26129522|P2|Overall Study|Ongoing in Study (Follow-up)|7
7523356|NCT02835690|26129523|P1|Overall Study|Ongoing in Study (Follow-up)|10
7523357|NCT02835690|26129521|P3|Overall Study|Death|6
7523358|NCT02835690|26129522|P2|Overall Study|Death|6
7523359|NCT02835690|26129523|P1|Overall Study|Death|4
7523360|NCT02835495|26129610|P2|Overall Study|Declined in-person follow-up visit|2
7523361|NCT02835495|26129611|P1|Overall Study|Declined in-person follow-up visit|4
7523362|NCT02835495|26129610|P2|Overall Study|Cancer diagnosis prior intervention|0
7523363|NCT02835495|26129611|P1|Overall Study|Cancer diagnosis prior intervention|1
7523364|NCT02835339|26129637|P2|Overall Study|Did not receive allocated intervention|16
7523365|NCT02835339|26129638|P1|Overall Study|Did not receive allocated intervention|13
7523366|NCT02835092|26129660|P3|Overall Study|Lost to Follow-up|0
7523367|NCT02835092|26129661|P2|Overall Study|Lost to Follow-up|2
7523368|NCT02835092|26129662|P1|Overall Study|Lost to Follow-up|0
7523369|NCT02835092|26129660|P3|Overall Study|Withdrawal by Subject|3
7523370|NCT02835092|26129661|P2|Overall Study|Withdrawal by Subject|6
7523371|NCT02835092|26129662|P1|Overall Study|Withdrawal by Subject|3
7523372|NCT02834819|26129672|P2|Overall Study|Did not complete 7 day follow up call.|0
7523373|NCT02834819|26129673|P1|Overall Study|Did not complete 7 day follow up call.|5
7523374|NCT02834390|26129730|P2|Consolidation Phase|Physician Decision|1
7523375|NCT02834390|26129731|P1|Consolidation Phase|Physician Decision|1
7523376|NCT02834390|26129730|P2|Induction Phase|Relapse after CR, CRp, or CRi|1
7523377|NCT02834390|26129731|P1|Induction Phase|Relapse after CR, CRp, or CRi|0
7523378|NCT02834390|26129730|P2|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
7523379|NCT02834390|26129731|P1|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
7523380|NCT02834390|26129730|P2|Induction Phase|Progressive disease|1
7523381|NCT02834390|26129731|P1|Induction Phase|Progressive disease|0
7523382|NCT02834247|26129759|P4|Dose Expansion Phase|Withdrawal by Subject|1
7523383|NCT02834247|26129760|P3|Dose Expansion Phase|Withdrawal by Subject|0
7523384|NCT02834247|26129761|P2|Dose Expansion Phase|Withdrawal by Subject|0
7523385|NCT02834247|26129762|P1|Dose Expansion Phase|Withdrawal by Subject|0
7523386|NCT02834247|26129759|P4|Dose Expansion Phase|Lost to Follow-up|1
7523387|NCT02834247|26129760|P3|Dose Expansion Phase|Lost to Follow-up|0
7523388|NCT02834247|26129761|P2|Dose Expansion Phase|Lost to Follow-up|0
7523389|NCT02834247|26129762|P1|Dose Expansion Phase|Lost to Follow-up|0
7523390|NCT02834247|26129759|P4|Dose Expansion Phase|Death|8
7523391|NCT02834247|26129760|P3|Dose Expansion Phase|Death|0
7523392|NCT02834247|26129761|P2|Dose Expansion Phase|Death|0
7523393|NCT02834247|26129762|P1|Dose Expansion Phase|Death|0
7523394|NCT02834247|26129759|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
7523395|NCT02834247|26129760|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
7523396|NCT02834247|26129761|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
7523397|NCT02834247|26129762|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
7523398|NCT02834247|26129759|P4|Dose Escalation Phase|Withdrawal by Subject|0
7523399|NCT02834247|26129760|P3|Dose Escalation Phase|Withdrawal by Subject|0
7523400|NCT02834247|26129761|P2|Dose Escalation Phase|Withdrawal by Subject|2
7523401|NCT02834247|26129762|P1|Dose Escalation Phase|Withdrawal by Subject|2
7523402|NCT02834247|26129759|P4|Dose Escalation Phase|Lost to Follow-up|0
7523403|NCT02834247|26129760|P3|Dose Escalation Phase|Lost to Follow-up|0
7523404|NCT02834247|26129761|P2|Dose Escalation Phase|Lost to Follow-up|1
7523405|NCT02834247|26129762|P1|Dose Escalation Phase|Lost to Follow-up|0
7523406|NCT02834247|26129759|P4|Dose Escalation Phase|Death|0
7523407|NCT02834247|26129760|P3|Dose Escalation Phase|Death|5
7523408|NCT02834247|26129761|P2|Dose Escalation Phase|Death|6
7523409|NCT02834247|26129762|P1|Dose Escalation Phase|Death|5
7523410|NCT02834247|26129759|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
7523411|NCT02834247|26129760|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
7523412|NCT02834247|26129761|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
7523413|NCT02834247|26129762|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
7523414|NCT02833974|26129791|P2|Overall Study|Adverse Event|3
7523415|NCT02833974|26129792|P1|Overall Study|Adverse Event|0
7523416|NCT02833974|26129791|P2|Overall Study|Lost to Follow-up|0
7523417|NCT02833974|26129792|P1|Overall Study|Lost to Follow-up|1
7523418|NCT02833948|26129818|P2|Overall Study|scans could not be evaluated|2
7523419|NCT02833948|26129819|P1|Overall Study|scans could not be evaluated|5
7523420|NCT02833948|26129818|P2|Overall Study|were not scanned|13
7523421|NCT02833948|26129819|P1|Overall Study|were not scanned|8
7523422|NCT02833948|26129818|P2|Overall Study|Death|3
7523423|NCT02833948|26129819|P1|Overall Study|Death|2
7523424|NCT02833844|26129878|P2|Open-Label Period|Withdrawal by Subject|0
7523425|NCT02833844|26129879|P1|Open-Label Period|Withdrawal by Subject|1
7523426|NCT02833844|26129878|P2|Open-Label Period|Lost to Follow-up|0
7523427|NCT02833844|26129879|P1|Open-Label Period|Lost to Follow-up|1
7523428|NCT02833844|26129878|P2|Open-Label Period|Death|2
7523429|NCT02833844|26129879|P1|Open-Label Period|Death|0
7523430|NCT02833844|26129878|P2|Double-Blind Period|Protocol Violation|4
7523431|NCT02833844|26129879|P1|Double-Blind Period|Protocol Violation|0
7523432|NCT02833844|26129878|P2|Double-Blind Period|Withdrawal by Subject|3
7523433|NCT02833844|26129879|P1|Double-Blind Period|Withdrawal by Subject|2
7523434|NCT02833350|26129923|P7|Overall Study|Withdrawal by Subject|2
7523435|NCT02833350|26129924|P6|Overall Study|Withdrawal by Subject|0
7523436|NCT02833350|26129925|P5|Overall Study|Withdrawal by Subject|2
7523437|NCT02833350|26129926|P4|Overall Study|Withdrawal by Subject|0
7523438|NCT02833350|26129927|P3|Overall Study|Withdrawal by Subject|2
7523439|NCT02833350|26129928|P2|Overall Study|Withdrawal by Subject|3
7523440|NCT02833350|26129929|P1|Overall Study|Withdrawal by Subject|3
7523441|NCT02833350|26129923|P7|Overall Study|Lost to Follow-up|1
7523442|NCT02833350|26129924|P6|Overall Study|Lost to Follow-up|0
7523443|NCT02833350|26129925|P5|Overall Study|Lost to Follow-up|0
7523444|NCT02833350|26129926|P4|Overall Study|Lost to Follow-up|0
7523445|NCT02833350|26129927|P3|Overall Study|Lost to Follow-up|0
7523446|NCT02833350|26129928|P2|Overall Study|Lost to Follow-up|1
7523447|NCT02833350|26129929|P1|Overall Study|Lost to Follow-up|0
7523448|NCT02833350|26129923|P7|Overall Study|Lack of Efficacy|1
7523449|NCT02833350|26129924|P6|Overall Study|Lack of Efficacy|1
7523450|NCT02833350|26129925|P5|Overall Study|Lack of Efficacy|0
7523451|NCT02833350|26129926|P4|Overall Study|Lack of Efficacy|4
7523452|NCT02833350|26129927|P3|Overall Study|Lack of Efficacy|1
7523453|NCT02833350|26129928|P2|Overall Study|Lack of Efficacy|2
7523454|NCT02833350|26129929|P1|Overall Study|Lack of Efficacy|0
7523455|NCT02833350|26129923|P7|Overall Study|Death|0
7523456|NCT02833350|26129924|P6|Overall Study|Death|0
7523457|NCT02833350|26129925|P5|Overall Study|Death|0
7523458|NCT02833350|26129926|P4|Overall Study|Death|0
7523459|NCT02833350|26129927|P3|Overall Study|Death|1
7523460|NCT02833350|26129928|P2|Overall Study|Death|0
7523461|NCT02833350|26129929|P1|Overall Study|Death|0
7523462|NCT02833350|26129923|P7|Overall Study|Adverse Event|1
7523463|NCT02833350|26129924|P6|Overall Study|Adverse Event|0
7523464|NCT02833350|26129925|P5|Overall Study|Adverse Event|1
7523465|NCT02833350|26129926|P4|Overall Study|Adverse Event|4
7523466|NCT02833350|26129927|P3|Overall Study|Adverse Event|4
7523467|NCT02833350|26129928|P2|Overall Study|Adverse Event|3
7523468|NCT02833350|26129929|P1|Overall Study|Adverse Event|0
7523469|NCT02833077|26130136|P2|Overall Study|Protocol Deviation|1
7523470|NCT02833077|26130137|P1|Overall Study|Protocol Deviation|0
7523471|NCT02833077|26130136|P2|Overall Study|Personal Reasons|4
7523472|NCT02833077|26130137|P1|Overall Study|Personal Reasons|6
7523473|NCT02833077|26130136|P2|Overall Study|Lost to Follow-up|1
7523474|NCT02833077|26130137|P1|Overall Study|Lost to Follow-up|10
7523475|NCT02833077|26130136|P2|Overall Study|Adverse Event|2
7523476|NCT02833077|26130137|P1|Overall Study|Adverse Event|1
7523477|NCT02832622|26130158|P1|Overall Study|Physician Decision|6
7523478|NCT02832622|26130158|P1|Overall Study|System explant|24
7523479|NCT02832622|26130158|P1|Overall Study|Withdrawal by other reasons|25
7523480|NCT02832622|26130158|P1|Overall Study|Patient non-compliance|42
7523481|NCT02832622|26130158|P1|Overall Study|Lost to Follow-up|45
7523482|NCT02832622|26130158|P1|Overall Study|Unsuccessful CRT implant|93
7523483|NCT02832622|26130158|P1|Overall Study|Death|119
7523484|NCT02832622|26130158|P1|Overall Study|Withdrawal by Subject|123
7523485|NCT02832622|26130158|P1|Overall Study|MPP not programmed|1259
7523486|NCT02832375|26130173|P2|Overall Study|Withdrawal of Consent|0
7523487|NCT02832375|26130174|P1|Overall Study|Withdrawal of Consent|1
7523488|NCT02832375|26130173|P2|Overall Study|Lost to Follow-up|0
7523489|NCT02832375|26130174|P1|Overall Study|Lost to Follow-up|1
7523490|NCT02832167|26130192|P1|Treatment Period 2|Other reasons|3
7523491|NCT02832167|26130192|P1|Treatment Period 2|Participant withdrew consent|3
7523492|NCT02832167|26130192|P1|Treatment Period 2|Participant request to discontinue|2
7523493|NCT02832167|26130192|P1|Treatment Period 2|Study Drug Toxicity|5
7523494|NCT02832167|26130192|P1|Treatment Period 2|Maximum clinical benefit|1
7523495|NCT02832167|26130192|P1|Treatment Period 2|Adverse event unrelated to study drug|1
7523496|NCT02832167|26130192|P1|Treatment Period 2|Disease progression|68
7523497|NCT02832167|26130192|P1|Transition From Period 1 to Period 2|Lost to Follow-up|3
7523498|NCT02832167|26130192|P1|Transition From Period 1 to Period 2|Death|2
7523499|NCT02832167|26130192|P1|Transition From Period 1 to Period 2|Participant withdrew consent|1
7523500|NCT02832167|26130192|P1|Transition From Period 1 to Period 2|Other reasons|1
7523501|NCT02832167|26130192|P1|Treatment Period 1|Other reasons|6
7523502|NCT02832167|26130192|P1|Treatment Period 1|Participant withdrew consent|3
7523503|NCT02832167|26130192|P1|Treatment Period 1|No longer meet study criteria|1
7523504|NCT02832167|26130192|P1|Treatment Period 1|Participant request to discontinue|9
7523505|NCT02832167|26130192|P1|Treatment Period 1|Study Drug Toxicity|6
7523506|NCT02832167|26130192|P1|Treatment Period 1|Death|1
7523507|NCT02832167|26130192|P1|Treatment Period 1|Adverse event unrelated to study drug|11
7523508|NCT02832167|26130192|P1|Treatment Period 1|Disease progression|92
7523509|NCT02832037|26130238|P5|Overall Study|Adverse Event|4
7523510|NCT02832037|26130239|P4|Overall Study|Adverse Event|2
7523511|NCT02832037|26130240|P3|Overall Study|Adverse Event|0
7523512|NCT02832037|26130241|P2|Overall Study|Adverse Event|4
7523513|NCT02832037|26130242|P1|Overall Study|Adverse Event|5
7523514|NCT02832037|26130238|P5|Overall Study|Withdrawal by Subject|8
7523515|NCT02832037|26130239|P4|Overall Study|Withdrawal by Subject|4
7523516|NCT02832037|26130240|P3|Overall Study|Withdrawal by Subject|0
7523517|NCT02832037|26130241|P2|Overall Study|Withdrawal by Subject|8
7523518|NCT02832037|26130242|P1|Overall Study|Withdrawal by Subject|9
7523519|NCT02832037|26130238|P5|Overall Study|Lost to Follow-up|5
7523520|NCT02832037|26130239|P4|Overall Study|Lost to Follow-up|0
7523521|NCT02832037|26130240|P3|Overall Study|Lost to Follow-up|3
7523522|NCT02832037|26130241|P2|Overall Study|Lost to Follow-up|0
7523523|NCT02832037|26130242|P1|Overall Study|Lost to Follow-up|2
7523524|NCT02832037|26130238|P5|Overall Study|Protocol Violation|2
7523525|NCT02832037|26130239|P4|Overall Study|Protocol Violation|1
7523526|NCT02832037|26130240|P3|Overall Study|Protocol Violation|4
7523527|NCT02832037|26130241|P2|Overall Study|Protocol Violation|0
7523528|NCT02832037|26130242|P1|Overall Study|Protocol Violation|3
7523529|NCT02832037|26130238|P5|Overall Study|Administrative reasons|0
7523530|NCT02832037|26130239|P4|Overall Study|Administrative reasons|0
7523531|NCT02832037|26130240|P3|Overall Study|Administrative reasons|1
7523532|NCT02832037|26130241|P2|Overall Study|Administrative reasons|0
7523533|NCT02832037|26130242|P1|Overall Study|Administrative reasons|0
7523534|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7523535|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
7523536|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7523537|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
7523538|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
7523539|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
7523540|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
7523541|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
7523542|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
7523543|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Other|5
7523544|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Other|2
7523545|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Other|0
7523546|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
7523547|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
7523548|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
7523549|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
7523550|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
7523551|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
7523552|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7523553|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7523554|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
7523555|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Death|2
7523556|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Death|0
7523557|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Death|0
7523558|NCT02831855|26130275|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
7523559|NCT02831855|26130276|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
7523560|NCT02831855|26130277|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
7523561|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Other|0
7523562|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Other|0
7523563|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Other|4
7523564|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7523565|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7523566|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
7523567|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
7523568|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
7523569|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
7523570|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7523571|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7523572|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
7523573|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7523574|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7523575|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
7523576|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7523577|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7523578|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
7523579|NCT02831855|26130275|P3|Open Label Phase (24 Weeks)|Adverse Event|0
7523580|NCT02831855|26130276|P2|Open Label Phase (24 Weeks)|Adverse Event|0
7523581|NCT02831855|26130277|P1|Open Label Phase (24 Weeks)|Adverse Event|39
7523614|NCT02831387|26130488|P2|Overall Study|Discontinued due to stock recovery|1
7523615|NCT02831387|26130489|P1|Overall Study|Discontinued due to stock recovery|0
7523616|NCT02831387|26130488|P2|Overall Study|Withdrawal by Subject|1
7523617|NCT02831387|26130489|P1|Overall Study|Withdrawal by Subject|1
7523618|NCT02831257|26130507|P1|Overall Study|Withdrawal by Subject|6
7523619|NCT02831257|26130507|P1|Overall Study|Physician Decision|1
7523620|NCT02831257|26130507|P1|Overall Study|Adverse Event|2
7523621|NCT02831257|26130507|P1|Overall Study|Lack of Efficacy|3
7523622|NCT02830893|26130521|P2|Overall Study|Discharged to SNF, no transportation.|1
7523623|NCT02830893|26130522|P1|Overall Study|Discharged to SNF, no transportation.|0
7523624|NCT02830893|26130521|P2|Overall Study|Lost to Follow-up|2
7523625|NCT02830893|26130522|P1|Overall Study|Lost to Follow-up|0
7523626|NCT02830893|26130521|P2|Overall Study|Relocation to out of the country|0
7523627|NCT02830893|26130522|P1|Overall Study|Relocation to out of the country|1
7523628|NCT02830880|26130534|P1|Overall Study|Physician Decision|1
7523629|NCT02830880|26130534|P1|Overall Study|Death|1
7523630|NCT02830880|26130534|P1|Overall Study|Adverse reaction to chemotherapy|1
7523631|NCT02830776|26130543|P1|Overall Study|Lost to Follow-up|1
7523632|NCT02830087|26130558|P6|Overall Study|No study staff to follow-up patients|3
7523633|NCT02830087|26130559|P5|Overall Study|No study staff to follow-up patients|3
7523634|NCT02830087|26130560|P4|Overall Study|No study staff to follow-up patients|3
7523635|NCT02830087|26130561|P3|Overall Study|No study staff to follow-up patients|4
7523636|NCT02830087|26130562|P2|Overall Study|No study staff to follow-up patients|4
7523637|NCT02830087|26130563|P1|Overall Study|No study staff to follow-up patients|4
7523638|NCT02829996|26130653|P5|Overall Study|Withdrawal by Subject|0
7523639|NCT02829996|26130654|P4|Overall Study|Withdrawal by Subject|0
7523640|NCT02829996|26130655|P3|Overall Study|Withdrawal by Subject|0
7523641|NCT02829996|26130656|P2|Overall Study|Withdrawal by Subject|0
7523642|NCT02829996|26130657|P1|Overall Study|Withdrawal by Subject|1
7523643|NCT02829944|26130682|P2|Overall Study|Staff unavailable|1
7523644|NCT02829944|26130683|P1|Overall Study|Staff unavailable|0
7523645|NCT02829944|26130682|P2|Overall Study|Catheter broke|1
7523646|NCT02829944|26130683|P1|Overall Study|Catheter broke|0
7523647|NCT02829944|26130682|P2|Overall Study|Catheter Displacement|0
7523648|NCT02829944|26130683|P1|Overall Study|Catheter Displacement|1
7523649|NCT02829944|26130682|P2|Overall Study|Withdrawal by Subject|1
7523650|NCT02829944|26130683|P1|Overall Study|Withdrawal by Subject|2
7523651|NCT02829944|26130682|P2|Overall Study|Inadequate Neuraxial Block|1
7523652|NCT02829944|26130683|P1|Overall Study|Inadequate Neuraxial Block|1
7523653|NCT02829944|26130682|P2|Overall Study|Screen Failure|2
7523654|NCT02829944|26130683|P1|Overall Study|Screen Failure|2
7523655|NCT02829944|26130682|P2|Overall Study|Physician Decision|1
7523656|NCT02829944|26130683|P1|Overall Study|Physician Decision|0
7523661|NCT02829775|26130738|P1|Overall Study|Disease remission|1
7523662|NCT02829775|26130738|P1|Overall Study|Withdrawal by Subject|3
7523663|NCT02829775|26130738|P1|Overall Study|Death|1
7523664|NCT02829138|26130820|P2|Overall Study|Withdrawal by Subject|0
7523665|NCT02829138|26130821|P1|Overall Study|Withdrawal by Subject|1
7523666|NCT02828982|26130844|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
7523667|NCT02828982|26130845|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
7523668|NCT02828644|26130867|P2|Overall Study|Lost to Follow-up|22
7523669|NCT02828644|26130868|P1|Overall Study|Lost to Follow-up|23
7523670|NCT02828436|26130875|P2|Period 2|Lost to Follow-up|0
7523671|NCT02828436|26130876|P1|Period 2|Lost to Follow-up|1
7523672|NCT02828436|26130875|P2|Period 2|Did Not Meet Inclusion Criteria|0
7523673|NCT02828436|26130876|P1|Period 2|Did Not Meet Inclusion Criteria|3
7523674|NCT02828436|26130875|P2|Period 2|Withdrawal by Subject|0
7523675|NCT02828436|26130876|P1|Period 2|Withdrawal by Subject|4
7523676|NCT02828436|26130875|P2|Period 1|Lost to Follow-up|1
7523677|NCT02828436|26130876|P1|Period 1|Lost to Follow-up|0
7523678|NCT02828436|26130875|P2|Period 1|Did Not Meet Inclusion Criteria|3
7523679|NCT02828436|26130876|P1|Period 1|Did Not Meet Inclusion Criteria|0
7523680|NCT02828241|26130911|P2|Overall Study|Protocol Violation|0
7523681|NCT02828241|26130912|P1|Overall Study|Protocol Violation|1
7523682|NCT02828241|26130911|P2|Overall Study|Adverse Event|2
7523683|NCT02828241|26130912|P1|Overall Study|Adverse Event|7
7523684|NCT02828124|26130939|P4|Overall Study|Subject Withdrew Consent|1
7523685|NCT02828124|26130940|P3|Overall Study|Subject Withdrew Consent|0
7523686|NCT02828124|26130941|P2|Overall Study|Subject Withdrew Consent|0
7523687|NCT02828124|26130942|P1|Overall Study|Subject Withdrew Consent|0
7523688|NCT02828124|26130939|P4|Overall Study|AE Unrelated to Study Drug|1
7523689|NCT02828124|26130940|P3|Overall Study|AE Unrelated to Study Drug|0
7523690|NCT02828124|26130941|P2|Overall Study|AE Unrelated to Study Drug|0
7523691|NCT02828124|26130942|P1|Overall Study|AE Unrelated to Study Drug|0
7523692|NCT02828124|26130939|P4|Overall Study|Disease Progression|4
7523693|NCT02828124|26130940|P3|Overall Study|Disease Progression|1
7523694|NCT02828124|26130941|P2|Overall Study|Disease Progression|2
7523695|NCT02828124|26130942|P1|Overall Study|Disease Progression|1
7523696|NCT02828111|26131057|P5|Overall Study|Lost to Follow-up|1
7523697|NCT02828111|26131058|P4|Overall Study|Lost to Follow-up|1
7523698|NCT02828111|26131059|P3|Overall Study|Lost to Follow-up|0
7523699|NCT02828111|26131060|P2|Overall Study|Lost to Follow-up|0
7523700|NCT02828111|26131061|P1|Overall Study|Lost to Follow-up|0
7523701|NCT02828111|26131057|P5|Overall Study|Withdrawal by Subject|0
7523702|NCT02828111|26131058|P4|Overall Study|Withdrawal by Subject|0
7523703|NCT02828111|26131059|P3|Overall Study|Withdrawal by Subject|2
7523704|NCT02828111|26131060|P2|Overall Study|Withdrawal by Subject|0
7523705|NCT02828111|26131061|P1|Overall Study|Withdrawal by Subject|0
7523706|NCT02828020|26131122|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
7523707|NCT02828020|26131123|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
7523708|NCT02828020|26131124|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
7523709|NCT02828020|26131122|P3|Safety Follow-up Period|Protocol Violation|1
7523710|NCT02828020|26131123|P2|Safety Follow-up Period|Protocol Violation|2
7523711|NCT02828020|26131124|P1|Safety Follow-up Period|Protocol Violation|0
7523712|NCT02828020|26131122|P3|Safety Follow-up Period|Lost to Follow-up|11
7523713|NCT02828020|26131123|P2|Safety Follow-up Period|Lost to Follow-up|8
7523714|NCT02828020|26131124|P1|Safety Follow-up Period|Lost to Follow-up|9
7523715|NCT02828020|26131122|P3|Safety Follow-up Period|Withdrawal of Consent|7
7523716|NCT02828020|26131123|P2|Safety Follow-up Period|Withdrawal of Consent|8
7523717|NCT02828020|26131124|P1|Safety Follow-up Period|Withdrawal of Consent|10
7523718|NCT02828020|26131122|P3|Treatment Period|Other Miscellaneous Reasons|0
7523719|NCT02828020|26131123|P2|Treatment Period|Other Miscellaneous Reasons|1
7523720|NCT02828020|26131124|P1|Treatment Period|Other Miscellaneous Reasons|0
7523721|NCT02828020|26131122|P3|Treatment Period|Protocol Violation|7
7523722|NCT02828020|26131123|P2|Treatment Period|Protocol Violation|4
7523723|NCT02828020|26131124|P1|Treatment Period|Protocol Violation|2
7523724|NCT02828020|26131122|P3|Treatment Period|Pregnancy|0
7523725|NCT02828020|26131123|P2|Treatment Period|Pregnancy|2
7523726|NCT02828020|26131124|P1|Treatment Period|Pregnancy|0
7523727|NCT02828020|26131122|P3|Treatment Period|Lack of Qualifying Event|43
7523728|NCT02828020|26131123|P2|Treatment Period|Lack of Qualifying Event|53
7523729|NCT02828020|26131124|P1|Treatment Period|Lack of Qualifying Event|44
7523730|NCT02828020|26131122|P3|Treatment Period|Lost to Follow-up|18
7523731|NCT02828020|26131123|P2|Treatment Period|Lost to Follow-up|24
7523732|NCT02828020|26131124|P1|Treatment Period|Lost to Follow-up|21
7523733|NCT02828020|26131122|P3|Treatment Period|Withdrawal of Consent|9
7523734|NCT02828020|26131123|P2|Treatment Period|Withdrawal of Consent|14
7523735|NCT02828020|26131124|P1|Treatment Period|Withdrawal of Consent|10
7523736|NCT02828020|26131122|P3|Treatment Period|Adverse Event|1
7523737|NCT02828020|26131123|P2|Treatment Period|Adverse Event|1
7523738|NCT02828020|26131124|P1|Treatment Period|Adverse Event|3
7523739|NCT02827708|26131155|P2|Overall Study|Death|2
7523740|NCT02827708|26131156|P1|Overall Study|Death|1
7523741|NCT02827708|26131155|P2|Overall Study|Withdrawal by Subject|2
7523742|NCT02827708|26131156|P1|Overall Study|Withdrawal by Subject|1
7523743|NCT02827708|26131155|P2|Overall Study|Lost to Follow-up|1
7523744|NCT02827708|26131156|P1|Overall Study|Lost to Follow-up|3
7523745|NCT02827500|26131235|P2|Overall Study|Other|1
7523746|NCT02827500|26131236|P1|Overall Study|Other|5
7523747|NCT02827500|26131235|P2|Overall Study|Missing primary endpoint data|1
7523748|NCT02827500|26131236|P1|Overall Study|Missing primary endpoint data|3
7523749|NCT02827500|26131235|P2|Overall Study|Withdrawal by Subject|1
7523750|NCT02827500|26131236|P1|Overall Study|Withdrawal by Subject|3
7523751|NCT02827500|26131235|P2|Overall Study|Lost to Follow-up|1
7523752|NCT02827500|26131236|P1|Overall Study|Lost to Follow-up|1
7523753|NCT02827500|26131235|P2|Overall Study|Death|3
7523754|NCT02827500|26131236|P1|Overall Study|Death|7
7523755|NCT02826798|26131257|P5|Overall Study|Withdrawal by Subject|0
7523756|NCT02826798|26131258|P4|Overall Study|Withdrawal by Subject|1
7523757|NCT02826798|26131259|P3|Overall Study|Withdrawal by Subject|0
7523758|NCT02826798|26131260|P2|Overall Study|Withdrawal by Subject|1
7523759|NCT02826798|26131261|P1|Overall Study|Withdrawal by Subject|0
7523760|NCT02826603|26131323|P2|Overall Study|New therapy for study indication|1
7523761|NCT02826603|26131324|P1|Overall Study|New therapy for study indication|0
7523762|NCT02826603|26131323|P2|Overall Study|Death|0
7523763|NCT02826603|26131324|P1|Overall Study|Death|2
7523764|NCT02826603|26131323|P2|Overall Study|Withdrawal by Subject|19
7523765|NCT02826603|26131324|P1|Overall Study|Withdrawal by Subject|20
7523766|NCT02826603|26131323|P2|Overall Study|Protocol Violation|3
7523767|NCT02826603|26131324|P1|Overall Study|Protocol Violation|3
7523768|NCT02826603|26131323|P2|Overall Study|Pregnancy|2
7523769|NCT02826603|26131324|P1|Overall Study|Pregnancy|1
7523770|NCT02826603|26131323|P2|Overall Study|Physician Decision|7
7523771|NCT02826603|26131324|P1|Overall Study|Physician Decision|1
7523772|NCT02826603|26131323|P2|Overall Study|Noncompliance with treatment|2
7523773|NCT02826603|26131324|P1|Overall Study|Noncompliance with treatment|0
7523774|NCT02826603|26131323|P2|Overall Study|Lost to Follow-up|12
7523775|NCT02826603|26131324|P1|Overall Study|Lost to Follow-up|13
7523776|NCT02826603|26131323|P2|Overall Study|Lack of Efficacy|9
7523777|NCT02826603|26131324|P1|Overall Study|Lack of Efficacy|4
7523778|NCT02826603|26131323|P2|Overall Study|Adverse Event|9
7523779|NCT02826603|26131324|P1|Overall Study|Adverse Event|17
7523780|NCT02826421|26131364|P4|Overall Study|Reason not given|0
7523781|NCT02826421|26131365|P3|Overall Study|Reason not given|1
7523782|NCT02826421|26131366|P2|Overall Study|Reason not given|0
7523783|NCT02826421|26131367|P1|Overall Study|Reason not given|1
7523784|NCT02826421|26131364|P4|Overall Study|Withdrawal by Subject|1
7523785|NCT02826421|26131365|P3|Overall Study|Withdrawal by Subject|1
7523786|NCT02826421|26131366|P2|Overall Study|Withdrawal by Subject|3
7523787|NCT02826421|26131367|P1|Overall Study|Withdrawal by Subject|1
7523788|NCT02826421|26131364|P4|Overall Study|Adverse Event|1
7523789|NCT02826421|26131365|P3|Overall Study|Adverse Event|0
7523790|NCT02826421|26131366|P2|Overall Study|Adverse Event|0
7523791|NCT02826421|26131367|P1|Overall Study|Adverse Event|1
7523792|NCT02825992|26131394|P1|Overall Study|Procedure terminated|2
7523793|NCT02825992|26131394|P1|Overall Study|Lost to Follow-up|2
7523794|NCT02825992|26131394|P1|Overall Study|Withdrawal by Subject|4
7523795|NCT02825550|26131433|P1|Overall Study|Physician Decision|1
7523796|NCT02825251|26131441|P2|Overall Study|Unclassified|0
7523797|NCT02825251|26131442|P1|Overall Study|Unclassified|2
7523798|NCT02825251|26131441|P2|Overall Study|Withdrawal by Subject|4
7523799|NCT02825251|26131442|P1|Overall Study|Withdrawal by Subject|1
7523800|NCT02825251|26131441|P2|Overall Study|Lost to Follow-up|1
7523801|NCT02825251|26131442|P1|Overall Study|Lost to Follow-up|0
7523802|NCT02825251|26131441|P2|Overall Study|Adverse Event|1
7523803|NCT02825251|26131442|P1|Overall Study|Adverse Event|0
7523804|NCT02825043|26131633|P1|Overall Study|Lost to Follow-up|4
7523805|NCT02824562|26131655|P2|Overall Study|Death|1
7523806|NCT02824562|26131656|P1|Overall Study|Death|0
7523807|NCT02824562|26131655|P2|Overall Study|Lost to Follow-up|4
7523808|NCT02824562|26131656|P1|Overall Study|Lost to Follow-up|3
7523809|NCT02824432|26131665|P2|Overall Study|Major Protocol Deviation|0
7523810|NCT02824432|26131666|P1|Overall Study|Major Protocol Deviation|1
7523811|NCT02824224|26131742|P2|Overall Study|Did not show up for allocation visit|0
7523812|NCT02824224|26131743|P1|Overall Study|Did not show up for allocation visit|2
7523813|NCT02824224|26131742|P2|Overall Study|Discontinued, IUS expulsion|1
7523814|NCT02824224|26131743|P1|Overall Study|Discontinued, IUS expulsion|0
7523815|NCT02824198|26131763|P2|Overall Study|Withdrawal by Subject|0
7523816|NCT02824198|26131764|P1|Overall Study|Withdrawal by Subject|5
7523817|NCT02824198|26131763|P2|Overall Study|Lost to Follow-up|2
7523818|NCT02824198|26131764|P1|Overall Study|Lost to Follow-up|5
7523819|NCT02824198|26131763|P2|Overall Study|Non-compliance with the protocol|1
7523820|NCT02824198|26131764|P1|Overall Study|Non-compliance with the protocol|5
7523821|NCT02823964|26131794|P1|Overall Study|Withdrawal by Subject|1
7523822|NCT02823964|26131794|P1|Overall Study|Lack of Efficacy|1
7523823|NCT02823964|26131794|P1|Overall Study|Physician Decision|1
7523824|NCT02823964|26131794|P1|Overall Study|Adverse Event|2
7523825|NCT02823470|26131808|P2|Overall Study|Study terminated by sponsor|15
7523826|NCT02823470|26131809|P1|Overall Study|Study terminated by sponsor|8
7523827|NCT02823470|26131808|P2|Overall Study|Adverse Event|0
7523828|NCT02823470|26131809|P1|Overall Study|Adverse Event|1
7523829|NCT02822794|26131882|P2|Overall Study|Withdrew Consent|0
7523830|NCT02822794|26131883|P1|Overall Study|Withdrew Consent|1
7523831|NCT02822235|26132025|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
7523832|NCT02822235|26132026|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
7523833|NCT02822235|26132025|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
7523834|NCT02822235|26132026|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
7523835|NCT02822235|26132025|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
7523836|NCT02822235|26132026|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
7523837|NCT02822235|26132025|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
7523838|NCT02822235|26132026|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
7523839|NCT02822235|26132025|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
7523840|NCT02822235|26132026|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
7523841|NCT02822235|26132025|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
7523842|NCT02822235|26132026|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
7523843|NCT02822222|26132081|P2|Overall Study|Protocol requirement SBP<110 mmHg|0
7523844|NCT02822222|26132082|P1|Overall Study|Protocol requirement SBP<110 mmHg|1
7523845|NCT02821962|26132132|P2|Overall Study|Lost to Follow-up|0
7523846|NCT02821962|26132133|P1|Overall Study|Lost to Follow-up|2
7523847|NCT02821910|26132177|P6|Overall Study|Other than specified|0
7523848|NCT02821910|26132178|P5|Overall Study|Other than specified|0
7523849|NCT02821910|26132179|P4|Overall Study|Other than specified|0
7523850|NCT02821910|26132180|P3|Overall Study|Other than specified|1
7523851|NCT02821910|26132181|P2|Overall Study|Other than specified|0
7523852|NCT02821910|26132182|P1|Overall Study|Other than specified|1
7523853|NCT02821910|26132177|P6|Overall Study|Withdrawal by Subject|1
7523854|NCT02821910|26132178|P5|Overall Study|Withdrawal by Subject|0
7523855|NCT02821910|26132179|P4|Overall Study|Withdrawal by Subject|0
7523856|NCT02821910|26132180|P3|Overall Study|Withdrawal by Subject|1
7523857|NCT02821910|26132181|P2|Overall Study|Withdrawal by Subject|0
7523858|NCT02821910|26132182|P1|Overall Study|Withdrawal by Subject|0
7523859|NCT02821819|26132244|P1|Overall Study|Protocol Violation|1
7523860|NCT02821715|26132249|P6|Overall Study|Protocol Violation|0
7523861|NCT02821715|26132250|P5|Overall Study|Protocol Violation|0
7523862|NCT02821715|26132251|P4|Overall Study|Protocol Violation|0
7523863|NCT02821715|26132252|P3|Overall Study|Protocol Violation|0
7523864|NCT02821715|26132253|P2|Overall Study|Protocol Violation|0
7523865|NCT02821715|26132254|P1|Overall Study|Protocol Violation|1
7523866|NCT02821416|26132305|P2|Overall Study|Lost to Follow-up|0
7523867|NCT02821416|26132306|P1|Overall Study|Lost to Follow-up|1
7523868|NCT02821416|26132305|P2|Overall Study|Withdrawal by Subject|0
7523869|NCT02821416|26132306|P1|Overall Study|Withdrawal by Subject|2
7523870|NCT02821416|26132305|P2|Overall Study|Adverse Event|1
7523871|NCT02821416|26132306|P1|Overall Study|Adverse Event|0
7523872|NCT02821000|26132366|P1|Overall Study|Ongoing in Study|58
7523873|NCT02821000|26132366|P1|Overall Study|Withdrawal by Subject|1
7523874|NCT02821000|26132366|P1|Overall Study|Death|44
7523875|NCT02820844|26132404|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
7523876|NCT02820844|26132405|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523877|NCT02820844|26132406|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523878|NCT02820844|26132407|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523879|NCT02820844|26132408|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523880|NCT02820844|26132409|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523881|NCT02820844|26132404|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7523882|NCT02820844|26132405|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
7523883|NCT02820844|26132406|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7523884|NCT02820844|26132407|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7523885|NCT02820844|26132408|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7523886|NCT02820844|26132409|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7523887|NCT02820844|26132404|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523888|NCT02820844|26132405|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523889|NCT02820844|26132406|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
7523890|NCT02820844|26132407|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
7523891|NCT02820844|26132408|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523892|NCT02820844|26132409|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7523893|NCT02820844|26132404|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7523894|NCT02820844|26132405|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7523895|NCT02820844|26132406|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7523896|NCT02820844|26132407|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
7523897|NCT02820844|26132408|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7523898|NCT02820844|26132409|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7523899|NCT02820844|26132404|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7523900|NCT02820844|26132405|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7523901|NCT02820844|26132406|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
7523902|NCT02820844|26132407|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
7523903|NCT02820844|26132408|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7523904|NCT02820844|26132409|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7523905|NCT02820844|26132404|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7523906|NCT02820844|26132405|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7523907|NCT02820844|26132406|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7523908|NCT02820844|26132407|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7523909|NCT02820844|26132408|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7523910|NCT02820844|26132409|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
7523911|NCT02820844|26132404|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7523912|NCT02820844|26132405|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7523913|NCT02820844|26132406|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7523914|NCT02820844|26132407|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7523915|NCT02820844|26132408|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
7523916|NCT02820844|26132409|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
7523917|NCT02820844|26132404|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7523918|NCT02820844|26132405|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7523919|NCT02820844|26132406|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7523920|NCT02820844|26132407|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7523921|NCT02820844|26132408|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
7523922|NCT02820844|26132409|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7523923|NCT02820844|26132404|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7523924|NCT02820844|26132405|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7523925|NCT02820844|26132406|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7523926|NCT02820844|26132407|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7523927|NCT02820844|26132408|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
7523928|NCT02820844|26132409|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
7523929|NCT02820844|26132404|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7523930|NCT02820844|26132405|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7523931|NCT02820844|26132406|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7523932|NCT02820844|26132407|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7523933|NCT02820844|26132408|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
7523934|NCT02820844|26132409|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
7523935|NCT02820597|26132623|P1|Overall Study|Lost to Follow-up|12
7523936|NCT02820298|26132672|P2|Overall Study|Protocol Violation|1
7523937|NCT02820298|26132673|P1|Overall Study|Protocol Violation|0
7523938|NCT02820298|26132672|P2|Overall Study|Physician Decision|0
7523939|NCT02820298|26132673|P1|Overall Study|Physician Decision|1
7523940|NCT02820298|26132672|P2|Overall Study|Withdrawal by Subject|1
7523941|NCT02820298|26132673|P1|Overall Study|Withdrawal by Subject|0
7523942|NCT02820038|26132691|P4|Overall Study|Withdrawal by Subject|13
7523943|NCT02820038|26132692|P3|Overall Study|Withdrawal by Subject|3
7523944|NCT02820038|26132693|P2|Overall Study|Withdrawal by Subject|14
7523945|NCT02820038|26132694|P1|Overall Study|Withdrawal by Subject|3
7523946|NCT02820038|26132691|P4|Overall Study|Lost to Follow-up|9
7523947|NCT02820038|26132692|P3|Overall Study|Lost to Follow-up|2
7523948|NCT02820038|26132693|P2|Overall Study|Lost to Follow-up|11
7523949|NCT02820038|26132694|P1|Overall Study|Lost to Follow-up|7
7523950|NCT02819804|26132845|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
7523951|NCT02819726|26132852|P4|Part B (All Participants)|Protocol non-compliance|0
7523952|NCT02819726|26132853|P3|Part B (All Participants)|Protocol non-compliance|1
7523953|NCT02819726|26132854|P2|Part B (All Participants)|Protocol non-compliance|0
7523954|NCT02819726|26132855|P1|Part B (All Participants)|Protocol non-compliance|0
7523955|NCT02819726|26132852|P4|Part B (All Participants)|Withdrawal by Subject|0
7523956|NCT02819726|26132853|P3|Part B (All Participants)|Withdrawal by Subject|1
7523957|NCT02819726|26132854|P2|Part B (All Participants)|Withdrawal by Subject|1
7523958|NCT02819726|26132855|P1|Part B (All Participants)|Withdrawal by Subject|2
7523959|NCT02819726|26132852|P4|Part B (All Participants)|Lost to Follow-up|2
7523960|NCT02819726|26132853|P3|Part B (All Participants)|Lost to Follow-up|2
7523961|NCT02819726|26132854|P2|Part B (All Participants)|Lost to Follow-up|1
7523962|NCT02819726|26132855|P1|Part B (All Participants)|Lost to Follow-up|1
7523963|NCT02819726|26132852|P4|Part A (All Participants)|Protocol non-compliance|0
7523964|NCT02819726|26132853|P3|Part A (All Participants)|Protocol non-compliance|5
7523965|NCT02819726|26132854|P2|Part A (All Participants)|Protocol non-compliance|4
7523966|NCT02819726|26132855|P1|Part A (All Participants)|Protocol non-compliance|3
7523967|NCT02819726|26132852|P4|Part A (All Participants)|Withdrawal by Subject|0
7523968|NCT02819726|26132853|P3|Part A (All Participants)|Withdrawal by Subject|6
7523969|NCT02819726|26132854|P2|Part A (All Participants)|Withdrawal by Subject|5
7523970|NCT02819726|26132855|P1|Part A (All Participants)|Withdrawal by Subject|3
7523971|NCT02819726|26132852|P4|Part A (All Participants)|Lost to Follow-up|0
7523972|NCT02819726|26132853|P3|Part A (All Participants)|Lost to Follow-up|0
7523973|NCT02819726|26132854|P2|Part A (All Participants)|Lost to Follow-up|1
7523974|NCT02819726|26132855|P1|Part A (All Participants)|Lost to Follow-up|0
7523975|NCT02819479|26132982|P1|Overall Study|Adverse Event|2
7523976|NCT02819310|26133006|P1|Overall Study|Protocol Violation|30
7523977|NCT02819310|26133006|P1|Overall Study|Physician Decision|8
7523978|NCT02819310|26133006|P1|Overall Study|Lack of Efficacy|5
7523979|NCT02819310|26133006|P1|Overall Study|Adverse Event|13
7523980|NCT02819310|26133006|P1|Overall Study|Lost to Follow-up|16
7523981|NCT02819310|26133006|P1|Overall Study|Withdrawal by Subject|37
7523982|NCT02819297|26133012|P2|Overall Study|Protocol Violation|2
7523983|NCT02819297|26133013|P1|Overall Study|Protocol Violation|1
7523984|NCT02819297|26133012|P2|Overall Study|Lack of Efficacy|8
7523985|NCT02819297|26133013|P1|Overall Study|Lack of Efficacy|5
7523986|NCT02819297|26133012|P2|Overall Study|Physician Decision|5
7523987|NCT02819297|26133013|P1|Overall Study|Physician Decision|5
7523988|NCT02819297|26133012|P2|Overall Study|Adverse Event|10
7523989|NCT02819297|26133013|P1|Overall Study|Adverse Event|12
7523990|NCT02819297|26133012|P2|Overall Study|Lost to Follow-up|14
7523991|NCT02819297|26133013|P1|Overall Study|Lost to Follow-up|12
7523992|NCT02819297|26133012|P2|Overall Study|Withdrawal by Subject|13
7523993|NCT02819297|26133013|P1|Overall Study|Withdrawal by Subject|25
7523994|NCT02818998|26133087|P3|Overall Study|Physician Decision|0
7523995|NCT02818998|26133088|P2|Overall Study|Physician Decision|0
7523996|NCT02818998|26133089|P1|Overall Study|Physician Decision|1
7523997|NCT02818998|26133087|P3|Overall Study|Withdrawal by Subject|6
7523998|NCT02818998|26133088|P2|Overall Study|Withdrawal by Subject|6
7523999|NCT02818998|26133089|P1|Overall Study|Withdrawal by Subject|7
7524000|NCT02818998|26133087|P3|Overall Study|Death|8
7524001|NCT02818998|26133088|P2|Overall Study|Death|6
7524002|NCT02818998|26133089|P1|Overall Study|Death|3
7524003|NCT02818998|26133087|P3|Overall Study|Withdrawal by sponsor|1
7524004|NCT02818998|26133088|P2|Overall Study|Withdrawal by sponsor|1
7524005|NCT02818998|26133089|P1|Overall Study|Withdrawal by sponsor|0
7524006|NCT02818998|26133087|P3|Overall Study|Lost to Follow-up|2
7524007|NCT02818998|26133088|P2|Overall Study|Lost to Follow-up|1
7524008|NCT02818998|26133089|P1|Overall Study|Lost to Follow-up|4
7524009|NCT02818998|26133087|P3|Overall Study|Adverse Event|1
7524010|NCT02818998|26133088|P2|Overall Study|Adverse Event|2
7524011|NCT02818998|26133089|P1|Overall Study|Adverse Event|3
7524012|NCT02818920|26133122|P1|Overall Study|Refused Further Treatment|1
7524013|NCT02818920|26133122|P1|Overall Study|Developed Other Disease|1
7524014|NCT02818920|26133122|P1|Overall Study|Adverse Event|3
7524015|NCT02818920|26133122|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
7524016|NCT02818920|26133122|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
7524017|NCT02818920|26133122|P1|Overall Study|Unresectable|4
7524018|NCT02818777|26133126|P1|Overall Study|Adverse Event|3
7524019|NCT02818036|26133193|P2|Overall Study|Withdrawal by Subject|0
7524020|NCT02818036|26133194|P1|Overall Study|Withdrawal by Subject|1
7524021|NCT02818036|26133193|P2|Overall Study|head did not fit in fMRI scanner headres|0
7524022|NCT02818036|26133194|P1|Overall Study|head did not fit in fMRI scanner headres|1
7524023|NCT02817906|26133204|P2|Overall Study|Other|2
7524024|NCT02817906|26133205|P1|Overall Study|Other|2
7524025|NCT02817906|26133204|P2|Overall Study|Withdrawal by Subject|0
7524026|NCT02817906|26133205|P1|Overall Study|Withdrawal by Subject|7
7524027|NCT02817906|26133204|P2|Overall Study|Study Terminated by Sponsor|2
7524028|NCT02817906|26133205|P1|Overall Study|Study Terminated by Sponsor|2
7524029|NCT02817906|26133204|P2|Overall Study|Protocol Violation|1
7524030|NCT02817906|26133205|P1|Overall Study|Protocol Violation|1
7524031|NCT02817906|26133204|P2|Overall Study|Lack of Efficacy|0
7524032|NCT02817906|26133205|P1|Overall Study|Lack of Efficacy|1
7524033|NCT02817906|26133204|P2|Overall Study|Adverse Event|0
7524034|NCT02817906|26133205|P1|Overall Study|Adverse Event|3
7524035|NCT02817841|26133213|P1|Overall Study|Protocol Violation|94
7524036|NCT02817841|26133213|P1|Overall Study|Other reasons|53
7524037|NCT02817841|26133213|P1|Overall Study|Pregnancy wish|17
7524038|NCT02817841|26133213|P1|Overall Study|Pregnancy|32
7524039|NCT02817841|26133213|P1|Overall Study|Adverse event related to bleeding|51
7524040|NCT02817841|26133213|P1|Overall Study|Adverse event not related to bleeding|131
7524041|NCT02817841|26133213|P1|Overall Study|Withdrawal by Subject|183
7524042|NCT02817841|26133213|P1|Overall Study|Lost to Follow-up|287
7524043|NCT02817828|26133240|P1|Overall Study|Other|26
7524044|NCT02817828|26133240|P1|Overall Study|Withdrawal by Subject|78
7524045|NCT02817828|26133240|P1|Overall Study|Pregnancy wish|15
7524046|NCT02817828|26133240|P1|Overall Study|Pregnancy|7
7524047|NCT02817828|26133240|P1|Overall Study|Protocol Violation|11
7524048|NCT02817828|26133240|P1|Overall Study|Adverse event related to bleeding|53
7524049|NCT02817828|26133240|P1|Overall Study|Adverse event not related to bleeding|104
7524050|NCT02817828|26133240|P1|Overall Study|Lost to Follow-up|41
7524051|NCT02817776|26133264|P1|Overall Study|Death|2
7524052|NCT02817776|26133264|P1|Overall Study|Withdrawal by Subject|33
7524053|NCT02817776|26133264|P1|Overall Study|Lost to Follow-up|20
7524054|NCT02817776|26133264|P1|Overall Study|Excluded|33
7524055|NCT02817594|26133285|P1|Overall Study|Did Not Receive Treatment|1
7524056|NCT02817594|26133285|P1|Overall Study|Other|1
7524057|NCT02817594|26133285|P1|Overall Study|Withdrawal by Subject|1
7524058|NCT02817555|26133306|P2|Overall Study|changed to Peritoneal Dialysis|1
7524059|NCT02817555|26133307|P1|Overall Study|changed to Peritoneal Dialysis|0
7524060|NCT02817555|26133306|P2|Overall Study|transplant|1
7524061|NCT02817555|26133307|P1|Overall Study|transplant|1
7524062|NCT02817555|26133306|P2|Overall Study|moved away|0
7524063|NCT02817555|26133307|P1|Overall Study|moved away|1
7524064|NCT02817555|26133306|P2|Overall Study|Death|3
7524065|NCT02817555|26133307|P1|Overall Study|Death|1
7524066|NCT02817516|26133327|P4|Overall Study|Other|0
7524067|NCT02817516|26133328|P3|Overall Study|Other|1
7524068|NCT02817516|26133329|P2|Overall Study|Other|0
7524069|NCT02817516|26133330|P1|Overall Study|Other|0
7524070|NCT02817087|26133367|P2|Overall Study|Withdrawal by Subject|0
7524071|NCT02817087|26133368|P1|Overall Study|Withdrawal by Subject|2
7524072|NCT02816398|26133439|P1|Overall Study|Lost to Follow-up|1
7524073|NCT02816398|26133439|P1|Overall Study|Lack of Efficacy|8
7524074|NCT02816398|26133439|P1|Overall Study|Death|5
7524075|NCT02816138|26133497|P1|Overall Study|Adverse Event|1
7524076|NCT02815735|26133543|P2|Second Intervention (4 Weeks)|Protocol Violation|0
7524077|NCT02815735|26133544|P1|Second Intervention (4 Weeks)|Protocol Violation|1
7524078|NCT02815735|26133543|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
7524079|NCT02815735|26133544|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
7524080|NCT02815735|26133543|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
7524081|NCT02815735|26133544|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
7524082|NCT02815735|26133543|P2|First Intervention (4 Weeks)|Discomfort|0
7524083|NCT02815735|26133544|P1|First Intervention (4 Weeks)|Discomfort|1
7524084|NCT02815670|26133598|P1|Overall Study|Prematurely discontinued of the trial|1
7524085|NCT02815397|26133630|P1|Overall Study|Physician Decision|2
7524086|NCT02815293|26133640|P3|Overall Study|Adverse Event|0
7524087|NCT02815293|26133641|P2|Overall Study|Adverse Event|1
7524088|NCT02815293|26133642|P1|Overall Study|Adverse Event|0
7524089|NCT02815293|26133640|P3|Overall Study|Participants not randomized|18
7524090|NCT02815293|26133641|P2|Overall Study|Participants not randomized|0
7524091|NCT02815293|26133642|P1|Overall Study|Participants not randomized|0
7524092|NCT02815293|26133640|P3|Overall Study|Study termination by sponsor|0
7524093|NCT02815293|26133641|P2|Overall Study|Study termination by sponsor|7
7524094|NCT02815293|26133642|P1|Overall Study|Study termination by sponsor|10
7524095|NCT02815280|26133652|P2|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
7524096|NCT02815280|26133653|P1|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
7524097|NCT02815280|26133652|P2|Open-Label Phase|Administrative|12
7524098|NCT02815280|26133653|P1|Open-Label Phase|Administrative|26
7524099|NCT02815280|26133652|P2|Open-Label Phase|Protocol Violation|0
7524100|NCT02815280|26133653|P1|Open-Label Phase|Protocol Violation|3
7524101|NCT02815280|26133652|P2|Open-Label Phase|Withdrawal by Subject|18
7524102|NCT02815280|26133653|P1|Open-Label Phase|Withdrawal by Subject|33
7524103|NCT02815280|26133652|P2|Open-Label Phase|Lost to Follow-up|9
7524104|NCT02815280|26133653|P1|Open-Label Phase|Lost to Follow-up|18
7524105|NCT02815280|26133652|P2|Open-Label Phase|Adverse Event|3
7524106|NCT02815280|26133653|P1|Open-Label Phase|Adverse Event|2
7524107|NCT02815280|26133652|P2|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
7524108|NCT02815280|26133653|P1|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
7524109|NCT02815280|26133652|P2|Double-Blind Phase|Protocol Violation|2
7524110|NCT02815280|26133653|P1|Double-Blind Phase|Protocol Violation|2
7524111|NCT02815280|26133652|P2|Double-Blind Phase|Withdrawal by Subject|11
7524112|NCT02815280|26133653|P1|Double-Blind Phase|Withdrawal by Subject|20
7524113|NCT02815280|26133652|P2|Double-Blind Phase|Lost to Follow-up|9
7524114|NCT02815280|26133653|P1|Double-Blind Phase|Lost to Follow-up|10
7524115|NCT02815280|26133652|P2|Double-Blind Phase|Adverse Event|1
7524116|NCT02815280|26133653|P1|Double-Blind Phase|Adverse Event|1
7524117|NCT02815267|26133673|P2|Open-Label Phase|Other|5
7524118|NCT02815267|26133674|P1|Open-Label Phase|Other|2
7524119|NCT02815267|26133673|P2|Open-Label Phase|Administrative|12
7524120|NCT02815267|26133674|P1|Open-Label Phase|Administrative|21
7524121|NCT02815267|26133673|P2|Open-Label Phase|Protocol Violation|1
7524122|NCT02815267|26133674|P1|Open-Label Phase|Protocol Violation|0
7524123|NCT02815267|26133673|P2|Open-Label Phase|Withdrawal by Subject|13
7524124|NCT02815267|26133674|P1|Open-Label Phase|Withdrawal by Subject|24
7524125|NCT02815267|26133673|P2|Open-Label Phase|Lost to Follow-up|9
7524126|NCT02815267|26133674|P1|Open-Label Phase|Lost to Follow-up|23
7524127|NCT02815267|26133673|P2|Open-Label Phase|Adverse Event|1
7524128|NCT02815267|26133674|P1|Open-Label Phase|Adverse Event|1
7524129|NCT02815267|26133673|P2|Double-Blind Phase|Received a disallowed medication|1
7524130|NCT02815267|26133674|P1|Double-Blind Phase|Received a disallowed medication|1
7524131|NCT02815267|26133673|P2|Double-Blind Phase|Site withdrawal|6
7524132|NCT02815267|26133674|P1|Double-Blind Phase|Site withdrawal|1
7524133|NCT02815267|26133673|P2|Double-Blind Phase|Protocol Violation|2
7524134|NCT02815267|26133674|P1|Double-Blind Phase|Protocol Violation|3
7524135|NCT02815267|26133673|P2|Double-Blind Phase|Withdrawal by Subject|10
7524136|NCT02815267|26133674|P1|Double-Blind Phase|Withdrawal by Subject|11
7524137|NCT02815267|26133673|P2|Double-Blind Phase|Lost to Follow-up|9
7524138|NCT02815267|26133674|P1|Double-Blind Phase|Lost to Follow-up|17
7524139|NCT02815267|26133673|P2|Double-Blind Phase|Adverse Event|3
7524140|NCT02815267|26133674|P1|Double-Blind Phase|Adverse Event|0
7524141|NCT02814838|26133709|P2|Overall Study|Consent withdrawal|1
7524142|NCT02814838|26133710|P1|Overall Study|Consent withdrawal|1
7524143|NCT02814838|26133709|P2|Overall Study|3 agreed dates for the final visit missed|0
7524144|NCT02814838|26133710|P1|Overall Study|3 agreed dates for the final visit missed|1
7524145|NCT02814643|26133849|P2|Overall Study|Withdrawal by Subject|2
7524146|NCT02814643|26133850|P1|Overall Study|Withdrawal by Subject|1
7524147|NCT02814643|26133849|P2|Overall Study|Lost to Follow-up|1
7524148|NCT02814643|26133850|P1|Overall Study|Lost to Follow-up|0
7524149|NCT02814565|26133874|P2|Overall Study|Subject decision, caused by AE Influenza|1
7524150|NCT02814565|26133875|P1|Overall Study|Subject decision, caused by AE Influenza|1
7524151|NCT02814565|26133874|P2|Overall Study|Lack of Efficacy|1
7524152|NCT02814565|26133875|P1|Overall Study|Lack of Efficacy|0
7524153|NCT02814175|26133945|P6|Part 2|Lack of Efficacy|3
7524154|NCT02814175|26133946|P5|Part 2|Lack of Efficacy|0
7524155|NCT02814175|26133947|P4|Part 2|Lack of Efficacy|0
7524156|NCT02814175|26133948|P3|Part 2|Lack of Efficacy|0
7524157|NCT02814175|26133949|P2|Part 2|Lack of Efficacy|0
7524158|NCT02814175|26133950|P1|Part 2|Lack of Efficacy|0
7524159|NCT02814175|26133945|P6|Part 2|Lost to Follow-up|0
7524160|NCT02814175|26133946|P5|Part 2|Lost to Follow-up|0
7524161|NCT02814175|26133947|P4|Part 2|Lost to Follow-up|1
7524162|NCT02814175|26133948|P3|Part 2|Lost to Follow-up|0
7524163|NCT02814175|26133949|P2|Part 2|Lost to Follow-up|0
7524164|NCT02814175|26133950|P1|Part 2|Lost to Follow-up|0
7524165|NCT02814175|26133945|P6|Part 2|Withdrawal Consent|1
7524166|NCT02814175|26133946|P5|Part 2|Withdrawal Consent|1
7524167|NCT02814175|26133947|P4|Part 2|Withdrawal Consent|2
7524168|NCT02814175|26133948|P3|Part 2|Withdrawal Consent|0
7524169|NCT02814175|26133949|P2|Part 2|Withdrawal Consent|0
7524170|NCT02814175|26133950|P1|Part 2|Withdrawal Consent|0
7524171|NCT02814175|26133945|P6|Part 2|Adverse Event|2
7524172|NCT02814175|26133946|P5|Part 2|Adverse Event|1
7524173|NCT02814175|26133947|P4|Part 2|Adverse Event|1
7524174|NCT02814175|26133948|P3|Part 2|Adverse Event|0
7524175|NCT02814175|26133949|P2|Part 2|Adverse Event|0
7524176|NCT02814175|26133950|P1|Part 2|Adverse Event|0
7524177|NCT02814175|26133945|P6|Part 1|Lack of Efficacy|0
7524178|NCT02814175|26133946|P5|Part 1|Lack of Efficacy|0
7524179|NCT02814175|26133947|P4|Part 1|Lack of Efficacy|0
7524180|NCT02814175|26133948|P3|Part 1|Lack of Efficacy|0
7524181|NCT02814175|26133949|P2|Part 1|Lack of Efficacy|2
7524182|NCT02814175|26133950|P1|Part 1|Lack of Efficacy|1
7524183|NCT02814175|26133945|P6|Part 1|Lost to Follow-up|0
7524184|NCT02814175|26133946|P5|Part 1|Lost to Follow-up|0
7524185|NCT02814175|26133947|P4|Part 1|Lost to Follow-up|0
7524186|NCT02814175|26133948|P3|Part 1|Lost to Follow-up|0
7524187|NCT02814175|26133949|P2|Part 1|Lost to Follow-up|0
7524188|NCT02814175|26133950|P1|Part 1|Lost to Follow-up|1
7524189|NCT02814175|26133945|P6|Part 1|Withdrawal Consent|0
7524190|NCT02814175|26133946|P5|Part 1|Withdrawal Consent|0
7524191|NCT02814175|26133947|P4|Part 1|Withdrawal Consent|0
7524192|NCT02814175|26133948|P3|Part 1|Withdrawal Consent|0
7524193|NCT02814175|26133949|P2|Part 1|Withdrawal Consent|1
7524194|NCT02814175|26133950|P1|Part 1|Withdrawal Consent|8
7524195|NCT02814175|26133945|P6|Part 1|Adverse Event|0
7524196|NCT02814175|26133946|P5|Part 1|Adverse Event|0
7524197|NCT02814175|26133947|P4|Part 1|Adverse Event|0
7524198|NCT02814175|26133948|P3|Part 1|Adverse Event|0
7524199|NCT02814175|26133949|P2|Part 1|Adverse Event|3
7524200|NCT02814175|26133950|P1|Part 1|Adverse Event|2
7524201|NCT02813694|26133988|P2|Overall Study|Patient hospitalized|0
7524202|NCT02813694|26133989|P1|Overall Study|Patient hospitalized|1
7524203|NCT02813694|26133988|P2|Overall Study|Randomized- did not receive study drug|0
7524204|NCT02813694|26133989|P1|Overall Study|Randomized- did not receive study drug|2
7524205|NCT02813694|26133988|P2|Overall Study|Death|3
7524206|NCT02813694|26133989|P1|Overall Study|Death|3
7524207|NCT02813694|26133988|P2|Overall Study|Lost to Follow-up|1
7524208|NCT02813694|26133989|P1|Overall Study|Lost to Follow-up|1
7524209|NCT02813694|26133988|P2|Overall Study|Withdrawal by Subject|9
7524210|NCT02813694|26133989|P1|Overall Study|Withdrawal by Subject|10
7524211|NCT02813694|26133988|P2|Overall Study|Physician Decision|1
7524212|NCT02813694|26133989|P1|Overall Study|Physician Decision|0
7524213|NCT02813681|26134002|P3|Overall Study|Lost to Follow-up|0
7524214|NCT02813681|26134003|P2|Overall Study|Lost to Follow-up|1
7524215|NCT02813681|26134004|P1|Overall Study|Lost to Follow-up|0
7524216|NCT02813681|26134002|P3|Overall Study|Physician Decision|0
7524217|NCT02813681|26134003|P2|Overall Study|Physician Decision|5
7524218|NCT02813681|26134004|P1|Overall Study|Physician Decision|5
7524219|NCT02813577|26134025|P1|Overall Study|Study terminated|4
7524220|NCT02813421|26134076|P2|Overall Study|Lost to Follow-up|1
7524221|NCT02813421|26134077|P1|Overall Study|Lost to Follow-up|1
7524222|NCT02813421|26134076|P2|Overall Study|Withdrawal by Subject|2
7524223|NCT02813421|26134077|P1|Overall Study|Withdrawal by Subject|1
7524224|NCT02812186|26134168|P2|Period 1|nonevaluable data sets|6
7524225|NCT02812186|26134169|P1|Period 1|nonevaluable data sets|6
7524226|NCT02812186|26134168|P2|Period 1|Post randomization screen failure|9
7524227|NCT02812186|26134169|P1|Period 1|Post randomization screen failure|5
7524228|NCT02811861|26134225|P3|Overall Study|Randomized but not treated|17
7524229|NCT02811861|26134226|P2|Overall Study|Randomized but not treated|3
7524230|NCT02811861|26134227|P1|Overall Study|Randomized but not treated|2
7524231|NCT02811861|26134225|P3|Overall Study|Treatment Ongoing at Cutoff Date|67
7524232|NCT02811861|26134226|P2|Overall Study|Treatment Ongoing at Cutoff Date|142
7524233|NCT02811861|26134227|P1|Overall Study|Treatment Ongoing at Cutoff Date|112
7524234|NCT02811861|26134225|P3|Overall Study|Other|3
7524235|NCT02811861|26134226|P2|Overall Study|Other|13
7524236|NCT02811861|26134227|P1|Overall Study|Other|4
7524237|NCT02811861|26134225|P3|Overall Study|Withdrawal by Subject|9
7524238|NCT02811861|26134226|P2|Overall Study|Withdrawal by Subject|4
7524239|NCT02811861|26134227|P1|Overall Study|Withdrawal by Subject|4
7524240|NCT02811861|26134225|P3|Overall Study|Subject Choice|23
7524241|NCT02811861|26134226|P2|Overall Study|Subject Choice|17
7524242|NCT02811861|26134227|P1|Overall Study|Subject Choice|29
7524243|NCT02811861|26134225|P3|Overall Study|Lost to Follow-up|1
7524244|NCT02811861|26134226|P2|Overall Study|Lost to Follow-up|0
7524245|NCT02811861|26134227|P1|Overall Study|Lost to Follow-up|0
7524246|NCT02811861|26134225|P3|Overall Study|Adverse Event|41
7524247|NCT02811861|26134226|P2|Overall Study|Adverse Event|60
7524248|NCT02811861|26134227|P1|Overall Study|Adverse Event|63
7524249|NCT02811861|26134225|P3|Overall Study|Clinical Disease Progression|22
7524250|NCT02811861|26134226|P2|Overall Study|Clinical Disease Progression|19
7524251|NCT02811861|26134227|P1|Overall Study|Clinical Disease Progression|20
7524252|NCT02811861|26134225|P3|Overall Study|Radiological Disease Progression|174
7524253|NCT02811861|26134226|P2|Overall Study|Radiological Disease Progression|97
7524254|NCT02811861|26134227|P1|Overall Study|Radiological Disease Progression|123
7524255|NCT02811640|26134235|P1|Overall Study|Technology malfunction|2
7524256|NCT02811159|26134270|P1|Treatment Course 1|Lost to Follow-up|1
7524257|NCT02810964|26134287|P2|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
7524258|NCT02810964|26134288|P1|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
7524259|NCT02810964|26134287|P2|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
7524260|NCT02810964|26134288|P1|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
7524261|NCT02810964|26134287|P2|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
7524262|NCT02810964|26134288|P1|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
7524263|NCT02810964|26134287|P2|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
7524264|NCT02810964|26134288|P1|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
7524266|NCT02810457|26134338|P2|Overall Study|Physician Decision|1
7524267|NCT02810457|26134339|P1|Overall Study|Physician Decision|0
7524268|NCT02810457|26134338|P2|Overall Study|Miscalculated PD|0
7524269|NCT02810457|26134339|P1|Overall Study|Miscalculated PD|1
7524270|NCT02810457|26134338|P2|Overall Study|Patient ineligibility|0
7524271|NCT02810457|26134339|P1|Overall Study|Patient ineligibility|3
7524272|NCT02810457|26134338|P2|Overall Study|Investigator decision|2
7524273|NCT02810457|26134339|P1|Overall Study|Investigator decision|3
7524274|NCT02810457|26134338|P2|Overall Study|Clinical progression|16
7524275|NCT02810457|26134339|P1|Overall Study|Clinical progression|15
7524276|NCT02810457|26134338|P2|Overall Study|Ongoing at data cutoff and discontinued|2
7524277|NCT02810457|26134339|P1|Overall Study|Ongoing at data cutoff and discontinued|3
7524278|NCT02810457|26134338|P2|Overall Study|Death|28
7524279|NCT02810457|26134339|P1|Overall Study|Death|39
7524280|NCT02810457|26134338|P2|Overall Study|Patient lost to follow-up|2
7524281|NCT02810457|26134339|P1|Overall Study|Patient lost to follow-up|2
7524282|NCT02810457|26134338|P2|Overall Study|Patient decision|35
7524283|NCT02810457|26134339|P1|Overall Study|Patient decision|31
7524284|NCT02810457|26134338|P2|Overall Study|Adverse Event|43
7524285|NCT02810457|26134339|P1|Overall Study|Adverse Event|37
7524286|NCT02810457|26134338|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
7524287|NCT02810457|26134339|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
7524288|NCT02810457|26134338|P2|Overall Study|Randomised but no treatment received|1
7524289|NCT02810457|26134339|P1|Overall Study|Randomised but no treatment received|2
7524290|NCT02810418|26134366|P7|Arm B Dose Escalation|Adverse Event|0
7524291|NCT02810418|26134367|P6|Arm B Dose Escalation|Adverse Event|2
7524292|NCT02810418|26134368|P5|Arm B Dose Escalation|Adverse Event|1
7524293|NCT02810418|26134369|P4|Arm B Dose Escalation|Adverse Event|0
7524294|NCT02810418|26134370|P3|Arm B Dose Escalation|Adverse Event|0
7524295|NCT02810418|26134371|P2|Arm B Dose Escalation|Adverse Event|0
7524296|NCT02810418|26134372|P1|Arm B Dose Escalation|Adverse Event|0
7524297|NCT02810418|26134366|P7|Dose Expansion|Physician Decision|0
7524298|NCT02810418|26134367|P6|Dose Expansion|Physician Decision|0
7524299|NCT02810418|26134368|P5|Dose Expansion|Physician Decision|0
7524300|NCT02810418|26134369|P4|Dose Expansion|Physician Decision|0
7524301|NCT02810418|26134370|P3|Dose Expansion|Physician Decision|2
7524302|NCT02810418|26134371|P2|Dose Expansion|Physician Decision|0
7524303|NCT02810418|26134372|P1|Dose Expansion|Physician Decision|0
7524304|NCT02810418|26134366|P7|Dose Expansion|Adverse Event|0
7524305|NCT02810418|26134367|P6|Dose Expansion|Adverse Event|0
7524306|NCT02810418|26134368|P5|Dose Expansion|Adverse Event|0
7524307|NCT02810418|26134369|P4|Dose Expansion|Adverse Event|0
7524308|NCT02810418|26134370|P3|Dose Expansion|Adverse Event|1
7524309|NCT02810418|26134371|P2|Dose Expansion|Adverse Event|1
7524310|NCT02810418|26134372|P1|Dose Expansion|Adverse Event|0
7524311|NCT02810418|26134366|P7|Arm A Dose Escalation|Adverse Event|0
7524312|NCT02810418|26134367|P6|Arm A Dose Escalation|Adverse Event|0
7524313|NCT02810418|26134368|P5|Arm A Dose Escalation|Adverse Event|0
7524314|NCT02810418|26134369|P4|Arm A Dose Escalation|Adverse Event|0
7524315|NCT02810418|26134370|P3|Arm A Dose Escalation|Adverse Event|0
7524316|NCT02810418|26134371|P2|Arm A Dose Escalation|Adverse Event|1
7524317|NCT02810418|26134372|P1|Arm A Dose Escalation|Adverse Event|2
7524318|NCT02810392|26134466|P2|Overall Study|COVID 19 research restrictions|1
7524319|NCT02810392|26134467|P1|Overall Study|COVID 19 research restrictions|0
7524320|NCT02810392|26134466|P2|Overall Study|Subject too ill to continue|0
7524321|NCT02810392|26134467|P1|Overall Study|Subject too ill to continue|1
7524322|NCT02810340|26134504|P3|Overall Study|Lost to Follow-up|1
7524323|NCT02810340|26134505|P2|Overall Study|Lost to Follow-up|0
7524324|NCT02810340|26134506|P1|Overall Study|Lost to Follow-up|0
7524325|NCT02810340|26134504|P3|Overall Study|Incarceration|0
7524326|NCT02810340|26134505|P2|Overall Study|Incarceration|1
7524327|NCT02810340|26134506|P1|Overall Study|Incarceration|0
7524328|NCT02810340|26134504|P3|Overall Study|Withdrawal by Subject|0
7524329|NCT02810340|26134505|P2|Overall Study|Withdrawal by Subject|0
7524330|NCT02810340|26134506|P1|Overall Study|Withdrawal by Subject|1
7524331|NCT02809976|26134544|P1|Overall Study|Withdrawal by Subject|1
7524332|NCT02809976|26134544|P1|Overall Study|Lost to Follow-up|1
7524333|NCT02809833|26134582|P1|Overall Study|Missing Information|52
7524334|NCT02809833|26134582|P1|Overall Study|Other|5
7524335|NCT02809833|26134582|P1|Overall Study|Adverse Event (AE)|24
7524336|NCT02809833|26134582|P1|Overall Study|Lost to Follow-up|35
7524337|NCT02809833|26134582|P1|Overall Study|Withdrawal by Subject|34
7524338|NCT02809833|26134582|P1|Overall Study|Noncompliance|1
7524339|NCT02809833|26134582|P1|Overall Study|Remission/Treatment No Longer Needed|3
7524340|NCT02809833|26134582|P1|Overall Study|Lack of Efficacy|89
7524341|NCT02809833|26134582|P1|Overall Study|Intolerance|54
7524342|NCT02809833|26134582|P1|Overall Study|Death|3
7524343|NCT02809118|26134714|P3|Overall Study|Withdrawal by Subject|1
7524344|NCT02809118|26134715|P2|Overall Study|Withdrawal by Subject|1
7524345|NCT02809118|26134716|P1|Overall Study|Withdrawal by Subject|0
7524346|NCT02809053|26134729|P2|Overall Study|Disease Progression|1
7524347|NCT02809053|26134730|P1|Overall Study|Disease Progression|2
7524348|NCT02809053|26134729|P2|Overall Study|Withdrawal by Subject|3
7524349|NCT02809053|26134730|P1|Overall Study|Withdrawal by Subject|2
7524350|NCT02809053|26134729|P2|Overall Study|Lost to Follow-up|1
7524351|NCT02809053|26134730|P1|Overall Study|Lost to Follow-up|3
7524352|NCT02809053|26134729|P2|Overall Study|Death|1
7524353|NCT02809053|26134730|P1|Overall Study|Death|0
7524354|NCT02808975|26134776|P2|Overall Study|Other, not specified|1
7524355|NCT02808975|26134777|P1|Overall Study|Other, not specified|5
7524356|NCT02808975|26134776|P2|Overall Study|Planned HS surgery performed prior Wk 13|0
7524357|NCT02808975|26134777|P1|Overall Study|Planned HS surgery performed prior Wk 13|1
7524358|NCT02808975|26134776|P2|Overall Study|Lost to Follow-up|6
7524359|NCT02808975|26134777|P1|Overall Study|Lost to Follow-up|4
7524360|NCT02808975|26134776|P2|Overall Study|Withdrew consent|8
7524361|NCT02808975|26134777|P1|Overall Study|Withdrew consent|9
7524362|NCT02808975|26134776|P2|Overall Study|Adverse Event|4
7524363|NCT02808975|26134777|P1|Overall Study|Adverse Event|3
7524364|NCT02808819|26134793|P2|Overall Study|Adverse Event|4
7524365|NCT02808819|26134794|P1|Overall Study|Adverse Event|3
7524366|NCT02808819|26134793|P2|Overall Study|Death|0
7524367|NCT02808819|26134794|P1|Overall Study|Death|1
7524368|NCT02808819|26134793|P2|Overall Study|Development of study-specific withdrawal criteria|3
7524369|NCT02808819|26134794|P1|Overall Study|Development of study-specific withdrawal criteria|8
7524370|NCT02808819|26134793|P2|Overall Study|Protocol Violation|1
7524371|NCT02808819|26134794|P1|Overall Study|Protocol Violation|0
7524372|NCT02808819|26134793|P2|Overall Study|Lost to Follow-up|6
7524373|NCT02808819|26134794|P1|Overall Study|Lost to Follow-up|1
7524374|NCT02808819|26134793|P2|Overall Study|Pregnancy|0
7524375|NCT02808819|26134794|P1|Overall Study|Pregnancy|1
7524376|NCT02808819|26134793|P2|Overall Study|Site terminated by sponsor|0
7524377|NCT02808819|26134794|P1|Overall Study|Site terminated by sponsor|2
7524378|NCT02808819|26134793|P2|Overall Study|Withdrawal by Subject|13
7524379|NCT02808819|26134794|P1|Overall Study|Withdrawal by Subject|10
7524380|NCT02808819|26134793|P2|Overall Study|eg. no treatment efficacy on asthma|4
7524381|NCT02808819|26134794|P1|Overall Study|eg. no treatment efficacy on asthma|5
7524382|NCT02808429|26134852|P3|Overall Study|Relocation|1
7524383|NCT02808429|26134853|P2|Overall Study|Relocation|0
7524384|NCT02808429|26134854|P1|Overall Study|Relocation|0
7524385|NCT02808429|26134852|P3|Overall Study|Premature study termination by sponsor|1
7524386|NCT02808429|26134853|P2|Overall Study|Premature study termination by sponsor|0
7524387|NCT02808429|26134854|P1|Overall Study|Premature study termination by sponsor|2
7524388|NCT02808429|26134852|P3|Overall Study|Protocol Violation|0
7524389|NCT02808429|26134853|P2|Overall Study|Protocol Violation|1
7524390|NCT02808429|26134854|P1|Overall Study|Protocol Violation|0
7524391|NCT02808429|26134852|P3|Overall Study|Lost to Follow-up|0
7524392|NCT02808429|26134853|P2|Overall Study|Lost to Follow-up|0
7524393|NCT02808429|26134854|P1|Overall Study|Lost to Follow-up|1
7524394|NCT02808338|26134911|P1|Overnight In-lab Polysomonography|Reason not given|1
7524395|NCT02808338|26134911|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
7524396|NCT02808338|26134911|P1|Screening|Screen Failure|10
7524397|NCT02808312|26134927|P5|Overall Study|Enrolled but Never Treated|0
7524398|NCT02808312|26134928|P4|Overall Study|Enrolled but Never Treated|0
7524399|NCT02808312|26134929|P3|Overall Study|Enrolled but Never Treated|1
7524400|NCT02808312|26134930|P2|Overall Study|Enrolled but Never Treated|0
7524401|NCT02808312|26134931|P1|Overall Study|Enrolled but Never Treated|0
7524402|NCT02807948|26135088|P2|Overall Study|Physician Decision|0
7524403|NCT02807948|26135089|P1|Overall Study|Physician Decision|1
7524404|NCT02807857|26135094|P1|Follow-Up Set|Relocation|2
7524405|NCT02807857|26135094|P1|Follow-Up Set|Death|27
7524406|NCT02807857|26135094|P1|Follow-Up Set|Adverse Event|3
7524407|NCT02807857|26135094|P1|Follow-Up Set|Physician Decision|6
7524408|NCT02807857|26135094|P1|Follow-Up Set|Lost to Follow-up|7
7524409|NCT02807857|26135094|P1|Follow-Up Set|Withdrawal by Subject|8
7524410|NCT02807857|26135094|P1|Follow-Up Set|Study Terminated By Sponsor|131
7524411|NCT02807857|26135094|P1|Enrolled Set|Patients not suitable for follow-up.|551
7524412|NCT02807844|26135150|P10|Overall Study|Adverse Event|2
7524413|NCT02807844|26135151|P9|Overall Study|Adverse Event|1
7524414|NCT02807844|26135152|P8|Overall Study|Adverse Event|1
7524415|NCT02807844|26135153|P7|Overall Study|Adverse Event|1
7524416|NCT02807844|26135154|P6|Overall Study|Adverse Event|1
7524417|NCT02807844|26135155|P5|Overall Study|Adverse Event|1
7524418|NCT02807844|26135156|P4|Overall Study|Adverse Event|0
7524419|NCT02807844|26135157|P3|Overall Study|Adverse Event|0
7524420|NCT02807844|26135158|P2|Overall Study|Adverse Event|0
7524421|NCT02807844|26135159|P1|Overall Study|Adverse Event|1
7524422|NCT02807844|26135150|P10|Overall Study|Progressive disease|15
7524423|NCT02807844|26135151|P9|Overall Study|Progressive disease|19
7524424|NCT02807844|26135152|P8|Overall Study|Progressive disease|17
7524425|NCT02807844|26135153|P7|Overall Study|Progressive disease|14
7524426|NCT02807844|26135154|P6|Overall Study|Progressive disease|8
7524427|NCT02807844|26135155|P5|Overall Study|Progressive disease|3
7524428|NCT02807844|26135156|P4|Overall Study|Progressive disease|8
7524429|NCT02807844|26135157|P3|Overall Study|Progressive disease|8
7524430|NCT02807844|26135158|P2|Overall Study|Progressive disease|12
7524431|NCT02807844|26135159|P1|Overall Study|Progressive disease|5
7524432|NCT02807844|26135150|P10|Overall Study|Withdrawal by Subject|0
7524433|NCT02807844|26135151|P9|Overall Study|Withdrawal by Subject|0
7524434|NCT02807844|26135152|P8|Overall Study|Withdrawal by Subject|0
7524435|NCT02807844|26135153|P7|Overall Study|Withdrawal by Subject|1
7524436|NCT02807844|26135154|P6|Overall Study|Withdrawal by Subject|0
7524437|NCT02807844|26135155|P5|Overall Study|Withdrawal by Subject|1
7524438|NCT02807844|26135156|P4|Overall Study|Withdrawal by Subject|1
7524439|NCT02807844|26135157|P3|Overall Study|Withdrawal by Subject|2
7524440|NCT02807844|26135158|P2|Overall Study|Withdrawal by Subject|0
7524441|NCT02807844|26135159|P1|Overall Study|Withdrawal by Subject|0
7524442|NCT02807844|26135150|P10|Overall Study|Death|1
7524443|NCT02807844|26135151|P9|Overall Study|Death|0
7524444|NCT02807844|26135152|P8|Overall Study|Death|2
7524445|NCT02807844|26135153|P7|Overall Study|Death|1
7524446|NCT02807844|26135154|P6|Overall Study|Death|2
7524447|NCT02807844|26135155|P5|Overall Study|Death|1
7524448|NCT02807844|26135156|P4|Overall Study|Death|4
7524449|NCT02807844|26135157|P3|Overall Study|Death|2
7524450|NCT02807844|26135158|P2|Overall Study|Death|0
7524451|NCT02807844|26135159|P1|Overall Study|Death|0
7524452|NCT02807844|26135150|P10|Overall Study|Physician Decision|2
7524453|NCT02807844|26135151|P9|Overall Study|Physician Decision|1
7524454|NCT02807844|26135152|P8|Overall Study|Physician Decision|0
7524455|NCT02807844|26135153|P7|Overall Study|Physician Decision|3
7524456|NCT02807844|26135154|P6|Overall Study|Physician Decision|0
7524457|NCT02807844|26135155|P5|Overall Study|Physician Decision|0
7524458|NCT02807844|26135156|P4|Overall Study|Physician Decision|0
7524459|NCT02807844|26135157|P3|Overall Study|Physician Decision|0
7524460|NCT02807844|26135158|P2|Overall Study|Physician Decision|0
7524461|NCT02807844|26135159|P1|Overall Study|Physician Decision|0
7524462|NCT02807623|26135486|P3|Overall Study|incomplete blood draw|1
7524463|NCT02807623|26135487|P2|Overall Study|incomplete blood draw|2
7524464|NCT02807623|26135488|P1|Overall Study|incomplete blood draw|0
7524465|NCT02807623|26135486|P3|Overall Study|Drug intolerance|0
7524466|NCT02807623|26135487|P2|Overall Study|Drug intolerance|1
7524467|NCT02807623|26135488|P1|Overall Study|Drug intolerance|0
7524468|NCT02807623|26135486|P3|Overall Study|Lost to Follow-up|22
7524469|NCT02807623|26135487|P2|Overall Study|Lost to Follow-up|18
7524470|NCT02807623|26135488|P1|Overall Study|Lost to Follow-up|23
7524471|NCT02807402|26135515|P1|Overall Study|Other|2
7524472|NCT02807402|26135515|P1|Overall Study|Death|3
7524473|NCT02807402|26135515|P1|Overall Study|Failure to Return|1
7524474|NCT02807376|26135553|P2|Overall Study|Lost to Follow-up|1
7524475|NCT02807376|26135554|P1|Overall Study|Lost to Follow-up|0
7524476|NCT02807376|26135553|P2|Overall Study|Intra-operative exclusion criteria|0
7524477|NCT02807376|26135554|P1|Overall Study|Intra-operative exclusion criteria|3
7524478|NCT02807259|26135564|P2|Endline (3 Months)|migration, refusal, not available|87
7524479|NCT02807259|26135565|P1|Endline (3 Months)|migration, refusal, not available|35
7524480|NCT02807259|26135564|P2|Midline (3 Months)|migration, refusal, not available|34
7524481|NCT02807259|26135565|P1|Midline (3 Months)|migration, refusal, not available|30
7524482|NCT02807259|26135564|P2|Baseline (3 Months)|migration, refusal, not available|112
7524483|NCT02807259|26135565|P1|Baseline (3 Months)|migration, refusal, not available|77
7524484|NCT02806986|26135583|P1|Treatment Stage 2|Withdrawal by Subject|2
7524485|NCT02806986|26135583|P1|Treatment Stage 2|Adverse Event|3
7524486|NCT02806986|26135583|P1|Treatment Stage 1|Adverse Event|1
7524487|NCT02806973|26135603|P4|Period 3|Adverse Event|0
7524488|NCT02806973|26135604|P3|Period 3|Adverse Event|1
7524489|NCT02806973|26135605|P2|Period 3|Adverse Event|0
7524490|NCT02806973|26135606|P1|Period 3|Adverse Event|0
7524491|NCT02806973|26135603|P4|Period 3|Withdrawal by Subject|3
7524492|NCT02806973|26135604|P3|Period 3|Withdrawal by Subject|0
7524493|NCT02806973|26135605|P2|Period 3|Withdrawal by Subject|0
7524494|NCT02806973|26135606|P1|Period 3|Withdrawal by Subject|0
7524495|NCT02806973|26135603|P4|Period 1|Adverse Event|1
7524496|NCT02806973|26135604|P3|Period 1|Adverse Event|0
7524497|NCT02806973|26135605|P2|Period 1|Adverse Event|0
7524498|NCT02806973|26135606|P1|Period 1|Adverse Event|0
7524499|NCT02806973|26135603|P4|Period 1|Withdrawal by Subject|1
7524500|NCT02806973|26135604|P3|Period 1|Withdrawal by Subject|1
7524501|NCT02806973|26135605|P2|Period 1|Withdrawal by Subject|2
7524502|NCT02806973|26135606|P1|Period 1|Withdrawal by Subject|0
7524503|NCT02806960|26135640|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
7524504|NCT02806960|26135641|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
7524505|NCT02806960|26135642|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
7524506|NCT02806960|26135643|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
7524507|NCT02806947|26135679|P2|Overall Study|Withdrawal by Subject|1
7524508|NCT02806947|26135680|P1|Overall Study|Withdrawal by Subject|5
7524509|NCT02806726|26135819|P1|Overall Study|Lost to Follow-up|1
7524510|NCT02806713|26135828|P2|Overall Study|cancelled surgery|2
7524511|NCT02806713|26135829|P1|Overall Study|cancelled surgery|1
7524512|NCT02806713|26135828|P2|Overall Study|Urethral injury during procedure|0
7524513|NCT02806713|26135829|P1|Overall Study|Urethral injury during procedure|1
7524514|NCT02806505|26135848|P2|Overall Study|Insufficient therapeutic response|4
7524515|NCT02806505|26135849|P1|Overall Study|Insufficient therapeutic response|2
7524516|NCT02806505|26135848|P2|Overall Study|Failure to return|1
7524517|NCT02806505|26135849|P1|Overall Study|Failure to return|0
7524518|NCT02806505|26135848|P2|Overall Study|Did not cooperate/refused treatment|3
7524519|NCT02806505|26135849|P1|Overall Study|Did not cooperate/refused treatment|3
7524520|NCT02806505|26135848|P2|Overall Study|Death|0
7524521|NCT02806505|26135849|P1|Overall Study|Death|4
7524522|NCT02806505|26135848|P2|Overall Study|Adverse event/intercurrent illness|3
7524523|NCT02806505|26135849|P1|Overall Study|Adverse event/intercurrent illness|1
7524524|NCT02806414|26135859|P1|Overall Study|Lost to Follow-up|2
7524525|NCT02806232|26135873|P9|Overall Study|Withdrawal by Subject|0
7524526|NCT02806232|26135874|P8|Overall Study|Withdrawal by Subject|0
7524527|NCT02806232|26135875|P7|Overall Study|Withdrawal by Subject|0
7524528|NCT02806232|26135876|P6|Overall Study|Withdrawal by Subject|1
7524529|NCT02806232|26135877|P5|Overall Study|Withdrawal by Subject|2
7524530|NCT02806232|26135878|P4|Overall Study|Withdrawal by Subject|0
7524531|NCT02806232|26135879|P3|Overall Study|Withdrawal by Subject|0
7524532|NCT02806232|26135880|P2|Overall Study|Withdrawal by Subject|2
7524533|NCT02806232|26135881|P1|Overall Study|Withdrawal by Subject|0
7524534|NCT02806232|26135873|P9|Overall Study|Lost to Follow-up|0
7524535|NCT02806232|26135874|P8|Overall Study|Lost to Follow-up|0
7524536|NCT02806232|26135875|P7|Overall Study|Lost to Follow-up|0
7524537|NCT02806232|26135876|P6|Overall Study|Lost to Follow-up|1
7524538|NCT02806232|26135877|P5|Overall Study|Lost to Follow-up|0
7524539|NCT02806232|26135878|P4|Overall Study|Lost to Follow-up|0
7524540|NCT02806232|26135879|P3|Overall Study|Lost to Follow-up|1
7524541|NCT02806232|26135880|P2|Overall Study|Lost to Follow-up|2
7524542|NCT02806232|26135881|P1|Overall Study|Lost to Follow-up|1
7524543|NCT02806024|26135921|P2|Overall Study|DVT during antepartum admission|1
7524544|NCT02806024|26135922|P1|Overall Study|DVT during antepartum admission|0
7524545|NCT02806024|26135921|P2|Overall Study|Night Delivery|1
7524546|NCT02806024|26135922|P1|Overall Study|Night Delivery|1
7524547|NCT02805907|26135932|P2|Overall Study|Lost to Follow-up|3
7524548|NCT02805907|26135933|P1|Overall Study|Lost to Follow-up|3
7524549|NCT02805790|26135947|P2|Second Intervention (4 Weeks)|Physician Decision|1
7524550|NCT02805790|26135948|P1|Second Intervention (4 Weeks)|Physician Decision|0
7524551|NCT02805660|26135979|P7|Overall Study|Miscellaneous|4
7524552|NCT02805660|26135980|P6|Overall Study|Miscellaneous|6
7524553|NCT02805660|26135981|P5|Overall Study|Miscellaneous|0
7524554|NCT02805660|26135982|P4|Overall Study|Miscellaneous|4
7524555|NCT02805660|26135983|P3|Overall Study|Miscellaneous|0
7524556|NCT02805660|26135984|P2|Overall Study|Miscellaneous|1
7524557|NCT02805660|26135985|P1|Overall Study|Miscellaneous|0
7524558|NCT02805660|26135979|P7|Overall Study|Study terminated by Sponsor|1
7524559|NCT02805660|26135980|P6|Overall Study|Study terminated by Sponsor|3
7524560|NCT02805660|26135981|P5|Overall Study|Study terminated by Sponsor|2
7524561|NCT02805660|26135982|P4|Overall Study|Study terminated by Sponsor|4
7524562|NCT02805660|26135983|P3|Overall Study|Study terminated by Sponsor|1
7524563|NCT02805660|26135984|P2|Overall Study|Study terminated by Sponsor|0
7524564|NCT02805660|26135985|P1|Overall Study|Study terminated by Sponsor|0
7524565|NCT02805660|26135979|P7|Overall Study|Withdrawal by Subject|2
7524566|NCT02805660|26135980|P6|Overall Study|Withdrawal by Subject|0
7524567|NCT02805660|26135981|P5|Overall Study|Withdrawal by Subject|1
7524568|NCT02805660|26135982|P4|Overall Study|Withdrawal by Subject|3
7524569|NCT02805660|26135983|P3|Overall Study|Withdrawal by Subject|0
7524570|NCT02805660|26135984|P2|Overall Study|Withdrawal by Subject|0
7524571|NCT02805660|26135985|P1|Overall Study|Withdrawal by Subject|0
7524572|NCT02805660|26135979|P7|Overall Study|Lost to Follow-up|0
7524573|NCT02805660|26135980|P6|Overall Study|Lost to Follow-up|0
7524574|NCT02805660|26135981|P5|Overall Study|Lost to Follow-up|0
7524575|NCT02805660|26135982|P4|Overall Study|Lost to Follow-up|2
7524576|NCT02805660|26135983|P3|Overall Study|Lost to Follow-up|1
7524577|NCT02805660|26135984|P2|Overall Study|Lost to Follow-up|1
7524578|NCT02805660|26135985|P1|Overall Study|Lost to Follow-up|0
7524579|NCT02805660|26135979|P7|Overall Study|Death|12
7524580|NCT02805660|26135980|P6|Overall Study|Death|14
7524581|NCT02805660|26135981|P5|Overall Study|Death|0
7524582|NCT02805660|26135982|P4|Overall Study|Death|5
7524583|NCT02805660|26135983|P3|Overall Study|Death|9
7524584|NCT02805660|26135984|P2|Overall Study|Death|2
7524585|NCT02805660|26135985|P1|Overall Study|Death|5
7524586|NCT02805309|26136076|P3|Overall Study|Post-Randomization Exclusion|1
7524587|NCT02805309|26136077|P2|Overall Study|Post-Randomization Exclusion|2
7524588|NCT02805309|26136078|P1|Overall Study|Post-Randomization Exclusion|0
7524589|NCT02805309|26136076|P3|Overall Study|Lost to Follow-up|2
7524590|NCT02805309|26136077|P2|Overall Study|Lost to Follow-up|2
7524591|NCT02805309|26136078|P1|Overall Study|Lost to Follow-up|2
7524592|NCT02804763|26136126|P4|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7524593|NCT02804763|26136127|P3|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7524594|NCT02804763|26136128|P2|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
7524595|NCT02804763|26136129|P1|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7524596|NCT02804763|26136126|P4|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7524597|NCT02804763|26136127|P3|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7524598|NCT02804763|26136128|P2|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
7524599|NCT02804763|26136129|P1|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
7524600|NCT02804763|26136126|P4|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7524601|NCT02804763|26136127|P3|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7524602|NCT02804763|26136128|P2|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
7524603|NCT02804763|26136129|P1|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
7524604|NCT02804763|26136126|P4|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7524605|NCT02804763|26136127|P3|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7524606|NCT02804763|26136128|P2|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
7524607|NCT02804763|26136129|P1|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7524608|NCT02804763|26136126|P4|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
7524609|NCT02804763|26136127|P3|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
7524610|NCT02804763|26136128|P2|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7524611|NCT02804763|26136129|P1|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7524612|NCT02804763|26136126|P4|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7524613|NCT02804763|26136127|P3|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7524614|NCT02804763|26136128|P2|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7524615|NCT02804763|26136129|P1|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
7524616|NCT02804750|26136369|P2|Period 4|Adverse Event|5
7524617|NCT02804750|26136370|P1|Period 4|Adverse Event|0
7524618|NCT02804750|26136369|P2|Period 3|Adverse Event|2
7524619|NCT02804750|26136370|P1|Period 3|Adverse Event|0
7524620|NCT02804750|26136369|P2|Period 2|Adverse Event|0
7524621|NCT02804750|26136370|P1|Period 2|Adverse Event|1
7524622|NCT02804750|26136369|P2|Period 1|Withdrawal by Subject|1
7524623|NCT02804750|26136370|P1|Period 1|Withdrawal by Subject|0
7524624|NCT02804750|26136369|P2|Period 1|Adverse Event|2
7524625|NCT02804750|26136370|P1|Period 1|Adverse Event|0
7524626|NCT02804399|26136397|P2|Period 2|Adverse Event|1
7524627|NCT02804399|26136398|P1|Period 2|Adverse Event|0
7524628|NCT02804178|26136447|P1|Overall Study|Adverse Event|1
7524629|NCT02803580|26136474|P1|Overall Study|Inclusion in clinical trial|1
7524630|NCT02803580|26136474|P1|Overall Study|Withdrawal by Subject|3
7524631|NCT02803580|26136474|P1|Overall Study|Lost to Follow-up|19
7524632|NCT02803580|26136474|P1|Overall Study|Death|13
7524633|NCT02803138|26136537|P1|Overall Study|Other, not specified|28
7524634|NCT02803138|26136537|P1|Overall Study|Death|1
7524635|NCT02803138|26136537|P1|Overall Study|Withdrawn consent|1
7524636|NCT02803138|26136537|P1|Overall Study|Insufficient virological response|2
7524637|NCT02803138|26136537|P1|Overall Study|Failure to return|38
7524638|NCT02802878|26136553|P2|Overall Study|Protocol Violation|0
7524639|NCT02802878|26136554|P1|Overall Study|Protocol Violation|1
7524640|NCT02802878|26136553|P2|Overall Study|Withdrawal by Subject|3
7524641|NCT02802878|26136554|P1|Overall Study|Withdrawal by Subject|3
7524642|NCT02802865|26136570|P2|Overall Study|Ineliegible due to tuberculosis|1
7524643|NCT02802865|26136571|P1|Overall Study|Ineliegible due to tuberculosis|0
7524644|NCT02802865|26136570|P2|Overall Study|Pregnancy|1
7524645|NCT02802865|26136571|P1|Overall Study|Pregnancy|1
7524646|NCT02802735|26136596|P5|Overall Study|Withdrawal by Subject|0
7524647|NCT02802735|26136597|P4|Overall Study|Withdrawal by Subject|0
7524648|NCT02802735|26136598|P3|Overall Study|Withdrawal by Subject|0
7524649|NCT02802735|26136599|P2|Overall Study|Withdrawal by Subject|1
7524650|NCT02802735|26136600|P1|Overall Study|Withdrawal by Subject|0
7524651|NCT02802592|26136642|P1|Overall Study|Study terminated due to loss of funding|4
7524652|NCT02802345|26136819|P2|Overall Study|Other than listed|5
7524653|NCT02802345|26136820|P1|Overall Study|Other than listed|1
7524654|NCT02802345|26136819|P2|Overall Study|Protocol Violation|1
7524655|NCT02802345|26136820|P1|Overall Study|Protocol Violation|0
7524656|NCT02802345|26136819|P2|Overall Study|Withdrawal by Subject|3
7524657|NCT02802345|26136820|P1|Overall Study|Withdrawal by Subject|3
7524658|NCT02802345|26136819|P2|Overall Study|Adverse Event|20
7524659|NCT02802345|26136820|P1|Overall Study|Adverse Event|28
7524660|NCT02802345|26136819|P2|Overall Study|Not Treated|1
7524661|NCT02802345|26136820|P1|Overall Study|Not Treated|0
7524662|NCT02802319|26136836|P2|Overall Study|Lost to Follow-up|4
7524663|NCT02802319|26136837|P1|Overall Study|Lost to Follow-up|0
7524664|NCT02802319|26136836|P2|Overall Study|Physician Decision|1
7524665|NCT02802319|26136837|P1|Overall Study|Physician Decision|2
7524666|NCT02801877|26137000|P4|Overall Study|Never Started Treatment|0
7524667|NCT02801877|26137001|P3|Overall Study|Never Started Treatment|4
7524668|NCT02801877|26137002|P2|Overall Study|Never Started Treatment|0
7524669|NCT02801877|26137003|P1|Overall Study|Never Started Treatment|2
7524670|NCT02801877|26137000|P4|Overall Study|Lost to Follow-up|0
7524671|NCT02801877|26137001|P3|Overall Study|Lost to Follow-up|2
7524672|NCT02801877|26137002|P2|Overall Study|Lost to Follow-up|1
7524673|NCT02801877|26137003|P1|Overall Study|Lost to Follow-up|1
7524674|NCT02801669|26137023|P2|Overall Study|Other|6
7524675|NCT02801669|26137024|P1|Overall Study|Other|4
7524676|NCT02801669|26137023|P2|Overall Study|Withdrawal by Subject|77
7524677|NCT02801669|26137024|P1|Overall Study|Withdrawal by Subject|81
7524678|NCT02801669|26137023|P2|Overall Study|Death|69
7524679|NCT02801669|26137024|P1|Overall Study|Death|66
7524680|NCT02801617|26137051|P2|Overall Study|Protocol Violation|6
7524681|NCT02801617|26137052|P1|Overall Study|Protocol Violation|2
7524682|NCT02801578|26137070|P1|Overall Study|Adverse Event|2
7524683|NCT02801396|26137074|P6|Period 1|Withdrawal by Subject|0
7524684|NCT02801396|26137075|P5|Period 1|Withdrawal by Subject|1
7524685|NCT02801396|26137076|P4|Period 1|Withdrawal by Subject|0
7524686|NCT02801396|26137077|P3|Period 1|Withdrawal by Subject|0
7524687|NCT02801396|26137078|P2|Period 1|Withdrawal by Subject|0
7524688|NCT02801396|26137079|P1|Period 1|Withdrawal by Subject|0
7524689|NCT02800928|26137124|P2|Overall Study|Protocol Violation|1
7524690|NCT02800928|26137125|P1|Overall Study|Protocol Violation|1
7524691|NCT02800928|26137124|P2|Overall Study|Withdrawal by Subject|1
7524692|NCT02800928|26137125|P1|Overall Study|Withdrawal by Subject|1
7524693|NCT02800642|26137133|P1|Overall Study|Lost to Follow-up|1
7524694|NCT02800642|26137133|P1|Overall Study|Withdrawal by Subject|3
7524695|NCT02800642|26137133|P1|Overall Study|Adverse Event|6
7524696|NCT02800642|26137133|P1|Overall Study|Physician Decision|2
7524697|NCT02800642|26137133|P1|Overall Study|Other|10
7524698|NCT02800642|26137133|P1|Overall Study|Death|3
7524699|NCT02799784|26137177|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
7524700|NCT02799784|26137178|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
7524701|NCT02799784|26137177|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
7524702|NCT02799784|26137178|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
7524703|NCT02799784|26137177|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
7524704|NCT02799784|26137178|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
7524705|NCT02799784|26137177|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
7524706|NCT02799784|26137178|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
7524707|NCT02799784|26137177|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
7524708|NCT02799784|26137178|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
7524709|NCT02799784|26137177|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7524710|NCT02799784|26137178|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7524711|NCT02799472|26137205|P2|Overall Study|Lost to Follow-up|1
7524712|NCT02799472|26137206|P1|Overall Study|Lost to Follow-up|0
7524713|NCT02799472|26137205|P2|Overall Study|Lack of Efficacy|0
7524714|NCT02799472|26137206|P1|Overall Study|Lack of Efficacy|2
7524715|NCT02799472|26137205|P2|Overall Study|Withdrawal by Subject|4
7524716|NCT02799472|26137206|P1|Overall Study|Withdrawal by Subject|2
7524717|NCT02799381|26137266|P2|Overall Study|Participant did not take any study drug|0
7524718|NCT02799381|26137267|P1|Overall Study|Participant did not take any study drug|1
7524719|NCT02799381|26137266|P2|Overall Study|Adverse Event|1
7524720|NCT02799381|26137267|P1|Overall Study|Adverse Event|0
7524721|NCT02799381|26137266|P2|Overall Study|Withdrew consent|2
7524722|NCT02799381|26137267|P1|Overall Study|Withdrew consent|3
7524723|NCT02799082|26137312|P2|Overall Study|Protocol Violation|1
7524724|NCT02799082|26137313|P1|Overall Study|Protocol Violation|0
7524725|NCT02799082|26137312|P2|Overall Study|Refused second PDT or withdraw consent|3
7524726|NCT02799082|26137313|P1|Overall Study|Refused second PDT or withdraw consent|4
7524727|NCT02799069|26137350|P3|Overall Study|Protocol Violation|2
7524728|NCT02799069|26137351|P2|Overall Study|Protocol Violation|0
7524729|NCT02799069|26137352|P1|Overall Study|Protocol Violation|1
7524730|NCT02799069|26137350|P3|Overall Study|Withdrawal by Subject|3
7524731|NCT02799069|26137351|P2|Overall Study|Withdrawal by Subject|4
7524732|NCT02799069|26137352|P1|Overall Study|Withdrawal by Subject|4
7524733|NCT02799069|26137350|P3|Overall Study|Lost to Follow-up|0
7524734|NCT02799069|26137351|P2|Overall Study|Lost to Follow-up|1
7524735|NCT02799069|26137352|P1|Overall Study|Lost to Follow-up|1
7524736|NCT02799069|26137350|P3|Overall Study|Lack of Efficacy|0
7524737|NCT02799069|26137351|P2|Overall Study|Lack of Efficacy|0
7524738|NCT02799069|26137352|P1|Overall Study|Lack of Efficacy|2
7524739|NCT02799069|26137350|P3|Overall Study|Adverse Event|2
7524740|NCT02799069|26137351|P2|Overall Study|Adverse Event|2
7524741|NCT02799069|26137352|P1|Overall Study|Adverse Event|0
7524742|NCT02798861|26137690|P1|Overall Study|Withdrawal by Subject|1
7524743|NCT02798861|26137690|P1|Overall Study|Lost to Follow-up|22
7524744|NCT02798835|26137698|P3|Overall Study|Protocol Violation|3
7524745|NCT02798835|26137699|P2|Overall Study|Protocol Violation|0
7524746|NCT02798835|26137700|P1|Overall Study|Protocol Violation|0
7524747|NCT02798315|26137777|P1|Overall Study|Failure to return|1
7524748|NCT02798211|26137798|P6|Period 2|Withdrawal of Informed Consent|3
7524749|NCT02798211|26137799|P5|Period 2|Withdrawal of Informed Consent|2
7524750|NCT02798211|26137800|P4|Period 2|Withdrawal of Informed Consent|2
7524751|NCT02798211|26137801|P3|Period 2|Withdrawal of Informed Consent|0
7524752|NCT02798211|26137802|P2|Period 2|Withdrawal of Informed Consent|0
7524753|NCT02798211|26137803|P1|Period 2|Withdrawal of Informed Consent|1
7524754|NCT02798211|26137798|P6|Period 2|Technical problems|0
7524755|NCT02798211|26137799|P5|Period 2|Technical problems|0
7524756|NCT02798211|26137800|P4|Period 2|Technical problems|1
7524757|NCT02798211|26137801|P3|Period 2|Technical problems|0
7524758|NCT02798211|26137802|P2|Period 2|Technical problems|0
7524759|NCT02798211|26137803|P1|Period 2|Technical problems|1
7524760|NCT02798211|26137798|P6|Period 2|Pregnancy|0
7524761|NCT02798211|26137799|P5|Period 2|Pregnancy|0
7524762|NCT02798211|26137800|P4|Period 2|Pregnancy|2
7524763|NCT02798211|26137801|P3|Period 2|Pregnancy|0
7524764|NCT02798211|26137802|P2|Period 2|Pregnancy|0
7524765|NCT02798211|26137803|P1|Period 2|Pregnancy|0
7524766|NCT02798211|26137798|P6|Period 2|Physician Decision|0
7524767|NCT02798211|26137799|P5|Period 2|Physician Decision|1
7524768|NCT02798211|26137800|P4|Period 2|Physician Decision|1
7524769|NCT02798211|26137801|P3|Period 2|Physician Decision|0
7524770|NCT02798211|26137802|P2|Period 2|Physician Decision|0
7524771|NCT02798211|26137803|P1|Period 2|Physician Decision|1
7524772|NCT02798211|26137798|P6|Period 2|Lost to Follow-up|0
7524773|NCT02798211|26137799|P5|Period 2|Lost to Follow-up|2
7524774|NCT02798211|26137800|P4|Period 2|Lost to Follow-up|0
7524775|NCT02798211|26137801|P3|Period 2|Lost to Follow-up|0
7524776|NCT02798211|26137802|P2|Period 2|Lost to Follow-up|0
7524777|NCT02798211|26137803|P1|Period 2|Lost to Follow-up|3
7524778|NCT02798211|26137798|P6|Period 2|Lack of Efficacy|1
7524779|NCT02798211|26137799|P5|Period 2|Lack of Efficacy|0
7524780|NCT02798211|26137800|P4|Period 2|Lack of Efficacy|1
7524781|NCT02798211|26137801|P3|Period 2|Lack of Efficacy|0
7524782|NCT02798211|26137802|P2|Period 2|Lack of Efficacy|0
7524783|NCT02798211|26137803|P1|Period 2|Lack of Efficacy|1
7524784|NCT02798211|26137798|P6|Period 2|Adverse Event|0
7524785|NCT02798211|26137799|P5|Period 2|Adverse Event|1
7524786|NCT02798211|26137800|P4|Period 2|Adverse Event|0
7524787|NCT02798211|26137801|P3|Period 2|Adverse Event|0
7524788|NCT02798211|26137802|P2|Period 2|Adverse Event|0
7524789|NCT02798211|26137803|P1|Period 2|Adverse Event|5
7524790|NCT02798211|26137798|P6|Period 2|Withdrawal by Subject|2
7524791|NCT02798211|26137799|P5|Period 2|Withdrawal by Subject|2
7524792|NCT02798211|26137800|P4|Period 2|Withdrawal by Subject|0
7524793|NCT02798211|26137801|P3|Period 2|Withdrawal by Subject|0
7524794|NCT02798211|26137802|P2|Period 2|Withdrawal by Subject|0
7524795|NCT02798211|26137803|P1|Period 2|Withdrawal by Subject|2
7524796|NCT02798211|26137798|P6|Period 1|Withdrawal of Informed Consent|0
7524797|NCT02798211|26137799|P5|Period 1|Withdrawal of Informed Consent|0
7524798|NCT02798211|26137800|P4|Period 1|Withdrawal of Informed Consent|0
7524799|NCT02798211|26137801|P3|Period 1|Withdrawal of Informed Consent|3
7524800|NCT02798211|26137802|P2|Period 1|Withdrawal of Informed Consent|7
7524801|NCT02798211|26137803|P1|Period 1|Withdrawal of Informed Consent|2
7524802|NCT02798211|26137798|P6|Period 1|Death|0
7524803|NCT02798211|26137799|P5|Period 1|Death|0
7524804|NCT02798211|26137800|P4|Period 1|Death|0
7524805|NCT02798211|26137801|P3|Period 1|Death|1
7524806|NCT02798211|26137802|P2|Period 1|Death|0
7524807|NCT02798211|26137803|P1|Period 1|Death|0
7524808|NCT02798211|26137798|P6|Period 1|Withdrawal by Subject|0
7524809|NCT02798211|26137799|P5|Period 1|Withdrawal by Subject|0
7524810|NCT02798211|26137800|P4|Period 1|Withdrawal by Subject|0
7524811|NCT02798211|26137801|P3|Period 1|Withdrawal by Subject|0
7524812|NCT02798211|26137802|P2|Period 1|Withdrawal by Subject|1
7524813|NCT02798211|26137803|P1|Period 1|Withdrawal by Subject|1
7524814|NCT02798211|26137798|P6|Period 1|Protocol Violation|0
7524815|NCT02798211|26137799|P5|Period 1|Protocol Violation|0
7524816|NCT02798211|26137800|P4|Period 1|Protocol Violation|0
7524817|NCT02798211|26137801|P3|Period 1|Protocol Violation|2
7524818|NCT02798211|26137802|P2|Period 1|Protocol Violation|0
7524819|NCT02798211|26137803|P1|Period 1|Protocol Violation|0
7524820|NCT02798211|26137798|P6|Period 1|Lost to Follow-up|0
7524821|NCT02798211|26137799|P5|Period 1|Lost to Follow-up|0
7524822|NCT02798211|26137800|P4|Period 1|Lost to Follow-up|0
7524823|NCT02798211|26137801|P3|Period 1|Lost to Follow-up|0
7524824|NCT02798211|26137802|P2|Period 1|Lost to Follow-up|1
7524825|NCT02798211|26137803|P1|Period 1|Lost to Follow-up|2
7524826|NCT02798211|26137798|P6|Period 1|Adverse Event|0
7524827|NCT02798211|26137799|P5|Period 1|Adverse Event|0
7524828|NCT02798211|26137800|P4|Period 1|Adverse Event|0
7524829|NCT02798211|26137801|P3|Period 1|Adverse Event|0
7524830|NCT02798211|26137802|P2|Period 1|Adverse Event|1
7524831|NCT02798211|26137803|P1|Period 1|Adverse Event|1
7524832|NCT02797808|26137892|P2|Overall Study|Physician Decision|2
7524833|NCT02797808|26137893|P1|Overall Study|Physician Decision|6
7524834|NCT02797808|26137892|P2|Overall Study|Withdrawal by Subject|1
7524835|NCT02797808|26137893|P1|Overall Study|Withdrawal by Subject|1
7524836|NCT02797678|26137901|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
7524837|NCT02797678|26137902|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
7524838|NCT02797678|26137903|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
7524839|NCT02797678|26137904|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
7524840|NCT02797678|26137901|P4|First Intervention (5 Nights)|study/device use non-compliance|0
7524841|NCT02797678|26137902|P3|First Intervention (5 Nights)|study/device use non-compliance|0
7524842|NCT02797678|26137903|P2|First Intervention (5 Nights)|study/device use non-compliance|1
7524843|NCT02797678|26137904|P1|First Intervention (5 Nights)|study/device use non-compliance|0
7524844|NCT02797678|26137901|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7524845|NCT02797678|26137902|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7524846|NCT02797678|26137903|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7524847|NCT02797678|26137904|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
7524848|NCT02797522|26137939|P11|Overall Study|Study Terminated by Sponsor|1
7524849|NCT02797522|26137940|P10|Overall Study|Study Terminated by Sponsor|4
7524850|NCT02797522|26137941|P9|Overall Study|Study Terminated by Sponsor|2
7524851|NCT02797522|26137942|P8|Overall Study|Study Terminated by Sponsor|4
7524852|NCT02797522|26137943|P7|Overall Study|Study Terminated by Sponsor|0
7524853|NCT02797522|26137944|P6|Overall Study|Study Terminated by Sponsor|0
7524854|NCT02797522|26137945|P5|Overall Study|Study Terminated by Sponsor|0
7524855|NCT02797522|26137946|P4|Overall Study|Study Terminated by Sponsor|0
7524856|NCT02797522|26137947|P3|Overall Study|Study Terminated by Sponsor|0
7524857|NCT02797522|26137948|P2|Overall Study|Study Terminated by Sponsor|0
7524858|NCT02797522|26137949|P1|Overall Study|Study Terminated by Sponsor|0
7524859|NCT02797171|26138061|P6|Overall Study|Not Randomized|1
7524860|NCT02797171|26138062|P5|Overall Study|Not Randomized|0
7524861|NCT02797171|26138063|P4|Overall Study|Not Randomized|0
7524862|NCT02797171|26138064|P3|Overall Study|Not Randomized|0
7524863|NCT02797171|26138065|P2|Overall Study|Not Randomized|0
7524864|NCT02797171|26138066|P1|Overall Study|Not Randomized|0
7524865|NCT02797171|26138061|P6|Overall Study|Participant unable to adhere|0
7524866|NCT02797171|26138062|P5|Overall Study|Participant unable to adhere|0
7524867|NCT02797171|26138063|P4|Overall Study|Participant unable to adhere|0
7524868|NCT02797171|26138064|P3|Overall Study|Participant unable to adhere|0
7524869|NCT02797171|26138065|P2|Overall Study|Participant unable to adhere|1
7524870|NCT02797171|26138066|P1|Overall Study|Participant unable to adhere|0
7524871|NCT02797171|26138061|P6|Overall Study|Protocol Violation|0
7524872|NCT02797171|26138062|P5|Overall Study|Protocol Violation|0
7524873|NCT02797171|26138063|P4|Overall Study|Protocol Violation|0
7524874|NCT02797171|26138064|P3|Overall Study|Protocol Violation|0
7524875|NCT02797171|26138065|P2|Overall Study|Protocol Violation|0
7524876|NCT02797171|26138066|P1|Overall Study|Protocol Violation|1
7524877|NCT02797171|26138061|P6|Overall Study|Withdrawal by Subject|0
7524878|NCT02797171|26138062|P5|Overall Study|Withdrawal by Subject|0
7524879|NCT02797171|26138063|P4|Overall Study|Withdrawal by Subject|0
7524880|NCT02797171|26138064|P3|Overall Study|Withdrawal by Subject|0
7524881|NCT02797171|26138065|P2|Overall Study|Withdrawal by Subject|1
7524882|NCT02797171|26138066|P1|Overall Study|Withdrawal by Subject|1
7524883|NCT02797171|26138061|P6|Overall Study|Lost to Follow-up|0
7524884|NCT02797171|26138062|P5|Overall Study|Lost to Follow-up|2
7524885|NCT02797171|26138063|P4|Overall Study|Lost to Follow-up|1
7524886|NCT02797171|26138064|P3|Overall Study|Lost to Follow-up|2
7524887|NCT02797171|26138065|P2|Overall Study|Lost to Follow-up|0
7524888|NCT02797171|26138066|P1|Overall Study|Lost to Follow-up|2
7524889|NCT02797132|26138128|P1|Part B (24 Weeks)|Adverse Event|3
7524890|NCT02797132|26138128|P1|Part A (15 Days)|Adverse Event|1
7524891|NCT02797080|26138180|P1|Overall Study|Withdrawal by Subject|1
7524892|NCT02797080|26138180|P1|Overall Study|Lost to Follow-up|1
7524893|NCT02796963|26138222|P4|Overall Study|Lost to Follow-up|72
7524894|NCT02796963|26138223|P3|Overall Study|Lost to Follow-up|69
7524895|NCT02796963|26138224|P2|Overall Study|Lost to Follow-up|76
7524896|NCT02796963|26138225|P1|Overall Study|Lost to Follow-up|89
7524897|NCT02796755|26138293|P2|Overall Study|Adverse Event|0
7524898|NCT02796755|26138294|P1|Overall Study|Adverse Event|2
7524899|NCT02796677|26138308|P4|Overall Study|Reason not mentioned|5
7524900|NCT02796677|26138309|P3|Overall Study|Reason not mentioned|0
7524901|NCT02796677|26138310|P2|Overall Study|Reason not mentioned|3
7524902|NCT02796677|26138311|P1|Overall Study|Reason not mentioned|2
7524903|NCT02796677|26138308|P4|Overall Study|Progressive disease|18
7524904|NCT02796677|26138309|P3|Overall Study|Progressive disease|13
7524905|NCT02796677|26138310|P2|Overall Study|Progressive disease|15
7524906|NCT02796677|26138311|P1|Overall Study|Progressive disease|6
7524907|NCT02796677|26138308|P4|Overall Study|Withdrawal by Subject|7
7524908|NCT02796677|26138309|P3|Overall Study|Withdrawal by Subject|6
7524909|NCT02796677|26138310|P2|Overall Study|Withdrawal by Subject|14
7524910|NCT02796677|26138311|P1|Overall Study|Withdrawal by Subject|4
7524911|NCT02796677|26138308|P4|Overall Study|Lack of Efficacy|20
7524912|NCT02796677|26138309|P3|Overall Study|Lack of Efficacy|14
7524913|NCT02796677|26138310|P2|Overall Study|Lack of Efficacy|9
7524914|NCT02796677|26138311|P1|Overall Study|Lack of Efficacy|7
7524915|NCT02796677|26138308|P4|Overall Study|Lost to Follow-up|2
7524916|NCT02796677|26138309|P3|Overall Study|Lost to Follow-up|2
7524917|NCT02796677|26138310|P2|Overall Study|Lost to Follow-up|5
7524918|NCT02796677|26138311|P1|Overall Study|Lost to Follow-up|1
7524919|NCT02796677|26138308|P4|Overall Study|Protocol Violation|8
7524920|NCT02796677|26138309|P3|Overall Study|Protocol Violation|4
7524921|NCT02796677|26138310|P2|Overall Study|Protocol Violation|5
7524922|NCT02796677|26138311|P1|Overall Study|Protocol Violation|7
7524923|NCT02796677|26138308|P4|Overall Study|Adverse Event|14
7524924|NCT02796677|26138309|P3|Overall Study|Adverse Event|14
7524925|NCT02796677|26138310|P2|Overall Study|Adverse Event|22
7524926|NCT02796677|26138311|P1|Overall Study|Adverse Event|11
7524927|NCT02796664|26138337|P2|Overall Study|Death|1
7524928|NCT02796664|26138338|P1|Overall Study|Death|0
7524929|NCT02796664|26138337|P2|Overall Study|Noncompliance|1
7524930|NCT02796664|26138338|P1|Overall Study|Noncompliance|1
7524931|NCT02796664|26138337|P2|Overall Study|Withdrawal by Subject|3
7524932|NCT02796664|26138338|P1|Overall Study|Withdrawal by Subject|0
7524933|NCT02796651|26138354|P1|Overall Study|Other|10
7524934|NCT02796651|26138354|P1|Overall Study|Lack of Efficacy|1
7524935|NCT02796651|26138354|P1|Overall Study|Protocol Violation|4
7524936|NCT02796651|26138354|P1|Overall Study|Withdrawal by Subject|4
7524937|NCT02796651|26138354|P1|Overall Study|Lost to Follow-up|1
7524938|NCT02796651|26138354|P1|Overall Study|Adverse Event|6
7524939|NCT02796560|26138390|P2|Overall Study|Withdrawal by Subject|2
7524940|NCT02796560|26138391|P1|Overall Study|Withdrawal by Subject|2
7524941|NCT02796560|26138390|P2|Overall Study|Adverse Event|0
7524942|NCT02796560|26138391|P1|Overall Study|Adverse Event|2
7524943|NCT02795832|26138498|P6|Overall Study|Adverse Event|3
7524944|NCT02795832|26138499|P5|Overall Study|Adverse Event|0
7524945|NCT02795832|26138500|P4|Overall Study|Adverse Event|0
7524946|NCT02795832|26138501|P3|Overall Study|Adverse Event|0
7524947|NCT02795832|26138502|P2|Overall Study|Adverse Event|0
7524948|NCT02795832|26138503|P1|Overall Study|Adverse Event|0
7524949|NCT02795767|26138581|P3|Overall Study|Received Commercial Emicizumab|0
7524950|NCT02795767|26138582|P2|Overall Study|Received Commercial Emicizumab|0
7524951|NCT02795767|26138583|P1|Overall Study|Received Commercial Emicizumab|1
7524952|NCT02794974|26138750|P2|Overall Study|Physician Decision|1
7524953|NCT02794974|26138751|P1|Overall Study|Physician Decision|0
7524954|NCT02794870|26138767|P2|Overall Study|Withdrawal by Subject|0
7524955|NCT02794870|26138768|P1|Overall Study|Withdrawal by Subject|2
7524956|NCT02794480|26138865|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7524957|NCT02794480|26138866|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7524958|NCT02794480|26138867|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7524959|NCT02794480|26138868|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7524960|NCT02794480|26138865|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7524961|NCT02794480|26138866|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7524962|NCT02794480|26138867|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
7524963|NCT02794480|26138868|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7524964|NCT02794480|26138865|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
7524965|NCT02794480|26138866|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7524966|NCT02794480|26138867|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7524967|NCT02794480|26138868|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7524968|NCT02794480|26138865|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7524969|NCT02794480|26138866|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
7524970|NCT02794480|26138867|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7524971|NCT02794480|26138868|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7524972|NCT02794480|26138865|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7524973|NCT02794480|26138866|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
7524974|NCT02794480|26138867|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7524975|NCT02794480|26138868|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7524976|NCT02794246|26138911|P1|Overall Study|Physician Decision|4
7524977|NCT02794246|26138911|P1|Overall Study|Withdrawal by Subject|2
7524978|NCT02794103|26138923|P1|Overall Study|Loss to follow up due to high sedation|3
7524979|NCT02793947|26138934|P2|Overall Study|Physician Decision|5
7524980|NCT02793947|26138935|P1|Overall Study|Physician Decision|1
7524981|NCT02793947|26138934|P2|Overall Study|Death|0
7524982|NCT02793947|26138935|P1|Overall Study|Death|1
7524983|NCT02793622|26139032|P2|Overall Study|Protocol Violation|5
7524984|NCT02793622|26139033|P1|Overall Study|Protocol Violation|1
7524985|NCT02793622|26139032|P2|Overall Study|Adverse Event|1
7524986|NCT02793622|26139033|P1|Overall Study|Adverse Event|0
7524987|NCT02793622|26139032|P2|Overall Study|Withdrawal by Subject|17
7524988|NCT02793622|26139033|P1|Overall Study|Withdrawal by Subject|21
7524989|NCT02793622|26139032|P2|Overall Study|Lost to Follow-up|19
7524990|NCT02793622|26139033|P1|Overall Study|Lost to Follow-up|31
7524991|NCT02793232|26139074|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7524992|NCT02793232|26139075|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7524993|NCT02793232|26139076|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7524994|NCT02793232|26139077|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7524995|NCT02793232|26139078|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7524996|NCT02793232|26139079|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7524997|NCT02793232|26139080|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7524998|NCT02793232|26139081|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7524999|NCT02793232|26139082|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7525000|NCT02793128|26139335|P1|Overall Study|Patient elected nephroureterectomy|1
7525001|NCT02793128|26139335|P1|Overall Study|Comorbid conditions and noncompliance|1
7525002|NCT02793128|26139335|P1|Overall Study|Physician Decision|1
7525003|NCT02793128|26139335|P1|Overall Study|Withdrawal by Subject|2
7525004|NCT02793128|26139335|P1|Overall Study|Death|4
7525005|NCT02792959|26139349|P1|Overall Study|Protocol Violation|1
7525006|NCT02792829|26139416|P8|Treatment Period 2|Use of proscribed medications|1
7525007|NCT02792829|26139417|P7|Treatment Period 2|Use of proscribed medications|0
7525008|NCT02792829|26139418|P6|Treatment Period 2|Use of proscribed medications|0
7525009|NCT02792829|26139419|P5|Treatment Period 2|Use of proscribed medications|0
7525010|NCT02792829|26139420|P4|Treatment Period 2|Use of proscribed medications|0
7525011|NCT02792829|26139421|P3|Treatment Period 2|Use of proscribed medications|0
7525012|NCT02792829|26139422|P2|Treatment Period 2|Use of proscribed medications|0
7525013|NCT02792829|26139423|P1|Treatment Period 2|Use of proscribed medications|0
7525014|NCT02792829|26139416|P8|Treatment Period 2|Adverse Event|1
7525015|NCT02792829|26139417|P7|Treatment Period 2|Adverse Event|1
7525016|NCT02792829|26139418|P6|Treatment Period 2|Adverse Event|0
7525017|NCT02792829|26139419|P5|Treatment Period 2|Adverse Event|1
7525018|NCT02792829|26139420|P4|Treatment Period 2|Adverse Event|0
7525019|NCT02792829|26139421|P3|Treatment Period 2|Adverse Event|0
7525020|NCT02792829|26139422|P2|Treatment Period 2|Adverse Event|0
7525021|NCT02792829|26139423|P1|Treatment Period 2|Adverse Event|0
7525022|NCT02792829|26139416|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
7525023|NCT02792829|26139417|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
7525024|NCT02792829|26139418|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
7525025|NCT02792829|26139419|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
7525026|NCT02792829|26139420|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
7525027|NCT02792829|26139421|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
7525028|NCT02792829|26139422|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
7525029|NCT02792829|26139423|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
7525030|NCT02792777|26139531|P2|Overall Study|Participant interviewed twice|0
7525031|NCT02792777|26139532|P1|Overall Study|Participant interviewed twice|1
7525032|NCT02792777|26139531|P2|Overall Study|Later determined to be ineligible|0
7525033|NCT02792777|26139532|P1|Overall Study|Later determined to be ineligible|2
7525034|NCT02792777|26139531|P2|Overall Study|Recording malfunction|0
7525035|NCT02792777|26139532|P1|Overall Study|Recording malfunction|2
7525036|NCT02792777|26139531|P2|Overall Study|Withdrawal by Subject|0
7525037|NCT02792777|26139532|P1|Overall Study|Withdrawal by Subject|2
7525038|NCT02792699|26139548|P3|Overall Study|Other|0
7525039|NCT02792699|26139549|P2|Overall Study|Other|0
7525040|NCT02792699|26139550|P1|Overall Study|Other|1
7525041|NCT02792699|26139548|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
7525042|NCT02792699|26139549|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
7525043|NCT02792699|26139550|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
7525044|NCT02792699|26139548|P3|Overall Study|Physician Decision|0
7525045|NCT02792699|26139549|P2|Overall Study|Physician Decision|0
7525046|NCT02792699|26139550|P1|Overall Study|Physician Decision|2
7525047|NCT02792699|26139548|P3|Overall Study|Lost to Follow-up|2
7525048|NCT02792699|26139549|P2|Overall Study|Lost to Follow-up|1
7525049|NCT02792699|26139550|P1|Overall Study|Lost to Follow-up|0
7525050|NCT02792699|26139548|P3|Overall Study|Withdrawal by Subject|3
7525051|NCT02792699|26139549|P2|Overall Study|Withdrawal by Subject|4
7525052|NCT02792699|26139550|P1|Overall Study|Withdrawal by Subject|4
7525053|NCT02792699|26139548|P3|Overall Study|Adverse Event|4
7525054|NCT02792699|26139549|P2|Overall Study|Adverse Event|2
7525055|NCT02792699|26139550|P1|Overall Study|Adverse Event|1
7525056|NCT02792517|26139631|P1|Overall Study|Lost to Follow-up|3
7525057|NCT02792517|26139631|P1|Overall Study|Decision by Sponsor|7
7525058|NCT02792517|26139631|P1|Overall Study|Withdrawal by Subject|10
7525059|NCT02792504|26139645|P1|Overall Study|Violated inclusion/exclusion criteria|6
7525060|NCT02792504|26139645|P1|Overall Study|Lost to Follow-up|24
7525061|NCT02792231|26139659|P2|Overall Study|Ongoing at interim data cutoff|1
7525062|NCT02792231|26139660|P1|Overall Study|Ongoing at interim data cutoff|1
7525063|NCT02792231|26139659|P2|Overall Study|Technical problems|1
7525064|NCT02792231|26139660|P1|Overall Study|Technical problems|0
7525065|NCT02792231|26139659|P2|Overall Study|Protocol deviation|0
7525066|NCT02792231|26139660|P1|Overall Study|Protocol deviation|2
7525067|NCT02792231|26139659|P2|Overall Study|Non-compliance with study treatment|1
7525068|NCT02792231|26139660|P1|Overall Study|Non-compliance with study treatment|2
7525069|NCT02792231|26139659|P2|Overall Study|Pregnancy|3
7525070|NCT02792231|26139660|P1|Overall Study|Pregnancy|1
7525071|NCT02792231|26139659|P2|Overall Study|Lost to Follow-up|5
7525072|NCT02792231|26139660|P1|Overall Study|Lost to Follow-up|9
7525073|NCT02792231|26139659|P2|Overall Study|Lack of Efficacy|9
7525074|NCT02792231|26139660|P1|Overall Study|Lack of Efficacy|7
7525075|NCT02792231|26139659|P2|Overall Study|Physician Decision|11
7525076|NCT02792231|26139660|P1|Overall Study|Physician Decision|14
7525077|NCT02792231|26139659|P2|Overall Study|Adverse Event|13
7525078|NCT02792231|26139660|P1|Overall Study|Adverse Event|16
7525079|NCT02792231|26139659|P2|Overall Study|Patient/guardian decision|41
7525080|NCT02792231|26139660|P1|Overall Study|Patient/guardian decision|32
7525081|NCT02792218|26139682|P2|Overall Study|Pregnancy|0
7525082|NCT02792218|26139683|P1|Overall Study|Pregnancy|1
7525083|NCT02792218|26139682|P2|Overall Study|Non-compliance with study treatment|1
7525084|NCT02792218|26139683|P1|Overall Study|Non-compliance with study treatment|0
7525085|NCT02792218|26139682|P2|Overall Study|New therapy for study indication|1
7525086|NCT02792218|26139683|P1|Overall Study|New therapy for study indication|0
7525087|NCT02792218|26139682|P2|Overall Study|Protocol deviation|2
7525088|NCT02792218|26139683|P1|Overall Study|Protocol deviation|3
7525089|NCT02792218|26139682|P2|Overall Study|Physician Decision|4
7525090|NCT02792218|26139683|P1|Overall Study|Physician Decision|4
7525091|NCT02792218|26139682|P2|Overall Study|Lack of Efficacy|12
7525092|NCT02792218|26139683|P1|Overall Study|Lack of Efficacy|1
7525093|NCT02792218|26139682|P2|Overall Study|Lost to Follow-up|5
7525094|NCT02792218|26139683|P1|Overall Study|Lost to Follow-up|10
7525095|NCT02792218|26139682|P2|Overall Study|Adverse Event|14
7525096|NCT02792218|26139683|P1|Overall Study|Adverse Event|15
7525097|NCT02792218|26139682|P2|Overall Study|Patient/guardian decision|42
7525098|NCT02792218|26139683|P1|Overall Study|Patient/guardian decision|15
7525099|NCT02792062|26139752|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7525100|NCT02792062|26139753|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7525101|NCT02792062|26139754|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7525102|NCT02792062|26139755|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7525103|NCT02792062|26139756|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7525104|NCT02792062|26139757|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
7525105|NCT02791893|26139838|P2|Open Label Phase|Withdrawal by Subject|2
7525106|NCT02791893|26139839|P1|Open Label Phase|Withdrawal by Subject|0
7525107|NCT02791893|26139838|P2|Open Label Phase|Lost to Follow-up|0
7525108|NCT02791893|26139839|P1|Open Label Phase|Lost to Follow-up|3
7525109|NCT02791893|26139838|P2|Blinded Phase|Withdrawal by Subject|2
7525110|NCT02791893|26139839|P1|Blinded Phase|Withdrawal by Subject|1
7525111|NCT02791893|26139838|P2|Blinded Phase|Lost to Follow-up|2
7525112|NCT02791893|26139839|P1|Blinded Phase|Lost to Follow-up|2
7525113|NCT02791763|26139857|P3|Overall Study|Adverse Event|7
7525114|NCT02791763|26139858|P2|Overall Study|Adverse Event|13
7525115|NCT02791763|26139859|P1|Overall Study|Adverse Event|12
7525116|NCT02791763|26139857|P3|Overall Study|Met hemoglobin stopping criteria|0
7525117|NCT02791763|26139858|P2|Overall Study|Met hemoglobin stopping criteria|0
7525118|NCT02791763|26139859|P1|Overall Study|Met hemoglobin stopping criteria|1
7525119|NCT02791763|26139857|P3|Overall Study|Participant had renal transplant|0
7525120|NCT02791763|26139858|P2|Overall Study|Participant had renal transplant|0
7525121|NCT02791763|26139859|P1|Overall Study|Participant had renal transplant|3
7525122|NCT02791763|26139857|P3|Overall Study|Cancer event|0
7525123|NCT02791763|26139858|P2|Overall Study|Cancer event|3
7525124|NCT02791763|26139859|P1|Overall Study|Cancer event|1
7525125|NCT02791763|26139857|P3|Overall Study|Needs maintenance/changes in dialysis|5
7525126|NCT02791763|26139858|P2|Overall Study|Needs maintenance/changes in dialysis|19
7525127|NCT02791763|26139859|P1|Overall Study|Needs maintenance/changes in dialysis|16
7525128|NCT02791763|26139857|P3|Overall Study|Physician Decision|0
7525129|NCT02791763|26139858|P2|Overall Study|Physician Decision|1
7525130|NCT02791763|26139859|P1|Overall Study|Physician Decision|0
7525131|NCT02791763|26139857|P3|Overall Study|Withdrawal by Subject|0
7525132|NCT02791763|26139858|P2|Overall Study|Withdrawal by Subject|1
7525133|NCT02791763|26139859|P1|Overall Study|Withdrawal by Subject|5
7525134|NCT02791763|26139857|P3|Overall Study|Protocol Violation|1
7525135|NCT02791763|26139858|P2|Overall Study|Protocol Violation|0
7525136|NCT02791763|26139859|P1|Overall Study|Protocol Violation|0
7525137|NCT02791659|26139978|P2|Overall Study|Protocol Violation|1
7525138|NCT02791659|26139979|P1|Overall Study|Protocol Violation|0
7525139|NCT02791516|26139987|P2|Overall Study|Withdrawal by Subject|1
7525140|NCT02791516|26139988|P1|Overall Study|Withdrawal by Subject|1
7525141|NCT02791490|26140000|P2|Overall Study|Withdrawal by Subject|6
7525142|NCT02791490|26140001|P1|Overall Study|Withdrawal by Subject|2
7525143|NCT02791490|26140000|P2|Overall Study|Lost to Follow-up|2
7525144|NCT02791490|26140001|P1|Overall Study|Lost to Follow-up|1
7525145|NCT02791438|26140021|P2|Treatment Period|Withdrawal by Parent/Guardian|0
7525146|NCT02791438|26140022|P1|Treatment Period|Withdrawal by Parent/Guardian|2
7525147|NCT02791438|26140021|P2|Treatment Period|Withdrawal by Subject|1
7525148|NCT02791438|26140022|P1|Treatment Period|Withdrawal by Subject|0
7525149|NCT02791438|26140021|P2|Treatment Period|Adverse Event|0
7525150|NCT02791438|26140022|P1|Treatment Period|Adverse Event|1
7525151|NCT02791269|26140080|P2|Overall Study|Lost to Follow-up|1
7525152|NCT02791269|26140081|P1|Overall Study|Lost to Follow-up|0
7525153|NCT02791191|26140098|P3|Overall Study|Subject Withdrew Caregiver Circumstances|0
7525154|NCT02791191|26140099|P2|Overall Study|Subject Withdrew Caregiver Circumstances|1
7525155|NCT02791191|26140100|P1|Overall Study|Subject Withdrew Caregiver Circumstances|2
7525156|NCT02791191|26140098|P3|Overall Study|Withdrawal by Subject|3
7525157|NCT02791191|26140099|P2|Overall Study|Withdrawal by Subject|1
7525158|NCT02791191|26140100|P1|Overall Study|Withdrawal by Subject|3
7525159|NCT02791191|26140098|P3|Overall Study|Study Terminated by Sponsor|109
7525160|NCT02791191|26140099|P2|Overall Study|Study Terminated by Sponsor|101
7525161|NCT02791191|26140100|P1|Overall Study|Study Terminated by Sponsor|29
7525162|NCT02791191|26140098|P3|Overall Study|Progressive Disease|0
7525163|NCT02791191|26140099|P2|Overall Study|Progressive Disease|0
7525164|NCT02791191|26140100|P1|Overall Study|Progressive Disease|1
7525165|NCT02791191|26140098|P3|Overall Study|Site Closed by Sponsor|3
7525166|NCT02791191|26140099|P2|Overall Study|Site Closed by Sponsor|1
7525167|NCT02791191|26140100|P1|Overall Study|Site Closed by Sponsor|1
7525168|NCT02791191|26140098|P3|Overall Study|Study Drug Non-Compliance|0
7525169|NCT02791191|26140099|P2|Overall Study|Study Drug Non-Compliance|2
7525170|NCT02791191|26140100|P1|Overall Study|Study Drug Non-Compliance|0
7525171|NCT02791191|26140098|P3|Overall Study|Lack of Efficacy|0
7525172|NCT02791191|26140099|P2|Overall Study|Lack of Efficacy|1
7525173|NCT02791191|26140100|P1|Overall Study|Lack of Efficacy|0
7525174|NCT02791191|26140098|P3|Overall Study|Adverse Event|5
7525175|NCT02791191|26140099|P2|Overall Study|Adverse Event|4
7525176|NCT02791191|26140100|P1|Overall Study|Adverse Event|2
7525177|NCT02790606|26140195|P1|Overall Study|Withdrawal by Subject|1
7525178|NCT02790606|26140195|P1|Overall Study|Physician Decision|3
7525179|NCT02790606|26140195|P1|Overall Study|Lost to Follow-up|4
7525180|NCT02790606|26140195|P1|Overall Study|Death|27
7525181|NCT02790437|26140223|P2|Overall Study|Withdrawal by Subject|0
7525182|NCT02790437|26140224|P1|Overall Study|Withdrawal by Subject|1
7525183|NCT02790437|26140223|P2|Overall Study|Adverse Event|0
7525184|NCT02790437|26140224|P1|Overall Study|Adverse Event|1
7525185|NCT02790437|26140223|P2|Overall Study|Patient graft failure - nephrectomy|0
7525186|NCT02790437|26140224|P1|Overall Study|Patient graft failure - nephrectomy|1
7525187|NCT02790138|26140259|P2|Overall Study|Reason not Specified|0
7525188|NCT02790138|26140260|P1|Overall Study|Reason not Specified|1
7525189|NCT02790138|26140259|P2|Overall Study|Lack of Efficacy|7
7525190|NCT02790138|26140260|P1|Overall Study|Lack of Efficacy|6
7525191|NCT02790138|26140259|P2|Overall Study|Voluntary Withdrawal|9
7525192|NCT02790138|26140260|P1|Overall Study|Voluntary Withdrawal|8
7525193|NCT02790138|26140259|P2|Overall Study|Lost to Follow-up|0
7525194|NCT02790138|26140260|P1|Overall Study|Lost to Follow-up|1
7525195|NCT02790138|26140259|P2|Overall Study|Significant Protocol Deviation|1
7525196|NCT02790138|26140260|P1|Overall Study|Significant Protocol Deviation|0
7525197|NCT02790138|26140259|P2|Overall Study|Adverse Event|2
7525198|NCT02790138|26140260|P1|Overall Study|Adverse Event|5
7525199|NCT02790073|26140266|P1|Overall Study|Withdrawal by Subject|1
7525200|NCT02790073|26140266|P1|Overall Study|Withdrawal from HD|1
7525201|NCT02790073|26140266|P1|Overall Study|Death|1
7525202|NCT02789176|26140289|P4|Overall Study|Lost to Follow-up|1
7525203|NCT02789176|26140290|P3|Overall Study|Lost to Follow-up|6
7525204|NCT02789176|26140291|P2|Overall Study|Lost to Follow-up|2
7525205|NCT02789176|26140292|P1|Overall Study|Lost to Follow-up|8
7525206|NCT02789176|26140289|P4|Overall Study|Withdrawal by Subject|0
7525207|NCT02789176|26140290|P3|Overall Study|Withdrawal by Subject|1
7525208|NCT02789176|26140291|P2|Overall Study|Withdrawal by Subject|0
7525209|NCT02789176|26140292|P1|Overall Study|Withdrawal by Subject|0
7525210|NCT02789176|26140289|P4|Overall Study|Death|0
7525211|NCT02789176|26140290|P3|Overall Study|Death|3
7525212|NCT02789176|26140291|P2|Overall Study|Death|0
7525213|NCT02789176|26140292|P1|Overall Study|Death|0
7525214|NCT02789111|26140316|P2|Overall Study|Withdrawal by Subject|4
7525215|NCT02789111|26140317|P1|Overall Study|Withdrawal by Subject|1
7525216|NCT02788747|26140369|P3|Overall Study|Adverse Event|0
7525217|NCT02788747|26140370|P2|Overall Study|Adverse Event|0
7525218|NCT02788747|26140371|P1|Overall Study|Adverse Event|1
7525219|NCT02788656|26140441|P2|Overall Study|Withdrawal by Subject|0
7525220|NCT02788656|26140442|P1|Overall Study|Withdrawal by Subject|1
7525221|NCT02788513|26140467|P5|Overall Study|Decision by the study team|1
7525222|NCT02788513|26140468|P4|Overall Study|Decision by the study team|0
7525223|NCT02788513|26140469|P3|Overall Study|Decision by the study team|0
7525224|NCT02788513|26140470|P2|Overall Study|Decision by the study team|0
7525225|NCT02788513|26140471|P1|Overall Study|Decision by the study team|0
7525226|NCT02788513|26140467|P5|Overall Study|Subject decided to stop taking treatment|0
7525227|NCT02788513|26140468|P4|Overall Study|Subject decided to stop taking treatment|0
7525228|NCT02788513|26140469|P3|Overall Study|Subject decided to stop taking treatment|1
7525229|NCT02788513|26140470|P2|Overall Study|Subject decided to stop taking treatment|0
7525230|NCT02788513|26140471|P1|Overall Study|Subject decided to stop taking treatment|0
7525231|NCT02788513|26140467|P5|Overall Study|Protocol Violation|0
7525232|NCT02788513|26140468|P4|Overall Study|Protocol Violation|1
7525233|NCT02788513|26140469|P3|Overall Study|Protocol Violation|1
7525234|NCT02788513|26140470|P2|Overall Study|Protocol Violation|0
7525235|NCT02788513|26140471|P1|Overall Study|Protocol Violation|0
7525236|NCT02788513|26140467|P5|Overall Study|Adverse Event|2
7525237|NCT02788513|26140468|P4|Overall Study|Adverse Event|2
7525238|NCT02788513|26140469|P3|Overall Study|Adverse Event|4
7525239|NCT02788513|26140470|P2|Overall Study|Adverse Event|8
7525240|NCT02788513|26140471|P1|Overall Study|Adverse Event|5
7525241|NCT02788513|26140467|P5|Overall Study|Lost to Follow-up|1
7525242|NCT02788513|26140468|P4|Overall Study|Lost to Follow-up|0
7525243|NCT02788513|26140469|P3|Overall Study|Lost to Follow-up|0
7525244|NCT02788513|26140470|P2|Overall Study|Lost to Follow-up|0
7525245|NCT02788513|26140471|P1|Overall Study|Lost to Follow-up|1
7525246|NCT02788513|26140467|P5|Overall Study|Withdrawal by Subject|1
7525247|NCT02788513|26140468|P4|Overall Study|Withdrawal by Subject|3
7525248|NCT02788513|26140469|P3|Overall Study|Withdrawal by Subject|2
7525249|NCT02788513|26140470|P2|Overall Study|Withdrawal by Subject|0
7525250|NCT02788513|26140471|P1|Overall Study|Withdrawal by Subject|3
7525251|NCT02788474|26140495|P2|Open Label Treatment Period|Non-compliance|0
7525252|NCT02788474|26140496|P1|Open Label Treatment Period|Non-compliance|1
7525253|NCT02788474|26140495|P2|Open Label Treatment Period|Patient's refusal|3
7525254|NCT02788474|26140496|P1|Open Label Treatment Period|Patient's refusal|1
7525255|NCT02788474|26140495|P2|Open Label Treatment Period|Other than reason specified|0
7525256|NCT02788474|26140496|P1|Open Label Treatment Period|Other than reason specified|1
7525257|NCT02788474|26140495|P2|Open Label Treatment Period|Adverse Event|9
7525258|NCT02788474|26140496|P1|Open Label Treatment Period|Adverse Event|29
7525259|NCT02788474|26140495|P2|Double Blind Treatment Period|Adverse Event|4
7525260|NCT02788474|26140496|P1|Double Blind Treatment Period|Adverse Event|6
7525261|NCT02788474|26140495|P2|Double Blind Treatment Period|Patient's refusal|0
7525262|NCT02788474|26140496|P1|Double Blind Treatment Period|Patient's refusal|3
7525263|NCT02788474|26140495|P2|Double Blind Treatment Period|Not treated|0
7525264|NCT02788474|26140496|P1|Double Blind Treatment Period|Not treated|1
7525265|NCT02788357|26140511|P2|Overall Study|Lost to Follow-up|0
7525266|NCT02788357|26140512|P1|Overall Study|Lost to Follow-up|3
7525267|NCT02788279|26140527|P3|Overall Study|Sponsor decision|11
7525268|NCT02788279|26140528|P2|Overall Study|Sponsor decision|29
7525269|NCT02788279|26140529|P1|Overall Study|Sponsor decision|18
7525270|NCT02788279|26140527|P3|Overall Study|Lost to Follow-up|2
7525271|NCT02788279|26140528|P2|Overall Study|Lost to Follow-up|3
7525272|NCT02788279|26140529|P1|Overall Study|Lost to Follow-up|0
7525273|NCT02788279|26140527|P3|Overall Study|Withdrawal by Subject|5
7525274|NCT02788279|26140528|P2|Overall Study|Withdrawal by Subject|15
7525275|NCT02788279|26140529|P1|Overall Study|Withdrawal by Subject|10
7525276|NCT02788279|26140527|P3|Overall Study|Death|72
7525277|NCT02788279|26140528|P2|Overall Study|Death|136
7525278|NCT02788279|26140529|P1|Overall Study|Death|62
7525279|NCT02788201|26140566|P6|Overall Study|Withdrawal by Subject|1
7525280|NCT02788201|26140567|P5|Overall Study|Withdrawal by Subject|0
7525281|NCT02788201|26140568|P4|Overall Study|Withdrawal by Subject|0
7525282|NCT02788201|26140569|P3|Overall Study|Withdrawal by Subject|0
7525283|NCT02788201|26140570|P2|Overall Study|Withdrawal by Subject|0
7525284|NCT02788201|26140571|P1|Overall Study|Withdrawal by Subject|0
7525285|NCT02788201|26140566|P6|Overall Study|Ineligible|1
7525286|NCT02788201|26140567|P5|Overall Study|Ineligible|0
7525287|NCT02788201|26140568|P4|Overall Study|Ineligible|0
7525288|NCT02788201|26140569|P3|Overall Study|Ineligible|0
7525289|NCT02788201|26140570|P2|Overall Study|Ineligible|0
7525290|NCT02788201|26140571|P1|Overall Study|Ineligible|0
7525291|NCT02788201|26140566|P6|Overall Study|Death|1
7525292|NCT02788201|26140567|P5|Overall Study|Death|0
7525293|NCT02788201|26140568|P4|Overall Study|Death|1
7525294|NCT02788201|26140569|P3|Overall Study|Death|1
7525295|NCT02788201|26140570|P2|Overall Study|Death|1
7525296|NCT02788201|26140571|P1|Overall Study|Death|1
7525297|NCT02788175|26140624|P1|Overall Study|Ineligible prior to study agent|6
7525298|NCT02788175|26140624|P1|Overall Study|Withdrawal by Subject|4
7525299|NCT02788175|26140624|P1|Overall Study|Protocol Violation|3
7525300|NCT02787863|26140655|P8|Overall Study|Withdrawal by Subject|0
7525301|NCT02787863|26140656|P7|Overall Study|Withdrawal by Subject|0
7525302|NCT02787863|26140657|P6|Overall Study|Withdrawal by Subject|0
7525303|NCT02787863|26140658|P5|Overall Study|Withdrawal by Subject|0
7525304|NCT02787863|26140659|P4|Overall Study|Withdrawal by Subject|0
7525305|NCT02787863|26140660|P3|Overall Study|Withdrawal by Subject|1
7525306|NCT02787863|26140661|P2|Overall Study|Withdrawal by Subject|1
7525307|NCT02787863|26140662|P1|Overall Study|Withdrawal by Subject|0
7525308|NCT02787863|26140655|P8|Overall Study|Death|0
7525309|NCT02787863|26140656|P7|Overall Study|Death|0
7525310|NCT02787863|26140657|P6|Overall Study|Death|0
7525311|NCT02787863|26140658|P5|Overall Study|Death|0
7525312|NCT02787863|26140659|P4|Overall Study|Death|0
7525313|NCT02787863|26140660|P3|Overall Study|Death|1
7525314|NCT02787863|26140661|P2|Overall Study|Death|0
7525315|NCT02787863|26140662|P1|Overall Study|Death|1
7525316|NCT02787850|26140724|P2|Overall Study|Withdrawal by Subject|1
7525317|NCT02787850|26140725|P1|Overall Study|Withdrawal by Subject|0
7525318|NCT02787551|26140778|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
7525319|NCT02787551|26140779|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
7525320|NCT02787551|26140778|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
7525321|NCT02787551|26140779|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
7525322|NCT02787551|26140778|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
7525323|NCT02787551|26140779|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
7525324|NCT02787551|26140778|P2|Core Period: 26 Weeks|Other than specified|1
7525325|NCT02787551|26140779|P1|Core Period: 26 Weeks|Other than specified|3
7525326|NCT02787551|26140778|P2|Core Period: 26 Weeks|Randomized but not treated|1
7525327|NCT02787551|26140779|P1|Core Period: 26 Weeks|Randomized but not treated|2
7525328|NCT02787551|26140778|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
7525329|NCT02787551|26140779|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
7525330|NCT02787551|26140778|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
7525331|NCT02787551|26140779|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
7525332|NCT02787551|26140778|P2|Core Period: 26 Weeks|Lack of Efficacy|0
7525333|NCT02787551|26140779|P1|Core Period: 26 Weeks|Lack of Efficacy|1
7525334|NCT02787551|26140778|P2|Core Period: 26 Weeks|Adverse Event|0
7525335|NCT02787551|26140779|P1|Core Period: 26 Weeks|Adverse Event|10
7525336|NCT02787304|26140815|P4|Overall Study|Study terminated by sponsor|32
7525337|NCT02787304|26140816|P3|Overall Study|Study terminated by sponsor|31
7525338|NCT02787304|26140817|P2|Overall Study|Study terminated by sponsor|31
7525339|NCT02787304|26140818|P1|Overall Study|Study terminated by sponsor|25
7525340|NCT02787304|26140815|P4|Overall Study|Physician Decision|0
7525341|NCT02787304|26140816|P3|Overall Study|Physician Decision|1
7525342|NCT02787304|26140817|P2|Overall Study|Physician Decision|0
7525343|NCT02787304|26140818|P1|Overall Study|Physician Decision|0
7525344|NCT02787304|26140815|P4|Overall Study|Noncompliance with study drug|0
7525345|NCT02787304|26140816|P3|Overall Study|Noncompliance with study drug|1
7525346|NCT02787304|26140817|P2|Overall Study|Noncompliance with study drug|0
7525347|NCT02787304|26140818|P1|Overall Study|Noncompliance with study drug|0
7525348|NCT02787304|26140815|P4|Overall Study|Lost to Follow-up|1
7525349|NCT02787304|26140816|P3|Overall Study|Lost to Follow-up|0
7525350|NCT02787304|26140817|P2|Overall Study|Lost to Follow-up|0
7525351|NCT02787304|26140818|P1|Overall Study|Lost to Follow-up|1
7525352|NCT02787304|26140815|P4|Overall Study|Withdrawal by Subject|0
7525353|NCT02787304|26140816|P3|Overall Study|Withdrawal by Subject|0
7525354|NCT02787304|26140817|P2|Overall Study|Withdrawal by Subject|4
7525355|NCT02787304|26140818|P1|Overall Study|Withdrawal by Subject|1
7525356|NCT02787304|26140815|P4|Overall Study|Adverse Event|1
7525357|NCT02787304|26140816|P3|Overall Study|Adverse Event|8
7525358|NCT02787304|26140817|P2|Overall Study|Adverse Event|3
7525359|NCT02787304|26140818|P1|Overall Study|Adverse Event|9
7525360|NCT02787083|26140872|P2|Overall Study|Withdrawal by Subject|2
7525361|NCT02787083|26140873|P1|Overall Study|Withdrawal by Subject|2
7525362|NCT02787083|26140872|P2|Overall Study|Adverse Event|0
7525363|NCT02787083|26140873|P1|Overall Study|Adverse Event|1
7525364|NCT02787044|26140898|P2|Overall Study|Lost to Follow-up|19
7525365|NCT02787044|26140899|P1|Overall Study|Lost to Follow-up|15
7525366|NCT02786953|26140915|P2|Overall Study|Physician Decision|1
7525367|NCT02786953|26140916|P1|Overall Study|Physician Decision|0
7525368|NCT02786953|26140915|P2|Overall Study|Withdrawal by Subject|0
7525369|NCT02786953|26140916|P1|Overall Study|Withdrawal by Subject|3
7525370|NCT02786927|26140938|P1|Overall Study|Protocol Violation|4
7525371|NCT02786927|26140938|P1|Overall Study|Adverse Event|1
7525372|NCT02786901|26140948|P3|Overall Study|Randomized in error|1
7525373|NCT02786901|26140949|P2|Overall Study|Randomized in error|0
7525374|NCT02786901|26140950|P1|Overall Study|Randomized in error|2
7525375|NCT02786901|26140948|P3|Overall Study|Disallowed medication|0
7525376|NCT02786901|26140949|P2|Overall Study|Disallowed medication|1
7525377|NCT02786901|26140950|P1|Overall Study|Disallowed medication|1
7525378|NCT02786901|26140948|P3|Overall Study|Subject Request/Lost to Follow up|5
7525379|NCT02786901|26140949|P2|Overall Study|Subject Request/Lost to Follow up|5
7525380|NCT02786901|26140950|P1|Overall Study|Subject Request/Lost to Follow up|1
7525381|NCT02786901|26140948|P3|Overall Study|Rescue Therapy Use|33
7525382|NCT02786901|26140949|P2|Overall Study|Rescue Therapy Use|49
7525383|NCT02786901|26140950|P1|Overall Study|Rescue Therapy Use|71
7525384|NCT02786901|26140948|P3|Overall Study|Physician Decision|0
7525385|NCT02786901|26140949|P2|Overall Study|Physician Decision|0
7525386|NCT02786901|26140950|P1|Overall Study|Physician Decision|1
7525387|NCT02786901|26140948|P3|Overall Study|Adverse Event|2
7525388|NCT02786901|26140949|P2|Overall Study|Adverse Event|1
7525389|NCT02786901|26140950|P1|Overall Study|Adverse Event|1
7525390|NCT02786836|26140979|P1|Overall Study|Device or Pharmacy Issues|3
7525391|NCT02786836|26140979|P1|Overall Study|Liver Transplantation|2
7525392|NCT02786836|26140979|P1|Overall Study|Withdrawal by Subject|3
7525393|NCT02786836|26140979|P1|Overall Study|Protocol Violation|3
7525394|NCT02786836|26140979|P1|Overall Study|Lack of Efficacy|2
7525395|NCT02786836|26140979|P1|Overall Study|Death|1
7525396|NCT02786537|26141011|P6|As Treated|Advised to stop tx after loss of meds|0
7525397|NCT02786537|26141012|P5|As Treated|Advised to stop tx after loss of meds|0
7525398|NCT02786537|26141013|P4|As Treated|Advised to stop tx after loss of meds|0
7525399|NCT02786537|26141014|P3|As Treated|Advised to stop tx after loss of meds|0
7525400|NCT02786537|26141015|P2|As Treated|Advised to stop tx after loss of meds|1
7525401|NCT02786537|26141016|P1|As Treated|Advised to stop tx after loss of meds|0
7525402|NCT02786537|26141011|P6|As Treated|Drugs stolen from patient|0
7525403|NCT02786537|26141012|P5|As Treated|Drugs stolen from patient|0
7525404|NCT02786537|26141013|P4|As Treated|Drugs stolen from patient|0
7525405|NCT02786537|26141014|P3|As Treated|Drugs stolen from patient|0
7525406|NCT02786537|26141015|P2|As Treated|Drugs stolen from patient|1
7525407|NCT02786537|26141016|P1|As Treated|Drugs stolen from patient|0
7525408|NCT02786537|26141011|P6|As Treated|Opiate dependency relapse|0
7525409|NCT02786537|26141012|P5|As Treated|Opiate dependency relapse|0
7525410|NCT02786537|26141013|P4|As Treated|Opiate dependency relapse|0
7525411|NCT02786537|26141014|P3|As Treated|Opiate dependency relapse|0
7525412|NCT02786537|26141015|P2|As Treated|Opiate dependency relapse|1
7525413|NCT02786537|26141016|P1|As Treated|Opiate dependency relapse|0
7525414|NCT02786537|26141011|P6|As Treated|Incarceration|0
7525415|NCT02786537|26141012|P5|As Treated|Incarceration|0
7525416|NCT02786537|26141013|P4|As Treated|Incarceration|0
7525417|NCT02786537|26141014|P3|As Treated|Incarceration|0
7525418|NCT02786537|26141015|P2|As Treated|Incarceration|1
7525419|NCT02786537|26141016|P1|As Treated|Incarceration|0
7525420|NCT02786537|26141011|P6|As Treated|Withdrawal by Subject|0
7525421|NCT02786537|26141012|P5|As Treated|Withdrawal by Subject|1
7525422|NCT02786537|26141013|P4|As Treated|Withdrawal by Subject|0
7525423|NCT02786537|26141014|P3|As Treated|Withdrawal by Subject|0
7525424|NCT02786537|26141015|P2|As Treated|Withdrawal by Subject|2
7525425|NCT02786537|26141016|P1|As Treated|Withdrawal by Subject|1
7525426|NCT02786537|26141011|P6|As Treated|Lost insurance|0
7525427|NCT02786537|26141012|P5|As Treated|Lost insurance|0
7525428|NCT02786537|26141013|P4|As Treated|Lost insurance|1
7525429|NCT02786537|26141014|P3|As Treated|Lost insurance|0
7525430|NCT02786537|26141015|P2|As Treated|Lost insurance|0
7525431|NCT02786537|26141016|P1|As Treated|Lost insurance|0
7525432|NCT02786537|26141011|P6|As Treated|Non-compliance with study drug|1
7525433|NCT02786537|26141012|P5|As Treated|Non-compliance with study drug|0
7525434|NCT02786537|26141013|P4|As Treated|Non-compliance with study drug|1
7525435|NCT02786537|26141014|P3|As Treated|Non-compliance with study drug|0
7525436|NCT02786537|26141015|P2|As Treated|Non-compliance with study drug|11
7525437|NCT02786537|26141016|P1|As Treated|Non-compliance with study drug|1
7525438|NCT02786537|26141011|P6|As Treated|Lost to Follow-up|4
7525439|NCT02786537|26141012|P5|As Treated|Lost to Follow-up|4
7525440|NCT02786537|26141013|P4|As Treated|Lost to Follow-up|25
7525441|NCT02786537|26141014|P3|As Treated|Lost to Follow-up|0
7525442|NCT02786537|26141015|P2|As Treated|Lost to Follow-up|32
7525443|NCT02786537|26141016|P1|As Treated|Lost to Follow-up|4
7525444|NCT02786537|26141011|P6|As Treated|Lack of Efficacy|0
7525445|NCT02786537|26141012|P5|As Treated|Lack of Efficacy|0
7525446|NCT02786537|26141013|P4|As Treated|Lack of Efficacy|1
7525447|NCT02786537|26141014|P3|As Treated|Lack of Efficacy|0
7525448|NCT02786537|26141015|P2|As Treated|Lack of Efficacy|0
7525449|NCT02786537|26141016|P1|As Treated|Lack of Efficacy|0
7525450|NCT02786537|26141011|P6|As Treated|Death|0
7525451|NCT02786537|26141012|P5|As Treated|Death|1
7525452|NCT02786537|26141013|P4|As Treated|Death|3
7525453|NCT02786537|26141014|P3|As Treated|Death|0
7525454|NCT02786537|26141015|P2|As Treated|Death|2
7525455|NCT02786537|26141016|P1|As Treated|Death|0
7525456|NCT02786537|26141011|P6|As Treated|Adverse Event|2
7525457|NCT02786537|26141012|P5|As Treated|Adverse Event|6
7525458|NCT02786537|26141013|P4|As Treated|Adverse Event|4
7525459|NCT02786537|26141014|P3|As Treated|Adverse Event|0
7525460|NCT02786537|26141015|P2|As Treated|Adverse Event|11
7525461|NCT02786537|26141016|P1|As Treated|Adverse Event|0
7525462|NCT02786537|26141011|P6|As Randomized|Subject lost insurance|0
7525463|NCT02786537|26141012|P5|As Randomized|Subject lost insurance|0
7525464|NCT02786537|26141013|P4|As Randomized|Subject lost insurance|1
7525465|NCT02786537|26141014|P3|As Randomized|Subject lost insurance|0
7525466|NCT02786537|26141015|P2|As Randomized|Subject lost insurance|0
7525467|NCT02786537|26141016|P1|As Randomized|Subject lost insurance|0
7525468|NCT02786537|26141011|P6|As Randomized|Advised to stop after lapse in dosing|0
7525469|NCT02786537|26141012|P5|As Randomized|Advised to stop after lapse in dosing|0
7525470|NCT02786537|26141013|P4|As Randomized|Advised to stop after lapse in dosing|0
7525471|NCT02786537|26141014|P3|As Randomized|Advised to stop after lapse in dosing|0
7525472|NCT02786537|26141015|P2|As Randomized|Advised to stop after lapse in dosing|1
7525473|NCT02786537|26141016|P1|As Randomized|Advised to stop after lapse in dosing|0
7525474|NCT02786537|26141011|P6|As Randomized|HCV drugs stolen from pt|0
7525475|NCT02786537|26141012|P5|As Randomized|HCV drugs stolen from pt|0
7525476|NCT02786537|26141013|P4|As Randomized|HCV drugs stolen from pt|0
7525477|NCT02786537|26141014|P3|As Randomized|HCV drugs stolen from pt|0
7525478|NCT02786537|26141015|P2|As Randomized|HCV drugs stolen from pt|1
7525479|NCT02786537|26141016|P1|As Randomized|HCV drugs stolen from pt|0
7525480|NCT02786537|26141011|P6|As Randomized|Opiate Dependency Relapse|0
7525481|NCT02786537|26141012|P5|As Randomized|Opiate Dependency Relapse|0
7525482|NCT02786537|26141013|P4|As Randomized|Opiate Dependency Relapse|0
7525483|NCT02786537|26141014|P3|As Randomized|Opiate Dependency Relapse|0
7525484|NCT02786537|26141015|P2|As Randomized|Opiate Dependency Relapse|1
7525485|NCT02786537|26141016|P1|As Randomized|Opiate Dependency Relapse|0
7525486|NCT02786537|26141011|P6|As Randomized|Incarceration|0
7525487|NCT02786537|26141012|P5|As Randomized|Incarceration|0
7525488|NCT02786537|26141013|P4|As Randomized|Incarceration|0
7525489|NCT02786537|26141014|P3|As Randomized|Incarceration|0
7525490|NCT02786537|26141015|P2|As Randomized|Incarceration|1
7525491|NCT02786537|26141016|P1|As Randomized|Incarceration|0
7525492|NCT02786537|26141011|P6|As Randomized|Lost to treatment follow-up|4
7525493|NCT02786537|26141012|P5|As Randomized|Lost to treatment follow-up|4
7525494|NCT02786537|26141013|P4|As Randomized|Lost to treatment follow-up|24
7525495|NCT02786537|26141014|P3|As Randomized|Lost to treatment follow-up|0
7525496|NCT02786537|26141015|P2|As Randomized|Lost to treatment follow-up|32
7525497|NCT02786537|26141016|P1|As Randomized|Lost to treatment follow-up|4
7525498|NCT02786537|26141011|P6|As Randomized|Non-compliance with study drug|1
7525499|NCT02786537|26141012|P5|As Randomized|Non-compliance with study drug|0
7525500|NCT02786537|26141013|P4|As Randomized|Non-compliance with study drug|1
7525501|NCT02786537|26141014|P3|As Randomized|Non-compliance with study drug|0
7525502|NCT02786537|26141015|P2|As Randomized|Non-compliance with study drug|11
7525503|NCT02786537|26141016|P1|As Randomized|Non-compliance with study drug|1
7525504|NCT02786537|26141011|P6|As Randomized|Death|0
7525505|NCT02786537|26141012|P5|As Randomized|Death|1
7525506|NCT02786537|26141013|P4|As Randomized|Death|3
7525507|NCT02786537|26141014|P3|As Randomized|Death|0
7525508|NCT02786537|26141015|P2|As Randomized|Death|2
7525509|NCT02786537|26141016|P1|As Randomized|Death|0
7525510|NCT02786537|26141011|P6|As Randomized|Withdrawal by Subject|0
7525511|NCT02786537|26141012|P5|As Randomized|Withdrawal by Subject|1
7525512|NCT02786537|26141013|P4|As Randomized|Withdrawal by Subject|1
7525513|NCT02786537|26141014|P3|As Randomized|Withdrawal by Subject|0
7525514|NCT02786537|26141015|P2|As Randomized|Withdrawal by Subject|2
7525515|NCT02786537|26141016|P1|As Randomized|Withdrawal by Subject|1
7525516|NCT02786537|26141011|P6|As Randomized|Lack of Efficacy|0
7525517|NCT02786537|26141012|P5|As Randomized|Lack of Efficacy|0
7525518|NCT02786537|26141013|P4|As Randomized|Lack of Efficacy|1
7525519|NCT02786537|26141014|P3|As Randomized|Lack of Efficacy|0
7525520|NCT02786537|26141015|P2|As Randomized|Lack of Efficacy|0
7525521|NCT02786537|26141016|P1|As Randomized|Lack of Efficacy|0
7525522|NCT02786537|26141011|P6|As Randomized|Adverse Event|2
7525523|NCT02786537|26141012|P5|As Randomized|Adverse Event|6
7525524|NCT02786537|26141013|P4|As Randomized|Adverse Event|4
7525525|NCT02786537|26141014|P3|As Randomized|Adverse Event|0
7525526|NCT02786537|26141015|P2|As Randomized|Adverse Event|11
7525527|NCT02786537|26141016|P1|As Randomized|Adverse Event|0
7525528|NCT02786004|26141220|P2|Overall Study|Withdrawal by Subject|1
7525529|NCT02786004|26141221|P1|Overall Study|Withdrawal by Subject|0
7525530|NCT02785939|26141231|P2|Overall Study|Not protocol specified|1
7525531|NCT02785939|26141232|P1|Overall Study|Not protocol specified|0
7525532|NCT02785939|26141231|P2|Overall Study|Deteriorating health|0
7525533|NCT02785939|26141232|P1|Overall Study|Deteriorating health|1
7525534|NCT02785939|26141231|P2|Overall Study|Refusal|0
7525535|NCT02785939|26141232|P1|Overall Study|Refusal|1
7525536|NCT02785939|26141231|P2|Overall Study|Death|0
7525537|NCT02785939|26141232|P1|Overall Study|Death|1
7525538|NCT02785939|26141231|P2|Overall Study|Adverse Event|1
7525539|NCT02785939|26141232|P1|Overall Study|Adverse Event|3
7525540|NCT02785939|26141231|P2|Overall Study|Progression|8
7525541|NCT02785939|26141232|P1|Overall Study|Progression|25
7525542|NCT02785913|26141241|P1|Overall Study|Not protocol specified|1
7525543|NCT02785913|26141241|P1|Overall Study|Progression|18
7525544|NCT02785913|26141241|P1|Overall Study|Death|2
7525545|NCT02785913|26141241|P1|Overall Study|Adverse Event|5
7525546|NCT02785900|26141252|P2|Overall Study|Physician Decision|2
7525547|NCT02785900|26141253|P1|Overall Study|Physician Decision|3
7525548|NCT02785900|26141252|P2|Overall Study|Withdrawal by Subject|8
7525549|NCT02785900|26141253|P1|Overall Study|Withdrawal by Subject|4
7525550|NCT02785900|26141252|P2|Overall Study|Death|32
7525551|NCT02785900|26141253|P1|Overall Study|Death|46
7525552|NCT02785900|26141252|P2|Overall Study|Study Termination by Sponsor|81
7525553|NCT02785900|26141253|P1|Overall Study|Study Termination by Sponsor|64
7525554|NCT02785770|26141277|P4|Intervention Period 3 (1 Day)|Adverse Event|1
7525555|NCT02785770|26141278|P3|Intervention Period 3 (1 Day)|Adverse Event|0
7525556|NCT02785770|26141279|P2|Intervention Period 3 (1 Day)|Adverse Event|0
7525557|NCT02785770|26141280|P1|Intervention Period 3 (1 Day)|Adverse Event|0
7525558|NCT02785770|26141277|P4|Intervention Period 2 (1 Day)|Family related obligations|0
7525559|NCT02785770|26141278|P3|Intervention Period 2 (1 Day)|Family related obligations|1
7525560|NCT02785770|26141279|P2|Intervention Period 2 (1 Day)|Family related obligations|0
7525561|NCT02785770|26141280|P1|Intervention Period 2 (1 Day)|Family related obligations|0
7525562|NCT02785770|26141277|P4|Intervention Period 2 (1 Day)|Adverse Event|0
7525563|NCT02785770|26141278|P3|Intervention Period 2 (1 Day)|Adverse Event|0
7525564|NCT02785770|26141279|P2|Intervention Period 2 (1 Day)|Adverse Event|1
7525565|NCT02785770|26141280|P1|Intervention Period 2 (1 Day)|Adverse Event|0
7525566|NCT02785588|26141347|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
7525567|NCT02785588|26141347|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
7525568|NCT02785458|26141363|P2|3 Months|Completed Evaluation at 1 Month|89
7525569|NCT02785458|26141364|P1|3 Months|Completed Evaluation at 1 Month|100
7525570|NCT02785458|26141363|P2|3 Months|Lost to Follow-up|21
7525571|NCT02785458|26141364|P1|3 Months|Lost to Follow-up|25
7525572|NCT02785458|26141363|P2|3 Months|Withdrawal by Subject|1
7525573|NCT02785458|26141364|P1|3 Months|Withdrawal by Subject|3
7525574|NCT02785458|26141363|P2|1 Month|Partial Interview|4
7525575|NCT02785458|26141364|P1|1 Month|Partial Interview|0
7525576|NCT02785458|26141363|P2|1 Month|Completed Evaluation by Baseline|39
7525577|NCT02785458|26141364|P1|1 Month|Completed Evaluation by Baseline|42
7525578|NCT02785458|26141363|P2|1 Month|Deemed Ineligible|0
7525579|NCT02785458|26141364|P1|1 Month|Deemed Ineligible|1
7525580|NCT02785458|26141363|P2|1 Month|Lost to Follow-up|31
7525581|NCT02785458|26141364|P1|1 Month|Lost to Follow-up|38
7525582|NCT02785458|26141363|P2|1 Month|Withdrawal by Subject|1
7525583|NCT02785458|26141364|P1|1 Month|Withdrawal by Subject|2
7525584|NCT02784834|26141551|P1|Overall Study|Lack of Efficacy|1
7525585|NCT02784704|26141557|P2|Overall Study|Subject Non Compliance|0
7525586|NCT02784704|26141558|P1|Overall Study|Subject Non Compliance|2
7525587|NCT02784704|26141557|P2|Overall Study|Withdrawal by Subject|3
7525588|NCT02784704|26141558|P1|Overall Study|Withdrawal by Subject|1
7525589|NCT02784704|26141557|P2|Overall Study|Lost to Follow-up|4
7525590|NCT02784704|26141558|P1|Overall Study|Lost to Follow-up|6
7525591|NCT02784704|26141557|P2|Overall Study|Adverse Event|2
7525592|NCT02784704|26141558|P1|Overall Study|Adverse Event|4
7525593|NCT02784431|26141628|P1|Overall Study|Early Study Termination|19
7525594|NCT02784431|26141628|P1|Overall Study|Unsuccessful Implant Attempt|1
7525595|NCT02784106|26141684|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7525596|NCT02784106|26141685|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7525597|NCT02784106|26141686|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7525598|NCT02784106|26141687|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7525599|NCT02784106|26141684|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
7525600|NCT02784106|26141685|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
7525601|NCT02784106|26141686|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7525602|NCT02784106|26141687|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7525603|NCT02784106|26141684|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7525604|NCT02784106|26141685|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7525605|NCT02784106|26141686|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7525606|NCT02784106|26141687|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
7525607|NCT02784106|26141684|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
7525608|NCT02784106|26141685|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
7525609|NCT02784106|26141686|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
7525610|NCT02784106|26141687|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
7525611|NCT02784106|26141684|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7525612|NCT02784106|26141685|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7525613|NCT02784106|26141686|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
7525614|NCT02784106|26141687|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
7525615|NCT02784106|26141684|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7525616|NCT02784106|26141685|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7525617|NCT02784106|26141686|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
7525618|NCT02784106|26141687|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
7525619|NCT02783911|26141761|P2|Overall Study|Lost to Follow-up|32
7525620|NCT02783911|26141762|P1|Overall Study|Lost to Follow-up|3
7525621|NCT02783768|26141808|P2|Overall Study|Lost to Follow-up|0
7525622|NCT02783768|26141809|P1|Overall Study|Lost to Follow-up|1
7525623|NCT02783729|26141831|P4|Overall Study|Lost to Follow-up|0
7525624|NCT02783729|26141832|P3|Overall Study|Lost to Follow-up|1
7525625|NCT02783729|26141833|P2|Overall Study|Lost to Follow-up|1
7525626|NCT02783729|26141834|P1|Overall Study|Lost to Follow-up|2
7525627|NCT02783729|26141831|P4|Overall Study|Participant's choice|1
7525628|NCT02783729|26141832|P3|Overall Study|Participant's choice|2
7525629|NCT02783729|26141833|P2|Overall Study|Participant's choice|1
7525630|NCT02783729|26141834|P1|Overall Study|Participant's choice|2
7525631|NCT02783729|26141831|P4|Overall Study|Withdrawal by Subject|2
7525632|NCT02783729|26141832|P3|Overall Study|Withdrawal by Subject|1
7525633|NCT02783729|26141833|P2|Overall Study|Withdrawal by Subject|3
7525634|NCT02783729|26141834|P1|Overall Study|Withdrawal by Subject|2
7525635|NCT02783729|26141831|P4|Overall Study|Other|3
7525636|NCT02783729|26141832|P3|Overall Study|Other|2
7525637|NCT02783729|26141833|P2|Overall Study|Other|6
7525638|NCT02783729|26141834|P1|Overall Study|Other|1
7525639|NCT02783729|26141831|P4|Overall Study|Adverse Event|3
7525640|NCT02783729|26141832|P3|Overall Study|Adverse Event|2
7525641|NCT02783729|26141833|P2|Overall Study|Adverse Event|6
7525642|NCT02783729|26141834|P1|Overall Study|Adverse Event|2
7525643|NCT02783729|26141831|P4|Overall Study|Lack of Efficacy|0
7525644|NCT02783729|26141832|P3|Overall Study|Lack of Efficacy|0
7525645|NCT02783729|26141833|P2|Overall Study|Lack of Efficacy|0
7525646|NCT02783729|26141834|P1|Overall Study|Lack of Efficacy|1
7525647|NCT02783599|26141900|P1|Overall Study|Death|1
7525648|NCT02783599|26141900|P1|Overall Study|Physician Decision|2
7525649|NCT02783599|26141900|P1|Overall Study|Adverse Event|4
7525650|NCT02783599|26141900|P1|Overall Study|Surgical Resection|10
7525651|NCT02783599|26141900|P1|Overall Study|Progressive disease|23
7525652|NCT02783573|26141916|P3|Delayed-Start Period|Sponsor Decision|12
7525653|NCT02783573|26141917|P2|Delayed-Start Period|Sponsor Decision|17
7525654|NCT02783573|26141918|P1|Delayed-Start Period|Sponsor Decision|0
7525655|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
7525656|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
7525657|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
7525658|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
7525659|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7525660|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7525661|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
7525662|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
7525663|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
7525664|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
7525665|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
7525666|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
7525667|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Physician Decision|3
7525668|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Physician Decision|1
7525669|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Physician Decision|3
7525670|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
7525671|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
7525672|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
7525673|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
7525674|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
7525675|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
7525676|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
7525677|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7525678|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7525679|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
7525680|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7525681|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7525682|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Death|3
7525683|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Death|2
7525684|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Death|4
7525685|NCT02783573|26141916|P3|Placebo-Controlled Treatment Period|Adverse Event|13
7525686|NCT02783573|26141917|P2|Placebo-Controlled Treatment Period|Adverse Event|17
7525687|NCT02783573|26141918|P1|Placebo-Controlled Treatment Period|Adverse Event|13
7525688|NCT02783170|26141987|P2|Overall Study|Randomized but not Vaccinated|0
7525689|NCT02783170|26141988|P1|Overall Study|Randomized but not Vaccinated|1
7525690|NCT02783066|26142029|P1|Overall Study|Withdrawal by Subject|13
7525691|NCT02782923|26142060|P1|Overall Study|Lost to Follow-up|15
7525692|NCT02782780|26142068|P2|Overall Study|Protocol Violation|2
7525693|NCT02782780|26142069|P1|Overall Study|Protocol Violation|0
7525694|NCT02782780|26142068|P2|Overall Study|dropped out after randomization.|5
7525695|NCT02782780|26142069|P1|Overall Study|dropped out after randomization.|7
7525696|NCT02782741|26142099|P2|Open-label Long-term: Week 50 to 145|Ongoing|43
7525697|NCT02782741|26142100|P1|Open-label Long-term: Week 50 to 145|Ongoing|48
7525698|NCT02782741|26142099|P2|Open-label Long-term: Week 50 to 145|Other|0
7525699|NCT02782741|26142100|P1|Open-label Long-term: Week 50 to 145|Other|1
7525700|NCT02782741|26142099|P2|Open-label Long-term: Week 50 to 145|Adverse Event|1
7525701|NCT02782741|26142100|P1|Open-label Long-term: Week 50 to 145|Adverse Event|2
7525702|NCT02782741|26142099|P2|Blinded Treatment Period: up to Week 49|Other|1
7525703|NCT02782741|26142100|P1|Blinded Treatment Period: up to Week 49|Other|0
7525704|NCT02782741|26142099|P2|Blinded Treatment Period: up to Week 49|Adverse Event|4
7525705|NCT02782741|26142100|P1|Blinded Treatment Period: up to Week 49|Adverse Event|0
7525706|NCT02782676|26142126|P2|Overall Study|Lost to Follow-up|1
7525707|NCT02782676|26142127|P1|Overall Study|Lost to Follow-up|0
7525708|NCT02782377|26142155|P1|Overall Study|Physician Decision|5
7525709|NCT02782325|26142190|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
7525710|NCT02782325|26142191|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7525711|NCT02782325|26142192|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7525712|NCT02782325|26142190|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
7525713|NCT02782325|26142191|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
7525714|NCT02782325|26142192|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
7525715|NCT02782169|26142220|P2|Overall Study|Lost to Follow-up|2
7525716|NCT02782169|26142221|P1|Overall Study|Lost to Follow-up|1
7525717|NCT02781844|26142247|P8|Treatment Period 1|Adverse Event|0
7525718|NCT02781844|26142248|P7|Treatment Period 1|Adverse Event|0
7525719|NCT02781844|26142249|P6|Treatment Period 1|Adverse Event|1
7525720|NCT02781844|26142250|P5|Treatment Period 1|Adverse Event|0
7525721|NCT02781844|26142251|P4|Treatment Period 1|Adverse Event|0
7525722|NCT02781844|26142252|P3|Treatment Period 1|Adverse Event|0
7525723|NCT02781844|26142253|P2|Treatment Period 1|Adverse Event|0
7525724|NCT02781844|26142254|P1|Treatment Period 1|Adverse Event|0
7525725|NCT02781818|26142387|P3|Overall Study|Lost to Follow-up|1
7525726|NCT02781818|26142388|P2|Overall Study|Lost to Follow-up|2
7525727|NCT02781818|26142389|P1|Overall Study|Lost to Follow-up|4
7525728|NCT02781558|26142480|P2|Overall Study|Adverse Event|0
7525729|NCT02781558|26142481|P1|Overall Study|Adverse Event|1
7525730|NCT02781558|26142480|P2|Overall Study|Lost to Follow-up|2
7525731|NCT02781558|26142481|P1|Overall Study|Lost to Follow-up|2
7525732|NCT02781324|26142581|P2|Overall Study|Physician Decision|2
7525733|NCT02781324|26142582|P1|Overall Study|Physician Decision|1
7525734|NCT02781324|26142581|P2|Overall Study|Withdrawal by Subject|0
7525735|NCT02781324|26142582|P1|Overall Study|Withdrawal by Subject|1
7525736|NCT02781311|26142611|P3|Overall Study|Non-Compliance with Study Drug|0
7525737|NCT02781311|26142612|P2|Overall Study|Non-Compliance with Study Drug|0
7525738|NCT02781311|26142613|P1|Overall Study|Non-Compliance with Study Drug|2
7525739|NCT02781311|26142611|P3|Overall Study|Lost to Follow-up|1
7525740|NCT02781311|26142612|P2|Overall Study|Lost to Follow-up|8
7525741|NCT02781311|26142613|P1|Overall Study|Lost to Follow-up|11
7525742|NCT02781311|26142611|P3|Overall Study|Withdrawal of Consent|2
7525743|NCT02781311|26142612|P2|Overall Study|Withdrawal of Consent|12
7525744|NCT02781311|26142613|P1|Overall Study|Withdrawal of Consent|11
7525745|NCT02781311|26142611|P3|Overall Study|Adverse Event|1
7525746|NCT02781311|26142612|P2|Overall Study|Adverse Event|6
7525747|NCT02781311|26142613|P1|Overall Study|Adverse Event|2
7525748|NCT02780856|26142640|P1|Overall Study|Lost to Follow-up|1
7525749|NCT02780713|26142659|P5|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7525750|NCT02780713|26142660|P4|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7525751|NCT02780713|26142661|P3|Period 3: Variant B (100mg)|Withdrawal by Subject|2
7525752|NCT02780713|26142662|P2|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7525753|NCT02780713|26142663|P1|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7525754|NCT02780700|26142740|P1|Overall Study|Progressive disease|1
7525755|NCT02780687|26142750|P2|Overall Study|progressive disease|6
7525756|NCT02780687|26142751|P1|Overall Study|progressive disease|29
7525757|NCT02780687|26142750|P2|Overall Study|Switched to commercial program (in CTP)|0
7525758|NCT02780687|26142751|P1|Overall Study|Switched to commercial program (in CTP)|2
7525759|NCT02780687|26142750|P2|Overall Study|Withdrawal by Subject|1
7525760|NCT02780687|26142751|P1|Overall Study|Withdrawal by Subject|2
7525761|NCT02780687|26142750|P2|Overall Study|Adverse Event|1
7525762|NCT02780687|26142751|P1|Overall Study|Adverse Event|1
7525763|NCT02780388|26142823|P5|Overall Study|Withdrawal by Subject|0
7525764|NCT02780388|26142824|P4|Overall Study|Withdrawal by Subject|0
7525765|NCT02780388|26142825|P3|Overall Study|Withdrawal by Subject|0
7525766|NCT02780388|26142826|P2|Overall Study|Withdrawal by Subject|1
7525767|NCT02780388|26142827|P1|Overall Study|Withdrawal by Subject|1
7525768|NCT02780388|26142823|P5|Overall Study|Lost to Follow-up|0
7525769|NCT02780388|26142824|P4|Overall Study|Lost to Follow-up|0
7525770|NCT02780388|26142825|P3|Overall Study|Lost to Follow-up|0
7525771|NCT02780388|26142826|P2|Overall Study|Lost to Follow-up|1
7525772|NCT02780388|26142827|P1|Overall Study|Lost to Follow-up|0
7525773|NCT02780167|26142893|P5|Overall Study|Other|2
7525774|NCT02780167|26142894|P4|Overall Study|Other|1
7525775|NCT02780167|26142895|P3|Overall Study|Other|3
7525776|NCT02780167|26142896|P2|Overall Study|Other|0
7525777|NCT02780167|26142897|P1|Overall Study|Other|0
7525778|NCT02780167|26142893|P5|Overall Study|Withdrawal by Subject|4
7525779|NCT02780167|26142894|P4|Overall Study|Withdrawal by Subject|3
7525780|NCT02780167|26142895|P3|Overall Study|Withdrawal by Subject|4
7525781|NCT02780167|26142896|P2|Overall Study|Withdrawal by Subject|4
7525782|NCT02780167|26142897|P1|Overall Study|Withdrawal by Subject|6
7525783|NCT02780167|26142893|P5|Overall Study|Protocol Violation|2
7525784|NCT02780167|26142894|P4|Overall Study|Protocol Violation|1
7525785|NCT02780167|26142895|P3|Overall Study|Protocol Violation|1
7525786|NCT02780167|26142896|P2|Overall Study|Protocol Violation|5
7525787|NCT02780167|26142897|P1|Overall Study|Protocol Violation|5
7525788|NCT02780167|26142893|P5|Overall Study|No longer meets eligibility criteria|1
7525789|NCT02780167|26142894|P4|Overall Study|No longer meets eligibility criteria|1
7525790|NCT02780167|26142895|P3|Overall Study|No longer meets eligibility criteria|0
7525791|NCT02780167|26142896|P2|Overall Study|No longer meets eligibility criteria|0
7525792|NCT02780167|26142897|P1|Overall Study|No longer meets eligibility criteria|0
7525793|NCT02780167|26142893|P5|Overall Study|Does not meet entrance criteria|0
7525794|NCT02780167|26142894|P4|Overall Study|Does not meet entrance criteria|0
7525795|NCT02780167|26142895|P3|Overall Study|Does not meet entrance criteria|1
7525796|NCT02780167|26142896|P2|Overall Study|Does not meet entrance criteria|0
7525797|NCT02780167|26142897|P1|Overall Study|Does not meet entrance criteria|0
7525798|NCT02780167|26142893|P5|Overall Study|Lost to Follow-up|0
7525799|NCT02780167|26142894|P4|Overall Study|Lost to Follow-up|0
7525800|NCT02780167|26142895|P3|Overall Study|Lost to Follow-up|1
7525801|NCT02780167|26142896|P2|Overall Study|Lost to Follow-up|0
7525802|NCT02780167|26142897|P1|Overall Study|Lost to Follow-up|2
7525803|NCT02780167|26142893|P5|Overall Study|Lack of Efficacy|0
7525804|NCT02780167|26142894|P4|Overall Study|Lack of Efficacy|1
7525805|NCT02780167|26142895|P3|Overall Study|Lack of Efficacy|6
7525806|NCT02780167|26142896|P2|Overall Study|Lack of Efficacy|5
7525807|NCT02780167|26142897|P1|Overall Study|Lack of Efficacy|6
7525808|NCT02780167|26142893|P5|Overall Study|Adverse Event|8
7525809|NCT02780167|26142894|P4|Overall Study|Adverse Event|12
7525810|NCT02780167|26142895|P3|Overall Study|Adverse Event|8
7525811|NCT02780167|26142896|P2|Overall Study|Adverse Event|8
7525812|NCT02780167|26142897|P1|Overall Study|Adverse Event|9
7525813|NCT02780115|26143034|P5|Overall Study|Adverse Event|1
7525814|NCT02780115|26143035|P4|Overall Study|Adverse Event|1
7525815|NCT02780115|26143036|P3|Overall Study|Adverse Event|0
7525816|NCT02780115|26143037|P2|Overall Study|Adverse Event|0
7525817|NCT02780115|26143038|P1|Overall Study|Adverse Event|0
7525818|NCT02780115|26143034|P5|Overall Study|Withdrawal by Subject|0
7525819|NCT02780115|26143035|P4|Overall Study|Withdrawal by Subject|0
7525820|NCT02780115|26143036|P3|Overall Study|Withdrawal by Subject|1
7525821|NCT02780115|26143037|P2|Overall Study|Withdrawal by Subject|1
7525822|NCT02780115|26143038|P1|Overall Study|Withdrawal by Subject|0
7525823|NCT02779075|26143108|P2|Overall Study|IV lost during 2nd study|0
7525824|NCT02779075|26143109|P1|Overall Study|IV lost during 2nd study|1
7525825|NCT02779075|26143108|P2|Overall Study|Withdrawal by Subject|3
7525826|NCT02779075|26143109|P1|Overall Study|Withdrawal by Subject|1
7525827|NCT02778867|26143183|P4|Phase 2|Adverse Event|1
7525828|NCT02778867|26143184|P3|Phase 2|Adverse Event|0
7525829|NCT02778867|26143185|P2|Phase 2|Adverse Event|0
7525830|NCT02778867|26143186|P1|Phase 2|Adverse Event|0
7525831|NCT02778867|26143183|P4|Phase 2|Physician Decision|1
7525832|NCT02778867|26143184|P3|Phase 2|Physician Decision|0
7525833|NCT02778867|26143185|P2|Phase 2|Physician Decision|0
7525834|NCT02778867|26143186|P1|Phase 2|Physician Decision|0
7525835|NCT02778867|26143183|P4|Phase 2|Withdrawal by Subject|0
7525836|NCT02778867|26143184|P3|Phase 2|Withdrawal by Subject|1
7525837|NCT02778867|26143185|P2|Phase 2|Withdrawal by Subject|0
7525838|NCT02778867|26143186|P1|Phase 2|Withdrawal by Subject|0
7525839|NCT02778867|26143183|P4|Phase 1|Withdrawal by Subject|0
7525840|NCT02778867|26143184|P3|Phase 1|Withdrawal by Subject|0
7525841|NCT02778867|26143185|P2|Phase 1|Withdrawal by Subject|3
7525842|NCT02778867|26143186|P1|Phase 1|Withdrawal by Subject|2
7525843|NCT02778555|26143207|P3|Overall Study|Withdrawal by Subject|107
7525844|NCT02778555|26143208|P2|Overall Study|Withdrawal by Subject|32
7525845|NCT02778555|26143209|P1|Overall Study|Withdrawal by Subject|55
7525846|NCT02778204|26143221|P4|Overall Study|Eligibility Violation|1
7525847|NCT02778204|26143222|P3|Overall Study|Eligibility Violation|0
7525848|NCT02778204|26143223|P2|Overall Study|Eligibility Violation|0
7525849|NCT02778204|26143224|P1|Overall Study|Eligibility Violation|0
7525850|NCT02778204|26143221|P4|Overall Study|Protocol Violation|0
7525851|NCT02778204|26143222|P3|Overall Study|Protocol Violation|1
7525852|NCT02778204|26143223|P2|Overall Study|Protocol Violation|0
7525853|NCT02778204|26143224|P1|Overall Study|Protocol Violation|0
7525854|NCT02778204|26143221|P4|Overall Study|Lost to Follow-up|1
7525855|NCT02778204|26143222|P3|Overall Study|Lost to Follow-up|2
7525856|NCT02778204|26143223|P2|Overall Study|Lost to Follow-up|0
7525857|NCT02778204|26143224|P1|Overall Study|Lost to Follow-up|1
7525858|NCT02778204|26143221|P4|Overall Study|Withdrawal by Subject|2
7525859|NCT02778204|26143222|P3|Overall Study|Withdrawal by Subject|1
7525860|NCT02778204|26143223|P2|Overall Study|Withdrawal by Subject|0
7525861|NCT02778204|26143224|P1|Overall Study|Withdrawal by Subject|0
7525862|NCT02778204|26143221|P4|Overall Study|Adverse Event|0
7525863|NCT02778204|26143222|P3|Overall Study|Adverse Event|0
7525864|NCT02778204|26143223|P2|Overall Study|Adverse Event|0
7525865|NCT02778204|26143224|P1|Overall Study|Adverse Event|1
7525866|NCT02778100|26143316|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
7525867|NCT02778100|26143317|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
7525868|NCT02778074|26143348|P2|Overall Study|Lost to Follow-up|10
7525869|NCT02778074|26143349|P1|Overall Study|Lost to Follow-up|7
7525870|NCT02777970|26143358|P3|Overall Study|Protocol Violation|0
7525871|NCT02777970|26143359|P2|Overall Study|Protocol Violation|0
7525872|NCT02777970|26143360|P1|Overall Study|Protocol Violation|1
7525873|NCT02777970|26143358|P3|Overall Study|Lost to Follow-up|0
7525874|NCT02777970|26143359|P2|Overall Study|Lost to Follow-up|1
7525875|NCT02777970|26143360|P1|Overall Study|Lost to Follow-up|0
7525876|NCT02777918|26143408|P2|Overall Study|Withdrawal by Subject|1
7525877|NCT02777918|26143409|P1|Overall Study|Withdrawal by Subject|1
7525878|NCT02777918|26143408|P2|Overall Study|Too busy / stressed|1
7525879|NCT02777918|26143409|P1|Overall Study|Too busy / stressed|1
7525880|NCT02777918|26143408|P2|Overall Study|Medical reasons|2
7525881|NCT02777918|26143409|P1|Overall Study|Medical reasons|1
7525882|NCT02777827|26143427|P6|Washout Between Periods 3 and 4|Protocol Violation|0
7525883|NCT02777827|26143428|P5|Washout Between Periods 3 and 4|Protocol Violation|0
7525884|NCT02777827|26143429|P4|Washout Between Periods 3 and 4|Protocol Violation|0
7525885|NCT02777827|26143430|P3|Washout Between Periods 3 and 4|Protocol Violation|1
7525886|NCT02777827|26143431|P2|Washout Between Periods 3 and 4|Protocol Violation|0
7525887|NCT02777827|26143432|P1|Washout Between Periods 3 and 4|Protocol Violation|0
7525888|NCT02777554|26143611|P6|Overall Study|Other - Miscellaneous|0
7525889|NCT02777554|26143612|P5|Overall Study|Other - Miscellaneous|0
7525890|NCT02777554|26143613|P4|Overall Study|Other - Miscellaneous|0
7525891|NCT02777554|26143614|P3|Overall Study|Other - Miscellaneous|0
7525892|NCT02777554|26143615|P2|Overall Study|Other - Miscellaneous|0
7525893|NCT02777554|26143616|P1|Overall Study|Other - Miscellaneous|1
7525894|NCT02777554|26143611|P6|Overall Study|Discharged early due to hurricane|0
7525895|NCT02777554|26143612|P5|Overall Study|Discharged early due to hurricane|0
7525896|NCT02777554|26143613|P4|Overall Study|Discharged early due to hurricane|0
7525897|NCT02777554|26143614|P3|Overall Study|Discharged early due to hurricane|0
7525898|NCT02777554|26143615|P2|Overall Study|Discharged early due to hurricane|20
7525899|NCT02777554|26143616|P1|Overall Study|Discharged early due to hurricane|22
7525900|NCT02777554|26143611|P6|Overall Study|Withdrawal by Subject|0
7525901|NCT02777554|26143612|P5|Overall Study|Withdrawal by Subject|0
7525902|NCT02777554|26143613|P4|Overall Study|Withdrawal by Subject|0
7525903|NCT02777554|26143614|P3|Overall Study|Withdrawal by Subject|1
7525904|NCT02777554|26143615|P2|Overall Study|Withdrawal by Subject|1
7525905|NCT02777554|26143616|P1|Overall Study|Withdrawal by Subject|3
7525906|NCT02777554|26143611|P6|Overall Study|Adverse Event|0
7525907|NCT02777554|26143612|P5|Overall Study|Adverse Event|0
7525908|NCT02777554|26143613|P4|Overall Study|Adverse Event|1
7525909|NCT02777554|26143614|P3|Overall Study|Adverse Event|0
7525910|NCT02777554|26143615|P2|Overall Study|Adverse Event|4
7525911|NCT02777554|26143616|P1|Overall Study|Adverse Event|4
7525912|NCT02777333|26143650|P2|Overall Study|Lost to Follow-up|1
7525913|NCT02777333|26143651|P1|Overall Study|Lost to Follow-up|0
7525914|NCT02777333|26143650|P2|Overall Study|Withdrawal by Subject|1
7525915|NCT02777333|26143651|P1|Overall Study|Withdrawal by Subject|0
7525916|NCT02777242|26143701|P1|Overall Study|Withdrawal by Subject|1
7525917|NCT02777242|26143701|P1|Overall Study|Sponsor's request|1
7525918|NCT02777242|26143701|P1|Overall Study|Multiple|1
7525919|NCT02777242|26143701|P1|Overall Study|Lost to Follow-up|1
7525920|NCT02777242|26143701|P1|Overall Study|Other|2
7525921|NCT02777125|26143707|P2|Overall Study|Protocol Violation|12
7525922|NCT02777125|26143708|P1|Overall Study|Protocol Violation|8
7525923|NCT02777125|26143707|P2|Overall Study|Assent form violation|23
7525924|NCT02777125|26143708|P1|Overall Study|Assent form violation|21
7525925|NCT02777125|26143707|P2|Overall Study|Consent form violation|12
7525926|NCT02777125|26143708|P1|Overall Study|Consent form violation|14
7525927|NCT02777086|26143724|P2|Overall Study|Lost to Follow-up|99
7525928|NCT02777086|26143725|P1|Overall Study|Lost to Follow-up|96
7525929|NCT02776683|26143768|P2|Post-switch Period|Other than listed|15
7525930|NCT02776683|26143769|P1|Post-switch Period|Other than listed|0
7525931|NCT02776683|26143768|P2|Post-switch Period|Progressive disease|20
7525932|NCT02776683|26143769|P1|Post-switch Period|Progressive disease|0
7525933|NCT02776683|26143768|P2|Post-switch Period|Physician Decision|3
7525934|NCT02776683|26143769|P1|Post-switch Period|Physician Decision|0
7525935|NCT02776683|26143768|P2|Post-switch Period|Withdrawal by Subject|2
7525936|NCT02776683|26143769|P1|Post-switch Period|Withdrawal by Subject|0
7525937|NCT02776683|26143768|P2|Post-switch Period|Adverse Event|3
7525938|NCT02776683|26143769|P1|Post-switch Period|Adverse Event|0
7525939|NCT02776683|26143768|P2|Pre-switch Period|Other than listed|0
7525940|NCT02776683|26143769|P1|Pre-switch Period|Other than listed|3
7525941|NCT02776683|26143768|P2|Pre-switch Period|Progressive disease|0
7525942|NCT02776683|26143769|P1|Pre-switch Period|Progressive disease|39
7525943|NCT02776683|26143768|P2|Pre-switch Period|Physician Decision|0
7525944|NCT02776683|26143769|P1|Pre-switch Period|Physician Decision|7
7525945|NCT02776683|26143768|P2|Pre-switch Period|Withdrawal by Subject|0
7525946|NCT02776683|26143769|P1|Pre-switch Period|Withdrawal by Subject|9
7525947|NCT02776683|26143768|P2|Pre-switch Period|Adverse Event|0
7525948|NCT02776683|26143769|P1|Pre-switch Period|Adverse Event|21
7525949|NCT02776683|26143768|P2|Pre-switch Period|Protocol Violation|0
7525950|NCT02776683|26143769|P1|Pre-switch Period|Protocol Violation|1
7525951|NCT02776670|26143780|P2|Overall Study|Other - Reason not given|1
7525952|NCT02776670|26143781|P1|Overall Study|Other - Reason not given|0
7525953|NCT02776670|26143780|P2|Overall Study|Withdrawal by Subject|1
7525954|NCT02776670|26143781|P1|Overall Study|Withdrawal by Subject|0
7525955|NCT02776670|26143780|P2|Overall Study|Protocol Violation|2
7525956|NCT02776670|26143781|P1|Overall Study|Protocol Violation|0
7525957|NCT02776670|26143780|P2|Overall Study|Adverse Event|2
7525958|NCT02776670|26143781|P1|Overall Study|Adverse Event|0
7525959|NCT02776553|26143838|P2|Overall Study|Protocol Violation|1
7525960|NCT02776553|26143839|P1|Overall Study|Protocol Violation|0
7525961|NCT02776553|26143838|P2|Overall Study|had other surgery|0
7525962|NCT02776553|26143839|P1|Overall Study|had other surgery|1
7525963|NCT02776553|26143838|P2|Overall Study|got liver transplant|2
7525964|NCT02776553|26143839|P1|Overall Study|got liver transplant|1
7525965|NCT02776553|26143838|P2|Overall Study|Lost to Follow-up|0
7525966|NCT02776553|26143839|P1|Overall Study|Lost to Follow-up|1
7525967|NCT02776033|26143852|P3|Overall Study|Adverse Event|0
7525968|NCT02776033|26143853|P2|Overall Study|Adverse Event|2
7525969|NCT02776033|26143854|P1|Overall Study|Adverse Event|1
7525970|NCT02776033|26143852|P3|Overall Study|Lost to Follow-up|0
7525971|NCT02776033|26143853|P2|Overall Study|Lost to Follow-up|0
7525972|NCT02776033|26143854|P1|Overall Study|Lost to Follow-up|1
7525973|NCT02776033|26143852|P3|Overall Study|Physician Decision|0
7525974|NCT02776033|26143853|P2|Overall Study|Physician Decision|0
7525975|NCT02776033|26143854|P1|Overall Study|Physician Decision|2
7525976|NCT02776033|26143852|P3|Overall Study|Withdrawal by Subject|2
7525977|NCT02776033|26143853|P2|Overall Study|Withdrawal by Subject|0
7525978|NCT02776033|26143854|P1|Overall Study|Withdrawal by Subject|0
7525979|NCT02775916|26143919|P2|Overall Study|Subject/Guardian Decision|0
7525980|NCT02775916|26143920|P1|Overall Study|Subject/Guardian Decision|2
7525981|NCT02775916|26143919|P2|Overall Study|Adverse Event|0
7525982|NCT02775916|26143920|P1|Overall Study|Adverse Event|1
7525983|NCT02775903|26143942|P4|Overall Study|Other-Miscellaneous|5
7525984|NCT02775903|26143943|P3|Overall Study|Other-Miscellaneous|4
7525985|NCT02775903|26143944|P2|Overall Study|Other-Miscellaneous|3
7525986|NCT02775903|26143945|P1|Overall Study|Other-Miscellaneous|4
7525987|NCT02775903|26143942|P4|Overall Study|Lost to Follow-up|1
7525988|NCT02775903|26143943|P3|Overall Study|Lost to Follow-up|1
7525989|NCT02775903|26143944|P2|Overall Study|Lost to Follow-up|0
7525990|NCT02775903|26143945|P1|Overall Study|Lost to Follow-up|0
7525991|NCT02775903|26143942|P4|Overall Study|Adverse Event|1
7525992|NCT02775903|26143943|P3|Overall Study|Adverse Event|1
7525993|NCT02775903|26143944|P2|Overall Study|Adverse Event|0
7525994|NCT02775903|26143945|P1|Overall Study|Adverse Event|0
7525995|NCT02775903|26143942|P4|Overall Study|Withdrawal by Subject|4
7525996|NCT02775903|26143943|P3|Overall Study|Withdrawal by Subject|5
7525997|NCT02775903|26143944|P2|Overall Study|Withdrawal by Subject|5
7525998|NCT02775903|26143945|P1|Overall Study|Withdrawal by Subject|5
7525999|NCT02775903|26143942|P4|Overall Study|Death|35
7526000|NCT02775903|26143943|P3|Overall Study|Death|38
7526001|NCT02775903|26143944|P2|Overall Study|Death|18
7526002|NCT02775903|26143945|P1|Overall Study|Death|19
7526003|NCT02775903|26143942|P4|Overall Study|Ongoing|19
7526004|NCT02775903|26143943|P3|Overall Study|Ongoing|15
7526005|NCT02775903|26143944|P2|Overall Study|Ongoing|15
7526006|NCT02775903|26143945|P1|Overall Study|Ongoing|14
7526007|NCT02775864|26143997|P4|Overall Study|Medicaid eligibility discontinued|890
7526008|NCT02775864|26143998|P3|Overall Study|Medicaid eligibility discontinued|720
7526009|NCT02775864|26143999|P2|Overall Study|Medicaid eligibility discontinued|2019
7526010|NCT02775864|26144000|P1|Overall Study|Medicaid eligibility discontinued|1478
7526011|NCT02775864|26143997|P4|Overall Study|Data ended end of 2010|1194
7526012|NCT02775864|26143998|P3|Overall Study|Data ended end of 2010|1140
7526013|NCT02775864|26143999|P2|Overall Study|Data ended end of 2010|2880
7526014|NCT02775864|26144000|P1|Overall Study|Data ended end of 2010|1764
7526015|NCT02775435|26144033|P2|Overall Study|Not Treated|1
7526016|NCT02775435|26144034|P1|Overall Study|Not Treated|0
7526017|NCT02775435|26144033|P2|Overall Study|Ongoing in Study|72
7526018|NCT02775435|26144034|P1|Overall Study|Ongoing in Study|121
7526019|NCT02775435|26144033|P2|Overall Study|Clinical Progression|26
7526020|NCT02775435|26144034|P1|Overall Study|Clinical Progression|13
7526021|NCT02775435|26144033|P2|Overall Study|Progressive Disease|140
7526022|NCT02775435|26144034|P1|Overall Study|Progressive Disease|86
7526023|NCT02775435|26144033|P2|Overall Study|Withdrawal by Subject|9
7526024|NCT02775435|26144034|P1|Overall Study|Withdrawal by Subject|5
7526025|NCT02775435|26144033|P2|Overall Study|Physician Decision|6
7526026|NCT02775435|26144034|P1|Overall Study|Physician Decision|5
7526027|NCT02775435|26144033|P2|Overall Study|Lost to Follow-up|2
7526028|NCT02775435|26144034|P1|Overall Study|Lost to Follow-up|0
7526029|NCT02775435|26144033|P2|Overall Study|Adverse Event|25
7526030|NCT02775435|26144034|P1|Overall Study|Adverse Event|48
7526031|NCT02775344|26144052|P2|Overall Study|No ovarian cyst identified|2
7526032|NCT02775344|26144053|P1|Overall Study|No ovarian cyst identified|3
7526033|NCT02774681|26144186|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
7526034|NCT02774681|26144186|P1|Follow-Up for 3 Years|Death|11
7526035|NCT02774681|26144186|P1|Treatment on Study|Progressive Disease|7
7526036|NCT02774278|26144250|P1|Overall Study|Protocol Violation|2
7526037|NCT02774278|26144250|P1|Overall Study|Withdrawal by Subject|3
7526038|NCT02774278|26144250|P1|Overall Study|Administrative reasons|6
7526039|NCT02774278|26144250|P1|Overall Study|Refused treatment/did not cooperate|9
7526040|NCT02774278|26144250|P1|Overall Study|Adverse event/intercurrent illness|16
7526041|NCT02774278|26144250|P1|Overall Study|Death|29
7526042|NCT02774278|26144250|P1|Overall Study|Lack of Efficacy|199
7526043|NCT02773537|26144440|P3|Overall Study|Lost to Follow-up|4
7526044|NCT02773537|26144441|P2|Overall Study|Lost to Follow-up|1
7526045|NCT02773537|26144442|P1|Overall Study|Lost to Follow-up|0
7526046|NCT02773446|26144477|P6|First Admission|Lost to Follow-up|0
7526047|NCT02773446|26144478|P5|First Admission|Lost to Follow-up|0
7526048|NCT02773446|26144479|P4|First Admission|Lost to Follow-up|0
7526049|NCT02773446|26144480|P3|First Admission|Lost to Follow-up|0
7526050|NCT02773446|26144481|P2|First Admission|Lost to Follow-up|0
7526051|NCT02773446|26144482|P1|First Admission|Lost to Follow-up|1
7526052|NCT02773446|26144477|P6|First Admission|Withdrawal by Subject|0
7526053|NCT02773446|26144478|P5|First Admission|Withdrawal by Subject|0
7526054|NCT02773446|26144479|P4|First Admission|Withdrawal by Subject|1
7526055|NCT02773446|26144480|P3|First Admission|Withdrawal by Subject|0
7526056|NCT02773446|26144481|P2|First Admission|Withdrawal by Subject|0
7526057|NCT02773446|26144482|P1|First Admission|Withdrawal by Subject|0
7526058|NCT02773368|26144523|P2|Overall Study|Missing|1
7526059|NCT02773368|26144524|P1|Overall Study|Missing|0
7526060|NCT02773368|26144523|P2|Overall Study|Unclassified|1
7526061|NCT02773368|26144524|P1|Overall Study|Unclassified|1
7526062|NCT02773368|26144523|P2|Overall Study|Withdrawal by Subject|1
7526063|NCT02773368|26144524|P1|Overall Study|Withdrawal by Subject|5
7526064|NCT02773368|26144523|P2|Overall Study|Lost to Follow-up|1
7526065|NCT02773368|26144524|P1|Overall Study|Lost to Follow-up|4
7526066|NCT02772978|26144594|P2|Overall Study|Withdrawal by Subject|1
7526067|NCT02772978|26144595|P1|Overall Study|Withdrawal by Subject|1
7526068|NCT02772809|26144601|P1|Overall Study|not completed some tasks|6
7526069|NCT02772757|26144637|P3|Overall Study|Physician Decision|3
7526070|NCT02772757|26144638|P2|Overall Study|Physician Decision|3
7526071|NCT02772757|26144639|P1|Overall Study|Physician Decision|0
7526072|NCT02772757|26144637|P3|Overall Study|Protocol Violation|1
7526073|NCT02772757|26144638|P2|Overall Study|Protocol Violation|0
7526074|NCT02772757|26144639|P1|Overall Study|Protocol Violation|0
7526075|NCT02772757|26144637|P3|Overall Study|Withdrawal by Subject|1
7526076|NCT02772757|26144638|P2|Overall Study|Withdrawal by Subject|0
7526077|NCT02772757|26144639|P1|Overall Study|Withdrawal by Subject|1
7526078|NCT02771522|26144742|P1|Overall Study|No white spot lesions|3
7526079|NCT02771522|26144742|P1|Overall Study|Withdrawal by Subject|2
7526080|NCT02771522|26144742|P1|Overall Study|Lost to Follow-up|3
7526081|NCT02771366|26144753|P2|Period 2 (Crossover)|Withdrawal by Subject|0
7526082|NCT02771366|26144754|P1|Period 2 (Crossover)|Withdrawal by Subject|2
7526083|NCT02771366|26144753|P2|Period 1|Withdrawal by Subject|2
7526084|NCT02771366|26144754|P1|Period 1|Withdrawal by Subject|0
7526085|NCT02771275|26144780|P1|Overall Study|On Study|11
7526086|NCT02771275|26144780|P1|Overall Study|Reoperation|2
7526087|NCT02771210|26144790|P2|Period 2|Withdrawal of informed consent|2
7526088|NCT02771210|26144791|P1|Period 2|Withdrawal of informed consent|0
7526089|NCT02771210|26144790|P2|Period 2|Withdrawal by Subject|0
7526090|NCT02771210|26144791|P1|Period 2|Withdrawal by Subject|1
7526091|NCT02771210|26144790|P2|Period 2|Lack of Efficacy|1
7526092|NCT02771210|26144791|P1|Period 2|Lack of Efficacy|0
7526093|NCT02771210|26144790|P2|Period 2|Adverse Event|0
7526094|NCT02771210|26144791|P1|Period 2|Adverse Event|1
7526095|NCT02771210|26144790|P2|Period 1|Withdrawal of informed consent|5
7526096|NCT02771210|26144791|P1|Period 1|Withdrawal of informed consent|1
7526097|NCT02771210|26144790|P2|Period 1|Withdrawal by Subject|3
7526098|NCT02771210|26144791|P1|Period 1|Withdrawal by Subject|0
7526099|NCT02771210|26144790|P2|Period 1|Physician Decision|1
7526100|NCT02771210|26144791|P1|Period 1|Physician Decision|0
7526101|NCT02771210|26144790|P2|Period 1|Lost to Follow-up|0
7526102|NCT02771210|26144791|P1|Period 1|Lost to Follow-up|2
7526103|NCT02771210|26144790|P2|Period 1|Lack of Efficacy|6
7526104|NCT02771210|26144791|P1|Period 1|Lack of Efficacy|3
7526105|NCT02771210|26144790|P2|Period 1|Adverse Event|3
7526106|NCT02771210|26144791|P1|Period 1|Adverse Event|5
7526107|NCT02771145|26144817|P1|Overall Study|Lost to Follow-up|1
7526108|NCT02771145|26144817|P1|Overall Study|Adverse Event|3
7526111|NCT02770612|26144957|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
7526112|NCT02770547|26144963|P2|Overall Study|Adverse Event|1
7526113|NCT02770547|26144964|P1|Overall Study|Adverse Event|0
7526114|NCT02770547|26144963|P2|Overall Study|Patient non-compliant|0
7526115|NCT02770547|26144964|P1|Overall Study|Patient non-compliant|1
7526116|NCT02770248|26145037|P2|Overall Study|Randomized in error, prior to treatment|1
7526117|NCT02770248|26145038|P1|Overall Study|Randomized in error, prior to treatment|0
7526118|NCT02770248|26145037|P2|Overall Study|Adverse Event|1
7526119|NCT02770248|26145038|P1|Overall Study|Adverse Event|0
7526120|NCT02770170|26145054|P4|Overall Study|due to disease worsening|1
7526121|NCT02770170|26145055|P3|Overall Study|due to disease worsening|0
7526122|NCT02770170|26145056|P2|Overall Study|due to disease worsening|0
7526123|NCT02770170|26145057|P1|Overall Study|due to disease worsening|0
7526124|NCT02770170|26145054|P4|Overall Study|Adverse Event|3
7526125|NCT02770170|26145055|P3|Overall Study|Adverse Event|5
7526126|NCT02770170|26145056|P2|Overall Study|Adverse Event|3
7526127|NCT02770170|26145057|P1|Overall Study|Adverse Event|4
7526128|NCT02770170|26145054|P4|Overall Study|Lack of Efficacy|1
7526129|NCT02770170|26145055|P3|Overall Study|Lack of Efficacy|0
7526130|NCT02770170|26145056|P2|Overall Study|Lack of Efficacy|0
7526131|NCT02770170|26145057|P1|Overall Study|Lack of Efficacy|2
7526132|NCT02770170|26145054|P4|Overall Study|due to pregnancy|0
7526133|NCT02770170|26145055|P3|Overall Study|due to pregnancy|0
7526134|NCT02770170|26145056|P2|Overall Study|due to pregnancy|0
7526135|NCT02770170|26145057|P1|Overall Study|due to pregnancy|1
7526136|NCT02770170|26145054|P4|Overall Study|Withdrawal by Subject|2
7526137|NCT02770170|26145055|P3|Overall Study|Withdrawal by Subject|0
7526138|NCT02770170|26145056|P2|Overall Study|Withdrawal by Subject|0
7526139|NCT02770170|26145057|P1|Overall Study|Withdrawal by Subject|0
7526140|NCT02769858|26145093|P1|Overall Study|Withdrawal by Subject|2
7526141|NCT02769624|26145104|P2|Overall Study|Lost to Follow-up|1
7526142|NCT02769624|26145105|P1|Overall Study|Lost to Follow-up|0
7526143|NCT02769481|26145123|P2|Overall Study|Undefined|1
7526144|NCT02769481|26145124|P1|Overall Study|Undefined|4
7526145|NCT02769481|26145123|P2|Overall Study|Death|1
7526146|NCT02769481|26145124|P1|Overall Study|Death|0
7526147|NCT02769481|26145123|P2|Overall Study|Terminated by Sponsor|0
7526148|NCT02769481|26145124|P1|Overall Study|Terminated by Sponsor|1
7526149|NCT02769481|26145123|P2|Overall Study|Physician Decision|1
7526150|NCT02769481|26145124|P1|Overall Study|Physician Decision|0
7526151|NCT02769481|26145123|P2|Overall Study|Lost to Follow-up|9
7526152|NCT02769481|26145124|P1|Overall Study|Lost to Follow-up|9
7526153|NCT02769481|26145123|P2|Overall Study|Withdrawal by Subject|16
7526154|NCT02769481|26145124|P1|Overall Study|Withdrawal by Subject|14
7526155|NCT02769481|26145123|P2|Overall Study|Entry Criteria Not Met|2
7526156|NCT02769481|26145124|P1|Overall Study|Entry Criteria Not Met|1
7526157|NCT02769481|26145123|P2|Overall Study|Adverse Event|6
7526158|NCT02769481|26145124|P1|Overall Study|Adverse Event|3
7526159|NCT02769481|26145123|P2|Overall Study|Protocol Violation|0
7526160|NCT02769481|26145124|P1|Overall Study|Protocol Violation|1
7526161|NCT02769312|26145159|P2|Follow-up|Lost to Follow-up|1
7526162|NCT02769312|26145160|P1|Follow-up|Lost to Follow-up|1
7526163|NCT02769312|26145159|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
7526164|NCT02769312|26145160|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
7526165|NCT02769312|26145159|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
7526166|NCT02769312|26145160|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
7526167|NCT02769312|26145159|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
7526168|NCT02769312|26145160|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
7526169|NCT02769312|26145159|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7526170|NCT02769312|26145160|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7526171|NCT02769247|26145177|P4|Overall Study|Physician Decision|0
7526172|NCT02769247|26145178|P3|Overall Study|Physician Decision|0
7526173|NCT02769247|26145179|P2|Overall Study|Physician Decision|0
7526174|NCT02769247|26145180|P1|Overall Study|Physician Decision|1
7526175|NCT02769247|26145177|P4|Overall Study|Protocol Violation|0
7526176|NCT02769247|26145178|P3|Overall Study|Protocol Violation|1
7526177|NCT02769247|26145179|P2|Overall Study|Protocol Violation|0
7526178|NCT02769247|26145180|P1|Overall Study|Protocol Violation|0
7526179|NCT02769247|26145177|P4|Overall Study|Withdrawal by Subject|1
7526180|NCT02769247|26145178|P3|Overall Study|Withdrawal by Subject|0
7526181|NCT02769247|26145179|P2|Overall Study|Withdrawal by Subject|0
7526182|NCT02769247|26145180|P1|Overall Study|Withdrawal by Subject|1
7526183|NCT02769065|26145248|P30|Overall Study|Pre-treatment Event/Adverse Event|0
7526184|NCT02769065|26145249|P29|Overall Study|Pre-treatment Event/Adverse Event|0
7526185|NCT02769065|26145250|P28|Overall Study|Pre-treatment Event/Adverse Event|0
7526186|NCT02769065|26145251|P27|Overall Study|Pre-treatment Event/Adverse Event|0
7526187|NCT02769065|26145252|P26|Overall Study|Pre-treatment Event/Adverse Event|0
7526188|NCT02769065|26145253|P25|Overall Study|Pre-treatment Event/Adverse Event|0
7526189|NCT02769065|26145254|P24|Overall Study|Pre-treatment Event/Adverse Event|0
7526190|NCT02769065|26145255|P23|Overall Study|Pre-treatment Event/Adverse Event|0
7526191|NCT02769065|26145256|P22|Overall Study|Pre-treatment Event/Adverse Event|0
7526192|NCT02769065|26145257|P21|Overall Study|Pre-treatment Event/Adverse Event|0
7526193|NCT02769065|26145258|P20|Overall Study|Pre-treatment Event/Adverse Event|0
7526194|NCT02769065|26145259|P19|Overall Study|Pre-treatment Event/Adverse Event|0
7526195|NCT02769065|26145260|P18|Overall Study|Pre-treatment Event/Adverse Event|0
7526196|NCT02769065|26145261|P17|Overall Study|Pre-treatment Event/Adverse Event|0
7526197|NCT02769065|26145262|P16|Overall Study|Pre-treatment Event/Adverse Event|0
7526198|NCT02769065|26145263|P15|Overall Study|Pre-treatment Event/Adverse Event|0
7526199|NCT02769065|26145264|P14|Overall Study|Pre-treatment Event/Adverse Event|0
7526200|NCT02769065|26145265|P13|Overall Study|Pre-treatment Event/Adverse Event|0
7526201|NCT02769065|26145266|P12|Overall Study|Pre-treatment Event/Adverse Event|0
7526202|NCT02769065|26145267|P11|Overall Study|Pre-treatment Event/Adverse Event|1
7526203|NCT02769065|26145268|P10|Overall Study|Pre-treatment Event/Adverse Event|0
7526204|NCT02769065|26145269|P9|Overall Study|Pre-treatment Event/Adverse Event|0
7526205|NCT02769065|26145270|P8|Overall Study|Pre-treatment Event/Adverse Event|0
7526206|NCT02769065|26145271|P7|Overall Study|Pre-treatment Event/Adverse Event|0
7526207|NCT02769065|26145272|P6|Overall Study|Pre-treatment Event/Adverse Event|0
7526208|NCT02769065|26145273|P5|Overall Study|Pre-treatment Event/Adverse Event|0
7526209|NCT02769065|26145274|P4|Overall Study|Pre-treatment Event/Adverse Event|0
7526210|NCT02769065|26145275|P3|Overall Study|Pre-treatment Event/Adverse Event|0
7526211|NCT02769065|26145276|P2|Overall Study|Pre-treatment Event/Adverse Event|0
7526212|NCT02769065|26145277|P1|Overall Study|Pre-treatment Event/Adverse Event|0
7526213|NCT02769065|26145248|P30|Overall Study|Reason Not Specified|0
7526214|NCT02769065|26145249|P29|Overall Study|Reason Not Specified|0
7526215|NCT02769065|26145250|P28|Overall Study|Reason Not Specified|0
7526216|NCT02769065|26145251|P27|Overall Study|Reason Not Specified|0
7526217|NCT02769065|26145252|P26|Overall Study|Reason Not Specified|0
7526218|NCT02769065|26145253|P25|Overall Study|Reason Not Specified|0
7526219|NCT02769065|26145254|P24|Overall Study|Reason Not Specified|0
7526220|NCT02769065|26145255|P23|Overall Study|Reason Not Specified|0
7526221|NCT02769065|26145256|P22|Overall Study|Reason Not Specified|0
7526222|NCT02769065|26145257|P21|Overall Study|Reason Not Specified|0
7526223|NCT02769065|26145258|P20|Overall Study|Reason Not Specified|0
7526224|NCT02769065|26145259|P19|Overall Study|Reason Not Specified|0
7526225|NCT02769065|26145260|P18|Overall Study|Reason Not Specified|0
7526226|NCT02769065|26145261|P17|Overall Study|Reason Not Specified|0
7526227|NCT02769065|26145262|P16|Overall Study|Reason Not Specified|0
7526228|NCT02769065|26145263|P15|Overall Study|Reason Not Specified|0
7526229|NCT02769065|26145264|P14|Overall Study|Reason Not Specified|0
7526230|NCT02769065|26145265|P13|Overall Study|Reason Not Specified|0
7526231|NCT02769065|26145266|P12|Overall Study|Reason Not Specified|0
7526232|NCT02769065|26145267|P11|Overall Study|Reason Not Specified|0
7526233|NCT02769065|26145268|P10|Overall Study|Reason Not Specified|0
7526234|NCT02769065|26145269|P9|Overall Study|Reason Not Specified|0
7526235|NCT02769065|26145270|P8|Overall Study|Reason Not Specified|0
7526236|NCT02769065|26145271|P7|Overall Study|Reason Not Specified|1
7526237|NCT02769065|26145272|P6|Overall Study|Reason Not Specified|0
7526238|NCT02769065|26145273|P5|Overall Study|Reason Not Specified|0
7526239|NCT02769065|26145274|P4|Overall Study|Reason Not Specified|0
7526240|NCT02769065|26145275|P3|Overall Study|Reason Not Specified|0
7526241|NCT02769065|26145276|P2|Overall Study|Reason Not Specified|0
7526242|NCT02769065|26145277|P1|Overall Study|Reason Not Specified|0
7526243|NCT02769065|26145248|P30|Overall Study|Voluntary Withdrawal|0
7526244|NCT02769065|26145249|P29|Overall Study|Voluntary Withdrawal|0
7526245|NCT02769065|26145250|P28|Overall Study|Voluntary Withdrawal|0
7526246|NCT02769065|26145251|P27|Overall Study|Voluntary Withdrawal|0
7526247|NCT02769065|26145252|P26|Overall Study|Voluntary Withdrawal|0
7526248|NCT02769065|26145253|P25|Overall Study|Voluntary Withdrawal|0
7526249|NCT02769065|26145254|P24|Overall Study|Voluntary Withdrawal|0
7526250|NCT02769065|26145255|P23|Overall Study|Voluntary Withdrawal|0
7526251|NCT02769065|26145256|P22|Overall Study|Voluntary Withdrawal|0
7526252|NCT02769065|26145257|P21|Overall Study|Voluntary Withdrawal|0
7526253|NCT02769065|26145258|P20|Overall Study|Voluntary Withdrawal|0
7526254|NCT02769065|26145259|P19|Overall Study|Voluntary Withdrawal|0
7526255|NCT02769065|26145260|P18|Overall Study|Voluntary Withdrawal|0
7526256|NCT02769065|26145261|P17|Overall Study|Voluntary Withdrawal|0
7526257|NCT02769065|26145262|P16|Overall Study|Voluntary Withdrawal|0
7526258|NCT02769065|26145263|P15|Overall Study|Voluntary Withdrawal|0
7526259|NCT02769065|26145264|P14|Overall Study|Voluntary Withdrawal|0
7526260|NCT02769065|26145265|P13|Overall Study|Voluntary Withdrawal|0
7526261|NCT02769065|26145266|P12|Overall Study|Voluntary Withdrawal|0
7526262|NCT02769065|26145267|P11|Overall Study|Voluntary Withdrawal|0
7526263|NCT02769065|26145268|P10|Overall Study|Voluntary Withdrawal|0
7526264|NCT02769065|26145269|P9|Overall Study|Voluntary Withdrawal|0
7526265|NCT02769065|26145270|P8|Overall Study|Voluntary Withdrawal|0
7526266|NCT02769065|26145271|P7|Overall Study|Voluntary Withdrawal|0
7526267|NCT02769065|26145272|P6|Overall Study|Voluntary Withdrawal|0
7526268|NCT02769065|26145273|P5|Overall Study|Voluntary Withdrawal|0
7526269|NCT02769065|26145274|P4|Overall Study|Voluntary Withdrawal|0
7526270|NCT02769065|26145275|P3|Overall Study|Voluntary Withdrawal|0
7526271|NCT02769065|26145276|P2|Overall Study|Voluntary Withdrawal|0
7526272|NCT02769065|26145277|P1|Overall Study|Voluntary Withdrawal|1
7526273|NCT02768870|26145687|P1|Overall Study|On Study|19
7526274|NCT02768870|26145687|P1|Overall Study|Reoperation|4
7526275|NCT02768870|26145687|P1|Overall Study|Death|1
7526276|NCT02768870|26145687|P1|Overall Study|Not Implanted with Device|2
7526277|NCT02768792|26145695|P1|Overall Study|Adverse Event|1
7526278|NCT02768298|26145740|P2|Overall Study|Withdrawal of informed consent|1
7526279|NCT02768298|26145741|P1|Overall Study|Withdrawal of informed consent|0
7526280|NCT02768298|26145740|P2|Overall Study|Subject/guardian decision|0
7526281|NCT02768298|26145741|P1|Overall Study|Subject/guardian decision|1
7526282|NCT02768298|26145740|P2|Overall Study|Non-compliance with study treatment|1
7526283|NCT02768298|26145741|P1|Overall Study|Non-compliance with study treatment|0
7526284|NCT02768298|26145740|P2|Overall Study|Death|1
7526285|NCT02768298|26145741|P1|Overall Study|Death|2
7526286|NCT02768298|26145740|P2|Overall Study|Adverse Event|4
7526287|NCT02768298|26145741|P1|Overall Study|Adverse Event|1
7526288|NCT02768194|26145755|P6|Period 3|Other (Reason not specified)|0
7526289|NCT02768194|26145756|P5|Period 3|Other (Reason not specified)|0
7526290|NCT02768194|26145757|P4|Period 3|Other (Reason not specified)|0
7526291|NCT02768194|26145758|P3|Period 3|Other (Reason not specified)|0
7526292|NCT02768194|26145759|P2|Period 3|Other (Reason not specified)|1
7526293|NCT02768194|26145760|P1|Period 3|Other (Reason not specified)|0
7526294|NCT02768194|26145755|P6|Period 2|Other (Reason not specified)|0
7526295|NCT02768194|26145756|P5|Period 2|Other (Reason not specified)|0
7526296|NCT02768194|26145757|P4|Period 2|Other (Reason not specified)|0
7526297|NCT02768194|26145758|P3|Period 2|Other (Reason not specified)|0
7526298|NCT02768194|26145759|P2|Period 2|Other (Reason not specified)|0
7526299|NCT02768194|26145760|P1|Period 2|Other (Reason not specified)|1
7526300|NCT02768194|26145755|P6|Period 1|Adverse Event|0
7526301|NCT02768194|26145756|P5|Period 1|Adverse Event|0
7526302|NCT02768194|26145757|P4|Period 1|Adverse Event|1
7526303|NCT02768194|26145758|P3|Period 1|Adverse Event|0
7526304|NCT02768194|26145759|P2|Period 1|Adverse Event|0
7526305|NCT02768194|26145760|P1|Period 1|Adverse Event|0
7526306|NCT02768103|26145782|P1|Overall Study|1 participant did not fit in the fMRI|1
7526307|NCT02767765|26145843|P1|Overall Study|Withdrawal by Subject|1
7526308|NCT02767765|26145843|P1|Overall Study|Non-Compliance|1
7526309|NCT02767765|26145843|P1|Overall Study|Investigator decision|1
7526310|NCT02767765|26145843|P1|Overall Study|Lost to Follow-up|2
7526311|NCT02767765|26145843|P1|Overall Study|Insufficient response|1
7526312|NCT02767765|26145843|P1|Overall Study|Death|1
7526313|NCT02767765|26145843|P1|Overall Study|Adverse Event|4
7526314|NCT02767323|26145898|P4|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
7526315|NCT02767323|26145899|P3|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7526316|NCT02767323|26145900|P2|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
7526317|NCT02767323|26145901|P1|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7526318|NCT02767323|26145898|P4|Overall Study|Withdrawal by Subject|0
7526319|NCT02767323|26145899|P3|Overall Study|Withdrawal by Subject|13
7526320|NCT02767323|26145900|P2|Overall Study|Withdrawal by Subject|5
7526321|NCT02767323|26145901|P1|Overall Study|Withdrawal by Subject|17
7526322|NCT02766777|26145992|P1|Overall Study|Withdrawal by Subject|4
7526323|NCT02766777|26145992|P1|Overall Study|Protocol Violation|1
7526324|NCT02766777|26145992|P1|Overall Study|Non-Compliance With Study Drug|1
7526325|NCT02766777|26145992|P1|Overall Study|Lost to Follow-up|16
7526326|NCT02766777|26145992|P1|Overall Study|Adverse Event|12
7526327|NCT02766608|26146017|P5|Overall Study|Administrative Reasons|0
7526328|NCT02766608|26146018|P4|Overall Study|Administrative Reasons|0
7526329|NCT02766608|26146019|P3|Overall Study|Administrative Reasons|1
7526330|NCT02766608|26146020|P2|Overall Study|Administrative Reasons|1
7526331|NCT02766608|26146021|P1|Overall Study|Administrative Reasons|3
7526332|NCT02766608|26146017|P5|Overall Study|Protocol Violation|1
7526333|NCT02766608|26146018|P4|Overall Study|Protocol Violation|0
7526334|NCT02766608|26146019|P3|Overall Study|Protocol Violation|4
7526335|NCT02766608|26146020|P2|Overall Study|Protocol Violation|4
7526336|NCT02766608|26146021|P1|Overall Study|Protocol Violation|0
7526337|NCT02766608|26146017|P5|Overall Study|Protocol disc criteria|0
7526338|NCT02766608|26146018|P4|Overall Study|Protocol disc criteria|0
7526339|NCT02766608|26146019|P3|Overall Study|Protocol disc criteria|4
7526340|NCT02766608|26146020|P2|Overall Study|Protocol disc criteria|3
7526341|NCT02766608|26146021|P1|Overall Study|Protocol disc criteria|3
7526342|NCT02766608|26146017|P5|Overall Study|Physician Decision|2
7526343|NCT02766608|26146018|P4|Overall Study|Physician Decision|1
7526344|NCT02766608|26146019|P3|Overall Study|Physician Decision|3
7526345|NCT02766608|26146020|P2|Overall Study|Physician Decision|2
7526346|NCT02766608|26146021|P1|Overall Study|Physician Decision|3
7526347|NCT02766608|26146017|P5|Overall Study|Lost to Follow-up|2
7526348|NCT02766608|26146018|P4|Overall Study|Lost to Follow-up|2
7526349|NCT02766608|26146019|P3|Overall Study|Lost to Follow-up|5
7526350|NCT02766608|26146020|P2|Overall Study|Lost to Follow-up|3
7526351|NCT02766608|26146021|P1|Overall Study|Lost to Follow-up|6
7526352|NCT02766608|26146017|P5|Overall Study|Lack of Efficacy|2
7526353|NCT02766608|26146018|P4|Overall Study|Lack of Efficacy|8
7526354|NCT02766608|26146019|P3|Overall Study|Lack of Efficacy|32
7526355|NCT02766608|26146020|P2|Overall Study|Lack of Efficacy|15
7526356|NCT02766608|26146021|P1|Overall Study|Lack of Efficacy|16
7526357|NCT02766608|26146017|P5|Overall Study|Withdrawal by Subject|10
7526358|NCT02766608|26146018|P4|Overall Study|Withdrawal by Subject|13
7526359|NCT02766608|26146019|P3|Overall Study|Withdrawal by Subject|24
7526360|NCT02766608|26146020|P2|Overall Study|Withdrawal by Subject|20
7526361|NCT02766608|26146021|P1|Overall Study|Withdrawal by Subject|21
7526362|NCT02766608|26146017|P5|Overall Study|Adverse Event|12
7526363|NCT02766608|26146018|P4|Overall Study|Adverse Event|13
7526364|NCT02766608|26146019|P3|Overall Study|Adverse Event|17
7526365|NCT02766608|26146020|P2|Overall Study|Adverse Event|22
7526366|NCT02766608|26146021|P1|Overall Study|Adverse Event|27
7526367|NCT02766400|26146113|P2|Overall Study|Withdrawal by Subject|0
7526368|NCT02766400|26146114|P1|Overall Study|Withdrawal by Subject|1
7526369|NCT02766400|26146113|P2|Overall Study|Death|2
7526370|NCT02766400|26146114|P1|Overall Study|Death|1
7526371|NCT02766283|26146129|P1|Overall Study|Lost to Follow-up|27
7526372|NCT02766088|26146162|P1|Overall Study|Death|1
7526373|NCT02766088|26146162|P1|Overall Study|Other|1
7526374|NCT02766088|26146162|P1|Overall Study|Lost to Follow-up|5
7526375|NCT02766088|26146162|P1|Overall Study|Migrated/moved from the study area|1
7526376|NCT02766088|26146162|P1|Overall Study|Sponsor study termination|498
7526377|NCT02766023|26146177|P2|Overall Study|Not Eligible at Enrollment|1
7526378|NCT02766023|26146178|P1|Overall Study|Not Eligible at Enrollment|0
7526379|NCT02766023|26146177|P2|Overall Study|Physician Decision|0
7526380|NCT02766023|26146178|P1|Overall Study|Physician Decision|1
7526381|NCT02766023|26146177|P2|Overall Study|Withdrawal by Subject|5
7526382|NCT02766023|26146178|P1|Overall Study|Withdrawal by Subject|4
7526383|NCT02766023|26146177|P2|Overall Study|Adverse Event|0
7526384|NCT02766023|26146178|P1|Overall Study|Adverse Event|1
7526385|NCT02766023|26146177|P2|Overall Study|Pregnancy|0
7526386|NCT02766023|26146178|P1|Overall Study|Pregnancy|1
7526387|NCT02766023|26146177|P2|Overall Study|Lost to Follow-up|11
7526388|NCT02766023|26146178|P1|Overall Study|Lost to Follow-up|23
7526389|NCT02765490|26146228|P2|Overall Study|Death|1
7526390|NCT02765490|26146229|P1|Overall Study|Death|0
7526391|NCT02765490|26146228|P2|Overall Study|Other|1
7526392|NCT02765490|26146229|P1|Overall Study|Other|0
7526393|NCT02765490|26146228|P2|Overall Study|Lost to Follow-up|1
7526394|NCT02765490|26146229|P1|Overall Study|Lost to Follow-up|1
7526395|NCT02765165|26146282|P7|Post-treatment Follow-up|Study terminated by the sponsor|1
7526396|NCT02765165|26146283|P6|Post-treatment Follow-up|Study terminated by the sponsor|2
7526397|NCT02765165|26146284|P5|Post-treatment Follow-up|Study terminated by the sponsor|2
7526398|NCT02765165|26146285|P4|Post-treatment Follow-up|Study terminated by the sponsor|0
7526399|NCT02765165|26146286|P3|Post-treatment Follow-up|Study terminated by the sponsor|0
7526400|NCT02765165|26146287|P2|Post-treatment Follow-up|Study terminated by the sponsor|0
7526401|NCT02765165|26146288|P1|Post-treatment Follow-up|Study terminated by the sponsor|0
7526402|NCT02765165|26146282|P7|Post-treatment Follow-up|Withdrawal by Subject|0
7526403|NCT02765165|26146283|P6|Post-treatment Follow-up|Withdrawal by Subject|0
7526404|NCT02765165|26146284|P5|Post-treatment Follow-up|Withdrawal by Subject|0
7526405|NCT02765165|26146285|P4|Post-treatment Follow-up|Withdrawal by Subject|0
7526406|NCT02765165|26146286|P3|Post-treatment Follow-up|Withdrawal by Subject|0
7526407|NCT02765165|26146287|P2|Post-treatment Follow-up|Withdrawal by Subject|1
7526408|NCT02765165|26146288|P1|Post-treatment Follow-up|Withdrawal by Subject|0
7526409|NCT02765165|26146282|P7|Post-treatment Follow-up|Initiation of subsequent treatment|0
7526410|NCT02765165|26146283|P6|Post-treatment Follow-up|Initiation of subsequent treatment|0
7526411|NCT02765165|26146284|P5|Post-treatment Follow-up|Initiation of subsequent treatment|0
7526412|NCT02765165|26146285|P4|Post-treatment Follow-up|Initiation of subsequent treatment|1
7526413|NCT02765165|26146286|P3|Post-treatment Follow-up|Initiation of subsequent treatment|1
7526414|NCT02765165|26146287|P2|Post-treatment Follow-up|Initiation of subsequent treatment|0
7526415|NCT02765165|26146288|P1|Post-treatment Follow-up|Initiation of subsequent treatment|0
7526416|NCT02765165|26146282|P7|Post-treatment Follow-up|Site terminated by sponsor|0
7526417|NCT02765165|26146283|P6|Post-treatment Follow-up|Site terminated by sponsor|0
7526418|NCT02765165|26146284|P5|Post-treatment Follow-up|Site terminated by sponsor|0
7526419|NCT02765165|26146285|P4|Post-treatment Follow-up|Site terminated by sponsor|0
7526420|NCT02765165|26146286|P3|Post-treatment Follow-up|Site terminated by sponsor|1
7526421|NCT02765165|26146287|P2|Post-treatment Follow-up|Site terminated by sponsor|0
7526422|NCT02765165|26146288|P1|Post-treatment Follow-up|Site terminated by sponsor|0
7526423|NCT02765165|26146282|P7|Post-treatment Follow-up|Lost to Follow-up|0
7526424|NCT02765165|26146283|P6|Post-treatment Follow-up|Lost to Follow-up|0
7526425|NCT02765165|26146284|P5|Post-treatment Follow-up|Lost to Follow-up|0
7526426|NCT02765165|26146285|P4|Post-treatment Follow-up|Lost to Follow-up|1
7526427|NCT02765165|26146286|P3|Post-treatment Follow-up|Lost to Follow-up|0
7526428|NCT02765165|26146287|P2|Post-treatment Follow-up|Lost to Follow-up|0
7526429|NCT02765165|26146288|P1|Post-treatment Follow-up|Lost to Follow-up|0
7526430|NCT02765165|26146282|P7|Post-treatment Follow-up|Death|0
7526431|NCT02765165|26146283|P6|Post-treatment Follow-up|Death|1
7526432|NCT02765165|26146284|P5|Post-treatment Follow-up|Death|1
7526433|NCT02765165|26146285|P4|Post-treatment Follow-up|Death|1
7526434|NCT02765165|26146286|P3|Post-treatment Follow-up|Death|1
7526435|NCT02765165|26146287|P2|Post-treatment Follow-up|Death|2
7526436|NCT02765165|26146288|P1|Post-treatment Follow-up|Death|1
7526437|NCT02765165|26146282|P7|Treatment Period|Study terminated|2
7526438|NCT02765165|26146283|P6|Treatment Period|Study terminated|1
7526439|NCT02765165|26146284|P5|Treatment Period|Study terminated|0
7526440|NCT02765165|26146285|P4|Treatment Period|Study terminated|0
7526441|NCT02765165|26146286|P3|Treatment Period|Study terminated|0
7526442|NCT02765165|26146287|P2|Treatment Period|Study terminated|0
7526443|NCT02765165|26146288|P1|Treatment Period|Study terminated|0
7526444|NCT02765165|26146282|P7|Treatment Period|Withdrawal by Subject|0
7526445|NCT02765165|26146283|P6|Treatment Period|Withdrawal by Subject|0
7526446|NCT02765165|26146284|P5|Treatment Period|Withdrawal by Subject|2
7526447|NCT02765165|26146285|P4|Treatment Period|Withdrawal by Subject|0
7526448|NCT02765165|26146286|P3|Treatment Period|Withdrawal by Subject|0
7526449|NCT02765165|26146287|P2|Treatment Period|Withdrawal by Subject|0
7526450|NCT02765165|26146288|P1|Treatment Period|Withdrawal by Subject|0
7526451|NCT02765165|26146282|P7|Treatment Period|Adverse Event|0
7526452|NCT02765165|26146283|P6|Treatment Period|Adverse Event|0
7526453|NCT02765165|26146284|P5|Treatment Period|Adverse Event|0
7526454|NCT02765165|26146285|P4|Treatment Period|Adverse Event|0
7526455|NCT02765165|26146286|P3|Treatment Period|Adverse Event|0
7526456|NCT02765165|26146287|P2|Treatment Period|Adverse Event|1
7526457|NCT02765165|26146288|P1|Treatment Period|Adverse Event|0
7526458|NCT02765165|26146282|P7|Treatment Period|Physician Decision|0
7526459|NCT02765165|26146283|P6|Treatment Period|Physician Decision|0
7526460|NCT02765165|26146284|P5|Treatment Period|Physician Decision|0
7526461|NCT02765165|26146285|P4|Treatment Period|Physician Decision|0
7526462|NCT02765165|26146286|P3|Treatment Period|Physician Decision|0
7526463|NCT02765165|26146287|P2|Treatment Period|Physician Decision|1
7526464|NCT02765165|26146288|P1|Treatment Period|Physician Decision|0
7526465|NCT02765165|26146282|P7|Treatment Period|Progressive disease|2
7526466|NCT02765165|26146283|P6|Treatment Period|Progressive disease|2
7526467|NCT02765165|26146284|P5|Treatment Period|Progressive disease|4
7526468|NCT02765165|26146285|P4|Treatment Period|Progressive disease|3
7526469|NCT02765165|26146286|P3|Treatment Period|Progressive disease|3
7526470|NCT02765165|26146287|P2|Treatment Period|Progressive disease|2
7526471|NCT02765165|26146288|P1|Treatment Period|Progressive disease|3
7526472|NCT02765100|26146329|P2|Overall Study|Lost to Follow-up|1
7526473|NCT02765100|26146330|P1|Overall Study|Lost to Follow-up|0
7526474|NCT02765100|26146329|P2|Overall Study|subject found ineligible after baseline|1
7526475|NCT02765100|26146330|P1|Overall Study|subject found ineligible after baseline|1
7526476|NCT02765035|26146338|P2|Second Intervention (30 Days)|Protocol Violation|2
7526477|NCT02765035|26146339|P1|Second Intervention (30 Days)|Protocol Violation|2
7526478|NCT02765035|26146338|P2|First Intervention (90 Days)|Adverse Event|1
7526479|NCT02765035|26146339|P1|First Intervention (90 Days)|Adverse Event|1
7526480|NCT02764775|26146377|P1|Overall Study|Withdrawal by Subject|3
7526481|NCT02764775|26146377|P1|Overall Study|Lost to Follow-up|2
7526482|NCT02764775|26146377|P1|Overall Study|Death|1
7526483|NCT02764697|26146381|P1|Overall Study|Lack of Efficacy|3
7526484|NCT02764229|26146397|P1|Overall Study|Study Stopped by Sponsor|69
7526485|NCT02764229|26146397|P1|Overall Study|Lack of Efficacy|1
7526486|NCT02764229|26146397|P1|Overall Study|Lost to Follow-up|3
7526487|NCT02764229|26146397|P1|Overall Study|Physician Decision|5
7526488|NCT02764229|26146397|P1|Overall Study|Adverse Event|9
7526489|NCT02764229|26146397|P1|Overall Study|Withdrawal by Subject|15
7526490|NCT02764190|26146403|P2|Overall Study|Lost to Follow-up|13
7526491|NCT02764190|26146404|P1|Overall Study|Lost to Follow-up|17
7526492|NCT02764151|26146458|P4|Overall Study|Other|2
7526493|NCT02764151|26146459|P3|Overall Study|Other|0
7526494|NCT02764151|26146460|P2|Overall Study|Other|0
7526495|NCT02764151|26146461|P1|Overall Study|Other|0
7526496|NCT02764151|26146458|P4|Overall Study|Subject refused further follow-up|1
7526497|NCT02764151|26146459|P3|Overall Study|Subject refused further follow-up|0
7526498|NCT02764151|26146460|P2|Overall Study|Subject refused further follow-up|0
7526499|NCT02764151|26146461|P1|Overall Study|Subject refused further follow-up|0
7526500|NCT02763644|26146632|P2|Overall Study|Adverse Event|1
7526501|NCT02763644|26146633|P1|Overall Study|Adverse Event|1
7526502|NCT02763644|26146632|P2|Overall Study|Death|1
7526503|NCT02763644|26146633|P1|Overall Study|Death|1
7526504|NCT02763644|26146632|P2|Overall Study|Patient/guardian decision|0
7526505|NCT02763644|26146633|P1|Overall Study|Patient/guardian decision|1
7526506|NCT02763579|26146653|P2|Overall Study|On-going in study|60
7526507|NCT02763579|26146654|P1|Overall Study|On-going in study|77
7526508|NCT02763579|26146653|P2|Overall Study|Physician Decision|0
7526509|NCT02763579|26146654|P1|Overall Study|Physician Decision|2
7526510|NCT02763579|26146653|P2|Overall Study|Withdrawal by Subject|9
7526511|NCT02763579|26146654|P1|Overall Study|Withdrawal by Subject|18
7526512|NCT02763579|26146653|P2|Overall Study|Lost to Follow-up|1
7526513|NCT02763579|26146654|P1|Overall Study|Lost to Follow-up|3
7526514|NCT02763579|26146653|P2|Overall Study|Death|132
7526515|NCT02763579|26146654|P1|Overall Study|Death|101
7526528|NCT02763254|26146697|P1|Overall Study|Adverse Event|1
7526529|NCT02763215|26146702|P1|Overall Study|Lost to Follow-up|1
7526530|NCT02763215|26146702|P1|Overall Study|Death|1
7526531|NCT02763215|26146702|P1|Overall Study|Visit outside visit-window|1
7526532|NCT02763215|26146702|P1|Overall Study|Missed visit|1
7526533|NCT02763215|26146702|P1|Overall Study|Participants withdrew from study|3
7526534|NCT02763189|26146725|P2|Overall Study|Device failure|2
7526535|NCT02763189|26146726|P1|Overall Study|Device failure|0
7526536|NCT02763046|26146744|P3|Overall Study|Subject/guardian decision|4
7526537|NCT02763046|26146745|P2|Overall Study|Subject/guardian decision|0
7526538|NCT02763046|26146746|P1|Overall Study|Subject/guardian decision|2
7526539|NCT02763046|26146744|P3|Overall Study|Physician Decision|1
7526540|NCT02763046|26146745|P2|Overall Study|Physician Decision|0
7526541|NCT02763046|26146746|P1|Overall Study|Physician Decision|1
7526542|NCT02763046|26146744|P3|Overall Study|Lack of Efficacy|3
7526543|NCT02763046|26146745|P2|Overall Study|Lack of Efficacy|1
7526544|NCT02763046|26146746|P1|Overall Study|Lack of Efficacy|1
7526545|NCT02763046|26146744|P3|Overall Study|Adverse Event|0
7526546|NCT02763046|26146745|P2|Overall Study|Adverse Event|4
7526547|NCT02763046|26146746|P1|Overall Study|Adverse Event|5
7526548|NCT02762994|26146777|P4|Overall Study|Protocol Violation|2
7526549|NCT02762994|26146778|P3|Overall Study|Protocol Violation|0
7526550|NCT02762994|26146779|P2|Overall Study|Protocol Violation|0
7526551|NCT02762994|26146780|P1|Overall Study|Protocol Violation|1
7526552|NCT02762994|26146777|P4|Overall Study|Withdrawal by Subject|0
7526553|NCT02762994|26146778|P3|Overall Study|Withdrawal by Subject|2
7526554|NCT02762994|26146779|P2|Overall Study|Withdrawal by Subject|1
7526555|NCT02762994|26146780|P1|Overall Study|Withdrawal by Subject|0
7526556|NCT02762578|26146931|P2|Overall Study|Unclassified|0
7526557|NCT02762578|26146932|P1|Overall Study|Unclassified|6
7526558|NCT02762578|26146931|P2|Overall Study|Withdrawal by Subject|2
7526559|NCT02762578|26146932|P1|Overall Study|Withdrawal by Subject|4
7526560|NCT02762578|26146931|P2|Overall Study|Protocol Violation|2
7526561|NCT02762578|26146932|P1|Overall Study|Protocol Violation|4
7526562|NCT02762578|26146931|P2|Overall Study|Adverse Event|6
7526563|NCT02762578|26146932|P1|Overall Study|Adverse Event|1
7526564|NCT02762565|26147032|P1|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
7526565|NCT02762500|26147048|P2|Overall Study|Adverse Event|2
7526566|NCT02762500|26147049|P1|Overall Study|Adverse Event|0
7526567|NCT02762500|26147048|P2|Overall Study|Withdrawal by Subject|1
7526568|NCT02762500|26147049|P1|Overall Study|Withdrawal by Subject|1
7526569|NCT02762500|26147048|P2|Overall Study|Lack of Efficacy|0
7526570|NCT02762500|26147049|P1|Overall Study|Lack of Efficacy|1
7526571|NCT02762370|26147069|P2|Overall Study|Protocol Violation|0
7526572|NCT02762370|26147070|P1|Overall Study|Protocol Violation|1
7526573|NCT02762084|26147110|P3|Overall Study|Adverse Event|1
7526574|NCT02762084|26147111|P2|Overall Study|Adverse Event|0
7526575|NCT02762084|26147112|P1|Overall Study|Adverse Event|0
7526576|NCT02762084|26147110|P3|Overall Study|Withdrawal by Subject|0
7526577|NCT02762084|26147111|P2|Overall Study|Withdrawal by Subject|0
7526578|NCT02762084|26147112|P1|Overall Study|Withdrawal by Subject|1
7526579|NCT02761993|26147172|P3|Overall Study|Withdrawal by Subject|2
7526580|NCT02761993|26147173|P2|Overall Study|Withdrawal by Subject|1
7526581|NCT02761993|26147174|P1|Overall Study|Withdrawal by Subject|1
7526582|NCT02761993|26147172|P3|Overall Study|Lost to Follow-up|2
7526583|NCT02761993|26147173|P2|Overall Study|Lost to Follow-up|3
7526584|NCT02761993|26147174|P1|Overall Study|Lost to Follow-up|1
7526585|NCT02761993|26147172|P3|Overall Study|Adverse Event|0
7526586|NCT02761993|26147173|P2|Overall Study|Adverse Event|2
7526587|NCT02761993|26147174|P1|Overall Study|Adverse Event|0
7526588|NCT02761980|26147192|P4|Overall Study|Other|0
7526589|NCT02761980|26147193|P3|Overall Study|Other|1
7526590|NCT02761980|26147194|P2|Overall Study|Other|0
7526591|NCT02761980|26147195|P1|Overall Study|Other|0
7526592|NCT02761980|26147192|P4|Overall Study|Withdrawal by Subject|0
7526593|NCT02761980|26147193|P3|Overall Study|Withdrawal by Subject|0
7526594|NCT02761980|26147194|P2|Overall Study|Withdrawal by Subject|1
7526595|NCT02761980|26147195|P1|Overall Study|Withdrawal by Subject|0
7526596|NCT02761980|26147192|P4|Overall Study|Adverse Event|6
7526597|NCT02761980|26147193|P3|Overall Study|Adverse Event|5
7526598|NCT02761980|26147194|P2|Overall Study|Adverse Event|6
7526599|NCT02761980|26147195|P1|Overall Study|Adverse Event|4
7526600|NCT02761915|26147244|P6|Overall Study|Disease Progression|2
7526601|NCT02761915|26147245|P5|Overall Study|Disease Progression|2
7526602|NCT02761915|26147246|P4|Overall Study|Disease Progression|2
7526603|NCT02761915|26147247|P3|Overall Study|Disease Progression|0
7526604|NCT02761915|26147248|P2|Overall Study|Disease Progression|0
7526605|NCT02761915|26147249|P1|Overall Study|Disease Progression|0
7526606|NCT02761915|26147244|P6|Overall Study|Withdrawal by Subject|2
7526607|NCT02761915|26147245|P5|Overall Study|Withdrawal by Subject|1
7526608|NCT02761915|26147246|P4|Overall Study|Withdrawal by Subject|0
7526609|NCT02761915|26147247|P3|Overall Study|Withdrawal by Subject|0
7526610|NCT02761915|26147248|P2|Overall Study|Withdrawal by Subject|0
7526611|NCT02761915|26147249|P1|Overall Study|Withdrawal by Subject|1
7526612|NCT02761915|26147244|P6|Overall Study|Death|1
7526613|NCT02761915|26147245|P5|Overall Study|Death|0
7526614|NCT02761915|26147246|P4|Overall Study|Death|1
7526615|NCT02761915|26147247|P3|Overall Study|Death|1
7526616|NCT02761915|26147248|P2|Overall Study|Death|1
7526617|NCT02761915|26147249|P1|Overall Study|Death|3
7526618|NCT02761733|26147306|P4|Overall Study|Cognitive Impairment|0
7526619|NCT02761733|26147307|P3|Overall Study|Cognitive Impairment|1
7526620|NCT02761733|26147308|P2|Overall Study|Cognitive Impairment|0
7526621|NCT02761733|26147309|P1|Overall Study|Cognitive Impairment|5
7526622|NCT02761733|26147306|P4|Overall Study|Discharged from Study Site|11
7526623|NCT02761733|26147307|P3|Overall Study|Discharged from Study Site|25
7526624|NCT02761733|26147308|P2|Overall Study|Discharged from Study Site|9
7526625|NCT02761733|26147309|P1|Overall Study|Discharged from Study Site|10
7526626|NCT02761733|26147306|P4|Overall Study|Withdrawal by Subject|0
7526627|NCT02761733|26147307|P3|Overall Study|Withdrawal by Subject|0
7526628|NCT02761733|26147308|P2|Overall Study|Withdrawal by Subject|0
7526629|NCT02761733|26147309|P1|Overall Study|Withdrawal by Subject|2
7526630|NCT02761733|26147306|P4|Overall Study|Physician Decision|0
7526631|NCT02761733|26147307|P3|Overall Study|Physician Decision|0
7526632|NCT02761733|26147308|P2|Overall Study|Physician Decision|0
7526633|NCT02761733|26147309|P1|Overall Study|Physician Decision|4
7526634|NCT02761733|26147306|P4|Overall Study|Lost to Follow-up|3
7526635|NCT02761733|26147307|P3|Overall Study|Lost to Follow-up|0
7526636|NCT02761733|26147308|P2|Overall Study|Lost to Follow-up|7
7526637|NCT02761733|26147309|P1|Overall Study|Lost to Follow-up|6
7526638|NCT02761733|26147306|P4|Overall Study|Death|1
7526639|NCT02761733|26147307|P3|Overall Study|Death|1
7526640|NCT02761733|26147308|P2|Overall Study|Death|5
7526641|NCT02761733|26147309|P1|Overall Study|Death|3
7526642|NCT02761642|26147339|P1|Overall Study|Reason Unspecified|21
7526643|NCT02761642|26147339|P1|Overall Study|Physician Decision|1
7526644|NCT02761642|26147339|P1|Overall Study|Lack of Efficacy|20
7526645|NCT02761642|26147339|P1|Overall Study|Death|3
7526646|NCT02761642|26147339|P1|Overall Study|Non-compliant|7
7526647|NCT02761642|26147339|P1|Overall Study|Withdrawal by Subject|2
7526648|NCT02761642|26147339|P1|Overall Study|Adverse Event|13
7526649|NCT02761642|26147339|P1|Overall Study|Did not Receive Study Treatment|3
7526650|NCT02761629|26147352|P2|Overall Study|Randomized But Not Treated|4
7526651|NCT02761629|26147353|P1|Overall Study|Randomized But Not Treated|8
7526652|NCT02761629|26147352|P2|Overall Study|Lost to Follow-up|1
7526653|NCT02761629|26147353|P1|Overall Study|Lost to Follow-up|4
7526654|NCT02761629|26147352|P2|Overall Study|Other|2
7526655|NCT02761629|26147353|P1|Overall Study|Other|0
7526656|NCT02761629|26147352|P2|Overall Study|Withdrawal by Subject|3
7526657|NCT02761629|26147353|P1|Overall Study|Withdrawal by Subject|0
7526658|NCT02761629|26147352|P2|Overall Study|Protocol Violation|2
7526659|NCT02761629|26147353|P1|Overall Study|Protocol Violation|2
7526660|NCT02761629|26147352|P2|Overall Study|Did not Cooperate/Refused Treatment|4
7526661|NCT02761629|26147353|P1|Overall Study|Did not Cooperate/Refused Treatment|2
7526662|NCT02761629|26147352|P2|Overall Study|Failure to Return|4
7526663|NCT02761629|26147353|P1|Overall Study|Failure to Return|2
7526664|NCT02761629|26147352|P2|Overall Study|Insufficient Therapeutic Response|7
7526665|NCT02761629|26147353|P1|Overall Study|Insufficient Therapeutic Response|2
7526666|NCT02761629|26147352|P2|Overall Study|Adverse Event/Intercurrent Illness|5
7526667|NCT02761629|26147353|P1|Overall Study|Adverse Event/Intercurrent Illness|7
7526668|NCT02761330|26147373|P6|Treatment Week 1|Withdrawal by Subject|1
7526669|NCT02761330|26147374|P5|Treatment Week 1|Withdrawal by Subject|0
7526670|NCT02761330|26147375|P4|Treatment Week 1|Withdrawal by Subject|1
7526671|NCT02761330|26147376|P3|Treatment Week 1|Withdrawal by Subject|0
7526672|NCT02761330|26147377|P2|Treatment Week 1|Withdrawal by Subject|0
7526673|NCT02761330|26147378|P1|Treatment Week 1|Withdrawal by Subject|0
7526674|NCT02760927|26147448|P1|Overall Study|Tube Slippage from Device|1
7526675|NCT02760810|26147465|P1|Overall Study|Protocol Violation|1
7526676|NCT02760654|26147473|P2|Overall Study|Withdrawal by Subject|3
7526677|NCT02760654|26147474|P1|Overall Study|Withdrawal by Subject|4
7526678|NCT02760654|26147473|P2|Overall Study|Lost to Follow-up|3
7526679|NCT02760654|26147474|P1|Overall Study|Lost to Follow-up|3
7526680|NCT02760602|26147500|P2|Overall Study|Terminated by sponsor|13
7526681|NCT02760602|26147501|P1|Overall Study|Terminated by sponsor|12
7526682|NCT02760602|26147500|P2|Overall Study|Withdrawal by Subject|0
7526683|NCT02760602|26147501|P1|Overall Study|Withdrawal by Subject|1
7526684|NCT02760433|26147544|P5|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7526685|NCT02760433|26147545|P4|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7526686|NCT02760433|26147546|P3|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7526687|NCT02760433|26147547|P2|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
7526688|NCT02760433|26147548|P1|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7526689|NCT02760433|26147544|P5|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7526690|NCT02760433|26147545|P4|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7526691|NCT02760433|26147546|P3|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7526692|NCT02760433|26147547|P2|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7526693|NCT02760433|26147548|P1|Overall Study|Subject was taking prohibited medications and refused to stop.|2
7526694|NCT02760433|26147544|P5|Overall Study|Subject refused to continue the study|0
7526695|NCT02760433|26147545|P4|Overall Study|Subject refused to continue the study|0
7526696|NCT02760433|26147546|P3|Overall Study|Subject refused to continue the study|0
7526697|NCT02760433|26147547|P2|Overall Study|Subject refused to continue the study|0
7526698|NCT02760433|26147548|P1|Overall Study|Subject refused to continue the study|1
7526699|NCT02760433|26147544|P5|Overall Study|Lack of Response At Week 14|1
7526700|NCT02760433|26147545|P4|Overall Study|Lack of Response At Week 14|0
7526701|NCT02760433|26147546|P3|Overall Study|Lack of Response At Week 14|0
7526702|NCT02760433|26147547|P2|Overall Study|Lack of Response At Week 14|0
7526703|NCT02760433|26147548|P1|Overall Study|Lack of Response At Week 14|0
7526704|NCT02760433|26147544|P5|Overall Study|Withdrawal by Subject|9
7526705|NCT02760433|26147545|P4|Overall Study|Withdrawal by Subject|2
7526706|NCT02760433|26147546|P3|Overall Study|Withdrawal by Subject|0
7526707|NCT02760433|26147547|P2|Overall Study|Withdrawal by Subject|9
7526708|NCT02760433|26147548|P1|Overall Study|Withdrawal by Subject|23
7526709|NCT02760433|26147544|P5|Overall Study|Lost to Follow-up|0
7526710|NCT02760433|26147545|P4|Overall Study|Lost to Follow-up|0
7526711|NCT02760433|26147546|P3|Overall Study|Lost to Follow-up|1
7526712|NCT02760433|26147547|P2|Overall Study|Lost to Follow-up|0
7526713|NCT02760433|26147548|P1|Overall Study|Lost to Follow-up|1
7526714|NCT02760407|26147577|P4|Overall Study|Investigator recorded as Adverse Event|0
7526715|NCT02760407|26147578|P3|Overall Study|Investigator recorded as Adverse Event|2
7526716|NCT02760407|26147579|P2|Overall Study|Investigator recorded as Adverse Event|0
7526717|NCT02760407|26147580|P1|Overall Study|Investigator recorded as Adverse Event|1
7526718|NCT02760407|26147577|P4|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7526719|NCT02760407|26147578|P3|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7526720|NCT02760407|26147579|P2|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7526721|NCT02760407|26147580|P1|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
7526722|NCT02760407|26147577|P4|Overall Study|Lack Of Efficacy Per PI|1
7526723|NCT02760407|26147578|P3|Overall Study|Lack Of Efficacy Per PI|0
7526724|NCT02760407|26147579|P2|Overall Study|Lack Of Efficacy Per PI|0
7526725|NCT02760407|26147580|P1|Overall Study|Lack Of Efficacy Per PI|0
7526726|NCT02760407|26147577|P4|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7526727|NCT02760407|26147578|P3|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7526728|NCT02760407|26147579|P2|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7526729|NCT02760407|26147580|P1|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
7526730|NCT02760407|26147577|P4|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7526731|NCT02760407|26147578|P3|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7526732|NCT02760407|26147579|P2|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7526733|NCT02760407|26147580|P1|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
7526734|NCT02760407|26147577|P4|Overall Study|Study Treatment Was Terminated At The Site|0
7526735|NCT02760407|26147578|P3|Overall Study|Study Treatment Was Terminated At The Site|1
7526736|NCT02760407|26147579|P2|Overall Study|Study Treatment Was Terminated At The Site|0
7526737|NCT02760407|26147580|P1|Overall Study|Study Treatment Was Terminated At The Site|0
7526738|NCT02760407|26147577|P4|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7526739|NCT02760407|26147578|P3|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7526740|NCT02760407|26147579|P2|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7526741|NCT02760407|26147580|P1|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
7526742|NCT02760407|26147577|P4|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7526743|NCT02760407|26147578|P3|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
7526744|NCT02760407|26147579|P2|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7526745|NCT02760407|26147580|P1|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7526746|NCT02760407|26147577|P4|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7526747|NCT02760407|26147578|P3|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7526748|NCT02760407|26147579|P2|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7526749|NCT02760407|26147580|P1|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7526750|NCT02760407|26147577|P4|Overall Study|Withdrawal By PI's Decision|0
7526751|NCT02760407|26147578|P3|Overall Study|Withdrawal By PI's Decision|0
7526752|NCT02760407|26147579|P2|Overall Study|Withdrawal By PI's Decision|1
7526753|NCT02760407|26147580|P1|Overall Study|Withdrawal By PI's Decision|0
7526754|NCT02760407|26147577|P4|Overall Study|Inadequately Enrolled|1
7526755|NCT02760407|26147578|P3|Overall Study|Inadequately Enrolled|0
7526756|NCT02760407|26147579|P2|Overall Study|Inadequately Enrolled|0
7526757|NCT02760407|26147580|P1|Overall Study|Inadequately Enrolled|0
7526758|NCT02760407|26147577|P4|Overall Study|Investigator's Decision (Adverse Event)|0
7526759|NCT02760407|26147578|P3|Overall Study|Investigator's Decision (Adverse Event)|0
7526760|NCT02760407|26147579|P2|Overall Study|Investigator's Decision (Adverse Event)|1
7526761|NCT02760407|26147580|P1|Overall Study|Investigator's Decision (Adverse Event)|0
7526762|NCT02760407|26147577|P4|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7526763|NCT02760407|26147578|P3|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7526764|NCT02760407|26147579|P2|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7526765|NCT02760407|26147580|P1|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
7526766|NCT02760407|26147577|P4|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7526767|NCT02760407|26147578|P3|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
7526768|NCT02760407|26147579|P2|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7526769|NCT02760407|26147580|P1|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7526770|NCT02760407|26147577|P4|Overall Study|Use of prohibited Medication|0
7526771|NCT02760407|26147578|P3|Overall Study|Use of prohibited Medication|1
7526772|NCT02760407|26147579|P2|Overall Study|Use of prohibited Medication|0
7526773|NCT02760407|26147580|P1|Overall Study|Use of prohibited Medication|0
7526774|NCT02760407|26147577|P4|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7526775|NCT02760407|26147578|P3|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7526776|NCT02760407|26147579|P2|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7526777|NCT02760407|26147580|P1|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
7526778|NCT02760407|26147577|P4|Overall Study|Personal reasons|1
7526779|NCT02760407|26147578|P3|Overall Study|Personal reasons|0
7526780|NCT02760407|26147579|P2|Overall Study|Personal reasons|0
7526781|NCT02760407|26147580|P1|Overall Study|Personal reasons|0
7526782|NCT02760407|26147577|P4|Overall Study|Violation of Eligibility criteria|1
7526783|NCT02760407|26147578|P3|Overall Study|Violation of Eligibility criteria|1
7526784|NCT02760407|26147579|P2|Overall Study|Violation of Eligibility criteria|0
7526785|NCT02760407|26147580|P1|Overall Study|Violation of Eligibility criteria|0
7526786|NCT02760407|26147577|P4|Overall Study|Withdrawal by Subject|25
7526787|NCT02760407|26147578|P3|Overall Study|Withdrawal by Subject|37
7526788|NCT02760407|26147579|P2|Overall Study|Withdrawal by Subject|31
7526789|NCT02760407|26147580|P1|Overall Study|Withdrawal by Subject|25
7526790|NCT02760407|26147577|P4|Overall Study|Lost to Follow-up|6
7526791|NCT02760407|26147578|P3|Overall Study|Lost to Follow-up|4
7526792|NCT02760407|26147579|P2|Overall Study|Lost to Follow-up|7
7526793|NCT02760407|26147580|P1|Overall Study|Lost to Follow-up|1
7526794|NCT02760407|26147577|P4|Overall Study|Death|1
7526795|NCT02760407|26147578|P3|Overall Study|Death|1
7526796|NCT02760407|26147579|P2|Overall Study|Death|3
7526797|NCT02760407|26147580|P1|Overall Study|Death|2
7526798|NCT02760368|26147617|P3|Overall Study|Withdrawal by Sponsor|1
7526799|NCT02760368|26147618|P2|Overall Study|Withdrawal by Sponsor|0
7526800|NCT02760368|26147619|P1|Overall Study|Withdrawal by Sponsor|0
7526801|NCT02760368|26147617|P3|Overall Study|Death|0
7526802|NCT02760368|26147618|P2|Overall Study|Death|0
7526803|NCT02760368|26147619|P1|Overall Study|Death|1
7526804|NCT02760368|26147617|P3|Overall Study|Screen Failure|1
7526805|NCT02760368|26147618|P2|Overall Study|Screen Failure|0
7526806|NCT02760368|26147619|P1|Overall Study|Screen Failure|0
7526807|NCT02760368|26147617|P3|Overall Study|Withdrawal by Subject|9
7526808|NCT02760368|26147618|P2|Overall Study|Withdrawal by Subject|8
7526809|NCT02760368|26147619|P1|Overall Study|Withdrawal by Subject|12
7526810|NCT02760069|26147801|P3|Overall Study|Withdrawal by Subject|1
7526811|NCT02760069|26147802|P2|Overall Study|Withdrawal by Subject|1
7526812|NCT02760069|26147803|P1|Overall Study|Withdrawal by Subject|0
7526813|NCT02759939|26147829|P4|Overall Study|Lost to Follow-up|650
7526814|NCT02759939|26147830|P3|Overall Study|Lost to Follow-up|783
7526815|NCT02759939|26147831|P2|Overall Study|Lost to Follow-up|791
7526816|NCT02759939|26147832|P1|Overall Study|Lost to Follow-up|735
7526817|NCT02759939|26147829|P4|Overall Study|Ineligible for T2 and T3|391
7526818|NCT02759939|26147830|P3|Overall Study|Ineligible for T2 and T3|366
7526819|NCT02759939|26147831|P2|Overall Study|Ineligible for T2 and T3|179
7526820|NCT02759939|26147832|P1|Overall Study|Ineligible for T2 and T3|310
7526821|NCT02759939|26147829|P4|Overall Study|Missing data on first outcome assessed|2
7526822|NCT02759939|26147830|P3|Overall Study|Missing data on first outcome assessed|5
7526823|NCT02759939|26147831|P2|Overall Study|Missing data on first outcome assessed|2
7526824|NCT02759939|26147832|P1|Overall Study|Missing data on first outcome assessed|11
7526825|NCT02759692|26147842|P2|Period 2|Test article no longer available|1
7526826|NCT02759692|26147843|P1|Period 2|Test article no longer available|0
7526827|NCT02759692|26147842|P2|Period 2|Lost to Follow-up|0
7526828|NCT02759692|26147843|P1|Period 2|Lost to Follow-up|1
7526829|NCT02759692|26147842|P2|Period 1|Miss-Randomized|1
7526830|NCT02759692|26147843|P1|Period 1|Miss-Randomized|1
7526831|NCT02759692|26147842|P2|Period 1|No longer meets eligibility criteria.|0
7526832|NCT02759692|26147843|P1|Period 1|No longer meets eligibility criteria.|1
7526833|NCT02759692|26147842|P2|Period 1|Test article no longer available|1
7526834|NCT02759692|26147843|P1|Period 1|Test article no longer available|1
7526835|NCT02759562|26147867|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
7526836|NCT02759562|26147868|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
7526837|NCT02759562|26147867|P2|Open-Label Treatment Period|Withdrew Consent|0
7526838|NCT02759562|26147868|P1|Open-Label Treatment Period|Withdrew Consent|1
7526839|NCT02759471|26147881|P1|Overall Study|discomfort|2
7526840|NCT02759315|26147937|P5|Overall Study|Study terminated prior to completion|1
7526841|NCT02759315|26147938|P4|Overall Study|Study terminated prior to completion|0
7526842|NCT02759315|26147939|P3|Overall Study|Study terminated prior to completion|5
7526843|NCT02759315|26147940|P2|Overall Study|Study terminated prior to completion|0
7526844|NCT02759315|26147941|P1|Overall Study|Study terminated prior to completion|2
7526845|NCT02759315|26147937|P5|Overall Study|Protocol Violation|0
7526846|NCT02759315|26147938|P4|Overall Study|Protocol Violation|0
7526847|NCT02759315|26147939|P3|Overall Study|Protocol Violation|0
7526848|NCT02759315|26147940|P2|Overall Study|Protocol Violation|1
7526849|NCT02759315|26147941|P1|Overall Study|Protocol Violation|0
7526850|NCT02759315|26147937|P5|Overall Study|Lost to Follow-up|0
7526851|NCT02759315|26147938|P4|Overall Study|Lost to Follow-up|0
7526852|NCT02759315|26147939|P3|Overall Study|Lost to Follow-up|4
7526853|NCT02759315|26147940|P2|Overall Study|Lost to Follow-up|0
7526854|NCT02759315|26147941|P1|Overall Study|Lost to Follow-up|2
7526855|NCT02759315|26147937|P5|Overall Study|Death|0
7526856|NCT02759315|26147938|P4|Overall Study|Death|0
7526857|NCT02759315|26147939|P3|Overall Study|Death|1
7526858|NCT02759315|26147940|P2|Overall Study|Death|0
7526859|NCT02759315|26147941|P1|Overall Study|Death|0
7526860|NCT02759315|26147937|P5|Overall Study|Adverse Event|0
7526861|NCT02759315|26147938|P4|Overall Study|Adverse Event|1
7526862|NCT02759315|26147939|P3|Overall Study|Adverse Event|0
7526863|NCT02759315|26147940|P2|Overall Study|Adverse Event|0
7526864|NCT02759315|26147941|P1|Overall Study|Adverse Event|0
7526865|NCT02759185|26147989|P4|Overall Study|Withdrawal by Subject|0
7526866|NCT02759185|26147990|P3|Overall Study|Withdrawal by Subject|0
7526867|NCT02759185|26147991|P2|Overall Study|Withdrawal by Subject|0
7526868|NCT02759185|26147992|P1|Overall Study|Withdrawal by Subject|1
7526869|NCT02759185|26147989|P4|Overall Study|Adverse Event|0
7526870|NCT02759185|26147990|P3|Overall Study|Adverse Event|2
7526871|NCT02759185|26147991|P2|Overall Study|Adverse Event|1
7526872|NCT02759185|26147992|P1|Overall Study|Adverse Event|0
7526873|NCT02759120|26148089|P2|Overall Study|Other reason not completed|12
7526874|NCT02759120|26148090|P1|Overall Study|Other reason not completed|10
7526875|NCT02759120|26148089|P2|Overall Study|Lung transplant|5
7526876|NCT02759120|26148090|P1|Overall Study|Lung transplant|3
7526877|NCT02759120|26148089|P2|Overall Study|Moved out of area|4
7526878|NCT02759120|26148090|P1|Overall Study|Moved out of area|3
7526879|NCT02759120|26148089|P2|Overall Study|Withdrawal by Subject|15
7526880|NCT02759120|26148090|P1|Overall Study|Withdrawal by Subject|28
7526881|NCT02759120|26148089|P2|Overall Study|Physician Decision|0
7526882|NCT02759120|26148090|P1|Overall Study|Physician Decision|3
7526883|NCT02759120|26148089|P2|Overall Study|Lost to Follow-up|7
7526884|NCT02759120|26148090|P1|Overall Study|Lost to Follow-up|4
7526885|NCT02759120|26148089|P2|Overall Study|Death|36
7526886|NCT02759120|26148090|P1|Overall Study|Death|34
7526887|NCT02759055|26148130|P2|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
7526888|NCT02759055|26148131|P1|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
7526889|NCT02759016|26148139|P2|Overall Study|Other not defined above|1
7526890|NCT02759016|26148140|P1|Overall Study|Other not defined above|2
7526891|NCT02759016|26148139|P2|Overall Study|SD, PR-MRDpos or PR-L|2
7526892|NCT02759016|26148140|P1|Overall Study|SD, PR-MRDpos or PR-L|0
7526893|NCT02759016|26148139|P2|Overall Study|Progressive disease|0
7526894|NCT02759016|26148140|P1|Overall Study|Progressive disease|1
7526895|NCT02759016|26148139|P2|Overall Study|Not treated with BI 836826|0
7526896|NCT02759016|26148140|P1|Overall Study|Not treated with BI 836826|1
7526897|NCT02758613|26148169|P4|Treatment|Withdrawal by Subject|0
7526898|NCT02758613|26148170|P3|Treatment|Withdrawal by Subject|1
7526899|NCT02758613|26148171|P2|Treatment|Withdrawal by Subject|0
7526900|NCT02758613|26148172|P1|Treatment|Withdrawal by Subject|1
7526901|NCT02758613|26148169|P4|Treatment|Physician and Sponsor Decision|0
7526902|NCT02758613|26148170|P3|Treatment|Physician and Sponsor Decision|0
7526903|NCT02758613|26148171|P2|Treatment|Physician and Sponsor Decision|0
7526904|NCT02758613|26148172|P1|Treatment|Physician and Sponsor Decision|1
7526905|NCT02758301|26148190|P2|Overall Study|Protocol Violation|1
7526906|NCT02758301|26148191|P1|Overall Study|Protocol Violation|0
7526907|NCT02758301|26148190|P2|Overall Study|Lost to Follow-up|0
7526908|NCT02758301|26148191|P1|Overall Study|Lost to Follow-up|7
7526909|NCT02758301|26148190|P2|Overall Study|Withdrawal by Subject|6
7526910|NCT02758301|26148191|P1|Overall Study|Withdrawal by Subject|5
7526911|NCT02758301|26148190|P2|Overall Study|Physician Decision|1
7526912|NCT02758301|26148191|P1|Overall Study|Physician Decision|10
7526913|NCT02758301|26148190|P2|Overall Study|Death|0
7526914|NCT02758301|26148191|P1|Overall Study|Death|12
7526915|NCT02758171|26148210|P2|Wash-out|Other reason|0
7526916|NCT02758171|26148211|P1|Wash-out|Other reason|1
7526917|NCT02758171|26148210|P2|Wash-out|Withdrawal by Subject|0
7526918|NCT02758171|26148211|P1|Wash-out|Withdrawal by Subject|1
7526919|NCT02757963|26148265|P1|Overall Study|Withdrawal by Subject|34
7526920|NCT02757963|26148265|P1|Overall Study|Physician Decision|1
7526921|NCT02757963|26148265|P1|Overall Study|Lost to Follow-up|5
7526922|NCT02757963|26148265|P1|Overall Study|Reached Stopping Criteria|1054
7526923|NCT02757963|26148265|P1|Overall Study|Adverse Event|3
7526924|NCT02757768|26148305|P2|Overall Study|Miscellaneous|2
7526925|NCT02757768|26148306|P1|Overall Study|Miscellaneous|4
7526926|NCT02757768|26148305|P2|Overall Study|Withdrawal by Subject|9
7526927|NCT02757768|26148306|P1|Overall Study|Withdrawal by Subject|16
7526928|NCT02757768|26148305|P2|Overall Study|Protocol Deviation|9
7526929|NCT02757768|26148306|P1|Overall Study|Protocol Deviation|2
7526930|NCT02757768|26148305|P2|Overall Study|Lost to Follow-up|0
7526931|NCT02757768|26148306|P1|Overall Study|Lost to Follow-up|1
7526932|NCT02757768|26148305|P2|Overall Study|Lack of Efficacy|1
7526933|NCT02757768|26148306|P1|Overall Study|Lack of Efficacy|2
7526934|NCT02757768|26148305|P2|Overall Study|Adverse Event|3
7526935|NCT02757768|26148306|P1|Overall Study|Adverse Event|5
7526936|NCT02757768|26148305|P2|Overall Study|Randomized Never Received Study Drug|4
7526937|NCT02757768|26148306|P1|Overall Study|Randomized Never Received Study Drug|3
7526938|NCT02757625|26148356|P4|Overall Study|Adverse Event|0
7526939|NCT02757625|26148357|P3|Overall Study|Adverse Event|1
7526940|NCT02757625|26148358|P2|Overall Study|Adverse Event|0
7526941|NCT02757625|26148359|P1|Overall Study|Adverse Event|0
7526942|NCT02757625|26148356|P4|Overall Study|Investigator's discretion|0
7526943|NCT02757625|26148357|P3|Overall Study|Investigator's discretion|1
7526944|NCT02757625|26148358|P2|Overall Study|Investigator's discretion|0
7526945|NCT02757625|26148359|P1|Overall Study|Investigator's discretion|0
7526946|NCT02757521|26148518|P2|Overall Study|Adverse Event|0
7526947|NCT02757521|26148519|P1|Overall Study|Adverse Event|1
7526948|NCT02757430|26148525|P1|Overall Study|No procedure performed|2
7526949|NCT02757430|26148525|P1|Overall Study|No informed consent|1
7526950|NCT02757430|26148525|P1|Overall Study|Inclusion/Exclusion criteria not met|3
7526951|NCT02757430|26148525|P1|Overall Study|Physician Decision|6
7526952|NCT02757352|26148544|P10|Follow-Up Period|Withdrawal by Subject|2
7526953|NCT02757352|26148545|P9|Follow-Up Period|Withdrawal by Subject|6
7526954|NCT02757352|26148546|P8|Follow-Up Period|Withdrawal by Subject|1
7526955|NCT02757352|26148547|P7|Follow-Up Period|Withdrawal by Subject|0
7526956|NCT02757352|26148548|P6|Follow-Up Period|Withdrawal by Subject|0
7526957|NCT02757352|26148549|P5|Follow-Up Period|Withdrawal by Subject|0
7526958|NCT02757352|26148550|P4|Follow-Up Period|Withdrawal by Subject|0
7526959|NCT02757352|26148551|P3|Follow-Up Period|Withdrawal by Subject|0
7526960|NCT02757352|26148552|P2|Follow-Up Period|Withdrawal by Subject|0
7526961|NCT02757352|26148553|P1|Follow-Up Period|Withdrawal by Subject|0
7526962|NCT02757352|26148544|P10|Follow-Up Period|Lack of Efficacy|1
7526963|NCT02757352|26148545|P9|Follow-Up Period|Lack of Efficacy|1
7526964|NCT02757352|26148546|P8|Follow-Up Period|Lack of Efficacy|0
7526965|NCT02757352|26148547|P7|Follow-Up Period|Lack of Efficacy|0
7526966|NCT02757352|26148548|P6|Follow-Up Period|Lack of Efficacy|0
7526967|NCT02757352|26148549|P5|Follow-Up Period|Lack of Efficacy|0
7526968|NCT02757352|26148550|P4|Follow-Up Period|Lack of Efficacy|0
7526969|NCT02757352|26148551|P3|Follow-Up Period|Lack of Efficacy|0
7526970|NCT02757352|26148552|P2|Follow-Up Period|Lack of Efficacy|0
7526971|NCT02757352|26148553|P1|Follow-Up Period|Lack of Efficacy|0
7526972|NCT02757352|26148544|P10|Follow-Up Period|Lost to Follow-up|0
7526973|NCT02757352|26148545|P9|Follow-Up Period|Lost to Follow-up|1
7526974|NCT02757352|26148546|P8|Follow-Up Period|Lost to Follow-up|0
7526975|NCT02757352|26148547|P7|Follow-Up Period|Lost to Follow-up|0
7526976|NCT02757352|26148548|P6|Follow-Up Period|Lost to Follow-up|0
7526977|NCT02757352|26148549|P5|Follow-Up Period|Lost to Follow-up|0
7526978|NCT02757352|26148550|P4|Follow-Up Period|Lost to Follow-up|0
7526979|NCT02757352|26148551|P3|Follow-Up Period|Lost to Follow-up|0
7526980|NCT02757352|26148552|P2|Follow-Up Period|Lost to Follow-up|0
7526981|NCT02757352|26148553|P1|Follow-Up Period|Lost to Follow-up|0
7526982|NCT02757352|26148544|P10|Follow-Up Period|Adverse Event|0
7526983|NCT02757352|26148545|P9|Follow-Up Period|Adverse Event|2
7526984|NCT02757352|26148546|P8|Follow-Up Period|Adverse Event|0
7526985|NCT02757352|26148547|P7|Follow-Up Period|Adverse Event|1
7526986|NCT02757352|26148548|P6|Follow-Up Period|Adverse Event|0
7526987|NCT02757352|26148549|P5|Follow-Up Period|Adverse Event|0
7526988|NCT02757352|26148550|P4|Follow-Up Period|Adverse Event|0
7526989|NCT02757352|26148551|P3|Follow-Up Period|Adverse Event|0
7526990|NCT02757352|26148552|P2|Follow-Up Period|Adverse Event|0
7526991|NCT02757352|26148553|P1|Follow-Up Period|Adverse Event|0
7526992|NCT02757352|26148544|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7526993|NCT02757352|26148545|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7526994|NCT02757352|26148546|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7526995|NCT02757352|26148547|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7526996|NCT02757352|26148548|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7526997|NCT02757352|26148549|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7526998|NCT02757352|26148550|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
7526999|NCT02757352|26148551|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527000|NCT02757352|26148552|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527001|NCT02757352|26148553|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527002|NCT02757352|26148544|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527003|NCT02757352|26148545|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527004|NCT02757352|26148546|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527005|NCT02757352|26148547|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527006|NCT02757352|26148548|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
7527007|NCT02757352|26148549|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527008|NCT02757352|26148550|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527009|NCT02757352|26148551|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527010|NCT02757352|26148552|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527011|NCT02757352|26148553|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7527012|NCT02757352|26148544|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527013|NCT02757352|26148545|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527014|NCT02757352|26148546|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527015|NCT02757352|26148547|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527016|NCT02757352|26148548|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527017|NCT02757352|26148549|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
7527018|NCT02757352|26148550|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527019|NCT02757352|26148551|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527020|NCT02757352|26148552|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527021|NCT02757352|26148553|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7527022|NCT02757352|26148544|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527023|NCT02757352|26148545|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527024|NCT02757352|26148546|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527025|NCT02757352|26148547|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527026|NCT02757352|26148548|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
7527027|NCT02757352|26148549|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
7527028|NCT02757352|26148550|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
7527029|NCT02757352|26148551|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527030|NCT02757352|26148552|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527031|NCT02757352|26148553|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7527032|NCT02757352|26148544|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527033|NCT02757352|26148545|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527034|NCT02757352|26148546|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527035|NCT02757352|26148547|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527036|NCT02757352|26148548|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
7527037|NCT02757352|26148549|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527038|NCT02757352|26148550|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
7527039|NCT02757352|26148551|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527040|NCT02757352|26148552|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527041|NCT02757352|26148553|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7527042|NCT02757352|26148544|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527043|NCT02757352|26148545|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527044|NCT02757352|26148546|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527045|NCT02757352|26148547|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527046|NCT02757352|26148548|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527047|NCT02757352|26148549|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527048|NCT02757352|26148550|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7527049|NCT02757352|26148551|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
7527050|NCT02757352|26148552|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
7527051|NCT02757352|26148553|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
7527052|NCT02757352|26148544|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527053|NCT02757352|26148545|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527054|NCT02757352|26148546|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527055|NCT02757352|26148547|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527056|NCT02757352|26148548|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527057|NCT02757352|26148549|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527058|NCT02757352|26148550|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7527059|NCT02757352|26148551|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
7527060|NCT02757352|26148552|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7527061|NCT02757352|26148553|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7527062|NCT02757352|26148544|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527063|NCT02757352|26148545|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527064|NCT02757352|26148546|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527065|NCT02757352|26148547|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527066|NCT02757352|26148548|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527067|NCT02757352|26148549|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527068|NCT02757352|26148550|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527069|NCT02757352|26148551|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527070|NCT02757352|26148552|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
7527071|NCT02757352|26148553|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7527072|NCT02757352|26148544|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527073|NCT02757352|26148545|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527074|NCT02757352|26148546|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527075|NCT02757352|26148547|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527076|NCT02757352|26148548|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527077|NCT02757352|26148549|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527078|NCT02757352|26148550|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527079|NCT02757352|26148551|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527080|NCT02757352|26148552|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
7527081|NCT02757352|26148553|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7527082|NCT02757352|26148544|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527083|NCT02757352|26148545|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527084|NCT02757352|26148546|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527085|NCT02757352|26148547|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527086|NCT02757352|26148548|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527087|NCT02757352|26148549|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527088|NCT02757352|26148550|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7527089|NCT02757352|26148551|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
7527090|NCT02757352|26148552|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
7527091|NCT02757352|26148553|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
7527092|NCT02757352|26148544|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527093|NCT02757352|26148545|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527094|NCT02757352|26148546|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527095|NCT02757352|26148547|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527096|NCT02757352|26148548|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527097|NCT02757352|26148549|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527098|NCT02757352|26148550|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527099|NCT02757352|26148551|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
7527100|NCT02757352|26148552|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527101|NCT02757352|26148553|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7527102|NCT02757352|26148544|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527103|NCT02757352|26148545|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527104|NCT02757352|26148546|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527105|NCT02757352|26148547|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527106|NCT02757352|26148548|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527107|NCT02757352|26148549|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527108|NCT02757352|26148550|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527109|NCT02757352|26148551|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
7527110|NCT02757352|26148552|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7527111|NCT02757352|26148553|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
7527112|NCT02756832|26148800|P1|Overall Study|Protocol Deviation|10
7527113|NCT02756832|26148800|P1|Overall Study|Reason not Specified|9
7527114|NCT02756832|26148800|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
7527115|NCT02756832|26148800|P1|Overall Study|Insufficient Efficacy|2
7527116|NCT02756832|26148800|P1|Overall Study|Patient's Unwillingness|12
7527117|NCT02756832|26148800|P1|Overall Study|Lost for Observation|13
7527118|NCT02756832|26148800|P1|Overall Study|Lost for Observation after Baseline|6
7527119|NCT02756819|26148814|P1|Overall Study|Reason not Specified|9
7527120|NCT02756819|26148814|P1|Overall Study|Adverse Event|2
7527121|NCT02756819|26148814|P1|Overall Study|Insufficient efficacy|2
7527122|NCT02756819|26148814|P1|Overall Study|Patient's unwillingness|16
7527123|NCT02756819|26148814|P1|Overall Study|Lost for observation|23
7527124|NCT02756650|26148913|P1|Overall Study|Adverse Event|1
7527125|NCT02756650|26148913|P1|Overall Study|Physician Decision|1
7527126|NCT02756637|26148936|P2|Overall Study|Did not complete curative therapy|0
7527127|NCT02756637|26148937|P1|Overall Study|Did not complete curative therapy|33
7527128|NCT02756637|26148936|P2|Overall Study|No available NLR value|44
7527129|NCT02756637|26148937|P1|Overall Study|No available NLR value|44
7527130|NCT02756637|26148936|P2|Overall Study|Not eligible for initial SWOG study|10
7527131|NCT02756637|26148937|P1|Overall Study|Not eligible for initial SWOG study|10
7527132|NCT02756611|26148958|P1|Overall Study|Active on Study|205
7527133|NCT02756611|26148958|P1|Overall Study|Missing|2
7527134|NCT02756611|26148958|P1|Overall Study|Other|7
7527135|NCT02756611|26148958|P1|Overall Study|Lost to Follow-up|2
7527136|NCT02756611|26148958|P1|Overall Study|Withdrawal by Subject|1
7527137|NCT02756611|26148958|P1|Overall Study|Death|39
7527138|NCT02756364|26148980|P3|Overall Study|Lost to Follow-up|1
7527139|NCT02756364|26148981|P2|Overall Study|Lost to Follow-up|1
7527140|NCT02756364|26148982|P1|Overall Study|Lost to Follow-up|0
7527141|NCT02756364|26148980|P3|Overall Study|Withdrawal by Patient|8
7527142|NCT02756364|26148981|P2|Overall Study|Withdrawal by Patient|1
7527143|NCT02756364|26148982|P1|Overall Study|Withdrawal by Patient|2
7527144|NCT02756364|26148980|P3|Overall Study|Death|18
7527145|NCT02756364|26148981|P2|Overall Study|Death|15
7527146|NCT02756364|26148982|P1|Overall Study|Death|20
7527147|NCT02756364|26148980|P3|Overall Study|Site Terminated by Sponsor|21
7527148|NCT02756364|26148981|P2|Overall Study|Site Terminated by Sponsor|30
7527149|NCT02756364|26148982|P1|Overall Study|Site Terminated by Sponsor|24
7527150|NCT02756338|26149016|P1|Overall Study|Device Replaced with Pacemaker|4
7527151|NCT02756338|26149016|P1|Overall Study|Withdrawn by Investigator|1
7527152|NCT02756182|26149025|P1|Overall Study|StudyTechnical Difficulties|4
7527153|NCT02756078|26149040|P2|Period 2|Withdrawal by Subject|1
7527154|NCT02756078|26149041|P1|Period 2|Withdrawal by Subject|3
7527155|NCT02756078|26149040|P2|Period 2|Unsatisfactory Lens Fitting|1
7527156|NCT02756078|26149041|P1|Period 2|Unsatisfactory Lens Fitting|0
7527157|NCT02756078|26149040|P2|Period 2|Adverse Event|5
7527158|NCT02756078|26149041|P1|Period 2|Adverse Event|3
7527159|NCT02756078|26149040|P2|Period 1|Lens Discomfort|2
7527160|NCT02756078|26149041|P1|Period 1|Lens Discomfort|2
7527161|NCT02756078|26149040|P2|Period 1|Withdrawal by Subject|6
7527162|NCT02756078|26149041|P1|Period 1|Withdrawal by Subject|6
7527163|NCT02756078|26149040|P2|Period 1|Adverse Event|10
7527164|NCT02756078|26149041|P1|Period 1|Adverse Event|1
7527165|NCT02756078|26149040|P2|Period 1|Protocol Violation|1
7527166|NCT02756078|26149041|P1|Period 1|Protocol Violation|0
7527167|NCT02756078|26149040|P2|Period 1|Lost to Follow-up|2
7527168|NCT02756078|26149041|P1|Period 1|Lost to Follow-up|0
7527169|NCT02756078|26149040|P2|Period 1|Unsatisfactory Lens Fitting|1
7527170|NCT02756078|26149041|P1|Period 1|Unsatisfactory Lens Fitting|0
7527171|NCT02756013|26149059|P1|Overall Study|Hypersensitivity|1
7527172|NCT02756013|26149059|P1|Overall Study|Adverse Event|1
7527173|NCT02755831|26149071|P2|Overall Study|Lost to Follow-up|3
7527174|NCT02755831|26149072|P1|Overall Study|Lost to Follow-up|3
7527175|NCT02755818|26149088|P4|Overall Study|withdrawal by PI|1
7527176|NCT02755818|26149089|P3|Overall Study|withdrawal by PI|1
7527177|NCT02755818|26149090|P2|Overall Study|withdrawal by PI|0
7527178|NCT02755818|26149091|P1|Overall Study|withdrawal by PI|0
7527179|NCT02755818|26149088|P4|Overall Study|Withdrawal by Subject|2
7527180|NCT02755818|26149089|P3|Overall Study|Withdrawal by Subject|0
7527181|NCT02755818|26149090|P2|Overall Study|Withdrawal by Subject|0
7527182|NCT02755818|26149091|P1|Overall Study|Withdrawal by Subject|0
7527183|NCT02755805|26149127|P2|Overall Study|Withdrawal by Subject|2
7527184|NCT02755805|26149128|P1|Overall Study|Withdrawal by Subject|0
7527185|NCT02755805|26149127|P2|Overall Study|Refused assessments|0
7527186|NCT02755805|26149128|P1|Overall Study|Refused assessments|1
7527187|NCT02755805|26149127|P2|Overall Study|Lost to Follow-up|2
7527188|NCT02755805|26149128|P1|Overall Study|Lost to Follow-up|1
7527189|NCT02755649|26149143|P3|Overall Study|Undecided|0
7527190|NCT02755649|26149144|P2|Overall Study|Undecided|0
7527191|NCT02755649|26149145|P1|Overall Study|Undecided|1
7527192|NCT02755649|26149143|P3|Overall Study|Withdrawal by Subject|0
7527193|NCT02755649|26149144|P2|Overall Study|Withdrawal by Subject|1
7527194|NCT02755649|26149145|P1|Overall Study|Withdrawal by Subject|0
7527195|NCT02755649|26149143|P3|Overall Study|Physician Decision|2
7527196|NCT02755649|26149144|P2|Overall Study|Physician Decision|0
7527197|NCT02755649|26149145|P1|Overall Study|Physician Decision|0
7527198|NCT02755649|26149143|P3|Overall Study|Did Not Complete Follow-up Visits|0
7527199|NCT02755649|26149144|P2|Overall Study|Did Not Complete Follow-up Visits|0
7527200|NCT02755649|26149145|P1|Overall Study|Did Not Complete Follow-up Visits|1
7527201|NCT02755649|26149143|P3|Overall Study|Transitioned into OLE study|100
7527202|NCT02755649|26149144|P2|Overall Study|Transitioned into OLE study|98
7527203|NCT02755649|26149145|P1|Overall Study|Transitioned into OLE study|99
7527204|NCT02755116|26149220|P2|Overall Study|surgery converted to open, pt admitted|1
7527205|NCT02755116|26149221|P1|Overall Study|surgery converted to open, pt admitted|3
7527206|NCT02755090|26149237|P2|Overall Study|equipment malfunction|0
7527207|NCT02755090|26149238|P1|Overall Study|equipment malfunction|1
7527208|NCT02754492|26149328|P4|Overall Study|Venous access issues not resulting in AE|4
7527209|NCT02754492|26149329|P3|Overall Study|Venous access issues not resulting in AE|0
7527210|NCT02754492|26149330|P2|Overall Study|Venous access issues not resulting in AE|0
7527211|NCT02754492|26149331|P1|Overall Study|Venous access issues not resulting in AE|0
7527212|NCT02754492|26149328|P4|Overall Study|Adverse Event|13
7527213|NCT02754492|26149329|P3|Overall Study|Adverse Event|0
7527214|NCT02754492|26149330|P2|Overall Study|Adverse Event|0
7527215|NCT02754492|26149331|P1|Overall Study|Adverse Event|0
7527216|NCT02754492|26149328|P4|Overall Study|Equipment malfuntion|5
7527217|NCT02754492|26149329|P3|Overall Study|Equipment malfuntion|2
7527218|NCT02754492|26149330|P2|Overall Study|Equipment malfuntion|0
7527219|NCT02754492|26149331|P1|Overall Study|Equipment malfuntion|0
7527220|NCT02754492|26149328|P4|Overall Study|Withdrawal by Subject|0
7527221|NCT02754492|26149329|P3|Overall Study|Withdrawal by Subject|0
7527222|NCT02754492|26149330|P2|Overall Study|Withdrawal by Subject|0
7527223|NCT02754492|26149331|P1|Overall Study|Withdrawal by Subject|2
7527224|NCT02754492|26149328|P4|Overall Study|Protocol Violation|1
7527225|NCT02754492|26149329|P3|Overall Study|Protocol Violation|0
7527226|NCT02754492|26149330|P2|Overall Study|Protocol Violation|2
7527227|NCT02754492|26149331|P1|Overall Study|Protocol Violation|2
7527228|NCT02754440|26149347|P4|Overall Study|Subject issues not resulting in AE|12
7527229|NCT02754440|26149348|P3|Overall Study|Subject issues not resulting in AE|0
7527230|NCT02754440|26149349|P2|Overall Study|Subject issues not resulting in AE|0
7527231|NCT02754440|26149350|P1|Overall Study|Subject issues not resulting in AE|0
7527232|NCT02754440|26149347|P4|Overall Study|Equipment failure|7
7527233|NCT02754440|26149348|P3|Overall Study|Equipment failure|5
7527234|NCT02754440|26149349|P2|Overall Study|Equipment failure|5
7527235|NCT02754440|26149350|P1|Overall Study|Equipment failure|0
7527236|NCT02754440|26149347|P4|Overall Study|Withdrawal by Subject|1
7527237|NCT02754440|26149348|P3|Overall Study|Withdrawal by Subject|0
7527238|NCT02754440|26149349|P2|Overall Study|Withdrawal by Subject|0
7527239|NCT02754440|26149350|P1|Overall Study|Withdrawal by Subject|0
7527240|NCT02754440|26149347|P4|Overall Study|Adverse Event|9
7527241|NCT02754440|26149348|P3|Overall Study|Adverse Event|0
7527242|NCT02754440|26149349|P2|Overall Study|Adverse Event|1
7527243|NCT02754440|26149350|P1|Overall Study|Adverse Event|3
7527244|NCT02754440|26149347|P4|Overall Study|Protocol Violation|6
7527245|NCT02754440|26149348|P3|Overall Study|Protocol Violation|2
7527246|NCT02754440|26149349|P2|Overall Study|Protocol Violation|2
7527247|NCT02754440|26149350|P1|Overall Study|Protocol Violation|3
7527248|NCT02753946|26149402|P2|Overall Study|Physician Decision|2
7527249|NCT02753946|26149403|P1|Overall Study|Physician Decision|0
7527250|NCT02753946|26149402|P2|Overall Study|Lack of Efficacy|0
7527251|NCT02753946|26149403|P1|Overall Study|Lack of Efficacy|1
7527252|NCT02753946|26149402|P2|Overall Study|Withdrawal by Subject|1
7527253|NCT02753946|26149403|P1|Overall Study|Withdrawal by Subject|6
7527254|NCT02753946|26149402|P2|Overall Study|Adverse Event|6
7527255|NCT02753946|26149403|P1|Overall Study|Adverse Event|7
7527256|NCT02753816|26149486|P3|Overall Study|Protocol Violation|0
7527257|NCT02753816|26149487|P2|Overall Study|Protocol Violation|1
7527258|NCT02753816|26149488|P1|Overall Study|Protocol Violation|0
7527259|NCT02753595|26149519|P2|Overall Study|Sponsor termination|2
7527260|NCT02753595|26149520|P1|Overall Study|Sponsor termination|2
7527261|NCT02753400|26149563|P2|Overall Study|Withdrawal by Subject|1
7527262|NCT02753400|26149564|P1|Overall Study|Withdrawal by Subject|2
7527263|NCT02753400|26149563|P2|Overall Study|Adverse Event|0
7527264|NCT02753400|26149564|P1|Overall Study|Adverse Event|3
7527265|NCT02753075|26149573|P3|Overall Study|Physician Decision|0
7527266|NCT02753075|26149574|P2|Overall Study|Physician Decision|1
7527267|NCT02753075|26149575|P1|Overall Study|Physician Decision|3
7527268|NCT02753075|26149573|P3|Overall Study|Withdrawal of Consent|3
7527269|NCT02753075|26149574|P2|Overall Study|Withdrawal of Consent|1
7527270|NCT02753075|26149575|P1|Overall Study|Withdrawal of Consent|1
7527271|NCT02753075|26149573|P3|Overall Study|Lost to Follow-up|0
7527272|NCT02753075|26149574|P2|Overall Study|Lost to Follow-up|0
7527273|NCT02753075|26149575|P1|Overall Study|Lost to Follow-up|2
7527274|NCT02753075|26149573|P3|Overall Study|Adverse Event|0
7527275|NCT02753075|26149574|P2|Overall Study|Adverse Event|1
7527276|NCT02753075|26149575|P1|Overall Study|Adverse Event|2
7527277|NCT02752958|26149600|P1|Overall Study|Other (Reason not specified)|2
7527278|NCT02752958|26149600|P1|Overall Study|Withdrawal by Subject|2
7527279|NCT02752958|26149600|P1|Overall Study|Protocol Violation|1
7527280|NCT02752958|26149600|P1|Overall Study|Lost to Follow-up|1
7527281|NCT02752958|26149600|P1|Overall Study|Adverse Event|3
7527282|NCT02752906|26149671|P2|Overall Study|Lost to Follow-up|2
7527283|NCT02752906|26149672|P1|Overall Study|Lost to Follow-up|3
7527284|NCT02752906|26149671|P2|Overall Study|Withdrawal by Subject|2
7527285|NCT02752906|26149672|P1|Overall Study|Withdrawal by Subject|2
7527286|NCT02752906|26149671|P2|Overall Study|Protocol Violation|1
7527287|NCT02752906|26149672|P1|Overall Study|Protocol Violation|2
7527288|NCT02752802|26149697|P2|Overall Study|Contrast Volume Not Collected|0
7527289|NCT02752802|26149698|P1|Overall Study|Contrast Volume Not Collected|1
7527290|NCT02752776|26149710|P3|Overall Study|Withdrawal by Subject|2
7527291|NCT02752776|26149711|P2|Overall Study|Withdrawal by Subject|4
7527292|NCT02752776|26149712|P1|Overall Study|Withdrawal by Subject|3
7527293|NCT02752776|26149710|P3|Overall Study|Death|1
7527294|NCT02752776|26149711|P2|Overall Study|Death|0
7527295|NCT02752776|26149712|P1|Overall Study|Death|0
7527296|NCT02752776|26149710|P3|Overall Study|Subject/guardian decision|4
7527297|NCT02752776|26149711|P2|Overall Study|Subject/guardian decision|6
7527298|NCT02752776|26149712|P1|Overall Study|Subject/guardian decision|8
7527299|NCT02752776|26149710|P3|Overall Study|Protocol Violation|6
7527300|NCT02752776|26149711|P2|Overall Study|Protocol Violation|13
7527301|NCT02752776|26149712|P1|Overall Study|Protocol Violation|10
7527302|NCT02752776|26149710|P3|Overall Study|Pregnancy|3
7527303|NCT02752776|26149711|P2|Overall Study|Pregnancy|6
7527304|NCT02752776|26149712|P1|Overall Study|Pregnancy|1
7527305|NCT02752776|26149710|P3|Overall Study|Physician Decision|2
7527306|NCT02752776|26149711|P2|Overall Study|Physician Decision|6
7527307|NCT02752776|26149712|P1|Overall Study|Physician Decision|2
7527308|NCT02752776|26149710|P3|Overall Study|Non-compliance with study treatment|1
7527309|NCT02752776|26149711|P2|Overall Study|Non-compliance with study treatment|0
7527310|NCT02752776|26149712|P1|Overall Study|Non-compliance with study treatment|0
7527311|NCT02752776|26149710|P3|Overall Study|Lost to Follow-up|4
7527312|NCT02752776|26149711|P2|Overall Study|Lost to Follow-up|12
7527313|NCT02752776|26149712|P1|Overall Study|Lost to Follow-up|11
7527314|NCT02752776|26149710|P3|Overall Study|Lack of Efficacy|14
7527315|NCT02752776|26149711|P2|Overall Study|Lack of Efficacy|6
7527316|NCT02752776|26149712|P1|Overall Study|Lack of Efficacy|2
7527317|NCT02752776|26149710|P3|Overall Study|Adverse Event|11
7527318|NCT02752776|26149711|P2|Overall Study|Adverse Event|23
7527319|NCT02752776|26149712|P1|Overall Study|Adverse Event|15
7527320|NCT02752633|26149758|P1|Overall Study|Withdrawal by Subject|1
7527321|NCT02752087|26149796|P2|Washout|Physician Decision|0
7527322|NCT02752087|26149797|P1|Washout|Physician Decision|1
7527323|NCT02752074|26149807|P2|Overall Study|Withdrawal by Subject|10
7527324|NCT02752074|26149808|P1|Overall Study|Withdrawal by Subject|9
7527325|NCT02752074|26149807|P2|Overall Study|Death|129
7527326|NCT02752074|26149808|P1|Overall Study|Death|146
7527327|NCT02752074|26149807|P2|Overall Study|Lost to Follow-up|4
7527328|NCT02752074|26149808|P1|Overall Study|Lost to Follow-up|1
7527329|NCT02752048|26149833|P3|Overall Study|Withdrawal by Subject|3
7527330|NCT02752048|26149834|P2|Overall Study|Withdrawal by Subject|0
7527331|NCT02752048|26149835|P1|Overall Study|Withdrawal by Subject|0
7527332|NCT02751983|26149854|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
7527333|NCT02751983|26149855|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
7527334|NCT02751983|26149854|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
7527335|NCT02751983|26149855|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
7527336|NCT02751983|26149854|P2|Post-Treatment Assessment|Lost to Follow-up|0
7527337|NCT02751983|26149855|P1|Post-Treatment Assessment|Lost to Follow-up|5
7527338|NCT02751983|26149854|P2|Treatment|Discharged prior to beginning ACT|0
7527339|NCT02751983|26149855|P1|Treatment|Discharged prior to beginning ACT|2
7527340|NCT02751983|26149854|P2|Treatment|Stopped ACT, but Remained in study|0
7527341|NCT02751983|26149855|P1|Treatment|Stopped ACT, but Remained in study|2
7527342|NCT02751931|26149876|P2|Overall Study|Other: Miscelleneous|8
7527343|NCT02751931|26149877|P1|Overall Study|Other: Miscelleneous|10
7527344|NCT02751931|26149876|P2|Overall Study|Adverse Event|0
7527345|NCT02751931|26149877|P1|Overall Study|Adverse Event|3
7527346|NCT02751827|26149968|P3|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
7527347|NCT02751827|26149969|P2|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7527348|NCT02751827|26149970|P1|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7527349|NCT02751580|26149978|P1|Overall Study|Death|2
7527350|NCT02751580|26149978|P1|Overall Study|Lost to Follow-up|4
7527351|NCT02751450|26149991|P2|Overall Study|Adverse Event|0
7527352|NCT02751450|26149992|P1|Overall Study|Adverse Event|1
7527353|NCT02751424|26150013|P9|Part 2|Adverse Event|0
7527354|NCT02751424|26150014|P8|Part 2|Adverse Event|5
7527355|NCT02751424|26150015|P7|Part 2|Adverse Event|0
7527356|NCT02751424|26150016|P6|Part 2|Adverse Event|0
7527357|NCT02751424|26150017|P5|Part 2|Adverse Event|0
7527358|NCT02751424|26150018|P4|Part 2|Adverse Event|0
7527359|NCT02751424|26150019|P3|Part 2|Adverse Event|0
7527360|NCT02751424|26150020|P2|Part 2|Adverse Event|0
7527361|NCT02751424|26150021|P1|Part 2|Adverse Event|0
7527362|NCT02751359|26150177|P1|Overall Study|Lost to Follow-up|1
7527363|NCT02751320|26150191|P1|Overall Study|Withdrawal by Subject|1
7527364|NCT02751320|26150191|P1|Overall Study|Adverse Event|2
7527365|NCT02750943|26150229|P2|Overall Study|Withdrawal by Subject|7
7527366|NCT02750943|26150230|P1|Overall Study|Withdrawal by Subject|5
7527367|NCT02750943|26150229|P2|Overall Study|Lost to Follow-up|2
7527368|NCT02750943|26150230|P1|Overall Study|Lost to Follow-up|1
7527369|NCT02750930|26150244|P1|Overall Study|Study closed/terminated|8
7527370|NCT02750813|26150256|P2|Period 1, First 14 Days of Wear|Reason not given|1
7527371|NCT02750813|26150257|P1|Period 1, First 14 Days of Wear|Reason not given|0
7527372|NCT02750813|26150256|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
7527373|NCT02750813|26150257|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
7527374|NCT02750800|26150272|P1|Overall Study|Other, not specified|3
7527375|NCT02750800|26150272|P1|Overall Study|Patient request|12
7527376|NCT02750800|26150272|P1|Overall Study|Investigator decision|53
7527377|NCT02750800|26150272|P1|Overall Study|Lost to Follow-up|12
7527378|NCT02750800|26150272|P1|Overall Study|Adverse Event|18
7527379|NCT02750761|26150377|P6|Overall Study|Lost to Follow-up|0
7527380|NCT02750761|26150378|P5|Overall Study|Lost to Follow-up|0
7527381|NCT02750761|26150379|P4|Overall Study|Lost to Follow-up|0
7527382|NCT02750761|26150380|P3|Overall Study|Lost to Follow-up|1
7527383|NCT02750761|26150381|P2|Overall Study|Lost to Follow-up|0
7527384|NCT02750761|26150382|P1|Overall Study|Lost to Follow-up|0
7527385|NCT02750709|26150478|P6|Treatment Period 1|Adverse Event|1
7527386|NCT02750709|26150479|P5|Treatment Period 1|Adverse Event|0
7527387|NCT02750709|26150480|P4|Treatment Period 1|Adverse Event|0
7527388|NCT02750709|26150481|P3|Treatment Period 1|Adverse Event|0
7527389|NCT02750709|26150482|P2|Treatment Period 1|Adverse Event|0
7527390|NCT02750709|26150483|P1|Treatment Period 1|Adverse Event|0
7527391|NCT02750618|26150509|P1|Overall Study|Withdrawal by Subject|1
7527392|NCT02750592|26150525|P1|Overall Study|Lack of Efficacy|2
7527393|NCT02750592|26150525|P1|Overall Study|Adverse Event|3
7527394|NCT02750514|26150549|P5|Track 5|Other reasons|2
7527395|NCT02750514|26150550|P4|Track 5|Other reasons|0
7527396|NCT02750514|26150551|P3|Track 5|Other reasons|0
7527397|NCT02750514|26150552|P2|Track 5|Other reasons|0
7527398|NCT02750514|26150553|P1|Track 5|Other reasons|0
7527399|NCT02750514|26150549|P5|Track 5|Participant request to discontinue|3
7527400|NCT02750514|26150550|P4|Track 5|Participant request to discontinue|0
7527401|NCT02750514|26150551|P3|Track 5|Participant request to discontinue|0
7527402|NCT02750514|26150552|P2|Track 5|Participant request to discontinue|0
7527403|NCT02750514|26150553|P1|Track 5|Participant request to discontinue|0
7527404|NCT02750514|26150549|P5|Track 5|Study drug toxicity|2
7527405|NCT02750514|26150550|P4|Track 5|Study drug toxicity|0
7527406|NCT02750514|26150551|P3|Track 5|Study drug toxicity|0
7527407|NCT02750514|26150552|P2|Track 5|Study drug toxicity|0
7527408|NCT02750514|26150553|P1|Track 5|Study drug toxicity|0
7527409|NCT02750514|26150549|P5|Track 5|Adverse event unrelated to study drug|2
7527410|NCT02750514|26150550|P4|Track 5|Adverse event unrelated to study drug|0
7527411|NCT02750514|26150551|P3|Track 5|Adverse event unrelated to study drug|0
7527412|NCT02750514|26150552|P2|Track 5|Adverse event unrelated to study drug|0
7527413|NCT02750514|26150553|P1|Track 5|Adverse event unrelated to study drug|0
7527414|NCT02750514|26150549|P5|Track 5|Disease progression|34
7527415|NCT02750514|26150550|P4|Track 5|Disease progression|0
7527416|NCT02750514|26150551|P3|Track 5|Disease progression|0
7527417|NCT02750514|26150552|P2|Track 5|Disease progression|0
7527418|NCT02750514|26150553|P1|Track 5|Disease progression|0
7527419|NCT02750514|26150549|P5|Track 4|Death|0
7527420|NCT02750514|26150550|P4|Track 4|Death|1
7527421|NCT02750514|26150551|P3|Track 4|Death|0
7527422|NCT02750514|26150552|P2|Track 4|Death|0
7527423|NCT02750514|26150553|P1|Track 4|Death|0
7527424|NCT02750514|26150549|P5|Track 4|Adverse event unrelated to study drug|0
7527425|NCT02750514|26150550|P4|Track 4|Adverse event unrelated to study drug|0
7527426|NCT02750514|26150551|P3|Track 4|Adverse event unrelated to study drug|0
7527427|NCT02750514|26150552|P2|Track 4|Adverse event unrelated to study drug|5
7527428|NCT02750514|26150553|P1|Track 4|Adverse event unrelated to study drug|0
7527429|NCT02750514|26150549|P5|Track 4|Disease progression|0
7527430|NCT02750514|26150550|P4|Track 4|Disease progression|32
7527431|NCT02750514|26150551|P3|Track 4|Disease progression|0
7527432|NCT02750514|26150552|P2|Track 4|Disease progression|33
7527433|NCT02750514|26150553|P1|Track 4|Disease progression|0
7527434|NCT02750514|26150549|P5|Track 4|Other reasons|0
7527435|NCT02750514|26150550|P4|Track 4|Other reasons|3
7527436|NCT02750514|26150551|P3|Track 4|Other reasons|0
7527437|NCT02750514|26150552|P2|Track 4|Other reasons|5
7527438|NCT02750514|26150553|P1|Track 4|Other reasons|0
7527439|NCT02750514|26150549|P5|Track 4|Participant withdrew consent|0
7527440|NCT02750514|26150550|P4|Track 4|Participant withdrew consent|0
7527441|NCT02750514|26150551|P3|Track 4|Participant withdrew consent|0
7527442|NCT02750514|26150552|P2|Track 4|Participant withdrew consent|1
7527443|NCT02750514|26150553|P1|Track 4|Participant withdrew consent|0
7527444|NCT02750514|26150549|P5|Track 4|Participant request to discontinue|0
7527445|NCT02750514|26150550|P4|Track 4|Participant request to discontinue|1
7527446|NCT02750514|26150551|P3|Track 4|Participant request to discontinue|0
7527447|NCT02750514|26150552|P2|Track 4|Participant request to discontinue|1
7527448|NCT02750514|26150553|P1|Track 4|Participant request to discontinue|0
7527449|NCT02750514|26150549|P5|Track 4|Study drug toxicity|0
7527450|NCT02750514|26150550|P4|Track 4|Study drug toxicity|5
7527451|NCT02750514|26150551|P3|Track 4|Study drug toxicity|0
7527452|NCT02750514|26150552|P2|Track 4|Study drug toxicity|6
7527453|NCT02750514|26150553|P1|Track 4|Study drug toxicity|0
7527454|NCT02750514|26150549|P5|Track 3|Other reasons|0
7527455|NCT02750514|26150550|P4|Track 3|Other reasons|0
7527456|NCT02750514|26150551|P3|Track 3|Other reasons|0
7527457|NCT02750514|26150552|P2|Track 3|Other reasons|3
7527458|NCT02750514|26150553|P1|Track 3|Other reasons|0
7527459|NCT02750514|26150549|P5|Track 3|Participant withdrew consent|0
7527460|NCT02750514|26150550|P4|Track 3|Participant withdrew consent|0
7527461|NCT02750514|26150551|P3|Track 3|Participant withdrew consent|1
7527462|NCT02750514|26150552|P2|Track 3|Participant withdrew consent|3
7527463|NCT02750514|26150553|P1|Track 3|Participant withdrew consent|0
7527464|NCT02750514|26150549|P5|Track 3|Participant request to discontinue|0
7527465|NCT02750514|26150550|P4|Track 3|Participant request to discontinue|0
7527466|NCT02750514|26150551|P3|Track 3|Participant request to discontinue|0
7527467|NCT02750514|26150552|P2|Track 3|Participant request to discontinue|2
7527468|NCT02750514|26150553|P1|Track 3|Participant request to discontinue|0
7527469|NCT02750514|26150549|P5|Track 3|Study drug toxicity|0
7527470|NCT02750514|26150550|P4|Track 3|Study drug toxicity|1
7527471|NCT02750514|26150551|P3|Track 3|Study drug toxicity|0
7527472|NCT02750514|26150552|P2|Track 3|Study drug toxicity|3
7527473|NCT02750514|26150553|P1|Track 3|Study drug toxicity|0
7527474|NCT02750514|26150549|P5|Track 3|Adverse event unrelated to study drug|0
7527475|NCT02750514|26150550|P4|Track 3|Adverse event unrelated to study drug|1
7527476|NCT02750514|26150551|P3|Track 3|Adverse event unrelated to study drug|1
7527477|NCT02750514|26150552|P2|Track 3|Adverse event unrelated to study drug|1
7527478|NCT02750514|26150553|P1|Track 3|Adverse event unrelated to study drug|0
7527479|NCT02750514|26150549|P5|Track 3|Disease progression|0
7527480|NCT02750514|26150550|P4|Track 3|Disease progression|14
7527481|NCT02750514|26150551|P3|Track 3|Disease progression|13
7527482|NCT02750514|26150552|P2|Track 3|Disease progression|24
7527483|NCT02750514|26150553|P1|Track 3|Disease progression|0
7527484|NCT02750514|26150549|P5|Track 2|Participant withdrew consent|0
7527485|NCT02750514|26150550|P4|Track 2|Participant withdrew consent|0
7527486|NCT02750514|26150551|P3|Track 2|Participant withdrew consent|0
7527487|NCT02750514|26150552|P2|Track 2|Participant withdrew consent|1
7527488|NCT02750514|26150553|P1|Track 2|Participant withdrew consent|0
7527489|NCT02750514|26150549|P5|Track 2|Study drug toxicity|0
7527490|NCT02750514|26150550|P4|Track 2|Study drug toxicity|2
7527491|NCT02750514|26150551|P3|Track 2|Study drug toxicity|0
7527492|NCT02750514|26150552|P2|Track 2|Study drug toxicity|2
7527493|NCT02750514|26150553|P1|Track 2|Study drug toxicity|1
7527494|NCT02750514|26150549|P5|Track 2|Adverse event unrelated to study drug|0
7527495|NCT02750514|26150550|P4|Track 2|Adverse event unrelated to study drug|0
7527496|NCT02750514|26150551|P3|Track 2|Adverse event unrelated to study drug|0
7527497|NCT02750514|26150552|P2|Track 2|Adverse event unrelated to study drug|0
7527498|NCT02750514|26150553|P1|Track 2|Adverse event unrelated to study drug|1
7527499|NCT02750514|26150549|P5|Track 2|Disease progression|0
7527500|NCT02750514|26150550|P4|Track 2|Disease progression|5
7527501|NCT02750514|26150551|P3|Track 2|Disease progression|2
7527502|NCT02750514|26150552|P2|Track 2|Disease progression|5
7527503|NCT02750514|26150553|P1|Track 2|Disease progression|4
7527504|NCT02750514|26150549|P5|Track 1|Other reasons|0
7527505|NCT02750514|26150550|P4|Track 1|Other reasons|0
7527506|NCT02750514|26150551|P3|Track 1|Other reasons|0
7527507|NCT02750514|26150552|P2|Track 1|Other reasons|0
7527508|NCT02750514|26150553|P1|Track 1|Other reasons|1
7527509|NCT02750514|26150549|P5|Track 1|Participant request to discontinue|0
7527510|NCT02750514|26150550|P4|Track 1|Participant request to discontinue|0
7527511|NCT02750514|26150551|P3|Track 1|Participant request to discontinue|0
7527512|NCT02750514|26150552|P2|Track 1|Participant request to discontinue|0
7527513|NCT02750514|26150553|P1|Track 1|Participant request to discontinue|1
7527514|NCT02750514|26150549|P5|Track 1|Study drug toxicity|0
7527515|NCT02750514|26150550|P4|Track 1|Study drug toxicity|1
7527516|NCT02750514|26150551|P3|Track 1|Study drug toxicity|0
7527517|NCT02750514|26150552|P2|Track 1|Study drug toxicity|1
7527518|NCT02750514|26150553|P1|Track 1|Study drug toxicity|4
7527519|NCT02750514|26150549|P5|Track 1|Adverse event unrelated to study drug|0
7527520|NCT02750514|26150550|P4|Track 1|Adverse event unrelated to study drug|0
7527521|NCT02750514|26150551|P3|Track 1|Adverse event unrelated to study drug|0
7527522|NCT02750514|26150552|P2|Track 1|Adverse event unrelated to study drug|0
7527523|NCT02750514|26150553|P1|Track 1|Adverse event unrelated to study drug|1
7527524|NCT02750514|26150549|P5|Track 1|Disease progression|0
7527525|NCT02750514|26150550|P4|Track 1|Disease progression|1
7527526|NCT02750514|26150551|P3|Track 1|Disease progression|0
7527527|NCT02750514|26150552|P2|Track 1|Disease progression|1
7527528|NCT02750514|26150553|P1|Track 1|Disease progression|20
7527529|NCT02750501|26150613|P1|Overall Study|Non-compliant use of PERT|1
7527530|NCT02750501|26150613|P1|Overall Study|G-tube came out|1
7527531|NCT02750501|26150613|P1|Overall Study|Protocol Violation|1
7527532|NCT02750501|26150613|P1|Overall Study|Physician Decision|1
7527533|NCT02750501|26150613|P1|Overall Study|Adverse Event|4
7527534|NCT02750410|26150627|P2|Open-Label Extension Period|Withdrawal by Subject|2
7527535|NCT02750410|26150628|P1|Open-Label Extension Period|Withdrawal by Subject|1
7527536|NCT02750410|26150627|P2|Open-Label Extension Period|Protocol Violation|1
7527537|NCT02750410|26150628|P1|Open-Label Extension Period|Protocol Violation|0
7527538|NCT02750410|26150627|P2|Open-Label Extension Period|Adverse Event|3
7527539|NCT02750410|26150628|P1|Open-Label Extension Period|Adverse Event|5
7527540|NCT02750410|26150627|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
7527541|NCT02750410|26150628|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7527542|NCT02750410|26150627|P2|Double-Blind Treatment Period|Adverse Event|2
7527543|NCT02750410|26150628|P1|Double-Blind Treatment Period|Adverse Event|2
7527544|NCT02750345|26150646|P6|Intervention 1|Adverse Event|0
7527545|NCT02750345|26150647|P5|Intervention 1|Adverse Event|1
7527546|NCT02750345|26150648|P4|Intervention 1|Adverse Event|0
7527547|NCT02750345|26150649|P3|Intervention 1|Adverse Event|0
7527548|NCT02750345|26150650|P2|Intervention 1|Adverse Event|0
7527549|NCT02750345|26150651|P1|Intervention 1|Adverse Event|0
7527550|NCT02750332|26150677|P2|Treatment Period 1|Withdrawal by Subject|1
7527551|NCT02750332|26150678|P1|Treatment Period 1|Withdrawal by Subject|0
7527552|NCT02750306|26150698|P2|Overall Study|Protocol Violation|0
7527553|NCT02750306|26150699|P1|Overall Study|Protocol Violation|1
7527554|NCT02750306|26150698|P2|Overall Study|Withdrawal by Subject|2
7527555|NCT02750306|26150699|P1|Overall Study|Withdrawal by Subject|5
7527556|NCT02749799|26150758|P1|Overall Study|Withdrawal by Subject|1
7527557|NCT02749799|26150758|P1|Overall Study|Protocol Violation|1
7527558|NCT02749799|26150758|P1|Overall Study|Lost to Follow-up|4
7527559|NCT02749799|26150758|P1|Overall Study|Adverse Event|2
7527560|NCT02749721|26150764|P1|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
7527561|NCT02749721|26150764|P1|8-week Open-Label Treatment Phase|Lost to Follow-up|2
7527562|NCT02749721|26150764|P1|Screening|Protocol Violation|3
7527563|NCT02749721|26150764|P1|Screening|Lost to Follow-up|2
7527564|NCT02749721|26150764|P1|Screening|Withdrawal by Subject|1
7527565|NCT02749370|26150781|P1|Overall Study|Lost to Follow-up|3
7527566|NCT02749370|26150781|P1|Overall Study|Withdrawal by Subject|11
7527567|NCT02748863|26150836|P5|Treatment Period 2|Pregnancy|1
7527568|NCT02748863|26150837|P4|Treatment Period 2|Pregnancy|0
7527569|NCT02748863|26150838|P3|Treatment Period 2|Pregnancy|0
7527570|NCT02748863|26150839|P2|Treatment Period 2|Pregnancy|0
7527571|NCT02748863|26150840|P1|Treatment Period 2|Pregnancy|0
7527572|NCT02748863|26150836|P5|Treatment Period 2|Lack of Efficacy|0
7527573|NCT02748863|26150837|P4|Treatment Period 2|Lack of Efficacy|0
7527574|NCT02748863|26150838|P3|Treatment Period 2|Lack of Efficacy|0
7527575|NCT02748863|26150839|P2|Treatment Period 2|Lack of Efficacy|1
7527576|NCT02748863|26150840|P1|Treatment Period 2|Lack of Efficacy|0
7527577|NCT02748863|26150836|P5|Treatment Period 2|Adverse Event|0
7527578|NCT02748863|26150837|P4|Treatment Period 2|Adverse Event|2
7527579|NCT02748863|26150838|P3|Treatment Period 2|Adverse Event|0
7527580|NCT02748863|26150839|P2|Treatment Period 2|Adverse Event|2
7527581|NCT02748863|26150840|P1|Treatment Period 2|Adverse Event|3
7527582|NCT02748863|26150836|P5|Treatment Period 2|Lost to Follow-up|0
7527583|NCT02748863|26150837|P4|Treatment Period 2|Lost to Follow-up|0
7527584|NCT02748863|26150838|P3|Treatment Period 2|Lost to Follow-up|0
7527585|NCT02748863|26150839|P2|Treatment Period 2|Lost to Follow-up|0
7527586|NCT02748863|26150840|P1|Treatment Period 2|Lost to Follow-up|2
7527587|NCT02748863|26150836|P5|Treatment Period 1|Withdrawal by Subject|0
7527588|NCT02748863|26150837|P4|Treatment Period 1|Withdrawal by Subject|0
7527589|NCT02748863|26150838|P3|Treatment Period 1|Withdrawal by Subject|1
7527590|NCT02748863|26150839|P2|Treatment Period 1|Withdrawal by Subject|1
7527591|NCT02748863|26150840|P1|Treatment Period 1|Withdrawal by Subject|0
7527592|NCT02748863|26150836|P5|Treatment Period 1|Lack of Efficacy|0
7527593|NCT02748863|26150837|P4|Treatment Period 1|Lack of Efficacy|0
7527594|NCT02748863|26150838|P3|Treatment Period 1|Lack of Efficacy|1
7527595|NCT02748863|26150839|P2|Treatment Period 1|Lack of Efficacy|0
7527596|NCT02748863|26150840|P1|Treatment Period 1|Lack of Efficacy|0
7527597|NCT02748863|26150836|P5|Treatment Period 1|Adverse Event|0
7527598|NCT02748863|26150837|P4|Treatment Period 1|Adverse Event|0
7527599|NCT02748863|26150838|P3|Treatment Period 1|Adverse Event|0
7527600|NCT02748863|26150839|P2|Treatment Period 1|Adverse Event|1
7527601|NCT02748863|26150840|P1|Treatment Period 1|Adverse Event|0
7527602|NCT02748694|26150930|P15|Overall Study|Voluntary Withdrawal|2
7527603|NCT02748694|26150931|P14|Overall Study|Voluntary Withdrawal|0
7527604|NCT02748694|26150932|P13|Overall Study|Voluntary Withdrawal|0
7527605|NCT02748694|26150933|P12|Overall Study|Voluntary Withdrawal|0
7527606|NCT02748694|26150934|P11|Overall Study|Voluntary Withdrawal|0
7527607|NCT02748694|26150935|P10|Overall Study|Voluntary Withdrawal|0
7527608|NCT02748694|26150936|P9|Overall Study|Voluntary Withdrawal|0
7527609|NCT02748694|26150937|P8|Overall Study|Voluntary Withdrawal|0
7527610|NCT02748694|26150938|P7|Overall Study|Voluntary Withdrawal|0
7527611|NCT02748694|26150939|P6|Overall Study|Voluntary Withdrawal|0
7527612|NCT02748694|26150940|P5|Overall Study|Voluntary Withdrawal|0
7527613|NCT02748694|26150941|P4|Overall Study|Voluntary Withdrawal|0
7527614|NCT02748694|26150942|P3|Overall Study|Voluntary Withdrawal|0
7527615|NCT02748694|26150943|P2|Overall Study|Voluntary Withdrawal|0
7527616|NCT02748694|26150944|P1|Overall Study|Voluntary Withdrawal|0
7527617|NCT02748616|26151152|P1|Overall Study|Did Not Complete Ursodial Course|2
7527618|NCT02748616|26151152|P1|Overall Study|Physician Decision|2
7527619|NCT02748616|26151152|P1|Overall Study|Withdrawal by Subject|2
7527620|NCT02748616|26151152|P1|Overall Study|Lost to Follow-up|1
7527621|NCT02748512|26151165|P2|Overall Study|Lost to Follow-up|1
7527622|NCT02748512|26151166|P1|Overall Study|Lost to Follow-up|1
7527623|NCT02748356|26151174|P1|Overall Study|Withdrawal by Subject|1
7527624|NCT02748317|26151179|P1|Overall Study|Death|1
7527625|NCT02748317|26151179|P1|Overall Study|Lost to Follow-up|8
7527626|NCT02748317|26151179|P1|Overall Study|Withdrawal by Subject|14
7527627|NCT02748213|26151186|P2|Overall Study|Other|29
7527628|NCT02748213|26151187|P1|Overall Study|Other|30
7527629|NCT02748213|26151186|P2|Overall Study|Failure to Return|0
7527630|NCT02748213|26151187|P1|Overall Study|Failure to Return|1
7527631|NCT02748213|26151186|P2|Overall Study|Refused Treatment*|6
7527632|NCT02748213|26151187|P1|Overall Study|Refused Treatment*|6
7527633|NCT02748213|26151186|P2|Overall Study|Protocol Violation|4
7527634|NCT02748213|26151187|P1|Overall Study|Protocol Violation|6
7527635|NCT02748213|26151186|P2|Overall Study|Violation of Selection Criteria|0
7527636|NCT02748213|26151187|P1|Overall Study|Violation of Selection Criteria|2
7527637|NCT02748213|26151186|P2|Overall Study|Insufficient Therapeutic Response|57
7527638|NCT02748213|26151187|P1|Overall Study|Insufficient Therapeutic Response|56
7527639|NCT02748213|26151186|P2|Overall Study|Death|3
7527640|NCT02748213|26151187|P1|Overall Study|Death|5
7527641|NCT02748213|26151186|P2|Overall Study|Adverse Event or Intercurrent Illness|11
7527642|NCT02748213|26151187|P1|Overall Study|Adverse Event or Intercurrent Illness|5
7527643|NCT02748213|26151186|P2|Overall Study|Abnormal Laboratory Test|0
7527644|NCT02748213|26151187|P1|Overall Study|Abnormal Laboratory Test|1
7527645|NCT02748213|26151186|P2|Overall Study|Withdrawal Prior to Treatment|2
7527646|NCT02748213|26151187|P1|Overall Study|Withdrawal Prior to Treatment|1
7527647|NCT02748057|26151216|P2|Overall Study|Withdrawal by Subject|0
7527648|NCT02748057|26151217|P1|Overall Study|Withdrawal by Subject|1
7527649|NCT02748057|26151216|P2|Overall Study|Participant Moved|0
7527650|NCT02748057|26151217|P1|Overall Study|Participant Moved|1
7527651|NCT02748057|26151216|P2|Overall Study|Protocol Violation|1
7527652|NCT02748057|26151217|P1|Overall Study|Protocol Violation|2
7527653|NCT02748057|26151216|P2|Overall Study|Physician Decision|1
7527654|NCT02748057|26151217|P1|Overall Study|Physician Decision|0
7527655|NCT02748057|26151216|P2|Overall Study|Adverse Event|0
7527656|NCT02748057|26151217|P1|Overall Study|Adverse Event|1
7527657|NCT02747927|26151229|P2|Overall Study|Reason not Specified|27
7527658|NCT02747927|26151230|P1|Overall Study|Reason not Specified|11
7527659|NCT02747927|26151229|P2|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
7527660|NCT02747927|26151230|P1|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
7527661|NCT02747927|26151229|P2|Overall Study|Protocol Violation|4
7527662|NCT02747927|26151230|P1|Overall Study|Protocol Violation|2
7527663|NCT02747927|26151229|P2|Overall Study|Pregnancy|66
7527664|NCT02747927|26151230|P1|Overall Study|Pregnancy|34
7527665|NCT02747927|26151229|P2|Overall Study|Lost to Follow-up|43
7527666|NCT02747927|26151230|P1|Overall Study|Lost to Follow-up|22
7527667|NCT02747927|26151229|P2|Overall Study|Adverse Event|14
7527668|NCT02747927|26151230|P1|Overall Study|Adverse Event|5
7527669|NCT02747875|26151238|P2|Overall Study|Adverse Event|1
7527670|NCT02747875|26151239|P1|Overall Study|Adverse Event|0
7527671|NCT02747875|26151238|P2|Overall Study|Physician Decision|0
7527672|NCT02747875|26151239|P1|Overall Study|Physician Decision|1
7527673|NCT02747420|26151306|P2|Overall Study|Withdrawal by Subject|2
7527674|NCT02747420|26151307|P1|Overall Study|Withdrawal by Subject|3
7527675|NCT02747420|26151306|P2|Overall Study|Lost to Follow-up|2
7527676|NCT02747420|26151307|P1|Overall Study|Lost to Follow-up|4
7527677|NCT02747238|26151315|P2|Overall Study|Data lost|5
7527678|NCT02747238|26151316|P1|Overall Study|Data lost|3
7527679|NCT02747238|26151315|P2|Overall Study|Lack of Efficacy|1
7527680|NCT02747238|26151316|P1|Overall Study|Lack of Efficacy|0
7527681|NCT02747108|26151339|P2|Overall Study|Protocol Violation|0
7527682|NCT02747108|26151340|P1|Overall Study|Protocol Violation|2
7527683|NCT02747108|26151339|P2|Overall Study|Withdrawal by Subject|0
7527684|NCT02747108|26151340|P1|Overall Study|Withdrawal by Subject|1
7527685|NCT02747108|26151339|P2|Overall Study|Death|2
7527686|NCT02747108|26151340|P1|Overall Study|Death|2
7527687|NCT02747043|26151382|P2|Overall Study|Disease progression|0
7527688|NCT02747043|26151383|P1|Overall Study|Disease progression|4
7527689|NCT02747043|26151382|P2|Overall Study|Protocol Violation|1
7527690|NCT02747043|26151383|P1|Overall Study|Protocol Violation|0
7527691|NCT02747043|26151382|P2|Overall Study|Physician Decision|1
7527692|NCT02747043|26151383|P1|Overall Study|Physician Decision|1
7527693|NCT02747043|26151382|P2|Overall Study|Withdrawal by Subject|1
7527694|NCT02747043|26151383|P1|Overall Study|Withdrawal by Subject|1
7527695|NCT02747043|26151382|P2|Overall Study|Adverse Event|1
7527696|NCT02747043|26151383|P1|Overall Study|Adverse Event|3
7527697|NCT02747043|26151382|P2|Overall Study|Other|1
7527698|NCT02747043|26151383|P1|Overall Study|Other|1
7527699|NCT02747004|26151412|P3|Overall Study|on study treatment/follow-up|41
7527700|NCT02747004|26151413|P2|Overall Study|on study treatment/follow-up|42
7527701|NCT02747004|26151414|P1|Overall Study|on study treatment/follow-up|48
7527702|NCT02747004|26151412|P3|Overall Study|Lost to Follow-up|2
7527703|NCT02747004|26151413|P2|Overall Study|Lost to Follow-up|2
7527704|NCT02747004|26151414|P1|Overall Study|Lost to Follow-up|1
7527705|NCT02747004|26151412|P3|Overall Study|Withdrawal by Subject|4
7527706|NCT02747004|26151413|P2|Overall Study|Withdrawal by Subject|5
7527707|NCT02747004|26151414|P1|Overall Study|Withdrawal by Subject|8
7527708|NCT02746874|26151455|P2|Overall Study|Surgery Date Changed|2
7527709|NCT02746874|26151456|P1|Overall Study|Surgery Date Changed|0
7527710|NCT02746874|26151455|P2|Overall Study|Withdrawal by Subject|1
7527711|NCT02746874|26151456|P1|Overall Study|Withdrawal by Subject|0
7527712|NCT02746705|26151522|P2|Overall Study|outlier scores deemed not valid|1
7527713|NCT02746705|26151523|P1|Overall Study|outlier scores deemed not valid|0
7527714|NCT02746705|26151522|P2|Overall Study|Lost to Follow-up|0
7527715|NCT02746705|26151523|P1|Overall Study|Lost to Follow-up|1
7527716|NCT02746705|26151522|P2|Overall Study|Physician Decision|1
7527717|NCT02746705|26151523|P1|Overall Study|Physician Decision|1
7527718|NCT02746679|26151537|P2|Overall Study|Lost to Follow-up|6
7527719|NCT02746679|26151538|P1|Overall Study|Lost to Follow-up|4
7527720|NCT02746627|26151571|P3|Overall Study|Withdrawal by Subject|1
7527721|NCT02746627|26151572|P2|Overall Study|Withdrawal by Subject|1
7527722|NCT02746627|26151573|P1|Overall Study|Withdrawal by Subject|1
7527723|NCT02746575|26151596|P1|Overall Study|Unknown history of CVA|1
7527724|NCT02746575|26151596|P1|Overall Study|PI unavailable|1
7527725|NCT02746575|26151596|P1|Overall Study|typ of surgery|1
7527726|NCT02746575|26151596|P1|Overall Study|type of surgery|1
7527727|NCT02746575|26151596|P1|Overall Study|put on beta-blocker|3
7527728|NCT02746575|26151596|P1|Overall Study|Study paused|8
7527729|NCT02746575|26151596|P1|Overall Study|Bradycardia/hypotension|9
7527730|NCT02746575|26151596|P1|Overall Study|Withdrawal by Subject|3
7527731|NCT02746575|26151596|P1|Overall Study|Received epidural|10
7527732|NCT02746575|26151596|P1|Overall Study|Surgery cancelled or time chaned|13
7527733|NCT02745535|26151659|P1|Overall Study|Lost to Follow-up|2
7527734|NCT02745535|26151659|P1|Overall Study|Adverse Event|3
7527735|NCT02745535|26151659|P1|Overall Study|Death|1
7527736|NCT02745392|26151671|P4|Overall Study|Lost to Follow-up|0
7527737|NCT02745392|26151672|P3|Overall Study|Lost to Follow-up|0
7527738|NCT02745392|26151673|P2|Overall Study|Lost to Follow-up|1
7527739|NCT02745392|26151674|P1|Overall Study|Lost to Follow-up|0
7527740|NCT02745145|26151707|P3|Overall Study|Study Termination|7
7527741|NCT02745145|26151708|P2|Overall Study|Study Termination|3
7527742|NCT02745145|26151709|P1|Overall Study|Study Termination|8
7527743|NCT02745145|26151707|P3|Overall Study|Withdrew consent|1
7527744|NCT02745145|26151708|P2|Overall Study|Withdrew consent|1
7527745|NCT02745145|26151709|P1|Overall Study|Withdrew consent|1
7527746|NCT02745145|26151707|P3|Overall Study|Progressive disease|1
7527747|NCT02745145|26151708|P2|Overall Study|Progressive disease|0
7527748|NCT02745145|26151709|P1|Overall Study|Progressive disease|0
7527749|NCT02745145|26151707|P3|Overall Study|Death|0
7527750|NCT02745145|26151708|P2|Overall Study|Death|1
7527751|NCT02745145|26151709|P1|Overall Study|Death|0
7527752|NCT02745145|26151707|P3|Overall Study|Adverse Event|0
7527753|NCT02745145|26151708|P2|Overall Study|Adverse Event|0
7527754|NCT02745145|26151709|P1|Overall Study|Adverse Event|1
7527755|NCT02745119|26151748|P4|Overall Study|Reason Not Specified|1
7527756|NCT02745119|26151749|P3|Overall Study|Reason Not Specified|0
7527757|NCT02745119|26151750|P2|Overall Study|Reason Not Specified|2
7527758|NCT02745119|26151751|P1|Overall Study|Reason Not Specified|0
7527759|NCT02745119|26151748|P4|Overall Study|Physician Decision|2
7527760|NCT02745119|26151749|P3|Overall Study|Physician Decision|2
7527761|NCT02745119|26151750|P2|Overall Study|Physician Decision|2
7527762|NCT02745119|26151751|P1|Overall Study|Physician Decision|0
7527763|NCT02745119|26151748|P4|Overall Study|Study Terminated by Sponsor|251
7527764|NCT02745119|26151749|P3|Overall Study|Study Terminated by Sponsor|135
7527765|NCT02745119|26151750|P2|Overall Study|Study Terminated by Sponsor|252
7527766|NCT02745119|26151751|P1|Overall Study|Study Terminated by Sponsor|134
7527767|NCT02745119|26151748|P4|Overall Study|Withdrawal by Subject|14
7527768|NCT02745119|26151749|P3|Overall Study|Withdrawal by Subject|8
7527769|NCT02745119|26151750|P2|Overall Study|Withdrawal by Subject|15
7527770|NCT02745119|26151751|P1|Overall Study|Withdrawal by Subject|7
7527771|NCT02745119|26151748|P4|Overall Study|Protocol Deviation|1
7527772|NCT02745119|26151749|P3|Overall Study|Protocol Deviation|0
7527773|NCT02745119|26151750|P2|Overall Study|Protocol Deviation|0
7527774|NCT02745119|26151751|P1|Overall Study|Protocol Deviation|0
7527775|NCT02745119|26151748|P4|Overall Study|Lost to Follow-up|1
7527776|NCT02745119|26151749|P3|Overall Study|Lost to Follow-up|0
7527777|NCT02745119|26151750|P2|Overall Study|Lost to Follow-up|0
7527778|NCT02745119|26151751|P1|Overall Study|Lost to Follow-up|0
7527779|NCT02745119|26151748|P4|Overall Study|Death|4
7527780|NCT02745119|26151749|P3|Overall Study|Death|0
7527781|NCT02745119|26151750|P2|Overall Study|Death|3
7527782|NCT02745119|26151751|P1|Overall Study|Death|3
7527783|NCT02745119|26151748|P4|Overall Study|Adverse Event|3
7527784|NCT02745119|26151749|P3|Overall Study|Adverse Event|1
7527785|NCT02745119|26151750|P2|Overall Study|Adverse Event|0
7527786|NCT02745119|26151751|P1|Overall Study|Adverse Event|1
7527787|NCT02745080|26151775|P2|Overall Study|Withdrawal by Subject|41
7527788|NCT02745080|26151776|P1|Overall Study|Withdrawal by Subject|22
7527789|NCT02745080|26151775|P2|Overall Study|Protocol Violation|1
7527790|NCT02745080|26151776|P1|Overall Study|Protocol Violation|3
7527791|NCT02745080|26151775|P2|Overall Study|Physician Decision|0
7527792|NCT02745080|26151776|P1|Overall Study|Physician Decision|3
7527793|NCT02745080|26151775|P2|Overall Study|Lost to Follow-up|3
7527794|NCT02745080|26151776|P1|Overall Study|Lost to Follow-up|3
7527795|NCT02745080|26151775|P2|Overall Study|Lack of Efficacy|23
7527796|NCT02745080|26151776|P1|Overall Study|Lack of Efficacy|11
7527797|NCT02745080|26151775|P2|Overall Study|Adverse Event|21
7527798|NCT02745080|26151776|P1|Overall Study|Adverse Event|13
7527799|NCT02744898|26151791|P1|Overall Study|Toxicity|1
7527800|NCT02744898|26151791|P1|Overall Study|Physician Decision|1
7527801|NCT02744898|26151791|P1|Overall Study|Progressive Disease|2
7527802|NCT02744755|26151805|P2|Study Period 2|Lack of Efficacy|2
7527803|NCT02744755|26151806|P1|Study Period 2|Lack of Efficacy|3
7527804|NCT02744755|26151805|P2|Study Period 2|Withdrawal by Subject|2
7527805|NCT02744755|26151806|P1|Study Period 2|Withdrawal by Subject|2
7527806|NCT02744755|26151805|P2|Study Period 2|Lost to Follow-up|2
7527807|NCT02744755|26151806|P1|Study Period 2|Lost to Follow-up|0
7527808|NCT02744755|26151805|P2|Study Period 2|not defined|2
7527809|NCT02744755|26151806|P1|Study Period 2|not defined|3
7527810|NCT02744755|26151805|P2|Study Period 2|Protocol Violation|0
7527811|NCT02744755|26151806|P1|Study Period 2|Protocol Violation|1
7527812|NCT02744755|26151805|P2|Study Period 2|Adverse Event|0
7527813|NCT02744755|26151806|P1|Study Period 2|Adverse Event|5
7527814|NCT02744755|26151805|P2|Study Period 1|Withdrawal by Subject|4
7527815|NCT02744755|26151806|P1|Study Period 1|Withdrawal by Subject|8
7527816|NCT02744755|26151805|P2|Study Period 1|Lack of Efficacy|0
7527817|NCT02744755|26151806|P1|Study Period 1|Lack of Efficacy|1
7527818|NCT02744755|26151805|P2|Study Period 1|Lost to Follow-up|1
7527819|NCT02744755|26151806|P1|Study Period 1|Lost to Follow-up|1
7527820|NCT02744755|26151805|P2|Study Period 1|Adverse Event|1
7527821|NCT02744755|26151806|P1|Study Period 1|Adverse Event|1
7527822|NCT02744755|26151805|P2|Study Period 1|Pregnancy|0
7527823|NCT02744755|26151806|P1|Study Period 1|Pregnancy|1
7527824|NCT02744755|26151805|P2|Study Period 1|not defined|1
7527825|NCT02744755|26151806|P1|Study Period 1|not defined|0
7527826|NCT02744755|26151805|P2|Study Period 1|Protocol Violation|1
7527827|NCT02744755|26151806|P1|Study Period 1|Protocol Violation|2
7527828|NCT02744391|26151866|P1|Overall Study|Withdrawal by Subject|3
7527829|NCT02744391|26151866|P1|Overall Study|Physician Decision|2
7527830|NCT02744391|26151866|P1|Overall Study|Lost to Follow-up|9
7527831|NCT02744066|26151907|P2|Overall Study|Discharged from NICU prior to completion|4
7527832|NCT02744066|26151908|P1|Overall Study|Discharged from NICU prior to completion|0
7527833|NCT02744066|26151907|P2|Overall Study|Withdrawal by parent|1
7527834|NCT02744066|26151908|P1|Overall Study|Withdrawal by parent|0
7527835|NCT02743962|26151918|P2|Overall Study|Atrophic vaginitis diagnosed|0
7527836|NCT02743962|26151919|P1|Overall Study|Atrophic vaginitis diagnosed|1
7527837|NCT02743949|26151941|P3|Overall Study|Voluntary Withdrawal|0
7527838|NCT02743949|26151942|P2|Overall Study|Voluntary Withdrawal|1
7527839|NCT02743949|26151943|P1|Overall Study|Voluntary Withdrawal|2
7527840|NCT02743949|26151941|P3|Overall Study|Significant Protocol Deviation|1
7527841|NCT02743949|26151942|P2|Overall Study|Significant Protocol Deviation|0
7527842|NCT02743949|26151943|P1|Overall Study|Significant Protocol Deviation|2
7527843|NCT02743949|26151941|P3|Overall Study|Adverse Event|2
7527844|NCT02743949|26151942|P2|Overall Study|Adverse Event|0
7527845|NCT02743949|26151943|P1|Overall Study|Adverse Event|0
7527846|NCT02743793|26151967|P2|Overall Study|Study stopped due to COVID-19 pandemic|32
7527847|NCT02743793|26151968|P1|Overall Study|Study stopped due to COVID-19 pandemic|0
7527848|NCT02743793|26151967|P2|Overall Study|Travel/remote visits could not be performed at nursing facility|1
7527849|NCT02743793|26151968|P1|Overall Study|Travel/remote visits could not be performed at nursing facility|0
7527850|NCT02743793|26151967|P2|Overall Study|No Primary Care Physician|1
7527851|NCT02743793|26151968|P1|Overall Study|No Primary Care Physician|0
7527852|NCT02743793|26151967|P2|Overall Study|Screen Failure|0
7527853|NCT02743793|26151968|P1|Overall Study|Screen Failure|4
7527854|NCT02743793|26151967|P2|Overall Study|Withdrawal by Subject|1
7527855|NCT02743793|26151968|P1|Overall Study|Withdrawal by Subject|0
7527856|NCT02743793|26151967|P2|Overall Study|Death|1
7527857|NCT02743793|26151968|P1|Overall Study|Death|1
7527858|NCT02743780|26151980|P5|Part 3 (7 Days)|Adverse Event|0
7527859|NCT02743780|26151981|P4|Part 3 (7 Days)|Adverse Event|0
7527860|NCT02743780|26151982|P3|Part 3 (7 Days)|Adverse Event|1
7527861|NCT02743780|26151983|P2|Part 3 (7 Days)|Adverse Event|0
7527862|NCT02743780|26151984|P1|Part 3 (7 Days)|Adverse Event|0
7527863|NCT02743520|26152038|P1|Overall Study|Withdrawal by Subject|1
7527864|NCT02743494|26152048|P2|Treatment Period|Other reasons|2
7527865|NCT02743494|26152049|P1|Treatment Period|Other reasons|7
7527866|NCT02743494|26152048|P2|Treatment Period|Poor/Non-compliance|0
7527867|NCT02743494|26152049|P1|Treatment Period|Poor/Non-compliance|1
7527868|NCT02743494|26152048|P2|Treatment Period|Lost to Follow-up|1
7527869|NCT02743494|26152049|P1|Treatment Period|Lost to Follow-up|0
7527870|NCT02743494|26152048|P2|Treatment Period|Participant withdrew consent|4
7527871|NCT02743494|26152049|P1|Treatment Period|Participant withdrew consent|12
7527872|NCT02743494|26152048|P2|Treatment Period|Participant request to discontinue treatment|5
7527873|NCT02743494|26152049|P1|Treatment Period|Participant request to discontinue treatment|30
7527874|NCT02743494|26152048|P2|Treatment Period|Adverse event unrelated to study drug|9
7527875|NCT02743494|26152049|P1|Treatment Period|Adverse event unrelated to study drug|15
7527876|NCT02743494|26152048|P2|Treatment Period|Death|0
7527877|NCT02743494|26152049|P1|Treatment Period|Death|1
7527878|NCT02743494|26152048|P2|Treatment Period|Study drug toxicity|8
7527879|NCT02743494|26152049|P1|Treatment Period|Study drug toxicity|57
7527880|NCT02743494|26152048|P2|Treatment Period|Disease recurrence|113
7527881|NCT02743494|26152049|P1|Treatment Period|Disease recurrence|149
7527882|NCT02743494|26152048|P2|Treatment Period|Completed treatment|99
7527883|NCT02743494|26152049|P1|Treatment Period|Completed treatment|229
7527884|NCT02743494|26152048|P2|Pre-treatment Period|Participant no longer meeting study criteria|1
7527885|NCT02743494|26152049|P1|Pre-treatment Period|Participant no longer meeting study criteria|0
7527886|NCT02743494|26152048|P2|Pre-treatment Period|Participant request to discontinue treatment|1
7527887|NCT02743494|26152049|P1|Pre-treatment Period|Participant request to discontinue treatment|0
7527888|NCT02743221|26152124|P2|Overall Study|Patient not eligible, not treated|1
7527889|NCT02743221|26152125|P1|Overall Study|Patient not eligible, not treated|0
7527890|NCT02743221|26152124|P2|Overall Study|Physician Decision|5
7527891|NCT02743221|26152125|P1|Overall Study|Physician Decision|2
7527892|NCT02743221|26152124|P2|Overall Study|non medical reason|2
7527893|NCT02743221|26152125|P1|Overall Study|non medical reason|8
7527894|NCT02743221|26152124|P2|Overall Study|Adverse Event|14
7527895|NCT02743221|26152125|P1|Overall Study|Adverse Event|17
7527896|NCT02743221|26152124|P2|Overall Study|Progressive disease|38
7527897|NCT02743221|26152125|P1|Overall Study|Progressive disease|29
7527898|NCT02743117|26152141|P2|Overall Study|Other|0
7527899|NCT02743117|26152142|P1|Overall Study|Other|1
7527900|NCT02743117|26152141|P2|Overall Study|Lost to Follow-up|1
7527901|NCT02743117|26152142|P1|Overall Study|Lost to Follow-up|0
7527902|NCT02742818|26152175|P2|Overall Study|Protocol Violation|1
7527903|NCT02742818|26152176|P1|Overall Study|Protocol Violation|0
7527904|NCT02742818|26152175|P2|Overall Study|Adverse Event|1
7527905|NCT02742818|26152176|P1|Overall Study|Adverse Event|0
7527906|NCT02742766|26152209|P19|Part 2 (Up to 22 Days)|Physician Decision|0
7527907|NCT02742766|26152210|P18|Part 2 (Up to 22 Days)|Physician Decision|0
7527908|NCT02742766|26152211|P17|Part 2 (Up to 22 Days)|Physician Decision|0
7527909|NCT02742766|26152212|P16|Part 2 (Up to 22 Days)|Physician Decision|1
7527910|NCT02742766|26152213|P15|Part 2 (Up to 22 Days)|Physician Decision|0
7527911|NCT02742766|26152214|P14|Part 2 (Up to 22 Days)|Physician Decision|5
7527912|NCT02742766|26152215|P13|Part 2 (Up to 22 Days)|Physician Decision|2
7527913|NCT02742766|26152216|P12|Part 2 (Up to 22 Days)|Physician Decision|0
7527914|NCT02742766|26152217|P11|Part 2 (Up to 22 Days)|Physician Decision|0
7527915|NCT02742766|26152218|P10|Part 2 (Up to 22 Days)|Physician Decision|0
7527916|NCT02742766|26152219|P9|Part 2 (Up to 22 Days)|Physician Decision|0
7527917|NCT02742766|26152220|P8|Part 2 (Up to 22 Days)|Physician Decision|0
7527918|NCT02742766|26152221|P7|Part 2 (Up to 22 Days)|Physician Decision|0
7527919|NCT02742766|26152222|P6|Part 2 (Up to 22 Days)|Physician Decision|0
7527920|NCT02742766|26152223|P5|Part 2 (Up to 22 Days)|Physician Decision|0
7527921|NCT02742766|26152224|P4|Part 2 (Up to 22 Days)|Physician Decision|0
7527922|NCT02742766|26152225|P3|Part 2 (Up to 22 Days)|Physician Decision|0
7527923|NCT02742766|26152226|P2|Part 2 (Up to 22 Days)|Physician Decision|0
7527924|NCT02742766|26152227|P1|Part 2 (Up to 22 Days)|Physician Decision|0
7527925|NCT02742766|26152209|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527926|NCT02742766|26152210|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527927|NCT02742766|26152211|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527928|NCT02742766|26152212|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527929|NCT02742766|26152213|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527930|NCT02742766|26152214|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
7527931|NCT02742766|26152215|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527932|NCT02742766|26152216|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527933|NCT02742766|26152217|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527934|NCT02742766|26152218|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527935|NCT02742766|26152219|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527936|NCT02742766|26152220|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527937|NCT02742766|26152221|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527938|NCT02742766|26152222|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527939|NCT02742766|26152223|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527940|NCT02742766|26152224|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527941|NCT02742766|26152225|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527942|NCT02742766|26152226|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527943|NCT02742766|26152227|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7527944|NCT02742649|26152487|P5|Open-Label Period|Lost to Follow-up|1
7527945|NCT02742649|26152488|P4|Open-Label Period|Lost to Follow-up|0
7527946|NCT02742649|26152489|P3|Open-Label Period|Lost to Follow-up|0
7527947|NCT02742649|26152490|P2|Open-Label Period|Lost to Follow-up|0
7527948|NCT02742649|26152491|P1|Open-Label Period|Lost to Follow-up|0
7527949|NCT02742649|26152487|P5|Double-Blind Treatment Period|Adverse Event|0
7527950|NCT02742649|26152488|P4|Double-Blind Treatment Period|Adverse Event|0
7527951|NCT02742649|26152489|P3|Double-Blind Treatment Period|Adverse Event|0
7527952|NCT02742649|26152490|P2|Double-Blind Treatment Period|Adverse Event|1
7527953|NCT02742649|26152491|P1|Double-Blind Treatment Period|Adverse Event|0
7527954|NCT02742649|26152487|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7527955|NCT02742649|26152488|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7527956|NCT02742649|26152489|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7527957|NCT02742649|26152490|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7527958|NCT02742649|26152491|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
7527959|NCT02742519|26152530|P3|Part 2 Open Label Period (32 Weeks)|Other|1
7527960|NCT02742519|26152531|P2|Part 2 Open Label Period (32 Weeks)|Other|0
7527961|NCT02742519|26152532|P1|Part 2 Open Label Period (32 Weeks)|Other|0
7527962|NCT02742519|26152530|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
7527963|NCT02742519|26152531|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7527964|NCT02742519|26152532|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7527965|NCT02742519|26152530|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
7527966|NCT02742519|26152531|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7527967|NCT02742519|26152532|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7527968|NCT02742441|26152552|P2|Overall Study|Adverse Event|2
7527969|NCT02742441|26152553|P1|Overall Study|Adverse Event|0
7527970|NCT02742441|26152552|P2|Overall Study|Withdrawal by Subject|2
7527971|NCT02742441|26152553|P1|Overall Study|Withdrawal by Subject|2
7527972|NCT02742441|26152552|P2|Overall Study|Lost to Follow-up|4
7527973|NCT02742441|26152553|P1|Overall Study|Lost to Follow-up|4
7527974|NCT02742103|26152600|P2|Overall Study|Withdrawal by Subject|2
7527975|NCT02742103|26152601|P1|Overall Study|Withdrawal by Subject|5
7527976|NCT02742103|26152600|P2|Overall Study|Moved to another town|1
7527977|NCT02742103|26152601|P1|Overall Study|Moved to another town|0
7527978|NCT02742103|26152600|P2|Overall Study|Adverse Event|0
7527979|NCT02742103|26152601|P1|Overall Study|Adverse Event|1
7527980|NCT02742103|26152600|P2|Overall Study|Death|2
7527981|NCT02742103|26152601|P1|Overall Study|Death|2
7527982|NCT02742103|26152600|P2|Overall Study|Protocol Violation|0
7527983|NCT02742103|26152601|P1|Overall Study|Protocol Violation|1
7527984|NCT02741713|26152647|P2|Overall Study|Surgery type changed intra-operatively|1
7527985|NCT02741713|26152648|P1|Overall Study|Surgery type changed intra-operatively|2
7527986|NCT02741635|26152688|P1|Overall Study|Withdrawal by Subject|1
7527987|NCT02741596|26152696|P2|Overall Study|Subject withdrawn-to commercial product|63
7527988|NCT02741596|26152697|P1|Overall Study|Subject withdrawn-to commercial product|54
7527989|NCT02741596|26152696|P2|Overall Study|Subject withdrawn-Other|4
7527990|NCT02741596|26152697|P1|Overall Study|Subject withdrawn-Other|17
7527991|NCT02741596|26152696|P2|Overall Study|Other (Unspecified)|3
7527992|NCT02741596|26152697|P1|Overall Study|Other (Unspecified)|0
7527993|NCT02741596|26152696|P2|Overall Study|Pregnancy|1
7527994|NCT02741596|26152697|P1|Overall Study|Pregnancy|3
7527995|NCT02741596|26152696|P2|Overall Study|Physician Decision|1
7527996|NCT02741596|26152697|P1|Overall Study|Physician Decision|2
7527997|NCT02741596|26152696|P2|Overall Study|Lost to Follow-up|1
7527998|NCT02741596|26152697|P1|Overall Study|Lost to Follow-up|1
7527999|NCT02741596|26152696|P2|Overall Study|Adverse Event|5
7528000|NCT02741596|26152697|P1|Overall Study|Adverse Event|1
7528001|NCT02741518|26152715|P2|Overall Study|Withdrawal by Subject|1
7528002|NCT02741518|26152716|P1|Overall Study|Withdrawal by Subject|1
7528003|NCT02741310|26152726|P2|Overall Study|Sponsor Decision|2
7528004|NCT02741310|26152727|P1|Overall Study|Sponsor Decision|2
7528005|NCT02741271|26152774|P2|Overall Study|Withdrawal by Parent/Guardian|2
7528006|NCT02741271|26152775|P1|Overall Study|Withdrawal by Parent/Guardian|0
7528007|NCT02741271|26152774|P2|Overall Study|Lost to Follow-up|0
7528008|NCT02741271|26152775|P1|Overall Study|Lost to Follow-up|2
7528009|NCT02741245|26152808|P5|Overall Study|Withdrawal by Subject|0
7528010|NCT02741245|26152809|P4|Overall Study|Withdrawal by Subject|1
7528011|NCT02741245|26152810|P3|Overall Study|Withdrawal by Subject|0
7528012|NCT02741245|26152811|P2|Overall Study|Withdrawal by Subject|0
7528013|NCT02741245|26152812|P1|Overall Study|Withdrawal by Subject|0
7528014|NCT02741245|26152808|P5|Overall Study|Protocol Violation|0
7528015|NCT02741245|26152809|P4|Overall Study|Protocol Violation|1
7528016|NCT02741245|26152810|P3|Overall Study|Protocol Violation|0
7528017|NCT02741245|26152811|P2|Overall Study|Protocol Violation|1
7528018|NCT02741245|26152812|P1|Overall Study|Protocol Violation|0
7528019|NCT02741245|26152808|P5|Overall Study|Adverse Event|2
7528020|NCT02741245|26152809|P4|Overall Study|Adverse Event|2
7528021|NCT02741245|26152810|P3|Overall Study|Adverse Event|0
7528022|NCT02741245|26152811|P2|Overall Study|Adverse Event|0
7528023|NCT02741245|26152812|P1|Overall Study|Adverse Event|0
7528024|NCT02741076|26152918|P4|Overall Study|No additional information available|1
7528025|NCT02741076|26152919|P3|Overall Study|No additional information available|1
7528026|NCT02741076|26152920|P2|Overall Study|No additional information available|0
7528027|NCT02741076|26152921|P1|Overall Study|No additional information available|0
7528028|NCT02741076|26152918|P4|Overall Study|Sponsor Request|1
7528029|NCT02741076|26152919|P3|Overall Study|Sponsor Request|0
7528030|NCT02741076|26152920|P2|Overall Study|Sponsor Request|3
7528031|NCT02741076|26152921|P1|Overall Study|Sponsor Request|2
7528032|NCT02741076|26152918|P4|Overall Study|Withdrawal by Subject|0
7528033|NCT02741076|26152919|P3|Overall Study|Withdrawal by Subject|0
7528034|NCT02741076|26152920|P2|Overall Study|Withdrawal by Subject|1
7528035|NCT02741076|26152921|P1|Overall Study|Withdrawal by Subject|0
7528036|NCT02741076|26152918|P4|Overall Study|Lack of Efficacy|0
7528037|NCT02741076|26152919|P3|Overall Study|Lack of Efficacy|0
7528038|NCT02741076|26152920|P2|Overall Study|Lack of Efficacy|0
7528039|NCT02741076|26152921|P1|Overall Study|Lack of Efficacy|1
7528040|NCT02741076|26152918|P4|Overall Study|Adverse Event|0
7528041|NCT02741076|26152919|P3|Overall Study|Adverse Event|1
7528042|NCT02741076|26152920|P2|Overall Study|Adverse Event|1
7528043|NCT02741076|26152921|P1|Overall Study|Adverse Event|0
7528044|NCT02740478|26153096|P1|Overall Study|Withdrawal by Subject|1
7528045|NCT02740049|26153177|P1|Overall Study|Isolated cells did not grow sufficiently|1
7528046|NCT02739997|26153183|P1|Overall Study|Withdrawal by Subject|1
7528047|NCT02739997|26153183|P1|Overall Study|Death|1
7528048|NCT02739984|26153197|P2|Overall Study|Lost to Follow-up|0
7528049|NCT02739984|26153198|P1|Overall Study|Lost to Follow-up|3
7528050|NCT02739984|26153197|P2|Overall Study|Death|1
7528051|NCT02739984|26153198|P1|Overall Study|Death|0
7528052|NCT02739984|26153197|P2|Overall Study|Withdrawal by Subject|1
7528053|NCT02739984|26153198|P1|Overall Study|Withdrawal by Subject|1
7528054|NCT02739984|26153197|P2|Overall Study|Sponsor Decision|0
7528055|NCT02739984|26153198|P1|Overall Study|Sponsor Decision|1
7528056|NCT02739828|26153246|P1|Overall Study|Lost to Follow-up|4
7528057|NCT02739828|26153246|P1|Overall Study|Adverse Event|1
7528058|NCT02739594|26153306|P2|Overall Study|Other|2
7528059|NCT02739594|26153307|P1|Overall Study|Other|6
7528060|NCT02739594|26153306|P2|Overall Study|Elevated Serum Creatinine|1
7528061|NCT02739594|26153307|P1|Overall Study|Elevated Serum Creatinine|0
7528062|NCT02739594|26153306|P2|Overall Study|Lost to Follow-up|1
7528063|NCT02739594|26153307|P1|Overall Study|Lost to Follow-up|0
7528064|NCT02739594|26153306|P2|Overall Study|Withdrawal by Subject|1
7528065|NCT02739594|26153307|P1|Overall Study|Withdrawal by Subject|1
7528066|NCT02739594|26153306|P2|Overall Study|Administrative Reasons|3
7528067|NCT02739594|26153307|P1|Overall Study|Administrative Reasons|1
7528068|NCT02739594|26153306|P2|Overall Study|Renal Insufficiency|6
7528069|NCT02739594|26153307|P1|Overall Study|Renal Insufficiency|4
7528070|NCT02739594|26153306|P2|Overall Study|Death|2
7528071|NCT02739594|26153307|P1|Overall Study|Death|4
7528072|NCT02739594|26153306|P2|Overall Study|Protocol Violation|6
7528073|NCT02739594|26153307|P1|Overall Study|Protocol Violation|5
7528074|NCT02739594|26153306|P2|Overall Study|Violation of Eligibility Criteria|2
7528075|NCT02739594|26153307|P1|Overall Study|Violation of Eligibility Criteria|1
7528076|NCT02739594|26153306|P2|Overall Study|Undesired Event|4
7528077|NCT02739594|26153307|P1|Overall Study|Undesired Event|3
7528078|NCT02739360|26153337|P1|Overall Study|Study terminated by Sponsor|2
7528079|NCT02739360|26153337|P1|Overall Study|Adverse Event|1
7528080|NCT02739321|26153343|P2|Overall Study|Withdrawal by Subject|2
7528081|NCT02739321|26153344|P1|Overall Study|Withdrawal by Subject|1
7528082|NCT02739321|26153343|P2|Overall Study|Lost to Follow-up|1
7528083|NCT02739321|26153344|P1|Overall Study|Lost to Follow-up|1
7528084|NCT02739321|26153343|P2|Overall Study|Lack of Efficacy|1
7528085|NCT02739321|26153344|P1|Overall Study|Lack of Efficacy|1
7528086|NCT02739269|26153390|P2|Overall Study|Withdrawal by Subject|2
7528087|NCT02739269|26153391|P1|Overall Study|Withdrawal by Subject|0
7528088|NCT02739269|26153390|P2|Overall Study|Cycle cancellation|2
7528089|NCT02739269|26153391|P1|Overall Study|Cycle cancellation|2
7528090|NCT02739269|26153390|P2|Overall Study|Protocol Violation|0
7528091|NCT02739269|26153391|P1|Overall Study|Protocol Violation|5
7528092|NCT02738879|26153418|P2|Overall Study|Withdrawal by Subject|7
7528093|NCT02738879|26153419|P1|Overall Study|Withdrawal by Subject|5
7528094|NCT02738879|26153418|P2|Overall Study|Site Discontinued Study Participation|0
7528095|NCT02738879|26153419|P1|Overall Study|Site Discontinued Study Participation|1
7528096|NCT02738879|26153418|P2|Overall Study|Screen Failure|2
7528097|NCT02738879|26153419|P1|Overall Study|Screen Failure|1
7528098|NCT02738879|26153418|P2|Overall Study|Pregnancy|1
7528099|NCT02738879|26153419|P1|Overall Study|Pregnancy|0
7528100|NCT02738879|26153418|P2|Overall Study|Physician Decision|4
7528101|NCT02738879|26153419|P1|Overall Study|Physician Decision|3
7528102|NCT02738879|26153418|P2|Overall Study|Protocol Violation|3
7528103|NCT02738879|26153419|P1|Overall Study|Protocol Violation|1
7528104|NCT02738879|26153418|P2|Overall Study|Lost to Follow-up|5
7528105|NCT02738879|26153419|P1|Overall Study|Lost to Follow-up|1
7528106|NCT02738879|26153418|P2|Overall Study|Death|2
7528107|NCT02738879|26153419|P1|Overall Study|Death|0
7528108|NCT02738879|26153418|P2|Overall Study|Adverse Event|1
7528109|NCT02738879|26153419|P1|Overall Study|Adverse Event|1
7528110|NCT02738840|26153469|P1|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
7528111|NCT02738840|26153469|P1|Overall Study|Subject Participation Terminated by Investigator|1
7528112|NCT02738840|26153469|P1|Overall Study|Lost to Follow-up|1
7528113|NCT02738840|26153469|P1|Overall Study|MRI Scan not Performed|5
7528114|NCT02738801|26153486|P2|Overall Study|Withdrawal by Subject|1
7528115|NCT02738801|26153487|P1|Overall Study|Withdrawal by Subject|0
7528116|NCT02738801|26153486|P2|Overall Study|Adverse Event|1
7528117|NCT02738801|26153487|P1|Overall Study|Adverse Event|1
7528118|NCT02738775|26153507|P6|Overall Study|Missing|1
7528119|NCT02738775|26153508|P5|Overall Study|Missing|0
7528120|NCT02738775|26153509|P4|Overall Study|Missing|0
7528121|NCT02738775|26153510|P3|Overall Study|Missing|0
7528122|NCT02738775|26153511|P2|Overall Study|Missing|0
7528123|NCT02738775|26153512|P1|Overall Study|Missing|0
7528124|NCT02738775|26153507|P6|Overall Study|Pregnancy|0
7528125|NCT02738775|26153508|P5|Overall Study|Pregnancy|0
7528126|NCT02738775|26153509|P4|Overall Study|Pregnancy|0
7528127|NCT02738775|26153510|P3|Overall Study|Pregnancy|0
7528128|NCT02738775|26153511|P2|Overall Study|Pregnancy|1
7528129|NCT02738775|26153512|P1|Overall Study|Pregnancy|0
7528130|NCT02738775|26153507|P6|Overall Study|Adverse Event|0
7528131|NCT02738775|26153508|P5|Overall Study|Adverse Event|0
7528132|NCT02738775|26153509|P4|Overall Study|Adverse Event|1
7528133|NCT02738775|26153510|P3|Overall Study|Adverse Event|0
7528134|NCT02738775|26153511|P2|Overall Study|Adverse Event|0
7528135|NCT02738775|26153512|P1|Overall Study|Adverse Event|0
7528136|NCT02738775|26153507|P6|Overall Study|Withdrawal by Subject|0
7528137|NCT02738775|26153508|P5|Overall Study|Withdrawal by Subject|0
7528138|NCT02738775|26153509|P4|Overall Study|Withdrawal by Subject|0
7528139|NCT02738775|26153510|P3|Overall Study|Withdrawal by Subject|0
7528140|NCT02738775|26153511|P2|Overall Study|Withdrawal by Subject|1
7528141|NCT02738775|26153512|P1|Overall Study|Withdrawal by Subject|0
7528142|NCT02738580|26153601|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
7528143|NCT02738580|26153602|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
7528144|NCT02738580|26153601|P2|Overall Study|Withdrawal by Subject|1
7528145|NCT02738580|26153602|P1|Overall Study|Withdrawal by Subject|0
7528146|NCT02738580|26153601|P2|Overall Study|Lack of Efficacy|2
7528147|NCT02738580|26153602|P1|Overall Study|Lack of Efficacy|3
7528148|NCT02738580|26153601|P2|Overall Study|Adverse Event|0
7528149|NCT02738580|26153602|P1|Overall Study|Adverse Event|1
7528150|NCT02738450|26153614|P3|Overall Study|Withdrawal by Subject|0
7528151|NCT02738450|26153615|P2|Overall Study|Withdrawal by Subject|2
7528152|NCT02738450|26153616|P1|Overall Study|Withdrawal by Subject|0
7528153|NCT02738333|26153655|P3|Overall Study|Lost to Follow-up|0
7528154|NCT02738333|26153656|P2|Overall Study|Lost to Follow-up|0
7528155|NCT02738333|26153657|P1|Overall Study|Lost to Follow-up|1
7528156|NCT02738333|26153655|P3|Overall Study|Death|0
7528157|NCT02738333|26153656|P2|Overall Study|Death|0
7528158|NCT02738333|26153657|P1|Overall Study|Death|1
7528159|NCT02738203|26153746|P2|Overall Study|Protocol Violation|1
7528160|NCT02738203|26153747|P1|Overall Study|Protocol Violation|0
7528161|NCT02738203|26153746|P2|Overall Study|Failed IUD Insertion|2
7528162|NCT02738203|26153747|P1|Overall Study|Failed IUD Insertion|2
7528163|NCT02738151|26153763|P2|Overall Study|Other than specified above|21
7528164|NCT02738151|26153764|P1|Overall Study|Other than specified above|11
7528165|NCT02738151|26153763|P2|Overall Study|Poor Compliance to Protocol|3
7528166|NCT02738151|26153764|P1|Overall Study|Poor Compliance to Protocol|4
7528167|NCT02738151|26153763|P2|Overall Study|Hypoglycemia|1
7528168|NCT02738151|26153764|P1|Overall Study|Hypoglycemia|0
7528169|NCT02738151|26153763|P2|Overall Study|Adverse Event|5
7528170|NCT02738151|26153764|P1|Overall Study|Adverse Event|4
7528171|NCT02738151|26153763|P2|Overall Study|Randomized but not treated|1
7528172|NCT02738151|26153764|P1|Overall Study|Randomized but not treated|4
7528173|NCT02738138|26153808|P2|Overall Study|Other - not further specified|0
7528174|NCT02738138|26153809|P1|Overall Study|Other - not further specified|1
7528175|NCT02738138|26153808|P2|Overall Study|Lost to Follow-up|0
7528176|NCT02738138|26153809|P1|Overall Study|Lost to Follow-up|2
7528177|NCT02738138|26153808|P2|Overall Study|Adverse Event|1
7528178|NCT02738138|26153809|P1|Overall Study|Adverse Event|0
7528179|NCT02738008|26153846|P3|Overall Study|Adverse Event|2
7528180|NCT02738008|26153847|P2|Overall Study|Adverse Event|1
7528181|NCT02738008|26153848|P1|Overall Study|Adverse Event|0
7528182|NCT02738008|26153846|P3|Overall Study|Study Terminated by Sponsor|3
7528183|NCT02738008|26153847|P2|Overall Study|Study Terminated by Sponsor|5
7528184|NCT02738008|26153848|P1|Overall Study|Study Terminated by Sponsor|1
7528185|NCT02737930|26153864|P2|Overall Study|Withdrawal by Subject|1
7528186|NCT02737930|26153865|P1|Overall Study|Withdrawal by Subject|0
7528187|NCT02737852|26153911|P1|Overall Study|Withdrawal by Subject|2
7528188|NCT02737826|26153916|P3|Phase II - Randomization + Taper|Withdrawal by Subject|14
7528189|NCT02737826|26153917|P2|Phase II - Randomization + Taper|Withdrawal by Subject|12
7528190|NCT02737826|26153918|P1|Phase II - Randomization + Taper|Withdrawal by Subject|0
7528191|NCT02737722|26153931|P4|Overall Study|Physician Decision|0
7528192|NCT02737722|26153932|P3|Overall Study|Physician Decision|1
7528193|NCT02737722|26153933|P2|Overall Study|Physician Decision|0
7528194|NCT02737722|26153934|P1|Overall Study|Physician Decision|0
7528195|NCT02737618|26153984|P1|Overall Study|Withdrawal by Subject|9
7528196|NCT02737592|26153989|P1|Overall Study|Withdrawal by Subject|1
7528197|NCT02737501|26154011|P3|Crossover Phase|Site Terminated by Sponsor|23
7528198|NCT02737501|26154012|P2|Crossover Phase|Site Terminated by Sponsor|0
7528199|NCT02737501|26154013|P1|Crossover Phase|Site Terminated by Sponsor|0
7528200|NCT02737501|26154011|P3|Crossover Phase|Physician Decision|1
7528201|NCT02737501|26154012|P2|Crossover Phase|Physician Decision|0
7528202|NCT02737501|26154013|P1|Crossover Phase|Physician Decision|0
7528203|NCT02737501|26154011|P3|Crossover Phase|Withdrew Consent|9
7528204|NCT02737501|26154012|P2|Crossover Phase|Withdrew Consent|0
7528205|NCT02737501|26154013|P1|Crossover Phase|Withdrew Consent|0
7528206|NCT02737501|26154011|P3|Crossover Phase|Died|22
7528207|NCT02737501|26154012|P2|Crossover Phase|Died|0
7528208|NCT02737501|26154013|P1|Crossover Phase|Died|0
7528209|NCT02737501|26154011|P3|Randomized Phase|Never Treated|0
7528210|NCT02737501|26154012|P2|Randomized Phase|Never Treated|1
7528211|NCT02737501|26154013|P1|Randomized Phase|Never Treated|1
7528212|NCT02737501|26154011|P3|Randomized Phase|Reason not Specified|0
7528213|NCT02737501|26154012|P2|Randomized Phase|Reason not Specified|1
7528214|NCT02737501|26154013|P1|Randomized Phase|Reason not Specified|1
7528215|NCT02737501|26154011|P3|Randomized Phase|Site Terminated by Sponsor|0
7528216|NCT02737501|26154012|P2|Randomized Phase|Site Terminated by Sponsor|16
7528217|NCT02737501|26154013|P1|Randomized Phase|Site Terminated by Sponsor|58
7528218|NCT02737501|26154011|P3|Randomized Phase|Lost to Follow-up|0
7528219|NCT02737501|26154012|P2|Randomized Phase|Lost to Follow-up|1
7528220|NCT02737501|26154013|P1|Randomized Phase|Lost to Follow-up|0
7528221|NCT02737501|26154011|P3|Randomized Phase|Withdrawal by Subject|0
7528222|NCT02737501|26154012|P2|Randomized Phase|Withdrawal by Subject|6
7528223|NCT02737501|26154013|P1|Randomized Phase|Withdrawal by Subject|16
7528224|NCT02737501|26154011|P3|Randomized Phase|Died|0
7528225|NCT02737501|26154012|P2|Randomized Phase|Died|29
7528226|NCT02737501|26154013|P1|Randomized Phase|Died|41
7528227|NCT02737358|26154063|P2|Overall Study|Lost to Follow-up|3
7528228|NCT02737358|26154064|P1|Overall Study|Lost to Follow-up|2
7528229|NCT02737358|26154063|P2|Overall Study|Withdrawal by Subject|12
7528230|NCT02737358|26154064|P1|Overall Study|Withdrawal by Subject|7
7528231|NCT02736890|26154153|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
7528232|NCT02736890|26154154|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
7528233|NCT02736890|26154153|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
7528234|NCT02736890|26154154|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
7528235|NCT02736825|26154176|P2|Overall Study|Early Termination|1
7528236|NCT02736825|26154177|P1|Overall Study|Early Termination|0
7528237|NCT02736825|26154176|P2|Overall Study|Lost to Follow-up|11
7528238|NCT02736825|26154177|P1|Overall Study|Lost to Follow-up|10
7528239|NCT02736721|26154217|P1|Overall Study|Other|5
7528240|NCT02736721|26154217|P1|Overall Study|Lost to Follow-up|3
7528241|NCT02736721|26154217|P1|Overall Study|Adverse Event|8
7528242|NCT02736578|26154228|P2|Overall Study|Adverse Event|0
7528243|NCT02736578|26154229|P1|Overall Study|Adverse Event|1
7528244|NCT02736409|26154251|P4|Overall Study|Physician Decision|2
7528245|NCT02736409|26154252|P3|Overall Study|Physician Decision|0
7528246|NCT02736409|26154253|P2|Overall Study|Physician Decision|0
7528247|NCT02736409|26154254|P1|Overall Study|Physician Decision|0
7528248|NCT02736409|26154251|P4|Overall Study|Lost to Follow-up|1
7528249|NCT02736409|26154252|P3|Overall Study|Lost to Follow-up|2
7528250|NCT02736409|26154253|P2|Overall Study|Lost to Follow-up|0
7528251|NCT02736409|26154254|P1|Overall Study|Lost to Follow-up|0
7528252|NCT02736409|26154251|P4|Overall Study|Pregnancy|0
7528253|NCT02736409|26154252|P3|Overall Study|Pregnancy|1
7528254|NCT02736409|26154253|P2|Overall Study|Pregnancy|0
7528255|NCT02736409|26154254|P1|Overall Study|Pregnancy|0
7528256|NCT02736409|26154251|P4|Overall Study|Other|1
7528257|NCT02736409|26154252|P3|Overall Study|Other|1
7528258|NCT02736409|26154253|P2|Overall Study|Other|0
7528259|NCT02736409|26154254|P1|Overall Study|Other|0
7528260|NCT02736409|26154251|P4|Overall Study|Adverse Event|4
7528261|NCT02736409|26154252|P3|Overall Study|Adverse Event|5
7528262|NCT02736409|26154253|P2|Overall Study|Adverse Event|1
7528263|NCT02736409|26154254|P1|Overall Study|Adverse Event|0
7528264|NCT02736409|26154251|P4|Overall Study|Non-Compliance with Study Drug|1
7528265|NCT02736409|26154252|P3|Overall Study|Non-Compliance with Study Drug|0
7528266|NCT02736409|26154253|P2|Overall Study|Non-Compliance with Study Drug|0
7528267|NCT02736409|26154254|P1|Overall Study|Non-Compliance with Study Drug|0
7528268|NCT02736409|26154251|P4|Overall Study|Withdrawal by Subject|3
7528269|NCT02736409|26154252|P3|Overall Study|Withdrawal by Subject|17
7528270|NCT02736409|26154253|P2|Overall Study|Withdrawal by Subject|2
7528271|NCT02736409|26154254|P1|Overall Study|Withdrawal by Subject|4
7528272|NCT02736188|26154394|P1|Overall Study|Other|6
7528273|NCT02736188|26154394|P1|Overall Study|Withdrawal by Subject|1
7528274|NCT02736188|26154394|P1|Overall Study|Adverse Event|1
7528275|NCT02736188|26154394|P1|Overall Study|Discontinuation of Study by Sponsor|134
7528276|NCT02735980|26154432|P3|Overall Study|Withdrawal by Subject|0
7528277|NCT02735980|26154433|P2|Overall Study|Withdrawal by Subject|2
7528278|NCT02735980|26154434|P1|Overall Study|Withdrawal by Subject|1
7528279|NCT02735980|26154432|P3|Overall Study|Screen failure|0
7528280|NCT02735980|26154433|P2|Overall Study|Screen failure|0
7528281|NCT02735980|26154434|P1|Overall Study|Screen failure|1
7528282|NCT02735980|26154432|P3|Overall Study|Physician Decision|0
7528283|NCT02735980|26154433|P2|Overall Study|Physician Decision|1
7528284|NCT02735980|26154434|P1|Overall Study|Physician Decision|3
7528285|NCT02735980|26154432|P3|Overall Study|Death|0
7528286|NCT02735980|26154433|P2|Overall Study|Death|4
7528287|NCT02735980|26154434|P1|Overall Study|Death|5
7528288|NCT02735980|26154432|P3|Overall Study|Adverse Event|1
7528289|NCT02735980|26154433|P2|Overall Study|Adverse Event|4
7528290|NCT02735980|26154434|P1|Overall Study|Adverse Event|0
7528291|NCT02735915|26154463|P1|Overall Study|Withdrawal by Subject|1
7528292|NCT02735915|26154463|P1|Overall Study|Withdrawal following SAE|2
7528293|NCT02735915|26154463|P1|Overall Study|Not vaccinated but subject ID assigned|8
7528294|NCT02735577|26154495|P1|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
7528295|NCT02735577|26154495|P1|Disulfiram Treatment|Lost to Follow-up|1
7528296|NCT02735421|26154512|P1|Overall Study|Pregnancy|1
7528297|NCT02735421|26154512|P1|Overall Study|Inadequate compliance to treatment|1
7528298|NCT02735421|26154512|P1|Overall Study|Lost to Follow-up|3
7528299|NCT02735421|26154512|P1|Overall Study|Withdrawal by Subject|6
7528300|NCT02735421|26154512|P1|Overall Study|Adverse Event|2
7528301|NCT02735200|26154542|P2|Overall Study|Withdrawal by Subject|0
7528302|NCT02735200|26154543|P1|Overall Study|Withdrawal by Subject|8
7528303|NCT02735200|26154542|P2|Overall Study|Lost to Follow-up|5
7528304|NCT02735200|26154543|P1|Overall Study|Lost to Follow-up|0
7528305|NCT02735096|26154586|P1|Overall Study|No symptoms in clinic/personal leave|1
7528306|NCT02735044|26154595|P2|Overall Study|Other, not specified above|11
7528307|NCT02735044|26154596|P1|Overall Study|Other, not specified above|5
7528308|NCT02735044|26154595|P2|Overall Study|Randomized and not treated|2
7528309|NCT02735044|26154596|P1|Overall Study|Randomized and not treated|0
7528310|NCT02735044|26154595|P2|Overall Study|Poor compliance to protocol|7
7528311|NCT02735044|26154596|P1|Overall Study|Poor compliance to protocol|7
7528312|NCT02735044|26154595|P2|Overall Study|Lack of Efficacy|0
7528313|NCT02735044|26154596|P1|Overall Study|Lack of Efficacy|1
7528314|NCT02735044|26154595|P2|Overall Study|Adverse Event|3
7528315|NCT02735044|26154596|P1|Overall Study|Adverse Event|3
7528316|NCT02734862|26154680|P3|Part B|Other|0
7528317|NCT02734862|26154681|P2|Part B|Other|1
7528318|NCT02734862|26154682|P1|Part B|Other|0
7528319|NCT02734862|26154680|P3|Part B|Withdrawal by Subject|0
7528320|NCT02734862|26154681|P2|Part B|Withdrawal by Subject|1
7528321|NCT02734862|26154682|P1|Part B|Withdrawal by Subject|3
7528322|NCT02734862|26154680|P3|Part B|Lost to Follow-up|0
7528323|NCT02734862|26154681|P2|Part B|Lost to Follow-up|2
7528324|NCT02734862|26154682|P1|Part B|Lost to Follow-up|2
7528325|NCT02734862|26154680|P3|Part B|Death|5
7528326|NCT02734862|26154681|P2|Part B|Death|3
7528327|NCT02734862|26154682|P1|Part B|Death|8
7528328|NCT02734862|26154680|P3|Part A|Other|3
7528329|NCT02734862|26154681|P2|Part A|Other|1
7528330|NCT02734862|26154682|P1|Part A|Other|1
7528331|NCT02734862|26154680|P3|Part A|Noncompliance|0
7528332|NCT02734862|26154681|P2|Part A|Noncompliance|1
7528333|NCT02734862|26154682|P1|Part A|Noncompliance|1
7528334|NCT02734862|26154680|P3|Part A|Adverse Event|1
7528335|NCT02734862|26154681|P2|Part A|Adverse Event|0
7528336|NCT02734862|26154682|P1|Part A|Adverse Event|2
7528337|NCT02734862|26154680|P3|Part A|Physician Decision|1
7528338|NCT02734862|26154681|P2|Part A|Physician Decision|0
7528339|NCT02734862|26154682|P1|Part A|Physician Decision|2
7528340|NCT02734862|26154680|P3|Part A|Withdrawal by Subject|2
7528341|NCT02734862|26154681|P2|Part A|Withdrawal by Subject|1
7528342|NCT02734862|26154682|P1|Part A|Withdrawal by Subject|1
7528343|NCT02734862|26154680|P3|Part A|Lost to Follow-up|1
7528344|NCT02734862|26154681|P2|Part A|Lost to Follow-up|1
7528345|NCT02734862|26154682|P1|Part A|Lost to Follow-up|2
7528346|NCT02734862|26154680|P3|Part A|Death|6
7528347|NCT02734862|26154681|P2|Part A|Death|4
7528348|NCT02734862|26154682|P1|Part A|Death|3
7528349|NCT02734810|26154723|P2|Overall Study|Lack of Efficacy|0
7528350|NCT02734810|26154724|P1|Overall Study|Lack of Efficacy|1
7528351|NCT02734810|26154723|P2|Overall Study|Adverse Event|0
7528352|NCT02734810|26154724|P1|Overall Study|Adverse Event|1
7528353|NCT02734693|26154733|P3|Overall Study|Withdrawal by Subject|0
7528354|NCT02734693|26154734|P2|Overall Study|Withdrawal by Subject|0
7528355|NCT02734693|26154735|P1|Overall Study|Withdrawal by Subject|1
7528356|NCT02734693|26154733|P3|Overall Study|Protocol Violation|0
7528357|NCT02734693|26154734|P2|Overall Study|Protocol Violation|0
7528358|NCT02734693|26154735|P1|Overall Study|Protocol Violation|1
7528359|NCT02734693|26154733|P3|Overall Study|Lost to Follow-up|0
7528360|NCT02734693|26154734|P2|Overall Study|Lost to Follow-up|0
7528361|NCT02734693|26154735|P1|Overall Study|Lost to Follow-up|2
7528362|NCT02734693|26154733|P3|Overall Study|Lack of Efficacy|0
7528363|NCT02734693|26154734|P2|Overall Study|Lack of Efficacy|0
7528364|NCT02734693|26154735|P1|Overall Study|Lack of Efficacy|1
7528365|NCT02734693|26154733|P3|Overall Study|Adverse Event|3
7528366|NCT02734693|26154734|P2|Overall Study|Adverse Event|3
7528367|NCT02734693|26154735|P1|Overall Study|Adverse Event|1
7528368|NCT02734433|26154800|P2|Overall Study|Withdrawal by Subject|2
7528369|NCT02734433|26154801|P1|Overall Study|Withdrawal by Subject|1
7528370|NCT02734433|26154800|P2|Overall Study|Clinical progression|1
7528371|NCT02734433|26154801|P1|Overall Study|Clinical progression|0
7528372|NCT02734433|26154800|P2|Overall Study|Disease progression|5
7528373|NCT02734433|26154801|P1|Overall Study|Disease progression|1
7528374|NCT02734212|26154877|P2|Overall Study|Lost to Follow-up|10
7528375|NCT02734212|26154878|P1|Overall Study|Lost to Follow-up|5
7528376|NCT02733991|26154920|P2|Overall Study|Withdrawal by Subject|5
7528377|NCT02733991|26154921|P1|Overall Study|Withdrawal by Subject|0
7528378|NCT02733991|26154920|P2|Overall Study|Adverse Event|0
7528379|NCT02733991|26154921|P1|Overall Study|Adverse Event|1
7528380|NCT02733627|26154958|P4|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7528381|NCT02733627|26154959|P3|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
7528382|NCT02733627|26154960|P2|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7528383|NCT02733627|26154961|P1|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7528384|NCT02733627|26154958|P4|Overall Study|Adverse Event|0
7528385|NCT02733627|26154959|P3|Overall Study|Adverse Event|1
7528386|NCT02733627|26154960|P2|Overall Study|Adverse Event|1
7528387|NCT02733627|26154961|P1|Overall Study|Adverse Event|0
7528388|NCT02733367|26154990|P1|Overall Study|Withdrawal by Subject|6
7528389|NCT02733042|26155016|P19|Follow-up Period|Withdrawal by Subject|0
7528390|NCT02733042|26155017|P18|Follow-up Period|Withdrawal by Subject|0
7528391|NCT02733042|26155018|P17|Follow-up Period|Withdrawal by Subject|0
7528392|NCT02733042|26155019|P16|Follow-up Period|Withdrawal by Subject|1
7528393|NCT02733042|26155020|P15|Follow-up Period|Withdrawal by Subject|0
7528394|NCT02733042|26155021|P14|Follow-up Period|Withdrawal by Subject|0
7528395|NCT02733042|26155022|P13|Follow-up Period|Withdrawal by Subject|0
7528396|NCT02733042|26155023|P12|Follow-up Period|Withdrawal by Subject|0
7528397|NCT02733042|26155024|P11|Follow-up Period|Withdrawal by Subject|1
7528398|NCT02733042|26155025|P10|Follow-up Period|Withdrawal by Subject|0
7528399|NCT02733042|26155026|P9|Follow-up Period|Withdrawal by Subject|1
7528400|NCT02733042|26155027|P8|Follow-up Period|Withdrawal by Subject|0
7528401|NCT02733042|26155028|P7|Follow-up Period|Withdrawal by Subject|0
7528402|NCT02733042|26155029|P6|Follow-up Period|Withdrawal by Subject|0
7528403|NCT02733042|26155030|P5|Follow-up Period|Withdrawal by Subject|0
7528404|NCT02733042|26155031|P4|Follow-up Period|Withdrawal by Subject|0
7528405|NCT02733042|26155032|P3|Follow-up Period|Withdrawal by Subject|0
7528406|NCT02733042|26155033|P2|Follow-up Period|Withdrawal by Subject|0
7528407|NCT02733042|26155034|P1|Follow-up Period|Withdrawal by Subject|0
7528408|NCT02733042|26155016|P19|Follow-up Period|Other|0
7528409|NCT02733042|26155017|P18|Follow-up Period|Other|0
7528410|NCT02733042|26155018|P17|Follow-up Period|Other|0
7528411|NCT02733042|26155019|P16|Follow-up Period|Other|0
7528412|NCT02733042|26155020|P15|Follow-up Period|Other|0
7528413|NCT02733042|26155021|P14|Follow-up Period|Other|0
7528414|NCT02733042|26155022|P13|Follow-up Period|Other|0
7528415|NCT02733042|26155023|P12|Follow-up Period|Other|0
7528416|NCT02733042|26155024|P11|Follow-up Period|Other|0
7528417|NCT02733042|26155025|P10|Follow-up Period|Other|0
7528418|NCT02733042|26155026|P9|Follow-up Period|Other|0
7528419|NCT02733042|26155027|P8|Follow-up Period|Other|0
7528420|NCT02733042|26155028|P7|Follow-up Period|Other|0
7528421|NCT02733042|26155029|P6|Follow-up Period|Other|0
7528422|NCT02733042|26155030|P5|Follow-up Period|Other|0
7528423|NCT02733042|26155031|P4|Follow-up Period|Other|1
7528424|NCT02733042|26155032|P3|Follow-up Period|Other|0
7528425|NCT02733042|26155033|P2|Follow-up Period|Other|0
7528426|NCT02733042|26155034|P1|Follow-up Period|Other|0
7528427|NCT02733042|26155016|P19|Follow-up Period|Death|2
7528428|NCT02733042|26155017|P18|Follow-up Period|Death|1
7528429|NCT02733042|26155018|P17|Follow-up Period|Death|0
7528430|NCT02733042|26155019|P16|Follow-up Period|Death|4
7528431|NCT02733042|26155020|P15|Follow-up Period|Death|1
7528432|NCT02733042|26155021|P14|Follow-up Period|Death|1
7528433|NCT02733042|26155022|P13|Follow-up Period|Death|8
7528434|NCT02733042|26155023|P12|Follow-up Period|Death|0
7528435|NCT02733042|26155024|P11|Follow-up Period|Death|0
7528436|NCT02733042|26155025|P10|Follow-up Period|Death|0
7528437|NCT02733042|26155026|P9|Follow-up Period|Death|3
7528438|NCT02733042|26155027|P8|Follow-up Period|Death|3
7528439|NCT02733042|26155028|P7|Follow-up Period|Death|0
7528440|NCT02733042|26155029|P6|Follow-up Period|Death|2
7528441|NCT02733042|26155030|P5|Follow-up Period|Death|1
7528442|NCT02733042|26155031|P4|Follow-up Period|Death|0
7528443|NCT02733042|26155032|P3|Follow-up Period|Death|2
7528444|NCT02733042|26155033|P2|Follow-up Period|Death|1
7528445|NCT02733042|26155034|P1|Follow-up Period|Death|1
7528446|NCT02733042|26155016|P19|Follow-up Period|Ongoing on Follow-up|0
7528447|NCT02733042|26155017|P18|Follow-up Period|Ongoing on Follow-up|1
7528448|NCT02733042|26155018|P17|Follow-up Period|Ongoing on Follow-up|0
7528449|NCT02733042|26155019|P16|Follow-up Period|Ongoing on Follow-up|0
7528450|NCT02733042|26155020|P15|Follow-up Period|Ongoing on Follow-up|0
7528451|NCT02733042|26155021|P14|Follow-up Period|Ongoing on Follow-up|3
7528452|NCT02733042|26155022|P13|Follow-up Period|Ongoing on Follow-up|1
7528453|NCT02733042|26155023|P12|Follow-up Period|Ongoing on Follow-up|9
7528454|NCT02733042|26155024|P11|Follow-up Period|Ongoing on Follow-up|4
7528455|NCT02733042|26155025|P10|Follow-up Period|Ongoing on Follow-up|2
7528456|NCT02733042|26155026|P9|Follow-up Period|Ongoing on Follow-up|0
7528457|NCT02733042|26155027|P8|Follow-up Period|Ongoing on Follow-up|1
7528458|NCT02733042|26155028|P7|Follow-up Period|Ongoing on Follow-up|0
7528459|NCT02733042|26155029|P6|Follow-up Period|Ongoing on Follow-up|0
7528460|NCT02733042|26155030|P5|Follow-up Period|Ongoing on Follow-up|0
7528461|NCT02733042|26155031|P4|Follow-up Period|Ongoing on Follow-up|2
7528462|NCT02733042|26155032|P3|Follow-up Period|Ongoing on Follow-up|4
7528463|NCT02733042|26155033|P2|Follow-up Period|Ongoing on Follow-up|2
7528464|NCT02733042|26155034|P1|Follow-up Period|Ongoing on Follow-up|2
7528465|NCT02733042|26155016|P19|Treatment Period|Death|0
7528466|NCT02733042|26155017|P18|Treatment Period|Death|0
7528467|NCT02733042|26155018|P17|Treatment Period|Death|0
7528468|NCT02733042|26155019|P16|Treatment Period|Death|2
7528469|NCT02733042|26155020|P15|Treatment Period|Death|1
7528470|NCT02733042|26155021|P14|Treatment Period|Death|0
7528471|NCT02733042|26155022|P13|Treatment Period|Death|0
7528472|NCT02733042|26155023|P12|Treatment Period|Death|0
7528473|NCT02733042|26155024|P11|Treatment Period|Death|1
7528474|NCT02733042|26155025|P10|Treatment Period|Death|0
7528475|NCT02733042|26155026|P9|Treatment Period|Death|1
7528476|NCT02733042|26155027|P8|Treatment Period|Death|0
7528477|NCT02733042|26155028|P7|Treatment Period|Death|1
7528478|NCT02733042|26155029|P6|Treatment Period|Death|0
7528479|NCT02733042|26155030|P5|Treatment Period|Death|0
7528480|NCT02733042|26155031|P4|Treatment Period|Death|0
7528481|NCT02733042|26155032|P3|Treatment Period|Death|0
7528482|NCT02733042|26155033|P2|Treatment Period|Death|0
7528483|NCT02733042|26155034|P1|Treatment Period|Death|0
7528484|NCT02733042|26155016|P19|Treatment Period|Ongoing on Assigned Treatment|1
7528485|NCT02733042|26155017|P18|Treatment Period|Ongoing on Assigned Treatment|0
7528486|NCT02733042|26155018|P17|Treatment Period|Ongoing on Assigned Treatment|0
7528487|NCT02733042|26155019|P16|Treatment Period|Ongoing on Assigned Treatment|0
7528488|NCT02733042|26155020|P15|Treatment Period|Ongoing on Assigned Treatment|0
7528489|NCT02733042|26155021|P14|Treatment Period|Ongoing on Assigned Treatment|0
7528490|NCT02733042|26155022|P13|Treatment Period|Ongoing on Assigned Treatment|0
7528491|NCT02733042|26155023|P12|Treatment Period|Ongoing on Assigned Treatment|0
7528492|NCT02733042|26155024|P11|Treatment Period|Ongoing on Assigned Treatment|4
7528493|NCT02733042|26155025|P10|Treatment Period|Ongoing on Assigned Treatment|8
7528494|NCT02733042|26155026|P9|Treatment Period|Ongoing on Assigned Treatment|0
7528495|NCT02733042|26155027|P8|Treatment Period|Ongoing on Assigned Treatment|0
7528496|NCT02733042|26155028|P7|Treatment Period|Ongoing on Assigned Treatment|0
7528497|NCT02733042|26155029|P6|Treatment Period|Ongoing on Assigned Treatment|0
7528498|NCT02733042|26155030|P5|Treatment Period|Ongoing on Assigned Treatment|3
7528499|NCT02733042|26155031|P4|Treatment Period|Ongoing on Assigned Treatment|0
7528500|NCT02733042|26155032|P3|Treatment Period|Ongoing on Assigned Treatment|0
7528501|NCT02733042|26155033|P2|Treatment Period|Ongoing on Assigned Treatment|0
7528502|NCT02733042|26155034|P1|Treatment Period|Ongoing on Assigned Treatment|0
7528503|NCT02733042|26155016|P19|Treatment Period|Other|0
7528504|NCT02733042|26155017|P18|Treatment Period|Other|1
7528505|NCT02733042|26155018|P17|Treatment Period|Other|0
7528506|NCT02733042|26155019|P16|Treatment Period|Other|1
7528507|NCT02733042|26155020|P15|Treatment Period|Other|0
7528508|NCT02733042|26155021|P14|Treatment Period|Other|0
7528509|NCT02733042|26155022|P13|Treatment Period|Other|0
7528510|NCT02733042|26155023|P12|Treatment Period|Other|0
7528511|NCT02733042|26155024|P11|Treatment Period|Other|1
7528512|NCT02733042|26155025|P10|Treatment Period|Other|1
7528513|NCT02733042|26155026|P9|Treatment Period|Other|0
7528514|NCT02733042|26155027|P8|Treatment Period|Other|0
7528515|NCT02733042|26155028|P7|Treatment Period|Other|0
7528516|NCT02733042|26155029|P6|Treatment Period|Other|0
7528517|NCT02733042|26155030|P5|Treatment Period|Other|0
7528518|NCT02733042|26155031|P4|Treatment Period|Other|0
7528519|NCT02733042|26155032|P3|Treatment Period|Other|1
7528520|NCT02733042|26155033|P2|Treatment Period|Other|0
7528521|NCT02733042|26155034|P1|Treatment Period|Other|0
7528522|NCT02733042|26155016|P19|Treatment Period|Withdrawal by Subject|0
7528523|NCT02733042|26155017|P18|Treatment Period|Withdrawal by Subject|0
7528524|NCT02733042|26155018|P17|Treatment Period|Withdrawal by Subject|0
7528525|NCT02733042|26155019|P16|Treatment Period|Withdrawal by Subject|0
7528526|NCT02733042|26155020|P15|Treatment Period|Withdrawal by Subject|0
7528527|NCT02733042|26155021|P14|Treatment Period|Withdrawal by Subject|1
7528528|NCT02733042|26155022|P13|Treatment Period|Withdrawal by Subject|1
7528529|NCT02733042|26155023|P12|Treatment Period|Withdrawal by Subject|2
7528530|NCT02733042|26155024|P11|Treatment Period|Withdrawal by Subject|0
7528531|NCT02733042|26155025|P10|Treatment Period|Withdrawal by Subject|1
7528532|NCT02733042|26155026|P9|Treatment Period|Withdrawal by Subject|1
7528533|NCT02733042|26155027|P8|Treatment Period|Withdrawal by Subject|0
7528534|NCT02733042|26155028|P7|Treatment Period|Withdrawal by Subject|0
7528535|NCT02733042|26155029|P6|Treatment Period|Withdrawal by Subject|0
7528536|NCT02733042|26155030|P5|Treatment Period|Withdrawal by Subject|0
7528537|NCT02733042|26155031|P4|Treatment Period|Withdrawal by Subject|1
7528538|NCT02733042|26155032|P3|Treatment Period|Withdrawal by Subject|2
7528539|NCT02733042|26155033|P2|Treatment Period|Withdrawal by Subject|1
7528540|NCT02733042|26155034|P1|Treatment Period|Withdrawal by Subject|0
7528541|NCT02733042|26155016|P19|Treatment Period|Progressive Disease|4
7528542|NCT02733042|26155017|P18|Treatment Period|Progressive Disease|3
7528543|NCT02733042|26155018|P17|Treatment Period|Progressive Disease|2
7528544|NCT02733042|26155019|P16|Treatment Period|Progressive Disease|7
7528545|NCT02733042|26155020|P15|Treatment Period|Progressive Disease|4
7528546|NCT02733042|26155021|P14|Treatment Period|Progressive Disease|1
7528547|NCT02733042|26155022|P13|Treatment Period|Progressive Disease|8
7528548|NCT02733042|26155023|P12|Treatment Period|Progressive Disease|2
7528549|NCT02733042|26155024|P11|Treatment Period|Progressive Disease|2
7528550|NCT02733042|26155025|P10|Treatment Period|Progressive Disease|0
7528551|NCT02733042|26155026|P9|Treatment Period|Progressive Disease|3
7528552|NCT02733042|26155027|P8|Treatment Period|Progressive Disease|3
7528553|NCT02733042|26155028|P7|Treatment Period|Progressive Disease|0
7528554|NCT02733042|26155029|P6|Treatment Period|Progressive Disease|3
7528555|NCT02733042|26155030|P5|Treatment Period|Progressive Disease|1
7528556|NCT02733042|26155031|P4|Treatment Period|Progressive Disease|1
7528557|NCT02733042|26155032|P3|Treatment Period|Progressive Disease|3
7528558|NCT02733042|26155033|P2|Treatment Period|Progressive Disease|1
7528559|NCT02733042|26155034|P1|Treatment Period|Progressive Disease|2
7528560|NCT02733042|26155016|P19|Treatment Period|Adverse Event|0
7528561|NCT02733042|26155017|P18|Treatment Period|Adverse Event|1
7528562|NCT02733042|26155018|P17|Treatment Period|Adverse Event|0
7528563|NCT02733042|26155019|P16|Treatment Period|Adverse Event|0
7528564|NCT02733042|26155020|P15|Treatment Period|Adverse Event|0
7528565|NCT02733042|26155021|P14|Treatment Period|Adverse Event|2
7528566|NCT02733042|26155022|P13|Treatment Period|Adverse Event|0
7528567|NCT02733042|26155023|P12|Treatment Period|Adverse Event|2
7528568|NCT02733042|26155024|P11|Treatment Period|Adverse Event|2
7528569|NCT02733042|26155025|P10|Treatment Period|Adverse Event|0
7528570|NCT02733042|26155026|P9|Treatment Period|Adverse Event|0
7528571|NCT02733042|26155027|P8|Treatment Period|Adverse Event|0
7528572|NCT02733042|26155028|P7|Treatment Period|Adverse Event|0
7528573|NCT02733042|26155029|P6|Treatment Period|Adverse Event|0
7528574|NCT02733042|26155030|P5|Treatment Period|Adverse Event|0
7528575|NCT02733042|26155031|P4|Treatment Period|Adverse Event|1
7528576|NCT02733042|26155032|P3|Treatment Period|Adverse Event|1
7528577|NCT02733042|26155033|P2|Treatment Period|Adverse Event|0
7528578|NCT02733042|26155034|P1|Treatment Period|Adverse Event|1
7528579|NCT02732951|26155239|P2|Overall Study|Protocol Violation|1
7528580|NCT02732951|26155240|P1|Overall Study|Protocol Violation|0
7528581|NCT02732951|26155239|P2|Overall Study|Adverse Event|4
7528582|NCT02732951|26155240|P1|Overall Study|Adverse Event|4
7528583|NCT02732951|26155239|P2|Overall Study|Lost to Follow-up|1
7528584|NCT02732951|26155240|P1|Overall Study|Lost to Follow-up|0
7528585|NCT02732951|26155239|P2|Overall Study|Other than listed|0
7528586|NCT02732951|26155240|P1|Overall Study|Other than listed|1
7528587|NCT02732938|26155250|P3|Overall Study|Study terminated by sponsor|0
7528588|NCT02732938|26155251|P2|Overall Study|Study terminated by sponsor|6
7528589|NCT02732938|26155252|P1|Overall Study|Study terminated by sponsor|3
7528590|NCT02732938|26155250|P3|Overall Study|Refused further follow-up|0
7528591|NCT02732938|26155251|P2|Overall Study|Refused further follow-up|0
7528592|NCT02732938|26155252|P1|Overall Study|Refused further follow-up|1
7528593|NCT02732938|26155250|P3|Overall Study|Randomized but did not receive treatment|0
7528594|NCT02732938|26155251|P2|Overall Study|Randomized but did not receive treatment|1
7528595|NCT02732938|26155252|P1|Overall Study|Randomized but did not receive treatment|0
7528596|NCT02732938|26155250|P3|Overall Study|Death|0
7528597|NCT02732938|26155251|P2|Overall Study|Death|11
7528598|NCT02732938|26155252|P1|Overall Study|Death|0
7528599|NCT02732912|26155298|P2|Overall Study|No outcome; discharged or refused|9
7528600|NCT02732912|26155299|P1|Overall Study|No outcome; discharged or refused|6
7528601|NCT02732912|26155298|P2|Overall Study|Incomplete completion of questionnaire|3
7528602|NCT02732912|26155299|P1|Overall Study|Incomplete completion of questionnaire|2
7528603|NCT02732912|26155298|P2|Overall Study|Discharged before night|6
7528604|NCT02732912|26155299|P1|Overall Study|Discharged before night|2
7528605|NCT02732847|26155326|P2|Overall Study|some filled early|42
7528606|NCT02732847|26155327|P1|Overall Study|some filled early|42
7528607|NCT02732639|26155333|P1|Overall Study|Lost to Follow-up|1
7528608|NCT02732561|26155375|P2|Overall Study|Withdrawal by Subject|0
7528609|NCT02732561|26155376|P1|Overall Study|Withdrawal by Subject|1
7528610|NCT02732561|26155375|P2|Overall Study|Lost to Follow-up|1
7528611|NCT02732561|26155376|P1|Overall Study|Lost to Follow-up|1
7528612|NCT02732327|26155402|P2|Overall Study|Protocol Violation|1
7528613|NCT02732327|26155403|P1|Overall Study|Protocol Violation|0
7528614|NCT02732210|26155411|P2|Overall Study|Missing|8
7528615|NCT02732210|26155412|P1|Overall Study|Missing|0
7528616|NCT02732210|26155411|P2|Overall Study|Other|103
7528617|NCT02732210|26155412|P1|Overall Study|Other|35
7528618|NCT02732210|26155411|P2|Overall Study|Death|15
7528619|NCT02732210|26155412|P1|Overall Study|Death|4
7528620|NCT02732210|26155411|P2|Overall Study|Lost to Follow-up|57
7528621|NCT02732210|26155412|P1|Overall Study|Lost to Follow-up|5
7528622|NCT02732210|26155411|P2|Overall Study|Withdrawal by Subject|87
7528623|NCT02732210|26155412|P1|Overall Study|Withdrawal by Subject|28
7528624|NCT02732210|26155411|P2|Overall Study|Study Ended|13
7528625|NCT02732210|26155412|P1|Overall Study|Study Ended|13
7528626|NCT02732210|26155411|P2|Overall Study|Site Closed|11
7528627|NCT02732210|26155412|P1|Overall Study|Site Closed|0
7528628|NCT02732119|26155566|P5|Phase II|Physician Decision|5
7528629|NCT02732119|26155567|P4|Phase II|Physician Decision|8
7528630|NCT02732119|26155568|P3|Phase II|Physician Decision|0
7528631|NCT02732119|26155569|P2|Phase II|Physician Decision|0
7528632|NCT02732119|26155570|P1|Phase II|Physician Decision|0
7528633|NCT02732119|26155566|P5|Phase II|Other|0
7528634|NCT02732119|26155567|P4|Phase II|Other|2
7528635|NCT02732119|26155568|P3|Phase II|Other|0
7528636|NCT02732119|26155569|P2|Phase II|Other|0
7528637|NCT02732119|26155570|P1|Phase II|Other|0
7528638|NCT02732119|26155566|P5|Phase II|Study terminated by sponsor|2
7528639|NCT02732119|26155567|P4|Phase II|Study terminated by sponsor|2
7528640|NCT02732119|26155568|P3|Phase II|Study terminated by sponsor|0
7528641|NCT02732119|26155569|P2|Phase II|Study terminated by sponsor|0
7528642|NCT02732119|26155570|P1|Phase II|Study terminated by sponsor|0
7528643|NCT02732119|26155566|P5|Phase II|Progressive dissease|23
7528644|NCT02732119|26155567|P4|Phase II|Progressive dissease|30
7528645|NCT02732119|26155568|P3|Phase II|Progressive dissease|0
7528646|NCT02732119|26155569|P2|Phase II|Progressive dissease|0
7528647|NCT02732119|26155570|P1|Phase II|Progressive dissease|0
7528648|NCT02732119|26155566|P5|Phase II|Death|0
7528649|NCT02732119|26155567|P4|Phase II|Death|1
7528650|NCT02732119|26155568|P3|Phase II|Death|0
7528651|NCT02732119|26155569|P2|Phase II|Death|0
7528652|NCT02732119|26155570|P1|Phase II|Death|0
7528653|NCT02732119|26155566|P5|Phase II|Adverse Event|3
7528654|NCT02732119|26155567|P4|Phase II|Adverse Event|3
7528655|NCT02732119|26155568|P3|Phase II|Adverse Event|0
7528656|NCT02732119|26155569|P2|Phase II|Adverse Event|0
7528657|NCT02732119|26155570|P1|Phase II|Adverse Event|0
7528658|NCT02732119|26155566|P5|Phase I|Physician Decision|0
7528659|NCT02732119|26155567|P4|Phase I|Physician Decision|0
7528660|NCT02732119|26155568|P3|Phase I|Physician Decision|4
7528661|NCT02732119|26155569|P2|Phase I|Physician Decision|3
7528662|NCT02732119|26155570|P1|Phase I|Physician Decision|0
7528663|NCT02732119|26155566|P5|Phase I|Protocol deviation|0
7528664|NCT02732119|26155567|P4|Phase I|Protocol deviation|0
7528665|NCT02732119|26155568|P3|Phase I|Protocol deviation|0
7528666|NCT02732119|26155569|P2|Phase I|Protocol deviation|1
7528667|NCT02732119|26155570|P1|Phase I|Protocol deviation|0
7528668|NCT02732119|26155566|P5|Phase I|Progressive disease|0
7528669|NCT02732119|26155567|P4|Phase I|Progressive disease|0
7528670|NCT02732119|26155568|P3|Phase I|Progressive disease|2
7528671|NCT02732119|26155569|P2|Phase I|Progressive disease|3
7528672|NCT02732119|26155570|P1|Phase I|Progressive disease|7
7528673|NCT02732119|26155566|P5|Phase I|Adverse Event|0
7528674|NCT02732119|26155567|P4|Phase I|Adverse Event|0
7528675|NCT02732119|26155568|P3|Phase I|Adverse Event|1
7528676|NCT02732119|26155569|P2|Phase I|Adverse Event|3
7528677|NCT02732119|26155570|P1|Phase I|Adverse Event|1
7528678|NCT02732015|26155605|P2|Overall Study|Lost to Follow-up|1
7528679|NCT02732015|26155606|P1|Overall Study|Lost to Follow-up|0
7528680|NCT02731755|26155642|P2|First Intervention|Withdrawal by Subject|2
7528681|NCT02731755|26155643|P1|First Intervention|Withdrawal by Subject|0
7528682|NCT02731742|26155667|P4|Overall Study|Study Terminated by Sponsor|1
7528683|NCT02731742|26155668|P3|Overall Study|Study Terminated by Sponsor|1
7528684|NCT02731742|26155669|P2|Overall Study|Study Terminated by Sponsor|1
7528685|NCT02731742|26155670|P1|Overall Study|Study Terminated by Sponsor|2
7528686|NCT02731742|26155667|P4|Overall Study|Physician Decision|1
7528687|NCT02731742|26155668|P3|Overall Study|Physician Decision|0
7528688|NCT02731742|26155669|P2|Overall Study|Physician Decision|0
7528689|NCT02731742|26155670|P1|Overall Study|Physician Decision|0
7528690|NCT02731742|26155667|P4|Overall Study|Death|0
7528691|NCT02731742|26155668|P3|Overall Study|Death|5
7528692|NCT02731742|26155669|P2|Overall Study|Death|2
7528693|NCT02731742|26155670|P1|Overall Study|Death|1
7528694|NCT02731729|26155690|P2|Overall Study|Withdrawal by Subject|0
7528695|NCT02731729|26155691|P1|Overall Study|Withdrawal by Subject|1
7528696|NCT02731729|26155690|P2|Overall Study|Study terminated by Sponsor|6
7528697|NCT02731729|26155691|P1|Overall Study|Study terminated by Sponsor|6
7528698|NCT02731729|26155690|P2|Overall Study|Death|2
7528699|NCT02731729|26155691|P1|Overall Study|Death|2
7528700|NCT02731690|26155707|P1|Overall Study|Discontinuation of Study by Sponsor|26
7528701|NCT02731690|26155707|P1|Overall Study|Withdrawal by Subject|3
7528702|NCT02731690|26155707|P1|Overall Study|Adverse Event|1
7528703|NCT02731638|26155727|P2|Overall Study|Lost to Follow-up|9
7528704|NCT02731638|26155728|P1|Overall Study|Lost to Follow-up|6
7528705|NCT02731157|26155971|P1|First Rejuvenated RCE|Withdrawal by Subject|1
7528706|NCT02731131|26155989|P2|Overall Study|Refused Therapy|1
7528707|NCT02731131|26155990|P1|Overall Study|Refused Therapy|0
7528708|NCT02731131|26155989|P2|Overall Study|Psychiatric Disorder|1
7528709|NCT02731131|26155990|P1|Overall Study|Psychiatric Disorder|0
7528710|NCT02730871|26156040|P2|Overall Study|Adverse Event|0
7528711|NCT02730871|26156041|P1|Overall Study|Adverse Event|6
7528712|NCT02730819|26156055|P1|Overall Study|Lost to Follow-up|9
7528713|NCT02730793|26156063|P2|Overall Study|Withdrawal by Subject|1
7528714|NCT02730793|26156064|P1|Overall Study|Withdrawal by Subject|0
7528715|NCT02730793|26156063|P2|Overall Study|Physician Decision|1
7528716|NCT02730793|26156064|P1|Overall Study|Physician Decision|0
7528717|NCT02730728|26156089|P3|Overall Study|Lack of Efficacy|1
7528718|NCT02730728|26156090|P2|Overall Study|Lack of Efficacy|1
7528719|NCT02730728|26156091|P1|Overall Study|Lack of Efficacy|0
7528720|NCT02730728|26156089|P3|Overall Study|Withdrawal by Subject|0
7528721|NCT02730728|26156090|P2|Overall Study|Withdrawal by Subject|1
7528722|NCT02730728|26156091|P1|Overall Study|Withdrawal by Subject|0
7528723|NCT02730598|26156120|P2|Overall Study|Unrelated Injury affecting outcomes.|0
7528724|NCT02730598|26156121|P1|Overall Study|Unrelated Injury affecting outcomes.|1
7528725|NCT02730598|26156120|P2|Overall Study|Protocol Violation|1
7528726|NCT02730598|26156121|P1|Overall Study|Protocol Violation|0
7528727|NCT02730598|26156120|P2|Overall Study|Withdrawal by Subject|3
7528728|NCT02730598|26156121|P1|Overall Study|Withdrawal by Subject|3
7528729|NCT02730455|26156144|P3|Overall Study|Other|0
7528730|NCT02730455|26156145|P2|Overall Study|Other|2
7528731|NCT02730455|26156146|P1|Overall Study|Other|2
7528732|NCT02730455|26156144|P3|Overall Study|Other|2
7528733|NCT02730455|26156145|P2|Overall Study|Other|1
7528734|NCT02730455|26156146|P1|Overall Study|Other|1
7528735|NCT02730455|26156144|P3|Overall Study|Lost to Follow-up|4
7528736|NCT02730455|26156145|P2|Overall Study|Lost to Follow-up|1
7528737|NCT02730455|26156146|P1|Overall Study|Lost to Follow-up|3
7528738|NCT02730455|26156144|P3|Overall Study|Consent withdrawn|1
7528739|NCT02730455|26156145|P2|Overall Study|Consent withdrawn|4
7528740|NCT02730455|26156146|P1|Overall Study|Consent withdrawn|2
7528741|NCT02730455|26156144|P3|Overall Study|Death|4
7528742|NCT02730455|26156145|P2|Overall Study|Death|6
7528743|NCT02730455|26156146|P1|Overall Study|Death|5
7528744|NCT02730377|26156196|P2|Overall Study|Lost to Follow-up|21
7528745|NCT02730377|26156197|P1|Overall Study|Lost to Follow-up|25
7528746|NCT02730377|26156196|P2|Overall Study|Withdrawal by Subject|42
7528747|NCT02730377|26156197|P1|Overall Study|Withdrawal by Subject|45
7528748|NCT02730377|26156196|P2|Overall Study|Pregnancy|1
7528749|NCT02730377|26156197|P1|Overall Study|Pregnancy|0
7528750|NCT02730377|26156196|P2|Overall Study|Lack of Efficacy|13
7528751|NCT02730377|26156197|P1|Overall Study|Lack of Efficacy|4
7528752|NCT02730377|26156196|P2|Overall Study|Protocol Violation|30
7528753|NCT02730377|26156197|P1|Overall Study|Protocol Violation|23
7528754|NCT02730377|26156196|P2|Overall Study|Adverse Event|41
7528755|NCT02730377|26156197|P1|Overall Study|Adverse Event|79
7528756|NCT02730377|26156196|P2|Overall Study|Inadequate glycaemic control|473
7528757|NCT02730377|26156197|P1|Overall Study|Inadequate glycaemic control|368
7528758|NCT02730377|26156196|P2|Overall Study|Death|8
7528759|NCT02730377|26156197|P1|Overall Study|Death|1
7528760|NCT02730377|26156196|P2|Overall Study|Other|4
7528761|NCT02730377|26156197|P1|Overall Study|Other|5
7528762|NCT02730351|26156247|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
7528763|NCT02730351|26156248|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
7528764|NCT02730351|26156247|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
7528765|NCT02730351|26156248|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
7528766|NCT02730351|26156247|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
7528767|NCT02730351|26156248|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
7528768|NCT02730351|26156247|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
7528769|NCT02730351|26156248|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
7528770|NCT02730351|26156247|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
7528771|NCT02730351|26156248|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
7528772|NCT02730208|26156301|P2|Overall Study|Withdrawal of consent (not due to AE)|1
7528773|NCT02730208|26156302|P1|Overall Study|Withdrawal of consent (not due to AE)|0
7528774|NCT02730195|26156310|P1|Overall Study|Withdrawal by Subject|1
7528775|NCT02730169|26156320|P4|Overall Study|Other|1
7528776|NCT02730169|26156321|P3|Overall Study|Other|1
7528777|NCT02730169|26156322|P2|Overall Study|Other|0
7528778|NCT02730169|26156323|P1|Overall Study|Other|0
7528779|NCT02730169|26156320|P4|Overall Study|Lost to Follow-up|6
7528780|NCT02730169|26156321|P3|Overall Study|Lost to Follow-up|5
7528781|NCT02730169|26156322|P2|Overall Study|Lost to Follow-up|6
7528782|NCT02730169|26156323|P1|Overall Study|Lost to Follow-up|5
7528783|NCT02730169|26156320|P4|Overall Study|Withdrawal by Subject|8
7528784|NCT02730169|26156321|P3|Overall Study|Withdrawal by Subject|6
7528785|NCT02730169|26156322|P2|Overall Study|Withdrawal by Subject|11
7528786|NCT02730169|26156323|P1|Overall Study|Withdrawal by Subject|6
7528787|NCT02730169|26156320|P4|Overall Study|Adverse Event of Special Interest|0
7528788|NCT02730169|26156321|P3|Overall Study|Adverse Event of Special Interest|2
7528789|NCT02730169|26156322|P2|Overall Study|Adverse Event of Special Interest|1
7528790|NCT02730169|26156323|P1|Overall Study|Adverse Event of Special Interest|0
7528791|NCT02730169|26156320|P4|Overall Study|Adverse Event|0
7528792|NCT02730169|26156321|P3|Overall Study|Adverse Event|3
7528793|NCT02730169|26156322|P2|Overall Study|Adverse Event|3
7528794|NCT02730169|26156323|P1|Overall Study|Adverse Event|2
7528795|NCT02730169|26156320|P4|Overall Study|Protocol Violation|1
7528796|NCT02730169|26156321|P3|Overall Study|Protocol Violation|0
7528797|NCT02730169|26156322|P2|Overall Study|Protocol Violation|0
7528798|NCT02730169|26156323|P1|Overall Study|Protocol Violation|1
7528799|NCT02729909|26156391|P2|Overall Study|Voluntary Withdrawal|0
7528800|NCT02729909|26156392|P1|Overall Study|Voluntary Withdrawal|1
7528801|NCT02729909|26156391|P2|Overall Study|Significant Protocol Deviation|2
7528802|NCT02729909|26156392|P1|Overall Study|Significant Protocol Deviation|0
7528803|NCT02729909|26156391|P2|Overall Study|Lack of Efficacy|2
7528804|NCT02729909|26156392|P1|Overall Study|Lack of Efficacy|0
7528805|NCT02729909|26156391|P2|Overall Study|Lost to Follow-up|1
7528806|NCT02729909|26156392|P1|Overall Study|Lost to Follow-up|0
7528807|NCT02729896|26156411|P3|Overall Study|Withdrawal by Subject|3
7528808|NCT02729896|26156412|P2|Overall Study|Withdrawal by Subject|0
7528809|NCT02729896|26156413|P1|Overall Study|Withdrawal by Subject|1
7528810|NCT02729896|26156411|P3|Overall Study|Progressive Disease|0
7528811|NCT02729896|26156412|P2|Overall Study|Progressive Disease|1
7528812|NCT02729896|26156413|P1|Overall Study|Progressive Disease|0
7528813|NCT02729896|26156411|P3|Overall Study|Physician Decision|3
7528814|NCT02729896|26156412|P2|Overall Study|Physician Decision|2
7528815|NCT02729896|26156413|P1|Overall Study|Physician Decision|1
7528816|NCT02729896|26156411|P3|Overall Study|Other|0
7528817|NCT02729896|26156412|P2|Overall Study|Other|2
7528818|NCT02729896|26156413|P1|Overall Study|Other|0
7528819|NCT02729896|26156411|P3|Overall Study|Lost to Follow-up|3
7528820|NCT02729896|26156412|P2|Overall Study|Lost to Follow-up|2
7528821|NCT02729896|26156413|P1|Overall Study|Lost to Follow-up|0
7528822|NCT02729896|26156411|P3|Overall Study|Death|13
7528823|NCT02729896|26156412|P2|Overall Study|Death|2
7528824|NCT02729896|26156413|P1|Overall Study|Death|0
7528825|NCT02729831|26156458|P4|6 Month Follow-up|Death|1
7528826|NCT02729831|26156459|P3|6 Month Follow-up|Death|0
7528827|NCT02729831|26156460|P2|6 Month Follow-up|Death|3
7528828|NCT02729831|26156461|P1|6 Month Follow-up|Death|1
7528829|NCT02729831|26156458|P4|6 Month Follow-up|Lost to Follow-up|42
7528830|NCT02729831|26156459|P3|6 Month Follow-up|Lost to Follow-up|48
7528831|NCT02729831|26156460|P2|6 Month Follow-up|Lost to Follow-up|51
7528832|NCT02729831|26156461|P1|6 Month Follow-up|Lost to Follow-up|54
7528833|NCT02729831|26156458|P4|1 Week Post-visit|Lost to Follow-up|36
7528834|NCT02729831|26156459|P3|1 Week Post-visit|Lost to Follow-up|38
7528835|NCT02729831|26156460|P2|1 Week Post-visit|Lost to Follow-up|40
7528836|NCT02729831|26156461|P1|1 Week Post-visit|Lost to Follow-up|43
7528837|NCT02729831|26156458|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
7528838|NCT02729831|26156459|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
7528839|NCT02729831|26156460|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
7528840|NCT02729831|26156461|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
7528841|NCT02729753|26156489|P2|Overall Study|Device Malfunction. No units in stock.|1
7528842|NCT02729753|26156490|P1|Overall Study|Device Malfunction. No units in stock.|0
7528843|NCT02729740|26156502|P1|Overall Study|Other|1
7528844|NCT02729740|26156502|P1|Overall Study|Early Termination|130
7528845|NCT02729545|26156511|P2|Overall Study|Withdrawal by Subject|3
7528846|NCT02729545|26156512|P1|Overall Study|Withdrawal by Subject|2
7528847|NCT02729545|26156511|P2|Overall Study|Lost to Follow-up|1
7528848|NCT02729545|26156512|P1|Overall Study|Lost to Follow-up|0
7528849|NCT02729545|26156511|P2|Overall Study|Pregnancy|1
7528850|NCT02729545|26156512|P1|Overall Study|Pregnancy|1
7528851|NCT02729194|26156534|P1|Overall Study|Withdrawal by Subject|3
7528852|NCT02729051|26156546|P2|Overall Study|Withdrawal by Subject|17
7528853|NCT02729051|26156547|P1|Overall Study|Withdrawal by Subject|6
7528854|NCT02729051|26156546|P2|Overall Study|Physician Decision|1
7528855|NCT02729051|26156547|P1|Overall Study|Physician Decision|1
7528856|NCT02729051|26156546|P2|Overall Study|Lost to Follow-up|2
7528857|NCT02729051|26156547|P1|Overall Study|Lost to Follow-up|1
7528858|NCT02729051|26156546|P2|Overall Study|Lack of Efficacy|1
7528859|NCT02729051|26156547|P1|Overall Study|Lack of Efficacy|1
7528860|NCT02729051|26156546|P2|Overall Study|Adverse Event|11
7528861|NCT02729051|26156547|P1|Overall Study|Adverse Event|21
7528862|NCT02729025|26156691|P2|Overall Study|Sponsor Decision|1
7528863|NCT02729025|26156692|P1|Overall Study|Sponsor Decision|0
7528864|NCT02728895|26156706|P2|Overall Study|Withdrawal by Subject|3
7528865|NCT02728895|26156707|P1|Overall Study|Withdrawal by Subject|0
7528866|NCT02728895|26156706|P2|Overall Study|Other|2
7528867|NCT02728895|26156707|P1|Overall Study|Other|1
7528868|NCT02728830|26156727|P1|Overall Study|Language Barrier|1
7528869|NCT02728830|26156727|P1|Overall Study|Contraindicated Illness|1
7528870|NCT02728830|26156727|P1|Overall Study|Exclusionary Lab Values|1
7528871|NCT02728830|26156727|P1|Overall Study|Lost to Follow-up|1
7528872|NCT02728830|26156727|P1|Overall Study|Withdrawal by Subject|2
7528873|NCT02728830|26156727|P1|Overall Study|Physician Decision|3
7528874|NCT02728830|26156727|P1|Overall Study|Exclusionary Pathology|6
7528875|NCT02728830|26156727|P1|Overall Study|Exclusionary Surgery|9
7528876|NCT02728206|26156787|P1|Overall Study|Death|1
7528883|NCT02728089|26156807|P1|Overall Study|Withdrawal by Subject|1
7528884|NCT02728089|26156807|P1|Overall Study|Physician Decision|2
7528885|NCT02727777|26156895|P3|Overall Study|Progressive disease|0
7528886|NCT02727777|26156896|P2|Overall Study|Progressive disease|0
7528887|NCT02727777|26156897|P1|Overall Study|Progressive disease|2
7528888|NCT02727777|26156895|P3|Overall Study|Screen Failure|0
7528889|NCT02727777|26156896|P2|Overall Study|Screen Failure|0
7528890|NCT02727777|26156897|P1|Overall Study|Screen Failure|2
7528891|NCT02727699|26156917|P2|Overall Study|Sponsor Decision|0
7528892|NCT02727699|26156918|P1|Overall Study|Sponsor Decision|1
7528893|NCT02727699|26156917|P2|Overall Study|Lost to Follow-up|0
7528894|NCT02727699|26156918|P1|Overall Study|Lost to Follow-up|1
7528895|NCT02727699|26156917|P2|Overall Study|Physician Decision|1
7528896|NCT02727699|26156918|P1|Overall Study|Physician Decision|0
7528897|NCT02727699|26156917|P2|Overall Study|Protocol Violation|1
7528898|NCT02727699|26156918|P1|Overall Study|Protocol Violation|0
7528899|NCT02727699|26156917|P2|Overall Study|Withdrawal by Subject|3
7528900|NCT02727699|26156918|P1|Overall Study|Withdrawal by Subject|5
7528901|NCT02727699|26156917|P2|Overall Study|Adverse Event|0
7528902|NCT02727699|26156918|P1|Overall Study|Adverse Event|2
7528903|NCT02727660|26156939|P3|Overall Study|Administrative Reasons|4
7528904|NCT02727660|26156940|P2|Overall Study|Administrative Reasons|3
7528905|NCT02727660|26156941|P1|Overall Study|Administrative Reasons|2
7528906|NCT02727660|26156939|P3|Overall Study|Protocol Specified Disc. Criteria|2
7528907|NCT02727660|26156940|P2|Overall Study|Protocol Specified Disc. Criteria|5
7528908|NCT02727660|26156941|P1|Overall Study|Protocol Specified Disc. Criteria|5
7528909|NCT02727660|26156939|P3|Overall Study|Protocol Violation|5
7528910|NCT02727660|26156940|P2|Overall Study|Protocol Violation|5
7528911|NCT02727660|26156941|P1|Overall Study|Protocol Violation|7
7528912|NCT02727660|26156939|P3|Overall Study|Lost to Follow-up|8
7528913|NCT02727660|26156940|P2|Overall Study|Lost to Follow-up|9
7528914|NCT02727660|26156941|P1|Overall Study|Lost to Follow-up|5
7528915|NCT02727660|26156939|P3|Overall Study|Physician Decision|14
7528916|NCT02727660|26156940|P2|Overall Study|Physician Decision|8
7528917|NCT02727660|26156941|P1|Overall Study|Physician Decision|3
7528918|NCT02727660|26156939|P3|Overall Study|Withdrawal by Subject|30
7528919|NCT02727660|26156940|P2|Overall Study|Withdrawal by Subject|25
7528920|NCT02727660|26156941|P1|Overall Study|Withdrawal by Subject|26
7528921|NCT02727660|26156939|P3|Overall Study|Adverse Event|32
7528922|NCT02727660|26156940|P2|Overall Study|Adverse Event|21
7528923|NCT02727660|26156941|P1|Overall Study|Adverse Event|28
7528924|NCT02727660|26156939|P3|Overall Study|Lack of Efficacy|70
7528925|NCT02727660|26156940|P2|Overall Study|Lack of Efficacy|40
7528926|NCT02727660|26156941|P1|Overall Study|Lack of Efficacy|40
7528927|NCT02727322|26156960|P2|Overall Study|Protocol Violation|0
7528928|NCT02727322|26156961|P1|Overall Study|Protocol Violation|1
7528929|NCT02727322|26156960|P2|Overall Study|Withdrawal by Subject|1
7528930|NCT02727322|26156961|P1|Overall Study|Withdrawal by Subject|1
7528931|NCT02727192|26156973|P3|Overall Study|Lost to Follow-up|0
7528932|NCT02727192|26156974|P2|Overall Study|Lost to Follow-up|0
7528933|NCT02727192|26156975|P1|Overall Study|Lost to Follow-up|1
7528934|NCT02726945|26157018|P3|Overall Study|Elected to have total knee replacement|0
7528935|NCT02726945|26157019|P2|Overall Study|Elected to have total knee replacement|1
7528936|NCT02726945|26157020|P1|Overall Study|Elected to have total knee replacement|0
7528937|NCT02726945|26157018|P3|Overall Study|Withdrawal by Subject|1
7528938|NCT02726945|26157019|P2|Overall Study|Withdrawal by Subject|0
7528939|NCT02726945|26157020|P1|Overall Study|Withdrawal by Subject|0
7528940|NCT02726399|26157171|P1|Overall Study|Progression of disease|4
7528941|NCT02726399|26157171|P1|Overall Study|Adverse Event|2
7528942|NCT02726399|26157171|P1|Overall Study|Participant Non-Compliance|1
7528943|NCT02726113|26157188|P2|Genomic Analysis|Insurance non-coverage for surgery|1
7528944|NCT02726113|26157189|P1|Genomic Analysis|Insurance non-coverage for surgery|1
7528945|NCT02726113|26157188|P2|Genomic Analysis|Withdrawal by Subject|1
7528946|NCT02726113|26157189|P1|Genomic Analysis|Withdrawal by Subject|2
7528947|NCT02726113|26157188|P2|Genomic Analysis|Protocol Violation|0
7528948|NCT02726113|26157189|P1|Genomic Analysis|Protocol Violation|1
7528949|NCT02726113|26157188|P2|Total Enrollment|Insurance non-coverage for surgery|1
7528950|NCT02726113|26157189|P1|Total Enrollment|Insurance non-coverage for surgery|1
7528951|NCT02726113|26157188|P2|Total Enrollment|Withdrawal by Subject|1
7528952|NCT02726113|26157189|P1|Total Enrollment|Withdrawal by Subject|2
7528953|NCT02726113|26157188|P2|Total Enrollment|Protocol Violation|0
7528954|NCT02726113|26157189|P1|Total Enrollment|Protocol Violation|1
7528955|NCT02726113|26157188|P2|Total Enrollment|Physician Decision|1
7528956|NCT02726113|26157189|P1|Total Enrollment|Physician Decision|0
7528957|NCT02726074|26157196|P1|Overall Study|Others|3
7528958|NCT02726074|26157196|P1|Overall Study|Lost to Follow-up|2
7528959|NCT02726074|26157196|P1|Overall Study|Protocol Violation|3
7528960|NCT02726074|26157196|P1|Overall Study|Adverse Event|14
7528961|NCT02726074|26157196|P1|Overall Study|Withdrawal by Subject|4
7528962|NCT02726022|26157208|P1|Overall Study|Treatment Failure and Poor Compliance|1
7528963|NCT02726022|26157208|P1|Overall Study|Poor Compliance|13
7528964|NCT02726022|26157208|P1|Overall Study|Treatment Failure|8
7528965|NCT02726022|26157208|P1|Overall Study|Adverse Event|14
7528966|NCT02725866|26157217|P1|Overall Study|Other, not specified|4
7528967|NCT02725866|26157217|P1|Overall Study|Insufficient virological response|1
7528968|NCT02725866|26157217|P1|Overall Study|Withdrew consent|3
7528969|NCT02725866|26157217|P1|Overall Study|Failure to return|6
7528970|NCT02725788|26157241|P2|Overall Study|Protocol Violation|1
7528971|NCT02725788|26157242|P1|Overall Study|Protocol Violation|0
7528972|NCT02725788|26157241|P2|Overall Study|Lost to Follow-up|1
7528973|NCT02725788|26157242|P1|Overall Study|Lost to Follow-up|1
7528974|NCT02725710|26157250|P2|Overall Study|Lost to Follow-up|0
7528975|NCT02725710|26157251|P1|Overall Study|Lost to Follow-up|1
7528976|NCT02725671|26157279|P1|Overall Study|Lost to Follow-up|1
7528977|NCT02725593|26157294|P2|Long Term Extension|Withdrawal by Subject|1
7528978|NCT02725593|26157295|P1|Long Term Extension|Withdrawal by Subject|1
7528979|NCT02725593|26157294|P2|Blinded Treatment Period|Lost to Follow-up|1
7528980|NCT02725593|26157295|P1|Blinded Treatment Period|Lost to Follow-up|1
7528981|NCT02725593|26157294|P2|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
7528982|NCT02725593|26157295|P1|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
7528983|NCT02725593|26157294|P2|Blinded Treatment Period|Withdrawal by Subject|3
7528984|NCT02725593|26157295|P1|Blinded Treatment Period|Withdrawal by Subject|4
7528985|NCT02725515|26157309|P2|Overall Study|Lack of Response|1
7528986|NCT02725515|26157310|P1|Overall Study|Lack of Response|0
7528987|NCT02725515|26157309|P2|Overall Study|Completed Study Under Original Protocol|1
7528988|NCT02725515|26157310|P1|Overall Study|Completed Study Under Original Protocol|0
7528989|NCT02725515|26157309|P2|Overall Study|No Documented Disease Improvement|1
7528990|NCT02725515|26157310|P1|Overall Study|No Documented Disease Improvement|0
7528991|NCT02725515|26157309|P2|Overall Study|Adverse Event|2
7528992|NCT02725515|26157310|P1|Overall Study|Adverse Event|7
7528993|NCT02725515|26157309|P2|Overall Study|Lost to Follow-up|1
7528994|NCT02725515|26157310|P1|Overall Study|Lost to Follow-up|1
7528995|NCT02725515|26157309|P2|Overall Study|Non-Compliance With Study Drug|3
7528996|NCT02725515|26157310|P1|Overall Study|Non-Compliance With Study Drug|0
7528997|NCT02725515|26157309|P2|Overall Study|Withdrawal by Subject|1
7528998|NCT02725515|26157310|P1|Overall Study|Withdrawal by Subject|2
7528999|NCT02725515|26157309|P2|Overall Study|Loss of Improvement per Protocol|25
7529000|NCT02725515|26157310|P1|Overall Study|Loss of Improvement per Protocol|14
7529001|NCT02725515|26157309|P2|Overall Study|Refused infusion (no study treatment)|0
7529002|NCT02725515|26157310|P1|Overall Study|Refused infusion (no study treatment)|1
7529003|NCT02725476|26157322|P2|Overall Study|Adverse Event|1
7529004|NCT02725476|26157323|P1|Overall Study|Adverse Event|1
7529005|NCT02725476|26157322|P2|Overall Study|Physician Decision|0
7529006|NCT02725476|26157323|P1|Overall Study|Physician Decision|2
7529007|NCT02725411|26157334|P3|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7529008|NCT02725411|26157335|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7529009|NCT02725411|26157336|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7529010|NCT02725411|26157334|P3|Follow-up Period (24 Weeks)|Other|2
7529011|NCT02725411|26157335|P2|Follow-up Period (24 Weeks)|Other|4
7529012|NCT02725411|26157336|P1|Follow-up Period (24 Weeks)|Other|1
7529013|NCT02725411|26157334|P3|Follow-up Period (24 Weeks)|Lost to Follow-up|0
7529014|NCT02725411|26157335|P2|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7529015|NCT02725411|26157336|P1|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7529016|NCT02725411|26157334|P3|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7529017|NCT02725411|26157335|P2|Follow-up Period (24 Weeks)|Lack of Efficacy|2
7529018|NCT02725411|26157336|P1|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7529019|NCT02725411|26157334|P3|Follow-up Period (24 Weeks)|Adverse Event|0
7529020|NCT02725411|26157335|P2|Follow-up Period (24 Weeks)|Adverse Event|1
7529021|NCT02725411|26157336|P1|Follow-up Period (24 Weeks)|Adverse Event|1
7529022|NCT02725411|26157334|P3|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7529023|NCT02725411|26157335|P2|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7529024|NCT02725411|26157336|P1|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
7529025|NCT02725411|26157334|P3|Treatment Period (56 Weeks)|Withdrawal by Subject|4
7529026|NCT02725411|26157335|P2|Treatment Period (56 Weeks)|Withdrawal by Subject|1
7529027|NCT02725411|26157336|P1|Treatment Period (56 Weeks)|Withdrawal by Subject|0
7529028|NCT02725411|26157334|P3|Treatment Period (56 Weeks)|Other|5
7529029|NCT02725411|26157335|P2|Treatment Period (56 Weeks)|Other|4
7529030|NCT02725411|26157336|P1|Treatment Period (56 Weeks)|Other|1
7529031|NCT02725411|26157334|P3|Treatment Period (56 Weeks)|Lost to Follow-up|0
7529032|NCT02725411|26157335|P2|Treatment Period (56 Weeks)|Lost to Follow-up|1
7529033|NCT02725411|26157336|P1|Treatment Period (56 Weeks)|Lost to Follow-up|0
7529034|NCT02725411|26157334|P3|Treatment Period (56 Weeks)|Lack of Efficacy|1
7529035|NCT02725411|26157335|P2|Treatment Period (56 Weeks)|Lack of Efficacy|4
7529036|NCT02725411|26157336|P1|Treatment Period (56 Weeks)|Lack of Efficacy|1
7529037|NCT02725411|26157334|P3|Treatment Period (56 Weeks)|Adverse Event|4
7529038|NCT02725411|26157335|P2|Treatment Period (56 Weeks)|Adverse Event|5
7529039|NCT02725411|26157336|P1|Treatment Period (56 Weeks)|Adverse Event|3
7529040|NCT02725268|26157552|P4|Overall Study|Ongoing|0
7529041|NCT02725268|26157553|P3|Overall Study|Ongoing|0
7529042|NCT02725268|26157554|P2|Overall Study|Ongoing|3
7529043|NCT02725268|26157555|P1|Overall Study|Ongoing|3
7529044|NCT02725268|26157552|P4|Overall Study|Reason not Specified|0
7529045|NCT02725268|26157553|P3|Overall Study|Reason not Specified|0
7529046|NCT02725268|26157554|P2|Overall Study|Reason not Specified|1
7529047|NCT02725268|26157555|P1|Overall Study|Reason not Specified|1
7529048|NCT02725268|26157552|P4|Overall Study|Withdrawal by Subject|1
7529049|NCT02725268|26157553|P3|Overall Study|Withdrawal by Subject|8
7529050|NCT02725268|26157554|P2|Overall Study|Withdrawal by Subject|4
7529051|NCT02725268|26157555|P1|Overall Study|Withdrawal by Subject|8
7529052|NCT02725268|26157552|P4|Overall Study|Lost to Follow-up|0
7529053|NCT02725268|26157553|P3|Overall Study|Lost to Follow-up|0
7529054|NCT02725268|26157554|P2|Overall Study|Lost to Follow-up|3
7529055|NCT02725268|26157555|P1|Overall Study|Lost to Follow-up|2
7529056|NCT02725268|26157552|P4|Overall Study|Death|16
7529057|NCT02725268|26157553|P3|Overall Study|Death|29
7529058|NCT02725268|26157554|P2|Overall Study|Death|48
7529059|NCT02725268|26157555|P1|Overall Study|Death|45
7529060|NCT02725008|26157591|P2|Overall Study|Admitted to hospital|1
7529061|NCT02725008|26157592|P1|Overall Study|Admitted to hospital|0
7529062|NCT02725008|26157591|P2|Overall Study|Withdrawal by Subject|2
7529063|NCT02725008|26157592|P1|Overall Study|Withdrawal by Subject|2
7529064|NCT02725008|26157591|P2|Overall Study|Lost to Follow-up|9
7529065|NCT02725008|26157592|P1|Overall Study|Lost to Follow-up|7
7529066|NCT02724956|26157602|P2|Overall Study|Withdrawal by Subject|1
7529067|NCT02724956|26157603|P1|Overall Study|Withdrawal by Subject|0
7529068|NCT02724956|26157602|P2|Overall Study|Lack of Efficacy|1
7529069|NCT02724956|26157603|P1|Overall Study|Lack of Efficacy|0
7529070|NCT02724956|26157602|P2|Overall Study|Physician Decision|0
7529071|NCT02724956|26157603|P1|Overall Study|Physician Decision|1
7529072|NCT02724878|26157619|P1|Overall Study|Other|1
7529073|NCT02724878|26157619|P1|Overall Study|Ineligible for Study Drug|5
7529074|NCT02724878|26157619|P1|Overall Study|Protocol Violation|1
7529075|NCT02724878|26157619|P1|Overall Study|Lost to Follow-up|2
7529076|NCT02724878|26157619|P1|Overall Study|Withdrawal by Subject|4
7529077|NCT02724878|26157619|P1|Overall Study|Death|1
7529078|NCT02724878|26157619|P1|Overall Study|Toxicity|5
7529079|NCT02724878|26157619|P1|Overall Study|Disease Progression|31
7529080|NCT02724878|26157619|P1|Overall Study|Still on Active Therapy|15
7529081|NCT02724839|26157645|P3|Overall Study|Physician Decision|3
7529082|NCT02724839|26157646|P2|Overall Study|Physician Decision|0
7529083|NCT02724839|26157647|P1|Overall Study|Physician Decision|0
7529084|NCT02724839|26157645|P3|Overall Study|Lost to Follow-up|2
7529085|NCT02724839|26157646|P2|Overall Study|Lost to Follow-up|3
7529086|NCT02724839|26157647|P1|Overall Study|Lost to Follow-up|0
7529087|NCT02724839|26157645|P3|Overall Study|Withdrawal by Subject|0
7529088|NCT02724839|26157646|P2|Overall Study|Withdrawal by Subject|1
7529089|NCT02724839|26157647|P1|Overall Study|Withdrawal by Subject|1
7529090|NCT02724644|26157724|P2|Overall Study|Administrative|0
7529091|NCT02724644|26157725|P1|Overall Study|Administrative|1
7529092|NCT02724644|26157724|P2|Overall Study|Withdrawal by Subject|1
7529093|NCT02724644|26157725|P1|Overall Study|Withdrawal by Subject|7
7529094|NCT02724644|26157724|P2|Overall Study|Lost to Follow-up|2
7529095|NCT02724644|26157725|P1|Overall Study|Lost to Follow-up|6
7529096|NCT02724644|26157724|P2|Overall Study|Adverse Event|1
7529097|NCT02724644|26157725|P1|Overall Study|Adverse Event|7
7529098|NCT02724592|26157755|P2|Overall Study|Lost to Follow-up|1
7529099|NCT02724592|26157756|P1|Overall Study|Lost to Follow-up|4
7529100|NCT02724462|26157770|P2|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
7529101|NCT02724462|26157771|P1|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
7529102|NCT02724462|26157770|P2|12 Month Follow-up Survey|Lost to Follow-up|134
7529103|NCT02724462|26157771|P1|12 Month Follow-up Survey|Lost to Follow-up|174
7529104|NCT02724462|26157770|P2|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
7529105|NCT02724462|26157771|P1|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
7529106|NCT02724462|26157770|P2|6 Month Follow-up Survey|Lost to Follow-up|123
7529107|NCT02724462|26157771|P1|6 Month Follow-up Survey|Lost to Follow-up|156
7529108|NCT02724462|26157770|P2|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
7529109|NCT02724462|26157771|P1|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
7529110|NCT02724462|26157770|P2|3 Month Follow-up Survey|Lost to Follow-up|151
7529111|NCT02724462|26157771|P1|3 Month Follow-up Survey|Lost to Follow-up|171
7529112|NCT02724111|26157792|P2|Overall Study|Protocol Violation|5
7529113|NCT02724111|26157793|P1|Overall Study|Protocol Violation|2
7529114|NCT02724020|26157829|P3|Overall Study|Withdrawal by Subject|5
7529115|NCT02724020|26157830|P2|Overall Study|Withdrawal by Subject|3
7529116|NCT02724020|26157831|P1|Overall Study|Withdrawal by Subject|1
7529117|NCT02724020|26157829|P3|Overall Study|Site Terminated by Sponsor|8
7529118|NCT02724020|26157830|P2|Overall Study|Site Terminated by Sponsor|8
7529119|NCT02724020|26157831|P1|Overall Study|Site Terminated by Sponsor|13
7529120|NCT02724020|26157829|P3|Overall Study|Lost to Follow-up|0
7529121|NCT02724020|26157830|P2|Overall Study|Lost to Follow-up|3
7529122|NCT02724020|26157831|P1|Overall Study|Lost to Follow-up|0
7529123|NCT02724020|26157829|P3|Overall Study|Death|19
7529124|NCT02724020|26157830|P2|Overall Study|Death|18
7529125|NCT02724020|26157831|P1|Overall Study|Death|16
7529126|NCT02724020|26157829|P3|Overall Study|Ongoing at Data Cut-off: 6 Mar 2020|0
7529127|NCT02724020|26157830|P2|Overall Study|Ongoing at Data Cut-off: 6 Mar 2020|0
7529128|NCT02724020|26157831|P1|Overall Study|Ongoing at Data Cut-off: 6 Mar 2020|2
7529129|NCT02723786|26157897|P1|Overall Study|Lost to Follow-up|1
7529130|NCT02723630|26157925|P6|Intervention Period 3|consumption of restricted item|0
7529131|NCT02723630|26157926|P5|Intervention Period 3|consumption of restricted item|0
7529132|NCT02723630|26157927|P4|Intervention Period 3|consumption of restricted item|0
7529133|NCT02723630|26157928|P3|Intervention Period 3|consumption of restricted item|0
7529134|NCT02723630|26157929|P2|Intervention Period 3|consumption of restricted item|1
7529135|NCT02723630|26157930|P1|Intervention Period 3|consumption of restricted item|0
7529136|NCT02723630|26157925|P6|Intervention Period 1|Adverse Event|0
7529137|NCT02723630|26157926|P5|Intervention Period 1|Adverse Event|0
7529138|NCT02723630|26157927|P4|Intervention Period 1|Adverse Event|0
7529139|NCT02723630|26157928|P3|Intervention Period 1|Adverse Event|0
7529140|NCT02723630|26157929|P2|Intervention Period 1|Adverse Event|0
7529141|NCT02723630|26157930|P1|Intervention Period 1|Adverse Event|1
7529142|NCT02723591|26157961|P2|Overall Study|Miscellaneous|6
7529143|NCT02723591|26157962|P1|Overall Study|Miscellaneous|5
7529144|NCT02723591|26157961|P2|Overall Study|Randomized but Never Received StudyDrug|12
7529145|NCT02723591|26157962|P1|Overall Study|Randomized but Never Received StudyDrug|12
7529146|NCT02723591|26157961|P2|Overall Study|Withdrawal by Subject|8
7529147|NCT02723591|26157962|P1|Overall Study|Withdrawal by Subject|4
7529148|NCT02723591|26157961|P2|Overall Study|Protocol Violation|23
7529149|NCT02723591|26157962|P1|Overall Study|Protocol Violation|20
7529150|NCT02723591|26157961|P2|Overall Study|Lost to Follow-up|7
7529151|NCT02723591|26157962|P1|Overall Study|Lost to Follow-up|1
7529152|NCT02723591|26157961|P2|Overall Study|Lack of Efficacy|3
7529153|NCT02723591|26157962|P1|Overall Study|Lack of Efficacy|4
7529154|NCT02723591|26157961|P2|Overall Study|Death|2
7529155|NCT02723591|26157962|P1|Overall Study|Death|2
7529156|NCT02723591|26157961|P2|Overall Study|Adverse Event|40
7529157|NCT02723591|26157962|P1|Overall Study|Adverse Event|48
7529158|NCT02723344|26158090|P2|Overall Study|Lost to Follow-up|4
7529159|NCT02723344|26158091|P1|Overall Study|Lost to Follow-up|0
7529160|NCT02723201|26158114|P3|Second Intervention Period|Adverse Event|0
7529161|NCT02723201|26158115|P2|Second Intervention Period|Adverse Event|0
7529162|NCT02723201|26158116|P1|Second Intervention Period|Adverse Event|1
7529163|NCT02723201|26158114|P3|Second Intervention Period|Protocol Violation|0
7529164|NCT02723201|26158115|P2|Second Intervention Period|Protocol Violation|0
7529165|NCT02723201|26158116|P1|Second Intervention Period|Protocol Violation|1
7529166|NCT02723188|26158175|P3|Overall Study|Withdrawal by Subject|0
7529167|NCT02723188|26158176|P2|Overall Study|Withdrawal by Subject|0
7529168|NCT02723188|26158177|P1|Overall Study|Withdrawal by Subject|1
7529169|NCT02723175|26158190|P2|Overall Study|Lost to 3 Month Follow Up|1
7529170|NCT02723175|26158191|P1|Overall Study|Lost to 3 Month Follow Up|1
7529171|NCT02723175|26158190|P2|Overall Study|Lost to 1 Month Follow Up|2
7529172|NCT02723175|26158191|P1|Overall Study|Lost to 1 Month Follow Up|3
7529173|NCT02723084|26158233|P2|Overall Study|Lost to Follow-up|0
7529174|NCT02723084|26158234|P1|Overall Study|Lost to Follow-up|3
7529175|NCT02723084|26158233|P2|Overall Study|Withdrawal by Subject|1
7529176|NCT02723084|26158234|P1|Overall Study|Withdrawal by Subject|1
7529177|NCT02723006|26158248|P3|Overall Study|Study Terminated by Sponsor|6
7529178|NCT02723006|26158249|P2|Overall Study|Study Terminated by Sponsor|6
7529179|NCT02723006|26158250|P1|Overall Study|Study Terminated by Sponsor|1
7529180|NCT02723006|26158248|P3|Overall Study|Withdrawal by Subject|1
7529181|NCT02723006|26158249|P2|Overall Study|Withdrawal by Subject|1
7529182|NCT02723006|26158250|P1|Overall Study|Withdrawal by Subject|0
7529183|NCT02722967|26158276|P3|Overall Study|Non-adherence of the patch to the skin|2
7529184|NCT02722967|26158277|P2|Overall Study|Non-adherence of the patch to the skin|0
7529185|NCT02722967|26158278|P1|Overall Study|Non-adherence of the patch to the skin|0
7529186|NCT02722967|26158276|P3|Overall Study|Physician Decision|0
7529187|NCT02722967|26158277|P2|Overall Study|Physician Decision|0
7529188|NCT02722967|26158278|P1|Overall Study|Physician Decision|1
7529189|NCT02722967|26158276|P3|Overall Study|Withdrawal by Subject|1
7529190|NCT02722967|26158277|P2|Overall Study|Withdrawal by Subject|0
7529191|NCT02722967|26158278|P1|Overall Study|Withdrawal by Subject|1
7529192|NCT02722967|26158276|P3|Overall Study|Non-compliance with patch wearing|1
7529193|NCT02722967|26158277|P2|Overall Study|Non-compliance with patch wearing|1
7529194|NCT02722967|26158278|P1|Overall Study|Non-compliance with patch wearing|2
7529195|NCT02722967|26158276|P3|Overall Study|Lost to Follow-up|0
7529196|NCT02722967|26158277|P2|Overall Study|Lost to Follow-up|1
7529197|NCT02722967|26158278|P1|Overall Study|Lost to Follow-up|0
7529198|NCT02722967|26158276|P3|Overall Study|Adverse Event|0
7529199|NCT02722967|26158277|P2|Overall Study|Adverse Event|0
7529200|NCT02722967|26158278|P1|Overall Study|Adverse Event|1
7529201|NCT02722928|26158303|P2|Overall Study|Required Intraoperative MRI|7
7529202|NCT02722928|26158304|P1|Overall Study|Required Intraoperative MRI|5
7529203|NCT02722928|26158303|P2|Overall Study|Standard CT was not as required per prot|13
7529204|NCT02722928|26158304|P1|Overall Study|Standard CT was not as required per prot|5
7529205|NCT02722304|26158434|P5|Overall Study|Other|1
7529206|NCT02722304|26158435|P4|Overall Study|Other|1
7529207|NCT02722304|26158436|P3|Overall Study|Other|0
7529208|NCT02722304|26158437|P2|Overall Study|Other|0
7529209|NCT02722304|26158438|P1|Overall Study|Other|0
7529210|NCT02722304|26158434|P5|Overall Study|Study Terminated by Sponsor|1
7529211|NCT02722304|26158435|P4|Overall Study|Study Terminated by Sponsor|1
7529212|NCT02722304|26158436|P3|Overall Study|Study Terminated by Sponsor|2
7529213|NCT02722304|26158437|P2|Overall Study|Study Terminated by Sponsor|0
7529214|NCT02722304|26158438|P1|Overall Study|Study Terminated by Sponsor|1
7529215|NCT02722278|26158490|P2|Overall Study|Site closure not study related|1
7529216|NCT02722278|26158491|P1|Overall Study|Site closure not study related|0
7529217|NCT02722278|26158490|P2|Overall Study|Subject declined after tx assignment|1
7529218|NCT02722278|26158491|P1|Overall Study|Subject declined after tx assignment|0
7529219|NCT02722278|26158490|P2|Overall Study|High PSA pre-study/ not eligible|1
7529220|NCT02722278|26158491|P1|Overall Study|High PSA pre-study/ not eligible|0
7529221|NCT02722278|26158490|P2|Overall Study|Protocol Violation|0
7529222|NCT02722278|26158491|P1|Overall Study|Protocol Violation|1
7529223|NCT02722278|26158490|P2|Overall Study|Lost to Follow-up|0
7529224|NCT02722278|26158491|P1|Overall Study|Lost to Follow-up|2
7529225|NCT02722278|26158490|P2|Overall Study|Adverse Event|1
7529226|NCT02722278|26158491|P1|Overall Study|Adverse Event|4
7529227|NCT02722278|26158490|P2|Overall Study|Withdrawal by Subject|3
7529228|NCT02722278|26158491|P1|Overall Study|Withdrawal by Subject|5
7529229|NCT02722148|26158515|P1|Overall Study|Non compliant with treatment regimen|3
7529230|NCT02722148|26158515|P1|Overall Study|Lost to Follow-up|2
7529231|NCT02722044|26158522|P1|Overall Study|Did Not Meet Criteria at Week 14|1
7529232|NCT02722044|26158522|P1|Overall Study|Withdrawal by Subject|1
7529233|NCT02722044|26158522|P1|Overall Study|Physician Decision|1
7529234|NCT02722044|26158522|P1|Overall Study|Adverse Event|2
7529235|NCT02721966|26158557|P5|Overall Study|Did not continue to period 2|5
7529236|NCT02721966|26158558|P4|Overall Study|Did not continue to period 2|0
7529237|NCT02721966|26158559|P3|Overall Study|Did not continue to period 2|0
7529238|NCT02721966|26158560|P2|Overall Study|Did not continue to period 2|12
7529239|NCT02721966|26158561|P1|Overall Study|Did not continue to period 2|5
7529240|NCT02721966|26158557|P5|Overall Study|Pregnancy|0
7529241|NCT02721966|26158558|P4|Overall Study|Pregnancy|0
7529242|NCT02721966|26158559|P3|Overall Study|Pregnancy|0
7529243|NCT02721966|26158560|P2|Overall Study|Pregnancy|0
7529244|NCT02721966|26158561|P1|Overall Study|Pregnancy|1
7529245|NCT02721966|26158557|P5|Overall Study|Physician Decision|0
7529246|NCT02721966|26158558|P4|Overall Study|Physician Decision|0
7529247|NCT02721966|26158559|P3|Overall Study|Physician Decision|0
7529248|NCT02721966|26158560|P2|Overall Study|Physician Decision|1
7529249|NCT02721966|26158561|P1|Overall Study|Physician Decision|1
7529250|NCT02721966|26158557|P5|Overall Study|Lost to Follow-up|0
7529251|NCT02721966|26158558|P4|Overall Study|Lost to Follow-up|0
7529252|NCT02721966|26158559|P3|Overall Study|Lost to Follow-up|3
7529253|NCT02721966|26158560|P2|Overall Study|Lost to Follow-up|0
7529254|NCT02721966|26158561|P1|Overall Study|Lost to Follow-up|0
7529255|NCT02721966|26158557|P5|Overall Study|Lack of Efficacy|0
7529256|NCT02721966|26158558|P4|Overall Study|Lack of Efficacy|0
7529257|NCT02721966|26158559|P3|Overall Study|Lack of Efficacy|0
7529258|NCT02721966|26158560|P2|Overall Study|Lack of Efficacy|4
7529259|NCT02721966|26158561|P1|Overall Study|Lack of Efficacy|7
7529260|NCT02721966|26158557|P5|Overall Study|Death|0
7529261|NCT02721966|26158558|P4|Overall Study|Death|0
7529262|NCT02721966|26158559|P3|Overall Study|Death|0
7529263|NCT02721966|26158560|P2|Overall Study|Death|0
7529264|NCT02721966|26158561|P1|Overall Study|Death|1
7529265|NCT02721966|26158557|P5|Overall Study|Adverse Event|0
7529266|NCT02721966|26158558|P4|Overall Study|Adverse Event|0
7529267|NCT02721966|26158559|P3|Overall Study|Adverse Event|3
7529268|NCT02721966|26158560|P2|Overall Study|Adverse Event|4
7529269|NCT02721966|26158561|P1|Overall Study|Adverse Event|4
7529270|NCT02721966|26158557|P5|Overall Study|Withdrawal by Subject|0
7529271|NCT02721966|26158558|P4|Overall Study|Withdrawal by Subject|7
7529272|NCT02721966|26158559|P3|Overall Study|Withdrawal by Subject|3
7529273|NCT02721966|26158560|P2|Overall Study|Withdrawal by Subject|2
7529274|NCT02721966|26158561|P1|Overall Study|Withdrawal by Subject|9
7529275|NCT02721966|26158557|P5|Overall Study|Protocol Violation|0
7529276|NCT02721966|26158558|P4|Overall Study|Protocol Violation|0
7529277|NCT02721966|26158559|P3|Overall Study|Protocol Violation|0
7529278|NCT02721966|26158560|P2|Overall Study|Protocol Violation|0
7529279|NCT02721966|26158561|P1|Overall Study|Protocol Violation|1
7529280|NCT02721875|26158601|P2|Overall Study|Progressive disease/relapse|0
7529281|NCT02721875|26158602|P1|Overall Study|Progressive disease/relapse|1
7529282|NCT02721355|26158623|P2|Overall Study|Lost to Follow-up|1
7529283|NCT02721355|26158624|P1|Overall Study|Lost to Follow-up|6
7529284|NCT02721251|26158668|P3|Overall Study|poor adherence|2
7529285|NCT02721251|26158669|P2|Overall Study|poor adherence|2
7529286|NCT02721251|26158670|P1|Overall Study|poor adherence|2
7529287|NCT02721251|26158668|P3|Overall Study|Withdrawal by Subject|9
7529288|NCT02721251|26158669|P2|Overall Study|Withdrawal by Subject|7
7529289|NCT02721251|26158670|P1|Overall Study|Withdrawal by Subject|8
7529290|NCT02721147|26158702|P3|Overall Study|Lost to Follow-up|0
7529291|NCT02721147|26158703|P2|Overall Study|Lost to Follow-up|0
7529292|NCT02721147|26158704|P1|Overall Study|Lost to Follow-up|2
7529293|NCT02720757|26158763|P1|Overall Study|General exclusion|3
7529294|NCT02720757|26158763|P1|Overall Study|Missing|3
7529295|NCT02720757|26158763|P1|Overall Study|Patients wish to withdraw|2
7529296|NCT02720757|26158763|P1|Overall Study|Informed consent withdrawal|1
7529297|NCT02720757|26158763|P1|Overall Study|Loss of contact|4
7529298|NCT02720757|26158763|P1|Overall Study|Other reason|5
7529299|NCT02720536|26158777|P1|Overall Study|PR- unwilling to comply with procedures|1
7529300|NCT02720536|26158777|P1|Overall Study|PR - abnormal lab value(s)|1
7529301|NCT02720536|26158777|P1|Overall Study|PR - adverse event|1
7529302|NCT02720536|26158777|P1|Overall Study|PR - death|1
7529303|NCT02720536|26158777|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
7529304|NCT02720536|26158777|P1|Overall Study|PR - pregnancy|2
7529305|NCT02720536|26158777|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
7529306|NCT02720523|26158812|P7|Period 2: Long-term Extension Period|Other|3
7529307|NCT02720523|26158813|P6|Period 2: Long-term Extension Period|Other|0
7529308|NCT02720523|26158814|P5|Period 2: Long-term Extension Period|Other|2
7529309|NCT02720523|26158815|P4|Period 2: Long-term Extension Period|Other|0
7529310|NCT02720523|26158816|P3|Period 2: Long-term Extension Period|Other|0
7529311|NCT02720523|26158817|P2|Period 2: Long-term Extension Period|Other|0
7529312|NCT02720523|26158818|P1|Period 2: Long-term Extension Period|Other|0
7529313|NCT02720523|26158812|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7529314|NCT02720523|26158813|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7529315|NCT02720523|26158814|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
7529316|NCT02720523|26158815|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7529317|NCT02720523|26158816|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7529318|NCT02720523|26158817|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7529319|NCT02720523|26158818|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7529320|NCT02720523|26158812|P7|Period 2: Long-term Extension Period|Adverse Event|11
7529321|NCT02720523|26158813|P6|Period 2: Long-term Extension Period|Adverse Event|7
7529322|NCT02720523|26158814|P5|Period 2: Long-term Extension Period|Adverse Event|4
7529323|NCT02720523|26158815|P4|Period 2: Long-term Extension Period|Adverse Event|0
7529324|NCT02720523|26158816|P3|Period 2: Long-term Extension Period|Adverse Event|0
7529325|NCT02720523|26158817|P2|Period 2: Long-term Extension Period|Adverse Event|0
7529326|NCT02720523|26158818|P1|Period 2: Long-term Extension Period|Adverse Event|0
7529327|NCT02720523|26158812|P7|Period 2: Long-term Extension Period|Ongoing|45
7529328|NCT02720523|26158813|P6|Period 2: Long-term Extension Period|Ongoing|54
7529329|NCT02720523|26158814|P5|Period 2: Long-term Extension Period|Ongoing|57
7529330|NCT02720523|26158815|P4|Period 2: Long-term Extension Period|Ongoing|0
7529331|NCT02720523|26158816|P3|Period 2: Long-term Extension Period|Ongoing|0
7529332|NCT02720523|26158817|P2|Period 2: Long-term Extension Period|Ongoing|0
7529333|NCT02720523|26158818|P1|Period 2: Long-term Extension Period|Ongoing|0
7529334|NCT02720523|26158812|P7|Period 1: Placebo-controlled Period|Other|0
7529335|NCT02720523|26158813|P6|Period 1: Placebo-controlled Period|Other|0
7529336|NCT02720523|26158814|P5|Period 1: Placebo-controlled Period|Other|0
7529337|NCT02720523|26158815|P4|Period 1: Placebo-controlled Period|Other|1
7529338|NCT02720523|26158816|P3|Period 1: Placebo-controlled Period|Other|1
7529339|NCT02720523|26158817|P2|Period 1: Placebo-controlled Period|Other|0
7529340|NCT02720523|26158818|P1|Period 1: Placebo-controlled Period|Other|0
7529341|NCT02720523|26158812|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7529342|NCT02720523|26158813|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7529343|NCT02720523|26158814|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7529344|NCT02720523|26158815|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7529345|NCT02720523|26158816|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7529346|NCT02720523|26158817|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7529347|NCT02720523|26158818|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
7529348|NCT02720523|26158812|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7529349|NCT02720523|26158813|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7529350|NCT02720523|26158814|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7529351|NCT02720523|26158815|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7529352|NCT02720523|26158816|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7529353|NCT02720523|26158817|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7529354|NCT02720523|26158818|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
7529355|NCT02720523|26158812|P7|Period 1: Placebo-controlled Period|Adverse Event|0
7529356|NCT02720523|26158813|P6|Period 1: Placebo-controlled Period|Adverse Event|0
7529357|NCT02720523|26158814|P5|Period 1: Placebo-controlled Period|Adverse Event|0
7529358|NCT02720523|26158815|P4|Period 1: Placebo-controlled Period|Adverse Event|5
7529359|NCT02720523|26158816|P3|Period 1: Placebo-controlled Period|Adverse Event|1
7529360|NCT02720523|26158817|P2|Period 1: Placebo-controlled Period|Adverse Event|0
7529361|NCT02720523|26158818|P1|Period 1: Placebo-controlled Period|Adverse Event|0
7529362|NCT02720510|26158877|P2|Overall Study|Physician Decision|2
7529363|NCT02720510|26158878|P1|Overall Study|Physician Decision|1
7529364|NCT02720510|26158877|P2|Overall Study|Adverse Event|1
7529365|NCT02720510|26158878|P1|Overall Study|Adverse Event|0
7529366|NCT02720510|26158877|P2|Overall Study|Study Terminated by the sponsor|0
7529367|NCT02720510|26158878|P1|Overall Study|Study Terminated by the sponsor|2
7529368|NCT02720484|26158896|P1|Follow Up for 2 Years|Lost to Follow-up|2
7529369|NCT02720484|26158896|P1|Follow Up for 2 Years|Death|3
7529370|NCT02720484|26158896|P1|Follow Up for 2 Years|Withdrawal by Subject|1
7529371|NCT02720484|26158896|P1|Treatment on Study|Progressive Disease|4
7529372|NCT02720484|26158896|P1|Treatment on Study|Withdrawal by Subject|1
7529373|NCT02720484|26158896|P1|Treatment on Study|Adverse Event|1
7529374|NCT02720198|26158928|P2|Overall Study|Withdrawal by Subject|1
7529375|NCT02720198|26158929|P1|Overall Study|Withdrawal by Subject|0
7529376|NCT02720081|26158964|P2|Overall Study|Protocol Violation|1
7529377|NCT02720081|26158965|P1|Overall Study|Protocol Violation|4
7529378|NCT02720081|26158964|P2|Overall Study|Adverse Event|3
7529379|NCT02720081|26158965|P1|Overall Study|Adverse Event|0
7529380|NCT02720042|26159021|P1|Overall Study|unable due to non-study-related illness|3
7529381|NCT02720042|26159021|P1|Overall Study|Phasix Mesh explanted|1
7529382|NCT02720042|26159021|P1|Overall Study|Physician Decision|3
7529383|NCT02720042|26159021|P1|Overall Study|Withdrawal by Subject|1
7529384|NCT02720042|26159021|P1|Overall Study|Lost to Follow-up|4
7529385|NCT02720042|26159021|P1|Overall Study|Death|3
7529386|NCT02719743|26159062|P5|Overall Study|Lost to Follow-up|0
7529387|NCT02719743|26159063|P4|Overall Study|Lost to Follow-up|0
7529388|NCT02719743|26159064|P3|Overall Study|Lost to Follow-up|0
7529389|NCT02719743|26159065|P2|Overall Study|Lost to Follow-up|1
7529390|NCT02719743|26159066|P1|Overall Study|Lost to Follow-up|1
7529391|NCT02719743|26159062|P5|Overall Study|Migrated/moved from study area|2
7529392|NCT02719743|26159063|P4|Overall Study|Migrated/moved from study area|0
7529393|NCT02719743|26159064|P3|Overall Study|Migrated/moved from study area|0
7529394|NCT02719743|26159065|P2|Overall Study|Migrated/moved from study area|0
7529395|NCT02719743|26159066|P1|Overall Study|Migrated/moved from study area|0
7529396|NCT02719743|26159062|P5|Overall Study|Consent withdrawal|0
7529397|NCT02719743|26159063|P4|Overall Study|Consent withdrawal|1
7529398|NCT02719743|26159064|P3|Overall Study|Consent withdrawal|0
7529399|NCT02719743|26159065|P2|Overall Study|Consent withdrawal|2
7529400|NCT02719743|26159066|P1|Overall Study|Consent withdrawal|0
7529401|NCT02719522|26159207|P1|Overall Study|Lost to Follow-up|5
7529402|NCT02719522|26159207|P1|Overall Study|Death|2
7529403|NCT02719522|26159207|P1|Overall Study|Implant Failure|4
7529404|NCT02719353|26159249|P2|First Intervention|Physician Decision|1
7529405|NCT02719353|26159250|P1|First Intervention|Physician Decision|0
7529406|NCT02719171|26159289|P5|Overall Study|Other|0
7529407|NCT02719171|26159290|P4|Overall Study|Other|1
7529408|NCT02719171|26159291|P3|Overall Study|Other|0
7529409|NCT02719171|26159292|P2|Overall Study|Other|0
7529410|NCT02719171|26159293|P1|Overall Study|Other|0
7529411|NCT02719171|26159289|P5|Overall Study|Subject Withdrawal|0
7529412|NCT02719171|26159290|P4|Overall Study|Subject Withdrawal|1
7529413|NCT02719171|26159291|P3|Overall Study|Subject Withdrawal|2
7529414|NCT02719171|26159292|P2|Overall Study|Subject Withdrawal|2
7529415|NCT02719171|26159293|P1|Overall Study|Subject Withdrawal|0
7529416|NCT02719171|26159289|P5|Overall Study|Lost to Follow-up|0
7529417|NCT02719171|26159290|P4|Overall Study|Lost to Follow-up|0
7529418|NCT02719171|26159291|P3|Overall Study|Lost to Follow-up|1
7529419|NCT02719171|26159292|P2|Overall Study|Lost to Follow-up|0
7529420|NCT02719171|26159293|P1|Overall Study|Lost to Follow-up|0
7529421|NCT02719171|26159289|P5|Overall Study|Adverse Event|2
7529422|NCT02719171|26159290|P4|Overall Study|Adverse Event|0
7529423|NCT02719171|26159291|P3|Overall Study|Adverse Event|0
7529424|NCT02719171|26159292|P2|Overall Study|Adverse Event|2
7529425|NCT02719171|26159293|P1|Overall Study|Adverse Event|1
7529426|NCT02719028|26159410|P4|Overall Study|Protocol Violation|1
7529427|NCT02719028|26159411|P3|Overall Study|Protocol Violation|0
7529428|NCT02719028|26159412|P2|Overall Study|Protocol Violation|0
7529429|NCT02719028|26159413|P1|Overall Study|Protocol Violation|0
7529430|NCT02719028|26159410|P4|Overall Study|Use of prohibited medication|0
7529431|NCT02719028|26159411|P3|Overall Study|Use of prohibited medication|1
7529432|NCT02719028|26159412|P2|Overall Study|Use of prohibited medication|0
7529433|NCT02719028|26159413|P1|Overall Study|Use of prohibited medication|0
7529434|NCT02719028|26159410|P4|Overall Study|Physician Decision|1
7529435|NCT02719028|26159411|P3|Overall Study|Physician Decision|1
7529436|NCT02719028|26159412|P2|Overall Study|Physician Decision|1
7529437|NCT02719028|26159413|P1|Overall Study|Physician Decision|0
7529438|NCT02719028|26159410|P4|Overall Study|Adverse Event|8
7529439|NCT02719028|26159411|P3|Overall Study|Adverse Event|4
7529440|NCT02719028|26159412|P2|Overall Study|Adverse Event|1
7529441|NCT02719028|26159413|P1|Overall Study|Adverse Event|2
7529442|NCT02718898|26159446|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
7529443|NCT02718898|26159447|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
7529444|NCT02718898|26159448|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
7529445|NCT02718898|26159449|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
7529446|NCT02718898|26159450|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
7529447|NCT02718898|26159451|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
7529448|NCT02718898|26159452|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
7529449|NCT02718898|26159446|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
7529450|NCT02718898|26159447|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
7529451|NCT02718898|26159448|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
7529452|NCT02718898|26159449|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
7529453|NCT02718898|26159450|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
7529454|NCT02718898|26159451|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
7529455|NCT02718898|26159452|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
7529456|NCT02718898|26159446|P7|Post Treatment Follow-up Period|Adverse Event|1
7529457|NCT02718898|26159447|P6|Post Treatment Follow-up Period|Adverse Event|1
7529458|NCT02718898|26159448|P5|Post Treatment Follow-up Period|Adverse Event|0
7529459|NCT02718898|26159449|P4|Post Treatment Follow-up Period|Adverse Event|0
7529460|NCT02718898|26159450|P3|Post Treatment Follow-up Period|Adverse Event|0
7529461|NCT02718898|26159451|P2|Post Treatment Follow-up Period|Adverse Event|0
7529462|NCT02718898|26159452|P1|Post Treatment Follow-up Period|Adverse Event|0
7529463|NCT02718898|26159446|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7529464|NCT02718898|26159447|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7529465|NCT02718898|26159448|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7529466|NCT02718898|26159449|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
7529467|NCT02718898|26159450|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7529468|NCT02718898|26159451|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7529469|NCT02718898|26159452|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7529470|NCT02718898|26159446|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7529471|NCT02718898|26159447|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7529472|NCT02718898|26159448|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7529473|NCT02718898|26159449|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
7529474|NCT02718898|26159450|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7529475|NCT02718898|26159451|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7529476|NCT02718898|26159452|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7529477|NCT02718898|26159446|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7529478|NCT02718898|26159447|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7529479|NCT02718898|26159448|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7529480|NCT02718898|26159449|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
7529481|NCT02718898|26159450|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
7529482|NCT02718898|26159451|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7529483|NCT02718898|26159452|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7529484|NCT02718898|26159446|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7529485|NCT02718898|26159447|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7529486|NCT02718898|26159448|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7529487|NCT02718898|26159449|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
7529488|NCT02718898|26159450|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
7529489|NCT02718898|26159451|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7529490|NCT02718898|26159452|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7529491|NCT02718898|26159446|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7529492|NCT02718898|26159447|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7529493|NCT02718898|26159448|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7529494|NCT02718898|26159449|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
7529495|NCT02718898|26159450|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7529496|NCT02718898|26159451|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7529497|NCT02718898|26159452|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7529498|NCT02718898|26159446|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
7529499|NCT02718898|26159447|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
7529500|NCT02718898|26159448|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
7529501|NCT02718898|26159449|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
7529502|NCT02718898|26159450|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
7529503|NCT02718898|26159451|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
7529504|NCT02718898|26159452|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
7529505|NCT02718898|26159446|P7|Blinded Treatment Period|Lost to Follow-up|0
7529506|NCT02718898|26159447|P6|Blinded Treatment Period|Lost to Follow-up|0
7529507|NCT02718898|26159448|P5|Blinded Treatment Period|Lost to Follow-up|0
7529508|NCT02718898|26159449|P4|Blinded Treatment Period|Lost to Follow-up|0
7529509|NCT02718898|26159450|P3|Blinded Treatment Period|Lost to Follow-up|0
7529510|NCT02718898|26159451|P2|Blinded Treatment Period|Lost to Follow-up|0
7529511|NCT02718898|26159452|P1|Blinded Treatment Period|Lost to Follow-up|2
7529512|NCT02718898|26159446|P7|Blinded Treatment Period|Lack of Efficacy|0
7529513|NCT02718898|26159447|P6|Blinded Treatment Period|Lack of Efficacy|0
7529514|NCT02718898|26159448|P5|Blinded Treatment Period|Lack of Efficacy|0
7529515|NCT02718898|26159449|P4|Blinded Treatment Period|Lack of Efficacy|0
7529516|NCT02718898|26159450|P3|Blinded Treatment Period|Lack of Efficacy|0
7529517|NCT02718898|26159451|P2|Blinded Treatment Period|Lack of Efficacy|0
7529518|NCT02718898|26159452|P1|Blinded Treatment Period|Lack of Efficacy|1
7529519|NCT02718898|26159446|P7|Blinded Treatment Period|Physician Decision|0
7529520|NCT02718898|26159447|P6|Blinded Treatment Period|Physician Decision|0
7529521|NCT02718898|26159448|P5|Blinded Treatment Period|Physician Decision|0
7529522|NCT02718898|26159449|P4|Blinded Treatment Period|Physician Decision|0
7529523|NCT02718898|26159450|P3|Blinded Treatment Period|Physician Decision|0
7529524|NCT02718898|26159451|P2|Blinded Treatment Period|Physician Decision|0
7529525|NCT02718898|26159452|P1|Blinded Treatment Period|Physician Decision|1
7529526|NCT02718898|26159446|P7|Blinded Treatment Period|Adverse Event|0
7529527|NCT02718898|26159447|P6|Blinded Treatment Period|Adverse Event|0
7529528|NCT02718898|26159448|P5|Blinded Treatment Period|Adverse Event|0
7529529|NCT02718898|26159449|P4|Blinded Treatment Period|Adverse Event|0
7529530|NCT02718898|26159450|P3|Blinded Treatment Period|Adverse Event|0
7529531|NCT02718898|26159451|P2|Blinded Treatment Period|Adverse Event|1
7529532|NCT02718898|26159452|P1|Blinded Treatment Period|Adverse Event|5
7529533|NCT02718625|26159487|P2|Overall Study|Termination of Study by Sponsor|1
7529534|NCT02718625|26159488|P1|Overall Study|Termination of Study by Sponsor|0
7529535|NCT02718625|26159487|P2|Overall Study|Adverse Event|1
7529536|NCT02718625|26159488|P1|Overall Study|Adverse Event|0
7529537|NCT02718417|26159507|P3|Long-term Follow-up Phase|Other|0
7529538|NCT02718417|26159508|P2|Long-term Follow-up Phase|Other|2
7529539|NCT02718417|26159509|P1|Long-term Follow-up Phase|Other|0
7529540|NCT02718417|26159507|P3|Long-term Follow-up Phase|Withdrawal by Subject|9
7529541|NCT02718417|26159508|P2|Long-term Follow-up Phase|Withdrawal by Subject|9
7529542|NCT02718417|26159509|P1|Long-term Follow-up Phase|Withdrawal by Subject|6
7529543|NCT02718417|26159507|P3|Long-term Follow-up Phase|Study terminated by sponsor|112
7529544|NCT02718417|26159508|P2|Long-term Follow-up Phase|Study terminated by sponsor|80
7529545|NCT02718417|26159509|P1|Long-term Follow-up Phase|Study terminated by sponsor|105
7529546|NCT02718417|26159507|P3|Long-term Follow-up Phase|Lost to Follow-up|3
7529547|NCT02718417|26159508|P2|Long-term Follow-up Phase|Lost to Follow-up|4
7529548|NCT02718417|26159509|P1|Long-term Follow-up Phase|Lost to Follow-up|8
7529549|NCT02718417|26159507|P3|Long-term Follow-up Phase|Death leading to discontinuation|11
7529550|NCT02718417|26159508|P2|Long-term Follow-up Phase|Death leading to discontinuation|17
7529551|NCT02718417|26159509|P1|Long-term Follow-up Phase|Death leading to discontinuation|20
7529552|NCT02718417|26159507|P3|Follow-up Phase|Death leading to discontinuation|3
7529553|NCT02718417|26159508|P2|Follow-up Phase|Death leading to discontinuation|7
7529554|NCT02718417|26159509|P1|Follow-up Phase|Death leading to discontinuation|7
7529555|NCT02718417|26159507|P3|Follow-up Phase|Lost to Follow-up|0
7529556|NCT02718417|26159508|P2|Follow-up Phase|Lost to Follow-up|3
7529557|NCT02718417|26159509|P1|Follow-up Phase|Lost to Follow-up|2
7529558|NCT02718417|26159507|P3|Follow-up Phase|Study terminated by sponsor|6
7529559|NCT02718417|26159508|P2|Follow-up Phase|Study terminated by sponsor|138
7529560|NCT02718417|26159509|P1|Follow-up Phase|Study terminated by sponsor|100
7529561|NCT02718417|26159507|P3|Follow-up Phase|Withdrawal by Subject|5
7529562|NCT02718417|26159508|P2|Follow-up Phase|Withdrawal by Subject|17
7529563|NCT02718417|26159509|P1|Follow-up Phase|Withdrawal by Subject|19
7529564|NCT02718417|26159507|P3|Follow-up Phase|Other|4
7529565|NCT02718417|26159508|P2|Follow-up Phase|Other|6
7529566|NCT02718417|26159509|P1|Follow-up Phase|Other|4
7529567|NCT02718417|26159507|P3|Follow-up Phase|Adverse Event|1
7529568|NCT02718417|26159508|P2|Follow-up Phase|Adverse Event|1
7529569|NCT02718417|26159509|P1|Follow-up Phase|Adverse Event|3
7529570|NCT02718417|26159507|P3|Observation Phase (OP)|Other|7
7529571|NCT02718417|26159508|P2|Observation Phase (OP)|Other|0
7529572|NCT02718417|26159509|P1|Observation Phase (OP)|Other|0
7529573|NCT02718417|26159507|P3|Observation Phase (OP)|Global deterioration of health status|1
7529574|NCT02718417|26159508|P2|Observation Phase (OP)|Global deterioration of health status|0
7529575|NCT02718417|26159509|P1|Observation Phase (OP)|Global deterioration of health status|0
7529576|NCT02718417|26159507|P3|Observation Phase (OP)|Withdrawal by Subject|34
7529577|NCT02718417|26159508|P2|Observation Phase (OP)|Withdrawal by Subject|0
7529578|NCT02718417|26159509|P1|Observation Phase (OP)|Withdrawal by Subject|0
7529579|NCT02718417|26159507|P3|Observation Phase (OP)|Study terminated by sponsor|135
7529580|NCT02718417|26159508|P2|Observation Phase (OP)|Study terminated by sponsor|0
7529581|NCT02718417|26159509|P1|Observation Phase (OP)|Study terminated by sponsor|0
7529582|NCT02718417|26159507|P3|Observation Phase (OP)|Progressive disease|92
7529583|NCT02718417|26159508|P2|Observation Phase (OP)|Progressive disease|0
7529584|NCT02718417|26159509|P1|Observation Phase (OP)|Progressive disease|0
7529585|NCT02718417|26159507|P3|Observation Phase (OP)|Physician Decision|9
7529586|NCT02718417|26159508|P2|Observation Phase (OP)|Physician Decision|0
7529587|NCT02718417|26159509|P1|Observation Phase (OP)|Physician Decision|0
7529588|NCT02718417|26159507|P3|Observation Phase (OP)|Lost to Follow-up|1
7529589|NCT02718417|26159508|P2|Observation Phase (OP)|Lost to Follow-up|0
7529590|NCT02718417|26159509|P1|Observation Phase (OP)|Lost to Follow-up|0
7529591|NCT02718417|26159507|P3|Observation Phase (OP)|Death leading to discontinuation|2
7529592|NCT02718417|26159508|P2|Observation Phase (OP)|Death leading to discontinuation|0
7529593|NCT02718417|26159509|P1|Observation Phase (OP)|Death leading to discontinuation|0
7529594|NCT02718417|26159507|P3|Observation Phase (OP)|Adverse Event|1
7529595|NCT02718417|26159508|P2|Observation Phase (OP)|Adverse Event|0
7529596|NCT02718417|26159509|P1|Observation Phase (OP)|Adverse Event|0
7529597|NCT02718417|26159507|P3|Maintenance Phase (MP)|Study terminated by sponsor|0
7529598|NCT02718417|26159508|P2|Maintenance Phase (MP)|Study terminated by sponsor|140
7529599|NCT02718417|26159509|P1|Maintenance Phase (MP)|Study terminated by sponsor|114
7529600|NCT02718417|26159507|P3|Maintenance Phase (MP)|Withdrawal by Subject|0
7529601|NCT02718417|26159508|P2|Maintenance Phase (MP)|Withdrawal by Subject|20
7529602|NCT02718417|26159509|P1|Maintenance Phase (MP)|Withdrawal by Subject|17
7529603|NCT02718417|26159507|P3|Maintenance Phase (MP)|Other|0
7529604|NCT02718417|26159508|P2|Maintenance Phase (MP)|Other|1
7529605|NCT02718417|26159509|P1|Maintenance Phase (MP)|Other|2
7529606|NCT02718417|26159507|P3|Maintenance Phase (MP)|Progressive disease|0
7529607|NCT02718417|26159508|P2|Maintenance Phase (MP)|Progressive disease|88
7529608|NCT02718417|26159509|P1|Maintenance Phase (MP)|Progressive disease|100
7529609|NCT02718417|26159507|P3|Maintenance Phase (MP)|Physician's decision|0
7529610|NCT02718417|26159508|P2|Maintenance Phase (MP)|Physician's decision|7
7529611|NCT02718417|26159509|P1|Maintenance Phase (MP)|Physician's decision|6
7529612|NCT02718417|26159507|P3|Maintenance Phase (MP)|No longer met eligibility criteria|0
7529613|NCT02718417|26159508|P2|Maintenance Phase (MP)|No longer met eligibility criteria|1
7529614|NCT02718417|26159509|P1|Maintenance Phase (MP)|No longer met eligibility criteria|0
7529615|NCT02718417|26159507|P3|Maintenance Phase (MP)|Global deterioration of health status|0
7529616|NCT02718417|26159508|P2|Maintenance Phase (MP)|Global deterioration of health status|3
7529617|NCT02718417|26159509|P1|Maintenance Phase (MP)|Global deterioration of health status|5
7529618|NCT02718417|26159507|P3|Maintenance Phase (MP)|Death leading to discontinuation|0
7529619|NCT02718417|26159508|P2|Maintenance Phase (MP)|Death leading to discontinuation|1
7529620|NCT02718417|26159509|P1|Maintenance Phase (MP)|Death leading to discontinuation|1
7529621|NCT02718417|26159507|P3|Maintenance Phase (MP)|Adverse Event|0
7529622|NCT02718417|26159508|P2|Maintenance Phase (MP)|Adverse Event|26
7529623|NCT02718417|26159509|P1|Maintenance Phase (MP)|Adverse Event|21
7529624|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Other|1
7529625|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Other|0
7529626|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Other|2
7529627|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Withdrawal by Subject|15
7529628|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Withdrawal by Subject|8
7529629|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Withdrawal by Subject|13
7529630|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Progressive disease|10
7529631|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Progressive disease|7
7529632|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Progressive disease|11
7529633|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Physician's decision|4
7529634|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Physician's decision|0
7529635|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Physician's decision|5
7529636|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
7529637|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
7529638|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
7529639|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Global deterioration of health status|1
7529640|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Global deterioration of health status|2
7529641|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Global deterioration of health status|3
7529642|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Death leading to discontinuation|1
7529643|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Death leading to discontinuation|4
7529644|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Death leading to discontinuation|5
7529645|NCT02718417|26159507|P3|Chemotherapy Phase (CP)|Adverse Event|13
7529646|NCT02718417|26159508|P2|Chemotherapy Phase (CP)|Adverse Event|14
7529647|NCT02718417|26159509|P1|Chemotherapy Phase (CP)|Adverse Event|9
7529648|NCT02718326|26159615|P3|Overall Study|Pregnancy|0
7529649|NCT02718326|26159616|P2|Overall Study|Pregnancy|0
7529650|NCT02718326|26159617|P1|Overall Study|Pregnancy|1
7529651|NCT02718326|26159615|P3|Overall Study|Protocol Deviation|0
7529652|NCT02718326|26159616|P2|Overall Study|Protocol Deviation|0
7529653|NCT02718326|26159617|P1|Overall Study|Protocol Deviation|1
7529654|NCT02718326|26159615|P3|Overall Study|Lost to Follow-up|14
7529655|NCT02718326|26159616|P2|Overall Study|Lost to Follow-up|5
7529656|NCT02718326|26159617|P1|Overall Study|Lost to Follow-up|18
7529657|NCT02718326|26159615|P3|Overall Study|Withdrawal by Subject|6
7529658|NCT02718326|26159616|P2|Overall Study|Withdrawal by Subject|9
7529659|NCT02718326|26159617|P1|Overall Study|Withdrawal by Subject|4
7529660|NCT02718326|26159615|P3|Overall Study|Death|2
7529661|NCT02718326|26159616|P2|Overall Study|Death|1
7529662|NCT02718326|26159617|P1|Overall Study|Death|8
7529663|NCT02718326|26159615|P3|Overall Study|Adverse Event|0
7529664|NCT02718326|26159616|P2|Overall Study|Adverse Event|9
7529665|NCT02718326|26159617|P1|Overall Study|Adverse Event|4
7529666|NCT02717754|26159738|P6|Overall Study|Incorrect Infusion Duration|20
7529667|NCT02717754|26159739|P5|Overall Study|Incorrect Infusion Duration|20
7529668|NCT02717754|26159740|P4|Overall Study|Incorrect Infusion Duration|10
7529669|NCT02717754|26159741|P3|Overall Study|Incorrect Infusion Duration|0
7529670|NCT02717754|26159742|P2|Overall Study|Incorrect Infusion Duration|0
7529671|NCT02717754|26159743|P1|Overall Study|Incorrect Infusion Duration|0
7529672|NCT02717546|26159771|P1|Overall Study|Lost to Follow-up|12
7529673|NCT02717494|26159786|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
7529674|NCT02717494|26159787|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7529675|NCT02717494|26159788|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7529676|NCT02717494|26159786|P3|First Intervention (Step 1)|Death|1
7529677|NCT02717494|26159787|P2|First Intervention (Step 1)|Death|0
7529678|NCT02717494|26159788|P1|First Intervention (Step 1)|Death|0
7529679|NCT02717494|26159786|P3|First Intervention (Step 1)|Withdrawal by Subject|1
7529680|NCT02717494|26159787|P2|First Intervention (Step 1)|Withdrawal by Subject|0
7529681|NCT02717494|26159788|P1|First Intervention (Step 1)|Withdrawal by Subject|2
7529682|NCT02717494|26159786|P3|First Intervention (Step 1)|Lost to Follow-up|3
7529683|NCT02717494|26159787|P2|First Intervention (Step 1)|Lost to Follow-up|7
7529684|NCT02717494|26159788|P1|First Intervention (Step 1)|Lost to Follow-up|4
7529685|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7529686|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7529687|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7529688|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7529689|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7529690|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7529691|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7529692|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
7529693|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7529694|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7529695|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
7529696|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7529697|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7529698|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7529699|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7529700|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Change of residence|1
7529701|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Change of residence|1
7529702|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Change of residence|0
7529703|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Change of residence|0
7529704|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Change of residence|0
7529705|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
7529706|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
7529707|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
7529708|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
7529709|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
7529710|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
7529711|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
7529712|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
7529713|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
7529714|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
7529715|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Patient decision|2
7529716|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Patient decision|2
7529717|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Patient decision|0
7529718|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Patient decision|0
7529719|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Patient decision|0
7529720|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7529721|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7529722|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
7529723|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7529724|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7529725|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
7529726|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
7529727|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7529728|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7529729|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7529730|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
7529731|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
7529732|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
7529733|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7529734|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7529735|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
7529736|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
7529737|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
7529738|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
7529739|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
7529740|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
7529741|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
7529742|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
7529743|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7529744|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7529745|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
7529746|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
7529747|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
7529748|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7529749|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7529750|NCT02717195|26159850|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
7529751|NCT02717195|26159851|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
7529752|NCT02717195|26159852|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
7529753|NCT02717195|26159853|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
7529754|NCT02717195|26159854|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
7529755|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7529756|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7529757|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7529758|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7529759|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
7529760|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7529761|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7529762|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7529763|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7529764|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
7529765|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
7529766|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
7529767|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
7529768|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
7529769|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
7529770|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
7529771|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
7529772|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
7529773|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
7529774|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
7529775|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7529776|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7529777|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7529778|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
7529779|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7529780|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7529781|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7529782|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7529783|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7529784|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
7529785|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7529786|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7529787|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7529788|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
7529789|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7529790|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Investigator decision|0
7529791|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Investigator decision|0
7529792|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Investigator decision|0
7529793|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Investigator decision|1
7529794|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Investigator decision|2
7529795|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7529796|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7529797|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7529798|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
7529799|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7529800|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
7529801|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
7529802|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
7529803|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
7529804|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
7529805|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7529806|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7529807|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7529808|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7529809|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
7529810|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Patient decision|0
7529811|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Patient decision|0
7529812|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Patient decision|0
7529813|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Patient decision|2
7529814|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Patient decision|5
7529815|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Technical error|0
7529816|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Technical error|0
7529817|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Technical error|0
7529818|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Technical error|0
7529819|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Technical error|1
7529820|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7529821|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7529822|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7529823|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7529824|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
7529825|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7529826|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7529827|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7529828|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7529829|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7529830|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7529831|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7529832|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7529833|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
7529834|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
7529835|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7529836|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7529837|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7529838|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
7529839|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
7529840|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7529841|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7529842|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7529843|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
7529844|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
7529845|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
7529846|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
7529847|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
7529848|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
7529849|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
7529850|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7529851|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7529852|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7529853|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
7529854|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
7529855|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7529856|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7529857|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7529858|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
7529859|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7529860|NCT02717195|26159850|P5|Prospective Confirmation (PC) Period|Adverse Event|0
7529861|NCT02717195|26159851|P4|Prospective Confirmation (PC) Period|Adverse Event|0
7529862|NCT02717195|26159852|P3|Prospective Confirmation (PC) Period|Adverse Event|0
7529863|NCT02717195|26159853|P2|Prospective Confirmation (PC) Period|Adverse Event|7
7529864|NCT02717195|26159854|P1|Prospective Confirmation (PC) Period|Adverse Event|19
7529865|NCT02717130|26159885|P1|Overall Study|Study Closure|4
7529866|NCT02717130|26159885|P1|Overall Study|Physician Decision|1
7529867|NCT02717130|26159885|P1|Overall Study|Adverse Event|1
7529868|NCT02717130|26159885|P1|Overall Study|Withdrawal by Subject|1
7529869|NCT02716987|26159895|P6|Overall Study|Withdrawal by Subject|1
7529870|NCT02716987|26159896|P5|Overall Study|Withdrawal by Subject|1
7529871|NCT02716987|26159897|P4|Overall Study|Withdrawal by Subject|0
7529872|NCT02716987|26159898|P3|Overall Study|Withdrawal by Subject|0
7529873|NCT02716987|26159899|P2|Overall Study|Withdrawal by Subject|0
7529874|NCT02716987|26159900|P1|Overall Study|Withdrawal by Subject|0
7529875|NCT02716987|26159895|P6|Overall Study|Ligand synthesis failure|0
7529876|NCT02716987|26159896|P5|Overall Study|Ligand synthesis failure|0
7529877|NCT02716987|26159897|P4|Overall Study|Ligand synthesis failure|0
7529878|NCT02716987|26159898|P3|Overall Study|Ligand synthesis failure|1
7529879|NCT02716987|26159899|P2|Overall Study|Ligand synthesis failure|0
7529880|NCT02716987|26159900|P1|Overall Study|Ligand synthesis failure|0
7529881|NCT02716896|26159966|P2|Overall Study|Physician Decision|1
7529882|NCT02716896|26159967|P1|Overall Study|Physician Decision|0
7529883|NCT02716805|26160018|P4|Overall Study|Progressive disease|0
7529884|NCT02716805|26160019|P3|Overall Study|Progressive disease|0
7529885|NCT02716805|26160020|P2|Overall Study|Progressive disease|0
7529886|NCT02716805|26160021|P1|Overall Study|Progressive disease|2
7529887|NCT02716779|26160029|P3|Combination Therapy|Adverse Event|1
7529888|NCT02716779|26160030|P2|Combination Therapy|Adverse Event|2
7529889|NCT02716779|26160031|P1|Combination Therapy|Adverse Event|0
7529890|NCT02716779|26160029|P3|Monotherapy|Adverse Event|1
7529891|NCT02716779|26160030|P2|Monotherapy|Adverse Event|1
7529892|NCT02716779|26160031|P1|Monotherapy|Adverse Event|0
7529893|NCT02716584|26160131|P2|Overall Study|Lost to Follow-up|5
7529894|NCT02716584|26160132|P1|Overall Study|Lost to Follow-up|8
7529895|NCT02716298|26160188|P2|First Intervention (1 Month)|Lens discomfort|1
7529896|NCT02716298|26160189|P1|First Intervention (1 Month)|Lens discomfort|1
7529897|NCT02716194|26160207|P3|Period 1 - ADVATE|Withdrawal by Subject|0
7529898|NCT02716194|26160208|P2|Period 1 - ADVATE|Withdrawal by Subject|1
7529899|NCT02716194|26160209|P1|Period 1 - ADVATE|Withdrawal by Subject|1
7529900|NCT02715804|26160289|P2|Overall Study|Other than specified|3
7529901|NCT02715804|26160290|P1|Overall Study|Other than specified|2
7529902|NCT02715804|26160289|P2|Overall Study|Withdrawal by Subject|4
7529903|NCT02715804|26160290|P1|Overall Study|Withdrawal by Subject|5
7529904|NCT02715804|26160289|P2|Overall Study|Death|106
7529905|NCT02715804|26160290|P1|Overall Study|Death|222
7529906|NCT02715765|26160313|P3|Overall Study|Study Termination|0
7529907|NCT02715765|26160314|P2|Overall Study|Study Termination|0
7529908|NCT02715765|26160315|P1|Overall Study|Study Termination|3
7529909|NCT02715726|26160328|P2|Overall Study|Randomized but not treated|2
7529910|NCT02715726|26160329|P1|Overall Study|Randomized but not treated|1
7529911|NCT02715726|26160328|P2|Overall Study|Other than specified above|15
7529912|NCT02715726|26160329|P1|Overall Study|Other than specified above|11
7529913|NCT02715726|26160328|P2|Overall Study|Participant moved|3
7529914|NCT02715726|26160329|P1|Overall Study|Participant moved|1
7529915|NCT02715726|26160328|P2|Overall Study|Death|1
7529916|NCT02715726|26160329|P1|Overall Study|Death|2
7529917|NCT02715726|26160328|P2|Overall Study|Protocol Violation|0
7529918|NCT02715726|26160329|P1|Overall Study|Protocol Violation|1
7529919|NCT02715726|26160328|P2|Overall Study|Adverse Event|6
7529920|NCT02715726|26160329|P1|Overall Study|Adverse Event|2
7529921|NCT02715258|26160409|P2|Overall Study|GCP violation|1
7529922|NCT02715258|26160410|P1|Overall Study|GCP violation|2
7529923|NCT02715258|26160409|P2|Overall Study|Subject non-compliant|1
7529924|NCT02715258|26160410|P1|Overall Study|Subject non-compliant|1
7529925|NCT02715258|26160409|P2|Overall Study|Death|1
7529926|NCT02715258|26160410|P1|Overall Study|Death|0
7529927|NCT02715258|26160409|P2|Overall Study|Terminated by Sponsor|1
7529928|NCT02715258|26160410|P1|Overall Study|Terminated by Sponsor|0
7529929|NCT02715258|26160409|P2|Overall Study|Lost to Follow-up|1
7529930|NCT02715258|26160410|P1|Overall Study|Lost to Follow-up|7
7529931|NCT02715258|26160409|P2|Overall Study|Withdrawal by Subject|1
7529932|NCT02715258|26160410|P1|Overall Study|Withdrawal by Subject|6
7529933|NCT02714868|26160453|P2|Overall Study|PI withdraw did not meet inclusion|0
7529934|NCT02714868|26160454|P1|Overall Study|PI withdraw did not meet inclusion|1
7529935|NCT02714868|26160453|P2|Overall Study|PI withdrawal safety risk self/others|0
7529936|NCT02714868|26160454|P1|Overall Study|PI withdrawal safety risk self/others|1
7529937|NCT02714868|26160453|P2|Overall Study|Withdrawal by Subject|0
7529938|NCT02714868|26160454|P1|Overall Study|Withdrawal by Subject|3
7529939|NCT02714595|26160472|P2|Overall Study|Other-Miscellaneous|1
7529940|NCT02714595|26160473|P1|Overall Study|Other-Miscellaneous|0
7529941|NCT02714595|26160472|P2|Overall Study|Death|9
7529942|NCT02714595|26160473|P1|Overall Study|Death|30
7529943|NCT02714595|26160472|P2|Overall Study|Lack of Efficacy|1
7529944|NCT02714595|26160473|P1|Overall Study|Lack of Efficacy|0
7529945|NCT02714595|26160472|P2|Overall Study|Withdrawal by Subject|2
7529946|NCT02714595|26160473|P1|Overall Study|Withdrawal by Subject|1
7529947|NCT02714595|26160472|P2|Overall Study|Lost to Follow-up|0
7529948|NCT02714595|26160473|P1|Overall Study|Lost to Follow-up|1
7529949|NCT02714569|26160730|P11|Part B (Overall)|Adverse Event|0
7529950|NCT02714569|26160731|P10|Part B (Overall)|Adverse Event|1
7529951|NCT02714569|26160732|P9|Part B (Overall)|Adverse Event|0
7529952|NCT02714569|26160733|P8|Part B (Overall)|Adverse Event|0
7529953|NCT02714569|26160734|P7|Part B (Overall)|Adverse Event|0
7529954|NCT02714569|26160735|P6|Part B (Overall)|Adverse Event|0
7529955|NCT02714569|26160736|P5|Part B (Overall)|Adverse Event|0
7529956|NCT02714569|26160737|P4|Part B (Overall)|Adverse Event|0
7529957|NCT02714569|26160738|P3|Part B (Overall)|Adverse Event|0
7529958|NCT02714569|26160739|P2|Part B (Overall)|Adverse Event|0
7529959|NCT02714569|26160740|P1|Part B (Overall)|Adverse Event|0
7529960|NCT02714569|26160730|P11|Part B (Overall)|Withdrawal by Subject|0
7529961|NCT02714569|26160731|P10|Part B (Overall)|Withdrawal by Subject|1
7529962|NCT02714569|26160732|P9|Part B (Overall)|Withdrawal by Subject|0
7529963|NCT02714569|26160733|P8|Part B (Overall)|Withdrawal by Subject|1
7529964|NCT02714569|26160734|P7|Part B (Overall)|Withdrawal by Subject|0
7529965|NCT02714569|26160735|P6|Part B (Overall)|Withdrawal by Subject|0
7529966|NCT02714569|26160736|P5|Part B (Overall)|Withdrawal by Subject|0
7529967|NCT02714569|26160737|P4|Part B (Overall)|Withdrawal by Subject|0
7529968|NCT02714569|26160738|P3|Part B (Overall)|Withdrawal by Subject|0
7529969|NCT02714569|26160739|P2|Part B (Overall)|Withdrawal by Subject|0
7529970|NCT02714569|26160740|P1|Part B (Overall)|Withdrawal by Subject|0
7529971|NCT02714569|26160730|P11|Part B (Overall)|Lost to Follow-up|0
7529972|NCT02714569|26160731|P10|Part B (Overall)|Lost to Follow-up|0
7529973|NCT02714569|26160732|P9|Part B (Overall)|Lost to Follow-up|0
7529974|NCT02714569|26160733|P8|Part B (Overall)|Lost to Follow-up|0
7529975|NCT02714569|26160734|P7|Part B (Overall)|Lost to Follow-up|1
7529976|NCT02714569|26160735|P6|Part B (Overall)|Lost to Follow-up|0
7529977|NCT02714569|26160736|P5|Part B (Overall)|Lost to Follow-up|0
7529978|NCT02714569|26160737|P4|Part B (Overall)|Lost to Follow-up|0
7529979|NCT02714569|26160738|P3|Part B (Overall)|Lost to Follow-up|0
7529980|NCT02714569|26160739|P2|Part B (Overall)|Lost to Follow-up|0
7529981|NCT02714569|26160740|P1|Part B (Overall)|Lost to Follow-up|0
7529982|NCT02714569|26160730|P11|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529983|NCT02714569|26160731|P10|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529984|NCT02714569|26160732|P9|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529985|NCT02714569|26160733|P8|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529986|NCT02714569|26160734|P7|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529987|NCT02714569|26160735|P6|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7529988|NCT02714569|26160736|P5|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529989|NCT02714569|26160737|P4|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529990|NCT02714569|26160738|P3|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529991|NCT02714569|26160739|P2|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7529992|NCT02714569|26160740|P1|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7529993|NCT02714569|26160730|P11|Part A Third Intervention|Adverse Event|0
7529994|NCT02714569|26160731|P10|Part A Third Intervention|Adverse Event|0
7529995|NCT02714569|26160732|P9|Part A Third Intervention|Adverse Event|0
7529996|NCT02714569|26160733|P8|Part A Third Intervention|Adverse Event|0
7529997|NCT02714569|26160734|P7|Part A Third Intervention|Adverse Event|0
7529998|NCT02714569|26160735|P6|Part A Third Intervention|Adverse Event|0
7529999|NCT02714569|26160736|P5|Part A Third Intervention|Adverse Event|0
7530000|NCT02714569|26160737|P4|Part A Third Intervention|Adverse Event|0
7530001|NCT02714569|26160738|P3|Part A Third Intervention|Adverse Event|1
7530002|NCT02714569|26160739|P2|Part A Third Intervention|Adverse Event|0
7530003|NCT02714569|26160740|P1|Part A Third Intervention|Adverse Event|0
7530004|NCT02714569|26160730|P11|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530005|NCT02714569|26160731|P10|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530006|NCT02714569|26160732|P9|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530007|NCT02714569|26160733|P8|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530008|NCT02714569|26160734|P7|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530009|NCT02714569|26160735|P6|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530010|NCT02714569|26160736|P5|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530011|NCT02714569|26160737|P4|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
7530012|NCT02714569|26160738|P3|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530013|NCT02714569|26160739|P2|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530014|NCT02714569|26160740|P1|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7530015|NCT02714569|26160730|P11|Part A Second Intervention|Withdrawal by Subject|0
7530016|NCT02714569|26160731|P10|Part A Second Intervention|Withdrawal by Subject|0
7530017|NCT02714569|26160732|P9|Part A Second Intervention|Withdrawal by Subject|0
7530018|NCT02714569|26160733|P8|Part A Second Intervention|Withdrawal by Subject|0
7530019|NCT02714569|26160734|P7|Part A Second Intervention|Withdrawal by Subject|0
7530020|NCT02714569|26160735|P6|Part A Second Intervention|Withdrawal by Subject|0
7530021|NCT02714569|26160736|P5|Part A Second Intervention|Withdrawal by Subject|0
7530022|NCT02714569|26160737|P4|Part A Second Intervention|Withdrawal by Subject|0
7530023|NCT02714569|26160738|P3|Part A Second Intervention|Withdrawal by Subject|0
7530024|NCT02714569|26160739|P2|Part A Second Intervention|Withdrawal by Subject|1
7530025|NCT02714569|26160740|P1|Part A Second Intervention|Withdrawal by Subject|0
7530026|NCT02714426|26160874|P2|Overall Study|Withdrawal by Subject|2
7530027|NCT02714426|26160875|P1|Overall Study|Withdrawal by Subject|2
7530028|NCT02714218|26160936|P3|Overall Study|Stop treatment, but will do follow up|0
7530029|NCT02714218|26160937|P2|Overall Study|Stop treatment, but will do follow up|1
7530030|NCT02714218|26160938|P1|Overall Study|Stop treatment, but will do follow up|0
7530031|NCT02714218|26160936|P3|Overall Study|Complete Response|0
7530032|NCT02714218|26160937|P2|Overall Study|Complete Response|0
7530033|NCT02714218|26160938|P1|Overall Study|Complete Response|1
7530034|NCT02714218|26160936|P3|Overall Study|Dose Delayed > 6 weeks|0
7530035|NCT02714218|26160937|P2|Overall Study|Dose Delayed > 6 weeks|0
7530036|NCT02714218|26160938|P1|Overall Study|Dose Delayed > 6 weeks|1
7530037|NCT02714218|26160936|P3|Overall Study|Completed|0
7530038|NCT02714218|26160937|P2|Overall Study|Completed|0
7530039|NCT02714218|26160938|P1|Overall Study|Completed|2
7530040|NCT02714218|26160936|P3|Overall Study|Not Reported|0
7530041|NCT02714218|26160937|P2|Overall Study|Not Reported|5
7530042|NCT02714218|26160938|P1|Overall Study|Not Reported|9
7530043|NCT02714218|26160936|P3|Overall Study|Medical Decision|0
7530044|NCT02714218|26160937|P2|Overall Study|Medical Decision|1
7530045|NCT02714218|26160938|P1|Overall Study|Medical Decision|0
7530046|NCT02714218|26160936|P3|Overall Study|Maximum Clinical Benefit|0
7530047|NCT02714218|26160937|P2|Overall Study|Maximum Clinical Benefit|2
7530048|NCT02714218|26160938|P1|Overall Study|Maximum Clinical Benefit|2
7530049|NCT02714218|26160936|P3|Overall Study|Participant Withdrew Consent|0
7530050|NCT02714218|26160937|P2|Overall Study|Participant Withdrew Consent|3
7530051|NCT02714218|26160938|P1|Overall Study|Participant Withdrew Consent|2
7530052|NCT02714218|26160936|P3|Overall Study|Request to Discontinue Treatment|1
7530053|NCT02714218|26160937|P2|Overall Study|Request to Discontinue Treatment|5
7530054|NCT02714218|26160938|P1|Overall Study|Request to Discontinue Treatment|1
7530055|NCT02714218|26160936|P3|Overall Study|Study Drug Toxicity|4
7530056|NCT02714218|26160937|P2|Overall Study|Study Drug Toxicity|69
7530057|NCT02714218|26160938|P1|Overall Study|Study Drug Toxicity|46
7530058|NCT02714218|26160936|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
7530059|NCT02714218|26160937|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
7530060|NCT02714218|26160938|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
7530061|NCT02714218|26160936|P3|Overall Study|Disease Progression|14
7530062|NCT02714218|26160937|P2|Overall Study|Disease Progression|51
7530063|NCT02714218|26160938|P1|Overall Study|Disease Progression|56
7530064|NCT02714153|26160985|P1|Overall Study|Death|1
7530065|NCT02714062|26160996|P3|Overall Study|Protocol Violation|0
7530066|NCT02714062|26160997|P2|Overall Study|Protocol Violation|1
7530067|NCT02714062|26160998|P1|Overall Study|Protocol Violation|0
7530068|NCT02714062|26160996|P3|Overall Study|Withdrawal by Subject|1
7530069|NCT02714062|26160997|P2|Overall Study|Withdrawal by Subject|0
7530070|NCT02714062|26160998|P1|Overall Study|Withdrawal by Subject|1
7530071|NCT02714062|26160996|P3|Overall Study|Adverse Event|2
7530072|NCT02714062|26160997|P2|Overall Study|Adverse Event|0
7530073|NCT02714062|26160998|P1|Overall Study|Adverse Event|0
7530074|NCT02713867|26161044|P2|Treatment Period|Disease Progression|78
7530075|NCT02713867|26161045|P1|Treatment Period|Disease Progression|79
7530076|NCT02713867|26161044|P2|Treatment Period|Study Drug Toxicity|20
7530077|NCT02713867|26161045|P1|Treatment Period|Study Drug Toxicity|16
7530078|NCT02713867|26161044|P2|Treatment Period|Death|3
7530079|NCT02713867|26161045|P1|Treatment Period|Death|7
7530080|NCT02713867|26161044|P2|Treatment Period|AE unrelated to Study Drug|9
7530081|NCT02713867|26161045|P1|Treatment Period|AE unrelated to Study Drug|8
7530082|NCT02713867|26161044|P2|Treatment Period|Requested to Discontinue|7
7530083|NCT02713867|26161045|P1|Treatment Period|Requested to Discontinue|8
7530084|NCT02713867|26161044|P2|Treatment Period|Withdrew consent|6
7530085|NCT02713867|26161045|P1|Treatment Period|Withdrew consent|1
7530086|NCT02713867|26161044|P2|Treatment Period|Maximum Clinical Benefit|4
7530087|NCT02713867|26161045|P1|Treatment Period|Maximum Clinical Benefit|3
7530088|NCT02713867|26161044|P2|Treatment Period|Poor/Non Compliance|0
7530089|NCT02713867|26161045|P1|Treatment Period|Poor/Non Compliance|1
7530090|NCT02713867|26161044|P2|Treatment Period|No longer meets study criteria|1
7530091|NCT02713867|26161045|P1|Treatment Period|No longer meets study criteria|2
7530092|NCT02713867|26161044|P2|Treatment Period|Administrative reason by sponsor|4
7530093|NCT02713867|26161045|P1|Treatment Period|Administrative reason by sponsor|9
7530094|NCT02713867|26161044|P2|Treatment Period|Other Reasons|18
7530095|NCT02713867|26161045|P1|Treatment Period|Other Reasons|12
7530096|NCT02713867|26161044|P2|Treatment Period|Not Reported|0
7530097|NCT02713867|26161045|P1|Treatment Period|Not Reported|1
7530098|NCT02713867|26161044|P2|Randomization|Participant Withdrew consent|2
7530099|NCT02713867|26161045|P1|Randomization|Participant Withdrew consent|0
7530100|NCT02713867|26161044|P2|Randomization|Other Reason|1
7530101|NCT02713867|26161045|P1|Randomization|Other Reason|2
7530102|NCT02713828|26161083|P2|Overall Study|study terminated but patient allowed to|0
7530103|NCT02713828|26161084|P1|Overall Study|study terminated but patient allowed to|2
7530104|NCT02713828|26161083|P2|Overall Study|Withdrawal by Subject|0
7530105|NCT02713828|26161084|P1|Overall Study|Withdrawal by Subject|1
7530106|NCT02713828|26161083|P2|Overall Study|Death|0
7530107|NCT02713828|26161084|P1|Overall Study|Death|2
7530108|NCT02713789|26161096|P3|Overall Study|Lost to Follow-up|1
7530109|NCT02713789|26161097|P2|Overall Study|Lost to Follow-up|1
7530110|NCT02713789|26161098|P1|Overall Study|Lost to Follow-up|0
7530111|NCT02713594|26161181|P2|Overall Study|Lost to Follow-up|374
7530112|NCT02713594|26161182|P1|Overall Study|Lost to Follow-up|358
7530113|NCT02713594|26161181|P2|Overall Study|Withdrawal by Subject|22
7530114|NCT02713594|26161182|P1|Overall Study|Withdrawal by Subject|32
7530115|NCT02713542|26161194|P2|Overall Study|Withdrawal by Subject|1
7530116|NCT02713542|26161195|P1|Overall Study|Withdrawal by Subject|4
7530117|NCT02713542|26161194|P2|Overall Study|Use of prohibited medication|5
7530118|NCT02713542|26161195|P1|Overall Study|Use of prohibited medication|14
7530119|NCT02713529|26161208|P7|Overall Study|Death|3
7530120|NCT02713529|26161209|P6|Overall Study|Death|13
7530121|NCT02713529|26161210|P5|Overall Study|Death|3
7530122|NCT02713529|26161211|P4|Overall Study|Death|27
7530123|NCT02713529|26161212|P3|Overall Study|Death|26
7530124|NCT02713529|26161213|P2|Overall Study|Death|3
7530125|NCT02713529|26161214|P1|Overall Study|Death|3
7530126|NCT02713529|26161208|P7|Overall Study|Lost to Follow-up|0
7530127|NCT02713529|26161209|P6|Overall Study|Lost to Follow-up|0
7530128|NCT02713529|26161210|P5|Overall Study|Lost to Follow-up|0
7530129|NCT02713529|26161211|P4|Overall Study|Lost to Follow-up|0
7530130|NCT02713529|26161212|P3|Overall Study|Lost to Follow-up|1
7530131|NCT02713529|26161213|P2|Overall Study|Lost to Follow-up|0
7530132|NCT02713529|26161214|P1|Overall Study|Lost to Follow-up|1
7530133|NCT02713529|26161208|P7|Overall Study|Withdrawal by Subject|1
7530134|NCT02713529|26161209|P6|Overall Study|Withdrawal by Subject|1
7530135|NCT02713529|26161210|P5|Overall Study|Withdrawal by Subject|0
7530136|NCT02713529|26161211|P4|Overall Study|Withdrawal by Subject|2
7530137|NCT02713529|26161212|P3|Overall Study|Withdrawal by Subject|4
7530138|NCT02713529|26161213|P2|Overall Study|Withdrawal by Subject|1
7530139|NCT02713529|26161214|P1|Overall Study|Withdrawal by Subject|3
7530140|NCT02713490|26161296|P2|Overall Study|Met exclusion criteria|1
7530141|NCT02713490|26161297|P1|Overall Study|Met exclusion criteria|0
7530142|NCT02713490|26161296|P2|Overall Study|Did not receive study drug|0
7530143|NCT02713490|26161297|P1|Overall Study|Did not receive study drug|1
7530144|NCT02713490|26161296|P2|Overall Study|Withdrawal by Subject|1
7530145|NCT02713490|26161297|P1|Overall Study|Withdrawal by Subject|2
7530146|NCT02713243|26161324|P2|Overall Study|Protocol deviation|1
7530147|NCT02713243|26161325|P1|Overall Study|Protocol deviation|0
7530148|NCT02713243|26161324|P2|Overall Study|Administrative problems|1
7530149|NCT02713243|26161325|P1|Overall Study|Administrative problems|0
7530150|NCT02713243|26161324|P2|Overall Study|Abnormal laboratory value(s)#|0
7530151|NCT02713243|26161325|P1|Overall Study|Abnormal laboratory value(s)#|1
7530152|NCT02713204|26161361|P8|From Week 12 up to Week 36|Participant Re-located|0
7530153|NCT02713204|26161362|P7|From Week 12 up to Week 36|Participant Re-located|0
7530154|NCT02713204|26161363|P6|From Week 12 up to Week 36|Participant Re-located|0
7530155|NCT02713204|26161364|P5|From Week 12 up to Week 36|Participant Re-located|1
7530156|NCT02713204|26161365|P4|From Week 12 up to Week 36|Participant Re-located|0
7530157|NCT02713204|26161366|P3|From Week 12 up to Week 36|Participant Re-located|0
7530158|NCT02713204|26161367|P2|From Week 12 up to Week 36|Participant Re-located|0
7530159|NCT02713204|26161368|P1|From Week 12 up to Week 36|Participant Re-located|0
7530160|NCT02713204|26161361|P8|From Week 12 up to Week 36|Lost to Follow-up|0
7530161|NCT02713204|26161362|P7|From Week 12 up to Week 36|Lost to Follow-up|0
7530162|NCT02713204|26161363|P6|From Week 12 up to Week 36|Lost to Follow-up|0
7530163|NCT02713204|26161364|P5|From Week 12 up to Week 36|Lost to Follow-up|0
7530164|NCT02713204|26161365|P4|From Week 12 up to Week 36|Lost to Follow-up|2
7530165|NCT02713204|26161366|P3|From Week 12 up to Week 36|Lost to Follow-up|0
7530166|NCT02713204|26161367|P2|From Week 12 up to Week 36|Lost to Follow-up|0
7530167|NCT02713204|26161368|P1|From Week 12 up to Week 36|Lost to Follow-up|0
7530168|NCT02713204|26161361|P8|From Week 12 up to Week 36|Death|3
7530169|NCT02713204|26161362|P7|From Week 12 up to Week 36|Death|0
7530170|NCT02713204|26161363|P6|From Week 12 up to Week 36|Death|1
7530171|NCT02713204|26161364|P5|From Week 12 up to Week 36|Death|0
7530172|NCT02713204|26161365|P4|From Week 12 up to Week 36|Death|1
7530173|NCT02713204|26161366|P3|From Week 12 up to Week 36|Death|0
7530174|NCT02713204|26161367|P2|From Week 12 up to Week 36|Death|0
7530175|NCT02713204|26161368|P1|From Week 12 up to Week 36|Death|0
7530176|NCT02713204|26161361|P8|From Week 12 up to Week 36|Adverse Event|1
7530177|NCT02713204|26161362|P7|From Week 12 up to Week 36|Adverse Event|2
7530178|NCT02713204|26161363|P6|From Week 12 up to Week 36|Adverse Event|0
7530179|NCT02713204|26161364|P5|From Week 12 up to Week 36|Adverse Event|1
7530180|NCT02713204|26161365|P4|From Week 12 up to Week 36|Adverse Event|1
7530181|NCT02713204|26161366|P3|From Week 12 up to Week 36|Adverse Event|0
7530182|NCT02713204|26161367|P2|From Week 12 up to Week 36|Adverse Event|0
7530183|NCT02713204|26161368|P1|From Week 12 up to Week 36|Adverse Event|1
7530184|NCT02713204|26161361|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530185|NCT02713204|26161362|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530186|NCT02713204|26161363|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530187|NCT02713204|26161364|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530188|NCT02713204|26161365|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530189|NCT02713204|26161366|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530190|NCT02713204|26161367|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7530191|NCT02713204|26161368|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530192|NCT02713204|26161361|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530193|NCT02713204|26161362|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530194|NCT02713204|26161363|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530195|NCT02713204|26161364|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530196|NCT02713204|26161365|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530197|NCT02713204|26161366|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7530198|NCT02713204|26161367|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530199|NCT02713204|26161368|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530200|NCT02713204|26161361|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
7530201|NCT02713204|26161362|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
7530202|NCT02713204|26161363|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
7530203|NCT02713204|26161364|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
7530204|NCT02713204|26161365|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
7530205|NCT02713204|26161366|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
7530206|NCT02713204|26161367|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
7530207|NCT02713204|26161368|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
7530208|NCT02712996|26161449|P2|Second Intervention (Study Days 43-84)|Adverse Event|1
7530209|NCT02712996|26161450|P1|Second Intervention (Study Days 43-84)|Adverse Event|0
7530210|NCT02712983|26161509|P9|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7530211|NCT02712983|26161510|P8|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7530212|NCT02712983|26161511|P7|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7530213|NCT02712983|26161512|P6|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7530214|NCT02712983|26161513|P5|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7530215|NCT02712983|26161514|P4|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7530216|NCT02712983|26161515|P3|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7530217|NCT02712983|26161516|P2|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7530218|NCT02712983|26161517|P1|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7530219|NCT02712983|26161509|P9|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530220|NCT02712983|26161510|P8|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530221|NCT02712983|26161511|P7|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530222|NCT02712983|26161512|P6|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530223|NCT02712983|26161513|P5|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530224|NCT02712983|26161514|P4|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
7530225|NCT02712983|26161515|P3|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530226|NCT02712983|26161516|P2|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530227|NCT02712983|26161517|P1|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7530228|NCT02712983|26161509|P9|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7530229|NCT02712983|26161510|P8|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7530230|NCT02712983|26161511|P7|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7530231|NCT02712983|26161512|P6|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7530232|NCT02712983|26161513|P5|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7530233|NCT02712983|26161514|P4|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7530234|NCT02712983|26161515|P3|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7530235|NCT02712983|26161516|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7530236|NCT02712983|26161517|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7530237|NCT02712983|26161509|P9|Treatment Phase|Subject Decision|0
7530238|NCT02712983|26161510|P8|Treatment Phase|Subject Decision|2
7530239|NCT02712983|26161511|P7|Treatment Phase|Subject Decision|1
7530240|NCT02712983|26161512|P6|Treatment Phase|Subject Decision|0
7530241|NCT02712983|26161513|P5|Treatment Phase|Subject Decision|1
7530242|NCT02712983|26161514|P4|Treatment Phase|Subject Decision|2
7530243|NCT02712983|26161515|P3|Treatment Phase|Subject Decision|0
7530244|NCT02712983|26161516|P2|Treatment Phase|Subject Decision|0
7530245|NCT02712983|26161517|P1|Treatment Phase|Subject Decision|2
7530246|NCT02712983|26161509|P9|Treatment Phase|Physician Decision|1
7530247|NCT02712983|26161510|P8|Treatment Phase|Physician Decision|1
7530248|NCT02712983|26161511|P7|Treatment Phase|Physician Decision|0
7530249|NCT02712983|26161512|P6|Treatment Phase|Physician Decision|0
7530250|NCT02712983|26161513|P5|Treatment Phase|Physician Decision|0
7530251|NCT02712983|26161514|P4|Treatment Phase|Physician Decision|0
7530252|NCT02712983|26161515|P3|Treatment Phase|Physician Decision|0
7530253|NCT02712983|26161516|P2|Treatment Phase|Physician Decision|0
7530254|NCT02712983|26161517|P1|Treatment Phase|Physician Decision|0
7530255|NCT02712983|26161509|P9|Treatment Phase|Technical Problems|0
7530256|NCT02712983|26161510|P8|Treatment Phase|Technical Problems|0
7530257|NCT02712983|26161511|P7|Treatment Phase|Technical Problems|1
7530258|NCT02712983|26161512|P6|Treatment Phase|Technical Problems|0
7530259|NCT02712983|26161513|P5|Treatment Phase|Technical Problems|0
7530260|NCT02712983|26161514|P4|Treatment Phase|Technical Problems|0
7530261|NCT02712983|26161515|P3|Treatment Phase|Technical Problems|0
7530262|NCT02712983|26161516|P2|Treatment Phase|Technical Problems|0
7530263|NCT02712983|26161517|P1|Treatment Phase|Technical Problems|0
7530264|NCT02712983|26161509|P9|Treatment Phase|Protocol Deviation|0
7530265|NCT02712983|26161510|P8|Treatment Phase|Protocol Deviation|0
7530266|NCT02712983|26161511|P7|Treatment Phase|Protocol Deviation|1
7530267|NCT02712983|26161512|P6|Treatment Phase|Protocol Deviation|0
7530268|NCT02712983|26161513|P5|Treatment Phase|Protocol Deviation|0
7530269|NCT02712983|26161514|P4|Treatment Phase|Protocol Deviation|2
7530270|NCT02712983|26161515|P3|Treatment Phase|Protocol Deviation|0
7530271|NCT02712983|26161516|P2|Treatment Phase|Protocol Deviation|0
7530272|NCT02712983|26161517|P1|Treatment Phase|Protocol Deviation|0
7530273|NCT02712983|26161509|P9|Treatment Phase|Adverse Event|1
7530274|NCT02712983|26161510|P8|Treatment Phase|Adverse Event|6
7530275|NCT02712983|26161511|P7|Treatment Phase|Adverse Event|6
7530276|NCT02712983|26161512|P6|Treatment Phase|Adverse Event|0
7530277|NCT02712983|26161513|P5|Treatment Phase|Adverse Event|3
7530278|NCT02712983|26161514|P4|Treatment Phase|Adverse Event|4
7530279|NCT02712983|26161515|P3|Treatment Phase|Adverse Event|1
7530280|NCT02712983|26161516|P2|Treatment Phase|Adverse Event|1
7530281|NCT02712983|26161517|P1|Treatment Phase|Adverse Event|3
7530282|NCT02712788|26161749|P2|Overall Study|Protocol Violation|0
7530283|NCT02712788|26161750|P1|Overall Study|Protocol Violation|1
7530284|NCT02712788|26161749|P2|Overall Study|Physician Decision|0
7530285|NCT02712788|26161750|P1|Overall Study|Physician Decision|1
7530286|NCT02712554|26161760|P2|Part B: Treatment Phase|Other|1
7530287|NCT02712554|26161761|P1|Part B: Treatment Phase|Other|0
7530288|NCT02712554|26161760|P2|Part B: Treatment Phase|Withdrawal by Subject|1
7530289|NCT02712554|26161761|P1|Part B: Treatment Phase|Withdrawal by Subject|0
7530290|NCT02712554|26161760|P2|Part B: Treatment Phase|Adverse Event|1
7530291|NCT02712554|26161761|P1|Part B: Treatment Phase|Adverse Event|0
7530292|NCT02712554|26161760|P2|Part B: Qualification Phase|Adverse Event|1
7530293|NCT02712554|26161761|P1|Part B: Qualification Phase|Adverse Event|0
7530294|NCT02712554|26161760|P2|Part B: Qualification Phase|Withdrawal by Subject|3
7530295|NCT02712554|26161761|P1|Part B: Qualification Phase|Withdrawal by Subject|0
7530296|NCT02712554|26161760|P2|Part B: Qualification Phase|Sponsor Decision|4
7530297|NCT02712554|26161761|P1|Part B: Qualification Phase|Sponsor Decision|0
7530298|NCT02712554|26161760|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
7530299|NCT02712554|26161761|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
7530300|NCT02712424|26161881|P2|Overall Study|Lost to Follow-up|32
7530301|NCT02712424|26161882|P1|Overall Study|Lost to Follow-up|34
7530302|NCT02712398|26161890|P1|Overall Study|Re-operation|21
7530303|NCT02712398|26161890|P1|Overall Study|Death|2
7530304|NCT02712398|26161890|P1|Overall Study|Physician Decision|1
7530305|NCT02712398|26161890|P1|Overall Study|Sponsor Decision|1
7530306|NCT02712398|26161890|P1|Overall Study|Lost to Follow-up|6
7530307|NCT02712398|26161890|P1|Overall Study|Withdrawal by Subject|6
7530308|NCT02712333|26161930|P2|First Period|Withdrawal by Subject|2
7530309|NCT02712333|26161931|P1|First Period|Withdrawal by Subject|3
7530310|NCT02712320|26161949|P1|Overall Study|Treating with the prohibited medications|2
7530311|NCT02712320|26161949|P1|Overall Study|Transferred to another facility|1
7530312|NCT02712320|26161949|P1|Overall Study|Withdrawal by Subject|1
7530313|NCT02712320|26161949|P1|Overall Study|Lost to Follow-up|1
7530314|NCT02712008|26161992|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
7530315|NCT02712008|26161993|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
7530316|NCT02712008|26161994|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
7530317|NCT02712008|26161995|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
7530318|NCT02712008|26161996|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
7530319|NCT02712008|26161997|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
7530320|NCT02712008|26161998|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
7530321|NCT02712008|26161999|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
7530322|NCT02712008|26161992|P8|From Week 12 up to Week 36|Physician Decision|0
7530323|NCT02712008|26161993|P7|From Week 12 up to Week 36|Physician Decision|0
7530324|NCT02712008|26161994|P6|From Week 12 up to Week 36|Physician Decision|0
7530325|NCT02712008|26161995|P5|From Week 12 up to Week 36|Physician Decision|1
7530326|NCT02712008|26161996|P4|From Week 12 up to Week 36|Physician Decision|1
7530327|NCT02712008|26161997|P3|From Week 12 up to Week 36|Physician Decision|0
7530328|NCT02712008|26161998|P2|From Week 12 up to Week 36|Physician Decision|0
7530329|NCT02712008|26161999|P1|From Week 12 up to Week 36|Physician Decision|0
7530330|NCT02712008|26161992|P8|From Week 12 up to Week 36|Lost to Follow-up|0
7530331|NCT02712008|26161993|P7|From Week 12 up to Week 36|Lost to Follow-up|1
7530332|NCT02712008|26161994|P6|From Week 12 up to Week 36|Lost to Follow-up|0
7530333|NCT02712008|26161995|P5|From Week 12 up to Week 36|Lost to Follow-up|0
7530334|NCT02712008|26161996|P4|From Week 12 up to Week 36|Lost to Follow-up|1
7530335|NCT02712008|26161997|P3|From Week 12 up to Week 36|Lost to Follow-up|0
7530336|NCT02712008|26161998|P2|From Week 12 up to Week 36|Lost to Follow-up|0
7530337|NCT02712008|26161999|P1|From Week 12 up to Week 36|Lost to Follow-up|0
7530338|NCT02712008|26161992|P8|From Week 12 up to Week 36|Death|0
7530339|NCT02712008|26161993|P7|From Week 12 up to Week 36|Death|1
7530340|NCT02712008|26161994|P6|From Week 12 up to Week 36|Death|0
7530341|NCT02712008|26161995|P5|From Week 12 up to Week 36|Death|0
7530342|NCT02712008|26161996|P4|From Week 12 up to Week 36|Death|0
7530343|NCT02712008|26161997|P3|From Week 12 up to Week 36|Death|0
7530344|NCT02712008|26161998|P2|From Week 12 up to Week 36|Death|0
7530345|NCT02712008|26161999|P1|From Week 12 up to Week 36|Death|1
7530346|NCT02712008|26161992|P8|From Week 12 up to Week 36|Adverse Event|2
7530347|NCT02712008|26161993|P7|From Week 12 up to Week 36|Adverse Event|0
7530348|NCT02712008|26161994|P6|From Week 12 up to Week 36|Adverse Event|0
7530349|NCT02712008|26161995|P5|From Week 12 up to Week 36|Adverse Event|1
7530350|NCT02712008|26161996|P4|From Week 12 up to Week 36|Adverse Event|0
7530351|NCT02712008|26161997|P3|From Week 12 up to Week 36|Adverse Event|0
7530352|NCT02712008|26161998|P2|From Week 12 up to Week 36|Adverse Event|0
7530353|NCT02712008|26161999|P1|From Week 12 up to Week 36|Adverse Event|0
7530354|NCT02712008|26161992|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530355|NCT02712008|26161993|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530356|NCT02712008|26161994|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530357|NCT02712008|26161995|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530358|NCT02712008|26161996|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530359|NCT02712008|26161997|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530360|NCT02712008|26161998|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
7530361|NCT02712008|26161999|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
7530362|NCT02712008|26161992|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530363|NCT02712008|26161993|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530364|NCT02712008|26161994|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530365|NCT02712008|26161995|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530366|NCT02712008|26161996|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530367|NCT02712008|26161997|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
7530368|NCT02712008|26161998|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530369|NCT02712008|26161999|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
7530370|NCT02712008|26161992|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530371|NCT02712008|26161993|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530372|NCT02712008|26161994|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530373|NCT02712008|26161995|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530451|NCT02711956|26162079|P4|Overall Study|Clinical progression|0
7530374|NCT02712008|26161996|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530375|NCT02712008|26161997|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
7530376|NCT02712008|26161998|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7530377|NCT02712008|26161999|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7530378|NCT02712008|26161992|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530379|NCT02712008|26161993|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530380|NCT02712008|26161994|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530381|NCT02712008|26161995|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530382|NCT02712008|26161996|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530383|NCT02712008|26161997|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7530384|NCT02712008|26161998|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
7530385|NCT02712008|26161999|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7530386|NCT02712008|26161992|P8|Baseline (Day 1) up to Week 12|Death|0
7530387|NCT02712008|26161993|P7|Baseline (Day 1) up to Week 12|Death|0
7530388|NCT02712008|26161994|P6|Baseline (Day 1) up to Week 12|Death|0
7530389|NCT02712008|26161995|P5|Baseline (Day 1) up to Week 12|Death|0
7530390|NCT02712008|26161996|P4|Baseline (Day 1) up to Week 12|Death|0
7530391|NCT02712008|26161997|P3|Baseline (Day 1) up to Week 12|Death|0
7530392|NCT02712008|26161998|P2|Baseline (Day 1) up to Week 12|Death|0
7530393|NCT02712008|26161999|P1|Baseline (Day 1) up to Week 12|Death|3
7530394|NCT02711995|26162031|P1|Washout (90 Days)|Conflicting medication|1
7530395|NCT02711956|26162068|P15|Overall Study|PSA progression with radiographic progression|3
7530396|NCT02711956|26162069|P14|Overall Study|PSA progression with radiographic progression|3
7530397|NCT02711956|26162070|P13|Overall Study|PSA progression with radiographic progression|2
7530398|NCT02711956|26162071|P12|Overall Study|PSA progression with radiographic progression|1
7530399|NCT02711956|26162072|P11|Overall Study|PSA progression with radiographic progression|0
7530400|NCT02711956|26162073|P10|Overall Study|PSA progression with radiographic progression|1
7530401|NCT02711956|26162074|P9|Overall Study|PSA progression with radiographic progression|0
7530402|NCT02711956|26162075|P8|Overall Study|PSA progression with radiographic progression|1
7530403|NCT02711956|26162076|P7|Overall Study|PSA progression with radiographic progression|2
7530404|NCT02711956|26162077|P6|Overall Study|PSA progression with radiographic progression|2
7530405|NCT02711956|26162078|P5|Overall Study|PSA progression with radiographic progression|0
7530406|NCT02711956|26162079|P4|Overall Study|PSA progression with radiographic progression|0
7530407|NCT02711956|26162080|P3|Overall Study|PSA progression with radiographic progression|0
7530408|NCT02711956|26162081|P2|Overall Study|PSA progression with radiographic progression|1
7530409|NCT02711956|26162082|P1|Overall Study|PSA progression with radiographic progression|0
7530410|NCT02711956|26162068|P15|Overall Study|PSA progression with clinical progression|0
7530411|NCT02711956|26162069|P14|Overall Study|PSA progression with clinical progression|1
7530412|NCT02711956|26162070|P13|Overall Study|PSA progression with clinical progression|1
7530413|NCT02711956|26162071|P12|Overall Study|PSA progression with clinical progression|0
7530414|NCT02711956|26162072|P11|Overall Study|PSA progression with clinical progression|0
7530415|NCT02711956|26162073|P10|Overall Study|PSA progression with clinical progression|0
7530416|NCT02711956|26162074|P9|Overall Study|PSA progression with clinical progression|0
7530417|NCT02711956|26162075|P8|Overall Study|PSA progression with clinical progression|0
7530418|NCT02711956|26162076|P7|Overall Study|PSA progression with clinical progression|0
7530419|NCT02711956|26162077|P6|Overall Study|PSA progression with clinical progression|0
7530420|NCT02711956|26162078|P5|Overall Study|PSA progression with clinical progression|1
7530421|NCT02711956|26162079|P4|Overall Study|PSA progression with clinical progression|0
7530422|NCT02711956|26162080|P3|Overall Study|PSA progression with clinical progression|0
7530423|NCT02711956|26162081|P2|Overall Study|PSA progression with clinical progression|0
7530424|NCT02711956|26162082|P1|Overall Study|PSA progression with clinical progression|0
7530425|NCT02711956|26162068|P15|Overall Study|Radiographic progression|1
7530426|NCT02711956|26162069|P14|Overall Study|Radiographic progression|0
7530427|NCT02711956|26162070|P13|Overall Study|Radiographic progression|3
7530428|NCT02711956|26162071|P12|Overall Study|Radiographic progression|5
7530429|NCT02711956|26162072|P11|Overall Study|Radiographic progression|0
7530430|NCT02711956|26162073|P10|Overall Study|Radiographic progression|1
7530431|NCT02711956|26162074|P9|Overall Study|Radiographic progression|2
7530432|NCT02711956|26162075|P8|Overall Study|Radiographic progression|0
7530433|NCT02711956|26162076|P7|Overall Study|Radiographic progression|0
7530434|NCT02711956|26162077|P6|Overall Study|Radiographic progression|0
7530435|NCT02711956|26162078|P5|Overall Study|Radiographic progression|1
7530436|NCT02711956|26162079|P4|Overall Study|Radiographic progression|0
7530437|NCT02711956|26162080|P3|Overall Study|Radiographic progression|2
7530438|NCT02711956|26162081|P2|Overall Study|Radiographic progression|1
7530439|NCT02711956|26162082|P1|Overall Study|Radiographic progression|1
7530440|NCT02711956|26162068|P15|Overall Study|Clinical progression|1
7530441|NCT02711956|26162069|P14|Overall Study|Clinical progression|1
7530442|NCT02711956|26162070|P13|Overall Study|Clinical progression|4
7530443|NCT02711956|26162071|P12|Overall Study|Clinical progression|2
7530444|NCT02711956|26162072|P11|Overall Study|Clinical progression|0
7530445|NCT02711956|26162073|P10|Overall Study|Clinical progression|0
7530446|NCT02711956|26162074|P9|Overall Study|Clinical progression|1
7530447|NCT02711956|26162075|P8|Overall Study|Clinical progression|0
7530448|NCT02711956|26162076|P7|Overall Study|Clinical progression|1
7530449|NCT02711956|26162077|P6|Overall Study|Clinical progression|0
7530450|NCT02711956|26162078|P5|Overall Study|Clinical progression|0
7530452|NCT02711956|26162080|P3|Overall Study|Clinical progression|0
7530453|NCT02711956|26162081|P2|Overall Study|Clinical progression|0
7530454|NCT02711956|26162082|P1|Overall Study|Clinical progression|1
7530455|NCT02711956|26162068|P15|Overall Study|Withdrawal by Subject|1
7530456|NCT02711956|26162069|P14|Overall Study|Withdrawal by Subject|0
7530457|NCT02711956|26162070|P13|Overall Study|Withdrawal by Subject|6
7530458|NCT02711956|26162071|P12|Overall Study|Withdrawal by Subject|1
7530459|NCT02711956|26162072|P11|Overall Study|Withdrawal by Subject|0
7530460|NCT02711956|26162073|P10|Overall Study|Withdrawal by Subject|0
7530461|NCT02711956|26162074|P9|Overall Study|Withdrawal by Subject|0
7530462|NCT02711956|26162075|P8|Overall Study|Withdrawal by Subject|0
7530463|NCT02711956|26162076|P7|Overall Study|Withdrawal by Subject|1
7530464|NCT02711956|26162077|P6|Overall Study|Withdrawal by Subject|0
7530465|NCT02711956|26162078|P5|Overall Study|Withdrawal by Subject|0
7530466|NCT02711956|26162079|P4|Overall Study|Withdrawal by Subject|0
7530467|NCT02711956|26162080|P3|Overall Study|Withdrawal by Subject|0
7530468|NCT02711956|26162081|P2|Overall Study|Withdrawal by Subject|0
7530469|NCT02711956|26162082|P1|Overall Study|Withdrawal by Subject|0
7530470|NCT02711956|26162068|P15|Overall Study|Physician Decision|0
7530471|NCT02711956|26162069|P14|Overall Study|Physician Decision|0
7530472|NCT02711956|26162070|P13|Overall Study|Physician Decision|0
7530473|NCT02711956|26162071|P12|Overall Study|Physician Decision|0
7530474|NCT02711956|26162072|P11|Overall Study|Physician Decision|0
7530475|NCT02711956|26162073|P10|Overall Study|Physician Decision|0
7530476|NCT02711956|26162074|P9|Overall Study|Physician Decision|0
7530477|NCT02711956|26162075|P8|Overall Study|Physician Decision|0
7530478|NCT02711956|26162076|P7|Overall Study|Physician Decision|0
7530479|NCT02711956|26162077|P6|Overall Study|Physician Decision|0
7530480|NCT02711956|26162078|P5|Overall Study|Physician Decision|0
7530481|NCT02711956|26162079|P4|Overall Study|Physician Decision|2
7530482|NCT02711956|26162080|P3|Overall Study|Physician Decision|0
7530483|NCT02711956|26162081|P2|Overall Study|Physician Decision|0
7530484|NCT02711956|26162082|P1|Overall Study|Physician Decision|0
7530485|NCT02711956|26162068|P15|Overall Study|Adverse Event|2
7530486|NCT02711956|26162069|P14|Overall Study|Adverse Event|0
7530487|NCT02711956|26162070|P13|Overall Study|Adverse Event|0
7530488|NCT02711956|26162071|P12|Overall Study|Adverse Event|0
7530489|NCT02711956|26162072|P11|Overall Study|Adverse Event|1
7530490|NCT02711956|26162073|P10|Overall Study|Adverse Event|1
7530491|NCT02711956|26162074|P9|Overall Study|Adverse Event|1
7530492|NCT02711956|26162075|P8|Overall Study|Adverse Event|1
7530493|NCT02711956|26162076|P7|Overall Study|Adverse Event|0
7530494|NCT02711956|26162077|P6|Overall Study|Adverse Event|0
7530495|NCT02711956|26162078|P5|Overall Study|Adverse Event|2
7530496|NCT02711956|26162079|P4|Overall Study|Adverse Event|1
7530497|NCT02711956|26162080|P3|Overall Study|Adverse Event|0
7530498|NCT02711956|26162081|P2|Overall Study|Adverse Event|0
7530499|NCT02711956|26162082|P1|Overall Study|Adverse Event|0
7530500|NCT02711800|26162144|P1|Overall Study|Withdrawal by Subject|1
7530501|NCT02711800|26162144|P1|Overall Study|Lost to Follow-up|1
7530502|NCT02711553|26162157|P4|Overall Study|On Study Treatment at Study Conclusion|1
7530503|NCT02711553|26162158|P3|Overall Study|On Study Treatment at Study Conclusion|3
7530504|NCT02711553|26162159|P2|Overall Study|On Study Treatment at Study Conclusion|1
7530505|NCT02711553|26162160|P1|Overall Study|On Study Treatment at Study Conclusion|1
7530506|NCT02711553|26162157|P4|Overall Study|Lost to Follow-up|3
7530507|NCT02711553|26162158|P3|Overall Study|Lost to Follow-up|6
7530508|NCT02711553|26162159|P2|Overall Study|Lost to Follow-up|3
7530509|NCT02711553|26162160|P1|Overall Study|Lost to Follow-up|3
7530510|NCT02711553|26162157|P4|Overall Study|Withdrawal by Subject|0
7530511|NCT02711553|26162158|P3|Overall Study|Withdrawal by Subject|1
7530512|NCT02711553|26162159|P2|Overall Study|Withdrawal by Subject|1
7530513|NCT02711553|26162160|P1|Overall Study|Withdrawal by Subject|2
7530514|NCT02711345|26162201|P10|Overall Study|Death|0
7530515|NCT02711345|26162202|P9|Overall Study|Death|0
7530516|NCT02711345|26162203|P8|Overall Study|Death|1
7530517|NCT02711345|26162204|P7|Overall Study|Death|0
7530518|NCT02711345|26162205|P6|Overall Study|Death|0
7530519|NCT02711345|26162206|P5|Overall Study|Death|0
7530520|NCT02711345|26162207|P4|Overall Study|Death|0
7530521|NCT02711345|26162208|P3|Overall Study|Death|0
7530522|NCT02711345|26162209|P2|Overall Study|Death|0
7530523|NCT02711345|26162210|P1|Overall Study|Death|1
7530524|NCT02711345|26162201|P10|Overall Study|Subject/guardian decision|4
7530525|NCT02711345|26162202|P9|Overall Study|Subject/guardian decision|0
7530526|NCT02711345|26162203|P8|Overall Study|Subject/guardian decision|1
7530527|NCT02711345|26162204|P7|Overall Study|Subject/guardian decision|3
7530528|NCT02711345|26162205|P6|Overall Study|Subject/guardian decision|2
7530529|NCT02711345|26162206|P5|Overall Study|Subject/guardian decision|0
7530530|NCT02711345|26162207|P4|Overall Study|Subject/guardian decision|0
7530531|NCT02711345|26162208|P3|Overall Study|Subject/guardian decision|0
7530532|NCT02711345|26162209|P2|Overall Study|Subject/guardian decision|0
7530533|NCT02711345|26162210|P1|Overall Study|Subject/guardian decision|0
7530534|NCT02711345|26162201|P10|Overall Study|Progressive disease|6
7530535|NCT02711345|26162202|P9|Overall Study|Progressive disease|5
7530536|NCT02711345|26162203|P8|Overall Study|Progressive disease|4
7530537|NCT02711345|26162204|P7|Overall Study|Progressive disease|8
7530538|NCT02711345|26162205|P6|Overall Study|Progressive disease|2
7530539|NCT02711345|26162206|P5|Overall Study|Progressive disease|7
7530540|NCT02711345|26162207|P4|Overall Study|Progressive disease|3
7530541|NCT02711345|26162208|P3|Overall Study|Progressive disease|5
7530542|NCT02711345|26162209|P2|Overall Study|Progressive disease|3
7530543|NCT02711345|26162210|P1|Overall Study|Progressive disease|1
7530544|NCT02711345|26162201|P10|Overall Study|Physician Decision|0
7530545|NCT02711345|26162202|P9|Overall Study|Physician Decision|1
7530546|NCT02711345|26162203|P8|Overall Study|Physician Decision|0
7530547|NCT02711345|26162204|P7|Overall Study|Physician Decision|0
7530548|NCT02711345|26162205|P6|Overall Study|Physician Decision|0
7530549|NCT02711345|26162206|P5|Overall Study|Physician Decision|0
7530550|NCT02711345|26162207|P4|Overall Study|Physician Decision|0
7530551|NCT02711345|26162208|P3|Overall Study|Physician Decision|1
7530552|NCT02711345|26162209|P2|Overall Study|Physician Decision|0
7530553|NCT02711345|26162210|P1|Overall Study|Physician Decision|0
7530554|NCT02711345|26162201|P10|Overall Study|Adverse Event|2
7530555|NCT02711345|26162202|P9|Overall Study|Adverse Event|0
7530556|NCT02711345|26162203|P8|Overall Study|Adverse Event|0
7530557|NCT02711345|26162204|P7|Overall Study|Adverse Event|1
7530558|NCT02711345|26162205|P6|Overall Study|Adverse Event|2
7530559|NCT02711345|26162206|P5|Overall Study|Adverse Event|1
7530560|NCT02711345|26162207|P4|Overall Study|Adverse Event|1
7530561|NCT02711345|26162208|P3|Overall Study|Adverse Event|0
7530562|NCT02711345|26162209|P2|Overall Study|Adverse Event|0
7530563|NCT02711345|26162210|P1|Overall Study|Adverse Event|0
7530564|NCT02711306|26162396|P2|Overall Study|Withdrawal by Subject|2
7530565|NCT02711306|26162397|P1|Overall Study|Withdrawal by Subject|2
7530566|NCT02710669|26162434|P3|Overall Study|arrived in afib/aflutter|2
7530567|NCT02710669|26162435|P2|Overall Study|arrived in afib/aflutter|8
7530568|NCT02710669|26162436|P1|Overall Study|arrived in afib/aflutter|10
7530569|NCT02710669|26162434|P3|Overall Study|Institutional delays (including COVID)|0
7530570|NCT02710669|26162435|P2|Overall Study|Institutional delays (including COVID)|2
7530571|NCT02710669|26162436|P1|Overall Study|Institutional delays (including COVID)|2
7530572|NCT02710669|26162434|P3|Overall Study|Physician Decision|0
7530573|NCT02710669|26162435|P2|Overall Study|Physician Decision|1
7530574|NCT02710669|26162436|P1|Overall Study|Physician Decision|2
7530575|NCT02710422|26162609|P2|Overall Study|Termination of study|9
7530576|NCT02710422|26162610|P1|Overall Study|Termination of study|9
7530577|NCT02710292|26162626|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
7530578|NCT02710292|26162627|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
7530579|NCT02710292|26162626|P2|Period 1, First 10 Days of Wear|Adverse Event|1
7530580|NCT02710292|26162627|P1|Period 1, First 10 Days of Wear|Adverse Event|0
7530581|NCT02710214|26162636|P2|Overall Study|Death|1
7530582|NCT02710214|26162637|P1|Overall Study|Death|0
7530583|NCT02710214|26162636|P2|Overall Study|Lack of Efficacy|1
7530584|NCT02710214|26162637|P1|Overall Study|Lack of Efficacy|0
7530585|NCT02710214|26162636|P2|Overall Study|Lost to Follow-up|0
7530586|NCT02710214|26162637|P1|Overall Study|Lost to Follow-up|1
7530587|NCT02710136|26162671|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
7530588|NCT02710136|26162672|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
7530589|NCT02710071|26162697|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7530590|NCT02710071|26162698|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|1
7530591|NCT02710071|26162697|P2|First Intervention (6 Weeks).|Withdrawal by Subject|4
7530592|NCT02710071|26162698|P1|First Intervention (6 Weeks).|Withdrawal by Subject|3
7530593|NCT02710045|26162708|P3|Overall Study|Poor Attendance|0
7530594|NCT02710045|26162709|P2|Overall Study|Poor Attendance|1
7530595|NCT02710045|26162710|P1|Overall Study|Poor Attendance|0
7530596|NCT02710045|26162708|P3|Overall Study|Physician Decision|1
7530597|NCT02710045|26162709|P2|Overall Study|Physician Decision|0
7530598|NCT02710045|26162710|P1|Overall Study|Physician Decision|0
7530599|NCT02710045|26162708|P3|Overall Study|Lost to Follow-up|7
7530600|NCT02710045|26162709|P2|Overall Study|Lost to Follow-up|6
7530601|NCT02710045|26162710|P1|Overall Study|Lost to Follow-up|3
7530602|NCT02710045|26162708|P3|Overall Study|Protocol Violation|3
7530603|NCT02710045|26162709|P2|Overall Study|Protocol Violation|2
7530604|NCT02710045|26162710|P1|Overall Study|Protocol Violation|1
7530605|NCT02710045|26162708|P3|Overall Study|Withdrawal by Subject|2
7530606|NCT02710045|26162709|P2|Overall Study|Withdrawal by Subject|6
7530607|NCT02710045|26162710|P1|Overall Study|Withdrawal by Subject|6
7530608|NCT02710045|26162708|P3|Overall Study|Death|0
7530609|NCT02710045|26162709|P2|Overall Study|Death|2
7530610|NCT02710045|26162710|P1|Overall Study|Death|1
7530611|NCT02709889|26162744|P4|Overall Study|Other, Not Specified|6
7530612|NCT02709889|26162745|P3|Overall Study|Other, Not Specified|1
7530613|NCT02709889|26162746|P2|Overall Study|Other, Not Specified|1
7530614|NCT02709889|26162747|P1|Overall Study|Other, Not Specified|0
7530615|NCT02709889|26162744|P4|Overall Study|Study Terminated by Sponsor|17
7530616|NCT02709889|26162745|P3|Overall Study|Study Terminated by Sponsor|2
7530617|NCT02709889|26162746|P2|Overall Study|Study Terminated by Sponsor|6
7530618|NCT02709889|26162747|P1|Overall Study|Study Terminated by Sponsor|4
7530619|NCT02709889|26162744|P4|Overall Study|Lost to Follow-up|4
7530620|NCT02709889|26162745|P3|Overall Study|Lost to Follow-up|0
7530621|NCT02709889|26162746|P2|Overall Study|Lost to Follow-up|0
7530622|NCT02709889|26162747|P1|Overall Study|Lost to Follow-up|2
7530623|NCT02709889|26162744|P4|Overall Study|Physician Decision|5
7530624|NCT02709889|26162745|P3|Overall Study|Physician Decision|3
7530625|NCT02709889|26162746|P2|Overall Study|Physician Decision|2
7530626|NCT02709889|26162747|P1|Overall Study|Physician Decision|1
7530627|NCT02709889|26162744|P4|Overall Study|Death|44
7530628|NCT02709889|26162745|P3|Overall Study|Death|4
7530629|NCT02709889|26162746|P2|Overall Study|Death|38
7530630|NCT02709889|26162747|P1|Overall Study|Death|25
7530631|NCT02709889|26162744|P4|Overall Study|Withdrawal by Subject|12
7530632|NCT02709889|26162745|P3|Overall Study|Withdrawal by Subject|2
7530633|NCT02709889|26162746|P2|Overall Study|Withdrawal by Subject|10
7530634|NCT02709889|26162747|P1|Overall Study|Withdrawal by Subject|11
7530635|NCT02709785|26162828|P3|Overall Study|Withdrawal by Subject|1
7530636|NCT02709785|26162829|P2|Overall Study|Withdrawal by Subject|2
7530637|NCT02709785|26162830|P1|Overall Study|Withdrawal by Subject|1
7530638|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7530639|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7530640|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7530641|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
7530642|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7530643|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7530644|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7530645|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|enrolled not treated|1
7530646|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7530647|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7530648|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
7530649|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7530650|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7530651|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7530652|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
7530653|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Adverse Event|2
7530654|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Adverse Event|5
7530655|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Adverse Event|8
7530656|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Adverse Event|4
7530657|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Adverse Event|0
7530658|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
7530659|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
7530660|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7530661|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
7530662|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7530663|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7530664|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7530665|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
7530666|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7530667|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7530668|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Other|7
7530669|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Other|6
7530670|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Other|5
7530671|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Other|6
7530672|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Other|0
7530673|NCT02709746|26162855|P5|Phase B (Double-blind Treatment Period)|Protocol Violation|2
7530674|NCT02709746|26162856|P4|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7530675|NCT02709746|26162857|P3|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7530676|NCT02709746|26162858|P2|Phase B (Double-blind Treatment Period)|Protocol Violation|1
7530677|NCT02709746|26162859|P1|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7530678|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7530679|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7530680|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7530681|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7530682|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
7530683|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7530684|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7530685|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7530686|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7530687|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
7530688|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7530689|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7530690|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7530691|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7530692|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
7530693|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7530694|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7530695|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7530696|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7530697|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
7530698|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Adverse Event|0
7530699|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Adverse Event|0
7530700|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Adverse Event|0
7530701|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Adverse Event|0
7530702|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Adverse Event|2
7530703|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7530704|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7530705|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7530706|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7530707|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
7530708|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7530709|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7530710|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7530711|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7530712|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
7530713|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Not sepcified|0
7530714|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Not sepcified|0
7530715|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Not sepcified|0
7530716|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Not sepcified|0
7530717|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Not sepcified|14
7530718|NCT02709746|26162855|P5|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7530719|NCT02709746|26162856|P4|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7530720|NCT02709746|26162857|P3|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7530721|NCT02709746|26162858|P2|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7530722|NCT02709746|26162859|P1|Phase A (Single-blind Treatment Period)|Protocol Violation|4
7530723|NCT02709577|26162981|P4|Overall Study|Withdrawal by Subject|0
7530724|NCT02709577|26162982|P3|Overall Study|Withdrawal by Subject|2
7530725|NCT02709577|26162983|P2|Overall Study|Withdrawal by Subject|3
7530726|NCT02709577|26162984|P1|Overall Study|Withdrawal by Subject|2
7530727|NCT02709577|26162981|P4|Overall Study|procedural complication|0
7530728|NCT02709577|26162982|P3|Overall Study|procedural complication|0
7530729|NCT02709577|26162983|P2|Overall Study|procedural complication|1
7530730|NCT02709577|26162984|P1|Overall Study|procedural complication|0
7530731|NCT02709577|26162981|P4|Overall Study|non-accommodating anatomy|0
7530732|NCT02709577|26162982|P3|Overall Study|non-accommodating anatomy|0
7530733|NCT02709577|26162983|P2|Overall Study|non-accommodating anatomy|1
7530734|NCT02709577|26162984|P1|Overall Study|non-accommodating anatomy|0
7530735|NCT02709538|26162999|P3|Overall Study|Other|5
7530736|NCT02709538|26163000|P2|Overall Study|Other|7
7530737|NCT02709538|26163001|P1|Overall Study|Other|16
7530738|NCT02709538|26162999|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
7530739|NCT02709538|26163000|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
7530740|NCT02709538|26163001|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
7530741|NCT02709538|26162999|P3|Overall Study|Protocol deviation|4
7530742|NCT02709538|26163000|P2|Overall Study|Protocol deviation|4
7530743|NCT02709538|26163001|P1|Overall Study|Protocol deviation|10
7530744|NCT02709538|26162999|P3|Overall Study|Non-compliance with study drug|0
7530745|NCT02709538|26163000|P2|Overall Study|Non-compliance with study drug|0
7530746|NCT02709538|26163001|P1|Overall Study|Non-compliance with study drug|2
7530747|NCT02709538|26162999|P3|Overall Study|Non-compliance with study procedures|0
7530748|NCT02709538|26163000|P2|Overall Study|Non-compliance with study procedures|0
7530749|NCT02709538|26163001|P1|Overall Study|Non-compliance with study procedures|5
7530750|NCT02709538|26162999|P3|Overall Study|Withdrawal by Subject|4
7530751|NCT02709538|26163000|P2|Overall Study|Withdrawal by Subject|7
7530752|NCT02709538|26163001|P1|Overall Study|Withdrawal by Subject|40
7530753|NCT02709538|26162999|P3|Overall Study|Physician Decision|0
7530754|NCT02709538|26163000|P2|Overall Study|Physician Decision|0
7530755|NCT02709538|26163001|P1|Overall Study|Physician Decision|1
7530756|NCT02709538|26162999|P3|Overall Study|Lost to Follow-up|4
7530757|NCT02709538|26163000|P2|Overall Study|Lost to Follow-up|8
7530758|NCT02709538|26163001|P1|Overall Study|Lost to Follow-up|24
7530759|NCT02709538|26162999|P3|Overall Study|Lack of Efficacy|0
7530760|NCT02709538|26163000|P2|Overall Study|Lack of Efficacy|0
7530761|NCT02709538|26163001|P1|Overall Study|Lack of Efficacy|1
7530762|NCT02709538|26162999|P3|Overall Study|Adverse Event|3
7530763|NCT02709538|26163000|P2|Overall Study|Adverse Event|2
7530764|NCT02709538|26163001|P1|Overall Study|Adverse Event|13
7530765|NCT02709486|26163012|P3|Overall Study|Withdrawal by Subject|32
7530766|NCT02709486|26163013|P2|Overall Study|Withdrawal by Subject|22
7530767|NCT02709486|26163014|P1|Overall Study|Withdrawal by Subject|32
7530768|NCT02709486|26163012|P3|Overall Study|Other|3
7530769|NCT02709486|26163013|P2|Overall Study|Other|2
7530770|NCT02709486|26163014|P1|Overall Study|Other|0
7530771|NCT02709486|26163012|P3|Overall Study|Lost to Follow-up|2
7530772|NCT02709486|26163013|P2|Overall Study|Lost to Follow-up|2
7530773|NCT02709486|26163014|P1|Overall Study|Lost to Follow-up|3
7530774|NCT02709486|26163012|P3|Overall Study|Insufficient clinical response|3
7530775|NCT02709486|26163013|P2|Overall Study|Insufficient clinical response|3
7530776|NCT02709486|26163014|P1|Overall Study|Insufficient clinical response|7
7530777|NCT02709486|26163012|P3|Overall Study|Death|2
7530778|NCT02709486|26163013|P2|Overall Study|Death|0
7530779|NCT02709486|26163014|P1|Overall Study|Death|0
7530780|NCT02709486|26163012|P3|Overall Study|Adverse Event|3
7530781|NCT02709486|26163013|P2|Overall Study|Adverse Event|5
7530782|NCT02709486|26163014|P1|Overall Study|Adverse Event|2
7530783|NCT02709369|26163205|P1|Overall Study|Did not received intervention|2
7530784|NCT02709369|26163205|P1|Overall Study|Withdrawal by Subject|10
7530785|NCT02709369|26163205|P1|Overall Study|Lost to Follow-up|15
7530786|NCT02709330|26163239|P2|Overall Study|Withdrawal by Subject|0
7530787|NCT02709330|26163240|P1|Overall Study|Withdrawal by Subject|4
7530788|NCT02709330|26163239|P2|Overall Study|Physician Decision|0
7530789|NCT02709330|26163240|P1|Overall Study|Physician Decision|2
7530790|NCT02709330|26163239|P2|Overall Study|Lost to Follow-up|0
7530791|NCT02709330|26163240|P1|Overall Study|Lost to Follow-up|2
7530792|NCT02709330|26163239|P2|Overall Study|Death|0
7530793|NCT02709330|26163240|P1|Overall Study|Death|5
7530794|NCT02709109|26163256|P4|Treatment Period 2 (28 Days)|Other|0
7530795|NCT02709109|26163257|P3|Treatment Period 2 (28 Days)|Other|1
7530796|NCT02709109|26163258|P2|Treatment Period 2 (28 Days)|Other|0
7530797|NCT02709109|26163259|P1|Treatment Period 2 (28 Days)|Other|0
7530798|NCT02709109|26163256|P4|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7530799|NCT02709109|26163257|P3|Treatment Period 2 (28 Days)|Requires prohibited medication|1
7530800|NCT02709109|26163258|P2|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7530801|NCT02709109|26163259|P1|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7530802|NCT02709109|26163256|P4|Treatment Period 2 (28 Days)|Other non-compliance|0
7530803|NCT02709109|26163257|P3|Treatment Period 2 (28 Days)|Other non-compliance|1
7530804|NCT02709109|26163258|P2|Treatment Period 2 (28 Days)|Other non-compliance|1
7530805|NCT02709109|26163259|P1|Treatment Period 2 (28 Days)|Other non-compliance|0
7530806|NCT02709109|26163256|P4|Treatment Period 2 (28 Days)|Adverse Event|0
7530807|NCT02709109|26163257|P3|Treatment Period 2 (28 Days)|Adverse Event|0
7530808|NCT02709109|26163258|P2|Treatment Period 2 (28 Days)|Adverse Event|3
7530809|NCT02709109|26163259|P1|Treatment Period 2 (28 Days)|Adverse Event|2
7530810|NCT02709109|26163256|P4|Washout Period (28 Days)|Other|0
7530811|NCT02709109|26163257|P3|Washout Period (28 Days)|Other|3
7530812|NCT02709109|26163258|P2|Washout Period (28 Days)|Other|2
7530813|NCT02709109|26163259|P1|Washout Period (28 Days)|Other|2
7530814|NCT02709109|26163256|P4|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7530815|NCT02709109|26163257|P3|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7530816|NCT02709109|26163258|P2|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7530817|NCT02709109|26163259|P1|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
7530818|NCT02709109|26163256|P4|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7530819|NCT02709109|26163257|P3|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7530820|NCT02709109|26163258|P2|Treatment Period 1 (28 Days)|Participant refused further dosing|2
7530821|NCT02709109|26163259|P1|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7530822|NCT02709109|26163256|P4|Treatment Period 1 (28 Days)|Adverse Event|0
7530823|NCT02709109|26163257|P3|Treatment Period 1 (28 Days)|Adverse Event|1
7530824|NCT02709109|26163258|P2|Treatment Period 1 (28 Days)|Adverse Event|3
7530825|NCT02709109|26163259|P1|Treatment Period 1 (28 Days)|Adverse Event|3
7530826|NCT02709096|26163279|P2|Overall Study|non-compliance|1
7530827|NCT02709096|26163280|P1|Overall Study|non-compliance|1
7530828|NCT02709083|26163286|P1|Overall Study|Original PI left institution|7
7530829|NCT02709005|26163310|P2|Overall Study|Withdrawal by Subject|0
7530830|NCT02709005|26163311|P1|Overall Study|Withdrawal by Subject|3
7530831|NCT02709005|26163310|P2|Overall Study|Lost to Follow-up|1
7530832|NCT02709005|26163311|P1|Overall Study|Lost to Follow-up|1
7530833|NCT02708966|26163341|P2|Overall Study|Lost to Follow-up|2
7530834|NCT02708966|26163342|P1|Overall Study|Lost to Follow-up|2
7530835|NCT02708524|26163433|P4|Overall Study|Subject lost study lens|0
7530836|NCT02708524|26163434|P3|Overall Study|Subject lost study lens|0
7530837|NCT02708524|26163435|P2|Overall Study|Subject lost study lens|0
7530838|NCT02708524|26163436|P1|Overall Study|Subject lost study lens|1
7530839|NCT02708524|26163433|P4|Overall Study|Did not wear lens at final visit|0
7530840|NCT02708524|26163434|P3|Overall Study|Did not wear lens at final visit|0
7530841|NCT02708524|26163435|P2|Overall Study|Did not wear lens at final visit|1
7530842|NCT02708524|26163436|P1|Overall Study|Did not wear lens at final visit|0
7530843|NCT02708524|26163433|P4|Overall Study|Dispensed incorrect study lens|0
7530844|NCT02708524|26163434|P3|Overall Study|Dispensed incorrect study lens|1
7530845|NCT02708524|26163435|P2|Overall Study|Dispensed incorrect study lens|1
7530846|NCT02708524|26163436|P1|Overall Study|Dispensed incorrect study lens|0
7530847|NCT02708524|26163433|P4|Overall Study|Withdrawal by Subject|0
7530848|NCT02708524|26163434|P3|Overall Study|Withdrawal by Subject|0
7530849|NCT02708524|26163435|P2|Overall Study|Withdrawal by Subject|1
7530850|NCT02708524|26163436|P1|Overall Study|Withdrawal by Subject|1
7530851|NCT02708524|26163433|P4|Overall Study|Protocol Violation|0
7530852|NCT02708524|26163434|P3|Overall Study|Protocol Violation|0
7530853|NCT02708524|26163435|P2|Overall Study|Protocol Violation|1
7530854|NCT02708524|26163436|P1|Overall Study|Protocol Violation|0
7530855|NCT02708524|26163433|P4|Overall Study|Lost to Follow-up|0
7530856|NCT02708524|26163434|P3|Overall Study|Lost to Follow-up|1
7530857|NCT02708524|26163435|P2|Overall Study|Lost to Follow-up|1
7530858|NCT02708524|26163436|P1|Overall Study|Lost to Follow-up|1
7530859|NCT02708524|26163433|P4|Overall Study|Lens Discomfort|0
7530860|NCT02708524|26163434|P3|Overall Study|Lens Discomfort|1
7530861|NCT02708524|26163435|P2|Overall Study|Lens Discomfort|0
7530862|NCT02708524|26163436|P1|Overall Study|Lens Discomfort|1
7530863|NCT02708524|26163433|P4|Overall Study|Adverse Event|0
7530864|NCT02708524|26163434|P3|Overall Study|Adverse Event|0
7530865|NCT02708524|26163435|P2|Overall Study|Adverse Event|1
7530866|NCT02708524|26163436|P1|Overall Study|Adverse Event|0
7530867|NCT02708498|26163490|P8|Overall Study|Unknown reason, missing data|0
7530868|NCT02708498|26163491|P7|Overall Study|Unknown reason, missing data|0
7530869|NCT02708498|26163492|P6|Overall Study|Unknown reason, missing data|132
7530870|NCT02708498|26163493|P5|Overall Study|Unknown reason, missing data|195
7530871|NCT02708498|26163494|P4|Overall Study|Unknown reason, missing data|51
7530872|NCT02708498|26163495|P3|Overall Study|Unknown reason, missing data|62
7530873|NCT02708498|26163496|P2|Overall Study|Unknown reason, missing data|0
7530874|NCT02708498|26163497|P1|Overall Study|Unknown reason, missing data|0
7530875|NCT02708498|26163490|P8|Overall Study|Death|0
7530876|NCT02708498|26163491|P7|Overall Study|Death|0
7530877|NCT02708498|26163492|P6|Overall Study|Death|0
7530878|NCT02708498|26163493|P5|Overall Study|Death|1
7530879|NCT02708498|26163494|P4|Overall Study|Death|0
7530880|NCT02708498|26163495|P3|Overall Study|Death|0
7530881|NCT02708498|26163496|P2|Overall Study|Death|19
7530882|NCT02708498|26163497|P1|Overall Study|Death|20
7530883|NCT02708485|26163525|P2|Overall Study|Withdrawal by Subject|2
7530884|NCT02708485|26163526|P1|Overall Study|Withdrawal by Subject|3
7530885|NCT02708355|26163546|P3|Overall Study|Adverse Event|0
7530886|NCT02708355|26163547|P2|Overall Study|Adverse Event|0
7530887|NCT02708355|26163548|P1|Overall Study|Adverse Event|1
7530888|NCT02708277|26163570|P2|Overall Study|Lost to Follow-up|4
7530889|NCT02708277|26163571|P1|Overall Study|Lost to Follow-up|7
7530890|NCT02708121|26163623|P2|Overall Study|Withdrawal by Subject|4
7530891|NCT02708121|26163624|P1|Overall Study|Withdrawal by Subject|0
7530892|NCT02708121|26163623|P2|Overall Study|Withdrawn by Study Team|1
7530893|NCT02708121|26163624|P1|Overall Study|Withdrawn by Study Team|1
7530894|NCT02708095|26163636|P3|Overall Study|Withdrawal by Subject|4
7530895|NCT02708095|26163637|P2|Overall Study|Withdrawal by Subject|3
7530896|NCT02708095|26163638|P1|Overall Study|Withdrawal by Subject|5
7530897|NCT02708095|26163636|P3|Overall Study|Protocol Violation|1
7530898|NCT02708095|26163637|P2|Overall Study|Protocol Violation|0
7530899|NCT02708095|26163638|P1|Overall Study|Protocol Violation|0
7530900|NCT02708095|26163636|P3|Overall Study|Physician Decision|2
7530901|NCT02708095|26163637|P2|Overall Study|Physician Decision|3
7530902|NCT02708095|26163638|P1|Overall Study|Physician Decision|2
7530903|NCT02708095|26163636|P3|Overall Study|Lost to Follow-up|0
7530904|NCT02708095|26163637|P2|Overall Study|Lost to Follow-up|0
7530905|NCT02708095|26163638|P1|Overall Study|Lost to Follow-up|2
7530906|NCT02708095|26163636|P3|Overall Study|Lack of Efficacy|0
7530907|NCT02708095|26163637|P2|Overall Study|Lack of Efficacy|3
7530908|NCT02708095|26163638|P1|Overall Study|Lack of Efficacy|9
7530909|NCT02708095|26163636|P3|Overall Study|Adverse Event|11
7530910|NCT02708095|26163637|P2|Overall Study|Adverse Event|10
7530911|NCT02708095|26163638|P1|Overall Study|Adverse Event|4
7530912|NCT02707991|26163661|P2|Overall Study|Became ineligible|1
7530913|NCT02707991|26163662|P1|Overall Study|Became ineligible|0
7530914|NCT02707991|26163661|P2|Overall Study|Protocol Violation|0
7530915|NCT02707991|26163662|P1|Overall Study|Protocol Violation|1
7530916|NCT02707965|26163679|P16|Overall Study|Protocol deviation|0
7530917|NCT02707965|26163680|P15|Overall Study|Protocol deviation|0
7530918|NCT02707965|26163681|P14|Overall Study|Protocol deviation|0
7530919|NCT02707965|26163682|P13|Overall Study|Protocol deviation|0
7530920|NCT02707965|26163683|P12|Overall Study|Protocol deviation|0
7530921|NCT02707965|26163684|P11|Overall Study|Protocol deviation|0
7530922|NCT02707965|26163685|P10|Overall Study|Protocol deviation|0
7530923|NCT02707965|26163686|P9|Overall Study|Protocol deviation|0
7530924|NCT02707965|26163687|P8|Overall Study|Protocol deviation|1
7530925|NCT02707965|26163688|P7|Overall Study|Protocol deviation|0
7530926|NCT02707965|26163689|P6|Overall Study|Protocol deviation|0
7530927|NCT02707965|26163690|P5|Overall Study|Protocol deviation|0
7530928|NCT02707965|26163691|P4|Overall Study|Protocol deviation|0
7530929|NCT02707965|26163692|P3|Overall Study|Protocol deviation|0
7530930|NCT02707965|26163693|P2|Overall Study|Protocol deviation|1
7530931|NCT02707965|26163694|P1|Overall Study|Protocol deviation|1
7530932|NCT02707965|26163679|P16|Overall Study|PI decisions|0
7530933|NCT02707965|26163680|P15|Overall Study|PI decisions|2
7530934|NCT02707965|26163681|P14|Overall Study|PI decisions|0
7530935|NCT02707965|26163682|P13|Overall Study|PI decisions|0
7530936|NCT02707965|26163683|P12|Overall Study|PI decisions|0
7530937|NCT02707965|26163684|P11|Overall Study|PI decisions|0
7530938|NCT02707965|26163685|P10|Overall Study|PI decisions|0
7530939|NCT02707965|26163686|P9|Overall Study|PI decisions|0
7530940|NCT02707965|26163687|P8|Overall Study|PI decisions|0
7530941|NCT02707965|26163688|P7|Overall Study|PI decisions|0
7530942|NCT02707965|26163689|P6|Overall Study|PI decisions|0
7530943|NCT02707965|26163690|P5|Overall Study|PI decisions|0
7530944|NCT02707965|26163691|P4|Overall Study|PI decisions|0
7530945|NCT02707965|26163692|P3|Overall Study|PI decisions|0
7530946|NCT02707965|26163693|P2|Overall Study|PI decisions|0
7530947|NCT02707965|26163694|P1|Overall Study|PI decisions|0
7530948|NCT02707965|26163679|P16|Overall Study|Withdrawal by Subject|0
7530949|NCT02707965|26163680|P15|Overall Study|Withdrawal by Subject|0
7530950|NCT02707965|26163681|P14|Overall Study|Withdrawal by Subject|0
7530951|NCT02707965|26163682|P13|Overall Study|Withdrawal by Subject|0
7530952|NCT02707965|26163683|P12|Overall Study|Withdrawal by Subject|0
7530953|NCT02707965|26163684|P11|Overall Study|Withdrawal by Subject|0
7530954|NCT02707965|26163685|P10|Overall Study|Withdrawal by Subject|0
7530955|NCT02707965|26163686|P9|Overall Study|Withdrawal by Subject|0
7530956|NCT02707965|26163687|P8|Overall Study|Withdrawal by Subject|2
7530957|NCT02707965|26163688|P7|Overall Study|Withdrawal by Subject|0
7530958|NCT02707965|26163689|P6|Overall Study|Withdrawal by Subject|0
7530959|NCT02707965|26163690|P5|Overall Study|Withdrawal by Subject|0
7530960|NCT02707965|26163691|P4|Overall Study|Withdrawal by Subject|0
7530961|NCT02707965|26163692|P3|Overall Study|Withdrawal by Subject|1
7530962|NCT02707965|26163693|P2|Overall Study|Withdrawal by Subject|0
7530963|NCT02707965|26163694|P1|Overall Study|Withdrawal by Subject|0
7530964|NCT02707952|26163746|P4|Overall Study|Withdrawal by Subject|0
7530965|NCT02707952|26163747|P3|Overall Study|Withdrawal by Subject|2
7530966|NCT02707952|26163748|P2|Overall Study|Withdrawal by Subject|1
7530967|NCT02707952|26163749|P1|Overall Study|Withdrawal by Subject|0
7530968|NCT02707952|26163746|P4|Overall Study|Lost to Follow-up|0
7530969|NCT02707952|26163747|P3|Overall Study|Lost to Follow-up|0
7530970|NCT02707952|26163748|P2|Overall Study|Lost to Follow-up|0
7530971|NCT02707952|26163749|P1|Overall Study|Lost to Follow-up|1
7530972|NCT02707952|26163746|P4|Overall Study|Adverse Event|0
7530973|NCT02707952|26163747|P3|Overall Study|Adverse Event|0
7530974|NCT02707952|26163748|P2|Overall Study|Adverse Event|0
7530975|NCT02707952|26163749|P1|Overall Study|Adverse Event|1
7530976|NCT02707861|26163770|P2|Overall Study|Lost to Follow-up|3
7530977|NCT02707861|26163771|P1|Overall Study|Lost to Follow-up|1
7530978|NCT02707861|26163770|P2|Overall Study|Withdrawal by Subject|1
7530979|NCT02707861|26163771|P1|Overall Study|Withdrawal by Subject|2
7530980|NCT02707861|26163770|P2|Overall Study|Physician Decision|4
7530981|NCT02707861|26163771|P1|Overall Study|Physician Decision|1
7530982|NCT02707861|26163770|P2|Overall Study|Lack of Efficacy|2
7530983|NCT02707861|26163771|P1|Overall Study|Lack of Efficacy|0
7530984|NCT02707861|26163770|P2|Overall Study|Death|2
7530985|NCT02707861|26163771|P1|Overall Study|Death|5
7530986|NCT02707861|26163770|P2|Overall Study|Adverse Event|3
7530987|NCT02707861|26163771|P1|Overall Study|Adverse Event|2
7530988|NCT02707861|26163770|P2|Overall Study|Went onto commercial drug|23
7530989|NCT02707861|26163771|P1|Overall Study|Went onto commercial drug|30
7530990|NCT02707757|26163810|P2|Overall Study|Renal transplant/elective operation|5
7530991|NCT02707757|26163811|P1|Overall Study|Renal transplant/elective operation|1
7530992|NCT02707757|26163810|P2|Overall Study|Adverse Event|4
7530993|NCT02707757|26163811|P1|Overall Study|Adverse Event|6
7530994|NCT02707757|26163810|P2|Overall Study|Death|1
7530995|NCT02707757|26163811|P1|Overall Study|Death|0
7530996|NCT02707757|26163810|P2|Overall Study|Withdrawal by Subject|0
7530997|NCT02707757|26163811|P1|Overall Study|Withdrawal by Subject|2
7530998|NCT02707757|26163810|P2|Overall Study|Protocol Violation|2
7530999|NCT02707757|26163811|P1|Overall Study|Protocol Violation|3
7531000|NCT02707640|26163819|P2|Overall Study|Sponsor Discretion|0
7531001|NCT02707640|26163820|P1|Overall Study|Sponsor Discretion|1
7531002|NCT02707640|26163819|P2|Overall Study|Participant's Personal Decision|2
7531003|NCT02707640|26163820|P1|Overall Study|Participant's Personal Decision|1
7531004|NCT02707640|26163819|P2|Overall Study|Withdrawal by Subject|1
7531005|NCT02707640|26163820|P1|Overall Study|Withdrawal by Subject|0
7531006|NCT02707640|26163819|P2|Overall Study|Physician Decision|0
7531007|NCT02707640|26163820|P1|Overall Study|Physician Decision|2
7531008|NCT02707640|26163819|P2|Overall Study|Death|2
7531009|NCT02707640|26163820|P1|Overall Study|Death|1
7531010|NCT02707640|26163819|P2|Overall Study|Adverse Event|2
7531011|NCT02707640|26163820|P1|Overall Study|Adverse Event|4
7531012|NCT02707601|26163840|P2|Overall Study|Participants Randomized but Not Treated|0
7531013|NCT02707601|26163841|P1|Overall Study|Participants Randomized but Not Treated|2
7531014|NCT02707601|26163840|P2|Overall Study|Lost to Follow-up|1
7531015|NCT02707601|26163841|P1|Overall Study|Lost to Follow-up|1
7531016|NCT02707601|26163840|P2|Overall Study|Withdrew Consent|1
7531017|NCT02707601|26163841|P1|Overall Study|Withdrew Consent|0
7531018|NCT02707601|26163840|P2|Overall Study|Investigator's Discretion|0
7531019|NCT02707601|26163841|P1|Overall Study|Investigator's Discretion|1
7531020|NCT02707601|26163840|P2|Overall Study|Lack of Efficacy|1
7531021|NCT02707601|26163841|P1|Overall Study|Lack of Efficacy|0
7531022|NCT02707601|26163840|P2|Overall Study|Death|1
7531023|NCT02707601|26163841|P1|Overall Study|Death|0
7531024|NCT02706951|26163930|P3|Overall Study|Other|0
7531025|NCT02706951|26163931|P2|Overall Study|Other|1
7531026|NCT02706951|26163932|P1|Overall Study|Other|2
7531027|NCT02706951|26163930|P3|Overall Study|Lost to Follow-up|1
7531028|NCT02706951|26163931|P2|Overall Study|Lost to Follow-up|4
7531029|NCT02706951|26163932|P1|Overall Study|Lost to Follow-up|0
7531030|NCT02706951|26163930|P3|Overall Study|Withdrawal by Subject|6
7531031|NCT02706951|26163931|P2|Overall Study|Withdrawal by Subject|6
7531032|NCT02706951|26163932|P1|Overall Study|Withdrawal by Subject|11
7531033|NCT02706951|26163930|P3|Overall Study|Adverse Event|3
7531034|NCT02706951|26163931|P2|Overall Study|Adverse Event|5
7531035|NCT02706951|26163932|P1|Overall Study|Adverse Event|1
7531036|NCT02706938|26163966|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
7531037|NCT02706938|26163967|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
7531038|NCT02706938|26163966|P2|Second Period, 6 Weeks|Adverse Event|7
7531039|NCT02706938|26163967|P1|Second Period, 6 Weeks|Adverse Event|0
7531040|NCT02706938|26163966|P2|First Period, 6 Weeks|Withdrawal by Subject|0
7531041|NCT02706938|26163967|P1|First Period, 6 Weeks|Withdrawal by Subject|1
7531042|NCT02706938|26163966|P2|First Period, 6 Weeks|Lost to Follow-up|2
7531043|NCT02706938|26163967|P1|First Period, 6 Weeks|Lost to Follow-up|2
7531044|NCT02706938|26163966|P2|First Period, 6 Weeks|Adverse Event|0
7531045|NCT02706938|26163967|P1|First Period, 6 Weeks|Adverse Event|8
7531046|NCT02706899|26164031|P2|Overall Study|Study Termination by Sponsor|6
7531047|NCT02706899|26164032|P1|Overall Study|Study Termination by Sponsor|4
7531048|NCT02706899|26164031|P2|Overall Study|Death|0
7531049|NCT02706899|26164032|P1|Overall Study|Death|8
7531050|NCT02706899|26164031|P2|Overall Study|Withdrawal by Subject|0
7531051|NCT02706899|26164032|P1|Overall Study|Withdrawal by Subject|1
7531052|NCT02706886|26164063|P9|Part A: SAD Period|Withdrawal by Subject|0
7531053|NCT02706886|26164064|P8|Part A: SAD Period|Withdrawal by Subject|0
7531054|NCT02706886|26164065|P7|Part A: SAD Period|Withdrawal by Subject|0
7531055|NCT02706886|26164066|P6|Part A: SAD Period|Withdrawal by Subject|0
7531056|NCT02706886|26164067|P5|Part A: SAD Period|Withdrawal by Subject|0
7531057|NCT02706886|26164068|P4|Part A: SAD Period|Withdrawal by Subject|2
7531058|NCT02706886|26164069|P3|Part A: SAD Period|Withdrawal by Subject|0
7531059|NCT02706886|26164070|P2|Part A: SAD Period|Withdrawal by Subject|0
7531060|NCT02706886|26164071|P1|Part A: SAD Period|Withdrawal by Subject|0
7531061|NCT02706873|26164188|P4|Overall Study|Ongoing|1
7531062|NCT02706873|26164189|P3|Overall Study|Ongoing|0
7531063|NCT02706873|26164190|P2|Overall Study|Ongoing|0
7531064|NCT02706873|26164191|P1|Overall Study|Ongoing|0
7531065|NCT02706873|26164188|P4|Overall Study|Not Dosed|1
7531066|NCT02706873|26164189|P3|Overall Study|Not Dosed|0
7531067|NCT02706873|26164190|P2|Overall Study|Not Dosed|0
7531068|NCT02706873|26164191|P1|Overall Study|Not Dosed|1
7531069|NCT02706873|26164188|P4|Overall Study|Other|3
7531070|NCT02706873|26164189|P3|Overall Study|Other|2
7531071|NCT02706873|26164190|P2|Overall Study|Other|1
7531072|NCT02706873|26164191|P1|Overall Study|Other|5
7531073|NCT02706873|26164188|P4|Overall Study|Lack of Efficacy|3
7531074|NCT02706873|26164189|P3|Overall Study|Lack of Efficacy|0
7531075|NCT02706873|26164190|P2|Overall Study|Lack of Efficacy|0
7531076|NCT02706873|26164191|P1|Overall Study|Lack of Efficacy|10
7531077|NCT02706873|26164188|P4|Overall Study|Lost to Follow-up|2
7531078|NCT02706873|26164189|P3|Overall Study|Lost to Follow-up|4
7531079|NCT02706873|26164190|P2|Overall Study|Lost to Follow-up|0
7531080|NCT02706873|26164191|P1|Overall Study|Lost to Follow-up|3
7531081|NCT02706873|26164188|P4|Overall Study|Withdrawal by Subject|11
7531082|NCT02706873|26164189|P3|Overall Study|Withdrawal by Subject|8
7531083|NCT02706873|26164190|P2|Overall Study|Withdrawal by Subject|0
7531084|NCT02706873|26164191|P1|Overall Study|Withdrawal by Subject|15
7531085|NCT02706873|26164188|P4|Overall Study|Adverse Event|12
7531086|NCT02706873|26164189|P3|Overall Study|Adverse Event|13
7531087|NCT02706873|26164190|P2|Overall Study|Adverse Event|3
7531088|NCT02706873|26164191|P1|Overall Study|Adverse Event|13
7531089|NCT02706847|26164291|P4|Week 12 to Week 24|Other|4
7531090|NCT02706847|26164292|P3|Week 12 to Week 24|Other|1
7531091|NCT02706847|26164293|P2|Week 12 to Week 24|Other|0
7531092|NCT02706847|26164294|P1|Week 12 to Week 24|Other|1
7531093|NCT02706847|26164291|P4|Week 12 to Week 24|Lost to Follow-up|1
7531094|NCT02706847|26164292|P3|Week 12 to Week 24|Lost to Follow-up|0
7531095|NCT02706847|26164293|P2|Week 12 to Week 24|Lost to Follow-up|0
7531096|NCT02706847|26164294|P1|Week 12 to Week 24|Lost to Follow-up|0
7531097|NCT02706847|26164291|P4|Week 12 to Week 24|Withdrawal by Subject|4
7531098|NCT02706847|26164292|P3|Week 12 to Week 24|Withdrawal by Subject|1
7531099|NCT02706847|26164293|P2|Week 12 to Week 24|Withdrawal by Subject|0
7531100|NCT02706847|26164294|P1|Week 12 to Week 24|Withdrawal by Subject|1
7531101|NCT02706847|26164291|P4|Week 12 to Week 24|Adverse Event|5
7531102|NCT02706847|26164292|P3|Week 12 to Week 24|Adverse Event|2
7531103|NCT02706847|26164293|P2|Week 12 to Week 24|Adverse Event|2
7531104|NCT02706847|26164294|P1|Week 12 to Week 24|Adverse Event|1
7531105|NCT02706847|26164291|P4|Day 1 to Week 12|Randomized in Error|0
7531106|NCT02706847|26164292|P3|Day 1 to Week 12|Randomized in Error|1
7531107|NCT02706847|26164293|P2|Day 1 to Week 12|Randomized in Error|0
7531108|NCT02706847|26164294|P1|Day 1 to Week 12|Randomized in Error|0
7531109|NCT02706847|26164291|P4|Day 1 to Week 12|Other|2
7531110|NCT02706847|26164292|P3|Day 1 to Week 12|Other|2
7531111|NCT02706847|26164293|P2|Day 1 to Week 12|Other|4
7531112|NCT02706847|26164294|P1|Day 1 to Week 12|Other|4
7531113|NCT02706847|26164291|P4|Day 1 to Week 12|Lost to Follow-up|0
7531114|NCT02706847|26164292|P3|Day 1 to Week 12|Lost to Follow-up|0
7531115|NCT02706847|26164293|P2|Day 1 to Week 12|Lost to Follow-up|1
7531116|NCT02706847|26164294|P1|Day 1 to Week 12|Lost to Follow-up|2
7531117|NCT02706847|26164291|P4|Day 1 to Week 12|Withdrawal by Subject|2
7531118|NCT02706847|26164292|P3|Day 1 to Week 12|Withdrawal by Subject|4
7531119|NCT02706847|26164293|P2|Day 1 to Week 12|Withdrawal by Subject|1
7531120|NCT02706847|26164294|P1|Day 1 to Week 12|Withdrawal by Subject|2
7531121|NCT02706847|26164291|P4|Day 1 to Week 12|Adverse Event|12
7531122|NCT02706847|26164292|P3|Day 1 to Week 12|Adverse Event|1
7531123|NCT02706847|26164293|P2|Day 1 to Week 12|Adverse Event|2
7531124|NCT02706847|26164294|P1|Day 1 to Week 12|Adverse Event|2
7531125|NCT02706834|26164336|P11|Overall Study|Other Reason Not Specified|0
7531126|NCT02706834|26164337|P10|Overall Study|Other Reason Not Specified|0
7531127|NCT02706834|26164338|P9|Overall Study|Other Reason Not Specified|0
7531128|NCT02706834|26164339|P8|Overall Study|Other Reason Not Specified|0
7531129|NCT02706834|26164340|P7|Overall Study|Other Reason Not Specified|0
7531130|NCT02706834|26164341|P6|Overall Study|Other Reason Not Specified|0
7531131|NCT02706834|26164342|P5|Overall Study|Other Reason Not Specified|1
7531132|NCT02706834|26164343|P4|Overall Study|Other Reason Not Specified|0
7531133|NCT02706834|26164344|P3|Overall Study|Other Reason Not Specified|0
7531134|NCT02706834|26164345|P2|Overall Study|Other Reason Not Specified|0
7531135|NCT02706834|26164346|P1|Overall Study|Other Reason Not Specified|1
7531136|NCT02706834|26164336|P11|Overall Study|Voluntary Withdrawal|0
7531137|NCT02706834|26164337|P10|Overall Study|Voluntary Withdrawal|1
7531138|NCT02706834|26164338|P9|Overall Study|Voluntary Withdrawal|0
7531139|NCT02706834|26164339|P8|Overall Study|Voluntary Withdrawal|0
7531140|NCT02706834|26164340|P7|Overall Study|Voluntary Withdrawal|0
7531141|NCT02706834|26164341|P6|Overall Study|Voluntary Withdrawal|0
7531142|NCT02706834|26164342|P5|Overall Study|Voluntary Withdrawal|0
7531143|NCT02706834|26164343|P4|Overall Study|Voluntary Withdrawal|0
7531144|NCT02706834|26164344|P3|Overall Study|Voluntary Withdrawal|0
7531145|NCT02706834|26164345|P2|Overall Study|Voluntary Withdrawal|0
7531146|NCT02706834|26164346|P1|Overall Study|Voluntary Withdrawal|1
7531147|NCT02706834|26164336|P11|Overall Study|Lost to Follow-up|0
7531148|NCT02706834|26164337|P10|Overall Study|Lost to Follow-up|0
7531149|NCT02706834|26164338|P9|Overall Study|Lost to Follow-up|0
7531150|NCT02706834|26164339|P8|Overall Study|Lost to Follow-up|0
7531151|NCT02706834|26164340|P7|Overall Study|Lost to Follow-up|0
7531152|NCT02706834|26164341|P6|Overall Study|Lost to Follow-up|0
7531153|NCT02706834|26164342|P5|Overall Study|Lost to Follow-up|0
7531154|NCT02706834|26164343|P4|Overall Study|Lost to Follow-up|0
7531155|NCT02706834|26164344|P3|Overall Study|Lost to Follow-up|1
7531156|NCT02706834|26164345|P2|Overall Study|Lost to Follow-up|0
7531157|NCT02706834|26164346|P1|Overall Study|Lost to Follow-up|0
7531158|NCT02706834|26164336|P11|Overall Study|Pretreatment Event/Adverse Event|1
7531159|NCT02706834|26164337|P10|Overall Study|Pretreatment Event/Adverse Event|0
7531160|NCT02706834|26164338|P9|Overall Study|Pretreatment Event/Adverse Event|0
7531161|NCT02706834|26164339|P8|Overall Study|Pretreatment Event/Adverse Event|0
7531162|NCT02706834|26164340|P7|Overall Study|Pretreatment Event/Adverse Event|0
7531163|NCT02706834|26164341|P6|Overall Study|Pretreatment Event/Adverse Event|0
7531164|NCT02706834|26164342|P5|Overall Study|Pretreatment Event/Adverse Event|0
7531165|NCT02706834|26164343|P4|Overall Study|Pretreatment Event/Adverse Event|0
7531166|NCT02706834|26164344|P3|Overall Study|Pretreatment Event/Adverse Event|0
7531167|NCT02706834|26164345|P2|Overall Study|Pretreatment Event/Adverse Event|1
7531168|NCT02706834|26164346|P1|Overall Study|Pretreatment Event/Adverse Event|0
7531169|NCT02706717|26164490|P2|Overall Study|Death|1
7531170|NCT02706717|26164491|P1|Overall Study|Death|0
7531171|NCT02706717|26164490|P2|Overall Study|Physician Decision|1
7531172|NCT02706717|26164491|P1|Overall Study|Physician Decision|0
7531173|NCT02706717|26164490|P2|Overall Study|Lost to Follow-up|1
7531174|NCT02706717|26164491|P1|Overall Study|Lost to Follow-up|0
7531175|NCT02706717|26164490|P2|Overall Study|Withdrawal by Subject|8
7531176|NCT02706717|26164491|P1|Overall Study|Withdrawal by Subject|1
7531177|NCT02706691|26164555|P1|Overall Study|Adverse Event|1
7531178|NCT02706483|26164562|P1|Overall Study|Subject moved|1
7531179|NCT02706483|26164562|P1|Overall Study|Site closure|4
7531180|NCT02706483|26164562|P1|Overall Study|Non-compliance with visits|6
7531181|NCT02706483|26164562|P1|Overall Study|Withdrawal by Subject|136
7531182|NCT02706483|26164562|P1|Overall Study|Protocol Violation|18
7531183|NCT02706483|26164562|P1|Overall Study|Pregnancy|6
7531184|NCT02706483|26164562|P1|Overall Study|Physician Decision|6
7531185|NCT02706483|26164562|P1|Overall Study|Non-compliance with study drug|15
7531186|NCT02706483|26164562|P1|Overall Study|Lost to Follow-up|101
7531187|NCT02706483|26164562|P1|Overall Study|Lack of Efficacy|39
7531188|NCT02706483|26164562|P1|Overall Study|Death|1
7531189|NCT02706483|26164562|P1|Overall Study|Adverse Event|97
7531190|NCT02706327|26164569|P3|Overall Study|Lost to Follow-up|2
7531191|NCT02706327|26164570|P2|Overall Study|Lost to Follow-up|1
7531192|NCT02706327|26164571|P1|Overall Study|Lost to Follow-up|1
7531193|NCT02705716|26164635|P2|Overall Study|Withdrawal of Consent|1
7531194|NCT02705716|26164636|P1|Overall Study|Withdrawal of Consent|1
7531195|NCT02705716|26164635|P2|Overall Study|Protocol Violation|0
7531196|NCT02705716|26164636|P1|Overall Study|Protocol Violation|3
7531197|NCT02705716|26164635|P2|Overall Study|Adverse Event|1
7531198|NCT02705716|26164636|P1|Overall Study|Adverse Event|0
7531199|NCT02705625|26164649|P3|Overall Study|Overdosing|1
7531200|NCT02705625|26164650|P2|Overall Study|Overdosing|0
7531201|NCT02705625|26164651|P1|Overall Study|Overdosing|0
7531202|NCT02705625|26164649|P3|Overall Study|Non-compliance|1
7531203|NCT02705625|26164650|P2|Overall Study|Non-compliance|1
7531204|NCT02705625|26164651|P1|Overall Study|Non-compliance|0
7531205|NCT02705625|26164649|P3|Overall Study|Lost to Follow-up|1
7531206|NCT02705625|26164650|P2|Overall Study|Lost to Follow-up|0
7531207|NCT02705625|26164651|P1|Overall Study|Lost to Follow-up|0
7531208|NCT02705625|26164649|P3|Overall Study|Withdrawal by Subject|5
7531209|NCT02705625|26164650|P2|Overall Study|Withdrawal by Subject|4
7531210|NCT02705625|26164651|P1|Overall Study|Withdrawal by Subject|1
7531211|NCT02705625|26164649|P3|Overall Study|Death|1
7531212|NCT02705625|26164650|P2|Overall Study|Death|0
7531213|NCT02705625|26164651|P1|Overall Study|Death|0
7531214|NCT02705625|26164649|P3|Overall Study|Adverse Event|2
7531215|NCT02705625|26164650|P2|Overall Study|Adverse Event|5
7531216|NCT02705625|26164651|P1|Overall Study|Adverse Event|6
7531217|NCT02705625|26164649|P3|Overall Study|Protocol Violation|0
7531218|NCT02705625|26164650|P2|Overall Study|Protocol Violation|0
7531219|NCT02705625|26164651|P1|Overall Study|Protocol Violation|1
7531220|NCT02705586|26164680|P1|Overall Study|Vacation/Planned Absence|1
7531221|NCT02705586|26164680|P1|Overall Study|Transportation Difficulties|5
7531222|NCT02705586|26164680|P1|Overall Study|Health Issues|2
7531223|NCT02705105|26164718|P2|Follow-Up|Discontinued per Amendment 3|2
7531224|NCT02705105|26164719|P1|Follow-Up|Discontinued per Amendment 3|0
7531225|NCT02705105|26164718|P2|Follow-Up|Study Terminated|26
7531226|NCT02705105|26164719|P1|Follow-Up|Study Terminated|0
7531227|NCT02705105|26164718|P2|Follow-Up|Withdrawal by Subject|14
7531228|NCT02705105|26164719|P1|Follow-Up|Withdrawal by Subject|1
7531229|NCT02705105|26164718|P2|Follow-Up|Death|68
7531230|NCT02705105|26164719|P1|Follow-Up|Death|3
7531231|NCT02705105|26164718|P2|Treatment|Ongoing w/ Treatment at time of data cut|2
7531232|NCT02705105|26164719|P1|Treatment|Ongoing w/ Treatment at time of data cut|0
7531233|NCT02705105|26164718|P2|Treatment|Physician Decision|3
7531234|NCT02705105|26164719|P1|Treatment|Physician Decision|0
7531235|NCT02705105|26164718|P2|Treatment|Clinical Disease Progression|32
7531236|NCT02705105|26164719|P1|Treatment|Clinical Disease Progression|0
7531237|NCT02705105|26164718|P2|Treatment|Adverse Event|17
7531238|NCT02705105|26164719|P1|Treatment|Adverse Event|0
7531239|NCT02705105|26164718|P2|Treatment|Withdrawal by Subject|5
7531240|NCT02705105|26164719|P1|Treatment|Withdrawal by Subject|3
7531241|NCT02705105|26164718|P2|Treatment|Objective Disease Progression|50
7531242|NCT02705105|26164719|P1|Treatment|Objective Disease Progression|1
7531243|NCT02704689|26164782|P1|Overall Study|Study device not implanted|2
7531244|NCT02704689|26164782|P1|Overall Study|Physician Decision|1
7531245|NCT02704143|26164818|P1|Overall Study|disease progression|10
7531246|NCT02704091|26164843|P2|Overall Study|Other|8
7531247|NCT02704091|26164844|P1|Overall Study|Other|2
7531248|NCT02704091|26164843|P2|Overall Study|Lost to Follow-up|5
7531249|NCT02704091|26164844|P1|Overall Study|Lost to Follow-up|13
7531250|NCT02704091|26164843|P2|Overall Study|Consent withdrawn|4
7531251|NCT02704091|26164844|P1|Overall Study|Consent withdrawn|4
7531252|NCT02704091|26164843|P2|Overall Study|Protocol Violation|3
7531253|NCT02704091|26164844|P1|Overall Study|Protocol Violation|5
7531254|NCT02704091|26164843|P2|Overall Study|Adverse Event|3
7531255|NCT02704091|26164844|P1|Overall Study|Adverse Event|4
7531256|NCT02703636|26164917|P1|Overall Study|Withdrawal by Subject|1
7531257|NCT02703636|26164917|P1|Overall Study|Study stopped by sponsor|1
7531258|NCT02703636|26164917|P1|Overall Study|Adverse Event|14
7531259|NCT02703532|26164932|P4|Overall Study|Lost to Follow-up|0
7531260|NCT02703532|26164933|P3|Overall Study|Lost to Follow-up|2
7531261|NCT02703532|26164934|P2|Overall Study|Lost to Follow-up|0
7531262|NCT02703532|26164935|P1|Overall Study|Lost to Follow-up|2
7531263|NCT02703532|26164932|P4|Overall Study|Withdrawal by Subject|1
7531264|NCT02703532|26164933|P3|Overall Study|Withdrawal by Subject|0
7531265|NCT02703532|26164934|P2|Overall Study|Withdrawal by Subject|1
7531266|NCT02703532|26164935|P1|Overall Study|Withdrawal by Subject|0
7531267|NCT02703454|26164997|P2|Overall Study|Study discontinuation|8
7531268|NCT02703454|26164998|P1|Overall Study|Study discontinuation|5
7531269|NCT02703454|26164997|P2|Overall Study|Lost to Follow-up|2
7531270|NCT02703454|26164998|P1|Overall Study|Lost to Follow-up|1
7531271|NCT02703454|26164997|P2|Overall Study|Withdrawal by Subject|3
7531272|NCT02703454|26164998|P1|Overall Study|Withdrawal by Subject|4
7531273|NCT02703454|26164997|P2|Overall Study|Not treated|3
7531274|NCT02703454|26164998|P1|Overall Study|Not treated|1
7531275|NCT02703337|26165033|P8|Period One (Part A)|Withdrawal by Subject|0
7531276|NCT02703337|26165034|P7|Period One (Part A)|Withdrawal by Subject|0
7531277|NCT02703337|26165035|P6|Period One (Part A)|Withdrawal by Subject|0
7531278|NCT02703337|26165036|P5|Period One (Part A)|Withdrawal by Subject|1
7531279|NCT02703337|26165037|P4|Period One (Part A)|Withdrawal by Subject|0
7531280|NCT02703337|26165038|P3|Period One (Part A)|Withdrawal by Subject|0
7531281|NCT02703337|26165039|P2|Period One (Part A)|Withdrawal by Subject|0
7531282|NCT02703337|26165040|P1|Period One (Part A)|Withdrawal by Subject|0
7531283|NCT02703324|26165060|P6|Period Two|Withdrawal by Subject|0
7531284|NCT02703324|26165061|P5|Period Two|Withdrawal by Subject|0
7531285|NCT02703324|26165062|P4|Period Two|Withdrawal by Subject|0
7531286|NCT02703324|26165063|P3|Period Two|Withdrawal by Subject|1
7531287|NCT02703324|26165064|P2|Period Two|Withdrawal by Subject|0
7531288|NCT02703324|26165065|P1|Period Two|Withdrawal by Subject|0
7531289|NCT02703311|26165074|P1|Overall Study|Withdrawal by Subject|3
7531290|NCT02703311|26165074|P1|Overall Study|Death|5
7531291|NCT02703259|26165092|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7531292|NCT02703259|26165093|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7531293|NCT02703259|26165092|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
7531294|NCT02703259|26165093|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
7531295|NCT02703259|26165092|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
7531296|NCT02703259|26165093|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
7531297|NCT02702609|26165141|P2|Overall Study|Physician Decision|0
7531298|NCT02702609|26165142|P1|Overall Study|Physician Decision|1
7531299|NCT02702609|26165141|P2|Overall Study|Lost to Follow-up|4
7531300|NCT02702609|26165142|P1|Overall Study|Lost to Follow-up|8
7531301|NCT02702518|26165160|P2|Overall Study|Lost to Follow-up|4
7531302|NCT02702518|26165161|P1|Overall Study|Lost to Follow-up|3
7531303|NCT02702401|26165171|P2|Overall Study|Ongoing in study|34
7531304|NCT02702401|26165172|P1|Overall Study|Ongoing in study|94
7531305|NCT02702401|26165171|P2|Overall Study|Withdrawal by Subject|0
7531306|NCT02702401|26165172|P1|Overall Study|Withdrawal by Subject|4
7531307|NCT02702401|26165171|P2|Overall Study|Death|101
7531308|NCT02702401|26165172|P1|Overall Study|Death|180
7531309|NCT02702388|26165194|P2|Overall Study|Ongoing: In Survival Follow-up|26
7531310|NCT02702388|26165195|P1|Overall Study|Ongoing: In Survival Follow-up|18
7531311|NCT02702388|26165194|P2|Overall Study|Ongoing: Receiving Treatment|35
7531312|NCT02702388|26165195|P1|Overall Study|Ongoing: Receiving Treatment|43
7531313|NCT02702388|26165194|P2|Overall Study|Withdrawal by Subject|4
7531314|NCT02702388|26165195|P1|Overall Study|Withdrawal by Subject|3
7531315|NCT02702388|26165194|P2|Overall Study|Death|12
7531316|NCT02702388|26165195|P1|Overall Study|Death|11
7531317|NCT02702193|26165217|P2|12 Month Follow up|Lost to Follow-up|18
7531318|NCT02702193|26165218|P1|12 Month Follow up|Lost to Follow-up|16
7531319|NCT02702193|26165217|P2|12 Month Follow up|Withdrawal by Subject|0
7531320|NCT02702193|26165218|P1|12 Month Follow up|Withdrawal by Subject|1
7531321|NCT02702193|26165217|P2|8 Month Follow up|Lost to Follow-up|18
7531322|NCT02702193|26165218|P1|8 Month Follow up|Lost to Follow-up|14
7531323|NCT02702193|26165217|P2|8 Month Follow up|Withdrawal by Subject|0
7531324|NCT02702193|26165218|P1|8 Month Follow up|Withdrawal by Subject|1
7531325|NCT02702193|26165217|P2|4 Month Follow up|Lost to Follow-up|18
7531326|NCT02702193|26165218|P1|4 Month Follow up|Lost to Follow-up|17
7531327|NCT02702193|26165217|P2|4 Month Follow up|Withdrawal by Subject|0
7531328|NCT02702193|26165218|P1|4 Month Follow up|Withdrawal by Subject|1
7531329|NCT02702193|26165217|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
7531330|NCT02702193|26165218|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
7531331|NCT02702011|26165246|P4|Overall Study|Withdrawal by Subject|0
7531332|NCT02702011|26165247|P3|Overall Study|Withdrawal by Subject|0
7531333|NCT02702011|26165248|P2|Overall Study|Withdrawal by Subject|1
7531334|NCT02702011|26165249|P1|Overall Study|Withdrawal by Subject|0
7531335|NCT02701985|26165261|P2|Overall Study|Adverse Event|5
7531336|NCT02701985|26165262|P1|Overall Study|Adverse Event|0
7531337|NCT02701985|26165261|P2|Overall Study|Death|0
7531338|NCT02701985|26165262|P1|Overall Study|Death|1
7531339|NCT02701985|26165261|P2|Overall Study|Lost to Follow-up|0
7531340|NCT02701985|26165262|P1|Overall Study|Lost to Follow-up|1
7531341|NCT02701985|26165261|P2|Overall Study|Withdrawal by Subject|1
7531342|NCT02701985|26165262|P1|Overall Study|Withdrawal by Subject|1
7531343|NCT02701777|26165321|P3|Overall Study|Some subjects were unable to commit to the training study.|4
7531344|NCT02701777|26165322|P2|Overall Study|Some subjects were unable to commit to the training study.|3
7531345|NCT02701777|26165323|P1|Overall Study|Some subjects were unable to commit to the training study.|0
7531346|NCT02701777|26165321|P3|Overall Study|Some subjects did not like the stimulation.|0
7531347|NCT02701777|26165322|P2|Overall Study|Some subjects did not like the stimulation.|0
7531348|NCT02701777|26165323|P1|Overall Study|Some subjects did not like the stimulation.|4
7531349|NCT02701764|26165339|P2|Overall Study|Lost to Follow-up|1
7531350|NCT02701764|26165340|P1|Overall Study|Lost to Follow-up|0
7531351|NCT02701634|26165399|P2|Overall Study|Randomized but not treated|0
7531352|NCT02701634|26165400|P1|Overall Study|Randomized but not treated|1
7531353|NCT02701634|26165399|P2|Overall Study|Withdrew Consent|7
7531354|NCT02701634|26165400|P1|Overall Study|Withdrew Consent|6
7531355|NCT02701634|26165399|P2|Overall Study|Study terminated by Sponsor|17
7531356|NCT02701634|26165400|P1|Overall Study|Study terminated by Sponsor|15
7531357|NCT02701634|26165399|P2|Overall Study|Investigator's Discretion|4
7531358|NCT02701634|26165400|P1|Overall Study|Investigator's Discretion|7
7531359|NCT02701634|26165399|P2|Overall Study|Death|0
7531360|NCT02701634|26165400|P1|Overall Study|Death|1
7531361|NCT02701634|26165399|P2|Overall Study|Adverse Event|3
7531362|NCT02701634|26165400|P1|Overall Study|Adverse Event|2
7531363|NCT02701413|26165464|P2|Overall Study|Withdrawal by Subject|11
7531364|NCT02701413|26165465|P1|Overall Study|Withdrawal by Subject|7
7531365|NCT02701361|26165503|P3|Overall Study|incarceration|1
7531366|NCT02701361|26165504|P2|Overall Study|incarceration|0
7531367|NCT02701361|26165505|P1|Overall Study|incarceration|0
7531368|NCT02701361|26165503|P3|Overall Study|timed out in rehab center|0
7531369|NCT02701361|26165504|P2|Overall Study|timed out in rehab center|1
7531370|NCT02701361|26165505|P1|Overall Study|timed out in rehab center|0
7531371|NCT02701361|26165503|P3|Overall Study|Withdrawal by Subject|0
7531372|NCT02701361|26165504|P2|Overall Study|Withdrawal by Subject|0
7531373|NCT02701361|26165505|P1|Overall Study|Withdrawal by Subject|4
7531374|NCT02701361|26165503|P3|Overall Study|Lost to Follow-up|1
7531375|NCT02701361|26165504|P2|Overall Study|Lost to Follow-up|2
7531376|NCT02701361|26165505|P1|Overall Study|Lost to Follow-up|5
7531377|NCT02701296|26165546|P2|Overall Study|Incomplete Data|2
7531378|NCT02701296|26165547|P1|Overall Study|Incomplete Data|0
7531389|NCT02701192|26165816|P1|Overall Study|Lost to Follow-up|4
7531390|NCT02701192|26165816|P1|Overall Study|Protocol Violation|2
7531391|NCT02700997|26165855|P1|Overall Study|No CT measurement - pelvic calcification|1
7531392|NCT02700997|26165855|P1|Overall Study|Did not undergo CT imaging|1
7531393|NCT02700984|26165861|P2|Overall Study|Reason not specified|2
7531394|NCT02700984|26165862|P1|Overall Study|Reason not specified|3
7531395|NCT02700984|26165861|P2|Overall Study|Withdrawal by Subject|9
7531396|NCT02700984|26165862|P1|Overall Study|Withdrawal by Subject|8
7531397|NCT02700984|26165861|P2|Overall Study|Physician Decision|1
7531398|NCT02700984|26165862|P1|Overall Study|Physician Decision|0
7531399|NCT02700984|26165861|P2|Overall Study|Lost to Follow-up|1
7531400|NCT02700984|26165862|P1|Overall Study|Lost to Follow-up|2
7531401|NCT02700984|26165861|P2|Overall Study|Death|1
7531402|NCT02700984|26165862|P1|Overall Study|Death|2
7531403|NCT02700919|26165914|P3|Overall Study|Other|1
7531404|NCT02700919|26165915|P2|Overall Study|Other|1
7531405|NCT02700919|26165916|P1|Overall Study|Other|2
7531406|NCT02700919|26165914|P3|Overall Study|Lost to Follow-up|0
7531407|NCT02700919|26165915|P2|Overall Study|Lost to Follow-up|0
7531408|NCT02700919|26165916|P1|Overall Study|Lost to Follow-up|2
7531409|NCT02700919|26165914|P3|Overall Study|Withdrawal by Subject|2
7531410|NCT02700919|26165915|P2|Overall Study|Withdrawal by Subject|8
7531411|NCT02700919|26165916|P1|Overall Study|Withdrawal by Subject|5
7531412|NCT02700919|26165914|P3|Overall Study|Adverse Event|1
7531413|NCT02700919|26165915|P2|Overall Study|Adverse Event|3
7531414|NCT02700919|26165916|P1|Overall Study|Adverse Event|1
7531415|NCT02700919|26165914|P3|Overall Study|Protocol Violation|0
7531416|NCT02700919|26165915|P2|Overall Study|Protocol Violation|0
7531417|NCT02700919|26165916|P1|Overall Study|Protocol Violation|1
7531418|NCT02700919|26165914|P3|Overall Study|Physician Decision|0
7531419|NCT02700919|26165915|P2|Overall Study|Physician Decision|0
7531420|NCT02700919|26165916|P1|Overall Study|Physician Decision|1
7531421|NCT02700815|26165978|P4|Overall Study|Withdrawal by Subject|0
7531422|NCT02700815|26165979|P3|Overall Study|Withdrawal by Subject|1
7531423|NCT02700815|26165980|P2|Overall Study|Withdrawal by Subject|0
7531424|NCT02700815|26165981|P1|Overall Study|Withdrawal by Subject|0
7531425|NCT02700815|26165978|P4|Overall Study|Refusal to continue medication|1
7531426|NCT02700815|26165979|P3|Overall Study|Refusal to continue medication|0
7531427|NCT02700815|26165980|P2|Overall Study|Refusal to continue medication|1
7531428|NCT02700815|26165981|P1|Overall Study|Refusal to continue medication|0
7531429|NCT02700815|26165978|P4|Overall Study|Lost to Follow-up|1
7531430|NCT02700815|26165979|P3|Overall Study|Lost to Follow-up|0
7531431|NCT02700815|26165980|P2|Overall Study|Lost to Follow-up|0
7531432|NCT02700815|26165981|P1|Overall Study|Lost to Follow-up|1
7531433|NCT02700815|26165978|P4|Overall Study|Lack of Efficacy|2
7531434|NCT02700815|26165979|P3|Overall Study|Lack of Efficacy|1
7531435|NCT02700815|26165980|P2|Overall Study|Lack of Efficacy|0
7531436|NCT02700815|26165981|P1|Overall Study|Lack of Efficacy|0
7531437|NCT02700815|26165978|P4|Overall Study|Adverse Event|3
7531438|NCT02700815|26165979|P3|Overall Study|Adverse Event|2
7531439|NCT02700815|26165980|P2|Overall Study|Adverse Event|6
7531440|NCT02700815|26165981|P1|Overall Study|Adverse Event|0
7531441|NCT02700412|26166040|P1|Overall Study|Withdrawal by Subject|2
7531442|NCT02700412|26166040|P1|Overall Study|Protocol Violation|5
7531443|NCT02700412|26166040|P1|Overall Study|Lack of Efficacy|19
7531444|NCT02700412|26166040|P1|Overall Study|Death|1
7531445|NCT02700412|26166040|P1|Overall Study|Adverse Event|6
7531446|NCT02699996|26166098|P2|Overall Study|Withdrawal by Subject|2
7531447|NCT02699996|26166099|P1|Overall Study|Withdrawal by Subject|5
7531448|NCT02699983|26166117|P2|Overall Study|Withdrawal by Subject|0
7531449|NCT02699983|26166118|P1|Overall Study|Withdrawal by Subject|1
7531450|NCT02699892|26166183|P1|Overall Study|Other|36
7531451|NCT02699866|26166188|P1|Overall Study|Adverse Event|3
7531452|NCT02699866|26166188|P1|Overall Study|Physician Decision|2
7531453|NCT02699866|26166188|P1|Overall Study|Withdrawal by Subject|3
7531454|NCT02699749|26166210|P14|Overall Study|Lost to Follow-up|0
7531455|NCT02699749|26166211|P13|Overall Study|Lost to Follow-up|0
7531456|NCT02699749|26166212|P12|Overall Study|Lost to Follow-up|0
7531457|NCT02699749|26166213|P11|Overall Study|Lost to Follow-up|0
7531458|NCT02699749|26166214|P10|Overall Study|Lost to Follow-up|0
7531459|NCT02699749|26166215|P9|Overall Study|Lost to Follow-up|0
7531460|NCT02699749|26166216|P8|Overall Study|Lost to Follow-up|1
7531461|NCT02699749|26166217|P7|Overall Study|Lost to Follow-up|0
7531462|NCT02699749|26166218|P6|Overall Study|Lost to Follow-up|1
7531463|NCT02699749|26166219|P5|Overall Study|Lost to Follow-up|0
7531464|NCT02699749|26166220|P4|Overall Study|Lost to Follow-up|0
7531465|NCT02699749|26166221|P3|Overall Study|Lost to Follow-up|0
7531466|NCT02699749|26166222|P2|Overall Study|Lost to Follow-up|0
7531467|NCT02699749|26166223|P1|Overall Study|Lost to Follow-up|0
7531468|NCT02699749|26166210|P14|Overall Study|Death|1
7531469|NCT02699749|26166211|P13|Overall Study|Death|0
7531470|NCT02699749|26166212|P12|Overall Study|Death|0
7531471|NCT02699749|26166213|P11|Overall Study|Death|0
7531472|NCT02699749|26166214|P10|Overall Study|Death|0
7531473|NCT02699749|26166215|P9|Overall Study|Death|0
7531474|NCT02699749|26166216|P8|Overall Study|Death|0
7531475|NCT02699749|26166217|P7|Overall Study|Death|0
7531476|NCT02699749|26166218|P6|Overall Study|Death|0
7531477|NCT02699749|26166219|P5|Overall Study|Death|0
7531478|NCT02699749|26166220|P4|Overall Study|Death|0
7531479|NCT02699749|26166221|P3|Overall Study|Death|0
7531480|NCT02699749|26166222|P2|Overall Study|Death|0
7531481|NCT02699749|26166223|P1|Overall Study|Death|0
7531482|NCT02699749|26166210|P14|Overall Study|Progressive Disease|5
7531483|NCT02699749|26166211|P13|Overall Study|Progressive Disease|3
7531484|NCT02699749|26166212|P12|Overall Study|Progressive Disease|4
7531485|NCT02699749|26166213|P11|Overall Study|Progressive Disease|5
7531486|NCT02699749|26166214|P10|Overall Study|Progressive Disease|6
7531487|NCT02699749|26166215|P9|Overall Study|Progressive Disease|6
7531488|NCT02699749|26166216|P8|Overall Study|Progressive Disease|5
7531489|NCT02699749|26166217|P7|Overall Study|Progressive Disease|5
7531490|NCT02699749|26166218|P6|Overall Study|Progressive Disease|7
7531491|NCT02699749|26166219|P5|Overall Study|Progressive Disease|3
7531492|NCT02699749|26166220|P4|Overall Study|Progressive Disease|3
7531493|NCT02699749|26166221|P3|Overall Study|Progressive Disease|14
7531494|NCT02699749|26166222|P2|Overall Study|Progressive Disease|3
7531495|NCT02699749|26166223|P1|Overall Study|Progressive Disease|3
7531496|NCT02699749|26166210|P14|Overall Study|Other|0
7531497|NCT02699749|26166211|P13|Overall Study|Other|0
7531498|NCT02699749|26166212|P12|Overall Study|Other|0
7531499|NCT02699749|26166213|P11|Overall Study|Other|1
7531500|NCT02699749|26166214|P10|Overall Study|Other|0
7531501|NCT02699749|26166215|P9|Overall Study|Other|0
7531502|NCT02699749|26166216|P8|Overall Study|Other|0
7531503|NCT02699749|26166217|P7|Overall Study|Other|1
7531504|NCT02699749|26166218|P6|Overall Study|Other|1
7531505|NCT02699749|26166219|P5|Overall Study|Other|0
7531506|NCT02699749|26166220|P4|Overall Study|Other|0
7531507|NCT02699749|26166221|P3|Overall Study|Other|2
7531508|NCT02699749|26166222|P2|Overall Study|Other|0
7531509|NCT02699749|26166223|P1|Overall Study|Other|0
7531510|NCT02699684|26166457|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
7531511|NCT02699684|26166458|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
7531512|NCT02699593|26166475|P2|Period 2|Torn Contact Lens|0
7531513|NCT02699593|26166476|P1|Period 2|Torn Contact Lens|1
7531514|NCT02699593|26166475|P2|Period 2|Lost Contact Lens|1
7531515|NCT02699593|26166476|P1|Period 2|Lost Contact Lens|0
7531516|NCT02699593|26166475|P2|Period 2|Adverse Event|1
7531517|NCT02699593|26166476|P1|Period 2|Adverse Event|1
7531518|NCT02699593|26166475|P2|Period 1|Adverse Event|1
7531519|NCT02699593|26166476|P1|Period 1|Adverse Event|1
7531520|NCT02699593|26166475|P2|Period 1|Withdrawal by Subject|1
7531521|NCT02699593|26166476|P1|Period 1|Withdrawal by Subject|0
7531522|NCT02699593|26166475|P2|Period 1|Protocol Violation|1
7531523|NCT02699593|26166476|P1|Period 1|Protocol Violation|0
7531524|NCT02699593|26166475|P2|Period 1|Torn Contact Len|3
7531525|NCT02699593|26166476|P1|Period 1|Torn Contact Len|4
7531526|NCT02699593|26166475|P2|Period 1|Unsatisfactory Visual Response|1
7531527|NCT02699593|26166476|P1|Period 1|Unsatisfactory Visual Response|0
7531528|NCT02699463|26166486|P2|Overall Study|Withdrawal by Subject|1
7531529|NCT02699463|26166487|P1|Overall Study|Withdrawal by Subject|4
7531530|NCT02699463|26166486|P2|Overall Study|Lost to Follow-up|8
7531531|NCT02699463|26166487|P1|Overall Study|Lost to Follow-up|11
7531532|NCT02699450|26166496|P3|Overall Study|Adverse Event|0
7531533|NCT02699450|26166497|P2|Overall Study|Adverse Event|0
7531534|NCT02699450|26166498|P1|Overall Study|Adverse Event|1
7531535|NCT02699450|26166496|P3|Overall Study|Withdrawal by Subject|2
7531536|NCT02699450|26166497|P2|Overall Study|Withdrawal by Subject|1
7531537|NCT02699450|26166498|P1|Overall Study|Withdrawal by Subject|3
7531538|NCT02699450|26166496|P3|Overall Study|Physician Decision|0
7531539|NCT02699450|26166497|P2|Overall Study|Physician Decision|0
7531540|NCT02699450|26166498|P1|Overall Study|Physician Decision|2
7531541|NCT02699450|26166496|P3|Overall Study|Lost to Follow-up|5
7531542|NCT02699450|26166497|P2|Overall Study|Lost to Follow-up|0
7531543|NCT02699450|26166498|P1|Overall Study|Lost to Follow-up|3
7531544|NCT02699450|26166496|P3|Overall Study|Protocol Violation|5
7531545|NCT02699450|26166497|P2|Overall Study|Protocol Violation|3
7531546|NCT02699450|26166498|P1|Overall Study|Protocol Violation|4
7531547|NCT02699450|26166496|P3|Overall Study|Met Criteria for Study Exit|1
7531548|NCT02699450|26166497|P2|Overall Study|Met Criteria for Study Exit|0
7531549|NCT02699450|26166498|P1|Overall Study|Met Criteria for Study Exit|0
7531550|NCT02699450|26166496|P3|Overall Study|Death|2
7531551|NCT02699450|26166497|P2|Overall Study|Death|1
7531552|NCT02699450|26166498|P1|Overall Study|Death|2
7531553|NCT02699125|26166633|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7531554|NCT02699125|26166634|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|7
7531555|NCT02699125|26166633|P2|Placebo|Withdrawal by Subject|4
7531556|NCT02699125|26166634|P1|Placebo|Withdrawal by Subject|0
7531557|NCT02699125|26166633|P2|Placebo|Protocol Violation|0
7531558|NCT02699125|26166634|P1|Placebo|Protocol Violation|1
7531559|NCT02699125|26166633|P2|Placebo|Lost to Follow-up|0
7531560|NCT02699125|26166634|P1|Placebo|Lost to Follow-up|2
7531561|NCT02699099|26166648|P3|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
7531562|NCT02699099|26166649|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7531563|NCT02699099|26166650|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
7531564|NCT02699099|26166648|P3|Overall Study|Lost to Follow-up|0
7531565|NCT02699099|26166649|P2|Overall Study|Lost to Follow-up|1
7531566|NCT02699099|26166650|P1|Overall Study|Lost to Follow-up|0
7531567|NCT02699099|26166648|P3|Overall Study|Adverse Event|2
7531568|NCT02699099|26166649|P2|Overall Study|Adverse Event|0
7531569|NCT02699099|26166650|P1|Overall Study|Adverse Event|1
7531570|NCT02698865|26166743|P2|Overall Study|Lost to Follow-up|2
7531571|NCT02698865|26166744|P1|Overall Study|Lost to Follow-up|4
7531572|NCT02698865|26166743|P2|Overall Study|Physician Decision|4
7531573|NCT02698865|26166744|P1|Overall Study|Physician Decision|0
7531574|NCT02698865|26166743|P2|Overall Study|Withdrawal by Subject|16
7531575|NCT02698865|26166744|P1|Overall Study|Withdrawal by Subject|20
7531576|NCT02698865|26166743|P2|Overall Study|Other|11
7531577|NCT02698865|26166744|P1|Overall Study|Other|11
7531578|NCT02698787|26166763|P2|Second Intervention (3 Months)|Withdrawal by Subject|1
7531579|NCT02698787|26166764|P1|Second Intervention (3 Months)|Withdrawal by Subject|0
7531580|NCT02698475|26166794|P1|Overall Study|Protocol Violation|1
7531581|NCT02698475|26166794|P1|Overall Study|Withdrawal by Subject|3
7531582|NCT02698475|26166794|P1|Overall Study|Lack of Efficacy|1
7531583|NCT02698436|26166811|P2|Overall Study|Non-compliance with study regimen|0
7531584|NCT02698436|26166812|P1|Overall Study|Non-compliance with study regimen|1
7531585|NCT02698436|26166811|P2|Overall Study|Lost to Follow-up|4
7531586|NCT02698436|26166812|P1|Overall Study|Lost to Follow-up|2
7531587|NCT02698436|26166811|P2|Overall Study|Withdrawal by Subject|3
7531588|NCT02698436|26166812|P1|Overall Study|Withdrawal by Subject|3
7531589|NCT02698436|26166811|P2|Overall Study|Adverse Event|0
7531590|NCT02698436|26166812|P1|Overall Study|Adverse Event|1
7531591|NCT02698423|26166852|P2|Overall Study|Lost to Follow-up|24
7531592|NCT02698423|26166853|P1|Overall Study|Lost to Follow-up|19
7531593|NCT02698410|26166861|P1|Overall Study|Other|1
7531594|NCT02698410|26166861|P1|Overall Study|Withdrawal by Subject|1
7531595|NCT02698410|26166861|P1|Overall Study|Adverse Event|2
7531596|NCT02698371|26166880|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
7531597|NCT02698371|26166880|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
7531598|NCT02698371|26166880|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
7531599|NCT02698371|26166880|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
7531600|NCT02698371|26166880|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
7531601|NCT02698371|26166880|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
7531602|NCT02698371|26166880|P1|All Participants Flow|Lost to Follow-up|3
7531603|NCT02698241|26167002|P1|Overall Study|Death|2
7531604|NCT02698241|26167002|P1|Overall Study|geographic and licensing issue|1
7531605|NCT02698241|26167002|P1|Overall Study|Subject on inodrip not safe to continue|6
7531606|NCT02698241|26167002|P1|Overall Study|Lost to Follow-up|3
7531607|NCT02698241|26167002|P1|Overall Study|Subject underwent system modification|2
7531608|NCT02698241|26167002|P1|Overall Study|Physician Decision|2
7531609|NCT02698241|26167002|P1|Overall Study|Withdrawal by Subject|7
7531610|NCT02698241|26167002|P1|Overall Study|Screening not met|7
7531611|NCT02698241|26167002|P1|Overall Study|Inclusion/exclusion criteria not met|4
7531616|NCT02698176|26167051|P4|Overall Study|Clinical progression|0
7531617|NCT02698176|26167052|P3|Overall Study|Clinical progression|0
7531618|NCT02698176|26167053|P2|Overall Study|Clinical progression|0
7531619|NCT02698176|26167054|P1|Overall Study|Clinical progression|3
7531620|NCT02698176|26167051|P4|Overall Study|Adverse Event|0
7531621|NCT02698176|26167052|P3|Overall Study|Adverse Event|0
7531622|NCT02698176|26167053|P2|Overall Study|Adverse Event|0
7531623|NCT02698176|26167054|P1|Overall Study|Adverse Event|2
7531624|NCT02698176|26167051|P4|Overall Study|Progressive disease|0
7531625|NCT02698176|26167052|P3|Overall Study|Progressive disease|1
7531626|NCT02698176|26167053|P2|Overall Study|Progressive disease|3
7531627|NCT02698176|26167054|P1|Overall Study|Progressive disease|4
7531628|NCT02697916|26167095|P2|Overall Study|Withdrawal by Subject|393
7531629|NCT02697916|26167096|P1|Overall Study|Withdrawal by Subject|221
7531630|NCT02697916|26167095|P2|Overall Study|Death|315
7531631|NCT02697916|26167096|P1|Overall Study|Death|357
7531632|NCT02697773|26167132|P3|Overall Study|Randomized but not treated|0
7531633|NCT02697773|26167133|P2|Overall Study|Randomized but not treated|1
7531634|NCT02697773|26167134|P1|Overall Study|Randomized but not treated|1
7531635|NCT02697773|26167132|P3|Overall Study|Withdrawal by Subject|13
7531636|NCT02697773|26167133|P2|Overall Study|Withdrawal by Subject|13
7531637|NCT02697773|26167134|P1|Overall Study|Withdrawal by Subject|10
7531638|NCT02697773|26167132|P3|Overall Study|Protocol Violation|0
7531639|NCT02697773|26167133|P2|Overall Study|Protocol Violation|1
7531640|NCT02697773|26167134|P1|Overall Study|Protocol Violation|1
7531641|NCT02697773|26167132|P3|Overall Study|Other|10
7531642|NCT02697773|26167133|P2|Overall Study|Other|11
7531643|NCT02697773|26167134|P1|Overall Study|Other|15
7531644|NCT02697773|26167132|P3|Overall Study|Lost to Follow-up|7
7531645|NCT02697773|26167133|P2|Overall Study|Lost to Follow-up|5
7531646|NCT02697773|26167134|P1|Overall Study|Lost to Follow-up|5
7531647|NCT02697773|26167132|P3|Overall Study|Lack of Efficacy|6
7531648|NCT02697773|26167133|P2|Overall Study|Lack of Efficacy|6
7531649|NCT02697773|26167134|P1|Overall Study|Lack of Efficacy|4
7531650|NCT02697773|26167132|P3|Overall Study|Death|2
7531651|NCT02697773|26167133|P2|Overall Study|Death|0
7531652|NCT02697773|26167134|P1|Overall Study|Death|0
7531653|NCT02697773|26167132|P3|Overall Study|Adverse Event|2
7531654|NCT02697773|26167133|P2|Overall Study|Adverse Event|1
7531655|NCT02697773|26167134|P1|Overall Study|Adverse Event|2
7531656|NCT02697617|26167313|P2|Overall Study|Pregnancy|0
7531657|NCT02697617|26167314|P1|Overall Study|Pregnancy|1
7531658|NCT02697617|26167313|P2|Overall Study|Withdrawal by Subject|2
7531659|NCT02697617|26167314|P1|Overall Study|Withdrawal by Subject|0
7531660|NCT02697591|26167342|P10|Overall Study|Reason not Specified|3
7531661|NCT02697591|26167343|P9|Overall Study|Reason not Specified|1
7531662|NCT02697591|26167344|P8|Overall Study|Reason not Specified|1
7531663|NCT02697591|26167345|P7|Overall Study|Reason not Specified|3
7531664|NCT02697591|26167346|P6|Overall Study|Reason not Specified|2
7531665|NCT02697591|26167347|P5|Overall Study|Reason not Specified|1
7531666|NCT02697591|26167348|P4|Overall Study|Reason not Specified|1
7531667|NCT02697591|26167349|P3|Overall Study|Reason not Specified|0
7531668|NCT02697591|26167350|P2|Overall Study|Reason not Specified|0
7531669|NCT02697591|26167351|P1|Overall Study|Reason not Specified|0
7531670|NCT02697591|26167342|P10|Overall Study|Death|5
7531671|NCT02697591|26167343|P9|Overall Study|Death|1
7531672|NCT02697591|26167344|P8|Overall Study|Death|1
7531673|NCT02697591|26167345|P7|Overall Study|Death|3
7531674|NCT02697591|26167346|P6|Overall Study|Death|5
7531675|NCT02697591|26167347|P5|Overall Study|Death|4
7531676|NCT02697591|26167348|P4|Overall Study|Death|1
7531677|NCT02697591|26167349|P3|Overall Study|Death|1
7531678|NCT02697591|26167350|P2|Overall Study|Death|3
7531679|NCT02697591|26167351|P1|Overall Study|Death|2
7531680|NCT02697591|26167342|P10|Overall Study|Physician Decision|1
7531681|NCT02697591|26167343|P9|Overall Study|Physician Decision|1
7531682|NCT02697591|26167344|P8|Overall Study|Physician Decision|0
7531683|NCT02697591|26167345|P7|Overall Study|Physician Decision|0
7531684|NCT02697591|26167346|P6|Overall Study|Physician Decision|2
7531685|NCT02697591|26167347|P5|Overall Study|Physician Decision|1
7531686|NCT02697591|26167348|P4|Overall Study|Physician Decision|0
7531687|NCT02697591|26167349|P3|Overall Study|Physician Decision|0
7531688|NCT02697591|26167350|P2|Overall Study|Physician Decision|0
7531689|NCT02697591|26167351|P1|Overall Study|Physician Decision|1
7531690|NCT02697591|26167342|P10|Overall Study|Withdrawal by Subject|10
7531691|NCT02697591|26167343|P9|Overall Study|Withdrawal by Subject|6
7531692|NCT02697591|26167344|P8|Overall Study|Withdrawal by Subject|1
7531693|NCT02697591|26167345|P7|Overall Study|Withdrawal by Subject|9
7531694|NCT02697591|26167346|P6|Overall Study|Withdrawal by Subject|6
7531695|NCT02697591|26167347|P5|Overall Study|Withdrawal by Subject|7
7531696|NCT02697591|26167348|P4|Overall Study|Withdrawal by Subject|1
7531697|NCT02697591|26167349|P3|Overall Study|Withdrawal by Subject|2
7531698|NCT02697591|26167350|P2|Overall Study|Withdrawal by Subject|1
7531699|NCT02697591|26167351|P1|Overall Study|Withdrawal by Subject|1
7531700|NCT02697591|26167342|P10|Overall Study|Lost to Follow-up|1
7531701|NCT02697591|26167343|P9|Overall Study|Lost to Follow-up|0
7531702|NCT02697591|26167344|P8|Overall Study|Lost to Follow-up|0
7531703|NCT02697591|26167345|P7|Overall Study|Lost to Follow-up|1
7531704|NCT02697591|26167346|P6|Overall Study|Lost to Follow-up|1
7531705|NCT02697591|26167347|P5|Overall Study|Lost to Follow-up|0
7531706|NCT02697591|26167348|P4|Overall Study|Lost to Follow-up|0
7531707|NCT02697591|26167349|P3|Overall Study|Lost to Follow-up|0
7531708|NCT02697591|26167350|P2|Overall Study|Lost to Follow-up|0
7531709|NCT02697591|26167351|P1|Overall Study|Lost to Follow-up|0
7531710|NCT02697435|26167456|P2|Overall Study|Physician Decision|4
7531711|NCT02697435|26167457|P1|Overall Study|Physician Decision|0
7531712|NCT02697435|26167456|P2|Overall Study|Withdrawal by Subject|0
7531713|NCT02697435|26167457|P1|Overall Study|Withdrawal by Subject|1
7531714|NCT02696902|26167579|P3|Overall Study|Transferred to other hospital|0
7531715|NCT02696902|26167580|P2|Overall Study|Transferred to other hospital|0
7531716|NCT02696902|26167581|P1|Overall Study|Transferred to other hospital|1
7531717|NCT02696902|26167579|P3|Overall Study|Sponsor's decision|0
7531718|NCT02696902|26167580|P2|Overall Study|Sponsor's decision|0
7531719|NCT02696902|26167581|P1|Overall Study|Sponsor's decision|1
7531720|NCT02696902|26167579|P3|Overall Study|Principal investigator's decision|0
7531721|NCT02696902|26167580|P2|Overall Study|Principal investigator's decision|0
7531722|NCT02696902|26167581|P1|Overall Study|Principal investigator's decision|1
7531723|NCT02696902|26167579|P3|Overall Study|Participant not eligible (negative PCR)|1
7531724|NCT02696902|26167580|P2|Overall Study|Participant not eligible (negative PCR)|0
7531725|NCT02696902|26167581|P1|Overall Study|Participant not eligible (negative PCR)|0
7531726|NCT02696902|26167579|P3|Overall Study|Participant not fit post-randomization|1
7531727|NCT02696902|26167580|P2|Overall Study|Participant not fit post-randomization|0
7531728|NCT02696902|26167581|P1|Overall Study|Participant not fit post-randomization|0
7531729|NCT02696902|26167579|P3|Overall Study|Death|24
7531730|NCT02696902|26167580|P2|Overall Study|Death|3
7531731|NCT02696902|26167581|P1|Overall Study|Death|19
7531732|NCT02696902|26167579|P3|Overall Study|Withdrawal by Subject|1
7531733|NCT02696902|26167580|P2|Overall Study|Withdrawal by Subject|0
7531734|NCT02696902|26167581|P1|Overall Study|Withdrawal by Subject|0
7531735|NCT02696902|26167579|P3|Overall Study|Lost to Follow-up|1
7531736|NCT02696902|26167580|P2|Overall Study|Lost to Follow-up|1
7531737|NCT02696902|26167581|P1|Overall Study|Lost to Follow-up|0
7531738|NCT02696850|26167613|P2|Overall Study|Lost to Follow-up|5
7531739|NCT02696850|26167614|P1|Overall Study|Lost to Follow-up|8
7531740|NCT02696850|26167613|P2|Overall Study|Withdrawal by Subject|3
7531741|NCT02696850|26167614|P1|Overall Study|Withdrawal by Subject|3
7531742|NCT02696798|26167627|P3|Post-treatment Follow-up Period|No progressive improvement|0
7531743|NCT02696798|26167628|P2|Post-treatment Follow-up Period|No progressive improvement|1
7531744|NCT02696798|26167629|P1|Post-treatment Follow-up Period|No progressive improvement|0
7531745|NCT02696798|26167627|P3|Post-treatment Follow-up Period|Physician Decision|0
7531746|NCT02696798|26167628|P2|Post-treatment Follow-up Period|Physician Decision|2
7531747|NCT02696798|26167629|P1|Post-treatment Follow-up Period|Physician Decision|0
7531748|NCT02696798|26167627|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
7531749|NCT02696798|26167628|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
7531830|NCT02696785|26167727|P3|Blinded Treatment Period|Screen Failure|0
7531750|NCT02696798|26167629|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
7531751|NCT02696798|26167627|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
7531752|NCT02696798|26167628|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
7531753|NCT02696798|26167629|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
7531754|NCT02696798|26167627|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
7531755|NCT02696798|26167628|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
7531756|NCT02696798|26167629|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
7531757|NCT02696798|26167627|P3|Post-treatment Follow-up Period|Adverse Event|6
7531758|NCT02696798|26167628|P2|Post-treatment Follow-up Period|Adverse Event|12
7531759|NCT02696798|26167629|P1|Post-treatment Follow-up Period|Adverse Event|2
7531760|NCT02696798|26167627|P3|Extended Treatment Period|Withdrawal by Subject|3
7531761|NCT02696798|26167628|P2|Extended Treatment Period|Withdrawal by Subject|2
7531762|NCT02696798|26167629|P1|Extended Treatment Period|Withdrawal by Subject|3
7531763|NCT02696798|26167627|P3|Extended Treatment Period|Physician Decision|0
7531764|NCT02696798|26167628|P2|Extended Treatment Period|Physician Decision|1
7531765|NCT02696798|26167629|P1|Extended Treatment Period|Physician Decision|0
7531766|NCT02696798|26167627|P3|Extended Treatment Period|Lost to Follow-up|0
7531767|NCT02696798|26167628|P2|Extended Treatment Period|Lost to Follow-up|0
7531768|NCT02696798|26167629|P1|Extended Treatment Period|Lost to Follow-up|1
7531769|NCT02696798|26167627|P3|Extended Treatment Period|Lack of Efficacy|2
7531770|NCT02696798|26167628|P2|Extended Treatment Period|Lack of Efficacy|2
7531771|NCT02696798|26167629|P1|Extended Treatment Period|Lack of Efficacy|7
7531772|NCT02696798|26167627|P3|Extended Treatment Period|Adverse Event|5
7531773|NCT02696798|26167628|P2|Extended Treatment Period|Adverse Event|4
7531774|NCT02696798|26167629|P1|Extended Treatment Period|Adverse Event|1
7531775|NCT02696798|26167627|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
7531776|NCT02696798|26167628|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
7531777|NCT02696798|26167629|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
7531778|NCT02696798|26167627|P3|Blinded Treatment Dosing Period|Physician Decision|0
7531779|NCT02696798|26167628|P2|Blinded Treatment Dosing Period|Physician Decision|1
7531780|NCT02696798|26167629|P1|Blinded Treatment Dosing Period|Physician Decision|0
7531781|NCT02696798|26167627|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
7531782|NCT02696798|26167628|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
7531783|NCT02696798|26167629|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
7531784|NCT02696798|26167627|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
7531785|NCT02696798|26167628|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
7531786|NCT02696798|26167629|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
7531787|NCT02696798|26167627|P3|Blinded Treatment Dosing Period|Death|1
7531788|NCT02696798|26167628|P2|Blinded Treatment Dosing Period|Death|0
7531789|NCT02696798|26167629|P1|Blinded Treatment Dosing Period|Death|0
7531790|NCT02696798|26167627|P3|Blinded Treatment Dosing Period|Adverse Event|2
7531791|NCT02696798|26167628|P2|Blinded Treatment Dosing Period|Adverse Event|9
7531792|NCT02696798|26167629|P1|Blinded Treatment Dosing Period|Adverse Event|2
7531793|NCT02696785|26167726|P4|Follow-up Period|Withdrawal by Subject|4
7531794|NCT02696785|26167727|P3|Follow-up Period|Withdrawal by Subject|5
7531795|NCT02696785|26167728|P2|Follow-up Period|Withdrawal by Subject|0
7531796|NCT02696785|26167729|P1|Follow-up Period|Withdrawal by Subject|1
7531797|NCT02696785|26167726|P4|Follow-up Period|Lack of Efficacy|1
7531798|NCT02696785|26167727|P3|Follow-up Period|Lack of Efficacy|0
7531799|NCT02696785|26167728|P2|Follow-up Period|Lack of Efficacy|0
7531800|NCT02696785|26167729|P1|Follow-up Period|Lack of Efficacy|0
7531801|NCT02696785|26167726|P4|Follow-up Period|Lost to Follow-up|1
7531802|NCT02696785|26167727|P3|Follow-up Period|Lost to Follow-up|0
7531803|NCT02696785|26167728|P2|Follow-up Period|Lost to Follow-up|0
7531804|NCT02696785|26167729|P1|Follow-up Period|Lost to Follow-up|0
7531805|NCT02696785|26167726|P4|Follow-up Period|Adverse Event|2
7531806|NCT02696785|26167727|P3|Follow-up Period|Adverse Event|8
7531807|NCT02696785|26167728|P2|Follow-up Period|Adverse Event|0
7531808|NCT02696785|26167729|P1|Follow-up Period|Adverse Event|0
7531809|NCT02696785|26167726|P4|Extended Treatment Period|Withdrawal by Subject|5
7531810|NCT02696785|26167727|P3|Extended Treatment Period|Withdrawal by Subject|3
7531811|NCT02696785|26167728|P2|Extended Treatment Period|Withdrawal by Subject|2
7531812|NCT02696785|26167729|P1|Extended Treatment Period|Withdrawal by Subject|1
7531813|NCT02696785|26167726|P4|Extended Treatment Period|Lack of Efficacy|0
7531814|NCT02696785|26167727|P3|Extended Treatment Period|Lack of Efficacy|0
7531815|NCT02696785|26167728|P2|Extended Treatment Period|Lack of Efficacy|1
7531816|NCT02696785|26167729|P1|Extended Treatment Period|Lack of Efficacy|0
7531817|NCT02696785|26167726|P4|Extended Treatment Period|Adverse Event|1
7531818|NCT02696785|26167727|P3|Extended Treatment Period|Adverse Event|2
7531819|NCT02696785|26167728|P2|Extended Treatment Period|Adverse Event|3
7531820|NCT02696785|26167729|P1|Extended Treatment Period|Adverse Event|2
7531821|NCT02696785|26167726|P4|Washout Period|Lack of Efficacy|0
7531822|NCT02696785|26167727|P3|Washout Period|Lack of Efficacy|0
7531823|NCT02696785|26167728|P2|Washout Period|Lack of Efficacy|1
7531824|NCT02696785|26167729|P1|Washout Period|Lack of Efficacy|0
7531825|NCT02696785|26167726|P4|Washout Period|Withdrawal by Subject|0
7531826|NCT02696785|26167727|P3|Washout Period|Withdrawal by Subject|0
7531827|NCT02696785|26167728|P2|Washout Period|Withdrawal by Subject|1
7531828|NCT02696785|26167729|P1|Washout Period|Withdrawal by Subject|0
7531829|NCT02696785|26167726|P4|Blinded Treatment Period|Screen Failure|0
7531831|NCT02696785|26167728|P2|Blinded Treatment Period|Screen Failure|0
7531832|NCT02696785|26167729|P1|Blinded Treatment Period|Screen Failure|1
7531833|NCT02696785|26167726|P4|Blinded Treatment Period|Lack of Efficacy|1
7531834|NCT02696785|26167727|P3|Blinded Treatment Period|Lack of Efficacy|0
7531835|NCT02696785|26167728|P2|Blinded Treatment Period|Lack of Efficacy|0
7531836|NCT02696785|26167729|P1|Blinded Treatment Period|Lack of Efficacy|0
7531837|NCT02696785|26167726|P4|Blinded Treatment Period|Withdrawal by Subject|2
7531838|NCT02696785|26167727|P3|Blinded Treatment Period|Withdrawal by Subject|1
7531839|NCT02696785|26167728|P2|Blinded Treatment Period|Withdrawal by Subject|1
7531840|NCT02696785|26167729|P1|Blinded Treatment Period|Withdrawal by Subject|0
7531841|NCT02696785|26167726|P4|Blinded Treatment Period|Adverse Event|0
7531842|NCT02696785|26167727|P3|Blinded Treatment Period|Adverse Event|3
7531843|NCT02696785|26167728|P2|Blinded Treatment Period|Adverse Event|1
7531844|NCT02696785|26167729|P1|Blinded Treatment Period|Adverse Event|0
7531845|NCT02696434|26167853|P2|Overall Study|Physician Decision|1
7531846|NCT02696434|26167854|P1|Overall Study|Physician Decision|0
7531847|NCT02696434|26167853|P2|Overall Study|Withdrawal by Subject|12
7531848|NCT02696434|26167854|P1|Overall Study|Withdrawal by Subject|14
7531849|NCT02696434|26167853|P2|Overall Study|Lost to Follow-up|4
7531850|NCT02696434|26167854|P1|Overall Study|Lost to Follow-up|5
7531851|NCT02696434|26167853|P2|Overall Study|Adverse Event|1
7531852|NCT02696434|26167854|P1|Overall Study|Adverse Event|3
7531853|NCT02696317|26167872|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
7531854|NCT02696317|26167873|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
7531855|NCT02696317|26167872|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
7531856|NCT02696317|26167873|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
7531857|NCT02696226|26167917|P4|Overall Study|Study terminated - lack of enrollment|0
7531858|NCT02696226|26167918|P3|Overall Study|Study terminated - lack of enrollment|2
7531859|NCT02696226|26167919|P2|Overall Study|Study terminated - lack of enrollment|0
7531860|NCT02696226|26167920|P1|Overall Study|Study terminated - lack of enrollment|1
7531900|NCT02695719|26167980|P2|Overall Study|Voluntary Withdrawal|0
7531901|NCT02695719|26167981|P1|Overall Study|Voluntary Withdrawal|1
7531902|NCT02695719|26167980|P2|Overall Study|Significant Protocol Deviation|1
7531903|NCT02695719|26167981|P1|Overall Study|Significant Protocol Deviation|0
7531904|NCT02695719|26167980|P2|Overall Study|Pretreatment Event/Adverse Event|9
7531905|NCT02695719|26167981|P1|Overall Study|Pretreatment Event/Adverse Event|2
7531906|NCT02695628|26167999|P1|Overall Study|Withdrawal by Subject|1
7531907|NCT02695537|26168005|P1|Overall Study|Protocol Violation|3
7531908|NCT02695537|26168005|P1|Overall Study|Withdrawal by Subject|4
7531909|NCT02695537|26168005|P1|Overall Study|Lack of Efficacy|28
7531910|NCT02695537|26168005|P1|Overall Study|Adverse Event|3
7531911|NCT02695524|26168015|P2|Overall Study|Death|1
7531912|NCT02695524|26168016|P1|Overall Study|Death|0
7531913|NCT02695524|26168015|P2|Overall Study|Lost to Follow-up|2
7531914|NCT02695524|26168016|P1|Overall Study|Lost to Follow-up|3
7531915|NCT02695420|26168045|P4|Overall Study|Death|0
7531916|NCT02695420|26168046|P3|Overall Study|Death|0
7531917|NCT02695420|26168047|P2|Overall Study|Death|1
7531918|NCT02695420|26168048|P1|Overall Study|Death|0
7531919|NCT02695329|26168070|P2|Overall Study|Poor X-ray quality for measurement|5
7531920|NCT02695329|26168071|P1|Overall Study|Poor X-ray quality for measurement|4
7531921|NCT02695329|26168070|P2|Overall Study|Adverse Event|0
7531922|NCT02695329|26168071|P1|Overall Study|Adverse Event|1
7531923|NCT02694978|26168091|P2|Overall Study|Other-Withdrew prior to dosing|8
7531924|NCT02694978|26168092|P1|Overall Study|Other-Withdrew prior to dosing|9
7531925|NCT02694978|26168091|P2|Overall Study|Other-Personal reasons|3
7531926|NCT02694978|26168092|P1|Overall Study|Other-Personal reasons|3
7531927|NCT02694978|26168091|P2|Overall Study|Other-Protocol noncompliant|1
7531928|NCT02694978|26168092|P1|Overall Study|Other-Protocol noncompliant|2
7531929|NCT02694978|26168091|P2|Overall Study|Other-Unable to be reached|1
7531930|NCT02694978|26168092|P1|Overall Study|Other-Unable to be reached|0
7531931|NCT02694978|26168091|P2|Overall Study|Other-Investigator's decision|0
7531932|NCT02694978|26168092|P1|Overall Study|Other-Investigator's decision|1
7531933|NCT02694978|26168091|P2|Overall Study|Other-Decision of Participant|1
7531934|NCT02694978|26168092|P1|Overall Study|Other-Decision of Participant|6
7531935|NCT02694978|26168091|P2|Overall Study|Death|1
7531936|NCT02694978|26168092|P1|Overall Study|Death|4
7531937|NCT02694978|26168091|P2|Overall Study|Lost to Follow-up|17
7531938|NCT02694978|26168092|P1|Overall Study|Lost to Follow-up|14
7531939|NCT02694978|26168091|P2|Overall Study|Withdrawal by Subject|19
7531940|NCT02694978|26168092|P1|Overall Study|Withdrawal by Subject|22
7531941|NCT02694978|26168091|P2|Overall Study|Adverse Event|9
7531942|NCT02694978|26168092|P1|Overall Study|Adverse Event|10
7531943|NCT02694757|26168113|P1|Overall Study|Lack of Efficacy|3
7531944|NCT02694744|26168119|P2|Overall Study|Taking potassium supplement: exclusion 6|1
7531945|NCT02694744|26168120|P1|Overall Study|Taking potassium supplement: exclusion 6|0
7531946|NCT02694744|26168119|P2|Overall Study|Lost to Follow-up|0
7531947|NCT02694744|26168120|P1|Overall Study|Lost to Follow-up|1
7531948|NCT02694744|26168119|P2|Overall Study|Physician Decision|2
7531949|NCT02694744|26168120|P1|Overall Study|Physician Decision|1
7531950|NCT02694744|26168119|P2|Overall Study|Withdrawal by Subject|1
7531951|NCT02694744|26168120|P1|Overall Study|Withdrawal by Subject|2
7531952|NCT02694744|26168119|P2|Overall Study|Adverse Event|1
7531953|NCT02694744|26168120|P1|Overall Study|Adverse Event|2
7531954|NCT02694718|26168128|P1|Overall Study|Withdrawal by Subject|1
7531955|NCT02694718|26168128|P1|Overall Study|Death|1
7531956|NCT02694562|26168146|P1|Overall Study|Physician Decision|1
7531957|NCT02694562|26168146|P1|Overall Study|Screen Failure|2
7531958|NCT02694562|26168146|P1|Overall Study|Lost to Follow-up|3
7531959|NCT02694562|26168146|P1|Overall Study|Protocol Violation|4
7531960|NCT02694562|26168146|P1|Overall Study|Death|8
7531961|NCT02694549|26168155|P1|Overall Study|screen failures|2
7531962|NCT02694536|26168161|P1|Overall Study|Other|22
7531963|NCT02694536|26168161|P1|Overall Study|Death|8
7531964|NCT02694536|26168161|P1|Overall Study|Withdrawal by Subject|8
7531965|NCT02694536|26168161|P1|Overall Study|Study Drug-Related Adverse Event|1
7531966|NCT02694536|26168161|P1|Overall Study|Lost to Follow-up|1
7531967|NCT02694536|26168161|P1|Overall Study|Progressive Disease|40
7531968|NCT02694523|26168172|P7|Part B|Other|1
7531969|NCT02694523|26168173|P6|Part B|Other|0
7531970|NCT02694523|26168174|P5|Part B|Other|0
7531971|NCT02694523|26168175|P4|Part B|Other|0
7531972|NCT02694523|26168176|P3|Part B|Other|1
7531973|NCT02694523|26168177|P2|Part B|Other|0
7531974|NCT02694523|26168178|P1|Part B|Other|0
7531975|NCT02694523|26168172|P7|Part B|Withdrawal by Subject|0
7531976|NCT02694523|26168173|P6|Part B|Withdrawal by Subject|3
7531977|NCT02694523|26168174|P5|Part B|Withdrawal by Subject|1
7531978|NCT02694523|26168175|P4|Part B|Withdrawal by Subject|0
7531979|NCT02694523|26168176|P3|Part B|Withdrawal by Subject|9
7531980|NCT02694523|26168177|P2|Part B|Withdrawal by Subject|0
7531981|NCT02694523|26168178|P1|Part B|Withdrawal by Subject|0
7531982|NCT02694523|26168172|P7|Part B|Lost to Follow-up|1
7531983|NCT02694523|26168173|P6|Part B|Lost to Follow-up|0
7531984|NCT02694523|26168174|P5|Part B|Lost to Follow-up|2
7531985|NCT02694523|26168175|P4|Part B|Lost to Follow-up|3
7531986|NCT02694523|26168176|P3|Part B|Lost to Follow-up|2
7531987|NCT02694523|26168177|P2|Part B|Lost to Follow-up|0
7531988|NCT02694523|26168178|P1|Part B|Lost to Follow-up|0
7531989|NCT02694523|26168172|P7|Part B|Protocol Violation|0
7531990|NCT02694523|26168173|P6|Part B|Protocol Violation|0
7531991|NCT02694523|26168174|P5|Part B|Protocol Violation|0
7531992|NCT02694523|26168175|P4|Part B|Protocol Violation|0
7531993|NCT02694523|26168176|P3|Part B|Protocol Violation|1
7531994|NCT02694523|26168177|P2|Part B|Protocol Violation|0
7531995|NCT02694523|26168178|P1|Part B|Protocol Violation|0
7531996|NCT02694523|26168172|P7|Part B|Adverse Event|0
7531997|NCT02694523|26168173|P6|Part B|Adverse Event|2
7531998|NCT02694523|26168174|P5|Part B|Adverse Event|1
7531999|NCT02694523|26168175|P4|Part B|Adverse Event|1
7532000|NCT02694523|26168176|P3|Part B|Adverse Event|7
7532001|NCT02694523|26168177|P2|Part B|Adverse Event|0
7532002|NCT02694523|26168178|P1|Part B|Adverse Event|0
7532003|NCT02694523|26168172|P7|Part A|Other|0
7532004|NCT02694523|26168173|P6|Part A|Other|0
7532005|NCT02694523|26168174|P5|Part A|Other|0
7532006|NCT02694523|26168175|P4|Part A|Other|0
7532007|NCT02694523|26168176|P3|Part A|Other|0
7532008|NCT02694523|26168177|P2|Part A|Other|1
7532009|NCT02694523|26168178|P1|Part A|Other|1
7532010|NCT02694523|26168172|P7|Part A|Withdrawal by Subject|0
7532011|NCT02694523|26168173|P6|Part A|Withdrawal by Subject|0
7532012|NCT02694523|26168174|P5|Part A|Withdrawal by Subject|0
7532013|NCT02694523|26168175|P4|Part A|Withdrawal by Subject|0
7532014|NCT02694523|26168176|P3|Part A|Withdrawal by Subject|0
7532015|NCT02694523|26168177|P2|Part A|Withdrawal by Subject|1
7532016|NCT02694523|26168178|P1|Part A|Withdrawal by Subject|3
7532017|NCT02694523|26168172|P7|Part A|Lost to Follow-up|0
7532018|NCT02694523|26168173|P6|Part A|Lost to Follow-up|0
7532019|NCT02694523|26168174|P5|Part A|Lost to Follow-up|0
7532020|NCT02694523|26168175|P4|Part A|Lost to Follow-up|0
7532021|NCT02694523|26168176|P3|Part A|Lost to Follow-up|0
7532022|NCT02694523|26168177|P2|Part A|Lost to Follow-up|2
7532023|NCT02694523|26168178|P1|Part A|Lost to Follow-up|1
7532024|NCT02694523|26168172|P7|Part A|Protocol Violation|0
7532025|NCT02694523|26168173|P6|Part A|Protocol Violation|0
7532026|NCT02694523|26168174|P5|Part A|Protocol Violation|0
7532027|NCT02694523|26168175|P4|Part A|Protocol Violation|0
7532028|NCT02694523|26168176|P3|Part A|Protocol Violation|0
7532029|NCT02694523|26168177|P2|Part A|Protocol Violation|0
7532030|NCT02694523|26168178|P1|Part A|Protocol Violation|1
7532031|NCT02694523|26168172|P7|Part A|Adverse Event|0
7532032|NCT02694523|26168173|P6|Part A|Adverse Event|0
7532033|NCT02694523|26168174|P5|Part A|Adverse Event|0
7532034|NCT02694523|26168175|P4|Part A|Adverse Event|0
7532035|NCT02694523|26168176|P3|Part A|Adverse Event|0
7532036|NCT02694523|26168177|P2|Part A|Adverse Event|3
7532037|NCT02694523|26168178|P1|Part A|Adverse Event|7
7532038|NCT02694328|26168208|P2|Overall Study|Abnormal Laboratory Value|3
7532039|NCT02694328|26168209|P1|Overall Study|Abnormal Laboratory Value|0
7532040|NCT02694328|26168208|P2|Overall Study|Protocol Violation|5
7532041|NCT02694328|26168209|P1|Overall Study|Protocol Violation|6
7532042|NCT02694328|26168208|P2|Overall Study|Pregnancy|1
7532043|NCT02694328|26168209|P1|Overall Study|Pregnancy|1
7532044|NCT02694328|26168208|P2|Overall Study|Lack of Efficacy|2
7532045|NCT02694328|26168209|P1|Overall Study|Lack of Efficacy|1
7532046|NCT02694328|26168208|P2|Overall Study|Incarceration|1
7532047|NCT02694328|26168209|P1|Overall Study|Incarceration|1
7532048|NCT02694328|26168208|P2|Overall Study|Noncompliant with study drug|8
7532049|NCT02694328|26168209|P1|Overall Study|Noncompliant with study drug|11
7532050|NCT02694328|26168208|P2|Overall Study|Lost to Follow-up|22
7532051|NCT02694328|26168209|P1|Overall Study|Lost to Follow-up|26
7532052|NCT02694328|26168208|P2|Overall Study|Withdrawal by Subject|23
7532053|NCT02694328|26168209|P1|Overall Study|Withdrawal by Subject|27
7532054|NCT02694328|26168208|P2|Overall Study|Adverse Event|33
7532055|NCT02694328|26168209|P1|Overall Study|Adverse Event|27
7532056|NCT02694185|26168233|P2|Overall Study|Withdrawal by Subject|0
7532057|NCT02694185|26168234|P1|Overall Study|Withdrawal by Subject|45
7532058|NCT02693834|26168263|P2|Week 2 Practice|Adverse Event|1
7532059|NCT02693834|26168264|P1|Week 2 Practice|Adverse Event|0
7532060|NCT02693834|26168263|P2|Baseline Measurement|Adverse Event|0
7532061|NCT02693834|26168264|P1|Baseline Measurement|Adverse Event|1
7532062|NCT02693834|26168263|P2|Baseline Measurement|Withdrawal by Subject|0
7532063|NCT02693834|26168264|P1|Baseline Measurement|Withdrawal by Subject|1
7532064|NCT02693743|26168274|P2|Overall Study|Physician Decision|0
7532065|NCT02693743|26168275|P1|Overall Study|Physician Decision|1
7532066|NCT02693691|26168312|P1|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
7532067|NCT02693691|26168312|P1|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
7532068|NCT02693691|26168312|P1|Extended Follow-Up (Until Last pt 12M)|Death|12
7532069|NCT02693691|26168312|P1|Primary Endpoint Analysis (First 12M)|Adverse Event|1
7532070|NCT02693691|26168312|P1|Primary Endpoint Analysis (First 12M)|Physician Decision|7
7532071|NCT02693691|26168312|P1|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
7532072|NCT02693691|26168312|P1|Primary Endpoint Analysis (First 12M)|Death|30
7532073|NCT02693418|26168324|P5|Overall Study|Menses during study period|0
7532074|NCT02693418|26168325|P4|Overall Study|Menses during study period|0
7532075|NCT02693418|26168326|P3|Overall Study|Menses during study period|2
7532076|NCT02693418|26168327|P2|Overall Study|Menses during study period|0
7532077|NCT02693418|26168328|P1|Overall Study|Menses during study period|0
7532078|NCT02693418|26168324|P5|Overall Study|Lost to Follow-up|0
7532079|NCT02693418|26168325|P4|Overall Study|Lost to Follow-up|0
7532080|NCT02693418|26168326|P3|Overall Study|Lost to Follow-up|0
7532081|NCT02693418|26168327|P2|Overall Study|Lost to Follow-up|2
7532082|NCT02693418|26168328|P1|Overall Study|Lost to Follow-up|1
7532083|NCT02693171|26168358|P1|Overall Study|Discontinuation of Study by Sponsor|8
7532084|NCT02693171|26168358|P1|Overall Study|Adverse Event|1
7532085|NCT02693119|26168392|P2|Open-Label Period|Withdrawal by Subject|1
7532086|NCT02693119|26168393|P1|Open-Label Period|Withdrawal by Subject|0
7532087|NCT02693106|26168525|P1|Overall Study|No time|3
7532088|NCT02693002|26168537|P2|Overall Study|Withdrawal by Subject|0
7532089|NCT02693002|26168538|P1|Overall Study|Withdrawal by Subject|1
7532090|NCT02692716|26168568|P2|Overall Study|Withdrawal by Subject|1
7532091|NCT02692716|26168569|P1|Overall Study|Withdrawal by Subject|3
7532092|NCT02692716|26168568|P2|Overall Study|Lost to Follow-up|5
7532093|NCT02692716|26168569|P1|Overall Study|Lost to Follow-up|2
7532094|NCT02692703|26168609|P1|Overall Study|Other|1
7532095|NCT02692703|26168609|P1|Overall Study|Lost to Follow-up|1
7532096|NCT02692586|26168615|P1|Overall Study|Received adjunctive thrombolytics|2
7532097|NCT02692586|26168615|P1|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
7532098|NCT02692560|26168622|P2|Overall Study|Withdrawal by Subject|6
7532099|NCT02692560|26168623|P1|Overall Study|Withdrawal by Subject|0
7532100|NCT02692482|26168663|P2|Overall Study|Withdrawal by Subject|2
7532101|NCT02692482|26168664|P1|Overall Study|Withdrawal by Subject|1
7532102|NCT02692482|26168663|P2|Overall Study|Death|2
7532103|NCT02692482|26168664|P1|Overall Study|Death|2
7532104|NCT02692417|26168678|P2|Overall Study|Adverse Event|0
7532105|NCT02692417|26168679|P1|Overall Study|Adverse Event|1
7532106|NCT02692417|26168678|P2|Overall Study|Withdrawal by Subject|1
7532107|NCT02692417|26168679|P1|Overall Study|Withdrawal by Subject|5
7532108|NCT02692235|26168706|P2|Overall Study|Adverse Event|2
7532109|NCT02692235|26168707|P1|Overall Study|Adverse Event|1
7532110|NCT02692235|26168706|P2|Overall Study|Withdrawal by Subject|1
7532111|NCT02692235|26168707|P1|Overall Study|Withdrawal by Subject|2
7532112|NCT02692040|26168738|P17|Overall Study|Adverse Event|0
7532113|NCT02692040|26168739|P16|Overall Study|Adverse Event|1
7532114|NCT02692040|26168740|P15|Overall Study|Adverse Event|1
7532115|NCT02692040|26168741|P14|Overall Study|Adverse Event|3
7532116|NCT02692040|26168742|P13|Overall Study|Adverse Event|0
7532117|NCT02692040|26168743|P12|Overall Study|Adverse Event|0
7532118|NCT02692040|26168744|P11|Overall Study|Adverse Event|0
7532119|NCT02692040|26168745|P10|Overall Study|Adverse Event|0
7532120|NCT02692040|26168746|P9|Overall Study|Adverse Event|0
7532121|NCT02692040|26168747|P8|Overall Study|Adverse Event|0
7532122|NCT02692040|26168748|P7|Overall Study|Adverse Event|0
7532123|NCT02692040|26168749|P6|Overall Study|Adverse Event|0
7532124|NCT02692040|26168750|P5|Overall Study|Adverse Event|0
7532125|NCT02692040|26168751|P4|Overall Study|Adverse Event|0
7532126|NCT02692040|26168752|P3|Overall Study|Adverse Event|0
7532127|NCT02692040|26168753|P2|Overall Study|Adverse Event|0
7532128|NCT02692040|26168754|P1|Overall Study|Adverse Event|0
7532129|NCT02692040|26168738|P17|Overall Study|Protocol Violation|0
7532130|NCT02692040|26168739|P16|Overall Study|Protocol Violation|0
7532131|NCT02692040|26168740|P15|Overall Study|Protocol Violation|0
7532132|NCT02692040|26168741|P14|Overall Study|Protocol Violation|0
7532133|NCT02692040|26168742|P13|Overall Study|Protocol Violation|1
7532134|NCT02692040|26168743|P12|Overall Study|Protocol Violation|0
7532135|NCT02692040|26168744|P11|Overall Study|Protocol Violation|0
7532136|NCT02692040|26168745|P10|Overall Study|Protocol Violation|0
7532137|NCT02692040|26168746|P9|Overall Study|Protocol Violation|0
7532138|NCT02692040|26168747|P8|Overall Study|Protocol Violation|0
7532139|NCT02692040|26168748|P7|Overall Study|Protocol Violation|0
7532140|NCT02692040|26168749|P6|Overall Study|Protocol Violation|0
7532141|NCT02692040|26168750|P5|Overall Study|Protocol Violation|0
7532142|NCT02692040|26168751|P4|Overall Study|Protocol Violation|0
7532143|NCT02692040|26168752|P3|Overall Study|Protocol Violation|0
7532144|NCT02692040|26168753|P2|Overall Study|Protocol Violation|0
7532145|NCT02692040|26168754|P1|Overall Study|Protocol Violation|0
7532146|NCT02691936|26168846|P2|Overall Study|Withdrawal by Subject|5
7532147|NCT02691936|26168847|P1|Overall Study|Withdrawal by Subject|2
7532148|NCT02691741|26168869|P2|Overall Study|Withdrawal by Subject|4
7532149|NCT02691741|26168870|P1|Overall Study|Withdrawal by Subject|0
7532150|NCT02691741|26168869|P2|Overall Study|Physician Decision|1
7532151|NCT02691741|26168870|P1|Overall Study|Physician Decision|0
7532152|NCT02691741|26168869|P2|Overall Study|Lost to Follow-up|0
7532153|NCT02691741|26168870|P1|Overall Study|Lost to Follow-up|1
7532154|NCT02691741|26168869|P2|Overall Study|Adverse Event|2
7532155|NCT02691741|26168870|P1|Overall Study|Adverse Event|0
7532156|NCT02691702|26168910|P11|Overall Study|Protocol Violation|0
7532157|NCT02691702|26168911|P10|Overall Study|Protocol Violation|2
7532158|NCT02691702|26168912|P9|Overall Study|Protocol Violation|0
7532159|NCT02691702|26168913|P8|Overall Study|Protocol Violation|0
7532160|NCT02691702|26168914|P7|Overall Study|Protocol Violation|0
7532161|NCT02691702|26168915|P6|Overall Study|Protocol Violation|0
7532162|NCT02691702|26168916|P5|Overall Study|Protocol Violation|0
7532163|NCT02691702|26168917|P4|Overall Study|Protocol Violation|0
7532164|NCT02691702|26168918|P3|Overall Study|Protocol Violation|0
7532165|NCT02691702|26168919|P2|Overall Study|Protocol Violation|0
7532166|NCT02691702|26168920|P1|Overall Study|Protocol Violation|0
7532167|NCT02691702|26168910|P11|Overall Study|Other|0
7532168|NCT02691702|26168911|P10|Overall Study|Other|0
7532169|NCT02691702|26168912|P9|Overall Study|Other|1
7532170|NCT02691702|26168913|P8|Overall Study|Other|0
7532171|NCT02691702|26168914|P7|Overall Study|Other|1
7532172|NCT02691702|26168915|P6|Overall Study|Other|0
7532173|NCT02691702|26168916|P5|Overall Study|Other|0
7532174|NCT02691702|26168917|P4|Overall Study|Other|0
7532175|NCT02691702|26168918|P3|Overall Study|Other|0
7532176|NCT02691702|26168919|P2|Overall Study|Other|0
7532177|NCT02691702|26168920|P1|Overall Study|Other|0
7532178|NCT02691702|26168910|P11|Overall Study|Withdrawal by Subject|0
7532179|NCT02691702|26168911|P10|Overall Study|Withdrawal by Subject|0
7532180|NCT02691702|26168912|P9|Overall Study|Withdrawal by Subject|0
7532181|NCT02691702|26168913|P8|Overall Study|Withdrawal by Subject|0
7532182|NCT02691702|26168914|P7|Overall Study|Withdrawal by Subject|2
7532183|NCT02691702|26168915|P6|Overall Study|Withdrawal by Subject|1
7532184|NCT02691702|26168916|P5|Overall Study|Withdrawal by Subject|0
7532185|NCT02691702|26168917|P4|Overall Study|Withdrawal by Subject|0
7532186|NCT02691702|26168918|P3|Overall Study|Withdrawal by Subject|0
7532187|NCT02691702|26168919|P2|Overall Study|Withdrawal by Subject|1
7532188|NCT02691702|26168920|P1|Overall Study|Withdrawal by Subject|1
7532189|NCT02691702|26168910|P11|Overall Study|Lost to Follow-up|1
7532190|NCT02691702|26168911|P10|Overall Study|Lost to Follow-up|0
7532191|NCT02691702|26168912|P9|Overall Study|Lost to Follow-up|0
7532192|NCT02691702|26168913|P8|Overall Study|Lost to Follow-up|0
7532193|NCT02691702|26168914|P7|Overall Study|Lost to Follow-up|0
7532194|NCT02691702|26168915|P6|Overall Study|Lost to Follow-up|2
7532195|NCT02691702|26168916|P5|Overall Study|Lost to Follow-up|0
7532196|NCT02691702|26168917|P4|Overall Study|Lost to Follow-up|0
7532197|NCT02691702|26168918|P3|Overall Study|Lost to Follow-up|1
7532198|NCT02691702|26168919|P2|Overall Study|Lost to Follow-up|0
7532199|NCT02691702|26168920|P1|Overall Study|Lost to Follow-up|0
7532200|NCT02691702|26168910|P11|Overall Study|Adverse Event|1
7532201|NCT02691702|26168911|P10|Overall Study|Adverse Event|0
7532202|NCT02691702|26168912|P9|Overall Study|Adverse Event|1
7532203|NCT02691702|26168913|P8|Overall Study|Adverse Event|0
7532204|NCT02691702|26168914|P7|Overall Study|Adverse Event|0
7532205|NCT02691702|26168915|P6|Overall Study|Adverse Event|0
7532206|NCT02691702|26168916|P5|Overall Study|Adverse Event|0
7532207|NCT02691702|26168917|P4|Overall Study|Adverse Event|0
7532208|NCT02691702|26168918|P3|Overall Study|Adverse Event|0
7532209|NCT02691702|26168919|P2|Overall Study|Adverse Event|0
7532210|NCT02691702|26168920|P1|Overall Study|Adverse Event|1
7532211|NCT02691572|26169206|P2|Overall Study|Protocol Violation|1
7532212|NCT02691572|26169207|P1|Overall Study|Protocol Violation|0
7532213|NCT02691572|26169206|P2|Overall Study|Withdrawal by Subject|0
7532214|NCT02691572|26169207|P1|Overall Study|Withdrawal by Subject|1
7532215|NCT02691507|26169215|P2|Overall Study|Missed Visit 3|1
7532216|NCT02691507|26169216|P1|Overall Study|Missed Visit 3|0
7532217|NCT02691494|26169349|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
7532218|NCT02691494|26169350|P2|Post-Treatment Follow-Up Period|Non-Compliance|1
7532219|NCT02691494|26169351|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
7532220|NCT02691494|26169349|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
7532221|NCT02691494|26169350|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7532222|NCT02691494|26169351|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7532223|NCT02691494|26169349|P3|Post-Treatment Follow-Up Period|Other|1
7532224|NCT02691494|26169350|P2|Post-Treatment Follow-Up Period|Other|1
7532225|NCT02691494|26169351|P1|Post-Treatment Follow-Up Period|Other|2
7532226|NCT02691494|26169349|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7532227|NCT02691494|26169350|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7532228|NCT02691494|26169351|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7532229|NCT02691494|26169349|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7532230|NCT02691494|26169350|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7532231|NCT02691494|26169351|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7532232|NCT02691468|26169379|P2|Overall Study|Failure to advance FOB|0
7532233|NCT02691468|26169380|P1|Overall Study|Failure to advance FOB|2
7532234|NCT02691468|26169379|P2|Overall Study|Lost to Follow-up|1
7532235|NCT02691468|26169380|P1|Overall Study|Lost to Follow-up|2
7532236|NCT02691468|26169379|P2|Overall Study|Bronchial blocker use|1
7532237|NCT02691468|26169380|P1|Overall Study|Bronchial blocker use|2
7532238|NCT02691455|26169390|P2|Overall Study|Lost to Follow-up|15
7532239|NCT02691455|26169391|P1|Overall Study|Lost to Follow-up|15
7532240|NCT02691455|26169390|P2|Overall Study|Withdrawal by Subject|2
7532241|NCT02691455|26169391|P1|Overall Study|Withdrawal by Subject|1
7532242|NCT02691247|26169522|P3|Overall Study|Lost to Follow-up|1
7532243|NCT02691247|26169523|P2|Overall Study|Lost to Follow-up|0
7532244|NCT02691247|26169524|P1|Overall Study|Lost to Follow-up|2
7532245|NCT02691247|26169522|P3|Overall Study|Withdrawal by Subject|2
7532246|NCT02691247|26169523|P2|Overall Study|Withdrawal by Subject|2
7532247|NCT02691247|26169524|P1|Overall Study|Withdrawal by Subject|1
7532248|NCT02691013|26169554|P2|Overall Study|Withdrawal by Subject|0
7532249|NCT02691013|26169555|P1|Overall Study|Withdrawal by Subject|3
7532250|NCT02690974|26169569|P1|Overall Study|Protocol Deviation|1
7532251|NCT02690974|26169569|P1|Overall Study|Protocol-defined stopping criteria|1
7532252|NCT02690974|26169569|P1|Overall Study|Non-compliance with study treatment|1
7532253|NCT02690974|26169569|P1|Overall Study|Physician Decision|2
7532254|NCT02690974|26169569|P1|Overall Study|Withdrawal of Informed Consent|3
7532255|NCT02690974|26169569|P1|Overall Study|Lost to Follow-up|3
7532256|NCT02690974|26169569|P1|Overall Study|Subject/guardian decision|4
7532257|NCT02690974|26169569|P1|Overall Study|Death|9
7532258|NCT02690974|26169569|P1|Overall Study|Adverse Event|16
7532259|NCT02690727|26169610|P2|Overall Study|Adverse Event|2
7532260|NCT02690727|26169611|P1|Overall Study|Adverse Event|2
7532261|NCT02690714|26169621|P1|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
7532262|NCT02690714|26169621|P1|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
7532263|NCT02690701|26169642|P2|Treatment Period 2|Protocol Violation|1
7532264|NCT02690701|26169643|P1|Treatment Period 2|Protocol Violation|0
7532265|NCT02690701|26169642|P2|Treatment Period 2|Withdrawal by Subject|2
7532266|NCT02690701|26169643|P1|Treatment Period 2|Withdrawal by Subject|0
7532267|NCT02690701|26169642|P2|Treatment Period 2|Lost to Follow-up|2
7532268|NCT02690701|26169643|P1|Treatment Period 2|Lost to Follow-up|0
7532269|NCT02690701|26169642|P2|Treatment Period 2|Lack of Efficacy|0
7532270|NCT02690701|26169643|P1|Treatment Period 2|Lack of Efficacy|1
7532271|NCT02690701|26169642|P2|Treatment Period 2|Adverse Event|0
7532272|NCT02690701|26169643|P1|Treatment Period 2|Adverse Event|2
7532273|NCT02690701|26169642|P2|Treatment Period 1|Withdrawal by Subject|1
7532274|NCT02690701|26169643|P1|Treatment Period 1|Withdrawal by Subject|0
7532275|NCT02690701|26169642|P2|Treatment Period 1|Adverse Event|2
7532276|NCT02690701|26169643|P1|Treatment Period 1|Adverse Event|2
7532277|NCT02690207|26169713|P1|Overall Study|Other reasons for withdrawal|23
7532278|NCT02690207|26169713|P1|Overall Study|Suspected HZ Episode|1
7532279|NCT02690207|26169713|P1|Overall Study|Migrated/moved from study area|5
7532280|NCT02690207|26169713|P1|Overall Study|Non-serious Adverse Event|18
7532281|NCT02690207|26169713|P1|Overall Study|Serious adverse event|110
7532282|NCT02690207|26169713|P1|Overall Study|Protocol Violation|2
7532283|NCT02690207|26169713|P1|Overall Study|Withdrawal by Subject|46
7532284|NCT02690207|26169713|P1|Overall Study|Lost to Follow-up|48
7532285|NCT02690194|26169723|P3|Overall Study|Withdrawal by Subject|0
7532286|NCT02690194|26169724|P2|Overall Study|Withdrawal by Subject|4
7532287|NCT02690194|26169725|P1|Overall Study|Withdrawal by Subject|1
7532288|NCT02689804|26169940|P2|Overall Study|Withdrawal by Subject|0
7532289|NCT02689804|26169941|P1|Overall Study|Withdrawal by Subject|2
7532290|NCT02689518|26169967|P1|Overall Study|Withdrawal by Subject|3
7532291|NCT02689492|26169973|P1|Overall Study|Other than listed|1
7532292|NCT02689492|26169973|P1|Overall Study|Withdrawal/ Physician's Decision|1
7532293|NCT02689492|26169973|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
7532294|NCT02689492|26169973|P1|Overall Study|Physician Decision|2
7532295|NCT02689492|26169973|P1|Overall Study|Death|9
7532296|NCT02689492|26169973|P1|Overall Study|Withdrawal by Subject|11
7532297|NCT02689492|26169973|P1|Overall Study|Lost to Follow-up|61
7532298|NCT02689219|26169989|P2|Overall Study|Disease Progression|6
7532299|NCT02689219|26169990|P1|Overall Study|Disease Progression|10
7532300|NCT02689219|26169989|P2|Overall Study|Death|1
7532301|NCT02689219|26169990|P1|Overall Study|Death|1
7532302|NCT02689206|26170007|P5|Overall Study|Withdrawal by Subject|0
7532303|NCT02689206|26170008|P4|Overall Study|Withdrawal by Subject|0
7532304|NCT02689206|26170009|P3|Overall Study|Withdrawal by Subject|1
7532305|NCT02689206|26170010|P2|Overall Study|Withdrawal by Subject|0
7532306|NCT02689206|26170011|P1|Overall Study|Withdrawal by Subject|1
7532307|NCT02689206|26170007|P5|Overall Study|Physician Decision|0
7532308|NCT02689206|26170008|P4|Overall Study|Physician Decision|0
7532309|NCT02689206|26170009|P3|Overall Study|Physician Decision|0
7532310|NCT02689206|26170010|P2|Overall Study|Physician Decision|0
7532311|NCT02689206|26170011|P1|Overall Study|Physician Decision|1
7532312|NCT02689206|26170007|P5|Overall Study|Other: Reached stopping criteria|4
7532313|NCT02689206|26170008|P4|Overall Study|Other: Reached stopping criteria|3
7532314|NCT02689206|26170009|P3|Overall Study|Other: Reached stopping criteria|2
7532315|NCT02689206|26170010|P2|Overall Study|Other: Reached stopping criteria|1
7532316|NCT02689206|26170011|P1|Overall Study|Other: Reached stopping criteria|0
7532317|NCT02689206|26170007|P5|Overall Study|Protocol Violation|2
7532318|NCT02689206|26170008|P4|Overall Study|Protocol Violation|1
7532319|NCT02689206|26170009|P3|Overall Study|Protocol Violation|0
7532320|NCT02689206|26170010|P2|Overall Study|Protocol Violation|0
7532321|NCT02689206|26170011|P1|Overall Study|Protocol Violation|1
7532322|NCT02689206|26170007|P5|Overall Study|Adverse Event|2
7532323|NCT02689206|26170008|P4|Overall Study|Adverse Event|0
7532324|NCT02689206|26170009|P3|Overall Study|Adverse Event|1
7532325|NCT02689206|26170010|P2|Overall Study|Adverse Event|0
7532326|NCT02689206|26170011|P1|Overall Study|Adverse Event|0
7532327|NCT02689076|26170225|P3|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7532328|NCT02689076|26170226|P2|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
7532329|NCT02689076|26170227|P1|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7532330|NCT02689076|26170225|P3|Overall Study|Participant no longer active in VA system|0
7532331|NCT02689076|26170226|P2|Overall Study|Participant no longer active in VA system|0
7532332|NCT02689076|26170227|P1|Overall Study|Participant no longer active in VA system|1
7532333|NCT02689076|26170225|P3|Overall Study|Provider declined to participate after participant assignment|0
7532334|NCT02689076|26170226|P2|Overall Study|Provider declined to participate after participant assignment|1
7532335|NCT02689076|26170227|P1|Overall Study|Provider declined to participate after participant assignment|1
7532336|NCT02689076|26170225|P3|Overall Study|Death during non-VA encounter|0
7532337|NCT02689076|26170226|P2|Overall Study|Death during non-VA encounter|5
7532338|NCT02689076|26170227|P1|Overall Study|Death during non-VA encounter|2
7532339|NCT02689076|26170225|P3|Overall Study|Did not have an HIE match|0
7532340|NCT02689076|26170226|P2|Overall Study|Did not have an HIE match|0
7532341|NCT02689076|26170227|P1|Overall Study|Did not have an HIE match|2
7532342|NCT02689076|26170225|P3|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
7532343|NCT02689076|26170226|P2|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
7532344|NCT02689076|26170227|P1|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
7532345|NCT02689076|26170225|P3|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
7532346|NCT02689076|26170226|P2|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
7532347|NCT02689076|26170227|P1|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
7532348|NCT02688933|26170313|P2|Overall Study|Lost to Follow-up|5
7532349|NCT02688933|26170314|P1|Overall Study|Lost to Follow-up|1
7532350|NCT02688933|26170313|P2|Overall Study|Other than Specified|25
7532351|NCT02688933|26170314|P1|Overall Study|Other than Specified|14
7532352|NCT02688933|26170313|P2|Overall Study|Hypoglycemia|0
7532353|NCT02688933|26170314|P1|Overall Study|Hypoglycemia|2
7532354|NCT02688933|26170313|P2|Overall Study|Poor compliance to protocol|4
7532355|NCT02688933|26170314|P1|Overall Study|Poor compliance to protocol|7
7532356|NCT02688933|26170313|P2|Overall Study|Lack of Efficacy|2
7532357|NCT02688933|26170314|P1|Overall Study|Lack of Efficacy|2
7532358|NCT02688933|26170313|P2|Overall Study|Adverse Event|1
7532359|NCT02688933|26170314|P1|Overall Study|Adverse Event|3
7532360|NCT02688764|26170374|P2|Overall Study|Withdrawal by parent|0
7532361|NCT02688764|26170375|P1|Overall Study|Withdrawal by parent|3
7532362|NCT02688764|26170374|P2|Overall Study|Subject taken off dialysis|0
7532363|NCT02688764|26170375|P1|Overall Study|Subject taken off dialysis|1
7532364|NCT02688764|26170374|P2|Overall Study|Subject moving out|0
7532365|NCT02688764|26170375|P1|Overall Study|Subject moving out|2
7532366|NCT02688764|26170374|P2|Overall Study|Study drug taste/Withd. parent|0
7532367|NCT02688764|26170375|P1|Overall Study|Study drug taste/Withd. parent|1
7532368|NCT02688764|26170374|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
7532369|NCT02688764|26170375|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
7532370|NCT02688764|26170374|P2|Overall Study|Phosphorus level outside safe range|1
7532371|NCT02688764|26170375|P1|Overall Study|Phosphorus level outside safe range|0
7532372|NCT02688764|26170374|P2|Overall Study|Non-compl./Withd. subject|2
7532373|NCT02688764|26170375|P1|Overall Study|Non-compl./Withd. subject|0
7532374|NCT02688764|26170374|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7532375|NCT02688764|26170375|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7532376|NCT02688764|26170374|P2|Overall Study|Non-compl./Physician decision|0
7532377|NCT02688764|26170375|P1|Overall Study|Non-compl./Physician decision|2
7532378|NCT02688764|26170374|P2|Overall Study|Non-compliance with study drug|0
7532379|NCT02688764|26170375|P1|Overall Study|Non-compliance with study drug|4
7532380|NCT02688764|26170374|P2|Overall Study|Lack of efficacy/Physician decision|1
7532381|NCT02688764|26170375|P1|Overall Study|Lack of efficacy/Physician decision|0
7532382|NCT02688764|26170374|P2|Overall Study|Lack of Efficacy|2
7532383|NCT02688764|26170375|P1|Overall Study|Lack of Efficacy|3
7532384|NCT02688764|26170374|P2|Overall Study|Kidney transplant|4
7532385|NCT02688764|26170375|P1|Overall Study|Kidney transplant|10
7532386|NCT02688764|26170374|P2|Overall Study|AE/Withd. subject|0
7532387|NCT02688764|26170375|P1|Overall Study|AE/Withd. subject|1
7532388|NCT02688764|26170374|P2|Overall Study|AE/Withd. parent/Withd. subject|1
7532389|NCT02688764|26170375|P1|Overall Study|AE/Withd. parent/Withd. subject|1
7532390|NCT02688764|26170374|P2|Overall Study|AE/Withd. parent|0
7532391|NCT02688764|26170375|P1|Overall Study|AE/Withd. parent|3
7532392|NCT02688764|26170374|P2|Overall Study|AE/Physician decision|0
7532393|NCT02688764|26170375|P1|Overall Study|AE/Physician decision|1
7532394|NCT02688764|26170374|P2|Overall Study|AE/Other|1
7532395|NCT02688764|26170375|P1|Overall Study|AE/Other|0
7532396|NCT02688764|26170374|P2|Overall Study|AE/Non-compl./Withd. parent|1
7532397|NCT02688764|26170375|P1|Overall Study|AE/Non-compl./Withd. parent|0
7532398|NCT02688764|26170374|P2|Overall Study|AE/Non-compl.|0
7532399|NCT02688764|26170375|P1|Overall Study|AE/Non-compl.|1
7532400|NCT02688764|26170374|P2|Overall Study|AE/Lack of efficacy|0
7532401|NCT02688764|26170375|P1|Overall Study|AE/Lack of efficacy|1
7532402|NCT02688764|26170374|P2|Overall Study|AE/Kidney transplant|0
7532403|NCT02688764|26170375|P1|Overall Study|AE/Kidney transplant|1
7532404|NCT02688764|26170374|P2|Overall Study|Adverse Event|3
7532405|NCT02688764|26170375|P1|Overall Study|Adverse Event|3
7532412|NCT02688387|26170461|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532413|NCT02688387|26170462|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532414|NCT02688387|26170463|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
7532415|NCT02688387|26170464|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532416|NCT02688387|26170465|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532417|NCT02688387|26170466|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532418|NCT02688387|26170467|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532419|NCT02688387|26170468|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532420|NCT02688387|26170469|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532421|NCT02688387|26170470|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532422|NCT02688387|26170471|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532423|NCT02688387|26170472|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532424|NCT02688387|26170473|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532425|NCT02688387|26170474|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532426|NCT02688387|26170475|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532427|NCT02688387|26170476|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532428|NCT02688387|26170477|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532429|NCT02688387|26170478|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532430|NCT02688387|26170479|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532431|NCT02688387|26170480|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532432|NCT02688387|26170481|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532433|NCT02688387|26170482|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7532434|NCT02688387|26170461|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532435|NCT02688387|26170462|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7532436|NCT02688387|26170463|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532437|NCT02688387|26170464|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7532438|NCT02688387|26170465|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532439|NCT02688387|26170466|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532440|NCT02688387|26170467|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532441|NCT02688387|26170468|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532442|NCT02688387|26170469|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532443|NCT02688387|26170470|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532444|NCT02688387|26170471|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532445|NCT02688387|26170472|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532446|NCT02688387|26170473|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532447|NCT02688387|26170474|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532448|NCT02688387|26170475|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532449|NCT02688387|26170476|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532450|NCT02688387|26170477|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532451|NCT02688387|26170478|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532452|NCT02688387|26170479|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532453|NCT02688387|26170480|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532454|NCT02688387|26170481|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532455|NCT02688387|26170482|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7532456|NCT02688387|26170461|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532457|NCT02688387|26170462|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
7532458|NCT02688387|26170463|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532459|NCT02688387|26170464|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532460|NCT02688387|26170465|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532461|NCT02688387|26170466|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532462|NCT02688387|26170467|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532463|NCT02688387|26170468|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532464|NCT02688387|26170469|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532465|NCT02688387|26170470|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532466|NCT02688387|26170471|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532467|NCT02688387|26170472|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532468|NCT02688387|26170473|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532469|NCT02688387|26170474|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532470|NCT02688387|26170475|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532471|NCT02688387|26170476|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532472|NCT02688387|26170477|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532473|NCT02688387|26170478|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532474|NCT02688387|26170479|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532475|NCT02688387|26170480|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532476|NCT02688387|26170481|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532477|NCT02688387|26170482|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7532478|NCT02688387|26170461|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532479|NCT02688387|26170462|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532480|NCT02688387|26170463|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532481|NCT02688387|26170464|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532482|NCT02688387|26170465|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532483|NCT02688387|26170466|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532484|NCT02688387|26170467|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532485|NCT02688387|26170468|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7532486|NCT02688387|26170469|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532487|NCT02688387|26170470|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532488|NCT02688387|26170471|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532489|NCT02688387|26170472|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532490|NCT02688387|26170473|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532491|NCT02688387|26170474|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532492|NCT02688387|26170475|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532493|NCT02688387|26170476|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532494|NCT02688387|26170477|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532495|NCT02688387|26170478|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532496|NCT02688387|26170479|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532497|NCT02688387|26170480|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532498|NCT02688387|26170481|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532499|NCT02688387|26170482|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532500|NCT02688387|26170461|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532501|NCT02688387|26170462|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532502|NCT02688387|26170463|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532503|NCT02688387|26170464|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532504|NCT02688387|26170465|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532505|NCT02688387|26170466|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532506|NCT02688387|26170467|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532507|NCT02688387|26170468|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532508|NCT02688387|26170469|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532509|NCT02688387|26170470|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532510|NCT02688387|26170471|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532511|NCT02688387|26170472|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
7532512|NCT02688387|26170473|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532513|NCT02688387|26170474|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532514|NCT02688387|26170475|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532515|NCT02688387|26170476|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532516|NCT02688387|26170477|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532517|NCT02688387|26170478|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532518|NCT02688387|26170479|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532519|NCT02688387|26170480|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532520|NCT02688387|26170481|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532521|NCT02688387|26170482|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7532522|NCT02688387|26170461|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532523|NCT02688387|26170462|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532524|NCT02688387|26170463|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532525|NCT02688387|26170464|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532526|NCT02688387|26170465|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532527|NCT02688387|26170466|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532528|NCT02688387|26170467|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532529|NCT02688387|26170468|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532530|NCT02688387|26170469|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532531|NCT02688387|26170470|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532532|NCT02688387|26170471|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532533|NCT02688387|26170472|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532534|NCT02688387|26170473|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532535|NCT02688387|26170474|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532536|NCT02688387|26170475|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532537|NCT02688387|26170476|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532538|NCT02688387|26170477|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532539|NCT02688387|26170478|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532540|NCT02688387|26170479|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532541|NCT02688387|26170480|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532542|NCT02688387|26170481|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7532543|NCT02688387|26170482|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
7532544|NCT02688387|26170461|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532545|NCT02688387|26170462|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532546|NCT02688387|26170463|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532547|NCT02688387|26170464|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532548|NCT02688387|26170465|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532549|NCT02688387|26170466|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532550|NCT02688387|26170467|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532551|NCT02688387|26170468|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532552|NCT02688387|26170469|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532553|NCT02688387|26170470|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532554|NCT02688387|26170471|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532555|NCT02688387|26170472|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532556|NCT02688387|26170473|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532557|NCT02688387|26170474|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532558|NCT02688387|26170475|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532559|NCT02688387|26170476|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532560|NCT02688387|26170477|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532561|NCT02688387|26170478|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7532562|NCT02688387|26170479|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532563|NCT02688387|26170480|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7532564|NCT02688387|26170481|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532565|NCT02688387|26170482|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7532566|NCT02688387|26170461|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532567|NCT02688387|26170462|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532568|NCT02688387|26170463|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532569|NCT02688387|26170464|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532570|NCT02688387|26170465|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532571|NCT02688387|26170466|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532572|NCT02688387|26170467|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532573|NCT02688387|26170468|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532574|NCT02688387|26170469|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532575|NCT02688387|26170470|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532576|NCT02688387|26170471|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532577|NCT02688387|26170472|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532578|NCT02688387|26170473|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532579|NCT02688387|26170474|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532580|NCT02688387|26170475|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532581|NCT02688387|26170476|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532582|NCT02688387|26170477|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532583|NCT02688387|26170478|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532584|NCT02688387|26170479|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532585|NCT02688387|26170480|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532586|NCT02688387|26170481|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
7532587|NCT02688387|26170482|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7532588|NCT02688387|26170461|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532589|NCT02688387|26170462|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532590|NCT02688387|26170463|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532591|NCT02688387|26170464|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532592|NCT02688387|26170465|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532593|NCT02688387|26170466|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532594|NCT02688387|26170467|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532595|NCT02688387|26170468|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532596|NCT02688387|26170469|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532597|NCT02688387|26170470|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532598|NCT02688387|26170471|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532599|NCT02688387|26170472|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532600|NCT02688387|26170473|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532601|NCT02688387|26170474|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532602|NCT02688387|26170475|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532603|NCT02688387|26170476|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532604|NCT02688387|26170477|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532605|NCT02688387|26170478|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532606|NCT02688387|26170479|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7532607|NCT02688387|26170480|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532608|NCT02688387|26170481|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532609|NCT02688387|26170482|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7532610|NCT02688387|26170461|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532611|NCT02688387|26170462|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532612|NCT02688387|26170463|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532613|NCT02688387|26170464|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532614|NCT02688387|26170465|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532615|NCT02688387|26170466|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532616|NCT02688387|26170467|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532617|NCT02688387|26170468|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532618|NCT02688387|26170469|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532619|NCT02688387|26170470|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532620|NCT02688387|26170471|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532621|NCT02688387|26170472|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532622|NCT02688387|26170473|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532623|NCT02688387|26170474|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532624|NCT02688387|26170475|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532625|NCT02688387|26170476|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532626|NCT02688387|26170477|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532627|NCT02688387|26170478|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532628|NCT02688387|26170479|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532629|NCT02688387|26170480|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
7532630|NCT02688387|26170481|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532631|NCT02688387|26170482|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7532632|NCT02688192|26170750|P2|Overall Study|Physician Decision|0
7532633|NCT02688192|26170751|P1|Overall Study|Physician Decision|1
7532634|NCT02688192|26170750|P2|Overall Study|Lost to Follow-up|5
7532635|NCT02688192|26170751|P1|Overall Study|Lost to Follow-up|11
7532636|NCT02688153|26170770|P2|Overall Study|Conversion to Commercial Valve|0
7532637|NCT02688153|26170771|P1|Overall Study|Conversion to Commercial Valve|3
7532638|NCT02688153|26170770|P2|Overall Study|Valve Explant|0
7532639|NCT02688153|26170771|P1|Overall Study|Valve Explant|1
7532640|NCT02688153|26170770|P2|Overall Study|Withdrawal by Subject|2
7532641|NCT02688153|26170771|P1|Overall Study|Withdrawal by Subject|4
7532642|NCT02688153|26170770|P2|Overall Study|Death|5
7532643|NCT02688153|26170771|P1|Overall Study|Death|7
7532644|NCT02687919|26170831|P2|Overall Study|Protocol Violation|0
7532645|NCT02687919|26170832|P1|Overall Study|Protocol Violation|2
7532646|NCT02687919|26170831|P2|Overall Study|Withdrawal by Subject|6
7532647|NCT02687919|26170832|P1|Overall Study|Withdrawal by Subject|6
7532648|NCT02687815|26170862|P2|Overall Study|Withdrawal by Subject|4
7532649|NCT02687815|26170863|P1|Overall Study|Withdrawal by Subject|2
7532650|NCT02687815|26170862|P2|Overall Study|Lost to Follow-up|4
7532651|NCT02687815|26170863|P1|Overall Study|Lost to Follow-up|2
7532652|NCT02687711|26170875|P1|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
7532653|NCT02687711|26170875|P1|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
7532654|NCT02687711|26170875|P1|Overall Study|Stopped in preparation for epilepsy surgery|1
7532740|NCT02685826|26171334|P2|Overall Study|Full Clinical Hold by FDA|9
7532655|NCT02687711|26170875|P1|Overall Study|Withdrawn due to intake interruption|1
7532656|NCT02687711|26170875|P1|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
7532657|NCT02687711|26170875|P1|Overall Study|Liver Encephalopathy|1
7532658|NCT02687711|26170875|P1|Overall Study|Change of Hospital|1
7532659|NCT02687711|26170875|P1|Overall Study|Side effects|1
7532660|NCT02687711|26170875|P1|Overall Study|Low mood|1
7532661|NCT02687711|26170875|P1|Overall Study|Disliked taste|1
7532662|NCT02687711|26170875|P1|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
7532663|NCT02687711|26170875|P1|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
7532664|NCT02687711|26170875|P1|Overall Study|Participant moved abroad|1
7532665|NCT02687711|26170875|P1|Overall Study|Too expensive|4
7532666|NCT02687711|26170875|P1|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
7532667|NCT02687711|26170875|P1|Overall Study|Consent withdrawn|15
7532668|NCT02687711|26170875|P1|Overall Study|Lost to Follow-up|20
7532669|NCT02687711|26170875|P1|Overall Study|Lack of Efficacy|70
7532670|NCT02687711|26170875|P1|Overall Study|Adverse Event|89
7532671|NCT02687542|26170917|P5|Overall Study|Withdrawal by Subject|4
7532672|NCT02687542|26170918|P4|Overall Study|Withdrawal by Subject|2
7532673|NCT02687542|26170919|P3|Overall Study|Withdrawal by Subject|1
7532674|NCT02687542|26170920|P2|Overall Study|Withdrawal by Subject|1
7532675|NCT02687542|26170921|P1|Overall Study|Withdrawal by Subject|0
7532676|NCT02687542|26170917|P5|Overall Study|Adverse Event|9
7532677|NCT02687542|26170918|P4|Overall Study|Adverse Event|2
7532678|NCT02687542|26170919|P3|Overall Study|Adverse Event|3
7532679|NCT02687542|26170920|P2|Overall Study|Adverse Event|1
7532680|NCT02687542|26170921|P1|Overall Study|Adverse Event|3
7532681|NCT02687542|26170917|P5|Overall Study|Other|5
7532682|NCT02687542|26170918|P4|Overall Study|Other|6
7532683|NCT02687542|26170919|P3|Overall Study|Other|10
7532684|NCT02687542|26170920|P2|Overall Study|Other|9
7532685|NCT02687542|26170921|P1|Overall Study|Other|5
7532686|NCT02687542|26170917|P5|Overall Study|Protocol Violation|0
7532687|NCT02687542|26170918|P4|Overall Study|Protocol Violation|0
7532688|NCT02687542|26170919|P3|Overall Study|Protocol Violation|0
7532689|NCT02687542|26170920|P2|Overall Study|Protocol Violation|1
7532690|NCT02687542|26170921|P1|Overall Study|Protocol Violation|0
7532691|NCT02687542|26170917|P5|Overall Study|Lost to Follow-up|1
7532692|NCT02687542|26170918|P4|Overall Study|Lost to Follow-up|0
7532693|NCT02687542|26170919|P3|Overall Study|Lost to Follow-up|0
7532694|NCT02687542|26170920|P2|Overall Study|Lost to Follow-up|0
7532695|NCT02687542|26170921|P1|Overall Study|Lost to Follow-up|0
7532696|NCT02687542|26170917|P5|Overall Study|Medication error without associated AEs|1
7532697|NCT02687542|26170918|P4|Overall Study|Medication error without associated AEs|0
7532698|NCT02687542|26170919|P3|Overall Study|Medication error without associated AEs|0
7532699|NCT02687542|26170920|P2|Overall Study|Medication error without associated AEs|0
7532700|NCT02687542|26170921|P1|Overall Study|Medication error without associated AEs|0
7532701|NCT02687191|26171050|P6|Overall Study|Withdrawal by Subject|0
7532702|NCT02687191|26171051|P5|Overall Study|Withdrawal by Subject|0
7532703|NCT02687191|26171052|P4|Overall Study|Withdrawal by Subject|1
7532704|NCT02687191|26171053|P3|Overall Study|Withdrawal by Subject|0
7532705|NCT02687191|26171054|P2|Overall Study|Withdrawal by Subject|0
7532706|NCT02687191|26171055|P1|Overall Study|Withdrawal by Subject|0
7532707|NCT02687191|26171050|P6|Overall Study|Death|1
7532708|NCT02687191|26171051|P5|Overall Study|Death|1
7532709|NCT02687191|26171052|P4|Overall Study|Death|0
7532710|NCT02687191|26171053|P3|Overall Study|Death|1
7532711|NCT02687191|26171054|P2|Overall Study|Death|1
7532712|NCT02687191|26171055|P1|Overall Study|Death|0
7532713|NCT02687035|26171208|P1|Overall Study|Did not receive Study Device|8
7532714|NCT02687035|26171208|P1|Overall Study|Missed Visit|87
7532715|NCT02687035|26171208|P1|Overall Study|Lost to Follow-up|1
7532716|NCT02687035|26171208|P1|Overall Study|Death|87
7532717|NCT02687035|26171208|P1|Overall Study|Withdrawal by Subject|1
7532718|NCT02686164|26171236|P1|Overall Study|Clinical progression|1
7532719|NCT02686164|26171236|P1|Overall Study|Withdrawal of consent|1
7532720|NCT02686164|26171236|P1|Overall Study|Adverse Event|1
7532721|NCT02686034|26171273|P2|Open Label Period 3|Lost to Follow-up|1
7532722|NCT02686034|26171274|P1|Open Label Period 3|Lost to Follow-up|0
7532723|NCT02686034|26171273|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
7532724|NCT02686034|26171274|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
7532725|NCT02686034|26171273|P2|Randomized Controlled Period 2|Adverse Event|2
7532726|NCT02686034|26171274|P1|Randomized Controlled Period 2|Adverse Event|0
7532727|NCT02686034|26171273|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
7532728|NCT02686034|26171274|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
7532729|NCT02686034|26171273|P2|Randomized Controlled Period 2|Lost to Follow-up|2
7532730|NCT02686034|26171274|P1|Randomized Controlled Period 2|Lost to Follow-up|1
7532731|NCT02686034|26171273|P2|Run-In Period 1|Lost to Follow-up|4
7532732|NCT02686034|26171274|P1|Run-In Period 1|Lost to Follow-up|4
7532733|NCT02686034|26171273|P2|Run-In Period 1|Withdrawal by Subject|3
7532734|NCT02686034|26171274|P1|Run-In Period 1|Withdrawal by Subject|4
7532735|NCT02686034|26171273|P2|Run-In Period 1|Eligibility|10
7532736|NCT02686034|26171274|P1|Run-In Period 1|Eligibility|12
7532737|NCT02685995|26171312|P2|Overall Study|Insertion of immediately puncturable graft.|1
7532738|NCT02685995|26171313|P1|Overall Study|Insertion of immediately puncturable graft.|1
7532739|NCT02685826|26171333|P3|Overall Study|Full Clinical Hold by FDA|20
7532741|NCT02685826|26171335|P1|Overall Study|Full Clinical Hold by FDA|19
7532742|NCT02685826|26171333|P3|Overall Study|Withdrawal by Subject|0
7532743|NCT02685826|26171334|P2|Overall Study|Withdrawal by Subject|0
7532744|NCT02685826|26171335|P1|Overall Study|Withdrawal by Subject|2
7532745|NCT02685826|26171333|P3|Overall Study|Progressive Disease|0
7532746|NCT02685826|26171334|P2|Overall Study|Progressive Disease|1
7532747|NCT02685826|26171335|P1|Overall Study|Progressive Disease|2
7532748|NCT02685826|26171333|P3|Overall Study|Adverse Event|1
7532749|NCT02685826|26171334|P2|Overall Study|Adverse Event|0
7532750|NCT02685826|26171335|P1|Overall Study|Adverse Event|2
7532751|NCT02685488|26171429|P2|Overall Study|Withdrawal by Subject|1
7532752|NCT02685488|26171430|P1|Overall Study|Withdrawal by Subject|0
7532753|NCT02685202|26171496|P1|Overall Study|Lost to Follow-up|9
7532754|NCT02685072|26171504|P2|1-Month Follow-Up|Withdrawal by Subject|0
7532755|NCT02685072|26171505|P1|1-Month Follow-Up|Withdrawal by Subject|1
7532756|NCT02685072|26171504|P2|Treatment Period|Withdrawal by Subject|3
7532757|NCT02685072|26171505|P1|Treatment Period|Withdrawal by Subject|1
7532758|NCT02685072|26171504|P2|Treatment Period|Lost to Follow-up|6
7532759|NCT02685072|26171505|P1|Treatment Period|Lost to Follow-up|12
7532760|NCT02685033|26171549|P2|Overall Study|Adverse Event|0
7532761|NCT02685033|26171550|P1|Overall Study|Adverse Event|1
7532762|NCT02685033|26171549|P2|Overall Study|Lost to Follow-up|1
7532763|NCT02685033|26171550|P1|Overall Study|Lost to Follow-up|2
7532764|NCT02685033|26171549|P2|Overall Study|Withdrawal of Consent|1
7532765|NCT02685033|26171550|P1|Overall Study|Withdrawal of Consent|0
7532766|NCT02684981|26171586|P3|Overall Study|Other|17
7532767|NCT02684981|26171587|P2|Overall Study|Other|49
7532768|NCT02684981|26171588|P1|Overall Study|Other|83
7532769|NCT02684981|26171586|P3|Overall Study|Permanently discontinued the treatment|110
7532770|NCT02684981|26171587|P2|Overall Study|Permanently discontinued the treatment|161
7532771|NCT02684981|26171588|P1|Overall Study|Permanently discontinued the treatment|157
7532772|NCT02684617|26171672|P3|Overall Study|Study Terminated by Sponsor|5
7532773|NCT02684617|26171673|P2|Overall Study|Study Terminated by Sponsor|1
7532774|NCT02684617|26171674|P1|Overall Study|Study Terminated by Sponsor|6
7532775|NCT02684617|26171672|P3|Overall Study|Screen Failure|2
7532776|NCT02684617|26171673|P2|Overall Study|Screen Failure|0
7532777|NCT02684617|26171674|P1|Overall Study|Screen Failure|1
7532778|NCT02684617|26171672|P3|Overall Study|Withdrawal by Subject|4
7532779|NCT02684617|26171673|P2|Overall Study|Withdrawal by Subject|0
7532780|NCT02684617|26171674|P1|Overall Study|Withdrawal by Subject|2
7532781|NCT02684617|26171672|P3|Overall Study|Death|28
7532782|NCT02684617|26171673|P2|Overall Study|Death|16
7532783|NCT02684617|26171674|P1|Overall Study|Death|8
7532784|NCT02684617|26171672|P3|Overall Study|Adverse Event|1
7532785|NCT02684617|26171673|P2|Overall Study|Adverse Event|0
7532786|NCT02684617|26171674|P1|Overall Study|Adverse Event|1
7532787|NCT02684370|26171794|P6|Part B|Subject Withdrawal|2
7532788|NCT02684370|26171795|P5|Part B|Subject Withdrawal|1
7532789|NCT02684370|26171796|P4|Part B|Subject Withdrawal|1
7532790|NCT02684370|26171797|P3|Part B|Subject Withdrawal|0
7532791|NCT02684370|26171798|P2|Part B|Subject Withdrawal|0
7532792|NCT02684370|26171799|P1|Part B|Subject Withdrawal|0
7532793|NCT02684370|26171794|P6|Part B|Lost to Follow-up|5
7532794|NCT02684370|26171795|P5|Part B|Lost to Follow-up|2
7532795|NCT02684370|26171796|P4|Part B|Lost to Follow-up|1
7532796|NCT02684370|26171797|P3|Part B|Lost to Follow-up|0
7532797|NCT02684370|26171798|P2|Part B|Lost to Follow-up|0
7532798|NCT02684370|26171799|P1|Part B|Lost to Follow-up|0
7532799|NCT02684370|26171794|P6|Part B|Adverse Event|1
7532800|NCT02684370|26171795|P5|Part B|Adverse Event|2
7532801|NCT02684370|26171796|P4|Part B|Adverse Event|0
7532802|NCT02684370|26171797|P3|Part B|Adverse Event|0
7532803|NCT02684370|26171798|P2|Part B|Adverse Event|0
7532804|NCT02684370|26171799|P1|Part B|Adverse Event|0
7532805|NCT02684370|26171794|P6|Part A|Other|0
7532806|NCT02684370|26171795|P5|Part A|Other|0
7532807|NCT02684370|26171796|P4|Part A|Other|0
7532808|NCT02684370|26171797|P3|Part A|Other|1
7532809|NCT02684370|26171798|P2|Part A|Other|0
7532810|NCT02684370|26171799|P1|Part A|Other|0
7532811|NCT02684370|26171794|P6|Part A|Subject Withdrawal|0
7532812|NCT02684370|26171795|P5|Part A|Subject Withdrawal|0
7532813|NCT02684370|26171796|P4|Part A|Subject Withdrawal|0
7532814|NCT02684370|26171797|P3|Part A|Subject Withdrawal|3
7532815|NCT02684370|26171798|P2|Part A|Subject Withdrawal|0
7532816|NCT02684370|26171799|P1|Part A|Subject Withdrawal|1
7532817|NCT02684370|26171794|P6|Part A|Lost to Follow-up|0
7532818|NCT02684370|26171795|P5|Part A|Lost to Follow-up|0
7532819|NCT02684370|26171796|P4|Part A|Lost to Follow-up|0
7532820|NCT02684370|26171797|P3|Part A|Lost to Follow-up|0
7532821|NCT02684370|26171798|P2|Part A|Lost to Follow-up|1
7532822|NCT02684370|26171799|P1|Part A|Lost to Follow-up|1
7532823|NCT02684370|26171794|P6|Part A|Adverse Event|0
7532824|NCT02684370|26171795|P5|Part A|Adverse Event|0
7532825|NCT02684370|26171796|P4|Part A|Adverse Event|0
7532826|NCT02684370|26171797|P3|Part A|Adverse Event|1
7532827|NCT02684370|26171798|P2|Part A|Adverse Event|0
7532828|NCT02684370|26171799|P1|Part A|Adverse Event|2
7532829|NCT02684357|26171844|P6|Part B|Other|1
7532830|NCT02684357|26171845|P5|Part B|Other|0
7532831|NCT02684357|26171846|P4|Part B|Other|1
7532832|NCT02684357|26171847|P3|Part B|Other|0
7532833|NCT02684357|26171848|P2|Part B|Other|0
7532834|NCT02684357|26171849|P1|Part B|Other|0
7532835|NCT02684357|26171844|P6|Part B|Withdrawal by Subject|4
7532836|NCT02684357|26171845|P5|Part B|Withdrawal by Subject|2
7532837|NCT02684357|26171846|P4|Part B|Withdrawal by Subject|0
7532838|NCT02684357|26171847|P3|Part B|Withdrawal by Subject|0
7532839|NCT02684357|26171848|P2|Part B|Withdrawal by Subject|0
7532840|NCT02684357|26171849|P1|Part B|Withdrawal by Subject|0
7532841|NCT02684357|26171844|P6|Part B|Lost to Follow-up|7
7532842|NCT02684357|26171845|P5|Part B|Lost to Follow-up|1
7532843|NCT02684357|26171846|P4|Part B|Lost to Follow-up|1
7532844|NCT02684357|26171847|P3|Part B|Lost to Follow-up|0
7532845|NCT02684357|26171848|P2|Part B|Lost to Follow-up|0
7532846|NCT02684357|26171849|P1|Part B|Lost to Follow-up|0
7532847|NCT02684357|26171844|P6|Part B|Adverse Event (Other)|1
7532848|NCT02684357|26171845|P5|Part B|Adverse Event (Other)|1
7532849|NCT02684357|26171846|P4|Part B|Adverse Event (Other)|1
7532850|NCT02684357|26171847|P3|Part B|Adverse Event (Other)|0
7532851|NCT02684357|26171848|P2|Part B|Adverse Event (Other)|0
7532852|NCT02684357|26171849|P1|Part B|Adverse Event (Other)|0
7532853|NCT02684357|26171844|P6|Part A|Other|0
7532854|NCT02684357|26171845|P5|Part A|Other|0
7532855|NCT02684357|26171846|P4|Part A|Other|0
7532856|NCT02684357|26171847|P3|Part A|Other|0
7532857|NCT02684357|26171848|P2|Part A|Other|1
7532858|NCT02684357|26171849|P1|Part A|Other|0
7532859|NCT02684357|26171844|P6|Part A|Withdrawal by Subject|0
7532860|NCT02684357|26171845|P5|Part A|Withdrawal by Subject|0
7532861|NCT02684357|26171846|P4|Part A|Withdrawal by Subject|0
7532862|NCT02684357|26171847|P3|Part A|Withdrawal by Subject|0
7532863|NCT02684357|26171848|P2|Part A|Withdrawal by Subject|0
7532864|NCT02684357|26171849|P1|Part A|Withdrawal by Subject|3
7532865|NCT02684357|26171844|P6|Part A|Lost to Follow-up|0
7532866|NCT02684357|26171845|P5|Part A|Lost to Follow-up|0
7532867|NCT02684357|26171846|P4|Part A|Lost to Follow-up|0
7532868|NCT02684357|26171847|P3|Part A|Lost to Follow-up|2
7532869|NCT02684357|26171848|P2|Part A|Lost to Follow-up|2
7532870|NCT02684357|26171849|P1|Part A|Lost to Follow-up|0
7532871|NCT02684357|26171844|P6|Part A|Adverse Event (Worsening of Disease)|0
7532872|NCT02684357|26171845|P5|Part A|Adverse Event (Worsening of Disease)|0
7532873|NCT02684357|26171846|P4|Part A|Adverse Event (Worsening of Disease)|0
7532874|NCT02684357|26171847|P3|Part A|Adverse Event (Worsening of Disease)|0
7532875|NCT02684357|26171848|P2|Part A|Adverse Event (Worsening of Disease)|0
7532876|NCT02684357|26171849|P1|Part A|Adverse Event (Worsening of Disease)|1
7532877|NCT02684344|26171899|P2|Overall Study|Withdrawal by Subject|1
7532878|NCT02684344|26171900|P1|Overall Study|Withdrawal by Subject|0
7532879|NCT02684279|26171906|P1|Overall Study|Physician Decision|1
7532880|NCT02684279|26171906|P1|Overall Study|Site closures|7
7532881|NCT02684279|26171906|P1|Overall Study|family emergency|1
7532882|NCT02684279|26171906|P1|Overall Study|subject to have surgery|1
7532883|NCT02684279|26171906|P1|Overall Study|non compliance with study visits|2
7532884|NCT02684279|26171906|P1|Overall Study|non-compliance with study drug|9
7532885|NCT02684279|26171906|P1|Overall Study|Withdrawal by Subject|92
7532886|NCT02684279|26171906|P1|Overall Study|Pregnancy|8
7532887|NCT02684279|26171906|P1|Overall Study|Protocol Violation|6
7532888|NCT02684279|26171906|P1|Overall Study|Lost to Follow-up|61
7532889|NCT02684279|26171906|P1|Overall Study|Lack of Efficacy|4
7532890|NCT02684279|26171906|P1|Overall Study|Adverse Event|87
7532891|NCT02684097|26171967|P2|Overall Study|Lack of Efficacy|6
7532892|NCT02684097|26171968|P1|Overall Study|Lack of Efficacy|13
7532893|NCT02683876|26172016|P2|Overall Study|samples damaged during shipping|0
7532894|NCT02683876|26172017|P1|Overall Study|samples damaged during shipping|2
7532895|NCT02683785|26172027|P2|Overall Study|Adverse Event|2
7532896|NCT02683785|26172028|P1|Overall Study|Adverse Event|0
7532897|NCT02683785|26172027|P2|Overall Study|Lost to Follow-up|1
7532898|NCT02683785|26172028|P1|Overall Study|Lost to Follow-up|0
7532899|NCT02683785|26172027|P2|Overall Study|Withdrawal by Subject|1
7532900|NCT02683785|26172028|P1|Overall Study|Withdrawal by Subject|1
7532901|NCT02683746|26172085|P2|Overall Study|Physician Decision|1
7532902|NCT02683746|26172086|P1|Overall Study|Physician Decision|2
7532903|NCT02683746|26172085|P2|Overall Study|Withdrawal by Subject|5
7532904|NCT02683746|26172086|P1|Overall Study|Withdrawal by Subject|6
7532905|NCT02683746|26172085|P2|Overall Study|Lost to Follow-up|6
7532906|NCT02683746|26172086|P1|Overall Study|Lost to Follow-up|5
7532907|NCT02683746|26172085|P2|Overall Study|Adverse Event|2
7532908|NCT02683746|26172086|P1|Overall Study|Adverse Event|3
7532909|NCT02683668|26172129|P3|Period 2|Withdrawal by Subject|0
7532910|NCT02683668|26172130|P2|Period 2|Withdrawal by Subject|1
7532911|NCT02683668|26172131|P1|Period 2|Withdrawal by Subject|0
7532912|NCT02683525|26172197|P1|Overall Study|Disease Progression|6
7532913|NCT02683525|26172197|P1|Overall Study|Physician Decision|1
7532914|NCT02683525|26172197|P1|Overall Study|Lost to Follow-up|1
7532915|NCT02683187|26172236|P1|Overall Study|Withdrawal by Subject|5
7532916|NCT02683187|26172236|P1|Overall Study|Failed IV access|3
7532917|NCT02683109|26172260|P2|Overall Study|Adverse Event|0
7532918|NCT02683109|26172261|P1|Overall Study|Adverse Event|1
7532919|NCT02682823|26172282|P5|Overall Study|Adverse Event|0
7532920|NCT02682823|26172283|P4|Overall Study|Adverse Event|1
7532921|NCT02682823|26172284|P3|Overall Study|Adverse Event|0
7532922|NCT02682823|26172285|P2|Overall Study|Adverse Event|0
7532923|NCT02682823|26172286|P1|Overall Study|Adverse Event|0
7532924|NCT02682823|26172282|P5|Overall Study|Protocol Deviation|0
7532925|NCT02682823|26172283|P4|Overall Study|Protocol Deviation|0
7532926|NCT02682823|26172284|P3|Overall Study|Protocol Deviation|0
7532927|NCT02682823|26172285|P2|Overall Study|Protocol Deviation|1
7532928|NCT02682823|26172286|P1|Overall Study|Protocol Deviation|0
7532929|NCT02682823|26172282|P5|Overall Study|Withdrawal by Subject|1
7532930|NCT02682823|26172283|P4|Overall Study|Withdrawal by Subject|0
7532931|NCT02682823|26172284|P3|Overall Study|Withdrawal by Subject|1
7532932|NCT02682823|26172285|P2|Overall Study|Withdrawal by Subject|0
7532933|NCT02682823|26172286|P1|Overall Study|Withdrawal by Subject|0
7532934|NCT02682602|26172322|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
7532935|NCT02682602|26172323|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
7532936|NCT02682602|26172322|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
7532937|NCT02682602|26172323|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
7532938|NCT02682264|26172456|P2|Overall Study|Stopped test article application|1
7532939|NCT02682264|26172457|P1|Overall Study|Stopped test article application|0
7532940|NCT02682264|26172456|P2|Overall Study|Moved abroad and unable to continue|3
7532941|NCT02682264|26172457|P1|Overall Study|Moved abroad and unable to continue|0
7532942|NCT02682264|26172456|P2|Overall Study|Technical Problems|1
7532943|NCT02682264|26172457|P1|Overall Study|Technical Problems|0
7532944|NCT02682264|26172456|P2|Overall Study|Progressive Disease|0
7532945|NCT02682264|26172457|P1|Overall Study|Progressive Disease|1
7532946|NCT02682264|26172456|P2|Overall Study|Recovery|2
7532947|NCT02682264|26172457|P1|Overall Study|Recovery|1
7532948|NCT02682264|26172456|P2|Overall Study|Pregnancy|2
7532949|NCT02682264|26172457|P1|Overall Study|Pregnancy|1
7532950|NCT02682264|26172456|P2|Overall Study|Noncompliance with study drug|4
7532951|NCT02682264|26172457|P1|Overall Study|Noncompliance with study drug|1
7532952|NCT02682264|26172456|P2|Overall Study|Adverse Event|0
7532953|NCT02682264|26172457|P1|Overall Study|Adverse Event|9
7532954|NCT02682264|26172456|P2|Overall Study|Withdrawal by Parent|7
7532955|NCT02682264|26172457|P1|Overall Study|Withdrawal by Parent|6
7532956|NCT02682264|26172456|P2|Overall Study|Lack of Efficacy|16
7532957|NCT02682264|26172457|P1|Overall Study|Lack of Efficacy|14
7532958|NCT02682264|26172456|P2|Overall Study|Lost to Follow-up|41
7532959|NCT02682264|26172457|P1|Overall Study|Lost to Follow-up|49
7532960|NCT02682264|26172456|P2|Overall Study|Withdrawal by Subject|45
7532961|NCT02682264|26172457|P1|Overall Study|Withdrawal by Subject|56
7532962|NCT02681523|26172543|P1|Overall Study|Patient Non-compliance|1
7532963|NCT02681523|26172543|P1|Overall Study|Adverse Event|1
7532964|NCT02681510|26172549|P1|Overall Study|Lost to Follow-up|9
7532965|NCT02681510|26172549|P1|Overall Study|Withdrawal by Subject|1
7532966|NCT02681094|26172579|P3|2 - Enrolled Participants Set|No treatment given|1
7532967|NCT02681094|26172580|P2|2 - Enrolled Participants Set|No treatment given|1
7532968|NCT02681094|26172581|P1|2 - Enrolled Participants Set|No treatment given|0
7532969|NCT02681094|26172579|P3|2 - Enrolled Participants Set|Other|7
7532970|NCT02681094|26172580|P2|2 - Enrolled Participants Set|Other|6
7532971|NCT02681094|26172581|P1|2 - Enrolled Participants Set|Other|6
7532972|NCT02681094|26172579|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
7532973|NCT02681094|26172580|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
7532974|NCT02681094|26172581|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
7532975|NCT02681094|26172579|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
7532976|NCT02681094|26172580|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
7532977|NCT02681094|26172581|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
7532978|NCT02681094|26172579|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
7532979|NCT02681094|26172580|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
7532980|NCT02681094|26172581|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
7532981|NCT02681094|26172579|P3|2 - Enrolled Participants Set|Adverse Event|1
7532982|NCT02681094|26172580|P2|2 - Enrolled Participants Set|Adverse Event|4
7532983|NCT02681094|26172581|P1|2 - Enrolled Participants Set|Adverse Event|10
7532984|NCT02681094|26172579|P3|2 - Enrolled Participants Set|Participant decision|9
7532985|NCT02681094|26172580|P2|2 - Enrolled Participants Set|Participant decision|10
7532986|NCT02681094|26172581|P1|2 - Enrolled Participants Set|Participant decision|7
7532987|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|No treatment given|1
7532988|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|No treatment given|1
7532989|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|No treatment given|0
7532990|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|Other|7
7532991|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|Other|6
7532992|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|Other|6
7532993|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
7532994|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
7532995|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
7532996|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
7532997|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
7532998|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
7532999|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
7533000|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
7533001|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
7533002|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
7533003|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
7533004|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
7533005|NCT02681094|26172579|P3|1 -Modified Enrolled Participants Set|Participant decision|9
7533006|NCT02681094|26172580|P2|1 -Modified Enrolled Participants Set|Participant decision|10
7533007|NCT02681094|26172581|P1|1 -Modified Enrolled Participants Set|Participant decision|7
7533008|NCT02680847|26172600|P3|Overall Study|Adverse Event|1
7533009|NCT02680847|26172601|P2|Overall Study|Adverse Event|0
7533010|NCT02680847|26172602|P1|Overall Study|Adverse Event|0
7533011|NCT02680847|26172600|P3|Overall Study|Lack of Efficacy|2
7533012|NCT02680847|26172601|P2|Overall Study|Lack of Efficacy|0
7533013|NCT02680847|26172602|P1|Overall Study|Lack of Efficacy|0
7533014|NCT02680847|26172600|P3|Overall Study|Unwilling to participate in study|0
7533015|NCT02680847|26172601|P2|Overall Study|Unwilling to participate in study|1
7533016|NCT02680847|26172602|P1|Overall Study|Unwilling to participate in study|1
7533017|NCT02680847|26172600|P3|Overall Study|No longer met eligibility criteria|0
7533018|NCT02680847|26172601|P2|Overall Study|No longer met eligibility criteria|2
7533019|NCT02680847|26172602|P1|Overall Study|No longer met eligibility criteria|2
7533020|NCT02680847|26172600|P3|Overall Study|Other|0
7533021|NCT02680847|26172601|P2|Overall Study|Other|0
7533022|NCT02680847|26172602|P1|Overall Study|Other|2
7533023|NCT02680834|26172639|P2|Overall Study|Lost to Follow-up|1
7533024|NCT02680834|26172640|P1|Overall Study|Lost to Follow-up|0
7533025|NCT02680834|26172639|P2|Overall Study|Withdrawal by Subject|0
7533026|NCT02680834|26172640|P1|Overall Study|Withdrawal by Subject|6
7533027|NCT02680834|26172639|P2|Overall Study|Physician Decision|2
7533028|NCT02680834|26172640|P1|Overall Study|Physician Decision|5
7533029|NCT02680756|26172652|P2|Overall Study|None of above or not recorded|2
7533030|NCT02680756|26172653|P1|Overall Study|None of above or not recorded|3
7533031|NCT02680756|26172652|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
7533032|NCT02680756|26172653|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
7533033|NCT02680756|26172652|P2|Overall Study|Protocol Violation|0
7533034|NCT02680756|26172653|P1|Overall Study|Protocol Violation|1
7533035|NCT02680756|26172652|P2|Overall Study|Death|0
7533036|NCT02680756|26172653|P1|Overall Study|Death|1
7533037|NCT02680756|26172652|P2|Overall Study|Blood transfusion for any reason|1
7533038|NCT02680756|26172653|P1|Overall Study|Blood transfusion for any reason|0
7533039|NCT02680756|26172652|P2|Overall Study|Hb ≤7.5 g/dL|2
7533040|NCT02680756|26172653|P1|Overall Study|Hb ≤7.5 g/dL|0
7533041|NCT02680756|26172652|P2|Overall Study|Physician Decision|1
7533042|NCT02680756|26172653|P1|Overall Study|Physician Decision|4
7533043|NCT02680756|26172652|P2|Overall Study|Withdrawal by Subject|5
7533044|NCT02680756|26172653|P1|Overall Study|Withdrawal by Subject|5
7533045|NCT02680756|26172652|P2|Overall Study|Lost to Follow-up|6
7533046|NCT02680756|26172653|P1|Overall Study|Lost to Follow-up|7
7533047|NCT02680756|26172652|P2|Overall Study|Adverse Event|2
7533048|NCT02680756|26172653|P1|Overall Study|Adverse Event|10
7533049|NCT02680665|26172701|P1|Overall Study|No visit after the first prescription|5
7533050|NCT02680639|26172707|P3|Screening Period|Screen Failure|0
7533051|NCT02680639|26172708|P2|Screening Period|Screen Failure|0
7533052|NCT02680639|26172709|P1|Screening Period|Screen Failure|7
7533053|NCT02680041|26172800|P1|Overall Study|Lost to Follow-up|2
7533054|NCT02680041|26172800|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
7533055|NCT02680002|26172815|P6|Overall Study|Adverse Event|2
7533056|NCT02680002|26172816|P5|Overall Study|Adverse Event|1
7533057|NCT02680002|26172817|P4|Overall Study|Adverse Event|0
7533058|NCT02680002|26172818|P3|Overall Study|Adverse Event|0
7533059|NCT02680002|26172819|P2|Overall Study|Adverse Event|0
7533060|NCT02680002|26172820|P1|Overall Study|Adverse Event|0
7533061|NCT02680002|26172815|P6|Overall Study|Other|0
7533062|NCT02680002|26172816|P5|Overall Study|Other|1
7533063|NCT02680002|26172817|P4|Overall Study|Other|0
7533064|NCT02680002|26172818|P3|Overall Study|Other|0
7533065|NCT02680002|26172819|P2|Overall Study|Other|1
7533066|NCT02680002|26172820|P1|Overall Study|Other|0
7533067|NCT02680002|26172815|P6|Overall Study|Missed Visit 8 (Day 201)|0
7533068|NCT02680002|26172816|P5|Overall Study|Missed Visit 8 (Day 201)|5
7533069|NCT02680002|26172817|P4|Overall Study|Missed Visit 8 (Day 201)|1
7533070|NCT02680002|26172818|P3|Overall Study|Missed Visit 8 (Day 201)|3
7533071|NCT02680002|26172819|P2|Overall Study|Missed Visit 8 (Day 201)|1
7533072|NCT02680002|26172820|P1|Overall Study|Missed Visit 8 (Day 201)|2
7533073|NCT02680002|26172815|P6|Overall Study|Withdrawal by Subject|2
7533074|NCT02680002|26172816|P5|Overall Study|Withdrawal by Subject|2
7533075|NCT02680002|26172817|P4|Overall Study|Withdrawal by Subject|0
7533076|NCT02680002|26172818|P3|Overall Study|Withdrawal by Subject|1
7533077|NCT02680002|26172819|P2|Overall Study|Withdrawal by Subject|0
7533078|NCT02680002|26172820|P1|Overall Study|Withdrawal by Subject|0
7533079|NCT02680002|26172815|P6|Overall Study|Protocol Violation|2
7533080|NCT02680002|26172816|P5|Overall Study|Protocol Violation|1
7533081|NCT02680002|26172817|P4|Overall Study|Protocol Violation|0
7533082|NCT02680002|26172818|P3|Overall Study|Protocol Violation|1
7533083|NCT02680002|26172819|P2|Overall Study|Protocol Violation|0
7533084|NCT02680002|26172820|P1|Overall Study|Protocol Violation|1
7533085|NCT02680002|26172815|P6|Overall Study|Physician Decision|1
7533086|NCT02680002|26172816|P5|Overall Study|Physician Decision|1
7533087|NCT02680002|26172817|P4|Overall Study|Physician Decision|1
7533088|NCT02680002|26172818|P3|Overall Study|Physician Decision|1
7533089|NCT02680002|26172819|P2|Overall Study|Physician Decision|1
7533090|NCT02680002|26172820|P1|Overall Study|Physician Decision|5
7533091|NCT02680002|26172815|P6|Overall Study|Lost to Follow-up|2
7533092|NCT02680002|26172816|P5|Overall Study|Lost to Follow-up|0
7533093|NCT02680002|26172817|P4|Overall Study|Lost to Follow-up|2
7533094|NCT02680002|26172818|P3|Overall Study|Lost to Follow-up|4
7533095|NCT02680002|26172819|P2|Overall Study|Lost to Follow-up|1
7533096|NCT02680002|26172820|P1|Overall Study|Lost to Follow-up|5
7533097|NCT02679755|26172963|P2|Overall Study|Adverse events not related to study drug|2
7533098|NCT02679755|26172964|P1|Overall Study|Adverse events not related to study drug|1
7533099|NCT02679755|26172963|P2|Overall Study|Adverse Event|4
7533100|NCT02679755|26172964|P1|Overall Study|Adverse Event|1
7533101|NCT02679755|26172963|P2|Overall Study|Withdrawal by participant|3
7533102|NCT02679755|26172964|P1|Overall Study|Withdrawal by participant|6
7533103|NCT02679755|26172963|P2|Overall Study|Not defined|2
7533104|NCT02679755|26172964|P1|Overall Study|Not defined|0
7533105|NCT02679755|26172963|P2|Overall Study|Objective progression or relapse|83
7533106|NCT02679755|26172964|P1|Overall Study|Objective progression or relapse|24
7533107|NCT02679755|26172963|P2|Overall Study|Lost to Follow-up|0
7533108|NCT02679755|26172964|P1|Overall Study|Lost to Follow-up|1
7533109|NCT02679755|26172963|P2|Overall Study|Global deterioration of health status|8
7533110|NCT02679755|26172964|P1|Overall Study|Global deterioration of health status|1
7533111|NCT02679755|26172963|P2|Overall Study|Death|3
7533112|NCT02679755|26172964|P1|Overall Study|Death|0
7533113|NCT02679729|26173006|P9|Overall Study|Participant decision|0
7533114|NCT02679729|26173007|P8|Overall Study|Participant decision|0
7533115|NCT02679729|26173008|P7|Overall Study|Participant decision|1
7533116|NCT02679729|26173009|P6|Overall Study|Participant decision|0
7533117|NCT02679729|26173010|P5|Overall Study|Participant decision|0
7533118|NCT02679729|26173011|P4|Overall Study|Participant decision|0
7533119|NCT02679729|26173012|P3|Overall Study|Participant decision|0
7533120|NCT02679729|26173013|P2|Overall Study|Participant decision|1
7533121|NCT02679729|26173014|P1|Overall Study|Participant decision|0
7533122|NCT02679729|26173006|P9|Overall Study|Lost to Follow-up|0
7533123|NCT02679729|26173007|P8|Overall Study|Lost to Follow-up|0
7533124|NCT02679729|26173008|P7|Overall Study|Lost to Follow-up|0
7533125|NCT02679729|26173009|P6|Overall Study|Lost to Follow-up|0
7533126|NCT02679729|26173010|P5|Overall Study|Lost to Follow-up|1
7533127|NCT02679729|26173011|P4|Overall Study|Lost to Follow-up|0
7533128|NCT02679729|26173012|P3|Overall Study|Lost to Follow-up|0
7533129|NCT02679729|26173013|P2|Overall Study|Lost to Follow-up|1
7533130|NCT02679729|26173014|P1|Overall Study|Lost to Follow-up|0
7533131|NCT02679573|26173126|P2|Overall Study|Lost to Follow-up|3
7533132|NCT02679573|26173127|P1|Overall Study|Lost to Follow-up|0
7533133|NCT02679573|26173126|P2|Overall Study|Physician Decision|4
7533134|NCT02679573|26173127|P1|Overall Study|Physician Decision|2
7533135|NCT02679573|26173126|P2|Overall Study|Death|0
7533136|NCT02679573|26173127|P1|Overall Study|Death|2
7533137|NCT02679573|26173126|P2|Overall Study|Withdrawal by Subject|9
7533138|NCT02679573|26173127|P1|Overall Study|Withdrawal by Subject|2
7533139|NCT02679573|26173126|P2|Overall Study|Could not complete required study visits|2
7533140|NCT02679573|26173127|P1|Overall Study|Could not complete required study visits|6
7533141|NCT02679573|26173126|P2|Overall Study|Lack of Efficacy|15
7533142|NCT02679573|26173127|P1|Overall Study|Lack of Efficacy|12
7533143|NCT02679573|26173126|P2|Overall Study|Adverse Event|6
7533144|NCT02679573|26173127|P1|Overall Study|Adverse Event|13
7533145|NCT02679287|26173162|P2|Period 3|Work/Scheduling Conflict|1
7533146|NCT02679287|26173163|P1|Period 3|Work/Scheduling Conflict|0
7533147|NCT02679287|26173162|P2|Period 2|Disliked Mobile System|0
7533148|NCT02679287|26173163|P1|Period 2|Disliked Mobile System|2
7533149|NCT02679287|26173162|P2|Period 2|Work/Scheduling Conflict|0
7533150|NCT02679287|26173163|P1|Period 2|Work/Scheduling Conflict|1
7533151|NCT02679287|26173162|P2|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
7533152|NCT02679287|26173163|P1|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
7533153|NCT02679287|26173162|P2|Period 1: Randomization-Study Session 1|Disliked mobile system|1
7533154|NCT02679287|26173163|P1|Period 1: Randomization-Study Session 1|Disliked mobile system|0
7533155|NCT02679287|26173162|P2|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
7533156|NCT02679287|26173163|P1|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
7533157|NCT02679287|26173162|P2|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
7533158|NCT02679287|26173163|P1|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
7533159|NCT02679274|26173193|P2|Overall Study|Withdrawal by Subject|0
7533160|NCT02679274|26173194|P1|Overall Study|Withdrawal by Subject|1
7533161|NCT02679235|26173224|P1|Overall Study|Adverse Event|1
7533162|NCT02679235|26173224|P1|Overall Study|Withdrawal by Subject|3
7533163|NCT02679222|26173231|P1|Overall Study|No time for project|1
7533164|NCT02679079|26173251|P3|Overall Study|Withdrawal by Subject|0
7533165|NCT02679079|26173252|P2|Overall Study|Withdrawal by Subject|1
7533166|NCT02679079|26173253|P1|Overall Study|Withdrawal by Subject|2
7533167|NCT02679079|26173251|P3|Overall Study|Protocol Violation|0
7533168|NCT02679079|26173252|P2|Overall Study|Protocol Violation|1
7533169|NCT02679079|26173253|P1|Overall Study|Protocol Violation|0
7533170|NCT02679079|26173251|P3|Overall Study|Adverse Event|2
7533171|NCT02679079|26173252|P2|Overall Study|Adverse Event|0
7533172|NCT02679079|26173253|P1|Overall Study|Adverse Event|2
7533173|NCT02678923|26173298|P2|Overall Study|Did Not Return for Study Visits|0
7533174|NCT02678923|26173299|P1|Overall Study|Did Not Return for Study Visits|1
7533175|NCT02678923|26173298|P2|Overall Study|Lost to Follow-up|0
7533176|NCT02678923|26173299|P1|Overall Study|Lost to Follow-up|1
7533177|NCT02678923|26173298|P2|Overall Study|Withdrawal by Subject|2
7533178|NCT02678923|26173299|P1|Overall Study|Withdrawal by Subject|3
7533179|NCT02678923|26173298|P2|Overall Study|Protocol Deviation (Not Dosed)|3
7533180|NCT02678923|26173299|P1|Overall Study|Protocol Deviation (Not Dosed)|1
7533181|NCT02678676|26173315|P2|Overall Study|Unconfirmed for lost to follow-up|67
7533182|NCT02678676|26173316|P1|Overall Study|Unconfirmed for lost to follow-up|85
7533183|NCT02678676|26173315|P2|Overall Study|Lost to Follow-up|151
7533184|NCT02678676|26173316|P1|Overall Study|Lost to Follow-up|171
7533185|NCT02678676|26173315|P2|Overall Study|Withdrawal by Subject|5
7533186|NCT02678676|26173316|P1|Overall Study|Withdrawal by Subject|13
7533187|NCT02678676|26173315|P2|Overall Study|Death|649
7533188|NCT02678676|26173316|P1|Overall Study|Death|619
7533189|NCT02678416|26173347|P1|Part 2|Withdrawal by Subject|1
7533190|NCT02678416|26173347|P1|Part 2|Adverse Event|2
7533191|NCT02678416|26173347|P1|Part 1|Withdrawal by Subject|1
7533192|NCT02678390|26173367|P2|AE (1 Day)|Withdrawal by Subject|1
7533193|NCT02678390|26173368|P1|AE (1 Day)|Withdrawal by Subject|0
7533194|NCT02678286|26173384|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7533195|NCT02678286|26173385|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7533196|NCT02678286|26173384|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
7533197|NCT02678286|26173385|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
7533198|NCT02678286|26173384|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
7533199|NCT02678286|26173385|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
7533200|NCT02678286|26173384|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
7533201|NCT02678286|26173385|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
7533202|NCT02678286|26173384|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
7533203|NCT02678286|26173385|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
7533204|NCT02678247|26173417|P2|Second Intervention (7 Weeks)|Physician Decision|0
7533205|NCT02678247|26173418|P1|Second Intervention (7 Weeks)|Physician Decision|1
7533206|NCT02678247|26173417|P2|Second Intervention (7 Weeks)|Adverse Event|1
7533207|NCT02678247|26173418|P1|Second Intervention (7 Weeks)|Adverse Event|2
7533208|NCT02678247|26173417|P2|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7533209|NCT02678247|26173418|P1|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7533210|NCT02678247|26173417|P2|First Intervention (7 Weeks)|Physician Decision|0
7533211|NCT02678247|26173418|P1|First Intervention (7 Weeks)|Physician Decision|1
7533212|NCT02678247|26173417|P2|First Intervention (7 Weeks)|Adverse Event|2
7533213|NCT02678247|26173418|P1|First Intervention (7 Weeks)|Adverse Event|1
7533214|NCT02678247|26173417|P2|First Intervention (7 Weeks)|Withdrawal by Subject|2
7533215|NCT02678247|26173418|P1|First Intervention (7 Weeks)|Withdrawal by Subject|0
7533216|NCT02678000|26173468|P5|PART 2|Withdrawal by Subject|0
7533217|NCT02678000|26173469|P4|PART 2|Withdrawal by Subject|0
7533218|NCT02678000|26173470|P3|PART 2|Withdrawal by Subject|1
7533219|NCT02678000|26173471|P2|PART 2|Withdrawal by Subject|0
7533220|NCT02678000|26173472|P1|PART 2|Withdrawal by Subject|0
7533221|NCT02678000|26173468|P5|PART 2|Adverse Event|0
7533222|NCT02678000|26173469|P4|PART 2|Adverse Event|1
7533223|NCT02678000|26173470|P3|PART 2|Adverse Event|2
7533224|NCT02678000|26173471|P2|PART 2|Adverse Event|0
7533225|NCT02678000|26173472|P1|PART 2|Adverse Event|0
7533226|NCT02677896|26173510|P2|Overall Study|Did not receive study drug|2
7533227|NCT02677896|26173511|P1|Overall Study|Did not receive study drug|2
7533228|NCT02677896|26173510|P2|Overall Study|Miscellaneous|11
7533229|NCT02677896|26173511|P1|Overall Study|Miscellaneous|6
7533230|NCT02677896|26173510|P2|Overall Study|Withdrawal by patient:|30
7533231|NCT02677896|26173511|P1|Overall Study|Withdrawal by patient:|25
7533232|NCT02677896|26173510|P2|Overall Study|Protocol deviation|1
7533233|NCT02677896|26173511|P1|Overall Study|Protocol deviation|2
7533234|NCT02677896|26173510|P2|Overall Study|Progressive disease:|171
7533235|NCT02677896|26173511|P1|Overall Study|Progressive disease:|65
7533236|NCT02677896|26173510|P2|Overall Study|Lost to Follow-up|1
7533237|NCT02677896|26173511|P1|Overall Study|Lost to Follow-up|0
7533238|NCT02677896|26173510|P2|Overall Study|Death|7
7533239|NCT02677896|26173511|P1|Overall Study|Death|9
7533240|NCT02677896|26173510|P2|Overall Study|Adverse Event|21
7533241|NCT02677896|26173511|P1|Overall Study|Adverse Event|28
7533242|NCT02677844|26173539|P7|Period 3|Withdrawal by Subject|0
7533243|NCT02677844|26173540|P6|Period 3|Withdrawal by Subject|0
7533244|NCT02677844|26173541|P5|Period 3|Withdrawal by Subject|0
7533245|NCT02677844|26173542|P4|Period 3|Withdrawal by Subject|1
7533246|NCT02677844|26173543|P3|Period 3|Withdrawal by Subject|0
7533247|NCT02677844|26173544|P2|Period 3|Withdrawal by Subject|0
7533248|NCT02677844|26173545|P1|Period 3|Withdrawal by Subject|0
7533249|NCT02677714|26173625|P2|Overall Study|Withdrawal by Subject|0
7533250|NCT02677714|26173626|P1|Overall Study|Withdrawal by Subject|2
7533251|NCT02677324|26173714|P1|Overall Study|IgM Myeloma diagnosis|1
7533252|NCT02677324|26173714|P1|Overall Study|Adverse Event|1
7533253|NCT02677324|26173714|P1|Overall Study|Medical insurance coverage|1
7533254|NCT02677324|26173714|P1|Overall Study|Lack of Efficacy|1
7533255|NCT02677324|26173714|P1|Overall Study|Non-compliance|1
7533256|NCT02677324|26173714|P1|Overall Study|Inability to Swallow pills|1
7533257|NCT02677324|26173714|P1|Overall Study|Disease Progression|6
7533258|NCT02677220|26173727|P1|Overall Study|Adverse Event|1
7533259|NCT02677116|26173742|P9|Overall Study|Withdrawal by Subject|0
7533260|NCT02677116|26173743|P8|Overall Study|Withdrawal by Subject|0
7533261|NCT02677116|26173744|P7|Overall Study|Withdrawal by Subject|0
7533262|NCT02677116|26173745|P6|Overall Study|Withdrawal by Subject|0
7533263|NCT02677116|26173746|P5|Overall Study|Withdrawal by Subject|0
7533264|NCT02677116|26173747|P4|Overall Study|Withdrawal by Subject|0
7533265|NCT02677116|26173748|P3|Overall Study|Withdrawal by Subject|0
7533266|NCT02677116|26173749|P2|Overall Study|Withdrawal by Subject|0
7533267|NCT02677116|26173750|P1|Overall Study|Withdrawal by Subject|1
7533268|NCT02677116|26173742|P9|Overall Study|Withdrawal by parent or guardian|0
7533269|NCT02677116|26173743|P8|Overall Study|Withdrawal by parent or guardian|1
7533270|NCT02677116|26173744|P7|Overall Study|Withdrawal by parent or guardian|2
7533271|NCT02677116|26173745|P6|Overall Study|Withdrawal by parent or guardian|0
7533272|NCT02677116|26173746|P5|Overall Study|Withdrawal by parent or guardian|0
7533273|NCT02677116|26173747|P4|Overall Study|Withdrawal by parent or guardian|1
7533274|NCT02677116|26173748|P3|Overall Study|Withdrawal by parent or guardian|0
7533275|NCT02677116|26173749|P2|Overall Study|Withdrawal by parent or guardian|1
7533276|NCT02677116|26173750|P1|Overall Study|Withdrawal by parent or guardian|2
7533277|NCT02677116|26173742|P9|Overall Study|Physician Decision|2
7533278|NCT02677116|26173743|P8|Overall Study|Physician Decision|1
7533279|NCT02677116|26173744|P7|Overall Study|Physician Decision|1
7533280|NCT02677116|26173745|P6|Overall Study|Physician Decision|3
7533281|NCT02677116|26173746|P5|Overall Study|Physician Decision|1
7533282|NCT02677116|26173747|P4|Overall Study|Physician Decision|2
7533283|NCT02677116|26173748|P3|Overall Study|Physician Decision|3
7533284|NCT02677116|26173749|P2|Overall Study|Physician Decision|2
7533285|NCT02677116|26173750|P1|Overall Study|Physician Decision|0
7533286|NCT02677116|26173742|P9|Overall Study|Adverse Event|0
7533287|NCT02677116|26173743|P8|Overall Study|Adverse Event|0
7533288|NCT02677116|26173744|P7|Overall Study|Adverse Event|1
7533289|NCT02677116|26173745|P6|Overall Study|Adverse Event|1
7533290|NCT02677116|26173746|P5|Overall Study|Adverse Event|0
7533291|NCT02677116|26173747|P4|Overall Study|Adverse Event|0
7533292|NCT02677116|26173748|P3|Overall Study|Adverse Event|0
7533293|NCT02677116|26173749|P2|Overall Study|Adverse Event|1
7533294|NCT02677116|26173750|P1|Overall Study|Adverse Event|0
7533295|NCT02676895|26173823|P3|Overall Study|Withdrawal by Subject|1
7533296|NCT02676895|26173824|P2|Overall Study|Withdrawal by Subject|0
7533297|NCT02676895|26173825|P1|Overall Study|Withdrawal by Subject|0
7533298|NCT02676895|26173823|P3|Overall Study|Lost to Follow-up|1
7533299|NCT02676895|26173824|P2|Overall Study|Lost to Follow-up|0
7533300|NCT02676895|26173825|P1|Overall Study|Lost to Follow-up|0
7533301|NCT02676895|26173823|P3|Overall Study|Adverse Event|1
7533302|NCT02676895|26173824|P2|Overall Study|Adverse Event|3
7533303|NCT02676895|26173825|P1|Overall Study|Adverse Event|0
7533304|NCT02676895|26173823|P3|Overall Study|Protocol Violation|0
7533305|NCT02676895|26173824|P2|Overall Study|Protocol Violation|0
7533306|NCT02676895|26173825|P1|Overall Study|Protocol Violation|1
7533307|NCT02676895|26173823|P3|Overall Study|Administrative reason|0
7533308|NCT02676895|26173824|P2|Overall Study|Administrative reason|0
7533309|NCT02676895|26173825|P1|Overall Study|Administrative reason|1
7533310|NCT02676882|26173868|P2|Overall Study|Withdrawal by Subject|2
7533311|NCT02676882|26173869|P1|Overall Study|Withdrawal by Subject|1
7533312|NCT02676882|26173868|P2|Overall Study|Lost to Follow-up|0
7533313|NCT02676882|26173869|P1|Overall Study|Lost to Follow-up|1
7533314|NCT02676882|26173868|P2|Overall Study|Adverse Event|0
7533315|NCT02676882|26173869|P1|Overall Study|Adverse Event|1
7533316|NCT02676778|26173883|P3|Overall Study|Adverse Event|0
7533317|NCT02676778|26173884|P2|Overall Study|Adverse Event|3
7533318|NCT02676778|26173885|P1|Overall Study|Adverse Event|2
7533319|NCT02676778|26173883|P3|Overall Study|Other|0
7533320|NCT02676778|26173884|P2|Overall Study|Other|3
7533321|NCT02676778|26173885|P1|Overall Study|Other|4
7533322|NCT02676778|26173883|P3|Overall Study|Withdrawal by Subject|0
7533323|NCT02676778|26173884|P2|Overall Study|Withdrawal by Subject|2
7533324|NCT02676778|26173885|P1|Overall Study|Withdrawal by Subject|3
7533325|NCT02676778|26173883|P3|Overall Study|Couldn't Start Cycle After Planned Date|0
7533326|NCT02676778|26173884|P2|Overall Study|Couldn't Start Cycle After Planned Date|1
7533327|NCT02676778|26173885|P1|Overall Study|Couldn't Start Cycle After Planned Date|1
7533328|NCT02676778|26173883|P3|Overall Study|Disease Progression|1
7533329|NCT02676778|26173884|P2|Overall Study|Disease Progression|3
7533330|NCT02676778|26173885|P1|Overall Study|Disease Progression|7
7533331|NCT02676466|26173936|P8|Overall Study|Withdrawal by Subject|1
7533332|NCT02676466|26173937|P7|Overall Study|Withdrawal by Subject|1
7533333|NCT02676466|26173938|P6|Overall Study|Withdrawal by Subject|1
7533334|NCT02676466|26173939|P5|Overall Study|Withdrawal by Subject|3
7533335|NCT02676466|26173940|P4|Overall Study|Withdrawal by Subject|0
7533336|NCT02676466|26173941|P3|Overall Study|Withdrawal by Subject|1
7533337|NCT02676466|26173942|P2|Overall Study|Withdrawal by Subject|3
7533338|NCT02676466|26173943|P1|Overall Study|Withdrawal by Subject|4
7533339|NCT02676466|26173936|P8|Overall Study|Death|0
7533340|NCT02676466|26173937|P7|Overall Study|Death|0
7533341|NCT02676466|26173938|P6|Overall Study|Death|0
7533342|NCT02676466|26173939|P5|Overall Study|Death|0
7533343|NCT02676466|26173940|P4|Overall Study|Death|0
7533344|NCT02676466|26173941|P3|Overall Study|Death|1
7533345|NCT02676466|26173942|P2|Overall Study|Death|2
7533346|NCT02676466|26173943|P1|Overall Study|Death|0
7533347|NCT02675998|26174026|P4|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
7533348|NCT02675998|26174027|P3|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7533349|NCT02675998|26174028|P2|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7533350|NCT02675998|26174029|P1|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7533351|NCT02675998|26174026|P4|4-Week Randomized Withdrawal Period|Physician Decision|0
7533352|NCT02675998|26174027|P3|4-Week Randomized Withdrawal Period|Physician Decision|0
7533353|NCT02675998|26174028|P2|4-Week Randomized Withdrawal Period|Physician Decision|0
7533354|NCT02675998|26174029|P1|4-Week Randomized Withdrawal Period|Physician Decision|1
7533355|NCT02675998|26174026|P4|4-Week Randomized Withdrawal Period|Protocol Violation|1
7533356|NCT02675998|26174027|P3|4-Week Randomized Withdrawal Period|Protocol Violation|0
7533357|NCT02675998|26174028|P2|4-Week Randomized Withdrawal Period|Protocol Violation|0
7533358|NCT02675998|26174029|P1|4-Week Randomized Withdrawal Period|Protocol Violation|0
7533359|NCT02675998|26174026|P4|4-Week Randomized Withdrawal Period|Adverse Event|3
7533360|NCT02675998|26174027|P3|4-Week Randomized Withdrawal Period|Adverse Event|1
7533361|NCT02675998|26174028|P2|4-Week Randomized Withdrawal Period|Adverse Event|0
7533362|NCT02675998|26174029|P1|4-Week Randomized Withdrawal Period|Adverse Event|0
7533363|NCT02675998|26174026|P4|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
7533364|NCT02675998|26174027|P3|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7533365|NCT02675998|26174028|P2|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7533366|NCT02675998|26174029|P1|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
7533367|NCT02675998|26174026|P4|8-Week Treatment Period|Other|0
7533368|NCT02675998|26174027|P3|8-Week Treatment Period|Other|2
7533369|NCT02675998|26174028|P2|8-Week Treatment Period|Other|1
7533370|NCT02675998|26174029|P1|8-Week Treatment Period|Other|3
7533371|NCT02675998|26174026|P4|8-Week Treatment Period|Protocol Violation|0
7533372|NCT02675998|26174027|P3|8-Week Treatment Period|Protocol Violation|1
7533373|NCT02675998|26174028|P2|8-Week Treatment Period|Protocol Violation|1
7533374|NCT02675998|26174029|P1|8-Week Treatment Period|Protocol Violation|1
7533375|NCT02675998|26174026|P4|8-Week Treatment Period|GI side Effects|0
7533376|NCT02675998|26174027|P3|8-Week Treatment Period|GI side Effects|2
7533377|NCT02675998|26174028|P2|8-Week Treatment Period|GI side Effects|4
7533378|NCT02675998|26174029|P1|8-Week Treatment Period|GI side Effects|1
7533379|NCT02675998|26174026|P4|8-Week Treatment Period|Physician Decision|0
7533380|NCT02675998|26174027|P3|8-Week Treatment Period|Physician Decision|2
7533381|NCT02675998|26174028|P2|8-Week Treatment Period|Physician Decision|0
7533382|NCT02675998|26174029|P1|8-Week Treatment Period|Physician Decision|1
7533383|NCT02675998|26174026|P4|8-Week Treatment Period|Lack of Efficacy|0
7533384|NCT02675998|26174027|P3|8-Week Treatment Period|Lack of Efficacy|3
7533385|NCT02675998|26174028|P2|8-Week Treatment Period|Lack of Efficacy|5
7533386|NCT02675998|26174029|P1|8-Week Treatment Period|Lack of Efficacy|2
7533387|NCT02675998|26174026|P4|8-Week Treatment Period|Withdrawal by Subject|0
7533388|NCT02675998|26174027|P3|8-Week Treatment Period|Withdrawal by Subject|3
7533389|NCT02675998|26174028|P2|8-Week Treatment Period|Withdrawal by Subject|3
7533390|NCT02675998|26174029|P1|8-Week Treatment Period|Withdrawal by Subject|3
7533391|NCT02675998|26174026|P4|8-Week Treatment Period|Adverse Event|0
7533392|NCT02675998|26174027|P3|8-Week Treatment Period|Adverse Event|6
7533393|NCT02675998|26174028|P2|8-Week Treatment Period|Adverse Event|5
7533394|NCT02675998|26174029|P1|8-Week Treatment Period|Adverse Event|6
7533395|NCT02675907|26174045|P2|Study Overall|Lost to Follow-up|2
7533396|NCT02675907|26174046|P1|Study Overall|Lost to Follow-up|0
7533397|NCT02675907|26174045|P2|Study Overall|Withdrawal by Subject|2
7533398|NCT02675907|26174046|P1|Study Overall|Withdrawal by Subject|2
7533399|NCT02675907|26174045|P2|Study Overall|Lack of Efficacy|0
7533400|NCT02675907|26174046|P1|Study Overall|Lack of Efficacy|1
7533401|NCT02675907|26174045|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7533402|NCT02675907|26174046|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7533403|NCT02675907|26174045|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7533404|NCT02675907|26174046|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7533405|NCT02675751|26174091|P1|Overall Study|Lost to Follow-up|16
7533406|NCT02675634|26174095|P6|Test Period 2|Adverse Event|1
7533407|NCT02675634|26174096|P5|Test Period 2|Adverse Event|0
7533408|NCT02675634|26174097|P4|Test Period 2|Adverse Event|0
7533409|NCT02675634|26174098|P3|Test Period 2|Adverse Event|0
7533410|NCT02675634|26174099|P2|Test Period 2|Adverse Event|0
7533411|NCT02675634|26174100|P1|Test Period 2|Adverse Event|0
7533412|NCT02675634|26174095|P6|Test Period 2|Lack of Efficacy|0
7533413|NCT02675634|26174096|P5|Test Period 2|Lack of Efficacy|0
7533414|NCT02675634|26174097|P4|Test Period 2|Lack of Efficacy|0
7533415|NCT02675634|26174098|P3|Test Period 2|Lack of Efficacy|0
7533416|NCT02675634|26174099|P2|Test Period 2|Lack of Efficacy|0
7533417|NCT02675634|26174100|P1|Test Period 2|Lack of Efficacy|1
7533418|NCT02675634|26174095|P6|Test Period 1|Device deficiency that did not lead to A|0
7533419|NCT02675634|26174096|P5|Test Period 1|Device deficiency that did not lead to A|0
7533420|NCT02675634|26174097|P4|Test Period 1|Device deficiency that did not lead to A|0
7533421|NCT02675634|26174098|P3|Test Period 1|Device deficiency that did not lead to A|1
7533422|NCT02675634|26174099|P2|Test Period 1|Device deficiency that did not lead to A|0
7533423|NCT02675634|26174100|P1|Test Period 1|Device deficiency that did not lead to A|0
7533424|NCT02675634|26174095|P6|Test Period 1|Adverse Event|0
7533425|NCT02675634|26174096|P5|Test Period 1|Adverse Event|0
7533426|NCT02675634|26174097|P4|Test Period 1|Adverse Event|1
7533427|NCT02675634|26174098|P3|Test Period 1|Adverse Event|0
7533428|NCT02675634|26174099|P2|Test Period 1|Adverse Event|1
7533429|NCT02675634|26174100|P1|Test Period 1|Adverse Event|0
7533430|NCT02675517|26174117|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
7533431|NCT02675517|26174117|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
7533432|NCT02675426|26174129|P3|Overall Study|Other|2
7533433|NCT02675426|26174130|P2|Overall Study|Other|1
7533434|NCT02675426|26174131|P1|Overall Study|Other|3
7533435|NCT02675426|26174129|P3|Overall Study|Lost to Follow-up|2
7533436|NCT02675426|26174130|P2|Overall Study|Lost to Follow-up|0
7533437|NCT02675426|26174131|P1|Overall Study|Lost to Follow-up|1
7533438|NCT02675426|26174129|P3|Overall Study|Withdrawal by Subject|5
7533439|NCT02675426|26174130|P2|Overall Study|Withdrawal by Subject|5
7533440|NCT02675426|26174131|P1|Overall Study|Withdrawal by Subject|3
7533441|NCT02675426|26174129|P3|Overall Study|Adverse Event|9
7533442|NCT02675426|26174130|P2|Overall Study|Adverse Event|2
7533443|NCT02675426|26174131|P1|Overall Study|Adverse Event|6
7533444|NCT02675231|26174175|P3|Overall Study|On study treatment/follow up|23
7533445|NCT02675231|26174176|P2|Overall Study|On study treatment/follow up|31
7533446|NCT02675231|26174177|P1|Overall Study|On study treatment/follow up|23
7533447|NCT02675231|26174175|P3|Overall Study|Lost to Follow-up|2
7533448|NCT02675231|26174176|P2|Overall Study|Lost to Follow-up|2
7533449|NCT02675231|26174177|P1|Overall Study|Lost to Follow-up|2
7533450|NCT02675231|26174175|P3|Overall Study|Withdrawal by Subject|1
7533451|NCT02675231|26174176|P2|Overall Study|Withdrawal by Subject|3
7533452|NCT02675231|26174177|P1|Overall Study|Withdrawal by Subject|1
7533453|NCT02675075|26174213|P2|Overall Study|Lost to Follow-up|0
7533454|NCT02675075|26174214|P1|Overall Study|Lost to Follow-up|3
7533455|NCT02674854|26174226|P3|Overall Study|Subject missed V6.2|0
7533456|NCT02674854|26174227|P2|Overall Study|Subject missed V6.2|0
7533457|NCT02674854|26174228|P1|Overall Study|Subject missed V6.2|1
7533458|NCT02674854|26174226|P3|Overall Study|Death|0
7533459|NCT02674854|26174227|P2|Overall Study|Death|1
7533460|NCT02674854|26174228|P1|Overall Study|Death|0
7533461|NCT02674854|26174226|P3|Overall Study|Protocol Violation|2
7533462|NCT02674854|26174227|P2|Overall Study|Protocol Violation|1
7533463|NCT02674854|26174228|P1|Overall Study|Protocol Violation|1
7533464|NCT02674854|26174226|P3|Overall Study|Disallowed Concurrent Medication|0
7533465|NCT02674854|26174227|P2|Overall Study|Disallowed Concurrent Medication|2
7533466|NCT02674854|26174228|P1|Overall Study|Disallowed Concurrent Medication|2
7533467|NCT02674854|26174226|P3|Overall Study|Lack of Efficacy|0
7533468|NCT02674854|26174227|P2|Overall Study|Lack of Efficacy|3
7533469|NCT02674854|26174228|P1|Overall Study|Lack of Efficacy|0
7533470|NCT02674854|26174226|P3|Overall Study|Lost to Follow-up|2
7533471|NCT02674854|26174227|P2|Overall Study|Lost to Follow-up|0
7533472|NCT02674854|26174228|P1|Overall Study|Lost to Follow-up|1
7533473|NCT02674854|26174226|P3|Overall Study|No-compliant subject|1
7533474|NCT02674854|26174227|P2|Overall Study|No-compliant subject|0
7533475|NCT02674854|26174228|P1|Overall Study|No-compliant subject|1
7533476|NCT02674854|26174226|P3|Overall Study|Withdrawal by Subject|4
7533477|NCT02674854|26174227|P2|Overall Study|Withdrawal by Subject|5
7533478|NCT02674854|26174228|P1|Overall Study|Withdrawal by Subject|1
7533479|NCT02674854|26174226|P3|Overall Study|Adverse Event|5
7533480|NCT02674854|26174227|P2|Overall Study|Adverse Event|15
7533481|NCT02674854|26174228|P1|Overall Study|Adverse Event|17
7533482|NCT02674685|26174236|P1|Overall Study|Protocol Violation|4
7533483|NCT02674633|26174277|P2|Overall Study|Withdrawal by Parent/Guardian|2
7533484|NCT02674633|26174278|P1|Overall Study|Withdrawal by Parent/Guardian|1
7533485|NCT02674633|26174277|P2|Overall Study|Physician Decision|0
7533486|NCT02674633|26174278|P1|Overall Study|Physician Decision|1
7533487|NCT02674633|26174277|P2|Overall Study|Lost to Follow-up|2
7533488|NCT02674633|26174278|P1|Overall Study|Lost to Follow-up|3
7533489|NCT02674568|26174298|P1|Overall Study|Other, Not Specified|20
7533490|NCT02674568|26174298|P1|Overall Study|Lost to Follow-up|9
7533491|NCT02674568|26174298|P1|Overall Study|Physician Decision|2
7533492|NCT02674568|26174298|P1|Overall Study|Death|303
7533493|NCT02674568|26174298|P1|Overall Study|Withdrawal by Subject|5
7533494|NCT02674477|26174323|P2|Overall Study|Protocol Violation|2
7533495|NCT02674477|26174324|P1|Overall Study|Protocol Violation|8
7533496|NCT02674399|26174347|P2|Overall Study|Lost to Follow-up|0
7533497|NCT02674399|26174348|P1|Overall Study|Lost to Follow-up|2
7533498|NCT02674386|26174387|P3|Overall Study|Enrolled but not evaluated|0
7533499|NCT02674386|26174388|P2|Overall Study|Enrolled but not evaluated|4
7533500|NCT02674386|26174389|P1|Overall Study|Enrolled but not evaluated|0
7533501|NCT02674386|26174387|P3|Overall Study|Other|0
7533502|NCT02674386|26174388|P2|Overall Study|Other|1
7533503|NCT02674386|26174389|P1|Overall Study|Other|0
7533504|NCT02674386|26174387|P3|Overall Study|Withdrawal by Subject|0
7533505|NCT02674386|26174388|P2|Overall Study|Withdrawal by Subject|4
7533506|NCT02674386|26174389|P1|Overall Study|Withdrawal by Subject|0
7533507|NCT02674386|26174387|P3|Overall Study|Lost to Follow-up|1
7533508|NCT02674386|26174388|P2|Overall Study|Lost to Follow-up|1
7533509|NCT02674386|26174389|P1|Overall Study|Lost to Follow-up|0
7533510|NCT02674334|26174444|P2|Overall Study|NIRS not recording|0
7533511|NCT02674334|26174445|P1|Overall Study|NIRS not recording|1
7533512|NCT02674334|26174444|P2|Overall Study|participant difficulty breathing|0
7533513|NCT02674334|26174445|P1|Overall Study|participant difficulty breathing|1
7533514|NCT02674334|26174444|P2|Overall Study|Lost to Follow-up|3
7533515|NCT02674334|26174445|P1|Overall Study|Lost to Follow-up|5
7533516|NCT02674204|26174455|P2|Overall Study|Adverse Event|0
7533517|NCT02674204|26174456|P1|Overall Study|Adverse Event|1
7533518|NCT02674061|26174492|P2|Overall Study|Ongoing in Study|20
7533519|NCT02674061|26174493|P1|Overall Study|Ongoing in Study|71
7533520|NCT02674061|26174492|P2|Overall Study|Withdrawal by Subject|2
7533521|NCT02674061|26174493|P1|Overall Study|Withdrawal by Subject|9
7533522|NCT02674061|26174492|P2|Overall Study|Lost to Follow-up|0
7533523|NCT02674061|26174493|P1|Overall Study|Lost to Follow-up|1
7533524|NCT02674061|26174492|P2|Overall Study|Death|69
7533525|NCT02674061|26174493|P1|Overall Study|Death|204
7533526|NCT02673684|26174717|P2|Overall Study|Study not completed d/t loss of funding|8
7533527|NCT02673684|26174718|P1|Overall Study|Study not completed d/t loss of funding|9
7533528|NCT02673619|26174734|P4|Overall Study|Lack of Efficacy|0
7533529|NCT02673619|26174735|P3|Overall Study|Lack of Efficacy|1
7533530|NCT02673619|26174736|P2|Overall Study|Lack of Efficacy|0
7533531|NCT02673619|26174737|P1|Overall Study|Lack of Efficacy|0
7533532|NCT02673619|26174734|P4|Overall Study|Adverse Event|0
7533533|NCT02673619|26174735|P3|Overall Study|Adverse Event|1
7533534|NCT02673619|26174736|P2|Overall Study|Adverse Event|0
7533535|NCT02673619|26174737|P1|Overall Study|Adverse Event|0
7533536|NCT02673619|26174734|P4|Overall Study|Withdrawal by Subject|0
7533537|NCT02673619|26174735|P3|Overall Study|Withdrawal by Subject|1
7533538|NCT02673619|26174736|P2|Overall Study|Withdrawal by Subject|1
7533539|NCT02673619|26174737|P1|Overall Study|Withdrawal by Subject|1
7533540|NCT02673619|26174734|P4|Overall Study|Lost to Follow-up|0
7533541|NCT02673619|26174735|P3|Overall Study|Lost to Follow-up|0
7533542|NCT02673619|26174736|P2|Overall Study|Lost to Follow-up|0
7533543|NCT02673619|26174737|P1|Overall Study|Lost to Follow-up|1
7533544|NCT02673515|26174848|P2|Overall Study|Lack of motivation|1
7533545|NCT02673515|26174849|P1|Overall Study|Lack of motivation|2
7533546|NCT02673489|26174865|P2|Follow Up Period|Unable to return for follow-up|1
7533547|NCT02673489|26174866|P1|Follow Up Period|Unable to return for follow-up|0
7533548|NCT02673489|26174865|P2|Follow Up Period|Unable to return for week 24 follow-up|1
7533549|NCT02673489|26174866|P1|Follow Up Period|Unable to return for week 24 follow-up|0
7533550|NCT02673489|26174865|P2|Treatment Period|Adverse Event|1
7533551|NCT02673489|26174866|P1|Treatment Period|Adverse Event|0
7533552|NCT02673489|26174865|P2|Treatment Period|Participant was incarcerated|1
7533553|NCT02673489|26174866|P1|Treatment Period|Participant was incarcerated|0
7533554|NCT02673489|26174865|P2|Treatment Period|Participant moved to another province|0
7533555|NCT02673489|26174866|P1|Treatment Period|Participant moved to another province|1
7533556|NCT02673489|26174865|P2|Treatment Period|Participant request to discontinue|1
7533557|NCT02673489|26174866|P1|Treatment Period|Participant request to discontinue|1
7533558|NCT02673489|26174865|P2|Treatment Period|Lost to Follow-up|0
7533559|NCT02673489|26174866|P1|Treatment Period|Lost to Follow-up|3
7533560|NCT02672852|26174931|P7|Part B|Other|2
7533561|NCT02672852|26174932|P6|Part B|Other|1
7533562|NCT02672852|26174933|P5|Part B|Other|4
7533563|NCT02672852|26174934|P4|Part B|Other|0
7533564|NCT02672852|26174935|P3|Part B|Other|0
7533565|NCT02672852|26174936|P2|Part B|Other|0
7533566|NCT02672852|26174937|P1|Part B|Other|0
7533567|NCT02672852|26174931|P7|Part B|Withdrawal by Subject|7
7533568|NCT02672852|26174932|P6|Part B|Withdrawal by Subject|0
7533569|NCT02672852|26174933|P5|Part B|Withdrawal by Subject|5
7533570|NCT02672852|26174934|P4|Part B|Withdrawal by Subject|0
7533571|NCT02672852|26174935|P3|Part B|Withdrawal by Subject|0
7533572|NCT02672852|26174936|P2|Part B|Withdrawal by Subject|0
7533573|NCT02672852|26174937|P1|Part B|Withdrawal by Subject|0
7533574|NCT02672852|26174931|P7|Part B|Lost to Follow-up|1
7533575|NCT02672852|26174932|P6|Part B|Lost to Follow-up|4
7533576|NCT02672852|26174933|P5|Part B|Lost to Follow-up|3
7533577|NCT02672852|26174934|P4|Part B|Lost to Follow-up|0
7533578|NCT02672852|26174935|P3|Part B|Lost to Follow-up|0
7533579|NCT02672852|26174936|P2|Part B|Lost to Follow-up|0
7533580|NCT02672852|26174937|P1|Part B|Lost to Follow-up|0
7533581|NCT02672852|26174931|P7|Part B|Other adverse event|1
7533582|NCT02672852|26174932|P6|Part B|Other adverse event|5
7533583|NCT02672852|26174933|P5|Part B|Other adverse event|3
7533584|NCT02672852|26174934|P4|Part B|Other adverse event|0
7533585|NCT02672852|26174935|P3|Part B|Other adverse event|0
7533586|NCT02672852|26174936|P2|Part B|Other adverse event|0
7533587|NCT02672852|26174937|P1|Part B|Other adverse event|0
7533588|NCT02672852|26174931|P7|Part B|Worsening pre-existing condition|0
7533589|NCT02672852|26174932|P6|Part B|Worsening pre-existing condition|1
7533590|NCT02672852|26174933|P5|Part B|Worsening pre-existing condition|0
7533591|NCT02672852|26174934|P4|Part B|Worsening pre-existing condition|0
7533592|NCT02672852|26174935|P3|Part B|Worsening pre-existing condition|0
7533593|NCT02672852|26174936|P2|Part B|Worsening pre-existing condition|0
7533594|NCT02672852|26174937|P1|Part B|Worsening pre-existing condition|0
7533595|NCT02672852|26174931|P7|Part B|Disease worsening|1
7533596|NCT02672852|26174932|P6|Part B|Disease worsening|0
7533597|NCT02672852|26174933|P5|Part B|Disease worsening|1
7533598|NCT02672852|26174934|P4|Part B|Disease worsening|0
7533599|NCT02672852|26174935|P3|Part B|Disease worsening|0
7533600|NCT02672852|26174936|P2|Part B|Disease worsening|0
7533601|NCT02672852|26174937|P1|Part B|Disease worsening|0
7533602|NCT02672852|26174931|P7|Part A2|Not entered in Part B|0
7533603|NCT02672852|26174932|P6|Part A2|Not entered in Part B|0
7533604|NCT02672852|26174933|P5|Part A2|Not entered in Part B|0
7533605|NCT02672852|26174934|P4|Part A2|Not entered in Part B|4
7533606|NCT02672852|26174935|P3|Part A2|Not entered in Part B|0
7533607|NCT02672852|26174936|P2|Part A2|Not entered in Part B|0
7533608|NCT02672852|26174937|P1|Part A2|Not entered in Part B|0
7533609|NCT02672852|26174931|P7|Part A2|Other|0
7533610|NCT02672852|26174932|P6|Part A2|Other|0
7533611|NCT02672852|26174933|P5|Part A2|Other|0
7533612|NCT02672852|26174934|P4|Part A2|Other|0
7533613|NCT02672852|26174935|P3|Part A2|Other|3
7533614|NCT02672852|26174936|P2|Part A2|Other|0
7533615|NCT02672852|26174937|P1|Part A2|Other|0
7533616|NCT02672852|26174931|P7|Part A2|Withdrawal by Subject|0
7533617|NCT02672852|26174932|P6|Part A2|Withdrawal by Subject|0
7533618|NCT02672852|26174933|P5|Part A2|Withdrawal by Subject|0
7533619|NCT02672852|26174934|P4|Part A2|Withdrawal by Subject|0
7533620|NCT02672852|26174935|P3|Part A2|Withdrawal by Subject|1
7533621|NCT02672852|26174936|P2|Part A2|Withdrawal by Subject|0
7533622|NCT02672852|26174937|P1|Part A2|Withdrawal by Subject|0
7533623|NCT02672852|26174931|P7|Part A2|Lost to Follow-up|0
7533624|NCT02672852|26174932|P6|Part A2|Lost to Follow-up|0
7533625|NCT02672852|26174933|P5|Part A2|Lost to Follow-up|0
7533626|NCT02672852|26174934|P4|Part A2|Lost to Follow-up|0
7533627|NCT02672852|26174935|P3|Part A2|Lost to Follow-up|2
7533628|NCT02672852|26174936|P2|Part A2|Lost to Follow-up|0
7533629|NCT02672852|26174937|P1|Part A2|Lost to Follow-up|0
7533630|NCT02672852|26174931|P7|Part A2|Adverse Event|0
7533631|NCT02672852|26174932|P6|Part A2|Adverse Event|0
7533632|NCT02672852|26174933|P5|Part A2|Adverse Event|0
7533633|NCT02672852|26174934|P4|Part A2|Adverse Event|0
7533634|NCT02672852|26174935|P3|Part A2|Adverse Event|3
7533635|NCT02672852|26174936|P2|Part A2|Adverse Event|0
7533636|NCT02672852|26174937|P1|Part A2|Adverse Event|0
7533637|NCT02672852|26174931|P7|Part A2|Disease worsening|0
7533638|NCT02672852|26174932|P6|Part A2|Disease worsening|0
7533639|NCT02672852|26174933|P5|Part A2|Disease worsening|0
7533640|NCT02672852|26174934|P4|Part A2|Disease worsening|0
7533641|NCT02672852|26174935|P3|Part A2|Disease worsening|1
7533642|NCT02672852|26174936|P2|Part A2|Disease worsening|0
7533643|NCT02672852|26174937|P1|Part A2|Disease worsening|0
7533644|NCT02672852|26174931|P7|Part A1|Withdrawal by Subject|0
7533645|NCT02672852|26174932|P6|Part A1|Withdrawal by Subject|0
7533646|NCT02672852|26174933|P5|Part A1|Withdrawal by Subject|0
7533647|NCT02672852|26174934|P4|Part A1|Withdrawal by Subject|0
7533648|NCT02672852|26174935|P3|Part A1|Withdrawal by Subject|0
7533649|NCT02672852|26174936|P2|Part A1|Withdrawal by Subject|1
7533650|NCT02672852|26174937|P1|Part A1|Withdrawal by Subject|1
7533651|NCT02672852|26174931|P7|Part A1|Lost to Follow-up|0
7533652|NCT02672852|26174932|P6|Part A1|Lost to Follow-up|0
7533653|NCT02672852|26174933|P5|Part A1|Lost to Follow-up|0
7533654|NCT02672852|26174934|P4|Part A1|Lost to Follow-up|0
7533655|NCT02672852|26174935|P3|Part A1|Lost to Follow-up|0
7533656|NCT02672852|26174936|P2|Part A1|Lost to Follow-up|2
7533657|NCT02672852|26174937|P1|Part A1|Lost to Follow-up|1
7533658|NCT02672852|26174931|P7|Part A1|Adverse Event|0
7533659|NCT02672852|26174932|P6|Part A1|Adverse Event|0
7533660|NCT02672852|26174933|P5|Part A1|Adverse Event|0
7533661|NCT02672852|26174934|P4|Part A1|Adverse Event|0
7533662|NCT02672852|26174935|P3|Part A1|Adverse Event|0
7533663|NCT02672852|26174936|P2|Part A1|Adverse Event|1
7533664|NCT02672852|26174937|P1|Part A1|Adverse Event|0
7533665|NCT02672852|26174931|P7|Part A1|Disease Worsening|0
7533666|NCT02672852|26174932|P6|Part A1|Disease Worsening|0
7533667|NCT02672852|26174933|P5|Part A1|Disease Worsening|0
7533668|NCT02672852|26174934|P4|Part A1|Disease Worsening|0
7533669|NCT02672852|26174935|P3|Part A1|Disease Worsening|0
7533670|NCT02672852|26174936|P2|Part A1|Disease Worsening|0
7533671|NCT02672852|26174937|P1|Part A1|Disease Worsening|1
7533672|NCT02672553|26174968|P2|Overall Study|Intraoperative screen failure|0
7533673|NCT02672553|26174969|P1|Overall Study|Intraoperative screen failure|2
7533674|NCT02672553|26174968|P2|Overall Study|Withdrawal by Subject|3
7533675|NCT02672553|26174969|P1|Overall Study|Withdrawal by Subject|3
7533676|NCT02672553|26174968|P2|Overall Study|Conversion to Commercial Valve|0
7533677|NCT02672553|26174969|P1|Overall Study|Conversion to Commercial Valve|3
7533678|NCT02672553|26174968|P2|Overall Study|Valve Explant|0
7533679|NCT02672553|26174969|P1|Overall Study|Valve Explant|1
7533680|NCT02672553|26174968|P2|Overall Study|Death|5
7533681|NCT02672553|26174969|P1|Overall Study|Death|3
7533682|NCT02672423|26175041|P10|Period 3|Physician Decision|0
7533683|NCT02672423|26175042|P9|Period 3|Physician Decision|0
7533684|NCT02672423|26175043|P8|Period 3|Physician Decision|0
7533685|NCT02672423|26175044|P7|Period 3|Physician Decision|0
7533686|NCT02672423|26175045|P6|Period 3|Physician Decision|1
7533687|NCT02672423|26175046|P5|Period 3|Physician Decision|0
7533688|NCT02672423|26175047|P4|Period 3|Physician Decision|0
7533689|NCT02672423|26175048|P3|Period 3|Physician Decision|0
7533690|NCT02672423|26175049|P2|Period 3|Physician Decision|0
7533691|NCT02672423|26175050|P1|Period 3|Physician Decision|0
7533692|NCT02672423|26175041|P10|Period 3|Withdrawal by Subject|0
7533693|NCT02672423|26175042|P9|Period 3|Withdrawal by Subject|0
7533694|NCT02672423|26175043|P8|Period 3|Withdrawal by Subject|1
7533695|NCT02672423|26175044|P7|Period 3|Withdrawal by Subject|0
7533696|NCT02672423|26175045|P6|Period 3|Withdrawal by Subject|0
7533697|NCT02672423|26175046|P5|Period 3|Withdrawal by Subject|0
7533698|NCT02672423|26175047|P4|Period 3|Withdrawal by Subject|0
7533699|NCT02672423|26175048|P3|Period 3|Withdrawal by Subject|0
7533700|NCT02672423|26175049|P2|Period 3|Withdrawal by Subject|0
7533701|NCT02672423|26175050|P1|Period 3|Withdrawal by Subject|0
7533702|NCT02672423|26175041|P10|Period 2|Withdrawal by Subject|0
7533703|NCT02672423|26175042|P9|Period 2|Withdrawal by Subject|0
7533704|NCT02672423|26175043|P8|Period 2|Withdrawal by Subject|0
7533705|NCT02672423|26175044|P7|Period 2|Withdrawal by Subject|0
7533706|NCT02672423|26175045|P6|Period 2|Withdrawal by Subject|0
7533707|NCT02672423|26175046|P5|Period 2|Withdrawal by Subject|0
7533708|NCT02672423|26175047|P4|Period 2|Withdrawal by Subject|0
7533709|NCT02672423|26175048|P3|Period 2|Withdrawal by Subject|1
7533710|NCT02672423|26175049|P2|Period 2|Withdrawal by Subject|0
7533711|NCT02672423|26175050|P1|Period 2|Withdrawal by Subject|0
7533712|NCT02672423|26175041|P10|Period 1|Adverse Event|0
7533713|NCT02672423|26175042|P9|Period 1|Adverse Event|0
7533714|NCT02672423|26175043|P8|Period 1|Adverse Event|0
7533715|NCT02672423|26175044|P7|Period 1|Adverse Event|0
7533716|NCT02672423|26175045|P6|Period 1|Adverse Event|0
7533717|NCT02672423|26175046|P5|Period 1|Adverse Event|1
7533718|NCT02672423|26175047|P4|Period 1|Adverse Event|0
7533719|NCT02672423|26175048|P3|Period 1|Adverse Event|0
7533720|NCT02672423|26175049|P2|Period 1|Adverse Event|0
7533721|NCT02672423|26175050|P1|Period 1|Adverse Event|0
7533722|NCT02671760|26175145|P3|Overall Study|Lost to Follow-up|0
7533723|NCT02671760|26175146|P2|Overall Study|Lost to Follow-up|1
7533724|NCT02671760|26175147|P1|Overall Study|Lost to Follow-up|0
7533725|NCT02671500|26175173|P1|Overall Study|Lost to Follow-up|2
7533726|NCT02671500|26175173|P1|Overall Study|Lack of Efficacy|12
7533727|NCT02671461|26175188|P3|Follow-up|Administrative Reason by Sponsor|0
7533728|NCT02671461|26175189|P2|Follow-up|Administrative Reason by Sponsor|1
7533729|NCT02671461|26175190|P1|Follow-up|Administrative Reason by Sponsor|0
7533730|NCT02671461|26175188|P3|Follow-up|Lost to Follow-up|1
7533731|NCT02671461|26175189|P2|Follow-up|Lost to Follow-up|0
7533732|NCT02671461|26175190|P1|Follow-up|Lost to Follow-up|0
7533733|NCT02671461|26175188|P3|Follow-up|Withdrawal by Subject|0
7533734|NCT02671461|26175189|P2|Follow-up|Withdrawal by Subject|0
7533735|NCT02671461|26175190|P1|Follow-up|Withdrawal by Subject|1
7533736|NCT02671461|26175188|P3|Treatment|Randomized, not treated|0
7533737|NCT02671461|26175189|P2|Treatment|Randomized, not treated|0
7533738|NCT02671461|26175190|P1|Treatment|Randomized, not treated|1
7533739|NCT02671461|26175188|P3|Treatment|Administrative Reason by Sponsor|4
7533740|NCT02671461|26175189|P2|Treatment|Administrative Reason by Sponsor|3
7533741|NCT02671461|26175190|P1|Treatment|Administrative Reason by Sponsor|1
7533742|NCT02671461|26175188|P3|Treatment|Adverse Event|1
7533743|NCT02671461|26175189|P2|Treatment|Adverse Event|0
7533744|NCT02671461|26175190|P1|Treatment|Adverse Event|0
7533745|NCT02671422|26175213|P1|Overall Study|Other not defined above|3
7533746|NCT02671422|26175213|P1|Overall Study|Not treated with Vargatef®|3
7533747|NCT02671422|26175213|P1|Overall Study|Adverse Event unrelated to Vargatef®|8
7533748|NCT02671422|26175213|P1|Overall Study|Sponsor decision|5
7533749|NCT02671422|26175213|P1|Overall Study|Worsening of Disease|4
7533750|NCT02671422|26175213|P1|Overall Study|Progressive Disease|156
7533751|NCT02671422|26175213|P1|Overall Study|Withdrawal by Subject|7
7533752|NCT02671422|26175213|P1|Overall Study|Lost to Follow-up|4
7533753|NCT02671422|26175213|P1|Overall Study|Lack of Efficacy|1
7533754|NCT02671422|26175213|P1|Overall Study|Adverse Event|68
7533755|NCT02671422|26175213|P1|Overall Study|Lost to Follow-up|1
7533756|NCT02671266|26175219|P2|Overall Study|Withdrawal by Subject|1
7533757|NCT02671266|26175220|P1|Overall Study|Withdrawal by Subject|1
7533758|NCT02670928|26175251|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
7533759|NCT02670928|26175252|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
7533760|NCT02670928|26175251|P2|Overall Study|Lost to Follow-up|0
7533761|NCT02670928|26175252|P1|Overall Study|Lost to Follow-up|1
7533762|NCT02670928|26175251|P2|Overall Study|Withdrawal by Subject|0
7533763|NCT02670928|26175252|P1|Overall Study|Withdrawal by Subject|4
7533764|NCT02670928|26175251|P2|Overall Study|Adverse Event|1
7533765|NCT02670928|26175252|P1|Overall Study|Adverse Event|3
7533766|NCT02670915|26175279|P3|Overall Study|Unclassified|0
7533767|NCT02670915|26175280|P2|Overall Study|Unclassified|3
7533768|NCT02670915|26175281|P1|Overall Study|Unclassified|0
7533769|NCT02670915|26175279|P3|Overall Study|Withdrawal by parent/guardian|1
7533770|NCT02670915|26175280|P2|Overall Study|Withdrawal by parent/guardian|4
7533771|NCT02670915|26175281|P1|Overall Study|Withdrawal by parent/guardian|4
7533772|NCT02670915|26175279|P3|Overall Study|Withdrawal by Subject|4
7533773|NCT02670915|26175280|P2|Overall Study|Withdrawal by Subject|1
7533774|NCT02670915|26175281|P1|Overall Study|Withdrawal by Subject|0
7533775|NCT02670551|26175565|P3|Overall Study|Did Not Receive Treatment|0
7533776|NCT02670551|26175566|P2|Overall Study|Did Not Receive Treatment|3
7533777|NCT02670551|26175567|P1|Overall Study|Did Not Receive Treatment|5
7533778|NCT02670551|26175565|P3|Overall Study|Other Miscellaneous Reasons|3
7533779|NCT02670551|26175566|P2|Overall Study|Other Miscellaneous Reasons|3
7533780|NCT02670551|26175567|P1|Overall Study|Other Miscellaneous Reasons|2
7533781|NCT02670551|26175565|P3|Overall Study|Noncompliance with study drug|2
7533782|NCT02670551|26175566|P2|Overall Study|Noncompliance with study drug|3
7533783|NCT02670551|26175567|P1|Overall Study|Noncompliance with study drug|3
7533784|NCT02670551|26175565|P3|Overall Study|Protocol Violation|0
7533785|NCT02670551|26175566|P2|Overall Study|Protocol Violation|0
7533786|NCT02670551|26175567|P1|Overall Study|Protocol Violation|1
7533787|NCT02670551|26175565|P3|Overall Study|Lost to Follow-up|6
7533788|NCT02670551|26175566|P2|Overall Study|Lost to Follow-up|7
7533789|NCT02670551|26175567|P1|Overall Study|Lost to Follow-up|5
7533790|NCT02670551|26175565|P3|Overall Study|Withdrawal of Consent|8
7533791|NCT02670551|26175566|P2|Overall Study|Withdrawal of Consent|3
7533792|NCT02670551|26175567|P1|Overall Study|Withdrawal of Consent|6
7533793|NCT02670551|26175565|P3|Overall Study|Lack of Efficacy|3
7533794|NCT02670551|26175566|P2|Overall Study|Lack of Efficacy|0
7533795|NCT02670551|26175567|P1|Overall Study|Lack of Efficacy|2
7533796|NCT02670551|26175565|P3|Overall Study|Adverse Event|9
7533797|NCT02670551|26175566|P2|Overall Study|Adverse Event|7
7533798|NCT02670551|26175567|P1|Overall Study|Adverse Event|4
7533799|NCT02670538|26175581|P3|Overall Study|Other Miscellaneous Reasons|2
7533800|NCT02670538|26175582|P2|Overall Study|Other Miscellaneous Reasons|1
7533801|NCT02670538|26175583|P1|Overall Study|Other Miscellaneous Reasons|0
7533802|NCT02670538|26175581|P3|Overall Study|Noncompliance with Study Drug|2
7533803|NCT02670538|26175582|P2|Overall Study|Noncompliance with Study Drug|3
7533804|NCT02670538|26175583|P1|Overall Study|Noncompliance with Study Drug|1
7533805|NCT02670538|26175581|P3|Overall Study|Protocol Violation|1
7533806|NCT02670538|26175582|P2|Overall Study|Protocol Violation|4
7533807|NCT02670538|26175583|P1|Overall Study|Protocol Violation|3
7533808|NCT02670538|26175581|P3|Overall Study|Lack of Efficacy|2
7533809|NCT02670538|26175582|P2|Overall Study|Lack of Efficacy|1
7533810|NCT02670538|26175583|P1|Overall Study|Lack of Efficacy|7
7533811|NCT02670538|26175581|P3|Overall Study|Adverse Event|11
7533812|NCT02670538|26175582|P2|Overall Study|Adverse Event|5
7533813|NCT02670538|26175583|P1|Overall Study|Adverse Event|5
7533814|NCT02670538|26175581|P3|Overall Study|Lost to Follow-up|7
7533815|NCT02670538|26175582|P2|Overall Study|Lost to Follow-up|12
7533816|NCT02670538|26175583|P1|Overall Study|Lost to Follow-up|8
7533817|NCT02670538|26175581|P3|Overall Study|Withdrawal of Consent|5
7533818|NCT02670538|26175582|P2|Overall Study|Withdrawal of Consent|6
7533819|NCT02670538|26175583|P1|Overall Study|Withdrawal of Consent|8
7533820|NCT02670473|26175594|P1|Overall Study|Withdrawal by Subject|1
7533821|NCT02670382|26175647|P2|Placebo lead-in Phase|Withdrawal by Subject|1
7533822|NCT02670382|26175648|P1|Placebo lead-in Phase|Withdrawal by Subject|2
7533823|NCT02670330|26175668|P2|Overall Study|Lost to Follow-up|2
7533824|NCT02670330|26175669|P1|Overall Study|Lost to Follow-up|3
7533825|NCT02670330|26175668|P2|Overall Study|Withdrawal by Subject|29
7533826|NCT02670330|26175669|P1|Overall Study|Withdrawal by Subject|34
7533827|NCT02670330|26175668|P2|Overall Study|Adverse Event|3
7533828|NCT02670330|26175669|P1|Overall Study|Adverse Event|1
7533829|NCT02670330|26175668|P2|Overall Study|Study Terminated By Sponsor|43
7533830|NCT02670330|26175669|P1|Overall Study|Study Terminated By Sponsor|36
7533831|NCT02670330|26175668|P2|Overall Study|Protocol Deviation|0
7533832|NCT02670330|26175669|P1|Overall Study|Protocol Deviation|1
7533833|NCT02670122|26175679|P1|Overall Study|Lost to Follow-up|4
7533834|NCT02670083|26175692|P2|Overall Study|Non-Compliance With Study Drug|0
7533835|NCT02670083|26175693|P1|Overall Study|Non-Compliance With Study Drug|1
7533836|NCT02670083|26175692|P2|Overall Study|Withdrawal by Subject|31
7533837|NCT02670083|26175693|P1|Overall Study|Withdrawal by Subject|32
7533838|NCT02670083|26175692|P2|Overall Study|Symptomatic Deterioration|2
7533839|NCT02670083|26175693|P1|Overall Study|Symptomatic Deterioration|0
7533840|NCT02670083|26175692|P2|Overall Study|Study Terminated By Sponsor|254
7533841|NCT02670083|26175693|P1|Overall Study|Study Terminated By Sponsor|257
7533842|NCT02670083|26175692|P2|Overall Study|Physician Decision|2
7533843|NCT02670083|26175693|P1|Overall Study|Physician Decision|0
7533844|NCT02670083|26175692|P2|Overall Study|Multiple Reasons|9
7533845|NCT02670083|26175693|P1|Overall Study|Multiple Reasons|9
7533846|NCT02670083|26175692|P2|Overall Study|Lost to Follow-up|2
7533847|NCT02670083|26175693|P1|Overall Study|Lost to Follow-up|2
7533848|NCT02670083|26175692|P2|Overall Study|Death|6
7533849|NCT02670083|26175693|P1|Overall Study|Death|4
7533850|NCT02670083|26175692|P2|Overall Study|Adverse Event|13
7533851|NCT02670083|26175693|P1|Overall Study|Adverse Event|16
7533852|NCT02669940|26175738|P2|Overall Study|Insufficient follow-up data|0
7533853|NCT02669940|26175739|P1|Overall Study|Insufficient follow-up data|1
7533854|NCT02669940|26175738|P2|Overall Study|Failure to return|3
7533855|NCT02669940|26175739|P1|Overall Study|Failure to return|0
7533856|NCT02669862|26175841|P3|Overall Study|Protocol Violation|1
7533857|NCT02669862|26175842|P2|Overall Study|Protocol Violation|0
7533858|NCT02669862|26175843|P1|Overall Study|Protocol Violation|0
7533859|NCT02669862|26175841|P3|Overall Study|moved|0
7533860|NCT02669862|26175842|P2|Overall Study|moved|1
7533861|NCT02669862|26175843|P1|Overall Study|moved|0
7533862|NCT02669862|26175841|P3|Overall Study|Withdrawal by Subject|3
7533863|NCT02669862|26175842|P2|Overall Study|Withdrawal by Subject|2
7533864|NCT02669862|26175843|P1|Overall Study|Withdrawal by Subject|2
7533865|NCT02669862|26175841|P3|Overall Study|Lost to Follow-up|1
7533866|NCT02669862|26175842|P2|Overall Study|Lost to Follow-up|2
7533867|NCT02669862|26175843|P1|Overall Study|Lost to Follow-up|0
7533868|NCT02669849|26175859|P3|Overall Study|Other|2
7533869|NCT02669849|26175860|P2|Overall Study|Other|0
7533870|NCT02669849|26175861|P1|Overall Study|Other|0
7533871|NCT02669849|26175859|P3|Overall Study|Study terminated by sponsor|14
7533872|NCT02669849|26175860|P2|Overall Study|Study terminated by sponsor|1
7533873|NCT02669849|26175861|P1|Overall Study|Study terminated by sponsor|16
7533874|NCT02669849|26175859|P3|Overall Study|Death|2
7533875|NCT02669849|26175860|P2|Overall Study|Death|1
7533876|NCT02669849|26175861|P1|Overall Study|Death|1
7533877|NCT02669849|26175859|P3|Overall Study|Lost to Follow-up|3
7533878|NCT02669849|26175860|P2|Overall Study|Lost to Follow-up|0
7533879|NCT02669849|26175861|P1|Overall Study|Lost to Follow-up|1
7533880|NCT02669849|26175859|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
7533881|NCT02669849|26175860|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
7533882|NCT02669849|26175861|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
7533883|NCT02669758|26175904|P1|Overall Study|Protocol Violation|1
7533884|NCT02669758|26175904|P1|Overall Study|Study noncompliance|1
7533885|NCT02669758|26175904|P1|Overall Study|Pregnancy|1
7533886|NCT02669758|26175904|P1|Overall Study|Lack of Efficacy|5
7533887|NCT02669758|26175904|P1|Overall Study|Non-Compliance with Study Drug|8
7533888|NCT02669758|26175904|P1|Overall Study|Adverse Event|16
7533889|NCT02669758|26175904|P1|Overall Study|Lost to Follow-up|19
7533890|NCT02669758|26175904|P1|Overall Study|Withdrawal by Subject|43
7533891|NCT02669667|26175915|P7|Overall Study|Lost to Follow-up|0
7533892|NCT02669667|26175916|P6|Overall Study|Lost to Follow-up|1
7533893|NCT02669667|26175917|P5|Overall Study|Lost to Follow-up|0
7533894|NCT02669667|26175918|P4|Overall Study|Lost to Follow-up|0
7533895|NCT02669667|26175919|P3|Overall Study|Lost to Follow-up|0
7533896|NCT02669667|26175920|P2|Overall Study|Lost to Follow-up|0
7533897|NCT02669667|26175921|P1|Overall Study|Lost to Follow-up|0
7533898|NCT02669433|26176024|P3|Overall Study|Death|1
7533899|NCT02669433|26176025|P2|Overall Study|Death|1
7533900|NCT02669433|26176026|P1|Overall Study|Death|0
7533901|NCT02669433|26176024|P3|Overall Study|Withdrawal by Caregiver|2
7533902|NCT02669433|26176025|P2|Overall Study|Withdrawal by Caregiver|0
7533903|NCT02669433|26176026|P1|Overall Study|Withdrawal by Caregiver|1
7533904|NCT02669433|26176024|P3|Overall Study|Withdrawal by Subject|0
7533905|NCT02669433|26176025|P2|Overall Study|Withdrawal by Subject|1
7533906|NCT02669433|26176026|P1|Overall Study|Withdrawal by Subject|5
7533907|NCT02669433|26176024|P3|Overall Study|Sponsor Termination|1
7533908|NCT02669433|26176025|P2|Overall Study|Sponsor Termination|0
7533909|NCT02669433|26176026|P1|Overall Study|Sponsor Termination|1
7533910|NCT02669433|26176024|P3|Overall Study|Adverse Event|10
7533911|NCT02669433|26176025|P2|Overall Study|Adverse Event|7
7533912|NCT02669433|26176026|P1|Overall Study|Adverse Event|6
7533913|NCT02669433|26176024|P3|Overall Study|Physician Decision|0
7533914|NCT02669433|26176025|P2|Overall Study|Physician Decision|1
7533915|NCT02669433|26176026|P1|Overall Study|Physician Decision|1
7533916|NCT02669433|26176024|P3|Overall Study|Disease Progression|0
7533917|NCT02669433|26176025|P2|Overall Study|Disease Progression|0
7533918|NCT02669433|26176026|P1|Overall Study|Disease Progression|1
7533919|NCT02669433|26176024|P3|Overall Study|Protocol Violation|1
7533920|NCT02669433|26176025|P2|Overall Study|Protocol Violation|4
7533921|NCT02669433|26176026|P1|Overall Study|Protocol Violation|0
7533922|NCT02669407|26176040|P1|Overall Study|Physician Decision|3
7533923|NCT02669264|26176069|P7|Overall Study|Miscellaneous|2
7533924|NCT02669264|26176070|P6|Overall Study|Miscellaneous|0
7533925|NCT02669264|26176071|P5|Overall Study|Miscellaneous|0
7533926|NCT02669264|26176072|P4|Overall Study|Miscellaneous|0
7533927|NCT02669264|26176073|P3|Overall Study|Miscellaneous|0
7533928|NCT02669264|26176074|P2|Overall Study|Miscellaneous|0
7533929|NCT02669264|26176075|P1|Overall Study|Miscellaneous|0
7533930|NCT02669264|26176069|P7|Overall Study|Lost to Follow-up|0
7533931|NCT02669264|26176070|P6|Overall Study|Lost to Follow-up|0
7533932|NCT02669264|26176071|P5|Overall Study|Lost to Follow-up|1
7533933|NCT02669264|26176072|P4|Overall Study|Lost to Follow-up|0
7533934|NCT02669264|26176073|P3|Overall Study|Lost to Follow-up|0
7533935|NCT02669264|26176074|P2|Overall Study|Lost to Follow-up|0
7533936|NCT02669264|26176075|P1|Overall Study|Lost to Follow-up|0
7533937|NCT02669264|26176069|P7|Overall Study|Withdrawal by Subject|0
7533938|NCT02669264|26176070|P6|Overall Study|Withdrawal by Subject|0
7533939|NCT02669264|26176071|P5|Overall Study|Withdrawal by Subject|1
7533940|NCT02669264|26176072|P4|Overall Study|Withdrawal by Subject|0
7533941|NCT02669264|26176073|P3|Overall Study|Withdrawal by Subject|0
7533942|NCT02669264|26176074|P2|Overall Study|Withdrawal by Subject|1
7533943|NCT02669264|26176075|P1|Overall Study|Withdrawal by Subject|0
7533944|NCT02669264|26176069|P7|Overall Study|Death|3
7533945|NCT02669264|26176070|P6|Overall Study|Death|6
7533946|NCT02669264|26176071|P5|Overall Study|Death|3
7533947|NCT02669264|26176072|P4|Overall Study|Death|3
7533948|NCT02669264|26176073|P3|Overall Study|Death|3
7533949|NCT02669264|26176074|P2|Overall Study|Death|5
7533950|NCT02669264|26176075|P1|Overall Study|Death|5
7533951|NCT02669121|26176221|P2|Overall Study|Reason not Specified|18
7533952|NCT02669121|26176222|P1|Overall Study|Reason not Specified|22
7533953|NCT02669121|26176221|P2|Overall Study|Discharged from US Military Active Service|91
7533954|NCT02669121|26176222|P1|Overall Study|Discharged from US Military Active Service|117
7533955|NCT02669121|26176221|P2|Overall Study|Pregnancy|1
7533956|NCT02669121|26176222|P1|Overall Study|Pregnancy|0
7533957|NCT02669121|26176221|P2|Overall Study|Withdrawal by Subject|140
7533958|NCT02669121|26176222|P1|Overall Study|Withdrawal by Subject|132
7533959|NCT02669121|26176221|P2|Overall Study|Lost to Follow-up|27
7533960|NCT02669121|26176222|P1|Overall Study|Lost to Follow-up|15
7533961|NCT02669121|26176221|P2|Overall Study|Adverse Event|5
7533962|NCT02669121|26176222|P1|Overall Study|Adverse Event|4
7533963|NCT02669095|26176236|P2|Overall Study|Visit 5 assessments not completed|1
7533964|NCT02669095|26176237|P1|Overall Study|Visit 5 assessments not completed|0
7533965|NCT02669095|26176236|P2|Overall Study|Torn Lens|1
7533966|NCT02669095|26176237|P1|Overall Study|Torn Lens|0
7533967|NCT02669095|26176236|P2|Overall Study|Unsatisfactory Lens Fitting|1
7533968|NCT02669095|26176237|P1|Overall Study|Unsatisfactory Lens Fitting|0
7533969|NCT02669095|26176236|P2|Overall Study|Adverse Event|0
7533970|NCT02669095|26176237|P1|Overall Study|Adverse Event|1
7533971|NCT02669082|26176245|P1|Overall Study|Adverse Event|1
7533972|NCT02669043|26176257|P1|Overall Study|Didn't meet I/E criteria|4
7533973|NCT02669017|26176270|P9|Overall Study|Miscellaneous|2
7533974|NCT02669017|26176271|P8|Overall Study|Miscellaneous|13
7533975|NCT02669017|26176272|P7|Overall Study|Miscellaneous|1
7533976|NCT02669017|26176273|P6|Overall Study|Miscellaneous|1
7533977|NCT02669017|26176274|P5|Overall Study|Miscellaneous|2
7533978|NCT02669017|26176275|P4|Overall Study|Miscellaneous|0
7533979|NCT02669017|26176276|P3|Overall Study|Miscellaneous|0
7533980|NCT02669017|26176277|P2|Overall Study|Miscellaneous|0
7533981|NCT02669017|26176278|P1|Overall Study|Miscellaneous|0
7533982|NCT02669017|26176270|P9|Overall Study|Lost to Follow-up|1
7533983|NCT02669017|26176271|P8|Overall Study|Lost to Follow-up|0
7533984|NCT02669017|26176272|P7|Overall Study|Lost to Follow-up|0
7533985|NCT02669017|26176273|P6|Overall Study|Lost to Follow-up|0
7533986|NCT02669017|26176274|P5|Overall Study|Lost to Follow-up|0
7533987|NCT02669017|26176275|P4|Overall Study|Lost to Follow-up|0
7533988|NCT02669017|26176276|P3|Overall Study|Lost to Follow-up|0
7533989|NCT02669017|26176277|P2|Overall Study|Lost to Follow-up|0
7533990|NCT02669017|26176278|P1|Overall Study|Lost to Follow-up|0
7533991|NCT02669017|26176270|P9|Overall Study|Withdrawal by Subject|2
7533992|NCT02669017|26176271|P8|Overall Study|Withdrawal by Subject|2
7533993|NCT02669017|26176272|P7|Overall Study|Withdrawal by Subject|0
7533994|NCT02669017|26176273|P6|Overall Study|Withdrawal by Subject|0
7533995|NCT02669017|26176274|P5|Overall Study|Withdrawal by Subject|2
7533996|NCT02669017|26176275|P4|Overall Study|Withdrawal by Subject|1
7533997|NCT02669017|26176276|P3|Overall Study|Withdrawal by Subject|0
7533998|NCT02669017|26176277|P2|Overall Study|Withdrawal by Subject|0
7533999|NCT02669017|26176278|P1|Overall Study|Withdrawal by Subject|0
7534000|NCT02669017|26176270|P9|Overall Study|Death|20
7534001|NCT02669017|26176271|P8|Overall Study|Death|47
7534002|NCT02669017|26176272|P7|Overall Study|Death|10
7534003|NCT02669017|26176273|P6|Overall Study|Death|18
7534004|NCT02669017|26176274|P5|Overall Study|Death|8
7534005|NCT02669017|26176275|P4|Overall Study|Death|3
7534006|NCT02669017|26176276|P3|Overall Study|Death|2
7534007|NCT02669017|26176277|P2|Overall Study|Death|2
7534008|NCT02669017|26176278|P1|Overall Study|Death|1
7534009|NCT02668822|26176423|P2|Overall Study|Study Terminated by Sponsor|9
7534010|NCT02668822|26176424|P1|Overall Study|Study Terminated by Sponsor|7
7534011|NCT02668822|26176423|P2|Overall Study|Protocol Violation|0
7534012|NCT02668822|26176424|P1|Overall Study|Protocol Violation|2
7534013|NCT02668783|26176446|P2|Overall Study|Withdrawal by Subject|0
7534014|NCT02668783|26176447|P1|Overall Study|Withdrawal by Subject|1
7534015|NCT02668783|26176446|P2|Overall Study|Subject moved|0
7534016|NCT02668783|26176447|P1|Overall Study|Subject moved|1
7534017|NCT02668783|26176446|P2|Overall Study|Study terminated by sponsor|10
7534018|NCT02668783|26176447|P1|Overall Study|Study terminated by sponsor|9
7534019|NCT02668783|26176446|P2|Overall Study|Protocol Violation|1
7534020|NCT02668783|26176447|P1|Overall Study|Protocol Violation|2
7534021|NCT02668783|26176446|P2|Overall Study|Pregnancy|1
7534022|NCT02668783|26176447|P1|Overall Study|Pregnancy|0
7534023|NCT02668692|26176469|P2|Overall Study|Adverse Event|0
7534024|NCT02668692|26176470|P1|Overall Study|Adverse Event|1
7534025|NCT02668640|26176480|P1|Overall Study|Other, not specified|1
7534026|NCT02668640|26176480|P1|Overall Study|Lost to Follow-up|13
7534027|NCT02668393|26176532|P2|Overall Study|Lack of benefit and side effects|0
7534028|NCT02668393|26176533|P1|Overall Study|Lack of benefit and side effects|1
7534029|NCT02668393|26176532|P2|Overall Study|Withdrawal from the trial|1
7534030|NCT02668393|26176533|P1|Overall Study|Withdrawal from the trial|0
7534031|NCT02668393|26176532|P2|Overall Study|Adverse Event|2
7534032|NCT02668393|26176533|P1|Overall Study|Adverse Event|0
7534033|NCT02668393|26176532|P2|Overall Study|Progressive disease|3
7534034|NCT02668393|26176533|P1|Overall Study|Progressive disease|6
7534035|NCT02668302|26176542|P2|Overall Study|Withdrawal by Subject|0
7534036|NCT02668302|26176543|P1|Overall Study|Withdrawal by Subject|1
7534037|NCT02668185|26176561|P2|Second Intervention (4 Weeks)|Physician Decision|3
7534038|NCT02668185|26176562|P1|Second Intervention (4 Weeks)|Physician Decision|1
7534039|NCT02668185|26176561|P2|Washout Period (2 Weeks)|Physician Decision|2
7534040|NCT02668185|26176562|P1|Washout Period (2 Weeks)|Physician Decision|0
7534041|NCT02668185|26176561|P2|Washout Period (2 Weeks)|Adverse Event|0
7534042|NCT02668185|26176562|P1|Washout Period (2 Weeks)|Adverse Event|1
7534043|NCT02668185|26176561|P2|First Intervention (4 Weeks)|Physician Decision|0
7534044|NCT02668185|26176562|P1|First Intervention (4 Weeks)|Physician Decision|2
7534051|NCT02667626|26176767|P2|Overall Study|Withdrawal by Subject|1
7534052|NCT02667626|26176768|P1|Overall Study|Withdrawal by Subject|0
7534053|NCT02667457|26176784|P2|Overall Study|Other Reason|2
7534054|NCT02667457|26176785|P1|Overall Study|Other Reason|0
7534055|NCT02667457|26176784|P2|Overall Study|Withdrawal by Subject|0
7534056|NCT02667457|26176785|P1|Overall Study|Withdrawal by Subject|1
7534057|NCT02667301|26176823|P1|Overall Study|Lack of Efficacy|1
7534058|NCT02667301|26176823|P1|Overall Study|Adverse Event|1
7534059|NCT02667288|26176829|P1|Overall Study|Withdrawal by Subject|5
7534060|NCT02667288|26176829|P1|Overall Study|Lost to Follow-up|3
7534061|NCT02667288|26176829|P1|Overall Study|Protocol Violation|5
7534062|NCT02667275|26176836|P2|Overall Study|Discontinued early without completing|1
7534063|NCT02667275|26176837|P1|Overall Study|Discontinued early without completing|0
7534064|NCT02667275|26176836|P2|Overall Study|Withdrawal by Subject|5
7534065|NCT02667275|26176837|P1|Overall Study|Withdrawal by Subject|0
7534066|NCT02667275|26176836|P2|Overall Study|Lost to Follow-up|2
7534067|NCT02667275|26176837|P1|Overall Study|Lost to Follow-up|0
7534068|NCT02667275|26176836|P2|Overall Study|Protocol Violation|7
7534069|NCT02667275|26176837|P1|Overall Study|Protocol Violation|11
7534070|NCT02667236|26176847|P2|Overall Study|Withdrawal by Subject|0
7534071|NCT02667236|26176848|P1|Overall Study|Withdrawal by Subject|2
7534072|NCT02667236|26176847|P2|Overall Study|Adverse Event|1
7534073|NCT02667236|26176848|P1|Overall Study|Adverse Event|1
7534074|NCT02666664|26177001|P2|Overall Study|Lost to Follow-up|2
7534075|NCT02666664|26177002|P1|Overall Study|Lost to Follow-up|1
7534076|NCT02666664|26177001|P2|Overall Study|Sponsor decision|1
7534077|NCT02666664|26177002|P1|Overall Study|Sponsor decision|0
7534078|NCT02666664|26177001|P2|Overall Study|Withdrawal by participant|40
7534079|NCT02666664|26177002|P1|Overall Study|Withdrawal by participant|23
7534080|NCT02666664|26177001|P2|Overall Study|Adverse Event|37
7534081|NCT02666664|26177002|P1|Overall Study|Adverse Event|12
7534082|NCT02666664|26177001|P2|Overall Study|Other|1
7534083|NCT02666664|26177002|P1|Overall Study|Other|0
7534084|NCT02666664|26177001|P2|Overall Study|Protocol Violation|2
7534085|NCT02666664|26177002|P1|Overall Study|Protocol Violation|0
7534086|NCT02666664|26177001|P2|Overall Study|Physician Decision|1
7534087|NCT02666664|26177002|P1|Overall Study|Physician Decision|0
7534088|NCT02666430|26177100|P2|Period 3|Lost to Follow-up|0
7534089|NCT02666430|26177101|P1|Period 3|Lost to Follow-up|1
7534090|NCT02666430|26177100|P2|Period 2|Withdrawal by Subject|4
7534091|NCT02666430|26177101|P1|Period 2|Withdrawal by Subject|1
7534092|NCT02666430|26177100|P2|Period 1|Adverse Event|1
7534093|NCT02666430|26177101|P1|Period 1|Adverse Event|0
7534094|NCT02666430|26177100|P2|Period 1|Lost to Follow-up|0
7534095|NCT02666430|26177101|P1|Period 1|Lost to Follow-up|1
7534096|NCT02666222|26177236|P1|Overall Study|Death|2
7534097|NCT02665689|26177306|P2|Overall Study|Lost to Follow-up|1
7534098|NCT02665689|26177307|P1|Overall Study|Lost to Follow-up|0
7534099|NCT02665689|26177306|P2|Overall Study|Trial termination|1
7534100|NCT02665689|26177307|P1|Overall Study|Trial termination|1
7534101|NCT02665689|26177306|P2|Overall Study|Adverse Event|0
7534102|NCT02665689|26177307|P1|Overall Study|Adverse Event|1
7534103|NCT02665455|26177342|P1|Overall Study|Protocol Violation|1
7534104|NCT02665455|26177342|P1|Overall Study|Adverse Event|1
7534105|NCT02665455|26177342|P1|Overall Study|Lost to Follow-up|1
7534106|NCT02665455|26177342|P1|Overall Study|Withdrawal by Subject|6
7534107|NCT02665286|26177386|P3|Overall Study|Lost to Follow-up|1
7534108|NCT02665286|26177387|P2|Overall Study|Lost to Follow-up|2
7534109|NCT02665286|26177388|P1|Overall Study|Lost to Follow-up|3
7534110|NCT02665052|26177460|P4|Overall Study|Adverse Event|0
7534111|NCT02665052|26177461|P3|Overall Study|Adverse Event|0
7534112|NCT02665052|26177462|P2|Overall Study|Adverse Event|1
7534113|NCT02665052|26177463|P1|Overall Study|Adverse Event|1
7534114|NCT02665052|26177460|P4|Overall Study|Withdrawal by Subject|5
7534115|NCT02665052|26177461|P3|Overall Study|Withdrawal by Subject|0
7534116|NCT02665052|26177462|P2|Overall Study|Withdrawal by Subject|1
7534117|NCT02665052|26177463|P1|Overall Study|Withdrawal by Subject|1
7534118|NCT02665052|26177460|P4|Overall Study|Lost to Follow-up|0
7534119|NCT02665052|26177461|P3|Overall Study|Lost to Follow-up|0
7534120|NCT02665052|26177462|P2|Overall Study|Lost to Follow-up|0
7534121|NCT02665052|26177463|P1|Overall Study|Lost to Follow-up|1
7534122|NCT02664415|26177582|P2|Overall Study|Adverse Event|0
7534123|NCT02664415|26177583|P1|Overall Study|Adverse Event|1
7534124|NCT02664272|26177629|P1|Overall Study|Fluoroscopic images not made available|2
7534125|NCT02663895|26177663|P1|Overall Study|Withdrawal by Subject|1
7534126|NCT02663895|26177663|P1|Overall Study|Progressive Systemic Sclerosis (SSc)|1
7534127|NCT02663895|26177663|P1|Overall Study|Physician Decision|2
7534128|NCT02663895|26177663|P1|Overall Study|Adverse Event|3
7534129|NCT02663882|26177680|P2|Overall Study|Lost to Follow-up|2
7534130|NCT02663882|26177681|P1|Overall Study|Lost to Follow-up|4
7534131|NCT02663817|26177693|P1|Overall Study|Screen failure|2
7534132|NCT02663687|26177713|P5|Overall Study|Other|0
7534133|NCT02663687|26177714|P4|Overall Study|Other|0
7534134|NCT02663687|26177715|P3|Overall Study|Other|1
7534135|NCT02663687|26177716|P2|Overall Study|Other|0
7534136|NCT02663687|26177717|P1|Overall Study|Other|1
7534137|NCT02663687|26177713|P5|Overall Study|Adverse Event|0
7534138|NCT02663687|26177714|P4|Overall Study|Adverse Event|0
7534139|NCT02663687|26177715|P3|Overall Study|Adverse Event|0
7534140|NCT02663687|26177716|P2|Overall Study|Adverse Event|0
7534141|NCT02663687|26177717|P1|Overall Study|Adverse Event|1
7534142|NCT02663674|26177771|P2|Overall Study|Other Event (Health Related)|1
7534143|NCT02663674|26177772|P1|Overall Study|Other Event (Health Related)|0
7534144|NCT02663674|26177771|P2|Overall Study|Physician Decision|1
7534145|NCT02663674|26177772|P1|Overall Study|Physician Decision|1
7534146|NCT02663674|26177771|P2|Overall Study|Withdrawal by Subject|4
7534147|NCT02663674|26177772|P1|Overall Study|Withdrawal by Subject|1
7534148|NCT02663674|26177771|P2|Overall Study|Lost to Follow-up|4
7534149|NCT02663674|26177772|P1|Overall Study|Lost to Follow-up|5
7534150|NCT02663622|26178038|P4|Overall Study|Protocol Violation|1
7534151|NCT02663622|26178039|P3|Overall Study|Protocol Violation|0
7534152|NCT02663622|26178040|P2|Overall Study|Protocol Violation|0
7534153|NCT02663622|26178041|P1|Overall Study|Protocol Violation|0
7534154|NCT02663622|26178038|P4|Overall Study|Death|8
7534155|NCT02663622|26178039|P3|Overall Study|Death|1
7534156|NCT02663622|26178040|P2|Overall Study|Death|1
7534157|NCT02663622|26178041|P1|Overall Study|Death|3
7534158|NCT02663622|26178038|P4|Overall Study|Ongoing in study|6
7534159|NCT02663622|26178039|P3|Overall Study|Ongoing in study|0
7534160|NCT02663622|26178040|P2|Overall Study|Ongoing in study|0
7534161|NCT02663622|26178041|P1|Overall Study|Ongoing in study|0
7534162|NCT02663453|26178070|P2|Overall Study|Withdrawal by Subject|0
7534163|NCT02663453|26178071|P1|Overall Study|Withdrawal by Subject|1
7534164|NCT02663453|26178070|P2|Overall Study|Death|4
7534165|NCT02663453|26178071|P1|Overall Study|Death|4
7534166|NCT02663128|26178116|P6|Period 2|Physician Decision|0
7534167|NCT02663128|26178117|P5|Period 2|Physician Decision|1
7534168|NCT02663128|26178118|P4|Period 2|Physician Decision|0
7534169|NCT02663128|26178119|P3|Period 2|Physician Decision|0
7534170|NCT02663128|26178120|P2|Period 2|Physician Decision|0
7534171|NCT02663128|26178121|P1|Period 2|Physician Decision|0
7534172|NCT02662764|26178135|P1|Overall Study|Patient discharged prior to 24 hrs|5
7534173|NCT02662764|26178135|P1|Overall Study|Patient changed treatment|1
7534174|NCT02662764|26178135|P1|Overall Study|Device failure|4
7534175|NCT02662764|26178135|P1|Overall Study|Withdrawal by Subject|5
7534176|NCT02662764|26178135|P1|Overall Study|Protocol Violation|1
7534177|NCT02662764|26178135|P1|Overall Study|Lack of Efficacy|8
7534178|NCT02662764|26178135|P1|Overall Study|Adverse Event|6
7534179|NCT02662582|26178201|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7534180|NCT02662582|26178202|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7534181|NCT02662582|26178201|P2|Treatment Period 1 (14 Days)|Protocol Deviation|0
7534182|NCT02662582|26178202|P1|Treatment Period 1 (14 Days)|Protocol Deviation|1
7534183|NCT02662582|26178201|P2|Treatment Period 1 (14 Days)|Miscellaneous|1
7534184|NCT02662582|26178202|P1|Treatment Period 1 (14 Days)|Miscellaneous|0
7534185|NCT02662582|26178201|P2|Treatment Period 1 (14 Days)|Adverse Event|2
7534186|NCT02662582|26178202|P1|Treatment Period 1 (14 Days)|Adverse Event|3
7534187|NCT02662569|26178260|P4|Overall Study|Lost to Follow-up|0
7534188|NCT02662569|26178261|P3|Overall Study|Lost to Follow-up|0
7534189|NCT02662569|26178262|P2|Overall Study|Lost to Follow-up|0
7534190|NCT02662569|26178263|P1|Overall Study|Lost to Follow-up|1
7534191|NCT02662569|26178260|P4|Overall Study|Withdrawal by Subject|4
7534192|NCT02662569|26178261|P3|Overall Study|Withdrawal by Subject|6
7534193|NCT02662569|26178262|P2|Overall Study|Withdrawal by Subject|1
7534194|NCT02662569|26178263|P1|Overall Study|Withdrawal by Subject|6
7534195|NCT02662556|26178361|P1|Overall Study|Lack of Efficacy|4
7534196|NCT02662556|26178361|P1|Overall Study|Adverse Event|4
7534197|NCT02661815|26178447|P4|Overall Study|Withdrawal by Subject|0
7534198|NCT02661815|26178448|P3|Overall Study|Withdrawal by Subject|0
7534199|NCT02661815|26178449|P2|Overall Study|Withdrawal by Subject|0
7534200|NCT02661815|26178450|P1|Overall Study|Withdrawal by Subject|1
7534201|NCT02661594|26178472|P4|Overall Study|Protocol Violation|0
7534202|NCT02661594|26178473|P3|Overall Study|Protocol Violation|1
7534203|NCT02661594|26178474|P2|Overall Study|Protocol Violation|0
7534204|NCT02661594|26178475|P1|Overall Study|Protocol Violation|1
7534205|NCT02661490|26178490|P5|Overall Study|Reason not Specified|1
7534206|NCT02661490|26178491|P4|Overall Study|Reason not Specified|0
7534207|NCT02661490|26178492|P3|Overall Study|Reason not Specified|0
7534208|NCT02661490|26178493|P2|Overall Study|Reason not Specified|0
7534209|NCT02661490|26178494|P1|Overall Study|Reason not Specified|0
7534210|NCT02661490|26178490|P5|Overall Study|Death|0
7534211|NCT02661490|26178491|P4|Overall Study|Death|1
7534212|NCT02661490|26178492|P3|Overall Study|Death|0
7534213|NCT02661490|26178493|P2|Overall Study|Death|1
7534214|NCT02661490|26178494|P1|Overall Study|Death|1
7534215|NCT02661490|26178490|P5|Overall Study|Withdrawal by Subject|0
7534216|NCT02661490|26178491|P4|Overall Study|Withdrawal by Subject|0
7534217|NCT02661490|26178492|P3|Overall Study|Withdrawal by Subject|2
7534218|NCT02661490|26178493|P2|Overall Study|Withdrawal by Subject|0
7534219|NCT02661490|26178494|P1|Overall Study|Withdrawal by Subject|2
7534220|NCT02661490|26178490|P5|Overall Study|Lost to Follow-up|2
7534221|NCT02661490|26178491|P4|Overall Study|Lost to Follow-up|0
7534222|NCT02661490|26178492|P3|Overall Study|Lost to Follow-up|0
7534223|NCT02661490|26178493|P2|Overall Study|Lost to Follow-up|1
7534224|NCT02661490|26178494|P1|Overall Study|Lost to Follow-up|0
7534225|NCT02661217|26178649|P2|Overall Study|Mis-randomized (not in treatment epoch)|1
7534226|NCT02661217|26178650|P1|Overall Study|Mis-randomized (not in treatment epoch)|3
7534227|NCT02661217|26178649|P2|Overall Study|Death - no study drug received|2
7534228|NCT02661217|26178650|P1|Overall Study|Death - no study drug received|1
7534229|NCT02661217|26178649|P2|Overall Study|Did not enter follow-up epoch|10
7534230|NCT02661217|26178650|P1|Overall Study|Did not enter follow-up epoch|7
7534231|NCT02661217|26178649|P2|Overall Study|Withdrawal by Subject|19
7534232|NCT02661217|26178650|P1|Overall Study|Withdrawal by Subject|15
7534233|NCT02661217|26178649|P2|Overall Study|Adverse Event|8
7534234|NCT02661217|26178650|P1|Overall Study|Adverse Event|10
7534235|NCT02661217|26178649|P2|Overall Study|Death|15
7534236|NCT02661217|26178650|P1|Overall Study|Death|21
7534237|NCT02661217|26178649|P2|Overall Study|Non-compliance with study treatment|5
7534238|NCT02661217|26178650|P1|Overall Study|Non-compliance with study treatment|5
7534239|NCT02661217|26178649|P2|Overall Study|Protocol Deviation|4
7534240|NCT02661217|26178650|P1|Overall Study|Protocol Deviation|0
7534241|NCT02661217|26178649|P2|Overall Study|Lost to Follow-up|4
7534242|NCT02661217|26178650|P1|Overall Study|Lost to Follow-up|1
7534243|NCT02661217|26178649|P2|Overall Study|Physician Decision|15
7534244|NCT02661217|26178650|P1|Overall Study|Physician Decision|12
7534245|NCT02661178|26178680|P15|Part 1|Protocol Violation|0
7534246|NCT02661178|26178681|P14|Part 1|Protocol Violation|0
7534247|NCT02661178|26178682|P13|Part 1|Protocol Violation|0
7534248|NCT02661178|26178683|P12|Part 1|Protocol Violation|0
7534249|NCT02661178|26178684|P11|Part 1|Protocol Violation|0
7534250|NCT02661178|26178685|P10|Part 1|Protocol Violation|0
7534251|NCT02661178|26178686|P9|Part 1|Protocol Violation|0
7534252|NCT02661178|26178687|P8|Part 1|Protocol Violation|0
7534253|NCT02661178|26178688|P7|Part 1|Protocol Violation|0
7534254|NCT02661178|26178689|P6|Part 1|Protocol Violation|0
7534255|NCT02661178|26178690|P5|Part 1|Protocol Violation|0
7534256|NCT02661178|26178691|P4|Part 1|Protocol Violation|0
7534257|NCT02661178|26178692|P3|Part 1|Protocol Violation|0
7534258|NCT02661178|26178693|P2|Part 1|Protocol Violation|0
7534259|NCT02661178|26178694|P1|Part 1|Protocol Violation|1
7534260|NCT02661061|26179052|P2|Overall Study|Withdrawal by Subject|1
7534261|NCT02661061|26179053|P1|Overall Study|Withdrawal by Subject|1
7534262|NCT02661061|26179052|P2|Overall Study|Lack of Efficacy|1
7534263|NCT02661061|26179053|P1|Overall Study|Lack of Efficacy|1
7534264|NCT02660983|26179063|P2|Open Label Extension Phase (24 Weeks)|Other|1
7534265|NCT02660983|26179064|P1|Open Label Extension Phase (24 Weeks)|Other|0
7534266|NCT02660983|26179063|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
7534267|NCT02660983|26179064|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
7534268|NCT02660983|26179063|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
7534269|NCT02660983|26179064|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
7534270|NCT02660983|26179063|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7534271|NCT02660983|26179064|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7534272|NCT02660983|26179063|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
7534273|NCT02660983|26179064|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
7534274|NCT02660983|26179063|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
7534275|NCT02660983|26179064|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
7534276|NCT02660983|26179063|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
7534277|NCT02660983|26179064|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
7534278|NCT02660944|26179079|P2|Overall Study|Exclusion criteria met|0
7534279|NCT02660944|26179080|P1|Overall Study|Exclusion criteria met|2
7534280|NCT02660944|26179079|P2|Overall Study|Subject schedule|1
7534281|NCT02660944|26179080|P1|Overall Study|Subject schedule|0
7534282|NCT02660944|26179079|P2|Overall Study|Lost to Follow-up|1
7534283|NCT02660944|26179080|P1|Overall Study|Lost to Follow-up|4
7534284|NCT02660944|26179079|P2|Overall Study|Withdrawal by Subject|3
7534285|NCT02660944|26179080|P1|Overall Study|Withdrawal by Subject|5
7534286|NCT02660944|26179079|P2|Overall Study|Physician Decision|1
7534287|NCT02660944|26179080|P1|Overall Study|Physician Decision|3
7534288|NCT02660944|26179079|P2|Overall Study|Adverse Event|4
7534289|NCT02660944|26179080|P1|Overall Study|Adverse Event|3
7534291|NCT02660580|26179173|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7534292|NCT02660580|26179174|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7534293|NCT02660580|26179175|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7534294|NCT02660580|26179176|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7534295|NCT02660580|26179177|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7534296|NCT02660580|26179173|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7534297|NCT02660580|26179174|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7534298|NCT02660580|26179175|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
7534299|NCT02660580|26179176|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7534300|NCT02660580|26179177|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7534301|NCT02660580|26179173|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
7534302|NCT02660580|26179174|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
7534303|NCT02660580|26179175|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
7534304|NCT02660580|26179176|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7534305|NCT02660580|26179177|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7534306|NCT02660580|26179173|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7534307|NCT02660580|26179174|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7534308|NCT02660580|26179175|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
7534309|NCT02660580|26179176|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7534310|NCT02660580|26179177|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7534311|NCT02660580|26179173|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7534312|NCT02660580|26179174|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7534313|NCT02660580|26179175|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7534314|NCT02660580|26179176|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7534315|NCT02660580|26179177|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7534316|NCT02660580|26179173|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
7534317|NCT02660580|26179174|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7534318|NCT02660580|26179175|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
7534319|NCT02660580|26179176|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7534320|NCT02660580|26179177|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7534321|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7534322|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7534323|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7534324|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
7534325|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
7534326|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7534327|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7534328|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7534329|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
7534330|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
7534331|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7534332|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7534333|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7534334|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
7534335|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
7534336|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7534337|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7534338|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7534339|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
7534340|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7534341|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7534342|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7534343|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7534344|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7534345|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
7534346|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7534347|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7534348|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7534349|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
7534350|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
7534351|NCT02660580|26179173|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7534352|NCT02660580|26179174|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7534353|NCT02660580|26179175|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7534354|NCT02660580|26179176|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7534355|NCT02660580|26179177|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7534356|NCT02660489|26179294|P2|Overall Study|no rhinovirus infection|4
7534357|NCT02660489|26179295|P1|Overall Study|no rhinovirus infection|4
7534358|NCT02660489|26179294|P2|Overall Study|Adverse Event|3
7534359|NCT02660489|26179295|P1|Overall Study|Adverse Event|1
7534360|NCT02660489|26179294|P2|Overall Study|Lost to Follow-up|1
7534361|NCT02660489|26179295|P1|Overall Study|Lost to Follow-up|1
7534362|NCT02660359|26179318|P3|Overall Study|Lost to Follow-up|0
7534363|NCT02660359|26179319|P2|Overall Study|Lost to Follow-up|3
7534364|NCT02660359|26179320|P1|Overall Study|Lost to Follow-up|3
7534365|NCT02660359|26179318|P3|Overall Study|Withdrawal by Subject|8
7534366|NCT02660359|26179319|P2|Overall Study|Withdrawal by Subject|5
7534367|NCT02660359|26179320|P1|Overall Study|Withdrawal by Subject|7
7534368|NCT02660359|26179318|P3|Overall Study|Other|3
7534369|NCT02660359|26179319|P2|Overall Study|Other|1
7534370|NCT02660359|26179320|P1|Overall Study|Other|2
7534371|NCT02660359|26179318|P3|Overall Study|Adverse Event|0
7534372|NCT02660359|26179319|P2|Overall Study|Adverse Event|1
7534373|NCT02660359|26179320|P1|Overall Study|Adverse Event|0
7534374|NCT02660359|26179318|P3|Overall Study|Lack of Efficacy|1
7534375|NCT02660359|26179319|P2|Overall Study|Lack of Efficacy|1
7534376|NCT02660359|26179320|P1|Overall Study|Lack of Efficacy|1
7534377|NCT02660359|26179318|P3|Overall Study|Sponsor Decision to Terminate Study|71
7534378|NCT02660359|26179319|P2|Overall Study|Sponsor Decision to Terminate Study|75
7534379|NCT02660359|26179320|P1|Overall Study|Sponsor Decision to Terminate Study|73
7534380|NCT02660359|26179318|P3|Overall Study|Protocol Deviation|1
7534381|NCT02660359|26179319|P2|Overall Study|Protocol Deviation|0
7534382|NCT02660359|26179320|P1|Overall Study|Protocol Deviation|0
7534383|NCT02660242|26179352|P1|Glucagon Injection|Lost to Follow-up|1
7534384|NCT02660242|26179352|P1|Glucose Tabs|Lost to Follow-up|1
7534385|NCT02660229|26179408|P2|Overall Study|Withdrawal by Subject|1
7534386|NCT02660229|26179409|P1|Overall Study|Withdrawal by Subject|0
7534387|NCT02660229|26179408|P2|Overall Study|Adverse Event|0
7534388|NCT02660229|26179409|P1|Overall Study|Adverse Event|2
7534389|NCT02660138|26179424|P3|Overall Study|Not treated|0
7534390|NCT02660138|26179425|P2|Overall Study|Not treated|1
7534391|NCT02660138|26179426|P1|Overall Study|Not treated|0
7534392|NCT02660138|26179424|P3|Overall Study|Other|0
7534393|NCT02660138|26179425|P2|Overall Study|Other|1
7534394|NCT02660138|26179426|P1|Overall Study|Other|1
7534395|NCT02660138|26179424|P3|Overall Study|Sponsor Decision to Terminate Study|62
7534396|NCT02660138|26179425|P2|Overall Study|Sponsor Decision to Terminate Study|57
7534397|NCT02660138|26179426|P1|Overall Study|Sponsor Decision to Terminate Study|57
7534398|NCT02660138|26179424|P3|Overall Study|Lost to Follow-up|1
7534399|NCT02660138|26179425|P2|Overall Study|Lost to Follow-up|4
7534400|NCT02660138|26179426|P1|Overall Study|Lost to Follow-up|4
7534401|NCT02660138|26179424|P3|Overall Study|Withdrawal by Subject|6
7534402|NCT02660138|26179425|P2|Overall Study|Withdrawal by Subject|6
7534403|NCT02660138|26179426|P1|Overall Study|Withdrawal by Subject|7
7534404|NCT02660138|26179424|P3|Overall Study|Lack of Efficacy|1
7534405|NCT02660138|26179425|P2|Overall Study|Lack of Efficacy|2
7534406|NCT02660138|26179426|P1|Overall Study|Lack of Efficacy|1
7534407|NCT02660138|26179424|P3|Overall Study|Adverse Event|2
7534408|NCT02660138|26179425|P2|Overall Study|Adverse Event|3
7534409|NCT02660138|26179426|P1|Overall Study|Adverse Event|0
7534410|NCT02659943|26179473|P7|Overall Study|No treatment, per protocol|3
7534411|NCT02659943|26179474|P6|Overall Study|No treatment, per protocol|0
7534412|NCT02659943|26179475|P5|Overall Study|No treatment, per protocol|0
7534413|NCT02659943|26179476|P4|Overall Study|No treatment, per protocol|0
7534414|NCT02659943|26179477|P3|Overall Study|No treatment, per protocol|0
7534415|NCT02659943|26179478|P2|Overall Study|No treatment, per protocol|0
7534416|NCT02659943|26179479|P1|Overall Study|No treatment, per protocol|0
7534417|NCT02659943|26179473|P7|Overall Study|No longer meets eligibility|1
7534418|NCT02659943|26179474|P6|Overall Study|No longer meets eligibility|0
7534419|NCT02659943|26179475|P5|Overall Study|No longer meets eligibility|0
7534420|NCT02659943|26179476|P4|Overall Study|No longer meets eligibility|0
7534421|NCT02659943|26179477|P3|Overall Study|No longer meets eligibility|0
7534422|NCT02659943|26179478|P2|Overall Study|No longer meets eligibility|0
7534423|NCT02659943|26179479|P1|Overall Study|No longer meets eligibility|0
7534424|NCT02659943|26179473|P7|Overall Study|Ineligible|1
7534425|NCT02659943|26179474|P6|Overall Study|Ineligible|0
7534426|NCT02659943|26179475|P5|Overall Study|Ineligible|0
7534427|NCT02659943|26179476|P4|Overall Study|Ineligible|0
7534428|NCT02659943|26179477|P3|Overall Study|Ineligible|0
7534429|NCT02659943|26179478|P2|Overall Study|Ineligible|0
7534430|NCT02659943|26179479|P1|Overall Study|Ineligible|0
7534431|NCT02659943|26179473|P7|Overall Study|Patient's condition per principal investigator|0
7534432|NCT02659943|26179474|P6|Overall Study|Patient's condition per principal investigator|1
7534433|NCT02659943|26179475|P5|Overall Study|Patient's condition per principal investigator|0
7534434|NCT02659943|26179476|P4|Overall Study|Patient's condition per principal investigator|0
7534435|NCT02659943|26179477|P3|Overall Study|Patient's condition per principal investigator|0
7534436|NCT02659943|26179478|P2|Overall Study|Patient's condition per principal investigator|0
7534437|NCT02659943|26179479|P1|Overall Study|Patient's condition per principal investigator|0
7534438|NCT02659943|26179473|P7|Overall Study|Disease progression on study|0
7534439|NCT02659943|26179474|P6|Overall Study|Disease progression on study|4
7534440|NCT02659943|26179475|P5|Overall Study|Disease progression on study|1
7534441|NCT02659943|26179476|P4|Overall Study|Disease progression on study|1
7534442|NCT02659943|26179477|P3|Overall Study|Disease progression on study|1
7534443|NCT02659943|26179478|P2|Overall Study|Disease progression on study|1
7534444|NCT02659943|26179479|P1|Overall Study|Disease progression on study|0
7534445|NCT02659943|26179473|P7|Overall Study|Switched to alternative treatment|1
7534446|NCT02659943|26179474|P6|Overall Study|Switched to alternative treatment|0
7534447|NCT02659943|26179475|P5|Overall Study|Switched to alternative treatment|1
7534448|NCT02659943|26179476|P4|Overall Study|Switched to alternative treatment|2
7534449|NCT02659943|26179477|P3|Overall Study|Switched to alternative treatment|0
7534450|NCT02659943|26179478|P2|Overall Study|Switched to alternative treatment|1
7534451|NCT02659943|26179479|P1|Overall Study|Switched to alternative treatment|1
7534452|NCT02659631|26179568|P10|Overall Study|Death (treatment phase)|0
7534453|NCT02659631|26179569|P9|Overall Study|Death (treatment phase)|0
7534454|NCT02659631|26179570|P8|Overall Study|Death (treatment phase)|0
7534455|NCT02659631|26179571|P7|Overall Study|Death (treatment phase)|1
7534456|NCT02659631|26179572|P6|Overall Study|Death (treatment phase)|0
7534457|NCT02659631|26179573|P5|Overall Study|Death (treatment phase)|1
7534458|NCT02659631|26179574|P4|Overall Study|Death (treatment phase)|0
7534459|NCT02659631|26179575|P3|Overall Study|Death (treatment phase)|0
7534460|NCT02659631|26179576|P2|Overall Study|Death (treatment phase)|0
7534461|NCT02659631|26179577|P1|Overall Study|Death (treatment phase)|0
7534462|NCT02659631|26179568|P10|Overall Study|Death (follow-up phase)|0
7534463|NCT02659631|26179569|P9|Overall Study|Death (follow-up phase)|1
7534464|NCT02659631|26179570|P8|Overall Study|Death (follow-up phase)|3
7534465|NCT02659631|26179571|P7|Overall Study|Death (follow-up phase)|0
7534466|NCT02659631|26179572|P6|Overall Study|Death (follow-up phase)|2
7534467|NCT02659631|26179573|P5|Overall Study|Death (follow-up phase)|3
7534468|NCT02659631|26179574|P4|Overall Study|Death (follow-up phase)|1
7534469|NCT02659631|26179575|P3|Overall Study|Death (follow-up phase)|1
7534470|NCT02659631|26179576|P2|Overall Study|Death (follow-up phase)|2
7534471|NCT02659631|26179577|P1|Overall Study|Death (follow-up phase)|1
7534472|NCT02659631|26179568|P10|Overall Study|Participant refused further follow-up|0
7534473|NCT02659631|26179569|P9|Overall Study|Participant refused further follow-up|1
7534474|NCT02659631|26179570|P8|Overall Study|Participant refused further follow-up|0
7534475|NCT02659631|26179571|P7|Overall Study|Participant refused further follow-up|0
7534476|NCT02659631|26179572|P6|Overall Study|Participant refused further follow-up|0
7534477|NCT02659631|26179573|P5|Overall Study|Participant refused further follow-up|0
7534478|NCT02659631|26179574|P4|Overall Study|Participant refused further follow-up|1
7534479|NCT02659631|26179575|P3|Overall Study|Participant refused further follow-up|0
7534480|NCT02659631|26179576|P2|Overall Study|Participant refused further follow-up|0
7534481|NCT02659631|26179577|P1|Overall Study|Participant refused further follow-up|0
7534482|NCT02659631|26179568|P10|Overall Study|Withdrawal prior to treatment|0
7534483|NCT02659631|26179569|P9|Overall Study|Withdrawal prior to treatment|0
7534484|NCT02659631|26179570|P8|Overall Study|Withdrawal prior to treatment|0
7534485|NCT02659631|26179571|P7|Overall Study|Withdrawal prior to treatment|0
7534486|NCT02659631|26179572|P6|Overall Study|Withdrawal prior to treatment|0
7534487|NCT02659631|26179573|P5|Overall Study|Withdrawal prior to treatment|1
7534488|NCT02659631|26179574|P4|Overall Study|Withdrawal prior to treatment|0
7534489|NCT02659631|26179575|P3|Overall Study|Withdrawal prior to treatment|0
7534490|NCT02659631|26179576|P2|Overall Study|Withdrawal prior to treatment|0
7534491|NCT02659631|26179577|P1|Overall Study|Withdrawal prior to treatment|0
7534492|NCT02659631|26179568|P10|Overall Study|Lost to Follow-up|0
7534493|NCT02659631|26179569|P9|Overall Study|Lost to Follow-up|0
7534494|NCT02659631|26179570|P8|Overall Study|Lost to Follow-up|0
7534495|NCT02659631|26179571|P7|Overall Study|Lost to Follow-up|0
7534496|NCT02659631|26179572|P6|Overall Study|Lost to Follow-up|1
7534497|NCT02659631|26179573|P5|Overall Study|Lost to Follow-up|0
7534498|NCT02659631|26179574|P4|Overall Study|Lost to Follow-up|0
7534499|NCT02659631|26179575|P3|Overall Study|Lost to Follow-up|2
7534500|NCT02659631|26179576|P2|Overall Study|Lost to Follow-up|0
7534501|NCT02659631|26179577|P1|Overall Study|Lost to Follow-up|0
7534502|NCT02659540|26179711|P2|Overall Study|Progressive disease|6
7534503|NCT02659540|26179712|P1|Overall Study|Progressive disease|2
7534504|NCT02659540|26179711|P2|Overall Study|Death|0
7534505|NCT02659540|26179712|P1|Overall Study|Death|1
7534506|NCT02659540|26179711|P2|Overall Study|Adverse Event|2
7534507|NCT02659540|26179712|P1|Overall Study|Adverse Event|3
7534508|NCT02659150|26179749|P1|Study Drug Dosing|Adverse Event|1
7534509|NCT02659150|26179749|P1|Baseline Imaging|Physician Decision|1
7534510|NCT02659150|26179749|P1|Baseline Imaging|Withdrawal by Subject|1
7534511|NCT02659150|26179749|P1|Subject Enrollment|Withdrawal by Subject|2
7534512|NCT02659150|26179749|P1|Subject Enrollment|Physician Decision|3
7534513|NCT02659098|26179758|P1|Overall Study|Withdrawal by Subject|7
7534514|NCT02659059|26179789|P2|Overall Study|Lost to Follow-up|0
7534515|NCT02659059|26179790|P1|Overall Study|Lost to Follow-up|1
7534516|NCT02659059|26179789|P2|Overall Study|Participant withdrew consent|0
7534517|NCT02659059|26179790|P1|Overall Study|Participant withdrew consent|4
7534518|NCT02659059|26179789|P2|Overall Study|Participant request to discontinue study treatment|0
7534519|NCT02659059|26179790|P1|Overall Study|Participant request to discontinue study treatment|5
7534520|NCT02659059|26179789|P2|Overall Study|Adverse Event unrelated to Study drug|4
7534521|NCT02659059|26179790|P1|Overall Study|Adverse Event unrelated to Study drug|22
7534522|NCT02659059|26179789|P2|Overall Study|Death|1
7534523|NCT02659059|26179790|P1|Overall Study|Death|2
7534524|NCT02659059|26179789|P2|Overall Study|Study Drug toxicity|9
7534525|NCT02659059|26179790|P1|Overall Study|Study Drug toxicity|37
7534526|NCT02659059|26179789|P2|Overall Study|Disease Progression|16
7534527|NCT02659059|26179790|P1|Overall Study|Disease Progression|120
7534528|NCT02659059|26179789|P2|Overall Study|Other reasons|2
7534529|NCT02659059|26179790|P1|Overall Study|Other reasons|8
7534530|NCT02659059|26179789|P2|Overall Study|Completed|0
7534531|NCT02659059|26179790|P1|Overall Study|Completed|1
7534574|NCT02658734|26179951|P1|Overall Study|Disease Progression|28
7534575|NCT02658734|26179951|P1|Overall Study|Withdrawal of Consent|16
7534576|NCT02658734|26179951|P1|Overall Study|Lost to Follow-up|7
7534577|NCT02658734|26179951|P1|Overall Study|Death|4
7534578|NCT02658734|26179951|P1|Overall Study|Adverse Event|2
7534579|NCT02658630|26179970|P1|Overall Study|Withdrawal by Subject|4
7534580|NCT02658487|26179978|P1|Overall Study|Refractory AML|1
7534581|NCT02658487|26179978|P1|Overall Study|Treatment Failure, circulating blasts|1
7534582|NCT02658487|26179978|P1|Overall Study|Adverse Event|1
7534583|NCT02658487|26179978|P1|Overall Study|Alternative therapy|1
7534584|NCT02658487|26179978|P1|Overall Study|Disease progression|10
7534585|NCT02658487|26179978|P1|Overall Study|Death|2
7534586|NCT02658448|26180019|P1|Overall Study|Lost to Follow-up|1
7534587|NCT02658175|26180056|P3|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7534588|NCT02658175|26180057|P2|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7534589|NCT02658175|26180058|P1|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
7534590|NCT02658175|26180056|P3|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
7534591|NCT02658175|26180057|P2|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7534592|NCT02658175|26180058|P1|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7534593|NCT02658175|26180056|P3|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
7534594|NCT02658175|26180057|P2|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
7534595|NCT02658175|26180058|P1|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
7534596|NCT02658175|26180056|P3|1st Extended Treatment: Weeks 53 to 104|Other|1
7534597|NCT02658175|26180057|P2|1st Extended Treatment: Weeks 53 to 104|Other|0
7534598|NCT02658175|26180058|P1|1st Extended Treatment: Weeks 53 to 104|Other|1
7534599|NCT02658175|26180056|P3|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7534600|NCT02658175|26180057|P2|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7534601|NCT02658175|26180058|P1|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
7534602|NCT02658175|26180056|P3|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
7534603|NCT02658175|26180057|P2|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
7534604|NCT02658175|26180058|P1|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
7534605|NCT02658175|26180056|P3|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7534606|NCT02658175|26180057|P2|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7534607|NCT02658175|26180058|P1|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
7534608|NCT02658175|26180056|P3|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
7534609|NCT02658175|26180057|P2|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
7534610|NCT02658175|26180058|P1|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
7534611|NCT02658175|26180056|P3|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
7534612|NCT02658175|26180057|P2|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
7534613|NCT02658175|26180058|P1|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
7534614|NCT02658175|26180056|P3|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7534615|NCT02658175|26180057|P2|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7534616|NCT02658175|26180058|P1|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
7534617|NCT02658149|26180071|P2|Overall Study|Physician Decision|0
7534618|NCT02658149|26180072|P1|Overall Study|Physician Decision|1
7534619|NCT02658084|26180088|P2|Overall Study|Study Termination|0
7534620|NCT02658084|26180089|P1|Overall Study|Study Termination|1
7534621|NCT02658084|26180088|P2|Overall Study|Withdrawal by Subject|0
7534622|NCT02658084|26180089|P1|Overall Study|Withdrawal by Subject|1
7534623|NCT02658019|26180098|P1|Overall Study|Adverse Event|1
7534640|NCT02657434|26180195|P2|Overall Study|Protocol Violation|0
7534641|NCT02657434|26180196|P1|Overall Study|Protocol Violation|1
7534642|NCT02657434|26180195|P2|Overall Study|Withdrawal by Subject|16
7534643|NCT02657434|26180196|P1|Overall Study|Withdrawal by Subject|27
7534644|NCT02657434|26180195|P2|Overall Study|Randomization by Error|0
7534645|NCT02657434|26180196|P1|Overall Study|Randomization by Error|2
7534646|NCT02657434|26180195|P2|Overall Study|Lost to Follow-up|2
7534647|NCT02657434|26180196|P1|Overall Study|Lost to Follow-up|2
7534648|NCT02657434|26180195|P2|Overall Study|Death|183
7534649|NCT02657434|26180196|P1|Overall Study|Death|177
7534650|NCT02657434|26180195|P2|Overall Study|On-Going in Study|91
7534651|NCT02657434|26180196|P1|Overall Study|On-Going in Study|77
7534652|NCT02657408|26180226|P2|Overall Study|Adverse Event|7
7534653|NCT02657408|26180227|P1|Overall Study|Adverse Event|3
7534654|NCT02657369|26180251|P1|Overall Study|Study terminated by sponsor|7
7534655|NCT02657369|26180251|P1|Overall Study|Death|27
7534656|NCT02657031|26180282|P2|Overall Study|Adverse Event|2
7534657|NCT02657031|26180283|P1|Overall Study|Adverse Event|1
7534658|NCT02656693|26180315|P3|Overall Study|Bariatric surgery|2
7534659|NCT02656693|26180316|P2|Overall Study|Bariatric surgery|1
7534660|NCT02656693|26180317|P1|Overall Study|Bariatric surgery|0
7534661|NCT02656693|26180315|P3|Overall Study|Pregnancy|1
7534662|NCT02656693|26180316|P2|Overall Study|Pregnancy|1
7534663|NCT02656693|26180317|P1|Overall Study|Pregnancy|1
7534664|NCT02656680|26180402|P2|Overall Study|Lost to Follow-up|1
7534665|NCT02656680|26180403|P1|Overall Study|Lost to Follow-up|0
7534666|NCT02656329|26180459|P2|Overall Study|Other than specified above|6
7534667|NCT02656329|26180460|P1|Overall Study|Other than specified above|5
7534668|NCT02656329|26180459|P2|Overall Study|Study termination by Sponsor|142
7534669|NCT02656329|26180460|P1|Overall Study|Study termination by Sponsor|150
7534670|NCT02656329|26180459|P2|Overall Study|Withdrawal by Subject|6
7534671|NCT02656329|26180460|P1|Overall Study|Withdrawal by Subject|7
7534672|NCT02656329|26180459|P2|Overall Study|Lost to Follow-up|3
7534673|NCT02656329|26180460|P1|Overall Study|Lost to Follow-up|2
7534674|NCT02656290|26180483|P1|Overall Study|Subjects Remain On Study|26
7534675|NCT02656173|26180494|P2|Overall Study|Miscellaneous|0
7534676|NCT02656173|26180495|P1|Overall Study|Miscellaneous|2
7534677|NCT02656173|26180494|P2|Overall Study|Protocol Violation|1
7534678|NCT02656173|26180495|P1|Overall Study|Protocol Violation|0
7534679|NCT02656173|26180494|P2|Overall Study|Withdrawal by Subject|3
7534680|NCT02656173|26180495|P1|Overall Study|Withdrawal by Subject|1
7534681|NCT02656173|26180494|P2|Overall Study|Adverse Event|5
7534682|NCT02656173|26180495|P1|Overall Study|Adverse Event|7
7534683|NCT02656173|26180494|P2|Overall Study|Deviation from the Eligible Criteria|2
7534684|NCT02656173|26180495|P1|Overall Study|Deviation from the Eligible Criteria|3
7534685|NCT02655887|26180567|P1|Overall Study|Missed 12-month follow-up visit|4
7534686|NCT02655887|26180567|P1|Overall Study|Withdrawal by Subject|3
7534687|NCT02655887|26180567|P1|Overall Study|Death|4
7534688|NCT02655887|26180567|P1|Overall Study|Lost to Follow-up|3
7534689|NCT02655679|26180586|P5|Overall Study|Other Miscellaneous Reasons|0
7534690|NCT02655679|26180587|P4|Overall Study|Other Miscellaneous Reasons|0
7534691|NCT02655679|26180588|P3|Overall Study|Other Miscellaneous Reasons|0
7534692|NCT02655679|26180589|P2|Overall Study|Other Miscellaneous Reasons|0
7534693|NCT02655679|26180590|P1|Overall Study|Other Miscellaneous Reasons|1
7534694|NCT02655679|26180586|P5|Overall Study|Lost to Follow-up|0
7534695|NCT02655679|26180587|P4|Overall Study|Lost to Follow-up|1
7534696|NCT02655679|26180588|P3|Overall Study|Lost to Follow-up|1
7534697|NCT02655679|26180589|P2|Overall Study|Lost to Follow-up|1
7534698|NCT02655679|26180590|P1|Overall Study|Lost to Follow-up|0
7534699|NCT02655679|26180586|P5|Overall Study|Inability to Comply with the Protocol|0
7534700|NCT02655679|26180587|P4|Overall Study|Inability to Comply with the Protocol|0
7534701|NCT02655679|26180588|P3|Overall Study|Inability to Comply with the Protocol|0
7534702|NCT02655679|26180589|P2|Overall Study|Inability to Comply with the Protocol|0
7534703|NCT02655679|26180590|P1|Overall Study|Inability to Comply with the Protocol|1
7534704|NCT02655679|26180586|P5|Overall Study|Withdrawal by Subject|1
7534705|NCT02655679|26180587|P4|Overall Study|Withdrawal by Subject|3
7534706|NCT02655679|26180588|P3|Overall Study|Withdrawal by Subject|0
7534707|NCT02655679|26180589|P2|Overall Study|Withdrawal by Subject|1
7534708|NCT02655679|26180590|P1|Overall Study|Withdrawal by Subject|1
7534709|NCT02655679|26180586|P5|Overall Study|Adverse Event|0
7534710|NCT02655679|26180587|P4|Overall Study|Adverse Event|0
7534711|NCT02655679|26180588|P3|Overall Study|Adverse Event|0
7534712|NCT02655679|26180589|P2|Overall Study|Adverse Event|1
7534713|NCT02655679|26180590|P1|Overall Study|Adverse Event|0
7534714|NCT02655666|26180662|P1|Overall Study|Sponsor stopped this clinical research.|12
7534715|NCT02655419|26180716|P2|Overall Study|Other|1
7534716|NCT02655419|26180717|P1|Overall Study|Other|0
7534717|NCT02655419|26180716|P2|Overall Study|Withdrawal by Subject|1
7534718|NCT02655419|26180717|P1|Overall Study|Withdrawal by Subject|4
7534719|NCT02655419|26180716|P2|Overall Study|Enrolled but not treated|5
7534720|NCT02655419|26180717|P1|Overall Study|Enrolled but not treated|1
7534721|NCT02655237|26180870|P2|Overall Study|Randomized but Not Treated|0
7534722|NCT02655237|26180871|P1|Overall Study|Randomized but Not Treated|1
7534723|NCT02655237|26180870|P2|Overall Study|Reduction of Hemoglobin Concentration|0
7534724|NCT02655237|26180871|P1|Overall Study|Reduction of Hemoglobin Concentration|1
7534725|NCT02655237|26180870|P2|Overall Study|Recovery Leading to Surgery|1
7534726|NCT02655237|26180871|P1|Overall Study|Recovery Leading to Surgery|2
7534727|NCT02655237|26180870|P2|Overall Study|Lack of Efficacy|1
7534728|NCT02655237|26180871|P1|Overall Study|Lack of Efficacy|0
7534729|NCT02655237|26180870|P2|Overall Study|Withdrawal by Participant|2
7534730|NCT02655237|26180871|P1|Overall Study|Withdrawal by Participant|1
7534731|NCT02655237|26180870|P2|Overall Study|Protocol Deviation|0
7534732|NCT02655237|26180871|P1|Overall Study|Protocol Deviation|2
7534733|NCT02655237|26180870|P2|Overall Study|Adverse Event|7
7534734|NCT02655237|26180871|P1|Overall Study|Adverse Event|10
7534735|NCT02655224|26180911|P2|Overall Study|Adverse Event|1
7534736|NCT02655224|26180912|P1|Overall Study|Adverse Event|1
7534747|NCT02654977|26180977|P1|Overall Study|Lack of Efficacy|3
7534748|NCT02654977|26180977|P1|Overall Study|Withdrawal by Subject|1
7534749|NCT02654977|26180977|P1|Overall Study|Adverse Event|1
7534750|NCT02654977|26180977|P1|Overall Study|Lost to Follow-up|1
7534751|NCT02654977|26180977|P1|Overall Study|Death|1
7534752|NCT02654717|26181112|P2|Overall Study|Non-permitted medication|0
7534753|NCT02654717|26181113|P1|Overall Study|Non-permitted medication|3
7534754|NCT02654717|26181112|P2|Overall Study|Withdrawal by Subject|1
7534755|NCT02654717|26181113|P1|Overall Study|Withdrawal by Subject|0
7534756|NCT02654717|26181112|P2|Overall Study|Protocol Violation|2
7534757|NCT02654717|26181113|P1|Overall Study|Protocol Violation|1
7534758|NCT02654717|26181112|P2|Overall Study|Adverse Event|2
7534759|NCT02654717|26181113|P1|Overall Study|Adverse Event|2
7534760|NCT02654145|26181189|P1|Overall Study|Withdrawal by Subject|5
7534761|NCT02654145|26181189|P1|Overall Study|Protocol Violation|1
7534762|NCT02654145|26181189|P1|Overall Study|Lack of Efficacy|1
7534763|NCT02654132|26181198|P2|Overall Study|Never treated|2
7534764|NCT02654132|26181199|P1|Overall Study|Never treated|0
7534765|NCT02654132|26181198|P2|Overall Study|Clinical Progression (not protocol)|1
7534766|NCT02654132|26181199|P1|Overall Study|Clinical Progression (not protocol)|0
7534767|NCT02654132|26181198|P2|Overall Study|Inadequate response to therapy|0
7534768|NCT02654132|26181199|P1|Overall Study|Inadequate response to therapy|1
7534769|NCT02654132|26181198|P2|Overall Study|Subject Withdrew Consent|1
7534770|NCT02654132|26181199|P1|Overall Study|Subject Withdrew Consent|2
7534771|NCT02654132|26181198|P2|Overall Study|Not Reported|1
7534772|NCT02654132|26181199|P1|Overall Study|Not Reported|0
7534773|NCT02654132|26181198|P2|Overall Study|Subj Request to Discontinue Treatment|0
7534774|NCT02654132|26181199|P1|Overall Study|Subj Request to Discontinue Treatment|1
7534775|NCT02654132|26181198|P2|Overall Study|Maximum Clinical Benefit|2
7534776|NCT02654132|26181199|P1|Overall Study|Maximum Clinical Benefit|0
7534777|NCT02654132|26181198|P2|Overall Study|Study Drug Toxicity|2
7534778|NCT02654132|26181199|P1|Overall Study|Study Drug Toxicity|1
7534779|NCT02654132|26181198|P2|Overall Study|Switched to another tx|1
7534780|NCT02654132|26181199|P1|Overall Study|Switched to another tx|0
7534781|NCT02654132|26181198|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
7534782|NCT02654132|26181199|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
7534783|NCT02654132|26181198|P2|Overall Study|Disease Progression|31
7534784|NCT02654132|26181199|P1|Overall Study|Disease Progression|26
7534785|NCT02654054|26181210|P3|Post-Treatment Follow-Up Period|Non-Compliance|4
7534786|NCT02654054|26181211|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
7534787|NCT02654054|26181212|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
7534788|NCT02654054|26181210|P3|Post-Treatment Follow-Up Period|Other|4
7534789|NCT02654054|26181211|P2|Post-Treatment Follow-Up Period|Other|0
7534790|NCT02654054|26181212|P1|Post-Treatment Follow-Up Period|Other|1
7534791|NCT02654054|26181210|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7534792|NCT02654054|26181211|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7534793|NCT02654054|26181212|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7534794|NCT02654054|26181210|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7534795|NCT02654054|26181211|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7534796|NCT02654054|26181212|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7534797|NCT02654054|26181210|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7534798|NCT02654054|26181211|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7534799|NCT02654054|26181212|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7534800|NCT02654002|26181247|P9|Overall Study|Withdrew Consent|0
7534801|NCT02654002|26181248|P8|Overall Study|Withdrew Consent|1
7534802|NCT02654002|26181249|P7|Overall Study|Withdrew Consent|0
7534803|NCT02654002|26181250|P6|Overall Study|Withdrew Consent|1
7534804|NCT02654002|26181251|P5|Overall Study|Withdrew Consent|0
7534805|NCT02654002|26181252|P4|Overall Study|Withdrew Consent|0
7534806|NCT02654002|26181253|P3|Overall Study|Withdrew Consent|0
7534807|NCT02654002|26181254|P2|Overall Study|Withdrew Consent|0
7534808|NCT02654002|26181255|P1|Overall Study|Withdrew Consent|0
7534809|NCT02654002|26181247|P9|Overall Study|Adverse Event|0
7534810|NCT02654002|26181248|P8|Overall Study|Adverse Event|0
7534811|NCT02654002|26181249|P7|Overall Study|Adverse Event|1
7534812|NCT02654002|26181250|P6|Overall Study|Adverse Event|0
7534813|NCT02654002|26181251|P5|Overall Study|Adverse Event|0
7534814|NCT02654002|26181252|P4|Overall Study|Adverse Event|0
7534815|NCT02654002|26181253|P3|Overall Study|Adverse Event|0
7534816|NCT02654002|26181254|P2|Overall Study|Adverse Event|0
7534817|NCT02654002|26181255|P1|Overall Study|Adverse Event|0
7534818|NCT02653625|26181429|P1|Overall Study|Suspected Drug Induced Liver Injury|1
7534819|NCT02653625|26181429|P1|Overall Study|Protocol Violation|1
7534820|NCT02653625|26181429|P1|Overall Study|Non-compliance with Study Drug|1
7534821|NCT02653625|26181429|P1|Overall Study|Adverse Event|1
7534822|NCT02653495|26181453|P2|Overall Study|Screening Failure|0
7534823|NCT02653495|26181454|P1|Overall Study|Screening Failure|10
7534824|NCT02653495|26181453|P2|Overall Study|Lost to Follow-up|0
7534825|NCT02653495|26181454|P1|Overall Study|Lost to Follow-up|2
7534826|NCT02653326|26181573|P2|Overall Study|Lost to Follow-up|7
7534827|NCT02653326|26181574|P1|Overall Study|Lost to Follow-up|10
7534828|NCT02653300|26181586|P1|Overall Study|Withdrawal by Subject|2
7534829|NCT02653170|26181618|P3|Overall Study|Lost to Follow-up|10
7534830|NCT02653170|26181619|P2|Overall Study|Lost to Follow-up|4
7534831|NCT02653170|26181620|P1|Overall Study|Lost to Follow-up|12
7534832|NCT02653170|26181618|P3|Overall Study|withdrawn by study team|5
7534833|NCT02653170|26181619|P2|Overall Study|withdrawn by study team|4
7534834|NCT02653170|26181620|P1|Overall Study|withdrawn by study team|2
7534835|NCT02653170|26181618|P3|Overall Study|Withdrawal by Subject|3
7534836|NCT02653170|26181619|P2|Overall Study|Withdrawal by Subject|8
7534837|NCT02653170|26181620|P1|Overall Study|Withdrawal by Subject|3
7534838|NCT02652949|26181662|P1|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
7534839|NCT02652949|26181662|P1|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7534840|NCT02652949|26181662|P1|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7534841|NCT02652949|26181662|P1|24-Month Follow-up Secondary Endpoint|Death|2
7534842|NCT02652949|26181662|P1|12-Month Follow-up Secondary Endpoint|Death|4
7534843|NCT02652949|26181662|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
7534844|NCT02652949|26181662|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
7534845|NCT02652949|26181662|P1|6-Month Follow-up Secondary Endpoint|Death|5
7534846|NCT02652949|26181662|P1|30-Day Follow-up for Secondary Endpoint|Death|1
7534847|NCT02652949|26181662|P1|30-Day Follow-up for Primary Endpoint|Death|1
7534848|NCT02652767|26181699|P1|Overall Study|Withdrawal by Subject|1
7534849|NCT02652767|26181699|P1|Overall Study|Lost to Follow-up|1
7534850|NCT02652767|26181699|P1|Overall Study|Death|2
7534851|NCT02652624|26181727|P2|Extension Phase|Withdrew Consent|1
7534852|NCT02652624|26181728|P1|Extension Phase|Withdrew Consent|0
7534853|NCT02652624|26181727|P2|Extension Phase|Adverse Event|1
7534854|NCT02652624|26181728|P1|Extension Phase|Adverse Event|0
7534855|NCT02652624|26181727|P2|Extension Phase|Pregnancy|1
7534856|NCT02652624|26181728|P1|Extension Phase|Pregnancy|1
7534857|NCT02652624|26181727|P2|Extension Phase|Lost to Follow-up|1
7534858|NCT02652624|26181728|P1|Extension Phase|Lost to Follow-up|3
7534859|NCT02652624|26181727|P2|Randomized Phase|Lost to Follow-up|1
7534860|NCT02652624|26181728|P1|Randomized Phase|Lost to Follow-up|0
7534861|NCT02652624|26181727|P2|Randomized Phase|Death|1
7534862|NCT02652624|26181728|P1|Randomized Phase|Death|0
7534863|NCT02652624|26181727|P2|Randomized Phase|Investigator's Discretion|2
7534864|NCT02652624|26181728|P1|Randomized Phase|Investigator's Discretion|0
7534865|NCT02652624|26181727|P2|Randomized Phase|Pregnancy|1
7534866|NCT02652624|26181728|P1|Randomized Phase|Pregnancy|3
7534867|NCT02652260|26181816|P2|Overall Study|Withdrawal by Subject|1
7534868|NCT02652260|26181817|P1|Overall Study|Withdrawal by Subject|0
7534869|NCT02652260|26181816|P2|Overall Study|Pregnancy|1
7534870|NCT02652260|26181817|P1|Overall Study|Pregnancy|0
7534871|NCT02652156|26181876|P3|Overall Study|Physician Decision|0
7534872|NCT02652156|26181877|P2|Overall Study|Physician Decision|0
7534873|NCT02652156|26181878|P1|Overall Study|Physician Decision|1
7534874|NCT02651987|26181906|P2|Overall Study|Investigator Decision|1
7534875|NCT02651987|26181907|P1|Overall Study|Investigator Decision|1
7534876|NCT02651987|26181906|P2|Overall Study|Local PD|2
7534877|NCT02651987|26181907|P1|Overall Study|Local PD|0
7534878|NCT02651987|26181906|P2|Overall Study|Consent Withdrawn|0
7534879|NCT02651987|26181907|P1|Overall Study|Consent Withdrawn|2
7534880|NCT02651987|26181906|P2|Overall Study|Adverse Event|2
7534881|NCT02651987|26181907|P1|Overall Study|Adverse Event|2
7534882|NCT02651922|26181948|P1|Overall Study|due to exclusion criteria|2
7534883|NCT02651688|26181968|P3|Overall Study|Withdrawal by Subject|2
7534884|NCT02651688|26181969|P2|Overall Study|Withdrawal by Subject|0
7534885|NCT02651688|26181970|P1|Overall Study|Withdrawal by Subject|1
7534886|NCT02651688|26181968|P3|Overall Study|Lost to Follow-up|0
7534887|NCT02651688|26181969|P2|Overall Study|Lost to Follow-up|3
7534888|NCT02651688|26181970|P1|Overall Study|Lost to Follow-up|1
7534889|NCT02651688|26181968|P3|Overall Study|Principal Investigator (PI) decision|0
7534890|NCT02651688|26181969|P2|Overall Study|Principal Investigator (PI) decision|2
7534891|NCT02651688|26181970|P1|Overall Study|Principal Investigator (PI) decision|0
7534892|NCT02651688|26181968|P3|Overall Study|Non-compliance|1
7534893|NCT02651688|26181969|P2|Overall Study|Non-compliance|0
7534894|NCT02651688|26181970|P1|Overall Study|Non-compliance|0
7534895|NCT02651467|26182073|P3|Overall Study|Other (Not specified)|2
7534896|NCT02651467|26182074|P2|Overall Study|Other (Not specified)|0
7534897|NCT02651467|26182075|P1|Overall Study|Other (Not specified)|1
7534898|NCT02651467|26182073|P3|Overall Study|Withdrawal by Subject|2
7534899|NCT02651467|26182074|P2|Overall Study|Withdrawal by Subject|0
7534900|NCT02651467|26182075|P1|Overall Study|Withdrawal by Subject|0
7534901|NCT02651220|26182180|P3|Overall Study|Withdrawal by Parent/Guardian|1
7534902|NCT02651220|26182181|P2|Overall Study|Withdrawal by Parent/Guardian|1
7534903|NCT02651220|26182182|P1|Overall Study|Withdrawal by Parent/Guardian|0
7534904|NCT02651220|26182180|P3|Overall Study|Miscellaneous|2
7534905|NCT02651220|26182181|P2|Overall Study|Miscellaneous|1
7534906|NCT02651220|26182182|P1|Overall Study|Miscellaneous|4
7534907|NCT02651220|26182180|P3|Overall Study|Withdrawal by Subject|8
7534908|NCT02651220|26182181|P2|Overall Study|Withdrawal by Subject|6
7534909|NCT02651220|26182182|P1|Overall Study|Withdrawal by Subject|5
7534910|NCT02651220|26182180|P3|Overall Study|Protocol Violation|1
7534911|NCT02651220|26182181|P2|Overall Study|Protocol Violation|0
7534912|NCT02651220|26182182|P1|Overall Study|Protocol Violation|0
7534913|NCT02651220|26182180|P3|Overall Study|Pregnancy|1
7534914|NCT02651220|26182181|P2|Overall Study|Pregnancy|0
7534915|NCT02651220|26182182|P1|Overall Study|Pregnancy|1
7534916|NCT02651220|26182180|P3|Overall Study|Non-Compliance with Study Drug|1
7534917|NCT02651220|26182181|P2|Overall Study|Non-Compliance with Study Drug|0
7534918|NCT02651220|26182182|P1|Overall Study|Non-Compliance with Study Drug|4
7534919|NCT02651220|26182180|P3|Overall Study|Lost to Follow-up|14
7534920|NCT02651220|26182181|P2|Overall Study|Lost to Follow-up|14
7534921|NCT02651220|26182182|P1|Overall Study|Lost to Follow-up|8
7534922|NCT02651220|26182180|P3|Overall Study|Adverse Event|1
7534923|NCT02651220|26182181|P2|Overall Study|Adverse Event|5
7534924|NCT02651220|26182182|P1|Overall Study|Adverse Event|1
7534925|NCT02651194|26182196|P1|Overall Study|Other|2
7534926|NCT02651194|26182196|P1|Overall Study|Lost to Follow-up|3
7534927|NCT02651155|26182204|P2|Overall Study|Voluntary Withdrawal|0
7534928|NCT02651155|26182205|P1|Overall Study|Voluntary Withdrawal|5
7534929|NCT02651155|26182204|P2|Overall Study|Pretreatment Event/Adverse Event|2
7534930|NCT02651155|26182205|P1|Overall Study|Pretreatment Event/Adverse Event|1
7534931|NCT02651116|26182223|P2|Overall Study|No Longer Willing To Participate In Study|0
7534932|NCT02651116|26182224|P1|Overall Study|No Longer Willing To Participate In Study|1
7534933|NCT02651116|26182223|P2|Overall Study|Adverse Event|1
7534934|NCT02651116|26182224|P1|Overall Study|Adverse Event|0
7534935|NCT02650921|26182263|P1|Overall Study|Due to Medical Condition|1
7534936|NCT02650921|26182263|P1|Overall Study|Adverse Event|1
7534937|NCT02650921|26182263|P1|Overall Study|Lost to Follow-up|2
7534938|NCT02650921|26182263|P1|Overall Study|Withdrawal by Subject|4
7534939|NCT02650895|26182317|P6|Overall Study|Withdrawal by Subject|0
7534940|NCT02650895|26182318|P5|Overall Study|Withdrawal by Subject|0
7534941|NCT02650895|26182319|P4|Overall Study|Withdrawal by Subject|0
7534942|NCT02650895|26182320|P3|Overall Study|Withdrawal by Subject|0
7534943|NCT02650895|26182321|P2|Overall Study|Withdrawal by Subject|1
7534944|NCT02650895|26182322|P1|Overall Study|Withdrawal by Subject|0
7534945|NCT02650466|26182369|P1|Overall Study|Lost to Follow-up|1
7534946|NCT02650466|26182369|P1|Overall Study|Withdrawal by Subject|5
7534947|NCT02650466|26182369|P1|Overall Study|Physician Decision|1
7534948|NCT02650284|26182396|P2|Overall Study|Consent incorrectly taken|1
7534949|NCT02650284|26182397|P1|Overall Study|Consent incorrectly taken|0
7534950|NCT02650284|26182396|P2|Overall Study|Lost to Follow-up|3
7534951|NCT02650284|26182397|P1|Overall Study|Lost to Follow-up|3
7534952|NCT02650128|26182520|P1|Overall Study|Death|2
7534965|NCT02649894|26182559|P2|Overall Study|Other, not specified|0
7534966|NCT02649894|26182560|P1|Overall Study|Other, not specified|6
7534967|NCT02649894|26182559|P2|Overall Study|Death|7
7534968|NCT02649894|26182560|P1|Overall Study|Death|30
7534969|NCT02649894|26182559|P2|Overall Study|Lost to Follow-up|1
7534970|NCT02649894|26182560|P1|Overall Study|Lost to Follow-up|2
7534971|NCT02649894|26182559|P2|Overall Study|Withdrawal by Subject|2
7534972|NCT02649894|26182560|P1|Overall Study|Withdrawal by Subject|5
7534973|NCT02649894|26182559|P2|Overall Study|Physician Decision|1
7534974|NCT02649894|26182560|P1|Overall Study|Physician Decision|0
7534975|NCT02649894|26182559|P2|Overall Study|Adverse Event|0
7534976|NCT02649894|26182560|P1|Overall Study|Adverse Event|1
7534977|NCT02649634|26182588|P2|Overall Study|Lost to Follow-up|1
7534978|NCT02649634|26182589|P1|Overall Study|Lost to Follow-up|0
7534979|NCT02649634|26182588|P2|Overall Study|Withdrawal by Subject|5
7534980|NCT02649634|26182589|P1|Overall Study|Withdrawal by Subject|3
7534981|NCT02649439|26182740|P2|Overall Study|Signed follow up protocol|1
7534982|NCT02649439|26182741|P1|Overall Study|Signed follow up protocol|0
7534983|NCT02649439|26182740|P2|Overall Study|Rising PSA|1
7534984|NCT02649439|26182741|P1|Overall Study|Rising PSA|0
7534985|NCT02649439|26182740|P2|Overall Study|Rising PSA No Mets|1
7534986|NCT02649439|26182741|P1|Overall Study|Rising PSA No Mets|0
7534987|NCT02649439|26182740|P2|Overall Study|PSA DT makes ineligible|1
7534988|NCT02649439|26182741|P1|Overall Study|PSA DT makes ineligible|0
7534989|NCT02649439|26182740|P2|Overall Study|No treatment, per protocol|0
7534990|NCT02649439|26182741|P1|Overall Study|No treatment, per protocol|1
7534991|NCT02649439|26182740|P2|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
7534992|NCT02649439|26182741|P1|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
7534993|NCT02649439|26182740|P2|Overall Study|Refused further follow up|7
7534994|NCT02649439|26182741|P1|Overall Study|Refused further follow up|2
7534995|NCT02649439|26182740|P2|Overall Study|Refused further treatment|0
7534996|NCT02649439|26182741|P1|Overall Study|Refused further treatment|1
7534997|NCT02649439|26182740|P2|Overall Study|Disease progression on study|13
7534998|NCT02649439|26182741|P1|Overall Study|Disease progression on study|12
7534999|NCT02649439|26182740|P2|Overall Study|Physician Decision|0
7535000|NCT02649439|26182741|P1|Overall Study|Physician Decision|1
7535001|NCT02649439|26182740|P2|Overall Study|To start finasteride|0
7535002|NCT02649439|26182741|P1|Overall Study|To start finasteride|1
7535003|NCT02649439|26182740|P2|Overall Study|Patient going out of country|0
7535004|NCT02649439|26182741|P1|Overall Study|Patient going out of country|1
7535005|NCT02649439|26182740|P2|Overall Study|Patient decision|0
7535006|NCT02649439|26182741|P1|Overall Study|Patient decision|1
7535007|NCT02649439|26182740|P2|Overall Study|Switched to alternative treatment|4
7535008|NCT02649439|26182741|P1|Overall Study|Switched to alternative treatment|6
7535009|NCT02649231|26182778|P4|Overall Study|Protocol Violation|0
7535010|NCT02649231|26182779|P3|Overall Study|Protocol Violation|1
7535011|NCT02649231|26182780|P2|Overall Study|Protocol Violation|1
7535012|NCT02649231|26182781|P1|Overall Study|Protocol Violation|2
7535013|NCT02649231|26182778|P4|Overall Study|Withdrawal by Subject|1
7535014|NCT02649231|26182779|P3|Overall Study|Withdrawal by Subject|0
7535015|NCT02649231|26182780|P2|Overall Study|Withdrawal by Subject|1
7535016|NCT02649231|26182781|P1|Overall Study|Withdrawal by Subject|0
7535017|NCT02649231|26182778|P4|Overall Study|Lost to Follow-up|0
7535018|NCT02649231|26182779|P3|Overall Study|Lost to Follow-up|1
7535019|NCT02649231|26182780|P2|Overall Study|Lost to Follow-up|1
7535020|NCT02649231|26182781|P1|Overall Study|Lost to Follow-up|2
7535021|NCT02649231|26182778|P4|Overall Study|Adverse Event|1
7535022|NCT02649231|26182779|P3|Overall Study|Adverse Event|0
7535023|NCT02649231|26182780|P2|Overall Study|Adverse Event|0
7535024|NCT02649231|26182781|P1|Overall Study|Adverse Event|0
7535025|NCT02649218|26182795|P1|Overall Study|Withdrawal by Subject|2
7535026|NCT02649218|26182795|P1|Overall Study|Physician Decision|1
7535027|NCT02649218|26182795|P1|Overall Study|Protocol Violation|3
7535028|NCT02649218|26182795|P1|Overall Study|Pregnancy|3
7535029|NCT02649218|26182795|P1|Overall Study|Lack of Efficacy|8
7535030|NCT02649218|26182795|P1|Overall Study|Adverse Event|8
7535031|NCT02648932|26182894|P2|Overall Study|No transplant|1
7535032|NCT02648932|26182895|P1|Overall Study|No transplant|3
7535033|NCT02648698|26182907|P2|Overall Study|Protocol Violation|5
7535034|NCT02648698|26182908|P1|Overall Study|Protocol Violation|1
7535035|NCT02648438|26182965|P3|Overall Study|Withdrawal by Subject|0
7535036|NCT02648438|26182966|P2|Overall Study|Withdrawal by Subject|1
7535037|NCT02648438|26182967|P1|Overall Study|Withdrawal by Subject|1
7535038|NCT02648438|26182965|P3|Overall Study|Protocol Violation|0
7535039|NCT02648438|26182966|P2|Overall Study|Protocol Violation|0
7535040|NCT02648438|26182967|P1|Overall Study|Protocol Violation|2
7535041|NCT02648438|26182965|P3|Overall Study|Eligibility criteria not fulfilled|0
7535042|NCT02648438|26182966|P2|Overall Study|Eligibility criteria not fulfilled|2
7535043|NCT02648438|26182967|P1|Overall Study|Eligibility criteria not fulfilled|0
7535044|NCT02648217|26183013|P2|Overall Study|Unclassified|0
7535045|NCT02648217|26183014|P1|Overall Study|Unclassified|5
7535046|NCT02648217|26183013|P2|Overall Study|Withdrawal by Subject|3
7535047|NCT02648217|26183014|P1|Overall Study|Withdrawal by Subject|4
7535048|NCT02648217|26183013|P2|Overall Study|Lost to Follow-up|1
7535049|NCT02648217|26183014|P1|Overall Study|Lost to Follow-up|1
7535050|NCT02648217|26183013|P2|Overall Study|Adverse Event|1
7535051|NCT02648217|26183014|P1|Overall Study|Adverse Event|0
7535052|NCT02648204|26183036|P4|Overall Study|Adverse Event|0
7535053|NCT02648204|26183037|P3|Overall Study|Adverse Event|1
7535054|NCT02648204|26183038|P2|Overall Study|Adverse Event|0
7535055|NCT02648204|26183039|P1|Overall Study|Adverse Event|0
7535056|NCT02648204|26183036|P4|Overall Study|Death|2
7535057|NCT02648204|26183037|P3|Overall Study|Death|2
7535058|NCT02648204|26183038|P2|Overall Study|Death|1
7535059|NCT02648204|26183039|P1|Overall Study|Death|1
7535060|NCT02648204|26183036|P4|Overall Study|Missing follow-up information|2
7535061|NCT02648204|26183037|P3|Overall Study|Missing follow-up information|4
7535062|NCT02648204|26183038|P2|Overall Study|Missing follow-up information|4
7535063|NCT02648204|26183039|P1|Overall Study|Missing follow-up information|4
7535064|NCT02648204|26183036|P4|Overall Study|Lost to Follow-up|6
7535065|NCT02648204|26183037|P3|Overall Study|Lost to Follow-up|4
7535066|NCT02648204|26183038|P2|Overall Study|Lost to Follow-up|8
7535067|NCT02648204|26183039|P1|Overall Study|Lost to Follow-up|5
7535068|NCT02648204|26183036|P4|Overall Study|Withdrawal by Subject|6
7535069|NCT02648204|26183037|P3|Overall Study|Withdrawal by Subject|2
7535070|NCT02648204|26183038|P2|Overall Study|Withdrawal by Subject|8
7535071|NCT02648204|26183039|P1|Overall Study|Withdrawal by Subject|12
7535072|NCT02647944|26183177|P2|Overall Study|Adverse Event|0
7535073|NCT02647944|26183178|P1|Overall Study|Adverse Event|2
7535074|NCT02647944|26183177|P2|Overall Study|Withdrawal by Subject|3
7535075|NCT02647944|26183178|P1|Overall Study|Withdrawal by Subject|0
7535076|NCT02647905|26183202|P1|Overall Study|Withdrawal by Subject|2
7535077|NCT02647905|26183202|P1|Overall Study|Lost to Follow-up|1
7535078|NCT02647866|26183212|P5|Overall Study|Subject moved to different country|0
7535079|NCT02647866|26183213|P4|Overall Study|Subject moved to different country|0
7535080|NCT02647866|26183214|P3|Overall Study|Subject moved to different country|0
7535081|NCT02647866|26183215|P2|Overall Study|Subject moved to different country|0
7535082|NCT02647866|26183216|P1|Overall Study|Subject moved to different country|1
7535083|NCT02647866|26183212|P5|Overall Study|Death|0
7535084|NCT02647866|26183213|P4|Overall Study|Death|0
7535085|NCT02647866|26183214|P3|Overall Study|Death|0
7535086|NCT02647866|26183215|P2|Overall Study|Death|1
7535087|NCT02647866|26183216|P1|Overall Study|Death|0
7535088|NCT02647866|26183212|P5|Overall Study|Physician Decision|2
7535089|NCT02647866|26183213|P4|Overall Study|Physician Decision|0
7535090|NCT02647866|26183214|P3|Overall Study|Physician Decision|1
7535091|NCT02647866|26183215|P2|Overall Study|Physician Decision|1
7535092|NCT02647866|26183216|P1|Overall Study|Physician Decision|0
7535093|NCT02647866|26183212|P5|Overall Study|Withdrawal by Subject|4
7535094|NCT02647866|26183213|P4|Overall Study|Withdrawal by Subject|4
7535095|NCT02647866|26183214|P3|Overall Study|Withdrawal by Subject|2
7535096|NCT02647866|26183215|P2|Overall Study|Withdrawal by Subject|1
7535097|NCT02647866|26183216|P1|Overall Study|Withdrawal by Subject|1
7535098|NCT02647866|26183212|P5|Overall Study|Disease Worsening|1
7535099|NCT02647866|26183213|P4|Overall Study|Disease Worsening|0
7535100|NCT02647866|26183214|P3|Overall Study|Disease Worsening|0
7535101|NCT02647866|26183215|P2|Overall Study|Disease Worsening|1
7535102|NCT02647866|26183216|P1|Overall Study|Disease Worsening|3
7535103|NCT02647866|26183212|P5|Overall Study|Adverse Event|1
7535104|NCT02647866|26183213|P4|Overall Study|Adverse Event|2
7535105|NCT02647866|26183214|P3|Overall Study|Adverse Event|2
7535106|NCT02647866|26183215|P2|Overall Study|Adverse Event|0
7535107|NCT02647866|26183216|P1|Overall Study|Adverse Event|0
7535108|NCT02647788|26183293|P2|Overall Study|Felt nauseous with assigned medication|1
7535109|NCT02647788|26183294|P1|Overall Study|Felt nauseous with assigned medication|1
7535110|NCT02647788|26183293|P2|Overall Study|Felt itchy with assigned medication|0
7535111|NCT02647788|26183294|P1|Overall Study|Felt itchy with assigned medication|1
7535112|NCT02647788|26183293|P2|Overall Study|Withdrawal by Subject|0
7535113|NCT02647788|26183294|P1|Overall Study|Withdrawal by Subject|1
7535114|NCT02647788|26183293|P2|Overall Study|Did not want opiate|1
7535115|NCT02647788|26183294|P1|Overall Study|Did not want opiate|0
7535116|NCT02647788|26183293|P2|Overall Study|Lost to Follow-up|11
7535117|NCT02647788|26183294|P1|Overall Study|Lost to Follow-up|13
7535118|NCT02647658|26183306|P2|Overall Study|Consent refusal|24
7535119|NCT02647658|26183307|P1|Overall Study|Consent refusal|15
7535120|NCT02647645|26183335|P2|Overall Study|Lost to Follow-up|1
7535121|NCT02647645|26183336|P1|Overall Study|Lost to Follow-up|2
7535122|NCT02647320|26183358|P5|Overall Study|Disposition Missing Due to Fire at Site|4
7535123|NCT02647320|26183359|P4|Overall Study|Disposition Missing Due to Fire at Site|3
7535124|NCT02647320|26183360|P3|Overall Study|Disposition Missing Due to Fire at Site|4
7535125|NCT02647320|26183361|P2|Overall Study|Disposition Missing Due to Fire at Site|3
7535126|NCT02647320|26183362|P1|Overall Study|Disposition Missing Due to Fire at Site|2
7535127|NCT02647320|26183358|P5|Overall Study|Lack of Efficacy|0
7535128|NCT02647320|26183359|P4|Overall Study|Lack of Efficacy|1
7535129|NCT02647320|26183360|P3|Overall Study|Lack of Efficacy|0
7535130|NCT02647320|26183361|P2|Overall Study|Lack of Efficacy|0
7535131|NCT02647320|26183362|P1|Overall Study|Lack of Efficacy|0
7535132|NCT02647320|26183358|P5|Overall Study|Develop anemia|0
7535133|NCT02647320|26183359|P4|Overall Study|Develop anemia|0
7535134|NCT02647320|26183360|P3|Overall Study|Develop anemia|0
7535135|NCT02647320|26183361|P2|Overall Study|Develop anemia|0
7535136|NCT02647320|26183362|P1|Overall Study|Develop anemia|1
7535137|NCT02647320|26183358|P5|Overall Study|Lost to Follow-up|0
7535138|NCT02647320|26183359|P4|Overall Study|Lost to Follow-up|0
7535139|NCT02647320|26183360|P3|Overall Study|Lost to Follow-up|0
7535140|NCT02647320|26183361|P2|Overall Study|Lost to Follow-up|1
7535141|NCT02647320|26183362|P1|Overall Study|Lost to Follow-up|1
7535142|NCT02647320|26183358|P5|Overall Study|Reason not provided|2
7535143|NCT02647320|26183359|P4|Overall Study|Reason not provided|0
7535144|NCT02647320|26183360|P3|Overall Study|Reason not provided|1
7535145|NCT02647320|26183361|P2|Overall Study|Reason not provided|0
7535146|NCT02647320|26183362|P1|Overall Study|Reason not provided|0
7535147|NCT02647320|26183358|P5|Overall Study|Study terminated by sponsor|2
7535148|NCT02647320|26183359|P4|Overall Study|Study terminated by sponsor|1
7535149|NCT02647320|26183360|P3|Overall Study|Study terminated by sponsor|1
7535150|NCT02647320|26183361|P2|Overall Study|Study terminated by sponsor|1
7535151|NCT02647320|26183362|P1|Overall Study|Study terminated by sponsor|1
7535152|NCT02647320|26183358|P5|Overall Study|Persistent hyperglycemia|1
7535153|NCT02647320|26183359|P4|Overall Study|Persistent hyperglycemia|1
7535154|NCT02647320|26183360|P3|Overall Study|Persistent hyperglycemia|1
7535155|NCT02647320|26183361|P2|Overall Study|Persistent hyperglycemia|1
7535156|NCT02647320|26183362|P1|Overall Study|Persistent hyperglycemia|0
7535157|NCT02647320|26183358|P5|Overall Study|Withdrawal by Subject|7
7535158|NCT02647320|26183359|P4|Overall Study|Withdrawal by Subject|2
7535159|NCT02647320|26183360|P3|Overall Study|Withdrawal by Subject|2
7535160|NCT02647320|26183361|P2|Overall Study|Withdrawal by Subject|4
7535161|NCT02647320|26183362|P1|Overall Study|Withdrawal by Subject|7
7535162|NCT02647320|26183358|P5|Overall Study|Protocol Violation|0
7535163|NCT02647320|26183359|P4|Overall Study|Protocol Violation|0
7535164|NCT02647320|26183360|P3|Overall Study|Protocol Violation|3
7535165|NCT02647320|26183361|P2|Overall Study|Protocol Violation|0
7535166|NCT02647320|26183362|P1|Overall Study|Protocol Violation|0
7535167|NCT02647320|26183358|P5|Overall Study|Adverse Event|1
7535168|NCT02647320|26183359|P4|Overall Study|Adverse Event|2
7535169|NCT02647320|26183360|P3|Overall Study|Adverse Event|3
7535170|NCT02647320|26183361|P2|Overall Study|Adverse Event|1
7535171|NCT02647320|26183362|P1|Overall Study|Adverse Event|0
7535172|NCT02647281|26183453|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
7535173|NCT02647281|26183454|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535174|NCT02647281|26183455|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535175|NCT02647281|26183456|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535176|NCT02647281|26183457|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535177|NCT02647281|26183458|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535178|NCT02647281|26183459|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535179|NCT02647281|26183460|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535180|NCT02647281|26183461|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7535181|NCT02646891|26183677|P10|Overall Study|Death|0
7535182|NCT02646891|26183678|P9|Overall Study|Death|1
7535183|NCT02646891|26183679|P8|Overall Study|Death|1
7535184|NCT02646891|26183680|P7|Overall Study|Death|1
7535185|NCT02646891|26183681|P6|Overall Study|Death|0
7535186|NCT02646891|26183682|P5|Overall Study|Death|0
7535187|NCT02646891|26183683|P4|Overall Study|Death|0
7535188|NCT02646891|26183684|P3|Overall Study|Death|0
7535189|NCT02646891|26183685|P2|Overall Study|Death|0
7535190|NCT02646891|26183686|P1|Overall Study|Death|0
7535191|NCT02646891|26183677|P10|Overall Study|Withdrawal by Subject|3
7535192|NCT02646891|26183678|P9|Overall Study|Withdrawal by Subject|7
7535193|NCT02646891|26183679|P8|Overall Study|Withdrawal by Subject|9
7535194|NCT02646891|26183680|P7|Overall Study|Withdrawal by Subject|5
7535195|NCT02646891|26183681|P6|Overall Study|Withdrawal by Subject|0
7535196|NCT02646891|26183682|P5|Overall Study|Withdrawal by Subject|0
7535197|NCT02646891|26183683|P4|Overall Study|Withdrawal by Subject|0
7535198|NCT02646891|26183684|P3|Overall Study|Withdrawal by Subject|1
7535199|NCT02646891|26183685|P2|Overall Study|Withdrawal by Subject|0
7535200|NCT02646891|26183686|P1|Overall Study|Withdrawal by Subject|2
7535201|NCT02646891|26183677|P10|Overall Study|Protocol Violation|0
7535202|NCT02646891|26183678|P9|Overall Study|Protocol Violation|0
7535203|NCT02646891|26183679|P8|Overall Study|Protocol Violation|1
7535204|NCT02646891|26183680|P7|Overall Study|Protocol Violation|1
7535205|NCT02646891|26183681|P6|Overall Study|Protocol Violation|0
7535206|NCT02646891|26183682|P5|Overall Study|Protocol Violation|0
7535207|NCT02646891|26183683|P4|Overall Study|Protocol Violation|0
7535208|NCT02646891|26183684|P3|Overall Study|Protocol Violation|0
7535209|NCT02646891|26183685|P2|Overall Study|Protocol Violation|0
7535210|NCT02646891|26183686|P1|Overall Study|Protocol Violation|0
7535211|NCT02646891|26183677|P10|Overall Study|Lost to Follow-up|2
7535212|NCT02646891|26183678|P9|Overall Study|Lost to Follow-up|2
7535213|NCT02646891|26183679|P8|Overall Study|Lost to Follow-up|2
7535214|NCT02646891|26183680|P7|Overall Study|Lost to Follow-up|2
7535215|NCT02646891|26183681|P6|Overall Study|Lost to Follow-up|0
7535216|NCT02646891|26183682|P5|Overall Study|Lost to Follow-up|0
7535217|NCT02646891|26183683|P4|Overall Study|Lost to Follow-up|0
7535218|NCT02646891|26183684|P3|Overall Study|Lost to Follow-up|0
7535219|NCT02646891|26183685|P2|Overall Study|Lost to Follow-up|0
7535220|NCT02646891|26183686|P1|Overall Study|Lost to Follow-up|0
7535221|NCT02646891|26183677|P10|Overall Study|Adverse Event|0
7535222|NCT02646891|26183678|P9|Overall Study|Adverse Event|0
7535223|NCT02646891|26183679|P8|Overall Study|Adverse Event|0
7535224|NCT02646891|26183680|P7|Overall Study|Adverse Event|0
7535225|NCT02646891|26183681|P6|Overall Study|Adverse Event|0
7535226|NCT02646891|26183682|P5|Overall Study|Adverse Event|0
7535227|NCT02646891|26183683|P4|Overall Study|Adverse Event|0
7535228|NCT02646891|26183684|P3|Overall Study|Adverse Event|0
7535229|NCT02646891|26183685|P2|Overall Study|Adverse Event|1
7535230|NCT02646891|26183686|P1|Overall Study|Adverse Event|0
7535231|NCT02646618|26183859|P2|Overall Study|Lost to Follow-up|14
7535232|NCT02646618|26183860|P1|Overall Study|Lost to Follow-up|10
7535233|NCT02646566|26183965|P3|Overall Study|Treatment failure|0
7535234|NCT02646566|26183966|P2|Overall Study|Treatment failure|0
7535235|NCT02646566|26183967|P1|Overall Study|Treatment failure|1
7535236|NCT02646566|26183965|P3|Overall Study|Lost to Follow-up|5
7535237|NCT02646566|26183966|P2|Overall Study|Lost to Follow-up|4
7535238|NCT02646566|26183967|P1|Overall Study|Lost to Follow-up|5
7535239|NCT02646423|26184018|P2|Overall Study|Ineligible|1
7535240|NCT02646423|26184019|P1|Overall Study|Ineligible|2
7535241|NCT02646423|26184018|P2|Overall Study|Adverse Event|7
7535242|NCT02646423|26184019|P1|Overall Study|Adverse Event|5
7535243|NCT02646332|26184060|P2|Overall Study|Lost to Follow-up|3
7535244|NCT02646332|26184061|P1|Overall Study|Lost to Follow-up|0
7535245|NCT02646124|26184069|P2|Overall Study|Lost to Follow-up|2
7535246|NCT02646124|26184070|P1|Overall Study|Lost to Follow-up|0
7535247|NCT02645409|26184106|P2|Overall Study|Physician Decision|0
7535248|NCT02645409|26184107|P1|Overall Study|Physician Decision|1
7535249|NCT02645409|26184106|P2|Overall Study|Withdrawal by Subject|0
7535250|NCT02645409|26184107|P1|Overall Study|Withdrawal by Subject|3
7535251|NCT02644668|26184294|P3|Overall Study|Withdrawal by Subject|1
7535252|NCT02644668|26184295|P2|Overall Study|Withdrawal by Subject|0
7535253|NCT02644668|26184296|P1|Overall Study|Withdrawal by Subject|0
7535254|NCT02644668|26184294|P3|Overall Study|Protocol Violation|1
7535255|NCT02644668|26184295|P2|Overall Study|Protocol Violation|0
7535256|NCT02644668|26184296|P1|Overall Study|Protocol Violation|0
7535257|NCT02644668|26184294|P3|Overall Study|Adverse Event|1
7535258|NCT02644668|26184295|P2|Overall Study|Adverse Event|0
7535259|NCT02644668|26184296|P1|Overall Study|Adverse Event|2
7535260|NCT02644356|26184335|P1|Overall Study|Withdrawal by Subject|2
7535261|NCT02644343|26184345|P1|Overall Study|Withdrawal by Subject|1
7535262|NCT02644122|26184422|P1|Overall Study|Withdrawal by Subject|1
7535263|NCT02644109|26184432|P2|Overall Study|Adverse Event|4
7535264|NCT02644109|26184433|P1|Overall Study|Adverse Event|0
7535265|NCT02644096|26184441|P2|Overall Study|Withdrawal by Subject|25
7535266|NCT02644096|26184442|P1|Overall Study|Withdrawal by Subject|28
7535267|NCT02643693|26184494|P6|Overall Study|Protocol Adherence Issues|1
7535268|NCT02643693|26184495|P5|Overall Study|Protocol Adherence Issues|0
7535269|NCT02643693|26184496|P4|Overall Study|Protocol Adherence Issues|0
7535270|NCT02643693|26184497|P3|Overall Study|Protocol Adherence Issues|1
7535271|NCT02643693|26184498|P2|Overall Study|Protocol Adherence Issues|0
7535272|NCT02643693|26184499|P1|Overall Study|Protocol Adherence Issues|2
7535273|NCT02643693|26184494|P6|Overall Study|Withdrawal by Subject|0
7535274|NCT02643693|26184495|P5|Overall Study|Withdrawal by Subject|0
7535275|NCT02643693|26184496|P4|Overall Study|Withdrawal by Subject|0
7535276|NCT02643693|26184497|P3|Overall Study|Withdrawal by Subject|0
7535277|NCT02643693|26184498|P2|Overall Study|Withdrawal by Subject|1
7535278|NCT02643693|26184499|P1|Overall Study|Withdrawal by Subject|0
7535279|NCT02643693|26184494|P6|Overall Study|Physician Decision|0
7535280|NCT02643693|26184495|P5|Overall Study|Physician Decision|0
7535281|NCT02643693|26184496|P4|Overall Study|Physician Decision|0
7535282|NCT02643693|26184497|P3|Overall Study|Physician Decision|0
7535283|NCT02643693|26184498|P2|Overall Study|Physician Decision|1
7535284|NCT02643693|26184499|P1|Overall Study|Physician Decision|0
7535285|NCT02643628|26184512|P2|Overall Study|Relocated out of state|1
7535286|NCT02643628|26184513|P1|Overall Study|Relocated out of state|0
7535287|NCT02643628|26184512|P2|Overall Study|Withdrawal by Subject|1
7535288|NCT02643628|26184513|P1|Overall Study|Withdrawal by Subject|0
7535289|NCT02643628|26184512|P2|Overall Study|Lost to Follow-up|4
7535290|NCT02643628|26184513|P1|Overall Study|Lost to Follow-up|1
7535291|NCT02643472|26184544|P2|Overall Study|Lost to Follow-up|26
7535292|NCT02643472|26184545|P1|Overall Study|Lost to Follow-up|22
7535293|NCT02643472|26184544|P2|Overall Study|Protocol Violation|1
7535294|NCT02643472|26184545|P1|Overall Study|Protocol Violation|0
7535295|NCT02643472|26184544|P2|Overall Study|Withdrawal by Subject|2
7535296|NCT02643472|26184545|P1|Overall Study|Withdrawal by Subject|3
7535297|NCT02643472|26184544|P2|Overall Study|Death|5
7535298|NCT02643472|26184545|P1|Overall Study|Death|2
7535299|NCT02643394|26184594|P2|Overall Study|Protocol Violation|5
7535300|NCT02643394|26184595|P1|Overall Study|Protocol Violation|4
7535301|NCT02643355|26184605|P2|Overall Study|Protocol Violation|2
7535302|NCT02643355|26184606|P1|Overall Study|Protocol Violation|0
7535303|NCT02643355|26184605|P2|Overall Study|Withdrawal by Subject|3
7535304|NCT02643355|26184606|P1|Overall Study|Withdrawal by Subject|1
7535305|NCT02643251|26184620|P2|Overall Study|PI Decision to terminate patient|0
7535306|NCT02643251|26184621|P1|Overall Study|PI Decision to terminate patient|1
7535307|NCT02643251|26184620|P2|Overall Study|Protocol Violation|0
7535308|NCT02643251|26184621|P1|Overall Study|Protocol Violation|1
7535309|NCT02643251|26184620|P2|Overall Study|Lost to Follow-up|1
7535310|NCT02643251|26184621|P1|Overall Study|Lost to Follow-up|4
7535311|NCT02643251|26184620|P2|Overall Study|Withdrawal by Subject|0
7535312|NCT02643251|26184621|P1|Overall Study|Withdrawal by Subject|2
7535313|NCT02643251|26184620|P2|Overall Study|Adverse Event|1
7535314|NCT02643251|26184621|P1|Overall Study|Adverse Event|3
7535315|NCT02643082|26184653|P2|Period 1|Adverse Event|0
7535316|NCT02643082|26184654|P1|Period 1|Adverse Event|1
7535317|NCT02642965|26184794|P1|Overall Study|Physician Decision|9
7535318|NCT02642965|26184794|P1|Overall Study|Lack of Efficacy|4
7535319|NCT02642679|26184838|P1|Overall Study|Physician Decision|1
7535320|NCT02642679|26184838|P1|Overall Study|Physician Decision|1
7535321|NCT02642679|26184838|P1|Overall Study|Withdrawal by Subject|1
7535322|NCT02642653|26184846|P2|Overall Study|Adverse Event|0
7535323|NCT02642653|26184847|P1|Overall Study|Adverse Event|2
7535324|NCT02642614|26184888|P4|Overall Study|Withdrawal by Subject|0
7535325|NCT02642614|26184889|P3|Overall Study|Withdrawal by Subject|0
7535326|NCT02642614|26184890|P2|Overall Study|Withdrawal by Subject|1
7535327|NCT02642614|26184891|P1|Overall Study|Withdrawal by Subject|1
7535328|NCT02642614|26184888|P4|Overall Study|Lost to Follow-up|0
7535329|NCT02642614|26184889|P3|Overall Study|Lost to Follow-up|0
7535330|NCT02642614|26184890|P2|Overall Study|Lost to Follow-up|0
7535331|NCT02642614|26184891|P1|Overall Study|Lost to Follow-up|1
7535332|NCT02642614|26184888|P4|Overall Study|Adverse Event|2
7535333|NCT02642614|26184889|P3|Overall Study|Adverse Event|2
7535334|NCT02642614|26184890|P2|Overall Study|Adverse Event|1
7535335|NCT02642614|26184891|P1|Overall Study|Adverse Event|1
7535336|NCT02642432|26184958|P1|Overall Study|Other|3
7535337|NCT02642432|26184958|P1|Overall Study|Lost to Follow-up|2
7535338|NCT02642432|26184958|P1|Overall Study|Withdrew Consent|1
7535339|NCT02642432|26184958|P1|Overall Study|Adverse Event|2
7535340|NCT02642159|26185004|P2|Overall Study|Other than specified above|3
7535341|NCT02642159|26185005|P1|Overall Study|Other than specified above|10
7535342|NCT02642159|26185004|P2|Overall Study|Poor compliance to study protocol|0
7535343|NCT02642159|26185005|P1|Overall Study|Poor compliance to study protocol|1
7535344|NCT02642159|26185004|P2|Overall Study|Withdrawal by Subject|1
7535345|NCT02642159|26185005|P1|Overall Study|Withdrawal by Subject|9
7535346|NCT02642159|26185004|P2|Overall Study|Adverse Event|4
7535347|NCT02642159|26185005|P1|Overall Study|Adverse Event|10
7535348|NCT02642159|26185004|P2|Overall Study|Randomized but not treated|0
7535349|NCT02642159|26185005|P1|Overall Study|Randomized but not treated|1
7535350|NCT02642042|26185055|P1|Overall Study|Not Protocol Specified|2
7535351|NCT02642042|26185055|P1|Overall Study|Death|1
7535352|NCT02642042|26185055|P1|Overall Study|Progression/Relapse|28
7535353|NCT02642042|26185055|P1|Overall Study|Refusal Unrelated to Adverse Event|1
7535354|NCT02642042|26185055|P1|Overall Study|Adverse Event|22
7535355|NCT02641730|26185169|P5|Observational Period (Week 60 - Week 84)|Other|1
7535356|NCT02641730|26185170|P4|Observational Period (Week 60 - Week 84)|Other|0
7535357|NCT02641730|26185171|P3|Observational Period (Week 60 - Week 84)|Other|0
7535358|NCT02641730|26185172|P2|Observational Period (Week 60 - Week 84)|Other|0
7535359|NCT02641730|26185173|P1|Observational Period (Week 60 - Week 84)|Other|0
7535360|NCT02641730|26185169|P5|After Controlled Period (Week 16 - 52)|Other|1
7535361|NCT02641730|26185170|P4|After Controlled Period (Week 16 - 52)|Other|0
7535362|NCT02641730|26185171|P3|After Controlled Period (Week 16 - 52)|Other|1
7535363|NCT02641730|26185172|P2|After Controlled Period (Week 16 - 52)|Other|1
7535364|NCT02641730|26185173|P1|After Controlled Period (Week 16 - 52)|Other|0
7535365|NCT02641730|26185169|P5|After Controlled Period (Week 16 - 52)|Pregnancy|1
7535366|NCT02641730|26185170|P4|After Controlled Period (Week 16 - 52)|Pregnancy|1
7535367|NCT02641730|26185171|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
7535368|NCT02641730|26185172|P2|After Controlled Period (Week 16 - 52)|Pregnancy|0
7535369|NCT02641730|26185173|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
7535370|NCT02641730|26185169|P5|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7535371|NCT02641730|26185170|P4|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7535372|NCT02641730|26185171|P3|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7535373|NCT02641730|26185172|P2|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7535374|NCT02641730|26185173|P1|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7535375|NCT02641730|26185169|P5|After Controlled Period (Week 16 - 52)|Adverse Event|4
7535376|NCT02641730|26185170|P4|After Controlled Period (Week 16 - 52)|Adverse Event|5
7535377|NCT02641730|26185171|P3|After Controlled Period (Week 16 - 52)|Adverse Event|1
7535378|NCT02641730|26185172|P2|After Controlled Period (Week 16 - 52)|Adverse Event|1
7535379|NCT02641730|26185173|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
7535380|NCT02641730|26185169|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7535381|NCT02641730|26185170|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7535382|NCT02641730|26185171|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7535383|NCT02641730|26185172|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7535384|NCT02641730|26185173|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7535385|NCT02641587|26185316|P2|Ambulatory Period|Withdrawal by Subject|0
7535386|NCT02641587|26185317|P1|Ambulatory Period|Withdrawal by Subject|1
7535387|NCT02641587|26185316|P2|Confinement Period|Withdrawal by Subject|1
7535388|NCT02641587|26185317|P1|Confinement Period|Withdrawal by Subject|2
7535389|NCT02641587|26185316|P2|Confinement Period|Adverse Event|0
7535390|NCT02641587|26185317|P1|Confinement Period|Adverse Event|1
7535391|NCT02641392|26185438|P3|Overall Study|Death|1
7535392|NCT02641392|26185439|P2|Overall Study|Death|0
7535393|NCT02641392|26185440|P1|Overall Study|Death|0
7535394|NCT02641392|26185438|P3|Overall Study|Miscellaneous|3
7535395|NCT02641392|26185439|P2|Overall Study|Miscellaneous|0
7535396|NCT02641392|26185440|P1|Overall Study|Miscellaneous|0
7535397|NCT02641392|26185438|P3|Overall Study|Lack of Efficacy|101
7535398|NCT02641392|26185439|P2|Overall Study|Lack of Efficacy|0
7535399|NCT02641392|26185440|P1|Overall Study|Lack of Efficacy|0
7535400|NCT02641392|26185438|P3|Overall Study|Study Terminated by Sponsor|144
7535401|NCT02641392|26185439|P2|Overall Study|Study Terminated by Sponsor|12
7535402|NCT02641392|26185440|P1|Overall Study|Study Terminated by Sponsor|4
7535403|NCT02641392|26185438|P3|Overall Study|Adverse Event|25
7535404|NCT02641392|26185439|P2|Overall Study|Adverse Event|1
7535405|NCT02641392|26185440|P1|Overall Study|Adverse Event|0
7535406|NCT02641392|26185438|P3|Overall Study|Withdrawal by Subject|17
7535407|NCT02641392|26185439|P2|Overall Study|Withdrawal by Subject|0
7535408|NCT02641392|26185440|P1|Overall Study|Withdrawal by Subject|0
7535409|NCT02641392|26185438|P3|Overall Study|Lost to Follow-up|2
7535410|NCT02641392|26185439|P2|Overall Study|Lost to Follow-up|0
7535411|NCT02641392|26185440|P1|Overall Study|Lost to Follow-up|0
7535412|NCT02641379|26185459|P11|Overall Study|PCR positive|0
7535413|NCT02641379|26185460|P10|Overall Study|PCR positive|0
7535414|NCT02641379|26185461|P9|Overall Study|PCR positive|0
7535415|NCT02641379|26185462|P8|Overall Study|PCR positive|0
7535416|NCT02641379|26185463|P7|Overall Study|PCR positive|1
7535417|NCT02641379|26185464|P6|Overall Study|PCR positive|0
7535418|NCT02641379|26185465|P5|Overall Study|PCR positive|0
7535419|NCT02641379|26185466|P4|Overall Study|PCR positive|0
7535420|NCT02641379|26185467|P3|Overall Study|PCR positive|0
7535421|NCT02641379|26185468|P2|Overall Study|PCR positive|0
7535422|NCT02641379|26185469|P1|Overall Study|PCR positive|0
7535423|NCT02641379|26185459|P11|Overall Study|Missing PCR result at Week 8|0
7535424|NCT02641379|26185460|P10|Overall Study|Missing PCR result at Week 8|1
7535425|NCT02641379|26185461|P9|Overall Study|Missing PCR result at Week 8|0
7535426|NCT02641379|26185462|P8|Overall Study|Missing PCR result at Week 8|0
7535427|NCT02641379|26185463|P7|Overall Study|Missing PCR result at Week 8|0
7535428|NCT02641379|26185464|P6|Overall Study|Missing PCR result at Week 8|0
7535429|NCT02641379|26185465|P5|Overall Study|Missing PCR result at Week 8|0
7535430|NCT02641379|26185466|P4|Overall Study|Missing PCR result at Week 8|0
7535431|NCT02641379|26185467|P3|Overall Study|Missing PCR result at Week 8|0
7535432|NCT02641379|26185468|P2|Overall Study|Missing PCR result at Week 8|0
7535433|NCT02641379|26185469|P1|Overall Study|Missing PCR result at Week 8|0
7535434|NCT02641379|26185459|P11|Overall Study|Participant treated after Week 24|0
7535435|NCT02641379|26185460|P10|Overall Study|Participant treated after Week 24|0
7535436|NCT02641379|26185461|P9|Overall Study|Participant treated after Week 24|1
7535437|NCT02641379|26185462|P8|Overall Study|Participant treated after Week 24|0
7535438|NCT02641379|26185463|P7|Overall Study|Participant treated after Week 24|0
7535439|NCT02641379|26185464|P6|Overall Study|Participant treated after Week 24|0
7535440|NCT02641379|26185465|P5|Overall Study|Participant treated after Week 24|0
7535441|NCT02641379|26185466|P4|Overall Study|Participant treated after Week 24|0
7535442|NCT02641379|26185467|P3|Overall Study|Participant treated after Week 24|0
7535443|NCT02641379|26185468|P2|Overall Study|Participant treated after Week 24|0
7535444|NCT02641379|26185469|P1|Overall Study|Participant treated after Week 24|0
7535445|NCT02641379|26185459|P11|Overall Study|Participant's PCR high|0
7535446|NCT02641379|26185460|P10|Overall Study|Participant's PCR high|0
7535447|NCT02641379|26185461|P9|Overall Study|Participant's PCR high|0
7535448|NCT02641379|26185462|P8|Overall Study|Participant's PCR high|1
7535449|NCT02641379|26185463|P7|Overall Study|Participant's PCR high|0
7535450|NCT02641379|26185464|P6|Overall Study|Participant's PCR high|0
7535451|NCT02641379|26185465|P5|Overall Study|Participant's PCR high|0
7535452|NCT02641379|26185466|P4|Overall Study|Participant's PCR high|0
7535453|NCT02641379|26185467|P3|Overall Study|Participant's PCR high|0
7535454|NCT02641379|26185468|P2|Overall Study|Participant's PCR high|0
7535455|NCT02641379|26185469|P1|Overall Study|Participant's PCR high|0
7535456|NCT02641379|26185459|P11|Overall Study|Negative PCR result|0
7535457|NCT02641379|26185460|P10|Overall Study|Negative PCR result|1
7535458|NCT02641379|26185461|P9|Overall Study|Negative PCR result|0
7535459|NCT02641379|26185462|P8|Overall Study|Negative PCR result|0
7535460|NCT02641379|26185463|P7|Overall Study|Negative PCR result|0
7535461|NCT02641379|26185464|P6|Overall Study|Negative PCR result|0
7535462|NCT02641379|26185465|P5|Overall Study|Negative PCR result|0
7535463|NCT02641379|26185466|P4|Overall Study|Negative PCR result|0
7535464|NCT02641379|26185467|P3|Overall Study|Negative PCR result|0
7535465|NCT02641379|26185468|P2|Overall Study|Negative PCR result|0
7535466|NCT02641379|26185469|P1|Overall Study|Negative PCR result|0
7535467|NCT02641379|26185459|P11|Overall Study|No 2 Log drop at Week 12|1
7535468|NCT02641379|26185460|P10|Overall Study|No 2 Log drop at Week 12|0
7535469|NCT02641379|26185461|P9|Overall Study|No 2 Log drop at Week 12|0
7535470|NCT02641379|26185462|P8|Overall Study|No 2 Log drop at Week 12|0
7535471|NCT02641379|26185463|P7|Overall Study|No 2 Log drop at Week 12|0
7535472|NCT02641379|26185464|P6|Overall Study|No 2 Log drop at Week 12|0
7535473|NCT02641379|26185465|P5|Overall Study|No 2 Log drop at Week 12|0
7535474|NCT02641379|26185466|P4|Overall Study|No 2 Log drop at Week 12|0
7535475|NCT02641379|26185467|P3|Overall Study|No 2 Log drop at Week 12|0
7535476|NCT02641379|26185468|P2|Overall Study|No 2 Log drop at Week 12|0
7535477|NCT02641379|26185469|P1|Overall Study|No 2 Log drop at Week 12|0
7535478|NCT02641379|26185459|P11|Overall Study|Non-response Week 12|0
7535479|NCT02641379|26185460|P10|Overall Study|Non-response Week 12|0
7535480|NCT02641379|26185461|P9|Overall Study|Non-response Week 12|0
7535481|NCT02641379|26185462|P8|Overall Study|Non-response Week 12|1
7535482|NCT02641379|26185463|P7|Overall Study|Non-response Week 12|0
7535483|NCT02641379|26185464|P6|Overall Study|Non-response Week 12|0
7535484|NCT02641379|26185465|P5|Overall Study|Non-response Week 12|0
7535485|NCT02641379|26185466|P4|Overall Study|Non-response Week 12|0
7535486|NCT02641379|26185467|P3|Overall Study|Non-response Week 12|0
7535487|NCT02641379|26185468|P2|Overall Study|Non-response Week 12|0
7535488|NCT02641379|26185469|P1|Overall Study|Non-response Week 12|0
7535489|NCT02641379|26185459|P11|Overall Study|Participant showed weight reduction|0
7535490|NCT02641379|26185460|P10|Overall Study|Participant showed weight reduction|0
7535491|NCT02641379|26185461|P9|Overall Study|Participant showed weight reduction|0
7535492|NCT02641379|26185462|P8|Overall Study|Participant showed weight reduction|1
7535493|NCT02641379|26185463|P7|Overall Study|Participant showed weight reduction|0
7535494|NCT02641379|26185464|P6|Overall Study|Participant showed weight reduction|0
7535495|NCT02641379|26185465|P5|Overall Study|Participant showed weight reduction|0
7535496|NCT02641379|26185466|P4|Overall Study|Participant showed weight reduction|0
7535497|NCT02641379|26185467|P3|Overall Study|Participant showed weight reduction|0
7535498|NCT02641379|26185468|P2|Overall Study|Participant showed weight reduction|0
7535499|NCT02641379|26185469|P1|Overall Study|Participant showed weight reduction|0
7535500|NCT02641379|26185459|P11|Overall Study|Source data not found|0
7535501|NCT02641379|26185460|P10|Overall Study|Source data not found|0
7535502|NCT02641379|26185461|P9|Overall Study|Source data not found|0
7535503|NCT02641379|26185462|P8|Overall Study|Source data not found|0
7535504|NCT02641379|26185463|P7|Overall Study|Source data not found|0
7535505|NCT02641379|26185464|P6|Overall Study|Source data not found|1
7535506|NCT02641379|26185465|P5|Overall Study|Source data not found|0
7535507|NCT02641379|26185466|P4|Overall Study|Source data not found|0
7535508|NCT02641379|26185467|P3|Overall Study|Source data not found|0
7535509|NCT02641379|26185468|P2|Overall Study|Source data not found|0
7535510|NCT02641379|26185469|P1|Overall Study|Source data not found|0
7535511|NCT02641379|26185459|P11|Overall Study|Lost to Follow-up|0
7535512|NCT02641379|26185460|P10|Overall Study|Lost to Follow-up|0
7535513|NCT02641379|26185461|P9|Overall Study|Lost to Follow-up|1
7535514|NCT02641379|26185462|P8|Overall Study|Lost to Follow-up|0
7535515|NCT02641379|26185463|P7|Overall Study|Lost to Follow-up|0
7535516|NCT02641379|26185464|P6|Overall Study|Lost to Follow-up|0
7535517|NCT02641379|26185465|P5|Overall Study|Lost to Follow-up|0
7535518|NCT02641379|26185466|P4|Overall Study|Lost to Follow-up|0
7535519|NCT02641379|26185467|P3|Overall Study|Lost to Follow-up|0
7535520|NCT02641379|26185468|P2|Overall Study|Lost to Follow-up|0
7535521|NCT02641379|26185469|P1|Overall Study|Lost to Follow-up|0
7535522|NCT02641379|26185459|P11|Overall Study|Participation in sili rescue study|0
7535523|NCT02641379|26185460|P10|Overall Study|Participation in sili rescue study|0
7535524|NCT02641379|26185461|P9|Overall Study|Participation in sili rescue study|0
7535525|NCT02641379|26185462|P8|Overall Study|Participation in sili rescue study|0
7535526|NCT02641379|26185463|P7|Overall Study|Participation in sili rescue study|0
7535527|NCT02641379|26185464|P6|Overall Study|Participation in sili rescue study|1
7535528|NCT02641379|26185465|P5|Overall Study|Participation in sili rescue study|0
7535529|NCT02641379|26185466|P4|Overall Study|Participation in sili rescue study|0
7535530|NCT02641379|26185467|P3|Overall Study|Participation in sili rescue study|0
7535531|NCT02641379|26185468|P2|Overall Study|Participation in sili rescue study|0
7535532|NCT02641379|26185469|P1|Overall Study|Participation in sili rescue study|0
7535533|NCT02641379|26185459|P11|Overall Study|Protocol Violation|0
7535534|NCT02641379|26185460|P10|Overall Study|Protocol Violation|0
7535535|NCT02641379|26185461|P9|Overall Study|Protocol Violation|1
7535536|NCT02641379|26185462|P8|Overall Study|Protocol Violation|0
7535537|NCT02641379|26185463|P7|Overall Study|Protocol Violation|0
7535538|NCT02641379|26185464|P6|Overall Study|Protocol Violation|0
7535539|NCT02641379|26185465|P5|Overall Study|Protocol Violation|2
7535540|NCT02641379|26185466|P4|Overall Study|Protocol Violation|0
7535541|NCT02641379|26185467|P3|Overall Study|Protocol Violation|0
7535542|NCT02641379|26185468|P2|Overall Study|Protocol Violation|0
7535543|NCT02641379|26185469|P1|Overall Study|Protocol Violation|0
7535544|NCT02641379|26185459|P11|Overall Study|Blood could not be drawn|0
7535545|NCT02641379|26185460|P10|Overall Study|Blood could not be drawn|0
7535546|NCT02641379|26185461|P9|Overall Study|Blood could not be drawn|0
7535547|NCT02641379|26185462|P8|Overall Study|Blood could not be drawn|0
7535548|NCT02641379|26185463|P7|Overall Study|Blood could not be drawn|0
7535549|NCT02641379|26185464|P6|Overall Study|Blood could not be drawn|0
7535550|NCT02641379|26185465|P5|Overall Study|Blood could not be drawn|1
7535551|NCT02641379|26185466|P4|Overall Study|Blood could not be drawn|0
7535552|NCT02641379|26185467|P3|Overall Study|Blood could not be drawn|0
7535553|NCT02641379|26185468|P2|Overall Study|Blood could not be drawn|0
7535554|NCT02641379|26185469|P1|Overall Study|Blood could not be drawn|0
7535555|NCT02641379|26185459|P11|Overall Study|Baseline viral load unavailable|0
7535556|NCT02641379|26185460|P10|Overall Study|Baseline viral load unavailable|0
7535557|NCT02641379|26185461|P9|Overall Study|Baseline viral load unavailable|0
7535558|NCT02641379|26185462|P8|Overall Study|Baseline viral load unavailable|0
7535559|NCT02641379|26185463|P7|Overall Study|Baseline viral load unavailable|0
7535560|NCT02641379|26185464|P6|Overall Study|Baseline viral load unavailable|0
7535561|NCT02641379|26185465|P5|Overall Study|Baseline viral load unavailable|0
7535562|NCT02641379|26185466|P4|Overall Study|Baseline viral load unavailable|1
7535563|NCT02641379|26185467|P3|Overall Study|Baseline viral load unavailable|0
7535564|NCT02641379|26185468|P2|Overall Study|Baseline viral load unavailable|0
7535565|NCT02641379|26185469|P1|Overall Study|Baseline viral load unavailable|0
7535566|NCT02641379|26185459|P11|Overall Study|Inclusion criteria not fulfilled|0
7535567|NCT02641379|26185460|P10|Overall Study|Inclusion criteria not fulfilled|0
7535568|NCT02641379|26185461|P9|Overall Study|Inclusion criteria not fulfilled|0
7535569|NCT02641379|26185462|P8|Overall Study|Inclusion criteria not fulfilled|0
7535570|NCT02641379|26185463|P7|Overall Study|Inclusion criteria not fulfilled|0
7535571|NCT02641379|26185464|P6|Overall Study|Inclusion criteria not fulfilled|0
7535572|NCT02641379|26185465|P5|Overall Study|Inclusion criteria not fulfilled|0
7535573|NCT02641379|26185466|P4|Overall Study|Inclusion criteria not fulfilled|1
7535574|NCT02641379|26185467|P3|Overall Study|Inclusion criteria not fulfilled|0
7535575|NCT02641379|26185468|P2|Overall Study|Inclusion criteria not fulfilled|0
7535576|NCT02641379|26185469|P1|Overall Study|Inclusion criteria not fulfilled|0
7535577|NCT02641379|26185459|P11|Overall Study|PCR sample for Week 4 not drawn|0
7535578|NCT02641379|26185460|P10|Overall Study|PCR sample for Week 4 not drawn|0
7535579|NCT02641379|26185461|P9|Overall Study|PCR sample for Week 4 not drawn|0
7535580|NCT02641379|26185462|P8|Overall Study|PCR sample for Week 4 not drawn|0
7535581|NCT02641379|26185463|P7|Overall Study|PCR sample for Week 4 not drawn|0
7535582|NCT02641379|26185464|P6|Overall Study|PCR sample for Week 4 not drawn|0
7535583|NCT02641379|26185465|P5|Overall Study|PCR sample for Week 4 not drawn|0
7535584|NCT02641379|26185466|P4|Overall Study|PCR sample for Week 4 not drawn|1
7535585|NCT02641379|26185467|P3|Overall Study|PCR sample for Week 4 not drawn|0
7535586|NCT02641379|26185468|P2|Overall Study|PCR sample for Week 4 not drawn|0
7535587|NCT02641379|26185469|P1|Overall Study|PCR sample for Week 4 not drawn|0
7535588|NCT02641379|26185459|P11|Overall Study|PCR positive at Week 28|0
7535589|NCT02641379|26185460|P10|Overall Study|PCR positive at Week 28|0
7535590|NCT02641379|26185461|P9|Overall Study|PCR positive at Week 28|0
7535591|NCT02641379|26185462|P8|Overall Study|PCR positive at Week 28|0
7535592|NCT02641379|26185463|P7|Overall Study|PCR positive at Week 28|0
7535593|NCT02641379|26185464|P6|Overall Study|PCR positive at Week 28|0
7535594|NCT02641379|26185465|P5|Overall Study|PCR positive at Week 28|0
7535595|NCT02641379|26185466|P4|Overall Study|PCR positive at Week 28|0
7535596|NCT02641379|26185467|P3|Overall Study|PCR positive at Week 28|1
7535597|NCT02641379|26185468|P2|Overall Study|PCR positive at Week 28|0
7535598|NCT02641379|26185469|P1|Overall Study|PCR positive at Week 28|0
7535599|NCT02641379|26185459|P11|Overall Study|No PCR at baseline|0
7535600|NCT02641379|26185460|P10|Overall Study|No PCR at baseline|0
7535601|NCT02641379|26185461|P9|Overall Study|No PCR at baseline|0
7535602|NCT02641379|26185462|P8|Overall Study|No PCR at baseline|0
7535603|NCT02641379|26185463|P7|Overall Study|No PCR at baseline|0
7535604|NCT02641379|26185464|P6|Overall Study|No PCR at baseline|0
7535605|NCT02641379|26185465|P5|Overall Study|No PCR at baseline|0
7535606|NCT02641379|26185466|P4|Overall Study|No PCR at baseline|0
7535607|NCT02641379|26185467|P3|Overall Study|No PCR at baseline|1
7535608|NCT02641379|26185468|P2|Overall Study|No PCR at baseline|0
7535609|NCT02641379|26185469|P1|Overall Study|No PCR at baseline|0
7535610|NCT02641379|26185459|P11|Overall Study|PCR not performed at Week 12|0
7535611|NCT02641379|26185460|P10|Overall Study|PCR not performed at Week 12|0
7535612|NCT02641379|26185461|P9|Overall Study|PCR not performed at Week 12|0
7535613|NCT02641379|26185462|P8|Overall Study|PCR not performed at Week 12|0
7535614|NCT02641379|26185463|P7|Overall Study|PCR not performed at Week 12|0
7535615|NCT02641379|26185464|P6|Overall Study|PCR not performed at Week 12|0
7535616|NCT02641379|26185465|P5|Overall Study|PCR not performed at Week 12|0
7535617|NCT02641379|26185466|P4|Overall Study|PCR not performed at Week 12|0
7535618|NCT02641379|26185467|P3|Overall Study|PCR not performed at Week 12|1
7535619|NCT02641379|26185468|P2|Overall Study|PCR not performed at Week 12|0
7535620|NCT02641379|26185469|P1|Overall Study|PCR not performed at Week 12|0
7535621|NCT02641379|26185459|P11|Overall Study|PCR positive at Week 48|0
7535622|NCT02641379|26185460|P10|Overall Study|PCR positive at Week 48|0
7535623|NCT02641379|26185461|P9|Overall Study|PCR positive at Week 48|0
7535624|NCT02641379|26185462|P8|Overall Study|PCR positive at Week 48|0
7535625|NCT02641379|26185463|P7|Overall Study|PCR positive at Week 48|0
7535626|NCT02641379|26185464|P6|Overall Study|PCR positive at Week 48|0
7535627|NCT02641379|26185465|P5|Overall Study|PCR positive at Week 48|0
7535628|NCT02641379|26185466|P4|Overall Study|PCR positive at Week 48|0
7535629|NCT02641379|26185467|P3|Overall Study|PCR positive at Week 48|0
7535630|NCT02641379|26185468|P2|Overall Study|PCR positive at Week 48|1
7535631|NCT02641379|26185469|P1|Overall Study|PCR positive at Week 48|0
7535632|NCT02641379|26185459|P11|Overall Study|PCR positive at Week 68|0
7535633|NCT02641379|26185460|P10|Overall Study|PCR positive at Week 68|0
7535634|NCT02641379|26185461|P9|Overall Study|PCR positive at Week 68|0
7535635|NCT02641379|26185462|P8|Overall Study|PCR positive at Week 68|0
7535636|NCT02641379|26185463|P7|Overall Study|PCR positive at Week 68|0
7535637|NCT02641379|26185464|P6|Overall Study|PCR positive at Week 68|0
7535638|NCT02641379|26185465|P5|Overall Study|PCR positive at Week 68|0
7535639|NCT02641379|26185466|P4|Overall Study|PCR positive at Week 68|0
7535640|NCT02641379|26185467|P3|Overall Study|PCR positive at Week 68|0
7535641|NCT02641379|26185468|P2|Overall Study|PCR positive at Week 68|1
7535642|NCT02641379|26185469|P1|Overall Study|PCR positive at Week 68|0
7535643|NCT02641379|26185459|P11|Overall Study|Financial problems|0
7535644|NCT02641379|26185460|P10|Overall Study|Financial problems|0
7535645|NCT02641379|26185461|P9|Overall Study|Financial problems|0
7535646|NCT02641379|26185462|P8|Overall Study|Financial problems|0
7535647|NCT02641379|26185463|P7|Overall Study|Financial problems|0
7535648|NCT02641379|26185464|P6|Overall Study|Financial problems|0
7535649|NCT02641379|26185465|P5|Overall Study|Financial problems|0
7535650|NCT02641379|26185466|P4|Overall Study|Financial problems|0
7535651|NCT02641379|26185467|P3|Overall Study|Financial problems|0
7535652|NCT02641379|26185468|P2|Overall Study|Financial problems|1
7535653|NCT02641379|26185469|P1|Overall Study|Financial problems|0
7535654|NCT02641379|26185459|P11|Overall Study|Therapy stopped due to misunderstanding|0
7535655|NCT02641379|26185460|P10|Overall Study|Therapy stopped due to misunderstanding|0
7535656|NCT02641379|26185461|P9|Overall Study|Therapy stopped due to misunderstanding|0
7535657|NCT02641379|26185462|P8|Overall Study|Therapy stopped due to misunderstanding|0
7535658|NCT02641379|26185463|P7|Overall Study|Therapy stopped due to misunderstanding|0
7535659|NCT02641379|26185464|P6|Overall Study|Therapy stopped due to misunderstanding|0
7535660|NCT02641379|26185465|P5|Overall Study|Therapy stopped due to misunderstanding|0
7535661|NCT02641379|26185466|P4|Overall Study|Therapy stopped due to misunderstanding|0
7535662|NCT02641379|26185467|P3|Overall Study|Therapy stopped due to misunderstanding|0
7535663|NCT02641379|26185468|P2|Overall Study|Therapy stopped due to misunderstanding|0
7535664|NCT02641379|26185469|P1|Overall Study|Therapy stopped due to misunderstanding|1
7535665|NCT02641379|26185459|P11|Overall Study|Participant stopped study/treatment|0
7535666|NCT02641379|26185460|P10|Overall Study|Participant stopped study/treatment|0
7535667|NCT02641379|26185461|P9|Overall Study|Participant stopped study/treatment|1
7535668|NCT02641379|26185462|P8|Overall Study|Participant stopped study/treatment|0
7535669|NCT02641379|26185463|P7|Overall Study|Participant stopped study/treatment|2
7535670|NCT02641379|26185464|P6|Overall Study|Participant stopped study/treatment|1
7535671|NCT02641379|26185465|P5|Overall Study|Participant stopped study/treatment|0
7535672|NCT02641379|26185466|P4|Overall Study|Participant stopped study/treatment|0
7535673|NCT02641379|26185467|P3|Overall Study|Participant stopped study/treatment|1
7535674|NCT02641379|26185468|P2|Overall Study|Participant stopped study/treatment|3
7535675|NCT02641379|26185469|P1|Overall Study|Participant stopped study/treatment|1
7535676|NCT02641379|26185459|P11|Overall Study|Participant showed relapse|0
7535677|NCT02641379|26185460|P10|Overall Study|Participant showed relapse|0
7535678|NCT02641379|26185461|P9|Overall Study|Participant showed relapse|0
7535679|NCT02641379|26185462|P8|Overall Study|Participant showed relapse|0
7535680|NCT02641379|26185463|P7|Overall Study|Participant showed relapse|1
7535681|NCT02641379|26185464|P6|Overall Study|Participant showed relapse|0
7535682|NCT02641379|26185465|P5|Overall Study|Participant showed relapse|0
7535683|NCT02641379|26185466|P4|Overall Study|Participant showed relapse|0
7535684|NCT02641379|26185467|P3|Overall Study|Participant showed relapse|0
7535685|NCT02641379|26185468|P2|Overall Study|Participant showed relapse|0
7535686|NCT02641379|26185469|P1|Overall Study|Participant showed relapse|1
7535687|NCT02641379|26185459|P11|Overall Study|PCR positive at follow up 2|0
7535688|NCT02641379|26185460|P10|Overall Study|PCR positive at follow up 2|0
7535689|NCT02641379|26185461|P9|Overall Study|PCR positive at follow up 2|0
7535690|NCT02641379|26185462|P8|Overall Study|PCR positive at follow up 2|0
7535691|NCT02641379|26185463|P7|Overall Study|PCR positive at follow up 2|0
7535692|NCT02641379|26185464|P6|Overall Study|PCR positive at follow up 2|0
7535693|NCT02641379|26185465|P5|Overall Study|PCR positive at follow up 2|0
7535694|NCT02641379|26185466|P4|Overall Study|PCR positive at follow up 2|0
7535695|NCT02641379|26185467|P3|Overall Study|PCR positive at follow up 2|0
7535696|NCT02641379|26185468|P2|Overall Study|PCR positive at follow up 2|0
7535697|NCT02641379|26185469|P1|Overall Study|PCR positive at follow up 2|1
7535698|NCT02641379|26185459|P11|Overall Study|PCR positive at Week 24|0
7535699|NCT02641379|26185460|P10|Overall Study|PCR positive at Week 24|1
7535700|NCT02641379|26185461|P9|Overall Study|PCR positive at Week 24|0
7535701|NCT02641379|26185462|P8|Overall Study|PCR positive at Week 24|8
7535702|NCT02641379|26185463|P7|Overall Study|PCR positive at Week 24|3
7535703|NCT02641379|26185464|P6|Overall Study|PCR positive at Week 24|6
7535704|NCT02641379|26185465|P5|Overall Study|PCR positive at Week 24|0
7535705|NCT02641379|26185466|P4|Overall Study|PCR positive at Week 24|0
7535706|NCT02641379|26185467|P3|Overall Study|PCR positive at Week 24|62
7535707|NCT02641379|26185468|P2|Overall Study|PCR positive at Week 24|21
7535708|NCT02641379|26185469|P1|Overall Study|PCR positive at Week 24|15
7535709|NCT02641379|26185459|P11|Overall Study|Participant cannot be reached|1
7535710|NCT02641379|26185460|P10|Overall Study|Participant cannot be reached|2
7535711|NCT02641379|26185461|P9|Overall Study|Participant cannot be reached|0
7535712|NCT02641379|26185462|P8|Overall Study|Participant cannot be reached|1
7535713|NCT02641379|26185463|P7|Overall Study|Participant cannot be reached|0
7535714|NCT02641379|26185464|P6|Overall Study|Participant cannot be reached|1
7535715|NCT02641379|26185465|P5|Overall Study|Participant cannot be reached|2
7535716|NCT02641379|26185466|P4|Overall Study|Participant cannot be reached|8
7535717|NCT02641379|26185467|P3|Overall Study|Participant cannot be reached|0
7535718|NCT02641379|26185468|P2|Overall Study|Participant cannot be reached|4
7535719|NCT02641379|26185469|P1|Overall Study|Participant cannot be reached|4
7535720|NCT02641379|26185459|P11|Overall Study|Participant's compliance|1
7535721|NCT02641379|26185460|P10|Overall Study|Participant's compliance|1
7535722|NCT02641379|26185461|P9|Overall Study|Participant's compliance|1
7535723|NCT02641379|26185462|P8|Overall Study|Participant's compliance|0
7535724|NCT02641379|26185463|P7|Overall Study|Participant's compliance|0
7535725|NCT02641379|26185464|P6|Overall Study|Participant's compliance|2
7535726|NCT02641379|26185465|P5|Overall Study|Participant's compliance|0
7535727|NCT02641379|26185466|P4|Overall Study|Participant's compliance|1
7535728|NCT02641379|26185467|P3|Overall Study|Participant's compliance|0
7535729|NCT02641379|26185468|P2|Overall Study|Participant's compliance|1
7535730|NCT02641379|26185469|P1|Overall Study|Participant's compliance|0
7535731|NCT02641379|26185459|P11|Overall Study|Participant unable to attend study visit|0
7535732|NCT02641379|26185460|P10|Overall Study|Participant unable to attend study visit|2
7535733|NCT02641379|26185461|P9|Overall Study|Participant unable to attend study visit|0
7535734|NCT02641379|26185462|P8|Overall Study|Participant unable to attend study visit|1
7535735|NCT02641379|26185463|P7|Overall Study|Participant unable to attend study visit|1
7535736|NCT02641379|26185464|P6|Overall Study|Participant unable to attend study visit|1
7535737|NCT02641379|26185465|P5|Overall Study|Participant unable to attend study visit|5
7535738|NCT02641379|26185466|P4|Overall Study|Participant unable to attend study visit|2
7535739|NCT02641379|26185467|P3|Overall Study|Participant unable to attend study visit|1
7535740|NCT02641379|26185468|P2|Overall Study|Participant unable to attend study visit|10
7535741|NCT02641379|26185469|P1|Overall Study|Participant unable to attend study visit|4
7535742|NCT02641379|26185459|P11|Overall Study|Lack of Efficacy|0
7535743|NCT02641379|26185460|P10|Overall Study|Lack of Efficacy|0
7535744|NCT02641379|26185461|P9|Overall Study|Lack of Efficacy|0
7535745|NCT02641379|26185462|P8|Overall Study|Lack of Efficacy|5
7535746|NCT02641379|26185463|P7|Overall Study|Lack of Efficacy|0
7535747|NCT02641379|26185464|P6|Overall Study|Lack of Efficacy|2
7535748|NCT02641379|26185465|P5|Overall Study|Lack of Efficacy|0
7535749|NCT02641379|26185466|P4|Overall Study|Lack of Efficacy|0
7535750|NCT02641379|26185467|P3|Overall Study|Lack of Efficacy|2
7535751|NCT02641379|26185468|P2|Overall Study|Lack of Efficacy|0
7535752|NCT02641379|26185469|P1|Overall Study|Lack of Efficacy|0
7535753|NCT02641379|26185459|P11|Overall Study|Adverse Event|5
7535754|NCT02641379|26185460|P10|Overall Study|Adverse Event|1
7535755|NCT02641379|26185461|P9|Overall Study|Adverse Event|1
7535756|NCT02641379|26185462|P8|Overall Study|Adverse Event|0
7535757|NCT02641379|26185463|P7|Overall Study|Adverse Event|5
7535758|NCT02641379|26185464|P6|Overall Study|Adverse Event|1
7535759|NCT02641379|26185465|P5|Overall Study|Adverse Event|5
7535760|NCT02641379|26185466|P4|Overall Study|Adverse Event|2
7535761|NCT02641379|26185467|P3|Overall Study|Adverse Event|2
7535762|NCT02641379|26185468|P2|Overall Study|Adverse Event|8
7535763|NCT02641379|26185469|P1|Overall Study|Adverse Event|7
7535764|NCT02641379|26185459|P11|Overall Study|Withdrawal of informed consent|0
7535765|NCT02641379|26185460|P10|Overall Study|Withdrawal of informed consent|0
7535766|NCT02641379|26185461|P9|Overall Study|Withdrawal of informed consent|0
7535767|NCT02641379|26185462|P8|Overall Study|Withdrawal of informed consent|1
7535768|NCT02641379|26185463|P7|Overall Study|Withdrawal of informed consent|0
7535769|NCT02641379|26185464|P6|Overall Study|Withdrawal of informed consent|0
7535770|NCT02641379|26185465|P5|Overall Study|Withdrawal of informed consent|0
7535771|NCT02641379|26185466|P4|Overall Study|Withdrawal of informed consent|0
7535772|NCT02641379|26185467|P3|Overall Study|Withdrawal of informed consent|0
7535773|NCT02641379|26185468|P2|Overall Study|Withdrawal of informed consent|1
7535774|NCT02641379|26185469|P1|Overall Study|Withdrawal of informed consent|0
7535775|NCT02641379|26185459|P11|Overall Study|Exclusion criterion during screening|0
7535776|NCT02641379|26185460|P10|Overall Study|Exclusion criterion during screening|0
7535777|NCT02641379|26185461|P9|Overall Study|Exclusion criterion during screening|0
7535778|NCT02641379|26185462|P8|Overall Study|Exclusion criterion during screening|0
7535779|NCT02641379|26185463|P7|Overall Study|Exclusion criterion during screening|0
7535780|NCT02641379|26185464|P6|Overall Study|Exclusion criterion during screening|0
7535781|NCT02641379|26185465|P5|Overall Study|Exclusion criterion during screening|2
7535782|NCT02641379|26185466|P4|Overall Study|Exclusion criterion during screening|1
7535783|NCT02641379|26185467|P3|Overall Study|Exclusion criterion during screening|0
7535784|NCT02641379|26185468|P2|Overall Study|Exclusion criterion during screening|0
7535785|NCT02641379|26185469|P1|Overall Study|Exclusion criterion during screening|1
7535786|NCT02641080|26185585|P2|Overall Study|Lost to Follow-up|3
7535787|NCT02641080|26185586|P1|Overall Study|Lost to Follow-up|0
7535788|NCT02641080|26185585|P2|Overall Study|Rehab Center denied use of pumps|3
7535789|NCT02641080|26185586|P1|Overall Study|Rehab Center denied use of pumps|0
7535790|NCT02641080|26185585|P2|Overall Study|Withdrawal by Subject|1
7535791|NCT02641080|26185586|P1|Overall Study|Withdrawal by Subject|0
7535792|NCT02641080|26185585|P2|Overall Study|Physician Decision|0
7535793|NCT02641080|26185586|P1|Overall Study|Physician Decision|2
7535794|NCT02640755|26185642|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
7535795|NCT02640755|26185643|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
7535796|NCT02640755|26185642|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
7535797|NCT02640755|26185643|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
7535798|NCT02640755|26185642|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
7535799|NCT02640755|26185643|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
7535800|NCT02640677|26185697|P1|Overall Study|Withdrawal by Subject|1
7535801|NCT02640677|26185697|P1|Overall Study|Lost to Follow-up|1
7535802|NCT02640625|26185704|P1|Overall Study|Adverse Event|1
7535803|NCT02640612|26185713|P3|Overall Study|Lack of Efficacy|0
7535804|NCT02640612|26185714|P2|Overall Study|Lack of Efficacy|1
7535805|NCT02640612|26185715|P1|Overall Study|Lack of Efficacy|1
7535806|NCT02640612|26185713|P3|Overall Study|Protocol Violation|0
7535807|NCT02640612|26185714|P2|Overall Study|Protocol Violation|2
7535808|NCT02640612|26185715|P1|Overall Study|Protocol Violation|0
7535809|NCT02640612|26185713|P3|Overall Study|Lost to Follow-up|1
7535810|NCT02640612|26185714|P2|Overall Study|Lost to Follow-up|1
7535811|NCT02640612|26185715|P1|Overall Study|Lost to Follow-up|4
7535812|NCT02640612|26185713|P3|Overall Study|Withdrawal by Subject|3
7535813|NCT02640612|26185714|P2|Overall Study|Withdrawal by Subject|3
7535814|NCT02640612|26185715|P1|Overall Study|Withdrawal by Subject|10
7535815|NCT02640612|26185713|P3|Overall Study|Death|0
7535816|NCT02640612|26185714|P2|Overall Study|Death|0
7535817|NCT02640612|26185715|P1|Overall Study|Death|1
7535818|NCT02640612|26185713|P3|Overall Study|Adverse Event|2
7535819|NCT02640612|26185714|P2|Overall Study|Adverse Event|7
7535820|NCT02640612|26185715|P1|Overall Study|Adverse Event|6
7535821|NCT02640547|26185739|P1|Overall Study|Miscellaneous|3
7535822|NCT02640547|26185739|P1|Overall Study|Death|6
7535823|NCT02640547|26185739|P1|Overall Study|Withdrawal by Subject|1
7535824|NCT02640547|26185739|P1|Overall Study|Failure to Return|1
7535825|NCT02640482|26185816|P2|Overall Study|Lost to Follow-up|0
7535826|NCT02640482|26185817|P1|Overall Study|Lost to Follow-up|3
7535827|NCT02640404|26185829|P2|Overall Study|Withdrawal by Subject|0
7535828|NCT02640404|26185830|P1|Overall Study|Withdrawal by Subject|1
7535829|NCT02640404|26185829|P2|Overall Study|Protocol Violation|0
7535830|NCT02640404|26185830|P1|Overall Study|Protocol Violation|1
7535831|NCT02640235|26185840|P2|Overall Study|Other|2
7535832|NCT02640235|26185841|P1|Overall Study|Other|1
7535833|NCT02640235|26185840|P2|Overall Study|Death|3
7535834|NCT02640235|26185841|P1|Overall Study|Death|2
7535835|NCT02640235|26185840|P2|Overall Study|Lost to Follow-up|3
7535836|NCT02640235|26185841|P1|Overall Study|Lost to Follow-up|4
7535837|NCT02640235|26185840|P2|Overall Study|Withdrawal by Subject|6
7535838|NCT02640235|26185841|P1|Overall Study|Withdrawal by Subject|7
7535839|NCT02640157|26185864|P3|Overall Study|Randomized in error; did not receive Tx|0
7535840|NCT02640157|26185865|P2|Overall Study|Randomized in error; did not receive Tx|1
7535841|NCT02640157|26185866|P1|Overall Study|Randomized in error; did not receive Tx|0
7535842|NCT02640157|26185864|P3|Overall Study|Lost to Follow-up|7
7535843|NCT02640157|26185865|P2|Overall Study|Lost to Follow-up|2
7535844|NCT02640157|26185866|P1|Overall Study|Lost to Follow-up|9
7535845|NCT02640157|26185864|P3|Overall Study|Withdrew consent|2
7535846|NCT02640157|26185865|P2|Overall Study|Withdrew consent|0
7535847|NCT02640157|26185866|P1|Overall Study|Withdrew consent|2
7535848|NCT02640157|26185864|P3|Overall Study|Adverse Event|1
7535849|NCT02640157|26185865|P2|Overall Study|Adverse Event|2
7535850|NCT02640157|26185866|P1|Overall Study|Adverse Event|2
7535851|NCT02640053|26185885|P2|Overall Study|Chemo regimen changed after 1st Rx|1
7535852|NCT02640053|26185886|P1|Overall Study|Chemo regimen changed after 1st Rx|0
7535853|NCT02640053|26185885|P2|Overall Study|Alternative Therapy|1
7535854|NCT02640053|26185886|P1|Overall Study|Alternative Therapy|1
7535855|NCT02640053|26185885|P2|Overall Study|Adverse Event|1
7535856|NCT02640053|26185886|P1|Overall Study|Adverse Event|1
7535857|NCT02640053|26185885|P2|Overall Study|Withdrawal by Subject|1
7535858|NCT02640053|26185886|P1|Overall Study|Withdrawal by Subject|2
7535859|NCT02639559|26185998|P2|Overall Study|Issues with vascular acess|0
7535860|NCT02639559|26185999|P1|Overall Study|Issues with vascular acess|1
7535861|NCT02639559|26185998|P2|Overall Study|Mobilization failure|3
7535862|NCT02639559|26185999|P1|Overall Study|Mobilization failure|0
7535863|NCT02639390|26186079|P2|Overall Study|Subject unable to comply with treatment schedule.|2
7535864|NCT02639390|26186080|P1|Overall Study|Subject unable to comply with treatment schedule.|0
7535865|NCT02639338|26186454|P2|Overall Study|Randomized but Not Treated|1
7535866|NCT02639338|26186455|P1|Overall Study|Randomized but Not Treated|0
7535867|NCT02639338|26186454|P2|Overall Study|Death|0
7535868|NCT02639338|26186455|P1|Overall Study|Death|1
7535869|NCT02639338|26186454|P2|Overall Study|Withdrew Consent|2
7535870|NCT02639338|26186455|P1|Overall Study|Withdrew Consent|1
7535871|NCT02639338|26186454|P2|Overall Study|Lost to Follow-up|2
7535872|NCT02639338|26186455|P1|Overall Study|Lost to Follow-up|2
7535873|NCT02639247|26186500|P2|Overall Study|Protocol Violation|0
7535874|NCT02639247|26186501|P1|Overall Study|Protocol Violation|1
7535875|NCT02639247|26186500|P2|Overall Study|Withdrew Consent|1
7535876|NCT02639247|26186501|P1|Overall Study|Withdrew Consent|0
7535877|NCT02639247|26186500|P2|Overall Study|Death|0
7535878|NCT02639247|26186501|P1|Overall Study|Death|2
7535879|NCT02639247|26186500|P2|Overall Study|Lost to Follow-up|1
7535880|NCT02639247|26186501|P1|Overall Study|Lost to Follow-up|2
7535881|NCT02639182|26186519|P2|Overall Study|Participants Still on Study|24
7535882|NCT02639182|26186520|P1|Overall Study|Participants Still on Study|25
7535883|NCT02639182|26186519|P2|Overall Study|Withdrew consent|0
7535884|NCT02639182|26186520|P1|Overall Study|Withdrew consent|6
7535885|NCT02639182|26186519|P2|Overall Study|Lost to Follow-up|1
7535886|NCT02639182|26186520|P1|Overall Study|Lost to Follow-up|1
7535887|NCT02639182|26186519|P2|Overall Study|Death|41
7535888|NCT02639182|26186520|P1|Overall Study|Death|35
7535889|NCT02639052|26186553|P1|Overall Study|Lost to Follow-up|1
7535890|NCT02638948|26186590|P4|Overall Study|Other than specified above|1
7535891|NCT02638948|26186591|P3|Overall Study|Other than specified above|1
7535892|NCT02638948|26186592|P2|Overall Study|Other than specified above|1
7535893|NCT02638948|26186593|P1|Overall Study|Other than specified above|4
7535894|NCT02638948|26186590|P4|Overall Study|Participant no longer met study criteria|0
7535895|NCT02638948|26186591|P3|Overall Study|Participant no longer met study criteria|0
7535896|NCT02638948|26186592|P2|Overall Study|Participant no longer met study criteria|1
7535897|NCT02638948|26186593|P1|Overall Study|Participant no longer met study criteria|0
7535898|NCT02638948|26186590|P4|Overall Study|Poor/Non-Compliance|0
7535899|NCT02638948|26186591|P3|Overall Study|Poor/Non-Compliance|1
7535900|NCT02638948|26186592|P2|Overall Study|Poor/Non-Compliance|2
7535901|NCT02638948|26186593|P1|Overall Study|Poor/Non-Compliance|0
7535902|NCT02638948|26186590|P4|Overall Study|Lost to Follow-up|1
7535903|NCT02638948|26186591|P3|Overall Study|Lost to Follow-up|1
7535904|NCT02638948|26186592|P2|Overall Study|Lost to Follow-up|0
7535905|NCT02638948|26186593|P1|Overall Study|Lost to Follow-up|0
7535906|NCT02638948|26186590|P4|Overall Study|Lack of Efficacy|0
7535907|NCT02638948|26186591|P3|Overall Study|Lack of Efficacy|0
7535908|NCT02638948|26186592|P2|Overall Study|Lack of Efficacy|1
7535909|NCT02638948|26186593|P1|Overall Study|Lack of Efficacy|1
7535910|NCT02638948|26186590|P4|Overall Study|Adverse Event|1
7535911|NCT02638948|26186591|P3|Overall Study|Adverse Event|1
7535912|NCT02638948|26186592|P2|Overall Study|Adverse Event|0
7535913|NCT02638948|26186593|P1|Overall Study|Adverse Event|0
7535914|NCT02638948|26186590|P4|Overall Study|Administrative Reason by Sponsor|4
7535915|NCT02638948|26186591|P3|Overall Study|Administrative Reason by Sponsor|0
7535916|NCT02638948|26186592|P2|Overall Study|Administrative Reason by Sponsor|1
7535917|NCT02638948|26186593|P1|Overall Study|Administrative Reason by Sponsor|0
7535918|NCT02638948|26186590|P4|Overall Study|Withdrawal by Subject|1
7535919|NCT02638948|26186591|P3|Overall Study|Withdrawal by Subject|3
7535920|NCT02638948|26186592|P2|Overall Study|Withdrawal by Subject|5
7535921|NCT02638948|26186593|P1|Overall Study|Withdrawal by Subject|4
7535922|NCT02638623|26186680|P2|Overall Study|Not given intervention|0
7535923|NCT02638623|26186681|P1|Overall Study|Not given intervention|2
7535924|NCT02638623|26186680|P2|Overall Study|Surgery timing|6
7535925|NCT02638623|26186681|P1|Overall Study|Surgery timing|5
7535926|NCT02638493|26186711|P3|Overall Study|Inability to provide semen samples|0
7535927|NCT02638493|26186712|P2|Overall Study|Inability to provide semen samples|0
7535928|NCT02638493|26186713|P1|Overall Study|Inability to provide semen samples|2
7535929|NCT02638337|26186744|P2|Overall Study|Other - Miscellaneous|3
7535930|NCT02638337|26186745|P1|Overall Study|Other - Miscellaneous|4
7535931|NCT02638337|26186744|P2|Overall Study|Lost to Follow-up|7
7535932|NCT02638337|26186745|P1|Overall Study|Lost to Follow-up|7
7535933|NCT02638337|26186744|P2|Overall Study|Withdrawal by Subject|16
7535934|NCT02638337|26186745|P1|Overall Study|Withdrawal by Subject|13
7535935|NCT02638337|26186744|P2|Overall Study|Protocol Violation|0
7535936|NCT02638337|26186745|P1|Overall Study|Protocol Violation|3
7535937|NCT02638337|26186744|P2|Overall Study|Adverse Event|10
7535938|NCT02638337|26186745|P1|Overall Study|Adverse Event|6
7535939|NCT02638259|26186829|P2|Treatment Period 2|Withdrawal by Subject|7
7535940|NCT02638259|26186830|P1|Treatment Period 2|Withdrawal by Subject|1
7535941|NCT02638259|26186829|P2|Treatment Period 2|Adverse Event|4
7535942|NCT02638259|26186830|P1|Treatment Period 2|Adverse Event|5
7535943|NCT02638259|26186829|P2|Treatment Period 1|Withdrawn per sponsor decision|2
7535944|NCT02638259|26186830|P1|Treatment Period 1|Withdrawn per sponsor decision|0
7535945|NCT02638259|26186829|P2|Treatment Period 1|Withdrawal by Subject|6
7535946|NCT02638259|26186830|P1|Treatment Period 1|Withdrawal by Subject|4
7535947|NCT02638259|26186829|P2|Treatment Period 1|Protocol Violation|3
7535948|NCT02638259|26186830|P1|Treatment Period 1|Protocol Violation|0
7535949|NCT02638259|26186829|P2|Treatment Period 1|Lack of Efficacy|1
7535950|NCT02638259|26186830|P1|Treatment Period 1|Lack of Efficacy|0
7535951|NCT02638259|26186829|P2|Treatment Period 1|Death|1
7535952|NCT02638259|26186830|P1|Treatment Period 1|Death|0
7535953|NCT02638259|26186829|P2|Treatment Period 1|Adverse Event|5
7535954|NCT02638259|26186830|P1|Treatment Period 1|Adverse Event|1
7535955|NCT02638129|26186967|P2|Overall Study|Study terminated|30
7535956|NCT02638129|26186968|P1|Overall Study|Study terminated|28
7535957|NCT02638103|26186984|P4|Overall Study|Other than specified|4
7535958|NCT02638103|26186985|P3|Overall Study|Other than specified|2
7535959|NCT02638103|26186986|P2|Overall Study|Other than specified|4
7535960|NCT02638103|26186987|P1|Overall Study|Other than specified|5
7535961|NCT02638103|26186984|P4|Overall Study|Lack of Efficacy|22
7535962|NCT02638103|26186985|P3|Overall Study|Lack of Efficacy|12
7535963|NCT02638103|26186986|P2|Overall Study|Lack of Efficacy|10
7535964|NCT02638103|26186987|P1|Overall Study|Lack of Efficacy|14
7535965|NCT02638103|26186984|P4|Overall Study|Lost to Follow-up|37
7535966|NCT02638103|26186985|P3|Overall Study|Lost to Follow-up|20
7535967|NCT02638103|26186986|P2|Overall Study|Lost to Follow-up|33
7535968|NCT02638103|26186987|P1|Overall Study|Lost to Follow-up|26
7535969|NCT02638103|26186984|P4|Overall Study|Non-compliance to Study Procedures|1
7535970|NCT02638103|26186985|P3|Overall Study|Non-compliance to Study Procedures|1
7535971|NCT02638103|26186986|P2|Overall Study|Non-compliance to Study Procedures|1
7535972|NCT02638103|26186987|P1|Overall Study|Non-compliance to Study Procedures|2
7535973|NCT02638103|26186984|P4|Overall Study|Pregnancy|1
7535974|NCT02638103|26186985|P3|Overall Study|Pregnancy|0
7535975|NCT02638103|26186986|P2|Overall Study|Pregnancy|3
7535976|NCT02638103|26186987|P1|Overall Study|Pregnancy|2
7535977|NCT02638103|26186984|P4|Overall Study|Protocol Violation|4
7535978|NCT02638103|26186985|P3|Overall Study|Protocol Violation|1
7535979|NCT02638103|26186986|P2|Overall Study|Protocol Violation|2
7535980|NCT02638103|26186987|P1|Overall Study|Protocol Violation|1
7535981|NCT02638103|26186984|P4|Overall Study|Withdrawal by Subject|61
7535982|NCT02638103|26186985|P3|Overall Study|Withdrawal by Subject|30
7535983|NCT02638103|26186986|P2|Overall Study|Withdrawal by Subject|53
7535984|NCT02638103|26186987|P1|Overall Study|Withdrawal by Subject|43
7535985|NCT02638103|26186984|P4|Overall Study|Adverse Event|12
7535986|NCT02638103|26186985|P3|Overall Study|Adverse Event|19
7535987|NCT02638103|26186986|P2|Overall Study|Adverse Event|12
7535988|NCT02638103|26186987|P1|Overall Study|Adverse Event|13
7535989|NCT02638012|26187074|P1|Overall Study|Lost to Follow-up|1
7535990|NCT02637895|26187121|P2|Overall Study|Abnormal baseline lab|1
7535991|NCT02637895|26187122|P1|Overall Study|Abnormal baseline lab|0
7535992|NCT02637895|26187121|P2|Overall Study|Withdrawal by Subject|1
7535993|NCT02637895|26187122|P1|Overall Study|Withdrawal by Subject|1
7535994|NCT02637895|26187121|P2|Overall Study|Lack of Efficacy|0
7535995|NCT02637895|26187122|P1|Overall Study|Lack of Efficacy|1
7535996|NCT02637895|26187121|P2|Overall Study|Protocol Violation|1
7535997|NCT02637895|26187122|P1|Overall Study|Protocol Violation|0
7535998|NCT02637895|26187121|P2|Overall Study|Lost to Follow-up|0
7535999|NCT02637895|26187122|P1|Overall Study|Lost to Follow-up|4
7536000|NCT02637856|26187134|P2|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
7536001|NCT02637856|26187135|P1|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
7536002|NCT02637856|26187134|P2|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
7536003|NCT02637856|26187135|P1|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
7536004|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Site Closing|0
7536005|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Site Closing|6
7536006|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
7536007|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
7536008|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Incarceration|0
7536009|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Incarceration|1
7536010|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Failed Drug Test|0
7536011|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Failed Drug Test|1
7536012|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
7536013|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
7536014|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Protocol Deviation|0
7536015|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Protocol Deviation|2
7536016|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
7536017|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
7536018|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Pregnancy|0
7536019|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Pregnancy|7
7536020|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Physician Decision|0
7536021|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Physician Decision|2
7536022|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Lost to Follow-up|0
7536023|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Lost to Follow-up|5
7536024|NCT02637856|26187134|P2|Main Study (Baseline to Week 100)|Adverse Event|0
7536025|NCT02637856|26187135|P1|Main Study (Baseline to Week 100)|Adverse Event|9
7536026|NCT02637557|26187265|P4|Overall Study|Withdrawal by Subject|2
7536027|NCT02637557|26187266|P3|Overall Study|Withdrawal by Subject|4
7536028|NCT02637557|26187267|P2|Overall Study|Withdrawal by Subject|3
7536029|NCT02637557|26187268|P1|Overall Study|Withdrawal by Subject|1
7536030|NCT02637557|26187265|P4|Overall Study|Protocol Violation|1
7536031|NCT02637557|26187266|P3|Overall Study|Protocol Violation|2
7536032|NCT02637557|26187267|P2|Overall Study|Protocol Violation|0
7536033|NCT02637557|26187268|P1|Overall Study|Protocol Violation|2
7536034|NCT02637557|26187265|P4|Overall Study|Physician Decision|0
7536035|NCT02637557|26187266|P3|Overall Study|Physician Decision|0
7536036|NCT02637557|26187267|P2|Overall Study|Physician Decision|0
7536037|NCT02637557|26187268|P1|Overall Study|Physician Decision|1
7536038|NCT02637557|26187265|P4|Overall Study|Lost to Follow-up|1
7536039|NCT02637557|26187266|P3|Overall Study|Lost to Follow-up|0
7536040|NCT02637557|26187267|P2|Overall Study|Lost to Follow-up|1
7536041|NCT02637557|26187268|P1|Overall Study|Lost to Follow-up|1
7536042|NCT02637557|26187265|P4|Overall Study|Adverse Event|3
7536043|NCT02637557|26187266|P3|Overall Study|Adverse Event|3
7536044|NCT02637557|26187267|P2|Overall Study|Adverse Event|1
7536045|NCT02637557|26187268|P1|Overall Study|Adverse Event|3
7536046|NCT02637323|26187389|P2|Overall Study|Protocol Violation|1
7536047|NCT02637323|26187390|P1|Overall Study|Protocol Violation|0
7536048|NCT02637323|26187389|P2|Overall Study|Lost to Follow-up|0
7536049|NCT02637323|26187390|P1|Overall Study|Lost to Follow-up|2
7536050|NCT02637232|26187398|P1|Overall Study|patient 's decision|2
7536051|NCT02637232|26187398|P1|Overall Study|Adverse Event|11
7536052|NCT02637232|26187398|P1|Overall Study|Lost to Follow-up|42
7536053|NCT02637141|26187405|P3|Overall Study|Withdrawal by Subject|1
7536054|NCT02637141|26187406|P2|Overall Study|Withdrawal by Subject|1
7536055|NCT02637141|26187407|P1|Overall Study|Withdrawal by Subject|1
7536056|NCT02637141|26187405|P3|Overall Study|Adverse Event|0
7536057|NCT02637141|26187406|P2|Overall Study|Adverse Event|1
7536058|NCT02637141|26187407|P1|Overall Study|Adverse Event|1
7536059|NCT02637076|26187441|P2|Overall Study|Withdrawal by Subject|4
7536060|NCT02637076|26187442|P1|Overall Study|Withdrawal by Subject|0
7536061|NCT02637076|26187441|P2|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7536062|NCT02637076|26187442|P1|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7536063|NCT02637063|26187467|P3|Overall Study|Withdrawal by Subject|3
7536064|NCT02637063|26187468|P2|Overall Study|Withdrawal by Subject|2
7536065|NCT02637063|26187469|P1|Overall Study|Withdrawal by Subject|2
7536066|NCT02637063|26187467|P3|Overall Study|Lost to Follow-up|3
7536067|NCT02637063|26187468|P2|Overall Study|Lost to Follow-up|2
7536068|NCT02637063|26187469|P1|Overall Study|Lost to Follow-up|3
7536069|NCT02637037|26187497|P2|Overall Study|Adverse Event|0
7536070|NCT02637037|26187498|P1|Overall Study|Adverse Event|1
7536071|NCT02637037|26187497|P2|Overall Study|Withdrawal by Subject|1
7536072|NCT02637037|26187498|P1|Overall Study|Withdrawal by Subject|2
7536073|NCT02637037|26187497|P2|Overall Study|Positive drug screen at admission|0
7536074|NCT02637037|26187498|P1|Overall Study|Positive drug screen at admission|1
7536075|NCT02636907|26187564|P1|Extension Phase|Lack of Efficacy|1
7536076|NCT02636907|26187564|P1|Extension Phase|Lost to Follow-up|2
7536077|NCT02636907|26187564|P1|Extension Phase|Physician Decision|1
7536078|NCT02636907|26187564|P1|Extension Phase|Withdrawal by Subject|4
7536079|NCT02636907|26187564|P1|Extension Phase|Adverse Event|2
7536080|NCT02636907|26187564|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
7536081|NCT02636907|26187564|P1|Autoinjector Assessment Period|Adverse Event|2
7536082|NCT02636868|26187576|P3|Overall Study|Death|2
7536083|NCT02636868|26187577|P2|Overall Study|Death|1
7536084|NCT02636868|26187578|P1|Overall Study|Death|0
7536085|NCT02636699|26187611|P2|Overall Study|Other|1
7536086|NCT02636699|26187612|P1|Overall Study|Other|3
7536087|NCT02636699|26187611|P2|Overall Study|Withdrawal by Subject|6
7536088|NCT02636699|26187612|P1|Overall Study|Withdrawal by Subject|13
7536089|NCT02636699|26187611|P2|Overall Study|Physician Decision|1
7536090|NCT02636699|26187612|P1|Overall Study|Physician Decision|0
7536091|NCT02636699|26187611|P2|Overall Study|Non-compliance with the investigational product (IP)|0
7536092|NCT02636699|26187612|P1|Overall Study|Non-compliance with the investigational product (IP)|2
7536093|NCT02636699|26187611|P2|Overall Study|Lost to Follow-up|3
7536094|NCT02636699|26187612|P1|Overall Study|Lost to Follow-up|3
7536095|NCT02636699|26187611|P2|Overall Study|Adverse Event|0
7536096|NCT02636699|26187612|P1|Overall Study|Adverse Event|4
7536097|NCT02636608|26187626|P1|Overall Study|Did Not Receive Treatment|1
7536098|NCT02636608|26187626|P1|Overall Study|Other|2
7536099|NCT02636608|26187626|P1|Overall Study|Death|3
7536100|NCT02636608|26187626|P1|Overall Study|Insufficient Virological Response|1
7536101|NCT02636608|26187626|P1|Overall Study|Failure to Return|4
7536102|NCT02636595|26187654|P1|Overall Study|Other|1
7536103|NCT02636595|26187654|P1|Overall Study|Lost to Follow-up|1
7536104|NCT02636361|26187660|P5|Period 4|Physician Decision|0
7536105|NCT02636361|26187661|P4|Period 4|Physician Decision|1
7536106|NCT02636361|26187662|P3|Period 4|Physician Decision|0
7536107|NCT02636361|26187663|P2|Period 4|Physician Decision|0
7536108|NCT02636361|26187664|P1|Period 4|Physician Decision|0
7536109|NCT02636283|26187683|P2|Overall Study|Trial Terminated Prematurely|3
7536110|NCT02636283|26187684|P1|Overall Study|Trial Terminated Prematurely|0
7536111|NCT02636283|26187683|P2|Overall Study|Adverse Event|0
7536112|NCT02636283|26187684|P1|Overall Study|Adverse Event|2
7536113|NCT02635984|26187712|P2|Overall Study|Study Arm Closed|0
7536114|NCT02635984|26187713|P1|Overall Study|Study Arm Closed|1
7536115|NCT02635984|26187712|P2|Overall Study|Lost to Follow-up|4
7536116|NCT02635984|26187713|P1|Overall Study|Lost to Follow-up|2
7536117|NCT02635737|26187743|P1|Overall Study|Protocol Violation|1
7536118|NCT02635724|26187757|P3|Overall Study|Withdrawal by Subject|0
7536119|NCT02635724|26187758|P2|Overall Study|Withdrawal by Subject|1
7536120|NCT02635724|26187759|P1|Overall Study|Withdrawal by Subject|0
7536121|NCT02635646|26187790|P2|Overall Study|Pregnancy|1
7536122|NCT02635646|26187791|P1|Overall Study|Pregnancy|1
7536123|NCT02635646|26187790|P2|Overall Study|Lost to Follow-up|25
7536124|NCT02635646|26187791|P1|Overall Study|Lost to Follow-up|24
7536125|NCT02635386|26187830|P5|Overall Study|Other medical problems not drug related|0
7536126|NCT02635386|26187831|P4|Overall Study|Other medical problems not drug related|1
7536127|NCT02635386|26187832|P3|Overall Study|Other medical problems not drug related|0
7536128|NCT02635386|26187833|P2|Overall Study|Other medical problems not drug related|0
7536129|NCT02635386|26187834|P1|Overall Study|Other medical problems not drug related|0
7536130|NCT02635386|26187830|P5|Overall Study|needed other major surgery|0
7536131|NCT02635386|26187831|P4|Overall Study|needed other major surgery|0
7536132|NCT02635386|26187832|P3|Overall Study|needed other major surgery|0
7536133|NCT02635386|26187833|P2|Overall Study|needed other major surgery|1
7536134|NCT02635386|26187834|P1|Overall Study|needed other major surgery|0
7536135|NCT02635386|26187830|P5|Overall Study|side effects|6
7536136|NCT02635386|26187831|P4|Overall Study|side effects|4
7536137|NCT02635386|26187832|P3|Overall Study|side effects|1
7536138|NCT02635386|26187833|P2|Overall Study|side effects|0
7536139|NCT02635386|26187834|P1|Overall Study|side effects|0
7536140|NCT02635386|26187830|P5|Overall Study|Noncompliant|1
7536141|NCT02635386|26187831|P4|Overall Study|Noncompliant|1
7536142|NCT02635386|26187832|P3|Overall Study|Noncompliant|1
7536143|NCT02635386|26187833|P2|Overall Study|Noncompliant|2
7536144|NCT02635386|26187834|P1|Overall Study|Noncompliant|0
7536145|NCT02635386|26187830|P5|Overall Study|Moved Out of State|0
7536146|NCT02635386|26187831|P4|Overall Study|Moved Out of State|0
7536147|NCT02635386|26187832|P3|Overall Study|Moved Out of State|0
7536148|NCT02635386|26187833|P2|Overall Study|Moved Out of State|1
7536149|NCT02635386|26187834|P1|Overall Study|Moved Out of State|0
7536150|NCT02635386|26187830|P5|Overall Study|Physician Decision|0
7536151|NCT02635386|26187831|P4|Overall Study|Physician Decision|0
7536152|NCT02635386|26187832|P3|Overall Study|Physician Decision|0
7536153|NCT02635386|26187833|P2|Overall Study|Physician Decision|1
7536154|NCT02635386|26187834|P1|Overall Study|Physician Decision|0
7536155|NCT02635386|26187830|P5|Overall Study|Withdrawal by Subject|0
7536156|NCT02635386|26187831|P4|Overall Study|Withdrawal by Subject|1
7536157|NCT02635386|26187832|P3|Overall Study|Withdrawal by Subject|0
7536158|NCT02635386|26187833|P2|Overall Study|Withdrawal by Subject|1
7536159|NCT02635386|26187834|P1|Overall Study|Withdrawal by Subject|1
7536160|NCT02635386|26187830|P5|Overall Study|Pregnancy|2
7536161|NCT02635386|26187831|P4|Overall Study|Pregnancy|0
7536162|NCT02635386|26187832|P3|Overall Study|Pregnancy|0
7536163|NCT02635386|26187833|P2|Overall Study|Pregnancy|0
7536164|NCT02635386|26187834|P1|Overall Study|Pregnancy|2
7536165|NCT02635347|26187958|P2|Overall Study|Failed screening|7
7536166|NCT02635347|26187959|P1|Overall Study|Failed screening|20
7536167|NCT02635204|26187990|P2|Overall Study|Lost to Follow-up|1
7536168|NCT02635204|26187991|P1|Overall Study|Lost to Follow-up|1
7536169|NCT02635204|26187990|P2|Overall Study|Adverse Event|0
7536170|NCT02635204|26187991|P1|Overall Study|Adverse Event|1
7536171|NCT02634983|26188001|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
7536172|NCT02634983|26188002|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
7536173|NCT02634801|26188061|P3|Follow-up Period|Adverse Event|0
7536174|NCT02634801|26188062|P2|Follow-up Period|Adverse Event|5
7536175|NCT02634801|26188063|P1|Follow-up Period|Adverse Event|1
7536176|NCT02634801|26188061|P3|Follow-up Period|Withdrawal by Subject|5
7536177|NCT02634801|26188062|P2|Follow-up Period|Withdrawal by Subject|2
7536178|NCT02634801|26188063|P1|Follow-up Period|Withdrawal by Subject|1
7536179|NCT02634801|26188061|P3|Follow-up Period|Physician Decision|1
7536180|NCT02634801|26188062|P2|Follow-up Period|Physician Decision|0
7536181|NCT02634801|26188063|P1|Follow-up Period|Physician Decision|0
7536182|NCT02634801|26188061|P3|Follow-up Period|Lost to Follow-up|2
7536183|NCT02634801|26188062|P2|Follow-up Period|Lost to Follow-up|1
7536184|NCT02634801|26188063|P1|Follow-up Period|Lost to Follow-up|3
7536185|NCT02634801|26188061|P3|Extension Period (Weeks 24 to 36)|Missing|0
7536186|NCT02634801|26188062|P2|Extension Period (Weeks 24 to 36)|Missing|0
7536187|NCT02634801|26188063|P1|Extension Period (Weeks 24 to 36)|Missing|1
7536188|NCT02634801|26188061|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7536189|NCT02634801|26188062|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7536190|NCT02634801|26188063|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7536191|NCT02634801|26188061|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7536192|NCT02634801|26188062|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7536193|NCT02634801|26188063|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
7536194|NCT02634801|26188061|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
7536195|NCT02634801|26188062|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
7536196|NCT02634801|26188063|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
7536197|NCT02634801|26188061|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
7536198|NCT02634801|26188062|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
7536199|NCT02634801|26188063|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
7536200|NCT02634801|26188061|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
7536201|NCT02634801|26188062|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7536202|NCT02634801|26188063|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7536203|NCT02634801|26188061|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7536204|NCT02634801|26188062|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7536205|NCT02634801|26188063|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
7536206|NCT02634801|26188061|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7536207|NCT02634801|26188062|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
7536208|NCT02634801|26188063|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7536209|NCT02634801|26188061|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
7536210|NCT02634801|26188062|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
7536211|NCT02634801|26188063|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
7536212|NCT02634788|26188163|P4|Overall Study|Withdrawal by Subject|0
7536213|NCT02634788|26188164|P3|Overall Study|Withdrawal by Subject|1
7536214|NCT02634788|26188165|P2|Overall Study|Withdrawal by Subject|1
7536215|NCT02634788|26188166|P1|Overall Study|Withdrawal by Subject|0
7536216|NCT02634788|26188163|P4|Overall Study|Lost to Follow-up|0
7536217|NCT02634788|26188164|P3|Overall Study|Lost to Follow-up|0
7536218|NCT02634788|26188165|P2|Overall Study|Lost to Follow-up|1
7536219|NCT02634788|26188166|P1|Overall Study|Lost to Follow-up|0
7536220|NCT02634788|26188163|P4|Overall Study|Lack of Efficacy|4
7536221|NCT02634788|26188164|P3|Overall Study|Lack of Efficacy|1
7536222|NCT02634788|26188165|P2|Overall Study|Lack of Efficacy|0
7536223|NCT02634788|26188166|P1|Overall Study|Lack of Efficacy|4
7536224|NCT02634788|26188163|P4|Overall Study|Adverse Event|1
7536225|NCT02634788|26188164|P3|Overall Study|Adverse Event|3
7536226|NCT02634788|26188165|P2|Overall Study|Adverse Event|8
7536227|NCT02634788|26188166|P1|Overall Study|Adverse Event|0
7536228|NCT02634606|26188257|P1|Overall Study|unable to obtain the drug at start|13
7536229|NCT02634580|26188269|P4|Open-label Extension Period|Withdrawal by Subject|1
7536230|NCT02634580|26188270|P3|Open-label Extension Period|Withdrawal by Subject|0
7536231|NCT02634580|26188271|P2|Open-label Extension Period|Withdrawal by Subject|1
7536232|NCT02634580|26188272|P1|Open-label Extension Period|Withdrawal by Subject|0
7536233|NCT02634580|26188269|P4|Double-blind Treatment Period|Subject Request|1
7536234|NCT02634580|26188270|P3|Double-blind Treatment Period|Subject Request|1
7536235|NCT02634580|26188271|P2|Double-blind Treatment Period|Subject Request|0
7536236|NCT02634580|26188272|P1|Double-blind Treatment Period|Subject Request|1
7536237|NCT02634346|26188330|P3|Overall Study|Protocol Violation|0
7536238|NCT02634346|26188331|P2|Overall Study|Protocol Violation|1
7536239|NCT02634346|26188332|P1|Overall Study|Protocol Violation|0
7536240|NCT02634346|26188330|P3|Overall Study|Lost to Follow-up|0
7536241|NCT02634346|26188331|P2|Overall Study|Lost to Follow-up|0
7536242|NCT02634346|26188332|P1|Overall Study|Lost to Follow-up|1
7536243|NCT02634346|26188330|P3|Overall Study|Lack of Efficacy|8
7536244|NCT02634346|26188331|P2|Overall Study|Lack of Efficacy|2
7536245|NCT02634346|26188332|P1|Overall Study|Lack of Efficacy|1
7536246|NCT02634346|26188330|P3|Overall Study|Adverse Event|7
7536247|NCT02634346|26188331|P2|Overall Study|Adverse Event|2
7536248|NCT02634346|26188332|P1|Overall Study|Adverse Event|2
7536249|NCT02634346|26188330|P3|Overall Study|Withdrawal by Subject|8
7536250|NCT02634346|26188331|P2|Overall Study|Withdrawal by Subject|9
7536251|NCT02634346|26188332|P1|Overall Study|Withdrawal by Subject|8
7536252|NCT02634320|26188346|P1|Overall Study|Lack of Efficacy|2
7536253|NCT02634320|26188346|P1|Overall Study|Withdrawal by Subject|5
7536254|NCT02634320|26188346|P1|Overall Study|Protocol Violation|1
7536255|NCT02634320|26188346|P1|Overall Study|Out of window for study visits|1
7536256|NCT02634320|26188346|P1|Overall Study|Moved out of area|2
7536257|NCT02634320|26188346|P1|Overall Study|Lost to Follow-up|3
7536258|NCT02634320|26188346|P1|Overall Study|Adverse Event|2
7536259|NCT02634151|26188382|P2|Overall Study|Other|1
7536260|NCT02634151|26188383|P1|Overall Study|Other|0
7536261|NCT02634151|26188382|P2|Overall Study|Non-Compliance|1
7536262|NCT02634151|26188383|P1|Overall Study|Non-Compliance|0
7536263|NCT02634151|26188382|P2|Overall Study|Withdrawal by Subject|0
7536264|NCT02634151|26188383|P1|Overall Study|Withdrawal by Subject|1
7536265|NCT02633800|26188585|P2|Overall Study|Patient Request|1
7536266|NCT02633800|26188586|P1|Overall Study|Patient Request|1
7536267|NCT02633800|26188585|P2|Overall Study|Withdrawal by Subject|3
7536268|NCT02633800|26188586|P1|Overall Study|Withdrawal by Subject|0
7536269|NCT02633800|26188585|P2|Overall Study|Adverse event, non-fatal|2
7536270|NCT02633800|26188586|P1|Overall Study|Adverse event, non-fatal|7
7536271|NCT02633800|26188585|P2|Overall Study|Study terminated by sponsor|5
7536272|NCT02633800|26188586|P1|Overall Study|Study terminated by sponsor|6
7536273|NCT02633800|26188585|P2|Overall Study|Clinical progression|6
7536274|NCT02633800|26188586|P1|Overall Study|Clinical progression|3
7536275|NCT02633800|26188585|P2|Overall Study|Radiologic(al) progression|23
7536276|NCT02633800|26188586|P1|Overall Study|Radiologic(al) progression|23
7536277|NCT02633800|26188585|P2|Overall Study|Reason not provided|0
7536278|NCT02633800|26188586|P1|Overall Study|Reason not provided|1
7536279|NCT02633800|26188585|P2|Overall Study|Death|3
7536280|NCT02633800|26188586|P1|Overall Study|Death|3
7536281|NCT02633787|26188596|P1|Overall Study|Withdrawal by Subject|1
7536306|NCT02633306|26188677|P1|Overall Study|Withdrawal by Subject|3
7536307|NCT02633215|26188700|P2|Overall Study|Lost to Follow-up|3
7536308|NCT02633215|26188701|P1|Overall Study|Lost to Follow-up|2
7536309|NCT02633046|26188711|P1|Overall Study|Mutual decision patient and physician|1
7536310|NCT02633046|26188711|P1|Overall Study|Participant decided not to continue with open label extension|1
7536311|NCT02633046|26188711|P1|Overall Study|Increased proteinuria|2
7536312|NCT02633046|26188711|P1|Overall Study|Withdrawal by Subject|8
7536313|NCT02633046|26188711|P1|Overall Study|Physician Decision|7
7536314|NCT02633046|26188711|P1|Overall Study|Adverse Event|8
7536315|NCT02633020|26188717|P2|Overall Study|Adverse Event|0
7536316|NCT02633020|26188718|P1|Overall Study|Adverse Event|1
7536317|NCT02632838|26188742|P2|Overall Study|Lost to Follow-up|2
7536318|NCT02632838|26188743|P1|Overall Study|Lost to Follow-up|0
7536319|NCT02632838|26188742|P2|Overall Study|Withdrawal by Subject|0
7536320|NCT02632838|26188743|P1|Overall Study|Withdrawal by Subject|3
7536321|NCT02632786|26188780|P2|Overall Study|Withdrawal by Subject|0
7536322|NCT02632786|26188781|P1|Overall Study|Withdrawal by Subject|1
7536323|NCT02632786|26188780|P2|Overall Study|Physician Decision|4
7536324|NCT02632786|26188781|P1|Overall Study|Physician Decision|5
7536325|NCT02632786|26188780|P2|Overall Study|Death|2
7536326|NCT02632786|26188781|P1|Overall Study|Death|3
7536327|NCT02632786|26188780|P2|Overall Study|Adverse Event|1
7536328|NCT02632786|26188781|P1|Overall Study|Adverse Event|2
7536329|NCT02632747|26188801|P2|Wash-out Period|Adverse Event|0
7536330|NCT02632747|26188802|P1|Wash-out Period|Adverse Event|1
7536331|NCT02632110|26189002|P10|Overall Study|Withdrawal by Subject|1
7536332|NCT02632110|26189003|P9|Overall Study|Withdrawal by Subject|1
7536333|NCT02632110|26189004|P8|Overall Study|Withdrawal by Subject|3
7536334|NCT02632110|26189005|P7|Overall Study|Withdrawal by Subject|3
7536335|NCT02632110|26189006|P6|Overall Study|Withdrawal by Subject|1
7536336|NCT02632110|26189007|P5|Overall Study|Withdrawal by Subject|1
7536337|NCT02632110|26189008|P4|Overall Study|Withdrawal by Subject|0
7536338|NCT02632110|26189009|P3|Overall Study|Withdrawal by Subject|0
7536339|NCT02632110|26189010|P2|Overall Study|Withdrawal by Subject|1
7536340|NCT02632110|26189011|P1|Overall Study|Withdrawal by Subject|1
7536341|NCT02631876|26189501|P2|Overall Study|Other than specified|4
7536342|NCT02631876|26189502|P1|Overall Study|Other than specified|4
7536343|NCT02631876|26189501|P2|Overall Study|Withdrawal by Subject|9
7536344|NCT02631876|26189502|P1|Overall Study|Withdrawal by Subject|16
7536345|NCT02631876|26189501|P2|Overall Study|Lost to Follow-up|0
7536346|NCT02631876|26189502|P1|Overall Study|Lost to Follow-up|2
7536347|NCT02631876|26189501|P2|Overall Study|Investigator's discretion|0
7536348|NCT02631876|26189502|P1|Overall Study|Investigator's discretion|1
7536349|NCT02631876|26189501|P2|Overall Study|Death|50
7536350|NCT02631876|26189502|P1|Overall Study|Death|96
7536351|NCT02631850|26189530|P4|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7536352|NCT02631850|26189531|P3|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
7536353|NCT02631850|26189532|P2|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7536354|NCT02631850|26189533|P1|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
7536355|NCT02631850|26189530|P4|6 Month Follow up|Adverse Event|3
7536356|NCT02631850|26189531|P3|6 Month Follow up|Adverse Event|1
7536357|NCT02631850|26189532|P2|6 Month Follow up|Adverse Event|4
7536358|NCT02631850|26189533|P1|6 Month Follow up|Adverse Event|1
7536359|NCT02631850|26189530|P4|6 Month Follow up|Withdrawal by Subject|2
7536360|NCT02631850|26189531|P3|6 Month Follow up|Withdrawal by Subject|0
7536361|NCT02631850|26189532|P2|6 Month Follow up|Withdrawal by Subject|0
7536362|NCT02631850|26189533|P1|6 Month Follow up|Withdrawal by Subject|1
7536363|NCT02631850|26189530|P4|6 Month Follow up|Lost to Follow-up|5
7536364|NCT02631850|26189531|P3|6 Month Follow up|Lost to Follow-up|3
7536365|NCT02631850|26189532|P2|6 Month Follow up|Lost to Follow-up|8
7536366|NCT02631850|26189533|P1|6 Month Follow up|Lost to Follow-up|5
7536367|NCT02631850|26189530|P4|Treatment Period|Family medical issue|0
7536368|NCT02631850|26189531|P3|Treatment Period|Family medical issue|0
7536369|NCT02631850|26189532|P2|Treatment Period|Family medical issue|0
7536370|NCT02631850|26189533|P1|Treatment Period|Family medical issue|1
7536371|NCT02631850|26189530|P4|Treatment Period|Adverse Event|3
7536372|NCT02631850|26189531|P3|Treatment Period|Adverse Event|2
7536373|NCT02631850|26189532|P2|Treatment Period|Adverse Event|0
7536374|NCT02631850|26189533|P1|Treatment Period|Adverse Event|1
7536375|NCT02631850|26189530|P4|Treatment Period|Withdrawal by Subject|2
7536376|NCT02631850|26189531|P3|Treatment Period|Withdrawal by Subject|2
7536377|NCT02631850|26189532|P2|Treatment Period|Withdrawal by Subject|5
7536378|NCT02631850|26189533|P1|Treatment Period|Withdrawal by Subject|0
7536379|NCT02631850|26189530|P4|Treatment Period|Protocol Violation|0
7536380|NCT02631850|26189531|P3|Treatment Period|Protocol Violation|0
7536381|NCT02631850|26189532|P2|Treatment Period|Protocol Violation|0
7536382|NCT02631850|26189533|P1|Treatment Period|Protocol Violation|1
7536383|NCT02631850|26189530|P4|Treatment Period|Lost to Follow-up|0
7536384|NCT02631850|26189531|P3|Treatment Period|Lost to Follow-up|0
7536385|NCT02631850|26189532|P2|Treatment Period|Lost to Follow-up|1
7536386|NCT02631850|26189533|P1|Treatment Period|Lost to Follow-up|0
7536387|NCT02631746|26189623|P1|Overall Study|Lack of Efficacy|3
7536392|NCT02631551|26189677|P4|Overall Study|Other, specific reasons not collected|2
7536393|NCT02631551|26189678|P3|Overall Study|Other, specific reasons not collected|2
7536394|NCT02631551|26189679|P2|Overall Study|Other, specific reasons not collected|7
7536395|NCT02631551|26189680|P1|Overall Study|Other, specific reasons not collected|5
7536396|NCT02631551|26189677|P4|Overall Study|Non-compliance with study drug|0
7536397|NCT02631551|26189678|P3|Overall Study|Non-compliance with study drug|0
7536398|NCT02631551|26189679|P2|Overall Study|Non-compliance with study drug|0
7536399|NCT02631551|26189680|P1|Overall Study|Non-compliance with study drug|1
7536400|NCT02631551|26189677|P4|Overall Study|Non-compliance with study procedures|1
7536401|NCT02631551|26189678|P3|Overall Study|Non-compliance with study procedures|1
7536402|NCT02631551|26189679|P2|Overall Study|Non-compliance with study procedures|0
7536403|NCT02631551|26189680|P1|Overall Study|Non-compliance with study procedures|0
7536404|NCT02631551|26189677|P4|Overall Study|Protocol deviation|0
7536405|NCT02631551|26189678|P3|Overall Study|Protocol deviation|3
7536406|NCT02631551|26189679|P2|Overall Study|Protocol deviation|6
7536407|NCT02631551|26189680|P1|Overall Study|Protocol deviation|3
7536408|NCT02631551|26189677|P4|Overall Study|Withdrawal by Subject|5
7536409|NCT02631551|26189678|P3|Overall Study|Withdrawal by Subject|0
7536410|NCT02631551|26189679|P2|Overall Study|Withdrawal by Subject|2
7536411|NCT02631551|26189680|P1|Overall Study|Withdrawal by Subject|2
7536412|NCT02631551|26189677|P4|Overall Study|Lost to Follow-up|3
7536413|NCT02631551|26189678|P3|Overall Study|Lost to Follow-up|0
7536414|NCT02631551|26189679|P2|Overall Study|Lost to Follow-up|2
7536415|NCT02631551|26189680|P1|Overall Study|Lost to Follow-up|1
7536416|NCT02631551|26189677|P4|Overall Study|Lack of Efficacy|0
7536417|NCT02631551|26189678|P3|Overall Study|Lack of Efficacy|1
7536418|NCT02631551|26189679|P2|Overall Study|Lack of Efficacy|0
7536419|NCT02631551|26189680|P1|Overall Study|Lack of Efficacy|0
7536420|NCT02631551|26189677|P4|Overall Study|Adverse Event|0
7536421|NCT02631551|26189678|P3|Overall Study|Adverse Event|4
7536422|NCT02631551|26189679|P2|Overall Study|Adverse Event|2
7536423|NCT02631551|26189680|P1|Overall Study|Adverse Event|1
7536424|NCT02631538|26189694|P4|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7536425|NCT02631538|26189695|P3|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7536426|NCT02631538|26189696|P2|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7536427|NCT02631538|26189697|P1|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7536428|NCT02631538|26189694|P4|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7536429|NCT02631538|26189695|P3|Treatment Period (Up to Week 52)|Reached stopping criteria|1
7536430|NCT02631538|26189696|P2|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7536431|NCT02631538|26189697|P1|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7536432|NCT02631538|26189694|P4|Treatment Period (Up to Week 52)|Physician Decision|1
7536433|NCT02631538|26189695|P3|Treatment Period (Up to Week 52)|Physician Decision|0
7536434|NCT02631538|26189696|P2|Treatment Period (Up to Week 52)|Physician Decision|0
7536435|NCT02631538|26189697|P1|Treatment Period (Up to Week 52)|Physician Decision|1
7536436|NCT02631538|26189694|P4|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7536437|NCT02631538|26189695|P3|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7536438|NCT02631538|26189696|P2|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7536439|NCT02631538|26189697|P1|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7536601|NCT02629133|26190503|P1|Overall Study|Withdrawal by Subject|1
7536440|NCT02631538|26189694|P4|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
7536441|NCT02631538|26189695|P3|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
7536442|NCT02631538|26189696|P2|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7536443|NCT02631538|26189697|P1|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7536444|NCT02631538|26189694|P4|Treatment Period (Up to Week 52)|Adverse Event|2
7536445|NCT02631538|26189695|P3|Treatment Period (Up to Week 52)|Adverse Event|2
7536446|NCT02631538|26189696|P2|Treatment Period (Up to Week 52)|Adverse Event|5
7536447|NCT02631538|26189697|P1|Treatment Period (Up to Week 52)|Adverse Event|1
7536448|NCT02631148|26189738|P2|Overall Study|PAH not available to study participant|0
7536449|NCT02631148|26189739|P1|Overall Study|PAH not available to study participant|1
7536450|NCT02631148|26189738|P2|Overall Study|Withdrawal by Subject|0
7536451|NCT02631148|26189739|P1|Overall Study|Withdrawal by Subject|1
7536452|NCT02631148|26189738|P2|Overall Study|8 were ineligible|0
7536453|NCT02631148|26189739|P1|Overall Study|8 were ineligible|8
7536454|NCT02631070|26189753|P2|Overall Study|Miscellaneous|10
7536455|NCT02631070|26189754|P1|Overall Study|Miscellaneous|4
7536456|NCT02631070|26189753|P2|Overall Study|Progressive Disease|2
7536457|NCT02631070|26189754|P1|Overall Study|Progressive Disease|6
7536458|NCT02631070|26189753|P2|Overall Study|Protocol Violation|0
7536459|NCT02631070|26189754|P1|Overall Study|Protocol Violation|2
7536460|NCT02631070|26189753|P2|Overall Study|Withdrawal by Subject|10
7536461|NCT02631070|26189754|P1|Overall Study|Withdrawal by Subject|17
7536462|NCT02631070|26189753|P2|Overall Study|Lack of Efficacy|50
7536463|NCT02631070|26189754|P1|Overall Study|Lack of Efficacy|68
7536464|NCT02631070|26189753|P2|Overall Study|Adverse Event|4
7536465|NCT02631070|26189754|P1|Overall Study|Adverse Event|15
7536466|NCT02630966|26189848|P2|Overall Study|Lack of Efficacy|2
7536467|NCT02630966|26189849|P1|Overall Study|Lack of Efficacy|0
7536468|NCT02630966|26189848|P2|Overall Study|Voluntary Withdrawal|1
7536469|NCT02630966|26189849|P1|Overall Study|Voluntary Withdrawal|1
7536470|NCT02630966|26189848|P2|Overall Study|Significant Protocol Deviation|2
7536471|NCT02630966|26189849|P1|Overall Study|Significant Protocol Deviation|0
7536472|NCT02630966|26189848|P2|Overall Study|Adverse Event|3
7536473|NCT02630966|26189849|P1|Overall Study|Adverse Event|1
7536474|NCT02630706|26189894|P3|Overall Study|Withdrawal by Subject|7
7536475|NCT02630706|26189895|P2|Overall Study|Withdrawal by Subject|5
7536476|NCT02630706|26189896|P1|Overall Study|Withdrawal by Subject|4
7536477|NCT02630706|26189894|P3|Overall Study|Pregnancy|0
7536478|NCT02630706|26189895|P2|Overall Study|Pregnancy|1
7536479|NCT02630706|26189896|P1|Overall Study|Pregnancy|0
7536480|NCT02630706|26189894|P3|Overall Study|Physician Decision|0
7536481|NCT02630706|26189895|P2|Overall Study|Physician Decision|1
7536482|NCT02630706|26189896|P1|Overall Study|Physician Decision|1
7536483|NCT02630706|26189894|P3|Overall Study|Lost to Follow-up|2
7536484|NCT02630706|26189895|P2|Overall Study|Lost to Follow-up|1
7536485|NCT02630706|26189896|P1|Overall Study|Lost to Follow-up|0
7536486|NCT02630706|26189894|P3|Overall Study|Adverse Event|1
7536487|NCT02630706|26189895|P2|Overall Study|Adverse Event|1
7536488|NCT02630706|26189896|P1|Overall Study|Adverse Event|2
7536489|NCT02630693|26190005|P2|Overall Study|No receive treatment|1
7536490|NCT02630693|26190006|P1|Overall Study|No receive treatment|0
7536491|NCT02630563|26190018|P1|Overall Study|Administrative|1
7536492|NCT02630472|26190029|P2|Overall Study|Physician Decision|0
7536493|NCT02630472|26190030|P1|Overall Study|Physician Decision|10
7536494|NCT02630459|26190048|P8|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536495|NCT02630459|26190049|P7|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536496|NCT02630459|26190050|P6|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536497|NCT02630459|26190051|P5|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
7536498|NCT02630459|26190052|P4|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536499|NCT02630459|26190053|P3|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536500|NCT02630459|26190054|P2|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536501|NCT02630459|26190055|P1|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7536502|NCT02630459|26190048|P8|Open-Label Treatment Phase (OLTP)|Subject Request|0
7536503|NCT02630459|26190049|P7|Open-Label Treatment Phase (OLTP)|Subject Request|0
7536504|NCT02630459|26190050|P6|Open-Label Treatment Phase (OLTP)|Subject Request|3
7536505|NCT02630459|26190051|P5|Open-Label Treatment Phase (OLTP)|Subject Request|24
7536506|NCT02630459|26190052|P4|Open-Label Treatment Phase (OLTP)|Subject Request|0
7536507|NCT02630459|26190053|P3|Open-Label Treatment Phase (OLTP)|Subject Request|0
7536508|NCT02630459|26190054|P2|Open-Label Treatment Phase (OLTP)|Subject Request|0
7536509|NCT02630459|26190055|P1|Open-Label Treatment Phase (OLTP)|Subject Request|0
7536510|NCT02630459|26190048|P8|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7536511|NCT02630459|26190049|P7|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7536512|NCT02630459|26190050|P6|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
7536513|NCT02630459|26190051|P5|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
7536514|NCT02630459|26190052|P4|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7536515|NCT02630459|26190053|P3|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7536516|NCT02630459|26190054|P2|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7536517|NCT02630459|26190055|P1|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7536518|NCT02630459|26190048|P8|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536519|NCT02630459|26190049|P7|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536520|NCT02630459|26190050|P6|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536521|NCT02630459|26190051|P5|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536522|NCT02630459|26190052|P4|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536523|NCT02630459|26190053|P3|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536524|NCT02630459|26190054|P2|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7536525|NCT02630459|26190055|P1|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
7536526|NCT02630459|26190048|P8|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7536527|NCT02630459|26190049|P7|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7536528|NCT02630459|26190050|P6|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7536529|NCT02630459|26190051|P5|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7536530|NCT02630459|26190052|P4|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7536531|NCT02630459|26190053|P3|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
7536532|NCT02630459|26190054|P2|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7536533|NCT02630459|26190055|P1|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
7536534|NCT02630459|26190048|P8|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536535|NCT02630459|26190049|P7|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536536|NCT02630459|26190050|P6|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536537|NCT02630459|26190051|P5|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536538|NCT02630459|26190052|P4|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536539|NCT02630459|26190053|P3|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
7536540|NCT02630459|26190054|P2|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536541|NCT02630459|26190055|P1|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7536542|NCT02630459|26190048|P8|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7536543|NCT02630459|26190049|P7|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7536544|NCT02630459|26190050|P6|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7536545|NCT02630459|26190051|P5|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7536546|NCT02630459|26190052|P4|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
7536547|NCT02630459|26190053|P3|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7536548|NCT02630459|26190054|P2|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
7536549|NCT02630459|26190055|P1|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7536550|NCT02630251|26190131|P4|Overall Study|Physician Decision|0
7536551|NCT02630251|26190132|P3|Overall Study|Physician Decision|1
7536552|NCT02630251|26190133|P2|Overall Study|Physician Decision|0
7536553|NCT02630251|26190134|P1|Overall Study|Physician Decision|0
7536554|NCT02630186|26190248|P1|Overall Study|Withdrawal by Subject|1
7536555|NCT02629965|26190313|P2|Period 2|Adverse Event|0
7536556|NCT02629965|26190314|P1|Period 2|Adverse Event|1
7536557|NCT02629965|26190313|P2|Period 1|Other than listed above|2
7536558|NCT02629965|26190314|P1|Period 1|Other than listed above|1
7536559|NCT02629965|26190313|P2|Period 1|Unexpected worsening of disease|0
7536560|NCT02629965|26190314|P1|Period 1|Unexpected worsening of disease|2
7536561|NCT02629965|26190313|P2|Period 1|Adverse Event|0
7536562|NCT02629965|26190314|P1|Period 1|Adverse Event|1
7536563|NCT02629861|26190353|P3|Overall Study|Pregnancy|0
7536564|NCT02629861|26190354|P2|Overall Study|Pregnancy|1
7536565|NCT02629861|26190355|P1|Overall Study|Pregnancy|2
7536566|NCT02629861|26190353|P3|Overall Study|Other|0
7536567|NCT02629861|26190354|P2|Overall Study|Other|1
7536568|NCT02629861|26190355|P1|Overall Study|Other|1
7536569|NCT02629861|26190353|P3|Overall Study|Lost to Follow-up|4
7536570|NCT02629861|26190354|P2|Overall Study|Lost to Follow-up|9
7536571|NCT02629861|26190355|P1|Overall Study|Lost to Follow-up|12
7536572|NCT02629861|26190353|P3|Overall Study|Protocol Violation|7
7536573|NCT02629861|26190354|P2|Overall Study|Protocol Violation|3
7536574|NCT02629861|26190355|P1|Overall Study|Protocol Violation|2
7536575|NCT02629861|26190353|P3|Overall Study|Withdrawal by Subject|13
7536576|NCT02629861|26190354|P2|Overall Study|Withdrawal by Subject|8
7536577|NCT02629861|26190355|P1|Overall Study|Withdrawal by Subject|5
7536578|NCT02629861|26190353|P3|Overall Study|Adverse Event|4
7536579|NCT02629861|26190354|P2|Overall Study|Adverse Event|5
7536580|NCT02629861|26190355|P1|Overall Study|Adverse Event|7
7536585|NCT02629159|26190448|P3|Overall Study|Other|8
7536586|NCT02629159|26190449|P2|Overall Study|Other|4
7536587|NCT02629159|26190450|P1|Overall Study|Other|6
7536588|NCT02629159|26190448|P3|Overall Study|Lack of Efficacy|1
7536589|NCT02629159|26190449|P2|Overall Study|Lack of Efficacy|0
7536590|NCT02629159|26190450|P1|Overall Study|Lack of Efficacy|4
7536591|NCT02629159|26190448|P3|Overall Study|Lost to Follow-up|5
7536592|NCT02629159|26190449|P2|Overall Study|Lost to Follow-up|4
7536593|NCT02629159|26190450|P1|Overall Study|Lost to Follow-up|7
7536594|NCT02629159|26190448|P3|Overall Study|Withdrawal by Subject|15
7536595|NCT02629159|26190449|P2|Overall Study|Withdrawal by Subject|11
7536596|NCT02629159|26190450|P1|Overall Study|Withdrawal by Subject|22
7536597|NCT02629159|26190448|P3|Overall Study|Adverse Event|22
7536598|NCT02629159|26190449|P2|Overall Study|Adverse Event|20
7536599|NCT02629159|26190450|P1|Overall Study|Adverse Event|17
7536600|NCT02629133|26190502|P2|Overall Study|Withdrawal by Subject|1
7536602|NCT02629133|26190502|P2|Overall Study|Lost to Follow-up|1
7536603|NCT02629133|26190503|P1|Overall Study|Lost to Follow-up|3
7536604|NCT02628938|26190546|P3|Overall Study|Failure to comply with the instructions|3
7536605|NCT02628938|26190547|P2|Overall Study|Failure to comply with the instructions|0
7536606|NCT02628938|26190548|P1|Overall Study|Failure to comply with the instructions|3
7536607|NCT02628938|26190546|P3|Overall Study|Did not attend the follow up recall|1
7536608|NCT02628938|26190547|P2|Overall Study|Did not attend the follow up recall|2
7536609|NCT02628938|26190548|P1|Overall Study|Did not attend the follow up recall|2
7536610|NCT02628873|26190564|P2|Second Test (1 Hour)|Physician Decision|0
7536611|NCT02628873|26190565|P1|Second Test (1 Hour)|Physician Decision|1
7536612|NCT02628873|26190564|P2|Break (1 Hour)|Withdrawal by Subject|1
7536613|NCT02628873|26190565|P1|Break (1 Hour)|Withdrawal by Subject|0
7536614|NCT02628769|26190575|P2|Second Intervention|Physician Decision|1
7536615|NCT02628769|26190576|P1|Second Intervention|Physician Decision|0
7536616|NCT02628769|26190575|P2|Second Intervention|Adverse Event|0
7536617|NCT02628769|26190576|P1|Second Intervention|Adverse Event|2
7536618|NCT02628769|26190575|P2|First Intervention|Withdrawal by Subject|1
7536619|NCT02628769|26190576|P1|First Intervention|Withdrawal by Subject|0
7536620|NCT02628769|26190575|P2|First Intervention|Adverse Event|0
7536621|NCT02628769|26190576|P1|First Intervention|Adverse Event|1
7536622|NCT02628743|26190614|P1|Overall Study|Physician Decision|2
7536623|NCT02628743|26190614|P1|Overall Study|Study Terminated by Sponsor|76
7536624|NCT02628743|26190614|P1|Overall Study|Withdrawal by Subject|50
7536625|NCT02628743|26190614|P1|Overall Study|Other|3
7536626|NCT02628600|26190640|P2|Overall Study|Other not specified|0
7536627|NCT02628600|26190641|P1|Overall Study|Other not specified|1
7536628|NCT02628600|26190640|P2|Overall Study|Physician Decision|2
7536629|NCT02628600|26190641|P1|Overall Study|Physician Decision|2
7536630|NCT02628600|26190640|P2|Overall Study|Lost to Follow-up|0
7536631|NCT02628600|26190641|P1|Overall Study|Lost to Follow-up|1
7536632|NCT02628600|26190640|P2|Overall Study|Withdrawal by Subject|8
7536633|NCT02628600|26190641|P1|Overall Study|Withdrawal by Subject|13
7536634|NCT02628600|26190640|P2|Overall Study|Lack of Efficacy|0
7536635|NCT02628600|26190641|P1|Overall Study|Lack of Efficacy|2
7536636|NCT02628600|26190640|P2|Overall Study|Protocol Violation|1
7536637|NCT02628600|26190641|P1|Overall Study|Protocol Violation|0
7536638|NCT02628600|26190640|P2|Overall Study|Adverse Event|20
7536639|NCT02628600|26190641|P1|Overall Study|Adverse Event|3
7536640|NCT02628600|26190640|P2|Overall Study|Death|1
7536641|NCT02628600|26190641|P1|Overall Study|Death|2
7536642|NCT02628444|26190656|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7536643|NCT02628444|26190657|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7536644|NCT02628444|26190658|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
7536645|NCT02628444|26190659|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7536646|NCT02628444|26190660|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7536647|NCT02628444|26190661|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7536648|NCT02628444|26190662|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7536649|NCT02628444|26190663|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7536650|NCT02628444|26190664|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7536651|NCT02628444|26190656|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7536652|NCT02628444|26190657|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
7536653|NCT02628444|26190658|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7536654|NCT02628444|26190659|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7536655|NCT02628444|26190660|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7536656|NCT02628444|26190661|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7536657|NCT02628444|26190662|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7536658|NCT02628444|26190663|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7536659|NCT02628444|26190664|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7536660|NCT02628444|26190656|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
7536661|NCT02628444|26190657|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
7536662|NCT02628444|26190658|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
7536663|NCT02628444|26190659|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
7536664|NCT02628444|26190660|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
7536665|NCT02628444|26190661|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
7536666|NCT02628444|26190662|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7536667|NCT02628444|26190663|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7536668|NCT02628444|26190664|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7536669|NCT02628444|26190656|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
7536670|NCT02628444|26190657|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
7536671|NCT02628444|26190658|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
7536672|NCT02628444|26190659|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7536673|NCT02628444|26190660|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7536674|NCT02628444|26190661|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7536675|NCT02628444|26190662|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7536676|NCT02628444|26190663|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7536677|NCT02628444|26190664|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7536678|NCT02628444|26190656|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536679|NCT02628444|26190657|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536680|NCT02628444|26190658|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536681|NCT02628444|26190659|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536682|NCT02628444|26190660|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536683|NCT02628444|26190661|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
7536684|NCT02628444|26190662|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536685|NCT02628444|26190663|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536686|NCT02628444|26190664|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7536687|NCT02628444|26190656|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7536688|NCT02628444|26190657|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7536689|NCT02628444|26190658|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7536690|NCT02628444|26190659|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7536691|NCT02628444|26190660|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7536692|NCT02628444|26190661|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7536693|NCT02628444|26190662|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7536694|NCT02628444|26190663|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
7536695|NCT02628444|26190664|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7536696|NCT02628444|26190656|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7536697|NCT02628444|26190657|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7536698|NCT02628444|26190658|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7536699|NCT02628444|26190659|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7536700|NCT02628444|26190660|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7536701|NCT02628444|26190661|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7536702|NCT02628444|26190662|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7536703|NCT02628444|26190663|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
7536704|NCT02628444|26190664|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7536705|NCT02628444|26190656|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7536706|NCT02628444|26190657|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7536707|NCT02628444|26190658|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7536708|NCT02628444|26190659|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7536709|NCT02628444|26190660|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7536710|NCT02628444|26190661|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7536711|NCT02628444|26190662|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
7536712|NCT02628444|26190663|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
7536713|NCT02628444|26190664|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
7536714|NCT02628444|26190656|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536715|NCT02628444|26190657|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536716|NCT02628444|26190658|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536717|NCT02628444|26190659|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536718|NCT02628444|26190660|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536719|NCT02628444|26190661|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536720|NCT02628444|26190662|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
7536721|NCT02628444|26190663|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
7536722|NCT02628444|26190664|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7536723|NCT02628444|26190656|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536724|NCT02628444|26190657|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536725|NCT02628444|26190658|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536726|NCT02628444|26190659|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536727|NCT02628444|26190660|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536728|NCT02628444|26190661|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536729|NCT02628444|26190662|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536730|NCT02628444|26190663|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7536731|NCT02628444|26190664|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
7536732|NCT02628418|26190763|P2|Overall Study|Lost to Follow-up|2
7536733|NCT02628418|26190764|P1|Overall Study|Lost to Follow-up|1
7536734|NCT02628028|26190874|P8|Long-term Extension (LTE) Period|Other|3
7536735|NCT02628028|26190875|P7|Long-term Extension (LTE) Period|Other|4
7536736|NCT02628028|26190876|P6|Long-term Extension (LTE) Period|Other|3
7536737|NCT02628028|26190877|P5|Long-term Extension (LTE) Period|Other|0
7536738|NCT02628028|26190878|P4|Long-term Extension (LTE) Period|Other|0
7536739|NCT02628028|26190879|P3|Long-term Extension (LTE) Period|Other|0
7536740|NCT02628028|26190880|P2|Long-term Extension (LTE) Period|Other|0
7536741|NCT02628028|26190881|P1|Long-term Extension (LTE) Period|Other|0
7536742|NCT02628028|26190874|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7536743|NCT02628028|26190875|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7536744|NCT02628028|26190876|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
7536745|NCT02628028|26190877|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7536746|NCT02628028|26190878|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7536747|NCT02628028|26190879|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7536748|NCT02628028|26190880|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7536749|NCT02628028|26190881|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7536750|NCT02628028|26190874|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7536751|NCT02628028|26190875|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7536752|NCT02628028|26190876|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
7536753|NCT02628028|26190877|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7536754|NCT02628028|26190878|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7536755|NCT02628028|26190879|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7536756|NCT02628028|26190880|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7536757|NCT02628028|26190881|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7536758|NCT02628028|26190874|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
7536759|NCT02628028|26190875|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
7536760|NCT02628028|26190876|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
7536761|NCT02628028|26190877|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
7536762|NCT02628028|26190878|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
7536763|NCT02628028|26190879|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
7536764|NCT02628028|26190880|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
7536765|NCT02628028|26190881|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
7536766|NCT02628028|26190874|P8|Long-term Extension (LTE) Period|Adverse Event|3
7536767|NCT02628028|26190875|P7|Long-term Extension (LTE) Period|Adverse Event|0
7536768|NCT02628028|26190876|P6|Long-term Extension (LTE) Period|Adverse Event|1
7536769|NCT02628028|26190877|P5|Long-term Extension (LTE) Period|Adverse Event|0
7536770|NCT02628028|26190878|P4|Long-term Extension (LTE) Period|Adverse Event|0
7536771|NCT02628028|26190879|P3|Long-term Extension (LTE) Period|Adverse Event|0
7536772|NCT02628028|26190880|P2|Long-term Extension (LTE) Period|Adverse Event|0
7536773|NCT02628028|26190881|P1|Long-term Extension (LTE) Period|Adverse Event|0
7536774|NCT02628028|26190874|P8|Dosing Period|Other|4
7536775|NCT02628028|26190875|P7|Dosing Period|Other|2
7536776|NCT02628028|26190876|P6|Dosing Period|Other|1
7536777|NCT02628028|26190877|P5|Dosing Period|Other|2
7536778|NCT02628028|26190878|P4|Dosing Period|Other|0
7536779|NCT02628028|26190879|P3|Dosing Period|Other|0
7536780|NCT02628028|26190880|P2|Dosing Period|Other|0
7536781|NCT02628028|26190881|P1|Dosing Period|Other|0
7536782|NCT02628028|26190874|P8|Dosing Period|Lost to Follow-up|0
7536783|NCT02628028|26190875|P7|Dosing Period|Lost to Follow-up|1
7536784|NCT02628028|26190876|P6|Dosing Period|Lost to Follow-up|0
7536785|NCT02628028|26190877|P5|Dosing Period|Lost to Follow-up|0
7536786|NCT02628028|26190878|P4|Dosing Period|Lost to Follow-up|0
7536787|NCT02628028|26190879|P3|Dosing Period|Lost to Follow-up|0
7536788|NCT02628028|26190880|P2|Dosing Period|Lost to Follow-up|0
7536789|NCT02628028|26190881|P1|Dosing Period|Lost to Follow-up|0
7536790|NCT02628028|26190874|P8|Dosing Period|Site Terminated by Sponsor|0
7536791|NCT02628028|26190875|P7|Dosing Period|Site Terminated by Sponsor|1
7536792|NCT02628028|26190876|P6|Dosing Period|Site Terminated by Sponsor|1
7536793|NCT02628028|26190877|P5|Dosing Period|Site Terminated by Sponsor|0
7536794|NCT02628028|26190878|P4|Dosing Period|Site Terminated by Sponsor|0
7536795|NCT02628028|26190879|P3|Dosing Period|Site Terminated by Sponsor|0
7536796|NCT02628028|26190880|P2|Dosing Period|Site Terminated by Sponsor|0
7536797|NCT02628028|26190881|P1|Dosing Period|Site Terminated by Sponsor|0
7536798|NCT02628028|26190874|P8|Dosing Period|Physician Decision|0
7536799|NCT02628028|26190875|P7|Dosing Period|Physician Decision|0
7536800|NCT02628028|26190876|P6|Dosing Period|Physician Decision|1
7536801|NCT02628028|26190877|P5|Dosing Period|Physician Decision|0
7536802|NCT02628028|26190878|P4|Dosing Period|Physician Decision|0
7536803|NCT02628028|26190879|P3|Dosing Period|Physician Decision|0
7536804|NCT02628028|26190880|P2|Dosing Period|Physician Decision|0
7536805|NCT02628028|26190881|P1|Dosing Period|Physician Decision|0
7536806|NCT02628028|26190874|P8|Dosing Period|Study Terminated by Sponsor|7
7536807|NCT02628028|26190875|P7|Dosing Period|Study Terminated by Sponsor|7
7536808|NCT02628028|26190876|P6|Dosing Period|Study Terminated by Sponsor|6
7536809|NCT02628028|26190877|P5|Dosing Period|Study Terminated by Sponsor|7
7536810|NCT02628028|26190878|P4|Dosing Period|Study Terminated by Sponsor|0
7536811|NCT02628028|26190879|P3|Dosing Period|Study Terminated by Sponsor|0
7536812|NCT02628028|26190880|P2|Dosing Period|Study Terminated by Sponsor|0
7536813|NCT02628028|26190881|P1|Dosing Period|Study Terminated by Sponsor|0
7536814|NCT02628028|26190874|P8|Dosing Period|Lack of Efficacy|0
7536815|NCT02628028|26190875|P7|Dosing Period|Lack of Efficacy|1
7536816|NCT02628028|26190876|P6|Dosing Period|Lack of Efficacy|0
7536817|NCT02628028|26190877|P5|Dosing Period|Lack of Efficacy|3
7536818|NCT02628028|26190878|P4|Dosing Period|Lack of Efficacy|0
7536819|NCT02628028|26190879|P3|Dosing Period|Lack of Efficacy|0
7536820|NCT02628028|26190880|P2|Dosing Period|Lack of Efficacy|0
7536821|NCT02628028|26190881|P1|Dosing Period|Lack of Efficacy|0
7536822|NCT02628028|26190874|P8|Dosing Period|Death|1
7536823|NCT02628028|26190875|P7|Dosing Period|Death|0
7536824|NCT02628028|26190876|P6|Dosing Period|Death|0
7536825|NCT02628028|26190877|P5|Dosing Period|Death|0
7536826|NCT02628028|26190878|P4|Dosing Period|Death|0
7536827|NCT02628028|26190879|P3|Dosing Period|Death|0
7536828|NCT02628028|26190880|P2|Dosing Period|Death|0
7536829|NCT02628028|26190881|P1|Dosing Period|Death|0
7536830|NCT02628028|26190874|P8|Dosing Period|Adverse Event|2
7536831|NCT02628028|26190875|P7|Dosing Period|Adverse Event|3
7536832|NCT02628028|26190876|P6|Dosing Period|Adverse Event|1
7536833|NCT02628028|26190877|P5|Dosing Period|Adverse Event|2
7536834|NCT02628028|26190878|P4|Dosing Period|Adverse Event|0
7536835|NCT02628028|26190879|P3|Dosing Period|Adverse Event|0
7536836|NCT02628028|26190880|P2|Dosing Period|Adverse Event|0
7536837|NCT02628028|26190881|P1|Dosing Period|Adverse Event|0
7536838|NCT02628028|26190874|P8|Dosing Period|Withdrawal by Subject|1
7536839|NCT02628028|26190875|P7|Dosing Period|Withdrawal by Subject|1
7536840|NCT02628028|26190876|P6|Dosing Period|Withdrawal by Subject|4
7536841|NCT02628028|26190877|P5|Dosing Period|Withdrawal by Subject|2
7536842|NCT02628028|26190878|P4|Dosing Period|Withdrawal by Subject|0
7536843|NCT02628028|26190879|P3|Dosing Period|Withdrawal by Subject|1
7536844|NCT02628028|26190880|P2|Dosing Period|Withdrawal by Subject|0
7536845|NCT02628028|26190881|P1|Dosing Period|Withdrawal by Subject|0
7536846|NCT02627495|26190968|P1|Overall Study|Withdrawal by Subject|4
7536847|NCT02627144|26190972|P1|Overall Study|Other|17
7536848|NCT02627144|26190972|P1|Overall Study|Enrolled, not treated|6
7536849|NCT02627144|26190972|P1|Overall Study|Lost to Follow-up|8
7536850|NCT02627144|26190972|P1|Overall Study|Administrative reasons|65
7536851|NCT02627144|26190972|P1|Overall Study|Refusal of treatment / poor cooperation|38
7536852|NCT02627144|26190972|P1|Overall Study|Death from other cause|8
7536853|NCT02627144|26190972|P1|Overall Study|Death from cancer|20
7536854|NCT02627144|26190972|P1|Overall Study|Cancer progression|171
7536855|NCT02627144|26190972|P1|Overall Study|Serious adverse event|32
7536856|NCT02626819|26191013|P2|Overall Study|Diagnosed w/ catastrophic illness|1
7536857|NCT02626819|26191014|P1|Overall Study|Diagnosed w/ catastrophic illness|0
7536858|NCT02626819|26191013|P2|Overall Study|Withdrawal by Subject|0
7536859|NCT02626819|26191014|P1|Overall Study|Withdrawal by Subject|1
7536860|NCT02626819|26191013|P2|Overall Study|Lost to Follow-up|2
7536861|NCT02626819|26191014|P1|Overall Study|Lost to Follow-up|3
7536862|NCT02626780|26191034|P1|Overall Study|Withdrawal by Subject|3
7536863|NCT02626520|26191067|P2|Overall Study|Study terminated|1
7536864|NCT02626520|26191068|P1|Overall Study|Study terminated|0
7536865|NCT02626520|26191067|P2|Overall Study|Did not start protocol therapy|2
7536866|NCT02626520|26191068|P1|Overall Study|Did not start protocol therapy|0
7536867|NCT02626520|26191067|P2|Overall Study|Lack of Efficacy|2
7536868|NCT02626520|26191068|P1|Overall Study|Lack of Efficacy|0
7536869|NCT02626520|26191067|P2|Overall Study|Adverse Event|4
7536870|NCT02626520|26191068|P1|Overall Study|Adverse Event|0
7536871|NCT02626520|26191067|P2|Overall Study|Physician Decision|1
7536872|NCT02626520|26191068|P1|Overall Study|Physician Decision|1
7536873|NCT02626182|26191080|P2|Overall Study|Adverse Event|0
7536874|NCT02626182|26191081|P1|Overall Study|Adverse Event|2
7536875|NCT02626026|26191145|P6|Overall Study|Randomized but Never Treated|0
7536876|NCT02626026|26191146|P5|Overall Study|Randomized but Never Treated|1
7536877|NCT02626026|26191147|P4|Overall Study|Randomized but Never Treated|0
7536878|NCT02626026|26191148|P3|Overall Study|Randomized but Never Treated|0
7536879|NCT02626026|26191149|P2|Overall Study|Randomized but Never Treated|0
7536880|NCT02626026|26191150|P1|Overall Study|Randomized but Never Treated|0
7536881|NCT02626000|26191228|P1|Overall Study|Death|29
7536882|NCT02626000|26191228|P1|Overall Study|Decision by Sponsor|1
7536883|NCT02625974|26191242|P2|Overall Study|Protocol Violation|1
7536884|NCT02625974|26191243|P1|Overall Study|Protocol Violation|0
7536885|NCT02625974|26191242|P2|Overall Study|non-compliance with study drug|2
7536886|NCT02625974|26191243|P1|Overall Study|non-compliance with study drug|0
7536887|NCT02625974|26191242|P2|Overall Study|positive parasitemia|0
7536888|NCT02625974|26191243|P1|Overall Study|positive parasitemia|1
7536889|NCT02625974|26191242|P2|Overall Study|Withdrawal by Subject|1
7536890|NCT02625974|26191243|P1|Overall Study|Withdrawal by Subject|3
7536891|NCT02625974|26191242|P2|Overall Study|Adverse Event|2
7536892|NCT02625974|26191243|P1|Overall Study|Adverse Event|12
7536893|NCT02625922|26191353|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
7536894|NCT02625922|26191354|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
7536895|NCT02625922|26191353|P2|Overall Study|Non-availability of IMP|1
7536896|NCT02625922|26191354|P1|Overall Study|Non-availability of IMP|1
7536897|NCT02625623|26191373|P2|Overall Study|Participants randomized but not treated|1
7536898|NCT02625623|26191374|P1|Overall Study|Participants randomized but not treated|9
7536899|NCT02625324|26191437|P1|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
7536900|NCT02625324|26191437|P1|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7536901|NCT02625324|26191437|P1|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7536902|NCT02625324|26191437|P1|24-Month Follow-up Secondary Endpoint|Death|2
7536903|NCT02625324|26191437|P1|12-Month Follow-up Secondary Endpoint|Death|4
7536904|NCT02625324|26191437|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
7536905|NCT02625324|26191437|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
7536906|NCT02625324|26191437|P1|6-Month Follow-up Subject Accountability|Death|5
7536907|NCT02625324|26191437|P1|30-Day Follow-up for Secondary Endpoint|Death|1
7536908|NCT02625324|26191437|P1|30-Day Follow-up for Primary Endpoint|Death|1
7536909|NCT02625259|26191464|P5|First Intervention (Day 1)|Withdrawal by Subject|0
7536910|NCT02625259|26191465|P4|First Intervention (Day 1)|Withdrawal by Subject|1
7536911|NCT02625259|26191466|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7537000|NCT02624050|26192000|P2|Overall Study|Protocol Violation|0
7536912|NCT02625259|26191467|P2|First Intervention (Day 1)|Withdrawal by Subject|0
7536913|NCT02625259|26191468|P1|First Intervention (Day 1)|Withdrawal by Subject|0
7536914|NCT02625259|26191464|P5|First Intervention (Day 1)|Adverse Event|0
7536915|NCT02625259|26191465|P4|First Intervention (Day 1)|Adverse Event|0
7536916|NCT02625259|26191466|P3|First Intervention (Day 1)|Adverse Event|0
7536917|NCT02625259|26191467|P2|First Intervention (Day 1)|Adverse Event|1
7536918|NCT02625259|26191468|P1|First Intervention (Day 1)|Adverse Event|2
7536919|NCT02625259|26191464|P5|First Intervention (Day 1)|Other|0
7536920|NCT02625259|26191465|P4|First Intervention (Day 1)|Other|0
7536921|NCT02625259|26191466|P3|First Intervention (Day 1)|Other|1
7536922|NCT02625259|26191467|P2|First Intervention (Day 1)|Other|0
7536923|NCT02625259|26191468|P1|First Intervention (Day 1)|Other|0
7536924|NCT02625233|26191505|P2|Overall Study|Adverse Event|0
7536925|NCT02625233|26191506|P1|Overall Study|Adverse Event|2
7536926|NCT02625220|26191514|P1|Overall Study|Study discontinued at site|2
7536927|NCT02625220|26191514|P1|Overall Study|Protocol Violation|1
7536928|NCT02625220|26191514|P1|Overall Study|Lost to Follow-up|2
7536929|NCT02625220|26191514|P1|Overall Study|Adverse Event|2
7536930|NCT02624986|26191642|P8|Overall Study|Withdrawal by Subject|1
7536931|NCT02624986|26191643|P7|Overall Study|Withdrawal by Subject|0
7536932|NCT02624986|26191644|P6|Overall Study|Withdrawal by Subject|0
7536933|NCT02624986|26191645|P5|Overall Study|Withdrawal by Subject|0
7536934|NCT02624986|26191646|P4|Overall Study|Withdrawal by Subject|0
7536935|NCT02624986|26191647|P3|Overall Study|Withdrawal by Subject|0
7536936|NCT02624986|26191648|P2|Overall Study|Withdrawal by Subject|0
7536937|NCT02624986|26191649|P1|Overall Study|Withdrawal by Subject|0
7536938|NCT02624986|26191642|P8|Overall Study|Protocol Violation|0
7536939|NCT02624986|26191643|P7|Overall Study|Protocol Violation|0
7536940|NCT02624986|26191644|P6|Overall Study|Protocol Violation|0
7536941|NCT02624986|26191645|P5|Overall Study|Protocol Violation|0
7536942|NCT02624986|26191646|P4|Overall Study|Protocol Violation|0
7536943|NCT02624986|26191647|P3|Overall Study|Protocol Violation|0
7536944|NCT02624986|26191648|P2|Overall Study|Protocol Violation|0
7536945|NCT02624986|26191649|P1|Overall Study|Protocol Violation|1
7536946|NCT02624986|26191642|P8|Overall Study|Progressive Disease|0
7536947|NCT02624986|26191643|P7|Overall Study|Progressive Disease|0
7536948|NCT02624986|26191644|P6|Overall Study|Progressive Disease|0
7536949|NCT02624986|26191645|P5|Overall Study|Progressive Disease|0
7536950|NCT02624986|26191646|P4|Overall Study|Progressive Disease|0
7536951|NCT02624986|26191647|P3|Overall Study|Progressive Disease|0
7536952|NCT02624986|26191648|P2|Overall Study|Progressive Disease|1
7536953|NCT02624986|26191649|P1|Overall Study|Progressive Disease|0
7536954|NCT02624986|26191642|P8|Overall Study|Study Terminated by Sponsor|3
7536955|NCT02624986|26191643|P7|Overall Study|Study Terminated by Sponsor|4
7536956|NCT02624986|26191644|P6|Overall Study|Study Terminated by Sponsor|2
7536957|NCT02624986|26191645|P5|Overall Study|Study Terminated by Sponsor|2
7536958|NCT02624986|26191646|P4|Overall Study|Study Terminated by Sponsor|1
7536959|NCT02624986|26191647|P3|Overall Study|Study Terminated by Sponsor|0
7536960|NCT02624986|26191648|P2|Overall Study|Study Terminated by Sponsor|1
7536961|NCT02624986|26191649|P1|Overall Study|Study Terminated by Sponsor|1
7536962|NCT02624986|26191642|P8|Overall Study|Death|1
7536963|NCT02624986|26191643|P7|Overall Study|Death|0
7536964|NCT02624986|26191644|P6|Overall Study|Death|0
7536965|NCT02624986|26191645|P5|Overall Study|Death|2
7536966|NCT02624986|26191646|P4|Overall Study|Death|2
7536967|NCT02624986|26191647|P3|Overall Study|Death|2
7536968|NCT02624986|26191648|P2|Overall Study|Death|1
7536969|NCT02624986|26191649|P1|Overall Study|Death|0
7536970|NCT02624791|26191839|P6|Overall Study|Withdrawal by Subject|0
7536971|NCT02624791|26191840|P5|Overall Study|Withdrawal by Subject|0
7536972|NCT02624791|26191841|P4|Overall Study|Withdrawal by Subject|0
7536973|NCT02624791|26191842|P3|Overall Study|Withdrawal by Subject|0
7536974|NCT02624791|26191843|P2|Overall Study|Withdrawal by Subject|0
7536975|NCT02624791|26191844|P1|Overall Study|Withdrawal by Subject|2
7536976|NCT02624713|26191876|P2|Overall Study|Lost to Follow-up|0
7536977|NCT02624713|26191877|P1|Overall Study|Lost to Follow-up|14
7536978|NCT02624687|26191901|P2|Overall Study|medical leave from work|1
7536979|NCT02624687|26191902|P1|Overall Study|medical leave from work|0
7536980|NCT02624687|26191901|P2|Overall Study|Withdrawal by Subject|1
7536981|NCT02624687|26191902|P1|Overall Study|Withdrawal by Subject|1
7536982|NCT02624492|26191933|P3|Overall Study|Progressive disease|3
7536983|NCT02624492|26191934|P2|Overall Study|Progressive disease|2
7536984|NCT02624492|26191935|P1|Overall Study|Progressive disease|0
7536985|NCT02624492|26191933|P3|Overall Study|Adverse Event|2
7536986|NCT02624492|26191934|P2|Overall Study|Adverse Event|2
7536987|NCT02624492|26191935|P1|Overall Study|Adverse Event|2
7536988|NCT02624284|26191970|P3|Overall Study|Adverse Event|1
7536989|NCT02624284|26191971|P2|Overall Study|Adverse Event|0
7536990|NCT02624284|26191972|P1|Overall Study|Adverse Event|0
7536991|NCT02624284|26191970|P3|Overall Study|Revealed exclusionary condition|0
7536992|NCT02624284|26191971|P2|Overall Study|Revealed exclusionary condition|2
7536993|NCT02624284|26191972|P1|Overall Study|Revealed exclusionary condition|2
7536994|NCT02624284|26191970|P3|Overall Study|Protocol Violation|7
7536995|NCT02624284|26191971|P2|Overall Study|Protocol Violation|10
7536996|NCT02624284|26191972|P1|Overall Study|Protocol Violation|9
7536997|NCT02624284|26191970|P3|Overall Study|Withdrawal by Subject|3
7536998|NCT02624284|26191971|P2|Overall Study|Withdrawal by Subject|6
7536999|NCT02624284|26191972|P1|Overall Study|Withdrawal by Subject|3
7537001|NCT02624050|26192001|P1|Overall Study|Protocol Violation|2
7537002|NCT02624050|26192000|P2|Overall Study|Physician Decision|0
7537003|NCT02624050|26192001|P1|Overall Study|Physician Decision|4
7537004|NCT02623959|26192029|P2|Overall Study|Progression|1
7537005|NCT02623959|26192030|P1|Overall Study|Progression|0
7537006|NCT02623829|26192063|P2|Overall Study|Lost to Follow-up|1
7537007|NCT02623829|26192064|P1|Overall Study|Lost to Follow-up|1
7537008|NCT02623725|26192123|P2|Overall Study|Withdrawal by Subject|1
7537009|NCT02623725|26192124|P1|Overall Study|Withdrawal by Subject|7
7537010|NCT02623725|26192123|P2|Overall Study|Serious adverse event|2
7537011|NCT02623725|26192124|P1|Overall Study|Serious adverse event|0
7537012|NCT02623725|26192123|P2|Overall Study|Non compliance with protocol|3
7537013|NCT02623725|26192124|P1|Overall Study|Non compliance with protocol|9
7537014|NCT02623361|26192158|P2|Overall Study|Withdrawal by Subject|1
7537015|NCT02623361|26192159|P1|Overall Study|Withdrawal by Subject|0
7537016|NCT02623361|26192158|P2|Overall Study|Protocol Violation|1
7537017|NCT02623361|26192159|P1|Overall Study|Protocol Violation|0
7537018|NCT02623335|26192198|P2|Overall Study|Protocol Violation|1
7537019|NCT02623335|26192199|P1|Overall Study|Protocol Violation|2
7537020|NCT02623335|26192198|P2|Overall Study|Withdrawal by Subject|5
7537021|NCT02623335|26192199|P1|Overall Study|Withdrawal by Subject|2
7537022|NCT02623335|26192198|P2|Overall Study|Lost to Follow-up|23
7537023|NCT02623335|26192199|P1|Overall Study|Lost to Follow-up|15
7537024|NCT02623335|26192198|P2|Overall Study|Death|7
7537025|NCT02623335|26192199|P1|Overall Study|Death|8
7537026|NCT02623322|26192226|P3|Overall Study|Lost to Follow-up|0
7537027|NCT02623322|26192227|P2|Overall Study|Lost to Follow-up|1
7537028|NCT02623322|26192228|P1|Overall Study|Lost to Follow-up|2
7537029|NCT02623218|26192266|P5|Overall Study|Lost to Follow-up|0
7537030|NCT02623218|26192267|P4|Overall Study|Lost to Follow-up|0
7537031|NCT02623218|26192268|P3|Overall Study|Lost to Follow-up|0
7537032|NCT02623218|26192269|P2|Overall Study|Lost to Follow-up|1
7537033|NCT02623218|26192270|P1|Overall Study|Lost to Follow-up|0
7537034|NCT02622828|26192292|P1|Overall Study|participant withdrew|3
7537035|NCT02622724|26192299|P2|Overall Study|Early termination of study|43
7537036|NCT02622724|26192300|P1|Overall Study|Early termination of study|38
7537037|NCT02622724|26192299|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
7537038|NCT02622724|26192300|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
7537039|NCT02622724|26192299|P2|Overall Study|Death|53
7537040|NCT02622724|26192300|P1|Overall Study|Death|51
7537041|NCT02622568|26192378|P2|Overall Study|Lost to Follow-up|5
7537042|NCT02622568|26192379|P1|Overall Study|Lost to Follow-up|5
7537043|NCT02622321|26192389|P4|Overall Study|Physician Decision|0
7537044|NCT02622321|26192390|P3|Overall Study|Physician Decision|0
7537045|NCT02622321|26192391|P2|Overall Study|Physician Decision|0
7537046|NCT02622321|26192392|P1|Overall Study|Physician Decision|1
7537047|NCT02622321|26192389|P4|Overall Study|Death|0
7537048|NCT02622321|26192390|P3|Overall Study|Death|1
7537049|NCT02622321|26192391|P2|Overall Study|Death|0
7537050|NCT02622321|26192392|P1|Overall Study|Death|0
7537051|NCT02622321|26192389|P4|Overall Study|Withdrawal by Subject|0
7537052|NCT02622321|26192390|P3|Overall Study|Withdrawal by Subject|0
7537053|NCT02622321|26192391|P2|Overall Study|Withdrawal by Subject|0
7537054|NCT02622321|26192392|P1|Overall Study|Withdrawal by Subject|2
7537055|NCT02622113|26192498|P2|Overall Study|Stopping Criteria|3
7537056|NCT02622113|26192499|P1|Overall Study|Stopping Criteria|1
7537057|NCT02622113|26192498|P2|Overall Study|Withdrawal by Subject|2
7537058|NCT02622113|26192499|P1|Overall Study|Withdrawal by Subject|0
7537059|NCT02622113|26192498|P2|Overall Study|Physician Decision|1
7537060|NCT02622113|26192499|P1|Overall Study|Physician Decision|0
7537061|NCT02622113|26192498|P2|Overall Study|Adverse Event|4
7537062|NCT02622113|26192499|P1|Overall Study|Adverse Event|4
7537063|NCT02622074|26192517|P6|Overall Study|Withdrawal by Subject|0
7537064|NCT02622074|26192518|P5|Overall Study|Withdrawal by Subject|0
7537065|NCT02622074|26192519|P4|Overall Study|Withdrawal by Subject|0
7537066|NCT02622074|26192520|P3|Overall Study|Withdrawal by Subject|0
7537067|NCT02622074|26192521|P2|Overall Study|Withdrawal by Subject|1
7537068|NCT02622074|26192522|P1|Overall Study|Withdrawal by Subject|0
7537069|NCT02622074|26192517|P6|Overall Study|Death|0
7537070|NCT02622074|26192518|P5|Overall Study|Death|1
7537071|NCT02622074|26192519|P4|Overall Study|Death|1
7537072|NCT02622074|26192520|P3|Overall Study|Death|0
7537073|NCT02622074|26192521|P2|Overall Study|Death|0
7537074|NCT02622074|26192522|P1|Overall Study|Death|4
7537075|NCT02621931|26192626|P3|Overall Study|Other|3
7537076|NCT02621931|26192627|P2|Overall Study|Other|1
7537077|NCT02621931|26192628|P1|Overall Study|Other|1
7537078|NCT02621931|26192626|P3|Overall Study|Lack of Efficacy|1
7537079|NCT02621931|26192627|P2|Overall Study|Lack of Efficacy|0
7537080|NCT02621931|26192628|P1|Overall Study|Lack of Efficacy|0
7537081|NCT02621931|26192626|P3|Overall Study|Lost to Follow-up|10
7537082|NCT02621931|26192627|P2|Overall Study|Lost to Follow-up|7
7537083|NCT02621931|26192628|P1|Overall Study|Lost to Follow-up|8
7537084|NCT02621931|26192626|P3|Overall Study|Noncompliance to study procedures|2
7537085|NCT02621931|26192627|P2|Overall Study|Noncompliance to study procedures|1
7537086|NCT02621931|26192628|P1|Overall Study|Noncompliance to study procedures|0
7537087|NCT02621931|26192626|P3|Overall Study|Pregnancy|0
7537088|NCT02621931|26192627|P2|Overall Study|Pregnancy|0
7537089|NCT02621931|26192628|P1|Overall Study|Pregnancy|2
7537090|NCT02621931|26192626|P3|Overall Study|Protocol Violation|2
7537091|NCT02621931|26192627|P2|Overall Study|Protocol Violation|2
7537092|NCT02621931|26192628|P1|Overall Study|Protocol Violation|2
7537093|NCT02621931|26192626|P3|Overall Study|Withdrawal by Subject|11
7537094|NCT02621931|26192627|P2|Overall Study|Withdrawal by Subject|10
7537095|NCT02621931|26192628|P1|Overall Study|Withdrawal by Subject|12
7537096|NCT02621931|26192626|P3|Overall Study|Adverse Event|7
7537097|NCT02621931|26192627|P2|Overall Study|Adverse Event|5
7537098|NCT02621931|26192628|P1|Overall Study|Adverse Event|8
7537099|NCT02621931|26192626|P3|Overall Study|Death|0
7537100|NCT02621931|26192627|P2|Overall Study|Death|1
7537101|NCT02621931|26192628|P1|Overall Study|Death|0
7537102|NCT02621606|26192710|P3|Overall Study|Withdrawal by Subject|0
7537103|NCT02621606|26192711|P2|Overall Study|Withdrawal by Subject|1
7537104|NCT02621606|26192712|P1|Overall Study|Withdrawal by Subject|0
7537105|NCT02621424|26192744|P2|Overall Study|Withdrawal by Subject|2
7537106|NCT02621424|26192745|P1|Overall Study|Withdrawal by Subject|1
7537107|NCT02621073|26192765|P2|Overall Study|Physician Decision|2
7537108|NCT02621073|26192766|P1|Overall Study|Physician Decision|3
7537109|NCT02621073|26192765|P2|Overall Study|Lost to Follow-up|1
7537110|NCT02621073|26192766|P1|Overall Study|Lost to Follow-up|0
7537111|NCT02621047|26192828|P3|Overall Study|Adverse Event|1
7537112|NCT02621047|26192829|P2|Overall Study|Adverse Event|0
7537113|NCT02621047|26192830|P1|Overall Study|Adverse Event|0
7537114|NCT02621034|26192946|P3|Overall Study|Lost to Follow-up|5
7537115|NCT02621034|26192947|P2|Overall Study|Lost to Follow-up|2
7537116|NCT02621034|26192948|P1|Overall Study|Lost to Follow-up|3
7537117|NCT02620787|26192991|P2|Overall Study|Eligibility Criteria Not Met|0
7537118|NCT02620787|26192992|P1|Overall Study|Eligibility Criteria Not Met|1
7537119|NCT02620787|26192991|P2|Overall Study|Adverse Event|0
7537120|NCT02620787|26192992|P1|Overall Study|Adverse Event|1
7537121|NCT02620384|26193034|P2|Overall Study|Drug shortage prevented 2nd dose|1
7537122|NCT02620384|26193035|P1|Overall Study|Drug shortage prevented 2nd dose|0
7537123|NCT02620384|26193034|P2|Overall Study|Discharged prior to 2nd dose|5
7537124|NCT02620384|26193035|P1|Overall Study|Discharged prior to 2nd dose|2
7537125|NCT02620384|26193034|P2|Overall Study|Adverse Event|1
7537126|NCT02620384|26193035|P1|Overall Study|Adverse Event|2
7537127|NCT02620020|26193067|P4|Overall Study|Death|0
7537128|NCT02620020|26193068|P3|Overall Study|Death|0
7537129|NCT02620020|26193069|P2|Overall Study|Death|1
7537130|NCT02620020|26193070|P1|Overall Study|Death|0
7537131|NCT02620020|26193067|P4|Overall Study|Withdrawal by Subject|12
7537132|NCT02620020|26193068|P3|Overall Study|Withdrawal by Subject|17
7537133|NCT02620020|26193069|P2|Overall Study|Withdrawal by Subject|16
7537134|NCT02620020|26193070|P1|Overall Study|Withdrawal by Subject|20
7537135|NCT02620020|26193067|P4|Overall Study|Protocol Violation|1
7537136|NCT02620020|26193068|P3|Overall Study|Protocol Violation|1
7537137|NCT02620020|26193069|P2|Overall Study|Protocol Violation|2
7537138|NCT02620020|26193070|P1|Overall Study|Protocol Violation|5
7537139|NCT02620020|26193067|P4|Overall Study|Physician Decision|4
7537140|NCT02620020|26193068|P3|Overall Study|Physician Decision|3
7537141|NCT02620020|26193069|P2|Overall Study|Physician Decision|4
7537142|NCT02620020|26193070|P1|Overall Study|Physician Decision|7
7537143|NCT02620020|26193067|P4|Overall Study|Lost to Follow-up|4
7537144|NCT02620020|26193068|P3|Overall Study|Lost to Follow-up|1
7537145|NCT02620020|26193069|P2|Overall Study|Lost to Follow-up|8
7537146|NCT02620020|26193070|P1|Overall Study|Lost to Follow-up|4
7537147|NCT02620020|26193067|P4|Overall Study|Adverse Event|5
7537148|NCT02620020|26193068|P3|Overall Study|Adverse Event|3
7537149|NCT02620020|26193069|P2|Overall Study|Adverse Event|4
7537150|NCT02620020|26193070|P1|Overall Study|Adverse Event|8
7537151|NCT02619812|26193096|P4|Overall Study|Withdrawal by Subject|2
7537152|NCT02619812|26193097|P3|Overall Study|Withdrawal by Subject|1
7537153|NCT02619812|26193098|P2|Overall Study|Withdrawal by Subject|0
7537154|NCT02619812|26193099|P1|Overall Study|Withdrawal by Subject|0
7537155|NCT02619617|26193132|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
7537156|NCT02619617|26193133|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
7537157|NCT02619617|26193132|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
7537158|NCT02619617|26193133|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
7537159|NCT02619175|26193229|P2|Overall Study|foot pain|0
7537160|NCT02619175|26193230|P1|Overall Study|foot pain|1
7537161|NCT02619175|26193229|P2|Overall Study|Withdrawal by Subject|0
7537162|NCT02619175|26193230|P1|Overall Study|Withdrawal by Subject|1
7537163|NCT02618967|26193252|P8|Overall Study|Withdrawal by Subject|0
7537164|NCT02618967|26193253|P7|Overall Study|Withdrawal by Subject|0
7537165|NCT02618967|26193254|P6|Overall Study|Withdrawal by Subject|0
7537166|NCT02618967|26193255|P5|Overall Study|Withdrawal by Subject|0
7537167|NCT02618967|26193256|P4|Overall Study|Withdrawal by Subject|0
7537168|NCT02618967|26193257|P3|Overall Study|Withdrawal by Subject|0
7537169|NCT02618967|26193258|P2|Overall Study|Withdrawal by Subject|0
7537170|NCT02618967|26193259|P1|Overall Study|Withdrawal by Subject|1
7537171|NCT02618967|26193252|P8|Overall Study|Lost to Follow-up|0
7537172|NCT02618967|26193253|P7|Overall Study|Lost to Follow-up|0
7537173|NCT02618967|26193254|P6|Overall Study|Lost to Follow-up|0
7537174|NCT02618967|26193255|P5|Overall Study|Lost to Follow-up|2
7537175|NCT02618967|26193256|P4|Overall Study|Lost to Follow-up|0
7537176|NCT02618967|26193257|P3|Overall Study|Lost to Follow-up|1
7537177|NCT02618967|26193258|P2|Overall Study|Lost to Follow-up|0
7537178|NCT02618967|26193259|P1|Overall Study|Lost to Follow-up|0
7537179|NCT02618928|26193368|P1|Overall Study|Treatment Never Started|7
7537180|NCT02618928|26193368|P1|Overall Study|Missing|6
7537181|NCT02618928|26193368|P1|Overall Study|Other|11
7537182|NCT02618928|26193368|P1|Overall Study|Death|3
7537183|NCT02618928|26193368|P1|Overall Study|Withdrawal by Subject|2
7537184|NCT02618928|26193368|P1|Overall Study|Insufficient Virological Response|1
7537185|NCT02618928|26193368|P1|Overall Study|Failure to Return|28
7537186|NCT02618759|26193463|P2|Overall Study|Other Reasons|4
7537187|NCT02618759|26193464|P1|Overall Study|Other Reasons|1
7537188|NCT02618759|26193463|P2|Overall Study|Withdrawal by Subject|0
7537189|NCT02618759|26193464|P1|Overall Study|Withdrawal by Subject|1
7537190|NCT02618759|26193463|P2|Overall Study|Lost to Follow-up|1
7537191|NCT02618759|26193464|P1|Overall Study|Lost to Follow-up|0
7537192|NCT02618616|26193515|P2|Overall Study|Lost to Follow-up|1
7537193|NCT02618616|26193516|P1|Overall Study|Lost to Follow-up|0
7537194|NCT02618616|26193515|P2|Overall Study|Consent withdrawn by subject|5
7537195|NCT02618616|26193516|P1|Overall Study|Consent withdrawn by subject|8
7537196|NCT02618616|26193515|P2|Overall Study|Failure to comply with dosing/evaluation|0
7537197|NCT02618616|26193516|P1|Overall Study|Failure to comply with dosing/evaluation|1
7537198|NCT02618616|26193515|P2|Overall Study|Adverse Event|0
7537199|NCT02618616|26193516|P1|Overall Study|Adverse Event|8
7537200|NCT02618616|26193515|P2|Overall Study|Pregnancy|1
7537201|NCT02618616|26193516|P1|Overall Study|Pregnancy|0
7537202|NCT02618616|26193515|P2|Overall Study|Lack of Efficacy|0
7537203|NCT02618616|26193516|P1|Overall Study|Lack of Efficacy|4
7537204|NCT02617628|26193690|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
7537205|NCT02617628|26193691|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
7537206|NCT02617589|26193701|P2|Treatment Period|Completed Treatment|76
7537207|NCT02617589|26193702|P1|Treatment Period|Completed Treatment|0
7537208|NCT02617589|26193701|P2|Treatment Period|Disease Progression|137
7537209|NCT02617589|26193702|P1|Treatment Period|Disease Progression|214
7537210|NCT02617589|26193701|P2|Treatment Period|Study Drug Toxicity|20
7537211|NCT02617589|26193702|P1|Treatment Period|Study Drug Toxicity|26
7537212|NCT02617589|26193701|P2|Treatment Period|Death|1
7537213|NCT02617589|26193702|P1|Treatment Period|Death|1
7537214|NCT02617589|26193701|P2|Treatment Period|Adverse event unrelated to study drug|9
7537215|NCT02617589|26193702|P1|Treatment Period|Adverse event unrelated to study drug|15
7537216|NCT02617589|26193701|P2|Treatment Period|Participant Request to discontinue|20
7537217|NCT02617589|26193702|P1|Treatment Period|Participant Request to discontinue|12
7537218|NCT02617589|26193701|P2|Treatment Period|Participant Withdrew Consent|6
7537219|NCT02617589|26193702|P1|Treatment Period|Participant Withdrew Consent|2
7537220|NCT02617589|26193701|P2|Treatment Period|Maximum Clinical Benefit|2
7537221|NCT02617589|26193702|P1|Treatment Period|Maximum Clinical Benefit|0
7537222|NCT02617589|26193701|P2|Treatment Period|Poor/Non compliance|1
7537223|NCT02617589|26193702|P1|Treatment Period|Poor/Non compliance|1
7537224|NCT02617589|26193701|P2|Treatment Period|Not reported|0
7537225|NCT02617589|26193702|P1|Treatment Period|Not reported|1
7537226|NCT02617589|26193701|P2|Treatment Period|Other Reasons|2
7537227|NCT02617589|26193702|P1|Treatment Period|Other Reasons|2
7537228|NCT02617589|26193701|P2|All Randomized|Participant Withdrew Consent|2
7537229|NCT02617589|26193702|P1|All Randomized|Participant Withdrew Consent|1
7537230|NCT02617589|26193701|P2|All Randomized|Request to discontinue study treatment|3
7537231|NCT02617589|26193702|P1|All Randomized|Request to discontinue study treatment|1
7537232|NCT02616900|26193716|P1|Overall Study|Incomplete data|6
7537233|NCT02616900|26193716|P1|Overall Study|Withdrawal by Subject|3
7537234|NCT02616900|26193716|P1|Overall Study|Protocol Violation|5
7537235|NCT02616900|26193716|P1|Overall Study|Lost to Follow-up|2
7537236|NCT02616900|26193716|P1|Overall Study|Lack of Efficacy|7
7537237|NCT02616783|26193724|P2|Overall Study|Withdrew Consent|1
7537238|NCT02616783|26193725|P1|Overall Study|Withdrew Consent|1
7537239|NCT02616783|26193724|P2|Overall Study|Protocol Violation|1
7537240|NCT02616783|26193725|P1|Overall Study|Protocol Violation|1
7537241|NCT02616783|26193724|P2|Overall Study|Non-Compliance with Study Drug|0
7537242|NCT02616783|26193725|P1|Overall Study|Non-Compliance with Study Drug|1
7537243|NCT02616783|26193724|P2|Overall Study|Death|0
7537244|NCT02616783|26193725|P1|Overall Study|Death|1
7537245|NCT02616783|26193724|P2|Overall Study|Adverse Event|0
7537246|NCT02616783|26193725|P1|Overall Study|Adverse Event|1
7537247|NCT02616783|26193724|P2|Overall Study|Randomized but Not Treated|0
7537248|NCT02616783|26193725|P1|Overall Study|Randomized but Not Treated|1
7537249|NCT02616614|26193748|P3|Overall Study|Other|1
7537250|NCT02616614|26193749|P2|Overall Study|Other|2
7537251|NCT02616614|26193750|P1|Overall Study|Other|1
7537252|NCT02616614|26193748|P3|Overall Study|Pregnancy|1
7537253|NCT02616614|26193749|P2|Overall Study|Pregnancy|0
7537254|NCT02616614|26193750|P1|Overall Study|Pregnancy|2
7537255|NCT02616614|26193748|P3|Overall Study|Lost to Follow-up|13
7537256|NCT02616614|26193749|P2|Overall Study|Lost to Follow-up|28
7537257|NCT02616614|26193750|P1|Overall Study|Lost to Follow-up|31
7537258|NCT02616614|26193748|P3|Overall Study|More than 3 applications missed|1
7537259|NCT02616614|26193749|P2|Overall Study|More than 3 applications missed|8
7537260|NCT02616614|26193750|P1|Overall Study|More than 3 applications missed|6
7537261|NCT02616614|26193748|P3|Overall Study|Prohibited Medication|5
7537262|NCT02616614|26193749|P2|Overall Study|Prohibited Medication|9
7537263|NCT02616614|26193750|P1|Overall Study|Prohibited Medication|12
7537264|NCT02616614|26193748|P3|Overall Study|Protocol Violation|1
7537265|NCT02616614|26193749|P2|Overall Study|Protocol Violation|3
7537266|NCT02616614|26193750|P1|Overall Study|Protocol Violation|0
7537267|NCT02616614|26193748|P3|Overall Study|Adverse Event|1
7537268|NCT02616614|26193749|P2|Overall Study|Adverse Event|4
7537269|NCT02616614|26193750|P1|Overall Study|Adverse Event|1
7537270|NCT02616614|26193748|P3|Overall Study|Physician Decision|0
7537271|NCT02616614|26193749|P2|Overall Study|Physician Decision|1
7537272|NCT02616614|26193750|P1|Overall Study|Physician Decision|2
7537273|NCT02616614|26193748|P3|Overall Study|Withdrawal by Subject|6
7537274|NCT02616614|26193749|P2|Overall Study|Withdrawal by Subject|5
7537275|NCT02616614|26193750|P1|Overall Study|Withdrawal by Subject|10
7537276|NCT02616601|26193767|P3|Overall Study|Non-Compliance with Test Article|1
7537277|NCT02616601|26193768|P2|Overall Study|Non-Compliance with Test Article|0
7537278|NCT02616601|26193769|P1|Overall Study|Non-Compliance with Test Article|1
7537279|NCT02616601|26193767|P3|Overall Study|Lost to Follow-up|1
7537280|NCT02616601|26193768|P2|Overall Study|Lost to Follow-up|0
7537281|NCT02616601|26193769|P1|Overall Study|Lost to Follow-up|1
7537282|NCT02616601|26193767|P3|Overall Study|Death|0
7537283|NCT02616601|26193768|P2|Overall Study|Death|0
7537284|NCT02616601|26193769|P1|Overall Study|Death|1
7537285|NCT02616601|26193767|P3|Overall Study|Adverse Event|2
7537286|NCT02616601|26193768|P2|Overall Study|Adverse Event|0
7537287|NCT02616601|26193769|P1|Overall Study|Adverse Event|2
7537288|NCT02616601|26193767|P3|Overall Study|Withdrawal by Subject|3
7537289|NCT02616601|26193768|P2|Overall Study|Withdrawal by Subject|4
7537290|NCT02616601|26193769|P1|Overall Study|Withdrawal by Subject|4
7537291|NCT02616380|26193796|P1|Overall Study|Other|2
7537292|NCT02616380|26193796|P1|Overall Study|Lost to Follow-up|1
7537293|NCT02616146|26193820|P2|Overall Study|Physician Decision|1
7537294|NCT02616146|26193821|P1|Overall Study|Physician Decision|2
7537295|NCT02616146|26193820|P2|Overall Study|Withdrawal by Subject|24
7537296|NCT02616146|26193821|P1|Overall Study|Withdrawal by Subject|30
7537297|NCT02616146|26193820|P2|Overall Study|Participant moved|3
7537298|NCT02616146|26193821|P1|Overall Study|Participant moved|4
7537299|NCT02616146|26193820|P2|Overall Study|Study terminated by sponsor|432
7537300|NCT02616146|26193821|P1|Overall Study|Study terminated by sponsor|1372
7537301|NCT02616146|26193820|P2|Overall Study|Protocol Violation|3
7537302|NCT02616146|26193821|P1|Overall Study|Protocol Violation|6
7537303|NCT02616146|26193820|P2|Overall Study|Pregnancy wish|0
7537304|NCT02616146|26193821|P1|Overall Study|Pregnancy wish|3
7537305|NCT02616146|26193820|P2|Overall Study|Pregnancy|2
7537306|NCT02616146|26193821|P1|Overall Study|Pregnancy|2
7537307|NCT02616146|26193820|P2|Overall Study|Non-compliance with study drug|2
7537308|NCT02616146|26193821|P1|Overall Study|Non-compliance with study drug|4
7537309|NCT02616146|26193820|P2|Overall Study|Non-compliance with study protocol|0
7537310|NCT02616146|26193821|P1|Overall Study|Non-compliance with study protocol|2
7537311|NCT02616146|26193820|P2|Overall Study|Lost to Follow-up|13
7537312|NCT02616146|26193821|P1|Overall Study|Lost to Follow-up|23
7537313|NCT02616146|26193820|P2|Overall Study|Adverse Event|24
7537314|NCT02616146|26193821|P1|Overall Study|Adverse Event|64
7537315|NCT02616029|26193837|P2|Overall Study|Enrolled and Never Treated|1
7537316|NCT02616029|26193838|P1|Overall Study|Enrolled and Never Treated|1
7537317|NCT02616029|26193837|P2|Overall Study|Withdrew Consent|0
7537318|NCT02616029|26193838|P1|Overall Study|Withdrew Consent|1
7537319|NCT02616029|26193837|P2|Overall Study|Protocol Violation|0
7537320|NCT02616029|26193838|P1|Overall Study|Protocol Violation|1
7537321|NCT02616029|26193837|P2|Overall Study|Death|1
7537322|NCT02616029|26193838|P1|Overall Study|Death|0
7537323|NCT02616029|26193837|P2|Overall Study|Adverse Event|0
7537324|NCT02616029|26193838|P1|Overall Study|Adverse Event|1
7537325|NCT02615990|26193909|P2|Overall Study|study terminated|1
7537326|NCT02615990|26193910|P1|Overall Study|study terminated|1
7537327|NCT02615509|26194007|P1|Overall Study|Withdrawal by Subject|8
7537328|NCT02615509|26194007|P1|Overall Study|Death|4
7537329|NCT02615509|26194007|P1|Overall Study|Lost to Follow-up|134
7537330|NCT02615470|26194017|P2|Overall Study|Lost to Follow-up|32
7537331|NCT02615470|26194018|P1|Overall Study|Lost to Follow-up|21
7537332|NCT02615249|26194028|P1|Overall Study|Withdrawal by Subject|1
7537333|NCT02615171|26194037|P2|Overall Study|Lost to Follow-up|1
7537334|NCT02615171|26194038|P1|Overall Study|Lost to Follow-up|2
7537335|NCT02615145|26194090|P4|Overall Study|Other, Not Specified|0
7537336|NCT02615145|26194091|P3|Overall Study|Other, Not Specified|0
7537337|NCT02615145|26194092|P2|Overall Study|Other, Not Specified|2
7537338|NCT02615145|26194093|P1|Overall Study|Other, Not Specified|5
7537339|NCT02615145|26194090|P4|Overall Study|Death|0
7537340|NCT02615145|26194091|P3|Overall Study|Death|0
7537341|NCT02615145|26194092|P2|Overall Study|Death|3
7537342|NCT02615145|26194093|P1|Overall Study|Death|2
7537343|NCT02615145|26194090|P4|Overall Study|Failure to Return|0
7537344|NCT02615145|26194091|P3|Overall Study|Failure to Return|7
7537345|NCT02615145|26194092|P2|Overall Study|Failure to Return|10
7537346|NCT02615145|26194093|P1|Overall Study|Failure to Return|20
7537347|NCT02615145|26194090|P4|Overall Study|Did Not Start Treatment|1
7537348|NCT02615145|26194091|P3|Overall Study|Did Not Start Treatment|1
7537349|NCT02615145|26194092|P2|Overall Study|Did Not Start Treatment|0
7537350|NCT02615145|26194093|P1|Overall Study|Did Not Start Treatment|0
7537351|NCT02614898|26194180|P2|Overall Study|Missing|1
7537352|NCT02614898|26194181|P1|Overall Study|Missing|0
7537353|NCT02614898|26194180|P2|Overall Study|Other-Additional Information Unavailable|11
7537354|NCT02614898|26194181|P1|Overall Study|Other-Additional Information Unavailable|0
7537355|NCT02614898|26194180|P2|Overall Study|Withdrawal by Parent/Guardian|1
7537356|NCT02614898|26194181|P1|Overall Study|Withdrawal by Parent/Guardian|1
7537357|NCT02614898|26194180|P2|Overall Study|Withdrawal by Subject|2
7537358|NCT02614898|26194181|P1|Overall Study|Withdrawal by Subject|0
7537359|NCT02614898|26194180|P2|Overall Study|Study Terminated by Sponsor|0
7537360|NCT02614898|26194181|P1|Overall Study|Study Terminated by Sponsor|3
7537361|NCT02614898|26194180|P2|Overall Study|Physician Decision|8
7537362|NCT02614898|26194181|P1|Overall Study|Physician Decision|1
7537363|NCT02614898|26194180|P2|Overall Study|Lost to Follow-up|2
7537364|NCT02614898|26194181|P1|Overall Study|Lost to Follow-up|0
7537365|NCT02614898|26194180|P2|Overall Study|Participated until study termination|26
7537366|NCT02614898|26194181|P1|Overall Study|Participated until study termination|10
7537367|NCT02614794|26194193|P2|Overall Study|Physician Decision|1
7537368|NCT02614794|26194194|P1|Overall Study|Physician Decision|0
7537369|NCT02614794|26194193|P2|Overall Study|Lost to Follow-up|0
7537370|NCT02614794|26194194|P1|Overall Study|Lost to Follow-up|2
7537371|NCT02614794|26194193|P2|Overall Study|Withdrawal by Subject|5
7537372|NCT02614794|26194194|P1|Overall Study|Withdrawal by Subject|16
7537373|NCT02614794|26194193|P2|Overall Study|Death|84
7537374|NCT02614794|26194194|P1|Overall Study|Death|126
7537375|NCT02614794|26194193|P2|Overall Study|In long term follow up|85
7537376|NCT02614794|26194194|P1|Overall Study|In long term follow up|148
7537377|NCT02614794|26194193|P2|Overall Study|On treatment|27
7537378|NCT02614794|26194194|P1|Overall Study|On treatment|118
7537379|NCT02614729|26194228|P2|Overall Study|Withdrawal by Subject|0
7537380|NCT02614729|26194229|P1|Overall Study|Withdrawal by Subject|1
7537381|NCT02614703|26194249|P2|Overall Study|Withdrawal by Subject|1
7537382|NCT02614703|26194250|P1|Overall Study|Withdrawal by Subject|7
7537383|NCT02614560|26194294|P2|Overall Study|Death|2
7537384|NCT02614560|26194295|P1|Overall Study|Death|6
7537385|NCT02614287|26194368|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
7537386|NCT02614287|26194369|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
7537387|NCT02614287|26194368|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
7537388|NCT02614287|26194369|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
7537389|NCT02614287|26194368|P2|Post Treatment Follow-up Phase|Adverse Event|0
7537390|NCT02614287|26194369|P1|Post Treatment Follow-up Phase|Adverse Event|1
7537391|NCT02614287|26194368|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
7537392|NCT02614287|26194369|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
7537393|NCT02614287|26194368|P2|Open Label (OL) Treatment Phase|Physician Decision|0
7537394|NCT02614287|26194369|P1|Open Label (OL) Treatment Phase|Physician Decision|1
7537395|NCT02614287|26194368|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
7537396|NCT02614287|26194369|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
7537397|NCT02614287|26194368|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
7537398|NCT02614287|26194369|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
7537399|NCT02614287|26194368|P2|Open Label (OL) Treatment Phase|Adverse Event|6
7537400|NCT02614287|26194369|P1|Open Label (OL) Treatment Phase|Adverse Event|7
7537401|NCT02614261|26194415|P3|Overall Study|Withdrawal by Subject|7
7537402|NCT02614261|26194416|P2|Overall Study|Withdrawal by Subject|4
7537403|NCT02614261|26194417|P1|Overall Study|Withdrawal by Subject|19
7537404|NCT02614261|26194415|P3|Overall Study|Protocol Violation|0
7537405|NCT02614261|26194416|P2|Overall Study|Protocol Violation|1
7537406|NCT02614261|26194417|P1|Overall Study|Protocol Violation|6
7537407|NCT02614261|26194415|P3|Overall Study|Pregnancy|0
7537408|NCT02614261|26194416|P2|Overall Study|Pregnancy|2
7537409|NCT02614261|26194417|P1|Overall Study|Pregnancy|2
7537410|NCT02614261|26194415|P3|Overall Study|Physician Decision|1
7537411|NCT02614261|26194416|P2|Overall Study|Physician Decision|1
7537412|NCT02614261|26194417|P1|Overall Study|Physician Decision|2
7537413|NCT02614261|26194415|P3|Overall Study|Lost to Follow-up|1
7537414|NCT02614261|26194416|P2|Overall Study|Lost to Follow-up|4
7537415|NCT02614261|26194417|P1|Overall Study|Lost to Follow-up|10
7537416|NCT02614261|26194415|P3|Overall Study|Lack of Efficacy|0
7537417|NCT02614261|26194416|P2|Overall Study|Lack of Efficacy|0
7537418|NCT02614261|26194417|P1|Overall Study|Lack of Efficacy|4
7537419|NCT02614261|26194415|P3|Overall Study|Adverse Event|2
7537420|NCT02614261|26194416|P2|Overall Study|Adverse Event|3
7537421|NCT02614261|26194417|P1|Overall Study|Adverse Event|6
7537422|NCT02614196|26194483|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7537423|NCT02614196|26194484|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7537424|NCT02614196|26194485|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7537425|NCT02614196|26194486|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7537426|NCT02614196|26194487|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7537427|NCT02614196|26194488|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
7537428|NCT02614196|26194483|P6|Post Treatment Follow-up Phase|Protocol Violation|0
7537429|NCT02614196|26194484|P5|Post Treatment Follow-up Phase|Protocol Violation|1
7537430|NCT02614196|26194485|P4|Post Treatment Follow-up Phase|Protocol Violation|0
7537431|NCT02614196|26194486|P3|Post Treatment Follow-up Phase|Protocol Violation|0
7537432|NCT02614196|26194487|P2|Post Treatment Follow-up Phase|Protocol Violation|1
7537433|NCT02614196|26194488|P1|Post Treatment Follow-up Phase|Protocol Violation|0
7537434|NCT02614196|26194483|P6|Post Treatment Follow-up Phase|Pregnancy|0
7537435|NCT02614196|26194484|P5|Post Treatment Follow-up Phase|Pregnancy|0
7537436|NCT02614196|26194485|P4|Post Treatment Follow-up Phase|Pregnancy|0
7537437|NCT02614196|26194486|P3|Post Treatment Follow-up Phase|Pregnancy|0
7537438|NCT02614196|26194487|P2|Post Treatment Follow-up Phase|Pregnancy|0
7537439|NCT02614196|26194488|P1|Post Treatment Follow-up Phase|Pregnancy|2
7537440|NCT02614196|26194483|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
7537441|NCT02614196|26194484|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
7537442|NCT02614196|26194485|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
7537443|NCT02614196|26194486|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
7537444|NCT02614196|26194487|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
7537445|NCT02614196|26194488|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
7537446|NCT02614196|26194483|P6|Double Blind Treatment Phase|Did not receive study drug|0
7537447|NCT02614196|26194484|P5|Double Blind Treatment Phase|Did not receive study drug|0
7537448|NCT02614196|26194485|P4|Double Blind Treatment Phase|Did not receive study drug|0
7537449|NCT02614196|26194486|P3|Double Blind Treatment Phase|Did not receive study drug|3
7537450|NCT02614196|26194487|P2|Double Blind Treatment Phase|Did not receive study drug|2
7537451|NCT02614196|26194488|P1|Double Blind Treatment Phase|Did not receive study drug|2
7537452|NCT02614196|26194483|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
7537453|NCT02614196|26194484|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
7537454|NCT02614196|26194485|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
7537455|NCT02614196|26194486|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
7537456|NCT02614196|26194487|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
7537457|NCT02614196|26194488|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
7537458|NCT02614196|26194483|P6|Double Blind Treatment Phase|Terminated by sponsor|0
7537459|NCT02614196|26194484|P5|Double Blind Treatment Phase|Terminated by sponsor|0
7537460|NCT02614196|26194485|P4|Double Blind Treatment Phase|Terminated by sponsor|0
7537461|NCT02614196|26194486|P3|Double Blind Treatment Phase|Terminated by sponsor|0
7537462|NCT02614196|26194487|P2|Double Blind Treatment Phase|Terminated by sponsor|0
7537463|NCT02614196|26194488|P1|Double Blind Treatment Phase|Terminated by sponsor|1
7537464|NCT02614196|26194483|P6|Double Blind Treatment Phase|Protocol Violation|0
7537465|NCT02614196|26194484|P5|Double Blind Treatment Phase|Protocol Violation|1
7537466|NCT02614196|26194485|P4|Double Blind Treatment Phase|Protocol Violation|0
7537467|NCT02614196|26194486|P3|Double Blind Treatment Phase|Protocol Violation|1
7537468|NCT02614196|26194487|P2|Double Blind Treatment Phase|Protocol Violation|2
7537469|NCT02614196|26194488|P1|Double Blind Treatment Phase|Protocol Violation|5
7537470|NCT02614196|26194483|P6|Double Blind Treatment Phase|Pregnancy|0
7537471|NCT02614196|26194484|P5|Double Blind Treatment Phase|Pregnancy|0
7537472|NCT02614196|26194485|P4|Double Blind Treatment Phase|Pregnancy|0
7537473|NCT02614196|26194486|P3|Double Blind Treatment Phase|Pregnancy|0
7537474|NCT02614196|26194487|P2|Double Blind Treatment Phase|Pregnancy|2
7537475|NCT02614196|26194488|P1|Double Blind Treatment Phase|Pregnancy|1
7537476|NCT02614196|26194483|P6|Double Blind Treatment Phase|Physician Decision|0
7537477|NCT02614196|26194484|P5|Double Blind Treatment Phase|Physician Decision|0
7537478|NCT02614196|26194485|P4|Double Blind Treatment Phase|Physician Decision|0
7537479|NCT02614196|26194486|P3|Double Blind Treatment Phase|Physician Decision|2
7537480|NCT02614196|26194487|P2|Double Blind Treatment Phase|Physician Decision|0
7537481|NCT02614196|26194488|P1|Double Blind Treatment Phase|Physician Decision|4
7537482|NCT02614196|26194483|P6|Double Blind Treatment Phase|Lost to Follow-up|0
7537483|NCT02614196|26194484|P5|Double Blind Treatment Phase|Lost to Follow-up|0
7537484|NCT02614196|26194485|P4|Double Blind Treatment Phase|Lost to Follow-up|0
7537485|NCT02614196|26194486|P3|Double Blind Treatment Phase|Lost to Follow-up|1
7537486|NCT02614196|26194487|P2|Double Blind Treatment Phase|Lost to Follow-up|7
7537487|NCT02614196|26194488|P1|Double Blind Treatment Phase|Lost to Follow-up|10
7537488|NCT02614196|26194483|P6|Double Blind Treatment Phase|Lack of Efficacy|0
7537489|NCT02614196|26194484|P5|Double Blind Treatment Phase|Lack of Efficacy|0
7537490|NCT02614196|26194485|P4|Double Blind Treatment Phase|Lack of Efficacy|0
7537491|NCT02614196|26194486|P3|Double Blind Treatment Phase|Lack of Efficacy|1
7537492|NCT02614196|26194487|P2|Double Blind Treatment Phase|Lack of Efficacy|1
7537493|NCT02614196|26194488|P1|Double Blind Treatment Phase|Lack of Efficacy|6
7537494|NCT02614196|26194483|P6|Double Blind Treatment Phase|Adverse Event|0
7537495|NCT02614196|26194484|P5|Double Blind Treatment Phase|Adverse Event|0
7537496|NCT02614196|26194485|P4|Double Blind Treatment Phase|Adverse Event|0
7537497|NCT02614196|26194486|P3|Double Blind Treatment Phase|Adverse Event|9
7537498|NCT02614196|26194487|P2|Double Blind Treatment Phase|Adverse Event|5
7537499|NCT02614196|26194488|P1|Double Blind Treatment Phase|Adverse Event|8
7537500|NCT02614183|26194534|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7537501|NCT02614183|26194535|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
7537502|NCT02614183|26194536|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
7537503|NCT02614183|26194534|P3|Post Treatment Follow-up Phase|Protocol Violation|0
7537504|NCT02614183|26194535|P2|Post Treatment Follow-up Phase|Protocol Violation|0
7537505|NCT02614183|26194536|P1|Post Treatment Follow-up Phase|Protocol Violation|1
7537506|NCT02614183|26194534|P3|Post Treatment Follow-up Phase|Physician Decision|2
7537507|NCT02614183|26194535|P2|Post Treatment Follow-up Phase|Physician Decision|1
7537508|NCT02614183|26194536|P1|Post Treatment Follow-up Phase|Physician Decision|5
7537509|NCT02614183|26194534|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
7537510|NCT02614183|26194535|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
7537511|NCT02614183|26194536|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
7537512|NCT02614183|26194534|P3|Double Blind Treatment Phase|Did not receive study drug|2
7537513|NCT02614183|26194535|P2|Double Blind Treatment Phase|Did not receive study drug|1
7537514|NCT02614183|26194536|P1|Double Blind Treatment Phase|Did not receive study drug|1
7537515|NCT02614183|26194534|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
7537516|NCT02614183|26194535|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
7537517|NCT02614183|26194536|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
7537518|NCT02614183|26194534|P3|Double Blind Treatment Phase|Protocol Violation|2
7537519|NCT02614183|26194535|P2|Double Blind Treatment Phase|Protocol Violation|2
7537520|NCT02614183|26194536|P1|Double Blind Treatment Phase|Protocol Violation|2
7537521|NCT02614183|26194534|P3|Double Blind Treatment Phase|Pregnancy|3
7537522|NCT02614183|26194535|P2|Double Blind Treatment Phase|Pregnancy|1
7537523|NCT02614183|26194536|P1|Double Blind Treatment Phase|Pregnancy|2
7537524|NCT02614183|26194534|P3|Double Blind Treatment Phase|Physician Decision|2
7537525|NCT02614183|26194535|P2|Double Blind Treatment Phase|Physician Decision|3
7537526|NCT02614183|26194536|P1|Double Blind Treatment Phase|Physician Decision|7
7537527|NCT02614183|26194534|P3|Double Blind Treatment Phase|Lost to Follow-up|5
7537528|NCT02614183|26194535|P2|Double Blind Treatment Phase|Lost to Follow-up|9
7537529|NCT02614183|26194536|P1|Double Blind Treatment Phase|Lost to Follow-up|18
7537530|NCT02614183|26194534|P3|Double Blind Treatment Phase|Lack of Efficacy|2
7537531|NCT02614183|26194535|P2|Double Blind Treatment Phase|Lack of Efficacy|1
7537532|NCT02614183|26194536|P1|Double Blind Treatment Phase|Lack of Efficacy|10
7537533|NCT02614183|26194534|P3|Double Blind Treatment Phase|Adverse Event|7
7537534|NCT02614183|26194535|P2|Double Blind Treatment Phase|Adverse Event|9
7537535|NCT02614183|26194536|P1|Double Blind Treatment Phase|Adverse Event|10
7537536|NCT02614131|26194580|P7|Overall Study|Adverse Event|1
7537537|NCT02614131|26194581|P6|Overall Study|Adverse Event|0
7537538|NCT02614131|26194582|P5|Overall Study|Adverse Event|0
7537539|NCT02614131|26194583|P4|Overall Study|Adverse Event|0
7537540|NCT02614131|26194584|P3|Overall Study|Adverse Event|0
7537541|NCT02614131|26194585|P2|Overall Study|Adverse Event|0
7537542|NCT02614131|26194586|P1|Overall Study|Adverse Event|0
7537543|NCT02614131|26194580|P7|Overall Study|Withdrawal by Subject|0
7537544|NCT02614131|26194581|P6|Overall Study|Withdrawal by Subject|0
7537545|NCT02614131|26194582|P5|Overall Study|Withdrawal by Subject|0
7537546|NCT02614131|26194583|P4|Overall Study|Withdrawal by Subject|0
7537547|NCT02614131|26194584|P3|Overall Study|Withdrawal by Subject|0
7537548|NCT02614131|26194585|P2|Overall Study|Withdrawal by Subject|0
7537549|NCT02614131|26194586|P1|Overall Study|Withdrawal by Subject|1
7537550|NCT02614079|26194617|P1|Overall Study|Withdrawal by Subject|1
7537551|NCT02613910|26194621|P1|Overall Study|Termination of study|1
7537552|NCT02613884|26194707|P1|Overall Study|Lost to Follow-up|1
7537553|NCT02613884|26194707|P1|Overall Study|Death|1
7537554|NCT02613871|26194713|P1|Overall Study|Withdrew Consent|1
7537555|NCT02613871|26194713|P1|Overall Study|Death|2
7537556|NCT02613572|26194735|P3|Phase II: Double-Blind Rand Plac Control|Death|0
7537557|NCT02613572|26194736|P2|Phase II: Double-Blind Rand Plac Control|Death|1
7537558|NCT02613572|26194737|P1|Phase II: Double-Blind Rand Plac Control|Death|0
7537559|NCT02613572|26194735|P3|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7537560|NCT02613572|26194736|P2|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7537561|NCT02613572|26194737|P1|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
7537562|NCT02613507|26194759|P2|Overall Study|Randomized but not Treated|10
7537563|NCT02613507|26194760|P1|Overall Study|Randomized but not Treated|1
7537564|NCT02613507|26194759|P2|Overall Study|Subject no Longer Meets Study Criteria|0
7537565|NCT02613507|26194760|P1|Overall Study|Subject no Longer Meets Study Criteria|1
7537566|NCT02613507|26194759|P2|Overall Study|Brain Radiotherapy Activity Limited|0
7537567|NCT02613507|26194760|P1|Overall Study|Brain Radiotherapy Activity Limited|1
7537568|NCT02613507|26194759|P2|Overall Study|Maximum Clinical Benefit|10
7537569|NCT02613507|26194760|P1|Overall Study|Maximum Clinical Benefit|4
7537570|NCT02613507|26194759|P2|Overall Study|Lost to Follow-up|0
7537571|NCT02613507|26194760|P1|Overall Study|Lost to Follow-up|1
7537572|NCT02613507|26194759|P2|Overall Study|Participant Withdrew Consent|2
7537573|NCT02613507|26194760|P1|Overall Study|Participant Withdrew Consent|0
7537574|NCT02613507|26194759|P2|Overall Study|Request to Discontinue Study Treatment|17
7537575|NCT02613507|26194760|P1|Overall Study|Request to Discontinue Study Treatment|8
7537576|NCT02613507|26194759|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
7537577|NCT02613507|26194760|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
7537578|NCT02613507|26194759|P2|Overall Study|Death|0
7537579|NCT02613507|26194760|P1|Overall Study|Death|3
7537580|NCT02613507|26194759|P2|Overall Study|Study Drug Toxicity|14
7537581|NCT02613507|26194760|P1|Overall Study|Study Drug Toxicity|15
7537582|NCT02613507|26194759|P2|Overall Study|Disease Progression|109
7537583|NCT02613507|26194760|P1|Overall Study|Disease Progression|237
7537584|NCT02613481|26194776|P1|Overall Study|Withdrawal by Subject|2
7537585|NCT02613481|26194776|P1|Overall Study|Lost to Follow-up|7
7537586|NCT02613403|26194787|P5|Overall Study|Withdrawal by Subject|0
7537587|NCT02613403|26194788|P4|Overall Study|Withdrawal by Subject|0
7537588|NCT02613403|26194789|P3|Overall Study|Withdrawal by Subject|0
7537589|NCT02613403|26194790|P2|Overall Study|Withdrawal by Subject|0
7537590|NCT02613403|26194791|P1|Overall Study|Withdrawal by Subject|2
7537591|NCT02613403|26194787|P5|Overall Study|Lost to Follow-up|0
7537592|NCT02613403|26194788|P4|Overall Study|Lost to Follow-up|0
7537593|NCT02613403|26194789|P3|Overall Study|Lost to Follow-up|0
7537594|NCT02613403|26194790|P2|Overall Study|Lost to Follow-up|1
7537595|NCT02613403|26194791|P1|Overall Study|Lost to Follow-up|0
7537596|NCT02613364|26194836|P3|Overall Study|Disliked Intervention|3
7537597|NCT02613364|26194837|P2|Overall Study|Disliked Intervention|3
7537598|NCT02613364|26194838|P1|Overall Study|Disliked Intervention|0
7537599|NCT02613364|26194836|P3|Overall Study|Disliked Study Procedure|4
7537600|NCT02613364|26194837|P2|Overall Study|Disliked Study Procedure|1
7537601|NCT02613364|26194838|P1|Overall Study|Disliked Study Procedure|1
7537602|NCT02613364|26194836|P3|Overall Study|Medical|9
7537603|NCT02613364|26194837|P2|Overall Study|Medical|13
7537604|NCT02613364|26194838|P1|Overall Study|Medical|12
7537605|NCT02613364|26194836|P3|Overall Study|Withdrawal by Subject|17
7537606|NCT02613364|26194837|P2|Overall Study|Withdrawal by Subject|18
7537607|NCT02613364|26194838|P1|Overall Study|Withdrawal by Subject|13
7537608|NCT02613364|26194836|P3|Overall Study|Too time consuming|26
7537609|NCT02613364|26194837|P2|Overall Study|Too time consuming|26
7537610|NCT02613364|26194838|P1|Overall Study|Too time consuming|21
7537611|NCT02613364|26194836|P3|Overall Study|Other|17
7537612|NCT02613364|26194837|P2|Overall Study|Other|29
7537613|NCT02613364|26194838|P1|Overall Study|Other|19
7537614|NCT02613221|26194901|P1|Overall Study|Enrolled but Not Treated|1
7537615|NCT02613221|26194901|P1|Overall Study|Delayed Treatment|1
7537616|NCT02613221|26194901|P1|Overall Study|Voluntary Discontinuation|1
7537617|NCT02613221|26194901|P1|Overall Study|Adverse Event|2
7537618|NCT02613221|26194901|P1|Overall Study|Lack of efficacy (exacerbation)|50
7537619|NCT02613208|26194913|P1|Overall Study|Death|37
7537620|NCT02613208|26194913|P1|Overall Study|Lost to Follow-up|5
7537621|NCT02613208|26194913|P1|Overall Study|Physician Decision|2
7537622|NCT02613208|26194913|P1|Overall Study|Change of address|2
7537623|NCT02613208|26194913|P1|Overall Study|Withdrawal by Subject|1
7537624|NCT02613182|26194927|P1|Overall Study|Withdrawal by Subject|6
7537625|NCT02613182|26194927|P1|Overall Study|Study Terminated by Sponsor|21
7537626|NCT02613182|26194927|P1|Overall Study|Physician Decision|1
7537627|NCT02613182|26194927|P1|Overall Study|Death|6
7537628|NCT02613169|26194933|P2|Overall Study|No TB infection endpoint|9
7537629|NCT02613169|26194934|P1|Overall Study|No TB infection endpoint|14
7537630|NCT02613169|26194933|P2|Overall Study|HIV|2
7537631|NCT02613169|26194934|P1|Overall Study|HIV|0
7537632|NCT02613169|26194933|P2|Overall Study|Lost to Follow-up|5
7537633|NCT02613169|26194934|P1|Overall Study|Lost to Follow-up|0
7537634|NCT02613169|26194933|P2|Overall Study|Withdrawal by Subject|1
7537635|NCT02613169|26194934|P1|Overall Study|Withdrawal by Subject|4
7537636|NCT02612909|26194964|P5|Phase 3|Withdrawal by Subject|0
7537637|NCT02612909|26194965|P4|Phase 3|Withdrawal by Subject|1
7537638|NCT02612909|26194966|P3|Phase 3|Withdrawal by Subject|0
7537639|NCT02612909|26194967|P2|Phase 3|Withdrawal by Subject|0
7537640|NCT02612909|26194968|P1|Phase 3|Withdrawal by Subject|0
7537641|NCT02612909|26194964|P5|Phase 2|Pregnancy|0
7537642|NCT02612909|26194965|P4|Phase 2|Pregnancy|0
7537643|NCT02612909|26194966|P3|Phase 2|Pregnancy|1
7537644|NCT02612909|26194967|P2|Phase 2|Pregnancy|0
7537645|NCT02612909|26194968|P1|Phase 2|Pregnancy|0
7537646|NCT02612909|26194964|P5|Phase 2|Withdrawal by Subject|0
7537647|NCT02612909|26194965|P4|Phase 2|Withdrawal by Subject|0
7537648|NCT02612909|26194966|P3|Phase 2|Withdrawal by Subject|0
7537649|NCT02612909|26194967|P2|Phase 2|Withdrawal by Subject|5
7537650|NCT02612909|26194968|P1|Phase 2|Withdrawal by Subject|2
7537651|NCT02612779|26195051|P2|Overall Study|Other reasons|0
7537652|NCT02612779|26195052|P1|Overall Study|Other reasons|4
7537653|NCT02612779|26195051|P2|Overall Study|Maximum clinical benefit|1
7537654|NCT02612779|26195052|P1|Overall Study|Maximum clinical benefit|10
7537655|NCT02612779|26195051|P2|Overall Study|Lost to Follow-up|0
7537656|NCT02612779|26195052|P1|Overall Study|Lost to Follow-up|1
7537657|NCT02612779|26195051|P2|Overall Study|Participant withdrew consent|0
7537658|NCT02612779|26195052|P1|Overall Study|Participant withdrew consent|4
7537659|NCT02612779|26195051|P2|Overall Study|Adverse event unrelated to study drug|0
7537660|NCT02612779|26195052|P1|Overall Study|Adverse event unrelated to study drug|5
7537661|NCT02612779|26195051|P2|Overall Study|Death|0
7537662|NCT02612779|26195052|P1|Overall Study|Death|1
7537663|NCT02612779|26195051|P2|Overall Study|Study drug toxicity|1
7537664|NCT02612779|26195052|P1|Overall Study|Study drug toxicity|10
7537665|NCT02612779|26195051|P2|Overall Study|Disease progression|2
7537666|NCT02612779|26195052|P1|Overall Study|Disease progression|29
7537667|NCT02612779|26195051|P2|Overall Study|No longer meet study criteria|1
7537668|NCT02612779|26195052|P1|Overall Study|No longer meet study criteria|0
7537669|NCT02612779|26195051|P2|Overall Study|Administrative reason by sponsor|1
7537670|NCT02612779|26195052|P1|Overall Study|Administrative reason by sponsor|4
7537671|NCT02612727|26195064|P2|Overall Study|Direct hyperbilirubinemia|2
7537672|NCT02612727|26195065|P1|Overall Study|Direct hyperbilirubinemia|0
7537673|NCT02612727|26195064|P2|Overall Study|Needed treatment incompatible with PT|1
7537674|NCT02612727|26195065|P1|Overall Study|Needed treatment incompatible with PT|1
7537675|NCT02612727|26195064|P2|Overall Study|Parent request|1
7537676|NCT02612727|26195065|P1|Overall Study|Parent request|4
7537677|NCT02612623|26195124|P4|Overall Study|Adverse Event|0
7537678|NCT02612623|26195125|P3|Overall Study|Adverse Event|1
7537679|NCT02612623|26195126|P2|Overall Study|Adverse Event|0
7537680|NCT02612623|26195127|P1|Overall Study|Adverse Event|1
7537681|NCT02612623|26195124|P4|Overall Study|Withdrawal by Subject|0
7537682|NCT02612623|26195125|P3|Overall Study|Withdrawal by Subject|0
7537683|NCT02612623|26195126|P2|Overall Study|Withdrawal by Subject|1
7537684|NCT02612623|26195127|P1|Overall Study|Withdrawal by Subject|0
7537685|NCT02612610|26195141|P4|Overall Study|Cough Improvement|0
7537686|NCT02612610|26195142|P3|Overall Study|Cough Improvement|1
7537687|NCT02612610|26195143|P2|Overall Study|Cough Improvement|0
7537688|NCT02612610|26195144|P1|Overall Study|Cough Improvement|0
7537689|NCT02612610|26195141|P4|Overall Study|Noncompliance|0
7537690|NCT02612610|26195142|P3|Overall Study|Noncompliance|0
7537691|NCT02612610|26195143|P2|Overall Study|Noncompliance|0
7537692|NCT02612610|26195144|P1|Overall Study|Noncompliance|1
7537693|NCT02612610|26195141|P4|Overall Study|Physician Decision|0
7537694|NCT02612610|26195142|P3|Overall Study|Physician Decision|0
7537695|NCT02612610|26195143|P2|Overall Study|Physician Decision|1
7537696|NCT02612610|26195144|P1|Overall Study|Physician Decision|0
7537697|NCT02612610|26195141|P4|Overall Study|Lack of Efficacy|1
7537698|NCT02612610|26195142|P3|Overall Study|Lack of Efficacy|0
7537699|NCT02612610|26195143|P2|Overall Study|Lack of Efficacy|2
7537700|NCT02612610|26195144|P1|Overall Study|Lack of Efficacy|1
7537701|NCT02612610|26195141|P4|Overall Study|Protocol Violation|0
7537702|NCT02612610|26195142|P3|Overall Study|Protocol Violation|1
7537703|NCT02612610|26195143|P2|Overall Study|Protocol Violation|1
7537704|NCT02612610|26195144|P1|Overall Study|Protocol Violation|0
7537705|NCT02612610|26195141|P4|Overall Study|Lost to Follow-up|0
7537706|NCT02612610|26195142|P3|Overall Study|Lost to Follow-up|0
7537707|NCT02612610|26195143|P2|Overall Study|Lost to Follow-up|1
7537708|NCT02612610|26195144|P1|Overall Study|Lost to Follow-up|0
7537709|NCT02612610|26195141|P4|Overall Study|Adverse Event|10
7537710|NCT02612610|26195142|P3|Overall Study|Adverse Event|3
7537711|NCT02612610|26195143|P2|Overall Study|Adverse Event|2
7537712|NCT02612610|26195144|P1|Overall Study|Adverse Event|2
7537713|NCT02612610|26195141|P4|Overall Study|Withdrawal by Subject|2
7537714|NCT02612610|26195142|P3|Overall Study|Withdrawal by Subject|0
7537715|NCT02612610|26195143|P2|Overall Study|Withdrawal by Subject|1
7537716|NCT02612610|26195144|P1|Overall Study|Withdrawal by Subject|1
7537717|NCT02612428|26195388|P2|VTL-308E|Lost to Follow-up|0
7537718|NCT02612428|26195389|P1|VTL-308E|Lost to Follow-up|2
7537719|NCT02612428|26195388|P2|VTL-308E|Death|7
7537720|NCT02612428|26195389|P1|VTL-308E|Death|9
7537721|NCT02612428|26195388|P2|VTL-308|Withdrawal by Subject|1
7537722|NCT02612428|26195389|P1|VTL-308|Withdrawal by Subject|0
7537723|NCT02612428|26195388|P2|VTL-308|Death|16
7537724|NCT02612428|26195389|P1|VTL-308|Death|14
7537725|NCT02612285|26195399|P1|Overall Study|Withdrawal by Subject|1
7537726|NCT02612194|26195406|P3|Overall Study|Early Study Termination|0
7537727|NCT02612194|26195407|P2|Overall Study|Early Study Termination|0
7537728|NCT02612194|26195408|P1|Overall Study|Early Study Termination|1
7537729|NCT02612194|26195406|P3|Overall Study|Death|2
7537730|NCT02612194|26195407|P2|Overall Study|Death|0
7537731|NCT02612194|26195408|P1|Overall Study|Death|5
7537732|NCT02612155|26195419|P2|Overall Study|Lost to Follow-up|2
7537733|NCT02612155|26195420|P1|Overall Study|Lost to Follow-up|2
7537734|NCT02612155|26195419|P2|Overall Study|Death|1
7537735|NCT02612155|26195420|P1|Overall Study|Death|1
7537736|NCT02612077|26195440|P1|Overall Study|Unknown reason|2
7537737|NCT02612077|26195440|P1|Overall Study|Disease Progression|3
7537738|NCT02612077|26195440|P1|Overall Study|Enrollment in a Clinical Trial|1
7537739|NCT02612077|26195440|P1|Overall Study|Moved or Changed Medical Team|23
7537740|NCT02612077|26195440|P1|Overall Study|Death|377
7537741|NCT02612077|26195440|P1|Overall Study|Lost to Follow-up|20
7537742|NCT02612077|26195440|P1|Overall Study|Protocol Violation|28
7537743|NCT02612077|26195440|P1|Overall Study|Withdrawal by Subject|9
7537744|NCT02612077|26195440|P1|Overall Study|Adverse Event|3
7537745|NCT02612064|26195452|P2|Overall Study|Other|2
7537746|NCT02612064|26195453|P1|Overall Study|Other|0
7537747|NCT02612064|26195452|P2|Overall Study|Withdrawal by Subject|1
7537748|NCT02612064|26195453|P1|Overall Study|Withdrawal by Subject|1
7537749|NCT02611882|26195466|P3|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7537750|NCT02611882|26195467|P2|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7537751|NCT02611882|26195468|P1|Overall Study|Did not complete prostatectomy per protocol stipulation|33
7537752|NCT02611830|26195486|P4|Maintenance Phase|Reason not specified|0
7537753|NCT02611830|26195487|P3|Maintenance Phase|Reason not specified|4
7537754|NCT02611830|26195488|P2|Maintenance Phase|Reason not specified|1
7537755|NCT02611830|26195489|P1|Maintenance Phase|Reason not specified|0
7537756|NCT02611830|26195486|P4|Maintenance Phase|Pregnancy|0
7537757|NCT02611830|26195487|P3|Maintenance Phase|Pregnancy|1
7537758|NCT02611830|26195488|P2|Maintenance Phase|Pregnancy|0
7537759|NCT02611830|26195489|P1|Maintenance Phase|Pregnancy|0
7537760|NCT02611830|26195486|P4|Maintenance Phase|Voluntary Withdrawal|5
7537761|NCT02611830|26195487|P3|Maintenance Phase|Voluntary Withdrawal|2
7537762|NCT02611830|26195488|P2|Maintenance Phase|Voluntary Withdrawal|1
7537763|NCT02611830|26195489|P1|Maintenance Phase|Voluntary Withdrawal|0
7537764|NCT02611830|26195486|P4|Maintenance Phase|Lost to Follow-up|1
7537765|NCT02611830|26195487|P3|Maintenance Phase|Lost to Follow-up|0
7537766|NCT02611830|26195488|P2|Maintenance Phase|Lost to Follow-up|0
7537767|NCT02611830|26195489|P1|Maintenance Phase|Lost to Follow-up|0
7537768|NCT02611830|26195486|P4|Maintenance Phase|Significant Protocol Deviation|1
7537769|NCT02611830|26195487|P3|Maintenance Phase|Significant Protocol Deviation|1
7537770|NCT02611830|26195488|P2|Maintenance Phase|Significant Protocol Deviation|0
7537771|NCT02611830|26195489|P1|Maintenance Phase|Significant Protocol Deviation|0
7537772|NCT02611830|26195486|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
7537773|NCT02611830|26195487|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
7537774|NCT02611830|26195488|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
7537775|NCT02611830|26195489|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
7537776|NCT02611830|26195486|P4|Maintenance Phase|Lack of Efficacy|6
7537777|NCT02611830|26195487|P3|Maintenance Phase|Lack of Efficacy|18
7537778|NCT02611830|26195488|P2|Maintenance Phase|Lack of Efficacy|29
7537779|NCT02611830|26195489|P1|Maintenance Phase|Lack of Efficacy|0
7537780|NCT02611830|26195486|P4|OL Induction Phase|Reason not specified|0
7537781|NCT02611830|26195487|P3|OL Induction Phase|Reason not specified|0
7537782|NCT02611830|26195488|P2|OL Induction Phase|Reason not specified|0
7537783|NCT02611830|26195489|P1|OL Induction Phase|Reason not specified|3
7537784|NCT02611830|26195486|P4|OL Induction Phase|Lack of Efficacy|0
7537785|NCT02611830|26195487|P3|OL Induction Phase|Lack of Efficacy|0
7537786|NCT02611830|26195488|P2|OL Induction Phase|Lack of Efficacy|0
7537787|NCT02611830|26195489|P1|OL Induction Phase|Lack of Efficacy|9
7537788|NCT02611830|26195486|P4|OL Induction Phase|Voluntary Withdrawal|0
7537789|NCT02611830|26195487|P3|OL Induction Phase|Voluntary Withdrawal|0
7537790|NCT02611830|26195488|P2|OL Induction Phase|Voluntary Withdrawal|0
7537791|NCT02611830|26195489|P1|OL Induction Phase|Voluntary Withdrawal|5
7537792|NCT02611830|26195486|P4|OL Induction Phase|Significant Protocol Deviation|0
7537793|NCT02611830|26195487|P3|OL Induction Phase|Significant Protocol Deviation|0
7537794|NCT02611830|26195488|P2|OL Induction Phase|Significant Protocol Deviation|0
7537795|NCT02611830|26195489|P1|OL Induction Phase|Significant Protocol Deviation|4
7537796|NCT02611830|26195486|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
7537797|NCT02611830|26195487|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
7537798|NCT02611830|26195488|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
7537799|NCT02611830|26195489|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
7537800|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Lost to Follow-up|1
7537801|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Lost to Follow-up|0
7537802|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Lost to Follow-up|0
7537803|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Withdrawal by Subject|14
7537804|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Withdrawal by Subject|5
7537805|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Withdrawal by Subject|0
7537806|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Pregnancy|1
7537807|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Pregnancy|0
7537808|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Pregnancy|0
7537809|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Lack of Efficacy|78
7537810|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Lack of Efficacy|43
7537811|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Lack of Efficacy|0
7537812|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Reason not Specified|2
7537813|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Reason not Specified|1
7537814|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Reason not Specified|0
7537815|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Randomized but not Treated|0
7537816|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Randomized but not Treated|1
7537817|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Randomized but not Treated|0
7537818|NCT02611817|26195513|P3|Double-blind Maintenance Phase|Adverse Event|11
7537819|NCT02611817|26195514|P2|Double-blind Maintenance Phase|Adverse Event|12
7537820|NCT02611817|26195515|P1|Double-blind Maintenance Phase|Adverse Event|0
7537821|NCT02611817|26195513|P3|Open-label Induction Phase|Adverse Event|0
7537822|NCT02611817|26195514|P2|Open-label Induction Phase|Adverse Event|0
7537823|NCT02611817|26195515|P1|Open-label Induction Phase|Adverse Event|16
7537824|NCT02611817|26195513|P3|Open-label Induction Phase|Protocol Violation|0
7537825|NCT02611817|26195514|P2|Open-label Induction Phase|Protocol Violation|0
7537826|NCT02611817|26195515|P1|Open-label Induction Phase|Protocol Violation|5
7537827|NCT02611817|26195513|P3|Open-label Induction Phase|Lost to Follow-up|0
7537828|NCT02611817|26195514|P2|Open-label Induction Phase|Lost to Follow-up|0
7537829|NCT02611817|26195515|P1|Open-label Induction Phase|Lost to Follow-up|2
7537830|NCT02611817|26195513|P3|Open-label Induction Phase|Withdrawal by Subject|0
7537831|NCT02611817|26195514|P2|Open-label Induction Phase|Withdrawal by Subject|0
7537832|NCT02611817|26195515|P1|Open-label Induction Phase|Withdrawal by Subject|9
7537833|NCT02611817|26195513|P3|Open-label Induction Phase|Pregnancy|0
7537834|NCT02611817|26195514|P2|Open-label Induction Phase|Pregnancy|0
7537835|NCT02611817|26195515|P1|Open-label Induction Phase|Pregnancy|1
7537836|NCT02611817|26195513|P3|Open-label Induction Phase|Lack of Efficacy|0
7537837|NCT02611817|26195514|P2|Open-label Induction Phase|Lack of Efficacy|0
7537838|NCT02611817|26195515|P1|Open-label Induction Phase|Lack of Efficacy|8
7537839|NCT02611817|26195513|P3|Open-label Induction Phase|Reason not Specified|0
7537840|NCT02611817|26195514|P2|Open-label Induction Phase|Reason not Specified|0
7537841|NCT02611817|26195515|P1|Open-label Induction Phase|Reason not Specified|9
7537842|NCT02611778|26195530|P2|Overall Study|Other Reason|1
7537843|NCT02611778|26195531|P1|Overall Study|Other Reason|2
7537844|NCT02611778|26195530|P2|Overall Study|Need for alternative treatment|0
7537845|NCT02611778|26195531|P1|Overall Study|Need for alternative treatment|1
7537846|NCT02611778|26195530|P2|Overall Study|Lost to Follow-up|1
7537847|NCT02611778|26195531|P1|Overall Study|Lost to Follow-up|3
7537848|NCT02611778|26195530|P2|Overall Study|Protocol Violation|0
7537849|NCT02611778|26195531|P1|Overall Study|Protocol Violation|1
7537850|NCT02611778|26195530|P2|Overall Study|Death|1
7537851|NCT02611778|26195531|P1|Overall Study|Death|2
7537852|NCT02611778|26195530|P2|Overall Study|Adverse Event|2
7537853|NCT02611778|26195531|P1|Overall Study|Adverse Event|1
7537854|NCT02611778|26195530|P2|Overall Study|Withdrawal by Subject|8
7537855|NCT02611778|26195531|P1|Overall Study|Withdrawal by Subject|2
7537856|NCT02611752|26195597|P2|Overall Study|Adverse Event|1
7537857|NCT02611752|26195598|P1|Overall Study|Adverse Event|0
7537858|NCT02611479|26195630|P1|Data Cleaning|No baseline function or pain metrics|2
7537859|NCT02611479|26195630|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
7537860|NCT02611479|26195630|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
7537861|NCT02611479|26195630|P1|Baseline Enrollment|Exited study|13
7537862|NCT02611362|26195636|P2|Overall Study|Lost to Follow-up|4
7537863|NCT02611362|26195637|P1|Overall Study|Lost to Follow-up|2
7537864|NCT02611362|26195636|P2|Overall Study|Withdrawal by Subject|2
7537865|NCT02611362|26195637|P1|Overall Study|Withdrawal by Subject|7
7537866|NCT02610842|26195781|P1|Overall Study|Lost to Follow-up|5
7537867|NCT02610816|26195790|P4|Phase 2|Pregnancy|1
7537868|NCT02610816|26195791|P3|Phase 2|Pregnancy|0
7537869|NCT02610816|26195792|P2|Phase 2|Pregnancy|0
7537870|NCT02610816|26195793|P1|Phase 2|Pregnancy|0
7537871|NCT02610816|26195790|P4|Phase 2|Physician Decision|2
7537872|NCT02610816|26195791|P3|Phase 2|Physician Decision|0
7537873|NCT02610816|26195792|P2|Phase 2|Physician Decision|0
7537874|NCT02610816|26195793|P1|Phase 2|Physician Decision|0
7537875|NCT02610816|26195790|P4|Phase 2|Lost to Follow-up|0
7537876|NCT02610816|26195791|P3|Phase 2|Lost to Follow-up|2
7537877|NCT02610816|26195792|P2|Phase 2|Lost to Follow-up|0
7537878|NCT02610816|26195793|P1|Phase 2|Lost to Follow-up|0
7537879|NCT02610816|26195790|P4|Phase 2|Withdrawal by Subject|3
7537880|NCT02610816|26195791|P3|Phase 2|Withdrawal by Subject|9
7537881|NCT02610816|26195792|P2|Phase 2|Withdrawal by Subject|0
7537882|NCT02610816|26195793|P1|Phase 2|Withdrawal by Subject|0
7537883|NCT02610816|26195790|P4|Phase 1|Physician Decision|0
7537884|NCT02610816|26195791|P3|Phase 1|Physician Decision|0
7537885|NCT02610816|26195792|P2|Phase 1|Physician Decision|1
7537886|NCT02610816|26195793|P1|Phase 1|Physician Decision|0
7537887|NCT02610816|26195790|P4|Phase 1|Lost to Follow-up|0
7537888|NCT02610816|26195791|P3|Phase 1|Lost to Follow-up|0
7537889|NCT02610816|26195792|P2|Phase 1|Lost to Follow-up|1
7537890|NCT02610816|26195793|P1|Phase 1|Lost to Follow-up|2
7537891|NCT02610816|26195790|P4|Phase 1|Withdrawal by Subject|0
7537892|NCT02610816|26195791|P3|Phase 1|Withdrawal by Subject|0
7537893|NCT02610816|26195792|P2|Phase 1|Withdrawal by Subject|6
7537894|NCT02610816|26195793|P1|Phase 1|Withdrawal by Subject|2
7537895|NCT02610777|26195816|P2|Overall Study|Ongoing on Treatment|7
7537896|NCT02610777|26195817|P1|Overall Study|Ongoing on Treatment|6
7537897|NCT02610777|26195816|P2|Overall Study|Other|1
7537898|NCT02610777|26195817|P1|Overall Study|Other|0
7537899|NCT02610777|26195816|P2|Overall Study|Withdrawal by Subject|2
7537900|NCT02610777|26195817|P1|Overall Study|Withdrawal by Subject|1
7537901|NCT02610777|26195816|P2|Overall Study|Ongoing in Follow-up|12
7537902|NCT02610777|26195817|P1|Overall Study|Ongoing in Follow-up|14
7537903|NCT02610725|26195823|P1|Overall Study|self-reported contraindication|9
7537904|NCT02610725|26195823|P1|Overall Study|Lost to Follow-up|197
7537905|NCT02610231|26195838|P1|Overall Study|Other|3
7537906|NCT02610231|26195838|P1|Overall Study|Non Compliance|2
7537907|NCT02610231|26195838|P1|Overall Study|Physician Decision|1
7537908|NCT02610231|26195838|P1|Overall Study|Surgery|2
7537909|NCT02610231|26195838|P1|Overall Study|Death|5
7537910|NCT02610231|26195838|P1|Overall Study|Adverse Event|20
7537911|NCT02610231|26195838|P1|Overall Study|Withdrawal by Subject|27
7537912|NCT02610192|26195845|P1|Overall Study|Physician Decision|1
7537913|NCT02610192|26195845|P1|Overall Study|Received other treatment|8
7537914|NCT02610140|26195860|P2|Long-term Follow-up|Ongoing but not completed|17
7537915|NCT02610140|26195861|P1|Long-term Follow-up|Ongoing but not completed|30
7537916|NCT02610140|26195860|P2|Long-term Follow-up|Lost to Follow-up|2
7537917|NCT02610140|26195861|P1|Long-term Follow-up|Lost to Follow-up|1
7537918|NCT02610140|26195860|P2|Long-term Follow-up|Withdrawal by Subject|3
7537919|NCT02610140|26195861|P1|Long-term Follow-up|Withdrawal by Subject|6
7537920|NCT02610140|26195860|P2|Long-term Follow-up|Death|44
7537921|NCT02610140|26195861|P1|Long-term Follow-up|Death|86
7537922|NCT02610140|26195860|P2|Active Follow-up|Ongoing but not completed|1
7537923|NCT02610140|26195861|P1|Active Follow-up|Ongoing but not completed|4
7537924|NCT02610140|26195860|P2|Active Follow-up|Deterioration of general conditions|0
7537925|NCT02610140|26195861|P1|Active Follow-up|Deterioration of general conditions|1
7537926|NCT02610140|26195860|P2|Active Follow-up|Progressive disease - clinical|2
7537927|NCT02610140|26195861|P1|Active Follow-up|Progressive disease - clinical|1
7537928|NCT02610140|26195860|P2|Active Follow-up|Withdrawal by Subject|0
7537929|NCT02610140|26195861|P1|Active Follow-up|Withdrawal by Subject|4
7537930|NCT02610140|26195860|P2|Active Follow-up|Death|1
7537931|NCT02610140|26195861|P1|Active Follow-up|Death|8
7537932|NCT02610140|26195860|P2|Active Follow-up|Progressive disease - radiological|22
7537933|NCT02610140|26195861|P1|Active Follow-up|Progressive disease - radiological|30
7537934|NCT02610140|26195860|P2|Safety Follow-up|Withdrawal by Subject|12
7537935|NCT02610140|26195861|P1|Safety Follow-up|Withdrawal by Subject|12
7537936|NCT02610140|26195860|P2|Safety Follow-up|Deterioration of general conditions|5
7537937|NCT02610140|26195861|P1|Safety Follow-up|Deterioration of general conditions|15
7537938|NCT02610140|26195860|P2|Safety Follow-up|Death|2
7537939|NCT02610140|26195861|P1|Safety Follow-up|Death|12
7537940|NCT02610140|26195860|P2|Safety Follow-up|No follow-up|3
7537941|NCT02610140|26195861|P1|Safety Follow-up|No follow-up|5
7537942|NCT02610140|26195860|P2|Safety Follow-up|Lost to Follow-up|0
7537943|NCT02610140|26195861|P1|Safety Follow-up|Lost to Follow-up|1
7537944|NCT02610140|26195860|P2|Safety Follow-up|Other|2
7537945|NCT02610140|26195861|P1|Safety Follow-up|Other|0
7537946|NCT02610140|26195860|P2|Randomization and Treatment Period|Not treated|10
7537947|NCT02610140|26195861|P1|Randomization and Treatment Period|Not treated|3
7537948|NCT02610140|26195860|P2|Randomization and Treatment Period|Ongoing but not completed|2
7537949|NCT02610140|26195861|P1|Randomization and Treatment Period|Ongoing but not completed|9
7537950|NCT02610140|26195860|P2|Randomization and Treatment Period|Progressive disease - clinical|5
7537951|NCT02610140|26195861|P1|Randomization and Treatment Period|Progressive disease - clinical|12
7537952|NCT02610140|26195860|P2|Randomization and Treatment Period|Adverse Event|13
7537953|NCT02610140|26195861|P1|Randomization and Treatment Period|Adverse Event|44
7537954|NCT02610140|26195860|P2|Randomization and Treatment Period|Withdrawal by Subject|12
7537955|NCT02610140|26195861|P1|Randomization and Treatment Period|Withdrawal by Subject|12
7537956|NCT02610140|26195860|P2|Randomization and Treatment Period|Death|1
7537957|NCT02610140|26195861|P1|Randomization and Treatment Period|Death|7
7537958|NCT02610140|26195860|P2|Randomization and Treatment Period|Lack of Efficacy|0
7537959|NCT02610140|26195861|P1|Randomization and Treatment Period|Lack of Efficacy|1
7537960|NCT02610140|26195860|P2|Randomization and Treatment Period|Physician Decision|1
7537961|NCT02610140|26195861|P1|Randomization and Treatment Period|Physician Decision|0
7537962|NCT02610140|26195860|P2|Randomization and Treatment Period|Protocol Violation|0
7537963|NCT02610140|26195861|P1|Randomization and Treatment Period|Protocol Violation|1
7537964|NCT02610140|26195860|P2|Randomization and Treatment Period|Progressive disease - radiological|23
7537965|NCT02610140|26195861|P1|Randomization and Treatment Period|Progressive disease - radiological|54
7537966|NCT02610140|26195860|P2|Randomization and Treatment Period|Radiological progression|15
7537967|NCT02610140|26195861|P1|Randomization and Treatment Period|Radiological progression|23
7537968|NCT02609984|26195893|P2|Overall Study|Disease Progression|0
7537969|NCT02609984|26195894|P1|Overall Study|Disease Progression|2
7537970|NCT02609984|26195893|P2|Overall Study|Withdrawal by Subject|1
7537971|NCT02609984|26195894|P1|Overall Study|Withdrawal by Subject|0
7537972|NCT02609984|26195893|P2|Overall Study|Lost to Follow-up|2
7537973|NCT02609984|26195894|P1|Overall Study|Lost to Follow-up|1
7537974|NCT02609984|26195893|P2|Overall Study|Participation Discontinued by Sponsor|10
7537975|NCT02609984|26195894|P1|Overall Study|Participation Discontinued by Sponsor|12
7537976|NCT02609984|26195893|P2|Overall Study|Death|26
7537977|NCT02609984|26195894|P1|Overall Study|Death|29
7537978|NCT02609672|26195936|P2|Overall Study|Lost to Follow-up|1
7537979|NCT02609672|26195937|P1|Overall Study|Lost to Follow-up|3
7537980|NCT02609659|26195971|P1|Overall Study|Other|1
7537981|NCT02609659|26195971|P1|Overall Study|Lost to Follow-up|6
7537982|NCT02609659|26195971|P1|Overall Study|Adverse Event|1
7537983|NCT02609633|26195981|P2|Overall Study|Reason not Specified|1
7537984|NCT02609633|26195982|P1|Overall Study|Reason not Specified|2
7537985|NCT02609633|26195981|P2|Overall Study|Non-Compliant with Study Procedures|0
7537986|NCT02609633|26195982|P1|Overall Study|Non-Compliant with Study Procedures|2
7537987|NCT02609633|26195981|P2|Overall Study|Protocol Deviation|0
7537988|NCT02609633|26195982|P1|Overall Study|Protocol Deviation|1
7537989|NCT02609633|26195981|P2|Overall Study|Consent Withdrawn|1
7537990|NCT02609633|26195982|P1|Overall Study|Consent Withdrawn|0
7537991|NCT02609607|26196009|P2|Overall Study|Lost to Follow-up|1
7537992|NCT02609607|26196010|P1|Overall Study|Lost to Follow-up|0
7537993|NCT02609503|26196032|P1|Overall Study|Disease progression|1
7537994|NCT02609503|26196032|P1|Overall Study|Withdrawal by Subject|1
7537995|NCT02609503|26196032|P1|Overall Study|Death|1
7537996|NCT02609503|26196032|P1|Overall Study|Adverse Event|1
7537997|NCT02609399|26196049|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
7537998|NCT02609399|26196050|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
7537999|NCT02609399|26196049|P2|Influenza Season 2016-2017|Lost to Follow-up|5
7538000|NCT02609399|26196050|P1|Influenza Season 2016-2017|Lost to Follow-up|8
7538001|NCT02609399|26196049|P2|Influenza Season 2015-2016|Lost to Follow-up|2
7538002|NCT02609399|26196050|P1|Influenza Season 2015-2016|Lost to Follow-up|3
7538003|NCT02609178|26196080|P6|First Crown|Withdrawal by Subject|0
7538004|NCT02609178|26196081|P5|First Crown|Withdrawal by Subject|0
7538005|NCT02609178|26196082|P4|First Crown|Withdrawal by Subject|1
7538006|NCT02609178|26196083|P3|First Crown|Withdrawal by Subject|1
7538007|NCT02609178|26196084|P2|First Crown|Withdrawal by Subject|0
7538008|NCT02609178|26196085|P1|First Crown|Withdrawal by Subject|0
7538009|NCT02608892|26196147|P2|Overall Study|Lost to Follow-up|0
7538010|NCT02608892|26196148|P1|Overall Study|Lost to Follow-up|1
7538011|NCT02608879|26196160|P3|Overall Study|Did not meet continuation criteria|3
7538012|NCT02608879|26196161|P2|Overall Study|Did not meet continuation criteria|0
7538013|NCT02608879|26196162|P1|Overall Study|Did not meet continuation criteria|0
7538014|NCT02608879|26196160|P3|Overall Study|Lost to Follow-up|0
7538015|NCT02608879|26196161|P2|Overall Study|Lost to Follow-up|0
7538016|NCT02608879|26196162|P1|Overall Study|Lost to Follow-up|1
7538019|NCT02608476|26196216|P2|Overall Study|Progressive disease|0
7538020|NCT02608476|26196217|P1|Overall Study|Progressive disease|1
7538021|NCT02608476|26196216|P2|Overall Study|Pregnancy|1
7538022|NCT02608476|26196217|P1|Overall Study|Pregnancy|0
7538023|NCT02608476|26196216|P2|Overall Study|Physician Decision|0
7538024|NCT02608476|26196217|P1|Overall Study|Physician Decision|1
7538025|NCT02608476|26196216|P2|Overall Study|Other|1
7538026|NCT02608476|26196217|P1|Overall Study|Other|0
7538027|NCT02608476|26196216|P2|Overall Study|Lack of Efficacy|1
7538028|NCT02608476|26196217|P1|Overall Study|Lack of Efficacy|3
7538029|NCT02608476|26196216|P2|Overall Study|Noncompliance with treatment|5
7538030|NCT02608476|26196217|P1|Overall Study|Noncompliance with treatment|1
7538031|NCT02608476|26196216|P2|Overall Study|Withdrawal by Parent/Guardian|4
7538032|NCT02608476|26196217|P1|Overall Study|Withdrawal by Parent/Guardian|5
7538033|NCT02608476|26196216|P2|Overall Study|Adverse Event|8
7538034|NCT02608476|26196217|P1|Overall Study|Adverse Event|2
7538035|NCT02608476|26196216|P2|Overall Study|Lost to Follow-up|24
7538036|NCT02608476|26196217|P1|Overall Study|Lost to Follow-up|24
7538037|NCT02608476|26196216|P2|Overall Study|Withdrawal by Subject|37
7538038|NCT02608476|26196217|P1|Overall Study|Withdrawal by Subject|30
7538039|NCT02608450|26196251|P2|Overall Study|Multiple reasons|2
7538040|NCT02608450|26196252|P1|Overall Study|Multiple reasons|0
7538041|NCT02608450|26196251|P2|Overall Study|Progressive disease|0
7538042|NCT02608450|26196252|P1|Overall Study|Progressive disease|1
7538043|NCT02608450|26196251|P2|Overall Study|Pregnancy|1
7538044|NCT02608450|26196252|P1|Overall Study|Pregnancy|0
7538045|NCT02608450|26196251|P2|Overall Study|Physician Decision|1
7538046|NCT02608450|26196252|P1|Overall Study|Physician Decision|0
7538047|NCT02608450|26196251|P2|Overall Study|Noncompliance with study drug|2
7538048|NCT02608450|26196252|P1|Overall Study|Noncompliance with study drug|0
7538049|NCT02608450|26196251|P2|Overall Study|Lack of Efficacy|3
7538050|NCT02608450|26196252|P1|Overall Study|Lack of Efficacy|0
7538051|NCT02608450|26196251|P2|Overall Study|Withdrawal by parent|3
7538052|NCT02608450|26196252|P1|Overall Study|Withdrawal by parent|2
7538053|NCT02608450|26196251|P2|Overall Study|Adverse Event|6
7538054|NCT02608450|26196252|P1|Overall Study|Adverse Event|3
7538055|NCT02608450|26196251|P2|Overall Study|Withdrawal by Subject|15
7538056|NCT02608450|26196252|P1|Overall Study|Withdrawal by Subject|21
7538057|NCT02608450|26196251|P2|Overall Study|Lost to Follow-up|32
7538058|NCT02608450|26196252|P1|Overall Study|Lost to Follow-up|39
7538059|NCT02608099|26196316|P2|Overall Study|Ablation procedure not initiated|2
7538060|NCT02608099|26196317|P1|Overall Study|Ablation procedure not initiated|3
7538061|NCT02607956|26196355|P2|Open-Label Extension Phase|Lost to Follow-up|5
7538062|NCT02607956|26196356|P1|Open-Label Extension Phase|Lost to Follow-up|3
7538063|NCT02607956|26196355|P2|Open-Label Extension Phase|Withdrew Consent|5
7538064|NCT02607956|26196356|P1|Open-Label Extension Phase|Withdrew Consent|6
7538065|NCT02607956|26196355|P2|Open-Label Extension Phase|Non Compliance with Study Drug|0
7538066|NCT02607956|26196356|P1|Open-Label Extension Phase|Non Compliance with Study Drug|1
7538067|NCT02607956|26196355|P2|Open-Label Extension Phase|Investigator's Discretion|1
7538068|NCT02607956|26196356|P1|Open-Label Extension Phase|Investigator's Discretion|0
7538069|NCT02607956|26196355|P2|Open-Label Extension Phase|Still in Study up to Data Cut Date For OL Week 48|254
7538070|NCT02607956|26196356|P1|Open-Label Extension Phase|Still in Study up to Data Cut Date For OL Week 48|244
7538071|NCT02607956|26196355|P2|Double-Blinded Phase|Lost to Follow-up|16
7538072|NCT02607956|26196356|P1|Double-Blinded Phase|Lost to Follow-up|19
7538073|NCT02607956|26196355|P2|Double-Blinded Phase|Withdrew Consent|19
7538074|NCT02607956|26196356|P1|Double-Blinded Phase|Withdrew Consent|17
7538075|NCT02607956|26196355|P2|Double-Blinded Phase|Protocol Violation|1
7538076|NCT02607956|26196356|P1|Double-Blinded Phase|Protocol Violation|3
7538077|NCT02607956|26196355|P2|Double-Blinded Phase|Non-Compliance with Study Drug|3
7538078|NCT02607956|26196356|P1|Double-Blinded Phase|Non-Compliance with Study Drug|0
7538079|NCT02607956|26196355|P2|Double-Blinded Phase|Investigator's Discretion|2
7538080|NCT02607956|26196356|P1|Double-Blinded Phase|Investigator's Discretion|7
7538081|NCT02607956|26196355|P2|Double-Blinded Phase|Death|4
7538082|NCT02607956|26196356|P1|Double-Blinded Phase|Death|4
7538083|NCT02607956|26196355|P2|Double-Blinded Phase|Adverse Event|3
7538084|NCT02607956|26196356|P1|Double-Blinded Phase|Adverse Event|4
7538085|NCT02607956|26196355|P2|Double-Blinded Phase|Randomized and Never Treated|5
7538086|NCT02607956|26196356|P1|Double-Blinded Phase|Randomized and Never Treated|7
7538087|NCT02607930|26196392|P2|Open-Label Extension Phase|Lost to Follow-up|5
7538088|NCT02607930|26196393|P1|Open-Label Extension Phase|Lost to Follow-up|6
7538089|NCT02607930|26196392|P2|Open-Label Extension Phase|Withdrew Consent|6
7538090|NCT02607930|26196393|P1|Open-Label Extension Phase|Withdrew Consent|4
7538091|NCT02607930|26196392|P2|Open-Label Extension Phase|Protocol Violation|1
7538092|NCT02607930|26196393|P1|Open-Label Extension Phase|Protocol Violation|1
7538093|NCT02607930|26196392|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7538094|NCT02607930|26196393|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|1
7538095|NCT02607930|26196392|P2|Open-Label Extension Phase|Investigator's Discretion|1
7538096|NCT02607930|26196393|P1|Open-Label Extension Phase|Investigator's Discretion|0
7538097|NCT02607930|26196392|P2|Open-Label Extension Phase|Death|1
7538098|NCT02607930|26196393|P1|Open-Label Extension Phase|Death|1
7538099|NCT02607930|26196392|P2|Open-Label Extension Phase|Adverse Event|0
7538100|NCT02607930|26196393|P1|Open-Label Extension Phase|Adverse Event|2
7538101|NCT02607930|26196392|P2|Open-Label Extension Phase|Still in Study up to Data Cut Date for OL Week 48|240
7538102|NCT02607930|26196393|P1|Open-Label Extension Phase|Still in Study up to Data Cut Date for OL Week 48|237
7538103|NCT02607930|26196392|P2|Double-Blinded Phase|Lost to Follow-up|19
7538104|NCT02607930|26196393|P1|Double-Blinded Phase|Lost to Follow-up|25
7538105|NCT02607930|26196392|P2|Double-Blinded Phase|Withdrew Consent|18
7538106|NCT02607930|26196393|P1|Double-Blinded Phase|Withdrew Consent|14
7538107|NCT02607930|26196392|P2|Double-Blinded Phase|Protocol Violation|3
7538108|NCT02607930|26196393|P1|Double-Blinded Phase|Protocol Violation|2
7538109|NCT02607930|26196392|P2|Double-Blinded Phase|Non-Compliance with Study Drug|5
7538110|NCT02607930|26196393|P1|Double-Blinded Phase|Non-Compliance with Study Drug|3
7538111|NCT02607930|26196392|P2|Double-Blinded Phase|Investigator's Discretion|3
7538112|NCT02607930|26196393|P1|Double-Blinded Phase|Investigator's Discretion|6
7538113|NCT02607930|26196392|P2|Double-Blinded Phase|Death|1
7538114|NCT02607930|26196393|P1|Double-Blinded Phase|Death|2
7538115|NCT02607930|26196392|P2|Double-Blinded Phase|Adverse Event|4
7538116|NCT02607930|26196393|P1|Double-Blinded Phase|Adverse Event|0
7538117|NCT02607930|26196392|P2|Double-Blinded Phase|Randomized and Never Treated|0
7538118|NCT02607930|26196393|P1|Double-Blinded Phase|Randomized and Never Treated|2
7538119|NCT02607865|26196443|P4|Overall Study|Unclassified|0
7538120|NCT02607865|26196444|P3|Overall Study|Unclassified|2
7538121|NCT02607865|26196445|P2|Overall Study|Unclassified|1
7538122|NCT02607865|26196446|P1|Overall Study|Unclassified|1
7538123|NCT02607865|26196443|P4|Overall Study|Death|3
7538124|NCT02607865|26196444|P3|Overall Study|Death|1
7538125|NCT02607865|26196445|P2|Overall Study|Death|4
7538126|NCT02607865|26196446|P1|Overall Study|Death|5
7538127|NCT02607865|26196443|P4|Overall Study|Withdrawal by Subject|8
7538128|NCT02607865|26196444|P3|Overall Study|Withdrawal by Subject|17
7538129|NCT02607865|26196445|P2|Overall Study|Withdrawal by Subject|18
7538130|NCT02607865|26196446|P1|Overall Study|Withdrawal by Subject|18
7538131|NCT02607865|26196443|P4|Overall Study|Lost to Follow-up|5
7538132|NCT02607865|26196444|P3|Overall Study|Lost to Follow-up|7
7538133|NCT02607865|26196445|P2|Overall Study|Lost to Follow-up|7
7538134|NCT02607865|26196446|P1|Overall Study|Lost to Follow-up|9
7538135|NCT02607800|26196620|P2|Overall Study|Randomized/Enrolled but Not Treated|1
7538136|NCT02607800|26196621|P1|Overall Study|Randomized/Enrolled but Not Treated|1
7538137|NCT02607800|26196620|P2|Overall Study|Withdrew Consent|0
7538138|NCT02607800|26196621|P1|Overall Study|Withdrew Consent|2
7538139|NCT02607800|26196620|P2|Overall Study|Lost to Follow-up|10
7538140|NCT02607800|26196621|P1|Overall Study|Lost to Follow-up|7
7538141|NCT02607735|26196639|P3|Deferred Treatment Substudy|Withdrew Consent|1
7538142|NCT02607735|26196640|P2|Deferred Treatment Substudy|Withdrew Consent|0
7538143|NCT02607735|26196641|P1|Deferred Treatment Substudy|Withdrew Consent|0
7538144|NCT02607735|26196639|P3|Deferred Treatment Substudy|Lost to Follow-up|4
7538145|NCT02607735|26196640|P2|Deferred Treatment Substudy|Lost to Follow-up|0
7538146|NCT02607735|26196641|P1|Deferred Treatment Substudy|Lost to Follow-up|0
7538147|NCT02607735|26196639|P3|Primary Study|Withdrew Consent|0
7538148|NCT02607735|26196640|P2|Primary Study|Withdrew Consent|0
7538149|NCT02607735|26196641|P1|Primary Study|Withdrew Consent|2
7538150|NCT02607735|26196639|P3|Primary Study|Lost to Follow-up|0
7538151|NCT02607735|26196640|P2|Primary Study|Lost to Follow-up|0
7538152|NCT02607735|26196641|P1|Primary Study|Lost to Follow-up|4
7538153|NCT02607735|26196639|P3|Primary Study|Randomized but Never Treated|0
7538154|NCT02607735|26196640|P2|Primary Study|Randomized but Never Treated|0
7538155|NCT02607735|26196641|P1|Primary Study|Randomized but Never Treated|1
7538156|NCT02607306|26196675|P3|Overall Study|Protocol Violation|1
7538157|NCT02607306|26196676|P2|Overall Study|Protocol Violation|2
7538158|NCT02607306|26196677|P1|Overall Study|Protocol Violation|4
7538159|NCT02607306|26196675|P3|Overall Study|Lack of Efficacy|1
7538160|NCT02607306|26196676|P2|Overall Study|Lack of Efficacy|1
7538161|NCT02607306|26196677|P1|Overall Study|Lack of Efficacy|0
7538162|NCT02607306|26196675|P3|Overall Study|Withdrawal by Subject|2
7538163|NCT02607306|26196676|P2|Overall Study|Withdrawal by Subject|10
7538164|NCT02607306|26196677|P1|Overall Study|Withdrawal by Subject|8
7538165|NCT02607306|26196675|P3|Overall Study|Unclassified|0
7538166|NCT02607306|26196676|P2|Overall Study|Unclassified|4
7538167|NCT02607306|26196677|P1|Overall Study|Unclassified|1
7538168|NCT02607306|26196675|P3|Overall Study|Adverse Event|6
7538169|NCT02607306|26196676|P2|Overall Study|Adverse Event|6
7538170|NCT02607306|26196677|P1|Overall Study|Adverse Event|8
7538171|NCT02607280|26196799|P2|Overall Study|Decrease in CrCl <15|1
7538172|NCT02607280|26196800|P1|Overall Study|Decrease in CrCl <15|0
7538173|NCT02607280|26196799|P2|Overall Study|Adverse Event|0
7538174|NCT02607280|26196800|P1|Overall Study|Adverse Event|4
7538175|NCT02607228|26196835|P7|Overall Study|Study Terminated by Sponsor|0
7538176|NCT02607228|26196836|P6|Overall Study|Study Terminated by Sponsor|0
7538177|NCT02607228|26196837|P5|Overall Study|Study Terminated by Sponsor|0
7538178|NCT02607228|26196838|P4|Overall Study|Study Terminated by Sponsor|1
7538179|NCT02607228|26196839|P3|Overall Study|Study Terminated by Sponsor|0
7538180|NCT02607228|26196840|P2|Overall Study|Study Terminated by Sponsor|0
7538181|NCT02607228|26196841|P1|Overall Study|Study Terminated by Sponsor|0
7538182|NCT02607228|26196835|P7|Overall Study|Withdrew Consent|0
7538183|NCT02607228|26196836|P6|Overall Study|Withdrew Consent|1
7538184|NCT02607228|26196837|P5|Overall Study|Withdrew Consent|0
7538185|NCT02607228|26196838|P4|Overall Study|Withdrew Consent|0
7538186|NCT02607228|26196839|P3|Overall Study|Withdrew Consent|0
7538187|NCT02607228|26196840|P2|Overall Study|Withdrew Consent|1
7538188|NCT02607228|26196841|P1|Overall Study|Withdrew Consent|0
7538189|NCT02607228|26196835|P7|Overall Study|Investigator's Discretion|0
7538190|NCT02607228|26196836|P6|Overall Study|Investigator's Discretion|1
7538191|NCT02607228|26196837|P5|Overall Study|Investigator's Discretion|0
7538192|NCT02607228|26196838|P4|Overall Study|Investigator's Discretion|0
7538193|NCT02607228|26196839|P3|Overall Study|Investigator's Discretion|1
7538194|NCT02607228|26196840|P2|Overall Study|Investigator's Discretion|0
7538195|NCT02607228|26196841|P1|Overall Study|Investigator's Discretion|0
7538196|NCT02607228|26196835|P7|Overall Study|Adverse Event|1
7538197|NCT02607228|26196836|P6|Overall Study|Adverse Event|1
7538198|NCT02607228|26196837|P5|Overall Study|Adverse Event|1
7538199|NCT02607228|26196838|P4|Overall Study|Adverse Event|0
7538200|NCT02607228|26196839|P3|Overall Study|Adverse Event|1
7538201|NCT02607228|26196840|P2|Overall Study|Adverse Event|0
7538202|NCT02607228|26196841|P1|Overall Study|Adverse Event|1
7538203|NCT02607228|26196835|P7|Overall Study|Progressive Disease|1
7538204|NCT02607228|26196836|P6|Overall Study|Progressive Disease|3
7538205|NCT02607228|26196837|P5|Overall Study|Progressive Disease|4
7538206|NCT02607228|26196838|P4|Overall Study|Progressive Disease|5
7538207|NCT02607228|26196839|P3|Overall Study|Progressive Disease|1
7538208|NCT02607228|26196840|P2|Overall Study|Progressive Disease|3
7538209|NCT02607228|26196841|P1|Overall Study|Progressive Disease|4
7538210|NCT02606877|26196957|P2|Overall Study|Other than listed above|0
7538211|NCT02606877|26196958|P1|Overall Study|Other than listed above|1
7538212|NCT02606877|26196957|P2|Overall Study|Non-compliance with protocol|1
7538213|NCT02606877|26196958|P1|Overall Study|Non-compliance with protocol|0
7538214|NCT02606877|26196957|P2|Overall Study|Adverse Event|0
7538215|NCT02606877|26196958|P1|Overall Study|Adverse Event|3
7538216|NCT02606643|26196997|P2|Overall Study|did not meet inclusion criteria|3
7538217|NCT02606643|26196998|P1|Overall Study|did not meet inclusion criteria|1
7538218|NCT02606279|26197056|P2|Overall Study|Lost to Follow-up|1
7538219|NCT02606279|26197057|P1|Overall Study|Lost to Follow-up|0
7538220|NCT02606253|26197072|P3|Overall Study|Physician Decision|0
7538221|NCT02606253|26197073|P2|Overall Study|Physician Decision|1
7538222|NCT02606253|26197074|P1|Overall Study|Physician Decision|1
7538223|NCT02606253|26197072|P3|Overall Study|Protocol Violation|0
7538224|NCT02606253|26197073|P2|Overall Study|Protocol Violation|1
7538225|NCT02606253|26197074|P1|Overall Study|Protocol Violation|2
7538226|NCT02606253|26197072|P3|Overall Study|Adverse Event|0
7538227|NCT02606253|26197073|P2|Overall Study|Adverse Event|0
7538228|NCT02606253|26197074|P1|Overall Study|Adverse Event|2
7538229|NCT02605967|26197176|P3|After Cross Over|progressive disease|16
7538230|NCT02605967|26197177|P2|After Cross Over|progressive disease|0
7538231|NCT02605967|26197178|P1|After Cross Over|progressive disease|59
7538232|NCT02605967|26197176|P3|After Cross Over|treatment ongoing|3
7538233|NCT02605967|26197177|P2|After Cross Over|treatment ongoing|0
7538234|NCT02605967|26197178|P1|After Cross Over|treatment ongoing|16
7538235|NCT02605967|26197176|P3|After Cross Over|Adverse Event|1
7538236|NCT02605967|26197177|P2|After Cross Over|Adverse Event|0
7538237|NCT02605967|26197178|P1|After Cross Over|Adverse Event|1
7538238|NCT02605967|26197176|P3|After Cross Over|Death|2
7538239|NCT02605967|26197177|P2|After Cross Over|Death|0
7538240|NCT02605967|26197178|P1|After Cross Over|Death|4
7538241|NCT02605967|26197176|P3|After Cross Over|Physician Decision|2
7538242|NCT02605967|26197177|P2|After Cross Over|Physician Decision|0
7538243|NCT02605967|26197178|P1|After Cross Over|Physician Decision|1
7538244|NCT02605967|26197176|P3|After Cross Over|subject / guardian decision|1
7538245|NCT02605967|26197177|P2|After Cross Over|subject / guardian decision|0
7538246|NCT02605967|26197178|P1|After Cross Over|subject / guardian decision|1
7538247|NCT02605967|26197176|P3|Overall Study : Prior to Cross Over|progressive disease|0
7538248|NCT02605967|26197177|P2|Overall Study : Prior to Cross Over|progressive disease|32
7538249|NCT02605967|26197178|P1|Overall Study : Prior to Cross Over|progressive disease|59
7538250|NCT02605967|26197176|P3|Overall Study : Prior to Cross Over|treatment ongoing|0
7538251|NCT02605967|26197177|P2|Overall Study : Prior to Cross Over|treatment ongoing|3
7538252|NCT02605967|26197178|P1|Overall Study : Prior to Cross Over|treatment ongoing|16
7538253|NCT02605967|26197176|P3|Overall Study : Prior to Cross Over|Adverse Event|0
7538254|NCT02605967|26197177|P2|Overall Study : Prior to Cross Over|Adverse Event|0
7538255|NCT02605967|26197178|P1|Overall Study : Prior to Cross Over|Adverse Event|1
7538256|NCT02605967|26197176|P3|Overall Study : Prior to Cross Over|Death|0
7538257|NCT02605967|26197177|P2|Overall Study : Prior to Cross Over|Death|2
7538258|NCT02605967|26197178|P1|Overall Study : Prior to Cross Over|Death|4
7538259|NCT02605967|26197176|P3|Overall Study : Prior to Cross Over|Physician Decision|0
7538260|NCT02605967|26197177|P2|Overall Study : Prior to Cross Over|Physician Decision|1
7538261|NCT02605967|26197178|P1|Overall Study : Prior to Cross Over|Physician Decision|1
7538262|NCT02605967|26197176|P3|Overall Study : Prior to Cross Over|subject / guardian decision|0
7538263|NCT02605967|26197177|P2|Overall Study : Prior to Cross Over|subject / guardian decision|2
7538264|NCT02605967|26197178|P1|Overall Study : Prior to Cross Over|subject / guardian decision|1
7538265|NCT02605954|26197192|P2|Overall Study|Randomized but not treated|1
7538266|NCT02605954|26197193|P1|Overall Study|Randomized but not treated|0
7538267|NCT02605954|26197192|P2|Overall Study|Lost to Follow-up|0
7538268|NCT02605954|26197193|P1|Overall Study|Lost to Follow-up|3
7538269|NCT02605954|26197192|P2|Overall Study|Withdrew Consent|2
7538270|NCT02605954|26197193|P1|Overall Study|Withdrew Consent|2
7538271|NCT02605954|26197192|P2|Overall Study|Non-Compliance with Study Drug|0
7538272|NCT02605954|26197193|P1|Overall Study|Non-Compliance with Study Drug|1
7538273|NCT02605954|26197192|P2|Overall Study|Investigator's Discretion|0
7538274|NCT02605954|26197193|P1|Overall Study|Investigator's Discretion|1
7538275|NCT02605954|26197192|P2|Overall Study|Adverse Event|1
7538276|NCT02605954|26197193|P1|Overall Study|Adverse Event|5
7538277|NCT02605928|26197210|P1|Overall Study|Lack of Efficacy|5
7538278|NCT02605928|26197210|P1|Overall Study|Model tuning phase|28
7538279|NCT02605837|26197253|P2|Overall Study|Physician Decision|1
7538280|NCT02605837|26197254|P1|Overall Study|Physician Decision|0
7538281|NCT02605837|26197253|P2|Overall Study|Withdrawal by Subject|8
7538282|NCT02605837|26197254|P1|Overall Study|Withdrawal by Subject|8
7538283|NCT02605837|26197253|P2|Overall Study|Non-Compliance with Study Drug|1
7538284|NCT02605837|26197254|P1|Overall Study|Non-Compliance with Study Drug|0
7538285|NCT02605837|26197253|P2|Overall Study|Adverse Event|1
7538286|NCT02605837|26197254|P1|Overall Study|Adverse Event|3
7538287|NCT02605824|26197293|P2|Overall Study|Physician Decision|0
7538288|NCT02605824|26197294|P1|Overall Study|Physician Decision|1
7538289|NCT02605642|26197304|P2|Overall Study|Lack of response|11
7538290|NCT02605642|26197305|P1|Overall Study|Lack of response|24
7538291|NCT02605642|26197304|P2|Overall Study|Withdrawal by Subject|2
7538292|NCT02605642|26197305|P1|Overall Study|Withdrawal by Subject|23
7538293|NCT02605642|26197304|P2|Overall Study|Adverse Event|2
7538294|NCT02605642|26197305|P1|Overall Study|Adverse Event|14
7538295|NCT02605642|26197304|P2|Overall Study|Lost to Follow-up|1
7538296|NCT02605642|26197305|P1|Overall Study|Lost to Follow-up|12
7538297|NCT02605642|26197304|P2|Overall Study|Physician Decision|0
7538298|NCT02605642|26197305|P1|Overall Study|Physician Decision|10
7538299|NCT02605642|26197304|P2|Overall Study|Participant non-compliance|4
7538300|NCT02605642|26197305|P1|Overall Study|Participant non-compliance|2
7538301|NCT02605642|26197304|P2|Overall Study|Other|1
7538302|NCT02605642|26197305|P1|Overall Study|Other|11
7538303|NCT02605447|26197347|P1|Overall Study|Not disclosed|1
7538304|NCT02605447|26197347|P1|Overall Study|Withdrawal by Subject|10
7538305|NCT02605447|26197347|P1|Overall Study|Lost to Follow-up|24
7538306|NCT02605447|26197347|P1|Overall Study|Physician Decision|1
7538307|NCT02605447|26197347|P1|Overall Study|Death|66
7538308|NCT02605174|26197458|P7|Overall Study|Randomization Failure|30
7538309|NCT02605174|26197459|P6|Overall Study|Randomization Failure|11
7538310|NCT02605174|26197460|P5|Overall Study|Randomization Failure|16
7538311|NCT02605174|26197461|P4|Overall Study|Randomization Failure|7
7538312|NCT02605174|26197462|P3|Overall Study|Randomization Failure|20
7538313|NCT02605174|26197463|P2|Overall Study|Randomization Failure|6
7538314|NCT02605174|26197464|P1|Overall Study|Randomization Failure|22
7538315|NCT02605174|26197458|P7|Overall Study|Physician Decision|3
7538316|NCT02605174|26197459|P6|Overall Study|Physician Decision|0
7538317|NCT02605174|26197460|P5|Overall Study|Physician Decision|0
7538318|NCT02605174|26197461|P4|Overall Study|Physician Decision|0
7538319|NCT02605174|26197462|P3|Overall Study|Physician Decision|0
7538320|NCT02605174|26197463|P2|Overall Study|Physician Decision|0
7538321|NCT02605174|26197464|P1|Overall Study|Physician Decision|2
7538322|NCT02605174|26197458|P7|Overall Study|Withdrawal by Subject|15
7538323|NCT02605174|26197459|P6|Overall Study|Withdrawal by Subject|4
7538324|NCT02605174|26197460|P5|Overall Study|Withdrawal by Subject|6
7538325|NCT02605174|26197461|P4|Overall Study|Withdrawal by Subject|11
7538326|NCT02605174|26197462|P3|Overall Study|Withdrawal by Subject|14
7538327|NCT02605174|26197463|P2|Overall Study|Withdrawal by Subject|6
7538328|NCT02605174|26197464|P1|Overall Study|Withdrawal by Subject|9
7538329|NCT02605174|26197458|P7|Overall Study|Pregnancy|0
7538330|NCT02605174|26197459|P6|Overall Study|Pregnancy|0
7538331|NCT02605174|26197460|P5|Overall Study|Pregnancy|0
7538332|NCT02605174|26197461|P4|Overall Study|Pregnancy|2
7538333|NCT02605174|26197462|P3|Overall Study|Pregnancy|0
7538334|NCT02605174|26197463|P2|Overall Study|Pregnancy|0
7538335|NCT02605174|26197464|P1|Overall Study|Pregnancy|1
7538336|NCT02605174|26197458|P7|Overall Study|Protocol Violation|12
7538337|NCT02605174|26197459|P6|Overall Study|Protocol Violation|7
7538338|NCT02605174|26197460|P5|Overall Study|Protocol Violation|7
7538339|NCT02605174|26197461|P4|Overall Study|Protocol Violation|6
7538340|NCT02605174|26197462|P3|Overall Study|Protocol Violation|14
7538341|NCT02605174|26197463|P2|Overall Study|Protocol Violation|4
7538342|NCT02605174|26197464|P1|Overall Study|Protocol Violation|10
7538343|NCT02605174|26197458|P7|Overall Study|Lost to Follow-up|29
7538344|NCT02605174|26197459|P6|Overall Study|Lost to Follow-up|10
7538345|NCT02605174|26197460|P5|Overall Study|Lost to Follow-up|20
7538346|NCT02605174|26197461|P4|Overall Study|Lost to Follow-up|10
7538347|NCT02605174|26197462|P3|Overall Study|Lost to Follow-up|27
7538348|NCT02605174|26197463|P2|Overall Study|Lost to Follow-up|7
7538349|NCT02605174|26197464|P1|Overall Study|Lost to Follow-up|20
7538350|NCT02605174|26197458|P7|Overall Study|Adverse Event|0
7538351|NCT02605174|26197459|P6|Overall Study|Adverse Event|0
7538352|NCT02605174|26197460|P5|Overall Study|Adverse Event|4
7538353|NCT02605174|26197461|P4|Overall Study|Adverse Event|0
7538354|NCT02605174|26197462|P3|Overall Study|Adverse Event|1
7538355|NCT02605174|26197463|P2|Overall Study|Adverse Event|0
7538356|NCT02605174|26197464|P1|Overall Study|Adverse Event|0
7538357|NCT02605122|26197526|P2|Overall Study|Lost to Follow-up|1
7538358|NCT02605122|26197527|P1|Overall Study|Lost to Follow-up|1
7538359|NCT02605122|26197526|P2|Overall Study|Withdrawal by Subject|1
7538360|NCT02605122|26197527|P1|Overall Study|Withdrawal by Subject|4
7538361|NCT02604589|26197550|P3|Overall Study|catheter dislodgement|1
7538362|NCT02604589|26197551|P2|Overall Study|catheter dislodgement|0
7538363|NCT02604589|26197552|P1|Overall Study|catheter dislodgement|0
7538364|NCT02604550|26197580|P2|Overall Study|Incomplete data using paper journal|19
7538365|NCT02604550|26197581|P1|Overall Study|Incomplete data using paper journal|18
7538366|NCT02604550|26197580|P2|Overall Study|Withdrawal by Subject|1
7538367|NCT02604550|26197581|P1|Overall Study|Withdrawal by Subject|0
7538368|NCT02604550|26197580|P2|Overall Study|Lost to Follow-up|6
7538369|NCT02604550|26197581|P1|Overall Study|Lost to Follow-up|7
7538370|NCT02604433|26197607|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
7538371|NCT02604433|26197608|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
7538372|NCT02604433|26197607|P2|Double-blind Treatment Period|Study is ongoing|74
7538373|NCT02604433|26197608|P1|Double-blind Treatment Period|Study is ongoing|156
7538374|NCT02604433|26197607|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
7538375|NCT02604433|26197608|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
7538376|NCT02604433|26197607|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
7538377|NCT02604433|26197608|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
7538378|NCT02604433|26197607|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
7538379|NCT02604433|26197608|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
7538380|NCT02604433|26197607|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
7538381|NCT02604433|26197608|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
7538382|NCT02604433|26197607|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
7538383|NCT02604433|26197608|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
7538384|NCT02604433|26197607|P2|Double-blind Treatment Period|Death|1
7538385|NCT02604433|26197608|P1|Double-blind Treatment Period|Death|1
7538386|NCT02604433|26197607|P2|Double-blind Treatment Period|Personal reasons or moved|1
7538387|NCT02604433|26197608|P1|Double-blind Treatment Period|Personal reasons or moved|2
7538388|NCT02604433|26197607|P2|Double-blind Treatment Period|Adverse Event|0
7538389|NCT02604433|26197608|P1|Double-blind Treatment Period|Adverse Event|4
7538390|NCT02604433|26197607|P2|Double-blind Treatment Period|Withdrawal by Subject|6
7538391|NCT02604433|26197608|P1|Double-blind Treatment Period|Withdrawal by Subject|13
7538392|NCT02604407|26197677|P3|Overall Study|Other|4
7538393|NCT02604407|26197678|P2|Overall Study|Other|1
7538394|NCT02604407|26197679|P1|Overall Study|Other|3
7538395|NCT02604407|26197677|P3|Overall Study|Lack of Efficacy|0
7538396|NCT02604407|26197678|P2|Overall Study|Lack of Efficacy|0
7538397|NCT02604407|26197679|P1|Overall Study|Lack of Efficacy|1
7538398|NCT02604407|26197677|P3|Overall Study|Lost to Follow-up|2
7538399|NCT02604407|26197678|P2|Overall Study|Lost to Follow-up|1
7538400|NCT02604407|26197679|P1|Overall Study|Lost to Follow-up|2
7538401|NCT02604407|26197677|P3|Overall Study|Withdrawal by Subject|5
7538402|NCT02604407|26197678|P2|Overall Study|Withdrawal by Subject|3
7538403|NCT02604407|26197679|P1|Overall Study|Withdrawal by Subject|3
7538404|NCT02604407|26197677|P3|Overall Study|Protocol Violation|0
7538405|NCT02604407|26197678|P2|Overall Study|Protocol Violation|0
7538406|NCT02604407|26197679|P1|Overall Study|Protocol Violation|2
7538407|NCT02604407|26197677|P3|Overall Study|Adverse Event|5
7538408|NCT02604407|26197678|P2|Overall Study|Adverse Event|7
7538409|NCT02604407|26197679|P1|Overall Study|Adverse Event|0
7538410|NCT02604342|26197692|P2|Overall Study|Physician Decision|0
7538411|NCT02604342|26197693|P1|Overall Study|Physician Decision|2
7538412|NCT02604342|26197692|P2|Overall Study|Lost to Follow-up|1
7538413|NCT02604342|26197693|P1|Overall Study|Lost to Follow-up|1
7538414|NCT02604342|26197692|P2|Overall Study|Study Termination by Sponsor|0
7538415|NCT02604342|26197693|P1|Overall Study|Study Termination by Sponsor|1
7538416|NCT02604342|26197692|P2|Overall Study|Other|0
7538417|NCT02604342|26197693|P1|Overall Study|Other|1
7538418|NCT02604342|26197692|P2|Overall Study|Withdrawal by Subject|6
7538419|NCT02604342|26197693|P1|Overall Study|Withdrawal by Subject|5
7538420|NCT02604342|26197692|P2|Overall Study|Progression of disease|0
7538421|NCT02604342|26197693|P1|Overall Study|Progression of disease|1
7538422|NCT02604342|26197692|P2|Overall Study|Death|16
7538423|NCT02604342|26197693|P1|Overall Study|Death|32
7538424|NCT02604264|26197745|P2|Intervention|Didn't use CVC for at least 21 days|242
7538425|NCT02604264|26197746|P1|Intervention|Didn't use CVC for at least 21 days|200
7538426|NCT02604212|26197756|P4|Overall Study|Withdrawal by Subject|0
7538427|NCT02604212|26197757|P3|Overall Study|Withdrawal by Subject|1
7538428|NCT02604212|26197758|P2|Overall Study|Withdrawal by Subject|0
7538429|NCT02604212|26197759|P1|Overall Study|Withdrawal by Subject|0
7538430|NCT02604212|26197756|P4|Overall Study|Study Terminated by Sponsor|3
7538431|NCT02604212|26197757|P3|Overall Study|Study Terminated by Sponsor|3
7538432|NCT02604212|26197758|P2|Overall Study|Study Terminated by Sponsor|1
7538433|NCT02604212|26197759|P1|Overall Study|Study Terminated by Sponsor|2
7538434|NCT02604199|26197827|P4|Overall Study|Withdrawal by Subject|0
7538435|NCT02604199|26197828|P3|Overall Study|Withdrawal by Subject|0
7538436|NCT02604199|26197829|P2|Overall Study|Withdrawal by Subject|1
7538437|NCT02604199|26197830|P1|Overall Study|Withdrawal by Subject|0
7538438|NCT02604199|26197827|P4|Overall Study|Study terminated by sponsor|2
7538439|NCT02604199|26197828|P3|Overall Study|Study terminated by sponsor|0
7538440|NCT02604199|26197829|P2|Overall Study|Study terminated by sponsor|2
7538441|NCT02604199|26197830|P1|Overall Study|Study terminated by sponsor|0
7538442|NCT02604199|26197827|P4|Overall Study|Pregnancy|1
7538443|NCT02604199|26197828|P3|Overall Study|Pregnancy|0
7538444|NCT02604199|26197829|P2|Overall Study|Pregnancy|0
7538445|NCT02604199|26197830|P1|Overall Study|Pregnancy|0
7538446|NCT02604160|26197899|P2|Overall Study|Physician Decision|1
7538447|NCT02604160|26197900|P1|Overall Study|Physician Decision|0
7538448|NCT02604160|26197899|P2|Overall Study|Protocol Violation|1
7538449|NCT02604160|26197900|P1|Overall Study|Protocol Violation|0
7538450|NCT02604017|26197914|P2|Overall Study|Other|0
7538451|NCT02604017|26197915|P1|Overall Study|Other|1
7538452|NCT02604017|26197914|P2|Overall Study|Lost to Follow-up|6
7538453|NCT02604017|26197915|P1|Overall Study|Lost to Follow-up|5
7538454|NCT02604017|26197914|P2|Overall Study|Withdrew Consent|2
7538455|NCT02604017|26197915|P1|Overall Study|Withdrew Consent|0
7538456|NCT02603952|26197944|P4|Overall Study|Received oseltamivir by error|1
7538457|NCT02603952|26197945|P3|Overall Study|Received oseltamivir by error|0
7538458|NCT02603952|26197946|P2|Overall Study|Received oseltamivir by error|0
7538459|NCT02603952|26197947|P1|Overall Study|Received oseltamivir by error|0
7538460|NCT02603952|26197944|P4|Overall Study|Withdrawal by Subject|0
7538461|NCT02603952|26197945|P3|Overall Study|Withdrawal by Subject|0
7538462|NCT02603952|26197946|P2|Overall Study|Withdrawal by Subject|0
7538463|NCT02603952|26197947|P1|Overall Study|Withdrawal by Subject|1
7538464|NCT02603887|26197995|P1|Overall Study|Disease progression|1
7538465|NCT02603887|26197995|P1|Overall Study|Adverse Event|4
7538466|NCT02603887|26197995|P1|Overall Study|FDA Guidance|1
7538467|NCT02603809|26198008|P6|Overall Study|Lack of Efficacy|1
7538468|NCT02603809|26198009|P5|Overall Study|Lack of Efficacy|0
7538469|NCT02603809|26198010|P4|Overall Study|Lack of Efficacy|0
7538470|NCT02603809|26198011|P3|Overall Study|Lack of Efficacy|0
7538471|NCT02603809|26198012|P2|Overall Study|Lack of Efficacy|1
7538472|NCT02603809|26198013|P1|Overall Study|Lack of Efficacy|0
7538473|NCT02603809|26198008|P6|Overall Study|Adverse Event|1
7538474|NCT02603809|26198009|P5|Overall Study|Adverse Event|1
7538475|NCT02603809|26198010|P4|Overall Study|Adverse Event|2
7538476|NCT02603809|26198011|P3|Overall Study|Adverse Event|2
7538477|NCT02603809|26198012|P2|Overall Study|Adverse Event|0
7538478|NCT02603809|26198013|P1|Overall Study|Adverse Event|3
7538479|NCT02603809|26198008|P6|Overall Study|Physician Decision|1
7538480|NCT02603809|26198009|P5|Overall Study|Physician Decision|2
7538481|NCT02603809|26198010|P4|Overall Study|Physician Decision|1
7538482|NCT02603809|26198011|P3|Overall Study|Physician Decision|0
7538483|NCT02603809|26198012|P2|Overall Study|Physician Decision|0
7538484|NCT02603809|26198013|P1|Overall Study|Physician Decision|0
7538485|NCT02603809|26198008|P6|Overall Study|Pre-specified discontinuation criteria|1
7538486|NCT02603809|26198009|P5|Overall Study|Pre-specified discontinuation criteria|3
7538487|NCT02603809|26198010|P4|Overall Study|Pre-specified discontinuation criteria|2
7538488|NCT02603809|26198011|P3|Overall Study|Pre-specified discontinuation criteria|2
7538489|NCT02603809|26198012|P2|Overall Study|Pre-specified discontinuation criteria|3
7538490|NCT02603809|26198013|P1|Overall Study|Pre-specified discontinuation criteria|3
7538491|NCT02603809|26198008|P6|Overall Study|Lost to Follow-up|2
7538492|NCT02603809|26198009|P5|Overall Study|Lost to Follow-up|2
7538493|NCT02603809|26198010|P4|Overall Study|Lost to Follow-up|4
7538494|NCT02603809|26198011|P3|Overall Study|Lost to Follow-up|1
7538495|NCT02603809|26198012|P2|Overall Study|Lost to Follow-up|3
7538496|NCT02603809|26198013|P1|Overall Study|Lost to Follow-up|2
7538497|NCT02603809|26198008|P6|Overall Study|Withdrawal by Subject|4
7538498|NCT02603809|26198009|P5|Overall Study|Withdrawal by Subject|3
7538499|NCT02603809|26198010|P4|Overall Study|Withdrawal by Subject|3
7538500|NCT02603809|26198011|P3|Overall Study|Withdrawal by Subject|2
7538501|NCT02603809|26198012|P2|Overall Study|Withdrawal by Subject|1
7538502|NCT02603809|26198013|P1|Overall Study|Withdrawal by Subject|4
7538503|NCT02603432|26198075|P2|Overall Study|Other|1
7538504|NCT02603432|26198076|P1|Overall Study|Other|0
7538505|NCT02603432|26198075|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7538506|NCT02603432|26198076|P1|Overall Study|No Longer Meets Eligibility Criteria|3
7538507|NCT02603432|26198075|P2|Overall Study|Withdrawal by Subject|17
7538508|NCT02603432|26198076|P1|Overall Study|Withdrawal by Subject|9
7538509|NCT02603432|26198075|P2|Overall Study|Progressive Disease|5
7538510|NCT02603432|26198076|P1|Overall Study|Progressive Disease|5
7538511|NCT02603432|26198075|P2|Overall Study|Lost to Follow-up|6
7538512|NCT02603432|26198076|P1|Overall Study|Lost to Follow-up|4
7538513|NCT02603432|26198075|P2|Overall Study|Death|177
7538514|NCT02603432|26198076|P1|Overall Study|Death|144
7538515|NCT02603432|26198075|P2|Overall Study|Adverse Event|0
7538516|NCT02603432|26198076|P1|Overall Study|Adverse Event|1
7538517|NCT02603432|26198075|P2|Overall Study|Ongoing|144
7538518|NCT02603432|26198076|P1|Overall Study|Ongoing|184
7538519|NCT02603419|26198130|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
7538520|NCT02603419|26198131|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7538521|NCT02603419|26198132|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7538522|NCT02603419|26198133|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7538523|NCT02603419|26198134|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7538524|NCT02603419|26198135|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7538525|NCT02603419|26198130|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
7538526|NCT02603419|26198131|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7538527|NCT02603419|26198132|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7538528|NCT02603419|26198133|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7538529|NCT02603419|26198134|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7538530|NCT02603419|26198135|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7538531|NCT02603419|26198130|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
7538532|NCT02603419|26198131|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7538533|NCT02603419|26198132|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7538534|NCT02603419|26198133|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7538535|NCT02603419|26198134|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7538536|NCT02603419|26198135|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7538695|NCT02601469|26198947|P1|Overall Study|Enrolled in Error|1
7538537|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7538538|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7538539|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
7538540|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7538541|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7538542|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7538543|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7538544|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7538545|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7538546|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7538547|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7538548|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
7538549|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7538550|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7538551|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7538552|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7538553|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
7538554|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7538555|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7538556|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
7538557|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7538558|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7538559|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7538560|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7538561|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7538562|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
7538563|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7538564|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
7538565|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7538566|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
7538567|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
7538568|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
7538569|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7538570|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7538571|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7538572|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7538573|NCT02603419|26198130|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7538574|NCT02603419|26198131|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7538575|NCT02603419|26198132|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7538576|NCT02603419|26198133|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7538577|NCT02603419|26198134|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
7538578|NCT02603419|26198135|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7538579|NCT02603393|26198322|P2|Overall Study|Sponsor decision|0
7538580|NCT02603393|26198323|P1|Overall Study|Sponsor decision|1
7538581|NCT02603393|26198322|P2|Overall Study|Non-compliance with study treatment|0
7538582|NCT02603393|26198323|P1|Overall Study|Non-compliance with study treatment|1
7538583|NCT02603393|26198322|P2|Overall Study|Lost to Follow-up|2
7538584|NCT02603393|26198323|P1|Overall Study|Lost to Follow-up|1
7538585|NCT02603393|26198322|P2|Overall Study|Protocol deviation|3
7538586|NCT02603393|26198323|P1|Overall Study|Protocol deviation|2
7538587|NCT02603393|26198322|P2|Overall Study|Physician Decision|3
7538588|NCT02603393|26198323|P1|Overall Study|Physician Decision|3
7538589|NCT02603393|26198322|P2|Overall Study|Death|4
7538590|NCT02603393|26198323|P1|Overall Study|Death|3
7538591|NCT02603393|26198322|P2|Overall Study|Lack of Efficacy|2
7538592|NCT02603393|26198323|P1|Overall Study|Lack of Efficacy|7
7538593|NCT02603393|26198322|P2|Overall Study|Technical problems|7
7538594|NCT02603393|26198323|P1|Overall Study|Technical problems|4
7538595|NCT02603393|26198322|P2|Overall Study|Adverse Event|15
7538596|NCT02603393|26198323|P1|Overall Study|Adverse Event|17
7538597|NCT02603393|26198322|P2|Overall Study|Patient/guardian decision|18
7538598|NCT02603393|26198323|P1|Overall Study|Patient/guardian decision|32
7538599|NCT02603172|26198362|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
7538600|NCT02603172|26198363|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
7538601|NCT02603172|26198364|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
7538602|NCT02603172|26198365|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
7538603|NCT02603172|26198366|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
7538604|NCT02603172|26198367|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
7538605|NCT02603172|26198368|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
7538606|NCT02603172|26198369|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
7538607|NCT02603120|26198497|P2|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
7538608|NCT02603120|26198498|P1|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
7538609|NCT02603120|26198497|P2|OL Extension B/F/TAF Treatment Phase|Death|1
7538610|NCT02603120|26198498|P1|OL Extension B/F/TAF Treatment Phase|Death|0
7538611|NCT02603120|26198497|P2|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
7538612|NCT02603120|26198498|P1|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
7538613|NCT02603120|26198497|P2|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
7538614|NCT02603120|26198498|P1|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
7538615|NCT02603120|26198497|P2|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
7538616|NCT02603120|26198498|P1|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
7538617|NCT02603120|26198497|P2|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
7538618|NCT02603120|26198498|P1|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
7538619|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Did not receive study drug|2
7538620|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Did not receive study drug|2
7538621|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Non-compliance with study drug|0
7538622|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Non-compliance with study drug|1
7538623|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Pregnancy|1
7538624|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Pregnancy|1
7538625|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Investigator's discretion|0
7538626|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Investigator's discretion|2
7538627|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Death|0
7538628|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Death|2
7538629|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
7538630|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Lost to Follow-up|4
7538631|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Adverse Event|3
7538632|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Adverse Event|3
7538633|NCT02603120|26198497|P2|Double-Blind Treatment Phase|Withdrew consent|8
7538634|NCT02603120|26198498|P1|Double-Blind Treatment Phase|Withdrew consent|4
7538635|NCT02603107|26198520|P2|Optional Extension Phase|Protocol Violation|0
7538636|NCT02603107|26198521|P1|Optional Extension Phase|Protocol Violation|1
7538637|NCT02603107|26198520|P2|Optional Extension Phase|Not treated in extension phase|1
7538638|NCT02603107|26198521|P1|Optional Extension Phase|Not treated in extension phase|0
7538639|NCT02603107|26198520|P2|Optional Extension Phase|Adverse Event|2
7538640|NCT02603107|26198521|P1|Optional Extension Phase|Adverse Event|0
7538641|NCT02603107|26198520|P2|Optional Extension Phase|Pregnancy|3
7538642|NCT02603107|26198521|P1|Optional Extension Phase|Pregnancy|0
7538643|NCT02603107|26198520|P2|Optional Extension Phase|Investigator's discretion|2
7538644|NCT02603107|26198521|P1|Optional Extension Phase|Investigator's discretion|2
7538645|NCT02603107|26198520|P2|Optional Extension Phase|Withdrew consent|2
7538646|NCT02603107|26198521|P1|Optional Extension Phase|Withdrew consent|3
7538647|NCT02603107|26198520|P2|Optional Extension Phase|Lost to Follow-up|3
7538648|NCT02603107|26198521|P1|Optional Extension Phase|Lost to Follow-up|3
7538649|NCT02603107|26198520|P2|Randomized Phase|Protocol Violation|0
7538650|NCT02603107|26198521|P1|Randomized Phase|Protocol Violation|1
7538651|NCT02603107|26198520|P2|Randomized Phase|Lack of Efficacy|0
7538652|NCT02603107|26198521|P1|Randomized Phase|Lack of Efficacy|1
7538653|NCT02603107|26198520|P2|Randomized Phase|Investigator's discretion|1
7538654|NCT02603107|26198521|P1|Randomized Phase|Investigator's discretion|0
7538655|NCT02603107|26198520|P2|Randomized Phase|Non-compliance with study drug|1
7538656|NCT02603107|26198521|P1|Randomized Phase|Non-compliance with study drug|1
7538657|NCT02603107|26198520|P2|Randomized Phase|Death|1
7538658|NCT02603107|26198521|P1|Randomized Phase|Death|1
7538659|NCT02603107|26198520|P2|Randomized Phase|Adverse Event|0
7538660|NCT02603107|26198521|P1|Randomized Phase|Adverse Event|2
7538661|NCT02603107|26198520|P2|Randomized Phase|Lost to Follow-up|3
7538662|NCT02603107|26198521|P1|Randomized Phase|Lost to Follow-up|1
7538663|NCT02603107|26198520|P2|Randomized Phase|Withdrew consent|15
7538664|NCT02603107|26198521|P1|Randomized Phase|Withdrew consent|8
7538665|NCT02602080|26198586|P3|Overall Study|Protocol Violation|3
7538666|NCT02602080|26198587|P2|Overall Study|Protocol Violation|1
7538667|NCT02602080|26198588|P1|Overall Study|Protocol Violation|6
7538668|NCT02601820|26198631|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
7538669|NCT02601820|26198631|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
7538670|NCT02601820|26198631|P1|Late On-Treatment (T3)|missing T3 Record|49
7538671|NCT02601820|26198631|P1|Early On-Treatment (T2)|Missing T2 Record|51
7538672|NCT02601625|26198660|P4|Overall Study|Lost to Follow-up|1
7538673|NCT02601625|26198661|P3|Overall Study|Lost to Follow-up|1
7538674|NCT02601625|26198662|P2|Overall Study|Lost to Follow-up|0
7538675|NCT02601625|26198663|P1|Overall Study|Lost to Follow-up|0
7538676|NCT02601573|26198716|P5|Overall Study|Withdrawal by Subject|0
7538677|NCT02601573|26198717|P4|Overall Study|Withdrawal by Subject|1
7538678|NCT02601573|26198718|P3|Overall Study|Withdrawal by Subject|0
7538679|NCT02601573|26198719|P2|Overall Study|Withdrawal by Subject|1
7538680|NCT02601573|26198720|P1|Overall Study|Withdrawal by Subject|0
7538681|NCT02601573|26198716|P5|Overall Study|Lost to Follow-up|2
7538682|NCT02601573|26198717|P4|Overall Study|Lost to Follow-up|0
7538683|NCT02601573|26198718|P3|Overall Study|Lost to Follow-up|1
7538684|NCT02601573|26198719|P2|Overall Study|Lost to Follow-up|3
7538685|NCT02601573|26198720|P1|Overall Study|Lost to Follow-up|0
7538686|NCT02601560|26198755|P8|Overall Study|Other|0
7538687|NCT02601560|26198756|P7|Overall Study|Other|1
7538688|NCT02601560|26198757|P6|Overall Study|Other|0
7538689|NCT02601560|26198758|P5|Overall Study|Other|0
7538690|NCT02601560|26198759|P4|Overall Study|Other|0
7538691|NCT02601560|26198760|P3|Overall Study|Other|0
7538692|NCT02601560|26198761|P2|Overall Study|Other|0
7538693|NCT02601560|26198762|P1|Overall Study|Other|0
7538694|NCT02601469|26198946|P2|Overall Study|Enrolled in Error|0
7538696|NCT02601313|26198956|P3|Overall Study|Enrolled, did not initiate AC|0
7538697|NCT02601313|26198957|P2|Overall Study|Enrolled, did not initiate AC|0
7538698|NCT02601313|26198958|P1|Overall Study|Enrolled, did not initiate AC|4
7538699|NCT02601313|26198956|P3|Overall Study|Still on study|10
7538700|NCT02601313|26198957|P2|Overall Study|Still on study|52
7538701|NCT02601313|26198958|P1|Overall Study|Still on study|0
7538702|NCT02601313|26198956|P3|Overall Study|Enrolled, did not initiate KTE-X19|1
7538703|NCT02601313|26198957|P2|Overall Study|Enrolled, did not initiate KTE-X19|1
7538704|NCT02601313|26198958|P1|Overall Study|Enrolled, did not initiate KTE-X19|0
7538705|NCT02601313|26198956|P3|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
7538706|NCT02601313|26198957|P2|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
7538707|NCT02601313|26198958|P1|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
7538708|NCT02601313|26198956|P3|Overall Study|Death|4
7538709|NCT02601313|26198957|P2|Overall Study|Death|16
7538710|NCT02601313|26198958|P1|Overall Study|Death|2
7538711|NCT02601300|26198977|P1|Extension Phase|Lack of Efficacy|10
7538712|NCT02601300|26198977|P1|Extension Phase|Adverse Event|4
7538713|NCT02601300|26198977|P1|Extension Phase|Withdrawal by Subject|3
7538714|NCT02601300|26198977|P1|Induction Phase|Protocol Violation|1
7538715|NCT02601300|26198977|P1|Induction Phase|Lack of Efficacy|2
7538716|NCT02601209|26198997|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7538717|NCT02601209|26198998|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7538718|NCT02601209|26198999|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7538719|NCT02601209|26199000|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
7538720|NCT02601209|26199001|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7538721|NCT02601209|26199002|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7538722|NCT02601209|26199003|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7538723|NCT02601209|26199004|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7538724|NCT02601209|26199005|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7538725|NCT02601209|26198997|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7538726|NCT02601209|26198998|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7538727|NCT02601209|26198999|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7538728|NCT02601209|26199000|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7538729|NCT02601209|26199001|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7538730|NCT02601209|26199002|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7538731|NCT02601209|26199003|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7538732|NCT02601209|26199004|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7538733|NCT02601209|26199005|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7538734|NCT02601027|26199062|P2|Registration to Surgery|Withdrawal by Subject|10
7538735|NCT02601027|26199063|P1|Registration to Surgery|Withdrawal by Subject|20
7538736|NCT02601001|26199082|P7|Dosing Period 2|Adverse Event|1
7538737|NCT02601001|26199083|P6|Dosing Period 2|Adverse Event|0
7538738|NCT02601001|26199084|P5|Dosing Period 2|Adverse Event|0
7538739|NCT02601001|26199085|P4|Dosing Period 2|Adverse Event|0
7538740|NCT02601001|26199086|P3|Dosing Period 2|Adverse Event|0
7538741|NCT02601001|26199087|P2|Dosing Period 2|Adverse Event|0
7538742|NCT02601001|26199088|P1|Dosing Period 2|Adverse Event|0
7538743|NCT02600923|26199148|P1|Overall Study|Not treated|1
7538744|NCT02600923|26199148|P1|Overall Study|Study terminated by Sponsor|53
7538745|NCT02600923|26199148|P1|Overall Study|Objective progression or relapse|50
7538746|NCT02600923|26199148|P1|Overall Study|Withdrawal by Subject|5
7538747|NCT02600923|26199148|P1|Overall Study|Lost to Follow-up|1
7538748|NCT02600923|26199148|P1|Overall Study|Insufficient clinical response|6
7538749|NCT02600923|26199148|P1|Overall Study|Global deterioration of health status|2
7538750|NCT02600923|26199148|P1|Overall Study|Adverse Event|3
7538751|NCT02600923|26199148|P1|Overall Study|Death|10
7538752|NCT02600871|26199158|P2|Overall Study|Lost to Follow-up|10
7538753|NCT02600871|26199159|P1|Overall Study|Lost to Follow-up|13
7538754|NCT02600845|26199169|P1|Overall Study|Consent Withdrawal|5
7538755|NCT02600845|26199169|P1|Overall Study|Non-compliance with Study Procedures|10
7538756|NCT02600845|26199169|P1|Overall Study|Reason Not Specified|3
7538757|NCT02600819|26199184|P2|GEN Phase|Lost to Follow-up|0
7538758|NCT02600819|26199185|P1|GEN Phase|Lost to Follow-up|2
7538759|NCT02600819|26199184|P2|GEN Phase|Withdrew Consent|0
7538760|NCT02600819|26199185|P1|GEN Phase|Withdrew Consent|5
7538761|NCT02600819|26199184|P2|GEN Phase|Non-Compliance with Study Drug|0
7538762|NCT02600819|26199185|P1|GEN Phase|Non-Compliance with Study Drug|1
7538763|NCT02600819|26199184|P2|GEN Phase|Investigator's Discretion|0
7538764|NCT02600819|26199185|P1|GEN Phase|Investigator's Discretion|4
7538765|NCT02600819|26199184|P2|GEN Phase|Death|0
7538766|NCT02600819|26199185|P1|GEN Phase|Death|2
7538767|NCT02600819|26199184|P2|GEN Phase|Adverse Event|0
7538768|NCT02600819|26199185|P1|GEN Phase|Adverse Event|2
7538769|NCT02600559|26199265|P1|Overall Study|Lost to Follow-up|20
7538770|NCT02600559|26199265|P1|Overall Study|Withdrawal by Subject|3
7538771|NCT02600351|26199306|P4|Overall Study|Randomized but Not Treated|3
7538772|NCT02600351|26199307|P3|Overall Study|Randomized but Not Treated|1
7538773|NCT02600351|26199308|P2|Overall Study|Randomized but Not Treated|0
7538774|NCT02600351|26199309|P1|Overall Study|Randomized but Not Treated|1
7538775|NCT02600351|26199306|P4|Overall Study|Lost to Follow-up|0
7538776|NCT02600351|26199307|P3|Overall Study|Lost to Follow-up|0
7538777|NCT02600351|26199308|P2|Overall Study|Lost to Follow-up|0
7538778|NCT02600351|26199309|P1|Overall Study|Lost to Follow-up|1
7538779|NCT02600351|26199306|P4|Overall Study|Lack of Efficacy|2
7538780|NCT02600351|26199307|P3|Overall Study|Lack of Efficacy|5
7538781|NCT02600351|26199308|P2|Overall Study|Lack of Efficacy|0
7538782|NCT02600351|26199309|P1|Overall Study|Lack of Efficacy|3
7538783|NCT02599961|26199344|P1|Overall Study|Other, Not Specified|3
7538784|NCT02599961|26199344|P1|Overall Study|Discontinuation of Study by Sponsor|9
7538785|NCT02599961|26199344|P1|Overall Study|Subject Non-Compliance|2
7538786|NCT02599961|26199344|P1|Overall Study|Withdrawal by Subject|1
7538787|NCT02599688|26199386|P1|Overall Study|Termination by Sponsor|2
7538788|NCT02599688|26199386|P1|Overall Study|Withdrawal by Subject|1
7538789|NCT02599688|26199386|P1|Overall Study|Lack of Efficacy|1
7538790|NCT02599402|26199413|P1|Overall Study|Other Reasons|95
7538791|NCT02599402|26199413|P1|Overall Study|Participant no longer met study criteria|7
7538792|NCT02599402|26199413|P1|Overall Study|Pregnancy|1
7538793|NCT02599402|26199413|P1|Overall Study|Poor/non-compliance|1
7538794|NCT02599402|26199413|P1|Overall Study|Maximum Clinical Benefit|7
7538795|NCT02599402|26199413|P1|Overall Study|Lost to Follow-up|1
7538796|NCT02599402|26199413|P1|Overall Study|Participant withdrew consent|5
7538797|NCT02599402|26199413|P1|Overall Study|Participant request to discontinue study treatment|13
7538798|NCT02599402|26199413|P1|Overall Study|Adverse Event unrelated to study drug|23
7538799|NCT02599402|26199413|P1|Overall Study|Death|26
7538800|NCT02599402|26199413|P1|Overall Study|Study drug toxicity|201
7538801|NCT02599402|26199413|P1|Overall Study|Disease progression|153
7538802|NCT02599129|26199541|P2|Overall Study|Withdrawal by Subject|1
7538803|NCT02599129|26199542|P1|Overall Study|Withdrawal by Subject|2
7538804|NCT02599129|26199541|P2|Overall Study|Lost to Follow-up|0
7538805|NCT02599129|26199542|P1|Overall Study|Lost to Follow-up|1
7538806|NCT02599129|26199541|P2|Overall Study|Lack of Efficacy|2
7538807|NCT02599129|26199542|P1|Overall Study|Lack of Efficacy|2
7538808|NCT02598934|26199558|P2|Overall Study|Protocol Violation|2
7538809|NCT02598934|26199559|P1|Overall Study|Protocol Violation|1
7538810|NCT02598934|26199558|P2|Overall Study|Administrative|1
7538811|NCT02598934|26199559|P1|Overall Study|Administrative|2
7538812|NCT02598934|26199558|P2|Overall Study|Withdrawal by Subject|3
7538813|NCT02598934|26199559|P1|Overall Study|Withdrawal by Subject|2
7538814|NCT02598934|26199558|P2|Overall Study|Failure to Return|3
7538815|NCT02598934|26199559|P1|Overall Study|Failure to Return|3
7538816|NCT02598934|26199558|P2|Overall Study|Adverse Event|13
7538817|NCT02598934|26199559|P1|Overall Study|Adverse Event|11
7538818|NCT02598622|26199571|P2|Overall Study|Physician Decision|0
7538819|NCT02598622|26199572|P1|Overall Study|Physician Decision|3
7538820|NCT02598622|26199571|P2|Overall Study|Withdrawal by Subject|0
7538821|NCT02598622|26199572|P1|Overall Study|Withdrawal by Subject|3
7538822|NCT02598297|26199601|P2|Overall Study|Followed for survival|0
7538823|NCT02598297|26199602|P1|Overall Study|Followed for survival|1
7538824|NCT02598297|26199601|P2|Overall Study|Subject/guardian decision|0
7538825|NCT02598297|26199602|P1|Overall Study|Subject/guardian decision|1
7538826|NCT02598297|26199601|P2|Overall Study|Physician Decision|0
7538827|NCT02598297|26199602|P1|Overall Study|Physician Decision|1
7538828|NCT02598297|26199601|P2|Overall Study|Adverse Event|1
7538829|NCT02598297|26199602|P1|Overall Study|Adverse Event|1
7538830|NCT02598297|26199601|P2|Overall Study|Study terminated by Sponsor|23
7538831|NCT02598297|26199602|P1|Overall Study|Study terminated by Sponsor|21
7538832|NCT02598193|26199628|P1|Overall Study|Does not want to take Nintedanib|1
7538833|NCT02598193|26199628|P1|Overall Study|Listed in active lung transplant list|1
7538834|NCT02598193|26199628|P1|Overall Study|Withdrawal by Subject|1
7538835|NCT02598193|26199628|P1|Overall Study|Adverse Event|13
7538836|NCT02598128|26199636|P4|Period A: Days -7 to -1|Adverse Event|0
7538837|NCT02598128|26199637|P3|Period A: Days -7 to -1|Adverse Event|0
7538838|NCT02598128|26199638|P2|Period A: Days -7 to -1|Adverse Event|0
7538839|NCT02598128|26199639|P1|Period A: Days -7 to -1|Adverse Event|1
7538840|NCT02598076|26199682|P2|Overall Study|Lost to Follow-up|3
7538841|NCT02598076|26199683|P1|Overall Study|Lost to Follow-up|2
7538842|NCT02597946|26199697|P1|Overall Study|Other than above|1
7538843|NCT02597946|26199697|P1|Overall Study|Progressive disease|16
7538844|NCT02597946|26199697|P1|Overall Study|Withdrawal by Subject|1
7538845|NCT02597933|26199708|P2|Overall Study|Other than stated above|14
7538846|NCT02597933|26199709|P1|Overall Study|Other than stated above|7
7538847|NCT02597933|26199708|P2|Overall Study|Not treated|2
7538848|NCT02597933|26199709|P1|Overall Study|Not treated|2
7538849|NCT02597933|26199708|P2|Overall Study|Adverse Event|28
7538850|NCT02597933|26199709|P1|Overall Study|Adverse Event|20
7538851|NCT02597933|26199708|P2|Overall Study|Protocol Violation|2
7538852|NCT02597933|26199709|P1|Overall Study|Protocol Violation|2
7538853|NCT02597933|26199708|P2|Overall Study|Withdrawal by Subject|5
7538854|NCT02597933|26199709|P1|Overall Study|Withdrawal by Subject|7
7538855|NCT02597920|26199740|P3|Overall Study|Other|0
7538856|NCT02597920|26199741|P2|Overall Study|Other|0
7538857|NCT02597920|26199742|P1|Overall Study|Other|1
7538858|NCT02597920|26199740|P3|Overall Study|Other than specified|5
7538859|NCT02597920|26199741|P2|Overall Study|Other than specified|31
7538860|NCT02597920|26199742|P1|Overall Study|Other than specified|10
7538861|NCT02597920|26199740|P3|Overall Study|Refuse to continue in the study|1
7538862|NCT02597920|26199741|P2|Overall Study|Refuse to continue in the study|13
7538863|NCT02597920|26199742|P1|Overall Study|Refuse to continue in the study|3
7538864|NCT02597920|26199740|P3|Overall Study|Lost to Follow-up|0
7538865|NCT02597920|26199741|P2|Overall Study|Lost to Follow-up|9
7538866|NCT02597920|26199742|P1|Overall Study|Lost to Follow-up|7
7538867|NCT02597920|26199740|P3|Overall Study|Other adverse event|0
7538868|NCT02597920|26199741|P2|Overall Study|Other adverse event|30
7538869|NCT02597920|26199742|P1|Overall Study|Other adverse event|20
7538870|NCT02597920|26199740|P3|Overall Study|Worsening of other pre-existing disease|0
7538871|NCT02597920|26199741|P2|Overall Study|Worsening of other pre-existing disease|1
7538872|NCT02597920|26199742|P1|Overall Study|Worsening of other pre-existing disease|0
7538873|NCT02597855|26199776|P2|Overall Study|Lost to Follow-up|1
7538874|NCT02597855|26199777|P1|Overall Study|Lost to Follow-up|2
7538875|NCT02597712|26199787|P2|Overall Study|Recurrent metastatic prostate cancer|1
7538876|NCT02597712|26199788|P1|Overall Study|Recurrent metastatic prostate cancer|0
7538877|NCT02597712|26199787|P2|Overall Study|Baseline biopsies showed low grade dysplasia|0
7538878|NCT02597712|26199788|P1|Overall Study|Baseline biopsies showed low grade dysplasia|1
7538879|NCT02597712|26199787|P2|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
7538880|NCT02597712|26199788|P1|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
7538881|NCT02597478|26199896|P2|Overall Study|Insufficient exertional dyspnea|1
7538882|NCT02597478|26199897|P1|Overall Study|Insufficient exertional dyspnea|0
7538883|NCT02597478|26199896|P2|Overall Study|Change of opioid dose|0
7538884|NCT02597478|26199897|P1|Overall Study|Change of opioid dose|1
7538885|NCT02597478|26199896|P2|Overall Study|Withdrawal by Subject|0
7538886|NCT02597478|26199897|P1|Overall Study|Withdrawal by Subject|2
7538887|NCT02597452|26199911|P1|Overall Study|testing incomplete|30
7538888|NCT02597062|26200048|P1|Overall Study|Ineligible|1
7538889|NCT02597049|26200057|P3|Overall Study|Noncompliant with Study Visits|0
7538890|NCT02597049|26200058|P2|Overall Study|Noncompliant with Study Visits|0
7538891|NCT02597049|26200059|P1|Overall Study|Noncompliant with Study Visits|1
7538892|NCT02597049|26200057|P3|Overall Study|Death|0
7538893|NCT02597049|26200058|P2|Overall Study|Death|0
7538894|NCT02597049|26200059|P1|Overall Study|Death|2
7538895|NCT02597049|26200057|P3|Overall Study|Adverse Event|0
7538896|NCT02597049|26200058|P2|Overall Study|Adverse Event|0
7538897|NCT02597049|26200059|P1|Overall Study|Adverse Event|2
7538898|NCT02597049|26200057|P3|Overall Study|Withdrawal by Subject|1
7538899|NCT02597049|26200058|P2|Overall Study|Withdrawal by Subject|2
7538900|NCT02597049|26200059|P1|Overall Study|Withdrawal by Subject|2
7538901|NCT02597049|26200057|P3|Overall Study|Lost to Follow-up|2
7538902|NCT02597049|26200058|P2|Overall Study|Lost to Follow-up|3
7538903|NCT02597049|26200059|P1|Overall Study|Lost to Follow-up|0
7538904|NCT02596971|26200100|P3|Overall Study|Withdrawal by Subject|4
7538905|NCT02596971|26200101|P2|Overall Study|Withdrawal by Subject|1
7538906|NCT02596971|26200102|P1|Overall Study|Withdrawal by Subject|5
7538907|NCT02596971|26200100|P3|Overall Study|Death|5
7538908|NCT02596971|26200101|P2|Overall Study|Death|1
7538909|NCT02596971|26200102|P1|Overall Study|Death|5
7538910|NCT02596958|26200139|P1|Overall Study|Excluded Due to Second Line Treatment|9
7538911|NCT02596958|26200139|P1|Overall Study|Missing|32
7538912|NCT02596958|26200139|P1|Overall Study|Lost to Follow-up|33
7538913|NCT02596958|26200139|P1|Overall Study|Administrative Reasons/Other|231
7538914|NCT02596958|26200139|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
7538915|NCT02596958|26200139|P1|Overall Study|Death From Other Cause|33
7538916|NCT02596958|26200139|P1|Overall Study|Death From Cancer|112
7538917|NCT02596958|26200139|P1|Overall Study|Cancer Progression|441
7538918|NCT02596958|26200139|P1|Overall Study|Serious Adverse Drug Reactions|44
7538919|NCT02596945|26200151|P1|Overall Study|Missing|1
7538920|NCT02596945|26200151|P1|Overall Study|Withdrawal by Subject|1
7538921|NCT02596945|26200151|P1|Overall Study|Other Erythropoietin stimulating agent|4
7538922|NCT02596945|26200151|P1|Overall Study|Change to hemodialysis|15
7538923|NCT02596945|26200151|P1|Overall Study|Other|32
7538924|NCT02596945|26200151|P1|Overall Study|No documentation of study drug dosing|3
7538925|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
7538926|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
7538927|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
7538928|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
7538929|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
7538930|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7538931|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7538932|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7538933|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Death|0
7538934|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Death|1
7538935|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Death|0
7538936|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Death|0
7538937|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
7538938|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
7538939|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7538940|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7538941|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7538942|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7538943|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7538944|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
7538945|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7538946|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
7538947|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7538948|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
7538949|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
7538950|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
7538951|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
7538952|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
7538953|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
7538954|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7538955|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7538956|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
7538957|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
7538958|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7538959|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7538960|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7538961|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
7538962|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7538963|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7538964|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
7538965|NCT02596893|26200172|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
7538966|NCT02596893|26200173|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
7538967|NCT02596893|26200174|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
7538968|NCT02596893|26200175|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
7538969|NCT02596854|26200234|P1|Overall Study|Withdrawn|8
7538970|NCT02596711|26200256|P3|Overall Study|Lost to Follow-up|3
7538971|NCT02596711|26200257|P2|Overall Study|Lost to Follow-up|2
7538972|NCT02596711|26200258|P1|Overall Study|Lost to Follow-up|1
7538973|NCT02596620|26200274|P2|Overall Study|Lost to Follow-up|1
7538974|NCT02596620|26200275|P1|Overall Study|Lost to Follow-up|1
7538975|NCT02596230|26200313|P5|Objective 2, One Year|Other|0
7538976|NCT02596230|26200314|P4|Objective 2, One Year|Other|0
7538977|NCT02596230|26200315|P3|Objective 2, One Year|Other|2
7538978|NCT02596230|26200316|P2|Objective 2, One Year|Other|3
7538979|NCT02596230|26200317|P1|Objective 2, One Year|Other|0
7538980|NCT02596230|26200313|P5|Objective 2, One Year|Death|30
7538981|NCT02596230|26200314|P4|Objective 2, One Year|Death|21
7538982|NCT02596230|26200315|P3|Objective 2, One Year|Death|41
7538983|NCT02596230|26200316|P2|Objective 2, One Year|Death|12
7538984|NCT02596230|26200317|P1|Objective 2, One Year|Death|0
7538985|NCT02596230|26200313|P5|Objective 2, One Year|Adverse drug reaction|0
7538986|NCT02596230|26200314|P4|Objective 2, One Year|Adverse drug reaction|0
7538987|NCT02596230|26200315|P3|Objective 2, One Year|Adverse drug reaction|0
7538988|NCT02596230|26200316|P2|Objective 2, One Year|Adverse drug reaction|1
7538989|NCT02596230|26200317|P1|Objective 2, One Year|Adverse drug reaction|0
7538990|NCT02596230|26200313|P5|Objective 2, One Year|Withdrawal by Subject|2
7538991|NCT02596230|26200314|P4|Objective 2, One Year|Withdrawal by Subject|5
7538992|NCT02596230|26200315|P3|Objective 2, One Year|Withdrawal by Subject|14
7538993|NCT02596230|26200316|P2|Objective 2, One Year|Withdrawal by Subject|11
7538994|NCT02596230|26200317|P1|Objective 2, One Year|Withdrawal by Subject|0
7538995|NCT02596230|26200313|P5|Objective 2, One Year|Lost to Follow-up|46
7538996|NCT02596230|26200314|P4|Objective 2, One Year|Lost to Follow-up|32
7538997|NCT02596230|26200315|P3|Objective 2, One Year|Lost to Follow-up|41
7538998|NCT02596230|26200316|P2|Objective 2, One Year|Lost to Follow-up|41
7538999|NCT02596230|26200317|P1|Objective 2, One Year|Lost to Follow-up|0
7539000|NCT02596230|26200313|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
7539001|NCT02596230|26200314|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
7539002|NCT02596230|26200315|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
7539003|NCT02596230|26200316|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
7539004|NCT02596230|26200317|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
7539005|NCT02596035|26200341|P3|Overall Study|Other Reasons|0
7539006|NCT02596035|26200342|P2|Overall Study|Other Reasons|4
7539007|NCT02596035|26200343|P1|Overall Study|Other Reasons|3
7539008|NCT02596035|26200341|P3|Overall Study|Poor/Non-Compliance|0
7539009|NCT02596035|26200342|P2|Overall Study|Poor/Non-Compliance|1
7539010|NCT02596035|26200343|P1|Overall Study|Poor/Non-Compliance|0
7539011|NCT02596035|26200341|P3|Overall Study|Withdrawal by Subject|0
7539012|NCT02596035|26200342|P2|Overall Study|Withdrawal by Subject|2
7539013|NCT02596035|26200343|P1|Overall Study|Withdrawal by Subject|4
7539014|NCT02596035|26200341|P3|Overall Study|Adverse Event|0
7539015|NCT02596035|26200342|P2|Overall Study|Adverse Event|2
7539016|NCT02596035|26200343|P1|Overall Study|Adverse Event|6
7539017|NCT02596035|26200341|P3|Overall Study|Study Drug Toxicity|0
7539018|NCT02596035|26200342|P2|Overall Study|Study Drug Toxicity|3
7539019|NCT02596035|26200343|P1|Overall Study|Study Drug Toxicity|11
7539020|NCT02596035|26200341|P3|Overall Study|Disease Progression|1
7539021|NCT02596035|26200342|P2|Overall Study|Disease Progression|32
7539022|NCT02596035|26200343|P1|Overall Study|Disease Progression|62
7539023|NCT02596009|26200379|P6|Overall Study|Administrative problems|0
7539024|NCT02596009|26200380|P5|Overall Study|Administrative problems|0
7539025|NCT02596009|26200381|P4|Overall Study|Administrative problems|0
7539026|NCT02596009|26200382|P3|Overall Study|Administrative problems|0
7539027|NCT02596009|26200383|P2|Overall Study|Administrative problems|1
7539028|NCT02596009|26200384|P1|Overall Study|Administrative problems|0
7539029|NCT02595970|26200401|P1|Overall Study|Lack of Efficacy|7
7539030|NCT02595970|26200401|P1|Overall Study|Adverse Event|5
7539031|NCT02595970|26200401|P1|Overall Study|Protocol Violation|4
7539032|NCT02595970|26200401|P1|Overall Study|Physician Decision|2
7539033|NCT02595970|26200401|P1|Overall Study|Withdrawal by Subject|2
7539034|NCT02595723|26200418|P3|First Washout (21 Days)|Lost to Follow-up|0
7539035|NCT02595723|26200419|P2|First Washout (21 Days)|Lost to Follow-up|0
7539036|NCT02595723|26200420|P1|First Washout (21 Days)|Lost to Follow-up|1
7539037|NCT02595723|26200418|P3|First Washout (21 Days)|Withdrawal by Subject|0
7539038|NCT02595723|26200419|P2|First Washout (21 Days)|Withdrawal by Subject|0
7539039|NCT02595723|26200420|P1|First Washout (21 Days)|Withdrawal by Subject|1
7539040|NCT02595528|26200477|P4|Overall Study|Lost to Follow-up|1
7539041|NCT02595528|26200478|P3|Overall Study|Lost to Follow-up|0
7539042|NCT02595528|26200479|P2|Overall Study|Lost to Follow-up|1
7539043|NCT02595528|26200480|P1|Overall Study|Lost to Follow-up|1
7539044|NCT02595528|26200477|P4|Overall Study|Withdrawal by Subject|3
7539045|NCT02595528|26200478|P3|Overall Study|Withdrawal by Subject|1
7539046|NCT02595528|26200479|P2|Overall Study|Withdrawal by Subject|2
7539047|NCT02595528|26200480|P1|Overall Study|Withdrawal by Subject|1
7539048|NCT02595502|26200490|P2|Period 3|Received Incorrect Treatment at period 3|1
7539049|NCT02595502|26200491|P1|Period 3|Received Incorrect Treatment at period 3|0
7539050|NCT02595502|26200490|P2|Period 3|Lost to Follow-up|0
7539051|NCT02595502|26200491|P1|Period 3|Lost to Follow-up|1
7539052|NCT02595502|26200490|P2|Period 3|Protocol Violation|1
7539053|NCT02595502|26200491|P1|Period 3|Protocol Violation|0
7539054|NCT02595502|26200490|P2|Period 2|Received incorrect lens at Period 1|1
7539055|NCT02595502|26200491|P1|Period 2|Received incorrect lens at Period 1|0
7539056|NCT02595502|26200490|P2|Period 2|Adverse Event|1
7539057|NCT02595502|26200491|P1|Period 2|Adverse Event|1
7539058|NCT02595502|26200490|P2|Period 1|Lost to Follow-up|1
7539059|NCT02595502|26200491|P1|Period 1|Lost to Follow-up|0
7539060|NCT02595502|26200490|P2|Period 1|Withdrawal by Subject|0
7539061|NCT02595502|26200491|P1|Period 1|Withdrawal by Subject|1
7539062|NCT02595502|26200490|P2|Period 1|Adverse Event|1
7539063|NCT02595502|26200491|P1|Period 1|Adverse Event|0
7539064|NCT02595450|26200497|P1|Overall Study|Enrolled, but not treated|8
7539065|NCT02595450|26200497|P1|Overall Study|Unspecified (only completed 1 cycle)|73
7539066|NCT02595437|26200503|P1|Triferic Via IV|Withdrawal by Subject|1
7539067|NCT02595398|26200523|P2|Overall Study|Lost to Follow-up|0
7539068|NCT02595398|26200524|P1|Overall Study|Lost to Follow-up|1
7539069|NCT02595398|26200523|P2|Overall Study|Withdrawal by Subject|1
7539070|NCT02595398|26200524|P1|Overall Study|Withdrawal by Subject|2
7539071|NCT02595398|26200523|P2|Overall Study|Non-compliance|0
7539072|NCT02595398|26200524|P1|Overall Study|Non-compliance|1
7539073|NCT02595372|26200534|P1|Overall Study|Disease Progression|1
7539074|NCT02595372|26200534|P1|Overall Study|Physician Decision|2
7539075|NCT02595372|26200534|P1|Overall Study|Adverse Event|6
7539076|NCT02595073|26200545|P2|Overall Study|Protocol Violation|0
7539077|NCT02595073|26200546|P1|Overall Study|Protocol Violation|2
7539078|NCT02595073|26200545|P2|Overall Study|Progressive Disease|1
7539079|NCT02595073|26200546|P1|Overall Study|Progressive Disease|0
7539080|NCT02595008|26200556|P2|Overall Study|Enrolled In Error|0
7539081|NCT02595008|26200557|P1|Overall Study|Enrolled In Error|1
7539082|NCT02594163|26200595|P2|Follow-up Period|Physician Decision|1
7539083|NCT02594163|26200596|P1|Follow-up Period|Physician Decision|0
7539084|NCT02594163|26200595|P2|Follow-up Period|Progressive Disease|0
7539085|NCT02594163|26200596|P1|Follow-up Period|Progressive Disease|2
7539086|NCT02594163|26200595|P2|Follow-up Period|Adverse Event|1
7539087|NCT02594163|26200596|P1|Follow-up Period|Adverse Event|0
7539088|NCT02594163|26200595|P2|Follow-up Period|Death|5
7539089|NCT02594163|26200596|P1|Follow-up Period|Death|2
7539090|NCT02594163|26200595|P2|Follow-up Period|Lost to Follow-up|0
7539091|NCT02594163|26200596|P1|Follow-up Period|Lost to Follow-up|1
7539092|NCT02594163|26200595|P2|Follow-up Period|Study Termination by Sponsor|4
7539093|NCT02594163|26200596|P1|Follow-up Period|Study Termination by Sponsor|6
7539094|NCT02594163|26200595|P2|Follow-up Period|Withdrawal by Subject|1
7539095|NCT02594163|26200596|P1|Follow-up Period|Withdrawal by Subject|0
7539096|NCT02594163|26200595|P2|Treatment Period|Other, Non-AE|0
7539097|NCT02594163|26200596|P1|Treatment Period|Other, Non-AE|1
7539098|NCT02594163|26200595|P2|Treatment Period|Study termination by sponsor|1
7539099|NCT02594163|26200596|P1|Treatment Period|Study termination by sponsor|2
7539100|NCT02594163|26200595|P2|Treatment Period|Physician Decision|3
7539101|NCT02594163|26200596|P1|Treatment Period|Physician Decision|1
7539102|NCT02594163|26200595|P2|Treatment Period|Adverse Event|5
7539103|NCT02594163|26200596|P1|Treatment Period|Adverse Event|1
7539104|NCT02594163|26200595|P2|Treatment Period|Progressive disease|3
7539105|NCT02594163|26200596|P1|Treatment Period|Progressive disease|2
7539106|NCT02594098|26200627|P2|Overall Study|Other|1
7539107|NCT02594098|26200628|P1|Overall Study|Other|0
7539108|NCT02594098|26200627|P2|Overall Study|Seek alternative treatment|1
7539109|NCT02594098|26200628|P1|Overall Study|Seek alternative treatment|2
7539110|NCT02594098|26200627|P2|Overall Study|Terminated participation|2
7539111|NCT02594098|26200628|P1|Overall Study|Terminated participation|6
7539112|NCT02594098|26200627|P2|Overall Study|Withdrawal by Subject|3
7539113|NCT02594098|26200628|P1|Overall Study|Withdrawal by Subject|1
7539114|NCT02594098|26200627|P2|Overall Study|Lack of Efficacy|6
7539115|NCT02594098|26200628|P1|Overall Study|Lack of Efficacy|17
7539116|NCT02593864|26200697|P1|Overall Study|Lost to Follow-up|3
7539117|NCT02593864|26200697|P1|Overall Study|Withdrawal by Subject|3
7539118|NCT02593825|26200704|P2|Intervention|Lost to Follow-up|12
7539119|NCT02593825|26200705|P1|Intervention|Lost to Follow-up|10
7539120|NCT02593773|26200717|P1|Overall Study|Death|1
7539121|NCT02593773|26200717|P1|Overall Study|Study Terminated by Sponsor|31
7539122|NCT02593773|26200717|P1|Overall Study|Voluntary Withdrawal|3
7539123|NCT02593539|26200748|P1|Overall Study|Adverse Event|1
7539124|NCT02593318|26200788|P2|Overall Study|Withdrawal by Subject|1
7539125|NCT02593318|26200789|P1|Overall Study|Withdrawal by Subject|1
7539126|NCT02593305|26200804|P3|Post 1|Comparison only group. No intervention.|10
7539127|NCT02593305|26200805|P2|Post 1|Comparison only group. No intervention.|0
7539128|NCT02593305|26200806|P1|Post 1|Comparison only group. No intervention.|0
7539129|NCT02593149|26200821|P2|Intervention|Didn't use CVC for at least 21 day|115
7539130|NCT02593149|26200822|P1|Intervention|Didn't use CVC for at least 21 day|116
7539131|NCT02593149|26200821|P2|Run-In|Didn't use CVC for at least 21 days|38
7539132|NCT02593149|26200822|P1|Run-In|Didn't use CVC for at least 21 days|36
7539133|NCT02593097|26200830|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7539134|NCT02593097|26200831|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7539135|NCT02593097|26200830|P2|Second Intervention (12 Weeks)|Lack of Efficacy|0
7539136|NCT02593097|26200831|P1|Second Intervention (12 Weeks)|Lack of Efficacy|1
7539137|NCT02593097|26200830|P2|Second Intervention (12 Weeks)|Lost to Follow-up|1
7539138|NCT02593097|26200831|P1|Second Intervention (12 Weeks)|Lost to Follow-up|1
7539139|NCT02593097|26200830|P2|First Intervention (12 Weeks)|Withdrawal by Subject|2
7539140|NCT02593097|26200831|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
7539141|NCT02593097|26200830|P2|First Intervention (12 Weeks)|Lost to Follow-up|2
7539142|NCT02593097|26200831|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
7539143|NCT02592876|26200868|P2|Overall Study|Death|9
7539144|NCT02592876|26200869|P1|Overall Study|Death|6
7539145|NCT02592876|26200868|P2|Overall Study|Lost to Follow-up|1
7539146|NCT02592876|26200869|P1|Overall Study|Lost to Follow-up|0
7539147|NCT02592876|26200868|P2|Overall Study|Study Termination by Sponsor|27
7539148|NCT02592876|26200869|P1|Overall Study|Study Termination by Sponsor|32
7539149|NCT02592876|26200868|P2|Overall Study|Withdrawal by Subject|3
7539150|NCT02592876|26200869|P1|Overall Study|Withdrawal by Subject|3
7539151|NCT02592798|26200895|P2|Open Label Period (OLE)|Adverse Event|1
7539152|NCT02592798|26200896|P1|Open Label Period (OLE)|Adverse Event|0
7539153|NCT02592798|26200895|P2|Open Label Period (OLE)|Lack of Efficacy|5
7539154|NCT02592798|26200896|P1|Open Label Period (OLE)|Lack of Efficacy|3
7539155|NCT02592798|26200895|P2|Open Label Period (OLE)|Lost to Follow-up|1
7539156|NCT02592798|26200896|P1|Open Label Period (OLE)|Lost to Follow-up|0
7539157|NCT02592798|26200895|P2|Open Label Period (OLE)|Participant request to discontinue|0
7539158|NCT02592798|26200896|P1|Open Label Period (OLE)|Participant request to discontinue|1
7539159|NCT02592798|26200895|P2|Open Label Period (OLE)|Other reasons|2
7539160|NCT02592798|26200896|P1|Open Label Period (OLE)|Other reasons|0
7539161|NCT02592798|26200895|P2|Transition From DB2 to OLE|Other reasons|0
7539162|NCT02592798|26200896|P1|Transition From DB2 to OLE|Other reasons|1
7539163|NCT02592798|26200895|P2|Double-Blind Period 2 (DB2)|Adverse Event|0
7539164|NCT02592798|26200896|P1|Double-Blind Period 2 (DB2)|Adverse Event|1
7539165|NCT02592798|26200895|P2|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
7539166|NCT02592798|26200896|P1|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
7539167|NCT02592798|26200895|P2|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
7539168|NCT02592798|26200896|P1|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
7539169|NCT02592798|26200895|P2|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
7539170|NCT02592798|26200896|P1|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
7539171|NCT02592798|26200895|P2|Double-Blind Period 2 (DB2)|Other reasons|0
7539172|NCT02592798|26200896|P1|Double-Blind Period 2 (DB2)|Other reasons|1
7539173|NCT02592798|26200895|P2|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
7539174|NCT02592798|26200896|P1|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
7539175|NCT02592798|26200895|P2|Double-Blind Period 1 (DB1)|Adverse Event|2
7539176|NCT02592798|26200896|P1|Double-Blind Period 1 (DB1)|Adverse Event|1
7539177|NCT02592798|26200895|P2|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
7539178|NCT02592798|26200896|P1|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
7539179|NCT02592798|26200895|P2|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
7539180|NCT02592798|26200896|P1|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
7539181|NCT02592798|26200895|P2|Double-Blind Period 1 (DB1)|Pregnancy|0
7539182|NCT02592798|26200896|P1|Double-Blind Period 1 (DB1)|Pregnancy|1
7539183|NCT02592447|26200979|P2|Overall Study|Withdrawal by Subject|1
7539184|NCT02592447|26200980|P1|Overall Study|Withdrawal by Subject|0
7539185|NCT02592447|26200979|P2|Overall Study|Ineligible after randomization|0
7539186|NCT02592447|26200980|P1|Overall Study|Ineligible after randomization|1
7539187|NCT02592447|26200979|P2|Overall Study|Lost to Follow-up|0
7539188|NCT02592447|26200980|P1|Overall Study|Lost to Follow-up|1
7539189|NCT02592434|26200988|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7539190|NCT02592434|26200989|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
7539191|NCT02592434|26200990|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7539192|NCT02592434|26200988|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7539193|NCT02592434|26200989|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
7539194|NCT02592434|26200990|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7539195|NCT02592434|26200988|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
7539196|NCT02592434|26200989|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7539197|NCT02592434|26200990|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7539198|NCT02592434|26200988|P3|Double Blind Phase (26 Weeks)|Other|0
7539199|NCT02592434|26200989|P2|Double Blind Phase (26 Weeks)|Other|1
7539200|NCT02592434|26200990|P1|Double Blind Phase (26 Weeks)|Other|0
7539201|NCT02592434|26200988|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
7539202|NCT02592434|26200989|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
7539203|NCT02592434|26200990|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
7539204|NCT02592434|26200988|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
7539205|NCT02592434|26200989|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
7539206|NCT02592434|26200990|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
7539207|NCT02592434|26200988|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7539208|NCT02592434|26200989|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7539209|NCT02592434|26200990|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
7539210|NCT02592434|26200988|P3|Open-Label Phase (18 Weeks)|Other|0
7539211|NCT02592434|26200989|P2|Open-Label Phase (18 Weeks)|Other|0
7539212|NCT02592434|26200990|P1|Open-Label Phase (18 Weeks)|Other|3
7539213|NCT02592434|26200988|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7539214|NCT02592434|26200989|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7539215|NCT02592434|26200990|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
7539216|NCT02592434|26200988|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
7539217|NCT02592434|26200989|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
7539218|NCT02592434|26200990|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
7539219|NCT02592018|26201121|P1|Overall Study|Lost to Follow-up|1
7539220|NCT02592018|26201121|P1|Overall Study|Adverse Event|1
7539221|NCT02591290|26201168|P1|Overall Study|Withdrawal by Subject|2
7539222|NCT02591238|26201178|P4|Overall Study|personal circumstances|0
7539223|NCT02591238|26201179|P3|Overall Study|personal circumstances|0
7539224|NCT02591238|26201180|P2|Overall Study|personal circumstances|1
7539225|NCT02591238|26201181|P1|Overall Study|personal circumstances|0
7539226|NCT02591238|26201178|P4|Overall Study|personal circumstances|1
7539227|NCT02591238|26201179|P3|Overall Study|personal circumstances|0
7539228|NCT02591238|26201180|P2|Overall Study|personal circumstances|0
7539229|NCT02591238|26201181|P1|Overall Study|personal circumstances|0
7539230|NCT02591238|26201178|P4|Overall Study|influenza|1
7539231|NCT02591238|26201179|P3|Overall Study|influenza|0
7539232|NCT02591238|26201180|P2|Overall Study|influenza|0
7539233|NCT02591238|26201181|P1|Overall Study|influenza|0
7539234|NCT02591238|26201178|P4|Overall Study|Withdrawal by Subject|1
7539235|NCT02591238|26201179|P3|Overall Study|Withdrawal by Subject|0
7539236|NCT02591238|26201180|P2|Overall Study|Withdrawal by Subject|0
7539237|NCT02591238|26201181|P1|Overall Study|Withdrawal by Subject|0
7539238|NCT02591238|26201178|P4|Overall Study|Pregnancy|0
7539239|NCT02591238|26201179|P3|Overall Study|Pregnancy|0
7539240|NCT02591238|26201180|P2|Overall Study|Pregnancy|0
7539241|NCT02591238|26201181|P1|Overall Study|Pregnancy|1
7539242|NCT02590939|26201217|P2|Overall Study|Failed the nociceptive test|1
7539243|NCT02590939|26201218|P1|Overall Study|Failed the nociceptive test|2
7539244|NCT02590939|26201217|P2|Overall Study|Withdrawal by Subject|1
7539245|NCT02590939|26201218|P1|Overall Study|Withdrawal by Subject|3
7539246|NCT02590588|26201238|P1|Overall Study|Adverse Event|1
7539247|NCT02590562|26201246|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
7539248|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539249|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
7539250|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539251|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539252|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539253|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539254|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539255|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539256|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7539257|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539258|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
7539259|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539260|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539261|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539262|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539263|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539264|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539265|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7539266|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
7539267|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539268|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539269|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539270|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539271|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539272|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539273|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539274|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7539275|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
7539276|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539277|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539278|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539279|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539280|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539281|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539282|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539283|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7539284|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
7539285|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
7539286|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539287|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539288|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539289|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539290|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539291|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539292|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7539293|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539294|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
7539295|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539296|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539297|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539298|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539299|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539300|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539301|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7539302|NCT02590432|26201305|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
7539303|NCT02590432|26201306|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
7539304|NCT02590432|26201307|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539305|NCT02590432|26201308|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539306|NCT02590432|26201309|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539307|NCT02590432|26201310|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539308|NCT02590432|26201311|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539309|NCT02590432|26201312|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539310|NCT02590432|26201313|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
7539311|NCT02590432|26201305|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539312|NCT02590432|26201306|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539313|NCT02590432|26201307|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539314|NCT02590432|26201308|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
7539315|NCT02590432|26201309|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539316|NCT02590432|26201310|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539317|NCT02590432|26201311|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539318|NCT02590432|26201312|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539319|NCT02590432|26201313|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
7539320|NCT02590432|26201305|P9|Double-blind Treatment Period|Lost to Follow-up|0
7539321|NCT02590432|26201306|P8|Double-blind Treatment Period|Lost to Follow-up|0
7539322|NCT02590432|26201307|P7|Double-blind Treatment Period|Lost to Follow-up|0
7539323|NCT02590432|26201308|P6|Double-blind Treatment Period|Lost to Follow-up|2
7539324|NCT02590432|26201309|P5|Double-blind Treatment Period|Lost to Follow-up|0
7539325|NCT02590432|26201310|P4|Double-blind Treatment Period|Lost to Follow-up|0
7539326|NCT02590432|26201311|P3|Double-blind Treatment Period|Lost to Follow-up|1
7539327|NCT02590432|26201312|P2|Double-blind Treatment Period|Lost to Follow-up|0
7539328|NCT02590432|26201313|P1|Double-blind Treatment Period|Lost to Follow-up|0
7539329|NCT02590432|26201305|P9|Double-blind Treatment Period|Withdrawal of Consent|0
7539330|NCT02590432|26201306|P8|Double-blind Treatment Period|Withdrawal of Consent|0
7539331|NCT02590432|26201307|P7|Double-blind Treatment Period|Withdrawal of Consent|1
7539332|NCT02590432|26201308|P6|Double-blind Treatment Period|Withdrawal of Consent|1
7539333|NCT02590432|26201309|P5|Double-blind Treatment Period|Withdrawal of Consent|3
7539334|NCT02590432|26201310|P4|Double-blind Treatment Period|Withdrawal of Consent|3
7539335|NCT02590432|26201311|P3|Double-blind Treatment Period|Withdrawal of Consent|1
7539336|NCT02590432|26201312|P2|Double-blind Treatment Period|Withdrawal of Consent|0
7539337|NCT02590432|26201313|P1|Double-blind Treatment Period|Withdrawal of Consent|0
7539338|NCT02590432|26201305|P9|Double-blind Treatment Period|Lack of Efficacy|0
7539339|NCT02590432|26201306|P8|Double-blind Treatment Period|Lack of Efficacy|0
7539340|NCT02590432|26201307|P7|Double-blind Treatment Period|Lack of Efficacy|0
7539341|NCT02590432|26201308|P6|Double-blind Treatment Period|Lack of Efficacy|0
7539342|NCT02590432|26201309|P5|Double-blind Treatment Period|Lack of Efficacy|0
7539343|NCT02590432|26201310|P4|Double-blind Treatment Period|Lack of Efficacy|0
7539344|NCT02590432|26201311|P3|Double-blind Treatment Period|Lack of Efficacy|1
7539345|NCT02590432|26201312|P2|Double-blind Treatment Period|Lack of Efficacy|0
7539346|NCT02590432|26201313|P1|Double-blind Treatment Period|Lack of Efficacy|0
7539347|NCT02590432|26201305|P9|Double-blind Treatment Period|Adverse Event|0
7539348|NCT02590432|26201306|P8|Double-blind Treatment Period|Adverse Event|0
7539349|NCT02590432|26201307|P7|Double-blind Treatment Period|Adverse Event|20
7539350|NCT02590432|26201308|P6|Double-blind Treatment Period|Adverse Event|22
7539351|NCT02590432|26201309|P5|Double-blind Treatment Period|Adverse Event|6
7539352|NCT02590432|26201310|P4|Double-blind Treatment Period|Adverse Event|12
7539353|NCT02590432|26201311|P3|Double-blind Treatment Period|Adverse Event|14
7539354|NCT02590432|26201312|P2|Double-blind Treatment Period|Adverse Event|0
7539355|NCT02590432|26201313|P1|Double-blind Treatment Period|Adverse Event|0
7539356|NCT02590432|26201305|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539357|NCT02590432|26201306|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539358|NCT02590432|26201307|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539359|NCT02590432|26201308|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539360|NCT02590432|26201309|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539361|NCT02590432|26201310|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539362|NCT02590432|26201311|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
7539363|NCT02590432|26201312|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
7539364|NCT02590432|26201313|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
7539365|NCT02590432|26201305|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
7539366|NCT02590432|26201306|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
7539367|NCT02590432|26201307|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
7539368|NCT02590432|26201308|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
7539369|NCT02590432|26201309|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
7539370|NCT02590432|26201310|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
7539371|NCT02590432|26201311|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
7539372|NCT02590432|26201312|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
7539373|NCT02590432|26201313|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
7539374|NCT02590432|26201305|P9|Open-label Treatment Period|Protocol Violation|0
7539375|NCT02590432|26201306|P8|Open-label Treatment Period|Protocol Violation|0
7539376|NCT02590432|26201307|P7|Open-label Treatment Period|Protocol Violation|0
7539377|NCT02590432|26201308|P6|Open-label Treatment Period|Protocol Violation|0
7539378|NCT02590432|26201309|P5|Open-label Treatment Period|Protocol Violation|0
7539379|NCT02590432|26201310|P4|Open-label Treatment Period|Protocol Violation|0
7539380|NCT02590432|26201311|P3|Open-label Treatment Period|Protocol Violation|0
7539381|NCT02590432|26201312|P2|Open-label Treatment Period|Protocol Violation|4
7539382|NCT02590432|26201313|P1|Open-label Treatment Period|Protocol Violation|10
7539383|NCT02590432|26201305|P9|Open-label Treatment Period|Lost to Follow-up|0
7539384|NCT02590432|26201306|P8|Open-label Treatment Period|Lost to Follow-up|0
7539385|NCT02590432|26201307|P7|Open-label Treatment Period|Lost to Follow-up|0
7539386|NCT02590432|26201308|P6|Open-label Treatment Period|Lost to Follow-up|0
7539387|NCT02590432|26201309|P5|Open-label Treatment Period|Lost to Follow-up|0
7539388|NCT02590432|26201310|P4|Open-label Treatment Period|Lost to Follow-up|0
7539389|NCT02590432|26201311|P3|Open-label Treatment Period|Lost to Follow-up|0
7539390|NCT02590432|26201312|P2|Open-label Treatment Period|Lost to Follow-up|29
7539391|NCT02590432|26201313|P1|Open-label Treatment Period|Lost to Follow-up|51
7539392|NCT02590432|26201305|P9|Open-label Treatment Period|Withdrawal of Consent|0
7539393|NCT02590432|26201306|P8|Open-label Treatment Period|Withdrawal of Consent|0
7539394|NCT02590432|26201307|P7|Open-label Treatment Period|Withdrawal of Consent|0
7539395|NCT02590432|26201308|P6|Open-label Treatment Period|Withdrawal of Consent|0
7539396|NCT02590432|26201309|P5|Open-label Treatment Period|Withdrawal of Consent|0
7539397|NCT02590432|26201310|P4|Open-label Treatment Period|Withdrawal of Consent|0
7539398|NCT02590432|26201311|P3|Open-label Treatment Period|Withdrawal of Consent|0
7539399|NCT02590432|26201312|P2|Open-label Treatment Period|Withdrawal of Consent|28
7539400|NCT02590432|26201313|P1|Open-label Treatment Period|Withdrawal of Consent|43
7539401|NCT02590432|26201305|P9|Open-label Treatment Period|Lack of Efficacy|0
7539402|NCT02590432|26201306|P8|Open-label Treatment Period|Lack of Efficacy|0
7539403|NCT02590432|26201307|P7|Open-label Treatment Period|Lack of Efficacy|0
7539404|NCT02590432|26201308|P6|Open-label Treatment Period|Lack of Efficacy|0
7539405|NCT02590432|26201309|P5|Open-label Treatment Period|Lack of Efficacy|0
7539406|NCT02590432|26201310|P4|Open-label Treatment Period|Lack of Efficacy|0
7539407|NCT02590432|26201311|P3|Open-label Treatment Period|Lack of Efficacy|0
7539408|NCT02590432|26201312|P2|Open-label Treatment Period|Lack of Efficacy|5
7539409|NCT02590432|26201313|P1|Open-label Treatment Period|Lack of Efficacy|14
7539410|NCT02590432|26201305|P9|Open-label Treatment Period|Adverse Event|0
7539411|NCT02590432|26201306|P8|Open-label Treatment Period|Adverse Event|0
7539412|NCT02590432|26201307|P7|Open-label Treatment Period|Adverse Event|0
7539413|NCT02590432|26201308|P6|Open-label Treatment Period|Adverse Event|0
7539414|NCT02590432|26201309|P5|Open-label Treatment Period|Adverse Event|0
7539415|NCT02590432|26201310|P4|Open-label Treatment Period|Adverse Event|0
7539416|NCT02590432|26201311|P3|Open-label Treatment Period|Adverse Event|0
7539417|NCT02590432|26201312|P2|Open-label Treatment Period|Adverse Event|79
7539418|NCT02590432|26201313|P1|Open-label Treatment Period|Adverse Event|97
7539419|NCT02590406|26201349|P2|Overall Study|Saturometer malfunction|1
7539420|NCT02590406|26201350|P1|Overall Study|Saturometer malfunction|0
7539421|NCT02590406|26201349|P2|Overall Study|Adverse Event|0
7539422|NCT02590406|26201350|P1|Overall Study|Adverse Event|1
7539423|NCT02590354|26201364|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
7539424|NCT02590354|26201364|P1|Phase 1|Lost to Follow-up|1
7539425|NCT02590354|26201364|P1|Phase 1|Subject does not want to participate|20
7539426|NCT02590354|26201364|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
7539427|NCT02590354|26201364|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
7539428|NCT02590354|26201364|P1|Phase 1|Active hepatitis B or C infection|1
7539429|NCT02590003|26201391|P2|Overall Study|Death|2
7539430|NCT02590003|26201392|P1|Overall Study|Death|1
7539431|NCT02589665|26201458|P10|Maintenance Extension Period|Non-responder|1
7539432|NCT02589665|26201459|P9|Maintenance Extension Period|Non-responder|0
7539433|NCT02589665|26201460|P8|Maintenance Extension Period|Non-responder|0
7539434|NCT02589665|26201461|P7|Maintenance Extension Period|Non-responder|0
7539435|NCT02589665|26201462|P6|Maintenance Extension Period|Non-responder|0
7539436|NCT02589665|26201463|P5|Maintenance Extension Period|Non-responder|0
7539437|NCT02589665|26201464|P4|Maintenance Extension Period|Non-responder|0
7539438|NCT02589665|26201465|P3|Maintenance Extension Period|Non-responder|0
7539439|NCT02589665|26201466|P2|Maintenance Extension Period|Non-responder|0
7539440|NCT02589665|26201467|P1|Maintenance Extension Period|Non-responder|0
7539441|NCT02589665|26201458|P10|Maintenance Extension Period|Adverse Event|2
7539442|NCT02589665|26201459|P9|Maintenance Extension Period|Adverse Event|0
7539443|NCT02589665|26201460|P8|Maintenance Extension Period|Adverse Event|0
7539444|NCT02589665|26201461|P7|Maintenance Extension Period|Adverse Event|0
7539445|NCT02589665|26201462|P6|Maintenance Extension Period|Adverse Event|0
7539446|NCT02589665|26201463|P5|Maintenance Extension Period|Adverse Event|0
7539447|NCT02589665|26201464|P4|Maintenance Extension Period|Adverse Event|0
7539448|NCT02589665|26201465|P3|Maintenance Extension Period|Adverse Event|0
7539449|NCT02589665|26201466|P2|Maintenance Extension Period|Adverse Event|0
7539450|NCT02589665|26201467|P1|Maintenance Extension Period|Adverse Event|0
7539451|NCT02589665|26201458|P10|Maintenance Extension Period|Lack of Efficacy|4
7539452|NCT02589665|26201459|P9|Maintenance Extension Period|Lack of Efficacy|0
7539453|NCT02589665|26201460|P8|Maintenance Extension Period|Lack of Efficacy|0
7539454|NCT02589665|26201461|P7|Maintenance Extension Period|Lack of Efficacy|0
7539455|NCT02589665|26201462|P6|Maintenance Extension Period|Lack of Efficacy|0
7539456|NCT02589665|26201463|P5|Maintenance Extension Period|Lack of Efficacy|0
7539457|NCT02589665|26201464|P4|Maintenance Extension Period|Lack of Efficacy|0
7539458|NCT02589665|26201465|P3|Maintenance Extension Period|Lack of Efficacy|0
7539459|NCT02589665|26201466|P2|Maintenance Extension Period|Lack of Efficacy|0
7539460|NCT02589665|26201467|P1|Maintenance Extension Period|Lack of Efficacy|0
7539461|NCT02589665|26201458|P10|Maintenance Extension Period|Withdrawal by Subject|4
7539462|NCT02589665|26201459|P9|Maintenance Extension Period|Withdrawal by Subject|0
7539463|NCT02589665|26201460|P8|Maintenance Extension Period|Withdrawal by Subject|0
7539464|NCT02589665|26201461|P7|Maintenance Extension Period|Withdrawal by Subject|0
7539465|NCT02589665|26201462|P6|Maintenance Extension Period|Withdrawal by Subject|0
7539466|NCT02589665|26201463|P5|Maintenance Extension Period|Withdrawal by Subject|0
7539467|NCT02589665|26201464|P4|Maintenance Extension Period|Withdrawal by Subject|0
7539468|NCT02589665|26201465|P3|Maintenance Extension Period|Withdrawal by Subject|0
7539469|NCT02589665|26201466|P2|Maintenance Extension Period|Withdrawal by Subject|0
7539470|NCT02589665|26201467|P1|Maintenance Extension Period|Withdrawal by Subject|0
7539471|NCT02589665|26201458|P10|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
7539472|NCT02589665|26201459|P9|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539473|NCT02589665|26201460|P8|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539474|NCT02589665|26201461|P7|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539475|NCT02589665|26201462|P6|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539476|NCT02589665|26201463|P5|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539477|NCT02589665|26201464|P4|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539478|NCT02589665|26201465|P3|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539479|NCT02589665|26201466|P2|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539480|NCT02589665|26201467|P1|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7539481|NCT02589665|26201458|P10|Induction Extension Period|Reason Not Collected|0
7539482|NCT02589665|26201459|P9|Induction Extension Period|Reason Not Collected|1
7539483|NCT02589665|26201460|P8|Induction Extension Period|Reason Not Collected|0
7539484|NCT02589665|26201461|P7|Induction Extension Period|Reason Not Collected|0
7539485|NCT02589665|26201462|P6|Induction Extension Period|Reason Not Collected|0
7539486|NCT02589665|26201463|P5|Induction Extension Period|Reason Not Collected|0
7539487|NCT02589665|26201464|P4|Induction Extension Period|Reason Not Collected|0
7539488|NCT02589665|26201465|P3|Induction Extension Period|Reason Not Collected|0
7539489|NCT02589665|26201466|P2|Induction Extension Period|Reason Not Collected|0
7539490|NCT02589665|26201467|P1|Induction Extension Period|Reason Not Collected|0
7539491|NCT02589665|26201458|P10|Induction Extension Period|Physician Decision|0
7539492|NCT02589665|26201459|P9|Induction Extension Period|Physician Decision|1
7539493|NCT02589665|26201460|P8|Induction Extension Period|Physician Decision|0
7539494|NCT02589665|26201461|P7|Induction Extension Period|Physician Decision|0
7539495|NCT02589665|26201462|P6|Induction Extension Period|Physician Decision|0
7539496|NCT02589665|26201463|P5|Induction Extension Period|Physician Decision|0
7539497|NCT02589665|26201464|P4|Induction Extension Period|Physician Decision|0
7539498|NCT02589665|26201465|P3|Induction Extension Period|Physician Decision|0
7539499|NCT02589665|26201466|P2|Induction Extension Period|Physician Decision|0
7539500|NCT02589665|26201467|P1|Induction Extension Period|Physician Decision|0
7539501|NCT02589665|26201458|P10|Induction Extension Period|Withdrawal by Subject|0
7539502|NCT02589665|26201459|P9|Induction Extension Period|Withdrawal by Subject|3
7539503|NCT02589665|26201460|P8|Induction Extension Period|Withdrawal by Subject|2
7539504|NCT02589665|26201461|P7|Induction Extension Period|Withdrawal by Subject|0
7539505|NCT02589665|26201462|P6|Induction Extension Period|Withdrawal by Subject|0
7539506|NCT02589665|26201463|P5|Induction Extension Period|Withdrawal by Subject|0
7539507|NCT02589665|26201464|P4|Induction Extension Period|Withdrawal by Subject|0
7539508|NCT02589665|26201465|P3|Induction Extension Period|Withdrawal by Subject|0
7539509|NCT02589665|26201466|P2|Induction Extension Period|Withdrawal by Subject|0
7539510|NCT02589665|26201467|P1|Induction Extension Period|Withdrawal by Subject|0
7539511|NCT02589665|26201458|P10|Induction Extension Period|Lack of Efficacy|0
7539512|NCT02589665|26201459|P9|Induction Extension Period|Lack of Efficacy|3
7539513|NCT02589665|26201460|P8|Induction Extension Period|Lack of Efficacy|0
7539514|NCT02589665|26201461|P7|Induction Extension Period|Lack of Efficacy|0
7539515|NCT02589665|26201462|P6|Induction Extension Period|Lack of Efficacy|0
7539516|NCT02589665|26201463|P5|Induction Extension Period|Lack of Efficacy|0
7539517|NCT02589665|26201464|P4|Induction Extension Period|Lack of Efficacy|0
7539518|NCT02589665|26201465|P3|Induction Extension Period|Lack of Efficacy|0
7539519|NCT02589665|26201466|P2|Induction Extension Period|Lack of Efficacy|0
7539520|NCT02589665|26201467|P1|Induction Extension Period|Lack of Efficacy|0
7539521|NCT02589665|26201458|P10|Induction Extension Period|Adverse Event|0
7539522|NCT02589665|26201459|P9|Induction Extension Period|Adverse Event|4
7539523|NCT02589665|26201460|P8|Induction Extension Period|Adverse Event|0
7539524|NCT02589665|26201461|P7|Induction Extension Period|Adverse Event|0
7539525|NCT02589665|26201462|P6|Induction Extension Period|Adverse Event|0
7539526|NCT02589665|26201463|P5|Induction Extension Period|Adverse Event|0
7539527|NCT02589665|26201464|P4|Induction Extension Period|Adverse Event|0
7539528|NCT02589665|26201465|P3|Induction Extension Period|Adverse Event|0
7539529|NCT02589665|26201466|P2|Induction Extension Period|Adverse Event|0
7539530|NCT02589665|26201467|P1|Induction Extension Period|Adverse Event|0
7539531|NCT02589665|26201458|P10|Maintenance Period|Reason Not Collected|0
7539532|NCT02589665|26201459|P9|Maintenance Period|Reason Not Collected|0
7539533|NCT02589665|26201460|P8|Maintenance Period|Reason Not Collected|0
7539534|NCT02589665|26201461|P7|Maintenance Period|Reason Not Collected|1
7539535|NCT02589665|26201462|P6|Maintenance Period|Reason Not Collected|1
7539536|NCT02589665|26201463|P5|Maintenance Period|Reason Not Collected|0
7539537|NCT02589665|26201464|P4|Maintenance Period|Reason Not Collected|0
7539538|NCT02589665|26201465|P3|Maintenance Period|Reason Not Collected|0
7539539|NCT02589665|26201466|P2|Maintenance Period|Reason Not Collected|0
7539540|NCT02589665|26201467|P1|Maintenance Period|Reason Not Collected|0
7539541|NCT02589665|26201458|P10|Maintenance Period|Physician Decision|0
7539542|NCT02589665|26201459|P9|Maintenance Period|Physician Decision|0
7539543|NCT02589665|26201460|P8|Maintenance Period|Physician Decision|0
7539544|NCT02589665|26201461|P7|Maintenance Period|Physician Decision|0
7539545|NCT02589665|26201462|P6|Maintenance Period|Physician Decision|1
7539546|NCT02589665|26201463|P5|Maintenance Period|Physician Decision|0
7539547|NCT02589665|26201464|P4|Maintenance Period|Physician Decision|0
7539548|NCT02589665|26201465|P3|Maintenance Period|Physician Decision|0
7539549|NCT02589665|26201466|P2|Maintenance Period|Physician Decision|0
7539550|NCT02589665|26201467|P1|Maintenance Period|Physician Decision|0
7539551|NCT02589665|26201458|P10|Maintenance Period|Lost to Follow-up|0
7539552|NCT02589665|26201459|P9|Maintenance Period|Lost to Follow-up|0
7539553|NCT02589665|26201460|P8|Maintenance Period|Lost to Follow-up|0
7539554|NCT02589665|26201461|P7|Maintenance Period|Lost to Follow-up|0
7539555|NCT02589665|26201462|P6|Maintenance Period|Lost to Follow-up|1
7539556|NCT02589665|26201463|P5|Maintenance Period|Lost to Follow-up|0
7539557|NCT02589665|26201464|P4|Maintenance Period|Lost to Follow-up|0
7539558|NCT02589665|26201465|P3|Maintenance Period|Lost to Follow-up|0
7539559|NCT02589665|26201466|P2|Maintenance Period|Lost to Follow-up|0
7539560|NCT02589665|26201467|P1|Maintenance Period|Lost to Follow-up|0
7539561|NCT02589665|26201458|P10|Maintenance Period|Adverse Event|0
7539562|NCT02589665|26201459|P9|Maintenance Period|Adverse Event|0
7539563|NCT02589665|26201460|P8|Maintenance Period|Adverse Event|0
7539564|NCT02589665|26201461|P7|Maintenance Period|Adverse Event|2
7539565|NCT02589665|26201462|P6|Maintenance Period|Adverse Event|0
7539566|NCT02589665|26201463|P5|Maintenance Period|Adverse Event|0
7539567|NCT02589665|26201464|P4|Maintenance Period|Adverse Event|0
7539568|NCT02589665|26201465|P3|Maintenance Period|Adverse Event|0
7539569|NCT02589665|26201466|P2|Maintenance Period|Adverse Event|0
7539570|NCT02589665|26201467|P1|Maintenance Period|Adverse Event|0
7539571|NCT02589665|26201458|P10|Maintenance Period|Lack of Efficacy|0
7539572|NCT02589665|26201459|P9|Maintenance Period|Lack of Efficacy|0
7539573|NCT02589665|26201460|P8|Maintenance Period|Lack of Efficacy|0
7539574|NCT02589665|26201461|P7|Maintenance Period|Lack of Efficacy|0
7539575|NCT02589665|26201462|P6|Maintenance Period|Lack of Efficacy|1
7539576|NCT02589665|26201463|P5|Maintenance Period|Lack of Efficacy|2
7539577|NCT02589665|26201464|P4|Maintenance Period|Lack of Efficacy|0
7539578|NCT02589665|26201465|P3|Maintenance Period|Lack of Efficacy|0
7539579|NCT02589665|26201466|P2|Maintenance Period|Lack of Efficacy|0
7539580|NCT02589665|26201467|P1|Maintenance Period|Lack of Efficacy|0
7539581|NCT02589665|26201458|P10|Maintenance Period|Withdrawal by Subject|0
7539582|NCT02589665|26201459|P9|Maintenance Period|Withdrawal by Subject|0
7539583|NCT02589665|26201460|P8|Maintenance Period|Withdrawal by Subject|0
7539584|NCT02589665|26201461|P7|Maintenance Period|Withdrawal by Subject|4
7539585|NCT02589665|26201462|P6|Maintenance Period|Withdrawal by Subject|2
7539586|NCT02589665|26201463|P5|Maintenance Period|Withdrawal by Subject|4
7539587|NCT02589665|26201464|P4|Maintenance Period|Withdrawal by Subject|0
7539588|NCT02589665|26201465|P3|Maintenance Period|Withdrawal by Subject|0
7539589|NCT02589665|26201466|P2|Maintenance Period|Withdrawal by Subject|0
7539590|NCT02589665|26201467|P1|Maintenance Period|Withdrawal by Subject|0
7539591|NCT02589665|26201458|P10|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539592|NCT02589665|26201459|P9|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539593|NCT02589665|26201460|P8|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539594|NCT02589665|26201461|P7|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
7539595|NCT02589665|26201462|P6|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
7539596|NCT02589665|26201463|P5|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
7539597|NCT02589665|26201464|P4|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539598|NCT02589665|26201465|P3|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539599|NCT02589665|26201466|P2|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539600|NCT02589665|26201467|P1|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7539601|NCT02589665|26201458|P10|Induction Period|Protocol Violation|0
7539602|NCT02589665|26201459|P9|Induction Period|Protocol Violation|0
7539603|NCT02589665|26201460|P8|Induction Period|Protocol Violation|0
7539604|NCT02589665|26201461|P7|Induction Period|Protocol Violation|0
7539605|NCT02589665|26201462|P6|Induction Period|Protocol Violation|0
7539606|NCT02589665|26201463|P5|Induction Period|Protocol Violation|0
7539607|NCT02589665|26201464|P4|Induction Period|Protocol Violation|0
7539608|NCT02589665|26201465|P3|Induction Period|Protocol Violation|0
7539609|NCT02589665|26201466|P2|Induction Period|Protocol Violation|1
7539610|NCT02589665|26201467|P1|Induction Period|Protocol Violation|0
7539611|NCT02589665|26201458|P10|Induction Period|Withdrawal by Subject|0
7539612|NCT02589665|26201459|P9|Induction Period|Withdrawal by Subject|0
7539613|NCT02589665|26201460|P8|Induction Period|Withdrawal by Subject|0
7539614|NCT02589665|26201461|P7|Induction Period|Withdrawal by Subject|0
7539615|NCT02589665|26201462|P6|Induction Period|Withdrawal by Subject|0
7539616|NCT02589665|26201463|P5|Induction Period|Withdrawal by Subject|0
7539617|NCT02589665|26201464|P4|Induction Period|Withdrawal by Subject|1
7539618|NCT02589665|26201465|P3|Induction Period|Withdrawal by Subject|0
7539619|NCT02589665|26201466|P2|Induction Period|Withdrawal by Subject|1
7539620|NCT02589665|26201467|P1|Induction Period|Withdrawal by Subject|0
7539621|NCT02589665|26201458|P10|Induction Period|Adverse Event|0
7539622|NCT02589665|26201459|P9|Induction Period|Adverse Event|0
7539623|NCT02589665|26201460|P8|Induction Period|Adverse Event|0
7539624|NCT02589665|26201461|P7|Induction Period|Adverse Event|0
7539625|NCT02589665|26201462|P6|Induction Period|Adverse Event|0
7539626|NCT02589665|26201463|P5|Induction Period|Adverse Event|0
7539627|NCT02589665|26201464|P4|Induction Period|Adverse Event|2
7539628|NCT02589665|26201465|P3|Induction Period|Adverse Event|2
7539629|NCT02589665|26201466|P2|Induction Period|Adverse Event|0
7539630|NCT02589665|26201467|P1|Induction Period|Adverse Event|3
7539631|NCT02589665|26201458|P10|Induction Period|Did not receive drug|0
7539632|NCT02589665|26201459|P9|Induction Period|Did not receive drug|0
7539633|NCT02589665|26201460|P8|Induction Period|Did not receive drug|0
7539634|NCT02589665|26201461|P7|Induction Period|Did not receive drug|0
7539635|NCT02589665|26201462|P6|Induction Period|Did not receive drug|0
7539636|NCT02589665|26201463|P5|Induction Period|Did not receive drug|0
7539637|NCT02589665|26201464|P4|Induction Period|Did not receive drug|1
7539638|NCT02589665|26201465|P3|Induction Period|Did not receive drug|0
7539639|NCT02589665|26201466|P2|Induction Period|Did not receive drug|0
7539640|NCT02589665|26201467|P1|Induction Period|Did not receive drug|0
7539641|NCT02589639|26201532|P3|Overall Study|Not Treated|0
7539642|NCT02589639|26201533|P2|Overall Study|Not Treated|3
7539643|NCT02589639|26201534|P1|Overall Study|Not Treated|0
7539644|NCT02589639|26201532|P3|Overall Study|Other reason than specified above|1
7539645|NCT02589639|26201533|P2|Overall Study|Other reason than specified above|2
7539646|NCT02589639|26201534|P1|Overall Study|Other reason than specified above|1
7539647|NCT02589639|26201532|P3|Overall Study|Adverse Event|3
7539648|NCT02589639|26201533|P2|Overall Study|Adverse Event|5
7539649|NCT02589639|26201534|P1|Overall Study|Adverse Event|4
7539650|NCT02589639|26201532|P3|Overall Study|Patient withdrawal, not due to AE|0
7539651|NCT02589639|26201533|P2|Overall Study|Patient withdrawal, not due to AE|0
7539652|NCT02589639|26201534|P1|Overall Study|Patient withdrawal, not due to AE|3
7539653|NCT02589639|26201532|P3|Overall Study|Protocol Violation|0
7539654|NCT02589639|26201533|P2|Overall Study|Protocol Violation|0
7539655|NCT02589639|26201534|P1|Overall Study|Protocol Violation|1
7539656|NCT02589639|26201532|P3|Overall Study|Lost to Follow-up|0
7539657|NCT02589639|26201533|P2|Overall Study|Lost to Follow-up|0
7539658|NCT02589639|26201534|P1|Overall Study|Lost to Follow-up|1
7539659|NCT02589626|26201547|P2|Overall Study|Adverse Event|1
7539660|NCT02589626|26201548|P1|Overall Study|Adverse Event|1
7539661|NCT02589626|26201547|P2|Overall Study|Withdrawal by Subject|1
7539662|NCT02589626|26201548|P1|Overall Study|Withdrawal by Subject|1
7539663|NCT02589626|26201547|P2|Overall Study|Other than the reason specified|0
7539664|NCT02589626|26201548|P1|Overall Study|Other than the reason specified|1
7539665|NCT02589405|26201556|P1|Overall Study|Withdrawal by Subject|1
7539666|NCT02589405|26201556|P1|Overall Study|Adverse Event|3
7539667|NCT02588833|26201673|P2|Part 3 (Safety Follow-up)|Other|2
7539668|NCT02588833|26201674|P1|Part 3 (Safety Follow-up)|Other|0
7539669|NCT02588833|26201673|P2|Part 2C|Withdrawal by Subject|1
7539670|NCT02588833|26201674|P1|Part 2C|Withdrawal by Subject|0
7539671|NCT02588833|26201673|P2|Part 2C|Adverse Event|1
7539672|NCT02588833|26201674|P1|Part 2C|Adverse Event|0
7539673|NCT02588833|26201673|P2|Part 2B|Adverse Event|1
7539674|NCT02588833|26201674|P1|Part 2B|Adverse Event|0
7539675|NCT02588833|26201673|P2|Part 2A|Withdrawal by Subject|1
7539676|NCT02588833|26201674|P1|Part 2A|Withdrawal by Subject|0
7539677|NCT02588833|26201673|P2|Part 2A|Physician Decision|1
7539678|NCT02588833|26201674|P1|Part 2A|Physician Decision|0
7539679|NCT02588833|26201673|P2|Part 1|Withdrawal by Subject|0
7539680|NCT02588833|26201674|P1|Part 1|Withdrawal by Subject|1
7539681|NCT02588664|26201695|P2|Overall Study|Lost to Follow-up|990
7539682|NCT02588664|26201696|P1|Overall Study|Lost to Follow-up|1305
7539683|NCT02588664|26201695|P2|Overall Study|Death|55
7539684|NCT02588664|26201696|P1|Overall Study|Death|56
7539685|NCT02588612|26201754|P1|Overall Study|Death prior to T-cell infusion|1
7539686|NCT02588612|26201754|P1|Overall Study|Failed eligibility prior to chemotherapy|2
7539687|NCT02588612|26201754|P1|Overall Study|Leukapheresis did not yield enough cells|1
7539688|NCT02588612|26201754|P1|Overall Study|Physician Decision|1
7539689|NCT02588339|26201812|P1|Overall Study|GVHD Progression prior to treatment|2
7539690|NCT02588339|26201812|P1|Overall Study|Withdrawal by Subject|1
7539691|NCT02588261|26201824|P2|Overall Study|Lost to Follow-up|0
7539692|NCT02588261|26201825|P1|Overall Study|Lost to Follow-up|1
7539693|NCT02588261|26201824|P2|Overall Study|Adverse Event|24
7539694|NCT02588261|26201825|P1|Overall Study|Adverse Event|29
7539695|NCT02588261|26201824|P2|Overall Study|Progressive Disease|82
7539696|NCT02588261|26201825|P1|Overall Study|Progressive Disease|61
7539697|NCT02588261|26201824|P2|Overall Study|Miscellaneous|4
7539698|NCT02588261|26201825|P1|Overall Study|Miscellaneous|5
7539699|NCT02588261|26201824|P2|Overall Study|Noncompliance with Study Drug|1
7539700|NCT02588261|26201825|P1|Overall Study|Noncompliance with Study Drug|0
7539701|NCT02588261|26201824|P2|Overall Study|Withdrawal by Subject|8
7539702|NCT02588261|26201825|P1|Overall Study|Withdrawal by Subject|12
7539703|NCT02588261|26201824|P2|Overall Study|Death|2
7539704|NCT02588261|26201825|P1|Overall Study|Death|1
7539705|NCT02588261|26201824|P2|Overall Study|Protocol Deviation|0
7539706|NCT02588261|26201825|P1|Overall Study|Protocol Deviation|1
7539707|NCT02588261|26201824|P2|Overall Study|Study Terminated by Sponsor|142
7539708|NCT02588261|26201825|P1|Overall Study|Study Terminated by Sponsor|157
7539709|NCT02588092|26201861|P10|Overall Study|Sponsor Decision|1
7539710|NCT02588092|26201862|P9|Overall Study|Sponsor Decision|1
7539711|NCT02588092|26201863|P8|Overall Study|Sponsor Decision|0
7539712|NCT02588092|26201864|P7|Overall Study|Sponsor Decision|0
7539713|NCT02588092|26201865|P6|Overall Study|Sponsor Decision|0
7539714|NCT02588092|26201866|P5|Overall Study|Sponsor Decision|0
7539715|NCT02588092|26201867|P4|Overall Study|Sponsor Decision|0
7539716|NCT02588092|26201868|P3|Overall Study|Sponsor Decision|0
7539717|NCT02588092|26201869|P2|Overall Study|Sponsor Decision|0
7539718|NCT02588092|26201870|P1|Overall Study|Sponsor Decision|0
7539719|NCT02588092|26201861|P10|Overall Study|Started Another Treatment|0
7539720|NCT02588092|26201862|P9|Overall Study|Started Another Treatment|0
7539721|NCT02588092|26201863|P8|Overall Study|Started Another Treatment|1
7539722|NCT02588092|26201864|P7|Overall Study|Started Another Treatment|0
7539723|NCT02588092|26201865|P6|Overall Study|Started Another Treatment|0
7539724|NCT02588092|26201866|P5|Overall Study|Started Another Treatment|1
7539725|NCT02588092|26201867|P4|Overall Study|Started Another Treatment|0
7539726|NCT02588092|26201868|P3|Overall Study|Started Another Treatment|0
7539727|NCT02588092|26201869|P2|Overall Study|Started Another Treatment|0
7539728|NCT02588092|26201870|P1|Overall Study|Started Another Treatment|0
7539729|NCT02588092|26201861|P10|Overall Study|Withdrawal by Subject|0
7539730|NCT02588092|26201862|P9|Overall Study|Withdrawal by Subject|0
7539731|NCT02588092|26201863|P8|Overall Study|Withdrawal by Subject|2
7539732|NCT02588092|26201864|P7|Overall Study|Withdrawal by Subject|1
7539733|NCT02588092|26201865|P6|Overall Study|Withdrawal by Subject|1
7539734|NCT02588092|26201866|P5|Overall Study|Withdrawal by Subject|0
7539735|NCT02588092|26201867|P4|Overall Study|Withdrawal by Subject|0
7539736|NCT02588092|26201868|P3|Overall Study|Withdrawal by Subject|0
7539737|NCT02588092|26201869|P2|Overall Study|Withdrawal by Subject|0
7539738|NCT02588092|26201870|P1|Overall Study|Withdrawal by Subject|0
7539739|NCT02588092|26201861|P10|Overall Study|Death|2
7539740|NCT02588092|26201862|P9|Overall Study|Death|5
7539741|NCT02588092|26201863|P8|Overall Study|Death|1
7539742|NCT02588092|26201864|P7|Overall Study|Death|2
7539743|NCT02588092|26201865|P6|Overall Study|Death|2
7539744|NCT02588092|26201866|P5|Overall Study|Death|2
7539745|NCT02588092|26201867|P4|Overall Study|Death|3
7539746|NCT02588092|26201868|P3|Overall Study|Death|3
7539747|NCT02588092|26201869|P2|Overall Study|Death|3
7539748|NCT02588092|26201870|P1|Overall Study|Death|4
7539749|NCT02587962|26202069|P5|Overall Study|Clinical progression|1
7539750|NCT02587962|26202070|P4|Overall Study|Clinical progression|0
7539751|NCT02587962|26202071|P3|Overall Study|Clinical progression|2
7539752|NCT02587962|26202072|P2|Overall Study|Clinical progression|1
7539753|NCT02587962|26202073|P1|Overall Study|Clinical progression|0
7539754|NCT02587962|26202069|P5|Overall Study|Radiological progression|10
7539755|NCT02587962|26202070|P4|Overall Study|Radiological progression|5
7539756|NCT02587962|26202071|P3|Overall Study|Radiological progression|2
7539757|NCT02587962|26202072|P2|Overall Study|Radiological progression|2
7539758|NCT02587962|26202073|P1|Overall Study|Radiological progression|2
7539759|NCT02587962|26202069|P5|Overall Study|Withdrawal by Subject|4
7539760|NCT02587962|26202070|P4|Overall Study|Withdrawal by Subject|1
7539761|NCT02587962|26202071|P3|Overall Study|Withdrawal by Subject|1
7539762|NCT02587962|26202072|P2|Overall Study|Withdrawal by Subject|0
7539763|NCT02587962|26202073|P1|Overall Study|Withdrawal by Subject|0
7539764|NCT02587962|26202069|P5|Overall Study|Adverse Event|0
7539765|NCT02587962|26202070|P4|Overall Study|Adverse Event|0
7539766|NCT02587962|26202071|P3|Overall Study|Adverse Event|1
7539767|NCT02587962|26202072|P2|Overall Study|Adverse Event|0
7539768|NCT02587962|26202073|P1|Overall Study|Adverse Event|0
7539769|NCT02587819|26202145|P1|Overall Study|Lost to Follow-up|1
7539770|NCT02587819|26202145|P1|Overall Study|Adverse Event|1
7539771|NCT02587520|26202181|P18|Overall Study|Lost to Follow-up|0
7539772|NCT02587520|26202182|P17|Overall Study|Lost to Follow-up|0
7539773|NCT02587520|26202183|P16|Overall Study|Lost to Follow-up|0
7539774|NCT02587520|26202184|P15|Overall Study|Lost to Follow-up|0
7539775|NCT02587520|26202185|P14|Overall Study|Lost to Follow-up|0
7539776|NCT02587520|26202186|P13|Overall Study|Lost to Follow-up|0
7539777|NCT02587520|26202187|P12|Overall Study|Lost to Follow-up|1
7539778|NCT02587520|26202188|P11|Overall Study|Lost to Follow-up|2
7539779|NCT02587520|26202189|P10|Overall Study|Lost to Follow-up|2
7539780|NCT02587520|26202190|P9|Overall Study|Lost to Follow-up|0
7539781|NCT02587520|26202191|P8|Overall Study|Lost to Follow-up|1
7539782|NCT02587520|26202192|P7|Overall Study|Lost to Follow-up|1
7539783|NCT02587520|26202193|P6|Overall Study|Lost to Follow-up|1
7539784|NCT02587520|26202194|P5|Overall Study|Lost to Follow-up|0
7539785|NCT02587520|26202195|P4|Overall Study|Lost to Follow-up|2
7539786|NCT02587520|26202196|P3|Overall Study|Lost to Follow-up|0
7539787|NCT02587520|26202197|P2|Overall Study|Lost to Follow-up|2
7539788|NCT02587520|26202198|P1|Overall Study|Lost to Follow-up|0
7539789|NCT02587520|26202181|P18|Overall Study|Withdrawal by Subject|0
7539790|NCT02587520|26202182|P17|Overall Study|Withdrawal by Subject|0
7539791|NCT02587520|26202183|P16|Overall Study|Withdrawal by Subject|0
7539792|NCT02587520|26202184|P15|Overall Study|Withdrawal by Subject|0
7539793|NCT02587520|26202185|P14|Overall Study|Withdrawal by Subject|1
7539794|NCT02587520|26202186|P13|Overall Study|Withdrawal by Subject|0
7539795|NCT02587520|26202187|P12|Overall Study|Withdrawal by Subject|0
7539796|NCT02587520|26202188|P11|Overall Study|Withdrawal by Subject|0
7539797|NCT02587520|26202189|P10|Overall Study|Withdrawal by Subject|0
7539798|NCT02587520|26202190|P9|Overall Study|Withdrawal by Subject|0
7539799|NCT02587520|26202191|P8|Overall Study|Withdrawal by Subject|0
7539800|NCT02587520|26202192|P7|Overall Study|Withdrawal by Subject|1
7539801|NCT02587520|26202193|P6|Overall Study|Withdrawal by Subject|1
7539802|NCT02587520|26202194|P5|Overall Study|Withdrawal by Subject|0
7539803|NCT02587520|26202195|P4|Overall Study|Withdrawal by Subject|1
7539804|NCT02587520|26202196|P3|Overall Study|Withdrawal by Subject|1
7539805|NCT02587520|26202197|P2|Overall Study|Withdrawal by Subject|0
7539806|NCT02587520|26202198|P1|Overall Study|Withdrawal by Subject|0
7539807|NCT02587520|26202181|P18|Overall Study|Adverse Event|0
7539808|NCT02587520|26202182|P17|Overall Study|Adverse Event|0
7539809|NCT02587520|26202183|P16|Overall Study|Adverse Event|0
7539810|NCT02587520|26202184|P15|Overall Study|Adverse Event|0
7539811|NCT02587520|26202185|P14|Overall Study|Adverse Event|0
7539812|NCT02587520|26202186|P13|Overall Study|Adverse Event|0
7539813|NCT02587520|26202187|P12|Overall Study|Adverse Event|1
7539814|NCT02587520|26202188|P11|Overall Study|Adverse Event|0
7539815|NCT02587520|26202189|P10|Overall Study|Adverse Event|0
7539816|NCT02587520|26202190|P9|Overall Study|Adverse Event|0
7539817|NCT02587520|26202191|P8|Overall Study|Adverse Event|0
7539818|NCT02587520|26202192|P7|Overall Study|Adverse Event|0
7539819|NCT02587520|26202193|P6|Overall Study|Adverse Event|0
7539820|NCT02587520|26202194|P5|Overall Study|Adverse Event|0
7539821|NCT02587520|26202195|P4|Overall Study|Adverse Event|0
7539822|NCT02587520|26202196|P3|Overall Study|Adverse Event|0
7539823|NCT02587520|26202197|P2|Overall Study|Adverse Event|0
7539824|NCT02587520|26202198|P1|Overall Study|Adverse Event|0
7539825|NCT02587520|26202181|P18|Overall Study|Protocol Violation|0
7539826|NCT02587520|26202182|P17|Overall Study|Protocol Violation|0
7539827|NCT02587520|26202183|P16|Overall Study|Protocol Violation|0
7539828|NCT02587520|26202184|P15|Overall Study|Protocol Violation|0
7539829|NCT02587520|26202185|P14|Overall Study|Protocol Violation|0
7539830|NCT02587520|26202186|P13|Overall Study|Protocol Violation|0
7539831|NCT02587520|26202187|P12|Overall Study|Protocol Violation|2
7539832|NCT02587520|26202188|P11|Overall Study|Protocol Violation|1
7539833|NCT02587520|26202189|P10|Overall Study|Protocol Violation|3
7539834|NCT02587520|26202190|P9|Overall Study|Protocol Violation|3
7539835|NCT02587520|26202191|P8|Overall Study|Protocol Violation|1
7539836|NCT02587520|26202192|P7|Overall Study|Protocol Violation|1
7539837|NCT02587520|26202193|P6|Overall Study|Protocol Violation|1
7539838|NCT02587520|26202194|P5|Overall Study|Protocol Violation|0
7539839|NCT02587520|26202195|P4|Overall Study|Protocol Violation|2
7539840|NCT02587520|26202196|P3|Overall Study|Protocol Violation|0
7539841|NCT02587520|26202197|P2|Overall Study|Protocol Violation|0
7539842|NCT02587520|26202198|P1|Overall Study|Protocol Violation|2
7539843|NCT02587234|26202293|P2|Overall Study|Lost to Follow-up|2
7539844|NCT02587234|26202294|P1|Overall Study|Lost to Follow-up|0
7539845|NCT02587234|26202293|P2|Overall Study|Withdrawal by Subject|1
7539846|NCT02587234|26202294|P1|Overall Study|Withdrawal by Subject|1
7539847|NCT02587221|26202306|P2|Overall Study|Other Reason or Unspecified|1
7539848|NCT02587221|26202307|P1|Overall Study|Other Reason or Unspecified|2
7539849|NCT02587221|26202306|P2|Overall Study|Protocol Violation|5
7539850|NCT02587221|26202307|P1|Overall Study|Protocol Violation|6
7539851|NCT02587221|26202306|P2|Overall Study|Lost to Follow-up|19
7539852|NCT02587221|26202307|P1|Overall Study|Lost to Follow-up|21
7539853|NCT02587221|26202306|P2|Overall Study|Withdrawal by Subject|61
7539854|NCT02587221|26202307|P1|Overall Study|Withdrawal by Subject|66
7539855|NCT02587221|26202306|P2|Overall Study|Death|34
7539856|NCT02587221|26202307|P1|Overall Study|Death|33
7539857|NCT02587221|26202306|P2|Overall Study|Adverse Event|3
7539858|NCT02587221|26202307|P1|Overall Study|Adverse Event|3
7539859|NCT02587143|26202353|P2|Overall Study|Adverse Event|0
7539860|NCT02587143|26202354|P1|Overall Study|Adverse Event|1
7539861|NCT02587065|26202371|P1|Overall Study|Reason not Specified|3
7539862|NCT02587065|26202371|P1|Overall Study|Discontinuation of Study Medication|2
7539863|NCT02587065|26202371|P1|Overall Study|Non-adherence to the Protocol|3
7539864|NCT02587065|26202371|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
7539865|NCT02587065|26202371|P1|Overall Study|Adverse Event|14
7539866|NCT02586805|26202436|P4|Overall Study|Physician Decision|0
7539867|NCT02586805|26202437|P3|Overall Study|Physician Decision|0
7539868|NCT02586805|26202438|P2|Overall Study|Physician Decision|0
7539869|NCT02586805|26202439|P1|Overall Study|Physician Decision|1
7539870|NCT02586805|26202436|P4|Overall Study|Lost to Follow-up|0
7539871|NCT02586805|26202437|P3|Overall Study|Lost to Follow-up|1
7539872|NCT02586805|26202438|P2|Overall Study|Lost to Follow-up|0
7539873|NCT02586805|26202439|P1|Overall Study|Lost to Follow-up|0
7539874|NCT02586805|26202436|P4|Overall Study|Adverse Event|0
7539875|NCT02586805|26202437|P3|Overall Study|Adverse Event|1
7539876|NCT02586805|26202438|P2|Overall Study|Adverse Event|0
7539877|NCT02586805|26202439|P1|Overall Study|Adverse Event|2
7539878|NCT02586805|26202436|P4|Overall Study|Withdrawal by Subject|2
7539879|NCT02586805|26202437|P3|Overall Study|Withdrawal by Subject|1
7539880|NCT02586805|26202438|P2|Overall Study|Withdrawal by Subject|1
7539881|NCT02586805|26202439|P1|Overall Study|Withdrawal by Subject|3
7539882|NCT02586727|26202463|P2|Overall Study|Lost to Follow-up|0
7539883|NCT02586727|26202464|P1|Overall Study|Lost to Follow-up|1
7539884|NCT02586506|26202478|P1|Overall Study|Other Reason|2
7539885|NCT02586506|26202478|P1|Overall Study|Lost to Follow-up|1
7539886|NCT02586506|26202478|P1|Overall Study|Protocol Violation|6
7539887|NCT02586493|26202484|P1|Overall Study|Withdrawal by Subject|1
7539888|NCT02586493|26202484|P1|Overall Study|Lost to Follow-up|1
7539889|NCT02586493|26202484|P1|Overall Study|Protocol Violation|6
7539890|NCT02586493|26202484|P1|Overall Study|Adverse Event|4
7539891|NCT02586415|26202492|P2|Overall Study|Lost to Follow-up|2
7539892|NCT02586415|26202493|P1|Overall Study|Lost to Follow-up|1
7539893|NCT02586415|26202492|P2|Overall Study|Death|23
7539894|NCT02586415|26202493|P1|Overall Study|Death|13
7539895|NCT02586233|26202510|P7|Overall Study|Death|0
7539896|NCT02586233|26202511|P6|Overall Study|Death|0
7539897|NCT02586233|26202512|P5|Overall Study|Death|2
7539898|NCT02586233|26202513|P4|Overall Study|Death|0
7539899|NCT02586233|26202514|P3|Overall Study|Death|0
7539900|NCT02586233|26202515|P2|Overall Study|Death|1
7539901|NCT02586233|26202516|P1|Overall Study|Death|0
7539902|NCT02586233|26202510|P7|Overall Study|Randomized but did not receive treatment|2
7539903|NCT02586233|26202511|P6|Overall Study|Randomized but did not receive treatment|2
7539904|NCT02586233|26202512|P5|Overall Study|Randomized but did not receive treatment|0
7539905|NCT02586233|26202513|P4|Overall Study|Randomized but did not receive treatment|0
7539906|NCT02586233|26202514|P3|Overall Study|Randomized but did not receive treatment|0
7539907|NCT02586233|26202515|P2|Overall Study|Randomized but did not receive treatment|1
7539908|NCT02586233|26202516|P1|Overall Study|Randomized but did not receive treatment|0
7539909|NCT02586207|26202575|P1|Overall Study|Withdrawal by Subject|1
7539910|NCT02586207|26202575|P1|Overall Study|Physician Decision|1
7539911|NCT02586155|26202582|P2|Overall Study|Other reasons|15
7539912|NCT02586155|26202583|P1|Overall Study|Other reasons|26
7539913|NCT02586155|26202582|P2|Overall Study|Death|72
7539914|NCT02586155|26202583|P1|Overall Study|Death|61
7539915|NCT02586155|26202582|P2|Overall Study|Lost to Follow-up|13
7539916|NCT02586155|26202583|P1|Overall Study|Lost to Follow-up|7
7539917|NCT02586155|26202582|P2|Overall Study|Withdrawal by Subject|24
7539918|NCT02586155|26202583|P1|Overall Study|Withdrawal by Subject|31
7539919|NCT02586155|26202582|P2|Overall Study|Adverse Event|3
7539920|NCT02586155|26202583|P1|Overall Study|Adverse Event|2
7539921|NCT02586077|26202617|P1|Overall Study|Lost to Follow-up|3
7539922|NCT02586077|26202617|P1|Overall Study|Physician Decision|4
7539923|NCT02586077|26202617|P1|Overall Study|Withdrawal by Subject|1
7539924|NCT02586064|26202627|P2|Overall Study|Legal Issue|0
7539925|NCT02586064|26202628|P1|Overall Study|Legal Issue|1
7539926|NCT02586064|26202627|P2|Overall Study|AUD relapse|2
7539927|NCT02586064|26202628|P1|Overall Study|AUD relapse|0
7539928|NCT02586064|26202627|P2|Overall Study|Timed Out|0
7539929|NCT02586064|26202628|P1|Overall Study|Timed Out|2
7539930|NCT02586064|26202627|P2|Overall Study|Infrequent Attendance|1
7539931|NCT02586064|26202628|P1|Overall Study|Infrequent Attendance|2
7539932|NCT02586064|26202627|P2|Overall Study|Miscellaneous Life Issues|5
7539933|NCT02586064|26202628|P1|Overall Study|Miscellaneous Life Issues|0
7539934|NCT02586064|26202627|P2|Overall Study|Lost Interest|4
7539935|NCT02586064|26202628|P1|Overall Study|Lost Interest|1
7539936|NCT02586064|26202627|P2|Overall Study|Never Started|3
7539937|NCT02586064|26202628|P1|Overall Study|Never Started|3
7539938|NCT02586064|26202627|P2|Overall Study|Other|7
7539939|NCT02586064|26202628|P1|Overall Study|Other|3
7539940|NCT02586064|26202627|P2|Overall Study|Other Obligations|6
7539941|NCT02586064|26202628|P1|Overall Study|Other Obligations|6
7539942|NCT02586025|26202676|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
7539943|NCT02586025|26202677|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
7539944|NCT02586025|26202676|P2|Adjuvant Treatment|Recurrent Disease|4
7539945|NCT02586025|26202677|P1|Adjuvant Treatment|Recurrent Disease|1
7539946|NCT02586025|26202676|P2|Adjuvant Treatment|Physician Decision|1
7539947|NCT02586025|26202677|P1|Adjuvant Treatment|Physician Decision|0
7539948|NCT02586025|26202676|P2|Adjuvant Treatment|Withdrawal by Subject|3
7539949|NCT02586025|26202677|P1|Adjuvant Treatment|Withdrawal by Subject|5
7539950|NCT02586025|26202676|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
7539951|NCT02586025|26202677|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
7539952|NCT02586025|26202676|P2|Neoadjuvant Treatment|Progressive Disease|3
7539953|NCT02586025|26202677|P1|Neoadjuvant Treatment|Progressive Disease|2
7539954|NCT02586025|26202676|P2|Neoadjuvant Treatment|Physician Decision|1
7539955|NCT02586025|26202677|P1|Neoadjuvant Treatment|Physician Decision|2
7539956|NCT02586025|26202676|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
7539957|NCT02586025|26202677|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
7539958|NCT02586025|26202676|P2|Neoadjuvant Treatment|Adverse Event|0
7539959|NCT02586025|26202677|P1|Neoadjuvant Treatment|Adverse Event|1
7539960|NCT02586025|26202676|P2|Neoadjuvant Treatment|Death|0
7539961|NCT02586025|26202677|P1|Neoadjuvant Treatment|Death|1
7539962|NCT02586025|26202676|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
7539963|NCT02586025|26202677|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
7539964|NCT02586012|26202713|P6|Overall Study|study terminated|0
7539965|NCT02586012|26202714|P5|Overall Study|study terminated|1
7539966|NCT02586012|26202715|P4|Overall Study|study terminated|1
7539967|NCT02586012|26202716|P3|Overall Study|study terminated|1
7539968|NCT02586012|26202717|P2|Overall Study|study terminated|2
7539969|NCT02586012|26202718|P1|Overall Study|study terminated|0
7539970|NCT02586012|26202713|P6|Overall Study|Protocol Violation|1
7539971|NCT02586012|26202714|P5|Overall Study|Protocol Violation|0
7539972|NCT02586012|26202715|P4|Overall Study|Protocol Violation|0
7539973|NCT02586012|26202716|P3|Overall Study|Protocol Violation|0
7539974|NCT02586012|26202717|P2|Overall Study|Protocol Violation|0
7539975|NCT02586012|26202718|P1|Overall Study|Protocol Violation|0
7539976|NCT02586012|26202713|P6|Overall Study|Withdrawal by Subject|2
7539977|NCT02586012|26202714|P5|Overall Study|Withdrawal by Subject|0
7539978|NCT02586012|26202715|P4|Overall Study|Withdrawal by Subject|1
7539979|NCT02586012|26202716|P3|Overall Study|Withdrawal by Subject|0
7539980|NCT02586012|26202717|P2|Overall Study|Withdrawal by Subject|1
7539981|NCT02586012|26202718|P1|Overall Study|Withdrawal by Subject|1
7539982|NCT02585999|26202729|P1|Overall Study|Protocol Violation|1
7539983|NCT02585999|26202729|P1|Overall Study|Lost to Follow-up|1
7539984|NCT02585960|26202737|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7539985|NCT02585960|26202738|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
7539986|NCT02585960|26202739|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7539987|NCT02585960|26202737|P3|Prophylactic Treatment Period|Major protocol deviation|0
7539988|NCT02585960|26202738|P2|Prophylactic Treatment Period|Major protocol deviation|4
7539989|NCT02585960|26202739|P1|Prophylactic Treatment Period|Major protocol deviation|0
7539990|NCT02585960|26202737|P3|PK/Safety Assessment Period|Screen Failure|1
7539991|NCT02585960|26202738|P2|PK/Safety Assessment Period|Screen Failure|0
7539992|NCT02585960|26202739|P1|PK/Safety Assessment Period|Screen Failure|0
7539993|NCT02585960|26202737|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
7539994|NCT02585960|26202738|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
7539995|NCT02585960|26202739|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
7539996|NCT02585960|26202737|P3|PK/Safety Assessment Period|Other|0
7539997|NCT02585960|26202738|P2|PK/Safety Assessment Period|Other|4
7539998|NCT02585960|26202739|P1|PK/Safety Assessment Period|Other|4
7539999|NCT02585960|26202737|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
7540000|NCT02585960|26202738|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
7540001|NCT02585960|26202739|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
7540002|NCT02585960|26202737|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
7540003|NCT02585960|26202738|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
7540004|NCT02585960|26202739|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
7540005|NCT02585960|26202737|P3|PK/Safety Assessment Period|Physician Decision|0
7540006|NCT02585960|26202738|P2|PK/Safety Assessment Period|Physician Decision|1
7540007|NCT02585960|26202739|P1|PK/Safety Assessment Period|Physician Decision|0
7540008|NCT02585934|26202809|P2|Overall Study|Another Reason|5
7540009|NCT02585934|26202810|P1|Overall Study|Another Reason|10
7540010|NCT02585934|26202809|P2|Overall Study|Sponsor Termination|2
7540011|NCT02585934|26202810|P1|Overall Study|Sponsor Termination|1
7540012|NCT02585934|26202809|P2|Overall Study|Caregiver Withdrew Consent|7
7540013|NCT02585934|26202810|P1|Overall Study|Caregiver Withdrew Consent|7
7540014|NCT02585934|26202809|P2|Overall Study|Death|0
7540015|NCT02585934|26202810|P1|Overall Study|Death|2
7540016|NCT02585934|26202809|P2|Overall Study|Lack of Efficacy|1
7540017|NCT02585934|26202810|P1|Overall Study|Lack of Efficacy|2
7540018|NCT02585934|26202809|P2|Overall Study|Withdrawal by Subject|21
7540019|NCT02585934|26202810|P1|Overall Study|Withdrawal by Subject|7
7540020|NCT02585934|26202809|P2|Overall Study|Physician Decision|2
7540021|NCT02585934|26202810|P1|Overall Study|Physician Decision|3
7540022|NCT02585934|26202809|P2|Overall Study|Adverse Event|22
7540023|NCT02585934|26202810|P1|Overall Study|Adverse Event|21
7540024|NCT02585934|26202809|P2|Overall Study|Protocol Violation|11
7540025|NCT02585934|26202810|P1|Overall Study|Protocol Violation|14
7540026|NCT02585934|26202809|P2|Overall Study|Lost to Follow-up|2
7540027|NCT02585934|26202810|P1|Overall Study|Lost to Follow-up|2
7540028|NCT02585830|26202866|P1|Overall Study|Withdrawal by Subject|3
7540029|NCT02585778|26202875|P2|Overall Study|Other than specified above|2
7540030|NCT02585778|26202876|P1|Overall Study|Other than specified above|6
7540031|NCT02585778|26202875|P2|Overall Study|Randomized but not treated|2
7540032|NCT02585778|26202876|P1|Overall Study|Randomized but not treated|1
7540033|NCT02585778|26202875|P2|Overall Study|Death|1
7540034|NCT02585778|26202876|P1|Overall Study|Death|0
7540035|NCT02585778|26202875|P2|Overall Study|Poor compliance to study protocol|2
7540036|NCT02585778|26202876|P1|Overall Study|Poor compliance to study protocol|0
7540037|NCT02585778|26202875|P2|Overall Study|Participant did not wish to continue|4
7540038|NCT02585778|26202876|P1|Overall Study|Participant did not wish to continue|9
7540039|NCT02585778|26202875|P2|Overall Study|Adverse Event|4
7540040|NCT02585778|26202876|P1|Overall Study|Adverse Event|17
7540041|NCT02585713|26202992|P2|Overall Study|Other|1
7540042|NCT02585713|26202993|P1|Overall Study|Other|3
7540043|NCT02585713|26202992|P2|Overall Study|Withdrew prior to treatment|7
7540044|NCT02585713|26202993|P1|Overall Study|Withdrew prior to treatment|2
7540045|NCT02585232|26203039|P2|Overall Study|Withdrawal by Subject|8
7540046|NCT02585232|26203040|P1|Overall Study|Withdrawal by Subject|4
7540047|NCT02585232|26203039|P2|Overall Study|Lost to Follow-up|8
7540048|NCT02585232|26203040|P1|Overall Study|Lost to Follow-up|8
7540049|NCT02584959|26203073|P3|Period 2|Withdrawn from study|2
7540050|NCT02584959|26203074|P2|Period 2|Withdrawn from study|1
7540051|NCT02584959|26203075|P1|Period 2|Withdrawn from study|6
7540052|NCT02584959|26203073|P3|Period 1|Withdrawn from study|0
7540053|NCT02584959|26203074|P2|Period 1|Withdrawn from study|4
7540054|NCT02584959|26203075|P1|Period 1|Withdrawn from study|3
7540055|NCT02584855|26203203|P6|Post Treatment Follow-up Period|Protocol Violation|0
7540056|NCT02584855|26203204|P5|Post Treatment Follow-up Period|Protocol Violation|1
7540057|NCT02584855|26203205|P4|Post Treatment Follow-up Period|Protocol Violation|0
7540058|NCT02584855|26203206|P3|Post Treatment Follow-up Period|Protocol Violation|0
7540059|NCT02584855|26203207|P2|Post Treatment Follow-up Period|Protocol Violation|0
7540060|NCT02584855|26203208|P1|Post Treatment Follow-up Period|Protocol Violation|0
7540061|NCT02584855|26203203|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
7540062|NCT02584855|26203204|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
7540063|NCT02584855|26203205|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
7540064|NCT02584855|26203206|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
7540065|NCT02584855|26203207|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
7540066|NCT02584855|26203208|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
7540067|NCT02584855|26203203|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7540068|NCT02584855|26203204|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7540069|NCT02584855|26203205|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7540070|NCT02584855|26203206|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7540071|NCT02584855|26203207|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
7540072|NCT02584855|26203208|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7540073|NCT02584855|26203203|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
7540074|NCT02584855|26203204|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
7540075|NCT02584855|26203205|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
7540076|NCT02584855|26203206|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
7540077|NCT02584855|26203207|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
7540078|NCT02584855|26203208|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
7540079|NCT02584855|26203203|P6|Double-Blind Withdrawal Period|Adverse Event|0
7540080|NCT02584855|26203204|P5|Double-Blind Withdrawal Period|Adverse Event|0
7540081|NCT02584855|26203205|P4|Double-Blind Withdrawal Period|Adverse Event|1
7540082|NCT02584855|26203206|P3|Double-Blind Withdrawal Period|Adverse Event|0
7540083|NCT02584855|26203207|P2|Double-Blind Withdrawal Period|Adverse Event|4
7540084|NCT02584855|26203208|P1|Double-Blind Withdrawal Period|Adverse Event|0
7540085|NCT02584855|26203203|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7540086|NCT02584855|26203204|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7540087|NCT02584855|26203205|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7540088|NCT02584855|26203206|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
7540089|NCT02584855|26203207|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7540090|NCT02584855|26203208|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7540091|NCT02584855|26203203|P6|Open-Label Treatment Period|Sponsor Decision|0
7540092|NCT02584855|26203204|P5|Open-Label Treatment Period|Sponsor Decision|0
7540093|NCT02584855|26203205|P4|Open-Label Treatment Period|Sponsor Decision|0
7540094|NCT02584855|26203206|P3|Open-Label Treatment Period|Sponsor Decision|0
7540095|NCT02584855|26203207|P2|Open-Label Treatment Period|Sponsor Decision|0
7540096|NCT02584855|26203208|P1|Open-Label Treatment Period|Sponsor Decision|1
7540097|NCT02584855|26203203|P6|Open-Label Treatment Period|No PI Available|0
7540098|NCT02584855|26203204|P5|Open-Label Treatment Period|No PI Available|0
7540099|NCT02584855|26203205|P4|Open-Label Treatment Period|No PI Available|0
7540100|NCT02584855|26203206|P3|Open-Label Treatment Period|No PI Available|0
7540101|NCT02584855|26203207|P2|Open-Label Treatment Period|No PI Available|0
7540102|NCT02584855|26203208|P1|Open-Label Treatment Period|No PI Available|2
7540103|NCT02584855|26203203|P6|Open-Label Treatment Period|Protocol Violation|0
7540104|NCT02584855|26203204|P5|Open-Label Treatment Period|Protocol Violation|0
7540105|NCT02584855|26203205|P4|Open-Label Treatment Period|Protocol Violation|0
7540106|NCT02584855|26203206|P3|Open-Label Treatment Period|Protocol Violation|0
7540107|NCT02584855|26203207|P2|Open-Label Treatment Period|Protocol Violation|0
7540108|NCT02584855|26203208|P1|Open-Label Treatment Period|Protocol Violation|1
7540109|NCT02584855|26203203|P6|Open-Label Treatment Period|Lost to Follow-up|0
7540110|NCT02584855|26203204|P5|Open-Label Treatment Period|Lost to Follow-up|0
7540111|NCT02584855|26203205|P4|Open-Label Treatment Period|Lost to Follow-up|0
7540112|NCT02584855|26203206|P3|Open-Label Treatment Period|Lost to Follow-up|0
7540113|NCT02584855|26203207|P2|Open-Label Treatment Period|Lost to Follow-up|0
7540114|NCT02584855|26203208|P1|Open-Label Treatment Period|Lost to Follow-up|1
7540115|NCT02584855|26203203|P6|Open-Label Treatment Period|Death|0
7540116|NCT02584855|26203204|P5|Open-Label Treatment Period|Death|0
7540117|NCT02584855|26203205|P4|Open-Label Treatment Period|Death|0
7540118|NCT02584855|26203206|P3|Open-Label Treatment Period|Death|0
7540119|NCT02584855|26203207|P2|Open-Label Treatment Period|Death|0
7540120|NCT02584855|26203208|P1|Open-Label Treatment Period|Death|2
7540121|NCT02584855|26203203|P6|Open-Label Treatment Period|Adverse Event|0
7540122|NCT02584855|26203204|P5|Open-Label Treatment Period|Adverse Event|0
7540123|NCT02584855|26203205|P4|Open-Label Treatment Period|Adverse Event|0
7540124|NCT02584855|26203206|P3|Open-Label Treatment Period|Adverse Event|0
7540125|NCT02584855|26203207|P2|Open-Label Treatment Period|Adverse Event|0
7540126|NCT02584855|26203208|P1|Open-Label Treatment Period|Adverse Event|14
7540127|NCT02584855|26203203|P6|Open-Label Treatment Period|Withdrawal by Subject|0
7540128|NCT02584855|26203204|P5|Open-Label Treatment Period|Withdrawal by Subject|0
7540129|NCT02584855|26203205|P4|Open-Label Treatment Period|Withdrawal by Subject|0
7540130|NCT02584855|26203206|P3|Open-Label Treatment Period|Withdrawal by Subject|0
7540131|NCT02584855|26203207|P2|Open-Label Treatment Period|Withdrawal by Subject|0
7540132|NCT02584855|26203208|P1|Open-Label Treatment Period|Withdrawal by Subject|21
7540133|NCT02584855|26203203|P6|Open-Label Treatment Period|Lack of Efficacy|0
7540134|NCT02584855|26203204|P5|Open-Label Treatment Period|Lack of Efficacy|0
7540135|NCT02584855|26203205|P4|Open-Label Treatment Period|Lack of Efficacy|0
7540136|NCT02584855|26203206|P3|Open-Label Treatment Period|Lack of Efficacy|0
7540137|NCT02584855|26203207|P2|Open-Label Treatment Period|Lack of Efficacy|0
7540138|NCT02584855|26203208|P1|Open-Label Treatment Period|Lack of Efficacy|61
7540139|NCT02584660|26203340|P2|Overall Study|Other|1
7540140|NCT02584660|26203341|P1|Overall Study|Other|0
7540141|NCT02584660|26203340|P2|Overall Study|Withdrawal by Subject|2
7540142|NCT02584660|26203341|P1|Overall Study|Withdrawal by Subject|0
7540143|NCT02584660|26203340|P2|Overall Study|Protocol Violation|1
7540144|NCT02584660|26203341|P1|Overall Study|Protocol Violation|0
7540145|NCT02584660|26203340|P2|Overall Study|Lost to Follow-up|4
7540146|NCT02584660|26203341|P1|Overall Study|Lost to Follow-up|3
7540147|NCT02584660|26203340|P2|Overall Study|Adverse Event|0
7540148|NCT02584660|26203341|P1|Overall Study|Adverse Event|4
7540149|NCT02584504|26203365|P3|Open-label Treatment|Entered but not treated|1
7540150|NCT02584504|26203366|P2|Open-label Treatment|Entered but not treated|1
7540151|NCT02584504|26203367|P1|Open-label Treatment|Entered but not treated|0
7540152|NCT02584504|26203365|P3|Open-label Treatment|Physician Decision|0
7540153|NCT02584504|26203366|P2|Open-label Treatment|Physician Decision|1
7540154|NCT02584504|26203367|P1|Open-label Treatment|Physician Decision|0
7540155|NCT02584504|26203365|P3|Open-label Treatment|Adverse Event|3
7540156|NCT02584504|26203366|P2|Open-label Treatment|Adverse Event|2
7540157|NCT02584504|26203367|P1|Open-label Treatment|Adverse Event|2
7540158|NCT02584504|26203365|P3|Open-label Treatment|Participant withdrew consent|4
7540159|NCT02584504|26203366|P2|Open-label Treatment|Participant withdrew consent|0
7540160|NCT02584504|26203367|P1|Open-label Treatment|Participant withdrew consent|0
7540161|NCT02584504|26203365|P3|Double-blind Treatment|Family Matter|0
7540162|NCT02584504|26203366|P2|Double-blind Treatment|Family Matter|1
7540163|NCT02584504|26203367|P1|Double-blind Treatment|Family Matter|0
7540164|NCT02584504|26203365|P3|Double-blind Treatment|Adverse Event|0
7540165|NCT02584504|26203366|P2|Double-blind Treatment|Adverse Event|1
7540166|NCT02584504|26203367|P1|Double-blind Treatment|Adverse Event|0
7540167|NCT02584504|26203365|P3|Double-blind Treatment|Participant withdrew consent|1
7540168|NCT02584504|26203366|P2|Double-blind Treatment|Participant withdrew consent|0
7540169|NCT02584504|26203367|P1|Double-blind Treatment|Participant withdrew consent|0
7540170|NCT02584452|26203423|P2|Overall Study|Lost to Follow-up|1
7540171|NCT02584452|26203424|P1|Overall Study|Lost to Follow-up|1
7540172|NCT02584452|26203423|P2|Overall Study|Physician Decision|1
7540173|NCT02584452|26203424|P1|Overall Study|Physician Decision|1
7540174|NCT02584257|26203452|P9|Period 2|Adverse Event|0
7540175|NCT02584257|26203453|P8|Period 2|Adverse Event|0
7540176|NCT02584257|26203454|P7|Period 2|Adverse Event|0
7540177|NCT02584257|26203455|P6|Period 2|Adverse Event|0
7540178|NCT02584257|26203456|P5|Period 2|Adverse Event|0
7540179|NCT02584257|26203457|P4|Period 2|Adverse Event|0
7540180|NCT02584257|26203458|P3|Period 2|Adverse Event|0
7540181|NCT02584257|26203459|P2|Period 2|Adverse Event|1
7540182|NCT02584257|26203460|P1|Period 2|Adverse Event|0
7540183|NCT02584257|26203452|P9|Period 2|Physician Decision|0
7540184|NCT02584257|26203453|P8|Period 2|Physician Decision|0
7540185|NCT02584257|26203454|P7|Period 2|Physician Decision|0
7540186|NCT02584257|26203455|P6|Period 2|Physician Decision|0
7540187|NCT02584257|26203456|P5|Period 2|Physician Decision|0
7540188|NCT02584257|26203457|P4|Period 2|Physician Decision|0
7540189|NCT02584257|26203458|P3|Period 2|Physician Decision|0
7540190|NCT02584257|26203459|P2|Period 2|Physician Decision|0
7540191|NCT02584257|26203460|P1|Period 2|Physician Decision|1
7540192|NCT02584257|26203452|P9|Period 1|Withdrawal by Subject|0
7540193|NCT02584257|26203453|P8|Period 1|Withdrawal by Subject|0
7540194|NCT02584257|26203454|P7|Period 1|Withdrawal by Subject|1
7540195|NCT02584257|26203455|P6|Period 1|Withdrawal by Subject|0
7540196|NCT02584257|26203456|P5|Period 1|Withdrawal by Subject|0
7540197|NCT02584257|26203457|P4|Period 1|Withdrawal by Subject|0
7540198|NCT02584257|26203458|P3|Period 1|Withdrawal by Subject|0
7540199|NCT02584257|26203459|P2|Period 1|Withdrawal by Subject|0
7540200|NCT02584257|26203460|P1|Period 1|Withdrawal by Subject|0
7540201|NCT02583711|26203482|P3|Overall Study|Withdrawal by Subject|0
7540202|NCT02583711|26203483|P2|Overall Study|Withdrawal by Subject|10
7540203|NCT02583711|26203484|P1|Overall Study|Withdrawal by Subject|0
7540204|NCT02583477|26203509|P2|Overall Study|Study terminated|2
7540205|NCT02583477|26203510|P1|Overall Study|Study terminated|2
7540206|NCT02583477|26203509|P2|Overall Study|Death|16
7540207|NCT02583477|26203510|P1|Overall Study|Death|1
7540208|NCT02583477|26203509|P2|Overall Study|Adverse Event|2
7540209|NCT02583477|26203510|P1|Overall Study|Adverse Event|0
7540210|NCT02583425|26203530|P1|Treatment Period|Adverse Event|1
7540211|NCT02583425|26203530|P1|Baseline|Did not meet continued criteria|5
7540212|NCT02583425|26203530|P1|Screening|Did not meet entry criteria|12
7540213|NCT02583399|26203535|P1|Overall Study|Wanted to use a restricted medication|3
7540214|NCT02583399|26203535|P1|Overall Study|Able to be discharged|3
7540215|NCT02583269|26203560|P5|Overall Study|Patient hospitalized prior to start|0
7540216|NCT02583269|26203561|P4|Overall Study|Patient hospitalized prior to start|0
7540217|NCT02583269|26203562|P3|Overall Study|Patient hospitalized prior to start|0
7540218|NCT02583269|26203563|P2|Overall Study|Patient hospitalized prior to start|0
7540219|NCT02583269|26203564|P1|Overall Study|Patient hospitalized prior to start|1
7540220|NCT02583256|26203599|P4|Overall Study|Administrative/Other|2
7540221|NCT02583256|26203600|P3|Overall Study|Administrative/Other|1
7540222|NCT02583256|26203601|P2|Overall Study|Administrative/Other|0
7540223|NCT02583256|26203602|P1|Overall Study|Administrative/Other|2
7540224|NCT02583256|26203599|P4|Overall Study|Lost to Follow-up|1
7540225|NCT02583256|26203600|P3|Overall Study|Lost to Follow-up|0
7540226|NCT02583256|26203601|P2|Overall Study|Lost to Follow-up|1
7540227|NCT02583256|26203602|P1|Overall Study|Lost to Follow-up|1
7540228|NCT02583256|26203599|P4|Overall Study|Withdrawal by Subject|0
7540229|NCT02583256|26203600|P3|Overall Study|Withdrawal by Subject|1
7540230|NCT02583256|26203601|P2|Overall Study|Withdrawal by Subject|1
7540231|NCT02583256|26203602|P1|Overall Study|Withdrawal by Subject|0
7540232|NCT02583048|26203699|P3|Overall Study|Failed to meet eligibility criterion|1
7540233|NCT02583048|26203700|P2|Overall Study|Failed to meet eligibility criterion|0
7540234|NCT02583048|26203701|P1|Overall Study|Failed to meet eligibility criterion|0
7540235|NCT02583048|26203699|P3|Overall Study|Withdrawal by Subject|0
7540236|NCT02583048|26203700|P2|Overall Study|Withdrawal by Subject|1
7540237|NCT02583048|26203701|P1|Overall Study|Withdrawal by Subject|0
7540238|NCT02582983|26203760|P1|Overall Study|Adverse Event|1
7540239|NCT02582983|26203760|P1|Overall Study|Withdrawal by Subject|2
7540240|NCT02582983|26203760|P1|Overall Study|Death|3
7540241|NCT02582866|26203775|P1|Overall Study|Withdrawal due to personal reasons|1
7540242|NCT02582866|26203775|P1|Overall Study|Sponsor decision|1
7540243|NCT02582866|26203775|P1|Overall Study|Pregnancy|2
7540244|NCT02582866|26203775|P1|Overall Study|Participant wants to get pregnant|1
7540245|NCT02582866|26203775|P1|Overall Study|Investigator decision|5
7540246|NCT02582866|26203775|P1|Overall Study|Withdrawal by Subject|7
7540247|NCT02582866|26203775|P1|Overall Study|Lost to Follow-up|2
7540248|NCT02582866|26203775|P1|Overall Study|Lack of Efficacy|2
7540249|NCT02582866|26203775|P1|Overall Study|Death|1
7540250|NCT02582814|26203829|P2|Overall Study|Adverse Event|4
7540251|NCT02582814|26203830|P1|Overall Study|Adverse Event|4
7540252|NCT02582814|26203829|P2|Overall Study|Withdrawal by Subject|3
7540253|NCT02582814|26203830|P1|Overall Study|Withdrawal by Subject|4
7540254|NCT02582814|26203829|P2|Overall Study|Study-specific withdrawal criteria|0
7540255|NCT02582814|26203830|P1|Overall Study|Study-specific withdrawal criteria|1
7540256|NCT02582749|26203870|P2|Overall Study|Withdrawal by Subject|1
7540257|NCT02582749|26203871|P1|Overall Study|Withdrawal by Subject|0
7540258|NCT02582749|26203870|P2|Overall Study|Study terminated by funder|10
7540259|NCT02582749|26203871|P1|Overall Study|Study terminated by funder|5
7540260|NCT02582684|26203901|P1|Overall Study|Found to be ineligible after enrollment|2
7540261|NCT02582684|26203901|P1|Overall Study|Subject withdrew consent|1
7540262|NCT02582684|26203901|P1|Overall Study|Subject not able to get to clinic|10
7540263|NCT02582684|26203901|P1|Overall Study|Unable to contact subject/parent|4
7540264|NCT02582671|26203920|P1|Overall Study|Other, not specified|1
7540265|NCT02582671|26203920|P1|Overall Study|Failure to return|1
7540266|NCT02582658|26203932|P1|Overall Study|Not further specified|11
7540267|NCT02582658|26203932|P1|Overall Study|Death|1
7540268|NCT02582658|26203932|P1|Overall Study|Withdrawn Consent|1
7540269|NCT02582658|26203932|P1|Overall Study|Insufficient Virological Response|2
7540270|NCT02582658|26203932|P1|Overall Study|Failure to Return|10
7540271|NCT02582632|26203950|P1|Overall Study|Other|1
7540272|NCT02582515|26203965|P2|Overall Study|Withdrawal by Subject|1
7540273|NCT02582515|26203966|P1|Overall Study|Withdrawal by Subject|0
7540274|NCT02582255|26203974|P2|Overall Study|Protocol Violation|3
7540275|NCT02582255|26203975|P1|Overall Study|Protocol Violation|0
7540276|NCT02582242|26203988|P2|Overall Study|Unclassified|1
7540277|NCT02582242|26203989|P1|Overall Study|Unclassified|2
7540278|NCT02582242|26203988|P2|Overall Study|Withdrawal by Subject|11
7540279|NCT02582242|26203989|P1|Overall Study|Withdrawal by Subject|11
7540280|NCT02582242|26203988|P2|Overall Study|Lost to Follow-up|1
7540281|NCT02582242|26203989|P1|Overall Study|Lost to Follow-up|0
7540282|NCT02582242|26203988|P2|Overall Study|Protocol Violation|1
7540283|NCT02582242|26203989|P1|Overall Study|Protocol Violation|3
7540284|NCT02582242|26203988|P2|Overall Study|Adverse Event|3
7540285|NCT02582242|26203989|P1|Overall Study|Adverse Event|4
7540286|NCT02581995|26204053|P1|Overall Study|Death|4
7540287|NCT02581995|26204053|P1|Overall Study|Physician Decision|1
7540288|NCT02581995|26204053|P1|Overall Study|Withdrawal by participant|12
7540289|NCT02581995|26204053|P1|Overall Study|Lost to Follow-up|5
7540290|NCT02581995|26204053|P1|Overall Study|Adverse Event|6
7540291|NCT02581995|26204053|P1|Overall Study|Unspecified other|3
7540292|NCT02581930|26204067|P1|Overall Study|patient declined further treatment|1
7540293|NCT02581930|26204067|P1|Overall Study|Withdrawal by Subject|1
7540294|NCT02581891|26204075|P2|Overall Study|Discontinued during followup|0
7540295|NCT02581891|26204076|P1|Overall Study|Discontinued during followup|1
7540296|NCT02581891|26204075|P2|Overall Study|Other Reasons|1
7540297|NCT02581891|26204076|P1|Overall Study|Other Reasons|3
7540298|NCT02581891|26204075|P2|Overall Study|Withdrawal by Subject|5
7540299|NCT02581891|26204076|P1|Overall Study|Withdrawal by Subject|4
7540300|NCT02581891|26204075|P2|Overall Study|Physician Decision|1
7540301|NCT02581891|26204076|P1|Overall Study|Physician Decision|0
7540302|NCT02581891|26204075|P2|Overall Study|Lost to Follow-up|2
7540303|NCT02581891|26204076|P1|Overall Study|Lost to Follow-up|1
7540304|NCT02581891|26204075|P2|Overall Study|Death|4
7540305|NCT02581891|26204076|P1|Overall Study|Death|3
7540306|NCT02581891|26204075|P2|Overall Study|Adverse Event|6
7540307|NCT02581891|26204076|P1|Overall Study|Adverse Event|4
7540308|NCT02581488|26204139|P2|Overall Study|Protocol Violation|4
7540309|NCT02581488|26204140|P1|Overall Study|Protocol Violation|0
7540310|NCT02581488|26204139|P2|Overall Study|Non-Compliance|0
7540311|NCT02581488|26204140|P1|Overall Study|Non-Compliance|1
7540312|NCT02581488|26204139|P2|Overall Study|Withdrawal by Subject|0
7540313|NCT02581488|26204140|P1|Overall Study|Withdrawal by Subject|1
7540314|NCT02581488|26204139|P2|Overall Study|Lost to Follow-up|0
7540315|NCT02581488|26204140|P1|Overall Study|Lost to Follow-up|1
7540316|NCT02581488|26204139|P2|Overall Study|Adverse Event|7
7540317|NCT02581488|26204140|P1|Overall Study|Adverse Event|6
7540318|NCT02581410|26204171|P2|End of Study Phase|Other-transfer of subject not completed|1
7540319|NCT02581410|26204172|P1|End of Study Phase|Other-transfer of subject not completed|0
7540320|NCT02581410|26204171|P2|End of Study Phase|Lost to Follow-up|2
7540321|NCT02581410|26204172|P1|End of Study Phase|Lost to Follow-up|0
7540322|NCT02581410|26204171|P2|End of Study Phase|Migrated/moved from study area|3
7540323|NCT02581410|26204172|P1|End of Study Phase|Migrated/moved from study area|0
7540324|NCT02581410|26204171|P2|End of Study Phase|Withdrawal by Subject|2
7540325|NCT02581410|26204172|P1|End of Study Phase|Withdrawal by Subject|1
7540326|NCT02581410|26204171|P2|End of Study Phase|Adverse Event|3
7540327|NCT02581410|26204172|P1|End of Study Phase|Adverse Event|4
7540328|NCT02581410|26204171|P2|Vaccination Phase|Migrated/moved from study area|1
7540329|NCT02581410|26204172|P1|Vaccination Phase|Migrated/moved from study area|0
7540330|NCT02581410|26204171|P2|Vaccination Phase|Withdrawal by Subject|1
7540331|NCT02581410|26204172|P1|Vaccination Phase|Withdrawal by Subject|0
7540332|NCT02581410|26204171|P2|Vaccination Phase|Adverse Event|1
7540333|NCT02581410|26204172|P1|Vaccination Phase|Adverse Event|2
7540334|NCT02581345|26204214|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
7540335|NCT02581345|26204215|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
7540336|NCT02581345|26204216|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
7540337|NCT02581345|26204217|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
7540338|NCT02581345|26204214|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
7540339|NCT02581345|26204215|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7540340|NCT02581345|26204216|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7540341|NCT02581345|26204217|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
7540342|NCT02581345|26204214|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
7540343|NCT02581345|26204215|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
7540429|NCT02580357|26204479|P1|Overall Study|Lost to Follow-up|2
7540344|NCT02581345|26204216|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
7540345|NCT02581345|26204217|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
7540346|NCT02581345|26204214|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
7540347|NCT02581345|26204215|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
7540348|NCT02581345|26204216|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
7540349|NCT02581345|26204217|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
7540350|NCT02581345|26204214|P4|Part 2: Week 17 to Week 47|Physician Decision|1
7540351|NCT02581345|26204215|P3|Part 2: Week 17 to Week 47|Physician Decision|2
7540352|NCT02581345|26204216|P2|Part 2: Week 17 to Week 47|Physician Decision|0
7540353|NCT02581345|26204217|P1|Part 2: Week 17 to Week 47|Physician Decision|3
7540354|NCT02581345|26204214|P4|Part 2: Week 17 to Week 47|Adverse Event|2
7540355|NCT02581345|26204215|P3|Part 2: Week 17 to Week 47|Adverse Event|2
7540356|NCT02581345|26204216|P2|Part 2: Week 17 to Week 47|Adverse Event|0
7540357|NCT02581345|26204217|P1|Part 2: Week 17 to Week 47|Adverse Event|5
7540358|NCT02581345|26204214|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
7540359|NCT02581345|26204215|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
7540360|NCT02581345|26204216|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
7540361|NCT02581345|26204217|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
7540362|NCT02581345|26204214|P4|Part 1: up to Week 16|Unspecified Reason|0
7540363|NCT02581345|26204215|P3|Part 1: up to Week 16|Unspecified Reason|0
7540364|NCT02581345|26204216|P2|Part 1: up to Week 16|Unspecified Reason|3
7540365|NCT02581345|26204217|P1|Part 1: up to Week 16|Unspecified Reason|3
7540366|NCT02581345|26204214|P4|Part 1: up to Week 16|Lost to Follow-up|0
7540367|NCT02581345|26204215|P3|Part 1: up to Week 16|Lost to Follow-up|0
7540368|NCT02581345|26204216|P2|Part 1: up to Week 16|Lost to Follow-up|0
7540369|NCT02581345|26204217|P1|Part 1: up to Week 16|Lost to Follow-up|2
7540370|NCT02581345|26204214|P4|Part 1: up to Week 16|Withdrawal by Subject|0
7540371|NCT02581345|26204215|P3|Part 1: up to Week 16|Withdrawal by Subject|0
7540372|NCT02581345|26204216|P2|Part 1: up to Week 16|Withdrawal by Subject|7
7540373|NCT02581345|26204217|P1|Part 1: up to Week 16|Withdrawal by Subject|4
7540374|NCT02581345|26204214|P4|Part 1: up to Week 16|Physician Decision|0
7540375|NCT02581345|26204215|P3|Part 1: up to Week 16|Physician Decision|0
7540376|NCT02581345|26204216|P2|Part 1: up to Week 16|Physician Decision|4
7540377|NCT02581345|26204217|P1|Part 1: up to Week 16|Physician Decision|2
7540378|NCT02581345|26204214|P4|Part 1: up to Week 16|Adverse Event|0
7540379|NCT02581345|26204215|P3|Part 1: up to Week 16|Adverse Event|0
7540380|NCT02581345|26204216|P2|Part 1: up to Week 16|Adverse Event|8
7540381|NCT02581345|26204217|P1|Part 1: up to Week 16|Adverse Event|3
7540382|NCT02581202|26204319|P1|Overall Study|Pregnancy|3
7540383|NCT02581202|26204319|P1|Overall Study|Lost to Follow-up|5
7540384|NCT02581202|26204319|P1|Overall Study|Withdrawal by Subject|4
7540385|NCT02581202|26204319|P1|Overall Study|Lack of Efficacy|2
7540386|NCT02581189|26204358|P1|Overall Study|Other, not specified|7
7540387|NCT02581189|26204358|P1|Overall Study|Insufficient virological response|2
7540388|NCT02581189|26204358|P1|Overall Study|Death|3
7540389|NCT02581189|26204358|P1|Overall Study|Withdrew consent|5
7540390|NCT02581189|26204358|P1|Overall Study|Failure to return|36
7540391|NCT02581163|26204372|P1|Overall Study|Other, not specified|9
7540392|NCT02581163|26204372|P1|Overall Study|Death|1
7540393|NCT02581163|26204372|P1|Overall Study|Withdrew consent|1
7540394|NCT02581163|26204372|P1|Overall Study|Insufficient virological response|3
7540395|NCT02581163|26204372|P1|Overall Study|Failure to return|15
7540396|NCT02580877|26204406|P2|Overall Study|Adverse Event|1
7540397|NCT02580877|26204407|P1|Overall Study|Adverse Event|0
7540398|NCT02580877|26204406|P2|Overall Study|Withdrawal by Subject|3
7540399|NCT02580877|26204407|P1|Overall Study|Withdrawal by Subject|1
7540400|NCT02580591|26204441|P4|Overall Study|Other than specified|2
7540401|NCT02580591|26204442|P3|Overall Study|Other than specified|5
7540402|NCT02580591|26204443|P2|Overall Study|Other than specified|2
7540403|NCT02580591|26204444|P1|Overall Study|Other than specified|3
7540404|NCT02580591|26204441|P4|Overall Study|Not treated|0
7540405|NCT02580591|26204442|P3|Overall Study|Not treated|0
7540406|NCT02580591|26204443|P2|Overall Study|Not treated|1
7540407|NCT02580591|26204444|P1|Overall Study|Not treated|1
7540408|NCT02580591|26204441|P4|Overall Study|Withdrawal by Subject|3
7540409|NCT02580591|26204442|P3|Overall Study|Withdrawal by Subject|2
7540410|NCT02580591|26204443|P2|Overall Study|Withdrawal by Subject|1
7540411|NCT02580591|26204444|P1|Overall Study|Withdrawal by Subject|6
7540412|NCT02580591|26204441|P4|Overall Study|Lost to Follow-up|1
7540413|NCT02580591|26204442|P3|Overall Study|Lost to Follow-up|3
7540414|NCT02580591|26204443|P2|Overall Study|Lost to Follow-up|3
7540415|NCT02580591|26204444|P1|Overall Study|Lost to Follow-up|5
7540416|NCT02580591|26204441|P4|Overall Study|Protocol Violation|1
7540417|NCT02580591|26204442|P3|Overall Study|Protocol Violation|1
7540418|NCT02580591|26204443|P2|Overall Study|Protocol Violation|2
7540419|NCT02580591|26204444|P1|Overall Study|Protocol Violation|3
7540420|NCT02580591|26204441|P4|Overall Study|Adverse Event|5
7540421|NCT02580591|26204442|P3|Overall Study|Adverse Event|2
7540422|NCT02580591|26204443|P2|Overall Study|Adverse Event|1
7540423|NCT02580591|26204444|P1|Overall Study|Adverse Event|0
7540424|NCT02580357|26204477|P3|Overall Study|Protocol Violation|0
7540425|NCT02580357|26204478|P2|Overall Study|Protocol Violation|0
7540426|NCT02580357|26204479|P1|Overall Study|Protocol Violation|1
7540427|NCT02580357|26204477|P3|Overall Study|Lost to Follow-up|0
7540428|NCT02580357|26204478|P2|Overall Study|Lost to Follow-up|0
7540430|NCT02580240|26204496|P2|Overall Study|Physician Decision|0
7540431|NCT02580240|26204497|P1|Overall Study|Physician Decision|2
7540432|NCT02580058|26204535|P3|Overall Study|Withdrawal by Subject|36
7540433|NCT02580058|26204536|P2|Overall Study|Withdrawal by Subject|26
7540434|NCT02580058|26204537|P1|Overall Study|Withdrawal by Subject|24
7540435|NCT02580058|26204535|P3|Overall Study|Ongoing|46
7540436|NCT02580058|26204536|P2|Overall Study|Ongoing|55
7540437|NCT02580058|26204537|P1|Overall Study|Ongoing|51
7540438|NCT02580058|26204535|P3|Overall Study|Lost to Follow-up|4
7540439|NCT02580058|26204536|P2|Overall Study|Lost to Follow-up|5
7540440|NCT02580058|26204537|P1|Overall Study|Lost to Follow-up|4
7540441|NCT02579928|26204604|P2|Overall Study|Withdrawal by Subject|0
7540442|NCT02579928|26204605|P1|Overall Study|Withdrawal by Subject|1
7540443|NCT02579863|26204645|P2|Overall Study|Withdrawal by Subject|20
7540444|NCT02579863|26204646|P1|Overall Study|Withdrawal by Subject|20
7540445|NCT02579863|26204645|P2|Overall Study|Study Terminated at Selected Sites|88
7540446|NCT02579863|26204646|P1|Overall Study|Study Terminated at Selected Sites|82
7540447|NCT02579863|26204645|P2|Overall Study|Screen Failure|2
7540448|NCT02579863|26204646|P1|Overall Study|Screen Failure|0
7540449|NCT02579863|26204645|P2|Overall Study|Physician Decision|2
7540450|NCT02579863|26204646|P1|Overall Study|Physician Decision|1
7540451|NCT02579863|26204645|P2|Overall Study|Lost to Follow-up|1
7540452|NCT02579863|26204646|P1|Overall Study|Lost to Follow-up|2
7540453|NCT02579863|26204645|P2|Overall Study|Death|29
7540454|NCT02579863|26204646|P1|Overall Study|Death|31
7540455|NCT02579863|26204645|P2|Overall Study|Adverse Event|11
7540456|NCT02579863|26204646|P1|Overall Study|Adverse Event|18
7540457|NCT02579863|26204645|P2|Overall Study|Final Disposition Unknown|1
7540458|NCT02579863|26204646|P1|Overall Study|Final Disposition Unknown|2
7540459|NCT02579772|26204673|P2|Overall Study|flu-like illness, orthopedic trauma|1
7540460|NCT02579772|26204674|P1|Overall Study|flu-like illness, orthopedic trauma|1
7540461|NCT02579772|26204673|P2|Overall Study|Usage of additional antioxidants|0
7540462|NCT02579772|26204674|P1|Overall Study|Usage of additional antioxidants|1
7540463|NCT02579772|26204673|P2|Overall Study|Withdrawal by Subject|1
7540464|NCT02579772|26204674|P1|Overall Study|Withdrawal by Subject|0
7540465|NCT02579759|26204695|P3|Overall Study|Lost to Follow-up|2
7540466|NCT02579759|26204696|P2|Overall Study|Lost to Follow-up|2
7540467|NCT02579759|26204697|P1|Overall Study|Lost to Follow-up|2
7540468|NCT02579759|26204695|P3|Overall Study|Withdrawal by Subject|5
7540469|NCT02579759|26204696|P2|Overall Study|Withdrawal by Subject|3
7540470|NCT02579759|26204697|P1|Overall Study|Withdrawal by Subject|3
7540471|NCT02579759|26204695|P3|Overall Study|Adverse Event|1
7540472|NCT02579759|26204696|P2|Overall Study|Adverse Event|3
7540473|NCT02579759|26204697|P1|Overall Study|Adverse Event|4
7540474|NCT02579759|26204695|P3|Overall Study|Inclusion/exclusion criteria|1
7540475|NCT02579759|26204696|P2|Overall Study|Inclusion/exclusion criteria|0
7540476|NCT02579759|26204697|P1|Overall Study|Inclusion/exclusion criteria|0
7540477|NCT02579759|26204695|P3|Overall Study|Pregnancy|0
7540478|NCT02579759|26204696|P2|Overall Study|Pregnancy|1
7540479|NCT02579759|26204697|P1|Overall Study|Pregnancy|0
7540480|NCT02579759|26204695|P3|Overall Study|Non compliance|0
7540481|NCT02579759|26204696|P2|Overall Study|Non compliance|1
7540482|NCT02579759|26204697|P1|Overall Study|Non compliance|0
7540483|NCT02579759|26204695|P3|Overall Study|Sponsor stopped Dose 2|0
7540484|NCT02579759|26204696|P2|Overall Study|Sponsor stopped Dose 2|41
7540485|NCT02579759|26204697|P1|Overall Study|Sponsor stopped Dose 2|0
7540486|NCT02579759|26204695|P3|Overall Study|BfArM hold|12
7540487|NCT02579759|26204696|P2|Overall Study|BfArM hold|12
7540488|NCT02579759|26204697|P1|Overall Study|BfArM hold|13
7540489|NCT02579759|26204695|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
7540490|NCT02579759|26204696|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
7540491|NCT02579759|26204697|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
7540492|NCT02579759|26204695|P3|Overall Study|Protocol Violation|0
7540493|NCT02579759|26204696|P2|Overall Study|Protocol Violation|0
7540494|NCT02579759|26204697|P1|Overall Study|Protocol Violation|2
7540495|NCT02579629|26204744|P3|Overall Study|Screen Failure|2
7540496|NCT02579629|26204745|P2|Overall Study|Screen Failure|0
7540497|NCT02579629|26204746|P1|Overall Study|Screen Failure|2
7540498|NCT02579629|26204744|P3|Overall Study|Withdrawal by Subject|0
7540499|NCT02579629|26204745|P2|Overall Study|Withdrawal by Subject|1
7540500|NCT02579629|26204746|P1|Overall Study|Withdrawal by Subject|0
7540501|NCT02579616|26204793|P1|Overall Study|Participants did not receive treatment|3
7540502|NCT02579603|26204806|P2|Overall Study|Other than stated|0
7540503|NCT02579603|26204807|P1|Overall Study|Other than stated|1
7540504|NCT02579603|26204806|P2|Overall Study|Adverse Event|2
7540505|NCT02579603|26204807|P1|Overall Study|Adverse Event|2
7540506|NCT02579603|26204806|P2|Overall Study|Not treated|0
7540507|NCT02579603|26204807|P1|Overall Study|Not treated|1
7540508|NCT02579382|26204837|P4|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7540509|NCT02579382|26204838|P3|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7540510|NCT02579382|26204839|P2|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
7540511|NCT02579382|26204840|P1|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7540512|NCT02579382|26204837|P4|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7540513|NCT02579382|26204838|P3|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7540514|NCT02579382|26204839|P2|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
7540515|NCT02579382|26204840|P1|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7540516|NCT02579382|26204837|P4|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7540517|NCT02579382|26204838|P3|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7540518|NCT02579382|26204839|P2|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
7540519|NCT02579382|26204840|P1|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7540520|NCT02579382|26204837|P4|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7540521|NCT02579382|26204838|P3|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7540522|NCT02579382|26204839|P2|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7540523|NCT02579382|26204840|P1|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
7540524|NCT02579382|26204837|P4|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7540525|NCT02579382|26204838|P3|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
7540526|NCT02579382|26204839|P2|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7540527|NCT02579382|26204840|P1|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
7540528|NCT02579382|26204837|P4|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
7540529|NCT02579382|26204838|P3|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
7540530|NCT02579382|26204839|P2|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
7540531|NCT02579382|26204840|P1|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
7540532|NCT02579382|26204837|P4|Main Study Phase|Lack of Efficacy|1
7540533|NCT02579382|26204838|P3|Main Study Phase|Lack of Efficacy|0
7540534|NCT02579382|26204839|P2|Main Study Phase|Lack of Efficacy|0
7540535|NCT02579382|26204840|P1|Main Study Phase|Lack of Efficacy|0
7540536|NCT02579382|26204837|P4|Main Study Phase|Withdrew Consent|2
7540537|NCT02579382|26204838|P3|Main Study Phase|Withdrew Consent|0
7540538|NCT02579382|26204839|P2|Main Study Phase|Withdrew Consent|0
7540539|NCT02579382|26204840|P1|Main Study Phase|Withdrew Consent|0
7540540|NCT02579382|26204837|P4|Main Study Phase|Lost to Follow-up|0
7540541|NCT02579382|26204838|P3|Main Study Phase|Lost to Follow-up|2
7540542|NCT02579382|26204839|P2|Main Study Phase|Lost to Follow-up|0
7540543|NCT02579382|26204840|P1|Main Study Phase|Lost to Follow-up|0
7540544|NCT02578992|26204973|P2|Overall Study|equipment not available or malfunction|3
7540545|NCT02578992|26204974|P1|Overall Study|equipment not available or malfunction|3
7540546|NCT02578940|26204986|P1|Overall Study|Lost to Follow-up|1
7540547|NCT02578940|26204986|P1|Overall Study|Screening failure|5
7540548|NCT02578862|26205008|P2|Overall Study|Unplanned unilateral procedure|1
7540549|NCT02578862|26205009|P1|Overall Study|Unplanned unilateral procedure|0
7540550|NCT02578862|26205008|P2|Overall Study|Withdrawal by Subject|1
7540551|NCT02578862|26205009|P1|Overall Study|Withdrawal by Subject|0
7540552|NCT02578706|26205051|P3|Overall Study|Physician Decision|0
7540553|NCT02578706|26205052|P2|Overall Study|Physician Decision|1
7540554|NCT02578706|26205053|P1|Overall Study|Physician Decision|0
7540555|NCT02578706|26205051|P3|Overall Study|Lost to Follow-up|0
7540556|NCT02578706|26205052|P2|Overall Study|Lost to Follow-up|4
7540557|NCT02578706|26205053|P1|Overall Study|Lost to Follow-up|0
7540558|NCT02578706|26205051|P3|Overall Study|Withdrawal by Subject|0
7540559|NCT02578706|26205052|P2|Overall Study|Withdrawal by Subject|0
7540560|NCT02578706|26205053|P1|Overall Study|Withdrawal by Subject|1
7540561|NCT02578680|26205132|P2|Overall Study|Ongoing in Study|96
7540562|NCT02578680|26205133|P1|Overall Study|Ongoing in Study|276
7540563|NCT02578680|26205132|P2|Overall Study|Withdrawal by Subject|5
7540564|NCT02578680|26205133|P1|Overall Study|Withdrawal by Subject|8
7540565|NCT02578680|26205132|P2|Overall Study|Withdrawal by Parent/Guardian|0
7540566|NCT02578680|26205133|P1|Overall Study|Withdrawal by Parent/Guardian|1
7540567|NCT02578680|26205132|P2|Overall Study|Protocol Violation|1
7540568|NCT02578680|26205133|P1|Overall Study|Protocol Violation|1
7540569|NCT02578680|26205132|P2|Overall Study|Death|104
7540570|NCT02578680|26205133|P1|Overall Study|Death|124
7540571|NCT02578316|26205149|P1|Extension Phase|Progression of disease|6
7540572|NCT02578186|26205182|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
7540573|NCT02578186|26205183|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
7540574|NCT02578186|26205182|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7540575|NCT02578186|26205183|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7540576|NCT02577887|26205272|P1|Overall Study|Withdrawal by Subject|80
7540577|NCT02577887|26205272|P1|Overall Study|Protocol Violation|125
7540578|NCT02577887|26205272|P1|Overall Study|Death|93
7540579|NCT02577718|26205298|P1|Overall Study|Withdrawal by Subject|2
7540580|NCT02577718|26205298|P1|Overall Study|Death|6
7540581|NCT02577354|26205340|P2|Overall Study|Adverse Event|5
7540582|NCT02577354|26205341|P1|Overall Study|Adverse Event|4
7540583|NCT02577354|26205340|P2|Overall Study|Missed Visit|3
7540584|NCT02577354|26205341|P1|Overall Study|Missed Visit|4
7540585|NCT02577354|26205340|P2|Overall Study|Lost to Follow-up|1
7540586|NCT02577354|26205341|P1|Overall Study|Lost to Follow-up|3
7540587|NCT02577354|26205340|P2|Overall Study|Lack of Efficacy|4
7540588|NCT02577354|26205341|P1|Overall Study|Lack of Efficacy|4
7540589|NCT02577315|26205401|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7540590|NCT02577315|26205402|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7540591|NCT02577146|26205418|P1|Overall Study|Screen Failure|17
7540592|NCT02577146|26205418|P1|Overall Study|Physician Decision|3
7540593|NCT02577146|26205418|P1|Overall Study|Lost to Follow-up|8
7540594|NCT02577107|26205425|P2|Overall Study|Protocol deviation|1
7540595|NCT02577107|26205426|P1|Overall Study|Protocol deviation|0
7540596|NCT02577029|26205493|P8|Overall Study|Sponsor Termination of the Study|12
7540597|NCT02577029|26205494|P7|Overall Study|Sponsor Termination of the Study|12
7540598|NCT02577029|26205495|P6|Overall Study|Sponsor Termination of the Study|12
7540599|NCT02577029|26205496|P5|Overall Study|Sponsor Termination of the Study|10
7540600|NCT02577029|26205497|P4|Overall Study|Sponsor Termination of the Study|12
7540601|NCT02577029|26205498|P3|Overall Study|Sponsor Termination of the Study|5
7540602|NCT02577029|26205499|P2|Overall Study|Sponsor Termination of the Study|2
7540603|NCT02577029|26205500|P1|Overall Study|Sponsor Termination of the Study|9
7540604|NCT02577029|26205493|P8|Overall Study|Withdrawal by Subject|0
7540605|NCT02577029|26205494|P7|Overall Study|Withdrawal by Subject|0
7540606|NCT02577029|26205495|P6|Overall Study|Withdrawal by Subject|1
7540607|NCT02577029|26205496|P5|Overall Study|Withdrawal by Subject|0
7540608|NCT02577029|26205497|P4|Overall Study|Withdrawal by Subject|0
7540609|NCT02577029|26205498|P3|Overall Study|Withdrawal by Subject|0
7540610|NCT02577029|26205499|P2|Overall Study|Withdrawal by Subject|0
7540611|NCT02577029|26205500|P1|Overall Study|Withdrawal by Subject|0
7540612|NCT02577029|26205493|P8|Overall Study|Adverse Event|0
7540613|NCT02577029|26205494|P7|Overall Study|Adverse Event|0
7540614|NCT02577029|26205495|P6|Overall Study|Adverse Event|0
7540615|NCT02577029|26205496|P5|Overall Study|Adverse Event|1
7540616|NCT02577029|26205497|P4|Overall Study|Adverse Event|0
7540617|NCT02577029|26205498|P3|Overall Study|Adverse Event|2
7540618|NCT02577029|26205499|P2|Overall Study|Adverse Event|0
7540619|NCT02577029|26205500|P1|Overall Study|Adverse Event|1
7540620|NCT02577016|26205608|P2|Overall Study|Physician Decision|1
7540621|NCT02577016|26205609|P1|Overall Study|Physician Decision|0
7540622|NCT02577016|26205608|P2|Overall Study|Adverse Event|1
7540623|NCT02577016|26205609|P1|Overall Study|Adverse Event|2
7540624|NCT02577003|26205627|P2|Overall Study|Withdrawal by Subject|1
7540625|NCT02577003|26205628|P1|Overall Study|Withdrawal by Subject|0
7540626|NCT02577003|26205627|P2|Overall Study|Adverse Event|4
7540627|NCT02577003|26205628|P1|Overall Study|Adverse Event|2
7540642|NCT02576977|26205677|P2|Overall Study|Progressive Disease|1
7540643|NCT02576977|26205678|P1|Overall Study|Progressive Disease|0
7540644|NCT02576977|26205677|P2|Overall Study|Lost to Follow-up|0
7540645|NCT02576977|26205678|P1|Overall Study|Lost to Follow-up|1
7540646|NCT02576977|26205677|P2|Overall Study|Final Disposition Unknown|1
7540647|NCT02576977|26205678|P1|Overall Study|Final Disposition Unknown|0
7540648|NCT02576977|26205677|P2|Overall Study|Withdrawal by Subject|11
7540649|NCT02576977|26205678|P1|Overall Study|Withdrawal by Subject|11
7540650|NCT02576977|26205677|P2|Overall Study|Study Terminated at Selected Sites|50
7540651|NCT02576977|26205678|P1|Overall Study|Study Terminated at Selected Sites|27
7540652|NCT02576977|26205677|P2|Overall Study|Screen failure|0
7540653|NCT02576977|26205678|P1|Overall Study|Screen failure|1
7540654|NCT02576977|26205677|P2|Overall Study|Death|60
7540655|NCT02576977|26205678|P1|Overall Study|Death|73
7540656|NCT02576977|26205677|P2|Overall Study|Adverse Event|2
7540657|NCT02576977|26205678|P1|Overall Study|Adverse Event|13
7540658|NCT02576951|26205700|P4|Overall Study|Protocol Violation|1
7540659|NCT02576951|26205701|P3|Overall Study|Protocol Violation|0
7540660|NCT02576951|26205702|P2|Overall Study|Protocol Violation|0
7540661|NCT02576951|26205703|P1|Overall Study|Protocol Violation|0
7540662|NCT02576951|26205700|P4|Overall Study|Withdrawal by Subject|2
7540663|NCT02576951|26205701|P3|Overall Study|Withdrawal by Subject|0
7540664|NCT02576951|26205702|P2|Overall Study|Withdrawal by Subject|0
7540665|NCT02576951|26205703|P1|Overall Study|Withdrawal by Subject|1
7540666|NCT02576951|26205700|P4|Overall Study|Lost to Follow-up|2
7540667|NCT02576951|26205701|P3|Overall Study|Lost to Follow-up|2
7540668|NCT02576951|26205702|P2|Overall Study|Lost to Follow-up|0
7540669|NCT02576951|26205703|P1|Overall Study|Lost to Follow-up|0
7540670|NCT02576938|26205727|P3|Overall Study|Met Exclusion Criteria|0
7540671|NCT02576938|26205728|P2|Overall Study|Met Exclusion Criteria|1
7540672|NCT02576938|26205729|P1|Overall Study|Met Exclusion Criteria|0
7540673|NCT02576938|26205727|P3|Overall Study|Physician Decision|0
7540674|NCT02576938|26205728|P2|Overall Study|Physician Decision|1
7540675|NCT02576938|26205729|P1|Overall Study|Physician Decision|0
7540676|NCT02576938|26205727|P3|Overall Study|Lost to Follow-up|1
7540677|NCT02576938|26205728|P2|Overall Study|Lost to Follow-up|0
7540678|NCT02576938|26205729|P1|Overall Study|Lost to Follow-up|2
7540679|NCT02576938|26205727|P3|Overall Study|Lack of Efficacy|0
7540680|NCT02576938|26205728|P2|Overall Study|Lack of Efficacy|4
7540681|NCT02576938|26205729|P1|Overall Study|Lack of Efficacy|9
7540682|NCT02576938|26205727|P3|Overall Study|Withdrawal by Subject|4
7540683|NCT02576938|26205728|P2|Overall Study|Withdrawal by Subject|2
7540684|NCT02576938|26205729|P1|Overall Study|Withdrawal by Subject|3
7540685|NCT02576938|26205727|P3|Overall Study|Protocol Violation|1
7540686|NCT02576938|26205728|P2|Overall Study|Protocol Violation|1
7540687|NCT02576938|26205729|P1|Overall Study|Protocol Violation|1
7540688|NCT02576938|26205727|P3|Overall Study|Adverse Event|6
7540689|NCT02576938|26205728|P2|Overall Study|Adverse Event|3
7540690|NCT02576938|26205729|P1|Overall Study|Adverse Event|5
7540691|NCT02576678|26205775|P3|Overall Study|Miscellaneous|0
7540692|NCT02576678|26205776|P2|Overall Study|Miscellaneous|0
7540693|NCT02576678|26205777|P1|Overall Study|Miscellaneous|2
7540694|NCT02576678|26205775|P3|Overall Study|Lost to Follow-up|1
7540695|NCT02576678|26205776|P2|Overall Study|Lost to Follow-up|0
7540696|NCT02576678|26205777|P1|Overall Study|Lost to Follow-up|0
7540697|NCT02576678|26205775|P3|Overall Study|Withdrawal by Subject|2
7540698|NCT02576678|26205776|P2|Overall Study|Withdrawal by Subject|1
7540699|NCT02576678|26205777|P1|Overall Study|Withdrawal by Subject|3
7540700|NCT02576678|26205775|P3|Overall Study|Adverse Event|2
7540701|NCT02576678|26205776|P2|Overall Study|Adverse Event|0
7540702|NCT02576678|26205777|P1|Overall Study|Adverse Event|0
7540703|NCT02576652|26205809|P1|Overall Study|Withdrawal by Subject|2
7540704|NCT02576639|26205821|P5|Overall Study|Physician Decision|1
7540705|NCT02576639|26205822|P4|Overall Study|Physician Decision|0
7540706|NCT02576639|26205823|P3|Overall Study|Physician Decision|0
7540707|NCT02576639|26205824|P2|Overall Study|Physician Decision|0
7540708|NCT02576639|26205825|P1|Overall Study|Physician Decision|0
7540709|NCT02576639|26205821|P5|Overall Study|Adverse Event|2
7540710|NCT02576639|26205822|P4|Overall Study|Adverse Event|1
7540711|NCT02576639|26205823|P3|Overall Study|Adverse Event|1
7540712|NCT02576639|26205824|P2|Overall Study|Adverse Event|0
7540713|NCT02576639|26205825|P1|Overall Study|Adverse Event|1
7540714|NCT02576639|26205821|P5|Overall Study|Withdrawal by Subject|1
7540715|NCT02576639|26205822|P4|Overall Study|Withdrawal by Subject|0
7540716|NCT02576639|26205823|P3|Overall Study|Withdrawal by Subject|1
7540717|NCT02576639|26205824|P2|Overall Study|Withdrawal by Subject|2
7540718|NCT02576639|26205825|P1|Overall Study|Withdrawal by Subject|1
7540719|NCT02576587|26205884|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
7540720|NCT02576587|26205885|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
7540721|NCT02576587|26205884|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
7540722|NCT02576587|26205885|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
7540723|NCT02576587|26205884|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
7540724|NCT02576587|26205885|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
7540725|NCT02576587|26205884|P2|Baseline|Equipment failure|1
7540726|NCT02576587|26205885|P1|Baseline|Equipment failure|0
7540727|NCT02576535|26205903|P1|Overall Study|Withdrawal by Subject|2
7540764|NCT02576145|26205944|P2|Overall Study|Tetanus Titers Decreased|1
7540765|NCT02576145|26205945|P1|Overall Study|Tetanus Titers Decreased|0
7540766|NCT02576145|26205944|P2|Overall Study|Acute rejection|0
7540767|NCT02576145|26205945|P1|Overall Study|Acute rejection|1
7540768|NCT02576145|26205944|P2|Overall Study|Withdrawal by Subject|0
7540769|NCT02576145|26205945|P1|Overall Study|Withdrawal by Subject|1
7540770|NCT02576145|26205944|P2|Overall Study|Adverse Event|0
7540771|NCT02576145|26205945|P1|Overall Study|Adverse Event|1
7540772|NCT02576067|26205983|P2|Overall Study|Physician Decision|0
7540773|NCT02576067|26205984|P1|Overall Study|Physician Decision|4
7540774|NCT02576067|26205983|P2|Overall Study|screen failure/ re-enrolled|25
7540775|NCT02576067|26205984|P1|Overall Study|screen failure/ re-enrolled|0
7540776|NCT02576067|26205983|P2|Overall Study|not randomized, failed run-in|0
7540777|NCT02576067|26205984|P1|Overall Study|not randomized, failed run-in|7
7540778|NCT02576067|26205983|P2|Overall Study|study closure of main CIRT trial)|8
7540779|NCT02576067|26205984|P1|Overall Study|study closure of main CIRT trial)|0
7540780|NCT02576067|26205983|P2|Overall Study|Withdrawal by Subject|2
7540781|NCT02576067|26205984|P1|Overall Study|Withdrawal by Subject|11
7540782|NCT02576067|26205983|P2|Overall Study|Lost to Follow-up|0
7540783|NCT02576067|26205984|P1|Overall Study|Lost to Follow-up|11
7540784|NCT02576067|26205983|P2|Overall Study|Lack of Efficacy|0
7540785|NCT02576067|26205984|P1|Overall Study|Lack of Efficacy|1
7540786|NCT02576067|26205983|P2|Overall Study|Death|1
7540787|NCT02576067|26205984|P1|Overall Study|Death|0
7540788|NCT02576054|26205994|P1|Overall Study|Withdrawal by Subject|1
7540789|NCT02575950|26206015|P4|Overall Study|Lost to Follow-up|3
7540790|NCT02575950|26206016|P3|Overall Study|Lost to Follow-up|0
7540791|NCT02575950|26206017|P2|Overall Study|Lost to Follow-up|1
7540792|NCT02575950|26206018|P1|Overall Study|Lost to Follow-up|0
7540793|NCT02575950|26206015|P4|Overall Study|Withdrawal by Subject|2
7540794|NCT02575950|26206016|P3|Overall Study|Withdrawal by Subject|0
7540795|NCT02575950|26206017|P2|Overall Study|Withdrawal by Subject|0
7540796|NCT02575950|26206018|P1|Overall Study|Withdrawal by Subject|0
7540797|NCT02575911|26206047|P1|Overall Study|Lost to Follow-up|1
7540798|NCT02575833|26206067|P2|Overall Study|Lost to Follow-up|0
7540799|NCT02575833|26206068|P1|Overall Study|Lost to Follow-up|1
7540800|NCT02575833|26206067|P2|Overall Study|Withdrawal by Subject|1
7540801|NCT02575833|26206068|P1|Overall Study|Withdrawal by Subject|0
7540802|NCT02575807|26206083|P5|Overall Study|Withdrawal by Subject|2
7540803|NCT02575807|26206084|P4|Overall Study|Withdrawal by Subject|1
7540804|NCT02575807|26206085|P3|Overall Study|Withdrawal by Subject|1
7540805|NCT02575807|26206086|P2|Overall Study|Withdrawal by Subject|0
7540806|NCT02575807|26206087|P1|Overall Study|Withdrawal by Subject|0
7540807|NCT02575807|26206083|P5|Overall Study|Subject ineligible - medical implant|0
7540808|NCT02575807|26206084|P4|Overall Study|Subject ineligible - medical implant|1
7540809|NCT02575807|26206085|P3|Overall Study|Subject ineligible - medical implant|0
7540810|NCT02575807|26206086|P2|Overall Study|Subject ineligible - medical implant|0
7540811|NCT02575807|26206087|P1|Overall Study|Subject ineligible - medical implant|0
7540812|NCT02575807|26206083|P5|Overall Study|Terminated due to physician decision|0
7540813|NCT02575807|26206084|P4|Overall Study|Terminated due to physician decision|0
7540814|NCT02575807|26206085|P3|Overall Study|Terminated due to physician decision|1
7540815|NCT02575807|26206086|P2|Overall Study|Terminated due to physician decision|0
7540816|NCT02575807|26206087|P1|Overall Study|Terminated due to physician decision|0
7540817|NCT02575807|26206083|P5|Overall Study|Terminated due to FDA clinical hold|0
7540818|NCT02575807|26206084|P4|Overall Study|Terminated due to FDA clinical hold|0
7540819|NCT02575807|26206085|P3|Overall Study|Terminated due to FDA clinical hold|0
7540820|NCT02575807|26206086|P2|Overall Study|Terminated due to FDA clinical hold|0
7540821|NCT02575807|26206087|P1|Overall Study|Terminated due to FDA clinical hold|1
7540822|NCT02575807|26206083|P5|Overall Study|Study terminated by Sponsor|1
7540823|NCT02575807|26206084|P4|Overall Study|Study terminated by Sponsor|0
7540824|NCT02575807|26206085|P3|Overall Study|Study terminated by Sponsor|7
7540825|NCT02575807|26206086|P2|Overall Study|Study terminated by Sponsor|1
7540826|NCT02575807|26206087|P1|Overall Study|Study terminated by Sponsor|0
7540827|NCT02575807|26206083|P5|Overall Study|Death|1
7540828|NCT02575807|26206084|P4|Overall Study|Death|0
7540829|NCT02575807|26206085|P3|Overall Study|Death|7
7540830|NCT02575807|26206086|P2|Overall Study|Death|3
7540831|NCT02575807|26206087|P1|Overall Study|Death|8
7540832|NCT02575365|26206127|P1|Overall Study|Lost to Follow-up|4
7540833|NCT02575079|26206147|P2|Overall Study|Withdrawal by Subject|0
7540834|NCT02575079|26206148|P1|Overall Study|Withdrawal by Subject|3
7540835|NCT02575079|26206147|P2|Overall Study|Death|0
7540836|NCT02575079|26206148|P1|Overall Study|Death|3
7540837|NCT02574845|26206173|P6|Overall Study|Adverse Event|1
7540838|NCT02574845|26206174|P5|Overall Study|Adverse Event|0
7540839|NCT02574845|26206175|P4|Overall Study|Adverse Event|0
7540840|NCT02574845|26206176|P3|Overall Study|Adverse Event|0
7540841|NCT02574845|26206177|P2|Overall Study|Adverse Event|1
7540842|NCT02574845|26206178|P1|Overall Study|Adverse Event|0
7540843|NCT02574845|26206173|P6|Overall Study|Consent withdrawn further participation|0
7540844|NCT02574845|26206174|P5|Overall Study|Consent withdrawn further participation|1
7540845|NCT02574845|26206175|P4|Overall Study|Consent withdrawn further participation|0
7540846|NCT02574845|26206176|P3|Overall Study|Consent withdrawn further participation|0
7540847|NCT02574845|26206177|P2|Overall Study|Consent withdrawn further participation|0
7540848|NCT02574845|26206178|P1|Overall Study|Consent withdrawn further participation|0
7540849|NCT02574637|26206213|P10|Open-label (OL) Period|Study Terminated By Sponsor|0
7540850|NCT02574637|26206214|P9|Open-label (OL) Period|Study Terminated By Sponsor|1
7540851|NCT02574637|26206215|P8|Open-label (OL) Period|Study Terminated By Sponsor|1
7540852|NCT02574637|26206216|P7|Open-label (OL) Period|Study Terminated By Sponsor|2
7540853|NCT02574637|26206217|P6|Open-label (OL) Period|Study Terminated By Sponsor|1
7540854|NCT02574637|26206218|P5|Open-label (OL) Period|Study Terminated By Sponsor|0
7540855|NCT02574637|26206219|P4|Open-label (OL) Period|Study Terminated By Sponsor|0
7540856|NCT02574637|26206220|P3|Open-label (OL) Period|Study Terminated By Sponsor|0
7540857|NCT02574637|26206221|P2|Open-label (OL) Period|Study Terminated By Sponsor|0
7540858|NCT02574637|26206222|P1|Open-label (OL) Period|Study Terminated By Sponsor|0
7540859|NCT02574637|26206213|P10|Open-label (OL) Period|Withdrawal by Subject|1
7540860|NCT02574637|26206214|P9|Open-label (OL) Period|Withdrawal by Subject|0
7540861|NCT02574637|26206215|P8|Open-label (OL) Period|Withdrawal by Subject|0
7540862|NCT02574637|26206216|P7|Open-label (OL) Period|Withdrawal by Subject|0
7540863|NCT02574637|26206217|P6|Open-label (OL) Period|Withdrawal by Subject|1
7540864|NCT02574637|26206218|P5|Open-label (OL) Period|Withdrawal by Subject|0
7540865|NCT02574637|26206219|P4|Open-label (OL) Period|Withdrawal by Subject|0
7540866|NCT02574637|26206220|P3|Open-label (OL) Period|Withdrawal by Subject|0
7540867|NCT02574637|26206221|P2|Open-label (OL) Period|Withdrawal by Subject|0
7540868|NCT02574637|26206222|P1|Open-label (OL) Period|Withdrawal by Subject|0
7540869|NCT02574637|26206213|P10|Open-label (OL) Period|Adverse Event|0
7540870|NCT02574637|26206214|P9|Open-label (OL) Period|Adverse Event|1
7540871|NCT02574637|26206215|P8|Open-label (OL) Period|Adverse Event|0
7540872|NCT02574637|26206216|P7|Open-label (OL) Period|Adverse Event|0
7540873|NCT02574637|26206217|P6|Open-label (OL) Period|Adverse Event|0
7540874|NCT02574637|26206218|P5|Open-label (OL) Period|Adverse Event|0
7540875|NCT02574637|26206219|P4|Open-label (OL) Period|Adverse Event|0
7540876|NCT02574637|26206220|P3|Open-label (OL) Period|Adverse Event|0
7540877|NCT02574637|26206221|P2|Open-label (OL) Period|Adverse Event|0
7540878|NCT02574637|26206222|P1|Open-label (OL) Period|Adverse Event|0
7540879|NCT02574637|26206213|P10|Double-blind Period|Reason Not Specified|0
7540880|NCT02574637|26206214|P9|Double-blind Period|Reason Not Specified|0
7540881|NCT02574637|26206215|P8|Double-blind Period|Reason Not Specified|0
7540882|NCT02574637|26206216|P7|Double-blind Period|Reason Not Specified|0
7540883|NCT02574637|26206217|P6|Double-blind Period|Reason Not Specified|0
7540884|NCT02574637|26206218|P5|Double-blind Period|Reason Not Specified|0
7540885|NCT02574637|26206219|P4|Double-blind Period|Reason Not Specified|1
7540886|NCT02574637|26206220|P3|Double-blind Period|Reason Not Specified|0
7540887|NCT02574637|26206221|P2|Double-blind Period|Reason Not Specified|0
7540888|NCT02574637|26206222|P1|Double-blind Period|Reason Not Specified|0
7540889|NCT02574637|26206213|P10|Double-blind Period|Study Terminated By Sponsor|0
7540890|NCT02574637|26206214|P9|Double-blind Period|Study Terminated By Sponsor|0
7540891|NCT02574637|26206215|P8|Double-blind Period|Study Terminated By Sponsor|0
7540892|NCT02574637|26206216|P7|Double-blind Period|Study Terminated By Sponsor|0
7540893|NCT02574637|26206217|P6|Double-blind Period|Study Terminated By Sponsor|0
7540894|NCT02574637|26206218|P5|Double-blind Period|Study Terminated By Sponsor|2
7540895|NCT02574637|26206219|P4|Double-blind Period|Study Terminated By Sponsor|2
7540896|NCT02574637|26206220|P3|Double-blind Period|Study Terminated By Sponsor|5
7540897|NCT02574637|26206221|P2|Double-blind Period|Study Terminated By Sponsor|1
7540898|NCT02574637|26206222|P1|Double-blind Period|Study Terminated By Sponsor|1
7540899|NCT02574637|26206213|P10|Double-blind Period|Non-Compliance With Study Drug|0
7540900|NCT02574637|26206214|P9|Double-blind Period|Non-Compliance With Study Drug|0
7540901|NCT02574637|26206215|P8|Double-blind Period|Non-Compliance With Study Drug|0
7540902|NCT02574637|26206216|P7|Double-blind Period|Non-Compliance With Study Drug|0
7540903|NCT02574637|26206217|P6|Double-blind Period|Non-Compliance With Study Drug|0
7540904|NCT02574637|26206218|P5|Double-blind Period|Non-Compliance With Study Drug|0
7540905|NCT02574637|26206219|P4|Double-blind Period|Non-Compliance With Study Drug|1
7540906|NCT02574637|26206220|P3|Double-blind Period|Non-Compliance With Study Drug|0
7540907|NCT02574637|26206221|P2|Double-blind Period|Non-Compliance With Study Drug|0
7540908|NCT02574637|26206222|P1|Double-blind Period|Non-Compliance With Study Drug|0
7540909|NCT02574637|26206213|P10|Double-blind Period|Protocol Deviation|0
7540910|NCT02574637|26206214|P9|Double-blind Period|Protocol Deviation|0
7540911|NCT02574637|26206215|P8|Double-blind Period|Protocol Deviation|0
7540912|NCT02574637|26206216|P7|Double-blind Period|Protocol Deviation|0
7540913|NCT02574637|26206217|P6|Double-blind Period|Protocol Deviation|0
7540914|NCT02574637|26206218|P5|Double-blind Period|Protocol Deviation|0
7540915|NCT02574637|26206219|P4|Double-blind Period|Protocol Deviation|0
7540916|NCT02574637|26206220|P3|Double-blind Period|Protocol Deviation|0
7540917|NCT02574637|26206221|P2|Double-blind Period|Protocol Deviation|0
7540918|NCT02574637|26206222|P1|Double-blind Period|Protocol Deviation|1
7540919|NCT02574637|26206213|P10|Double-blind Period|Lack of Efficacy|0
7540920|NCT02574637|26206214|P9|Double-blind Period|Lack of Efficacy|0
7540921|NCT02574637|26206215|P8|Double-blind Period|Lack of Efficacy|0
7540922|NCT02574637|26206216|P7|Double-blind Period|Lack of Efficacy|0
7540923|NCT02574637|26206217|P6|Double-blind Period|Lack of Efficacy|0
7540924|NCT02574637|26206218|P5|Double-blind Period|Lack of Efficacy|0
7540925|NCT02574637|26206219|P4|Double-blind Period|Lack of Efficacy|0
7540926|NCT02574637|26206220|P3|Double-blind Period|Lack of Efficacy|2
7540927|NCT02574637|26206221|P2|Double-blind Period|Lack of Efficacy|0
7540928|NCT02574637|26206222|P1|Double-blind Period|Lack of Efficacy|0
7540929|NCT02574637|26206213|P10|Double-blind Period|Adverse Event|0
7540930|NCT02574637|26206214|P9|Double-blind Period|Adverse Event|0
7540931|NCT02574637|26206215|P8|Double-blind Period|Adverse Event|0
7540932|NCT02574637|26206216|P7|Double-blind Period|Adverse Event|0
7540933|NCT02574637|26206217|P6|Double-blind Period|Adverse Event|0
7540934|NCT02574637|26206218|P5|Double-blind Period|Adverse Event|0
7540935|NCT02574637|26206219|P4|Double-blind Period|Adverse Event|0
7540936|NCT02574637|26206220|P3|Double-blind Period|Adverse Event|0
7540937|NCT02574637|26206221|P2|Double-blind Period|Adverse Event|0
7540938|NCT02574637|26206222|P1|Double-blind Period|Adverse Event|1
7540939|NCT02574520|26206331|P4|Overall Study|Other|2
7540940|NCT02574520|26206332|P3|Overall Study|Other|0
7540941|NCT02574520|26206333|P2|Overall Study|Other|0
7540942|NCT02574520|26206334|P1|Overall Study|Other|0
7540943|NCT02574520|26206331|P4|Overall Study|Withdrawal by Subject|1
7540944|NCT02574520|26206332|P3|Overall Study|Withdrawal by Subject|0
7540945|NCT02574520|26206333|P2|Overall Study|Withdrawal by Subject|0
7540946|NCT02574520|26206334|P1|Overall Study|Withdrawal by Subject|0
7540947|NCT02574520|26206331|P4|Overall Study|Adverse Event|1
7540948|NCT02574520|26206332|P3|Overall Study|Adverse Event|0
7540949|NCT02574520|26206333|P2|Overall Study|Adverse Event|0
7540950|NCT02574520|26206334|P1|Overall Study|Adverse Event|0
7540951|NCT02574520|26206331|P4|Overall Study|Not dosed|4
7540952|NCT02574520|26206332|P3|Overall Study|Not dosed|5
7540953|NCT02574520|26206333|P2|Overall Study|Not dosed|0
7540954|NCT02574520|26206334|P1|Overall Study|Not dosed|2
7540975|NCT02574455|26206401|P2|Overall Study|Lost to Follow-up|4
7540976|NCT02574455|26206402|P1|Overall Study|Lost to Follow-up|3
7540977|NCT02574455|26206401|P2|Overall Study|Withdrawal by Subject|27
7540978|NCT02574455|26206402|P1|Overall Study|Withdrawal by Subject|8
7540979|NCT02574455|26206401|P2|Overall Study|Death|197
7540980|NCT02574455|26206402|P1|Overall Study|Death|174
7540981|NCT02574312|26206432|P2|3 Months Follow-up|Withdrawal by Subject|0
7540982|NCT02574312|26206433|P1|3 Months Follow-up|Withdrawal by Subject|1
7540983|NCT02574260|26206449|P1|Overall Study|Disease Progression|1
7540984|NCT02574247|26206458|P3|Overall Study|Did not meet inclusion criteria|5
7540985|NCT02574247|26206459|P2|Overall Study|Did not meet inclusion criteria|3
7540986|NCT02574247|26206460|P1|Overall Study|Did not meet inclusion criteria|4
7540987|NCT02574247|26206458|P3|Overall Study|Withdrawal by Subject|0
7540988|NCT02574247|26206459|P2|Overall Study|Withdrawal by Subject|0
7540989|NCT02574247|26206460|P1|Overall Study|Withdrawal by Subject|1
7540990|NCT02574078|26206485|P13|Treatment Period|Maximum clinical benefit|0
7540991|NCT02574078|26206486|P12|Treatment Period|Maximum clinical benefit|0
7540992|NCT02574078|26206487|P11|Treatment Period|Maximum clinical benefit|0
7540993|NCT02574078|26206488|P10|Treatment Period|Maximum clinical benefit|1
7540994|NCT02574078|26206489|P9|Treatment Period|Maximum clinical benefit|0
7540995|NCT02574078|26206490|P8|Treatment Period|Maximum clinical benefit|0
7540996|NCT02574078|26206491|P7|Treatment Period|Maximum clinical benefit|0
7540997|NCT02574078|26206492|P6|Treatment Period|Maximum clinical benefit|0
7540998|NCT02574078|26206493|P5|Treatment Period|Maximum clinical benefit|0
7540999|NCT02574078|26206494|P4|Treatment Period|Maximum clinical benefit|0
7541000|NCT02574078|26206495|P3|Treatment Period|Maximum clinical benefit|0
7541001|NCT02574078|26206496|P2|Treatment Period|Maximum clinical benefit|0
7541002|NCT02574078|26206497|P1|Treatment Period|Maximum clinical benefit|0
7541003|NCT02574078|26206485|P13|Treatment Period|Lost to Follow-up|0
7541004|NCT02574078|26206486|P12|Treatment Period|Lost to Follow-up|1
7541005|NCT02574078|26206487|P11|Treatment Period|Lost to Follow-up|0
7541006|NCT02574078|26206488|P10|Treatment Period|Lost to Follow-up|1
7541007|NCT02574078|26206489|P9|Treatment Period|Lost to Follow-up|0
7541008|NCT02574078|26206490|P8|Treatment Period|Lost to Follow-up|0
7541009|NCT02574078|26206491|P7|Treatment Period|Lost to Follow-up|0
7541010|NCT02574078|26206492|P6|Treatment Period|Lost to Follow-up|0
7541011|NCT02574078|26206493|P5|Treatment Period|Lost to Follow-up|0
7541012|NCT02574078|26206494|P4|Treatment Period|Lost to Follow-up|0
7541013|NCT02574078|26206495|P3|Treatment Period|Lost to Follow-up|0
7541014|NCT02574078|26206496|P2|Treatment Period|Lost to Follow-up|0
7541015|NCT02574078|26206497|P1|Treatment Period|Lost to Follow-up|0
7541016|NCT02574078|26206485|P13|Treatment Period|Participant no longer meets criteria|0
7541017|NCT02574078|26206486|P12|Treatment Period|Participant no longer meets criteria|1
7541018|NCT02574078|26206487|P11|Treatment Period|Participant no longer meets criteria|1
7541019|NCT02574078|26206488|P10|Treatment Period|Participant no longer meets criteria|1
7541020|NCT02574078|26206489|P9|Treatment Period|Participant no longer meets criteria|0
7541021|NCT02574078|26206490|P8|Treatment Period|Participant no longer meets criteria|0
7541022|NCT02574078|26206491|P7|Treatment Period|Participant no longer meets criteria|0
7541023|NCT02574078|26206492|P6|Treatment Period|Participant no longer meets criteria|0
7541024|NCT02574078|26206493|P5|Treatment Period|Participant no longer meets criteria|1
7541025|NCT02574078|26206494|P4|Treatment Period|Participant no longer meets criteria|0
7541026|NCT02574078|26206495|P3|Treatment Period|Participant no longer meets criteria|0
7541027|NCT02574078|26206496|P2|Treatment Period|Participant no longer meets criteria|0
7541028|NCT02574078|26206497|P1|Treatment Period|Participant no longer meets criteria|0
7541029|NCT02574078|26206485|P13|Treatment Period|Participant withdrew consent|1
7541030|NCT02574078|26206486|P12|Treatment Period|Participant withdrew consent|4
7541031|NCT02574078|26206487|P11|Treatment Period|Participant withdrew consent|1
7541032|NCT02574078|26206488|P10|Treatment Period|Participant withdrew consent|2
7541033|NCT02574078|26206489|P9|Treatment Period|Participant withdrew consent|0
7541034|NCT02574078|26206490|P8|Treatment Period|Participant withdrew consent|1
7541035|NCT02574078|26206491|P7|Treatment Period|Participant withdrew consent|0
7541036|NCT02574078|26206492|P6|Treatment Period|Participant withdrew consent|1
7541037|NCT02574078|26206493|P5|Treatment Period|Participant withdrew consent|1
7541038|NCT02574078|26206494|P4|Treatment Period|Participant withdrew consent|0
7541039|NCT02574078|26206495|P3|Treatment Period|Participant withdrew consent|0
7541040|NCT02574078|26206496|P2|Treatment Period|Participant withdrew consent|0
7541041|NCT02574078|26206497|P1|Treatment Period|Participant withdrew consent|0
7541042|NCT02574078|26206485|P13|Treatment Period|Participant request to stop drug|1
7541043|NCT02574078|26206486|P12|Treatment Period|Participant request to stop drug|4
7541044|NCT02574078|26206487|P11|Treatment Period|Participant request to stop drug|2
7541045|NCT02574078|26206488|P10|Treatment Period|Participant request to stop drug|2
7541046|NCT02574078|26206489|P9|Treatment Period|Participant request to stop drug|3
7541047|NCT02574078|26206490|P8|Treatment Period|Participant request to stop drug|0
7541048|NCT02574078|26206491|P7|Treatment Period|Participant request to stop drug|1
7541049|NCT02574078|26206492|P6|Treatment Period|Participant request to stop drug|0
7541050|NCT02574078|26206493|P5|Treatment Period|Participant request to stop drug|4
7541051|NCT02574078|26206494|P4|Treatment Period|Participant request to stop drug|2
7541052|NCT02574078|26206495|P3|Treatment Period|Participant request to stop drug|0
7541053|NCT02574078|26206496|P2|Treatment Period|Participant request to stop drug|0
7541054|NCT02574078|26206497|P1|Treatment Period|Participant request to stop drug|0
7541055|NCT02574078|26206485|P13|Treatment Period|Other reasons|1
7541056|NCT02574078|26206486|P12|Treatment Period|Other reasons|3
7541057|NCT02574078|26206487|P11|Treatment Period|Other reasons|1
7541058|NCT02574078|26206488|P10|Treatment Period|Other reasons|1
7541059|NCT02574078|26206489|P9|Treatment Period|Other reasons|3
7541060|NCT02574078|26206490|P8|Treatment Period|Other reasons|1
7541061|NCT02574078|26206491|P7|Treatment Period|Other reasons|2
7541062|NCT02574078|26206492|P6|Treatment Period|Other reasons|1
7541063|NCT02574078|26206493|P5|Treatment Period|Other reasons|3
7541064|NCT02574078|26206494|P4|Treatment Period|Other reasons|3
7541065|NCT02574078|26206495|P3|Treatment Period|Other reasons|1
7541066|NCT02574078|26206496|P2|Treatment Period|Other reasons|0
7541067|NCT02574078|26206497|P1|Treatment Period|Other reasons|1
7541068|NCT02574078|26206485|P13|Treatment Period|Administrative reason by Sponsor|3
7541069|NCT02574078|26206486|P12|Treatment Period|Administrative reason by Sponsor|0
7541070|NCT02574078|26206487|P11|Treatment Period|Administrative reason by Sponsor|0
7541071|NCT02574078|26206488|P10|Treatment Period|Administrative reason by Sponsor|0
7541072|NCT02574078|26206489|P9|Treatment Period|Administrative reason by Sponsor|0
7541073|NCT02574078|26206490|P8|Treatment Period|Administrative reason by Sponsor|0
7541074|NCT02574078|26206491|P7|Treatment Period|Administrative reason by Sponsor|1
7541075|NCT02574078|26206492|P6|Treatment Period|Administrative reason by Sponsor|0
7541076|NCT02574078|26206493|P5|Treatment Period|Administrative reason by Sponsor|0
7541077|NCT02574078|26206494|P4|Treatment Period|Administrative reason by Sponsor|0
7541078|NCT02574078|26206495|P3|Treatment Period|Administrative reason by Sponsor|0
7541079|NCT02574078|26206496|P2|Treatment Period|Administrative reason by Sponsor|1
7541080|NCT02574078|26206497|P1|Treatment Period|Administrative reason by Sponsor|0
7541081|NCT02574078|26206485|P13|Treatment Period|Adverse event unrelated to drug|0
7541082|NCT02574078|26206486|P12|Treatment Period|Adverse event unrelated to drug|1
7541083|NCT02574078|26206487|P11|Treatment Period|Adverse event unrelated to drug|4
7541084|NCT02574078|26206488|P10|Treatment Period|Adverse event unrelated to drug|2
7541085|NCT02574078|26206489|P9|Treatment Period|Adverse event unrelated to drug|1
7541086|NCT02574078|26206490|P8|Treatment Period|Adverse event unrelated to drug|0
7541087|NCT02574078|26206491|P7|Treatment Period|Adverse event unrelated to drug|0
7541088|NCT02574078|26206492|P6|Treatment Period|Adverse event unrelated to drug|3
7541089|NCT02574078|26206493|P5|Treatment Period|Adverse event unrelated to drug|2
7541090|NCT02574078|26206494|P4|Treatment Period|Adverse event unrelated to drug|0
7541091|NCT02574078|26206495|P3|Treatment Period|Adverse event unrelated to drug|1
7541092|NCT02574078|26206496|P2|Treatment Period|Adverse event unrelated to drug|0
7541093|NCT02574078|26206497|P1|Treatment Period|Adverse event unrelated to drug|0
7541094|NCT02574078|26206485|P13|Treatment Period|Death|1
7541095|NCT02574078|26206486|P12|Treatment Period|Death|2
7541096|NCT02574078|26206487|P11|Treatment Period|Death|0
7541097|NCT02574078|26206488|P10|Treatment Period|Death|1
7541098|NCT02574078|26206489|P9|Treatment Period|Death|7
7541099|NCT02574078|26206490|P8|Treatment Period|Death|1
7541100|NCT02574078|26206491|P7|Treatment Period|Death|1
7541101|NCT02574078|26206492|P6|Treatment Period|Death|1
7541102|NCT02574078|26206493|P5|Treatment Period|Death|1
7541103|NCT02574078|26206494|P4|Treatment Period|Death|0
7541104|NCT02574078|26206495|P3|Treatment Period|Death|0
7541105|NCT02574078|26206496|P2|Treatment Period|Death|0
7541106|NCT02574078|26206497|P1|Treatment Period|Death|2
7541107|NCT02574078|26206485|P13|Treatment Period|Study drug toxicity|4
7541108|NCT02574078|26206486|P12|Treatment Period|Study drug toxicity|2
7541109|NCT02574078|26206487|P11|Treatment Period|Study drug toxicity|16
7541110|NCT02574078|26206488|P10|Treatment Period|Study drug toxicity|1
7541111|NCT02574078|26206489|P9|Treatment Period|Study drug toxicity|2
7541112|NCT02574078|26206490|P8|Treatment Period|Study drug toxicity|0
7541113|NCT02574078|26206491|P7|Treatment Period|Study drug toxicity|2
7541114|NCT02574078|26206492|P6|Treatment Period|Study drug toxicity|1
7541115|NCT02574078|26206493|P5|Treatment Period|Study drug toxicity|3
7541116|NCT02574078|26206494|P4|Treatment Period|Study drug toxicity|5
7541117|NCT02574078|26206495|P3|Treatment Period|Study drug toxicity|0
7541118|NCT02574078|26206496|P2|Treatment Period|Study drug toxicity|1
7541119|NCT02574078|26206497|P1|Treatment Period|Study drug toxicity|1
7541120|NCT02574078|26206485|P13|Treatment Period|Disease progression|2
7541121|NCT02574078|26206486|P12|Treatment Period|Disease progression|29
7541122|NCT02574078|26206487|P11|Treatment Period|Disease progression|20
7541123|NCT02574078|26206488|P10|Treatment Period|Disease progression|5
7541124|NCT02574078|26206489|P9|Treatment Period|Disease progression|8
7541125|NCT02574078|26206490|P8|Treatment Period|Disease progression|9
7541126|NCT02574078|26206491|P7|Treatment Period|Disease progression|5
7541127|NCT02574078|26206492|P6|Treatment Period|Disease progression|26
7541128|NCT02574078|26206493|P5|Treatment Period|Disease progression|16
7541129|NCT02574078|26206494|P4|Treatment Period|Disease progression|18
7541130|NCT02574078|26206495|P3|Treatment Period|Disease progression|7
7541131|NCT02574078|26206496|P2|Treatment Period|Disease progression|4
7541132|NCT02574078|26206497|P1|Treatment Period|Disease progression|6
7541133|NCT02574078|26206485|P13|Pre-Treatment Period|Poor/non-compliance|0
7541134|NCT02574078|26206486|P12|Pre-Treatment Period|Poor/non-compliance|1
7541135|NCT02574078|26206487|P11|Pre-Treatment Period|Poor/non-compliance|0
7541136|NCT02574078|26206488|P10|Pre-Treatment Period|Poor/non-compliance|0
7541137|NCT02574078|26206489|P9|Pre-Treatment Period|Poor/non-compliance|0
7541138|NCT02574078|26206490|P8|Pre-Treatment Period|Poor/non-compliance|0
7541139|NCT02574078|26206491|P7|Pre-Treatment Period|Poor/non-compliance|0
7541140|NCT02574078|26206492|P6|Pre-Treatment Period|Poor/non-compliance|0
7541141|NCT02574078|26206493|P5|Pre-Treatment Period|Poor/non-compliance|0
7541142|NCT02574078|26206494|P4|Pre-Treatment Period|Poor/non-compliance|0
7541143|NCT02574078|26206495|P3|Pre-Treatment Period|Poor/non-compliance|0
7541144|NCT02574078|26206496|P2|Pre-Treatment Period|Poor/non-compliance|0
7541145|NCT02574078|26206497|P1|Pre-Treatment Period|Poor/non-compliance|0
7541146|NCT02574078|26206485|P13|Pre-Treatment Period|Other reasons|0
7541147|NCT02574078|26206486|P12|Pre-Treatment Period|Other reasons|0
7541148|NCT02574078|26206487|P11|Pre-Treatment Period|Other reasons|2
7541149|NCT02574078|26206488|P10|Pre-Treatment Period|Other reasons|0
7541150|NCT02574078|26206489|P9|Pre-Treatment Period|Other reasons|0
7541151|NCT02574078|26206490|P8|Pre-Treatment Period|Other reasons|0
7541152|NCT02574078|26206491|P7|Pre-Treatment Period|Other reasons|2
7541153|NCT02574078|26206492|P6|Pre-Treatment Period|Other reasons|0
7541154|NCT02574078|26206493|P5|Pre-Treatment Period|Other reasons|0
7541155|NCT02574078|26206494|P4|Pre-Treatment Period|Other reasons|0
7541156|NCT02574078|26206495|P3|Pre-Treatment Period|Other reasons|0
7541157|NCT02574078|26206496|P2|Pre-Treatment Period|Other reasons|0
7541158|NCT02574078|26206497|P1|Pre-Treatment Period|Other reasons|0
7541159|NCT02574078|26206485|P13|Pre-Treatment Period|Participant withdrew consent|0
7541160|NCT02574078|26206486|P12|Pre-Treatment Period|Participant withdrew consent|0
7541161|NCT02574078|26206487|P11|Pre-Treatment Period|Participant withdrew consent|2
7541162|NCT02574078|26206488|P10|Pre-Treatment Period|Participant withdrew consent|0
7541163|NCT02574078|26206489|P9|Pre-Treatment Period|Participant withdrew consent|0
7541164|NCT02574078|26206490|P8|Pre-Treatment Period|Participant withdrew consent|3
7541165|NCT02574078|26206491|P7|Pre-Treatment Period|Participant withdrew consent|0
7541166|NCT02574078|26206492|P6|Pre-Treatment Period|Participant withdrew consent|0
7541167|NCT02574078|26206493|P5|Pre-Treatment Period|Participant withdrew consent|0
7541168|NCT02574078|26206494|P4|Pre-Treatment Period|Participant withdrew consent|0
7541169|NCT02574078|26206495|P3|Pre-Treatment Period|Participant withdrew consent|0
7541170|NCT02574078|26206496|P2|Pre-Treatment Period|Participant withdrew consent|0
7541171|NCT02574078|26206497|P1|Pre-Treatment Period|Participant withdrew consent|0
7541172|NCT02574078|26206485|P13|Pre-Treatment Period|Participant no longer meets study criteria|0
7541173|NCT02574078|26206486|P12|Pre-Treatment Period|Participant no longer meets study criteria|0
7541174|NCT02574078|26206487|P11|Pre-Treatment Period|Participant no longer meets study criteria|0
7541175|NCT02574078|26206488|P10|Pre-Treatment Period|Participant no longer meets study criteria|0
7541176|NCT02574078|26206489|P9|Pre-Treatment Period|Participant no longer meets study criteria|1
7541177|NCT02574078|26206490|P8|Pre-Treatment Period|Participant no longer meets study criteria|0
7541178|NCT02574078|26206491|P7|Pre-Treatment Period|Participant no longer meets study criteria|2
7541179|NCT02574078|26206492|P6|Pre-Treatment Period|Participant no longer meets study criteria|1
7541180|NCT02574078|26206493|P5|Pre-Treatment Period|Participant no longer meets study criteria|0
7541181|NCT02574078|26206494|P4|Pre-Treatment Period|Participant no longer meets study criteria|0
7541182|NCT02574078|26206495|P3|Pre-Treatment Period|Participant no longer meets study criteria|0
7541183|NCT02574078|26206496|P2|Pre-Treatment Period|Participant no longer meets study criteria|0
7541184|NCT02574078|26206497|P1|Pre-Treatment Period|Participant no longer meets study criteria|0
7541185|NCT02573948|26206563|P1|Longitudinal Cohort|Incarcerated|25
7541186|NCT02573948|26206563|P1|Longitudinal Cohort|Lost to Follow-up|22
7541187|NCT02573948|26206563|P1|Longitudinal Cohort|Death|9
7541188|NCT02573883|26206573|P4|One Year Follow Up|Lost to Follow-up|0
7541189|NCT02573883|26206574|P3|One Year Follow Up|Lost to Follow-up|0
7541190|NCT02573883|26206575|P2|One Year Follow Up|Lost to Follow-up|1
7541191|NCT02573883|26206576|P1|One Year Follow Up|Lost to Follow-up|2
7541192|NCT02573883|26206573|P4|Six Month Follow Up|Lost to Follow-up|0
7541193|NCT02573883|26206574|P3|Six Month Follow Up|Lost to Follow-up|0
7541194|NCT02573883|26206575|P2|Six Month Follow Up|Lost to Follow-up|0
7541195|NCT02573883|26206576|P1|Six Month Follow Up|Lost to Follow-up|1
7541196|NCT02573870|26206630|P2|Overall Study|Other: Fail to Meet Visit|2
7541197|NCT02573870|26206631|P1|Overall Study|Other: Fail to Meet Visit|0
7541198|NCT02573870|26206630|P2|Overall Study|Lost to Follow-up|1
7541199|NCT02573870|26206631|P1|Overall Study|Lost to Follow-up|0
7541200|NCT02573870|26206630|P2|Overall Study|Other: Reached defined stopping criteria|1
7541201|NCT02573870|26206631|P1|Overall Study|Other: Reached defined stopping criteria|0
7541202|NCT02573870|26206630|P2|Overall Study|Lack of Efficacy|1
7541203|NCT02573870|26206631|P1|Overall Study|Lack of Efficacy|0
7541204|NCT02573870|26206630|P2|Overall Study|Adverse Event|2
7541205|NCT02573870|26206631|P1|Overall Study|Adverse Event|0
7541206|NCT02573493|26206679|P4|Overall Study|Determined to not be eligible after enrollment|1
7541207|NCT02573493|26206680|P3|Overall Study|Determined to not be eligible after enrollment|0
7541208|NCT02573493|26206681|P2|Overall Study|Determined to not be eligible after enrollment|0
7541209|NCT02573493|26206682|P1|Overall Study|Determined to not be eligible after enrollment|0
7541210|NCT02573467|26206740|P4|Post-treatment Follow up Epoch|Technical problems|0
7541211|NCT02573467|26206741|P3|Post-treatment Follow up Epoch|Technical problems|1
7541212|NCT02573467|26206742|P2|Post-treatment Follow up Epoch|Technical problems|0
7541213|NCT02573467|26206743|P1|Post-treatment Follow up Epoch|Technical problems|0
7541214|NCT02573467|26206740|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
7541215|NCT02573467|26206741|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
7541216|NCT02573467|26206742|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
7541217|NCT02573467|26206743|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
7541218|NCT02573467|26206740|P4|Post-treatment Follow up Epoch|Death|1
7541219|NCT02573467|26206741|P3|Post-treatment Follow up Epoch|Death|0
7541220|NCT02573467|26206742|P2|Post-treatment Follow up Epoch|Death|1
7541221|NCT02573467|26206743|P1|Post-treatment Follow up Epoch|Death|1
7541222|NCT02573467|26206740|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
7541223|NCT02573467|26206741|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
7541224|NCT02573467|26206742|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
7541225|NCT02573467|26206743|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
7541226|NCT02573467|26206740|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
7541227|NCT02573467|26206741|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
7541228|NCT02573467|26206742|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
7541229|NCT02573467|26206743|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
7541230|NCT02573467|26206740|P4|Double-blind Treatment Epoch|Adverse Event|0
7541231|NCT02573467|26206741|P3|Double-blind Treatment Epoch|Adverse Event|1
7541232|NCT02573467|26206742|P2|Double-blind Treatment Epoch|Adverse Event|0
7541233|NCT02573467|26206743|P1|Double-blind Treatment Epoch|Adverse Event|1
7541234|NCT02573467|26206740|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
7541235|NCT02573467|26206741|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
7541236|NCT02573467|26206742|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
7541237|NCT02573467|26206743|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
7541238|NCT02573311|26206807|P2|Disposition for Part 2|Other than specified above|3
7541239|NCT02573311|26206808|P1|Disposition for Part 2|Other than specified above|13
7541240|NCT02573311|26206807|P2|Disposition for Part 2|Investigator decision|1
7541241|NCT02573311|26206808|P1|Disposition for Part 2|Investigator decision|0
7541242|NCT02573311|26206807|P2|Disposition for Part 2|Withdrawal by Subject|3
7541243|NCT02573311|26206808|P1|Disposition for Part 2|Withdrawal by Subject|60
7541244|NCT02573311|26206807|P2|Disposition for Part 2|Lost to Follow-up|7
7541245|NCT02573311|26206808|P1|Disposition for Part 2|Lost to Follow-up|76
7541246|NCT02573311|26206807|P2|Disposition for Part 2|Adverse Event|5
7541247|NCT02573311|26206808|P1|Disposition for Part 2|Adverse Event|36
7541248|NCT02573311|26206807|P2|Disposition for Part 2|Physician Decision|7
7541249|NCT02573311|26206808|P1|Disposition for Part 2|Physician Decision|25
7541250|NCT02573311|26206807|P2|Disposition for Part 1|Withdrawal by Subject|3
7541251|NCT02573311|26206808|P1|Disposition for Part 1|Withdrawal by Subject|7
7541252|NCT02573246|26206827|P5|Overall Study|Physician Decision|2
7541253|NCT02573246|26206828|P4|Overall Study|Physician Decision|2
7541254|NCT02573246|26206829|P3|Overall Study|Physician Decision|3
7541255|NCT02573246|26206830|P2|Overall Study|Physician Decision|1
7541256|NCT02573246|26206831|P1|Overall Study|Physician Decision|1
7541257|NCT02573246|26206827|P5|Overall Study|Withdrawal by Subject|1
7541258|NCT02573246|26206828|P4|Overall Study|Withdrawal by Subject|0
7541259|NCT02573246|26206829|P3|Overall Study|Withdrawal by Subject|0
7541260|NCT02573246|26206830|P2|Overall Study|Withdrawal by Subject|0
7541261|NCT02573246|26206831|P1|Overall Study|Withdrawal by Subject|0
7541262|NCT02573246|26206827|P5|Overall Study|Lost to Follow-up|1
7541263|NCT02573246|26206828|P4|Overall Study|Lost to Follow-up|0
7541264|NCT02573246|26206829|P3|Overall Study|Lost to Follow-up|0
7541265|NCT02573246|26206830|P2|Overall Study|Lost to Follow-up|0
7541266|NCT02573246|26206831|P1|Overall Study|Lost to Follow-up|2
7541267|NCT02573155|26206938|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
7541268|NCT02573155|26206939|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
7541269|NCT02573155|26206938|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
7541270|NCT02573155|26206939|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
7541271|NCT02573155|26206938|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
7541272|NCT02573155|26206939|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
7541273|NCT02573155|26206938|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
7541274|NCT02573155|26206939|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
7541275|NCT02573155|26206938|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
7541276|NCT02573155|26206939|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
7541277|NCT02573155|26206938|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
7541278|NCT02573155|26206939|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
7541279|NCT02573155|26206938|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
7541280|NCT02573155|26206939|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
7541281|NCT02573155|26206938|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
7541282|NCT02573155|26206939|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
7541283|NCT02573012|26207087|P2|Overall Study|Physician Decision|2
7541284|NCT02573012|26207088|P1|Overall Study|Physician Decision|1
7541285|NCT02573012|26207087|P2|Overall Study|Study Ended per Protocol|0
7541286|NCT02573012|26207088|P1|Overall Study|Study Ended per Protocol|1
7541287|NCT02573012|26207087|P2|Overall Study|Withdrawal by Subject|2
7541288|NCT02573012|26207088|P1|Overall Study|Withdrawal by Subject|2
7541289|NCT02573012|26207087|P2|Overall Study|Non-compliance|2
7541290|NCT02573012|26207088|P1|Overall Study|Non-compliance|1
7541291|NCT02573012|26207087|P2|Overall Study|Lack of Efficacy|4
7541292|NCT02573012|26207088|P1|Overall Study|Lack of Efficacy|5
7541293|NCT02573012|26207087|P2|Overall Study|Adverse Event|5
7541294|NCT02573012|26207088|P1|Overall Study|Adverse Event|5
7541295|NCT02572817|26207140|P2|Overall Study|Lost to Follow-up|3
7541296|NCT02572817|26207141|P1|Overall Study|Lost to Follow-up|3
7541297|NCT02572817|26207140|P2|Overall Study|Death|3
7541298|NCT02572817|26207141|P1|Overall Study|Death|6
7541299|NCT02572570|26207234|P1|Overall Study|Study Terminated|27
7541300|NCT02572401|26207264|P4|Overall Study|Death|1
7541301|NCT02572401|26207265|P3|Overall Study|Death|0
7541302|NCT02572401|26207266|P2|Overall Study|Death|0
7541303|NCT02572401|26207267|P1|Overall Study|Death|0
7541304|NCT02572401|26207264|P4|Overall Study|Lost to Follow-up|9
7541305|NCT02572401|26207265|P3|Overall Study|Lost to Follow-up|9
7541306|NCT02572401|26207266|P2|Overall Study|Lost to Follow-up|8
7541307|NCT02572401|26207267|P1|Overall Study|Lost to Follow-up|5
7541308|NCT02572388|26207297|P4|Overall Study|Withdrawal by Subject|2
7541309|NCT02572388|26207298|P3|Overall Study|Withdrawal by Subject|2
7541310|NCT02572388|26207299|P2|Overall Study|Withdrawal by Subject|1
7541311|NCT02572388|26207300|P1|Overall Study|Withdrawal by Subject|1
7541312|NCT02572167|26207325|P3|Overall Study|Did not meet inclusion criteria|1
7541313|NCT02572167|26207326|P2|Overall Study|Did not meet inclusion criteria|0
7541314|NCT02572167|26207327|P1|Overall Study|Did not meet inclusion criteria|0
7541315|NCT02572167|26207325|P3|Overall Study|Death|1
7541316|NCT02572167|26207326|P2|Overall Study|Death|3
7541317|NCT02572167|26207327|P1|Overall Study|Death|0
7541318|NCT02572167|26207325|P3|Overall Study|Lost to Follow-up|1
7541319|NCT02572167|26207326|P2|Overall Study|Lost to Follow-up|2
7541320|NCT02572167|26207327|P1|Overall Study|Lost to Follow-up|0
7541321|NCT02572167|26207325|P3|Overall Study|Withdrawal by Subject|1
7541322|NCT02572167|26207326|P2|Overall Study|Withdrawal by Subject|3
7541323|NCT02572167|26207327|P1|Overall Study|Withdrawal by Subject|0
7541324|NCT02572167|26207325|P3|Overall Study|In follow up|27
7541325|NCT02572167|26207326|P2|Overall Study|In follow up|48
7541326|NCT02572167|26207327|P1|Overall Study|In follow up|6
7541327|NCT02572076|26207341|P1|Overall Study|Protocol Violation|1
7541328|NCT02571972|26207345|P1|Overall Study|Withdrawal by Subject|2
7541329|NCT02571972|26207345|P1|Overall Study|Protocol Violation|2
7541330|NCT02571777|26207357|P5|Overall Study|Pregnancy|0
7541331|NCT02571777|26207358|P4|Overall Study|Pregnancy|2
7541332|NCT02571777|26207359|P3|Overall Study|Pregnancy|0
7541333|NCT02571777|26207360|P2|Overall Study|Pregnancy|0
7541334|NCT02571777|26207361|P1|Overall Study|Pregnancy|0
7541335|NCT02571777|26207357|P5|Overall Study|Physician Decision|4
7541336|NCT02571777|26207358|P4|Overall Study|Physician Decision|2
7541337|NCT02571777|26207359|P3|Overall Study|Physician Decision|5
7541338|NCT02571777|26207360|P2|Overall Study|Physician Decision|7
7541339|NCT02571777|26207361|P1|Overall Study|Physician Decision|1
7541340|NCT02571777|26207357|P5|Overall Study|Lost to Follow-up|1
7541341|NCT02571777|26207358|P4|Overall Study|Lost to Follow-up|0
7541342|NCT02571777|26207359|P3|Overall Study|Lost to Follow-up|2
7541343|NCT02571777|26207360|P2|Overall Study|Lost to Follow-up|1
7541344|NCT02571777|26207361|P1|Overall Study|Lost to Follow-up|1
7541345|NCT02571777|26207357|P5|Overall Study|Death|0
7541346|NCT02571777|26207358|P4|Overall Study|Death|0
7541347|NCT02571777|26207359|P3|Overall Study|Death|4
7541348|NCT02571777|26207360|P2|Overall Study|Death|1
7541349|NCT02571777|26207361|P1|Overall Study|Death|1
7541350|NCT02571777|26207357|P5|Overall Study|Protocol Deviation|4
7541351|NCT02571777|26207358|P4|Overall Study|Protocol Deviation|8
7541352|NCT02571777|26207359|P3|Overall Study|Protocol Deviation|4
7541353|NCT02571777|26207360|P2|Overall Study|Protocol Deviation|3
7541354|NCT02571777|26207361|P1|Overall Study|Protocol Deviation|2
7541355|NCT02571777|26207357|P5|Overall Study|Subject/guardian decision|27
7541356|NCT02571777|26207358|P4|Overall Study|Subject/guardian decision|25
7541357|NCT02571777|26207359|P3|Overall Study|Subject/guardian decision|26
7541358|NCT02571777|26207360|P2|Overall Study|Subject/guardian decision|26
7541359|NCT02571777|26207361|P1|Overall Study|Subject/guardian decision|34
7541360|NCT02571452|26207498|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
7541361|NCT02571452|26207499|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
7541362|NCT02571452|26207498|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
7541363|NCT02571452|26207499|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
7541364|NCT02571452|26207498|P2|Overall Study Treatment|Protocol Violation|1
7541365|NCT02571452|26207499|P1|Overall Study Treatment|Protocol Violation|0
7541366|NCT02571244|26207540|P2|Overall Study|Unable to reach out post discharge|0
7541367|NCT02571244|26207541|P1|Overall Study|Unable to reach out post discharge|3
7541368|NCT02571244|26207540|P2|Overall Study|Lost to Follow-up|1
7541369|NCT02571244|26207541|P1|Overall Study|Lost to Follow-up|0
7541370|NCT02571075|26207599|P2|Overall Study|Lost to Follow-up|24
7541371|NCT02571075|26207600|P1|Overall Study|Lost to Follow-up|20
7541372|NCT02571049|26207614|P2|Randomization|Adverse Event|1
7541373|NCT02571049|26207615|P1|Randomization|Adverse Event|0
7541374|NCT02571049|26207614|P2|Randomization|No migraine attack|1
7541375|NCT02571049|26207615|P1|Randomization|No migraine attack|0
7541376|NCT02571049|26207614|P2|Screening|Did not meet entry criteria|2
7541377|NCT02571049|26207615|P1|Screening|Did not meet entry criteria|2
7541378|NCT02570750|26207623|P2|Overall Study|Adverse Event|1
7541379|NCT02570750|26207624|P1|Overall Study|Adverse Event|2
7541380|NCT02570750|26207623|P2|Overall Study|Lost to Follow-up|2
7541381|NCT02570750|26207624|P1|Overall Study|Lost to Follow-up|2
7541382|NCT02570750|26207623|P2|Overall Study|Withdrawal by Subject|0
7541383|NCT02570750|26207624|P1|Overall Study|Withdrawal by Subject|5
7541384|NCT02570750|26207623|P2|Overall Study|Protocol deviation|2
7541385|NCT02570750|26207624|P1|Overall Study|Protocol deviation|4
7541386|NCT02570750|26207623|P2|Overall Study|Inclusion/exclusion criteria deviation|0
7541387|NCT02570750|26207624|P1|Overall Study|Inclusion/exclusion criteria deviation|1
7541388|NCT02570711|26207642|P2|Overall Study|Early Termination of Study by Sponsor|2
7541389|NCT02570711|26207643|P1|Overall Study|Early Termination of Study by Sponsor|0
7541390|NCT02570711|26207642|P2|Overall Study|Death|0
7541391|NCT02570711|26207643|P1|Overall Study|Death|1
7541392|NCT02570308|26207704|P5|Overall Study|Other|2
7541393|NCT02570308|26207705|P4|Overall Study|Other|0
7541394|NCT02570308|26207706|P3|Overall Study|Other|0
7541395|NCT02570308|26207707|P2|Overall Study|Other|0
7541396|NCT02570308|26207708|P1|Overall Study|Other|0
7541397|NCT02570308|26207704|P5|Overall Study|Withdrawal by Subject|1
7541398|NCT02570308|26207705|P4|Overall Study|Withdrawal by Subject|0
7541399|NCT02570308|26207706|P3|Overall Study|Withdrawal by Subject|0
7541400|NCT02570308|26207707|P2|Overall Study|Withdrawal by Subject|0
7541401|NCT02570308|26207708|P1|Overall Study|Withdrawal by Subject|0
7541402|NCT02570308|26207704|P5|Overall Study|Lost to Follow-up|2
7541403|NCT02570308|26207705|P4|Overall Study|Lost to Follow-up|0
7541404|NCT02570308|26207706|P3|Overall Study|Lost to Follow-up|0
7541405|NCT02570308|26207707|P2|Overall Study|Lost to Follow-up|0
7541406|NCT02570308|26207708|P1|Overall Study|Lost to Follow-up|0
7541407|NCT02570308|26207704|P5|Overall Study|Death|69
7541408|NCT02570308|26207705|P4|Overall Study|Death|4
7541409|NCT02570308|26207706|P3|Overall Study|Death|4
7541410|NCT02570308|26207707|P2|Overall Study|Death|5
7541411|NCT02570308|26207708|P1|Overall Study|Death|1
7541412|NCT02570165|26207791|P7|Overall Study|Withdrawal Request by GSK|0
7541413|NCT02570165|26207792|P6|Overall Study|Withdrawal Request by GSK|0
7541414|NCT02570165|26207793|P5|Overall Study|Withdrawal Request by GSK|0
7541415|NCT02570165|26207794|P4|Overall Study|Withdrawal Request by GSK|0
7541416|NCT02570165|26207795|P3|Overall Study|Withdrawal Request by GSK|2
7541417|NCT02570165|26207796|P2|Overall Study|Withdrawal Request by GSK|0
7541418|NCT02570165|26207797|P1|Overall Study|Withdrawal Request by GSK|0
7541419|NCT02570165|26207791|P7|Overall Study|Par. did not Meet Continuation Criteria|0
7541420|NCT02570165|26207792|P6|Overall Study|Par. did not Meet Continuation Criteria|1
7541421|NCT02570165|26207793|P5|Overall Study|Par. did not Meet Continuation Criteria|0
7541422|NCT02570165|26207794|P4|Overall Study|Par. did not Meet Continuation Criteria|0
7541423|NCT02570165|26207795|P3|Overall Study|Par. did not Meet Continuation Criteria|0
7541424|NCT02570165|26207796|P2|Overall Study|Par. did not Meet Continuation Criteria|0
7541425|NCT02570165|26207797|P1|Overall Study|Par. did not Meet Continuation Criteria|0
7541426|NCT02570165|26207791|P7|Overall Study|Withdrawal by Subject|0
7541427|NCT02570165|26207792|P6|Overall Study|Withdrawal by Subject|0
7541428|NCT02570165|26207793|P5|Overall Study|Withdrawal by Subject|1
7541429|NCT02570165|26207794|P4|Overall Study|Withdrawal by Subject|2
7541430|NCT02570165|26207795|P3|Overall Study|Withdrawal by Subject|0
7541431|NCT02570165|26207796|P2|Overall Study|Withdrawal by Subject|0
7541432|NCT02570165|26207797|P1|Overall Study|Withdrawal by Subject|0
7541433|NCT02570165|26207791|P7|Overall Study|Physician Decision|0
7541434|NCT02570165|26207792|P6|Overall Study|Physician Decision|0
7541435|NCT02570165|26207793|P5|Overall Study|Physician Decision|0
7541436|NCT02570165|26207794|P4|Overall Study|Physician Decision|0
7541437|NCT02570165|26207795|P3|Overall Study|Physician Decision|0
7541438|NCT02570165|26207796|P2|Overall Study|Physician Decision|1
7541439|NCT02570165|26207797|P1|Overall Study|Physician Decision|0
7541440|NCT02570165|26207791|P7|Overall Study|Lost to Follow-up|0
7541441|NCT02570165|26207792|P6|Overall Study|Lost to Follow-up|0
7541442|NCT02570165|26207793|P5|Overall Study|Lost to Follow-up|0
7541443|NCT02570165|26207794|P4|Overall Study|Lost to Follow-up|1
7541444|NCT02570165|26207795|P3|Overall Study|Lost to Follow-up|1
7541445|NCT02570165|26207796|P2|Overall Study|Lost to Follow-up|0
7541446|NCT02570165|26207797|P1|Overall Study|Lost to Follow-up|0
7541447|NCT02570165|26207791|P7|Overall Study|Par. Reached Stopping Criteria|0
7541448|NCT02570165|26207792|P6|Overall Study|Par. Reached Stopping Criteria|1
7541449|NCT02570165|26207793|P5|Overall Study|Par. Reached Stopping Criteria|1
7541450|NCT02570165|26207794|P4|Overall Study|Par. Reached Stopping Criteria|2
7541451|NCT02570165|26207795|P3|Overall Study|Par. Reached Stopping Criteria|0
7541452|NCT02570165|26207796|P2|Overall Study|Par. Reached Stopping Criteria|1
7541453|NCT02570165|26207797|P1|Overall Study|Par. Reached Stopping Criteria|1
7541454|NCT02570165|26207791|P7|Overall Study|Lack of Efficacy|0
7541455|NCT02570165|26207792|P6|Overall Study|Lack of Efficacy|0
7541456|NCT02570165|26207793|P5|Overall Study|Lack of Efficacy|4
7541457|NCT02570165|26207794|P4|Overall Study|Lack of Efficacy|0
7541458|NCT02570165|26207795|P3|Overall Study|Lack of Efficacy|0
7541459|NCT02570165|26207796|P2|Overall Study|Lack of Efficacy|1
7541460|NCT02570165|26207797|P1|Overall Study|Lack of Efficacy|0
7541461|NCT02570165|26207791|P7|Overall Study|Adverse Event|0
7541462|NCT02570165|26207792|P6|Overall Study|Adverse Event|0
7541463|NCT02570165|26207793|P5|Overall Study|Adverse Event|0
7541464|NCT02570165|26207794|P4|Overall Study|Adverse Event|0
7541465|NCT02570165|26207795|P3|Overall Study|Adverse Event|2
7541466|NCT02570165|26207796|P2|Overall Study|Adverse Event|0
7541467|NCT02570165|26207797|P1|Overall Study|Adverse Event|1
7541468|NCT02570152|26207820|P1|Overall Study|Migrated/moved from study area|13
7541469|NCT02570152|26207820|P1|Overall Study|Protocol Violation|2
7541470|NCT02570126|26207851|P2|Overall Study|Withdrawal by Subject|7
7541471|NCT02570126|26207852|P1|Overall Study|Withdrawal by Subject|3
7541472|NCT02570126|26207851|P2|Overall Study|Protocol Violation|1
7541473|NCT02570126|26207852|P1|Overall Study|Protocol Violation|0
7541474|NCT02570126|26207851|P2|Overall Study|Violation Of Procedures GSK|1
7541475|NCT02570126|26207852|P1|Overall Study|Violation Of Procedures GSK|0
7541476|NCT02570126|26207851|P2|Overall Study|Unable To Arrange Visit 3|0
7541477|NCT02570126|26207852|P1|Overall Study|Unable To Arrange Visit 3|1
7541478|NCT02570126|26207851|P2|Overall Study|Lost to Follow-up|0
7541479|NCT02570126|26207852|P1|Overall Study|Lost to Follow-up|2
7541480|NCT02570074|26207878|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
7541481|NCT02570074|26207879|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
7541482|NCT02569996|26207948|P1|Overall Study|Unknown reason|1
7541483|NCT02569996|26207948|P1|Overall Study|Complete remission|7
7541484|NCT02569996|26207948|P1|Overall Study|Lost to Follow-up|5
7541485|NCT02569996|26207948|P1|Overall Study|Withdrawal by Subject|5
7541486|NCT02569996|26207948|P1|Overall Study|Non-compliance|9
7541487|NCT02569996|26207948|P1|Overall Study|New anti-lymphoma treatment|1
7541488|NCT02569996|26207948|P1|Overall Study|Progression of the disease|18
7541489|NCT02569996|26207948|P1|Overall Study|Physician Decision|3
7541490|NCT02569996|26207948|P1|Overall Study|Adverse Event|6
7541491|NCT02569957|26207960|P2|Overall Study|Withdrawal by Subject|1
7541492|NCT02569957|26207961|P1|Overall Study|Withdrawal by Subject|0
7541493|NCT02569853|26208004|P2|Overall Study|Physician Decision|1
7541494|NCT02569853|26208005|P1|Overall Study|Physician Decision|1
7541495|NCT02569853|26208004|P2|Overall Study|Did not experience migraine attack|7
7541496|NCT02569853|26208005|P1|Overall Study|Did not experience migraine attack|10
7541497|NCT02569853|26208004|P2|Overall Study|Protocol Violation|1
7541498|NCT02569853|26208005|P1|Overall Study|Protocol Violation|1
7541499|NCT02569853|26208004|P2|Overall Study|Lost to Follow-up|3
7541500|NCT02569853|26208005|P1|Overall Study|Lost to Follow-up|3
7541501|NCT02569853|26208004|P2|Overall Study|Withdrawal by Subject|2
7541502|NCT02569853|26208005|P1|Overall Study|Withdrawal by Subject|3
7541503|NCT02569853|26208004|P2|Overall Study|Adverse Event|0
7541504|NCT02569853|26208005|P1|Overall Study|Adverse Event|2
7541505|NCT02569801|26208015|P2|Overall Study|Death|4
7541506|NCT02569801|26208016|P1|Overall Study|Death|12
7541507|NCT02569801|26208015|P2|Overall Study|Lost to Follow-up|1
7541508|NCT02569801|26208016|P1|Overall Study|Lost to Follow-up|0
7541509|NCT02569801|26208015|P2|Overall Study|Progressive Disease|7
7541510|NCT02569801|26208016|P1|Overall Study|Progressive Disease|2
7541511|NCT02569801|26208015|P2|Overall Study|Sponsor Decision|14
7541512|NCT02569801|26208016|P1|Overall Study|Sponsor Decision|13
7541513|NCT02569801|26208015|P2|Overall Study|Withdrawal by Subject|9
7541514|NCT02569801|26208016|P1|Overall Study|Withdrawal by Subject|9
7541515|NCT02569710|26208052|P10|Overall Study|Withdrawal by Subject|0
7541516|NCT02569710|26208053|P9|Overall Study|Withdrawal by Subject|0
7541517|NCT02569710|26208054|P8|Overall Study|Withdrawal by Subject|0
7541518|NCT02569710|26208055|P7|Overall Study|Withdrawal by Subject|0
7541519|NCT02569710|26208056|P6|Overall Study|Withdrawal by Subject|1
7541520|NCT02569710|26208057|P5|Overall Study|Withdrawal by Subject|0
7541521|NCT02569710|26208058|P4|Overall Study|Withdrawal by Subject|0
7541522|NCT02569710|26208059|P3|Overall Study|Withdrawal by Subject|0
7541523|NCT02569710|26208060|P2|Overall Study|Withdrawal by Subject|0
7541524|NCT02569710|26208061|P1|Overall Study|Withdrawal by Subject|0
7541525|NCT02569710|26208052|P10|Overall Study|Virologic failure|0
7541526|NCT02569710|26208053|P9|Overall Study|Virologic failure|0
7541527|NCT02569710|26208054|P8|Overall Study|Virologic failure|0
7541528|NCT02569710|26208055|P7|Overall Study|Virologic failure|1
7541529|NCT02569710|26208056|P6|Overall Study|Virologic failure|0
7541530|NCT02569710|26208057|P5|Overall Study|Virologic failure|1
7541531|NCT02569710|26208058|P4|Overall Study|Virologic failure|0
7541532|NCT02569710|26208059|P3|Overall Study|Virologic failure|0
7541533|NCT02569710|26208060|P2|Overall Study|Virologic failure|0
7541534|NCT02569710|26208061|P1|Overall Study|Virologic failure|0
7541535|NCT02569710|26208052|P10|Overall Study|Lost to Follow-up|0
7541536|NCT02569710|26208053|P9|Overall Study|Lost to Follow-up|1
7541537|NCT02569710|26208054|P8|Overall Study|Lost to Follow-up|0
7541538|NCT02569710|26208055|P7|Overall Study|Lost to Follow-up|1
7541539|NCT02569710|26208056|P6|Overall Study|Lost to Follow-up|0
7541540|NCT02569710|26208057|P5|Overall Study|Lost to Follow-up|0
7541541|NCT02569710|26208058|P4|Overall Study|Lost to Follow-up|0
7541542|NCT02569710|26208059|P3|Overall Study|Lost to Follow-up|0
7541543|NCT02569710|26208060|P2|Overall Study|Lost to Follow-up|0
7541544|NCT02569710|26208061|P1|Overall Study|Lost to Follow-up|0
7541545|NCT02569710|26208052|P10|Overall Study|Adverse Event|0
7541546|NCT02569710|26208053|P9|Overall Study|Adverse Event|0
7541547|NCT02569710|26208054|P8|Overall Study|Adverse Event|0
7541548|NCT02569710|26208055|P7|Overall Study|Adverse Event|0
7541549|NCT02569710|26208056|P6|Overall Study|Adverse Event|0
7541550|NCT02569710|26208057|P5|Overall Study|Adverse Event|0
7541551|NCT02569710|26208058|P4|Overall Study|Adverse Event|0
7541552|NCT02569710|26208059|P3|Overall Study|Adverse Event|0
7541553|NCT02569710|26208060|P2|Overall Study|Adverse Event|0
7541554|NCT02569710|26208061|P1|Overall Study|Adverse Event|1
7541555|NCT02569437|26208406|P2|Overall Study|Lost to Follow-up|14
7541556|NCT02569437|26208407|P1|Overall Study|Lost to Follow-up|12
7541557|NCT02569398|26208437|P3|Overall Study|Other|13
7541558|NCT02569398|26208438|P2|Overall Study|Other|14
7541559|NCT02569398|26208439|P1|Overall Study|Other|12
7541560|NCT02569398|26208437|P3|Overall Study|Study terminated by sponsor|134
7541561|NCT02569398|26208438|P2|Overall Study|Study terminated by sponsor|131
7541562|NCT02569398|26208439|P1|Overall Study|Study terminated by sponsor|130
7541563|NCT02569398|26208437|P3|Overall Study|Withdrawal by Subject|30
7541564|NCT02569398|26208438|P2|Overall Study|Withdrawal by Subject|43
7541565|NCT02569398|26208439|P1|Overall Study|Withdrawal by Subject|43
7541566|NCT02569398|26208437|P3|Overall Study|Adverse Event|6
7541567|NCT02569398|26208438|P2|Overall Study|Adverse Event|1
7541568|NCT02569398|26208439|P1|Overall Study|Adverse Event|0
7541569|NCT02568683|26208514|P2|Overall Study|Study Terminated By Sponsor|2
7541570|NCT02568683|26208515|P1|Overall Study|Study Terminated By Sponsor|5
7541571|NCT02568683|26208514|P2|Overall Study|Withdrew Consent|0
7541572|NCT02568683|26208515|P1|Overall Study|Withdrew Consent|1
7541573|NCT02568683|26208514|P2|Overall Study|Death|2
7541574|NCT02568683|26208515|P1|Overall Study|Death|0
7541575|NCT02568475|26208544|P2|Overall Study|Transferred to another facility|0
7541576|NCT02568475|26208545|P1|Overall Study|Transferred to another facility|1
7541577|NCT02568475|26208544|P2|Overall Study|Short-term: Discharge location unknown|0
7541578|NCT02568475|26208545|P1|Overall Study|Short-term: Discharge location unknown|4
7541579|NCT02568475|26208544|P2|Overall Study|Discharged home|4
7541580|NCT02568475|26208545|P1|Overall Study|Discharged home|4
7541581|NCT02568475|26208544|P2|Overall Study|Withdrawal by Subject|0
7541582|NCT02568475|26208545|P1|Overall Study|Withdrawal by Subject|2
7541583|NCT02568475|26208544|P2|Overall Study|Lost to Follow-up|39
7541584|NCT02568475|26208545|P1|Overall Study|Lost to Follow-up|40
7541585|NCT02568397|26208559|P2|Period 2|Physician Decision|1
7541586|NCT02568397|26208560|P1|Period 2|Physician Decision|0
7541587|NCT02568397|26208559|P2|Period 2|Withdrawal by Subject|1
7541588|NCT02568397|26208560|P1|Period 2|Withdrawal by Subject|0
7541589|NCT02568384|26208584|P1|Overall Study|Mobile devices incompatible with App|2
7541590|NCT02568254|26208598|P6|Period 3|Unstatisfactory Lens fitting|0
7541591|NCT02568254|26208599|P5|Period 3|Unstatisfactory Lens fitting|1
7541592|NCT02568254|26208600|P4|Period 3|Unstatisfactory Lens fitting|0
7541593|NCT02568254|26208601|P3|Period 3|Unstatisfactory Lens fitting|0
7541594|NCT02568254|26208602|P2|Period 3|Unstatisfactory Lens fitting|0
7541595|NCT02568254|26208603|P1|Period 3|Unstatisfactory Lens fitting|0
7541596|NCT02568254|26208598|P6|Period 2|Adverse Event|0
7541597|NCT02568254|26208599|P5|Period 2|Adverse Event|0
7541598|NCT02568254|26208600|P4|Period 2|Adverse Event|0
7541599|NCT02568254|26208601|P3|Period 2|Adverse Event|1
7541600|NCT02568254|26208602|P2|Period 2|Adverse Event|0
7541601|NCT02568254|26208603|P1|Period 2|Adverse Event|0
7541602|NCT02568072|26208611|P1|Overall Study|Sustained injury, marathon not run|24
7541603|NCT02568072|26208611|P1|Overall Study|Withdrawal by Subject|1
7541604|NCT02568072|26208611|P1|Overall Study|Diagnosis of Long QT Syndrome|1
7541605|NCT02568072|26208611|P1|Overall Study|Unable to contact|3
7541606|NCT02568072|26208611|P1|Overall Study|Unavailable for appointment|23
7541607|NCT02568046|26208626|P2|Overall Study|Other Events|1
7541608|NCT02568046|26208627|P1|Overall Study|Other Events|0
7541609|NCT02568046|26208626|P2|Overall Study|Withdrawal by Subject|1
7541610|NCT02568046|26208627|P1|Overall Study|Withdrawal by Subject|2
7541611|NCT02568046|26208626|P2|Overall Study|Progressive Disease|0
7541612|NCT02568046|26208627|P1|Overall Study|Progressive Disease|1
7541613|NCT02568046|26208626|P2|Overall Study|Death|0
7541614|NCT02568046|26208627|P1|Overall Study|Death|2
7541615|NCT02568046|26208626|P2|Overall Study|Adverse Event|1
7541616|NCT02568046|26208627|P1|Overall Study|Adverse Event|0
7541617|NCT02567708|26208690|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
7541618|NCT02567708|26208691|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7541619|NCT02567708|26208690|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7541620|NCT02567708|26208691|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
7541621|NCT02567708|26208690|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
7541622|NCT02567708|26208691|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
7541623|NCT02567708|26208690|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
7541624|NCT02567708|26208691|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7541625|NCT02567656|26208736|P6|Overall Study|Premature discontinuation due to PD|0
7541626|NCT02567656|26208737|P5|Overall Study|Premature discontinuation due to PD|0
7541627|NCT02567656|26208738|P4|Overall Study|Premature discontinuation due to PD|0
7541628|NCT02567656|26208739|P3|Overall Study|Premature discontinuation due to PD|2
7541629|NCT02567656|26208740|P2|Overall Study|Premature discontinuation due to PD|1
7541630|NCT02567656|26208741|P1|Overall Study|Premature discontinuation due to PD|1
7541631|NCT02567552|26208773|P2|Overall Study|Adverse Event|1
7541632|NCT02567552|26208774|P1|Overall Study|Adverse Event|0
7541633|NCT02567266|26208807|P3|Overall Study|Lost to Follow-up|10
7541634|NCT02567266|26208808|P2|Overall Study|Lost to Follow-up|8
7541635|NCT02567266|26208809|P1|Overall Study|Lost to Follow-up|13
7541636|NCT02567266|26208807|P3|Overall Study|Withdrawal by Subject|6
7541637|NCT02567266|26208808|P2|Overall Study|Withdrawal by Subject|7
7541638|NCT02567266|26208809|P1|Overall Study|Withdrawal by Subject|10
7541639|NCT02567227|26208825|P2|12 Months|Death|2
7541640|NCT02567227|26208826|P1|12 Months|Death|0
7541641|NCT02567227|26208825|P2|12 Months|Lost to Follow-up|32
7541642|NCT02567227|26208826|P1|12 Months|Lost to Follow-up|31
7541643|NCT02567227|26208825|P2|6 Month|Lost to Follow-up|40
7541644|NCT02567227|26208826|P1|6 Month|Lost to Follow-up|43
7541645|NCT02567227|26208825|P2|6 Month|Death|0
7541646|NCT02567227|26208826|P1|6 Month|Death|2
7541647|NCT02567227|26208825|P2|9 Weeks|Study suspended due to COVID-19 pandemic|11
7541648|NCT02567227|26208826|P1|9 Weeks|Study suspended due to COVID-19 pandemic|11
7541649|NCT02567227|26208825|P2|9 Weeks|Withdrawal by Subject|8
7541650|NCT02567227|26208826|P1|9 Weeks|Withdrawal by Subject|18
7541651|NCT02567227|26208825|P2|9 Weeks|Adverse Event|5
7541652|NCT02567227|26208826|P1|9 Weeks|Adverse Event|5
7541653|NCT02567188|26208870|P1|Overall Study|Protocol Violation|5
7541654|NCT02567188|26208870|P1|Overall Study|Started Hemodialysis|2
7541655|NCT02567188|26208870|P1|Overall Study|Moved and Changed Clinic|1
7541656|NCT02567188|26208870|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
7541657|NCT02567188|26208870|P1|Overall Study|Withdrawal by Subject|1
7541658|NCT02567188|26208870|P1|Overall Study|Adverse Event|1
7541659|NCT02567188|26208870|P1|Overall Study|Lost to Follow-up|5
7541660|NCT02567188|26208870|P1|Overall Study|Terminated Mircera Treatment|9
7541661|NCT02567188|26208870|P1|Overall Study|Death|10
7541662|NCT02566902|26208901|P2|Overall Study|Protocol Violation|1
7541663|NCT02566902|26208902|P1|Overall Study|Protocol Violation|2
7541664|NCT02566889|26208926|P2|Overall Study|Other|2
7541665|NCT02566889|26208927|P1|Overall Study|Other|6
7541666|NCT02566889|26208926|P2|Overall Study|Adverse Event|2
7541667|NCT02566889|26208927|P1|Overall Study|Adverse Event|4
7541668|NCT02566889|26208926|P2|Overall Study|Withdrawal by Subject|1
7541669|NCT02566889|26208927|P1|Overall Study|Withdrawal by Subject|3
7541670|NCT02566785|26208945|P2|Overall Study|Worsening condition|1
7541671|NCT02566785|26208946|P1|Overall Study|Worsening condition|1
7541672|NCT02566785|26208945|P2|Overall Study|Lost to Follow-up|2
7541673|NCT02566785|26208946|P1|Overall Study|Lost to Follow-up|0
7541674|NCT02566759|26208973|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
7541675|NCT02566759|26208974|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541676|NCT02566759|26208975|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541677|NCT02566759|26208976|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541678|NCT02566759|26208977|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541679|NCT02566759|26208978|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541680|NCT02566759|26208979|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541681|NCT02566759|26208980|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541682|NCT02566759|26208981|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541683|NCT02566759|26208982|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541684|NCT02566759|26208983|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541685|NCT02566759|26208984|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541686|NCT02566759|26208985|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541687|NCT02566759|26208986|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541688|NCT02566759|26208987|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541689|NCT02566759|26208988|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541690|NCT02566759|26208989|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7541691|NCT02566759|26208973|P17|All Parts|Other|0
7541692|NCT02566759|26208974|P16|All Parts|Other|0
7541693|NCT02566759|26208975|P15|All Parts|Other|0
7541694|NCT02566759|26208976|P14|All Parts|Other|2
7541695|NCT02566759|26208977|P13|All Parts|Other|0
7541696|NCT02566759|26208978|P12|All Parts|Other|0
7541697|NCT02566759|26208979|P11|All Parts|Other|0
7541698|NCT02566759|26208980|P10|All Parts|Other|0
7541699|NCT02566759|26208981|P9|All Parts|Other|0
7541700|NCT02566759|26208982|P8|All Parts|Other|0
7541701|NCT02566759|26208983|P7|All Parts|Other|0
7541702|NCT02566759|26208984|P6|All Parts|Other|0
7541703|NCT02566759|26208985|P5|All Parts|Other|0
7541704|NCT02566759|26208986|P4|All Parts|Other|0
7541705|NCT02566759|26208987|P3|All Parts|Other|0
7541706|NCT02566759|26208988|P2|All Parts|Other|0
7541707|NCT02566759|26208989|P1|All Parts|Other|0
7541708|NCT02566759|26208973|P17|All Parts|Adverse Event|0
7541709|NCT02566759|26208974|P16|All Parts|Adverse Event|0
7541710|NCT02566759|26208975|P15|All Parts|Adverse Event|0
7541711|NCT02566759|26208976|P14|All Parts|Adverse Event|3
7541712|NCT02566759|26208977|P13|All Parts|Adverse Event|1
7541713|NCT02566759|26208978|P12|All Parts|Adverse Event|0
7541714|NCT02566759|26208979|P11|All Parts|Adverse Event|0
7541715|NCT02566759|26208980|P10|All Parts|Adverse Event|0
7541716|NCT02566759|26208981|P9|All Parts|Adverse Event|0
7541717|NCT02566759|26208982|P8|All Parts|Adverse Event|0
7541718|NCT02566759|26208983|P7|All Parts|Adverse Event|0
7541719|NCT02566759|26208984|P6|All Parts|Adverse Event|0
7541720|NCT02566759|26208985|P5|All Parts|Adverse Event|0
7541721|NCT02566759|26208986|P4|All Parts|Adverse Event|0
7541722|NCT02566759|26208987|P3|All Parts|Adverse Event|0
7541723|NCT02566759|26208988|P2|All Parts|Adverse Event|0
7541724|NCT02566759|26208989|P1|All Parts|Adverse Event|0
7541725|NCT02566759|26208973|P17|All Parts|Withdrawal by Subject|0
7541726|NCT02566759|26208974|P16|All Parts|Withdrawal by Subject|0
7541727|NCT02566759|26208975|P15|All Parts|Withdrawal by Subject|0
7541728|NCT02566759|26208976|P14|All Parts|Withdrawal by Subject|0
7541729|NCT02566759|26208977|P13|All Parts|Withdrawal by Subject|0
7541730|NCT02566759|26208978|P12|All Parts|Withdrawal by Subject|0
7541731|NCT02566759|26208979|P11|All Parts|Withdrawal by Subject|0
7541732|NCT02566759|26208980|P10|All Parts|Withdrawal by Subject|0
7541733|NCT02566759|26208981|P9|All Parts|Withdrawal by Subject|0
7541734|NCT02566759|26208982|P8|All Parts|Withdrawal by Subject|0
7541735|NCT02566759|26208983|P7|All Parts|Withdrawal by Subject|0
7541736|NCT02566759|26208984|P6|All Parts|Withdrawal by Subject|0
7541737|NCT02566759|26208985|P5|All Parts|Withdrawal by Subject|0
7541738|NCT02566759|26208986|P4|All Parts|Withdrawal by Subject|0
7541739|NCT02566759|26208987|P3|All Parts|Withdrawal by Subject|0
7541740|NCT02566759|26208988|P2|All Parts|Withdrawal by Subject|1
7541741|NCT02566759|26208989|P1|All Parts|Withdrawal by Subject|0
7541742|NCT02566577|26209151|P2|Overall Study|Physical limitation|0
7541743|NCT02566577|26209152|P1|Overall Study|Physical limitation|1
7541744|NCT02566577|26209151|P2|Overall Study|Equipment failure|1
7541745|NCT02566577|26209152|P1|Overall Study|Equipment failure|1
7541746|NCT02566577|26209151|P2|Overall Study|Withdrawal by Subject|1
7541747|NCT02566577|26209152|P1|Overall Study|Withdrawal by Subject|1
7541748|NCT02566525|26209180|P2|Overall Study|Protocol Violation|5
7541749|NCT02566525|26209181|P1|Overall Study|Protocol Violation|3
7541750|NCT02566109|26209262|P1|Overall Study|Withdrawal by Subject|1
7541751|NCT02566031|26209326|P2|Overall Study|Lost to Follow-up|1
7541752|NCT02566031|26209327|P1|Overall Study|Lost to Follow-up|1
7541753|NCT02566031|26209326|P2|Overall Study|Adverse Event|1
7541754|NCT02566031|26209327|P1|Overall Study|Adverse Event|3
7541755|NCT02566031|26209326|P2|Overall Study|Protocol deviation|3
7541756|NCT02566031|26209327|P1|Overall Study|Protocol deviation|2
7541757|NCT02566031|26209326|P2|Overall Study|Patient/guardian decision|7
7541758|NCT02566031|26209327|P1|Overall Study|Patient/guardian decision|14
7541759|NCT02566005|26209344|P2|Overall Study|labor after randomization|4
7541760|NCT02566005|26209345|P1|Overall Study|labor after randomization|0
7541761|NCT02566005|26209344|P2|Overall Study|did not receive foley|1
7541762|NCT02566005|26209345|P1|Overall Study|did not receive foley|0
7541763|NCT02566005|26209344|P2|Overall Study|received foley|0
7541764|NCT02566005|26209345|P1|Overall Study|received foley|8
7541765|NCT02566005|26209344|P2|Overall Study|vaginal bleeding|1
7541766|NCT02566005|26209345|P1|Overall Study|vaginal bleeding|0
7541767|NCT02565914|26209373|P1|Overall Study|Enrolled, but did not receive study drug|2
7541768|NCT02565914|26209373|P1|Overall Study|Other|18
7541769|NCT02565914|26209373|P1|Overall Study|Commercial drug available|5
7541770|NCT02565914|26209373|P1|Overall Study|Parent study termination by sponsor|1
7541771|NCT02565914|26209373|P1|Overall Study|Physician Decision|6
7541772|NCT02565914|26209373|P1|Overall Study|Other noncompliance|6
7541773|NCT02565914|26209373|P1|Overall Study|Death (not treatment emergent)|1
7541774|NCT02565914|26209373|P1|Overall Study|Lost to Follow-up|12
7541775|NCT02565914|26209373|P1|Overall Study|Withdrawal of consent (not due to AE)|25
7541776|NCT02565914|26209373|P1|Overall Study|Adverse Event|17
7541777|NCT02565810|26209425|P1|Overall Study|Withdrawal by Subject|1
7541778|NCT02565784|26209434|P1|Second Treatment|Withdrawal by Subject|2
7541779|NCT02565784|26209434|P1|First Treatment|Withdrawal by Subject|1
7541780|NCT02565784|26209434|P1|First Treatment|Adverse Event|1
7541781|NCT02565706|26209446|P4|Overall Study|Lost to Follow-up|74
7541782|NCT02565706|26209447|P3|Overall Study|Lost to Follow-up|82
7541783|NCT02565706|26209448|P2|Overall Study|Lost to Follow-up|75
7541784|NCT02565706|26209449|P1|Overall Study|Lost to Follow-up|72
7541785|NCT02565706|26209446|P4|Overall Study|Withdrawal by Subject|11
7541786|NCT02565706|26209447|P3|Overall Study|Withdrawal by Subject|7
7541787|NCT02565706|26209448|P2|Overall Study|Withdrawal by Subject|7
7541788|NCT02565706|26209449|P1|Overall Study|Withdrawal by Subject|5
7541789|NCT02565615|26209555|P5|Overall Study|Untreated|567
7541790|NCT02565615|26209556|P4|Overall Study|Untreated|0
7541791|NCT02565615|26209557|P3|Overall Study|Untreated|0
7541792|NCT02565615|26209558|P2|Overall Study|Untreated|0
7541793|NCT02565615|26209559|P1|Overall Study|Untreated|0
7541794|NCT02565615|26209555|P5|Overall Study|Adverse Event|9
7541795|NCT02565615|26209556|P4|Overall Study|Adverse Event|0
7541796|NCT02565615|26209557|P3|Overall Study|Adverse Event|0
7541797|NCT02565615|26209558|P2|Overall Study|Adverse Event|1
7541798|NCT02565615|26209559|P1|Overall Study|Adverse Event|1
7541799|NCT02565615|26209555|P5|Overall Study|Reason not defined|62
7541800|NCT02565615|26209556|P4|Overall Study|Reason not defined|1
7541801|NCT02565615|26209557|P3|Overall Study|Reason not defined|0
7541802|NCT02565615|26209558|P2|Overall Study|Reason not defined|2
7541803|NCT02565615|26209559|P1|Overall Study|Reason not defined|0
7541804|NCT02565615|26209555|P5|Overall Study|Not meeting eligibility criteria|25
7541805|NCT02565615|26209556|P4|Overall Study|Not meeting eligibility criteria|0
7541806|NCT02565615|26209557|P3|Overall Study|Not meeting eligibility criteria|0
7541807|NCT02565615|26209558|P2|Overall Study|Not meeting eligibility criteria|7
7541808|NCT02565615|26209559|P1|Overall Study|Not meeting eligibility criteria|0
7541809|NCT02565615|26209555|P5|Overall Study|Lost to Follow-up|765
7541810|NCT02565615|26209556|P4|Overall Study|Lost to Follow-up|1
7541811|NCT02565615|26209557|P3|Overall Study|Lost to Follow-up|0
7541812|NCT02565615|26209558|P2|Overall Study|Lost to Follow-up|4
7541813|NCT02565615|26209559|P1|Overall Study|Lost to Follow-up|0
7541814|NCT02565615|26209555|P5|Overall Study|Not willing to participate in study|169
7541815|NCT02565615|26209556|P4|Overall Study|Not willing to participate in study|1
7541816|NCT02565615|26209557|P3|Overall Study|Not willing to participate in study|0
7541817|NCT02565615|26209558|P2|Overall Study|Not willing to participate in study|21
7541818|NCT02565615|26209559|P1|Overall Study|Not willing to participate in study|2
7541819|NCT02565615|26209555|P5|Overall Study|Death|4
7541820|NCT02565615|26209556|P4|Overall Study|Death|0
7541821|NCT02565615|26209557|P3|Overall Study|Death|0
7541822|NCT02565615|26209558|P2|Overall Study|Death|1
7541823|NCT02565615|26209559|P1|Overall Study|Death|0
7541824|NCT02565576|26209673|P2|Overall Study|Adverse Event|0
7541825|NCT02565576|26209674|P1|Overall Study|Adverse Event|1
7541826|NCT02565576|26209673|P2|Overall Study|Death|2
7541827|NCT02565576|26209674|P1|Overall Study|Death|0
7541828|NCT02565576|26209673|P2|Overall Study|Lost to Follow-up|0
7541829|NCT02565576|26209674|P1|Overall Study|Lost to Follow-up|1
7541830|NCT02565576|26209673|P2|Overall Study|subject / guardian decision|3
7541831|NCT02565576|26209674|P1|Overall Study|subject / guardian decision|1
7541832|NCT02565576|26209673|P2|Overall Study|abnormal lab value|0
7541833|NCT02565576|26209674|P1|Overall Study|abnormal lab value|2
7541834|NCT02565511|26209703|P4|Overall Study|Protocol deviation|0
7541835|NCT02565511|26209704|P3|Overall Study|Protocol deviation|3
7541836|NCT02565511|26209705|P2|Overall Study|Protocol deviation|0
7541837|NCT02565511|26209706|P1|Overall Study|Protocol deviation|0
7541838|NCT02565511|26209703|P4|Overall Study|Physician Decision|1
7541839|NCT02565511|26209704|P3|Overall Study|Physician Decision|0
7541840|NCT02565511|26209705|P2|Overall Study|Physician Decision|0
7541841|NCT02565511|26209706|P1|Overall Study|Physician Decision|0
7541842|NCT02565511|26209703|P4|Overall Study|Lost to Follow-up|1
7541843|NCT02565511|26209704|P3|Overall Study|Lost to Follow-up|0
7541844|NCT02565511|26209705|P2|Overall Study|Lost to Follow-up|1
7541845|NCT02565511|26209706|P1|Overall Study|Lost to Follow-up|4
7541846|NCT02565511|26209703|P4|Overall Study|Adverse Event|1
7541847|NCT02565511|26209704|P3|Overall Study|Adverse Event|1
7541848|NCT02565511|26209705|P2|Overall Study|Adverse Event|0
7541849|NCT02565511|26209706|P1|Overall Study|Adverse Event|0
7541850|NCT02565511|26209703|P4|Overall Study|Withdrawal by Subject|5
7541851|NCT02565511|26209704|P3|Overall Study|Withdrawal by Subject|12
7541852|NCT02565511|26209705|P2|Overall Study|Withdrawal by Subject|0
7541853|NCT02565511|26209706|P1|Overall Study|Withdrawal by Subject|3
7541854|NCT02565511|26209703|P4|Overall Study|Study terminated by Sponsor|156
7541855|NCT02565511|26209704|P3|Overall Study|Study terminated by Sponsor|235
7541856|NCT02565511|26209705|P2|Overall Study|Study terminated by Sponsor|22
7541857|NCT02565511|26209706|P1|Overall Study|Study terminated by Sponsor|35
7541858|NCT02565381|26209798|P3|Overall Study|Lost to Follow-up|1
7541859|NCT02565381|26209799|P2|Overall Study|Lost to Follow-up|0
7541860|NCT02565381|26209800|P1|Overall Study|Lost to Follow-up|1
7541861|NCT02565186|26209840|P2|Overall Study|Did Not Receive Study Drug|86
7541862|NCT02565186|26209841|P1|Overall Study|Did Not Receive Study Drug|55
7541863|NCT02565186|26209840|P2|Overall Study|Missing|0
7541864|NCT02565186|26209841|P1|Overall Study|Missing|1
7541865|NCT02565186|26209840|P2|Overall Study|Sponsor Request|9
7541866|NCT02565186|26209841|P1|Overall Study|Sponsor Request|5
7541867|NCT02565186|26209840|P2|Overall Study|Physician Decision|16
7541868|NCT02565186|26209841|P1|Overall Study|Physician Decision|18
7541869|NCT02565186|26209840|P2|Overall Study|Withdrawal by Subject|214
7541870|NCT02565186|26209841|P1|Overall Study|Withdrawal by Subject|229
7541871|NCT02565186|26209840|P2|Overall Study|Non-Compliance|55
7541872|NCT02565186|26209841|P1|Overall Study|Non-Compliance|57
7541873|NCT02565186|26209840|P2|Overall Study|Lost to Follow-up|93
7541874|NCT02565186|26209841|P1|Overall Study|Lost to Follow-up|102
7541875|NCT02565186|26209840|P2|Overall Study|Adverse Event|148
7541876|NCT02565186|26209841|P1|Overall Study|Adverse Event|113
7541877|NCT02565147|26209855|P2|Overall Study|Death|1
7541878|NCT02565147|26209856|P1|Overall Study|Death|1
7541879|NCT02565147|26209855|P2|Overall Study|Lost to Follow-up|1
7541880|NCT02565147|26209856|P1|Overall Study|Lost to Follow-up|0
7541881|NCT02565147|26209855|P2|Overall Study|Withdrawal by Subject|1
7541882|NCT02565147|26209856|P1|Overall Study|Withdrawal by Subject|5
7541883|NCT02565108|26209880|P2|Overall Study|Withdrew Consent|0
7541884|NCT02565108|26209881|P1|Overall Study|Withdrew Consent|1
7541885|NCT02565108|26209880|P2|Overall Study|Adverse Event|0
7541886|NCT02565108|26209881|P1|Overall Study|Adverse Event|1
7541887|NCT02564952|26209897|P1|Overall Study|Participant Met Withdrawal Criteria|1
7541888|NCT02564952|26209897|P1|Overall Study|Low Efficacy|1
7541889|NCT02564952|26209897|P1|Overall Study|Withdrawal by Subject|1
7541890|NCT02564952|26209897|P1|Overall Study|Participant Withdrawn by Investigator|1
7541891|NCT02564952|26209897|P1|Overall Study|Lost to Follow-up|1
7541892|NCT02564952|26209897|P1|Overall Study|Adverse Event|6
7542058|NCT02564887|26210136|P2|Overall Study|Lost to Follow-up|0
7542059|NCT02564887|26210137|P1|Overall Study|Lost to Follow-up|6
7542060|NCT02564718|26210155|P2|Overall Study|Withdrew from treatment|1
7542061|NCT02564718|26210156|P1|Overall Study|Withdrew from treatment|0
7542062|NCT02564471|26210209|P4|Overall Study|Lost to Follow-up|0
7542063|NCT02564471|26210210|P3|Overall Study|Lost to Follow-up|0
7542064|NCT02564471|26210211|P2|Overall Study|Lost to Follow-up|2
7542065|NCT02564471|26210212|P1|Overall Study|Lost to Follow-up|0
7542066|NCT02564471|26210209|P4|Overall Study|Withdrawal by Subject|0
7542067|NCT02564471|26210210|P3|Overall Study|Withdrawal by Subject|3
7542068|NCT02564471|26210211|P2|Overall Study|Withdrawal by Subject|1
7542069|NCT02564471|26210212|P1|Overall Study|Withdrawal by Subject|2
7542070|NCT02564471|26210209|P4|Overall Study|Adverse Event|0
7542071|NCT02564471|26210210|P3|Overall Study|Adverse Event|0
7542072|NCT02564471|26210211|P2|Overall Study|Adverse Event|0
7542073|NCT02564471|26210212|P1|Overall Study|Adverse Event|1
7542074|NCT02564263|26210273|P2|Overall Study|Ongoing in Study|25
7542075|NCT02564263|26210274|P1|Overall Study|Ongoing in Study|42
7542076|NCT02564263|26210273|P2|Overall Study|Withdrawal by Subject|18
7542077|NCT02564263|26210274|P1|Overall Study|Withdrawal by Subject|5
7542078|NCT02564263|26210273|P2|Overall Study|Death|242
7542079|NCT02564263|26210274|P1|Overall Study|Death|236
7542080|NCT02564263|26210273|P2|Overall Study|Adverse Event|29
7542081|NCT02564263|26210274|P1|Overall Study|Adverse Event|31
7542082|NCT02564211|26210296|P1|Overall Study|Adverse Event|4
7542083|NCT02564198|26210305|P3|Overall Study|Adverse Event|0
7542084|NCT02564198|26210306|P2|Overall Study|Adverse Event|1
7542085|NCT02564198|26210307|P1|Overall Study|Adverse Event|0
7542086|NCT02564198|26210305|P3|Overall Study|Withdrawal by Subject|0
7542087|NCT02564198|26210306|P2|Overall Study|Withdrawal by Subject|4
7542088|NCT02564198|26210307|P1|Overall Study|Withdrawal by Subject|2
7542089|NCT02564120|26210336|P1|Overall Study|Other medical condition|24
7542090|NCT02564120|26210336|P1|Overall Study|Withdrawal by Subject|204
7542091|NCT02564120|26210336|P1|Overall Study|Death|58
7542092|NCT02564120|26210336|P1|Overall Study|Did not return release forms|160
7542093|NCT02564055|26210384|P6|Overall Study|Withdrawal by Subject|10
7542094|NCT02564055|26210385|P5|Overall Study|Withdrawal by Subject|10
7542095|NCT02564055|26210386|P4|Overall Study|Withdrawal by Subject|3
7542096|NCT02564055|26210387|P3|Overall Study|Withdrawal by Subject|3
7542097|NCT02564055|26210388|P2|Overall Study|Withdrawal by Subject|4
7542098|NCT02564055|26210389|P1|Overall Study|Withdrawal by Subject|4
7542099|NCT02564055|26210384|P6|Overall Study|Physician Decision|0
7542100|NCT02564055|26210385|P5|Overall Study|Physician Decision|0
7542101|NCT02564055|26210386|P4|Overall Study|Physician Decision|0
7542102|NCT02564055|26210387|P3|Overall Study|Physician Decision|1
7542103|NCT02564055|26210388|P2|Overall Study|Physician Decision|0
7542104|NCT02564055|26210389|P1|Overall Study|Physician Decision|0
7542105|NCT02564055|26210384|P6|Overall Study|Lost to Follow-up|0
7542106|NCT02564055|26210385|P5|Overall Study|Lost to Follow-up|1
7542107|NCT02564055|26210386|P4|Overall Study|Lost to Follow-up|2
7542108|NCT02564055|26210387|P3|Overall Study|Lost to Follow-up|4
7542109|NCT02564055|26210388|P2|Overall Study|Lost to Follow-up|1
7542110|NCT02564055|26210389|P1|Overall Study|Lost to Follow-up|0
7542111|NCT02564055|26210384|P6|Overall Study|Reached stopping criteria|1
7542112|NCT02564055|26210385|P5|Overall Study|Reached stopping criteria|0
7542113|NCT02564055|26210386|P4|Overall Study|Reached stopping criteria|0
7542114|NCT02564055|26210387|P3|Overall Study|Reached stopping criteria|0
7542115|NCT02564055|26210388|P2|Overall Study|Reached stopping criteria|0
7542116|NCT02564055|26210389|P1|Overall Study|Reached stopping criteria|0
7542117|NCT02564055|26210384|P6|Overall Study|Protocol Violation|0
7542118|NCT02564055|26210385|P5|Overall Study|Protocol Violation|0
7542119|NCT02564055|26210386|P4|Overall Study|Protocol Violation|0
7542120|NCT02564055|26210387|P3|Overall Study|Protocol Violation|0
7542121|NCT02564055|26210388|P2|Overall Study|Protocol Violation|0
7542122|NCT02564055|26210389|P1|Overall Study|Protocol Violation|1
7542123|NCT02564055|26210384|P6|Overall Study|Adverse Event|1
7542124|NCT02564055|26210385|P5|Overall Study|Adverse Event|4
7542125|NCT02564055|26210386|P4|Overall Study|Adverse Event|1
7542126|NCT02564055|26210387|P3|Overall Study|Adverse Event|4
7542127|NCT02564055|26210388|P2|Overall Study|Adverse Event|0
7542128|NCT02564055|26210389|P1|Overall Study|Adverse Event|1
7542129|NCT02564042|26210643|P6|Overall Study|Withdrawal by Subject|12
7542130|NCT02564042|26210644|P5|Overall Study|Withdrawal by Subject|10
7542131|NCT02564042|26210645|P4|Overall Study|Withdrawal by Subject|2
7542132|NCT02564042|26210646|P3|Overall Study|Withdrawal by Subject|2
7542133|NCT02564042|26210647|P2|Overall Study|Withdrawal by Subject|3
7542134|NCT02564042|26210648|P1|Overall Study|Withdrawal by Subject|5
7542135|NCT02564042|26210643|P6|Overall Study|Physician Decision|0
7542136|NCT02564042|26210644|P5|Overall Study|Physician Decision|0
7542137|NCT02564042|26210645|P4|Overall Study|Physician Decision|1
7542138|NCT02564042|26210646|P3|Overall Study|Physician Decision|0
7542139|NCT02564042|26210647|P2|Overall Study|Physician Decision|0
7542140|NCT02564042|26210648|P1|Overall Study|Physician Decision|1
7542141|NCT02564042|26210643|P6|Overall Study|Lost to Follow-up|1
7542142|NCT02564042|26210644|P5|Overall Study|Lost to Follow-up|1
7542143|NCT02564042|26210645|P4|Overall Study|Lost to Follow-up|0
7542144|NCT02564042|26210646|P3|Overall Study|Lost to Follow-up|1
7542145|NCT02564042|26210647|P2|Overall Study|Lost to Follow-up|1
7542146|NCT02564042|26210648|P1|Overall Study|Lost to Follow-up|1
7542147|NCT02564042|26210643|P6|Overall Study|Adverse Event|1
7542148|NCT02564042|26210644|P5|Overall Study|Adverse Event|0
7542149|NCT02564042|26210645|P4|Overall Study|Adverse Event|0
7542150|NCT02564042|26210646|P3|Overall Study|Adverse Event|3
7542151|NCT02564042|26210647|P2|Overall Study|Adverse Event|4
7542152|NCT02564042|26210648|P1|Overall Study|Adverse Event|4
7542153|NCT02563899|26210943|P4|Overall Study|Withdrawal by Subject|0
7542154|NCT02563899|26210944|P3|Overall Study|Withdrawal by Subject|1
7542155|NCT02563899|26210945|P2|Overall Study|Withdrawal by Subject|0
7542156|NCT02563899|26210946|P1|Overall Study|Withdrawal by Subject|0
7542157|NCT02563899|26210943|P4|Overall Study|Protocol Violation|0
7542158|NCT02563899|26210944|P3|Overall Study|Protocol Violation|0
7542159|NCT02563899|26210945|P2|Overall Study|Protocol Violation|0
7542160|NCT02563899|26210946|P1|Overall Study|Protocol Violation|1
7542182|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7542183|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
7542184|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7542185|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7542186|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7542187|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7542188|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
7542189|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7542190|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7542191|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7542192|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7542193|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7542194|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
7542195|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7542196|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7542197|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7542198|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7542199|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7542200|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
7542201|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7542202|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7542203|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7542204|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7542205|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7542206|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
7542207|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
7542208|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7542209|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7542210|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7542211|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7542212|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7542213|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
7542214|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7542215|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7542216|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7542217|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7542218|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
7542219|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
7542220|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7542221|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7542222|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7542223|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7542224|NCT02563548|26211047|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
7542225|NCT02563548|26211048|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
7542226|NCT02563548|26211049|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7542227|NCT02563548|26211050|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7542228|NCT02563548|26211051|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7542229|NCT02563548|26211052|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7542230|NCT02563548|26211047|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7542231|NCT02563548|26211048|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7542232|NCT02563548|26211049|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
7542233|NCT02563548|26211050|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
7542234|NCT02563548|26211051|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7542235|NCT02563548|26211052|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7542236|NCT02563548|26211047|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7542237|NCT02563548|26211048|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7542238|NCT02563548|26211049|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7542239|NCT02563548|26211050|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
7542240|NCT02563548|26211051|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7542241|NCT02563548|26211052|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7542242|NCT02563548|26211047|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7542243|NCT02563548|26211048|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7542244|NCT02563548|26211049|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7542245|NCT02563548|26211050|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7542246|NCT02563548|26211051|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7542247|NCT02563548|26211052|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
7542248|NCT02563548|26211047|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7542249|NCT02563548|26211048|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7542250|NCT02563548|26211049|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
7542251|NCT02563548|26211050|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7542252|NCT02563548|26211051|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7542253|NCT02563548|26211052|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
7542254|NCT02563106|26211161|P2|Overall Study|Other reason - not specified|1
7542255|NCT02563106|26211162|P1|Overall Study|Other reason - not specified|2
7542256|NCT02563106|26211161|P2|Overall Study|Physician Decision|1
7542257|NCT02563106|26211162|P1|Overall Study|Physician Decision|3
7542258|NCT02563106|26211161|P2|Overall Study|Lost to Follow-up|2
7542259|NCT02563106|26211162|P1|Overall Study|Lost to Follow-up|3
7542260|NCT02563106|26211161|P2|Overall Study|Use of non-permitted concurrent therapy|2
7542261|NCT02563106|26211162|P1|Overall Study|Use of non-permitted concurrent therapy|1
7542262|NCT02563106|26211161|P2|Overall Study|Protocol Violation|0
7542263|NCT02563106|26211162|P1|Overall Study|Protocol Violation|1
7542264|NCT02563106|26211161|P2|Overall Study|Adverse Event|15
7542265|NCT02563106|26211162|P1|Overall Study|Adverse Event|17
7542266|NCT02563106|26211161|P2|Overall Study|Withdrawal by Subject|8
7542267|NCT02563106|26211162|P1|Overall Study|Withdrawal by Subject|7
7542268|NCT02563067|26211204|P3|Overall Study|Death post Treatment/safety period|0
7542269|NCT02563067|26211205|P2|Overall Study|Death post Treatment/safety period|0
7542270|NCT02563067|26211206|P1|Overall Study|Death post Treatment/safety period|1
7542271|NCT02563067|26211204|P3|Overall Study|Adverse Event|0
7542272|NCT02563067|26211205|P2|Overall Study|Adverse Event|1
7542273|NCT02563067|26211206|P1|Overall Study|Adverse Event|2
7542274|NCT02563067|26211204|P3|Overall Study|Death|1
7542275|NCT02563067|26211205|P2|Overall Study|Death|1
7542276|NCT02563067|26211206|P1|Overall Study|Death|0
7542277|NCT02563067|26211204|P3|Overall Study|Lack of Efficacy|0
7542278|NCT02563067|26211205|P2|Overall Study|Lack of Efficacy|0
7542279|NCT02563067|26211206|P1|Overall Study|Lack of Efficacy|1
7542280|NCT02563067|26211204|P3|Overall Study|Technical problems|0
7542281|NCT02563067|26211205|P2|Overall Study|Technical problems|1
7542282|NCT02563067|26211206|P1|Overall Study|Technical problems|0
7542283|NCT02563067|26211204|P3|Overall Study|Lost to Follow-up|0
7542284|NCT02563067|26211205|P2|Overall Study|Lost to Follow-up|2
7542285|NCT02563067|26211206|P1|Overall Study|Lost to Follow-up|1
7542286|NCT02563067|26211204|P3|Overall Study|Physician Decision|3
7542287|NCT02563067|26211205|P2|Overall Study|Physician Decision|1
7542288|NCT02563067|26211206|P1|Overall Study|Physician Decision|0
7542289|NCT02563067|26211204|P3|Overall Study|Subject/guardian decision|16
7542290|NCT02563067|26211205|P2|Overall Study|Subject/guardian decision|20
7542291|NCT02563067|26211206|P1|Overall Study|Subject/guardian decision|14
7542292|NCT02563028|26211238|P1|Overall Study|Unable to elicit VEP post induction|1
7542293|NCT02563028|26211238|P1|Overall Study|Lack of equipment|1
7542294|NCT02562716|26211325|P2|Overall Study|Not protocol specified|2
7542295|NCT02562716|26211326|P1|Overall Study|Not protocol specified|4
7542296|NCT02562716|26211325|P2|Overall Study|Death|1
7542297|NCT02562716|26211326|P1|Overall Study|Death|2
7542298|NCT02562716|26211325|P2|Overall Study|Progression|10
7542299|NCT02562716|26211326|P1|Overall Study|Progression|8
7542300|NCT02562716|26211325|P2|Overall Study|Withdrawal unrelated to AE|1
7542301|NCT02562716|26211326|P1|Overall Study|Withdrawal unrelated to AE|7
7542302|NCT02562716|26211325|P2|Overall Study|Adverse Event|14
7542303|NCT02562716|26211326|P1|Overall Study|Adverse Event|7
7542304|NCT02562482|26211365|P2|Overall Study|Illness/Injury unrelated to product|1
7542305|NCT02562482|26211366|P1|Overall Study|Illness/Injury unrelated to product|0
7542306|NCT02562482|26211365|P2|Overall Study|Physician Decision|3
7542307|NCT02562482|26211366|P1|Overall Study|Physician Decision|1
7542308|NCT02562482|26211365|P2|Overall Study|Withdrawal by Subject|3
7542309|NCT02562482|26211366|P1|Overall Study|Withdrawal by Subject|5
7542310|NCT02562482|26211365|P2|Overall Study|Moved from area|3
7542311|NCT02562482|26211366|P1|Overall Study|Moved from area|2
7542312|NCT02562482|26211365|P2|Overall Study|Lost to Follow-up|6
7542313|NCT02562482|26211366|P1|Overall Study|Lost to Follow-up|9
7542314|NCT02562482|26211365|P2|Overall Study|Enrolled, but did not receive product|0
7542315|NCT02562482|26211366|P1|Overall Study|Enrolled, but did not receive product|4
7542317|NCT02561962|26211480|P9|Overall Study|Lost to Follow-up|0
7542318|NCT02561962|26211481|P8|Overall Study|Lost to Follow-up|0
7542319|NCT02561962|26211482|P7|Overall Study|Lost to Follow-up|0
7542320|NCT02561962|26211483|P6|Overall Study|Lost to Follow-up|1
7542321|NCT02561962|26211484|P5|Overall Study|Lost to Follow-up|0
7542322|NCT02561962|26211485|P4|Overall Study|Lost to Follow-up|0
7542323|NCT02561962|26211486|P3|Overall Study|Lost to Follow-up|0
7542324|NCT02561962|26211487|P2|Overall Study|Lost to Follow-up|0
7542325|NCT02561962|26211488|P1|Overall Study|Lost to Follow-up|0
7542326|NCT02561962|26211480|P9|Overall Study|Decision by sponsor|0
7542327|NCT02561962|26211481|P8|Overall Study|Decision by sponsor|3
7542328|NCT02561962|26211482|P7|Overall Study|Decision by sponsor|0
7542329|NCT02561962|26211483|P6|Overall Study|Decision by sponsor|1
7542330|NCT02561962|26211484|P5|Overall Study|Decision by sponsor|1
7542331|NCT02561962|26211485|P4|Overall Study|Decision by sponsor|0
7542332|NCT02561962|26211486|P3|Overall Study|Decision by sponsor|0
7542333|NCT02561962|26211487|P2|Overall Study|Decision by sponsor|0
7542334|NCT02561962|26211488|P1|Overall Study|Decision by sponsor|0
7542335|NCT02561962|26211480|P9|Overall Study|Withdrawal by Subject|0
7542336|NCT02561962|26211481|P8|Overall Study|Withdrawal by Subject|1
7542337|NCT02561962|26211482|P7|Overall Study|Withdrawal by Subject|2
7542338|NCT02561962|26211483|P6|Overall Study|Withdrawal by Subject|1
7542339|NCT02561962|26211484|P5|Overall Study|Withdrawal by Subject|1
7542340|NCT02561962|26211485|P4|Overall Study|Withdrawal by Subject|0
7542341|NCT02561962|26211486|P3|Overall Study|Withdrawal by Subject|0
7542342|NCT02561962|26211487|P2|Overall Study|Withdrawal by Subject|0
7542343|NCT02561962|26211488|P1|Overall Study|Withdrawal by Subject|1
7542344|NCT02561962|26211480|P9|Overall Study|Ongoing in study|1
7542345|NCT02561962|26211481|P8|Overall Study|Ongoing in study|4
7542346|NCT02561962|26211482|P7|Overall Study|Ongoing in study|0
7542347|NCT02561962|26211483|P6|Overall Study|Ongoing in study|1
7542348|NCT02561962|26211484|P5|Overall Study|Ongoing in study|0
7542349|NCT02561962|26211485|P4|Overall Study|Ongoing in study|1
7542350|NCT02561962|26211486|P3|Overall Study|Ongoing in study|0
7542351|NCT02561962|26211487|P2|Overall Study|Ongoing in study|0
7542352|NCT02561962|26211488|P1|Overall Study|Ongoing in study|1
7542353|NCT02561832|26211530|P2|Overall Study|Disease progression|3
7542354|NCT02561832|26211531|P1|Overall Study|Disease progression|3
7542355|NCT02561832|26211530|P2|Overall Study|Adverse Event|0
7542356|NCT02561832|26211531|P1|Overall Study|Adverse Event|3
7542357|NCT02561832|26211530|P2|Overall Study|Withdrawal by Subject|1
7542358|NCT02561832|26211531|P1|Overall Study|Withdrawal by Subject|1
7542359|NCT02561806|26211539|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
7542360|NCT02561806|26211540|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
7542361|NCT02561806|26211539|P2|Post-Treatment Follow-up|Lost to Follow-up|1
7542362|NCT02561806|26211540|P1|Post-Treatment Follow-up|Lost to Follow-up|1
7542363|NCT02561806|26211539|P2|Maintenance Period|Site staff became unblinded|1
7542364|NCT02561806|26211540|P1|Maintenance Period|Site staff became unblinded|0
7542365|NCT02561806|26211539|P2|Maintenance Period|Withdrawal by Subject|3
7542366|NCT02561806|26211540|P1|Maintenance Period|Withdrawal by Subject|5
7542367|NCT02561806|26211539|P2|Maintenance Period|Protocol Violation|0
7542368|NCT02561806|26211540|P1|Maintenance Period|Protocol Violation|1
7542369|NCT02561806|26211539|P2|Maintenance Period|Lost to Follow-up|2
7542370|NCT02561806|26211540|P1|Maintenance Period|Lost to Follow-up|2
7542371|NCT02561806|26211539|P2|Maintenance Period|Lack of Efficacy|1
7542372|NCT02561806|26211540|P1|Maintenance Period|Lack of Efficacy|3
7542373|NCT02561806|26211539|P2|Maintenance Period|Adverse Event|1
7542374|NCT02561806|26211540|P1|Maintenance Period|Adverse Event|2
7542375|NCT02561806|26211539|P2|Induction Period|Randomized but not treated|1
7542376|NCT02561806|26211540|P1|Induction Period|Randomized but not treated|0
7542377|NCT02561806|26211539|P2|Induction Period|Site staff became unblinded|0
7542378|NCT02561806|26211540|P1|Induction Period|Site staff became unblinded|1
7542379|NCT02561806|26211539|P2|Induction Period|Withdrawal by Subject|2
7542380|NCT02561806|26211540|P1|Induction Period|Withdrawal by Subject|0
7542381|NCT02561806|26211539|P2|Induction Period|Lack of Efficacy|0
7542382|NCT02561806|26211540|P1|Induction Period|Lack of Efficacy|1
7542383|NCT02561806|26211539|P2|Induction Period|Adverse Event|2
7542384|NCT02561806|26211540|P1|Induction Period|Adverse Event|0
7542385|NCT02561572|26211644|P2|Overall Study|Protocol Violation|1
7542386|NCT02561572|26211645|P1|Overall Study|Protocol Violation|0
7542387|NCT02561572|26211644|P2|Overall Study|Inadequate time before surgery|1
7542388|NCT02561572|26211645|P1|Overall Study|Inadequate time before surgery|2
7542389|NCT02561455|26211706|P4|Overall Study|Disease Progression|0
7542390|NCT02561455|26211707|P3|Overall Study|Disease Progression|0
7542391|NCT02561455|26211708|P2|Overall Study|Disease Progression|1
7542392|NCT02561455|26211709|P1|Overall Study|Disease Progression|0
7542393|NCT02561455|26211706|P4|Overall Study|Withdrawal by Subject|0
7542394|NCT02561455|26211707|P3|Overall Study|Withdrawal by Subject|1
7542395|NCT02561455|26211708|P2|Overall Study|Withdrawal by Subject|0
7542396|NCT02561455|26211709|P1|Overall Study|Withdrawal by Subject|1
7542397|NCT02561455|26211706|P4|Overall Study|Participant Transitioned to Commercial Drug|1
7542398|NCT02561455|26211707|P3|Overall Study|Participant Transitioned to Commercial Drug|2
7542399|NCT02561455|26211708|P2|Overall Study|Participant Transitioned to Commercial Drug|1
7542400|NCT02561455|26211709|P1|Overall Study|Participant Transitioned to Commercial Drug|1
7542401|NCT02561299|26211761|P2|Overall Study|Withdrawal by Subject|2
7542402|NCT02561299|26211762|P1|Overall Study|Withdrawal by Subject|2
7542403|NCT02561299|26211761|P2|Overall Study|Lost to Follow-up|0
7542404|NCT02561299|26211762|P1|Overall Study|Lost to Follow-up|1
7542405|NCT02561299|26211761|P2|Overall Study|Death|4
7542406|NCT02561299|26211762|P1|Overall Study|Death|2
7542407|NCT02561273|26211780|P2|Overall Study|Protocol Violation|0
7542408|NCT02561273|26211781|P1|Overall Study|Protocol Violation|1
7542409|NCT02561247|26211793|P1|Overall Study|Two filter changes required within the first 24 hours.|4
7542410|NCT02561247|26211793|P1|Overall Study|Withdrawal by Subject|1
7542411|NCT02561247|26211793|P1|Overall Study|Protocol Violation|1
7542412|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|Protocol Violation|1
7542413|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|Protocol Violation|0
7542414|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|Protocol Violation|1
7542415|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|Protocol Violation|2
7542416|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|Protocol Violation|0
7542417|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|Protocol Violation|0
7542418|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|Protocol Violation|0
7542419|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|Protocol Violation|1
7542420|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|Protocol Violation|0
7542421|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|Protocol Violation|0
7542422|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|Protocol Violation|0
7542423|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|Protocol Violation|0
7542424|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|Protocol Violation|0
7542425|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|Protocol Violation|0
7542426|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|Other|0
7542427|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|Other|1
7542428|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|Other|2
7542429|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|Other|2
7542430|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|Other|0
7542431|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|Other|0
7542432|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|Other|0
7542433|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|Other|0
7542434|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|Other|0
7542435|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|Other|0
7542436|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|Other|0
7542437|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|Other|0
7542438|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|Other|0
7542439|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|Other|0
7542440|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7542441|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7542442|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7542443|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542444|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542445|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542446|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542447|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542448|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542449|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542450|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542451|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542452|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542453|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7542454|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7542455|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7542456|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7542457|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7542458|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542459|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542460|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7542461|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7542462|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542463|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542464|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542465|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542466|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542467|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7542468|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|Death|0
7542469|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|Death|0
7542470|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|Death|0
7542471|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|Death|0
7542472|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|Death|1
7542473|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|Death|0
7542474|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|Death|0
7542475|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|Death|0
7542476|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|Death|0
7542477|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|Death|0
7542478|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|Death|0
7542479|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|Death|0
7542480|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|Death|0
7542481|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|Death|0
7542482|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|Adverse Event|2
7542483|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|Adverse Event|0
7542484|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|Adverse Event|0
7542485|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|Adverse Event|0
7542486|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|Adverse Event|0
7542487|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|Adverse Event|0
7542488|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|Adverse Event|0
7542489|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|Adverse Event|0
7542490|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|Adverse Event|0
7542491|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|Adverse Event|0
7542492|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|Adverse Event|0
7542493|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|Adverse Event|0
7542494|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|Adverse Event|0
7542495|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|Adverse Event|0
7542496|NCT02561195|26211862|P14|Extension Stage (Vaccination 4)|Withdrew consent|0
7542497|NCT02561195|26211863|P13|Extension Stage (Vaccination 4)|Withdrew consent|3
7542498|NCT02561195|26211864|P12|Extension Stage (Vaccination 4)|Withdrew consent|2
7542499|NCT02561195|26211865|P11|Extension Stage (Vaccination 4)|Withdrew consent|2
7542500|NCT02561195|26211866|P10|Extension Stage (Vaccination 4)|Withdrew consent|1
7542501|NCT02561195|26211867|P9|Extension Stage (Vaccination 4)|Withdrew consent|3
7542502|NCT02561195|26211868|P8|Extension Stage (Vaccination 4)|Withdrew consent|0
7542503|NCT02561195|26211869|P7|Extension Stage (Vaccination 4)|Withdrew consent|0
7542504|NCT02561195|26211870|P6|Extension Stage (Vaccination 4)|Withdrew consent|0
7542505|NCT02561195|26211871|P5|Extension Stage (Vaccination 4)|Withdrew consent|0
7542506|NCT02561195|26211872|P4|Extension Stage (Vaccination 4)|Withdrew consent|0
7542507|NCT02561195|26211873|P3|Extension Stage (Vaccination 4)|Withdrew consent|0
7542508|NCT02561195|26211874|P2|Extension Stage (Vaccination 4)|Withdrew consent|0
7542509|NCT02561195|26211875|P1|Extension Stage (Vaccination 4)|Withdrew consent|0
7542510|NCT02561195|26211862|P14|Vaccination 1 to 3|Randomized but not treated|0
7542511|NCT02561195|26211863|P13|Vaccination 1 to 3|Randomized but not treated|0
7542512|NCT02561195|26211864|P12|Vaccination 1 to 3|Randomized but not treated|0
7542513|NCT02561195|26211865|P11|Vaccination 1 to 3|Randomized but not treated|0
7542514|NCT02561195|26211866|P10|Vaccination 1 to 3|Randomized but not treated|0
7542515|NCT02561195|26211867|P9|Vaccination 1 to 3|Randomized but not treated|0
7542516|NCT02561195|26211868|P8|Vaccination 1 to 3|Randomized but not treated|0
7542517|NCT02561195|26211869|P7|Vaccination 1 to 3|Randomized but not treated|0
7542518|NCT02561195|26211870|P6|Vaccination 1 to 3|Randomized but not treated|0
7542519|NCT02561195|26211871|P5|Vaccination 1 to 3|Randomized but not treated|0
7542520|NCT02561195|26211872|P4|Vaccination 1 to 3|Randomized but not treated|0
7542521|NCT02561195|26211873|P3|Vaccination 1 to 3|Randomized but not treated|0
7542522|NCT02561195|26211874|P2|Vaccination 1 to 3|Randomized but not treated|0
7542523|NCT02561195|26211875|P1|Vaccination 1 to 3|Randomized but not treated|1
7542524|NCT02561195|26211862|P14|Vaccination 1 to 3|Withdrawal by Subject|0
7542525|NCT02561195|26211863|P13|Vaccination 1 to 3|Withdrawal by Subject|0
7542526|NCT02561195|26211864|P12|Vaccination 1 to 3|Withdrawal by Subject|0
7542527|NCT02561195|26211865|P11|Vaccination 1 to 3|Withdrawal by Subject|0
7542528|NCT02561195|26211866|P10|Vaccination 1 to 3|Withdrawal by Subject|0
7542529|NCT02561195|26211867|P9|Vaccination 1 to 3|Withdrawal by Subject|0
7542530|NCT02561195|26211868|P8|Vaccination 1 to 3|Withdrawal by Subject|0
7542531|NCT02561195|26211869|P7|Vaccination 1 to 3|Withdrawal by Subject|0
7542532|NCT02561195|26211870|P6|Vaccination 1 to 3|Withdrawal by Subject|0
7542533|NCT02561195|26211871|P5|Vaccination 1 to 3|Withdrawal by Subject|6
7542534|NCT02561195|26211872|P4|Vaccination 1 to 3|Withdrawal by Subject|2
7542535|NCT02561195|26211873|P3|Vaccination 1 to 3|Withdrawal by Subject|4
7542536|NCT02561195|26211874|P2|Vaccination 1 to 3|Withdrawal by Subject|4
7542537|NCT02561195|26211875|P1|Vaccination 1 to 3|Withdrawal by Subject|3
7542538|NCT02561195|26211862|P14|Vaccination 1 to 3|Death|0
7542539|NCT02561195|26211863|P13|Vaccination 1 to 3|Death|0
7542540|NCT02561195|26211864|P12|Vaccination 1 to 3|Death|0
7542541|NCT02561195|26211865|P11|Vaccination 1 to 3|Death|0
7542542|NCT02561195|26211866|P10|Vaccination 1 to 3|Death|0
7542543|NCT02561195|26211867|P9|Vaccination 1 to 3|Death|0
7542544|NCT02561195|26211868|P8|Vaccination 1 to 3|Death|0
7542545|NCT02561195|26211869|P7|Vaccination 1 to 3|Death|0
7542546|NCT02561195|26211870|P6|Vaccination 1 to 3|Death|0
7542547|NCT02561195|26211871|P5|Vaccination 1 to 3|Death|0
7542548|NCT02561195|26211872|P4|Vaccination 1 to 3|Death|2
7542549|NCT02561195|26211873|P3|Vaccination 1 to 3|Death|0
7542550|NCT02561195|26211874|P2|Vaccination 1 to 3|Death|1
7542551|NCT02561195|26211875|P1|Vaccination 1 to 3|Death|2
7542552|NCT02561195|26211862|P14|Vaccination 1 to 3|Protocol Violation|0
7542553|NCT02561195|26211863|P13|Vaccination 1 to 3|Protocol Violation|0
7542554|NCT02561195|26211864|P12|Vaccination 1 to 3|Protocol Violation|0
7542555|NCT02561195|26211865|P11|Vaccination 1 to 3|Protocol Violation|0
7542556|NCT02561195|26211866|P10|Vaccination 1 to 3|Protocol Violation|0
7542557|NCT02561195|26211867|P9|Vaccination 1 to 3|Protocol Violation|0
7542558|NCT02561195|26211868|P8|Vaccination 1 to 3|Protocol Violation|0
7542559|NCT02561195|26211869|P7|Vaccination 1 to 3|Protocol Violation|0
7542560|NCT02561195|26211870|P6|Vaccination 1 to 3|Protocol Violation|2
7542561|NCT02561195|26211871|P5|Vaccination 1 to 3|Protocol Violation|5
7542562|NCT02561195|26211872|P4|Vaccination 1 to 3|Protocol Violation|2
7542563|NCT02561195|26211873|P3|Vaccination 1 to 3|Protocol Violation|1
7542564|NCT02561195|26211874|P2|Vaccination 1 to 3|Protocol Violation|0
7542565|NCT02561195|26211875|P1|Vaccination 1 to 3|Protocol Violation|1
7542566|NCT02561195|26211862|P14|Vaccination 1 to 3|Other|0
7542567|NCT02561195|26211863|P13|Vaccination 1 to 3|Other|0
7542568|NCT02561195|26211864|P12|Vaccination 1 to 3|Other|0
7542569|NCT02561195|26211865|P11|Vaccination 1 to 3|Other|0
7542570|NCT02561195|26211866|P10|Vaccination 1 to 3|Other|0
7542571|NCT02561195|26211867|P9|Vaccination 1 to 3|Other|0
7542572|NCT02561195|26211868|P8|Vaccination 1 to 3|Other|0
7542573|NCT02561195|26211869|P7|Vaccination 1 to 3|Other|0
7542574|NCT02561195|26211870|P6|Vaccination 1 to 3|Other|1
7542575|NCT02561195|26211871|P5|Vaccination 1 to 3|Other|5
7542576|NCT02561195|26211872|P4|Vaccination 1 to 3|Other|7
7542577|NCT02561195|26211873|P3|Vaccination 1 to 3|Other|1
7542578|NCT02561195|26211874|P2|Vaccination 1 to 3|Other|3
7542579|NCT02561195|26211875|P1|Vaccination 1 to 3|Other|7
7542580|NCT02561195|26211862|P14|Vaccination 1 to 3|No longer willing to participate|0
7542581|NCT02561195|26211863|P13|Vaccination 1 to 3|No longer willing to participate|0
7542582|NCT02561195|26211864|P12|Vaccination 1 to 3|No longer willing to participate|0
7542583|NCT02561195|26211865|P11|Vaccination 1 to 3|No longer willing to participate|0
7542584|NCT02561195|26211866|P10|Vaccination 1 to 3|No longer willing to participate|0
7542585|NCT02561195|26211867|P9|Vaccination 1 to 3|No longer willing to participate|0
7542586|NCT02561195|26211868|P8|Vaccination 1 to 3|No longer willing to participate|0
7542587|NCT02561195|26211869|P7|Vaccination 1 to 3|No longer willing to participate|0
7542588|NCT02561195|26211870|P6|Vaccination 1 to 3|No longer willing to participate|3
7542589|NCT02561195|26211871|P5|Vaccination 1 to 3|No longer willing to participate|1
7542590|NCT02561195|26211872|P4|Vaccination 1 to 3|No longer willing to participate|4
7542591|NCT02561195|26211873|P3|Vaccination 1 to 3|No longer willing to participate|0
7542592|NCT02561195|26211874|P2|Vaccination 1 to 3|No longer willing to participate|4
7542593|NCT02561195|26211875|P1|Vaccination 1 to 3|No longer willing to participate|2
7542594|NCT02561195|26211862|P14|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542595|NCT02561195|26211863|P13|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542596|NCT02561195|26211864|P12|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542597|NCT02561195|26211865|P11|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542598|NCT02561195|26211866|P10|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542599|NCT02561195|26211867|P9|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542600|NCT02561195|26211868|P8|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542601|NCT02561195|26211869|P7|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542602|NCT02561195|26211870|P6|Vaccination 1 to 3|No longer meets eligibility criteria|1
7542603|NCT02561195|26211871|P5|Vaccination 1 to 3|No longer meets eligibility criteria|4
7542604|NCT02561195|26211872|P4|Vaccination 1 to 3|No longer meets eligibility criteria|4
7542605|NCT02561195|26211873|P3|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542606|NCT02561195|26211874|P2|Vaccination 1 to 3|No longer meets eligibility criteria|1
7542607|NCT02561195|26211875|P1|Vaccination 1 to 3|No longer meets eligibility criteria|0
7542608|NCT02561195|26211862|P14|Vaccination 1 to 3|Lost to Follow-up|0
7542609|NCT02561195|26211863|P13|Vaccination 1 to 3|Lost to Follow-up|0
7542610|NCT02561195|26211864|P12|Vaccination 1 to 3|Lost to Follow-up|0
7542611|NCT02561195|26211865|P11|Vaccination 1 to 3|Lost to Follow-up|0
7542612|NCT02561195|26211866|P10|Vaccination 1 to 3|Lost to Follow-up|0
7542613|NCT02561195|26211867|P9|Vaccination 1 to 3|Lost to Follow-up|0
7542614|NCT02561195|26211868|P8|Vaccination 1 to 3|Lost to Follow-up|0
7542615|NCT02561195|26211869|P7|Vaccination 1 to 3|Lost to Follow-up|0
7542616|NCT02561195|26211870|P6|Vaccination 1 to 3|Lost to Follow-up|3
7542617|NCT02561195|26211871|P5|Vaccination 1 to 3|Lost to Follow-up|3
7542618|NCT02561195|26211872|P4|Vaccination 1 to 3|Lost to Follow-up|2
7542619|NCT02561195|26211873|P3|Vaccination 1 to 3|Lost to Follow-up|0
7542620|NCT02561195|26211874|P2|Vaccination 1 to 3|Lost to Follow-up|4
7542621|NCT02561195|26211875|P1|Vaccination 1 to 3|Lost to Follow-up|3
7542622|NCT02561195|26211862|P14|Vaccination 1 to 3|Adverse Event|0
7542623|NCT02561195|26211863|P13|Vaccination 1 to 3|Adverse Event|0
7542624|NCT02561195|26211864|P12|Vaccination 1 to 3|Adverse Event|0
7542625|NCT02561195|26211865|P11|Vaccination 1 to 3|Adverse Event|0
7542626|NCT02561195|26211866|P10|Vaccination 1 to 3|Adverse Event|0
7542627|NCT02561195|26211867|P9|Vaccination 1 to 3|Adverse Event|0
7542628|NCT02561195|26211868|P8|Vaccination 1 to 3|Adverse Event|0
7542629|NCT02561195|26211869|P7|Vaccination 1 to 3|Adverse Event|0
7542630|NCT02561195|26211870|P6|Vaccination 1 to 3|Adverse Event|0
7542631|NCT02561195|26211871|P5|Vaccination 1 to 3|Adverse Event|4
7542632|NCT02561195|26211872|P4|Vaccination 1 to 3|Adverse Event|3
7542633|NCT02561195|26211873|P3|Vaccination 1 to 3|Adverse Event|0
7542634|NCT02561195|26211874|P2|Vaccination 1 to 3|Adverse Event|5
7542635|NCT02561195|26211875|P1|Vaccination 1 to 3|Adverse Event|4
7542636|NCT02561156|26212142|P13|Part 2|Adverse Event|0
7542637|NCT02561156|26212143|P12|Part 2|Adverse Event|1
7542638|NCT02561156|26212144|P11|Part 2|Adverse Event|0
7542639|NCT02561156|26212145|P10|Part 2|Adverse Event|0
7542640|NCT02561156|26212146|P9|Part 2|Adverse Event|0
7542641|NCT02561156|26212147|P8|Part 2|Adverse Event|0
7542642|NCT02561156|26212148|P7|Part 2|Adverse Event|0
7542643|NCT02561156|26212149|P6|Part 2|Adverse Event|0
7542644|NCT02561156|26212150|P5|Part 2|Adverse Event|0
7542645|NCT02561156|26212151|P4|Part 2|Adverse Event|0
7542646|NCT02561156|26212152|P3|Part 2|Adverse Event|0
7542647|NCT02561156|26212153|P2|Part 2|Adverse Event|0
7542648|NCT02561156|26212154|P1|Part 2|Adverse Event|0
7542649|NCT02561078|26212351|P2|Overall Study|Withdrawal by Subject|10
7542650|NCT02561078|26212352|P1|Overall Study|Withdrawal by Subject|13
7542651|NCT02561078|26212351|P2|Overall Study|Physician Decision|3
7542652|NCT02561078|26212352|P1|Overall Study|Physician Decision|2
7542653|NCT02561078|26212351|P2|Overall Study|Non-Compliance with Study Drug|3
7542654|NCT02561078|26212352|P1|Overall Study|Non-Compliance with Study Drug|6
7542655|NCT02561078|26212351|P2|Overall Study|Lost to Follow-up|6
7542656|NCT02561078|26212352|P1|Overall Study|Lost to Follow-up|2
7542657|NCT02561078|26212351|P2|Overall Study|Death|1
7542658|NCT02561078|26212352|P1|Overall Study|Death|2
7542659|NCT02561078|26212351|P2|Overall Study|Adverse Event|2
7542660|NCT02561078|26212352|P1|Overall Study|Adverse Event|5
7542661|NCT02561000|26212377|P3|Overall Study|Adverse Event|0
7542662|NCT02561000|26212378|P2|Overall Study|Adverse Event|1
7542663|NCT02561000|26212379|P1|Overall Study|Adverse Event|0
7542664|NCT02561000|26212377|P3|Overall Study|Withdrawal by Subject|0
7542665|NCT02561000|26212378|P2|Overall Study|Withdrawal by Subject|3
7542666|NCT02561000|26212379|P1|Overall Study|Withdrawal by Subject|2
7542667|NCT02560558|26212496|P2|Overall Study|Withdrawal by Subject|0
7542668|NCT02560558|26212497|P1|Overall Study|Withdrawal by Subject|3
7542669|NCT02560558|26212496|P2|Overall Study|Protocol Violation|0
7542670|NCT02560558|26212497|P1|Overall Study|Protocol Violation|3
7542671|NCT02560558|26212496|P2|Overall Study|Lost to Follow-up|4
7542672|NCT02560558|26212497|P1|Overall Study|Lost to Follow-up|0
7542673|NCT02560558|26212496|P2|Overall Study|Death|2
7542674|NCT02560558|26212497|P1|Overall Study|Death|0
7542675|NCT02560558|26212496|P2|Overall Study|Adverse Event|0
7542676|NCT02560558|26212497|P1|Overall Study|Adverse Event|1
7542677|NCT02560389|26212549|P3|Overall Study|Tested positive for illicit substance|0
7542678|NCT02560389|26212550|P2|Overall Study|Tested positive for illicit substance|1
7542679|NCT02560389|26212551|P1|Overall Study|Tested positive for illicit substance|0
7542680|NCT02560389|26212549|P3|Overall Study|Lost to Follow-up|2
7542681|NCT02560389|26212550|P2|Overall Study|Lost to Follow-up|2
7542682|NCT02560389|26212551|P1|Overall Study|Lost to Follow-up|1
7542683|NCT02560025|26212649|P1|Overall Study|Ineligible after consent/ registration|3
7542684|NCT02560012|26212658|P1|Overall Study|Study Terminated|2
7542685|NCT02559895|26212666|P4|Overall Study|Other|3
7542686|NCT02559895|26212667|P3|Overall Study|Other|3
7542687|NCT02559895|26212668|P2|Overall Study|Other|5
7542688|NCT02559895|26212669|P1|Overall Study|Other|1
7542689|NCT02559895|26212666|P4|Overall Study|Study Burden|22
7542690|NCT02559895|26212667|P3|Overall Study|Study Burden|12
7542691|NCT02559895|26212668|P2|Overall Study|Study Burden|16
7542692|NCT02559895|26212669|P1|Overall Study|Study Burden|10
7542693|NCT02559895|26212666|P4|Overall Study|Withdrawal by Subject|9
7542694|NCT02559895|26212667|P3|Overall Study|Withdrawal by Subject|20
7542695|NCT02559895|26212668|P2|Overall Study|Withdrawal by Subject|9
7542696|NCT02559895|26212669|P1|Overall Study|Withdrawal by Subject|16
7542697|NCT02559895|26212666|P4|Overall Study|Physician Decision|0
7542698|NCT02559895|26212667|P3|Overall Study|Physician Decision|3
7542699|NCT02559895|26212668|P2|Overall Study|Physician Decision|1
7542700|NCT02559895|26212669|P1|Overall Study|Physician Decision|1
7542701|NCT02559895|26212666|P4|Overall Study|Lost to Follow-up|17
7542702|NCT02559895|26212667|P3|Overall Study|Lost to Follow-up|12
7542703|NCT02559895|26212668|P2|Overall Study|Lost to Follow-up|16
7542704|NCT02559895|26212669|P1|Overall Study|Lost to Follow-up|22
7542705|NCT02559895|26212666|P4|Overall Study|Lack of Efficacy|8
7542706|NCT02559895|26212667|P3|Overall Study|Lack of Efficacy|2
7542707|NCT02559895|26212668|P2|Overall Study|Lack of Efficacy|3
7542708|NCT02559895|26212669|P1|Overall Study|Lack of Efficacy|2
7542709|NCT02559895|26212666|P4|Overall Study|Adverse Event|1
7542710|NCT02559895|26212667|P3|Overall Study|Adverse Event|2
7542711|NCT02559895|26212668|P2|Overall Study|Adverse Event|3
7542712|NCT02559895|26212669|P1|Overall Study|Adverse Event|3
7542713|NCT02559817|26212764|P5|Treatment Period|Protocol Violation|0
7542714|NCT02559817|26212765|P4|Treatment Period|Protocol Violation|1
7542715|NCT02559817|26212766|P3|Treatment Period|Protocol Violation|0
7542716|NCT02559817|26212767|P2|Treatment Period|Protocol Violation|0
7542717|NCT02559817|26212768|P1|Treatment Period|Protocol Violation|0
7542718|NCT02559817|26212764|P5|Treatment Period|Non-Compliance With Study Drug|0
7542719|NCT02559817|26212765|P4|Treatment Period|Non-Compliance With Study Drug|0
7542720|NCT02559817|26212766|P3|Treatment Period|Non-Compliance With Study Drug|1
7542721|NCT02559817|26212767|P2|Treatment Period|Non-Compliance With Study Drug|0
7542722|NCT02559817|26212768|P1|Treatment Period|Non-Compliance With Study Drug|0
7542723|NCT02559817|26212764|P5|Treatment Period|Lost to Follow-up|0
7542724|NCT02559817|26212765|P4|Treatment Period|Lost to Follow-up|1
7542725|NCT02559817|26212766|P3|Treatment Period|Lost to Follow-up|0
7542726|NCT02559817|26212767|P2|Treatment Period|Lost to Follow-up|1
7542727|NCT02559817|26212768|P1|Treatment Period|Lost to Follow-up|0
7542728|NCT02559817|26212764|P5|Treatment Period|Lack of Efficacy|0
7542729|NCT02559817|26212765|P4|Treatment Period|Lack of Efficacy|0
7542730|NCT02559817|26212766|P3|Treatment Period|Lack of Efficacy|0
7542731|NCT02559817|26212767|P2|Treatment Period|Lack of Efficacy|1
7542732|NCT02559817|26212768|P1|Treatment Period|Lack of Efficacy|0
7542733|NCT02559817|26212764|P5|Treatment Period|Adverse Event|0
7542734|NCT02559817|26212765|P4|Treatment Period|Adverse Event|0
7542735|NCT02559817|26212766|P3|Treatment Period|Adverse Event|1
7542736|NCT02559817|26212767|P2|Treatment Period|Adverse Event|0
7542737|NCT02559817|26212768|P1|Treatment Period|Adverse Event|1
7542738|NCT02559713|26212805|P1|Overall Study|Pretreatment Event/ Adverse Event|1
7542739|NCT02559687|26212815|P1|Overall Study|Ongoing Follow-Up|14
7542740|NCT02559687|26212815|P1|Overall Study|Withdrawal by Subject|4
7542741|NCT02559687|26212815|P1|Overall Study|Death|103
7542742|NCT02559622|26212828|P4|Overall Study|Patient/guardian decision|1
7542743|NCT02559622|26212829|P3|Overall Study|Patient/guardian decision|0
7542744|NCT02559622|26212830|P2|Overall Study|Patient/guardian decision|2
7542745|NCT02559622|26212831|P1|Overall Study|Patient/guardian decision|1
7542746|NCT02559622|26212828|P4|Overall Study|Adverse Event|2
7542747|NCT02559622|26212829|P3|Overall Study|Adverse Event|2
7542748|NCT02559622|26212830|P2|Overall Study|Adverse Event|2
7542749|NCT02559622|26212831|P1|Overall Study|Adverse Event|0
7542750|NCT02559622|26212828|P4|Overall Study|Progressive disease|0
7542751|NCT02559622|26212829|P3|Overall Study|Progressive disease|0
7542752|NCT02559622|26212830|P2|Overall Study|Progressive disease|1
7542753|NCT02559622|26212831|P1|Overall Study|Progressive disease|0
7542754|NCT02559570|26212915|P5|Overall Study|Other Miscellaneous Reasons|0
7542755|NCT02559570|26212916|P4|Overall Study|Other Miscellaneous Reasons|0
7542756|NCT02559570|26212917|P3|Overall Study|Other Miscellaneous Reasons|1
7542757|NCT02559570|26212918|P2|Overall Study|Other Miscellaneous Reasons|0
7542758|NCT02559570|26212919|P1|Overall Study|Other Miscellaneous Reasons|0
7542759|NCT02559570|26212915|P5|Overall Study|Protocol Violation|1
7542760|NCT02559570|26212916|P4|Overall Study|Protocol Violation|0
7542761|NCT02559570|26212917|P3|Overall Study|Protocol Violation|0
7542762|NCT02559570|26212918|P2|Overall Study|Protocol Violation|0
7542763|NCT02559570|26212919|P1|Overall Study|Protocol Violation|1
7542764|NCT02559570|26212915|P5|Overall Study|Lost to Follow-up|0
7542765|NCT02559570|26212916|P4|Overall Study|Lost to Follow-up|0
7542766|NCT02559570|26212917|P3|Overall Study|Lost to Follow-up|0
7542767|NCT02559570|26212918|P2|Overall Study|Lost to Follow-up|0
7542768|NCT02559570|26212919|P1|Overall Study|Lost to Follow-up|1
7542769|NCT02559570|26212915|P5|Overall Study|Withdrawal of Consent|1
7542770|NCT02559570|26212916|P4|Overall Study|Withdrawal of Consent|2
7542771|NCT02559570|26212917|P3|Overall Study|Withdrawal of Consent|1
7542772|NCT02559570|26212918|P2|Overall Study|Withdrawal of Consent|0
7542773|NCT02559570|26212919|P1|Overall Study|Withdrawal of Consent|0
7542774|NCT02559570|26212915|P5|Overall Study|Adverse Event|0
7542775|NCT02559570|26212916|P4|Overall Study|Adverse Event|1
7542776|NCT02559570|26212917|P3|Overall Study|Adverse Event|0
7542777|NCT02559570|26212918|P2|Overall Study|Adverse Event|2
7542778|NCT02559570|26212919|P1|Overall Study|Adverse Event|0
7542779|NCT02559505|26212962|P2|Overall Study|Withdrawal by Subject|2
7542780|NCT02559505|26212963|P1|Overall Study|Withdrawal by Subject|4
7542781|NCT02559505|26212962|P2|Overall Study|Lost to Follow-up|20
7542782|NCT02559505|26212963|P1|Overall Study|Lost to Follow-up|23
7542783|NCT02559414|26212994|P3|Overall Study|Other|1
7542784|NCT02559414|26212995|P2|Overall Study|Other|1
7542785|NCT02559414|26212996|P1|Overall Study|Other|0
7542786|NCT02559414|26212994|P3|Overall Study|Withdrawal by Subject|1
7542787|NCT02559414|26212995|P2|Overall Study|Withdrawal by Subject|0
7542788|NCT02559414|26212996|P1|Overall Study|Withdrawal by Subject|1
7542789|NCT02559414|26212994|P3|Overall Study|Lost to Follow-up|0
7542790|NCT02559414|26212995|P2|Overall Study|Lost to Follow-up|1
7542791|NCT02559414|26212996|P1|Overall Study|Lost to Follow-up|0
7542792|NCT02559310|26213036|P2|Overall Study|Randomized but not treated|2
7542793|NCT02559310|26213037|P1|Overall Study|Randomized but not treated|3
7542794|NCT02559310|26213036|P2|Overall Study|Sponsor Decision|1
7542795|NCT02559310|26213037|P1|Overall Study|Sponsor Decision|0
7542796|NCT02559310|26213036|P2|Overall Study|Withdrawal by Subject|9
7542797|NCT02559310|26213037|P1|Overall Study|Withdrawal by Subject|13
7542798|NCT02559310|26213036|P2|Overall Study|Physician Decision|1
7542799|NCT02559310|26213037|P1|Overall Study|Physician Decision|2
7542800|NCT02559310|26213036|P2|Overall Study|Lost to Follow-up|3
7542801|NCT02559310|26213037|P1|Overall Study|Lost to Follow-up|5
7542802|NCT02559310|26213036|P2|Overall Study|Death|3
7542803|NCT02559310|26213037|P1|Overall Study|Death|4
7542804|NCT02559206|26213055|P8|Overall Study|Other Not Specified|0
7542805|NCT02559206|26213056|P7|Overall Study|Other Not Specified|0
7542806|NCT02559206|26213057|P6|Overall Study|Other Not Specified|0
7542807|NCT02559206|26213058|P5|Overall Study|Other Not Specified|0
7542808|NCT02559206|26213059|P4|Overall Study|Other Not Specified|1
7542809|NCT02559206|26213060|P3|Overall Study|Other Not Specified|0
7542810|NCT02559206|26213061|P2|Overall Study|Other Not Specified|0
7542811|NCT02559206|26213062|P1|Overall Study|Other Not Specified|0
7542812|NCT02559206|26213055|P8|Overall Study|Lack of Efficacy|3
7542813|NCT02559206|26213056|P7|Overall Study|Lack of Efficacy|3
7542814|NCT02559206|26213057|P6|Overall Study|Lack of Efficacy|3
7542815|NCT02559206|26213058|P5|Overall Study|Lack of Efficacy|2
7542816|NCT02559206|26213059|P4|Overall Study|Lack of Efficacy|2
7542817|NCT02559206|26213060|P3|Overall Study|Lack of Efficacy|3
7542818|NCT02559206|26213061|P2|Overall Study|Lack of Efficacy|0
7542819|NCT02559206|26213062|P1|Overall Study|Lack of Efficacy|1
7542820|NCT02559206|26213055|P8|Overall Study|Lost to Follow-up|4
7542821|NCT02559206|26213056|P7|Overall Study|Lost to Follow-up|1
7542822|NCT02559206|26213057|P6|Overall Study|Lost to Follow-up|5
7542823|NCT02559206|26213058|P5|Overall Study|Lost to Follow-up|2
7542824|NCT02559206|26213059|P4|Overall Study|Lost to Follow-up|3
7542825|NCT02559206|26213060|P3|Overall Study|Lost to Follow-up|3
7542826|NCT02559206|26213061|P2|Overall Study|Lost to Follow-up|5
7542827|NCT02559206|26213062|P1|Overall Study|Lost to Follow-up|3
7542828|NCT02559206|26213055|P8|Overall Study|Withdrawal by Subject|2
7542829|NCT02559206|26213056|P7|Overall Study|Withdrawal by Subject|1
7542830|NCT02559206|26213057|P6|Overall Study|Withdrawal by Subject|4
7542831|NCT02559206|26213058|P5|Overall Study|Withdrawal by Subject|5
7542832|NCT02559206|26213059|P4|Overall Study|Withdrawal by Subject|3
7542833|NCT02559206|26213060|P3|Overall Study|Withdrawal by Subject|1
7542834|NCT02559206|26213061|P2|Overall Study|Withdrawal by Subject|3
7542835|NCT02559206|26213062|P1|Overall Study|Withdrawal by Subject|3
7542836|NCT02559206|26213055|P8|Overall Study|Protocol Violation|0
7542837|NCT02559206|26213056|P7|Overall Study|Protocol Violation|0
7542838|NCT02559206|26213057|P6|Overall Study|Protocol Violation|2
7542839|NCT02559206|26213058|P5|Overall Study|Protocol Violation|0
7542840|NCT02559206|26213059|P4|Overall Study|Protocol Violation|0
7542841|NCT02559206|26213060|P3|Overall Study|Protocol Violation|1
7542842|NCT02559206|26213061|P2|Overall Study|Protocol Violation|0
7542843|NCT02559206|26213062|P1|Overall Study|Protocol Violation|1
7542844|NCT02559206|26213055|P8|Overall Study|Adverse Event|0
7542845|NCT02559206|26213056|P7|Overall Study|Adverse Event|1
7542846|NCT02559206|26213057|P6|Overall Study|Adverse Event|0
7542847|NCT02559206|26213058|P5|Overall Study|Adverse Event|3
7542848|NCT02559206|26213059|P4|Overall Study|Adverse Event|5
7542849|NCT02559206|26213060|P3|Overall Study|Adverse Event|1
7542850|NCT02559206|26213061|P2|Overall Study|Adverse Event|4
7542851|NCT02559206|26213062|P1|Overall Study|Adverse Event|0
7542852|NCT02559115|26213102|P1|Overall Study|Withdrawal by Subject|3
7542853|NCT02558894|26213108|P2|Overall Study|Closure of Part A|1
7542854|NCT02558894|26213109|P1|Overall Study|Closure of Part A|2
7542855|NCT02558894|26213108|P2|Overall Study|Withdrawal by Subject|1
7542856|NCT02558894|26213109|P1|Overall Study|Withdrawal by Subject|2
7542857|NCT02558894|26213108|P2|Overall Study|Death; any cause, entire study duration|31
7542858|NCT02558894|26213109|P1|Overall Study|Death; any cause, entire study duration|28
7542859|NCT02558790|26213170|P1|Overall Study|Screen Fail|3
7542860|NCT02558790|26213170|P1|Overall Study|Withdrawal by Subject|1
7542861|NCT02558790|26213170|P1|Overall Study|Physician Decision|1
7542862|NCT02558790|26213170|P1|Overall Study|Lost to Follow-up|2
7542863|NCT02558400|26213177|P3|Overall Study|Ineligible for the study|0
7542864|NCT02558400|26213178|P2|Overall Study|Ineligible for the study|2
7542865|NCT02558400|26213179|P1|Overall Study|Ineligible for the study|0
7542866|NCT02558400|26213177|P3|Overall Study|Death|0
7542867|NCT02558400|26213178|P2|Overall Study|Death|1
7542868|NCT02558400|26213179|P1|Overall Study|Death|0
7542869|NCT02558400|26213177|P3|Overall Study|Protocol Violation|8
7542870|NCT02558400|26213178|P2|Overall Study|Protocol Violation|3
7542871|NCT02558400|26213179|P1|Overall Study|Protocol Violation|6
7542872|NCT02558400|26213177|P3|Overall Study|Physician Decision|0
7542873|NCT02558400|26213178|P2|Overall Study|Physician Decision|2
7542874|NCT02558400|26213179|P1|Overall Study|Physician Decision|2
7542875|NCT02558400|26213177|P3|Overall Study|Disallowed Concurrent Medication|5
7542876|NCT02558400|26213178|P2|Overall Study|Disallowed Concurrent Medication|7
7542877|NCT02558400|26213179|P1|Overall Study|Disallowed Concurrent Medication|6
7542878|NCT02558400|26213177|P3|Overall Study|Lack of Efficacy|1
7542879|NCT02558400|26213178|P2|Overall Study|Lack of Efficacy|13
7542880|NCT02558400|26213179|P1|Overall Study|Lack of Efficacy|0
7542881|NCT02558400|26213177|P3|Overall Study|Lost to Follow-up|4
7542882|NCT02558400|26213178|P2|Overall Study|Lost to Follow-up|5
7542883|NCT02558400|26213179|P1|Overall Study|Lost to Follow-up|5
7542884|NCT02558400|26213177|P3|Overall Study|Non-Compliant|3
7542885|NCT02558400|26213178|P2|Overall Study|Non-Compliant|1
7542886|NCT02558400|26213179|P1|Overall Study|Non-Compliant|0
7542887|NCT02558400|26213177|P3|Overall Study|Withdrawal by Subject|8
7542888|NCT02558400|26213178|P2|Overall Study|Withdrawal by Subject|9
7542889|NCT02558400|26213179|P1|Overall Study|Withdrawal by Subject|13
7542890|NCT02558400|26213177|P3|Overall Study|Adverse Event|4
7542891|NCT02558400|26213178|P2|Overall Study|Adverse Event|53
7542892|NCT02558400|26213179|P1|Overall Study|Adverse Event|47
7542893|NCT02558296|26213203|P2|Completed the Study|The subject was randomized, but did not take any investigational product|0
7542894|NCT02558296|26213204|P1|Completed the Study|The subject was randomized, but did not take any investigational product|1
7542895|NCT02558296|26213203|P2|Completed the Study|Withdrawal by Subject|31
7542896|NCT02558296|26213204|P1|Completed the Study|Withdrawal by Subject|53
7542897|NCT02558296|26213203|P2|Completed the Study|Protocol Violation|1
7542898|NCT02558296|26213204|P1|Completed the Study|Protocol Violation|2
7542899|NCT02558296|26213203|P2|Completed the Study|Physician Decision|0
7542900|NCT02558296|26213204|P1|Completed the Study|Physician Decision|6
7542901|NCT02558296|26213203|P2|Completed the Study|Lost to Follow-up|23
7542902|NCT02558296|26213204|P1|Completed the Study|Lost to Follow-up|31
7542903|NCT02558296|26213203|P2|Completed the Study|Death|25
7542904|NCT02558296|26213204|P1|Completed the Study|Death|39
7542905|NCT02558296|26213203|P2|Completed the Study|Adverse Event|5
7542906|NCT02558296|26213204|P1|Completed the Study|Adverse Event|14
7542907|NCT02558296|26213203|P2|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
7542908|NCT02558296|26213204|P1|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
7542909|NCT02558296|26213203|P2|Completed the Study Through Week 24|Withdrawal by Subject|13
7542910|NCT02558296|26213204|P1|Completed the Study Through Week 24|Withdrawal by Subject|17
7542911|NCT02558296|26213203|P2|Completed the Study Through Week 24|Protocol Violation|1
7542912|NCT02558296|26213204|P1|Completed the Study Through Week 24|Protocol Violation|1
7542913|NCT02558296|26213203|P2|Completed the Study Through Week 24|Physician Decision|0
7542914|NCT02558296|26213204|P1|Completed the Study Through Week 24|Physician Decision|1
7542915|NCT02558296|26213203|P2|Completed the Study Through Week 24|Lost to Follow-up|1
7542916|NCT02558296|26213204|P1|Completed the Study Through Week 24|Lost to Follow-up|8
7542917|NCT02558296|26213203|P2|Completed the Study Through Week 24|Death|7
7542918|NCT02558296|26213204|P1|Completed the Study Through Week 24|Death|7
7542919|NCT02558296|26213203|P2|Completed the Study Through Week 24|Adverse Event|3
7542920|NCT02558296|26213204|P1|Completed the Study Through Week 24|Adverse Event|9
7542921|NCT02558231|26213234|P2|Overall Study|Sponsor Decision|1
7542922|NCT02558231|26213235|P1|Overall Study|Sponsor Decision|0
7542923|NCT02558231|26213234|P2|Overall Study|Physician Decision|5
7542924|NCT02558231|26213235|P1|Overall Study|Physician Decision|7
7542925|NCT02558231|26213234|P2|Overall Study|Withdrawal by Subject|4
7542926|NCT02558231|26213235|P1|Overall Study|Withdrawal by Subject|7
7542927|NCT02558231|26213234|P2|Overall Study|Lost to Follow-up|4
7542928|NCT02558231|26213235|P1|Overall Study|Lost to Follow-up|7
7542929|NCT02558231|26213234|P2|Overall Study|Death|12
7542930|NCT02558231|26213235|P1|Overall Study|Death|4
7542931|NCT02557646|26213326|P1|Overall Study|Other|14
7542932|NCT02557646|26213326|P1|Overall Study|Lost to Follow-up|17
7542933|NCT02557646|26213326|P1|Overall Study|Withdrawal by Subject|18
7542934|NCT02557646|26213326|P1|Overall Study|Lack of Efficacy|186
7542935|NCT02557646|26213326|P1|Overall Study|Death|1
7542936|NCT02557646|26213326|P1|Overall Study|Adverse Event|40
7542937|NCT02557516|26213353|P4|Overall Study|Sponsor decision|8
7542938|NCT02557516|26213354|P3|Overall Study|Sponsor decision|2
7542939|NCT02557516|26213355|P2|Overall Study|Sponsor decision|1
7542940|NCT02557516|26213356|P1|Overall Study|Sponsor decision|0
7542941|NCT02557516|26213353|P4|Overall Study|Physician Decision|0
7542942|NCT02557516|26213354|P3|Overall Study|Physician Decision|0
7542943|NCT02557516|26213355|P2|Overall Study|Physician Decision|2
7542944|NCT02557516|26213356|P1|Overall Study|Physician Decision|0
7542945|NCT02557516|26213353|P4|Overall Study|Disease progression|0
7542946|NCT02557516|26213354|P3|Overall Study|Disease progression|0
7542947|NCT02557516|26213355|P2|Overall Study|Disease progression|2
7542948|NCT02557516|26213356|P1|Overall Study|Disease progression|0
7542949|NCT02557516|26213353|P4|Overall Study|Adverse Event|1
7542950|NCT02557516|26213354|P3|Overall Study|Adverse Event|2
7542951|NCT02557516|26213355|P2|Overall Study|Adverse Event|0
7542952|NCT02557516|26213356|P1|Overall Study|Adverse Event|1
7542953|NCT02557399|26213377|P2|Overall Study|Withdrawal by Subject|1
7542954|NCT02557399|26213378|P1|Overall Study|Withdrawal by Subject|1
7542955|NCT02557399|26213377|P2|Overall Study|Protocol-defined stopping criteria|1
7542956|NCT02557399|26213378|P1|Overall Study|Protocol-defined stopping criteria|0
7542957|NCT02557399|26213377|P2|Overall Study|Protocol Violation|1
7542958|NCT02557399|26213378|P1|Overall Study|Protocol Violation|0
7542959|NCT02557399|26213377|P2|Overall Study|Adverse Event|5
7542960|NCT02557399|26213378|P1|Overall Study|Adverse Event|6
7542961|NCT02557100|26213424|P3|Cumulative Abatacept Period|Request to Discontinue|1
7542962|NCT02557100|26213425|P2|Cumulative Abatacept Period|Request to Discontinue|0
7542963|NCT02557100|26213426|P1|Cumulative Abatacept Period|Request to Discontinue|0
7542964|NCT02557100|26213424|P3|Cumulative Abatacept Period|Lost to Follow-up|2
7542965|NCT02557100|26213425|P2|Cumulative Abatacept Period|Lost to Follow-up|0
7542966|NCT02557100|26213426|P1|Cumulative Abatacept Period|Lost to Follow-up|0
7542967|NCT02557100|26213424|P3|Cumulative Abatacept Period|Other Reasons|1
7542968|NCT02557100|26213425|P2|Cumulative Abatacept Period|Other Reasons|0
7542969|NCT02557100|26213426|P1|Cumulative Abatacept Period|Other Reasons|0
7542970|NCT02557100|26213424|P3|Transition to Open Label|Entered Cumulative Abatacept Period|0
7542971|NCT02557100|26213425|P2|Transition to Open Label|Entered Cumulative Abatacept Period|36
7542972|NCT02557100|26213426|P1|Transition to Open Label|Entered Cumulative Abatacept Period|40
7542973|NCT02557100|26213424|P3|Single Blind Treatment Period|Adverse Event|0
7542974|NCT02557100|26213425|P2|Single Blind Treatment Period|Adverse Event|1
7542975|NCT02557100|26213426|P1|Single Blind Treatment Period|Adverse Event|0
7542976|NCT02557100|26213424|P3|Single Blind Treatment Period|Request to Discontinue|0
7542977|NCT02557100|26213425|P2|Single Blind Treatment Period|Request to Discontinue|1
7542978|NCT02557100|26213426|P1|Single Blind Treatment Period|Request to Discontinue|0
7542979|NCT02557100|26213424|P3|Single Blind Treatment Period|Death|0
7542980|NCT02557100|26213425|P2|Single Blind Treatment Period|Death|1
7542981|NCT02557100|26213426|P1|Single Blind Treatment Period|Death|0
7542982|NCT02557100|26213424|P3|Single Blind Treatment Period|Lost to Follow-up|0
7542983|NCT02557100|26213425|P2|Single Blind Treatment Period|Lost to Follow-up|1
7542984|NCT02557100|26213426|P1|Single Blind Treatment Period|Lost to Follow-up|0
7542985|NCT02556918|26213479|P2|Overall Study|Withdrawal by Subject|4
7542986|NCT02556918|26213480|P1|Overall Study|Withdrawal by Subject|4
7542987|NCT02556918|26213479|P2|Overall Study|Protocol Violation|6
7542988|NCT02556918|26213480|P1|Overall Study|Protocol Violation|5
7542989|NCT02556801|26213540|P4|Overall Study|Personal reasons patient|1
7542990|NCT02556801|26213541|P3|Overall Study|Personal reasons patient|0
7542991|NCT02556801|26213542|P2|Overall Study|Personal reasons patient|0
7542992|NCT02556801|26213543|P1|Overall Study|Personal reasons patient|0
7542993|NCT02556801|26213540|P4|Overall Study|Pregnancy|0
7542994|NCT02556801|26213541|P3|Overall Study|Pregnancy|0
7542995|NCT02556801|26213542|P2|Overall Study|Pregnancy|1
7542996|NCT02556801|26213543|P1|Overall Study|Pregnancy|0
7542997|NCT02556801|26213540|P4|Overall Study|Adverse Event|3
7542998|NCT02556801|26213541|P3|Overall Study|Adverse Event|0
7542999|NCT02556801|26213542|P2|Overall Study|Adverse Event|2
7543000|NCT02556801|26213543|P1|Overall Study|Adverse Event|0
7543001|NCT02556801|26213540|P4|Overall Study|Protocol Violation|1
7543002|NCT02556801|26213541|P3|Overall Study|Protocol Violation|1
7543003|NCT02556801|26213542|P2|Overall Study|Protocol Violation|3
7543004|NCT02556801|26213543|P1|Overall Study|Protocol Violation|0
7543005|NCT02556801|26213540|P4|Overall Study|Withdrawal by Subject|0
7543006|NCT02556801|26213541|P3|Overall Study|Withdrawal by Subject|1
7543007|NCT02556801|26213542|P2|Overall Study|Withdrawal by Subject|1
7543008|NCT02556801|26213543|P1|Overall Study|Withdrawal by Subject|1
7543009|NCT02556801|26213540|P4|Overall Study|Lost to Follow-up|0
7543010|NCT02556801|26213541|P3|Overall Study|Lost to Follow-up|2
7543011|NCT02556801|26213542|P2|Overall Study|Lost to Follow-up|0
7543012|NCT02556801|26213543|P1|Overall Study|Lost to Follow-up|1
7543013|NCT02556775|26213606|P4|Overall Study|Lost to Follow-up|0
7543014|NCT02556775|26213607|P3|Overall Study|Lost to Follow-up|0
7543015|NCT02556775|26213608|P2|Overall Study|Lost to Follow-up|0
7543016|NCT02556775|26213609|P1|Overall Study|Lost to Follow-up|1
7543017|NCT02556775|26213606|P4|Overall Study|Withdrawal by Subject|0
7543018|NCT02556775|26213607|P3|Overall Study|Withdrawal by Subject|1
7543019|NCT02556775|26213608|P2|Overall Study|Withdrawal by Subject|0
7543020|NCT02556775|26213609|P1|Overall Study|Withdrawal by Subject|1
7543021|NCT02556632|26213646|P3|Overall Study|Treatment or Change Delay|1
7543022|NCT02556632|26213647|P2|Overall Study|Treatment or Change Delay|0
7543023|NCT02556632|26213648|P1|Overall Study|Treatment or Change Delay|0
7543024|NCT02556632|26213646|P3|Overall Study|Disliked Study Procedures|1
7543025|NCT02556632|26213647|P2|Overall Study|Disliked Study Procedures|0
7543026|NCT02556632|26213648|P1|Overall Study|Disliked Study Procedures|0
7543027|NCT02556632|26213646|P3|Overall Study|Ineligible|0
7543028|NCT02556632|26213647|P2|Overall Study|Ineligible|1
7543029|NCT02556632|26213648|P1|Overall Study|Ineligible|0
7543030|NCT02556632|26213646|P3|Overall Study|Did Not Start RT|0
7543031|NCT02556632|26213647|P2|Overall Study|Did Not Start RT|1
7543032|NCT02556632|26213648|P1|Overall Study|Did Not Start RT|0
7543033|NCT02556632|26213646|P3|Overall Study|Possibly Related Adverse Event|1
7543034|NCT02556632|26213647|P2|Overall Study|Possibly Related Adverse Event|0
7543035|NCT02556632|26213648|P1|Overall Study|Possibly Related Adverse Event|0
7543036|NCT02556632|26213646|P3|Overall Study|Related Adverse Event|0
7543037|NCT02556632|26213647|P2|Overall Study|Related Adverse Event|1
7543038|NCT02556632|26213648|P1|Overall Study|Related Adverse Event|0
7543039|NCT02556632|26213646|P3|Overall Study|Unrelated Adverse Event|3
7543040|NCT02556632|26213647|P2|Overall Study|Unrelated Adverse Event|0
7543041|NCT02556632|26213648|P1|Overall Study|Unrelated Adverse Event|1
7543042|NCT02556632|26213646|P3|Overall Study|Withdrew (Unrelated Medical)|0
7543043|NCT02556632|26213647|P2|Overall Study|Withdrew (Unrelated Medical)|0
7543044|NCT02556632|26213648|P1|Overall Study|Withdrew (Unrelated Medical)|1
7543045|NCT02556632|26213646|P3|Overall Study|Changed Mind|0
7543046|NCT02556632|26213647|P2|Overall Study|Changed Mind|1
7543047|NCT02556632|26213648|P1|Overall Study|Changed Mind|0
7543048|NCT02556632|26213646|P3|Overall Study|Personal Issues|1
7543049|NCT02556632|26213647|P2|Overall Study|Personal Issues|1
7543050|NCT02556632|26213648|P1|Overall Study|Personal Issues|0
7543051|NCT02556632|26213646|P3|Overall Study|No Reason|1
7543052|NCT02556632|26213647|P2|Overall Study|No Reason|0
7543053|NCT02556632|26213648|P1|Overall Study|No Reason|1
7543054|NCT02556632|26213646|P3|Overall Study|Disliked Intervention|1
7543055|NCT02556632|26213647|P2|Overall Study|Disliked Intervention|1
7543056|NCT02556632|26213648|P1|Overall Study|Disliked Intervention|1
7543057|NCT02556632|26213646|P3|Overall Study|Lost to Follow-up|0
7543058|NCT02556632|26213647|P2|Overall Study|Lost to Follow-up|0
7543059|NCT02556632|26213648|P1|Overall Study|Lost to Follow-up|1
7543060|NCT02556307|26213709|P1|Overall Study|Enrolled but not treated|2
7543061|NCT02556307|26213709|P1|Overall Study|Change to triple therapy|4
7543062|NCT02556307|26213709|P1|Overall Study|Lost to Follow-up|36
7543063|NCT02556307|26213709|P1|Overall Study|Premature treatment interruption|11
7543064|NCT02556255|26213719|P1|Overall Study|Lost to Follow-up|4
7543065|NCT02556203|26213734|P2|Overall Study|Adverse Event|0
7543066|NCT02556203|26213735|P1|Overall Study|Adverse Event|1
7543067|NCT02556203|26213734|P2|Overall Study|Lost to Follow-up|5
7543068|NCT02556203|26213735|P1|Overall Study|Lost to Follow-up|5
7543069|NCT02556203|26213734|P2|Overall Study|Withdrawal by Subject|21
7543070|NCT02556203|26213735|P1|Overall Study|Withdrawal by Subject|21
7543071|NCT02556177|26213757|P2|Overall Study|Subjects did not complete all 4 visits|61
7543072|NCT02556177|26213758|P1|Overall Study|Subjects did not complete all 4 visits|283
7543073|NCT02556138|26213766|P1|Overall Study|Withdrawal by Subject|1
7543074|NCT02555878|26213808|P2|Overall Study|Other|17
7543075|NCT02555878|26213809|P1|Overall Study|Other|17
7543076|NCT02555878|26213808|P2|Overall Study|Physician Decision|13
7543077|NCT02555878|26213809|P1|Overall Study|Physician Decision|12
7543078|NCT02555878|26213808|P2|Overall Study|Protocol Violation|2
7543079|NCT02555878|26213809|P1|Overall Study|Protocol Violation|1
7543080|NCT02555878|26213808|P2|Overall Study|Death|59
7543081|NCT02555878|26213809|P1|Overall Study|Death|74
7543082|NCT02555878|26213808|P2|Overall Study|Adverse Event|8
7543083|NCT02555878|26213809|P1|Overall Study|Adverse Event|12
7543084|NCT02555878|26213808|P2|Overall Study|Withdrawal by Subject|48
7543085|NCT02555878|26213809|P1|Overall Study|Withdrawal by Subject|48
7543086|NCT02555878|26213808|P2|Overall Study|Lost to Follow-up|3
7543087|NCT02555878|26213809|P1|Overall Study|Lost to Follow-up|2
7543088|NCT02555722|26213841|P2|Month 2|Lost to Follow-up|0
7543089|NCT02555722|26213842|P1|Month 2|Lost to Follow-up|1
7543090|NCT02555722|26213841|P2|Month 2|Withdrawal by Subject|0
7543091|NCT02555722|26213842|P1|Month 2|Withdrawal by Subject|3
7543092|NCT02555722|26213841|P2|Month 1|Lens Discomfort|0
7543093|NCT02555722|26213842|P1|Month 1|Lens Discomfort|1
7543094|NCT02555722|26213841|P2|Week 2|Withdrawal by Subject|0
7543095|NCT02555722|26213842|P1|Week 2|Withdrawal by Subject|1
7543096|NCT02555722|26213841|P2|Week 2|Adverse Event|1
7543097|NCT02555722|26213842|P1|Week 2|Adverse Event|0
7543098|NCT02555683|26214027|P3|Overall Study|Death post Treatment/safety period|0
7543099|NCT02555683|26214028|P2|Overall Study|Death post Treatment/safety period|1
7543100|NCT02555683|26214029|P1|Overall Study|Death post Treatment/safety period|0
7543101|NCT02555683|26214027|P3|Overall Study|Subject/guardian decision|22
7543102|NCT02555683|26214028|P2|Overall Study|Subject/guardian decision|12
7543103|NCT02555683|26214029|P1|Overall Study|Subject/guardian decision|12
7543104|NCT02555683|26214027|P3|Overall Study|Adverse Event|1
7543105|NCT02555683|26214028|P2|Overall Study|Adverse Event|0
7543106|NCT02555683|26214029|P1|Overall Study|Adverse Event|1
7543107|NCT02555683|26214027|P3|Overall Study|Death|2
7543108|NCT02555683|26214028|P2|Overall Study|Death|1
7543109|NCT02555683|26214029|P1|Overall Study|Death|0
7543110|NCT02555683|26214027|P3|Overall Study|Lack of Efficacy|0
7543111|NCT02555683|26214028|P2|Overall Study|Lack of Efficacy|0
7543112|NCT02555683|26214029|P1|Overall Study|Lack of Efficacy|2
7543113|NCT02555683|26214027|P3|Overall Study|Protocol deviation|0
7543114|NCT02555683|26214028|P2|Overall Study|Protocol deviation|1
7543115|NCT02555683|26214029|P1|Overall Study|Protocol deviation|0
7543116|NCT02555683|26214027|P3|Overall Study|Technical Problems|0
7543117|NCT02555683|26214028|P2|Overall Study|Technical Problems|1
7543118|NCT02555683|26214029|P1|Overall Study|Technical Problems|1
7543119|NCT02555683|26214027|P3|Overall Study|Lost to Follow-up|2
7543120|NCT02555683|26214028|P2|Overall Study|Lost to Follow-up|1
7543121|NCT02555683|26214029|P1|Overall Study|Lost to Follow-up|2
7543122|NCT02555683|26214027|P3|Overall Study|Physician Decision|2
7543123|NCT02555683|26214028|P2|Overall Study|Physician Decision|0
7543124|NCT02555683|26214029|P1|Overall Study|Physician Decision|1
7543125|NCT02555657|26214060|P2|Overall Study|Status Not Recorded|31
7543126|NCT02555657|26214061|P1|Overall Study|Status Not Recorded|44
7543127|NCT02555657|26214060|P2|Overall Study|Withdrawal by Subject|32
7543128|NCT02555657|26214061|P1|Overall Study|Withdrawal by Subject|11
7543129|NCT02555657|26214060|P2|Overall Study|Death|247
7543130|NCT02555657|26214061|P1|Overall Study|Death|257
7543131|NCT02555618|26214108|P2|Overall Study|Sponsor's Circumstances|0
7543132|NCT02555618|26214109|P1|Overall Study|Sponsor's Circumstances|1
7543133|NCT02555371|26214161|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7543134|NCT02555371|26214162|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
7543135|NCT02555371|26214163|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7543136|NCT02555371|26214164|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7543137|NCT02555371|26214165|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7543138|NCT02555371|26214161|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
7543139|NCT02555371|26214162|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7543140|NCT02555371|26214163|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7543141|NCT02555371|26214164|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7543142|NCT02555371|26214165|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7543143|NCT02555371|26214161|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
7543144|NCT02555371|26214162|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7543145|NCT02555371|26214163|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7543146|NCT02555371|26214164|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7543147|NCT02555371|26214165|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7543148|NCT02555371|26214161|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7543149|NCT02555371|26214162|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
7543150|NCT02555371|26214163|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7543151|NCT02555371|26214164|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7543152|NCT02555371|26214165|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7543153|NCT02555371|26214161|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7543154|NCT02555371|26214162|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
7543155|NCT02555371|26214163|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7543156|NCT02555371|26214164|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7543157|NCT02555371|26214165|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7543158|NCT02555371|26214161|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
7543159|NCT02555371|26214162|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
7543160|NCT02555371|26214163|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
7543161|NCT02555371|26214164|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
7543162|NCT02555371|26214165|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
7543163|NCT02555371|26214161|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7543164|NCT02555371|26214162|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7543165|NCT02555371|26214163|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7543166|NCT02555371|26214164|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
7543167|NCT02555371|26214165|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7543168|NCT02555371|26214161|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7543169|NCT02555371|26214162|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7543170|NCT02555371|26214163|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7543171|NCT02555371|26214164|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7543172|NCT02555371|26214165|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7543173|NCT02555371|26214161|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7543174|NCT02555371|26214162|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7543175|NCT02555371|26214163|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
7543176|NCT02555371|26214164|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
7543177|NCT02555371|26214165|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7543178|NCT02555371|26214161|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7543179|NCT02555371|26214162|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7543180|NCT02555371|26214163|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7543181|NCT02555371|26214164|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7543182|NCT02555371|26214165|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
7543183|NCT02555371|26214161|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7543184|NCT02555371|26214162|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7543185|NCT02555371|26214163|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7543186|NCT02555371|26214164|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7543187|NCT02555371|26214165|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
7543188|NCT02555371|26214161|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7543189|NCT02555371|26214162|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7543190|NCT02555371|26214163|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7543191|NCT02555371|26214164|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7543192|NCT02555371|26214165|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
7543193|NCT02555371|26214161|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7543194|NCT02555371|26214162|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7543195|NCT02555371|26214163|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7543196|NCT02555371|26214164|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7543197|NCT02555371|26214165|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
7543198|NCT02555371|26214161|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7543199|NCT02555371|26214162|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7543200|NCT02555371|26214163|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7543201|NCT02555371|26214164|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7543202|NCT02555371|26214165|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
7543203|NCT02555215|26214216|P1|Overall Study|Investigator Decision|2
7543204|NCT02555215|26214216|P1|Overall Study|Other|1
7543205|NCT02554981|26214248|P1|Overall Study|Other Miscellaneous Reasons|3
7543206|NCT02554981|26214248|P1|Overall Study|Administrative Reasons|1
7543207|NCT02554981|26214248|P1|Overall Study|Adverse Event|1
7543208|NCT02554929|26214274|P2|Overall Study|Withdrawal by Subject|8
7543209|NCT02554929|26214275|P1|Overall Study|Withdrawal by Subject|2
7543210|NCT02554929|26214274|P2|Overall Study|Lost to Follow-up|4
7543211|NCT02554929|26214275|P1|Overall Study|Lost to Follow-up|4
7543212|NCT02554903|26214293|P2|Overall Study|Heart Transplant|2
7543213|NCT02554903|26214294|P1|Overall Study|Heart Transplant|1
7543214|NCT02554903|26214293|P2|Overall Study|Physician Decision|2
7543215|NCT02554903|26214294|P1|Overall Study|Physician Decision|2
7543216|NCT02554903|26214293|P2|Overall Study|Death|1
7543217|NCT02554903|26214294|P1|Overall Study|Death|1
7543218|NCT02554890|26214318|P2|Open-label|Withdrawal by Subject|1
7543219|NCT02554890|26214319|P1|Open-label|Withdrawal by Subject|0
7543220|NCT02554890|26214318|P2|Open-label|Technical problems|1
7543221|NCT02554890|26214319|P1|Open-label|Technical problems|0
7543222|NCT02554890|26214318|P2|Open-label|Lost to Follow-up|7
7543223|NCT02554890|26214319|P1|Open-label|Lost to Follow-up|0
7543224|NCT02554890|26214318|P2|Open-label|Subject/Guardian decision|11
7543225|NCT02554890|26214319|P1|Open-label|Subject/Guardian decision|0
7543226|NCT02554890|26214318|P2|Open-label|Physician Decision|1
7543227|NCT02554890|26214319|P1|Open-label|Physician Decision|0
7543228|NCT02554890|26214318|P2|Open-label|Death|1
7543229|NCT02554890|26214319|P1|Open-label|Death|0
7543230|NCT02554890|26214318|P2|Open-label|Adverse Event|30
7543231|NCT02554890|26214319|P1|Open-label|Adverse Event|0
7543232|NCT02554890|26214318|P2|Double-blind|Noncompliance with study treatment|5
7543233|NCT02554890|26214319|P1|Double-blind|Noncompliance with study treatment|6
7543234|NCT02554890|26214318|P2|Double-blind|Withdrawal by Subject|6
7543235|NCT02554890|26214319|P1|Double-blind|Withdrawal by Subject|5
7543236|NCT02554890|26214318|P2|Double-blind|Technical problems|0
7543237|NCT02554890|26214319|P1|Double-blind|Technical problems|1
7543238|NCT02554890|26214318|P2|Double-blind|Lost to Follow-up|5
7543239|NCT02554890|26214319|P1|Double-blind|Lost to Follow-up|7
7543240|NCT02554890|26214318|P2|Double-blind|Subject/Guardian decision|16
7543241|NCT02554890|26214319|P1|Double-blind|Subject/Guardian decision|21
7543242|NCT02554890|26214318|P2|Double-blind|Physician Decision|3
7543243|NCT02554890|26214319|P1|Double-blind|Physician Decision|4
7543244|NCT02554890|26214318|P2|Double-blind|Protocol Violation|1
7543245|NCT02554890|26214319|P1|Double-blind|Protocol Violation|1
7543246|NCT02554890|26214318|P2|Double-blind|Death|4
7543247|NCT02554890|26214319|P1|Double-blind|Death|6
7543248|NCT02554890|26214318|P2|Double-blind|Adverse Event|51
7543249|NCT02554890|26214319|P1|Double-blind|Adverse Event|45
7543250|NCT02554877|26214347|P4|Overall Study|No longer willing to participate|0
7543251|NCT02554877|26214348|P3|Overall Study|No longer willing to participate|2
7543252|NCT02554877|26214349|P2|Overall Study|No longer willing to participate|2
7543253|NCT02554877|26214350|P1|Overall Study|No longer willing to participate|0
7543254|NCT02554877|26214347|P4|Overall Study|Insufficient clinical response|0
7543255|NCT02554877|26214348|P3|Overall Study|Insufficient clinical response|0
7543256|NCT02554877|26214349|P2|Overall Study|Insufficient clinical response|0
7543257|NCT02554877|26214350|P1|Overall Study|Insufficient clinical response|4
7543258|NCT02554877|26214347|P4|Overall Study|Other|3
7543259|NCT02554877|26214348|P3|Overall Study|Other|0
7543260|NCT02554877|26214349|P2|Overall Study|Other|3
7543261|NCT02554877|26214350|P1|Overall Study|Other|1
7543262|NCT02554877|26214347|P4|Overall Study|Protocol Violation|0
7543263|NCT02554877|26214348|P3|Overall Study|Protocol Violation|1
7543264|NCT02554877|26214349|P2|Overall Study|Protocol Violation|1
7543265|NCT02554877|26214350|P1|Overall Study|Protocol Violation|3
7543266|NCT02554877|26214347|P4|Overall Study|No longer met eligibility criteria|1
7543267|NCT02554877|26214348|P3|Overall Study|No longer met eligibility criteria|1
7543268|NCT02554877|26214349|P2|Overall Study|No longer met eligibility criteria|0
7543269|NCT02554877|26214350|P1|Overall Study|No longer met eligibility criteria|1
7543270|NCT02554877|26214347|P4|Overall Study|Did not meet entrance criteria|0
7543271|NCT02554877|26214348|P3|Overall Study|Did not meet entrance criteria|1
7543272|NCT02554877|26214349|P2|Overall Study|Did not meet entrance criteria|0
7543273|NCT02554877|26214350|P1|Overall Study|Did not meet entrance criteria|0
7543274|NCT02554877|26214347|P4|Overall Study|Lost to Follow-up|2
7543275|NCT02554877|26214348|P3|Overall Study|Lost to Follow-up|1
7543276|NCT02554877|26214349|P2|Overall Study|Lost to Follow-up|1
7543277|NCT02554877|26214350|P1|Overall Study|Lost to Follow-up|1
7543278|NCT02554877|26214347|P4|Overall Study|Adverse Event|1
7543279|NCT02554877|26214348|P3|Overall Study|Adverse Event|0
7543280|NCT02554877|26214349|P2|Overall Study|Adverse Event|0
7543281|NCT02554877|26214350|P1|Overall Study|Adverse Event|2
7543282|NCT02554786|26214438|P5|Overall Study|Pregnancy|1
7543283|NCT02554786|26214439|P4|Overall Study|Pregnancy|1
7543284|NCT02554786|26214440|P3|Overall Study|Pregnancy|0
7543285|NCT02554786|26214441|P2|Overall Study|Pregnancy|0
7543286|NCT02554786|26214442|P1|Overall Study|Pregnancy|0
7543287|NCT02554786|26214438|P5|Overall Study|Physician Decision|1
7543288|NCT02554786|26214439|P4|Overall Study|Physician Decision|1
7543289|NCT02554786|26214440|P3|Overall Study|Physician Decision|4
7543290|NCT02554786|26214441|P2|Overall Study|Physician Decision|1
7543291|NCT02554786|26214442|P1|Overall Study|Physician Decision|0
7543292|NCT02554786|26214438|P5|Overall Study|Non-compliance with study treatment|1
7543293|NCT02554786|26214439|P4|Overall Study|Non-compliance with study treatment|0
7543294|NCT02554786|26214440|P3|Overall Study|Non-compliance with study treatment|1
7543295|NCT02554786|26214441|P2|Overall Study|Non-compliance with study treatment|1
7543296|NCT02554786|26214442|P1|Overall Study|Non-compliance with study treatment|0
7543297|NCT02554786|26214438|P5|Overall Study|Death|0
7543298|NCT02554786|26214439|P4|Overall Study|Death|1
7543299|NCT02554786|26214440|P3|Overall Study|Death|0
7543300|NCT02554786|26214441|P2|Overall Study|Death|0
7543301|NCT02554786|26214442|P1|Overall Study|Death|0
7543302|NCT02554786|26214438|P5|Overall Study|Adverse Event|2
7543303|NCT02554786|26214439|P4|Overall Study|Adverse Event|0
7543304|NCT02554786|26214440|P3|Overall Study|Adverse Event|0
7543305|NCT02554786|26214441|P2|Overall Study|Adverse Event|0
7543306|NCT02554786|26214442|P1|Overall Study|Adverse Event|0
7543307|NCT02554786|26214438|P5|Overall Study|Technical problems|1
7543308|NCT02554786|26214439|P4|Overall Study|Technical problems|2
7543309|NCT02554786|26214440|P3|Overall Study|Technical problems|0
7543310|NCT02554786|26214441|P2|Overall Study|Technical problems|1
7543311|NCT02554786|26214442|P1|Overall Study|Technical problems|1
7543312|NCT02554786|26214438|P5|Overall Study|Protocol deviation|2
7543313|NCT02554786|26214439|P4|Overall Study|Protocol deviation|4
7543314|NCT02554786|26214440|P3|Overall Study|Protocol deviation|3
7543315|NCT02554786|26214441|P2|Overall Study|Protocol deviation|3
7543316|NCT02554786|26214442|P1|Overall Study|Protocol deviation|1
7543317|NCT02554786|26214438|P5|Overall Study|Lost to Follow-up|2
7543318|NCT02554786|26214439|P4|Overall Study|Lost to Follow-up|2
7543319|NCT02554786|26214440|P3|Overall Study|Lost to Follow-up|4
7543320|NCT02554786|26214441|P2|Overall Study|Lost to Follow-up|3
7543321|NCT02554786|26214442|P1|Overall Study|Lost to Follow-up|4
7543322|NCT02554786|26214438|P5|Overall Study|Subject/guardian decision|20
7543323|NCT02554786|26214439|P4|Overall Study|Subject/guardian decision|30
7543324|NCT02554786|26214440|P3|Overall Study|Subject/guardian decision|18
7543325|NCT02554786|26214441|P2|Overall Study|Subject/guardian decision|17
7543326|NCT02554786|26214442|P1|Overall Study|Subject/guardian decision|29
7543327|NCT02554721|26214599|P5|Overall Study|Noncompliance|1
7543328|NCT02554721|26214600|P4|Overall Study|Noncompliance|0
7543329|NCT02554721|26214601|P3|Overall Study|Noncompliance|0
7543330|NCT02554721|26214602|P2|Overall Study|Noncompliance|0
7543331|NCT02554721|26214603|P1|Overall Study|Noncompliance|0
7543332|NCT02554721|26214599|P5|Overall Study|Adverse Event|1
7543333|NCT02554721|26214600|P4|Overall Study|Adverse Event|0
7543334|NCT02554721|26214601|P3|Overall Study|Adverse Event|0
7543335|NCT02554721|26214602|P2|Overall Study|Adverse Event|0
7543336|NCT02554721|26214603|P1|Overall Study|Adverse Event|1
7543337|NCT02554682|26214624|P10|Overall Study|Physician Decision|0
7543338|NCT02554682|26214625|P9|Overall Study|Physician Decision|0
7543339|NCT02554682|26214626|P8|Overall Study|Physician Decision|0
7543340|NCT02554682|26214627|P7|Overall Study|Physician Decision|0
7543341|NCT02554682|26214628|P6|Overall Study|Physician Decision|0
7543342|NCT02554682|26214629|P5|Overall Study|Physician Decision|0
7543343|NCT02554682|26214630|P4|Overall Study|Physician Decision|0
7543344|NCT02554682|26214631|P3|Overall Study|Physician Decision|0
7543345|NCT02554682|26214632|P2|Overall Study|Physician Decision|2
7543346|NCT02554682|26214633|P1|Overall Study|Physician Decision|2
7543347|NCT02554682|26214624|P10|Overall Study|Withdrawal by Subject|0
7543348|NCT02554682|26214625|P9|Overall Study|Withdrawal by Subject|0
7543349|NCT02554682|26214626|P8|Overall Study|Withdrawal by Subject|0
7543350|NCT02554682|26214627|P7|Overall Study|Withdrawal by Subject|0
7543351|NCT02554682|26214628|P6|Overall Study|Withdrawal by Subject|0
7543352|NCT02554682|26214629|P5|Overall Study|Withdrawal by Subject|0
7543353|NCT02554682|26214630|P4|Overall Study|Withdrawal by Subject|0
7543354|NCT02554682|26214631|P3|Overall Study|Withdrawal by Subject|0
7543355|NCT02554682|26214632|P2|Overall Study|Withdrawal by Subject|1
7543356|NCT02554682|26214633|P1|Overall Study|Withdrawal by Subject|2
7543357|NCT02554682|26214624|P10|Overall Study|Lost to Follow-up|2
7543358|NCT02554682|26214625|P9|Overall Study|Lost to Follow-up|2
7543359|NCT02554682|26214626|P8|Overall Study|Lost to Follow-up|6
7543360|NCT02554682|26214627|P7|Overall Study|Lost to Follow-up|6
7543361|NCT02554682|26214628|P6|Overall Study|Lost to Follow-up|1
7543362|NCT02554682|26214629|P5|Overall Study|Lost to Follow-up|2
7543363|NCT02554682|26214630|P4|Overall Study|Lost to Follow-up|3
7543364|NCT02554682|26214631|P3|Overall Study|Lost to Follow-up|4
7543365|NCT02554682|26214632|P2|Overall Study|Lost to Follow-up|9
7543366|NCT02554682|26214633|P1|Overall Study|Lost to Follow-up|11
7543367|NCT02554656|26214682|P1|Overall Study|Protocol Violation|3
7543368|NCT02554474|26214692|P2|Overall Study|Withdrawal by Subject|1
7543369|NCT02554474|26214693|P1|Overall Study|Withdrawal by Subject|1
7543370|NCT02554474|26214692|P2|Overall Study|Health issue not related to the study|0
7543371|NCT02554474|26214693|P1|Overall Study|Health issue not related to the study|1
7543372|NCT02554474|26214692|P2|Overall Study|Protocol Violation|1
7543373|NCT02554474|26214693|P1|Overall Study|Protocol Violation|1
7543374|NCT02554279|26214752|P2|Overall Study|Other reason|6
7543375|NCT02554279|26214753|P1|Overall Study|Other reason|19
7543376|NCT02554279|26214752|P2|Overall Study|Protocol Violation|1
7543377|NCT02554279|26214753|P1|Overall Study|Protocol Violation|2
7543378|NCT02554279|26214752|P2|Overall Study|Withdrawal by Subject|4
7543379|NCT02554279|26214753|P1|Overall Study|Withdrawal by Subject|6
7543380|NCT02554279|26214752|P2|Overall Study|Lost to Follow-up|2
7543381|NCT02554279|26214753|P1|Overall Study|Lost to Follow-up|3
7543382|NCT02554279|26214752|P2|Overall Study|Adverse Event|5
7543383|NCT02554279|26214753|P1|Overall Study|Adverse Event|2
7543384|NCT02554019|26214788|P3|Overall Study|Adverse Event|0
7543385|NCT02554019|26214789|P2|Overall Study|Adverse Event|0
7543386|NCT02554019|26214790|P1|Overall Study|Adverse Event|1
7543387|NCT02554019|26214788|P3|Overall Study|Withdrawal by Subject|2
7543388|NCT02554019|26214789|P2|Overall Study|Withdrawal by Subject|0
7543389|NCT02554019|26214790|P1|Overall Study|Withdrawal by Subject|1
7543390|NCT02553928|26214812|P2|Overall Study|Administrative reason(s)|1
7543391|NCT02553928|26214813|P1|Overall Study|Administrative reason(s)|0
7543392|NCT02553928|26214812|P2|Overall Study|Lost to Follow-up|1
7543393|NCT02553928|26214813|P1|Overall Study|Lost to Follow-up|0
7543394|NCT02553928|26214812|P2|Overall Study|Adverse Event|1
7543395|NCT02553928|26214813|P1|Overall Study|Adverse Event|2
7543396|NCT02553772|26214867|P2|Overall Study|Other Miscellaneous Reasons|1
7543397|NCT02553772|26214868|P1|Overall Study|Other Miscellaneous Reasons|0
7543398|NCT02553772|26214867|P2|Overall Study|Lack of Efficacy|0
7543399|NCT02553772|26214868|P1|Overall Study|Lack of Efficacy|1
7543400|NCT02553772|26214867|P2|Overall Study|Withdrawal of Consent|1
7543401|NCT02553772|26214868|P1|Overall Study|Withdrawal of Consent|1
7543402|NCT02553772|26214867|P2|Overall Study|Lost to Follow-up|1
7543403|NCT02553772|26214868|P1|Overall Study|Lost to Follow-up|2
7543404|NCT02553772|26214867|P2|Overall Study|Adverse Event|3
7543405|NCT02553772|26214868|P1|Overall Study|Adverse Event|2
7543406|NCT02553629|26214913|P2|Overall Study|Logistic reasons|6
7543407|NCT02553629|26214914|P1|Overall Study|Logistic reasons|3
7543408|NCT02553538|26214930|P2|Overall Study|Died or Left Network|56
7543409|NCT02553538|26214931|P1|Overall Study|Died or Left Network|54
7543410|NCT02553538|26214930|P2|Overall Study|Could Not Reach by Telephone|0
7543411|NCT02553538|26214931|P1|Overall Study|Could Not Reach by Telephone|133
7543412|NCT02553499|26214965|P14|Overall Study|Withdrawal by Subject|0
7543413|NCT02553499|26214966|P13|Overall Study|Withdrawal by Subject|0
7543414|NCT02553499|26214967|P12|Overall Study|Withdrawal by Subject|0
7543415|NCT02553499|26214968|P11|Overall Study|Withdrawal by Subject|1
7543416|NCT02553499|26214969|P10|Overall Study|Withdrawal by Subject|0
7543417|NCT02553499|26214970|P9|Overall Study|Withdrawal by Subject|1
7543418|NCT02553499|26214971|P8|Overall Study|Withdrawal by Subject|1
7543419|NCT02553499|26214972|P7|Overall Study|Withdrawal by Subject|0
7543420|NCT02553499|26214973|P6|Overall Study|Withdrawal by Subject|0
7543421|NCT02553499|26214974|P5|Overall Study|Withdrawal by Subject|0
7543422|NCT02553499|26214975|P4|Overall Study|Withdrawal by Subject|0
7543423|NCT02553499|26214976|P3|Overall Study|Withdrawal by Subject|0
7543424|NCT02553499|26214977|P2|Overall Study|Withdrawal by Subject|0
7543425|NCT02553499|26214978|P1|Overall Study|Withdrawal by Subject|2
7543426|NCT02553499|26214965|P14|Overall Study|Study Terminated by Sponsor|0
7543427|NCT02553499|26214966|P13|Overall Study|Study Terminated by Sponsor|0
7543428|NCT02553499|26214967|P12|Overall Study|Study Terminated by Sponsor|0
7543429|NCT02553499|26214968|P11|Overall Study|Study Terminated by Sponsor|0
7543430|NCT02553499|26214969|P10|Overall Study|Study Terminated by Sponsor|0
7543431|NCT02553499|26214970|P9|Overall Study|Study Terminated by Sponsor|1
7543432|NCT02553499|26214971|P8|Overall Study|Study Terminated by Sponsor|0
7543433|NCT02553499|26214972|P7|Overall Study|Study Terminated by Sponsor|0
7543434|NCT02553499|26214973|P6|Overall Study|Study Terminated by Sponsor|0
7543435|NCT02553499|26214974|P5|Overall Study|Study Terminated by Sponsor|0
7543436|NCT02553499|26214975|P4|Overall Study|Study Terminated by Sponsor|0
7543437|NCT02553499|26214976|P3|Overall Study|Study Terminated by Sponsor|0
7543438|NCT02553499|26214977|P2|Overall Study|Study Terminated by Sponsor|0
7543439|NCT02553499|26214978|P1|Overall Study|Study Terminated by Sponsor|0
7543440|NCT02553499|26214965|P14|Overall Study|Progressive Disease|1
7543441|NCT02553499|26214966|P13|Overall Study|Progressive Disease|2
7543442|NCT02553499|26214967|P12|Overall Study|Progressive Disease|0
7543443|NCT02553499|26214968|P11|Overall Study|Progressive Disease|0
7543444|NCT02553499|26214969|P10|Overall Study|Progressive Disease|1
7543445|NCT02553499|26214970|P9|Overall Study|Progressive Disease|0
7543446|NCT02553499|26214971|P8|Overall Study|Progressive Disease|0
7543447|NCT02553499|26214972|P7|Overall Study|Progressive Disease|1
7543448|NCT02553499|26214973|P6|Overall Study|Progressive Disease|1
7543449|NCT02553499|26214974|P5|Overall Study|Progressive Disease|1
7543450|NCT02553499|26214975|P4|Overall Study|Progressive Disease|2
7543451|NCT02553499|26214976|P3|Overall Study|Progressive Disease|0
7543452|NCT02553499|26214977|P2|Overall Study|Progressive Disease|0
7543453|NCT02553499|26214978|P1|Overall Study|Progressive Disease|0
7543454|NCT02553499|26214965|P14|Overall Study|Physician Decision|0
7543455|NCT02553499|26214966|P13|Overall Study|Physician Decision|1
7543456|NCT02553499|26214967|P12|Overall Study|Physician Decision|3
7543457|NCT02553499|26214968|P11|Overall Study|Physician Decision|1
7543458|NCT02553499|26214969|P10|Overall Study|Physician Decision|2
7543459|NCT02553499|26214970|P9|Overall Study|Physician Decision|1
7543460|NCT02553499|26214971|P8|Overall Study|Physician Decision|1
7543461|NCT02553499|26214972|P7|Overall Study|Physician Decision|0
7543462|NCT02553499|26214973|P6|Overall Study|Physician Decision|0
7543463|NCT02553499|26214974|P5|Overall Study|Physician Decision|1
7543464|NCT02553499|26214975|P4|Overall Study|Physician Decision|0
7543465|NCT02553499|26214976|P3|Overall Study|Physician Decision|1
7543466|NCT02553499|26214977|P2|Overall Study|Physician Decision|1
7543467|NCT02553499|26214978|P1|Overall Study|Physician Decision|0
7543468|NCT02553499|26214965|P14|Overall Study|Lost to Follow-up|0
7543469|NCT02553499|26214966|P13|Overall Study|Lost to Follow-up|0
7543470|NCT02553499|26214967|P12|Overall Study|Lost to Follow-up|0
7543471|NCT02553499|26214968|P11|Overall Study|Lost to Follow-up|0
7543472|NCT02553499|26214969|P10|Overall Study|Lost to Follow-up|0
7543473|NCT02553499|26214970|P9|Overall Study|Lost to Follow-up|0
7543474|NCT02553499|26214971|P8|Overall Study|Lost to Follow-up|0
7543475|NCT02553499|26214972|P7|Overall Study|Lost to Follow-up|1
7543476|NCT02553499|26214973|P6|Overall Study|Lost to Follow-up|0
7543477|NCT02553499|26214974|P5|Overall Study|Lost to Follow-up|0
7543478|NCT02553499|26214975|P4|Overall Study|Lost to Follow-up|0
7543479|NCT02553499|26214976|P3|Overall Study|Lost to Follow-up|0
7543480|NCT02553499|26214977|P2|Overall Study|Lost to Follow-up|0
7543481|NCT02553499|26214978|P1|Overall Study|Lost to Follow-up|0
7543482|NCT02553499|26214965|P14|Overall Study|Death|0
7543483|NCT02553499|26214966|P13|Overall Study|Death|0
7543484|NCT02553499|26214967|P12|Overall Study|Death|0
7543485|NCT02553499|26214968|P11|Overall Study|Death|1
7543486|NCT02553499|26214969|P10|Overall Study|Death|0
7543487|NCT02553499|26214970|P9|Overall Study|Death|0
7543488|NCT02553499|26214971|P8|Overall Study|Death|0
7543489|NCT02553499|26214972|P7|Overall Study|Death|0
7543490|NCT02553499|26214973|P6|Overall Study|Death|2
7543491|NCT02553499|26214974|P5|Overall Study|Death|1
7543492|NCT02553499|26214975|P4|Overall Study|Death|0
7543493|NCT02553499|26214976|P3|Overall Study|Death|1
7543494|NCT02553499|26214977|P2|Overall Study|Death|1
7543495|NCT02553499|26214978|P1|Overall Study|Death|0
7543496|NCT02553499|26214965|P14|Overall Study|Adverse Event|1
7543497|NCT02553499|26214966|P13|Overall Study|Adverse Event|0
7543498|NCT02553499|26214967|P12|Overall Study|Adverse Event|0
7543499|NCT02553499|26214968|P11|Overall Study|Adverse Event|0
7543500|NCT02553499|26214969|P10|Overall Study|Adverse Event|0
7543501|NCT02553499|26214970|P9|Overall Study|Adverse Event|0
7543502|NCT02553499|26214971|P8|Overall Study|Adverse Event|1
7543503|NCT02553499|26214972|P7|Overall Study|Adverse Event|1
7543504|NCT02553499|26214973|P6|Overall Study|Adverse Event|0
7543505|NCT02553499|26214974|P5|Overall Study|Adverse Event|0
7543506|NCT02553499|26214975|P4|Overall Study|Adverse Event|0
7543507|NCT02553499|26214976|P3|Overall Study|Adverse Event|0
7543508|NCT02553499|26214977|P2|Overall Study|Adverse Event|0
7543509|NCT02553499|26214978|P1|Overall Study|Adverse Event|0
7543510|NCT02553421|26215080|P2|Overall Study|Improper Device Placement|0
7543511|NCT02553421|26215081|P1|Overall Study|Improper Device Placement|3
7543512|NCT02553421|26215080|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
7543513|NCT02553421|26215081|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
7543514|NCT02553421|26215080|P2|Overall Study|Lost to Follow-up|1
7543515|NCT02553421|26215081|P1|Overall Study|Lost to Follow-up|21
7543516|NCT02553330|26215136|P3|Overall Study|Lost to Follow-up|4
7543517|NCT02553330|26215137|P2|Overall Study|Lost to Follow-up|4
7543518|NCT02553330|26215138|P1|Overall Study|Lost to Follow-up|0
7543519|NCT02553330|26215136|P3|Overall Study|Adverse Event|0
7543520|NCT02553330|26215137|P2|Overall Study|Adverse Event|1
7543521|NCT02553330|26215138|P1|Overall Study|Adverse Event|0
7543522|NCT02553330|26215136|P3|Overall Study|Non compliance to study treatment|0
7543523|NCT02553330|26215137|P2|Overall Study|Non compliance to study treatment|1
7543524|NCT02553330|26215138|P1|Overall Study|Non compliance to study treatment|0
7543525|NCT02553330|26215136|P3|Overall Study|Other|0
7543526|NCT02553330|26215137|P2|Overall Study|Other|1
7543527|NCT02553330|26215138|P1|Overall Study|Other|0
7543528|NCT02553330|26215136|P3|Overall Study|Withdrawal by Subject|21
7543529|NCT02553330|26215137|P2|Overall Study|Withdrawal by Subject|19
7543530|NCT02553330|26215138|P1|Overall Study|Withdrawal by Subject|3
7543531|NCT02553330|26215136|P3|Overall Study|Study Terminated by Sponsor|12
7543532|NCT02553330|26215137|P2|Overall Study|Study Terminated by Sponsor|13
7543533|NCT02553330|26215138|P1|Overall Study|Study Terminated by Sponsor|2
7543534|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
7543535|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
7543536|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
7543537|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
7543538|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7543539|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7543540|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
7543541|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
7543542|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
7543543|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
7543544|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Adverse Event|5
7543545|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Adverse Event|6
7543546|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Death|3
7543547|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Death|1
7543548|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
7543549|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
7543550|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Physician Decision|4
7543551|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Physician Decision|2
7543552|NCT02553317|26215162|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
7543553|NCT02553317|26215163|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
7543554|NCT02552966|26215193|P1|Overall Study|Withdrawal by Subject|3
7543555|NCT02552966|26215193|P1|Overall Study|Lost to Follow-up|2
7543556|NCT02552888|26215202|P2|Overall Study|Lost to Follow-up|1
7543557|NCT02552888|26215203|P1|Overall Study|Lost to Follow-up|1
7543558|NCT02552732|26215268|P1|Overall Study|Withdrawal by Subject|6
7543559|NCT02552732|26215268|P1|Overall Study|Day 1 SpO2 > 96%|1
7543560|NCT02552732|26215268|P1|Overall Study|Physician Decision|1
7543561|NCT02552732|26215268|P1|Overall Study|Lost to Follow-up|2
7543562|NCT02552355|26215304|P4|Overall Study|Withdrawal by Subject|1
7543563|NCT02552355|26215305|P3|Overall Study|Withdrawal by Subject|0
7543564|NCT02552355|26215306|P2|Overall Study|Withdrawal by Subject|0
7543565|NCT02552355|26215307|P1|Overall Study|Withdrawal by Subject|0
7543566|NCT02552355|26215304|P4|Overall Study|Adverse Event|0
7543567|NCT02552355|26215305|P3|Overall Study|Adverse Event|2
7543568|NCT02552355|26215306|P2|Overall Study|Adverse Event|2
7543569|NCT02552355|26215307|P1|Overall Study|Adverse Event|0
7543570|NCT02552316|26215349|P1|Overall Study|Withdrawal due to non-compliance|1
7543571|NCT02552316|26215349|P1|Overall Study|Withdrawal by Subject|1
7543572|NCT02552303|26215401|P4|Follow-Up|ineligible|0
7543573|NCT02552303|26215402|P3|Follow-Up|ineligible|0
7543574|NCT02552303|26215403|P2|Follow-Up|ineligible|2
7543575|NCT02552303|26215404|P1|Follow-Up|ineligible|0
7543576|NCT02552303|26215401|P4|Follow-Up|Lost to Follow-up|0
7543577|NCT02552303|26215402|P3|Follow-Up|Lost to Follow-up|1
7543578|NCT02552303|26215403|P2|Follow-Up|Lost to Follow-up|0
7543579|NCT02552303|26215404|P1|Follow-Up|Lost to Follow-up|0
7543580|NCT02552303|26215401|P4|Allocation|ineligible|0
7543581|NCT02552303|26215402|P3|Allocation|ineligible|0
7543582|NCT02552303|26215403|P2|Allocation|ineligible|1
7543583|NCT02552303|26215404|P1|Allocation|ineligible|1
7543584|NCT02552303|26215401|P4|Allocation|Withdrawal by Subject|1
7543585|NCT02552303|26215402|P3|Allocation|Withdrawal by Subject|1
7543586|NCT02552303|26215403|P2|Allocation|Withdrawal by Subject|1
7543587|NCT02552303|26215404|P1|Allocation|Withdrawal by Subject|2
7543588|NCT02552238|26215418|P1|Overall Study|Adverse Event|2
7543589|NCT02552238|26215418|P1|Overall Study|Withdrawal by Subject|2
7543590|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Decision of Patient|1
7543591|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Decision of Patient|0
7543592|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Decision of Patient|0
7543593|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
7543594|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
7543595|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
7543596|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Compassionate access|2
7543597|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Compassionate access|0
7543598|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Compassionate access|0
7543599|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
7543600|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
7543601|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
7543602|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Investigator decision|1
7543603|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Investigator decision|0
7543604|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Investigator decision|0
7543605|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Patient's personal reason|1
7543606|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Patient's personal reason|0
7543607|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Patient's personal reason|0
7543608|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
7543609|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
7543610|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
7543611|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
7543612|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
7543613|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
7543614|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Lost to Follow-up|2
7543615|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Lost to Follow-up|0
7543616|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Lost to Follow-up|0
7543617|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Lack of Efficacy|4
7543618|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Lack of Efficacy|0
7543619|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Lack of Efficacy|0
7543620|NCT02552212|26215431|P3|SFE Period (Week 52 - 156)|Adverse Event|5
7543621|NCT02552212|26215432|P2|SFE Period (Week 52 - 156)|Adverse Event|0
7543622|NCT02552212|26215433|P1|SFE Period (Week 52 - 156)|Adverse Event|0
7543623|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
7543624|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
7543625|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
7543626|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Not eligible|0
7543627|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Not eligible|1
7543628|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Not eligible|0
7543629|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|As per suggestion|0
7543630|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|As per suggestion|1
7543631|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|As per suggestion|0
7543632|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Patient's decision|0
7543633|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Patient's decision|1
7543634|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Patient's decision|0
7543635|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
7543636|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
7543637|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
7543638|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
7543639|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
7543640|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
7543641|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
7543642|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
7543643|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
7543644|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
7543645|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
7543646|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
7543647|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
7543648|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
7543649|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
7543650|NCT02552212|26215431|P3|Double-Blind Period (Week 0 - 52)|Adverse Event|0
7543651|NCT02552212|26215432|P2|Double-Blind Period (Week 0 - 52)|Adverse Event|3
7543652|NCT02552212|26215433|P1|Double-Blind Period (Week 0 - 52)|Adverse Event|6
7543653|NCT02552147|26215511|P2|Second Intervention (7 Days)|Protocol Violation|0
7543654|NCT02552147|26215512|P1|Second Intervention (7 Days)|Protocol Violation|2
7543655|NCT02552147|26215511|P2|First Intervention (7 Days)|Protocol Violation|0
7543656|NCT02552147|26215512|P1|First Intervention (7 Days)|Protocol Violation|1
7543657|NCT02552121|26215546|P8|Part 2: Cohort Expansion|Death|0
7543658|NCT02552121|26215547|P7|Part 2: Cohort Expansion|Death|0
7543659|NCT02552121|26215548|P6|Part 2: Cohort Expansion|Death|0
7543660|NCT02552121|26215549|P5|Part 2: Cohort Expansion|Death|0
7543661|NCT02552121|26215550|P4|Part 2: Cohort Expansion|Death|0
7543662|NCT02552121|26215551|P3|Part 2: Cohort Expansion|Death|1
7543663|NCT02552121|26215552|P2|Part 2: Cohort Expansion|Death|0
7543664|NCT02552121|26215553|P1|Part 2: Cohort Expansion|Death|0
7543665|NCT02552121|26215546|P8|Part 2: Cohort Expansion|Adverse Event|0
7543666|NCT02552121|26215547|P7|Part 2: Cohort Expansion|Adverse Event|0
7543667|NCT02552121|26215548|P6|Part 2: Cohort Expansion|Adverse Event|0
7543668|NCT02552121|26215549|P5|Part 2: Cohort Expansion|Adverse Event|0
7543669|NCT02552121|26215550|P4|Part 2: Cohort Expansion|Adverse Event|1
7543670|NCT02552121|26215551|P3|Part 2: Cohort Expansion|Adverse Event|6
7543671|NCT02552121|26215552|P2|Part 2: Cohort Expansion|Adverse Event|0
7543672|NCT02552121|26215553|P1|Part 2: Cohort Expansion|Adverse Event|0
7543673|NCT02552121|26215546|P8|Part 2: Cohort Expansion|Disease Progression|3
7543674|NCT02552121|26215547|P7|Part 2: Cohort Expansion|Disease Progression|0
7543675|NCT02552121|26215548|P6|Part 2: Cohort Expansion|Disease Progression|4
7543676|NCT02552121|26215549|P5|Part 2: Cohort Expansion|Disease Progression|1
7543677|NCT02552121|26215550|P4|Part 2: Cohort Expansion|Disease Progression|2
7543678|NCT02552121|26215551|P3|Part 2: Cohort Expansion|Disease Progression|3
7543679|NCT02552121|26215552|P2|Part 2: Cohort Expansion|Disease Progression|0
7543680|NCT02552121|26215553|P1|Part 2: Cohort Expansion|Disease Progression|0
7543681|NCT02552121|26215546|P8|Part 2: Cohort Expansion|Patient Choice|0
7543682|NCT02552121|26215547|P7|Part 2: Cohort Expansion|Patient Choice|1
7543683|NCT02552121|26215548|P6|Part 2: Cohort Expansion|Patient Choice|0
7543684|NCT02552121|26215549|P5|Part 2: Cohort Expansion|Patient Choice|0
7543685|NCT02552121|26215550|P4|Part 2: Cohort Expansion|Patient Choice|0
7543686|NCT02552121|26215551|P3|Part 2: Cohort Expansion|Patient Choice|1
7543687|NCT02552121|26215552|P2|Part 2: Cohort Expansion|Patient Choice|0
7543688|NCT02552121|26215553|P1|Part 2: Cohort Expansion|Patient Choice|0
7543689|NCT02552121|26215546|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543690|NCT02552121|26215547|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543691|NCT02552121|26215548|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543692|NCT02552121|26215549|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543693|NCT02552121|26215550|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543694|NCT02552121|26215551|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543695|NCT02552121|26215552|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
7543696|NCT02552121|26215553|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7543697|NCT02552121|26215546|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543698|NCT02552121|26215547|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543699|NCT02552121|26215548|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543700|NCT02552121|26215549|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543701|NCT02552121|26215550|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543702|NCT02552121|26215551|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543703|NCT02552121|26215552|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
7543704|NCT02552121|26215553|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7543705|NCT02552121|26215546|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543706|NCT02552121|26215547|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543707|NCT02552121|26215548|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543708|NCT02552121|26215549|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543709|NCT02552121|26215550|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543710|NCT02552121|26215551|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543711|NCT02552121|26215552|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
7543712|NCT02552121|26215553|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7543713|NCT02552121|26215546|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543714|NCT02552121|26215547|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543715|NCT02552121|26215548|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543716|NCT02552121|26215549|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543717|NCT02552121|26215550|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543718|NCT02552121|26215551|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543719|NCT02552121|26215552|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
7543720|NCT02552121|26215553|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7543721|NCT02552121|26215546|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543722|NCT02552121|26215547|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543723|NCT02552121|26215548|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543724|NCT02552121|26215549|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543725|NCT02552121|26215550|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543726|NCT02552121|26215551|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543727|NCT02552121|26215552|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7543728|NCT02552121|26215553|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
7543729|NCT02552121|26215546|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543730|NCT02552121|26215547|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543731|NCT02552121|26215548|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543732|NCT02552121|26215549|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543733|NCT02552121|26215550|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543734|NCT02552121|26215551|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543735|NCT02552121|26215552|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7543736|NCT02552121|26215553|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
7543737|NCT02551874|26215814|P2|Overall Study|Did not enter long-term study|25
7543738|NCT02551874|26215815|P1|Overall Study|Did not enter long-term study|18
7543739|NCT02551874|26215814|P2|Overall Study|Did not receive randomized treatment|7
7543740|NCT02551874|26215815|P1|Overall Study|Did not receive randomized treatment|0
7543741|NCT02551874|26215814|P2|Overall Study|Reason not reported|4
7543742|NCT02551874|26215815|P1|Overall Study|Reason not reported|10
7543743|NCT02551874|26215814|P2|Overall Study|Pregnancy|1
7543744|NCT02551874|26215815|P1|Overall Study|Pregnancy|0
7543745|NCT02551874|26215814|P2|Overall Study|Lost to Follow-up|2
7543746|NCT02551874|26215815|P1|Overall Study|Lost to Follow-up|0
7543747|NCT02551731|26215897|P1|Overall Study|Withdrawal by Subject|2
7543748|NCT02551692|26215921|P3|Overall Study|Withdrawal by Subject|1
7543749|NCT02551692|26215922|P2|Overall Study|Withdrawal by Subject|0
7543750|NCT02551692|26215923|P1|Overall Study|Withdrawal by Subject|1
7543751|NCT02551692|26215921|P3|Overall Study|Lost to Follow-up|4
7543752|NCT02551692|26215922|P2|Overall Study|Lost to Follow-up|1
7543753|NCT02551692|26215923|P1|Overall Study|Lost to Follow-up|0
7543754|NCT02551666|26215939|P2|Overall Study|Withdrawal by Subject|3
7543755|NCT02551666|26215940|P1|Overall Study|Withdrawal by Subject|1
7543756|NCT02551159|26215995|P3|Overall Study|Patients alive or lost to follow-up at DCO|29
7543757|NCT02551159|26215996|P2|Overall Study|Patients alive or lost to follow-up at DCO|25
7543758|NCT02551159|26215997|P1|Overall Study|Patients alive or lost to follow-up at DCO|53
7543759|NCT02551159|26215995|P3|Overall Study|Withdrawal by Subject|16
7543760|NCT02551159|26215996|P2|Overall Study|Withdrawal by Subject|5
7543761|NCT02551159|26215997|P1|Overall Study|Withdrawal by Subject|8
7543762|NCT02551159|26215995|P3|Overall Study|Death|161
7543763|NCT02551159|26215996|P2|Overall Study|Death|174
7543764|NCT02551159|26215997|P1|Overall Study|Death|352
7543765|NCT02551055|26216079|P8|Overall Study|Reason not specified|0
7543766|NCT02551055|26216080|P7|Overall Study|Reason not specified|1
7543767|NCT02551055|26216081|P6|Overall Study|Reason not specified|0
7543768|NCT02551055|26216082|P5|Overall Study|Reason not specified|1
7543769|NCT02551055|26216083|P4|Overall Study|Reason not specified|0
7543770|NCT02551055|26216084|P3|Overall Study|Reason not specified|0
7543771|NCT02551055|26216085|P2|Overall Study|Reason not specified|0
7543772|NCT02551055|26216086|P1|Overall Study|Reason not specified|0
7543773|NCT02551055|26216079|P8|Overall Study|Withdrawal by Subject|0
7543774|NCT02551055|26216080|P7|Overall Study|Withdrawal by Subject|0
7543775|NCT02551055|26216081|P6|Overall Study|Withdrawal by Subject|0
7543776|NCT02551055|26216082|P5|Overall Study|Withdrawal by Subject|2
7543777|NCT02551055|26216083|P4|Overall Study|Withdrawal by Subject|1
7543778|NCT02551055|26216084|P3|Overall Study|Withdrawal by Subject|0
7543779|NCT02551055|26216085|P2|Overall Study|Withdrawal by Subject|1
7543780|NCT02551055|26216086|P1|Overall Study|Withdrawal by Subject|1
7543781|NCT02551055|26216079|P8|Overall Study|Study Terminated by Sponsor|0
7543782|NCT02551055|26216080|P7|Overall Study|Study Terminated by Sponsor|0
7543783|NCT02551055|26216081|P6|Overall Study|Study Terminated by Sponsor|0
7543784|NCT02551055|26216082|P5|Overall Study|Study Terminated by Sponsor|2
7543785|NCT02551055|26216083|P4|Overall Study|Study Terminated by Sponsor|2
7543786|NCT02551055|26216084|P3|Overall Study|Study Terminated by Sponsor|0
7543787|NCT02551055|26216085|P2|Overall Study|Study Terminated by Sponsor|1
7543788|NCT02551055|26216086|P1|Overall Study|Study Terminated by Sponsor|1
7543789|NCT02551055|26216079|P8|Overall Study|Death|0
7543790|NCT02551055|26216080|P7|Overall Study|Death|2
7543791|NCT02551055|26216081|P6|Overall Study|Death|1
7543792|NCT02551055|26216082|P5|Overall Study|Death|2
7543793|NCT02551055|26216083|P4|Overall Study|Death|2
7543794|NCT02551055|26216084|P3|Overall Study|Death|2
7543795|NCT02551055|26216085|P2|Overall Study|Death|4
7543796|NCT02551055|26216086|P1|Overall Study|Death|2
7543797|NCT02550938|26216163|P4|Overall Study|Lost to Follow-up|11
7543798|NCT02550938|26216164|P3|Overall Study|Lost to Follow-up|12
7543799|NCT02550938|26216165|P2|Overall Study|Lost to Follow-up|7
7543800|NCT02550938|26216166|P1|Overall Study|Lost to Follow-up|8
7543801|NCT02550873|26216190|P3|Open Label Extension|Study ongoing|111
7543802|NCT02550873|26216191|P2|Open Label Extension|Study ongoing|0
7543803|NCT02550873|26216192|P1|Open Label Extension|Study ongoing|0
7543804|NCT02550873|26216190|P3|Randomized Double Blind|Disease progression|0
7543805|NCT02550873|26216191|P2|Randomized Double Blind|Disease progression|1
7543806|NCT02550873|26216192|P1|Randomized Double Blind|Disease progression|1
7543807|NCT02550873|26216190|P3|Randomized Double Blind|Adverse Event|0
7543808|NCT02550873|26216191|P2|Randomized Double Blind|Adverse Event|1
7543809|NCT02550873|26216192|P1|Randomized Double Blind|Adverse Event|3
7543810|NCT02550795|26216273|P3|Overall Study|Physician Decision|0
7543811|NCT02550795|26216274|P2|Overall Study|Physician Decision|1
7543812|NCT02550795|26216275|P1|Overall Study|Physician Decision|0
7543813|NCT02550652|26216309|P2|Overall Study|Ongoing in safety/B-cell follow-up period|5
7543814|NCT02550652|26216310|P1|Overall Study|Ongoing in safety/B-cell follow-up period|14
7543815|NCT02550652|26216309|P2|Overall Study|Physician Decision|2
7543816|NCT02550652|26216310|P1|Overall Study|Physician Decision|0
7543817|NCT02550652|26216309|P2|Overall Study|Lost to Follow-up|3
7543818|NCT02550652|26216310|P1|Overall Study|Lost to Follow-up|1
7543819|NCT02550652|26216309|P2|Overall Study|Post Trial Access|0
7543820|NCT02550652|26216310|P1|Overall Study|Post Trial Access|1
7543821|NCT02550652|26216309|P2|Overall Study|Withdrawal by Subject|7
7543822|NCT02550652|26216310|P1|Overall Study|Withdrawal by Subject|3
7543823|NCT02550652|26216309|P2|Overall Study|Lack of Efficacy|0
7543824|NCT02550652|26216310|P1|Overall Study|Lack of Efficacy|1
7543825|NCT02550652|26216309|P2|Overall Study|Death|4
7543826|NCT02550652|26216310|P1|Overall Study|Death|1
7543827|NCT02550288|26216357|P5|Overall Study|Withdrawal by Subject|0
7543828|NCT02550288|26216358|P4|Overall Study|Withdrawal by Subject|1
7543829|NCT02550288|26216359|P3|Overall Study|Withdrawal by Subject|0
7543830|NCT02550288|26216360|P2|Overall Study|Withdrawal by Subject|0
7543831|NCT02550288|26216361|P1|Overall Study|Withdrawal by Subject|0
7543832|NCT02550288|26216357|P5|Overall Study|Participant moved|0
7543833|NCT02550288|26216358|P4|Overall Study|Participant moved|1
7543834|NCT02550288|26216359|P3|Overall Study|Participant moved|0
7543835|NCT02550288|26216360|P2|Overall Study|Participant moved|0
7543836|NCT02550288|26216361|P1|Overall Study|Participant moved|0
7543837|NCT02550288|26216357|P5|Overall Study|Protocol Violation|3
7543838|NCT02550288|26216358|P4|Overall Study|Protocol Violation|0
7543839|NCT02550288|26216359|P3|Overall Study|Protocol Violation|1
7543840|NCT02550288|26216360|P2|Overall Study|Protocol Violation|2
7543841|NCT02550288|26216361|P1|Overall Study|Protocol Violation|2
7543842|NCT02550288|26216357|P5|Overall Study|Physician Decision|0
7543843|NCT02550288|26216358|P4|Overall Study|Physician Decision|1
7543844|NCT02550288|26216359|P3|Overall Study|Physician Decision|0
7543845|NCT02550288|26216360|P2|Overall Study|Physician Decision|0
7543846|NCT02550288|26216361|P1|Overall Study|Physician Decision|0
7543847|NCT02550288|26216357|P5|Overall Study|Adverse Event|0
7543848|NCT02550288|26216358|P4|Overall Study|Adverse Event|0
7543849|NCT02550288|26216359|P3|Overall Study|Adverse Event|0
7543850|NCT02550288|26216360|P2|Overall Study|Adverse Event|1
7543851|NCT02550288|26216361|P1|Overall Study|Adverse Event|0
7543852|NCT02550106|26216517|P1|Overall Study|Withdrawal by Subject|2
7543853|NCT02550106|26216517|P1|Overall Study|Protocol Violation|6
7543854|NCT02550106|26216517|P1|Overall Study|Lack of Efficacy|3
7543855|NCT02550106|26216517|P1|Overall Study|Adverse Event|1
7543856|NCT02549859|26216541|P1|Long-term 60 Hz DBS|Study Closed|1
7543857|NCT02549573|26216627|P2|Overall Study|Protocol Violation|1
7543858|NCT02549573|26216628|P1|Overall Study|Protocol Violation|0
7543859|NCT02549573|26216627|P2|Overall Study|Withdrawal by Subject|2
7543860|NCT02549573|26216628|P1|Overall Study|Withdrawal by Subject|0
7543861|NCT02549352|26216695|P2|12-month Follow-up|Other|3
7543862|NCT02549352|26216696|P1|12-month Follow-up|Other|1
7543863|NCT02549352|26216695|P2|12-month Follow-up|Protocol Violation|1
7543864|NCT02549352|26216696|P1|12-month Follow-up|Protocol Violation|0
7543865|NCT02549352|26216695|P2|12-month Follow-up|Death|1
7543866|NCT02549352|26216696|P1|12-month Follow-up|Death|0
7543867|NCT02549352|26216695|P2|12-month Follow-up|Lost to Follow-up|2
7543868|NCT02549352|26216696|P1|12-month Follow-up|Lost to Follow-up|3
7543869|NCT02549352|26216695|P2|12-month Follow-up|Withdrawal by Subject|5
7543870|NCT02549352|26216696|P1|12-month Follow-up|Withdrawal by Subject|4
7543871|NCT02549352|26216695|P2|3-day Treatment and 8-week Follow-up|Other|2
7543872|NCT02549352|26216696|P1|3-day Treatment and 8-week Follow-up|Other|0
7543873|NCT02549352|26216695|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7543874|NCT02549352|26216696|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7543875|NCT02549352|26216695|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
7543876|NCT02549352|26216696|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
7543877|NCT02549339|26216712|P2|12-month Follow-up|Other|3
7543878|NCT02549339|26216713|P1|12-month Follow-up|Other|0
7543879|NCT02549339|26216712|P2|12-month Follow-up|Lost to Follow-up|3
7543880|NCT02549339|26216713|P1|12-month Follow-up|Lost to Follow-up|1
7543881|NCT02549339|26216712|P2|12-month Follow-up|Withdrawal by Subject|3
7543882|NCT02549339|26216713|P1|12-month Follow-up|Withdrawal by Subject|8
7543883|NCT02549339|26216712|P2|12-month Follow-up|Lack of Efficacy|2
7543884|NCT02549339|26216713|P1|12-month Follow-up|Lack of Efficacy|0
7543885|NCT02549339|26216712|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
7543886|NCT02549339|26216713|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7543887|NCT02549339|26216712|P2|3-day Treatment and 8-week Follow-up|Other|0
7543888|NCT02549339|26216713|P1|3-day Treatment and 8-week Follow-up|Other|1
7543889|NCT02549339|26216712|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7543890|NCT02549339|26216713|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
7543891|NCT02549339|26216712|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
7543892|NCT02549339|26216713|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
7543893|NCT02549287|26216729|P2|Overall Study|Withdrawal by Subject|6
7543894|NCT02549287|26216730|P1|Overall Study|Withdrawal by Subject|15
7543895|NCT02549287|26216729|P2|Overall Study|Lost to Follow-up|26
7543896|NCT02549287|26216730|P1|Overall Study|Lost to Follow-up|65
7543897|NCT02549196|26216764|P4|Overall Study|Withdrawal by Subject|0
7543898|NCT02549196|26216765|P3|Overall Study|Withdrawal by Subject|1
7543899|NCT02549196|26216766|P2|Overall Study|Withdrawal by Subject|0
7543900|NCT02549196|26216767|P1|Overall Study|Withdrawal by Subject|1
7543901|NCT02549196|26216764|P4|Overall Study|Protocol Violation|1
7543902|NCT02549196|26216765|P3|Overall Study|Protocol Violation|0
7543903|NCT02549196|26216766|P2|Overall Study|Protocol Violation|0
7543904|NCT02549196|26216767|P1|Overall Study|Protocol Violation|0
7543905|NCT02549092|26216783|P2|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7543906|NCT02549092|26216784|P1|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7543907|NCT02549092|26216783|P2|Extension/Transition Period|Still in Extension/Transition Period|8
7543908|NCT02549092|26216784|P1|Extension/Transition Period|Still in Extension/Transition Period|4
7543909|NCT02549092|26216783|P2|Treatment Period|Lack of Efficacy|2
7543910|NCT02549092|26216784|P1|Treatment Period|Lack of Efficacy|0
7543911|NCT02549092|26216783|P2|Treatment Period|Withdrawal by Subject|3
7543912|NCT02549092|26216784|P1|Treatment Period|Withdrawal by Subject|1
7543913|NCT02549092|26216783|P2|Treatment Period|Adverse Event|2
7543914|NCT02549092|26216784|P1|Treatment Period|Adverse Event|2
7543915|NCT02549027|26216856|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7543916|NCT02549027|26216857|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
7543917|NCT02549027|26216858|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7543918|NCT02549027|26216859|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7543919|NCT02549027|26216860|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7543920|NCT02549027|26216861|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7543921|NCT02549027|26216856|P6|Washout After Period 4|Withdrawal by Subject|0
7543922|NCT02549027|26216857|P5|Washout After Period 4|Withdrawal by Subject|0
7543923|NCT02549027|26216858|P4|Washout After Period 4|Withdrawal by Subject|1
7543924|NCT02549027|26216859|P3|Washout After Period 4|Withdrawal by Subject|1
7543925|NCT02549027|26216860|P2|Washout After Period 4|Withdrawal by Subject|1
7543926|NCT02549027|26216861|P1|Washout After Period 4|Withdrawal by Subject|0
7543927|NCT02548962|26216991|P2|Overall Study|Withdrawal by Subject|0
7543928|NCT02548962|26216992|P1|Overall Study|Withdrawal by Subject|1
7543929|NCT02548650|26217068|P2|Double Therapy|Withdrawal by Subject|1
7543930|NCT02548650|26217069|P1|Double Therapy|Withdrawal by Subject|0
7543931|NCT02548650|26217068|P2|Double Therapy|Adverse Event|1
7543932|NCT02548650|26217069|P1|Double Therapy|Adverse Event|1
7543933|NCT02548650|26217068|P2|Triple Therapy|Withdrawal by Subject|4
7543934|NCT02548650|26217069|P1|Triple Therapy|Withdrawal by Subject|0
7543935|NCT02548650|26217068|P2|Triple Therapy|Adverse Event|0
7543936|NCT02548650|26217069|P1|Triple Therapy|Adverse Event|1
7543937|NCT02548585|26217084|P7|Overall Study|Randomized but not treated|0
7543938|NCT02548585|26217085|P6|Overall Study|Randomized but not treated|1
7543939|NCT02548585|26217086|P5|Overall Study|Randomized but not treated|0
7543940|NCT02548585|26217087|P4|Overall Study|Randomized but not treated|0
7543941|NCT02548585|26217088|P3|Overall Study|Randomized but not treated|0
7543942|NCT02548585|26217089|P2|Overall Study|Randomized but not treated|0
7543943|NCT02548585|26217090|P1|Overall Study|Randomized but not treated|0
7543944|NCT02548585|26217084|P7|Overall Study|Other|1
7543945|NCT02548585|26217085|P6|Overall Study|Other|0
7543946|NCT02548585|26217086|P5|Overall Study|Other|3
7543947|NCT02548585|26217087|P4|Overall Study|Other|2
7543948|NCT02548585|26217088|P3|Overall Study|Other|0
7543949|NCT02548585|26217089|P2|Overall Study|Other|0
7543950|NCT02548585|26217090|P1|Overall Study|Other|1
7543951|NCT02548585|26217084|P7|Overall Study|Lost to Follow-up|0
7543952|NCT02548585|26217085|P6|Overall Study|Lost to Follow-up|0
7543953|NCT02548585|26217086|P5|Overall Study|Lost to Follow-up|0
7543954|NCT02548585|26217087|P4|Overall Study|Lost to Follow-up|0
7543955|NCT02548585|26217088|P3|Overall Study|Lost to Follow-up|0
7543956|NCT02548585|26217089|P2|Overall Study|Lost to Follow-up|0
7543957|NCT02548585|26217090|P1|Overall Study|Lost to Follow-up|1
7543958|NCT02548585|26217084|P7|Overall Study|Withdrawal by Subject|0
7543959|NCT02548585|26217085|P6|Overall Study|Withdrawal by Subject|1
7543960|NCT02548585|26217086|P5|Overall Study|Withdrawal by Subject|0
7543961|NCT02548585|26217087|P4|Overall Study|Withdrawal by Subject|0
7543962|NCT02548585|26217088|P3|Overall Study|Withdrawal by Subject|0
7543963|NCT02548585|26217089|P2|Overall Study|Withdrawal by Subject|0
7543964|NCT02548585|26217090|P1|Overall Study|Withdrawal by Subject|0
7543965|NCT02548455|26217308|P1|Overall Study|Visit not completed|173
7543966|NCT02548455|26217308|P1|Overall Study|Lost to Follow-up|14
7543967|NCT02548455|26217308|P1|Overall Study|Death|26
7543968|NCT02548455|26217308|P1|Overall Study|Withdrawal by Subject|27
7543969|NCT02548156|26217369|P6|Washout Period 1|Lost to Follow-up|0
7543970|NCT02548156|26217370|P5|Washout Period 1|Lost to Follow-up|1
7543971|NCT02548156|26217371|P4|Washout Period 1|Lost to Follow-up|0
7543972|NCT02548156|26217372|P3|Washout Period 1|Lost to Follow-up|0
7543973|NCT02548156|26217373|P2|Washout Period 1|Lost to Follow-up|0
7543974|NCT02548156|26217374|P1|Washout Period 1|Lost to Follow-up|0
7543975|NCT02548143|26217393|P2|Overall Study|Withdrawal by Subject|1
7543976|NCT02548143|26217394|P1|Overall Study|Withdrawal by Subject|0
7543977|NCT02548143|26217393|P2|Overall Study|Adverse Event|0
7543978|NCT02548143|26217394|P1|Overall Study|Adverse Event|1
7543979|NCT02548078|26217406|P2|Overall Study|Lost to Follow-up|3
7543980|NCT02548078|26217407|P1|Overall Study|Lost to Follow-up|1
7543981|NCT02548078|26217406|P2|Overall Study|Moved from study area|3
7543982|NCT02548078|26217407|P1|Overall Study|Moved from study area|3
7543983|NCT02548078|26217406|P2|Overall Study|Serious adverse event/Adverse event|0
7543984|NCT02548078|26217407|P1|Overall Study|Serious adverse event/Adverse event|1
7543985|NCT02547987|26217595|P1|Overall Study|Adverse Event|2
7543986|NCT02547987|26217595|P1|Overall Study|Withdrawal by Subject|1
7543987|NCT02547974|26217603|P4|Overall Study|Withdrawal by Subject|0
7543988|NCT02547974|26217604|P3|Overall Study|Withdrawal by Subject|0
7543989|NCT02547974|26217605|P2|Overall Study|Withdrawal by Subject|0
7543990|NCT02547974|26217606|P1|Overall Study|Withdrawal by Subject|1
7543991|NCT02547935|26217693|P3|Overall Study|Death|0
7543992|NCT02547935|26217694|P2|Overall Study|Death|1
7543993|NCT02547935|26217695|P1|Overall Study|Death|1
7543994|NCT02547935|26217693|P3|Overall Study|Lost to Follow-up|1
7543995|NCT02547935|26217694|P2|Overall Study|Lost to Follow-up|2
7543996|NCT02547935|26217695|P1|Overall Study|Lost to Follow-up|0
7543997|NCT02547935|26217693|P3|Overall Study|Physician Decision|0
7543998|NCT02547935|26217694|P2|Overall Study|Physician Decision|1
7543999|NCT02547935|26217695|P1|Overall Study|Physician Decision|0
7544000|NCT02547935|26217693|P3|Overall Study|Screen Failure|0
7544001|NCT02547935|26217694|P2|Overall Study|Screen Failure|0
7544002|NCT02547935|26217695|P1|Overall Study|Screen Failure|2
7544003|NCT02547935|26217693|P3|Overall Study|Withdrawal by Subject|4
7544004|NCT02547935|26217694|P2|Overall Study|Withdrawal by Subject|3
7544005|NCT02547935|26217695|P1|Overall Study|Withdrawal by Subject|2
7544006|NCT02547935|26217693|P3|Overall Study|Other|0
7544007|NCT02547935|26217694|P2|Overall Study|Other|1
7544008|NCT02547935|26217695|P1|Overall Study|Other|0
7544009|NCT02547766|26217733|P1|Overall Study|Withdrawal by Subject|1
7544010|NCT02547649|26217753|P3|Overall Study|Withdrawal by Subject|2
7544011|NCT02547649|26217754|P2|Overall Study|Withdrawal by Subject|4
7544012|NCT02547649|26217755|P1|Overall Study|Withdrawal by Subject|0
7544013|NCT02547649|26217753|P3|Overall Study|Not vaccinated|1
7544014|NCT02547649|26217754|P2|Overall Study|Not vaccinated|0
7544015|NCT02547649|26217755|P1|Overall Study|Not vaccinated|0
7544016|NCT02547649|26217753|P3|Overall Study|Lost to Follow-up|1
7544017|NCT02547649|26217754|P2|Overall Study|Lost to Follow-up|1
7544018|NCT02547649|26217755|P1|Overall Study|Lost to Follow-up|3
7544019|NCT02547454|26217820|P1|Overall Study|No data|11
7544020|NCT02547454|26217820|P1|Overall Study|Other|39
7544021|NCT02547454|26217820|P1|Overall Study|Lost to Follow-up|26
7544022|NCT02547454|26217820|P1|Overall Study|Death|38
7544023|NCT02547454|26217820|P1|Overall Study|Due to no further need to treat|4
7544024|NCT02547454|26217820|P1|Overall Study|Due to transplantation|1
7544025|NCT02547454|26217820|P1|Overall Study|Due to hemodialysis|53
7544026|NCT02547363|26217850|P2|12-month Follow-up|Other|0
7544027|NCT02547363|26217851|P1|12-month Follow-up|Other|1
7544028|NCT02547363|26217850|P2|12-month Follow-up|Lack of Efficacy|1
7544029|NCT02547363|26217851|P1|12-month Follow-up|Lack of Efficacy|1
7544030|NCT02547363|26217850|P2|12-month Follow-up|Lost to Follow-up|1
7544031|NCT02547363|26217851|P1|12-month Follow-up|Lost to Follow-up|4
7544032|NCT02547363|26217850|P2|12-month Follow-up|Withdrawal by Subject|3
7544033|NCT02547363|26217851|P1|12-month Follow-up|Withdrawal by Subject|4
7544034|NCT02547363|26217850|P2|3-day Treatment and 8-week Follow-up|Other|1
7544035|NCT02547363|26217851|P1|3-day Treatment and 8-week Follow-up|Other|1
7544036|NCT02547363|26217850|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7544037|NCT02547363|26217851|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7544038|NCT02547363|26217850|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
7544039|NCT02547363|26217851|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7544040|NCT02547363|26217850|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
7544041|NCT02547363|26217851|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
7544042|NCT02547233|26217867|P2|12-month Follow-up|Other|1
7544043|NCT02547233|26217868|P1|12-month Follow-up|Other|0
7544044|NCT02547233|26217867|P2|12-month Follow-up|Protocol Violation|1
7544045|NCT02547233|26217868|P1|12-month Follow-up|Protocol Violation|0
7544046|NCT02547233|26217867|P2|12-month Follow-up|Lack of Efficacy|2
7544047|NCT02547233|26217868|P1|12-month Follow-up|Lack of Efficacy|1
7544048|NCT02547233|26217867|P2|12-month Follow-up|Lost to Follow-up|3
7544049|NCT02547233|26217868|P1|12-month Follow-up|Lost to Follow-up|3
7544050|NCT02547233|26217867|P2|12-month Follow-up|Withdrawal by Subject|10
7544051|NCT02547233|26217868|P1|12-month Follow-up|Withdrawal by Subject|10
7544052|NCT02547233|26217867|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7544053|NCT02547233|26217868|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7544054|NCT02547233|26217867|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
7544055|NCT02547233|26217868|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
7544056|NCT02547233|26217867|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
7544057|NCT02547233|26217868|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
7544058|NCT02547233|26217867|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
7544059|NCT02547233|26217868|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
7544060|NCT02547220|26217884|P2|Overall Study|Study terminated by sponsor|20
7544061|NCT02547220|26217885|P1|Overall Study|Study terminated by sponsor|18
7544062|NCT02547220|26217884|P2|Overall Study|Withdrawal by Subject|0
7544063|NCT02547220|26217885|P1|Overall Study|Withdrawal by Subject|1
7544064|NCT02547129|26217921|P2|Overall Study|Difficulty with ongoing infection|0
7544065|NCT02547129|26217922|P1|Overall Study|Difficulty with ongoing infection|1
7544066|NCT02547038|26217965|P2|Overall Study|Lost to Follow-up|2
7544067|NCT02547038|26217966|P1|Overall Study|Lost to Follow-up|3
7544068|NCT02546986|26217983|P2|Survival Follow-Up Phase|Lost to Follow-up|2
7544069|NCT02546986|26217984|P1|Survival Follow-Up Phase|Lost to Follow-up|2
7544070|NCT02546986|26217983|P2|Survival Follow-Up Phase|Alive|16
7544071|NCT02546986|26217984|P1|Survival Follow-Up Phase|Alive|13
7544072|NCT02546986|26217983|P2|Survival Follow-Up Phase|Death|12
7544073|NCT02546986|26217984|P1|Survival Follow-Up Phase|Death|18
7544074|NCT02546986|26217983|P2|Survival Follow-Up Phase|Missing Status|5
7544075|NCT02546986|26217984|P1|Survival Follow-Up Phase|Missing Status|3
7544076|NCT02546986|26217983|P2|Treatment Period|Miscellaneous|9
7544077|NCT02546986|26217984|P1|Treatment Period|Miscellaneous|7
7544078|NCT02546986|26217983|P2|Treatment Period|Study Terminated by Sponsor|1
7544079|NCT02546986|26217984|P1|Treatment Period|Study Terminated by Sponsor|0
7544080|NCT02546986|26217983|P2|Treatment Period|Non-compliance with Study Drug|1
7544081|NCT02546986|26217984|P1|Treatment Period|Non-compliance with Study Drug|0
7544082|NCT02546986|26217983|P2|Treatment Period|Withdrawal by Subject|1
7544083|NCT02546986|26217984|P1|Treatment Period|Withdrawal by Subject|1
7544084|NCT02546986|26217983|P2|Treatment Period|Protocol Violation|0
7544085|NCT02546986|26217984|P1|Treatment Period|Protocol Violation|1
7544086|NCT02546986|26217983|P2|Treatment Period|Physician Decision|2
7544087|NCT02546986|26217984|P1|Treatment Period|Physician Decision|1
7544088|NCT02546986|26217983|P2|Treatment Period|Death|4
7544089|NCT02546986|26217984|P1|Treatment Period|Death|3
7544090|NCT02546986|26217983|P2|Treatment Period|Symptomatic Deterioration|3
7544091|NCT02546986|26217984|P1|Treatment Period|Symptomatic Deterioration|4
7544092|NCT02546986|26217983|P2|Treatment Period|Adverse Event|6
7544093|NCT02546986|26217984|P1|Treatment Period|Adverse Event|14
7544094|NCT02546986|26217983|P2|Treatment Period|Progressive Disease|22
7544095|NCT02546986|26217984|P1|Treatment Period|Progressive Disease|20
7544096|NCT02546856|26218009|P2|6 Months Evaluation|reasons not due to titration|1
7544097|NCT02546856|26218010|P1|6 Months Evaluation|reasons not due to titration|0
7544098|NCT02546856|26218009|P2|6 Months Evaluation|Working or living abroad|4
7544099|NCT02546856|26218010|P1|6 Months Evaluation|Working or living abroad|6
7544100|NCT02546856|26218009|P2|6 Months Evaluation|Lost to Follow-up|1
7544101|NCT02546856|26218010|P1|6 Months Evaluation|Lost to Follow-up|1
7544102|NCT02546856|26218009|P2|6 Months Evaluation|Death|1
7544103|NCT02546856|26218010|P1|6 Months Evaluation|Death|1
7544104|NCT02546856|26218009|P2|4 Months Evaluation|HF Unit not active in summer|0
7544105|NCT02546856|26218010|P1|4 Months Evaluation|HF Unit not active in summer|1
7544106|NCT02546856|26218009|P2|4 Months Evaluation|reasons not due to titration|1
7544107|NCT02546856|26218010|P1|4 Months Evaluation|reasons not due to titration|4
7544108|NCT02546856|26218009|P2|4 Months Evaluation|Working or living abroad|1
7544109|NCT02546856|26218010|P1|4 Months Evaluation|Working or living abroad|5
7544110|NCT02546856|26218009|P2|4 Months Evaluation|Physician Decision|0
7544111|NCT02546856|26218010|P1|4 Months Evaluation|Physician Decision|3
7544112|NCT02546856|26218009|P2|4 Months Evaluation|Lost to Follow-up|3
7544113|NCT02546856|26218010|P1|4 Months Evaluation|Lost to Follow-up|3
7544114|NCT02546856|26218009|P2|4 Months Evaluation|Withdrawal by Subject|3
7544115|NCT02546856|26218010|P1|4 Months Evaluation|Withdrawal by Subject|2
7544116|NCT02546856|26218009|P2|4 Months Evaluation|Death|3
7544117|NCT02546856|26218010|P1|4 Months Evaluation|Death|2
7544118|NCT02546765|26218060|P4|Overall Study|Withdrawal by Subject|0
7544119|NCT02546765|26218061|P3|Overall Study|Withdrawal by Subject|0
7544120|NCT02546765|26218062|P2|Overall Study|Withdrawal by Subject|1
7544121|NCT02546765|26218063|P1|Overall Study|Withdrawal by Subject|0
7544122|NCT02546609|26218104|P3|Overall Study|travel or work schedule restriction|2
7544123|NCT02546609|26218105|P2|Overall Study|travel or work schedule restriction|0
7544124|NCT02546609|26218106|P1|Overall Study|travel or work schedule restriction|0
7544125|NCT02546609|26218104|P3|Overall Study|Lost to Follow-up|1
7544126|NCT02546609|26218105|P2|Overall Study|Lost to Follow-up|3
7544127|NCT02546609|26218106|P1|Overall Study|Lost to Follow-up|2
7544128|NCT02546609|26218104|P3|Overall Study|Protocol Violation|1
7544129|NCT02546609|26218105|P2|Overall Study|Protocol Violation|1
7544130|NCT02546609|26218106|P1|Overall Study|Protocol Violation|0
7544131|NCT02546609|26218104|P3|Overall Study|Adverse Event|1
7544132|NCT02546609|26218105|P2|Overall Study|Adverse Event|6
7544133|NCT02546609|26218106|P1|Overall Study|Adverse Event|0
7544134|NCT02546609|26218104|P3|Overall Study|Withdrawal by Subject|2
7544135|NCT02546609|26218105|P2|Overall Study|Withdrawal by Subject|1
7544136|NCT02546609|26218106|P1|Overall Study|Withdrawal by Subject|0
7544137|NCT02546544|26218186|P1|Overall Study|Withdrawal by Subject|1
7544138|NCT02546544|26218186|P1|Overall Study|Adverse Event|1
7544139|NCT02546544|26218186|P1|Overall Study|Disease Progression|14
7544140|NCT02546362|26218227|P1|12-week Treatment Period|Change in medication|1
7544141|NCT02546362|26218227|P1|12-week Treatment Period|Lost to Follow-up|2
7544142|NCT02546362|26218227|P1|12-week Treatment Period|Withdrawal by Subject|6
7544143|NCT02546362|26218227|P1|4-week Treatment Period|Change in medication|2
7544144|NCT02546362|26218227|P1|4-week Treatment Period|Lost to Follow-up|1
7544145|NCT02546323|26218248|P2|Overall Study|Met Withdrawal Criteria|14
7544146|NCT02546323|26218249|P1|Overall Study|Met Withdrawal Criteria|2
7544147|NCT02546323|26218248|P2|Overall Study|Non-compliance with Study Drug|2
7544148|NCT02546323|26218249|P1|Overall Study|Non-compliance with Study Drug|2
7544149|NCT02546323|26218248|P2|Overall Study|Lost to Follow-up|3
7544150|NCT02546323|26218249|P1|Overall Study|Lost to Follow-up|2
7544151|NCT02546323|26218248|P2|Overall Study|Patient Specific Reasons|2
7544152|NCT02546323|26218249|P1|Overall Study|Patient Specific Reasons|1
7544153|NCT02546323|26218248|P2|Overall Study|Adverse Event|11
7544154|NCT02546323|26218249|P1|Overall Study|Adverse Event|17
7544155|NCT02546323|26218248|P2|Overall Study|Eligibility Criteria not Fulfilled|1
7544156|NCT02546323|26218249|P1|Overall Study|Eligibility Criteria not Fulfilled|0
7544157|NCT02546323|26218248|P2|Overall Study|Withdrawal by Subject|33
7544158|NCT02546323|26218249|P1|Overall Study|Withdrawal by Subject|36
7544159|NCT02546193|26218269|P4|Overall Study|Not eligible at time of induction|0
7544160|NCT02546193|26218270|P3|Overall Study|Not eligible at time of induction|1
7544161|NCT02546193|26218271|P2|Overall Study|Not eligible at time of induction|6
7544162|NCT02546193|26218272|P1|Overall Study|Not eligible at time of induction|4
7544163|NCT02546193|26218269|P4|Overall Study|Withdrawal by Subject|0
7544164|NCT02546193|26218270|P3|Overall Study|Withdrawal by Subject|1
7544165|NCT02546193|26218271|P2|Overall Study|Withdrawal by Subject|0
7544166|NCT02546193|26218272|P1|Overall Study|Withdrawal by Subject|2
7544167|NCT02545933|26218309|P3|Overall Study|Protocol Violation|1
7544168|NCT02545933|26218310|P2|Overall Study|Protocol Violation|0
7544169|NCT02545933|26218311|P1|Overall Study|Protocol Violation|1
7544170|NCT02545933|26218309|P3|Overall Study|Withdrawal by Subject|3
7544171|NCT02545933|26218310|P2|Overall Study|Withdrawal by Subject|3
7544172|NCT02545933|26218311|P1|Overall Study|Withdrawal by Subject|2
7544173|NCT02545933|26218309|P3|Overall Study|Adverse Event|0
7544174|NCT02545933|26218310|P2|Overall Study|Adverse Event|0
7544175|NCT02545933|26218311|P1|Overall Study|Adverse Event|3
7544176|NCT02545868|26218353|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
7544177|NCT02545868|26218354|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
7544178|NCT02545868|26218355|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
7544179|NCT02545543|26218438|P2|Overall Study|Enrolment of subject at >1 study site|1
7544180|NCT02545543|26218439|P1|Overall Study|Enrolment of subject at >1 study site|1
7544181|NCT02545543|26218438|P2|Overall Study|Noncomplaince|0
7544182|NCT02545543|26218439|P1|Overall Study|Noncomplaince|1
7544183|NCT02545543|26218438|P2|Overall Study|Withdrawal by Subject|8
7544184|NCT02545543|26218439|P1|Overall Study|Withdrawal by Subject|9
7544185|NCT02545543|26218438|P2|Overall Study|Physician Decision|0
7544186|NCT02545543|26218439|P1|Overall Study|Physician Decision|3
7544187|NCT02545543|26218438|P2|Overall Study|Lost to Follow-up|25
7544188|NCT02545543|26218439|P1|Overall Study|Lost to Follow-up|67
7544189|NCT02545504|26218465|P2|Overall Study|Lost to Follow-up|2
7544190|NCT02545504|26218466|P1|Overall Study|Lost to Follow-up|2
7544191|NCT02545504|26218465|P2|Overall Study|Investigator's discretion|1
7544192|NCT02545504|26218466|P1|Overall Study|Investigator's discretion|3
7544193|NCT02545504|26218465|P2|Overall Study|Withdrew consent|11
7544194|NCT02545504|26218466|P1|Overall Study|Withdrew consent|9
7544195|NCT02545504|26218465|P2|Overall Study|Unknown reason|32
7544196|NCT02545504|26218466|P1|Overall Study|Unknown reason|30
7544197|NCT02545504|26218465|P2|Overall Study|Death|168
7544198|NCT02545504|26218466|P1|Overall Study|Death|174
7544199|NCT02545322|26218480|P1|Overall Study|Withdrawal by Subject|3
7544200|NCT02545283|26218487|P2|Overall Study|Study Terminated By Sponsor|71
7544201|NCT02545283|26218488|P1|Overall Study|Study Terminated By Sponsor|33
7544202|NCT02545283|26218487|P2|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
7544203|NCT02545283|26218488|P1|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
7544204|NCT02545283|26218487|P2|Overall Study|Death|211
7544205|NCT02545283|26218488|P1|Overall Study|Death|109
7544206|NCT02545283|26218487|P2|Overall Study|Withdrawal by Subject|9
7544207|NCT02545283|26218488|P1|Overall Study|Withdrawal by Subject|5
7544208|NCT02545283|26218487|P2|Overall Study|Lost to Follow-up|4
7544209|NCT02545283|26218488|P1|Overall Study|Lost to Follow-up|2
7544210|NCT02545270|26218565|P3|Overall Study|Videos being too similar to other|2
7544211|NCT02545270|26218566|P2|Overall Study|Videos being too similar to other|0
7544212|NCT02545270|26218567|P1|Overall Study|Videos being too similar to other|0
7544213|NCT02545270|26218565|P3|Overall Study|technical difficulties|0
7544214|NCT02545270|26218566|P2|Overall Study|technical difficulties|1
7544215|NCT02545270|26218567|P1|Overall Study|technical difficulties|0
7544216|NCT02545075|26218596|P2|Treatment|Completed treatment|12
7544217|NCT02545075|26218597|P1|Treatment|Completed treatment|40
7544218|NCT02545075|26218596|P2|Treatment|Participant drug toxicity|0
7544219|NCT02545075|26218597|P1|Treatment|Participant drug toxicity|1
7544220|NCT02545075|26218596|P2|Treatment|Death|0
7544221|NCT02545075|26218597|P1|Treatment|Death|1
7544222|NCT02545075|26218596|P2|Treatment|Adverse event not related to study drug|0
7544223|NCT02545075|26218597|P1|Treatment|Adverse event not related to study drug|1
7544224|NCT02545075|26218596|P2|Treatment|Withdrawal by Subject|0
7544225|NCT02545075|26218597|P1|Treatment|Withdrawal by Subject|1
7544226|NCT02545075|26218596|P2|Treatment|Participant dicontinued study treatment|9
7544227|NCT02545075|26218597|P1|Treatment|Participant dicontinued study treatment|7
7544228|NCT02545075|26218596|P2|Treatment|Disease progression|32
7544229|NCT02545075|26218597|P1|Treatment|Disease progression|71
7544230|NCT02545075|26218596|P2|Randomization|Withdrawal by Subject|6
7544231|NCT02545075|26218597|P1|Randomization|Withdrawal by Subject|0
7544232|NCT02545075|26218596|P2|Randomization|Lost to Follow-up|1
7544233|NCT02545075|26218597|P1|Randomization|Lost to Follow-up|0
7544234|NCT02544763|26218633|P3|Overall Study|Difficulties taking IMP|0
7544235|NCT02544763|26218634|P2|Overall Study|Difficulties taking IMP|0
7544236|NCT02544763|26218635|P1|Overall Study|Difficulties taking IMP|1
7544237|NCT02544763|26218633|P3|Overall Study|Physician Decision|0
7544238|NCT02544763|26218634|P2|Overall Study|Physician Decision|1
7544239|NCT02544763|26218635|P1|Overall Study|Physician Decision|0
7544240|NCT02544763|26218633|P3|Overall Study|Met withdrawal criteria|0
7544241|NCT02544763|26218634|P2|Overall Study|Met withdrawal criteria|2
7544242|NCT02544763|26218635|P1|Overall Study|Met withdrawal criteria|0
7544243|NCT02544763|26218633|P3|Overall Study|Withdrawn by parent/guardian|1
7544244|NCT02544763|26218634|P2|Overall Study|Withdrawn by parent/guardian|1
7544245|NCT02544763|26218635|P1|Overall Study|Withdrawn by parent/guardian|1
7544246|NCT02544763|26218633|P3|Overall Study|Adverse Event|0
7544247|NCT02544763|26218634|P2|Overall Study|Adverse Event|8
7544248|NCT02544763|26218635|P1|Overall Study|Adverse Event|8
7544249|NCT02544633|26218659|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
7544250|NCT02544633|26218660|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
7544251|NCT02544633|26218661|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
7544252|NCT02544633|26218662|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
7544253|NCT02544633|26218659|P4|Survival Follow-up Period|Withdrawal by Subject|0
7544254|NCT02544633|26218660|P3|Survival Follow-up Period|Withdrawal by Subject|1
7544255|NCT02544633|26218661|P2|Survival Follow-up Period|Withdrawal by Subject|0
7544256|NCT02544633|26218662|P1|Survival Follow-up Period|Withdrawal by Subject|4
7544257|NCT02544633|26218659|P4|Survival Follow-up Period|Lost to Follow-up|0
7544258|NCT02544633|26218660|P3|Survival Follow-up Period|Lost to Follow-up|1
7544259|NCT02544633|26218661|P2|Survival Follow-up Period|Lost to Follow-up|1
7544260|NCT02544633|26218662|P1|Survival Follow-up Period|Lost to Follow-up|0
7544261|NCT02544633|26218659|P4|Survival Follow-up Period|Death|9
7544262|NCT02544633|26218660|P3|Survival Follow-up Period|Death|3
7544263|NCT02544633|26218661|P2|Survival Follow-up Period|Death|14
7544264|NCT02544633|26218662|P1|Survival Follow-up Period|Death|12
7544265|NCT02544633|26218659|P4|Treatment Period|Clinical Disease Progression|1
7544266|NCT02544633|26218660|P3|Treatment Period|Clinical Disease Progression|0
7544267|NCT02544633|26218661|P2|Treatment Period|Clinical Disease Progression|0
7544268|NCT02544633|26218662|P1|Treatment Period|Clinical Disease Progression|0
7544269|NCT02544633|26218659|P4|Treatment Period|Non-compliance|0
7544270|NCT02544633|26218660|P3|Treatment Period|Non-compliance|1
7544271|NCT02544633|26218661|P2|Treatment Period|Non-compliance|0
7544272|NCT02544633|26218662|P1|Treatment Period|Non-compliance|0
7544273|NCT02544633|26218659|P4|Treatment Period|Death|0
7544274|NCT02544633|26218660|P3|Treatment Period|Death|1
7544275|NCT02544633|26218661|P2|Treatment Period|Death|0
7544276|NCT02544633|26218662|P1|Treatment Period|Death|0
7544277|NCT02544633|26218659|P4|Treatment Period|Lost to Follow-up|0
7544278|NCT02544633|26218660|P3|Treatment Period|Lost to Follow-up|0
7544279|NCT02544633|26218661|P2|Treatment Period|Lost to Follow-up|1
7544280|NCT02544633|26218662|P1|Treatment Period|Lost to Follow-up|0
7544281|NCT02544633|26218659|P4|Treatment Period|Withdrawal by Subject|0
7544282|NCT02544633|26218660|P3|Treatment Period|Withdrawal by Subject|0
7544283|NCT02544633|26218661|P2|Treatment Period|Withdrawal by Subject|0
7544284|NCT02544633|26218662|P1|Treatment Period|Withdrawal by Subject|1
7544285|NCT02544633|26218659|P4|Treatment Period|Global Deterioration of Health|1
7544286|NCT02544633|26218660|P3|Treatment Period|Global Deterioration of Health|0
7544287|NCT02544633|26218661|P2|Treatment Period|Global Deterioration of Health|3
7544288|NCT02544633|26218662|P1|Treatment Period|Global Deterioration of Health|3
7544289|NCT02544633|26218659|P4|Treatment Period|Lack of Efficacy|5
7544290|NCT02544633|26218660|P3|Treatment Period|Lack of Efficacy|5
7544291|NCT02544633|26218661|P2|Treatment Period|Lack of Efficacy|11
7544292|NCT02544633|26218662|P1|Treatment Period|Lack of Efficacy|17
7544293|NCT02544633|26218659|P4|Treatment Period|Adverse Event|5
7544294|NCT02544633|26218660|P3|Treatment Period|Adverse Event|0
7544295|NCT02544633|26218661|P2|Treatment Period|Adverse Event|4
7544296|NCT02544633|26218662|P1|Treatment Period|Adverse Event|7
7544297|NCT02544633|26218659|P4|Treatment Period|Patient Still on Treatment/Study|0
7544298|NCT02544633|26218660|P3|Treatment Period|Patient Still on Treatment/Study|1
7544299|NCT02544633|26218661|P2|Treatment Period|Patient Still on Treatment/Study|1
7544300|NCT02544633|26218662|P1|Treatment Period|Patient Still on Treatment/Study|0
7544301|NCT02544451|26218746|P4|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
7544302|NCT02544451|26218747|P3|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7544303|NCT02544451|26218748|P2|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7544304|NCT02544451|26218749|P1|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7544305|NCT02544451|26218746|P4|Treatment Period 1 (96 Weeks)|Other|0
7544306|NCT02544451|26218747|P3|Treatment Period 1 (96 Weeks)|Other|0
7544307|NCT02544451|26218748|P2|Treatment Period 1 (96 Weeks)|Other|4
7544308|NCT02544451|26218749|P1|Treatment Period 1 (96 Weeks)|Other|4
7544309|NCT02544451|26218746|P4|Treatment Period 1 (96 Weeks)|Physician Decision|0
7544310|NCT02544451|26218747|P3|Treatment Period 1 (96 Weeks)|Physician Decision|0
7544311|NCT02544451|26218748|P2|Treatment Period 1 (96 Weeks)|Physician Decision|0
7544312|NCT02544451|26218749|P1|Treatment Period 1 (96 Weeks)|Physician Decision|4
7544313|NCT02544451|26218746|P4|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7544314|NCT02544451|26218747|P3|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7544315|NCT02544451|26218748|P2|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7544316|NCT02544451|26218749|P1|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
7544317|NCT02544451|26218746|P4|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
7544318|NCT02544451|26218747|P3|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
7544319|NCT02544451|26218748|P2|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
7544320|NCT02544451|26218749|P1|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
7544321|NCT02544451|26218746|P4|Treatment Period 1 (96 Weeks)|Adverse Event|0
7544322|NCT02544451|26218747|P3|Treatment Period 1 (96 Weeks)|Adverse Event|0
7544323|NCT02544451|26218748|P2|Treatment Period 1 (96 Weeks)|Adverse Event|6
7544324|NCT02544451|26218749|P1|Treatment Period 1 (96 Weeks)|Adverse Event|1
7544325|NCT02544321|26218796|P2|Overall Study|Protocol Violation|1
7544326|NCT02544321|26218797|P1|Overall Study|Protocol Violation|0
7544327|NCT02544321|26218796|P2|Overall Study|Adverse Event|1
7544328|NCT02544321|26218797|P1|Overall Study|Adverse Event|1
7544329|NCT02544321|26218796|P2|Overall Study|Withdrawal by Subject|2
7544330|NCT02544321|26218797|P1|Overall Study|Withdrawal by Subject|1
7544337|NCT02544152|26219669|P2|Overall Study|Other|0
7544338|NCT02544152|26219670|P1|Overall Study|Other|1
7544339|NCT02544152|26219669|P2|Overall Study|Withdrawal by Subject|3
7544340|NCT02544152|26219670|P1|Overall Study|Withdrawal by Subject|0
7544341|NCT02544152|26219669|P2|Overall Study|Adverse Event|4
7544342|NCT02544152|26219670|P1|Overall Study|Adverse Event|0
7544343|NCT02544113|26219694|P2|Overall Study|Death|4
7544344|NCT02544113|26219695|P1|Overall Study|Death|3
7544345|NCT02544074|26219726|P21|Overall Study|Tablet error|0
7544346|NCT02544074|26219727|P20|Overall Study|Tablet error|0
7544347|NCT02544074|26219728|P19|Overall Study|Tablet error|0
7544348|NCT02544074|26219729|P18|Overall Study|Tablet error|0
7544349|NCT02544074|26219730|P17|Overall Study|Tablet error|0
7544350|NCT02544074|26219731|P16|Overall Study|Tablet error|0
7544351|NCT02544074|26219732|P15|Overall Study|Tablet error|0
7544352|NCT02544074|26219733|P14|Overall Study|Tablet error|0
7544353|NCT02544074|26219734|P13|Overall Study|Tablet error|0
7544354|NCT02544074|26219735|P12|Overall Study|Tablet error|0
7544355|NCT02544074|26219736|P11|Overall Study|Tablet error|0
7544356|NCT02544074|26219737|P10|Overall Study|Tablet error|1
7544357|NCT02544074|26219738|P9|Overall Study|Tablet error|0
7544358|NCT02544074|26219739|P8|Overall Study|Tablet error|0
7544359|NCT02544074|26219740|P7|Overall Study|Tablet error|0
7544360|NCT02544074|26219741|P6|Overall Study|Tablet error|1
7544361|NCT02544074|26219742|P5|Overall Study|Tablet error|0
7544362|NCT02544074|26219743|P4|Overall Study|Tablet error|0
7544363|NCT02544074|26219744|P3|Overall Study|Tablet error|0
7544364|NCT02544074|26219745|P2|Overall Study|Tablet error|0
7544365|NCT02544074|26219746|P1|Overall Study|Tablet error|0
7544366|NCT02544074|26219726|P21|Overall Study|Withdrawal by Subject|0
7544367|NCT02544074|26219727|P20|Overall Study|Withdrawal by Subject|0
7544368|NCT02544074|26219728|P19|Overall Study|Withdrawal by Subject|0
7544369|NCT02544074|26219729|P18|Overall Study|Withdrawal by Subject|0
7544370|NCT02544074|26219730|P17|Overall Study|Withdrawal by Subject|0
7544371|NCT02544074|26219731|P16|Overall Study|Withdrawal by Subject|0
7544372|NCT02544074|26219732|P15|Overall Study|Withdrawal by Subject|0
7544373|NCT02544074|26219733|P14|Overall Study|Withdrawal by Subject|0
7544374|NCT02544074|26219734|P13|Overall Study|Withdrawal by Subject|0
7544375|NCT02544074|26219735|P12|Overall Study|Withdrawal by Subject|0
7544376|NCT02544074|26219736|P11|Overall Study|Withdrawal by Subject|0
7544377|NCT02544074|26219737|P10|Overall Study|Withdrawal by Subject|0
7544378|NCT02544074|26219738|P9|Overall Study|Withdrawal by Subject|0
7544379|NCT02544074|26219739|P8|Overall Study|Withdrawal by Subject|0
7544380|NCT02544074|26219740|P7|Overall Study|Withdrawal by Subject|0
7544381|NCT02544074|26219741|P6|Overall Study|Withdrawal by Subject|0
7544382|NCT02544074|26219742|P5|Overall Study|Withdrawal by Subject|0
7544383|NCT02544074|26219743|P4|Overall Study|Withdrawal by Subject|0
7544384|NCT02544074|26219744|P3|Overall Study|Withdrawal by Subject|0
7544385|NCT02544074|26219745|P2|Overall Study|Withdrawal by Subject|1
7544386|NCT02544074|26219746|P1|Overall Study|Withdrawal by Subject|0
7544387|NCT02543918|26219782|P2|Overall Study|Adverse Event|1
7544388|NCT02543918|26219783|P1|Overall Study|Adverse Event|1
7544389|NCT02543918|26219782|P2|Overall Study|Withdrawal by Subject|1
7544390|NCT02543918|26219783|P1|Overall Study|Withdrawal by Subject|1
7544391|NCT02543918|26219782|P2|Overall Study|Lost to Follow-up|1
7544392|NCT02543918|26219783|P1|Overall Study|Lost to Follow-up|1
7544393|NCT02543918|26219782|P2|Overall Study|Never treated|1
7544394|NCT02543918|26219783|P1|Overall Study|Never treated|0
7544395|NCT02543892|26219797|P8|Had Immunology Data|Withdrawal by Subject|0
7544396|NCT02543892|26219798|P7|Had Immunology Data|Withdrawal by Subject|1
7544397|NCT02543892|26219799|P6|Had Immunology Data|Withdrawal by Subject|0
7544398|NCT02543892|26219800|P5|Had Immunology Data|Withdrawal by Subject|0
7544399|NCT02543892|26219801|P4|Had Immunology Data|Withdrawal by Subject|0
7544400|NCT02543892|26219802|P3|Had Immunology Data|Withdrawal by Subject|0
7544401|NCT02543892|26219803|P2|Had Immunology Data|Withdrawal by Subject|0
7544402|NCT02543892|26219804|P1|Had Immunology Data|Withdrawal by Subject|0
7544403|NCT02543892|26219797|P8|Received Vaccination 2|Adverse Event|0
7544404|NCT02543892|26219798|P7|Received Vaccination 2|Adverse Event|0
7544405|NCT02543892|26219799|P6|Received Vaccination 2|Adverse Event|0
7544406|NCT02543892|26219800|P5|Received Vaccination 2|Adverse Event|0
7544407|NCT02543892|26219801|P4|Received Vaccination 2|Adverse Event|0
7544408|NCT02543892|26219802|P3|Received Vaccination 2|Adverse Event|0
7544409|NCT02543892|26219803|P2|Received Vaccination 2|Adverse Event|1
7544410|NCT02543892|26219804|P1|Received Vaccination 2|Adverse Event|0
7544411|NCT02543892|26219797|P8|Received Vaccination 2|Physician Decision|0
7544412|NCT02543892|26219798|P7|Received Vaccination 2|Physician Decision|0
7544413|NCT02543892|26219799|P6|Received Vaccination 2|Physician Decision|1
7544414|NCT02543892|26219800|P5|Received Vaccination 2|Physician Decision|0
7544415|NCT02543892|26219801|P4|Received Vaccination 2|Physician Decision|0
7544416|NCT02543892|26219802|P3|Received Vaccination 2|Physician Decision|0
7544417|NCT02543892|26219803|P2|Received Vaccination 2|Physician Decision|0
7544418|NCT02543892|26219804|P1|Received Vaccination 2|Physician Decision|0
7544419|NCT02543892|26219797|P8|Received Vaccination 2|Withdrawal by Subject|1
7544420|NCT02543892|26219798|P7|Received Vaccination 2|Withdrawal by Subject|0
7544421|NCT02543892|26219799|P6|Received Vaccination 2|Withdrawal by Subject|0
7544422|NCT02543892|26219800|P5|Received Vaccination 2|Withdrawal by Subject|0
7544423|NCT02543892|26219801|P4|Received Vaccination 2|Withdrawal by Subject|0
7544424|NCT02543892|26219802|P3|Received Vaccination 2|Withdrawal by Subject|0
7544425|NCT02543892|26219803|P2|Received Vaccination 2|Withdrawal by Subject|0
7544426|NCT02543892|26219804|P1|Received Vaccination 2|Withdrawal by Subject|1
7544427|NCT02543801|26219871|P4|Overall Study|Protocol Violation|0
7544428|NCT02543801|26219872|P3|Overall Study|Protocol Violation|0
7544429|NCT02543801|26219873|P2|Overall Study|Protocol Violation|2
7544430|NCT02543801|26219874|P1|Overall Study|Protocol Violation|1
7544431|NCT02543658|26219905|P2|Overall Study|Lack of Efficacy|4
7544432|NCT02543658|26219906|P1|Overall Study|Lack of Efficacy|0
7544433|NCT02543528|26219943|P5|Extended Wear Period|Withdrawal by Subject|0
7544434|NCT02543528|26219944|P4|Extended Wear Period|Withdrawal by Subject|5
7544435|NCT02543528|26219945|P3|Extended Wear Period|Withdrawal by Subject|4
7544436|NCT02543528|26219946|P2|Extended Wear Period|Withdrawal by Subject|9
7544437|NCT02543528|26219947|P1|Extended Wear Period|Withdrawal by Subject|10
7544438|NCT02543528|26219943|P5|Extended Wear Period|Lost to Follow-up|0
7544439|NCT02543528|26219944|P4|Extended Wear Period|Lost to Follow-up|1
7544440|NCT02543528|26219945|P3|Extended Wear Period|Lost to Follow-up|2
7544441|NCT02543528|26219946|P2|Extended Wear Period|Lost to Follow-up|1
7544442|NCT02543528|26219947|P1|Extended Wear Period|Lost to Follow-up|0
7544443|NCT02543528|26219943|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
7544444|NCT02543528|26219944|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
7544445|NCT02543528|26219945|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
7544446|NCT02543528|26219946|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
7544447|NCT02543528|26219947|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
7544448|NCT02543528|26219943|P5|Extended Wear Period|Missed too many scheduled visits|0
7544449|NCT02543528|26219944|P4|Extended Wear Period|Missed too many scheduled visits|3
7544450|NCT02543528|26219945|P3|Extended Wear Period|Missed too many scheduled visits|1
7544451|NCT02543528|26219946|P2|Extended Wear Period|Missed too many scheduled visits|0
7544452|NCT02543528|26219947|P1|Extended Wear Period|Missed too many scheduled visits|0
7544453|NCT02543528|26219943|P5|Extended Wear Period|Adverse Event|0
7544454|NCT02543528|26219944|P4|Extended Wear Period|Adverse Event|3
7544455|NCT02543528|26219945|P3|Extended Wear Period|Adverse Event|16
7544456|NCT02543528|26219946|P2|Extended Wear Period|Adverse Event|11
7544457|NCT02543528|26219947|P1|Extended Wear Period|Adverse Event|17
7544458|NCT02543528|26219943|P5|Adaptation Period|Adverse Event|2
7544459|NCT02543528|26219944|P4|Adaptation Period|Adverse Event|0
7544460|NCT02543528|26219945|P3|Adaptation Period|Adverse Event|0
7544461|NCT02543528|26219946|P2|Adaptation Period|Adverse Event|0
7544462|NCT02543528|26219947|P1|Adaptation Period|Adverse Event|0
7544463|NCT02543528|26219943|P5|Adaptation Period|Lost to Follow-up|14
7544464|NCT02543528|26219944|P4|Adaptation Period|Lost to Follow-up|0
7544465|NCT02543528|26219945|P3|Adaptation Period|Lost to Follow-up|0
7544466|NCT02543528|26219946|P2|Adaptation Period|Lost to Follow-up|0
7544467|NCT02543528|26219947|P1|Adaptation Period|Lost to Follow-up|0
7544468|NCT02543528|26219943|P5|Adaptation Period|Lens Handling Difficultes|8
7544469|NCT02543528|26219944|P4|Adaptation Period|Lens Handling Difficultes|0
7544470|NCT02543528|26219945|P3|Adaptation Period|Lens Handling Difficultes|0
7544471|NCT02543528|26219946|P2|Adaptation Period|Lens Handling Difficultes|0
7544472|NCT02543528|26219947|P1|Adaptation Period|Lens Handling Difficultes|0
7544473|NCT02543528|26219943|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
7544474|NCT02543528|26219944|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
7544475|NCT02543528|26219945|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
7544476|NCT02543528|26219946|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
7544477|NCT02543528|26219947|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
7544478|NCT02543346|26219980|P4|Second Priming Visit|Adverse Event|0
7544479|NCT02543346|26219981|P3|Second Priming Visit|Adverse Event|0
7544480|NCT02543346|26219982|P2|Second Priming Visit|Adverse Event|0
7544481|NCT02543346|26219983|P1|Second Priming Visit|Adverse Event|1
7544482|NCT02543346|26219980|P4|Second Priming Visit|Withdrawal by Subject|2
7544483|NCT02543346|26219981|P3|Second Priming Visit|Withdrawal by Subject|2
7544484|NCT02543346|26219982|P2|Second Priming Visit|Withdrawal by Subject|2
7544485|NCT02543346|26219983|P1|Second Priming Visit|Withdrawal by Subject|0
7544486|NCT02543294|26220009|P1|Overall Study|Withdrawal by Subject|7
7544487|NCT02543294|26220009|P1|Overall Study|Physician Decision|2
7544488|NCT02543294|26220009|P1|Overall Study|Lost to Follow-up|3
7544489|NCT02543203|26220016|P2|Overall Study|Withdrawal by Subject|1
7544490|NCT02543203|26220017|P1|Overall Study|Withdrawal by Subject|0
7544491|NCT02543203|26220016|P2|Overall Study|Negative Behavior|0
7544492|NCT02543203|26220017|P1|Overall Study|Negative Behavior|1
7544493|NCT02543203|26220016|P2|Overall Study|Family|2
7544494|NCT02543203|26220017|P1|Overall Study|Family|1
7544495|NCT02543203|26220016|P2|Overall Study|Increased Irritability|0
7544496|NCT02543203|26220017|P1|Overall Study|Increased Irritability|1
7544497|NCT02543203|26220016|P2|Overall Study|Lost to Follow-up|0
7544498|NCT02543203|26220017|P1|Overall Study|Lost to Follow-up|1
7544499|NCT02543203|26220016|P2|Overall Study|Unpalatable Fragrance|2
7544500|NCT02543203|26220017|P1|Overall Study|Unpalatable Fragrance|2
7544501|NCT02542943|26220034|P3|Overall Study|Withdrawal by Subject|0
7544502|NCT02542943|26220035|P2|Overall Study|Withdrawal by Subject|1
7544503|NCT02542943|26220036|P1|Overall Study|Withdrawal by Subject|0
7544504|NCT02542943|26220034|P3|Overall Study|Lost to Follow-up|0
7544505|NCT02542943|26220035|P2|Overall Study|Lost to Follow-up|0
7544506|NCT02542943|26220036|P1|Overall Study|Lost to Follow-up|1
7544507|NCT02542865|26220063|P2|Overall Study|Withdrawal by Subject|0
7544508|NCT02542865|26220064|P1|Overall Study|Withdrawal by Subject|16
7544509|NCT02542865|26220063|P2|Overall Study|Identified as screen failure|0
7544510|NCT02542865|26220064|P1|Overall Study|Identified as screen failure|1
7544511|NCT02542631|26220127|P2|Overall Study|Used Prohibited Medication|1
7544512|NCT02542631|26220128|P1|Overall Study|Used Prohibited Medication|2
7544513|NCT02542631|26220127|P2|Overall Study|Other|1
7544514|NCT02542631|26220128|P1|Overall Study|Other|2
7544515|NCT02542631|26220127|P2|Overall Study|Death|2
7544516|NCT02542631|26220128|P1|Overall Study|Death|1
7544517|NCT02542631|26220127|P2|Overall Study|Lost to Follow-up|5
7544518|NCT02542631|26220128|P1|Overall Study|Lost to Follow-up|6
7544519|NCT02542631|26220127|P2|Overall Study|Physician Decision|4
7544520|NCT02542631|26220128|P1|Overall Study|Physician Decision|6
7544521|NCT02542631|26220127|P2|Overall Study|Protocol Violation|1
7544522|NCT02542631|26220128|P1|Overall Study|Protocol Violation|1
7544523|NCT02542631|26220127|P2|Overall Study|Withdrawal by Subject|16
7544524|NCT02542631|26220128|P1|Overall Study|Withdrawal by Subject|11
7544525|NCT02542631|26220127|P2|Overall Study|Sponsor Termination|0
7544526|NCT02542631|26220128|P1|Overall Study|Sponsor Termination|1
7544527|NCT02542631|26220127|P2|Overall Study|Adverse Event|1
7544528|NCT02542631|26220128|P1|Overall Study|Adverse Event|1
7544529|NCT02542605|26220150|P3|Part B: Randomization Phase|Withdrawal by Subject|1
7544530|NCT02542605|26220151|P2|Part B: Randomization Phase|Withdrawal by Subject|0
7544531|NCT02542605|26220152|P1|Part B: Randomization Phase|Withdrawal by Subject|0
7544532|NCT02542605|26220150|P3|Part B: Challenge Phase|Sponsor decision|0
7544533|NCT02542605|26220151|P2|Part B: Challenge Phase|Sponsor decision|0
7544534|NCT02542605|26220152|P1|Part B: Challenge Phase|Sponsor decision|1
7544535|NCT02542397|26220229|P1|Overall Study|Lost to Follow-up|2
7544536|NCT02542397|26220229|P1|Overall Study|Withdrawal by Subject|6
7544537|NCT02542397|26220229|P1|Overall Study|Physician Decision|6
7544538|NCT02542397|26220229|P1|Overall Study|Death|2
7544539|NCT02542267|26220246|P1|Overall Study|Other|5
7544540|NCT02542267|26220246|P1|Overall Study|Surgical Bypass of All Study Devices|12
7544541|NCT02542267|26220246|P1|Overall Study|Death|12
7544542|NCT02542267|26220246|P1|Overall Study|Lost to Follow-up|4
7544543|NCT02542267|26220246|P1|Overall Study|Physician Decision|5
7544544|NCT02542267|26220246|P1|Overall Study|Withdrawal by Subject|8
7544545|NCT02542267|26220246|P1|Overall Study|Ongoing|31
7544546|NCT02542072|26220267|P2|Second Intervention (1 Month)|Lens discomfort|0
7544547|NCT02542072|26220268|P1|Second Intervention (1 Month)|Lens discomfort|1
7544548|NCT02542072|26220267|P2|Second Intervention (1 Month)|Lost to Follow-up|0
7544549|NCT02542072|26220268|P1|Second Intervention (1 Month)|Lost to Follow-up|1
7544550|NCT02542072|26220267|P2|First Intervention (1 Month)|Protocol Violation|0
7544551|NCT02542072|26220268|P1|First Intervention (1 Month)|Protocol Violation|1
7544552|NCT02542072|26220267|P2|First Intervention (1 Month)|Lens discomfort|2
7544553|NCT02542072|26220268|P1|First Intervention (1 Month)|Lens discomfort|1
7544554|NCT02542072|26220267|P2|First Intervention (1 Month)|Lost to Follow-up|0
7544555|NCT02542072|26220268|P1|First Intervention (1 Month)|Lost to Follow-up|2
7544556|NCT02542072|26220267|P2|First Intervention (1 Month)|Adverse Event|1
7544557|NCT02542072|26220268|P1|First Intervention (1 Month)|Adverse Event|1
7544558|NCT02541903|26220392|P1|Overall Study|Death|1
7544559|NCT02541669|26220423|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
7544560|NCT02541669|26220424|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
7544561|NCT02541669|26220425|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
7544562|NCT02541669|26220426|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
7544563|NCT02541669|26220427|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
7544564|NCT02541604|26220474|P12|Overall Study|Medical condition may jeopardize safety|0
7544565|NCT02541604|26220475|P11|Overall Study|Medical condition may jeopardize safety|0
7544566|NCT02541604|26220476|P10|Overall Study|Medical condition may jeopardize safety|0
7544567|NCT02541604|26220477|P9|Overall Study|Medical condition may jeopardize safety|0
7544568|NCT02541604|26220478|P8|Overall Study|Medical condition may jeopardize safety|1
7544569|NCT02541604|26220479|P7|Overall Study|Medical condition may jeopardize safety|0
7544570|NCT02541604|26220480|P6|Overall Study|Medical condition may jeopardize safety|0
7544571|NCT02541604|26220481|P5|Overall Study|Medical condition may jeopardize safety|0
7544572|NCT02541604|26220482|P4|Overall Study|Medical condition may jeopardize safety|0
7544573|NCT02541604|26220483|P3|Overall Study|Medical condition may jeopardize safety|0
7544574|NCT02541604|26220484|P2|Overall Study|Medical condition may jeopardize safety|0
7544575|NCT02541604|26220485|P1|Overall Study|Medical condition may jeopardize safety|0
7544576|NCT02541604|26220474|P12|Overall Study|Study Terminated by Sponsor|0
7544577|NCT02541604|26220475|P11|Overall Study|Study Terminated by Sponsor|0
7544578|NCT02541604|26220476|P10|Overall Study|Study Terminated by Sponsor|0
7544579|NCT02541604|26220477|P9|Overall Study|Study Terminated by Sponsor|0
7544580|NCT02541604|26220478|P8|Overall Study|Study Terminated by Sponsor|0
7544581|NCT02541604|26220479|P7|Overall Study|Study Terminated by Sponsor|0
7544582|NCT02541604|26220480|P6|Overall Study|Study Terminated by Sponsor|0
7544583|NCT02541604|26220481|P5|Overall Study|Study Terminated by Sponsor|0
7544584|NCT02541604|26220482|P4|Overall Study|Study Terminated by Sponsor|1
7544585|NCT02541604|26220483|P3|Overall Study|Study Terminated by Sponsor|2
7544586|NCT02541604|26220484|P2|Overall Study|Study Terminated by Sponsor|4
7544587|NCT02541604|26220485|P1|Overall Study|Study Terminated by Sponsor|1
7544588|NCT02541604|26220474|P12|Overall Study|Withdrawal by Subject|0
7544589|NCT02541604|26220475|P11|Overall Study|Withdrawal by Subject|0
7544590|NCT02541604|26220476|P10|Overall Study|Withdrawal by Subject|0
7544591|NCT02541604|26220477|P9|Overall Study|Withdrawal by Subject|1
7544592|NCT02541604|26220478|P8|Overall Study|Withdrawal by Subject|0
7544593|NCT02541604|26220479|P7|Overall Study|Withdrawal by Subject|0
7544594|NCT02541604|26220480|P6|Overall Study|Withdrawal by Subject|1
7544595|NCT02541604|26220481|P5|Overall Study|Withdrawal by Subject|1
7544596|NCT02541604|26220482|P4|Overall Study|Withdrawal by Subject|0
7544597|NCT02541604|26220483|P3|Overall Study|Withdrawal by Subject|1
7544598|NCT02541604|26220484|P2|Overall Study|Withdrawal by Subject|0
7544599|NCT02541604|26220485|P1|Overall Study|Withdrawal by Subject|2
7544600|NCT02541604|26220474|P12|Overall Study|Lost to Follow-up|0
7544601|NCT02541604|26220475|P11|Overall Study|Lost to Follow-up|0
7544602|NCT02541604|26220476|P10|Overall Study|Lost to Follow-up|0
7544603|NCT02541604|26220477|P9|Overall Study|Lost to Follow-up|0
7544604|NCT02541604|26220478|P8|Overall Study|Lost to Follow-up|0
7544605|NCT02541604|26220479|P7|Overall Study|Lost to Follow-up|1
7544606|NCT02541604|26220480|P6|Overall Study|Lost to Follow-up|1
7544607|NCT02541604|26220481|P5|Overall Study|Lost to Follow-up|0
7544608|NCT02541604|26220482|P4|Overall Study|Lost to Follow-up|0
7544609|NCT02541604|26220483|P3|Overall Study|Lost to Follow-up|1
7544610|NCT02541604|26220484|P2|Overall Study|Lost to Follow-up|0
7544611|NCT02541604|26220485|P1|Overall Study|Lost to Follow-up|2
7544612|NCT02541604|26220474|P12|Overall Study|Death|3
7544613|NCT02541604|26220475|P11|Overall Study|Death|2
7544614|NCT02541604|26220476|P10|Overall Study|Death|4
7544615|NCT02541604|26220477|P9|Overall Study|Death|3
7544616|NCT02541604|26220478|P8|Overall Study|Death|9
7544617|NCT02541604|26220479|P7|Overall Study|Death|9
7544618|NCT02541604|26220480|P6|Overall Study|Death|8
7544619|NCT02541604|26220481|P5|Overall Study|Death|9
7544620|NCT02541604|26220482|P4|Overall Study|Death|2
7544621|NCT02541604|26220483|P3|Overall Study|Death|7
7544622|NCT02541604|26220484|P2|Overall Study|Death|5
7544623|NCT02541604|26220485|P1|Overall Study|Death|6
7544624|NCT02540993|26220618|P2|Overall Study|GCP violations|27
7544625|NCT02540993|26220619|P1|Overall Study|GCP violations|33
7544626|NCT02540993|26220618|P2|Overall Study|Withdrawal by Subject|6
7544627|NCT02540993|26220619|P1|Overall Study|Withdrawal by Subject|4
7544628|NCT02540993|26220618|P2|Overall Study|Lost to Follow-up|3
7544629|NCT02540993|26220619|P1|Overall Study|Lost to Follow-up|5
7544630|NCT02540954|26220637|P2|Overall Study|Other reason|2
7544631|NCT02540954|26220638|P1|Overall Study|Other reason|4
7544632|NCT02540954|26220637|P2|Overall Study|Treatment failure|0
7544633|NCT02540954|26220638|P1|Overall Study|Treatment failure|1
7544634|NCT02540954|26220637|P2|Overall Study|Death|3
7544635|NCT02540954|26220638|P1|Overall Study|Death|0
7544636|NCT02540954|26220637|P2|Overall Study|Adverse Event|2
7544637|NCT02540954|26220638|P1|Overall Study|Adverse Event|4
7544638|NCT02540954|26220637|P2|Overall Study|Lost to Follow-up|1
7544639|NCT02540954|26220638|P1|Overall Study|Lost to Follow-up|1
7544640|NCT02540954|26220637|P2|Overall Study|Withdrawal by Subject|5
7544641|NCT02540954|26220638|P1|Overall Study|Withdrawal by Subject|6
7544642|NCT02540954|26220637|P2|Overall Study|Physician Decision|1
7544643|NCT02540954|26220638|P1|Overall Study|Physician Decision|3
7544644|NCT02540850|26220661|P3|Overall Study|Lost to Follow-up|34
7544645|NCT02540850|26220662|P2|Overall Study|Lost to Follow-up|66
7544646|NCT02540850|26220663|P1|Overall Study|Lost to Follow-up|69
7544647|NCT02540668|26220704|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
7544648|NCT02540668|26220705|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
7544649|NCT02540538|26220736|P3|Overall Study|Pregnancy|0
7544650|NCT02540538|26220737|P2|Overall Study|Pregnancy|1
7544651|NCT02540538|26220738|P1|Overall Study|Pregnancy|0
7544652|NCT02540356|26220806|P2|Overall Study|Terminated due to disease progression|0
7544653|NCT02540356|26220807|P1|Overall Study|Terminated due to disease progression|1
7544654|NCT02540291|26220842|P4|Overall Study|Other|0
7544655|NCT02540291|26220843|P3|Overall Study|Other|1
7544656|NCT02540291|26220844|P2|Overall Study|Other|0
7544657|NCT02540291|26220845|P1|Overall Study|Other|0
7544658|NCT02540291|26220842|P4|Overall Study|Study Terminated By Sponsor|0
7544659|NCT02540291|26220843|P3|Overall Study|Study Terminated By Sponsor|0
7544660|NCT02540291|26220844|P2|Overall Study|Study Terminated By Sponsor|0
7544661|NCT02540291|26220845|P1|Overall Study|Study Terminated By Sponsor|1
7544662|NCT02540291|26220842|P4|Overall Study|Withdrawal Of Consent|0
7544663|NCT02540291|26220843|P3|Overall Study|Withdrawal Of Consent|0
7544664|NCT02540291|26220844|P2|Overall Study|Withdrawal Of Consent|1
7544665|NCT02540291|26220845|P1|Overall Study|Withdrawal Of Consent|0
7544666|NCT02540291|26220842|P4|Overall Study|Lost to Follow-up|0
7544667|NCT02540291|26220843|P3|Overall Study|Lost to Follow-up|1
7544668|NCT02540291|26220844|P2|Overall Study|Lost to Follow-up|0
7544669|NCT02540291|26220845|P1|Overall Study|Lost to Follow-up|0
7544670|NCT02540291|26220842|P4|Overall Study|Death|7
7544671|NCT02540291|26220843|P3|Overall Study|Death|5
7544672|NCT02540291|26220844|P2|Overall Study|Death|7
7544673|NCT02540291|26220845|P1|Overall Study|Death|7
7544674|NCT02540265|26220880|P3|Overall Study|Lost to Follow-up|1
7544675|NCT02540265|26220881|P2|Overall Study|Lost to Follow-up|0
7544676|NCT02540265|26220882|P1|Overall Study|Lost to Follow-up|0
7544677|NCT02540213|26220937|P1|Overall Study|Enrolled but not treated|2
7544678|NCT02540213|26220937|P1|Overall Study|Consent withdrawn|7
7544679|NCT02540213|26220937|P1|Overall Study|Lack of Efficacy|6
7544680|NCT02540213|26220937|P1|Overall Study|Kidney transplant|3
7544681|NCT02540213|26220937|P1|Overall Study|Administrative reasons|3
7544682|NCT02540213|26220937|P1|Overall Study|Death/adverse event|18
7544683|NCT02540083|26220991|P1|Overall Study|Withdrawal by Subject|16
7544684|NCT02539797|26221032|P3|Overall Study|Lost to Follow-up|0
7544685|NCT02539797|26221033|P2|Overall Study|Lost to Follow-up|1
7544686|NCT02539797|26221034|P1|Overall Study|Lost to Follow-up|0
7544687|NCT02539368|26221091|P5|Overall Study|Missing|0
7544688|NCT02539368|26221092|P4|Overall Study|Missing|0
7544689|NCT02539368|26221093|P3|Overall Study|Missing|0
7544690|NCT02539368|26221094|P2|Overall Study|Missing|3
7544691|NCT02539368|26221095|P1|Overall Study|Missing|10
7544692|NCT02539368|26221091|P5|Overall Study|Other|3
7544693|NCT02539368|26221092|P4|Overall Study|Other|1
7544694|NCT02539368|26221093|P3|Overall Study|Other|24
7544695|NCT02539368|26221094|P2|Overall Study|Other|18
7544696|NCT02539368|26221095|P1|Overall Study|Other|145
7544697|NCT02539368|26221091|P5|Overall Study|Participant Non-compliant|0
7544698|NCT02539368|26221092|P4|Overall Study|Participant Non-compliant|1
7544699|NCT02539368|26221093|P3|Overall Study|Participant Non-compliant|1
7544700|NCT02539368|26221094|P2|Overall Study|Participant Non-compliant|2
7544701|NCT02539368|26221095|P1|Overall Study|Participant Non-compliant|13
7544702|NCT02539368|26221091|P5|Overall Study|Adverse Event|3
7544703|NCT02539368|26221092|P4|Overall Study|Adverse Event|0
7544704|NCT02539368|26221093|P3|Overall Study|Adverse Event|9
7544705|NCT02539368|26221094|P2|Overall Study|Adverse Event|5
7544706|NCT02539368|26221095|P1|Overall Study|Adverse Event|44
7544707|NCT02539368|26221091|P5|Overall Study|Lost to Follow-up|3
7544708|NCT02539368|26221092|P4|Overall Study|Lost to Follow-up|4
7544709|NCT02539368|26221093|P3|Overall Study|Lost to Follow-up|16
7544710|NCT02539368|26221094|P2|Overall Study|Lost to Follow-up|21
7544711|NCT02539368|26221095|P1|Overall Study|Lost to Follow-up|96
7544712|NCT02539368|26221091|P5|Overall Study|Physician Decision|2
7544713|NCT02539368|26221092|P4|Overall Study|Physician Decision|0
7544714|NCT02539368|26221093|P3|Overall Study|Physician Decision|7
7544715|NCT02539368|26221094|P2|Overall Study|Physician Decision|15
7544716|NCT02539368|26221095|P1|Overall Study|Physician Decision|49
7544717|NCT02539368|26221091|P5|Overall Study|Withdrawal by Subject|3
7544718|NCT02539368|26221092|P4|Overall Study|Withdrawal by Subject|1
7544719|NCT02539368|26221093|P3|Overall Study|Withdrawal by Subject|9
7544720|NCT02539368|26221094|P2|Overall Study|Withdrawal by Subject|35
7544721|NCT02539368|26221095|P1|Overall Study|Withdrawal by Subject|44
7544722|NCT02539368|26221091|P5|Overall Study|Death|0
7544723|NCT02539368|26221092|P4|Overall Study|Death|0
7544724|NCT02539368|26221093|P3|Overall Study|Death|1
7544725|NCT02539368|26221094|P2|Overall Study|Death|2
7544726|NCT02539368|26221095|P1|Overall Study|Death|4
7544727|NCT02539225|26221228|P2|Part B|Physician Decision|9
7544728|NCT02539225|26221229|P1|Part B|Physician Decision|0
7544729|NCT02539225|26221228|P2|Part B|Withdrawal by Subject|3
7544730|NCT02539225|26221229|P1|Part B|Withdrawal by Subject|0
7544731|NCT02539225|26221228|P2|Part B|Adverse Event|4
7544732|NCT02539225|26221229|P1|Part B|Adverse Event|4
7544733|NCT02539225|26221228|P2|Pre Treatment for Part B|Physician Decision|0
7544734|NCT02539225|26221229|P1|Pre Treatment for Part B|Physician Decision|2
7544735|NCT02539225|26221228|P2|Pre Treatment for Part B|Withdrawal by Subject|0
7544736|NCT02539225|26221229|P1|Pre Treatment for Part B|Withdrawal by Subject|1
7544737|NCT02539225|26221228|P2|Pre Treatment for Part B|Adverse Event|1
7544738|NCT02539225|26221229|P1|Pre Treatment for Part B|Adverse Event|1
7544739|NCT02539225|26221228|P2|Pre Treatment for Part B|Progressive disease|1
7544740|NCT02539225|26221229|P1|Pre Treatment for Part B|Progressive disease|1
7544741|NCT02539225|26221228|P2|Part A|Did Not Receive study Drug|1
7544742|NCT02539225|26221229|P1|Part A|Did Not Receive study Drug|1
7544743|NCT02539225|26221228|P2|Part A|Physician Decision|7
7544744|NCT02539225|26221229|P1|Part A|Physician Decision|4
7544745|NCT02539225|26221228|P2|Part A|Withdrawal by Subject|4
7544746|NCT02539225|26221229|P1|Part A|Withdrawal by Subject|2
7544747|NCT02539225|26221228|P2|Part A|Adverse Event|4
7544748|NCT02539225|26221229|P1|Part A|Adverse Event|13
7544749|NCT02539134|26221256|P6|Overall Study|Lost to Follow-up|0
7544750|NCT02539134|26221257|P5|Overall Study|Lost to Follow-up|0
7544751|NCT02539134|26221258|P4|Overall Study|Lost to Follow-up|0
7544752|NCT02539134|26221259|P3|Overall Study|Lost to Follow-up|0
7544753|NCT02539134|26221260|P2|Overall Study|Lost to Follow-up|0
7544754|NCT02539134|26221261|P1|Overall Study|Lost to Follow-up|1
7544755|NCT02538965|26221330|P1|Follow-Up Period|Withdrawal by Parent|4
7544756|NCT02538965|26221330|P1|Follow-Up Period|Other = Death due to disease progression|13
7544757|NCT02538965|26221330|P1|Treatment Period|Physician Decision|2
7544758|NCT02538965|26221330|P1|Treatment Period|Disease Progression|1
7544759|NCT02538965|26221330|P1|Treatment Period|Treatment Failure|9
7544760|NCT02538965|26221330|P1|Treatment Period|Withdrawal by Parent/Guardian|2
7544761|NCT02538965|26221330|P1|Treatment Period|Adverse Event|2
7544762|NCT02538965|26221330|P1|Treatment Period|Other = Death due to disease progression|1
7544763|NCT02538666|26221376|P3|Overall Study|Withdrew Consent|1
7544764|NCT02538666|26221377|P2|Overall Study|Withdrew Consent|1
7544765|NCT02538666|26221378|P1|Overall Study|Withdrew Consent|0
7544766|NCT02538666|26221376|P3|Overall Study|no longer meets study criteria|0
7544767|NCT02538666|26221377|P2|Overall Study|no longer meets study criteria|0
7544768|NCT02538666|26221378|P1|Overall Study|no longer meets study criteria|1
7544769|NCT02538666|26221376|P3|Overall Study|Disease progression|0
7544770|NCT02538666|26221377|P2|Overall Study|Disease progression|0
7544771|NCT02538666|26221378|P1|Overall Study|Disease progression|1
7544772|NCT02538614|26221397|P1|Overall Study|Progressive Disease|2
7544773|NCT02538471|26221437|P1|Overall Study|Progression of disease|2
7544774|NCT02538107|26221473|P1|Overall Study|Not recorded|7
7544775|NCT02538107|26221473|P1|Overall Study|Other|7
7544776|NCT02538107|26221473|P1|Overall Study|Surgery|1
7544777|NCT02538107|26221473|P1|Overall Study|Adverse Event|4
7544778|NCT02538107|26221473|P1|Overall Study|Administrative reason|5
7544779|NCT02538107|26221473|P1|Overall Study|Death|4
7544780|NCT02538107|26221473|P1|Overall Study|Withdrawal by Subject|17
7544781|NCT02538107|26221473|P1|Overall Study|No further treatment necessary|18
7544782|NCT02538107|26221473|P1|Overall Study|Administration of other ESA|11
7544783|NCT02538107|26221473|P1|Overall Study|Necessity of dialysis|20
7544784|NCT02538107|26221473|P1|Overall Study|Missing|5
7544785|NCT02538107|26221473|P1|Overall Study|Did not receive any Mircera dose|11
7544786|NCT02538094|26221493|P2|Washout (4 Weeks)|Withdrawal by Subject|1
7544787|NCT02538094|26221494|P1|Washout (4 Weeks)|Withdrawal by Subject|0
7544788|NCT02538094|26221493|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
7544789|NCT02538094|26221494|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
7544790|NCT02538029|26221524|P3|Overall Study|unable to complete cognitive assessments|1
7544791|NCT02538029|26221525|P2|Overall Study|unable to complete cognitive assessments|0
7544792|NCT02538029|26221526|P1|Overall Study|unable to complete cognitive assessments|1
7544793|NCT02537574|26221617|P3|Overall Study|Noncompliance with Protocol|1
7544794|NCT02537574|26221618|P2|Overall Study|Noncompliance with Protocol|0
7544795|NCT02537574|26221619|P1|Overall Study|Noncompliance with Protocol|0
7544796|NCT02537574|26221617|P3|Overall Study|Subject did not want last Vivitrol Injec|1
7544797|NCT02537574|26221618|P2|Overall Study|Subject did not want last Vivitrol Injec|0
7544798|NCT02537574|26221619|P1|Overall Study|Subject did not want last Vivitrol Injec|0
7544799|NCT02537574|26221617|P3|Overall Study|Transportation Issues|1
7544800|NCT02537574|26221618|P2|Overall Study|Transportation Issues|0
7544801|NCT02537574|26221619|P1|Overall Study|Transportation Issues|0
7544802|NCT02537574|26221617|P3|Overall Study|Failed Naloxone Challenge|0
7544803|NCT02537574|26221618|P2|Overall Study|Failed Naloxone Challenge|1
7544804|NCT02537574|26221619|P1|Overall Study|Failed Naloxone Challenge|0
7544805|NCT02537574|26221617|P3|Overall Study|Incarceration|0
7544806|NCT02537574|26221618|P2|Overall Study|Incarceration|1
7544807|NCT02537574|26221619|P1|Overall Study|Incarceration|0
7544808|NCT02537574|26221617|P3|Overall Study|Patient not Stable|0
7544809|NCT02537574|26221618|P2|Overall Study|Patient not Stable|1
7544810|NCT02537574|26221619|P1|Overall Study|Patient not Stable|0
7544811|NCT02537574|26221617|P3|Overall Study|Duplicate Patient|0
7544812|NCT02537574|26221618|P2|Overall Study|Duplicate Patient|0
7544813|NCT02537574|26221619|P1|Overall Study|Duplicate Patient|1
7544814|NCT02537574|26221617|P3|Overall Study|Lack of Efficacy|15
7544815|NCT02537574|26221618|P2|Overall Study|Lack of Efficacy|16
7544816|NCT02537574|26221619|P1|Overall Study|Lack of Efficacy|14
7544817|NCT02537574|26221617|P3|Overall Study|Withdrawal by Subject|29
7544818|NCT02537574|26221618|P2|Overall Study|Withdrawal by Subject|27
7544819|NCT02537574|26221619|P1|Overall Study|Withdrawal by Subject|37
7544820|NCT02537574|26221617|P3|Overall Study|Protocol Violation|3
7544821|NCT02537574|26221618|P2|Overall Study|Protocol Violation|2
7544822|NCT02537574|26221619|P1|Overall Study|Protocol Violation|4
7544823|NCT02537574|26221617|P3|Overall Study|Physician Decision|0
7544824|NCT02537574|26221618|P2|Overall Study|Physician Decision|0
7544825|NCT02537574|26221619|P1|Overall Study|Physician Decision|2
7544826|NCT02537574|26221617|P3|Overall Study|Noncompliance with study drug|1
7544827|NCT02537574|26221618|P2|Overall Study|Noncompliance with study drug|1
7544828|NCT02537574|26221619|P1|Overall Study|Noncompliance with study drug|0
7544829|NCT02537574|26221617|P3|Overall Study|Lost to Follow-up|55
7544830|NCT02537574|26221618|P2|Overall Study|Lost to Follow-up|51
7544831|NCT02537574|26221619|P1|Overall Study|Lost to Follow-up|40
7544832|NCT02537574|26221617|P3|Overall Study|Adverse Event|2
7544833|NCT02537574|26221618|P2|Overall Study|Adverse Event|3
7544834|NCT02537574|26221619|P1|Overall Study|Adverse Event|1
7544835|NCT02537522|26221645|P4|Phase II - Period 1 Bilateral|Adverse Event|1
7544836|NCT02537522|26221646|P3|Phase II - Period 1 Bilateral|Adverse Event|0
7544837|NCT02537522|26221647|P2|Phase II - Period 1 Bilateral|Adverse Event|0
7544838|NCT02537522|26221648|P1|Phase II - Period 1 Bilateral|Adverse Event|0
7544839|NCT02537522|26221645|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
7544840|NCT02537522|26221646|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
7544841|NCT02537522|26221647|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
7544842|NCT02537522|26221648|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
7544843|NCT02537522|26221645|P4|Phase I - Contralateral|incorrect randomization|0
7544844|NCT02537522|26221646|P3|Phase I - Contralateral|incorrect randomization|0
7544845|NCT02537522|26221647|P2|Phase I - Contralateral|incorrect randomization|1
7544846|NCT02537522|26221648|P1|Phase I - Contralateral|incorrect randomization|0
7544847|NCT02537522|26221645|P4|Phase I - Contralateral|Withdrawal by Subject|0
7544848|NCT02537522|26221646|P3|Phase I - Contralateral|Withdrawal by Subject|0
7544849|NCT02537522|26221647|P2|Phase I - Contralateral|Withdrawal by Subject|1
7544850|NCT02537522|26221648|P1|Phase I - Contralateral|Withdrawal by Subject|0
7544851|NCT02537522|26221645|P4|Phase I - Contralateral|Subject no longer eligible|0
7544852|NCT02537522|26221646|P3|Phase I - Contralateral|Subject no longer eligible|0
7544853|NCT02537522|26221647|P2|Phase I - Contralateral|Subject no longer eligible|7
7544854|NCT02537522|26221648|P1|Phase I - Contralateral|Subject no longer eligible|15
7544855|NCT02537431|26221665|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
7544856|NCT02537015|26221694|P1|Overall Study|Other Miscellaneous Reasons|1
7544857|NCT02537015|26221694|P1|Overall Study|Withdrawal by Subject|2
7544858|NCT02537015|26221694|P1|Overall Study|Adverse Event|3
7544859|NCT02536976|26221700|P2|Overall Study|Physician Decision|1
7544860|NCT02536976|26221701|P1|Overall Study|Physician Decision|0
7544861|NCT02536963|26221711|P1|Overall Study|Withdrawal by Subject|18
7544862|NCT02536846|26221715|P1|Overall Study|Withdrawal by Subject|1
7544863|NCT02536833|26221755|P4|Overall Study|Withdrawal by Subject|11
7544864|NCT02536833|26221756|P3|Overall Study|Withdrawal by Subject|5
7544865|NCT02536833|26221757|P2|Overall Study|Withdrawal by Subject|3
7544866|NCT02536833|26221758|P1|Overall Study|Withdrawal by Subject|4
7544867|NCT02536833|26221755|P4|Overall Study|Subject Non-Compliance|0
7544868|NCT02536833|26221756|P3|Overall Study|Subject Non-Compliance|1
7544869|NCT02536833|26221757|P2|Overall Study|Subject Non-Compliance|1
7544870|NCT02536833|26221758|P1|Overall Study|Subject Non-Compliance|0
7544871|NCT02536833|26221755|P4|Overall Study|Site Terminated by Sponsor|2
7544872|NCT02536833|26221756|P3|Overall Study|Site Terminated by Sponsor|2
7544873|NCT02536833|26221757|P2|Overall Study|Site Terminated by Sponsor|2
7544874|NCT02536833|26221758|P1|Overall Study|Site Terminated by Sponsor|2
7544875|NCT02536833|26221755|P4|Overall Study|Physician Decision|1
7544876|NCT02536833|26221756|P3|Overall Study|Physician Decision|0
7544877|NCT02536833|26221757|P2|Overall Study|Physician Decision|0
7544878|NCT02536833|26221758|P1|Overall Study|Physician Decision|0
7544879|NCT02536833|26221755|P4|Overall Study|Lost to Follow-up|2
7544880|NCT02536833|26221756|P3|Overall Study|Lost to Follow-up|2
7544881|NCT02536833|26221757|P2|Overall Study|Lost to Follow-up|1
7544882|NCT02536833|26221758|P1|Overall Study|Lost to Follow-up|2
7544883|NCT02536833|26221755|P4|Overall Study|Adverse Event|1
7544884|NCT02536833|26221756|P3|Overall Study|Adverse Event|4
7544885|NCT02536833|26221757|P2|Overall Study|Adverse Event|3
7544886|NCT02536833|26221758|P1|Overall Study|Adverse Event|1
7544887|NCT02536833|26221755|P4|Overall Study|Discontinued Before Treatment|2
7544888|NCT02536833|26221756|P3|Overall Study|Discontinued Before Treatment|1
7544889|NCT02536833|26221757|P2|Overall Study|Discontinued Before Treatment|0
7544890|NCT02536833|26221758|P1|Overall Study|Discontinued Before Treatment|0
7544891|NCT02536794|26221817|P1|Continued Treatment After 1st Response|Adverse Event|1
7544892|NCT02536794|26221817|P1|Continued Treatment After 1st Response|Progressive disease|7
7544893|NCT02536794|26221817|P1|Reached 1st Response Assessment|Protocol Violation|1
7544894|NCT02536794|26221817|P1|Reached 1st Response Assessment|Withdrawal by Subject|1
7544895|NCT02536794|26221817|P1|Reached 1st Response Assessment|Progressive Disease|2
7544896|NCT02536794|26221817|P1|Reached 1st Response Assessment|Adverse Event|2
7544897|NCT02536781|26221828|P2|Overall Study|Lost to Follow-up|0
7544898|NCT02536781|26221829|P1|Overall Study|Lost to Follow-up|2
7544899|NCT02536664|26221839|P2|Overall Study|Missing|20
7544900|NCT02536664|26221840|P1|Overall Study|Missing|53
7544901|NCT02536664|26221839|P2|Overall Study|Other|24
7544902|NCT02536664|26221840|P1|Overall Study|Other|18
7544903|NCT02536664|26221839|P2|Overall Study|Withdrawal by Subject|5
7544904|NCT02536664|26221840|P1|Overall Study|Withdrawal by Subject|8
7544905|NCT02536664|26221839|P2|Overall Study|Intolerability|6
7544906|NCT02536664|26221840|P1|Overall Study|Intolerability|8
7544907|NCT02536664|26221839|P2|Overall Study|Death due to other reason|2
7544908|NCT02536664|26221840|P1|Overall Study|Death due to other reason|3
7544909|NCT02536664|26221839|P2|Overall Study|Death due to lymphoma|1
7544910|NCT02536664|26221840|P1|Overall Study|Death due to lymphoma|2
7544911|NCT02536664|26221839|P2|Overall Study|Progression|18
7544912|NCT02536664|26221840|P1|Overall Study|Progression|13
7544913|NCT02536664|26221839|P2|Overall Study|Inadequate completion of documentation|4
7544914|NCT02536664|26221840|P1|Overall Study|Inadequate completion of documentation|2
7544915|NCT02536508|26221861|P3|Overall Study|Administrative Reasons|0
7544916|NCT02536508|26221862|P2|Overall Study|Administrative Reasons|1
7544917|NCT02536508|26221863|P1|Overall Study|Administrative Reasons|0
7544918|NCT02536508|26221861|P3|Overall Study|Major Protocol Deviation|2
7544919|NCT02536508|26221862|P2|Overall Study|Major Protocol Deviation|2
7544920|NCT02536508|26221863|P1|Overall Study|Major Protocol Deviation|2
7544921|NCT02536508|26221861|P3|Overall Study|Physician Decision|2
7544922|NCT02536508|26221862|P2|Overall Study|Physician Decision|4
7544923|NCT02536508|26221863|P1|Overall Study|Physician Decision|0
7544924|NCT02536508|26221861|P3|Overall Study|Protocol Discontinuation Criteria|2
7544925|NCT02536508|26221862|P2|Overall Study|Protocol Discontinuation Criteria|2
7544926|NCT02536508|26221863|P1|Overall Study|Protocol Discontinuation Criteria|3
7544927|NCT02536508|26221861|P3|Overall Study|Lack of Efficacy|4
7544928|NCT02536508|26221862|P2|Overall Study|Lack of Efficacy|5
7544929|NCT02536508|26221863|P1|Overall Study|Lack of Efficacy|3
7544930|NCT02536508|26221861|P3|Overall Study|Lost to Follow-up|0
7544931|NCT02536508|26221862|P2|Overall Study|Lost to Follow-up|4
7544932|NCT02536508|26221863|P1|Overall Study|Lost to Follow-up|12
7544933|NCT02536508|26221861|P3|Overall Study|Adverse Event|6
7544934|NCT02536508|26221862|P2|Overall Study|Adverse Event|13
7544935|NCT02536508|26221863|P1|Overall Study|Adverse Event|14
7544936|NCT02536508|26221861|P3|Overall Study|Withdrawal by Subject|7
7544937|NCT02536508|26221862|P2|Overall Study|Withdrawal by Subject|13
7544938|NCT02536508|26221863|P1|Overall Study|Withdrawal by Subject|18
7544939|NCT02536378|26221876|P2|Overall Study|Patient refused further follow up|2
7544940|NCT02536378|26221877|P1|Overall Study|Patient refused further follow up|6
7544941|NCT02536378|26221876|P2|Overall Study|Death|2
7544942|NCT02536378|26221877|P1|Overall Study|Death|1
7544943|NCT02536378|26221876|P2|Overall Study|Withdrawal by Subject|1
7544944|NCT02536378|26221877|P1|Overall Study|Withdrawal by Subject|0
7544945|NCT02536378|26221876|P2|Overall Study|Physician Decision|2
7544946|NCT02536378|26221877|P1|Overall Study|Physician Decision|0
7544947|NCT02536339|26221891|P1|Overall Study|Death|20
7544948|NCT02536339|26221891|P1|Overall Study|Withdrawal by Subject|3
7544949|NCT02536339|26221891|P1|Overall Study|Lost to Follow-up|2
7544950|NCT02536339|26221891|P1|Overall Study|Treatment Ongoing|2
7544951|NCT02536339|26221891|P1|Overall Study|In Survival Follow-Up|4
7544952|NCT02536313|26221917|P2|Overall Study|Lack of Efficacy|1
7544953|NCT02536313|26221918|P1|Overall Study|Lack of Efficacy|0
7544954|NCT02535741|26222036|P1|Overall Study|Missing data|6
7544955|NCT02535741|26222036|P1|Overall Study|Exclusion criteria: Bilateral implant|4
7544956|NCT02535741|26222036|P1|Overall Study|Lost to Follow-up|10
7544957|NCT02535741|26222036|P1|Overall Study|Withdrawal by Subject|9
7544958|NCT02535741|26222036|P1|Overall Study|Adverse Event|3
7544959|NCT02535715|26222044|P3|Overall Study|Withdrawal by Subject|1
7544960|NCT02535715|26222045|P2|Overall Study|Withdrawal by Subject|0
7544961|NCT02535715|26222046|P1|Overall Study|Withdrawal by Subject|0
7544962|NCT02535416|26222124|P9|Overall Study|Family bereavement overseas|0
7544963|NCT02535416|26222125|P8|Overall Study|Family bereavement overseas|0
7544964|NCT02535416|26222126|P7|Overall Study|Family bereavement overseas|0
7544965|NCT02535416|26222127|P6|Overall Study|Family bereavement overseas|0
7544966|NCT02535416|26222128|P5|Overall Study|Family bereavement overseas|0
7544967|NCT02535416|26222129|P4|Overall Study|Family bereavement overseas|0
7544968|NCT02535416|26222130|P3|Overall Study|Family bereavement overseas|0
7544969|NCT02535416|26222131|P2|Overall Study|Family bereavement overseas|0
7544970|NCT02535416|26222132|P1|Overall Study|Family bereavement overseas|1
7544971|NCT02535364|26222184|P1|12-Month Follow-up Period|Subject transferred to hospice|1
7544972|NCT02535364|26222184|P1|12-Month Follow-up Period|Subject received alternative therapy|2
7544973|NCT02535364|26222184|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
7544974|NCT02535364|26222184|P1|12-Month Follow-up Period|Death|5
7544975|NCT02535364|26222184|P1|12-Month Follow-up Period|Disease progression|22
7544976|NCT02535364|26222184|P1|Study Treatment|Study placed on clinical hold by FDA|1
7544977|NCT02535364|26222184|P1|Study Treatment|Death|1
7544978|NCT02535364|26222184|P1|Part B Screening|Change in diagnosis, no longer eligible|2
7544979|NCT02535364|26222184|P1|Part B Screening|Adverse Event|1
7544980|NCT02535364|26222184|P1|Part B Screening|Withdrawal by Subject|1
7544981|NCT02535364|26222184|P1|Part B Screening|Physician Decision|1
7544982|NCT02535364|26222184|P1|Part B Screening|Death|2
7544983|NCT02535364|26222184|P1|Part B Screening|Unable to manufacture JCAR015|3
7544984|NCT02535364|26222184|P1|Part B Screening|Study placed on clinical hold by FDA|7
7544985|NCT02535364|26222184|P1|Part A Screening Through Leukapheresis|Disease progression|1
7544986|NCT02535364|26222184|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
7544987|NCT02535364|26222184|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
7544988|NCT02535000|26222268|P2|Overall Study|Cancellation of surgery.|2
7544989|NCT02535000|26222269|P1|Overall Study|Cancellation of surgery.|1
7544990|NCT02534935|26222280|P3|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7544991|NCT02534935|26222281|P2|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
7544992|NCT02534935|26222282|P1|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7544993|NCT02534935|26222280|P3|Stage 2: 8 Months|Moved away/parents resigned from study|0
7544994|NCT02534935|26222281|P2|Stage 2: 8 Months|Moved away/parents resigned from study|4
7544995|NCT02534935|26222282|P1|Stage 2: 8 Months|Moved away/parents resigned from study|0
7544996|NCT02534935|26222280|P3|Stage 1: 24 Months|Adverse Event|0
7544997|NCT02534935|26222281|P2|Stage 1: 24 Months|Adverse Event|2
7544998|NCT02534935|26222282|P1|Stage 1: 24 Months|Adverse Event|0
7544999|NCT02534935|26222280|P3|Stage 1: 24 Months|Lost to Follow-up|1
7545000|NCT02534935|26222281|P2|Stage 1: 24 Months|Lost to Follow-up|1
7545001|NCT02534935|26222282|P1|Stage 1: 24 Months|Lost to Follow-up|0
7545002|NCT02534935|26222280|P3|Stage 1: 24 Months|No longer meets eligibility criteria|0
7545003|NCT02534935|26222281|P2|Stage 1: 24 Months|No longer meets eligibility criteria|3
7545004|NCT02534935|26222282|P1|Stage 1: 24 Months|No longer meets eligibility criteria|0
7545005|NCT02534935|26222280|P3|Stage 1: 24 Months|No longer willing to participate in study|1
7545006|NCT02534935|26222281|P2|Stage 1: 24 Months|No longer willing to participate in study|1
7545007|NCT02534935|26222282|P1|Stage 1: 24 Months|No longer willing to participate in study|0
7545008|NCT02534935|26222280|P3|Stage 1: 24 Months|Withdrawal by Subject|3
7545009|NCT02534935|26222281|P2|Stage 1: 24 Months|Withdrawal by Subject|3
7545010|NCT02534935|26222282|P1|Stage 1: 24 Months|Withdrawal by Subject|0
7545011|NCT02534896|26222454|P3|Overall Study|Insufficient therapeutic response|0
7545012|NCT02534896|26222455|P2|Overall Study|Insufficient therapeutic response|0
7545013|NCT02534896|26222456|P1|Overall Study|Insufficient therapeutic response|2
7545014|NCT02534896|26222454|P3|Overall Study|Adverse Event|1
7545015|NCT02534896|26222455|P2|Overall Study|Adverse Event|1
7545016|NCT02534896|26222456|P1|Overall Study|Adverse Event|2
7545017|NCT02534883|26222475|P2|Overall Study|Early Termination|3
7545018|NCT02534883|26222476|P1|Overall Study|Early Termination|8
7545019|NCT02534493|26222492|P1|Overall Study|Withdrawal by Subject|1
7545020|NCT02534493|26222492|P1|Overall Study|Lost to Follow-up|1
7545021|NCT02534350|26222503|P2|Overall Study|Withdrew Consent|0
7545022|NCT02534350|26222504|P1|Overall Study|Withdrew Consent|2
7545023|NCT02534350|26222503|P2|Overall Study|Protocol Violation|0
7545024|NCT02534350|26222504|P1|Overall Study|Protocol Violation|1
7545025|NCT02534350|26222503|P2|Overall Study|Randomized But Not Treated|0
7545026|NCT02534350|26222504|P1|Overall Study|Randomized But Not Treated|1
7545027|NCT02534324|26222518|P2|Overall Study|Adverse Event|0
7545028|NCT02534324|26222519|P1|Overall Study|Adverse Event|1
7545029|NCT02534324|26222518|P2|Overall Study|Lost to Follow-up|7
7545030|NCT02534324|26222519|P1|Overall Study|Lost to Follow-up|20
7545031|NCT02534324|26222518|P2|Overall Study|Protocol Violation|1
7545032|NCT02534324|26222519|P1|Overall Study|Protocol Violation|4
7545033|NCT02533999|26222584|P2|Overall Study|Randomized but intervention not received|1
7545034|NCT02533999|26222585|P1|Overall Study|Randomized but intervention not received|0
7545035|NCT02533999|26222584|P2|Overall Study|Adverse Event|1
7545036|NCT02533999|26222585|P1|Overall Study|Adverse Event|0
7545037|NCT02533999|26222584|P2|Overall Study|Protocol Violation|0
7545038|NCT02533999|26222585|P1|Overall Study|Protocol Violation|3
7545039|NCT02533999|26222584|P2|Overall Study|Lost to Follow-up|5
7545040|NCT02533999|26222585|P1|Overall Study|Lost to Follow-up|3
7545041|NCT02533674|26222657|P8|Dose Level VIII|Never treated|1
7545042|NCT02533674|26222658|P7|Dose Level VIII|Never treated|0
7545043|NCT02533674|26222659|P6|Dose Level VIII|Never treated|0
7545044|NCT02533674|26222660|P5|Dose Level VIII|Never treated|0
7545045|NCT02533674|26222661|P4|Dose Level VIII|Never treated|0
7545046|NCT02533674|26222662|P3|Dose Level VIII|Never treated|0
7545047|NCT02533674|26222663|P2|Dose Level VIII|Never treated|0
7545048|NCT02533674|26222664|P1|Dose Level VIII|Never treated|0
7545049|NCT02533674|26222657|P8|Dose Level VIII|Treatment-related AE|1
7545050|NCT02533674|26222658|P7|Dose Level VIII|Treatment-related AE|0
7545051|NCT02533674|26222659|P6|Dose Level VIII|Treatment-related AE|0
7545052|NCT02533674|26222660|P5|Dose Level VIII|Treatment-related AE|0
7545053|NCT02533674|26222661|P4|Dose Level VIII|Treatment-related AE|0
7545054|NCT02533674|26222662|P3|Dose Level VIII|Treatment-related AE|0
7545055|NCT02533674|26222663|P2|Dose Level VIII|Treatment-related AE|0
7545056|NCT02533674|26222664|P1|Dose Level VIII|Treatment-related AE|0
7545057|NCT02533674|26222657|P8|Dose Level VIII|Withdrawal by Subject|1
7545058|NCT02533674|26222658|P7|Dose Level VIII|Withdrawal by Subject|0
7545059|NCT02533674|26222659|P6|Dose Level VIII|Withdrawal by Subject|0
7545060|NCT02533674|26222660|P5|Dose Level VIII|Withdrawal by Subject|0
7545061|NCT02533674|26222661|P4|Dose Level VIII|Withdrawal by Subject|0
7545062|NCT02533674|26222662|P3|Dose Level VIII|Withdrawal by Subject|0
7545063|NCT02533674|26222663|P2|Dose Level VIII|Withdrawal by Subject|0
7545064|NCT02533674|26222664|P1|Dose Level VIII|Withdrawal by Subject|0
7545065|NCT02533674|26222657|P8|Dose Level VIII|Progressive disease|3
7545066|NCT02533674|26222658|P7|Dose Level VIII|Progressive disease|0
7545067|NCT02533674|26222659|P6|Dose Level VIII|Progressive disease|0
7545068|NCT02533674|26222660|P5|Dose Level VIII|Progressive disease|0
7545069|NCT02533674|26222661|P4|Dose Level VIII|Progressive disease|0
7545070|NCT02533674|26222662|P3|Dose Level VIII|Progressive disease|0
7545071|NCT02533674|26222663|P2|Dose Level VIII|Progressive disease|0
7545072|NCT02533674|26222664|P1|Dose Level VIII|Progressive disease|0
7545073|NCT02533674|26222657|P8|Dose Level VII|Death|0
7545074|NCT02533674|26222658|P7|Dose Level VII|Death|2
7545075|NCT02533674|26222659|P6|Dose Level VII|Death|0
7545076|NCT02533674|26222660|P5|Dose Level VII|Death|0
7545077|NCT02533674|26222661|P4|Dose Level VII|Death|0
7545078|NCT02533674|26222662|P3|Dose Level VII|Death|0
7545079|NCT02533674|26222663|P2|Dose Level VII|Death|0
7545080|NCT02533674|26222664|P1|Dose Level VII|Death|0
7545081|NCT02533674|26222657|P8|Dose Level VII|Treatment-related AE|0
7545082|NCT02533674|26222658|P7|Dose Level VII|Treatment-related AE|1
7545083|NCT02533674|26222659|P6|Dose Level VII|Treatment-related AE|0
7545084|NCT02533674|26222660|P5|Dose Level VII|Treatment-related AE|0
7545085|NCT02533674|26222661|P4|Dose Level VII|Treatment-related AE|0
7545086|NCT02533674|26222662|P3|Dose Level VII|Treatment-related AE|0
7545087|NCT02533674|26222663|P2|Dose Level VII|Treatment-related AE|0
7545088|NCT02533674|26222664|P1|Dose Level VII|Treatment-related AE|0
7545089|NCT02533674|26222657|P8|Dose Level VII|Withdrawal by Subject|0
7545090|NCT02533674|26222658|P7|Dose Level VII|Withdrawal by Subject|3
7545091|NCT02533674|26222659|P6|Dose Level VII|Withdrawal by Subject|0
7545092|NCT02533674|26222660|P5|Dose Level VII|Withdrawal by Subject|0
7545093|NCT02533674|26222661|P4|Dose Level VII|Withdrawal by Subject|0
7545094|NCT02533674|26222662|P3|Dose Level VII|Withdrawal by Subject|0
7545095|NCT02533674|26222663|P2|Dose Level VII|Withdrawal by Subject|0
7545096|NCT02533674|26222664|P1|Dose Level VII|Withdrawal by Subject|0
7545097|NCT02533674|26222657|P8|Dose Level VII|Progressive disease|0
7545098|NCT02533674|26222658|P7|Dose Level VII|Progressive disease|10
7545099|NCT02533674|26222659|P6|Dose Level VII|Progressive disease|0
7545100|NCT02533674|26222660|P5|Dose Level VII|Progressive disease|0
7545101|NCT02533674|26222661|P4|Dose Level VII|Progressive disease|0
7545102|NCT02533674|26222662|P3|Dose Level VII|Progressive disease|0
7545103|NCT02533674|26222663|P2|Dose Level VII|Progressive disease|0
7545104|NCT02533674|26222664|P1|Dose Level VII|Progressive disease|0
7545105|NCT02533674|26222657|P8|Dose Level VI|Treatment-related AE|0
7545106|NCT02533674|26222658|P7|Dose Level VI|Treatment-related AE|0
7545107|NCT02533674|26222659|P6|Dose Level VI|Treatment-related AE|1
7545108|NCT02533674|26222660|P5|Dose Level VI|Treatment-related AE|0
7545109|NCT02533674|26222661|P4|Dose Level VI|Treatment-related AE|0
7545110|NCT02533674|26222662|P3|Dose Level VI|Treatment-related AE|0
7545111|NCT02533674|26222663|P2|Dose Level VI|Treatment-related AE|0
7545112|NCT02533674|26222664|P1|Dose Level VI|Treatment-related AE|0
7545113|NCT02533674|26222657|P8|Dose Level VI|Withdrawal by Subject|0
7545114|NCT02533674|26222658|P7|Dose Level VI|Withdrawal by Subject|0
7545115|NCT02533674|26222659|P6|Dose Level VI|Withdrawal by Subject|1
7545116|NCT02533674|26222660|P5|Dose Level VI|Withdrawal by Subject|0
7545117|NCT02533674|26222661|P4|Dose Level VI|Withdrawal by Subject|0
7545118|NCT02533674|26222662|P3|Dose Level VI|Withdrawal by Subject|0
7545119|NCT02533674|26222663|P2|Dose Level VI|Withdrawal by Subject|0
7545120|NCT02533674|26222664|P1|Dose Level VI|Withdrawal by Subject|0
7545121|NCT02533674|26222657|P8|Dose Level VI|Progressive disease|0
7545122|NCT02533674|26222658|P7|Dose Level VI|Progressive disease|0
7545123|NCT02533674|26222659|P6|Dose Level VI|Progressive disease|7
7545124|NCT02533674|26222660|P5|Dose Level VI|Progressive disease|0
7545125|NCT02533674|26222661|P4|Dose Level VI|Progressive disease|0
7545126|NCT02533674|26222662|P3|Dose Level VI|Progressive disease|0
7545127|NCT02533674|26222663|P2|Dose Level VI|Progressive disease|0
7545128|NCT02533674|26222664|P1|Dose Level VI|Progressive disease|0
7545129|NCT02533674|26222657|P8|Dose Level V|Physician Decision|0
7545130|NCT02533674|26222658|P7|Dose Level V|Physician Decision|0
7545131|NCT02533674|26222659|P6|Dose Level V|Physician Decision|0
7545132|NCT02533674|26222660|P5|Dose Level V|Physician Decision|1
7545133|NCT02533674|26222661|P4|Dose Level V|Physician Decision|0
7545134|NCT02533674|26222662|P3|Dose Level V|Physician Decision|0
7545135|NCT02533674|26222663|P2|Dose Level V|Physician Decision|0
7545136|NCT02533674|26222664|P1|Dose Level V|Physician Decision|0
7545137|NCT02533674|26222657|P8|Dose Level V|Withdrawal by Subject|0
7545138|NCT02533674|26222658|P7|Dose Level V|Withdrawal by Subject|0
7545139|NCT02533674|26222659|P6|Dose Level V|Withdrawal by Subject|0
7545140|NCT02533674|26222660|P5|Dose Level V|Withdrawal by Subject|1
7545141|NCT02533674|26222661|P4|Dose Level V|Withdrawal by Subject|0
7545142|NCT02533674|26222662|P3|Dose Level V|Withdrawal by Subject|0
7545143|NCT02533674|26222663|P2|Dose Level V|Withdrawal by Subject|0
7545144|NCT02533674|26222664|P1|Dose Level V|Withdrawal by Subject|0
7545145|NCT02533674|26222657|P8|Dose Level V|Progressive disease|0
7545146|NCT02533674|26222658|P7|Dose Level V|Progressive disease|0
7545147|NCT02533674|26222659|P6|Dose Level V|Progressive disease|0
7545148|NCT02533674|26222660|P5|Dose Level V|Progressive disease|3
7545149|NCT02533674|26222661|P4|Dose Level V|Progressive disease|0
7545150|NCT02533674|26222662|P3|Dose Level V|Progressive disease|0
7545151|NCT02533674|26222663|P2|Dose Level V|Progressive disease|0
7545152|NCT02533674|26222664|P1|Dose Level V|Progressive disease|0
7545153|NCT02533674|26222657|P8|Dose Level IV|Physician Decision|0
7545154|NCT02533674|26222658|P7|Dose Level IV|Physician Decision|0
7545155|NCT02533674|26222659|P6|Dose Level IV|Physician Decision|0
7545156|NCT02533674|26222660|P5|Dose Level IV|Physician Decision|0
7545157|NCT02533674|26222661|P4|Dose Level IV|Physician Decision|1
7545158|NCT02533674|26222662|P3|Dose Level IV|Physician Decision|0
7545159|NCT02533674|26222663|P2|Dose Level IV|Physician Decision|0
7545160|NCT02533674|26222664|P1|Dose Level IV|Physician Decision|0
7545161|NCT02533674|26222657|P8|Dose Level IV|Withdrawal by Subject|0
7545162|NCT02533674|26222658|P7|Dose Level IV|Withdrawal by Subject|0
7545163|NCT02533674|26222659|P6|Dose Level IV|Withdrawal by Subject|0
7545164|NCT02533674|26222660|P5|Dose Level IV|Withdrawal by Subject|0
7545165|NCT02533674|26222661|P4|Dose Level IV|Withdrawal by Subject|1
7545166|NCT02533674|26222662|P3|Dose Level IV|Withdrawal by Subject|0
7545167|NCT02533674|26222663|P2|Dose Level IV|Withdrawal by Subject|0
7545168|NCT02533674|26222664|P1|Dose Level IV|Withdrawal by Subject|0
7545169|NCT02533674|26222657|P8|Dose Level IV|Progressive disease|0
7545170|NCT02533674|26222658|P7|Dose Level IV|Progressive disease|0
7545171|NCT02533674|26222659|P6|Dose Level IV|Progressive disease|0
7545172|NCT02533674|26222660|P5|Dose Level IV|Progressive disease|0
7545173|NCT02533674|26222661|P4|Dose Level IV|Progressive disease|3
7545174|NCT02533674|26222662|P3|Dose Level IV|Progressive disease|0
7545175|NCT02533674|26222663|P2|Dose Level IV|Progressive disease|0
7545176|NCT02533674|26222664|P1|Dose Level IV|Progressive disease|0
7545177|NCT02533674|26222657|P8|Dose Level III|Treatment-related AE|0
7545178|NCT02533674|26222658|P7|Dose Level III|Treatment-related AE|0
7545179|NCT02533674|26222659|P6|Dose Level III|Treatment-related AE|0
7545180|NCT02533674|26222660|P5|Dose Level III|Treatment-related AE|0
7545181|NCT02533674|26222661|P4|Dose Level III|Treatment-related AE|0
7545182|NCT02533674|26222662|P3|Dose Level III|Treatment-related AE|1
7545183|NCT02533674|26222663|P2|Dose Level III|Treatment-related AE|0
7545184|NCT02533674|26222664|P1|Dose Level III|Treatment-related AE|0
7545185|NCT02533674|26222657|P8|Dose Level III|Withdrawal by Subject|0
7545186|NCT02533674|26222658|P7|Dose Level III|Withdrawal by Subject|0
7545187|NCT02533674|26222659|P6|Dose Level III|Withdrawal by Subject|0
7545188|NCT02533674|26222660|P5|Dose Level III|Withdrawal by Subject|0
7545189|NCT02533674|26222661|P4|Dose Level III|Withdrawal by Subject|0
7545190|NCT02533674|26222662|P3|Dose Level III|Withdrawal by Subject|1
7545191|NCT02533674|26222663|P2|Dose Level III|Withdrawal by Subject|0
7545192|NCT02533674|26222664|P1|Dose Level III|Withdrawal by Subject|0
7545193|NCT02533674|26222657|P8|Dose Level III|Progressive disease|0
7545194|NCT02533674|26222658|P7|Dose Level III|Progressive disease|0
7545195|NCT02533674|26222659|P6|Dose Level III|Progressive disease|0
7545196|NCT02533674|26222660|P5|Dose Level III|Progressive disease|0
7545197|NCT02533674|26222661|P4|Dose Level III|Progressive disease|0
7545198|NCT02533674|26222662|P3|Dose Level III|Progressive disease|2
7545199|NCT02533674|26222663|P2|Dose Level III|Progressive disease|0
7545200|NCT02533674|26222664|P1|Dose Level III|Progressive disease|0
7545201|NCT02533674|26222657|P8|Dose Level II|Non-treatment-related AE|0
7545202|NCT02533674|26222658|P7|Dose Level II|Non-treatment-related AE|0
7545203|NCT02533674|26222659|P6|Dose Level II|Non-treatment-related AE|0
7545204|NCT02533674|26222660|P5|Dose Level II|Non-treatment-related AE|0
7545205|NCT02533674|26222661|P4|Dose Level II|Non-treatment-related AE|0
7545206|NCT02533674|26222662|P3|Dose Level II|Non-treatment-related AE|0
7545207|NCT02533674|26222663|P2|Dose Level II|Non-treatment-related AE|1
7545208|NCT02533674|26222664|P1|Dose Level II|Non-treatment-related AE|0
7545209|NCT02533674|26222657|P8|Dose Level II|Physician Decision|0
7545210|NCT02533674|26222658|P7|Dose Level II|Physician Decision|0
7545211|NCT02533674|26222659|P6|Dose Level II|Physician Decision|0
7545212|NCT02533674|26222660|P5|Dose Level II|Physician Decision|0
7545213|NCT02533674|26222661|P4|Dose Level II|Physician Decision|0
7545214|NCT02533674|26222662|P3|Dose Level II|Physician Decision|0
7545215|NCT02533674|26222663|P2|Dose Level II|Physician Decision|1
7545216|NCT02533674|26222664|P1|Dose Level II|Physician Decision|0
7545217|NCT02533674|26222657|P8|Dose Level II|Treatment-related AE|0
7545218|NCT02533674|26222658|P7|Dose Level II|Treatment-related AE|0
7545219|NCT02533674|26222659|P6|Dose Level II|Treatment-related AE|0
7545220|NCT02533674|26222660|P5|Dose Level II|Treatment-related AE|0
7545221|NCT02533674|26222661|P4|Dose Level II|Treatment-related AE|0
7545222|NCT02533674|26222662|P3|Dose Level II|Treatment-related AE|0
7545223|NCT02533674|26222663|P2|Dose Level II|Treatment-related AE|1
7545224|NCT02533674|26222664|P1|Dose Level II|Treatment-related AE|0
7545225|NCT02533674|26222657|P8|Dose Level II|Withdrawal by Subject|0
7545226|NCT02533674|26222658|P7|Dose Level II|Withdrawal by Subject|0
7545227|NCT02533674|26222659|P6|Dose Level II|Withdrawal by Subject|0
7545228|NCT02533674|26222660|P5|Dose Level II|Withdrawal by Subject|0
7545229|NCT02533674|26222661|P4|Dose Level II|Withdrawal by Subject|0
7545230|NCT02533674|26222662|P3|Dose Level II|Withdrawal by Subject|0
7545231|NCT02533674|26222663|P2|Dose Level II|Withdrawal by Subject|1
7545232|NCT02533674|26222664|P1|Dose Level II|Withdrawal by Subject|0
7545233|NCT02533674|26222657|P8|Dose Level II|Progressive disease|0
7545234|NCT02533674|26222658|P7|Dose Level II|Progressive disease|0
7545235|NCT02533674|26222659|P6|Dose Level II|Progressive disease|0
7545236|NCT02533674|26222660|P5|Dose Level II|Progressive disease|0
7545237|NCT02533674|26222661|P4|Dose Level II|Progressive disease|0
7545238|NCT02533674|26222662|P3|Dose Level II|Progressive disease|0
7545239|NCT02533674|26222663|P2|Dose Level II|Progressive disease|3
7545240|NCT02533674|26222664|P1|Dose Level II|Progressive disease|0
7545241|NCT02533674|26222657|P8|Dose Level I|Never Treated|0
7545242|NCT02533674|26222658|P7|Dose Level I|Never Treated|0
7545243|NCT02533674|26222659|P6|Dose Level I|Never Treated|0
7545244|NCT02533674|26222660|P5|Dose Level I|Never Treated|0
7545245|NCT02533674|26222661|P4|Dose Level I|Never Treated|0
7545246|NCT02533674|26222662|P3|Dose Level I|Never Treated|0
7545247|NCT02533674|26222663|P2|Dose Level I|Never Treated|0
7545248|NCT02533674|26222664|P1|Dose Level I|Never Treated|1
7545249|NCT02533674|26222657|P8|Dose Level I|Death|0
7545250|NCT02533674|26222658|P7|Dose Level I|Death|0
7545251|NCT02533674|26222659|P6|Dose Level I|Death|0
7545252|NCT02533674|26222660|P5|Dose Level I|Death|0
7545253|NCT02533674|26222661|P4|Dose Level I|Death|0
7545254|NCT02533674|26222662|P3|Dose Level I|Death|0
7545255|NCT02533674|26222663|P2|Dose Level I|Death|0
7545256|NCT02533674|26222664|P1|Dose Level I|Death|1
7545257|NCT02533674|26222657|P8|Dose Level I|Physician Decision|0
7545258|NCT02533674|26222658|P7|Dose Level I|Physician Decision|0
7545259|NCT02533674|26222659|P6|Dose Level I|Physician Decision|0
7545260|NCT02533674|26222660|P5|Dose Level I|Physician Decision|0
7545261|NCT02533674|26222661|P4|Dose Level I|Physician Decision|0
7545262|NCT02533674|26222662|P3|Dose Level I|Physician Decision|0
7545263|NCT02533674|26222663|P2|Dose Level I|Physician Decision|0
7545264|NCT02533674|26222664|P1|Dose Level I|Physician Decision|1
7545265|NCT02533674|26222657|P8|Dose Level I|Withdrawal by Subject|0
7545266|NCT02533674|26222658|P7|Dose Level I|Withdrawal by Subject|0
7545267|NCT02533674|26222659|P6|Dose Level I|Withdrawal by Subject|0
7545268|NCT02533674|26222660|P5|Dose Level I|Withdrawal by Subject|0
7545269|NCT02533674|26222661|P4|Dose Level I|Withdrawal by Subject|0
7545270|NCT02533674|26222662|P3|Dose Level I|Withdrawal by Subject|0
7545271|NCT02533674|26222663|P2|Dose Level I|Withdrawal by Subject|0
7545272|NCT02533674|26222664|P1|Dose Level I|Withdrawal by Subject|1
7545273|NCT02533674|26222657|P8|Dose Level I|Progressive disease|0
7545274|NCT02533674|26222658|P7|Dose Level I|Progressive disease|0
7545275|NCT02533674|26222659|P6|Dose Level I|Progressive disease|0
7545276|NCT02533674|26222660|P5|Dose Level I|Progressive disease|0
7545277|NCT02533674|26222661|P4|Dose Level I|Progressive disease|0
7545278|NCT02533674|26222662|P3|Dose Level I|Progressive disease|0
7545279|NCT02533674|26222663|P2|Dose Level I|Progressive disease|0
7545280|NCT02533674|26222664|P1|Dose Level I|Progressive disease|1
7545281|NCT02533570|26222693|P3|Overall Study|Adverse Event|1
7545282|NCT02533570|26222694|P2|Overall Study|Adverse Event|1
7545283|NCT02533570|26222695|P1|Overall Study|Adverse Event|0
7545284|NCT02533531|26222706|P1|Overall Study|Device did not turn on|1
7545285|NCT02533453|26222769|P1|Overall Study|Withdrawal by Subject|2
7545286|NCT02533453|26222769|P1|Overall Study|Protocol Violation|1
7545287|NCT02533453|26222769|P1|Overall Study|Adverse Event|6
7545288|NCT02533401|26222828|P1|Overall Study|Violation of Selection Criteria|1
7545289|NCT02533401|26222828|P1|Overall Study|Lost to Follow-up|1
7545290|NCT02533401|26222828|P1|Overall Study|Insufficient Response/Progressed Disease|1
7545291|NCT02533401|26222828|P1|Overall Study|Death|5
7545292|NCT02533401|26222828|P1|Overall Study|Adverse Event/Intercurrent Disease|3
7545293|NCT02533375|26222836|P1|Overall Study|Adverse Event|2
7545294|NCT02533375|26222836|P1|Overall Study|Lack of Efficacy|3
7545295|NCT02533258|26222868|P1|Overall Study|Lack of Efficacy|2
7545296|NCT02533258|26222868|P1|Overall Study|Progression of pleural effusion|1
7545297|NCT02533258|26222868|P1|Overall Study|Economic factor|1
7545298|NCT02533258|26222868|P1|Overall Study|Other|1
7545299|NCT02533258|26222868|P1|Overall Study|Death|2
7545300|NCT02533258|26222868|P1|Overall Study|Adverse Event|1
7545301|NCT02533180|26222882|P2|Overall Study|On Study|39
7545302|NCT02533180|26222883|P1|Overall Study|On Study|0
7545303|NCT02533180|26222882|P2|Overall Study|Protocol Deviation|1
7545304|NCT02533180|26222883|P1|Overall Study|Protocol Deviation|0
7545305|NCT02533180|26222882|P2|Overall Study|Screen Failure|0
7545306|NCT02533180|26222883|P1|Overall Study|Screen Failure|37
7545307|NCT02533180|26222882|P2|Overall Study|Withdrawal by Subject|4
7545308|NCT02533180|26222883|P1|Overall Study|Withdrawal by Subject|2
7545309|NCT02533180|26222882|P2|Overall Study|Physician Decision|1
7545310|NCT02533180|26222883|P1|Overall Study|Physician Decision|0
7545311|NCT02533180|26222882|P2|Overall Study|Lost to Follow-up|1
7545312|NCT02533180|26222883|P1|Overall Study|Lost to Follow-up|0
7545313|NCT02533180|26222882|P2|Overall Study|Death|1
7545314|NCT02533180|26222883|P1|Overall Study|Death|0
7545315|NCT02532972|26223017|P1|Overall Study|Withdrawal by Subject|1
7545316|NCT02532855|26223034|P2|Overall Study|Withdrawal by Subject|8
7545317|NCT02532855|26223035|P1|Overall Study|Withdrawal by Subject|4
7545318|NCT02532855|26223034|P2|Overall Study|Lost to Follow-up|3
7545319|NCT02532855|26223035|P1|Overall Study|Lost to Follow-up|4
7545320|NCT02532764|26223069|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7545321|NCT02532764|26223070|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7545322|NCT02532764|26223071|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7545323|NCT02532764|26223072|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545324|NCT02532764|26223073|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545325|NCT02532764|26223074|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545326|NCT02532764|26223075|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545327|NCT02532764|26223076|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545328|NCT02532764|26223077|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545329|NCT02532764|26223078|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7545330|NCT02532647|26223229|P3|Overall Study|Did not receive trial medication|1
7545331|NCT02532647|26223230|P2|Overall Study|Did not receive trial medication|0
7545332|NCT02532647|26223231|P1|Overall Study|Did not receive trial medication|1
7545333|NCT02532543|26223273|P4|Overall Study|Lost to Follow-up|0
7545334|NCT02532543|26223274|P3|Overall Study|Lost to Follow-up|1
7545335|NCT02532543|26223275|P2|Overall Study|Lost to Follow-up|0
7545336|NCT02532543|26223276|P1|Overall Study|Lost to Follow-up|0
7545337|NCT02532517|26223310|P1|Overall Study|Death|4
7545338|NCT02532517|26223310|P1|Overall Study|Withdrawal by Subject|4
7545339|NCT02532517|26223310|P1|Overall Study|Lost to Follow-up|4
7545340|NCT02532517|26223310|P1|Overall Study|Failed Angiographic eligibility|1
7545341|NCT02532517|26223310|P1|Overall Study|Did not complete 24-Month visit|4
7545342|NCT02532465|26223330|P2|Overall Study|Lack of Efficacy|1
7545343|NCT02532465|26223331|P1|Overall Study|Lack of Efficacy|0
7545344|NCT02532465|26223330|P2|Overall Study|Protocol Violation|0
7545345|NCT02532465|26223331|P1|Overall Study|Protocol Violation|1
7545346|NCT02532374|26223341|P1|Overall Study|Physician Decision|1
7545347|NCT02532374|26223341|P1|Overall Study|Withdrawal by Subject|1
7545348|NCT02532283|26223367|P2|Overall Study|Withdrawal by Subject|3
7545349|NCT02532283|26223368|P1|Overall Study|Withdrawal by Subject|8
7545350|NCT02532283|26223367|P2|Overall Study|Lost to Follow-up|1
7545351|NCT02532283|26223368|P1|Overall Study|Lost to Follow-up|0
7545352|NCT02532283|26223367|P2|Overall Study|Death|0
7545353|NCT02532283|26223368|P1|Overall Study|Death|1
7545354|NCT02532283|26223367|P2|Overall Study|Adverse Event|1
7545355|NCT02532283|26223368|P1|Overall Study|Adverse Event|0
7545356|NCT02532179|26223410|P1|Overall Study|Subject received depot steroid injection|1
7545357|NCT02532179|26223410|P1|Overall Study|Pregnancy|1
7545358|NCT02532179|26223410|P1|Overall Study|Lost to Follow-up|1
7545359|NCT02531802|26223480|P21|Received Vaccination 2|Withdrawal by Subject|0
7545360|NCT02531802|26223481|P20|Received Vaccination 2|Withdrawal by Subject|1
7545361|NCT02531802|26223482|P19|Received Vaccination 2|Withdrawal by Subject|1
7545362|NCT02531802|26223483|P18|Received Vaccination 2|Withdrawal by Subject|1
7545363|NCT02531802|26223484|P17|Received Vaccination 2|Withdrawal by Subject|0
7545364|NCT02531802|26223485|P16|Received Vaccination 2|Withdrawal by Subject|0
7545365|NCT02531802|26223486|P15|Received Vaccination 2|Withdrawal by Subject|1
7545366|NCT02531802|26223487|P14|Received Vaccination 2|Withdrawal by Subject|1
7545367|NCT02531802|26223488|P13|Received Vaccination 2|Withdrawal by Subject|1
7545368|NCT02531802|26223489|P12|Received Vaccination 2|Withdrawal by Subject|0
7545369|NCT02531802|26223490|P11|Received Vaccination 2|Withdrawal by Subject|1
7545370|NCT02531802|26223491|P10|Received Vaccination 2|Withdrawal by Subject|0
7545371|NCT02531802|26223492|P9|Received Vaccination 2|Withdrawal by Subject|0
7545372|NCT02531802|26223493|P8|Received Vaccination 2|Withdrawal by Subject|0
7545373|NCT02531802|26223494|P7|Received Vaccination 2|Withdrawal by Subject|0
7545374|NCT02531802|26223495|P6|Received Vaccination 2|Withdrawal by Subject|0
7545375|NCT02531802|26223496|P5|Received Vaccination 2|Withdrawal by Subject|0
7545376|NCT02531802|26223497|P4|Received Vaccination 2|Withdrawal by Subject|0
7545377|NCT02531802|26223498|P3|Received Vaccination 2|Withdrawal by Subject|0
7545378|NCT02531802|26223499|P2|Received Vaccination 2|Withdrawal by Subject|0
7545379|NCT02531802|26223500|P1|Received Vaccination 2|Withdrawal by Subject|0
7545380|NCT02531802|26223480|P21|Received Vaccination 2|Adverse Event|1
7545381|NCT02531802|26223481|P20|Received Vaccination 2|Adverse Event|0
7545382|NCT02531802|26223482|P19|Received Vaccination 2|Adverse Event|1
7545383|NCT02531802|26223483|P18|Received Vaccination 2|Adverse Event|2
7545384|NCT02531802|26223484|P17|Received Vaccination 2|Adverse Event|0
7545385|NCT02531802|26223485|P16|Received Vaccination 2|Adverse Event|0
7545386|NCT02531802|26223486|P15|Received Vaccination 2|Adverse Event|0
7545387|NCT02531802|26223487|P14|Received Vaccination 2|Adverse Event|0
7545388|NCT02531802|26223488|P13|Received Vaccination 2|Adverse Event|0
7545389|NCT02531802|26223489|P12|Received Vaccination 2|Adverse Event|0
7545390|NCT02531802|26223490|P11|Received Vaccination 2|Adverse Event|0
7545391|NCT02531802|26223491|P10|Received Vaccination 2|Adverse Event|0
7545392|NCT02531802|26223492|P9|Received Vaccination 2|Adverse Event|0
7545393|NCT02531802|26223493|P8|Received Vaccination 2|Adverse Event|0
7545394|NCT02531802|26223494|P7|Received Vaccination 2|Adverse Event|0
7545395|NCT02531802|26223495|P6|Received Vaccination 2|Adverse Event|2
7545396|NCT02531802|26223496|P5|Received Vaccination 2|Adverse Event|0
7545397|NCT02531802|26223497|P4|Received Vaccination 2|Adverse Event|0
7545398|NCT02531802|26223498|P3|Received Vaccination 2|Adverse Event|0
7545399|NCT02531802|26223499|P2|Received Vaccination 2|Adverse Event|0
7545400|NCT02531802|26223500|P1|Received Vaccination 2|Adverse Event|0
7545401|NCT02531802|26223480|P21|Received Vaccination 2|Physician Decision|0
7545402|NCT02531802|26223481|P20|Received Vaccination 2|Physician Decision|0
7545403|NCT02531802|26223482|P19|Received Vaccination 2|Physician Decision|0
7545404|NCT02531802|26223483|P18|Received Vaccination 2|Physician Decision|1
7545405|NCT02531802|26223484|P17|Received Vaccination 2|Physician Decision|0
7545406|NCT02531802|26223485|P16|Received Vaccination 2|Physician Decision|0
7545407|NCT02531802|26223486|P15|Received Vaccination 2|Physician Decision|0
7545408|NCT02531802|26223487|P14|Received Vaccination 2|Physician Decision|1
7545409|NCT02531802|26223488|P13|Received Vaccination 2|Physician Decision|0
7545410|NCT02531802|26223489|P12|Received Vaccination 2|Physician Decision|0
7545411|NCT02531802|26223490|P11|Received Vaccination 2|Physician Decision|0
7545412|NCT02531802|26223491|P10|Received Vaccination 2|Physician Decision|2
7545413|NCT02531802|26223492|P9|Received Vaccination 2|Physician Decision|0
7545414|NCT02531802|26223493|P8|Received Vaccination 2|Physician Decision|0
7545415|NCT02531802|26223494|P7|Received Vaccination 2|Physician Decision|0
7545416|NCT02531802|26223495|P6|Received Vaccination 2|Physician Decision|1
7545417|NCT02531802|26223496|P5|Received Vaccination 2|Physician Decision|0
7545418|NCT02531802|26223497|P4|Received Vaccination 2|Physician Decision|0
7545419|NCT02531802|26223498|P3|Received Vaccination 2|Physician Decision|0
7545420|NCT02531802|26223499|P2|Received Vaccination 2|Physician Decision|0
7545421|NCT02531802|26223500|P1|Received Vaccination 2|Physician Decision|0
7545422|NCT02531802|26223480|P21|Received Vaccination 2|Medication interfering with study taken|0
7545423|NCT02531802|26223481|P20|Received Vaccination 2|Medication interfering with study taken|0
7545424|NCT02531802|26223482|P19|Received Vaccination 2|Medication interfering with study taken|1
7545425|NCT02531802|26223483|P18|Received Vaccination 2|Medication interfering with study taken|0
7545426|NCT02531802|26223484|P17|Received Vaccination 2|Medication interfering with study taken|0
7545427|NCT02531802|26223485|P16|Received Vaccination 2|Medication interfering with study taken|0
7545428|NCT02531802|26223486|P15|Received Vaccination 2|Medication interfering with study taken|0
7545429|NCT02531802|26223487|P14|Received Vaccination 2|Medication interfering with study taken|0
7545430|NCT02531802|26223488|P13|Received Vaccination 2|Medication interfering with study taken|1
7545431|NCT02531802|26223489|P12|Received Vaccination 2|Medication interfering with study taken|0
7545432|NCT02531802|26223490|P11|Received Vaccination 2|Medication interfering with study taken|1
7545433|NCT02531802|26223491|P10|Received Vaccination 2|Medication interfering with study taken|1
7545434|NCT02531802|26223492|P9|Received Vaccination 2|Medication interfering with study taken|0
7545435|NCT02531802|26223493|P8|Received Vaccination 2|Medication interfering with study taken|0
7545436|NCT02531802|26223494|P7|Received Vaccination 2|Medication interfering with study taken|0
7545437|NCT02531802|26223495|P6|Received Vaccination 2|Medication interfering with study taken|0
7545438|NCT02531802|26223496|P5|Received Vaccination 2|Medication interfering with study taken|0
7545439|NCT02531802|26223497|P4|Received Vaccination 2|Medication interfering with study taken|0
7545440|NCT02531802|26223498|P3|Received Vaccination 2|Medication interfering with study taken|1
7545441|NCT02531802|26223499|P2|Received Vaccination 2|Medication interfering with study taken|0
7545442|NCT02531802|26223500|P1|Received Vaccination 2|Medication interfering with study taken|0
7545443|NCT02531698|26223932|P2|Overall Study|Lost to Follow-up|0
7545444|NCT02531698|26223933|P1|Overall Study|Lost to Follow-up|1
7545445|NCT02531698|26223932|P2|Overall Study|Protocol Violation|0
7545446|NCT02531698|26223933|P1|Overall Study|Protocol Violation|2
7545447|NCT02531698|26223932|P2|Overall Study|Withdrawal by Subject|1
7545448|NCT02531698|26223933|P1|Overall Study|Withdrawal by Subject|6
7545449|NCT02531698|26223932|P2|Overall Study|Adverse Event|1
7545450|NCT02531698|26223933|P1|Overall Study|Adverse Event|2
7545451|NCT02531646|26224180|P3|Overall Study|equip. image processing issue|0
7545452|NCT02531646|26224181|P2|Overall Study|equip. image processing issue|1
7545453|NCT02531646|26224182|P1|Overall Study|equip. image processing issue|5
7545454|NCT02531633|26224201|P10|Part B (104 Weeks)|Lost to Follow-up|0
7545455|NCT02531633|26224202|P9|Part B (104 Weeks)|Lost to Follow-up|0
7545456|NCT02531633|26224203|P8|Part B (104 Weeks)|Lost to Follow-up|1
7545457|NCT02531633|26224204|P7|Part B (104 Weeks)|Lost to Follow-up|0
7545458|NCT02531633|26224205|P6|Part B (104 Weeks)|Lost to Follow-up|0
7545459|NCT02531633|26224206|P5|Part B (104 Weeks)|Lost to Follow-up|0
7545460|NCT02531633|26224207|P4|Part B (104 Weeks)|Lost to Follow-up|0
7545461|NCT02531633|26224208|P3|Part B (104 Weeks)|Lost to Follow-up|0
7545462|NCT02531633|26224209|P2|Part B (104 Weeks)|Lost to Follow-up|0
7545463|NCT02531633|26224210|P1|Part B (104 Weeks)|Lost to Follow-up|0
7545464|NCT02531633|26224201|P10|Part B (104 Weeks)|Sponsor request|4
7545465|NCT02531633|26224202|P9|Part B (104 Weeks)|Sponsor request|5
7545466|NCT02531633|26224203|P8|Part B (104 Weeks)|Sponsor request|3
7545467|NCT02531633|26224204|P7|Part B (104 Weeks)|Sponsor request|5
7545468|NCT02531633|26224205|P6|Part B (104 Weeks)|Sponsor request|8
7545469|NCT02531633|26224206|P5|Part B (104 Weeks)|Sponsor request|0
7545470|NCT02531633|26224207|P4|Part B (104 Weeks)|Sponsor request|0
7545471|NCT02531633|26224208|P3|Part B (104 Weeks)|Sponsor request|0
7545472|NCT02531633|26224209|P2|Part B (104 Weeks)|Sponsor request|0
7545473|NCT02531633|26224210|P1|Part B (104 Weeks)|Sponsor request|0
7545474|NCT02531633|26224201|P10|Part A (52 Weeks)|Other|0
7545475|NCT02531633|26224202|P9|Part A (52 Weeks)|Other|0
7545476|NCT02531633|26224203|P8|Part A (52 Weeks)|Other|0
7545477|NCT02531633|26224204|P7|Part A (52 Weeks)|Other|0
7545478|NCT02531633|26224205|P6|Part A (52 Weeks)|Other|0
7545479|NCT02531633|26224206|P5|Part A (52 Weeks)|Other|0
7545480|NCT02531633|26224207|P4|Part A (52 Weeks)|Other|0
7545481|NCT02531633|26224208|P3|Part A (52 Weeks)|Other|0
7545482|NCT02531633|26224209|P2|Part A (52 Weeks)|Other|0
7545483|NCT02531633|26224210|P1|Part A (52 Weeks)|Other|2
7545484|NCT02531633|26224201|P10|Part A (52 Weeks)|Withdrawal by Subject|0
7545485|NCT02531633|26224202|P9|Part A (52 Weeks)|Withdrawal by Subject|0
7545486|NCT02531633|26224203|P8|Part A (52 Weeks)|Withdrawal by Subject|0
7545487|NCT02531633|26224204|P7|Part A (52 Weeks)|Withdrawal by Subject|0
7545488|NCT02531633|26224205|P6|Part A (52 Weeks)|Withdrawal by Subject|0
7545489|NCT02531633|26224206|P5|Part A (52 Weeks)|Withdrawal by Subject|3
7545490|NCT02531633|26224207|P4|Part A (52 Weeks)|Withdrawal by Subject|3
7545491|NCT02531633|26224208|P3|Part A (52 Weeks)|Withdrawal by Subject|1
7545492|NCT02531633|26224209|P2|Part A (52 Weeks)|Withdrawal by Subject|6
7545493|NCT02531633|26224210|P1|Part A (52 Weeks)|Withdrawal by Subject|6
7545494|NCT02531633|26224201|P10|Part A (52 Weeks)|Physician Decision|0
7545495|NCT02531633|26224202|P9|Part A (52 Weeks)|Physician Decision|0
7545496|NCT02531633|26224203|P8|Part A (52 Weeks)|Physician Decision|0
7545497|NCT02531633|26224204|P7|Part A (52 Weeks)|Physician Decision|0
7545498|NCT02531633|26224205|P6|Part A (52 Weeks)|Physician Decision|0
7545499|NCT02531633|26224206|P5|Part A (52 Weeks)|Physician Decision|0
7545500|NCT02531633|26224207|P4|Part A (52 Weeks)|Physician Decision|1
7545501|NCT02531633|26224208|P3|Part A (52 Weeks)|Physician Decision|3
7545502|NCT02531633|26224209|P2|Part A (52 Weeks)|Physician Decision|4
7545503|NCT02531633|26224210|P1|Part A (52 Weeks)|Physician Decision|1
7545504|NCT02531633|26224201|P10|Part A (52 Weeks)|Lost to Follow-up|0
7545505|NCT02531633|26224202|P9|Part A (52 Weeks)|Lost to Follow-up|0
7545506|NCT02531633|26224203|P8|Part A (52 Weeks)|Lost to Follow-up|0
7545507|NCT02531633|26224204|P7|Part A (52 Weeks)|Lost to Follow-up|0
7545508|NCT02531633|26224205|P6|Part A (52 Weeks)|Lost to Follow-up|0
7545509|NCT02531633|26224206|P5|Part A (52 Weeks)|Lost to Follow-up|1
7545510|NCT02531633|26224207|P4|Part A (52 Weeks)|Lost to Follow-up|0
7545511|NCT02531633|26224208|P3|Part A (52 Weeks)|Lost to Follow-up|0
7545512|NCT02531633|26224209|P2|Part A (52 Weeks)|Lost to Follow-up|0
7545513|NCT02531633|26224210|P1|Part A (52 Weeks)|Lost to Follow-up|0
7545514|NCT02531633|26224201|P10|Part A (52 Weeks)|Protocol Violation|0
7545515|NCT02531633|26224202|P9|Part A (52 Weeks)|Protocol Violation|0
7545516|NCT02531633|26224203|P8|Part A (52 Weeks)|Protocol Violation|0
7545517|NCT02531633|26224204|P7|Part A (52 Weeks)|Protocol Violation|0
7545518|NCT02531633|26224205|P6|Part A (52 Weeks)|Protocol Violation|0
7545519|NCT02531633|26224206|P5|Part A (52 Weeks)|Protocol Violation|0
7545520|NCT02531633|26224207|P4|Part A (52 Weeks)|Protocol Violation|0
7545521|NCT02531633|26224208|P3|Part A (52 Weeks)|Protocol Violation|0
7545522|NCT02531633|26224209|P2|Part A (52 Weeks)|Protocol Violation|0
7545523|NCT02531633|26224210|P1|Part A (52 Weeks)|Protocol Violation|1
7545524|NCT02531633|26224201|P10|Part A (52 Weeks)|Sponsor request|0
7545525|NCT02531633|26224202|P9|Part A (52 Weeks)|Sponsor request|0
7545526|NCT02531633|26224203|P8|Part A (52 Weeks)|Sponsor request|0
7545527|NCT02531633|26224204|P7|Part A (52 Weeks)|Sponsor request|0
7545528|NCT02531633|26224205|P6|Part A (52 Weeks)|Sponsor request|0
7545529|NCT02531633|26224206|P5|Part A (52 Weeks)|Sponsor request|19
7545530|NCT02531633|26224207|P4|Part A (52 Weeks)|Sponsor request|18
7545531|NCT02531633|26224208|P3|Part A (52 Weeks)|Sponsor request|18
7545532|NCT02531633|26224209|P2|Part A (52 Weeks)|Sponsor request|24
7545533|NCT02531633|26224210|P1|Part A (52 Weeks)|Sponsor request|24
7545534|NCT02531438|26224689|P2|Overall Study|Randomized with Exclusion Criteria|0
7545535|NCT02531438|26224690|P1|Overall Study|Randomized with Exclusion Criteria|1
7545536|NCT02531438|26224689|P2|Overall Study|Missed EOT/PTE Visit|2
7545537|NCT02531438|26224690|P1|Overall Study|Missed EOT/PTE Visit|5
7545538|NCT02531438|26224689|P2|Overall Study|Randomized, but Not Treated|0
7545539|NCT02531438|26224690|P1|Overall Study|Randomized, but Not Treated|4
7545540|NCT02531438|26224689|P2|Overall Study|Death|3
7545541|NCT02531438|26224690|P1|Overall Study|Death|6
7545542|NCT02531438|26224689|P2|Overall Study|Physician Decision|1
7545543|NCT02531438|26224690|P1|Overall Study|Physician Decision|0
7545544|NCT02531438|26224689|P2|Overall Study|Withdrawal by Subject|8
7545545|NCT02531438|26224690|P1|Overall Study|Withdrawal by Subject|7
7545546|NCT02531438|26224689|P2|Overall Study|Lost to Follow-up|3
7545547|NCT02531438|26224690|P1|Overall Study|Lost to Follow-up|0
7545548|NCT02531438|26224689|P2|Overall Study|Adverse Event|9
7545549|NCT02531438|26224690|P1|Overall Study|Adverse Event|7
7545550|NCT02531373|26224709|P9|Overall Study|Withdrawal by Subject|0
7545551|NCT02531373|26224710|P8|Overall Study|Withdrawal by Subject|0
7545552|NCT02531373|26224711|P7|Overall Study|Withdrawal by Subject|0
7545553|NCT02531373|26224712|P6|Overall Study|Withdrawal by Subject|0
7545554|NCT02531373|26224713|P5|Overall Study|Withdrawal by Subject|3
7545555|NCT02531373|26224714|P4|Overall Study|Withdrawal by Subject|0
7545556|NCT02531373|26224715|P3|Overall Study|Withdrawal by Subject|0
7545557|NCT02531373|26224716|P2|Overall Study|Withdrawal by Subject|0
7545558|NCT02531373|26224717|P1|Overall Study|Withdrawal by Subject|0
7545559|NCT02531373|26224709|P9|Overall Study|Withdrawal by Parent/Guardian|3
7545560|NCT02531373|26224710|P8|Overall Study|Withdrawal by Parent/Guardian|1
7545561|NCT02531373|26224711|P7|Overall Study|Withdrawal by Parent/Guardian|4
7545562|NCT02531373|26224712|P6|Overall Study|Withdrawal by Parent/Guardian|3
7545563|NCT02531373|26224713|P5|Overall Study|Withdrawal by Parent/Guardian|0
7545564|NCT02531373|26224714|P4|Overall Study|Withdrawal by Parent/Guardian|0
7545565|NCT02531373|26224715|P3|Overall Study|Withdrawal by Parent/Guardian|0
7545566|NCT02531373|26224716|P2|Overall Study|Withdrawal by Parent/Guardian|0
7545567|NCT02531373|26224717|P1|Overall Study|Withdrawal by Parent/Guardian|0
7545568|NCT02531373|26224709|P9|Overall Study|Protocol Violation|1
7545569|NCT02531373|26224710|P8|Overall Study|Protocol Violation|0
7545570|NCT02531373|26224711|P7|Overall Study|Protocol Violation|1
7545571|NCT02531373|26224712|P6|Overall Study|Protocol Violation|1
7545572|NCT02531373|26224713|P5|Overall Study|Protocol Violation|0
7545573|NCT02531373|26224714|P4|Overall Study|Protocol Violation|0
7545574|NCT02531373|26224715|P3|Overall Study|Protocol Violation|0
7545575|NCT02531373|26224716|P2|Overall Study|Protocol Violation|0
7545576|NCT02531373|26224717|P1|Overall Study|Protocol Violation|0
7545577|NCT02531373|26224709|P9|Overall Study|Physician Decision|0
7545578|NCT02531373|26224710|P8|Overall Study|Physician Decision|0
7545579|NCT02531373|26224711|P7|Overall Study|Physician Decision|0
7545580|NCT02531373|26224712|P6|Overall Study|Physician Decision|1
7545581|NCT02531373|26224713|P5|Overall Study|Physician Decision|2
7545582|NCT02531373|26224714|P4|Overall Study|Physician Decision|0
7545583|NCT02531373|26224715|P3|Overall Study|Physician Decision|0
7545584|NCT02531373|26224716|P2|Overall Study|Physician Decision|0
7545585|NCT02531373|26224717|P1|Overall Study|Physician Decision|0
7545586|NCT02531373|26224709|P9|Overall Study|Lost to Follow-up|0
7545587|NCT02531373|26224710|P8|Overall Study|Lost to Follow-up|0
7545588|NCT02531373|26224711|P7|Overall Study|Lost to Follow-up|2
7545589|NCT02531373|26224712|P6|Overall Study|Lost to Follow-up|2
7545590|NCT02531373|26224713|P5|Overall Study|Lost to Follow-up|0
7545591|NCT02531373|26224714|P4|Overall Study|Lost to Follow-up|0
7545592|NCT02531373|26224715|P3|Overall Study|Lost to Follow-up|0
7545593|NCT02531373|26224716|P2|Overall Study|Lost to Follow-up|0
7545594|NCT02531373|26224717|P1|Overall Study|Lost to Follow-up|0
7545595|NCT02531373|26224709|P9|Overall Study|Lack of Efficacy|5
7545596|NCT02531373|26224710|P8|Overall Study|Lack of Efficacy|8
7545597|NCT02531373|26224711|P7|Overall Study|Lack of Efficacy|4
7545598|NCT02531373|26224712|P6|Overall Study|Lack of Efficacy|2
7545599|NCT02531373|26224713|P5|Overall Study|Lack of Efficacy|3
7545600|NCT02531373|26224714|P4|Overall Study|Lack of Efficacy|0
7545601|NCT02531373|26224715|P3|Overall Study|Lack of Efficacy|0
7545602|NCT02531373|26224716|P2|Overall Study|Lack of Efficacy|0
7545603|NCT02531373|26224717|P1|Overall Study|Lack of Efficacy|0
7545604|NCT02531113|26224789|P1|Extension Period: Week 12 up to Week 160|Pregnancy|1
7545605|NCT02531113|26224789|P1|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
7545606|NCT02531113|26224789|P1|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
7545607|NCT02531113|26224789|P1|Extension Period: Week 12 up to Week 160|Adverse Event|5
7545608|NCT02531113|26224789|P1|Extension Period: Week 12 up to Week 160|Physician Decision|2
7545609|NCT02531113|26224789|P1|Induction Period: Week 0 to 12|Withdrawal by Subject|3
7545610|NCT02531113|26224789|P1|Induction Period: Week 0 to 12|Lack of Efficacy|4
7545611|NCT02531113|26224789|P1|Induction Period: Week 0 to 12|Adverse Event|4
7545612|NCT02531035|26224825|P2|Overall Study|Randomized, not treated|1
7545613|NCT02531035|26224826|P1|Overall Study|Randomized, not treated|2
7545614|NCT02531035|26224825|P2|Overall Study|Lost to Follow-up|10
7545615|NCT02531035|26224826|P1|Overall Study|Lost to Follow-up|8
7545616|NCT02531035|26224825|P2|Overall Study|Withdrawal by Subject|32
7545617|NCT02531035|26224826|P1|Overall Study|Withdrawal by Subject|42
7545618|NCT02531035|26224825|P2|Overall Study|Other|2
7545619|NCT02531035|26224826|P1|Overall Study|Other|3
7545620|NCT02531035|26224825|P2|Overall Study|Adverse Event|45
7545621|NCT02531035|26224826|P1|Overall Study|Adverse Event|16
7545622|NCT02531035|26224825|P2|Overall Study|Physician Decision|0
7545623|NCT02531035|26224826|P1|Overall Study|Physician Decision|1
7545624|NCT02531035|26224825|P2|Overall Study|Noncompliance with study drug|3
7545625|NCT02531035|26224826|P1|Overall Study|Noncompliance with study drug|8
7545626|NCT02531035|26224825|P2|Overall Study|Protocol Violation|1
7545627|NCT02531035|26224826|P1|Overall Study|Protocol Violation|1
7545628|NCT02531035|26224825|P2|Overall Study|Death|1
7545629|NCT02531035|26224826|P1|Overall Study|Death|0
7545630|NCT02530970|26224880|P1|Overall Study|Relocation|3
7545631|NCT02530970|26224880|P1|Overall Study|Change in Provider|5
7545632|NCT02530970|26224880|P1|Overall Study|Explant|2
7545633|NCT02530970|26224880|P1|Overall Study|Insurance|2
7545634|NCT02530970|26224880|P1|Overall Study|Hospitalization|1
7545635|NCT02530970|26224880|P1|Overall Study|Death|6
7545636|NCT02530970|26224880|P1|Overall Study|Withdrawal by Subject|14
7545637|NCT02530970|26224880|P1|Overall Study|Physician Decision|5
7545638|NCT02530970|26224880|P1|Overall Study|Lost to Follow-up|88
7545639|NCT02530970|26224880|P1|Overall Study|Adverse Event|8
7545640|NCT02530905|26224887|P3|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
7545641|NCT02530905|26224888|P2|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7545642|NCT02530905|26224889|P1|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7545643|NCT02530671|26224978|P2|Overall Study|Withdrawal by Subject|0
7545644|NCT02530671|26224979|P1|Overall Study|Withdrawal by Subject|1
7545645|NCT02530671|26224978|P2|Overall Study|Lost to Follow-up|0
7545646|NCT02530671|26224979|P1|Overall Study|Lost to Follow-up|2
7545647|NCT02530619|26224995|P1|Follow-up Period (6 Months)|Withdrawal by Subject|5
7545648|NCT02530619|26224995|P1|Follow-up Period (6 Months)|Lost to Follow-up|2
7545649|NCT02530619|26224995|P1|Follow-up Period (6 Months)|Death|4
7545650|NCT02530619|26224995|P1|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
7545651|NCT02530619|26224995|P1|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
7545652|NCT02530619|26224995|P1|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
7545653|NCT02530619|26224995|P1|Continued Treatment Cycles 2 Through 6|Adverse Event|2
7545654|NCT02530619|26224995|P1|Registered for Study|Withdrawal by Subject|2
7545655|NCT02530385|26225106|P2|Overall Study|Withdrawal by Subject|1
7545656|NCT02530385|26225107|P1|Overall Study|Withdrawal by Subject|0
7545657|NCT02530242|26225159|P2|Overall Study|excluded due to asthma and oxcarbazepine|1
7545658|NCT02530242|26225160|P1|Overall Study|excluded due to asthma and oxcarbazepine|0
7545659|NCT02530125|26225179|P1|Followed for Survival for 2 Years|Early termination of study|3
7545660|NCT02530125|26225179|P1|Completed Treatment|Early termination of study|1
7545661|NCT02529995|26225193|P2|Part B|Discontinued Study|5
7545662|NCT02529995|26225194|P1|Part B|Discontinued Study|6
7545663|NCT02529995|26225193|P2|Part B|Ongoing Study at Data Cut-off|7
7545664|NCT02529995|26225194|P1|Part B|Ongoing Study at Data Cut-off|0
7545665|NCT02529995|26225193|P2|Part A|Discontinued Study|0
7545666|NCT02529995|26225194|P1|Part A|Discontinued Study|1
7545667|NCT02529995|26225193|P2|Part A|Ongoing Study at Data Cut-off|16
7545668|NCT02529995|26225194|P1|Part A|Ongoing Study at Data Cut-off|14
7545669|NCT02529553|26225237|P9|Overall Study|Withdrawal by Subject|0
7545670|NCT02529553|26225238|P8|Overall Study|Withdrawal by Subject|1
7545671|NCT02529553|26225239|P7|Overall Study|Withdrawal by Subject|0
7545672|NCT02529553|26225240|P6|Overall Study|Withdrawal by Subject|1
7545673|NCT02529553|26225241|P5|Overall Study|Withdrawal by Subject|0
7545674|NCT02529553|26225242|P4|Overall Study|Withdrawal by Subject|0
7545675|NCT02529553|26225243|P3|Overall Study|Withdrawal by Subject|0
7545676|NCT02529553|26225244|P2|Overall Study|Withdrawal by Subject|0
7545677|NCT02529553|26225245|P1|Overall Study|Withdrawal by Subject|0
7545678|NCT02529553|26225237|P9|Overall Study|Physician Decision|0
7545679|NCT02529553|26225238|P8|Overall Study|Physician Decision|0
7545680|NCT02529553|26225239|P7|Overall Study|Physician Decision|0
7545681|NCT02529553|26225240|P6|Overall Study|Physician Decision|0
7545682|NCT02529553|26225241|P5|Overall Study|Physician Decision|1
7545683|NCT02529553|26225242|P4|Overall Study|Physician Decision|0
7545684|NCT02529553|26225243|P3|Overall Study|Physician Decision|0
7545685|NCT02529553|26225244|P2|Overall Study|Physician Decision|1
7545686|NCT02529553|26225245|P1|Overall Study|Physician Decision|0
7545687|NCT02529553|26225237|P9|Overall Study|Progressive Disease|3
7545688|NCT02529553|26225238|P8|Overall Study|Progressive Disease|5
7545689|NCT02529553|26225239|P7|Overall Study|Progressive Disease|3
7545690|NCT02529553|26225240|P6|Overall Study|Progressive Disease|3
7545691|NCT02529553|26225241|P5|Overall Study|Progressive Disease|2
7545692|NCT02529553|26225242|P4|Overall Study|Progressive Disease|3
7545693|NCT02529553|26225243|P3|Overall Study|Progressive Disease|1
7545694|NCT02529553|26225244|P2|Overall Study|Progressive Disease|0
7545695|NCT02529553|26225245|P1|Overall Study|Progressive Disease|1
7545696|NCT02529488|26225284|P1|Overall Study|Death|3
7545697|NCT02529488|26225284|P1|Overall Study|Adverse Event|1
7545698|NCT02529137|26225292|P1|Overall Study|Discontinuation for different reasons|8
7545699|NCT02528942|26225310|P1|Overall Study|Lost to Follow-up|25
7545700|NCT02528942|26225310|P1|Overall Study|Did not meet imaging criteria|9
7545701|NCT02528643|26225334|P2|Overall Study|No End of Study Information Available|0
7545702|NCT02528643|26225335|P1|Overall Study|No End of Study Information Available|1
7545703|NCT02528643|26225334|P2|Overall Study|Miscellaneous|1
7545704|NCT02528643|26225335|P1|Overall Study|Miscellaneous|0
7545705|NCT02528643|26225334|P2|Overall Study|Withdrawal by Subject|7
7545706|NCT02528643|26225335|P1|Overall Study|Withdrawal by Subject|0
7545707|NCT02528643|26225334|P2|Overall Study|Lost to Follow-up|1
7545708|NCT02528643|26225335|P1|Overall Study|Lost to Follow-up|0
7545709|NCT02528643|26225334|P2|Overall Study|Death|76
7545710|NCT02528643|26225335|P1|Overall Study|Death|38
7545711|NCT02528357|26225405|P19|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7545712|NCT02528357|26225406|P18|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7545713|NCT02528357|26225407|P17|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7545714|NCT02528357|26225408|P16|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545715|NCT02528357|26225409|P15|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545716|NCT02528357|26225410|P14|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545717|NCT02528357|26225411|P13|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545718|NCT02528357|26225412|P12|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545719|NCT02528357|26225413|P11|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545720|NCT02528357|26225414|P10|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545721|NCT02528357|26225415|P9|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545722|NCT02528357|26225416|P8|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545723|NCT02528357|26225417|P7|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545724|NCT02528357|26225418|P6|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545725|NCT02528357|26225419|P5|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545726|NCT02528357|26225420|P4|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545727|NCT02528357|26225421|P3|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545728|NCT02528357|26225422|P2|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545729|NCT02528357|26225423|P1|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545730|NCT02528357|26225405|P19|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545731|NCT02528357|26225406|P18|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545732|NCT02528357|26225407|P17|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
7545733|NCT02528357|26225408|P16|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545734|NCT02528357|26225409|P15|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545735|NCT02528357|26225410|P14|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545736|NCT02528357|26225411|P13|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545737|NCT02528357|26225412|P12|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545738|NCT02528357|26225413|P11|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545739|NCT02528357|26225414|P10|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545740|NCT02528357|26225415|P9|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545741|NCT02528357|26225416|P8|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545742|NCT02528357|26225417|P7|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545743|NCT02528357|26225418|P6|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545744|NCT02528357|26225419|P5|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545745|NCT02528357|26225420|P4|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545746|NCT02528357|26225421|P3|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545747|NCT02528357|26225422|P2|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545748|NCT02528357|26225423|P1|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7545749|NCT02528357|26225405|P19|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545750|NCT02528357|26225406|P18|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545751|NCT02528357|26225407|P17|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545752|NCT02528357|26225408|P16|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545753|NCT02528357|26225409|P15|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7545754|NCT02528357|26225410|P14|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7545755|NCT02528357|26225411|P13|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7545756|NCT02528357|26225412|P12|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7545757|NCT02528357|26225413|P11|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545758|NCT02528357|26225414|P10|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7545759|NCT02528357|26225415|P9|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7545760|NCT02528357|26225416|P8|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545761|NCT02528357|26225417|P7|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545762|NCT02528357|26225418|P6|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545763|NCT02528357|26225419|P5|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545764|NCT02528357|26225420|P4|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545765|NCT02528357|26225421|P3|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545766|NCT02528357|26225422|P2|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545767|NCT02528357|26225423|P1|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545768|NCT02528357|26225405|P19|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545769|NCT02528357|26225406|P18|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545770|NCT02528357|26225407|P17|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545771|NCT02528357|26225408|P16|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545772|NCT02528357|26225409|P15|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7545773|NCT02528357|26225410|P14|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7545774|NCT02528357|26225411|P13|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7545775|NCT02528357|26225412|P12|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545776|NCT02528357|26225413|P11|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7545777|NCT02528357|26225414|P10|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545778|NCT02528357|26225415|P9|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545779|NCT02528357|26225416|P8|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545780|NCT02528357|26225417|P7|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545781|NCT02528357|26225418|P6|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545782|NCT02528357|26225419|P5|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545783|NCT02528357|26225420|P4|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545784|NCT02528357|26225421|P3|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545785|NCT02528357|26225422|P2|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545786|NCT02528357|26225423|P1|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7545787|NCT02528357|26225405|P19|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545788|NCT02528357|26225406|P18|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545789|NCT02528357|26225407|P17|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545790|NCT02528357|26225408|P16|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545791|NCT02528357|26225409|P15|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545792|NCT02528357|26225410|P14|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
7545793|NCT02528357|26225411|P13|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545794|NCT02528357|26225412|P12|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545795|NCT02528357|26225413|P11|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545796|NCT02528357|26225414|P10|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545797|NCT02528357|26225415|P9|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545798|NCT02528357|26225416|P8|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545799|NCT02528357|26225417|P7|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545800|NCT02528357|26225418|P6|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545801|NCT02528357|26225419|P5|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545802|NCT02528357|26225420|P4|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545803|NCT02528357|26225421|P3|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545804|NCT02528357|26225422|P2|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545805|NCT02528357|26225423|P1|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7545806|NCT02528357|26225405|P19|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545807|NCT02528357|26225406|P18|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545808|NCT02528357|26225407|P17|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545809|NCT02528357|26225408|P16|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545810|NCT02528357|26225409|P15|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
7545811|NCT02528357|26225410|P14|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
7545812|NCT02528357|26225411|P13|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545813|NCT02528357|26225412|P12|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545814|NCT02528357|26225413|P11|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545815|NCT02528357|26225414|P10|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545816|NCT02528357|26225415|P9|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545817|NCT02528357|26225416|P8|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545818|NCT02528357|26225417|P7|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545819|NCT02528357|26225418|P6|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545820|NCT02528357|26225419|P5|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545821|NCT02528357|26225420|P4|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545822|NCT02528357|26225421|P3|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545823|NCT02528357|26225422|P2|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545824|NCT02528357|26225423|P1|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7545825|NCT02528357|26225405|P19|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545826|NCT02528357|26225406|P18|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545827|NCT02528357|26225407|P17|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545828|NCT02528357|26225408|P16|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545829|NCT02528357|26225409|P15|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545830|NCT02528357|26225410|P14|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545831|NCT02528357|26225411|P13|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545832|NCT02528357|26225412|P12|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545833|NCT02528357|26225413|P11|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545834|NCT02528357|26225414|P10|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545835|NCT02528357|26225415|P9|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545836|NCT02528357|26225416|P8|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545837|NCT02528357|26225417|P7|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545838|NCT02528357|26225418|P6|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545839|NCT02528357|26225419|P5|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
7545840|NCT02528357|26225420|P4|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545841|NCT02528357|26225421|P3|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545842|NCT02528357|26225422|P2|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545843|NCT02528357|26225423|P1|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7545844|NCT02528357|26225405|P19|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545845|NCT02528357|26225406|P18|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545846|NCT02528357|26225407|P17|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545847|NCT02528357|26225408|P16|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545848|NCT02528357|26225409|P15|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545849|NCT02528357|26225410|P14|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545850|NCT02528357|26225411|P13|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545851|NCT02528357|26225412|P12|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545852|NCT02528357|26225413|P11|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545853|NCT02528357|26225414|P10|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545854|NCT02528357|26225415|P9|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545855|NCT02528357|26225416|P8|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
7545856|NCT02528357|26225417|P7|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7545857|NCT02528357|26225418|P6|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545858|NCT02528357|26225419|P5|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
7545859|NCT02528357|26225420|P4|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545860|NCT02528357|26225421|P3|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7545861|NCT02528357|26225422|P2|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545862|NCT02528357|26225423|P1|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7545863|NCT02528357|26225405|P19|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545864|NCT02528357|26225406|P18|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545865|NCT02528357|26225407|P17|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545866|NCT02528357|26225408|P16|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545867|NCT02528357|26225409|P15|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545868|NCT02528357|26225410|P14|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545869|NCT02528357|26225411|P13|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545870|NCT02528357|26225412|P12|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545871|NCT02528357|26225413|P11|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545872|NCT02528357|26225414|P10|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545873|NCT02528357|26225415|P9|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545874|NCT02528357|26225416|P8|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7545875|NCT02528357|26225417|P7|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545876|NCT02528357|26225418|P6|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
7545877|NCT02528357|26225419|P5|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545878|NCT02528357|26225420|P4|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7545879|NCT02528357|26225421|P3|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545880|NCT02528357|26225422|P2|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545881|NCT02528357|26225423|P1|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7545882|NCT02528357|26225405|P19|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545883|NCT02528357|26225406|P18|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545884|NCT02528357|26225407|P17|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545885|NCT02528357|26225408|P16|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545886|NCT02528357|26225409|P15|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545887|NCT02528357|26225410|P14|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545888|NCT02528357|26225411|P13|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545889|NCT02528357|26225412|P12|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545890|NCT02528357|26225413|P11|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545891|NCT02528357|26225414|P10|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545892|NCT02528357|26225415|P9|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545893|NCT02528357|26225416|P8|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545894|NCT02528357|26225417|P7|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545895|NCT02528357|26225418|P6|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545896|NCT02528357|26225419|P5|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545897|NCT02528357|26225420|P4|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545898|NCT02528357|26225421|P3|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545899|NCT02528357|26225422|P2|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
7545900|NCT02528357|26225423|P1|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7545901|NCT02528331|26225803|P1|Overall Study|Withdrawal by Subject|2
7545902|NCT02528305|26225871|P1|Overall Study|Physician Decision|1
7545903|NCT02528305|26225871|P1|Overall Study|Adverse Event|1
7545904|NCT02528305|26225871|P1|Overall Study|Withdrawal by Subject|1
7545905|NCT02528253|26225918|P5|Overall Study|Withdrawn Due to Pregnancy|1
7545906|NCT02528253|26225919|P4|Overall Study|Withdrawn Due to Pregnancy|0
7545907|NCT02528253|26225920|P3|Overall Study|Withdrawn Due to Pregnancy|0
7545908|NCT02528253|26225921|P2|Overall Study|Withdrawn Due to Pregnancy|1
7545909|NCT02528253|26225922|P1|Overall Study|Withdrawn Due to Pregnancy|0
7545910|NCT02528253|26225918|P5|Overall Study|Protocol Violation|4
7545911|NCT02528253|26225919|P4|Overall Study|Protocol Violation|0
7545912|NCT02528253|26225920|P3|Overall Study|Protocol Violation|4
7545913|NCT02528253|26225921|P2|Overall Study|Protocol Violation|2
7545914|NCT02528253|26225922|P1|Overall Study|Protocol Violation|1
7545915|NCT02528253|26225918|P5|Overall Study|Withdrawal by Subject|73
7545916|NCT02528253|26225919|P4|Overall Study|Withdrawal by Subject|48
7545917|NCT02528253|26225920|P3|Overall Study|Withdrawal by Subject|29
7545918|NCT02528253|26225921|P2|Overall Study|Withdrawal by Subject|20
7545919|NCT02528253|26225922|P1|Overall Study|Withdrawal by Subject|25
7545920|NCT02528253|26225918|P5|Overall Study|Other|76
7545921|NCT02528253|26225919|P4|Overall Study|Other|52
7545922|NCT02528253|26225920|P3|Overall Study|Other|58
7545923|NCT02528253|26225921|P2|Overall Study|Other|22
7545924|NCT02528253|26225922|P1|Overall Study|Other|21
7545925|NCT02528253|26225918|P5|Overall Study|Lost to Follow-up|34
7545926|NCT02528253|26225919|P4|Overall Study|Lost to Follow-up|16
7545927|NCT02528253|26225920|P3|Overall Study|Lost to Follow-up|31
7545928|NCT02528253|26225921|P2|Overall Study|Lost to Follow-up|9
7545929|NCT02528253|26225922|P1|Overall Study|Lost to Follow-up|16
7545930|NCT02528253|26225918|P5|Overall Study|Insufficient clinical response|16
7545931|NCT02528253|26225919|P4|Overall Study|Insufficient clinical response|12
7545932|NCT02528253|26225920|P3|Overall Study|Insufficient clinical response|13
7545933|NCT02528253|26225921|P2|Overall Study|Insufficient clinical response|10
7545934|NCT02528253|26225922|P1|Overall Study|Insufficient clinical response|7
7545935|NCT02528253|26225918|P5|Overall Study|Death|1
7545936|NCT02528253|26225919|P4|Overall Study|Death|0
7545937|NCT02528253|26225920|P3|Overall Study|Death|1
7545938|NCT02528253|26225921|P2|Overall Study|Death|2
7545939|NCT02528253|26225922|P1|Overall Study|Death|2
7545940|NCT02528253|26225918|P5|Overall Study|Adverse Event|18
7545941|NCT02528253|26225919|P4|Overall Study|Adverse Event|8
7545942|NCT02528253|26225920|P3|Overall Study|Adverse Event|4
7545943|NCT02528253|26225921|P2|Overall Study|Adverse Event|4
7545944|NCT02528253|26225922|P1|Overall Study|Adverse Event|3
7545945|NCT02528214|26226215|P2|Overall Study|Other than specified above|1
7545946|NCT02528214|26226216|P1|Overall Study|Other than specified above|0
7545947|NCT02528214|26226215|P2|Overall Study|Adverse Event|1
7545948|NCT02528214|26226216|P1|Overall Study|Adverse Event|0
7545949|NCT02528214|26226215|P2|Overall Study|Protocol Violation|1
7545950|NCT02528214|26226216|P1|Overall Study|Protocol Violation|0
7545951|NCT02528188|26226251|P3|Overall Study|Randomized but not treated|12
7545952|NCT02528188|26226252|P2|Overall Study|Randomized but not treated|7
7545953|NCT02528188|26226253|P1|Overall Study|Randomized but not treated|6
7545954|NCT02528188|26226251|P3|Overall Study|Other|74
7545955|NCT02528188|26226252|P2|Overall Study|Other|91
7545956|NCT02528188|26226253|P1|Overall Study|Other|89
7545957|NCT02528188|26226251|P3|Overall Study|Death|0
7545958|NCT02528188|26226252|P2|Overall Study|Death|4
7545959|NCT02528188|26226253|P1|Overall Study|Death|4
7545960|NCT02528188|26226251|P3|Overall Study|Lost to Follow-up|31
7545961|NCT02528188|26226252|P2|Overall Study|Lost to Follow-up|21
7545962|NCT02528188|26226253|P1|Overall Study|Lost to Follow-up|25
7545963|NCT02528188|26226251|P3|Overall Study|Withdrawal by Subject|100
7545964|NCT02528188|26226252|P2|Overall Study|Withdrawal by Subject|104
7545965|NCT02528188|26226253|P1|Overall Study|Withdrawal by Subject|97
7545966|NCT02528188|26226251|P3|Overall Study|Lack of Efficacy|22
7545967|NCT02528188|26226252|P2|Overall Study|Lack of Efficacy|21
7545968|NCT02528188|26226253|P1|Overall Study|Lack of Efficacy|19
7545969|NCT02528188|26226251|P3|Overall Study|Protocol Violation|4
7545970|NCT02528188|26226252|P2|Overall Study|Protocol Violation|6
7545971|NCT02528188|26226253|P1|Overall Study|Protocol Violation|4
7545972|NCT02528188|26226251|P3|Overall Study|Adverse Event|8
7545973|NCT02528188|26226252|P2|Overall Study|Adverse Event|22
7545974|NCT02528188|26226253|P1|Overall Study|Adverse Event|23
7545975|NCT02527434|26226548|P3|Overall Study|Site closure|0
7545976|NCT02527434|26226549|P2|Overall Study|Site closure|0
7545977|NCT02527434|26226550|P1|Overall Study|Site closure|1
7545978|NCT02527434|26226548|P3|Overall Study|Reason Not Specified|0
7545979|NCT02527434|26226549|P2|Overall Study|Reason Not Specified|0
7545980|NCT02527434|26226550|P1|Overall Study|Reason Not Specified|1
7545981|NCT02527434|26226548|P3|Overall Study|Withdrawal by Subject|3
7545982|NCT02527434|26226549|P2|Overall Study|Withdrawal by Subject|3
7545983|NCT02527434|26226550|P1|Overall Study|Withdrawal by Subject|5
7545984|NCT02527434|26226548|P3|Overall Study|Death|17
7545985|NCT02527434|26226549|P2|Overall Study|Death|6
7545986|NCT02527434|26226550|P1|Overall Study|Death|19
7545987|NCT02527434|26226548|P3|Overall Study|Lost to Follow-up|0
7545988|NCT02527434|26226549|P2|Overall Study|Lost to Follow-up|2
7545989|NCT02527434|26226550|P1|Overall Study|Lost to Follow-up|2
7545990|NCT02527161|26226623|P1|Overall Study|Lost to Follow-up|6
7545991|NCT02527161|26226623|P1|Overall Study|Adverse Event|1
7545992|NCT02527161|26226623|P1|Overall Study|Physician Decision|1
7545993|NCT02527161|26226623|P1|Overall Study|Only Recruited to Part A|27
7545994|NCT02527161|26226623|P1|Overall Study|Consent violation|4
7545995|NCT02527161|26226623|P1|Overall Study|MRI contraindication|6
7545996|NCT02527161|26226623|P1|Overall Study|Delay in or unfit for surgery|16
7545997|NCT02527161|26226623|P1|Overall Study|Withdrawal by Subject|19
7545998|NCT02527161|26226623|P1|Overall Study|Failed MRI|52
7545999|NCT02527148|26226642|P2|Overall Study|Did not receive study intervention|0
7546000|NCT02527148|26226643|P1|Overall Study|Did not receive study intervention|1
7546001|NCT02526693|26226673|P2|Overall Study|Physician Decision|1
7546002|NCT02526693|26226674|P1|Overall Study|Physician Decision|3
7546003|NCT02526550|26226719|P1|Overall Study|Lost to Follow-up|1
7546004|NCT02526524|26226731|P6|Overall Study|Sponsor Decision|0
7546005|NCT02526524|26226732|P5|Overall Study|Sponsor Decision|0
7546006|NCT02526524|26226733|P4|Overall Study|Sponsor Decision|0
7546007|NCT02526524|26226734|P3|Overall Study|Sponsor Decision|0
7546008|NCT02526524|26226735|P2|Overall Study|Sponsor Decision|0
7546009|NCT02526524|26226736|P1|Overall Study|Sponsor Decision|1
7546010|NCT02526524|26226731|P6|Overall Study|Physician Decision|0
7546011|NCT02526524|26226732|P5|Overall Study|Physician Decision|1
7546012|NCT02526524|26226733|P4|Overall Study|Physician Decision|0
7546013|NCT02526524|26226734|P3|Overall Study|Physician Decision|0
7546014|NCT02526524|26226735|P2|Overall Study|Physician Decision|0
7546015|NCT02526524|26226736|P1|Overall Study|Physician Decision|0
7546016|NCT02526524|26226731|P6|Overall Study|Loss of Glucose Control|0
7546017|NCT02526524|26226732|P5|Overall Study|Loss of Glucose Control|2
7546018|NCT02526524|26226733|P4|Overall Study|Loss of Glucose Control|0
7546019|NCT02526524|26226734|P3|Overall Study|Loss of Glucose Control|3
7546020|NCT02526524|26226735|P2|Overall Study|Loss of Glucose Control|0
7546021|NCT02526524|26226736|P1|Overall Study|Loss of Glucose Control|0
7546022|NCT02526524|26226731|P6|Overall Study|Protocol Violation|3
7546023|NCT02526524|26226732|P5|Overall Study|Protocol Violation|4
7546024|NCT02526524|26226733|P4|Overall Study|Protocol Violation|3
7546025|NCT02526524|26226734|P3|Overall Study|Protocol Violation|5
7546026|NCT02526524|26226735|P2|Overall Study|Protocol Violation|1
7546027|NCT02526524|26226736|P1|Overall Study|Protocol Violation|3
7546028|NCT02526524|26226731|P6|Overall Study|Lost to Follow-up|5
7546029|NCT02526524|26226732|P5|Overall Study|Lost to Follow-up|2
7546030|NCT02526524|26226733|P4|Overall Study|Lost to Follow-up|1
7546031|NCT02526524|26226734|P3|Overall Study|Lost to Follow-up|8
7546032|NCT02526524|26226735|P2|Overall Study|Lost to Follow-up|3
7546033|NCT02526524|26226736|P1|Overall Study|Lost to Follow-up|2
7546034|NCT02526524|26226731|P6|Overall Study|Adverse Event|8
7546035|NCT02526524|26226732|P5|Overall Study|Adverse Event|6
7546036|NCT02526524|26226733|P4|Overall Study|Adverse Event|2
7546037|NCT02526524|26226734|P3|Overall Study|Adverse Event|4
7546038|NCT02526524|26226735|P2|Overall Study|Adverse Event|2
7546039|NCT02526524|26226736|P1|Overall Study|Adverse Event|3
7546040|NCT02526524|26226731|P6|Overall Study|Withdrawal by Subject|5
7546041|NCT02526524|26226732|P5|Overall Study|Withdrawal by Subject|9
7546042|NCT02526524|26226733|P4|Overall Study|Withdrawal by Subject|1
7546043|NCT02526524|26226734|P3|Overall Study|Withdrawal by Subject|6
7546044|NCT02526524|26226735|P2|Overall Study|Withdrawal by Subject|3
7546045|NCT02526524|26226736|P1|Overall Study|Withdrawal by Subject|3
7546046|NCT02526290|26226750|P1|Overall Study|Physician Decision|1
7546047|NCT02526290|26226750|P1|Overall Study|Withdrawal by Subject|4
7546048|NCT02526290|26226750|P1|Overall Study|Adverse Event|3
7546049|NCT02526212|26226784|P2|Overall Study|Death|1
7546050|NCT02526212|26226785|P1|Overall Study|Death|0
7546051|NCT02526212|26226784|P2|Overall Study|Lost to Follow-up|0
7546052|NCT02526212|26226785|P1|Overall Study|Lost to Follow-up|1
7546053|NCT02526212|26226784|P2|Overall Study|Incarceration|0
7546054|NCT02526212|26226785|P1|Overall Study|Incarceration|1
7546141|NCT02524847|26227195|P1|Overall Study|Death|1
7546055|NCT02526160|26226801|P2|Open-Label Treatment Extension Period II|Other, Not Specified|0
7546056|NCT02526160|26226802|P1|Open-Label Treatment Extension Period II|Other, Not Specified|1
7546057|NCT02526160|26226801|P2|Open-Label Treatment Extension Period I|Lost to Follow-up|1
7546058|NCT02526160|26226802|P1|Open-Label Treatment Extension Period I|Lost to Follow-up|0
7546059|NCT02526160|26226801|P2|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
7546060|NCT02526160|26226802|P1|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
7546061|NCT02526160|26226801|P2|Open-Label Treatment Extension Period I|Other, Not Specified|1
7546062|NCT02526160|26226802|P1|Open-Label Treatment Extension Period I|Other, Not Specified|3
7546063|NCT02526160|26226801|P2|Open-Label Treatment Extension Period I|Death|1
7546064|NCT02526160|26226802|P1|Open-Label Treatment Extension Period I|Death|0
7546065|NCT02526160|26226801|P2|Open-label Treatment Continuation Period|Other, Not Specified|3
7546066|NCT02526160|26226802|P1|Open-label Treatment Continuation Period|Other, Not Specified|3
7546067|NCT02526160|26226801|P2|Open-label Treatment Continuation Period|Withdrawal by Subject|1
7546068|NCT02526160|26226802|P1|Open-label Treatment Continuation Period|Withdrawal by Subject|0
7546069|NCT02526160|26226801|P2|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
7546070|NCT02526160|26226802|P1|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
7546071|NCT02525874|26226874|P1|Overall Study|New lesions in Brain|1
7546072|NCT02525874|26226874|P1|Overall Study|Alternative Treatment for MS|2
7546073|NCT02525874|26226874|P1|Overall Study|Disease relapse|4
7546074|NCT02525874|26226874|P1|Overall Study|Disease progression, defined by protocol|2
7546075|NCT02525874|26226874|P1|Overall Study|Lost to Follow-up|7
7546076|NCT02525874|26226874|P1|Overall Study|Adverse Event|17
7546077|NCT02525874|26226874|P1|Overall Study|Non-compliance with study drug|3
7546078|NCT02525874|26226874|P1|Overall Study|Consent withdrawn|22
7546079|NCT02525874|26226874|P1|Overall Study|Investigator Decision|1
7546080|NCT02525874|26226874|P1|Overall Study|Other|1
7546081|NCT02525861|26226889|P2|Overall Study|Physician Decision|1
7546082|NCT02525861|26226890|P1|Overall Study|Physician Decision|0
7546083|NCT02525861|26226889|P2|Overall Study|Withdrawal by Subject|1
7546084|NCT02525861|26226890|P1|Overall Study|Withdrawal by Subject|0
7546085|NCT02525861|26226889|P2|Overall Study|Adverse Event|0
7546086|NCT02525861|26226890|P1|Overall Study|Adverse Event|1
7546087|NCT02525744|26226912|P4|Period 5|Physician Decision|0
7546088|NCT02525744|26226913|P3|Period 5|Physician Decision|0
7546089|NCT02525744|26226914|P2|Period 5|Physician Decision|0
7546090|NCT02525744|26226915|P1|Period 5|Physician Decision|1
7546091|NCT02525744|26226912|P4|Period 4|Withdrawal by Subject|0
7546092|NCT02525744|26226913|P3|Period 4|Withdrawal by Subject|0
7546093|NCT02525744|26226914|P2|Period 4|Withdrawal by Subject|0
7546094|NCT02525744|26226915|P1|Period 4|Withdrawal by Subject|1
7546095|NCT02525744|26226912|P4|Period 3|Adverse Event|0
7546096|NCT02525744|26226913|P3|Period 3|Adverse Event|0
7546097|NCT02525744|26226914|P2|Period 3|Adverse Event|1
7546098|NCT02525744|26226915|P1|Period 3|Adverse Event|0
7546099|NCT02525744|26226912|P4|Period 1|Physician Decision|0
7546100|NCT02525744|26226913|P3|Period 1|Physician Decision|1
7546101|NCT02525744|26226914|P2|Period 1|Physician Decision|0
7546102|NCT02525744|26226915|P1|Period 1|Physician Decision|0
7546103|NCT02525627|26226951|P2|Overall Study|Site terminated|10
7546104|NCT02525627|26226952|P1|Overall Study|Site terminated|11
7546105|NCT02525627|26226951|P2|Overall Study|Death|0
7546106|NCT02525627|26226952|P1|Overall Study|Death|1
7546107|NCT02525627|26226951|P2|Overall Study|Withdrawal by Subject|2
7546108|NCT02525627|26226952|P1|Overall Study|Withdrawal by Subject|1
7546109|NCT02525627|26226951|P2|Overall Study|Revision|1
7546110|NCT02525627|26226952|P1|Overall Study|Revision|1
7546111|NCT02525588|26226964|P2|Overall Study|Adverse Event|1
7546112|NCT02525588|26226965|P1|Overall Study|Adverse Event|0
7546113|NCT02525588|26226964|P2|Overall Study|Withdrawal by Subject|1
7546114|NCT02525588|26226965|P1|Overall Study|Withdrawal by Subject|1
7546115|NCT02525588|26226964|P2|Overall Study|Lost to Follow-up|0
7546116|NCT02525588|26226965|P1|Overall Study|Lost to Follow-up|2
7546117|NCT02525588|26226964|P2|Overall Study|Death|1
7546118|NCT02525588|26226965|P1|Overall Study|Death|3
7546119|NCT02525471|26227091|P1|Overall Study|Death|1
7546120|NCT02525471|26227091|P1|Overall Study|Withdrawal by Subject|4
7546121|NCT02525471|26227091|P1|Overall Study|Screen Failure|6
7546122|NCT02525133|26227112|P2|Overall Study|Withdrawal by Subject|0
7546123|NCT02525133|26227113|P1|Overall Study|Withdrawal by Subject|1
7546124|NCT02525133|26227112|P2|Overall Study|randomized not enrolled|0
7546125|NCT02525133|26227113|P1|Overall Study|randomized not enrolled|3
7546126|NCT02525133|26227112|P2|Overall Study|Lost to Follow-up|1
7546127|NCT02525133|26227113|P1|Overall Study|Lost to Follow-up|5
7546128|NCT02525133|26227112|P2|Overall Study|did not meet randomization criteria|0
7546129|NCT02525133|26227113|P1|Overall Study|did not meet randomization criteria|1
7546130|NCT02525133|26227112|P2|Overall Study|Death|1
7546131|NCT02525133|26227113|P1|Overall Study|Death|0
7546132|NCT02525133|26227112|P2|Overall Study|Adverse Event|1
7546133|NCT02525133|26227113|P1|Overall Study|Adverse Event|0
7546134|NCT02525094|26227131|P2|Overall Study|Not Treated|1
7546135|NCT02525094|26227132|P1|Overall Study|Not Treated|1
7546136|NCT02525094|26227131|P2|Overall Study|Withdrawal by Subject|6
7546137|NCT02525094|26227132|P1|Overall Study|Withdrawal by Subject|5
7546138|NCT02525094|26227131|P2|Overall Study|Lost to Follow-up|1
7546139|NCT02525094|26227132|P1|Overall Study|Lost to Follow-up|2
7546140|NCT02524847|26227195|P1|Overall Study|Reason not Specified|1
7546142|NCT02524847|26227195|P1|Overall Study|Condition no Longer Requires Treatment|4
7546143|NCT02524847|26227195|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
7546144|NCT02524847|26227195|P1|Overall Study|Adverse Event|4
7546145|NCT02524730|26227215|P1|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
7546146|NCT02524730|26227215|P1|Overall Study|Protocol Violation|1
7546147|NCT02524730|26227215|P1|Overall Study|Adverse Event|8
7546148|NCT02524730|26227215|P1|Overall Study|Death|10
7546149|NCT02524730|26227215|P1|Overall Study|Withdrawal by Subject|18
7546150|NCT02524730|26227215|P1|Overall Study|Lost to Follow-up|5
7546151|NCT02524665|26227224|P1|Overall Study|Lost to Follow-up|1
7546152|NCT02524288|26227275|P1|Overall Study|Physician Decision|2
7546153|NCT02524288|26227275|P1|Overall Study|Pregnancy|22
7546154|NCT02524288|26227275|P1|Overall Study|Withdrawal by Subject|76
7546155|NCT02524288|26227275|P1|Overall Study|Subject Moved|32
7546156|NCT02524288|26227275|P1|Overall Study|Study Terminated By Sponsor|1417
7546157|NCT02524288|26227275|P1|Overall Study|Site Discontinued Study Participation|1
7546158|NCT02524288|26227275|P1|Overall Study|Screen Failure|2
7546159|NCT02524288|26227275|P1|Overall Study|Protocol Violation|6
7546160|NCT02524288|26227275|P1|Overall Study|Pregnancy Wish|6
7546161|NCT02524288|26227275|P1|Overall Study|Non-Compliance With Study Drug|14
7546162|NCT02524288|26227275|P1|Overall Study|Non-Compliance With Protocol|32
7546163|NCT02524288|26227275|P1|Overall Study|Lost to Follow-up|216
7546164|NCT02524288|26227275|P1|Overall Study|Adverse Event|115
7546165|NCT02524158|26227285|P2|6-month Assessment|Lost to Follow-up|20
7546166|NCT02524158|26227286|P1|6-month Assessment|Lost to Follow-up|21
7546167|NCT02524158|26227285|P2|6-month Assessment|Withdrawal by Subject|1
7546168|NCT02524158|26227286|P1|6-month Assessment|Withdrawal by Subject|1
7546169|NCT02524158|26227285|P2|12-weeks Assessment|Lost to Follow-up|12
7546170|NCT02524158|26227286|P1|12-weeks Assessment|Lost to Follow-up|18
7546171|NCT02524158|26227285|P2|12-weeks Assessment|Withdrawal by Subject|1
7546172|NCT02524158|26227286|P1|12-weeks Assessment|Withdrawal by Subject|1
7546173|NCT02524145|26227328|P3|Overall Study|Withdrawal by Subject|3
7546174|NCT02524145|26227329|P2|Overall Study|Withdrawal by Subject|2
7546175|NCT02524145|26227330|P1|Overall Study|Withdrawal by Subject|2
7546176|NCT02523599|26227403|P2|Overall Study|Did not return for Day 30 visit|0
7546177|NCT02523599|26227404|P1|Overall Study|Did not return for Day 30 visit|2
7546178|NCT02523599|26227403|P2|Overall Study|Lost to Follow-up|1
7546179|NCT02523599|26227404|P1|Overall Study|Lost to Follow-up|4
7546180|NCT02523599|26227403|P2|Overall Study|Physician Decision|0
7546181|NCT02523599|26227404|P1|Overall Study|Physician Decision|1
7546182|NCT02523599|26227403|P2|Overall Study|Adverse Event|0
7546183|NCT02523599|26227404|P1|Overall Study|Adverse Event|1
7546184|NCT02522884|26227486|P1|Overall Study|Missed 12-month Follow-up|9
7546185|NCT02522884|26227486|P1|Overall Study|Death|3
7546186|NCT02522884|26227486|P1|Overall Study|Withdrawal by Subject|6
7546187|NCT02522780|26227518|P2|Overall Study|Adverse event, non-fatal|16
7546188|NCT02522780|26227519|P1|Overall Study|Adverse event, non-fatal|11
7546189|NCT02522780|26227518|P2|Overall Study|Subject refused endoscopic procedure|1
7546190|NCT02522780|26227519|P1|Overall Study|Subject refused endoscopic procedure|0
7546191|NCT02522780|26227518|P2|Overall Study|Protocol deviation|3
7546192|NCT02522780|26227519|P1|Overall Study|Protocol deviation|1
7546193|NCT02522780|26227518|P2|Overall Study|Consent withdrawn by subject|7
7546194|NCT02522780|26227519|P1|Overall Study|Consent withdrawn by subject|5
7546195|NCT02522767|26227549|P2|Open-label|Protocol Violation|1
7546196|NCT02522767|26227550|P1|Open-label|Protocol Violation|0
7546197|NCT02522767|26227549|P2|Open-label|Lack of Efficacy|1
7546198|NCT02522767|26227550|P1|Open-label|Lack of Efficacy|1
7546199|NCT02522767|26227549|P2|Open-label|Adverse Event|1
7546200|NCT02522767|26227550|P1|Open-label|Adverse Event|2
7546201|NCT02522767|26227549|P2|Open-label|Lost to Follow-up|1
7546202|NCT02522767|26227550|P1|Open-label|Lost to Follow-up|0
7546203|NCT02522767|26227549|P2|Open-label|Withdrawal by Subject|3
7546204|NCT02522767|26227550|P1|Open-label|Withdrawal by Subject|2
7546205|NCT02522767|26227549|P2|Double-blind|Protocol Deviation|0
7546206|NCT02522767|26227550|P1|Double-blind|Protocol Deviation|1
7546207|NCT02522767|26227549|P2|Double-blind|Lack of Efficacy|2
7546208|NCT02522767|26227550|P1|Double-blind|Lack of Efficacy|0
7546209|NCT02522767|26227549|P2|Double-blind|Protocol Violation|1
7546210|NCT02522767|26227550|P1|Double-blind|Protocol Violation|0
7546211|NCT02522767|26227549|P2|Double-blind|Adverse Event|10
7546212|NCT02522767|26227550|P1|Double-blind|Adverse Event|1
7546213|NCT02522767|26227549|P2|Double-blind|Lost to Follow-up|0
7546214|NCT02522767|26227550|P1|Double-blind|Lost to Follow-up|1
7546215|NCT02522767|26227549|P2|Double-blind|Withdrawal by Subject|11
7546216|NCT02522767|26227550|P1|Double-blind|Withdrawal by Subject|8
7546217|NCT02522728|26227592|P2|Overall Study|Did not receive randomized study device|1
7546218|NCT02522728|26227593|P1|Overall Study|Did not receive randomized study device|0
7546219|NCT02522728|26227592|P2|Overall Study|Adverse Event|1
7546220|NCT02522728|26227593|P1|Overall Study|Adverse Event|2
7546221|NCT02522728|26227592|P2|Overall Study|Death|3
7546222|NCT02522728|26227593|P1|Overall Study|Death|4
7546223|NCT02522728|26227592|P2|Overall Study|Withdrawal by Subject|6
7546224|NCT02522728|26227593|P1|Overall Study|Withdrawal by Subject|6
7546225|NCT02522624|26227620|P2|Overall Study|Technical failure|0
7546226|NCT02522624|26227621|P1|Overall Study|Technical failure|1
7546227|NCT02522494|26227639|P2|Overall Study|Death|1
7546228|NCT02522494|26227640|P1|Overall Study|Death|0
7546313|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Progressive Disease|17
7546229|NCT02522494|26227639|P2|Overall Study|Participant did not watch the video|0
7546230|NCT02522494|26227640|P1|Overall Study|Participant did not watch the video|1
7546231|NCT02522494|26227639|P2|Overall Study|CVT visit cancelled or no-show for CVT visit|2
7546232|NCT02522494|26227640|P1|Overall Study|CVT visit cancelled or no-show for CVT visit|6
7546233|NCT02522494|26227639|P2|Overall Study|Withdrawal by Subject|0
7546234|NCT02522494|26227640|P1|Overall Study|Withdrawal by Subject|1
7546235|NCT02522494|26227639|P2|Overall Study|Lost to Follow-up|2
7546236|NCT02522494|26227640|P1|Overall Study|Lost to Follow-up|6
7546237|NCT02522481|26227668|P1|Overall Study|Not dosed|2
7546238|NCT02522481|26227668|P1|Overall Study|discontinued|1
7546239|NCT02522403|26227698|P2|Overall Study|Withdrawal by Subject|4
7546240|NCT02522403|26227699|P1|Overall Study|Withdrawal by Subject|2
7546241|NCT02522403|26227698|P2|Overall Study|Lost to Follow-up|2
7546242|NCT02522403|26227699|P1|Overall Study|Lost to Follow-up|2
7546243|NCT02522377|26227711|P2|Overall Study|Remission Achieved|0
7546244|NCT02522377|26227712|P1|Overall Study|Remission Achieved|3
7546245|NCT02522377|26227711|P2|Overall Study|Withdrawal by Subject|0
7546246|NCT02522377|26227712|P1|Overall Study|Withdrawal by Subject|1
7546247|NCT02522325|26227728|P2|Overall Study|Adverse Event|1
7546248|NCT02522325|26227729|P1|Overall Study|Adverse Event|0
7546249|NCT02522299|26227737|P2|Overall Study|Withdrawal by Subject|0
7546250|NCT02522299|26227738|P1|Overall Study|Withdrawal by Subject|2
7546251|NCT02522299|26227737|P2|Overall Study|Physician Decision|1
7546252|NCT02522299|26227738|P1|Overall Study|Physician Decision|0
7546253|NCT02522299|26227737|P2|Overall Study|Adverse Event|0
7546254|NCT02522299|26227738|P1|Overall Study|Adverse Event|2
7546255|NCT02522286|26227821|P4|Overall Study|Withdrawal by Subject|3
7546256|NCT02522286|26227822|P3|Overall Study|Withdrawal by Subject|0
7546257|NCT02522286|26227823|P2|Overall Study|Withdrawal by Subject|0
7546258|NCT02522286|26227824|P1|Overall Study|Withdrawal by Subject|3
7546259|NCT02521948|26227897|P1|Overall Study|Did not attend one or both follow-ups|6
7546260|NCT02521948|26227897|P1|Overall Study|Lost to Follow-up|1
7546261|NCT02521948|26227897|P1|Overall Study|Death|4
7546262|NCT02521948|26227897|P1|Overall Study|Adverse Event|2
7546263|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546264|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546265|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546266|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546267|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546268|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546269|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546270|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
7546271|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546272|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546273|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546274|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7546275|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Lost to Follow-up|0
7546276|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Lost to Follow-up|0
7546277|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Lost to Follow-up|0
7546278|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Lost to Follow-up|0
7546279|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Lost to Follow-up|0
7546280|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Lost to Follow-up|0
7546281|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Lost to Follow-up|0
7546282|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Lost to Follow-up|1
7546283|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Lost to Follow-up|0
7546284|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Lost to Follow-up|0
7546285|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Lost to Follow-up|0
7546286|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Lost to Follow-up|0
7546287|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Other|7
7546288|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Other|1
7546289|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Other|5
7546290|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Other|10
7546291|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Other|0
7546292|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Other|2
7546293|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Other|3
7546294|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Other|10
7546295|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Other|0
7546296|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Other|0
7546297|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Other|0
7546298|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Other|0
7546299|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Death|2
7546300|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Death|2
7546301|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Death|5
7546302|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Death|1
7546303|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Death|1
7546304|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Death|3
7546305|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Death|1
7546306|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Death|1
7546307|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Death|0
7546308|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Death|0
7546309|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Death|0
7546310|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Death|0
7546311|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Progressive Disease|21
7546312|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Progressive Disease|17
7546314|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Progressive Disease|5
7546315|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Progressive Disease|7
7546316|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Progressive Disease|17
7546317|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Progressive Disease|18
7546318|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Progressive Disease|22
7546319|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Progressive Disease|0
7546320|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Progressive Disease|0
7546321|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Progressive Disease|0
7546322|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Progressive Disease|0
7546323|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Adverse Event|0
7546324|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Adverse Event|1
7546325|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Adverse Event|0
7546326|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Adverse Event|5
7546327|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Adverse Event|1
7546328|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Adverse Event|0
7546329|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Adverse Event|2
7546330|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Adverse Event|11
7546331|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Adverse Event|0
7546332|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Adverse Event|0
7546333|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Adverse Event|0
7546334|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Adverse Event|0
7546335|NCT02521870|26227914|P12|Phase 2: Dose Expansion|Withdrawal by Subject|0
7546336|NCT02521870|26227915|P11|Phase 2: Dose Expansion|Withdrawal by Subject|2
7546337|NCT02521870|26227916|P10|Phase 2: Dose Expansion|Withdrawal by Subject|1
7546338|NCT02521870|26227917|P9|Phase 2: Dose Expansion|Withdrawal by Subject|1
7546339|NCT02521870|26227918|P8|Phase 2: Dose Expansion|Withdrawal by Subject|0
7546340|NCT02521870|26227919|P7|Phase 2: Dose Expansion|Withdrawal by Subject|1
7546341|NCT02521870|26227920|P6|Phase 2: Dose Expansion|Withdrawal by Subject|1
7546342|NCT02521870|26227921|P5|Phase 2: Dose Expansion|Withdrawal by Subject|5
7546343|NCT02521870|26227922|P4|Phase 2: Dose Expansion|Withdrawal by Subject|0
7546344|NCT02521870|26227923|P3|Phase 2: Dose Expansion|Withdrawal by Subject|0
7546345|NCT02521870|26227924|P2|Phase 2: Dose Expansion|Withdrawal by Subject|0
7546346|NCT02521870|26227925|P1|Phase 2: Dose Expansion|Withdrawal by Subject|0
7546347|NCT02521870|26227914|P12|Phase 1: Dose Escalation|Progressive Disease|0
7546348|NCT02521870|26227915|P11|Phase 1: Dose Escalation|Progressive Disease|0
7546349|NCT02521870|26227916|P10|Phase 1: Dose Escalation|Progressive Disease|0
7546350|NCT02521870|26227917|P9|Phase 1: Dose Escalation|Progressive Disease|0
7546351|NCT02521870|26227918|P8|Phase 1: Dose Escalation|Progressive Disease|0
7546352|NCT02521870|26227919|P7|Phase 1: Dose Escalation|Progressive Disease|0
7546353|NCT02521870|26227920|P6|Phase 1: Dose Escalation|Progressive Disease|0
7546354|NCT02521870|26227921|P5|Phase 1: Dose Escalation|Progressive Disease|0
7546355|NCT02521870|26227922|P4|Phase 1: Dose Escalation|Progressive Disease|6
7546356|NCT02521870|26227923|P3|Phase 1: Dose Escalation|Progressive Disease|4
7546357|NCT02521870|26227924|P2|Phase 1: Dose Escalation|Progressive Disease|2
7546358|NCT02521870|26227925|P1|Phase 1: Dose Escalation|Progressive Disease|3
7546359|NCT02521870|26227914|P12|Phase 1: Dose Escalation|Adverse Event|0
7546360|NCT02521870|26227915|P11|Phase 1: Dose Escalation|Adverse Event|0
7546361|NCT02521870|26227916|P10|Phase 1: Dose Escalation|Adverse Event|0
7546362|NCT02521870|26227917|P9|Phase 1: Dose Escalation|Adverse Event|0
7546363|NCT02521870|26227918|P8|Phase 1: Dose Escalation|Adverse Event|0
7546364|NCT02521870|26227919|P7|Phase 1: Dose Escalation|Adverse Event|0
7546365|NCT02521870|26227920|P6|Phase 1: Dose Escalation|Adverse Event|0
7546366|NCT02521870|26227921|P5|Phase 1: Dose Escalation|Adverse Event|0
7546367|NCT02521870|26227922|P4|Phase 1: Dose Escalation|Adverse Event|0
7546368|NCT02521870|26227923|P3|Phase 1: Dose Escalation|Adverse Event|0
7546369|NCT02521870|26227924|P2|Phase 1: Dose Escalation|Adverse Event|1
7546370|NCT02521870|26227925|P1|Phase 1: Dose Escalation|Adverse Event|2
7546371|NCT02521870|26227914|P12|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546372|NCT02521870|26227915|P11|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546373|NCT02521870|26227916|P10|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546374|NCT02521870|26227917|P9|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546375|NCT02521870|26227918|P8|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546376|NCT02521870|26227919|P7|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546377|NCT02521870|26227920|P6|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546378|NCT02521870|26227921|P5|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546379|NCT02521870|26227922|P4|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546380|NCT02521870|26227923|P3|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546381|NCT02521870|26227924|P2|Phase 1: Dose Escalation|Withdrawal by Subject|1
7546382|NCT02521870|26227925|P1|Phase 1: Dose Escalation|Withdrawal by Subject|0
7546383|NCT02521792|26227987|P1|Overall Study|Study Terminated|6
7546384|NCT02521376|26228037|P4|Overall Study|Enrolled, But Not Treated|0
7546385|NCT02521376|26228038|P3|Overall Study|Enrolled, But Not Treated|0
7546386|NCT02521376|26228039|P2|Overall Study|Enrolled, But Not Treated|0
7546387|NCT02521376|26228040|P1|Overall Study|Enrolled, But Not Treated|1
7546388|NCT02520726|26228094|P2|Overall Study|Lost to Follow-up|2
7546389|NCT02520726|26228095|P1|Overall Study|Lost to Follow-up|3
7546390|NCT02520531|26228105|P2|Overall Study|Not study device|0
7546391|NCT02520531|26228106|P1|Overall Study|Not study device|1
7546392|NCT02520531|26228105|P2|Overall Study|Withdrawal by Subject|0
7546393|NCT02520531|26228106|P1|Overall Study|Withdrawal by Subject|1
7546394|NCT02520531|26228105|P2|Overall Study|Meet exclusion criterion|1
7546395|NCT02520531|26228106|P1|Overall Study|Meet exclusion criterion|0
7546396|NCT02520531|26228105|P2|Overall Study|Lost to Follow-up|1
7546397|NCT02520531|26228106|P1|Overall Study|Lost to Follow-up|1
7546398|NCT02520531|26228105|P2|Overall Study|Death|2
7546399|NCT02520531|26228106|P1|Overall Study|Death|1
7546400|NCT02520531|26228105|P2|Overall Study|Revision of study device components|2
7546401|NCT02520531|26228106|P1|Overall Study|Revision of study device components|2
7546402|NCT02520388|26228191|P2|Overall Study|Other (reason not defined)|4
7546403|NCT02520388|26228192|P1|Overall Study|Other (reason not defined)|4
7546404|NCT02520388|26228191|P2|Overall Study|Lost to Follow-up|2
7546405|NCT02520388|26228192|P1|Overall Study|Lost to Follow-up|3
7546406|NCT02520388|26228191|P2|Overall Study|Adverse Event|4
7546407|NCT02520388|26228192|P1|Overall Study|Adverse Event|1
7546408|NCT02520388|26228191|P2|Overall Study|Subject or parent/guardian request|6
7546409|NCT02520388|26228192|P1|Overall Study|Subject or parent/guardian request|0
7546410|NCT02520388|26228191|P2|Overall Study|Physician Decision|0
7546411|NCT02520388|26228192|P1|Overall Study|Physician Decision|1
7546412|NCT02520310|26228200|P1|AT 4 Year Clinical Follow-up|missed visit|1
7546413|NCT02520310|26228200|P1|AT 4 Year Clinical Follow-up|Death|1
7546414|NCT02520310|26228200|P1|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
7546415|NCT02520310|26228200|P1|AT 3 Year Clinical Follow-up|Death|2
7546416|NCT02520310|26228200|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
7546417|NCT02520310|26228200|P1|At 6 Months Clinical Follow-up|Death|1
7546418|NCT02520284|26228400|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7546419|NCT02520284|26228401|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7546420|NCT02520284|26228402|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
7546421|NCT02520284|26228400|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
7546422|NCT02520284|26228401|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
7546423|NCT02520284|26228402|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
7546424|NCT02520284|26228400|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
7546425|NCT02520284|26228401|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
7546426|NCT02520284|26228402|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
7546427|NCT02520284|26228400|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
7546428|NCT02520284|26228401|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
7546429|NCT02520284|26228402|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
7546430|NCT02520284|26228400|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7546431|NCT02520284|26228401|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
7546432|NCT02520284|26228402|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7546433|NCT02520284|26228400|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
7546434|NCT02520284|26228401|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7546435|NCT02520284|26228402|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7546436|NCT02520284|26228400|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
7546437|NCT02520284|26228401|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7546438|NCT02520284|26228402|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7546439|NCT02520284|26228400|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
7546440|NCT02520284|26228401|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
7546441|NCT02520284|26228402|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
7546442|NCT02520284|26228400|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
7546443|NCT02520284|26228401|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7546444|NCT02520284|26228402|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7546445|NCT02520284|26228400|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7546446|NCT02520284|26228401|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7546447|NCT02520284|26228402|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7546448|NCT02520284|26228400|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
7546449|NCT02520284|26228401|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
7546450|NCT02520284|26228402|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
7546451|NCT02520089|26228436|P2|Overall Study|Lost to Follow-up|4
7546452|NCT02520089|26228437|P1|Overall Study|Lost to Follow-up|3
7546453|NCT02520011|26228448|P3|Overall Study|Progressive disease following response|2
7546454|NCT02520011|26228449|P2|Overall Study|Progressive disease following response|4
7546455|NCT02520011|26228450|P1|Overall Study|Progressive disease following response|0
7546456|NCT02520011|26228448|P3|Overall Study|Patient went to hospice|0
7546457|NCT02520011|26228449|P2|Overall Study|Patient went to hospice|1
7546458|NCT02520011|26228450|P1|Overall Study|Patient went to hospice|0
7546459|NCT02520011|26228448|P3|Overall Study|Protocol Deviation|0
7546460|NCT02520011|26228449|P2|Overall Study|Protocol Deviation|1
7546461|NCT02520011|26228450|P1|Overall Study|Protocol Deviation|0
7546462|NCT02520011|26228448|P3|Overall Study|Withdrawal by Subject|0
7546463|NCT02520011|26228449|P2|Overall Study|Withdrawal by Subject|3
7546464|NCT02520011|26228450|P1|Overall Study|Withdrawal by Subject|1
7546465|NCT02520011|26228448|P3|Overall Study|Physician Decision|0
7546466|NCT02520011|26228449|P2|Overall Study|Physician Decision|2
7546467|NCT02520011|26228450|P1|Overall Study|Physician Decision|0
7546468|NCT02520011|26228448|P3|Overall Study|Lack of Efficacy|4
7546469|NCT02520011|26228449|P2|Overall Study|Lack of Efficacy|26
7546470|NCT02520011|26228450|P1|Overall Study|Lack of Efficacy|4
7546471|NCT02520011|26228448|P3|Overall Study|Death|1
7546472|NCT02520011|26228449|P2|Overall Study|Death|8
7546473|NCT02520011|26228450|P1|Overall Study|Death|0
7546474|NCT02520011|26228448|P3|Overall Study|Adverse Event|2
7546475|NCT02520011|26228449|P2|Overall Study|Adverse Event|1
7546476|NCT02520011|26228450|P1|Overall Study|Adverse Event|0
7546477|NCT02519855|26228465|P2|Overall Study|Lost to Follow-up|3
7546478|NCT02519855|26228466|P1|Overall Study|Lost to Follow-up|3
7546479|NCT02519855|26228465|P2|Overall Study|Adverse Event|1
7546480|NCT02519855|26228466|P1|Overall Study|Adverse Event|0
7546481|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
7546482|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7546483|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7546484|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
7546485|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7546486|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7546487|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
7546488|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7546489|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7546490|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
7546491|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7546492|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7546493|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Death|1
7546494|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Death|0
7546495|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Death|0
7546496|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
7546497|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7546498|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7546499|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
7546500|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7546501|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7546502|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Adverse Event|1
7546503|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Adverse Event|0
7546504|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Adverse Event|0
7546505|NCT02519842|26228484|P3|Optional Extension: Cycles 2-6|Physician Decision|5
7546506|NCT02519842|26228485|P2|Optional Extension: Cycles 2-6|Physician Decision|0
7546507|NCT02519842|26228486|P1|Optional Extension: Cycles 2-6|Physician Decision|0
7546508|NCT02519842|26228484|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
7546509|NCT02519842|26228485|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
7546510|NCT02519842|26228486|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
7546511|NCT02519842|26228484|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7546512|NCT02519842|26228485|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
7546513|NCT02519842|26228486|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7546514|NCT02519842|26228484|P3|Base Study: Cycle 1|Adverse Event|0
7546515|NCT02519842|26228485|P2|Base Study: Cycle 1|Adverse Event|0
7546516|NCT02519842|26228486|P1|Base Study: Cycle 1|Adverse Event|1
7546517|NCT02519842|26228484|P3|Base Study: Cycle 1|Screening Failure|0
7546518|NCT02519842|26228485|P2|Base Study: Cycle 1|Screening Failure|1
7546519|NCT02519842|26228486|P1|Base Study: Cycle 1|Screening Failure|1
7546520|NCT02519712|26228505|P1|Overall Study|Accruals are donors|2
7546521|NCT02519712|26228505|P1|Overall Study|Disease Progression|1
7546522|NCT02519712|26228505|P1|Overall Study|Disease Relapse|1
7546523|NCT02519595|26228534|P3|Overall Study|Protocol Violation|16
7546524|NCT02519595|26228535|P2|Overall Study|Protocol Violation|22
7546525|NCT02519595|26228536|P1|Overall Study|Protocol Violation|8
7546526|NCT02519504|26228561|P2|Overall Study|Did not participate in direct testing|86
7546527|NCT02519504|26228562|P1|Overall Study|Did not participate in direct testing|95
7546528|NCT02519504|26228561|P2|Overall Study|Ineligible for direct testing|12
7546529|NCT02519504|26228562|P1|Overall Study|Ineligible for direct testing|12
7546530|NCT02519504|26228561|P2|Overall Study|Protocol Violation|5
7546531|NCT02519504|26228562|P1|Overall Study|Protocol Violation|6
7546532|NCT02519231|26228670|P2|Overall Study|Withdrawal by Subject|1
7546533|NCT02519231|26228671|P1|Overall Study|Withdrawal by Subject|0
7546534|NCT02519231|26228670|P2|Overall Study|Lost to Follow-up|5
7546535|NCT02519231|26228671|P1|Overall Study|Lost to Follow-up|2
7546536|NCT02518971|26228787|P2|Overall Study|eligibility criteria no longer met|3
7546537|NCT02518971|26228788|P1|Overall Study|eligibility criteria no longer met|6
7546538|NCT02518971|26228787|P2|Overall Study|medication lost in mail|1
7546539|NCT02518971|26228788|P1|Overall Study|medication lost in mail|0
7546540|NCT02518971|26228787|P2|Overall Study|Side effects|0
7546541|NCT02518971|26228788|P1|Overall Study|Side effects|1
7546542|NCT02518971|26228787|P2|Overall Study|Withdrawal by Subject|5
7546543|NCT02518971|26228788|P1|Overall Study|Withdrawal by Subject|4
7546544|NCT02518971|26228787|P2|Overall Study|Protocol Violation|4
7546545|NCT02518971|26228788|P1|Overall Study|Protocol Violation|6
7546546|NCT02518971|26228787|P2|Overall Study|Physician Decision|6
7546547|NCT02518971|26228788|P1|Overall Study|Physician Decision|6
7546548|NCT02518971|26228787|P2|Overall Study|Lost to Follow-up|1
7546549|NCT02518971|26228788|P1|Overall Study|Lost to Follow-up|0
7546550|NCT02518919|26228808|P3|Overall Study|Protocol Violation|2
7546551|NCT02518919|26228809|P2|Overall Study|Protocol Violation|1
7546552|NCT02518919|26228810|P1|Overall Study|Protocol Violation|1
7546553|NCT02518685|26228840|P2|Overall Study|Lost to Follow-up|4
7546554|NCT02518685|26228841|P1|Overall Study|Lost to Follow-up|1
7546555|NCT02518685|26228840|P2|Overall Study|Physician Decision|0
7546556|NCT02518685|26228841|P1|Overall Study|Physician Decision|1
7546557|NCT02518685|26228840|P2|Overall Study|Pregnancy|0
7546558|NCT02518685|26228841|P1|Overall Study|Pregnancy|1
7546559|NCT02518685|26228840|P2|Overall Study|relocation, study fatigue|2
7546560|NCT02518685|26228841|P1|Overall Study|relocation, study fatigue|7
7546561|NCT02518685|26228840|P2|Overall Study|Withdrawal by Subject|3
7546562|NCT02518685|26228841|P1|Overall Study|Withdrawal by Subject|10
7546563|NCT02518685|26228840|P2|Overall Study|Adverse Event|1
7546564|NCT02518685|26228841|P1|Overall Study|Adverse Event|29
7546565|NCT02518620|26228850|P2|Overall Study|Relocation|1
7546566|NCT02518620|26228851|P1|Overall Study|Relocation|2
7546567|NCT02518620|26228850|P2|Overall Study|Pregnancy|0
7546568|NCT02518620|26228851|P1|Overall Study|Pregnancy|1
7546569|NCT02518620|26228850|P2|Overall Study|Pregnancy Wish|0
7546570|NCT02518620|26228851|P1|Overall Study|Pregnancy Wish|3
7546571|NCT02518620|26228850|P2|Overall Study|Death|0
7546572|NCT02518620|26228851|P1|Overall Study|Death|1
7546573|NCT02518620|26228850|P2|Overall Study|Withdrawal by Subject|9
7546574|NCT02518620|26228851|P1|Overall Study|Withdrawal by Subject|17
7546575|NCT02518620|26228850|P2|Overall Study|Lost to Follow-up|1
7546576|NCT02518620|26228851|P1|Overall Study|Lost to Follow-up|1
7546577|NCT02518620|26228850|P2|Overall Study|Sponsor's Decision|3
7546578|NCT02518620|26228851|P1|Overall Study|Sponsor's Decision|0
7546579|NCT02518620|26228850|P2|Overall Study|Physician Decision|1
7546580|NCT02518620|26228851|P1|Overall Study|Physician Decision|1
7546581|NCT02518620|26228850|P2|Overall Study|Non-Compliance with Study Drug|0
7546582|NCT02518620|26228851|P1|Overall Study|Non-Compliance with Study Drug|1
7546583|NCT02518620|26228850|P2|Overall Study|Lack of Efficacy|0
7546584|NCT02518620|26228851|P1|Overall Study|Lack of Efficacy|2
7546585|NCT02518620|26228850|P2|Overall Study|Adverse Event|11
7546586|NCT02518620|26228851|P1|Overall Study|Adverse Event|23
7546587|NCT02518490|26228874|P2|Overall Study|Withdrawal by Subject|1
7546588|NCT02518490|26228875|P1|Overall Study|Withdrawal by Subject|1
7546589|NCT02518464|26228893|P1|Overall Study|Adverse Event|2
7546590|NCT02518113|26228935|P4|Overall Study|Progressive Disease|0
7546591|NCT02518113|26228936|P3|Overall Study|Progressive Disease|3
7546592|NCT02518113|26228937|P2|Overall Study|Progressive Disease|2
7546593|NCT02518113|26228938|P1|Overall Study|Progressive Disease|1
7546594|NCT02518113|26228935|P4|Overall Study|Physician Decision|0
7546595|NCT02518113|26228936|P3|Overall Study|Physician Decision|0
7546596|NCT02518113|26228937|P2|Overall Study|Physician Decision|1
7546597|NCT02518113|26228938|P1|Overall Study|Physician Decision|0
7546598|NCT02518113|26228935|P4|Overall Study|Death|0
7546599|NCT02518113|26228936|P3|Overall Study|Death|0
7546600|NCT02518113|26228937|P2|Overall Study|Death|2
7546601|NCT02518113|26228938|P1|Overall Study|Death|1
7546602|NCT02518113|26228935|P4|Overall Study|Adverse Event|0
7546603|NCT02518113|26228936|P3|Overall Study|Adverse Event|1
7546604|NCT02518113|26228937|P2|Overall Study|Adverse Event|0
7546605|NCT02518113|26228938|P1|Overall Study|Adverse Event|1
7546606|NCT02518048|26228979|P1|Overall Study|Withdrawal by Subject|1
7546607|NCT02517905|26229007|P2|Overall Study|Screen failure|2
7546608|NCT02517905|26229008|P1|Overall Study|Screen failure|2
7546609|NCT02517905|26229007|P2|Overall Study|Withdrawal by Subject|0
7546610|NCT02517905|26229008|P1|Overall Study|Withdrawal by Subject|4
7546611|NCT02517905|26229007|P2|Overall Study|Lost to Follow-up|0
7546612|NCT02517905|26229008|P1|Overall Study|Lost to Follow-up|4
7546613|NCT02517866|26229024|P3|Overall Study|Reason not specified|0
7546614|NCT02517866|26229025|P2|Overall Study|Reason not specified|0
7546615|NCT02517866|26229026|P1|Overall Study|Reason not specified|2
7546616|NCT02517866|26229024|P3|Overall Study|Investigator Decision|0
7546617|NCT02517866|26229025|P2|Overall Study|Investigator Decision|1
7546618|NCT02517866|26229026|P1|Overall Study|Investigator Decision|2
7546619|NCT02517866|26229024|P3|Overall Study|Voluntary Withdrawal|0
7546620|NCT02517866|26229025|P2|Overall Study|Voluntary Withdrawal|2
7546621|NCT02517866|26229026|P1|Overall Study|Voluntary Withdrawal|2
7546622|NCT02517866|26229024|P3|Overall Study|Lost to Follow-up|0
7546623|NCT02517866|26229025|P2|Overall Study|Lost to Follow-up|0
7546624|NCT02517866|26229026|P1|Overall Study|Lost to Follow-up|1
7546625|NCT02517866|26229024|P3|Overall Study|Significant Protocol Deviation|0
7546626|NCT02517866|26229025|P2|Overall Study|Significant Protocol Deviation|1
7546627|NCT02517866|26229026|P1|Overall Study|Significant Protocol Deviation|4
7546628|NCT02517866|26229024|P3|Overall Study|Pretreatment Event/Adverse Event|0
7546629|NCT02517866|26229025|P2|Overall Study|Pretreatment Event/Adverse Event|2
7546630|NCT02517866|26229026|P1|Overall Study|Pretreatment Event/Adverse Event|9
7546631|NCT02517541|26229097|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
7546632|NCT02517541|26229097|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
7546633|NCT02517541|26229097|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
7546634|NCT02517541|26229097|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
7546635|NCT02517541|26229097|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
7546636|NCT02517541|26229097|P1|Baseline Period (Own Product)|Protocol Violation|1
7546637|NCT02517528|26229103|P1|Overall Study|Withdrawal by Subject|1
7546638|NCT02517515|26229113|P2|Overall Study|Other|0
7546639|NCT02517515|26229114|P1|Overall Study|Other|1
7546640|NCT02517515|26229113|P2|Overall Study|Lost to Follow-up|0
7546641|NCT02517515|26229114|P1|Overall Study|Lost to Follow-up|1
7546642|NCT02517515|26229113|P2|Overall Study|Withdrew Consent|1
7546643|NCT02517515|26229114|P1|Overall Study|Withdrew Consent|0
7546644|NCT02517515|26229113|P2|Overall Study|Adverse Event|1
7546645|NCT02517515|26229114|P1|Overall Study|Adverse Event|0
7546646|NCT02517463|26229131|P2|Overall Study|Lost to Follow-up|2
7546647|NCT02517463|26229132|P1|Overall Study|Lost to Follow-up|5
7546648|NCT02517268|26229144|P2|Overall Study|Withdrawal by Subject|0
7546649|NCT02517268|26229145|P1|Overall Study|Withdrawal by Subject|1
7546650|NCT02516982|26229197|P4|Overall Study|Did not install the app|47
7546651|NCT02516982|26229198|P3|Overall Study|Did not install the app|46
7546652|NCT02516982|26229199|P2|Overall Study|Did not install the app|0
7546653|NCT02516982|26229200|P1|Overall Study|Did not install the app|0
7546654|NCT02516982|26229197|P4|Overall Study|Protocol Violation|1
7546655|NCT02516982|26229198|P3|Overall Study|Protocol Violation|1
7546656|NCT02516982|26229199|P2|Overall Study|Protocol Violation|0
7546657|NCT02516982|26229200|P1|Overall Study|Protocol Violation|0
7546658|NCT02516982|26229197|P4|Overall Study|Withdrawal by Subject|2
7546659|NCT02516982|26229198|P3|Overall Study|Withdrawal by Subject|1
7546660|NCT02516982|26229199|P2|Overall Study|Withdrawal by Subject|0
7546661|NCT02516982|26229200|P1|Overall Study|Withdrawal by Subject|0
7546662|NCT02516982|26229197|P4|Overall Study|Called in to antenatal appointment|0
7546663|NCT02516982|26229198|P3|Overall Study|Called in to antenatal appointment|0
7546664|NCT02516982|26229199|P2|Overall Study|Called in to antenatal appointment|35
7546665|NCT02516982|26229200|P1|Overall Study|Called in to antenatal appointment|32
7546666|NCT02516605|26229227|P5|Overall Study|Withdrawal by Subject|0
7546667|NCT02516605|26229228|P4|Overall Study|Withdrawal by Subject|1
7546668|NCT02516605|26229229|P3|Overall Study|Withdrawal by Subject|0
7546669|NCT02516605|26229230|P2|Overall Study|Withdrawal by Subject|0
7546670|NCT02516605|26229231|P1|Overall Study|Withdrawal by Subject|0
7546671|NCT02516605|26229227|P5|Overall Study|Protocol Violation|1
7546672|NCT02516605|26229228|P4|Overall Study|Protocol Violation|0
7546673|NCT02516605|26229229|P3|Overall Study|Protocol Violation|0
7546674|NCT02516605|26229230|P2|Overall Study|Protocol Violation|0
7546675|NCT02516605|26229231|P1|Overall Study|Protocol Violation|0
7546676|NCT02516592|26229302|P2|Overall Study|Death|1
7546677|NCT02516592|26229303|P1|Overall Study|Death|1
7546678|NCT02516592|26229302|P2|Overall Study|Abnormal test procedure result|0
7546679|NCT02516592|26229303|P1|Overall Study|Abnormal test procedure result|1
7546680|NCT02516592|26229302|P2|Overall Study|Adverse Event|2
7546681|NCT02516592|26229303|P1|Overall Study|Adverse Event|1
7546682|NCT02516592|26229302|P2|Overall Study|Patient/guardian decision|1
7546683|NCT02516592|26229303|P1|Overall Study|Patient/guardian decision|2
7546684|NCT02516592|26229302|P2|Overall Study|Lost to Follow-up|3
7546685|NCT02516592|26229303|P1|Overall Study|Lost to Follow-up|2
7546686|NCT02516592|26229302|P2|Overall Study|Protocol deviation|4
7546687|NCT02516592|26229303|P1|Overall Study|Protocol deviation|4
7546688|NCT02516592|26229302|P2|Overall Study|Patient withdrew consent|2
7546689|NCT02516592|26229303|P1|Overall Study|Patient withdrew consent|5
7546690|NCT02516410|26229325|P2|Overall Study|Withdrawal by Subject|1
7546691|NCT02516410|26229326|P1|Overall Study|Withdrawal by Subject|0
7546692|NCT02516410|26229325|P2|Overall Study|Adverse Event|1
7546693|NCT02516410|26229326|P1|Overall Study|Adverse Event|0
7546694|NCT02516332|26229356|P3|Overall Study|Withdrawal by Subject|2
7546695|NCT02516332|26229357|P2|Overall Study|Withdrawal by Subject|1
7546696|NCT02516332|26229358|P1|Overall Study|Withdrawal by Subject|2
7546697|NCT02516306|26229386|P2|Period 2: Day 8 - 91|Protocol Violation|2
7546698|NCT02516306|26229387|P1|Period 2: Day 8 - 91|Protocol Violation|1
7546699|NCT02516241|26229396|P3|Overall Study|participants ongoing at data cut-off|59
7546700|NCT02516241|26229397|P2|Overall Study|participants ongoing at data cut-off|76
7546701|NCT02516241|26229398|P1|Overall Study|participants ongoing at data cut-off|84
7546702|NCT02516241|26229396|P3|Overall Study|Withdrawal by Subject|12
7546703|NCT02516241|26229397|P2|Overall Study|Withdrawal by Subject|7
7546704|NCT02516241|26229398|P1|Overall Study|Withdrawal by Subject|2
7546705|NCT02516241|26229396|P3|Overall Study|Lost to Follow-up|3
7546706|NCT02516241|26229397|P2|Overall Study|Lost to Follow-up|1
7546707|NCT02516241|26229398|P1|Overall Study|Lost to Follow-up|1
7546708|NCT02516241|26229396|P3|Overall Study|Death|270
7546709|NCT02516241|26229397|P2|Overall Study|Death|262
7546710|NCT02516241|26229398|P1|Overall Study|Death|255
7546711|NCT02516228|26229513|P1|Overall Study|Physician Decision|1
7546712|NCT02516228|26229513|P1|Overall Study|Withdrawal by Subject|1
7546713|NCT02516228|26229513|P1|Overall Study|Lost to Follow-up|1
7546714|NCT02516202|26229524|P3|Overall Study|Stopped Follow-up|1
7546715|NCT02516202|26229525|P2|Overall Study|Stopped Follow-up|0
7546716|NCT02516202|26229526|P1|Overall Study|Stopped Follow-up|0
7546717|NCT02516202|26229524|P3|Overall Study|Lost to Follow-up|1
7546718|NCT02516202|26229525|P2|Overall Study|Lost to Follow-up|1
7546719|NCT02516202|26229526|P1|Overall Study|Lost to Follow-up|1
7546720|NCT02516202|26229524|P3|Overall Study|Withdrawal by Subject|1
7546721|NCT02516202|26229525|P2|Overall Study|Withdrawal by Subject|0
7546722|NCT02516202|26229526|P1|Overall Study|Withdrawal by Subject|1
7546723|NCT02516163|26229552|P1|Overall Study|MRI contraindication exclusion|6
7546724|NCT02516163|26229552|P1|Overall Study|Data not recorded|2
7546725|NCT02516163|26229552|P1|Overall Study|Use of incorrect measurement technique|5
7546726|NCT02516163|26229552|P1|Overall Study|Unfit/delay in surgery|3
7546727|NCT02516163|26229552|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
7546728|NCT02516163|26229552|P1|Overall Study|Withdrawal by Subject|1
7546729|NCT02516098|26229566|P2|Period 2|Withdrawal by Subject|1
7546730|NCT02516098|26229567|P1|Period 2|Withdrawal by Subject|0
7546731|NCT02516098|26229566|P2|Washout After Period 1|Adverse Event|1
7546732|NCT02516098|26229567|P1|Washout After Period 1|Adverse Event|0
7546733|NCT02516098|26229566|P2|Period 1|Protocol Violation|0
7546734|NCT02516098|26229567|P1|Period 1|Protocol Violation|1
7546735|NCT02515994|26229595|P2|Overall Study|Withdrawal by Subject|0
7546736|NCT02515994|26229596|P1|Overall Study|Withdrawal by Subject|2
7546737|NCT02515994|26229595|P2|Overall Study|Adverse Event|1
7546738|NCT02515994|26229596|P1|Overall Study|Adverse Event|3
7546739|NCT02515994|26229595|P2|Overall Study|No Longer Meets Eligibility Criteria|1
7546740|NCT02515994|26229596|P1|Overall Study|No Longer Meets Eligibility Criteria|2
7546741|NCT02515994|26229595|P2|Overall Study|Protocol Violation|5
7546742|NCT02515994|26229596|P1|Overall Study|Protocol Violation|3
7546743|NCT02515942|26229611|P3|Overall Study|Withdrawal by Subject|2
7546744|NCT02515942|26229612|P2|Overall Study|Withdrawal by Subject|3
7546745|NCT02515942|26229613|P1|Overall Study|Withdrawal by Subject|0
7546746|NCT02515942|26229611|P3|Overall Study|Lost to Follow-up|0
7546747|NCT02515942|26229612|P2|Overall Study|Lost to Follow-up|0
7546748|NCT02515942|26229613|P1|Overall Study|Lost to Follow-up|2
7546749|NCT02515942|26229611|P3|Overall Study|Lack of Efficacy|1
7546750|NCT02515942|26229612|P2|Overall Study|Lack of Efficacy|0
7546751|NCT02515942|26229613|P1|Overall Study|Lack of Efficacy|0
7546752|NCT02515942|26229611|P3|Overall Study|Death|1
7546753|NCT02515942|26229612|P2|Overall Study|Death|0
7546754|NCT02515942|26229613|P1|Overall Study|Death|0
7546755|NCT02515942|26229611|P3|Overall Study|Adverse Event|0
7546756|NCT02515942|26229612|P2|Overall Study|Adverse Event|0
7546757|NCT02515942|26229613|P1|Overall Study|Adverse Event|5
7546758|NCT02515669|26229709|P4|228 Week Open-Label Phase|Missing|2
7546759|NCT02515669|26229710|P3|228 Week Open-Label Phase|Missing|2
7546760|NCT02515669|26229711|P2|228 Week Open-Label Phase|Missing|2
7546761|NCT02515669|26229712|P1|228 Week Open-Label Phase|Missing|0
7546762|NCT02515669|26229709|P4|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
7546763|NCT02515669|26229710|P3|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
7546764|NCT02515669|26229711|P2|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
7546765|NCT02515669|26229712|P1|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
7546766|NCT02515669|26229709|P4|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
7546767|NCT02515669|26229710|P3|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
7546768|NCT02515669|26229711|P2|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7546769|NCT02515669|26229712|P1|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7546770|NCT02515669|26229709|P4|228 Week Open-Label Phase|Lack of Efficacy|0
7546771|NCT02515669|26229710|P3|228 Week Open-Label Phase|Lack of Efficacy|1
7546772|NCT02515669|26229711|P2|228 Week Open-Label Phase|Lack of Efficacy|0
7546773|NCT02515669|26229712|P1|228 Week Open-Label Phase|Lack of Efficacy|0
7546774|NCT02515669|26229709|P4|228 Week Open-Label Phase|Other|4
7546775|NCT02515669|26229710|P3|228 Week Open-Label Phase|Other|1
7546776|NCT02515669|26229711|P2|228 Week Open-Label Phase|Other|0
7546777|NCT02515669|26229712|P1|228 Week Open-Label Phase|Other|0
7546778|NCT02515630|26229809|P1|Overall Study|Disease Progression|1
7546779|NCT02515630|26229809|P1|Overall Study|Death|2
7546780|NCT02515630|26229809|P1|Overall Study|Physician Decision|4
7546781|NCT02515630|26229809|P1|Overall Study|Adverse Event|4
7546782|NCT02515630|26229809|P1|Overall Study|Withdrawal by Subject|5
7546783|NCT02515331|26229882|P3|Overall Study|Adverse Event|0
7546784|NCT02515331|26229883|P2|Overall Study|Adverse Event|0
7546785|NCT02515331|26229884|P1|Overall Study|Adverse Event|2
7546786|NCT02515331|26229882|P3|Overall Study|Protocol deviation|3
7546787|NCT02515331|26229883|P2|Overall Study|Protocol deviation|0
7546788|NCT02515331|26229884|P1|Overall Study|Protocol deviation|0
7546789|NCT02515331|26229882|P3|Overall Study|Withdrawal by Subject|1
7546790|NCT02515331|26229883|P2|Overall Study|Withdrawal by Subject|0
7546791|NCT02515331|26229884|P1|Overall Study|Withdrawal by Subject|0
7546792|NCT02515279|26229921|P1|Overall Study|Other|22
7546793|NCT02515279|26229921|P1|Overall Study|End-of-treatment visit not attended|17
7546794|NCT02515279|26229921|P1|Overall Study|Withdrawal by Subject|18
7546795|NCT02515279|26229921|P1|Overall Study|Lost to Follow-up|9
7546796|NCT02515279|26229921|P1|Overall Study|Lack of Efficacy|31
7546797|NCT02515279|26229921|P1|Overall Study|Adverse Event|7
7546798|NCT02515097|26229940|P2|Overall Study|Adverse Event|1
7546799|NCT02515097|26229941|P1|Overall Study|Adverse Event|2
7546800|NCT02515097|26229940|P2|Overall Study|Withdrawal by Subject|3
7546801|NCT02515097|26229941|P1|Overall Study|Withdrawal by Subject|1
7546802|NCT02515097|26229940|P2|Overall Study|Lost to Follow-up|2
7546803|NCT02515097|26229941|P1|Overall Study|Lost to Follow-up|4
7546804|NCT02515045|26229962|P3|Overall Study|Lost to Follow-up|1
7546805|NCT02515045|26229963|P2|Overall Study|Lost to Follow-up|1
7546806|NCT02515045|26229964|P1|Overall Study|Lost to Follow-up|0
7546807|NCT02515045|26229962|P3|Overall Study|Adverse Event|3
7546808|NCT02515045|26229963|P2|Overall Study|Adverse Event|3
7546809|NCT02515045|26229964|P1|Overall Study|Adverse Event|0
7546810|NCT02514824|26230001|P4|Overall Study|Dose-Limiting Toxicity|0
7546811|NCT02514824|26230002|P3|Overall Study|Dose-Limiting Toxicity|0
7546812|NCT02514824|26230003|P2|Overall Study|Dose-Limiting Toxicity|1
7546813|NCT02514824|26230004|P1|Overall Study|Dose-Limiting Toxicity|0
7546814|NCT02514824|26230001|P4|Overall Study|Withdrawal by Subject|0
7546815|NCT02514824|26230002|P3|Overall Study|Withdrawal by Subject|0
7546816|NCT02514824|26230003|P2|Overall Study|Withdrawal by Subject|0
7546817|NCT02514824|26230004|P1|Overall Study|Withdrawal by Subject|1
7546818|NCT02514772|26230015|P2|Overall Study|Withdrawal by Subject|1
7546819|NCT02514772|26230016|P1|Overall Study|Withdrawal by Subject|2
7546820|NCT02514772|26230015|P2|Overall Study|Death|1
7546821|NCT02514772|26230016|P1|Overall Study|Death|0
7546822|NCT02514772|26230015|P2|Overall Study|Adverse Event|0
7546823|NCT02514772|26230016|P1|Overall Study|Adverse Event|1
7546824|NCT02514746|26230030|P2|Overall Study|Other|1
7546825|NCT02514746|26230031|P1|Overall Study|Other|5
7546826|NCT02514746|26230030|P2|Overall Study|Withdrawal by Subject|10
7546827|NCT02514746|26230031|P1|Overall Study|Withdrawal by Subject|12
7546828|NCT02514746|26230030|P2|Overall Study|Physician Decision|2
7546829|NCT02514746|26230031|P1|Overall Study|Physician Decision|4
7546830|NCT02514746|26230030|P2|Overall Study|Chronically Ill|2
7546831|NCT02514746|26230031|P1|Overall Study|Chronically Ill|1
7546832|NCT02514577|26230068|P2|Overall Study|Adverse Event|1
7546833|NCT02514577|26230069|P1|Overall Study|Adverse Event|1
7546834|NCT02514577|26230068|P2|Overall Study|Withdrawal by Subject|6
7546835|NCT02514577|26230069|P1|Overall Study|Withdrawal by Subject|6
7546836|NCT02514577|26230068|P2|Overall Study|Protocol Violation|0
7546837|NCT02514577|26230069|P1|Overall Study|Protocol Violation|1
7546838|NCT02514577|26230068|P2|Overall Study|Lost to Follow-up|6
7546839|NCT02514577|26230069|P1|Overall Study|Lost to Follow-up|6
7546840|NCT02514551|26230079|P2|Overall Study|Participant Never Treated|2
7546841|NCT02514551|26230080|P1|Overall Study|Participant Never Treated|0
7546842|NCT02514551|26230079|P2|Overall Study|Lost to Follow-up|1
7546843|NCT02514551|26230080|P1|Overall Study|Lost to Follow-up|0
7546844|NCT02514473|26230097|P2|Overall Study|Other|1
7546845|NCT02514473|26230098|P1|Overall Study|Other|1
7546846|NCT02514473|26230097|P2|Overall Study|Lost to Follow-up|1
7546847|NCT02514473|26230098|P1|Overall Study|Lost to Follow-up|0
7546848|NCT02514473|26230097|P2|Overall Study|Withdrawal by Subject|1
7546849|NCT02514473|26230098|P1|Overall Study|Withdrawal by Subject|2
7546850|NCT02514473|26230097|P2|Overall Study|Adverse Event|2
7546851|NCT02514473|26230098|P1|Overall Study|Adverse Event|0
7546852|NCT02514239|26230155|P10|Overall Study|Progressive disease|0
7546853|NCT02514239|26230156|P9|Overall Study|Progressive disease|5
7546854|NCT02514239|26230157|P8|Overall Study|Progressive disease|2
7546855|NCT02514239|26230158|P7|Overall Study|Progressive disease|4
7546856|NCT02514239|26230159|P6|Overall Study|Progressive disease|3
7546857|NCT02514239|26230160|P5|Overall Study|Progressive disease|3
7546858|NCT02514239|26230161|P4|Overall Study|Progressive disease|2
7546859|NCT02514239|26230162|P3|Overall Study|Progressive disease|2
7546860|NCT02514239|26230163|P2|Overall Study|Progressive disease|3
7546861|NCT02514239|26230164|P1|Overall Study|Progressive disease|3
7546862|NCT02514239|26230155|P10|Overall Study|Other Adverse Events|0
7546863|NCT02514239|26230156|P9|Overall Study|Other Adverse Events|2
7546864|NCT02514239|26230157|P8|Overall Study|Other Adverse Events|1
7546865|NCT02514239|26230158|P7|Overall Study|Other Adverse Events|0
7546866|NCT02514239|26230159|P6|Overall Study|Other Adverse Events|1
7546867|NCT02514239|26230160|P5|Overall Study|Other Adverse Events|0
7546868|NCT02514239|26230161|P4|Overall Study|Other Adverse Events|1
7546869|NCT02514239|26230162|P3|Overall Study|Other Adverse Events|0
7546870|NCT02514239|26230163|P2|Overall Study|Other Adverse Events|0
7546871|NCT02514239|26230164|P1|Overall Study|Other Adverse Events|2
7546872|NCT02514239|26230155|P10|Overall Study|Not treated|0
7546873|NCT02514239|26230156|P9|Overall Study|Not treated|0
7546874|NCT02514239|26230157|P8|Overall Study|Not treated|0
7546875|NCT02514239|26230158|P7|Overall Study|Not treated|0
7546876|NCT02514239|26230159|P6|Overall Study|Not treated|0
7546877|NCT02514239|26230160|P5|Overall Study|Not treated|0
7546878|NCT02514239|26230161|P4|Overall Study|Not treated|0
7546879|NCT02514239|26230162|P3|Overall Study|Not treated|0
7546880|NCT02514239|26230163|P2|Overall Study|Not treated|1
7546881|NCT02514239|26230164|P1|Overall Study|Not treated|0
7546882|NCT02514239|26230155|P10|Overall Study|Dose-limiting toxicity (DLT)|2
7546883|NCT02514239|26230156|P9|Overall Study|Dose-limiting toxicity (DLT)|1
7546884|NCT02514239|26230157|P8|Overall Study|Dose-limiting toxicity (DLT)|0
7546885|NCT02514239|26230158|P7|Overall Study|Dose-limiting toxicity (DLT)|0
7546886|NCT02514239|26230159|P6|Overall Study|Dose-limiting toxicity (DLT)|0
7546887|NCT02514239|26230160|P5|Overall Study|Dose-limiting toxicity (DLT)|0
7546888|NCT02514239|26230161|P4|Overall Study|Dose-limiting toxicity (DLT)|0
7546889|NCT02514239|26230162|P3|Overall Study|Dose-limiting toxicity (DLT)|0
7546890|NCT02514239|26230163|P2|Overall Study|Dose-limiting toxicity (DLT)|0
7546891|NCT02514239|26230164|P1|Overall Study|Dose-limiting toxicity (DLT)|0
7546892|NCT02514239|26230155|P10|Overall Study|Refused to continue trial medication|1
7546893|NCT02514239|26230156|P9|Overall Study|Refused to continue trial medication|0
7546894|NCT02514239|26230157|P8|Overall Study|Refused to continue trial medication|0
7546895|NCT02514239|26230158|P7|Overall Study|Refused to continue trial medication|0
7546896|NCT02514239|26230159|P6|Overall Study|Refused to continue trial medication|0
7546897|NCT02514239|26230160|P5|Overall Study|Refused to continue trial medication|0
7546898|NCT02514239|26230161|P4|Overall Study|Refused to continue trial medication|0
7546899|NCT02514239|26230162|P3|Overall Study|Refused to continue trial medication|0
7546900|NCT02514239|26230163|P2|Overall Study|Refused to continue trial medication|0
7546901|NCT02514239|26230164|P1|Overall Study|Refused to continue trial medication|0
7546902|NCT02514174|26230284|P1|Overall Study|Treated off study with Afatinib.|1
7546903|NCT02514174|26230284|P1|Overall Study|Treatment change|1
7546904|NCT02514174|26230284|P1|Overall Study|Progressive disease|11
7546905|NCT02514174|26230284|P1|Overall Study|Study closed by sponsor|9
7546906|NCT02514174|26230284|P1|Overall Study|Adverse Event|2
7546907|NCT02514174|26230284|P1|Overall Study|Patient refused to continue medication|1
7546908|NCT02514122|26230295|P2|Overall Study|Withdrawal by Subject|0
7546909|NCT02514122|26230296|P1|Overall Study|Withdrawal by Subject|2
7546910|NCT02514083|26230304|P1|Overall Study|Adverse Event|1
7546911|NCT02513823|26230362|P1|Overall Study|Physician Decision|1
7546912|NCT02513823|26230362|P1|Overall Study|Lost to Follow-up|4
7546913|NCT02513771|26230369|P2|Overall Study|Not being able to get to clinic|0
7546914|NCT02513771|26230370|P1|Overall Study|Not being able to get to clinic|1
7546915|NCT02513771|26230369|P2|Overall Study|Lost to Follow-up|1
7546916|NCT02513771|26230370|P1|Overall Study|Lost to Follow-up|1
7546917|NCT02513745|26230408|P2|Overall Study|Criteria at time of surgery not met.|3
7546918|NCT02513745|26230409|P1|Overall Study|Criteria at time of surgery not met.|3
7546919|NCT02513732|26230419|P1|Overall Study|Changing hospital|2
7546920|NCT02513732|26230419|P1|Overall Study|Death|9
7546921|NCT02513732|26230419|P1|Overall Study|Lost to Follow-up|11
7546922|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Labor Reasons|0
7546923|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Labor Reasons|0
7546924|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Labor Reasons|0
7546925|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Labor Reasons|1
7546926|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Labor Reasons|0
7546927|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Labor Reasons|0
7546928|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7546929|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7546930|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7546931|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
7546932|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7546933|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7546934|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Subject move out of town|0
7546935|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Subject move out of town|0
7546936|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Subject move out of town|0
7546937|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Subject move out of town|1
7546938|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Subject move out of town|0
7546939|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Subject move out of town|0
7546940|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Death|0
7546941|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Death|0
7546942|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Death|0
7546943|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Death|1
7546944|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Death|0
7546945|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Death|0
7546946|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Physician Decision|0
7546947|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Physician Decision|0
7546948|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Physician Decision|0
7546949|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Physician Decision|0
7546950|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Physician Decision|0
7546951|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Physician Decision|2
7546952|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Adverse Event|0
7546953|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Adverse Event|0
7546954|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Adverse Event|0
7546955|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Adverse Event|4
7546956|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Adverse Event|1
7546957|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Adverse Event|1
7546958|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
7546959|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
7546960|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
7546961|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
7546962|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
7546963|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
7546964|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7546965|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7546966|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7546967|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
7546968|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
7546969|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
7546970|NCT02513550|26230663|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7546971|NCT02513550|26230664|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7546972|NCT02513550|26230665|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7546973|NCT02513550|26230666|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
7546974|NCT02513550|26230667|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
7546975|NCT02513550|26230668|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
7546976|NCT02513550|26230663|P6|Double Blind Treatment Period|Death|0
7546977|NCT02513550|26230664|P5|Double Blind Treatment Period|Death|0
7546978|NCT02513550|26230665|P4|Double Blind Treatment Period|Death|0
7546979|NCT02513550|26230666|P3|Double Blind Treatment Period|Death|2
7546980|NCT02513550|26230667|P2|Double Blind Treatment Period|Death|0
7546981|NCT02513550|26230668|P1|Double Blind Treatment Period|Death|1
7546982|NCT02513550|26230663|P6|Double Blind Treatment Period|Due to personal business|0
7546983|NCT02513550|26230664|P5|Double Blind Treatment Period|Due to personal business|0
7546984|NCT02513550|26230665|P4|Double Blind Treatment Period|Due to personal business|0
7546985|NCT02513550|26230666|P3|Double Blind Treatment Period|Due to personal business|1
7546986|NCT02513550|26230667|P2|Double Blind Treatment Period|Due to personal business|0
7546987|NCT02513550|26230668|P1|Double Blind Treatment Period|Due to personal business|2
7546988|NCT02513550|26230663|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7546989|NCT02513550|26230664|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7546990|NCT02513550|26230665|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7546991|NCT02513550|26230666|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
7546992|NCT02513550|26230667|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7546993|NCT02513550|26230668|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7546994|NCT02513550|26230663|P6|Double Blind Treatment Period|Site terminated by sponsor|0
7546995|NCT02513550|26230664|P5|Double Blind Treatment Period|Site terminated by sponsor|0
7546996|NCT02513550|26230665|P4|Double Blind Treatment Period|Site terminated by sponsor|0
7546997|NCT02513550|26230666|P3|Double Blind Treatment Period|Site terminated by sponsor|3
7546998|NCT02513550|26230667|P2|Double Blind Treatment Period|Site terminated by sponsor|1
7546999|NCT02513550|26230668|P1|Double Blind Treatment Period|Site terminated by sponsor|1
7547000|NCT02513550|26230663|P6|Double Blind Treatment Period|Physician Decision|0
7547001|NCT02513550|26230664|P5|Double Blind Treatment Period|Physician Decision|0
7547002|NCT02513550|26230665|P4|Double Blind Treatment Period|Physician Decision|0
7547003|NCT02513550|26230666|P3|Double Blind Treatment Period|Physician Decision|4
7547004|NCT02513550|26230667|P2|Double Blind Treatment Period|Physician Decision|0
7547005|NCT02513550|26230668|P1|Double Blind Treatment Period|Physician Decision|2
7547006|NCT02513550|26230663|P6|Double Blind Treatment Period|Protocol Violation|0
7547007|NCT02513550|26230664|P5|Double Blind Treatment Period|Protocol Violation|0
7547008|NCT02513550|26230665|P4|Double Blind Treatment Period|Protocol Violation|0
7547009|NCT02513550|26230666|P3|Double Blind Treatment Period|Protocol Violation|4
7547010|NCT02513550|26230667|P2|Double Blind Treatment Period|Protocol Violation|1
7547011|NCT02513550|26230668|P1|Double Blind Treatment Period|Protocol Violation|1
7547012|NCT02513550|26230663|P6|Double Blind Treatment Period|Lack of Efficacy|0
7547013|NCT02513550|26230664|P5|Double Blind Treatment Period|Lack of Efficacy|0
7547014|NCT02513550|26230665|P4|Double Blind Treatment Period|Lack of Efficacy|0
7547015|NCT02513550|26230666|P3|Double Blind Treatment Period|Lack of Efficacy|6
7547016|NCT02513550|26230667|P2|Double Blind Treatment Period|Lack of Efficacy|5
7547017|NCT02513550|26230668|P1|Double Blind Treatment Period|Lack of Efficacy|4
7547018|NCT02513550|26230663|P6|Double Blind Treatment Period|Lost to Follow-up|1
7547019|NCT02513550|26230664|P5|Double Blind Treatment Period|Lost to Follow-up|0
7547020|NCT02513550|26230665|P4|Double Blind Treatment Period|Lost to Follow-up|0
7547021|NCT02513550|26230666|P3|Double Blind Treatment Period|Lost to Follow-up|11
7547022|NCT02513550|26230667|P2|Double Blind Treatment Period|Lost to Follow-up|7
7547023|NCT02513550|26230668|P1|Double Blind Treatment Period|Lost to Follow-up|9
7547024|NCT02513550|26230663|P6|Double Blind Treatment Period|Adverse Event|0
7547025|NCT02513550|26230664|P5|Double Blind Treatment Period|Adverse Event|1
7547026|NCT02513550|26230665|P4|Double Blind Treatment Period|Adverse Event|0
7547027|NCT02513550|26230666|P3|Double Blind Treatment Period|Adverse Event|17
7547028|NCT02513550|26230667|P2|Double Blind Treatment Period|Adverse Event|13
7547029|NCT02513550|26230668|P1|Double Blind Treatment Period|Adverse Event|5
7547030|NCT02513550|26230663|P6|Double Blind Treatment Period|Withdrawal by Subject|0
7547031|NCT02513550|26230664|P5|Double Blind Treatment Period|Withdrawal by Subject|0
7547032|NCT02513550|26230665|P4|Double Blind Treatment Period|Withdrawal by Subject|0
7547033|NCT02513550|26230666|P3|Double Blind Treatment Period|Withdrawal by Subject|25
7547034|NCT02513550|26230667|P2|Double Blind Treatment Period|Withdrawal by Subject|11
7547035|NCT02513550|26230668|P1|Double Blind Treatment Period|Withdrawal by Subject|11
7547036|NCT02513472|26230762|P2|Overall Study|Other|3
7547037|NCT02513472|26230763|P1|Overall Study|Other|3
7547038|NCT02513472|26230762|P2|Overall Study|Treatment Completed as per Protocol|1
7547039|NCT02513472|26230763|P1|Overall Study|Treatment Completed as per Protocol|3
7547040|NCT02513472|26230762|P2|Overall Study|Subject Choice|6
7547041|NCT02513472|26230763|P1|Overall Study|Subject Choice|2
7547042|NCT02513472|26230762|P2|Overall Study|Withdrawal by Subject|4
7547043|NCT02513472|26230763|P1|Overall Study|Withdrawal by Subject|0
7547044|NCT02513472|26230762|P2|Overall Study|Adverse Event|11
7547045|NCT02513472|26230763|P1|Overall Study|Adverse Event|7
7547046|NCT02513472|26230762|P2|Overall Study|Clinical Disease Progression|12
7547047|NCT02513472|26230763|P1|Overall Study|Clinical Disease Progression|5
7547048|NCT02513472|26230762|P2|Overall Study|Radiological Disease Progression|56
7547049|NCT02513472|26230763|P1|Overall Study|Radiological Disease Progression|45
7547050|NCT02513459|26230798|P1|Overall Study|Surgery planned-- not done|1
7547051|NCT02513459|26230798|P1|Overall Study|Reproductive plans|1
7547052|NCT02513459|26230798|P1|Overall Study|Lack of response|1
7547053|NCT02513459|26230798|P1|Overall Study|Subject decision|2
7547054|NCT02513459|26230798|P1|Overall Study|Pregnancy|2
7547055|NCT02513459|26230798|P1|Overall Study|Loss of efficacy|2
7547056|NCT02513459|26230798|P1|Overall Study|Withdrew consent|5
7547057|NCT02513459|26230798|P1|Overall Study|Adverse Event|7
7547058|NCT02513160|26230866|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7547059|NCT02513160|26230867|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7547060|NCT02513160|26230868|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
7547061|NCT02513160|26230869|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7547062|NCT02513160|26230866|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7547063|NCT02513160|26230867|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7547064|NCT02513160|26230868|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7547065|NCT02513160|26230869|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
7547066|NCT02513160|26230866|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7547067|NCT02513160|26230867|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7547068|NCT02513160|26230868|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7547069|NCT02513160|26230869|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
7547070|NCT02513160|26230866|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7547071|NCT02513160|26230867|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7547072|NCT02513160|26230868|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7547073|NCT02513160|26230869|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
7547074|NCT02513160|26230866|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
7547075|NCT02513160|26230867|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
7547076|NCT02513160|26230868|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7547077|NCT02513160|26230869|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7547078|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7547079|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7547080|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7547081|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
7547082|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7547083|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7547084|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7547085|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
7547086|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7547087|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7547088|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7547089|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
7547090|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7547091|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7547092|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7547093|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
7547094|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7547095|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7547096|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7547097|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
7547098|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7547099|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7547100|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7547101|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
7547102|NCT02513160|26230866|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7547103|NCT02513160|26230867|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7547104|NCT02513160|26230868|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7547105|NCT02513160|26230869|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
7547106|NCT02512965|26230936|P2|Overall Study|Withdrawal by Subject|4
7547107|NCT02512965|26230937|P1|Overall Study|Withdrawal by Subject|0
7547108|NCT02512861|26230994|P2|Overall Study|Withdrawal by Subject|1
7547109|NCT02512861|26230995|P1|Overall Study|Withdrawal by Subject|0
7547110|NCT02512861|26230994|P2|Overall Study|Physician Decision|1
7547111|NCT02512861|26230995|P1|Overall Study|Physician Decision|3
7547112|NCT02512861|26230994|P2|Overall Study|Protocol Violation|7
7547113|NCT02512861|26230995|P1|Overall Study|Protocol Violation|3
7547114|NCT02512302|26231273|P10|Period 4|Adverse Event|0
7547115|NCT02512302|26231274|P9|Period 4|Adverse Event|0
7547116|NCT02512302|26231275|P8|Period 4|Adverse Event|0
7547117|NCT02512302|26231276|P7|Period 4|Adverse Event|1
7547118|NCT02512302|26231277|P6|Period 4|Adverse Event|0
7547119|NCT02512302|26231278|P5|Period 4|Adverse Event|0
7547120|NCT02512302|26231279|P4|Period 4|Adverse Event|0
7547121|NCT02512302|26231280|P3|Period 4|Adverse Event|0
7547122|NCT02512302|26231281|P2|Period 4|Adverse Event|0
7547123|NCT02512302|26231282|P1|Period 4|Adverse Event|0
7547124|NCT02512302|26231273|P10|Period 3|Lost to Follow-up|0
7547125|NCT02512302|26231274|P9|Period 3|Lost to Follow-up|0
7547126|NCT02512302|26231275|P8|Period 3|Lost to Follow-up|0
7547127|NCT02512302|26231276|P7|Period 3|Lost to Follow-up|0
7547128|NCT02512302|26231277|P6|Period 3|Lost to Follow-up|0
7547129|NCT02512302|26231278|P5|Period 3|Lost to Follow-up|0
7547130|NCT02512302|26231279|P4|Period 3|Lost to Follow-up|0
7547131|NCT02512302|26231280|P3|Period 3|Lost to Follow-up|1
7547132|NCT02512302|26231281|P2|Period 3|Lost to Follow-up|0
7547133|NCT02512302|26231282|P1|Period 3|Lost to Follow-up|0
7547134|NCT02512302|26231273|P10|Period 2|Adverse Event|1
7547135|NCT02512302|26231274|P9|Period 2|Adverse Event|0
7547136|NCT02512302|26231275|P8|Period 2|Adverse Event|0
7547137|NCT02512302|26231276|P7|Period 2|Adverse Event|0
7547138|NCT02512302|26231277|P6|Period 2|Adverse Event|0
7547139|NCT02512302|26231278|P5|Period 2|Adverse Event|0
7547140|NCT02512302|26231279|P4|Period 2|Adverse Event|0
7547141|NCT02512302|26231280|P3|Period 2|Adverse Event|0
7547142|NCT02512302|26231281|P2|Period 2|Adverse Event|0
7547143|NCT02512302|26231282|P1|Period 2|Adverse Event|0
7547144|NCT02512302|26231273|P10|Period 1|Adverse Event|0
7547145|NCT02512302|26231274|P9|Period 1|Adverse Event|0
7547146|NCT02512302|26231275|P8|Period 1|Adverse Event|0
7547147|NCT02512302|26231276|P7|Period 1|Adverse Event|0
7547148|NCT02512302|26231277|P6|Period 1|Adverse Event|0
7547149|NCT02512302|26231278|P5|Period 1|Adverse Event|0
7547150|NCT02512302|26231279|P4|Period 1|Adverse Event|0
7547151|NCT02512302|26231280|P3|Period 1|Adverse Event|0
7547152|NCT02512302|26231281|P2|Period 1|Adverse Event|1
7547153|NCT02512302|26231282|P1|Period 1|Adverse Event|0
7547154|NCT02512068|26231398|P2|Overall Study|Reason Not Specified|5
7547155|NCT02512068|26231399|P1|Overall Study|Reason Not Specified|3
7547156|NCT02512068|26231398|P2|Overall Study|Lack of Efficacy|1
7547157|NCT02512068|26231399|P1|Overall Study|Lack of Efficacy|0
7547158|NCT02512068|26231398|P2|Overall Study|Voluntary Withdrawal|1
7547159|NCT02512068|26231399|P1|Overall Study|Voluntary Withdrawal|0
7547160|NCT02512068|26231398|P2|Overall Study|Major Protocol Deviation|0
7547161|NCT02512068|26231399|P1|Overall Study|Major Protocol Deviation|1
7547162|NCT02512068|26231398|P2|Overall Study|Pretreatment Event/Adverse Event|6
7547163|NCT02512068|26231399|P1|Overall Study|Pretreatment Event/Adverse Event|8
7547164|NCT02512042|26231425|P2|Overall Study|Other|11
7547165|NCT02512042|26231426|P1|Overall Study|Other|11
7547166|NCT02512042|26231425|P2|Overall Study|Lost to Follow-up|2
7547167|NCT02512042|26231426|P1|Overall Study|Lost to Follow-up|5
7547168|NCT02512042|26231425|P2|Overall Study|Non-compliance with study drug|2
7547169|NCT02512042|26231426|P1|Overall Study|Non-compliance with study drug|1
7547170|NCT02512042|26231425|P2|Overall Study|Withdrawal by Subject|6
7547171|NCT02512042|26231426|P1|Overall Study|Withdrawal by Subject|6
7547172|NCT02512042|26231425|P2|Overall Study|Adverse Event|4
7547173|NCT02512042|26231426|P1|Overall Study|Adverse Event|0
7547174|NCT02511782|26231435|P3|Overall Study|Withdrawal by Subject|0
7547175|NCT02511782|26231436|P2|Overall Study|Withdrawal by Subject|0
7547176|NCT02511782|26231437|P1|Overall Study|Withdrawal by Subject|1
7547177|NCT02511678|26231463|P1|Overall Study|Received Radiation Treatment|1
7547178|NCT02511678|26231463|P1|Overall Study|Protocol Violation|1
7547179|NCT02511678|26231463|P1|Overall Study|Biopsy was Negative|1
7547180|NCT02511678|26231463|P1|Overall Study|Required Radiofrequency Ablation|1
7547181|NCT02511678|26231463|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
7547182|NCT02511678|26231463|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
7547183|NCT02511678|26231463|P1|Overall Study|Adverse Event|1
7547184|NCT02511678|26231463|P1|Overall Study|Death|19
7547185|NCT02511678|26231463|P1|Overall Study|Lost to Follow-up|4
7547186|NCT02511678|26231463|P1|Overall Study|Withdrawal by Subject|2
7547187|NCT02511431|26231545|P6|Treatment|Lost to Follow-up|1
7547188|NCT02511431|26231546|P5|Treatment|Lost to Follow-up|0
7547189|NCT02511431|26231547|P4|Treatment|Lost to Follow-up|0
7547190|NCT02511431|26231548|P3|Treatment|Lost to Follow-up|1
7547191|NCT02511431|26231549|P2|Treatment|Lost to Follow-up|0
7547192|NCT02511431|26231550|P1|Treatment|Lost to Follow-up|0
7547193|NCT02511184|26231590|P2|Overall Study|Withdrawal by Subject|1
7547194|NCT02511184|26231591|P1|Overall Study|Withdrawal by Subject|0
7547195|NCT02511184|26231590|P2|Overall Study|Study terminated by sponsor|5
7547196|NCT02511184|26231591|P1|Overall Study|Study terminated by sponsor|1
7547197|NCT02511184|26231590|P2|Overall Study|Lost to Follow-up|1
7547198|NCT02511184|26231591|P1|Overall Study|Lost to Follow-up|0
7547199|NCT02511184|26231590|P2|Overall Study|Death|0
7547200|NCT02511184|26231591|P1|Overall Study|Death|1
7547211|NCT02510820|26231669|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7547212|NCT02510820|26231670|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7547213|NCT02510820|26231669|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
7547214|NCT02510820|26231670|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
7547215|NCT02510794|26231712|P4|Overall Study|Withdrawal by Subject|3
7547216|NCT02510794|26231713|P3|Overall Study|Withdrawal by Subject|4
7547217|NCT02510794|26231714|P2|Overall Study|Withdrawal by Subject|2
7547218|NCT02510794|26231715|P1|Overall Study|Withdrawal by Subject|1
7547219|NCT02510794|26231712|P4|Overall Study|Protocol Violation|0
7547220|NCT02510794|26231713|P3|Overall Study|Protocol Violation|1
7547221|NCT02510794|26231714|P2|Overall Study|Protocol Violation|0
7547222|NCT02510794|26231715|P1|Overall Study|Protocol Violation|0
7547223|NCT02510794|26231712|P4|Overall Study|Physician Decision|0
7547224|NCT02510794|26231713|P3|Overall Study|Physician Decision|0
7547225|NCT02510794|26231714|P2|Overall Study|Physician Decision|0
7547226|NCT02510794|26231715|P1|Overall Study|Physician Decision|3
7547227|NCT02510794|26231712|P4|Overall Study|Participant moved out of the area|1
7547228|NCT02510794|26231713|P3|Overall Study|Participant moved out of the area|0
7547229|NCT02510794|26231714|P2|Overall Study|Participant moved out of the area|0
7547230|NCT02510794|26231715|P1|Overall Study|Participant moved out of the area|0
7547231|NCT02510794|26231712|P4|Overall Study|Lack of Efficacy|0
7547232|NCT02510794|26231713|P3|Overall Study|Lack of Efficacy|1
7547233|NCT02510794|26231714|P2|Overall Study|Lack of Efficacy|1
7547234|NCT02510794|26231715|P1|Overall Study|Lack of Efficacy|3
7547235|NCT02510794|26231712|P4|Overall Study|Death|1
7547236|NCT02510794|26231713|P3|Overall Study|Death|1
7547237|NCT02510794|26231714|P2|Overall Study|Death|2
7547238|NCT02510794|26231715|P1|Overall Study|Death|1
7547239|NCT02510794|26231712|P4|Overall Study|Adverse Event|0
7547240|NCT02510794|26231713|P3|Overall Study|Adverse Event|0
7547241|NCT02510794|26231714|P2|Overall Study|Adverse Event|1
7547242|NCT02510794|26231715|P1|Overall Study|Adverse Event|0
7547243|NCT02510664|26231776|P3|Overall Study|Time Constraints|0
7547244|NCT02510664|26231777|P2|Overall Study|Time Constraints|1
7547245|NCT02510664|26231778|P1|Overall Study|Time Constraints|1
7547246|NCT02510664|26231776|P3|Overall Study|Provider Retired/No Time to Reschedule|0
7547247|NCT02510664|26231777|P2|Overall Study|Provider Retired/No Time to Reschedule|10
7547248|NCT02510664|26231778|P1|Overall Study|Provider Retired/No Time to Reschedule|10
7547249|NCT02510664|26231776|P3|Overall Study|Transferred Care|0
7547250|NCT02510664|26231777|P2|Overall Study|Transferred Care|9
7547251|NCT02510664|26231778|P1|Overall Study|Transferred Care|9
7547252|NCT02510040|26231821|P3|Overall Study|Deemed no longer eligible|1
7547253|NCT02510040|26231822|P2|Overall Study|Deemed no longer eligible|3
7547254|NCT02510040|26231823|P1|Overall Study|Deemed no longer eligible|18
7547255|NCT02510014|26231837|P2|Treatment Period|Incarceration, pregnancy, misc|5
7547256|NCT02510014|26231838|P1|Treatment Period|Incarceration, pregnancy, misc|29
7547257|NCT02510014|26231837|P2|Treatment Period|Protocol Violation|4
7547258|NCT02510014|26231838|P1|Treatment Period|Protocol Violation|4
7547259|NCT02510014|26231837|P2|Treatment Period|Withdrawn by the investigator|1
7547260|NCT02510014|26231838|P1|Treatment Period|Withdrawn by the investigator|7
7547261|NCT02510014|26231837|P2|Treatment Period|Withdrawal by Subject|24
7547262|NCT02510014|26231838|P1|Treatment Period|Withdrawal by Subject|67
7547263|NCT02510014|26231837|P2|Treatment Period|Physician Decision|0
7547264|NCT02510014|26231838|P1|Treatment Period|Physician Decision|5
7547265|NCT02510014|26231837|P2|Treatment Period|Lost to Follow-up|19
7547266|NCT02510014|26231838|P1|Treatment Period|Lost to Follow-up|80
7547267|NCT02510014|26231837|P2|Treatment Period|Withdrawal symptoms|0
7547268|NCT02510014|26231838|P1|Treatment Period|Withdrawal symptoms|3
7547269|NCT02510014|26231837|P2|Treatment Period|Adverse Event|4
7547270|NCT02510014|26231838|P1|Treatment Period|Adverse Event|11
7547271|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Other|1
7547272|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Other|19
7547273|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
7547274|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
7547275|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
7547276|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
7547277|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
7547278|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
7547279|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
7547280|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
7547281|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
7547282|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
7547283|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
7547284|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
7547285|NCT02510014|26231837|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7547286|NCT02510014|26231838|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7547287|NCT02510001|26231866|P8|Overall Study|Withdrawal by Subject|2
7547288|NCT02510001|26231867|P7|Overall Study|Withdrawal by Subject|0
7547289|NCT02510001|26231868|P6|Overall Study|Withdrawal by Subject|0
7547290|NCT02510001|26231869|P5|Overall Study|Withdrawal by Subject|0
7547291|NCT02510001|26231870|P4|Overall Study|Withdrawal by Subject|0
7547292|NCT02510001|26231871|P3|Overall Study|Withdrawal by Subject|0
7547293|NCT02510001|26231872|P2|Overall Study|Withdrawal by Subject|0
7547294|NCT02510001|26231873|P1|Overall Study|Withdrawal by Subject|0
7547295|NCT02510001|26231866|P8|Overall Study|Physician Decision|0
7547296|NCT02510001|26231867|P7|Overall Study|Physician Decision|0
7547297|NCT02510001|26231868|P6|Overall Study|Physician Decision|0
7547298|NCT02510001|26231869|P5|Overall Study|Physician Decision|1
7547299|NCT02510001|26231870|P4|Overall Study|Physician Decision|0
7547300|NCT02510001|26231871|P3|Overall Study|Physician Decision|0
7547301|NCT02510001|26231872|P2|Overall Study|Physician Decision|0
7547302|NCT02510001|26231873|P1|Overall Study|Physician Decision|0
7547303|NCT02510001|26231866|P8|Overall Study|Adverse Event|5
7547304|NCT02510001|26231867|P7|Overall Study|Adverse Event|2
7547305|NCT02510001|26231868|P6|Overall Study|Adverse Event|1
7547306|NCT02510001|26231869|P5|Overall Study|Adverse Event|2
7547307|NCT02510001|26231870|P4|Overall Study|Adverse Event|1
7547308|NCT02510001|26231871|P3|Overall Study|Adverse Event|0
7547309|NCT02510001|26231872|P2|Overall Study|Adverse Event|0
7547310|NCT02510001|26231873|P1|Overall Study|Adverse Event|0
7547311|NCT02510001|26231866|P8|Overall Study|Early disease progression|0
7547312|NCT02510001|26231867|P7|Overall Study|Early disease progression|0
7547313|NCT02510001|26231868|P6|Overall Study|Early disease progression|1
7547314|NCT02510001|26231869|P5|Overall Study|Early disease progression|1
7547315|NCT02510001|26231870|P4|Overall Study|Early disease progression|1
7547316|NCT02510001|26231871|P3|Overall Study|Early disease progression|0
7547317|NCT02510001|26231872|P2|Overall Study|Early disease progression|0
7547318|NCT02510001|26231873|P1|Overall Study|Early disease progression|0
7547319|NCT02509156|26232062|P2|Randomized Phase|Withdrawal by Subject|1
7547320|NCT02509156|26232063|P1|Randomized Phase|Withdrawal by Subject|1
7547321|NCT02509156|26232062|P2|Randomized Phase|Death|0
7547322|NCT02509156|26232063|P1|Randomized Phase|Death|1
7547323|NCT02509117|26232133|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
7547324|NCT02509117|26232134|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547325|NCT02509117|26232135|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547326|NCT02509117|26232136|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547327|NCT02509117|26232137|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547328|NCT02509117|26232138|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547329|NCT02509117|26232139|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547330|NCT02509117|26232140|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547331|NCT02509117|26232141|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547332|NCT02509117|26232142|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7547333|NCT02509117|26232133|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
7547334|NCT02509117|26232134|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547335|NCT02509117|26232135|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547336|NCT02509117|26232136|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547337|NCT02509117|26232137|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547338|NCT02509117|26232138|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547339|NCT02509117|26232139|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547340|NCT02509117|26232140|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547341|NCT02509117|26232141|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547342|NCT02509117|26232142|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7547343|NCT02509117|26232133|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547344|NCT02509117|26232134|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547345|NCT02509117|26232135|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547346|NCT02509117|26232136|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547347|NCT02509117|26232137|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547348|NCT02509117|26232138|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547349|NCT02509117|26232139|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547350|NCT02509117|26232140|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547351|NCT02509117|26232141|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
7547352|NCT02509117|26232142|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7547353|NCT02509078|26232353|P2|Overall Study|Protocol Violation|1
7547354|NCT02509078|26232354|P1|Overall Study|Protocol Violation|1
7547355|NCT02509026|26232497|P1|Retreatment Period (12 Weeks)|Enrolled but not treated|1
7547356|NCT02509026|26232497|P1|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
7547357|NCT02509026|26232497|P1|Retreatment Period (12 Weeks)|Lost to Follow-up|1
7547358|NCT02509026|26232497|P1|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
7547359|NCT02509026|26232497|P1|Withdrawal Period (40 Weeks)|Protocol Violation|2
7547360|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Enrolled but not treated|1
7547361|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Withdrawal by Subject|1
7547362|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Protocol Violation|1
7547363|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Other|2
7547364|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Lost to Follow-up|1
7547365|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Lack of Efficacy|6
7547366|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Eligibility Criteria|5
7547367|NCT02509026|26232497|P1|Induction Period (24 Weeks)|Adverse Event|5
7547368|NCT02508935|26232694|P1|Overall Study|Trial terminated by sponsor|5
7547369|NCT02508935|26232694|P1|Overall Study|Physician Decision|1
7547370|NCT02508935|26232694|P1|Overall Study|Protocol Violation|1
7547371|NCT02508935|26232694|P1|Overall Study|Adverse Event|3
7547372|NCT02508935|26232694|P1|Overall Study|Emesis|3
7547373|NCT02508935|26232694|P1|Overall Study|Pain Score <4|1
7547374|NCT02508935|26232694|P1|Overall Study|Withdrawal by Caregiver|8
7547375|NCT02508935|26232694|P1|Overall Study|Withdrawal by Subject|1
7547376|NCT02508701|26232710|P4|Overall Study|Lost to Follow-up|3
7547377|NCT02508701|26232711|P3|Overall Study|Lost to Follow-up|5
7547378|NCT02508701|26232712|P2|Overall Study|Lost to Follow-up|5
7547379|NCT02508701|26232713|P1|Overall Study|Lost to Follow-up|9
7547380|NCT02508649|26232739|P4|Overall Study|Lost to Follow-up|1
7547381|NCT02508649|26232740|P3|Overall Study|Lost to Follow-up|0
7547382|NCT02508649|26232741|P2|Overall Study|Lost to Follow-up|1
7547383|NCT02508649|26232742|P1|Overall Study|Lost to Follow-up|1
7547384|NCT02508649|26232739|P4|Overall Study|Post randomization screening failure|3
7547385|NCT02508649|26232740|P3|Overall Study|Post randomization screening failure|9
7547386|NCT02508649|26232741|P2|Overall Study|Post randomization screening failure|4
7547387|NCT02508649|26232742|P1|Overall Study|Post randomization screening failure|12
7547388|NCT02508649|26232739|P4|Overall Study|Investigator withdrew the subject|0
7547389|NCT02508649|26232740|P3|Overall Study|Investigator withdrew the subject|1
7547390|NCT02508649|26232741|P2|Overall Study|Investigator withdrew the subject|2
7547391|NCT02508649|26232742|P1|Overall Study|Investigator withdrew the subject|1
7547392|NCT02508649|26232739|P4|Overall Study|Withdrawal by Subject|6
7547393|NCT02508649|26232740|P3|Overall Study|Withdrawal by Subject|5
7547394|NCT02508649|26232741|P2|Overall Study|Withdrawal by Subject|6
7547395|NCT02508649|26232742|P1|Overall Study|Withdrawal by Subject|4
7547396|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Continuing in study|1
7547397|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Continuing in study|0
7547398|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Continuing in study|0
7547399|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Continuing in study|0
7547400|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Continuing in study|0
7547401|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Continuing in study|0
7547402|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Continuing in study|0
7547403|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Continuing in study|0
7547404|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Continuing in study|0
7547405|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Sponsor Decision|67
7547406|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Sponsor Decision|1
7547407|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Sponsor Decision|0
7547408|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Sponsor Decision|0
7547409|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Sponsor Decision|2
7547410|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Sponsor Decision|2
7547411|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Sponsor Decision|1
7547412|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Sponsor Decision|1
7547413|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Sponsor Decision|2
7547414|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Initiation of another therapy|1
7547415|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547416|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547417|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547418|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547419|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547420|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547421|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547422|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7547423|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Physician Decision|8
7547424|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Physician Decision|0
7547425|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Physician Decision|0
7547426|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Physician Decision|0
7547427|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Physician Decision|1
7547428|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Physician Decision|0
7547429|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Physician Decision|1
7547430|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Physician Decision|0
7547431|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Physician Decision|0
7547432|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
7547433|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547434|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547435|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547436|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547437|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547438|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547439|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547440|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7547441|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Lost to Follow-up|6
7547442|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7547443|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7547444|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7547445|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7547446|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7547447|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7547448|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7547449|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7547450|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Death|111
7547451|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Death|1
7547452|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Death|0
7547453|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Death|0
7547454|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Death|3
7547455|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Death|4
7547456|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Death|2
7547457|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Death|4
7547458|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Death|0
7547459|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Adverse Event|2
7547460|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Adverse Event|0
7547461|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Adverse Event|0
7547462|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Adverse Event|0
7547463|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Adverse Event|0
7547464|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Adverse Event|0
7547465|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Adverse Event|1
7547466|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Adverse Event|0
7547467|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Adverse Event|1
7547468|NCT02508532|26232859|P9|Part 1 and Part 2 End of Study|Disease Progression|6
7547469|NCT02508532|26232860|P8|Part 1 and Part 2 End of Study|Disease Progression|1
7547470|NCT02508532|26232861|P7|Part 1 and Part 2 End of Study|Disease Progression|0
7547471|NCT02508532|26232862|P6|Part 1 and Part 2 End of Study|Disease Progression|0
7547472|NCT02508532|26232863|P5|Part 1 and Part 2 End of Study|Disease Progression|0
7547473|NCT02508532|26232864|P4|Part 1 and Part 2 End of Study|Disease Progression|0
7547474|NCT02508532|26232865|P3|Part 1 and Part 2 End of Study|Disease Progression|0
7547475|NCT02508532|26232866|P2|Part 1 and Part 2 End of Study|Disease Progression|0
7547476|NCT02508532|26232867|P1|Part 1 and Part 2 End of Study|Disease Progression|2
7547477|NCT02508532|26232859|P9|Part 2 - Treatment|Withdrawal by Subject|6
7547478|NCT02508532|26232860|P8|Part 2 - Treatment|Withdrawal by Subject|0
7547479|NCT02508532|26232861|P7|Part 2 - Treatment|Withdrawal by Subject|0
7547480|NCT02508532|26232862|P6|Part 2 - Treatment|Withdrawal by Subject|0
7547481|NCT02508532|26232863|P5|Part 2 - Treatment|Withdrawal by Subject|0
7547482|NCT02508532|26232864|P4|Part 2 - Treatment|Withdrawal by Subject|0
7547483|NCT02508532|26232865|P3|Part 2 - Treatment|Withdrawal by Subject|0
7547484|NCT02508532|26232866|P2|Part 2 - Treatment|Withdrawal by Subject|0
7547485|NCT02508532|26232867|P1|Part 2 - Treatment|Withdrawal by Subject|0
7547486|NCT02508532|26232859|P9|Part 2 - Treatment|Death|1
7547487|NCT02508532|26232860|P8|Part 2 - Treatment|Death|0
7547488|NCT02508532|26232861|P7|Part 2 - Treatment|Death|0
7547489|NCT02508532|26232862|P6|Part 2 - Treatment|Death|0
7547490|NCT02508532|26232863|P5|Part 2 - Treatment|Death|0
7547491|NCT02508532|26232864|P4|Part 2 - Treatment|Death|0
7547492|NCT02508532|26232865|P3|Part 2 - Treatment|Death|0
7547493|NCT02508532|26232866|P2|Part 2 - Treatment|Death|0
7547494|NCT02508532|26232867|P1|Part 2 - Treatment|Death|0
7547495|NCT02508532|26232859|P9|Part 2 - Treatment|Sponsor Decision|28
7547496|NCT02508532|26232860|P8|Part 2 - Treatment|Sponsor Decision|0
7547497|NCT02508532|26232861|P7|Part 2 - Treatment|Sponsor Decision|0
7547498|NCT02508532|26232862|P6|Part 2 - Treatment|Sponsor Decision|0
7547499|NCT02508532|26232863|P5|Part 2 - Treatment|Sponsor Decision|0
7547500|NCT02508532|26232864|P4|Part 2 - Treatment|Sponsor Decision|0
7547501|NCT02508532|26232865|P3|Part 2 - Treatment|Sponsor Decision|0
7547502|NCT02508532|26232866|P2|Part 2 - Treatment|Sponsor Decision|0
7547503|NCT02508532|26232867|P1|Part 2 - Treatment|Sponsor Decision|0
7547504|NCT02508532|26232859|P9|Part 2 - Treatment|Administrative|3
7547505|NCT02508532|26232860|P8|Part 2 - Treatment|Administrative|0
7547506|NCT02508532|26232861|P7|Part 2 - Treatment|Administrative|0
7547507|NCT02508532|26232862|P6|Part 2 - Treatment|Administrative|0
7547508|NCT02508532|26232863|P5|Part 2 - Treatment|Administrative|0
7547509|NCT02508532|26232864|P4|Part 2 - Treatment|Administrative|0
7547510|NCT02508532|26232865|P3|Part 2 - Treatment|Administrative|0
7547511|NCT02508532|26232866|P2|Part 2 - Treatment|Administrative|0
7547512|NCT02508532|26232867|P1|Part 2 - Treatment|Administrative|0
7547513|NCT02508532|26232859|P9|Part 2 - Treatment|Physician Decision|12
7547514|NCT02508532|26232860|P8|Part 2 - Treatment|Physician Decision|0
7547515|NCT02508532|26232861|P7|Part 2 - Treatment|Physician Decision|0
7547516|NCT02508532|26232862|P6|Part 2 - Treatment|Physician Decision|0
7547517|NCT02508532|26232863|P5|Part 2 - Treatment|Physician Decision|0
7547518|NCT02508532|26232864|P4|Part 2 - Treatment|Physician Decision|0
7547519|NCT02508532|26232865|P3|Part 2 - Treatment|Physician Decision|0
7547520|NCT02508532|26232866|P2|Part 2 - Treatment|Physician Decision|0
7547521|NCT02508532|26232867|P1|Part 2 - Treatment|Physician Decision|0
7547522|NCT02508532|26232859|P9|Part 2 - Treatment|Adverse Event|49
7547523|NCT02508532|26232860|P8|Part 2 - Treatment|Adverse Event|0
7547524|NCT02508532|26232861|P7|Part 2 - Treatment|Adverse Event|0
7547525|NCT02508532|26232862|P6|Part 2 - Treatment|Adverse Event|0
7547526|NCT02508532|26232863|P5|Part 2 - Treatment|Adverse Event|0
7547527|NCT02508532|26232864|P4|Part 2 - Treatment|Adverse Event|0
7547528|NCT02508532|26232865|P3|Part 2 - Treatment|Adverse Event|0
7547529|NCT02508532|26232866|P2|Part 2 - Treatment|Adverse Event|0
7547530|NCT02508532|26232867|P1|Part 2 - Treatment|Adverse Event|0
7547531|NCT02508532|26232859|P9|Part 2 - Treatment|Disease Progression|118
7547532|NCT02508532|26232860|P8|Part 2 - Treatment|Disease Progression|0
7547533|NCT02508532|26232861|P7|Part 2 - Treatment|Disease Progression|0
7547534|NCT02508532|26232862|P6|Part 2 - Treatment|Disease Progression|0
7547535|NCT02508532|26232863|P5|Part 2 - Treatment|Disease Progression|0
7547536|NCT02508532|26232864|P4|Part 2 - Treatment|Disease Progression|0
7547537|NCT02508532|26232865|P3|Part 2 - Treatment|Disease Progression|0
7547538|NCT02508532|26232866|P2|Part 2 - Treatment|Disease Progression|0
7547539|NCT02508532|26232867|P1|Part 2 - Treatment|Disease Progression|0
7547540|NCT02508532|26232859|P9|Part 1 - Dose Determining Period|Not Evaluable|0
7547541|NCT02508532|26232860|P8|Part 1 - Dose Determining Period|Not Evaluable|1
7547542|NCT02508532|26232861|P7|Part 1 - Dose Determining Period|Not Evaluable|0
7547543|NCT02508532|26232862|P6|Part 1 - Dose Determining Period|Not Evaluable|0
7547544|NCT02508532|26232863|P5|Part 1 - Dose Determining Period|Not Evaluable|0
7547545|NCT02508532|26232864|P4|Part 1 - Dose Determining Period|Not Evaluable|0
7547546|NCT02508532|26232865|P3|Part 1 - Dose Determining Period|Not Evaluable|0
7547547|NCT02508532|26232866|P2|Part 1 - Dose Determining Period|Not Evaluable|0
7547548|NCT02508532|26232867|P1|Part 1 - Dose Determining Period|Not Evaluable|0
7547549|NCT02508532|26232859|P9|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547550|NCT02508532|26232860|P8|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547551|NCT02508532|26232861|P7|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
7547552|NCT02508532|26232862|P6|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547553|NCT02508532|26232863|P5|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547554|NCT02508532|26232864|P4|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547555|NCT02508532|26232865|P3|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547556|NCT02508532|26232866|P2|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547557|NCT02508532|26232867|P1|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7547558|NCT02508428|26232964|P2|Overall Study|Incomplete follow-up|15
7547559|NCT02508428|26232965|P1|Overall Study|Incomplete follow-up|17
7547560|NCT02508428|26232964|P2|Overall Study|Liner revised|19
7547561|NCT02508428|26232965|P1|Overall Study|Liner revised|3
7547562|NCT02508428|26232964|P2|Overall Study|Death|33
7547563|NCT02508428|26232965|P1|Overall Study|Death|32
7547564|NCT02508194|26233048|P2|Overall Study|Principal Investigator Decision|2
7547565|NCT02508194|26233049|P1|Overall Study|Principal Investigator Decision|1
7547566|NCT02508194|26233048|P2|Overall Study|Error in Randomization|3
7547567|NCT02508194|26233049|P1|Overall Study|Error in Randomization|1
7547568|NCT02508194|26233048|P2|Overall Study|Withdrawal by Subject|18
7547569|NCT02508194|26233049|P1|Overall Study|Withdrawal by Subject|20
7547570|NCT02508194|26233048|P2|Overall Study|Lost to Follow-up|18
7547571|NCT02508194|26233049|P1|Overall Study|Lost to Follow-up|25
7547572|NCT02508194|26233048|P2|Overall Study|Death|3
7547573|NCT02508194|26233049|P1|Overall Study|Death|5
7547574|NCT02508116|26233089|P2|Overall Study|Physician Decision|0
7547575|NCT02508116|26233090|P1|Overall Study|Physician Decision|2
7547576|NCT02508116|26233089|P2|Overall Study|Protocol Violation|2
7547577|NCT02508116|26233090|P1|Overall Study|Protocol Violation|1
7547578|NCT02508116|26233089|P2|Overall Study|Withdrawal by Subject|2
7547579|NCT02508116|26233090|P1|Overall Study|Withdrawal by Subject|3
7547580|NCT02508116|26233089|P2|Overall Study|Lost to Follow-up|3
7547581|NCT02508116|26233090|P1|Overall Study|Lost to Follow-up|2
7547582|NCT02507973|26233117|P1|Overall Study|Adverse Event|1
7547583|NCT02507752|26233123|P1|Overall Study|Participant didn't perform visit Week 24|1
7547584|NCT02507752|26233123|P1|Overall Study|Participant didn't perform visit Week 12|1
7547585|NCT02507752|26233123|P1|Overall Study|Infusion reaction at first infusion|1
7547586|NCT02507752|26233123|P1|Overall Study|Lost to Follow-up|7
7547587|NCT02507752|26233123|P1|Overall Study|Protocol Violation|6
7547588|NCT02507752|26233123|P1|Overall Study|Adverse Event|1
7547589|NCT02507375|26233167|P2|Overall Study|Adverse Event|1
7547590|NCT02507375|26233168|P1|Overall Study|Adverse Event|0
7547591|NCT02507375|26233167|P2|Overall Study|Refused treatment|1
7547592|NCT02507375|26233168|P1|Overall Study|Refused treatment|0
7547593|NCT02507375|26233167|P2|Overall Study|Death|1
7547594|NCT02507375|26233168|P1|Overall Study|Death|0
7547595|NCT02507375|26233167|P2|Overall Study|Progressive Disease|5
7547596|NCT02507375|26233168|P1|Overall Study|Progressive Disease|4
7547597|NCT02507349|26233187|P2|Overall Study|Lost to Follow-up|144
7547598|NCT02507349|26233188|P1|Overall Study|Lost to Follow-up|174
7547599|NCT02507349|26233187|P2|Overall Study|Withdrawal by Subject|1
7547600|NCT02507349|26233188|P1|Overall Study|Withdrawal by Subject|1
7547601|NCT02507349|26233187|P2|Overall Study|Death|16
7547602|NCT02507349|26233188|P1|Overall Study|Death|12
7547603|NCT02507297|26233214|P2|Overall Study|Lost to Follow-up|1
7547604|NCT02507297|26233215|P1|Overall Study|Lost to Follow-up|0
7547605|NCT02507297|26233214|P2|Overall Study|Withdrawal by Subject|0
7547606|NCT02507297|26233215|P1|Overall Study|Withdrawal by Subject|1
7547607|NCT02507219|26233229|P6|Overall Study|Withdrawal by Subject|0
7547608|NCT02507219|26233230|P5|Overall Study|Withdrawal by Subject|1
7547609|NCT02507219|26233231|P4|Overall Study|Withdrawal by Subject|0
7547610|NCT02507219|26233232|P3|Overall Study|Withdrawal by Subject|0
7547611|NCT02507219|26233233|P2|Overall Study|Withdrawal by Subject|0
7547612|NCT02507219|26233234|P1|Overall Study|Withdrawal by Subject|0
7547613|NCT02507219|26233229|P6|Overall Study|Physician Decision|0
7547614|NCT02507219|26233230|P5|Overall Study|Physician Decision|0
7547615|NCT02507219|26233231|P4|Overall Study|Physician Decision|0
7547616|NCT02507219|26233232|P3|Overall Study|Physician Decision|0
7547617|NCT02507219|26233233|P2|Overall Study|Physician Decision|0
7547618|NCT02507219|26233234|P1|Overall Study|Physician Decision|1
7547619|NCT02506881|26233270|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
7547620|NCT02506881|26233271|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
7547621|NCT02506881|26233272|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
7547622|NCT02506881|26233273|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
7547623|NCT02506881|26233270|P4|First Intervention (Day 1)|Withdrawal by Subject|0
7547624|NCT02506881|26233271|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7547625|NCT02506881|26233272|P2|First Intervention (Day 1)|Withdrawal by Subject|0
7547626|NCT02506881|26233273|P1|First Intervention (Day 1)|Withdrawal by Subject|1
7547627|NCT02506881|26233270|P4|First Intervention (Day 1)|Protocol Violation|0
7547628|NCT02506881|26233271|P3|First Intervention (Day 1)|Protocol Violation|1
7547629|NCT02506881|26233272|P2|First Intervention (Day 1)|Protocol Violation|0
7547630|NCT02506881|26233273|P1|First Intervention (Day 1)|Protocol Violation|0
7547631|NCT02506816|26233346|P1|Overall Study|Adverse Event|3
7547632|NCT02506257|26233472|P4|Overall Study|Protocol Violation|0
7547633|NCT02506257|26233473|P3|Overall Study|Protocol Violation|1
7547634|NCT02506257|26233474|P2|Overall Study|Protocol Violation|0
7547635|NCT02506257|26233475|P1|Overall Study|Protocol Violation|0
7547636|NCT02506257|26233472|P4|Overall Study|Adverse Event|0
7547637|NCT02506257|26233473|P3|Overall Study|Adverse Event|3
7547638|NCT02506257|26233474|P2|Overall Study|Adverse Event|2
7547639|NCT02506257|26233475|P1|Overall Study|Adverse Event|0
7547640|NCT02506101|26233507|P2|Overall Study|No enrollment and staff unavailability|0
7547641|NCT02506101|26233508|P1|Overall Study|No enrollment and staff unavailability|1
7547642|NCT02506101|26233507|P2|Overall Study|Transportation issues|0
7547643|NCT02506101|26233508|P1|Overall Study|Transportation issues|1
7547644|NCT02506036|26233524|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
7547645|NCT02506036|26233525|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
7547646|NCT02506036|26233524|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
7547647|NCT02506036|26233525|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
7547648|NCT02506036|26233524|P2|First Intervention (4-6 Weeks)|Death|0
7547649|NCT02506036|26233525|P1|First Intervention (4-6 Weeks)|Death|1
7547650|NCT02505945|26233533|P2|Overall Study|Lost to Follow-up|1
7547651|NCT02505945|26233534|P1|Overall Study|Lost to Follow-up|6
7547652|NCT02505945|26233533|P2|Overall Study|Physician Decision|1
7547653|NCT02505945|26233534|P1|Overall Study|Physician Decision|2
7547654|NCT02505945|26233533|P2|Overall Study|Adverse Event|0
7547655|NCT02505945|26233534|P1|Overall Study|Adverse Event|1
7547656|NCT02505945|26233533|P2|Overall Study|Withdrawal by Subject|2
7547657|NCT02505945|26233534|P1|Overall Study|Withdrawal by Subject|13
7547658|NCT02505867|26233555|P2|Overall Study|Lack of Efficacy|6
7547659|NCT02505867|26233556|P1|Overall Study|Lack of Efficacy|6
7547660|NCT02505542|26233562|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
7547661|NCT02505542|26233563|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
7547662|NCT02505542|26233564|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
7547663|NCT02505542|26233565|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
7547664|NCT02505542|26233562|P4|Part B: Double-Blind Period|Miscalculation|0
7547665|NCT02505542|26233563|P3|Part B: Double-Blind Period|Miscalculation|0
7547666|NCT02505542|26233564|P2|Part B: Double-Blind Period|Miscalculation|1
7547667|NCT02505542|26233565|P1|Part B: Double-Blind Period|Miscalculation|0
7547668|NCT02505542|26233562|P4|Part B: Double-Blind Period|Lack of Efficacy|0
7547669|NCT02505542|26233563|P3|Part B: Double-Blind Period|Lack of Efficacy|0
7547670|NCT02505542|26233564|P2|Part B: Double-Blind Period|Lack of Efficacy|1
7547671|NCT02505542|26233565|P1|Part B: Double-Blind Period|Lack of Efficacy|0
7547672|NCT02505542|26233562|P4|Part B: Double-Blind Period|Patient was moved from the country|1
7547673|NCT02505542|26233563|P3|Part B: Double-Blind Period|Patient was moved from the country|0
7547674|NCT02505542|26233564|P2|Part B: Double-Blind Period|Patient was moved from the country|0
7547675|NCT02505542|26233565|P1|Part B: Double-Blind Period|Patient was moved from the country|0
7547676|NCT02505542|26233562|P4|Part B: Double-Blind Period|Week 94 missed|0
7547677|NCT02505542|26233563|P3|Part B: Double-Blind Period|Week 94 missed|1
7547678|NCT02505542|26233564|P2|Part B: Double-Blind Period|Week 94 missed|0
7547679|NCT02505542|26233565|P1|Part B: Double-Blind Period|Week 94 missed|0
7547680|NCT02505542|26233562|P4|Part B: Double-Blind Period|Planning pregnancy|0
7547681|NCT02505542|26233563|P3|Part B: Double-Blind Period|Planning pregnancy|0
7547682|NCT02505542|26233564|P2|Part B: Double-Blind Period|Planning pregnancy|1
7547683|NCT02505542|26233565|P1|Part B: Double-Blind Period|Planning pregnancy|0
7547684|NCT02505542|26233562|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
7547685|NCT02505542|26233563|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
7547686|NCT02505542|26233564|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
7547687|NCT02505542|26233565|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
7547688|NCT02505542|26233562|P4|Part B: Double-Blind Period|Lost to Follow-up|1
7547689|NCT02505542|26233563|P3|Part B: Double-Blind Period|Lost to Follow-up|0
7547690|NCT02505542|26233564|P2|Part B: Double-Blind Period|Lost to Follow-up|0
7547691|NCT02505542|26233565|P1|Part B: Double-Blind Period|Lost to Follow-up|0
7547692|NCT02505542|26233562|P4|Part B: Double-Blind Period|Adverse Event|3
7547693|NCT02505542|26233563|P3|Part B: Double-Blind Period|Adverse Event|1
7547694|NCT02505542|26233564|P2|Part B: Double-Blind Period|Adverse Event|0
7547695|NCT02505542|26233565|P1|Part B: Double-Blind Period|Adverse Event|0
7547696|NCT02505542|26233562|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7547697|NCT02505542|26233563|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7547698|NCT02505542|26233564|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7547699|NCT02505542|26233565|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
7547700|NCT02505542|26233562|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7547701|NCT02505542|26233563|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7547702|NCT02505542|26233564|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7547703|NCT02505542|26233565|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
7547704|NCT02505542|26233562|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7547705|NCT02505542|26233563|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7547706|NCT02505542|26233564|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7547707|NCT02505542|26233565|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
7547708|NCT02505542|26233562|P4|Part A: Open-Label Period|Non-compliance|0
7547709|NCT02505542|26233563|P3|Part A: Open-Label Period|Non-compliance|0
7547710|NCT02505542|26233564|P2|Part A: Open-Label Period|Non-compliance|0
7547711|NCT02505542|26233565|P1|Part A: Open-Label Period|Non-compliance|1
7547712|NCT02505542|26233562|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
7547713|NCT02505542|26233563|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
7547714|NCT02505542|26233564|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
7547715|NCT02505542|26233565|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
7547716|NCT02505542|26233562|P4|Part A: Open-Label Period|Medical monitor decision|0
7547717|NCT02505542|26233563|P3|Part A: Open-Label Period|Medical monitor decision|0
7547718|NCT02505542|26233564|P2|Part A: Open-Label Period|Medical monitor decision|0
7547719|NCT02505542|26233565|P1|Part A: Open-Label Period|Medical monitor decision|1
7547720|NCT02505542|26233562|P4|Part A: Open-Label Period|Sponsor directive|0
7547721|NCT02505542|26233563|P3|Part A: Open-Label Period|Sponsor directive|0
7547722|NCT02505542|26233564|P2|Part A: Open-Label Period|Sponsor directive|0
7547723|NCT02505542|26233565|P1|Part A: Open-Label Period|Sponsor directive|1
7547724|NCT02505542|26233562|P4|Part A: Open-Label Period|Pregnancy|0
7547725|NCT02505542|26233563|P3|Part A: Open-Label Period|Pregnancy|0
7547726|NCT02505542|26233564|P2|Part A: Open-Label Period|Pregnancy|0
7547727|NCT02505542|26233565|P1|Part A: Open-Label Period|Pregnancy|2
7547728|NCT02505542|26233562|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7547729|NCT02505542|26233563|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7547730|NCT02505542|26233564|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7547731|NCT02505542|26233565|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
7547732|NCT02505542|26233562|P4|Part A: Open-Label Period|New medical history available|0
7547733|NCT02505542|26233563|P3|Part A: Open-Label Period|New medical history available|0
7547734|NCT02505542|26233564|P2|Part A: Open-Label Period|New medical history available|0
7547735|NCT02505542|26233565|P1|Part A: Open-Label Period|New medical history available|1
7547736|NCT02505542|26233562|P4|Part A: Open-Label Period|Withdrawal by Subject|0
7547737|NCT02505542|26233563|P3|Part A: Open-Label Period|Withdrawal by Subject|0
7547738|NCT02505542|26233564|P2|Part A: Open-Label Period|Withdrawal by Subject|0
7547739|NCT02505542|26233565|P1|Part A: Open-Label Period|Withdrawal by Subject|27
7547740|NCT02505542|26233562|P4|Part A: Open-Label Period|Lost to Follow-up|0
7547741|NCT02505542|26233563|P3|Part A: Open-Label Period|Lost to Follow-up|0
7547742|NCT02505542|26233564|P2|Part A: Open-Label Period|Lost to Follow-up|0
7547743|NCT02505542|26233565|P1|Part A: Open-Label Period|Lost to Follow-up|5
7547744|NCT02505542|26233562|P4|Part A: Open-Label Period|Protocol Violation|0
7547745|NCT02505542|26233563|P3|Part A: Open-Label Period|Protocol Violation|0
7547746|NCT02505542|26233564|P2|Part A: Open-Label Period|Protocol Violation|0
7547747|NCT02505542|26233565|P1|Part A: Open-Label Period|Protocol Violation|1
7547748|NCT02505542|26233562|P4|Part A: Open-Label Period|Lack of Efficacy|0
7547749|NCT02505542|26233563|P3|Part A: Open-Label Period|Lack of Efficacy|0
7547750|NCT02505542|26233564|P2|Part A: Open-Label Period|Lack of Efficacy|0
7547751|NCT02505542|26233565|P1|Part A: Open-Label Period|Lack of Efficacy|5
7547752|NCT02505542|26233562|P4|Part A: Open-Label Period|Adverse Event|0
7547753|NCT02505542|26233563|P3|Part A: Open-Label Period|Adverse Event|0
7547754|NCT02505542|26233564|P2|Part A: Open-Label Period|Adverse Event|0
7547755|NCT02505542|26233565|P1|Part A: Open-Label Period|Adverse Event|31
7547756|NCT02505425|26233675|P4|Overall Study|Death|0
7547757|NCT02505425|26233676|P3|Overall Study|Death|0
7547758|NCT02505425|26233677|P2|Overall Study|Death|12
7547759|NCT02505425|26233678|P1|Overall Study|Death|8
7547760|NCT02505425|26233675|P4|Overall Study|Withdrawal by Subject|7
7547761|NCT02505425|26233676|P3|Overall Study|Withdrawal by Subject|19
7547762|NCT02505425|26233677|P2|Overall Study|Withdrawal by Subject|9
7547763|NCT02505425|26233678|P1|Overall Study|Withdrawal by Subject|39
7547764|NCT02505425|26233675|P4|Overall Study|Lost to Follow-up|19
7547765|NCT02505425|26233676|P3|Overall Study|Lost to Follow-up|31
7547766|NCT02505425|26233677|P2|Overall Study|Lost to Follow-up|61
7547767|NCT02505425|26233678|P1|Overall Study|Lost to Follow-up|41
7547768|NCT02505334|26233806|P2|Extension Treatment Period|Unclassified|0
7547769|NCT02505334|26233807|P1|Extension Treatment Period|Unclassified|3
7547770|NCT02505334|26233806|P2|Extension Treatment Period|Withdrawal by Subject|0
7547771|NCT02505334|26233807|P1|Extension Treatment Period|Withdrawal by Subject|6
7547772|NCT02505334|26233806|P2|Extension Treatment Period|Lack of Efficacy|0
7547773|NCT02505334|26233807|P1|Extension Treatment Period|Lack of Efficacy|4
7547774|NCT02505334|26233806|P2|Extension Treatment Period|Adverse Event|0
7547775|NCT02505334|26233807|P1|Extension Treatment Period|Adverse Event|5
7547776|NCT02505334|26233806|P2|Main Treatment Period|Unclassified|10
7547777|NCT02505334|26233807|P1|Main Treatment Period|Unclassified|4
7547778|NCT02505334|26233806|P2|Main Treatment Period|Withdrawal by Subject|8
7547779|NCT02505334|26233807|P1|Main Treatment Period|Withdrawal by Subject|1
7547780|NCT02505334|26233806|P2|Main Treatment Period|Protocol Violation|1
7547781|NCT02505334|26233807|P1|Main Treatment Period|Protocol Violation|0
7547782|NCT02505334|26233806|P2|Main Treatment Period|Lack of Efficacy|17
7547783|NCT02505334|26233807|P1|Main Treatment Period|Lack of Efficacy|7
7547784|NCT02505334|26233806|P2|Main Treatment Period|Adverse Event|3
7547785|NCT02505334|26233807|P1|Main Treatment Period|Adverse Event|3
7547786|NCT02505217|26233940|P2|Overall Study|Withdrawal by Subject|2
7547787|NCT02505217|26233941|P1|Overall Study|Withdrawal by Subject|1
7547788|NCT02504892|26233960|P1|Overall Study|Adverse event-pneumonitis|2
7547789|NCT02504827|26233967|P1|Overall Study|Could not produce sputum|1
7547790|NCT02504671|26234006|P6|Overall Study|Protocol defined stopping criteria|3
7547791|NCT02504671|26234007|P5|Overall Study|Protocol defined stopping criteria|3
7547792|NCT02504671|26234008|P4|Overall Study|Protocol defined stopping criteria|5
7547793|NCT02504671|26234009|P3|Overall Study|Protocol defined stopping criteria|3
7547794|NCT02504671|26234010|P2|Overall Study|Protocol defined stopping criteria|4
7547795|NCT02504671|26234011|P1|Overall Study|Protocol defined stopping criteria|7
7547796|NCT02504671|26234006|P6|Overall Study|Lost to Follow-up|1
7547797|NCT02504671|26234007|P5|Overall Study|Lost to Follow-up|0
7547798|NCT02504671|26234008|P4|Overall Study|Lost to Follow-up|0
7547799|NCT02504671|26234009|P3|Overall Study|Lost to Follow-up|2
7547800|NCT02504671|26234010|P2|Overall Study|Lost to Follow-up|0
7547801|NCT02504671|26234011|P1|Overall Study|Lost to Follow-up|0
7547802|NCT02504671|26234006|P6|Overall Study|Protocol Violation|1
7547803|NCT02504671|26234007|P5|Overall Study|Protocol Violation|0
7547804|NCT02504671|26234008|P4|Overall Study|Protocol Violation|0
7547805|NCT02504671|26234009|P3|Overall Study|Protocol Violation|0
7547806|NCT02504671|26234010|P2|Overall Study|Protocol Violation|1
7547807|NCT02504671|26234011|P1|Overall Study|Protocol Violation|2
7547808|NCT02504671|26234006|P6|Overall Study|Adverse Event|2
7547809|NCT02504671|26234007|P5|Overall Study|Adverse Event|0
7547810|NCT02504671|26234008|P4|Overall Study|Adverse Event|1
7547811|NCT02504671|26234009|P3|Overall Study|Adverse Event|0
7547812|NCT02504671|26234010|P2|Overall Study|Adverse Event|1
7547813|NCT02504671|26234011|P1|Overall Study|Adverse Event|1
7547814|NCT02504671|26234006|P6|Overall Study|Lack of Efficacy|4
7547815|NCT02504671|26234007|P5|Overall Study|Lack of Efficacy|4
7547816|NCT02504671|26234008|P4|Overall Study|Lack of Efficacy|0
7547817|NCT02504671|26234009|P3|Overall Study|Lack of Efficacy|1
7547818|NCT02504671|26234010|P2|Overall Study|Lack of Efficacy|3
7547819|NCT02504671|26234011|P1|Overall Study|Lack of Efficacy|1
7547820|NCT02504671|26234006|P6|Overall Study|Withdrawal by Subject|3
7547821|NCT02504671|26234007|P5|Overall Study|Withdrawal by Subject|5
7547822|NCT02504671|26234008|P4|Overall Study|Withdrawal by Subject|4
7547823|NCT02504671|26234009|P3|Overall Study|Withdrawal by Subject|4
7547824|NCT02504671|26234010|P2|Overall Study|Withdrawal by Subject|5
7547825|NCT02504671|26234011|P1|Overall Study|Withdrawal by Subject|1
7547826|NCT02504541|26234183|P1|Overall Study|Multiple|5
7547827|NCT02504541|26234183|P1|Overall Study|Other|2
7547828|NCT02504541|26234183|P1|Overall Study|Termination by Sponsor|1
7547829|NCT02504541|26234183|P1|Overall Study|Protocol Violation|2
7547830|NCT02504541|26234183|P1|Overall Study|Met Stopping Criteria|1
7547831|NCT02504541|26234183|P1|Overall Study|Lost to Follow-up|1
7547832|NCT02504541|26234183|P1|Overall Study|Withdrawal by Subject|4
7547833|NCT02504541|26234183|P1|Overall Study|Adverse Event|4
7547834|NCT02504502|26234189|P2|Crossover to Enhanced Report|Lost to Follow-up|0
7547835|NCT02504502|26234190|P1|Crossover to Enhanced Report|Lost to Follow-up|5
7547836|NCT02504502|26234189|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
7547837|NCT02504502|26234190|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
7547838|NCT02504424|26234196|P1|Overall Study|Withdrawal by Subject|2
7547839|NCT02504320|26234205|P4|Treatment Period 3|Adverse Event|0
7547840|NCT02504320|26234206|P3|Treatment Period 3|Adverse Event|1
7547841|NCT02504320|26234207|P2|Treatment Period 3|Adverse Event|0
7547842|NCT02504320|26234208|P1|Treatment Period 3|Adverse Event|0
7547843|NCT02504320|26234205|P4|Treatment Period 3|Positive Drug Screen|1
7547844|NCT02504320|26234206|P3|Treatment Period 3|Positive Drug Screen|0
7547845|NCT02504320|26234207|P2|Treatment Period 3|Positive Drug Screen|0
7547846|NCT02504320|26234208|P1|Treatment Period 3|Positive Drug Screen|0
7547847|NCT02504320|26234205|P4|Treatment Period 2|Positive Drug Screen|0
7547848|NCT02504320|26234206|P3|Treatment Period 2|Positive Drug Screen|0
7547849|NCT02504320|26234207|P2|Treatment Period 2|Positive Drug Screen|1
7547850|NCT02504320|26234208|P1|Treatment Period 2|Positive Drug Screen|0
7547851|NCT02504320|26234205|P4|Treatment Period 1|Positive Drug Screen|0
7547852|NCT02504320|26234206|P3|Treatment Period 1|Positive Drug Screen|1
7547853|NCT02504320|26234207|P2|Treatment Period 1|Positive Drug Screen|0
7547854|NCT02504320|26234208|P1|Treatment Period 1|Positive Drug Screen|0
7547855|NCT02504294|26234228|P2|Overall Study|Lost to Follow-up|7
7547856|NCT02504294|26234229|P1|Overall Study|Lost to Follow-up|6
7547857|NCT02504294|26234228|P2|Overall Study|Physician Decision|2
7547858|NCT02504294|26234229|P1|Overall Study|Physician Decision|1
7547859|NCT02504294|26234228|P2|Overall Study|Protocol Violation|26
7547860|NCT02504294|26234229|P1|Overall Study|Protocol Violation|27
7547861|NCT02504294|26234228|P2|Overall Study|Withdrawal by Subject|1
7547862|NCT02504294|26234229|P1|Overall Study|Withdrawal by Subject|7
7547863|NCT02504294|26234228|P2|Overall Study|Adverse Event|12
7547864|NCT02504294|26234229|P1|Overall Study|Adverse Event|15
7547865|NCT02504268|26234240|P9|Overall Study|Not Disclosed|0
7547866|NCT02504268|26234241|P8|Overall Study|Not Disclosed|0
7547867|NCT02504268|26234242|P7|Overall Study|Not Disclosed|0
7547868|NCT02504268|26234243|P6|Overall Study|Not Disclosed|0
7547869|NCT02504268|26234244|P5|Overall Study|Not Disclosed|0
7547870|NCT02504268|26234245|P4|Overall Study|Not Disclosed|0
7547871|NCT02504268|26234246|P3|Overall Study|Not Disclosed|2
7547872|NCT02504268|26234247|P2|Overall Study|Not Disclosed|0
7547873|NCT02504268|26234248|P1|Overall Study|Not Disclosed|1
7547874|NCT02504268|26234240|P9|Overall Study|Poor/Non-Compliance|0
7547875|NCT02504268|26234241|P8|Overall Study|Poor/Non-Compliance|0
7547876|NCT02504268|26234242|P7|Overall Study|Poor/Non-Compliance|0
7547877|NCT02504268|26234243|P6|Overall Study|Poor/Non-Compliance|0
7547878|NCT02504268|26234244|P5|Overall Study|Poor/Non-Compliance|0
7547879|NCT02504268|26234245|P4|Overall Study|Poor/Non-Compliance|0
7547880|NCT02504268|26234246|P3|Overall Study|Poor/Non-Compliance|3
7547881|NCT02504268|26234247|P2|Overall Study|Poor/Non-Compliance|2
7547882|NCT02504268|26234248|P1|Overall Study|Poor/Non-Compliance|3
7547883|NCT02504268|26234240|P9|Overall Study|Lack of Efficacy|0
7547884|NCT02504268|26234241|P8|Overall Study|Lack of Efficacy|0
7547885|NCT02504268|26234242|P7|Overall Study|Lack of Efficacy|0
7547886|NCT02504268|26234243|P6|Overall Study|Lack of Efficacy|0
7547887|NCT02504268|26234244|P5|Overall Study|Lack of Efficacy|0
7547888|NCT02504268|26234245|P4|Overall Study|Lack of Efficacy|0
7547889|NCT02504268|26234246|P3|Overall Study|Lack of Efficacy|9
7547890|NCT02504268|26234247|P2|Overall Study|Lack of Efficacy|35
7547891|NCT02504268|26234248|P1|Overall Study|Lack of Efficacy|11
7547892|NCT02504268|26234240|P9|Overall Study|No Longer Meets Study Criteria|0
7547893|NCT02504268|26234241|P8|Overall Study|No Longer Meets Study Criteria|0
7547894|NCT02504268|26234242|P7|Overall Study|No Longer Meets Study Criteria|0
7547895|NCT02504268|26234243|P6|Overall Study|No Longer Meets Study Criteria|0
7547896|NCT02504268|26234244|P5|Overall Study|No Longer Meets Study Criteria|0
7547897|NCT02504268|26234245|P4|Overall Study|No Longer Meets Study Criteria|0
7547898|NCT02504268|26234246|P3|Overall Study|No Longer Meets Study Criteria|0
7547899|NCT02504268|26234247|P2|Overall Study|No Longer Meets Study Criteria|3
7547900|NCT02504268|26234248|P1|Overall Study|No Longer Meets Study Criteria|2
7547901|NCT02504268|26234240|P9|Overall Study|Subject Request to Discontinue|0
7547902|NCT02504268|26234241|P8|Overall Study|Subject Request to Discontinue|0
7547903|NCT02504268|26234242|P7|Overall Study|Subject Request to Discontinue|0
7547904|NCT02504268|26234243|P6|Overall Study|Subject Request to Discontinue|0
7547905|NCT02504268|26234244|P5|Overall Study|Subject Request to Discontinue|0
7547906|NCT02504268|26234245|P4|Overall Study|Subject Request to Discontinue|0
7547907|NCT02504268|26234246|P3|Overall Study|Subject Request to Discontinue|6
7547908|NCT02504268|26234247|P2|Overall Study|Subject Request to Discontinue|3
7547909|NCT02504268|26234248|P1|Overall Study|Subject Request to Discontinue|11
7547910|NCT02504268|26234240|P9|Overall Study|Death|0
7547911|NCT02504268|26234241|P8|Overall Study|Death|0
7547912|NCT02504268|26234242|P7|Overall Study|Death|0
7547913|NCT02504268|26234243|P6|Overall Study|Death|0
7547914|NCT02504268|26234244|P5|Overall Study|Death|0
7547915|NCT02504268|26234245|P4|Overall Study|Death|0
7547916|NCT02504268|26234246|P3|Overall Study|Death|0
7547917|NCT02504268|26234247|P2|Overall Study|Death|1
7547918|NCT02504268|26234248|P1|Overall Study|Death|1
7547919|NCT02504268|26234240|P9|Overall Study|Lost to Follow-up|0
7547920|NCT02504268|26234241|P8|Overall Study|Lost to Follow-up|0
7547921|NCT02504268|26234242|P7|Overall Study|Lost to Follow-up|0
7547922|NCT02504268|26234243|P6|Overall Study|Lost to Follow-up|0
7547923|NCT02504268|26234244|P5|Overall Study|Lost to Follow-up|0
7547924|NCT02504268|26234245|P4|Overall Study|Lost to Follow-up|0
7547925|NCT02504268|26234246|P3|Overall Study|Lost to Follow-up|4
7547926|NCT02504268|26234247|P2|Overall Study|Lost to Follow-up|6
7547927|NCT02504268|26234248|P1|Overall Study|Lost to Follow-up|3
7547928|NCT02504268|26234240|P9|Overall Study|Pregnancy|0
7547929|NCT02504268|26234241|P8|Overall Study|Pregnancy|0
7547930|NCT02504268|26234242|P7|Overall Study|Pregnancy|0
7547931|NCT02504268|26234243|P6|Overall Study|Pregnancy|0
7547932|NCT02504268|26234244|P5|Overall Study|Pregnancy|0
7547933|NCT02504268|26234245|P4|Overall Study|Pregnancy|0
7547934|NCT02504268|26234246|P3|Overall Study|Pregnancy|0
7547935|NCT02504268|26234247|P2|Overall Study|Pregnancy|0
7547936|NCT02504268|26234248|P1|Overall Study|Pregnancy|2
7547937|NCT02504268|26234240|P9|Overall Study|Withdrawal of Consent|0
7547938|NCT02504268|26234241|P8|Overall Study|Withdrawal of Consent|0
7547939|NCT02504268|26234242|P7|Overall Study|Withdrawal of Consent|0
7547940|NCT02504268|26234243|P6|Overall Study|Withdrawal of Consent|0
7547941|NCT02504268|26234244|P5|Overall Study|Withdrawal of Consent|0
7547942|NCT02504268|26234245|P4|Overall Study|Withdrawal of Consent|0
7547943|NCT02504268|26234246|P3|Overall Study|Withdrawal of Consent|3
7547944|NCT02504268|26234247|P2|Overall Study|Withdrawal of Consent|10
7547945|NCT02504268|26234248|P1|Overall Study|Withdrawal of Consent|11
7547946|NCT02504268|26234240|P9|Overall Study|Adverse Event|0
7547947|NCT02504268|26234241|P8|Overall Study|Adverse Event|0
7547948|NCT02504268|26234242|P7|Overall Study|Adverse Event|0
7547949|NCT02504268|26234243|P6|Overall Study|Adverse Event|0
7547950|NCT02504268|26234244|P5|Overall Study|Adverse Event|0
7547951|NCT02504268|26234245|P4|Overall Study|Adverse Event|0
7547952|NCT02504268|26234246|P3|Overall Study|Adverse Event|14
7547953|NCT02504268|26234247|P2|Overall Study|Adverse Event|8
7547954|NCT02504268|26234248|P1|Overall Study|Adverse Event|18
7547955|NCT02504216|26234306|P2|Overall Study|Withdrawal by Subject|12
7547956|NCT02504216|26234307|P1|Overall Study|Withdrawal by Subject|8
7547957|NCT02504216|26234306|P2|Overall Study|Lost to Follow-up|3
7547958|NCT02504216|26234307|P1|Overall Study|Lost to Follow-up|3
7547959|NCT02503865|26234354|P3|Overall Study|Refused treatment|2
7547960|NCT02503865|26234355|P2|Overall Study|Refused treatment|39
7547961|NCT02503865|26234356|P1|Overall Study|Refused treatment|4
7547962|NCT02503865|26234354|P3|Overall Study|Moved out of area|0
7547963|NCT02503865|26234355|P2|Overall Study|Moved out of area|8
7547964|NCT02503865|26234356|P1|Overall Study|Moved out of area|1
7547965|NCT02503787|26234401|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
7547966|NCT02503787|26234401|P1|Implant to 3 Month Endpoint|Adverse Event|2
7547967|NCT02503787|26234401|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
7547968|NCT02503787|26234401|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
7547969|NCT02503787|26234401|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
7547970|NCT02503787|26234401|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
7547971|NCT02503787|26234401|P1|Enrollment|Unable to be programmed|1
7547972|NCT02503787|26234401|P1|Enrollment|Inability to implant system|1
7547973|NCT02503787|26234401|P1|Enrollment|Protocol Violation|1
7547974|NCT02503787|26234401|P1|Enrollment|Adverse Event|1
7547975|NCT02503787|26234401|P1|Enrollment|Study closure|1
7547976|NCT02503787|26234401|P1|Enrollment|Lost to Follow-up|1
7547977|NCT02503787|26234401|P1|Enrollment|Insurance issue|2
7547978|NCT02503787|26234401|P1|Enrollment|Physician Decision|2
7547979|NCT02503787|26234401|P1|Enrollment|Inclusion/exclusion criteria not met|4
7547980|NCT02503787|26234401|P1|Enrollment|Withdrawal by Subject|6
7547981|NCT02503540|26234418|P1|Overall Study|Withdrawal by Subject|1
7547982|NCT02503540|26234418|P1|Overall Study|Death|2
7547983|NCT02503501|26234440|P2|Overall Study|Withdrawal by Subject|2
7547984|NCT02503501|26234441|P1|Overall Study|Withdrawal by Subject|0
7547985|NCT02503501|26234440|P2|Overall Study|Protocol Violation|1
7547986|NCT02503501|26234441|P1|Overall Study|Protocol Violation|0
7547987|NCT02503501|26234440|P2|Overall Study|Physician Decision|0
7547988|NCT02503501|26234441|P1|Overall Study|Physician Decision|1
7547989|NCT02503332|26234477|P4|Overall Study|Other|1
7547990|NCT02503332|26234478|P3|Overall Study|Other|1
7547991|NCT02503332|26234479|P2|Overall Study|Other|6
7547992|NCT02503332|26234480|P1|Overall Study|Other|5
7547993|NCT02503332|26234477|P4|Overall Study|Death|0
7547994|NCT02503332|26234478|P3|Overall Study|Death|2
7547995|NCT02503332|26234479|P2|Overall Study|Death|2
7547996|NCT02503332|26234480|P1|Overall Study|Death|0
7547997|NCT02503332|26234477|P4|Overall Study|Subject Request|1
7547998|NCT02503332|26234478|P3|Overall Study|Subject Request|2
7547999|NCT02503332|26234479|P2|Overall Study|Subject Request|5
7548000|NCT02503332|26234480|P1|Overall Study|Subject Request|6
7548001|NCT02503332|26234477|P4|Overall Study|Sponsor's Decision|1
7548002|NCT02503332|26234478|P3|Overall Study|Sponsor's Decision|0
7548003|NCT02503332|26234479|P2|Overall Study|Sponsor's Decision|0
7548004|NCT02503332|26234480|P1|Overall Study|Sponsor's Decision|1
7548005|NCT02503332|26234477|P4|Overall Study|Investigator's Decision|0
7548006|NCT02503332|26234478|P3|Overall Study|Investigator's Decision|0
7548007|NCT02503332|26234479|P2|Overall Study|Investigator's Decision|1
7548008|NCT02503332|26234480|P1|Overall Study|Investigator's Decision|5
7548009|NCT02503332|26234477|P4|Overall Study|Adverse Event|1
7548010|NCT02503332|26234478|P3|Overall Study|Adverse Event|3
7548011|NCT02503332|26234479|P2|Overall Study|Adverse Event|5
7548012|NCT02503332|26234480|P1|Overall Study|Adverse Event|17
7548013|NCT02503215|26234531|P1|Overall Study|Unable to use positive airway pressure|2
7548014|NCT02503215|26234531|P1|Overall Study|Unable to wear compression stockings|1
7548015|NCT02503202|26234542|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
7548016|NCT02503202|26234543|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
7548017|NCT02503202|26234544|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
7548018|NCT02503202|26234545|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
7548019|NCT02503202|26234546|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
7548020|NCT02503202|26234542|P5|Extension: Month 6 to 24|Physician Decision|0
7548021|NCT02503202|26234543|P4|Extension: Month 6 to 24|Physician Decision|3
7548022|NCT02503202|26234544|P3|Extension: Month 6 to 24|Physician Decision|1
7548023|NCT02503202|26234545|P2|Extension: Month 6 to 24|Physician Decision|0
7548024|NCT02503202|26234546|P1|Extension: Month 6 to 24|Physician Decision|1
7548025|NCT02503202|26234542|P5|Extension: Month 6 to 24|Lost to Follow-up|1
7548026|NCT02503202|26234543|P4|Extension: Month 6 to 24|Lost to Follow-up|10
7548027|NCT02503202|26234544|P3|Extension: Month 6 to 24|Lost to Follow-up|6
7548028|NCT02503202|26234545|P2|Extension: Month 6 to 24|Lost to Follow-up|8
7548029|NCT02503202|26234546|P1|Extension: Month 6 to 24|Lost to Follow-up|4
7548030|NCT02503202|26234542|P5|Extension: Month 6 to 24|Death|0
7548031|NCT02503202|26234543|P4|Extension: Month 6 to 24|Death|0
7548032|NCT02503202|26234544|P3|Extension: Month 6 to 24|Death|0
7548033|NCT02503202|26234545|P2|Extension: Month 6 to 24|Death|0
7548034|NCT02503202|26234546|P1|Extension: Month 6 to 24|Death|1
7548035|NCT02503202|26234542|P5|Extension: Month 6 to 24|Protocol Violation|0
7548036|NCT02503202|26234543|P4|Extension: Month 6 to 24|Protocol Violation|1
7548037|NCT02503202|26234544|P3|Extension: Month 6 to 24|Protocol Violation|0
7548038|NCT02503202|26234545|P2|Extension: Month 6 to 24|Protocol Violation|0
7548039|NCT02503202|26234546|P1|Extension: Month 6 to 24|Protocol Violation|0
7548040|NCT02503202|26234542|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
7548041|NCT02503202|26234543|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
7548042|NCT02503202|26234544|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
7548043|NCT02503202|26234545|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
7548044|NCT02503202|26234546|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
7548045|NCT02503202|26234542|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
7548046|NCT02503202|26234543|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
7548047|NCT02503202|26234544|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
7548048|NCT02503202|26234545|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
7548049|NCT02503202|26234546|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
7548050|NCT02503202|26234542|P5|Base Study: Up to Month 6|Physician Decision|1
7548051|NCT02503202|26234543|P4|Base Study: Up to Month 6|Physician Decision|0
7548052|NCT02503202|26234544|P3|Base Study: Up to Month 6|Physician Decision|0
7548053|NCT02503202|26234545|P2|Base Study: Up to Month 6|Physician Decision|0
7548054|NCT02503202|26234546|P1|Base Study: Up to Month 6|Physician Decision|0
7548055|NCT02503202|26234542|P5|Base Study: Up to Month 6|Lost to Follow-up|1
7548056|NCT02503202|26234543|P4|Base Study: Up to Month 6|Lost to Follow-up|5
7548057|NCT02503202|26234544|P3|Base Study: Up to Month 6|Lost to Follow-up|10
7548058|NCT02503202|26234545|P2|Base Study: Up to Month 6|Lost to Follow-up|8
7548059|NCT02503202|26234546|P1|Base Study: Up to Month 6|Lost to Follow-up|11
7548060|NCT02503202|26234542|P5|Base Study: Up to Month 6|Death|0
7548061|NCT02503202|26234543|P4|Base Study: Up to Month 6|Death|0
7548062|NCT02503202|26234544|P3|Base Study: Up to Month 6|Death|0
7548063|NCT02503202|26234545|P2|Base Study: Up to Month 6|Death|1
7548064|NCT02503202|26234546|P1|Base Study: Up to Month 6|Death|1
7548065|NCT02503085|26234588|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7548066|NCT02503085|26234589|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7548067|NCT02503085|26234590|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7548068|NCT02503085|26234591|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7548069|NCT02502864|26234630|P1|Overall Study|Withdrawal by Subject|1
7548070|NCT02502734|26234639|P2|Washout Period|Adverse Event|0
7548071|NCT02502734|26234640|P1|Washout Period|Adverse Event|1
7548072|NCT02502734|26234639|P2|Double-blind Treatment Period 1|Adverse Event|0
7548073|NCT02502734|26234640|P1|Double-blind Treatment Period 1|Adverse Event|1
7548074|NCT02502526|26234651|P3|Overall Study|Enrollment suspension|1
7548075|NCT02502526|26234652|P2|Overall Study|Enrollment suspension|1
7548076|NCT02502526|26234653|P1|Overall Study|Enrollment suspension|4
7548077|NCT02502526|26234651|P3|Overall Study|Disqualified due to cataract grading|1
7548078|NCT02502526|26234652|P2|Overall Study|Disqualified due to cataract grading|0
7548079|NCT02502526|26234653|P1|Overall Study|Disqualified due to cataract grading|0
7548080|NCT02502526|26234651|P3|Overall Study|Withdrawal by Subject|1
7548081|NCT02502526|26234652|P2|Overall Study|Withdrawal by Subject|1
7548082|NCT02502526|26234653|P1|Overall Study|Withdrawal by Subject|0
7548083|NCT02502526|26234651|P3|Overall Study|Lost to Follow-up|3
7548084|NCT02502526|26234652|P2|Overall Study|Lost to Follow-up|2
7548085|NCT02502526|26234653|P1|Overall Study|Lost to Follow-up|2
7548086|NCT02502149|26234750|P5|Intermediate|Discontinued prematurely|0
7548087|NCT02502149|26234751|P4|Intermediate|Discontinued prematurely|0
7548088|NCT02502149|26234752|P3|Intermediate|Discontinued prematurely|0
7548089|NCT02502149|26234753|P2|Intermediate|Discontinued prematurely|0
7548090|NCT02502149|26234754|P1|Intermediate|Discontinued prematurely|1
7548091|NCT02502097|26234877|P4|Period 2|Adverse Event|0
7548092|NCT02502097|26234878|P3|Period 2|Adverse Event|1
7548093|NCT02502097|26234879|P2|Period 2|Adverse Event|0
7548094|NCT02502097|26234880|P1|Period 2|Adverse Event|0
7548095|NCT02502097|26234877|P4|Wash Out Period|Adverse Event|1
7548096|NCT02502097|26234878|P3|Wash Out Period|Adverse Event|1
7548097|NCT02502097|26234879|P2|Wash Out Period|Adverse Event|1
7548098|NCT02502097|26234880|P1|Wash Out Period|Adverse Event|0
7548099|NCT02502097|26234877|P4|Period 1|Adverse Event|0
7548100|NCT02502097|26234878|P3|Period 1|Adverse Event|1
7548101|NCT02502097|26234879|P2|Period 1|Adverse Event|0
7548102|NCT02502097|26234880|P1|Period 1|Adverse Event|0
7548103|NCT02501928|26234973|P6|Overall Study|Withdrawal By Parent/Guardian|0
7548104|NCT02501928|26234974|P5|Overall Study|Withdrawal By Parent/Guardian|1
7548105|NCT02501928|26234975|P4|Overall Study|Withdrawal By Parent/Guardian|0
7548106|NCT02501928|26234976|P3|Overall Study|Withdrawal By Parent/Guardian|0
7548107|NCT02501928|26234977|P2|Overall Study|Withdrawal By Parent/Guardian|0
7548108|NCT02501928|26234978|P1|Overall Study|Withdrawal By Parent/Guardian|0
7548109|NCT02501902|26235204|P8|Overall Study|Death|15
7548110|NCT02501902|26235205|P7|Overall Study|Death|7
7548111|NCT02501902|26235206|P6|Overall Study|Death|11
7548112|NCT02501902|26235207|P5|Overall Study|Death|10
7548113|NCT02501902|26235208|P4|Overall Study|Death|10
7548114|NCT02501902|26235209|P3|Overall Study|Death|4
7548115|NCT02501902|26235210|P2|Overall Study|Death|4
7548116|NCT02501902|26235211|P1|Overall Study|Death|3
7548117|NCT02501902|26235204|P8|Overall Study|Study Terminated by Sponsor|4
7548118|NCT02501902|26235205|P7|Overall Study|Study Terminated by Sponsor|2
7548119|NCT02501902|26235206|P6|Overall Study|Study Terminated by Sponsor|0
7548120|NCT02501902|26235207|P5|Overall Study|Study Terminated by Sponsor|1
7548121|NCT02501902|26235208|P4|Overall Study|Study Terminated by Sponsor|1
7548122|NCT02501902|26235209|P3|Overall Study|Study Terminated by Sponsor|0
7548123|NCT02501902|26235210|P2|Overall Study|Study Terminated by Sponsor|3
7548124|NCT02501902|26235211|P1|Overall Study|Study Terminated by Sponsor|0
7548125|NCT02501902|26235204|P8|Overall Study|Subject Refused Further Follow-up|1
7548126|NCT02501902|26235205|P7|Overall Study|Subject Refused Further Follow-up|0
7548127|NCT02501902|26235206|P6|Overall Study|Subject Refused Further Follow-up|0
7548128|NCT02501902|26235207|P5|Overall Study|Subject Refused Further Follow-up|0
7548129|NCT02501902|26235208|P4|Overall Study|Subject Refused Further Follow-up|0
7548130|NCT02501902|26235209|P3|Overall Study|Subject Refused Further Follow-up|0
7548131|NCT02501902|26235210|P2|Overall Study|Subject Refused Further Follow-up|0
7548132|NCT02501902|26235211|P1|Overall Study|Subject Refused Further Follow-up|0
7548133|NCT02501811|26235476|P4|Overall Study|Lost to Follow-up|1
7548134|NCT02501811|26235477|P3|Overall Study|Lost to Follow-up|2
7548135|NCT02501811|26235478|P2|Overall Study|Lost to Follow-up|0
7548136|NCT02501811|26235479|P1|Overall Study|Lost to Follow-up|0
7548137|NCT02501811|26235476|P4|Overall Study|Withdrawal by Subject|3
7548138|NCT02501811|26235477|P3|Overall Study|Withdrawal by Subject|2
7548139|NCT02501811|26235478|P2|Overall Study|Withdrawal by Subject|3
7548140|NCT02501811|26235479|P1|Overall Study|Withdrawal by Subject|3
7548141|NCT02501811|26235476|P4|Overall Study|Death|3
7548142|NCT02501811|26235477|P3|Overall Study|Death|2
7548143|NCT02501811|26235478|P2|Overall Study|Death|3
7548144|NCT02501811|26235479|P1|Overall Study|Death|1
7548145|NCT02501629|26235629|P2|Overall Study|Subject did not return to site|1
7548146|NCT02501629|26235630|P1|Overall Study|Subject did not return to site|0
7548147|NCT02501629|26235629|P2|Overall Study|Withdrawal by Subject|5
7548148|NCT02501629|26235630|P1|Overall Study|Withdrawal by Subject|3
7548149|NCT02501629|26235629|P2|Overall Study|Early termination by sponsor|0
7548150|NCT02501629|26235630|P1|Overall Study|Early termination by sponsor|1
7548151|NCT02501629|26235629|P2|Overall Study|Withdrawn from study by sponsor|0
7548152|NCT02501629|26235630|P1|Overall Study|Withdrawn from study by sponsor|1
7548153|NCT02501629|26235629|P2|Overall Study|Death|1
7548154|NCT02501629|26235630|P1|Overall Study|Death|0
7548155|NCT02501473|26235676|P8|Overall Study|Reason not specified|0
7548156|NCT02501473|26235677|P7|Overall Study|Reason not specified|0
7548157|NCT02501473|26235678|P6|Overall Study|Reason not specified|0
7548158|NCT02501473|26235679|P5|Overall Study|Reason not specified|0
7548159|NCT02501473|26235680|P4|Overall Study|Reason not specified|1
7548160|NCT02501473|26235681|P3|Overall Study|Reason not specified|1
7548161|NCT02501473|26235682|P2|Overall Study|Reason not specified|0
7548162|NCT02501473|26235683|P1|Overall Study|Reason not specified|0
7548163|NCT02501473|26235676|P8|Overall Study|Lost to Follow-up|0
7548164|NCT02501473|26235677|P7|Overall Study|Lost to Follow-up|0
7548165|NCT02501473|26235678|P6|Overall Study|Lost to Follow-up|1
7548166|NCT02501473|26235679|P5|Overall Study|Lost to Follow-up|0
7548167|NCT02501473|26235680|P4|Overall Study|Lost to Follow-up|0
7548168|NCT02501473|26235681|P3|Overall Study|Lost to Follow-up|1
7548169|NCT02501473|26235682|P2|Overall Study|Lost to Follow-up|0
7548170|NCT02501473|26235683|P1|Overall Study|Lost to Follow-up|1
7548171|NCT02501473|26235676|P8|Overall Study|Death|0
7548172|NCT02501473|26235677|P7|Overall Study|Death|0
7548173|NCT02501473|26235678|P6|Overall Study|Death|1
7548174|NCT02501473|26235679|P5|Overall Study|Death|0
7548175|NCT02501473|26235680|P4|Overall Study|Death|1
7548176|NCT02501473|26235681|P3|Overall Study|Death|1
7548177|NCT02501473|26235682|P2|Overall Study|Death|0
7548178|NCT02501473|26235683|P1|Overall Study|Death|0
7548179|NCT02501473|26235676|P8|Overall Study|Withdrawal by Subject|0
7548180|NCT02501473|26235677|P7|Overall Study|Withdrawal by Subject|0
7548181|NCT02501473|26235678|P6|Overall Study|Withdrawal by Subject|2
7548182|NCT02501473|26235679|P5|Overall Study|Withdrawal by Subject|2
7548183|NCT02501473|26235680|P4|Overall Study|Withdrawal by Subject|3
7548184|NCT02501473|26235681|P3|Overall Study|Withdrawal by Subject|3
7548185|NCT02501473|26235682|P2|Overall Study|Withdrawal by Subject|0
7548186|NCT02501473|26235683|P1|Overall Study|Withdrawal by Subject|0
7548187|NCT02501473|26235676|P8|Overall Study|Study Terminated|0
7548188|NCT02501473|26235677|P7|Overall Study|Study Terminated|1
7548189|NCT02501473|26235678|P6|Overall Study|Study Terminated|10
7548190|NCT02501473|26235679|P5|Overall Study|Study Terminated|2
7548191|NCT02501473|26235680|P4|Overall Study|Study Terminated|9
7548192|NCT02501473|26235681|P3|Overall Study|Study Terminated|7
7548193|NCT02501473|26235682|P2|Overall Study|Study Terminated|3
7548194|NCT02501473|26235683|P1|Overall Study|Study Terminated|2
7548195|NCT02501161|26235811|P2|Overall Study|Other|0
7548196|NCT02501161|26235812|P1|Overall Study|Other|3
7548197|NCT02501161|26235811|P2|Overall Study|Withdrawal by Subject|15
7548198|NCT02501161|26235812|P1|Overall Study|Withdrawal by Subject|10
7548199|NCT02501161|26235811|P2|Overall Study|Lost to Follow-up|4
7548200|NCT02501161|26235812|P1|Overall Study|Lost to Follow-up|7
7548201|NCT02501161|26235811|P2|Overall Study|Adverse Event|6
7548202|NCT02501161|26235812|P1|Overall Study|Adverse Event|2
7548203|NCT02500979|26235936|P2|Period 2|Change in risk|0
7548204|NCT02500979|26235937|P1|Period 2|Change in risk|1
7548205|NCT02500979|26235936|P2|Period 1|Subject decision|0
7548206|NCT02500979|26235937|P1|Period 1|Subject decision|2
7548207|NCT02500979|26235936|P2|Period 1|Adverse Event|0
7548208|NCT02500979|26235937|P1|Period 1|Adverse Event|1
7548209|NCT02500979|26235936|P2|Period 1|Severe non-compliance to protocol|1
7548210|NCT02500979|26235937|P1|Period 1|Severe non-compliance to protocol|0
7548211|NCT02500979|26235936|P2|Period 1|Hyperglycemia|0
7548212|NCT02500979|26235937|P1|Period 1|Hyperglycemia|1
7548213|NCT02500901|26235971|P1|Overall Study|Disease ProgressionDD|2
7548214|NCT02500797|26235999|P8|Overall Study|Withdrawal by Subject|0
7548215|NCT02500797|26236000|P7|Overall Study|Withdrawal by Subject|0
7548216|NCT02500797|26236001|P6|Overall Study|Withdrawal by Subject|0
7548217|NCT02500797|26236002|P5|Overall Study|Withdrawal by Subject|0
7548218|NCT02500797|26236003|P4|Overall Study|Withdrawal by Subject|0
7548219|NCT02500797|26236004|P3|Overall Study|Withdrawal by Subject|0
7548220|NCT02500797|26236005|P2|Overall Study|Withdrawal by Subject|0
7548221|NCT02500797|26236006|P1|Overall Study|Withdrawal by Subject|1
7548222|NCT02500797|26235999|P8|Overall Study|Cancel (rapid disease progression)|0
7548223|NCT02500797|26236000|P7|Overall Study|Cancel (rapid disease progression)|0
7548224|NCT02500797|26236001|P6|Overall Study|Cancel (rapid disease progression)|1
7548225|NCT02500797|26236002|P5|Overall Study|Cancel (rapid disease progression)|1
7548226|NCT02500797|26236003|P4|Overall Study|Cancel (rapid disease progression)|0
7548227|NCT02500797|26236004|P3|Overall Study|Cancel (rapid disease progression)|0
7548228|NCT02500797|26236005|P2|Overall Study|Cancel (rapid disease progression)|0
7548229|NCT02500797|26236006|P1|Overall Study|Cancel (rapid disease progression)|0
7548230|NCT02500758|26236066|P2|Second Intervention (2 Minutes)|Protocol Violation|1
7548231|NCT02500758|26236067|P1|Second Intervention (2 Minutes)|Protocol Violation|1
7548232|NCT02500758|26236066|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
7548233|NCT02500758|26236067|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
7548234|NCT02500758|26236066|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
7548235|NCT02500758|26236067|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
7548236|NCT02500758|26236066|P2|Washout (1 Week)|Lost to Follow-up|2
7548237|NCT02500758|26236067|P1|Washout (1 Week)|Lost to Follow-up|2
7548238|NCT02500758|26236066|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
7548239|NCT02500758|26236067|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
7548240|NCT02500732|26236077|P2|Overall Study|Physician Decision|1
7548241|NCT02500732|26236078|P1|Overall Study|Physician Decision|0
7548242|NCT02500719|26236094|P2|Overall Study|History of head trauma|1
7548243|NCT02500719|26236095|P1|Overall Study|History of head trauma|0
7548244|NCT02500719|26236094|P2|Overall Study|Claustrophobia|1
7548245|NCT02500719|26236095|P1|Overall Study|Claustrophobia|0
7548246|NCT02500719|26236094|P2|Overall Study|Did not meet criteria for PTSD|1
7548247|NCT02500719|26236095|P1|Overall Study|Did not meet criteria for PTSD|0
7548248|NCT02500719|26236094|P2|Overall Study|MRI data found to be unusable during analysis|1
7548249|NCT02500719|26236095|P1|Overall Study|MRI data found to be unusable during analysis|0
7548250|NCT02500719|26236094|P2|Overall Study|Trauma history|0
7548251|NCT02500719|26236095|P1|Overall Study|Trauma history|1
7548252|NCT02500719|26236094|P2|Overall Study|Lost to Follow-up|3
7548253|NCT02500719|26236095|P1|Overall Study|Lost to Follow-up|2
7548254|NCT02500706|26236104|P3|Overall Study|Unclassified|1
7548255|NCT02500706|26236105|P2|Overall Study|Unclassified|0
7548256|NCT02500706|26236106|P1|Overall Study|Unclassified|0
7548257|NCT02500706|26236104|P3|Overall Study|Withdrawal by Subject|4
7548258|NCT02500706|26236105|P2|Overall Study|Withdrawal by Subject|6
7548259|NCT02500706|26236106|P1|Overall Study|Withdrawal by Subject|4
7548260|NCT02500706|26236104|P3|Overall Study|Lost to Follow-up|1
7548261|NCT02500706|26236105|P2|Overall Study|Lost to Follow-up|1
7548262|NCT02500706|26236106|P1|Overall Study|Lost to Follow-up|0
7548263|NCT02500706|26236104|P3|Overall Study|Adverse Event|1
7548264|NCT02500706|26236105|P2|Overall Study|Adverse Event|0
7548265|NCT02500706|26236106|P1|Overall Study|Adverse Event|0
7548266|NCT02500641|26236260|P2|Overall Study|Non compliance to study drug|1
7548267|NCT02500641|26236261|P1|Overall Study|Non compliance to study drug|0
7548268|NCT02500641|26236260|P2|Overall Study|Sponsor decision|0
7548269|NCT02500641|26236261|P1|Overall Study|Sponsor decision|1
7548270|NCT02500641|26236260|P2|Overall Study|Lost to Follow-up|0
7548271|NCT02500641|26236261|P1|Overall Study|Lost to Follow-up|1
7548272|NCT02500641|26236260|P2|Overall Study|Protocol Violation|2
7548273|NCT02500641|26236261|P1|Overall Study|Protocol Violation|1
7548274|NCT02500641|26236260|P2|Overall Study|Unable to follow study procedures|2
7548275|NCT02500641|26236261|P1|Overall Study|Unable to follow study procedures|3
7548276|NCT02500641|26236260|P2|Overall Study|Withdrawal by Subject|5
7548277|NCT02500641|26236261|P1|Overall Study|Withdrawal by Subject|4
7548278|NCT02500641|26236260|P2|Overall Study|Adverse Event|2
7548279|NCT02500641|26236261|P1|Overall Study|Adverse Event|0
7548280|NCT02500550|26236293|P1|Overall Study|Death|7
7548281|NCT02500537|26236307|P2|Overall Study|Withdrawal by Subject|0
7548282|NCT02500537|26236308|P1|Overall Study|Withdrawal by Subject|1
7548283|NCT02500537|26236307|P2|Overall Study|Lost to Follow-up|1
7548284|NCT02500537|26236308|P1|Overall Study|Lost to Follow-up|0
7548285|NCT02500537|26236307|P2|Overall Study|Death|0
7548286|NCT02500537|26236308|P1|Overall Study|Death|2
7548287|NCT02500056|26236377|P2|Overall Study|Death|1
7548288|NCT02500056|26236378|P1|Overall Study|Death|3
7548289|NCT02500056|26236377|P2|Overall Study|Recurrence|0
7548290|NCT02500056|26236378|P1|Overall Study|Recurrence|1
7548291|NCT02500056|26236377|P2|Overall Study|Lost to Follow-up|7
7548292|NCT02500056|26236378|P1|Overall Study|Lost to Follow-up|3
7548293|NCT02500043|26236390|P2|Overall Study|Protocol Deviation|0
7548294|NCT02500043|26236391|P1|Overall Study|Protocol Deviation|1
7548295|NCT02500043|26236390|P2|Overall Study|Death|2
7548296|NCT02500043|26236391|P1|Overall Study|Death|11
7548297|NCT02500043|26236390|P2|Overall Study|Withdrawal by Subject|4
7548298|NCT02500043|26236391|P1|Overall Study|Withdrawal by Subject|14
7548299|NCT02500043|26236390|P2|Overall Study|Physician's Decision|3
7548300|NCT02500043|26236391|P1|Overall Study|Physician's Decision|11
7548301|NCT02500043|26236390|P2|Overall Study|Radiological Progression|110
7548302|NCT02500043|26236391|P1|Overall Study|Radiological Progression|192
7548303|NCT02500043|26236390|P2|Overall Study|Clinical Progression|35
7548304|NCT02500043|26236391|P1|Overall Study|Clinical Progression|54
7548305|NCT02500043|26236390|P2|Overall Study|Adverse Event|11
7548306|NCT02500043|26236391|P1|Overall Study|Adverse Event|33
7548307|NCT02500043|26236390|P2|Overall Study|Ongoing at Date of Cut-Off|3
7548308|NCT02500043|26236391|P1|Overall Study|Ongoing at Date of Cut-Off|19
7548309|NCT02500043|26236390|P2|Overall Study|Randomized, but not Treated|2
7548310|NCT02500043|26236391|P1|Overall Study|Randomized, but not Treated|2
7548311|NCT02499952|26236411|P1|Overall Study|Death|9
7548312|NCT02499952|26236411|P1|Overall Study|Lost to Follow-up|1
7548313|NCT02499900|26236420|P2|Extension Study Period|Other|2
7548314|NCT02499900|26236421|P1|Extension Study Period|Other|0
7548315|NCT02499900|26236420|P2|Extension Study Period|Lost to Follow-up|5
7548316|NCT02499900|26236421|P1|Extension Study Period|Lost to Follow-up|2
7548317|NCT02499900|26236420|P2|Extension Study Period|Pregnancy|2
7548318|NCT02499900|26236421|P1|Extension Study Period|Pregnancy|1
7548319|NCT02499900|26236420|P2|Extension Study Period|Physician Decision|5
7548320|NCT02499900|26236421|P1|Extension Study Period|Physician Decision|2
7548321|NCT02499900|26236420|P2|Extension Study Period|Withdrawal by Subject|2
7548322|NCT02499900|26236421|P1|Extension Study Period|Withdrawal by Subject|5
7548323|NCT02499900|26236420|P2|Extension Study Period|Adverse Event|4
7548324|NCT02499900|26236421|P1|Extension Study Period|Adverse Event|2
7548325|NCT02499900|26236420|P2|Completed Core, Continued Into Extension|Personal motivation|0
7548326|NCT02499900|26236421|P1|Completed Core, Continued Into Extension|Personal motivation|1
7548327|NCT02499900|26236420|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
7548328|NCT02499900|26236421|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
7548329|NCT02499900|26236420|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
7548330|NCT02499900|26236421|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
7548331|NCT02499900|26236420|P2|Completed Core, Continued Into Extension|Physician Decision|0
7548332|NCT02499900|26236421|P1|Completed Core, Continued Into Extension|Physician Decision|1
7548333|NCT02499900|26236420|P2|Core Study Period|Death|1
7548334|NCT02499900|26236421|P1|Core Study Period|Death|0
7548335|NCT02499900|26236420|P2|Core Study Period|Adverse Event|14
7548336|NCT02499900|26236421|P1|Core Study Period|Adverse Event|18
7548337|NCT02499900|26236420|P2|Core Study Period|Withdrawal by Subject|10
7548338|NCT02499900|26236421|P1|Core Study Period|Withdrawal by Subject|11
7548339|NCT02499900|26236420|P2|Core Study Period|Protocol Violation|0
7548340|NCT02499900|26236421|P1|Core Study Period|Protocol Violation|3
7548341|NCT02499900|26236420|P2|Core Study Period|Pregnancy|0
7548342|NCT02499900|26236421|P1|Core Study Period|Pregnancy|1
7548343|NCT02499900|26236420|P2|Core Study Period|Per sponsor request|1
7548344|NCT02499900|26236421|P1|Core Study Period|Per sponsor request|0
7548345|NCT02499900|26236420|P2|Core Study Period|Lost to Follow-up|2
7548346|NCT02499900|26236421|P1|Core Study Period|Lost to Follow-up|1
7548347|NCT02499900|26236420|P2|Core Study Period|Other|4
7548348|NCT02499900|26236421|P1|Core Study Period|Other|1
7548349|NCT02499783|26236452|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
7548350|NCT02499783|26236453|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7548351|NCT02499783|26236454|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7548352|NCT02499783|26236452|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
7548353|NCT02499783|26236453|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7548354|NCT02499783|26236454|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7548355|NCT02499783|26236452|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
7548356|NCT02499783|26236453|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7548357|NCT02499783|26236454|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7548358|NCT02499783|26236452|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
7548359|NCT02499783|26236453|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
7548360|NCT02499783|26236454|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
7548361|NCT02499783|26236452|P3|DB Period: Weeks 0-8|Other|0
7548362|NCT02499783|26236453|P2|DB Period: Weeks 0-8|Other|1
7548363|NCT02499783|26236454|P1|DB Period: Weeks 0-8|Other|1
7548364|NCT02499783|26236452|P3|DB Period: Weeks 0-8|Withdrew Consent|0
7548365|NCT02499783|26236453|P2|DB Period: Weeks 0-8|Withdrew Consent|0
7548366|NCT02499783|26236454|P1|DB Period: Weeks 0-8|Withdrew Consent|1
7548367|NCT02499783|26236452|P3|DB Period: Weeks 0-8|Adverse Event|0
7548368|NCT02499783|26236453|P2|DB Period: Weeks 0-8|Adverse Event|6
7548369|NCT02499783|26236454|P1|DB Period: Weeks 0-8|Adverse Event|8
7548370|NCT02499783|26236452|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
7548371|NCT02499783|26236453|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7548372|NCT02499783|26236454|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7548373|NCT02499783|26236452|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7548374|NCT02499783|26236453|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7548375|NCT02499783|26236454|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
7548376|NCT02499783|26236452|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
7548377|NCT02499783|26236453|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
7548378|NCT02499783|26236454|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
7548379|NCT02499770|26236503|P2|Overall Study|Randomized but not enrolled|1
7548380|NCT02499770|26236504|P1|Overall Study|Randomized but not enrolled|0
7548381|NCT02499770|26236503|P2|Overall Study|Withdrawn by PI for compassionate reason|1
7548382|NCT02499770|26236504|P1|Overall Study|Withdrawn by PI for compassionate reason|0
7548383|NCT02499770|26236503|P2|Overall Study|Subject declined further treatment|0
7548384|NCT02499770|26236504|P1|Overall Study|Subject declined further treatment|1
7548385|NCT02499770|26236503|P2|Overall Study|Lost to Follow-up|2
7548386|NCT02499770|26236504|P1|Overall Study|Lost to Follow-up|0
7548387|NCT02499770|26236503|P2|Overall Study|Withdrawal by Subject|7
7548388|NCT02499770|26236504|P1|Overall Study|Withdrawal by Subject|0
7548389|NCT02499770|26236503|P2|Overall Study|Study completion|10
7548390|NCT02499770|26236504|P1|Overall Study|Study completion|1
7548391|NCT02499770|26236503|P2|Overall Study|Death|56
7548392|NCT02499770|26236504|P1|Overall Study|Death|17
7548393|NCT02499575|26236624|P2|Overall Study|Protocol Violation|1
7548394|NCT02499575|26236625|P1|Overall Study|Protocol Violation|0
7548395|NCT02499406|26236784|P1|Overall Study|missed 3 treatment sessions|4
7548396|NCT02499263|26236805|P1|Overall Study|Pregnancy|1
7548397|NCT02499263|26236805|P1|Overall Study|Participant's decision|3
7548398|NCT02499263|26236805|P1|Overall Study|Adverse Events/Serious Adverse Events|11
7548399|NCT02499263|26236805|P1|Overall Study|investigator's judgment|12
7548400|NCT02499263|26236805|P1|Overall Study|Lack of Efficacy|22
7548401|NCT02499263|26236805|P1|Overall Study|Participant's withdrawal of consent|4
7548402|NCT02499263|26236805|P1|Overall Study|Lost to Follow-up|9
7548403|NCT02499172|26236842|P4|Overall Study|Lost to Follow-up|0
7548404|NCT02499172|26236843|P3|Overall Study|Lost to Follow-up|0
7548405|NCT02499172|26236844|P2|Overall Study|Lost to Follow-up|64
7548406|NCT02499172|26236845|P1|Overall Study|Lost to Follow-up|65
7548407|NCT02499172|26236842|P4|Overall Study|Financial reason|436
7548408|NCT02499172|26236843|P3|Overall Study|Financial reason|523
7548409|NCT02499172|26236844|P2|Overall Study|Financial reason|0
7548410|NCT02499172|26236845|P1|Overall Study|Financial reason|0
7548411|NCT02499159|26236857|P2|30-Day Follow-Up Phone Call|Other|0
7548412|NCT02499159|26236858|P1|30-Day Follow-Up Phone Call|Other|1
7548413|NCT02499159|26236857|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
7548414|NCT02499159|26236858|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
7548415|NCT02499159|26236857|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
7548416|NCT02499159|26236858|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
7548417|NCT02499159|26236857|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7548418|NCT02499159|26236858|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7548419|NCT02499159|26236857|P2|Randomization|Protocol Violation|1
7548420|NCT02499159|26236858|P1|Randomization|Protocol Violation|1
7548421|NCT02499146|26236882|P1|Overall Study|Began other treatment/therapy|13
7548422|NCT02499146|26236882|P1|Overall Study|Ongoing at date of cut-off|9
7548423|NCT02499146|26236882|P1|Overall Study|Other|2
7548424|NCT02499146|26236882|P1|Overall Study|Withdrawal by Subject|1
7548425|NCT02499146|26236882|P1|Overall Study|Lost to Follow-up|1
7548426|NCT02499120|26236922|P2|Overall Study|Ongoing on study|11
7548427|NCT02499120|26236923|P1|Overall Study|Ongoing on study|15
7548428|NCT02499120|26236922|P2|Overall Study|Other|0
7548429|NCT02499120|26236923|P1|Overall Study|Other|1
7548430|NCT02499120|26236922|P2|Overall Study|Withdrawal by Subject|5
7548431|NCT02499120|26236923|P1|Overall Study|Withdrawal by Subject|2
7548432|NCT02499120|26236922|P2|Overall Study|Participant refused further follow-up|0
7548433|NCT02499120|26236923|P1|Overall Study|Participant refused further follow-up|1
7548434|NCT02499120|26236922|P2|Overall Study|Lost to Follow-up|2
7548435|NCT02499120|26236923|P1|Overall Study|Lost to Follow-up|1
7548436|NCT02499120|26236922|P2|Overall Study|Death|42
7548437|NCT02499120|26236923|P1|Overall Study|Death|45
7548438|NCT02499029|26236958|P2|Overall Study|Death|0
7548439|NCT02499029|26236959|P1|Overall Study|Death|1
7548440|NCT02499029|26236958|P2|Overall Study|Physician Decision|1
7548441|NCT02499029|26236959|P1|Overall Study|Physician Decision|2
7548442|NCT02499029|26236958|P2|Overall Study|Lost to Follow-up|2
7548443|NCT02499029|26236959|P1|Overall Study|Lost to Follow-up|2
7548444|NCT02498821|26236986|P2|Overall Study|Screen failure|5
7548445|NCT02498821|26236987|P1|Overall Study|Screen failure|3
7548446|NCT02498678|26237031|P2|Overall Study|interference from the surgical team|2
7548447|NCT02498678|26237032|P1|Overall Study|interference from the surgical team|0
7548448|NCT02498652|26237048|P2|Overall Study|Protocol Violation|1
7548449|NCT02498652|26237049|P1|Overall Study|Protocol Violation|0
7548450|NCT02498418|26237192|P3|Overall Study|Participant taken prohibited medication|1
7548451|NCT02498418|26237193|P2|Overall Study|Participant taken prohibited medication|1
7548452|NCT02498418|26237194|P1|Overall Study|Participant taken prohibited medication|0
7548453|NCT02498418|26237192|P3|Overall Study|Lost to Follow-up|1
7548454|NCT02498418|26237193|P2|Overall Study|Lost to Follow-up|1
7548455|NCT02498418|26237194|P1|Overall Study|Lost to Follow-up|0
7548456|NCT02498418|26237192|P3|Overall Study|Withdrawal by Subject|3
7548457|NCT02498418|26237193|P2|Overall Study|Withdrawal by Subject|0
7548458|NCT02498418|26237194|P1|Overall Study|Withdrawal by Subject|2
7548459|NCT02498418|26237192|P3|Overall Study|Lack of Efficacy|1
7548460|NCT02498418|26237193|P2|Overall Study|Lack of Efficacy|0
7548461|NCT02498418|26237194|P1|Overall Study|Lack of Efficacy|0
7548462|NCT02498236|26237218|P8|Overall Study|Withdrawal by Subject|0
7548463|NCT02498236|26237219|P7|Overall Study|Withdrawal by Subject|0
7548464|NCT02498236|26237220|P6|Overall Study|Withdrawal by Subject|0
7548465|NCT02498236|26237221|P5|Overall Study|Withdrawal by Subject|1
7548466|NCT02498236|26237222|P4|Overall Study|Withdrawal by Subject|0
7548467|NCT02498236|26237223|P3|Overall Study|Withdrawal by Subject|0
7548468|NCT02498236|26237224|P2|Overall Study|Withdrawal by Subject|0
7548469|NCT02498236|26237225|P1|Overall Study|Withdrawal by Subject|0
7548470|NCT02498236|26237218|P8|Overall Study|Equipment failure|0
7548471|NCT02498236|26237219|P7|Overall Study|Equipment failure|1
7548472|NCT02498236|26237220|P6|Overall Study|Equipment failure|0
7548473|NCT02498236|26237221|P5|Overall Study|Equipment failure|0
7548474|NCT02498236|26237222|P4|Overall Study|Equipment failure|0
7548475|NCT02498236|26237223|P3|Overall Study|Equipment failure|0
7548476|NCT02498236|26237224|P2|Overall Study|Equipment failure|0
7548477|NCT02498236|26237225|P1|Overall Study|Equipment failure|0
7548478|NCT02498236|26237218|P8|Overall Study|Did not show for testing|1
7548479|NCT02498236|26237219|P7|Overall Study|Did not show for testing|0
7548480|NCT02498236|26237220|P6|Overall Study|Did not show for testing|0
7548481|NCT02498236|26237221|P5|Overall Study|Did not show for testing|0
7548482|NCT02498236|26237222|P4|Overall Study|Did not show for testing|0
7548483|NCT02498236|26237223|P3|Overall Study|Did not show for testing|0
7548484|NCT02498236|26237224|P2|Overall Study|Did not show for testing|0
7548485|NCT02498236|26237225|P1|Overall Study|Did not show for testing|1
7548486|NCT02498067|26237254|P1|Overall Study|Did not meet inclusion criteria|11
7548487|NCT02498067|26237254|P1|Overall Study|Lost to Follow-up|22
7548488|NCT02497976|26237275|P2|Overall Study|Moved out of area|1
7548489|NCT02497976|26237276|P1|Overall Study|Moved out of area|0
7548490|NCT02497976|26237275|P2|Overall Study|Withdrawal by Subject|0
7548491|NCT02497976|26237276|P1|Overall Study|Withdrawal by Subject|2
7548492|NCT02497781|26237371|P2|Overall Study|Lost to Follow-up|1
7548493|NCT02497781|26237372|P1|Overall Study|Lost to Follow-up|1
7548494|NCT02497781|26237371|P2|Overall Study|Randomised but not treated|1
7548495|NCT02497781|26237372|P1|Overall Study|Randomised but not treated|1
7548496|NCT02497781|26237371|P2|Overall Study|Lack of Efficacy|1
7548497|NCT02497781|26237372|P1|Overall Study|Lack of Efficacy|0
7548498|NCT02497781|26237371|P2|Overall Study|Withdrawal by Subject|0
7548499|NCT02497781|26237372|P1|Overall Study|Withdrawal by Subject|2
7548500|NCT02497755|26237435|P2|Overall Study|Protocol Violation|0
7548501|NCT02497755|26237436|P1|Overall Study|Protocol Violation|1
7548502|NCT02497612|26237453|P4|Overall Study|Not eligible|1
7548503|NCT02497612|26237454|P3|Overall Study|Not eligible|0
7548504|NCT02497612|26237455|P2|Overall Study|Not eligible|0
7548505|NCT02497612|26237456|P1|Overall Study|Not eligible|1
7548506|NCT02497612|26237453|P4|Overall Study|Other unspecified|0
7548507|NCT02497612|26237454|P3|Overall Study|Other unspecified|2
7548508|NCT02497612|26237455|P2|Overall Study|Other unspecified|1
7548509|NCT02497612|26237456|P1|Overall Study|Other unspecified|1
7548510|NCT02497612|26237453|P4|Overall Study|Lost to Follow-up|1
7548511|NCT02497612|26237454|P3|Overall Study|Lost to Follow-up|0
7548512|NCT02497612|26237455|P2|Overall Study|Lost to Follow-up|1
7548513|NCT02497612|26237456|P1|Overall Study|Lost to Follow-up|1
7548514|NCT02497612|26237453|P4|Overall Study|Adverse Event|1
7548515|NCT02497612|26237454|P3|Overall Study|Adverse Event|4
7548516|NCT02497612|26237455|P2|Overall Study|Adverse Event|1
7548517|NCT02497612|26237456|P1|Overall Study|Adverse Event|3
7548518|NCT02497612|26237453|P4|Overall Study|Investigator's judgement|2
7548519|NCT02497612|26237454|P3|Overall Study|Investigator's judgement|0
7548520|NCT02497612|26237455|P2|Overall Study|Investigator's judgement|0
7548521|NCT02497612|26237456|P1|Overall Study|Investigator's judgement|1
7548522|NCT02497612|26237453|P4|Overall Study|Participant's request|1
7548523|NCT02497612|26237454|P3|Overall Study|Participant's request|4
7548524|NCT02497612|26237455|P2|Overall Study|Participant's request|3
7548525|NCT02497612|26237456|P1|Overall Study|Participant's request|2
7548526|NCT02497612|26237453|P4|Overall Study|Met >=1 anti-malarial treatment criteria|41
7548527|NCT02497612|26237454|P3|Overall Study|Met >=1 anti-malarial treatment criteria|39
7548528|NCT02497612|26237455|P2|Overall Study|Met >=1 anti-malarial treatment criteria|51
7548529|NCT02497612|26237456|P1|Overall Study|Met >=1 anti-malarial treatment criteria|57
7548530|NCT02497469|26237584|P2|Overall Study|Reason not Specified|6
7548531|NCT02497469|26237585|P1|Overall Study|Reason not Specified|6
7548532|NCT02497469|26237584|P2|Overall Study|Lack of Efficacy|40
7548533|NCT02497469|26237585|P1|Overall Study|Lack of Efficacy|86
7548534|NCT02497469|26237584|P2|Overall Study|Pregnancy|1
7548535|NCT02497469|26237585|P1|Overall Study|Pregnancy|1
7548536|NCT02497469|26237584|P2|Overall Study|Voluntary Withdrawal|41
7548537|NCT02497469|26237585|P1|Overall Study|Voluntary Withdrawal|39
7548538|NCT02497469|26237584|P2|Overall Study|Lost to Follow-up|4
7548539|NCT02497469|26237585|P1|Overall Study|Lost to Follow-up|14
7548540|NCT02497469|26237584|P2|Overall Study|Significant Protocol Deviation|5
7548541|NCT02497469|26237585|P1|Overall Study|Significant Protocol Deviation|4
7548542|NCT02497469|26237584|P2|Overall Study|Leukopenia or Lymphopenia|0
7548543|NCT02497469|26237585|P1|Overall Study|Leukopenia or Lymphopenia|1
7548544|NCT02497469|26237584|P2|Overall Study|Pretreatment Event/Adverse Event|16
7548545|NCT02497469|26237585|P1|Overall Study|Pretreatment Event/Adverse Event|18
7548546|NCT02497469|26237584|P2|Overall Study|Randomized but not Treated|2
7548547|NCT02497469|26237585|P1|Overall Study|Randomized but not Treated|0
7548548|NCT02497404|26237595|P1|Overall Study|Adverse Event|1
7548549|NCT02497391|26237607|P6|Period 3 (14 Days)|Withdrawal by Subject|0
7548550|NCT02497391|26237608|P5|Period 3 (14 Days)|Withdrawal by Subject|0
7548551|NCT02497391|26237609|P4|Period 3 (14 Days)|Withdrawal by Subject|0
7548552|NCT02497391|26237610|P3|Period 3 (14 Days)|Withdrawal by Subject|1
7548553|NCT02497391|26237611|P2|Period 3 (14 Days)|Withdrawal by Subject|0
7548554|NCT02497391|26237612|P1|Period 3 (14 Days)|Withdrawal by Subject|0
7548555|NCT02497391|26237607|P6|Period 3 (14 Days)|Sponsor Decision|0
7548556|NCT02497391|26237608|P5|Period 3 (14 Days)|Sponsor Decision|1
7548557|NCT02497391|26237609|P4|Period 3 (14 Days)|Sponsor Decision|0
7548558|NCT02497391|26237610|P3|Period 3 (14 Days)|Sponsor Decision|0
7548559|NCT02497391|26237611|P2|Period 3 (14 Days)|Sponsor Decision|0
7548560|NCT02497391|26237612|P1|Period 3 (14 Days)|Sponsor Decision|0
7548561|NCT02497391|26237607|P6|Period 3 (14 Days)|Adverse Event|0
7548562|NCT02497391|26237608|P5|Period 3 (14 Days)|Adverse Event|0
7548563|NCT02497391|26237609|P4|Period 3 (14 Days)|Adverse Event|0
7548564|NCT02497391|26237610|P3|Period 3 (14 Days)|Adverse Event|0
7548565|NCT02497391|26237611|P2|Period 3 (14 Days)|Adverse Event|1
7548566|NCT02497391|26237612|P1|Period 3 (14 Days)|Adverse Event|0
7548567|NCT02497391|26237607|P6|Period 2 (14 Days)|Sponsor Decision|3
7548568|NCT02497391|26237608|P5|Period 2 (14 Days)|Sponsor Decision|2
7548569|NCT02497391|26237609|P4|Period 2 (14 Days)|Sponsor Decision|3
7548570|NCT02497391|26237610|P3|Period 2 (14 Days)|Sponsor Decision|2
7548571|NCT02497391|26237611|P2|Period 2 (14 Days)|Sponsor Decision|1
7548572|NCT02497391|26237612|P1|Period 2 (14 Days)|Sponsor Decision|3
7548573|NCT02497391|26237607|P6|Period 2 (14 Days)|Withdrawal by Subject|0
7548574|NCT02497391|26237608|P5|Period 2 (14 Days)|Withdrawal by Subject|0
7548575|NCT02497391|26237609|P4|Period 2 (14 Days)|Withdrawal by Subject|0
7548576|NCT02497391|26237610|P3|Period 2 (14 Days)|Withdrawal by Subject|1
7548577|NCT02497391|26237611|P2|Period 2 (14 Days)|Withdrawal by Subject|0
7548578|NCT02497391|26237612|P1|Period 2 (14 Days)|Withdrawal by Subject|1
7548579|NCT02497287|26237623|P1|Follow-up Phase (4 Week)|Other|1
7548580|NCT02497287|26237623|P1|Follow-up Phase (4 Week)|Adverse Event|3
7548581|NCT02497287|26237623|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
7548582|NCT02497287|26237623|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
7548583|NCT02497287|26237623|P1|Follow-up Phase (4 Week)|PI Decision|12
7548584|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
7548585|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Death|2
7548586|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
7548587|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
7548588|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
7548589|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
7548590|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Other|21
7548591|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
7548592|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
7548593|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
7548594|NCT02497287|26237623|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
7548595|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
7548596|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Protocol Violation|1
7548597|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
7548598|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Other|13
7548599|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
7548600|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
7548601|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Adverse Event|52
7548602|NCT02497287|26237623|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
7548603|NCT02497001|26237718|P4|Overall Study|Protocol Violation|1
7548604|NCT02497001|26237719|P3|Overall Study|Protocol Violation|3
7548605|NCT02497001|26237720|P2|Overall Study|Protocol Violation|1
7548606|NCT02497001|26237721|P1|Overall Study|Protocol Violation|3
7548607|NCT02497001|26237718|P4|Overall Study|Lack of Efficacy|6
7548608|NCT02497001|26237719|P3|Overall Study|Lack of Efficacy|6
7548609|NCT02497001|26237720|P2|Overall Study|Lack of Efficacy|16
7548610|NCT02497001|26237721|P1|Overall Study|Lack of Efficacy|10
7548611|NCT02497001|26237718|P4|Overall Study|Major Protocol Deviation|4
7548612|NCT02497001|26237719|P3|Overall Study|Major Protocol Deviation|4
7548613|NCT02497001|26237720|P2|Overall Study|Major Protocol Deviation|4
7548614|NCT02497001|26237721|P1|Overall Study|Major Protocol Deviation|3
7548615|NCT02497001|26237718|P4|Overall Study|subjects that were not treated|1
7548616|NCT02497001|26237719|P3|Overall Study|subjects that were not treated|2
7548617|NCT02497001|26237720|P2|Overall Study|subjects that were not treated|2
7548618|NCT02497001|26237721|P1|Overall Study|subjects that were not treated|1
7548619|NCT02497001|26237718|P4|Overall Study|Physician Decision|1
7548620|NCT02497001|26237719|P3|Overall Study|Physician Decision|5
7548621|NCT02497001|26237720|P2|Overall Study|Physician Decision|11
7548622|NCT02497001|26237721|P1|Overall Study|Physician Decision|5
7548623|NCT02497001|26237718|P4|Overall Study|Withdrawal by Subject|15
7548624|NCT02497001|26237719|P3|Overall Study|Withdrawal by Subject|19
7548625|NCT02497001|26237720|P2|Overall Study|Withdrawal by Subject|37
7548626|NCT02497001|26237721|P1|Overall Study|Withdrawal by Subject|14
7548627|NCT02497001|26237718|P4|Overall Study|Adverse Event|11
7548628|NCT02497001|26237719|P3|Overall Study|Adverse Event|11
7548629|NCT02497001|26237720|P2|Overall Study|Adverse Event|30
7548630|NCT02497001|26237721|P1|Overall Study|Adverse Event|28
7548631|NCT02497001|26237718|P4|Overall Study|Lost to Follow-up|2
7548632|NCT02497001|26237719|P3|Overall Study|Lost to Follow-up|0
7548633|NCT02497001|26237720|P2|Overall Study|Lost to Follow-up|2
7548634|NCT02497001|26237721|P1|Overall Study|Lost to Follow-up|10
7548635|NCT02496884|26237782|P4|Overall Study|Withdrawal by Subject|0
7548636|NCT02496884|26237783|P3|Overall Study|Withdrawal by Subject|0
7548637|NCT02496884|26237784|P2|Overall Study|Withdrawal by Subject|3
7548638|NCT02496884|26237785|P1|Overall Study|Withdrawal by Subject|0
7548639|NCT02496884|26237782|P4|Overall Study|Counted twice as enrolled|0
7548640|NCT02496884|26237783|P3|Overall Study|Counted twice as enrolled|0
7548641|NCT02496884|26237784|P2|Overall Study|Counted twice as enrolled|0
7548642|NCT02496884|26237785|P1|Overall Study|Counted twice as enrolled|2
7548643|NCT02496767|26237811|P8|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7548644|NCT02496767|26237812|P7|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7548645|NCT02496767|26237813|P6|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7548646|NCT02496767|26237814|P5|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7548647|NCT02496767|26237815|P4|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7548648|NCT02496767|26237816|P3|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7548649|NCT02496767|26237817|P2|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7548650|NCT02496767|26237818|P1|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7548651|NCT02496767|26237811|P8|Double-blind, Withdrawal Phase|Death|2
7548652|NCT02496767|26237812|P7|Double-blind, Withdrawal Phase|Death|1
7548653|NCT02496767|26237813|P6|Double-blind, Withdrawal Phase|Death|0
7548654|NCT02496767|26237814|P5|Double-blind, Withdrawal Phase|Death|0
7548655|NCT02496767|26237815|P4|Double-blind, Withdrawal Phase|Death|0
7548656|NCT02496767|26237816|P3|Double-blind, Withdrawal Phase|Death|0
7548657|NCT02496767|26237817|P2|Double-blind, Withdrawal Phase|Death|0
7548658|NCT02496767|26237818|P1|Double-blind, Withdrawal Phase|Death|0
7548659|NCT02496767|26237811|P8|Double-blind, Withdrawal Phase|Adverse Event|1
7548660|NCT02496767|26237812|P7|Double-blind, Withdrawal Phase|Adverse Event|2
7548661|NCT02496767|26237813|P6|Double-blind, Withdrawal Phase|Adverse Event|1
7548662|NCT02496767|26237814|P5|Double-blind, Withdrawal Phase|Adverse Event|0
7548663|NCT02496767|26237815|P4|Double-blind, Withdrawal Phase|Adverse Event|0
7548664|NCT02496767|26237816|P3|Double-blind, Withdrawal Phase|Adverse Event|0
7548665|NCT02496767|26237817|P2|Double-blind, Withdrawal Phase|Adverse Event|0
7548666|NCT02496767|26237818|P1|Double-blind, Withdrawal Phase|Adverse Event|0
7548667|NCT02496767|26237811|P8|Double-blind, Withdrawal Phase|Progressive disease|1
7548668|NCT02496767|26237812|P7|Double-blind, Withdrawal Phase|Progressive disease|0
7548669|NCT02496767|26237813|P6|Double-blind, Withdrawal Phase|Progressive disease|4
7548670|NCT02496767|26237814|P5|Double-blind, Withdrawal Phase|Progressive disease|0
7548671|NCT02496767|26237815|P4|Double-blind, Withdrawal Phase|Progressive disease|0
7548672|NCT02496767|26237816|P3|Double-blind, Withdrawal Phase|Progressive disease|0
7548673|NCT02496767|26237817|P2|Double-blind, Withdrawal Phase|Progressive disease|0
7548674|NCT02496767|26237818|P1|Double-blind, Withdrawal Phase|Progressive disease|0
7548675|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548676|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548677|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548678|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548679|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548680|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548681|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Protocol Violation|1
7548682|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7548683|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7548684|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7548685|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7548686|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
7548687|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7548688|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7548689|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7548690|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7548691|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Physician Decision|0
7548692|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Physician Decision|0
7548693|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Physician Decision|0
7548694|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Physician Decision|0
7548695|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Physician Decision|0
7548696|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Physician Decision|1
7548697|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Physician Decision|4
7548698|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
7548699|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7548700|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7548701|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7548702|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
7548703|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
7548704|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
7548705|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
7548706|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7548707|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Various|0
7548708|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Various|0
7548709|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Various|0
7548710|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Various|2
7548711|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Various|5
7548712|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Various|4
7548713|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Various|9
7548714|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Various|0
7548715|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Death|0
7548716|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Death|0
7548717|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Death|0
7548718|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Death|4
7548719|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Death|2
7548720|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Death|6
7548721|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Death|10
7548722|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Death|0
7548723|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Progressive disease|0
7548724|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Progressive disease|0
7548725|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Progressive disease|0
7548726|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Progressive disease|14
7548727|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Progressive disease|8
7548728|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Progressive disease|9
7548729|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Progressive disease|13
7548730|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Progressive disease|0
7548731|NCT02496767|26237811|P8|Double-blind, Placebo-controlled Phase|Adverse Event|0
7548732|NCT02496767|26237812|P7|Double-blind, Placebo-controlled Phase|Adverse Event|0
7548733|NCT02496767|26237813|P6|Double-blind, Placebo-controlled Phase|Adverse Event|0
7548734|NCT02496767|26237814|P5|Double-blind, Placebo-controlled Phase|Adverse Event|43
7548735|NCT02496767|26237815|P4|Double-blind, Placebo-controlled Phase|Adverse Event|43
7548736|NCT02496767|26237816|P3|Double-blind, Placebo-controlled Phase|Adverse Event|23
7548737|NCT02496767|26237817|P2|Double-blind, Placebo-controlled Phase|Adverse Event|13
7548738|NCT02496767|26237818|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
7548739|NCT02496767|26237811|P8|Open-label Lead-in Phase|Lost to Follow-up|0
7548740|NCT02496767|26237812|P7|Open-label Lead-in Phase|Lost to Follow-up|0
7548741|NCT02496767|26237813|P6|Open-label Lead-in Phase|Lost to Follow-up|0
7548742|NCT02496767|26237814|P5|Open-label Lead-in Phase|Lost to Follow-up|0
7548743|NCT02496767|26237815|P4|Open-label Lead-in Phase|Lost to Follow-up|0
7548744|NCT02496767|26237816|P3|Open-label Lead-in Phase|Lost to Follow-up|0
7548745|NCT02496767|26237817|P2|Open-label Lead-in Phase|Lost to Follow-up|0
7548746|NCT02496767|26237818|P1|Open-label Lead-in Phase|Lost to Follow-up|1
7548747|NCT02496767|26237811|P8|Open-label Lead-in Phase|Protocol Violation|0
7548748|NCT02496767|26237812|P7|Open-label Lead-in Phase|Protocol Violation|0
7548749|NCT02496767|26237813|P6|Open-label Lead-in Phase|Protocol Violation|0
7548750|NCT02496767|26237814|P5|Open-label Lead-in Phase|Protocol Violation|0
7548751|NCT02496767|26237815|P4|Open-label Lead-in Phase|Protocol Violation|0
7548752|NCT02496767|26237816|P3|Open-label Lead-in Phase|Protocol Violation|0
7548753|NCT02496767|26237817|P2|Open-label Lead-in Phase|Protocol Violation|0
7548754|NCT02496767|26237818|P1|Open-label Lead-in Phase|Protocol Violation|2
7548755|NCT02496767|26237811|P8|Open-label Lead-in Phase|Adverse Event|0
7548756|NCT02496767|26237812|P7|Open-label Lead-in Phase|Adverse Event|0
7548757|NCT02496767|26237813|P6|Open-label Lead-in Phase|Adverse Event|0
7548758|NCT02496767|26237814|P5|Open-label Lead-in Phase|Adverse Event|0
7548759|NCT02496767|26237815|P4|Open-label Lead-in Phase|Adverse Event|0
7548760|NCT02496767|26237816|P3|Open-label Lead-in Phase|Adverse Event|0
7548761|NCT02496767|26237817|P2|Open-label Lead-in Phase|Adverse Event|0
7548762|NCT02496767|26237818|P1|Open-label Lead-in Phase|Adverse Event|176
7548763|NCT02496702|26237858|P2|Overall Study|Only partially tested|2
7548764|NCT02496702|26237859|P1|Overall Study|Only partially tested|0
7548765|NCT02496702|26237858|P2|Overall Study|Lost to Follow-up|6
7548766|NCT02496702|26237859|P1|Overall Study|Lost to Follow-up|8
7548767|NCT02496533|26237881|P2|Overall Study|Late for radiologic testing|2
7548768|NCT02496533|26237882|P1|Overall Study|Late for radiologic testing|0
7548769|NCT02496533|26237881|P2|Overall Study|Patient did not complete all measures|4
7548770|NCT02496533|26237882|P1|Overall Study|Patient did not complete all measures|0
7548771|NCT02496533|26237881|P2|Overall Study|Lack of data on outcome|0
7548772|NCT02496533|26237882|P1|Overall Study|Lack of data on outcome|3
7548773|NCT02496221|26237894|P2|Treatment Period 2 - 4 Days|Physician Decision|0
7548774|NCT02496221|26237895|P1|Treatment Period 2 - 4 Days|Physician Decision|1
7548775|NCT02496221|26237894|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
7548776|NCT02496221|26237895|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
7548777|NCT02496221|26237894|P2|Treatment Period 2 - 4 Days|Adverse Event|1
7548778|NCT02496221|26237895|P1|Treatment Period 2 - 4 Days|Adverse Event|0
7548779|NCT02496091|26237929|P1|Overall Study|Eligibility criteria not fulfilled|2
7548780|NCT02496039|26237938|P1|Overall Study|Protocol Violation|1
7548781|NCT02496039|26237938|P1|Overall Study|Adverse Event|3
7548782|NCT02496000|26237953|P3|Overall Study|undetermined|0
7548783|NCT02496000|26237954|P2|Overall Study|undetermined|1
7548784|NCT02496000|26237955|P1|Overall Study|undetermined|0
7548785|NCT02496000|26237953|P3|Overall Study|Non-compliance or lack of cooperation|0
7548786|NCT02496000|26237954|P2|Overall Study|Non-compliance or lack of cooperation|2
7548787|NCT02496000|26237955|P1|Overall Study|Non-compliance or lack of cooperation|0
7548788|NCT02496000|26237953|P3|Overall Study|Protocol Violation|1
7548789|NCT02496000|26237954|P2|Overall Study|Protocol Violation|0
7548790|NCT02496000|26237955|P1|Overall Study|Protocol Violation|0
7548791|NCT02496000|26237953|P3|Overall Study|Lost to Follow-up|1
7548792|NCT02496000|26237954|P2|Overall Study|Lost to Follow-up|0
7548793|NCT02496000|26237955|P1|Overall Study|Lost to Follow-up|1
7548794|NCT02496000|26237953|P3|Overall Study|Withdrawal by Subject|0
7548795|NCT02496000|26237954|P2|Overall Study|Withdrawal by Subject|2
7548796|NCT02496000|26237955|P1|Overall Study|Withdrawal by Subject|1
7548797|NCT02495948|26237976|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7548798|NCT02495948|26237977|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7548799|NCT02495948|26237976|P2|Period 1, First 30 Days of Wear|Adverse Event|1
7548800|NCT02495948|26237977|P1|Period 1, First 30 Days of Wear|Adverse Event|0
7548801|NCT02495883|26237986|P2|Overall Study|Excessive head motion|0
7548802|NCT02495883|26237987|P1|Overall Study|Excessive head motion|1
7548803|NCT02495857|26237995|P3|Overall Study|Other|2
7548804|NCT02495857|26237996|P2|Overall Study|Other|3
7548805|NCT02495857|26237997|P1|Overall Study|Other|3
7548806|NCT02495857|26237995|P3|Overall Study|Lost to Follow-up|3
7548807|NCT02495857|26237996|P2|Overall Study|Lost to Follow-up|5
7548808|NCT02495857|26237997|P1|Overall Study|Lost to Follow-up|4
7548809|NCT02495857|26237995|P3|Overall Study|Protocol Violation|2
7548810|NCT02495857|26237996|P2|Overall Study|Protocol Violation|1
7548811|NCT02495857|26237997|P1|Overall Study|Protocol Violation|1
7548812|NCT02495857|26237995|P3|Overall Study|Physician Decision|0
7548813|NCT02495857|26237996|P2|Overall Study|Physician Decision|1
7548814|NCT02495857|26237997|P1|Overall Study|Physician Decision|0
7548815|NCT02495857|26237995|P3|Overall Study|Withdrawal by Subject|10
7548816|NCT02495857|26237996|P2|Overall Study|Withdrawal by Subject|6
7548817|NCT02495857|26237997|P1|Overall Study|Withdrawal by Subject|9
7548818|NCT02495857|26237995|P3|Overall Study|Adverse Event|1
7548819|NCT02495857|26237996|P2|Overall Study|Adverse Event|0
7548820|NCT02495857|26237997|P1|Overall Study|Adverse Event|5
7548821|NCT02495844|26238013|P2|Overall Study|Hepatitis Positivity|1
7548822|NCT02495844|26238014|P1|Overall Study|Hepatitis Positivity|0
7548823|NCT02495844|26238013|P2|Overall Study|AE, non-fatal|1
7548824|NCT02495844|26238014|P1|Overall Study|AE, non-fatal|0
7548825|NCT02495844|26238013|P2|Overall Study|Lack of Efficacy|2
7548826|NCT02495844|26238014|P1|Overall Study|Lack of Efficacy|1
7548827|NCT02495389|26238116|P1|Overall Study|Withdrawal by Subject|40
7548828|NCT02495233|26238154|P2|Overall Study|Miscellaneous|1
7548829|NCT02495233|26238155|P1|Overall Study|Miscellaneous|0
7548830|NCT02495168|26238184|P3|Overall Study|Lack of Efficacy|3
7548831|NCT02495168|26238185|P2|Overall Study|Lack of Efficacy|0
7548832|NCT02495168|26238186|P1|Overall Study|Lack of Efficacy|0
7548833|NCT02495168|26238184|P3|Overall Study|Adverse Event|3
7548834|NCT02495168|26238185|P2|Overall Study|Adverse Event|8
7548835|NCT02495168|26238186|P1|Overall Study|Adverse Event|4
7548836|NCT02495168|26238184|P3|Overall Study|Protocol Violation|1
7548837|NCT02495168|26238185|P2|Overall Study|Protocol Violation|10
7548838|NCT02495168|26238186|P1|Overall Study|Protocol Violation|0
7548839|NCT02495168|26238184|P3|Overall Study|Withdrawal by Subject|2
7548840|NCT02495168|26238185|P2|Overall Study|Withdrawal by Subject|4
7548841|NCT02495168|26238186|P1|Overall Study|Withdrawal by Subject|1
7548842|NCT02495168|26238184|P3|Overall Study|Lost to Follow-up|1
7548843|NCT02495168|26238185|P2|Overall Study|Lost to Follow-up|6
7548844|NCT02495168|26238186|P1|Overall Study|Lost to Follow-up|10
7548845|NCT02495168|26238184|P3|Overall Study|Physician Decision|0
7548846|NCT02495168|26238185|P2|Overall Study|Physician Decision|1
7548847|NCT02495168|26238186|P1|Overall Study|Physician Decision|1
7548848|NCT02495168|26238184|P3|Overall Study|Did not Complete Final Visit On Time|2
7548849|NCT02495168|26238185|P2|Overall Study|Did not Complete Final Visit On Time|3
7548850|NCT02495168|26238186|P1|Overall Study|Did not Complete Final Visit On Time|4
7548851|NCT02495168|26238184|P3|Overall Study|Other than Specified|5
7548852|NCT02495168|26238185|P2|Overall Study|Other than Specified|22
7548853|NCT02495168|26238186|P1|Overall Study|Other than Specified|18
7548854|NCT02495025|26238260|P2|Overall Study|Withdrawal by Subject|0
7548855|NCT02495025|26238261|P1|Overall Study|Withdrawal by Subject|5
7548856|NCT02495025|26238260|P2|Overall Study|Lost to Follow-up|14
7548857|NCT02495025|26238261|P1|Overall Study|Lost to Follow-up|21
7548858|NCT02494778|26238296|P1|Overall Study|Noncompliant with study drug admin.|1
7548859|NCT02494778|26238296|P1|Overall Study|Lost to Follow-up|2
7548860|NCT02494778|26238296|P1|Overall Study|Withdrawal by Subject|20
7548861|NCT02494778|26238296|P1|Overall Study|Adverse Event|18
7548862|NCT02494778|26238296|P1|Overall Study|Lack of Efficacy|4
7548863|NCT02494778|26238296|P1|Overall Study|Other|173
7548864|NCT02494778|26238296|P1|Overall Study|Death|3
7548865|NCT02494596|26238319|P3|Overall Study|Refused Treatment|0
7548866|NCT02494596|26238320|P2|Overall Study|Refused Treatment|1
7548867|NCT02494596|26238321|P1|Overall Study|Refused Treatment|0
7548868|NCT02494596|26238319|P3|Overall Study|Adverse Event|0
7548869|NCT02494596|26238320|P2|Overall Study|Adverse Event|1
7548870|NCT02494596|26238321|P1|Overall Study|Adverse Event|0
7548871|NCT02494596|26238319|P3|Overall Study|Insufficient Therapeutic Response|1
7548872|NCT02494596|26238320|P2|Overall Study|Insufficient Therapeutic Response|3
7548873|NCT02494596|26238321|P1|Overall Study|Insufficient Therapeutic Response|3
7548874|NCT02494583|26238349|P3|Overall Study|Ongoing in Study|34
7548875|NCT02494583|26238350|P2|Overall Study|Ongoing in Study|51
7548876|NCT02494583|26238351|P1|Overall Study|Ongoing in Study|56
7548877|NCT02494583|26238349|P3|Overall Study|Withdrawal by Subject|15
7548878|NCT02494583|26238350|P2|Overall Study|Withdrawal by Subject|15
7548879|NCT02494583|26238351|P1|Overall Study|Withdrawal by Subject|3
7548880|NCT02494583|26238349|P3|Overall Study|Protocol Violation|0
7548881|NCT02494583|26238350|P2|Overall Study|Protocol Violation|2
7548882|NCT02494583|26238351|P1|Overall Study|Protocol Violation|1
7548883|NCT02494583|26238349|P3|Overall Study|Lost to Follow-up|0
7548884|NCT02494583|26238350|P2|Overall Study|Lost to Follow-up|0
7548885|NCT02494583|26238351|P1|Overall Study|Lost to Follow-up|1
7548886|NCT02494583|26238349|P3|Overall Study|Death|201
7548887|NCT02494583|26238350|P2|Overall Study|Death|189
7548888|NCT02494583|26238351|P1|Overall Study|Death|195
7548889|NCT02494401|26238449|P2|Overall Study|Withdrawal by Subject|2
7548890|NCT02494401|26238450|P1|Overall Study|Withdrawal by Subject|3
7548891|NCT02494401|26238449|P2|Overall Study|Lost to Follow-up|25
7548892|NCT02494401|26238450|P1|Overall Study|Lost to Follow-up|22
7548893|NCT02494206|26238518|P1|Overall Study|Disease Progression|1
7548894|NCT02494206|26238518|P1|Overall Study|Adverse Event|1
7548895|NCT02493946|26238572|P3|Open Label Period|Site error|1
7548896|NCT02493946|26238573|P2|Open Label Period|Site error|0
7548897|NCT02493946|26238574|P1|Open Label Period|Site error|0
7548898|NCT02493946|26238572|P3|Open Label Period|Pregnancy|3
7548899|NCT02493946|26238573|P2|Open Label Period|Pregnancy|0
7548900|NCT02493946|26238574|P1|Open Label Period|Pregnancy|0
7548901|NCT02493946|26238572|P3|Open Label Period|Investigator decision, non-availability|1
7548902|NCT02493946|26238573|P2|Open Label Period|Investigator decision, non-availability|0
7548903|NCT02493946|26238574|P1|Open Label Period|Investigator decision, non-availability|0
7548904|NCT02493946|26238572|P3|Open Label Period|Investigator decision, non-compliance|2
7548905|NCT02493946|26238573|P2|Open Label Period|Investigator decision, non-compliance|0
7548906|NCT02493946|26238574|P1|Open Label Period|Investigator decision, non-compliance|0
7548907|NCT02493946|26238572|P3|Open Label Period|Lost to Follow-up|1
7548908|NCT02493946|26238573|P2|Open Label Period|Lost to Follow-up|0
7548909|NCT02493946|26238574|P1|Open Label Period|Lost to Follow-up|0
7548910|NCT02493946|26238572|P3|Open Label Period|Adverse Event|4
7548911|NCT02493946|26238573|P2|Open Label Period|Adverse Event|0
7548912|NCT02493946|26238574|P1|Open Label Period|Adverse Event|0
7548913|NCT02493946|26238572|P3|Open Label Period|Withdrawal by Subject|74
7548914|NCT02493946|26238573|P2|Open Label Period|Withdrawal by Subject|0
7548915|NCT02493946|26238574|P1|Open Label Period|Withdrawal by Subject|0
7548916|NCT02493946|26238572|P3|DB Period|Withdrawal by Subject|0
7548917|NCT02493946|26238573|P2|DB Period|Withdrawal by Subject|5
7548918|NCT02493946|26238574|P1|DB Period|Withdrawal by Subject|8
7548919|NCT02493868|26238607|P2|Follow-up Phase|Other|1
7548920|NCT02493868|26238608|P1|Follow-up Phase|Other|2
7548921|NCT02493868|26238607|P2|Follow-up Phase|Investigator Decision|1
7548922|NCT02493868|26238608|P1|Follow-up Phase|Investigator Decision|5
7548923|NCT02493868|26238607|P2|Follow-up Phase|Withdrawal by Subject|0
7548924|NCT02493868|26238608|P1|Follow-up Phase|Withdrawal by Subject|3
7548925|NCT02493868|26238607|P2|Follow-up Phase|Lost to Follow-up|0
7548926|NCT02493868|26238608|P1|Follow-up Phase|Lost to Follow-up|1
7548927|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Other|9
7548928|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Other|4
7548929|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
7548930|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
7548931|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
7548932|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
7548933|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
7548934|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
7548935|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7548936|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7548937|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
7548938|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
7548939|NCT02493868|26238607|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
7548940|NCT02493868|26238608|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
7548941|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Other|2
7548942|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Other|10
7548943|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
7548944|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
7548945|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
7548946|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
7548947|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
7548948|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
7548949|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
7548950|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
7548951|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
7548952|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
7548953|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
7548954|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
7548955|NCT02493868|26238607|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
7548956|NCT02493868|26238608|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
7548957|NCT02493868|26238607|P2|Induction Phase: DE Participants|Other|0
7548958|NCT02493868|26238608|P1|Induction Phase: DE Participants|Other|8
7548959|NCT02493868|26238607|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
7548960|NCT02493868|26238608|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
7549049|NCT02492958|26238967|P4|Overall Study|Withdrawal by Subject|0
7548961|NCT02493868|26238607|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
7548962|NCT02493868|26238608|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
7548963|NCT02493868|26238607|P2|Induction Phase: DE Participants|Protocol Violation|0
7548964|NCT02493868|26238608|P1|Induction Phase: DE Participants|Protocol Violation|2
7548965|NCT02493868|26238607|P2|Induction Phase: DE Participants|Lack of Efficacy|0
7548966|NCT02493868|26238608|P1|Induction Phase: DE Participants|Lack of Efficacy|2
7548967|NCT02493868|26238607|P2|Induction Phase: DE Participants|Lost to Follow-up|0
7548968|NCT02493868|26238608|P1|Induction Phase: DE Participants|Lost to Follow-up|1
7548969|NCT02493868|26238607|P2|Induction Phase: DE Participants|Adverse Event|0
7548970|NCT02493868|26238608|P1|Induction Phase: DE Participants|Adverse Event|22
7548971|NCT02493855|26238657|P3|Overall Study|Withdrawal by Subject|0
7548972|NCT02493855|26238658|P2|Overall Study|Withdrawal by Subject|0
7548973|NCT02493855|26238659|P1|Overall Study|Withdrawal by Subject|1
7548974|NCT02493855|26238657|P3|Overall Study|Adverse Event|0
7548975|NCT02493855|26238658|P2|Overall Study|Adverse Event|1
7548976|NCT02493855|26238659|P1|Overall Study|Adverse Event|0
7548977|NCT02493855|26238657|P3|Overall Study|Non-compliance|0
7548978|NCT02493855|26238658|P2|Overall Study|Non-compliance|0
7548979|NCT02493855|26238659|P1|Overall Study|Non-compliance|1
7548980|NCT02493777|26238669|P2|Overall Study|Lost to Follow-up|1
7548981|NCT02493777|26238670|P1|Overall Study|Lost to Follow-up|0
7548982|NCT02493764|26238680|P2|Overall Study|Withdrawal by Subject|7
7548983|NCT02493764|26238681|P1|Overall Study|Withdrawal by Subject|11
7548984|NCT02493764|26238680|P2|Overall Study|Withdrawal parent/guardian|1
7548985|NCT02493764|26238681|P1|Overall Study|Withdrawal parent/guardian|0
7548986|NCT02493764|26238680|P2|Overall Study|Participant moved|5
7548987|NCT02493764|26238681|P1|Overall Study|Participant moved|17
7548988|NCT02493764|26238680|P2|Overall Study|Physician Decision|1
7548989|NCT02493764|26238681|P1|Overall Study|Physician Decision|1
7548990|NCT02493764|26238680|P2|Overall Study|Protocol Violation|7
7548991|NCT02493764|26238681|P1|Overall Study|Protocol Violation|6
7548992|NCT02493764|26238680|P2|Overall Study|Lost to Follow-up|1
7548993|NCT02493764|26238681|P1|Overall Study|Lost to Follow-up|2
7548994|NCT02493764|26238680|P2|Overall Study|Death|58
7548995|NCT02493764|26238681|P1|Overall Study|Death|44
7548996|NCT02493764|26238680|P2|Overall Study|Adverse Event|2
7548997|NCT02493764|26238681|P1|Overall Study|Adverse Event|2
7548998|NCT02493751|26238731|P2|Overall Study|Ongoing|23
7548999|NCT02493751|26238732|P1|Overall Study|Ongoing|11
7549000|NCT02493751|26238731|P2|Overall Study|Withdrawal by Subject|5
7549001|NCT02493751|26238732|P1|Overall Study|Withdrawal by Subject|2
7549002|NCT02493751|26238731|P2|Overall Study|Lost to Follow-up|1
7549003|NCT02493751|26238732|P1|Overall Study|Lost to Follow-up|0
7549019|NCT02493660|26238755|P2|Overall Study|Physician Decision|1
7549020|NCT02493660|26238756|P1|Overall Study|Physician Decision|0
7549021|NCT02493517|26238802|P2|Overall Study|Missed study visit|1
7549022|NCT02493517|26238803|P1|Overall Study|Missed study visit|0
7549023|NCT02493517|26238802|P2|Overall Study|Adverse Event|2
7549024|NCT02493517|26238803|P1|Overall Study|Adverse Event|0
7549025|NCT02493517|26238802|P2|Overall Study|Withdrawal by Subject|2
7549026|NCT02493517|26238803|P1|Overall Study|Withdrawal by Subject|1
7549027|NCT02493517|26238802|P2|Overall Study|Protocol Violation|2
7549028|NCT02493517|26238803|P1|Overall Study|Protocol Violation|1
7549029|NCT02493361|26238862|P1|Overall Study|Withdrawal by Subject|3
7549030|NCT02493127|26238889|P2|Overall Study|Lost to Follow-up|1
7549031|NCT02493127|26238890|P1|Overall Study|Lost to Follow-up|1
7549032|NCT02493062|26238908|P1|Overall Study|Physician Decision|12
7549033|NCT02492997|26238931|P2|Overall Study|Lost to Follow-up|1
7549034|NCT02492997|26238932|P1|Overall Study|Lost to Follow-up|0
7549035|NCT02492997|26238931|P2|Overall Study|Gained Weight|0
7549036|NCT02492997|26238932|P1|Overall Study|Gained Weight|1
7549037|NCT02492997|26238931|P2|Overall Study|Withdrawal by Subject|0
7549038|NCT02492997|26238932|P1|Overall Study|Withdrawal by Subject|1
7549039|NCT02492984|26238942|P2|Overall Study|Withdrawal by Subject|0
7549040|NCT02492984|26238943|P1|Overall Study|Withdrawal by Subject|1
7549041|NCT02492984|26238942|P2|Overall Study|Protocol Violation|0
7549042|NCT02492984|26238943|P1|Overall Study|Protocol Violation|1
7549043|NCT02492984|26238942|P2|Overall Study|Adverse Event|0
7549044|NCT02492984|26238943|P1|Overall Study|Adverse Event|1
7549045|NCT02492958|26238967|P4|Overall Study|Adverse Event|0
7549046|NCT02492958|26238968|P3|Overall Study|Adverse Event|1
7549047|NCT02492958|26238969|P2|Overall Study|Adverse Event|0
7549048|NCT02492958|26238970|P1|Overall Study|Adverse Event|1
7549050|NCT02492958|26238968|P3|Overall Study|Withdrawal by Subject|1
7549051|NCT02492958|26238969|P2|Overall Study|Withdrawal by Subject|0
7549052|NCT02492958|26238970|P1|Overall Study|Withdrawal by Subject|0
7549053|NCT02492880|26239056|P1|Overall Study|Protocol Violation|1
7549054|NCT02492880|26239056|P1|Overall Study|Lost to Follow-up|1
7549055|NCT02492841|26239063|P3|Overall Study|Lost to Follow-up|35
7549056|NCT02492841|26239064|P2|Overall Study|Lost to Follow-up|31
7549057|NCT02492841|26239065|P1|Overall Study|Lost to Follow-up|34
7549058|NCT02492763|26239084|P4|Overall Study|Study Terminated by Sponsor|10
7549059|NCT02492763|26239085|P3|Overall Study|Study Terminated by Sponsor|6
7549060|NCT02492763|26239086|P2|Overall Study|Study Terminated by Sponsor|10
7549061|NCT02492763|26239087|P1|Overall Study|Study Terminated by Sponsor|13
7549062|NCT02492763|26239084|P4|Overall Study|Screen Failure|1
7549063|NCT02492763|26239085|P3|Overall Study|Screen Failure|0
7549064|NCT02492763|26239086|P2|Overall Study|Screen Failure|0
7549065|NCT02492763|26239087|P1|Overall Study|Screen Failure|0
7549066|NCT02492763|26239084|P4|Overall Study|Non-Compliance With Study Drug|0
7549067|NCT02492763|26239085|P3|Overall Study|Non-Compliance With Study Drug|0
7549068|NCT02492763|26239086|P2|Overall Study|Non-Compliance With Study Drug|1
7549069|NCT02492763|26239087|P1|Overall Study|Non-Compliance With Study Drug|0
7549070|NCT02492763|26239084|P4|Overall Study|Lost to Follow-up|0
7549071|NCT02492763|26239085|P3|Overall Study|Lost to Follow-up|1
7549072|NCT02492763|26239086|P2|Overall Study|Lost to Follow-up|0
7549073|NCT02492763|26239087|P1|Overall Study|Lost to Follow-up|0
7549074|NCT02492763|26239084|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
7549075|NCT02492763|26239085|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
7549076|NCT02492763|26239086|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
7549077|NCT02492763|26239087|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
7549078|NCT02492763|26239084|P4|Overall Study|Death|0
7549079|NCT02492763|26239085|P3|Overall Study|Death|1
7549080|NCT02492763|26239086|P2|Overall Study|Death|0
7549081|NCT02492763|26239087|P1|Overall Study|Death|0
7549082|NCT02492763|26239084|P4|Overall Study|Adverse Event|2
7549083|NCT02492763|26239085|P3|Overall Study|Adverse Event|1
7549084|NCT02492763|26239086|P2|Overall Study|Adverse Event|1
7549085|NCT02492763|26239087|P1|Overall Study|Adverse Event|3
7549086|NCT02492763|26239084|P4|Overall Study|Withdrawal by Subject|0
7549087|NCT02492763|26239085|P3|Overall Study|Withdrawal by Subject|1
7549088|NCT02492763|26239086|P2|Overall Study|Withdrawal by Subject|2
7549089|NCT02492763|26239087|P1|Overall Study|Withdrawal by Subject|0
7549090|NCT02492165|26239192|P4|Overall Study|Withdrawal by Subject|0
7549091|NCT02492165|26239193|P3|Overall Study|Withdrawal by Subject|0
7549092|NCT02492165|26239194|P2|Overall Study|Withdrawal by Subject|1
7549093|NCT02492165|26239195|P1|Overall Study|Withdrawal by Subject|0
7549094|NCT02492100|26239217|P1|Overall Study|Death|1
7549095|NCT02491892|26239246|P2|Overall Study|Lost to Follow-up|0
7549096|NCT02491892|26239247|P1|Overall Study|Lost to Follow-up|1
7549097|NCT02491892|26239246|P2|Overall Study|Refused Treatment|0
7549098|NCT02491892|26239247|P1|Overall Study|Refused Treatment|1
7549099|NCT02491892|26239246|P2|Overall Study|Lack of Efficacy|36
7549100|NCT02491892|26239247|P1|Overall Study|Lack of Efficacy|37
7549101|NCT02491892|26239246|P2|Overall Study|Death|1
7549102|NCT02491892|26239247|P1|Overall Study|Death|1
7549103|NCT02491892|26239246|P2|Overall Study|Adverse Event|1
7549104|NCT02491892|26239247|P1|Overall Study|Adverse Event|1
7549105|NCT02491684|26239302|P2|Treatment Phase|Investigator and Sponsor decision|1
7549106|NCT02491684|26239303|P1|Treatment Phase|Investigator and Sponsor decision|0
7549107|NCT02491684|26239302|P2|Treatment Phase|Incorrect randomisation|0
7549108|NCT02491684|26239303|P1|Treatment Phase|Incorrect randomisation|1
7549109|NCT02491684|26239302|P2|Treatment Phase|Adverse Event|2
7549110|NCT02491684|26239303|P1|Treatment Phase|Adverse Event|2
7549111|NCT02491671|26239339|P2|Overall Study|Use of sealants other than Hemopatch|3
7549112|NCT02491671|26239340|P1|Overall Study|Use of sealants other than Hemopatch|5
7549113|NCT02491671|26239339|P2|Overall Study|Death|2
7549114|NCT02491671|26239340|P1|Overall Study|Death|0
7549115|NCT02491671|26239339|P2|Overall Study|Adverse Event|8
7549116|NCT02491671|26239340|P1|Overall Study|Adverse Event|6
7549117|NCT02491463|26239356|P4|Overall Study|Lost to Follow-up|0
7549118|NCT02491463|26239357|P3|Overall Study|Lost to Follow-up|3
7549119|NCT02491463|26239358|P2|Overall Study|Lost to Follow-up|3
7549120|NCT02491463|26239359|P1|Overall Study|Lost to Follow-up|0
7549121|NCT02491463|26239356|P4|Overall Study|Migrated/moved from study area|1
7549122|NCT02491463|26239357|P3|Overall Study|Migrated/moved from study area|1
7549123|NCT02491463|26239358|P2|Overall Study|Migrated/moved from study area|5
7549124|NCT02491463|26239359|P1|Overall Study|Migrated/moved from study area|1
7549125|NCT02491463|26239356|P4|Overall Study|Withdrawal by Subject|0
7549126|NCT02491463|26239357|P3|Overall Study|Withdrawal by Subject|0
7549127|NCT02491463|26239358|P2|Overall Study|Withdrawal by Subject|2
7549128|NCT02491463|26239359|P1|Overall Study|Withdrawal by Subject|1
7549129|NCT02491411|26239462|P1|Overall Study|Physician Decision|4
7549130|NCT02491073|26239493|P2|Overall Study|screen failure|0
7549131|NCT02491073|26239494|P1|Overall Study|screen failure|1
7549132|NCT02490878|26239522|P2|Overall Study|only submitted baseline QOL|1
7549133|NCT02490878|26239523|P1|Overall Study|only submitted baseline QOL|0
7549134|NCT02490878|26239522|P2|Overall Study|progression prior to treatment|1
7549135|NCT02490878|26239523|P1|Overall Study|progression prior to treatment|0
7549136|NCT02490878|26239522|P2|Overall Study|deemed ineligible|1
7549137|NCT02490878|26239523|P1|Overall Study|deemed ineligible|0
7549138|NCT02490475|26239569|P4|Period 2: Extension Phase|Adverse Event|0
7549139|NCT02490475|26239570|P3|Period 2: Extension Phase|Adverse Event|1
7549140|NCT02490475|26239571|P2|Period 2: Extension Phase|Adverse Event|0
7549141|NCT02490475|26239572|P1|Period 2: Extension Phase|Adverse Event|0
7549142|NCT02490475|26239569|P4|Period 2: Extension Phase|Refused Treatment|1
7549143|NCT02490475|26239570|P3|Period 2: Extension Phase|Refused Treatment|0
7549144|NCT02490475|26239571|P2|Period 2: Extension Phase|Refused Treatment|0
7549145|NCT02490475|26239572|P1|Period 2: Extension Phase|Refused Treatment|0
7549146|NCT02490475|26239569|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7549147|NCT02490475|26239570|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
7549148|NCT02490475|26239571|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7549149|NCT02490475|26239572|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
7549150|NCT02490475|26239569|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
7549151|NCT02490475|26239570|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
7549152|NCT02490475|26239571|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7549153|NCT02490475|26239572|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7549154|NCT02490475|26239569|P4|Period 1: First 6 Cycles|Refused Treatment|0
7549155|NCT02490475|26239570|P3|Period 1: First 6 Cycles|Refused Treatment|0
7549156|NCT02490475|26239571|P2|Period 1: First 6 Cycles|Refused Treatment|0
7549157|NCT02490475|26239572|P1|Period 1: First 6 Cycles|Refused Treatment|1
7549158|NCT02490475|26239569|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7549159|NCT02490475|26239570|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7549160|NCT02490475|26239571|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
7549161|NCT02490475|26239572|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7549162|NCT02490475|26239569|P4|Period 1: First 6 Cycles|Adverse Event|1
7549163|NCT02490475|26239570|P3|Period 1: First 6 Cycles|Adverse Event|0
7549164|NCT02490475|26239571|P2|Period 1: First 6 Cycles|Adverse Event|1
7549165|NCT02490475|26239572|P1|Period 1: First 6 Cycles|Adverse Event|2
7549166|NCT02490371|26239650|P2|Overall Study|Lost to Follow-up|1
7549167|NCT02490371|26239651|P1|Overall Study|Lost to Follow-up|1
7549168|NCT02489981|26239678|P1|Overall Study|Other than listed|28
7549169|NCT02489981|26239678|P1|Overall Study|Lost to Follow-up|31
7549170|NCT02489981|26239678|P1|Overall Study|Improved|31
7549171|NCT02489981|26239678|P1|Overall Study|Insufficient effectiveness|16
7549172|NCT02489981|26239678|P1|Overall Study|Adverse Event|21
7549173|NCT02489968|26239685|P6|Double-blind Treatment Period|Other than specified above|0
7549174|NCT02489968|26239686|P5|Double-blind Treatment Period|Other than specified above|1
7549175|NCT02489968|26239687|P4|Double-blind Treatment Period|Other than specified above|0
7549176|NCT02489968|26239688|P3|Double-blind Treatment Period|Other than specified above|0
7549177|NCT02489968|26239689|P2|Double-blind Treatment Period|Other than specified above|0
7549178|NCT02489968|26239690|P1|Double-blind Treatment Period|Other than specified above|0
7549179|NCT02489968|26239685|P6|Double-blind Treatment Period|Withdrawal by Subject|2
7549180|NCT02489968|26239686|P5|Double-blind Treatment Period|Withdrawal by Subject|0
7549181|NCT02489968|26239687|P4|Double-blind Treatment Period|Withdrawal by Subject|2
7549182|NCT02489968|26239688|P3|Double-blind Treatment Period|Withdrawal by Subject|0
7549183|NCT02489968|26239689|P2|Double-blind Treatment Period|Withdrawal by Subject|0
7549184|NCT02489968|26239690|P1|Double-blind Treatment Period|Withdrawal by Subject|0
7549185|NCT02489968|26239685|P6|Double-blind Treatment Period|Protocol Violation|1
7549186|NCT02489968|26239686|P5|Double-blind Treatment Period|Protocol Violation|1
7549187|NCT02489968|26239687|P4|Double-blind Treatment Period|Protocol Violation|0
7549188|NCT02489968|26239688|P3|Double-blind Treatment Period|Protocol Violation|0
7549189|NCT02489968|26239689|P2|Double-blind Treatment Period|Protocol Violation|0
7549190|NCT02489968|26239690|P1|Double-blind Treatment Period|Protocol Violation|0
7549191|NCT02489968|26239685|P6|Double-blind Treatment Period|Adverse Event|5
7549192|NCT02489968|26239686|P5|Double-blind Treatment Period|Adverse Event|4
7549193|NCT02489968|26239687|P4|Double-blind Treatment Period|Adverse Event|6
7549194|NCT02489968|26239688|P3|Double-blind Treatment Period|Adverse Event|2
7549195|NCT02489968|26239689|P2|Double-blind Treatment Period|Adverse Event|0
7549196|NCT02489968|26239690|P1|Double-blind Treatment Period|Adverse Event|0
7549197|NCT02489968|26239685|P6|Open-label Treatment Period|Other than specified above|0
7549198|NCT02489968|26239686|P5|Open-label Treatment Period|Other than specified above|0
7549199|NCT02489968|26239687|P4|Open-label Treatment Period|Other than specified above|0
7549200|NCT02489968|26239688|P3|Open-label Treatment Period|Other than specified above|0
7549201|NCT02489968|26239689|P2|Open-label Treatment Period|Other than specified above|189
7549202|NCT02489968|26239690|P1|Open-label Treatment Period|Other than specified above|204
7549203|NCT02489968|26239685|P6|Open-label Treatment Period|Withdrawal by Subject|0
7549204|NCT02489968|26239686|P5|Open-label Treatment Period|Withdrawal by Subject|0
7549205|NCT02489968|26239687|P4|Open-label Treatment Period|Withdrawal by Subject|0
7549206|NCT02489968|26239688|P3|Open-label Treatment Period|Withdrawal by Subject|0
7549207|NCT02489968|26239689|P2|Open-label Treatment Period|Withdrawal by Subject|7
7549208|NCT02489968|26239690|P1|Open-label Treatment Period|Withdrawal by Subject|4
7549209|NCT02489968|26239685|P6|Open-label Treatment Period|Lost to Follow-up|0
7549210|NCT02489968|26239686|P5|Open-label Treatment Period|Lost to Follow-up|0
7549211|NCT02489968|26239687|P4|Open-label Treatment Period|Lost to Follow-up|0
7549212|NCT02489968|26239688|P3|Open-label Treatment Period|Lost to Follow-up|0
7549213|NCT02489968|26239689|P2|Open-label Treatment Period|Lost to Follow-up|3
7549214|NCT02489968|26239690|P1|Open-label Treatment Period|Lost to Follow-up|0
7549215|NCT02489968|26239685|P6|Open-label Treatment Period|Protocol Violation|0
7549216|NCT02489968|26239686|P5|Open-label Treatment Period|Protocol Violation|0
7549217|NCT02489968|26239687|P4|Open-label Treatment Period|Protocol Violation|0
7549218|NCT02489968|26239688|P3|Open-label Treatment Period|Protocol Violation|0
7549219|NCT02489968|26239689|P2|Open-label Treatment Period|Protocol Violation|2
7549220|NCT02489968|26239690|P1|Open-label Treatment Period|Protocol Violation|2
7549221|NCT02489968|26239685|P6|Open-label Treatment Period|Adverse Event|0
7549222|NCT02489968|26239686|P5|Open-label Treatment Period|Adverse Event|0
7549223|NCT02489968|26239687|P4|Open-label Treatment Period|Adverse Event|0
7549224|NCT02489968|26239688|P3|Open-label Treatment Period|Adverse Event|0
7549225|NCT02489968|26239689|P2|Open-label Treatment Period|Adverse Event|7
7549226|NCT02489968|26239690|P1|Open-label Treatment Period|Adverse Event|14
7549227|NCT02489799|26239704|P2|Overall Study|Death|1
7549228|NCT02489799|26239705|P1|Overall Study|Death|0
7549229|NCT02489799|26239704|P2|Overall Study|Withdrawal by Subject|1
7549230|NCT02489799|26239705|P1|Overall Study|Withdrawal by Subject|1
7549231|NCT02489799|26239704|P2|Overall Study|Failure to Maintain Eligibility|6
7549232|NCT02489799|26239705|P1|Overall Study|Failure to Maintain Eligibility|4
7549233|NCT02489799|26239704|P2|Overall Study|Lost to Follow-up|1
7549234|NCT02489799|26239705|P1|Overall Study|Lost to Follow-up|4
7549235|NCT02489773|26239731|P2|Overall Study|Leave the country or the state|1
7549236|NCT02489773|26239732|P1|Overall Study|Leave the country or the state|1
7549237|NCT02489773|26239731|P2|Overall Study|Withdrawal by Subject|0
7549238|NCT02489773|26239732|P1|Overall Study|Withdrawal by Subject|1
7549239|NCT02489773|26239731|P2|Overall Study|Physician Decision|0
7549240|NCT02489773|26239732|P1|Overall Study|Physician Decision|1
7549241|NCT02489773|26239731|P2|Overall Study|Lost to Follow-up|1
7549242|NCT02489773|26239732|P1|Overall Study|Lost to Follow-up|4
7549243|NCT02489630|26239751|P2|Overall Study|Time to med. admin. > protocol limit|1
7549244|NCT02489630|26239752|P1|Overall Study|Time to med. admin. > protocol limit|1
7549245|NCT02489630|26239751|P2|Overall Study|Oversedation|1
7549246|NCT02489630|26239752|P1|Overall Study|Oversedation|1
7549247|NCT02489500|26239764|P2|Overall Study|Death|1
7549248|NCT02489500|26239765|P1|Overall Study|Death|1
7549249|NCT02489344|26239827|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
7549250|NCT02489344|26239827|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
7549251|NCT02489344|26239827|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
7549252|NCT02489344|26239827|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
7549253|NCT02489279|26239870|P2|Overall Study|Lost to Follow-up|10
7549254|NCT02489279|26239871|P1|Overall Study|Lost to Follow-up|12
7549255|NCT02489045|26239918|P1|Follow-up|Lost to Follow-up|10
7549256|NCT02489045|26239918|P1|Overall Study|unable to collect usable data|53
7549257|NCT02488980|26239927|P3|Overall Study|Protocol Violation|2
7549258|NCT02488980|26239928|P2|Overall Study|Protocol Violation|2
7549259|NCT02488980|26239929|P1|Overall Study|Protocol Violation|2
7549260|NCT02488915|26239946|P1|Overall Study|Withdrawal by Subject|1
7549261|NCT02488915|26239946|P1|Overall Study|Lost to Follow-up|4
7549262|NCT02488915|26239946|P1|Overall Study|Death|21
7549263|NCT02488824|26239964|P2|Overall Study|Adverse Event|1
7549264|NCT02488824|26239965|P1|Overall Study|Adverse Event|1
7549265|NCT02488681|26239979|P1|Overall Study|Implant unsuccessful|7
7549266|NCT02488330|26239983|P1|Overall Study|Study Termination by Sponsor|4
7549267|NCT02488330|26239983|P1|Overall Study|Disease Progression|3
7549268|NCT02488330|26239983|P1|Overall Study|Death|2
7549269|NCT02488330|26239983|P1|Overall Study|Physician Decision|2
7549270|NCT02488330|26239983|P1|Overall Study|Adverse Event|1
7549271|NCT02488239|26240004|P1|Overall Study|Did not undergo implant procedure|1
7549272|NCT02488239|26240004|P1|Overall Study|Consent ineligible|1
7549273|NCT02488239|26240004|P1|Overall Study|Physician Decision|2
7549274|NCT02488239|26240004|P1|Overall Study|Withdrawal by Subject|3
7549275|NCT02488239|26240004|P1|Overall Study|Death|3
7549276|NCT02488109|26240011|P2|12-month Follow-Up|Lost to Follow-up|7
7549277|NCT02488109|26240012|P1|12-month Follow-Up|Lost to Follow-up|4
7549278|NCT02488109|26240011|P2|Treatment in Hospital|Withdrawal by Subject|5
7549279|NCT02488109|26240012|P1|Treatment in Hospital|Withdrawal by Subject|0
7549280|NCT02488005|26240034|P1|Overall Study|Lost to Follow-up|2
7549281|NCT02487979|26240044|P1|Overall Study|Progressive Disease|17
7549282|NCT02487979|26240044|P1|Overall Study|Withdrawal by Subject|2
7549283|NCT02487979|26240044|P1|Overall Study|Physician Decision|2
7549284|NCT02487810|26240081|P2|Overall Study|Withdrawal by Subject|0
7549285|NCT02487810|26240082|P1|Overall Study|Withdrawal by Subject|1
7549286|NCT02487771|26240114|P2|Overall Study|Withdrawal by Subject|5
7549287|NCT02487771|26240115|P1|Overall Study|Withdrawal by Subject|3
7549288|NCT02487771|26240114|P2|Overall Study|Moved out of area|6
7549289|NCT02487771|26240115|P1|Overall Study|Moved out of area|5
7549290|NCT02487771|26240114|P2|Overall Study|Lost to Follow-up|3
7549291|NCT02487771|26240115|P1|Overall Study|Lost to Follow-up|2
7549292|NCT02487498|26240281|P2|Period: Period 2|Physician Decision|0
7549293|NCT02487498|26240282|P1|Period: Period 2|Physician Decision|1
7549294|NCT02487498|26240281|P2|Period: Period 2|Death|1
7549295|NCT02487498|26240282|P1|Period: Period 2|Death|0
7549296|NCT02487498|26240281|P2|Period: Period 2|Lost to Follow-up|1
7549297|NCT02487498|26240282|P1|Period: Period 2|Lost to Follow-up|1
7549298|NCT02487498|26240281|P2|Period: Period 2|Subject/guardian decision|1
7549299|NCT02487498|26240282|P1|Period: Period 2|Subject/guardian decision|2
7549300|NCT02487498|26240281|P2|Period: Period 2|Adverse Event|2
7549301|NCT02487498|26240282|P1|Period: Period 2|Adverse Event|2
7549302|NCT02487498|26240281|P2|Period: Washout|Non-compliance with study treatment|1
7549303|NCT02487498|26240282|P1|Period: Washout|Non-compliance with study treatment|0
7549304|NCT02487498|26240281|P2|Period: Washout|Physician Decision|0
7549305|NCT02487498|26240282|P1|Period: Washout|Physician Decision|1
7549306|NCT02487498|26240281|P2|Period: Washout|Lack of Efficacy|1
7549307|NCT02487498|26240282|P1|Period: Washout|Lack of Efficacy|1
7549308|NCT02487498|26240281|P2|Period: Washout|Subject/guardian decision|5
7549309|NCT02487498|26240282|P1|Period: Washout|Subject/guardian decision|0
7549310|NCT02487498|26240281|P2|Period: Period 1|Protocol deviation|0
7549311|NCT02487498|26240282|P1|Period: Period 1|Protocol deviation|1
7549312|NCT02487498|26240281|P2|Period: Period 1|Physician Decision|1
7549313|NCT02487498|26240282|P1|Period: Period 1|Physician Decision|0
7549314|NCT02487498|26240281|P2|Period: Period 1|Lack of Efficacy|0
7549315|NCT02487498|26240282|P1|Period: Period 1|Lack of Efficacy|1
7549316|NCT02487498|26240281|P2|Period: Period 1|Lost to Follow-up|2
7549317|NCT02487498|26240282|P1|Period: Period 1|Lost to Follow-up|0
7549318|NCT02487498|26240281|P2|Period: Period 1|Subject/guardian decision|4
7549319|NCT02487498|26240282|P1|Period: Period 1|Subject/guardian decision|2
7549320|NCT02487498|26240281|P2|Period: Period 1|Adverse Event|4
7549321|NCT02487498|26240282|P1|Period: Period 1|Adverse Event|2
7549322|NCT02487472|26240326|P1|Overall Study|Other|2
7549323|NCT02487472|26240326|P1|Overall Study|Did not complete telephonic interviews|9
7549324|NCT02487446|26240342|P2|Period 2|Adverse Event|2
7549325|NCT02487446|26240343|P1|Period 2|Adverse Event|6
7549326|NCT02487446|26240342|P2|Period 2|Withdrawal by Subject|1
7549327|NCT02487446|26240343|P1|Period 2|Withdrawal by Subject|1
7549328|NCT02487446|26240342|P2|Period 2|Lost to Follow-up|1
7549329|NCT02487446|26240343|P1|Period 2|Lost to Follow-up|1
7549330|NCT02487446|26240342|P2|Period 2|Protocol deviation|1
7549331|NCT02487446|26240343|P1|Period 2|Protocol deviation|0
7549332|NCT02487446|26240342|P2|Washout|Adverse Event|2
7549333|NCT02487446|26240343|P1|Washout|Adverse Event|2
7549334|NCT02487446|26240342|P2|Washout|Withdrawal by Subject|4
7549335|NCT02487446|26240343|P1|Washout|Withdrawal by Subject|1
7549336|NCT02487446|26240342|P2|Washout|Lost to Follow-up|2
7549337|NCT02487446|26240343|P1|Washout|Lost to Follow-up|0
7549338|NCT02487446|26240342|P2|Period 1|Adverse Event|5
7549339|NCT02487446|26240343|P1|Period 1|Adverse Event|5
7549340|NCT02487446|26240342|P2|Period 1|Withdrawal by Subject|0
7549341|NCT02487446|26240343|P1|Period 1|Withdrawal by Subject|2
7549342|NCT02487446|26240342|P2|Period 1|Lost to Follow-up|0
7549343|NCT02487446|26240343|P1|Period 1|Lost to Follow-up|2
7549344|NCT02487446|26240342|P2|Period 1|Protocol deviation|2
7549345|NCT02487446|26240343|P1|Period 1|Protocol deviation|3
7549346|NCT02487446|26240342|P2|Period 1|Lack of Efficacy|0
7549347|NCT02487446|26240343|P1|Period 1|Lack of Efficacy|1
7549348|NCT02487446|26240342|P2|Period 1|Physician Decision|1
7549349|NCT02487446|26240343|P1|Period 1|Physician Decision|0
7549350|NCT02487199|26240423|P2|Overall Study|Withdrew Consent|1
7549351|NCT02487199|26240424|P1|Overall Study|Withdrew Consent|0
7549352|NCT02487030|26240449|P7|Overall Study|Death|0
7549353|NCT02487030|26240450|P6|Overall Study|Death|0
7549354|NCT02487030|26240451|P5|Overall Study|Death|1
7549355|NCT02487030|26240452|P4|Overall Study|Death|0
7549356|NCT02487030|26240453|P3|Overall Study|Death|0
7549357|NCT02487030|26240454|P2|Overall Study|Death|0
7549358|NCT02487030|26240455|P1|Overall Study|Death|0
7549359|NCT02487030|26240449|P7|Overall Study|Adverse Event|0
7549360|NCT02487030|26240450|P6|Overall Study|Adverse Event|0
7549361|NCT02487030|26240451|P5|Overall Study|Adverse Event|0
7549362|NCT02487030|26240452|P4|Overall Study|Adverse Event|1
7549363|NCT02487030|26240453|P3|Overall Study|Adverse Event|0
7549364|NCT02487030|26240454|P2|Overall Study|Adverse Event|0
7549365|NCT02487030|26240455|P1|Overall Study|Adverse Event|0
7549366|NCT02487030|26240449|P7|Overall Study|Lost to Follow-up|0
7549367|NCT02487030|26240450|P6|Overall Study|Lost to Follow-up|1
7549368|NCT02487030|26240451|P5|Overall Study|Lost to Follow-up|0
7549369|NCT02487030|26240452|P4|Overall Study|Lost to Follow-up|1
7549370|NCT02487030|26240453|P3|Overall Study|Lost to Follow-up|1
7549371|NCT02487030|26240454|P2|Overall Study|Lost to Follow-up|0
7549372|NCT02487030|26240455|P1|Overall Study|Lost to Follow-up|0
7549373|NCT02487030|26240449|P7|Overall Study|Lack of Efficacy|0
7549374|NCT02487030|26240450|P6|Overall Study|Lack of Efficacy|0
7549375|NCT02487030|26240451|P5|Overall Study|Lack of Efficacy|1
7549376|NCT02487030|26240452|P4|Overall Study|Lack of Efficacy|0
7549377|NCT02487030|26240453|P3|Overall Study|Lack of Efficacy|1
7549378|NCT02487030|26240454|P2|Overall Study|Lack of Efficacy|4
7549379|NCT02487030|26240455|P1|Overall Study|Lack of Efficacy|2
7549380|NCT02486952|26240486|P1|Overall Study|Other|2
7549381|NCT02486952|26240486|P1|Overall Study|Lost to Follow-up|26
7549382|NCT02486952|26240486|P1|Overall Study|Lack of Efficacy|3
7549383|NCT02486952|26240486|P1|Overall Study|Death|15
7549384|NCT02486952|26240486|P1|Overall Study|Adverse Event|1
7549385|NCT02486952|26240486|P1|Overall Study|Not Started Induction Therapy|3
7549386|NCT02486796|26240504|P2|Overall Study|Physician Decision|0
7549387|NCT02486796|26240505|P1|Overall Study|Physician Decision|1
7549388|NCT02486796|26240504|P2|Overall Study|Withdrawal by Subject|1
7549389|NCT02486796|26240505|P1|Overall Study|Withdrawal by Subject|1
7549390|NCT02486757|26240517|P1|Overall Study|Lost to Follow-up|1
7549391|NCT02486692|26240523|P2|Overall Study|did not login for randomization|7
7549392|NCT02486692|26240524|P1|Overall Study|did not login for randomization|4
7549393|NCT02486653|26240536|P2|Overall Study|surgery cancelled|1
7549394|NCT02486653|26240537|P1|Overall Study|surgery cancelled|4
7549395|NCT02486653|26240536|P2|Overall Study|Protocol Violation|0
7549396|NCT02486653|26240537|P1|Overall Study|Protocol Violation|1
7549397|NCT02486653|26240536|P2|Overall Study|Withdrawal by Subject|3
7549398|NCT02486653|26240537|P1|Overall Study|Withdrawal by Subject|1
7549399|NCT02486627|26240561|P2|Overall Study|Lost to Follow-up|3
7549400|NCT02486627|26240562|P1|Overall Study|Lost to Follow-up|1
7549401|NCT02486627|26240561|P2|Overall Study|Significant Participant Noncompliance|1
7549402|NCT02486627|26240562|P1|Overall Study|Significant Participant Noncompliance|1
7549403|NCT02486627|26240561|P2|Overall Study|Consent Withdrawn by Participant|3
7549404|NCT02486627|26240562|P1|Overall Study|Consent Withdrawn by Participant|4
7549405|NCT02486627|26240561|P2|Overall Study|Other Unspecified|2
7549406|NCT02486627|26240562|P1|Overall Study|Other Unspecified|0
7549407|NCT02486627|26240561|P2|Overall Study|Death|0
7549408|NCT02486627|26240562|P1|Overall Study|Death|1
7549409|NCT02486588|26240585|P6|Overall Study|Randomized in error- ineligible|746
7549410|NCT02486588|26240586|P5|Overall Study|Randomized in error- ineligible|746
7549411|NCT02486588|26240587|P4|Overall Study|Randomized in error- ineligible|738
7549412|NCT02486588|26240588|P3|Overall Study|Randomized in error- ineligible|755
7549413|NCT02486588|26240589|P2|Overall Study|Randomized in error- ineligible|750
7549414|NCT02486588|26240590|P1|Overall Study|Randomized in error- ineligible|738
7549415|NCT02486406|26240650|P4|Overall Study|Other, not specified|0
7549416|NCT02486406|26240651|P3|Overall Study|Other, not specified|1
7549417|NCT02486406|26240652|P2|Overall Study|Other, not specified|0
7549418|NCT02486406|26240653|P1|Overall Study|Other, not specified|0
7549419|NCT02486406|26240650|P4|Overall Study|Lost to Follow-up|3
7549420|NCT02486406|26240651|P3|Overall Study|Lost to Follow-up|1
7549421|NCT02486406|26240652|P2|Overall Study|Lost to Follow-up|3
7549422|NCT02486406|26240653|P1|Overall Study|Lost to Follow-up|1
7549423|NCT02486406|26240650|P4|Overall Study|Withdrew consent|1
7549424|NCT02486406|26240651|P3|Overall Study|Withdrew consent|0
7549425|NCT02486406|26240652|P2|Overall Study|Withdrew consent|0
7549426|NCT02486406|26240653|P1|Overall Study|Withdrew consent|1
7549427|NCT02486302|26240737|P1|Overall Study|Not treated|3
7549428|NCT02486302|26240737|P1|Overall Study|Excluded due to legal reasons|8
7549429|NCT02486302|26240737|P1|Overall Study|Documentation not completed|255
7549430|NCT02486302|26240737|P1|Overall Study|Discontinued prematurely|410
7549431|NCT02485925|26240838|P1|Overall Study|Lost to Follow-up|11
7549432|NCT02485925|26240838|P1|Overall Study|Death|1
7549433|NCT02485925|26240838|P1|Overall Study|Withdrawal by Subject|3
7549434|NCT02485717|26240870|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
7549435|NCT02485717|26240871|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
7549436|NCT02485717|26240872|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
7549437|NCT02485717|26240870|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
7549438|NCT02485717|26240871|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
7549439|NCT02485717|26240872|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
7549440|NCT02485717|26240870|P3|Overall Study|Withdrawal by Subject|1
7549441|NCT02485717|26240871|P2|Overall Study|Withdrawal by Subject|0
7549442|NCT02485717|26240872|P1|Overall Study|Withdrawal by Subject|0
7549443|NCT02485717|26240870|P3|Overall Study|Lost to Follow-up|0
7549444|NCT02485717|26240871|P2|Overall Study|Lost to Follow-up|0
7549445|NCT02485717|26240872|P1|Overall Study|Lost to Follow-up|6
7549446|NCT02485704|26240887|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
7549447|NCT02485704|26240888|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
7549448|NCT02485704|26240887|P2|Overall Study|Withdrawal by Subject|3
7549449|NCT02485704|26240888|P1|Overall Study|Withdrawal by Subject|0
7549450|NCT02485704|26240887|P2|Overall Study|Lost to Follow-up|5
7549451|NCT02485704|26240888|P1|Overall Study|Lost to Follow-up|4
7549452|NCT02485483|26240936|P2|Overall Study|Discontinued after baseline|0
7549453|NCT02485483|26240937|P1|Overall Study|Discontinued after baseline|39
7549454|NCT02485483|26240936|P2|Overall Study|Depression at baseline|0
7549455|NCT02485483|26240937|P1|Overall Study|Depression at baseline|15
7549456|NCT02485353|26240952|P1|Overall Study|Disease Progression|1
7549457|NCT02485353|26240952|P1|Overall Study|Death|1
7549458|NCT02485301|26240959|P2|Overall Study|Other|4
7549459|NCT02485301|26240960|P1|Overall Study|Other|3
7549460|NCT02485301|26240959|P2|Overall Study|Lost to Follow-up|17
7549461|NCT02485301|26240960|P1|Overall Study|Lost to Follow-up|17
7549462|NCT02485301|26240959|P2|Overall Study|Migrated/moved from study area|19
7549463|NCT02485301|26240960|P1|Overall Study|Migrated/moved from study area|10
7549464|NCT02485301|26240959|P2|Overall Study|Withdrawal by Subject|7
7549465|NCT02485301|26240960|P1|Overall Study|Withdrawal by Subject|6
7549466|NCT02485301|26240959|P2|Overall Study|Protocol Violation|1
7549467|NCT02485301|26240960|P1|Overall Study|Protocol Violation|0
7549468|NCT02485301|26240959|P2|Overall Study|Serious Adverse Events|1
7549469|NCT02485301|26240960|P1|Overall Study|Serious Adverse Events|2
7549470|NCT02485158|26241010|P1|Overall Study|expected drug side effect|1
7549471|NCT02485158|26241010|P1|Overall Study|Withdrawal by Subject|3
7549472|NCT02484911|26241099|P2|Overall Study|Protocol Violation|1
7549473|NCT02484911|26241100|P1|Overall Study|Protocol Violation|2
7549474|NCT02484911|26241099|P2|Overall Study|Withdrawal by Subject|1
7549475|NCT02484911|26241100|P1|Overall Study|Withdrawal by Subject|2
7549476|NCT02484729|26241190|P10|Overall Study|Failure of IntelliCap Error|1
7549477|NCT02484729|26241191|P9|Overall Study|Failure of IntelliCap Error|0
7549478|NCT02484729|26241192|P8|Overall Study|Failure of IntelliCap Error|0
7549479|NCT02484729|26241193|P7|Overall Study|Failure of IntelliCap Error|0
7549480|NCT02484729|26241194|P6|Overall Study|Failure of IntelliCap Error|0
7549481|NCT02484729|26241195|P5|Overall Study|Failure of IntelliCap Error|0
7549482|NCT02484729|26241196|P4|Overall Study|Failure of IntelliCap Error|0
7549483|NCT02484729|26241197|P3|Overall Study|Failure of IntelliCap Error|0
7549484|NCT02484729|26241198|P2|Overall Study|Failure of IntelliCap Error|0
7549485|NCT02484729|26241199|P1|Overall Study|Failure of IntelliCap Error|0
7549486|NCT02484690|26241400|P5|Overall Study|Lost to Follow-up|0
7549487|NCT02484690|26241401|P4|Overall Study|Lost to Follow-up|0
7549488|NCT02484690|26241402|P3|Overall Study|Lost to Follow-up|1
7549489|NCT02484690|26241403|P2|Overall Study|Lost to Follow-up|0
7549490|NCT02484690|26241404|P1|Overall Study|Lost to Follow-up|0
7549491|NCT02484690|26241400|P5|Overall Study|Physician Decision|0
7549492|NCT02484690|26241401|P4|Overall Study|Physician Decision|0
7549493|NCT02484690|26241402|P3|Overall Study|Physician Decision|1
7549494|NCT02484690|26241403|P2|Overall Study|Physician Decision|0
7549495|NCT02484690|26241404|P1|Overall Study|Physician Decision|2
7549496|NCT02484690|26241400|P5|Overall Study|Withdrawal by Subject|0
7549497|NCT02484690|26241401|P4|Overall Study|Withdrawal by Subject|2
7549498|NCT02484690|26241402|P3|Overall Study|Withdrawal by Subject|1
7549499|NCT02484690|26241403|P2|Overall Study|Withdrawal by Subject|3
7549500|NCT02484690|26241404|P1|Overall Study|Withdrawal by Subject|1
7549501|NCT02484690|26241400|P5|Overall Study|Death|1
7549502|NCT02484690|26241401|P4|Overall Study|Death|0
7549503|NCT02484690|26241402|P3|Overall Study|Death|0
7549504|NCT02484690|26241403|P2|Overall Study|Death|0
7549505|NCT02484690|26241404|P1|Overall Study|Death|0
7549506|NCT02484690|26241400|P5|Overall Study|Adverse Event|5
7549507|NCT02484690|26241401|P4|Overall Study|Adverse Event|0
7549508|NCT02484690|26241402|P3|Overall Study|Adverse Event|0
7549509|NCT02484690|26241403|P2|Overall Study|Adverse Event|3
7549510|NCT02484690|26241404|P1|Overall Study|Adverse Event|1
7549511|NCT02484651|26241548|P2|Overall Study|Time of the procedure less than 90 min.|2
7549512|NCT02484651|26241549|P1|Overall Study|Time of the procedure less than 90 min.|1
7549513|NCT02484651|26241548|P2|Overall Study|BIS monitoring failed.|1
7549514|NCT02484651|26241549|P1|Overall Study|BIS monitoring failed.|1
7549515|NCT02484651|26241548|P2|Overall Study|Patients' data files were corrupted.|1
7549516|NCT02484651|26241549|P1|Overall Study|Patients' data files were corrupted.|1
7549517|NCT02484547|26241564|P7|Long-Term Extension Period|Reason not Specified|231
7549518|NCT02484547|26241565|P6|Long-Term Extension Period|Reason not Specified|223
7549519|NCT02484547|26241566|P5|Long-Term Extension Period|Reason not Specified|117
7549520|NCT02484547|26241567|P4|Long-Term Extension Period|Reason not Specified|119
7549521|NCT02484547|26241568|P3|Long-Term Extension Period|Reason not Specified|0
7549522|NCT02484547|26241569|P2|Long-Term Extension Period|Reason not Specified|0
7549523|NCT02484547|26241570|P1|Long-Term Extension Period|Reason not Specified|0
7549524|NCT02484547|26241564|P7|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
7549525|NCT02484547|26241565|P6|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
7549526|NCT02484547|26241566|P5|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
7549527|NCT02484547|26241567|P4|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7549528|NCT02484547|26241568|P3|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7549529|NCT02484547|26241569|P2|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7549530|NCT02484547|26241570|P1|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7549531|NCT02484547|26241564|P7|Long-Term Extension Period|Study Visit Burden|3
7549532|NCT02484547|26241565|P6|Long-Term Extension Period|Study Visit Burden|0
7549533|NCT02484547|26241566|P5|Long-Term Extension Period|Study Visit Burden|0
7549534|NCT02484547|26241567|P4|Long-Term Extension Period|Study Visit Burden|2
7549535|NCT02484547|26241568|P3|Long-Term Extension Period|Study Visit Burden|0
7549536|NCT02484547|26241569|P2|Long-Term Extension Period|Study Visit Burden|0
7549537|NCT02484547|26241570|P1|Long-Term Extension Period|Study Visit Burden|0
7549538|NCT02484547|26241564|P7|Long-Term Extension Period|Relocation|0
7549539|NCT02484547|26241565|P6|Long-Term Extension Period|Relocation|0
7549540|NCT02484547|26241566|P5|Long-Term Extension Period|Relocation|1
7549541|NCT02484547|26241567|P4|Long-Term Extension Period|Relocation|1
7549542|NCT02484547|26241568|P3|Long-Term Extension Period|Relocation|0
7549543|NCT02484547|26241569|P2|Long-Term Extension Period|Relocation|0
7549544|NCT02484547|26241570|P1|Long-Term Extension Period|Relocation|0
7549545|NCT02484547|26241564|P7|Long-Term Extension Period|Investigator Decision|1
7549546|NCT02484547|26241565|P6|Long-Term Extension Period|Investigator Decision|0
7549547|NCT02484547|26241566|P5|Long-Term Extension Period|Investigator Decision|1
7549548|NCT02484547|26241567|P4|Long-Term Extension Period|Investigator Decision|2
7549549|NCT02484547|26241568|P3|Long-Term Extension Period|Investigator Decision|0
7549550|NCT02484547|26241569|P2|Long-Term Extension Period|Investigator Decision|0
7549551|NCT02484547|26241570|P1|Long-Term Extension Period|Investigator Decision|0
7549552|NCT02484547|26241564|P7|Long-Term Extension Period|Consent Withdrawn|17
7549553|NCT02484547|26241565|P6|Long-Term Extension Period|Consent Withdrawn|13
7549554|NCT02484547|26241566|P5|Long-Term Extension Period|Consent Withdrawn|7
7549555|NCT02484547|26241567|P4|Long-Term Extension Period|Consent Withdrawn|6
7549556|NCT02484547|26241568|P3|Long-Term Extension Period|Consent Withdrawn|0
7549557|NCT02484547|26241569|P2|Long-Term Extension Period|Consent Withdrawn|0
7549558|NCT02484547|26241570|P1|Long-Term Extension Period|Consent Withdrawn|0
7549559|NCT02484547|26241564|P7|Long-Term Extension Period|Change of Treatment|1
7549560|NCT02484547|26241565|P6|Long-Term Extension Period|Change of Treatment|0
7549561|NCT02484547|26241566|P5|Long-Term Extension Period|Change of Treatment|0
7549562|NCT02484547|26241567|P4|Long-Term Extension Period|Change of Treatment|0
7549563|NCT02484547|26241568|P3|Long-Term Extension Period|Change of Treatment|0
7549564|NCT02484547|26241569|P2|Long-Term Extension Period|Change of Treatment|0
7549565|NCT02484547|26241570|P1|Long-Term Extension Period|Change of Treatment|0
7549566|NCT02484547|26241564|P7|Long-Term Extension Period|Loss of Capacity|0
7549567|NCT02484547|26241565|P6|Long-Term Extension Period|Loss of Capacity|0
7549568|NCT02484547|26241566|P5|Long-Term Extension Period|Loss of Capacity|1
7549569|NCT02484547|26241567|P4|Long-Term Extension Period|Loss of Capacity|0
7549570|NCT02484547|26241568|P3|Long-Term Extension Period|Loss of Capacity|0
7549571|NCT02484547|26241569|P2|Long-Term Extension Period|Loss of Capacity|0
7549572|NCT02484547|26241570|P1|Long-Term Extension Period|Loss of Capacity|0
7549573|NCT02484547|26241564|P7|Long-Term Extension Period|Lost to Follow-up|0
7549574|NCT02484547|26241565|P6|Long-Term Extension Period|Lost to Follow-up|2
7549575|NCT02484547|26241566|P5|Long-Term Extension Period|Lost to Follow-up|1
7549576|NCT02484547|26241567|P4|Long-Term Extension Period|Lost to Follow-up|1
7549577|NCT02484547|26241568|P3|Long-Term Extension Period|Lost to Follow-up|0
7549578|NCT02484547|26241569|P2|Long-Term Extension Period|Lost to Follow-up|0
7549579|NCT02484547|26241570|P1|Long-Term Extension Period|Lost to Follow-up|0
7549580|NCT02484547|26241564|P7|Long-Term Extension Period|Disease Progression|0
7549581|NCT02484547|26241565|P6|Long-Term Extension Period|Disease Progression|4
7549582|NCT02484547|26241566|P5|Long-Term Extension Period|Disease Progression|2
7549583|NCT02484547|26241567|P4|Long-Term Extension Period|Disease Progression|0
7549584|NCT02484547|26241568|P3|Long-Term Extension Period|Disease Progression|0
7549585|NCT02484547|26241569|P2|Long-Term Extension Period|Disease Progression|0
7549586|NCT02484547|26241570|P1|Long-Term Extension Period|Disease Progression|0
7549587|NCT02484547|26241564|P7|Long-Term Extension Period|Death|0
7549588|NCT02484547|26241565|P6|Long-Term Extension Period|Death|3
7549589|NCT02484547|26241566|P5|Long-Term Extension Period|Death|0
7549590|NCT02484547|26241567|P4|Long-Term Extension Period|Death|0
7549591|NCT02484547|26241568|P3|Long-Term Extension Period|Death|0
7549592|NCT02484547|26241569|P2|Long-Term Extension Period|Death|0
7549593|NCT02484547|26241570|P1|Long-Term Extension Period|Death|0
7549594|NCT02484547|26241564|P7|Long-Term Extension Period|Adverse Event|2
7549595|NCT02484547|26241565|P6|Long-Term Extension Period|Adverse Event|3
7549596|NCT02484547|26241566|P5|Long-Term Extension Period|Adverse Event|1
7549597|NCT02484547|26241567|P4|Long-Term Extension Period|Adverse Event|0
7549598|NCT02484547|26241568|P3|Long-Term Extension Period|Adverse Event|0
7549599|NCT02484547|26241569|P2|Long-Term Extension Period|Adverse Event|0
7549600|NCT02484547|26241570|P1|Long-Term Extension Period|Adverse Event|0
7549601|NCT02484547|26241564|P7|Placebo-Controlled Period|Reason not Specified|0
7549602|NCT02484547|26241565|P6|Placebo-Controlled Period|Reason not Specified|0
7549603|NCT02484547|26241566|P5|Placebo-Controlled Period|Reason not Specified|0
7549604|NCT02484547|26241567|P4|Placebo-Controlled Period|Reason not Specified|0
7549605|NCT02484547|26241568|P3|Placebo-Controlled Period|Reason not Specified|183
7549606|NCT02484547|26241569|P2|Placebo-Controlled Period|Reason not Specified|194
7549607|NCT02484547|26241570|P1|Placebo-Controlled Period|Reason not Specified|216
7549608|NCT02484547|26241564|P7|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7549609|NCT02484547|26241565|P6|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7549610|NCT02484547|26241566|P5|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7549611|NCT02484547|26241567|P4|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7549612|NCT02484547|26241568|P3|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7549613|NCT02484547|26241569|P2|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7549614|NCT02484547|26241570|P1|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
7549615|NCT02484547|26241564|P7|Placebo-Controlled Period|Study Visit Burden|0
7549616|NCT02484547|26241565|P6|Placebo-Controlled Period|Study Visit Burden|0
7549617|NCT02484547|26241566|P5|Placebo-Controlled Period|Study Visit Burden|0
7549618|NCT02484547|26241567|P4|Placebo-Controlled Period|Study Visit Burden|0
7549619|NCT02484547|26241568|P3|Placebo-Controlled Period|Study Visit Burden|5
7549620|NCT02484547|26241569|P2|Placebo-Controlled Period|Study Visit Burden|8
7549621|NCT02484547|26241570|P1|Placebo-Controlled Period|Study Visit Burden|2
7549622|NCT02484547|26241564|P7|Placebo-Controlled Period|Relocation|0
7549623|NCT02484547|26241565|P6|Placebo-Controlled Period|Relocation|0
7549624|NCT02484547|26241566|P5|Placebo-Controlled Period|Relocation|0
7549625|NCT02484547|26241567|P4|Placebo-Controlled Period|Relocation|0
7549626|NCT02484547|26241568|P3|Placebo-Controlled Period|Relocation|1
7549627|NCT02484547|26241569|P2|Placebo-Controlled Period|Relocation|1
7549628|NCT02484547|26241570|P1|Placebo-Controlled Period|Relocation|1
7549629|NCT02484547|26241564|P7|Placebo-Controlled Period|Lost to Follow-up|0
7549630|NCT02484547|26241565|P6|Placebo-Controlled Period|Lost to Follow-up|0
7549631|NCT02484547|26241566|P5|Placebo-Controlled Period|Lost to Follow-up|0
7549632|NCT02484547|26241567|P4|Placebo-Controlled Period|Lost to Follow-up|0
7549633|NCT02484547|26241568|P3|Placebo-Controlled Period|Lost to Follow-up|3
7549634|NCT02484547|26241569|P2|Placebo-Controlled Period|Lost to Follow-up|1
7549635|NCT02484547|26241570|P1|Placebo-Controlled Period|Lost to Follow-up|3
7549718|NCT02483520|26241809|P2|Overall Study|Lost to Follow-up|4
7549636|NCT02484547|26241564|P7|Placebo-Controlled Period|Investigator Decision|0
7549637|NCT02484547|26241565|P6|Placebo-Controlled Period|Investigator Decision|0
7549638|NCT02484547|26241566|P5|Placebo-Controlled Period|Investigator Decision|0
7549639|NCT02484547|26241567|P4|Placebo-Controlled Period|Investigator Decision|0
7549640|NCT02484547|26241568|P3|Placebo-Controlled Period|Investigator Decision|5
7549641|NCT02484547|26241569|P2|Placebo-Controlled Period|Investigator Decision|2
7549642|NCT02484547|26241570|P1|Placebo-Controlled Period|Investigator Decision|2
7549643|NCT02484547|26241564|P7|Placebo-Controlled Period|Disease Progression|0
7549644|NCT02484547|26241565|P6|Placebo-Controlled Period|Disease Progression|0
7549645|NCT02484547|26241566|P5|Placebo-Controlled Period|Disease Progression|0
7549646|NCT02484547|26241567|P4|Placebo-Controlled Period|Disease Progression|0
7549647|NCT02484547|26241568|P3|Placebo-Controlled Period|Disease Progression|1
7549648|NCT02484547|26241569|P2|Placebo-Controlled Period|Disease Progression|0
7549649|NCT02484547|26241570|P1|Placebo-Controlled Period|Disease Progression|2
7549650|NCT02484547|26241564|P7|Placebo-Controlled Period|Death|0
7549651|NCT02484547|26241565|P6|Placebo-Controlled Period|Death|0
7549652|NCT02484547|26241566|P5|Placebo-Controlled Period|Death|0
7549653|NCT02484547|26241567|P4|Placebo-Controlled Period|Death|0
7549654|NCT02484547|26241568|P3|Placebo-Controlled Period|Death|6
7549655|NCT02484547|26241569|P2|Placebo-Controlled Period|Death|0
7549656|NCT02484547|26241570|P1|Placebo-Controlled Period|Death|5
7549657|NCT02484547|26241564|P7|Placebo-Controlled Period|Consent Withdrawn|0
7549658|NCT02484547|26241565|P6|Placebo-Controlled Period|Consent Withdrawn|0
7549659|NCT02484547|26241566|P5|Placebo-Controlled Period|Consent Withdrawn|0
7549660|NCT02484547|26241567|P4|Placebo-Controlled Period|Consent Withdrawn|0
7549661|NCT02484547|26241568|P3|Placebo-Controlled Period|Consent Withdrawn|26
7549662|NCT02484547|26241569|P2|Placebo-Controlled Period|Consent Withdrawn|32
7549663|NCT02484547|26241570|P1|Placebo-Controlled Period|Consent Withdrawn|15
7549664|NCT02484547|26241564|P7|Placebo-Controlled Period|Change of Treatment|0
7549665|NCT02484547|26241565|P6|Placebo-Controlled Period|Change of Treatment|0
7549666|NCT02484547|26241566|P5|Placebo-Controlled Period|Change of Treatment|0
7549667|NCT02484547|26241567|P4|Placebo-Controlled Period|Change of Treatment|0
7549668|NCT02484547|26241568|P3|Placebo-Controlled Period|Change of Treatment|1
7549669|NCT02484547|26241569|P2|Placebo-Controlled Period|Change of Treatment|0
7549670|NCT02484547|26241570|P1|Placebo-Controlled Period|Change of Treatment|0
7549671|NCT02484547|26241564|P7|Placebo-Controlled Period|Adverse Event|0
7549672|NCT02484547|26241565|P6|Placebo-Controlled Period|Adverse Event|0
7549673|NCT02484547|26241566|P5|Placebo-Controlled Period|Adverse Event|0
7549674|NCT02484547|26241567|P4|Placebo-Controlled Period|Adverse Event|0
7549675|NCT02484547|26241568|P3|Placebo-Controlled Period|Adverse Event|20
7549676|NCT02484547|26241569|P2|Placebo-Controlled Period|Adverse Event|13
7549677|NCT02484547|26241570|P1|Placebo-Controlled Period|Adverse Event|10
7549681|NCT02483975|26241622|P2|Overall Study|Physician Decision|0
7549682|NCT02483975|26241623|P1|Overall Study|Physician Decision|2
7549683|NCT02483975|26241622|P2|Overall Study|Lost to Follow-up|1
7549684|NCT02483975|26241623|P1|Overall Study|Lost to Follow-up|0
7549685|NCT02483975|26241622|P2|Overall Study|Adverse Event|1
7549686|NCT02483975|26241623|P1|Overall Study|Adverse Event|0
7549687|NCT02483611|26241661|P3|Overall Study|Protocol Violation|1
7549688|NCT02483611|26241662|P2|Overall Study|Protocol Violation|0
7549689|NCT02483611|26241663|P1|Overall Study|Protocol Violation|0
7549690|NCT02483585|26241760|P2|Open-label Treatment Phase|Lost to Follow-up|5
7549691|NCT02483585|26241761|P1|Open-label Treatment Phase|Lost to Follow-up|3
7549692|NCT02483585|26241760|P2|Open-label Treatment Phase|Withdrawal by Subject|14
7549693|NCT02483585|26241761|P1|Open-label Treatment Phase|Withdrawal by Subject|18
7549694|NCT02483585|26241760|P2|Open-label Treatment Phase|Decision by Sponsor|1
7549695|NCT02483585|26241761|P1|Open-label Treatment Phase|Decision by Sponsor|0
7549696|NCT02483585|26241760|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
7549697|NCT02483585|26241761|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
7549698|NCT02483585|26241760|P2|Double-blind Treatment Phase|Lost to Follow-up|2
7549699|NCT02483585|26241761|P1|Double-blind Treatment Phase|Lost to Follow-up|3
7549700|NCT02483585|26241760|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
7549701|NCT02483585|26241761|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
7549702|NCT02483585|26241760|P2|Double-blind Treatment Phase|Decision by Sponsor|1
7549703|NCT02483585|26241761|P1|Double-blind Treatment Phase|Decision by Sponsor|1
7549704|NCT02483572|26241783|P2|Overall Study|Physician Decision|1
7549705|NCT02483572|26241784|P1|Overall Study|Physician Decision|0
7549706|NCT02483572|26241783|P2|Overall Study|Lost to Follow-up|0
7549707|NCT02483572|26241784|P1|Overall Study|Lost to Follow-up|1
7549708|NCT02483572|26241783|P2|Overall Study|Withdrawal by Subject|0
7549709|NCT02483572|26241784|P1|Overall Study|Withdrawal by Subject|1
7549710|NCT02483533|26241798|P2|Overall Study|Lack of Efficacy|50
7549711|NCT02483533|26241799|P1|Overall Study|Lack of Efficacy|50
7549712|NCT02483520|26241809|P2|Overall Study|Moved to LTC|3
7549713|NCT02483520|26241810|P1|Overall Study|Moved to LTC|2
7549714|NCT02483520|26241809|P2|Overall Study|Hospitalized|3
7549715|NCT02483520|26241810|P1|Overall Study|Hospitalized|2
7549716|NCT02483520|26241809|P2|Overall Study|Withdrawal by Subject|14
7549717|NCT02483520|26241810|P1|Overall Study|Withdrawal by Subject|4
7549719|NCT02483520|26241810|P1|Overall Study|Lost to Follow-up|3
7549720|NCT02483416|26241850|P2|Overall Study|Treatment stop|0
7549721|NCT02483416|26241851|P1|Overall Study|Treatment stop|3
7549722|NCT02483416|26241850|P2|Overall Study|Other reason|1
7549723|NCT02483416|26241851|P1|Overall Study|Other reason|0
7549724|NCT02482935|26241915|P2|Period 1|Withdrawal by Subject|0
7549725|NCT02482935|26241916|P1|Period 1|Withdrawal by Subject|1
7549726|NCT02482805|26241944|P3|Overall Study|Lost to Follow-up|0
7549727|NCT02482805|26241945|P2|Overall Study|Lost to Follow-up|4
7549728|NCT02482805|26241946|P1|Overall Study|Lost to Follow-up|4
7549729|NCT02482571|26242065|P1|Overall Study|Withdrawal by Subject|4
7549730|NCT02482571|26242065|P1|Overall Study|Scanner or Respiract failure|3
7549731|NCT02482571|26242065|P1|Overall Study|Adverse Event|1
7549732|NCT02482428|26242077|P5|Overall Study|subject/guardian decision|2
7549733|NCT02482428|26242078|P4|Overall Study|subject/guardian decision|0
7549734|NCT02482428|26242079|P3|Overall Study|subject/guardian decision|0
7549735|NCT02482428|26242080|P2|Overall Study|subject/guardian decision|2
7549736|NCT02482428|26242081|P1|Overall Study|subject/guardian decision|4
7549737|NCT02482428|26242077|P5|Overall Study|protocol deviation|0
7549738|NCT02482428|26242078|P4|Overall Study|protocol deviation|0
7549739|NCT02482428|26242079|P3|Overall Study|protocol deviation|0
7549740|NCT02482428|26242080|P2|Overall Study|protocol deviation|1
7549741|NCT02482428|26242081|P1|Overall Study|protocol deviation|1
7549742|NCT02482428|26242077|P5|Overall Study|Physician Decision|1
7549743|NCT02482428|26242078|P4|Overall Study|Physician Decision|0
7549744|NCT02482428|26242079|P3|Overall Study|Physician Decision|0
7549745|NCT02482428|26242080|P2|Overall Study|Physician Decision|0
7549746|NCT02482428|26242081|P1|Overall Study|Physician Decision|0
7549747|NCT02482428|26242077|P5|Overall Study|Lost to Follow-up|4
7549748|NCT02482428|26242078|P4|Overall Study|Lost to Follow-up|2
7549749|NCT02482428|26242079|P3|Overall Study|Lost to Follow-up|1
7549750|NCT02482428|26242080|P2|Overall Study|Lost to Follow-up|9
7549751|NCT02482428|26242081|P1|Overall Study|Lost to Follow-up|4
7549752|NCT02482298|26242104|P3|Overall Study|Lost to Follow-up|0
7549753|NCT02482298|26242105|P2|Overall Study|Lost to Follow-up|1
7549754|NCT02482298|26242106|P1|Overall Study|Lost to Follow-up|0
7549755|NCT02482298|26242104|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
7549756|NCT02482298|26242105|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7549757|NCT02482298|26242106|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7549758|NCT02482298|26242104|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
7549759|NCT02482298|26242105|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
7549760|NCT02482298|26242106|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
7549761|NCT02482298|26242104|P3|Overall Study|Withdrawal by Subject|2
7549762|NCT02482298|26242105|P2|Overall Study|Withdrawal by Subject|1
7549763|NCT02482298|26242106|P1|Overall Study|Withdrawal by Subject|2
7549764|NCT02482233|26242128|P2|Overall Study|Lost to Follow-up|1
7549765|NCT02482233|26242129|P1|Overall Study|Lost to Follow-up|1
7549766|NCT02482129|26242165|P2|Overall Study|Criteria not met|0
7549767|NCT02482129|26242166|P1|Overall Study|Criteria not met|1
7549768|NCT02482129|26242165|P2|Overall Study|Withdrawal by Subject|0
7549769|NCT02482129|26242166|P1|Overall Study|Withdrawal by Subject|2
7549770|NCT02482129|26242165|P2|Overall Study|Adverse Event|0
7549771|NCT02482129|26242166|P1|Overall Study|Adverse Event|1
7549772|NCT02482129|26242165|P2|Overall Study|Criteria not met-prior to treatment|0
7549773|NCT02482129|26242166|P1|Overall Study|Criteria not met-prior to treatment|1
7549774|NCT02482129|26242165|P2|Overall Study|Unable to draw blood-prior to treatment|0
7549775|NCT02482129|26242166|P1|Overall Study|Unable to draw blood-prior to treatment|1
7549776|NCT02482129|26242165|P2|Overall Study|Withdrawal by subject-prior to treatment|1
7549777|NCT02482129|26242166|P1|Overall Study|Withdrawal by subject-prior to treatment|0
7549778|NCT02482129|26242165|P2|Overall Study|Adverse Event-prior to treatment|1
7549779|NCT02482129|26242166|P1|Overall Study|Adverse Event-prior to treatment|0
7549780|NCT02481947|26242206|P2|Overall Study|Protocol Violation|5
7549781|NCT02481947|26242207|P1|Overall Study|Protocol Violation|1
7549782|NCT02481947|26242206|P2|Overall Study|Physician Decision|5
7549783|NCT02481947|26242207|P1|Overall Study|Physician Decision|4
7549784|NCT02481947|26242206|P2|Overall Study|Adverse Event|11
7549785|NCT02481947|26242207|P1|Overall Study|Adverse Event|6
7549786|NCT02481947|26242206|P2|Overall Study|Lost to Follow-up|5
7549787|NCT02481947|26242207|P1|Overall Study|Lost to Follow-up|11
7549788|NCT02481947|26242206|P2|Overall Study|Withdrawal by Subject|10
7549789|NCT02481947|26242207|P1|Overall Study|Withdrawal by Subject|24
7549790|NCT02481934|26242213|P1|Overall Study|Death|2
7549791|NCT02481869|26242220|P2|Overall Study|Withdrawal by Subject|0
7549792|NCT02481869|26242221|P1|Overall Study|Withdrawal by Subject|2
7549793|NCT02481869|26242220|P2|Overall Study|Lost to Follow-up|4
7549794|NCT02481869|26242221|P1|Overall Study|Lost to Follow-up|3
7549795|NCT02481830|26242241|P2|Overall Study|Participant not eligible for trial|1
7549796|NCT02481830|26242242|P1|Overall Study|Participant not eligible for trial|0
7549797|NCT02481830|26242241|P2|Overall Study|Disease Progression|1
7549798|NCT02481830|26242242|P1|Overall Study|Disease Progression|1
7549799|NCT02481830|26242241|P2|Overall Study|Withdrawal by Subject|14
7549800|NCT02481830|26242242|P1|Overall Study|Withdrawal by Subject|0
7549801|NCT02481830|26242241|P2|Overall Study|No longer meets Study Criteria|4
7549802|NCT02481830|26242242|P1|Overall Study|No longer meets Study Criteria|1
7549803|NCT02481050|26242531|P1|Overall Study|Other|3
7549804|NCT02481050|26242531|P1|Overall Study|Withdrawal by Subject|7
7549805|NCT02481050|26242531|P1|Overall Study|Disease Progression|47
7549806|NCT02481050|26242531|P1|Overall Study|Adverse Event|1
7549807|NCT02480764|26242562|P3|Overall Study|Reason not Specified|0
7549808|NCT02480764|26242563|P2|Overall Study|Reason not Specified|1
7549809|NCT02480764|26242564|P1|Overall Study|Reason not Specified|0
7549810|NCT02480764|26242562|P3|Overall Study|Lack of Efficacy|3
7549811|NCT02480764|26242563|P2|Overall Study|Lack of Efficacy|3
7549812|NCT02480764|26242564|P1|Overall Study|Lack of Efficacy|0
7549813|NCT02480764|26242562|P3|Overall Study|Voluntary Withdrawal|10
7549814|NCT02480764|26242563|P2|Overall Study|Voluntary Withdrawal|5
7549815|NCT02480764|26242564|P1|Overall Study|Voluntary Withdrawal|6
7549816|NCT02480764|26242562|P3|Overall Study|Lost to Follow-up|2
7549817|NCT02480764|26242563|P2|Overall Study|Lost to Follow-up|1
7549818|NCT02480764|26242564|P1|Overall Study|Lost to Follow-up|0
7549819|NCT02480764|26242562|P3|Overall Study|Major Protocol Deviation|3
7549820|NCT02480764|26242563|P2|Overall Study|Major Protocol Deviation|4
7549821|NCT02480764|26242564|P1|Overall Study|Major Protocol Deviation|1
7549822|NCT02480764|26242562|P3|Overall Study|Pretreatment Event/Adverse Event|3
7549823|NCT02480764|26242563|P2|Overall Study|Pretreatment Event/Adverse Event|6
7549824|NCT02480764|26242564|P1|Overall Study|Pretreatment Event/Adverse Event|3
7549825|NCT02480712|26242590|P1|Overall Study|Lack of Efficacy|1
7549826|NCT02480712|26242590|P1|Overall Study|Death|1
7549827|NCT02480712|26242590|P1|Overall Study|Withdrew Consent|3
7549828|NCT02480712|26242590|P1|Overall Study|Lost to Follow-up|5
7549829|NCT02480712|26242590|P1|Overall Study|Enrolled but Never Treated|1
7549830|NCT02480621|26242609|P2|Follow Up|Lost to Follow-up|2
7549831|NCT02480621|26242610|P1|Follow Up|Lost to Follow-up|4
7549832|NCT02480621|26242609|P2|Randomization|Surgeon did not give intervention|1
7549833|NCT02480621|26242610|P1|Randomization|Surgeon did not give intervention|0
7549834|NCT02480621|26242609|P2|Randomization|Withdrawal by Subject|0
7549835|NCT02480621|26242610|P1|Randomization|Withdrawal by Subject|1
7549836|NCT02480153|26242687|P3|Period 3: Week 52 Dosing to Week 78|Death|0
7549837|NCT02480153|26242688|P2|Period 3: Week 52 Dosing to Week 78|Death|1
7549838|NCT02480153|26242689|P1|Period 3: Week 52 Dosing to Week 78|Death|0
7549839|NCT02480153|26242687|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
7549840|NCT02480153|26242688|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7549841|NCT02480153|26242689|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7549842|NCT02480153|26242687|P3|Period 3: Week 52 Dosing to Week 78|Other|1
7549843|NCT02480153|26242688|P2|Period 3: Week 52 Dosing to Week 78|Other|0
7549844|NCT02480153|26242689|P1|Period 3: Week 52 Dosing to Week 78|Other|0
7549845|NCT02480153|26242687|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
7549846|NCT02480153|26242688|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
7549847|NCT02480153|26242689|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
7549848|NCT02480153|26242687|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
7549849|NCT02480153|26242688|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
7549850|NCT02480153|26242689|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
7549851|NCT02480153|26242687|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7549852|NCT02480153|26242688|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
7549853|NCT02480153|26242689|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7549854|NCT02480153|26242687|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7549855|NCT02480153|26242688|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7549856|NCT02480153|26242689|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
7549857|NCT02480153|26242687|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
7549858|NCT02480153|26242688|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
7549859|NCT02480153|26242689|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
7549860|NCT02480153|26242687|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
7549861|NCT02480153|26242688|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
7549862|NCT02480153|26242689|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
7549863|NCT02480153|26242687|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7549864|NCT02480153|26242688|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
7549865|NCT02480153|26242689|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7549866|NCT02480153|26242687|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
7549867|NCT02480153|26242688|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
7549868|NCT02480153|26242689|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
7549869|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7549870|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
7549871|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7549872|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
7549873|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
7549874|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
7549875|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
7549876|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
7549877|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
7549878|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
7549879|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
7549880|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
7549881|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
7549882|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
7549883|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
7549884|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7549885|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
7549886|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7549887|NCT02480153|26242687|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7549888|NCT02480153|26242688|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
7549889|NCT02480153|26242689|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7549890|NCT02480114|26242866|P2|Overall Study|Not eligible|1
7549891|NCT02480114|26242867|P1|Overall Study|Not eligible|0
7549892|NCT02480114|26242866|P2|Overall Study|Improper completion of survey|1
7549893|NCT02480114|26242867|P1|Overall Study|Improper completion of survey|1
7549894|NCT02480114|26242866|P2|Overall Study|Disease progression|0
7549895|NCT02480114|26242867|P1|Overall Study|Disease progression|3
7549896|NCT02480114|26242866|P2|Overall Study|Withdrawal by Subject|4
7549897|NCT02480114|26242867|P1|Overall Study|Withdrawal by Subject|2
7549898|NCT02480114|26242866|P2|Overall Study|Not completing surveys|2
7549899|NCT02480114|26242867|P1|Overall Study|Not completing surveys|3
7549900|NCT02480010|26242879|P2|Overall Study|Refused Treatment|3
7549901|NCT02480010|26242880|P1|Overall Study|Refused Treatment|0
7549902|NCT02480010|26242879|P2|Overall Study|Insufficient therapeutic response|29
7549903|NCT02480010|26242880|P1|Overall Study|Insufficient therapeutic response|31
7549904|NCT02480010|26242879|P2|Overall Study|Death|0
7549905|NCT02480010|26242880|P1|Overall Study|Death|1
7549906|NCT02480010|26242879|P2|Overall Study|Adverse Event|1
7549907|NCT02480010|26242880|P1|Overall Study|Adverse Event|3
7549908|NCT02479880|26242926|P2|Overall Study|Pregnancy|1
7549909|NCT02479880|26242927|P1|Overall Study|Pregnancy|0
7549910|NCT02479880|26242926|P2|Overall Study|Study Terminated by Sponsor|12
7549911|NCT02479880|26242927|P1|Overall Study|Study Terminated by Sponsor|13
7549912|NCT02479802|26242933|P1|Overall Study|Adverse Event|1
7549913|NCT02479802|26242933|P1|Overall Study|Lost to Follow-up|1
7549914|NCT02479412|26242960|P9|Overall Study|Randomization to wrong PK sampling group|0
7549915|NCT02479412|26242961|P8|Overall Study|Randomization to wrong PK sampling group|0
7549916|NCT02479412|26242962|P7|Overall Study|Randomization to wrong PK sampling group|0
7549917|NCT02479412|26242963|P6|Overall Study|Randomization to wrong PK sampling group|0
7549918|NCT02479412|26242964|P5|Overall Study|Randomization to wrong PK sampling group|1
7549919|NCT02479412|26242965|P4|Overall Study|Randomization to wrong PK sampling group|0
7549920|NCT02479412|26242966|P3|Overall Study|Randomization to wrong PK sampling group|0
7549921|NCT02479412|26242967|P2|Overall Study|Randomization to wrong PK sampling group|0
7549922|NCT02479412|26242968|P1|Overall Study|Randomization to wrong PK sampling group|0
7549923|NCT02479412|26242960|P9|Overall Study|Study-specific withdrawal criteria|1
7549924|NCT02479412|26242961|P8|Overall Study|Study-specific withdrawal criteria|1
7549925|NCT02479412|26242962|P7|Overall Study|Study-specific withdrawal criteria|0
7549926|NCT02479412|26242963|P6|Overall Study|Study-specific withdrawal criteria|0
7549927|NCT02479412|26242964|P5|Overall Study|Study-specific withdrawal criteria|0
7549928|NCT02479412|26242965|P4|Overall Study|Study-specific withdrawal criteria|1
7549929|NCT02479412|26242966|P3|Overall Study|Study-specific withdrawal criteria|1
7549930|NCT02479412|26242967|P2|Overall Study|Study-specific withdrawal criteria|0
7549931|NCT02479412|26242968|P1|Overall Study|Study-specific withdrawal criteria|0
7549932|NCT02479412|26242960|P9|Overall Study|Adverse Event|0
7549933|NCT02479412|26242961|P8|Overall Study|Adverse Event|0
7549934|NCT02479412|26242962|P7|Overall Study|Adverse Event|0
7549935|NCT02479412|26242963|P6|Overall Study|Adverse Event|0
7549936|NCT02479412|26242964|P5|Overall Study|Adverse Event|0
7549937|NCT02479412|26242965|P4|Overall Study|Adverse Event|0
7549938|NCT02479412|26242966|P3|Overall Study|Adverse Event|1
7549939|NCT02479412|26242967|P2|Overall Study|Adverse Event|0
7549940|NCT02479412|26242968|P1|Overall Study|Adverse Event|0
7549941|NCT02479139|26243045|P6|Overall Study|Other Miscellaneous Reasons|0
7549942|NCT02479139|26243046|P5|Overall Study|Other Miscellaneous Reasons|1
7549943|NCT02479139|26243047|P4|Overall Study|Other Miscellaneous Reasons|1
7549944|NCT02479139|26243048|P3|Overall Study|Other Miscellaneous Reasons|1
7549945|NCT02479139|26243049|P2|Overall Study|Other Miscellaneous Reasons|0
7549946|NCT02479139|26243050|P1|Overall Study|Other Miscellaneous Reasons|1
7549947|NCT02479139|26243045|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
7549948|NCT02479139|26243046|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
7549949|NCT02479139|26243047|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
7549950|NCT02479139|26243048|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
7549951|NCT02479139|26243049|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
7549952|NCT02479139|26243050|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
7549953|NCT02479139|26243045|P6|Overall Study|Withdrew Consent|1
7549954|NCT02479139|26243046|P5|Overall Study|Withdrew Consent|1
7549955|NCT02479139|26243047|P4|Overall Study|Withdrew Consent|4
7549956|NCT02479139|26243048|P3|Overall Study|Withdrew Consent|1
7549957|NCT02479139|26243049|P2|Overall Study|Withdrew Consent|6
7549958|NCT02479139|26243050|P1|Overall Study|Withdrew Consent|5
7549959|NCT02479139|26243045|P6|Overall Study|Lost to Follow-up|5
7549960|NCT02479139|26243046|P5|Overall Study|Lost to Follow-up|3
7549961|NCT02479139|26243047|P4|Overall Study|Lost to Follow-up|2
7549962|NCT02479139|26243048|P3|Overall Study|Lost to Follow-up|4
7549963|NCT02479139|26243049|P2|Overall Study|Lost to Follow-up|4
7549964|NCT02479139|26243050|P1|Overall Study|Lost to Follow-up|2
7549965|NCT02478632|26243083|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
7549966|NCT02478632|26243084|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
7549967|NCT02478632|26243083|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
7549968|NCT02478632|26243084|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
7549969|NCT02478632|26243083|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
7549970|NCT02478632|26243084|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
7549971|NCT02478463|26243130|P1|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
7549972|NCT02478463|26243130|P1|Washout Period (Up to 42 Days)|Lost to Follow-up|1
7549973|NCT02478463|26243130|P1|Treatment Period 1 (Up to Day 29)|Physician Decision|1
7549974|NCT02478398|26243247|P2|Overall Study|Withdrawal By Participant|4
7549975|NCT02478398|26243248|P1|Overall Study|Withdrawal By Participant|10
7549976|NCT02478398|26243247|P2|Overall Study|Withdrawal By Parent/Guardian|6
7549977|NCT02478398|26243248|P1|Overall Study|Withdrawal By Parent/Guardian|9
7549978|NCT02478398|26243247|P2|Overall Study|Protocol Violation|1
7549979|NCT02478398|26243248|P1|Overall Study|Protocol Violation|3
7549980|NCT02478398|26243247|P2|Overall Study|Non-Compliance With Study Drug|1
7549981|NCT02478398|26243248|P1|Overall Study|Non-Compliance With Study Drug|5
7549982|NCT02478398|26243247|P2|Overall Study|Lost to Follow-up|4
7549983|NCT02478398|26243248|P1|Overall Study|Lost to Follow-up|5
7549984|NCT02478398|26243247|P2|Overall Study|Adverse Event|5
7549985|NCT02478398|26243248|P1|Overall Study|Adverse Event|20
7549986|NCT02478372|26243268|P2|Overall Study|Death|2
7549987|NCT02478372|26243269|P1|Overall Study|Death|0
7549988|NCT02478372|26243268|P2|Overall Study|Lost to Follow-up|4
7549989|NCT02478372|26243269|P1|Overall Study|Lost to Follow-up|1
7549990|NCT02478372|26243268|P2|Overall Study|Protocol Violation|8
7549991|NCT02478372|26243269|P1|Overall Study|Protocol Violation|12
7549992|NCT02478359|26243293|P2|Overall Study|Disenrolled from health plan|65
7549993|NCT02478359|26243294|P1|Overall Study|Disenrolled from health plan|106
7549994|NCT02478164|26243366|P1|Overall Study|Withdrawal by Subject|1
7549995|NCT02478164|26243366|P1|Overall Study|Adverse Event|1
7549996|NCT02478164|26243366|P1|Overall Study|Lack of Efficacy|13
7549997|NCT02477839|26243375|P2|Overall Study|Exclusion criterion|1
7549998|NCT02477839|26243376|P1|Overall Study|Exclusion criterion|0
7549999|NCT02477839|26243375|P2|Overall Study|Lack of tolerability|1
7550000|NCT02477839|26243376|P1|Overall Study|Lack of tolerability|0
7550001|NCT02477839|26243375|P2|Overall Study|Parents decided to stop medication|1
7550002|NCT02477839|26243376|P1|Overall Study|Parents decided to stop medication|0
7550003|NCT02477839|26243375|P2|Overall Study|Participant had PGS during V6|1
7550004|NCT02477839|26243376|P1|Overall Study|Participant had PGS during V6|0
7550005|NCT02477839|26243375|P2|Overall Study|Withdrawal by Subject|3
7550006|NCT02477839|26243376|P1|Overall Study|Withdrawal by Subject|3
7550007|NCT02477839|26243375|P2|Overall Study|Protocol Violation|2
7550008|NCT02477839|26243376|P1|Overall Study|Protocol Violation|0
7550009|NCT02477839|26243375|P2|Overall Study|Adverse Event|1
7550010|NCT02477839|26243376|P1|Overall Study|Adverse Event|0
7550011|NCT02477800|26243407|P7|Long Term Extension Period|Reason not Specified|224
7550012|NCT02477800|26243408|P6|Long Term Extension Period|Reason not Specified|270
7550013|NCT02477800|26243409|P5|Long Term Extension Period|Reason not Specified|140
7550014|NCT02477800|26243410|P4|Long Term Extension Period|Reason not Specified|126
7550015|NCT02477800|26243411|P3|Long Term Extension Period|Reason not Specified|0
7550016|NCT02477800|26243412|P2|Long Term Extension Period|Reason not Specified|0
7550017|NCT02477800|26243413|P1|Long Term Extension Period|Reason not Specified|0
7550018|NCT02477800|26243407|P7|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7550019|NCT02477800|26243408|P6|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7550020|NCT02477800|26243409|P5|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7550021|NCT02477800|26243410|P4|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7550022|NCT02477800|26243411|P3|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7550023|NCT02477800|26243412|P2|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7550024|NCT02477800|26243413|P1|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7550025|NCT02477800|26243407|P7|Long Term Extension Period|Study Visit Burden|2
7550026|NCT02477800|26243408|P6|Long Term Extension Period|Study Visit Burden|2
7550027|NCT02477800|26243409|P5|Long Term Extension Period|Study Visit Burden|0
7550028|NCT02477800|26243410|P4|Long Term Extension Period|Study Visit Burden|3
7550029|NCT02477800|26243411|P3|Long Term Extension Period|Study Visit Burden|0
7550030|NCT02477800|26243412|P2|Long Term Extension Period|Study Visit Burden|0
7550031|NCT02477800|26243413|P1|Long Term Extension Period|Study Visit Burden|0
7550032|NCT02477800|26243407|P7|Long Term Extension Period|Site Terminated By Sponsor|1
7550033|NCT02477800|26243408|P6|Long Term Extension Period|Site Terminated By Sponsor|2
7550034|NCT02477800|26243409|P5|Long Term Extension Period|Site Terminated By Sponsor|0
7550035|NCT02477800|26243410|P4|Long Term Extension Period|Site Terminated By Sponsor|0
7550036|NCT02477800|26243411|P3|Long Term Extension Period|Site Terminated By Sponsor|0
7550037|NCT02477800|26243412|P2|Long Term Extension Period|Site Terminated By Sponsor|0
7550038|NCT02477800|26243413|P1|Long Term Extension Period|Site Terminated By Sponsor|0
7550039|NCT02477800|26243407|P7|Long Term Extension Period|Lost to Follow-up|0
7550040|NCT02477800|26243408|P6|Long Term Extension Period|Lost to Follow-up|3
7550041|NCT02477800|26243409|P5|Long Term Extension Period|Lost to Follow-up|1
7550042|NCT02477800|26243410|P4|Long Term Extension Period|Lost to Follow-up|0
7550043|NCT02477800|26243411|P3|Long Term Extension Period|Lost to Follow-up|0
7550044|NCT02477800|26243412|P2|Long Term Extension Period|Lost to Follow-up|0
7550045|NCT02477800|26243413|P1|Long Term Extension Period|Lost to Follow-up|0
7550046|NCT02477800|26243407|P7|Long Term Extension Period|Investigator Decision|2
7550047|NCT02477800|26243408|P6|Long Term Extension Period|Investigator Decision|0
7550048|NCT02477800|26243409|P5|Long Term Extension Period|Investigator Decision|0
7550049|NCT02477800|26243410|P4|Long Term Extension Period|Investigator Decision|0
7550050|NCT02477800|26243411|P3|Long Term Extension Period|Investigator Decision|0
7550051|NCT02477800|26243412|P2|Long Term Extension Period|Investigator Decision|0
7550052|NCT02477800|26243413|P1|Long Term Extension Period|Investigator Decision|0
7550053|NCT02477800|26243407|P7|Long Term Extension Period|Disease Progression|0
7550054|NCT02477800|26243408|P6|Long Term Extension Period|Disease Progression|1
7550055|NCT02477800|26243409|P5|Long Term Extension Period|Disease Progression|1
7550056|NCT02477800|26243410|P4|Long Term Extension Period|Disease Progression|3
7550057|NCT02477800|26243411|P3|Long Term Extension Period|Disease Progression|0
7550058|NCT02477800|26243412|P2|Long Term Extension Period|Disease Progression|0
7550059|NCT02477800|26243413|P1|Long Term Extension Period|Disease Progression|0
7550060|NCT02477800|26243407|P7|Long Term Extension Period|Consent Withdrawn|16
7550061|NCT02477800|26243408|P6|Long Term Extension Period|Consent Withdrawn|13
7550062|NCT02477800|26243409|P5|Long Term Extension Period|Consent Withdrawn|4
7550063|NCT02477800|26243410|P4|Long Term Extension Period|Consent Withdrawn|10
7550064|NCT02477800|26243411|P3|Long Term Extension Period|Consent Withdrawn|0
7550065|NCT02477800|26243412|P2|Long Term Extension Period|Consent Withdrawn|0
7550066|NCT02477800|26243413|P1|Long Term Extension Period|Consent Withdrawn|0
7550067|NCT02477800|26243407|P7|Long Term Extension Period|Death|2
7550068|NCT02477800|26243408|P6|Long Term Extension Period|Death|1
7550069|NCT02477800|26243409|P5|Long Term Extension Period|Death|1
7550070|NCT02477800|26243410|P4|Long Term Extension Period|Death|1
7550071|NCT02477800|26243411|P3|Long Term Extension Period|Death|0
7550072|NCT02477800|26243412|P2|Long Term Extension Period|Death|0
7550073|NCT02477800|26243413|P1|Long Term Extension Period|Death|0
7550074|NCT02477800|26243407|P7|Long Term Extension Period|Adverse Event|3
7550075|NCT02477800|26243408|P6|Long Term Extension Period|Adverse Event|4
7550076|NCT02477800|26243409|P5|Long Term Extension Period|Adverse Event|2
7550077|NCT02477800|26243410|P4|Long Term Extension Period|Adverse Event|6
7550078|NCT02477800|26243411|P3|Long Term Extension Period|Adverse Event|0
7550079|NCT02477800|26243412|P2|Long Term Extension Period|Adverse Event|0
7550080|NCT02477800|26243413|P1|Long Term Extension Period|Adverse Event|0
7550081|NCT02477800|26243407|P7|Placebo-Controlled Period|Reason not Specified|0
7550082|NCT02477800|26243408|P6|Placebo-Controlled Period|Reason not Specified|0
7550083|NCT02477800|26243409|P5|Placebo-Controlled Period|Reason not Specified|0
7550084|NCT02477800|26243410|P4|Placebo-Controlled Period|Reason not Specified|0
7550085|NCT02477800|26243411|P3|Placebo-Controlled Period|Reason not Specified|189
7550086|NCT02477800|26243412|P2|Placebo-Controlled Period|Reason not Specified|161
7550087|NCT02477800|26243413|P1|Placebo-Controlled Period|Reason not Specified|161
7550088|NCT02477800|26243407|P7|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7550089|NCT02477800|26243408|P6|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7550090|NCT02477800|26243409|P5|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7550091|NCT02477800|26243410|P4|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7550092|NCT02477800|26243411|P3|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
7550093|NCT02477800|26243412|P2|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
7550094|NCT02477800|26243413|P1|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7550095|NCT02477800|26243407|P7|Placebo-Controlled Period|Study Visit Burden|0
7550096|NCT02477800|26243408|P6|Placebo-Controlled Period|Study Visit Burden|0
7550097|NCT02477800|26243409|P5|Placebo-Controlled Period|Study Visit Burden|0
7550098|NCT02477800|26243410|P4|Placebo-Controlled Period|Study Visit Burden|0
7550099|NCT02477800|26243411|P3|Placebo-Controlled Period|Study Visit Burden|11
7550100|NCT02477800|26243412|P2|Placebo-Controlled Period|Study Visit Burden|3
7550101|NCT02477800|26243413|P1|Placebo-Controlled Period|Study Visit Burden|5
7550102|NCT02477800|26243407|P7|Placebo-Controlled Period|Site Terminated by Sponsor|0
7550103|NCT02477800|26243408|P6|Placebo-Controlled Period|Site Terminated by Sponsor|0
7550104|NCT02477800|26243409|P5|Placebo-Controlled Period|Site Terminated by Sponsor|0
7550105|NCT02477800|26243410|P4|Placebo-Controlled Period|Site Terminated by Sponsor|0
7550106|NCT02477800|26243411|P3|Placebo-Controlled Period|Site Terminated by Sponsor|0
7550107|NCT02477800|26243412|P2|Placebo-Controlled Period|Site Terminated by Sponsor|1
7550108|NCT02477800|26243413|P1|Placebo-Controlled Period|Site Terminated by Sponsor|2
7550109|NCT02477800|26243407|P7|Placebo-Controlled Period|Site Terminated by Investigator|0
7550110|NCT02477800|26243408|P6|Placebo-Controlled Period|Site Terminated by Investigator|0
7550111|NCT02477800|26243409|P5|Placebo-Controlled Period|Site Terminated by Investigator|0
7550112|NCT02477800|26243410|P4|Placebo-Controlled Period|Site Terminated by Investigator|0
7550113|NCT02477800|26243411|P3|Placebo-Controlled Period|Site Terminated by Investigator|1
7550114|NCT02477800|26243412|P2|Placebo-Controlled Period|Site Terminated by Investigator|1
7550115|NCT02477800|26243413|P1|Placebo-Controlled Period|Site Terminated by Investigator|1
7550116|NCT02477800|26243407|P7|Placebo-Controlled Period|Relocation|0
7550117|NCT02477800|26243408|P6|Placebo-Controlled Period|Relocation|0
7550118|NCT02477800|26243409|P5|Placebo-Controlled Period|Relocation|0
7550119|NCT02477800|26243410|P4|Placebo-Controlled Period|Relocation|0
7550120|NCT02477800|26243411|P3|Placebo-Controlled Period|Relocation|0
7550121|NCT02477800|26243412|P2|Placebo-Controlled Period|Relocation|0
7550122|NCT02477800|26243413|P1|Placebo-Controlled Period|Relocation|2
7550123|NCT02477800|26243407|P7|Placebo-Controlled Period|Lost to Follow-up|0
7550124|NCT02477800|26243408|P6|Placebo-Controlled Period|Lost to Follow-up|0
7550125|NCT02477800|26243409|P5|Placebo-Controlled Period|Lost to Follow-up|0
7550126|NCT02477800|26243410|P4|Placebo-Controlled Period|Lost to Follow-up|0
7550127|NCT02477800|26243411|P3|Placebo-Controlled Period|Lost to Follow-up|3
7550128|NCT02477800|26243412|P2|Placebo-Controlled Period|Lost to Follow-up|3
7550129|NCT02477800|26243413|P1|Placebo-Controlled Period|Lost to Follow-up|1
7550130|NCT02477800|26243407|P7|Placebo-Controlled Period|Investigator Decision|0
7550131|NCT02477800|26243408|P6|Placebo-Controlled Period|Investigator Decision|0
7550132|NCT02477800|26243409|P5|Placebo-Controlled Period|Investigator Decision|0
7550133|NCT02477800|26243410|P4|Placebo-Controlled Period|Investigator Decision|0
7550134|NCT02477800|26243411|P3|Placebo-Controlled Period|Investigator Decision|1
7550135|NCT02477800|26243412|P2|Placebo-Controlled Period|Investigator Decision|2
7550136|NCT02477800|26243413|P1|Placebo-Controlled Period|Investigator Decision|3
7550137|NCT02477800|26243407|P7|Placebo-Controlled Period|Disease Progression|0
7550138|NCT02477800|26243408|P6|Placebo-Controlled Period|Disease Progression|0
7550139|NCT02477800|26243409|P5|Placebo-Controlled Period|Disease Progression|0
7550140|NCT02477800|26243410|P4|Placebo-Controlled Period|Disease Progression|0
7550141|NCT02477800|26243411|P3|Placebo-Controlled Period|Disease Progression|1
7550142|NCT02477800|26243412|P2|Placebo-Controlled Period|Disease Progression|0
7550143|NCT02477800|26243413|P1|Placebo-Controlled Period|Disease Progression|1
7550144|NCT02477800|26243407|P7|Placebo-Controlled Period|Death|0
7550145|NCT02477800|26243408|P6|Placebo-Controlled Period|Death|0
7550146|NCT02477800|26243409|P5|Placebo-Controlled Period|Death|0
7550147|NCT02477800|26243410|P4|Placebo-Controlled Period|Death|0
7550148|NCT02477800|26243411|P3|Placebo-Controlled Period|Death|2
7550149|NCT02477800|26243412|P2|Placebo-Controlled Period|Death|3
7550150|NCT02477800|26243413|P1|Placebo-Controlled Period|Death|0
7550151|NCT02477800|26243407|P7|Placebo-Controlled Period|Consent Withdrawn|0
7550152|NCT02477800|26243408|P6|Placebo-Controlled Period|Consent Withdrawn|0
7550153|NCT02477800|26243409|P5|Placebo-Controlled Period|Consent Withdrawn|0
7550154|NCT02477800|26243410|P4|Placebo-Controlled Period|Consent Withdrawn|0
7550155|NCT02477800|26243411|P3|Placebo-Controlled Period|Consent Withdrawn|27
7550156|NCT02477800|26243412|P2|Placebo-Controlled Period|Consent Withdrawn|16
7550157|NCT02477800|26243413|P1|Placebo-Controlled Period|Consent Withdrawn|26
7550158|NCT02477800|26243407|P7|Placebo-Controlled Period|Change of Treatment|0
7550159|NCT02477800|26243408|P6|Placebo-Controlled Period|Change of Treatment|0
7550160|NCT02477800|26243409|P5|Placebo-Controlled Period|Change of Treatment|0
7550161|NCT02477800|26243410|P4|Placebo-Controlled Period|Change of Treatment|0
7550162|NCT02477800|26243411|P3|Placebo-Controlled Period|Change of Treatment|1
7550163|NCT02477800|26243412|P2|Placebo-Controlled Period|Change of Treatment|2
7550164|NCT02477800|26243413|P1|Placebo-Controlled Period|Change of Treatment|1
7550165|NCT02477800|26243407|P7|Placebo-Controlled Period|Adverse Event|0
7550166|NCT02477800|26243408|P6|Placebo-Controlled Period|Adverse Event|0
7550167|NCT02477800|26243409|P5|Placebo-Controlled Period|Adverse Event|0
7550168|NCT02477800|26243410|P4|Placebo-Controlled Period|Adverse Event|0
7550169|NCT02477800|26243411|P3|Placebo-Controlled Period|Adverse Event|28
7550170|NCT02477800|26243412|P2|Placebo-Controlled Period|Adverse Event|25
7550171|NCT02477800|26243413|P1|Placebo-Controlled Period|Adverse Event|16
7550172|NCT02477670|26243440|P7|Stage 2|Withdrawal by Subject|0
7550173|NCT02477670|26243441|P6|Stage 2|Withdrawal by Subject|0
7550174|NCT02477670|26243442|P5|Stage 2|Withdrawal by Subject|0
7550175|NCT02477670|26243443|P4|Stage 2|Withdrawal by Subject|1
7550176|NCT02477670|26243444|P3|Stage 2|Withdrawal by Subject|0
7550177|NCT02477670|26243445|P2|Stage 2|Withdrawal by Subject|0
7550178|NCT02477670|26243446|P1|Stage 2|Withdrawal by Subject|0
7550179|NCT02477670|26243440|P7|Stage 2|Antipsychotic Medication Changed|0
7550180|NCT02477670|26243441|P6|Stage 2|Antipsychotic Medication Changed|0
7550181|NCT02477670|26243442|P5|Stage 2|Antipsychotic Medication Changed|0
7550182|NCT02477670|26243443|P4|Stage 2|Antipsychotic Medication Changed|0
7550183|NCT02477670|26243444|P3|Stage 2|Antipsychotic Medication Changed|1
7550184|NCT02477670|26243445|P2|Stage 2|Antipsychotic Medication Changed|0
7550185|NCT02477670|26243446|P1|Stage 2|Antipsychotic Medication Changed|0
7550186|NCT02477670|26243440|P7|Stage 2|Adverse Event|0
7550187|NCT02477670|26243441|P6|Stage 2|Adverse Event|0
7550188|NCT02477670|26243442|P5|Stage 2|Adverse Event|0
7550189|NCT02477670|26243443|P4|Stage 2|Adverse Event|0
7550190|NCT02477670|26243444|P3|Stage 2|Adverse Event|1
7550191|NCT02477670|26243445|P2|Stage 2|Adverse Event|0
7550192|NCT02477670|26243446|P1|Stage 2|Adverse Event|0
7550193|NCT02477670|26243440|P7|Stage 1|Non-compliance with Study Drug|0
7550194|NCT02477670|26243441|P6|Stage 1|Non-compliance with Study Drug|0
7550195|NCT02477670|26243442|P5|Stage 1|Non-compliance with Study Drug|0
7550196|NCT02477670|26243443|P4|Stage 1|Non-compliance with Study Drug|0
7550197|NCT02477670|26243444|P3|Stage 1|Non-compliance with Study Drug|0
7550198|NCT02477670|26243445|P2|Stage 1|Non-compliance with Study Drug|2
7550199|NCT02477670|26243446|P1|Stage 1|Non-compliance with Study Drug|1
7550200|NCT02477670|26243440|P7|Stage 1|Withdrawal by Subject|0
7550201|NCT02477670|26243441|P6|Stage 1|Withdrawal by Subject|0
7550202|NCT02477670|26243442|P5|Stage 1|Withdrawal by Subject|0
7550203|NCT02477670|26243443|P4|Stage 1|Withdrawal by Subject|0
7550204|NCT02477670|26243444|P3|Stage 1|Withdrawal by Subject|0
7550205|NCT02477670|26243445|P2|Stage 1|Withdrawal by Subject|2
7550206|NCT02477670|26243446|P1|Stage 1|Withdrawal by Subject|1
7550207|NCT02477670|26243440|P7|Stage 1|Lost to Follow-up|0
7550208|NCT02477670|26243441|P6|Stage 1|Lost to Follow-up|0
7550209|NCT02477670|26243442|P5|Stage 1|Lost to Follow-up|0
7550210|NCT02477670|26243443|P4|Stage 1|Lost to Follow-up|0
7550211|NCT02477670|26243444|P3|Stage 1|Lost to Follow-up|0
7550212|NCT02477670|26243445|P2|Stage 1|Lost to Follow-up|2
7550213|NCT02477670|26243446|P1|Stage 1|Lost to Follow-up|0
7550214|NCT02477670|26243440|P7|Stage 1|Adverse Event|0
7550215|NCT02477670|26243441|P6|Stage 1|Adverse Event|0
7550216|NCT02477670|26243442|P5|Stage 1|Adverse Event|0
7550217|NCT02477670|26243443|P4|Stage 1|Adverse Event|0
7550218|NCT02477670|26243444|P3|Stage 1|Adverse Event|0
7550219|NCT02477670|26243445|P2|Stage 1|Adverse Event|7
7550220|NCT02477670|26243446|P1|Stage 1|Adverse Event|2
7550221|NCT02477618|26243662|P2|Overall Study|Left Study Site for Rehabilitation|1
7550222|NCT02477618|26243663|P1|Overall Study|Left Study Site for Rehabilitation|0
7550223|NCT02477618|26243662|P2|Overall Study|Transferred Away from Study Site|0
7550224|NCT02477618|26243663|P1|Overall Study|Transferred Away from Study Site|1
7550225|NCT02477618|26243662|P2|Overall Study|Adverse Event|1
7550226|NCT02477618|26243663|P1|Overall Study|Adverse Event|1
7550227|NCT02477618|26243662|P2|Overall Study|Died in Double-Blind Treatment Period|11
7550228|NCT02477618|26243663|P1|Overall Study|Died in Double-Blind Treatment Period|11
7550229|NCT02477618|26243662|P2|Overall Study|Completed Visits but Discontinued Drug|1
7550230|NCT02477618|26243663|P1|Overall Study|Completed Visits but Discontinued Drug|2
7550231|NCT02477605|26243687|P2|Overall Study|Administered gas during surgery|1
7550232|NCT02477605|26243688|P1|Overall Study|Administered gas during surgery|0
7550233|NCT02477605|26243687|P2|Overall Study|Withdrawal by Subject|1
7550234|NCT02477605|26243688|P1|Overall Study|Withdrawal by Subject|0
7550235|NCT02477605|26243687|P2|Overall Study|Lost to Follow-up|2
7550236|NCT02477605|26243688|P1|Overall Study|Lost to Follow-up|0
7550237|NCT02477605|26243687|P2|Overall Study|Discontinued prior to treatment|0
7550238|NCT02477605|26243688|P1|Overall Study|Discontinued prior to treatment|1
7550239|NCT02477553|26243704|P2|Overall Study|patient deceased|0
7550240|NCT02477553|26243705|P1|Overall Study|patient deceased|1
7550241|NCT02477553|26243704|P2|Overall Study|MD advised against screening|3
7550242|NCT02477553|26243705|P1|Overall Study|MD advised against screening|1
7550243|NCT02477553|26243704|P2|Overall Study|Elevated risk for CRC|2
7550244|NCT02477553|26243705|P1|Overall Study|Elevated risk for CRC|2
7550245|NCT02477553|26243704|P2|Overall Study|Technical issues with intervention|0
7550246|NCT02477553|26243705|P1|Overall Study|Technical issues with intervention|2
7550247|NCT02477553|26243704|P2|Overall Study|Workup consistent w/CRC|1
7550248|NCT02477553|26243705|P1|Overall Study|Workup consistent w/CRC|1
7550249|NCT02477553|26243704|P2|Overall Study|No MD visit|1
7550250|NCT02477553|26243705|P1|Overall Study|No MD visit|1
7550251|NCT02477553|26243704|P2|Overall Study|Screening up-to-date|13
7550252|NCT02477553|26243705|P1|Overall Study|Screening up-to-date|12
7550253|NCT02477527|26243725|P1|Overall Study|Screen Failure|3
7550254|NCT02477527|26243725|P1|Overall Study|Withdrawal by Subject|1
7550255|NCT02477527|26243725|P1|Overall Study|Lost to Follow-up|2
7550256|NCT02477332|26243760|P6|Overall Study|Withdrawal by Subject|0
7550257|NCT02477332|26243761|P5|Overall Study|Withdrawal by Subject|1
7550258|NCT02477332|26243762|P4|Overall Study|Withdrawal by Subject|2
7550259|NCT02477332|26243763|P3|Overall Study|Withdrawal by Subject|1
7550260|NCT02477332|26243764|P2|Overall Study|Withdrawal by Subject|3
7550261|NCT02477332|26243765|P1|Overall Study|Withdrawal by Subject|0
7550262|NCT02477332|26243760|P6|Overall Study|Physician Decision|1
7550263|NCT02477332|26243761|P5|Overall Study|Physician Decision|0
7550264|NCT02477332|26243762|P4|Overall Study|Physician Decision|3
7550265|NCT02477332|26243763|P3|Overall Study|Physician Decision|1
7550266|NCT02477332|26243764|P2|Overall Study|Physician Decision|0
7550267|NCT02477332|26243765|P1|Overall Study|Physician Decision|0
7550268|NCT02477332|26243760|P6|Overall Study|Lost to Follow-up|0
7550269|NCT02477332|26243761|P5|Overall Study|Lost to Follow-up|0
7550270|NCT02477332|26243762|P4|Overall Study|Lost to Follow-up|0
7550271|NCT02477332|26243763|P3|Overall Study|Lost to Follow-up|2
7550272|NCT02477332|26243764|P2|Overall Study|Lost to Follow-up|0
7550273|NCT02477332|26243765|P1|Overall Study|Lost to Follow-up|0
7550274|NCT02477332|26243760|P6|Overall Study|Technical problems|0
7550275|NCT02477332|26243761|P5|Overall Study|Technical problems|0
7550276|NCT02477332|26243762|P4|Overall Study|Technical problems|0
7550277|NCT02477332|26243763|P3|Overall Study|Technical problems|1
7550278|NCT02477332|26243764|P2|Overall Study|Technical problems|0
7550279|NCT02477332|26243765|P1|Overall Study|Technical problems|0
7550280|NCT02477332|26243760|P6|Overall Study|Protocol Violation|1
7550281|NCT02477332|26243761|P5|Overall Study|Protocol Violation|1
7550282|NCT02477332|26243762|P4|Overall Study|Protocol Violation|3
7550283|NCT02477332|26243763|P3|Overall Study|Protocol Violation|3
7550284|NCT02477332|26243764|P2|Overall Study|Protocol Violation|0
7550285|NCT02477332|26243765|P1|Overall Study|Protocol Violation|2
7550286|NCT02477332|26243760|P6|Overall Study|Pregnancy|0
7550287|NCT02477332|26243761|P5|Overall Study|Pregnancy|0
7550288|NCT02477332|26243762|P4|Overall Study|Pregnancy|1
7550289|NCT02477332|26243763|P3|Overall Study|Pregnancy|0
7550290|NCT02477332|26243764|P2|Overall Study|Pregnancy|0
7550291|NCT02477332|26243765|P1|Overall Study|Pregnancy|0
7550292|NCT02477332|26243760|P6|Overall Study|Non-compliance with study treatment|0
7550293|NCT02477332|26243761|P5|Overall Study|Non-compliance with study treatment|0
7550294|NCT02477332|26243762|P4|Overall Study|Non-compliance with study treatment|0
7550295|NCT02477332|26243763|P3|Overall Study|Non-compliance with study treatment|2
7550296|NCT02477332|26243764|P2|Overall Study|Non-compliance with study treatment|1
7550297|NCT02477332|26243765|P1|Overall Study|Non-compliance with study treatment|0
7550298|NCT02477332|26243760|P6|Overall Study|Lack of Efficacy|1
7550299|NCT02477332|26243761|P5|Overall Study|Lack of Efficacy|1
7550300|NCT02477332|26243762|P4|Overall Study|Lack of Efficacy|2
7550301|NCT02477332|26243763|P3|Overall Study|Lack of Efficacy|1
7550302|NCT02477332|26243764|P2|Overall Study|Lack of Efficacy|2
7550303|NCT02477332|26243765|P1|Overall Study|Lack of Efficacy|1
7550304|NCT02477332|26243760|P6|Overall Study|Adverse Event|2
7550305|NCT02477332|26243761|P5|Overall Study|Adverse Event|1
7550306|NCT02477332|26243762|P4|Overall Study|Adverse Event|2
7550307|NCT02477332|26243763|P3|Overall Study|Adverse Event|1
7550308|NCT02477332|26243764|P2|Overall Study|Adverse Event|1
7550309|NCT02477332|26243765|P1|Overall Study|Adverse Event|0
7550310|NCT02477215|26243857|P3|Fixed Dose Phase|Physician Decision|0
7550311|NCT02477215|26243858|P2|Fixed Dose Phase|Physician Decision|7
7550312|NCT02477215|26243859|P1|Fixed Dose Phase|Physician Decision|0
7550313|NCT02477215|26243857|P3|Dose Escalation Phase|Physician Decision|0
7550314|NCT02477215|26243858|P2|Dose Escalation Phase|Physician Decision|2
7550315|NCT02477215|26243859|P1|Dose Escalation Phase|Physician Decision|1
7550316|NCT02477111|26243873|P1|Overall Study|missed visit|4
7550317|NCT02477111|26243873|P1|Overall Study|Withdrawal by Subject|2
7550318|NCT02477111|26243873|P1|Overall Study|Death|5
7550319|NCT02477020|26243887|P2|Overall Study|Lack of Efficacy|5
7550320|NCT02477020|26243888|P1|Overall Study|Lack of Efficacy|14
7550321|NCT02477020|26243887|P2|Overall Study|Reason not Specified|1
7550322|NCT02477020|26243888|P1|Overall Study|Reason not Specified|3
7550323|NCT02477020|26243887|P2|Overall Study|Voluntary Withdrawal|16
7550324|NCT02477020|26243888|P1|Overall Study|Voluntary Withdrawal|7
7550325|NCT02477020|26243887|P2|Overall Study|Pretreatment Event/Adverse Event|6
7550326|NCT02477020|26243888|P1|Overall Study|Pretreatment Event/Adverse Event|6
7550327|NCT02476994|26243918|P2|Overall Study|Based on feedback from FDA|0
7550328|NCT02476994|26243919|P1|Overall Study|Based on feedback from FDA|1
7550329|NCT02476968|26243948|P3|Overall Study|Patient decision|0
7550330|NCT02476968|26243949|P2|Overall Study|Patient decision|7
7550331|NCT02476968|26243950|P1|Overall Study|Patient decision|30
7550332|NCT02476968|26243948|P3|Overall Study|Eligibility criteria not fulfilled|1
7550333|NCT02476968|26243949|P2|Overall Study|Eligibility criteria not fulfilled|0
7550334|NCT02476968|26243950|P1|Overall Study|Eligibility criteria not fulfilled|0
7550335|NCT02476968|26243948|P3|Overall Study|Death|0
7550336|NCT02476968|26243949|P2|Overall Study|Death|6
7550337|NCT02476968|26243950|P1|Overall Study|Death|34
7550338|NCT02476968|26243948|P3|Overall Study|Lost to Follow-up|1
7550339|NCT02476968|26243949|P2|Overall Study|Lost to Follow-up|0
7550340|NCT02476968|26243950|P1|Overall Study|Lost to Follow-up|10
7550341|NCT02476968|26243948|P3|Overall Study|Other|0
7550342|NCT02476968|26243949|P2|Overall Study|Other|2
7550343|NCT02476968|26243950|P1|Overall Study|Other|0
7550344|NCT02476916|26243977|P2|Extension Period|On Treatment|17
7550345|NCT02476916|26243978|P1|Extension Period|On Treatment|12
7550346|NCT02476916|26243977|P2|Extension Period|Prematurely Discontinued Treatment|1
7550347|NCT02476916|26243978|P1|Extension Period|Prematurely Discontinued Treatment|6
7550348|NCT02476916|26243977|P2|Core Period|Withdrawal by Subject|0
7550349|NCT02476916|26243978|P1|Core Period|Withdrawal by Subject|3
7550350|NCT02476916|26243977|P2|Core Period|Investigator decision|1
7550351|NCT02476916|26243978|P1|Core Period|Investigator decision|1
7550352|NCT02476916|26243977|P2|Core Period|Adverse Event|2
7550353|NCT02476916|26243978|P1|Core Period|Adverse Event|2
7550354|NCT02476617|26244063|P1|Overall Study|Lost to Follow-up|1
7550355|NCT02476617|26244063|P1|Overall Study|Adverse Event|1
7550356|NCT02476578|26244069|P2|Overall Study|Lost to Follow-up|13
7550357|NCT02476578|26244070|P1|Overall Study|Lost to Follow-up|6
7550358|NCT02476578|26244069|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
7550359|NCT02476578|26244070|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
7550360|NCT02476422|26244132|P2|Overall Study|Subject/guardian decision|1
7550361|NCT02476422|26244133|P1|Overall Study|Subject/guardian decision|0
7550362|NCT02476201|26244174|P1|Overall Study|Unsuccessful implant|1
7550363|NCT02476201|26244174|P1|Overall Study|Withdrawal by Subject|1
7550364|NCT02476201|26244174|P1|Overall Study|MPP programmed to OFF|2
7550365|NCT02476201|26244174|P1|Overall Study|Lost to Follow-up|2
7550366|NCT02476201|26244174|P1|Overall Study|Death|2
7550367|NCT02476201|26244174|P1|Overall Study|Adverse Event|4
7550368|NCT02476201|26244174|P1|Overall Study|Study echo not performed|5
7550369|NCT02476201|26244174|P1|Overall Study|Unable to program MPP|9
7550370|NCT02476175|26244182|P1|Overall Study|Adverse Event|2
7550371|NCT02476006|26244206|P1|Overall Study|Enrolled but not treated|4
7550372|NCT02476006|26244206|P1|Overall Study|Protocol Violation|1
7550373|NCT02476006|26244206|P1|Overall Study|Excluded from study|1
7550374|NCT02476006|26244206|P1|Overall Study|Switched to commercial drug|4
7550375|NCT02476006|26244206|P1|Overall Study|Study ended treatment not available|4
7550376|NCT02476006|26244206|P1|Overall Study|Physician Decision|5
7550377|NCT02476006|26244206|P1|Overall Study|Lost to Follow-up|5
7550378|NCT02476006|26244206|P1|Overall Study|Sponsor decision|6
7550379|NCT02476006|26244206|P1|Overall Study|Poor compliance to study protocol|3
7550380|NCT02476006|26244206|P1|Overall Study|Adverse Event|41
7550381|NCT02476006|26244206|P1|Overall Study|Participant did not wish to continue|39
7550382|NCT02476006|26244206|P1|Overall Study|Pregnancy|1
7550383|NCT02476006|26244206|P1|Overall Study|Lack of treatment efficacy|2
7550384|NCT02476006|26244206|P1|Overall Study|Death|4
7550385|NCT02475980|26244220|P1|Overall Study|Withdrawal by Subject|1
7550386|NCT02475980|26244220|P1|Overall Study|Lost to Follow-up|4
7550387|NCT02475954|26244231|P2|Overall Study|Death|1
7550388|NCT02475954|26244232|P1|Overall Study|Death|1
7550389|NCT02475954|26244231|P2|Overall Study|Lost to Follow-up|9
7550390|NCT02475954|26244232|P1|Overall Study|Lost to Follow-up|11
7550391|NCT02475954|26244231|P2|Overall Study|Withdrawal by Subject|2
7550392|NCT02475954|26244232|P1|Overall Study|Withdrawal by Subject|2
7550393|NCT02475850|26244242|P2|Overall Study|Withdrawal by Subject|155
7550394|NCT02475850|26244243|P1|Overall Study|Withdrawal by Subject|221
7550395|NCT02475850|26244242|P2|Overall Study|Lost to Follow-up|188
7550396|NCT02475850|26244243|P1|Overall Study|Lost to Follow-up|217
7550397|NCT02475850|26244242|P2|Overall Study|Death|141
7550398|NCT02475850|26244243|P1|Overall Study|Death|155
7550399|NCT02475733|26244280|P2|Overall Study|Physician Decision|0
7550400|NCT02475733|26244281|P1|Overall Study|Physician Decision|1
7550401|NCT02475733|26244280|P2|Overall Study|Withdrawal by Subject|0
7550402|NCT02475733|26244281|P1|Overall Study|Withdrawal by Subject|1
7550403|NCT02475655|26244338|P2|Overall Study|Lost to Follow-up|1
7550404|NCT02475655|26244339|P1|Overall Study|Lost to Follow-up|0
7550405|NCT02475629|26244491|P1|Overall Study|Subject non-compliance|1
7550406|NCT02475629|26244491|P1|Overall Study|Lost to Follow-up|1
7550407|NCT02475629|26244491|P1|Overall Study|Withdrawal by Subject|1
7550408|NCT02475629|26244491|P1|Overall Study|Physician Decision|1
7550409|NCT02475629|26244491|P1|Overall Study|Death|4
7550410|NCT02475629|26244491|P1|Overall Study|Adverse Event|1
7550411|NCT02475564|26244514|P2|Overall Study|Intense Menstrual bleeding|0
7550412|NCT02475564|26244515|P1|Overall Study|Intense Menstrual bleeding|1
7550413|NCT02475564|26244514|P2|Overall Study|Lost to Follow-up|1
7550414|NCT02475564|26244515|P1|Overall Study|Lost to Follow-up|2
7550415|NCT02475564|26244514|P2|Overall Study|Withdrawal by Subject|0
7550416|NCT02475564|26244515|P1|Overall Study|Withdrawal by Subject|1
7550417|NCT02475395|26244527|P2|Overall Study|Protocol Violation|3
7550418|NCT02475395|26244528|P1|Overall Study|Protocol Violation|30
7550419|NCT02475369|26244538|P2|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
7550420|NCT02475369|26244539|P1|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
7550421|NCT02475278|26244550|P1|Overall Study|Reason Not Specified|1
7550422|NCT02475278|26244550|P1|Overall Study|Lost to Follow-up|1
7550423|NCT02475265|26244561|P1|Overall Study|Withdrawal by Subject|2
7550424|NCT02475265|26244561|P1|Overall Study|Physician Decision|1
7550425|NCT02474589|26244612|P2|Overall Study|Inability to complete study procedures|1
7550426|NCT02474589|26244613|P1|Overall Study|Inability to complete study procedures|5
7550427|NCT02474589|26244612|P2|Overall Study|Withdrawal by Subject|0
7550428|NCT02474589|26244613|P1|Overall Study|Withdrawal by Subject|4
7550429|NCT02474589|26244612|P2|Overall Study|Protocol Violation|1
7550430|NCT02474589|26244613|P1|Overall Study|Protocol Violation|4
7550431|NCT02474589|26244612|P2|Overall Study|Lost to Follow-up|1
7550432|NCT02474589|26244613|P1|Overall Study|Lost to Follow-up|6
7550433|NCT02474589|26244612|P2|Overall Study|Adverse Event|2
7550434|NCT02474589|26244613|P1|Overall Study|Adverse Event|6
7550435|NCT02474199|26244672|P4|Overall Study|Did not meet eligibility criteria|2
7550436|NCT02474199|26244673|P3|Overall Study|Did not meet eligibility criteria|2
7550437|NCT02474199|26244674|P2|Overall Study|Did not meet eligibility criteria|0
7550438|NCT02474199|26244675|P1|Overall Study|Did not meet eligibility criteria|0
7550439|NCT02474199|26244672|P4|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7550440|NCT02474199|26244673|P3|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7550441|NCT02474199|26244674|P2|Overall Study|Did not receive Tregs due to insufficient manufacture|1
7550442|NCT02474199|26244675|P1|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7550443|NCT02474199|26244672|P4|Overall Study|Withdrawal by Subject|1
7550444|NCT02474199|26244673|P3|Overall Study|Withdrawal by Subject|0
7550445|NCT02474199|26244674|P2|Overall Study|Withdrawal by Subject|2
7550446|NCT02474199|26244675|P1|Overall Study|Withdrawal by Subject|1
7550447|NCT02474199|26244672|P4|Overall Study|Lost to Follow-up|0
7550448|NCT02474199|26244673|P3|Overall Study|Lost to Follow-up|0
7550449|NCT02474199|26244674|P2|Overall Study|Lost to Follow-up|0
7550450|NCT02474199|26244675|P1|Overall Study|Lost to Follow-up|1
7550451|NCT02474082|26244690|P2|Overall Study|Protocol deviation|1
7550452|NCT02474082|26244691|P1|Overall Study|Protocol deviation|0
7550453|NCT02474082|26244690|P2|Overall Study|Non-compliance with study treatment|2
7550454|NCT02474082|26244691|P1|Overall Study|Non-compliance with study treatment|0
7550455|NCT02474082|26244690|P2|Overall Study|Participant/guardian decision|2
7550456|NCT02474082|26244691|P1|Overall Study|Participant/guardian decision|1
7550457|NCT02474082|26244690|P2|Overall Study|Dose tapering not achieved|4
7550458|NCT02474082|26244691|P1|Overall Study|Dose tapering not achieved|0
7550459|NCT02474082|26244690|P2|Overall Study|Lost to Follow-up|2
7550460|NCT02474082|26244691|P1|Overall Study|Lost to Follow-up|2
7550461|NCT02474082|26244690|P2|Overall Study|Withdrawal of informed consent|11
7550462|NCT02474082|26244691|P1|Overall Study|Withdrawal of informed consent|1
7550463|NCT02474082|26244690|P2|Overall Study|Adverse Event|32
7550464|NCT02474082|26244691|P1|Overall Study|Adverse Event|2
7550465|NCT02474069|26244725|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7550466|NCT02474069|26244726|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7550467|NCT02474069|26244727|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
7550468|NCT02474069|26244725|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
7550469|NCT02474069|26244726|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7550470|NCT02474069|26244727|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7550471|NCT02474069|26244725|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
7550472|NCT02474069|26244726|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
7550473|NCT02474069|26244727|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
7550474|NCT02474069|26244725|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
7550475|NCT02474069|26244726|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
7550476|NCT02474069|26244727|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
7550477|NCT02474069|26244725|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
7550478|NCT02474069|26244726|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
7550479|NCT02474069|26244727|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
7550480|NCT02474069|26244725|P3|Selection Phase (SP)|Withdrawal by Subject|0
7550481|NCT02474069|26244726|P2|Selection Phase (SP)|Withdrawal by Subject|0
7550482|NCT02474069|26244727|P1|Selection Phase (SP)|Withdrawal by Subject|3
7550483|NCT02474069|26244725|P3|Selection Phase (SP)|Technical Problem|0
7550484|NCT02474069|26244726|P2|Selection Phase (SP)|Technical Problem|0
7550485|NCT02474069|26244727|P1|Selection Phase (SP)|Technical Problem|1
7550486|NCT02474069|26244725|P3|Selection Phase (SP)|No longer requires treatment|0
7550487|NCT02474069|26244726|P2|Selection Phase (SP)|No longer requires treatment|0
7550488|NCT02474069|26244727|P1|Selection Phase (SP)|No longer requires treatment|1
7550489|NCT02474069|26244725|P3|Selection Phase (SP)|Protocol Violation|0
7550490|NCT02474069|26244726|P2|Selection Phase (SP)|Protocol Violation|0
7550491|NCT02474069|26244727|P1|Selection Phase (SP)|Protocol Violation|1
7550492|NCT02474069|26244725|P3|Selection Phase (SP)|Physician Decision|0
7550493|NCT02474069|26244726|P2|Selection Phase (SP)|Physician Decision|0
7550494|NCT02474069|26244727|P1|Selection Phase (SP)|Physician Decision|1
7550495|NCT02474069|26244725|P3|Selection Phase (SP)|Lost to Follow-up|0
7550496|NCT02474069|26244726|P2|Selection Phase (SP)|Lost to Follow-up|0
7550497|NCT02474069|26244727|P1|Selection Phase (SP)|Lost to Follow-up|4
7550498|NCT02474069|26244725|P3|Selection Phase (SP)|Lack of Efficacy|0
7550499|NCT02474069|26244726|P2|Selection Phase (SP)|Lack of Efficacy|0
7550500|NCT02474069|26244727|P1|Selection Phase (SP)|Lack of Efficacy|1
7550501|NCT02474069|26244725|P3|Selection Phase (SP)|Adverse Event|0
7550502|NCT02474069|26244726|P2|Selection Phase (SP)|Adverse Event|0
7550503|NCT02474069|26244727|P1|Selection Phase (SP)|Adverse Event|8
7550504|NCT02473965|26244760|P2|Overall Study|Physician Decision|2
7550505|NCT02473965|26244761|P1|Overall Study|Physician Decision|0
7550506|NCT02473965|26244760|P2|Overall Study|Withdrawal by Subject|3
7550507|NCT02473965|26244761|P1|Overall Study|Withdrawal by Subject|2
7550508|NCT02473965|26244760|P2|Overall Study|MG worsening|1
7550509|NCT02473965|26244761|P1|Overall Study|MG worsening|4
7550510|NCT02473965|26244760|P2|Overall Study|Adverse Event|4
7550511|NCT02473965|26244761|P1|Overall Study|Adverse Event|6
7550512|NCT02473952|26244773|P2|Overall Study|Withdrawal by Subject|6
7550513|NCT02473952|26244774|P1|Overall Study|Withdrawal by Subject|0
7550514|NCT02473952|26244773|P2|Overall Study|Adverse Event|2
7550515|NCT02473952|26244774|P1|Overall Study|Adverse Event|2
7550516|NCT02473913|26244782|P2|Overall Study|Lost to Follow-up|3
7550517|NCT02473913|26244783|P1|Overall Study|Lost to Follow-up|3
7550518|NCT02473640|26244835|P1|Treatment Period 1|Adverse Event|1
7550519|NCT02473614|26244844|P2|First Intervention (3 Weeks)|Job duties/lack of transportation|0
7550520|NCT02473614|26244845|P1|First Intervention (3 Weeks)|Job duties/lack of transportation|1
7550521|NCT02473523|26244853|P1|Overall Study|Lost to Follow-up|1
7550522|NCT02473523|26244853|P1|Overall Study|Death|1
7550523|NCT02473510|26244874|P2|Overall Study|Lost to Follow-up|2
7550524|NCT02473510|26244875|P1|Overall Study|Lost to Follow-up|1
7550525|NCT02473471|26244889|P1|Overall Study|Lost to Follow-up|1
7550526|NCT02473471|26244889|P1|Overall Study|poor oral hygiene|2
7550527|NCT02473445|26244920|P1|Overall Study|Sponsor Decision|20
7550528|NCT02473445|26244920|P1|Overall Study|Withdrawal by Subject|2
7550529|NCT02473393|26244930|P4|Overall Study|Withdrawal by Subject|1
7550530|NCT02473393|26244931|P3|Overall Study|Withdrawal by Subject|1
7550531|NCT02473393|26244932|P2|Overall Study|Withdrawal by Subject|0
7550532|NCT02473393|26244933|P1|Overall Study|Withdrawal by Subject|0
7550533|NCT02473393|26244930|P4|Overall Study|Adverse Event|0
7550534|NCT02473393|26244931|P3|Overall Study|Adverse Event|1
7550535|NCT02473393|26244932|P2|Overall Study|Adverse Event|0
7550536|NCT02473393|26244933|P1|Overall Study|Adverse Event|0
7550537|NCT02473367|26244972|P1|Period 4|Lost to Follow-up|1
7550538|NCT02473367|26244972|P1|Wait 1|Withdrawal by Subject|1
7550539|NCT02473289|26244992|P2|Overall Study|Other|0
7550540|NCT02473289|26244993|P1|Overall Study|Other|2
7550541|NCT02473289|26244992|P2|Overall Study|Treatment Unblinded + Adverse event|1
7550542|NCT02473289|26244993|P1|Overall Study|Treatment Unblinded + Adverse event|0
7550543|NCT02473289|26244992|P2|Overall Study|Withdrawal of consent|7
7550544|NCT02473289|26244993|P1|Overall Study|Withdrawal of consent|6
7550545|NCT02473289|26244992|P2|Overall Study|Protocol Violation|1
7550546|NCT02473289|26244993|P1|Overall Study|Protocol Violation|0
7550547|NCT02473289|26244992|P2|Overall Study|Lost to Follow-up|1
7550548|NCT02473289|26244993|P1|Overall Study|Lost to Follow-up|1
7550549|NCT02473289|26244992|P2|Overall Study|Adverse Event|3
7550550|NCT02473289|26244993|P1|Overall Study|Adverse Event|2
7550551|NCT02473250|26245015|P1|Overall Study|Antidepressant effect of divalproex|2
7550552|NCT02473250|26245015|P1|Overall Study|Did not tolerate medication washout|3
7550553|NCT02473250|26245015|P1|Overall Study|Physician Decision|5
7550554|NCT02473250|26245015|P1|Overall Study|Lost to Follow-up|10
7550555|NCT02472977|26245025|P3|Overall Study|Subject request to discontinue treatment|0
7550556|NCT02472977|26245026|P2|Overall Study|Subject request to discontinue treatment|1
7550557|NCT02472977|26245027|P1|Overall Study|Subject request to discontinue treatment|0
7550558|NCT02472977|26245025|P3|Overall Study|Study drug toxicity|2
7550559|NCT02472977|26245026|P2|Overall Study|Study drug toxicity|0
7550560|NCT02472977|26245027|P1|Overall Study|Study drug toxicity|2
7550561|NCT02472977|26245025|P3|Overall Study|Withdrawal by Subject|0
7550562|NCT02472977|26245026|P2|Overall Study|Withdrawal by Subject|1
7550563|NCT02472977|26245027|P1|Overall Study|Withdrawal by Subject|0
7550564|NCT02472977|26245025|P3|Overall Study|Disease progression|6
7550565|NCT02472977|26245026|P2|Overall Study|Disease progression|25
7550566|NCT02472977|26245027|P1|Overall Study|Disease progression|4
7550567|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
7550568|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
7550569|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
7550570|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
7550571|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
7550572|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
7550573|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Physician Decision|1
7550574|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Physician Decision|1
7550575|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Death|1
7550576|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Death|0
7550577|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Disease Progression|56
7550578|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Disease Progression|52
7550579|NCT02472964|26245052|P2|Part 2 (Week 24-week 48)|Adverse Event|2
7550580|NCT02472964|26245053|P1|Part 2 (Week 24-week 48)|Adverse Event|4
7550581|NCT02472964|26245052|P2|Part 1 (up to Week 24)|Other|1
7550582|NCT02472964|26245053|P1|Part 1 (up to Week 24)|Other|2
7550583|NCT02472964|26245052|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
7550584|NCT02472964|26245053|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
7550585|NCT02472964|26245052|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
7550586|NCT02472964|26245053|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
7550587|NCT02472964|26245052|P2|Part 1 (up to Week 24)|Physician Decision|1
7550588|NCT02472964|26245053|P1|Part 1 (up to Week 24)|Physician Decision|3
7550589|NCT02472964|26245052|P2|Part 1 (up to Week 24)|Death|6
7550590|NCT02472964|26245053|P1|Part 1 (up to Week 24)|Death|3
7550591|NCT02472964|26245052|P2|Part 1 (up to Week 24)|disease progression|47
7550592|NCT02472964|26245053|P1|Part 1 (up to Week 24)|disease progression|58
7550593|NCT02472964|26245052|P2|Part 1 (up to Week 24)|Adverse Event|4
7550594|NCT02472964|26245053|P1|Part 1 (up to Week 24)|Adverse Event|2
7550595|NCT02472886|26245062|P3|Overall Study|Lack of Efficacy|1
7550596|NCT02472886|26245063|P2|Overall Study|Lack of Efficacy|2
7550597|NCT02472886|26245064|P1|Overall Study|Lack of Efficacy|0
7550598|NCT02472847|26245092|P2|Overall Study|Withdrawal by Subject|5
7550599|NCT02472847|26245093|P1|Overall Study|Withdrawal by Subject|1
7550600|NCT02472795|26245104|P5|Overall Study|Withdrawal by Subject|1
7550601|NCT02472795|26245105|P4|Overall Study|Withdrawal by Subject|0
7550602|NCT02472795|26245106|P3|Overall Study|Withdrawal by Subject|0
7550603|NCT02472795|26245107|P2|Overall Study|Withdrawal by Subject|0
7550604|NCT02472795|26245108|P1|Overall Study|Withdrawal by Subject|0
7550605|NCT02472795|26245104|P5|Overall Study|Adverse Event|2
7550606|NCT02472795|26245105|P4|Overall Study|Adverse Event|0
7550607|NCT02472795|26245106|P3|Overall Study|Adverse Event|0
7550608|NCT02472795|26245107|P2|Overall Study|Adverse Event|1
7550609|NCT02472795|26245108|P1|Overall Study|Adverse Event|0
7550610|NCT02472756|26245140|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
7550611|NCT02472756|26245140|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
7550612|NCT02472756|26245140|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
7550613|NCT02472756|26245140|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
7550614|NCT02472756|26245140|P1|Induction (Approximately 6 Months)|Adverse Event|1
7550615|NCT02472652|26245161|P1|Overall Study|Lost to Follow-up|1
7550616|NCT02472639|26245168|P2|Overall Study|Physician Decision|3
7550617|NCT02472639|26245169|P1|Overall Study|Physician Decision|4
7550618|NCT02472405|26245225|P1|Overall Study|Adverse Event|1
7550619|NCT02472405|26245225|P1|Overall Study|Lost to Follow-up|9
7550620|NCT02472366|26245233|P2|Overall Study|Lost to Follow-up|0
7550621|NCT02472366|26245234|P1|Overall Study|Lost to Follow-up|1
7550622|NCT02472353|26245250|P2|Overall Study|Study Termination|4
7550623|NCT02472353|26245251|P1|Overall Study|Study Termination|1
7550624|NCT02472353|26245250|P2|Overall Study|Withdrawal by Subject|1
7550625|NCT02472353|26245251|P1|Overall Study|Withdrawal by Subject|2
7550626|NCT02472353|26245250|P2|Overall Study|Lost to Follow-up|1
7550627|NCT02472353|26245251|P1|Overall Study|Lost to Follow-up|1
7550628|NCT02472145|26245299|P3|Overall Study|Other|43
7550629|NCT02472145|26245300|P2|Overall Study|Other|45
7550630|NCT02472145|26245301|P1|Overall Study|Other|0
7550631|NCT02472145|26245299|P3|Overall Study|Sponsor decision|2
7550632|NCT02472145|26245300|P2|Overall Study|Sponsor decision|3
7550633|NCT02472145|26245301|P1|Overall Study|Sponsor decision|0
7550634|NCT02472145|26245299|P3|Overall Study|Withdrawal by Subject|13
7550635|NCT02472145|26245300|P2|Overall Study|Withdrawal by Subject|9
7550636|NCT02472145|26245301|P1|Overall Study|Withdrawal by Subject|0
7550637|NCT02472145|26245299|P3|Overall Study|Lost to Follow-up|0
7550638|NCT02472145|26245300|P2|Overall Study|Lost to Follow-up|1
7550639|NCT02472145|26245301|P1|Overall Study|Lost to Follow-up|0
7550640|NCT02472145|26245299|P3|Overall Study|Death|99
7550641|NCT02472145|26245300|P2|Overall Study|Death|101
7550642|NCT02472145|26245301|P1|Overall Study|Death|10
7550643|NCT02471755|26245322|P2|Overall Study|Lost to Follow-up|1
7550644|NCT02471755|26245323|P1|Overall Study|Lost to Follow-up|0
7550645|NCT02471755|26245322|P2|Overall Study|Withdrawal by Subject|0
7550646|NCT02471755|26245323|P1|Overall Study|Withdrawal by Subject|1
7550647|NCT02471716|26245344|P5|Overall Study|Other|9
7550648|NCT02471716|26245345|P4|Overall Study|Other|8
7550649|NCT02471716|26245346|P3|Overall Study|Other|0
7550650|NCT02471716|26245347|P2|Overall Study|Other|0
7550651|NCT02471716|26245348|P1|Overall Study|Other|0
7550652|NCT02471716|26245344|P5|Overall Study|Death|0
7550653|NCT02471716|26245345|P4|Overall Study|Death|1
7550654|NCT02471716|26245346|P3|Overall Study|Death|0
7550655|NCT02471716|26245347|P2|Overall Study|Death|0
7550656|NCT02471716|26245348|P1|Overall Study|Death|0
7550657|NCT02471716|26245344|P5|Overall Study|Lost to Follow-up|2
7550658|NCT02471716|26245345|P4|Overall Study|Lost to Follow-up|3
7550659|NCT02471716|26245346|P3|Overall Study|Lost to Follow-up|0
7550660|NCT02471716|26245347|P2|Overall Study|Lost to Follow-up|0
7550661|NCT02471716|26245348|P1|Overall Study|Lost to Follow-up|0
7550662|NCT02471716|26245344|P5|Overall Study|Study Terminiated by sponsor|0
7550663|NCT02471716|26245345|P4|Overall Study|Study Terminiated by sponsor|1
7550664|NCT02471716|26245346|P3|Overall Study|Study Terminiated by sponsor|0
7550665|NCT02471716|26245347|P2|Overall Study|Study Terminiated by sponsor|0
7550666|NCT02471716|26245348|P1|Overall Study|Study Terminiated by sponsor|0
7550667|NCT02471716|26245344|P5|Overall Study|Withdrawal by Subject|5
7550668|NCT02471716|26245345|P4|Overall Study|Withdrawal by Subject|2
7550669|NCT02471716|26245346|P3|Overall Study|Withdrawal by Subject|0
7550670|NCT02471716|26245347|P2|Overall Study|Withdrawal by Subject|1
7550671|NCT02471716|26245348|P1|Overall Study|Withdrawal by Subject|0
7550672|NCT02471612|26245410|P1|Overall Study|Lost to Follow-up|2
7550673|NCT02471586|26245430|P3|Overall Study|Death|0
7550674|NCT02471586|26245431|P2|Overall Study|Death|2
7550675|NCT02471586|26245432|P1|Overall Study|Death|2
7550676|NCT02471586|26245430|P3|Overall Study|Lost to Follow-up|4
7550677|NCT02471586|26245431|P2|Overall Study|Lost to Follow-up|8
7550678|NCT02471586|26245432|P1|Overall Study|Lost to Follow-up|3
7550679|NCT02471404|26245553|P3|Overall Study|Other reasons not specified|12
7550680|NCT02471404|26245554|P2|Overall Study|Other reasons not specified|7
7550681|NCT02471404|26245555|P1|Overall Study|Other reasons not specified|10
7550682|NCT02471404|26245553|P3|Overall Study|Withdrawal by Subject|5
7550683|NCT02471404|26245554|P2|Overall Study|Withdrawal by Subject|4
7550684|NCT02471404|26245555|P1|Overall Study|Withdrawal by Subject|8
7550685|NCT02471404|26245553|P3|Overall Study|Protocol Violation|0
7550686|NCT02471404|26245554|P2|Overall Study|Protocol Violation|0
7550687|NCT02471404|26245555|P1|Overall Study|Protocol Violation|1
7550688|NCT02471404|26245553|P3|Overall Study|Lost to Follow-up|3
7550689|NCT02471404|26245554|P2|Overall Study|Lost to Follow-up|1
7550690|NCT02471404|26245555|P1|Overall Study|Lost to Follow-up|1
7550691|NCT02471404|26245553|P3|Overall Study|Failure to Meet Randomization Criteria|1
7550692|NCT02471404|26245554|P2|Overall Study|Failure to Meet Randomization Criteria|0
7550693|NCT02471404|26245555|P1|Overall Study|Failure to Meet Randomization Criteria|2
7550694|NCT02471404|26245553|P3|Overall Study|Developed Study Withdrawal Criteria|2
7550695|NCT02471404|26245554|P2|Overall Study|Developed Study Withdrawal Criteria|1
7550696|NCT02471404|26245555|P1|Overall Study|Developed Study Withdrawal Criteria|4
7550697|NCT02471404|26245553|P3|Overall Study|Adverse Event|2
7550698|NCT02471404|26245554|P2|Overall Study|Adverse Event|1
7550699|NCT02471404|26245555|P1|Overall Study|Adverse Event|7
7550700|NCT02471183|26245587|P1|Extended Treatment Period|Lack of Efficacy|1
7550701|NCT02471183|26245587|P1|Main Treatment Period|Withdrawal by Subject|1
7550702|NCT02471183|26245587|P1|Main Treatment Period|Adverse Event|1
7550703|NCT02471144|26245606|P11|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
7550704|NCT02471144|26245607|P10|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550705|NCT02471144|26245608|P9|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550706|NCT02471144|26245609|P8|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550707|NCT02471144|26245610|P7|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550708|NCT02471144|26245611|P6|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550709|NCT02471144|26245612|P5|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550710|NCT02471144|26245613|P4|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550711|NCT02471144|26245614|P3|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550712|NCT02471144|26245615|P2|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550713|NCT02471144|26245616|P1|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7550714|NCT02471144|26245606|P11|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550715|NCT02471144|26245607|P10|Extension Period (Week 52 to Week 236)|Pregnancy|2
7550716|NCT02471144|26245608|P9|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550717|NCT02471144|26245609|P8|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550718|NCT02471144|26245610|P7|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550719|NCT02471144|26245611|P6|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550720|NCT02471144|26245612|P5|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550721|NCT02471144|26245613|P4|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550722|NCT02471144|26245614|P3|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550723|NCT02471144|26245615|P2|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550724|NCT02471144|26245616|P1|Extension Period (Week 52 to Week 236)|Pregnancy|0
7550725|NCT02471144|26245606|P11|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
7550726|NCT02471144|26245607|P10|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
7550727|NCT02471144|26245608|P9|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550728|NCT02471144|26245609|P8|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550729|NCT02471144|26245610|P7|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550730|NCT02471144|26245611|P6|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550731|NCT02471144|26245612|P5|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550732|NCT02471144|26245613|P4|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550733|NCT02471144|26245614|P3|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550734|NCT02471144|26245615|P2|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550735|NCT02471144|26245616|P1|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7550736|NCT02471144|26245606|P11|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550737|NCT02471144|26245607|P10|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550738|NCT02471144|26245608|P9|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
7550739|NCT02471144|26245609|P8|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
7550740|NCT02471144|26245610|P7|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550741|NCT02471144|26245611|P6|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550742|NCT02471144|26245612|P5|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550743|NCT02471144|26245613|P4|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550744|NCT02471144|26245614|P3|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550745|NCT02471144|26245615|P2|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550746|NCT02471144|26245616|P1|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7550747|NCT02471144|26245606|P11|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550748|NCT02471144|26245607|P10|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550749|NCT02471144|26245608|P9|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
7550750|NCT02471144|26245609|P8|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550751|NCT02471144|26245610|P7|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550752|NCT02471144|26245611|P6|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550753|NCT02471144|26245612|P5|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550754|NCT02471144|26245613|P4|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550755|NCT02471144|26245614|P3|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550756|NCT02471144|26245615|P2|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550757|NCT02471144|26245616|P1|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7550758|NCT02471144|26245606|P11|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550759|NCT02471144|26245607|P10|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550760|NCT02471144|26245608|P9|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
7550761|NCT02471144|26245609|P8|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550762|NCT02471144|26245610|P7|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550763|NCT02471144|26245611|P6|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
7550764|NCT02471144|26245612|P5|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550765|NCT02471144|26245613|P4|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550766|NCT02471144|26245614|P3|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550767|NCT02471144|26245615|P2|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550768|NCT02471144|26245616|P1|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7550769|NCT02471144|26245606|P11|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550770|NCT02471144|26245607|P10|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550771|NCT02471144|26245608|P9|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7550772|NCT02471144|26245609|P8|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550773|NCT02471144|26245610|P7|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7550774|NCT02471144|26245611|P6|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550775|NCT02471144|26245612|P5|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7550776|NCT02471144|26245613|P4|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550777|NCT02471144|26245614|P3|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550778|NCT02471144|26245615|P2|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550779|NCT02471144|26245616|P1|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7550780|NCT02471144|26245606|P11|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550781|NCT02471144|26245607|P10|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550782|NCT02471144|26245608|P9|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550783|NCT02471144|26245609|P8|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550784|NCT02471144|26245610|P7|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550785|NCT02471144|26245611|P6|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550869|NCT02470091|26245914|P2|Overall Study|Ineligible|2
7550786|NCT02471144|26245612|P5|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550787|NCT02471144|26245613|P4|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550788|NCT02471144|26245614|P3|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7550789|NCT02471144|26245615|P2|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
7550790|NCT02471144|26245616|P1|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
7550791|NCT02471144|26245606|P11|Induction Period (Up to Week 12)|Protocol Deviation|0
7550792|NCT02471144|26245607|P10|Induction Period (Up to Week 12)|Protocol Deviation|0
7550793|NCT02471144|26245608|P9|Induction Period (Up to Week 12)|Protocol Deviation|0
7550794|NCT02471144|26245609|P8|Induction Period (Up to Week 12)|Protocol Deviation|0
7550795|NCT02471144|26245610|P7|Induction Period (Up to Week 12)|Protocol Deviation|0
7550796|NCT02471144|26245611|P6|Induction Period (Up to Week 12)|Protocol Deviation|0
7550797|NCT02471144|26245612|P5|Induction Period (Up to Week 12)|Protocol Deviation|0
7550798|NCT02471144|26245613|P4|Induction Period (Up to Week 12)|Protocol Deviation|0
7550799|NCT02471144|26245614|P3|Induction Period (Up to Week 12)|Protocol Deviation|1
7550800|NCT02471144|26245615|P2|Induction Period (Up to Week 12)|Protocol Deviation|0
7550801|NCT02471144|26245616|P1|Induction Period (Up to Week 12)|Protocol Deviation|0
7550802|NCT02471144|26245606|P11|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550803|NCT02471144|26245607|P10|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550804|NCT02471144|26245608|P9|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550805|NCT02471144|26245609|P8|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550806|NCT02471144|26245610|P7|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550807|NCT02471144|26245611|P6|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550808|NCT02471144|26245612|P5|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550809|NCT02471144|26245613|P4|Induction Period (Up to Week 12)|Lack of Efficacy|1
7550810|NCT02471144|26245614|P3|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550811|NCT02471144|26245615|P2|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550812|NCT02471144|26245616|P1|Induction Period (Up to Week 12)|Lack of Efficacy|0
7550813|NCT02471144|26245606|P11|Induction Period (Up to Week 12)|Adverse Event|0
7550814|NCT02471144|26245607|P10|Induction Period (Up to Week 12)|Adverse Event|0
7550815|NCT02471144|26245608|P9|Induction Period (Up to Week 12)|Adverse Event|0
7550816|NCT02471144|26245609|P8|Induction Period (Up to Week 12)|Adverse Event|0
7550817|NCT02471144|26245610|P7|Induction Period (Up to Week 12)|Adverse Event|0
7550818|NCT02471144|26245611|P6|Induction Period (Up to Week 12)|Adverse Event|0
7550819|NCT02471144|26245612|P5|Induction Period (Up to Week 12)|Adverse Event|0
7550820|NCT02471144|26245613|P4|Induction Period (Up to Week 12)|Adverse Event|0
7550821|NCT02471144|26245614|P3|Induction Period (Up to Week 12)|Adverse Event|1
7550822|NCT02471144|26245615|P2|Induction Period (Up to Week 12)|Adverse Event|1
7550823|NCT02471144|26245616|P1|Induction Period (Up to Week 12)|Adverse Event|0
7550824|NCT02471014|26245695|P2|Overall Study|Lost to Follow-up|2
7550825|NCT02471014|26245696|P1|Overall Study|Lost to Follow-up|2
7550826|NCT02470806|26245722|P2|Overall Study|Lack of Efficacy|15
7550827|NCT02470806|26245723|P1|Overall Study|Lack of Efficacy|5
7550828|NCT02470806|26245722|P2|Overall Study|Withdrawal by Subject|10
7550829|NCT02470806|26245723|P1|Overall Study|Withdrawal by Subject|3
7550830|NCT02470806|26245722|P2|Overall Study|Physician Decision|3
7550831|NCT02470806|26245723|P1|Overall Study|Physician Decision|0
7550832|NCT02470806|26245722|P2|Overall Study|Protocol Violation|11
7550833|NCT02470806|26245723|P1|Overall Study|Protocol Violation|4
7550834|NCT02470806|26245722|P2|Overall Study|Adverse Event|2
7550835|NCT02470806|26245723|P1|Overall Study|Adverse Event|5
7550836|NCT02470806|26245722|P2|Overall Study|Lost to Follow-up|1
7550837|NCT02470806|26245723|P1|Overall Study|Lost to Follow-up|1
7550838|NCT02470585|26245776|P3|Overall Study|Other|6
7550839|NCT02470585|26245777|P2|Overall Study|Other|4
7550840|NCT02470585|26245778|P1|Overall Study|Other|4
7550841|NCT02470585|26245776|P3|Overall Study|Lost to Follow-up|4
7550842|NCT02470585|26245777|P2|Overall Study|Lost to Follow-up|5
7550843|NCT02470585|26245778|P1|Overall Study|Lost to Follow-up|2
7550844|NCT02470585|26245776|P3|Overall Study|Withdrawal by Subject|29
7550845|NCT02470585|26245777|P2|Overall Study|Withdrawal by Subject|21
7550846|NCT02470585|26245778|P1|Overall Study|Withdrawal by Subject|19
7550847|NCT02470585|26245776|P3|Overall Study|Death|86
7550848|NCT02470585|26245777|P2|Overall Study|Death|87
7550849|NCT02470585|26245778|P1|Overall Study|Death|82
7550850|NCT02470429|26245811|P2|Overall Study|Withdrawal by Subject|0
7550851|NCT02470429|26245812|P1|Overall Study|Withdrawal by Subject|1
7550852|NCT02470429|26245811|P2|Overall Study|Adverse Event|0
7550853|NCT02470429|26245812|P1|Overall Study|Adverse Event|1
7550854|NCT02470403|26245830|P5|Overall Study|Subject/guardian decision|0
7550855|NCT02470403|26245831|P4|Overall Study|Subject/guardian decision|4
7550856|NCT02470403|26245832|P3|Overall Study|Subject/guardian decision|0
7550857|NCT02470403|26245833|P2|Overall Study|Subject/guardian decision|0
7550858|NCT02470403|26245834|P1|Overall Study|Subject/guardian decision|1
7550859|NCT02470403|26245830|P5|Overall Study|Lost to Follow-up|0
7550860|NCT02470403|26245831|P4|Overall Study|Lost to Follow-up|0
7550861|NCT02470403|26245832|P3|Overall Study|Lost to Follow-up|0
7550862|NCT02470403|26245833|P2|Overall Study|Lost to Follow-up|1
7550863|NCT02470403|26245834|P1|Overall Study|Lost to Follow-up|0
7550864|NCT02470403|26245830|P5|Overall Study|Adverse Event|0
7550865|NCT02470403|26245831|P4|Overall Study|Adverse Event|0
7550866|NCT02470403|26245832|P3|Overall Study|Adverse Event|0
7550867|NCT02470403|26245833|P2|Overall Study|Adverse Event|0
7550868|NCT02470403|26245834|P1|Overall Study|Adverse Event|1
7550870|NCT02470091|26245915|P1|Overall Study|Ineligible|0
7550871|NCT02470091|26245914|P2|Overall Study|Withdrawal by Subject|0
7550872|NCT02470091|26245915|P1|Overall Study|Withdrawal by Subject|1
7550873|NCT02469961|26245932|P2|Overall Study|Physician Decision|1
7550874|NCT02469961|26245933|P1|Overall Study|Physician Decision|4
7550875|NCT02469896|26245947|P2|Overall Study|Withdrawal by Subject|0
7550876|NCT02469896|26245948|P1|Overall Study|Withdrawal by Subject|2
7550877|NCT02469857|26245993|P2|Overall Study|Discontinuation|3
7550878|NCT02469857|26245994|P1|Overall Study|Discontinuation|1
7550879|NCT02469857|26245993|P2|Overall Study|Death|29
7550880|NCT02469857|26245994|P1|Overall Study|Death|24
7550881|NCT02469623|26246065|P1|Overall Study|Death|3
7550882|NCT02469623|26246065|P1|Overall Study|Withdrawal by Subject|2
7550883|NCT02469623|26246065|P1|Overall Study|Lost to Follow-up|4
7550884|NCT02469623|26246065|P1|Overall Study|Not consented for long-term follow-up|4
7550885|NCT02469610|26246072|P2|Overall Study|exclusion criteria|1
7550886|NCT02469610|26246073|P1|Overall Study|exclusion criteria|2
7550887|NCT02469610|26246072|P2|Overall Study|Lost to Follow-up|0
7550888|NCT02469610|26246073|P1|Overall Study|Lost to Follow-up|1
7550889|NCT02469610|26246072|P2|Overall Study|Death|0
7550890|NCT02469610|26246073|P1|Overall Study|Death|1
7550891|NCT02469415|26246100|P1|Overall Study|Investigational agent placed on hold|2
7550892|NCT02469415|26246100|P1|Overall Study|Withdrawal by Subject|1
7550893|NCT02469298|26246139|P4|Overall Study|Withdrawal by Subject|1
7550894|NCT02469298|26246140|P3|Overall Study|Withdrawal by Subject|0
7550895|NCT02469298|26246141|P2|Overall Study|Withdrawal by Subject|0
7550896|NCT02469298|26246142|P1|Overall Study|Withdrawal by Subject|0
7550897|NCT02469298|26246139|P4|Overall Study|Physician Decision|1
7550898|NCT02469298|26246140|P3|Overall Study|Physician Decision|0
7550899|NCT02469298|26246141|P2|Overall Study|Physician Decision|0
7550900|NCT02469298|26246142|P1|Overall Study|Physician Decision|0
7550901|NCT02469298|26246139|P4|Overall Study|Lost to Follow-up|0
7550902|NCT02469298|26246140|P3|Overall Study|Lost to Follow-up|1
7550903|NCT02469298|26246141|P2|Overall Study|Lost to Follow-up|0
7550904|NCT02469298|26246142|P1|Overall Study|Lost to Follow-up|1
7550905|NCT02469298|26246139|P4|Overall Study|Protocol Violation|0
7550906|NCT02469298|26246140|P3|Overall Study|Protocol Violation|1
7550907|NCT02469298|26246141|P2|Overall Study|Protocol Violation|1
7550908|NCT02469298|26246142|P1|Overall Study|Protocol Violation|0
7550909|NCT02469246|26246282|P2|Double-Blind Phase|Lost to Follow-up|5
7550910|NCT02469246|26246283|P1|Double-Blind Phase|Lost to Follow-up|9
7550911|NCT02469246|26246282|P2|Double-Blind Phase|Withdrew Consent|25
7550912|NCT02469246|26246283|P1|Double-Blind Phase|Withdrew Consent|25
7550913|NCT02469246|26246282|P2|Double-Blind Phase|Protocol Violation|1
7550914|NCT02469246|26246283|P1|Double-Blind Phase|Protocol Violation|1
7550915|NCT02469246|26246282|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
7550916|NCT02469246|26246283|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
7550917|NCT02469246|26246282|P2|Double-Blind Phase|Investigator's Discretion|8
7550918|NCT02469246|26246283|P1|Double-Blind Phase|Investigator's Discretion|8
7550919|NCT02469246|26246282|P2|Double-Blind Phase|Lack of Efficacy|1
7550920|NCT02469246|26246283|P1|Double-Blind Phase|Lack of Efficacy|2
7550921|NCT02469246|26246282|P2|Double-Blind Phase|Death|0
7550922|NCT02469246|26246283|P1|Double-Blind Phase|Death|2
7550923|NCT02469246|26246282|P2|Double-Blind Phase|Adverse Event|9
7550924|NCT02469246|26246283|P1|Double-Blind Phase|Adverse Event|12
7550925|NCT02469246|26246282|P2|Double-Blind Phase|Randomized and Never Treated|6
7550926|NCT02469246|26246283|P1|Double-Blind Phase|Randomized and Never Treated|5
7550927|NCT02469168|26246315|P2|Overall Study|Trial closed|0
7550928|NCT02469168|26246316|P1|Overall Study|Trial closed|1
7550929|NCT02469090|26246336|P3|Period 2: Maintenance Treatment Phase|Death|1
7550930|NCT02469090|26246337|P2|Period 2: Maintenance Treatment Phase|Death|0
7550931|NCT02469090|26246338|P1|Period 2: Maintenance Treatment Phase|Death|0
7550932|NCT02469090|26246336|P3|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7550933|NCT02469090|26246337|P2|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
7550934|NCT02469090|26246338|P1|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7550935|NCT02469090|26246336|P3|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
7550936|NCT02469090|26246337|P2|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
7550937|NCT02469090|26246338|P1|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
7550938|NCT02469090|26246336|P3|Period 2: Maintenance Treatment Phase|Adverse Event|15
7550939|NCT02469090|26246337|P2|Period 2: Maintenance Treatment Phase|Adverse Event|5
7550940|NCT02469090|26246338|P1|Period 2: Maintenance Treatment Phase|Adverse Event|0
7550941|NCT02469090|26246336|P3|Period 1: Dose Titration Phase|Lack of Efficacy|0
7550942|NCT02469090|26246337|P2|Period 1: Dose Titration Phase|Lack of Efficacy|0
7550943|NCT02469090|26246338|P1|Period 1: Dose Titration Phase|Lack of Efficacy|11
7550944|NCT02469090|26246336|P3|Period 1: Dose Titration Phase|Lost to Follow-up|0
7550945|NCT02469090|26246337|P2|Period 1: Dose Titration Phase|Lost to Follow-up|0
7550946|NCT02469090|26246338|P1|Period 1: Dose Titration Phase|Lost to Follow-up|1
7550947|NCT02469090|26246336|P3|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7550948|NCT02469090|26246337|P2|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7550949|NCT02469090|26246338|P1|Period 1: Dose Titration Phase|Withdrawal by Subject|8
7550950|NCT02469090|26246336|P3|Period 1: Dose Titration Phase|Adverse Event|0
7550951|NCT02469090|26246337|P2|Period 1: Dose Titration Phase|Adverse Event|0
7550952|NCT02469090|26246338|P1|Period 1: Dose Titration Phase|Adverse Event|12
7550953|NCT02469077|26246365|P2|Post Intervention /Followup|Withdrawal by Subject|1
7550954|NCT02469077|26246366|P1|Post Intervention /Followup|Withdrawal by Subject|2
7550955|NCT02469077|26246365|P2|Post Randomization/Intervention Period|Conflicting health issues|1
7550956|NCT02469077|26246366|P1|Post Randomization/Intervention Period|Conflicting health issues|0
7550957|NCT02469077|26246365|P2|Post Randomization/Intervention Period|Relocated|1
7550958|NCT02469077|26246366|P1|Post Randomization/Intervention Period|Relocated|1
7550959|NCT02469077|26246365|P2|Post Randomization/Intervention Period|Scheduling issues|2
7550960|NCT02469077|26246366|P1|Post Randomization/Intervention Period|Scheduling issues|3
7550961|NCT02469064|26246398|P2|Overall Study|Request not to receive intervention.|3
7550962|NCT02469064|26246399|P1|Overall Study|Request not to receive intervention.|1
7550963|NCT02469038|26246409|P2|Overall Study|Physician Decision|5
7550964|NCT02469038|26246410|P1|Overall Study|Physician Decision|4
7550965|NCT02468934|26246428|P1|Overall Study|Screen Failure|3
7550966|NCT02468934|26246428|P1|Overall Study|Withdrawal by Subject|4
7550967|NCT02468674|26246488|P9|Overall Study|Protocol Deviation|1
7550968|NCT02468674|26246489|P8|Overall Study|Protocol Deviation|1
7550969|NCT02468674|26246490|P7|Overall Study|Protocol Deviation|0
7550970|NCT02468674|26246491|P6|Overall Study|Protocol Deviation|0
7550971|NCT02468674|26246492|P5|Overall Study|Protocol Deviation|0
7550972|NCT02468674|26246493|P4|Overall Study|Protocol Deviation|0
7550973|NCT02468674|26246494|P3|Overall Study|Protocol Deviation|0
7550974|NCT02468674|26246495|P2|Overall Study|Protocol Deviation|0
7550975|NCT02468674|26246496|P1|Overall Study|Protocol Deviation|0
7550976|NCT02468674|26246488|P9|Overall Study|Patient/Guardian Decision|1
7550977|NCT02468674|26246489|P8|Overall Study|Patient/Guardian Decision|2
7550978|NCT02468674|26246490|P7|Overall Study|Patient/Guardian Decision|0
7550979|NCT02468674|26246491|P6|Overall Study|Patient/Guardian Decision|0
7550980|NCT02468674|26246492|P5|Overall Study|Patient/Guardian Decision|1
7550981|NCT02468674|26246493|P4|Overall Study|Patient/Guardian Decision|0
7550982|NCT02468674|26246494|P3|Overall Study|Patient/Guardian Decision|0
7550983|NCT02468674|26246495|P2|Overall Study|Patient/Guardian Decision|0
7550984|NCT02468674|26246496|P1|Overall Study|Patient/Guardian Decision|0
7550985|NCT02468674|26246488|P9|Overall Study|Physician Decision|0
7550986|NCT02468674|26246489|P8|Overall Study|Physician Decision|0
7550987|NCT02468674|26246490|P7|Overall Study|Physician Decision|1
7550988|NCT02468674|26246491|P6|Overall Study|Physician Decision|0
7550989|NCT02468674|26246492|P5|Overall Study|Physician Decision|0
7550990|NCT02468674|26246493|P4|Overall Study|Physician Decision|0
7550991|NCT02468674|26246494|P3|Overall Study|Physician Decision|0
7550992|NCT02468674|26246495|P2|Overall Study|Physician Decision|0
7550993|NCT02468674|26246496|P1|Overall Study|Physician Decision|0
7550994|NCT02468674|26246488|P9|Overall Study|Lost to Follow-up|1
7550995|NCT02468674|26246489|P8|Overall Study|Lost to Follow-up|1
7550996|NCT02468674|26246490|P7|Overall Study|Lost to Follow-up|0
7550997|NCT02468674|26246491|P6|Overall Study|Lost to Follow-up|0
7550998|NCT02468674|26246492|P5|Overall Study|Lost to Follow-up|0
7550999|NCT02468674|26246493|P4|Overall Study|Lost to Follow-up|0
7551000|NCT02468674|26246494|P3|Overall Study|Lost to Follow-up|0
7551001|NCT02468674|26246495|P2|Overall Study|Lost to Follow-up|0
7551002|NCT02468674|26246496|P1|Overall Study|Lost to Follow-up|1
7551003|NCT02468674|26246488|P9|Overall Study|Adverse Event|0
7551004|NCT02468674|26246489|P8|Overall Study|Adverse Event|0
7551005|NCT02468674|26246490|P7|Overall Study|Adverse Event|0
7551006|NCT02468674|26246491|P6|Overall Study|Adverse Event|1
7551007|NCT02468674|26246492|P5|Overall Study|Adverse Event|0
7551008|NCT02468674|26246493|P4|Overall Study|Adverse Event|1
7551009|NCT02468674|26246494|P3|Overall Study|Adverse Event|0
7551010|NCT02468674|26246495|P2|Overall Study|Adverse Event|0
7551011|NCT02468674|26246496|P1|Overall Study|Adverse Event|0
7551012|NCT02468648|26246552|P1|Overall Study|Death|1
7551013|NCT02468557|26246617|P1|Overall Study|All Enrolled but Never Dosed|4
7551014|NCT02468557|26246617|P1|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
7551015|NCT02468557|26246617|P1|Overall Study|Death|1
7551016|NCT02468557|26246617|P1|Overall Study|Adverse Event|1
7551017|NCT02468414|26246640|P2|Overall Study|Screen Failure|0
7551018|NCT02468414|26246641|P1|Overall Study|Screen Failure|1
7551019|NCT02468414|26246640|P2|Overall Study|Poor in-vitro secreting TARGTs|0
7551020|NCT02468414|26246641|P1|Overall Study|Poor in-vitro secreting TARGTs|1
7551021|NCT02468414|26246640|P2|Overall Study|Early Study Termination by Sponsor|0
7551022|NCT02468414|26246641|P1|Overall Study|Early Study Termination by Sponsor|1
7551023|NCT02468193|26246647|P1|Overall Study|Subject/ Guardian decision|2
7551024|NCT02468193|26246647|P1|Overall Study|Adverse Event|4
7551025|NCT02467270|26246927|P3|Overall Study|Reason not Specified|1
7551026|NCT02467270|26246928|P2|Overall Study|Reason not Specified|2
7551027|NCT02467270|26246929|P1|Overall Study|Reason not Specified|1
7551028|NCT02467270|26246927|P3|Overall Study|Withdrawal by Subject|5
7551029|NCT02467270|26246928|P2|Overall Study|Withdrawal by Subject|3
7551030|NCT02467270|26246929|P1|Overall Study|Withdrawal by Subject|4
7551031|NCT02467270|26246927|P3|Overall Study|Physician Decision|1
7551032|NCT02467270|26246928|P2|Overall Study|Physician Decision|4
7551033|NCT02467270|26246929|P1|Overall Study|Physician Decision|0
7551034|NCT02467270|26246927|P3|Overall Study|Pregnancy|0
7551035|NCT02467270|26246928|P2|Overall Study|Pregnancy|1
7551036|NCT02467270|26246929|P1|Overall Study|Pregnancy|0
7551037|NCT02467270|26246927|P3|Overall Study|Lost to Follow-up|0
7551038|NCT02467270|26246928|P2|Overall Study|Lost to Follow-up|1
7551039|NCT02467270|26246929|P1|Overall Study|Lost to Follow-up|2
7551040|NCT02467270|26246927|P3|Overall Study|Non-compliance With Study Drug|1
7551041|NCT02467270|26246928|P2|Overall Study|Non-compliance With Study Drug|2
7551042|NCT02467270|26246929|P1|Overall Study|Non-compliance With Study Drug|0
7551043|NCT02467270|26246927|P3|Overall Study|Lack of Efficacy|23
7551044|NCT02467270|26246928|P2|Overall Study|Lack of Efficacy|18
7551045|NCT02467270|26246929|P1|Overall Study|Lack of Efficacy|12
7551046|NCT02467270|26246927|P3|Overall Study|Death|2
7551047|NCT02467270|26246928|P2|Overall Study|Death|0
7551048|NCT02467270|26246929|P1|Overall Study|Death|2
7551049|NCT02467270|26246927|P3|Overall Study|Progressive Disease|4
7551050|NCT02467270|26246928|P2|Overall Study|Progressive Disease|7
7551051|NCT02467270|26246929|P1|Overall Study|Progressive Disease|7
7551052|NCT02467270|26246927|P3|Overall Study|Adverse Event|14
7551053|NCT02467270|26246928|P2|Overall Study|Adverse Event|15
7551054|NCT02467270|26246929|P1|Overall Study|Adverse Event|16
7551055|NCT02467270|26246927|P3|Overall Study|Ongoing|43
7551056|NCT02467270|26246928|P2|Overall Study|Ongoing|41
7551057|NCT02467270|26246929|P1|Overall Study|Ongoing|50
7551058|NCT02467270|26246927|P3|Overall Study|Participants Never Treated|0
7551059|NCT02467270|26246928|P2|Overall Study|Participants Never Treated|1
7551060|NCT02467270|26246929|P1|Overall Study|Participants Never Treated|0
7551061|NCT02466659|26247028|P2|Overall Study|Lost to Follow-up|2
7551062|NCT02466659|26247029|P1|Overall Study|Lost to Follow-up|5
7551063|NCT02466555|26247083|P1|Overall Study|Lost to Follow-up|2
7551064|NCT02466516|26247095|P5|Overall Study|Lost to Follow-up|0
7551065|NCT02466516|26247096|P4|Overall Study|Lost to Follow-up|0
7551066|NCT02466516|26247097|P3|Overall Study|Lost to Follow-up|1
7551067|NCT02466516|26247098|P2|Overall Study|Lost to Follow-up|0
7551068|NCT02466516|26247099|P1|Overall Study|Lost to Follow-up|2
7551069|NCT02466516|26247095|P5|Overall Study|Withdrew Consent|0
7551070|NCT02466516|26247096|P4|Overall Study|Withdrew Consent|0
7551071|NCT02466516|26247097|P3|Overall Study|Withdrew Consent|0
7551072|NCT02466516|26247098|P2|Overall Study|Withdrew Consent|0
7551073|NCT02466516|26247099|P1|Overall Study|Withdrew Consent|1
7551074|NCT02466516|26247095|P5|Overall Study|Adverse Event|0
7551075|NCT02466516|26247096|P4|Overall Study|Adverse Event|0
7551076|NCT02466516|26247097|P3|Overall Study|Adverse Event|0
7551077|NCT02466516|26247098|P2|Overall Study|Adverse Event|1
7551078|NCT02466516|26247099|P1|Overall Study|Adverse Event|1
7551079|NCT02466425|26247118|P2|Overall Study|Withdrawal by Parent/Guardian|0
7551080|NCT02466425|26247119|P1|Overall Study|Withdrawal by Parent/Guardian|2
7551081|NCT02466425|26247118|P2|Overall Study|Other|3
7551082|NCT02466425|26247119|P1|Overall Study|Other|1
7551083|NCT02466425|26247118|P2|Overall Study|Withdrawal by Subject|1
7551084|NCT02466425|26247119|P1|Overall Study|Withdrawal by Subject|0
7551085|NCT02466425|26247118|P2|Overall Study|Protocol Violation|0
7551086|NCT02466425|26247119|P1|Overall Study|Protocol Violation|1
7551087|NCT02466425|26247118|P2|Overall Study|Lost to Follow-up|0
7551088|NCT02466425|26247119|P1|Overall Study|Lost to Follow-up|3
7551089|NCT02466425|26247118|P2|Overall Study|Lack of Efficacy|1
7551090|NCT02466425|26247119|P1|Overall Study|Lack of Efficacy|4
7551091|NCT02466425|26247118|P2|Overall Study|Adverse Event|11
7551092|NCT02466425|26247119|P1|Overall Study|Adverse Event|3
7551093|NCT02466399|26247141|P2|Overall Study|Early exit due to family emergency|0
7551094|NCT02466399|26247142|P1|Overall Study|Early exit due to family emergency|1
7551095|NCT02466399|26247141|P2|Overall Study|Adverse Event|0
7551096|NCT02466399|26247142|P1|Overall Study|Adverse Event|1
7551097|NCT02466386|26247148|P1|Overall Study|Other|10
7551098|NCT02466386|26247148|P1|Overall Study|Lack of Efficacy|8
7551099|NCT02466386|26247148|P1|Overall Study|Lost to Follow-up|5
7551100|NCT02466386|26247148|P1|Overall Study|Withdrawal by Subject|14
7551101|NCT02466386|26247148|P1|Overall Study|Protocol Violation|2
7551102|NCT02466386|26247148|P1|Overall Study|Adverse Event|5
7551103|NCT02465931|26247195|P2|Overall Study|Withdrawal by Subject|0
7551104|NCT02465931|26247196|P1|Overall Study|Withdrawal by Subject|1
7551105|NCT02465931|26247195|P2|Overall Study|Protocol Violation|0
7551106|NCT02465931|26247196|P1|Overall Study|Protocol Violation|1
7551107|NCT02465931|26247195|P2|Overall Study|Lost to Follow-up|11
7551108|NCT02465931|26247196|P1|Overall Study|Lost to Follow-up|9
7551109|NCT02465866|26247202|P4|Period 3|Withdrawal by Subject|0
7551110|NCT02465866|26247203|P3|Period 3|Withdrawal by Subject|0
7551111|NCT02465866|26247204|P2|Period 3|Withdrawal by Subject|1
7551112|NCT02465866|26247205|P1|Period 3|Withdrawal by Subject|0
7551113|NCT02465567|26247295|P4|Overall Study|missing PI Signature|0
7551114|NCT02465567|26247296|P3|Overall Study|missing PI Signature|0
7551115|NCT02465567|26247297|P2|Overall Study|missing PI Signature|0
7551116|NCT02465567|26247298|P1|Overall Study|missing PI Signature|1
7551117|NCT02465567|26247295|P4|Overall Study|enrolled in >1 studies|15
7551118|NCT02465567|26247296|P3|Overall Study|enrolled in >1 studies|19
7551119|NCT02465567|26247297|P2|Overall Study|enrolled in >1 studies|11
7551120|NCT02465567|26247298|P1|Overall Study|enrolled in >1 studies|18
7551121|NCT02465567|26247295|P4|Overall Study|Randomized but not treated|5
7551122|NCT02465567|26247296|P3|Overall Study|Randomized but not treated|4
7551123|NCT02465567|26247297|P2|Overall Study|Randomized but not treated|5
7551124|NCT02465567|26247298|P1|Overall Study|Randomized but not treated|1
7551125|NCT02465567|26247295|P4|Overall Study|Administrative Reasons|5
7551126|NCT02465567|26247296|P3|Overall Study|Administrative Reasons|11
7551127|NCT02465567|26247297|P2|Overall Study|Administrative Reasons|9
7551128|NCT02465567|26247298|P1|Overall Study|Administrative Reasons|12
7551129|NCT02465567|26247295|P4|Overall Study|Protocol Specified Criteria|12
7551130|NCT02465567|26247296|P3|Overall Study|Protocol Specified Criteria|9
7551131|NCT02465567|26247297|P2|Overall Study|Protocol Specified Criteria|10
7551132|NCT02465567|26247298|P1|Overall Study|Protocol Specified Criteria|20
7551133|NCT02465567|26247295|P4|Overall Study|Lost to Follow-up|15
7551134|NCT02465567|26247296|P3|Overall Study|Lost to Follow-up|19
7551135|NCT02465567|26247297|P2|Overall Study|Lost to Follow-up|21
7551136|NCT02465567|26247298|P1|Overall Study|Lost to Follow-up|25
7551137|NCT02465567|26247295|P4|Overall Study|Major Protocol Deviation|25
7551138|NCT02465567|26247296|P3|Overall Study|Major Protocol Deviation|22
7551139|NCT02465567|26247297|P2|Overall Study|Major Protocol Deviation|26
7551140|NCT02465567|26247298|P1|Overall Study|Major Protocol Deviation|24
7551141|NCT02465567|26247295|P4|Overall Study|Physician Decision|28
7551142|NCT02465567|26247296|P3|Overall Study|Physician Decision|38
7551143|NCT02465567|26247297|P2|Overall Study|Physician Decision|33
7551144|NCT02465567|26247298|P1|Overall Study|Physician Decision|23
7551145|NCT02465567|26247295|P4|Overall Study|Withdrawal by Subject|130
7551146|NCT02465567|26247296|P3|Overall Study|Withdrawal by Subject|123
7551147|NCT02465567|26247297|P2|Overall Study|Withdrawal by Subject|94
7551148|NCT02465567|26247298|P1|Overall Study|Withdrawal by Subject|104
7551149|NCT02465567|26247295|P4|Overall Study|Lack of Efficacy|135
7551150|NCT02465567|26247296|P3|Overall Study|Lack of Efficacy|171
7551151|NCT02465567|26247297|P2|Overall Study|Lack of Efficacy|102
7551152|NCT02465567|26247298|P1|Overall Study|Lack of Efficacy|103
7551153|NCT02465567|26247295|P4|Overall Study|Adverse Event|138
7551154|NCT02465567|26247296|P3|Overall Study|Adverse Event|147
7551155|NCT02465567|26247297|P2|Overall Study|Adverse Event|113
7551156|NCT02465567|26247298|P1|Overall Study|Adverse Event|118
7551157|NCT02465528|26247332|P4|Overall Study|Physician Decision|0
7551158|NCT02465528|26247333|P3|Overall Study|Physician Decision|1
7551159|NCT02465528|26247334|P2|Overall Study|Physician Decision|0
7551160|NCT02465528|26247335|P1|Overall Study|Physician Decision|0
7551161|NCT02465528|26247332|P4|Overall Study|Adverse Event|1
7551162|NCT02465528|26247333|P3|Overall Study|Adverse Event|0
7551163|NCT02465528|26247334|P2|Overall Study|Adverse Event|0
7551164|NCT02465528|26247335|P1|Overall Study|Adverse Event|0
7551165|NCT02465528|26247332|P4|Overall Study|Withdrawal by Subject|0
7551166|NCT02465528|26247333|P3|Overall Study|Withdrawal by Subject|2
7551167|NCT02465528|26247334|P2|Overall Study|Withdrawal by Subject|0
7551168|NCT02465528|26247335|P1|Overall Study|Withdrawal by Subject|0
7551169|NCT02465528|26247332|P4|Overall Study|Study terminated by sponsor|0
7551170|NCT02465528|26247333|P3|Overall Study|Study terminated by sponsor|0
7551171|NCT02465528|26247334|P2|Overall Study|Study terminated by sponsor|2
7551172|NCT02465528|26247335|P1|Overall Study|Study terminated by sponsor|1
7551173|NCT02465528|26247332|P4|Overall Study|Progressive disease|4
7551174|NCT02465528|26247333|P3|Overall Study|Progressive disease|9
7551175|NCT02465528|26247334|P2|Overall Study|Progressive disease|2
7551176|NCT02465528|26247335|P1|Overall Study|Progressive disease|0
7551177|NCT02465515|26247368|P2|Overall Study|Lost to Follow-up|51
7551178|NCT02465515|26247369|P1|Overall Study|Lost to Follow-up|68
7551179|NCT02465515|26247368|P2|Overall Study|Physician Decision|12
7551180|NCT02465515|26247369|P1|Overall Study|Physician Decision|8
7551181|NCT02465515|26247368|P2|Overall Study|Withdrawal by Subject|43
7551182|NCT02465515|26247369|P1|Overall Study|Withdrawal by Subject|74
7551183|NCT02465515|26247368|P2|Overall Study|Investigator site closed|5
7551184|NCT02465515|26247369|P1|Overall Study|Investigator site closed|4
7551185|NCT02465489|26247415|P1|Overall Study|Adverse Event|5
7551186|NCT02465463|26247444|P2|Overall Study|Protocol Violation|0
7551187|NCT02465463|26247445|P1|Overall Study|Protocol Violation|1
7551188|NCT02465463|26247444|P2|Overall Study|Death|0
7551189|NCT02465463|26247445|P1|Overall Study|Death|1
7551190|NCT02465463|26247444|P2|Overall Study|Lost to Follow-up|1
7551191|NCT02465463|26247445|P1|Overall Study|Lost to Follow-up|2
7551192|NCT02465437|26247493|P4|Overall Study|Adverse Event|0
7551193|NCT02465437|26247494|P3|Overall Study|Adverse Event|0
7551194|NCT02465437|26247495|P2|Overall Study|Adverse Event|1
7551195|NCT02465437|26247496|P1|Overall Study|Adverse Event|0
7551196|NCT02465437|26247493|P4|Overall Study|Withdrawal by Subject|1
7551197|NCT02465437|26247494|P3|Overall Study|Withdrawal by Subject|0
7551198|NCT02465437|26247495|P2|Overall Study|Withdrawal by Subject|0
7551199|NCT02465437|26247496|P1|Overall Study|Withdrawal by Subject|1
7551200|NCT02465437|26247493|P4|Overall Study|Physician Decision|0
7551201|NCT02465437|26247494|P3|Overall Study|Physician Decision|1
7551202|NCT02465437|26247495|P2|Overall Study|Physician Decision|0
7551203|NCT02465437|26247496|P1|Overall Study|Physician Decision|0
7551204|NCT02465203|26247556|P3|Overall Study|Patient/guardian decision|1
7551205|NCT02465203|26247557|P2|Overall Study|Patient/guardian decision|1
7551206|NCT02465203|26247558|P1|Overall Study|Patient/guardian decision|1
7551207|NCT02465203|26247556|P3|Overall Study|New therapy for study indication|0
7551208|NCT02465203|26247557|P2|Overall Study|New therapy for study indication|0
7551209|NCT02465203|26247558|P1|Overall Study|New therapy for study indication|4
7551210|NCT02465203|26247556|P3|Overall Study|Study terminated by sponsor|11
7551211|NCT02465203|26247557|P2|Overall Study|Study terminated by sponsor|34
7551212|NCT02465203|26247558|P1|Overall Study|Study terminated by sponsor|50
7551213|NCT02465203|26247556|P3|Overall Study|Protocol Violation|1
7551214|NCT02465203|26247557|P2|Overall Study|Protocol Violation|1
7551215|NCT02465203|26247558|P1|Overall Study|Protocol Violation|1
7551216|NCT02464059|26247708|P1|Overall Study|Lost to Follow-up|6
7551217|NCT02463409|26247810|P1|Overall Study|Screen failure|1
7551218|NCT02463409|26247810|P1|Overall Study|Withdrawal by Subject|1
7551219|NCT02463357|26247821|P5|Overall Study|Withdrawal by Subject|1
7551220|NCT02463357|26247822|P4|Overall Study|Withdrawal by Subject|0
7551221|NCT02463357|26247823|P3|Overall Study|Withdrawal by Subject|0
7551222|NCT02463357|26247824|P2|Overall Study|Withdrawal by Subject|0
7551223|NCT02463357|26247825|P1|Overall Study|Withdrawal by Subject|0
7551224|NCT02463357|26247821|P5|Overall Study|Withdrawal by Subject|0
7551225|NCT02463357|26247822|P4|Overall Study|Withdrawal by Subject|0
7551226|NCT02463357|26247823|P3|Overall Study|Withdrawal by Subject|0
7551227|NCT02463357|26247824|P2|Overall Study|Withdrawal by Subject|0
7551228|NCT02463357|26247825|P1|Overall Study|Withdrawal by Subject|1
7551229|NCT02463331|26247859|P2|Overall Study|Physician Decision|0
7551230|NCT02463331|26247860|P1|Overall Study|Physician Decision|3
7551231|NCT02463331|26247859|P2|Overall Study|Lack of Efficacy|0
7551232|NCT02463331|26247860|P1|Overall Study|Lack of Efficacy|6
7551233|NCT02463331|26247859|P2|Overall Study|Pregnancy|3
7551234|NCT02463331|26247860|P1|Overall Study|Pregnancy|2
7551235|NCT02463331|26247859|P2|Overall Study|Lost to Follow-up|1
7551236|NCT02463331|26247860|P1|Overall Study|Lost to Follow-up|1
7551237|NCT02463331|26247859|P2|Overall Study|Adverse Event|2
7551238|NCT02463331|26247860|P1|Overall Study|Adverse Event|4
7551239|NCT02463097|26247876|P1|Overall Study|Withdrawal by Subject|1
7551240|NCT02463071|26247885|P3|Overall Study|Lost to Follow-up|1
7551241|NCT02463071|26247886|P2|Overall Study|Lost to Follow-up|0
7551242|NCT02463071|26247887|P1|Overall Study|Lost to Follow-up|0
7551243|NCT02463071|26247885|P3|Overall Study|Protocol Violation|0
7551244|NCT02463071|26247886|P2|Overall Study|Protocol Violation|2
7551245|NCT02463071|26247887|P1|Overall Study|Protocol Violation|0
7551246|NCT02463071|26247885|P3|Overall Study|Reason not specified|4
7551247|NCT02463071|26247886|P2|Overall Study|Reason not specified|9
7551248|NCT02463071|26247887|P1|Overall Study|Reason not specified|7
7551249|NCT02463071|26247885|P3|Overall Study|Eligibility criteria not fulfilled|0
7551250|NCT02463071|26247886|P2|Overall Study|Eligibility criteria not fulfilled|0
7551251|NCT02463071|26247887|P1|Overall Study|Eligibility criteria not fulfilled|1
7551252|NCT02463071|26247885|P3|Overall Study|Death|0
7551253|NCT02463071|26247886|P2|Overall Study|Death|0
7551254|NCT02463071|26247887|P1|Overall Study|Death|1
7551255|NCT02463071|26247885|P3|Overall Study|Adverse Event|1
7551256|NCT02463071|26247886|P2|Overall Study|Adverse Event|5
7551257|NCT02463071|26247887|P1|Overall Study|Adverse Event|3
7551258|NCT02463032|26247915|P2|Overall Study|Adverse Event|6
7551259|NCT02463032|26247916|P1|Overall Study|Adverse Event|2
7551260|NCT02463032|26247915|P2|Overall Study|Death|8
7551261|NCT02463032|26247916|P1|Overall Study|Death|8
7551262|NCT02463032|26247915|P2|Overall Study|Lack of Efficacy|50
7551263|NCT02463032|26247916|P1|Overall Study|Lack of Efficacy|61
7551264|NCT02462928|26247968|P3|Overall Study|Reason not Specified|5
7551265|NCT02462928|26247969|P2|Overall Study|Reason not Specified|6
7551266|NCT02462928|26247970|P1|Overall Study|Reason not Specified|4
7551267|NCT02462928|26247968|P3|Overall Study|Protocol Violation|0
7551268|NCT02462928|26247969|P2|Overall Study|Protocol Violation|1
7551269|NCT02462928|26247970|P1|Overall Study|Protocol Violation|0
7551270|NCT02462928|26247968|P3|Overall Study|Withdrawal by Patient|21
7551271|NCT02462928|26247969|P2|Overall Study|Withdrawal by Patient|21
7551272|NCT02462928|26247970|P1|Overall Study|Withdrawal by Patient|31
7551273|NCT02462928|26247968|P3|Overall Study|Lost to Follow-up|1
7551274|NCT02462928|26247969|P2|Overall Study|Lost to Follow-up|4
7551275|NCT02462928|26247970|P1|Overall Study|Lost to Follow-up|4
7551276|NCT02462928|26247968|P3|Overall Study|Lack of Efficacy|3
7551277|NCT02462928|26247969|P2|Overall Study|Lack of Efficacy|8
7551278|NCT02462928|26247970|P1|Overall Study|Lack of Efficacy|3
7551279|NCT02462928|26247968|P3|Overall Study|Adverse Event|25
7551280|NCT02462928|26247969|P2|Overall Study|Adverse Event|51
7551281|NCT02462928|26247970|P1|Overall Study|Adverse Event|47
7551282|NCT02462928|26247968|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|2
7551283|NCT02462928|26247969|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7551284|NCT02462928|26247970|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7551285|NCT02462876|26247990|P1|Overall Study|Ongoing|10
7551286|NCT02462876|26247990|P1|Overall Study|Other|6
7551287|NCT02462876|26247990|P1|Overall Study|Amputation Above the Metatarsals|1
7551288|NCT02462876|26247990|P1|Overall Study|Surgical Bypass|9
7551289|NCT02462876|26247990|P1|Overall Study|Lost to Follow-up|4
7551290|NCT02462876|26247990|P1|Overall Study|Death|3
7551291|NCT02462759|26248000|P3|Part 1: Double Blind|Death|0
7551292|NCT02462759|26248001|P2|Part 1: Double Blind|Death|0
7551293|NCT02462759|26248002|P1|Part 1: Double Blind|Death|1
7551294|NCT02462720|26248050|P2|Part 2|Protocol Violation|1
7551295|NCT02462720|26248051|P1|Part 2|Protocol Violation|0
7551296|NCT02462720|26248050|P2|Part 2|Withdrawal by Subject|0
7551297|NCT02462720|26248051|P1|Part 2|Withdrawal by Subject|1
7551298|NCT02462486|26248064|P3|Overall Study|Reason not Specified|3
7551299|NCT02462486|26248065|P2|Overall Study|Reason not Specified|4
7551300|NCT02462486|26248066|P1|Overall Study|Reason not Specified|3
7551301|NCT02462486|26248064|P3|Overall Study|Protocol Violation|1
7551302|NCT02462486|26248065|P2|Overall Study|Protocol Violation|1
7551303|NCT02462486|26248066|P1|Overall Study|Protocol Violation|3
7551304|NCT02462486|26248064|P3|Overall Study|Withdrawal by Subject|19
7551305|NCT02462486|26248065|P2|Overall Study|Withdrawal by Subject|22
7551306|NCT02462486|26248066|P1|Overall Study|Withdrawal by Subject|25
7551307|NCT02462486|26248064|P3|Overall Study|Lost to Follow-up|2
7551308|NCT02462486|26248065|P2|Overall Study|Lost to Follow-up|4
7551309|NCT02462486|26248066|P1|Overall Study|Lost to Follow-up|3
7551310|NCT02462486|26248064|P3|Overall Study|Lack of Efficacy|3
7551311|NCT02462486|26248065|P2|Overall Study|Lack of Efficacy|12
7551312|NCT02462486|26248066|P1|Overall Study|Lack of Efficacy|6
7551313|NCT02462486|26248064|P3|Overall Study|Adverse Event|21
7551314|NCT02462486|26248065|P2|Overall Study|Adverse Event|48
7551315|NCT02462486|26248066|P1|Overall Study|Adverse Event|53
7551316|NCT02462486|26248064|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|3
7551317|NCT02462486|26248065|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7551318|NCT02462486|26248066|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7551319|NCT02462473|26248086|P1|Overall Study|Other|3
7551320|NCT02462473|26248086|P1|Overall Study|Death|1
7551321|NCT02462083|26248192|P1|Overall Study|Other than specified|45
7551322|NCT02462083|26248192|P1|Overall Study|Worsening condition|16
7551323|NCT02462083|26248192|P1|Overall Study|Adverse Event|33
7551324|NCT02462083|26248192|P1|Overall Study|Protocol Violation|6
7551325|NCT02462083|26248192|P1|Overall Study|Pregnancy|1
7551326|NCT02462083|26248192|P1|Overall Study|Lack of Efficacy|151
7551327|NCT02462083|26248192|P1|Overall Study|Lost to Follow-up|41
7551328|NCT02462083|26248192|P1|Overall Study|Withdrawal by Subject|87
7551329|NCT02462083|26248192|P1|Overall Study|Sponsor request|39
7551330|NCT02462057|26248212|P5|Overall Study|Joined HealthyFood Before Intervention|17
7551331|NCT02462057|26248213|P4|Overall Study|Joined HealthyFood Before Intervention|16
7551332|NCT02462057|26248214|P3|Overall Study|Joined HealthyFood Before Intervention|23
7551333|NCT02462057|26248215|P2|Overall Study|Joined HealthyFood Before Intervention|13
7551334|NCT02462057|26248216|P1|Overall Study|Joined HealthyFood Before Intervention|22
7551335|NCT02462057|26248212|P5|Overall Study|Left Vitality|33
7551336|NCT02462057|26248213|P4|Overall Study|Left Vitality|35
7551337|NCT02462057|26248214|P3|Overall Study|Left Vitality|23
7551338|NCT02462057|26248215|P2|Overall Study|Left Vitality|27
7551339|NCT02462057|26248216|P1|Overall Study|Left Vitality|32
7551340|NCT02461758|26248302|P4|Overall Study|Lost to Follow-up|0
7551341|NCT02461758|26248303|P3|Overall Study|Lost to Follow-up|1
7551342|NCT02461758|26248304|P2|Overall Study|Lost to Follow-up|1
7551343|NCT02461758|26248305|P1|Overall Study|Lost to Follow-up|0
7551344|NCT02461745|26248331|P2|Overall Study|Withdrawal by Subject|1
7551345|NCT02461745|26248332|P1|Overall Study|Withdrawal by Subject|3
7551346|NCT02461745|26248331|P2|Overall Study|Lost to Follow-up|2
7551347|NCT02461745|26248332|P1|Overall Study|Lost to Follow-up|2
7551348|NCT02461745|26248331|P2|Overall Study|Lack of Efficacy|1
7551349|NCT02461745|26248332|P1|Overall Study|Lack of Efficacy|9
7551350|NCT02461628|26248357|P2|Overall Study|Refused to complete survey|7
7551351|NCT02461628|26248358|P1|Overall Study|Refused to complete survey|4
7551352|NCT02461589|26248382|P10|Overall Study|Withdrawal from trial before exposure|1
7551353|NCT02461589|26248383|P9|Overall Study|Withdrawal from trial before exposure|0
7551354|NCT02461589|26248384|P8|Overall Study|Withdrawal from trial before exposure|0
7551355|NCT02461589|26248385|P7|Overall Study|Withdrawal from trial before exposure|0
7551356|NCT02461589|26248386|P6|Overall Study|Withdrawal from trial before exposure|0
7551357|NCT02461589|26248387|P5|Overall Study|Withdrawal from trial before exposure|0
7551358|NCT02461589|26248388|P4|Overall Study|Withdrawal from trial before exposure|0
7551359|NCT02461589|26248389|P3|Overall Study|Withdrawal from trial before exposure|0
7551360|NCT02461589|26248390|P2|Overall Study|Withdrawal from trial before exposure|0
7551361|NCT02461589|26248391|P1|Overall Study|Withdrawal from trial before exposure|0
7551362|NCT02461589|26248382|P10|Overall Study|Missing follow-up information|0
7551363|NCT02461589|26248383|P9|Overall Study|Missing follow-up information|0
7551364|NCT02461589|26248384|P8|Overall Study|Missing follow-up information|0
7551365|NCT02461589|26248385|P7|Overall Study|Missing follow-up information|1
7551366|NCT02461589|26248386|P6|Overall Study|Missing follow-up information|0
7551367|NCT02461589|26248387|P5|Overall Study|Missing follow-up information|0
7551368|NCT02461589|26248388|P4|Overall Study|Missing follow-up information|0
7551369|NCT02461589|26248389|P3|Overall Study|Missing follow-up information|0
7551370|NCT02461589|26248390|P2|Overall Study|Missing follow-up information|1
7551371|NCT02461589|26248391|P1|Overall Study|Missing follow-up information|1
7551372|NCT02461589|26248382|P10|Overall Study|Unclassified|2
7551373|NCT02461589|26248383|P9|Overall Study|Unclassified|0
7551374|NCT02461589|26248384|P8|Overall Study|Unclassified|0
7551375|NCT02461589|26248385|P7|Overall Study|Unclassified|1
7551376|NCT02461589|26248386|P6|Overall Study|Unclassified|0
7551377|NCT02461589|26248387|P5|Overall Study|Unclassified|0
7551378|NCT02461589|26248388|P4|Overall Study|Unclassified|0
7551379|NCT02461589|26248389|P3|Overall Study|Unclassified|0
7551380|NCT02461589|26248390|P2|Overall Study|Unclassified|0
7551381|NCT02461589|26248391|P1|Overall Study|Unclassified|0
7551382|NCT02461589|26248382|P10|Overall Study|Death|0
7551383|NCT02461589|26248383|P9|Overall Study|Death|0
7551384|NCT02461589|26248384|P8|Overall Study|Death|1
7551385|NCT02461589|26248385|P7|Overall Study|Death|0
7551386|NCT02461589|26248386|P6|Overall Study|Death|0
7551387|NCT02461589|26248387|P5|Overall Study|Death|0
7551388|NCT02461589|26248388|P4|Overall Study|Death|0
7551389|NCT02461589|26248389|P3|Overall Study|Death|0
7551390|NCT02461589|26248390|P2|Overall Study|Death|0
7551391|NCT02461589|26248391|P1|Overall Study|Death|0
7551392|NCT02461589|26248382|P10|Overall Study|Lost to Follow-up|1
7551393|NCT02461589|26248383|P9|Overall Study|Lost to Follow-up|3
7551394|NCT02461589|26248384|P8|Overall Study|Lost to Follow-up|1
7551395|NCT02461589|26248385|P7|Overall Study|Lost to Follow-up|3
7551396|NCT02461589|26248386|P6|Overall Study|Lost to Follow-up|1
7551397|NCT02461589|26248387|P5|Overall Study|Lost to Follow-up|1
7551398|NCT02461589|26248388|P4|Overall Study|Lost to Follow-up|3
7551399|NCT02461589|26248389|P3|Overall Study|Lost to Follow-up|2
7551400|NCT02461589|26248390|P2|Overall Study|Lost to Follow-up|0
7551401|NCT02461589|26248391|P1|Overall Study|Lost to Follow-up|0
7551402|NCT02461589|26248382|P10|Overall Study|Withdrawal by Subject|1
7551403|NCT02461589|26248383|P9|Overall Study|Withdrawal by Subject|3
7551404|NCT02461589|26248384|P8|Overall Study|Withdrawal by Subject|3
7551405|NCT02461589|26248385|P7|Overall Study|Withdrawal by Subject|1
7551406|NCT02461589|26248386|P6|Overall Study|Withdrawal by Subject|2
7551407|NCT02461589|26248387|P5|Overall Study|Withdrawal by Subject|1
7551408|NCT02461589|26248388|P4|Overall Study|Withdrawal by Subject|2
7551409|NCT02461589|26248389|P3|Overall Study|Withdrawal by Subject|3
7551410|NCT02461589|26248390|P2|Overall Study|Withdrawal by Subject|1
7551411|NCT02461589|26248391|P1|Overall Study|Withdrawal by Subject|5
7551412|NCT02461290|26248524|P1|Overall Study|Lost to Follow-up|3
7551413|NCT02461290|26248524|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
7551414|NCT02461160|26248544|P13|Overall Study|Lost to Follow-up|0
7551415|NCT02461160|26248545|P12|Overall Study|Lost to Follow-up|0
7551416|NCT02461160|26248546|P11|Overall Study|Lost to Follow-up|0
7551417|NCT02461160|26248547|P10|Overall Study|Lost to Follow-up|0
7551418|NCT02461160|26248548|P9|Overall Study|Lost to Follow-up|0
7551419|NCT02461160|26248549|P8|Overall Study|Lost to Follow-up|1
7551420|NCT02461160|26248550|P7|Overall Study|Lost to Follow-up|0
7551421|NCT02461160|26248551|P6|Overall Study|Lost to Follow-up|0
7551422|NCT02461160|26248552|P5|Overall Study|Lost to Follow-up|0
7551423|NCT02461160|26248553|P4|Overall Study|Lost to Follow-up|0
7551424|NCT02461160|26248554|P3|Overall Study|Lost to Follow-up|0
7551425|NCT02461160|26248555|P2|Overall Study|Lost to Follow-up|0
7551426|NCT02461160|26248556|P1|Overall Study|Lost to Follow-up|0
7551427|NCT02461134|26248767|P1|Overall Study|Adverse Event|1
7551428|NCT02460991|26248775|P2|Overall Study|Withdrawal by Subject|2
7551429|NCT02460991|26248776|P1|Overall Study|Withdrawal by Subject|0
7551430|NCT02460978|26248793|P3|Overall Study|Pregnancy|2
7551431|NCT02460978|26248794|P2|Overall Study|Pregnancy|0
7551432|NCT02460978|26248795|P1|Overall Study|Pregnancy|0
7551433|NCT02460978|26248793|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
7551434|NCT02460978|26248794|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
7551435|NCT02460978|26248795|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
7551436|NCT02460978|26248793|P3|Overall Study|Protocol Violation|1
7551437|NCT02460978|26248794|P2|Overall Study|Protocol Violation|1
7551438|NCT02460978|26248795|P1|Overall Study|Protocol Violation|1
7551439|NCT02460978|26248793|P3|Overall Study|Lost to Follow-up|1
7551440|NCT02460978|26248794|P2|Overall Study|Lost to Follow-up|3
7551441|NCT02460978|26248795|P1|Overall Study|Lost to Follow-up|2
7551442|NCT02460978|26248793|P3|Overall Study|Withdrawal by Subject|14
7551443|NCT02460978|26248794|P2|Overall Study|Withdrawal by Subject|5
7551444|NCT02460978|26248795|P1|Overall Study|Withdrawal by Subject|5
7551445|NCT02460978|26248793|P3|Overall Study|Adverse Event|11
7551446|NCT02460978|26248794|P2|Overall Study|Adverse Event|11
7551447|NCT02460978|26248795|P1|Overall Study|Adverse Event|17
7551448|NCT02460822|26248821|P1|Overall Study|Withdrawal by Subject|1
7551449|NCT02460679|26248830|P1|Overall Study|Withdrawal by Subject|4
7551450|NCT02460679|26248830|P1|Overall Study|Investigator Decision|1
7551451|NCT02460575|26248872|P2|Overall Study|Lost to Follow-up|0
7551452|NCT02460575|26248873|P1|Overall Study|Lost to Follow-up|1
7551453|NCT02460562|26248883|P2|Overall Study|Lost to Follow-up|16
7551454|NCT02460562|26248884|P1|Overall Study|Lost to Follow-up|15
7551455|NCT02460458|26248892|P1|Confirmation of Clinical Phase Data|Lost to Follow-up|9
7551456|NCT02460458|26248892|P1|First Prospective Phase|Lost to Follow-up|16
7551457|NCT02460458|26248892|P1|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
7551458|NCT02460458|26248892|P1|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
7551459|NCT02460458|26248892|P1|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
7551460|NCT02460380|26248908|P2|Overall Study|Withdrawal by Subject|5
7551461|NCT02460380|26248909|P1|Overall Study|Withdrawal by Subject|10
7551462|NCT02460263|26248929|P1|Transition Period|Death|1
7551463|NCT02460263|26248929|P1|Transition Period|Withdrawal by Subject|1
7551464|NCT02460198|26248942|P2|Overall Study|Ongoing|30
7551465|NCT02460198|26248943|P1|Overall Study|Ongoing|25
7551466|NCT02460198|26248942|P2|Overall Study|Withdrawal by Subject|4
7551467|NCT02460198|26248943|P1|Overall Study|Withdrawal by Subject|2
7551468|NCT02460198|26248942|P2|Overall Study|Lost to Follow-up|1
7551469|NCT02460198|26248943|P1|Overall Study|Lost to Follow-up|1
7551470|NCT02460198|26248942|P2|Overall Study|Death|25
7551471|NCT02460198|26248943|P1|Overall Study|Death|32
7551472|NCT02460198|26248942|P2|Overall Study|Adverse Event|3
7551473|NCT02460198|26248943|P1|Overall Study|Adverse Event|1
7551474|NCT02460159|26248977|P2|Overall Study|Withdrawal by Subject|0
7551475|NCT02460159|26248978|P1|Overall Study|Withdrawal by Subject|2
7551476|NCT02460159|26248977|P2|Overall Study|Adverse Event|1
7551477|NCT02460159|26248978|P1|Overall Study|Adverse Event|4
7551478|NCT02459964|26249009|P3|Overall Study|Abnormal EKG changes|1
7551479|NCT02459964|26249010|P2|Overall Study|Abnormal EKG changes|0
7551480|NCT02459964|26249011|P1|Overall Study|Abnormal EKG changes|0
7551481|NCT02459964|26249009|P3|Overall Study|Withdrawal by Subject|1
7551482|NCT02459964|26249010|P2|Overall Study|Withdrawal by Subject|0
7551483|NCT02459964|26249011|P1|Overall Study|Withdrawal by Subject|0
7551484|NCT02459951|26249020|P1|Overall Study|Unable to meet holding requirement|1
7551485|NCT02459899|26249031|P4|Overall Study|Withdrawal by Subject|0
7551486|NCT02459899|26249032|P3|Overall Study|Withdrawal by Subject|0
7551487|NCT02459899|26249033|P2|Overall Study|Withdrawal by Subject|3
7551488|NCT02459899|26249034|P1|Overall Study|Withdrawal by Subject|1
7551489|NCT02459899|26249031|P4|Overall Study|Non-compliance with the treatment|1
7551490|NCT02459899|26249032|P3|Overall Study|Non-compliance with the treatment|0
7551491|NCT02459899|26249033|P2|Overall Study|Non-compliance with the treatment|0
7551492|NCT02459899|26249034|P1|Overall Study|Non-compliance with the treatment|0
7551493|NCT02459899|26249031|P4|Overall Study|Lost to Follow-up|1
7551494|NCT02459899|26249032|P3|Overall Study|Lost to Follow-up|0
7551495|NCT02459899|26249033|P2|Overall Study|Lost to Follow-up|2
7551496|NCT02459899|26249034|P1|Overall Study|Lost to Follow-up|1
7551497|NCT02459899|26249031|P4|Overall Study|Adverse Event|0
7551498|NCT02459899|26249032|P3|Overall Study|Adverse Event|0
7551499|NCT02459899|26249033|P2|Overall Study|Adverse Event|1
7551500|NCT02459899|26249034|P1|Overall Study|Adverse Event|1
7551501|NCT02459665|26249081|P4|Overall Study|Withdrawal by Subject|2
7551502|NCT02459665|26249082|P3|Overall Study|Withdrawal by Subject|1
7551503|NCT02459665|26249083|P2|Overall Study|Withdrawal by Subject|1
7551504|NCT02459665|26249084|P1|Overall Study|Withdrawal by Subject|0
7551505|NCT02459587|26249115|P2|12-month Follow-up Assessment|Researcher withdrew|1
7551506|NCT02459587|26249116|P1|12-month Follow-up Assessment|Researcher withdrew|0
7551507|NCT02459587|26249115|P2|12-month Follow-up Assessment|Lost to Follow-up|22
7551508|NCT02459587|26249116|P1|12-month Follow-up Assessment|Lost to Follow-up|18
7551509|NCT02459587|26249115|P2|12-month Follow-up Assessment|Withdrawal by Subject|4
7551510|NCT02459587|26249116|P1|12-month Follow-up Assessment|Withdrawal by Subject|2
7551511|NCT02459587|26249115|P2|12-month Follow-up Assessment|Death|0
7551512|NCT02459587|26249116|P1|12-month Follow-up Assessment|Death|2
7551513|NCT02459587|26249115|P2|6-month Follow-up Assessment|Lost to Follow-up|22
7551514|NCT02459587|26249116|P1|6-month Follow-up Assessment|Lost to Follow-up|21
7551515|NCT02459587|26249115|P2|6-month Follow-up Assessment|Withdrawal by Subject|2
7551516|NCT02459587|26249116|P1|6-month Follow-up Assessment|Withdrawal by Subject|1
7551517|NCT02459587|26249115|P2|6-month Follow-up Assessment|Death|1
7551518|NCT02459587|26249116|P1|6-month Follow-up Assessment|Death|2
7551519|NCT02459587|26249115|P2|3-Month Follow-up Assessment|Researcher withdrew|4
7551520|NCT02459587|26249116|P1|3-Month Follow-up Assessment|Researcher withdrew|2
7551521|NCT02459587|26249115|P2|3-Month Follow-up Assessment|Lost to Follow-up|22
7551522|NCT02459587|26249116|P1|3-Month Follow-up Assessment|Lost to Follow-up|27
7551523|NCT02459587|26249115|P2|3-Month Follow-up Assessment|Withdrawal by Subject|3
7551524|NCT02459587|26249116|P1|3-Month Follow-up Assessment|Withdrawal by Subject|3
7551525|NCT02459587|26249115|P2|3-Month Follow-up Assessment|Death|2
7551526|NCT02459587|26249116|P1|3-Month Follow-up Assessment|Death|0
7551527|NCT02459418|26249128|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
7551528|NCT02459418|26249129|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
7551529|NCT02459418|26249128|P2|Overall Study|Elevated Creatine Kinase|0
7551530|NCT02459418|26249129|P1|Overall Study|Elevated Creatine Kinase|1
7551531|NCT02459418|26249128|P2|Overall Study|Withdrawal by Subject|1
7551532|NCT02459418|26249129|P1|Overall Study|Withdrawal by Subject|1
7551533|NCT02459418|26249128|P2|Overall Study|Adverse Event|1
7551534|NCT02459418|26249129|P1|Overall Study|Adverse Event|0
7551535|NCT02459418|26249128|P2|Overall Study|Endometrial thickness of >5 mm|0
7551536|NCT02459418|26249129|P1|Overall Study|Endometrial thickness of >5 mm|1
7551537|NCT02459418|26249128|P2|Overall Study|Physician Decision|2
7551538|NCT02459418|26249129|P1|Overall Study|Physician Decision|0
7551539|NCT02459418|26249128|P2|Overall Study|Protocol Violation|2
7551540|NCT02459418|26249129|P1|Overall Study|Protocol Violation|0
7551541|NCT02459418|26249128|P2|Overall Study|Exclusion Criteria|0
7551542|NCT02459418|26249129|P1|Overall Study|Exclusion Criteria|4
7551543|NCT02459262|26249179|P11|Overall Study|Withdrawal by Subject|0
7551544|NCT02459262|26249180|P10|Overall Study|Withdrawal by Subject|1
7551545|NCT02459262|26249181|P9|Overall Study|Withdrawal by Subject|0
7551546|NCT02459262|26249182|P8|Overall Study|Withdrawal by Subject|0
7551547|NCT02459262|26249183|P7|Overall Study|Withdrawal by Subject|0
7551548|NCT02459262|26249184|P6|Overall Study|Withdrawal by Subject|0
7551549|NCT02459262|26249185|P5|Overall Study|Withdrawal by Subject|0
7551550|NCT02459262|26249186|P4|Overall Study|Withdrawal by Subject|0
7551551|NCT02459262|26249187|P3|Overall Study|Withdrawal by Subject|0
7551552|NCT02459262|26249188|P2|Overall Study|Withdrawal by Subject|0
7551553|NCT02459262|26249189|P1|Overall Study|Withdrawal by Subject|0
7551554|NCT02459093|26249259|P2|Overall Study|Lost to Follow-up|7
7551555|NCT02459093|26249260|P1|Overall Study|Lost to Follow-up|6
7551556|NCT02459093|26249259|P2|Overall Study|Protocol Violation|11
7551557|NCT02459093|26249260|P1|Overall Study|Protocol Violation|6
7551558|NCT02458638|26249314|P1|Overall Study|Withdrawal by Subject|47
7551559|NCT02458638|26249314|P1|Overall Study|Physician Decision|1
7551560|NCT02458638|26249314|P1|Overall Study|Other Reasons|4
7551561|NCT02458638|26249314|P1|Overall Study|Lost to Follow-up|31
7551562|NCT02458638|26249314|P1|Overall Study|End of Cohort/End of Study|67
7551563|NCT02458638|26249314|P1|Overall Study|Death|309
7551564|NCT02458469|26249334|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
7551565|NCT02458469|26249335|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7551566|NCT02458469|26249336|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7551567|NCT02458469|26249337|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7551568|NCT02458469|26249338|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7551569|NCT02458469|26249339|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7551570|NCT02458469|26249334|P6|First Intervention (2 Weeks)|Physician Decision|0
7551571|NCT02458469|26249335|P5|First Intervention (2 Weeks)|Physician Decision|0
7551572|NCT02458469|26249336|P4|First Intervention (2 Weeks)|Physician Decision|0
7551573|NCT02458469|26249337|P3|First Intervention (2 Weeks)|Physician Decision|0
7551574|NCT02458469|26249338|P2|First Intervention (2 Weeks)|Physician Decision|0
7551575|NCT02458469|26249339|P1|First Intervention (2 Weeks)|Physician Decision|1
7551576|NCT02458469|26249334|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
7551577|NCT02458469|26249335|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
7551578|NCT02458469|26249336|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
7551579|NCT02458469|26249337|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
7551580|NCT02458469|26249338|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
7551581|NCT02458469|26249339|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
7551582|NCT02458287|26249385|P4|Overall Study|Relocated Out of State|1
7551583|NCT02458287|26249386|P3|Overall Study|Relocated Out of State|0
7551584|NCT02458287|26249387|P2|Overall Study|Relocated Out of State|0
7551585|NCT02458287|26249388|P1|Overall Study|Relocated Out of State|0
7551586|NCT02458287|26249385|P4|Overall Study|Withdrawal by Subject|1
7551587|NCT02458287|26249386|P3|Overall Study|Withdrawal by Subject|2
7551588|NCT02458287|26249387|P2|Overall Study|Withdrawal by Subject|2
7551589|NCT02458287|26249388|P1|Overall Study|Withdrawal by Subject|0
7551590|NCT02458287|26249385|P4|Overall Study|Protocol Violation|0
7551591|NCT02458287|26249386|P3|Overall Study|Protocol Violation|0
7551592|NCT02458287|26249387|P2|Overall Study|Protocol Violation|1
7551593|NCT02458287|26249388|P1|Overall Study|Protocol Violation|0
7551594|NCT02458287|26249385|P4|Overall Study|Lost to Follow-up|0
7551595|NCT02458287|26249386|P3|Overall Study|Lost to Follow-up|1
7551596|NCT02458287|26249387|P2|Overall Study|Lost to Follow-up|1
7551597|NCT02458287|26249388|P1|Overall Study|Lost to Follow-up|0
7551598|NCT02458287|26249385|P4|Overall Study|Adverse Event|1
7551599|NCT02458287|26249386|P3|Overall Study|Adverse Event|0
7551600|NCT02458287|26249387|P2|Overall Study|Adverse Event|0
7551601|NCT02458287|26249388|P1|Overall Study|Adverse Event|0
7551602|NCT02458092|26249446|P2|Overall Study|Withdrawal by Subject|0
7551603|NCT02458092|26249447|P1|Overall Study|Withdrawal by Subject|1
7551604|NCT02457910|26249465|P6|Overall Study|Death|0
7551605|NCT02457910|26249466|P5|Overall Study|Death|0
7551606|NCT02457910|26249467|P4|Overall Study|Death|0
7551607|NCT02457910|26249468|P3|Overall Study|Death|1
7551608|NCT02457910|26249469|P2|Overall Study|Death|0
7551609|NCT02457910|26249470|P1|Overall Study|Death|0
7551610|NCT02457910|26249465|P6|Overall Study|Other complicating illness|1
7551611|NCT02457910|26249466|P5|Overall Study|Other complicating illness|0
7551612|NCT02457910|26249467|P4|Overall Study|Other complicating illness|0
7551613|NCT02457910|26249468|P3|Overall Study|Other complicating illness|0
7551614|NCT02457910|26249469|P2|Overall Study|Other complicating illness|0
7551615|NCT02457910|26249470|P1|Overall Study|Other complicating illness|0
7551616|NCT02457910|26249465|P6|Overall Study|Disease progression|6
7551617|NCT02457910|26249466|P5|Overall Study|Disease progression|4
7551618|NCT02457910|26249467|P4|Overall Study|Disease progression|1
7551619|NCT02457910|26249468|P3|Overall Study|Disease progression|1
7551620|NCT02457910|26249469|P2|Overall Study|Disease progression|3
7551621|NCT02457910|26249470|P1|Overall Study|Disease progression|3
7551622|NCT02457910|26249465|P6|Overall Study|Adverse Event|3
7551623|NCT02457910|26249466|P5|Overall Study|Adverse Event|1
7551624|NCT02457910|26249467|P4|Overall Study|Adverse Event|1
7551625|NCT02457910|26249468|P3|Overall Study|Adverse Event|1
7551626|NCT02457910|26249469|P2|Overall Study|Adverse Event|2
7551627|NCT02457910|26249470|P1|Overall Study|Adverse Event|0
7551628|NCT02457910|26249465|P6|Overall Study|Withdrawal by Subject|1
7551629|NCT02457910|26249466|P5|Overall Study|Withdrawal by Subject|0
7551630|NCT02457910|26249467|P4|Overall Study|Withdrawal by Subject|0
7551631|NCT02457910|26249468|P3|Overall Study|Withdrawal by Subject|0
7551632|NCT02457910|26249469|P2|Overall Study|Withdrawal by Subject|0
7551633|NCT02457910|26249470|P1|Overall Study|Withdrawal by Subject|0
7551634|NCT02457819|26249494|P1|Overall Study|Adverse Event|33
7551635|NCT02457819|26249494|P1|Overall Study|Lack of Efficacy|19
7551636|NCT02457819|26249494|P1|Overall Study|Lost to Follow-up|10
7551637|NCT02457819|26249494|P1|Overall Study|non compliance with study drug|4
7551638|NCT02457819|26249494|P1|Overall Study|Protocol Violation|1
7551639|NCT02457819|26249494|P1|Overall Study|Withdrawal by Subject|24
7551640|NCT02457819|26249494|P1|Overall Study|reason not given|8
7551641|NCT02457793|26249506|P6|Overall Study|Physician Decision|3
7551642|NCT02457793|26249507|P5|Overall Study|Physician Decision|1
7551643|NCT02457793|26249508|P4|Overall Study|Physician Decision|1
7551644|NCT02457793|26249509|P3|Overall Study|Physician Decision|1
7551645|NCT02457793|26249510|P2|Overall Study|Physician Decision|0
7551646|NCT02457793|26249511|P1|Overall Study|Physician Decision|1
7551647|NCT02457793|26249506|P6|Overall Study|Adverse Event|0
7551648|NCT02457793|26249507|P5|Overall Study|Adverse Event|0
7551649|NCT02457793|26249508|P4|Overall Study|Adverse Event|1
7551650|NCT02457793|26249509|P3|Overall Study|Adverse Event|0
7551651|NCT02457793|26249510|P2|Overall Study|Adverse Event|0
7551652|NCT02457793|26249511|P1|Overall Study|Adverse Event|0
7551653|NCT02457793|26249506|P6|Overall Study|Withdrawal by Subject|2
7551654|NCT02457793|26249507|P5|Overall Study|Withdrawal by Subject|2
7551655|NCT02457793|26249508|P4|Overall Study|Withdrawal by Subject|2
7551656|NCT02457793|26249509|P3|Overall Study|Withdrawal by Subject|2
7551657|NCT02457793|26249510|P2|Overall Study|Withdrawal by Subject|4
7551658|NCT02457793|26249511|P1|Overall Study|Withdrawal by Subject|0
7551659|NCT02457793|26249506|P6|Overall Study|Reason not specified|1
7551660|NCT02457793|26249507|P5|Overall Study|Reason not specified|1
7551661|NCT02457793|26249508|P4|Overall Study|Reason not specified|1
7551662|NCT02457793|26249509|P3|Overall Study|Reason not specified|0
7551663|NCT02457793|26249510|P2|Overall Study|Reason not specified|0
7551664|NCT02457793|26249511|P1|Overall Study|Reason not specified|0
7551665|NCT02457637|26249655|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
7551666|NCT02457611|26249663|P1|Overall Study|Lost to Follow-up|3
7551667|NCT02457546|26249677|P2|Overall Study|Adverse Event|1
7551668|NCT02457546|26249678|P1|Overall Study|Adverse Event|0
7551669|NCT02457546|26249677|P2|Overall Study|Lost to Follow-up|1
7551670|NCT02457546|26249678|P1|Overall Study|Lost to Follow-up|4
7551671|NCT02457546|26249677|P2|Overall Study|Refused to complete study/procedures|1
7551672|NCT02457546|26249678|P1|Overall Study|Refused to complete study/procedures|1
7551673|NCT02457546|26249677|P2|Overall Study|Other reasons|1
7551674|NCT02457546|26249678|P1|Overall Study|Other reasons|4
7551675|NCT02457520|26249686|P1|Post-treatment Period|Withdrawal by Subject|14
7551676|NCT02457520|26249686|P1|Post-treatment Period|Physician Decision|1
7551677|NCT02457520|26249686|P1|Post-treatment Period|Other|3
7551678|NCT02457520|26249686|P1|Post-treatment Period|Lost to Follow-up|23
7551679|NCT02457520|26249686|P1|Post-treatment Period|Other: Retreatment Required|7
7551680|NCT02457520|26249686|P1|Active Treatment Phase|Withdrawal by Subject|7
7551681|NCT02457520|26249686|P1|Active Treatment Phase|Protocol Violation|1
7551682|NCT02457520|26249686|P1|Active Treatment Phase|Physician Decision|1
7551683|NCT02457520|26249686|P1|Active Treatment Phase|other|4
7551684|NCT02457520|26249686|P1|Active Treatment Phase|Non-compliance with Study Treatment|3
7551685|NCT02457520|26249686|P1|Active Treatment Phase|Lost to Follow-up|8
7551686|NCT02457520|26249686|P1|Active Treatment Phase|Adverse Event|10
7551687|NCT02457325|26249740|P2|First Intervention (1 Day)|Lost to Follow-up|2
7551688|NCT02457325|26249741|P1|First Intervention (1 Day)|Lost to Follow-up|2
7551689|NCT02457247|26249814|P4|Period 2|Voluntary Withdrawal|0
7551690|NCT02457247|26249815|P3|Period 2|Voluntary Withdrawal|0
7551691|NCT02457247|26249816|P2|Period 2|Voluntary Withdrawal|1
7551692|NCT02457247|26249817|P1|Period 2|Voluntary Withdrawal|1
7551693|NCT02457247|26249814|P4|Period 2|Lost to Follow-up|0
7551694|NCT02457247|26249815|P3|Period 2|Lost to Follow-up|0
7551695|NCT02457247|26249816|P2|Period 2|Lost to Follow-up|1
7551696|NCT02457247|26249817|P1|Period 2|Lost to Follow-up|0
7551697|NCT02457247|26249814|P4|Period 2|Significant Protocol Deviation|0
7551698|NCT02457247|26249815|P3|Period 2|Significant Protocol Deviation|0
7551699|NCT02457247|26249816|P2|Period 2|Significant Protocol Deviation|0
7551700|NCT02457247|26249817|P1|Period 2|Significant Protocol Deviation|1
7551701|NCT02457247|26249814|P4|Period 2|Pretreatment Event/Adverse Event|0
7551702|NCT02457247|26249815|P3|Period 2|Pretreatment Event/Adverse Event|0
7551703|NCT02457247|26249816|P2|Period 2|Pretreatment Event/Adverse Event|1
7551704|NCT02457247|26249817|P1|Period 2|Pretreatment Event/Adverse Event|0
7551705|NCT02457247|26249814|P4|Period 1|Voluntary Withdrawal|0
7551706|NCT02457247|26249815|P3|Period 1|Voluntary Withdrawal|0
7551707|NCT02457247|26249816|P2|Period 1|Voluntary Withdrawal|0
7551708|NCT02457247|26249817|P1|Period 1|Voluntary Withdrawal|1
7551709|NCT02457247|26249814|P4|Period 1|Significant Protocol Deviation|0
7551710|NCT02457247|26249815|P3|Period 1|Significant Protocol Deviation|0
7551711|NCT02457247|26249816|P2|Period 1|Significant Protocol Deviation|1
7551712|NCT02457247|26249817|P1|Period 1|Significant Protocol Deviation|1
7551713|NCT02457247|26249814|P4|Period 1|Pretreatment Event/Adverse Event|0
7551714|NCT02457247|26249815|P3|Period 1|Pretreatment Event/Adverse Event|0
7551715|NCT02457247|26249816|P2|Period 1|Pretreatment Event/Adverse Event|1
7551716|NCT02457247|26249817|P1|Period 1|Pretreatment Event/Adverse Event|0
7551717|NCT02457195|26249837|P1|Overall Study|Withdrawal by Subject|4
7551718|NCT02457195|26249837|P1|Overall Study|Protocol Violation|2
7551719|NCT02457195|26249837|P1|Overall Study|Adverse Event|3
7551720|NCT02457182|26249843|P2|Overall Study|Lost to Follow-up|0
7551721|NCT02457182|26249844|P1|Overall Study|Lost to Follow-up|1
7551722|NCT02457065|26249862|P2|Overall Study|Lost to Follow-up|11
7551723|NCT02457065|26249863|P1|Overall Study|Lost to Follow-up|9
7551724|NCT02456909|26249873|P2|Overall Study|Did not complete the primary outcome|1
7551725|NCT02456909|26249874|P1|Overall Study|Did not complete the primary outcome|0
7551726|NCT02456909|26249873|P2|Overall Study|Did not receive allocated intervention|26
7551727|NCT02456909|26249874|P1|Overall Study|Did not receive allocated intervention|24
7551728|NCT02456740|26249898|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
7551729|NCT02456740|26249899|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
7551730|NCT02456740|26249900|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7551731|NCT02456740|26249901|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
7551732|NCT02456740|26249902|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
7551733|NCT02456740|26249903|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
7551734|NCT02456740|26249904|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7551735|NCT02456740|26249905|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7551736|NCT02456740|26249906|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7551737|NCT02456740|26249898|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551738|NCT02456740|26249899|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
7551739|NCT02456740|26249900|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551740|NCT02456740|26249901|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551741|NCT02456740|26249902|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551742|NCT02456740|26249903|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551743|NCT02456740|26249904|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551744|NCT02456740|26249905|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551745|NCT02456740|26249906|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
7551746|NCT02456740|26249898|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
7551747|NCT02456740|26249899|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
7551748|NCT02456740|26249900|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
7551749|NCT02456740|26249901|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
7551750|NCT02456740|26249902|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
7551751|NCT02456740|26249903|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
7551752|NCT02456740|26249904|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7551753|NCT02456740|26249905|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7551754|NCT02456740|26249906|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7551755|NCT02456740|26249898|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
7551756|NCT02456740|26249899|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7551757|NCT02456740|26249900|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7551758|NCT02456740|26249901|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7551759|NCT02456740|26249902|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
7551760|NCT02456740|26249903|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
7551761|NCT02456740|26249904|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7551762|NCT02456740|26249905|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7551763|NCT02456740|26249906|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7551764|NCT02456740|26249898|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7551765|NCT02456740|26249899|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7551766|NCT02456740|26249900|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7551767|NCT02456740|26249901|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7551768|NCT02456740|26249902|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7551769|NCT02456740|26249903|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7551770|NCT02456740|26249904|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
7551771|NCT02456740|26249905|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
7551772|NCT02456740|26249906|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
7551773|NCT02456740|26249898|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7551774|NCT02456740|26249899|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7551775|NCT02456740|26249900|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7551776|NCT02456740|26249901|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7551777|NCT02456740|26249902|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7551778|NCT02456740|26249903|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7551779|NCT02456740|26249904|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
7551780|NCT02456740|26249905|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
7551781|NCT02456740|26249906|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
7551782|NCT02456740|26249898|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7551783|NCT02456740|26249899|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7551784|NCT02456740|26249900|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7551785|NCT02456740|26249901|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7551786|NCT02456740|26249902|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7551787|NCT02456740|26249903|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7551788|NCT02456740|26249904|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7551789|NCT02456740|26249905|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7551790|NCT02456740|26249906|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7551791|NCT02456727|26249930|P2|Overall Study|Never Initiated Treatment|30
7551792|NCT02456727|26249931|P1|Overall Study|Never Initiated Treatment|43
7551793|NCT02456727|26249930|P2|Overall Study|Withdrawal by Subject|10
7551794|NCT02456727|26249931|P1|Overall Study|Withdrawal by Subject|1
7551795|NCT02456727|26249930|P2|Overall Study|Death|1
7551796|NCT02456727|26249931|P1|Overall Study|Death|2
7551797|NCT02456727|26249930|P2|Overall Study|Lost to Follow-up|65
7551798|NCT02456727|26249931|P1|Overall Study|Lost to Follow-up|63
7551799|NCT02456662|26250013|P2|Overall Study|Lost to Follow-up|1
7551800|NCT02456662|26250014|P1|Overall Study|Lost to Follow-up|2
7551801|NCT02456636|26250023|P3|Overall Study|Lost to Follow-up|50
7551802|NCT02456636|26250024|P2|Overall Study|Lost to Follow-up|44
7551803|NCT02456636|26250025|P1|Overall Study|Lost to Follow-up|50
7551804|NCT02456636|26250023|P3|Overall Study|Withdrawal by Subject|16
7551805|NCT02456636|26250024|P2|Overall Study|Withdrawal by Subject|14
7551806|NCT02456636|26250025|P1|Overall Study|Withdrawal by Subject|13
7551807|NCT02456636|26250023|P3|Overall Study|Physician Decision|4
7551808|NCT02456636|26250024|P2|Overall Study|Physician Decision|5
7551809|NCT02456636|26250025|P1|Overall Study|Physician Decision|4
7551810|NCT02456636|26250023|P3|Overall Study|Pregnancy|5
7551811|NCT02456636|26250024|P2|Overall Study|Pregnancy|3
7551812|NCT02456636|26250025|P1|Overall Study|Pregnancy|1
7551813|NCT02456636|26250023|P3|Overall Study|Death|0
7551814|NCT02456636|26250024|P2|Overall Study|Death|3
7551815|NCT02456636|26250025|P1|Overall Study|Death|0
7551816|NCT02456103|26250075|P1|Overall Study|Withdrawal by Subject|24
7551817|NCT02456103|26250075|P1|Overall Study|Lost to Follow-up|1
7551818|NCT02456103|26250075|P1|Overall Study|Abnormal Laboratory Value|2
7551819|NCT02456103|26250075|P1|Overall Study|Adverse Event|5
7551820|NCT02456103|26250075|P1|Overall Study|Protocol Violation|1
7551821|NCT02456103|26250075|P1|Overall Study|Required prohibited medications|5
7551822|NCT02456103|26250075|P1|Overall Study|Physician Decision|1
7551823|NCT02456103|26250075|P1|Overall Study|Study Closure|207
7551824|NCT02455557|26250084|P1|Overall Study|Withdrawal by Subject|2
7551825|NCT02455518|26250094|P4|Overall Study|Protocol Violation|3
7551826|NCT02455518|26250095|P3|Overall Study|Protocol Violation|1
7551827|NCT02455518|26250096|P2|Overall Study|Protocol Violation|1
7551828|NCT02455518|26250097|P1|Overall Study|Protocol Violation|0
7551829|NCT02455388|26250119|P3|Overall Study|Withdrawal by Subject|7
7551830|NCT02455388|26250120|P2|Overall Study|Withdrawal by Subject|0
7551831|NCT02455388|26250121|P1|Overall Study|Withdrawal by Subject|0
7551832|NCT02455388|26250119|P3|Overall Study|Protocol Violation|4
7551833|NCT02455388|26250120|P2|Overall Study|Protocol Violation|0
7551834|NCT02455388|26250121|P1|Overall Study|Protocol Violation|1
7551835|NCT02455336|26250132|P2|Overall Study|Non-responder to treatment|0
7551836|NCT02455336|26250133|P1|Overall Study|Non-responder to treatment|2
7551837|NCT02455336|26250132|P2|Overall Study|Adverse Event|0
7551838|NCT02455336|26250133|P1|Overall Study|Adverse Event|3
7551839|NCT02455336|26250132|P2|Overall Study|Withdrawal by Subject|2
7551840|NCT02455336|26250133|P1|Overall Study|Withdrawal by Subject|0
7551841|NCT02455076|26250154|P5|Outpatient|Lost to Follow-up|12
7551842|NCT02455076|26250155|P4|Outpatient|Lost to Follow-up|1
7551843|NCT02455076|26250156|P3|Outpatient|Lost to Follow-up|0
7551844|NCT02455076|26250157|P2|Outpatient|Lost to Follow-up|0
7551845|NCT02455076|26250158|P1|Outpatient|Lost to Follow-up|0
7551846|NCT02455076|26250154|P5|Outpatient|Adverse Event|0
7551847|NCT02455076|26250155|P4|Outpatient|Adverse Event|5
7551848|NCT02455076|26250156|P3|Outpatient|Adverse Event|0
7551849|NCT02455076|26250157|P2|Outpatient|Adverse Event|0
7551850|NCT02455076|26250158|P1|Outpatient|Adverse Event|0
7551851|NCT02455076|26250154|P5|Inpatient|Adverse Event|0
7551852|NCT02455076|26250155|P4|Inpatient|Adverse Event|0
7551853|NCT02455076|26250156|P3|Inpatient|Adverse Event|0
7551854|NCT02455076|26250157|P2|Inpatient|Adverse Event|0
7551855|NCT02455076|26250158|P1|Inpatient|Adverse Event|3
7551856|NCT02455076|26250154|P5|Inpatient|Discharged <24 h after admission|0
7551857|NCT02455076|26250155|P4|Inpatient|Discharged <24 h after admission|0
7551858|NCT02455076|26250156|P3|Inpatient|Discharged <24 h after admission|0
7551859|NCT02455076|26250157|P2|Inpatient|Discharged <24 h after admission|1
7551860|NCT02455076|26250158|P1|Inpatient|Discharged <24 h after admission|0
7551861|NCT02455076|26250154|P5|Inpatient|Withdrawal by Subject|0
7551862|NCT02455076|26250155|P4|Inpatient|Withdrawal by Subject|0
7551863|NCT02455076|26250156|P3|Inpatient|Withdrawal by Subject|0
7551864|NCT02455076|26250157|P2|Inpatient|Withdrawal by Subject|0
7551865|NCT02455076|26250158|P1|Inpatient|Withdrawal by Subject|1
7551866|NCT02455050|26250244|P4|Treatment Period 2|Lost to Follow-up|1
7551867|NCT02455050|26250245|P3|Treatment Period 2|Lost to Follow-up|2
7551868|NCT02455050|26250246|P2|Treatment Period 2|Lost to Follow-up|0
7551869|NCT02455050|26250247|P1|Treatment Period 2|Lost to Follow-up|1
7551870|NCT02455050|26250244|P4|Treatment Period 1|Lost to Follow-up|2
7551871|NCT02455050|26250245|P3|Treatment Period 1|Lost to Follow-up|1
7551872|NCT02455050|26250246|P2|Treatment Period 1|Lost to Follow-up|1
7551873|NCT02455050|26250247|P1|Treatment Period 1|Lost to Follow-up|1
7551874|NCT02454959|26250311|P1|Overall Study|Adverse Event|2
7551875|NCT02454959|26250311|P1|Overall Study|Withdrawal by Subject|3
7551876|NCT02454959|26250311|P1|Overall Study|Physician Decision|1
7551877|NCT02454959|26250311|P1|Overall Study|Protocol-Specified Criteria|3
7551884|NCT02454608|26250340|P3|Open Label Period|Withdrawal by Subject|8
7551885|NCT02454608|26250341|P2|Open Label Period|Withdrawal by Subject|0
7551886|NCT02454608|26250342|P1|Open Label Period|Withdrawal by Subject|0
7551887|NCT02454608|26250340|P3|Open Label Period|Lost to Follow-up|11
7551888|NCT02454608|26250341|P2|Open Label Period|Lost to Follow-up|0
7551889|NCT02454608|26250342|P1|Open Label Period|Lost to Follow-up|0
7551890|NCT02454608|26250340|P3|Double-Blind Period|Lack of Efficacy|0
7551891|NCT02454608|26250341|P2|Double-Blind Period|Lack of Efficacy|2
7551892|NCT02454608|26250342|P1|Double-Blind Period|Lack of Efficacy|0
7551893|NCT02454530|26250365|P2|Overall Study|Lost to Follow-up|4
7551894|NCT02454530|26250366|P1|Overall Study|Lost to Follow-up|4
7551895|NCT02454530|26250365|P2|Overall Study|Death|41
7551896|NCT02454530|26250366|P1|Overall Study|Death|2
7551897|NCT02454530|26250365|P2|Overall Study|Missing information|69
7551898|NCT02454530|26250366|P1|Overall Study|Missing information|56
7551899|NCT02454530|26250365|P2|Overall Study|Other|13
7551900|NCT02454530|26250366|P1|Overall Study|Other|8
7551901|NCT02454478|26250403|P1|Overall Study|Incomplete DLT Evaluation|1
7551902|NCT02454101|26250524|P2|Overall Study|Lost to Follow-up|4
7551903|NCT02454101|26250525|P1|Overall Study|Lost to Follow-up|3
7551904|NCT02454101|26250524|P2|Overall Study|Adverse Event|3
7551905|NCT02454101|26250525|P1|Overall Study|Adverse Event|2
7551906|NCT02453841|26250561|P1|Overall Study|Unable to obtain blood samples|2
7551907|NCT02453841|26250561|P1|Overall Study|Protocol Violation|1
7551908|NCT02453711|26250584|P9|Overall Study|Unclassified|0
7551909|NCT02453711|26250585|P8|Overall Study|Unclassified|0
7551910|NCT02453711|26250586|P7|Overall Study|Unclassified|0
7551911|NCT02453711|26250587|P6|Overall Study|Unclassified|0
7551912|NCT02453711|26250588|P5|Overall Study|Unclassified|0
7551913|NCT02453711|26250589|P4|Overall Study|Unclassified|0
7551914|NCT02453711|26250590|P3|Overall Study|Unclassified|1
7551915|NCT02453711|26250591|P2|Overall Study|Unclassified|0
7551916|NCT02453711|26250592|P1|Overall Study|Unclassified|1
7551917|NCT02453711|26250584|P9|Overall Study|Death|0
7551918|NCT02453711|26250585|P8|Overall Study|Death|0
7551919|NCT02453711|26250586|P7|Overall Study|Death|1
7551920|NCT02453711|26250587|P6|Overall Study|Death|0
7551921|NCT02453711|26250588|P5|Overall Study|Death|0
7551922|NCT02453711|26250589|P4|Overall Study|Death|0
7551923|NCT02453711|26250590|P3|Overall Study|Death|0
7551924|NCT02453711|26250591|P2|Overall Study|Death|0
7551925|NCT02453711|26250592|P1|Overall Study|Death|0
7551926|NCT02453711|26250584|P9|Overall Study|Lost to Follow-up|6
7551927|NCT02453711|26250585|P8|Overall Study|Lost to Follow-up|6
7551928|NCT02453711|26250586|P7|Overall Study|Lost to Follow-up|2
7551929|NCT02453711|26250587|P6|Overall Study|Lost to Follow-up|5
7551930|NCT02453711|26250588|P5|Overall Study|Lost to Follow-up|1
7551931|NCT02453711|26250589|P4|Overall Study|Lost to Follow-up|3
7551932|NCT02453711|26250590|P3|Overall Study|Lost to Follow-up|2
7551933|NCT02453711|26250591|P2|Overall Study|Lost to Follow-up|3
7551934|NCT02453711|26250592|P1|Overall Study|Lost to Follow-up|5
7551935|NCT02453711|26250584|P9|Overall Study|Withdrawal by Subject|7
7551936|NCT02453711|26250585|P8|Overall Study|Withdrawal by Subject|1
7551937|NCT02453711|26250586|P7|Overall Study|Withdrawal by Subject|0
7551938|NCT02453711|26250587|P6|Overall Study|Withdrawal by Subject|1
7551939|NCT02453711|26250588|P5|Overall Study|Withdrawal by Subject|1
7551940|NCT02453711|26250589|P4|Overall Study|Withdrawal by Subject|4
7551941|NCT02453711|26250590|P3|Overall Study|Withdrawal by Subject|6
7551942|NCT02453711|26250591|P2|Overall Study|Withdrawal by Subject|4
7551943|NCT02453711|26250592|P1|Overall Study|Withdrawal by Subject|5
7551944|NCT02453685|26250936|P2|Overall Study|Unclassified|2
7551945|NCT02453685|26250937|P1|Overall Study|Unclassified|4
7551946|NCT02453685|26250936|P2|Overall Study|Withdrawal by Subject|4
7551947|NCT02453685|26250937|P1|Overall Study|Withdrawal by Subject|8
7551948|NCT02453685|26250936|P2|Overall Study|Lost to Follow-up|1
7551949|NCT02453685|26250937|P1|Overall Study|Lost to Follow-up|0
7551950|NCT02453685|26250936|P2|Overall Study|Protocol Violation|4
7551951|NCT02453685|26250937|P1|Overall Study|Protocol Violation|7
7551952|NCT02453685|26250936|P2|Overall Study|Adverse Event|1
7551953|NCT02453685|26250937|P1|Overall Study|Adverse Event|0
7551954|NCT02453555|26250995|P6|Extension Period|Withdrawal by Subject|0
7551955|NCT02453555|26250996|P5|Extension Period|Withdrawal by Subject|0
7551956|NCT02453555|26250997|P4|Extension Period|Withdrawal by Subject|0
7551957|NCT02453555|26250998|P3|Extension Period|Withdrawal by Subject|1
7551958|NCT02453555|26250999|P2|Extension Period|Withdrawal by Subject|0
7551959|NCT02453555|26251000|P1|Extension Period|Withdrawal by Subject|0
7551960|NCT02453555|26250995|P6|Extension Period|Protocol Violation|0
7551961|NCT02453555|26250996|P5|Extension Period|Protocol Violation|0
7551962|NCT02453555|26250997|P4|Extension Period|Protocol Violation|0
7551963|NCT02453555|26250998|P3|Extension Period|Protocol Violation|1
7551964|NCT02453555|26250999|P2|Extension Period|Protocol Violation|0
7551965|NCT02453555|26251000|P1|Extension Period|Protocol Violation|0
7551966|NCT02453555|26250995|P6|Extension Period|Adverse Event|1
7551967|NCT02453555|26250996|P5|Extension Period|Adverse Event|1
7551968|NCT02453555|26250997|P4|Extension Period|Adverse Event|2
7551969|NCT02453555|26250998|P3|Extension Period|Adverse Event|1
7551970|NCT02453555|26250999|P2|Extension Period|Adverse Event|0
7551971|NCT02453555|26251000|P1|Extension Period|Adverse Event|0
7551972|NCT02453555|26250995|P6|24-week Double-blind Treatment Period|Other than specified above|0
7551973|NCT02453555|26250996|P5|24-week Double-blind Treatment Period|Other than specified above|0
7551974|NCT02453555|26250997|P4|24-week Double-blind Treatment Period|Other than specified above|0
7551975|NCT02453555|26250998|P3|24-week Double-blind Treatment Period|Other than specified above|0
7551976|NCT02453555|26250999|P2|24-week Double-blind Treatment Period|Other than specified above|3
7551977|NCT02453555|26251000|P1|24-week Double-blind Treatment Period|Other than specified above|0
7551978|NCT02453555|26250995|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7551979|NCT02453555|26250996|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7551980|NCT02453555|26250997|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7551981|NCT02453555|26250998|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7551982|NCT02453555|26250999|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
7551983|NCT02453555|26251000|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
7551984|NCT02453555|26250995|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
7551985|NCT02453555|26250996|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
7551986|NCT02453555|26250997|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
7551987|NCT02453555|26250998|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
7551988|NCT02453555|26250999|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
7551989|NCT02453555|26251000|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
7551990|NCT02453555|26250995|P6|24-week Double-blind Treatment Period|Adverse Event|0
7551991|NCT02453555|26250996|P5|24-week Double-blind Treatment Period|Adverse Event|0
7551992|NCT02453555|26250997|P4|24-week Double-blind Treatment Period|Adverse Event|0
7551993|NCT02453555|26250998|P3|24-week Double-blind Treatment Period|Adverse Event|0
7551994|NCT02453555|26250999|P2|24-week Double-blind Treatment Period|Adverse Event|0
7551995|NCT02453555|26251000|P1|24-week Double-blind Treatment Period|Adverse Event|2
7551996|NCT02453386|26251016|P3|Overall Study|Other|1
7551997|NCT02453386|26251017|P2|Overall Study|Other|0
7551998|NCT02453386|26251018|P1|Overall Study|Other|1
7551999|NCT02453386|26251016|P3|Overall Study|Lost to Follow-up|1
7552000|NCT02453386|26251017|P2|Overall Study|Lost to Follow-up|0
7552001|NCT02453386|26251018|P1|Overall Study|Lost to Follow-up|0
7552002|NCT02453386|26251016|P3|Overall Study|Sponsor Terminated by Investigator|2
7552003|NCT02453386|26251017|P2|Overall Study|Sponsor Terminated by Investigator|1
7552004|NCT02453386|26251018|P1|Overall Study|Sponsor Terminated by Investigator|0
7552005|NCT02453386|26251016|P3|Overall Study|Subject Terminated by Sponsor|1
7552006|NCT02453386|26251017|P2|Overall Study|Subject Terminated by Sponsor|1
7552007|NCT02453386|26251018|P1|Overall Study|Subject Terminated by Sponsor|1
7552008|NCT02453386|26251016|P3|Overall Study|Sponsor Terminated Study|11
7552009|NCT02453386|26251017|P2|Overall Study|Sponsor Terminated Study|8
7552010|NCT02453386|26251018|P1|Overall Study|Sponsor Terminated Study|14
7552011|NCT02453386|26251016|P3|Overall Study|Withdrawal by Subject|9
7552012|NCT02453386|26251017|P2|Overall Study|Withdrawal by Subject|9
7552013|NCT02453386|26251018|P1|Overall Study|Withdrawal by Subject|10
7552014|NCT02453386|26251016|P3|Overall Study|Protocol Violation|1
7552015|NCT02453386|26251017|P2|Overall Study|Protocol Violation|0
7552016|NCT02453386|26251018|P1|Overall Study|Protocol Violation|1
7552017|NCT02453386|26251016|P3|Overall Study|Adverse Event|15
7552018|NCT02453386|26251017|P2|Overall Study|Adverse Event|30
7552019|NCT02453386|26251018|P1|Overall Study|Adverse Event|22
7552020|NCT02453334|26251081|P2|Overall Study|Other reason|4
7552021|NCT02453334|26251082|P1|Overall Study|Other reason|1
7552022|NCT02453334|26251081|P2|Overall Study|Withdrawal by Subject|13
7552023|NCT02453334|26251082|P1|Overall Study|Withdrawal by Subject|17
7552024|NCT02453334|26251081|P2|Overall Study|Physician Decision|0
7552025|NCT02453334|26251082|P1|Overall Study|Physician Decision|1
7552026|NCT02453334|26251081|P2|Overall Study|Lost to Follow-up|9
7552027|NCT02453334|26251082|P1|Overall Study|Lost to Follow-up|5
7552028|NCT02453334|26251081|P2|Overall Study|Adverse Event|1
7552029|NCT02453334|26251082|P1|Overall Study|Adverse Event|2
7552030|NCT02453334|26251081|P2|Overall Study|Death|13
7552031|NCT02453334|26251082|P1|Overall Study|Death|15
7552032|NCT02453321|26251127|P3|Overall Study|Deep Venous Thrombosis|0
7552033|NCT02453321|26251128|P2|Overall Study|Deep Venous Thrombosis|1
7552034|NCT02453321|26251129|P1|Overall Study|Deep Venous Thrombosis|0
7552035|NCT02453321|26251127|P3|Overall Study|Weakness|2
7552036|NCT02453321|26251128|P2|Overall Study|Weakness|1
7552037|NCT02453321|26251129|P1|Overall Study|Weakness|1
7552053|NCT02453256|26251232|P2|Open Label Period|Withdrawal by Subject|1
7552054|NCT02453256|26251233|P1|Open Label Period|Withdrawal by Subject|5
7552055|NCT02453256|26251232|P2|Open Label Period|Other|2
7552056|NCT02453256|26251233|P1|Open Label Period|Other|0
7552057|NCT02453256|26251232|P2|Open Label Period|Lost to Follow-up|0
7552058|NCT02453256|26251233|P1|Open Label Period|Lost to Follow-up|1
7552059|NCT02453256|26251232|P2|Open Label Period|Death|1
7552060|NCT02453256|26251233|P1|Open Label Period|Death|0
7552061|NCT02453256|26251232|P2|Open Label Period|Adverse Event|3
7552062|NCT02453256|26251233|P1|Open Label Period|Adverse Event|1
7552063|NCT02453256|26251232|P2|Double Blind Period|Other|1
7552064|NCT02453256|26251233|P1|Double Blind Period|Other|0
7552065|NCT02453256|26251232|P2|Double Blind Period|Withdrawal by Subject|5
7552066|NCT02453256|26251233|P1|Double Blind Period|Withdrawal by Subject|9
7552067|NCT02453256|26251232|P2|Double Blind Period|Adverse Event|2
7552068|NCT02453256|26251233|P1|Double Blind Period|Adverse Event|3
7552069|NCT02453256|26251232|P2|Double Blind Period|Death|1
7552070|NCT02453256|26251233|P1|Double Blind Period|Death|1
7552071|NCT02453191|26251353|P1|Overall Study|Withdrawal by Subject|1
7552072|NCT02453048|26251370|P5|Overall Study|Lost to Follow-up|0
7552073|NCT02453048|26251371|P4|Overall Study|Lost to Follow-up|0
7552074|NCT02453048|26251372|P3|Overall Study|Lost to Follow-up|2
7552075|NCT02453048|26251373|P2|Overall Study|Lost to Follow-up|1
7552076|NCT02453048|26251374|P1|Overall Study|Lost to Follow-up|0
7552077|NCT02453048|26251370|P5|Overall Study|Only part of initial 6 mo. study|6
7552078|NCT02453048|26251371|P4|Overall Study|Only part of initial 6 mo. study|0
7552079|NCT02453048|26251372|P3|Overall Study|Only part of initial 6 mo. study|0
7552080|NCT02453048|26251373|P2|Overall Study|Only part of initial 6 mo. study|0
7552081|NCT02453048|26251374|P1|Overall Study|Only part of initial 6 mo. study|0
7552082|NCT02452892|26251434|P4|Follow-up|Subject left town on Day 42|0
7552083|NCT02452892|26251435|P3|Follow-up|Subject left town on Day 42|0
7552084|NCT02452892|26251436|P2|Follow-up|Subject left town on Day 42|0
7552085|NCT02452892|26251437|P1|Follow-up|Subject left town on Day 42|1
7552086|NCT02452892|26251434|P4|Follow-up|Withdrawal by Subject|1
7552087|NCT02452892|26251435|P3|Follow-up|Withdrawal by Subject|0
7552088|NCT02452892|26251436|P2|Follow-up|Withdrawal by Subject|0
7552089|NCT02452892|26251437|P1|Follow-up|Withdrawal by Subject|0
7552090|NCT02452892|26251434|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7552091|NCT02452892|26251435|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7552092|NCT02452892|26251436|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7552093|NCT02452892|26251437|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
7552094|NCT02452892|26251434|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
7552095|NCT02452892|26251435|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7552096|NCT02452892|26251436|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7552097|NCT02452892|26251437|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7552098|NCT02452892|26251434|P4|Week 1 Initial Randommization|Lost to Follow-up|0
7552099|NCT02452892|26251435|P3|Week 1 Initial Randommization|Lost to Follow-up|1
7552100|NCT02452892|26251436|P2|Week 1 Initial Randommization|Lost to Follow-up|0
7552101|NCT02452892|26251437|P1|Week 1 Initial Randommization|Lost to Follow-up|0
7552102|NCT02452892|26251434|P4|Week 1 Initial Randommization|Adverse Event|0
7552103|NCT02452892|26251435|P3|Week 1 Initial Randommization|Adverse Event|0
7552104|NCT02452892|26251436|P2|Week 1 Initial Randommization|Adverse Event|0
7552105|NCT02452892|26251437|P1|Week 1 Initial Randommization|Adverse Event|1
7552106|NCT02452762|26251472|P2|Overall Study|Withdrawal by Subject|0
7552107|NCT02452762|26251473|P1|Overall Study|Withdrawal by Subject|1
7552108|NCT02452762|26251472|P2|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
7552109|NCT02452762|26251473|P1|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
7552110|NCT02452554|26251494|P6|Overall Study|Never Received Treatment|0
7552111|NCT02452554|26251495|P5|Overall Study|Never Received Treatment|0
7552112|NCT02452554|26251496|P4|Overall Study|Never Received Treatment|0
7552113|NCT02452554|26251497|P3|Overall Study|Never Received Treatment|0
7552114|NCT02452554|26251498|P2|Overall Study|Never Received Treatment|0
7552115|NCT02452554|26251499|P1|Overall Study|Never Received Treatment|1
7552116|NCT02452554|26251494|P6|Overall Study|Ineligible|0
7552117|NCT02452554|26251495|P5|Overall Study|Ineligible|0
7552118|NCT02452554|26251496|P4|Overall Study|Ineligible|0
7552119|NCT02452554|26251497|P3|Overall Study|Ineligible|0
7552120|NCT02452554|26251498|P2|Overall Study|Ineligible|1
7552121|NCT02452554|26251499|P1|Overall Study|Ineligible|0
7552122|NCT02452554|26251494|P6|Overall Study|Withdrawal by Subject|1
7552123|NCT02452554|26251495|P5|Overall Study|Withdrawal by Subject|0
7552124|NCT02452554|26251496|P4|Overall Study|Withdrawal by Subject|0
7552125|NCT02452554|26251497|P3|Overall Study|Withdrawal by Subject|2
7552126|NCT02452554|26251498|P2|Overall Study|Withdrawal by Subject|0
7552127|NCT02452554|26251499|P1|Overall Study|Withdrawal by Subject|1
7552128|NCT02452554|26251494|P6|Overall Study|Physician Decision|0
7552129|NCT02452554|26251495|P5|Overall Study|Physician Decision|0
7552130|NCT02452554|26251496|P4|Overall Study|Physician Decision|0
7552131|NCT02452554|26251497|P3|Overall Study|Physician Decision|0
7552132|NCT02452554|26251498|P2|Overall Study|Physician Decision|1
7552133|NCT02452554|26251499|P1|Overall Study|Physician Decision|0
7552134|NCT02452554|26251494|P6|Overall Study|Lack of Efficacy|8
7552135|NCT02452554|26251495|P5|Overall Study|Lack of Efficacy|5
7552136|NCT02452554|26251496|P4|Overall Study|Lack of Efficacy|1
7552137|NCT02452554|26251497|P3|Overall Study|Lack of Efficacy|9
7552138|NCT02452554|26251498|P2|Overall Study|Lack of Efficacy|14
7552139|NCT02452554|26251499|P1|Overall Study|Lack of Efficacy|13
7552140|NCT02452554|26251494|P6|Overall Study|Death|0
7552141|NCT02452554|26251495|P5|Overall Study|Death|0
7552142|NCT02452554|26251496|P4|Overall Study|Death|0
7552143|NCT02452554|26251497|P3|Overall Study|Death|0
7552144|NCT02452554|26251498|P2|Overall Study|Death|1
7552145|NCT02452554|26251499|P1|Overall Study|Death|2
7552146|NCT02452476|26251551|P2|Overall Study|Not treated|1
7552147|NCT02452476|26251552|P1|Overall Study|Not treated|5
7552148|NCT02452476|26251551|P2|Overall Study|Physician Decision|1
7552149|NCT02452476|26251552|P1|Overall Study|Physician Decision|1
7552150|NCT02452476|26251551|P2|Overall Study|Lost to Follow-up|1
7552151|NCT02452476|26251552|P1|Overall Study|Lost to Follow-up|1
7552152|NCT02452476|26251551|P2|Overall Study|Death|7
7552153|NCT02452476|26251552|P1|Overall Study|Death|4
7552154|NCT02452463|26251575|P3|Overall Study|Withdrawal by Subject|0
7552155|NCT02452463|26251576|P2|Overall Study|Withdrawal by Subject|1
7552156|NCT02452463|26251577|P1|Overall Study|Withdrawal by Subject|0
7552157|NCT02452463|26251575|P3|Overall Study|Recommended by DSMB|0
7552158|NCT02452463|26251576|P2|Overall Study|Recommended by DSMB|1
7552159|NCT02452463|26251577|P1|Overall Study|Recommended by DSMB|0
7552160|NCT02452463|26251575|P3|Overall Study|Study Suspended|0
7552161|NCT02452463|26251576|P2|Overall Study|Study Suspended|0
7552162|NCT02452463|26251577|P1|Overall Study|Study Suspended|1
7552163|NCT02452463|26251575|P3|Overall Study|Death|0
7552164|NCT02452463|26251576|P2|Overall Study|Death|0
7552165|NCT02452463|26251577|P1|Overall Study|Death|1
7552166|NCT02452424|26251620|P11|Overall Study|Adverse Event|1
7552167|NCT02452424|26251621|P10|Overall Study|Adverse Event|0
7552168|NCT02452424|26251622|P9|Overall Study|Adverse Event|0
7552169|NCT02452424|26251623|P8|Overall Study|Adverse Event|0
7552170|NCT02452424|26251624|P7|Overall Study|Adverse Event|0
7552171|NCT02452424|26251625|P6|Overall Study|Adverse Event|0
7552172|NCT02452424|26251626|P5|Overall Study|Adverse Event|0
7552173|NCT02452424|26251627|P4|Overall Study|Adverse Event|0
7552174|NCT02452424|26251628|P3|Overall Study|Adverse Event|0
7552175|NCT02452424|26251629|P2|Overall Study|Adverse Event|0
7552176|NCT02452424|26251630|P1|Overall Study|Adverse Event|0
7552177|NCT02452424|26251620|P11|Overall Study|Progressive disease (per RECIST)|0
7552178|NCT02452424|26251621|P10|Overall Study|Progressive disease (per RECIST)|0
7552179|NCT02452424|26251622|P9|Overall Study|Progressive disease (per RECIST)|2
7552180|NCT02452424|26251623|P8|Overall Study|Progressive disease (per RECIST)|0
7552181|NCT02452424|26251624|P7|Overall Study|Progressive disease (per RECIST)|0
7552182|NCT02452424|26251625|P6|Overall Study|Progressive disease (per RECIST)|0
7552183|NCT02452424|26251626|P5|Overall Study|Progressive disease (per RECIST)|0
7552184|NCT02452424|26251627|P4|Overall Study|Progressive disease (per RECIST)|0
7552185|NCT02452424|26251628|P3|Overall Study|Progressive disease (per RECIST)|0
7552186|NCT02452424|26251629|P2|Overall Study|Progressive disease (per RECIST)|0
7552187|NCT02452424|26251630|P1|Overall Study|Progressive disease (per RECIST)|0
7552188|NCT02452424|26251620|P11|Overall Study|Other|1
7552189|NCT02452424|26251621|P10|Overall Study|Other|0
7552190|NCT02452424|26251622|P9|Overall Study|Other|0
7552191|NCT02452424|26251623|P8|Overall Study|Other|3
7552192|NCT02452424|26251624|P7|Overall Study|Other|4
7552193|NCT02452424|26251625|P6|Overall Study|Other|1
7552194|NCT02452424|26251626|P5|Overall Study|Other|0
7552195|NCT02452424|26251627|P4|Overall Study|Other|0
7552196|NCT02452424|26251628|P3|Overall Study|Other|1
7552197|NCT02452424|26251629|P2|Overall Study|Other|0
7552198|NCT02452424|26251630|P1|Overall Study|Other|0
7552199|NCT02452424|26251620|P11|Overall Study|Withdrawal by Subject|0
7552200|NCT02452424|26251621|P10|Overall Study|Withdrawal by Subject|1
7552201|NCT02452424|26251622|P9|Overall Study|Withdrawal by Subject|1
7552202|NCT02452424|26251623|P8|Overall Study|Withdrawal by Subject|0
7552203|NCT02452424|26251624|P7|Overall Study|Withdrawal by Subject|1
7552204|NCT02452424|26251625|P6|Overall Study|Withdrawal by Subject|0
7552205|NCT02452424|26251626|P5|Overall Study|Withdrawal by Subject|0
7552206|NCT02452424|26251627|P4|Overall Study|Withdrawal by Subject|2
7552207|NCT02452424|26251628|P3|Overall Study|Withdrawal by Subject|3
7552208|NCT02452424|26251629|P2|Overall Study|Withdrawal by Subject|0
7552209|NCT02452424|26251630|P1|Overall Study|Withdrawal by Subject|0
7552210|NCT02452424|26251620|P11|Overall Study|Lost to Follow-up|0
7552211|NCT02452424|26251621|P10|Overall Study|Lost to Follow-up|0
7552212|NCT02452424|26251622|P9|Overall Study|Lost to Follow-up|0
7552213|NCT02452424|26251623|P8|Overall Study|Lost to Follow-up|0
7552214|NCT02452424|26251624|P7|Overall Study|Lost to Follow-up|0
7552215|NCT02452424|26251625|P6|Overall Study|Lost to Follow-up|0
7552216|NCT02452424|26251626|P5|Overall Study|Lost to Follow-up|0
7552217|NCT02452424|26251627|P4|Overall Study|Lost to Follow-up|0
7552218|NCT02452424|26251628|P3|Overall Study|Lost to Follow-up|1
7552219|NCT02452424|26251629|P2|Overall Study|Lost to Follow-up|1
7552220|NCT02452424|26251630|P1|Overall Study|Lost to Follow-up|0
7552221|NCT02452424|26251620|P11|Overall Study|Death|0
7552222|NCT02452424|26251621|P10|Overall Study|Death|1
7552223|NCT02452424|26251622|P9|Overall Study|Death|3
7552224|NCT02452424|26251623|P8|Overall Study|Death|1
7552225|NCT02452424|26251624|P7|Overall Study|Death|5
7552226|NCT02452424|26251625|P6|Overall Study|Death|0
7552227|NCT02452424|26251626|P5|Overall Study|Death|2
7552228|NCT02452424|26251627|P4|Overall Study|Death|6
7552229|NCT02452424|26251628|P3|Overall Study|Death|2
7552230|NCT02452424|26251629|P2|Overall Study|Death|2
7552231|NCT02452424|26251630|P1|Overall Study|Death|2
7552232|NCT02452398|26251665|P1|Overall Study|Moved away|4
7552233|NCT02452398|26251665|P1|Overall Study|Withdrawal by Subject|6
7552234|NCT02452398|26251665|P1|Overall Study|Physician Decision|2
7552235|NCT02452398|26251665|P1|Overall Study|Lost to Follow-up|28
7552236|NCT02452398|26251665|P1|Overall Study|Adverse Event|1
7552237|NCT02452359|26251669|P1|Overall Study|Withdrawal by Subject|4
7552238|NCT02452359|26251669|P1|Overall Study|Pregnancy|1
7552239|NCT02452359|26251669|P1|Overall Study|Lost to Follow-up|15
7552240|NCT02452359|26251669|P1|Overall Study|Adverse Event|1
7552241|NCT02452320|26251681|P2|Overall Study|Adverse Event|1
7552242|NCT02452320|26251682|P1|Overall Study|Adverse Event|0
7552243|NCT02452190|26251694|P2|Overall Study|Death|1
7552244|NCT02452190|26251695|P1|Overall Study|Death|0
7552245|NCT02452190|26251694|P2|Overall Study|Participant traveled abroad|0
7552246|NCT02452190|26251695|P1|Overall Study|Participant traveled abroad|1
7552247|NCT02452190|26251694|P2|Overall Study|Noncompliance with study drug|0
7552248|NCT02452190|26251695|P1|Overall Study|Noncompliance with study drug|1
7552249|NCT02452190|26251694|P2|Overall Study|Withdrawal by Subject|11
7552250|NCT02452190|26251695|P1|Overall Study|Withdrawal by Subject|20
7552251|NCT02452190|26251694|P2|Overall Study|Adverse Event|5
7552252|NCT02452190|26251695|P1|Overall Study|Adverse Event|2
7552253|NCT02452190|26251694|P2|Overall Study|Lost to Follow-up|3
7552254|NCT02452190|26251695|P1|Overall Study|Lost to Follow-up|4
7552255|NCT02452190|26251694|P2|Overall Study|Lack of Efficacy|1
7552256|NCT02452190|26251695|P1|Overall Study|Lack of Efficacy|3
7552257|NCT02452190|26251694|P2|Overall Study|Investigator's Decision|0
7552258|NCT02452190|26251695|P1|Overall Study|Investigator's Decision|2
7552259|NCT02452190|26251694|P2|Overall Study|Pregnancy|0
7552260|NCT02452190|26251695|P1|Overall Study|Pregnancy|1
7552261|NCT02452190|26251694|P2|Overall Study|Withdrawal by Sponsor|3
7552262|NCT02452190|26251695|P1|Overall Study|Withdrawal by Sponsor|1
7552263|NCT02452047|26251733|P3|Overall Study|Withdrawal by Subject|0
7552264|NCT02452047|26251734|P2|Overall Study|Withdrawal by Subject|0
7552265|NCT02452047|26251735|P1|Overall Study|Withdrawal by Subject|1
7552266|NCT02452047|26251733|P3|Overall Study|Lost to Follow-up|0
7552267|NCT02452047|26251734|P2|Overall Study|Lost to Follow-up|1
7552268|NCT02452047|26251735|P1|Overall Study|Lost to Follow-up|1
7552269|NCT02452047|26251733|P3|Overall Study|Physician Decision|0
7552270|NCT02452047|26251734|P2|Overall Study|Physician Decision|0
7552271|NCT02452047|26251735|P1|Overall Study|Physician Decision|1
7552272|NCT02452047|26251733|P3|Overall Study|Death|1
7552273|NCT02452047|26251734|P2|Overall Study|Death|3
7552274|NCT02452047|26251735|P1|Overall Study|Death|1
7552275|NCT02452047|26251733|P3|Overall Study|Adverse Event|1
7552276|NCT02452047|26251734|P2|Overall Study|Adverse Event|1
7552277|NCT02452047|26251735|P1|Overall Study|Adverse Event|0
7552278|NCT02452034|26251800|P6|Overall Study|Withdrawn by Parent/Guardian|0
7552279|NCT02452034|26251801|P5|Overall Study|Withdrawn by Parent/Guardian|0
7552280|NCT02452034|26251802|P4|Overall Study|Withdrawn by Parent/Guardian|0
7552281|NCT02452034|26251803|P3|Overall Study|Withdrawn by Parent/Guardian|0
7552282|NCT02452034|26251804|P2|Overall Study|Withdrawn by Parent/Guardian|0
7552283|NCT02452034|26251805|P1|Overall Study|Withdrawn by Parent/Guardian|1
7552284|NCT02452034|26251800|P6|Overall Study|Screen Failure|0
7552285|NCT02452034|26251801|P5|Overall Study|Screen Failure|0
7552286|NCT02452034|26251802|P4|Overall Study|Screen Failure|1
7552287|NCT02452034|26251803|P3|Overall Study|Screen Failure|0
7552288|NCT02452034|26251804|P2|Overall Study|Screen Failure|0
7552289|NCT02452034|26251805|P1|Overall Study|Screen Failure|1
7552290|NCT02452034|26251800|P6|Overall Study|Protocol Violation|1
7552291|NCT02452034|26251801|P5|Overall Study|Protocol Violation|0
7552292|NCT02452034|26251802|P4|Overall Study|Protocol Violation|0
7552293|NCT02452034|26251803|P3|Overall Study|Protocol Violation|0
7552294|NCT02452034|26251804|P2|Overall Study|Protocol Violation|0
7552295|NCT02452034|26251805|P1|Overall Study|Protocol Violation|0
7552296|NCT02452034|26251800|P6|Overall Study|Physician Decision|0
7552297|NCT02452034|26251801|P5|Overall Study|Physician Decision|0
7552298|NCT02452034|26251802|P4|Overall Study|Physician Decision|0
7552299|NCT02452034|26251803|P3|Overall Study|Physician Decision|1
7552300|NCT02452034|26251804|P2|Overall Study|Physician Decision|1
7552301|NCT02452034|26251805|P1|Overall Study|Physician Decision|0
7552302|NCT02452034|26251800|P6|Overall Study|Death|1
7552303|NCT02452034|26251801|P5|Overall Study|Death|1
7552304|NCT02452034|26251802|P4|Overall Study|Death|0
7552305|NCT02452034|26251803|P3|Overall Study|Death|0
7552306|NCT02452034|26251804|P2|Overall Study|Death|0
7552307|NCT02452034|26251805|P1|Overall Study|Death|0
7552308|NCT02452034|26251800|P6|Overall Study|Adverse Event|1
7552309|NCT02452034|26251801|P5|Overall Study|Adverse Event|0
7552310|NCT02452034|26251802|P4|Overall Study|Adverse Event|0
7552311|NCT02452034|26251803|P3|Overall Study|Adverse Event|0
7552312|NCT02452034|26251804|P2|Overall Study|Adverse Event|0
7552313|NCT02452034|26251805|P1|Overall Study|Adverse Event|0
7552320|NCT02451930|26251908|P2|Overall Study|Other|1
7552321|NCT02451930|26251909|P1|Overall Study|Other|0
7552322|NCT02451930|26251908|P2|Overall Study|Withdrawal by Subject|1
7552323|NCT02451930|26251909|P1|Overall Study|Withdrawal by Subject|0
7552324|NCT02451930|26251908|P2|Overall Study|Sponsor Decision|10
7552325|NCT02451930|26251909|P1|Overall Study|Sponsor Decision|2
7552326|NCT02451930|26251908|P2|Overall Study|Lost to Follow-up|3
7552327|NCT02451930|26251909|P1|Overall Study|Lost to Follow-up|0
7552328|NCT02451930|26251908|P2|Overall Study|Death|15
7552329|NCT02451930|26251909|P1|Overall Study|Death|0
7552330|NCT02451917|26251932|P2|First Intervention (24 Weeks)|Adverse Event|2
7552331|NCT02451917|26251933|P1|First Intervention (24 Weeks)|Adverse Event|0
7552332|NCT02451917|26251932|P2|First Intervention (24 Weeks)|Death|1
7552333|NCT02451917|26251933|P1|First Intervention (24 Weeks)|Death|0
7552334|NCT02451917|26251932|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
7552335|NCT02451917|26251933|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
7552336|NCT02451696|26251975|P2|Overall Study|Surgery postponed|0
7552337|NCT02451696|26251976|P1|Overall Study|Surgery postponed|1
7552338|NCT02451670|26251992|P2|Overall Study|Did not have qualifying follow-up visit.|696
7552339|NCT02451670|26251993|P1|Overall Study|Did not have qualifying follow-up visit.|714
7552340|NCT02451358|26252103|P4|Overall Study|Protocol Violation|0
7552341|NCT02451358|26252104|P3|Overall Study|Protocol Violation|1
7552342|NCT02451358|26252105|P2|Overall Study|Protocol Violation|1
7552343|NCT02451358|26252106|P1|Overall Study|Protocol Violation|0
7552344|NCT02451358|26252103|P4|Overall Study|Withdrawal by Subject|0
7552345|NCT02451358|26252104|P3|Overall Study|Withdrawal by Subject|0
7552346|NCT02451358|26252105|P2|Overall Study|Withdrawal by Subject|1
7552347|NCT02451358|26252106|P1|Overall Study|Withdrawal by Subject|1
7552348|NCT02451137|26252194|P2|Overall Study|Other than specified above|3
7552349|NCT02451137|26252195|P1|Overall Study|Other than specified above|2
7552350|NCT02451137|26252194|P2|Overall Study|Withdrawal by Subject|63
7552351|NCT02451137|26252195|P1|Overall Study|Withdrawal by Subject|40
7552352|NCT02451137|26252194|P2|Overall Study|Sponsor decision|25
7552353|NCT02451137|26252195|P1|Overall Study|Sponsor decision|13
7552354|NCT02451137|26252194|P2|Overall Study|Physician Decision|5
7552355|NCT02451137|26252195|P1|Overall Study|Physician Decision|6
7552356|NCT02451137|26252194|P2|Overall Study|Lost to Follow-up|61
7552357|NCT02451137|26252195|P1|Overall Study|Lost to Follow-up|53
7552358|NCT02451137|26252194|P2|Overall Study|Investigator's decision|19
7552359|NCT02451137|26252195|P1|Overall Study|Investigator's decision|23
7552360|NCT02451137|26252194|P2|Overall Study|Hypoglycemia|1
7552361|NCT02451137|26252195|P1|Overall Study|Hypoglycemia|2
7552362|NCT02451137|26252194|P2|Overall Study|Participant decision:discontinue insulin|43
7552363|NCT02451137|26252195|P1|Overall Study|Participant decision:discontinue insulin|41
7552364|NCT02451137|26252194|P2|Overall Study|Lack of Efficacy|9
7552365|NCT02451137|26252195|P1|Overall Study|Lack of Efficacy|4
7552366|NCT02451137|26252194|P2|Overall Study|Adverse Event|42
7552367|NCT02451137|26252195|P1|Overall Study|Adverse Event|43
7552368|NCT02451137|26252194|P2|Overall Study|Randomized but not treated|27
7552369|NCT02451137|26252195|P1|Overall Study|Randomized but not treated|19
7552370|NCT02451124|26252225|P1|Overall Study|Withdrawal by Subject|1
7552371|NCT02451007|26252236|P1|Overall Study|Disease Progression|2
7552372|NCT02451007|26252236|P1|Overall Study|Adverse Event|1
7552373|NCT02451007|26252236|P1|Overall Study|Withdrawal by Subject|4
7552374|NCT02450903|26252243|P1|Overall Study|Subject/guardian decision|1
7552375|NCT02450903|26252243|P1|Overall Study|Switched to commercial drug|1
7552376|NCT02450903|26252243|P1|Overall Study|Progressive disease|15
7552377|NCT02450903|26252243|P1|Overall Study|Adverse Event|3
7552378|NCT02450578|26252287|P4|Overall Study|ECG abnormality so not treated|0
7552379|NCT02450578|26252288|P3|Overall Study|ECG abnormality so not treated|0
7552380|NCT02450578|26252289|P2|Overall Study|ECG abnormality so not treated|0
7552381|NCT02450578|26252290|P1|Overall Study|ECG abnormality so not treated|1
7552382|NCT02450552|26252336|P3|Overall Study|Physician Decision|1
7552383|NCT02450552|26252337|P2|Overall Study|Physician Decision|0
7552384|NCT02450552|26252338|P1|Overall Study|Physician Decision|1
7552385|NCT02450552|26252336|P3|Overall Study|Withdrawal by Subject|4
7552386|NCT02450552|26252337|P2|Overall Study|Withdrawal by Subject|0
7552387|NCT02450552|26252338|P1|Overall Study|Withdrawal by Subject|4
7552388|NCT02450539|26252381|P2|Overall Study|Lost to Follow-up|1
7552389|NCT02450539|26252382|P1|Overall Study|Lost to Follow-up|4
7552390|NCT02450539|26252381|P2|Overall Study|Withdrawal by Subject|6
7552391|NCT02450539|26252382|P1|Overall Study|Withdrawal by Subject|12
7552392|NCT02450526|26252408|P5|OL Period (Cycles 2-5)|Protocol Violation|7
7552393|NCT02450526|26252409|P4|OL Period (Cycles 2-5)|Protocol Violation|0
7552394|NCT02450526|26252410|P3|OL Period (Cycles 2-5)|Protocol Violation|0
7552395|NCT02450526|26252411|P2|OL Period (Cycles 2-5)|Protocol Violation|0
7552396|NCT02450526|26252412|P1|OL Period (Cycles 2-5)|Protocol Violation|0
7552397|NCT02450526|26252408|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
7552398|NCT02450526|26252409|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
7552399|NCT02450526|26252410|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
7552400|NCT02450526|26252411|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
7552401|NCT02450526|26252412|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
7552402|NCT02450526|26252408|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
7552403|NCT02450526|26252409|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7552404|NCT02450526|26252410|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7552405|NCT02450526|26252411|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7552406|NCT02450526|26252412|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7552407|NCT02450526|26252408|P5|OL Period (Cycles 2-5)|Adverse Event|2
7552408|NCT02450526|26252409|P4|OL Period (Cycles 2-5)|Adverse Event|0
7552409|NCT02450526|26252410|P3|OL Period (Cycles 2-5)|Adverse Event|0
7552410|NCT02450526|26252411|P2|OL Period (Cycles 2-5)|Adverse Event|0
7552411|NCT02450526|26252412|P1|OL Period (Cycles 2-5)|Adverse Event|0
7552412|NCT02450526|26252408|P5|DB Period (Cycle 1)|Protocol Violation|0
7552413|NCT02450526|26252409|P4|DB Period (Cycle 1)|Protocol Violation|1
7552414|NCT02450526|26252410|P3|DB Period (Cycle 1)|Protocol Violation|0
7552415|NCT02450526|26252411|P2|DB Period (Cycle 1)|Protocol Violation|0
7552416|NCT02450526|26252412|P1|DB Period (Cycle 1)|Protocol Violation|2
7552417|NCT02450526|26252408|P5|DB Period (Cycle 1)|Lost to Follow-up|0
7552418|NCT02450526|26252409|P4|DB Period (Cycle 1)|Lost to Follow-up|0
7552419|NCT02450526|26252410|P3|DB Period (Cycle 1)|Lost to Follow-up|0
7552420|NCT02450526|26252411|P2|DB Period (Cycle 1)|Lost to Follow-up|0
7552421|NCT02450526|26252412|P1|DB Period (Cycle 1)|Lost to Follow-up|1
7552422|NCT02450526|26252408|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
7552423|NCT02450526|26252409|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
7552424|NCT02450526|26252410|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
7552425|NCT02450526|26252411|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
7552426|NCT02450526|26252412|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
7552427|NCT02450526|26252408|P5|DB Period (Cycle 1)|Adverse Event|0
7552428|NCT02450526|26252409|P4|DB Period (Cycle 1)|Adverse Event|0
7552429|NCT02450526|26252410|P3|DB Period (Cycle 1)|Adverse Event|2
7552430|NCT02450526|26252411|P2|DB Period (Cycle 1)|Adverse Event|0
7552431|NCT02450526|26252412|P1|DB Period (Cycle 1)|Adverse Event|0
7552432|NCT02450487|26252497|P1|Overall Study|Lost to Follow-up|3
7552433|NCT02450331|26252519|P2|Overall Study|On-Study Status: In Survival follow-up|38
7552434|NCT02450331|26252520|P1|Overall Study|On-Study Status: In Survival follow-up|45
7552435|NCT02450331|26252519|P2|Overall Study|On-Study Status: In Disease recurrence follow-up|208
7552436|NCT02450331|26252520|P1|Overall Study|On-Study Status: In Disease recurrence follow-up|179
7552437|NCT02450331|26252519|P2|Overall Study|Withdrawal by Subject|39
7552438|NCT02450331|26252520|P1|Overall Study|Withdrawal by Subject|50
7552439|NCT02450331|26252519|P2|Overall Study|Lost to Follow-up|7
7552440|NCT02450331|26252520|P1|Overall Study|Lost to Follow-up|9
7552441|NCT02450331|26252519|P2|Overall Study|Death|114
7552442|NCT02450331|26252520|P1|Overall Study|Death|120
7552443|NCT02449915|26252543|P2|Overall Study|Abnormal preop lab|1
7552444|NCT02449915|26252544|P1|Overall Study|Abnormal preop lab|0
7552445|NCT02449915|26252543|P2|Overall Study|Intraoperative surgical findings|1
7552446|NCT02449915|26252544|P1|Overall Study|Intraoperative surgical findings|1
7552447|NCT02449915|26252543|P2|Overall Study|Withdrawal by Subject|2
7552448|NCT02449915|26252544|P1|Overall Study|Withdrawal by Subject|0
7552449|NCT02449915|26252543|P2|Overall Study|Exclusion criteria - drug use|0
7552450|NCT02449915|26252544|P1|Overall Study|Exclusion criteria - drug use|1
7552451|NCT02449902|26252552|P2|Overall Study|Withdrawal by Subject|1
7552452|NCT02449902|26252553|P1|Overall Study|Withdrawal by Subject|0
7552453|NCT02449902|26252552|P2|Overall Study|Adverse Event|1
7552454|NCT02449902|26252553|P1|Overall Study|Adverse Event|0
7552455|NCT02449889|26252580|P3|Overall Study|Protocol Violation|1
7552456|NCT02449889|26252581|P2|Overall Study|Protocol Violation|4
7552457|NCT02449889|26252582|P1|Overall Study|Protocol Violation|0
7552458|NCT02449889|26252580|P3|Overall Study|Adverse Event|0
7552459|NCT02449889|26252581|P2|Overall Study|Adverse Event|2
7552460|NCT02449889|26252582|P1|Overall Study|Adverse Event|1
7552461|NCT02449044|26252716|P1|Overall Study|Sponsor Discontinued Trial|3
7552462|NCT02449044|26252716|P1|Overall Study|Physician Decision|9
7552463|NCT02449044|26252716|P1|Overall Study|Met Withdrawal Criteria|7
7552464|NCT02449044|26252716|P1|Overall Study|Adverse Event|30
7552465|NCT02449044|26252716|P1|Overall Study|Withdrawal by Subject|13
7552466|NCT02449044|26252716|P1|Overall Study|Lost to Follow-up|2
7552467|NCT02449018|26252737|P2|Overall Study|Patient decision|0
7552468|NCT02449018|26252738|P1|Overall Study|Patient decision|2
7552469|NCT02449018|26252737|P2|Overall Study|Protocol deviation|0
7552470|NCT02449018|26252738|P1|Overall Study|Protocol deviation|4
7552471|NCT02449018|26252737|P2|Overall Study|Adverse Event|1
7552472|NCT02449018|26252738|P1|Overall Study|Adverse Event|5
7552473|NCT02449018|26252737|P2|Overall Study|Administrative problems|0
7552474|NCT02449018|26252738|P1|Overall Study|Administrative problems|1
7552475|NCT02449018|26252737|P2|Overall Study|Abnormal laboratory value|1
7552476|NCT02449018|26252738|P1|Overall Study|Abnormal laboratory value|0
7552477|NCT02448875|26252785|P3|Overall Study|Withdrawal by Subject|0
7552478|NCT02448875|26252786|P2|Overall Study|Withdrawal by Subject|0
7552479|NCT02448875|26252787|P1|Overall Study|Withdrawal by Subject|1
7552480|NCT02448875|26252785|P3|Overall Study|Investigator Decision|1
7552481|NCT02448875|26252786|P2|Overall Study|Investigator Decision|0
7552482|NCT02448875|26252787|P1|Overall Study|Investigator Decision|3
7552483|NCT02448875|26252785|P3|Overall Study|Lost to Follow-up|0
7552484|NCT02448875|26252786|P2|Overall Study|Lost to Follow-up|0
7552485|NCT02448875|26252787|P1|Overall Study|Lost to Follow-up|1
7552486|NCT02448875|26252785|P3|Overall Study|Adverse Event|0
7552487|NCT02448875|26252786|P2|Overall Study|Adverse Event|1
7552488|NCT02448875|26252787|P1|Overall Study|Adverse Event|2
7552489|NCT02448810|26252835|P8|Overall Study|Other (unspecified)|0
7552490|NCT02448810|26252836|P7|Overall Study|Other (unspecified)|2
7552491|NCT02448810|26252837|P6|Overall Study|Other (unspecified)|0
7552492|NCT02448810|26252838|P5|Overall Study|Other (unspecified)|0
7552493|NCT02448810|26252839|P4|Overall Study|Other (unspecified)|0
7552494|NCT02448810|26252840|P3|Overall Study|Other (unspecified)|0
7552495|NCT02448810|26252841|P2|Overall Study|Other (unspecified)|0
7552496|NCT02448810|26252842|P1|Overall Study|Other (unspecified)|0
7552497|NCT02448810|26252835|P8|Overall Study|Lost to Follow-up|0
7552498|NCT02448810|26252836|P7|Overall Study|Lost to Follow-up|0
7552499|NCT02448810|26252837|P6|Overall Study|Lost to Follow-up|0
7552500|NCT02448810|26252838|P5|Overall Study|Lost to Follow-up|0
7552501|NCT02448810|26252839|P4|Overall Study|Lost to Follow-up|0
7552502|NCT02448810|26252840|P3|Overall Study|Lost to Follow-up|0
7552503|NCT02448810|26252841|P2|Overall Study|Lost to Follow-up|1
7552504|NCT02448810|26252842|P1|Overall Study|Lost to Follow-up|0
7552505|NCT02448810|26252835|P8|Overall Study|Other (Progressive disease)|5
7552506|NCT02448810|26252836|P7|Overall Study|Other (Progressive disease)|14
7552507|NCT02448810|26252837|P6|Overall Study|Other (Progressive disease)|9
7552508|NCT02448810|26252838|P5|Overall Study|Other (Progressive disease)|23
7552509|NCT02448810|26252839|P4|Overall Study|Other (Progressive disease)|3
7552510|NCT02448810|26252840|P3|Overall Study|Other (Progressive disease)|0
7552511|NCT02448810|26252841|P2|Overall Study|Other (Progressive disease)|2
7552512|NCT02448810|26252842|P1|Overall Study|Other (Progressive disease)|2
7552513|NCT02448810|26252835|P8|Overall Study|Death|0
7552514|NCT02448810|26252836|P7|Overall Study|Death|0
7552515|NCT02448810|26252837|P6|Overall Study|Death|0
7552516|NCT02448810|26252838|P5|Overall Study|Death|1
7552517|NCT02448810|26252839|P4|Overall Study|Death|0
7552518|NCT02448810|26252840|P3|Overall Study|Death|1
7552519|NCT02448810|26252841|P2|Overall Study|Death|0
7552520|NCT02448810|26252842|P1|Overall Study|Death|1
7552521|NCT02448810|26252835|P8|Overall Study|Other (study terminated by sponsor)|1
7552522|NCT02448810|26252836|P7|Overall Study|Other (study terminated by sponsor)|2
7552523|NCT02448810|26252837|P6|Overall Study|Other (study terminated by sponsor)|2
7552524|NCT02448810|26252838|P5|Overall Study|Other (study terminated by sponsor)|4
7552525|NCT02448810|26252839|P4|Overall Study|Other (study terminated by sponsor)|0
7552526|NCT02448810|26252840|P3|Overall Study|Other (study terminated by sponsor)|0
7552527|NCT02448810|26252841|P2|Overall Study|Other (study terminated by sponsor)|0
7552528|NCT02448810|26252842|P1|Overall Study|Other (study terminated by sponsor)|0
7552529|NCT02448810|26252835|P8|Overall Study|Withdrawal by Subject|2
7552530|NCT02448810|26252836|P7|Overall Study|Withdrawal by Subject|0
7552531|NCT02448810|26252837|P6|Overall Study|Withdrawal by Subject|5
7552532|NCT02448810|26252838|P5|Overall Study|Withdrawal by Subject|3
7552533|NCT02448810|26252839|P4|Overall Study|Withdrawal by Subject|0
7552534|NCT02448810|26252840|P3|Overall Study|Withdrawal by Subject|1
7552535|NCT02448810|26252841|P2|Overall Study|Withdrawal by Subject|0
7552536|NCT02448810|26252842|P1|Overall Study|Withdrawal by Subject|0
7552537|NCT02448810|26252835|P8|Overall Study|Adverse Event|0
7552538|NCT02448810|26252836|P7|Overall Study|Adverse Event|0
7552539|NCT02448810|26252837|P6|Overall Study|Adverse Event|0
7552540|NCT02448810|26252838|P5|Overall Study|Adverse Event|0
7552541|NCT02448810|26252839|P4|Overall Study|Adverse Event|0
7552542|NCT02448810|26252840|P3|Overall Study|Adverse Event|1
7552543|NCT02448810|26252841|P2|Overall Study|Adverse Event|0
7552544|NCT02448810|26252842|P1|Overall Study|Adverse Event|0
7552545|NCT02448771|26252908|P1|Overall Study|Started new therapy|2
7552546|NCT02448771|26252908|P1|Overall Study|Physician Decision|3
7552547|NCT02448771|26252908|P1|Overall Study|Unacceptable Toxicity|1
7552548|NCT02448771|26252908|P1|Overall Study|Disease Progression|30
7552549|NCT02448719|26252932|P11|Overall Study|Withdrawal by Subject|0
7552550|NCT02448719|26252933|P10|Overall Study|Withdrawal by Subject|0
7552551|NCT02448719|26252934|P9|Overall Study|Withdrawal by Subject|0
7552552|NCT02448719|26252935|P8|Overall Study|Withdrawal by Subject|0
7552553|NCT02448719|26252936|P7|Overall Study|Withdrawal by Subject|0
7552554|NCT02448719|26252937|P6|Overall Study|Withdrawal by Subject|0
7552555|NCT02448719|26252938|P5|Overall Study|Withdrawal by Subject|1
7552556|NCT02448719|26252939|P4|Overall Study|Withdrawal by Subject|0
7552557|NCT02448719|26252940|P3|Overall Study|Withdrawal by Subject|0
7552558|NCT02448719|26252941|P2|Overall Study|Withdrawal by Subject|0
7552559|NCT02448719|26252942|P1|Overall Study|Withdrawal by Subject|0
7552560|NCT02448706|26253166|P2|Overall Study|Protocol Violation|1
7552561|NCT02448706|26253167|P1|Overall Study|Protocol Violation|1
7552562|NCT02448706|26253166|P2|Overall Study|Withdrawal by Subject|3
7552563|NCT02448706|26253167|P1|Overall Study|Withdrawal by Subject|4
7552564|NCT02448680|26253181|P2|Overall Study|Withdrawal by Subject|2
7552565|NCT02448680|26253182|P1|Overall Study|Withdrawal by Subject|0
7552566|NCT02448680|26253181|P2|Overall Study|Physician Decision|1
7552567|NCT02448680|26253182|P1|Overall Study|Physician Decision|1
7552568|NCT02448563|26253251|P2|Overall Study|Withdrawal by Subject|1
7552569|NCT02448563|26253252|P1|Overall Study|Withdrawal by Subject|0
7552570|NCT02448563|26253251|P2|Overall Study|Lost to Follow-up|10
7552571|NCT02448563|26253252|P1|Overall Study|Lost to Follow-up|16
7552572|NCT02448537|26253274|P3|Overall Study|Withdrawal by Subject|1
7552573|NCT02448537|26253275|P2|Overall Study|Withdrawal by Subject|1
7552574|NCT02448537|26253276|P1|Overall Study|Withdrawal by Subject|1
7552575|NCT02448446|26253292|P2|Overall Study|Withdrawal by Subject|0
7552576|NCT02448446|26253293|P1|Overall Study|Withdrawal by Subject|1
7552577|NCT02448043|26253415|P2|Overall Study|Protocol Violation|2
7552578|NCT02448043|26253416|P1|Overall Study|Protocol Violation|1
7552579|NCT02448043|26253415|P2|Overall Study|Withdrawal by Subject|2
7552580|NCT02448043|26253416|P1|Overall Study|Withdrawal by Subject|2
7552581|NCT02447952|26253434|P1|Overall Study|Withdrawal by Subject|4
7552582|NCT02447952|26253434|P1|Overall Study|Physician Decision|1
7552583|NCT02447952|26253434|P1|Overall Study|Adverse Event|2
7552584|NCT02447887|26253491|P1|Overall Study|Study was terminated|3
7552585|NCT02447848|26253504|P1|Overall Study|Withdrawal by Subject|4
7552586|NCT02447848|26253504|P1|Overall Study|Lack of Efficacy|4
7552587|NCT02447848|26253504|P1|Overall Study|Patient discharged|3
7552588|NCT02447744|26253512|P2|Overall Study|Data not collected b/c logistic reasons|0
7552589|NCT02447744|26253513|P1|Overall Study|Data not collected b/c logistic reasons|3
7552590|NCT02447744|26253512|P2|Overall Study|Withdrawal by Subject|1
7552591|NCT02447744|26253513|P1|Overall Study|Withdrawal by Subject|3
7552592|NCT02447718|26253525|P2|Overall Study|Screen Failure|0
7552593|NCT02447718|26253526|P1|Overall Study|Screen Failure|1
7552594|NCT02447718|26253525|P2|Overall Study|Withdrawal by Subject|0
7552595|NCT02447718|26253526|P1|Overall Study|Withdrawal by Subject|3
7552596|NCT02447718|26253525|P2|Overall Study|Lost to Follow-up|0
7552597|NCT02447718|26253526|P1|Overall Study|Lost to Follow-up|8
7552598|NCT02447497|26253552|P4|Overall Study|Dressing was compromised|0
7552599|NCT02447497|26253553|P3|Overall Study|Dressing was compromised|0
7552600|NCT02447497|26253554|P2|Overall Study|Dressing was compromised|1
7552601|NCT02447497|26253555|P1|Overall Study|Dressing was compromised|0
7552602|NCT02447497|26253552|P4|Overall Study|Did not meet treatment day baseline.|2
7552603|NCT02447497|26253553|P3|Overall Study|Did not meet treatment day baseline.|2
7552604|NCT02447497|26253554|P2|Overall Study|Did not meet treatment day baseline.|5
7552605|NCT02447497|26253555|P1|Overall Study|Did not meet treatment day baseline.|6
7552606|NCT02447458|26253579|P6|Overall Study|Other|0
7552607|NCT02447458|26253580|P5|Overall Study|Other|0
7552608|NCT02447458|26253581|P4|Overall Study|Other|0
7552609|NCT02447458|26253582|P3|Overall Study|Other|1
7552610|NCT02447458|26253583|P2|Overall Study|Other|0
7552611|NCT02447458|26253584|P1|Overall Study|Other|0
7552612|NCT02447432|26253682|P2|Epoch 001|Lost to Follow-up|3
7552613|NCT02447432|26253683|P1|Epoch 001|Lost to Follow-up|1
7552614|NCT02447432|26253682|P2|Epoch 001|Migrated/moved from study area|5
7552615|NCT02447432|26253683|P1|Epoch 001|Migrated/moved from study area|3
7552616|NCT02447432|26253682|P2|Epoch 001|Withdrawal by Subject|4
7552617|NCT02447432|26253683|P1|Epoch 001|Withdrawal by Subject|0
7552618|NCT02447432|26253682|P2|Epoch 001|Adverse Event|1
7552619|NCT02447432|26253683|P1|Epoch 001|Adverse Event|1
7552620|NCT02447328|26253715|P1|Overall Study|Withdrawal by Subject|1
7552621|NCT02447302|26253722|P3|Overall Study|Sponsor Decision|1
7552622|NCT02447302|26253723|P2|Overall Study|Sponsor Decision|0
7552623|NCT02447302|26253724|P1|Overall Study|Sponsor Decision|0
7552624|NCT02447302|26253722|P3|Overall Study|Withdrawal by Subject|5
7552625|NCT02447302|26253723|P2|Overall Study|Withdrawal by Subject|1
7552626|NCT02447302|26253724|P1|Overall Study|Withdrawal by Subject|0
7552627|NCT02447302|26253722|P3|Overall Study|Adverse Event|0
7552628|NCT02447302|26253723|P2|Overall Study|Adverse Event|3
7552629|NCT02447302|26253724|P1|Overall Study|Adverse Event|4
7552630|NCT02447302|26253722|P3|Overall Study|Physician Decision|0
7552631|NCT02447302|26253723|P2|Overall Study|Physician Decision|0
7552632|NCT02447302|26253724|P1|Overall Study|Physician Decision|1
7552633|NCT02447250|26253750|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
7552634|NCT02447250|26253750|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
7552635|NCT02447250|26253750|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
7552636|NCT02447172|26253764|P3|Overall Study|protocol specific treatment unrelated|2
7552637|NCT02447172|26253765|P2|Overall Study|protocol specific treatment unrelated|0
7552638|NCT02447172|26253766|P1|Overall Study|protocol specific treatment unrelated|3
7552639|NCT02447172|26253764|P3|Overall Study|Withdrawal by Subject|3
7552640|NCT02447172|26253765|P2|Overall Study|Withdrawal by Subject|1
7552641|NCT02447172|26253766|P1|Overall Study|Withdrawal by Subject|5
7552642|NCT02447172|26253764|P3|Overall Study|Lost to Follow-up|4
7552643|NCT02447172|26253765|P2|Overall Study|Lost to Follow-up|4
7552644|NCT02447172|26253766|P1|Overall Study|Lost to Follow-up|7
7552645|NCT02447172|26253764|P3|Overall Study|Protocol Violation|2
7552646|NCT02447172|26253765|P2|Overall Study|Protocol Violation|1
7552647|NCT02447172|26253766|P1|Overall Study|Protocol Violation|2
7552648|NCT02447172|26253764|P3|Overall Study|Death|0
7552649|NCT02447172|26253765|P2|Overall Study|Death|1
7552650|NCT02447172|26253766|P1|Overall Study|Death|3
7552651|NCT02447172|26253764|P3|Overall Study|Adverse Event|7
7552652|NCT02447172|26253765|P2|Overall Study|Adverse Event|8
7552653|NCT02447172|26253766|P1|Overall Study|Adverse Event|11
7552654|NCT02447081|26253789|P1|Overall Study|unsuccessful implant procedure|10
7552655|NCT02447081|26253789|P1|Overall Study|Visit not completed|17
7552656|NCT02447081|26253789|P1|Overall Study|Lost to Follow-up|36
7552657|NCT02447081|26253789|P1|Overall Study|Death|161
7552658|NCT02447029|26253805|P2|Overall Study|Withdrawal by Subject|2
7552659|NCT02447029|26253806|P1|Overall Study|Withdrawal by Subject|3
7552660|NCT02447003|26253826|P2|Overall Study|Death|63
7552661|NCT02447003|26253827|P1|Overall Study|Death|154
7552662|NCT02447003|26253826|P2|Overall Study|Lost to Follow-up|0
7552663|NCT02447003|26253827|P1|Overall Study|Lost to Follow-up|5
7552664|NCT02447003|26253826|P2|Overall Study|Progressive Disease|0
7552665|NCT02447003|26253827|P1|Overall Study|Progressive Disease|1
7552666|NCT02447003|26253826|P2|Overall Study|Sponsor Decision|11
7552667|NCT02447003|26253827|P1|Overall Study|Sponsor Decision|6
7552668|NCT02447003|26253826|P2|Overall Study|Withdrawal by Subject|3
7552669|NCT02447003|26253827|P1|Overall Study|Withdrawal by Subject|4
7552670|NCT02447003|26253826|P2|Overall Study|Physician Decision|1
7552671|NCT02447003|26253827|P1|Overall Study|Physician Decision|0
7552672|NCT02447003|26253826|P2|Overall Study|Site discontinued|2
7552673|NCT02447003|26253827|P1|Overall Study|Site discontinued|0
7552674|NCT02447003|26253826|P2|Overall Study|Other|4
7552675|NCT02447003|26253827|P1|Overall Study|Other|0
7552676|NCT02446990|26253863|P2|Overall Study|Withdrawal by Subject|199
7552677|NCT02446990|26253864|P1|Overall Study|Withdrawal by Subject|231
7552678|NCT02446990|26253863|P2|Overall Study|Physician Decision|0
7552679|NCT02446990|26253864|P1|Overall Study|Physician Decision|1
7552680|NCT02446990|26253863|P2|Overall Study|Lost to Follow-up|1
7552681|NCT02446990|26253864|P1|Overall Study|Lost to Follow-up|3
7552682|NCT02446990|26253863|P2|Overall Study|Death|458
7552683|NCT02446990|26253864|P1|Overall Study|Death|485
7552684|NCT02446912|26253899|P3|Overall Study|Miscellaneous|4
7552685|NCT02446912|26253900|P2|Overall Study|Miscellaneous|2
7552686|NCT02446912|26253901|P1|Overall Study|Miscellaneous|2
7552687|NCT02446912|26253899|P3|Overall Study|Withdrawal by Subject|15
7552688|NCT02446912|26253900|P2|Overall Study|Withdrawal by Subject|15
7552689|NCT02446912|26253901|P1|Overall Study|Withdrawal by Subject|10
7552690|NCT02446912|26253899|P3|Overall Study|Severe non-compliance to protocol|1
7552691|NCT02446912|26253900|P2|Overall Study|Severe non-compliance to protocol|0
7552692|NCT02446912|26253901|P1|Overall Study|Severe non-compliance to protocol|1
7552693|NCT02446912|26253899|P3|Overall Study|Lost to Follow-up|2
7552694|NCT02446912|26253900|P2|Overall Study|Lost to Follow-up|0
7552695|NCT02446912|26253901|P1|Overall Study|Lost to Follow-up|0
7552696|NCT02446912|26253899|P3|Overall Study|Lack of Efficacy|7
7552697|NCT02446912|26253900|P2|Overall Study|Lack of Efficacy|4
7552698|NCT02446912|26253901|P1|Overall Study|Lack of Efficacy|1
7552699|NCT02446912|26253899|P3|Overall Study|Study-specific withdrawal criteria|0
7552700|NCT02446912|26253900|P2|Overall Study|Study-specific withdrawal criteria|0
7552701|NCT02446912|26253901|P1|Overall Study|Study-specific withdrawal criteria|1
7552702|NCT02446912|26253899|P3|Overall Study|Condition under investigation worsened|1
7552703|NCT02446912|26253900|P2|Overall Study|Condition under investigation worsened|1
7552704|NCT02446912|26253901|P1|Overall Study|Condition under investigation worsened|0
7552705|NCT02446912|26253899|P3|Overall Study|Adverse Event|5
7552706|NCT02446912|26253900|P2|Overall Study|Adverse Event|13
7552707|NCT02446912|26253901|P1|Overall Study|Adverse Event|3
7552708|NCT02446899|26253974|P2|Overall Study|Failure to Meet Randomization Criteria|2
7552709|NCT02446899|26253975|P1|Overall Study|Failure to Meet Randomization Criteria|0
7552710|NCT02446899|26253974|P2|Overall Study|Miscellaneous|4
7552711|NCT02446899|26253975|P1|Overall Study|Miscellaneous|5
7552712|NCT02446899|26253974|P2|Overall Study|Withdrawal by Subject|19
7552713|NCT02446899|26253975|P1|Overall Study|Withdrawal by Subject|11
7552714|NCT02446899|26253974|P2|Overall Study|Severe Non-Compliance to Protocol|1
7552715|NCT02446899|26253975|P1|Overall Study|Severe Non-Compliance to Protocol|0
7552716|NCT02446899|26253974|P2|Overall Study|Lost to Follow-up|3
7552717|NCT02446899|26253975|P1|Overall Study|Lost to Follow-up|1
7552718|NCT02446899|26253974|P2|Overall Study|Lack of Efficacy|8
7552719|NCT02446899|26253975|P1|Overall Study|Lack of Efficacy|2
7552720|NCT02446899|26253974|P2|Overall Study|Study Specific Withdrawal Criteria|0
7552721|NCT02446899|26253975|P1|Overall Study|Study Specific Withdrawal Criteria|1
7552722|NCT02446899|26253974|P2|Overall Study|Condition Under Investigation Worsened|4
7552723|NCT02446899|26253975|P1|Overall Study|Condition Under Investigation Worsened|1
7552724|NCT02446899|26253974|P2|Overall Study|Adverse Event|7
7552725|NCT02446899|26253975|P1|Overall Study|Adverse Event|4
7552726|NCT02446886|26254001|P2|Overall Study|Withdrawal by Subject|1
7552727|NCT02446886|26254002|P1|Overall Study|Withdrawal by Subject|1
7552728|NCT02446886|26254001|P2|Overall Study|Adverse Event|3
7552729|NCT02446886|26254002|P1|Overall Study|Adverse Event|1
7552730|NCT02446769|26254031|P3|Study Period|Randomized in Error|0
7552731|NCT02446769|26254032|P2|Study Period|Randomized in Error|2
7552732|NCT02446769|26254033|P1|Study Period|Randomized in Error|0
7552733|NCT02446769|26254031|P3|Screening Period|Screen Failure|0
7552734|NCT02446769|26254032|P2|Screening Period|Screen Failure|0
7552735|NCT02446769|26254033|P1|Screening Period|Screen Failure|11
7552736|NCT02446743|26254056|P2|Overall Study|Other|3
7552737|NCT02446743|26254057|P1|Overall Study|Other|2
7552738|NCT02446743|26254056|P2|Overall Study|Adverse Event|1
7552739|NCT02446743|26254057|P1|Overall Study|Adverse Event|1
7552740|NCT02446743|26254056|P2|Overall Study|Lost to Follow-up|0
7552741|NCT02446743|26254057|P1|Overall Study|Lost to Follow-up|1
7552742|NCT02446743|26254056|P2|Overall Study|Withdrawal by Subject|1
7552743|NCT02446743|26254057|P1|Overall Study|Withdrawal by Subject|1
7552744|NCT02446717|26254212|P5|Overall Study|Withdrew consent|0
7552745|NCT02446717|26254213|P4|Overall Study|Withdrew consent|1
7552746|NCT02446717|26254214|P3|Overall Study|Withdrew consent|0
7552747|NCT02446717|26254215|P2|Overall Study|Withdrew consent|0
7552748|NCT02446717|26254216|P1|Overall Study|Withdrew consent|0
7552749|NCT02446717|26254212|P5|Overall Study|Lost to Follow-up|1
7552750|NCT02446717|26254213|P4|Overall Study|Lost to Follow-up|0
7552751|NCT02446717|26254214|P3|Overall Study|Lost to Follow-up|1
7552752|NCT02446717|26254215|P2|Overall Study|Lost to Follow-up|1
7552753|NCT02446717|26254216|P1|Overall Study|Lost to Follow-up|0
7552754|NCT02446717|26254212|P5|Overall Study|Adverse Event|0
7552755|NCT02446717|26254213|P4|Overall Study|Adverse Event|0
7552756|NCT02446717|26254214|P3|Overall Study|Adverse Event|1
7552757|NCT02446717|26254215|P2|Overall Study|Adverse Event|0
7552758|NCT02446717|26254216|P1|Overall Study|Adverse Event|0
7552759|NCT02446691|26254243|P1|Overall Study|Protocol Violation|1
7552760|NCT02446691|26254243|P1|Overall Study|Lost to Follow-up|8
7552761|NCT02446691|26254243|P1|Overall Study|Withdrawal by Subject|2
7552762|NCT02446600|26254290|P4|Overall Study|Duplicate Enrollment|0
7552763|NCT02446600|26254291|P3|Overall Study|Duplicate Enrollment|0
7552764|NCT02446600|26254292|P2|Overall Study|Duplicate Enrollment|1
7552765|NCT02446600|26254293|P1|Overall Study|Duplicate Enrollment|0
7552766|NCT02446600|26254290|P4|Overall Study|Ineligible|1
7552767|NCT02446600|26254291|P3|Overall Study|Ineligible|4
7552768|NCT02446600|26254292|P2|Overall Study|Ineligible|4
7552769|NCT02446600|26254293|P1|Overall Study|Ineligible|1
7552770|NCT02446600|26254290|P4|Overall Study|Withdrawal by Subject|0
7552771|NCT02446600|26254291|P3|Overall Study|Withdrawal by Subject|17
7552772|NCT02446600|26254292|P2|Overall Study|Withdrawal by Subject|5
7552773|NCT02446600|26254293|P1|Overall Study|Withdrawal by Subject|19
7552774|NCT02446600|26254290|P4|Overall Study|Never treated|0
7552775|NCT02446600|26254291|P3|Overall Study|Never treated|6
7552776|NCT02446600|26254292|P2|Overall Study|Never treated|2
7552777|NCT02446600|26254293|P1|Overall Study|Never treated|20
7552778|NCT02446418|26254339|P2|Overall Study|Protocol defined stopping criteria reach|0
7552779|NCT02446418|26254340|P1|Overall Study|Protocol defined stopping criteria reach|1
7552780|NCT02446418|26254339|P2|Overall Study|Lack of Efficacy|0
7552781|NCT02446418|26254340|P1|Overall Study|Lack of Efficacy|2
7552782|NCT02446418|26254339|P2|Overall Study|Protocol Violation|2
7552783|NCT02446418|26254340|P1|Overall Study|Protocol Violation|1
7552784|NCT02446418|26254339|P2|Overall Study|Lost to Follow-up|2
7552785|NCT02446418|26254340|P1|Overall Study|Lost to Follow-up|2
7552786|NCT02446418|26254339|P2|Overall Study|Withdrawal by Subject|3
7552787|NCT02446418|26254340|P1|Overall Study|Withdrawal by Subject|3
7552788|NCT02446418|26254339|P2|Overall Study|Physician Decision|1
7552789|NCT02446418|26254340|P1|Overall Study|Physician Decision|5
7552790|NCT02446418|26254339|P2|Overall Study|Adverse Event|8
7552791|NCT02446418|26254340|P1|Overall Study|Adverse Event|4
7552792|NCT02446171|26254411|P4|Overall Study|Withdrawal by Subject|0
7552793|NCT02446171|26254412|P3|Overall Study|Withdrawal by Subject|2
7552794|NCT02446171|26254413|P2|Overall Study|Withdrawal by Subject|0
7552795|NCT02446171|26254414|P1|Overall Study|Withdrawal by Subject|0
7552796|NCT02446015|26254485|P2|Overall Study|Withdrawal by Subject|0
7552797|NCT02446015|26254486|P1|Overall Study|Withdrawal by Subject|1
7552798|NCT02446015|26254485|P2|Overall Study|Adverse Event|1
7552799|NCT02446015|26254486|P1|Overall Study|Adverse Event|0
7552800|NCT02445963|26254501|P4|Overall Study|Symptoms post-vaccination|0
7552801|NCT02445963|26254502|P3|Overall Study|Symptoms post-vaccination|1
7552802|NCT02445963|26254503|P2|Overall Study|Symptoms post-vaccination|0
7552803|NCT02445963|26254504|P1|Overall Study|Symptoms post-vaccination|0
7552804|NCT02445963|26254501|P4|Overall Study|Change in employment|0
7552805|NCT02445963|26254502|P3|Overall Study|Change in employment|0
7552806|NCT02445963|26254503|P2|Overall Study|Change in employment|0
7552807|NCT02445963|26254504|P1|Overall Study|Change in employment|1
7552808|NCT02445963|26254501|P4|Overall Study|Lost to Follow-up|0
7552809|NCT02445963|26254502|P3|Overall Study|Lost to Follow-up|0
7552810|NCT02445963|26254503|P2|Overall Study|Lost to Follow-up|0
7552811|NCT02445963|26254504|P1|Overall Study|Lost to Follow-up|1
7552812|NCT02445794|26254629|P4|Overall Study|Adverse Event|0
7552813|NCT02445794|26254630|P3|Overall Study|Adverse Event|2
7552814|NCT02445794|26254631|P2|Overall Study|Adverse Event|0
7552815|NCT02445794|26254632|P1|Overall Study|Adverse Event|0
7552816|NCT02445755|26254662|P1|Overall Study|Screen Failure|5
7552817|NCT02445755|26254662|P1|Overall Study|Protocol Violation|6
7552818|NCT02445755|26254662|P1|Overall Study|Withdrawal by Subject|2
7552819|NCT02445586|26254676|P1|Overall Study|Medical Condition|1
7552820|NCT02445586|26254676|P1|Overall Study|Protocol Violation|1
7552821|NCT02445586|26254676|P1|Overall Study|Disease Progression|10
7552822|NCT02445586|26254676|P1|Overall Study|Withdrawal by Subject|13
7552823|NCT02445586|26254676|P1|Overall Study|Death|14
7552824|NCT02445573|26254716|P2|Overall Study|Lost to Follow-up|1
7552825|NCT02445573|26254717|P1|Overall Study|Lost to Follow-up|0
7552826|NCT02445573|26254716|P2|Overall Study|Withdrawal by Subject|1
7552827|NCT02445573|26254717|P1|Overall Study|Withdrawal by Subject|1
7552828|NCT02444793|26254814|P4|Overall Study|Objective progression or relapse|3
7552829|NCT02444793|26254815|P3|Overall Study|Objective progression or relapse|2
7552830|NCT02444793|26254816|P2|Overall Study|Objective progression or relapse|1
7552831|NCT02444793|26254817|P1|Overall Study|Objective progression or relapse|9
7552832|NCT02444793|26254814|P4|Overall Study|Other|0
7552833|NCT02444793|26254815|P3|Overall Study|Other|2
7552834|NCT02444793|26254816|P2|Overall Study|Other|0
7552835|NCT02444793|26254817|P1|Overall Study|Other|0
7552836|NCT02444793|26254814|P4|Overall Study|Death|0
7552837|NCT02444793|26254815|P3|Overall Study|Death|0
7552838|NCT02444793|26254816|P2|Overall Study|Death|3
7552839|NCT02444793|26254817|P1|Overall Study|Death|0
7552840|NCT02444793|26254814|P4|Overall Study|Lost to Follow-up|0
7552841|NCT02444793|26254815|P3|Overall Study|Lost to Follow-up|0
7552842|NCT02444793|26254816|P2|Overall Study|Lost to Follow-up|2
7552843|NCT02444793|26254817|P1|Overall Study|Lost to Follow-up|2
7552844|NCT02444533|26254976|P2|Overall Study|Only gave post-procedure complications|2
7552845|NCT02444533|26254977|P1|Overall Study|Only gave post-procedure complications|2
7552846|NCT02444533|26254976|P2|Overall Study|Not able to complete forms|2
7552847|NCT02444533|26254977|P1|Overall Study|Not able to complete forms|0
7552848|NCT02444182|26255010|P2|Overall Study|Lost to Follow-up|4
7552849|NCT02444182|26255011|P1|Overall Study|Lost to Follow-up|0
7552850|NCT02444182|26255010|P2|Overall Study|non-compliance|1
7552851|NCT02444182|26255011|P1|Overall Study|non-compliance|2
7552852|NCT02443883|26255034|P4|Overall Study|Randomized, but never treated|0
7552853|NCT02443883|26255035|P3|Overall Study|Randomized, but never treated|0
7552854|NCT02443883|26255036|P2|Overall Study|Randomized, but never treated|0
7552855|NCT02443883|26255037|P1|Overall Study|Randomized, but never treated|1
7552856|NCT02443883|26255034|P4|Overall Study|Withdrawal by Subject|2
7552857|NCT02443883|26255035|P3|Overall Study|Withdrawal by Subject|0
7552858|NCT02443883|26255036|P2|Overall Study|Withdrawal by Subject|0
7552859|NCT02443883|26255037|P1|Overall Study|Withdrawal by Subject|1
7552860|NCT02443883|26255034|P4|Overall Study|Physician Decision|3
7552861|NCT02443883|26255035|P3|Overall Study|Physician Decision|0
7552862|NCT02443883|26255036|P2|Overall Study|Physician Decision|1
7552863|NCT02443883|26255037|P1|Overall Study|Physician Decision|1
7552864|NCT02443883|26255034|P4|Overall Study|Lost to Follow-up|0
7552865|NCT02443883|26255035|P3|Overall Study|Lost to Follow-up|1
7552866|NCT02443883|26255036|P2|Overall Study|Lost to Follow-up|2
7552867|NCT02443883|26255037|P1|Overall Study|Lost to Follow-up|3
7552868|NCT02443883|26255034|P4|Overall Study|Adverse Event|0
7552869|NCT02443883|26255035|P3|Overall Study|Adverse Event|0
7552870|NCT02443883|26255036|P2|Overall Study|Adverse Event|1
7552871|NCT02443883|26255037|P1|Overall Study|Adverse Event|0
7552872|NCT02443805|26255057|P2|Overall Study|Any other reason not above-mentioned|2
7552873|NCT02443805|26255058|P1|Overall Study|Any other reason not above-mentioned|3
7552874|NCT02443805|26255057|P2|Overall Study|Withdrawal by parent/guardian|5
7552875|NCT02443805|26255058|P1|Overall Study|Withdrawal by parent/guardian|3
7552876|NCT02443805|26255057|P2|Overall Study|Non-compliance with study drug|4
7552877|NCT02443805|26255058|P1|Overall Study|Non-compliance with study drug|6
7552878|NCT02443805|26255057|P2|Overall Study|Lack of Efficacy|1
7552879|NCT02443805|26255058|P1|Overall Study|Lack of Efficacy|1
7552880|NCT02443805|26255057|P2|Overall Study|Protocol Violation|4
7552881|NCT02443805|26255058|P1|Overall Study|Protocol Violation|2
7552882|NCT02443805|26255057|P2|Overall Study|Pregnancy|5
7552883|NCT02443805|26255058|P1|Overall Study|Pregnancy|6
7552884|NCT02443805|26255057|P2|Overall Study|Lost to Follow-up|14
7552885|NCT02443805|26255058|P1|Overall Study|Lost to Follow-up|19
7552886|NCT02443805|26255057|P2|Overall Study|Withdrawal by Subject|74
7552887|NCT02443805|26255058|P1|Overall Study|Withdrawal by Subject|73
7552888|NCT02443805|26255057|P2|Overall Study|Adverse Event|18
7552889|NCT02443805|26255058|P1|Overall Study|Adverse Event|100
7552890|NCT02443740|26255089|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552891|NCT02443740|26255090|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552892|NCT02443740|26255091|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552893|NCT02443740|26255092|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552894|NCT02443740|26255093|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552895|NCT02443740|26255094|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
7552896|NCT02443740|26255095|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552897|NCT02443740|26255096|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552898|NCT02443740|26255097|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552899|NCT02443740|26255098|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552900|NCT02443740|26255099|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7552901|NCT02443740|26255089|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
7552902|NCT02443740|26255090|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
7552903|NCT02443740|26255091|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
7552904|NCT02443740|26255092|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
7552905|NCT02443740|26255093|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
7552906|NCT02443740|26255094|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
7552907|NCT02443740|26255095|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
7552908|NCT02443740|26255096|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
7552909|NCT02443740|26255097|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
7552910|NCT02443740|26255098|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
7552911|NCT02443740|26255099|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
7552912|NCT02443740|26255089|P11|Intervention Period 1 (3 Days)|Adverse Event|0
7552913|NCT02443740|26255090|P10|Intervention Period 1 (3 Days)|Adverse Event|0
7552914|NCT02443740|26255091|P9|Intervention Period 1 (3 Days)|Adverse Event|0
7552915|NCT02443740|26255092|P8|Intervention Period 1 (3 Days)|Adverse Event|0
7552916|NCT02443740|26255093|P7|Intervention Period 1 (3 Days)|Adverse Event|0
7552917|NCT02443740|26255094|P6|Intervention Period 1 (3 Days)|Adverse Event|1
7552918|NCT02443740|26255095|P5|Intervention Period 1 (3 Days)|Adverse Event|0
7552919|NCT02443740|26255096|P4|Intervention Period 1 (3 Days)|Adverse Event|0
7552920|NCT02443740|26255097|P3|Intervention Period 1 (3 Days)|Adverse Event|0
7552921|NCT02443740|26255098|P2|Intervention Period 1 (3 Days)|Adverse Event|0
7552922|NCT02443740|26255099|P1|Intervention Period 1 (3 Days)|Adverse Event|0
7552923|NCT02443688|26255281|P3|Overall Study|Sponsor Request|0
7552924|NCT02443688|26255282|P2|Overall Study|Sponsor Request|1
7552925|NCT02443688|26255283|P1|Overall Study|Sponsor Request|2
7552926|NCT02443688|26255281|P3|Overall Study|Non-compliance with study drug|4
7552927|NCT02443688|26255282|P2|Overall Study|Non-compliance with study drug|2
7552928|NCT02443688|26255283|P1|Overall Study|Non-compliance with study drug|1
7552929|NCT02443688|26255281|P3|Overall Study|Withdrawal by Subject|4
7552930|NCT02443688|26255282|P2|Overall Study|Withdrawal by Subject|3
7552931|NCT02443688|26255283|P1|Overall Study|Withdrawal by Subject|3
7552932|NCT02443688|26255281|P3|Overall Study|Pregnancy|1
7552933|NCT02443688|26255282|P2|Overall Study|Pregnancy|0
7552934|NCT02443688|26255283|P1|Overall Study|Pregnancy|0
7552935|NCT02443688|26255281|P3|Overall Study|Physician Decision|1
7552936|NCT02443688|26255282|P2|Overall Study|Physician Decision|0
7552937|NCT02443688|26255283|P1|Overall Study|Physician Decision|3
7552938|NCT02443688|26255281|P3|Overall Study|Lost to Follow-up|0
7552939|NCT02443688|26255282|P2|Overall Study|Lost to Follow-up|0
7552940|NCT02443688|26255283|P1|Overall Study|Lost to Follow-up|1
7552941|NCT02443688|26255281|P3|Overall Study|Adverse Event|2
7552942|NCT02443688|26255282|P2|Overall Study|Adverse Event|3
7552943|NCT02443688|26255283|P1|Overall Study|Adverse Event|2
7552944|NCT02443402|26255393|P2|Overall Study|Screen Failure|2
7552945|NCT02443402|26255394|P1|Overall Study|Screen Failure|1
7552946|NCT02443402|26255393|P2|Overall Study|Withdrawal by Subject|1
7552947|NCT02443402|26255394|P1|Overall Study|Withdrawal by Subject|3
7552948|NCT02443337|26255456|P2|Overall Study|Withdrawal by Subject|1
7552949|NCT02443337|26255457|P1|Overall Study|Withdrawal by Subject|2
7552950|NCT02443337|26255456|P2|Overall Study|Clinical Progressive Disease|0
7552951|NCT02443337|26255457|P1|Overall Study|Clinical Progressive Disease|3
7552952|NCT02443337|26255456|P2|Overall Study|Adverse Event|1
7552953|NCT02443337|26255457|P1|Overall Study|Adverse Event|0
7552954|NCT02443298|26255475|P2|Overall Study|Withdrawal by Subject|2
7552955|NCT02443298|26255476|P1|Overall Study|Withdrawal by Subject|1
7552956|NCT02443298|26255475|P2|Overall Study|Adverse Event|3
7552957|NCT02443298|26255476|P1|Overall Study|Adverse Event|3
7552958|NCT02443155|26255500|P4|Overall Study|Death|0
7552959|NCT02443155|26255501|P3|Overall Study|Death|1
7552960|NCT02443155|26255502|P2|Overall Study|Death|0
7552961|NCT02443155|26255503|P1|Overall Study|Death|0
7552962|NCT02443155|26255500|P4|Overall Study|Protocol Violation|1
7552963|NCT02443155|26255501|P3|Overall Study|Protocol Violation|1
7552964|NCT02443155|26255502|P2|Overall Study|Protocol Violation|0
7552965|NCT02443155|26255503|P1|Overall Study|Protocol Violation|1
7552966|NCT02443155|26255500|P4|Overall Study|Lost to Follow-up|1
7552967|NCT02443155|26255501|P3|Overall Study|Lost to Follow-up|0
7552968|NCT02443155|26255502|P2|Overall Study|Lost to Follow-up|2
7552969|NCT02443155|26255503|P1|Overall Study|Lost to Follow-up|1
7552970|NCT02443155|26255500|P4|Overall Study|Pregnancy|2
7552971|NCT02443155|26255501|P3|Overall Study|Pregnancy|1
7552972|NCT02443155|26255502|P2|Overall Study|Pregnancy|1
7552973|NCT02443155|26255503|P1|Overall Study|Pregnancy|3
7552974|NCT02443155|26255500|P4|Overall Study|Withdrawal by Subject|9
7552975|NCT02443155|26255501|P3|Overall Study|Withdrawal by Subject|3
7552976|NCT02443155|26255502|P2|Overall Study|Withdrawal by Subject|7
7552977|NCT02443155|26255503|P1|Overall Study|Withdrawal by Subject|4
7552978|NCT02443155|26255500|P4|Overall Study|Unclassified|1
7552979|NCT02443155|26255501|P3|Overall Study|Unclassified|2
7552980|NCT02443155|26255502|P2|Overall Study|Unclassified|0
7552981|NCT02443155|26255503|P1|Overall Study|Unclassified|0
7552982|NCT02443155|26255500|P4|Overall Study|Adverse Event|2
7552983|NCT02443155|26255501|P3|Overall Study|Adverse Event|1
7552984|NCT02443155|26255502|P2|Overall Study|Adverse Event|4
7552985|NCT02443155|26255503|P1|Overall Study|Adverse Event|3
7552986|NCT02443103|26255947|P1|Overall Study|Noncompliance|1
7552987|NCT02443103|26255947|P1|Overall Study|Adverse Event|2
7552988|NCT02442830|26256017|P2|Overall Study|Technical Failure|1
7552989|NCT02442830|26256018|P1|Overall Study|Technical Failure|0
7552990|NCT02442804|26256028|P2|Overall Study|Adverse Event|0
7552991|NCT02442804|26256029|P1|Overall Study|Adverse Event|1
7552992|NCT02442804|26256028|P2|Overall Study|Withdrawal by Subject|1
7552993|NCT02442804|26256029|P1|Overall Study|Withdrawal by Subject|0
7552994|NCT02442622|26256136|P2|Overall Study|Withdrawal by Subject|1
7552995|NCT02442622|26256137|P1|Overall Study|Withdrawal by Subject|3
7552996|NCT02442349|26256147|P1|Overall Study|On-going Study at Data Cut-off|149
7552997|NCT02442349|26256147|P1|Overall Study|Withdrawal by Subject|8
7552998|NCT02442349|26256147|P1|Overall Study|Death|14
7552999|NCT02442336|26256152|P1|Overall Study|Lost to Follow-up|11
7553000|NCT02442336|26256152|P1|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
7553001|NCT02442336|26256152|P1|Overall Study|6 patients assisted with the intervention development only.|6
7553002|NCT02442310|26256156|P1|Overall Study|Withdrawal by Subject|1
7553003|NCT02442310|26256156|P1|Overall Study|Adverse Event|2
7553004|NCT02442284|26256178|P1|Overall Study|Other|1
7553005|NCT02442284|26256178|P1|Overall Study|Lost to Follow-up|3
7553006|NCT02442284|26256178|P1|Overall Study|Withdrew Consent|2
7553007|NCT02442284|26256178|P1|Overall Study|Adverse Event|1
7553008|NCT02442271|26256185|P1|Overall Study|Other|1
7553009|NCT02442271|26256185|P1|Overall Study|Lost to Follow-up|1
7553010|NCT02442271|26256185|P1|Overall Study|Withdrew Consent|1
7553011|NCT02442271|26256185|P1|Overall Study|Adverse Event|1
7553012|NCT02442206|26256211|P2|Period 2|Adverse Event|0
7553013|NCT02442206|26256212|P1|Period 2|Adverse Event|1
7553014|NCT02442206|26256211|P2|Period 1|COPD exacerbation|1
7553015|NCT02442206|26256212|P1|Period 1|COPD exacerbation|0
7553016|NCT02442206|26256211|P2|Period 1|withdrew consent|1
7553017|NCT02442206|26256212|P1|Period 1|withdrew consent|0
7553018|NCT02442206|26256211|P2|Period 1|Adverse Event|1
7553019|NCT02442206|26256212|P1|Period 1|Adverse Event|1
7553020|NCT02441946|26256244|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
7553021|NCT02441946|26256245|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
7553022|NCT02441946|26256246|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
7553023|NCT02441946|26256244|P3|Extension Period (8 Weeks)|Adverse Event|0
7553024|NCT02441946|26256245|P2|Extension Period (8 Weeks)|Adverse Event|0
7553025|NCT02441946|26256246|P1|Extension Period (8 Weeks)|Adverse Event|1
7553026|NCT02441946|26256244|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7553027|NCT02441946|26256245|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7553028|NCT02441946|26256246|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
7553029|NCT02441946|26256244|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7553030|NCT02441946|26256245|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7553031|NCT02441946|26256246|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
7553032|NCT02441946|26256244|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7553033|NCT02441946|26256245|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7553034|NCT02441946|26256246|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
7553035|NCT02441946|26256244|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7553036|NCT02441946|26256245|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7553037|NCT02441946|26256246|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
7553038|NCT02441946|26256244|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7553039|NCT02441946|26256245|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7553040|NCT02441946|26256246|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
7553041|NCT02441946|26256244|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7553042|NCT02441946|26256245|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
7553043|NCT02441946|26256246|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7553044|NCT02441946|26256244|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7553045|NCT02441946|26256245|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
7553046|NCT02441946|26256246|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7553047|NCT02441946|26256244|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7553048|NCT02441946|26256245|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7553049|NCT02441946|26256246|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
7553050|NCT02441946|26256244|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
7553051|NCT02441946|26256245|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7553052|NCT02441946|26256246|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7553053|NCT02441517|26256267|P1|Overall Study|Study Terminated by Sponsor|1
7553054|NCT02441517|26256267|P1|Overall Study|Withdrawal by Subject|2
7553055|NCT02441517|26256267|P1|Overall Study|Lost to Follow-up|1
7553056|NCT02441309|26256280|P3|Overall Study|Withdrawal by Subject|1
7553057|NCT02441309|26256281|P2|Overall Study|Withdrawal by Subject|0
7553058|NCT02441309|26256282|P1|Overall Study|Withdrawal by Subject|1
7553059|NCT02441309|26256280|P3|Overall Study|Adverse Event|0
7553060|NCT02441309|26256281|P2|Overall Study|Adverse Event|1
7553061|NCT02441309|26256282|P1|Overall Study|Adverse Event|0
7553062|NCT02441309|26256280|P3|Overall Study|Disease progression|2
7553063|NCT02441309|26256281|P2|Overall Study|Disease progression|1
7553064|NCT02441309|26256282|P1|Overall Study|Disease progression|2
7553065|NCT02441283|26256311|P1|Overall Study|Other, not specified|32
7553066|NCT02441283|26256311|P1|Overall Study|Death|1
7553067|NCT02441283|26256311|P1|Overall Study|Lost to Follow-up|42
7553068|NCT02441283|26256311|P1|Overall Study|Withdrew consent|15
7553069|NCT02441218|26256324|P2|Overall Study|Lost to Follow-up|1
7553070|NCT02441218|26256325|P1|Overall Study|Lost to Follow-up|2
7553071|NCT02441218|26256324|P2|Overall Study|Withdrawal by Subject|58
7553072|NCT02441218|26256325|P1|Overall Study|Withdrawal by Subject|73
7553073|NCT02441218|26256324|P2|Overall Study|Death|553
7553074|NCT02441218|26256325|P1|Overall Study|Death|503
7553075|NCT02441179|26256351|P2|Overall Study|Withdrawal by Subject|1
7553076|NCT02441179|26256352|P1|Overall Study|Withdrawal by Subject|1
7553077|NCT02441114|26256370|P1|Washout2|Withdrawal by Subject|4
7553078|NCT02441036|26256385|P5|Overall Study|No tissue resected|0
7553079|NCT02441036|26256386|P4|Overall Study|No tissue resected|1
7553080|NCT02441036|26256387|P3|Overall Study|No tissue resected|0
7553081|NCT02441036|26256388|P2|Overall Study|No tissue resected|1
7553082|NCT02441036|26256389|P1|Overall Study|No tissue resected|0
7553083|NCT02440789|26256416|P1|Overall Study|Not willing to adhere to reqs|1
7553084|NCT02440789|26256416|P1|Overall Study|Withdrawal by Subject|3
7553085|NCT02440594|26256491|P8|Overall Study|Administratively w/drawn|1
7553086|NCT02440594|26256492|P7|Overall Study|Administratively w/drawn|2
7553087|NCT02440594|26256493|P6|Overall Study|Administratively w/drawn|0
7553088|NCT02440594|26256494|P5|Overall Study|Administratively w/drawn|0
7553089|NCT02440594|26256495|P4|Overall Study|Administratively w/drawn|0
7553090|NCT02440594|26256496|P3|Overall Study|Administratively w/drawn|0
7553091|NCT02440594|26256497|P2|Overall Study|Administratively w/drawn|2
7553092|NCT02440594|26256498|P1|Overall Study|Administratively w/drawn|3
7553093|NCT02440594|26256491|P8|Overall Study|Withdrawal by Subject|7
7553094|NCT02440594|26256492|P7|Overall Study|Withdrawal by Subject|7
7553095|NCT02440594|26256493|P6|Overall Study|Withdrawal by Subject|2
7553096|NCT02440594|26256494|P5|Overall Study|Withdrawal by Subject|2
7553097|NCT02440594|26256495|P4|Overall Study|Withdrawal by Subject|38
7553098|NCT02440594|26256496|P3|Overall Study|Withdrawal by Subject|59
7553099|NCT02440594|26256497|P2|Overall Study|Withdrawal by Subject|67
7553100|NCT02440594|26256498|P1|Overall Study|Withdrawal by Subject|81
7553101|NCT02440594|26256491|P8|Overall Study|Cognitive Impairment/Communication Issue|0
7553102|NCT02440594|26256492|P7|Overall Study|Cognitive Impairment/Communication Issue|0
7553103|NCT02440594|26256493|P6|Overall Study|Cognitive Impairment/Communication Issue|1
7553104|NCT02440594|26256494|P5|Overall Study|Cognitive Impairment/Communication Issue|2
7553105|NCT02440594|26256495|P4|Overall Study|Cognitive Impairment/Communication Issue|4
7553106|NCT02440594|26256496|P3|Overall Study|Cognitive Impairment/Communication Issue|4
7553107|NCT02440594|26256497|P2|Overall Study|Cognitive Impairment/Communication Issue|6
7553108|NCT02440594|26256498|P1|Overall Study|Cognitive Impairment/Communication Issue|14
7553109|NCT02440594|26256491|P8|Overall Study|Lost to Follow-up|48
7553110|NCT02440594|26256492|P7|Overall Study|Lost to Follow-up|28
7553111|NCT02440594|26256493|P6|Overall Study|Lost to Follow-up|4
7553112|NCT02440594|26256494|P5|Overall Study|Lost to Follow-up|5
7553113|NCT02440594|26256495|P4|Overall Study|Lost to Follow-up|47
7553114|NCT02440594|26256496|P3|Overall Study|Lost to Follow-up|54
7553115|NCT02440594|26256497|P2|Overall Study|Lost to Follow-up|33
7553116|NCT02440594|26256498|P1|Overall Study|Lost to Follow-up|34
7553117|NCT02440568|26256534|P4|Overall Study|Lost to Follow-up|0
7553118|NCT02440568|26256535|P3|Overall Study|Lost to Follow-up|0
7553119|NCT02440568|26256536|P2|Overall Study|Lost to Follow-up|0
7553120|NCT02440568|26256537|P1|Overall Study|Lost to Follow-up|1
7553121|NCT02440568|26256534|P4|Overall Study|Lack of Efficacy|0
7553122|NCT02440568|26256535|P3|Overall Study|Lack of Efficacy|1
7553123|NCT02440568|26256536|P2|Overall Study|Lack of Efficacy|0
7553124|NCT02440568|26256537|P1|Overall Study|Lack of Efficacy|2
7553125|NCT02440568|26256534|P4|Overall Study|Death|2
7553126|NCT02440568|26256535|P3|Overall Study|Death|4
7553127|NCT02440568|26256536|P2|Overall Study|Death|3
7553128|NCT02440568|26256537|P1|Overall Study|Death|1
7553129|NCT02440425|26256573|P1|Overall Study|Adverse Event/Ineligible|1
7553130|NCT02440425|26256573|P1|Overall Study|Adverse Event|1
7553131|NCT02440425|26256573|P1|Overall Study|Withdrawal by Subject|2
7553132|NCT02440425|26256573|P1|Overall Study|Death likely due to disease progression|1
7553133|NCT02439970|26256646|P2|Overall Study|Study Terminated|3
7553134|NCT02439970|26256647|P1|Overall Study|Study Terminated|2
7553135|NCT02439957|26256655|P2|Overall Study|Study Terminated|3
7553136|NCT02439957|26256656|P1|Overall Study|Study Terminated|3
7553137|NCT02439320|26256756|P3|Overall Study|Randomization Failure|34
7553138|NCT02439320|26256757|P2|Overall Study|Randomization Failure|46
7553139|NCT02439320|26256758|P1|Overall Study|Randomization Failure|35
7553140|NCT02439320|26256756|P3|Overall Study|Sponsor Request|1
7553141|NCT02439320|26256757|P2|Overall Study|Sponsor Request|2
7553142|NCT02439320|26256758|P1|Overall Study|Sponsor Request|0
7553143|NCT02439320|26256756|P3|Overall Study|Physician Decision|0
7553144|NCT02439320|26256757|P2|Overall Study|Physician Decision|1
7553145|NCT02439320|26256758|P1|Overall Study|Physician Decision|2
7553146|NCT02439320|26256756|P3|Overall Study|Withdrawal by Subject|14
7553147|NCT02439320|26256757|P2|Overall Study|Withdrawal by Subject|16
7553148|NCT02439320|26256758|P1|Overall Study|Withdrawal by Subject|12
7553149|NCT02439320|26256756|P3|Overall Study|Pregnancy|1
7553150|NCT02439320|26256757|P2|Overall Study|Pregnancy|1
7553151|NCT02439320|26256758|P1|Overall Study|Pregnancy|0
7553152|NCT02439320|26256756|P3|Overall Study|Noncompliance with Protocol|7
7553153|NCT02439320|26256757|P2|Overall Study|Noncompliance with Protocol|11
7553154|NCT02439320|26256758|P1|Overall Study|Noncompliance with Protocol|10
7553155|NCT02439320|26256756|P3|Overall Study|Death|0
7553156|NCT02439320|26256757|P2|Overall Study|Death|1
7553157|NCT02439320|26256758|P1|Overall Study|Death|0
7553158|NCT02439320|26256756|P3|Overall Study|Lost to Follow-up|42
7553159|NCT02439320|26256757|P2|Overall Study|Lost to Follow-up|34
7553160|NCT02439320|26256758|P1|Overall Study|Lost to Follow-up|37
7553161|NCT02439320|26256756|P3|Overall Study|Adverse Event|0
7553162|NCT02439320|26256757|P2|Overall Study|Adverse Event|2
7553163|NCT02439320|26256758|P1|Overall Study|Adverse Event|0
7553164|NCT02439138|26256838|P1|Overall Study|PI decision to terminate the study|2
7553165|NCT02439138|26256838|P1|Overall Study|Adverse Event|1
7553166|NCT02438826|26256851|P4|Post-Treatment Phase|Withdrawal by Subject|0
7553167|NCT02438826|26256852|P3|Post-Treatment Phase|Withdrawal by Subject|0
7553168|NCT02438826|26256853|P2|Post-Treatment Phase|Withdrawal by Subject|1
7553169|NCT02438826|26256854|P1|Post-Treatment Phase|Withdrawal by Subject|1
7553170|NCT02438826|26256851|P4|Post-Treatment Phase|Physician Decision|0
7553171|NCT02438826|26256852|P3|Post-Treatment Phase|Physician Decision|0
7553172|NCT02438826|26256853|P2|Post-Treatment Phase|Physician Decision|0
7553173|NCT02438826|26256854|P1|Post-Treatment Phase|Physician Decision|1
7553174|NCT02438826|26256851|P4|Post-Treatment Phase|Lack of Efficacy|0
7553175|NCT02438826|26256852|P3|Post-Treatment Phase|Lack of Efficacy|0
7553176|NCT02438826|26256853|P2|Post-Treatment Phase|Lack of Efficacy|0
7553177|NCT02438826|26256854|P1|Post-Treatment Phase|Lack of Efficacy|4
7553178|NCT02438826|26256851|P4|Post-Treatment Phase|Adverse Event|0
7553179|NCT02438826|26256852|P3|Post-Treatment Phase|Adverse Event|0
7553180|NCT02438826|26256853|P2|Post-Treatment Phase|Adverse Event|0
7553181|NCT02438826|26256854|P1|Post-Treatment Phase|Adverse Event|3
7553182|NCT02438826|26256851|P4|Open-Label Treatment Phase|Withdrawal by Subject|0
7553183|NCT02438826|26256852|P3|Open-Label Treatment Phase|Withdrawal by Subject|0
7553184|NCT02438826|26256853|P2|Open-Label Treatment Phase|Withdrawal by Subject|7
7553185|NCT02438826|26256854|P1|Open-Label Treatment Phase|Withdrawal by Subject|6
7553186|NCT02438826|26256851|P4|Open-Label Treatment Phase|Lost to Follow-up|0
7553187|NCT02438826|26256852|P3|Open-Label Treatment Phase|Lost to Follow-up|0
7553188|NCT02438826|26256853|P2|Open-Label Treatment Phase|Lost to Follow-up|2
7553189|NCT02438826|26256854|P1|Open-Label Treatment Phase|Lost to Follow-up|0
7553190|NCT02438826|26256851|P4|Open-Label Treatment Phase|Lack of Efficacy|0
7553191|NCT02438826|26256852|P3|Open-Label Treatment Phase|Lack of Efficacy|0
7553192|NCT02438826|26256853|P2|Open-Label Treatment Phase|Lack of Efficacy|18
7553193|NCT02438826|26256854|P1|Open-Label Treatment Phase|Lack of Efficacy|27
7553194|NCT02438826|26256851|P4|Open-Label Treatment Phase|Adverse Event|0
7553195|NCT02438826|26256852|P3|Open-Label Treatment Phase|Adverse Event|0
7553196|NCT02438826|26256853|P2|Open-Label Treatment Phase|Adverse Event|6
7553197|NCT02438826|26256854|P1|Open-Label Treatment Phase|Adverse Event|11
7553198|NCT02438826|26256851|P4|Double-Blind Treatment Phase|Screen Failure|0
7553199|NCT02438826|26256852|P3|Double-Blind Treatment Phase|Screen Failure|0
7553200|NCT02438826|26256853|P2|Double-Blind Treatment Phase|Screen Failure|0
7553201|NCT02438826|26256854|P1|Double-Blind Treatment Phase|Screen Failure|2
7553202|NCT02438826|26256851|P4|Double-Blind Treatment Phase|Protocol Violation|0
7553203|NCT02438826|26256852|P3|Double-Blind Treatment Phase|Protocol Violation|0
7553204|NCT02438826|26256853|P2|Double-Blind Treatment Phase|Protocol Violation|2
7553205|NCT02438826|26256854|P1|Double-Blind Treatment Phase|Protocol Violation|1
7553206|NCT02438826|26256851|P4|Double-Blind Treatment Phase|Withdrawal by Subject|0
7553207|NCT02438826|26256852|P3|Double-Blind Treatment Phase|Withdrawal by Subject|0
7553208|NCT02438826|26256853|P2|Double-Blind Treatment Phase|Withdrawal by Subject|1
7553209|NCT02438826|26256854|P1|Double-Blind Treatment Phase|Withdrawal by Subject|1
7553210|NCT02438826|26256851|P4|Double-Blind Treatment Phase|Lack of Efficacy|0
7553211|NCT02438826|26256852|P3|Double-Blind Treatment Phase|Lack of Efficacy|0
7553212|NCT02438826|26256853|P2|Double-Blind Treatment Phase|Lack of Efficacy|0
7553213|NCT02438826|26256854|P1|Double-Blind Treatment Phase|Lack of Efficacy|1
7553214|NCT02438826|26256851|P4|Double-Blind Treatment Phase|Adverse Event|0
7553215|NCT02438826|26256852|P3|Double-Blind Treatment Phase|Adverse Event|0
7553216|NCT02438826|26256853|P2|Double-Blind Treatment Phase|Adverse Event|1
7553217|NCT02438826|26256854|P1|Double-Blind Treatment Phase|Adverse Event|1
7553218|NCT02438813|26256888|P1|Overall Study|Patients Not Treated/No EOT Visit|249
7553219|NCT02438813|26256888|P1|Overall Study|Study Ended by Sponsor|80
7553220|NCT02438813|26256888|P1|Overall Study|Patient Lost to Follow-Up|137
7553221|NCT02438813|26256888|P1|Overall Study|Patient Decision|59
7553222|NCT02438787|26256940|P3|Overall Study|Site terminated by sponsor|1
7553223|NCT02438787|26256941|P2|Overall Study|Site terminated by sponsor|0
7553224|NCT02438787|26256942|P1|Overall Study|Site terminated by sponsor|0
7553225|NCT02438787|26256940|P3|Overall Study|Other|0
7553226|NCT02438787|26256941|P2|Overall Study|Other|1
7553227|NCT02438787|26256942|P1|Overall Study|Other|0
7553228|NCT02438787|26256940|P3|Overall Study|Study discontinued by sponsor|69
7553229|NCT02438787|26256941|P2|Overall Study|Study discontinued by sponsor|72
7553230|NCT02438787|26256942|P1|Overall Study|Study discontinued by sponsor|64
7553231|NCT02438787|26256940|P3|Overall Study|Withdrawal by Subject|10
7553232|NCT02438787|26256941|P2|Overall Study|Withdrawal by Subject|7
7553233|NCT02438787|26256942|P1|Overall Study|Withdrawal by Subject|15
7553234|NCT02438787|26256940|P3|Overall Study|Protocol Violation|1
7553235|NCT02438787|26256941|P2|Overall Study|Protocol Violation|0
7553236|NCT02438787|26256942|P1|Overall Study|Protocol Violation|0
7553237|NCT02438787|26256940|P3|Overall Study|Lost to Follow-up|0
7553238|NCT02438787|26256941|P2|Overall Study|Lost to Follow-up|1
7553239|NCT02438787|26256942|P1|Overall Study|Lost to Follow-up|0
7553240|NCT02438787|26256940|P3|Overall Study|Lack of Efficacy|0
7553241|NCT02438787|26256941|P2|Overall Study|Lack of Efficacy|2
7553242|NCT02438787|26256942|P1|Overall Study|Lack of Efficacy|1
7553243|NCT02438787|26256940|P3|Overall Study|Adverse Event|2
7553244|NCT02438787|26256941|P2|Overall Study|Adverse Event|0
7553245|NCT02438787|26256942|P1|Overall Study|Adverse Event|1
7553246|NCT02438722|26256987|P2|Overall Study|Did not receive protocol treatment|0
7553247|NCT02438722|26256988|P1|Overall Study|Did not receive protocol treatment|5
7553248|NCT02438722|26256987|P2|Overall Study|On protocol treatment|14
7553249|NCT02438722|26256988|P1|Overall Study|On protocol treatment|15
7553250|NCT02438722|26256987|P2|Overall Study|Withdrawal by Subject|1
7553251|NCT02438722|26256988|P1|Overall Study|Withdrawal by Subject|0
7553252|NCT02438722|26256987|P2|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
7553253|NCT02438722|26256988|P1|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
7553254|NCT02438722|26256987|P2|Overall Study|Physician Decision|2
7553255|NCT02438722|26256988|P1|Overall Study|Physician Decision|2
7553256|NCT02438722|26256987|P2|Overall Study|Death|3
7553257|NCT02438722|26256988|P1|Overall Study|Death|0
7553258|NCT02438722|26256987|P2|Overall Study|Disease progression/relapse|51
7553259|NCT02438722|26256988|P1|Overall Study|Disease progression/relapse|46
7553260|NCT02438722|26256987|P2|Overall Study|Refusal unrelated to AE|5
7553261|NCT02438722|26256988|P1|Overall Study|Refusal unrelated to AE|2
7553262|NCT02438722|26256987|P2|Overall Study|Adverse Event|9
7553263|NCT02438722|26256988|P1|Overall Study|Adverse Event|12
7553264|NCT02438384|26257094|P3|Overall Study|Lost to Follow-up|4
7553265|NCT02438384|26257095|P2|Overall Study|Lost to Follow-up|6
7553266|NCT02438384|26257096|P1|Overall Study|Lost to Follow-up|8
7553267|NCT02438280|26257115|P2|Overall Study|Physician Decision|0
7553268|NCT02438280|26257116|P1|Overall Study|Physician Decision|1
7553269|NCT02438137|26257126|P2|Overall Study|Physician Decision|1
7553270|NCT02438137|26257127|P1|Overall Study|Physician Decision|0
7553271|NCT02438137|26257126|P2|Overall Study|Withdrawal by Subject|3
7553272|NCT02438137|26257127|P1|Overall Study|Withdrawal by Subject|4
7553273|NCT02438137|26257126|P2|Overall Study|Adverse Event|0
7553274|NCT02438137|26257127|P1|Overall Study|Adverse Event|1
7553275|NCT02438137|26257126|P2|Overall Study|Lost to Follow-up|2
7553276|NCT02438137|26257127|P1|Overall Study|Lost to Follow-up|3
7553277|NCT02437903|26257135|P1|Overall Study|Lost to Follow-up|3
7553278|NCT02437903|26257135|P1|Overall Study|Withdrawal by Subject|1
7553279|NCT02437903|26257135|P1|Overall Study|Adverse Event|1
7553280|NCT02437890|26257148|P5|Overall Study|Death|0
7553281|NCT02437890|26257149|P4|Overall Study|Death|2
7553282|NCT02437890|26257150|P3|Overall Study|Death|0
7553283|NCT02437890|26257151|P2|Overall Study|Death|0
7553284|NCT02437890|26257152|P1|Overall Study|Death|0
7553285|NCT02437890|26257148|P5|Overall Study|Withdrawal by Subject|5
7553286|NCT02437890|26257149|P4|Overall Study|Withdrawal by Subject|5
7553287|NCT02437890|26257150|P3|Overall Study|Withdrawal by Subject|6
7553288|NCT02437890|26257151|P2|Overall Study|Withdrawal by Subject|2
7553289|NCT02437890|26257152|P1|Overall Study|Withdrawal by Subject|1
7553290|NCT02437890|26257148|P5|Overall Study|Adverse Event|7
7553291|NCT02437890|26257149|P4|Overall Study|Adverse Event|11
7553292|NCT02437890|26257150|P3|Overall Study|Adverse Event|5
7553293|NCT02437890|26257151|P2|Overall Study|Adverse Event|9
7553294|NCT02437890|26257152|P1|Overall Study|Adverse Event|4
7553295|NCT02437890|26257148|P5|Overall Study|Lack of Efficacy|1
7553296|NCT02437890|26257149|P4|Overall Study|Lack of Efficacy|3
7553297|NCT02437890|26257150|P3|Overall Study|Lack of Efficacy|0
7553298|NCT02437890|26257151|P2|Overall Study|Lack of Efficacy|3
7553299|NCT02437890|26257152|P1|Overall Study|Lack of Efficacy|1
7553300|NCT02437890|26257148|P5|Overall Study|Unable to attend visit(s)|0
7553301|NCT02437890|26257149|P4|Overall Study|Unable to attend visit(s)|0
7553302|NCT02437890|26257150|P3|Overall Study|Unable to attend visit(s)|0
7553303|NCT02437890|26257151|P2|Overall Study|Unable to attend visit(s)|0
7553304|NCT02437890|26257152|P1|Overall Study|Unable to attend visit(s)|1
7553305|NCT02437890|26257148|P5|Overall Study|Physician Decision|0
7553306|NCT02437890|26257149|P4|Overall Study|Physician Decision|1
7553307|NCT02437890|26257150|P3|Overall Study|Physician Decision|0
7553308|NCT02437890|26257151|P2|Overall Study|Physician Decision|0
7553309|NCT02437890|26257152|P1|Overall Study|Physician Decision|0
7553310|NCT02437890|26257148|P5|Overall Study|Sponsor's decision|2
7553311|NCT02437890|26257149|P4|Overall Study|Sponsor's decision|0
7553312|NCT02437890|26257150|P3|Overall Study|Sponsor's decision|4
7553313|NCT02437890|26257151|P2|Overall Study|Sponsor's decision|1
7553314|NCT02437890|26257152|P1|Overall Study|Sponsor's decision|1
7553315|NCT02437890|26257148|P5|Overall Study|Non-compliance to study drug|1
7553316|NCT02437890|26257149|P4|Overall Study|Non-compliance to study drug|0
7553317|NCT02437890|26257150|P3|Overall Study|Non-compliance to study drug|0
7553318|NCT02437890|26257151|P2|Overall Study|Non-compliance to study drug|1
7553319|NCT02437890|26257152|P1|Overall Study|Non-compliance to study drug|0
7553320|NCT02437864|26257365|P2|Overall Study|Protocol Violation|0
7553321|NCT02437864|26257366|P1|Overall Study|Protocol Violation|4
7553322|NCT02437513|26257387|P1|Overall Study|Withdrawal by Subject|2
7553323|NCT02437409|26257412|P1|Overall Study|Screening failure|12
7553324|NCT02437409|26257412|P1|Overall Study|Withdrawal by Subject|3
7553325|NCT02437318|26257505|P2|Overall Study|Untreated|1
7553326|NCT02437318|26257506|P1|Overall Study|Untreated|0
7553327|NCT02437318|26257505|P2|Overall Study|Protocol Violation|6
7553328|NCT02437318|26257506|P1|Overall Study|Protocol Violation|5
7553329|NCT02437318|26257505|P2|Overall Study|Death|4
7553330|NCT02437318|26257506|P1|Overall Study|Death|4
7553331|NCT02437318|26257505|P2|Overall Study|Adverse Event|3
7553332|NCT02437318|26257506|P1|Overall Study|Adverse Event|14
7553333|NCT02437318|26257505|P2|Overall Study|Physician Decision|10
7553334|NCT02437318|26257506|P1|Overall Study|Physician Decision|11
7553335|NCT02437318|26257505|P2|Overall Study|Subject/guardian decision|10
7553336|NCT02437318|26257506|P1|Overall Study|Subject/guardian decision|22
7553337|NCT02437318|26257505|P2|Overall Study|Progressive disease|208
7553338|NCT02437318|26257506|P1|Overall Study|Progressive disease|173
7553339|NCT02437305|26257514|P2|Overall Study|Lost to Follow-up|12
7553340|NCT02437305|26257515|P1|Overall Study|Lost to Follow-up|18
7553341|NCT02437188|26257542|P2|Overall Study|Adverse Event|1
7553342|NCT02437188|26257543|P1|Overall Study|Adverse Event|0
7553343|NCT02437188|26257542|P2|Overall Study|Randomized but did not receive surgery|8
7553344|NCT02437188|26257543|P1|Overall Study|Randomized but did not receive surgery|4
7553345|NCT02437162|26257560|P3|Overall Study|Other|1
7553346|NCT02437162|26257561|P2|Overall Study|Other|0
7553347|NCT02437162|26257562|P1|Overall Study|Other|0
7553348|NCT02437162|26257560|P3|Overall Study|Death|0
7553349|NCT02437162|26257561|P2|Overall Study|Death|1
7553350|NCT02437162|26257562|P1|Overall Study|Death|0
7553351|NCT02437162|26257560|P3|Overall Study|Lost to Follow-up|1
7553352|NCT02437162|26257561|P2|Overall Study|Lost to Follow-up|0
7553353|NCT02437162|26257562|P1|Overall Study|Lost to Follow-up|1
7553354|NCT02437162|26257560|P3|Overall Study|Adverse Event|0
7553355|NCT02437162|26257561|P2|Overall Study|Adverse Event|1
7553356|NCT02437162|26257562|P1|Overall Study|Adverse Event|0
7553357|NCT02437162|26257560|P3|Overall Study|Withdrawal by Subject|9
7553358|NCT02437162|26257561|P2|Overall Study|Withdrawal by Subject|7
7553359|NCT02437162|26257562|P1|Overall Study|Withdrawal by Subject|13
7553360|NCT02437162|26257560|P3|Overall Study|Study discontinued by Sponsor|97
7553361|NCT02437162|26257561|P2|Overall Study|Study discontinued by Sponsor|98
7553362|NCT02437162|26257562|P1|Overall Study|Study discontinued by Sponsor|93
7553363|NCT02437162|26257560|P3|Overall Study|Randomized but not treated|1
7553364|NCT02437162|26257561|P2|Overall Study|Randomized but not treated|0
7553365|NCT02437162|26257562|P1|Overall Study|Randomized but not treated|0
7553366|NCT02437162|26257560|P3|Overall Study|Protocol Violation|0
7553367|NCT02437162|26257561|P2|Overall Study|Protocol Violation|1
7553368|NCT02437162|26257562|P1|Overall Study|Protocol Violation|0
7553369|NCT02437084|26257680|P1|Overall Study|Physician Decision|1
7553370|NCT02437084|26257680|P1|Overall Study|Withdrawal by Subject|2
7553371|NCT02436915|26257691|P2|Overall Study|Withdrawal by Subject|1
7553372|NCT02436915|26257692|P1|Overall Study|Withdrawal by Subject|0
7553373|NCT02436889|26257714|P2|Overall Study|Does not like/could not tolerate medicat|1
7553374|NCT02436889|26257715|P1|Overall Study|Does not like/could not tolerate medicat|0
7553375|NCT02436889|26257714|P2|Overall Study|No improvement in symptoms|0
7553376|NCT02436889|26257715|P1|Overall Study|No improvement in symptoms|1
7553377|NCT02436876|26257735|P4|Overall Study|Inadequate amount of study drug available for randomization|0
7553378|NCT02436876|26257736|P3|Overall Study|Inadequate amount of study drug available for randomization|0
7553379|NCT02436876|26257737|P2|Overall Study|Inadequate amount of study drug available for randomization|1
7553380|NCT02436876|26257738|P1|Overall Study|Inadequate amount of study drug available for randomization|0
7553381|NCT02436876|26257735|P4|Overall Study|Physician Decision|0
7553382|NCT02436876|26257736|P3|Overall Study|Physician Decision|1
7553383|NCT02436876|26257737|P2|Overall Study|Physician Decision|2
7553384|NCT02436876|26257738|P1|Overall Study|Physician Decision|0
7553385|NCT02436876|26257735|P4|Overall Study|Withdrawal by Subject|1
7553386|NCT02436876|26257736|P3|Overall Study|Withdrawal by Subject|0
7553387|NCT02436876|26257737|P2|Overall Study|Withdrawal by Subject|0
7553388|NCT02436876|26257738|P1|Overall Study|Withdrawal by Subject|1
7553389|NCT02436876|26257735|P4|Overall Study|Lost to Follow-up|1
7553390|NCT02436876|26257736|P3|Overall Study|Lost to Follow-up|1
7553391|NCT02436876|26257737|P2|Overall Study|Lost to Follow-up|1
7553392|NCT02436876|26257738|P1|Overall Study|Lost to Follow-up|0
7553393|NCT02436811|26257759|P3|Overall Study|Lost to Follow-up|7
7553394|NCT02436811|26257760|P2|Overall Study|Lost to Follow-up|9
7553395|NCT02436811|26257761|P1|Overall Study|Lost to Follow-up|2
7553402|NCT02436681|26257780|P1|Overall Study|Death|2
7553403|NCT02436681|26257780|P1|Overall Study|Withdrawal by Subject|2
7553404|NCT02436681|26257780|P1|Overall Study|Lost to Follow-up|10
7553405|NCT02436577|26257820|P6|Overall Study|Protocol Deviation|0
7553406|NCT02436577|26257821|P5|Overall Study|Protocol Deviation|0
7553407|NCT02436577|26257822|P4|Overall Study|Protocol Deviation|0
7553408|NCT02436577|26257823|P3|Overall Study|Protocol Deviation|0
7553409|NCT02436577|26257824|P2|Overall Study|Protocol Deviation|1
7553410|NCT02436577|26257825|P1|Overall Study|Protocol Deviation|0
7553411|NCT02436356|26257881|P3|Overall Study|Withdrawal by Subject|0
7553412|NCT02436356|26257882|P2|Overall Study|Withdrawal by Subject|0
7553413|NCT02436356|26257883|P1|Overall Study|Withdrawal by Subject|1
7553414|NCT02436356|26257881|P3|Overall Study|Excluded due to other medical conditions|0
7553415|NCT02436356|26257882|P2|Overall Study|Excluded due to other medical conditions|0
7553416|NCT02436356|26257883|P1|Overall Study|Excluded due to other medical conditions|3
7553417|NCT02436356|26257881|P3|Overall Study|Surgical Approach (Dorsal not volar)|0
7553418|NCT02436356|26257882|P2|Overall Study|Surgical Approach (Dorsal not volar)|0
7553419|NCT02436356|26257883|P1|Overall Study|Surgical Approach (Dorsal not volar)|1
7553420|NCT02436356|26257881|P3|Overall Study|Lost to Follow-up|0
7553421|NCT02436356|26257882|P2|Overall Study|Lost to Follow-up|1
7553422|NCT02436356|26257883|P1|Overall Study|Lost to Follow-up|0
7553423|NCT02436356|26257881|P3|Overall Study|Excluded by MRI Screening|2
7553424|NCT02436356|26257882|P2|Overall Study|Excluded by MRI Screening|0
7553425|NCT02436356|26257883|P1|Overall Study|Excluded by MRI Screening|0
7553426|NCT02436330|26257914|P2|Cohort 6|Withdrawal by Subject|1
7553427|NCT02436330|26257915|P1|Cohort 6|Withdrawal by Subject|1
7553428|NCT02436330|26257914|P2|Cohort 6|Lost to Follow-up|0
7553429|NCT02436330|26257915|P1|Cohort 6|Lost to Follow-up|2
7553430|NCT02436330|26257914|P2|Cohort 5|Withdrawal by Subject|2
7553431|NCT02436330|26257915|P1|Cohort 5|Withdrawal by Subject|3
7553432|NCT02436330|26257914|P2|Cohort 5|Lost to Follow-up|2
7553433|NCT02436330|26257915|P1|Cohort 5|Lost to Follow-up|3
7553434|NCT02436330|26257914|P2|Cohort 4|Withdrawal by Subject|0
7553435|NCT02436330|26257915|P1|Cohort 4|Withdrawal by Subject|1
7553436|NCT02436330|26257914|P2|Cohort 4|Lost to Follow-up|0
7553437|NCT02436330|26257915|P1|Cohort 4|Lost to Follow-up|1
7553438|NCT02436330|26257914|P2|Cohort 3|Withdrawal by Subject|0
7553439|NCT02436330|26257915|P1|Cohort 3|Withdrawal by Subject|4
7553440|NCT02436330|26257914|P2|Cohort 3|Lost to Follow-up|0
7553441|NCT02436330|26257915|P1|Cohort 3|Lost to Follow-up|1
7553442|NCT02436330|26257914|P2|Cohort 2|Withdrawal by Subject|3
7553443|NCT02436330|26257915|P1|Cohort 2|Withdrawal by Subject|2
7553444|NCT02436330|26257914|P2|Cohort 2|Lost to Follow-up|0
7553445|NCT02436330|26257915|P1|Cohort 2|Lost to Follow-up|2
7553446|NCT02436330|26257914|P2|Cohort 1|Withdrawal by Subject|1
7553447|NCT02436330|26257915|P1|Cohort 1|Withdrawal by Subject|0
7553448|NCT02436330|26257914|P2|Cohort 1|Lost to Follow-up|2
7553449|NCT02436330|26257915|P1|Cohort 1|Lost to Follow-up|5
7553450|NCT02436304|26257960|P3|Overall Study|Randomized in error didn't meet I/E crit|1
7553451|NCT02436304|26257961|P2|Overall Study|Randomized in error didn't meet I/E crit|0
7553452|NCT02436304|26257962|P1|Overall Study|Randomized in error didn't meet I/E crit|0
7553453|NCT02436304|26257960|P3|Overall Study|Withdrawal by Subject|0
7553454|NCT02436304|26257961|P2|Overall Study|Withdrawal by Subject|1
7553455|NCT02436304|26257962|P1|Overall Study|Withdrawal by Subject|0
7553456|NCT02436304|26257960|P3|Overall Study|Lost to Follow-up|0
7553457|NCT02436304|26257961|P2|Overall Study|Lost to Follow-up|1
7553458|NCT02436304|26257962|P1|Overall Study|Lost to Follow-up|0
7553459|NCT02436239|26257990|P4|Down-Taper Period|Withdrawal by Subject|2
7553460|NCT02436239|26257991|P3|Down-Taper Period|Withdrawal by Subject|1
7553461|NCT02436239|26257992|P2|Down-Taper Period|Withdrawal by Subject|4
7553462|NCT02436239|26257993|P1|Down-Taper Period|Withdrawal by Subject|4
7553463|NCT02436239|26257990|P4|Open-Lable Treatment Period|Other Reason|0
7553464|NCT02436239|26257991|P3|Open-Lable Treatment Period|Other Reason|0
7553465|NCT02436239|26257992|P2|Open-Lable Treatment Period|Other Reason|1
7553466|NCT02436239|26257993|P1|Open-Lable Treatment Period|Other Reason|1
7553551|NCT02435836|26258240|P1|Overall Study|Protocol Violation|6
7553467|NCT02436239|26257990|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
7553468|NCT02436239|26257991|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
7553469|NCT02436239|26257992|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
7553470|NCT02436239|26257993|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
7553471|NCT02436239|26257990|P4|Open-Lable Treatment Period|Protocol Violation|0
7553472|NCT02436239|26257991|P3|Open-Lable Treatment Period|Protocol Violation|1
7553473|NCT02436239|26257992|P2|Open-Lable Treatment Period|Protocol Violation|1
7553474|NCT02436239|26257993|P1|Open-Lable Treatment Period|Protocol Violation|0
7553475|NCT02436239|26257990|P4|Open-Lable Treatment Period|Lost to Follow-up|1
7553476|NCT02436239|26257991|P3|Open-Lable Treatment Period|Lost to Follow-up|4
7553477|NCT02436239|26257992|P2|Open-Lable Treatment Period|Lost to Follow-up|2
7553478|NCT02436239|26257993|P1|Open-Lable Treatment Period|Lost to Follow-up|4
7553479|NCT02436239|26257990|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
7553480|NCT02436239|26257991|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
7553481|NCT02436239|26257992|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
7553482|NCT02436239|26257993|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
7553483|NCT02436239|26257990|P4|Open-Lable Treatment Period|Lack of Efficacy|1
7553484|NCT02436239|26257991|P3|Open-Lable Treatment Period|Lack of Efficacy|6
7553485|NCT02436239|26257992|P2|Open-Lable Treatment Period|Lack of Efficacy|6
7553486|NCT02436239|26257993|P1|Open-Lable Treatment Period|Lack of Efficacy|1
7553487|NCT02436239|26257990|P4|Open-Lable Treatment Period|Adverse Event|2
7553488|NCT02436239|26257991|P3|Open-Lable Treatment Period|Adverse Event|4
7553489|NCT02436239|26257992|P2|Open-Lable Treatment Period|Adverse Event|3
7553490|NCT02436239|26257993|P1|Open-Lable Treatment Period|Adverse Event|12
7553491|NCT02436200|26258015|P1|Overall Study|Significant outlier|1
7553492|NCT02436135|26258022|P2|Overall Study|Study Terminated By Sponsor|1
7553493|NCT02436135|26258023|P1|Overall Study|Study Terminated By Sponsor|0
7553494|NCT02436135|26258022|P2|Overall Study|Withdrawal by Participant|0
7553495|NCT02436135|26258023|P1|Overall Study|Withdrawal by Participant|1
7553496|NCT02436135|26258022|P2|Overall Study|Adverse Event|0
7553497|NCT02436135|26258023|P1|Overall Study|Adverse Event|1
7553498|NCT02436135|26258022|P2|Overall Study|Investigator Discretion|2
7553499|NCT02436135|26258023|P1|Overall Study|Investigator Discretion|1
7553500|NCT02436135|26258022|P2|Overall Study|Progressive Disease|1
7553501|NCT02436135|26258023|P1|Overall Study|Progressive Disease|3
7553502|NCT02436005|26258058|P2|Second Intervention|Adverse Event|1
7553503|NCT02436005|26258059|P1|Second Intervention|Adverse Event|0
7553504|NCT02435992|26258126|P5|Overall Study|Physician Decision|0
7553505|NCT02435992|26258127|P4|Overall Study|Physician Decision|0
7553506|NCT02435992|26258128|P3|Overall Study|Physician Decision|1
7553507|NCT02435992|26258129|P2|Overall Study|Physician Decision|0
7553508|NCT02435992|26258130|P1|Overall Study|Physician Decision|0
7553509|NCT02435992|26258126|P5|Overall Study|Other Reason|0
7553510|NCT02435992|26258127|P4|Overall Study|Other Reason|0
7553511|NCT02435992|26258128|P3|Overall Study|Other Reason|0
7553512|NCT02435992|26258129|P2|Overall Study|Other Reason|0
7553513|NCT02435992|26258130|P1|Overall Study|Other Reason|1
7553514|NCT02435992|26258126|P5|Overall Study|Withdrawal by Subject|0
7553515|NCT02435992|26258127|P4|Overall Study|Withdrawal by Subject|0
7553516|NCT02435992|26258128|P3|Overall Study|Withdrawal by Subject|20
7553517|NCT02435992|26258129|P2|Overall Study|Withdrawal by Subject|8
7553518|NCT02435992|26258130|P1|Overall Study|Withdrawal by Subject|10
7553519|NCT02435992|26258126|P5|Overall Study|Lack of Efficacy|0
7553520|NCT02435992|26258127|P4|Overall Study|Lack of Efficacy|0
7553521|NCT02435992|26258128|P3|Overall Study|Lack of Efficacy|9
7553522|NCT02435992|26258129|P2|Overall Study|Lack of Efficacy|10
7553523|NCT02435992|26258130|P1|Overall Study|Lack of Efficacy|4
7553524|NCT02435992|26258126|P5|Overall Study|Adverse Event|0
7553525|NCT02435992|26258127|P4|Overall Study|Adverse Event|0
7553526|NCT02435992|26258128|P3|Overall Study|Adverse Event|12
7553527|NCT02435992|26258129|P2|Overall Study|Adverse Event|6
7553528|NCT02435992|26258130|P1|Overall Study|Adverse Event|11
7553529|NCT02435992|26258126|P5|Overall Study|non compliance with protocol|0
7553530|NCT02435992|26258127|P4|Overall Study|non compliance with protocol|0
7553531|NCT02435992|26258128|P3|Overall Study|non compliance with protocol|1
7553532|NCT02435992|26258129|P2|Overall Study|non compliance with protocol|0
7553533|NCT02435992|26258130|P1|Overall Study|non compliance with protocol|2
7553534|NCT02435966|26258195|P3|Overall Study|Withdrawal by Subject|0
7553535|NCT02435966|26258196|P2|Overall Study|Withdrawal by Subject|1
7553536|NCT02435966|26258197|P1|Overall Study|Withdrawal by Subject|0
7553537|NCT02435914|26258209|P4|Overall Study|Other Miscellaneous Reason|0
7553538|NCT02435914|26258210|P3|Overall Study|Other Miscellaneous Reason|1
7553539|NCT02435914|26258211|P2|Overall Study|Other Miscellaneous Reason|0
7553540|NCT02435914|26258212|P1|Overall Study|Other Miscellaneous Reason|0
7553541|NCT02435914|26258209|P4|Overall Study|Withdrawal by Subject|0
7553542|NCT02435914|26258210|P3|Overall Study|Withdrawal by Subject|0
7553543|NCT02435914|26258211|P2|Overall Study|Withdrawal by Subject|1
7553544|NCT02435914|26258212|P1|Overall Study|Withdrawal by Subject|0
7553545|NCT02435914|26258209|P4|Overall Study|Ocular Adverse Event|0
7553546|NCT02435914|26258210|P3|Overall Study|Ocular Adverse Event|0
7553547|NCT02435914|26258211|P2|Overall Study|Ocular Adverse Event|0
7553548|NCT02435914|26258212|P1|Overall Study|Ocular Adverse Event|1
7553549|NCT02435836|26258240|P1|Overall Study|AE of Worsening Schizophrenia|96
7553550|NCT02435836|26258240|P1|Overall Study|Met Withdrawal Criteria|7
7553552|NCT02435836|26258240|P1|Overall Study|Noncompliance|27
7553553|NCT02435836|26258240|P1|Overall Study|Sponsor discontinued trial|167
7553554|NCT02435836|26258240|P1|Overall Study|Adverse Event|44
7553555|NCT02435836|26258240|P1|Overall Study|Insufficient Clinical Response|26
7553556|NCT02435836|26258240|P1|Overall Study|Withdrawal by Subject|236
7553557|NCT02435836|26258240|P1|Overall Study|Lack of Efficacy|1
7553558|NCT02435836|26258240|P1|Overall Study|Lost to Follow-up|21
7553559|NCT02435680|26258272|P3|Overall Study|not treated|1
7553560|NCT02435680|26258273|P2|Overall Study|not treated|0
7553561|NCT02435680|26258274|P1|Overall Study|not treated|0
7553562|NCT02435680|26258272|P3|Overall Study|progressive disease|11
7553563|NCT02435680|26258273|P2|Overall Study|progressive disease|7
7553564|NCT02435680|26258274|P1|Overall Study|progressive disease|10
7553565|NCT02435680|26258272|P3|Overall Study|Adverse Event|2
7553566|NCT02435680|26258273|P2|Overall Study|Adverse Event|3
7553567|NCT02435680|26258274|P1|Overall Study|Adverse Event|8
7553568|NCT02435680|26258272|P3|Overall Study|subject / guardian decision|2
7553569|NCT02435680|26258273|P2|Overall Study|subject / guardian decision|3
7553570|NCT02435680|26258274|P1|Overall Study|subject / guardian decision|0
7553571|NCT02435680|26258272|P3|Overall Study|Physician Decision|0
7553572|NCT02435680|26258273|P2|Overall Study|Physician Decision|0
7553573|NCT02435680|26258274|P1|Overall Study|Physician Decision|3
7553574|NCT02435433|26258338|P5|Overall Study|Lost to Follow-up|0
7553575|NCT02435433|26258339|P4|Overall Study|Lost to Follow-up|0
7553576|NCT02435433|26258340|P3|Overall Study|Lost to Follow-up|0
7553577|NCT02435433|26258341|P2|Overall Study|Lost to Follow-up|2
7553578|NCT02435433|26258342|P1|Overall Study|Lost to Follow-up|2
7553579|NCT02435433|26258338|P5|Overall Study|Withdrawal by Subject|0
7553580|NCT02435433|26258339|P4|Overall Study|Withdrawal by Subject|0
7553581|NCT02435433|26258340|P3|Overall Study|Withdrawal by Subject|0
7553582|NCT02435433|26258341|P2|Overall Study|Withdrawal by Subject|3
7553583|NCT02435433|26258342|P1|Overall Study|Withdrawal by Subject|2
7553584|NCT02435433|26258338|P5|Overall Study|On Treatment|0
7553585|NCT02435433|26258339|P4|Overall Study|On Treatment|0
7553586|NCT02435433|26258340|P3|Overall Study|On Treatment|0
7553587|NCT02435433|26258341|P2|Overall Study|On Treatment|0
7553588|NCT02435433|26258342|P1|Overall Study|On Treatment|11
7553589|NCT02435381|26258364|P2|Overall Study|Lost to Follow-up|1
7553590|NCT02435381|26258365|P1|Overall Study|Lost to Follow-up|2
7553591|NCT02435277|26258393|P4|Overall Study|Withdrawal by Subject|0
7553592|NCT02435277|26258394|P3|Overall Study|Withdrawal by Subject|0
7553593|NCT02435277|26258395|P2|Overall Study|Withdrawal by Subject|0
7553594|NCT02435277|26258396|P1|Overall Study|Withdrawal by Subject|1
7553595|NCT02435277|26258393|P4|Overall Study|Adverse Event|0
7553596|NCT02435277|26258394|P3|Overall Study|Adverse Event|0
7553597|NCT02435277|26258395|P2|Overall Study|Adverse Event|1
7553598|NCT02435277|26258396|P1|Overall Study|Adverse Event|1
7553599|NCT02435147|26258410|P1|Overall Study|non-evaluable DXA scan|11
7553600|NCT02435069|26258415|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
7553601|NCT02435069|26258416|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
7553602|NCT02435069|26258417|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
7553603|NCT02435069|26258418|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
7553604|NCT02435069|26258419|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
7553605|NCT02435069|26258415|P5|Dose Response - First Intervention|Adverse Event|0
7553606|NCT02435069|26258416|P4|Dose Response - First Intervention|Adverse Event|0
7553607|NCT02435069|26258417|P3|Dose Response - First Intervention|Adverse Event|1
7553608|NCT02435069|26258418|P2|Dose Response - First Intervention|Adverse Event|1
7553609|NCT02435069|26258419|P1|Dose Response - First Intervention|Adverse Event|0
7553610|NCT02434939|26258441|P2|Overall Study|Adverse Event|1
7553611|NCT02434939|26258442|P1|Overall Study|Adverse Event|0
7553612|NCT02434939|26258441|P2|Overall Study|Withdrawal by Subject|0
7553613|NCT02434939|26258442|P1|Overall Study|Withdrawal by Subject|3
7553614|NCT02434939|26258441|P2|Overall Study|Lack of Efficacy|48
7553615|NCT02434939|26258442|P1|Overall Study|Lack of Efficacy|34
7553616|NCT02434770|26258457|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
7553617|NCT02434770|26258458|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
7553618|NCT02434770|26258459|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
7553619|NCT02434770|26258457|P3|Week 18 to Week|Withdrawal by Subject|2
7553620|NCT02434770|26258458|P2|Week 18 to Week|Withdrawal by Subject|0
7553621|NCT02434770|26258459|P1|Week 18 to Week|Withdrawal by Subject|0
7553622|NCT02434770|26258457|P3|Week 18 to Week|Lost to Follow-up|1
7553623|NCT02434770|26258458|P2|Week 18 to Week|Lost to Follow-up|2
7553624|NCT02434770|26258459|P1|Week 18 to Week|Lost to Follow-up|2
7553625|NCT02434770|26258457|P3|Week 1 to Week 18|Death|0
7553626|NCT02434770|26258458|P2|Week 1 to Week 18|Death|0
7553627|NCT02434770|26258459|P1|Week 1 to Week 18|Death|1
7553628|NCT02434770|26258457|P3|Week 1 to Week 18|Relocated Out of Study Area|1
7553629|NCT02434770|26258458|P2|Week 1 to Week 18|Relocated Out of Study Area|0
7553630|NCT02434770|26258459|P1|Week 1 to Week 18|Relocated Out of Study Area|0
7553631|NCT02434770|26258457|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
7553632|NCT02434770|26258458|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
7553633|NCT02434770|26258459|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
7553634|NCT02434770|26258457|P3|Week 1 to Week 18|Withdrawal by Subject|5
7553635|NCT02434770|26258458|P2|Week 1 to Week 18|Withdrawal by Subject|12
7553636|NCT02434770|26258459|P1|Week 1 to Week 18|Withdrawal by Subject|6
7553637|NCT02434770|26258457|P3|Week 1 to Week 18|Lost to Follow-up|2
7553638|NCT02434770|26258458|P2|Week 1 to Week 18|Lost to Follow-up|0
7553639|NCT02434770|26258459|P1|Week 1 to Week 18|Lost to Follow-up|0
7553640|NCT02434471|26258609|P1|Overall Study|Physician Decision|9
7553641|NCT02434354|26258616|P1|Overall Study|screen fail|3
7553642|NCT02434328|26258622|P2|Overall Study|Other|1
7553643|NCT02434328|26258623|P1|Overall Study|Other|4
7553644|NCT02434328|26258622|P2|Overall Study|Lost to Follow-up|6
7553645|NCT02434328|26258623|P1|Overall Study|Lost to Follow-up|1
7553646|NCT02434328|26258622|P2|Overall Study|Death|7
7553647|NCT02434328|26258623|P1|Overall Study|Death|4
7553648|NCT02434328|26258622|P2|Overall Study|Withdrawal by Subject|21
7553649|NCT02434328|26258623|P1|Overall Study|Withdrawal by Subject|12
7553650|NCT02434328|26258622|P2|Overall Study|Physician Decision|1
7553651|NCT02434328|26258623|P1|Overall Study|Physician Decision|0
7553652|NCT02434328|26258622|P2|Overall Study|Lack of Efficacy|2
7553653|NCT02434328|26258623|P1|Overall Study|Lack of Efficacy|0
7553654|NCT02434328|26258622|P2|Overall Study|Adverse Event|4
7553655|NCT02434328|26258623|P1|Overall Study|Adverse Event|9
7553656|NCT02433834|26258711|P1|Overall Study|Physician Decision|1
7553657|NCT02433834|26258711|P1|Overall Study|Adverse Event|6
7553658|NCT02433834|26258711|P1|Overall Study|Withdrawal by Subject|14
7553659|NCT02433834|26258711|P1|Overall Study|Lost to Follow-up|6
7553660|NCT02433834|26258711|P1|Overall Study|Protocol Violation|3
7553661|NCT02433834|26258711|P1|Overall Study|Protocol-specified criteria|7
7553662|NCT02433678|26258771|P2|Overall Study|Lost to Follow-up|2
7553663|NCT02433678|26258772|P1|Overall Study|Lost to Follow-up|1
7553664|NCT02433483|26258865|P1|Overall Study|Other antineoplastic therapy/HSCT|1
7553665|NCT02433483|26258865|P1|Overall Study|Unacceptable toxicity|1
7553666|NCT02433379|26258877|P1|Overall Study|Total Withdrawals|209
7553667|NCT02433379|26258877|P1|Overall Study|Death|57
7553668|NCT02433379|26258877|P1|Overall Study|Screen Failures|55
7553669|NCT02433340|26258900|P4|Overall Study|Other|0
7553670|NCT02433340|26258901|P3|Overall Study|Other|0
7553671|NCT02433340|26258902|P2|Overall Study|Other|1
7553672|NCT02433340|26258903|P1|Overall Study|Other|0
7553673|NCT02433340|26258900|P4|Overall Study|Required Alternative/Prohibited Therapy|0
7553674|NCT02433340|26258901|P3|Overall Study|Required Alternative/Prohibited Therapy|0
7553675|NCT02433340|26258902|P2|Overall Study|Required Alternative/Prohibited Therapy|0
7553676|NCT02433340|26258903|P1|Overall Study|Required Alternative/Prohibited Therapy|1
7553677|NCT02433340|26258900|P4|Overall Study|Lost to Follow-up|0
7553678|NCT02433340|26258901|P3|Overall Study|Lost to Follow-up|0
7553679|NCT02433340|26258902|P2|Overall Study|Lost to Follow-up|1
7553680|NCT02433340|26258903|P1|Overall Study|Lost to Follow-up|0
7553681|NCT02433340|26258900|P4|Overall Study|Withdrawal by Subject|2
7553682|NCT02433340|26258901|P3|Overall Study|Withdrawal by Subject|1
7553683|NCT02433340|26258902|P2|Overall Study|Withdrawal by Subject|0
7553684|NCT02433340|26258903|P1|Overall Study|Withdrawal by Subject|1
7553685|NCT02433340|26258900|P4|Overall Study|Adverse Event|0
7553686|NCT02433340|26258901|P3|Overall Study|Adverse Event|1
7553687|NCT02433340|26258902|P2|Overall Study|Adverse Event|0
7553688|NCT02433340|26258903|P1|Overall Study|Adverse Event|0
7553689|NCT02433288|26259797|P2|Overall Study|Death|3
7553690|NCT02433288|26259798|P1|Overall Study|Death|0
7553691|NCT02433288|26259797|P2|Overall Study|Lost to Follow-up|14
7553692|NCT02433288|26259798|P1|Overall Study|Lost to Follow-up|2
7553693|NCT02433288|26259797|P2|Overall Study|Withdrawal by Subject|99
7553694|NCT02433288|26259798|P1|Overall Study|Withdrawal by Subject|101
7553695|NCT02433288|26259797|P2|Overall Study|Eligibility criteria not fullfilled|3
7553696|NCT02433288|26259798|P1|Overall Study|Eligibility criteria not fullfilled|7
7553697|NCT02433288|26259797|P2|Overall Study|Severe non-compliance to protocol|7
7553698|NCT02433288|26259798|P1|Overall Study|Severe non-compliance to protocol|13
7553699|NCT02433080|26259814|P2|Overall Study|Withdrawal by Subject|2
7553700|NCT02433080|26259815|P1|Overall Study|Withdrawal by Subject|0
7553701|NCT02433080|26259814|P2|Overall Study|Lost to Follow-up|2
7553702|NCT02433080|26259815|P1|Overall Study|Lost to Follow-up|1
7553703|NCT02432703|26259891|P2|Overall Study|Other|5
7553704|NCT02432703|26259892|P1|Overall Study|Other|6
7553705|NCT02432703|26259891|P2|Overall Study|Withdrawal by Subject|6
7553706|NCT02432703|26259892|P1|Overall Study|Withdrawal by Subject|9
7553707|NCT02432703|26259891|P2|Overall Study|Lost to Follow-up|3
7553708|NCT02432703|26259892|P1|Overall Study|Lost to Follow-up|5
7553709|NCT02432703|26259891|P2|Overall Study|Lack of Efficacy|0
7553710|NCT02432703|26259892|P1|Overall Study|Lack of Efficacy|1
7553711|NCT02432703|26259891|P2|Overall Study|Adverse Event|4
7553712|NCT02432703|26259892|P1|Overall Study|Adverse Event|1
7553713|NCT02432274|26259969|P8|Overall Study|Ongoing|7
7553714|NCT02432274|26259970|P7|Overall Study|Ongoing|0
7553715|NCT02432274|26259971|P6|Overall Study|Ongoing|0
7553716|NCT02432274|26259972|P5|Overall Study|Ongoing|3
7553717|NCT02432274|26259973|P4|Overall Study|Ongoing|1
7553718|NCT02432274|26259974|P3|Overall Study|Ongoing|1
7553719|NCT02432274|26259975|P2|Overall Study|Ongoing|0
7553720|NCT02432274|26259976|P1|Overall Study|Ongoing|0
7553721|NCT02432274|26259969|P8|Overall Study|Other than specified|1
7553722|NCT02432274|26259970|P7|Overall Study|Other than specified|0
7553723|NCT02432274|26259971|P6|Overall Study|Other than specified|1
7553724|NCT02432274|26259972|P5|Overall Study|Other than specified|0
7553725|NCT02432274|26259973|P4|Overall Study|Other than specified|0
7553726|NCT02432274|26259974|P3|Overall Study|Other than specified|0
7553727|NCT02432274|26259975|P2|Overall Study|Other than specified|1
7553728|NCT02432274|26259976|P1|Overall Study|Other than specified|0
7553729|NCT02432274|26259969|P8|Overall Study|Participant Choice|0
7553730|NCT02432274|26259970|P7|Overall Study|Participant Choice|1
7553731|NCT02432274|26259971|P6|Overall Study|Participant Choice|0
7553732|NCT02432274|26259972|P5|Overall Study|Participant Choice|0
7553733|NCT02432274|26259973|P4|Overall Study|Participant Choice|0
7553734|NCT02432274|26259974|P3|Overall Study|Participant Choice|1
7553735|NCT02432274|26259975|P2|Overall Study|Participant Choice|0
7553736|NCT02432274|26259976|P1|Overall Study|Participant Choice|0
7553737|NCT02432274|26259969|P8|Overall Study|Withdrawal by Subject|2
7553738|NCT02432274|26259970|P7|Overall Study|Withdrawal by Subject|1
7553739|NCT02432274|26259971|P6|Overall Study|Withdrawal by Subject|0
7553740|NCT02432274|26259972|P5|Overall Study|Withdrawal by Subject|2
7553741|NCT02432274|26259973|P4|Overall Study|Withdrawal by Subject|0
7553742|NCT02432274|26259974|P3|Overall Study|Withdrawal by Subject|0
7553743|NCT02432274|26259975|P2|Overall Study|Withdrawal by Subject|0
7553744|NCT02432274|26259976|P1|Overall Study|Withdrawal by Subject|0
7553745|NCT02432274|26259969|P8|Overall Study|Adverse Event|0
7553746|NCT02432274|26259970|P7|Overall Study|Adverse Event|2
7553747|NCT02432274|26259971|P6|Overall Study|Adverse Event|0
7553748|NCT02432274|26259972|P5|Overall Study|Adverse Event|1
7553749|NCT02432274|26259973|P4|Overall Study|Adverse Event|0
7553750|NCT02432274|26259974|P3|Overall Study|Adverse Event|1
7553751|NCT02432274|26259975|P2|Overall Study|Adverse Event|0
7553752|NCT02432274|26259976|P1|Overall Study|Adverse Event|0
7553753|NCT02432274|26259969|P8|Overall Study|Clinical Disease Progression|1
7553754|NCT02432274|26259970|P7|Overall Study|Clinical Disease Progression|0
7553755|NCT02432274|26259971|P6|Overall Study|Clinical Disease Progression|0
7553756|NCT02432274|26259972|P5|Overall Study|Clinical Disease Progression|1
7553757|NCT02432274|26259973|P4|Overall Study|Clinical Disease Progression|0
7553758|NCT02432274|26259974|P3|Overall Study|Clinical Disease Progression|1
7553759|NCT02432274|26259975|P2|Overall Study|Clinical Disease Progression|4
7553760|NCT02432274|26259976|P1|Overall Study|Clinical Disease Progression|0
7553761|NCT02432274|26259969|P8|Overall Study|Radiological Disease Progression|9
7553762|NCT02432274|26259970|P7|Overall Study|Radiological Disease Progression|11
7553763|NCT02432274|26259971|P6|Overall Study|Radiological Disease Progression|6
7553764|NCT02432274|26259972|P5|Overall Study|Radiological Disease Progression|24
7553765|NCT02432274|26259973|P4|Overall Study|Radiological Disease Progression|0
7553766|NCT02432274|26259974|P3|Overall Study|Radiological Disease Progression|7
7553767|NCT02432274|26259975|P2|Overall Study|Radiological Disease Progression|4
7553768|NCT02432274|26259976|P1|Overall Study|Radiological Disease Progression|3
7553769|NCT02432235|26260101|P12|Overall Study|Miscellaneous|1
7553770|NCT02432235|26260102|P11|Overall Study|Miscellaneous|0
7553771|NCT02432235|26260103|P10|Overall Study|Miscellaneous|0
7553772|NCT02432235|26260104|P9|Overall Study|Miscellaneous|4
7553773|NCT02432235|26260105|P8|Overall Study|Miscellaneous|2
7553774|NCT02432235|26260106|P7|Overall Study|Miscellaneous|2
7553775|NCT02432235|26260107|P6|Overall Study|Miscellaneous|6
7553776|NCT02432235|26260108|P5|Overall Study|Miscellaneous|1
7553777|NCT02432235|26260109|P4|Overall Study|Miscellaneous|0
7553778|NCT02432235|26260110|P3|Overall Study|Miscellaneous|0
7553779|NCT02432235|26260111|P2|Overall Study|Miscellaneous|0
7553780|NCT02432235|26260112|P1|Overall Study|Miscellaneous|0
7553781|NCT02432235|26260101|P12|Overall Study|Lost to Follow-up|0
7553782|NCT02432235|26260102|P11|Overall Study|Lost to Follow-up|0
7553783|NCT02432235|26260103|P10|Overall Study|Lost to Follow-up|0
7553784|NCT02432235|26260104|P9|Overall Study|Lost to Follow-up|1
7553785|NCT02432235|26260105|P8|Overall Study|Lost to Follow-up|0
7553786|NCT02432235|26260106|P7|Overall Study|Lost to Follow-up|0
7553787|NCT02432235|26260107|P6|Overall Study|Lost to Follow-up|1
7553788|NCT02432235|26260108|P5|Overall Study|Lost to Follow-up|0
7553789|NCT02432235|26260109|P4|Overall Study|Lost to Follow-up|0
7553790|NCT02432235|26260110|P3|Overall Study|Lost to Follow-up|0
7553791|NCT02432235|26260111|P2|Overall Study|Lost to Follow-up|0
7553792|NCT02432235|26260112|P1|Overall Study|Lost to Follow-up|0
7553793|NCT02432235|26260101|P12|Overall Study|Withdrawal by Subject|0
7553794|NCT02432235|26260102|P11|Overall Study|Withdrawal by Subject|0
7553795|NCT02432235|26260103|P10|Overall Study|Withdrawal by Subject|0
7553796|NCT02432235|26260104|P9|Overall Study|Withdrawal by Subject|1
7553797|NCT02432235|26260105|P8|Overall Study|Withdrawal by Subject|3
7553798|NCT02432235|26260106|P7|Overall Study|Withdrawal by Subject|5
7553799|NCT02432235|26260107|P6|Overall Study|Withdrawal by Subject|2
7553800|NCT02432235|26260108|P5|Overall Study|Withdrawal by Subject|0
7553801|NCT02432235|26260109|P4|Overall Study|Withdrawal by Subject|0
7553802|NCT02432235|26260110|P3|Overall Study|Withdrawal by Subject|0
7553803|NCT02432235|26260111|P2|Overall Study|Withdrawal by Subject|1
7553804|NCT02432235|26260112|P1|Overall Study|Withdrawal by Subject|0
7553805|NCT02432235|26260101|P12|Overall Study|Death|0
7553806|NCT02432235|26260102|P11|Overall Study|Death|1
7553807|NCT02432235|26260103|P10|Overall Study|Death|3
7553808|NCT02432235|26260104|P9|Overall Study|Death|15
7553809|NCT02432235|26260105|P8|Overall Study|Death|15
7553810|NCT02432235|26260106|P7|Overall Study|Death|11
7553811|NCT02432235|26260107|P6|Overall Study|Death|3
7553812|NCT02432235|26260108|P5|Overall Study|Death|1
7553813|NCT02432235|26260109|P4|Overall Study|Death|2
7553814|NCT02432235|26260110|P3|Overall Study|Death|2
7553815|NCT02432235|26260111|P2|Overall Study|Death|1
7553816|NCT02432235|26260112|P1|Overall Study|Death|1
7553817|NCT02432196|26260319|P1|Overall Study|On Study|20
7553818|NCT02432196|26260319|P1|Overall Study|Reoperation|3
7553819|NCT02432196|26260319|P1|Overall Study|Death|2
7553820|NCT02432196|26260319|P1|Overall Study|Not Implanted with Device|1
7553821|NCT02432144|26260352|P1|Overall Study|Participant Non-Compliance|1
7553822|NCT02432105|26260360|P3|Overall Study|Randomized in error|2
7553823|NCT02432105|26260361|P2|Overall Study|Randomized in error|0
7553824|NCT02432105|26260362|P1|Overall Study|Randomized in error|0
7553825|NCT02432105|26260360|P3|Overall Study|Culture positive for yeast|0
7553826|NCT02432105|26260361|P2|Overall Study|Culture positive for yeast|1
7553827|NCT02432105|26260362|P1|Overall Study|Culture positive for yeast|0
7553828|NCT02432105|26260360|P3|Overall Study|Withdrawal by Subject|1
7553829|NCT02432105|26260361|P2|Overall Study|Withdrawal by Subject|0
7553830|NCT02432105|26260362|P1|Overall Study|Withdrawal by Subject|1
7553831|NCT02432105|26260360|P3|Overall Study|Lost to Follow-up|0
7553832|NCT02432105|26260361|P2|Overall Study|Lost to Follow-up|1
7553833|NCT02432105|26260362|P1|Overall Study|Lost to Follow-up|1
7553834|NCT02432040|26260379|P2|Overall Study|Physician Decision|1
7553835|NCT02432040|26260380|P1|Overall Study|Physician Decision|1
7553836|NCT02432040|26260379|P2|Overall Study|Lost to Follow-up|5
7553837|NCT02432040|26260380|P1|Overall Study|Lost to Follow-up|4
7553838|NCT02432040|26260379|P2|Overall Study|Lack of Efficacy|0
7553839|NCT02432040|26260380|P1|Overall Study|Lack of Efficacy|3
7553840|NCT02431806|26260404|P4|Double-blind Treatment Period|Reason Not Specified|2
7553841|NCT02431806|26260405|P3|Double-blind Treatment Period|Reason Not Specified|5
7553842|NCT02431806|26260406|P2|Double-blind Treatment Period|Reason Not Specified|1
7553843|NCT02431806|26260407|P1|Double-blind Treatment Period|Reason Not Specified|0
7553844|NCT02431806|26260404|P4|Double-blind Treatment Period|Investigational Product Non-compliance|1
7553845|NCT02431806|26260405|P3|Double-blind Treatment Period|Investigational Product Non-compliance|3
7553846|NCT02431806|26260406|P2|Double-blind Treatment Period|Investigational Product Non-compliance|0
7553847|NCT02431806|26260407|P1|Double-blind Treatment Period|Investigational Product Non-compliance|1
7553848|NCT02431806|26260404|P4|Double-blind Treatment Period|Lost to Follow-up|8
7553849|NCT02431806|26260405|P3|Double-blind Treatment Period|Lost to Follow-up|5
7553850|NCT02431806|26260406|P2|Double-blind Treatment Period|Lost to Follow-up|4
7553851|NCT02431806|26260407|P1|Double-blind Treatment Period|Lost to Follow-up|7
7553852|NCT02431806|26260404|P4|Double-blind Treatment Period|Withdrawal of Consent|5
7553853|NCT02431806|26260405|P3|Double-blind Treatment Period|Withdrawal of Consent|5
7553854|NCT02431806|26260406|P2|Double-blind Treatment Period|Withdrawal of Consent|7
7553855|NCT02431806|26260407|P1|Double-blind Treatment Period|Withdrawal of Consent|10
7553856|NCT02431806|26260404|P4|Double-blind Treatment Period|Lack of Efficacy|2
7553857|NCT02431806|26260405|P3|Double-blind Treatment Period|Lack of Efficacy|2
7553858|NCT02431806|26260406|P2|Double-blind Treatment Period|Lack of Efficacy|0
7553859|NCT02431806|26260407|P1|Double-blind Treatment Period|Lack of Efficacy|2
7553860|NCT02431806|26260404|P4|Double-blind Treatment Period|Adverse Event|7
7553861|NCT02431806|26260405|P3|Double-blind Treatment Period|Adverse Event|11
7553862|NCT02431806|26260406|P2|Double-blind Treatment Period|Adverse Event|7
7553863|NCT02431806|26260407|P1|Double-blind Treatment Period|Adverse Event|4
7553864|NCT02431806|26260404|P4|Double-blind Treatment Period|Did not Receive Treatment|1
7553865|NCT02431806|26260405|P3|Double-blind Treatment Period|Did not Receive Treatment|1
7553866|NCT02431806|26260406|P2|Double-blind Treatment Period|Did not Receive Treatment|2
7553867|NCT02431806|26260407|P1|Double-blind Treatment Period|Did not Receive Treatment|1
7553868|NCT02431793|26260424|P3|Overall Study|Lost to Follow-up|104
7553869|NCT02431793|26260425|P2|Overall Study|Lost to Follow-up|122
7553870|NCT02431793|26260426|P1|Overall Study|Lost to Follow-up|101
7553871|NCT02431793|26260424|P3|Overall Study|Withdrawal by Subject|5
7553872|NCT02431793|26260425|P2|Overall Study|Withdrawal by Subject|5
7553873|NCT02431793|26260426|P1|Overall Study|Withdrawal by Subject|7
7553874|NCT02431793|26260424|P3|Overall Study|Ineligible doe to not filling Rx|8
7553875|NCT02431793|26260425|P2|Overall Study|Ineligible doe to not filling Rx|7
7553876|NCT02431793|26260426|P1|Overall Study|Ineligible doe to not filling Rx|11
7553877|NCT02431702|26260471|P7|Part 3: 9 Month of Additional Treatment|Other|0
7553878|NCT02431702|26260472|P6|Part 3: 9 Month of Additional Treatment|Other|6
7553879|NCT02431702|26260473|P5|Part 3: 9 Month of Additional Treatment|Other|1
7553880|NCT02431702|26260474|P4|Part 3: 9 Month of Additional Treatment|Other|1
7553881|NCT02431702|26260475|P3|Part 3: 9 Month of Additional Treatment|Other|0
7553882|NCT02431702|26260476|P2|Part 3: 9 Month of Additional Treatment|Other|0
7553883|NCT02431702|26260477|P1|Part 3: 9 Month of Additional Treatment|Other|0
7553884|NCT02431702|26260471|P7|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7553885|NCT02431702|26260472|P6|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7553886|NCT02431702|26260473|P5|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7553887|NCT02431702|26260474|P4|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
7553888|NCT02431702|26260475|P3|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7553889|NCT02431702|26260476|P2|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7553890|NCT02431702|26260477|P1|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7553891|NCT02431702|26260471|P7|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7553892|NCT02431702|26260472|P6|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
7553893|NCT02431702|26260473|P5|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7553894|NCT02431702|26260474|P4|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
7553895|NCT02431702|26260475|P3|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7553896|NCT02431702|26260476|P2|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7553897|NCT02431702|26260477|P1|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7553898|NCT02431702|26260471|P7|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7553899|NCT02431702|26260472|P6|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7553900|NCT02431702|26260473|P5|Part 3: 9 Month of Additional Treatment|Adverse Event|3
7553901|NCT02431702|26260474|P4|Part 3: 9 Month of Additional Treatment|Adverse Event|2
7553902|NCT02431702|26260475|P3|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7553903|NCT02431702|26260476|P2|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7553904|NCT02431702|26260477|P1|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7553905|NCT02431702|26260471|P7|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7553906|NCT02431702|26260472|P6|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7553907|NCT02431702|26260473|P5|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7553908|NCT02431702|26260474|P4|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7553909|NCT02431702|26260475|P3|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
7553910|NCT02431702|26260476|P2|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7553911|NCT02431702|26260477|P1|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7553912|NCT02431702|26260471|P7|Part 2: 9Month Disease Progression Phase|Other|0
7553913|NCT02431702|26260472|P6|Part 2: 9Month Disease Progression Phase|Other|0
7553914|NCT02431702|26260473|P5|Part 2: 9Month Disease Progression Phase|Other|0
7553915|NCT02431702|26260474|P4|Part 2: 9Month Disease Progression Phase|Other|0
7553916|NCT02431702|26260475|P3|Part 2: 9Month Disease Progression Phase|Other|2
7553917|NCT02431702|26260476|P2|Part 2: 9Month Disease Progression Phase|Other|2
7553918|NCT02431702|26260477|P1|Part 2: 9Month Disease Progression Phase|Other|0
7553919|NCT02431702|26260471|P7|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7553920|NCT02431702|26260472|P6|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7553921|NCT02431702|26260473|P5|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7553922|NCT02431702|26260474|P4|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7553923|NCT02431702|26260475|P3|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7553924|NCT02431702|26260476|P2|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
7553925|NCT02431702|26260477|P1|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7553926|NCT02431702|26260471|P7|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7553927|NCT02431702|26260472|P6|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7553928|NCT02431702|26260473|P5|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7553929|NCT02431702|26260474|P4|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7553930|NCT02431702|26260475|P3|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
7553931|NCT02431702|26260476|P2|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
7553932|NCT02431702|26260477|P1|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7553933|NCT02431702|26260471|P7|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7553934|NCT02431702|26260472|P6|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7553935|NCT02431702|26260473|P5|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7553936|NCT02431702|26260474|P4|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7553937|NCT02431702|26260475|P3|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
7553938|NCT02431702|26260476|P2|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
7553939|NCT02431702|26260477|P1|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7553940|NCT02431702|26260471|P7|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7553941|NCT02431702|26260472|P6|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7553942|NCT02431702|26260473|P5|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7553943|NCT02431702|26260474|P4|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7553944|NCT02431702|26260475|P3|Part 2: 9Month Disease Progression Phase|Adverse Event|1
7553945|NCT02431702|26260476|P2|Part 2: 9Month Disease Progression Phase|Adverse Event|5
7553946|NCT02431702|26260477|P1|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7553947|NCT02431702|26260471|P7|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7553948|NCT02431702|26260472|P6|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7553949|NCT02431702|26260473|P5|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7553950|NCT02431702|26260474|P4|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7553951|NCT02431702|26260475|P3|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7553952|NCT02431702|26260476|P2|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7553953|NCT02431702|26260477|P1|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
7553954|NCT02431702|26260471|P7|Part 1: 2-Month Oral Run-in Phase|Other|3
7553955|NCT02431702|26260472|P6|Part 1: 2-Month Oral Run-in Phase|Other|0
7553956|NCT02431702|26260473|P5|Part 1: 2-Month Oral Run-in Phase|Other|0
7553957|NCT02431702|26260474|P4|Part 1: 2-Month Oral Run-in Phase|Other|0
7553958|NCT02431702|26260475|P3|Part 1: 2-Month Oral Run-in Phase|Other|0
7553959|NCT02431702|26260476|P2|Part 1: 2-Month Oral Run-in Phase|Other|0
7553960|NCT02431702|26260477|P1|Part 1: 2-Month Oral Run-in Phase|Other|5
7553961|NCT02431702|26260471|P7|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
7553962|NCT02431702|26260472|P6|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7554047|NCT02431260|26260929|P5|Overall Study|Physician Decision|0
7553963|NCT02431702|26260473|P5|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7553964|NCT02431702|26260474|P4|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7553965|NCT02431702|26260475|P3|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7553966|NCT02431702|26260476|P2|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7553967|NCT02431702|26260477|P1|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
7553968|NCT02431702|26260471|P7|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
7553969|NCT02431702|26260472|P6|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7553970|NCT02431702|26260473|P5|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7553971|NCT02431702|26260474|P4|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7553972|NCT02431702|26260475|P3|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7553973|NCT02431702|26260476|P2|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7553974|NCT02431702|26260477|P1|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
7553975|NCT02431702|26260471|P7|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7553976|NCT02431702|26260472|P6|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7553977|NCT02431702|26260473|P5|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7553978|NCT02431702|26260474|P4|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7553979|NCT02431702|26260475|P3|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7553980|NCT02431702|26260476|P2|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7553981|NCT02431702|26260477|P1|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
7553982|NCT02431676|26260553|P3|Overall Study|no lab obtained|2
7553983|NCT02431676|26260554|P2|Overall Study|no lab obtained|1
7553984|NCT02431676|26260555|P1|Overall Study|no lab obtained|0
7553985|NCT02431559|26260631|P4|Overall Study|Physician Decision|1
7553986|NCT02431559|26260632|P3|Overall Study|Physician Decision|0
7553987|NCT02431559|26260633|P2|Overall Study|Physician Decision|0
7553988|NCT02431559|26260634|P1|Overall Study|Physician Decision|0
7553989|NCT02431559|26260631|P4|Overall Study|Withdrawal by Subject|4
7553990|NCT02431559|26260632|P3|Overall Study|Withdrawal by Subject|0
7553991|NCT02431559|26260633|P2|Overall Study|Withdrawal by Subject|1
7553992|NCT02431559|26260634|P1|Overall Study|Withdrawal by Subject|0
7553993|NCT02431559|26260631|P4|Overall Study|Progressive disease|22
7553994|NCT02431559|26260632|P3|Overall Study|Progressive disease|4
7553995|NCT02431559|26260633|P2|Overall Study|Progressive disease|1
7553996|NCT02431559|26260634|P1|Overall Study|Progressive disease|2
7553997|NCT02431559|26260631|P4|Overall Study|Adverse Event|4
7553998|NCT02431559|26260632|P3|Overall Study|Adverse Event|0
7553999|NCT02431559|26260633|P2|Overall Study|Adverse Event|1
7554000|NCT02431559|26260634|P1|Overall Study|Adverse Event|0
7554001|NCT02431533|26260682|P2|Overall Study|Developed Exclusionary criteria|0
7554002|NCT02431533|26260683|P1|Overall Study|Developed Exclusionary criteria|1
7554003|NCT02431533|26260682|P2|Overall Study|Withdrawal by Subject|3
7554004|NCT02431533|26260683|P1|Overall Study|Withdrawal by Subject|1
7554005|NCT02431468|26260749|P3|Overall Study|noncompliance, investigator termination,|2
7554006|NCT02431468|26260750|P2|Overall Study|noncompliance, investigator termination,|2
7554007|NCT02431468|26260751|P1|Overall Study|noncompliance, investigator termination,|2
7554008|NCT02431468|26260749|P3|Overall Study|Withdrawal by Subject|2
7554009|NCT02431468|26260750|P2|Overall Study|Withdrawal by Subject|12
7554010|NCT02431468|26260751|P1|Overall Study|Withdrawal by Subject|4
7554011|NCT02431468|26260749|P3|Overall Study|Adverse Event|5
7554012|NCT02431468|26260750|P2|Overall Study|Adverse Event|4
7554013|NCT02431468|26260751|P1|Overall Study|Adverse Event|2
7554014|NCT02431364|26260791|P5|Overall Study|Randomized but never treated|0
7554015|NCT02431364|26260792|P4|Overall Study|Randomized but never treated|1
7554016|NCT02431364|26260793|P3|Overall Study|Randomized but never treated|0
7554017|NCT02431364|26260794|P2|Overall Study|Randomized but never treated|0
7554018|NCT02431364|26260795|P1|Overall Study|Randomized but never treated|0
7554019|NCT02431364|26260791|P5|Overall Study|Adverse Event|0
7554020|NCT02431364|26260792|P4|Overall Study|Adverse Event|0
7554021|NCT02431364|26260793|P3|Overall Study|Adverse Event|0
7554022|NCT02431364|26260794|P2|Overall Study|Adverse Event|1
7554023|NCT02431364|26260795|P1|Overall Study|Adverse Event|0
7554024|NCT02431260|26260920|P14|Overall Study|Other Unspecified|0
7554025|NCT02431260|26260921|P13|Overall Study|Other Unspecified|1
7554026|NCT02431260|26260922|P12|Overall Study|Other Unspecified|1
7554027|NCT02431260|26260923|P11|Overall Study|Other Unspecified|0
7554028|NCT02431260|26260924|P10|Overall Study|Other Unspecified|0
7554029|NCT02431260|26260925|P9|Overall Study|Other Unspecified|0
7554030|NCT02431260|26260926|P8|Overall Study|Other Unspecified|0
7554031|NCT02431260|26260927|P7|Overall Study|Other Unspecified|0
7554032|NCT02431260|26260928|P6|Overall Study|Other Unspecified|0
7554033|NCT02431260|26260929|P5|Overall Study|Other Unspecified|0
7554034|NCT02431260|26260930|P4|Overall Study|Other Unspecified|0
7554035|NCT02431260|26260931|P3|Overall Study|Other Unspecified|0
7554036|NCT02431260|26260932|P2|Overall Study|Other Unspecified|0
7554037|NCT02431260|26260933|P1|Overall Study|Other Unspecified|0
7554038|NCT02431260|26260920|P14|Overall Study|Physician Decision|0
7554039|NCT02431260|26260921|P13|Overall Study|Physician Decision|0
7554040|NCT02431260|26260922|P12|Overall Study|Physician Decision|0
7554041|NCT02431260|26260923|P11|Overall Study|Physician Decision|0
7554042|NCT02431260|26260924|P10|Overall Study|Physician Decision|0
7554043|NCT02431260|26260925|P9|Overall Study|Physician Decision|0
7554044|NCT02431260|26260926|P8|Overall Study|Physician Decision|0
7554045|NCT02431260|26260927|P7|Overall Study|Physician Decision|0
7554046|NCT02431260|26260928|P6|Overall Study|Physician Decision|1
7554048|NCT02431260|26260930|P4|Overall Study|Physician Decision|0
7554049|NCT02431260|26260931|P3|Overall Study|Physician Decision|0
7554050|NCT02431260|26260932|P2|Overall Study|Physician Decision|0
7554051|NCT02431260|26260933|P1|Overall Study|Physician Decision|0
7554052|NCT02431260|26260920|P14|Overall Study|Study Terminated by the Sponsor|0
7554053|NCT02431260|26260921|P13|Overall Study|Study Terminated by the Sponsor|4
7554054|NCT02431260|26260922|P12|Overall Study|Study Terminated by the Sponsor|0
7554055|NCT02431260|26260923|P11|Overall Study|Study Terminated by the Sponsor|1
7554056|NCT02431260|26260924|P10|Overall Study|Study Terminated by the Sponsor|1
7554057|NCT02431260|26260925|P9|Overall Study|Study Terminated by the Sponsor|1
7554058|NCT02431260|26260926|P8|Overall Study|Study Terminated by the Sponsor|2
7554059|NCT02431260|26260927|P7|Overall Study|Study Terminated by the Sponsor|1
7554060|NCT02431260|26260928|P6|Overall Study|Study Terminated by the Sponsor|0
7554061|NCT02431260|26260929|P5|Overall Study|Study Terminated by the Sponsor|1
7554062|NCT02431260|26260930|P4|Overall Study|Study Terminated by the Sponsor|1
7554063|NCT02431260|26260931|P3|Overall Study|Study Terminated by the Sponsor|2
7554064|NCT02431260|26260932|P2|Overall Study|Study Terminated by the Sponsor|0
7554065|NCT02431260|26260933|P1|Overall Study|Study Terminated by the Sponsor|0
7554066|NCT02431260|26260920|P14|Overall Study|Lost to Follow-up|0
7554067|NCT02431260|26260921|P13|Overall Study|Lost to Follow-up|0
7554068|NCT02431260|26260922|P12|Overall Study|Lost to Follow-up|0
7554069|NCT02431260|26260923|P11|Overall Study|Lost to Follow-up|0
7554070|NCT02431260|26260924|P10|Overall Study|Lost to Follow-up|0
7554071|NCT02431260|26260925|P9|Overall Study|Lost to Follow-up|0
7554072|NCT02431260|26260926|P8|Overall Study|Lost to Follow-up|0
7554073|NCT02431260|26260927|P7|Overall Study|Lost to Follow-up|0
7554074|NCT02431260|26260928|P6|Overall Study|Lost to Follow-up|1
7554075|NCT02431260|26260929|P5|Overall Study|Lost to Follow-up|0
7554076|NCT02431260|26260930|P4|Overall Study|Lost to Follow-up|0
7554077|NCT02431260|26260931|P3|Overall Study|Lost to Follow-up|0
7554078|NCT02431260|26260932|P2|Overall Study|Lost to Follow-up|0
7554079|NCT02431260|26260933|P1|Overall Study|Lost to Follow-up|0
7554080|NCT02431260|26260920|P14|Overall Study|Death|1
7554081|NCT02431260|26260921|P13|Overall Study|Death|5
7554082|NCT02431260|26260922|P12|Overall Study|Death|2
7554083|NCT02431260|26260923|P11|Overall Study|Death|3
7554084|NCT02431260|26260924|P10|Overall Study|Death|6
7554085|NCT02431260|26260925|P9|Overall Study|Death|6
7554086|NCT02431260|26260926|P8|Overall Study|Death|1
7554087|NCT02431260|26260927|P7|Overall Study|Death|3
7554088|NCT02431260|26260928|P6|Overall Study|Death|2
7554089|NCT02431260|26260929|P5|Overall Study|Death|2
7554090|NCT02431260|26260930|P4|Overall Study|Death|4
7554091|NCT02431260|26260931|P3|Overall Study|Death|3
7554092|NCT02431260|26260932|P2|Overall Study|Death|4
7554093|NCT02431260|26260933|P1|Overall Study|Death|4
7554094|NCT02431260|26260920|P14|Overall Study|Subject Decision|0
7554095|NCT02431260|26260921|P13|Overall Study|Subject Decision|0
7554096|NCT02431260|26260922|P12|Overall Study|Subject Decision|1
7554097|NCT02431260|26260923|P11|Overall Study|Subject Decision|0
7554098|NCT02431260|26260924|P10|Overall Study|Subject Decision|1
7554099|NCT02431260|26260925|P9|Overall Study|Subject Decision|1
7554100|NCT02431260|26260926|P8|Overall Study|Subject Decision|0
7554101|NCT02431260|26260927|P7|Overall Study|Subject Decision|0
7554102|NCT02431260|26260928|P6|Overall Study|Subject Decision|0
7554103|NCT02431260|26260929|P5|Overall Study|Subject Decision|0
7554104|NCT02431260|26260930|P4|Overall Study|Subject Decision|0
7554105|NCT02431260|26260931|P3|Overall Study|Subject Decision|1
7554106|NCT02431260|26260932|P2|Overall Study|Subject Decision|1
7554107|NCT02431260|26260933|P1|Overall Study|Subject Decision|0
7554108|NCT02431247|26261026|P2|Overall Study|Non-compliance with study drug|0
7554109|NCT02431247|26261027|P1|Overall Study|Non-compliance with study drug|1
7554110|NCT02431247|26261026|P2|Overall Study|Ongoing|336
7554111|NCT02431247|26261027|P1|Overall Study|Ongoing|339
7554112|NCT02431247|26261026|P2|Overall Study|Other|1
7554113|NCT02431247|26261027|P1|Overall Study|Other|2
7554114|NCT02431247|26261026|P2|Overall Study|Withdrawal by Subject|6
7554115|NCT02431247|26261027|P1|Overall Study|Withdrawal by Subject|4
7554116|NCT02431247|26261026|P2|Overall Study|Physician Decision|0
7554117|NCT02431247|26261027|P1|Overall Study|Physician Decision|3
7554118|NCT02431247|26261026|P2|Overall Study|Adverse Event|15
7554119|NCT02431247|26261027|P1|Overall Study|Adverse Event|8
7554120|NCT02431247|26261026|P2|Overall Study|Lost to Follow-up|5
7554121|NCT02431247|26261027|P1|Overall Study|Lost to Follow-up|5
7554122|NCT02430870|26261120|P8|Part 2|Other Reason Not Specified|1
7554123|NCT02430870|26261121|P7|Part 2|Other Reason Not Specified|0
7554124|NCT02430870|26261122|P6|Part 2|Other Reason Not Specified|0
7554125|NCT02430870|26261123|P5|Part 2|Other Reason Not Specified|0
7554126|NCT02430870|26261124|P4|Part 2|Other Reason Not Specified|0
7554127|NCT02430870|26261125|P3|Part 2|Other Reason Not Specified|0
7554128|NCT02430870|26261126|P2|Part 2|Other Reason Not Specified|0
7554129|NCT02430870|26261127|P1|Part 2|Other Reason Not Specified|0
7554130|NCT02430870|26261120|P8|Part 2|Voluntary Withdrawal|0
7554131|NCT02430870|26261121|P7|Part 2|Voluntary Withdrawal|1
7554132|NCT02430870|26261122|P6|Part 2|Voluntary Withdrawal|0
7554133|NCT02430870|26261123|P5|Part 2|Voluntary Withdrawal|0
7554134|NCT02430870|26261124|P4|Part 2|Voluntary Withdrawal|0
7554135|NCT02430870|26261125|P3|Part 2|Voluntary Withdrawal|0
7554136|NCT02430870|26261126|P2|Part 2|Voluntary Withdrawal|0
7554137|NCT02430870|26261127|P1|Part 2|Voluntary Withdrawal|0
7554138|NCT02430532|26261214|P2|Overall Study|Adverse Event|1
7554139|NCT02430532|26261215|P1|Overall Study|Adverse Event|0
7554140|NCT02430532|26261214|P2|Overall Study|Consent Withdrawn|2
7554141|NCT02430532|26261215|P1|Overall Study|Consent Withdrawn|0
7554142|NCT02430532|26261214|P2|Overall Study|Sponsor Decision to Stop Study Early|25
7554143|NCT02430532|26261215|P1|Overall Study|Sponsor Decision to Stop Study Early|30
7554144|NCT02430480|26261229|P1|Overall Study|Progressed on treatment|1
7554145|NCT02430480|26261229|P1|Overall Study|Anesthesia concerns|1
7554146|NCT02430480|26261229|P1|Overall Study|Death|1
7554147|NCT02430311|26261272|P2|Part B|Death|0
7554148|NCT02430311|26261273|P1|Part B|Death|1
7554149|NCT02430311|26261272|P2|Part B|Adverse Event|0
7554150|NCT02430311|26261273|P1|Part B|Adverse Event|1
7554151|NCT02430311|26261272|P2|Part B|Withdrawal by Subject|2
7554152|NCT02430311|26261273|P1|Part B|Withdrawal by Subject|2
7554153|NCT02430311|26261272|P2|Part B|Meet study-specific withdrawal criteria|6
7554154|NCT02430311|26261273|P1|Part B|Meet study-specific withdrawal criteria|6
7554155|NCT02430311|26261272|P2|Part A|Withdrawal by Subject|0
7554156|NCT02430311|26261273|P1|Part A|Withdrawal by Subject|1
7554157|NCT02430311|26261272|P2|Part A|Adverse Event|1
7554158|NCT02430311|26261273|P1|Part A|Adverse Event|0
7554159|NCT02429934|26261321|P2|Overall Study|Physician Decision|0
7554160|NCT02429934|26261322|P1|Overall Study|Physician Decision|1
7554161|NCT02429934|26261321|P2|Overall Study|Lost to Follow-up|1
7554162|NCT02429934|26261322|P1|Overall Study|Lost to Follow-up|1
7554163|NCT02429934|26261321|P2|Overall Study|Adverse Event|0
7554164|NCT02429934|26261322|P1|Overall Study|Adverse Event|2
7554165|NCT02429934|26261321|P2|Overall Study|Withdrawal by Subject|2
7554166|NCT02429934|26261322|P1|Overall Study|Withdrawal by Subject|0
7554167|NCT02429856|26261354|P2|Overall Study|Withdrawal by Subject|1
7554168|NCT02429856|26261355|P1|Overall Study|Withdrawal by Subject|1
7554169|NCT02429856|26261354|P2|Overall Study|Lost to Follow-up|5
7554170|NCT02429856|26261355|P1|Overall Study|Lost to Follow-up|6
7554171|NCT02429856|26261354|P2|Overall Study|Death|13
7554172|NCT02429856|26261355|P1|Overall Study|Death|12
7554197|NCT02429778|26261462|P2|Overall Study|Withdrawal by Subject|0
7554198|NCT02429778|26261463|P1|Overall Study|Withdrawal by Subject|5
7554199|NCT02429778|26261462|P2|Overall Study|Lost to Follow-up|0
7554200|NCT02429778|26261463|P1|Overall Study|Lost to Follow-up|2
7554201|NCT02429427|26261494|P2|Overall Study|Other|41
7554202|NCT02429427|26261495|P1|Overall Study|Other|62
7554203|NCT02429427|26261494|P2|Overall Study|Withdrawal by Subject|34
7554204|NCT02429427|26261495|P1|Overall Study|Withdrawal by Subject|64
7554205|NCT02429427|26261494|P2|Overall Study|Lost to Follow-up|6
7554206|NCT02429427|26261495|P1|Overall Study|Lost to Follow-up|15
7554207|NCT02429427|26261494|P2|Overall Study|Protocol Violation|6
7554208|NCT02429427|26261495|P1|Overall Study|Protocol Violation|10
7554209|NCT02429427|26261494|P2|Overall Study|Adverse Event|92
7554210|NCT02429427|26261495|P1|Overall Study|Adverse Event|220
7554211|NCT02429310|26261509|P2|Overall Study|Protocol Violation|1
7554212|NCT02429310|26261510|P1|Overall Study|Protocol Violation|1
7554213|NCT02429310|26261509|P2|Overall Study|Lost to Follow-up|2
7554214|NCT02429310|26261510|P1|Overall Study|Lost to Follow-up|1
7554215|NCT02429258|26261520|P2|Overall Study|Protocol Violation|1
7554216|NCT02429258|26261521|P1|Overall Study|Protocol Violation|0
7554217|NCT02429258|26261520|P2|Overall Study|Withdrawal by Subject|0
7554218|NCT02429258|26261521|P1|Overall Study|Withdrawal by Subject|2
7554219|NCT02428855|26261575|P1|Overall Study|Withdrawal by Subject|2
7554220|NCT02428699|26261582|P2|Washout Period 1|Screen Failure|2
7554221|NCT02428699|26261583|P1|Washout Period 1|Screen Failure|1
7554222|NCT02428608|26261611|P1|Overall Study|various|16
7554223|NCT02428608|26261611|P1|Overall Study|Death|1
7554224|NCT02428608|26261611|P1|Overall Study|moved away|10
7554225|NCT02428608|26261611|P1|Overall Study|scheduling conflicts|15
7554226|NCT02428608|26261611|P1|Overall Study|Withdrawal by Subject|2
7554227|NCT02428608|26261611|P1|Overall Study|Lost to Follow-up|37
7554228|NCT02428608|26261611|P1|Overall Study|Pregnancy|2
7554229|NCT02428413|26261643|P2|Overall Study|Nurse Refusal|0
7554230|NCT02428413|26261644|P1|Overall Study|Nurse Refusal|1
7554231|NCT02428413|26261643|P2|Overall Study|Missed Cases|2
7554232|NCT02428413|26261644|P1|Overall Study|Missed Cases|1
7554233|NCT02428413|26261643|P2|Overall Study|Case Cancelled|0
7554234|NCT02428413|26261644|P1|Overall Study|Case Cancelled|2
7554235|NCT02428413|26261643|P2|Overall Study|Protocol Violation|2
7554236|NCT02428413|26261644|P1|Overall Study|Protocol Violation|1
7554237|NCT02428413|26261643|P2|Overall Study|Device to measure WAG malfunctioned|5
7554238|NCT02428413|26261644|P1|Overall Study|Device to measure WAG malfunctioned|3
7554239|NCT02428296|26261679|P1|Overall Study|Withdrawal by Subject|2
7554240|NCT02428296|26261679|P1|Overall Study|Adverse Event|7
7554241|NCT02428231|26261691|P2|Overall Study|Adverse Event|0
7554242|NCT02428231|26261692|P1|Overall Study|Adverse Event|3
7554243|NCT02428231|26261691|P2|Overall Study|Required Symptomatic Therapy|1
7554244|NCT02428231|26261692|P1|Overall Study|Required Symptomatic Therapy|0
7554245|NCT02428231|26261691|P2|Overall Study|Other|16
7554246|NCT02428231|26261692|P1|Overall Study|Other|10
7554247|NCT02427984|26261724|P3|Overall Study|Lost to Follow-up|18
7554248|NCT02427984|26261725|P2|Overall Study|Lost to Follow-up|5
7554249|NCT02427984|26261726|P1|Overall Study|Lost to Follow-up|13
7554250|NCT02427958|26261740|P1|Overall Study|Lack of Efficacy|1
7554251|NCT02427958|26261740|P1|Overall Study|Withdrawal by Subject|14
7554252|NCT02427958|26261740|P1|Overall Study|Lost to Follow-up|6
7554253|NCT02427958|26261740|P1|Overall Study|Pretreatment Event (PTE) or AE|3
7554254|NCT02427841|26261745|P1|Overall Study|Physician Decision|8
7554255|NCT02427802|26261752|P3|Overall Study|protocol specific treatment unrelated|11
7554256|NCT02427802|26261753|P2|Overall Study|protocol specific treatment unrelated|11
7554257|NCT02427802|26261754|P1|Overall Study|protocol specific treatment unrelated|18
7554258|NCT02427802|26261752|P3|Overall Study|Protocol Violation|1
7554259|NCT02427802|26261753|P2|Overall Study|Protocol Violation|1
7554260|NCT02427802|26261754|P1|Overall Study|Protocol Violation|3
7554261|NCT02427802|26261752|P3|Overall Study|Withdrawal by Subject|11
7554262|NCT02427802|26261753|P2|Overall Study|Withdrawal by Subject|5
7554263|NCT02427802|26261754|P1|Overall Study|Withdrawal by Subject|10
7554264|NCT02427802|26261752|P3|Overall Study|Physician Decision|4
7554265|NCT02427802|26261753|P2|Overall Study|Physician Decision|2
7554266|NCT02427802|26261754|P1|Overall Study|Physician Decision|4
7554267|NCT02427802|26261752|P3|Overall Study|Lost to Follow-up|8
7554268|NCT02427802|26261753|P2|Overall Study|Lost to Follow-up|8
7554269|NCT02427802|26261754|P1|Overall Study|Lost to Follow-up|13
7554270|NCT02427802|26261752|P3|Overall Study|Death|1
7554271|NCT02427802|26261753|P2|Overall Study|Death|4
7554272|NCT02427802|26261754|P1|Overall Study|Death|0
7554273|NCT02427802|26261752|P3|Overall Study|Adverse Event|7
7554274|NCT02427802|26261753|P2|Overall Study|Adverse Event|3
7554275|NCT02427802|26261754|P1|Overall Study|Adverse Event|11
7554276|NCT02427646|26261865|P2|Overall Study|Bothersome hand weakness|4
7554277|NCT02427646|26261866|P1|Overall Study|Bothersome hand weakness|2
7554278|NCT02427646|26261865|P2|Overall Study|Protocol Violation|3
7554279|NCT02427646|26261866|P1|Overall Study|Protocol Violation|3
7554280|NCT02427646|26261865|P2|Overall Study|Physician Decision|4
7554281|NCT02427646|26261866|P1|Overall Study|Physician Decision|1
7554282|NCT02427646|26261865|P2|Overall Study|Lack of Efficacy|3
7554283|NCT02427646|26261866|P1|Overall Study|Lack of Efficacy|2
7554284|NCT02427607|26261874|P1|Overall Study|Withdrawal by Subject|1
7554285|NCT02427477|26261915|P2|Period 1|Adverse Event|0
7554286|NCT02427477|26261916|P1|Period 1|Adverse Event|1
7554287|NCT02427399|26261929|P5|Overall Study|Protocol Violation|15
7554288|NCT02427399|26261930|P4|Overall Study|Protocol Violation|18
7554289|NCT02427399|26261931|P3|Overall Study|Protocol Violation|12
7554290|NCT02427399|26261932|P2|Overall Study|Protocol Violation|16
7554291|NCT02427399|26261933|P1|Overall Study|Protocol Violation|14
7554292|NCT02427100|26261957|P2|Overall Study|Lost to Follow-up|2
7554293|NCT02427100|26261958|P1|Overall Study|Lost to Follow-up|0
7554294|NCT02426918|26261969|P3|Overall Study|Other|9
7554295|NCT02426918|26261970|P2|Overall Study|Other|11
7554296|NCT02426918|26261971|P1|Overall Study|Other|9
7554297|NCT02426918|26261969|P3|Overall Study|Withdrawal by Subject|4
7554298|NCT02426918|26261970|P2|Overall Study|Withdrawal by Subject|5
7554299|NCT02426918|26261971|P1|Overall Study|Withdrawal by Subject|5
7554300|NCT02426918|26261969|P3|Overall Study|Physician Decision|1
7554301|NCT02426918|26261970|P2|Overall Study|Physician Decision|1
7554302|NCT02426918|26261971|P1|Overall Study|Physician Decision|1
7554303|NCT02426918|26261969|P3|Overall Study|Adverse Event|0
7554304|NCT02426918|26261970|P2|Overall Study|Adverse Event|2
7554305|NCT02426918|26261971|P1|Overall Study|Adverse Event|2
7554306|NCT02426658|26262006|P1|Overall Study|Patient expired before treatment|2
7554307|NCT02426658|26262006|P1|Overall Study|Withdrawal by Subject|1
7554308|NCT02426580|26262013|P2|Overall Study|Allergic to egg white|0
7554309|NCT02426580|26262014|P1|Overall Study|Allergic to egg white|1
7554310|NCT02426580|26262013|P2|Overall Study|Kidney transplant|0
7554311|NCT02426580|26262014|P1|Overall Study|Kidney transplant|3
7554312|NCT02426580|26262013|P2|Overall Study|transfer to hemodialysis|5
7554313|NCT02426580|26262014|P1|Overall Study|transfer to hemodialysis|5
7554314|NCT02426580|26262013|P2|Overall Study|Lost to Follow-up|9
7554315|NCT02426580|26262014|P1|Overall Study|Lost to Follow-up|0
7554316|NCT02426580|26262013|P2|Overall Study|Death|2
7554317|NCT02426580|26262014|P1|Overall Study|Death|2
7554318|NCT02426541|26262022|P2|Overall Study|Protocol Violation|0
7554319|NCT02426541|26262023|P1|Overall Study|Protocol Violation|1
7554320|NCT02426138|26262048|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
7554321|NCT02426138|26262049|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
7554322|NCT02426125|26262089|P2|Overall Study|Withdrawal by Subject|16
7554323|NCT02426125|26262090|P1|Overall Study|Withdrawal by Subject|16
7554324|NCT02426125|26262089|P2|Overall Study|Protocol Violation|0
7554325|NCT02426125|26262090|P1|Overall Study|Protocol Violation|1
7554326|NCT02426125|26262089|P2|Overall Study|Lost to Follow-up|10
7554327|NCT02426125|26262090|P1|Overall Study|Lost to Follow-up|12
7554328|NCT02426086|26262116|P2|Overall Study|Withdrawal by Subject|9
7554329|NCT02426086|26262117|P1|Overall Study|Withdrawal by Subject|8
7554330|NCT02426086|26262116|P2|Overall Study|Study Terminated by Sponsor|14
7554331|NCT02426086|26262117|P1|Overall Study|Study Terminated by Sponsor|5
7554332|NCT02426086|26262116|P2|Overall Study|Lost to Follow-up|0
7554333|NCT02426086|26262117|P1|Overall Study|Lost to Follow-up|2
7554334|NCT02426086|26262116|P2|Overall Study|Death|36
7554335|NCT02426086|26262117|P1|Overall Study|Death|33
7554356|NCT02425826|26262205|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
7554357|NCT02425826|26262206|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
7554358|NCT02425826|26262207|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
7554359|NCT02425826|26262205|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
7554360|NCT02425826|26262206|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
7554361|NCT02425826|26262207|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
7554362|NCT02425826|26262205|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
7554363|NCT02425826|26262206|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
7554364|NCT02425826|26262207|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
7554365|NCT02425826|26262205|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
7554366|NCT02425826|26262206|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
7554367|NCT02425826|26262207|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
7554368|NCT02425826|26262205|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
7554369|NCT02425826|26262206|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
7554370|NCT02425826|26262207|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
7554371|NCT02425826|26262205|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
7554372|NCT02425826|26262206|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
7554373|NCT02425826|26262207|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
7554374|NCT02425826|26262205|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
7554375|NCT02425826|26262206|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
7554376|NCT02425826|26262207|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
7554377|NCT02425826|26262205|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
7554378|NCT02425826|26262206|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
7554379|NCT02425826|26262207|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
7554380|NCT02425826|26262205|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
7554381|NCT02425826|26262206|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
7554382|NCT02425826|26262207|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
7554383|NCT02425826|26262205|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
7554384|NCT02425826|26262206|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
7554385|NCT02425826|26262207|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
7554386|NCT02425644|26262242|P2|Overall Study|Other|17
7554387|NCT02425644|26262243|P1|Overall Study|Other|18
7554388|NCT02425644|26262242|P2|Overall Study|Death|2
7554389|NCT02425644|26262243|P1|Overall Study|Death|0
7554390|NCT02425644|26262242|P2|Overall Study|Adverse Event|3
7554391|NCT02425644|26262243|P1|Overall Study|Adverse Event|13
7554392|NCT02425644|26262242|P2|Overall Study|Lack of Efficacy|10
7554393|NCT02425644|26262243|P1|Overall Study|Lack of Efficacy|3
7554394|NCT02425644|26262242|P2|Overall Study|Withdrawal by Subject|36
7554395|NCT02425644|26262243|P1|Overall Study|Withdrawal by Subject|41
7554396|NCT02425644|26262242|P2|Overall Study|Lost to Follow-up|3
7554397|NCT02425644|26262243|P1|Overall Study|Lost to Follow-up|2
7554398|NCT02425111|26262303|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
7554399|NCT02425111|26262303|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
7554400|NCT02425111|26262303|P1|Part A: Treatment Period|Lost to Follow-up|2
7554401|NCT02425111|26262303|P1|Part A: Treatment Period|Voluntary Withdrawal|4
7554402|NCT02425111|26262303|P1|Part A: Treatment Period|Lack of Efficacy|15
7554403|NCT02425111|26262303|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
7554404|NCT02425098|26262324|P2|Overall Study|Reason not Specified|1
7554405|NCT02425098|26262325|P1|Overall Study|Reason not Specified|0
7554406|NCT02425098|26262324|P2|Overall Study|Pregnancy|0
7554407|NCT02425098|26262325|P1|Overall Study|Pregnancy|2
7554408|NCT02425098|26262324|P2|Overall Study|Withdrawal by Subject|8
7554409|NCT02425098|26262325|P1|Overall Study|Withdrawal by Subject|4
7554410|NCT02425098|26262324|P2|Overall Study|Lost to Follow-up|7
7554411|NCT02425098|26262325|P1|Overall Study|Lost to Follow-up|7
7554412|NCT02424734|26262488|P3|Overall Study|Treatment stopped to be discharged home|0
7554413|NCT02424734|26262489|P2|Overall Study|Treatment stopped to be discharged home|2
7554414|NCT02424734|26262490|P1|Overall Study|Treatment stopped to be discharged home|2
7554415|NCT02424630|26262509|P2|Overall Study|Open procedure|1
7554416|NCT02424630|26262510|P1|Overall Study|Open procedure|0
7554417|NCT02424630|26262509|P2|Overall Study|No rotator cuff tear|2
7554418|NCT02424630|26262510|P1|Overall Study|No rotator cuff tear|1
7554419|NCT02424591|26262520|P2|Overall Study|Protocol Violation|3
7554420|NCT02424591|26262521|P1|Overall Study|Protocol Violation|2
7554421|NCT02424578|26262533|P2|Overall Study|Withdrawal by Subject|1
7554422|NCT02424578|26262534|P1|Overall Study|Withdrawal by Subject|0
7554423|NCT02424565|26262540|P2|Period 1 (D0)|Protocol Violation|1
7554424|NCT02424565|26262541|P1|Period 1 (D0)|Protocol Violation|0
7554425|NCT02424539|26262550|P3|Overall Study|Other: Reached stopping criteria|6
7554426|NCT02424539|26262551|P2|Overall Study|Other: Reached stopping criteria|7
7554427|NCT02424539|26262552|P1|Overall Study|Other: Reached stopping criteria|11
7554428|NCT02424539|26262550|P3|Overall Study|Withdrawal by Subject|0
7554429|NCT02424539|26262551|P2|Overall Study|Withdrawal by Subject|1
7554430|NCT02424539|26262552|P1|Overall Study|Withdrawal by Subject|3
7554431|NCT02424539|26262550|P3|Overall Study|Physician Decision|1
7554432|NCT02424539|26262551|P2|Overall Study|Physician Decision|0
7554433|NCT02424539|26262552|P1|Overall Study|Physician Decision|0
7554434|NCT02424539|26262550|P3|Overall Study|Adverse Event|1
7554435|NCT02424539|26262551|P2|Overall Study|Adverse Event|0
7554436|NCT02424539|26262552|P1|Overall Study|Adverse Event|0
7554437|NCT02424383|26262635|P1|Overall Study|Ineligible for Major Protocol Deviation|39
7554438|NCT02424383|26262635|P1|Overall Study|Other|7
7554439|NCT02424383|26262635|P1|Overall Study|Lost to Follow-up|81
7554440|NCT02424383|26262635|P1|Overall Study|Investigator's decision|44
7554441|NCT02424383|26262635|P1|Overall Study|Sponsor's decision|3
7554442|NCT02424383|26262635|P1|Overall Study|Death|170
7554443|NCT02424383|26262635|P1|Overall Study|Withdrawal by Subject|32
7554444|NCT02424344|26262659|P2|Overall Study|Adverse Event|8
7554445|NCT02424344|26262660|P1|Overall Study|Adverse Event|4
7554446|NCT02424344|26262659|P2|Overall Study|Lost to Follow-up|0
7554447|NCT02424344|26262660|P1|Overall Study|Lost to Follow-up|1
7554448|NCT02424344|26262659|P2|Overall Study|Withdrawal by Subject|1
7554449|NCT02424344|26262660|P1|Overall Study|Withdrawal by Subject|2
7554450|NCT02424344|26262659|P2|Overall Study|Lack of Efficacy|1
7554451|NCT02424344|26262660|P1|Overall Study|Lack of Efficacy|0
7554452|NCT02424253|26262672|P2|Overall Study|Lost to Follow-up|1
7554453|NCT02424253|26262673|P1|Overall Study|Lost to Follow-up|1
7554454|NCT02424253|26262672|P2|Overall Study|Consent withdrawn by subject|1
7554455|NCT02424253|26262673|P1|Overall Study|Consent withdrawn by subject|4
7554456|NCT02424253|26262672|P2|Overall Study|Adverse Event|0
7554457|NCT02424253|26262673|P1|Overall Study|Adverse Event|2
7554458|NCT02424253|26262672|P2|Overall Study|Lack of Efficacy|7
7554459|NCT02424253|26262673|P1|Overall Study|Lack of Efficacy|0
7554460|NCT02424253|26262672|P2|Overall Study|Physician Decision|0
7554461|NCT02424253|26262673|P1|Overall Study|Physician Decision|2
7554462|NCT02424253|26262672|P2|Overall Study|Compliance problems|0
7554463|NCT02424253|26262673|P1|Overall Study|Compliance problems|1
7554464|NCT02424253|26262672|P2|Overall Study|Other, unspecified|0
7554465|NCT02424253|26262673|P1|Overall Study|Other, unspecified|1
7554466|NCT02424149|26262689|P2|Overall Study|Withdrawal by Subject|1
7554467|NCT02424149|26262690|P1|Overall Study|Withdrawal by Subject|0
7554468|NCT02424149|26262689|P2|Overall Study|surgery cancelled|0
7554469|NCT02424149|26262690|P1|Overall Study|surgery cancelled|2
7554470|NCT02424097|26262706|P2|Overall Study|Lost to Follow-up|2
7554471|NCT02424097|26262707|P1|Overall Study|Lost to Follow-up|1
7554472|NCT02423798|26262762|P1|Overall Study|Withdrawal by Subject|3
7554473|NCT02423343|26262813|P6|Overall Study|Death|0
7554474|NCT02423343|26262814|P5|Overall Study|Death|1
7554475|NCT02423343|26262815|P4|Overall Study|Death|0
7554476|NCT02423343|26262816|P3|Overall Study|Death|0
7554477|NCT02423343|26262817|P2|Overall Study|Death|0
7554478|NCT02423343|26262818|P1|Overall Study|Death|0
7554479|NCT02423343|26262813|P6|Overall Study|Adverse Event|0
7554480|NCT02423343|26262814|P5|Overall Study|Adverse Event|2
7554481|NCT02423343|26262815|P4|Overall Study|Adverse Event|0
7554482|NCT02423343|26262816|P3|Overall Study|Adverse Event|0
7554483|NCT02423343|26262817|P2|Overall Study|Adverse Event|0
7554484|NCT02423343|26262818|P1|Overall Study|Adverse Event|0
7554485|NCT02423343|26262813|P6|Overall Study|Progressive Disease|0
7554486|NCT02423343|26262814|P5|Overall Study|Progressive Disease|2
7554487|NCT02423343|26262815|P4|Overall Study|Progressive Disease|0
7554488|NCT02423343|26262816|P3|Overall Study|Progressive Disease|0
7554489|NCT02423343|26262817|P2|Overall Study|Progressive Disease|0
7554490|NCT02423343|26262818|P1|Overall Study|Progressive Disease|0
7554491|NCT02423343|26262813|P6|Overall Study|Withdrawal by Subject|0
7554492|NCT02423343|26262814|P5|Overall Study|Withdrawal by Subject|0
7554493|NCT02423343|26262815|P4|Overall Study|Withdrawal by Subject|0
7554494|NCT02423343|26262816|P3|Overall Study|Withdrawal by Subject|0
7554495|NCT02423343|26262817|P2|Overall Study|Withdrawal by Subject|1
7554496|NCT02423343|26262818|P1|Overall Study|Withdrawal by Subject|0
7554497|NCT02423291|26262876|P1|Overall Study|Adverse Event|1
7554498|NCT02423291|26262876|P1|Overall Study|Lack of Efficacy|14
7554499|NCT02423109|26262906|P2|Lens 1|Adverse Event|0
7554500|NCT02423109|26262907|P1|Lens 1|Adverse Event|1
7554529|NCT02422615|26263029|P2|Overall Study|Technical problems|1
7554530|NCT02422615|26263030|P1|Overall Study|Technical problems|0
7554531|NCT02422615|26263029|P2|Overall Study|Protocol Violation|1
7554532|NCT02422615|26263030|P1|Overall Study|Protocol Violation|1
7554533|NCT02422615|26263029|P2|Overall Study|Death|0
7554534|NCT02422615|26263030|P1|Overall Study|Death|2
7554535|NCT02422615|26263029|P2|Overall Study|Subject/guardian decision|5
7554536|NCT02422615|26263030|P1|Overall Study|Subject/guardian decision|21
7554537|NCT02422615|26263029|P2|Overall Study|Physician Decision|7
7554538|NCT02422615|26263030|P1|Overall Study|Physician Decision|22
7554539|NCT02422615|26263029|P2|Overall Study|Adverse Event|10
7554540|NCT02422615|26263030|P1|Overall Study|Adverse Event|41
7554541|NCT02422615|26263029|P2|Overall Study|Progressive disease|142
7554542|NCT02422615|26263030|P1|Overall Study|Progressive disease|193
7554543|NCT02422303|26263116|P2|Overall Study|Lost to Follow-up|1
7554544|NCT02422303|26263117|P1|Overall Study|Lost to Follow-up|1
7554545|NCT02422264|26263132|P2|Overall Study|Subject vaccinated outside of the study|1
7554546|NCT02422264|26263133|P1|Overall Study|Subject vaccinated outside of the study|0
7554547|NCT02422264|26263132|P2|Overall Study|Migrated/moved from study area|1
7554548|NCT02422264|26263133|P1|Overall Study|Migrated/moved from study area|3
7554549|NCT02422264|26263132|P2|Overall Study|Withdrawal by Subject|2
7554550|NCT02422264|26263133|P1|Overall Study|Withdrawal by Subject|1
7554551|NCT02422264|26263132|P2|Overall Study|Serious Adverse Event|0
7554552|NCT02422264|26263133|P1|Overall Study|Serious Adverse Event|1
7554553|NCT02422186|26263179|P2|Follow-up Phase (2 Weeks)|Other|0
7554554|NCT02422186|26263180|P1|Follow-up Phase (2 Weeks)|Other|3
7554555|NCT02422186|26263179|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
7554556|NCT02422186|26263180|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
7554557|NCT02422186|26263179|P2|Double-blind Induction Phase (4 Weeks)|Other|0
7554558|NCT02422186|26263180|P1|Double-blind Induction Phase (4 Weeks)|Other|1
7554559|NCT02422186|26263179|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7554560|NCT02422186|26263180|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
7554561|NCT02422186|26263179|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7554562|NCT02422186|26263180|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
7554563|NCT02422186|26263179|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
7554564|NCT02422186|26263180|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7554565|NCT02422186|26263179|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7554566|NCT02422186|26263180|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
7554567|NCT02422186|26263179|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7554568|NCT02422186|26263180|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7554569|NCT02421952|26263202|P1|Overall Study|Surgery cancelled|1
7554570|NCT02421952|26263202|P1|Overall Study|Subject uncooperative for baseline test|2
7554571|NCT02421952|26263202|P1|Overall Study|Failed seriation task|13
7554572|NCT02421952|26263202|P1|Overall Study|Diary Not Returned|93
7554573|NCT02421939|26263211|P2|Overall Study|Protocol deviation|1
7554574|NCT02421939|26263212|P1|Overall Study|Protocol deviation|1
7554575|NCT02421939|26263211|P2|Overall Study|Miscellaneous|5
7554576|NCT02421939|26263212|P1|Overall Study|Miscellaneous|4
7554577|NCT02421939|26263211|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
7554578|NCT02421939|26263212|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
7554579|NCT02421939|26263211|P2|Overall Study|Physician Decision|11
7554580|NCT02421939|26263212|P1|Overall Study|Physician Decision|11
7554581|NCT02421939|26263211|P2|Overall Study|Withdrawal by Subject|24
7554582|NCT02421939|26263212|P1|Overall Study|Withdrawal by Subject|5
7554583|NCT02421939|26263211|P2|Overall Study|Adverse Event|5
7554584|NCT02421939|26263212|P1|Overall Study|Adverse Event|28
7554585|NCT02421939|26263211|P2|Overall Study|Disease relapse|2
7554586|NCT02421939|26263212|P1|Overall Study|Disease relapse|33
7554587|NCT02421939|26263211|P2|Overall Study|Death|10
7554588|NCT02421939|26263212|P1|Overall Study|Death|36
7554589|NCT02421939|26263211|P2|Overall Study|Lack of Efficacy|31
7554590|NCT02421939|26263212|P1|Overall Study|Lack of Efficacy|21
7554591|NCT02421939|26263211|P2|Overall Study|Progressive disease|16
7554592|NCT02421939|26263212|P1|Overall Study|Progressive disease|70
7554593|NCT02421887|26263240|P2|Overall Study|Adverse Event|0
7554594|NCT02421887|26263241|P1|Overall Study|Adverse Event|2
7554595|NCT02421887|26263240|P2|Overall Study|Physician Decision|4
7554596|NCT02421887|26263241|P1|Overall Study|Physician Decision|2
7554597|NCT02421887|26263240|P2|Overall Study|Withdrawal by Subject|5
7554598|NCT02421887|26263241|P1|Overall Study|Withdrawal by Subject|8
7554599|NCT02421887|26263240|P2|Overall Study|Lost to Follow-up|0
7554600|NCT02421887|26263241|P1|Overall Study|Lost to Follow-up|5
7554601|NCT02421666|26263267|P2|12-month Follow-up|Withdrawal by Subject|11
7554602|NCT02421666|26263268|P1|12-month Follow-up|Withdrawal by Subject|6
7554603|NCT02421666|26263267|P2|12-month Follow-up|Lost to Follow-up|5
7554604|NCT02421666|26263268|P1|12-month Follow-up|Lost to Follow-up|5
7554605|NCT02421666|26263267|P2|6-month Follow-up|Withdrawal by Subject|6
7554606|NCT02421666|26263268|P1|6-month Follow-up|Withdrawal by Subject|5
7554607|NCT02421666|26263267|P2|6-month Follow-up|Lost to Follow-up|7
7554608|NCT02421666|26263268|P1|6-month Follow-up|Lost to Follow-up|8
7554609|NCT02421588|26263276|P2|Overall Study|Not treated|8
7554610|NCT02421588|26263277|P1|Overall Study|Not treated|2
7554611|NCT02421588|26263276|P2|Overall Study|Withdrawal by Subject|16
7554612|NCT02421588|26263277|P1|Overall Study|Withdrawal by Subject|14
7554613|NCT02421588|26263276|P2|Overall Study|Treatment-related AE|14
7554614|NCT02421588|26263277|P1|Overall Study|Treatment-related AE|10
7554615|NCT02421588|26263276|P2|Overall Study|Symptomatic deterioration|19
7554616|NCT02421588|26263277|P1|Overall Study|Symptomatic deterioration|13
7554617|NCT02421588|26263276|P2|Overall Study|Other reason not specified|1
7554618|NCT02421588|26263277|P1|Overall Study|Other reason not specified|3
7554619|NCT02421588|26263276|P2|Overall Study|Physician Decision|17
7554620|NCT02421588|26263277|P1|Overall Study|Physician Decision|8
7554621|NCT02421588|26263276|P2|Overall Study|Death|3
7554622|NCT02421588|26263277|P1|Overall Study|Death|11
7554623|NCT02421588|26263276|P2|Overall Study|Progressive disease|135
7554624|NCT02421588|26263277|P1|Overall Study|Progressive disease|152
7554625|NCT02421588|26263276|P2|Overall Study|Non-treatment-related AE|8
7554626|NCT02421588|26263277|P1|Overall Study|Non-treatment-related AE|8
7554627|NCT02421510|26263300|P3|Overall Study|Lost to Follow-up|0
7554628|NCT02421510|26263301|P2|Overall Study|Lost to Follow-up|1
7554629|NCT02421510|26263302|P1|Overall Study|Lost to Follow-up|1
7554630|NCT02421510|26263300|P3|Overall Study|Withdrawal by Subject|12
7554631|NCT02421510|26263301|P2|Overall Study|Withdrawal by Subject|18
7554632|NCT02421510|26263302|P1|Overall Study|Withdrawal by Subject|14
7554633|NCT02421510|26263300|P3|Overall Study|Pregnancy|0
7554634|NCT02421510|26263301|P2|Overall Study|Pregnancy|1
7554635|NCT02421510|26263302|P1|Overall Study|Pregnancy|1
7554636|NCT02421510|26263300|P3|Overall Study|Adverse Event|18
7554637|NCT02421510|26263301|P2|Overall Study|Adverse Event|10
7554638|NCT02421510|26263302|P1|Overall Study|Adverse Event|9
7554639|NCT02421510|26263300|P3|Overall Study|Physician Decision|3
7554640|NCT02421510|26263301|P2|Overall Study|Physician Decision|1
7554641|NCT02421510|26263302|P1|Overall Study|Physician Decision|1
7554642|NCT02421510|26263300|P3|Overall Study|Noncompliance with study drug|0
7554643|NCT02421510|26263301|P2|Overall Study|Noncompliance with study drug|0
7554644|NCT02421510|26263302|P1|Overall Study|Noncompliance with study drug|1
7554645|NCT02421510|26263300|P3|Overall Study|Death|0
7554646|NCT02421510|26263301|P2|Overall Study|Death|0
7554647|NCT02421510|26263302|P1|Overall Study|Death|1
7554648|NCT02421510|26263300|P3|Overall Study|Protocol Violation|0
7554649|NCT02421510|26263301|P2|Overall Study|Protocol Violation|2
7554650|NCT02421510|26263302|P1|Overall Study|Protocol Violation|1
7554651|NCT02421510|26263300|P3|Overall Study|Other|3
7554652|NCT02421510|26263301|P2|Overall Study|Other|2
7554653|NCT02421510|26263302|P1|Overall Study|Other|4
7554654|NCT02421419|26263334|P3|Overall Study|Physician Decision|1
7554655|NCT02421419|26263335|P2|Overall Study|Physician Decision|0
7554656|NCT02421419|26263336|P1|Overall Study|Physician Decision|0
7554657|NCT02421172|26263470|P5|Period 2|Patient/guardian decision|1
7554658|NCT02421172|26263471|P4|Period 2|Patient/guardian decision|2
7554659|NCT02421172|26263472|P3|Period 2|Patient/guardian decision|3
7554660|NCT02421172|26263473|P2|Period 2|Patient/guardian decision|0
7554661|NCT02421172|26263474|P1|Period 2|Patient/guardian decision|0
7554662|NCT02421172|26263470|P5|Period 2|Lost to Follow-up|0
7554663|NCT02421172|26263471|P4|Period 2|Lost to Follow-up|1
7554664|NCT02421172|26263472|P3|Period 2|Lost to Follow-up|0
7554665|NCT02421172|26263473|P2|Period 2|Lost to Follow-up|0
7554666|NCT02421172|26263474|P1|Period 2|Lost to Follow-up|0
7554667|NCT02421172|26263470|P5|Period 2|Adverse Event|0
7554668|NCT02421172|26263471|P4|Period 2|Adverse Event|0
7554669|NCT02421172|26263472|P3|Period 2|Adverse Event|4
7554670|NCT02421172|26263473|P2|Period 2|Adverse Event|0
7554671|NCT02421172|26263474|P1|Period 2|Adverse Event|0
7554672|NCT02421172|26263470|P5|Period 1|Patient/guardian decision|0
7554673|NCT02421172|26263471|P4|Period 1|Patient/guardian decision|0
7554674|NCT02421172|26263472|P3|Period 1|Patient/guardian decision|0
7554675|NCT02421172|26263473|P2|Period 1|Patient/guardian decision|1
7554676|NCT02421172|26263474|P1|Period 1|Patient/guardian decision|0
7554677|NCT02421172|26263470|P5|Period 1|Lost to Follow-up|0
7554678|NCT02421172|26263471|P4|Period 1|Lost to Follow-up|0
7554679|NCT02421172|26263472|P3|Period 1|Lost to Follow-up|0
7554680|NCT02421172|26263473|P2|Period 1|Lost to Follow-up|1
7554681|NCT02421172|26263474|P1|Period 1|Lost to Follow-up|3
7554682|NCT02421172|26263470|P5|Period 1|Adverse Event|0
7554683|NCT02421172|26263471|P4|Period 1|Adverse Event|0
7554684|NCT02421172|26263472|P3|Period 1|Adverse Event|0
7554685|NCT02421172|26263473|P2|Period 1|Adverse Event|0
7554686|NCT02421172|26263474|P1|Period 1|Adverse Event|1
7554687|NCT02421120|26263518|P1|Overall Study|Adverse Event|1
7554698|NCT02420691|26263671|P1|Overall Study|Withdrawal by Subject|3
7554699|NCT02420691|26263671|P1|Overall Study|Adverse Event|3
7554700|NCT02420379|26263685|P2|Overall Study|Transitioned to commercial drug|0
7554701|NCT02420379|26263686|P1|Overall Study|Transitioned to commercial drug|1
7554702|NCT02420379|26263685|P2|Overall Study|Unable to complete due to schooling|1
7554703|NCT02420379|26263686|P1|Overall Study|Unable to complete due to schooling|0
7554704|NCT02420379|26263685|P2|Overall Study|Withdrawal by Subject|3
7554705|NCT02420379|26263686|P1|Overall Study|Withdrawal by Subject|0
7554706|NCT02420353|26263706|P2|Overall Study|Withdrawal by Subject|1
7554707|NCT02420353|26263707|P1|Overall Study|Withdrawal by Subject|0
7554708|NCT02420327|26263799|P1|Overall Study|Protocol Violation|1
7554709|NCT02420327|26263799|P1|Overall Study|Lost to Follow-up|1
7554710|NCT02420327|26263799|P1|Overall Study|Withdrawal by Subject|6
7554711|NCT02420327|26263799|P1|Overall Study|Pregnancy|1
7554712|NCT02420327|26263799|P1|Overall Study|Adverse Event|7
7554713|NCT02420262|26263835|P2|Overall Study|Unclassified|1
7554714|NCT02420262|26263836|P1|Overall Study|Unclassified|0
7554715|NCT02420262|26263835|P2|Overall Study|Withdrawal by Subject|4
7554716|NCT02420262|26263836|P1|Overall Study|Withdrawal by Subject|1
7554717|NCT02420262|26263835|P2|Overall Study|Adverse Event|0
7554718|NCT02420262|26263836|P1|Overall Study|Adverse Event|1
7554719|NCT02420223|26263852|P2|Overall Study|Physician Decision|2
7554720|NCT02420223|26263853|P1|Overall Study|Physician Decision|0
7554721|NCT02420223|26263852|P2|Overall Study|Adverse Event|0
7554722|NCT02420223|26263853|P1|Overall Study|Adverse Event|1
7554723|NCT02420093|26263883|P2|Overall Study|Withdrawal by Subject|1
7554724|NCT02420093|26263884|P1|Overall Study|Withdrawal by Subject|1
7554725|NCT02419937|26263946|P2|Overall Study|Lost to Follow-up|0
7554726|NCT02419937|26263947|P1|Overall Study|Lost to Follow-up|1
7554727|NCT02419807|26263960|P1|Overall Study|Protocol Violation|5
7554728|NCT02419807|26263960|P1|Overall Study|Physician Decision|1
7554729|NCT02419807|26263960|P1|Overall Study|Withdrawal by Subject|4
7554730|NCT02419755|26263966|P2|Overall Study|Withdrawal by Subject|0
7554731|NCT02419755|26263967|P1|Overall Study|Withdrawal by Subject|1
7554732|NCT02419755|26263966|P2|Overall Study|Ineligible|0
7554733|NCT02419755|26263967|P1|Overall Study|Ineligible|1
7554734|NCT02419755|26263966|P2|Overall Study|Relapse|1
7554735|NCT02419755|26263967|P1|Overall Study|Relapse|0
7554736|NCT02419755|26263966|P2|Overall Study|Death|3
7554737|NCT02419755|26263967|P1|Overall Study|Death|1
7554738|NCT02419612|26264008|P2|Long-term Treatment Period|Withdrawal by Subject|2
7554739|NCT02419612|26264009|P1|Long-term Treatment Period|Withdrawal by Subject|8
7554740|NCT02419612|26264008|P2|Long-term Treatment Period|Subject Decision|4
7554741|NCT02419612|26264009|P1|Long-term Treatment Period|Subject Decision|2
7554742|NCT02419612|26264008|P2|Long-term Treatment Period|Other|4
7554743|NCT02419612|26264009|P1|Long-term Treatment Period|Other|4
7554744|NCT02419612|26264008|P2|Long-term Treatment Period|Adverse Event|5
7554745|NCT02419612|26264009|P1|Long-term Treatment Period|Adverse Event|0
7554746|NCT02419612|26264008|P2|Long-term Treatment Period|Death|1
7554747|NCT02419612|26264009|P1|Long-term Treatment Period|Death|0
7554748|NCT02419612|26264008|P2|Long-term Treatment Period|Lack of Efficacy|1
7554749|NCT02419612|26264009|P1|Long-term Treatment Period|Lack of Efficacy|1
7554750|NCT02419612|26264008|P2|Long-term Treatment Period|Lost to Follow-up|4
7554751|NCT02419612|26264009|P1|Long-term Treatment Period|Lost to Follow-up|6
7554752|NCT02419612|26264008|P2|Long-term Treatment Period|Non-compliance with Study Drug|1
7554753|NCT02419612|26264009|P1|Long-term Treatment Period|Non-compliance with Study Drug|1
7554754|NCT02419612|26264008|P2|Short-term Treatment Period|Subject moved out of state|1
7554755|NCT02419612|26264009|P1|Short-term Treatment Period|Subject moved out of state|0
7554756|NCT02419612|26264008|P2|Short-term Treatment Period|Worsening of liver function|1
7554757|NCT02419612|26264009|P1|Short-term Treatment Period|Worsening of liver function|0
7554758|NCT02419612|26264008|P2|Short-term Treatment Period|Non-compliance with Study Drug|2
7554759|NCT02419612|26264009|P1|Short-term Treatment Period|Non-compliance with Study Drug|0
7554760|NCT02419612|26264008|P2|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7554761|NCT02419612|26264009|P1|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7554762|NCT02419612|26264008|P2|Short-term Treatment Period|Withdrawal by Subject|9
7554763|NCT02419612|26264009|P1|Short-term Treatment Period|Withdrawal by Subject|9
7554764|NCT02419612|26264008|P2|Short-term Treatment Period|Lost to Follow-up|6
7554765|NCT02419612|26264009|P1|Short-term Treatment Period|Lost to Follow-up|6
7554766|NCT02419612|26264008|P2|Short-term Treatment Period|Death|2
7554767|NCT02419612|26264009|P1|Short-term Treatment Period|Death|0
7554768|NCT02419612|26264008|P2|Short-term Treatment Period|Adverse Event|1
7554769|NCT02419612|26264009|P1|Short-term Treatment Period|Adverse Event|1
7554770|NCT02419573|26264031|P2|Overall Study|Withdrawal by Subject|0
7554771|NCT02419573|26264032|P1|Overall Study|Withdrawal by Subject|1
7554772|NCT02419573|26264031|P2|Overall Study|Lost to Follow-up|0
7554773|NCT02419573|26264032|P1|Overall Study|Lost to Follow-up|3
7554774|NCT02419508|26264062|P2|Overall Study|Other - Reason not specified|1
7554775|NCT02419508|26264063|P1|Overall Study|Other - Reason not specified|0
7554776|NCT02419508|26264062|P2|Overall Study|Withdrawal by Subject|0
7554777|NCT02419508|26264063|P1|Overall Study|Withdrawal by Subject|1
7554778|NCT02419508|26264062|P2|Overall Study|Adverse Event|3
7554779|NCT02419508|26264063|P1|Overall Study|Adverse Event|9
7554780|NCT02419469|26264081|P1|Overall Study|Withdrawal by Subject|1
7554781|NCT02419313|26264085|P2|Second Intervention|Lost to Follow-up|0
7554782|NCT02419313|26264086|P1|Second Intervention|Lost to Follow-up|1
7554783|NCT02419313|26264085|P2|First Intervention|Lost to Follow-up|0
7554784|NCT02419313|26264086|P1|First Intervention|Lost to Follow-up|2
7554785|NCT02419001|26264098|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
7554786|NCT02419001|26264099|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
7554787|NCT02418949|26264113|P4|Overall Study|Physician Decision|0
7554788|NCT02418949|26264114|P3|Overall Study|Physician Decision|1
7554789|NCT02418949|26264115|P2|Overall Study|Physician Decision|1
7554790|NCT02418949|26264116|P1|Overall Study|Physician Decision|1
7554791|NCT02418949|26264113|P4|Overall Study|Lost to Follow-up|0
7554792|NCT02418949|26264114|P3|Overall Study|Lost to Follow-up|1
7554793|NCT02418949|26264115|P2|Overall Study|Lost to Follow-up|0
7554794|NCT02418949|26264116|P1|Overall Study|Lost to Follow-up|1
7554795|NCT02418949|26264113|P4|Overall Study|Withdrawal by Subject|1
7554796|NCT02418949|26264114|P3|Overall Study|Withdrawal by Subject|1
7554797|NCT02418949|26264115|P2|Overall Study|Withdrawal by Subject|0
7554798|NCT02418949|26264116|P1|Overall Study|Withdrawal by Subject|1
7554799|NCT02418910|26264130|P1|Overall Study|Withdrawal by Subject|4
7554800|NCT02418910|26264130|P1|Overall Study|Lost to Follow-up|3
7554801|NCT02418845|26264136|P2|Overall Study|Withdrawal by Subject|2
7554802|NCT02418845|26264137|P1|Overall Study|Withdrawal by Subject|3
7554803|NCT02418845|26264136|P2|Overall Study|Protocol Violation|0
7554804|NCT02418845|26264137|P1|Overall Study|Protocol Violation|1
7554805|NCT02418845|26264136|P2|Overall Study|Physician Decision|5
7554806|NCT02418845|26264137|P1|Overall Study|Physician Decision|5
7554807|NCT02418845|26264136|P2|Overall Study|Lack of Efficacy|3
7554808|NCT02418845|26264137|P1|Overall Study|Lack of Efficacy|0
7554809|NCT02418845|26264136|P2|Overall Study|Lost to Follow-up|2
7554810|NCT02418845|26264137|P1|Overall Study|Lost to Follow-up|7
7554811|NCT02418819|26264155|P4|Overall Study|No longer willing to participate|1
7554812|NCT02418819|26264156|P3|Overall Study|No longer willing to participate|2
7554813|NCT02418819|26264157|P2|Overall Study|No longer willing to participate|0
7554814|NCT02418819|26264158|P1|Overall Study|No longer willing to participate|0
7554815|NCT02418819|26264155|P4|Overall Study|No longer meets eligibility criteria|0
7554816|NCT02418819|26264156|P3|Overall Study|No longer meets eligibility criteria|1
7554817|NCT02418819|26264157|P2|Overall Study|No longer meets eligibility criteria|0
7554818|NCT02418819|26264158|P1|Overall Study|No longer meets eligibility criteria|0
7554819|NCT02418819|26264155|P4|Overall Study|Lost to Follow-up|0
7554820|NCT02418819|26264156|P3|Overall Study|Lost to Follow-up|0
7554821|NCT02418819|26264157|P2|Overall Study|Lost to Follow-up|0
7554822|NCT02418819|26264158|P1|Overall Study|Lost to Follow-up|1
7554823|NCT02418819|26264155|P4|Overall Study|Adverse Event|0
7554824|NCT02418819|26264156|P3|Overall Study|Adverse Event|1
7554825|NCT02418819|26264157|P2|Overall Study|Adverse Event|0
7554826|NCT02418819|26264158|P1|Overall Study|Adverse Event|0
7554827|NCT02418754|26264201|P5|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7554828|NCT02418754|26264202|P4|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7554829|NCT02418754|26264203|P3|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7554830|NCT02418754|26264204|P2|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7554831|NCT02418754|26264205|P1|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7554832|NCT02418754|26264201|P5|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7554833|NCT02418754|26264202|P4|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7554834|NCT02418754|26264203|P3|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7554835|NCT02418754|26264204|P2|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7554836|NCT02418754|26264205|P1|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
7554837|NCT02418754|26264201|P5|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
7554838|NCT02418754|26264202|P4|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
7554839|NCT02418754|26264203|P3|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7554840|NCT02418754|26264204|P2|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7554841|NCT02418754|26264205|P1|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
7554842|NCT02418754|26264201|P5|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
7554843|NCT02418754|26264202|P4|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
7554844|NCT02418754|26264203|P3|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7554845|NCT02418754|26264204|P2|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
7554846|NCT02418754|26264205|P1|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7554847|NCT02418754|26264201|P5|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7554848|NCT02418754|26264202|P4|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7554849|NCT02418754|26264203|P3|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7554850|NCT02418754|26264204|P2|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7554851|NCT02418754|26264205|P1|Period 2 (Day 1 to Week 52/End of Study)|Death|1
7554852|NCT02418754|26264201|P5|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7554853|NCT02418754|26264202|P4|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7554854|NCT02418754|26264203|P3|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
7554855|NCT02418754|26264204|P2|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
7554856|NCT02418754|26264205|P1|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
7554857|NCT02418754|26264201|P5|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7554858|NCT02418754|26264202|P4|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7554859|NCT02418754|26264203|P3|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
7554860|NCT02418754|26264204|P2|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7554861|NCT02418754|26264205|P1|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7554862|NCT02418754|26264201|P5|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7554863|NCT02418754|26264202|P4|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7554864|NCT02418754|26264203|P3|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
7554865|NCT02418754|26264204|P2|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
7554866|NCT02418754|26264205|P1|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7554867|NCT02418754|26264201|P5|Period 1 (Day 1 to Week 12)|Physician Decision|0
7554868|NCT02418754|26264202|P4|Period 1 (Day 1 to Week 12)|Physician Decision|0
7554869|NCT02418754|26264203|P3|Period 1 (Day 1 to Week 12)|Physician Decision|0
7554870|NCT02418754|26264204|P2|Period 1 (Day 1 to Week 12)|Physician Decision|0
7554871|NCT02418754|26264205|P1|Period 1 (Day 1 to Week 12)|Physician Decision|1
7554872|NCT02418754|26264201|P5|Period 1 (Day 1 to Week 12)|Death|0
7554873|NCT02418754|26264202|P4|Period 1 (Day 1 to Week 12)|Death|0
7554874|NCT02418754|26264203|P3|Period 1 (Day 1 to Week 12)|Death|0
7554875|NCT02418754|26264204|P2|Period 1 (Day 1 to Week 12)|Death|0
7554876|NCT02418754|26264205|P1|Period 1 (Day 1 to Week 12)|Death|1
7554877|NCT02418754|26264201|P5|Period 1 (Day 1 to Week 12)|Adverse Event|0
7554878|NCT02418754|26264202|P4|Period 1 (Day 1 to Week 12)|Adverse Event|0
7554879|NCT02418754|26264203|P3|Period 1 (Day 1 to Week 12)|Adverse Event|0
7554880|NCT02418754|26264204|P2|Period 1 (Day 1 to Week 12)|Adverse Event|2
7554881|NCT02418754|26264205|P1|Period 1 (Day 1 to Week 12)|Adverse Event|0
7554882|NCT02418585|26264254|P2|Follow-up Phase (24 Weeks)|Other|2
7554883|NCT02418585|26264255|P1|Follow-up Phase (24 Weeks)|Other|3
7554884|NCT02418585|26264254|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
7554885|NCT02418585|26264255|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
7554886|NCT02418585|26264254|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7554887|NCT02418585|26264255|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
7554888|NCT02418585|26264254|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7554889|NCT02418585|26264255|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7554890|NCT02418585|26264254|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
7554891|NCT02418585|26264255|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
7554892|NCT02418585|26264254|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
7554893|NCT02418585|26264255|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
7554894|NCT02418585|26264254|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
7554895|NCT02418585|26264255|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
7554896|NCT02418585|26264254|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
7554897|NCT02418585|26264255|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
7554898|NCT02418585|26264254|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7554899|NCT02418585|26264255|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7554900|NCT02418585|26264254|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7554901|NCT02418585|26264255|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7554902|NCT02418468|26264311|P2|Overall Study|Withdrawal of informed consent|1
7554903|NCT02418468|26264312|P1|Overall Study|Withdrawal of informed consent|1
7554904|NCT02418468|26264311|P2|Overall Study|Adverse Event|0
7554905|NCT02418468|26264312|P1|Overall Study|Adverse Event|1
7554906|NCT02418455|26264318|P1|Continuation Period|Sponsor Decision|7
7554907|NCT02418455|26264318|P1|48-Week Treatment Period|Other- Not Specified|1
7554908|NCT02418182|26264361|P2|Overall Study|Lost to Follow-up|2
7554909|NCT02418182|26264362|P1|Overall Study|Lost to Follow-up|0
7554910|NCT02418182|26264361|P2|Overall Study|Unable to re-consent|15
7554911|NCT02418182|26264362|P1|Overall Study|Unable to re-consent|18
7554912|NCT02418156|26264374|P1|Overall Study|Subject refused to return|1
7554913|NCT02418156|26264374|P1|Overall Study|Withdrawal by Subject|1
7554914|NCT02418156|26264374|P1|Overall Study|Physician Decision|1
7554915|NCT02418156|26264374|P1|Overall Study|Death|2
7554916|NCT02418156|26264374|P1|Overall Study|Lost to Follow-up|12
7554917|NCT02418000|26264416|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
7554918|NCT02418000|26264417|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554919|NCT02418000|26264418|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554920|NCT02418000|26264419|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554921|NCT02418000|26264420|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554922|NCT02418000|26264416|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
7554923|NCT02418000|26264417|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7554924|NCT02418000|26264418|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7554925|NCT02418000|26264419|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7554926|NCT02418000|26264420|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7554927|NCT02418000|26264416|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554928|NCT02418000|26264417|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
7554929|NCT02418000|26264418|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554930|NCT02418000|26264419|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554931|NCT02418000|26264420|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554932|NCT02418000|26264416|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554933|NCT02418000|26264417|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554934|NCT02418000|26264418|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
7554935|NCT02418000|26264419|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554936|NCT02418000|26264420|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7554937|NCT02418000|26264416|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7554938|NCT02418000|26264417|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7554939|NCT02418000|26264418|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7554940|NCT02418000|26264419|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
7554941|NCT02418000|26264420|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7554942|NCT02418000|26264416|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7554943|NCT02418000|26264417|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7554944|NCT02418000|26264418|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7554945|NCT02418000|26264419|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
7554946|NCT02418000|26264420|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7554947|NCT02418000|26264416|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7554948|NCT02418000|26264417|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7554949|NCT02418000|26264418|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7554950|NCT02418000|26264419|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7554951|NCT02418000|26264420|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
7554952|NCT02418000|26264416|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7554953|NCT02418000|26264417|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7554954|NCT02418000|26264418|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7554955|NCT02418000|26264419|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7554956|NCT02418000|26264420|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
7554957|NCT02418000|26264416|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7554958|NCT02418000|26264417|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7554959|NCT02418000|26264418|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7554960|NCT02418000|26264419|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7554961|NCT02418000|26264420|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
7554962|NCT02417961|26264538|P1|Overall Study|Withdrawal by Subject|2
7554963|NCT02417961|26264538|P1|Overall Study|Lost to Follow-up|1
7554964|NCT02417961|26264538|P1|Overall Study|Adverse Event|1
7554965|NCT02417935|26264550|P2|Treatment Period|Physician Decision|1
7554966|NCT02417935|26264551|P1|Treatment Period|Physician Decision|3
7554967|NCT02417935|26264550|P2|Treatment Period|Withdrawal by Subject|3
7554968|NCT02417935|26264551|P1|Treatment Period|Withdrawal by Subject|3
7554969|NCT02417935|26264550|P2|Treatment Period|Protocol Violation|1
7554970|NCT02417935|26264551|P1|Treatment Period|Protocol Violation|2
7554971|NCT02417935|26264550|P2|Treatment Period|Entry Criteria not met|1
7554972|NCT02417935|26264551|P1|Treatment Period|Entry Criteria not met|0
7554973|NCT02417935|26264550|P2|Treatment Period|Lost to Follow-up|0
7554974|NCT02417935|26264551|P1|Treatment Period|Lost to Follow-up|1
7554975|NCT02417935|26264550|P2|Treatment Period|Adverse Event|10
7554976|NCT02417935|26264551|P1|Treatment Period|Adverse Event|12
7554977|NCT02417753|26264613|P1|Overall Study|Death|1
7554978|NCT02417441|26264633|P2|Overall Study|Inconclusive due to missing data|19
7554979|NCT02417441|26264634|P1|Overall Study|Inconclusive due to missing data|52
7554980|NCT02417246|26264702|P2|Phase 2 1st Generic Administered|Physician Decision|0
7554981|NCT02417246|26264703|P1|Phase 2 1st Generic Administered|Physician Decision|1
7554982|NCT02417246|26264702|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
7554983|NCT02417246|26264703|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
7554984|NCT02417246|26264702|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
7554985|NCT02417246|26264703|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
7554986|NCT02417246|26264702|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7554987|NCT02417246|26264703|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7554988|NCT02417233|26264726|P3|Overall Study|Mentally unstable|0
7554989|NCT02417233|26264727|P2|Overall Study|Mentally unstable|1
7554990|NCT02417233|26264728|P1|Overall Study|Mentally unstable|0
7554991|NCT02417233|26264726|P3|Overall Study|Relocation out of study area|1
7554992|NCT02417233|26264727|P2|Overall Study|Relocation out of study area|0
7554993|NCT02417233|26264728|P1|Overall Study|Relocation out of study area|1
7554994|NCT02417233|26264726|P3|Overall Study|Withdrawal by Subject|8
7554995|NCT02417233|26264727|P2|Overall Study|Withdrawal by Subject|1
7554996|NCT02417233|26264728|P1|Overall Study|Withdrawal by Subject|2
7554997|NCT02417233|26264726|P3|Overall Study|Protocol Violation|2
7554998|NCT02417233|26264727|P2|Overall Study|Protocol Violation|0
7554999|NCT02417233|26264728|P1|Overall Study|Protocol Violation|2
7555000|NCT02417233|26264726|P3|Overall Study|Lost to Follow-up|34
7555001|NCT02417233|26264727|P2|Overall Study|Lost to Follow-up|39
7555002|NCT02417233|26264728|P1|Overall Study|Lost to Follow-up|27
7555003|NCT02417233|26264726|P3|Overall Study|Death|14
7555004|NCT02417233|26264727|P2|Overall Study|Death|10
7555005|NCT02417233|26264728|P1|Overall Study|Death|4
7555006|NCT02417064|26264776|P3|Follow-up Phase (24 Weeks)|Other|3
7555007|NCT02417064|26264777|P2|Follow-up Phase (24 Weeks)|Other|2
7555008|NCT02417064|26264778|P1|Follow-up Phase (24 Weeks)|Other|2
7555009|NCT02417064|26264776|P3|Follow-up Phase (24 Weeks)|PI Decision|44
7555010|NCT02417064|26264777|P2|Follow-up Phase (24 Weeks)|PI Decision|29
7555011|NCT02417064|26264778|P1|Follow-up Phase (24 Weeks)|PI Decision|34
7555012|NCT02417064|26264776|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
7555013|NCT02417064|26264777|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
7555014|NCT02417064|26264778|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7555015|NCT02417064|26264776|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
7555016|NCT02417064|26264777|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
7555017|NCT02417064|26264778|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
7555018|NCT02417064|26264776|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
7555019|NCT02417064|26264777|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
7555020|NCT02417064|26264778|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
7555021|NCT02417064|26264776|P3|Double-blind Induction Phase (4 Weeks)|Other|2
7555022|NCT02417064|26264777|P2|Double-blind Induction Phase (4 Weeks)|Other|4
7555023|NCT02417064|26264778|P1|Double-blind Induction Phase (4 Weeks)|Other|1
7555024|NCT02417064|26264776|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7555025|NCT02417064|26264777|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
7555026|NCT02417064|26264778|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7555027|NCT02417064|26264776|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7555028|NCT02417064|26264777|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7555029|NCT02417064|26264778|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
7555030|NCT02417064|26264776|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7555031|NCT02417064|26264777|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7555032|NCT02417064|26264778|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7555033|NCT02417064|26264776|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
7555034|NCT02417064|26264777|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7555035|NCT02417064|26264778|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7555036|NCT02417064|26264776|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7555037|NCT02417064|26264777|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
7555038|NCT02417064|26264778|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
7555039|NCT02416934|26264849|P2|Overall Study|re-operation|0
7555040|NCT02416934|26264850|P1|Overall Study|re-operation|1
7555041|NCT02416934|26264849|P2|Overall Study|surgery started late|1
7555042|NCT02416934|26264850|P1|Overall Study|surgery started late|0
7555043|NCT02416934|26264849|P2|Overall Study|Protocol Violation|1
7555044|NCT02416934|26264850|P1|Overall Study|Protocol Violation|0
7555045|NCT02416934|26264849|P2|Overall Study|recruited during continuing renewal proc|1
7555046|NCT02416934|26264850|P1|Overall Study|recruited during continuing renewal proc|0
7555047|NCT02416934|26264849|P2|Overall Study|Withdrawal by Subject|0
7555048|NCT02416934|26264850|P1|Overall Study|Withdrawal by Subject|1
7555049|NCT02416934|26264849|P2|Overall Study|Lost to Follow-up|2
7555050|NCT02416934|26264850|P1|Overall Study|Lost to Follow-up|0
7555051|NCT02416934|26264849|P2|Overall Study|given steroids|2
7555052|NCT02416934|26264850|P1|Overall Study|given steroids|1
7555053|NCT02416908|26264865|P4|Dose Escalation Phase|Withdrawal by Subject|0
7555054|NCT02416908|26264866|P3|Dose Escalation Phase|Withdrawal by Subject|1
7555055|NCT02416908|26264867|P2|Dose Escalation Phase|Withdrawal by Subject|0
7555056|NCT02416908|26264868|P1|Dose Escalation Phase|Withdrawal by Subject|0
7555057|NCT02416908|26264865|P4|Dose Escalation Phase|Adverse Event|0
7555058|NCT02416908|26264866|P3|Dose Escalation Phase|Adverse Event|3
7555059|NCT02416908|26264867|P2|Dose Escalation Phase|Adverse Event|0
7555060|NCT02416908|26264868|P1|Dose Escalation Phase|Adverse Event|0
7555061|NCT02416791|26264886|P3|6 Months|Lost to Follow-up|1
7555062|NCT02416791|26264887|P2|6 Months|Lost to Follow-up|0
7555063|NCT02416791|26264888|P1|6 Months|Lost to Follow-up|0
7555064|NCT02416453|26264976|P11|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555065|NCT02416453|26264977|P10|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555066|NCT02416453|26264978|P9|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555067|NCT02416453|26264979|P8|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555068|NCT02416453|26264980|P7|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555069|NCT02416453|26264981|P6|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
7555070|NCT02416453|26264982|P5|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555071|NCT02416453|26264983|P4|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555072|NCT02416453|26264984|P3|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555073|NCT02416453|26264985|P2|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555074|NCT02416453|26264986|P1|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7555075|NCT02416453|26264976|P11|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555076|NCT02416453|26264977|P10|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555077|NCT02416453|26264978|P9|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555078|NCT02416453|26264979|P8|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555079|NCT02416453|26264980|P7|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555080|NCT02416453|26264981|P6|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555081|NCT02416453|26264982|P5|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555082|NCT02416453|26264983|P4|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555083|NCT02416453|26264984|P3|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
7555084|NCT02416453|26264985|P2|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555085|NCT02416453|26264986|P1|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7555086|NCT02416453|26264976|P11|Overall Study|Withdrawal by Subject|0
7555087|NCT02416453|26264977|P10|Overall Study|Withdrawal by Subject|0
7555088|NCT02416453|26264978|P9|Overall Study|Withdrawal by Subject|4
7555089|NCT02416453|26264979|P8|Overall Study|Withdrawal by Subject|8
7555090|NCT02416453|26264980|P7|Overall Study|Withdrawal by Subject|0
7555091|NCT02416453|26264981|P6|Overall Study|Withdrawal by Subject|8
7555092|NCT02416453|26264982|P5|Overall Study|Withdrawal by Subject|1
7555093|NCT02416453|26264983|P4|Overall Study|Withdrawal by Subject|5
7555094|NCT02416453|26264984|P3|Overall Study|Withdrawal by Subject|0
7555095|NCT02416453|26264985|P2|Overall Study|Withdrawal by Subject|0
7555096|NCT02416453|26264986|P1|Overall Study|Withdrawal by Subject|2
7555097|NCT02416453|26264976|P11|Overall Study|Physician Decision|0
7555098|NCT02416453|26264977|P10|Overall Study|Physician Decision|0
7555099|NCT02416453|26264978|P9|Overall Study|Physician Decision|0
7555100|NCT02416453|26264979|P8|Overall Study|Physician Decision|1
7555101|NCT02416453|26264980|P7|Overall Study|Physician Decision|1
7555102|NCT02416453|26264981|P6|Overall Study|Physician Decision|1
7555103|NCT02416453|26264982|P5|Overall Study|Physician Decision|0
7555104|NCT02416453|26264983|P4|Overall Study|Physician Decision|0
7555105|NCT02416453|26264984|P3|Overall Study|Physician Decision|0
7555106|NCT02416453|26264985|P2|Overall Study|Physician Decision|0
7555107|NCT02416453|26264986|P1|Overall Study|Physician Decision|0
7555108|NCT02416453|26264976|P11|Overall Study|Lost to Follow-up|0
7555109|NCT02416453|26264977|P10|Overall Study|Lost to Follow-up|0
7555110|NCT02416453|26264978|P9|Overall Study|Lost to Follow-up|1
7555111|NCT02416453|26264979|P8|Overall Study|Lost to Follow-up|3
7555112|NCT02416453|26264980|P7|Overall Study|Lost to Follow-up|1
7555113|NCT02416453|26264981|P6|Overall Study|Lost to Follow-up|5
7555114|NCT02416453|26264982|P5|Overall Study|Lost to Follow-up|0
7555115|NCT02416453|26264983|P4|Overall Study|Lost to Follow-up|8
7555116|NCT02416453|26264984|P3|Overall Study|Lost to Follow-up|0
7555117|NCT02416453|26264985|P2|Overall Study|Lost to Follow-up|3
7555118|NCT02416453|26264986|P1|Overall Study|Lost to Follow-up|1
7555119|NCT02416453|26264976|P11|Overall Study|Adverse Event|0
7555120|NCT02416453|26264977|P10|Overall Study|Adverse Event|0
7555121|NCT02416453|26264978|P9|Overall Study|Adverse Event|0
7555122|NCT02416453|26264979|P8|Overall Study|Adverse Event|0
7555123|NCT02416453|26264980|P7|Overall Study|Adverse Event|0
7555124|NCT02416453|26264981|P6|Overall Study|Adverse Event|1
7555125|NCT02416453|26264982|P5|Overall Study|Adverse Event|0
7555126|NCT02416453|26264983|P4|Overall Study|Adverse Event|2
7555127|NCT02416453|26264984|P3|Overall Study|Adverse Event|0
7555128|NCT02416453|26264985|P2|Overall Study|Adverse Event|0
7555129|NCT02416453|26264986|P1|Overall Study|Adverse Event|0
7555130|NCT02416180|26265099|P1|Overall Study|Withdrawal by Subject|1
7555131|NCT02415959|26265160|P5|Overall Study|Protocol Violation|0
7555132|NCT02415959|26265161|P4|Overall Study|Protocol Violation|1
7555133|NCT02415959|26265162|P3|Overall Study|Protocol Violation|0
7555134|NCT02415959|26265163|P2|Overall Study|Protocol Violation|0
7555135|NCT02415959|26265164|P1|Overall Study|Protocol Violation|0
7555136|NCT02415959|26265160|P5|Overall Study|Adverse Event|0
7555137|NCT02415959|26265161|P4|Overall Study|Adverse Event|0
7555138|NCT02415959|26265162|P3|Overall Study|Adverse Event|0
7555139|NCT02415959|26265163|P2|Overall Study|Adverse Event|1
7555140|NCT02415959|26265164|P1|Overall Study|Adverse Event|0
7555141|NCT02415595|26265610|P4|Overall Study|Other|0
7555142|NCT02415595|26265611|P3|Overall Study|Other|1
7555143|NCT02415595|26265612|P2|Overall Study|Other|1
7555144|NCT02415595|26265613|P1|Overall Study|Other|0
7555145|NCT02415595|26265610|P4|Overall Study|Withdrawal by Subject|3
7555146|NCT02415595|26265611|P3|Overall Study|Withdrawal by Subject|1
7555147|NCT02415595|26265612|P2|Overall Study|Withdrawal by Subject|0
7555148|NCT02415595|26265613|P1|Overall Study|Withdrawal by Subject|4
7555149|NCT02415595|26265610|P4|Overall Study|Reached stopping criteria|0
7555150|NCT02415595|26265611|P3|Overall Study|Reached stopping criteria|1
7555151|NCT02415595|26265612|P2|Overall Study|Reached stopping criteria|1
7555152|NCT02415595|26265613|P1|Overall Study|Reached stopping criteria|0
7555153|NCT02415595|26265610|P4|Overall Study|Poor/Non-compliance|0
7555154|NCT02415595|26265611|P3|Overall Study|Poor/Non-compliance|1
7555155|NCT02415595|26265612|P2|Overall Study|Poor/Non-compliance|0
7555156|NCT02415595|26265613|P1|Overall Study|Poor/Non-compliance|1
7555157|NCT02415595|26265610|P4|Overall Study|Lost to Follow-up|1
7555158|NCT02415595|26265611|P3|Overall Study|Lost to Follow-up|1
7555159|NCT02415595|26265612|P2|Overall Study|Lost to Follow-up|3
7555160|NCT02415595|26265613|P1|Overall Study|Lost to Follow-up|1
7555161|NCT02415595|26265610|P4|Overall Study|Lack of Efficacy|0
7555162|NCT02415595|26265611|P3|Overall Study|Lack of Efficacy|0
7555163|NCT02415595|26265612|P2|Overall Study|Lack of Efficacy|4
7555164|NCT02415595|26265613|P1|Overall Study|Lack of Efficacy|4
7555165|NCT02415595|26265610|P4|Overall Study|Adverse Event|10
7555166|NCT02415595|26265611|P3|Overall Study|Adverse Event|5
7555167|NCT02415595|26265612|P2|Overall Study|Adverse Event|3
7555168|NCT02415595|26265613|P1|Overall Study|Adverse Event|1
7555169|NCT02415595|26265610|P4|Overall Study|Administrative reason by sponsor|39
7555170|NCT02415595|26265611|P3|Overall Study|Administrative reason by sponsor|41
7555171|NCT02415595|26265612|P2|Overall Study|Administrative reason by sponsor|40
7555172|NCT02415595|26265613|P1|Overall Study|Administrative reason by sponsor|39
7555173|NCT02415556|26265676|P4|Overall Study|Family-related issues|1
7555174|NCT02415556|26265677|P3|Overall Study|Family-related issues|0
7555175|NCT02415556|26265678|P2|Overall Study|Family-related issues|0
7555176|NCT02415556|26265679|P1|Overall Study|Family-related issues|0
7555177|NCT02415556|26265676|P4|Overall Study|Censored - study completion|0
7555178|NCT02415556|26265677|P3|Overall Study|Censored - study completion|1
7555179|NCT02415556|26265678|P2|Overall Study|Censored - study completion|5
7555180|NCT02415556|26265679|P1|Overall Study|Censored - study completion|4
7555181|NCT02415556|26265676|P4|Overall Study|Physician Decision|2
7555182|NCT02415556|26265677|P3|Overall Study|Physician Decision|1
7555183|NCT02415556|26265678|P2|Overall Study|Physician Decision|3
7555184|NCT02415556|26265679|P1|Overall Study|Physician Decision|1
7555185|NCT02415556|26265676|P4|Overall Study|Withdrawal by Subject|12
7555186|NCT02415556|26265677|P3|Overall Study|Withdrawal by Subject|14
7555187|NCT02415556|26265678|P2|Overall Study|Withdrawal by Subject|4
7555188|NCT02415556|26265679|P1|Overall Study|Withdrawal by Subject|13
7555189|NCT02415556|26265676|P4|Overall Study|Lost to Follow-up|1
7555190|NCT02415556|26265677|P3|Overall Study|Lost to Follow-up|4
7555191|NCT02415556|26265678|P2|Overall Study|Lost to Follow-up|5
7555192|NCT02415556|26265679|P1|Overall Study|Lost to Follow-up|4
7555193|NCT02415556|26265676|P4|Overall Study|Adverse Event|4
7555194|NCT02415556|26265677|P3|Overall Study|Adverse Event|2
7555195|NCT02415556|26265678|P2|Overall Study|Adverse Event|4
7555196|NCT02415556|26265679|P1|Overall Study|Adverse Event|3
7555197|NCT02415400|26265796|P4|Overall Study|Site closure; participant won't transfer|1
7555198|NCT02415400|26265797|P3|Overall Study|Site closure; participant won't transfer|0
7555199|NCT02415400|26265798|P2|Overall Study|Site closure; participant won't transfer|0
7555200|NCT02415400|26265799|P1|Overall Study|Site closure; participant won't transfer|0
7555201|NCT02415400|26265796|P4|Overall Study|Investigator decision|1
7555202|NCT02415400|26265797|P3|Overall Study|Investigator decision|1
7555203|NCT02415400|26265798|P2|Overall Study|Investigator decision|0
7555204|NCT02415400|26265799|P1|Overall Study|Investigator decision|0
7555205|NCT02415400|26265796|P4|Overall Study|Participant in jail|0
7555206|NCT02415400|26265797|P3|Overall Study|Participant in jail|1
7555207|NCT02415400|26265798|P2|Overall Study|Participant in jail|0
7555208|NCT02415400|26265799|P1|Overall Study|Participant in jail|0
7555209|NCT02415400|26265796|P4|Overall Study|Poor treatment monitoring|0
7555210|NCT02415400|26265797|P3|Overall Study|Poor treatment monitoring|1
7555211|NCT02415400|26265798|P2|Overall Study|Poor treatment monitoring|0
7555212|NCT02415400|26265799|P1|Overall Study|Poor treatment monitoring|0
7555213|NCT02415400|26265796|P4|Overall Study|State regulations prevent participation|0
7555214|NCT02415400|26265797|P3|Overall Study|State regulations prevent participation|1
7555215|NCT02415400|26265798|P2|Overall Study|State regulations prevent participation|0
7555216|NCT02415400|26265799|P1|Overall Study|State regulations prevent participation|0
7555217|NCT02415400|26265796|P4|Overall Study|Coagulation values cannot be set|0
7555218|NCT02415400|26265797|P3|Overall Study|Coagulation values cannot be set|1
7555219|NCT02415400|26265798|P2|Overall Study|Coagulation values cannot be set|0
7555220|NCT02415400|26265799|P1|Overall Study|Coagulation values cannot be set|0
7555221|NCT02415400|26265796|P4|Overall Study|Stroke and stroke rehabilitation|0
7555222|NCT02415400|26265797|P3|Overall Study|Stroke and stroke rehabilitation|1
7555223|NCT02415400|26265798|P2|Overall Study|Stroke and stroke rehabilitation|0
7555224|NCT02415400|26265799|P1|Overall Study|Stroke and stroke rehabilitation|0
7555225|NCT02415400|26265796|P4|Overall Study|No study drug on site|0
7555226|NCT02415400|26265797|P3|Overall Study|No study drug on site|0
7555227|NCT02415400|26265798|P2|Overall Study|No study drug on site|1
7555228|NCT02415400|26265799|P1|Overall Study|No study drug on site|0
7555229|NCT02415400|26265796|P4|Overall Study|Randomized in error|0
7555230|NCT02415400|26265797|P3|Overall Study|Randomized in error|0
7555231|NCT02415400|26265798|P2|Overall Study|Randomized in error|0
7555232|NCT02415400|26265799|P1|Overall Study|Randomized in error|2
7555233|NCT02415400|26265796|P4|Overall Study|Participant wanted home visits|0
7555234|NCT02415400|26265797|P3|Overall Study|Participant wanted home visits|0
7555235|NCT02415400|26265798|P2|Overall Study|Participant wanted home visits|0
7555236|NCT02415400|26265799|P1|Overall Study|Participant wanted home visits|1
7555237|NCT02415400|26265796|P4|Overall Study|Participant doesn't answer phone|0
7555238|NCT02415400|26265797|P3|Overall Study|Participant doesn't answer phone|0
7555239|NCT02415400|26265798|P2|Overall Study|Participant doesn't answer phone|0
7555240|NCT02415400|26265799|P1|Overall Study|Participant doesn't answer phone|1
7555241|NCT02415400|26265796|P4|Overall Study|Participant no longer meets criteria|1
7555242|NCT02415400|26265797|P3|Overall Study|Participant no longer meets criteria|0
7555243|NCT02415400|26265798|P2|Overall Study|Participant no longer meets criteria|0
7555244|NCT02415400|26265799|P1|Overall Study|Participant no longer meets criteria|2
7555245|NCT02415400|26265796|P4|Overall Study|Poor/Non-Compliance|4
7555246|NCT02415400|26265797|P3|Overall Study|Poor/Non-Compliance|3
7555247|NCT02415400|26265798|P2|Overall Study|Poor/Non-Compliance|1
7555248|NCT02415400|26265799|P1|Overall Study|Poor/Non-Compliance|0
7555249|NCT02415400|26265796|P4|Overall Study|Lost to Follow-up|5
7555250|NCT02415400|26265797|P3|Overall Study|Lost to Follow-up|2
7555251|NCT02415400|26265798|P2|Overall Study|Lost to Follow-up|3
7555252|NCT02415400|26265799|P1|Overall Study|Lost to Follow-up|3
7555253|NCT02415400|26265796|P4|Overall Study|Death|42
7555254|NCT02415400|26265797|P3|Overall Study|Death|35
7555255|NCT02415400|26265798|P2|Overall Study|Death|41
7555256|NCT02415400|26265799|P1|Overall Study|Death|39
7555257|NCT02415400|26265796|P4|Overall Study|Participant withdrew consent|21
7555258|NCT02415400|26265797|P3|Overall Study|Participant withdrew consent|30
7555259|NCT02415400|26265798|P2|Overall Study|Participant withdrew consent|12
7555260|NCT02415400|26265799|P1|Overall Study|Participant withdrew consent|14
7555261|NCT02415400|26265796|P4|Overall Study|Participant request to stop therapy|6
7555262|NCT02415400|26265797|P3|Overall Study|Participant request to stop therapy|8
7555263|NCT02415400|26265798|P2|Overall Study|Participant request to stop therapy|3
7555264|NCT02415400|26265799|P1|Overall Study|Participant request to stop therapy|4
7555265|NCT02415400|26265796|P4|Overall Study|Adverse Event|2
7555266|NCT02415400|26265797|P3|Overall Study|Adverse Event|1
7555267|NCT02415400|26265798|P2|Overall Study|Adverse Event|1
7555268|NCT02415400|26265799|P1|Overall Study|Adverse Event|0
7555269|NCT02415127|26265867|P2|Overall Study|Adverse Event|0
7555270|NCT02415127|26265868|P1|Overall Study|Adverse Event|1
7555271|NCT02414958|26265885|P3|Overall Study|Other than specified|5
7555272|NCT02414958|26265886|P2|Overall Study|Other than specified|4
7555273|NCT02414958|26265887|P1|Overall Study|Other than specified|4
7555274|NCT02414958|26265885|P3|Overall Study|Withdrawal by Subject|5
7555275|NCT02414958|26265886|P2|Overall Study|Withdrawal by Subject|3
7555276|NCT02414958|26265887|P1|Overall Study|Withdrawal by Subject|5
7555277|NCT02414958|26265885|P3|Overall Study|Lost to Follow-up|0
7555278|NCT02414958|26265886|P2|Overall Study|Lost to Follow-up|4
7555279|NCT02414958|26265887|P1|Overall Study|Lost to Follow-up|7
7555280|NCT02414958|26265885|P3|Overall Study|Protocol Violation|1
7555281|NCT02414958|26265886|P2|Overall Study|Protocol Violation|3
7555282|NCT02414958|26265887|P1|Overall Study|Protocol Violation|10
7555283|NCT02414958|26265885|P3|Overall Study|Adverse Event|3
7555284|NCT02414958|26265886|P2|Overall Study|Adverse Event|6
7555285|NCT02414958|26265887|P1|Overall Study|Adverse Event|6
7555286|NCT02414932|26265918|P2|Overall Study|Adverse Event|0
7555287|NCT02414932|26265919|P1|Overall Study|Adverse Event|1
7555288|NCT02414932|26265918|P2|Overall Study|Withdrawal by Subject|3
7555289|NCT02414932|26265919|P1|Overall Study|Withdrawal by Subject|2
7555290|NCT02414854|26265931|P4|Overall Study|Other than specified above|37
7555291|NCT02414854|26265932|P3|Overall Study|Other than specified above|17
7555292|NCT02414854|26265933|P2|Overall Study|Other than specified above|37
7555293|NCT02414854|26265934|P1|Overall Study|Other than specified above|12
7555294|NCT02414854|26265931|P4|Overall Study|Poor compliance to protocol|2
7555295|NCT02414854|26265932|P3|Overall Study|Poor compliance to protocol|2
7555296|NCT02414854|26265933|P2|Overall Study|Poor compliance to protocol|1
7555297|NCT02414854|26265934|P1|Overall Study|Poor compliance to protocol|1
7555298|NCT02414854|26265931|P4|Overall Study|Adverse Event|12
7555299|NCT02414854|26265932|P3|Overall Study|Adverse Event|1
7555300|NCT02414854|26265933|P2|Overall Study|Adverse Event|7
7555301|NCT02414854|26265934|P1|Overall Study|Adverse Event|9
7555302|NCT02414841|26266098|P2|Overall Study|Randomized But Not Treated|4
7555303|NCT02414841|26266099|P1|Overall Study|Randomized But Not Treated|6
7555304|NCT02414841|26266098|P2|Overall Study|Received a Kidney Transplant|4
7555305|NCT02414841|26266099|P1|Overall Study|Received a Kidney Transplant|13
7555306|NCT02414841|26266098|P2|Overall Study|Death|14
7555307|NCT02414841|26266099|P1|Overall Study|Death|17
7555308|NCT02414841|26266098|P2|Overall Study|Lost to Follow-up|6
7555309|NCT02414841|26266099|P1|Overall Study|Lost to Follow-up|13
7555310|NCT02414841|26266098|P2|Overall Study|Withdrawal by Subject|5
7555311|NCT02414841|26266099|P1|Overall Study|Withdrawal by Subject|7
7555312|NCT02414828|26266111|P4|Overall Study|Lost to Follow-up|2
7555313|NCT02414828|26266112|P3|Overall Study|Lost to Follow-up|1
7555314|NCT02414828|26266113|P2|Overall Study|Lost to Follow-up|1
7555315|NCT02414828|26266114|P1|Overall Study|Lost to Follow-up|0
7555316|NCT02414152|26266207|P1|Overall Study|Lack of Efficacy|1
7555317|NCT02414152|26266207|P1|Overall Study|Withdrawal by Subject|1
7555318|NCT02413996|26266213|P2|Overall Study|not comfortable with the intervention|2
7555319|NCT02413996|26266214|P1|Overall Study|not comfortable with the intervention|9
7555320|NCT02413593|26266259|P1|Overall Study|Adverse Event|1
7555321|NCT02413593|26266259|P1|Overall Study|Lost to Follow-up|3
7555322|NCT02413489|26266278|P3|Overall Study|Study Terminated By Sponsor|1
7555323|NCT02413489|26266279|P2|Overall Study|Study Terminated By Sponsor|13
7555324|NCT02413489|26266280|P1|Overall Study|Study Terminated By Sponsor|2
7555325|NCT02413489|26266278|P3|Overall Study|Withdrawal by Subject|0
7555326|NCT02413489|26266279|P2|Overall Study|Withdrawal by Subject|0
7555327|NCT02413489|26266280|P1|Overall Study|Withdrawal by Subject|2
7555328|NCT02413489|26266278|P3|Overall Study|Death|4
7555329|NCT02413489|26266279|P2|Overall Study|Death|3
7555330|NCT02413489|26266280|P1|Overall Study|Death|11
7555331|NCT02413398|26266321|P2|Overall Study|Other Eligibility criteria|2
7555332|NCT02413398|26266322|P1|Overall Study|Other Eligibility criteria|1
7555333|NCT02413398|26266321|P2|Overall Study|Withdrawal by Subject|1
7555334|NCT02413398|26266322|P1|Overall Study|Withdrawal by Subject|1
7555335|NCT02413398|26266321|P2|Overall Study|Lost to Follow-up|4
7555336|NCT02413398|26266322|P1|Overall Study|Lost to Follow-up|2
7555337|NCT02413372|26266337|P3|Follow-up|Subject unable to return for visit|1
7555338|NCT02413372|26266338|P2|Follow-up|Subject unable to return for visit|0
7555339|NCT02413372|26266339|P1|Follow-up|Subject unable to return for visit|0
7555340|NCT02413372|26266337|P3|Follow-up|Subject Withdrew Consent|1
7555341|NCT02413372|26266338|P2|Follow-up|Subject Withdrew Consent|0
7555342|NCT02413372|26266339|P1|Follow-up|Subject Withdrew Consent|1
7555343|NCT02413372|26266337|P3|Follow-up|Lost to Follow-up|0
7555344|NCT02413372|26266338|P2|Follow-up|Lost to Follow-up|1
7555345|NCT02413372|26266339|P1|Follow-up|Lost to Follow-up|1
7555346|NCT02413372|26266337|P3|Treatment|Withdrawal by Subject|0
7555347|NCT02413372|26266338|P2|Treatment|Withdrawal by Subject|0
7555348|NCT02413372|26266339|P1|Treatment|Withdrawal by Subject|1
7555349|NCT02413372|26266337|P3|Treatment|Lost to Follow-up|1
7555350|NCT02413372|26266338|P2|Treatment|Lost to Follow-up|2
7555351|NCT02413372|26266339|P1|Treatment|Lost to Follow-up|0
7555352|NCT02413346|26266388|P2|Overall Study|Other Miscellaneous Reasons|3
7555353|NCT02413346|26266389|P1|Overall Study|Other Miscellaneous Reasons|4
7555354|NCT02413346|26266388|P2|Overall Study|Protocol Violation|0
7555355|NCT02413346|26266389|P1|Overall Study|Protocol Violation|2
7555356|NCT02413346|26266388|P2|Overall Study|Lost to Follow-up|21
7555357|NCT02413346|26266389|P1|Overall Study|Lost to Follow-up|17
7555358|NCT02413346|26266388|P2|Overall Study|Withdrawal by Subject|40
7555359|NCT02413346|26266389|P1|Overall Study|Withdrawal by Subject|30
7555360|NCT02413346|26266388|P2|Overall Study|Adverse Event|6
7555361|NCT02413346|26266389|P1|Overall Study|Adverse Event|6
7555362|NCT02413333|26266399|P2|Period 2|Protocol Deviation|0
7555363|NCT02413333|26266400|P1|Period 2|Protocol Deviation|1
7555364|NCT02413333|26266399|P2|Period 1|Reason Not Specified|1
7555365|NCT02413333|26266400|P1|Period 1|Reason Not Specified|0
7555366|NCT02413333|26266399|P2|Period 1|Adverse Event|0
7555367|NCT02413333|26266400|P1|Period 1|Adverse Event|1
7555368|NCT02413294|26266419|P1|Overall Study|Withdrawal by Subject|1
7555369|NCT02413255|26266454|P17|Overall Study|Voluntary Withdrawal|0
7555370|NCT02413255|26266455|P16|Overall Study|Voluntary Withdrawal|0
7555371|NCT02413255|26266456|P15|Overall Study|Voluntary Withdrawal|1
7555372|NCT02413255|26266457|P14|Overall Study|Voluntary Withdrawal|0
7555373|NCT02413255|26266458|P13|Overall Study|Voluntary Withdrawal|0
7555374|NCT02413255|26266459|P12|Overall Study|Voluntary Withdrawal|0
7555375|NCT02413255|26266460|P11|Overall Study|Voluntary Withdrawal|0
7555376|NCT02413255|26266461|P10|Overall Study|Voluntary Withdrawal|0
7555377|NCT02413255|26266462|P9|Overall Study|Voluntary Withdrawal|0
7555378|NCT02413255|26266463|P8|Overall Study|Voluntary Withdrawal|0
7555379|NCT02413255|26266464|P7|Overall Study|Voluntary Withdrawal|0
7555380|NCT02413255|26266465|P6|Overall Study|Voluntary Withdrawal|0
7555381|NCT02413255|26266466|P5|Overall Study|Voluntary Withdrawal|0
7555382|NCT02413255|26266467|P4|Overall Study|Voluntary Withdrawal|0
7555383|NCT02413255|26266468|P3|Overall Study|Voluntary Withdrawal|0
7555384|NCT02413255|26266469|P2|Overall Study|Voluntary Withdrawal|0
7555385|NCT02413255|26266470|P1|Overall Study|Voluntary Withdrawal|0
7555386|NCT02413229|26266826|P8|Overall Study|Progressive Disease|1
7555387|NCT02413229|26266827|P7|Overall Study|Progressive Disease|0
7555388|NCT02413229|26266828|P6|Overall Study|Progressive Disease|0
7555389|NCT02413229|26266829|P5|Overall Study|Progressive Disease|0
7555390|NCT02413229|26266830|P4|Overall Study|Progressive Disease|0
7555391|NCT02413229|26266831|P3|Overall Study|Progressive Disease|0
7555392|NCT02413229|26266832|P2|Overall Study|Progressive Disease|0
7555393|NCT02413229|26266833|P1|Overall Study|Progressive Disease|0
7555394|NCT02413229|26266826|P8|Overall Study|Withdrawal by Subject|2
7555395|NCT02413229|26266827|P7|Overall Study|Withdrawal by Subject|0
7555396|NCT02413229|26266828|P6|Overall Study|Withdrawal by Subject|0
7555397|NCT02413229|26266829|P5|Overall Study|Withdrawal by Subject|1
7555398|NCT02413229|26266830|P4|Overall Study|Withdrawal by Subject|0
7555399|NCT02413229|26266831|P3|Overall Study|Withdrawal by Subject|0
7555400|NCT02413229|26266832|P2|Overall Study|Withdrawal by Subject|1
7555401|NCT02413229|26266833|P1|Overall Study|Withdrawal by Subject|1
7555402|NCT02413229|26266826|P8|Overall Study|Lost to Follow-up|0
7555403|NCT02413229|26266827|P7|Overall Study|Lost to Follow-up|0
7555404|NCT02413229|26266828|P6|Overall Study|Lost to Follow-up|0
7555405|NCT02413229|26266829|P5|Overall Study|Lost to Follow-up|2
7555406|NCT02413229|26266830|P4|Overall Study|Lost to Follow-up|0
7555407|NCT02413229|26266831|P3|Overall Study|Lost to Follow-up|1
7555408|NCT02413229|26266832|P2|Overall Study|Lost to Follow-up|0
7555409|NCT02413229|26266833|P1|Overall Study|Lost to Follow-up|0
7555410|NCT02413229|26266826|P8|Overall Study|Adverse Event|1
7555411|NCT02413229|26266827|P7|Overall Study|Adverse Event|0
7555412|NCT02413229|26266828|P6|Overall Study|Adverse Event|0
7555413|NCT02413229|26266829|P5|Overall Study|Adverse Event|0
7555414|NCT02413229|26266830|P4|Overall Study|Adverse Event|1
7555415|NCT02413229|26266831|P3|Overall Study|Adverse Event|0
7555416|NCT02413229|26266832|P2|Overall Study|Adverse Event|0
7555417|NCT02413229|26266833|P1|Overall Study|Adverse Event|0
7555418|NCT02412878|26266972|P2|Overall Study|Lost to Follow-up|3
7555419|NCT02412878|26266973|P1|Overall Study|Lost to Follow-up|2
7555420|NCT02412878|26266972|P2|Overall Study|Withdrawal by Subject|10
7555421|NCT02412878|26266973|P1|Overall Study|Withdrawal by Subject|19
7555422|NCT02412852|26266991|P4|Overall Study|Physician Decision|1
7555423|NCT02412852|26266992|P3|Overall Study|Physician Decision|0
7555424|NCT02412852|26266993|P2|Overall Study|Physician Decision|0
7555425|NCT02412852|26266994|P1|Overall Study|Physician Decision|0
7555426|NCT02412852|26266991|P4|Overall Study|Withdrawal by Subject|0
7555427|NCT02412852|26266992|P3|Overall Study|Withdrawal by Subject|0
7555428|NCT02412852|26266993|P2|Overall Study|Withdrawal by Subject|1
7555429|NCT02412852|26266994|P1|Overall Study|Withdrawal by Subject|0
7555430|NCT02412761|26267020|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
7555431|NCT02412761|26267021|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
7555432|NCT02412761|26267022|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
7555433|NCT02412761|26267023|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
7555434|NCT02412761|26267024|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
7555435|NCT02412761|26267025|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
7555436|NCT02412722|26267039|P6|Overall Study|Reason not Specified|6
7555437|NCT02412722|26267040|P5|Overall Study|Reason not Specified|2
7555438|NCT02412722|26267041|P4|Overall Study|Reason not Specified|1
7555439|NCT02412722|26267042|P3|Overall Study|Reason not Specified|2
7555440|NCT02412722|26267043|P2|Overall Study|Reason not Specified|0
7555441|NCT02412722|26267044|P1|Overall Study|Reason not Specified|3
7555442|NCT02412722|26267039|P6|Overall Study|Received drug in run-in and discontinued|0
7555443|NCT02412722|26267040|P5|Overall Study|Received drug in run-in and discontinued|0
7555444|NCT02412722|26267041|P4|Overall Study|Received drug in run-in and discontinued|0
7555445|NCT02412722|26267042|P3|Overall Study|Received drug in run-in and discontinued|0
7555446|NCT02412722|26267043|P2|Overall Study|Received drug in run-in and discontinued|2
7555447|NCT02412722|26267044|P1|Overall Study|Received drug in run-in and discontinued|0
7555448|NCT02412722|26267039|P6|Overall Study|Lost to Follow-up|0
7555449|NCT02412722|26267040|P5|Overall Study|Lost to Follow-up|1
7555450|NCT02412722|26267041|P4|Overall Study|Lost to Follow-up|0
7555451|NCT02412722|26267042|P3|Overall Study|Lost to Follow-up|0
7555452|NCT02412722|26267043|P2|Overall Study|Lost to Follow-up|0
7555453|NCT02412722|26267044|P1|Overall Study|Lost to Follow-up|0
7555454|NCT02412722|26267039|P6|Overall Study|Withdrawal by Subject|1
7555455|NCT02412722|26267040|P5|Overall Study|Withdrawal by Subject|1
7555456|NCT02412722|26267041|P4|Overall Study|Withdrawal by Subject|2
7555457|NCT02412722|26267042|P3|Overall Study|Withdrawal by Subject|1
7555458|NCT02412722|26267043|P2|Overall Study|Withdrawal by Subject|0
7555459|NCT02412722|26267044|P1|Overall Study|Withdrawal by Subject|2
7555460|NCT02412722|26267039|P6|Overall Study|Progressive Disease|3
7555461|NCT02412722|26267040|P5|Overall Study|Progressive Disease|3
7555462|NCT02412722|26267041|P4|Overall Study|Progressive Disease|9
7555463|NCT02412722|26267042|P3|Overall Study|Progressive Disease|4
7555464|NCT02412722|26267043|P2|Overall Study|Progressive Disease|4
7555465|NCT02412722|26267044|P1|Overall Study|Progressive Disease|6
7555466|NCT02412722|26267039|P6|Overall Study|Adverse Event|3
7555467|NCT02412722|26267040|P5|Overall Study|Adverse Event|0
7555468|NCT02412722|26267041|P4|Overall Study|Adverse Event|3
7555469|NCT02412722|26267042|P3|Overall Study|Adverse Event|0
7555470|NCT02412722|26267043|P2|Overall Study|Adverse Event|2
7555471|NCT02412722|26267044|P1|Overall Study|Adverse Event|0
7555472|NCT02412670|26267114|P2|Overall Study|Ineligible|0
7555473|NCT02412670|26267115|P1|Overall Study|Ineligible|1
7555474|NCT02412670|26267114|P2|Overall Study|Withdrawal by Subject|0
7555475|NCT02412670|26267115|P1|Overall Study|Withdrawal by Subject|1
7555476|NCT02412670|26267114|P2|Overall Study|Physician Decision|0
7555477|NCT02412670|26267115|P1|Overall Study|Physician Decision|1
7555478|NCT02412670|26267114|P2|Overall Study|Adverse Event|1
7555479|NCT02412670|26267115|P1|Overall Study|Adverse Event|4
7555480|NCT02412657|26267136|P3|Overall Study|Protocol Violation|3
7555481|NCT02412657|26267137|P2|Overall Study|Protocol Violation|2
7555482|NCT02412657|26267138|P1|Overall Study|Protocol Violation|0
7555483|NCT02412657|26267136|P3|Overall Study|Lost to Follow-up|0
7555484|NCT02412657|26267137|P2|Overall Study|Lost to Follow-up|0
7555485|NCT02412657|26267138|P1|Overall Study|Lost to Follow-up|1
7555486|NCT02412631|26267163|P2|Overall Study|Unspecified reason|8
7555487|NCT02412631|26267164|P1|Overall Study|Unspecified reason|6
7555488|NCT02412631|26267163|P2|Overall Study|Early stop by FDA|2
7555489|NCT02412631|26267164|P1|Overall Study|Early stop by FDA|5
7555490|NCT02412631|26267163|P2|Overall Study|Withdrawal by Subject|3
7555491|NCT02412631|26267164|P1|Overall Study|Withdrawal by Subject|9
7555492|NCT02412631|26267163|P2|Overall Study|Lost to Follow-up|9
7555493|NCT02412631|26267164|P1|Overall Study|Lost to Follow-up|5
7555494|NCT02412631|26267163|P2|Overall Study|Adverse Event|2
7555495|NCT02412631|26267164|P1|Overall Study|Adverse Event|1
7555496|NCT02412488|26267199|P1|Overall Study|Reveal LINQ explant|1
7555497|NCT02412488|26267199|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
7555498|NCT02412488|26267199|P1|Overall Study|Physician Decision|1
7555499|NCT02412488|26267199|P1|Overall Study|Withdrawal by Subject|5
7555500|NCT02412488|26267199|P1|Overall Study|Lost to Follow-up|10
7555501|NCT02412436|26267203|P1|Overall Study|Not Willing to Adhere to Requirements|1
7555502|NCT02412436|26267203|P1|Overall Study|Death|1
7555503|NCT02412436|26267203|P1|Overall Study|Unable to get to clinic|3
7555504|NCT02412436|26267203|P1|Overall Study|Lost to Follow-up|6
7555505|NCT02412436|26267203|P1|Overall Study|Protocol-mandated Discontinuation|7
7555506|NCT02412371|26267223|P6|Overall Study|Other|3
7555507|NCT02412371|26267224|P5|Overall Study|Other|1
7555508|NCT02412371|26267225|P4|Overall Study|Other|0
7555509|NCT02412371|26267226|P3|Overall Study|Other|0
7555510|NCT02412371|26267227|P2|Overall Study|Other|1
7555511|NCT02412371|26267228|P1|Overall Study|Other|2
7555512|NCT02412371|26267223|P6|Overall Study|Death|2
7555513|NCT02412371|26267224|P5|Overall Study|Death|5
7555514|NCT02412371|26267225|P4|Overall Study|Death|3
7555515|NCT02412371|26267226|P3|Overall Study|Death|1
7555516|NCT02412371|26267227|P2|Overall Study|Death|2
7555517|NCT02412371|26267228|P1|Overall Study|Death|4
7555518|NCT02412371|26267223|P6|Overall Study|Sponsor Discontinued Study|0
7555519|NCT02412371|26267224|P5|Overall Study|Sponsor Discontinued Study|5
7555520|NCT02412371|26267225|P4|Overall Study|Sponsor Discontinued Study|4
7555521|NCT02412371|26267226|P3|Overall Study|Sponsor Discontinued Study|6
7555522|NCT02412371|26267227|P2|Overall Study|Sponsor Discontinued Study|4
7555523|NCT02412371|26267228|P1|Overall Study|Sponsor Discontinued Study|1
7555524|NCT02412371|26267223|P6|Overall Study|Withdrawal by Subject|0
7555525|NCT02412371|26267224|P5|Overall Study|Withdrawal by Subject|1
7555526|NCT02412371|26267225|P4|Overall Study|Withdrawal by Subject|1
7555527|NCT02412371|26267226|P3|Overall Study|Withdrawal by Subject|0
7555528|NCT02412371|26267227|P2|Overall Study|Withdrawal by Subject|2
7555529|NCT02412371|26267228|P1|Overall Study|Withdrawal by Subject|0
7555530|NCT02412306|26267256|P5|Overall Study|Death|2
7555531|NCT02412306|26267257|P4|Overall Study|Death|0
7555532|NCT02412306|26267258|P3|Overall Study|Death|15
7555533|NCT02412306|26267259|P2|Overall Study|Death|7
7555534|NCT02412306|26267260|P1|Overall Study|Death|5
7555535|NCT02412306|26267256|P5|Overall Study|Withdrawal by Subject|0
7555536|NCT02412306|26267257|P4|Overall Study|Withdrawal by Subject|0
7555537|NCT02412306|26267258|P3|Overall Study|Withdrawal by Subject|1
7555538|NCT02412306|26267259|P2|Overall Study|Withdrawal by Subject|0
7555539|NCT02412306|26267260|P1|Overall Study|Withdrawal by Subject|0
7555540|NCT02412306|26267256|P5|Overall Study|Lost to Follow-up|0
7555541|NCT02412306|26267257|P4|Overall Study|Lost to Follow-up|0
7555542|NCT02412306|26267258|P3|Overall Study|Lost to Follow-up|0
7555543|NCT02412306|26267259|P2|Overall Study|Lost to Follow-up|1
7555544|NCT02412306|26267260|P1|Overall Study|Lost to Follow-up|0
7555545|NCT02412111|26267327|P3|Active Comparator Period (8 Weeks)|Other|2
7555546|NCT02412111|26267328|P2|Active Comparator Period (8 Weeks)|Other|0
7555547|NCT02412111|26267329|P1|Active Comparator Period (8 Weeks)|Other|0
7555548|NCT02412111|26267327|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
7555549|NCT02412111|26267328|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
7555550|NCT02412111|26267329|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
7555551|NCT02412111|26267327|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
7555552|NCT02412111|26267328|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7555553|NCT02412111|26267329|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7555554|NCT02412111|26267327|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
7555555|NCT02412111|26267328|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7555556|NCT02412111|26267329|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7555557|NCT02412111|26267327|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
7555558|NCT02412111|26267328|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
7555559|NCT02412111|26267329|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
7555560|NCT02412111|26267327|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7555561|NCT02412111|26267328|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7555562|NCT02412111|26267329|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
7555563|NCT02412111|26267327|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7555564|NCT02412111|26267328|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7555565|NCT02412111|26267329|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
7555566|NCT02411747|26267421|P2|Overall Study|Protocol Violation|4
7555567|NCT02411747|26267422|P1|Overall Study|Protocol Violation|2
7555568|NCT02411747|26267421|P2|Overall Study|Withdrawal by Subject|0
7555569|NCT02411747|26267422|P1|Overall Study|Withdrawal by Subject|1
7555570|NCT02411591|26267438|P3|Overall Study|Physician Decision|1
7555571|NCT02411591|26267439|P2|Overall Study|Physician Decision|3
7555572|NCT02411591|26267440|P1|Overall Study|Physician Decision|0
7555573|NCT02411591|26267438|P3|Overall Study|Withdrawal by Subject|0
7555574|NCT02411591|26267439|P2|Overall Study|Withdrawal by Subject|3
7555575|NCT02411591|26267440|P1|Overall Study|Withdrawal by Subject|0
7555576|NCT02411591|26267438|P3|Overall Study|Adverse Event|2
7555577|NCT02411591|26267439|P2|Overall Study|Adverse Event|4
7555578|NCT02411591|26267440|P1|Overall Study|Adverse Event|0
7555579|NCT02411578|26267472|P2|Crossover Trial Phase|Pregnancy|1
7555580|NCT02411578|26267473|P1|Crossover Trial Phase|Pregnancy|0
7555581|NCT02411539|26267530|P2|Overall Study|Confounding medical condition|1
7555582|NCT02411539|26267531|P1|Overall Study|Confounding medical condition|0
7555583|NCT02411539|26267530|P2|Overall Study|Lost to Follow-up|0
7555584|NCT02411539|26267531|P1|Overall Study|Lost to Follow-up|2
7555585|NCT02411448|26267622|P3|Overall Study|Alive on study treatment|43
7555586|NCT02411448|26267623|P2|Overall Study|Alive on study treatment|64
7555587|NCT02411448|26267624|P1|Overall Study|Alive on study treatment|3
7555588|NCT02411448|26267622|P3|Overall Study|Did not receive study treatment|0
7555589|NCT02411448|26267623|P2|Overall Study|Did not receive study treatment|3
7555590|NCT02411448|26267624|P1|Overall Study|Did not receive study treatment|0
7555591|NCT02411448|26267622|P3|Overall Study|Other|0
7555592|NCT02411448|26267623|P2|Overall Study|Other|2
7555593|NCT02411448|26267624|P1|Overall Study|Other|0
7555594|NCT02411448|26267622|P3|Overall Study|Withdrawal by Subject|9
7555595|NCT02411448|26267623|P2|Overall Study|Withdrawal by Subject|14
7555596|NCT02411448|26267624|P1|Overall Study|Withdrawal by Subject|1
7555597|NCT02411396|26267653|P1|Overall Study|Death|10
7555598|NCT02411396|26267653|P1|Overall Study|Lost to Follow-up|31
7555599|NCT02411292|26267666|P1|Overall Study|Lost to Follow-up|3
7555600|NCT02411292|26267666|P1|Overall Study|Death|2
7555601|NCT02411292|26267666|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
7555602|NCT02411201|26267672|P1|Overall Study|Age group completed|2
7555603|NCT02411201|26267672|P1|Overall Study|Withdrawal by Subject|2
7555604|NCT02411201|26267672|P1|Overall Study|Adverse Event|2
7555605|NCT02411110|26267685|P2|Treatment Period 2|Personal Reasons|2
7555606|NCT02411110|26267686|P1|Treatment Period 2|Personal Reasons|0
7555607|NCT02411110|26267685|P2|Treatment Period 2|Lost to Follow-up|2
7555608|NCT02411110|26267686|P1|Treatment Period 2|Lost to Follow-up|0
7555609|NCT02411110|26267685|P2|Treatment Period 2|Adverse Event|0
7555610|NCT02411110|26267686|P1|Treatment Period 2|Adverse Event|1
7555611|NCT02411110|26267685|P2|Treatment Period 1|Other Miscellaneous Reasons|0
7555612|NCT02411110|26267686|P1|Treatment Period 1|Other Miscellaneous Reasons|2
7555613|NCT02411110|26267685|P2|Treatment Period 1|Personal Reasons|5
7555614|NCT02411110|26267686|P1|Treatment Period 1|Personal Reasons|2
7555615|NCT02411110|26267685|P2|Treatment Period 1|Lost to Follow-up|0
7555616|NCT02411110|26267686|P1|Treatment Period 1|Lost to Follow-up|1
7555617|NCT02411110|26267685|P2|Treatment Period 1|Adverse Event|2
7555618|NCT02411110|26267686|P1|Treatment Period 1|Adverse Event|4
7555619|NCT02411084|26267696|P2|Overall Study|Other reasons|5
7555620|NCT02411084|26267697|P1|Overall Study|Other reasons|0
7555621|NCT02411084|26267696|P2|Overall Study|Adverse Event|1
7555622|NCT02411084|26267697|P1|Overall Study|Adverse Event|2
7555623|NCT02411084|26267696|P2|Overall Study|Death|4
7555624|NCT02411084|26267697|P1|Overall Study|Death|5
7555625|NCT02411084|26267696|P2|Overall Study|Lack of Efficacy|3
7555626|NCT02411084|26267697|P1|Overall Study|Lack of Efficacy|6
7555627|NCT02410954|26267731|P2|Overall Study|Instrument malfunction generated unusable data|0
7555628|NCT02410954|26267732|P1|Overall Study|Instrument malfunction generated unusable data|8
7555629|NCT02410954|26267731|P2|Overall Study|Unable to collect usable data due to initial protocol issues|0
7555630|NCT02410954|26267732|P1|Overall Study|Unable to collect usable data due to initial protocol issues|6
7555631|NCT02410837|26267738|P1|Overall Study|Moved to nursing home, cannot communicat|1
7555632|NCT02410837|26267738|P1|Overall Study|Physician Decision|6
7555633|NCT02410837|26267738|P1|Overall Study|Withdrawal by Subject|44
7555634|NCT02410837|26267738|P1|Overall Study|Lost to Follow-up|50
7555635|NCT02410837|26267738|P1|Overall Study|Death|387
7555636|NCT02410824|26267760|P2|First Intervention (One Week)|Headache|1
7555637|NCT02410824|26267761|P1|First Intervention (One Week)|Headache|0
7555638|NCT02410811|26267797|P4|Overall Study|Withdrawal by Subject|0
7555639|NCT02410811|26267798|P3|Overall Study|Withdrawal by Subject|1
7555640|NCT02410811|26267799|P2|Overall Study|Withdrawal by Subject|0
7555641|NCT02410811|26267800|P1|Overall Study|Withdrawal by Subject|0
7555642|NCT02410772|26267829|P3|Overall Study|Reinfection with a new strain of MTB|0
7555643|NCT02410772|26267830|P2|Overall Study|Reinfection with a new strain of MTB|1
7555644|NCT02410772|26267831|P1|Overall Study|Reinfection with a new strain of MTB|0
7555645|NCT02410772|26267829|P3|Overall Study|No positive Mycobacterium tuberculosis culture|3
7555646|NCT02410772|26267830|P2|Overall Study|No positive Mycobacterium tuberculosis culture|6
7555647|NCT02410772|26267831|P1|Overall Study|No positive Mycobacterium tuberculosis culture|4
7555648|NCT02410772|26267829|P3|Overall Study|Baseline Drug Resistance|51
7555649|NCT02410772|26267830|P2|Overall Study|Baseline Drug Resistance|40
7555650|NCT02410772|26267831|P1|Overall Study|Baseline Drug Resistance|49
7555651|NCT02410772|26267829|P3|Overall Study|Protocol Violation|4
7555652|NCT02410772|26267830|P2|Overall Study|Protocol Violation|8
7555653|NCT02410772|26267831|P1|Overall Study|Protocol Violation|8
7555654|NCT02410772|26267829|P3|Overall Study|Pregnancy|5
7555655|NCT02410772|26267830|P2|Overall Study|Pregnancy|4
7555656|NCT02410772|26267831|P1|Overall Study|Pregnancy|8
7555657|NCT02410772|26267829|P3|Overall Study|Lost to Follow-up|22
7555658|NCT02410772|26267830|P2|Overall Study|Lost to Follow-up|23
7555659|NCT02410772|26267831|P1|Overall Study|Lost to Follow-up|31
7555660|NCT02410772|26267829|P3|Overall Study|Death|8
7555661|NCT02410772|26267830|P2|Overall Study|Death|4
7555662|NCT02410772|26267831|P1|Overall Study|Death|3
7555663|NCT02410629|26267858|P2|Overall Study|Subject underwent heart surgery|1
7555664|NCT02410629|26267859|P1|Overall Study|Subject underwent heart surgery|0
7555665|NCT02410629|26267858|P2|Overall Study|Subject moved back to home country|1
7555666|NCT02410629|26267859|P1|Overall Study|Subject moved back to home country|0
7555667|NCT02410629|26267858|P2|Overall Study|Subject returned to work|0
7555668|NCT02410629|26267859|P1|Overall Study|Subject returned to work|1
7555669|NCT02410629|26267858|P2|Overall Study|Family cannot commit to the study|1
7555670|NCT02410629|26267859|P1|Overall Study|Family cannot commit to the study|2
7555671|NCT02410551|26267875|P1|Overall Study|FDA Clinical hold-patients taken off|2
7555672|NCT02410551|26267875|P1|Overall Study|Withdrawal by Subject|1
7555673|NCT02410551|26267875|P1|Overall Study|Adverse Event|1
7555674|NCT02410343|26267893|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
7555675|NCT02410343|26267894|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
7555676|NCT02410343|26267893|P2|Extension Period (12 Months)|Adverse Event|0
7555677|NCT02410343|26267894|P1|Extension Period (12 Months)|Adverse Event|1
7555678|NCT02410343|26267893|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
7555679|NCT02410343|26267894|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
7555680|NCT02410343|26267893|P2|Core Period (24 Weeks)|Adverse Event|0
7555681|NCT02410343|26267894|P1|Core Period (24 Weeks)|Adverse Event|1
7555682|NCT02410278|26267940|P3|Study Treatment Period|GSRS Threshold Not Met|0
7555683|NCT02410278|26267941|P2|Study Treatment Period|GSRS Threshold Not Met|1
7555684|NCT02410278|26267942|P1|Study Treatment Period|GSRS Threshold Not Met|0
7555685|NCT02410278|26267940|P3|Study Treatment Period|Other|0
7555686|NCT02410278|26267941|P2|Study Treatment Period|Other|3
7555687|NCT02410278|26267942|P1|Study Treatment Period|Other|0
7555688|NCT02410278|26267940|P3|Study Treatment Period|Withdrawal by Subject|0
7555689|NCT02410278|26267941|P2|Study Treatment Period|Withdrawal by Subject|1
7555690|NCT02410278|26267942|P1|Study Treatment Period|Withdrawal by Subject|0
7555691|NCT02410278|26267940|P3|Study Treatment Period|Physician Decision|1
7555692|NCT02410278|26267941|P2|Study Treatment Period|Physician Decision|0
7555693|NCT02410278|26267942|P1|Study Treatment Period|Physician Decision|0
7555694|NCT02410278|26267940|P3|Study Treatment Period|Adverse Event|3
7555695|NCT02410278|26267941|P2|Study Treatment Period|Adverse Event|6
7555696|NCT02410278|26267942|P1|Study Treatment Period|Adverse Event|0
7555697|NCT02410278|26267940|P3|Run-in Period|Pregnancy|0
7555698|NCT02410278|26267941|P2|Run-in Period|Pregnancy|0
7555699|NCT02410278|26267942|P1|Run-in Period|Pregnancy|1
7555700|NCT02410278|26267940|P3|Run-in Period|Withdrawal by Subject|0
7555701|NCT02410278|26267941|P2|Run-in Period|Withdrawal by Subject|0
7555702|NCT02410278|26267942|P1|Run-in Period|Withdrawal by Subject|1
7555703|NCT02410278|26267940|P3|Run-in Period|Lost to Follow-up|0
7555704|NCT02410278|26267941|P2|Run-in Period|Lost to Follow-up|0
7555705|NCT02410278|26267942|P1|Run-in Period|Lost to Follow-up|1
7555706|NCT02410278|26267940|P3|Run-in Period|GSRS Threshold Not Met|0
7555707|NCT02410278|26267941|P2|Run-in Period|GSRS Threshold Not Met|0
7555708|NCT02410278|26267942|P1|Run-in Period|GSRS Threshold Not Met|30
7555709|NCT02410278|26267940|P3|Run-in Period|Adverse Event|0
7555710|NCT02410278|26267941|P2|Run-in Period|Adverse Event|0
7555711|NCT02410278|26267942|P1|Run-in Period|Adverse Event|5
7555712|NCT02410252|26267967|P1|Overall Study|Physician Decision|2
7555713|NCT02410252|26267967|P1|Overall Study|Withdrawal by Subject|4
7555714|NCT02410200|26267980|P1|Overall Study|Adverse Event|2
7555715|NCT02409732|26268050|P1|Overall Study|Lost to Follow-up|2
7555716|NCT02409732|26268050|P1|Overall Study|Withdrawal by Subject|4
7555717|NCT02409719|26268060|P2|Overall Study|Lost to Follow-up|3
7555718|NCT02409719|26268061|P1|Overall Study|Lost to Follow-up|3
7555719|NCT02409680|26268073|P2|Overall Study|Lost to Follow-up|30
7555720|NCT02409680|26268074|P1|Overall Study|Lost to Follow-up|15
7555721|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7555722|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7555723|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
7555724|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7555725|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7555726|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7555727|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7555728|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7555729|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7555730|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7555731|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7555732|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
7555733|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
7555734|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
7555735|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7555736|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7555737|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7555738|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
7555739|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
7555740|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7555741|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
7555742|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
7555743|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
7555744|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
7555745|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
7555746|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7555747|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
7555748|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7555749|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7555750|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7555751|NCT02409667|26268114|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7555752|NCT02409667|26268115|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
7555753|NCT02409667|26268116|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
7555754|NCT02409667|26268117|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
7555755|NCT02409667|26268118|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7555756|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7555757|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7555758|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7555759|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7555760|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
7555761|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7555762|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7555763|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7555764|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7555765|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
7555766|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7555767|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7555768|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7555769|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7555770|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
7555771|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7555772|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7555773|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7555774|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7555775|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
7555776|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7555777|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7555778|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7555779|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7555780|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
7555781|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7555782|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7555783|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7555784|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7555785|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
7555786|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7555787|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7555788|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7555789|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7555790|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
7555791|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7555792|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7555793|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7555794|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7555795|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
7555796|NCT02409667|26268114|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7555797|NCT02409667|26268115|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7555798|NCT02409667|26268116|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7555799|NCT02409667|26268117|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7555800|NCT02409667|26268118|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
7555801|NCT02409368|26268181|P3|Overall Study|Not Reported|0
7555802|NCT02409368|26268182|P2|Overall Study|Not Reported|1
7555803|NCT02409368|26268183|P1|Overall Study|Not Reported|0
7555804|NCT02409368|26268181|P3|Overall Study|Other Reasons|3
7555805|NCT02409368|26268182|P2|Overall Study|Other Reasons|17
7555806|NCT02409368|26268183|P1|Overall Study|Other Reasons|2
7555807|NCT02409368|26268181|P3|Overall Study|Participant withdrew consent|3
7555808|NCT02409368|26268182|P2|Overall Study|Participant withdrew consent|4
7555809|NCT02409368|26268183|P1|Overall Study|Participant withdrew consent|2
7555810|NCT02409368|26268181|P3|Overall Study|Participant request to discontinue|3
7555811|NCT02409368|26268182|P2|Overall Study|Participant request to discontinue|3
7555812|NCT02409368|26268183|P1|Overall Study|Participant request to discontinue|3
7555813|NCT02409368|26268181|P3|Overall Study|no longer meets study criteria|3
7555814|NCT02409368|26268182|P2|Overall Study|no longer meets study criteria|9
7555815|NCT02409368|26268183|P1|Overall Study|no longer meets study criteria|3
7555816|NCT02409368|26268181|P3|Overall Study|study drug toxicity|6
7555817|NCT02409368|26268182|P2|Overall Study|study drug toxicity|35
7555818|NCT02409368|26268183|P1|Overall Study|study drug toxicity|12
7555819|NCT02409368|26268181|P3|Overall Study|poor/non compliant|2
7555820|NCT02409368|26268182|P2|Overall Study|poor/non compliant|2
7555821|NCT02409368|26268183|P1|Overall Study|poor/non compliant|0
7555822|NCT02409368|26268181|P3|Overall Study|maximum clinical benefit|1
7555823|NCT02409368|26268182|P2|Overall Study|maximum clinical benefit|8
7555824|NCT02409368|26268183|P1|Overall Study|maximum clinical benefit|3
7555825|NCT02409368|26268181|P3|Overall Study|Lost to Follow-up|0
7555826|NCT02409368|26268182|P2|Overall Study|Lost to Follow-up|5
7555827|NCT02409368|26268183|P1|Overall Study|Lost to Follow-up|1
7555828|NCT02409368|26268181|P3|Overall Study|Disease Progression|63
7555829|NCT02409368|26268182|P2|Overall Study|Disease Progression|346
7555830|NCT02409368|26268183|P1|Overall Study|Disease Progression|101
7555831|NCT02409368|26268181|P3|Overall Study|Death|5
7555832|NCT02409368|26268182|P2|Overall Study|Death|17
7555833|NCT02409368|26268183|P1|Overall Study|Death|5
7555834|NCT02409368|26268181|P3|Overall Study|Adverse event unrelated to study drug|10
7555835|NCT02409368|26268182|P2|Overall Study|Adverse event unrelated to study drug|42
7555836|NCT02409368|26268183|P1|Overall Study|Adverse event unrelated to study drug|16
7555837|NCT02409355|26268209|P2|Overall Study|Study terminated by Sponsor|3
7555838|NCT02409355|26268210|P1|Overall Study|Study terminated by Sponsor|2
7555839|NCT02409355|26268209|P2|Overall Study|Death|1
7555840|NCT02409355|26268210|P1|Overall Study|Death|1
7555841|NCT02409355|26268209|P2|Overall Study|Withdrawal by Subject|0
7555842|NCT02409355|26268210|P1|Overall Study|Withdrawal by Subject|1
7555843|NCT02409342|26268218|P2|Overall Study|Lost to Follow-up|3
7555844|NCT02409342|26268219|P1|Overall Study|Lost to Follow-up|3
7555845|NCT02409342|26268218|P2|Overall Study|On-going in study|92
7555846|NCT02409342|26268219|P1|Overall Study|On-going in study|79
7555847|NCT02409342|26268218|P2|Overall Study|Withdrawal by Subject|16
7555848|NCT02409342|26268219|P1|Overall Study|Withdrawal by Subject|24
7555849|NCT02409342|26268218|P2|Overall Study|Death|174
7555850|NCT02409342|26268219|P1|Overall Study|Death|181
7555851|NCT02408523|26268381|P2|Overall Study|Did not satisfy extension conditions|1
7555852|NCT02408523|26268382|P1|Overall Study|Did not satisfy extension conditions|0
7555853|NCT02408523|26268381|P2|Overall Study|Sponsor request|0
7555854|NCT02408523|26268382|P1|Overall Study|Sponsor request|1
7555855|NCT02408523|26268381|P2|Overall Study|Withdrawal by Subject|1
7555856|NCT02408523|26268382|P1|Overall Study|Withdrawal by Subject|3
7555857|NCT02408523|26268381|P2|Overall Study|Lost to Follow-up|3
7555858|NCT02408523|26268382|P1|Overall Study|Lost to Follow-up|2
7555859|NCT02408523|26268381|P2|Overall Study|Protocol Violation|2
7555860|NCT02408523|26268382|P1|Overall Study|Protocol Violation|1
7555861|NCT02408523|26268381|P2|Overall Study|Lack of Efficacy|1
7555862|NCT02408523|26268382|P1|Overall Study|Lack of Efficacy|0
7555863|NCT02408523|26268381|P2|Overall Study|Adverse Event|10
7555864|NCT02408523|26268382|P1|Overall Study|Adverse Event|4
7555865|NCT02408484|26268402|P1|Overall Study|Not treated during study period|1
7555866|NCT02408484|26268402|P1|Overall Study|Withdrawal by Subject|3
7555867|NCT02408120|26268507|P2|Overall Study|Did not receive insulin|2
7555868|NCT02408120|26268508|P1|Overall Study|Did not receive insulin|1
7555869|NCT02408120|26268507|P2|Overall Study|Discharged same day|1
7555870|NCT02408120|26268508|P1|Overall Study|Discharged same day|1
7555871|NCT02408120|26268507|P2|Overall Study|Received Steroids|1
7555872|NCT02408120|26268508|P1|Overall Study|Received Steroids|1
7555873|NCT02408120|26268507|P2|Overall Study|Treatment Refusal|0
7555874|NCT02408120|26268508|P1|Overall Study|Treatment Refusal|1
7555875|NCT02408120|26268507|P2|Overall Study|Withdrawal by Subject|1
7555876|NCT02408120|26268508|P1|Overall Study|Withdrawal by Subject|0
7555877|NCT02408068|26268534|P6|Treatment 3 (1.5 Days)|Adverse Event|0
7555878|NCT02408068|26268535|P5|Treatment 3 (1.5 Days)|Adverse Event|0
7555879|NCT02408068|26268536|P4|Treatment 3 (1.5 Days)|Adverse Event|0
7555880|NCT02408068|26268537|P3|Treatment 3 (1.5 Days)|Adverse Event|1
7555881|NCT02408068|26268538|P2|Treatment 3 (1.5 Days)|Adverse Event|0
7555882|NCT02408068|26268539|P1|Treatment 3 (1.5 Days)|Adverse Event|0
7555883|NCT02408016|26268565|P3|Overall Study|Physician Decision|0
7555884|NCT02408016|26268566|P2|Overall Study|Physician Decision|2
7555885|NCT02408016|26268567|P1|Overall Study|Physician Decision|0
7555886|NCT02408016|26268565|P3|Overall Study|Death|0
7555887|NCT02408016|26268566|P2|Overall Study|Death|1
7555888|NCT02408016|26268567|P1|Overall Study|Death|6
7555889|NCT02407704|26268630|P4|Overall Study|Withdrawal by Subject|0
7555890|NCT02407704|26268631|P3|Overall Study|Withdrawal by Subject|1
7555891|NCT02407704|26268632|P2|Overall Study|Withdrawal by Subject|0
7555892|NCT02407704|26268633|P1|Overall Study|Withdrawal by Subject|0
7555893|NCT02407704|26268630|P4|Overall Study|Protocol Violation|1
7555894|NCT02407704|26268631|P3|Overall Study|Protocol Violation|0
7555895|NCT02407704|26268632|P2|Overall Study|Protocol Violation|0
7555896|NCT02407704|26268633|P1|Overall Study|Protocol Violation|0
7555897|NCT02407704|26268630|P4|Overall Study|Lost to Follow-up|2
7555898|NCT02407704|26268631|P3|Overall Study|Lost to Follow-up|0
7555899|NCT02407704|26268632|P2|Overall Study|Lost to Follow-up|0
7555900|NCT02407704|26268633|P1|Overall Study|Lost to Follow-up|0
7555901|NCT02407249|26268676|P1|Overall Study|Not treated|13
7555902|NCT02407249|26268676|P1|Overall Study|Did not complete 12-month follow-up|13
7555991|NCT02407223|26268939|P3|Overall Study|Other|25
7555992|NCT02407223|26268940|P2|Overall Study|Other|27
7555993|NCT02407223|26268941|P1|Overall Study|Other|29
7555994|NCT02407223|26268939|P3|Overall Study|Subject Refused Further Study Treatment|0
7555995|NCT02407223|26268940|P2|Overall Study|Subject Refused Further Study Treatment|1
7555996|NCT02407223|26268941|P1|Overall Study|Subject Refused Further Study Treatment|0
7555997|NCT02407223|26268939|P3|Overall Study|Study Terminated by Sponsor|86
7555998|NCT02407223|26268940|P2|Overall Study|Study Terminated by Sponsor|80
7555999|NCT02407223|26268941|P1|Overall Study|Study Terminated by Sponsor|77
7556000|NCT02407223|26268939|P3|Overall Study|Withdrawal by Subject|4
7556001|NCT02407223|26268940|P2|Overall Study|Withdrawal by Subject|4
7556002|NCT02407223|26268941|P1|Overall Study|Withdrawal by Subject|2
7556003|NCT02407223|26268939|P3|Overall Study|Lost to Follow-up|2
7556004|NCT02407223|26268940|P2|Overall Study|Lost to Follow-up|0
7556005|NCT02407223|26268941|P1|Overall Study|Lost to Follow-up|1
7556006|NCT02407223|26268939|P3|Overall Study|Lack of Efficacy|4
7556007|NCT02407223|26268940|P2|Overall Study|Lack of Efficacy|6
7556008|NCT02407223|26268941|P1|Overall Study|Lack of Efficacy|6
7556009|NCT02407223|26268939|P3|Overall Study|Adverse Event|1
7556010|NCT02407223|26268940|P2|Overall Study|Adverse Event|0
7556011|NCT02407223|26268941|P1|Overall Study|Adverse Event|1
7556012|NCT02407054|26269014|P3|Overall Study|Withdrawal by Subject|2
7556013|NCT02407054|26269015|P2|Overall Study|Withdrawal by Subject|9
7556014|NCT02407054|26269016|P1|Overall Study|Withdrawal by Subject|5
7556015|NCT02407054|26269014|P3|Overall Study|Physician Decision|3
7556016|NCT02407054|26269015|P2|Overall Study|Physician Decision|3
7556017|NCT02407054|26269016|P1|Overall Study|Physician Decision|1
7556018|NCT02407054|26269014|P3|Overall Study|Non-compliance with Study|1
7556019|NCT02407054|26269015|P2|Overall Study|Non-compliance with Study|2
7556020|NCT02407054|26269016|P1|Overall Study|Non-compliance with Study|0
7556021|NCT02407054|26269014|P3|Overall Study|Adverse Event|1
7556022|NCT02407054|26269015|P2|Overall Study|Adverse Event|4
7556023|NCT02407054|26269016|P1|Overall Study|Adverse Event|1
7556024|NCT02406742|26269136|P3|Overall Study|Other Reasons|5
7556025|NCT02406742|26269137|P2|Overall Study|Other Reasons|11
7556026|NCT02406742|26269138|P1|Overall Study|Other Reasons|1
7556027|NCT02406742|26269136|P3|Overall Study|Transition to other treatment|1
7556028|NCT02406742|26269137|P2|Overall Study|Transition to other treatment|0
7556029|NCT02406742|26269138|P1|Overall Study|Transition to other treatment|2
7556030|NCT02406742|26269136|P3|Overall Study|Physician Decision|1
7556031|NCT02406742|26269137|P2|Overall Study|Physician Decision|2
7556032|NCT02406742|26269138|P1|Overall Study|Physician Decision|1
7556033|NCT02406742|26269136|P3|Overall Study|Withdrawal by Participant|0
7556034|NCT02406742|26269137|P2|Overall Study|Withdrawal by Participant|2
7556035|NCT02406742|26269138|P1|Overall Study|Withdrawal by Participant|1
7556036|NCT02406742|26269136|P3|Overall Study|Lack of Efficacy|1
7556037|NCT02406742|26269137|P2|Overall Study|Lack of Efficacy|0
7556038|NCT02406742|26269138|P1|Overall Study|Lack of Efficacy|0
7556039|NCT02406742|26269136|P3|Overall Study|Death|0
7556040|NCT02406742|26269137|P2|Overall Study|Death|0
7556041|NCT02406742|26269138|P1|Overall Study|Death|1
7556042|NCT02406742|26269136|P3|Overall Study|Adverse Event|2
7556043|NCT02406742|26269137|P2|Overall Study|Adverse Event|0
7556044|NCT02406742|26269138|P1|Overall Study|Adverse Event|3
7556045|NCT02406742|26269136|P3|Overall Study|Progression of Disease|6
7556046|NCT02406742|26269137|P2|Overall Study|Progression of Disease|1
7556047|NCT02406742|26269138|P1|Overall Study|Progression of Disease|5
7556048|NCT02406677|26269178|P2|Overall Study|Withdrawal by Subject|0
7556049|NCT02406677|26269179|P1|Overall Study|Withdrawal by Subject|1
7556050|NCT02406677|26269178|P2|Overall Study|Discharged on prasugrel|587
7556051|NCT02406677|26269179|P1|Overall Study|Discharged on prasugrel|283
7556052|NCT02406677|26269178|P2|Overall Study|Discharged without P2Y12|3
7556053|NCT02406677|26269179|P1|Overall Study|Discharged without P2Y12|1
7556054|NCT02406677|26269178|P2|Overall Study|Death|8
7556055|NCT02406677|26269179|P1|Overall Study|Death|16
7556056|NCT02406651|26269191|P1|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
7556057|NCT02406612|26269201|P2|Overall Study|Guidewire Failure|1
7556058|NCT02406612|26269202|P1|Overall Study|Guidewire Failure|0
7556059|NCT02406612|26269201|P2|Overall Study|Intra-procedural Exclusion|3
7556060|NCT02406612|26269202|P1|Overall Study|Intra-procedural Exclusion|1
7556061|NCT02406612|26269201|P2|Overall Study|Screening Failure|0
7556062|NCT02406612|26269202|P1|Overall Study|Screening Failure|3
7556063|NCT02406586|26269217|P3|Overall Study|Withdrawal by Subject|0
7556064|NCT02406586|26269218|P2|Overall Study|Withdrawal by Subject|0
7556065|NCT02406586|26269219|P1|Overall Study|Withdrawal by Subject|1
7556066|NCT02406586|26269217|P3|Overall Study|Lost to Follow-up|2
7556067|NCT02406586|26269218|P2|Overall Study|Lost to Follow-up|4
7556068|NCT02406586|26269219|P1|Overall Study|Lost to Follow-up|0
7556069|NCT02406261|26269361|P2|Period 2|Withdrawal by Subject|1
7556070|NCT02406261|26269362|P1|Period 2|Withdrawal by Subject|0
7556071|NCT02406261|26269361|P2|Period 2|Protocol Violation|1
7556072|NCT02406261|26269362|P1|Period 2|Protocol Violation|0
7556073|NCT02406261|26269361|P2|Period 2|Physician Decision|1
7556074|NCT02406261|26269362|P1|Period 2|Physician Decision|0
7556075|NCT02406261|26269361|P2|Period 1|Adverse Event|0
7556076|NCT02406261|26269362|P1|Period 1|Adverse Event|1
7556077|NCT02406261|26269361|P2|Period 1|Lost to Follow-up|0
7556078|NCT02406261|26269362|P1|Period 1|Lost to Follow-up|2
7556079|NCT02406248|26269374|P1|Overall Study|Withdrawal by Subject|2
7556080|NCT02406248|26269374|P1|Overall Study|Death|7
7556081|NCT02406027|26269385|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7556082|NCT02406027|26269386|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7556083|NCT02406027|26269387|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
7556084|NCT02406027|26269388|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7556085|NCT02406027|26269389|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7556086|NCT02406027|26269390|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7556087|NCT02406027|26269391|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7556088|NCT02406027|26269385|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7556089|NCT02406027|26269386|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
7556090|NCT02406027|26269387|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7556091|NCT02406027|26269388|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7556092|NCT02406027|26269389|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7556093|NCT02406027|26269390|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7556094|NCT02406027|26269391|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7556095|NCT02406027|26269385|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
7556096|NCT02406027|26269386|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
7556097|NCT02406027|26269387|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
7556098|NCT02406027|26269388|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
7556099|NCT02406027|26269389|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7556100|NCT02406027|26269390|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7556101|NCT02406027|26269391|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7556102|NCT02406027|26269385|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
7556103|NCT02406027|26269386|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
7556104|NCT02406027|26269387|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
7556105|NCT02406027|26269388|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
7556106|NCT02406027|26269389|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
7556107|NCT02406027|26269390|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
7556108|NCT02406027|26269391|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
7556109|NCT02406027|26269385|P7|Open-label Phase (Period 2)|Physician Decision|1
7556110|NCT02406027|26269386|P6|Open-label Phase (Period 2)|Physician Decision|1
7556111|NCT02406027|26269387|P5|Open-label Phase (Period 2)|Physician Decision|0
7556112|NCT02406027|26269388|P4|Open-label Phase (Period 2)|Physician Decision|0
7556113|NCT02406027|26269389|P3|Open-label Phase (Period 2)|Physician Decision|0
7556114|NCT02406027|26269390|P2|Open-label Phase (Period 2)|Physician Decision|0
7556115|NCT02406027|26269391|P1|Open-label Phase (Period 2)|Physician Decision|0
7556116|NCT02406027|26269385|P7|Open-label Phase (Period 2)|Adverse Event|0
7556117|NCT02406027|26269386|P6|Open-label Phase (Period 2)|Adverse Event|0
7556118|NCT02406027|26269387|P5|Open-label Phase (Period 2)|Adverse Event|2
7556119|NCT02406027|26269388|P4|Open-label Phase (Period 2)|Adverse Event|2
7556120|NCT02406027|26269389|P3|Open-label Phase (Period 2)|Adverse Event|0
7556121|NCT02406027|26269390|P2|Open-label Phase (Period 2)|Adverse Event|0
7556122|NCT02406027|26269391|P1|Open-label Phase (Period 2)|Adverse Event|0
7556123|NCT02406027|26269385|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7556124|NCT02406027|26269386|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7556125|NCT02406027|26269387|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7556126|NCT02406027|26269388|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7556127|NCT02406027|26269389|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
7556128|NCT02406027|26269390|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7556129|NCT02406027|26269391|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
7556130|NCT02406027|26269385|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7556131|NCT02406027|26269386|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7556132|NCT02406027|26269387|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7556133|NCT02406027|26269388|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7556134|NCT02406027|26269389|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
7556135|NCT02406027|26269390|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
7556136|NCT02406027|26269391|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
7556137|NCT02406027|26269385|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7556138|NCT02406027|26269386|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7556139|NCT02406027|26269387|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7556140|NCT02406027|26269388|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7556141|NCT02406027|26269389|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
7556142|NCT02406027|26269390|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7556143|NCT02406027|26269391|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
7556144|NCT02406027|26269385|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7556145|NCT02406027|26269386|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7556146|NCT02406027|26269387|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7556147|NCT02406027|26269388|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7556148|NCT02406027|26269389|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
7556149|NCT02406027|26269390|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
7556150|NCT02406027|26269391|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7556151|NCT02405962|26269421|P2|Overall Study|A participant has moved to another place|1
7556152|NCT02405962|26269422|P1|Overall Study|A participant has moved to another place|0
7556153|NCT02405962|26269421|P2|Overall Study|Lost to Follow-up|4
7556154|NCT02405962|26269422|P1|Overall Study|Lost to Follow-up|1
7556155|NCT02405780|26269460|P4|Period II|Non-compliance with study procedures|4
7556156|NCT02405780|26269461|P3|Period II|Non-compliance with study procedures|7
7556157|NCT02405780|26269462|P2|Period II|Non-compliance with study procedures|2
7556158|NCT02405780|26269463|P1|Period II|Non-compliance with study procedures|5
7556159|NCT02405780|26269460|P4|Period II|Withdrawal by Subject|3
7556160|NCT02405780|26269461|P3|Period II|Withdrawal by Subject|0
7556161|NCT02405780|26269462|P2|Period II|Withdrawal by Subject|4
7556162|NCT02405780|26269463|P1|Period II|Withdrawal by Subject|7
7556163|NCT02405780|26269460|P4|Period II|Pregnancy|0
7556164|NCT02405780|26269461|P3|Period II|Pregnancy|1
7556165|NCT02405780|26269462|P2|Period II|Pregnancy|0
7556166|NCT02405780|26269463|P1|Period II|Pregnancy|0
7556167|NCT02405780|26269460|P4|Period II|Medical reason|0
7556168|NCT02405780|26269461|P3|Period II|Medical reason|0
7556169|NCT02405780|26269462|P2|Period II|Medical reason|1
7556170|NCT02405780|26269463|P1|Period II|Medical reason|0
7556171|NCT02405780|26269460|P4|Period II|Adverse Event|11
7556172|NCT02405780|26269461|P3|Period II|Adverse Event|4
7556173|NCT02405780|26269462|P2|Period II|Adverse Event|5
7556174|NCT02405780|26269463|P1|Period II|Adverse Event|3
7556175|NCT02405780|26269460|P4|Period I|Non-compliance with study procedures|11
7556176|NCT02405780|26269461|P3|Period I|Non-compliance with study procedures|8
7556177|NCT02405780|26269462|P2|Period I|Non-compliance with study procedures|6
7556178|NCT02405780|26269463|P1|Period I|Non-compliance with study procedures|8
7556179|NCT02405780|26269460|P4|Period I|Withdrawal by Subject|4
7556180|NCT02405780|26269461|P3|Period I|Withdrawal by Subject|3
7556181|NCT02405780|26269462|P2|Period I|Withdrawal by Subject|1
7556182|NCT02405780|26269463|P1|Period I|Withdrawal by Subject|9
7556183|NCT02405780|26269460|P4|Period I|Screening Failure|0
7556184|NCT02405780|26269461|P3|Period I|Screening Failure|1
7556185|NCT02405780|26269462|P2|Period I|Screening Failure|0
7556186|NCT02405780|26269463|P1|Period I|Screening Failure|1
7556187|NCT02405780|26269460|P4|Period I|Medical reasons|1
7556188|NCT02405780|26269461|P3|Period I|Medical reasons|0
7556189|NCT02405780|26269462|P2|Period I|Medical reasons|1
7556190|NCT02405780|26269463|P1|Period I|Medical reasons|1
7556191|NCT02405780|26269460|P4|Period I|Adverse Event|7
7556192|NCT02405780|26269461|P3|Period I|Adverse Event|3
7556193|NCT02405780|26269462|P2|Period I|Adverse Event|0
7556194|NCT02405780|26269463|P1|Period I|Adverse Event|8
7556195|NCT02405442|26269526|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7556196|NCT02405442|26269527|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7556197|NCT02405442|26269528|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7556198|NCT02405442|26269529|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
7556199|NCT02405442|26269526|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7556200|NCT02405442|26269527|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7556201|NCT02405442|26269528|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
7556202|NCT02405442|26269529|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7556203|NCT02405442|26269526|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7556204|NCT02405442|26269527|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7556205|NCT02405442|26269528|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
7556206|NCT02405442|26269529|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7556207|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7556208|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7556209|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
7556210|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7556211|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7556212|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7556213|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
7556214|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7556215|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7556216|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7556217|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
7556218|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7556219|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
7556220|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
7556221|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
7556222|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
7556223|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
7556224|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
7556225|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
7556226|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
7556227|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
7556228|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7556229|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7556230|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
7556231|NCT02405442|26269526|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
7556232|NCT02405442|26269527|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7556233|NCT02405442|26269528|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7556234|NCT02405442|26269529|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
7556235|NCT02405442|26269526|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7556236|NCT02405442|26269527|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7556237|NCT02405442|26269528|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
7556238|NCT02405442|26269529|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7556239|NCT02405442|26269526|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7556240|NCT02405442|26269527|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7556241|NCT02405442|26269528|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7556242|NCT02405442|26269529|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7556243|NCT02405442|26269526|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7556244|NCT02405442|26269527|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
7556245|NCT02405442|26269528|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
7556246|NCT02405442|26269529|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7556247|NCT02405442|26269526|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
7556248|NCT02405442|26269527|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
7556249|NCT02405442|26269528|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
7556250|NCT02405442|26269529|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
7556251|NCT02405091|26269592|P3|Overall Study|Physician Decision|0
7556252|NCT02405091|26269593|P2|Overall Study|Physician Decision|2
7556253|NCT02405091|26269594|P1|Overall Study|Physician Decision|2
7556254|NCT02405091|26269592|P3|Overall Study|Lost to Follow-up|0
7556255|NCT02405091|26269593|P2|Overall Study|Lost to Follow-up|6
7556256|NCT02405091|26269594|P1|Overall Study|Lost to Follow-up|5
7556257|NCT02405091|26269592|P3|Overall Study|Death|0
7556258|NCT02405091|26269593|P2|Overall Study|Death|1
7556259|NCT02405091|26269594|P1|Overall Study|Death|0
7556260|NCT02405091|26269592|P3|Overall Study|Withdrawal by Subject|0
7556261|NCT02405091|26269593|P2|Overall Study|Withdrawal by Subject|8
7556262|NCT02405091|26269594|P1|Overall Study|Withdrawal by Subject|4
7556263|NCT02405091|26269592|P3|Overall Study|Noncompliance|2
7556264|NCT02405091|26269593|P2|Overall Study|Noncompliance|6
7556265|NCT02405091|26269594|P1|Overall Study|Noncompliance|1
7556266|NCT02405091|26269592|P3|Overall Study|Protocol Violation|0
7556267|NCT02405091|26269593|P2|Overall Study|Protocol Violation|0
7556268|NCT02405091|26269594|P1|Overall Study|Protocol Violation|1
7556269|NCT02405091|26269592|P3|Overall Study|Adverse Event|0
7556270|NCT02405091|26269593|P2|Overall Study|Adverse Event|10
7556271|NCT02405091|26269594|P1|Overall Study|Adverse Event|16
7556272|NCT02404805|26269621|P6|Overall Study|Withdrawal by Subject|0
7556273|NCT02404805|26269622|P5|Overall Study|Withdrawal by Subject|0
7556274|NCT02404805|26269623|P4|Overall Study|Withdrawal by Subject|0
7556275|NCT02404805|26269624|P3|Overall Study|Withdrawal by Subject|0
7556276|NCT02404805|26269625|P2|Overall Study|Withdrawal by Subject|0
7556277|NCT02404805|26269626|P1|Overall Study|Withdrawal by Subject|1
7556278|NCT02404649|26269650|P2|Overall Study|Adverse Event|2
7556279|NCT02404649|26269651|P1|Overall Study|Adverse Event|1
7556280|NCT02404545|26269670|P2|Overall Study|Sponsor Termination|6
7556281|NCT02404545|26269671|P1|Overall Study|Sponsor Termination|6
7556282|NCT02404493|26269690|P2|Overall Study|Adverse Event|1
7556283|NCT02404493|26269691|P1|Overall Study|Adverse Event|1
7556284|NCT02404441|26269941|P10|Phase 2 Part|Death|9
7556285|NCT02404441|26269942|P9|Phase 2 Part|Death|10
7556286|NCT02404441|26269943|P8|Phase 2 Part|Death|4
7556287|NCT02404441|26269944|P7|Phase 2 Part|Death|8
7556288|NCT02404441|26269945|P6|Phase 2 Part|Death|4
7556289|NCT02404441|26269946|P5|Phase 2 Part|Death|0
7556290|NCT02404441|26269947|P4|Phase 2 Part|Death|0
7556291|NCT02404441|26269948|P3|Phase 2 Part|Death|0
7556292|NCT02404441|26269949|P2|Phase 2 Part|Death|0
7556293|NCT02404441|26269950|P1|Phase 2 Part|Death|0
7556294|NCT02404441|26269941|P10|Phase 2 Part|Subject/guardian decision|2
7556295|NCT02404441|26269942|P9|Phase 2 Part|Subject/guardian decision|3
7556296|NCT02404441|26269943|P8|Phase 2 Part|Subject/guardian decision|0
7556297|NCT02404441|26269944|P7|Phase 2 Part|Subject/guardian decision|9
7556298|NCT02404441|26269945|P6|Phase 2 Part|Subject/guardian decision|3
7556299|NCT02404441|26269946|P5|Phase 2 Part|Subject/guardian decision|0
7556300|NCT02404441|26269947|P4|Phase 2 Part|Subject/guardian decision|0
7556301|NCT02404441|26269948|P3|Phase 2 Part|Subject/guardian decision|0
7556302|NCT02404441|26269949|P2|Phase 2 Part|Subject/guardian decision|0
7556303|NCT02404441|26269950|P1|Phase 2 Part|Subject/guardian decision|0
7556304|NCT02404441|26269941|P10|Phase 2 Part|Progressive disease|27
7556305|NCT02404441|26269942|P9|Phase 2 Part|Progressive disease|39
7556306|NCT02404441|26269943|P8|Phase 2 Part|Progressive disease|31
7556307|NCT02404441|26269944|P7|Phase 2 Part|Progressive disease|32
7556308|NCT02404441|26269945|P6|Phase 2 Part|Progressive disease|43
7556309|NCT02404441|26269946|P5|Phase 2 Part|Progressive disease|0
7556310|NCT02404441|26269947|P4|Phase 2 Part|Progressive disease|0
7556311|NCT02404441|26269948|P3|Phase 2 Part|Progressive disease|0
7556312|NCT02404441|26269949|P2|Phase 2 Part|Progressive disease|0
7556313|NCT02404441|26269950|P1|Phase 2 Part|Progressive disease|0
7556314|NCT02404441|26269941|P10|Phase 2 Part|Physician Decision|3
7556315|NCT02404441|26269942|P9|Phase 2 Part|Physician Decision|1
7556316|NCT02404441|26269943|P8|Phase 2 Part|Physician Decision|2
7556317|NCT02404441|26269944|P7|Phase 2 Part|Physician Decision|9
7556318|NCT02404441|26269945|P6|Phase 2 Part|Physician Decision|7
7556319|NCT02404441|26269946|P5|Phase 2 Part|Physician Decision|0
7556320|NCT02404441|26269947|P4|Phase 2 Part|Physician Decision|0
7556321|NCT02404441|26269948|P3|Phase 2 Part|Physician Decision|0
7556322|NCT02404441|26269949|P2|Phase 2 Part|Physician Decision|0
7556323|NCT02404441|26269950|P1|Phase 2 Part|Physician Decision|0
7556324|NCT02404441|26269941|P10|Phase 2 Part|Adverse Event|1
7556325|NCT02404441|26269942|P9|Phase 2 Part|Adverse Event|6
7556326|NCT02404441|26269943|P8|Phase 2 Part|Adverse Event|3
7556327|NCT02404441|26269944|P7|Phase 2 Part|Adverse Event|3
7556328|NCT02404441|26269945|P6|Phase 2 Part|Adverse Event|2
7556329|NCT02404441|26269946|P5|Phase 2 Part|Adverse Event|0
7556330|NCT02404441|26269947|P4|Phase 2 Part|Adverse Event|0
7556331|NCT02404441|26269948|P3|Phase 2 Part|Adverse Event|0
7556332|NCT02404441|26269949|P2|Phase 2 Part|Adverse Event|0
7556333|NCT02404441|26269950|P1|Phase 2 Part|Adverse Event|0
7556334|NCT02404441|26269941|P10|Phase 1 Part|Death|0
7556335|NCT02404441|26269942|P9|Phase 1 Part|Death|0
7556336|NCT02404441|26269943|P8|Phase 1 Part|Death|0
7556337|NCT02404441|26269944|P7|Phase 1 Part|Death|0
7556338|NCT02404441|26269945|P6|Phase 1 Part|Death|0
7556339|NCT02404441|26269946|P5|Phase 1 Part|Death|1
7556340|NCT02404441|26269947|P4|Phase 1 Part|Death|0
7556341|NCT02404441|26269948|P3|Phase 1 Part|Death|1
7556342|NCT02404441|26269949|P2|Phase 1 Part|Death|1
7556343|NCT02404441|26269950|P1|Phase 1 Part|Death|1
7556344|NCT02404441|26269941|P10|Phase 1 Part|Subject/Guardian Decision|0
7556345|NCT02404441|26269942|P9|Phase 1 Part|Subject/Guardian Decision|0
7556346|NCT02404441|26269943|P8|Phase 1 Part|Subject/Guardian Decision|0
7556347|NCT02404441|26269944|P7|Phase 1 Part|Subject/Guardian Decision|0
7556348|NCT02404441|26269945|P6|Phase 1 Part|Subject/Guardian Decision|0
7556349|NCT02404441|26269946|P5|Phase 1 Part|Subject/Guardian Decision|0
7556350|NCT02404441|26269947|P4|Phase 1 Part|Subject/Guardian Decision|0
7556351|NCT02404441|26269948|P3|Phase 1 Part|Subject/Guardian Decision|3
7556352|NCT02404441|26269949|P2|Phase 1 Part|Subject/Guardian Decision|2
7556353|NCT02404441|26269950|P1|Phase 1 Part|Subject/Guardian Decision|0
7556354|NCT02404441|26269941|P10|Phase 1 Part|Progressive Disease|0
7556355|NCT02404441|26269942|P9|Phase 1 Part|Progressive Disease|0
7556356|NCT02404441|26269943|P8|Phase 1 Part|Progressive Disease|0
7556357|NCT02404441|26269944|P7|Phase 1 Part|Progressive Disease|0
7556358|NCT02404441|26269945|P6|Phase 1 Part|Progressive Disease|0
7556359|NCT02404441|26269946|P5|Phase 1 Part|Progressive Disease|9
7556360|NCT02404441|26269947|P4|Phase 1 Part|Progressive Disease|6
7556361|NCT02404441|26269948|P3|Phase 1 Part|Progressive Disease|7
7556362|NCT02404441|26269949|P2|Phase 1 Part|Progressive Disease|11
7556363|NCT02404441|26269950|P1|Phase 1 Part|Progressive Disease|14
7556364|NCT02404441|26269941|P10|Phase 1 Part|Physician Decision|0
7556365|NCT02404441|26269942|P9|Phase 1 Part|Physician Decision|0
7556366|NCT02404441|26269943|P8|Phase 1 Part|Physician Decision|0
7556367|NCT02404441|26269944|P7|Phase 1 Part|Physician Decision|0
7556368|NCT02404441|26269945|P6|Phase 1 Part|Physician Decision|0
7556369|NCT02404441|26269946|P5|Phase 1 Part|Physician Decision|0
7556370|NCT02404441|26269947|P4|Phase 1 Part|Physician Decision|0
7556371|NCT02404441|26269948|P3|Phase 1 Part|Physician Decision|0
7556372|NCT02404441|26269949|P2|Phase 1 Part|Physician Decision|1
7556373|NCT02404441|26269950|P1|Phase 1 Part|Physician Decision|0
7556374|NCT02404441|26269941|P10|Phase 1 Part|Adverse Event|0
7556375|NCT02404441|26269942|P9|Phase 1 Part|Adverse Event|0
7556376|NCT02404441|26269943|P8|Phase 1 Part|Adverse Event|0
7556377|NCT02404441|26269944|P7|Phase 1 Part|Adverse Event|0
7556378|NCT02404441|26269945|P6|Phase 1 Part|Adverse Event|0
7556379|NCT02404441|26269946|P5|Phase 1 Part|Adverse Event|0
7556380|NCT02404441|26269947|P4|Phase 1 Part|Adverse Event|0
7556381|NCT02404441|26269948|P3|Phase 1 Part|Adverse Event|0
7556382|NCT02404441|26269949|P2|Phase 1 Part|Adverse Event|0
7556383|NCT02404441|26269950|P1|Phase 1 Part|Adverse Event|1
7556384|NCT02404389|26270127|P5|Overall Study|Subject/guardian decision|1
7556385|NCT02404389|26270128|P4|Overall Study|Subject/guardian decision|1
7556386|NCT02404389|26270129|P3|Overall Study|Subject/guardian decision|0
7556387|NCT02404389|26270130|P2|Overall Study|Subject/guardian decision|0
7556388|NCT02404389|26270131|P1|Overall Study|Subject/guardian decision|1
7556389|NCT02404389|26270127|P5|Overall Study|Adverse Event|2
7556390|NCT02404389|26270128|P4|Overall Study|Adverse Event|0
7556391|NCT02404389|26270129|P3|Overall Study|Adverse Event|1
7556392|NCT02404389|26270130|P2|Overall Study|Adverse Event|0
7556393|NCT02404389|26270131|P1|Overall Study|Adverse Event|1
7556394|NCT02404350|26270171|P4|Overall Study|Due to Technical problems|1
7556395|NCT02404350|26270172|P3|Overall Study|Due to Technical problems|0
7556396|NCT02404350|26270173|P2|Overall Study|Due to Technical problems|0
7556397|NCT02404350|26270174|P1|Overall Study|Due to Technical problems|0
7556398|NCT02404350|26270171|P4|Overall Study|Due to Non-compliance with treatment|1
7556399|NCT02404350|26270172|P3|Overall Study|Due to Non-compliance with treatment|0
7556400|NCT02404350|26270173|P2|Overall Study|Due to Non-compliance with treatment|0
7556401|NCT02404350|26270174|P1|Overall Study|Due to Non-compliance with treatment|0
7556402|NCT02404350|26270171|P4|Overall Study|Withdrawal by Subject|19
7556403|NCT02404350|26270172|P3|Overall Study|Withdrawal by Subject|3
7556404|NCT02404350|26270173|P2|Overall Study|Withdrawal by Subject|3
7556405|NCT02404350|26270174|P1|Overall Study|Withdrawal by Subject|7
7556406|NCT02404350|26270171|P4|Overall Study|Pregnancy|1
7556407|NCT02404350|26270172|P3|Overall Study|Pregnancy|0
7556408|NCT02404350|26270173|P2|Overall Study|Pregnancy|0
7556409|NCT02404350|26270174|P1|Overall Study|Pregnancy|0
7556410|NCT02404350|26270171|P4|Overall Study|Physician Decision|2
7556411|NCT02404350|26270172|P3|Overall Study|Physician Decision|0
7556412|NCT02404350|26270173|P2|Overall Study|Physician Decision|0
7556413|NCT02404350|26270174|P1|Overall Study|Physician Decision|1
7556414|NCT02404350|26270171|P4|Overall Study|Lost to Follow-up|1
7556415|NCT02404350|26270172|P3|Overall Study|Lost to Follow-up|0
7556416|NCT02404350|26270173|P2|Overall Study|Lost to Follow-up|0
7556417|NCT02404350|26270174|P1|Overall Study|Lost to Follow-up|2
7556418|NCT02404350|26270171|P4|Overall Study|Lack of Efficacy|3
7556419|NCT02404350|26270172|P3|Overall Study|Lack of Efficacy|0
7556420|NCT02404350|26270173|P2|Overall Study|Lack of Efficacy|1
7556421|NCT02404350|26270174|P1|Overall Study|Lack of Efficacy|3
7556422|NCT02404350|26270171|P4|Overall Study|Adverse Event|9
7556423|NCT02404350|26270172|P3|Overall Study|Adverse Event|3
7556424|NCT02404350|26270173|P2|Overall Study|Adverse Event|2
7556425|NCT02404350|26270174|P1|Overall Study|Adverse Event|2
7556426|NCT02404311|26270222|P5|Part A: Month 0-18|Participant unable to adhere|0
7556427|NCT02404311|26270223|P4|Part A: Month 0-18|Participant unable to adhere|0
7556428|NCT02404311|26270224|P3|Part A: Month 0-18|Participant unable to adhere|0
7556429|NCT02404311|26270225|P2|Part A: Month 0-18|Participant unable to adhere|0
7556430|NCT02404311|26270226|P1|Part A: Month 0-18|Participant unable to adhere|7
7556431|NCT02404311|26270222|P5|Part A: Month 0-18|HIV Infection|0
7556432|NCT02404311|26270223|P4|Part A: Month 0-18|HIV Infection|0
7556433|NCT02404311|26270224|P3|Part A: Month 0-18|HIV Infection|0
7556434|NCT02404311|26270225|P2|Part A: Month 0-18|HIV Infection|2
7556435|NCT02404311|26270226|P1|Part A: Month 0-18|HIV Infection|6
7556436|NCT02404311|26270222|P5|Part A: Month 0-18|Withdrawal by Subject|0
7556437|NCT02404311|26270223|P4|Part A: Month 0-18|Withdrawal by Subject|0
7556438|NCT02404311|26270224|P3|Part A: Month 0-18|Withdrawal by Subject|0
7556439|NCT02404311|26270225|P2|Part A: Month 0-18|Withdrawal by Subject|2
7556440|NCT02404311|26270226|P1|Part A: Month 0-18|Withdrawal by Subject|6
7556441|NCT02404311|26270222|P5|Part A: Month 0-18|Lost to Follow-up|0
7556442|NCT02404311|26270223|P4|Part A: Month 0-18|Lost to Follow-up|0
7556443|NCT02404311|26270224|P3|Part A: Month 0-18|Lost to Follow-up|0
7556444|NCT02404311|26270225|P2|Part A: Month 0-18|Lost to Follow-up|2
7556445|NCT02404311|26270226|P1|Part A: Month 0-18|Lost to Follow-up|4
7556446|NCT02404311|26270222|P5|Part A: Month 0-18|Physician Decision|0
7556447|NCT02404311|26270223|P4|Part A: Month 0-18|Physician Decision|0
7556448|NCT02404311|26270224|P3|Part A: Month 0-18|Physician Decision|0
7556449|NCT02404311|26270225|P2|Part A: Month 0-18|Physician Decision|0
7556450|NCT02404311|26270226|P1|Part A: Month 0-18|Physician Decision|1
7556451|NCT02404311|26270222|P5|Part A: Month 0-18|Death|0
7556452|NCT02404311|26270223|P4|Part A: Month 0-18|Death|0
7556453|NCT02404311|26270224|P3|Part A: Month 0-18|Death|0
7556454|NCT02404311|26270225|P2|Part A: Month 0-18|Death|0
7556455|NCT02404311|26270226|P1|Part A: Month 0-18|Death|2
7556456|NCT02404220|26270367|P4|Overall Study|Enrolled but Never Treated|0
7556457|NCT02404220|26270368|P3|Overall Study|Enrolled but Never Treated|0
7556458|NCT02404220|26270369|P2|Overall Study|Enrolled but Never Treated|2
7556459|NCT02404220|26270370|P1|Overall Study|Enrolled but Never Treated|0
7556460|NCT02404220|26270367|P4|Overall Study|Withdrawal by Subject|0
7556461|NCT02404220|26270368|P3|Overall Study|Withdrawal by Subject|0
7556462|NCT02404220|26270369|P2|Overall Study|Withdrawal by Subject|1
7556463|NCT02404220|26270370|P1|Overall Study|Withdrawal by Subject|0
7556464|NCT02404220|26270367|P4|Overall Study|Study Terminated by Sponsor|1
7556465|NCT02404220|26270368|P3|Overall Study|Study Terminated by Sponsor|2
7556466|NCT02404220|26270369|P2|Overall Study|Study Terminated by Sponsor|0
7556467|NCT02404220|26270370|P1|Overall Study|Study Terminated by Sponsor|0
7556468|NCT02404220|26270367|P4|Overall Study|Progressive Disease|1
7556469|NCT02404220|26270368|P3|Overall Study|Progressive Disease|1
7556470|NCT02404220|26270369|P2|Overall Study|Progressive Disease|0
7556471|NCT02404220|26270370|P1|Overall Study|Progressive Disease|0
7556472|NCT02404220|26270367|P4|Overall Study|Death|8
7556473|NCT02404220|26270368|P3|Overall Study|Death|3
7556474|NCT02404220|26270369|P2|Overall Study|Death|5
7556475|NCT02404220|26270370|P1|Overall Study|Death|5
7556476|NCT02404220|26270367|P4|Overall Study|Adverse Event|0
7556477|NCT02404220|26270368|P3|Overall Study|Adverse Event|1
7556478|NCT02404220|26270369|P2|Overall Study|Adverse Event|0
7556479|NCT02404220|26270370|P1|Overall Study|Adverse Event|0
7556480|NCT02404103|26270406|P2|Overall Study|Lost to Follow-up|3
7556481|NCT02404103|26270407|P1|Overall Study|Lost to Follow-up|3
7556482|NCT02404103|26270406|P2|Overall Study|Adverse Event|0
7556483|NCT02404103|26270407|P1|Overall Study|Adverse Event|1
7556484|NCT02404025|26270427|P1|Overall Study|Lack of Efficacy|3
7556485|NCT02404025|26270427|P1|Overall Study|Adverse Event|1
7556486|NCT02403817|26270509|P2|Overall Study|Withdrawal by Subject|0
7556487|NCT02403817|26270510|P1|Overall Study|Withdrawal by Subject|5
7556488|NCT02403674|26270541|P2|Overall Study|Protocol Violation|2
7556489|NCT02403674|26270542|P1|Overall Study|Protocol Violation|4
7556490|NCT02403674|26270541|P2|Overall Study|Pregnancy|1
7556491|NCT02403674|26270542|P1|Overall Study|Pregnancy|1
7556492|NCT02403674|26270541|P2|Overall Study|Not treated with study drug|2
7556493|NCT02403674|26270542|P1|Overall Study|Not treated with study drug|4
7556494|NCT02403674|26270541|P2|Overall Study|Physician Decision|2
7556495|NCT02403674|26270542|P1|Overall Study|Physician Decision|2
7556496|NCT02403674|26270541|P2|Overall Study|Withdrawal by Subject|11
7556497|NCT02403674|26270542|P1|Overall Study|Withdrawal by Subject|8
7556498|NCT02403674|26270541|P2|Overall Study|Noncompliance with study drug|2
7556499|NCT02403674|26270542|P1|Overall Study|Noncompliance with study drug|1
7556500|NCT02403674|26270541|P2|Overall Study|Lost to Follow-up|7
7556501|NCT02403674|26270542|P1|Overall Study|Lost to Follow-up|6
7556502|NCT02403674|26270541|P2|Overall Study|Lack of Efficacy|10
7556503|NCT02403674|26270542|P1|Overall Study|Lack of Efficacy|18
7556504|NCT02403674|26270541|P2|Overall Study|Death|3
7556505|NCT02403674|26270542|P1|Overall Study|Death|1
7556506|NCT02403674|26270541|P2|Overall Study|Adverse Event|23
7556507|NCT02403674|26270542|P1|Overall Study|Adverse Event|10
7556508|NCT02403635|26270581|P1|Overall Study|Not eligible|9
7556509|NCT02403271|26270663|P2|Period 2|Other varied reasons|10
7556510|NCT02403271|26270664|P1|Period 2|Other varied reasons|0
7556511|NCT02403271|26270663|P2|Period 2|Study Terminated by Sponsor|14
7556512|NCT02403271|26270664|P1|Period 2|Study Terminated by Sponsor|0
7556513|NCT02403271|26270663|P2|Period 2|Lost to Follow-up|2
7556514|NCT02403271|26270664|P1|Period 2|Lost to Follow-up|0
7556515|NCT02403271|26270663|P2|Period 2|Death|84
7556516|NCT02403271|26270664|P1|Period 2|Death|0
7556517|NCT02403271|26270663|P2|Period 2|Withdrawal by Subject|14
7556518|NCT02403271|26270664|P1|Period 2|Withdrawal by Subject|0
7556519|NCT02403271|26270663|P2|Period 1|Other varied reasons|0
7556520|NCT02403271|26270664|P1|Period 1|Other varied reasons|1
7556521|NCT02403206|26270678|P2|Overall Study|Reason not given|4
7556522|NCT02403206|26270679|P1|Overall Study|Reason not given|2
7556523|NCT02403206|26270678|P2|Overall Study|Withdrawal by Subject|3
7556524|NCT02403206|26270679|P1|Overall Study|Withdrawal by Subject|3
7556525|NCT02403206|26270678|P2|Overall Study|Physician Decision|0
7556526|NCT02403206|26270679|P1|Overall Study|Physician Decision|2
7556527|NCT02403206|26270678|P2|Overall Study|Lost to Follow-up|3
7556528|NCT02403206|26270679|P1|Overall Study|Lost to Follow-up|4
7556529|NCT02403180|26270690|P2|Period 2 (5 Days)|Withdrawal by Subject|1
7556530|NCT02403180|26270691|P1|Period 2 (5 Days)|Withdrawal by Subject|0
7556531|NCT02403180|26270690|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
7556532|NCT02403180|26270691|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
7556533|NCT02402933|26270720|P1|Overall Study|Discontinued; Site Termination|10
7556534|NCT02402933|26270720|P1|Overall Study|Withdrawal by Subject|4
7556535|NCT02402907|26270729|P2|Overall Study|Lost to follow up after C-Section|23
7556536|NCT02402907|26270730|P1|Overall Study|Lost to follow up after C-Section|10
7556537|NCT02402907|26270729|P2|Overall Study|Delivered outside of Sinai|1
7556538|NCT02402907|26270730|P1|Overall Study|Delivered outside of Sinai|1
7556539|NCT02402907|26270729|P2|Overall Study|Delivered vaginally|3
7556540|NCT02402907|26270730|P1|Overall Study|Delivered vaginally|9
7556541|NCT02402322|26270785|P3|Follow-up|Withdrawal by Subject|24
7556542|NCT02402322|26270786|P2|Follow-up|Withdrawal by Subject|3
7556543|NCT02402322|26270787|P1|Follow-up|Withdrawal by Subject|6
7556544|NCT02402322|26270785|P3|Pretreatment|Withdrawal by Subject|1
7556545|NCT02402322|26270786|P2|Pretreatment|Withdrawal by Subject|1
7556546|NCT02402322|26270787|P1|Pretreatment|Withdrawal by Subject|3
7556547|NCT02402218|26270837|P3|Overall Study|Withdrawal by Subject|1
7556548|NCT02402218|26270838|P2|Overall Study|Withdrawal by Subject|1
7556549|NCT02402218|26270839|P1|Overall Study|Withdrawal by Subject|1
7556550|NCT02402218|26270837|P3|Overall Study|Adverse Event|1
7556551|NCT02402218|26270838|P2|Overall Study|Adverse Event|2
7556552|NCT02402218|26270839|P1|Overall Study|Adverse Event|0
7556553|NCT02402218|26270837|P3|Overall Study|Reinfection|1
7556554|NCT02402218|26270838|P2|Overall Study|Reinfection|0
7556555|NCT02402218|26270839|P1|Overall Study|Reinfection|0
7556556|NCT02402218|26270837|P3|Overall Study|Death|0
7556557|NCT02402218|26270838|P2|Overall Study|Death|0
7556558|NCT02402218|26270839|P1|Overall Study|Death|1
7556559|NCT02402218|26270837|P3|Overall Study|Lack of Efficacy|1
7556560|NCT02402218|26270838|P2|Overall Study|Lack of Efficacy|1
7556561|NCT02402218|26270839|P1|Overall Study|Lack of Efficacy|0
7556562|NCT02402218|26270837|P3|Overall Study|Did not pickup study medication|13
7556563|NCT02402218|26270838|P2|Overall Study|Did not pickup study medication|9
7556564|NCT02402218|26270839|P1|Overall Study|Did not pickup study medication|12
7556565|NCT02402166|26270862|P1|Overall Study|Lost to Follow-up|1
7556566|NCT02402166|26270862|P1|Overall Study|Withdrawal by Subject|2
7556567|NCT02402166|26270862|P1|Overall Study|Adverse Event|2
7556656|NCT02398188|26271483|P2|Overall Study|Pregnancy|0
7556568|NCT02401867|26270929|P1|Analysis|Cervical assay could not be conducted|9
7556569|NCT02401867|26270929|P1|Specimen Collection|Didn't receive 1 or more tests|10
7556570|NCT02401672|26270936|P2|Overall Study|Withdrawal by Subject|3
7556571|NCT02401672|26270937|P1|Overall Study|Withdrawal by Subject|1
7556572|NCT02401529|26270979|P2|Overall Study|Protocol Violation|0
7556573|NCT02401529|26270980|P1|Overall Study|Protocol Violation|5
7556574|NCT02401529|26270979|P2|Overall Study|Physician Decision|6
7556575|NCT02401529|26270980|P1|Overall Study|Physician Decision|2
7556576|NCT02401529|26270979|P2|Overall Study|Lost to Follow-up|1
7556577|NCT02401529|26270980|P1|Overall Study|Lost to Follow-up|2
7556578|NCT02401412|26271047|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
7556579|NCT02401412|26271048|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
7556580|NCT02401412|26271047|P2|Overall Study|Subject withdrawal prior to intervention|1
7556581|NCT02401412|26271048|P1|Overall Study|Subject withdrawal prior to intervention|0
7556582|NCT02401412|26271047|P2|Overall Study|Withdrawal by Subject|4
7556583|NCT02401412|26271048|P1|Overall Study|Withdrawal by Subject|4
7556584|NCT02401412|26271047|P2|Overall Study|Discontinued Intervention|21
7556585|NCT02401412|26271048|P1|Overall Study|Discontinued Intervention|15
7556586|NCT02401412|26271047|P2|Overall Study|Lost to Follow-up|0
7556587|NCT02401412|26271048|P1|Overall Study|Lost to Follow-up|1
7556588|NCT02401256|26271056|P1|Overall Study|Withdrawal by Subject|12
7556589|NCT02401256|26271056|P1|Overall Study|Adverse Event|5
7556590|NCT02401230|26271065|P3|Overall Study|Lost to Follow-up|3
7556591|NCT02401230|26271066|P2|Overall Study|Lost to Follow-up|3
7556592|NCT02401230|26271067|P1|Overall Study|Lost to Follow-up|1
7556593|NCT02401230|26271065|P3|Overall Study|Withdrawal by Subject|1
7556594|NCT02401230|26271066|P2|Overall Study|Withdrawal by Subject|1
7556595|NCT02401230|26271067|P1|Overall Study|Withdrawal by Subject|2
7556596|NCT02401230|26271065|P3|Overall Study|Adverse Event|0
7556597|NCT02401230|26271066|P2|Overall Study|Adverse Event|2
7556598|NCT02401230|26271067|P1|Overall Study|Adverse Event|3
7556599|NCT02400905|26271146|P1|Overall Study|Other|1
7556600|NCT02400905|26271146|P1|Overall Study|Physician Decision|4
7556601|NCT02400905|26271146|P1|Overall Study|Withdrawal by Subject|16
7556602|NCT02400905|26271146|P1|Overall Study|Lost to Follow-up|18
7556603|NCT02400905|26271146|P1|Overall Study|Death|24
7556604|NCT02400749|26271163|P2|Week 17 - 32|Adverse Event|1
7556605|NCT02400749|26271164|P1|Week 17 - 32|Adverse Event|2
7556606|NCT02400749|26271163|P2|Week 17 - 32|Withdrawal by Subject|2
7556607|NCT02400749|26271164|P1|Week 17 - 32|Withdrawal by Subject|3
7556608|NCT02400749|26271163|P2|Week 0 -16|Protocol Violation|0
7556609|NCT02400749|26271164|P1|Week 0 -16|Protocol Violation|1
7556610|NCT02400749|26271163|P2|Week 0 -16|Lost to Follow-up|0
7556611|NCT02400749|26271164|P1|Week 0 -16|Lost to Follow-up|2
7556612|NCT02400749|26271163|P2|Week 0 -16|Adverse Event|1
7556613|NCT02400749|26271164|P1|Week 0 -16|Adverse Event|3
7556614|NCT02400749|26271163|P2|Week 0 -16|Withdrawal by Subject|5
7556615|NCT02400749|26271164|P1|Week 0 -16|Withdrawal by Subject|5
7556616|NCT02400736|26271180|P2|Overall Study|Moved from the area|1
7556617|NCT02400736|26271181|P1|Overall Study|Moved from the area|3
7556618|NCT02400736|26271180|P2|Overall Study|Withdrawal by Subject|1
7556619|NCT02400736|26271181|P1|Overall Study|Withdrawal by Subject|2
7556620|NCT02400736|26271180|P2|Overall Study|Lost to Follow-up|6
7556621|NCT02400736|26271181|P1|Overall Study|Lost to Follow-up|6
7556622|NCT02400580|26271218|P2|Overall Study|Adverse Event|0
7556623|NCT02400580|26271219|P1|Overall Study|Adverse Event|1
7556624|NCT02400580|26271218|P2|Overall Study|Withdrawal by Subject|1
7556625|NCT02400580|26271219|P1|Overall Study|Withdrawal by Subject|1
7556626|NCT02400346|26271254|P1|Overall Study|Lost to Follow-up|1
7556627|NCT02400346|26271254|P1|Overall Study|Administrative or other reason(s)|2
7556628|NCT02400346|26271254|P1|Overall Study|Withdrawal by Subject|7
7556629|NCT02400346|26271254|P1|Overall Study|Non-compliance with IMP|1
7556630|NCT02400346|26271254|P1|Overall Study|Lack of Efficacy|9
7556631|NCT02400346|26271254|P1|Overall Study|Adverse Event|24
7556632|NCT02400333|26271262|P4|Overall Study|Protocol Violation|1
7556633|NCT02400333|26271263|P3|Overall Study|Protocol Violation|2
7556634|NCT02400333|26271264|P2|Overall Study|Protocol Violation|0
7556635|NCT02400333|26271265|P1|Overall Study|Protocol Violation|1
7556636|NCT02400333|26271262|P4|Overall Study|Withdrawal by Subject|1
7556637|NCT02400333|26271263|P3|Overall Study|Withdrawal by Subject|0
7556638|NCT02400333|26271264|P2|Overall Study|Withdrawal by Subject|1
7556639|NCT02400333|26271265|P1|Overall Study|Withdrawal by Subject|0
7556640|NCT02400307|26271325|P2|Overall Study|Enrolled and Never Dosed|0
7556641|NCT02400307|26271326|P1|Overall Study|Enrolled and Never Dosed|1
7556642|NCT02399475|26271376|P2|Overall Study|Physician Decision|0
7556643|NCT02399475|26271377|P1|Overall Study|Physician Decision|1
7556644|NCT02399254|26271395|P1|Overall Study|Physician Decision|2
7556645|NCT02399163|26271402|P1|Overall Study|Withdrawal by Participant|5
7556646|NCT02399163|26271402|P1|Overall Study|Protocol Deviation|2
7556647|NCT02399163|26271402|P1|Overall Study|Adverse Event|2
7556648|NCT02398227|26271472|P2|Overall Study|Removed from treatment and dropped out|0
7556649|NCT02398227|26271473|P1|Overall Study|Removed from treatment and dropped out|1
7556650|NCT02398227|26271472|P2|Overall Study|Withdrawal by Subject|6
7556651|NCT02398227|26271473|P1|Overall Study|Withdrawal by Subject|5
7556652|NCT02398227|26271472|P2|Overall Study|Lost to Follow-up|12
7556653|NCT02398227|26271473|P1|Overall Study|Lost to Follow-up|21
7556654|NCT02398188|26271483|P2|Overall Study|Withdrawal by Subject|16
7556655|NCT02398188|26271484|P1|Overall Study|Withdrawal by Subject|7
7556657|NCT02398188|26271484|P1|Overall Study|Pregnancy|1
7556658|NCT02398188|26271483|P2|Overall Study|Sponsor Decision|1
7556659|NCT02398188|26271484|P1|Overall Study|Sponsor Decision|2
7556660|NCT02398188|26271483|P2|Overall Study|Protocol Violation|10
7556661|NCT02398188|26271484|P1|Overall Study|Protocol Violation|6
7556662|NCT02398188|26271483|P2|Overall Study|Non-compliance|4
7556663|NCT02398188|26271484|P1|Overall Study|Non-compliance|4
7556664|NCT02398188|26271483|P2|Overall Study|Lost to Follow-up|0
7556665|NCT02398188|26271484|P1|Overall Study|Lost to Follow-up|5
7556666|NCT02398188|26271483|P2|Overall Study|Adverse Event|3
7556667|NCT02398188|26271484|P1|Overall Study|Adverse Event|2
7556668|NCT02397915|26271502|P4|Period 1|Physician Decision|0
7556669|NCT02397915|26271503|P3|Period 1|Physician Decision|0
7556670|NCT02397915|26271504|P2|Period 1|Physician Decision|0
7556671|NCT02397915|26271505|P1|Period 1|Physician Decision|1
7556672|NCT02397915|26271502|P4|Period 1|Protocol Violation|0
7556673|NCT02397915|26271503|P3|Period 1|Protocol Violation|0
7556674|NCT02397915|26271504|P2|Period 1|Protocol Violation|1
7556675|NCT02397915|26271505|P1|Period 1|Protocol Violation|0
7556676|NCT02397889|26271557|P2|Overall Study|Physician Decision|0
7556677|NCT02397889|26271558|P1|Overall Study|Physician Decision|1
7556678|NCT02397837|26271576|P2|Overall Study|Physician Decision|1
7556679|NCT02397837|26271577|P1|Overall Study|Physician Decision|1
7556680|NCT02397837|26271576|P2|Overall Study|Withdrawal by Subject|5
7556681|NCT02397837|26271577|P1|Overall Study|Withdrawal by Subject|6
7556682|NCT02397694|26271672|P2|Open Label Extension Phase|Lost to Follow-up|0
7556683|NCT02397694|26271673|P1|Open Label Extension Phase|Lost to Follow-up|4
7556684|NCT02397694|26271672|P2|Open Label Extension Phase|Withdrew Consent|1
7556685|NCT02397694|26271673|P1|Open Label Extension Phase|Withdrew Consent|3
7556686|NCT02397694|26271672|P2|Open Label Extension Phase|Protocol Violation|0
7556687|NCT02397694|26271673|P1|Open Label Extension Phase|Protocol Violation|1
7556688|NCT02397694|26271672|P2|Double-Blinded Phase|Lost to Follow-up|1
7556689|NCT02397694|26271673|P1|Double-Blinded Phase|Lost to Follow-up|1
7556690|NCT02397694|26271672|P2|Double-Blinded Phase|Withdrawal by Subject|0
7556691|NCT02397694|26271673|P1|Double-Blinded Phase|Withdrawal by Subject|1
7556692|NCT02397694|26271672|P2|Double-Blinded Phase|Non-compliance with study drug|2
7556693|NCT02397694|26271673|P1|Double-Blinded Phase|Non-compliance with study drug|0
7556694|NCT02397694|26271672|P2|Double-Blinded Phase|Adverse Event|0
7556695|NCT02397694|26271673|P1|Double-Blinded Phase|Adverse Event|1
7556696|NCT02397655|26271711|P1|Overall Study|data not completed|1301
7556697|NCT02397473|26271722|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7556698|NCT02397473|26271723|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7556699|NCT02397473|26271722|P2|Post Treatment Follow-up Phase|Protocol Violation|0
7556700|NCT02397473|26271723|P1|Post Treatment Follow-up Phase|Protocol Violation|1
7556701|NCT02397473|26271722|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
7556702|NCT02397473|26271723|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
7556703|NCT02397473|26271722|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
7556704|NCT02397473|26271723|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
7556705|NCT02397473|26271722|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
7556706|NCT02397473|26271723|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
7556707|NCT02397473|26271722|P2|Treatment Phase|Withdrawal by Subject|1
7556708|NCT02397473|26271723|P1|Treatment Phase|Withdrawal by Subject|2
7556709|NCT02397473|26271722|P2|Treatment Phase|Lost to Follow-up|0
7556710|NCT02397473|26271723|P1|Treatment Phase|Lost to Follow-up|1
7556711|NCT02397473|26271722|P2|Treatment Phase|Lack of Efficacy|1
7556712|NCT02397473|26271723|P1|Treatment Phase|Lack of Efficacy|8
7556713|NCT02397473|26271722|P2|Treatment Phase|Adverse Event|2
7556714|NCT02397473|26271723|P1|Treatment Phase|Adverse Event|1
7556715|NCT02397460|26271759|P8|Treatment Period 4|Physician Decision|0
7556716|NCT02397460|26271760|P7|Treatment Period 4|Physician Decision|0
7556717|NCT02397460|26271761|P6|Treatment Period 4|Physician Decision|0
7556718|NCT02397460|26271762|P5|Treatment Period 4|Physician Decision|1
7556719|NCT02397460|26271763|P4|Treatment Period 4|Physician Decision|0
7556720|NCT02397460|26271764|P3|Treatment Period 4|Physician Decision|0
7556721|NCT02397460|26271765|P2|Treatment Period 4|Physician Decision|0
7556722|NCT02397460|26271766|P1|Treatment Period 4|Physician Decision|0
7556723|NCT02397460|26271759|P8|Treatment Period 4|Adverse Event|0
7556724|NCT02397460|26271760|P7|Treatment Period 4|Adverse Event|0
7556725|NCT02397460|26271761|P6|Treatment Period 4|Adverse Event|0
7556726|NCT02397460|26271762|P5|Treatment Period 4|Adverse Event|0
7556727|NCT02397460|26271763|P4|Treatment Period 4|Adverse Event|0
7556728|NCT02397460|26271764|P3|Treatment Period 4|Adverse Event|0
7556729|NCT02397460|26271765|P2|Treatment Period 4|Adverse Event|1
7556730|NCT02397460|26271766|P1|Treatment Period 4|Adverse Event|0
7556731|NCT02397460|26271759|P8|Treatment Period 2|Adverse Event|1
7556732|NCT02397460|26271760|P7|Treatment Period 2|Adverse Event|0
7556733|NCT02397460|26271761|P6|Treatment Period 2|Adverse Event|0
7556734|NCT02397460|26271762|P5|Treatment Period 2|Adverse Event|0
7556735|NCT02397460|26271763|P4|Treatment Period 2|Adverse Event|0
7556736|NCT02397460|26271764|P3|Treatment Period 2|Adverse Event|0
7556737|NCT02397460|26271765|P2|Treatment Period 2|Adverse Event|0
7556738|NCT02397460|26271766|P1|Treatment Period 2|Adverse Event|0
7556739|NCT02397447|26271886|P2|Overall Study|Lost to Follow-up|2
7556740|NCT02397447|26271887|P1|Overall Study|Lost to Follow-up|2
7556741|NCT02397408|26271933|P1|Overall Study|Surgery not completed within protocol timeframe|2
7556742|NCT02397408|26271933|P1|Overall Study|Physician Decision|4
7556743|NCT02397278|26271953|P2|Overall Study|Deemed ineligible following surgery|1
7556744|NCT02397278|26271954|P1|Overall Study|Deemed ineligible following surgery|1
7556745|NCT02397278|26271953|P2|Overall Study|Withdrawal by Subject|2
7556746|NCT02397278|26271954|P1|Overall Study|Withdrawal by Subject|0
7556747|NCT02397096|26271999|P2|Study Extensions|Ongoing|202
7556748|NCT02397096|26272000|P1|Study Extensions|Ongoing|399
7556749|NCT02397096|26271999|P2|Week 24 to Week 48|Lost to Follow-up|0
7556750|NCT02397096|26272000|P1|Week 24 to Week 48|Lost to Follow-up|2
7556751|NCT02397096|26271999|P2|Week 24 to Week 48|Withdrawal by Subject|2
7556752|NCT02397096|26272000|P1|Week 24 to Week 48|Withdrawal by Subject|5
7556753|NCT02397096|26271999|P2|Week 24 to Week 48|Physician Decision|1
7556754|NCT02397096|26272000|P1|Week 24 to Week 48|Physician Decision|2
7556755|NCT02397096|26271999|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
7556756|NCT02397096|26272000|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
7556757|NCT02397096|26271999|P2|Week 24 to Week 48|Lack of Efficacy|1
7556758|NCT02397096|26272000|P1|Week 24 to Week 48|Lack of Efficacy|5
7556759|NCT02397096|26271999|P2|Week 24 to Week 48|Adverse Event|2
7556760|NCT02397096|26272000|P1|Week 24 to Week 48|Adverse Event|6
7556761|NCT02397096|26271999|P2|Day 1 to Week 24|Withdrawal by Subject|1
7556762|NCT02397096|26272000|P1|Day 1 to Week 24|Withdrawal by Subject|6
7556763|NCT02397096|26271999|P2|Day 1 to Week 24|Protocol Violation|4
7556764|NCT02397096|26272000|P1|Day 1 to Week 24|Protocol Violation|1
7556765|NCT02397096|26271999|P2|Day 1 to Week 24|Physician Decision|3
7556766|NCT02397096|26272000|P1|Day 1 to Week 24|Physician Decision|2
7556767|NCT02397096|26271999|P2|Day 1 to Week 24|Lost to Follow-up|4
7556768|NCT02397096|26272000|P1|Day 1 to Week 24|Lost to Follow-up|3
7556769|NCT02397096|26271999|P2|Day 1 to Week 24|Lack of Efficacy|1
7556770|NCT02397096|26272000|P1|Day 1 to Week 24|Lack of Efficacy|0
7556771|NCT02397096|26271999|P2|Day 1 to Week 24|Death|0
7556772|NCT02397096|26272000|P1|Day 1 to Week 24|Death|1
7556773|NCT02397096|26271999|P2|Day 1 to Week 24|Adverse Event|1
7556774|NCT02397096|26272000|P1|Day 1 to Week 24|Adverse Event|7
7556775|NCT02397057|26272032|P2|Overall Study|Subject did not receive study drug|1
7556776|NCT02397057|26272033|P1|Overall Study|Subject did not receive study drug|0
7556777|NCT02397057|26272032|P2|Overall Study|Physician Decision|1
7556778|NCT02397057|26272033|P1|Overall Study|Physician Decision|0
7556779|NCT02397057|26272032|P2|Overall Study|Adverse Event|1
7556780|NCT02397057|26272033|P1|Overall Study|Adverse Event|0
7556781|NCT02397057|26272032|P2|Overall Study|Death|0
7556782|NCT02397057|26272033|P1|Overall Study|Death|1
7556783|NCT02397057|26272032|P2|Overall Study|Lost to Follow-up|3
7556784|NCT02397057|26272033|P1|Overall Study|Lost to Follow-up|4
7556785|NCT02397057|26272032|P2|Overall Study|Withdrawal by Subject|7
7556786|NCT02397057|26272033|P1|Overall Study|Withdrawal by Subject|6
7556787|NCT02396953|26272054|P3|Overall Study|Personal Reasons|0
7556788|NCT02396953|26272055|P2|Overall Study|Personal Reasons|1
7556789|NCT02396953|26272056|P1|Overall Study|Personal Reasons|1
7556790|NCT02396953|26272054|P3|Overall Study|Insulin like Growth Factor-1 increased|2
7556791|NCT02396953|26272055|P2|Overall Study|Insulin like Growth Factor-1 increased|2
7556792|NCT02396953|26272056|P1|Overall Study|Insulin like Growth Factor-1 increased|3
7556793|NCT02396953|26272054|P3|Overall Study|Withdrawal by Subject|1
7556794|NCT02396953|26272055|P2|Overall Study|Withdrawal by Subject|0
7556795|NCT02396953|26272056|P1|Overall Study|Withdrawal by Subject|0
7556796|NCT02396849|26272108|P2|Overall Study|Did not tolerate intervention|1
7556797|NCT02396849|26272109|P1|Overall Study|Did not tolerate intervention|1
7556798|NCT02396849|26272108|P2|Overall Study|Lost to Follow-up|1
7556799|NCT02396849|26272109|P1|Overall Study|Lost to Follow-up|1
7556800|NCT02396758|26272121|P4|Overall Study|Randomized but not treated|0
7556801|NCT02396758|26272122|P3|Overall Study|Randomized but not treated|1
7556802|NCT02396758|26272123|P2|Overall Study|Randomized but not treated|0
7556803|NCT02396758|26272124|P1|Overall Study|Randomized but not treated|1
7556804|NCT02396758|26272121|P4|Overall Study|Death|1
7556805|NCT02396758|26272122|P3|Overall Study|Death|0
7556806|NCT02396758|26272123|P2|Overall Study|Death|1
7556807|NCT02396758|26272124|P1|Overall Study|Death|1
7556808|NCT02396758|26272121|P4|Overall Study|Lost to Follow-up|3
7556809|NCT02396758|26272122|P3|Overall Study|Lost to Follow-up|3
7556810|NCT02396758|26272123|P2|Overall Study|Lost to Follow-up|5
7556811|NCT02396758|26272124|P1|Overall Study|Lost to Follow-up|8
7556812|NCT02396758|26272121|P4|Overall Study|Withdrawal by Subject|1
7556813|NCT02396758|26272122|P3|Overall Study|Withdrawal by Subject|0
7556814|NCT02396758|26272123|P2|Overall Study|Withdrawal by Subject|0
7556815|NCT02396758|26272124|P1|Overall Study|Withdrawal by Subject|2
7556816|NCT02396537|26272263|P2|Overall Study|Protocol Violation|1
7556817|NCT02396537|26272264|P1|Overall Study|Protocol Violation|0
7556818|NCT02396420|26272276|P1|Overall Study|Death|1
7556819|NCT02396381|26272300|P2|Overall Study|Randomization/Screening Error|1
7556820|NCT02396381|26272301|P1|Overall Study|Randomization/Screening Error|3
7556821|NCT02396381|26272300|P2|Overall Study|Possible conflict of interest|0
7556822|NCT02396381|26272301|P1|Overall Study|Possible conflict of interest|1
7556823|NCT02396381|26272300|P2|Overall Study|Could not complete visit|0
7556824|NCT02396381|26272301|P1|Overall Study|Could not complete visit|1
7556825|NCT02396381|26272300|P2|Overall Study|Moved out of town/state|3
7556826|NCT02396381|26272301|P1|Overall Study|Moved out of town/state|1
7556827|NCT02396381|26272300|P2|Overall Study|Non-compliance with study procedures|0
7556828|NCT02396381|26272301|P1|Overall Study|Non-compliance with study procedures|1
7556829|NCT02396381|26272300|P2|Overall Study|Pregnancy|0
7556830|NCT02396381|26272301|P1|Overall Study|Pregnancy|2
7556831|NCT02396381|26272300|P2|Overall Study|Physician Decision|5
7556832|NCT02396381|26272301|P1|Overall Study|Physician Decision|5
7556833|NCT02396381|26272300|P2|Overall Study|Site terminated by sponsor|8
7556834|NCT02396381|26272301|P1|Overall Study|Site terminated by sponsor|7
7556835|NCT02396381|26272300|P2|Overall Study|Protocol Violation|0
7556836|NCT02396381|26272301|P1|Overall Study|Protocol Violation|1
7556837|NCT02396381|26272300|P2|Overall Study|Lost to Follow-up|31
7556838|NCT02396381|26272301|P1|Overall Study|Lost to Follow-up|49
7556839|NCT02396381|26272300|P2|Overall Study|Withdrawal by Subject|24
7556840|NCT02396381|26272301|P1|Overall Study|Withdrawal by Subject|33
7556841|NCT02396381|26272300|P2|Overall Study|Adverse Event|2
7556842|NCT02396381|26272301|P1|Overall Study|Adverse Event|3
7556843|NCT02396316|26272340|P2|Overall Study|Treatment unblinded|1
7556844|NCT02396316|26272341|P1|Overall Study|Treatment unblinded|0
7556845|NCT02396316|26272340|P2|Overall Study|Protocol Violation|1
7556846|NCT02396316|26272341|P1|Overall Study|Protocol Violation|0
7556847|NCT02396316|26272340|P2|Overall Study|Progressive disease|3
7556848|NCT02396316|26272341|P1|Overall Study|Progressive disease|6
7556849|NCT02396316|26272340|P2|Overall Study|Physician Decision|0
7556850|NCT02396316|26272341|P1|Overall Study|Physician Decision|1
7556851|NCT02396212|26272360|P1|Overall Study|Lack of Efficacy|2
7556852|NCT02396212|26272360|P1|Overall Study|Adverse Event|1
7556853|NCT02395822|26272519|P1|Overall Study|Death|1
7556854|NCT02395822|26272519|P1|Overall Study|Withdrawal by Subject|1
7556855|NCT02395666|26272540|P2|Overall Study|Withdrawal by Subject|1
7556856|NCT02395666|26272541|P1|Overall Study|Withdrawal by Subject|2
7556857|NCT02395666|26272540|P2|Overall Study|Lost to Follow-up|0
7556858|NCT02395666|26272541|P1|Overall Study|Lost to Follow-up|1
7556859|NCT02395666|26272540|P2|Overall Study|Physician Decision|0
7556860|NCT02395666|26272541|P1|Overall Study|Physician Decision|3
7556861|NCT02395653|26272555|P1|Overall Study|Lost to Follow-up|1
7556862|NCT02395653|26272555|P1|Overall Study|Withdrawal by Subject|1
7556863|NCT02395653|26272555|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
7556864|NCT02395653|26272555|P1|Overall Study|Investigator Decision at Screening|1
7556865|NCT02395653|26272555|P1|Overall Study|SSEC Application But With 0 Dose|1
7556866|NCT02395653|26272555|P1|Overall Study|Consent Withdrawn at Screening|1
7556867|NCT02395653|26272555|P1|Overall Study|Exclusion Criteria Met at Screening|4
7556868|NCT02395627|26272565|P3|Overall Study|Did not receive pembrolizumab|0
7556869|NCT02395627|26272566|P2|Overall Study|Did not receive pembrolizumab|1
7556870|NCT02395627|26272567|P1|Overall Study|Did not receive pembrolizumab|3
7556871|NCT02395627|26272565|P3|Overall Study|Withdrawal by Subject|0
7556872|NCT02395627|26272566|P2|Overall Study|Withdrawal by Subject|2
7556873|NCT02395627|26272567|P1|Overall Study|Withdrawal by Subject|0
7556874|NCT02395536|26272595|P2|Overall Study|Insurance issue|1
7556875|NCT02395536|26272596|P1|Overall Study|Insurance issue|0
7556876|NCT02395536|26272595|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
7556877|NCT02395536|26272596|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
7556878|NCT02395536|26272595|P2|Overall Study|Withdrawal by Subject|17
7556879|NCT02395536|26272596|P1|Overall Study|Withdrawal by Subject|9
7556880|NCT02395536|26272595|P2|Overall Study|Physician Decision|6
7556881|NCT02395536|26272596|P1|Overall Study|Physician Decision|4
7556882|NCT02395536|26272595|P2|Overall Study|Death|0
7556883|NCT02395536|26272596|P1|Overall Study|Death|2
7556884|NCT02395536|26272595|P2|Overall Study|Lost to Follow-up|4
7556885|NCT02395536|26272596|P1|Overall Study|Lost to Follow-up|4
7556886|NCT02395471|26272604|P2|Overall Study|Subject not eligible|0
7556887|NCT02395471|26272605|P1|Overall Study|Subject not eligible|1
7556888|NCT02395471|26272604|P2|Overall Study|Patient did not return for procedure|1
7556889|NCT02395471|26272605|P1|Overall Study|Patient did not return for procedure|0
7556890|NCT02395471|26272604|P2|Overall Study|Failure to swollow sponge twice|0
7556891|NCT02395471|26272605|P1|Overall Study|Failure to swollow sponge twice|1
7556892|NCT02395471|26272604|P2|Overall Study|Protocol Violation|1
7556893|NCT02395471|26272605|P1|Overall Study|Protocol Violation|0
7556894|NCT02395471|26272604|P2|Overall Study|Physician Decision|0
7556895|NCT02395471|26272605|P1|Overall Study|Physician Decision|1
7556896|NCT02395471|26272604|P2|Overall Study|Withdrawal by Subject|1
7556897|NCT02395471|26272605|P1|Overall Study|Withdrawal by Subject|2
7556898|NCT02395471|26272604|P2|Overall Study|Lost to Follow-up|0
7556899|NCT02395471|26272605|P1|Overall Study|Lost to Follow-up|2
7556900|NCT02395302|26272620|P1|Overall Study|Physician Decision|2
7556901|NCT02395302|26272620|P1|Overall Study|Withdrawal by Subject|2
7556902|NCT02395302|26272620|P1|Overall Study|Run In Failure|7
7556903|NCT02395302|26272620|P1|Overall Study|Screen Failure|3
7556904|NCT02395172|26272640|P2|Overall Study|Participants randomized but not treated|31
7556905|NCT02395172|26272641|P1|Overall Study|Participants randomized but not treated|3
7556906|NCT02395133|26272680|P4|Overall Study|Other than specified above|4
7556907|NCT02395133|26272681|P3|Overall Study|Other than specified above|2
7556908|NCT02395133|26272682|P2|Overall Study|Other than specified above|2
7556909|NCT02395133|26272683|P1|Overall Study|Other than specified above|5
7556910|NCT02395133|26272680|P4|Overall Study|Sponsor decision|1
7556911|NCT02395133|26272681|P3|Overall Study|Sponsor decision|0
7556912|NCT02395133|26272682|P2|Overall Study|Sponsor decision|0
7556913|NCT02395133|26272683|P1|Overall Study|Sponsor decision|2
7556914|NCT02395133|26272680|P4|Overall Study|Consent withdrawn with personal reason|3
7556915|NCT02395133|26272681|P3|Overall Study|Consent withdrawn with personal reason|0
7556916|NCT02395133|26272682|P2|Overall Study|Consent withdrawn with personal reason|1
7556917|NCT02395133|26272683|P1|Overall Study|Consent withdrawn with personal reason|0
7556918|NCT02395133|26272680|P4|Overall Study|Consent withdrawn with no reason given|2
7556919|NCT02395133|26272681|P3|Overall Study|Consent withdrawn with no reason given|0
7556920|NCT02395133|26272682|P2|Overall Study|Consent withdrawn with no reason given|3
7556921|NCT02395133|26272683|P1|Overall Study|Consent withdrawn with no reason given|1
7556922|NCT02395133|26272680|P4|Overall Study|Pregnancy|0
7556923|NCT02395133|26272681|P3|Overall Study|Pregnancy|3
7556924|NCT02395133|26272682|P2|Overall Study|Pregnancy|0
7556925|NCT02395133|26272683|P1|Overall Study|Pregnancy|0
7556926|NCT02395133|26272680|P4|Overall Study|Lost to Follow-up|0
7556927|NCT02395133|26272681|P3|Overall Study|Lost to Follow-up|1
7556928|NCT02395133|26272682|P2|Overall Study|Lost to Follow-up|1
7556929|NCT02395133|26272683|P1|Overall Study|Lost to Follow-up|0
7556930|NCT02395133|26272680|P4|Overall Study|Protocol Violation|3
7556931|NCT02395133|26272681|P3|Overall Study|Protocol Violation|0
7556932|NCT02395133|26272682|P2|Overall Study|Protocol Violation|1
7556933|NCT02395133|26272683|P1|Overall Study|Protocol Violation|1
7556934|NCT02395133|26272680|P4|Overall Study|Lack of Efficacy|1
7556935|NCT02395133|26272681|P3|Overall Study|Lack of Efficacy|1
7556936|NCT02395133|26272682|P2|Overall Study|Lack of Efficacy|0
7556937|NCT02395133|26272683|P1|Overall Study|Lack of Efficacy|1
7556938|NCT02395133|26272680|P4|Overall Study|Adverse Event|0
7556939|NCT02395133|26272681|P3|Overall Study|Adverse Event|3
7556940|NCT02395133|26272682|P2|Overall Study|Adverse Event|1
7556941|NCT02395133|26272683|P1|Overall Study|Adverse Event|4
7556942|NCT02395081|26272772|P3|Overall Study|Fetal Loss|1
7556943|NCT02395081|26272773|P2|Overall Study|Fetal Loss|3
7556944|NCT02395081|26272774|P1|Overall Study|Fetal Loss|2
7556945|NCT02395081|26272772|P3|Overall Study|Moved where blood couldn't be collected|3
7556946|NCT02395081|26272773|P2|Overall Study|Moved where blood couldn't be collected|1
7556947|NCT02395081|26272774|P1|Overall Study|Moved where blood couldn't be collected|4
7556948|NCT02395081|26272772|P3|Overall Study|Withdrawal by Subject|0
7556949|NCT02395081|26272773|P2|Overall Study|Withdrawal by Subject|1
7556950|NCT02395081|26272774|P1|Overall Study|Withdrawal by Subject|1
7556951|NCT02395055|26272820|P2|Overall Study|Withdrawal by Subject|3
7556952|NCT02395055|26272821|P1|Overall Study|Withdrawal by Subject|7
7556953|NCT02395042|26272834|P3|Treatment 2 Period|Lack of Efficacy|0
7556954|NCT02395042|26272835|P2|Treatment 2 Period|Lack of Efficacy|1
7556955|NCT02395042|26272836|P1|Treatment 2 Period|Lack of Efficacy|1
7556956|NCT02395042|26272834|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
7556957|NCT02395042|26272835|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
7556958|NCT02395042|26272836|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
7556959|NCT02395042|26272834|P3|Treatment 1 Period|Lost to Follow-up|0
7556960|NCT02395042|26272835|P2|Treatment 1 Period|Lost to Follow-up|0
7556961|NCT02395042|26272836|P1|Treatment 1 Period|Lost to Follow-up|1
7556962|NCT02395042|26272834|P3|Treatment 1 Period|Lack of Efficacy|0
7556963|NCT02395042|26272835|P2|Treatment 1 Period|Lack of Efficacy|1
7556964|NCT02395042|26272836|P1|Treatment 1 Period|Lack of Efficacy|1
7556965|NCT02395042|26272834|P3|Treatment 1 Period|Adverse Event|1
7556966|NCT02395042|26272835|P2|Treatment 1 Period|Adverse Event|3
7556967|NCT02395042|26272836|P1|Treatment 1 Period|Adverse Event|1
7556968|NCT02394925|26272874|P1|Overall Study|Unsatisfactory Visual Response|5
7556969|NCT02394925|26272874|P1|Overall Study|No longer meet eligibility criteria|1
7556970|NCT02394925|26272874|P1|Overall Study|Protocol Violation|5
7556971|NCT02394925|26272874|P1|Overall Study|Lost to Follow-up|9
7556972|NCT02394925|26272874|P1|Overall Study|Lens handling difficulities|5
7556973|NCT02394925|26272874|P1|Overall Study|Lens Discomfort|3
7556974|NCT02394925|26272874|P1|Overall Study|Adverse Event|1
7556975|NCT02394808|26272884|P2|Period 2|Lost to Follow-up|0
7556976|NCT02394808|26272885|P1|Period 2|Lost to Follow-up|1
7556977|NCT02394808|26272884|P2|Period 1|Unsatisfactory lens fitting|1
7556978|NCT02394808|26272885|P1|Period 1|Unsatisfactory lens fitting|0
7556979|NCT02394756|26272906|P6|Period 2|Unsatisfactory Visual Response|0
7556980|NCT02394756|26272907|P5|Period 2|Unsatisfactory Visual Response|1
7556981|NCT02394756|26272908|P4|Period 2|Unsatisfactory Visual Response|0
7556982|NCT02394756|26272909|P3|Period 2|Unsatisfactory Visual Response|0
7556983|NCT02394756|26272910|P2|Period 2|Unsatisfactory Visual Response|0
7556984|NCT02394756|26272911|P1|Period 2|Unsatisfactory Visual Response|0
7556985|NCT02394756|26272906|P6|Period 1|Withdrawal by Subject|0
7556986|NCT02394756|26272907|P5|Period 1|Withdrawal by Subject|0
7556987|NCT02394756|26272908|P4|Period 1|Withdrawal by Subject|1
7556988|NCT02394756|26272909|P3|Period 1|Withdrawal by Subject|1
7556989|NCT02394756|26272910|P2|Period 1|Withdrawal by Subject|1
7556990|NCT02394756|26272911|P1|Period 1|Withdrawal by Subject|0
7556991|NCT02394756|26272906|P6|Period 1|Lens Discomfort|1
7556992|NCT02394756|26272907|P5|Period 1|Lens Discomfort|0
7556993|NCT02394756|26272908|P4|Period 1|Lens Discomfort|0
7556994|NCT02394756|26272909|P3|Period 1|Lens Discomfort|0
7556995|NCT02394756|26272910|P2|Period 1|Lens Discomfort|0
7556996|NCT02394756|26272911|P1|Period 1|Lens Discomfort|0
7556997|NCT02394730|26272924|P2|Overall Study|Withdrawal by Subject|1
7556998|NCT02394730|26272925|P1|Overall Study|Withdrawal by Subject|0
7556999|NCT02394730|26272924|P2|Overall Study|Lost to Follow-up|0
7557000|NCT02394730|26272925|P1|Overall Study|Lost to Follow-up|1
7557001|NCT02394665|26272962|P3|Overall Study|Physician Decision|0
7557002|NCT02394665|26272963|P2|Overall Study|Physician Decision|0
7557003|NCT02394665|26272964|P1|Overall Study|Physician Decision|1
7557004|NCT02394600|26272986|P2|Overall Study|Protocol Violation|0
7557005|NCT02394600|26272987|P1|Overall Study|Protocol Violation|1
7557006|NCT02394600|26272986|P2|Overall Study|Withdrawal by Subject|1
7557007|NCT02394600|26272987|P1|Overall Study|Withdrawal by Subject|0
7557008|NCT02394600|26272986|P2|Overall Study|Lost to Follow-up|1
7557009|NCT02394600|26272987|P1|Overall Study|Lost to Follow-up|0
7557010|NCT02394600|26272986|P2|Overall Study|Adverse Event|0
7557011|NCT02394600|26272987|P1|Overall Study|Adverse Event|3
7557012|NCT02394561|26272997|P2|Extension Phase|Lack of Efficacy|3
7557013|NCT02394561|26272998|P1|Extension Phase|Lack of Efficacy|3
7557014|NCT02394561|26272997|P2|Extension Phase|Withdrawal by Subject|5
7557015|NCT02394561|26272998|P1|Extension Phase|Withdrawal by Subject|0
7557016|NCT02394561|26272997|P2|Extension Phase|Physician Decision|2
7557017|NCT02394561|26272998|P1|Extension Phase|Physician Decision|0
7557018|NCT02394561|26272997|P2|Extension Phase|Lost to Follow-up|0
7557019|NCT02394561|26272998|P1|Extension Phase|Lost to Follow-up|1
7557020|NCT02394561|26272997|P2|Extension Phase|Protocol Violation|0
7557021|NCT02394561|26272998|P1|Extension Phase|Protocol Violation|1
7557022|NCT02394561|26272997|P2|Extension Phase|Death|1
7557023|NCT02394561|26272998|P1|Extension Phase|Death|0
7557024|NCT02394561|26272997|P2|Extension Phase|Adverse Event|1
7557025|NCT02394561|26272998|P1|Extension Phase|Adverse Event|6
7557026|NCT02394561|26272997|P2|CORE Phase|Lack of Efficacy|6
7557027|NCT02394561|26272998|P1|CORE Phase|Lack of Efficacy|1
7557028|NCT02394561|26272997|P2|CORE Phase|Withdrawal by Subject|2
7557029|NCT02394561|26272998|P1|CORE Phase|Withdrawal by Subject|2
7557030|NCT02394561|26272997|P2|CORE Phase|Physician Decision|1
7557031|NCT02394561|26272998|P1|CORE Phase|Physician Decision|1
7557032|NCT02394561|26272997|P2|CORE Phase|Lost to Follow-up|0
7557033|NCT02394561|26272998|P1|CORE Phase|Lost to Follow-up|1
7557034|NCT02394561|26272997|P2|CORE Phase|Pregnancy|0
7557035|NCT02394561|26272998|P1|CORE Phase|Pregnancy|1
7557036|NCT02394561|26272997|P2|CORE Phase|Death|1
7557037|NCT02394561|26272998|P1|CORE Phase|Death|0
7557038|NCT02394561|26272997|P2|CORE Phase|Adverse Event|9
7557039|NCT02394561|26272998|P1|CORE Phase|Adverse Event|7
7557040|NCT02394340|26273045|P1|Overall Study|Adverse Event|1
7557041|NCT02394340|26273045|P1|Overall Study|Failed drug screen test|1
7557042|NCT02393950|26273052|P2|Overall Study|Withdrawal by Subject|1
7557043|NCT02393950|26273053|P1|Overall Study|Withdrawal by Subject|0
7557044|NCT02393950|26273052|P2|Overall Study|Adverse Event|0
7557045|NCT02393950|26273053|P1|Overall Study|Adverse Event|1
7557046|NCT02393859|26273120|P2|Overall Study|Continuing Study|43
7557047|NCT02393859|26273121|P1|Overall Study|Continuing Study|32
7557048|NCT02393859|26273120|P2|Overall Study|Death|8
7557049|NCT02393859|26273121|P1|Overall Study|Death|16
7557050|NCT02393859|26273120|P2|Overall Study|Withdrawal by Subject|2
7557051|NCT02393859|26273121|P1|Overall Study|Withdrawal by Subject|5
7557052|NCT02393859|26273120|P2|Overall Study|Decision by Sponsor|1
7557053|NCT02393859|26273121|P1|Overall Study|Decision by Sponsor|1
7557054|NCT02393755|26273146|P2|Overall Study|Physician Decision|2
7557055|NCT02393755|26273147|P1|Overall Study|Physician Decision|0
7557056|NCT02393755|26273146|P2|Overall Study|Adverse Event|2
7557057|NCT02393755|26273147|P1|Overall Study|Adverse Event|0
7557058|NCT02393755|26273146|P2|Overall Study|Withdrawal by Subject|3
7557059|NCT02393755|26273147|P1|Overall Study|Withdrawal by Subject|0
7557060|NCT02393547|26273175|P1|Overall Study|Lost to Follow-up|1
7557061|NCT02393547|26273175|P1|Overall Study|Withdrawal by Subject|3
7557062|NCT02393547|26273175|P1|Overall Study|Adverse Event|2
7557063|NCT02393209|26273275|P4|Overall Study|Lost to Follow-up|0
7557064|NCT02393209|26273276|P3|Overall Study|Lost to Follow-up|0
7557065|NCT02393209|26273277|P2|Overall Study|Lost to Follow-up|1
7557066|NCT02393209|26273278|P1|Overall Study|Lost to Follow-up|0
7557067|NCT02393209|26273275|P4|Overall Study|Patient Seen by Another Oncologist|0
7557068|NCT02393209|26273276|P3|Overall Study|Patient Seen by Another Oncologist|0
7557069|NCT02393209|26273277|P2|Overall Study|Patient Seen by Another Oncologist|1
7557070|NCT02393209|26273278|P1|Overall Study|Patient Seen by Another Oncologist|0
7557071|NCT02393209|26273275|P4|Overall Study|Death from Legionella Infection|0
7557072|NCT02393209|26273276|P3|Overall Study|Death from Legionella Infection|0
7557073|NCT02393209|26273277|P2|Overall Study|Death from Legionella Infection|1
7557074|NCT02393209|26273278|P1|Overall Study|Death from Legionella Infection|0
7557075|NCT02393209|26273275|P4|Overall Study|Death due to Disease Progression|0
7557076|NCT02393209|26273276|P3|Overall Study|Death due to Disease Progression|0
7557077|NCT02393209|26273277|P2|Overall Study|Death due to Disease Progression|2
7557078|NCT02393209|26273278|P1|Overall Study|Death due to Disease Progression|2
7557079|NCT02393209|26273275|P4|Overall Study|Death|0
7557080|NCT02393209|26273276|P3|Overall Study|Death|0
7557081|NCT02393209|26273277|P2|Overall Study|Death|2
7557082|NCT02393209|26273278|P1|Overall Study|Death|2
7557083|NCT02393209|26273275|P4|Overall Study|Withdrawal by Patient|0
7557084|NCT02393209|26273276|P3|Overall Study|Withdrawal by Patient|0
7557085|NCT02393209|26273277|P2|Overall Study|Withdrawal by Patient|0
7557086|NCT02393209|26273278|P1|Overall Study|Withdrawal by Patient|1
7557087|NCT02393209|26273275|P4|Overall Study|Study Terminated by Sponsor|0
7557088|NCT02393209|26273276|P3|Overall Study|Study Terminated by Sponsor|0
7557089|NCT02393209|26273277|P2|Overall Study|Study Terminated by Sponsor|1
7557090|NCT02393209|26273278|P1|Overall Study|Study Terminated by Sponsor|1
7557091|NCT02392624|26273367|P3|Overall Study|Other|1
7557092|NCT02392624|26273368|P2|Overall Study|Other|1
7557093|NCT02392624|26273369|P1|Overall Study|Other|49
7557094|NCT02392624|26273367|P3|Overall Study|Sponsor/Investigator Decision|0
7557095|NCT02392624|26273368|P2|Overall Study|Sponsor/Investigator Decision|1
7557096|NCT02392624|26273369|P1|Overall Study|Sponsor/Investigator Decision|2
7557097|NCT02392624|26273367|P3|Overall Study|Protocol Violation|1
7557098|NCT02392624|26273368|P2|Overall Study|Protocol Violation|0
7557099|NCT02392624|26273369|P1|Overall Study|Protocol Violation|0
7557100|NCT02392624|26273367|P3|Overall Study|Pregnancy|0
7557101|NCT02392624|26273368|P2|Overall Study|Pregnancy|0
7557102|NCT02392624|26273369|P1|Overall Study|Pregnancy|1
7557103|NCT02392624|26273367|P3|Overall Study|Adverse Event|2
7557104|NCT02392624|26273368|P2|Overall Study|Adverse Event|1
7557105|NCT02392624|26273369|P1|Overall Study|Adverse Event|4
7557106|NCT02392624|26273367|P3|Overall Study|Withdrawal by Subject|9
7557107|NCT02392624|26273368|P2|Overall Study|Withdrawal by Subject|12
7557108|NCT02392624|26273369|P1|Overall Study|Withdrawal by Subject|15
7557109|NCT02392611|26273391|P9|Overall Study|Enrolled, not treated|0
7557110|NCT02392611|26273392|P8|Overall Study|Enrolled, not treated|0
7557111|NCT02392611|26273393|P7|Overall Study|Enrolled, not treated|0
7557112|NCT02392611|26273394|P6|Overall Study|Enrolled, not treated|0
7557113|NCT02392611|26273395|P5|Overall Study|Enrolled, not treated|0
7557114|NCT02392611|26273396|P4|Overall Study|Enrolled, not treated|2
7557115|NCT02392611|26273397|P3|Overall Study|Enrolled, not treated|0
7557116|NCT02392611|26273398|P2|Overall Study|Enrolled, not treated|0
7557117|NCT02392611|26273399|P1|Overall Study|Enrolled, not treated|0
7557118|NCT02392611|26273391|P9|Overall Study|Lost to Follow-up|0
7557119|NCT02392611|26273392|P8|Overall Study|Lost to Follow-up|0
7557120|NCT02392611|26273393|P7|Overall Study|Lost to Follow-up|1
7557121|NCT02392611|26273394|P6|Overall Study|Lost to Follow-up|0
7557122|NCT02392611|26273395|P5|Overall Study|Lost to Follow-up|0
7557123|NCT02392611|26273396|P4|Overall Study|Lost to Follow-up|0
7557124|NCT02392611|26273397|P3|Overall Study|Lost to Follow-up|0
7557125|NCT02392611|26273398|P2|Overall Study|Lost to Follow-up|0
7557126|NCT02392611|26273399|P1|Overall Study|Lost to Follow-up|0
7557127|NCT02392611|26273391|P9|Overall Study|Withdrawal by Subject|0
7557128|NCT02392611|26273392|P8|Overall Study|Withdrawal by Subject|0
7557129|NCT02392611|26273393|P7|Overall Study|Withdrawal by Subject|0
7557130|NCT02392611|26273394|P6|Overall Study|Withdrawal by Subject|0
7557131|NCT02392611|26273395|P5|Overall Study|Withdrawal by Subject|0
7557132|NCT02392611|26273396|P4|Overall Study|Withdrawal by Subject|1
7557133|NCT02392611|26273397|P3|Overall Study|Withdrawal by Subject|0
7557134|NCT02392611|26273398|P2|Overall Study|Withdrawal by Subject|0
7557135|NCT02392611|26273399|P1|Overall Study|Withdrawal by Subject|0
7557136|NCT02392611|26273391|P9|Overall Study|Death|0
7557137|NCT02392611|26273392|P8|Overall Study|Death|0
7557138|NCT02392611|26273393|P7|Overall Study|Death|0
7557139|NCT02392611|26273394|P6|Overall Study|Death|1
7557140|NCT02392611|26273395|P5|Overall Study|Death|0
7557141|NCT02392611|26273396|P4|Overall Study|Death|0
7557142|NCT02392611|26273397|P3|Overall Study|Death|0
7557143|NCT02392611|26273398|P2|Overall Study|Death|0
7557144|NCT02392611|26273399|P1|Overall Study|Death|1
7557145|NCT02392611|26273391|P9|Overall Study|Progressive disease|0
7557146|NCT02392611|26273392|P8|Overall Study|Progressive disease|0
7557147|NCT02392611|26273393|P7|Overall Study|Progressive disease|0
7557148|NCT02392611|26273394|P6|Overall Study|Progressive disease|0
7557149|NCT02392611|26273395|P5|Overall Study|Progressive disease|1
7557150|NCT02392611|26273396|P4|Overall Study|Progressive disease|2
7557151|NCT02392611|26273397|P3|Overall Study|Progressive disease|0
7557152|NCT02392611|26273398|P2|Overall Study|Progressive disease|0
7557153|NCT02392611|26273399|P1|Overall Study|Progressive disease|0
7557154|NCT02392611|26273391|P9|Overall Study|Adverse Event|0
7557155|NCT02392611|26273392|P8|Overall Study|Adverse Event|0
7557156|NCT02392611|26273393|P7|Overall Study|Adverse Event|0
7557157|NCT02392611|26273394|P6|Overall Study|Adverse Event|0
7557158|NCT02392611|26273395|P5|Overall Study|Adverse Event|0
7557159|NCT02392611|26273396|P4|Overall Study|Adverse Event|1
7557160|NCT02392611|26273397|P3|Overall Study|Adverse Event|0
7557161|NCT02392611|26273398|P2|Overall Study|Adverse Event|0
7557162|NCT02392611|26273399|P1|Overall Study|Adverse Event|0
7557163|NCT02392559|26273475|P2|Overall Study|Withdrawal by Subject|1
7557164|NCT02392559|26273476|P1|Overall Study|Withdrawal by Subject|0
7557165|NCT02392507|26273507|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|1
7557166|NCT02392507|26273507|P1|Maintenance Regimen|Death|1
7557167|NCT02392507|26273507|P1|Induction Regimen|Withdrawal by Subject|2
7557168|NCT02392507|26273507|P1|Induction Regimen|Physician Decision|1
7557169|NCT02392507|26273507|P1|Induction Regimen|On Study Treatment at Study Conclusion|1
7557170|NCT02392507|26273507|P1|Induction Regimen|Death|3
7557171|NCT02392481|26273546|P4|Overall Study|Withdrawal by Subject|0
7557172|NCT02392481|26273547|P3|Overall Study|Withdrawal by Subject|1
7557173|NCT02392481|26273548|P2|Overall Study|Withdrawal by Subject|0
7557174|NCT02392481|26273549|P1|Overall Study|Withdrawal by Subject|0
7557175|NCT02392481|26273546|P4|Overall Study|Adverse Event|2
7557176|NCT02392481|26273547|P3|Overall Study|Adverse Event|1
7557177|NCT02392481|26273548|P2|Overall Study|Adverse Event|0
7557178|NCT02392481|26273549|P1|Overall Study|Adverse Event|0
7557179|NCT02392403|26273571|P1|Overall Study|Withdrawal by Subject|1
7557180|NCT02392403|26273571|P1|Overall Study|Death|1
7557181|NCT02392403|26273571|P1|Overall Study|Adverse Event|1
7557182|NCT02392377|26273585|P2|Overall Study|Withdrawal by Subject|1
7557183|NCT02392377|26273586|P1|Overall Study|Withdrawal by Subject|0
7557184|NCT02392247|26273678|P1|Overall Study|Surgery cancelled; no data|1
7557185|NCT02392247|26273678|P1|Overall Study|Withdrawal by Subject|1
7557186|NCT02392234|26273689|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
7557187|NCT02392234|26273690|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
7557188|NCT02392234|26273691|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
7557189|NCT02392234|26273692|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
7557190|NCT02392234|26273693|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
7557191|NCT02392234|26273694|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
7557192|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7557193|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7557194|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7557195|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7557196|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7557197|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7557198|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Other|0
7557199|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Other|0
7557200|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Other|0
7557201|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Other|0
7557202|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Other|0
7557203|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Other|1
7557204|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
7557205|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
7557206|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
7557207|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
7557208|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
7557209|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
7557210|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
7557211|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
7557212|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
7557213|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
7557214|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
7557215|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
7557216|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7557217|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7557218|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7557219|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7557220|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7557221|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7557222|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7557223|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
7557224|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7557225|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7557226|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7557227|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7557228|NCT02392234|26273689|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
7557229|NCT02392234|26273690|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
7557230|NCT02392234|26273691|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
7557231|NCT02392234|26273692|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
7557232|NCT02392234|26273693|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
7557233|NCT02392234|26273694|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
7557234|NCT02392195|26273726|P1|Overall Study|Withdrawal by Subject|4
7557235|NCT02392195|26273726|P1|Overall Study|Lost to Follow-up|4
7557236|NCT02392104|26273732|P1|Overall Study|INRs drawn by visiting nurse services|1
7557237|NCT02392104|26273732|P1|Overall Study|admitted to skilled nursing facility|3
7557238|NCT02392104|26273732|P1|Overall Study|INR goal range changed|1
7557239|NCT02392104|26273732|P1|Overall Study|transferred care to another doctor|2
7557240|NCT02392104|26273732|P1|Overall Study|bleeding event|1
7557241|NCT02392104|26273732|P1|Overall Study|discontinuation of warfarin|3
7557242|NCT02392000|26273743|P1|Overall Study|Lost to Follow-up|8
7557243|NCT02392000|26273743|P1|Overall Study|Withdrawal by Subject|1
7557244|NCT02392000|26273743|P1|Overall Study|Greater than mild sleep apnea exclusion|18
7557245|NCT02391961|26273766|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7557246|NCT02391961|26273767|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7557247|NCT02391961|26273766|P2|Washout (2 Weeks)|Withdrawal by Subject|1
7557248|NCT02391961|26273767|P1|Washout (2 Weeks)|Withdrawal by Subject|1
7557249|NCT02391961|26273766|P2|First Intervention (4 Weeks)|Adverse Event|0
7557250|NCT02391961|26273767|P1|First Intervention (4 Weeks)|Adverse Event|2
7557251|NCT02391948|26273790|P5|24-month Assessment|Not able to schedule visit in timeframe|8
7557252|NCT02391948|26273791|P4|24-month Assessment|Not able to schedule visit in timeframe|9
7557253|NCT02391948|26273792|P3|24-month Assessment|Not able to schedule visit in timeframe|2
7557254|NCT02391948|26273793|P2|24-month Assessment|Not able to schedule visit in timeframe|5
7557255|NCT02391948|26273794|P1|24-month Assessment|Not able to schedule visit in timeframe|8
7557256|NCT02391948|26273790|P5|24-month Assessment|Medical issue/illness|0
7557257|NCT02391948|26273791|P4|24-month Assessment|Medical issue/illness|0
7557258|NCT02391948|26273792|P3|24-month Assessment|Medical issue/illness|1
7557259|NCT02391948|26273793|P2|24-month Assessment|Medical issue/illness|0
7557260|NCT02391948|26273794|P1|24-month Assessment|Medical issue/illness|0
7557261|NCT02391948|26273790|P5|24-month Assessment|Lost to Follow-up|0
7557262|NCT02391948|26273791|P4|24-month Assessment|Lost to Follow-up|0
7557263|NCT02391948|26273792|P3|24-month Assessment|Lost to Follow-up|0
7557264|NCT02391948|26273793|P2|24-month Assessment|Lost to Follow-up|4
7557265|NCT02391948|26273794|P1|24-month Assessment|Lost to Follow-up|5
7557266|NCT02391948|26273790|P5|24-month Assessment|Withdrawal by Subject|1
7557267|NCT02391948|26273791|P4|24-month Assessment|Withdrawal by Subject|0
7557268|NCT02391948|26273792|P3|24-month Assessment|Withdrawal by Subject|0
7557269|NCT02391948|26273793|P2|24-month Assessment|Withdrawal by Subject|1
7557270|NCT02391948|26273794|P1|24-month Assessment|Withdrawal by Subject|1
7557271|NCT02391948|26273790|P5|24-month Assessment|Death|1
7557272|NCT02391948|26273791|P4|24-month Assessment|Death|0
7557273|NCT02391948|26273792|P3|24-month Assessment|Death|0
7557274|NCT02391948|26273793|P2|24-month Assessment|Death|0
7557275|NCT02391948|26273794|P1|24-month Assessment|Death|0
7557276|NCT02391948|26273790|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7557277|NCT02391948|26273791|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
7557278|NCT02391948|26273792|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7557279|NCT02391948|26273793|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
7557280|NCT02391948|26273794|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
7557281|NCT02391948|26273790|P5|18-month Assessment|Not able to schedule visit in timeframe|4
7557282|NCT02391948|26273791|P4|18-month Assessment|Not able to schedule visit in timeframe|1
7557283|NCT02391948|26273792|P3|18-month Assessment|Not able to schedule visit in timeframe|2
7557284|NCT02391948|26273793|P2|18-month Assessment|Not able to schedule visit in timeframe|3
7557285|NCT02391948|26273794|P1|18-month Assessment|Not able to schedule visit in timeframe|3
7557286|NCT02391948|26273790|P5|18-month Assessment|Lost to Follow-up|3
7557287|NCT02391948|26273791|P4|18-month Assessment|Lost to Follow-up|2
7557288|NCT02391948|26273792|P3|18-month Assessment|Lost to Follow-up|2
7557289|NCT02391948|26273793|P2|18-month Assessment|Lost to Follow-up|6
7557290|NCT02391948|26273794|P1|18-month Assessment|Lost to Follow-up|2
7557291|NCT02391948|26273790|P5|18-month Assessment|Withdrawal by Subject|0
7557292|NCT02391948|26273791|P4|18-month Assessment|Withdrawal by Subject|1
7557293|NCT02391948|26273792|P3|18-month Assessment|Withdrawal by Subject|0
7557294|NCT02391948|26273793|P2|18-month Assessment|Withdrawal by Subject|0
7557295|NCT02391948|26273794|P1|18-month Assessment|Withdrawal by Subject|1
7557296|NCT02391948|26273790|P5|18-month Assessment|Death|1
7557297|NCT02391948|26273791|P4|18-month Assessment|Death|1
7557298|NCT02391948|26273792|P3|18-month Assessment|Death|0
7557299|NCT02391948|26273793|P2|18-month Assessment|Death|0
7557300|NCT02391948|26273794|P1|18-month Assessment|Death|0
7557301|NCT02391948|26273790|P5|12-month Assessment|Not able to schedule visit in timeframe|1
7557302|NCT02391948|26273791|P4|12-month Assessment|Not able to schedule visit in timeframe|2
7557303|NCT02391948|26273792|P3|12-month Assessment|Not able to schedule visit in timeframe|0
7557304|NCT02391948|26273793|P2|12-month Assessment|Not able to schedule visit in timeframe|4
7557305|NCT02391948|26273794|P1|12-month Assessment|Not able to schedule visit in timeframe|2
7557306|NCT02391948|26273790|P5|12-month Assessment|Medical issue/illness|0
7557307|NCT02391948|26273791|P4|12-month Assessment|Medical issue/illness|1
7557308|NCT02391948|26273792|P3|12-month Assessment|Medical issue/illness|0
7557309|NCT02391948|26273793|P2|12-month Assessment|Medical issue/illness|1
7557310|NCT02391948|26273794|P1|12-month Assessment|Medical issue/illness|0
7557311|NCT02391948|26273790|P5|12-month Assessment|Lost to Follow-up|5
7557312|NCT02391948|26273791|P4|12-month Assessment|Lost to Follow-up|4
7557313|NCT02391948|26273792|P3|12-month Assessment|Lost to Follow-up|4
7557314|NCT02391948|26273793|P2|12-month Assessment|Lost to Follow-up|4
7557315|NCT02391948|26273794|P1|12-month Assessment|Lost to Follow-up|5
7557316|NCT02391948|26273790|P5|12-month Assessment|Withdrawal by Subject|0
7557317|NCT02391948|26273791|P4|12-month Assessment|Withdrawal by Subject|1
7557318|NCT02391948|26273792|P3|12-month Assessment|Withdrawal by Subject|0
7557319|NCT02391948|26273793|P2|12-month Assessment|Withdrawal by Subject|0
7557320|NCT02391948|26273794|P1|12-month Assessment|Withdrawal by Subject|1
7557321|NCT02391948|26273790|P5|12-month Assessment|Death|0
7557322|NCT02391948|26273791|P4|12-month Assessment|Death|1
7557323|NCT02391948|26273792|P3|12-month Assessment|Death|0
7557324|NCT02391948|26273793|P2|12-month Assessment|Death|0
7557325|NCT02391948|26273794|P1|12-month Assessment|Death|0
7557326|NCT02391948|26273790|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
7557327|NCT02391948|26273791|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
7557328|NCT02391948|26273792|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
7557329|NCT02391948|26273793|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
7557330|NCT02391948|26273794|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
7557331|NCT02391948|26273790|P5|6-month Assessment|Not able to schedule visit in timeframe|0
7557332|NCT02391948|26273791|P4|6-month Assessment|Not able to schedule visit in timeframe|5
7557333|NCT02391948|26273792|P3|6-month Assessment|Not able to schedule visit in timeframe|4
7557334|NCT02391948|26273793|P2|6-month Assessment|Not able to schedule visit in timeframe|8
7557335|NCT02391948|26273794|P1|6-month Assessment|Not able to schedule visit in timeframe|6
7557336|NCT02391948|26273790|P5|6-month Assessment|Medical issue/illness|0
7557337|NCT02391948|26273791|P4|6-month Assessment|Medical issue/illness|0
7557338|NCT02391948|26273792|P3|6-month Assessment|Medical issue/illness|0
7557339|NCT02391948|26273793|P2|6-month Assessment|Medical issue/illness|1
7557340|NCT02391948|26273794|P1|6-month Assessment|Medical issue/illness|1
7557341|NCT02391948|26273790|P5|6-month Assessment|Lost to Follow-up|1
7557342|NCT02391948|26273791|P4|6-month Assessment|Lost to Follow-up|3
7557343|NCT02391948|26273792|P3|6-month Assessment|Lost to Follow-up|2
7557344|NCT02391948|26273793|P2|6-month Assessment|Lost to Follow-up|5
7557345|NCT02391948|26273794|P1|6-month Assessment|Lost to Follow-up|4
7557346|NCT02391948|26273790|P5|6-month Assessment|Withdrawal by Subject|0
7557347|NCT02391948|26273791|P4|6-month Assessment|Withdrawal by Subject|2
7557348|NCT02391948|26273792|P3|6-month Assessment|Withdrawal by Subject|1
7557349|NCT02391948|26273793|P2|6-month Assessment|Withdrawal by Subject|0
7557350|NCT02391948|26273794|P1|6-month Assessment|Withdrawal by Subject|0
7557351|NCT02391948|26273790|P5|6-month Assessment|Death|1
7557352|NCT02391948|26273791|P4|6-month Assessment|Death|0
7557353|NCT02391948|26273792|P3|6-month Assessment|Death|0
7557354|NCT02391948|26273793|P2|6-month Assessment|Death|0
7557355|NCT02391948|26273794|P1|6-month Assessment|Death|0
7557356|NCT02391584|26273918|P2|12 Month (End of Study)|Lost to Follow-up|0
7557357|NCT02391584|26273919|P1|12 Month (End of Study)|Lost to Follow-up|2
7557358|NCT02391584|26273918|P2|6 Month|Withdrawal by Subject|0
7557359|NCT02391584|26273919|P1|6 Month|Withdrawal by Subject|1
7557360|NCT02391584|26273918|P2|3 Month|Lost to Follow-up|0
7557361|NCT02391584|26273919|P1|3 Month|Lost to Follow-up|1
7557362|NCT02391584|26273918|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
7557363|NCT02391584|26273919|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
7557364|NCT02391584|26273918|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
7557365|NCT02391584|26273919|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
7557366|NCT02391545|26273936|P2|Overall Study|Other Reasons|4
7557367|NCT02391545|26273937|P1|Overall Study|Other Reasons|6
7557368|NCT02391545|26273936|P2|Overall Study|Withdrawal by Subject|1
7557369|NCT02391545|26273937|P1|Overall Study|Withdrawal by Subject|0
7557370|NCT02391545|26273936|P2|Overall Study|Termination of study by sponsor|20
7557371|NCT02391545|26273937|P1|Overall Study|Termination of study by sponsor|20
7557372|NCT02391545|26273936|P2|Overall Study|Lost to Follow-up|1
7557373|NCT02391545|26273937|P1|Overall Study|Lost to Follow-up|0
7557374|NCT02391545|26273936|P2|Overall Study|Death|2
7557375|NCT02391545|26273937|P1|Overall Study|Death|0
7557376|NCT02391363|26273957|P2|Overall Study|Withdrawal by Subject|3
7557377|NCT02391363|26273958|P1|Overall Study|Withdrawal by Subject|6
7557378|NCT02391363|26273957|P2|Overall Study|Lost to Follow-up|5
7557379|NCT02391363|26273958|P1|Overall Study|Lost to Follow-up|5
7557380|NCT02391337|26274043|P2|12 Months Follow-up|Lost to Follow-up|2
7557381|NCT02391337|26274044|P1|12 Months Follow-up|Lost to Follow-up|0
7557382|NCT02391337|26274043|P2|12 Months Follow-up|Withdrawal by Subject|1
7557383|NCT02391337|26274044|P1|12 Months Follow-up|Withdrawal by Subject|0
7557384|NCT02391337|26274043|P2|12 Months Follow-up|Death|0
7557385|NCT02391337|26274044|P1|12 Months Follow-up|Death|2
7557386|NCT02391337|26274043|P2|6 Months Follow-up|Withdrawal by Subject|1
7557387|NCT02391337|26274044|P1|6 Months Follow-up|Withdrawal by Subject|1
7557388|NCT02391337|26274043|P2|6 Months Follow-up|Death|4
7557389|NCT02391337|26274044|P1|6 Months Follow-up|Death|5
7557390|NCT02391311|26274080|P2|Overall Study|deemed ineligible after baseline|1
7557391|NCT02391311|26274081|P1|Overall Study|deemed ineligible after baseline|1
7557392|NCT02391311|26274080|P2|Overall Study|Lost to Follow-up|1
7557393|NCT02391311|26274081|P1|Overall Study|Lost to Follow-up|2
7557394|NCT02391116|26274089|P1|Survival Follow-up|Switching to Other Therapy|1
7557395|NCT02391116|26274089|P1|Survival Follow-up|Withdrawal by Subject|3
7557396|NCT02391116|26274089|P1|Active Follow-up|Switching to Other Therapy|2
7557397|NCT02391116|26274089|P1|Active Follow-up|Withdrawal by Subject|1
7557398|NCT02391116|26274089|P1|Safety Follow-up|Deterioration of General Conditions|3
7557399|NCT02391116|26274089|P1|Safety Follow-up|No Follow Up|1
7557400|NCT02391116|26274089|P1|Safety Follow-up|Switching to Other Therapy|4
7557401|NCT02391116|26274089|P1|Safety Follow-up|Withdrawal by Subject|4
7557402|NCT02391116|26274089|P1|Safety Follow-up|Adverse Event|1
7557403|NCT02391116|26274089|P1|Treatment|AE with Clinical PD|3
7557404|NCT02391116|26274089|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
7557405|NCT02391116|26274089|P1|Treatment|Protocol Violation|1
7557406|NCT02391116|26274089|P1|Treatment|Withdrawal by Subject|1
7557407|NCT02391038|26274143|P3|Overall Study|Progressive disease|6
7557408|NCT02391038|26274144|P2|Overall Study|Progressive disease|3
7557409|NCT02391038|26274145|P1|Overall Study|Progressive disease|3
7557410|NCT02390557|26274323|P3|Wave 2|Survey non-respondent|23
7557411|NCT02390557|26274324|P2|Wave 2|Survey non-respondent|41
7557412|NCT02390557|26274325|P1|Wave 2|Survey non-respondent|72
7557413|NCT02390362|26274335|P2|Overall Study|Withdrawal by Subject|1
7557414|NCT02390362|26274336|P1|Overall Study|Withdrawal by Subject|0
7557415|NCT02390219|26274344|P1|Overall Study|Other|2
7557416|NCT02390219|26274344|P1|Overall Study|Lost to Follow-up|2
7557417|NCT02390219|26274344|P1|Overall Study|Withdrawal by Subject|1
7557418|NCT02390219|26274344|P1|Overall Study|Adverse Event|6
7557419|NCT02390219|26274344|P1|Overall Study|Physician Decision|1
7557420|NCT02390219|26274344|P1|Overall Study|Death|1
7557421|NCT02390167|26274354|P1|Overall Study|Lost to Follow-up|1
7557422|NCT02390076|26274376|P3|Overall Study|Lost to Follow-up|4
7557423|NCT02390076|26274377|P2|Overall Study|Lost to Follow-up|1
7557424|NCT02390076|26274378|P1|Overall Study|Lost to Follow-up|2
7557425|NCT02389998|26274428|P2|Overall Study|car accident|0
7557426|NCT02389998|26274429|P1|Overall Study|car accident|1
7557427|NCT02389894|26274472|P3|Overall Study|Lost to Follow-up|1
7557428|NCT02389894|26274473|P2|Overall Study|Lost to Follow-up|1
7557429|NCT02389894|26274474|P1|Overall Study|Lost to Follow-up|2
7557430|NCT02389894|26274472|P3|Overall Study|Withdrawal by Subject|5
7557431|NCT02389894|26274473|P2|Overall Study|Withdrawal by Subject|4
7557432|NCT02389894|26274474|P1|Overall Study|Withdrawal by Subject|2
7557433|NCT02389894|26274472|P3|Overall Study|Death|3
7557434|NCT02389894|26274473|P2|Overall Study|Death|5
7557435|NCT02389894|26274474|P1|Overall Study|Death|4
7557436|NCT02389829|26274606|P2|Overall Study|Lost to Follow-up|1
7557437|NCT02389829|26274607|P1|Overall Study|Lost to Follow-up|0
7557438|NCT02389816|26274622|P3|Overall Study|Reason not Specified|0
7557439|NCT02389816|26274623|P2|Overall Study|Reason not Specified|2
7557440|NCT02389816|26274624|P1|Overall Study|Reason not Specified|0
7557441|NCT02389816|26274622|P3|Overall Study|Non Compliance with Study Drug|1
7557442|NCT02389816|26274623|P2|Overall Study|Non Compliance with Study Drug|1
7557443|NCT02389816|26274624|P1|Overall Study|Non Compliance with Study Drug|1
7557444|NCT02389816|26274622|P3|Overall Study|Lack of Efficacy|0
7557445|NCT02389816|26274623|P2|Overall Study|Lack of Efficacy|0
7557446|NCT02389816|26274624|P1|Overall Study|Lack of Efficacy|1
7557447|NCT02389816|26274622|P3|Overall Study|Withdrawal of Consent|4
7557448|NCT02389816|26274623|P2|Overall Study|Withdrawal of Consent|4
7557449|NCT02389816|26274624|P1|Overall Study|Withdrawal of Consent|6
7557450|NCT02389816|26274622|P3|Overall Study|Lost to Follow-up|0
7557451|NCT02389816|26274623|P2|Overall Study|Lost to Follow-up|0
7557452|NCT02389816|26274624|P1|Overall Study|Lost to Follow-up|1
7557453|NCT02389816|26274622|P3|Overall Study|Major Protocol Deviation|0
7557454|NCT02389816|26274623|P2|Overall Study|Major Protocol Deviation|0
7557455|NCT02389816|26274624|P1|Overall Study|Major Protocol Deviation|1
7557456|NCT02389816|26274622|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
7557457|NCT02389816|26274623|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7557458|NCT02389816|26274624|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
7557459|NCT02389816|26274622|P3|Overall Study|Randomized but Not Treated|0
7557460|NCT02389816|26274623|P2|Overall Study|Randomized but Not Treated|0
7557461|NCT02389816|26274624|P1|Overall Study|Randomized but Not Treated|1
7557462|NCT02389764|26274656|P1|Overall Study|Lack of Efficacy|9
7557463|NCT02389621|26274691|P2|Posttreatment Period|Other - Miscellaneous|0
7557464|NCT02389621|26274692|P1|Posttreatment Period|Other - Miscellaneous|2
7557465|NCT02389621|26274691|P2|Posttreatment Period|Lost to Follow-up|1
7557466|NCT02389621|26274692|P1|Posttreatment Period|Lost to Follow-up|1
7557467|NCT02389621|26274691|P2|Posttreatment Period|Withdrawal by Subject|2
7557468|NCT02389621|26274692|P1|Posttreatment Period|Withdrawal by Subject|3
7557469|NCT02389621|26274691|P2|Posttreatment Period|Adverse Event|1
7557470|NCT02389621|26274692|P1|Posttreatment Period|Adverse Event|3
7557471|NCT02389621|26274691|P2|Treatment Period|Withdrawal by Subject|1
7557472|NCT02389621|26274692|P1|Treatment Period|Withdrawal by Subject|1
7557473|NCT02389452|26274722|P1|Overall Study|Enrolled but Not Eligible for Study|6
7557474|NCT02389452|26274722|P1|Overall Study|Withdrawal by Subject|5
7557475|NCT02389452|26274722|P1|Overall Study|Adverse Event|1
7557476|NCT02389452|26274722|P1|Overall Study|Lost to Follow-up|13
7557477|NCT02388997|26274834|P2|Overall Study|Tested positive for virus during run-in|1
7557478|NCT02388997|26274835|P1|Overall Study|Tested positive for virus during run-in|0
7557479|NCT02388997|26274834|P2|Overall Study|Lung function exclusion criteria|2
7557480|NCT02388997|26274835|P1|Overall Study|Lung function exclusion criteria|0
7557481|NCT02388997|26274834|P2|Overall Study|Withdrawal by Subject|1
7557482|NCT02388997|26274835|P1|Overall Study|Withdrawal by Subject|2
7557483|NCT02388997|26274834|P2|Overall Study|Adverse Event|2
7557484|NCT02388997|26274835|P1|Overall Study|Adverse Event|1
7557485|NCT02388932|26274853|P1|Overall Study|Death|1
7557486|NCT02388906|26274865|P2|Treatment Period|Other reasons|3
7557487|NCT02388906|26274866|P1|Treatment Period|Other reasons|3
7557488|NCT02388906|26274865|P2|Treatment Period|Participant no longer meets study criteria|1
7557489|NCT02388906|26274866|P1|Treatment Period|Participant no longer meets study criteria|0
7557490|NCT02388906|26274865|P2|Treatment Period|Poor/non-compliance|1
7557491|NCT02388906|26274866|P1|Treatment Period|Poor/non-compliance|0
7557492|NCT02388906|26274865|P2|Treatment Period|Participant withdrew consent|3
7557493|NCT02388906|26274866|P1|Treatment Period|Participant withdrew consent|2
7557494|NCT02388906|26274865|P2|Treatment Period|Participant request to stop treatment|9
7557495|NCT02388906|26274866|P1|Treatment Period|Participant request to stop treatment|5
7557496|NCT02388906|26274865|P2|Treatment Period|Adverse Event (AE) unrelated to study drug|5
7557497|NCT02388906|26274866|P1|Treatment Period|Adverse Event (AE) unrelated to study drug|5
7557498|NCT02388906|26274865|P2|Treatment Period|Study drug toxicity|208
7557499|NCT02388906|26274866|P1|Treatment Period|Study drug toxicity|41
7557500|NCT02388906|26274865|P2|Treatment Period|Disease progression|101
7557501|NCT02388906|26274866|P1|Treatment Period|Disease progression|121
7557502|NCT02388906|26274865|P2|Pre-Treatment Period|Participant withdrew consent|0
7557503|NCT02388906|26274866|P1|Pre-Treatment Period|Participant withdrew consent|1
7557504|NCT02388776|26274897|P1|Overall Study|Lost to Follow-up|1
7557505|NCT02388776|26274897|P1|Overall Study|Death|1
7557506|NCT02388763|26274902|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7557507|NCT02388763|26274903|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7557508|NCT02388763|26274902|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7557509|NCT02388763|26274903|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7557510|NCT02388737|26274917|P3|Overall Study|Reason Not Specified|4
7557511|NCT02388737|26274918|P2|Overall Study|Reason Not Specified|5
7557512|NCT02388737|26274919|P1|Overall Study|Reason Not Specified|5
7557513|NCT02388737|26274917|P3|Overall Study|Lack of Efficacy|3
7557514|NCT02388737|26274918|P2|Overall Study|Lack of Efficacy|0
7557515|NCT02388737|26274919|P1|Overall Study|Lack of Efficacy|3
7557516|NCT02388737|26274917|P3|Overall Study|Voluntary Withdrawal|17
7557517|NCT02388737|26274918|P2|Overall Study|Voluntary Withdrawal|18
7557518|NCT02388737|26274919|P1|Overall Study|Voluntary Withdrawal|10
7557519|NCT02388737|26274917|P3|Overall Study|Lost to Follow-up|4
7557520|NCT02388737|26274918|P2|Overall Study|Lost to Follow-up|1
7557521|NCT02388737|26274919|P1|Overall Study|Lost to Follow-up|5
7557522|NCT02388737|26274917|P3|Overall Study|Major Protocol Deviation|22
7557523|NCT02388737|26274918|P2|Overall Study|Major Protocol Deviation|25
7557524|NCT02388737|26274919|P1|Overall Study|Major Protocol Deviation|18
7557525|NCT02388737|26274917|P3|Overall Study|Pretreatment Event/Adverse Event|12
7557526|NCT02388737|26274918|P2|Overall Study|Pretreatment Event/Adverse Event|11
7557527|NCT02388737|26274919|P1|Overall Study|Pretreatment Event/Adverse Event|13
7557528|NCT02388724|26274953|P2|Overall Study|Randomized but not Treated|2
7557529|NCT02388724|26274954|P1|Overall Study|Randomized but not Treated|0
7557530|NCT02388724|26274953|P2|Overall Study|Voluntary Withdrawal|5
7557531|NCT02388724|26274954|P1|Overall Study|Voluntary Withdrawal|6
7557532|NCT02388724|26274953|P2|Overall Study|Pretreatment Event/Adverse Event|2
7557533|NCT02388724|26274954|P1|Overall Study|Pretreatment Event/Adverse Event|3
7557534|NCT02388724|26274953|P2|Overall Study|Major Protocol Deviation|3
7557535|NCT02388724|26274954|P1|Overall Study|Major Protocol Deviation|3
7557536|NCT02388724|26274953|P2|Overall Study|Reason not Specified|1
7557537|NCT02388724|26274954|P1|Overall Study|Reason not Specified|0
7557538|NCT02388347|26275029|P5|Overall Study|Withdrawal by Subject|0
7557539|NCT02388347|26275030|P4|Overall Study|Withdrawal by Subject|0
7557540|NCT02388347|26275031|P3|Overall Study|Withdrawal by Subject|1
7557541|NCT02388347|26275032|P2|Overall Study|Withdrawal by Subject|0
7557542|NCT02388347|26275033|P1|Overall Study|Withdrawal by Subject|0
7557543|NCT02388295|26275112|P3|Treatment Weeks 3 to 12|Adverse Event|0
7557544|NCT02388295|26275113|P2|Treatment Weeks 3 to 12|Adverse Event|1
7557545|NCT02388295|26275114|P1|Treatment Weeks 3 to 12|Adverse Event|1
7557546|NCT02388295|26275112|P3|Dose Escalation Week 2|Determined not eligible|1
7557547|NCT02388295|26275113|P2|Dose Escalation Week 2|Determined not eligible|1
7557548|NCT02388295|26275114|P1|Dose Escalation Week 2|Determined not eligible|1
7557549|NCT02388295|26275112|P3|Dose Escalation Week 2|Protocol Violation|0
7557550|NCT02388295|26275113|P2|Dose Escalation Week 2|Protocol Violation|1
7557551|NCT02388295|26275114|P1|Dose Escalation Week 2|Protocol Violation|0
7557552|NCT02388295|26275112|P3|Dose Escalation Week 1|Determined not eligible|1
7557553|NCT02388295|26275113|P2|Dose Escalation Week 1|Determined not eligible|1
7557554|NCT02388295|26275114|P1|Dose Escalation Week 1|Determined not eligible|1
7557555|NCT02388295|26275112|P3|Dose Escalation Week 1|Adverse Event|1
7557556|NCT02388295|26275113|P2|Dose Escalation Week 1|Adverse Event|2
7557557|NCT02388295|26275114|P1|Dose Escalation Week 1|Adverse Event|1
7557558|NCT02388269|26275132|P3|Overall Study|Screen Failure|10
7557559|NCT02388269|26275133|P2|Overall Study|Screen Failure|0
7557560|NCT02388269|26275134|P1|Overall Study|Screen Failure|0
7557561|NCT02388269|26275132|P3|Overall Study|Protocol Violation|0
7557562|NCT02388269|26275133|P2|Overall Study|Protocol Violation|0
7557563|NCT02388269|26275134|P1|Overall Study|Protocol Violation|2
7557564|NCT02388269|26275132|P3|Overall Study|no diary data|0
7557565|NCT02388269|26275133|P2|Overall Study|no diary data|0
7557566|NCT02388269|26275134|P1|Overall Study|no diary data|3
7557567|NCT02388269|26275132|P3|Overall Study|less than 50% stimulations|0
7557568|NCT02388269|26275133|P2|Overall Study|less than 50% stimulations|0
7557569|NCT02388269|26275134|P1|Overall Study|less than 50% stimulations|1
7557570|NCT02388269|26275132|P3|Overall Study|Withdrawal by Subject|0
7557571|NCT02388269|26275133|P2|Overall Study|Withdrawal by Subject|2
7557572|NCT02388269|26275134|P1|Overall Study|Withdrawal by Subject|1
7557573|NCT02388269|26275132|P3|Overall Study|Adverse Event|0
7557574|NCT02388269|26275133|P2|Overall Study|Adverse Event|0
7557575|NCT02388269|26275134|P1|Overall Study|Adverse Event|2
7557576|NCT02388191|26275166|P2|Overall Study|Patient did not receive IUD|0
7557577|NCT02388191|26275167|P1|Overall Study|Patient did not receive IUD|1
7557578|NCT02388165|26275183|P2|Overall Study|Did not meet entrance criteria|2
7557579|NCT02388165|26275184|P1|Overall Study|Did not meet entrance criteria|5
7557580|NCT02388165|26275183|P2|Overall Study|Adverse Event|5
7557581|NCT02388165|26275184|P1|Overall Study|Adverse Event|3
7557582|NCT02388165|26275183|P2|Overall Study|Death|10
7557583|NCT02388165|26275184|P1|Overall Study|Death|13
7557584|NCT02388165|26275183|P2|Overall Study|Lost to Follow-up|20
7557585|NCT02388165|26275184|P1|Overall Study|Lost to Follow-up|19
7557586|NCT02388165|26275183|P2|Overall Study|Withdrawal of consent|32
7557587|NCT02388165|26275184|P1|Overall Study|Withdrawal of consent|31
7557588|NCT02388165|26275183|P2|Overall Study|No longer meet eligibility criteria|43
7557589|NCT02388165|26275184|P1|Overall Study|No longer meet eligibility criteria|40
7557590|NCT02388165|26275183|P2|Overall Study|Other|13
7557591|NCT02388165|26275184|P1|Overall Study|Other|11
7557592|NCT02388165|26275183|P2|Overall Study|Study terminated by sponsor|5
7557593|NCT02388165|26275184|P1|Overall Study|Study terminated by sponsor|5
7557594|NCT02388074|26275214|P1|Overall Study|Sample Not Returned|1
7557595|NCT02388074|26275214|P1|Overall Study|Lost in Transit|2
7557596|NCT02387996|26275218|P1|Overall Study|Poor/Non-Compliance|1
7557597|NCT02387996|26275218|P1|Overall Study|Lost to Follow-up|1
7557598|NCT02387996|26275218|P1|Overall Study|Subject Withdrew Consent|1
7557599|NCT02387996|26275218|P1|Overall Study|Subject Request to Discontinue Treatment|9
7557600|NCT02387996|26275218|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
7557601|NCT02387996|26275218|P1|Overall Study|Study Drug Toxicity|14
7557602|NCT02387996|26275218|P1|Overall Study|Disease Progression|144
7557603|NCT02387983|26275229|P1|Overall Study|Withdrawal by Subject|2
7557604|NCT02387983|26275229|P1|Overall Study|Protocol Violation|1
7557605|NCT02387983|26275229|P1|Overall Study|Adverse Event|4
7557606|NCT02387970|26275243|P2|Overall Study|Did not complete 1-year follow up|2
7557607|NCT02387970|26275244|P1|Overall Study|Did not complete 1-year follow up|1
7557608|NCT02387957|26275265|P3|Overall Study|The study was discontinued|20
7557609|NCT02387957|26275266|P2|Overall Study|The study was discontinued|21
7557610|NCT02387957|26275267|P1|Overall Study|The study was discontinued|21
7557611|NCT02387840|26275300|P6|Overall Study|Death|1
7557612|NCT02387840|26275301|P5|Overall Study|Death|0
7557613|NCT02387840|26275302|P4|Overall Study|Death|0
7557614|NCT02387840|26275303|P3|Overall Study|Death|0
7557615|NCT02387840|26275304|P2|Overall Study|Death|0
7557616|NCT02387840|26275305|P1|Overall Study|Death|0
7557617|NCT02387762|26275375|P2|Overall Study|Withdrawal by Subject|0
7557618|NCT02387762|26275376|P1|Overall Study|Withdrawal by Subject|1
7557619|NCT02387580|26275408|P6|Overall Study|Withdrawal by Subject|0
7557620|NCT02387580|26275409|P5|Overall Study|Withdrawal by Subject|0
7557621|NCT02387580|26275410|P4|Overall Study|Withdrawal by Subject|1
7557622|NCT02387580|26275411|P3|Overall Study|Withdrawal by Subject|0
7557623|NCT02387580|26275412|P2|Overall Study|Withdrawal by Subject|0
7557624|NCT02387580|26275413|P1|Overall Study|Withdrawal by Subject|0
7557625|NCT02387372|26275506|P2|Overall Study|Not Treated|0
7557626|NCT02387372|26275507|P1|Overall Study|Not Treated|1
7557627|NCT02387216|26275622|P2|Overall Study|Lost to Follow-up|3
7557628|NCT02387216|26275623|P1|Overall Study|Lost to Follow-up|0
7557629|NCT02387216|26275622|P2|Overall Study|Other|4
7557630|NCT02387216|26275623|P1|Overall Study|Other|5
7557631|NCT02387216|26275622|P2|Overall Study|Death|23
7557632|NCT02387216|26275623|P1|Overall Study|Death|60
7557633|NCT02387216|26275622|P2|Overall Study|Sponsor Decision|12
7557634|NCT02387216|26275623|P1|Overall Study|Sponsor Decision|28
7557635|NCT02387216|26275622|P2|Overall Study|Physician Decision|0
7557636|NCT02387216|26275623|P1|Overall Study|Physician Decision|2
7557637|NCT02387216|26275622|P2|Overall Study|Withdrawal by Subject|5
7557638|NCT02387216|26275623|P1|Overall Study|Withdrawal by Subject|3
7557639|NCT02387216|26275622|P2|Overall Study|Progressive disease|0
7557640|NCT02387216|26275623|P1|Overall Study|Progressive disease|2
7557641|NCT02387164|26275643|P2|Overall Study|Diagnosed|2
7557642|NCT02387164|26275644|P1|Overall Study|Diagnosed|1
7557643|NCT02387164|26275643|P2|Overall Study|Lost to Follow-up|0
7557644|NCT02387164|26275644|P1|Overall Study|Lost to Follow-up|2
7557645|NCT02386345|26275704|P1|Overall Study|Did not complete 12-month follow-up|72
7557646|NCT02386345|26275704|P1|Overall Study|Repeat Procedure|10
7557647|NCT02386345|26275704|P1|Overall Study|Adverse Event|5
7557648|NCT02386345|26275704|P1|Overall Study|Lost to Follow-up|1
7557649|NCT02386345|26275704|P1|Overall Study|Not treated|14
7557650|NCT02386189|26275723|P2|Overall Study|Death|0
7557651|NCT02386189|26275724|P1|Overall Study|Death|1
7557652|NCT02386189|26275723|P2|Overall Study|Withdrawal by Subject|0
7557653|NCT02386189|26275724|P1|Overall Study|Withdrawal by Subject|1
7557654|NCT02386189|26275723|P2|Overall Study|Lost to Follow-up|3
7557655|NCT02386189|26275724|P1|Overall Study|Lost to Follow-up|2
7557656|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7557657|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7557658|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7557659|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
7557660|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
7557661|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Other|0
7557662|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Other|0
7557663|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Other|0
7557664|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Other|0
7557665|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Other|1
7557666|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7557667|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7557668|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7557669|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
7557670|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
7557671|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7557672|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7557673|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7557674|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
7557675|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7557676|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
7557677|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
7557678|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
7557679|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
7557680|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
7557681|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Adverse Event|0
7557682|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Adverse Event|0
7557683|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Adverse Event|0
7557684|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Adverse Event|1
7557685|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Adverse Event|2
7557686|NCT02386098|26275747|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7557687|NCT02386098|26275748|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7557688|NCT02386098|26275749|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7557689|NCT02386098|26275750|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
7557690|NCT02386098|26275751|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
7557691|NCT02385799|26275830|P2|Overall Study|Withdrawal by Subject|4
7557692|NCT02385799|26275831|P1|Overall Study|Withdrawal by Subject|0
7557693|NCT02385799|26275830|P2|Overall Study|Adverse Event|2
7557694|NCT02385799|26275831|P1|Overall Study|Adverse Event|4
7557695|NCT02385799|26275830|P2|Overall Study|Lost to Follow-up|2
7557696|NCT02385799|26275831|P1|Overall Study|Lost to Follow-up|1
7557697|NCT02385708|26275872|P2|Overall Study|Protocol Violation|1
7557698|NCT02385708|26275873|P1|Overall Study|Protocol Violation|1
7557699|NCT02385708|26275872|P2|Overall Study|Investigator decision|7
7557700|NCT02385708|26275873|P1|Overall Study|Investigator decision|5
7557701|NCT02385708|26275872|P2|Overall Study|Withdrawn - surgery canceled|5
7557702|NCT02385708|26275873|P1|Overall Study|Withdrawn - surgery canceled|2
7557703|NCT02385708|26275872|P2|Overall Study|Withdrawal by Subject|2
7557704|NCT02385708|26275873|P1|Overall Study|Withdrawal by Subject|0
7557705|NCT02385669|26275879|P1|Overall Study|Adverse Event|2
7557706|NCT02385526|26275887|P3|Overall Study|Protocol Violation|0
7557707|NCT02385526|26275888|P2|Overall Study|Protocol Violation|0
7557708|NCT02385526|26275889|P1|Overall Study|Protocol Violation|1
7557709|NCT02385526|26275887|P3|Overall Study|Physician Decision|0
7557710|NCT02385526|26275888|P2|Overall Study|Physician Decision|0
7557711|NCT02385526|26275889|P1|Overall Study|Physician Decision|1
7557712|NCT02385526|26275887|P3|Overall Study|Lost to Follow-up|0
7557713|NCT02385526|26275888|P2|Overall Study|Lost to Follow-up|1
7557714|NCT02385526|26275889|P1|Overall Study|Lost to Follow-up|0
7557715|NCT02385526|26275887|P3|Overall Study|Withdrawal by Subject|0
7557716|NCT02385526|26275888|P2|Overall Study|Withdrawal by Subject|2
7557717|NCT02385526|26275889|P1|Overall Study|Withdrawal by Subject|0
7557718|NCT02385084|26275964|P6|Period 2|Protocol Violation|0
7557719|NCT02385084|26275965|P5|Period 2|Protocol Violation|0
7557720|NCT02385084|26275966|P4|Period 2|Protocol Violation|0
7557721|NCT02385084|26275967|P3|Period 2|Protocol Violation|1
7557722|NCT02385084|26275968|P2|Period 2|Protocol Violation|0
7557723|NCT02385084|26275969|P1|Period 2|Protocol Violation|0
7557724|NCT02384993|26275982|P2|Overall Study|Adverse Event|1
7557725|NCT02384993|26275983|P1|Overall Study|Adverse Event|0
7557726|NCT02384941|26276011|P3|Overall Study|Other than specified above|1
7557727|NCT02384941|26276012|P2|Overall Study|Other than specified above|0
7557728|NCT02384941|26276013|P1|Overall Study|Other than specified above|4
7557729|NCT02384941|26276011|P3|Overall Study|Pregnancy|1
7557730|NCT02384941|26276012|P2|Overall Study|Pregnancy|0
7557731|NCT02384941|26276013|P1|Overall Study|Pregnancy|0
7557732|NCT02384941|26276011|P3|Overall Study|Withdrawal by Subject|20
7557733|NCT02384941|26276012|P2|Overall Study|Withdrawal by Subject|19
7557734|NCT02384941|26276013|P1|Overall Study|Withdrawal by Subject|26
7557735|NCT02384941|26276011|P3|Overall Study|Protocol Violation|0
7557736|NCT02384941|26276012|P2|Overall Study|Protocol Violation|0
7557737|NCT02384941|26276013|P1|Overall Study|Protocol Violation|3
7557738|NCT02384941|26276011|P3|Overall Study|Physician Decision|0
7557739|NCT02384941|26276012|P2|Overall Study|Physician Decision|1
7557740|NCT02384941|26276013|P1|Overall Study|Physician Decision|1
7557741|NCT02384941|26276011|P3|Overall Study|Non-Compliance With Study Drug|1
7557742|NCT02384941|26276012|P2|Overall Study|Non-Compliance With Study Drug|0
7557743|NCT02384941|26276013|P1|Overall Study|Non-Compliance With Study Drug|2
7557744|NCT02384941|26276011|P3|Overall Study|Lost to Follow-up|1
7557745|NCT02384941|26276012|P2|Overall Study|Lost to Follow-up|2
7557746|NCT02384941|26276013|P1|Overall Study|Lost to Follow-up|3
7557747|NCT02384941|26276011|P3|Overall Study|Adverse Event|17
7557748|NCT02384941|26276012|P2|Overall Study|Adverse Event|13
7557749|NCT02384941|26276013|P1|Overall Study|Adverse Event|11
7557750|NCT02384538|26276044|P2|Overall Study|Other|3
7557751|NCT02384538|26276045|P1|Overall Study|Other|1
7557752|NCT02384538|26276044|P2|Overall Study|Withdrew Consent|4
7557753|NCT02384538|26276045|P1|Overall Study|Withdrew Consent|0
7557754|NCT02384538|26276044|P2|Overall Study|Lack of Efficacy|4
7557755|NCT02384538|26276045|P1|Overall Study|Lack of Efficacy|4
7557756|NCT02384538|26276044|P2|Overall Study|Adverse Event|4
7557757|NCT02384538|26276045|P1|Overall Study|Adverse Event|1
7557758|NCT02384460|26276065|P2|Overall Study|Non-compliance|0
7557759|NCT02384460|26276066|P1|Overall Study|Non-compliance|1
7557760|NCT02384460|26276065|P2|Overall Study|Elective medical treatment|0
7557761|NCT02384460|26276066|P1|Overall Study|Elective medical treatment|1
7557762|NCT02384460|26276065|P2|Overall Study|Withdrawal by Subject|3
7557763|NCT02384460|26276066|P1|Overall Study|Withdrawal by Subject|0
7557764|NCT02384460|26276065|P2|Overall Study|Adverse Event|2
7557765|NCT02384460|26276066|P1|Overall Study|Adverse Event|5
7557766|NCT02384460|26276065|P2|Overall Study|Returned to previous therapeutic regimen|1
7557767|NCT02384460|26276066|P1|Overall Study|Returned to previous therapeutic regimen|0
7557768|NCT02384460|26276065|P2|Overall Study|Protocol Violation|1
7557769|NCT02384460|26276066|P1|Overall Study|Protocol Violation|0
7557770|NCT02384382|26276084|P1|Overall Study|Disease progression|16
7557771|NCT02384382|26276084|P1|Overall Study|Adverse Event|1
7557772|NCT02384382|26276084|P1|Overall Study|Death|1
7557773|NCT02384382|26276084|P1|Overall Study|Transitioned to study-NCT02960022|5
7557774|NCT02383966|26276156|P2|Overall Study|Randomized, but not treated|3
7557775|NCT02383966|26276157|P1|Overall Study|Randomized, but not treated|1
7557776|NCT02383966|26276156|P2|Overall Study|Ongoing at clinical cut-off date|4
7557777|NCT02383966|26276157|P1|Overall Study|Ongoing at clinical cut-off date|25
7557778|NCT02383940|26276177|P2|Overall Study|Other than specified above|0
7557779|NCT02383940|26276178|P1|Overall Study|Other than specified above|1
7557780|NCT02383940|26276177|P2|Overall Study|Randomized but not treated|0
7557781|NCT02383940|26276178|P1|Overall Study|Randomized but not treated|2
7557782|NCT02383940|26276177|P2|Overall Study|Withdrawal by Subject|1
7557783|NCT02383940|26276178|P1|Overall Study|Withdrawal by Subject|1
7557784|NCT02383940|26276177|P2|Overall Study|Physician Decision|0
7557785|NCT02383940|26276178|P1|Overall Study|Physician Decision|2
7557786|NCT02383940|26276177|P2|Overall Study|Lost to Follow-up|2
7557787|NCT02383940|26276178|P1|Overall Study|Lost to Follow-up|2
7557788|NCT02383940|26276177|P2|Overall Study|Adverse Event|0
7557789|NCT02383940|26276178|P1|Overall Study|Adverse Event|1
7557790|NCT02383862|26276194|P2|3 Month Follow up|Lost to Follow-up|21
7557791|NCT02383862|26276195|P1|3 Month Follow up|Lost to Follow-up|23
7557792|NCT02383758|26276228|P2|Overall Study|Withdrawal by Subject|2
7557793|NCT02383758|26276229|P1|Overall Study|Withdrawal by Subject|0
7557794|NCT02383589|26276257|P2|Safety Follow-up (SFU)|Treated by not accepted treatment|1
7557795|NCT02383589|26276258|P1|Safety Follow-up (SFU)|Treated by not accepted treatment|0
7557796|NCT02383589|26276257|P2|Safety Follow-up (SFU)|Withdrawal by Subject|0
7557797|NCT02383589|26276258|P1|Safety Follow-up (SFU)|Withdrawal by Subject|5
7557798|NCT02383589|26276257|P2|Safety Follow-up (SFU)|Lost to Follow-up|4
7557799|NCT02383589|26276258|P1|Safety Follow-up (SFU)|Lost to Follow-up|2
7557800|NCT02383589|26276257|P2|Treatment Period|Non-compliance with study drug|1
7557801|NCT02383589|26276258|P1|Treatment Period|Non-compliance with study drug|0
7557802|NCT02383589|26276257|P2|Treatment Period|Withdrawal by Subject|5
7557803|NCT02383589|26276258|P1|Treatment Period|Withdrawal by Subject|0
7557804|NCT02383589|26276257|P2|Treatment Period|Lost to Follow-up|1
7557805|NCT02383589|26276258|P1|Treatment Period|Lost to Follow-up|0
7557806|NCT02383589|26276257|P2|Treatment Period|Adverse Event|3
7557807|NCT02383589|26276258|P1|Treatment Period|Adverse Event|1
7557808|NCT02383576|26276283|P2|Overall Study|Administrative/Other|4
7557809|NCT02383576|26276284|P1|Overall Study|Administrative/Other|2
7557810|NCT02383576|26276283|P2|Overall Study|Investigator's Decision|1
7557811|NCT02383576|26276284|P1|Overall Study|Investigator's Decision|0
7557812|NCT02383576|26276283|P2|Overall Study|Withdrew Consent|6
7557813|NCT02383576|26276284|P1|Overall Study|Withdrew Consent|1
7557814|NCT02383576|26276283|P2|Overall Study|Lost to Follow-up|1
7557815|NCT02383576|26276284|P1|Overall Study|Lost to Follow-up|7
7557816|NCT02383576|26276283|P2|Overall Study|Death|33
7557817|NCT02383576|26276284|P1|Overall Study|Death|53
7557818|NCT02383472|26276300|P2|Overall Study|Withdrawal by Subject|1
7557819|NCT02383472|26276301|P1|Overall Study|Withdrawal by Subject|1
7557820|NCT02383433|26276315|P1|Overall Study|Disease progression|2
7557821|NCT02383355|26276334|P2|Overall Study|Adverse Event|0
7557822|NCT02383355|26276335|P1|Overall Study|Adverse Event|2
7557823|NCT02383173|26276351|P2|Overall Study|Palliative Care Team withdrew|2
7557824|NCT02383173|26276352|P1|Overall Study|Palliative Care Team withdrew|0
7557825|NCT02383056|26276376|P2|Overall Study|Lost to Follow-up|2
7557826|NCT02383056|26276377|P1|Overall Study|Lost to Follow-up|0
7557827|NCT02383056|26276376|P2|Overall Study|Adverse Event|0
7557828|NCT02383056|26276377|P1|Overall Study|Adverse Event|1
7557829|NCT02383017|26276403|P2|Overall Study|Found to be Hypogonadal|0
7557830|NCT02383017|26276404|P1|Overall Study|Found to be Hypogonadal|1
7557831|NCT02383017|26276403|P2|Overall Study|Compliance|2
7557832|NCT02383017|26276404|P1|Overall Study|Compliance|3
7557833|NCT02383017|26276403|P2|Overall Study|Injury Sustained Outside Study|0
7557834|NCT02383017|26276404|P1|Overall Study|Injury Sustained Outside Study|1
7557835|NCT02382991|26276428|P2|Overall Study|Withdrawal by Subject|1
7557836|NCT02382991|26276429|P1|Overall Study|Withdrawal by Subject|0
7557837|NCT02382991|26276428|P2|Overall Study|Lost to Follow-up|0
7557838|NCT02382991|26276429|P1|Overall Study|Lost to Follow-up|1
7557839|NCT02382991|26276428|P2|Overall Study|Adverse Event|2
7557840|NCT02382991|26276429|P1|Overall Study|Adverse Event|1
7557841|NCT02382939|26276441|P2|Overall Study|Withdrawal by Subject|2
7557842|NCT02382939|26276442|P1|Overall Study|Withdrawal by Subject|2
7557843|NCT02382939|26276441|P2|Overall Study|Adverse Event|1
7557844|NCT02382939|26276442|P1|Overall Study|Adverse Event|1
7557845|NCT02382796|26276525|P1|Overall Study|Commercial dacomitinib became available|3
7557846|NCT02382796|26276525|P1|Overall Study|Objective progression or relapse|3
7557847|NCT02382796|26276525|P1|Overall Study|Global deterioration of health status|1
7557848|NCT02382640|26276575|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7557849|NCT02382640|26276576|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7557850|NCT02382640|26276577|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7557851|NCT02382640|26276578|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
7557852|NCT02382276|26276628|P3|Overall Study|Physician Decision|2
7557853|NCT02382276|26276629|P2|Overall Study|Physician Decision|0
7557854|NCT02382276|26276630|P1|Overall Study|Physician Decision|0
7557855|NCT02382276|26276628|P3|Overall Study|Adverse Event|32
7557856|NCT02382276|26276629|P2|Overall Study|Adverse Event|2
7557857|NCT02382276|26276630|P1|Overall Study|Adverse Event|7
7557858|NCT02382276|26276628|P3|Overall Study|Withdrawal by Subject|5
7557859|NCT02382276|26276629|P2|Overall Study|Withdrawal by Subject|8
7557860|NCT02382276|26276630|P1|Overall Study|Withdrawal by Subject|4
7557861|NCT02382133|26276642|P1|Overall Study|pressure injury both sites|1
7557862|NCT02382133|26276642|P1|Overall Study|arterial catheter loss|4
7557863|NCT02382133|26276642|P1|Overall Study|Physician Decision|2
7557864|NCT02382133|26276642|P1|Overall Study|transfer out of ICU|4
7557865|NCT02382133|26276642|P1|Overall Study|Death|22
7557866|NCT02382016|26276649|P2|OL Extension Period|Withdrawal by Subject|0
7557867|NCT02382016|26276650|P1|OL Extension Period|Withdrawal by Subject|1
7557868|NCT02382016|26276649|P2|OL Extension Period|Death|0
7557869|NCT02382016|26276650|P1|OL Extension Period|Death|2
7557870|NCT02382016|26276649|P2|OL Extension Period|Physician Decision|0
7557871|NCT02382016|26276650|P1|OL Extension Period|Physician Decision|3
7557872|NCT02382016|26276649|P2|Open-label (OL) Treatment Period|Death|0
7557873|NCT02382016|26276650|P1|Open-label (OL) Treatment Period|Death|4
7557874|NCT02382016|26276649|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
7557875|NCT02382016|26276650|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
7557876|NCT02382016|26276649|P2|Open-label (OL) Treatment Period|Physician Decision|0
7557877|NCT02382016|26276650|P1|Open-label (OL) Treatment Period|Physician Decision|3
7557878|NCT02382016|26276649|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
7557879|NCT02382016|26276650|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
7557880|NCT02382016|26276649|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
7557881|NCT02382016|26276650|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
7557882|NCT02382016|26276649|P2|Double-blind (DB) Treatment Period|Physician Decision|0
7557883|NCT02382016|26276650|P1|Double-blind (DB) Treatment Period|Physician Decision|3
7557884|NCT02381795|26276674|P1|Overall Study|Study Terminated|2
7557885|NCT02381795|26276674|P1|Overall Study|Withdrawal by Subject|1
7557886|NCT02381652|26276689|P3|Overall Study|Withdrawal by Subject|1
7557887|NCT02381652|26276690|P2|Overall Study|Withdrawal by Subject|0
7557888|NCT02381652|26276691|P1|Overall Study|Withdrawal by Subject|0
7557889|NCT02380859|26276807|P2|Overall Study|Withdrawal by Subject|0
7557890|NCT02380859|26276808|P1|Overall Study|Withdrawal by Subject|2
7557891|NCT02380742|26276844|P2|Overall Study|Withdrawal by Subject|0
7557892|NCT02380742|26276845|P1|Overall Study|Withdrawal by Subject|1
7557893|NCT02380703|26276859|P2|Overall Study|Entered Long-term Care|7
7557894|NCT02380703|26276860|P1|Overall Study|Entered Long-term Care|4
7557895|NCT02380703|26276859|P2|Overall Study|Person with dementia (PWD) death|8
7557896|NCT02380703|26276860|P1|Overall Study|Person with dementia (PWD) death|7
7557897|NCT02380703|26276859|P2|Overall Study|Caregiver death|0
7557898|NCT02380703|26276860|P1|Overall Study|Caregiver death|1
7557899|NCT02380703|26276859|P2|Overall Study|Lost to Follow-up|12
7557900|NCT02380703|26276860|P1|Overall Study|Lost to Follow-up|12
7557901|NCT02380703|26276859|P2|Overall Study|Withdrawal by Subject|9
7557902|NCT02380703|26276860|P1|Overall Study|Withdrawal by Subject|12
7557903|NCT02380690|26276882|P2|Overall Study|Withdrawal by Subject|8
7557904|NCT02380690|26276883|P1|Overall Study|Withdrawal by Subject|20
7557905|NCT02380690|26276882|P2|Overall Study|Lost to Follow-up|4
7557906|NCT02380690|26276883|P1|Overall Study|Lost to Follow-up|14
7557907|NCT02380677|26276931|P12|Overall Study|Other|0
7557908|NCT02380677|26276932|P11|Overall Study|Other|0
7557909|NCT02380677|26276933|P10|Overall Study|Other|0
7557910|NCT02380677|26276934|P9|Overall Study|Other|0
7557911|NCT02380677|26276935|P8|Overall Study|Other|0
7557912|NCT02380677|26276936|P7|Overall Study|Other|0
7557913|NCT02380677|26276937|P6|Overall Study|Other|1
7557914|NCT02380677|26276938|P5|Overall Study|Other|1
7557915|NCT02380677|26276939|P4|Overall Study|Other|1
7557916|NCT02380677|26276940|P3|Overall Study|Other|0
7557917|NCT02380677|26276941|P2|Overall Study|Other|0
7557918|NCT02380677|26276942|P1|Overall Study|Other|0
7557919|NCT02380677|26276931|P12|Overall Study|Withdrawal by Subject|3
7557920|NCT02380677|26276932|P11|Overall Study|Withdrawal by Subject|0
7557921|NCT02380677|26276933|P10|Overall Study|Withdrawal by Subject|1
7557922|NCT02380677|26276934|P9|Overall Study|Withdrawal by Subject|0
7557923|NCT02380677|26276935|P8|Overall Study|Withdrawal by Subject|0
7557924|NCT02380677|26276936|P7|Overall Study|Withdrawal by Subject|0
7557925|NCT02380677|26276937|P6|Overall Study|Withdrawal by Subject|0
7557926|NCT02380677|26276938|P5|Overall Study|Withdrawal by Subject|0
7557927|NCT02380677|26276939|P4|Overall Study|Withdrawal by Subject|0
7557928|NCT02380677|26276940|P3|Overall Study|Withdrawal by Subject|0
7557929|NCT02380677|26276941|P2|Overall Study|Withdrawal by Subject|0
7557930|NCT02380677|26276942|P1|Overall Study|Withdrawal by Subject|0
7557931|NCT02380677|26276931|P12|Overall Study|Lack of Efficacy|1
7557932|NCT02380677|26276932|P11|Overall Study|Lack of Efficacy|2
7557933|NCT02380677|26276933|P10|Overall Study|Lack of Efficacy|0
7557934|NCT02380677|26276934|P9|Overall Study|Lack of Efficacy|2
7557935|NCT02380677|26276935|P8|Overall Study|Lack of Efficacy|2
7557936|NCT02380677|26276936|P7|Overall Study|Lack of Efficacy|1
7557937|NCT02380677|26276937|P6|Overall Study|Lack of Efficacy|1
7557938|NCT02380677|26276938|P5|Overall Study|Lack of Efficacy|4
7557939|NCT02380677|26276939|P4|Overall Study|Lack of Efficacy|0
7557940|NCT02380677|26276940|P3|Overall Study|Lack of Efficacy|2
7557941|NCT02380677|26276941|P2|Overall Study|Lack of Efficacy|1
7557942|NCT02380677|26276942|P1|Overall Study|Lack of Efficacy|0
7557943|NCT02380677|26276931|P12|Overall Study|Physician Decision|0
7557944|NCT02380677|26276932|P11|Overall Study|Physician Decision|0
7557945|NCT02380677|26276933|P10|Overall Study|Physician Decision|0
7557946|NCT02380677|26276934|P9|Overall Study|Physician Decision|0
7557947|NCT02380677|26276935|P8|Overall Study|Physician Decision|0
7557948|NCT02380677|26276936|P7|Overall Study|Physician Decision|0
7557949|NCT02380677|26276937|P6|Overall Study|Physician Decision|0
7557950|NCT02380677|26276938|P5|Overall Study|Physician Decision|0
7557951|NCT02380677|26276939|P4|Overall Study|Physician Decision|1
7557952|NCT02380677|26276940|P3|Overall Study|Physician Decision|1
7557953|NCT02380677|26276941|P2|Overall Study|Physician Decision|0
7557954|NCT02380677|26276942|P1|Overall Study|Physician Decision|1
7557955|NCT02380677|26276931|P12|Overall Study|Adverse Event|1
7557956|NCT02380677|26276932|P11|Overall Study|Adverse Event|2
7557957|NCT02380677|26276933|P10|Overall Study|Adverse Event|1
7557958|NCT02380677|26276934|P9|Overall Study|Adverse Event|2
7557959|NCT02380677|26276935|P8|Overall Study|Adverse Event|2
7557960|NCT02380677|26276936|P7|Overall Study|Adverse Event|2
7557961|NCT02380677|26276937|P6|Overall Study|Adverse Event|4
7557962|NCT02380677|26276938|P5|Overall Study|Adverse Event|1
7557963|NCT02380677|26276939|P4|Overall Study|Adverse Event|1
7557964|NCT02380677|26276940|P3|Overall Study|Adverse Event|0
7557965|NCT02380677|26276941|P2|Overall Study|Adverse Event|0
7557966|NCT02380677|26276942|P1|Overall Study|Adverse Event|0
7557967|NCT02380287|26277010|P8|Overall Study|Adverse Event|0
7557968|NCT02380287|26277011|P7|Overall Study|Adverse Event|0
7557969|NCT02380287|26277012|P6|Overall Study|Adverse Event|0
7557970|NCT02380287|26277013|P5|Overall Study|Adverse Event|0
7557971|NCT02380287|26277014|P4|Overall Study|Adverse Event|0
7557972|NCT02380287|26277015|P3|Overall Study|Adverse Event|1
7557973|NCT02380287|26277016|P2|Overall Study|Adverse Event|0
7557974|NCT02380287|26277017|P1|Overall Study|Adverse Event|0
7557975|NCT02380248|26277122|P1|Overall Study|Withdrawal by Subject|3
7557976|NCT02380248|26277122|P1|Overall Study|Lost to Follow-up|11
7557977|NCT02379923|26277138|P1|Overall Study|Death|5
7557978|NCT02379728|26277167|P4|Overall Study|Protocol Violation|0
7557979|NCT02379728|26277168|P3|Overall Study|Protocol Violation|2
7557980|NCT02379728|26277169|P2|Overall Study|Protocol Violation|0
7557981|NCT02379728|26277170|P1|Overall Study|Protocol Violation|0
7557982|NCT02379728|26277167|P4|Overall Study|Withdrawal by Subject|3
7557983|NCT02379728|26277168|P3|Overall Study|Withdrawal by Subject|5
7557984|NCT02379728|26277169|P2|Overall Study|Withdrawal by Subject|0
7557985|NCT02379728|26277170|P1|Overall Study|Withdrawal by Subject|5
7557986|NCT02379728|26277167|P4|Overall Study|Lost to Follow-up|0
7557987|NCT02379728|26277168|P3|Overall Study|Lost to Follow-up|3
7557988|NCT02379728|26277169|P2|Overall Study|Lost to Follow-up|0
7557989|NCT02379728|26277170|P1|Overall Study|Lost to Follow-up|1
7557990|NCT02379637|26277226|P2|Overall Study|Withdrawal by Subject|0
7557991|NCT02379637|26277227|P1|Overall Study|Withdrawal by Subject|1
7557992|NCT02379637|26277226|P2|Overall Study|Adverse Event|0
7557993|NCT02379637|26277227|P1|Overall Study|Adverse Event|1
7557994|NCT02379637|26277226|P2|Overall Study|Protocol Violation|1
7557995|NCT02379637|26277227|P1|Overall Study|Protocol Violation|0
7557996|NCT02379390|26277266|P2|Overall Study|Study Termination|1
7557997|NCT02379390|26277267|P1|Overall Study|Study Termination|0
7557998|NCT02379390|26277266|P2|Overall Study|Investigator's decision|0
7557999|NCT02379390|26277267|P1|Overall Study|Investigator's decision|1
7558000|NCT02379390|26277266|P2|Overall Study|Adverse Event|1
7558001|NCT02379390|26277267|P1|Overall Study|Adverse Event|1
7558002|NCT02379221|26277319|P1|Overall Study|Lost to Follow-up|1
7558003|NCT02379091|26277355|P4|Overall Study|Lack of Efficacy|0
7558004|NCT02379091|26277356|P3|Overall Study|Lack of Efficacy|0
7558005|NCT02379091|26277357|P2|Overall Study|Lack of Efficacy|0
7558006|NCT02379091|26277358|P1|Overall Study|Lack of Efficacy|3
7558007|NCT02379091|26277355|P4|Overall Study|Study Termination|8
7558008|NCT02379091|26277356|P3|Overall Study|Study Termination|5
7558009|NCT02379091|26277357|P2|Overall Study|Study Termination|2
7558010|NCT02379091|26277358|P1|Overall Study|Study Termination|7
7558011|NCT02379091|26277355|P4|Overall Study|Voluntary Withdrawal|4
7558012|NCT02379091|26277356|P3|Overall Study|Voluntary Withdrawal|2
7558013|NCT02379091|26277357|P2|Overall Study|Voluntary Withdrawal|5
7558014|NCT02379091|26277358|P1|Overall Study|Voluntary Withdrawal|2
7558015|NCT02379091|26277355|P4|Overall Study|Lost to Follow-up|1
7558016|NCT02379091|26277356|P3|Overall Study|Lost to Follow-up|0
7558017|NCT02379091|26277357|P2|Overall Study|Lost to Follow-up|0
7558018|NCT02379091|26277358|P1|Overall Study|Lost to Follow-up|0
7558019|NCT02379091|26277355|P4|Overall Study|Principal Investigator Discretion|0
7558020|NCT02379091|26277356|P3|Overall Study|Principal Investigator Discretion|0
7558021|NCT02379091|26277357|P2|Overall Study|Principal Investigator Discretion|1
7558022|NCT02379091|26277358|P1|Overall Study|Principal Investigator Discretion|0
7558023|NCT02379091|26277355|P4|Overall Study|Pretreatment Event/Adverse Event|1
7558024|NCT02379091|26277356|P3|Overall Study|Pretreatment Event/Adverse Event|0
7558025|NCT02379091|26277357|P2|Overall Study|Pretreatment Event/Adverse Event|2
7558026|NCT02379091|26277358|P1|Overall Study|Pretreatment Event/Adverse Event|0
7558027|NCT02379078|26277396|P2|Overall Study|Withdrawal by Subject|5
7558028|NCT02379078|26277397|P1|Overall Study|Withdrawal by Subject|6
7558029|NCT02379078|26277396|P2|Overall Study|Lost to Follow-up|30
7558030|NCT02379078|26277397|P1|Overall Study|Lost to Follow-up|33
7558031|NCT02379052|26277413|P2|Overall Study|Subject was Incarcerated|1
7558032|NCT02379052|26277414|P1|Overall Study|Subject was Incarcerated|0
7558033|NCT02379052|26277413|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
7558034|NCT02379052|26277414|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
7558035|NCT02379052|26277413|P2|Overall Study|Lost to Follow-up|1
7558036|NCT02379052|26277414|P1|Overall Study|Lost to Follow-up|2
7558037|NCT02379052|26277413|P2|Overall Study|Withdrawal by Subject|0
7558038|NCT02379052|26277414|P1|Overall Study|Withdrawal by Subject|2
7558039|NCT02379052|26277413|P2|Overall Study|Physician Decision|1
7558040|NCT02379052|26277414|P1|Overall Study|Physician Decision|1
7558041|NCT02379052|26277413|P2|Overall Study|Adverse Event|1
7558042|NCT02379052|26277414|P1|Overall Study|Adverse Event|0
7558043|NCT02379052|26277413|P2|Overall Study|Protocol Violation|1
7558044|NCT02379052|26277414|P1|Overall Study|Protocol Violation|0
7558045|NCT02378961|26277456|P4|Overall Study|Death|0
7558046|NCT02378961|26277457|P3|Overall Study|Death|1
7558047|NCT02378961|26277458|P2|Overall Study|Death|0
7558048|NCT02378961|26277459|P1|Overall Study|Death|0
7558049|NCT02378961|26277456|P4|Overall Study|Lack of Efficacy|1
7558050|NCT02378961|26277457|P3|Overall Study|Lack of Efficacy|0
7558051|NCT02378961|26277458|P2|Overall Study|Lack of Efficacy|2
7558052|NCT02378961|26277459|P1|Overall Study|Lack of Efficacy|4
7558053|NCT02378935|26277496|P7|Overall Study|Death|0
7558054|NCT02378935|26277497|P6|Overall Study|Death|0
7558055|NCT02378935|26277498|P5|Overall Study|Death|0
7558056|NCT02378935|26277499|P4|Overall Study|Death|0
7558057|NCT02378935|26277500|P3|Overall Study|Death|1
7558058|NCT02378935|26277501|P2|Overall Study|Death|0
7558059|NCT02378935|26277502|P1|Overall Study|Death|0
7558060|NCT02378935|26277496|P7|Overall Study|Lack of Efficacy|0
7558061|NCT02378935|26277497|P6|Overall Study|Lack of Efficacy|0
7558062|NCT02378935|26277498|P5|Overall Study|Lack of Efficacy|0
7558063|NCT02378935|26277499|P4|Overall Study|Lack of Efficacy|6
7558064|NCT02378935|26277500|P3|Overall Study|Lack of Efficacy|2
7558065|NCT02378935|26277501|P2|Overall Study|Lack of Efficacy|0
7558066|NCT02378935|26277502|P1|Overall Study|Lack of Efficacy|10
7558067|NCT02378883|26277553|P1|12 Months Follow-Up|Death|2
7558068|NCT02378883|26277553|P1|12 Months Follow-Up|Lost to Follow-up|3
7558069|NCT02378883|26277553|P1|30 Day Follow-Up|Death|1
7558070|NCT02378883|26277553|P1|30 Day Follow-Up|Missed Visit|2
7558071|NCT02378883|26277553|P1|30 Day Follow-Up|Physician Decision|2
7558072|NCT02378883|26277553|P1|30 Day Follow-Up|Withdrawal by Subject|1
7558073|NCT02378883|26277553|P1|Enrollment|Attempt to use Apollo was not performed|3
7558074|NCT02378883|26277553|P1|Enrollment|Subject did not meet Inclusion criteria|6
7558075|NCT02378662|26277674|P2|Overall Study|Early Discontinuation|0
7558076|NCT02378662|26277675|P1|Overall Study|Early Discontinuation|2
7558077|NCT02378506|26277681|P1|Overall Study|Randomized But Not Treated|1
7558078|NCT02378506|26277681|P1|Overall Study|Adverse Event|14
7558079|NCT02378506|26277681|P1|Overall Study|Death|1
7558080|NCT02378506|26277681|P1|Overall Study|Protocol Violation|2
7558081|NCT02378506|26277681|P1|Overall Study|Withdrawal by Subject|4
7558082|NCT02378506|26277681|P1|Overall Study|Lack of Efficacy|3
7558083|NCT02378480|26277700|P2|Overall Study|Lost to Follow-up|18
7558084|NCT02378480|26277701|P1|Overall Study|Lost to Follow-up|10
7558085|NCT02378480|26277700|P2|Overall Study|Withdrawal by Subject|4
7558086|NCT02378480|26277701|P1|Overall Study|Withdrawal by Subject|9
7558087|NCT02378480|26277700|P2|Overall Study|Missed EOT/PTE Visit|2
7558088|NCT02378480|26277701|P1|Overall Study|Missed EOT/PTE Visit|1
7558089|NCT02378480|26277700|P2|Overall Study|Adverse Event|1
7558090|NCT02378480|26277701|P1|Overall Study|Adverse Event|0
7558091|NCT02378480|26277700|P2|Overall Study|Randomized, but Not Treated|4
7558092|NCT02378480|26277701|P1|Overall Study|Randomized, but Not Treated|6
7558093|NCT02378480|26277700|P2|Overall Study|Death|2
7558094|NCT02378480|26277701|P1|Overall Study|Death|1
7558095|NCT02378480|26277700|P2|Overall Study|Physician Decision|1
7558096|NCT02378480|26277701|P1|Overall Study|Physician Decision|1
7558097|NCT02378220|26277728|P2|Overall Study|Death|1
7558098|NCT02378220|26277729|P1|Overall Study|Death|6
7558099|NCT02377921|26277827|P2|Overall Study|Subject non-compliance|1
7558100|NCT02377921|26277828|P1|Overall Study|Subject non-compliance|1
7558101|NCT02377817|26277852|P2|Overall Study|Unrelated injury prevented lateral sleep|0
7558102|NCT02377817|26277853|P1|Overall Study|Unrelated injury prevented lateral sleep|1
7558103|NCT02377817|26277852|P2|Overall Study|Transportation/childcare barriers.|0
7558104|NCT02377817|26277853|P1|Overall Study|Transportation/childcare barriers.|2
7558105|NCT02377466|26277964|P2|Overall Study|Other: Randomized and not treated|2
7558106|NCT02377466|26277965|P1|Overall Study|Other: Randomized and not treated|0
7558107|NCT02377427|26278083|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7558108|NCT02377427|26278084|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7558109|NCT02377427|26278085|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
7558110|NCT02377427|26278086|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7558111|NCT02377427|26278087|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7558112|NCT02377427|26278083|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
7558113|NCT02377427|26278084|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
7558114|NCT02377427|26278085|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
7558115|NCT02377427|26278086|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
7558116|NCT02377427|26278087|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
7558117|NCT02377427|26278083|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7558118|NCT02377427|26278084|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7558119|NCT02377427|26278085|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7558120|NCT02377427|26278086|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7558121|NCT02377427|26278087|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
7558122|NCT02377427|26278083|P5|Part A (Up to Week 20)|Physician Decision|0
7558123|NCT02377427|26278084|P4|Part A (Up to Week 20)|Physician Decision|0
7558124|NCT02377427|26278085|P3|Part A (Up to Week 20)|Physician Decision|0
7558125|NCT02377427|26278086|P2|Part A (Up to Week 20)|Physician Decision|0
7558126|NCT02377427|26278087|P1|Part A (Up to Week 20)|Physician Decision|1
7558127|NCT02377362|26278160|P13|Part B Overall|Withdrawal by Subject|0
7558128|NCT02377362|26278161|P12|Part B Overall|Withdrawal by Subject|1
7558129|NCT02377362|26278162|P11|Part B Overall|Withdrawal by Subject|0
7558130|NCT02377362|26278163|P10|Part B Overall|Withdrawal by Subject|0
7558131|NCT02377362|26278164|P9|Part B Overall|Withdrawal by Subject|0
7558132|NCT02377362|26278165|P8|Part B Overall|Withdrawal by Subject|0
7558133|NCT02377362|26278166|P7|Part B Overall|Withdrawal by Subject|1
7558134|NCT02377362|26278167|P6|Part B Overall|Withdrawal by Subject|0
7558135|NCT02377362|26278168|P5|Part B Overall|Withdrawal by Subject|0
7558136|NCT02377362|26278169|P4|Part B Overall|Withdrawal by Subject|0
7558137|NCT02377362|26278170|P3|Part B Overall|Withdrawal by Subject|0
7558138|NCT02377362|26278171|P2|Part B Overall|Withdrawal by Subject|0
7558139|NCT02377362|26278172|P1|Part B Overall|Withdrawal by Subject|0
7558140|NCT02377362|26278160|P13|Part B Overall|Adverse Event|0
7558141|NCT02377362|26278161|P12|Part B Overall|Adverse Event|0
7558142|NCT02377362|26278162|P11|Part B Overall|Adverse Event|0
7558143|NCT02377362|26278163|P10|Part B Overall|Adverse Event|0
7558144|NCT02377362|26278164|P9|Part B Overall|Adverse Event|0
7558145|NCT02377362|26278165|P8|Part B Overall|Adverse Event|1
7558146|NCT02377362|26278166|P7|Part B Overall|Adverse Event|1
7558147|NCT02377362|26278167|P6|Part B Overall|Adverse Event|0
7558148|NCT02377362|26278168|P5|Part B Overall|Adverse Event|0
7558149|NCT02377362|26278169|P4|Part B Overall|Adverse Event|0
7558150|NCT02377362|26278170|P3|Part B Overall|Adverse Event|0
7558151|NCT02377362|26278171|P2|Part B Overall|Adverse Event|0
7558152|NCT02377362|26278172|P1|Part B Overall|Adverse Event|0
7558153|NCT02377362|26278160|P13|Part B Overall|Protocol Violation|0
7558154|NCT02377362|26278161|P12|Part B Overall|Protocol Violation|0
7558155|NCT02377362|26278162|P11|Part B Overall|Protocol Violation|0
7558156|NCT02377362|26278163|P10|Part B Overall|Protocol Violation|1
7558157|NCT02377362|26278164|P9|Part B Overall|Protocol Violation|0
7558158|NCT02377362|26278165|P8|Part B Overall|Protocol Violation|0
7558159|NCT02377362|26278166|P7|Part B Overall|Protocol Violation|0
7558160|NCT02377362|26278167|P6|Part B Overall|Protocol Violation|0
7558161|NCT02377362|26278168|P5|Part B Overall|Protocol Violation|0
7558162|NCT02377362|26278169|P4|Part B Overall|Protocol Violation|0
7558163|NCT02377362|26278170|P3|Part B Overall|Protocol Violation|0
7558164|NCT02377362|26278171|P2|Part B Overall|Protocol Violation|0
7558165|NCT02377362|26278172|P1|Part B Overall|Protocol Violation|0
7558166|NCT02377362|26278160|P13|Part A Third Treatment|Highest dose level 1200 not used|0
7558167|NCT02377362|26278161|P12|Part A Third Treatment|Highest dose level 1200 not used|0
7558168|NCT02377362|26278162|P11|Part A Third Treatment|Highest dose level 1200 not used|0
7558169|NCT02377362|26278163|P10|Part A Third Treatment|Highest dose level 1200 not used|0
7558170|NCT02377362|26278164|P9|Part A Third Treatment|Highest dose level 1200 not used|0
7558171|NCT02377362|26278165|P8|Part A Third Treatment|Highest dose level 1200 not used|0
7558172|NCT02377362|26278166|P7|Part A Third Treatment|Highest dose level 1200 not used|0
7558173|NCT02377362|26278167|P6|Part A Third Treatment|Highest dose level 1200 not used|4
7558174|NCT02377362|26278168|P5|Part A Third Treatment|Highest dose level 1200 not used|3
7558175|NCT02377362|26278169|P4|Part A Third Treatment|Highest dose level 1200 not used|4
7558176|NCT02377362|26278170|P3|Part A Third Treatment|Highest dose level 1200 not used|0
7558177|NCT02377362|26278171|P2|Part A Third Treatment|Highest dose level 1200 not used|0
7558178|NCT02377362|26278172|P1|Part A Third Treatment|Highest dose level 1200 not used|0
7558179|NCT02377362|26278160|P13|Part A Second Treatment|Protocol Violation|0
7558180|NCT02377362|26278161|P12|Part A Second Treatment|Protocol Violation|0
7558181|NCT02377362|26278162|P11|Part A Second Treatment|Protocol Violation|0
7558182|NCT02377362|26278163|P10|Part A Second Treatment|Protocol Violation|0
7558183|NCT02377362|26278164|P9|Part A Second Treatment|Protocol Violation|0
7558184|NCT02377362|26278165|P8|Part A Second Treatment|Protocol Violation|0
7558185|NCT02377362|26278166|P7|Part A Second Treatment|Protocol Violation|0
7558186|NCT02377362|26278167|P6|Part A Second Treatment|Protocol Violation|0
7558187|NCT02377362|26278168|P5|Part A Second Treatment|Protocol Violation|1
7558188|NCT02377362|26278169|P4|Part A Second Treatment|Protocol Violation|0
7558189|NCT02377362|26278170|P3|Part A Second Treatment|Protocol Violation|0
7558190|NCT02377362|26278171|P2|Part A Second Treatment|Protocol Violation|0
7558191|NCT02377362|26278172|P1|Part A Second Treatment|Protocol Violation|0
7558192|NCT02377349|26278381|P2|Overall Study|Other|1
7558193|NCT02377349|26278382|P1|Overall Study|Other|0
7558194|NCT02377349|26278381|P2|Overall Study|Lost to follow-up (complete vaccination)|5
7558195|NCT02377349|26278382|P1|Overall Study|Lost to follow-up (complete vaccination)|6
7558196|NCT02377349|26278381|P2|Overall Study|Lost to follow-up (partial vaccination)|0
7558197|NCT02377349|26278382|P1|Overall Study|Lost to follow-up (partial vaccination)|1
7558198|NCT02377349|26278381|P2|Overall Study|Withdrawal by Subject|3
7558199|NCT02377349|26278382|P1|Overall Study|Withdrawal by Subject|5
7558200|NCT02377349|26278381|P2|Overall Study|Protocol Violation|2
7558201|NCT02377349|26278382|P1|Overall Study|Protocol Violation|3
7558202|NCT02377349|26278381|P2|Overall Study|Serious Adverse Event|0
7558203|NCT02377349|26278382|P1|Overall Study|Serious Adverse Event|1
7558204|NCT02377063|26278420|P1|Overall Study|Non-compliance|5
7558205|NCT02376790|26278438|P3|Overall Study|Lost to Follow-up|12
7558206|NCT02376790|26278439|P2|Overall Study|Lost to Follow-up|10
7558207|NCT02376790|26278440|P1|Overall Study|Lost to Follow-up|15
7558208|NCT02376790|26278438|P3|Overall Study|Decision by Sponsor|4
7558209|NCT02376790|26278439|P2|Overall Study|Decision by Sponsor|1
7558210|NCT02376790|26278440|P1|Overall Study|Decision by Sponsor|2
7558211|NCT02376790|26278438|P3|Overall Study|Withdrawal by Subject|37
7558212|NCT02376790|26278439|P2|Overall Study|Withdrawal by Subject|36
7558213|NCT02376790|26278440|P1|Overall Study|Withdrawal by Subject|43
7558214|NCT02376166|26278648|P1|Overall Study|Discontinued metformin early|2
7558215|NCT02376166|26278648|P1|Overall Study|Adverse Event|1
7558216|NCT02375971|26278692|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
7558217|NCT02375971|26278693|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7558218|NCT02375971|26278694|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7558219|NCT02375971|26278692|P3|Follow-Up Phase (up to Day 169)|Death|4
7558220|NCT02375971|26278693|P2|Follow-Up Phase (up to Day 169)|Death|4
7558221|NCT02375971|26278694|P1|Follow-Up Phase (up to Day 169)|Death|4
7558222|NCT02375971|26278692|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7558223|NCT02375971|26278693|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
7558224|NCT02375971|26278694|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7558225|NCT02375971|26278692|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
7558226|NCT02375971|26278693|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
7558227|NCT02375971|26278694|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
7558228|NCT02375971|26278692|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
7558229|NCT02375971|26278693|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
7558230|NCT02375971|26278694|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
7558231|NCT02375971|26278692|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
7558232|NCT02375971|26278693|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7558233|NCT02375971|26278694|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7558234|NCT02375971|26278692|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
7558235|NCT02375971|26278693|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
7558236|NCT02375971|26278694|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
7558237|NCT02375971|26278692|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
7558238|NCT02375971|26278693|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7558239|NCT02375971|26278694|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7558240|NCT02375724|26278736|P2|Overall Study|Adverse Event|4
7558241|NCT02375724|26278737|P1|Overall Study|Adverse Event|2
7558242|NCT02375724|26278736|P2|Overall Study|Protocol Violation|0
7558243|NCT02375724|26278737|P1|Overall Study|Protocol Violation|1
7558244|NCT02375724|26278736|P2|Overall Study|Lost to Follow-up|0
7558245|NCT02375724|26278737|P1|Overall Study|Lost to Follow-up|1
7558246|NCT02375724|26278736|P2|Overall Study|Withdrawal by Subject|1
7558247|NCT02375724|26278737|P1|Overall Study|Withdrawal by Subject|1
7558248|NCT02375724|26278736|P2|Overall Study|Lack of Efficacy|1
7558249|NCT02375724|26278737|P1|Overall Study|Lack of Efficacy|1
7558250|NCT02375698|26278749|P2|Overall Study|Physician Decision|0
7558251|NCT02375698|26278750|P1|Overall Study|Physician Decision|2
7558252|NCT02375698|26278749|P2|Overall Study|Withdrawal by Subject|2
7558253|NCT02375698|26278750|P1|Overall Study|Withdrawal by Subject|0
7558254|NCT02375672|26278758|P1|Overall Study|remain on follow up|20
7558255|NCT02375373|26278766|P1|Overall Study|Withdrawal by Subject|11
7558256|NCT02375347|26278770|P1|Overall Study|Protocol Violation|1
7558257|NCT02374957|26278776|P2|Overall Study|Patient did not complete forms correctly|0
7558258|NCT02374957|26278777|P1|Overall Study|Patient did not complete forms correctly|1
7558259|NCT02374918|26278807|P4|Overall Study|Lack of Efficacy|1
7558260|NCT02374918|26278808|P3|Overall Study|Lack of Efficacy|1
7558261|NCT02374918|26278809|P2|Overall Study|Lack of Efficacy|0
7558262|NCT02374918|26278810|P1|Overall Study|Lack of Efficacy|0
7558263|NCT02374918|26278807|P4|Overall Study|Withdrawal by Subject|0
7558264|NCT02374918|26278808|P3|Overall Study|Withdrawal by Subject|1
7558265|NCT02374918|26278809|P2|Overall Study|Withdrawal by Subject|1
7558266|NCT02374918|26278810|P1|Overall Study|Withdrawal by Subject|1
7558267|NCT02374918|26278807|P4|Overall Study|Protocol Violation|1
7558268|NCT02374918|26278808|P3|Overall Study|Protocol Violation|2
7558269|NCT02374918|26278809|P2|Overall Study|Protocol Violation|0
7558270|NCT02374918|26278810|P1|Overall Study|Protocol Violation|2
7558271|NCT02374671|26278839|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7558272|NCT02374671|26278840|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7558273|NCT02374671|26278841|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7558274|NCT02374671|26278839|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
7558275|NCT02374671|26278840|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
7558276|NCT02374671|26278841|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
7558277|NCT02374671|26278839|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
7558278|NCT02374671|26278840|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7558279|NCT02374671|26278841|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
7558280|NCT02374671|26278839|P3|Observation (Deferred Implantation)|Adverse Event|1
7558281|NCT02374671|26278840|P2|Observation (Deferred Implantation)|Adverse Event|0
7558282|NCT02374671|26278841|P1|Observation (Deferred Implantation)|Adverse Event|0
7558368|NCT02373813|26279152|P1|Run-In Period|Other, Not Specified|5
7558283|NCT02374671|26278839|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
7558284|NCT02374671|26278840|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
7558285|NCT02374671|26278841|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
7558286|NCT02374593|26278849|P2|Overall Study|non-compliant|0
7558287|NCT02374593|26278850|P1|Overall Study|non-compliant|2
7558288|NCT02374463|26278862|P2|Overall Study|Withdrawal by Subject|3
7558289|NCT02374463|26278863|P1|Overall Study|Withdrawal by Subject|3
7558290|NCT02374346|26278912|P1|Overall Study|operated or discharged during weekend|48
7558291|NCT02374307|26278920|P2|6-months Follow-up|Withdrawal by Subject|3
7558292|NCT02374307|26278921|P1|6-months Follow-up|Withdrawal by Subject|0
7558293|NCT02374307|26278920|P2|6-months Follow-up|Death|1
7558294|NCT02374307|26278921|P1|6-months Follow-up|Death|2
7558295|NCT02374307|26278920|P2|6-months Follow-up|Lost to Follow-up|2
7558296|NCT02374307|26278921|P1|6-months Follow-up|Lost to Follow-up|1
7558297|NCT02374307|26278920|P2|3-months Follow-up|Missed first follow-up|1
7558298|NCT02374307|26278921|P1|3-months Follow-up|Missed first follow-up|5
7558299|NCT02374307|26278920|P2|3-months Follow-up|Death|2
7558300|NCT02374307|26278921|P1|3-months Follow-up|Death|1
7558301|NCT02374307|26278920|P2|3-months Follow-up|Withdrawal by Subject|4
7558302|NCT02374307|26278921|P1|3-months Follow-up|Withdrawal by Subject|1
7558303|NCT02374307|26278920|P2|3-months Follow-up|Lost to Follow-up|2
7558304|NCT02374307|26278921|P1|3-months Follow-up|Lost to Follow-up|1
7558305|NCT02374255|26278952|P4|Overall Study|Withdrawal by Subject|0
7558306|NCT02374255|26278953|P3|Overall Study|Withdrawal by Subject|0
7558307|NCT02374255|26278954|P2|Overall Study|Withdrawal by Subject|0
7558308|NCT02374255|26278955|P1|Overall Study|Withdrawal by Subject|2
7558309|NCT02374099|26279056|P2|Overall Study|Study Terminated by Sponsor|4
7558310|NCT02374099|26279057|P1|Overall Study|Study Terminated by Sponsor|3
7558311|NCT02374099|26279056|P2|Overall Study|Randomized, but not treated|1
7558312|NCT02374099|26279057|P1|Overall Study|Randomized, but not treated|2
7558313|NCT02374099|26279056|P2|Overall Study|Miscellaneous|3
7558314|NCT02374099|26279057|P1|Overall Study|Miscellaneous|2
7558315|NCT02374099|26279056|P2|Overall Study|Withdrawal by Subject|1
7558316|NCT02374099|26279057|P1|Overall Study|Withdrawal by Subject|5
7558317|NCT02374099|26279056|P2|Overall Study|Progressive Disease|40
7558318|NCT02374099|26279057|P1|Overall Study|Progressive Disease|35
7558319|NCT02374099|26279056|P2|Overall Study|Adverse Event|0
7558320|NCT02374099|26279057|P1|Overall Study|Adverse Event|1
7558321|NCT02373813|26279149|P4|Double-Blind Treatment Period|Withdrawal by Subject|3
7558322|NCT02373813|26279150|P3|Double-Blind Treatment Period|Withdrawal by Subject|6
7558323|NCT02373813|26279151|P2|Double-Blind Treatment Period|Withdrawal by Subject|10
7558324|NCT02373813|26279152|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7558325|NCT02373813|26279149|P4|Double-Blind Treatment Period|Lost to Follow-up|1
7558326|NCT02373813|26279150|P3|Double-Blind Treatment Period|Lost to Follow-up|1
7558327|NCT02373813|26279151|P2|Double-Blind Treatment Period|Lost to Follow-up|0
7558328|NCT02373813|26279152|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7558329|NCT02373813|26279149|P4|Double-Blind Treatment Period|Protocol Violation|0
7558330|NCT02373813|26279150|P3|Double-Blind Treatment Period|Protocol Violation|0
7558331|NCT02373813|26279151|P2|Double-Blind Treatment Period|Protocol Violation|2
7558332|NCT02373813|26279152|P1|Double-Blind Treatment Period|Protocol Violation|0
7558333|NCT02373813|26279149|P4|Double-Blind Treatment Period|Decision by Sponsor|0
7558334|NCT02373813|26279150|P3|Double-Blind Treatment Period|Decision by Sponsor|2
7558335|NCT02373813|26279151|P2|Double-Blind Treatment Period|Decision by Sponsor|1
7558336|NCT02373813|26279152|P1|Double-Blind Treatment Period|Decision by Sponsor|0
7558337|NCT02373813|26279149|P4|Run-In Period|Ineligibility Determined|0
7558338|NCT02373813|26279150|P3|Run-In Period|Ineligibility Determined|0
7558339|NCT02373813|26279151|P2|Run-In Period|Ineligibility Determined|0
7558340|NCT02373813|26279152|P1|Run-In Period|Ineligibility Determined|3
7558341|NCT02373813|26279149|P4|Run-In Period|Noncompliance|0
7558342|NCT02373813|26279150|P3|Run-In Period|Noncompliance|0
7558343|NCT02373813|26279151|P2|Run-In Period|Noncompliance|0
7558344|NCT02373813|26279152|P1|Run-In Period|Noncompliance|1
7558345|NCT02373813|26279149|P4|Run-In Period|Adverse Event|0
7558346|NCT02373813|26279150|P3|Run-In Period|Adverse Event|0
7558347|NCT02373813|26279151|P2|Run-In Period|Adverse Event|0
7558348|NCT02373813|26279152|P1|Run-In Period|Adverse Event|3
7558349|NCT02373813|26279149|P4|Run-In Period|Lost to Follow-up|0
7558350|NCT02373813|26279150|P3|Run-In Period|Lost to Follow-up|0
7558351|NCT02373813|26279151|P2|Run-In Period|Lost to Follow-up|0
7558352|NCT02373813|26279152|P1|Run-In Period|Lost to Follow-up|2
7558353|NCT02373813|26279149|P4|Run-In Period|Protocol Violation|0
7558354|NCT02373813|26279150|P3|Run-In Period|Protocol Violation|0
7558355|NCT02373813|26279151|P2|Run-In Period|Protocol Violation|0
7558356|NCT02373813|26279152|P1|Run-In Period|Protocol Violation|75
7558357|NCT02373813|26279149|P4|Run-In Period|Decision by Sponsor|0
7558358|NCT02373813|26279150|P3|Run-In Period|Decision by Sponsor|0
7558359|NCT02373813|26279151|P2|Run-In Period|Decision by Sponsor|0
7558360|NCT02373813|26279152|P1|Run-In Period|Decision by Sponsor|11
7558361|NCT02373813|26279149|P4|Run-In Period|Withdrawal by Subject|0
7558362|NCT02373813|26279150|P3|Run-In Period|Withdrawal by Subject|0
7558363|NCT02373813|26279151|P2|Run-In Period|Withdrawal by Subject|0
7558364|NCT02373813|26279152|P1|Run-In Period|Withdrawal by Subject|16
7558365|NCT02373813|26279149|P4|Run-In Period|Other, Not Specified|0
7558366|NCT02373813|26279150|P3|Run-In Period|Other, Not Specified|0
7558367|NCT02373813|26279151|P2|Run-In Period|Other, Not Specified|0
7558369|NCT02373202|26279224|P4|Overall Study|Other|0
7558370|NCT02373202|26279225|P3|Overall Study|Other|0
7558371|NCT02373202|26279226|P2|Overall Study|Other|1
7558372|NCT02373202|26279227|P1|Overall Study|Other|0
7558373|NCT02373202|26279224|P4|Overall Study|Lack of Efficacy|0
7558374|NCT02373202|26279225|P3|Overall Study|Lack of Efficacy|1
7558375|NCT02373202|26279226|P2|Overall Study|Lack of Efficacy|0
7558376|NCT02373202|26279227|P1|Overall Study|Lack of Efficacy|0
7558377|NCT02373202|26279224|P4|Overall Study|Adverse Event|1
7558378|NCT02373202|26279225|P3|Overall Study|Adverse Event|2
7558379|NCT02373202|26279226|P2|Overall Study|Adverse Event|5
7558380|NCT02373202|26279227|P1|Overall Study|Adverse Event|2
7558381|NCT02373098|26279318|P2|Overall Study|Adverse Event|0
7558382|NCT02373098|26279319|P1|Overall Study|Adverse Event|3
7558383|NCT02373098|26279318|P2|Overall Study|Withdrawal by Subject|0
7558384|NCT02373098|26279319|P1|Overall Study|Withdrawal by Subject|5
7558385|NCT02373098|26279318|P2|Overall Study|Protocol Violation|0
7558386|NCT02373098|26279319|P1|Overall Study|Protocol Violation|3
7558387|NCT02373098|26279318|P2|Overall Study|Lost to Follow-up|0
7558388|NCT02373098|26279319|P1|Overall Study|Lost to Follow-up|1
7558389|NCT02372799|26279347|P3|Down-taper Period|Lost to Follow-up|2
7558390|NCT02372799|26279348|P2|Down-taper Period|Lost to Follow-up|2
7558391|NCT02372799|26279349|P1|Down-taper Period|Lost to Follow-up|1
7558392|NCT02372799|26279347|P3|Treatment Period|Miscellaneous Reasons|0
7558393|NCT02372799|26279348|P2|Treatment Period|Miscellaneous Reasons|1
7558394|NCT02372799|26279349|P1|Treatment Period|Miscellaneous Reasons|1
7558395|NCT02372799|26279347|P3|Treatment Period|Non-compliance with study drug|4
7558396|NCT02372799|26279348|P2|Treatment Period|Non-compliance with study drug|4
7558397|NCT02372799|26279349|P1|Treatment Period|Non-compliance with study drug|4
7558398|NCT02372799|26279347|P3|Treatment Period|Protocol Violation|0
7558399|NCT02372799|26279348|P2|Treatment Period|Protocol Violation|0
7558400|NCT02372799|26279349|P1|Treatment Period|Protocol Violation|3
7558401|NCT02372799|26279347|P3|Treatment Period|Lost to Follow-up|3
7558402|NCT02372799|26279348|P2|Treatment Period|Lost to Follow-up|5
7558403|NCT02372799|26279349|P1|Treatment Period|Lost to Follow-up|11
7558404|NCT02372799|26279347|P3|Treatment Period|Withdrawal by Subject|2
7558405|NCT02372799|26279348|P2|Treatment Period|Withdrawal by Subject|10
7558406|NCT02372799|26279349|P1|Treatment Period|Withdrawal by Subject|10
7558407|NCT02372799|26279347|P3|Treatment Period|Insufficient therapeutic response|0
7558408|NCT02372799|26279348|P2|Treatment Period|Insufficient therapeutic response|2
7558409|NCT02372799|26279349|P1|Treatment Period|Insufficient therapeutic response|2
7558410|NCT02372799|26279347|P3|Treatment Period|Adverse Event|6
7558411|NCT02372799|26279348|P2|Treatment Period|Adverse Event|10
7558412|NCT02372799|26279349|P1|Treatment Period|Adverse Event|3
7558413|NCT02372396|26279378|P2|Overall Study|Lost to Follow-up|9
7558414|NCT02372396|26279379|P1|Overall Study|Lost to Follow-up|7
7558415|NCT02372383|26279387|P3|First Intervention (1 Day)|Unable to collect blood|0
7558416|NCT02372383|26279388|P2|First Intervention (1 Day)|Unable to collect blood|1
7558417|NCT02372383|26279389|P1|First Intervention (1 Day)|Unable to collect blood|0
7558418|NCT02372253|26279442|P2|Overall Study|Non Compliance|0
7558419|NCT02372253|26279443|P1|Overall Study|Non Compliance|2
7558420|NCT02372136|26279461|P2|Overall Study|Death|1
7558421|NCT02372136|26279462|P1|Overall Study|Death|3
7558422|NCT02372071|26279505|P1|Overall Study|Protocol Violation|18
7558423|NCT02372058|26279510|P1|Overall Study|Withdrawal by Subject|3
7558424|NCT02372006|26279519|P3|Overall Study|Other reason for not completing|1
7558425|NCT02372006|26279520|P2|Overall Study|Other reason for not completing|0
7558426|NCT02372006|26279521|P1|Overall Study|Other reason for not completing|0
7558427|NCT02372006|26279519|P3|Overall Study|Withdrawal by Subject|1
7558428|NCT02372006|26279520|P2|Overall Study|Withdrawal by Subject|1
7558429|NCT02372006|26279521|P1|Overall Study|Withdrawal by Subject|0
7558430|NCT02372006|26279519|P3|Overall Study|Adverse Event|3
7558431|NCT02372006|26279520|P2|Overall Study|Adverse Event|0
7558432|NCT02372006|26279521|P1|Overall Study|Adverse Event|0
7558433|NCT02372006|26279519|P3|Overall Study|Dose limiting toxicity|0
7558434|NCT02372006|26279520|P2|Overall Study|Dose limiting toxicity|1
7558435|NCT02372006|26279521|P1|Overall Study|Dose limiting toxicity|0
7558436|NCT02372006|26279519|P3|Overall Study|Progressive disease|34
7558437|NCT02372006|26279520|P2|Overall Study|Progressive disease|7
7558438|NCT02372006|26279521|P1|Overall Study|Progressive disease|8
7558439|NCT02371980|26279553|P5|Double-blind Period|Missing|0
7558440|NCT02371980|26279554|P4|Double-blind Period|Missing|0
7558441|NCT02371980|26279555|P3|Double-blind Period|Missing|0
7558442|NCT02371980|26279556|P2|Double-blind Period|Missing|1
7558443|NCT02371980|26279557|P1|Double-blind Period|Missing|0
7558444|NCT02371980|26279553|P5|Double-blind Period|Reason not Specified|1
7558445|NCT02371980|26279554|P4|Double-blind Period|Reason not Specified|2
7558446|NCT02371980|26279555|P3|Double-blind Period|Reason not Specified|3
7558447|NCT02371980|26279556|P2|Double-blind Period|Reason not Specified|3
7558448|NCT02371980|26279557|P1|Double-blind Period|Reason not Specified|0
7558449|NCT02371980|26279553|P5|Double-blind Period|Relapse|26
7558450|NCT02371980|26279554|P4|Double-blind Period|Relapse|25
7558451|NCT02371980|26279555|P3|Double-blind Period|Relapse|25
7558452|NCT02371980|26279556|P2|Double-blind Period|Relapse|50
7558453|NCT02371980|26279557|P1|Double-blind Period|Relapse|0
7558454|NCT02371980|26279553|P5|Double-blind Period|Voluntary Withdrawal|11
7558455|NCT02371980|26279554|P4|Double-blind Period|Voluntary Withdrawal|9
7558456|NCT02371980|26279555|P3|Double-blind Period|Voluntary Withdrawal|8
7558457|NCT02371980|26279556|P2|Double-blind Period|Voluntary Withdrawal|12
7558458|NCT02371980|26279557|P1|Double-blind Period|Voluntary Withdrawal|0
7558459|NCT02371980|26279553|P5|Double-blind Period|Lost to Follow-up|5
7558460|NCT02371980|26279554|P4|Double-blind Period|Lost to Follow-up|6
7558461|NCT02371980|26279555|P3|Double-blind Period|Lost to Follow-up|8
7558462|NCT02371980|26279556|P2|Double-blind Period|Lost to Follow-up|8
7558463|NCT02371980|26279557|P1|Double-blind Period|Lost to Follow-up|0
7558464|NCT02371980|26279553|P5|Double-blind Period|Noncompliance with Study Drug|3
7558465|NCT02371980|26279554|P4|Double-blind Period|Noncompliance with Study Drug|2
7558466|NCT02371980|26279555|P3|Double-blind Period|Noncompliance with Study Drug|2
7558467|NCT02371980|26279556|P2|Double-blind Period|Noncompliance with Study Drug|1
7558468|NCT02371980|26279557|P1|Double-blind Period|Noncompliance with Study Drug|0
7558469|NCT02371980|26279553|P5|Double-blind Period|Significant Protocol Deviation|3
7558470|NCT02371980|26279554|P4|Double-blind Period|Significant Protocol Deviation|3
7558471|NCT02371980|26279555|P3|Double-blind Period|Significant Protocol Deviation|7
7558472|NCT02371980|26279556|P2|Double-blind Period|Significant Protocol Deviation|2
7558473|NCT02371980|26279557|P1|Double-blind Period|Significant Protocol Deviation|0
7558474|NCT02371980|26279553|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
7558475|NCT02371980|26279554|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
7558476|NCT02371980|26279555|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
7558477|NCT02371980|26279556|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
7558478|NCT02371980|26279557|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
7558479|NCT02371980|26279553|P5|Open-label Period|Reason not Specified|0
7558480|NCT02371980|26279554|P4|Open-label Period|Reason not Specified|0
7558481|NCT02371980|26279555|P3|Open-label Period|Reason not Specified|0
7558482|NCT02371980|26279556|P2|Open-label Period|Reason not Specified|0
7558483|NCT02371980|26279557|P1|Open-label Period|Reason not Specified|9
7558484|NCT02371980|26279553|P5|Open-label Period|Did not Meet Randomization Criteria|0
7558485|NCT02371980|26279554|P4|Open-label Period|Did not Meet Randomization Criteria|0
7558486|NCT02371980|26279555|P3|Open-label Period|Did not Meet Randomization Criteria|0
7558487|NCT02371980|26279556|P2|Open-label Period|Did not Meet Randomization Criteria|0
7558488|NCT02371980|26279557|P1|Open-label Period|Did not Meet Randomization Criteria|162
7558489|NCT02371980|26279553|P5|Open-label Period|Lack of Efficacy|0
7558490|NCT02371980|26279554|P4|Open-label Period|Lack of Efficacy|0
7558491|NCT02371980|26279555|P3|Open-label Period|Lack of Efficacy|0
7558492|NCT02371980|26279556|P2|Open-label Period|Lack of Efficacy|0
7558493|NCT02371980|26279557|P1|Open-label Period|Lack of Efficacy|116
7558494|NCT02371980|26279553|P5|Open-label Period|Pregnancy|0
7558495|NCT02371980|26279554|P4|Open-label Period|Pregnancy|0
7558496|NCT02371980|26279555|P3|Open-label Period|Pregnancy|0
7558497|NCT02371980|26279556|P2|Open-label Period|Pregnancy|0
7558498|NCT02371980|26279557|P1|Open-label Period|Pregnancy|1
7558499|NCT02371980|26279553|P5|Open-label Period|Voluntary Withdrawal|0
7558500|NCT02371980|26279554|P4|Open-label Period|Voluntary Withdrawal|0
7558501|NCT02371980|26279555|P3|Open-label Period|Voluntary Withdrawal|0
7558502|NCT02371980|26279556|P2|Open-label Period|Voluntary Withdrawal|0
7558503|NCT02371980|26279557|P1|Open-label Period|Voluntary Withdrawal|91
7558504|NCT02371980|26279553|P5|Open-label Period|Lost to Follow-up|0
7558505|NCT02371980|26279554|P4|Open-label Period|Lost to Follow-up|0
7558506|NCT02371980|26279555|P3|Open-label Period|Lost to Follow-up|0
7558507|NCT02371980|26279556|P2|Open-label Period|Lost to Follow-up|0
7558508|NCT02371980|26279557|P1|Open-label Period|Lost to Follow-up|55
7558509|NCT02371980|26279553|P5|Open-label Period|Noncompliance with Study Drug|0
7558510|NCT02371980|26279554|P4|Open-label Period|Noncompliance with Study Drug|0
7558511|NCT02371980|26279555|P3|Open-label Period|Noncompliance with Study Drug|0
7558512|NCT02371980|26279556|P2|Open-label Period|Noncompliance with Study Drug|0
7558513|NCT02371980|26279557|P1|Open-label Period|Noncompliance with Study Drug|10
7558514|NCT02371980|26279553|P5|Open-label Period|Significant Protocol Deviation|0
7558515|NCT02371980|26279554|P4|Open-label Period|Significant Protocol Deviation|0
7558516|NCT02371980|26279555|P3|Open-label Period|Significant Protocol Deviation|0
7558517|NCT02371980|26279556|P2|Open-label Period|Significant Protocol Deviation|0
7558518|NCT02371980|26279557|P1|Open-label Period|Significant Protocol Deviation|19
7558519|NCT02371980|26279553|P5|Open-label Period|Pretreatment Event/Adverse Event|0
7558520|NCT02371980|26279554|P4|Open-label Period|Pretreatment Event/Adverse Event|0
7558521|NCT02371980|26279555|P3|Open-label Period|Pretreatment Event/Adverse Event|0
7558522|NCT02371980|26279556|P2|Open-label Period|Pretreatment Event/Adverse Event|0
7558523|NCT02371980|26279557|P1|Open-label Period|Pretreatment Event/Adverse Event|63
7558524|NCT02371889|26279586|P2|Overall Study|Relapse|1
7558525|NCT02371889|26279587|P1|Overall Study|Relapse|0
7558526|NCT02371889|26279586|P2|Overall Study|Lack of Efficacy|2
7558527|NCT02371889|26279587|P1|Overall Study|Lack of Efficacy|0
7558528|NCT02371889|26279586|P2|Overall Study|Personal time constraints|4
7558529|NCT02371889|26279587|P1|Overall Study|Personal time constraints|2
7558530|NCT02371889|26279586|P2|Overall Study|Lost to Follow-up|5
7558531|NCT02371889|26279587|P1|Overall Study|Lost to Follow-up|6
7558532|NCT02371889|26279586|P2|Overall Study|Adverse medication effect|2
7558533|NCT02371889|26279587|P1|Overall Study|Adverse medication effect|11
7558534|NCT02371759|26279640|P8|Overall Study|Withdrawal by Subject|1
7558535|NCT02371759|26279641|P7|Overall Study|Withdrawal by Subject|0
7558536|NCT02371759|26279642|P6|Overall Study|Withdrawal by Subject|0
7558537|NCT02371759|26279643|P5|Overall Study|Withdrawal by Subject|0
7558538|NCT02371759|26279644|P4|Overall Study|Withdrawal by Subject|0
7558539|NCT02371759|26279645|P3|Overall Study|Withdrawal by Subject|0
7558540|NCT02371759|26279646|P2|Overall Study|Withdrawal by Subject|0
7558541|NCT02371759|26279647|P1|Overall Study|Withdrawal by Subject|0
7558542|NCT02371759|26279640|P8|Overall Study|Protocol Violation|3
7558543|NCT02371759|26279641|P7|Overall Study|Protocol Violation|0
7558544|NCT02371759|26279642|P6|Overall Study|Protocol Violation|1
7558545|NCT02371759|26279643|P5|Overall Study|Protocol Violation|3
7558546|NCT02371759|26279644|P4|Overall Study|Protocol Violation|0
7558547|NCT02371759|26279645|P3|Overall Study|Protocol Violation|1
7558548|NCT02371759|26279646|P2|Overall Study|Protocol Violation|1
7558549|NCT02371759|26279647|P1|Overall Study|Protocol Violation|3
7558550|NCT02371746|26279864|P7|Overall Study|Consent withdrawn|1
7558551|NCT02371746|26279865|P6|Overall Study|Consent withdrawn|0
7558552|NCT02371746|26279866|P5|Overall Study|Consent withdrawn|0
7558553|NCT02371746|26279867|P4|Overall Study|Consent withdrawn|0
7558554|NCT02371746|26279868|P3|Overall Study|Consent withdrawn|0
7558555|NCT02371746|26279869|P2|Overall Study|Consent withdrawn|0
7558556|NCT02371746|26279870|P1|Overall Study|Consent withdrawn|0
7558557|NCT02371629|26279913|P2|Overall Study|Protocol deviation|1
7558558|NCT02371629|26279914|P1|Overall Study|Protocol deviation|0
7558559|NCT02371629|26279913|P2|Overall Study|Lack of Efficacy|2
7558560|NCT02371629|26279914|P1|Overall Study|Lack of Efficacy|0
7558561|NCT02371629|26279913|P2|Overall Study|Noncompliance with study treatment|0
7558562|NCT02371629|26279914|P1|Overall Study|Noncompliance with study treatment|1
7558563|NCT02371629|26279913|P2|Overall Study|Death|1
7558564|NCT02371629|26279914|P1|Overall Study|Death|1
7558565|NCT02371629|26279913|P2|Overall Study|Physician Decision|3
7558566|NCT02371629|26279914|P1|Overall Study|Physician Decision|2
7558567|NCT02371629|26279913|P2|Overall Study|Adverse Event|8
7558568|NCT02371629|26279914|P1|Overall Study|Adverse Event|8
7558569|NCT02371629|26279913|P2|Overall Study|Patient decision|10
7558570|NCT02371629|26279914|P1|Overall Study|Patient decision|14
7558571|NCT02371616|26279950|P2|Overall Study|Other (Not specified)|5
7558572|NCT02371616|26279951|P1|Overall Study|Other (Not specified)|1
7558573|NCT02371616|26279950|P2|Overall Study|Withdrawal of Consent|0
7558574|NCT02371616|26279951|P1|Overall Study|Withdrawal of Consent|1
7558575|NCT02371616|26279950|P2|Overall Study|Adverse Event|1
7558576|NCT02371616|26279951|P1|Overall Study|Adverse Event|0
7558577|NCT02371616|26279950|P2|Overall Study|Protocol Violation|1
7558578|NCT02371616|26279951|P1|Overall Study|Protocol Violation|2
7558579|NCT02371369|26279969|P2|Part 2|Death|1
7558580|NCT02371369|26279970|P1|Part 2|Death|0
7558581|NCT02371369|26279969|P2|Part 2|Physician Decision|0
7558582|NCT02371369|26279970|P1|Part 2|Physician Decision|1
7558583|NCT02371369|26279969|P2|Part 2|Withdrawal by Subject|1
7558584|NCT02371369|26279970|P1|Part 2|Withdrawal by Subject|5
7558585|NCT02371369|26279969|P2|Part 2|Adverse Event|2
7558586|NCT02371369|26279970|P1|Part 2|Adverse Event|3
7558587|NCT02371369|26279969|P2|Part 1|Protocol Violation|1
7558588|NCT02371369|26279970|P1|Part 1|Protocol Violation|0
7558589|NCT02371369|26279969|P2|Part 1|Disease progression|1
7558590|NCT02371369|26279970|P1|Part 1|Disease progression|0
7558591|NCT02371369|26279969|P2|Part 1|Withdrawal by Subject|6
7558592|NCT02371369|26279970|P1|Part 1|Withdrawal by Subject|1
7558593|NCT02371369|26279969|P2|Part 1|Adverse Event|0
7558594|NCT02371369|26279970|P1|Part 1|Adverse Event|8
7558595|NCT02371369|26279969|P2|Part 1|Physician Decision|3
7558596|NCT02371369|26279970|P1|Part 1|Physician Decision|0
7558597|NCT02370914|26280072|P1|Overall Study|Protocol Violation|2
7558598|NCT02370888|26280080|P1|Overall Study|did not meet chimerism criteria|6
7558599|NCT02370888|26280080|P1|Overall Study|disease progression|2
7558600|NCT02370784|26280115|P2|Overall Study|Patient started prohibited medication|1
7558601|NCT02370784|26280116|P1|Overall Study|Patient started prohibited medication|0
7558602|NCT02370667|26280145|P3|Overall Study|Lost to Follow-up|0
7558603|NCT02370667|26280146|P2|Overall Study|Lost to Follow-up|1
7558604|NCT02370667|26280147|P1|Overall Study|Lost to Follow-up|0
7558605|NCT02370641|26280211|P2|Overall Study|dropped study|2
7558606|NCT02370641|26280212|P1|Overall Study|dropped study|4
7558607|NCT02370615|26280220|P2|Overall Study|Adverse Event|0
7558608|NCT02370615|26280221|P1|Overall Study|Adverse Event|1
7558609|NCT02370602|26280264|P6|Overall Study|Pretreatment Event/Adverse Event|0
7558610|NCT02370602|26280265|P5|Overall Study|Pretreatment Event/Adverse Event|0
7558611|NCT02370602|26280266|P4|Overall Study|Pretreatment Event/Adverse Event|0
7558612|NCT02370602|26280267|P3|Overall Study|Pretreatment Event/Adverse Event|0
7558613|NCT02370602|26280268|P2|Overall Study|Pretreatment Event/Adverse Event|0
7558614|NCT02370602|26280269|P1|Overall Study|Pretreatment Event/Adverse Event|1
7558615|NCT02370537|26280363|P3|Part B|Withdrawal by Subject|0
7558616|NCT02370537|26280364|P2|Part B|Withdrawal by Subject|1
7558617|NCT02370537|26280365|P1|Part B|Withdrawal by Subject|0
7558618|NCT02370537|26280363|P3|Part B|Not randomised to receive treatment|259
7558619|NCT02370537|26280364|P2|Part B|Not randomised to receive treatment|2
7558620|NCT02370537|26280365|P1|Part B|Not randomised to receive treatment|1
7558621|NCT02370537|26280363|P3|Part A (Open-label Recruitment)|Adverse Event|1
7558622|NCT02370537|26280364|P2|Part A (Open-label Recruitment)|Adverse Event|0
7558623|NCT02370537|26280365|P1|Part A (Open-label Recruitment)|Adverse Event|0
7558624|NCT02370537|26280363|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7558625|NCT02370537|26280364|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
7558718|NCT02368886|26281296|P2|Overall Study|Cancel|1
7558626|NCT02370537|26280365|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7558627|NCT02370511|26280415|P3|Overall Study|Lost to Follow-up|0
7558628|NCT02370511|26280416|P2|Overall Study|Lost to Follow-up|4
7558629|NCT02370511|26280417|P1|Overall Study|Lost to Follow-up|0
7558630|NCT02370511|26280415|P3|Overall Study|Withdrawal by Subject|0
7558631|NCT02370511|26280416|P2|Overall Study|Withdrawal by Subject|0
7558632|NCT02370511|26280417|P1|Overall Study|Withdrawal by Subject|2
7558633|NCT02370511|26280415|P3|Overall Study|Death|1
7558634|NCT02370511|26280416|P2|Overall Study|Death|7
7558635|NCT02370511|26280417|P1|Overall Study|Death|10
7558636|NCT02370498|26280436|P2|Overall Study|Ongoing In Trial|33
7558637|NCT02370498|26280437|P1|Overall Study|Ongoing In Trial|56
7558638|NCT02370498|26280436|P2|Overall Study|Withdrawal by Subject|11
7558639|NCT02370498|26280437|P1|Overall Study|Withdrawal by Subject|6
7558640|NCT02370498|26280436|P2|Overall Study|Protocol Violation|2
7558641|NCT02370498|26280437|P1|Overall Study|Protocol Violation|1
7558642|NCT02370498|26280436|P2|Overall Study|Lost to Follow-up|0
7558643|NCT02370498|26280437|P1|Overall Study|Lost to Follow-up|1
7558644|NCT02370498|26280436|P2|Overall Study|Death|242
7558645|NCT02370498|26280437|P1|Overall Study|Death|222
7558646|NCT02370498|26280436|P2|Overall Study|Adverse Event|8
7558647|NCT02370498|26280437|P1|Overall Study|Adverse Event|10
7558648|NCT02370420|26280491|P2|Overall Study|Lost to Follow-up|9
7558649|NCT02370420|26280492|P1|Overall Study|Lost to Follow-up|11
7558650|NCT02370420|26280491|P2|Overall Study|Physician Decision|3
7558651|NCT02370420|26280492|P1|Overall Study|Physician Decision|3
7558652|NCT02370394|26280529|P2|Overall Study|Withdrawal by Subject|1
7558653|NCT02370394|26280530|P1|Overall Study|Withdrawal by Subject|0
7558654|NCT02370394|26280529|P2|Overall Study|Lost to Follow-up|1
7558655|NCT02370394|26280530|P1|Overall Study|Lost to Follow-up|2
7558656|NCT02370368|26280546|P2|Overall Study|Withdrawal by Subject|4
7558657|NCT02370368|26280547|P1|Overall Study|Withdrawal by Subject|5
7558658|NCT02370368|26280546|P2|Overall Study|Adverse Event|2
7558659|NCT02370368|26280547|P1|Overall Study|Adverse Event|1
7558660|NCT02370251|26280557|P1|Overall Study|Death|4
7558661|NCT02370251|26280557|P1|Overall Study|Received less than 8 days of Omegaven|7
7558662|NCT02370238|26280565|P2|Overall Study|Other|1
7558663|NCT02370238|26280566|P1|Overall Study|Other|2
7558664|NCT02370238|26280565|P2|Overall Study|Withdrawal by Subject|6
7558665|NCT02370238|26280566|P1|Overall Study|Withdrawal by Subject|2
7558666|NCT02370238|26280565|P2|Overall Study|Lost to Follow-up|3
7558667|NCT02370238|26280566|P1|Overall Study|Lost to Follow-up|1
7558668|NCT02370238|26280565|P2|Overall Study|Death|35
7558669|NCT02370238|26280566|P1|Overall Study|Death|42
7558670|NCT02370160|26280586|P3|Overall Study|Death|1
7558671|NCT02370160|26280587|P2|Overall Study|Death|4
7558672|NCT02370160|26280588|P1|Overall Study|Death|3
7558673|NCT02370121|26280612|P2|Overall Study|Lost to Follow-up|1
7558674|NCT02370121|26280613|P1|Overall Study|Lost to Follow-up|1
7558675|NCT02370095|26280653|P2|Overall Study|Withdrawal by Subject|1
7558676|NCT02370095|26280654|P1|Overall Study|Withdrawal by Subject|0
7558677|NCT02370043|26280695|P6|Overall Study|Withdrawal by Subject|1
7558678|NCT02370043|26280696|P5|Overall Study|Withdrawal by Subject|1
7558679|NCT02370043|26280697|P4|Overall Study|Withdrawal by Subject|0
7558680|NCT02370043|26280698|P3|Overall Study|Withdrawal by Subject|0
7558681|NCT02370043|26280699|P2|Overall Study|Withdrawal by Subject|0
7558682|NCT02370043|26280700|P1|Overall Study|Withdrawal by Subject|0
7558683|NCT02369874|26280870|P3|Overall Study|On Treatment/Off Study|32
7558684|NCT02369874|26280871|P2|Overall Study|On Treatment/Off Study|45
7558685|NCT02369874|26280872|P1|Overall Study|On Treatment/Off Study|34
7558686|NCT02369874|26280870|P3|Overall Study|Miscellaneous|0
7558687|NCT02369874|26280871|P2|Overall Study|Miscellaneous|1
7558688|NCT02369874|26280872|P1|Overall Study|Miscellaneous|1
7558689|NCT02369874|26280870|P3|Overall Study|Withdrawal by Subject|27
7558690|NCT02369874|26280871|P2|Overall Study|Withdrawal by Subject|9
7558691|NCT02369874|26280872|P1|Overall Study|Withdrawal by Subject|7
7558692|NCT02369874|26280870|P3|Overall Study|Lost to Follow-up|2
7558693|NCT02369874|26280871|P2|Overall Study|Lost to Follow-up|2
7558694|NCT02369874|26280872|P1|Overall Study|Lost to Follow-up|2
7558695|NCT02369848|26280919|P1|Overall Study|Lost to Follow-up|1
7558696|NCT02369848|26280919|P1|Overall Study|Withdrawal by Subject|2
7558697|NCT02369848|26280919|P1|Overall Study|Death|1
7558698|NCT02369510|26281035|P3|Overall Study|Epidural Activation|5
7558699|NCT02369510|26281036|P2|Overall Study|Epidural Activation|1
7558700|NCT02369510|26281037|P1|Overall Study|Epidural Activation|1
7558701|NCT02369510|26281035|P3|Overall Study|Spilled Medication|1
7558702|NCT02369510|26281036|P2|Overall Study|Spilled Medication|2
7558703|NCT02369510|26281037|P1|Overall Study|Spilled Medication|1
7558704|NCT02369341|26281076|P2|Overall Study|Migrated/moved from study area|0
7558705|NCT02369341|26281077|P1|Overall Study|Migrated/moved from study area|1
7558706|NCT02369159|26281220|P2|Overall Study|Withdrawal by Subject|0
7558707|NCT02369159|26281221|P1|Overall Study|Withdrawal by Subject|7
7558708|NCT02369159|26281220|P2|Overall Study|Lost to Follow-up|1
7558709|NCT02369159|26281221|P1|Overall Study|Lost to Follow-up|1
7558710|NCT02369159|26281220|P2|Overall Study|Adverse Event|1
7558711|NCT02369159|26281221|P1|Overall Study|Adverse Event|0
7558712|NCT02368886|26281294|P4|Overall Study|Ineligible|1
7558713|NCT02368886|26281295|P3|Overall Study|Ineligible|0
7558714|NCT02368886|26281296|P2|Overall Study|Ineligible|0
7558715|NCT02368886|26281297|P1|Overall Study|Ineligible|0
7558716|NCT02368886|26281294|P4|Overall Study|Cancel|3
7558717|NCT02368886|26281295|P3|Overall Study|Cancel|1
7558719|NCT02368886|26281297|P1|Overall Study|Cancel|1
7558720|NCT02368691|26281315|P1|Overall Study|Physician Decision|4
7558721|NCT02368691|26281315|P1|Overall Study|Lack of Efficacy|15
7558722|NCT02368691|26281315|P1|Overall Study|Death|13
7558723|NCT02368314|26281360|P2|Overall Study|Adverse Event|2
7558724|NCT02368314|26281361|P1|Overall Study|Adverse Event|1
7558725|NCT02368314|26281360|P2|Overall Study|Withdrawal by Subject|1
7558726|NCT02368314|26281361|P1|Overall Study|Withdrawal by Subject|2
7558727|NCT02368210|26281373|P2|Overall Study|Adverse Event|1
7558728|NCT02368210|26281374|P1|Overall Study|Adverse Event|0
7558729|NCT02368210|26281373|P2|Overall Study|Withdrawal by Subject|0
7558730|NCT02368210|26281374|P1|Overall Study|Withdrawal by Subject|1
7558731|NCT02367911|26281401|P2|Overall Study|Lost to Follow-up|2
7558732|NCT02367911|26281402|P1|Overall Study|Lost to Follow-up|2
7558733|NCT02367911|26281401|P2|Overall Study|Withdrawal by Subject|2
7558734|NCT02367911|26281402|P1|Overall Study|Withdrawal by Subject|3
7558735|NCT02367885|26281413|P3|Overall Study|Withdrawal by Subject|0
7558736|NCT02367885|26281414|P2|Overall Study|Withdrawal by Subject|0
7558737|NCT02367885|26281415|P1|Overall Study|Withdrawal by Subject|1
7558738|NCT02367885|26281413|P3|Overall Study|Lost to Follow-up|0
7558739|NCT02367885|26281414|P2|Overall Study|Lost to Follow-up|0
7558740|NCT02367885|26281415|P1|Overall Study|Lost to Follow-up|1
7558741|NCT02367833|26281658|P3|Overall Study|Withdrawal by Subject|0
7558742|NCT02367833|26281659|P2|Overall Study|Withdrawal by Subject|1
7558743|NCT02367833|26281660|P1|Overall Study|Withdrawal by Subject|1
7558744|NCT02367794|26281699|P3|Overall Study|Hypercalcemia prior to C1D1|1
7558745|NCT02367794|26281700|P2|Overall Study|Hypercalcemia prior to C1D1|0
7558746|NCT02367794|26281701|P1|Overall Study|Hypercalcemia prior to C1D1|0
7558747|NCT02367794|26281699|P3|Overall Study|Patient unable to receive carboplatin|1
7558748|NCT02367794|26281700|P2|Overall Study|Patient unable to receive carboplatin|0
7558749|NCT02367794|26281701|P1|Overall Study|Patient unable to receive carboplatin|0
7558750|NCT02367794|26281699|P3|Overall Study|Randomized in error|1
7558751|NCT02367794|26281700|P2|Overall Study|Randomized in error|0
7558752|NCT02367794|26281701|P1|Overall Study|Randomized in error|0
7558753|NCT02367794|26281699|P3|Overall Study|Brain metastasis|0
7558754|NCT02367794|26281700|P2|Overall Study|Brain metastasis|0
7558755|NCT02367794|26281701|P1|Overall Study|Brain metastasis|1
7558756|NCT02367794|26281699|P3|Overall Study|Withdrawal by Subject|14
7558757|NCT02367794|26281700|P2|Overall Study|Withdrawal by Subject|12
7558758|NCT02367794|26281701|P1|Overall Study|Withdrawal by Subject|25
7558759|NCT02367794|26281699|P3|Overall Study|Protocol Violation|1
7558760|NCT02367794|26281700|P2|Overall Study|Protocol Violation|0
7558761|NCT02367794|26281701|P1|Overall Study|Protocol Violation|1
7558762|NCT02367794|26281699|P3|Overall Study|Physician Decision|1
7558763|NCT02367794|26281700|P2|Overall Study|Physician Decision|3
7558764|NCT02367794|26281701|P1|Overall Study|Physician Decision|0
7558765|NCT02367794|26281699|P3|Overall Study|Lost to Follow-up|1
7558766|NCT02367794|26281700|P2|Overall Study|Lost to Follow-up|2
7558767|NCT02367794|26281701|P1|Overall Study|Lost to Follow-up|1
7558768|NCT02367794|26281699|P3|Overall Study|Death|229
7558769|NCT02367794|26281700|P2|Overall Study|Death|223
7558770|NCT02367794|26281701|P1|Overall Study|Death|230
7558771|NCT02367781|26281714|P2|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
7558772|NCT02367781|26281715|P1|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
7558773|NCT02367781|26281714|P2|Overall Study|Sponsor Decision|0
7558774|NCT02367781|26281715|P1|Overall Study|Sponsor Decision|2
7558775|NCT02367781|26281714|P2|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
7558776|NCT02367781|26281715|P1|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
7558777|NCT02367781|26281714|P2|Overall Study|Study Terminated by Sponsor|1
7558778|NCT02367781|26281715|P1|Overall Study|Study Terminated by Sponsor|3
7558779|NCT02367781|26281714|P2|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
7558780|NCT02367781|26281715|P1|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
7558781|NCT02367781|26281714|P2|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
7558782|NCT02367781|26281715|P1|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
7558783|NCT02367781|26281714|P2|Overall Study|Administrative-Change Facility|0
7558784|NCT02367781|26281715|P1|Overall Study|Administrative-Change Facility|1
7558785|NCT02367781|26281714|P2|Overall Study|Death Prior First Dose|0
7558786|NCT02367781|26281715|P1|Overall Study|Death Prior First Dose|1
7558787|NCT02367781|26281714|P2|Overall Study|Prolonged Hospitalization|0
7558788|NCT02367781|26281715|P1|Overall Study|Prolonged Hospitalization|1
7558789|NCT02367781|26281714|P2|Overall Study|Patient Moving to Roll-Over Study|5
7558790|NCT02367781|26281715|P1|Overall Study|Patient Moving to Roll-Over Study|17
7558791|NCT02367781|26281714|P2|Overall Study|Death|176
7558792|NCT02367781|26281715|P1|Overall Study|Death|330
7558793|NCT02367781|26281714|P2|Overall Study|Lost to Follow-up|2
7558794|NCT02367781|26281715|P1|Overall Study|Lost to Follow-up|1
7558795|NCT02367781|26281714|P2|Overall Study|Non-Compliance|0
7558796|NCT02367781|26281715|P1|Overall Study|Non-Compliance|1
7558797|NCT02367781|26281714|P2|Overall Study|Randomized in Error|4
7558798|NCT02367781|26281715|P1|Overall Study|Randomized in Error|5
7558799|NCT02367781|26281714|P2|Overall Study|Physician Decision|0
7558800|NCT02367781|26281715|P1|Overall Study|Physician Decision|7
7558801|NCT02367781|26281714|P2|Overall Study|Protocol Violation|1
7558802|NCT02367781|26281715|P1|Overall Study|Protocol Violation|0
7558803|NCT02367781|26281714|P2|Overall Study|Withdrawal by Subject|13
7558804|NCT02367781|26281715|P1|Overall Study|Withdrawal by Subject|20
7558805|NCT02367729|26281756|P2|Overall Study|Withdrawal by Subject|5
7558806|NCT02367729|26281757|P1|Overall Study|Withdrawal by Subject|0
7558807|NCT02367729|26281756|P2|Overall Study|Adverse Event|2
7558808|NCT02367729|26281757|P1|Overall Study|Adverse Event|1
7558809|NCT02367729|26281756|P2|Overall Study|Organic disorder diagnosed|1
7558810|NCT02367729|26281757|P1|Overall Study|Organic disorder diagnosed|2
7558811|NCT02367716|26281773|P1|Overall Study|Patient did not meet inclusion criteria|1
7558812|NCT02367521|26281797|P2|Overall Study|unable to find transportation|0
7558813|NCT02367521|26281798|P1|Overall Study|unable to find transportation|2
7558814|NCT02367521|26281797|P2|Overall Study|severe headache after intervention|0
7558815|NCT02367521|26281798|P1|Overall Study|severe headache after intervention|2
7558828|NCT02367352|26281918|P3|Overall Study|Adverse Event|0
7558829|NCT02367352|26281919|P2|Overall Study|Adverse Event|0
7558830|NCT02367352|26281920|P1|Overall Study|Adverse Event|1
7558831|NCT02367352|26281918|P3|Overall Study|Participant Received Alternative Therapy|0
7558832|NCT02367352|26281919|P2|Overall Study|Participant Received Alternative Therapy|0
7558833|NCT02367352|26281920|P1|Overall Study|Participant Received Alternative Therapy|1
7558834|NCT02367352|26281918|P3|Overall Study|Progressive disease|0
7558835|NCT02367352|26281919|P2|Overall Study|Progressive disease|0
7558836|NCT02367352|26281920|P1|Overall Study|Progressive disease|7
7558837|NCT02367131|26281970|P1|Overall Study|Other than stated above|20
7558838|NCT02367131|26281970|P1|Overall Study|No change/progressive disease|78
7558839|NCT02367131|26281970|P1|Overall Study|Improvement/remission|2
7558840|NCT02367131|26281970|P1|Overall Study|Request by patient|54
7558841|NCT02367131|26281970|P1|Overall Study|No visit since the first visit|4
7558842|NCT02367131|26281970|P1|Overall Study|Adverse Event|64
7558843|NCT02366936|26282253|P1|Overall Study|Physician Decision|2
7558844|NCT02366936|26282253|P1|Overall Study|Lost to Follow-up|4
7558845|NCT02366936|26282253|P1|Overall Study|Withdrawal by Subject|2
7558846|NCT02366923|26282258|P1|Overall Study|High Astigmatism|3
7558847|NCT02366923|26282258|P1|Overall Study|Positive Slit Lamp Findings|2
7558848|NCT02366923|26282258|P1|Overall Study|Withdrawal by Subject|1
7558849|NCT02366910|26282271|P1|Overall Study|Screen Failure|3
7558850|NCT02366910|26282271|P1|Overall Study|Withdrawal by Subject|2
7558851|NCT02366767|26282319|P2|Overall Study|left for home after 1 day at camp|0
7558852|NCT02366767|26282320|P1|Overall Study|left for home after 1 day at camp|1
7558853|NCT02366689|26282333|P3|Overall Study|Pregnancy|1
7558854|NCT02366689|26282334|P2|Overall Study|Pregnancy|1
7558855|NCT02366689|26282335|P1|Overall Study|Pregnancy|0
7558856|NCT02366689|26282333|P3|Overall Study|Lost to Follow-up|0
7558857|NCT02366689|26282334|P2|Overall Study|Lost to Follow-up|2
7558858|NCT02366689|26282335|P1|Overall Study|Lost to Follow-up|3
7558859|NCT02366689|26282333|P3|Overall Study|Withdrawal by Subject|1
7558860|NCT02366689|26282334|P2|Overall Study|Withdrawal by Subject|0
7558861|NCT02366689|26282335|P1|Overall Study|Withdrawal by Subject|1
7558862|NCT02366637|26282387|P2|Second Intervention Period|Study Terminated by Sponsor|1
7558863|NCT02366637|26282388|P1|Second Intervention Period|Study Terminated by Sponsor|1
7558864|NCT02366637|26282387|P2|First Intervention Period|Study Terminated by Sponsor|4
7558865|NCT02366637|26282388|P1|First Intervention Period|Study Terminated by Sponsor|6
7558866|NCT02366637|26282387|P2|First Intervention Period|Adverse Event|1
7558867|NCT02366637|26282388|P1|First Intervention Period|Adverse Event|0
7558868|NCT02366468|26282436|P2|Overall Study|Other|2
7558869|NCT02366468|26282437|P1|Overall Study|Other|0
7558870|NCT02366468|26282436|P2|Overall Study|Death|2
7558871|NCT02366468|26282437|P1|Overall Study|Death|1
7558872|NCT02366468|26282436|P2|Overall Study|Lost to Follow-up|0
7558873|NCT02366468|26282437|P1|Overall Study|Lost to Follow-up|2
7558874|NCT02366468|26282436|P2|Overall Study|Withdrawal by Subject|5
7558875|NCT02366468|26282437|P1|Overall Study|Withdrawal by Subject|1
7558876|NCT02366468|26282436|P2|Overall Study|Adverse Event|0
7558877|NCT02366468|26282437|P1|Overall Study|Adverse Event|2
7558878|NCT02366312|26282481|P2|Overall Study|Lost to Follow-up|1
7558879|NCT02366312|26282482|P1|Overall Study|Lost to Follow-up|0
7558884|NCT02366143|26282509|P3|Overall Study|Patient moved to commercial atezolizumab use|7
7558885|NCT02366143|26282510|P2|Overall Study|Patient moved to commercial atezolizumab use|11
7558886|NCT02366143|26282511|P1|Overall Study|Patient moved to commercial atezolizumab use|0
7558887|NCT02366143|26282509|P3|Overall Study|Patient switched to PTAP|0
7558888|NCT02366143|26282510|P2|Overall Study|Patient switched to PTAP|1
7558889|NCT02366143|26282511|P1|Overall Study|Patient switched to PTAP|0
7558890|NCT02366143|26282509|P3|Overall Study|Patient moving onto PTAP commercial stock|0
7558891|NCT02366143|26282510|P2|Overall Study|Patient moving onto PTAP commercial stock|1
7558892|NCT02366143|26282511|P1|Overall Study|Patient moving onto PTAP commercial stock|0
7558893|NCT02366143|26282509|P3|Overall Study|Post Trial Migration|0
7558894|NCT02366143|26282510|P2|Overall Study|Post Trial Migration|1
7558895|NCT02366143|26282511|P1|Overall Study|Post Trial Migration|0
7558896|NCT02366143|26282509|P3|Overall Study|Uneligible|0
7558897|NCT02366143|26282510|P2|Overall Study|Uneligible|1
7558898|NCT02366143|26282511|P1|Overall Study|Uneligible|0
7558899|NCT02366143|26282509|P3|Overall Study|Requester's instructions|1
7558900|NCT02366143|26282510|P2|Overall Study|Requester's instructions|1
7558901|NCT02366143|26282511|P1|Overall Study|Requester's instructions|1
7558902|NCT02366143|26282509|P3|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
7558903|NCT02366143|26282510|P2|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7558904|NCT02366143|26282511|P1|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7558905|NCT02366143|26282509|P3|Overall Study|Patient rolling over to patient assistance program|1
7558906|NCT02366143|26282510|P2|Overall Study|Patient rolling over to patient assistance program|0
7558907|NCT02366143|26282511|P1|Overall Study|Patient rolling over to patient assistance program|0
7558908|NCT02366143|26282509|P3|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
7558909|NCT02366143|26282510|P2|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7558910|NCT02366143|26282511|P1|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7558911|NCT02366143|26282509|P3|Overall Study|Patient moved to commercial stock|1
7558912|NCT02366143|26282510|P2|Overall Study|Patient moved to commercial stock|0
7558913|NCT02366143|26282511|P1|Overall Study|Patient moved to commercial stock|0
7558914|NCT02366143|26282509|P3|Overall Study|Patient moved to roll-over study|28
7558915|NCT02366143|26282510|P2|Overall Study|Patient moved to roll-over study|19
7558916|NCT02366143|26282511|P1|Overall Study|Patient moved to roll-over study|1
7558917|NCT02366143|26282509|P3|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
7558918|NCT02366143|26282510|P2|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
7558919|NCT02366143|26282511|P1|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
7558920|NCT02366143|26282509|P3|Overall Study|Study Terminated By Sponsor|2
7558921|NCT02366143|26282510|P2|Overall Study|Study Terminated By Sponsor|0
7558922|NCT02366143|26282511|P1|Overall Study|Study Terminated By Sponsor|0
7558923|NCT02366143|26282509|P3|Overall Study|PI Move and Site Closure|1
7558924|NCT02366143|26282510|P2|Overall Study|PI Move and Site Closure|0
7558925|NCT02366143|26282511|P1|Overall Study|PI Move and Site Closure|1
7558926|NCT02366143|26282509|P3|Overall Study|Randomization Error|0
7558927|NCT02366143|26282510|P2|Overall Study|Randomization Error|0
7558928|NCT02366143|26282511|P1|Overall Study|Randomization Error|1
7558929|NCT02366143|26282509|P3|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7558930|NCT02366143|26282510|P2|Overall Study|Increased Microscopic RBCS on Urinalysis|1
7558931|NCT02366143|26282511|P1|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7558932|NCT02366143|26282509|P3|Overall Study|Sponsor request to withdraw/discontinue patient|0
7558933|NCT02366143|26282510|P2|Overall Study|Sponsor request to withdraw/discontinue patient|6
7558934|NCT02366143|26282511|P1|Overall Study|Sponsor request to withdraw/discontinue patient|0
7558935|NCT02366143|26282509|P3|Overall Study|Withdrawal by Subject|22
7558936|NCT02366143|26282510|P2|Overall Study|Withdrawal by Subject|17
7558937|NCT02366143|26282511|P1|Overall Study|Withdrawal by Subject|16
7558938|NCT02366143|26282509|P3|Overall Study|Protocol Violation|2
7558939|NCT02366143|26282510|P2|Overall Study|Protocol Violation|0
7558940|NCT02366143|26282511|P1|Overall Study|Protocol Violation|0
7558941|NCT02366143|26282509|P3|Overall Study|Physician Decision|1
7558942|NCT02366143|26282510|P2|Overall Study|Physician Decision|2
7558943|NCT02366143|26282511|P1|Overall Study|Physician Decision|1
7558944|NCT02366143|26282509|P3|Overall Study|Lost to Follow-up|2
7558945|NCT02366143|26282510|P2|Overall Study|Lost to Follow-up|4
7558946|NCT02366143|26282511|P1|Overall Study|Lost to Follow-up|2
7558947|NCT02366143|26282509|P3|Overall Study|Death|280
7558948|NCT02366143|26282510|P2|Overall Study|Death|278
7558949|NCT02366143|26282511|P1|Overall Study|Death|307
7558950|NCT02366130|26282577|P1|Overall Study|Ineligible|6
7558951|NCT02366130|26282577|P1|Overall Study|Withdrawal by Subject|3
7558952|NCT02365636|26282623|P3|Overall Study|Other|0
7558953|NCT02365636|26282624|P2|Overall Study|Other|0
7558954|NCT02365636|26282625|P1|Overall Study|Other|2
7558955|NCT02365636|26282623|P3|Overall Study|Lost to Follow-up|1
7558956|NCT02365636|26282624|P2|Overall Study|Lost to Follow-up|0
7558957|NCT02365636|26282625|P1|Overall Study|Lost to Follow-up|0
7558958|NCT02365636|26282623|P3|Overall Study|Protocol Violation|0
7558959|NCT02365636|26282624|P2|Overall Study|Protocol Violation|4
7558960|NCT02365636|26282625|P1|Overall Study|Protocol Violation|1
7558961|NCT02365636|26282623|P3|Overall Study|Adverse Event|2
7558962|NCT02365636|26282624|P2|Overall Study|Adverse Event|3
7558963|NCT02365636|26282625|P1|Overall Study|Adverse Event|3
7558964|NCT02365584|26282671|P2|Overall Study|Disease Progression|12
7558965|NCT02365584|26282672|P1|Overall Study|Disease Progression|9
7558966|NCT02365584|26282671|P2|Overall Study|Withdrawal by Subject|0
7558967|NCT02365584|26282672|P1|Overall Study|Withdrawal by Subject|1
7558968|NCT02365584|26282671|P2|Overall Study|Adverse Event|2
7558969|NCT02365584|26282672|P1|Overall Study|Adverse Event|2
7558970|NCT02365558|26282696|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
7558971|NCT02365558|26282697|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
7558972|NCT02365558|26282696|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
7558973|NCT02365558|26282697|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
7558974|NCT02365519|26282710|P3|Randomized and Treated|Withdrawal by Subject|1
7558975|NCT02365519|26282711|P2|Randomized and Treated|Withdrawal by Subject|1
7558976|NCT02365519|26282712|P1|Randomized and Treated|Withdrawal by Subject|0
7558977|NCT02365519|26282710|P3|Randomized and Treated|Adverse Event|0
7558978|NCT02365519|26282711|P2|Randomized and Treated|Adverse Event|1
7558979|NCT02365519|26282712|P1|Randomized and Treated|Adverse Event|0
7558980|NCT02365506|26282736|P3|Overall Study|Investigator's Discretion|1
7558981|NCT02365506|26282737|P2|Overall Study|Investigator's Discretion|0
7558982|NCT02365506|26282738|P1|Overall Study|Investigator's Discretion|0
7558983|NCT02365480|26282769|P2|Overall Study|Withdrawal by Subject|0
7558984|NCT02365480|26282770|P1|Overall Study|Withdrawal by Subject|2
7558985|NCT02365298|26282788|P2|Period 2|Protocol Violation|1
7558986|NCT02365298|26282789|P1|Period 2|Protocol Violation|0
7558987|NCT02365298|26282788|P2|Period 2|Test Article longer available|1
7558988|NCT02365298|26282789|P1|Period 2|Test Article longer available|0
7558989|NCT02365298|26282788|P2|Period 2|Discontinued at request of Sponsor|0
7558990|NCT02365298|26282789|P1|Period 2|Discontinued at request of Sponsor|1
7558991|NCT02365298|26282788|P2|Period 2|incorrect Rx dispensed|0
7558992|NCT02365298|26282789|P1|Period 2|incorrect Rx dispensed|1
7558993|NCT02365285|26282809|P4|Overall Study|Adverse Event|2
7558994|NCT02365285|26282810|P3|Overall Study|Adverse Event|0
7558995|NCT02365285|26282811|P2|Overall Study|Adverse Event|0
7558996|NCT02365285|26282812|P1|Overall Study|Adverse Event|0
7558997|NCT02365285|26282809|P4|Overall Study|Physician Decision|0
7558998|NCT02365285|26282810|P3|Overall Study|Physician Decision|1
7558999|NCT02365285|26282811|P2|Overall Study|Physician Decision|1
7559000|NCT02365285|26282812|P1|Overall Study|Physician Decision|0
7559001|NCT02365233|26282829|P3|Overall Study|IRB withheld the data|2
7559002|NCT02365233|26282830|P2|Overall Study|IRB withheld the data|2
7559003|NCT02365233|26282831|P1|Overall Study|IRB withheld the data|1
7559004|NCT02365207|26282839|P1|Overall Study|Physician Decision|1
7559005|NCT02365207|26282839|P1|Overall Study|Withdrawal by Subject|1
7559006|NCT02365064|26282845|P2|Overall Study|Treatment intolerance|4
7559007|NCT02365064|26282846|P1|Overall Study|Treatment intolerance|2
7559008|NCT02365064|26282845|P2|Overall Study|Withdrawal by Subject|9
7559009|NCT02365064|26282846|P1|Overall Study|Withdrawal by Subject|6
7559010|NCT02365064|26282845|P2|Overall Study|Patients met baseline exclusion requirem|15
7559011|NCT02365064|26282846|P1|Overall Study|Patients met baseline exclusion requirem|2
7559012|NCT02364999|26282864|P2|Overall Study|Randomized but did not receive treatment|3
7559013|NCT02364999|26282865|P1|Overall Study|Randomized but did not receive treatment|2
7559014|NCT02364999|26282864|P2|Overall Study|Other|1
7559015|NCT02364999|26282865|P1|Overall Study|Other|0
7559016|NCT02364999|26282864|P2|Overall Study|Withdrawal by Subject|14
7559017|NCT02364999|26282865|P1|Overall Study|Withdrawal by Subject|14
7559018|NCT02364999|26282864|P2|Overall Study|Protocol Violation|2
7559019|NCT02364999|26282865|P1|Overall Study|Protocol Violation|3
7559020|NCT02364999|26282864|P2|Overall Study|Lost to Follow-up|15
7559021|NCT02364999|26282865|P1|Overall Study|Lost to Follow-up|10
7559022|NCT02364999|26282864|P2|Overall Study|Death|138
7559023|NCT02364999|26282865|P1|Overall Study|Death|136
7559024|NCT02364947|26282891|P3|Overall Study|Death|0
7559025|NCT02364947|26282892|P2|Overall Study|Death|1
7559026|NCT02364947|26282893|P1|Overall Study|Death|0
7559027|NCT02364947|26282891|P3|Overall Study|Physician Decision|5
7559028|NCT02364947|26282892|P2|Overall Study|Physician Decision|2
7559029|NCT02364947|26282893|P1|Overall Study|Physician Decision|3
7559030|NCT02364947|26282891|P3|Overall Study|Protocol Violation|1
7559031|NCT02364947|26282892|P2|Overall Study|Protocol Violation|1
7559032|NCT02364947|26282893|P1|Overall Study|Protocol Violation|1
7559033|NCT02364947|26282891|P3|Overall Study|Adverse Event|11
7559034|NCT02364947|26282892|P2|Overall Study|Adverse Event|33
7559035|NCT02364947|26282893|P1|Overall Study|Adverse Event|45
7559036|NCT02364947|26282891|P3|Overall Study|Withdrawal by Subject|9
7559037|NCT02364947|26282892|P2|Overall Study|Withdrawal by Subject|8
7559038|NCT02364947|26282893|P1|Overall Study|Withdrawal by Subject|10
7559039|NCT02364388|26283062|P1|Overall Study|No Biopsy|2
7559040|NCT02364388|26283062|P1|Overall Study|No OA/US data|2
7559041|NCT02364388|26283062|P1|Overall Study|Technical Failure|3
7559042|NCT02364388|26283062|P1|Overall Study|Protocol Violation|1
7559043|NCT02364336|26283069|P2|Overall Study|Adverse Event|1
7559044|NCT02364336|26283070|P1|Overall Study|Adverse Event|0
7559045|NCT02364180|26283096|P1|Overall Study|Screen Fail|1
7559046|NCT02364037|26283109|P2|Overall Study|Lost to Follow-up|49
7559047|NCT02364037|26283110|P1|Overall Study|Lost to Follow-up|37
7559048|NCT02364037|26283109|P2|Overall Study|Withdrawal by Subject|4
7559049|NCT02364037|26283110|P1|Overall Study|Withdrawal by Subject|7
7559050|NCT02363959|26283219|P2|Overall Study|Medical instability|0
7559051|NCT02363959|26283220|P1|Overall Study|Medical instability|1
7559052|NCT02363946|26283249|P13|Overall Study|Lost to Follow-up|0
7559053|NCT02363946|26283250|P12|Overall Study|Lost to Follow-up|0
7559054|NCT02363946|26283251|P11|Overall Study|Lost to Follow-up|0
7559055|NCT02363946|26283252|P10|Overall Study|Lost to Follow-up|0
7559056|NCT02363946|26283253|P9|Overall Study|Lost to Follow-up|0
7559057|NCT02363946|26283254|P8|Overall Study|Lost to Follow-up|1
7559058|NCT02363946|26283255|P7|Overall Study|Lost to Follow-up|0
7559059|NCT02363946|26283256|P6|Overall Study|Lost to Follow-up|0
7559060|NCT02363946|26283257|P5|Overall Study|Lost to Follow-up|0
7559061|NCT02363946|26283258|P4|Overall Study|Lost to Follow-up|0
7559062|NCT02363946|26283259|P3|Overall Study|Lost to Follow-up|0
7559063|NCT02363946|26283260|P2|Overall Study|Lost to Follow-up|0
7559064|NCT02363946|26283261|P1|Overall Study|Lost to Follow-up|0
7559065|NCT02363738|26283479|P2|Overall Study|Lost to Follow-up|1
7559066|NCT02363738|26283480|P1|Overall Study|Lost to Follow-up|2
7559067|NCT02363738|26283479|P2|Overall Study|Lack of Efficacy|2
7559068|NCT02363738|26283480|P1|Overall Study|Lack of Efficacy|1
7559069|NCT02363738|26283479|P2|Overall Study|Adverse Event|2
7559070|NCT02363738|26283480|P1|Overall Study|Adverse Event|5
7559071|NCT02363686|26283492|P1|Overall Study|incomplete FEES examinations|13
7559072|NCT02363686|26283492|P1|Overall Study|Withdrawal by Subject|22
7559073|NCT02363478|26283509|P1|Overall Study|Adverse Event|4
7559074|NCT02363478|26283509|P1|Overall Study|Lost to Follow-up|4
7559075|NCT02363439|26283516|P1|Overall Study|Lack of Efficacy|4
7559076|NCT02363322|26283522|P2|Overall Study|Lost to Follow-up|0
7559077|NCT02363322|26283523|P1|Overall Study|Lost to Follow-up|1
7559078|NCT02363283|26283533|P1|Overall Study|Not eligible due to transaminitis|1
7559079|NCT02363283|26283533|P1|Overall Study|Withdrawal by Subject|1
7559080|NCT02362789|26283552|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
7559081|NCT02362789|26283553|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
7559082|NCT02362789|26283554|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
7559083|NCT02362789|26283552|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
7559084|NCT02362789|26283553|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
7559085|NCT02362789|26283554|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
7559086|NCT02362789|26283552|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
7559087|NCT02362789|26283553|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
7559088|NCT02362789|26283554|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
7559089|NCT02362789|26283552|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
7559090|NCT02362789|26283553|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
7559091|NCT02362789|26283554|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
7559092|NCT02362789|26283552|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7559093|NCT02362789|26283553|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7559094|NCT02362789|26283554|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
7559095|NCT02362724|26283563|P2|Overall Study|Adverse Event|0
7559096|NCT02362724|26283564|P1|Overall Study|Adverse Event|3
7559097|NCT02362724|26283563|P2|Overall Study|Withdrawal by Subject|1
7559098|NCT02362724|26283564|P1|Overall Study|Withdrawal by Subject|3
7559099|NCT02362646|26283623|P2|Overall Study|received transplant|14
7559100|NCT02362646|26283624|P1|Overall Study|received transplant|21
7559101|NCT02362646|26283623|P2|Overall Study|Withdrawal by Subject|2
7559102|NCT02362646|26283624|P1|Overall Study|Withdrawal by Subject|2
7559103|NCT02362646|26283623|P2|Overall Study|Death|8
7559104|NCT02362646|26283624|P1|Overall Study|Death|15
7559105|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
7559106|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
7559107|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
7559108|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
7559109|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
7559110|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
7559111|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Adverse Event|4
7559112|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Adverse Event|2
7559113|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Adverse Event|3
7559114|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
7559115|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
7559116|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
7559117|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Death|15
7559118|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Death|7
7559119|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Death|1
7559120|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
7559121|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
7559122|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
7559123|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
7559124|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
7559125|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
7559126|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Pregnancy|0
7559127|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Pregnancy|1
7559128|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Pregnancy|0
7559129|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
7559130|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
7559131|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
7559132|NCT02362503|26283656|P3|Open Label Period-Up to 96 Weeks|Other|1
7559133|NCT02362503|26283657|P2|Open Label Period-Up to 96 Weeks|Other|1
7559134|NCT02362503|26283658|P1|Open Label Period-Up to 96 Weeks|Other|0
7559135|NCT02362503|26283656|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
7559136|NCT02362503|26283657|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
7559137|NCT02362503|26283658|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
7559138|NCT02362503|26283656|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
7559139|NCT02362503|26283657|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
7559140|NCT02362503|26283658|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
7559141|NCT02362503|26283656|P3|Double-blind Period-Up to 8 Days|Death|0
7559142|NCT02362503|26283657|P2|Double-blind Period-Up to 8 Days|Death|0
7559143|NCT02362503|26283658|P1|Double-blind Period-Up to 8 Days|Death|1
7559144|NCT02362503|26283656|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
7559145|NCT02362503|26283657|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
7559146|NCT02362503|26283658|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
7559147|NCT02362425|26283687|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7559148|NCT02362425|26283688|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
7559149|NCT02362425|26283689|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7559150|NCT02362425|26283690|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7559151|NCT02362425|26283687|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
7559152|NCT02362425|26283688|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7559153|NCT02362425|26283689|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7559154|NCT02362425|26283690|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7559155|NCT02362425|26283687|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
7559156|NCT02362425|26283688|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7559157|NCT02362425|26283689|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7559158|NCT02362425|26283690|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7559159|NCT02362425|26283687|P4|Phase 1 (up to 6 Months)|Study closure|0
7559160|NCT02362425|26283688|P3|Phase 1 (up to 6 Months)|Study closure|0
7559161|NCT02362425|26283689|P2|Phase 1 (up to 6 Months)|Study closure|0
7559162|NCT02362425|26283690|P1|Phase 1 (up to 6 Months)|Study closure|9
7559163|NCT02362425|26283687|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7559164|NCT02362425|26283688|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7559165|NCT02362425|26283689|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7559166|NCT02362425|26283690|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
7559167|NCT02362425|26283687|P4|Phase 1 (up to 6 Months)|Screening failure|0
7559168|NCT02362425|26283688|P3|Phase 1 (up to 6 Months)|Screening failure|0
7559169|NCT02362425|26283689|P2|Phase 1 (up to 6 Months)|Screening failure|0
7559170|NCT02362425|26283690|P1|Phase 1 (up to 6 Months)|Screening failure|1
7559171|NCT02362425|26283687|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7559172|NCT02362425|26283688|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7559173|NCT02362425|26283689|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7559174|NCT02362425|26283690|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
7559175|NCT02362425|26283687|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7559176|NCT02362425|26283688|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7559177|NCT02362425|26283689|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7559178|NCT02362425|26283690|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
7559179|NCT02362412|26283808|P2|Treatment Period III|Lost to Follow-up|1
7559180|NCT02362412|26283809|P1|Treatment Period III|Lost to Follow-up|0
7559181|NCT02362360|26283843|P2|Period 1|Withdrawal by Subject|1
7559182|NCT02362360|26283844|P1|Period 1|Withdrawal by Subject|2
7559183|NCT02362360|26283843|P2|Period 1|Lack of Efficacy|0
7559184|NCT02362360|26283844|P1|Period 1|Lack of Efficacy|1
7559185|NCT02362282|26283861|P2|Overall Study|Withdrawal by Subject|0
7559186|NCT02362282|26283862|P1|Overall Study|Withdrawal by Subject|1
7559187|NCT02362269|26283870|P2|Overall Study|Lost to Follow-up|6
7559188|NCT02362269|26283871|P1|Overall Study|Lost to Follow-up|0
7559189|NCT02362269|26283870|P2|Overall Study|Moved|0
7559190|NCT02362269|26283871|P1|Overall Study|Moved|1
7559191|NCT02361762|26283893|P2|Overall Study|Lost to Follow-up|1
7559192|NCT02361762|26283894|P1|Overall Study|Lost to Follow-up|0
7559193|NCT02361762|26283893|P2|Overall Study|Withdrawal by Subject|1
7559194|NCT02361762|26283894|P1|Overall Study|Withdrawal by Subject|0
7559195|NCT02361580|26283947|P2|Overall Study|Lost to Follow-up|3
7559196|NCT02361580|26283948|P1|Overall Study|Lost to Follow-up|6
7559197|NCT02361307|26283977|P2|Overall Study|Unstable medical condition.|1
7559198|NCT02361307|26283978|P1|Overall Study|Unstable medical condition.|0
7559199|NCT02361216|26283986|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
7559200|NCT02361216|26283987|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
7559201|NCT02361216|26283986|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7559202|NCT02361216|26283987|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7559203|NCT02361216|26283986|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
7559204|NCT02361216|26283987|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
7559205|NCT02361216|26283986|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
7559206|NCT02361216|26283987|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
7559207|NCT02361216|26283986|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
7559208|NCT02361216|26283987|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
7559209|NCT02361216|26283986|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
7559210|NCT02361216|26283987|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
7559211|NCT02360995|26284002|P3|Overall Study|Withdrawal by Subject|0
7559212|NCT02360995|26284003|P2|Overall Study|Withdrawal by Subject|1
7559213|NCT02360995|26284004|P1|Overall Study|Withdrawal by Subject|0
7559214|NCT02360995|26284002|P3|Overall Study|Lost to Follow-up|2
7559215|NCT02360995|26284003|P2|Overall Study|Lost to Follow-up|0
7559216|NCT02360995|26284004|P1|Overall Study|Lost to Follow-up|2
7559217|NCT02360605|26284057|P2|Overall Study|Death|1
7559218|NCT02360605|26284058|P1|Overall Study|Death|0
7559219|NCT02360605|26284057|P2|Overall Study|Lost to Follow-up|8
7559220|NCT02360605|26284058|P1|Overall Study|Lost to Follow-up|7
7559221|NCT02360605|26284057|P2|Overall Study|Withdrawal by Subject|9
7559222|NCT02360605|26284058|P1|Overall Study|Withdrawal by Subject|4
7559223|NCT02360475|26284081|P4|Overall Study|Migrated/moved from study area|1
7559224|NCT02360475|26284082|P3|Overall Study|Migrated/moved from study area|0
7559225|NCT02360475|26284083|P2|Overall Study|Migrated/moved from study area|0
7559226|NCT02360475|26284084|P1|Overall Study|Migrated/moved from study area|0
7559227|NCT02360475|26284081|P4|Overall Study|Withdrawal by Subject|0
7559228|NCT02360475|26284082|P3|Overall Study|Withdrawal by Subject|2
7559229|NCT02360475|26284083|P2|Overall Study|Withdrawal by Subject|1
7559230|NCT02360475|26284084|P1|Overall Study|Withdrawal by Subject|0
7559231|NCT02360475|26284081|P4|Overall Study|Lost to Follow-up|4
7559232|NCT02360475|26284082|P3|Overall Study|Lost to Follow-up|6
7559233|NCT02360475|26284083|P2|Overall Study|Lost to Follow-up|12
7559234|NCT02360475|26284084|P1|Overall Study|Lost to Follow-up|4
7559235|NCT02360397|26284142|P1|Overall Study|Adverse Event|1
7559236|NCT02360397|26284142|P1|Overall Study|Incomplete screening|3
7559237|NCT02360293|26284181|P2|Overall Study|Excluded|0
7559238|NCT02360293|26284182|P1|Overall Study|Excluded|1
7559239|NCT02360293|26284181|P2|Overall Study|Withdrawal by Subject|1
7559240|NCT02360293|26284182|P1|Overall Study|Withdrawal by Subject|2
7559241|NCT02360293|26284181|P2|Overall Study|Lost to Follow-up|95
7559242|NCT02360293|26284182|P1|Overall Study|Lost to Follow-up|73
7559243|NCT02360280|26284196|P2|Overall Study|Lost to Follow-up|0
7559244|NCT02360280|26284197|P1|Overall Study|Lost to Follow-up|1
7559245|NCT02360280|26284196|P2|Overall Study|Adverse Event|1
7559246|NCT02360280|26284197|P1|Overall Study|Adverse Event|0
7559247|NCT02360280|26284196|P2|Overall Study|Withdrawal by Subject|0
7559248|NCT02360280|26284197|P1|Overall Study|Withdrawal by Subject|2
7559249|NCT02360228|26284212|P3|Overall Study|Unstable symptoms during screening|1
7559250|NCT02360228|26284213|P2|Overall Study|Unstable symptoms during screening|0
7559251|NCT02360228|26284214|P1|Overall Study|Unstable symptoms during screening|0
7559252|NCT02360228|26284212|P3|Overall Study|Self-discontinued medication|0
7559253|NCT02360228|26284213|P2|Overall Study|Self-discontinued medication|1
7559254|NCT02360228|26284214|P1|Overall Study|Self-discontinued medication|0
7559255|NCT02360228|26284212|P3|Overall Study|Withdrawal by Subject|0
7559256|NCT02360228|26284213|P2|Overall Study|Withdrawal by Subject|0
7559257|NCT02360228|26284214|P1|Overall Study|Withdrawal by Subject|1
7559258|NCT02360111|26284309|P1|Overall Study|Death|2
7559259|NCT02360098|26284319|P1|Overall Study|Physician Decision|7
7559260|NCT02359903|26284398|P2|Overall Study|Adverse Event|2
7559261|NCT02359903|26284399|P1|Overall Study|Adverse Event|0
7559262|NCT02359890|26284407|P1|Overall Study|Never treated with study catheter|6
7559263|NCT02359890|26284407|P1|Overall Study|Not meeting eligibility|4
7559264|NCT02359877|26284418|P4|Overall Study|Adverse Event|1
7559265|NCT02359877|26284419|P3|Overall Study|Adverse Event|0
7559266|NCT02359877|26284420|P2|Overall Study|Adverse Event|0
7559267|NCT02359877|26284421|P1|Overall Study|Adverse Event|0
7559268|NCT02359877|26284418|P4|Overall Study|Withdrawal by Subject|2
7559269|NCT02359877|26284419|P3|Overall Study|Withdrawal by Subject|0
7559270|NCT02359877|26284420|P2|Overall Study|Withdrawal by Subject|0
7559271|NCT02359877|26284421|P1|Overall Study|Withdrawal by Subject|1
7559272|NCT02359851|26284471|P1|Overall Study|Disease progression|1
7559273|NCT02359851|26284471|P1|Overall Study|Death|1
7559274|NCT02359552|26284481|P2|Overall Study|Lost to Follow-up|4
7559275|NCT02359552|26284482|P1|Overall Study|Lost to Follow-up|3
7559276|NCT02359435|26284504|P2|Overall Study|Lost to Follow-up|4
7559277|NCT02359435|26284505|P1|Overall Study|Lost to Follow-up|4
7559278|NCT02359045|26284565|P2|Overall Study|Adverse Event|1
7559279|NCT02359045|26284566|P1|Overall Study|Adverse Event|0
7559280|NCT02359045|26284565|P2|Overall Study|Lost to Follow-up|1
7559281|NCT02359045|26284566|P1|Overall Study|Lost to Follow-up|1
7559282|NCT02359045|26284565|P2|Overall Study|Eligibility criteria not fulfilled|1
7559283|NCT02359045|26284566|P1|Overall Study|Eligibility criteria not fulfilled|3
7559284|NCT02358863|26284874|P1|Overall Study|Physician Decision|3
7559285|NCT02358668|26284881|P3|Overall Study|Withdrawal by Subject|0
7559286|NCT02358668|26284882|P2|Overall Study|Withdrawal by Subject|1
7559287|NCT02358668|26284883|P1|Overall Study|Withdrawal by Subject|0
7559288|NCT02358668|26284881|P3|Overall Study|Adverse Event|0
7559289|NCT02358668|26284882|P2|Overall Study|Adverse Event|0
7559290|NCT02358668|26284883|P1|Overall Study|Adverse Event|2
7559291|NCT02358473|26285032|P1|Overall Study|Physician Decision|2
7559292|NCT02358473|26285032|P1|Overall Study|Withdrawal by Subject|2
7559293|NCT02358473|26285032|P1|Overall Study|Adverse Event|3
7559294|NCT02358473|26285032|P1|Overall Study|Disease Progession|6
7559295|NCT02358369|26285044|P5|Treatment Period C|Adverse Event|7
7559296|NCT02358369|26285045|P4|Treatment Period C|Adverse Event|0
7559297|NCT02358369|26285046|P3|Treatment Period C|Adverse Event|0
7559298|NCT02358369|26285047|P2|Treatment Period C|Adverse Event|0
7559299|NCT02358369|26285048|P1|Treatment Period C|Adverse Event|0
7559300|NCT02358369|26285044|P5|Treatment Period A/B|Withdrawal by Subject|0
7559301|NCT02358369|26285045|P4|Treatment Period A/B|Withdrawal by Subject|2
7559302|NCT02358369|26285046|P3|Treatment Period A/B|Withdrawal by Subject|0
7559303|NCT02358369|26285047|P2|Treatment Period A/B|Withdrawal by Subject|2
7559304|NCT02358369|26285048|P1|Treatment Period A/B|Withdrawal by Subject|0
7559305|NCT02358369|26285044|P5|Treatment Period A/B|Death|0
7559306|NCT02358369|26285045|P4|Treatment Period A/B|Death|0
7559307|NCT02358369|26285046|P3|Treatment Period A/B|Death|1
7559308|NCT02358369|26285047|P2|Treatment Period A/B|Death|0
7559309|NCT02358369|26285048|P1|Treatment Period A/B|Death|0
7559310|NCT02358369|26285044|P5|Treatment Period A/B|Adverse Event|0
7559311|NCT02358369|26285045|P4|Treatment Period A/B|Adverse Event|2
7559312|NCT02358369|26285046|P3|Treatment Period A/B|Adverse Event|1
7559313|NCT02358369|26285047|P2|Treatment Period A/B|Adverse Event|0
7559314|NCT02358369|26285048|P1|Treatment Period A/B|Adverse Event|0
7559315|NCT02358369|26285044|P5|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7559316|NCT02358369|26285045|P4|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7559317|NCT02358369|26285046|P3|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7559318|NCT02358369|26285047|P2|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7559319|NCT02358369|26285048|P1|Pre-Randomization Washout Period|Not Qualified for Randomization|35
7559320|NCT02358343|26285094|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7559321|NCT02358343|26285095|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7559322|NCT02358343|26285096|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
7559323|NCT02358343|26285097|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7559324|NCT02358343|26285098|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7559325|NCT02358343|26285094|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7559326|NCT02358343|26285095|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7559327|NCT02358343|26285096|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7559328|NCT02358343|26285097|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7559329|NCT02358343|26285098|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7559330|NCT02358343|26285094|P5|Comparative Efficacy Trial / Observation|Death|0
7559331|NCT02358343|26285095|P4|Comparative Efficacy Trial / Observation|Death|0
7559332|NCT02358343|26285096|P3|Comparative Efficacy Trial / Observation|Death|2
7559333|NCT02358343|26285097|P2|Comparative Efficacy Trial / Observation|Death|0
7559334|NCT02358343|26285098|P1|Comparative Efficacy Trial / Observation|Death|0
7559335|NCT02358343|26285094|P5|Screening Intervention|Determined Ineligible|0
7559336|NCT02358343|26285095|P4|Screening Intervention|Determined Ineligible|0
7559337|NCT02358343|26285096|P3|Screening Intervention|Determined Ineligible|0
7559338|NCT02358343|26285097|P2|Screening Intervention|Determined Ineligible|6
7559339|NCT02358343|26285098|P1|Screening Intervention|Determined Ineligible|5
7559340|NCT02358343|26285094|P5|Screening Intervention|Withdrawal by Subject|0
7559341|NCT02358343|26285095|P4|Screening Intervention|Withdrawal by Subject|0
7559342|NCT02358343|26285096|P3|Screening Intervention|Withdrawal by Subject|0
7559343|NCT02358343|26285097|P2|Screening Intervention|Withdrawal by Subject|0
7559344|NCT02358343|26285098|P1|Screening Intervention|Withdrawal by Subject|1
7559345|NCT02358343|26285094|P5|Screening Intervention|Death|0
7559346|NCT02358343|26285095|P4|Screening Intervention|Death|0
7559347|NCT02358343|26285096|P3|Screening Intervention|Death|0
7559348|NCT02358343|26285097|P2|Screening Intervention|Death|2
7559349|NCT02358343|26285098|P1|Screening Intervention|Death|0
7559350|NCT02358044|26285154|P2|Overall Study|Withdrawal by Subject|4
7559351|NCT02358044|26285155|P1|Overall Study|Withdrawal by Subject|0
7559352|NCT02358044|26285154|P2|Overall Study|Physician Decision|1
7559353|NCT02358044|26285155|P1|Overall Study|Physician Decision|0
7559354|NCT02358044|26285154|P2|Overall Study|Lost to Follow-up|1
7559355|NCT02358044|26285155|P1|Overall Study|Lost to Follow-up|2
7559356|NCT02358044|26285154|P2|Overall Study|Adverse Event|1
7559357|NCT02358044|26285155|P1|Overall Study|Adverse Event|0
7559358|NCT02358031|26285174|P3|Overall Study|Ongoing in Study|33
7559359|NCT02358031|26285175|P2|Overall Study|Ongoing in Study|64
7559360|NCT02358031|26285176|P1|Overall Study|Ongoing in Study|61
7559361|NCT02358031|26285174|P3|Overall Study|Withdrawal by Subject|17
7559362|NCT02358031|26285175|P2|Overall Study|Withdrawal by Subject|12
7559363|NCT02358031|26285176|P1|Overall Study|Withdrawal by Subject|14
7559364|NCT02358031|26285174|P3|Overall Study|Lost to Follow-up|1
7559365|NCT02358031|26285175|P2|Overall Study|Lost to Follow-up|1
7559366|NCT02358031|26285176|P1|Overall Study|Lost to Follow-up|0
7559367|NCT02358031|26285174|P3|Overall Study|Death|249
7559368|NCT02358031|26285175|P2|Overall Study|Death|204
7559369|NCT02358031|26285176|P1|Overall Study|Death|226
7559370|NCT02357979|26285303|P2|Overall Study|Lost to Follow-up|5
7559371|NCT02357979|26285304|P1|Overall Study|Lost to Follow-up|5
7559372|NCT02357940|26285316|P2|Overall Study|Investigator's judgement|1
7559373|NCT02357940|26285317|P1|Overall Study|Investigator's judgement|0
7559374|NCT02357940|26285316|P2|Overall Study|Adverse Event|1
7559375|NCT02357940|26285317|P1|Overall Study|Adverse Event|0
7559376|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
7559377|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
7559378|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
7559379|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
7559380|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7559381|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7559382|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7559383|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7559384|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
7559385|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7559386|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
7559387|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7559388|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7559389|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7559390|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7559391|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7559392|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
7559393|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7559394|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7559395|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
7559396|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7559397|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
7559398|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
7559399|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7559400|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
7559401|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
7559402|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
7559403|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
7559404|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
7559405|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
7559406|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
7559407|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
7559408|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
7559409|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
7559410|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
7559411|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
7559412|NCT02357901|26285444|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
7559413|NCT02357901|26285445|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
7559414|NCT02357901|26285446|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
7559415|NCT02357901|26285447|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
7559416|NCT02357901|26285444|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7559417|NCT02357901|26285445|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7559418|NCT02357901|26285446|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7559419|NCT02357901|26285447|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
7559420|NCT02357810|26285516|P1|Follow-up at Treatment Discontinuation|Still in Follow-up|11
7559421|NCT02357810|26285516|P1|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
7559422|NCT02357810|26285516|P1|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
7559423|NCT02357810|26285516|P1|12 Week Response and Further Treatment|Wound Complications|1
7559424|NCT02357810|26285516|P1|12 Week Response and Further Treatment|Progressive Disease|15
7559425|NCT02357810|26285516|P1|12 Week Response and Further Treatment|Withdrawal by Subject|1
7559426|NCT02357810|26285516|P1|12 Week Response and Further Treatment|Adverse Event|5
7559427|NCT02357810|26285516|P1|Reached 12 Weeks Response|Other|1
7559428|NCT02357810|26285516|P1|Reached 12 Weeks Response|Physician Decision|1
7559429|NCT02357810|26285516|P1|Reached 12 Weeks Response|Death|1
7559430|NCT02357810|26285516|P1|Reached 12 Weeks Response|Protocol Violation|1
7559431|NCT02357810|26285516|P1|Reached 12 Weeks Response|Withdrawal by Subject|8
7559432|NCT02357810|26285516|P1|Reached 12 Weeks Response|Progressive Disease|39
7559433|NCT02357810|26285516|P1|Reached 12 Weeks Response|Adverse Event|5
7559434|NCT02357810|26285516|P1|Registered and Started Treatment|Found not to be eligible for the study|26
7559435|NCT02357810|26285516|P1|Registered and Started Treatment|Withdrawal by Subject|1
7559436|NCT02357576|26285566|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
7559437|NCT02357576|26285567|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
7559438|NCT02357576|26285566|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
7559439|NCT02357576|26285567|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
7559440|NCT02357576|26285566|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
7559441|NCT02357576|26285567|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
7559442|NCT02357576|26285566|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7559443|NCT02357576|26285567|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7559444|NCT02357576|26285566|P2|Treatment Period|Physician Decision|1
7559445|NCT02357576|26285567|P1|Treatment Period|Physician Decision|0
7559446|NCT02357576|26285566|P2|Treatment Period|Withdrawal by Subject|1
7559447|NCT02357576|26285567|P1|Treatment Period|Withdrawal by Subject|0
7559448|NCT02357459|26285622|P3|Overall Study|Job Commitments|1
7559449|NCT02357459|26285623|P2|Overall Study|Job Commitments|0
7559450|NCT02357459|26285624|P1|Overall Study|Job Commitments|0
7559451|NCT02357459|26285622|P3|Overall Study|Pre-planned Knee surgery|2
7559452|NCT02357459|26285623|P2|Overall Study|Pre-planned Knee surgery|0
7559453|NCT02357459|26285624|P1|Overall Study|Pre-planned Knee surgery|0
7559454|NCT02357459|26285622|P3|Overall Study|Incarceration|1
7559455|NCT02357459|26285623|P2|Overall Study|Incarceration|0
7559456|NCT02357459|26285624|P1|Overall Study|Incarceration|0
7559457|NCT02357459|26285622|P3|Overall Study|Instruction from PCP|0
7559458|NCT02357459|26285623|P2|Overall Study|Instruction from PCP|0
7559459|NCT02357459|26285624|P1|Overall Study|Instruction from PCP|1
7559460|NCT02357459|26285622|P3|Overall Study|Patient Relocated|0
7559461|NCT02357459|26285623|P2|Overall Study|Patient Relocated|0
7559462|NCT02357459|26285624|P1|Overall Study|Patient Relocated|2
7559463|NCT02357459|26285622|P3|Overall Study|Lack of Efficacy|4
7559464|NCT02357459|26285623|P2|Overall Study|Lack of Efficacy|4
7559465|NCT02357459|26285624|P1|Overall Study|Lack of Efficacy|7
7559466|NCT02357459|26285622|P3|Overall Study|Lost to Follow-up|0
7559467|NCT02357459|26285623|P2|Overall Study|Lost to Follow-up|3
7559468|NCT02357459|26285624|P1|Overall Study|Lost to Follow-up|1
7559469|NCT02357459|26285622|P3|Overall Study|Protocol Violation|0
7559470|NCT02357459|26285623|P2|Overall Study|Protocol Violation|1
7559471|NCT02357459|26285624|P1|Overall Study|Protocol Violation|1
7559472|NCT02357459|26285622|P3|Overall Study|Physician Decision|0
7559473|NCT02357459|26285623|P2|Overall Study|Physician Decision|2
7559474|NCT02357459|26285624|P1|Overall Study|Physician Decision|0
7559475|NCT02357459|26285622|P3|Overall Study|Withdrawal by Subject|3
7559476|NCT02357459|26285623|P2|Overall Study|Withdrawal by Subject|3
7559477|NCT02357459|26285624|P1|Overall Study|Withdrawal by Subject|5
7559478|NCT02357459|26285622|P3|Overall Study|Adverse Event|1
7559479|NCT02357459|26285623|P2|Overall Study|Adverse Event|1
7559480|NCT02357459|26285624|P1|Overall Study|Adverse Event|0
7559481|NCT02357420|26285670|P4|Overall Study|Lost to Follow-up|3
7559482|NCT02357420|26285671|P3|Overall Study|Lost to Follow-up|2
7559483|NCT02357420|26285672|P2|Overall Study|Lost to Follow-up|0
7559484|NCT02357420|26285673|P1|Overall Study|Lost to Follow-up|3
7559485|NCT02357420|26285670|P4|Overall Study|Withdrawn Consent|6
7559486|NCT02357420|26285671|P3|Overall Study|Withdrawn Consent|6
7559487|NCT02357420|26285672|P2|Overall Study|Withdrawn Consent|8
7559488|NCT02357420|26285673|P1|Overall Study|Withdrawn Consent|4
7559489|NCT02357420|26285670|P4|Overall Study|Protocol Non-compliance|1
7559490|NCT02357420|26285671|P3|Overall Study|Protocol Non-compliance|0
7559491|NCT02357420|26285672|P2|Overall Study|Protocol Non-compliance|0
7559492|NCT02357420|26285673|P1|Overall Study|Protocol Non-compliance|0
7559493|NCT02357420|26285670|P4|Overall Study|Prohibited Medication|0
7559494|NCT02357420|26285671|P3|Overall Study|Prohibited Medication|0
7559495|NCT02357420|26285672|P2|Overall Study|Prohibited Medication|1
7559496|NCT02357420|26285673|P1|Overall Study|Prohibited Medication|1
7559497|NCT02357420|26285670|P4|Overall Study|Investigator Decision|0
7559498|NCT02357420|26285671|P3|Overall Study|Investigator Decision|0
7559499|NCT02357420|26285672|P2|Overall Study|Investigator Decision|0
7559500|NCT02357420|26285673|P1|Overall Study|Investigator Decision|1
7559501|NCT02357420|26285670|P4|Overall Study|Adverse Event|9
7559502|NCT02357420|26285671|P3|Overall Study|Adverse Event|8
7559503|NCT02357420|26285672|P2|Overall Study|Adverse Event|3
7559504|NCT02357420|26285673|P1|Overall Study|Adverse Event|3
7559505|NCT02357368|26285736|P4|Overall Study|Withdrawal by Subject|2
7559506|NCT02357368|26285737|P3|Overall Study|Withdrawal by Subject|1
7559507|NCT02357368|26285738|P2|Overall Study|Withdrawal by Subject|1
7559508|NCT02357368|26285739|P1|Overall Study|Withdrawal by Subject|3
7559509|NCT02357368|26285736|P4|Overall Study|Pregnancy|0
7559510|NCT02357368|26285737|P3|Overall Study|Pregnancy|0
7559511|NCT02357368|26285738|P2|Overall Study|Pregnancy|2
7559512|NCT02357368|26285739|P1|Overall Study|Pregnancy|3
7559513|NCT02357368|26285736|P4|Overall Study|Lost to Follow-up|1
7559514|NCT02357368|26285737|P3|Overall Study|Lost to Follow-up|0
7559515|NCT02357368|26285738|P2|Overall Study|Lost to Follow-up|0
7559516|NCT02357368|26285739|P1|Overall Study|Lost to Follow-up|0
7559517|NCT02357342|26285763|P2|First 6 Months|Death|0
7559518|NCT02357342|26285764|P1|First 6 Months|Death|2
7559519|NCT02357147|26285812|P2|Maintenance Treatment Phase|Not Treated|0
7559520|NCT02357147|26285813|P1|Maintenance Treatment Phase|Not Treated|1
7559521|NCT02357147|26285812|P2|Maintenance Treatment Phase|Sponsor Decision|15
7559522|NCT02357147|26285813|P1|Maintenance Treatment Phase|Sponsor Decision|0
7559523|NCT02357147|26285812|P2|Maintenance Treatment Phase|Adverse Event|3
7559524|NCT02357147|26285813|P1|Maintenance Treatment Phase|Adverse Event|0
7559525|NCT02357147|26285812|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
7559526|NCT02357147|26285813|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
7559527|NCT02357147|26285812|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
7559528|NCT02357147|26285813|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
7559529|NCT02357147|26285812|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
7559530|NCT02357147|26285813|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
7559531|NCT02357147|26285812|P2|Combination Treatment Phase|Not treated|2
7559532|NCT02357147|26285813|P1|Combination Treatment Phase|Not treated|0
7559533|NCT02357147|26285812|P2|Combination Treatment Phase|Other|0
7559534|NCT02357147|26285813|P1|Combination Treatment Phase|Other|1
7559535|NCT02357147|26285812|P2|Combination Treatment Phase|Sponsor Decision|12
7559536|NCT02357147|26285813|P1|Combination Treatment Phase|Sponsor Decision|0
7559537|NCT02357147|26285812|P2|Combination Treatment Phase|Death|1
7559538|NCT02357147|26285813|P1|Combination Treatment Phase|Death|1
7559539|NCT02357147|26285812|P2|Combination Treatment Phase|Adverse Event|4
7559540|NCT02357147|26285813|P1|Combination Treatment Phase|Adverse Event|12
7559541|NCT02357147|26285812|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
7559542|NCT02357147|26285813|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
7559543|NCT02357147|26285812|P2|Combination Treatment Phase|Withdrawal by Subject|2
7559544|NCT02357147|26285813|P1|Combination Treatment Phase|Withdrawal by Subject|4
7559545|NCT02357147|26285812|P2|Combination Treatment Phase|Investigator Discretion|1
7559546|NCT02357147|26285813|P1|Combination Treatment Phase|Investigator Discretion|1
7559547|NCT02357147|26285812|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
7559548|NCT02357147|26285813|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
7559549|NCT02357147|26285812|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7559550|NCT02357147|26285813|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7559551|NCT02357134|26285827|P4|Overall Study|Lost to Follow-up|0
7559552|NCT02357134|26285828|P3|Overall Study|Lost to Follow-up|0
7559553|NCT02357134|26285829|P2|Overall Study|Lost to Follow-up|0
7559554|NCT02357134|26285830|P1|Overall Study|Lost to Follow-up|1
7559555|NCT02356887|26285881|P1|Overall Study|poor compliance|2
7559556|NCT02356783|26285898|P2|Overall Study|Lost to Follow-up|3
7559557|NCT02356783|26285899|P1|Overall Study|Lost to Follow-up|1
7559558|NCT02356588|26285948|P2|Overall Study|Protocol Violation|1
7559559|NCT02356588|26285949|P1|Overall Study|Protocol Violation|0
7559560|NCT02356588|26285948|P2|Overall Study|Withdrawal by Subject|0
7559561|NCT02356588|26285949|P1|Overall Study|Withdrawal by Subject|1
7559562|NCT02356588|26285948|P2|Overall Study|Adverse Event|2
7559563|NCT02356588|26285949|P1|Overall Study|Adverse Event|0
7559564|NCT02356588|26285948|P2|Overall Study|Lack of Efficacy|10
7559565|NCT02356588|26285949|P1|Overall Study|Lack of Efficacy|4
7559566|NCT02356562|26286066|P2|Overall Study|site closure|0
7559567|NCT02356562|26286067|P1|Overall Study|site closure|1
7559568|NCT02356562|26286066|P2|Overall Study|Re-entered treatment in a previous study|0
7559569|NCT02356562|26286067|P1|Overall Study|Re-entered treatment in a previous study|1
7559570|NCT02356562|26286066|P2|Overall Study|Withdrawal by Subject|1
7559571|NCT02356562|26286067|P1|Overall Study|Withdrawal by Subject|0
7559572|NCT02356211|26286096|P2|Overall Study|ineligible|8
7559573|NCT02356211|26286097|P1|Overall Study|ineligible|1
7559574|NCT02356211|26286096|P2|Overall Study|Withdrawal by Subject|2
7559575|NCT02356211|26286097|P1|Overall Study|Withdrawal by Subject|2
7559576|NCT02355743|26286187|P1|Overall Study|Lost to Follow-up|1
7559577|NCT02355743|26286187|P1|Overall Study|Withdrawal by Subject|1
7559578|NCT02355691|26286195|P2|Overall Study|Loss of Research Personnel|9
7559579|NCT02355691|26286196|P1|Overall Study|Loss of Research Personnel|7
7559580|NCT02355665|26286206|P2|Overall Study|Compliance, PI decision, move, eligible|3
7559581|NCT02355665|26286207|P1|Overall Study|Compliance, PI decision, move, eligible|6
7559582|NCT02355665|26286206|P2|Overall Study|Death|2
7559583|NCT02355665|26286207|P1|Overall Study|Death|4
7559584|NCT02355665|26286206|P2|Overall Study|Lost to Follow-up|103
7559585|NCT02355665|26286207|P1|Overall Study|Lost to Follow-up|131
7559586|NCT02355665|26286206|P2|Overall Study|Withdrawal by Subject|100
7559587|NCT02355665|26286207|P1|Overall Study|Withdrawal by Subject|90
7559588|NCT02355665|26286206|P2|Overall Study|Protocol Violation|0
7559589|NCT02355665|26286207|P1|Overall Study|Protocol Violation|2
7559590|NCT02355665|26286206|P2|Overall Study|Adverse Event|24
7559591|NCT02355665|26286207|P1|Overall Study|Adverse Event|16
7559592|NCT02355028|26286665|P2|Overall Study|Deemed ineligible after randomization|4
7559593|NCT02355028|26286666|P1|Overall Study|Deemed ineligible after randomization|8
7559594|NCT02355028|26286665|P2|Overall Study|Withdrawal by Subject|1
7559595|NCT02355028|26286666|P1|Overall Study|Withdrawal by Subject|1
7559596|NCT02355028|26286665|P2|Overall Study|Adverse Event|0
7559597|NCT02355028|26286666|P1|Overall Study|Adverse Event|2
7559598|NCT02354976|26286702|P3|Overall Study|Adverse Event|2
7559599|NCT02354976|26286703|P2|Overall Study|Adverse Event|0
7559600|NCT02354976|26286704|P1|Overall Study|Adverse Event|1
7559601|NCT02354976|26286702|P3|Overall Study|Study-specifc withdrawal criteria|0
7559602|NCT02354976|26286703|P2|Overall Study|Study-specifc withdrawal criteria|1
7559603|NCT02354976|26286704|P1|Overall Study|Study-specifc withdrawal criteria|0
7559604|NCT02354976|26286702|P3|Overall Study|Other - reason not specified|1
7559605|NCT02354976|26286703|P2|Overall Study|Other - reason not specified|0
7559606|NCT02354976|26286704|P1|Overall Study|Other - reason not specified|1
7559607|NCT02354690|26286767|P1|Overall Study|Physician Decision|1
7559608|NCT02354599|26286781|P6|Overall Study|Withdrawal by Subject|0
7559609|NCT02354599|26286782|P5|Overall Study|Withdrawal by Subject|0
7559610|NCT02354599|26286783|P4|Overall Study|Withdrawal by Subject|0
7559611|NCT02354599|26286784|P3|Overall Study|Withdrawal by Subject|0
7559612|NCT02354599|26286785|P2|Overall Study|Withdrawal by Subject|1
7559613|NCT02354599|26286786|P1|Overall Study|Withdrawal by Subject|1
7559614|NCT02354599|26286781|P6|Overall Study|Pretreatment Event/Adverse Event|1
7559615|NCT02354599|26286782|P5|Overall Study|Pretreatment Event/Adverse Event|0
7559616|NCT02354599|26286783|P4|Overall Study|Pretreatment Event/Adverse Event|0
7559617|NCT02354599|26286784|P3|Overall Study|Pretreatment Event/Adverse Event|0
7559618|NCT02354599|26286785|P2|Overall Study|Pretreatment Event/Adverse Event|0
7559619|NCT02354599|26286786|P1|Overall Study|Pretreatment Event/Adverse Event|0
7559624|NCT02354508|26286900|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
7559625|NCT02354508|26286901|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
7559626|NCT02354508|26286902|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
7559627|NCT02354508|26286900|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7559628|NCT02354508|26286901|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
7559629|NCT02354508|26286902|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7559630|NCT02354508|26286900|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7559631|NCT02354508|26286901|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7559632|NCT02354508|26286902|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
7559633|NCT02354508|26286900|P3|Period 2: Extension Phase|Physician Decision|1
7559634|NCT02354508|26286901|P2|Period 2: Extension Phase|Physician Decision|0
7559635|NCT02354508|26286902|P1|Period 2: Extension Phase|Physician Decision|5
7559636|NCT02354508|26286900|P3|Period 2: Extension Phase|Withdrawal by Subject|0
7559637|NCT02354508|26286901|P2|Period 2: Extension Phase|Withdrawal by Subject|1
7559638|NCT02354508|26286902|P1|Period 2: Extension Phase|Withdrawal by Subject|0
7559639|NCT02354508|26286900|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
7559640|NCT02354508|26286901|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
7559641|NCT02354508|26286902|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
7559642|NCT02354508|26286900|P3|Period 1: Core Phase|Withdrawal by Subject|2
7559643|NCT02354508|26286901|P2|Period 1: Core Phase|Withdrawal by Subject|1
7559644|NCT02354508|26286902|P1|Period 1: Core Phase|Withdrawal by Subject|0
7559645|NCT02354508|26286900|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
7559646|NCT02354508|26286901|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
7559647|NCT02354508|26286902|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
7559648|NCT02354508|26286900|P3|Period 1: Core Phase|Adverse Event|2
7559649|NCT02354508|26286901|P2|Period 1: Core Phase|Adverse Event|1
7559650|NCT02354508|26286902|P1|Period 1: Core Phase|Adverse Event|1
7559651|NCT02354417|26287004|P1|Overall Study|Physician Decision|1
7559652|NCT02354235|26287071|P2|Overall Study|Conflict with the stopping criteria|1
7559653|NCT02354235|26287072|P1|Overall Study|Conflict with the stopping criteria|0
7559654|NCT02354235|26287071|P2|Overall Study|Withdrawal by Subject|3
7559655|NCT02354235|26287072|P1|Overall Study|Withdrawal by Subject|1
7559656|NCT02354235|26287071|P2|Overall Study|Physician Decision|1
7559657|NCT02354235|26287072|P1|Overall Study|Physician Decision|0
7559658|NCT02354235|26287071|P2|Overall Study|Adverse Event|2
7559659|NCT02354235|26287072|P1|Overall Study|Adverse Event|2
7559660|NCT02354222|26287088|P2|Overall Study|Conflict with the stopping criteria|4
7559661|NCT02354222|26287089|P1|Overall Study|Conflict with the stopping criteria|0
7559662|NCT02354222|26287088|P2|Overall Study|Withdrawal by Subject|3
7559663|NCT02354222|26287089|P1|Overall Study|Withdrawal by Subject|2
7559664|NCT02354222|26287088|P2|Overall Study|Pregnancy|0
7559665|NCT02354222|26287089|P1|Overall Study|Pregnancy|1
7559666|NCT02354222|26287088|P2|Overall Study|Physician Decision|1
7559667|NCT02354222|26287089|P1|Overall Study|Physician Decision|1
7559668|NCT02354222|26287088|P2|Overall Study|Adverse Event|3
7559669|NCT02354222|26287089|P1|Overall Study|Adverse Event|0
7559670|NCT02353871|26287133|P2|Overall Study|Lost to Follow-up|0
7559671|NCT02353871|26287134|P1|Overall Study|Lost to Follow-up|2
7559672|NCT02353871|26287133|P2|Overall Study|Consent withdrawn|8
7559673|NCT02353871|26287134|P1|Overall Study|Consent withdrawn|1
7559674|NCT02353871|26287133|P2|Overall Study|Protocol deviation|1
7559675|NCT02353871|26287134|P1|Overall Study|Protocol deviation|0
7559676|NCT02353572|26287227|P1|Overall Study|Study terminated|2
7559677|NCT02353572|26287227|P1|Overall Study|Withdrawal by Subject|1
7559678|NCT02353468|26287231|P1|Overall Study|Study terminated|3
7559679|NCT02353442|26287237|P2|Overall Study|Withdrawal by Subject|4
7559680|NCT02353442|26287238|P1|Overall Study|Withdrawal by Subject|3
7559681|NCT02353169|26287293|P4|Overall Study|Pre-op medication|0
7559682|NCT02353169|26287294|P3|Overall Study|Pre-op medication|1
7559683|NCT02353169|26287295|P2|Overall Study|Pre-op medication|0
7559684|NCT02353169|26287296|P1|Overall Study|Pre-op medication|0
7559685|NCT02353169|26287293|P4|Overall Study|ECG data error|2
7559686|NCT02353169|26287294|P3|Overall Study|ECG data error|2
7559687|NCT02353169|26287295|P2|Overall Study|ECG data error|3
7559688|NCT02353169|26287296|P1|Overall Study|ECG data error|0
7559689|NCT02353169|26287293|P4|Overall Study|Inhalational induction|0
7559690|NCT02353169|26287294|P3|Overall Study|Inhalational induction|0
7559691|NCT02353169|26287295|P2|Overall Study|Inhalational induction|2
7559692|NCT02353169|26287296|P1|Overall Study|Inhalational induction|0
7559693|NCT02353169|26287293|P4|Overall Study|OR team declined|0
7559694|NCT02353169|26287294|P3|Overall Study|OR team declined|0
7559695|NCT02353169|26287295|P2|Overall Study|OR team declined|0
7559696|NCT02353169|26287296|P1|Overall Study|OR team declined|2
7559697|NCT02353169|26287293|P4|Overall Study|QTc > 450 msec|1
7559698|NCT02353169|26287294|P3|Overall Study|QTc > 450 msec|1
7559699|NCT02353169|26287295|P2|Overall Study|QTc > 450 msec|1
7559700|NCT02353169|26287296|P1|Overall Study|QTc > 450 msec|1
7559701|NCT02352948|26287388|P6|Overall Study|Other|0
7559702|NCT02352948|26287389|P5|Overall Study|Other|0
7559703|NCT02352948|26287390|P4|Overall Study|Other|0
7559704|NCT02352948|26287391|P3|Overall Study|Other|2
7559705|NCT02352948|26287392|P2|Overall Study|Other|0
7559706|NCT02352948|26287393|P1|Overall Study|Other|0
7559707|NCT02352948|26287388|P6|Overall Study|Eligibility criteria not fulfilled|0
7559708|NCT02352948|26287389|P5|Overall Study|Eligibility criteria not fulfilled|0
7559709|NCT02352948|26287390|P4|Overall Study|Eligibility criteria not fulfilled|1
7559710|NCT02352948|26287391|P3|Overall Study|Eligibility criteria not fulfilled|0
7559711|NCT02352948|26287392|P2|Overall Study|Eligibility criteria not fulfilled|1
7559712|NCT02352948|26287393|P1|Overall Study|Eligibility criteria not fulfilled|0
7559713|NCT02352948|26287388|P6|Overall Study|Withdrawal by Subject|4
7559714|NCT02352948|26287389|P5|Overall Study|Withdrawal by Subject|9
7559715|NCT02352948|26287390|P4|Overall Study|Withdrawal by Subject|23
7559716|NCT02352948|26287391|P3|Overall Study|Withdrawal by Subject|11
7559717|NCT02352948|26287392|P2|Overall Study|Withdrawal by Subject|10
7559718|NCT02352948|26287393|P1|Overall Study|Withdrawal by Subject|1
7559719|NCT02352948|26287388|P6|Overall Study|Lost to Follow-up|1
7559720|NCT02352948|26287389|P5|Overall Study|Lost to Follow-up|2
7559721|NCT02352948|26287390|P4|Overall Study|Lost to Follow-up|1
7559722|NCT02352948|26287391|P3|Overall Study|Lost to Follow-up|2
7559723|NCT02352948|26287392|P2|Overall Study|Lost to Follow-up|0
7559724|NCT02352948|26287393|P1|Overall Study|Lost to Follow-up|1
7559725|NCT02352948|26287388|P6|Overall Study|Death|44
7559726|NCT02352948|26287389|P5|Overall Study|Death|77
7559727|NCT02352948|26287390|P4|Overall Study|Death|74
7559728|NCT02352948|26287391|P3|Overall Study|Death|114
7559729|NCT02352948|26287392|P2|Overall Study|Death|48
7559730|NCT02352948|26287393|P1|Overall Study|Death|47
7559731|NCT02352779|26287518|P3|Overall Study|No Reason|1
7559732|NCT02352779|26287519|P2|Overall Study|No Reason|0
7559733|NCT02352779|26287520|P1|Overall Study|No Reason|0
7559734|NCT02352779|26287518|P3|Overall Study|Other Medical Reason|1
7559735|NCT02352779|26287519|P2|Overall Study|Other Medical Reason|0
7559736|NCT02352779|26287520|P1|Overall Study|Other Medical Reason|0
7559737|NCT02352779|26287518|P3|Overall Study|Absence of Symptoms|0
7559738|NCT02352779|26287519|P2|Overall Study|Absence of Symptoms|0
7559739|NCT02352779|26287520|P1|Overall Study|Absence of Symptoms|1
7559740|NCT02352779|26287518|P3|Overall Study|Study Related Symptoms|0
7559741|NCT02352779|26287519|P2|Overall Study|Study Related Symptoms|0
7559742|NCT02352779|26287520|P1|Overall Study|Study Related Symptoms|1
7559743|NCT02352779|26287518|P3|Overall Study|Changed Mind|0
7559744|NCT02352779|26287519|P2|Overall Study|Changed Mind|0
7559745|NCT02352779|26287520|P1|Overall Study|Changed Mind|1
7559746|NCT02352779|26287518|P3|Overall Study|Disliked Intervention|0
7559747|NCT02352779|26287519|P2|Overall Study|Disliked Intervention|0
7559748|NCT02352779|26287520|P1|Overall Study|Disliked Intervention|1
7559749|NCT02352779|26287518|P3|Overall Study|Feeling Overwhelmed|0
7559750|NCT02352779|26287519|P2|Overall Study|Feeling Overwhelmed|0
7559751|NCT02352779|26287520|P1|Overall Study|Feeling Overwhelmed|1
7559752|NCT02352779|26287518|P3|Overall Study|Too Many Forms|0
7559753|NCT02352779|26287519|P2|Overall Study|Too Many Forms|0
7559754|NCT02352779|26287520|P1|Overall Study|Too Many Forms|2
7559755|NCT02352779|26287518|P3|Overall Study|Personal Issues|0
7559756|NCT02352779|26287519|P2|Overall Study|Personal Issues|1
7559757|NCT02352779|26287520|P1|Overall Study|Personal Issues|1
7559758|NCT02352493|26287546|P18|Overall Study|Lost to Follow-up|0
7559759|NCT02352493|26287547|P17|Overall Study|Lost to Follow-up|0
7559760|NCT02352493|26287548|P16|Overall Study|Lost to Follow-up|0
7559761|NCT02352493|26287549|P15|Overall Study|Lost to Follow-up|0
7559762|NCT02352493|26287550|P14|Overall Study|Lost to Follow-up|2
7559763|NCT02352493|26287551|P13|Overall Study|Lost to Follow-up|1
7559764|NCT02352493|26287552|P12|Overall Study|Lost to Follow-up|0
7559765|NCT02352493|26287553|P11|Overall Study|Lost to Follow-up|0
7559766|NCT02352493|26287554|P10|Overall Study|Lost to Follow-up|1
7559767|NCT02352493|26287555|P9|Overall Study|Lost to Follow-up|0
7559768|NCT02352493|26287556|P8|Overall Study|Lost to Follow-up|0
7559769|NCT02352493|26287557|P7|Overall Study|Lost to Follow-up|0
7559770|NCT02352493|26287558|P6|Overall Study|Lost to Follow-up|0
7559771|NCT02352493|26287559|P5|Overall Study|Lost to Follow-up|0
7559772|NCT02352493|26287560|P4|Overall Study|Lost to Follow-up|0
7559773|NCT02352493|26287561|P3|Overall Study|Lost to Follow-up|0
7559774|NCT02352493|26287562|P2|Overall Study|Lost to Follow-up|0
7559775|NCT02352493|26287563|P1|Overall Study|Lost to Follow-up|0
7559776|NCT02352493|26287546|P18|Overall Study|Withdrawal by Subject|0
7559777|NCT02352493|26287547|P17|Overall Study|Withdrawal by Subject|0
7559778|NCT02352493|26287548|P16|Overall Study|Withdrawal by Subject|0
7559779|NCT02352493|26287549|P15|Overall Study|Withdrawal by Subject|1
7559780|NCT02352493|26287550|P14|Overall Study|Withdrawal by Subject|0
7559781|NCT02352493|26287551|P13|Overall Study|Withdrawal by Subject|0
7559782|NCT02352493|26287552|P12|Overall Study|Withdrawal by Subject|0
7559783|NCT02352493|26287553|P11|Overall Study|Withdrawal by Subject|0
7559784|NCT02352493|26287554|P10|Overall Study|Withdrawal by Subject|0
7559785|NCT02352493|26287555|P9|Overall Study|Withdrawal by Subject|1
7559786|NCT02352493|26287556|P8|Overall Study|Withdrawal by Subject|0
7559787|NCT02352493|26287557|P7|Overall Study|Withdrawal by Subject|0
7559788|NCT02352493|26287558|P6|Overall Study|Withdrawal by Subject|0
7559789|NCT02352493|26287559|P5|Overall Study|Withdrawal by Subject|0
7559790|NCT02352493|26287560|P4|Overall Study|Withdrawal by Subject|0
7559791|NCT02352493|26287561|P3|Overall Study|Withdrawal by Subject|0
7559792|NCT02352493|26287562|P2|Overall Study|Withdrawal by Subject|0
7559793|NCT02352493|26287563|P1|Overall Study|Withdrawal by Subject|0
7559794|NCT02352493|26287546|P18|Overall Study|Pregnancy|0
7559795|NCT02352493|26287547|P17|Overall Study|Pregnancy|0
7559796|NCT02352493|26287548|P16|Overall Study|Pregnancy|0
7559797|NCT02352493|26287549|P15|Overall Study|Pregnancy|0
7559798|NCT02352493|26287550|P14|Overall Study|Pregnancy|0
7559799|NCT02352493|26287551|P13|Overall Study|Pregnancy|0
7559800|NCT02352493|26287552|P12|Overall Study|Pregnancy|0
7559801|NCT02352493|26287553|P11|Overall Study|Pregnancy|0
7559802|NCT02352493|26287554|P10|Overall Study|Pregnancy|0
7559803|NCT02352493|26287555|P9|Overall Study|Pregnancy|1
7559804|NCT02352493|26287556|P8|Overall Study|Pregnancy|0
7559805|NCT02352493|26287557|P7|Overall Study|Pregnancy|1
7559806|NCT02352493|26287558|P6|Overall Study|Pregnancy|0
7559807|NCT02352493|26287559|P5|Overall Study|Pregnancy|0
7559808|NCT02352493|26287560|P4|Overall Study|Pregnancy|0
7559809|NCT02352493|26287561|P3|Overall Study|Pregnancy|0
7559810|NCT02352493|26287562|P2|Overall Study|Pregnancy|0
7559811|NCT02352493|26287563|P1|Overall Study|Pregnancy|0
7559812|NCT02352090|26287802|P3|Overall Study|non-specified mild side-effects|2
7559813|NCT02352090|26287803|P2|Overall Study|non-specified mild side-effects|0
7559814|NCT02352090|26287804|P1|Overall Study|non-specified mild side-effects|0
7559815|NCT02352090|26287802|P3|Overall Study|general malaise|0
7559816|NCT02352090|26287803|P2|Overall Study|general malaise|0
7559817|NCT02352090|26287804|P1|Overall Study|general malaise|1
7559818|NCT02351960|26287832|P2|Overall Study|Significant Protocol Deviation|5
7559819|NCT02351960|26287833|P1|Overall Study|Significant Protocol Deviation|0
7559820|NCT02351960|26287832|P2|Overall Study|Voluntary Withdrawal|4
7559821|NCT02351960|26287833|P1|Overall Study|Voluntary Withdrawal|5
7559822|NCT02351960|26287832|P2|Overall Study|Pretreatment Event/Adverse Event|3
7559823|NCT02351960|26287833|P1|Overall Study|Pretreatment Event/Adverse Event|6
7559824|NCT02351934|26287854|P2|Follow-Up|2 ERAS Components Noncompliant|4
7559825|NCT02351934|26287855|P1|Follow-Up|2 ERAS Components Noncompliant|0
7559826|NCT02351934|26287854|P2|Follow-Up|1 ERAS Component Noncompliant|6
7559827|NCT02351934|26287855|P1|Follow-Up|1 ERAS Component Noncompliant|0
7559828|NCT02351934|26287854|P2|Follow-Up|No documentation|0
7559829|NCT02351934|26287855|P1|Follow-Up|No documentation|2
7559830|NCT02351934|26287854|P2|Follow-Up|Hypotension|0
7559831|NCT02351934|26287855|P1|Follow-Up|Hypotension|3
7559832|NCT02351934|26287854|P2|Follow-Up|Early dismissal|0
7559833|NCT02351934|26287855|P1|Follow-Up|Early dismissal|3
7559834|NCT02351934|26287854|P2|Follow-Up|Acute Kidney Injury|0
7559835|NCT02351934|26287855|P1|Follow-Up|Acute Kidney Injury|1
7559836|NCT02351934|26287854|P2|Follow-Up|POD weight<pre-op weight|0
7559837|NCT02351934|26287855|P1|Follow-Up|POD weight<pre-op weight|3
7559838|NCT02351934|26287854|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
7559839|NCT02351934|26287855|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
7559840|NCT02351934|26287854|P2|Allocation|Hypotension preventing administration|0
7559841|NCT02351934|26287855|P1|Allocation|Hypotension preventing administration|2
7559842|NCT02351934|26287854|P2|Allocation|POD weight<pre-op weight|0
7559843|NCT02351934|26287855|P1|Allocation|POD weight<pre-op weight|3
7559844|NCT02351817|26287871|P2|Period 2|Protocol Violation|0
7559845|NCT02351817|26287872|P1|Period 2|Protocol Violation|1
7559846|NCT02351817|26287871|P2|Period 2|Adverse Event|2
7559847|NCT02351817|26287872|P1|Period 2|Adverse Event|0
7559848|NCT02351817|26287871|P2|Period 1|Lack of Efficacy|1
7559849|NCT02351817|26287872|P1|Period 1|Lack of Efficacy|0
7559850|NCT02351817|26287871|P2|Period 1|Adverse Event|2
7559851|NCT02351817|26287872|P1|Period 1|Adverse Event|1
7559852|NCT02351349|26287901|P2|Overall Study|Withdrawal by Subject|3
7559853|NCT02351349|26287902|P1|Overall Study|Withdrawal by Subject|2
7559854|NCT02351167|26287952|P3|Overall Study|Withdrawal by Subject|21
7559855|NCT02351167|26287953|P2|Overall Study|Withdrawal by Subject|18
7559856|NCT02351167|26287954|P1|Overall Study|Withdrawal by Subject|19
7559857|NCT02350478|26288178|P2|Overall Study|Lost to Follow-up|1
7559858|NCT02350478|26288179|P1|Overall Study|Lost to Follow-up|5
7559859|NCT02350309|26288201|P6|Treatment Period 4 (2 Days)|Death in the Family|1
7559860|NCT02350309|26288202|P5|Treatment Period 4 (2 Days)|Death in the Family|0
7559861|NCT02350309|26288203|P4|Treatment Period 4 (2 Days)|Death in the Family|0
7559862|NCT02350309|26288204|P3|Treatment Period 4 (2 Days)|Death in the Family|0
7559863|NCT02350309|26288205|P2|Treatment Period 4 (2 Days)|Death in the Family|0
7559864|NCT02350309|26288206|P1|Treatment Period 4 (2 Days)|Death in the Family|0
7559865|NCT02350309|26288201|P6|Treatment Period 1 (2 Days)|Physician Decision|0
7559866|NCT02350309|26288202|P5|Treatment Period 1 (2 Days)|Physician Decision|0
7559867|NCT02350309|26288203|P4|Treatment Period 1 (2 Days)|Physician Decision|0
7559868|NCT02350309|26288204|P3|Treatment Period 1 (2 Days)|Physician Decision|1
7559869|NCT02350309|26288205|P2|Treatment Period 1 (2 Days)|Physician Decision|0
7559870|NCT02350309|26288206|P1|Treatment Period 1 (2 Days)|Physician Decision|0
7559871|NCT02350127|26288247|P2|8-Month Assessment|Withdrawal by Subject|8
7559872|NCT02350127|26288248|P1|8-Month Assessment|Withdrawal by Subject|5
7559873|NCT02350127|26288247|P2|8-Month Assessment|Death|1
7559874|NCT02350127|26288248|P1|8-Month Assessment|Death|1
7559875|NCT02350127|26288247|P2|4-Month Assessment|Death|0
7559876|NCT02350127|26288248|P1|4-Month Assessment|Death|1
7559877|NCT02350127|26288247|P2|4-Month Assessment|Withdrawal by Subject|9
7559878|NCT02350127|26288248|P1|4-Month Assessment|Withdrawal by Subject|10
7559879|NCT02349789|26288287|P1|Overall Study|Withdrawal by Subject|2
7559880|NCT02349711|26288298|P2|Overall Study|Lost to Follow-up|1
7559881|NCT02349711|26288299|P1|Overall Study|Lost to Follow-up|1
7559882|NCT02349711|26288298|P2|Overall Study|Withdrawal by Subject|1
7559883|NCT02349711|26288299|P1|Overall Study|Withdrawal by Subject|2
7559884|NCT02349633|26288346|P14|Overall Study|Other|0
7559885|NCT02349633|26288347|P13|Overall Study|Other|0
7559886|NCT02349633|26288348|P12|Overall Study|Other|0
7559887|NCT02349633|26288349|P11|Overall Study|Other|0
7559888|NCT02349633|26288350|P10|Overall Study|Other|0
7559889|NCT02349633|26288351|P9|Overall Study|Other|0
7559890|NCT02349633|26288352|P8|Overall Study|Other|2
7559891|NCT02349633|26288353|P7|Overall Study|Other|0
7559892|NCT02349633|26288354|P6|Overall Study|Other|0
7559893|NCT02349633|26288355|P5|Overall Study|Other|0
7559894|NCT02349633|26288356|P4|Overall Study|Other|0
7559895|NCT02349633|26288357|P3|Overall Study|Other|0
7559896|NCT02349633|26288358|P2|Overall Study|Other|0
7559897|NCT02349633|26288359|P1|Overall Study|Other|0
7559898|NCT02349633|26288346|P14|Overall Study|Termination by sponsor|0
7559899|NCT02349633|26288347|P13|Overall Study|Termination by sponsor|0
7559900|NCT02349633|26288348|P12|Overall Study|Termination by sponsor|0
7559901|NCT02349633|26288349|P11|Overall Study|Termination by sponsor|0
7559902|NCT02349633|26288350|P10|Overall Study|Termination by sponsor|2
7559903|NCT02349633|26288351|P9|Overall Study|Termination by sponsor|0
7559904|NCT02349633|26288352|P8|Overall Study|Termination by sponsor|1
7559905|NCT02349633|26288353|P7|Overall Study|Termination by sponsor|0
7559906|NCT02349633|26288354|P6|Overall Study|Termination by sponsor|0
7559907|NCT02349633|26288355|P5|Overall Study|Termination by sponsor|0
7559908|NCT02349633|26288356|P4|Overall Study|Termination by sponsor|0
7559909|NCT02349633|26288357|P3|Overall Study|Termination by sponsor|0
7559910|NCT02349633|26288358|P2|Overall Study|Termination by sponsor|0
7559911|NCT02349633|26288359|P1|Overall Study|Termination by sponsor|0
7559912|NCT02349633|26288346|P14|Overall Study|Early termination of survival follow-up|0
7559913|NCT02349633|26288347|P13|Overall Study|Early termination of survival follow-up|0
7559914|NCT02349633|26288348|P12|Overall Study|Early termination of survival follow-up|0
7559915|NCT02349633|26288349|P11|Overall Study|Early termination of survival follow-up|0
7559916|NCT02349633|26288350|P10|Overall Study|Early termination of survival follow-up|0
7559917|NCT02349633|26288351|P9|Overall Study|Early termination of survival follow-up|0
7559918|NCT02349633|26288352|P8|Overall Study|Early termination of survival follow-up|4
7559919|NCT02349633|26288353|P7|Overall Study|Early termination of survival follow-up|0
7559920|NCT02349633|26288354|P6|Overall Study|Early termination of survival follow-up|0
7559921|NCT02349633|26288355|P5|Overall Study|Early termination of survival follow-up|0
7559922|NCT02349633|26288356|P4|Overall Study|Early termination of survival follow-up|0
7559923|NCT02349633|26288357|P3|Overall Study|Early termination of survival follow-up|0
7559924|NCT02349633|26288358|P2|Overall Study|Early termination of survival follow-up|0
7559925|NCT02349633|26288359|P1|Overall Study|Early termination of survival follow-up|0
7559926|NCT02349633|26288346|P14|Overall Study|Transition to compassionate use|0
7559927|NCT02349633|26288347|P13|Overall Study|Transition to compassionate use|0
7559928|NCT02349633|26288348|P12|Overall Study|Transition to compassionate use|0
7559929|NCT02349633|26288349|P11|Overall Study|Transition to compassionate use|0
7559930|NCT02349633|26288350|P10|Overall Study|Transition to compassionate use|1
7559931|NCT02349633|26288351|P9|Overall Study|Transition to compassionate use|0
7559932|NCT02349633|26288352|P8|Overall Study|Transition to compassionate use|3
7559933|NCT02349633|26288353|P7|Overall Study|Transition to compassionate use|0
7559934|NCT02349633|26288354|P6|Overall Study|Transition to compassionate use|0
7559935|NCT02349633|26288355|P5|Overall Study|Transition to compassionate use|1
7559936|NCT02349633|26288356|P4|Overall Study|Transition to compassionate use|0
7559937|NCT02349633|26288357|P3|Overall Study|Transition to compassionate use|0
7559938|NCT02349633|26288358|P2|Overall Study|Transition to compassionate use|0
7559939|NCT02349633|26288359|P1|Overall Study|Transition to compassionate use|0
7559940|NCT02349633|26288346|P14|Overall Study|Withdrawal of informed consent|0
7559941|NCT02349633|26288347|P13|Overall Study|Withdrawal of informed consent|0
7559942|NCT02349633|26288348|P12|Overall Study|Withdrawal of informed consent|0
7559943|NCT02349633|26288349|P11|Overall Study|Withdrawal of informed consent|0
7559944|NCT02349633|26288350|P10|Overall Study|Withdrawal of informed consent|0
7559945|NCT02349633|26288351|P9|Overall Study|Withdrawal of informed consent|0
7559946|NCT02349633|26288352|P8|Overall Study|Withdrawal of informed consent|3
7559947|NCT02349633|26288353|P7|Overall Study|Withdrawal of informed consent|0
7559948|NCT02349633|26288354|P6|Overall Study|Withdrawal of informed consent|0
7559949|NCT02349633|26288355|P5|Overall Study|Withdrawal of informed consent|1
7559950|NCT02349633|26288356|P4|Overall Study|Withdrawal of informed consent|1
7559951|NCT02349633|26288357|P3|Overall Study|Withdrawal of informed consent|0
7559952|NCT02349633|26288358|P2|Overall Study|Withdrawal of informed consent|0
7559953|NCT02349633|26288359|P1|Overall Study|Withdrawal of informed consent|0
7559954|NCT02349633|26288346|P14|Overall Study|Withdrawal by Subject|0
7559955|NCT02349633|26288347|P13|Overall Study|Withdrawal by Subject|0
7559956|NCT02349633|26288348|P12|Overall Study|Withdrawal by Subject|0
7559957|NCT02349633|26288349|P11|Overall Study|Withdrawal by Subject|0
7559958|NCT02349633|26288350|P10|Overall Study|Withdrawal by Subject|1
7559959|NCT02349633|26288351|P9|Overall Study|Withdrawal by Subject|2
7559960|NCT02349633|26288352|P8|Overall Study|Withdrawal by Subject|2
7559961|NCT02349633|26288353|P7|Overall Study|Withdrawal by Subject|0
7559962|NCT02349633|26288354|P6|Overall Study|Withdrawal by Subject|0
7559963|NCT02349633|26288355|P5|Overall Study|Withdrawal by Subject|0
7559964|NCT02349633|26288356|P4|Overall Study|Withdrawal by Subject|1
7559965|NCT02349633|26288357|P3|Overall Study|Withdrawal by Subject|0
7559966|NCT02349633|26288358|P2|Overall Study|Withdrawal by Subject|0
7559967|NCT02349633|26288359|P1|Overall Study|Withdrawal by Subject|0
7559968|NCT02349633|26288346|P14|Overall Study|Death|0
7559969|NCT02349633|26288347|P13|Overall Study|Death|0
7559970|NCT02349633|26288348|P12|Overall Study|Death|0
7559971|NCT02349633|26288349|P11|Overall Study|Death|0
7559972|NCT02349633|26288350|P10|Overall Study|Death|1
7559973|NCT02349633|26288351|P9|Overall Study|Death|0
7559974|NCT02349633|26288352|P8|Overall Study|Death|1
7559975|NCT02349633|26288353|P7|Overall Study|Death|1
7559976|NCT02349633|26288354|P6|Overall Study|Death|1
7559977|NCT02349633|26288355|P5|Overall Study|Death|0
7559978|NCT02349633|26288356|P4|Overall Study|Death|0
7559979|NCT02349633|26288357|P3|Overall Study|Death|0
7559980|NCT02349633|26288358|P2|Overall Study|Death|1
7559981|NCT02349633|26288359|P1|Overall Study|Death|0
7559982|NCT02349542|26288666|P1|Overall Study|Withdrawal by Subject|5
7559983|NCT02349451|26288690|P4|Overall Study|Withdrawal by Subject|1
7559984|NCT02349451|26288691|P3|Overall Study|Withdrawal by Subject|2
7559985|NCT02349451|26288692|P2|Overall Study|Withdrawal by Subject|1
7559986|NCT02349451|26288693|P1|Overall Study|Withdrawal by Subject|0
7559987|NCT02349425|26288744|P4|Period 2|Adverse Event|0
7559988|NCT02349425|26288745|P3|Period 2|Adverse Event|1
7559989|NCT02349425|26288746|P2|Period 2|Adverse Event|1
7559990|NCT02349425|26288747|P1|Period 2|Adverse Event|0
7559991|NCT02349425|26288744|P4|Period 1|Adverse Event|0
7559992|NCT02349425|26288745|P3|Period 1|Adverse Event|0
7559993|NCT02349425|26288746|P2|Period 1|Adverse Event|1
7559994|NCT02349425|26288747|P1|Period 1|Adverse Event|1
7559995|NCT02349412|26288921|P2|Overall Study|Withdrawal by Subject|7
7559996|NCT02349412|26288922|P1|Overall Study|Withdrawal by Subject|7
7559997|NCT02349360|26288938|P2|Overall Study|Withdrawal by Subject|1
7559998|NCT02349360|26288939|P1|Overall Study|Withdrawal by Subject|0
7559999|NCT02349295|26288950|P14|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560000|NCT02349295|26288951|P13|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560001|NCT02349295|26288952|P12|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
7560002|NCT02349295|26288953|P11|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560003|NCT02349295|26288954|P10|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560004|NCT02349295|26288955|P9|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560005|NCT02349295|26288956|P8|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560006|NCT02349295|26288957|P7|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560007|NCT02349295|26288958|P6|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560008|NCT02349295|26288959|P5|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560009|NCT02349295|26288960|P4|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560010|NCT02349295|26288961|P3|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560011|NCT02349295|26288962|P2|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560012|NCT02349295|26288963|P1|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7560013|NCT02349295|26288950|P14|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560014|NCT02349295|26288951|P13|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560015|NCT02349295|26288952|P12|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
7560016|NCT02349295|26288953|P11|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560017|NCT02349295|26288954|P10|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560018|NCT02349295|26288955|P9|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560019|NCT02349295|26288956|P8|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560020|NCT02349295|26288957|P7|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560021|NCT02349295|26288958|P6|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560022|NCT02349295|26288959|P5|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560023|NCT02349295|26288960|P4|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560024|NCT02349295|26288961|P3|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560025|NCT02349295|26288962|P2|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560026|NCT02349295|26288963|P1|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7560027|NCT02349295|26288950|P14|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560028|NCT02349295|26288951|P13|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7560029|NCT02349295|26288952|P12|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7560030|NCT02349295|26288953|P11|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560031|NCT02349295|26288954|P10|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560032|NCT02349295|26288955|P9|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560033|NCT02349295|26288956|P8|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560034|NCT02349295|26288957|P7|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560035|NCT02349295|26288958|P6|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560036|NCT02349295|26288959|P5|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560037|NCT02349295|26288960|P4|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560038|NCT02349295|26288961|P3|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560039|NCT02349295|26288962|P2|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560040|NCT02349295|26288963|P1|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7560041|NCT02349295|26288950|P14|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560042|NCT02349295|26288951|P13|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
7560043|NCT02349295|26288952|P12|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
7560044|NCT02349295|26288953|P11|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560045|NCT02349295|26288954|P10|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560046|NCT02349295|26288955|P9|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560047|NCT02349295|26288956|P8|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560048|NCT02349295|26288957|P7|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560049|NCT02349295|26288958|P6|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560050|NCT02349295|26288959|P5|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560051|NCT02349295|26288960|P4|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560052|NCT02349295|26288961|P3|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560053|NCT02349295|26288962|P2|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560054|NCT02349295|26288963|P1|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7560055|NCT02349295|26288950|P14|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7560056|NCT02349295|26288951|P13|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
7560057|NCT02349295|26288952|P12|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7560058|NCT02349295|26288953|P11|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560059|NCT02349295|26288954|P10|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560060|NCT02349295|26288955|P9|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560061|NCT02349295|26288956|P8|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560062|NCT02349295|26288957|P7|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560063|NCT02349295|26288958|P6|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560064|NCT02349295|26288959|P5|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560065|NCT02349295|26288960|P4|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560066|NCT02349295|26288961|P3|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560067|NCT02349295|26288962|P2|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560068|NCT02349295|26288963|P1|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7560069|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560070|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560071|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560072|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560073|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560074|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7560075|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7560076|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560077|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560078|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560079|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560080|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560081|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560082|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7560083|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560084|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560085|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560086|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560087|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560088|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7560089|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7560090|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560091|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560092|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560093|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560094|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560095|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560096|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7560097|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560098|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560099|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560100|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
7560101|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
7560102|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
7560103|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
7560104|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560105|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560106|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560107|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560108|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560109|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560110|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7560111|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Death|0
7560112|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Death|0
7560113|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Death|0
7560114|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Death|0
7560115|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Death|1
7560116|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Death|1
7560345|NCT02347774|26289610|P1|On Study Treatment|ranomized in error|0
7560117|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Death|1
7560118|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Death|0
7560119|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Death|0
7560120|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Death|0
7560121|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Death|0
7560122|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Death|0
7560123|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Death|0
7560124|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Death|0
7560125|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560126|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560127|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560128|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560129|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
7560130|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560131|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
7560132|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560133|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560134|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560135|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560136|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560137|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560138|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7560139|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560140|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560141|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560142|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7560143|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7560144|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7560145|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7560146|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560147|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560148|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560149|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560150|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560151|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560152|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7560153|NCT02349295|26288950|P14|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560154|NCT02349295|26288951|P13|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560155|NCT02349295|26288952|P12|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560156|NCT02349295|26288953|P11|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
7560157|NCT02349295|26288954|P10|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
7560158|NCT02349295|26288955|P9|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
7560159|NCT02349295|26288956|P8|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
7560160|NCT02349295|26288957|P7|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560161|NCT02349295|26288958|P6|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560162|NCT02349295|26288959|P5|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560163|NCT02349295|26288960|P4|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560164|NCT02349295|26288961|P3|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560165|NCT02349295|26288962|P2|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560166|NCT02349295|26288963|P1|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7560167|NCT02349295|26288950|P14|IR (Week 16-24)|Lack of Efficacy|0
7560168|NCT02349295|26288951|P13|IR (Week 16-24)|Lack of Efficacy|0
7560169|NCT02349295|26288952|P12|IR (Week 16-24)|Lack of Efficacy|0
7560170|NCT02349295|26288953|P11|IR (Week 16-24)|Lack of Efficacy|0
7560171|NCT02349295|26288954|P10|IR (Week 16-24)|Lack of Efficacy|0
7560172|NCT02349295|26288955|P9|IR (Week 16-24)|Lack of Efficacy|0
7560173|NCT02349295|26288956|P8|IR (Week 16-24)|Lack of Efficacy|0
7560174|NCT02349295|26288957|P7|IR (Week 16-24)|Lack of Efficacy|0
7560175|NCT02349295|26288958|P6|IR (Week 16-24)|Lack of Efficacy|0
7560176|NCT02349295|26288959|P5|IR (Week 16-24)|Lack of Efficacy|0
7560177|NCT02349295|26288960|P4|IR (Week 16-24)|Lack of Efficacy|1
7560178|NCT02349295|26288961|P3|IR (Week 16-24)|Lack of Efficacy|0
7560179|NCT02349295|26288962|P2|IR (Week 16-24)|Lack of Efficacy|0
7560180|NCT02349295|26288963|P1|IR (Week 16-24)|Lack of Efficacy|0
7560181|NCT02349295|26288950|P14|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560182|NCT02349295|26288951|P13|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560183|NCT02349295|26288952|P12|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560184|NCT02349295|26288953|P11|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560185|NCT02349295|26288954|P10|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560186|NCT02349295|26288955|P9|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560187|NCT02349295|26288956|P8|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560188|NCT02349295|26288957|P7|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560189|NCT02349295|26288958|P6|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560190|NCT02349295|26288959|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560191|NCT02349295|26288960|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560192|NCT02349295|26288961|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7560193|NCT02349295|26288962|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7560194|NCT02349295|26288963|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7560195|NCT02349295|26288950|P14|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560196|NCT02349295|26288951|P13|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560197|NCT02349295|26288952|P12|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560198|NCT02349295|26288953|P11|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560199|NCT02349295|26288954|P10|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560200|NCT02349295|26288955|P9|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560201|NCT02349295|26288956|P8|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560202|NCT02349295|26288957|P7|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560203|NCT02349295|26288958|P6|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560204|NCT02349295|26288959|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560205|NCT02349295|26288960|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7560206|NCT02349295|26288961|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
7560207|NCT02349295|26288962|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7560208|NCT02349295|26288963|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7560209|NCT02349295|26288950|P14|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560210|NCT02349295|26288951|P13|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560211|NCT02349295|26288952|P12|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560212|NCT02349295|26288953|P11|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560213|NCT02349295|26288954|P10|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560214|NCT02349295|26288955|P9|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560215|NCT02349295|26288956|P8|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560216|NCT02349295|26288957|P7|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560217|NCT02349295|26288958|P6|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560218|NCT02349295|26288959|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560219|NCT02349295|26288960|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7560220|NCT02349295|26288961|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
7560221|NCT02349295|26288962|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7560222|NCT02349295|26288963|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7560223|NCT02349295|26288950|P14|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560224|NCT02349295|26288951|P13|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560225|NCT02349295|26288952|P12|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560226|NCT02349295|26288953|P11|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560227|NCT02349295|26288954|P10|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560228|NCT02349295|26288955|P9|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560229|NCT02349295|26288956|P8|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560230|NCT02349295|26288957|P7|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560231|NCT02349295|26288958|P6|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560232|NCT02349295|26288959|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560233|NCT02349295|26288960|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7560234|NCT02349295|26288961|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
7560235|NCT02349295|26288962|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
7560236|NCT02349295|26288963|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
7560237|NCT02349295|26288950|P14|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560238|NCT02349295|26288951|P13|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560239|NCT02349295|26288952|P12|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560240|NCT02349295|26288953|P11|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560241|NCT02349295|26288954|P10|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560242|NCT02349295|26288955|P9|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560243|NCT02349295|26288956|P8|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560244|NCT02349295|26288957|P7|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560245|NCT02349295|26288958|P6|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560246|NCT02349295|26288959|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560247|NCT02349295|26288960|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
7560248|NCT02349295|26288961|P3|Double Blind Treatment (Week 0-24)|Adverse Event|5
7560249|NCT02349295|26288962|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
7560250|NCT02349295|26288963|P1|Double Blind Treatment (Week 0-24)|Adverse Event|7
7560251|NCT02349061|26289103|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
7560252|NCT02349061|26289104|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
7560253|NCT02349061|26289105|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
7560254|NCT02349061|26289103|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
7560255|NCT02349061|26289104|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
7560256|NCT02349061|26289105|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
7560257|NCT02349061|26289103|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
7560258|NCT02349061|26289104|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7560259|NCT02349061|26289105|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7560260|NCT02349061|26289103|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
7560261|NCT02349061|26289104|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
7560262|NCT02349061|26289105|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
7560263|NCT02349061|26289103|P3|Main Study: Week 24 to 56|Physician Decision|1
7560264|NCT02349061|26289104|P2|Main Study: Week 24 to 56|Physician Decision|0
7560265|NCT02349061|26289105|P1|Main Study: Week 24 to 56|Physician Decision|0
7560266|NCT02349061|26289103|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
7560267|NCT02349061|26289104|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
7560268|NCT02349061|26289105|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
7560269|NCT02349061|26289103|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
7560270|NCT02349061|26289104|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
7560271|NCT02349061|26289105|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
7560272|NCT02349061|26289103|P3|Main Study: Week 24 to 56|Adverse Event|1
7560273|NCT02349061|26289104|P2|Main Study: Week 24 to 56|Adverse Event|2
7560274|NCT02349061|26289105|P1|Main Study: Week 24 to 56|Adverse Event|0
7560275|NCT02349061|26289103|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7560276|NCT02349061|26289104|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7560277|NCT02349061|26289105|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
7560278|NCT02349061|26289103|P3|Main Study: PCP (Up to Week 24)|Other|0
7560279|NCT02349061|26289104|P2|Main Study: PCP (Up to Week 24)|Other|1
7560280|NCT02349061|26289105|P1|Main Study: PCP (Up to Week 24)|Other|1
7560281|NCT02349061|26289103|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
7560282|NCT02349061|26289104|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
7560283|NCT02349061|26289105|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
7560284|NCT02349061|26289103|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7560285|NCT02349061|26289104|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7560286|NCT02349061|26289105|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
7560287|NCT02349061|26289103|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
7560288|NCT02349061|26289104|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
7560289|NCT02349061|26289105|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
7560290|NCT02349048|26289125|P2|Overall Study|Lost to Follow-up|0
7560291|NCT02349048|26289126|P1|Overall Study|Lost to Follow-up|1
7560292|NCT02349048|26289125|P2|Overall Study|Withdrawal by Subject|0
7560293|NCT02349048|26289126|P1|Overall Study|Withdrawal by Subject|4
7560294|NCT02348840|26289187|P4|Overall Study|Withdrawal by Subject|0
7560295|NCT02348840|26289188|P3|Overall Study|Withdrawal by Subject|0
7560296|NCT02348840|26289189|P2|Overall Study|Withdrawal by Subject|1
7560297|NCT02348840|26289190|P1|Overall Study|Withdrawal by Subject|2
7560298|NCT02348723|26289213|P2|Overall Study|Adverse Event|1
7560299|NCT02348723|26289214|P1|Overall Study|Adverse Event|3
7560300|NCT02348723|26289213|P2|Overall Study|Reason other than specified|1
7560301|NCT02348723|26289214|P1|Overall Study|Reason other than specified|1
7560302|NCT02348723|26289213|P2|Overall Study|Consent withdrawn|3
7560303|NCT02348723|26289214|P1|Overall Study|Consent withdrawn|1
7560304|NCT02348723|26289213|P2|Overall Study|Lost to Follow-up|1
7560305|NCT02348723|26289214|P1|Overall Study|Lost to Follow-up|1
7560306|NCT02348723|26289213|P2|Overall Study|Non-compliant with Protocol|0
7560307|NCT02348723|26289214|P1|Overall Study|Non-compliant with Protocol|1
7560308|NCT02348723|26289213|P2|Overall Study|No ablation|20
7560309|NCT02348723|26289214|P1|Overall Study|No ablation|21
7560310|NCT02348489|26289403|P2|Overall Study|Lost to Follow-up|5
7560311|NCT02348489|26289404|P1|Overall Study|Lost to Follow-up|3
7560312|NCT02348489|26289403|P2|Overall Study|Withdrawal by Subject|27
7560313|NCT02348489|26289404|P1|Overall Study|Withdrawal by Subject|14
7560314|NCT02348489|26289403|P2|Overall Study|Death|335
7560315|NCT02348489|26289404|P1|Overall Study|Death|336
7560316|NCT02348008|26289465|P3|Overall Study|Symptomatic Deterioration|0
7560317|NCT02348008|26289466|P2|Overall Study|Symptomatic Deterioration|1
7560318|NCT02348008|26289467|P1|Overall Study|Symptomatic Deterioration|0
7560319|NCT02348008|26289465|P3|Overall Study|Withdrawal by Subject|0
7560320|NCT02348008|26289466|P2|Overall Study|Withdrawal by Subject|1
7560321|NCT02348008|26289467|P1|Overall Study|Withdrawal by Subject|0
7560322|NCT02348008|26289465|P3|Overall Study|Disease Progression|16
7560323|NCT02348008|26289466|P2|Overall Study|Disease Progression|5
7560324|NCT02348008|26289467|P1|Overall Study|Disease Progression|1
7560325|NCT02348008|26289465|P3|Overall Study|Adverse Event|3
7560326|NCT02348008|26289466|P2|Overall Study|Adverse Event|3
7560327|NCT02348008|26289467|P1|Overall Study|Adverse Event|2
7560328|NCT02347943|26289483|P3|Overall Study|Study was cancelled|45
7560329|NCT02347943|26289484|P2|Overall Study|Study was cancelled|67
7560330|NCT02347943|26289485|P1|Overall Study|Study was cancelled|140
7560331|NCT02347813|26289534|P2|First Intervention, 24 Weeks|Adverse Event|1
7560332|NCT02347813|26289535|P1|First Intervention, 24 Weeks|Adverse Event|1
7560333|NCT02347813|26289534|P2|First Intervention, 24 Weeks|Withdrawal by Subject|1
7560334|NCT02347813|26289535|P1|First Intervention, 24 Weeks|Withdrawal by Subject|1
7560335|NCT02347787|26289545|P2|9 Month Follow-Up|Withdrawal by Subject|12
7560336|NCT02347787|26289546|P1|9 Month Follow-Up|Withdrawal by Subject|9
7560337|NCT02347787|26289545|P2|9 Month Follow-Up|Lost to Follow-up|59
7560338|NCT02347787|26289546|P1|9 Month Follow-Up|Lost to Follow-up|52
7560339|NCT02347787|26289545|P2|6 Month Follow-Up|Withdrawal by Subject|9
7560340|NCT02347787|26289546|P1|6 Month Follow-Up|Withdrawal by Subject|3
7560341|NCT02347787|26289545|P2|6 Month Follow-Up|Lost to Follow-up|47
7560342|NCT02347787|26289546|P1|6 Month Follow-Up|Lost to Follow-up|63
7560343|NCT02347774|26289608|P3|On Study Treatment|ranomized in error|1
7560344|NCT02347774|26289609|P2|On Study Treatment|ranomized in error|0
7560346|NCT02347774|26289608|P3|On Study Treatment|Met Prolonged QT criteria|0
7560347|NCT02347774|26289609|P2|On Study Treatment|Met Prolonged QT criteria|0
7560348|NCT02347774|26289610|P1|On Study Treatment|Met Prolonged QT criteria|1
7560349|NCT02347774|26289608|P3|On Study Treatment|Lost to Follow-up|1
7560350|NCT02347774|26289609|P2|On Study Treatment|Lost to Follow-up|6
7560351|NCT02347774|26289610|P1|On Study Treatment|Lost to Follow-up|2
7560352|NCT02347774|26289608|P3|On Study Treatment|withdrew consent|12
7560353|NCT02347774|26289609|P2|On Study Treatment|withdrew consent|8
7560354|NCT02347774|26289610|P1|On Study Treatment|withdrew consent|9
7560355|NCT02347774|26289608|P3|On Study Treatment|Protocol Violation|1
7560356|NCT02347774|26289609|P2|On Study Treatment|Protocol Violation|0
7560357|NCT02347774|26289610|P1|On Study Treatment|Protocol Violation|0
7560358|NCT02347774|26289608|P3|On Study Treatment|non-complicance with study medication|0
7560359|NCT02347774|26289609|P2|On Study Treatment|non-complicance with study medication|2
7560360|NCT02347774|26289610|P1|On Study Treatment|non-complicance with study medication|0
7560361|NCT02347774|26289608|P3|On Study Treatment|Lack of Efficacy|2
7560362|NCT02347774|26289609|P2|On Study Treatment|Lack of Efficacy|0
7560363|NCT02347774|26289610|P1|On Study Treatment|Lack of Efficacy|3
7560364|NCT02347774|26289608|P3|On Study Treatment|Adverse Event|19
7560365|NCT02347774|26289609|P2|On Study Treatment|Adverse Event|15
7560366|NCT02347774|26289610|P1|On Study Treatment|Adverse Event|9
7560367|NCT02347774|26289608|P3|Study Participation|randomized in error|1
7560368|NCT02347774|26289609|P2|Study Participation|randomized in error|0
7560369|NCT02347774|26289610|P1|Study Participation|randomized in error|0
7560370|NCT02347774|26289608|P3|Study Participation|incarceration|0
7560371|NCT02347774|26289609|P2|Study Participation|incarceration|0
7560372|NCT02347774|26289610|P1|Study Participation|incarceration|1
7560373|NCT02347774|26289608|P3|Study Participation|non-compliance with study drug|0
7560374|NCT02347774|26289609|P2|Study Participation|non-compliance with study drug|1
7560375|NCT02347774|26289610|P1|Study Participation|non-compliance with study drug|0
7560376|NCT02347774|26289608|P3|Study Participation|Met Prolonged QT criteria|0
7560377|NCT02347774|26289609|P2|Study Participation|Met Prolonged QT criteria|0
7560378|NCT02347774|26289610|P1|Study Participation|Met Prolonged QT criteria|1
7560379|NCT02347774|26289608|P3|Study Participation|withdrew consent|1
7560380|NCT02347774|26289609|P2|Study Participation|withdrew consent|1
7560381|NCT02347774|26289610|P1|Study Participation|withdrew consent|1
7560382|NCT02347774|26289608|P3|Study Participation|Adverse Event|6
7560383|NCT02347774|26289609|P2|Study Participation|Adverse Event|4
7560384|NCT02347774|26289610|P1|Study Participation|Adverse Event|1
7560385|NCT02347774|26289608|P3|Study Participation|Withdrawal by Subject|15
7560386|NCT02347774|26289609|P2|Study Participation|Withdrawal by Subject|9
7560387|NCT02347774|26289610|P1|Study Participation|Withdrawal by Subject|8
7560388|NCT02347774|26289608|P3|Study Participation|Lost to Follow-up|2
7560389|NCT02347774|26289609|P2|Study Participation|Lost to Follow-up|6
7560390|NCT02347774|26289610|P1|Study Participation|Lost to Follow-up|3
7560391|NCT02347761|26289666|P3|On Study Treatment|Adverse Event|20
7560392|NCT02347761|26289667|P2|On Study Treatment|Adverse Event|8
7560393|NCT02347761|26289668|P1|On Study Treatment|Adverse Event|10
7560394|NCT02347761|26289666|P3|On Study Treatment|durg not working|1
7560395|NCT02347761|26289667|P2|On Study Treatment|durg not working|1
7560396|NCT02347761|26289668|P1|On Study Treatment|durg not working|0
7560397|NCT02347761|26289666|P3|On Study Treatment|investigator discretion|0
7560398|NCT02347761|26289667|P2|On Study Treatment|investigator discretion|0
7560399|NCT02347761|26289668|P1|On Study Treatment|investigator discretion|2
7560400|NCT02347761|26289666|P3|On Study Treatment|Lost to Follow-up|1
7560401|NCT02347761|26289667|P2|On Study Treatment|Lost to Follow-up|1
7560402|NCT02347761|26289668|P1|On Study Treatment|Lost to Follow-up|2
7560403|NCT02347761|26289666|P3|On Study Treatment|dissastisfaction with device|4
7560404|NCT02347761|26289667|P2|On Study Treatment|dissastisfaction with device|1
7560405|NCT02347761|26289668|P1|On Study Treatment|dissastisfaction with device|2
7560406|NCT02347761|26289666|P3|On Study Treatment|move/travel|5
7560407|NCT02347761|26289667|P2|On Study Treatment|move/travel|6
7560408|NCT02347761|26289668|P1|On Study Treatment|move/travel|2
7560409|NCT02347761|26289666|P3|On Study Treatment|Withdrawal by Subject|5
7560410|NCT02347761|26289667|P2|On Study Treatment|Withdrawal by Subject|3
7560411|NCT02347761|26289668|P1|On Study Treatment|Withdrawal by Subject|7
7560412|NCT02347761|26289666|P3|On Study Treatment|non-compliance with study medication|2
7560413|NCT02347761|26289667|P2|On Study Treatment|non-compliance with study medication|0
7560414|NCT02347761|26289668|P1|On Study Treatment|non-compliance with study medication|0
7560415|NCT02347761|26289666|P3|On Study Treatment|Lack of Efficacy|4
7560416|NCT02347761|26289667|P2|On Study Treatment|Lack of Efficacy|3
7560417|NCT02347761|26289668|P1|On Study Treatment|Lack of Efficacy|2
7560418|NCT02347761|26289666|P3|All Collected|moved/travel|0
7560419|NCT02347761|26289667|P2|All Collected|moved/travel|1
7560420|NCT02347761|26289668|P1|All Collected|moved/travel|0
7560421|NCT02347761|26289666|P3|All Collected|exacerbation of COPD|1
7560422|NCT02347761|26289667|P2|All Collected|exacerbation of COPD|0
7560423|NCT02347761|26289668|P1|All Collected|exacerbation of COPD|0
7560424|NCT02347761|26289666|P3|All Collected|instillation site pain|1
7560425|NCT02347761|26289667|P2|All Collected|instillation site pain|0
7560426|NCT02347761|26289668|P1|All Collected|instillation site pain|0
7560427|NCT02347761|26289666|P3|All Collected|invetigator disretion|0
7560428|NCT02347761|26289667|P2|All Collected|invetigator disretion|0
7560429|NCT02347761|26289668|P1|All Collected|invetigator disretion|2
7560430|NCT02347761|26289666|P3|All Collected|Withdrawal by Subject|22
7560431|NCT02347761|26289667|P2|All Collected|Withdrawal by Subject|11
7560432|NCT02347761|26289668|P1|All Collected|Withdrawal by Subject|11
7560433|NCT02347761|26289666|P3|All Collected|Lost to Follow-up|3
7560434|NCT02347761|26289667|P2|All Collected|Lost to Follow-up|2
7560435|NCT02347761|26289668|P1|All Collected|Lost to Follow-up|3
7560436|NCT02347761|26289666|P3|All Collected|Death|0
7560437|NCT02347761|26289667|P2|All Collected|Death|0
7560438|NCT02347761|26289668|P1|All Collected|Death|1
7560439|NCT02347657|26289729|P2|Overall Study|Other|3
7560440|NCT02347657|26289730|P1|Overall Study|Other|3
7560441|NCT02347657|26289729|P2|Overall Study|Randomized but not treated|0
7560442|NCT02347657|26289730|P1|Overall Study|Randomized but not treated|1
7560443|NCT02347657|26289729|P2|Overall Study|Withdrawal by Subject|7
7560444|NCT02347657|26289730|P1|Overall Study|Withdrawal by Subject|6
7560445|NCT02347657|26289729|P2|Overall Study|Adverse Event|4
7560446|NCT02347657|26289730|P1|Overall Study|Adverse Event|8
7560447|NCT02347657|26289729|P2|Overall Study|Physician Decision|1
7560448|NCT02347657|26289730|P1|Overall Study|Physician Decision|0
7560449|NCT02347631|26289757|P2|Second Intervention (2 Months)|Withdrawal by Subject|0
7560450|NCT02347631|26289758|P1|Second Intervention (2 Months)|Withdrawal by Subject|6
7560451|NCT02347631|26289757|P2|Second Intervention (2 Months)|Lost to Follow-up|4
7560452|NCT02347631|26289758|P1|Second Intervention (2 Months)|Lost to Follow-up|7
7560453|NCT02347631|26289757|P2|Washout 2 (1 Month)|Lost to Follow-up|1
7560454|NCT02347631|26289758|P1|Washout 2 (1 Month)|Lost to Follow-up|0
7560455|NCT02347631|26289757|P2|Washout 2 (1 Month)|Withdrawal by Subject|2
7560456|NCT02347631|26289758|P1|Washout 2 (1 Month)|Withdrawal by Subject|2
7560457|NCT02347631|26289757|P2|First Intervention (2 Months)|Lost to Follow-up|3
7560458|NCT02347631|26289758|P1|First Intervention (2 Months)|Lost to Follow-up|5
7560459|NCT02347631|26289757|P2|First Intervention (2 Months)|Moved out of area|2
7560460|NCT02347631|26289758|P1|First Intervention (2 Months)|Moved out of area|0
7560461|NCT02347631|26289757|P2|First Intervention (2 Months)|Pregnancy|0
7560462|NCT02347631|26289758|P1|First Intervention (2 Months)|Pregnancy|1
7560463|NCT02347631|26289757|P2|First Intervention (2 Months)|Adverse Event|1
7560464|NCT02347631|26289758|P1|First Intervention (2 Months)|Adverse Event|1
7560465|NCT02347332|26289819|P2|Overall Study|Switch Post-Trial program|1
7560466|NCT02347332|26289820|P1|Overall Study|Switch Post-Trial program|0
7560467|NCT02347332|26289819|P2|Overall Study|Protocol requirement|1
7560468|NCT02347332|26289820|P1|Overall Study|Protocol requirement|1
7560469|NCT02347332|26289819|P2|Overall Study|Withdrawal by Subject|14
7560470|NCT02347332|26289820|P1|Overall Study|Withdrawal by Subject|20
7560471|NCT02347332|26289819|P2|Overall Study|Physician Decision|3
7560472|NCT02347332|26289820|P1|Overall Study|Physician Decision|4
7560473|NCT02347332|26289819|P2|Overall Study|Lost to Follow-up|1
7560474|NCT02347332|26289820|P1|Overall Study|Lost to Follow-up|2
7560475|NCT02347332|26289819|P2|Overall Study|Protocol Violation|1
7560476|NCT02347332|26289820|P1|Overall Study|Protocol Violation|1
7560477|NCT02347332|26289819|P2|Overall Study|Death (Unknown, Various reasons)|6
7560478|NCT02347332|26289820|P1|Overall Study|Death (Unknown, Various reasons)|6
7560479|NCT02347332|26289819|P2|Overall Study|Adverse Event|41
7560480|NCT02347332|26289820|P1|Overall Study|Adverse Event|50
7560481|NCT02347332|26289819|P2|Overall Study|Progressive disease|159
7560482|NCT02347332|26289820|P1|Overall Study|Progressive disease|141
7560483|NCT02347332|26289819|P2|Overall Study|Not treated|2
7560484|NCT02347332|26289820|P1|Overall Study|Not treated|5
7560485|NCT02347189|26289834|P1|Overall Study|No primary outcome data available|2
7560486|NCT02347189|26289834|P1|Overall Study|No implant attempted of study device|9
7560487|NCT02347176|26289853|P4|Overall Study|Other|0
7560488|NCT02347176|26289854|P3|Overall Study|Other|2
7560489|NCT02347176|26289855|P2|Overall Study|Other|2
7560490|NCT02347176|26289856|P1|Overall Study|Other|1
7560491|NCT02347176|26289853|P4|Overall Study|Withdrawal by Subject|3
7560492|NCT02347176|26289854|P3|Overall Study|Withdrawal by Subject|5
7560493|NCT02347176|26289855|P2|Overall Study|Withdrawal by Subject|5
7560494|NCT02347176|26289856|P1|Overall Study|Withdrawal by Subject|9
7560495|NCT02347176|26289853|P4|Overall Study|Lost to Follow-up|1
7560496|NCT02347176|26289854|P3|Overall Study|Lost to Follow-up|1
7560497|NCT02347176|26289855|P2|Overall Study|Lost to Follow-up|3
7560498|NCT02347176|26289856|P1|Overall Study|Lost to Follow-up|2
7560499|NCT02347098|26289941|P2|Overall Study|no visit due to illness|1
7560500|NCT02347098|26289942|P1|Overall Study|no visit due to illness|2
7560501|NCT02347098|26289941|P2|Overall Study|Refuse Follow-up Visit|5
7560502|NCT02347098|26289942|P1|Overall Study|Refuse Follow-up Visit|1
7560503|NCT02347098|26289941|P2|Overall Study|Lost to Follow-up|2
7560504|NCT02347098|26289942|P1|Overall Study|Lost to Follow-up|2
7560505|NCT02347098|26289941|P2|Overall Study|Withdrawal by Subject|0
7560506|NCT02347098|26289942|P1|Overall Study|Withdrawal by Subject|1
7560507|NCT02347098|26289941|P2|Overall Study|Death|0
7560508|NCT02347098|26289942|P1|Overall Study|Death|1
7560509|NCT02347085|26289954|P1|Overall Study|Protocol Criteria|2
7560510|NCT02347085|26289954|P1|Overall Study|Lost to Follow-up|1
7560511|NCT02347085|26289954|P1|Overall Study|Withdrawal by Subject|4
7560512|NCT02347085|26289954|P1|Overall Study|Lack of Efficacy|1
7560513|NCT02347085|26289954|P1|Overall Study|Adverse Event|2
7560514|NCT02347072|26289976|P1|Overall Study|Disc due to Protocol-specified Criteria|6
7560515|NCT02347072|26289976|P1|Overall Study|Protocol Violation|1
7560516|NCT02347072|26289976|P1|Overall Study|Lost to Follow-up|2
7560517|NCT02347072|26289976|P1|Overall Study|Physician Decision|1
7560518|NCT02347072|26289976|P1|Overall Study|Withdrawal by Subject|6
7560519|NCT02347072|26289976|P1|Overall Study|Adverse Event|2
7560520|NCT02346877|26290020|P2|Overall Study|Missing|0
7560521|NCT02346877|26290021|P1|Overall Study|Missing|5
7560522|NCT02346877|26290020|P2|Overall Study|Sponsor Decision|0
7560523|NCT02346877|26290021|P1|Overall Study|Sponsor Decision|12
7560524|NCT02346877|26290020|P2|Overall Study|Administrative Decision|0
7560525|NCT02346877|26290021|P1|Overall Study|Administrative Decision|1
7560526|NCT02346877|26290020|P2|Overall Study|Adverse Event|0
7560527|NCT02346877|26290021|P1|Overall Study|Adverse Event|1
7560528|NCT02346721|26290031|P1|Overall Study|Lack of Efficacy|1
7560529|NCT02346721|26290031|P1|Overall Study|Withdrew Consent|3
7560530|NCT02346708|26290042|P2|Overall Study|Protocol Violation|1
7560531|NCT02346708|26290043|P1|Overall Study|Protocol Violation|0
7560532|NCT02346708|26290042|P2|Overall Study|Adverse Event|0
7560533|NCT02346708|26290043|P1|Overall Study|Adverse Event|2
7560534|NCT02346370|26290092|P3|Overall Study|Physician Decision|0
7560535|NCT02346370|26290093|P2|Overall Study|Physician Decision|1
7560536|NCT02346370|26290094|P1|Overall Study|Physician Decision|0
7560537|NCT02346370|26290092|P3|Overall Study|Radiologic progression|1
7560538|NCT02346370|26290093|P2|Overall Study|Radiologic progression|0
7560539|NCT02346370|26290094|P1|Overall Study|Radiologic progression|0
7560540|NCT02346370|26290092|P3|Overall Study|Sponsor discontinued study|2
7560541|NCT02346370|26290093|P2|Overall Study|Sponsor discontinued study|0
7560542|NCT02346370|26290094|P1|Overall Study|Sponsor discontinued study|5
7560543|NCT02346370|26290092|P3|Overall Study|Death|1
7560544|NCT02346370|26290093|P2|Overall Study|Death|3
7560545|NCT02346370|26290094|P1|Overall Study|Death|1
7560546|NCT02346370|26290092|P3|Overall Study|Withdrawal of consent|0
7560547|NCT02346370|26290093|P2|Overall Study|Withdrawal of consent|0
7560548|NCT02346370|26290094|P1|Overall Study|Withdrawal of consent|1
7560549|NCT02346370|26290092|P3|Overall Study|Not treated|0
7560550|NCT02346370|26290093|P2|Overall Study|Not treated|0
7560551|NCT02346370|26290094|P1|Overall Study|Not treated|1
7560552|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560553|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560554|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560555|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560556|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560557|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
7560558|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560559|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560560|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560561|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560562|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560563|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560564|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560565|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560566|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560567|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560568|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560569|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560570|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560571|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560572|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560573|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560574|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560575|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7560576|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
7560577|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7560578|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
7560579|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560580|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560581|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7560582|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560583|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560584|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560585|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560586|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560587|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560588|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560589|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560590|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560591|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560592|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560593|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560594|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560595|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560596|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560597|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560598|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560599|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7560600|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7560601|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7560602|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
7560603|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560604|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7560605|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7560606|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560607|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560608|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560609|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560610|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560611|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560612|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560613|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560614|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560615|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560616|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560617|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560618|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560619|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560620|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560621|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560622|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560623|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7560624|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7560625|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7560626|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7560627|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560628|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
7560629|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7560630|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7560631|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560632|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560633|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560634|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560635|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560636|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560637|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560638|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560639|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560640|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560641|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560642|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560643|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560644|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560645|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560646|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560647|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7560648|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560649|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560650|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
7560651|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560652|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560653|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560654|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560655|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560656|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560657|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560658|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560659|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560660|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560661|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560662|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560663|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560664|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560665|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560666|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560667|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560668|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560669|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560670|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560671|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7560672|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560673|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560674|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7560675|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560676|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560677|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7560678|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560679|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560680|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560681|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560682|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560683|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560684|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560685|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560686|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560687|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560688|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560689|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560690|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560691|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560692|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560693|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560694|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560695|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7560696|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|Death|0
7560697|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|Death|0
7560698|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|Death|1
7560699|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|Death|0
7560700|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|Death|1
7560701|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|Death|1
7560702|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|Death|0
7560703|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|Death|0
7560704|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|Death|0
7560705|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|Death|0
7560706|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|Death|0
7560707|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|Death|0
7560708|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|Death|0
7560709|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|Death|0
7560710|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|Death|0
7560711|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|Death|0
7560712|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|Death|0
7560713|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|Death|0
7560714|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|Death|0
7560715|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|Death|0
7560716|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|Death|0
7560717|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|Death|0
7560718|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|Death|0
7560719|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|Death|0
7560720|NCT02346240|26290143|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7560721|NCT02346240|26290144|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7560722|NCT02346240|26290145|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
7560723|NCT02346240|26290146|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7560724|NCT02346240|26290147|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
7560725|NCT02346240|26290148|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
7560726|NCT02346240|26290149|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
7560727|NCT02346240|26290150|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560728|NCT02346240|26290151|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560729|NCT02346240|26290152|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560730|NCT02346240|26290153|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560731|NCT02346240|26290154|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560732|NCT02346240|26290155|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560733|NCT02346240|26290156|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560734|NCT02346240|26290157|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560735|NCT02346240|26290158|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560736|NCT02346240|26290159|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560737|NCT02346240|26290160|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560738|NCT02346240|26290161|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560739|NCT02346240|26290162|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560740|NCT02346240|26290163|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560741|NCT02346240|26290164|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560742|NCT02346240|26290165|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560743|NCT02346240|26290166|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7560744|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560745|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560746|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560747|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560748|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560749|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560750|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560751|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560752|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560753|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
7560754|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560755|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560756|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560757|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560758|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560759|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560760|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560761|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560762|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560763|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560764|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560765|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560766|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560767|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7560768|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560769|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560770|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560771|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560772|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560773|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560774|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560775|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560776|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560777|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
7560778|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560779|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560780|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560781|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560782|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560783|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560784|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560785|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560786|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560787|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560788|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560789|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560790|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560791|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7560792|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560793|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560794|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7561202|NCT02346136|26290205|P2|Overall Study|Death|0
7560795|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560796|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560797|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560798|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560799|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560800|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560801|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
7560802|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560803|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560804|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560805|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560806|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560807|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560808|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560809|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560810|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560811|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560812|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560813|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560814|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560815|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7560816|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560817|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560818|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560819|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560820|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560821|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560822|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560823|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560824|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560825|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560826|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560827|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560828|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560829|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
7560830|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560831|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560832|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560833|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560834|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560835|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560836|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560837|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560838|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560839|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7560840|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560841|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560842|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560843|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560844|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560845|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560846|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560847|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560848|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560849|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560850|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560851|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560852|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560853|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560854|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
7560855|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560856|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560857|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560858|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7561203|NCT02346136|26290206|P1|Overall Study|Death|1
7560859|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560860|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560861|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560862|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560863|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7560864|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560865|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560866|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560867|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560868|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560869|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560870|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560871|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560872|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560873|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7560874|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7560875|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560876|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7560877|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560878|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560879|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7560880|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560881|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560882|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560883|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560884|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560885|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560886|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560887|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7560888|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560889|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560890|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560891|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560892|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560893|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560894|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560895|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560896|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560897|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560898|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560899|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560900|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560901|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560902|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560903|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560904|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560905|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
7560906|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560907|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560908|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560909|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560910|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560911|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7560912|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560913|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560914|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560915|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560916|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560917|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560918|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560919|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
7560920|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
7560921|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7560922|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7560923|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560924|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560925|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560926|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560927|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560928|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560929|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560930|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560931|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560932|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560933|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560934|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560935|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7560936|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560937|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560938|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560939|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560940|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560941|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560942|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560943|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7560944|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7560945|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
7560946|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7560947|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560948|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7560949|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7560950|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560951|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7560952|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7560953|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7560954|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7560955|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560956|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560957|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560958|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560959|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7560960|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560961|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560962|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560963|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560964|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560965|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560966|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560967|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560968|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560969|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7560970|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560971|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560972|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560973|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560974|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560975|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560976|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560977|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560978|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560979|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560980|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560981|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560982|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560983|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7560984|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560985|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560986|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560987|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560988|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560989|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561204|NCT02346136|26290205|P2|Overall Study|Withdrawal by Subject|5
7560990|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560991|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560992|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
7560993|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560994|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7560995|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560996|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560997|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560998|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7560999|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561000|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561001|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561002|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561003|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561004|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561005|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561006|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561007|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7561008|NCT02346240|26290143|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561009|NCT02346240|26290144|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561010|NCT02346240|26290145|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561011|NCT02346240|26290146|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561012|NCT02346240|26290147|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561013|NCT02346240|26290148|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561014|NCT02346240|26290149|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561015|NCT02346240|26290150|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7561016|NCT02346240|26290151|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7561017|NCT02346240|26290152|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7561018|NCT02346240|26290153|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7561019|NCT02346240|26290154|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561020|NCT02346240|26290155|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561021|NCT02346240|26290156|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561022|NCT02346240|26290157|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561023|NCT02346240|26290158|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7561024|NCT02346240|26290159|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7561025|NCT02346240|26290160|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561026|NCT02346240|26290161|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561027|NCT02346240|26290162|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561028|NCT02346240|26290163|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561029|NCT02346240|26290164|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561030|NCT02346240|26290165|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561031|NCT02346240|26290166|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7561032|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561033|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561034|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561035|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561036|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561037|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561038|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561039|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561040|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561041|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561042|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561043|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561044|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561045|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561046|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561047|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561048|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561049|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561050|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561051|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561052|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561053|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
7561054|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561055|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7561056|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
7561057|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
7561058|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
7561059|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
7561060|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
7561061|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
7561062|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
7561063|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
7561064|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
7561065|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
7561066|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
7561067|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
7561068|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
7561069|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
7561070|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
7561071|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
7561072|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
7561073|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
7561074|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
7561075|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
7561076|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
7561077|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
7561078|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
7561079|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
7561080|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561081|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561082|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561083|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561084|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561085|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561086|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561087|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561088|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561089|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561090|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561091|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561092|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561093|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561094|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561095|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561096|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561097|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561098|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561099|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7561100|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7561101|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
7561102|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7561103|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
7561104|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561105|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561106|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561107|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561108|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561109|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561110|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561111|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561112|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561113|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561114|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561115|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561116|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561117|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561118|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561119|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561120|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561121|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561122|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561123|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7561124|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
7561125|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7561126|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
7561127|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7561128|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561129|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561205|NCT02346136|26290206|P1|Overall Study|Withdrawal by Subject|7
7561130|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561131|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561132|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561133|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561134|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561135|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561136|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561137|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561138|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561139|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561140|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561141|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561142|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561143|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561144|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561145|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561146|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561147|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561148|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561149|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561150|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
7561151|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
7561152|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561153|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561154|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561155|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561156|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561157|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561158|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561159|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561160|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561161|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561162|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561163|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561164|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561165|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561166|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561167|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561168|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561169|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561170|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561171|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561172|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561173|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561174|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
7561175|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7561176|NCT02346240|26290143|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
7561177|NCT02346240|26290144|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
7561178|NCT02346240|26290145|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
7561179|NCT02346240|26290146|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
7561180|NCT02346240|26290147|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
7561181|NCT02346240|26290148|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
7561182|NCT02346240|26290149|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
7561183|NCT02346240|26290150|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
7561184|NCT02346240|26290151|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
7561185|NCT02346240|26290152|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
7561186|NCT02346240|26290153|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
7561187|NCT02346240|26290154|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
7561188|NCT02346240|26290155|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
7561189|NCT02346240|26290156|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
7561190|NCT02346240|26290157|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
7561191|NCT02346240|26290158|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
7561192|NCT02346240|26290159|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
7561193|NCT02346240|26290160|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
7561194|NCT02346240|26290161|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
7561195|NCT02346240|26290162|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
7561196|NCT02346240|26290163|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
7561197|NCT02346240|26290164|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
7561198|NCT02346240|26290165|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
7561199|NCT02346240|26290166|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
7561200|NCT02346136|26290205|P2|Overall Study|Study termination|18
7561201|NCT02346136|26290206|P1|Overall Study|Study termination|14
7561206|NCT02345889|26290242|P4|Overall Study|Cecum not intubated|0
7561207|NCT02345889|26290243|P3|Overall Study|Cecum not intubated|0
7561208|NCT02345889|26290244|P2|Overall Study|Cecum not intubated|0
7561209|NCT02345889|26290245|P1|Overall Study|Cecum not intubated|1
7561210|NCT02345889|26290242|P4|Overall Study|Ulcerative Colitis identified|0
7561211|NCT02345889|26290243|P3|Overall Study|Ulcerative Colitis identified|0
7561212|NCT02345889|26290244|P2|Overall Study|Ulcerative Colitis identified|0
7561213|NCT02345889|26290245|P1|Overall Study|Ulcerative Colitis identified|1
7561214|NCT02345889|26290242|P4|Overall Study|Recognized ineligible post-randomization|1
7561215|NCT02345889|26290243|P3|Overall Study|Recognized ineligible post-randomization|2
7561216|NCT02345889|26290244|P2|Overall Study|Recognized ineligible post-randomization|0
7561217|NCT02345889|26290245|P1|Overall Study|Recognized ineligible post-randomization|1
7561218|NCT02345889|26290242|P4|Overall Study|Polyposis identified during procedure|1
7561219|NCT02345889|26290243|P3|Overall Study|Polyposis identified during procedure|0
7561220|NCT02345889|26290244|P2|Overall Study|Polyposis identified during procedure|1
7561221|NCT02345889|26290245|P1|Overall Study|Polyposis identified during procedure|1
7561222|NCT02345889|26290242|P4|Overall Study|Inadequate Bowel Prep|14
7561223|NCT02345889|26290243|P3|Overall Study|Inadequate Bowel Prep|18
7561224|NCT02345889|26290244|P2|Overall Study|Inadequate Bowel Prep|16
7561225|NCT02345889|26290245|P1|Overall Study|Inadequate Bowel Prep|17
7561226|NCT02345811|26290311|P2|First Intervention|Withdrawal by Subject|1
7561227|NCT02345811|26290312|P1|First Intervention|Withdrawal by Subject|1
7561228|NCT02345512|26290363|P1|Overall Study|Withdrawal by Subject|1
7561229|NCT02345512|26290363|P1|Overall Study|Adverse Event|1
7561230|NCT02345330|26290457|P1|Overall Study|Progressive Disease|2
7561231|NCT02345330|26290457|P1|Overall Study|Death|1
7561232|NCT02345252|26290469|P2|Double-Blind Phase|Randomized but Never Treated|2
7561233|NCT02345252|26290470|P1|Double-Blind Phase|Randomized but Never Treated|0
7561234|NCT02345252|26290469|P2|Double-Blind Phase|Lost to Follow-up|10
7561235|NCT02345252|26290470|P1|Double-Blind Phase|Lost to Follow-up|8
7561236|NCT02345252|26290469|P2|Double-Blind Phase|Withdrew Consent|23
7561237|NCT02345252|26290470|P1|Double-Blind Phase|Withdrew Consent|21
7561238|NCT02345252|26290469|P2|Double-Blind Phase|Protocol Violation|1
7561239|NCT02345252|26290470|P1|Double-Blind Phase|Protocol Violation|2
7561240|NCT02345252|26290469|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
7561241|NCT02345252|26290470|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
7561242|NCT02345252|26290469|P2|Double-Blind Phase|Investigator's Discretion|6
7561243|NCT02345252|26290470|P1|Double-Blind Phase|Investigator's Discretion|4
7561244|NCT02345252|26290469|P2|Double-Blind Phase|Lack of Efficacy|0
7561245|NCT02345252|26290470|P1|Double-Blind Phase|Lack of Efficacy|1
7561246|NCT02345252|26290469|P2|Double-Blind Phase|Death|2
7561247|NCT02345252|26290470|P1|Double-Blind Phase|Death|1
7561248|NCT02345252|26290469|P2|Double-Blind Phase|Adverse Event|3
7561249|NCT02345252|26290470|P1|Double-Blind Phase|Adverse Event|2
7561250|NCT02345226|26290498|P2|Open-Label Extension Phase|Lost to Follow-up|1
7561251|NCT02345226|26290499|P1|Open-Label Extension Phase|Lost to Follow-up|0
7561252|NCT02345226|26290498|P2|Double-Blind Phase|Randomized but Never Treated|4
7561253|NCT02345226|26290499|P1|Double-Blind Phase|Randomized but Never Treated|2
7561254|NCT02345226|26290498|P2|Double-Blind Phase|Lost to Follow-up|16
7561255|NCT02345226|26290499|P1|Double-Blind Phase|Lost to Follow-up|12
7561256|NCT02345226|26290498|P2|Double-Blind Phase|Withdrew Consent|39
7561257|NCT02345226|26290499|P1|Double-Blind Phase|Withdrew Consent|41
7561258|NCT02345226|26290498|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
7561259|NCT02345226|26290499|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
7561260|NCT02345226|26290498|P2|Double-Blind Phase|Investigator's Discretion|3
7561261|NCT02345226|26290499|P1|Double-Blind Phase|Investigator's Discretion|4
7561262|NCT02345226|26290498|P2|Double-Blind Phase|Lack of Efficacy|0
7561263|NCT02345226|26290499|P1|Double-Blind Phase|Lack of Efficacy|1
7561264|NCT02345226|26290498|P2|Double-Blind Phase|Pregnancy|1
7561265|NCT02345226|26290499|P1|Double-Blind Phase|Pregnancy|0
7561266|NCT02345226|26290498|P2|Double-Blind Phase|Death|0
7561267|NCT02345226|26290499|P1|Double-Blind Phase|Death|3
7561268|NCT02345226|26290498|P2|Double-Blind Phase|Adverse Event|6
7561269|NCT02345226|26290499|P1|Double-Blind Phase|Adverse Event|5
7561270|NCT02345161|26290531|P2|Overall Study|Lost to Follow-up|1
7561271|NCT02345161|26290532|P1|Overall Study|Lost to Follow-up|0
7561272|NCT02345161|26290531|P2|Overall Study|Physician Decision|4
7561273|NCT02345161|26290532|P1|Overall Study|Physician Decision|4
7561274|NCT02345161|26290531|P2|Overall Study|Adverse Event|19
7561275|NCT02345161|26290532|P1|Overall Study|Adverse Event|16
7561276|NCT02345161|26290531|P2|Overall Study|Withdrawal by Subject|33
7561277|NCT02345161|26290532|P1|Overall Study|Withdrawal by Subject|25
7561278|NCT02345070|26290637|P3|Overall Study|Other than specified above|7
7561279|NCT02345070|26290638|P2|Overall Study|Other than specified above|3
7561280|NCT02345070|26290639|P1|Overall Study|Other than specified above|6
7561281|NCT02345070|26290637|P3|Overall Study|Poor compliance to protocol|0
7561282|NCT02345070|26290638|P2|Overall Study|Poor compliance to protocol|0
7561283|NCT02345070|26290639|P1|Overall Study|Poor compliance to protocol|2
7561284|NCT02345070|26290637|P3|Overall Study|Adverse Event|16
7561285|NCT02345070|26290638|P2|Overall Study|Adverse Event|8
7561286|NCT02345070|26290639|P1|Overall Study|Adverse Event|12
7561287|NCT02344745|26290672|P2|Overall Study|Data collection sheets were lost|0
7561288|NCT02344745|26290673|P1|Overall Study|Data collection sheets were lost|2
7561289|NCT02344576|26290702|P4|6-Month Follow-Up|Lost to Follow-up|6
7561290|NCT02344576|26290703|P3|6-Month Follow-Up|Lost to Follow-up|13
7561291|NCT02344576|26290704|P2|6-Month Follow-Up|Lost to Follow-up|5
7561292|NCT02344576|26290705|P1|6-Month Follow-Up|Lost to Follow-up|4
7561293|NCT02344576|26290702|P4|6-Month Follow-Up|Withdrawal by Subject|2
7561294|NCT02344576|26290703|P3|6-Month Follow-Up|Withdrawal by Subject|1
7561295|NCT02344576|26290704|P2|6-Month Follow-Up|Withdrawal by Subject|0
7561296|NCT02344576|26290705|P1|6-Month Follow-Up|Withdrawal by Subject|1
7561297|NCT02344576|26290702|P4|6-Month Follow-Up|Death|0
7561298|NCT02344576|26290703|P3|6-Month Follow-Up|Death|0
7561299|NCT02344576|26290704|P2|6-Month Follow-Up|Death|14
7561300|NCT02344576|26290705|P1|6-Month Follow-Up|Death|14
7561301|NCT02344576|26290702|P4|1-Month Follow-Up|Lost to Follow-up|3
7561302|NCT02344576|26290703|P3|1-Month Follow-Up|Lost to Follow-up|11
7561303|NCT02344576|26290704|P2|1-Month Follow-Up|Lost to Follow-up|5
7561304|NCT02344576|26290705|P1|1-Month Follow-Up|Lost to Follow-up|2
7561305|NCT02344576|26290702|P4|1-Month Follow-Up|Withdrawal by Subject|10
7561306|NCT02344576|26290703|P3|1-Month Follow-Up|Withdrawal by Subject|8
7561307|NCT02344576|26290704|P2|1-Month Follow-Up|Withdrawal by Subject|14
7561308|NCT02344576|26290705|P1|1-Month Follow-Up|Withdrawal by Subject|3
7561309|NCT02344576|26290702|P4|1-Month Follow-Up|Death|0
7561310|NCT02344576|26290703|P3|1-Month Follow-Up|Death|0
7561311|NCT02344576|26290704|P2|1-Month Follow-Up|Death|8
7561312|NCT02344576|26290705|P1|1-Month Follow-Up|Death|13
7561313|NCT02344576|26290702|P4|Enrollment|Agreed to Medical Record Review Only|0
7561314|NCT02344576|26290703|P3|Enrollment|Agreed to Medical Record Review Only|0
7561315|NCT02344576|26290704|P2|Enrollment|Agreed to Medical Record Review Only|8
7561316|NCT02344576|26290705|P1|Enrollment|Agreed to Medical Record Review Only|7
7561317|NCT02344342|26290768|P4|Overall Study|Industry partner dropped out|10
7561318|NCT02344342|26290769|P3|Overall Study|Industry partner dropped out|14
7561319|NCT02344342|26290770|P2|Overall Study|Industry partner dropped out|9
7561320|NCT02344342|26290771|P1|Overall Study|Industry partner dropped out|11
7561321|NCT02344173|26290853|P1|12-month Visit|Lost to Follow-up|58
7561322|NCT02344173|26290853|P1|12-month Visit|Withdrawal by Subject|30
7561323|NCT02344173|26290853|P1|12-month Visit|Death|8
7561324|NCT02344173|26290853|P1|Procedure|Ablation Procedure Not Performed|7
7561325|NCT02344004|26290861|P2|Overall Study|Protocol Violation|0
7561326|NCT02344004|26290862|P1|Overall Study|Protocol Violation|1
7561327|NCT02344004|26290861|P2|Overall Study|Other Not Specified|0
7561328|NCT02344004|26290862|P1|Overall Study|Other Not Specified|12
7561329|NCT02344004|26290861|P2|Overall Study|Rescue Medication|0
7561330|NCT02344004|26290862|P1|Overall Study|Rescue Medication|2
7561331|NCT02344004|26290861|P2|Overall Study|Withdrawal by Subject|5
7561332|NCT02344004|26290862|P1|Overall Study|Withdrawal by Subject|22
7561333|NCT02344004|26290861|P2|Overall Study|Physician Decision|1
7561334|NCT02344004|26290862|P1|Overall Study|Physician Decision|4
7561335|NCT02344004|26290861|P2|Overall Study|Death|7
7561336|NCT02344004|26290862|P1|Overall Study|Death|9
7561337|NCT02344004|26290861|P2|Overall Study|Adverse Event|1
7561338|NCT02344004|26290862|P1|Overall Study|Adverse Event|11
7561339|NCT02343939|26290889|P9|Overall Study|Never Treated With ENTO|0
7561340|NCT02343939|26290890|P8|Overall Study|Never Treated With ENTO|2
7561341|NCT02343939|26290891|P7|Overall Study|Never Treated With ENTO|1
7561342|NCT02343939|26290892|P6|Overall Study|Never Treated With ENTO|0
7561343|NCT02343939|26290893|P5|Overall Study|Never Treated With ENTO|0
7561344|NCT02343939|26290894|P4|Overall Study|Never Treated With ENTO|0
7561345|NCT02343939|26290895|P3|Overall Study|Never Treated With ENTO|0
7561346|NCT02343939|26290896|P2|Overall Study|Never Treated With ENTO|0
7561347|NCT02343939|26290897|P1|Overall Study|Never Treated With ENTO|0
7561348|NCT02343939|26290889|P9|Overall Study|Adverse Event|0
7561349|NCT02343939|26290890|P8|Overall Study|Adverse Event|0
7561350|NCT02343939|26290891|P7|Overall Study|Adverse Event|0
7561351|NCT02343939|26290892|P6|Overall Study|Adverse Event|1
7561352|NCT02343939|26290893|P5|Overall Study|Adverse Event|0
7561353|NCT02343939|26290894|P4|Overall Study|Adverse Event|0
7561354|NCT02343939|26290895|P3|Overall Study|Adverse Event|0
7561355|NCT02343939|26290896|P2|Overall Study|Adverse Event|0
7561356|NCT02343939|26290897|P1|Overall Study|Adverse Event|0
7561357|NCT02343939|26290889|P9|Overall Study|Investigator's discretion|0
7561358|NCT02343939|26290890|P8|Overall Study|Investigator's discretion|0
7561359|NCT02343939|26290891|P7|Overall Study|Investigator's discretion|1
7561360|NCT02343939|26290892|P6|Overall Study|Investigator's discretion|0
7561361|NCT02343939|26290893|P5|Overall Study|Investigator's discretion|0
7561362|NCT02343939|26290894|P4|Overall Study|Investigator's discretion|1
7561363|NCT02343939|26290895|P3|Overall Study|Investigator's discretion|0
7561364|NCT02343939|26290896|P2|Overall Study|Investigator's discretion|0
7561365|NCT02343939|26290897|P1|Overall Study|Investigator's discretion|0
7561366|NCT02343939|26290889|P9|Overall Study|Treatment failure|0
7561367|NCT02343939|26290890|P8|Overall Study|Treatment failure|1
7561368|NCT02343939|26290891|P7|Overall Study|Treatment failure|2
7561369|NCT02343939|26290892|P6|Overall Study|Treatment failure|0
7561370|NCT02343939|26290893|P5|Overall Study|Treatment failure|0
7561371|NCT02343939|26290894|P4|Overall Study|Treatment failure|0
7561372|NCT02343939|26290895|P3|Overall Study|Treatment failure|0
7561373|NCT02343939|26290896|P2|Overall Study|Treatment failure|0
7561374|NCT02343939|26290897|P1|Overall Study|Treatment failure|0
7561375|NCT02343939|26290889|P9|Overall Study|Withdrew consent|6
7561376|NCT02343939|26290890|P8|Overall Study|Withdrew consent|8
7561377|NCT02343939|26290891|P7|Overall Study|Withdrew consent|0
7561378|NCT02343939|26290892|P6|Overall Study|Withdrew consent|0
7561379|NCT02343939|26290893|P5|Overall Study|Withdrew consent|2
7561380|NCT02343939|26290894|P4|Overall Study|Withdrew consent|2
7561381|NCT02343939|26290895|P3|Overall Study|Withdrew consent|1
7561382|NCT02343939|26290896|P2|Overall Study|Withdrew consent|6
7561383|NCT02343939|26290897|P1|Overall Study|Withdrew consent|3
7561384|NCT02343939|26290889|P9|Overall Study|Study terminated by sponsor|0
7561385|NCT02343939|26290890|P8|Overall Study|Study terminated by sponsor|4
7561386|NCT02343939|26290891|P7|Overall Study|Study terminated by sponsor|3
7561387|NCT02343939|26290892|P6|Overall Study|Study terminated by sponsor|5
7561388|NCT02343939|26290893|P5|Overall Study|Study terminated by sponsor|1
7561389|NCT02343939|26290894|P4|Overall Study|Study terminated by sponsor|1
7561390|NCT02343939|26290895|P3|Overall Study|Study terminated by sponsor|0
7561391|NCT02343939|26290896|P2|Overall Study|Study terminated by sponsor|27
7561392|NCT02343939|26290897|P1|Overall Study|Study terminated by sponsor|0
7561393|NCT02343939|26290889|P9|Overall Study|Death|1
7561394|NCT02343939|26290890|P8|Overall Study|Death|22
7561395|NCT02343939|26290891|P7|Overall Study|Death|8
7561396|NCT02343939|26290892|P6|Overall Study|Death|11
7561397|NCT02343939|26290893|P5|Overall Study|Death|5
7561398|NCT02343939|26290894|P4|Overall Study|Death|2
7561399|NCT02343939|26290895|P3|Overall Study|Death|4
7561400|NCT02343939|26290896|P2|Overall Study|Death|15
7561401|NCT02343939|26290897|P1|Overall Study|Death|0
7561404|NCT02343458|26291049|P4|Overall Study|Protocol Specified Criteria|8
7561405|NCT02343458|26291050|P3|Overall Study|Protocol Specified Criteria|14
7561406|NCT02343458|26291051|P2|Overall Study|Protocol Specified Criteria|13
7561407|NCT02343458|26291052|P1|Overall Study|Protocol Specified Criteria|17
7561408|NCT02343458|26291049|P4|Overall Study|Protocol Violation|2
7561409|NCT02343458|26291050|P3|Overall Study|Protocol Violation|2
7561410|NCT02343458|26291051|P2|Overall Study|Protocol Violation|5
7561411|NCT02343458|26291052|P1|Overall Study|Protocol Violation|2
7561412|NCT02343458|26291049|P4|Overall Study|Lost to Follow-up|1
7561413|NCT02343458|26291050|P3|Overall Study|Lost to Follow-up|3
7561414|NCT02343458|26291051|P2|Overall Study|Lost to Follow-up|5
7561415|NCT02343458|26291052|P1|Overall Study|Lost to Follow-up|5
7561416|NCT02343458|26291049|P4|Overall Study|Physician Decision|2
7561417|NCT02343458|26291050|P3|Overall Study|Physician Decision|2
7561418|NCT02343458|26291051|P2|Overall Study|Physician Decision|4
7561419|NCT02343458|26291052|P1|Overall Study|Physician Decision|1
7561420|NCT02343458|26291049|P4|Overall Study|Withdrawal by Subject|14
7561421|NCT02343458|26291050|P3|Overall Study|Withdrawal by Subject|23
7561422|NCT02343458|26291051|P2|Overall Study|Withdrawal by Subject|17
7561423|NCT02343458|26291052|P1|Overall Study|Withdrawal by Subject|18
7561424|NCT02343458|26291049|P4|Overall Study|Lack of Efficacy|8
7561425|NCT02343458|26291050|P3|Overall Study|Lack of Efficacy|4
7561426|NCT02343458|26291051|P2|Overall Study|Lack of Efficacy|8
7561427|NCT02343458|26291052|P1|Overall Study|Lack of Efficacy|3
7561428|NCT02343458|26291049|P4|Overall Study|Adverse Event|3
7561429|NCT02343458|26291050|P3|Overall Study|Adverse Event|15
7561430|NCT02343458|26291051|P2|Overall Study|Adverse Event|14
7561431|NCT02343458|26291052|P1|Overall Study|Adverse Event|15
7561432|NCT02343406|26291131|P5|Overall Study|Other, not specified|0
7561433|NCT02343406|26291132|P4|Overall Study|Other, not specified|4
7561434|NCT02343406|26291133|P3|Overall Study|Other, not specified|1
7561435|NCT02343406|26291134|P2|Overall Study|Other, not specified|1
7561436|NCT02343406|26291135|P1|Overall Study|Other, not specified|2
7561437|NCT02343406|26291131|P5|Overall Study|Other primary malignancy|0
7561438|NCT02343406|26291132|P4|Overall Study|Other primary malignancy|0
7561439|NCT02343406|26291133|P3|Overall Study|Other primary malignancy|0
7561440|NCT02343406|26291134|P2|Overall Study|Other primary malignancy|1
7561441|NCT02343406|26291135|P1|Overall Study|Other primary malignancy|0
7561442|NCT02343406|26291131|P5|Overall Study|Start of a new anti-cancer treatment|0
7561443|NCT02343406|26291132|P4|Overall Study|Start of a new anti-cancer treatment|1
7561444|NCT02343406|26291133|P3|Overall Study|Start of a new anti-cancer treatment|0
7561445|NCT02343406|26291134|P2|Overall Study|Start of a new anti-cancer treatment|1
7561446|NCT02343406|26291135|P1|Overall Study|Start of a new anti-cancer treatment|0
7561447|NCT02343406|26291131|P5|Overall Study|Death|0
7561448|NCT02343406|26291132|P4|Overall Study|Death|0
7561449|NCT02343406|26291133|P3|Overall Study|Death|0
7561450|NCT02343406|26291134|P2|Overall Study|Death|1
7561451|NCT02343406|26291135|P1|Overall Study|Death|2
7561452|NCT02343406|26291131|P5|Overall Study|Withdrawal by Subject|0
7561453|NCT02343406|26291132|P4|Overall Study|Withdrawal by Subject|3
7561454|NCT02343406|26291133|P3|Overall Study|Withdrawal by Subject|8
7561455|NCT02343406|26291134|P2|Overall Study|Withdrawal by Subject|4
7561456|NCT02343406|26291135|P1|Overall Study|Withdrawal by Subject|6
7561457|NCT02343406|26291131|P5|Overall Study|Adverse Event|0
7561458|NCT02343406|26291132|P4|Overall Study|Adverse Event|3
7561459|NCT02343406|26291133|P3|Overall Study|Adverse Event|6
7561460|NCT02343406|26291134|P2|Overall Study|Adverse Event|8
7561461|NCT02343406|26291135|P1|Overall Study|Adverse Event|6
7561462|NCT02343406|26291131|P5|Overall Study|Progressive disease|5
7561463|NCT02343406|26291132|P4|Overall Study|Progressive disease|15
7561464|NCT02343406|26291133|P3|Overall Study|Progressive disease|43
7561465|NCT02343406|26291134|P2|Overall Study|Progressive disease|70
7561466|NCT02343406|26291135|P1|Overall Study|Progressive disease|72
7561467|NCT02343263|26291203|P3|Overall Study|Physician Decision|1
7561468|NCT02343263|26291204|P2|Overall Study|Physician Decision|3
7561469|NCT02343263|26291205|P1|Overall Study|Physician Decision|5
7561470|NCT02343159|26291234|P3|Overall Study|Enrollment Error|0
7561471|NCT02343159|26291235|P2|Overall Study|Enrollment Error|0
7561472|NCT02343159|26291236|P1|Overall Study|Enrollment Error|1
7561473|NCT02343159|26291234|P3|Overall Study|Sponsor Decision|0
7561474|NCT02343159|26291235|P2|Overall Study|Sponsor Decision|1
7561475|NCT02343159|26291236|P1|Overall Study|Sponsor Decision|0
7561476|NCT02343159|26291234|P3|Overall Study|Adverse Event|2
7561477|NCT02343159|26291235|P2|Overall Study|Adverse Event|4
7561478|NCT02343159|26291236|P1|Overall Study|Adverse Event|4
7561479|NCT02343159|26291234|P3|Overall Study|Lost to Follow-up|2
7561480|NCT02343159|26291235|P2|Overall Study|Lost to Follow-up|2
7561481|NCT02343159|26291236|P1|Overall Study|Lost to Follow-up|0
7561482|NCT02343159|26291234|P3|Overall Study|Withdrawal by Subject|2
7561483|NCT02343159|26291235|P2|Overall Study|Withdrawal by Subject|0
7561484|NCT02343159|26291236|P1|Overall Study|Withdrawal by Subject|3
7561485|NCT02343159|26291234|P3|Overall Study|Physician Decision|1
7561486|NCT02343159|26291235|P2|Overall Study|Physician Decision|0
7561487|NCT02343159|26291236|P1|Overall Study|Physician Decision|2
7561488|NCT02343159|26291234|P3|Overall Study|Early Study Termination|23
7561489|NCT02343159|26291235|P2|Overall Study|Early Study Termination|19
7561490|NCT02343159|26291236|P1|Overall Study|Early Study Termination|16
7561491|NCT02343003|26291280|P2|Overall Study|terminated by sponsor|0
7561492|NCT02343003|26291281|P1|Overall Study|terminated by sponsor|2
7561493|NCT02343003|26291280|P2|Overall Study|exclusion criteria met|1
7561494|NCT02343003|26291281|P1|Overall Study|exclusion criteria met|1
7561495|NCT02343003|26291280|P2|Overall Study|Death|1
7561496|NCT02343003|26291281|P1|Overall Study|Death|0
7561497|NCT02343003|26291280|P2|Overall Study|Protocol Violation|0
7561498|NCT02343003|26291281|P1|Overall Study|Protocol Violation|1
7561499|NCT02343003|26291280|P2|Overall Study|Lost to Follow-up|1
7561500|NCT02343003|26291281|P1|Overall Study|Lost to Follow-up|5
7561501|NCT02343003|26291280|P2|Overall Study|Withdrawal by Subject|4
7561502|NCT02343003|26291281|P1|Overall Study|Withdrawal by Subject|9
7561503|NCT02342886|26291302|P5|Overall Study|Protocol Violation|0
7561504|NCT02342886|26291303|P4|Overall Study|Protocol Violation|2
7561505|NCT02342886|26291304|P3|Overall Study|Protocol Violation|0
7561506|NCT02342886|26291305|P2|Overall Study|Protocol Violation|0
7561507|NCT02342886|26291306|P1|Overall Study|Protocol Violation|0
7561508|NCT02342886|26291302|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
7561509|NCT02342886|26291303|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
7561510|NCT02342886|26291304|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
7561511|NCT02342886|26291305|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
7561512|NCT02342886|26291306|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
7561513|NCT02342886|26291302|P5|Overall Study|Pregnancy|0
7561514|NCT02342886|26291303|P4|Overall Study|Pregnancy|0
7561515|NCT02342886|26291304|P3|Overall Study|Pregnancy|2
7561516|NCT02342886|26291305|P2|Overall Study|Pregnancy|0
7561517|NCT02342886|26291306|P1|Overall Study|Pregnancy|0
7561518|NCT02342886|26291302|P5|Overall Study|Investigator/sponsor decision|1
7561519|NCT02342886|26291303|P4|Overall Study|Investigator/sponsor decision|3
7561520|NCT02342886|26291304|P3|Overall Study|Investigator/sponsor decision|0
7561521|NCT02342886|26291305|P2|Overall Study|Investigator/sponsor decision|2
7561522|NCT02342886|26291306|P1|Overall Study|Investigator/sponsor decision|0
7561523|NCT02342886|26291302|P5|Overall Study|Withdrawal by Subject|0
7561524|NCT02342886|26291303|P4|Overall Study|Withdrawal by Subject|1
7561525|NCT02342886|26291304|P3|Overall Study|Withdrawal by Subject|0
7561526|NCT02342886|26291305|P2|Overall Study|Withdrawal by Subject|1
7561527|NCT02342886|26291306|P1|Overall Study|Withdrawal by Subject|0
7561528|NCT02342886|26291302|P5|Overall Study|Death|1
7561529|NCT02342886|26291303|P4|Overall Study|Death|0
7561530|NCT02342886|26291304|P3|Overall Study|Death|1
7561531|NCT02342886|26291305|P2|Overall Study|Death|2
7561532|NCT02342886|26291306|P1|Overall Study|Death|1
7561533|NCT02342886|26291302|P5|Overall Study|Lost to Follow-up|0
7561534|NCT02342886|26291303|P4|Overall Study|Lost to Follow-up|0
7561535|NCT02342886|26291304|P3|Overall Study|Lost to Follow-up|0
7561536|NCT02342886|26291305|P2|Overall Study|Lost to Follow-up|0
7561537|NCT02342886|26291306|P1|Overall Study|Lost to Follow-up|1
7561538|NCT02342886|26291302|P5|Overall Study|Adverse event/specific toxicity|1
7561539|NCT02342886|26291303|P4|Overall Study|Adverse event/specific toxicity|2
7561540|NCT02342886|26291304|P3|Overall Study|Adverse event/specific toxicity|11
7561541|NCT02342886|26291305|P2|Overall Study|Adverse event/specific toxicity|3
7561542|NCT02342886|26291306|P1|Overall Study|Adverse event/specific toxicity|4
7561543|NCT02342886|26291302|P5|Overall Study|Late exclusion: rifampicin resistance|0
7561544|NCT02342886|26291303|P4|Overall Study|Late exclusion: rifampicin resistance|0
7561545|NCT02342886|26291304|P3|Overall Study|Late exclusion: rifampicin resistance|0
7561546|NCT02342886|26291305|P2|Overall Study|Late exclusion: rifampicin resistance|0
7561547|NCT02342886|26291306|P1|Overall Study|Late exclusion: rifampicin resistance|1
7561548|NCT02342886|26291302|P5|Overall Study|Treatment non-compliance|0
7561549|NCT02342886|26291303|P4|Overall Study|Treatment non-compliance|1
7561550|NCT02342886|26291304|P3|Overall Study|Treatment non-compliance|0
7561551|NCT02342886|26291305|P2|Overall Study|Treatment non-compliance|0
7561552|NCT02342886|26291306|P1|Overall Study|Treatment non-compliance|1
7561553|NCT02342743|26291323|P1|Treatment Period|Change in prophylactic medication|1
7561554|NCT02342743|26291323|P1|Treatment Period|Lost to Follow-up|8
7561555|NCT02342743|26291323|P1|Treatment Period|Withdrawal by Subject|2
7561556|NCT02342743|26291323|P1|Baseline Period|Screening failure regarding baseline|7
7561557|NCT02342743|26291323|P1|Baseline Period|Change in prophylactic medication|3
7561558|NCT02342743|26291323|P1|Baseline Period|Lost to Follow-up|2
7561559|NCT02342743|26291323|P1|Baseline Period|Withdrawal by Subject|3
7561560|NCT02342704|26291336|P2|Overall Study|Adverse Event|3
7561561|NCT02342704|26291337|P1|Overall Study|Adverse Event|1
7561562|NCT02342704|26291336|P2|Overall Study|Lost to Follow-up|1
7561563|NCT02342704|26291337|P1|Overall Study|Lost to Follow-up|2
7561564|NCT02342704|26291336|P2|Overall Study|Withdrawal by Subject|0
7561565|NCT02342704|26291337|P1|Overall Study|Withdrawal by Subject|1
7561566|NCT02342704|26291336|P2|Overall Study|Other|1
7561567|NCT02342704|26291337|P1|Overall Study|Other|0
7561568|NCT02342704|26291336|P2|Overall Study|Sponsor Termination|43
7561569|NCT02342704|26291337|P1|Overall Study|Sponsor Termination|49
7561570|NCT02342704|26291336|P2|Overall Study|Physician Decision|3
7561571|NCT02342704|26291337|P1|Overall Study|Physician Decision|0
7561572|NCT02342678|26291365|P2|Overall Study|Illness/medical reason|1
7561573|NCT02342678|26291366|P1|Overall Study|Illness/medical reason|1
7561574|NCT02342678|26291365|P2|Overall Study|Family illness/emergency|1
7561575|NCT02342678|26291366|P1|Overall Study|Family illness/emergency|0
7561576|NCT02342678|26291365|P2|Overall Study|Too busy to complete study|2
7561577|NCT02342678|26291366|P1|Overall Study|Too busy to complete study|0
7561578|NCT02342678|26291365|P2|Overall Study|Lost to Follow-up|1
7561579|NCT02342678|26291366|P1|Overall Study|Lost to Follow-up|0
7561580|NCT02342548|26291397|P3|Overall Study|Other|1
7561581|NCT02342548|26291398|P2|Overall Study|Other|1
7561582|NCT02342548|26291399|P1|Overall Study|Other|1
7561583|NCT02342548|26291397|P3|Overall Study|Withdrawal by Subject|4
7561584|NCT02342548|26291398|P2|Overall Study|Withdrawal by Subject|3
7561585|NCT02342548|26291399|P1|Overall Study|Withdrawal by Subject|1
7561586|NCT02342548|26291397|P3|Overall Study|Protocol Violation|0
7561587|NCT02342548|26291398|P2|Overall Study|Protocol Violation|1
7561588|NCT02342548|26291399|P1|Overall Study|Protocol Violation|0
7561589|NCT02342548|26291397|P3|Overall Study|Study terminated by sponsor|25
7561590|NCT02342548|26291398|P2|Overall Study|Study terminated by sponsor|39
7561591|NCT02342548|26291399|P1|Overall Study|Study terminated by sponsor|20
7561592|NCT02342548|26291397|P3|Overall Study|Lost to Follow-up|0
7561593|NCT02342548|26291398|P2|Overall Study|Lost to Follow-up|1
7561594|NCT02342548|26291399|P1|Overall Study|Lost to Follow-up|0
7561595|NCT02342548|26291397|P3|Overall Study|Adverse Event|13
7561596|NCT02342548|26291398|P2|Overall Study|Adverse Event|17
7561597|NCT02342548|26291399|P1|Overall Study|Adverse Event|12
7561598|NCT02342418|26291443|P2|Overall Study|Adverse Event|1
7561599|NCT02342418|26291444|P1|Overall Study|Adverse Event|0
7561600|NCT02342288|26291634|P2|Overall Study|coordinator not available|2
7561601|NCT02342288|26291635|P1|Overall Study|coordinator not available|0
7561602|NCT02342288|26291634|P2|Overall Study|subject cannot tolerate numbing drops|1
7561603|NCT02342288|26291635|P1|Overall Study|subject cannot tolerate numbing drops|0
7561604|NCT02342288|26291634|P2|Overall Study|coordinator contaminated with blood|1
7561605|NCT02342288|26291635|P1|Overall Study|coordinator contaminated with blood|0
7561606|NCT02342288|26291634|P2|Overall Study|Withdrawal by Subject|0
7561607|NCT02342288|26291635|P1|Overall Study|Withdrawal by Subject|1
7561608|NCT02342288|26291634|P2|Overall Study|anesthesia leak in system|0
7561609|NCT02342288|26291635|P1|Overall Study|anesthesia leak in system|1
7561610|NCT02342288|26291634|P2|Overall Study|no protocol anesthesiologist available|2
7561611|NCT02342288|26291635|P1|Overall Study|no protocol anesthesiologist available|3
7561612|NCT02342223|26291641|P1|Overall Study|Lost to Follow-up|1
7561613|NCT02342171|26291661|P2|Overall Study|Missing age data|1
7561614|NCT02342171|26291662|P1|Overall Study|Missing age data|0
7561615|NCT02342171|26291661|P2|Overall Study|Unknown outcome|1
7561616|NCT02342171|26291662|P1|Overall Study|Unknown outcome|0
7561617|NCT02342171|26291661|P2|Overall Study|Missing cycle treshold value|0
7561618|NCT02342171|26291662|P1|Overall Study|Missing cycle treshold value|1
7561619|NCT02342171|26291661|P2|Overall Study|Received favipiravir|0
7561620|NCT02342171|26291662|P1|Overall Study|Received favipiravir|10
7561621|NCT02342171|26291661|P2|Overall Study|Death|87
7561622|NCT02342171|26291662|P1|Overall Study|Death|4
7561623|NCT02341482|26291921|P1|Overall Study|Adverse Event|1
7561624|NCT02341456|26291950|P3|Overall Study|Physician Decision|0
7561625|NCT02341456|26291951|P2|Overall Study|Physician Decision|0
7561626|NCT02341456|26291952|P1|Overall Study|Physician Decision|1
7561627|NCT02341456|26291950|P3|Overall Study|Moved to local access programme.|1
7561628|NCT02341456|26291951|P2|Overall Study|Moved to local access programme.|1
7561629|NCT02341456|26291952|P1|Overall Study|Moved to local access programme.|0
7561630|NCT02341456|26291950|P3|Overall Study|Withdrawal by Subject|1
7561631|NCT02341456|26291951|P2|Overall Study|Withdrawal by Subject|1
7561632|NCT02341456|26291952|P1|Overall Study|Withdrawal by Subject|0
7561633|NCT02341456|26291950|P3|Overall Study|Death|1
7561634|NCT02341456|26291951|P2|Overall Study|Death|1
7561635|NCT02341456|26291952|P1|Overall Study|Death|1
7561636|NCT02341456|26291950|P3|Overall Study|Disease progression|1
7561637|NCT02341456|26291951|P2|Overall Study|Disease progression|3
7561638|NCT02341456|26291952|P1|Overall Study|Disease progression|2
7561639|NCT02341417|26292077|P3|Overall Study|Death|1
7561640|NCT02341417|26292078|P2|Overall Study|Death|0
7561641|NCT02341417|26292079|P1|Overall Study|Death|0
7561642|NCT02341417|26292077|P3|Overall Study|Decision by sponsor|0
7561643|NCT02341417|26292078|P2|Overall Study|Decision by sponsor|0
7561644|NCT02341417|26292079|P1|Overall Study|Decision by sponsor|2
7561645|NCT02341417|26292077|P3|Overall Study|Withdrawal by Subject|0
7561646|NCT02341417|26292078|P2|Overall Study|Withdrawal by Subject|2
7561647|NCT02341417|26292079|P1|Overall Study|Withdrawal by Subject|0
7561648|NCT02340975|26292144|P6|Overall Study|Other|6
7561649|NCT02340975|26292145|P5|Overall Study|Other|0
7561650|NCT02340975|26292146|P4|Overall Study|Other|2
7561651|NCT02340975|26292147|P3|Overall Study|Other|0
7561652|NCT02340975|26292148|P2|Overall Study|Other|4
7561653|NCT02340975|26292149|P1|Overall Study|Other|0
7561654|NCT02340975|26292144|P6|Overall Study|Withdrawal by Subject|0
7561655|NCT02340975|26292145|P5|Overall Study|Withdrawal by Subject|2
7561656|NCT02340975|26292146|P4|Overall Study|Withdrawal by Subject|3
7561657|NCT02340975|26292147|P3|Overall Study|Withdrawal by Subject|3
7561658|NCT02340975|26292148|P2|Overall Study|Withdrawal by Subject|0
7561659|NCT02340975|26292149|P1|Overall Study|Withdrawal by Subject|0
7561660|NCT02340975|26292144|P6|Overall Study|Lost to Follow-up|0
7561661|NCT02340975|26292145|P5|Overall Study|Lost to Follow-up|2
7561662|NCT02340975|26292146|P4|Overall Study|Lost to Follow-up|0
7561663|NCT02340975|26292147|P3|Overall Study|Lost to Follow-up|0
7561664|NCT02340975|26292148|P2|Overall Study|Lost to Follow-up|0
7561665|NCT02340975|26292149|P1|Overall Study|Lost to Follow-up|0
7561666|NCT02340975|26292144|P6|Overall Study|Death|13
7561667|NCT02340975|26292145|P5|Overall Study|Death|21
7561668|NCT02340975|26292146|P4|Overall Study|Death|7
7561669|NCT02340975|26292147|P3|Overall Study|Death|21
7561670|NCT02340975|26292148|P2|Overall Study|Death|23
7561671|NCT02340975|26292149|P1|Overall Study|Death|6
7561672|NCT02340962|26292263|P2|Overall Study|Lost to Follow-up|0
7561673|NCT02340962|26292264|P1|Overall Study|Lost to Follow-up|1
7561674|NCT02340949|26292286|P2|Overall Study|Physician Decision|0
7561675|NCT02340949|26292287|P1|Overall Study|Physician Decision|1
7561676|NCT02340949|26292286|P2|Overall Study|Death|0
7561677|NCT02340949|26292287|P1|Overall Study|Death|3
7561678|NCT02340949|26292286|P2|Overall Study|Progression disease|2
7561679|NCT02340949|26292287|P1|Overall Study|Progression disease|6
7561680|NCT02340949|26292286|P2|Overall Study|Withdrawal by Subject|0
7561681|NCT02340949|26292287|P1|Overall Study|Withdrawal by Subject|2
7561682|NCT02340949|26292286|P2|Overall Study|Adverse Event|2
7561683|NCT02340949|26292287|P1|Overall Study|Adverse Event|4
7561684|NCT02340819|26292303|P1|Overall Study|Discontinued with other reason|1
7561685|NCT02340819|26292303|P1|Overall Study|Withdrawal by Subject|2
7561686|NCT02340819|26292303|P1|Overall Study|Adverse Event|1
7561687|NCT02340806|26292332|P2|Overall Study|re-dose < 90 min of CSE|3
7561688|NCT02340806|26292333|P1|Overall Study|re-dose < 90 min of CSE|1
7561689|NCT02340806|26292332|P2|Overall Study|history of chronic pain medication|0
7561690|NCT02340806|26292333|P1|Overall Study|history of chronic pain medication|1
7561691|NCT02340806|26292332|P2|Overall Study|epidural catheter replaced|1
7561692|NCT02340806|26292333|P1|Overall Study|epidural catheter replaced|2
7561693|NCT02340806|26292332|P2|Overall Study|Protocol Violation|0
7561694|NCT02340806|26292333|P1|Overall Study|Protocol Violation|2
7561695|NCT02340780|26292359|P1|Overall Study|Ineligible|1
7561696|NCT02340663|26292427|P2|Overall Study|Withdrawal by Subject|1
7561697|NCT02340663|26292428|P1|Overall Study|Withdrawal by Subject|3
7561698|NCT02340663|26292427|P2|Overall Study|Protocol Violation|0
7561699|NCT02340663|26292428|P1|Overall Study|Protocol Violation|1
7561700|NCT02340663|26292427|P2|Overall Study|Lost to Follow-up|0
7561701|NCT02340663|26292428|P1|Overall Study|Lost to Follow-up|1
7561702|NCT02340520|26292484|P1|Overall Study|Withdrawal by Subject|1
7561703|NCT02340520|26292484|P1|Overall Study|Patient did not take drug as specified|1
7561704|NCT02340520|26292484|P1|Overall Study|Lost to Follow-up|1
7561705|NCT02340221|26292536|P2|Overall Study|Continued on study|290
7561706|NCT02340221|26292537|P1|Overall Study|Continued on study|140
7561707|NCT02340221|26292536|P2|Overall Study|Reason Not Specified|1
7561708|NCT02340221|26292537|P1|Overall Study|Reason Not Specified|0
7561709|NCT02340221|26292536|P2|Overall Study|Lost to Follow-up|3
7561710|NCT02340221|26292537|P1|Overall Study|Lost to Follow-up|2
7561711|NCT02340221|26292536|P2|Overall Study|Withdrawal by Participant|22
7561712|NCT02340221|26292537|P1|Overall Study|Withdrawal by Participant|14
7561713|NCT02340221|26292536|P2|Overall Study|Death|101
7561714|NCT02340221|26292537|P1|Overall Study|Death|58
7561715|NCT02340078|26292581|P1|Overall Study|Protocol Violation|1
7561716|NCT02340000|26292588|P2|Time Period 2|Lost to Follow-up|8
7561717|NCT02340000|26292589|P1|Time Period 2|Lost to Follow-up|10
7561718|NCT02340000|26292588|P2|Time Period 2|Withdrawal by Subject|7
7561719|NCT02340000|26292589|P1|Time Period 2|Withdrawal by Subject|9
7561720|NCT02340000|26292588|P2|Time Period 1|Lost to Follow-up|7
7561721|NCT02340000|26292589|P1|Time Period 1|Lost to Follow-up|6
7561722|NCT02340000|26292588|P2|Time Period 1|Withdrawal by Subject|8
7561723|NCT02340000|26292589|P1|Time Period 1|Withdrawal by Subject|6
7561724|NCT02339909|26292619|P3|Overall Study|Became ineligible after randomisation|71
7561725|NCT02339909|26292620|P2|Overall Study|Became ineligible after randomisation|63
7561726|NCT02339909|26292621|P1|Overall Study|Became ineligible after randomisation|89
7561727|NCT02339584|26292659|P2|Overall Study|Withdrawal by Subject|4
7561728|NCT02339584|26292660|P1|Overall Study|Withdrawal by Subject|2
7561729|NCT02339584|26292659|P2|Overall Study|Protocol Violation|1
7561730|NCT02339584|26292660|P1|Overall Study|Protocol Violation|1
7561731|NCT02339584|26292659|P2|Overall Study|Physician Decision|2
7561732|NCT02339584|26292660|P1|Overall Study|Physician Decision|1
7561733|NCT02339584|26292659|P2|Overall Study|Lack of Efficacy|1
7561734|NCT02339584|26292660|P1|Overall Study|Lack of Efficacy|0
7561735|NCT02339584|26292659|P2|Overall Study|Adverse Event|7
7561736|NCT02339584|26292660|P1|Overall Study|Adverse Event|11
7561737|NCT02339506|26292680|P2|Washout (Period 2)|Withdrawal by Subject|0
7561738|NCT02339506|26292681|P1|Washout (Period 2)|Withdrawal by Subject|2
7561739|NCT02339506|26292680|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
7561740|NCT02339506|26292681|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
7561741|NCT02339285|26292710|P3|Overall Study|Protocol Deviation|0
7561742|NCT02339285|26292711|P2|Overall Study|Protocol Deviation|1
7561743|NCT02339285|26292712|P1|Overall Study|Protocol Deviation|0
7561744|NCT02339285|26292710|P3|Overall Study|Lost to Follow-up|1
7561745|NCT02339285|26292711|P2|Overall Study|Lost to Follow-up|1
7561746|NCT02339285|26292712|P1|Overall Study|Lost to Follow-up|1
7561747|NCT02339285|26292710|P3|Overall Study|Withdrawal by Subject|1
7561748|NCT02339285|26292711|P2|Overall Study|Withdrawal by Subject|1
7561749|NCT02339285|26292712|P1|Overall Study|Withdrawal by Subject|0
7561750|NCT02339155|26292758|P2|Overall Study|Withdrawal by Subject|4
7561751|NCT02339155|26292759|P1|Overall Study|Withdrawal by Subject|4
7561752|NCT02339155|26292758|P2|Overall Study|Physician Decision|1
7561753|NCT02339155|26292759|P1|Overall Study|Physician Decision|2
7561754|NCT02339155|26292758|P2|Overall Study|Lost to Follow-up|9
7561755|NCT02339155|26292759|P1|Overall Study|Lost to Follow-up|8
7561756|NCT02339155|26292758|P2|Overall Study|Death|1
7561757|NCT02339155|26292759|P1|Overall Study|Death|1
7561758|NCT02339155|26292758|P2|Overall Study|Adverse Event|6
7561759|NCT02339155|26292759|P1|Overall Study|Adverse Event|0
7561760|NCT02338999|26292792|P2|Second Intervention|Withdrawal by Subject|2
7561761|NCT02338999|26292793|P1|Second Intervention|Withdrawal by Subject|0
7561762|NCT02338999|26292792|P2|Washout Period|Withdrawal by Subject|2
7561763|NCT02338999|26292793|P1|Washout Period|Withdrawal by Subject|0
7561764|NCT02338999|26292792|P2|First Intervention|Withdrawal by Subject|1
7561765|NCT02338999|26292793|P1|First Intervention|Withdrawal by Subject|3
7561766|NCT02338882|26293030|P2|Overall Study|Lost to Follow-up|3
7561767|NCT02338882|26293031|P1|Overall Study|Lost to Follow-up|6
7561768|NCT02338882|26293030|P2|Overall Study|Death|0
7561769|NCT02338882|26293031|P1|Overall Study|Death|1
7561770|NCT02338843|26293069|P2|Overall Study|Discontinued prior to randomizat|0
7561771|NCT02338843|26293070|P1|Overall Study|Discontinued prior to randomizat|1
7561772|NCT02338843|26293069|P2|Overall Study|Subject Recovered|2
7561773|NCT02338843|26293070|P1|Overall Study|Subject Recovered|0
7561774|NCT02338843|26293069|P2|Overall Study|Withdrawal by Subject|2
7561775|NCT02338843|26293070|P1|Overall Study|Withdrawal by Subject|0
7561776|NCT02338843|26293069|P2|Overall Study|Physician Decision|0
7561777|NCT02338843|26293070|P1|Overall Study|Physician Decision|1
7561778|NCT02338843|26293069|P2|Overall Study|Death|53
7561779|NCT02338843|26293070|P1|Overall Study|Death|40
7561780|NCT02338843|26293069|P2|Overall Study|Adverse Event|1
7561781|NCT02338843|26293070|P1|Overall Study|Adverse Event|2
7561782|NCT02338492|26293098|P1|Overall Study|Reason not captured above|6
7561783|NCT02338492|26293098|P1|Overall Study|Lost to Follow-up|4
7561784|NCT02338492|26293098|P1|Overall Study|Adverse Event|3
7561785|NCT02338492|26293098|P1|Overall Study|Death|32
7561786|NCT02338362|26293114|P2|Overall Study|Withdrawal by Subject|1
7561787|NCT02338362|26293115|P1|Overall Study|Withdrawal by Subject|1
7561788|NCT02338193|26293145|P3|Overall Study|intolerant of side effects|0
7561789|NCT02338193|26293146|P2|Overall Study|intolerant of side effects|0
7561790|NCT02338193|26293147|P1|Overall Study|intolerant of side effects|1
7561791|NCT02338193|26293145|P3|Overall Study|moved out of state|0
7561792|NCT02338193|26293146|P2|Overall Study|moved out of state|1
7561793|NCT02338193|26293147|P1|Overall Study|moved out of state|0
7561794|NCT02338193|26293145|P3|Overall Study|Noncompliant with visits|7
7561795|NCT02338193|26293146|P2|Overall Study|Noncompliant with visits|2
7561796|NCT02338193|26293147|P1|Overall Study|Noncompliant with visits|2
7561797|NCT02338193|26293145|P3|Overall Study|Pregnancy|1
7561798|NCT02338193|26293146|P2|Overall Study|Pregnancy|1
7561799|NCT02338193|26293147|P1|Overall Study|Pregnancy|0
7561800|NCT02338193|26293145|P3|Overall Study|Withdrawal by Subject|2
7561801|NCT02338193|26293146|P2|Overall Study|Withdrawal by Subject|0
7561802|NCT02338193|26293147|P1|Overall Study|Withdrawal by Subject|0
7561803|NCT02338154|26293200|P1|Overall Study|Missing Exit Reason on Exit Form|1
7561804|NCT02338154|26293200|P1|Overall Study|Patients Without Exit Form|47
7561805|NCT02338154|26293200|P1|Overall Study|Other Reason|3
7561806|NCT02338154|26293200|P1|Overall Study|Lost to Follow-up|8
7561807|NCT02338154|26293200|P1|Overall Study|Withdrawal by Subject or by Investigator|10
7561808|NCT02338154|26293200|P1|Overall Study|Valve Explant|11
7561809|NCT02338154|26293200|P1|Overall Study|Valve Implant Failure|17
7561810|NCT02338154|26293200|P1|Overall Study|Death|46
7561811|NCT02337946|26293324|P3|Protocol Treatment 2 Period|Reason not specified|4
7561812|NCT02337946|26293325|P2|Protocol Treatment 2 Period|Reason not specified|4
7561813|NCT02337946|26293326|P1|Protocol Treatment 2 Period|Reason not specified|0
7561814|NCT02337946|26293324|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
7561815|NCT02337946|26293325|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
7561816|NCT02337946|26293326|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
7561817|NCT02337946|26293324|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7561818|NCT02337946|26293325|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
7561819|NCT02337946|26293326|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7561820|NCT02337946|26293324|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
7561821|NCT02337946|26293325|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
7561822|NCT02337946|26293326|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
7561823|NCT02337946|26293324|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
7561824|NCT02337946|26293325|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
7561825|NCT02337946|26293326|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
7561826|NCT02337946|26293324|P3|Protocol Treatment 2 Period|Adverse Event|9
7561827|NCT02337946|26293325|P2|Protocol Treatment 2 Period|Adverse Event|9
7561828|NCT02337946|26293326|P1|Protocol Treatment 2 Period|Adverse Event|0
7561829|NCT02337946|26293324|P3|In-between Period|Without Informed Consent|0
7561830|NCT02337946|26293325|P2|In-between Period|Without Informed Consent|0
7561831|NCT02337946|26293326|P1|In-between Period|Without Informed Consent|1
7561832|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Reason not specified|0
7561833|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Reason not specified|0
7561834|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Reason not specified|8
7561835|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7561836|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7561837|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
7561838|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7561839|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7561840|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
7561841|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7561842|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7561843|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
7561844|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
7561845|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
7561846|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
7561847|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7561848|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7561849|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
7561850|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
7561851|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
7561852|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
7561853|NCT02337946|26293324|P3|Protocol Treatment 1 Period|Adverse Event|0
7561854|NCT02337946|26293325|P2|Protocol Treatment 1 Period|Adverse Event|0
7561855|NCT02337946|26293326|P1|Protocol Treatment 1 Period|Adverse Event|7
7561856|NCT02337907|26293387|P6|Overall Study|Adverse Event|0
7561857|NCT02337907|26293388|P5|Overall Study|Adverse Event|4
7561858|NCT02337907|26293389|P4|Overall Study|Adverse Event|1
7561859|NCT02337907|26293390|P3|Overall Study|Adverse Event|1
7561860|NCT02337907|26293391|P2|Overall Study|Adverse Event|1
7561861|NCT02337907|26293392|P1|Overall Study|Adverse Event|1
7561862|NCT02337907|26293387|P6|Overall Study|Lost to Follow-up|1
7561863|NCT02337907|26293388|P5|Overall Study|Lost to Follow-up|0
7561864|NCT02337907|26293389|P4|Overall Study|Lost to Follow-up|0
7561865|NCT02337907|26293390|P3|Overall Study|Lost to Follow-up|0
7561866|NCT02337907|26293391|P2|Overall Study|Lost to Follow-up|0
7561867|NCT02337907|26293392|P1|Overall Study|Lost to Follow-up|0
7561868|NCT02337907|26293387|P6|Overall Study|Withdrawal by Subject|0
7561869|NCT02337907|26293388|P5|Overall Study|Withdrawal by Subject|5
7561870|NCT02337907|26293389|P4|Overall Study|Withdrawal by Subject|2
7561871|NCT02337907|26293390|P3|Overall Study|Withdrawal by Subject|0
7561872|NCT02337907|26293391|P2|Overall Study|Withdrawal by Subject|3
7561873|NCT02337907|26293392|P1|Overall Study|Withdrawal by Subject|2
7561874|NCT02337907|26293387|P6|Overall Study|Other than listed|0
7561875|NCT02337907|26293388|P5|Overall Study|Other than listed|1
7561876|NCT02337907|26293389|P4|Overall Study|Other than listed|1
7561877|NCT02337907|26293390|P3|Overall Study|Other than listed|0
7561878|NCT02337907|26293391|P2|Overall Study|Other than listed|0
7561879|NCT02337907|26293392|P1|Overall Study|Other than listed|1
7561892|NCT02337764|26293446|P1|Overall Study|Lack of Efficacy|2
7561893|NCT02337764|26293446|P1|Overall Study|Voluntary Withdrawal|12
7561894|NCT02337764|26293446|P1|Overall Study|Pretreatment Event/Adverse Event|46
7561895|NCT02337751|26293459|P2|Overall Study|Investigator's Judgement|0
7561896|NCT02337751|26293460|P1|Overall Study|Investigator's Judgement|1
7561897|NCT02337751|26293459|P2|Overall Study|Lack of Efficacy|5
7561898|NCT02337751|26293460|P1|Overall Study|Lack of Efficacy|2
7561899|NCT02337751|26293459|P2|Overall Study|Voluntary Withdrawal|8
7561900|NCT02337751|26293460|P1|Overall Study|Voluntary Withdrawal|6
7561901|NCT02337751|26293459|P2|Overall Study|Pretreatment Event/Adverse Event|3
7561902|NCT02337751|26293460|P1|Overall Study|Pretreatment Event/Adverse Event|2
7561903|NCT02337738|26293479|P3|Overall Study|Investigator's Judgment|3
7561904|NCT02337738|26293480|P2|Overall Study|Investigator's Judgment|1
7561905|NCT02337738|26293481|P1|Overall Study|Investigator's Judgment|1
7561906|NCT02337738|26293479|P3|Overall Study|Lack of Efficacy|0
7561907|NCT02337738|26293480|P2|Overall Study|Lack of Efficacy|4
7561908|NCT02337738|26293481|P1|Overall Study|Lack of Efficacy|2
7561909|NCT02337738|26293479|P3|Overall Study|Voluntary Withdrawal|2
7561910|NCT02337738|26293480|P2|Overall Study|Voluntary Withdrawal|5
7561911|NCT02337738|26293481|P1|Overall Study|Voluntary Withdrawal|10
7561912|NCT02337738|26293479|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
7561913|NCT02337738|26293480|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
7561914|NCT02337738|26293481|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
7561915|NCT02337738|26293479|P3|Overall Study|Pretreatment Event/Adverse Event|21
7561916|NCT02337738|26293480|P2|Overall Study|Pretreatment Event/Adverse Event|18
7561917|NCT02337738|26293481|P1|Overall Study|Pretreatment Event/Adverse Event|9
7561918|NCT02337738|26293479|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
7561919|NCT02337738|26293480|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
7561920|NCT02337738|26293481|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
7561921|NCT02337725|26293521|P2|Overall Study|Lack of Efficacy|0
7561922|NCT02337725|26293522|P1|Overall Study|Lack of Efficacy|4
7561923|NCT02337725|26293521|P2|Overall Study|Voluntary Withdrawal|3
7561924|NCT02337725|26293522|P1|Overall Study|Voluntary Withdrawal|14
7561925|NCT02337725|26293521|P2|Overall Study|Major Protocol Deviation|1
7561926|NCT02337725|26293522|P1|Overall Study|Major Protocol Deviation|0
7561927|NCT02337725|26293521|P2|Overall Study|Pretreatment Event/AE in Treatment|3
7561928|NCT02337725|26293522|P1|Overall Study|Pretreatment Event/AE in Treatment|8
7561929|NCT02337725|26293521|P2|Overall Study|Pretreatment Event/AE before Treatment|1
7561930|NCT02337725|26293522|P1|Overall Study|Pretreatment Event/AE before Treatment|0
7561931|NCT02337491|26293573|P2|Overall Study|On Treatment|0
7561932|NCT02337491|26293574|P1|Overall Study|On Treatment|2
7561933|NCT02337491|26293573|P2|Overall Study|Progressive Disease|28
7561934|NCT02337491|26293574|P1|Overall Study|Progressive Disease|44
7561935|NCT02337491|26293573|P2|Overall Study|Withdrawal by Subject|0
7561936|NCT02337491|26293574|P1|Overall Study|Withdrawal by Subject|3
7561937|NCT02337491|26293573|P2|Overall Study|Adverse Event|1
7561938|NCT02337491|26293574|P1|Overall Study|Adverse Event|0
7561939|NCT02337491|26293573|P2|Overall Study|Death|1
7561940|NCT02337491|26293574|P1|Overall Study|Death|1
7561941|NCT02337478|26293588|P1|Overall Study|Lack of Efficacy|5
7561942|NCT02337387|26293604|P4|Overall Study|Sponsor Decision to Terminate Study|3
7561943|NCT02337387|26293605|P3|Overall Study|Sponsor Decision to Terminate Study|3
7561944|NCT02337387|26293606|P2|Overall Study|Sponsor Decision to Terminate Study|7
7561945|NCT02337387|26293607|P1|Overall Study|Sponsor Decision to Terminate Study|14
7561946|NCT02337387|26293604|P4|Overall Study|Adverse Event|0
7561947|NCT02337387|26293605|P3|Overall Study|Adverse Event|0
7561948|NCT02337387|26293606|P2|Overall Study|Adverse Event|1
7561949|NCT02337387|26293607|P1|Overall Study|Adverse Event|0
7561950|NCT02337361|26293625|P2|6-month Follow-up|Lost to Follow-up|4
7561951|NCT02337361|26293626|P1|6-month Follow-up|Lost to Follow-up|2
7561952|NCT02337361|26293625|P2|3-month Follow-up|Lost to Follow-up|14
7561953|NCT02337361|26293626|P1|3-month Follow-up|Lost to Follow-up|19
7561954|NCT02336815|26293689|P2|Overall Study|Other|5
7561955|NCT02336815|26293690|P1|Overall Study|Other|1
7561956|NCT02336815|26293689|P2|Overall Study|Lost to Follow-up|3
7561957|NCT02336815|26293690|P1|Overall Study|Lost to Follow-up|1
7561958|NCT02336815|26293689|P2|Overall Study|Withdrawal by Subject|2
7561959|NCT02336815|26293690|P1|Overall Study|Withdrawal by Subject|3
7561960|NCT02336815|26293689|P2|Overall Study|Physician Decision|4
7561961|NCT02336815|26293690|P1|Overall Study|Physician Decision|11
7561962|NCT02336815|26293689|P2|Overall Study|Adverse Event|39
7561963|NCT02336815|26293690|P1|Overall Study|Adverse Event|18
7561964|NCT02336815|26293689|P2|Overall Study|Disease Progression|70
7561965|NCT02336815|26293690|P1|Overall Study|Disease Progression|45
7561966|NCT02336737|26293727|P1|Overall Study|Physician Decision|8
7561967|NCT02336737|26293727|P1|Overall Study|Withdrawal by Subject|5
7561968|NCT02336607|26293738|P4|Overall Study|Withdrawal by Subject|20
7561969|NCT02336607|26293739|P3|Overall Study|Withdrawal by Subject|0
7561970|NCT02336607|26293740|P2|Overall Study|Withdrawal by Subject|2
7561971|NCT02336607|26293741|P1|Overall Study|Withdrawal by Subject|0
7561972|NCT02336607|26293738|P4|Overall Study|Adverse Event|26
7561973|NCT02336607|26293739|P3|Overall Study|Adverse Event|2
7561974|NCT02336607|26293740|P2|Overall Study|Adverse Event|2
7561975|NCT02336607|26293741|P1|Overall Study|Adverse Event|0
7561976|NCT02336607|26293738|P4|Overall Study|Protocol Violation|3
7561977|NCT02336607|26293739|P3|Overall Study|Protocol Violation|1
7561978|NCT02336607|26293740|P2|Overall Study|Protocol Violation|1
7561979|NCT02336607|26293741|P1|Overall Study|Protocol Violation|0
7561980|NCT02336607|26293738|P4|Overall Study|Lost to Follow-up|21
7561981|NCT02336607|26293739|P3|Overall Study|Lost to Follow-up|0
7561982|NCT02336607|26293740|P2|Overall Study|Lost to Follow-up|1
7561983|NCT02336607|26293741|P1|Overall Study|Lost to Follow-up|2
7561984|NCT02336607|26293738|P4|Overall Study|Lack of Efficacy|2
7561985|NCT02336607|26293739|P3|Overall Study|Lack of Efficacy|0
7561986|NCT02336607|26293740|P2|Overall Study|Lack of Efficacy|0
7561987|NCT02336607|26293741|P1|Overall Study|Lack of Efficacy|1
7561988|NCT02336607|26293738|P4|Overall Study|Physician Decision|15
7561989|NCT02336607|26293739|P3|Overall Study|Physician Decision|3
7561990|NCT02336607|26293740|P2|Overall Study|Physician Decision|4
7561991|NCT02336607|26293741|P1|Overall Study|Physician Decision|1
7561992|NCT02336555|26293844|P2|Treatment Period 2 (28 Days)|Adverse Event|1
7561993|NCT02336555|26293845|P1|Treatment Period 2 (28 Days)|Adverse Event|0
7561994|NCT02336555|26293844|P2|Treatment Period 1 (28 Days)|Physician Decision|0
7561995|NCT02336555|26293845|P1|Treatment Period 1 (28 Days)|Physician Decision|2
7561996|NCT02336555|26293844|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7561997|NCT02336555|26293845|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7561998|NCT02336451|26293858|P5|Overall Study|Patient/guardian decision|1
7561999|NCT02336451|26293859|P4|Overall Study|Patient/guardian decision|2
7562000|NCT02336451|26293860|P3|Overall Study|Patient/guardian decision|0
7562001|NCT02336451|26293861|P2|Overall Study|Patient/guardian decision|4
7562002|NCT02336451|26293862|P1|Overall Study|Patient/guardian decision|2
7562003|NCT02336451|26293858|P5|Overall Study|Protocol Violation|0
7562004|NCT02336451|26293859|P4|Overall Study|Protocol Violation|0
7562005|NCT02336451|26293860|P3|Overall Study|Protocol Violation|0
7562006|NCT02336451|26293861|P2|Overall Study|Protocol Violation|0
7562007|NCT02336451|26293862|P1|Overall Study|Protocol Violation|1
7562008|NCT02336451|26293858|P5|Overall Study|Progressive disease|4
7562009|NCT02336451|26293859|P4|Overall Study|Progressive disease|14
7562010|NCT02336451|26293860|P3|Overall Study|Progressive disease|2
7562011|NCT02336451|26293861|P2|Overall Study|Progressive disease|26
7562012|NCT02336451|26293862|P1|Overall Study|Progressive disease|23
7562013|NCT02336451|26293858|P5|Overall Study|Physician Decision|3
7562014|NCT02336451|26293859|P4|Overall Study|Physician Decision|16
7562015|NCT02336451|26293860|P3|Overall Study|Physician Decision|7
7562016|NCT02336451|26293861|P2|Overall Study|Physician Decision|6
7562017|NCT02336451|26293862|P1|Overall Study|Physician Decision|9
7562018|NCT02336451|26293858|P5|Overall Study|Death|6
7562019|NCT02336451|26293859|P4|Overall Study|Death|6
7562020|NCT02336451|26293860|P3|Overall Study|Death|3
7562021|NCT02336451|26293861|P2|Overall Study|Death|2
7562022|NCT02336451|26293862|P1|Overall Study|Death|6
7562023|NCT02336451|26293858|P5|Overall Study|Adverse Event|4
7562024|NCT02336451|26293859|P4|Overall Study|Adverse Event|6
7562025|NCT02336451|26293860|P3|Overall Study|Adverse Event|0
7562026|NCT02336451|26293861|P2|Overall Study|Adverse Event|2
7562027|NCT02336451|26293862|P1|Overall Study|Adverse Event|1
7562028|NCT02336425|26294019|P4|Overall Study|Study terminated.|3
7562029|NCT02336425|26294020|P3|Overall Study|Study terminated.|3
7562030|NCT02336425|26294021|P2|Overall Study|Study terminated.|2
7562031|NCT02336425|26294022|P1|Overall Study|Study terminated.|2
7562032|NCT02336373|26294072|P1|Overall Study|Physician Decision|14
7562033|NCT02336373|26294072|P1|Overall Study|Protocol closed early|4
7562034|NCT02336282|26294091|P1|Overall Study|Not enough time to complete sessions|2
7562035|NCT02336282|26294091|P1|Overall Study|Lost to Follow-up|1
7562036|NCT02336282|26294091|P1|Overall Study|Uncomfortable with technology|1
7562037|NCT02336282|26294091|P1|Overall Study|Unrelated illness|1
7562038|NCT02336178|26294115|P1|Overall Study|Other|1
7562039|NCT02336178|26294115|P1|Overall Study|Withdrawal by Subject|1
7562040|NCT02336178|26294115|P1|Overall Study|Protocol Violation|1
7562041|NCT02336178|26294115|P1|Overall Study|Lost to Follow-up|1
7562042|NCT02336165|26294206|P5|Overall Study|Other|0
7562043|NCT02336165|26294207|P4|Overall Study|Other|1
7562044|NCT02336165|26294208|P3|Overall Study|Other|0
7562045|NCT02336165|26294209|P2|Overall Study|Other|0
7562046|NCT02336165|26294210|P1|Overall Study|Other|1
7562047|NCT02336165|26294206|P5|Overall Study|Non-compliance|0
7562048|NCT02336165|26294207|P4|Overall Study|Non-compliance|1
7562049|NCT02336165|26294208|P3|Overall Study|Non-compliance|0
7562050|NCT02336165|26294209|P2|Overall Study|Non-compliance|0
7562051|NCT02336165|26294210|P1|Overall Study|Non-compliance|1
7562052|NCT02336165|26294206|P5|Overall Study|Progressive disease|19
7562053|NCT02336165|26294207|P4|Overall Study|Progressive disease|24
7562054|NCT02336165|26294208|P3|Overall Study|Progressive disease|27
7562055|NCT02336165|26294209|P2|Overall Study|Progressive disease|22
7562056|NCT02336165|26294210|P1|Overall Study|Progressive disease|23
7562057|NCT02336165|26294206|P5|Overall Study|Adverse Event|1
7562058|NCT02336165|26294207|P4|Overall Study|Adverse Event|4
7562059|NCT02336165|26294208|P3|Overall Study|Adverse Event|2
7562060|NCT02336165|26294209|P2|Overall Study|Adverse Event|1
7562061|NCT02336165|26294210|P1|Overall Study|Adverse Event|4
7562062|NCT02336165|26294206|P5|Overall Study|Withdrawal by Subject|1
7562063|NCT02336165|26294207|P4|Overall Study|Withdrawal by Subject|0
7562064|NCT02336165|26294208|P3|Overall Study|Withdrawal by Subject|1
7562065|NCT02336165|26294209|P2|Overall Study|Withdrawal by Subject|0
7562066|NCT02336165|26294210|P1|Overall Study|Withdrawal by Subject|0
7562067|NCT02336165|26294206|P5|Overall Study|Physician Decision|0
7562068|NCT02336165|26294207|P4|Overall Study|Physician Decision|1
7562069|NCT02336165|26294208|P3|Overall Study|Physician Decision|1
7562070|NCT02336165|26294209|P2|Overall Study|Physician Decision|2
7562071|NCT02336165|26294210|P1|Overall Study|Physician Decision|2
7562072|NCT02336165|26294206|P5|Overall Study|Death|1
7562073|NCT02336165|26294207|P4|Overall Study|Death|0
7562074|NCT02336165|26294208|P3|Overall Study|Death|0
7562075|NCT02336165|26294209|P2|Overall Study|Death|0
7562076|NCT02336165|26294210|P1|Overall Study|Death|3
7562077|NCT02336074|26294254|P2|Overall Study|Adverse Event|2
7562078|NCT02336074|26294255|P1|Overall Study|Adverse Event|0
7562079|NCT02335983|26294278|P6|Overall Study|Protocol Specified Criteria|21
7562080|NCT02335983|26294279|P5|Overall Study|Protocol Specified Criteria|5
7562081|NCT02335983|26294280|P4|Overall Study|Protocol Specified Criteria|7
7562082|NCT02335983|26294281|P3|Overall Study|Protocol Specified Criteria|27
7562083|NCT02335983|26294282|P2|Overall Study|Protocol Specified Criteria|7
7562084|NCT02335983|26294283|P1|Overall Study|Protocol Specified Criteria|5
7562085|NCT02335983|26294278|P6|Overall Study|Lost to Follow-up|1
7562086|NCT02335983|26294279|P5|Overall Study|Lost to Follow-up|0
7562087|NCT02335983|26294280|P4|Overall Study|Lost to Follow-up|0
7562088|NCT02335983|26294281|P3|Overall Study|Lost to Follow-up|0
7562089|NCT02335983|26294282|P2|Overall Study|Lost to Follow-up|0
7562090|NCT02335983|26294283|P1|Overall Study|Lost to Follow-up|0
7562091|NCT02335983|26294278|P6|Overall Study|Death|0
7562092|NCT02335983|26294279|P5|Overall Study|Death|0
7562093|NCT02335983|26294280|P4|Overall Study|Death|0
7562094|NCT02335983|26294281|P3|Overall Study|Death|2
7562095|NCT02335983|26294282|P2|Overall Study|Death|0
7562096|NCT02335983|26294283|P1|Overall Study|Death|0
7562097|NCT02335983|26294278|P6|Overall Study|Withdrawal by Subject|9
7562098|NCT02335983|26294279|P5|Overall Study|Withdrawal by Subject|3
7562099|NCT02335983|26294280|P4|Overall Study|Withdrawal by Subject|1
7562100|NCT02335983|26294281|P3|Overall Study|Withdrawal by Subject|2
7562101|NCT02335983|26294282|P2|Overall Study|Withdrawal by Subject|2
7562102|NCT02335983|26294283|P1|Overall Study|Withdrawal by Subject|3
7562103|NCT02335983|26294278|P6|Overall Study|Sponsor Decision|1
7562104|NCT02335983|26294279|P5|Overall Study|Sponsor Decision|0
7562105|NCT02335983|26294280|P4|Overall Study|Sponsor Decision|1
7562106|NCT02335983|26294281|P3|Overall Study|Sponsor Decision|1
7562107|NCT02335983|26294282|P2|Overall Study|Sponsor Decision|0
7562108|NCT02335983|26294283|P1|Overall Study|Sponsor Decision|0
7562109|NCT02335658|26294390|P2|Overall Study|other reason|3
7562110|NCT02335658|26294391|P1|Overall Study|other reason|2
7562111|NCT02335658|26294390|P2|Overall Study|non-compliance|3
7562112|NCT02335658|26294391|P1|Overall Study|non-compliance|2
7562113|NCT02335658|26294390|P2|Overall Study|Withdrawal by Subject|21
7562114|NCT02335658|26294391|P1|Overall Study|Withdrawal by Subject|13
7562115|NCT02335658|26294390|P2|Overall Study|Pregnancy|0
7562116|NCT02335658|26294391|P1|Overall Study|Pregnancy|1
7562117|NCT02335658|26294390|P2|Overall Study|Lack of Efficacy|5
7562118|NCT02335658|26294391|P1|Overall Study|Lack of Efficacy|4
7562119|NCT02335658|26294390|P2|Overall Study|Adverse Event|12
7562120|NCT02335658|26294391|P1|Overall Study|Adverse Event|18
7562121|NCT02335489|26294406|P1|Overall Study|Lack of Efficacy|1
7562122|NCT02335489|26294406|P1|Overall Study|Physician Decision|2
7562123|NCT02335489|26294406|P1|Overall Study|Withdrawal by Subject|2
7562124|NCT02335489|26294406|P1|Overall Study|Lost to Follow-up|1
7562125|NCT02335489|26294406|P1|Overall Study|Sponsor terminated study|4
7562126|NCT02335450|26294410|P1|Overall Study|Pregnancy|1
7562127|NCT02335424|26294420|P1|Overall Study|Not treated|4
7562128|NCT02335424|26294420|P1|Overall Study|Physician Decision|3
7562129|NCT02335424|26294420|P1|Overall Study|Lost to Follow-up|2
7562130|NCT02335424|26294420|P1|Overall Study|Death|239
7562131|NCT02335424|26294420|P1|Overall Study|Adverse Event|25
7562132|NCT02335424|26294420|P1|Overall Study|Ongoing In Study|89
7562133|NCT02335424|26294420|P1|Overall Study|Withdrawal by Subject|12
7562134|NCT02335346|26294453|P1|Overall Study|Withdrawal by Subject|1
7562135|NCT02335346|26294453|P1|Overall Study|Adverse Event|11
7562136|NCT02334748|26294775|P1|Overall Study|Lack of Efficacy|4
7562137|NCT02334748|26294775|P1|Overall Study|Patient no longer required study drug|2
7562138|NCT02334748|26294775|P1|Overall Study|Inclusion in the CACZ8852306 study|1
7562139|NCT02334748|26294775|P1|Overall Study|Adverse Event|1
7562140|NCT02334423|26294806|P2|Overall Study|Protocol Violation|3
7562141|NCT02334423|26294807|P1|Overall Study|Protocol Violation|10
7562142|NCT02334384|26294821|P2|Overall Study|Lost to Follow-up|1
7562143|NCT02334384|26294822|P1|Overall Study|Lost to Follow-up|1
7562144|NCT02334306|26294834|P2|Double-blind Period|Withdrawal by Subject|1
7562145|NCT02334306|26294835|P1|Double-blind Period|Withdrawal by Subject|1
7562146|NCT02334306|26294834|P2|Double-blind Period|Adverse Event|1
7562147|NCT02334306|26294835|P1|Double-blind Period|Adverse Event|0
7562148|NCT02334215|26294873|P3|Overall Study|Incarcerated|7
7562149|NCT02334215|26294874|P2|Overall Study|Incarcerated|0
7562150|NCT02334215|26294875|P1|Overall Study|Incarcerated|0
7562151|NCT02334215|26294873|P3|Overall Study|Not released from incarceration on time|3
7562152|NCT02334215|26294874|P2|Overall Study|Not released from incarceration on time|3
7562153|NCT02334215|26294875|P1|Overall Study|Not released from incarceration on time|3
7562154|NCT02334215|26294873|P3|Overall Study|Withdrawal by Subject|1
7562155|NCT02334215|26294874|P2|Overall Study|Withdrawal by Subject|2
7562156|NCT02334215|26294875|P1|Overall Study|Withdrawal by Subject|2
7562157|NCT02334215|26294873|P3|Overall Study|Lost to Follow-up|4
7562158|NCT02334215|26294874|P2|Overall Study|Lost to Follow-up|0
7562159|NCT02334215|26294875|P1|Overall Study|Lost to Follow-up|1
7562160|NCT02334215|26294873|P3|Overall Study|Death|0
7562161|NCT02334215|26294874|P2|Overall Study|Death|1
7562162|NCT02334215|26294875|P1|Overall Study|Death|1
7562163|NCT02333630|26294955|P2|Overall Study|Lost to Follow-up|2
7562164|NCT02333630|26294956|P1|Overall Study|Lost to Follow-up|5
7562165|NCT02333487|26294971|P3|Overall Study|Adverse Event|0
7562166|NCT02333487|26294972|P2|Overall Study|Adverse Event|2
7562167|NCT02333487|26294973|P1|Overall Study|Adverse Event|0
7562168|NCT02333383|26294984|P1|Overall Study|Transfer to another hospital|2
7562169|NCT02333383|26294984|P1|Overall Study|Withdrawal by Subject|3
7562170|NCT02333383|26294984|P1|Overall Study|Lost to Follow-up|15
7562171|NCT02333383|26294984|P1|Overall Study|Adalimumab discontinuation|21
7562172|NCT02333331|26294998|P4|Overall Study|Patient/Guardian Decision|1
7562173|NCT02333331|26294999|P3|Overall Study|Patient/Guardian Decision|9
7562174|NCT02333331|26295000|P2|Overall Study|Patient/Guardian Decision|2
7562175|NCT02333331|26295001|P1|Overall Study|Patient/Guardian Decision|1
7562176|NCT02333331|26294998|P4|Overall Study|Protocol Deviation|1
7562177|NCT02333331|26294999|P3|Overall Study|Protocol Deviation|2
7562178|NCT02333331|26295000|P2|Overall Study|Protocol Deviation|3
7562179|NCT02333331|26295001|P1|Overall Study|Protocol Deviation|0
7562180|NCT02333331|26294998|P4|Overall Study|Physician Decision|0
7562181|NCT02333331|26294999|P3|Overall Study|Physician Decision|0
7562182|NCT02333331|26295000|P2|Overall Study|Physician Decision|1
7562183|NCT02333331|26295001|P1|Overall Study|Physician Decision|0
7562184|NCT02333331|26294998|P4|Overall Study|Lost to Follow-up|0
7562185|NCT02333331|26294999|P3|Overall Study|Lost to Follow-up|1
7562186|NCT02333331|26295000|P2|Overall Study|Lost to Follow-up|0
7562187|NCT02333331|26295001|P1|Overall Study|Lost to Follow-up|0
7562188|NCT02333331|26294998|P4|Overall Study|Death|0
7562189|NCT02333331|26294999|P3|Overall Study|Death|2
7562190|NCT02333331|26295000|P2|Overall Study|Death|0
7562191|NCT02333331|26295001|P1|Overall Study|Death|0
7562192|NCT02333331|26294998|P4|Overall Study|Adverse Event|1
7562193|NCT02333331|26294999|P3|Overall Study|Adverse Event|4
7562194|NCT02333331|26295000|P2|Overall Study|Adverse Event|0
7562195|NCT02333331|26295001|P1|Overall Study|Adverse Event|1
7562196|NCT02332915|26295081|P2|Overall Study|did not meet inclusion criteria|4
7562197|NCT02332915|26295082|P1|Overall Study|did not meet inclusion criteria|2
7562198|NCT02332915|26295081|P2|Overall Study|Travel distance prohibitive|1
7562199|NCT02332915|26295082|P1|Overall Study|Travel distance prohibitive|0
7562200|NCT02332915|26295081|P2|Overall Study|Unrelated illness|1
7562201|NCT02332915|26295082|P1|Overall Study|Unrelated illness|1
7562202|NCT02332915|26295081|P2|Overall Study|Moved out of region|0
7562203|NCT02332915|26295082|P1|Overall Study|Moved out of region|3
7562204|NCT02332889|26295095|P1|Overall Study|Physician Decision|1
7562205|NCT02332876|26295101|P2|Overall Study|Lost to Follow-up|1
7562206|NCT02332876|26295102|P1|Overall Study|Lost to Follow-up|1
7562207|NCT02332824|26295137|P6|Overall Study|Transfer|0
7562208|NCT02332824|26295138|P5|Overall Study|Transfer|0
7562209|NCT02332824|26295139|P4|Overall Study|Transfer|1
7562210|NCT02332824|26295140|P3|Overall Study|Transfer|1
7562211|NCT02332824|26295141|P2|Overall Study|Transfer|0
7562212|NCT02332824|26295142|P1|Overall Study|Transfer|0
7562213|NCT02332824|26295137|P6|Overall Study|Inconvenient schedule|0
7562214|NCT02332824|26295138|P5|Overall Study|Inconvenient schedule|0
7562215|NCT02332824|26295139|P4|Overall Study|Inconvenient schedule|0
7562216|NCT02332824|26295140|P3|Overall Study|Inconvenient schedule|0
7562217|NCT02332824|26295141|P2|Overall Study|Inconvenient schedule|1
7562218|NCT02332824|26295142|P1|Overall Study|Inconvenient schedule|1
7562219|NCT02332824|26295137|P6|Overall Study|Voluntary Withdrawal|0
7562220|NCT02332824|26295138|P5|Overall Study|Voluntary Withdrawal|0
7562221|NCT02332824|26295139|P4|Overall Study|Voluntary Withdrawal|0
7562222|NCT02332824|26295140|P3|Overall Study|Voluntary Withdrawal|0
7562223|NCT02332824|26295141|P2|Overall Study|Voluntary Withdrawal|0
7562224|NCT02332824|26295142|P1|Overall Study|Voluntary Withdrawal|1
7562225|NCT02332824|26295137|P6|Overall Study|Pretreatment Event/Adverse Event|1
7562226|NCT02332824|26295138|P5|Overall Study|Pretreatment Event/Adverse Event|4
7562227|NCT02332824|26295139|P4|Overall Study|Pretreatment Event/Adverse Event|1
7562228|NCT02332824|26295140|P3|Overall Study|Pretreatment Event/Adverse Event|1
7562229|NCT02332824|26295141|P2|Overall Study|Pretreatment Event/Adverse Event|0
7562230|NCT02332824|26295142|P1|Overall Study|Pretreatment Event/Adverse Event|4
7562240|NCT02332720|26295258|P23|Part A and Part B|Withdrawal by Subject|0
7562241|NCT02332720|26295259|P22|Part A and Part B|Withdrawal by Subject|0
7562242|NCT02332720|26295260|P21|Part A and Part B|Withdrawal by Subject|0
7562243|NCT02332720|26295261|P20|Part A and Part B|Withdrawal by Subject|1
7562244|NCT02332720|26295262|P19|Part A and Part B|Withdrawal by Subject|0
7562245|NCT02332720|26295263|P18|Part A and Part B|Withdrawal by Subject|0
7562246|NCT02332720|26295264|P17|Part A and Part B|Withdrawal by Subject|0
7562247|NCT02332720|26295265|P16|Part A and Part B|Withdrawal by Subject|0
7562248|NCT02332720|26295266|P15|Part A and Part B|Withdrawal by Subject|0
7562249|NCT02332720|26295267|P14|Part A and Part B|Withdrawal by Subject|0
7562250|NCT02332720|26295268|P13|Part A and Part B|Withdrawal by Subject|0
7562251|NCT02332720|26295269|P12|Part A and Part B|Withdrawal by Subject|0
7562252|NCT02332720|26295270|P11|Part A and Part B|Withdrawal by Subject|0
7562253|NCT02332720|26295271|P10|Part A and Part B|Withdrawal by Subject|0
7562254|NCT02332720|26295272|P9|Part A and Part B|Withdrawal by Subject|0
7562255|NCT02332720|26295273|P8|Part A and Part B|Withdrawal by Subject|0
7562256|NCT02332720|26295274|P7|Part A and Part B|Withdrawal by Subject|0
7562257|NCT02332720|26295275|P6|Part A and Part B|Withdrawal by Subject|1
7562258|NCT02332720|26295276|P5|Part A and Part B|Withdrawal by Subject|0
7562259|NCT02332720|26295277|P4|Part A and Part B|Withdrawal by Subject|0
7562260|NCT02332720|26295278|P3|Part A and Part B|Withdrawal by Subject|0
7562261|NCT02332720|26295279|P2|Part A and Part B|Withdrawal by Subject|0
7562262|NCT02332720|26295280|P1|Part A and Part B|Withdrawal by Subject|0
7562263|NCT02332720|26295258|P23|Part A and Part B|Physician Decision|0
7562264|NCT02332720|26295259|P22|Part A and Part B|Physician Decision|0
7562265|NCT02332720|26295260|P21|Part A and Part B|Physician Decision|0
7562266|NCT02332720|26295261|P20|Part A and Part B|Physician Decision|0
7562267|NCT02332720|26295262|P19|Part A and Part B|Physician Decision|1
7562268|NCT02332720|26295263|P18|Part A and Part B|Physician Decision|0
7562269|NCT02332720|26295264|P17|Part A and Part B|Physician Decision|0
7562270|NCT02332720|26295265|P16|Part A and Part B|Physician Decision|0
7562271|NCT02332720|26295266|P15|Part A and Part B|Physician Decision|0
7562272|NCT02332720|26295267|P14|Part A and Part B|Physician Decision|0
7562273|NCT02332720|26295268|P13|Part A and Part B|Physician Decision|0
7562274|NCT02332720|26295269|P12|Part A and Part B|Physician Decision|0
7562275|NCT02332720|26295270|P11|Part A and Part B|Physician Decision|0
7562276|NCT02332720|26295271|P10|Part A and Part B|Physician Decision|0
7562277|NCT02332720|26295272|P9|Part A and Part B|Physician Decision|0
7562278|NCT02332720|26295273|P8|Part A and Part B|Physician Decision|0
7562279|NCT02332720|26295274|P7|Part A and Part B|Physician Decision|0
7562280|NCT02332720|26295275|P6|Part A and Part B|Physician Decision|0
7562281|NCT02332720|26295276|P5|Part A and Part B|Physician Decision|0
7562282|NCT02332720|26295277|P4|Part A and Part B|Physician Decision|0
7562283|NCT02332720|26295278|P3|Part A and Part B|Physician Decision|0
7562284|NCT02332720|26295279|P2|Part A and Part B|Physician Decision|0
7562285|NCT02332720|26295280|P1|Part A and Part B|Physician Decision|0
7562286|NCT02332720|26295258|P23|Part A and Part B|Adverse Event|0
7562287|NCT02332720|26295259|P22|Part A and Part B|Adverse Event|0
7562288|NCT02332720|26295260|P21|Part A and Part B|Adverse Event|0
7562289|NCT02332720|26295261|P20|Part A and Part B|Adverse Event|0
7562290|NCT02332720|26295262|P19|Part A and Part B|Adverse Event|0
7562291|NCT02332720|26295263|P18|Part A and Part B|Adverse Event|1
7562292|NCT02332720|26295264|P17|Part A and Part B|Adverse Event|0
7562293|NCT02332720|26295265|P16|Part A and Part B|Adverse Event|0
7562294|NCT02332720|26295266|P15|Part A and Part B|Adverse Event|0
7562295|NCT02332720|26295267|P14|Part A and Part B|Adverse Event|0
7562296|NCT02332720|26295268|P13|Part A and Part B|Adverse Event|0
7562297|NCT02332720|26295269|P12|Part A and Part B|Adverse Event|0
7562298|NCT02332720|26295270|P11|Part A and Part B|Adverse Event|0
7562299|NCT02332720|26295271|P10|Part A and Part B|Adverse Event|0
7562300|NCT02332720|26295272|P9|Part A and Part B|Adverse Event|0
7562301|NCT02332720|26295273|P8|Part A and Part B|Adverse Event|0
7562302|NCT02332720|26295274|P7|Part A and Part B|Adverse Event|0
7562303|NCT02332720|26295275|P6|Part A and Part B|Adverse Event|0
7562304|NCT02332720|26295276|P5|Part A and Part B|Adverse Event|0
7562305|NCT02332720|26295277|P4|Part A and Part B|Adverse Event|0
7562306|NCT02332720|26295278|P3|Part A and Part B|Adverse Event|0
7562307|NCT02332720|26295279|P2|Part A and Part B|Adverse Event|0
7562308|NCT02332720|26295280|P1|Part A and Part B|Adverse Event|0
7562309|NCT02332720|26295258|P23|Part A and Part B|Lost to Follow-up|0
7562310|NCT02332720|26295259|P22|Part A and Part B|Lost to Follow-up|0
7562311|NCT02332720|26295260|P21|Part A and Part B|Lost to Follow-up|0
7562312|NCT02332720|26295261|P20|Part A and Part B|Lost to Follow-up|0
7562313|NCT02332720|26295262|P19|Part A and Part B|Lost to Follow-up|0
7562314|NCT02332720|26295263|P18|Part A and Part B|Lost to Follow-up|0
7562315|NCT02332720|26295264|P17|Part A and Part B|Lost to Follow-up|0
7562316|NCT02332720|26295265|P16|Part A and Part B|Lost to Follow-up|1
7562317|NCT02332720|26295266|P15|Part A and Part B|Lost to Follow-up|0
7562318|NCT02332720|26295267|P14|Part A and Part B|Lost to Follow-up|0
7562319|NCT02332720|26295268|P13|Part A and Part B|Lost to Follow-up|0
7562320|NCT02332720|26295269|P12|Part A and Part B|Lost to Follow-up|0
7562321|NCT02332720|26295270|P11|Part A and Part B|Lost to Follow-up|0
7562322|NCT02332720|26295271|P10|Part A and Part B|Lost to Follow-up|0
7562323|NCT02332720|26295272|P9|Part A and Part B|Lost to Follow-up|0
7562324|NCT02332720|26295273|P8|Part A and Part B|Lost to Follow-up|1
7562325|NCT02332720|26295274|P7|Part A and Part B|Lost to Follow-up|1
7562326|NCT02332720|26295275|P6|Part A and Part B|Lost to Follow-up|2
7562327|NCT02332720|26295276|P5|Part A and Part B|Lost to Follow-up|0
7562328|NCT02332720|26295277|P4|Part A and Part B|Lost to Follow-up|0
7562329|NCT02332720|26295278|P3|Part A and Part B|Lost to Follow-up|0
7562330|NCT02332720|26295279|P2|Part A and Part B|Lost to Follow-up|0
7562331|NCT02332720|26295280|P1|Part A and Part B|Lost to Follow-up|1
7562332|NCT02332707|26295416|P18|Overall Study|Withdrawal by Subject|0
7562333|NCT02332707|26295417|P17|Overall Study|Withdrawal by Subject|0
7562334|NCT02332707|26295418|P16|Overall Study|Withdrawal by Subject|0
7562335|NCT02332707|26295419|P15|Overall Study|Withdrawal by Subject|0
7562336|NCT02332707|26295420|P14|Overall Study|Withdrawal by Subject|0
7562337|NCT02332707|26295421|P13|Overall Study|Withdrawal by Subject|0
7562338|NCT02332707|26295422|P12|Overall Study|Withdrawal by Subject|0
7562339|NCT02332707|26295423|P11|Overall Study|Withdrawal by Subject|0
7562340|NCT02332707|26295424|P10|Overall Study|Withdrawal by Subject|3
7562341|NCT02332707|26295425|P9|Overall Study|Withdrawal by Subject|0
7562342|NCT02332707|26295426|P8|Overall Study|Withdrawal by Subject|0
7562343|NCT02332707|26295427|P7|Overall Study|Withdrawal by Subject|0
7562344|NCT02332707|26295428|P6|Overall Study|Withdrawal by Subject|0
7562345|NCT02332707|26295429|P5|Overall Study|Withdrawal by Subject|0
7562346|NCT02332707|26295430|P4|Overall Study|Withdrawal by Subject|0
7562347|NCT02332707|26295431|P3|Overall Study|Withdrawal by Subject|1
7562348|NCT02332707|26295432|P2|Overall Study|Withdrawal by Subject|0
7562349|NCT02332707|26295433|P1|Overall Study|Withdrawal by Subject|0
7562350|NCT02332707|26295416|P18|Overall Study|Physician Decision|0
7562351|NCT02332707|26295417|P17|Overall Study|Physician Decision|0
7562352|NCT02332707|26295418|P16|Overall Study|Physician Decision|0
7562353|NCT02332707|26295419|P15|Overall Study|Physician Decision|0
7562354|NCT02332707|26295420|P14|Overall Study|Physician Decision|0
7562355|NCT02332707|26295421|P13|Overall Study|Physician Decision|1
7562356|NCT02332707|26295422|P12|Overall Study|Physician Decision|0
7562357|NCT02332707|26295423|P11|Overall Study|Physician Decision|0
7562358|NCT02332707|26295424|P10|Overall Study|Physician Decision|0
7562359|NCT02332707|26295425|P9|Overall Study|Physician Decision|0
7562360|NCT02332707|26295426|P8|Overall Study|Physician Decision|0
7562361|NCT02332707|26295427|P7|Overall Study|Physician Decision|0
7562362|NCT02332707|26295428|P6|Overall Study|Physician Decision|0
7562363|NCT02332707|26295429|P5|Overall Study|Physician Decision|0
7562364|NCT02332707|26295430|P4|Overall Study|Physician Decision|1
7562365|NCT02332707|26295431|P3|Overall Study|Physician Decision|0
7562366|NCT02332707|26295432|P2|Overall Study|Physician Decision|0
7562367|NCT02332707|26295433|P1|Overall Study|Physician Decision|0
7562368|NCT02332707|26295416|P18|Overall Study|Lost to Follow-up|0
7562369|NCT02332707|26295417|P17|Overall Study|Lost to Follow-up|0
7562370|NCT02332707|26295418|P16|Overall Study|Lost to Follow-up|0
7562371|NCT02332707|26295419|P15|Overall Study|Lost to Follow-up|0
7562372|NCT02332707|26295420|P14|Overall Study|Lost to Follow-up|0
7562373|NCT02332707|26295421|P13|Overall Study|Lost to Follow-up|3
7562374|NCT02332707|26295422|P12|Overall Study|Lost to Follow-up|0
7562375|NCT02332707|26295423|P11|Overall Study|Lost to Follow-up|2
7562376|NCT02332707|26295424|P10|Overall Study|Lost to Follow-up|0
7562377|NCT02332707|26295425|P9|Overall Study|Lost to Follow-up|0
7562378|NCT02332707|26295426|P8|Overall Study|Lost to Follow-up|0
7562379|NCT02332707|26295427|P7|Overall Study|Lost to Follow-up|0
7562380|NCT02332707|26295428|P6|Overall Study|Lost to Follow-up|1
7562381|NCT02332707|26295429|P5|Overall Study|Lost to Follow-up|0
7562382|NCT02332707|26295430|P4|Overall Study|Lost to Follow-up|0
7562383|NCT02332707|26295431|P3|Overall Study|Lost to Follow-up|0
7562384|NCT02332707|26295432|P2|Overall Study|Lost to Follow-up|0
7562385|NCT02332707|26295433|P1|Overall Study|Lost to Follow-up|0
7562386|NCT02332707|26295416|P18|Overall Study|Adverse Event|0
7562387|NCT02332707|26295417|P17|Overall Study|Adverse Event|0
7562388|NCT02332707|26295418|P16|Overall Study|Adverse Event|0
7562389|NCT02332707|26295419|P15|Overall Study|Adverse Event|0
7562390|NCT02332707|26295420|P14|Overall Study|Adverse Event|0
7562391|NCT02332707|26295421|P13|Overall Study|Adverse Event|1
7562392|NCT02332707|26295422|P12|Overall Study|Adverse Event|0
7562393|NCT02332707|26295423|P11|Overall Study|Adverse Event|0
7562394|NCT02332707|26295424|P10|Overall Study|Adverse Event|0
7562395|NCT02332707|26295425|P9|Overall Study|Adverse Event|0
7562396|NCT02332707|26295426|P8|Overall Study|Adverse Event|0
7562397|NCT02332707|26295427|P7|Overall Study|Adverse Event|0
7562398|NCT02332707|26295428|P6|Overall Study|Adverse Event|0
7562399|NCT02332707|26295429|P5|Overall Study|Adverse Event|0
7562400|NCT02332707|26295430|P4|Overall Study|Adverse Event|0
7562401|NCT02332707|26295431|P3|Overall Study|Adverse Event|0
7562402|NCT02332707|26295432|P2|Overall Study|Adverse Event|0
7562403|NCT02332707|26295433|P1|Overall Study|Adverse Event|0
7562404|NCT02332590|26295527|P2|Overall Study|Other than specified above|5
7562405|NCT02332590|26295528|P1|Overall Study|Other than specified above|6
7562406|NCT02332590|26295527|P2|Overall Study|Randomized but not treated|0
7562407|NCT02332590|26295528|P1|Overall Study|Randomized but not treated|1
7562408|NCT02332590|26295527|P2|Overall Study|Poor compliance to protocol|1
7562409|NCT02332590|26295528|P1|Overall Study|Poor compliance to protocol|3
7562410|NCT02332590|26295527|P2|Overall Study|Lack of Efficacy|2
7562411|NCT02332590|26295528|P1|Overall Study|Lack of Efficacy|4
7562412|NCT02332590|26295527|P2|Overall Study|Adverse Event|11
7562413|NCT02332590|26295528|P1|Overall Study|Adverse Event|15
7562414|NCT02332291|26295592|P2|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
7562415|NCT02332291|26295593|P1|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
7562416|NCT02332291|26295592|P2|Phase 2: Open-Label Bupropion|Worsening Depression|1
7562417|NCT02332291|26295593|P1|Phase 2: Open-Label Bupropion|Worsening Depression|0
7562418|NCT02332291|26295592|P2|Phase 2: Open-Label Bupropion|Adverse Event|7
7562419|NCT02332291|26295593|P1|Phase 2: Open-Label Bupropion|Adverse Event|2
7562420|NCT02332291|26295592|P2|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
7562421|NCT02332291|26295593|P1|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
7562422|NCT02332291|26295592|P2|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
7562423|NCT02332291|26295593|P1|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
7562424|NCT02332291|26295592|P2|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
7562425|NCT02332291|26295593|P1|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
7562426|NCT02332239|26295612|P2|Overall Study|Lost to Follow-up|6
7562427|NCT02332239|26295613|P1|Overall Study|Lost to Follow-up|4
7562428|NCT02331680|26295649|P3|Overall Study|Protocol Violation|3
7562429|NCT02331680|26295650|P2|Overall Study|Protocol Violation|0
7562430|NCT02331680|26295651|P1|Overall Study|Protocol Violation|0
7562431|NCT02331680|26295649|P3|Overall Study|Non-compliance with study drug|1
7562432|NCT02331680|26295650|P2|Overall Study|Non-compliance with study drug|0
7562433|NCT02331680|26295651|P1|Overall Study|Non-compliance with study drug|0
7562434|NCT02331680|26295649|P3|Overall Study|Met withdrawal criteria|5
7562435|NCT02331680|26295650|P2|Overall Study|Met withdrawal criteria|2
7562436|NCT02331680|26295651|P1|Overall Study|Met withdrawal criteria|2
7562437|NCT02331680|26295649|P3|Overall Study|Withdrawal by Subject|2
7562438|NCT02331680|26295650|P2|Overall Study|Withdrawal by Subject|1
7562439|NCT02331680|26295651|P1|Overall Study|Withdrawal by Subject|0
7562440|NCT02331680|26295649|P3|Overall Study|Physician Decision|2
7562441|NCT02331680|26295650|P2|Overall Study|Physician Decision|1
7562442|NCT02331680|26295651|P1|Overall Study|Physician Decision|1
7562443|NCT02331680|26295649|P3|Overall Study|Adverse Event|2
7562444|NCT02331680|26295650|P2|Overall Study|Adverse Event|0
7562445|NCT02331680|26295651|P1|Overall Study|Adverse Event|3
7562446|NCT02331446|26295681|P4|Overall Study|Lost before baseline analysis|0
7562447|NCT02331446|26295682|P3|Overall Study|Lost before baseline analysis|1
7562448|NCT02331446|26295683|P2|Overall Study|Lost before baseline analysis|1
7562449|NCT02331446|26295684|P1|Overall Study|Lost before baseline analysis|0
7562450|NCT02331446|26295681|P4|Overall Study|Physician Decision|1
7562451|NCT02331446|26295682|P3|Overall Study|Physician Decision|0
7562452|NCT02331446|26295683|P2|Overall Study|Physician Decision|1
7562453|NCT02331446|26295684|P1|Overall Study|Physician Decision|0
7562454|NCT02331446|26295681|P4|Overall Study|Disease|1
7562455|NCT02331446|26295682|P3|Overall Study|Disease|2
7562456|NCT02331446|26295683|P2|Overall Study|Disease|2
7562457|NCT02331446|26295684|P1|Overall Study|Disease|0
7562458|NCT02331446|26295681|P4|Overall Study|Personal Problem|0
7562459|NCT02331446|26295682|P3|Overall Study|Personal Problem|0
7562460|NCT02331446|26295683|P2|Overall Study|Personal Problem|0
7562461|NCT02331446|26295684|P1|Overall Study|Personal Problem|2
7562462|NCT02331446|26295681|P4|Overall Study|Lost to Follow-up|1
7562463|NCT02331446|26295682|P3|Overall Study|Lost to Follow-up|0
7562464|NCT02331446|26295683|P2|Overall Study|Lost to Follow-up|1
7562465|NCT02331446|26295684|P1|Overall Study|Lost to Follow-up|2
7562466|NCT02331394|26295760|P1|Overall Study|Disease progression|1
7562467|NCT02331368|26295771|P1|Overall Study|Withdrawal by Subject|3
7562468|NCT02330549|26295896|P2|Overall Study|Failure to meet randomization criteria|0
7562469|NCT02330549|26295897|P1|Overall Study|Failure to meet randomization criteria|1
7562470|NCT02330549|26295896|P2|Overall Study|Subject withdrew consent|1
7562471|NCT02330549|26295897|P1|Overall Study|Subject withdrew consent|2
7562472|NCT02330549|26295896|P2|Overall Study|Adverse Event|0
7562473|NCT02330549|26295897|P1|Overall Study|Adverse Event|1
7562474|NCT02330081|26296113|P1|Overall Study|Protocol Violation|6
7562475|NCT02330081|26296113|P1|Overall Study|Donation did not meet criteria|1
7562476|NCT02330081|26296113|P1|Overall Study|Adverse Event|1
7562477|NCT02330055|26296134|P2|Overall Study|participant did not sleep|1
7562478|NCT02330055|26296135|P1|Overall Study|participant did not sleep|0
7562479|NCT02330055|26296134|P2|Overall Study|data for less than 60 minutes|3
7562480|NCT02330055|26296135|P1|Overall Study|data for less than 60 minutes|3
7562481|NCT02330055|26296134|P2|Overall Study|participant forgot to wear device|5
7562482|NCT02330055|26296135|P1|Overall Study|participant forgot to wear device|5
7562483|NCT02330055|26296134|P2|Overall Study|technical issues|0
7562484|NCT02330055|26296135|P1|Overall Study|technical issues|2
7562485|NCT02329743|26296181|P3|Overall Study|Other|3
7562486|NCT02329743|26296182|P2|Overall Study|Other|2
7562487|NCT02329743|26296183|P1|Overall Study|Other|0
7562488|NCT02329743|26296181|P3|Overall Study|Withdrawal by Subject|1
7562489|NCT02329743|26296182|P2|Overall Study|Withdrawal by Subject|4
7562490|NCT02329743|26296183|P1|Overall Study|Withdrawal by Subject|4
7562491|NCT02329743|26296181|P3|Overall Study|Lost to Follow-up|1
7562492|NCT02329743|26296182|P2|Overall Study|Lost to Follow-up|0
7562493|NCT02329743|26296183|P1|Overall Study|Lost to Follow-up|1
7562494|NCT02329743|26296181|P3|Overall Study|Adverse Event|3
7562495|NCT02329743|26296182|P2|Overall Study|Adverse Event|1
7562496|NCT02329743|26296183|P1|Overall Study|Adverse Event|1
7562497|NCT02329730|26296198|P12|Overall Study|Withdrawal by Subject|0
7562498|NCT02329730|26296199|P11|Overall Study|Withdrawal by Subject|0
7562499|NCT02329730|26296200|P10|Overall Study|Withdrawal by Subject|1
7562500|NCT02329730|26296201|P9|Overall Study|Withdrawal by Subject|1
7562501|NCT02329730|26296202|P8|Overall Study|Withdrawal by Subject|1
7562502|NCT02329730|26296203|P7|Overall Study|Withdrawal by Subject|1
7562503|NCT02329730|26296204|P6|Overall Study|Withdrawal by Subject|0
7562504|NCT02329730|26296205|P5|Overall Study|Withdrawal by Subject|1
7562505|NCT02329730|26296206|P4|Overall Study|Withdrawal by Subject|0
7562506|NCT02329730|26296207|P3|Overall Study|Withdrawal by Subject|0
7562507|NCT02329730|26296208|P2|Overall Study|Withdrawal by Subject|0
7562508|NCT02329730|26296209|P1|Overall Study|Withdrawal by Subject|0
7562509|NCT02329730|26296198|P12|Overall Study|Protocol Violation|0
7562510|NCT02329730|26296199|P11|Overall Study|Protocol Violation|0
7562511|NCT02329730|26296200|P10|Overall Study|Protocol Violation|0
7562512|NCT02329730|26296201|P9|Overall Study|Protocol Violation|0
7562513|NCT02329730|26296202|P8|Overall Study|Protocol Violation|0
7562514|NCT02329730|26296203|P7|Overall Study|Protocol Violation|0
7562515|NCT02329730|26296204|P6|Overall Study|Protocol Violation|2
7562516|NCT02329730|26296205|P5|Overall Study|Protocol Violation|2
7562517|NCT02329730|26296206|P4|Overall Study|Protocol Violation|0
7562518|NCT02329730|26296207|P3|Overall Study|Protocol Violation|0
7562519|NCT02329730|26296208|P2|Overall Study|Protocol Violation|0
7562520|NCT02329730|26296209|P1|Overall Study|Protocol Violation|0
7562521|NCT02329431|26296320|P2|Overall Study|Lost to Follow-up|13
7562522|NCT02329431|26296321|P1|Overall Study|Lost to Follow-up|20
7562523|NCT02329223|26296340|P3|Overall Study|Adverse Event|0
7562524|NCT02329223|26296341|P2|Overall Study|Adverse Event|1
7562525|NCT02329223|26296342|P1|Overall Study|Adverse Event|0
7562526|NCT02329223|26296340|P3|Overall Study|Physician Decision|1
7562527|NCT02329223|26296341|P2|Overall Study|Physician Decision|0
7562528|NCT02329223|26296342|P1|Overall Study|Physician Decision|0
7562529|NCT02329223|26296340|P3|Overall Study|Withdrawal by Subject|5
7562530|NCT02329223|26296341|P2|Overall Study|Withdrawal by Subject|2
7562531|NCT02329223|26296342|P1|Overall Study|Withdrawal by Subject|1
7562532|NCT02328937|26296392|P6|Period 2|Adverse Event|0
7562533|NCT02328937|26296393|P5|Period 2|Adverse Event|0
7562534|NCT02328937|26296394|P4|Period 2|Adverse Event|0
7562535|NCT02328937|26296395|P3|Period 2|Adverse Event|1
7562536|NCT02328937|26296396|P2|Period 2|Adverse Event|0
7562537|NCT02328937|26296397|P1|Period 2|Adverse Event|0
7562538|NCT02328937|26296392|P6|Period 1|Lost to Follow-up|0
7562539|NCT02328937|26296393|P5|Period 1|Lost to Follow-up|0
7562540|NCT02328937|26296394|P4|Period 1|Lost to Follow-up|1
7562541|NCT02328937|26296395|P3|Period 1|Lost to Follow-up|0
7562542|NCT02328937|26296396|P2|Period 1|Lost to Follow-up|0
7562543|NCT02328937|26296397|P1|Period 1|Lost to Follow-up|0
7562544|NCT02328547|26296432|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
7562545|NCT02328547|26296433|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
7562546|NCT02328547|26296432|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
7562547|NCT02328547|26296433|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
7562548|NCT02328326|26296510|P2|Overall Study|Lost to Follow-up|4
7562549|NCT02328326|26296511|P1|Overall Study|Lost to Follow-up|10
7562550|NCT02328326|26296510|P2|Overall Study|Death|1
7562551|NCT02328326|26296511|P1|Overall Study|Death|2
7562552|NCT02328326|26296510|P2|Overall Study|Withdrawal by Subject|3
7562553|NCT02328326|26296511|P1|Overall Study|Withdrawal by Subject|10
7562554|NCT02328105|26296557|P1|Overall Study|Still On Study in Follow-Up|4
7562555|NCT02328105|26296557|P1|Overall Study|Withdrawal by Subject|1
7562556|NCT02328105|26296557|P1|Overall Study|Death|6
7562557|NCT02328040|26296566|P2|First Intervention (2 Days)|Withdrawal by Subject|1
7562558|NCT02328040|26296567|P1|First Intervention (2 Days)|Withdrawal by Subject|1
7562559|NCT02328027|26296577|P2|Overall Study|Withdrawal by Subject|1
7562560|NCT02328027|26296578|P1|Overall Study|Withdrawal by Subject|0
7562561|NCT02328014|26296597|P4|Overall Study|Withdrawal by Subject|1
7562562|NCT02328014|26296598|P3|Overall Study|Withdrawal by Subject|0
7562563|NCT02328014|26296599|P2|Overall Study|Withdrawal by Subject|0
7562564|NCT02328014|26296600|P1|Overall Study|Withdrawal by Subject|0
7562565|NCT02328014|26296597|P4|Overall Study|Subject Started Another Cancer Therapy|12
7562566|NCT02328014|26296598|P3|Overall Study|Subject Started Another Cancer Therapy|4
7562567|NCT02328014|26296599|P2|Overall Study|Subject Started Another Cancer Therapy|5
7562568|NCT02328014|26296600|P1|Overall Study|Subject Started Another Cancer Therapy|0
7562569|NCT02328014|26296597|P4|Overall Study|Study Terminated by Sponsor|0
7562570|NCT02328014|26296598|P3|Overall Study|Study Terminated by Sponsor|1
7562571|NCT02328014|26296599|P2|Overall Study|Study Terminated by Sponsor|1
7562572|NCT02328014|26296600|P1|Overall Study|Study Terminated by Sponsor|4
7562573|NCT02328014|26296597|P4|Overall Study|Disease Progression|3
7562574|NCT02328014|26296598|P3|Overall Study|Disease Progression|1
7562575|NCT02328014|26296599|P2|Overall Study|Disease Progression|0
7562576|NCT02328014|26296600|P1|Overall Study|Disease Progression|1
7562577|NCT02328014|26296597|P4|Overall Study|Physician Decision|1
7562578|NCT02328014|26296598|P3|Overall Study|Physician Decision|0
7562579|NCT02328014|26296599|P2|Overall Study|Physician Decision|0
7562580|NCT02328014|26296600|P1|Overall Study|Physician Decision|0
7562581|NCT02328014|26296597|P4|Overall Study|Death|4
7562582|NCT02328014|26296598|P3|Overall Study|Death|0
7562583|NCT02328014|26296599|P2|Overall Study|Death|0
7562584|NCT02328014|26296600|P1|Overall Study|Death|0
7562585|NCT02328014|26296597|P4|Overall Study|Adverse Event|1
7562586|NCT02328014|26296598|P3|Overall Study|Adverse Event|0
7562587|NCT02328014|26296599|P2|Overall Study|Adverse Event|0
7562588|NCT02328014|26296600|P1|Overall Study|Adverse Event|1
7562589|NCT02327325|26296667|P3|Overall Study|Excluded by Study Team|1
7562590|NCT02327325|26296668|P2|Overall Study|Excluded by Study Team|0
7562591|NCT02327325|26296669|P1|Overall Study|Excluded by Study Team|0
7562592|NCT02327325|26296667|P3|Overall Study|Withdrawal by Subject|4
7562593|NCT02327325|26296668|P2|Overall Study|Withdrawal by Subject|4
7562594|NCT02327325|26296669|P1|Overall Study|Withdrawal by Subject|1
7562595|NCT02327260|26296692|P3|Overall Study|cognitive concerns|0
7562596|NCT02327260|26296693|P2|Overall Study|cognitive concerns|0
7562597|NCT02327260|26296694|P1|Overall Study|cognitive concerns|1
7562598|NCT02327260|26296692|P3|Overall Study|non-adherence to protocol|0
7562599|NCT02327260|26296693|P2|Overall Study|non-adherence to protocol|0
7562600|NCT02327260|26296694|P1|Overall Study|non-adherence to protocol|2
7562601|NCT02327260|26296692|P3|Overall Study|invalid phone number|0
7562602|NCT02327260|26296693|P2|Overall Study|invalid phone number|1
7562603|NCT02327260|26296694|P1|Overall Study|invalid phone number|1
7562604|NCT02327260|26296692|P3|Overall Study|Lost to Follow-up|2
7562605|NCT02327260|26296693|P2|Overall Study|Lost to Follow-up|3
7562606|NCT02327260|26296694|P1|Overall Study|Lost to Follow-up|2
7562607|NCT02327169|26296741|P15|Overall Study|Lost to Follow-up|0
7562608|NCT02327169|26296742|P14|Overall Study|Lost to Follow-up|0
7562609|NCT02327169|26296743|P13|Overall Study|Lost to Follow-up|0
7562610|NCT02327169|26296744|P12|Overall Study|Lost to Follow-up|0
7562611|NCT02327169|26296745|P11|Overall Study|Lost to Follow-up|0
7562612|NCT02327169|26296746|P10|Overall Study|Lost to Follow-up|0
7562613|NCT02327169|26296747|P9|Overall Study|Lost to Follow-up|0
7562614|NCT02327169|26296748|P8|Overall Study|Lost to Follow-up|0
7562615|NCT02327169|26296749|P7|Overall Study|Lost to Follow-up|0
7562616|NCT02327169|26296750|P6|Overall Study|Lost to Follow-up|0
7562617|NCT02327169|26296751|P5|Overall Study|Lost to Follow-up|1
7562618|NCT02327169|26296752|P4|Overall Study|Lost to Follow-up|0
7562619|NCT02327169|26296753|P3|Overall Study|Lost to Follow-up|0
7562620|NCT02327169|26296754|P2|Overall Study|Lost to Follow-up|0
7562621|NCT02327169|26296755|P1|Overall Study|Lost to Follow-up|0
7562622|NCT02327169|26296741|P15|Overall Study|Withdrawal by Subject|3
7562623|NCT02327169|26296742|P14|Overall Study|Withdrawal by Subject|0
7562624|NCT02327169|26296743|P13|Overall Study|Withdrawal by Subject|0
7562625|NCT02327169|26296744|P12|Overall Study|Withdrawal by Subject|0
7562626|NCT02327169|26296745|P11|Overall Study|Withdrawal by Subject|0
7562627|NCT02327169|26296746|P10|Overall Study|Withdrawal by Subject|0
7562628|NCT02327169|26296747|P9|Overall Study|Withdrawal by Subject|0
7562629|NCT02327169|26296748|P8|Overall Study|Withdrawal by Subject|1
7562630|NCT02327169|26296749|P7|Overall Study|Withdrawal by Subject|0
7562631|NCT02327169|26296750|P6|Overall Study|Withdrawal by Subject|0
7562632|NCT02327169|26296751|P5|Overall Study|Withdrawal by Subject|1
7562633|NCT02327169|26296752|P4|Overall Study|Withdrawal by Subject|0
7562634|NCT02327169|26296753|P3|Overall Study|Withdrawal by Subject|0
7562635|NCT02327169|26296754|P2|Overall Study|Withdrawal by Subject|0
7562636|NCT02327169|26296755|P1|Overall Study|Withdrawal by Subject|1
7562637|NCT02327169|26296741|P15|Overall Study|Reason Not Specified|2
7562638|NCT02327169|26296742|P14|Overall Study|Reason Not Specified|0
7562639|NCT02327169|26296743|P13|Overall Study|Reason Not Specified|0
7562640|NCT02327169|26296744|P12|Overall Study|Reason Not Specified|1
7562641|NCT02327169|26296745|P11|Overall Study|Reason Not Specified|2
7562642|NCT02327169|26296746|P10|Overall Study|Reason Not Specified|1
7562643|NCT02327169|26296747|P9|Overall Study|Reason Not Specified|0
7562644|NCT02327169|26296748|P8|Overall Study|Reason Not Specified|0
7562645|NCT02327169|26296749|P7|Overall Study|Reason Not Specified|0
7562646|NCT02327169|26296750|P6|Overall Study|Reason Not Specified|0
7562647|NCT02327169|26296751|P5|Overall Study|Reason Not Specified|0
7562648|NCT02327169|26296752|P4|Overall Study|Reason Not Specified|0
7562649|NCT02327169|26296753|P3|Overall Study|Reason Not Specified|1
7562650|NCT02327169|26296754|P2|Overall Study|Reason Not Specified|0
7562651|NCT02327169|26296755|P1|Overall Study|Reason Not Specified|0
7562652|NCT02327169|26296741|P15|Overall Study|Symptomatic Deterioration|1
7562653|NCT02327169|26296742|P14|Overall Study|Symptomatic Deterioration|2
7562654|NCT02327169|26296743|P13|Overall Study|Symptomatic Deterioration|0
7562655|NCT02327169|26296744|P12|Overall Study|Symptomatic Deterioration|0
7562656|NCT02327169|26296745|P11|Overall Study|Symptomatic Deterioration|0
7562657|NCT02327169|26296746|P10|Overall Study|Symptomatic Deterioration|1
7562658|NCT02327169|26296747|P9|Overall Study|Symptomatic Deterioration|2
7562659|NCT02327169|26296748|P8|Overall Study|Symptomatic Deterioration|0
7562660|NCT02327169|26296749|P7|Overall Study|Symptomatic Deterioration|0
7562661|NCT02327169|26296750|P6|Overall Study|Symptomatic Deterioration|1
7562662|NCT02327169|26296751|P5|Overall Study|Symptomatic Deterioration|1
7562663|NCT02327169|26296752|P4|Overall Study|Symptomatic Deterioration|0
7562664|NCT02327169|26296753|P3|Overall Study|Symptomatic Deterioration|1
7562665|NCT02327169|26296754|P2|Overall Study|Symptomatic Deterioration|0
7562666|NCT02327169|26296755|P1|Overall Study|Symptomatic Deterioration|0
7562667|NCT02327169|26296741|P15|Overall Study|Adverse Event|1
7562668|NCT02327169|26296742|P14|Overall Study|Adverse Event|2
7562669|NCT02327169|26296743|P13|Overall Study|Adverse Event|0
7562670|NCT02327169|26296744|P12|Overall Study|Adverse Event|3
7562671|NCT02327169|26296745|P11|Overall Study|Adverse Event|0
7562672|NCT02327169|26296746|P10|Overall Study|Adverse Event|2
7562673|NCT02327169|26296747|P9|Overall Study|Adverse Event|0
7562674|NCT02327169|26296748|P8|Overall Study|Adverse Event|0
7562675|NCT02327169|26296749|P7|Overall Study|Adverse Event|0
7562676|NCT02327169|26296750|P6|Overall Study|Adverse Event|0
7562677|NCT02327169|26296751|P5|Overall Study|Adverse Event|1
7562678|NCT02327169|26296752|P4|Overall Study|Adverse Event|0
7562679|NCT02327169|26296753|P3|Overall Study|Adverse Event|1
7562680|NCT02327169|26296754|P2|Overall Study|Adverse Event|0
7562681|NCT02327169|26296755|P1|Overall Study|Adverse Event|2
7562682|NCT02327169|26296741|P15|Overall Study|Progressive Disease|3
7562683|NCT02327169|26296742|P14|Overall Study|Progressive Disease|3
7562684|NCT02327169|26296743|P13|Overall Study|Progressive Disease|1
7562685|NCT02327169|26296744|P12|Overall Study|Progressive Disease|3
7562686|NCT02327169|26296745|P11|Overall Study|Progressive Disease|4
7562687|NCT02327169|26296746|P10|Overall Study|Progressive Disease|4
7562688|NCT02327169|26296747|P9|Overall Study|Progressive Disease|4
7562689|NCT02327169|26296748|P8|Overall Study|Progressive Disease|3
7562690|NCT02327169|26296749|P7|Overall Study|Progressive Disease|3
7562691|NCT02327169|26296750|P6|Overall Study|Progressive Disease|3
7562692|NCT02327169|26296751|P5|Overall Study|Progressive Disease|4
7562693|NCT02327169|26296752|P4|Overall Study|Progressive Disease|3
7562694|NCT02327169|26296753|P3|Overall Study|Progressive Disease|4
7562695|NCT02327169|26296754|P2|Overall Study|Progressive Disease|3
7562696|NCT02327169|26296755|P1|Overall Study|Progressive Disease|1
7562697|NCT02327130|26296985|P1|Overall Study|Met exclusion criteria|3
7562698|NCT02327130|26296985|P1|Overall Study|Incorrectly place ventilator adaptor|1
7562699|NCT02327130|26296985|P1|Overall Study|Unable to provide breath sample|1
7562700|NCT02327130|26296985|P1|Overall Study|Physician Decision|2
7562701|NCT02327130|26296985|P1|Overall Study|Discharged in less than 5 days|5
7562702|NCT02327013|26297008|P5|Overall Study|Withdrawal before treatment|0
7562703|NCT02327013|26297009|P4|Overall Study|Withdrawal before treatment|0
7562704|NCT02327013|26297010|P3|Overall Study|Withdrawal before treatment|5
7562705|NCT02327013|26297011|P2|Overall Study|Withdrawal before treatment|1
7562706|NCT02327013|26297012|P1|Overall Study|Withdrawal before treatment|2
7562707|NCT02327013|26297008|P5|Overall Study|Protocol Violation|1
7562708|NCT02327013|26297009|P4|Overall Study|Protocol Violation|0
7562709|NCT02327013|26297010|P3|Overall Study|Protocol Violation|3
7562710|NCT02327013|26297011|P2|Overall Study|Protocol Violation|0
7562711|NCT02327013|26297012|P1|Overall Study|Protocol Violation|0
7562712|NCT02327013|26297008|P5|Overall Study|Administrative or other reason(s)|1
7562713|NCT02327013|26297009|P4|Overall Study|Administrative or other reason(s)|1
7562714|NCT02327013|26297010|P3|Overall Study|Administrative or other reason(s)|11
7562715|NCT02327013|26297011|P2|Overall Study|Administrative or other reason(s)|5
7562716|NCT02327013|26297012|P1|Overall Study|Administrative or other reason(s)|1
7562717|NCT02327013|26297008|P5|Overall Study|Lost to Follow-up|0
7562718|NCT02327013|26297009|P4|Overall Study|Lost to Follow-up|0
7562719|NCT02327013|26297010|P3|Overall Study|Lost to Follow-up|5
7562720|NCT02327013|26297011|P2|Overall Study|Lost to Follow-up|4
7562721|NCT02327013|26297012|P1|Overall Study|Lost to Follow-up|2
7562722|NCT02327013|26297008|P5|Overall Study|Withdrawal of Consent|0
7562723|NCT02327013|26297009|P4|Overall Study|Withdrawal of Consent|0
7562724|NCT02327013|26297010|P3|Overall Study|Withdrawal of Consent|3
7562725|NCT02327013|26297011|P2|Overall Study|Withdrawal of Consent|0
7562726|NCT02327013|26297012|P1|Overall Study|Withdrawal of Consent|1
7562727|NCT02327013|26297008|P5|Overall Study|Non-compliance with IMP|0
7562728|NCT02327013|26297009|P4|Overall Study|Non-compliance with IMP|0
7562729|NCT02327013|26297010|P3|Overall Study|Non-compliance with IMP|7
7562730|NCT02327013|26297011|P2|Overall Study|Non-compliance with IMP|2
7562731|NCT02327013|26297012|P1|Overall Study|Non-compliance with IMP|1
7562732|NCT02327013|26297008|P5|Overall Study|Lack of Efficacy|1
7562733|NCT02327013|26297009|P4|Overall Study|Lack of Efficacy|0
7562734|NCT02327013|26297010|P3|Overall Study|Lack of Efficacy|5
7562735|NCT02327013|26297011|P2|Overall Study|Lack of Efficacy|0
7562736|NCT02327013|26297012|P1|Overall Study|Lack of Efficacy|2
7562737|NCT02327013|26297008|P5|Overall Study|Adverse Event|1
7562738|NCT02327013|26297009|P4|Overall Study|Adverse Event|0
7562739|NCT02327013|26297010|P3|Overall Study|Adverse Event|3
7562740|NCT02327013|26297011|P2|Overall Study|Adverse Event|4
7562741|NCT02327013|26297012|P1|Overall Study|Adverse Event|4
7562742|NCT02326974|26297185|P1|Overall Study|failed heterogenity evaluation|5
7562743|NCT02326974|26297185|P1|Overall Study|Withdrawal by Subject|2
7562744|NCT02326597|26297212|P2|Overall Study|Lost to Follow-up|32
7562745|NCT02326597|26297213|P1|Overall Study|Lost to Follow-up|42
7562746|NCT02326467|26297231|P1|Overall Study|Withdrawal by Subject|1
7562747|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7562748|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7562749|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7562750|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562751|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562752|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562753|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562754|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562755|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562756|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562757|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562758|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562759|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562760|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7562761|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7562762|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
7562763|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
7562764|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562765|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562766|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563454|NCT02325791|26297468|P4|Overall Study|Lost to Follow-up|9
7562767|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562768|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562769|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562770|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562771|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562772|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562773|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562774|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7562775|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7562776|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7562777|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
7562778|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562779|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562780|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562781|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562782|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562783|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562784|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562785|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562786|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562787|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562788|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7562789|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
7562790|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562791|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562792|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562793|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562794|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562795|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562796|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562797|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562798|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562799|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562800|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562801|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562802|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7562803|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562804|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7562805|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7562806|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562807|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562808|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562809|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562810|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562811|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562812|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562813|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562814|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562815|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562816|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7562817|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562818|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7562819|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7562820|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562821|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562822|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562823|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562824|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562825|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562826|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562827|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562828|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562829|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562830|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7562831|NCT02326298|26297278|P14|Open-label Period (Week 48 to Week 144)|Death|0
7562832|NCT02326298|26297279|P13|Open-label Period (Week 48 to Week 144)|Death|0
7562833|NCT02326298|26297280|P12|Open-label Period (Week 48 to Week 144)|Death|1
7562834|NCT02326298|26297281|P11|Open-label Period (Week 48 to Week 144)|Death|0
7562835|NCT02326298|26297282|P10|Open-label Period (Week 48 to Week 144)|Death|0
7562836|NCT02326298|26297283|P9|Open-label Period (Week 48 to Week 144)|Death|0
7562837|NCT02326298|26297284|P8|Open-label Period (Week 48 to Week 144)|Death|0
7562838|NCT02326298|26297285|P7|Open-label Period (Week 48 to Week 144)|Death|0
7562839|NCT02326298|26297286|P6|Open-label Period (Week 48 to Week 144)|Death|0
7562840|NCT02326298|26297287|P5|Open-label Period (Week 48 to Week 144)|Death|0
7562841|NCT02326298|26297288|P4|Open-label Period (Week 48 to Week 144)|Death|0
7562842|NCT02326298|26297289|P3|Open-label Period (Week 48 to Week 144)|Death|0
7562843|NCT02326298|26297290|P2|Open-label Period (Week 48 to Week 144)|Death|0
7562844|NCT02326298|26297291|P1|Open-label Period (Week 48 to Week 144)|Death|0
7562845|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562846|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562847|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562848|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562849|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562850|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562851|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562852|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562853|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
7562854|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562855|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562856|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562857|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562858|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7562859|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562860|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562861|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562862|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562863|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562864|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562865|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7562866|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562867|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562868|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562869|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562870|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562871|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562872|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7562873|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562874|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562875|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562876|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562877|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562878|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562879|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7562880|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7562881|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562882|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562883|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562884|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562885|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562886|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7562887|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562888|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562889|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562890|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562891|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562892|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562893|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
7562894|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562895|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562896|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562897|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562898|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562899|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562900|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7562901|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563455|NCT02325791|26297469|P3|Overall Study|Lost to Follow-up|14
7562902|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562903|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562904|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562905|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562906|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562907|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562908|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7562909|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562910|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562911|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562912|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562913|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562914|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7562915|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562916|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562917|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562918|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562919|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562920|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562921|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562922|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562923|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
7562924|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562925|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562926|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562927|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562928|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7562929|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562930|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562931|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562932|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562933|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562934|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
7562935|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562936|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
7562937|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
7562938|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562939|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562940|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562941|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562942|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7562943|NCT02326298|26297278|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562944|NCT02326298|26297279|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562945|NCT02326298|26297280|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562946|NCT02326298|26297281|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562947|NCT02326298|26297282|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7562948|NCT02326298|26297283|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7562949|NCT02326298|26297284|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7562950|NCT02326298|26297285|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7562951|NCT02326298|26297286|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7562952|NCT02326298|26297287|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562953|NCT02326298|26297288|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562954|NCT02326298|26297289|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562955|NCT02326298|26297290|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562956|NCT02326298|26297291|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7562957|NCT02326298|26297278|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562958|NCT02326298|26297279|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562959|NCT02326298|26297280|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562960|NCT02326298|26297281|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562961|NCT02326298|26297282|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562962|NCT02326298|26297283|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562963|NCT02326298|26297284|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562964|NCT02326298|26297285|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562965|NCT02326298|26297286|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7563456|NCT02325791|26297470|P2|Overall Study|Lost to Follow-up|15
7562966|NCT02326298|26297287|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562967|NCT02326298|26297288|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562968|NCT02326298|26297289|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
7562969|NCT02326298|26297290|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562970|NCT02326298|26297291|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7562971|NCT02326298|26297278|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562972|NCT02326298|26297279|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562973|NCT02326298|26297280|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562974|NCT02326298|26297281|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562975|NCT02326298|26297282|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562976|NCT02326298|26297283|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562977|NCT02326298|26297284|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562978|NCT02326298|26297285|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562979|NCT02326298|26297286|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562980|NCT02326298|26297287|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562981|NCT02326298|26297288|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562982|NCT02326298|26297289|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7562983|NCT02326298|26297290|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7562984|NCT02326298|26297291|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7562985|NCT02326298|26297278|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562986|NCT02326298|26297279|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562987|NCT02326298|26297280|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562988|NCT02326298|26297281|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562989|NCT02326298|26297282|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562990|NCT02326298|26297283|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562991|NCT02326298|26297284|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562992|NCT02326298|26297285|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562993|NCT02326298|26297286|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562994|NCT02326298|26297287|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562995|NCT02326298|26297288|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562996|NCT02326298|26297289|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7562997|NCT02326298|26297290|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7562998|NCT02326298|26297291|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7562999|NCT02326298|26297278|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563000|NCT02326298|26297279|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563001|NCT02326298|26297280|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563002|NCT02326298|26297281|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563003|NCT02326298|26297282|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563004|NCT02326298|26297283|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563005|NCT02326298|26297284|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563006|NCT02326298|26297285|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563007|NCT02326298|26297286|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563008|NCT02326298|26297287|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563009|NCT02326298|26297288|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563010|NCT02326298|26297289|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563011|NCT02326298|26297290|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7563012|NCT02326298|26297291|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
7563013|NCT02326298|26297278|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563014|NCT02326298|26297279|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563015|NCT02326298|26297280|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563016|NCT02326298|26297281|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563017|NCT02326298|26297282|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563018|NCT02326298|26297283|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563019|NCT02326298|26297284|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563020|NCT02326298|26297285|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563021|NCT02326298|26297286|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563022|NCT02326298|26297287|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563023|NCT02326298|26297288|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563024|NCT02326298|26297289|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
7563025|NCT02326298|26297290|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563026|NCT02326298|26297291|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563027|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563028|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563029|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
7563030|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563031|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563032|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563033|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563034|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563035|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563036|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563037|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563038|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563039|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563040|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563041|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7563042|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563043|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563044|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563045|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
7563046|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563047|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563048|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563049|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563050|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563051|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563052|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563053|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563054|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563055|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563056|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7563057|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7563058|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563059|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7563060|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
7563061|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563062|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563063|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563064|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563065|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563066|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563067|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563068|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563069|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563070|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563071|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7563072|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7563073|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563074|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563075|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7563076|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563077|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563078|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563079|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563080|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563081|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563082|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563083|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563084|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563085|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563086|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7563087|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7563088|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563089|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
7563090|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563091|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
7563092|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563093|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563094|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563095|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563096|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563097|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563098|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563099|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563100|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563101|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7563102|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563103|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563104|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563105|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
7563106|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563107|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563108|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563109|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563110|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563111|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563112|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563113|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563114|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563115|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563116|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7563117|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563118|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563119|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7563120|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563121|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7563122|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563123|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563124|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563125|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563126|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563127|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563128|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563129|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563130|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563131|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7563132|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7563133|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563134|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7563135|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
7563136|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7563137|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563138|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563139|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563140|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563141|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563142|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563143|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563144|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563145|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563146|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7563147|NCT02326272|26297314|P15|Open-label Period (Week 48 to Week 144)|Death|0
7563148|NCT02326272|26297315|P14|Open-label Period (Week 48 to Week 144)|Death|0
7563149|NCT02326272|26297316|P13|Open-label Period (Week 48 to Week 144)|Death|1
7563150|NCT02326272|26297317|P12|Open-label Period (Week 48 to Week 144)|Death|0
7563151|NCT02326272|26297318|P11|Open-label Period (Week 48 to Week 144)|Death|0
7563152|NCT02326272|26297319|P10|Open-label Period (Week 48 to Week 144)|Death|0
7563153|NCT02326272|26297320|P9|Open-label Period (Week 48 to Week 144)|Death|0
7563154|NCT02326272|26297321|P8|Open-label Period (Week 48 to Week 144)|Death|0
7563155|NCT02326272|26297322|P7|Open-label Period (Week 48 to Week 144)|Death|0
7563156|NCT02326272|26297323|P6|Open-label Period (Week 48 to Week 144)|Death|0
7563157|NCT02326272|26297324|P5|Open-label Period (Week 48 to Week 144)|Death|0
7563158|NCT02326272|26297325|P4|Open-label Period (Week 48 to Week 144)|Death|0
7563159|NCT02326272|26297326|P3|Open-label Period (Week 48 to Week 144)|Death|0
7563160|NCT02326272|26297327|P2|Open-label Period (Week 48 to Week 144)|Death|0
7563161|NCT02326272|26297328|P1|Open-label Period (Week 48 to Week 144)|Death|0
7563162|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563163|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563164|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563165|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563166|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563167|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563168|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563169|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563170|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
7563171|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563172|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563173|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563174|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563175|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563176|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7563177|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563178|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563179|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563180|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563181|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563182|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563183|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563184|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563185|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563186|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
7563187|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563188|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563189|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563190|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563191|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7563192|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563193|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563194|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563195|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563196|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563197|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563198|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7563199|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7563200|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7563201|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7563202|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563203|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563204|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563205|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563206|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7563207|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563208|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563209|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563210|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563211|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563212|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563213|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
7563214|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563215|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563216|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563217|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563218|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563219|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563220|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563221|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7563222|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563223|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563224|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563225|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563226|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563227|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563228|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563229|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563230|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7563231|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563232|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563233|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563234|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563235|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563236|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7563237|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563238|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563239|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563240|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563241|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563242|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563243|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563244|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
7563245|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563246|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563247|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563248|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563249|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563250|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563251|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7563252|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563253|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563254|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563255|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563256|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563257|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7563258|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563259|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7563260|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7563261|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7563262|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563263|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7563264|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563265|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563266|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7563267|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563268|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563269|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563270|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563271|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563272|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563273|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563274|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7563275|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563276|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7563277|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563278|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563279|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563280|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563281|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7563282|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563283|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563284|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563285|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563286|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563287|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7563288|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7563289|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563290|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7563291|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
7563292|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563293|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563294|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563295|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563296|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7563297|NCT02326272|26297314|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563298|NCT02326272|26297315|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563299|NCT02326272|26297316|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563300|NCT02326272|26297317|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563301|NCT02326272|26297318|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563302|NCT02326272|26297319|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563303|NCT02326272|26297320|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7563304|NCT02326272|26297321|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7563305|NCT02326272|26297322|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7563306|NCT02326272|26297323|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
7563307|NCT02326272|26297324|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7563308|NCT02326272|26297325|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563309|NCT02326272|26297326|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563310|NCT02326272|26297327|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563311|NCT02326272|26297328|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7563312|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563313|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563314|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563315|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563316|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563317|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563318|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563319|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563320|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563321|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563322|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563323|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563324|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
7563325|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563326|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7563327|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563328|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563329|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563330|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563331|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563332|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563333|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563334|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563335|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563336|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563337|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563338|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563339|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
7563340|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563341|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7563342|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563343|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563344|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563345|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563346|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563347|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563348|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563349|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563350|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563351|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563352|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563353|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563354|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
7563355|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563356|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
7563357|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563358|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563359|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563360|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563361|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563362|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563363|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563364|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563365|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563366|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563367|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563368|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563369|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
7563370|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563371|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7563372|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563373|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563374|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563375|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563376|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563457|NCT02325791|26297471|P1|Overall Study|Lost to Follow-up|0
7563377|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563378|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563379|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563380|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563381|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563382|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563383|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7563384|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7563385|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7563386|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7563387|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563388|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563389|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563390|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563391|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563392|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563393|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563394|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563395|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563396|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563397|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563398|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563399|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7563400|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
7563401|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7563402|NCT02326272|26297314|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563403|NCT02326272|26297315|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563404|NCT02326272|26297316|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563405|NCT02326272|26297317|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563406|NCT02326272|26297318|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563407|NCT02326272|26297319|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563408|NCT02326272|26297320|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563409|NCT02326272|26297321|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563410|NCT02326272|26297322|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563411|NCT02326272|26297323|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563412|NCT02326272|26297324|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563413|NCT02326272|26297325|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563414|NCT02326272|26297326|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
7563415|NCT02326272|26297327|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
7563416|NCT02326272|26297328|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
7563417|NCT02326220|26297365|P3|Open-label Treatment Period|Lost to Follow-up|1
7563418|NCT02326220|26297366|P2|Open-label Treatment Period|Lost to Follow-up|0
7563419|NCT02326220|26297367|P1|Open-label Treatment Period|Lost to Follow-up|0
7563420|NCT02326220|26297365|P3|Open-label Treatment Period|Withdrawal by Subject|1
7563421|NCT02326220|26297366|P2|Open-label Treatment Period|Withdrawal by Subject|0
7563422|NCT02326220|26297367|P1|Open-label Treatment Period|Withdrawal by Subject|0
7563423|NCT02326220|26297365|P3|Double-blind Treatment Period|Withdrawal by Subject|0
7563424|NCT02326220|26297366|P2|Double-blind Treatment Period|Withdrawal by Subject|1
7563425|NCT02326220|26297367|P1|Double-blind Treatment Period|Withdrawal by Subject|0
7563426|NCT02326220|26297365|P3|Double-blind Treatment Period|Protocol Violation|0
7563427|NCT02326220|26297366|P2|Double-blind Treatment Period|Protocol Violation|1
7563428|NCT02326220|26297367|P1|Double-blind Treatment Period|Protocol Violation|0
7563429|NCT02326220|26297365|P3|Double-blind Treatment Period|Adverse Event|0
7563430|NCT02326220|26297366|P2|Double-blind Treatment Period|Adverse Event|2
7563431|NCT02326220|26297367|P1|Double-blind Treatment Period|Adverse Event|1
7563432|NCT02326025|26297420|P2|Overall Study|Protocol Violation|1
7563433|NCT02326025|26297421|P1|Overall Study|Protocol Violation|0
7563434|NCT02326025|26297420|P2|Overall Study|Withdrawal by Subject|2
7563435|NCT02326025|26297421|P1|Overall Study|Withdrawal by Subject|0
7563436|NCT02326025|26297420|P2|Overall Study|Physician and Participant Decision|0
7563437|NCT02326025|26297421|P1|Overall Study|Physician and Participant Decision|1
7563438|NCT02326025|26297420|P2|Overall Study|Physician Decision|2
7563439|NCT02326025|26297421|P1|Overall Study|Physician Decision|1
7563440|NCT02326025|26297420|P2|Overall Study|Adverse Event|0
7563441|NCT02326025|26297421|P1|Overall Study|Adverse Event|3
7563442|NCT02325791|26297468|P4|Overall Study|Withdrawal by Subject|16
7563443|NCT02325791|26297469|P3|Overall Study|Withdrawal by Subject|8
7563444|NCT02325791|26297470|P2|Overall Study|Withdrawal by Subject|5
7563445|NCT02325791|26297471|P1|Overall Study|Withdrawal by Subject|0
7563446|NCT02325791|26297468|P4|Overall Study|Protocol Violation|0
7563447|NCT02325791|26297469|P3|Overall Study|Protocol Violation|1
7563448|NCT02325791|26297470|P2|Overall Study|Protocol Violation|0
7563449|NCT02325791|26297471|P1|Overall Study|Protocol Violation|0
7563450|NCT02325791|26297468|P4|Overall Study|Physician Decision|0
7563451|NCT02325791|26297469|P3|Overall Study|Physician Decision|1
7563452|NCT02325791|26297470|P2|Overall Study|Physician Decision|1
7563453|NCT02325791|26297471|P1|Overall Study|Physician Decision|0
7563458|NCT02325791|26297468|P4|Overall Study|Death|1
7563459|NCT02325791|26297469|P3|Overall Study|Death|0
7563460|NCT02325791|26297470|P2|Overall Study|Death|3
7563461|NCT02325791|26297471|P1|Overall Study|Death|0
7563462|NCT02325791|26297468|P4|Overall Study|Adverse Event|0
7563463|NCT02325791|26297469|P3|Overall Study|Adverse Event|1
7563464|NCT02325791|26297470|P2|Overall Study|Adverse Event|1
7563465|NCT02325791|26297471|P1|Overall Study|Adverse Event|0
7563466|NCT02325739|26297501|P11|Phase II Part|Subject/guardian decision|1
7563467|NCT02325739|26297502|P10|Phase II Part|Subject/guardian decision|1
7563468|NCT02325739|26297503|P9|Phase II Part|Subject/guardian decision|4
7563469|NCT02325739|26297504|P8|Phase II Part|Subject/guardian decision|0
7563470|NCT02325739|26297505|P7|Phase II Part|Subject/guardian decision|0
7563471|NCT02325739|26297506|P6|Phase II Part|Subject/guardian decision|0
7563472|NCT02325739|26297507|P5|Phase II Part|Subject/guardian decision|0
7563473|NCT02325739|26297508|P4|Phase II Part|Subject/guardian decision|0
7563474|NCT02325739|26297509|P3|Phase II Part|Subject/guardian decision|0
7563475|NCT02325739|26297510|P2|Phase II Part|Subject/guardian decision|0
7563476|NCT02325739|26297511|P1|Phase II Part|Subject/guardian decision|0
7563477|NCT02325739|26297501|P11|Phase II Part|Progressive disease|18
7563478|NCT02325739|26297502|P10|Phase II Part|Progressive disease|29
7563479|NCT02325739|26297503|P9|Phase II Part|Progressive disease|22
7563480|NCT02325739|26297504|P8|Phase II Part|Progressive disease|0
7563481|NCT02325739|26297505|P7|Phase II Part|Progressive disease|0
7563482|NCT02325739|26297506|P6|Phase II Part|Progressive disease|0
7563483|NCT02325739|26297507|P5|Phase II Part|Progressive disease|0
7563484|NCT02325739|26297508|P4|Phase II Part|Progressive disease|0
7563485|NCT02325739|26297509|P3|Phase II Part|Progressive disease|0
7563486|NCT02325739|26297510|P2|Phase II Part|Progressive disease|0
7563487|NCT02325739|26297511|P1|Phase II Part|Progressive disease|0
7563488|NCT02325739|26297501|P11|Phase II Part|Physician Decision|0
7563489|NCT02325739|26297502|P10|Phase II Part|Physician Decision|1
7563490|NCT02325739|26297503|P9|Phase II Part|Physician Decision|0
7563491|NCT02325739|26297504|P8|Phase II Part|Physician Decision|0
7563492|NCT02325739|26297505|P7|Phase II Part|Physician Decision|0
7563493|NCT02325739|26297506|P6|Phase II Part|Physician Decision|0
7563494|NCT02325739|26297507|P5|Phase II Part|Physician Decision|0
7563495|NCT02325739|26297508|P4|Phase II Part|Physician Decision|0
7563496|NCT02325739|26297509|P3|Phase II Part|Physician Decision|0
7563497|NCT02325739|26297510|P2|Phase II Part|Physician Decision|0
7563498|NCT02325739|26297511|P1|Phase II Part|Physician Decision|0
7563499|NCT02325739|26297501|P11|Phase II Part|Adverse Event|1
7563500|NCT02325739|26297502|P10|Phase II Part|Adverse Event|5
7563501|NCT02325739|26297503|P9|Phase II Part|Adverse Event|4
7563502|NCT02325739|26297504|P8|Phase II Part|Adverse Event|0
7563503|NCT02325739|26297505|P7|Phase II Part|Adverse Event|0
7563504|NCT02325739|26297506|P6|Phase II Part|Adverse Event|0
7563505|NCT02325739|26297507|P5|Phase II Part|Adverse Event|0
7563506|NCT02325739|26297508|P4|Phase II Part|Adverse Event|0
7563507|NCT02325739|26297509|P3|Phase II Part|Adverse Event|0
7563508|NCT02325739|26297510|P2|Phase II Part|Adverse Event|0
7563509|NCT02325739|26297511|P1|Phase II Part|Adverse Event|0
7563510|NCT02325739|26297501|P11|Phase I Part|Death|0
7563511|NCT02325739|26297502|P10|Phase I Part|Death|0
7563512|NCT02325739|26297503|P9|Phase I Part|Death|0
7563513|NCT02325739|26297504|P8|Phase I Part|Death|0
7563514|NCT02325739|26297505|P7|Phase I Part|Death|0
7563515|NCT02325739|26297506|P6|Phase I Part|Death|0
7563516|NCT02325739|26297507|P5|Phase I Part|Death|2
7563517|NCT02325739|26297508|P4|Phase I Part|Death|0
7563518|NCT02325739|26297509|P3|Phase I Part|Death|0
7563519|NCT02325739|26297510|P2|Phase I Part|Death|0
7563520|NCT02325739|26297511|P1|Phase I Part|Death|0
7563521|NCT02325739|26297501|P11|Phase I Part|Subject/guardian decision|0
7563522|NCT02325739|26297502|P10|Phase I Part|Subject/guardian decision|0
7563523|NCT02325739|26297503|P9|Phase I Part|Subject/guardian decision|0
7563524|NCT02325739|26297504|P8|Phase I Part|Subject/guardian decision|1
7563525|NCT02325739|26297505|P7|Phase I Part|Subject/guardian decision|0
7563526|NCT02325739|26297506|P6|Phase I Part|Subject/guardian decision|0
7563527|NCT02325739|26297507|P5|Phase I Part|Subject/guardian decision|0
7563528|NCT02325739|26297508|P4|Phase I Part|Subject/guardian decision|1
7563529|NCT02325739|26297509|P3|Phase I Part|Subject/guardian decision|1
7563530|NCT02325739|26297510|P2|Phase I Part|Subject/guardian decision|0
7563531|NCT02325739|26297511|P1|Phase I Part|Subject/guardian decision|1
7563532|NCT02325739|26297501|P11|Phase I Part|Progressive disease|0
7563533|NCT02325739|26297502|P10|Phase I Part|Progressive disease|0
7563534|NCT02325739|26297503|P9|Phase I Part|Progressive disease|0
7563535|NCT02325739|26297504|P8|Phase I Part|Progressive disease|3
7563536|NCT02325739|26297505|P7|Phase I Part|Progressive disease|6
7563537|NCT02325739|26297506|P6|Phase I Part|Progressive disease|6
7563538|NCT02325739|26297507|P5|Phase I Part|Progressive disease|14
7563539|NCT02325739|26297508|P4|Phase I Part|Progressive disease|23
7563540|NCT02325739|26297509|P3|Phase I Part|Progressive disease|3
7563541|NCT02325739|26297510|P2|Phase I Part|Progressive disease|6
7563542|NCT02325739|26297511|P1|Phase I Part|Progressive disease|9
7563543|NCT02325739|26297501|P11|Phase I Part|Adverse Event|0
7563544|NCT02325739|26297502|P10|Phase I Part|Adverse Event|0
7563545|NCT02325739|26297503|P9|Phase I Part|Adverse Event|0
7563546|NCT02325739|26297504|P8|Phase I Part|Adverse Event|2
7563547|NCT02325739|26297505|P7|Phase I Part|Adverse Event|0
7563548|NCT02325739|26297506|P6|Phase I Part|Adverse Event|1
7563549|NCT02325739|26297507|P5|Phase I Part|Adverse Event|3
7563550|NCT02325739|26297508|P4|Phase I Part|Adverse Event|2
7563551|NCT02325739|26297509|P3|Phase I Part|Adverse Event|1
7563552|NCT02325739|26297510|P2|Phase I Part|Adverse Event|0
7563553|NCT02325739|26297511|P1|Phase I Part|Adverse Event|1
7563554|NCT02325713|26297641|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563555|NCT02325713|26297642|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563556|NCT02325713|26297643|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563557|NCT02325713|26297644|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563558|NCT02325713|26297645|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563559|NCT02325713|26297646|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563560|NCT02325713|26297647|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
7563561|NCT02325713|26297648|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563562|NCT02325713|26297649|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563563|NCT02325713|26297650|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563564|NCT02325713|26297651|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563565|NCT02325713|26297652|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563566|NCT02325713|26297653|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563567|NCT02325713|26297654|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563568|NCT02325713|26297655|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563569|NCT02325713|26297656|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7563570|NCT02325713|26297641|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563571|NCT02325713|26297642|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563572|NCT02325713|26297643|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563573|NCT02325713|26297644|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563574|NCT02325713|26297645|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563575|NCT02325713|26297646|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563576|NCT02325713|26297647|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563577|NCT02325713|26297648|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563578|NCT02325713|26297649|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563579|NCT02325713|26297650|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563580|NCT02325713|26297651|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563581|NCT02325713|26297652|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563582|NCT02325713|26297653|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563583|NCT02325713|26297654|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563584|NCT02325713|26297655|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7563585|NCT02325713|26297656|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
7563586|NCT02325713|26297641|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563587|NCT02325713|26297642|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563588|NCT02325713|26297643|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563589|NCT02325713|26297644|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563590|NCT02325713|26297645|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563591|NCT02325713|26297646|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
7563592|NCT02325713|26297647|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563593|NCT02325713|26297648|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563594|NCT02325713|26297649|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563595|NCT02325713|26297650|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563596|NCT02325713|26297651|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563597|NCT02325713|26297652|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563598|NCT02325713|26297653|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563599|NCT02325713|26297654|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563600|NCT02325713|26297655|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563601|NCT02325713|26297656|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7563602|NCT02325518|26297770|P2|Overall Study|Withdrawal by Subject|1
7563603|NCT02325518|26297771|P1|Overall Study|Withdrawal by Subject|0
7563604|NCT02325518|26297770|P2|Overall Study|Physician Decision|1
7563605|NCT02325518|26297771|P1|Overall Study|Physician Decision|0
7563606|NCT02325518|26297770|P2|Overall Study|Adverse Event|1
7563607|NCT02325518|26297771|P1|Overall Study|Adverse Event|4
7563608|NCT02325414|26297782|P2|Overall Study|Lost to Follow-up|5
7563609|NCT02325414|26297783|P1|Overall Study|Lost to Follow-up|5
7563610|NCT02325414|26297782|P2|Overall Study|Withdrawal by Subject|1
7563611|NCT02325414|26297783|P1|Overall Study|Withdrawal by Subject|3
7563612|NCT02325401|26297795|P3|Overall Study|Withdrawal by Subject|1
7563613|NCT02325401|26297796|P2|Overall Study|Withdrawal by Subject|1
7563614|NCT02325401|26297797|P1|Overall Study|Withdrawal by Subject|0
7563615|NCT02325219|26297820|P5|After Controlled Period (Week 16 - 52)|Pregnancy|0
7563616|NCT02325219|26297821|P4|After Controlled Period (Week 16 - 52)|Pregnancy|0
7563617|NCT02325219|26297822|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
7563618|NCT02325219|26297823|P2|After Controlled Period (Week 16 - 52)|Pregnancy|1
7563619|NCT02325219|26297824|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
7563620|NCT02325219|26297820|P5|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7563621|NCT02325219|26297821|P4|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7563622|NCT02325219|26297822|P3|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7563623|NCT02325219|26297823|P2|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
7563624|NCT02325219|26297824|P1|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7563625|NCT02325219|26297820|P5|After Controlled Period (Week 16 - 52)|Adverse Event|1
7563626|NCT02325219|26297821|P4|After Controlled Period (Week 16 - 52)|Adverse Event|0
7563627|NCT02325219|26297822|P3|After Controlled Period (Week 16 - 52)|Adverse Event|0
7563628|NCT02325219|26297823|P2|After Controlled Period (Week 16 - 52)|Adverse Event|0
7563629|NCT02325219|26297824|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
7563630|NCT02325219|26297820|P5|Controlled Period (Week 0 - 16)|Other|0
7563631|NCT02325219|26297821|P4|Controlled Period (Week 0 - 16)|Other|0
7563632|NCT02325219|26297822|P3|Controlled Period (Week 0 - 16)|Other|1
7563633|NCT02325219|26297823|P2|Controlled Period (Week 0 - 16)|Other|0
7563634|NCT02325219|26297824|P1|Controlled Period (Week 0 - 16)|Other|0
7563635|NCT02325219|26297820|P5|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7563636|NCT02325219|26297821|P4|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7563637|NCT02325219|26297822|P3|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7563638|NCT02325219|26297823|P2|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7563639|NCT02325219|26297824|P1|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
7563640|NCT02325219|26297820|P5|Controlled Period (Week 0 - 16)|Adverse Event|0
7563641|NCT02325219|26297821|P4|Controlled Period (Week 0 - 16)|Adverse Event|0
7563642|NCT02325219|26297822|P3|Controlled Period (Week 0 - 16)|Adverse Event|0
7563643|NCT02325219|26297823|P2|Controlled Period (Week 0 - 16)|Adverse Event|1
7563644|NCT02325219|26297824|P1|Controlled Period (Week 0 - 16)|Adverse Event|6
7563645|NCT02324842|26298016|P3|Overall Study|Lost to Follow-up|2
7563646|NCT02324842|26298017|P2|Overall Study|Lost to Follow-up|1
7563647|NCT02324842|26298018|P1|Overall Study|Lost to Follow-up|1
7563648|NCT02324699|26298052|P1|Overall Study|study terminated|1
7563649|NCT02324569|26298172|P2|Overall Study|Inconvenient Schedule|0
7563650|NCT02324569|26298173|P1|Overall Study|Inconvenient Schedule|2
7563651|NCT02324569|26298172|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
7563652|NCT02324569|26298173|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
7563653|NCT02324569|26298172|P2|Overall Study|Lack of Efficacy|3
7563654|NCT02324569|26298173|P1|Overall Study|Lack of Efficacy|2
7563655|NCT02324569|26298172|P2|Overall Study|Voluntary Withdrawal|6
7563656|NCT02324569|26298173|P1|Overall Study|Voluntary Withdrawal|3
7563657|NCT02324569|26298172|P2|Overall Study|Pretreatment Event/Adverse Event|10
7563658|NCT02324569|26298173|P1|Overall Study|Pretreatment Event/Adverse Event|9
7563659|NCT02324465|26298235|P2|Overall Study|device failure|1
7563660|NCT02324465|26298236|P1|Overall Study|device failure|0
7563661|NCT02324361|26298250|P2|Overall Study|Lost to Follow-up|2
7563662|NCT02324361|26298251|P1|Overall Study|Lost to Follow-up|5
7563663|NCT02324270|26298281|P3|Overall Study|Non Compliance with Study Drug|0
7563664|NCT02324270|26298282|P2|Overall Study|Non Compliance with Study Drug|2
7563665|NCT02324270|26298283|P1|Overall Study|Non Compliance with Study Drug|1
7563666|NCT02324270|26298281|P3|Overall Study|Protocol Violation|1
7563667|NCT02324270|26298282|P2|Overall Study|Protocol Violation|1
7563668|NCT02324270|26298283|P1|Overall Study|Protocol Violation|0
7563669|NCT02324270|26298281|P3|Overall Study|Lost to Follow-up|4
7563670|NCT02324270|26298282|P2|Overall Study|Lost to Follow-up|3
7563671|NCT02324270|26298283|P1|Overall Study|Lost to Follow-up|4
7563672|NCT02324270|26298281|P3|Overall Study|Withdrawal by Subject|0
7563673|NCT02324270|26298282|P2|Overall Study|Withdrawal by Subject|1
7563674|NCT02324270|26298283|P1|Overall Study|Withdrawal by Subject|0
7563675|NCT02324205|26298293|P1|Overall Study|Withdrawal by Subject|37
7563676|NCT02324153|26298305|P2|Overall Study|Developed delirium preoperatively|0
7563677|NCT02324153|26298306|P1|Overall Study|Developed delirium preoperatively|1
7563678|NCT02324153|26298305|P2|Overall Study|Surgery postponed after randomization|0
7563679|NCT02324153|26298306|P1|Overall Study|Surgery postponed after randomization|3
7563680|NCT02324153|26298305|P2|Overall Study|Withdrawal by Subject|1
7563681|NCT02324153|26298306|P1|Overall Study|Withdrawal by Subject|4
7563682|NCT02324049|26298351|P1|Part C|Study terminated|11
7563683|NCT02323646|26298364|P3|Treatment Course 2|Non-compliance|1
7563684|NCT02323646|26298365|P2|Treatment Course 2|Non-compliance|1
7563685|NCT02323646|26298366|P1|Treatment Course 2|Non-compliance|0
7563686|NCT02323646|26298364|P3|Treatment Course 2|Lost to Follow-up|1
7563687|NCT02323646|26298365|P2|Treatment Course 2|Lost to Follow-up|0
7563688|NCT02323646|26298366|P1|Treatment Course 2|Lost to Follow-up|0
7563689|NCT02323646|26298364|P3|Treatment Course 2|Adverse Event|1
7563690|NCT02323646|26298365|P2|Treatment Course 2|Adverse Event|0
7563691|NCT02323646|26298366|P1|Treatment Course 2|Adverse Event|1
7563692|NCT02323646|26298364|P3|Treatment Course 1|Withdrawal by Subject|0
7563693|NCT02323646|26298365|P2|Treatment Course 1|Withdrawal by Subject|2
7563694|NCT02323646|26298366|P1|Treatment Course 1|Withdrawal by Subject|0
7563695|NCT02323646|26298364|P3|Treatment Course 1|Lost to Follow-up|2
7563696|NCT02323646|26298365|P2|Treatment Course 1|Lost to Follow-up|0
7563697|NCT02323646|26298366|P1|Treatment Course 1|Lost to Follow-up|1
7563698|NCT02323646|26298364|P3|Treatment Course 1|Heavy Bleeding|0
7563699|NCT02323646|26298365|P2|Treatment Course 1|Heavy Bleeding|1
7563700|NCT02323646|26298366|P1|Treatment Course 1|Heavy Bleeding|1
7563701|NCT02323646|26298364|P3|Treatment Course 1|Adverse Event|1
7563702|NCT02323646|26298365|P2|Treatment Course 1|Adverse Event|0
7563703|NCT02323646|26298366|P1|Treatment Course 1|Adverse Event|1
7563704|NCT02323334|26298420|P17|Period 3|Withdrawal by Subject|0
7563705|NCT02323334|26298421|P16|Period 3|Withdrawal by Subject|0
7563706|NCT02323334|26298422|P15|Period 3|Withdrawal by Subject|0
7563707|NCT02323334|26298423|P14|Period 3|Withdrawal by Subject|0
7563708|NCT02323334|26298424|P13|Period 3|Withdrawal by Subject|0
7563709|NCT02323334|26298425|P12|Period 3|Withdrawal by Subject|0
7563710|NCT02323334|26298426|P11|Period 3|Withdrawal by Subject|0
7563711|NCT02323334|26298427|P10|Period 3|Withdrawal by Subject|0
7563712|NCT02323334|26298428|P9|Period 3|Withdrawal by Subject|0
7563713|NCT02323334|26298429|P8|Period 3|Withdrawal by Subject|0
7563714|NCT02323334|26298430|P7|Period 3|Withdrawal by Subject|0
7563715|NCT02323334|26298431|P6|Period 3|Withdrawal by Subject|0
7563716|NCT02323334|26298432|P5|Period 3|Withdrawal by Subject|0
7563717|NCT02323334|26298433|P4|Period 3|Withdrawal by Subject|0
7563718|NCT02323334|26298434|P3|Period 3|Withdrawal by Subject|0
7563719|NCT02323334|26298435|P2|Period 3|Withdrawal by Subject|0
7563720|NCT02323334|26298436|P1|Period 3|Withdrawal by Subject|1
7563721|NCT02323334|26298420|P17|Period 3|Lost to Follow-up|0
7563722|NCT02323334|26298421|P16|Period 3|Lost to Follow-up|0
7563723|NCT02323334|26298422|P15|Period 3|Lost to Follow-up|0
7563724|NCT02323334|26298423|P14|Period 3|Lost to Follow-up|0
7563725|NCT02323334|26298424|P13|Period 3|Lost to Follow-up|0
7563726|NCT02323334|26298425|P12|Period 3|Lost to Follow-up|0
7563727|NCT02323334|26298426|P11|Period 3|Lost to Follow-up|0
7563728|NCT02323334|26298427|P10|Period 3|Lost to Follow-up|0
7563729|NCT02323334|26298428|P9|Period 3|Lost to Follow-up|0
7563730|NCT02323334|26298429|P8|Period 3|Lost to Follow-up|0
7563731|NCT02323334|26298430|P7|Period 3|Lost to Follow-up|0
7563732|NCT02323334|26298431|P6|Period 3|Lost to Follow-up|0
7563733|NCT02323334|26298432|P5|Period 3|Lost to Follow-up|0
7563734|NCT02323334|26298433|P4|Period 3|Lost to Follow-up|0
7563735|NCT02323334|26298434|P3|Period 3|Lost to Follow-up|1
7563736|NCT02323334|26298435|P2|Period 3|Lost to Follow-up|0
7563737|NCT02323334|26298436|P1|Period 3|Lost to Follow-up|0
7563738|NCT02323204|26298512|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
7563739|NCT02323204|26298513|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
7563740|NCT02323204|26298514|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7563741|NCT02323204|26298515|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7563742|NCT02323204|26298512|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
7563743|NCT02323204|26298513|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
7563744|NCT02323204|26298514|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
7563745|NCT02323204|26298515|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
7563746|NCT02323204|26298512|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7563747|NCT02323204|26298513|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7563748|NCT02323204|26298514|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7563749|NCT02323204|26298515|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7563750|NCT02323204|26298512|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
7563751|NCT02323204|26298513|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
7563752|NCT02323204|26298514|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
7563753|NCT02323204|26298515|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
7563754|NCT02323204|26298512|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
7563755|NCT02323204|26298513|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7563756|NCT02323204|26298514|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
7563757|NCT02323204|26298515|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7563758|NCT02323204|26298512|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
7563759|NCT02323204|26298513|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7563760|NCT02323204|26298514|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
7563761|NCT02323204|26298515|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7563762|NCT02323204|26298512|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
7563763|NCT02323204|26298513|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
7563764|NCT02323204|26298514|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
7563765|NCT02323204|26298515|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
7563766|NCT02323204|26298512|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
7563767|NCT02323204|26298513|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
7563768|NCT02323204|26298514|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
7563769|NCT02323204|26298515|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
7563770|NCT02323204|26298512|P4|Baseline Survey Completion|Withdrawal by Subject|3
7563771|NCT02323204|26298513|P3|Baseline Survey Completion|Withdrawal by Subject|5
7563772|NCT02323204|26298514|P2|Baseline Survey Completion|Withdrawal by Subject|9
7563773|NCT02323204|26298515|P1|Baseline Survey Completion|Withdrawal by Subject|10
7563774|NCT02323126|26298567|P2|Overall Study|Adverse Event|6
7563775|NCT02323126|26298568|P1|Overall Study|Adverse Event|5
7563776|NCT02323126|26298567|P2|Overall Study|Death|4
7563777|NCT02323126|26298568|P1|Overall Study|Death|1
7563778|NCT02323126|26298567|P2|Overall Study|Physician Decision|3
7563779|NCT02323126|26298568|P1|Overall Study|Physician Decision|0
7563780|NCT02323126|26298567|P2|Overall Study|progressive disease|15
7563781|NCT02323126|26298568|P1|Overall Study|progressive disease|8
7563782|NCT02323126|26298567|P2|Overall Study|study terminated by sponsor|0
7563783|NCT02323126|26298568|P1|Overall Study|study terminated by sponsor|1
7563784|NCT02323126|26298567|P2|Overall Study|subject / guardian decision|1
7563785|NCT02323126|26298568|P1|Overall Study|subject / guardian decision|1
7563786|NCT02323126|26298567|P2|Overall Study|ongoing|1
7563787|NCT02323126|26298568|P1|Overall Study|ongoing|0
7563788|NCT02323113|26298582|P8|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563789|NCT02323113|26298583|P7|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563790|NCT02323113|26298584|P6|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563791|NCT02323113|26298585|P5|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563792|NCT02323113|26298586|P4|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563793|NCT02323113|26298587|P3|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563794|NCT02323113|26298588|P2|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
7563795|NCT02323113|26298589|P1|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7563796|NCT02323113|26298582|P8|Overall Study|Unsatisfactory Therapeutic Response|0
7563797|NCT02323113|26298583|P7|Overall Study|Unsatisfactory Therapeutic Response|0
7563798|NCT02323113|26298584|P6|Overall Study|Unsatisfactory Therapeutic Response|2
7563799|NCT02323113|26298585|P5|Overall Study|Unsatisfactory Therapeutic Response|0
7563800|NCT02323113|26298586|P4|Overall Study|Unsatisfactory Therapeutic Response|0
7563801|NCT02323113|26298587|P3|Overall Study|Unsatisfactory Therapeutic Response|0
7563802|NCT02323113|26298588|P2|Overall Study|Unsatisfactory Therapeutic Response|2
7563803|NCT02323113|26298589|P1|Overall Study|Unsatisfactory Therapeutic Response|1
7563804|NCT02323113|26298582|P8|Overall Study|Symptomatic Deterioration|0
7563805|NCT02323113|26298583|P7|Overall Study|Symptomatic Deterioration|0
7563806|NCT02323113|26298584|P6|Overall Study|Symptomatic Deterioration|0
7563807|NCT02323113|26298585|P5|Overall Study|Symptomatic Deterioration|1
7563808|NCT02323113|26298586|P4|Overall Study|Symptomatic Deterioration|0
7563809|NCT02323113|26298587|P3|Overall Study|Symptomatic Deterioration|1
7563810|NCT02323113|26298588|P2|Overall Study|Symptomatic Deterioration|0
7563811|NCT02323113|26298589|P1|Overall Study|Symptomatic Deterioration|0
7563812|NCT02323113|26298582|P8|Overall Study|Progressive Disease|0
7563813|NCT02323113|26298583|P7|Overall Study|Progressive Disease|0
7563814|NCT02323113|26298584|P6|Overall Study|Progressive Disease|3
7563815|NCT02323113|26298585|P5|Overall Study|Progressive Disease|0
7563816|NCT02323113|26298586|P4|Overall Study|Progressive Disease|0
7563817|NCT02323113|26298587|P3|Overall Study|Progressive Disease|1
7563818|NCT02323113|26298588|P2|Overall Study|Progressive Disease|1
7563819|NCT02323113|26298589|P1|Overall Study|Progressive Disease|0
7563820|NCT02323113|26298582|P8|Overall Study|Adverse Event|0
7563821|NCT02323113|26298583|P7|Overall Study|Adverse Event|6
7563822|NCT02323113|26298584|P6|Overall Study|Adverse Event|3
7563823|NCT02323113|26298585|P5|Overall Study|Adverse Event|8
7563824|NCT02323113|26298586|P4|Overall Study|Adverse Event|5
7563825|NCT02323113|26298587|P3|Overall Study|Adverse Event|2
7563826|NCT02323113|26298588|P2|Overall Study|Adverse Event|3
7563827|NCT02323113|26298589|P1|Overall Study|Adverse Event|3
7563828|NCT02322892|26298699|P2|Overall Study|Protocol Violation|0
7563829|NCT02322892|26298700|P1|Overall Study|Protocol Violation|1
7563830|NCT02322892|26298699|P2|Overall Study|Met exclusion criteria|1
7563831|NCT02322892|26298700|P1|Overall Study|Met exclusion criteria|0
7563832|NCT02322892|26298699|P2|Overall Study|Surgery cancelled|2
7563833|NCT02322892|26298700|P1|Overall Study|Surgery cancelled|1
7563834|NCT02322879|26298716|P2|First Intervention|Physician Decision|0
7563835|NCT02322879|26298717|P1|First Intervention|Physician Decision|1
7563836|NCT02322866|26298725|P2|Overall Study|Other Miscellaneous Reasons|6
7563837|NCT02322866|26298726|P1|Overall Study|Other Miscellaneous Reasons|6
7563838|NCT02322866|26298725|P2|Overall Study|Lack of Efficacy|1
7563839|NCT02322866|26298726|P1|Overall Study|Lack of Efficacy|3
7563840|NCT02322866|26298725|P2|Overall Study|Noncompliance with Treatment|4
7563841|NCT02322866|26298726|P1|Overall Study|Noncompliance with Treatment|3
7563842|NCT02322866|26298725|P2|Overall Study|Protocol Violation|0
7563843|NCT02322866|26298726|P1|Overall Study|Protocol Violation|1
7563844|NCT02322866|26298725|P2|Overall Study|Lost to Follow-up|39
7563845|NCT02322866|26298726|P1|Overall Study|Lost to Follow-up|36
7563846|NCT02322866|26298725|P2|Overall Study|Withdrawal of Consent|25
7563847|NCT02322866|26298726|P1|Overall Study|Withdrawal of Consent|16
7563848|NCT02322866|26298725|P2|Overall Study|Adverse Event|11
7563849|NCT02322866|26298726|P1|Overall Study|Adverse Event|6
7563850|NCT02322814|26298753|P5|Overall Study|Withdrawal by Subject|3
7563851|NCT02322814|26298754|P4|Overall Study|Withdrawal by Subject|1
7563852|NCT02322814|26298755|P3|Overall Study|Withdrawal by Subject|2
7563853|NCT02322814|26298756|P2|Overall Study|Withdrawal by Subject|4
7563854|NCT02322814|26298757|P1|Overall Study|Withdrawal by Subject|5
7563855|NCT02322814|26298753|P5|Overall Study|Death|6
7563856|NCT02322814|26298754|P4|Overall Study|Death|10
7563857|NCT02322814|26298755|P3|Overall Study|Death|30
7563858|NCT02322814|26298756|P2|Overall Study|Death|22
7563859|NCT02322814|26298757|P1|Overall Study|Death|7
7563860|NCT02322814|26298753|P5|Overall Study|Protocol Violation|0
7563861|NCT02322814|26298754|P4|Overall Study|Protocol Violation|0
7563862|NCT02322814|26298755|P3|Overall Study|Protocol Violation|0
7563863|NCT02322814|26298756|P2|Overall Study|Protocol Violation|0
7563864|NCT02322814|26298757|P1|Overall Study|Protocol Violation|1
7563865|NCT02322814|26298753|P5|Overall Study|Other|0
7563866|NCT02322814|26298754|P4|Overall Study|Other|0
7563867|NCT02322814|26298755|P3|Overall Study|Other|0
7563868|NCT02322814|26298756|P2|Overall Study|Other|0
7563869|NCT02322814|26298757|P1|Overall Study|Other|2
7563870|NCT02322814|26298753|P5|Overall Study|Lost to Follow-up|0
7563871|NCT02322814|26298754|P4|Overall Study|Lost to Follow-up|0
7563872|NCT02322814|26298755|P3|Overall Study|Lost to Follow-up|1
7563873|NCT02322814|26298756|P2|Overall Study|Lost to Follow-up|2
7563874|NCT02322814|26298757|P1|Overall Study|Lost to Follow-up|1
7563875|NCT02322814|26298753|P5|Overall Study|Progressive Disease|0
7563876|NCT02322814|26298754|P4|Overall Study|Progressive Disease|1
7563877|NCT02322814|26298755|P3|Overall Study|Progressive Disease|0
7563878|NCT02322814|26298756|P2|Overall Study|Progressive Disease|2
7563879|NCT02322814|26298757|P1|Overall Study|Progressive Disease|0
7563880|NCT02322814|26298753|P5|Overall Study|Ongoing Study|22
7563881|NCT02322814|26298754|P4|Overall Study|Ongoing Study|20
7563882|NCT02322814|26298755|P3|Overall Study|Ongoing Study|14
7563883|NCT02322814|26298756|P2|Overall Study|Ongoing Study|13
7563884|NCT02322814|26298757|P1|Overall Study|Ongoing Study|0
7563885|NCT02322775|26298783|P2|Overall Study|Not willing to perform all FU visits|1
7563886|NCT02322775|26298784|P1|Overall Study|Not willing to perform all FU visits|0
7563887|NCT02322775|26298783|P2|Overall Study|Withdrawal by Subject|4
7563888|NCT02322775|26298784|P1|Overall Study|Withdrawal by Subject|3
7563889|NCT02322775|26298783|P2|Overall Study|Protocol Violation|0
7563890|NCT02322775|26298784|P1|Overall Study|Protocol Violation|1
7563891|NCT02322775|26298783|P2|Overall Study|Lost to Follow-up|1
7563892|NCT02322775|26298784|P1|Overall Study|Lost to Follow-up|0
7563893|NCT02322775|26298783|P2|Overall Study|Adverse Event|0
7563894|NCT02322775|26298784|P1|Overall Study|Adverse Event|1
7563895|NCT02322749|26298810|P6|Period 3|Withdrawal by Subject|0
7563896|NCT02322749|26298811|P5|Period 3|Withdrawal by Subject|0
7563897|NCT02322749|26298812|P4|Period 3|Withdrawal by Subject|0
7563898|NCT02322749|26298813|P3|Period 3|Withdrawal by Subject|1
7563899|NCT02322749|26298814|P2|Period 3|Withdrawal by Subject|0
7563900|NCT02322749|26298815|P1|Period 3|Withdrawal by Subject|0
7563901|NCT02322749|26298810|P6|Period 2|Withdrawal by Subject|0
7563902|NCT02322749|26298811|P5|Period 2|Withdrawal by Subject|0
7563903|NCT02322749|26298812|P4|Period 2|Withdrawal by Subject|1
7563904|NCT02322749|26298813|P3|Period 2|Withdrawal by Subject|0
7563905|NCT02322749|26298814|P2|Period 2|Withdrawal by Subject|0
7563906|NCT02322749|26298815|P1|Period 2|Withdrawal by Subject|0
7563907|NCT02322749|26298810|P6|Period 2|Adverse Event|0
7563908|NCT02322749|26298811|P5|Period 2|Adverse Event|0
7563909|NCT02322749|26298812|P4|Period 2|Adverse Event|1
7563910|NCT02322749|26298813|P3|Period 2|Adverse Event|0
7563911|NCT02322749|26298814|P2|Period 2|Adverse Event|0
7563912|NCT02322749|26298815|P1|Period 2|Adverse Event|0
7563913|NCT02322710|26298840|P2|Overall Study|Protocol Violation|25
7563914|NCT02322710|26298841|P1|Overall Study|Protocol Violation|20
7563915|NCT02322710|26298840|P2|Overall Study|No efficacy assessment post-baseline|1
7563916|NCT02322710|26298841|P1|Overall Study|No efficacy assessment post-baseline|0
7563917|NCT02322411|26298854|P2|Overall Study|Withdrawal by Subject|0
7563918|NCT02322411|26298855|P1|Overall Study|Withdrawal by Subject|1
7563919|NCT02322411|26298854|P2|Overall Study|Lost to Follow-up|7
7563920|NCT02322411|26298855|P1|Overall Study|Lost to Follow-up|4
7563921|NCT02322281|26298924|P3|Overall Study|Miscellaneous|4
7563922|NCT02322281|26298925|P2|Overall Study|Miscellaneous|0
7563923|NCT02322281|26298926|P1|Overall Study|Miscellaneous|0
7563924|NCT02322281|26298924|P3|Overall Study|Missing|1
7563925|NCT02322281|26298925|P2|Overall Study|Missing|0
7563926|NCT02322281|26298926|P1|Overall Study|Missing|0
7563927|NCT02322281|26298924|P3|Overall Study|Study Terminated by Sponsor|0
7563928|NCT02322281|26298925|P2|Overall Study|Study Terminated by Sponsor|0
7563929|NCT02322281|26298926|P1|Overall Study|Study Terminated by Sponsor|2
7563930|NCT02322281|26298924|P3|Overall Study|Physician Decision|5
7563931|NCT02322281|26298925|P2|Overall Study|Physician Decision|0
7563932|NCT02322281|26298926|P1|Overall Study|Physician Decision|2
7563933|NCT02322281|26298924|P3|Overall Study|Withdrawal by Subject|6
7563934|NCT02322281|26298925|P2|Overall Study|Withdrawal by Subject|1
7563935|NCT02322281|26298926|P1|Overall Study|Withdrawal by Subject|1
7563936|NCT02322281|26298924|P3|Overall Study|Death|3
7563937|NCT02322281|26298925|P2|Overall Study|Death|3
7563938|NCT02322281|26298926|P1|Overall Study|Death|3
7563939|NCT02322281|26298924|P3|Overall Study|Adverse Event|6
7563940|NCT02322281|26298925|P2|Overall Study|Adverse Event|4
7563941|NCT02322281|26298926|P1|Overall Study|Adverse Event|3
7563942|NCT02322281|26298924|P3|Overall Study|Progressive Disease|49
7563943|NCT02322281|26298925|P2|Overall Study|Progressive Disease|14
7563944|NCT02322281|26298926|P1|Overall Study|Progressive Disease|42
7563945|NCT02322229|26298974|P1|Overall Study|Physician Decision|2
7563946|NCT02322216|26298986|P2|Overall Study|Withdrawal by Subject|4
7563947|NCT02322216|26298987|P1|Overall Study|Withdrawal by Subject|1
7563948|NCT02322216|26298986|P2|Overall Study|Adverse Event|0
7563949|NCT02322216|26298987|P1|Overall Study|Adverse Event|1
7563950|NCT02322190|26298994|P2|Overall Study|Death on study|0
7563951|NCT02322190|26298995|P1|Overall Study|Death on study|1
7563952|NCT02322125|26299003|P1|Overall Study|Withdrawal by Subject|2
7563953|NCT02322047|26299019|P4|Overall Study|Lost to Follow-up|1
7563954|NCT02322047|26299020|P3|Overall Study|Lost to Follow-up|1
7563955|NCT02322047|26299021|P2|Overall Study|Lost to Follow-up|0
7563956|NCT02322047|26299022|P1|Overall Study|Lost to Follow-up|0
7563957|NCT02322047|26299019|P4|Overall Study|Adverse Event|0
7563958|NCT02322047|26299020|P3|Overall Study|Adverse Event|0
7563959|NCT02322047|26299021|P2|Overall Study|Adverse Event|1
7563960|NCT02322047|26299022|P1|Overall Study|Adverse Event|0
7563961|NCT02322047|26299019|P4|Overall Study|Withdrawal by Subject|1
7563962|NCT02322047|26299020|P3|Overall Study|Withdrawal by Subject|0
7563963|NCT02322047|26299021|P2|Overall Study|Withdrawal by Subject|0
7563964|NCT02322047|26299022|P1|Overall Study|Withdrawal by Subject|1
7563965|NCT02322047|26299019|P4|Overall Study|Physician Decision|0
7563966|NCT02322047|26299020|P3|Overall Study|Physician Decision|0
7563967|NCT02322047|26299021|P2|Overall Study|Physician Decision|0
7563968|NCT02322047|26299022|P1|Overall Study|Physician Decision|1
7563969|NCT02322021|26299048|P5|Extension Phase|Study terminated by sponsor|28
7563970|NCT02322021|26299049|P4|Extension Phase|Study terminated by sponsor|0
7563971|NCT02322021|26299050|P3|Extension Phase|Study terminated by sponsor|0
7563972|NCT02322021|26299051|P2|Extension Phase|Study terminated by sponsor|0
7563973|NCT02322021|26299052|P1|Extension Phase|Study terminated by sponsor|0
7563974|NCT02322021|26299048|P5|Extension Phase|Lost to Follow-up|1
7563975|NCT02322021|26299049|P4|Extension Phase|Lost to Follow-up|0
7563976|NCT02322021|26299050|P3|Extension Phase|Lost to Follow-up|0
7563977|NCT02322021|26299051|P2|Extension Phase|Lost to Follow-up|0
7563978|NCT02322021|26299052|P1|Extension Phase|Lost to Follow-up|0
7563979|NCT02322021|26299048|P5|Extension Phase|Other|3
7563980|NCT02322021|26299049|P4|Extension Phase|Other|0
7563981|NCT02322021|26299050|P3|Extension Phase|Other|0
7563982|NCT02322021|26299051|P2|Extension Phase|Other|0
7563983|NCT02322021|26299052|P1|Extension Phase|Other|0
7563984|NCT02322021|26299048|P5|Extension Phase|Participant Choice|6
7563985|NCT02322021|26299049|P4|Extension Phase|Participant Choice|0
7563986|NCT02322021|26299050|P3|Extension Phase|Participant Choice|0
7563987|NCT02322021|26299051|P2|Extension Phase|Participant Choice|0
7563988|NCT02322021|26299052|P1|Extension Phase|Participant Choice|0
7563989|NCT02322021|26299048|P5|Extension Phase|Adverse Event|3
7563990|NCT02322021|26299049|P4|Extension Phase|Adverse Event|0
7563991|NCT02322021|26299050|P3|Extension Phase|Adverse Event|0
7563992|NCT02322021|26299051|P2|Extension Phase|Adverse Event|0
7563993|NCT02322021|26299052|P1|Extension Phase|Adverse Event|0
7563994|NCT02322021|26299048|P5|Core Phase|Other|0
7563995|NCT02322021|26299049|P4|Core Phase|Other|0
7563996|NCT02322021|26299050|P3|Core Phase|Other|1
7563997|NCT02322021|26299051|P2|Core Phase|Other|0
7563998|NCT02322021|26299052|P1|Core Phase|Other|0
7563999|NCT02322021|26299048|P5|Core Phase|Lost to Follow-up|0
7564000|NCT02322021|26299049|P4|Core Phase|Lost to Follow-up|1
7564001|NCT02322021|26299050|P3|Core Phase|Lost to Follow-up|0
7564002|NCT02322021|26299051|P2|Core Phase|Lost to Follow-up|0
7564003|NCT02322021|26299052|P1|Core Phase|Lost to Follow-up|0
7564004|NCT02322021|26299048|P5|Core Phase|Participant Choice|0
7564005|NCT02322021|26299049|P4|Core Phase|Participant Choice|2
7564006|NCT02322021|26299050|P3|Core Phase|Participant Choice|4
7564007|NCT02322021|26299051|P2|Core Phase|Participant Choice|5
7564008|NCT02322021|26299052|P1|Core Phase|Participant Choice|4
7564009|NCT02322021|26299048|P5|Core Phase|Adverse Event|0
7564010|NCT02322021|26299049|P4|Core Phase|Adverse Event|2
7564011|NCT02322021|26299050|P3|Core Phase|Adverse Event|4
7564012|NCT02322021|26299051|P2|Core Phase|Adverse Event|3
7564013|NCT02322021|26299052|P1|Core Phase|Adverse Event|1
7564014|NCT02321930|26299101|P1|Overall Study|Lost to Follow-up|1
7564015|NCT02321800|26299111|P2|Overall Study|Other, Miscellaneous|1
7564016|NCT02321800|26299112|P1|Overall Study|Other, Miscellaneous|3
7564017|NCT02321800|26299111|P2|Overall Study|Adverse Event|3
7564018|NCT02321800|26299112|P1|Overall Study|Adverse Event|2
7564019|NCT02321800|26299111|P2|Overall Study|Lost to Follow-up|4
7564020|NCT02321800|26299112|P1|Overall Study|Lost to Follow-up|10
7564021|NCT02321800|26299111|P2|Overall Study|Protocol Violation|0
7564022|NCT02321800|26299112|P1|Overall Study|Protocol Violation|1
7564023|NCT02321800|26299111|P2|Overall Study|Death|0
7564024|NCT02321800|26299112|P1|Overall Study|Death|1
7564025|NCT02321800|26299111|P2|Overall Study|Withdrawal by Subject|3
7564026|NCT02321800|26299112|P1|Overall Study|Withdrawal by Subject|3
7564027|NCT02321514|26299199|P1|Overall Study|Study Exit|3
7564028|NCT02321514|26299199|P1|Overall Study|Missed Visit|7
7564029|NCT02321514|26299199|P1|Overall Study|Death|15
7564030|NCT02321462|26299206|P2|Overall Study|Subject withdrawn before any treatment|1
7564031|NCT02321462|26299207|P1|Overall Study|Subject withdrawn before any treatment|1
7564032|NCT02321462|26299206|P2|Overall Study|Withdrawal by Subject|2
7564033|NCT02321462|26299207|P1|Overall Study|Withdrawal by Subject|5
7564034|NCT02321436|26299229|P2|Overall Study|Lost to Follow-up|1
7564035|NCT02321436|26299230|P1|Overall Study|Lost to Follow-up|0
7564036|NCT02321436|26299229|P2|Overall Study|Withdrawal by Subject|0
7564037|NCT02321436|26299230|P1|Overall Study|Withdrawal by Subject|1
7564038|NCT02321319|26299246|P1|Overall Study|Product discontinued|5
7564039|NCT02321098|26299278|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
7564040|NCT02321098|26299279|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
7564041|NCT02321098|26299280|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
7564042|NCT02321098|26299278|P3|Additional 15 Months Treatment|Lost to Follow-up|1
7564043|NCT02321098|26299279|P2|Additional 15 Months Treatment|Lost to Follow-up|0
7564044|NCT02321098|26299280|P1|Additional 15 Months Treatment|Lost to Follow-up|0
7564045|NCT02321098|26299278|P3|Additional 15 Months Treatment|Lack of Efficacy|6
7564046|NCT02321098|26299279|P2|Additional 15 Months Treatment|Lack of Efficacy|0
7564047|NCT02321098|26299280|P1|Additional 15 Months Treatment|Lack of Efficacy|0
7564048|NCT02321098|26299278|P3|12 Weeks Treament|Lost to Follow-up|0
7564049|NCT02321098|26299279|P2|12 Weeks Treament|Lost to Follow-up|1
7564050|NCT02321098|26299280|P1|12 Weeks Treament|Lost to Follow-up|1
7564051|NCT02320903|26299292|P3|Overall Study|Lost to Follow-up|5
7564052|NCT02320903|26299293|P2|Overall Study|Lost to Follow-up|5
7564053|NCT02320903|26299294|P1|Overall Study|Lost to Follow-up|0
7564054|NCT02320903|26299292|P3|Overall Study|Exited therapy; no longer eligible|2
7564055|NCT02320903|26299293|P2|Overall Study|Exited therapy; no longer eligible|2
7564056|NCT02320903|26299294|P1|Overall Study|Exited therapy; no longer eligible|8
7564057|NCT02320903|26299292|P3|Overall Study|Withdrawal by Subject|9
7564058|NCT02320903|26299293|P2|Overall Study|Withdrawal by Subject|9
7564059|NCT02320903|26299294|P1|Overall Study|Withdrawal by Subject|0
7564060|NCT02320721|26299419|P2|Overall Study|Other than specified above|20
7564061|NCT02320721|26299420|P1|Overall Study|Other than specified above|15
7564062|NCT02320721|26299419|P2|Overall Study|Hypoglycemia|0
7564063|NCT02320721|26299420|P1|Overall Study|Hypoglycemia|1
7564064|NCT02320721|26299419|P2|Overall Study|Randomized but not treated|1
7564065|NCT02320721|26299420|P1|Overall Study|Randomized but not treated|0
7564066|NCT02320721|26299419|P2|Overall Study|Poor compliance to protocol|7
7564067|NCT02320721|26299420|P1|Overall Study|Poor compliance to protocol|3
7564068|NCT02320721|26299419|P2|Overall Study|Lack of Efficacy|0
7564069|NCT02320721|26299420|P1|Overall Study|Lack of Efficacy|2
7564070|NCT02320721|26299419|P2|Overall Study|Adverse Event|6
7564071|NCT02320721|26299420|P1|Overall Study|Adverse Event|6
7564072|NCT02320487|26299475|P1|Overall Study|Adverse Event|11
7564073|NCT02320487|26299475|P1|Overall Study|Death|3
7564074|NCT02320487|26299475|P1|Overall Study|Withdrawal by Subject|1
7564075|NCT02320487|26299475|P1|Overall Study|Physician Decision|5
7564076|NCT02320487|26299475|P1|Overall Study|Reason not Specified|1
7564077|NCT02320396|26299495|P2|Overall Study|Withdrawal by Subject|0
7564078|NCT02320396|26299496|P1|Overall Study|Withdrawal by Subject|2
7564079|NCT02320396|26299495|P2|Overall Study|Protocol Violation|1
7564080|NCT02320396|26299496|P1|Overall Study|Protocol Violation|0
7564081|NCT02320396|26299495|P2|Overall Study|Pregnancy|1
7564082|NCT02320396|26299496|P1|Overall Study|Pregnancy|0
7564083|NCT02320396|26299495|P2|Overall Study|Adverse Event|2
7564084|NCT02320396|26299496|P1|Overall Study|Adverse Event|2
7564085|NCT02320253|26299529|P3|Overall Study|Death|1
7564086|NCT02320253|26299530|P2|Overall Study|Death|0
7564087|NCT02320253|26299531|P1|Overall Study|Death|1
7564088|NCT02320253|26299529|P3|Overall Study|Lost to Follow-up|1
7564089|NCT02320253|26299530|P2|Overall Study|Lost to Follow-up|2
7564090|NCT02320253|26299531|P1|Overall Study|Lost to Follow-up|2
7564091|NCT02320253|26299529|P3|Overall Study|Withdrawal by Subject|0
7564092|NCT02320253|26299530|P2|Overall Study|Withdrawal by Subject|0
7564093|NCT02320253|26299531|P1|Overall Study|Withdrawal by Subject|3
7564094|NCT02320149|26299595|P2|Overall Study|Other Miscellaneous Reasons|3
7564095|NCT02320149|26299596|P1|Overall Study|Other Miscellaneous Reasons|2
7564096|NCT02320149|26299595|P2|Overall Study|Lack of Efficacy|1
7564097|NCT02320149|26299596|P1|Overall Study|Lack of Efficacy|0
7564098|NCT02320149|26299595|P2|Overall Study|Noncompliance with Study Treatment|2
7564099|NCT02320149|26299596|P1|Overall Study|Noncompliance with Study Treatment|7
7564100|NCT02320149|26299595|P2|Overall Study|Protocol Violation|1
7564101|NCT02320149|26299596|P1|Overall Study|Protocol Violation|2
7564102|NCT02320149|26299595|P2|Overall Study|Lost to Follow-up|34
7564103|NCT02320149|26299596|P1|Overall Study|Lost to Follow-up|21
7564104|NCT02320149|26299595|P2|Overall Study|Withdrawal of Consent|32
7564105|NCT02320149|26299596|P1|Overall Study|Withdrawal of Consent|28
7564106|NCT02320149|26299595|P2|Overall Study|Adverse Event|7
7564107|NCT02320149|26299596|P1|Overall Study|Adverse Event|3
7564108|NCT02320123|26299636|P2|Overall Study|Death|5
7564109|NCT02320123|26299637|P1|Overall Study|Death|6
7564110|NCT02320123|26299636|P2|Overall Study|Lost to Follow-up|6
7564111|NCT02320123|26299637|P1|Overall Study|Lost to Follow-up|4
7564112|NCT02320058|26299661|P2|Overall Study|Not reported|0
7564113|NCT02320058|26299662|P1|Overall Study|Not reported|1
7564114|NCT02320058|26299661|P2|Overall Study|Withdrawal by Subject|2
7564115|NCT02320058|26299662|P1|Overall Study|Withdrawal by Subject|8
7564116|NCT02320058|26299661|P2|Overall Study|Other reasons|1
7564117|NCT02320058|26299662|P1|Overall Study|Other reasons|4
7564118|NCT02320058|26299661|P2|Overall Study|Lost to Follow-up|0
7564119|NCT02320058|26299662|P1|Overall Study|Lost to Follow-up|4
7564120|NCT02320058|26299661|P2|Overall Study|Death|10
7564121|NCT02320058|26299662|P1|Overall Study|Death|25
7564122|NCT02319759|26299763|P5|Week 24 - 56|Lost to Follow-up|1
7564123|NCT02319759|26299764|P4|Week 24 - 56|Lost to Follow-up|0
7564124|NCT02319759|26299765|P3|Week 24 - 56|Lost to Follow-up|0
7564125|NCT02319759|26299766|P2|Week 24 - 56|Lost to Follow-up|0
7564126|NCT02319759|26299767|P1|Week 24 - 56|Lost to Follow-up|0
7564127|NCT02319759|26299763|P5|Week 24 - 56|Withdrawal by Subject|0
7564128|NCT02319759|26299764|P4|Week 24 - 56|Withdrawal by Subject|0
7564129|NCT02319759|26299765|P3|Week 24 - 56|Withdrawal by Subject|0
7564130|NCT02319759|26299766|P2|Week 24 - 56|Withdrawal by Subject|1
7564131|NCT02319759|26299767|P1|Week 24 - 56|Withdrawal by Subject|0
7564132|NCT02319759|26299763|P5|Week 24 - 56|Lack of Efficacy|1
7564133|NCT02319759|26299764|P4|Week 24 - 56|Lack of Efficacy|2
7564134|NCT02319759|26299765|P3|Week 24 - 56|Lack of Efficacy|0
7564135|NCT02319759|26299766|P2|Week 24 - 56|Lack of Efficacy|0
7564136|NCT02319759|26299767|P1|Week 24 - 56|Lack of Efficacy|0
7564137|NCT02319759|26299763|P5|Week 24 - 56|Adverse Event|0
7564138|NCT02319759|26299764|P4|Week 24 - 56|Adverse Event|0
7564139|NCT02319759|26299765|P3|Week 24 - 56|Adverse Event|2
7564140|NCT02319759|26299766|P2|Week 24 - 56|Adverse Event|0
7564141|NCT02319759|26299767|P1|Week 24 - 56|Adverse Event|0
7564142|NCT02319759|26299763|P5|Week 16 - 24|Withdrawal by Subject|0
7564143|NCT02319759|26299764|P4|Week 16 - 24|Withdrawal by Subject|0
7564144|NCT02319759|26299765|P3|Week 16 - 24|Withdrawal by Subject|2
7564145|NCT02319759|26299766|P2|Week 16 - 24|Withdrawal by Subject|0
7564146|NCT02319759|26299767|P1|Week 16 - 24|Withdrawal by Subject|0
7564147|NCT02319759|26299763|P5|Week 16 - 24|Lost to Follow-up|0
7564148|NCT02319759|26299764|P4|Week 16 - 24|Lost to Follow-up|0
7564149|NCT02319759|26299765|P3|Week 16 - 24|Lost to Follow-up|0
7564150|NCT02319759|26299766|P2|Week 16 - 24|Lost to Follow-up|0
7564151|NCT02319759|26299767|P1|Week 16 - 24|Lost to Follow-up|1
7564152|NCT02319759|26299763|P5|Week 16 - 24|Lack of Efficacy|0
7564153|NCT02319759|26299764|P4|Week 16 - 24|Lack of Efficacy|0
7564154|NCT02319759|26299765|P3|Week 16 - 24|Lack of Efficacy|1
7564155|NCT02319759|26299766|P2|Week 16 - 24|Lack of Efficacy|0
7564156|NCT02319759|26299767|P1|Week 16 - 24|Lack of Efficacy|1
7564157|NCT02319759|26299763|P5|Week 0 - 16|Not met all Inclusion Criteria|0
7564158|NCT02319759|26299764|P4|Week 0 - 16|Not met all Inclusion Criteria|0
7564159|NCT02319759|26299765|P3|Week 0 - 16|Not met all Inclusion Criteria|1
7564160|NCT02319759|26299766|P2|Week 0 - 16|Not met all Inclusion Criteria|0
7564161|NCT02319759|26299767|P1|Week 0 - 16|Not met all Inclusion Criteria|0
7564162|NCT02319759|26299763|P5|Week 0 - 16|Lack of Efficacy|0
7564163|NCT02319759|26299764|P4|Week 0 - 16|Lack of Efficacy|0
7564164|NCT02319759|26299765|P3|Week 0 - 16|Lack of Efficacy|0
7564165|NCT02319759|26299766|P2|Week 0 - 16|Lack of Efficacy|0
7564166|NCT02319759|26299767|P1|Week 0 - 16|Lack of Efficacy|1
7564167|NCT02319668|26299864|P2|Overall Study|Other (Not specified)|2
7564168|NCT02319668|26299865|P1|Overall Study|Other (Not specified)|0
7564169|NCT02319642|26299879|P2|Overall Study|Withdrawal by Subject|1
7564170|NCT02319642|26299880|P1|Overall Study|Withdrawal by Subject|1
7564171|NCT02319642|26299879|P2|Overall Study|Lack of Efficacy|1
7564172|NCT02319642|26299880|P1|Overall Study|Lack of Efficacy|1
7564173|NCT02319642|26299879|P2|Overall Study|Adverse Event|4
7564174|NCT02319642|26299880|P1|Overall Study|Adverse Event|2
7564175|NCT02319525|26299900|P2|Overall Study|Withdrawal by Subject|1
7564176|NCT02319525|26299901|P1|Overall Study|Withdrawal by Subject|2
7564177|NCT02319148|26300058|P4|Second Intervention Period|Other|1
7564178|NCT02319148|26300059|P3|Second Intervention Period|Other|0
7564179|NCT02319148|26300060|P2|Second Intervention Period|Other|0
7564180|NCT02319148|26300061|P1|Second Intervention Period|Other|0
7564181|NCT02319148|26300058|P4|Second Intervention Period|No longer willing to participate|0
7564182|NCT02319148|26300059|P3|Second Intervention Period|No longer willing to participate|0
7564183|NCT02319148|26300060|P2|Second Intervention Period|No longer willing to participate|1
7564184|NCT02319148|26300061|P1|Second Intervention Period|No longer willing to participate|0
7564185|NCT02319148|26300058|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
7564186|NCT02319148|26300059|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
7564187|NCT02319148|26300060|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
7564188|NCT02319148|26300061|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
7564189|NCT02319044|26300124|P3|Overall Study|Not treated|2
7564190|NCT02319044|26300125|P2|Overall Study|Not treated|2
7564191|NCT02319044|26300126|P1|Overall Study|Not treated|0
7564192|NCT02319044|26300124|P3|Overall Study|Study specific discontinuation criteria|1
7564193|NCT02319044|26300125|P2|Overall Study|Study specific discontinuation criteria|2
7564194|NCT02319044|26300126|P1|Overall Study|Study specific discontinuation criteria|2
7564195|NCT02319044|26300124|P3|Overall Study|Adverse Event|8
7564196|NCT02319044|26300125|P2|Overall Study|Adverse Event|2
7564197|NCT02319044|26300126|P1|Overall Study|Adverse Event|17
7564198|NCT02319044|26300124|P3|Overall Study|Condition under investigation worsened|46
7564199|NCT02319044|26300125|P2|Overall Study|Condition under investigation worsened|50
7564200|NCT02319044|26300126|P1|Overall Study|Condition under investigation worsened|100
7564201|NCT02319044|26300124|P3|Overall Study|Withdrawal by Subject|6
7564202|NCT02319044|26300125|P2|Overall Study|Withdrawal by Subject|3
7564203|NCT02319044|26300126|P1|Overall Study|Withdrawal by Subject|3
7564204|NCT02319044|26300124|P3|Overall Study|Death, PI/sponsor decision, med history|4
7564205|NCT02319044|26300125|P2|Overall Study|Death, PI/sponsor decision, med history|1
7564206|NCT02319044|26300126|P1|Overall Study|Death, PI/sponsor decision, med history|0
7564207|NCT02319031|26300182|P2|Treatment Period|Death|0
7564208|NCT02319031|26300183|P1|Treatment Period|Death|1
7564209|NCT02318940|26300247|P2|Overall Study|lost the record|0
7564210|NCT02318940|26300248|P1|Overall Study|lost the record|1
7564211|NCT02318797|26300290|P2|Overall Study|Lost to Follow-up|96
7564212|NCT02318797|26300291|P1|Overall Study|Lost to Follow-up|85
7564213|NCT02318797|26300290|P2|Overall Study|Death|6
7564214|NCT02318797|26300291|P1|Overall Study|Death|3
7564215|NCT02318719|26300333|P5|Open-label Extension Phase|Other|7
7564216|NCT02318719|26300334|P4|Open-label Extension Phase|Other|0
7564217|NCT02318719|26300335|P3|Open-label Extension Phase|Other|0
7564218|NCT02318719|26300336|P2|Open-label Extension Phase|Other|0
7564219|NCT02318719|26300337|P1|Open-label Extension Phase|Other|0
7564220|NCT02318719|26300333|P5|Open-label Extension Phase|Withdrawal by Subject|31
7564221|NCT02318719|26300334|P4|Open-label Extension Phase|Withdrawal by Subject|0
7564222|NCT02318719|26300335|P3|Open-label Extension Phase|Withdrawal by Subject|0
7564223|NCT02318719|26300336|P2|Open-label Extension Phase|Withdrawal by Subject|0
7564224|NCT02318719|26300337|P1|Open-label Extension Phase|Withdrawal by Subject|0
7564225|NCT02318719|26300333|P5|Open-label Extension Phase|Lack of Efficacy|1
7564226|NCT02318719|26300334|P4|Open-label Extension Phase|Lack of Efficacy|0
7564227|NCT02318719|26300335|P3|Open-label Extension Phase|Lack of Efficacy|0
7564228|NCT02318719|26300336|P2|Open-label Extension Phase|Lack of Efficacy|0
7564229|NCT02318719|26300337|P1|Open-label Extension Phase|Lack of Efficacy|0
7564230|NCT02318719|26300333|P5|Open-label Extension Phase|Death|1
7564231|NCT02318719|26300334|P4|Open-label Extension Phase|Death|0
7564232|NCT02318719|26300335|P3|Open-label Extension Phase|Death|0
7564233|NCT02318719|26300336|P2|Open-label Extension Phase|Death|0
7564234|NCT02318719|26300337|P1|Open-label Extension Phase|Death|0
7564235|NCT02318719|26300333|P5|Open-label Extension Phase|Adverse Event|15
7564236|NCT02318719|26300334|P4|Open-label Extension Phase|Adverse Event|0
7564237|NCT02318719|26300335|P3|Open-label Extension Phase|Adverse Event|0
7564238|NCT02318719|26300336|P2|Open-label Extension Phase|Adverse Event|0
7564239|NCT02318719|26300337|P1|Open-label Extension Phase|Adverse Event|0
7564240|NCT02318719|26300333|P5|Double-blind Phase|Other|0
7564241|NCT02318719|26300334|P4|Double-blind Phase|Other|0
7564242|NCT02318719|26300335|P3|Double-blind Phase|Other|0
7564243|NCT02318719|26300336|P2|Double-blind Phase|Other|2
7564244|NCT02318719|26300337|P1|Double-blind Phase|Other|1
7564245|NCT02318719|26300333|P5|Double-blind Phase|Withdrawal by Subject|0
7564246|NCT02318719|26300334|P4|Double-blind Phase|Withdrawal by Subject|10
7564247|NCT02318719|26300335|P3|Double-blind Phase|Withdrawal by Subject|9
7564248|NCT02318719|26300336|P2|Double-blind Phase|Withdrawal by Subject|7
7564249|NCT02318719|26300337|P1|Double-blind Phase|Withdrawal by Subject|25
7564250|NCT02318719|26300333|P5|Double-blind Phase|Protocol Violation|0
7564251|NCT02318719|26300334|P4|Double-blind Phase|Protocol Violation|0
7564252|NCT02318719|26300335|P3|Double-blind Phase|Protocol Violation|3
7564253|NCT02318719|26300336|P2|Double-blind Phase|Protocol Violation|1
7564254|NCT02318719|26300337|P1|Double-blind Phase|Protocol Violation|0
7564255|NCT02318719|26300333|P5|Double-blind Phase|Lack of Efficacy|0
7564256|NCT02318719|26300334|P4|Double-blind Phase|Lack of Efficacy|1
7564257|NCT02318719|26300335|P3|Double-blind Phase|Lack of Efficacy|1
7564258|NCT02318719|26300336|P2|Double-blind Phase|Lack of Efficacy|0
7564259|NCT02318719|26300337|P1|Double-blind Phase|Lack of Efficacy|5
7564260|NCT02318719|26300333|P5|Double-blind Phase|Adverse Event|0
7564261|NCT02318719|26300334|P4|Double-blind Phase|Adverse Event|4
7564262|NCT02318719|26300335|P3|Double-blind Phase|Adverse Event|12
7564263|NCT02318719|26300336|P2|Double-blind Phase|Adverse Event|6
7564264|NCT02318719|26300337|P1|Double-blind Phase|Adverse Event|7
7564265|NCT02318706|26300353|P5|Open-label Extension Phase|Withdrawal by Subject|19
7564266|NCT02318706|26300354|P4|Open-label Extension Phase|Withdrawal by Subject|0
7564267|NCT02318706|26300355|P3|Open-label Extension Phase|Withdrawal by Subject|0
7564268|NCT02318706|26300356|P2|Open-label Extension Phase|Withdrawal by Subject|0
7564269|NCT02318706|26300357|P1|Open-label Extension Phase|Withdrawal by Subject|0
7564270|NCT02318706|26300353|P5|Open-label Extension Phase|Death|1
7564271|NCT02318706|26300354|P4|Open-label Extension Phase|Death|0
7564272|NCT02318706|26300355|P3|Open-label Extension Phase|Death|0
7564273|NCT02318706|26300356|P2|Open-label Extension Phase|Death|0
7564274|NCT02318706|26300357|P1|Open-label Extension Phase|Death|0
7564275|NCT02318706|26300353|P5|Open-label Extension Phase|Lack of Efficacy|1
7564276|NCT02318706|26300354|P4|Open-label Extension Phase|Lack of Efficacy|0
7564277|NCT02318706|26300355|P3|Open-label Extension Phase|Lack of Efficacy|0
7564278|NCT02318706|26300356|P2|Open-label Extension Phase|Lack of Efficacy|0
7564279|NCT02318706|26300357|P1|Open-label Extension Phase|Lack of Efficacy|0
7564280|NCT02318706|26300353|P5|Open-label Extension Phase|Adverse Event|21
7564281|NCT02318706|26300354|P4|Open-label Extension Phase|Adverse Event|0
7564282|NCT02318706|26300355|P3|Open-label Extension Phase|Adverse Event|0
7564283|NCT02318706|26300356|P2|Open-label Extension Phase|Adverse Event|0
7564284|NCT02318706|26300357|P1|Open-label Extension Phase|Adverse Event|0
7564285|NCT02318706|26300353|P5|Double-blind Phase|Death|0
7564286|NCT02318706|26300354|P4|Double-blind Phase|Death|0
7564287|NCT02318706|26300355|P3|Double-blind Phase|Death|2
7564288|NCT02318706|26300356|P2|Double-blind Phase|Death|0
7564289|NCT02318706|26300357|P1|Double-blind Phase|Death|0
7564290|NCT02318706|26300353|P5|Double-blind Phase|Other|0
7564291|NCT02318706|26300354|P4|Double-blind Phase|Other|1
7564292|NCT02318706|26300355|P3|Double-blind Phase|Other|2
7564293|NCT02318706|26300356|P2|Double-blind Phase|Other|1
7564294|NCT02318706|26300357|P1|Double-blind Phase|Other|4
7564295|NCT02318706|26300353|P5|Double-blind Phase|Withdrawal by Subject|0
7564296|NCT02318706|26300354|P4|Double-blind Phase|Withdrawal by Subject|10
7564297|NCT02318706|26300355|P3|Double-blind Phase|Withdrawal by Subject|7
7564298|NCT02318706|26300356|P2|Double-blind Phase|Withdrawal by Subject|5
7564299|NCT02318706|26300357|P1|Double-blind Phase|Withdrawal by Subject|9
7564300|NCT02318706|26300353|P5|Double-blind Phase|Protocol Violation|0
7564301|NCT02318706|26300354|P4|Double-blind Phase|Protocol Violation|3
7564302|NCT02318706|26300355|P3|Double-blind Phase|Protocol Violation|4
7564303|NCT02318706|26300356|P2|Double-blind Phase|Protocol Violation|2
7564304|NCT02318706|26300357|P1|Double-blind Phase|Protocol Violation|4
7564305|NCT02318706|26300353|P5|Double-blind Phase|Lost to Follow-up|0
7564306|NCT02318706|26300354|P4|Double-blind Phase|Lost to Follow-up|0
7564307|NCT02318706|26300355|P3|Double-blind Phase|Lost to Follow-up|0
7564308|NCT02318706|26300356|P2|Double-blind Phase|Lost to Follow-up|0
7564309|NCT02318706|26300357|P1|Double-blind Phase|Lost to Follow-up|1
7564310|NCT02318706|26300353|P5|Double-blind Phase|Adverse Event|0
7564311|NCT02318706|26300354|P4|Double-blind Phase|Adverse Event|10
7564312|NCT02318706|26300355|P3|Double-blind Phase|Adverse Event|3
7564313|NCT02318706|26300356|P2|Double-blind Phase|Adverse Event|4
7564314|NCT02318706|26300357|P1|Double-blind Phase|Adverse Event|7
7564315|NCT02318693|26300371|P2|Overall Study|Protocol Violation|1
7564316|NCT02318693|26300372|P1|Overall Study|Protocol Violation|0
7564317|NCT02318667|26300386|P1|Overall Study|Protocol Violation|2
7564318|NCT02318667|26300386|P1|Overall Study|Lack of Efficacy|6
7564319|NCT02318667|26300386|P1|Overall Study|Adverse Event|1
7564320|NCT02318602|26300405|P3|Overall Study|Guardian decision to withdraw|1
7564321|NCT02318602|26300406|P2|Overall Study|Guardian decision to withdraw|0
7564322|NCT02318602|26300407|P1|Overall Study|Guardian decision to withdraw|0
7564323|NCT02318602|26300405|P3|Overall Study|Death|0
7564324|NCT02318602|26300406|P2|Overall Study|Death|0
7564325|NCT02318602|26300407|P1|Overall Study|Death|1
7564326|NCT02318602|26300405|P3|Overall Study|Withdrawal by Subject|0
7564327|NCT02318602|26300406|P2|Overall Study|Withdrawal by Subject|3
7564328|NCT02318602|26300407|P1|Overall Study|Withdrawal by Subject|0
7564329|NCT02318602|26300405|P3|Overall Study|Adverse Event|1
7564330|NCT02318602|26300406|P2|Overall Study|Adverse Event|1
7564331|NCT02318602|26300407|P1|Overall Study|Adverse Event|0
7564332|NCT02318368|26300453|P2|Overall Study|Death|1
7564333|NCT02318368|26300454|P1|Overall Study|Death|0
7564334|NCT02318368|26300453|P2|Overall Study|Study terminated by the sponsor|2
7564335|NCT02318368|26300454|P1|Overall Study|Study terminated by the sponsor|5
7564336|NCT02318368|26300453|P2|Overall Study|Withdrawal by Subject|0
7564337|NCT02318368|26300454|P1|Overall Study|Withdrawal by Subject|2
7564338|NCT02318329|26300472|P10|Overall Study|Other|1
7564339|NCT02318329|26300473|P9|Overall Study|Other|1
7564340|NCT02318329|26300474|P8|Overall Study|Other|0
7564341|NCT02318329|26300475|P7|Overall Study|Other|0
7564342|NCT02318329|26300476|P6|Overall Study|Other|0
7564343|NCT02318329|26300477|P5|Overall Study|Other|0
7564344|NCT02318329|26300478|P4|Overall Study|Other|0
7564345|NCT02318329|26300479|P3|Overall Study|Other|1
7564346|NCT02318329|26300480|P2|Overall Study|Other|1
7564347|NCT02318329|26300481|P1|Overall Study|Other|1
7564348|NCT02318329|26300472|P10|Overall Study|Withdrawal by Subject|6
7564349|NCT02318329|26300473|P9|Overall Study|Withdrawal by Subject|0
7564350|NCT02318329|26300474|P8|Overall Study|Withdrawal by Subject|0
7564351|NCT02318329|26300475|P7|Overall Study|Withdrawal by Subject|0
7564352|NCT02318329|26300476|P6|Overall Study|Withdrawal by Subject|0
7564353|NCT02318329|26300477|P5|Overall Study|Withdrawal by Subject|0
7564354|NCT02318329|26300478|P4|Overall Study|Withdrawal by Subject|0
7564355|NCT02318329|26300479|P3|Overall Study|Withdrawal by Subject|0
7564356|NCT02318329|26300480|P2|Overall Study|Withdrawal by Subject|0
7564357|NCT02318329|26300481|P1|Overall Study|Withdrawal by Subject|0
7564358|NCT02318329|26300472|P10|Overall Study|Lost to Follow-up|1
7564359|NCT02318329|26300473|P9|Overall Study|Lost to Follow-up|0
7564360|NCT02318329|26300474|P8|Overall Study|Lost to Follow-up|0
7564361|NCT02318329|26300475|P7|Overall Study|Lost to Follow-up|0
7564362|NCT02318329|26300476|P6|Overall Study|Lost to Follow-up|0
7564363|NCT02318329|26300477|P5|Overall Study|Lost to Follow-up|0
7564364|NCT02318329|26300478|P4|Overall Study|Lost to Follow-up|0
7564365|NCT02318329|26300479|P3|Overall Study|Lost to Follow-up|0
7564366|NCT02318329|26300480|P2|Overall Study|Lost to Follow-up|0
7564367|NCT02318329|26300481|P1|Overall Study|Lost to Follow-up|0
7564368|NCT02318329|26300472|P10|Overall Study|Death|5
7564369|NCT02318329|26300473|P9|Overall Study|Death|0
7564370|NCT02318329|26300474|P8|Overall Study|Death|0
7564371|NCT02318329|26300475|P7|Overall Study|Death|0
7564372|NCT02318329|26300476|P6|Overall Study|Death|0
7564373|NCT02318329|26300477|P5|Overall Study|Death|0
7564374|NCT02318329|26300478|P4|Overall Study|Death|0
7564375|NCT02318329|26300479|P3|Overall Study|Death|0
7564376|NCT02318329|26300480|P2|Overall Study|Death|0
7564377|NCT02318329|26300481|P1|Overall Study|Death|0
7564378|NCT02318329|26300472|P10|Overall Study|Progressive Disease|39
7564379|NCT02318329|26300473|P9|Overall Study|Progressive Disease|5
7564380|NCT02318329|26300474|P8|Overall Study|Progressive Disease|1
7564381|NCT02318329|26300475|P7|Overall Study|Progressive Disease|1
7564382|NCT02318329|26300476|P6|Overall Study|Progressive Disease|3
7564383|NCT02318329|26300477|P5|Overall Study|Progressive Disease|3
7564384|NCT02318329|26300478|P4|Overall Study|Progressive Disease|3
7564385|NCT02318329|26300479|P3|Overall Study|Progressive Disease|2
7564386|NCT02318329|26300480|P2|Overall Study|Progressive Disease|3
7564387|NCT02318329|26300481|P1|Overall Study|Progressive Disease|2
7564388|NCT02318277|26300574|P8|Overall Study|Participants Ongoing in study|0
7564389|NCT02318277|26300575|P7|Overall Study|Participants Ongoing in study|0
7564390|NCT02318277|26300576|P6|Overall Study|Participants Ongoing in study|1
7564391|NCT02318277|26300577|P5|Overall Study|Participants Ongoing in study|0
7564392|NCT02318277|26300578|P4|Overall Study|Participants Ongoing in study|0
7564393|NCT02318277|26300579|P3|Overall Study|Participants Ongoing in study|0
7564394|NCT02318277|26300580|P2|Overall Study|Participants Ongoing in study|0
7564395|NCT02318277|26300581|P1|Overall Study|Participants Ongoing in study|0
7564396|NCT02318277|26300574|P8|Overall Study|Death|58
7564397|NCT02318277|26300575|P7|Overall Study|Death|34
7564398|NCT02318277|26300576|P6|Overall Study|Death|5
7564399|NCT02318277|26300577|P5|Overall Study|Death|6
7564400|NCT02318277|26300578|P4|Overall Study|Death|4
7564401|NCT02318277|26300579|P3|Overall Study|Death|1
7564402|NCT02318277|26300580|P2|Overall Study|Death|3
7564403|NCT02318277|26300581|P1|Overall Study|Death|5
7564404|NCT02318277|26300574|P8|Overall Study|Lost to Follow-up|4
7564405|NCT02318277|26300575|P7|Overall Study|Lost to Follow-up|3
7564406|NCT02318277|26300576|P6|Overall Study|Lost to Follow-up|0
7564407|NCT02318277|26300577|P5|Overall Study|Lost to Follow-up|0
7564408|NCT02318277|26300578|P4|Overall Study|Lost to Follow-up|0
7564409|NCT02318277|26300579|P3|Overall Study|Lost to Follow-up|1
7564410|NCT02318277|26300580|P2|Overall Study|Lost to Follow-up|0
7564411|NCT02318277|26300581|P1|Overall Study|Lost to Follow-up|1
7564412|NCT02318277|26300574|P8|Overall Study|Participant trial terminated by sponsor|16
7564413|NCT02318277|26300575|P7|Overall Study|Participant trial terminated by sponsor|5
7564414|NCT02318277|26300576|P6|Overall Study|Participant trial terminated by sponsor|2
7564415|NCT02318277|26300577|P5|Overall Study|Participant trial terminated by sponsor|1
7564416|NCT02318277|26300578|P4|Overall Study|Participant trial terminated by sponsor|0
7564417|NCT02318277|26300579|P3|Overall Study|Participant trial terminated by sponsor|1
7564418|NCT02318277|26300580|P2|Overall Study|Participant trial terminated by sponsor|0
7564419|NCT02318277|26300581|P1|Overall Study|Participant trial terminated by sponsor|0
7564420|NCT02318277|26300574|P8|Overall Study|Withdrawal by Subject|14
7564421|NCT02318277|26300575|P7|Overall Study|Withdrawal by Subject|6
7564422|NCT02318277|26300576|P6|Overall Study|Withdrawal by Subject|1
7564423|NCT02318277|26300577|P5|Overall Study|Withdrawal by Subject|1
7564424|NCT02318277|26300578|P4|Overall Study|Withdrawal by Subject|0
7564425|NCT02318277|26300579|P3|Overall Study|Withdrawal by Subject|1
7564426|NCT02318277|26300580|P2|Overall Study|Withdrawal by Subject|0
7564427|NCT02318277|26300581|P1|Overall Study|Withdrawal by Subject|0
7564428|NCT02318277|26300574|P8|Overall Study|Other|0
7564429|NCT02318277|26300575|P7|Overall Study|Other|1
7564430|NCT02318277|26300576|P6|Overall Study|Other|0
7564431|NCT02318277|26300577|P5|Overall Study|Other|0
7564432|NCT02318277|26300578|P4|Overall Study|Other|0
7564433|NCT02318277|26300579|P3|Overall Study|Other|0
7564434|NCT02318277|26300580|P2|Overall Study|Other|0
7564435|NCT02318277|26300581|P1|Overall Study|Other|0
7564436|NCT02318277|26300574|P8|Overall Study|Physician Decision|1
7564437|NCT02318277|26300575|P7|Overall Study|Physician Decision|0
7564438|NCT02318277|26300576|P6|Overall Study|Physician Decision|0
7564439|NCT02318277|26300577|P5|Overall Study|Physician Decision|0
7564440|NCT02318277|26300578|P4|Overall Study|Physician Decision|0
7564441|NCT02318277|26300579|P3|Overall Study|Physician Decision|0
7564442|NCT02318277|26300580|P2|Overall Study|Physician Decision|0
7564443|NCT02318277|26300581|P1|Overall Study|Physician Decision|0
7564444|NCT02318134|26300646|P2|Overall Study|Withdrawal by Subject|1
7564445|NCT02318134|26300647|P1|Overall Study|Withdrawal by Subject|2
7564446|NCT02318095|26300667|P1|Overall Study|Adverse Event|1
7564447|NCT02317809|26300674|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
7564448|NCT02317809|26300675|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
7564449|NCT02317809|26300674|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
7564450|NCT02317809|26300675|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
7564451|NCT02317614|26300763|P2|Overall Study|Death|1
7564452|NCT02317614|26300764|P1|Overall Study|Death|1
7564453|NCT02317614|26300763|P2|Overall Study|Withdrawal by Subject|0
7564454|NCT02317614|26300764|P1|Overall Study|Withdrawal by Subject|1
7564455|NCT02317614|26300763|P2|Overall Study|Lost to Follow-up|1
7564456|NCT02317614|26300764|P1|Overall Study|Lost to Follow-up|1
7564457|NCT02317575|26300780|P5|Period 1|Withdrawal by Subject|0
7564458|NCT02317575|26300781|P4|Period 1|Withdrawal by Subject|0
7564459|NCT02317575|26300782|P3|Period 1|Withdrawal by Subject|0
7564460|NCT02317575|26300783|P2|Period 1|Withdrawal by Subject|0
7564461|NCT02317575|26300784|P1|Period 1|Withdrawal by Subject|1
7564462|NCT02317575|26300780|P5|Period 1|Difficulty with venous cannulation|0
7564463|NCT02317575|26300781|P4|Period 1|Difficulty with venous cannulation|0
7564464|NCT02317575|26300782|P3|Period 1|Difficulty with venous cannulation|0
7564465|NCT02317575|26300783|P2|Period 1|Difficulty with venous cannulation|1
7564466|NCT02317575|26300784|P1|Period 1|Difficulty with venous cannulation|0
7564467|NCT02317562|26300808|P1|Overall Study|Withdrawal by Subject|1
7564468|NCT02317562|26300808|P1|Overall Study|Lack of Efficacy|4
7564469|NCT02317562|26300808|P1|Overall Study|early termination of the study|8
7564470|NCT02317562|26300808|P1|Overall Study|Physician Decision|1
7564471|NCT02317510|26300823|P2|Overall Study|Adverse Event|1
7564472|NCT02317510|26300824|P1|Overall Study|Adverse Event|0
7564473|NCT02317432|26300854|P2|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
7564474|NCT02317432|26300855|P1|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
7564475|NCT02317432|26300854|P2|Overall Study|Lost to Follow-up|5
7564476|NCT02317432|26300855|P1|Overall Study|Lost to Follow-up|0
7564477|NCT02317432|26300854|P2|Overall Study|Death|1
7564478|NCT02317432|26300855|P1|Overall Study|Death|4
7564479|NCT02317016|26300914|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
7564480|NCT02317016|26300914|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
7564481|NCT02317016|26300914|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
7564482|NCT02317016|26300914|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
7564483|NCT02317016|26300914|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
7564484|NCT02317016|26300914|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
7564485|NCT02317016|26300914|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
7564486|NCT02316847|26300942|P2|Overall Study|Withdrawn due to termination by Sponsor|67
7564487|NCT02316847|26300943|P1|Overall Study|Withdrawn due to termination by Sponsor|7
7564488|NCT02316847|26300942|P2|Overall Study|Noncompliance with study drug|3
7564489|NCT02316847|26300943|P1|Overall Study|Noncompliance with study drug|0
7564490|NCT02316847|26300942|P2|Overall Study|Withdrawal by Subject|9
7564491|NCT02316847|26300943|P1|Overall Study|Withdrawal by Subject|2
7564492|NCT02316847|26300942|P2|Overall Study|Pregnancy|1
7564493|NCT02316847|26300943|P1|Overall Study|Pregnancy|0
7564494|NCT02316847|26300942|P2|Overall Study|Physician Decision|1
7564495|NCT02316847|26300943|P1|Overall Study|Physician Decision|0
7564496|NCT02316847|26300942|P2|Overall Study|Lost to Follow-up|2
7564497|NCT02316847|26300943|P1|Overall Study|Lost to Follow-up|0
7564498|NCT02316847|26300942|P2|Overall Study|Adverse Event|3
7564499|NCT02316847|26300943|P1|Overall Study|Adverse Event|0
7564500|NCT02316769|26300954|P2|Overall Study|Withdrawal by Subject|0
7564501|NCT02316769|26300955|P1|Overall Study|Withdrawal by Subject|1
7564502|NCT02316769|26300954|P2|Overall Study|Physician Decision|0
7564503|NCT02316769|26300955|P1|Overall Study|Physician Decision|1
7564504|NCT02316717|26300966|P3|Overall Study|TBC|0
7564505|NCT02316717|26300967|P2|Overall Study|TBC|0
7564506|NCT02316717|26300968|P1|Overall Study|TBC|1
7564507|NCT02316717|26300966|P3|Overall Study|Physician Decision|0
7564508|NCT02316717|26300967|P2|Overall Study|Physician Decision|1
7564509|NCT02316717|26300968|P1|Overall Study|Physician Decision|0
7564510|NCT02316717|26300966|P3|Overall Study|Death|1
7564511|NCT02316717|26300967|P2|Overall Study|Death|0
7564512|NCT02316717|26300968|P1|Overall Study|Death|0
7564513|NCT02316717|26300966|P3|Overall Study|Withdrawal by Subject|1
7564514|NCT02316717|26300967|P2|Overall Study|Withdrawal by Subject|1
7564515|NCT02316717|26300968|P1|Overall Study|Withdrawal by Subject|2
7564516|NCT02316717|26300966|P3|Overall Study|Protocol Violation|0
7564517|NCT02316717|26300967|P2|Overall Study|Protocol Violation|0
7564518|NCT02316717|26300968|P1|Overall Study|Protocol Violation|2
7564519|NCT02316717|26300966|P3|Overall Study|Non compliance|0
7564520|NCT02316717|26300967|P2|Overall Study|Non compliance|1
7564521|NCT02316717|26300968|P1|Overall Study|Non compliance|3
7564522|NCT02316717|26300966|P3|Overall Study|Lost to Follow-up|1
7564523|NCT02316717|26300967|P2|Overall Study|Lost to Follow-up|2
7564524|NCT02316717|26300968|P1|Overall Study|Lost to Follow-up|1
7564525|NCT02316717|26300966|P3|Overall Study|Adverse Event|0
7564526|NCT02316717|26300967|P2|Overall Study|Adverse Event|2
7564527|NCT02316717|26300968|P1|Overall Study|Adverse Event|2
7564528|NCT02316613|26301105|P1|Overall Study|Did not met selection criteria|14
7564529|NCT02316613|26301105|P1|Overall Study|No data and duplicate cases|5
7564530|NCT02316613|26301105|P1|Overall Study|Participant moved/changed medical team|11
7564531|NCT02316613|26301105|P1|Overall Study|Lymphoma transformation|2
7564532|NCT02316613|26301105|P1|Overall Study|Lost to Follow-up|9
7564533|NCT02316613|26301105|P1|Overall Study|Death|63
7564534|NCT02316548|26301144|P2|Overall Study|Protocol Violation|1
7564535|NCT02316548|26301145|P1|Overall Study|Protocol Violation|0
7564536|NCT02316353|26301275|P2|Overall Study|Withdrawal by Subject|2
7564537|NCT02316353|26301276|P1|Overall Study|Withdrawal by Subject|6
7564538|NCT02316353|26301275|P2|Overall Study|Adverse Event|3
7564539|NCT02316353|26301276|P1|Overall Study|Adverse Event|1
7564540|NCT02316353|26301275|P2|Overall Study|Pregnancy|3
7564541|NCT02316353|26301276|P1|Overall Study|Pregnancy|1
7564542|NCT02316223|26301297|P3|Overall Study|Discontinued by PI|3
7564543|NCT02316223|26301298|P2|Overall Study|Discontinued by PI|19
7564544|NCT02316223|26301299|P1|Overall Study|Discontinued by PI|11
7564545|NCT02316223|26301297|P3|Overall Study|No asthma|0
7564546|NCT02316223|26301298|P2|Overall Study|No asthma|0
7564547|NCT02316223|26301299|P1|Overall Study|No asthma|2
7564548|NCT02316223|26301297|P3|Overall Study|Reside outside study area|1
7564549|NCT02316223|26301298|P2|Overall Study|Reside outside study area|1
7564550|NCT02316223|26301299|P1|Overall Study|Reside outside study area|1
7564551|NCT02316223|26301297|P3|Overall Study|COPD Diagnosis|3
7564552|NCT02316223|26301298|P2|Overall Study|COPD Diagnosis|2
7564553|NCT02316223|26301299|P1|Overall Study|COPD Diagnosis|3
7564554|NCT02316223|26301297|P3|Overall Study|Lost to Follow-up|36
7564555|NCT02316223|26301298|P2|Overall Study|Lost to Follow-up|34
7564556|NCT02316223|26301299|P1|Overall Study|Lost to Follow-up|27
7564557|NCT02316223|26301297|P3|Overall Study|Lack of Efficacy|1
7564558|NCT02316223|26301298|P2|Overall Study|Lack of Efficacy|1
7564559|NCT02316223|26301299|P1|Overall Study|Lack of Efficacy|0
7564560|NCT02316171|26301321|P4|Overall Study|difficulties with urinary catheter|0
7564561|NCT02316171|26301322|P3|Overall Study|difficulties with urinary catheter|0
7564562|NCT02316171|26301323|P2|Overall Study|difficulties with urinary catheter|0
7564563|NCT02316171|26301324|P1|Overall Study|difficulties with urinary catheter|1
7564612|NCT02315664|26301501|P2|Overall Study|Withdrawal by Subject|3
7564613|NCT02315664|26301502|P1|Overall Study|Withdrawal by Subject|0
7564614|NCT02315664|26301501|P2|Overall Study|Lost to Follow-up|1
7564615|NCT02315664|26301502|P1|Overall Study|Lost to Follow-up|1
7564616|NCT02315625|26301524|P2|Second Intervention|Disease Progression|0
7564617|NCT02315625|26301525|P1|Second Intervention|Disease Progression|1
7564618|NCT02315625|26301524|P2|Second Intervention|Study closure|0
7564619|NCT02315625|26301525|P1|Second Intervention|Study closure|1
7564620|NCT02315625|26301524|P2|Second Intervention|Physician Decision|1
7564621|NCT02315625|26301525|P1|Second Intervention|Physician Decision|2
7564622|NCT02315625|26301524|P2|First Intervention|Disease Progression|0
7564623|NCT02315625|26301525|P1|First Intervention|Disease Progression|1
7564624|NCT02315560|26301539|P1|Overall Study|noncompliance by subjects|3
7564625|NCT02314923|26301828|P10|Overall Study|Participant relocation|0
7564626|NCT02314923|26301829|P9|Overall Study|Participant relocation|0
7564627|NCT02314923|26301830|P8|Overall Study|Participant relocation|1
7564628|NCT02314923|26301831|P7|Overall Study|Participant relocation|0
7564629|NCT02314923|26301832|P6|Overall Study|Participant relocation|0
7564630|NCT02314923|26301833|P5|Overall Study|Participant relocation|0
7564631|NCT02314923|26301834|P4|Overall Study|Participant relocation|0
7564632|NCT02314923|26301835|P3|Overall Study|Participant relocation|0
7564633|NCT02314923|26301836|P2|Overall Study|Participant relocation|0
7564634|NCT02314923|26301837|P1|Overall Study|Participant relocation|1
7564635|NCT02314923|26301828|P10|Overall Study|Screen failure|0
7564636|NCT02314923|26301829|P9|Overall Study|Screen failure|0
7564637|NCT02314923|26301830|P8|Overall Study|Screen failure|0
7564638|NCT02314923|26301831|P7|Overall Study|Screen failure|1
7564639|NCT02314923|26301832|P6|Overall Study|Screen failure|0
7564640|NCT02314923|26301833|P5|Overall Study|Screen failure|0
7564641|NCT02314923|26301834|P4|Overall Study|Screen failure|0
7564642|NCT02314923|26301835|P3|Overall Study|Screen failure|0
7564643|NCT02314923|26301836|P2|Overall Study|Screen failure|0
7564644|NCT02314923|26301837|P1|Overall Study|Screen failure|0
7564645|NCT02314923|26301828|P10|Overall Study|Participant unavailable|0
7564646|NCT02314923|26301829|P9|Overall Study|Participant unavailable|0
7564647|NCT02314923|26301830|P8|Overall Study|Participant unavailable|0
7564648|NCT02314923|26301831|P7|Overall Study|Participant unavailable|0
7564649|NCT02314923|26301832|P6|Overall Study|Participant unavailable|1
7564650|NCT02314923|26301833|P5|Overall Study|Participant unavailable|0
7564651|NCT02314923|26301834|P4|Overall Study|Participant unavailable|0
7564652|NCT02314923|26301835|P3|Overall Study|Participant unavailable|0
7564653|NCT02314923|26301836|P2|Overall Study|Participant unavailable|0
7564654|NCT02314923|26301837|P1|Overall Study|Participant unavailable|0
7564655|NCT02314923|26301828|P10|Overall Study|Physician Decision|0
7564656|NCT02314923|26301829|P9|Overall Study|Physician Decision|0
7564657|NCT02314923|26301830|P8|Overall Study|Physician Decision|0
7564658|NCT02314923|26301831|P7|Overall Study|Physician Decision|0
7564659|NCT02314923|26301832|P6|Overall Study|Physician Decision|0
7564660|NCT02314923|26301833|P5|Overall Study|Physician Decision|0
7564661|NCT02314923|26301834|P4|Overall Study|Physician Decision|0
7564662|NCT02314923|26301835|P3|Overall Study|Physician Decision|0
7564663|NCT02314923|26301836|P2|Overall Study|Physician Decision|1
7564664|NCT02314923|26301837|P1|Overall Study|Physician Decision|0
7564665|NCT02314923|26301828|P10|Overall Study|Withdrawal by Subject|0
7564666|NCT02314923|26301829|P9|Overall Study|Withdrawal by Subject|0
7564667|NCT02314923|26301830|P8|Overall Study|Withdrawal by Subject|0
7564668|NCT02314923|26301831|P7|Overall Study|Withdrawal by Subject|1
7564669|NCT02314923|26301832|P6|Overall Study|Withdrawal by Subject|0
7564670|NCT02314923|26301833|P5|Overall Study|Withdrawal by Subject|1
7564671|NCT02314923|26301834|P4|Overall Study|Withdrawal by Subject|0
7564672|NCT02314923|26301835|P3|Overall Study|Withdrawal by Subject|1
7564673|NCT02314923|26301836|P2|Overall Study|Withdrawal by Subject|0
7564674|NCT02314923|26301837|P1|Overall Study|Withdrawal by Subject|0
7564675|NCT02314923|26301828|P10|Overall Study|Lost to Follow-up|0
7564676|NCT02314923|26301829|P9|Overall Study|Lost to Follow-up|2
7564677|NCT02314923|26301830|P8|Overall Study|Lost to Follow-up|4
7564678|NCT02314923|26301831|P7|Overall Study|Lost to Follow-up|3
7564679|NCT02314923|26301832|P6|Overall Study|Lost to Follow-up|0
7564680|NCT02314923|26301833|P5|Overall Study|Lost to Follow-up|0
7564681|NCT02314923|26301834|P4|Overall Study|Lost to Follow-up|0
7564682|NCT02314923|26301835|P3|Overall Study|Lost to Follow-up|1
7564683|NCT02314923|26301836|P2|Overall Study|Lost to Follow-up|3
7564684|NCT02314923|26301837|P1|Overall Study|Lost to Follow-up|2
7564685|NCT02314923|26301828|P10|Overall Study|Death|0
7564686|NCT02314923|26301829|P9|Overall Study|Death|0
7564687|NCT02314923|26301830|P8|Overall Study|Death|0
7564688|NCT02314923|26301831|P7|Overall Study|Death|0
7564689|NCT02314923|26301832|P6|Overall Study|Death|0
7564690|NCT02314923|26301833|P5|Overall Study|Death|0
7564691|NCT02314923|26301834|P4|Overall Study|Death|1
7564692|NCT02314923|26301835|P3|Overall Study|Death|0
7564693|NCT02314923|26301836|P2|Overall Study|Death|0
7564694|NCT02314923|26301837|P1|Overall Study|Death|0
7564695|NCT02314780|26301933|P3|Overall Study|Adverse Event|0
7564696|NCT02314780|26301934|P2|Overall Study|Adverse Event|1
7564697|NCT02314780|26301935|P1|Overall Study|Adverse Event|0
7564698|NCT02314780|26301933|P3|Overall Study|organizational reasons|0
7564699|NCT02314780|26301934|P2|Overall Study|organizational reasons|2
7564700|NCT02314780|26301935|P1|Overall Study|organizational reasons|0
7564701|NCT02314728|26301960|P2|Overall Study|Lost to Follow-up|1
7564702|NCT02314728|26301961|P1|Overall Study|Lost to Follow-up|0
7564703|NCT02314728|26301960|P2|Overall Study|Protocol Violation|0
7564704|NCT02314728|26301961|P1|Overall Study|Protocol Violation|1
7564705|NCT02314637|26301975|P2|Overall Study|Other Reason|0
7564706|NCT02314637|26301976|P1|Overall Study|Other Reason|1
7564707|NCT02314637|26301975|P2|Overall Study|Withdrawal by Subject|4
7564708|NCT02314637|26301976|P1|Overall Study|Withdrawal by Subject|5
7564709|NCT02314637|26301975|P2|Overall Study|Physician Decision|2
7564710|NCT02314637|26301976|P1|Overall Study|Physician Decision|5
7564711|NCT02314637|26301975|P2|Overall Study|Lack of Efficacy|0
7564712|NCT02314637|26301976|P1|Overall Study|Lack of Efficacy|1
7564713|NCT02314637|26301975|P2|Overall Study|Adverse Event|8
7564714|NCT02314637|26301976|P1|Overall Study|Adverse Event|4
7564715|NCT02314247|26302051|P3|Overall Study|Progression of Disease|0
7564716|NCT02314247|26302052|P2|Overall Study|Progression of Disease|2
7564717|NCT02314247|26302053|P1|Overall Study|Progression of Disease|6
7564718|NCT02314247|26302051|P3|Overall Study|Withdrawal by Subject|1
7564719|NCT02314247|26302052|P2|Overall Study|Withdrawal by Subject|3
7564720|NCT02314247|26302053|P1|Overall Study|Withdrawal by Subject|1
7564721|NCT02314247|26302051|P3|Overall Study|Adverse Event|0
7564722|NCT02314247|26302052|P2|Overall Study|Adverse Event|1
7564723|NCT02314247|26302053|P1|Overall Study|Adverse Event|2
7564724|NCT02314143|26302078|P3|Overall Study|Withdrawal by Subject|1
7564725|NCT02314143|26302079|P2|Overall Study|Withdrawal by Subject|0
7564726|NCT02314143|26302080|P1|Overall Study|Withdrawal by Subject|1
7564727|NCT02314143|26302078|P3|Overall Study|Physician Decision|0
7564728|NCT02314143|26302079|P2|Overall Study|Physician Decision|1
7564729|NCT02314143|26302080|P1|Overall Study|Physician Decision|2
7564730|NCT02314143|26302078|P3|Overall Study|Other (Study Closed/Terminated)|4
7564731|NCT02314143|26302079|P2|Overall Study|Other (Study Closed/Terminated)|3
7564732|NCT02314143|26302080|P1|Overall Study|Other (Study Closed/Terminated)|5
7564733|NCT02314143|26302078|P3|Overall Study|Adverse Event|4
7564734|NCT02314143|26302079|P2|Overall Study|Adverse Event|6
7564735|NCT02314143|26302080|P1|Overall Study|Adverse Event|0
7564736|NCT02314117|26302126|P2|Overall Study|Withdrawal by Subject|2
7564737|NCT02314117|26302127|P1|Overall Study|Withdrawal by Subject|3
7564738|NCT02314117|26302126|P2|Overall Study|Lost to Follow-up|14
7564739|NCT02314117|26302127|P1|Overall Study|Lost to Follow-up|9
7564740|NCT02314052|26302180|P6|Cycle One|Adverse Event|0
7564741|NCT02314052|26302181|P5|Cycle One|Adverse Event|0
7564742|NCT02314052|26302182|P4|Cycle One|Adverse Event|1
7564743|NCT02314052|26302183|P3|Cycle One|Adverse Event|0
7564744|NCT02314052|26302184|P2|Cycle One|Adverse Event|0
7564745|NCT02314052|26302185|P1|Cycle One|Adverse Event|0
7564746|NCT02314026|26302253|P1|Overall Study|Protocol Violation|28
7564747|NCT02313909|26302271|P2|Overall Study|Lost to Follow-up|17
7564748|NCT02313909|26302272|P1|Overall Study|Lost to Follow-up|24
7564749|NCT02313909|26302271|P2|Overall Study|Consent withdrawn by participant|33
7564750|NCT02313909|26302272|P1|Overall Study|Consent withdrawn by participant|33
7564751|NCT02313766|26302295|P3|Overall Study|Adverse Event|0
7564752|NCT02313766|26302296|P2|Overall Study|Adverse Event|1
7564753|NCT02313766|26302297|P1|Overall Study|Adverse Event|0
7564754|NCT02313766|26302295|P3|Overall Study|Lost to Follow-up|0
7564755|NCT02313766|26302296|P2|Overall Study|Lost to Follow-up|2
7564756|NCT02313766|26302297|P1|Overall Study|Lost to Follow-up|0
7564757|NCT02313766|26302295|P3|Overall Study|surgery cancelled|0
7564758|NCT02313766|26302296|P2|Overall Study|surgery cancelled|0
7564759|NCT02313766|26302297|P1|Overall Study|surgery cancelled|1
7564760|NCT02313558|26302351|P2|Overall Study|Lost to Follow-up|4
7564761|NCT02313558|26302352|P1|Overall Study|Lost to Follow-up|4
7564762|NCT02313558|26302351|P2|Overall Study|Withdrawal by Subject|0
7564763|NCT02313558|26302352|P1|Overall Study|Withdrawal by Subject|2
7564764|NCT02313233|26302398|P2|Overall Study|Administrative reason|1
7564765|NCT02313233|26302399|P1|Overall Study|Administrative reason|1
7564766|NCT02313233|26302398|P2|Overall Study|Withdrawal by Subject|2
7564767|NCT02313233|26302399|P1|Overall Study|Withdrawal by Subject|1
7564768|NCT02313155|26302421|P2|Overall Study|Lost to Follow-up|1
7564769|NCT02313155|26302422|P1|Overall Study|Lost to Follow-up|0
7564770|NCT02312934|26302477|P2|Overall Study|Physician Decision|0
7564771|NCT02312934|26302478|P1|Overall Study|Physician Decision|1
7564772|NCT02312934|26302477|P2|Overall Study|Lost to Follow-up|0
7564773|NCT02312934|26302478|P1|Overall Study|Lost to Follow-up|1
7564774|NCT02312856|26302490|P1|Overall Study|Lost to Follow-up|3
7564775|NCT02312856|26302490|P1|Overall Study|Death|1
7564776|NCT02312687|26302583|P1|Overall Study|Other, Not Specified|1
7564777|NCT02312258|26302675|P2|Overall Study|Participants Ongoing Treatment|83
7564778|NCT02312258|26302676|P1|Overall Study|Participants Ongoing Treatment|43
7564779|NCT02312258|26302675|P2|Overall Study|Reason not Specified|31
7564780|NCT02312258|26302676|P1|Overall Study|Reason not Specified|11
7564781|NCT02312258|26302675|P2|Overall Study|Withdrawal by Subject|9
7564782|NCT02312258|26302676|P1|Overall Study|Withdrawal by Subject|8
7564783|NCT02312258|26302675|P2|Overall Study|Progressive Disease|188
7564784|NCT02312258|26302676|P1|Overall Study|Progressive Disease|174
7564785|NCT02312258|26302675|P2|Overall Study|Lost to Follow-up|1
7564786|NCT02312258|26302676|P1|Overall Study|Lost to Follow-up|0
7564787|NCT02312258|26302675|P2|Overall Study|Adverse Event|47
7564788|NCT02312258|26302676|P1|Overall Study|Adverse Event|15
7564789|NCT02312219|26302684|P2|Overall Study|Not randomized. Ineligible|1
7564790|NCT02312219|26302685|P1|Overall Study|Not randomized. Ineligible|0
7564791|NCT02312219|26302684|P2|Overall Study|Other|1
7564792|NCT02312219|26302685|P1|Overall Study|Other|0
7564793|NCT02312219|26302684|P2|Overall Study|could not schedule imaging in time|2
7564794|NCT02312219|26302685|P1|Overall Study|could not schedule imaging in time|0
7564795|NCT02312219|26302684|P2|Overall Study|Withdrawal by Subject|2
7564796|NCT02312219|26302685|P1|Overall Study|Withdrawal by Subject|1
7564797|NCT02312206|26302695|P2|Overall Study|Subject missed 3 consecutive tx visits|1
7564798|NCT02312206|26302696|P1|Overall Study|Subject missed 3 consecutive tx visits|0
7564799|NCT02312206|26302695|P2|Overall Study|Patient transferred to hospice|1
7564800|NCT02312206|26302696|P1|Overall Study|Patient transferred to hospice|0
7564801|NCT02312206|26302695|P2|Overall Study|Patient progression and new therapy|0
7564802|NCT02312206|26302696|P1|Overall Study|Patient progression and new therapy|1
7564803|NCT02312206|26302695|P2|Overall Study|Disease Progression|0
7564804|NCT02312206|26302696|P1|Overall Study|Disease Progression|1
7564805|NCT02312206|26302695|P2|Overall Study|Study Terminated by Sponsor|74
7564806|NCT02312206|26302696|P1|Overall Study|Study Terminated by Sponsor|81
7564807|NCT02312206|26302695|P2|Overall Study|Death|36
7564808|NCT02312206|26302696|P1|Overall Study|Death|30
7564809|NCT02312206|26302695|P2|Overall Study|Physician Decision|6
7564810|NCT02312206|26302696|P1|Overall Study|Physician Decision|7
7564811|NCT02312206|26302695|P2|Overall Study|Withdrawal by Subject|6
7564812|NCT02312206|26302696|P1|Overall Study|Withdrawal by Subject|7
7564813|NCT02312206|26302695|P2|Overall Study|Adverse Event|6
7564814|NCT02312206|26302696|P1|Overall Study|Adverse Event|3
7564815|NCT02312063|26302719|P2|Overall Study|Withdrawal by Subject|1
7564816|NCT02312063|26302720|P1|Overall Study|Withdrawal by Subject|0
7564817|NCT02311894|26302782|P1|Overall Study|Withdrawal by Subject|1
7564818|NCT02311894|26302782|P1|Overall Study|Adverse Event|1
7564819|NCT02311894|26302782|P1|Overall Study|Lost to Follow-up|1
7564820|NCT02311894|26302782|P1|Overall Study|Discontinued in error|1
7564821|NCT02311881|26302794|P3|Overall Study|Serious Adverse Event|0
7564822|NCT02311881|26302795|P2|Overall Study|Serious Adverse Event|1
7564823|NCT02311881|26302796|P1|Overall Study|Serious Adverse Event|0
7564824|NCT02311881|26302794|P3|Overall Study|Participant taking another medication|1
7564825|NCT02311881|26302795|P2|Overall Study|Participant taking another medication|0
7564826|NCT02311881|26302796|P1|Overall Study|Participant taking another medication|0
7564827|NCT02311881|26302794|P3|Overall Study|Medical Monitor Discretion|1
7564828|NCT02311881|26302795|P2|Overall Study|Medical Monitor Discretion|0
7564829|NCT02311881|26302796|P1|Overall Study|Medical Monitor Discretion|0
7564830|NCT02311881|26302794|P3|Overall Study|Physician Decision|1
7564831|NCT02311881|26302795|P2|Overall Study|Physician Decision|0
7564832|NCT02311881|26302796|P1|Overall Study|Physician Decision|0
7564833|NCT02311881|26302794|P3|Overall Study|Non-Compliance|2
7564834|NCT02311881|26302795|P2|Overall Study|Non-Compliance|0
7564835|NCT02311881|26302796|P1|Overall Study|Non-Compliance|1
7564836|NCT02311881|26302794|P3|Overall Study|Protocol Deviation|0
7564837|NCT02311881|26302795|P2|Overall Study|Protocol Deviation|0
7564838|NCT02311881|26302796|P1|Overall Study|Protocol Deviation|1
7564839|NCT02311881|26302794|P3|Overall Study|Sponsor Decision|1
7564840|NCT02311881|26302795|P2|Overall Study|Sponsor Decision|1
7564841|NCT02311881|26302796|P1|Overall Study|Sponsor Decision|1
7564842|NCT02311881|26302794|P3|Overall Study|Withdrawal by Subject|4
7564843|NCT02311881|26302795|P2|Overall Study|Withdrawal by Subject|1
7564844|NCT02311881|26302796|P1|Overall Study|Withdrawal by Subject|3
7564845|NCT02311881|26302794|P3|Overall Study|Subject has border line pregnancy test|0
7564846|NCT02311881|26302795|P2|Overall Study|Subject has border line pregnancy test|0
7564847|NCT02311881|26302796|P1|Overall Study|Subject has border line pregnancy test|1
7564848|NCT02311881|26302794|P3|Overall Study|Lack of Efficacy|0
7564849|NCT02311881|26302795|P2|Overall Study|Lack of Efficacy|2
7564850|NCT02311881|26302796|P1|Overall Study|Lack of Efficacy|1
7564851|NCT02311881|26302794|P3|Overall Study|Other|1
7564852|NCT02311881|26302795|P2|Overall Study|Other|0
7564853|NCT02311881|26302796|P1|Overall Study|Other|0
7564854|NCT02311881|26302794|P3|Overall Study|Withdrawal of consent|17
7564855|NCT02311881|26302795|P2|Overall Study|Withdrawal of consent|16
7564856|NCT02311881|26302796|P1|Overall Study|Withdrawal of consent|14
7564857|NCT02311881|26302794|P3|Overall Study|Protocol Violation|3
7564858|NCT02311881|26302795|P2|Overall Study|Protocol Violation|2
7564859|NCT02311881|26302796|P1|Overall Study|Protocol Violation|1
7564860|NCT02311881|26302794|P3|Overall Study|Lost to Follow-up|2
7564861|NCT02311881|26302795|P2|Overall Study|Lost to Follow-up|3
7564862|NCT02311881|26302796|P1|Overall Study|Lost to Follow-up|3
7564863|NCT02311881|26302794|P3|Overall Study|Adverse Event|8
7564864|NCT02311881|26302795|P2|Overall Study|Adverse Event|15
7564865|NCT02311881|26302796|P1|Overall Study|Adverse Event|7
7564866|NCT02311881|26302794|P3|Overall Study|Did not meet the study criteria|0
7564867|NCT02311881|26302795|P2|Overall Study|Did not meet the study criteria|2
7564868|NCT02311881|26302796|P1|Overall Study|Did not meet the study criteria|2
7564869|NCT02311478|26302831|P1|Overall Study|Failed IUD Insertion|1
7564870|NCT02311478|26302831|P1|Overall Study|Lost to Follow-up|5
7564871|NCT02311478|26302831|P1|Overall Study|Withdrawal by Subject|1
7564872|NCT02311361|26302840|P4|Overall Study|Did not receive treatment|1
7564873|NCT02311361|26302841|P3|Overall Study|Did not receive treatment|0
7564874|NCT02311361|26302842|P2|Overall Study|Did not receive treatment|1
7564875|NCT02311361|26302843|P1|Overall Study|Did not receive treatment|0
7564876|NCT02311153|26302895|P2|Overall Study|Lost to Follow-up|7
7564877|NCT02311153|26302896|P1|Overall Study|Lost to Follow-up|5
7564878|NCT02310906|26302916|P4|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
7564879|NCT02310906|26302917|P3|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7564880|NCT02310906|26302918|P2|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7564881|NCT02310906|26302919|P1|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7564882|NCT02310906|26302916|P4|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
7564883|NCT02310906|26302917|P3|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7564884|NCT02310906|26302918|P2|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7564885|NCT02310906|26302919|P1|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7564886|NCT02310906|26302916|P4|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
7564887|NCT02310906|26302917|P3|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
7564888|NCT02310906|26302918|P2|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7564889|NCT02310906|26302919|P1|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7564890|NCT02310906|26302916|P4|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
7564891|NCT02310906|26302917|P3|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7564892|NCT02310906|26302918|P2|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7564893|NCT02310906|26302919|P1|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7564894|NCT02310789|26302998|P1|Overall Study|Adverse Event|1
7564895|NCT02310763|26303010|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7564896|NCT02310763|26303011|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7564897|NCT02310763|26303012|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7564898|NCT02310763|26303010|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
7564899|NCT02310763|26303011|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
7564900|NCT02310763|26303012|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
7564901|NCT02310763|26303010|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7564902|NCT02310763|26303011|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7564903|NCT02310763|26303012|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
7564904|NCT02310763|26303010|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7564905|NCT02310763|26303011|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7564906|NCT02310763|26303012|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
7564907|NCT02310763|26303010|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7564908|NCT02310763|26303011|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7564909|NCT02310763|26303012|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7564910|NCT02310750|26303215|P16|HP Washout 2|Lost to Follow-up|0
7564911|NCT02310750|26303216|P15|HP Washout 2|Lost to Follow-up|0
7564912|NCT02310750|26303217|P14|HP Washout 2|Lost to Follow-up|0
7564913|NCT02310750|26303218|P13|HP Washout 2|Lost to Follow-up|0
7564914|NCT02310750|26303219|P12|HP Washout 2|Lost to Follow-up|0
7564915|NCT02310750|26303220|P11|HP Washout 2|Lost to Follow-up|0
7564916|NCT02310750|26303221|P10|HP Washout 2|Lost to Follow-up|0
7564917|NCT02310750|26303222|P9|HP Washout 2|Lost to Follow-up|0
7564918|NCT02310750|26303223|P8|HP Washout 2|Lost to Follow-up|0
7564919|NCT02310750|26303224|P7|HP Washout 2|Lost to Follow-up|7
7564920|NCT02310750|26303225|P6|HP Washout 2|Lost to Follow-up|0
7564921|NCT02310750|26303226|P5|HP Washout 2|Lost to Follow-up|1
7564922|NCT02310750|26303227|P4|HP Washout 2|Lost to Follow-up|0
7564923|NCT02310750|26303228|P3|HP Washout 2|Lost to Follow-up|0
7564924|NCT02310750|26303229|P2|HP Washout 2|Lost to Follow-up|0
7564925|NCT02310750|26303230|P1|HP Washout 2|Lost to Follow-up|0
7564926|NCT02310750|26303215|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564927|NCT02310750|26303216|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564928|NCT02310750|26303217|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564929|NCT02310750|26303218|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564930|NCT02310750|26303219|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564931|NCT02310750|26303220|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564932|NCT02310750|26303221|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564933|NCT02310750|26303222|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7564934|NCT02310750|26303223|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7564935|NCT02310750|26303224|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564936|NCT02310750|26303225|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564937|NCT02310750|26303226|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564938|NCT02310750|26303227|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564939|NCT02310750|26303228|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564940|NCT02310750|26303229|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564941|NCT02310750|26303230|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7564942|NCT02310750|26303215|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564943|NCT02310750|26303216|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564944|NCT02310750|26303217|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564945|NCT02310750|26303218|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564946|NCT02310750|26303219|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564947|NCT02310750|26303220|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564948|NCT02310750|26303221|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7564949|NCT02310750|26303222|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7564950|NCT02310750|26303223|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7564951|NCT02310750|26303224|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564952|NCT02310750|26303225|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564953|NCT02310750|26303226|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564954|NCT02310750|26303227|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564955|NCT02310750|26303228|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564956|NCT02310750|26303229|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564957|NCT02310750|26303230|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7564958|NCT02310750|26303215|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564959|NCT02310750|26303216|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564960|NCT02310750|26303217|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564961|NCT02310750|26303218|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564962|NCT02310750|26303219|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564963|NCT02310750|26303220|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564964|NCT02310750|26303221|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
7564965|NCT02310750|26303222|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564966|NCT02310750|26303223|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564967|NCT02310750|26303224|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564968|NCT02310750|26303225|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564969|NCT02310750|26303226|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564970|NCT02310750|26303227|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564971|NCT02310750|26303228|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564972|NCT02310750|26303229|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564973|NCT02310750|26303230|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7564974|NCT02310750|26303215|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564975|NCT02310750|26303216|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564976|NCT02310750|26303217|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564977|NCT02310750|26303218|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564978|NCT02310750|26303219|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564979|NCT02310750|26303220|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564980|NCT02310750|26303221|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7564981|NCT02310750|26303222|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
7564982|NCT02310750|26303223|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564983|NCT02310750|26303224|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564984|NCT02310750|26303225|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
7564985|NCT02310750|26303226|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564986|NCT02310750|26303227|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7564987|NCT02310750|26303228|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564988|NCT02310750|26303229|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564989|NCT02310750|26303230|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7564990|NCT02310750|26303215|P16|HP Washout 1|Lost to Follow-up|0
7564991|NCT02310750|26303216|P15|HP Washout 1|Lost to Follow-up|0
7564992|NCT02310750|26303217|P14|HP Washout 1|Lost to Follow-up|0
7564993|NCT02310750|26303218|P13|HP Washout 1|Lost to Follow-up|0
7564994|NCT02310750|26303219|P12|HP Washout 1|Lost to Follow-up|0
7564995|NCT02310750|26303220|P11|HP Washout 1|Lost to Follow-up|0
7564996|NCT02310750|26303221|P10|HP Washout 1|Lost to Follow-up|0
7564997|NCT02310750|26303222|P9|HP Washout 1|Lost to Follow-up|0
7564998|NCT02310750|26303223|P8|HP Washout 1|Lost to Follow-up|0
7564999|NCT02310750|26303224|P7|HP Washout 1|Lost to Follow-up|3
7565000|NCT02310750|26303225|P6|HP Washout 1|Lost to Follow-up|2
7565001|NCT02310750|26303226|P5|HP Washout 1|Lost to Follow-up|2
7565002|NCT02310750|26303227|P4|HP Washout 1|Lost to Follow-up|1
7565003|NCT02310750|26303228|P3|HP Washout 1|Lost to Follow-up|1
7565004|NCT02310750|26303229|P2|HP Washout 1|Lost to Follow-up|0
7565005|NCT02310750|26303230|P1|HP Washout 1|Lost to Follow-up|0
7565006|NCT02310750|26303215|P16|HP Period 1|Withdrawal by Subject|0
7565007|NCT02310750|26303216|P15|HP Period 1|Withdrawal by Subject|0
7565008|NCT02310750|26303217|P14|HP Period 1|Withdrawal by Subject|0
7565009|NCT02310750|26303218|P13|HP Period 1|Withdrawal by Subject|0
7565010|NCT02310750|26303219|P12|HP Period 1|Withdrawal by Subject|0
7565011|NCT02310750|26303220|P11|HP Period 1|Withdrawal by Subject|0
7565012|NCT02310750|26303221|P10|HP Period 1|Withdrawal by Subject|0
7565013|NCT02310750|26303222|P9|HP Period 1|Withdrawal by Subject|0
7565014|NCT02310750|26303223|P8|HP Period 1|Withdrawal by Subject|0
7565015|NCT02310750|26303224|P7|HP Period 1|Withdrawal by Subject|0
7565016|NCT02310750|26303225|P6|HP Period 1|Withdrawal by Subject|0
7565017|NCT02310750|26303226|P5|HP Period 1|Withdrawal by Subject|0
7565018|NCT02310750|26303227|P4|HP Period 1|Withdrawal by Subject|1
7565019|NCT02310750|26303228|P3|HP Period 1|Withdrawal by Subject|0
7565020|NCT02310750|26303229|P2|HP Period 1|Withdrawal by Subject|0
7565021|NCT02310750|26303230|P1|HP Period 1|Withdrawal by Subject|1
7565022|NCT02310750|26303215|P16|HP Period 1|Lost to Follow-up|0
7565023|NCT02310750|26303216|P15|HP Period 1|Lost to Follow-up|0
7565024|NCT02310750|26303217|P14|HP Period 1|Lost to Follow-up|0
7565025|NCT02310750|26303218|P13|HP Period 1|Lost to Follow-up|0
7565026|NCT02310750|26303219|P12|HP Period 1|Lost to Follow-up|0
7565027|NCT02310750|26303220|P11|HP Period 1|Lost to Follow-up|0
7565028|NCT02310750|26303221|P10|HP Period 1|Lost to Follow-up|0
7565029|NCT02310750|26303222|P9|HP Period 1|Lost to Follow-up|0
7565030|NCT02310750|26303223|P8|HP Period 1|Lost to Follow-up|0
7565031|NCT02310750|26303224|P7|HP Period 1|Lost to Follow-up|1
7565032|NCT02310750|26303225|P6|HP Period 1|Lost to Follow-up|0
7565033|NCT02310750|26303226|P5|HP Period 1|Lost to Follow-up|0
7565034|NCT02310750|26303227|P4|HP Period 1|Lost to Follow-up|0
7565035|NCT02310750|26303228|P3|HP Period 1|Lost to Follow-up|0
7565036|NCT02310750|26303229|P2|HP Period 1|Lost to Follow-up|0
7565037|NCT02310750|26303230|P1|HP Period 1|Lost to Follow-up|0
7565038|NCT02310672|26303669|P1|Overall Study|Sponsor's decision|12
7565039|NCT02310672|26303669|P1|Overall Study|Withdrawal by Subject|1
7565040|NCT02310672|26303669|P1|Overall Study|Lost to Follow-up|1
7565041|NCT02310672|26303669|P1|Overall Study|Death|1
7565042|NCT02310646|26303682|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
7565043|NCT02310646|26303683|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
7565044|NCT02310646|26303682|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
7565045|NCT02310646|26303683|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
7565046|NCT02310581|26303711|P4|Overall Study|Withdrawal by Subject|1
7565047|NCT02310581|26303712|P3|Overall Study|Withdrawal by Subject|0
7565048|NCT02310581|26303713|P2|Overall Study|Withdrawal by Subject|1
7565049|NCT02310581|26303714|P1|Overall Study|Withdrawal by Subject|2
7565050|NCT02310581|26303711|P4|Overall Study|Adverse Event|0
7565051|NCT02310581|26303712|P3|Overall Study|Adverse Event|1
7565052|NCT02310581|26303713|P2|Overall Study|Adverse Event|1
7565053|NCT02310581|26303714|P1|Overall Study|Adverse Event|1
7565054|NCT02310568|26303753|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
7565055|NCT02310568|26303754|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
7565056|NCT02310568|26303755|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
7565057|NCT02310568|26303756|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
7565058|NCT02310568|26303757|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
7565059|NCT02310568|26303753|P5|Stage 2 (4 Weeks)|Protocol Violation|0
7565060|NCT02310568|26303754|P4|Stage 2 (4 Weeks)|Protocol Violation|1
7565061|NCT02310568|26303755|P3|Stage 2 (4 Weeks)|Protocol Violation|0
7565062|NCT02310568|26303756|P2|Stage 2 (4 Weeks)|Protocol Violation|0
7565063|NCT02310568|26303757|P1|Stage 2 (4 Weeks)|Protocol Violation|0
7565064|NCT02310568|26303753|P5|Stage 2 (4 Weeks)|Adverse Event|1
7565065|NCT02310568|26303754|P4|Stage 2 (4 Weeks)|Adverse Event|1
7565066|NCT02310568|26303755|P3|Stage 2 (4 Weeks)|Adverse Event|0
7565067|NCT02310568|26303756|P2|Stage 2 (4 Weeks)|Adverse Event|0
7565068|NCT02310568|26303757|P1|Stage 2 (4 Weeks)|Adverse Event|0
7565069|NCT02310568|26303753|P5|Stage 2 (4 Weeks)|Other|0
7565070|NCT02310568|26303754|P4|Stage 2 (4 Weeks)|Other|0
7565071|NCT02310568|26303755|P3|Stage 2 (4 Weeks)|Other|1
7565072|NCT02310568|26303756|P2|Stage 2 (4 Weeks)|Other|1
7565073|NCT02310568|26303757|P1|Stage 2 (4 Weeks)|Other|0
7565074|NCT02310568|26303753|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7565075|NCT02310568|26303754|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7565076|NCT02310568|26303755|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7565077|NCT02310568|26303756|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7565078|NCT02310568|26303757|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7565079|NCT02310568|26303753|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7565080|NCT02310568|26303754|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
7565081|NCT02310568|26303755|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7565082|NCT02310568|26303756|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7565083|NCT02310568|26303757|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7565084|NCT02310568|26303753|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7565173|NCT02309112|26304126|P2|Overall Study|Withdrawal by Subject|0
7565085|NCT02310568|26303754|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
7565086|NCT02310568|26303755|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7565087|NCT02310568|26303756|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7565088|NCT02310568|26303757|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7565089|NCT02310568|26303753|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
7565090|NCT02310568|26303754|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
7565091|NCT02310568|26303755|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
7565092|NCT02310568|26303756|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
7565093|NCT02310568|26303757|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
7565094|NCT02310568|26303753|P5|Stage 1 ( 4 Weeks)|Other|0
7565095|NCT02310568|26303754|P4|Stage 1 ( 4 Weeks)|Other|0
7565096|NCT02310568|26303755|P3|Stage 1 ( 4 Weeks)|Other|0
7565097|NCT02310568|26303756|P2|Stage 1 ( 4 Weeks)|Other|1
7565098|NCT02310568|26303757|P1|Stage 1 ( 4 Weeks)|Other|1
7565099|NCT02310568|26303753|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7565100|NCT02310568|26303754|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7565101|NCT02310568|26303755|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7565102|NCT02310568|26303756|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7565103|NCT02310568|26303757|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
7565104|NCT02310568|26303753|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
7565105|NCT02310568|26303754|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7565106|NCT02310568|26303755|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7565107|NCT02310568|26303756|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7565108|NCT02310568|26303757|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7565109|NCT02310126|26303837|P2|Period 1 (15 Minutes)|Protocol Violation|1
7565110|NCT02310126|26303838|P1|Period 1 (15 Minutes)|Protocol Violation|0
7565111|NCT02310126|26303837|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
7565112|NCT02310126|26303838|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
7565113|NCT02310100|26303844|P1|Overall Study|Lost to Follow-up|2
7565114|NCT02310100|26303844|P1|Overall Study|Visit compliance|1
7565115|NCT02310100|26303844|P1|Overall Study|Unapproved ablation operator|1
7565116|NCT02310100|26303844|P1|Overall Study|Enrollment closure|1
7565117|NCT02310100|26303844|P1|Overall Study|Withdrawal by Subject|10
7565118|NCT02310100|26303844|P1|Overall Study|Physician Decision|3
7565119|NCT02309723|26303863|P3|Overall Study|Withdrawal by Subject|24
7565120|NCT02309723|26303864|P2|Overall Study|Withdrawal by Subject|23
7565121|NCT02309723|26303865|P1|Overall Study|Withdrawal by Subject|24
7565122|NCT02309515|26303881|P2|Overall Study|Withdrawal by Subject|1
7565123|NCT02309515|26303882|P1|Overall Study|Withdrawal by Subject|0
7565124|NCT02309411|26303923|P3|Overall Study|Withdrawal by Subject|0
7565125|NCT02309411|26303924|P2|Overall Study|Withdrawal by Subject|1
7565126|NCT02309411|26303925|P1|Overall Study|Withdrawal by Subject|1
7565127|NCT02309411|26303923|P3|Overall Study|Physician Decision|0
7565128|NCT02309411|26303924|P2|Overall Study|Physician Decision|0
7565129|NCT02309411|26303925|P1|Overall Study|Physician Decision|1
7565130|NCT02309372|26303946|P2|Overall Study|Lost to Follow-up|2
7565131|NCT02309372|26303947|P1|Overall Study|Lost to Follow-up|3
7565132|NCT02309359|26303964|P5|Overall Study|Other|2
7565133|NCT02309359|26303965|P4|Overall Study|Other|3
7565134|NCT02309359|26303966|P3|Overall Study|Other|2
7565135|NCT02309359|26303967|P2|Overall Study|Other|0
7565136|NCT02309359|26303968|P1|Overall Study|Other|2
7565137|NCT02309359|26303964|P5|Overall Study|Lost to Follow-up|0
7565138|NCT02309359|26303965|P4|Overall Study|Lost to Follow-up|1
7565139|NCT02309359|26303966|P3|Overall Study|Lost to Follow-up|0
7565140|NCT02309359|26303967|P2|Overall Study|Lost to Follow-up|0
7565141|NCT02309359|26303968|P1|Overall Study|Lost to Follow-up|0
7565142|NCT02309359|26303964|P5|Overall Study|Lack of Efficacy|3
7565143|NCT02309359|26303965|P4|Overall Study|Lack of Efficacy|0
7565144|NCT02309359|26303966|P3|Overall Study|Lack of Efficacy|0
7565145|NCT02309359|26303967|P2|Overall Study|Lack of Efficacy|1
7565146|NCT02309359|26303968|P1|Overall Study|Lack of Efficacy|3
7565147|NCT02309359|26303964|P5|Overall Study|Withdrawal by Subject|0
7565148|NCT02309359|26303965|P4|Overall Study|Withdrawal by Subject|4
7565149|NCT02309359|26303966|P3|Overall Study|Withdrawal by Subject|4
7565150|NCT02309359|26303967|P2|Overall Study|Withdrawal by Subject|2
7565151|NCT02309359|26303968|P1|Overall Study|Withdrawal by Subject|2
7565152|NCT02309359|26303964|P5|Overall Study|Death|0
7565153|NCT02309359|26303965|P4|Overall Study|Death|0
7565154|NCT02309359|26303966|P3|Overall Study|Death|0
7565155|NCT02309359|26303967|P2|Overall Study|Death|0
7565156|NCT02309359|26303968|P1|Overall Study|Death|1
7565157|NCT02309359|26303964|P5|Overall Study|Adverse Event|4
7565158|NCT02309359|26303965|P4|Overall Study|Adverse Event|4
7565159|NCT02309359|26303966|P3|Overall Study|Adverse Event|5
7565160|NCT02309359|26303967|P2|Overall Study|Adverse Event|5
7565161|NCT02309359|26303968|P1|Overall Study|Adverse Event|4
7565162|NCT02309294|26304095|P1|Overall Study|Withdrawal by Subject|2
7565163|NCT02309138|26304101|P2|Overall Study|delivered before visit 2|1
7565164|NCT02309138|26304102|P1|Overall Study|delivered before visit 2|0
7565165|NCT02309138|26304101|P2|Overall Study|Protocol Violation|2
7565166|NCT02309138|26304102|P1|Overall Study|Protocol Violation|4
7565167|NCT02309138|26304101|P2|Overall Study|Withdrawal by Subject|15
7565168|NCT02309138|26304102|P1|Overall Study|Withdrawal by Subject|44
7565169|NCT02309112|26304125|P3|Overall Study|Lost to Follow-up|0
7565170|NCT02309112|26304126|P2|Overall Study|Lost to Follow-up|1
7565171|NCT02309112|26304127|P1|Overall Study|Lost to Follow-up|0
7565172|NCT02309112|26304125|P3|Overall Study|Withdrawal by Subject|1
7565174|NCT02309112|26304127|P1|Overall Study|Withdrawal by Subject|1
7565175|NCT02309099|26304150|P2|Overall Study|Adverse Event|0
7565176|NCT02309099|26304151|P1|Overall Study|Adverse Event|2
7565177|NCT02308748|26304222|P10|Period 5|Adverse Event|0
7565178|NCT02308748|26304223|P9|Period 5|Adverse Event|1
7565179|NCT02308748|26304224|P8|Period 5|Adverse Event|0
7565180|NCT02308748|26304225|P7|Period 5|Adverse Event|0
7565181|NCT02308748|26304226|P6|Period 5|Adverse Event|0
7565182|NCT02308748|26304227|P5|Period 5|Adverse Event|0
7565183|NCT02308748|26304228|P4|Period 5|Adverse Event|0
7565184|NCT02308748|26304229|P3|Period 5|Adverse Event|0
7565185|NCT02308748|26304230|P2|Period 5|Adverse Event|0
7565186|NCT02308748|26304231|P1|Period 5|Adverse Event|1
7565187|NCT02308748|26304222|P10|Period 3|Protocol Violation|1
7565188|NCT02308748|26304223|P9|Period 3|Protocol Violation|0
7565189|NCT02308748|26304224|P8|Period 3|Protocol Violation|0
7565190|NCT02308748|26304225|P7|Period 3|Protocol Violation|0
7565191|NCT02308748|26304226|P6|Period 3|Protocol Violation|0
7565192|NCT02308748|26304227|P5|Period 3|Protocol Violation|0
7565193|NCT02308748|26304228|P4|Period 3|Protocol Violation|0
7565194|NCT02308748|26304229|P3|Period 3|Protocol Violation|0
7565195|NCT02308748|26304230|P2|Period 3|Protocol Violation|0
7565196|NCT02308748|26304231|P1|Period 3|Protocol Violation|0
7565197|NCT02308748|26304222|P10|Period 2|Adverse Event|0
7565198|NCT02308748|26304223|P9|Period 2|Adverse Event|0
7565199|NCT02308748|26304224|P8|Period 2|Adverse Event|1
7565200|NCT02308748|26304225|P7|Period 2|Adverse Event|0
7565201|NCT02308748|26304226|P6|Period 2|Adverse Event|0
7565202|NCT02308748|26304227|P5|Period 2|Adverse Event|0
7565203|NCT02308748|26304228|P4|Period 2|Adverse Event|0
7565204|NCT02308748|26304229|P3|Period 2|Adverse Event|0
7565205|NCT02308748|26304230|P2|Period 2|Adverse Event|0
7565206|NCT02308748|26304231|P1|Period 2|Adverse Event|0
7565207|NCT02308748|26304222|P10|Period 1|Withdrawal by Subject|0
7565208|NCT02308748|26304223|P9|Period 1|Withdrawal by Subject|0
7565209|NCT02308748|26304224|P8|Period 1|Withdrawal by Subject|0
7565210|NCT02308748|26304225|P7|Period 1|Withdrawal by Subject|0
7565211|NCT02308748|26304226|P6|Period 1|Withdrawal by Subject|0
7565212|NCT02308748|26304227|P5|Period 1|Withdrawal by Subject|0
7565213|NCT02308748|26304228|P4|Period 1|Withdrawal by Subject|0
7565214|NCT02308748|26304229|P3|Period 1|Withdrawal by Subject|1
7565215|NCT02308748|26304230|P2|Period 1|Withdrawal by Subject|0
7565216|NCT02308748|26304231|P1|Period 1|Withdrawal by Subject|0
7565217|NCT02308735|26304247|P4|Overall Study|Physician Decision|2
7565218|NCT02308735|26304248|P3|Overall Study|Physician Decision|0
7565219|NCT02308735|26304249|P2|Overall Study|Physician Decision|0
7565220|NCT02308735|26304250|P1|Overall Study|Physician Decision|2
7565221|NCT02308696|26304262|P2|Overall Study|Moved to a Higher Level of Care|6
7565222|NCT02308696|26304263|P1|Overall Study|Moved to a Higher Level of Care|17
7565223|NCT02308696|26304262|P2|Overall Study|Death|4
7565224|NCT02308696|26304263|P1|Overall Study|Death|8
7565225|NCT02308696|26304262|P2|Overall Study|Lost to Follow-up|21
7565226|NCT02308696|26304263|P1|Overall Study|Lost to Follow-up|28
7565227|NCT02308540|26304297|P6|Overall Study|Lost to Follow-up|1
7565228|NCT02308540|26304298|P5|Overall Study|Lost to Follow-up|0
7565229|NCT02308540|26304299|P4|Overall Study|Lost to Follow-up|0
7565230|NCT02308540|26304300|P3|Overall Study|Lost to Follow-up|0
7565231|NCT02308540|26304301|P2|Overall Study|Lost to Follow-up|0
7565232|NCT02308540|26304302|P1|Overall Study|Lost to Follow-up|0
7565233|NCT02308228|26304406|P2|Overall Study|Withdrawal by Subject|3
7565234|NCT02308228|26304407|P1|Overall Study|Withdrawal by Subject|5
7565235|NCT02308228|26304406|P2|Overall Study|Adverse Event|4
7565236|NCT02308228|26304407|P1|Overall Study|Adverse Event|3
7565237|NCT02308163|26304436|P5|Overall Study|Miscellaneous|5
7565238|NCT02308163|26304437|P4|Overall Study|Miscellaneous|0
7565239|NCT02308163|26304438|P3|Overall Study|Miscellaneous|1
7565240|NCT02308163|26304439|P2|Overall Study|Miscellaneous|2
7565241|NCT02308163|26304440|P1|Overall Study|Miscellaneous|2
7565242|NCT02308163|26304436|P5|Overall Study|Lab data met discontinuation criteria|0
7565243|NCT02308163|26304437|P4|Overall Study|Lab data met discontinuation criteria|2
7565244|NCT02308163|26304438|P3|Overall Study|Lab data met discontinuation criteria|0
7565245|NCT02308163|26304439|P2|Overall Study|Lab data met discontinuation criteria|0
7565246|NCT02308163|26304440|P1|Overall Study|Lab data met discontinuation criteria|3
7565247|NCT02308163|26304436|P5|Overall Study|Protocol Violation|5
7565248|NCT02308163|26304437|P4|Overall Study|Protocol Violation|2
7565249|NCT02308163|26304438|P3|Overall Study|Protocol Violation|3
7565250|NCT02308163|26304439|P2|Overall Study|Protocol Violation|3
7565251|NCT02308163|26304440|P1|Overall Study|Protocol Violation|3
7565252|NCT02308163|26304436|P5|Overall Study|Withdrawal of consent|6
7565253|NCT02308163|26304437|P4|Overall Study|Withdrawal of consent|2
7565254|NCT02308163|26304438|P3|Overall Study|Withdrawal of consent|0
7565255|NCT02308163|26304439|P2|Overall Study|Withdrawal of consent|3
7565256|NCT02308163|26304440|P1|Overall Study|Withdrawal of consent|2
7565257|NCT02308163|26304436|P5|Overall Study|Lack of Efficacy|6
7565258|NCT02308163|26304437|P4|Overall Study|Lack of Efficacy|4
7565259|NCT02308163|26304438|P3|Overall Study|Lack of Efficacy|8
7565260|NCT02308163|26304439|P2|Overall Study|Lack of Efficacy|3
7565261|NCT02308163|26304440|P1|Overall Study|Lack of Efficacy|11
7565262|NCT02308163|26304436|P5|Overall Study|Adverse Event|11
7565263|NCT02308163|26304437|P4|Overall Study|Adverse Event|2
7565264|NCT02308163|26304438|P3|Overall Study|Adverse Event|2
7565265|NCT02308163|26304439|P2|Overall Study|Adverse Event|5
7565266|NCT02308163|26304440|P1|Overall Study|Adverse Event|9
7565267|NCT02308163|26304436|P5|Overall Study|Not fulfill eligible criteria|1
7565268|NCT02308163|26304437|P4|Overall Study|Not fulfill eligible criteria|1
7565269|NCT02308163|26304438|P3|Overall Study|Not fulfill eligible criteria|0
7565270|NCT02308163|26304439|P2|Overall Study|Not fulfill eligible criteria|2
7565271|NCT02308163|26304440|P1|Overall Study|Not fulfill eligible criteria|1
7565278|NCT02308046|26304774|P2|Overall Study|Lost to Follow-up|3
7565279|NCT02308046|26304775|P1|Overall Study|Lost to Follow-up|1
7565280|NCT02308046|26304774|P2|Overall Study|Positive for STD at Baseline|2
7565281|NCT02308046|26304775|P1|Overall Study|Positive for STD at Baseline|1
7565282|NCT02308046|26304774|P2|Overall Study|Negative yeast culture at Baseline|33
7565283|NCT02308046|26304775|P1|Overall Study|Negative yeast culture at Baseline|32
7565284|NCT02308033|26304791|P2|Overall Study|Lost to Follow-up|5
7565285|NCT02308033|26304792|P1|Overall Study|Lost to Follow-up|6
7565286|NCT02308033|26304791|P2|Overall Study|Positive for STD at Baseline|4
7565287|NCT02308033|26304792|P1|Overall Study|Positive for STD at Baseline|7
7565288|NCT02308033|26304791|P2|Overall Study|Normal Gram stain at Baseline|10
7565289|NCT02308033|26304792|P1|Overall Study|Normal Gram stain at Baseline|13
7565290|NCT02308020|26304812|P6|Overall Study|Withdrawal by Subject|2
7565291|NCT02308020|26304813|P5|Overall Study|Withdrawal by Subject|1
7565292|NCT02308020|26304814|P4|Overall Study|Withdrawal by Subject|2
7565293|NCT02308020|26304815|P3|Overall Study|Withdrawal by Subject|3
7565294|NCT02308020|26304816|P2|Overall Study|Withdrawal by Subject|5
7565295|NCT02308020|26304817|P1|Overall Study|Withdrawal by Subject|3
7565296|NCT02308020|26304812|P6|Overall Study|Sponsor Decision|1
7565297|NCT02308020|26304813|P5|Overall Study|Sponsor Decision|2
7565298|NCT02308020|26304814|P4|Overall Study|Sponsor Decision|2
7565299|NCT02308020|26304815|P3|Overall Study|Sponsor Decision|0
7565300|NCT02308020|26304816|P2|Overall Study|Sponsor Decision|8
7565301|NCT02308020|26304817|P1|Overall Study|Sponsor Decision|0
7565302|NCT02308020|26304812|P6|Overall Study|Lost to Follow-up|2
7565303|NCT02308020|26304813|P5|Overall Study|Lost to Follow-up|1
7565304|NCT02308020|26304814|P4|Overall Study|Lost to Follow-up|0
7565305|NCT02308020|26304815|P3|Overall Study|Lost to Follow-up|0
7565306|NCT02308020|26304816|P2|Overall Study|Lost to Follow-up|7
7565307|NCT02308020|26304817|P1|Overall Study|Lost to Follow-up|1
7565308|NCT02308007|26304874|P3|Overall Study|Lost to Follow-up|1
7565309|NCT02308007|26304875|P2|Overall Study|Lost to Follow-up|0
7565310|NCT02308007|26304876|P1|Overall Study|Lost to Follow-up|3
7565311|NCT02308007|26304874|P3|Overall Study|Positive for STD at Baseline|7
7565312|NCT02308007|26304875|P2|Overall Study|Positive for STD at Baseline|11
7565313|NCT02308007|26304876|P1|Overall Study|Positive for STD at Baseline|7
7565314|NCT02308007|26304874|P3|Overall Study|Normal Gram stain or neg yeast culture|67
7565315|NCT02308007|26304875|P2|Overall Study|Normal Gram stain or neg yeast culture|64
7565316|NCT02308007|26304876|P1|Overall Study|Normal Gram stain or neg yeast culture|66
7565317|NCT02307682|26304967|P3|Overall Study|Other|0
7565318|NCT02307682|26304968|P2|Overall Study|Other|1
7565319|NCT02307682|26304969|P1|Overall Study|Other|1
7565320|NCT02307682|26304967|P3|Overall Study|Protocol Deviation|2
7565321|NCT02307682|26304968|P2|Overall Study|Protocol Deviation|0
7565322|NCT02307682|26304969|P1|Overall Study|Protocol Deviation|0
7565323|NCT02307682|26304967|P3|Overall Study|Lost to Follow-up|6
7565324|NCT02307682|26304968|P2|Overall Study|Lost to Follow-up|5
7565325|NCT02307682|26304969|P1|Overall Study|Lost to Follow-up|1
7565326|NCT02307682|26304967|P3|Overall Study|Death|12
7565327|NCT02307682|26304968|P2|Overall Study|Death|7
7565328|NCT02307682|26304969|P1|Overall Study|Death|9
7565329|NCT02307682|26304967|P3|Overall Study|Withdrawal by Subject|23
7565330|NCT02307682|26304968|P2|Overall Study|Withdrawal by Subject|34
7565331|NCT02307682|26304969|P1|Overall Study|Withdrawal by Subject|26
7565332|NCT02307682|26304967|P3|Overall Study|Progressive Disease|0
7565333|NCT02307682|26304968|P2|Overall Study|Progressive Disease|0
7565334|NCT02307682|26304969|P1|Overall Study|Progressive Disease|1
7565335|NCT02307682|26304967|P3|Overall Study|Physician Decision|8
7565336|NCT02307682|26304968|P2|Overall Study|Physician Decision|2
7565337|NCT02307682|26304969|P1|Overall Study|Physician Decision|2
7565338|NCT02307682|26304967|P3|Overall Study|Lack of Efficacy|1
7565339|NCT02307682|26304968|P2|Overall Study|Lack of Efficacy|0
7565340|NCT02307682|26304969|P1|Overall Study|Lack of Efficacy|1
7565341|NCT02307682|26304967|P3|Overall Study|Adverse Event|12
7565342|NCT02307682|26304968|P2|Overall Study|Adverse Event|8
7565343|NCT02307682|26304969|P1|Overall Study|Adverse Event|9
7565344|NCT02307513|26305085|P2|Long-term Extension|Physician Decision|0
7565345|NCT02307513|26305086|P1|Long-term Extension|Physician Decision|1
7565346|NCT02307513|26305085|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
7565347|NCT02307513|26305086|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
7565348|NCT02307513|26305085|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7565349|NCT02307513|26305086|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7565350|NCT02307513|26305085|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7565435|NCT02305797|26305476|P2|Overall Study|Lack of Efficacy|0
7565351|NCT02307513|26305086|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7565352|NCT02307513|26305085|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7565353|NCT02307513|26305086|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7565354|NCT02307513|26305085|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
7565355|NCT02307513|26305086|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
7565356|NCT02307513|26305085|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
7565357|NCT02307513|26305086|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
7565358|NCT02307513|26305085|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7565359|NCT02307513|26305086|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7565360|NCT02307513|26305085|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
7565361|NCT02307513|26305086|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
7565362|NCT02307513|26305085|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
7565363|NCT02307513|26305086|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
7565364|NCT02307513|26305085|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
7565365|NCT02307513|26305086|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
7565366|NCT02307513|26305085|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
7565367|NCT02307513|26305086|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
7565368|NCT02307513|26305085|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
7565369|NCT02307513|26305086|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
7565370|NCT02307370|26305128|P1|Overall Study|Protocol Violation|1
7565371|NCT02307370|26305128|P1|Overall Study|No response during telephone contact|5
7565372|NCT02307370|26305128|P1|Overall Study|Declined Addendum ICF|6
7565373|NCT02307370|26305128|P1|Overall Study|Withdrawal by Subject|1
7565374|NCT02307370|26305128|P1|Overall Study|Lost to Follow-up|1
7565375|NCT02307370|26305128|P1|Overall Study|Death|5
7565376|NCT02307266|26305149|P3|Overall Study|Lost to Follow-up|0
7565377|NCT02307266|26305150|P2|Overall Study|Lost to Follow-up|0
7565378|NCT02307266|26305151|P1|Overall Study|Lost to Follow-up|3
7565379|NCT02307266|26305149|P3|Overall Study|Withdrawal by Subject|1
7565380|NCT02307266|26305150|P2|Overall Study|Withdrawal by Subject|0
7565381|NCT02307266|26305151|P1|Overall Study|Withdrawal by Subject|2
7565382|NCT02307266|26305149|P3|Overall Study|Adverse Event|5
7565383|NCT02307266|26305150|P2|Overall Study|Adverse Event|1
7565384|NCT02307266|26305151|P1|Overall Study|Adverse Event|3
7565385|NCT02306850|26305176|P1|Overall Study|Lack of Efficacy|2
7565386|NCT02306694|26305198|P1|Overall Study|Lost to Follow-up|1
7565387|NCT02306694|26305198|P1|Overall Study|Withdrawal by Subject|3
7565388|NCT02306265|26305208|P1|Overall Study|Withdrawal by Subject|1
7565389|NCT02305888|26305217|P3|Overall Study|Adverse Event|0
7565390|NCT02305888|26305218|P2|Overall Study|Adverse Event|1
7565391|NCT02305888|26305219|P1|Overall Study|Adverse Event|0
7565392|NCT02305888|26305217|P3|Overall Study|Lost to Follow-up|1
7565393|NCT02305888|26305218|P2|Overall Study|Lost to Follow-up|0
7565394|NCT02305888|26305219|P1|Overall Study|Lost to Follow-up|0
7565395|NCT02305849|26305239|P4|Overall Study|Not fulfill eligibility criteria|0
7565396|NCT02305849|26305240|P3|Overall Study|Not fulfill eligibility criteria|0
7565397|NCT02305849|26305241|P2|Overall Study|Not fulfill eligibility criteria|1
7565398|NCT02305849|26305242|P1|Overall Study|Not fulfill eligibility criteria|1
7565399|NCT02305849|26305239|P4|Overall Study|Miscellaneous|1
7565400|NCT02305849|26305240|P3|Overall Study|Miscellaneous|4
7565401|NCT02305849|26305241|P2|Overall Study|Miscellaneous|2
7565402|NCT02305849|26305242|P1|Overall Study|Miscellaneous|1
7565403|NCT02305849|26305239|P4|Overall Study|Lab data met discontinuation criteria|1
7565404|NCT02305849|26305240|P3|Overall Study|Lab data met discontinuation criteria|2
7565405|NCT02305849|26305241|P2|Overall Study|Lab data met discontinuation criteria|1
7565406|NCT02305849|26305242|P1|Overall Study|Lab data met discontinuation criteria|0
7565407|NCT02305849|26305239|P4|Overall Study|Protocol Violation|1
7565408|NCT02305849|26305240|P3|Overall Study|Protocol Violation|1
7565409|NCT02305849|26305241|P2|Overall Study|Protocol Violation|2
7565410|NCT02305849|26305242|P1|Overall Study|Protocol Violation|3
7565411|NCT02305849|26305239|P4|Overall Study|Lost to Follow-up|0
7565412|NCT02305849|26305240|P3|Overall Study|Lost to Follow-up|0
7565413|NCT02305849|26305241|P2|Overall Study|Lost to Follow-up|2
7565414|NCT02305849|26305242|P1|Overall Study|Lost to Follow-up|0
7565415|NCT02305849|26305239|P4|Overall Study|Withdrawal by Subject|4
7565416|NCT02305849|26305240|P3|Overall Study|Withdrawal by Subject|1
7565417|NCT02305849|26305241|P2|Overall Study|Withdrawal by Subject|2
7565418|NCT02305849|26305242|P1|Overall Study|Withdrawal by Subject|2
7565419|NCT02305849|26305239|P4|Overall Study|Lack of Efficacy|9
7565420|NCT02305849|26305240|P3|Overall Study|Lack of Efficacy|3
7565421|NCT02305849|26305241|P2|Overall Study|Lack of Efficacy|6
7565422|NCT02305849|26305242|P1|Overall Study|Lack of Efficacy|10
7565423|NCT02305849|26305239|P4|Overall Study|Adverse Event|3
7565424|NCT02305849|26305240|P3|Overall Study|Adverse Event|7
7565425|NCT02305849|26305241|P2|Overall Study|Adverse Event|12
7565426|NCT02305849|26305242|P1|Overall Study|Adverse Event|10
7565427|NCT02305797|26305476|P2|Overall Study|Reason not collected|1
7565428|NCT02305797|26305477|P1|Overall Study|Reason not collected|0
7565429|NCT02305797|26305476|P2|Overall Study|Noncompliance|12
7565430|NCT02305797|26305477|P1|Overall Study|Noncompliance|14
7565431|NCT02305797|26305476|P2|Overall Study|Pregnancy|2
7565432|NCT02305797|26305477|P1|Overall Study|Pregnancy|0
7565433|NCT02305797|26305476|P2|Overall Study|Lost to Follow-up|11
7565434|NCT02305797|26305477|P1|Overall Study|Lost to Follow-up|5
7565436|NCT02305797|26305477|P1|Overall Study|Lack of Efficacy|6
7565437|NCT02305797|26305476|P2|Overall Study|Withdrawal by Subject|10
7565438|NCT02305797|26305477|P1|Overall Study|Withdrawal by Subject|9
7565439|NCT02305797|26305476|P2|Overall Study|Adverse Event|2
7565440|NCT02305797|26305477|P1|Overall Study|Adverse Event|11
7565441|NCT02305758|26305487|P2|Overall Study|Other, not specified|1
7565442|NCT02305758|26305488|P1|Overall Study|Other, not specified|2
7565443|NCT02305758|26305487|P2|Overall Study|Study Terminated by Sponsor|34
7565444|NCT02305758|26305488|P1|Overall Study|Study Terminated by Sponsor|21
7565445|NCT02305758|26305487|P2|Overall Study|Lost to Follow-up|1
7565446|NCT02305758|26305488|P1|Overall Study|Lost to Follow-up|6
7565447|NCT02305758|26305487|P2|Overall Study|Withdrew consent|2
7565448|NCT02305758|26305488|P1|Overall Study|Withdrew consent|9
7565449|NCT02305758|26305487|P2|Overall Study|Death|27
7565450|NCT02305758|26305488|P1|Overall Study|Death|27
7565451|NCT02305563|26305511|P5|Follow-up Period|Followup no longer required per protocol|4
7565452|NCT02305563|26305512|P4|Follow-up Period|Followup no longer required per protocol|1
7565453|NCT02305563|26305513|P3|Follow-up Period|Followup no longer required per protocol|4
7565454|NCT02305563|26305514|P2|Follow-up Period|Followup no longer required per protocol|3
7565455|NCT02305563|26305515|P1|Follow-up Period|Followup no longer required per protocol|3
7565456|NCT02305563|26305511|P5|Follow-up Period|other reason|1
7565457|NCT02305563|26305512|P4|Follow-up Period|other reason|0
7565458|NCT02305563|26305513|P3|Follow-up Period|other reason|0
7565459|NCT02305563|26305514|P2|Follow-up Period|other reason|0
7565460|NCT02305563|26305515|P1|Follow-up Period|other reason|0
7565461|NCT02305563|26305511|P5|Follow-up Period|Participant withdrew consent|0
7565462|NCT02305563|26305512|P4|Follow-up Period|Participant withdrew consent|1
7565463|NCT02305563|26305513|P3|Follow-up Period|Participant withdrew consent|2
7565464|NCT02305563|26305514|P2|Follow-up Period|Participant withdrew consent|0
7565465|NCT02305563|26305515|P1|Follow-up Period|Participant withdrew consent|0
7565466|NCT02305563|26305511|P5|Follow-up Period|Death|7
7565467|NCT02305563|26305512|P4|Follow-up Period|Death|4
7565468|NCT02305563|26305513|P3|Follow-up Period|Death|5
7565469|NCT02305563|26305514|P2|Follow-up Period|Death|0
7565470|NCT02305563|26305515|P1|Follow-up Period|Death|0
7565471|NCT02305563|26305511|P5|Treatment Period|added ULO, then request to stop|1
7565472|NCT02305563|26305512|P4|Treatment Period|added ULO, then request to stop|0
7565473|NCT02305563|26305513|P3|Treatment Period|added ULO, then request to stop|0
7565474|NCT02305563|26305514|P2|Treatment Period|added ULO, then request to stop|0
7565475|NCT02305563|26305515|P1|Treatment Period|added ULO, then request to stop|0
7565476|NCT02305563|26305511|P5|Treatment Period|added ULO; then other reason|1
7565477|NCT02305563|26305512|P4|Treatment Period|added ULO; then other reason|0
7565478|NCT02305563|26305513|P3|Treatment Period|added ULO; then other reason|0
7565479|NCT02305563|26305514|P2|Treatment Period|added ULO; then other reason|0
7565480|NCT02305563|26305515|P1|Treatment Period|added ULO; then other reason|0
7565481|NCT02305563|26305511|P5|Treatment Period|added ULO, then disease progression|4
7565482|NCT02305563|26305512|P4|Treatment Period|added ULO, then disease progression|0
7565483|NCT02305563|26305513|P3|Treatment Period|added ULO, then disease progression|0
7565484|NCT02305563|26305514|P2|Treatment Period|added ULO, then disease progression|0
7565485|NCT02305563|26305515|P1|Treatment Period|added ULO, then disease progression|0
7565486|NCT02305563|26305511|P5|Treatment Period|Randomized but not treated|2
7565487|NCT02305563|26305512|P4|Treatment Period|Randomized but not treated|0
7565488|NCT02305563|26305513|P3|Treatment Period|Randomized but not treated|0
7565489|NCT02305563|26305514|P2|Treatment Period|Randomized but not treated|0
7565490|NCT02305563|26305515|P1|Treatment Period|Randomized but not treated|0
7565491|NCT02305563|26305511|P5|Treatment Period|other reason|1
7565492|NCT02305563|26305512|P4|Treatment Period|other reason|2
7565493|NCT02305563|26305513|P3|Treatment Period|other reason|2
7565494|NCT02305563|26305514|P2|Treatment Period|other reason|0
7565495|NCT02305563|26305515|P1|Treatment Period|other reason|2
7565496|NCT02305563|26305511|P5|Treatment Period|Administrative reason by Sponsor|1
7565497|NCT02305563|26305512|P4|Treatment Period|Administrative reason by Sponsor|0
7565498|NCT02305563|26305513|P3|Treatment Period|Administrative reason by Sponsor|0
7565499|NCT02305563|26305514|P2|Treatment Period|Administrative reason by Sponsor|0
7565500|NCT02305563|26305515|P1|Treatment Period|Administrative reason by Sponsor|0
7565501|NCT02305563|26305511|P5|Treatment Period|Poor/non-compliance|1
7565502|NCT02305563|26305512|P4|Treatment Period|Poor/non-compliance|0
7565503|NCT02305563|26305513|P3|Treatment Period|Poor/non-compliance|0
7565504|NCT02305563|26305514|P2|Treatment Period|Poor/non-compliance|0
7565505|NCT02305563|26305515|P1|Treatment Period|Poor/non-compliance|0
7565506|NCT02305563|26305511|P5|Treatment Period|Maximum clinical benefit|1
7565507|NCT02305563|26305512|P4|Treatment Period|Maximum clinical benefit|0
7565508|NCT02305563|26305513|P3|Treatment Period|Maximum clinical benefit|0
7565509|NCT02305563|26305514|P2|Treatment Period|Maximum clinical benefit|0
7565510|NCT02305563|26305515|P1|Treatment Period|Maximum clinical benefit|0
7565511|NCT02305563|26305511|P5|Treatment Period|Participant withdrew consent|1
7565512|NCT02305563|26305512|P4|Treatment Period|Participant withdrew consent|1
7565513|NCT02305563|26305513|P3|Treatment Period|Participant withdrew consent|1
7565514|NCT02305563|26305514|P2|Treatment Period|Participant withdrew consent|0
7565515|NCT02305563|26305515|P1|Treatment Period|Participant withdrew consent|0
7565516|NCT02305563|26305511|P5|Treatment Period|Participant request to stop therapy|0
7565517|NCT02305563|26305512|P4|Treatment Period|Participant request to stop therapy|1
7565518|NCT02305563|26305513|P3|Treatment Period|Participant request to stop therapy|0
7565519|NCT02305563|26305514|P2|Treatment Period|Participant request to stop therapy|2
7565520|NCT02305563|26305515|P1|Treatment Period|Participant request to stop therapy|0
7565521|NCT02305563|26305511|P5|Treatment Period|Adverse Event (AE) unrelated to drug|2
7565522|NCT02305563|26305512|P4|Treatment Period|Adverse Event (AE) unrelated to drug|1
7565523|NCT02305563|26305513|P3|Treatment Period|Adverse Event (AE) unrelated to drug|7
7565524|NCT02305563|26305514|P2|Treatment Period|Adverse Event (AE) unrelated to drug|0
7565525|NCT02305563|26305515|P1|Treatment Period|Adverse Event (AE) unrelated to drug|0
7565526|NCT02305563|26305511|P5|Treatment Period|Death|1
7565527|NCT02305563|26305512|P4|Treatment Period|Death|2
7565528|NCT02305563|26305513|P3|Treatment Period|Death|1
7565529|NCT02305563|26305514|P2|Treatment Period|Death|0
7565530|NCT02305563|26305515|P1|Treatment Period|Death|0
7565531|NCT02305563|26305511|P5|Treatment Period|Study drug toxicity|2
7565532|NCT02305563|26305512|P4|Treatment Period|Study drug toxicity|1
7565533|NCT02305563|26305513|P3|Treatment Period|Study drug toxicity|0
7565534|NCT02305563|26305514|P2|Treatment Period|Study drug toxicity|0
7565535|NCT02305563|26305515|P1|Treatment Period|Study drug toxicity|0
7565536|NCT02305563|26305511|P5|Treatment Period|Disease progression|6
7565537|NCT02305563|26305512|P4|Treatment Period|Disease progression|6
7565538|NCT02305563|26305513|P3|Treatment Period|Disease progression|15
7565539|NCT02305563|26305514|P2|Treatment Period|Disease progression|0
7565540|NCT02305563|26305515|P1|Treatment Period|Disease progression|0
7565541|NCT02305446|26305636|P1|Overall Study|Adverse Event|1
7565542|NCT02305381|26305644|P3|Overall Study|Unclassified|7
7565543|NCT02305381|26305645|P2|Overall Study|Unclassified|5
7565544|NCT02305381|26305646|P1|Overall Study|Unclassified|5
7565545|NCT02305238|26305759|P3|Overall Study|Required procedure failed|0
7565546|NCT02305238|26305760|P2|Overall Study|Required procedure failed|1
7565547|NCT02305238|26305761|P1|Overall Study|Required procedure failed|0
7565548|NCT02305238|26305759|P3|Overall Study|Randomized failure|8
7565549|NCT02305238|26305760|P2|Overall Study|Randomized failure|0
7565550|NCT02305238|26305761|P1|Overall Study|Randomized failure|0
7565551|NCT02305238|26305759|P3|Overall Study|Withdrawal by Subject|0
7565552|NCT02305238|26305760|P2|Overall Study|Withdrawal by Subject|4
7565553|NCT02305238|26305761|P1|Overall Study|Withdrawal by Subject|3
7565554|NCT02305238|26305759|P3|Overall Study|Adverse Event|0
7565555|NCT02305238|26305760|P2|Overall Study|Adverse Event|2
7565556|NCT02305238|26305761|P1|Overall Study|Adverse Event|4
7565557|NCT02305238|26305759|P3|Overall Study|Physician Decision|0
7565558|NCT02305238|26305760|P2|Overall Study|Physician Decision|1
7565559|NCT02305238|26305761|P1|Overall Study|Physician Decision|2
7565560|NCT02305238|26305759|P3|Overall Study|Protocol Violation|0
7565561|NCT02305238|26305760|P2|Overall Study|Protocol Violation|3
7565562|NCT02305238|26305761|P1|Overall Study|Protocol Violation|0
7565563|NCT02305238|26305759|P3|Overall Study|Logistical difficulties|0
7565564|NCT02305238|26305760|P2|Overall Study|Logistical difficulties|3
7565565|NCT02305238|26305761|P1|Overall Study|Logistical difficulties|1
7565566|NCT02305238|26305759|P3|Overall Study|Progressive disease|0
7565567|NCT02305238|26305760|P2|Overall Study|Progressive disease|4
7565568|NCT02305238|26305761|P1|Overall Study|Progressive disease|4
7565569|NCT02305238|26305759|P3|Overall Study|Death|0
7565570|NCT02305238|26305760|P2|Overall Study|Death|1
7565571|NCT02305238|26305761|P1|Overall Study|Death|2
7565572|NCT02304926|26305793|P2|Overall Study|Lost to Follow-up|1
7565573|NCT02304926|26305794|P1|Overall Study|Lost to Follow-up|2
7565574|NCT02304705|26305840|P2|Overall Study|Lost to Follow-up|2
7565575|NCT02304705|26305841|P1|Overall Study|Lost to Follow-up|0
7565576|NCT02304705|26305840|P2|Overall Study|Death|1
7565577|NCT02304705|26305841|P1|Overall Study|Death|0
7565578|NCT02304705|26305840|P2|Overall Study|Physician Decision|4
7565579|NCT02304705|26305841|P1|Overall Study|Physician Decision|2
7565580|NCT02304705|26305840|P2|Overall Study|Withdrawal by Subject|0
7565581|NCT02304705|26305841|P1|Overall Study|Withdrawal by Subject|2
7565582|NCT02304484|26305847|P1|Overall Study|Lost to Follow-up|2
7565583|NCT02304484|26305847|P1|Overall Study|Withdrawal by Subject|14
7565584|NCT02304484|26305847|P1|Overall Study|Death|9
7565585|NCT02304380|26305910|P6|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7565586|NCT02304380|26305911|P5|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7565587|NCT02304380|26305912|P4|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
7565588|NCT02304380|26305913|P3|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7565589|NCT02304380|26305914|P2|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7565590|NCT02304380|26305915|P1|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7565591|NCT02304367|26305965|P1|Overall Study|Ongoing in Study|12
7565592|NCT02304367|26305965|P1|Overall Study|Death|1
7565593|NCT02304367|26305965|P1|Overall Study|Sponsor Decision|3
7565594|NCT02304367|26305965|P1|Overall Study|Lack of Phosphorus Increase|1
7565595|NCT02303704|26306060|P2|Overall Study|Protocol Violation|9
7565596|NCT02303704|26306061|P1|Overall Study|Protocol Violation|5
7565597|NCT02303574|26306089|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565598|NCT02303574|26306090|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565599|NCT02303574|26306091|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
7565600|NCT02303574|26306092|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565601|NCT02303574|26306093|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565602|NCT02303574|26306094|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565603|NCT02303574|26306095|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565604|NCT02303574|26306096|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565605|NCT02303574|26306097|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565606|NCT02303574|26306098|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7565607|NCT02303574|26306089|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565608|NCT02303574|26306090|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565609|NCT02303574|26306091|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565610|NCT02303574|26306092|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565611|NCT02303574|26306093|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565612|NCT02303574|26306094|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565613|NCT02303574|26306095|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565614|NCT02303574|26306096|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
7565615|NCT02303574|26306097|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565616|NCT02303574|26306098|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7565617|NCT02303262|26306319|P1|Overall Study|Withdrawal by Subject|2
7565618|NCT02303041|26306354|P2|Overall Study|Adverse Event|2
7565619|NCT02303041|26306355|P1|Overall Study|Adverse Event|1
7565620|NCT02302859|26306371|P2|Overall Study|Withdrawal by Subject|1
7565621|NCT02302859|26306372|P1|Overall Study|Withdrawal by Subject|0
7565622|NCT02302859|26306371|P2|Overall Study|Lost Phone|1
7565623|NCT02302859|26306372|P1|Overall Study|Lost Phone|1
7565624|NCT02302846|26306378|P1|Overall Study|Withdrawal by Subject|1
7565625|NCT02302807|26306384|P2|Overall Study|Physician Decision|1
7565626|NCT02302807|26306385|P1|Overall Study|Physician Decision|0
7565627|NCT02302807|26306384|P2|Overall Study|Study Terminated By Sponsor|64
7565628|NCT02302807|26306385|P1|Overall Study|Study Terminated By Sponsor|35
7565629|NCT02302807|26306384|P2|Overall Study|Death|385
7565630|NCT02302807|26306385|P1|Overall Study|Death|397
7565631|NCT02302807|26306384|P2|Overall Study|Lost to Follow-up|6
7565632|NCT02302807|26306385|P1|Overall Study|Lost to Follow-up|4
7565633|NCT02302807|26306384|P2|Overall Study|Withdrawal by Subject|11
7565634|NCT02302807|26306385|P1|Overall Study|Withdrawal by Subject|28
7565635|NCT02302716|26306432|P2|Overall Study|Protocol Violation|1
7565636|NCT02302716|26306433|P1|Overall Study|Protocol Violation|0
7565637|NCT02302716|26306432|P2|Overall Study|Withdrawal by Subject|7
7565638|NCT02302716|26306433|P1|Overall Study|Withdrawal by Subject|13
7565639|NCT02302716|26306432|P2|Overall Study|Physician Decision|4
7565640|NCT02302716|26306433|P1|Overall Study|Physician Decision|3
7565641|NCT02302716|26306432|P2|Overall Study|Lost to Follow-up|4
7565642|NCT02302716|26306433|P1|Overall Study|Lost to Follow-up|2
7565643|NCT02302716|26306432|P2|Overall Study|Lack of Efficacy|1
7565644|NCT02302716|26306433|P1|Overall Study|Lack of Efficacy|0
7565645|NCT02302716|26306432|P2|Overall Study|Death|1
7565646|NCT02302716|26306433|P1|Overall Study|Death|0
7565647|NCT02302716|26306432|P2|Overall Study|Adverse Event|1
7565648|NCT02302716|26306433|P1|Overall Study|Adverse Event|1
7565649|NCT02302339|26306481|P4|Overall Study|Withdrawal by Subject|0
7565650|NCT02302339|26306482|P3|Overall Study|Withdrawal by Subject|1
7565651|NCT02302339|26306483|P2|Overall Study|Withdrawal by Subject|2
7565652|NCT02302339|26306484|P1|Overall Study|Withdrawal by Subject|0
7565653|NCT02302339|26306481|P4|Overall Study|Lost to Follow-up|0
7565654|NCT02302339|26306482|P3|Overall Study|Lost to Follow-up|0
7565655|NCT02302339|26306483|P2|Overall Study|Lost to Follow-up|0
7565656|NCT02302339|26306484|P1|Overall Study|Lost to Follow-up|1
7565657|NCT02302222|26306517|P2|Overall Study|Withdrawn prior to any treatment|1
7565658|NCT02302222|26306518|P1|Overall Study|Withdrawn prior to any treatment|0
7565659|NCT02302222|26306517|P2|Overall Study|Treatment discontinued before day 5|1
7565660|NCT02302222|26306518|P1|Overall Study|Treatment discontinued before day 5|0
7565661|NCT02302222|26306517|P2|Overall Study|Lost to Follow-up|0
7565662|NCT02302222|26306518|P1|Overall Study|Lost to Follow-up|1
7565663|NCT02302222|26306517|P2|Overall Study|Physician Decision|4
7565664|NCT02302222|26306518|P1|Overall Study|Physician Decision|0
7565665|NCT02302066|26306583|P4|Overall Study|Reason Not Specified|1
7565666|NCT02302066|26306584|P3|Overall Study|Reason Not Specified|9
7565667|NCT02302066|26306585|P2|Overall Study|Reason Not Specified|1
7565668|NCT02302066|26306586|P1|Overall Study|Reason Not Specified|1
7565669|NCT02302066|26306583|P4|Overall Study|Pregnancy|0
7565670|NCT02302066|26306584|P3|Overall Study|Pregnancy|12
7565671|NCT02302066|26306585|P2|Overall Study|Pregnancy|10
7565672|NCT02302066|26306586|P1|Overall Study|Pregnancy|2
7565673|NCT02302066|26306583|P4|Overall Study|Withdrawal by Subject|33
7565674|NCT02302066|26306584|P3|Overall Study|Withdrawal by Subject|124
7565675|NCT02302066|26306585|P2|Overall Study|Withdrawal by Subject|58
7565676|NCT02302066|26306586|P1|Overall Study|Withdrawal by Subject|25
7565677|NCT02302066|26306583|P4|Overall Study|Lost to Follow-up|7
7565678|NCT02302066|26306584|P3|Overall Study|Lost to Follow-up|24
7565679|NCT02302066|26306585|P2|Overall Study|Lost to Follow-up|5
7565680|NCT02302066|26306586|P1|Overall Study|Lost to Follow-up|4
7565681|NCT02302066|26306583|P4|Overall Study|Adverse Event|0
7565682|NCT02302066|26306584|P3|Overall Study|Adverse Event|3
7565683|NCT02302066|26306585|P2|Overall Study|Adverse Event|1
7565684|NCT02302066|26306586|P1|Overall Study|Adverse Event|1
7565685|NCT02301988|26306630|P2|Overall Study|Adverse Event|1
7565686|NCT02301988|26306631|P1|Overall Study|Adverse Event|1
7565687|NCT02301988|26306630|P2|Overall Study|Death|0
7565688|NCT02301988|26306631|P1|Overall Study|Death|1
7565689|NCT02301988|26306630|P2|Overall Study|Lack of Efficacy|2
7565690|NCT02301988|26306631|P1|Overall Study|Lack of Efficacy|3
7565691|NCT02301988|26306630|P2|Overall Study|Unknown Reason|3
7565692|NCT02301988|26306631|P1|Overall Study|Unknown Reason|1
7565693|NCT02301988|26306630|P2|Overall Study|Physician Decision|2
7565694|NCT02301988|26306631|P1|Overall Study|Physician Decision|2
7565695|NCT02301988|26306630|P2|Overall Study|Withdrawal by Subject|1
7565696|NCT02301988|26306631|P1|Overall Study|Withdrawal by Subject|2
7565697|NCT02301975|26306664|P3|Overall Study|Withdrawal by Subject|11
7565698|NCT02301975|26306665|P2|Overall Study|Withdrawal by Subject|12
7565699|NCT02301975|26306666|P1|Overall Study|Withdrawal by Subject|15
7565700|NCT02301975|26306664|P3|Overall Study|Physician Decision|3
7565701|NCT02301975|26306665|P2|Overall Study|Physician Decision|2
7565702|NCT02301975|26306666|P1|Overall Study|Physician Decision|4
7565703|NCT02301975|26306664|P3|Overall Study|Lost to Follow-up|2
7565704|NCT02301975|26306665|P2|Overall Study|Lost to Follow-up|2
7565705|NCT02301975|26306666|P1|Overall Study|Lost to Follow-up|0
7565706|NCT02301975|26306664|P3|Overall Study|Protocol Violation|3
7565707|NCT02301975|26306665|P2|Overall Study|Protocol Violation|5
7565708|NCT02301975|26306666|P1|Overall Study|Protocol Violation|3
7565709|NCT02301975|26306664|P3|Overall Study|Lack of Efficacy|1
7565710|NCT02301975|26306665|P2|Overall Study|Lack of Efficacy|1
7565711|NCT02301975|26306666|P1|Overall Study|Lack of Efficacy|1
7565712|NCT02301975|26306664|P3|Overall Study|Adverse Event|2
7565713|NCT02301975|26306665|P2|Overall Study|Adverse Event|3
7565714|NCT02301975|26306666|P1|Overall Study|Adverse Event|8
7565715|NCT02301936|26306694|P2|Overall Study|Lost to Follow-up|0
7565716|NCT02301936|26306695|P1|Overall Study|Lost to Follow-up|1
7565717|NCT02301897|26306720|P3|Treatment Course 2|Other Miscellaneous Reasons|0
7565718|NCT02301897|26306721|P2|Treatment Course 2|Other Miscellaneous Reasons|0
7565719|NCT02301897|26306722|P1|Treatment Course 2|Other Miscellaneous Reasons|1
7565720|NCT02301897|26306720|P3|Treatment Course 2|Withdrawal by Subject|0
7565721|NCT02301897|26306721|P2|Treatment Course 2|Withdrawal by Subject|2
7565722|NCT02301897|26306722|P1|Treatment Course 2|Withdrawal by Subject|0
7565723|NCT02301897|26306720|P3|Treatment Course 2|Pregnancy|1
7565724|NCT02301897|26306721|P2|Treatment Course 2|Pregnancy|1
7565725|NCT02301897|26306722|P1|Treatment Course 2|Pregnancy|0
7565726|NCT02301897|26306720|P3|Treatment Course 2|Lost to Follow-up|0
7565727|NCT02301897|26306721|P2|Treatment Course 2|Lost to Follow-up|2
7565728|NCT02301897|26306722|P1|Treatment Course 2|Lost to Follow-up|0
7565729|NCT02301897|26306720|P3|Treatment Course 1|Other Miscellaneous Reasons|0
7565730|NCT02301897|26306721|P2|Treatment Course 1|Other Miscellaneous Reasons|0
7565731|NCT02301897|26306722|P1|Treatment Course 1|Other Miscellaneous Reasons|1
7565732|NCT02301897|26306720|P3|Treatment Course 1|Withdrawal by Subject|2
7565733|NCT02301897|26306721|P2|Treatment Course 1|Withdrawal by Subject|0
7565734|NCT02301897|26306722|P1|Treatment Course 1|Withdrawal by Subject|0
7565735|NCT02301897|26306720|P3|Treatment Course 1|Withdrawal by Sponsor|2
7565736|NCT02301897|26306721|P2|Treatment Course 1|Withdrawal by Sponsor|0
7565737|NCT02301897|26306722|P1|Treatment Course 1|Withdrawal by Sponsor|0
7565738|NCT02301897|26306720|P3|Treatment Course 1|Lost to Follow-up|1
7565739|NCT02301897|26306721|P2|Treatment Course 1|Lost to Follow-up|2
7565740|NCT02301897|26306722|P1|Treatment Course 1|Lost to Follow-up|1
7565741|NCT02301897|26306720|P3|Treatment Course 1|Adverse Event|0
7565742|NCT02301897|26306721|P2|Treatment Course 1|Adverse Event|1
7565743|NCT02301897|26306722|P1|Treatment Course 1|Adverse Event|1
7565744|NCT02301897|26306720|P3|Treatment Course 1|Non-Compliance|1
7565745|NCT02301897|26306721|P2|Treatment Course 1|Non-Compliance|0
7565746|NCT02301897|26306722|P1|Treatment Course 1|Non-Compliance|0
7565747|NCT02301624|26306788|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
7565748|NCT02301624|26306789|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
7565749|NCT02301624|26306788|P2|Open-label Maintenance Phase|Death|1
7565750|NCT02301624|26306789|P1|Open-label Maintenance Phase|Death|2
7565751|NCT02301624|26306788|P2|Open-label Maintenance Phase|Physician Decision|3
7565752|NCT02301624|26306789|P1|Open-label Maintenance Phase|Physician Decision|3
7565753|NCT02301624|26306788|P2|Open-label Maintenance Phase|Adverse Event|5
7565754|NCT02301624|26306789|P1|Open-label Maintenance Phase|Adverse Event|2
7565755|NCT02301624|26306788|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
7565756|NCT02301624|26306789|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
7565757|NCT02301624|26306788|P2|Blind Induction Phase|Withdrawal by Subject|0
7565758|NCT02301624|26306789|P1|Blind Induction Phase|Withdrawal by Subject|1
7565759|NCT02301546|26306800|P2|Long Term Effectiveness (~1 Year)|moved away|2
7565760|NCT02301546|26306801|P1|Long Term Effectiveness (~1 Year)|moved away|1
7565761|NCT02301546|26306800|P2|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
7565762|NCT02301546|26306801|P1|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
7565763|NCT02301546|26306800|P2|Long Term Effectiveness (~1 Year)|Death|0
7565764|NCT02301546|26306801|P1|Long Term Effectiveness (~1 Year)|Death|2
7565765|NCT02301546|26306800|P2|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7565766|NCT02301546|26306801|P1|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7565767|NCT02301546|26306800|P2|Short-term Effectiveness (~13 Weeks)|screen fail|0
7565768|NCT02301546|26306801|P1|Short-term Effectiveness (~13 Weeks)|screen fail|1
7565769|NCT02301546|26306800|P2|Short-term Effectiveness (~13 Weeks)|non-compliant|7
7565770|NCT02301546|26306801|P1|Short-term Effectiveness (~13 Weeks)|non-compliant|10
7565771|NCT02301546|26306800|P2|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
7565772|NCT02301546|26306801|P1|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
7565773|NCT02301429|26306807|P1|Overall Study|not acceptable vascular anatomy|3
7565774|NCT02301403|26306853|P2|Overall Study|Withdrawal by Subject|41
7565775|NCT02301403|26306854|P1|Overall Study|Withdrawal by Subject|28
7565776|NCT02301390|26306862|P2|Overall Study|study terminated|0
7565777|NCT02301390|26306863|P1|Overall Study|study terminated|2
7565778|NCT02301390|26306862|P2|Overall Study|Missed multiple visits|1
7565779|NCT02301390|26306863|P1|Overall Study|Missed multiple visits|1
7565780|NCT02301390|26306862|P2|Overall Study|Procedure not completed|4
7565781|NCT02301390|26306863|P1|Overall Study|Procedure not completed|0
7565782|NCT02301390|26306862|P2|Overall Study|Death|2
7565783|NCT02301390|26306863|P1|Overall Study|Death|2
7565784|NCT02301390|26306862|P2|Overall Study|Lost to Follow-up|1
7565785|NCT02301390|26306863|P1|Overall Study|Lost to Follow-up|0
7565786|NCT02301390|26306862|P2|Overall Study|Physician Decision|0
7565787|NCT02301390|26306863|P1|Overall Study|Physician Decision|1
7565788|NCT02301390|26306862|P2|Overall Study|Protocol Violation|0
7565789|NCT02301390|26306863|P1|Overall Study|Protocol Violation|1
7565790|NCT02301390|26306862|P2|Overall Study|Withdrawal by Subject|5
7565791|NCT02301390|26306863|P1|Overall Study|Withdrawal by Subject|3
7565792|NCT02301169|26306904|P2|Overall Study|Adverse Event|0
7565793|NCT02301169|26306905|P1|Overall Study|Adverse Event|1
7565794|NCT02301143|26306919|P2|Investigator's Choice|Unresectable Surgery|1
7565795|NCT02301143|26306920|P1|Investigator's Choice|Unresectable Surgery|0
7565796|NCT02301143|26306919|P2|Investigator's Choice|Other|1
7565797|NCT02301143|26306920|P1|Investigator's Choice|Other|0
7565798|NCT02301143|26306919|P2|Investigator's Choice|Symptomatic Deterioration|1
7565799|NCT02301143|26306920|P1|Investigator's Choice|Symptomatic Deterioration|0
7565800|NCT02301143|26306919|P2|Investigator's Choice|Noncompliance With Study Drug|1
7565801|NCT02301143|26306920|P1|Investigator's Choice|Noncompliance With Study Drug|0
7565802|NCT02301143|26306919|P2|Investigator's Choice|Progressive Disease|3
7565803|NCT02301143|26306920|P1|Investigator's Choice|Progressive Disease|0
7565804|NCT02301143|26306919|P2|Investigator's Choice|Adverse Event|3
7565805|NCT02301143|26306920|P1|Investigator's Choice|Adverse Event|0
7565806|NCT02301143|26306919|P2|Induction Period|Other|0
7565807|NCT02301143|26306920|P1|Induction Period|Other|1
7565808|NCT02301143|26306919|P2|Induction Period|Protocol Violation|0
7565809|NCT02301143|26306920|P1|Induction Period|Protocol Violation|2
7565810|NCT02301143|26306919|P2|Induction Period|Symptomatic Deterioration|0
7565811|NCT02301143|26306920|P1|Induction Period|Symptomatic Deterioration|2
7565812|NCT02301143|26306919|P2|Induction Period|Physician Decision|0
7565813|NCT02301143|26306920|P1|Induction Period|Physician Decision|4
7565814|NCT02301143|26306919|P2|Induction Period|Noncompliance with Study Drug|0
7565815|NCT02301143|26306920|P1|Induction Period|Noncompliance with Study Drug|1
7565816|NCT02301143|26306919|P2|Induction Period|Withdrawal by Subject|0
7565817|NCT02301143|26306920|P1|Induction Period|Withdrawal by Subject|3
7565818|NCT02301143|26306919|P2|Induction Period|Progressive Disease|0
7565819|NCT02301143|26306920|P1|Induction Period|Progressive Disease|8
7565820|NCT02301143|26306919|P2|Induction Period|Adverse Event|0
7565821|NCT02301143|26306920|P1|Induction Period|Adverse Event|22
7565822|NCT02301143|26306919|P2|Induction Period|Death|0
7565823|NCT02301143|26306920|P1|Induction Period|Death|1
7565824|NCT02301143|26306919|P2|Induction Period|Enrolled But Not Treated|0
7565825|NCT02301143|26306920|P1|Induction Period|Enrolled But Not Treated|1
7565826|NCT02300987|26306963|P2|Secondary Phase : Cross-over to LEE011|Adverse Event|1
7565827|NCT02300987|26306964|P1|Secondary Phase : Cross-over to LEE011|Adverse Event|0
7565828|NCT02300987|26306963|P2|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
7565829|NCT02300987|26306964|P1|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
7565830|NCT02300987|26306963|P2|Primary Phase : Prior to Cross-over|progressive disease|2
7565831|NCT02300987|26306964|P1|Primary Phase : Prior to Cross-over|progressive disease|3
7565832|NCT02300987|26306963|P2|Primary Phase : Prior to Cross-over|Physician Decision|0
7565833|NCT02300987|26306964|P1|Primary Phase : Prior to Cross-over|Physician Decision|2
7565834|NCT02300987|26306963|P2|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
7565835|NCT02300987|26306964|P1|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
7565836|NCT02300610|26307011|P3|Overall Study|Withdrawal by Subject|1
7565837|NCT02300610|26307012|P2|Overall Study|Withdrawal by Subject|0
7565838|NCT02300610|26307013|P1|Overall Study|Withdrawal by Subject|1
7565839|NCT02300558|26307028|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
7565840|NCT02300558|26307028|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
7565841|NCT02300558|26307028|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
7565842|NCT02300558|26307028|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
7565843|NCT02300311|26307050|P2|Overall Study|Refused to continue taking medication|0
7565844|NCT02300311|26307051|P1|Overall Study|Refused to continue taking medication|18
7565845|NCT02300311|26307050|P2|Overall Study|Other than the reason specified|0
7565846|NCT02300311|26307051|P1|Overall Study|Other than the reason specified|1
7565847|NCT02300298|26307063|P2|Disposition for Docetaxel|other adverse event|4
7565848|NCT02300298|26307064|P1|Disposition for Docetaxel|other adverse event|0
7565849|NCT02300298|26307063|P2|Disposition for Docetaxel|Progressive disease|6
7565850|NCT02300298|26307064|P1|Disposition for Docetaxel|Progressive disease|0
7565851|NCT02300298|26307063|P2|Disposition for Nintedanib|Progressive disease|0
7565852|NCT02300298|26307064|P1|Disposition for Nintedanib|Progressive disease|10
7565853|NCT02300259|26307094|P3|Period 2|Withdrawal by Subject|1
7565854|NCT02300259|26307095|P2|Period 2|Withdrawal by Subject|0
7565855|NCT02300259|26307096|P1|Period 2|Withdrawal by Subject|0
7565856|NCT02300259|26307094|P3|Period 2|Adverse Event|0
7565857|NCT02300259|26307095|P2|Period 2|Adverse Event|0
7565858|NCT02300259|26307096|P1|Period 2|Adverse Event|1
7565859|NCT02300259|26307094|P3|Period 1|Withdrawal by Subject|1
7565860|NCT02300259|26307095|P2|Period 1|Withdrawal by Subject|0
7565861|NCT02300259|26307096|P1|Period 1|Withdrawal by Subject|0
7565862|NCT02300259|26307094|P3|Period 1|Adverse Event|1
7565863|NCT02300259|26307095|P2|Period 1|Adverse Event|0
7565864|NCT02300259|26307096|P1|Period 1|Adverse Event|0
7565865|NCT02300220|26307127|P2|Overall Study|Did not tolerate IMP|1
7565866|NCT02300220|26307128|P1|Overall Study|Did not tolerate IMP|0
7565867|NCT02300220|26307127|P2|Overall Study|Withdrawal by Subject|2
7565868|NCT02300220|26307128|P1|Overall Study|Withdrawal by Subject|0
7565869|NCT02300220|26307127|P2|Overall Study|Protocol Violation|0
7565870|NCT02300220|26307128|P1|Overall Study|Protocol Violation|1
7565871|NCT02300220|26307127|P2|Overall Study|Adverse Event|1
7565872|NCT02300220|26307128|P1|Overall Study|Adverse Event|1
7565873|NCT02300220|26307127|P2|Overall Study|Death|1
7565874|NCT02300220|26307128|P1|Overall Study|Death|1
7565875|NCT02300220|26307127|P2|Overall Study|Lost to Follow-up|2
7565876|NCT02300220|26307128|P1|Overall Study|Lost to Follow-up|1
7565877|NCT02300129|26307144|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7565878|NCT02300129|26307145|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7565879|NCT02300129|26307146|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7565880|NCT02300129|26307147|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
7565881|NCT02300129|26307144|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
7565882|NCT02300129|26307145|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7565883|NCT02300129|26307146|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7565884|NCT02300129|26307147|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7565885|NCT02300129|26307144|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7565886|NCT02300129|26307145|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7565887|NCT02300129|26307146|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
7565888|NCT02300129|26307147|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7565889|NCT02300103|26307157|P1|Overall Study|Withdrew Consent|2
7565890|NCT02300103|26307157|P1|Overall Study|Protocol Violation|1
7565891|NCT02300103|26307157|P1|Overall Study|Lack of Efficacy|3
7565892|NCT02299934|26307237|P1|Overall Study|Termination of study|13
7565893|NCT02299635|26307287|P1|Overall Study|Other|3
7565894|NCT02299635|26307287|P1|Overall Study|Withdrawal by Subject|2
7565895|NCT02299635|26307287|P1|Overall Study|Objective progression or relapse|10
7565896|NCT02299635|26307287|P1|Overall Study|Global deterioration of health status|1
7565897|NCT02299635|26307287|P1|Overall Study|Death|1
7565898|NCT02299635|26307287|P1|Overall Study|Adverse Event|2
7565899|NCT02299427|26307339|P2|Overall Study|not adherent to dog website use|0
7565900|NCT02299427|26307340|P1|Overall Study|not adherent to dog website use|21
7565901|NCT02299427|26307339|P2|Overall Study|Lost to Follow-up|3
7565902|NCT02299427|26307340|P1|Overall Study|Lost to Follow-up|1
7565903|NCT02299427|26307339|P2|Overall Study|Withdrawal by Subject|0
7565904|NCT02299427|26307340|P1|Overall Study|Withdrawal by Subject|1
7565905|NCT02299388|26307350|P2|Overall Study|Withdrawal by Subject|1
7565906|NCT02299388|26307351|P1|Overall Study|Withdrawal by Subject|0
7565907|NCT02299375|26307361|P2|Overall Study|Withdrawal by Subject|4
7565908|NCT02299375|26307362|P1|Overall Study|Withdrawal by Subject|1
7565909|NCT02299375|26307361|P2|Overall Study|Physician Decision|1
7565910|NCT02299375|26307362|P1|Overall Study|Physician Decision|1
7565911|NCT02299375|26307361|P2|Overall Study|Lost to Follow-up|2
7565912|NCT02299375|26307362|P1|Overall Study|Lost to Follow-up|0
7565913|NCT02299375|26307361|P2|Overall Study|Other: Study closed/terminated|55
7565914|NCT02299375|26307362|P1|Overall Study|Other: Study closed/terminated|66
7565915|NCT02299375|26307361|P2|Overall Study|Other: Met stopping criteria|0
7565916|NCT02299375|26307362|P1|Overall Study|Other: Met stopping criteria|1
7565917|NCT02299375|26307361|P2|Overall Study|Protocol Violation|3
7565918|NCT02299375|26307362|P1|Overall Study|Protocol Violation|1
7565919|NCT02299375|26307361|P2|Overall Study|Lack of Efficacy|3
7565920|NCT02299375|26307362|P1|Overall Study|Lack of Efficacy|1
7565921|NCT02299375|26307361|P2|Overall Study|Adverse Event, non-fatal|9
7565922|NCT02299375|26307362|P1|Overall Study|Adverse Event, non-fatal|8
7565923|NCT02299375|26307361|P2|Overall Study|Adverse Event, serious fatal|3
7565924|NCT02299375|26307362|P1|Overall Study|Adverse Event, serious fatal|1
7565925|NCT02299336|26307421|P1|Overall Study|Lost to Follow-up|1
7565926|NCT02299336|26307421|P1|Overall Study|Death|1
7565927|NCT02299336|26307421|P1|Overall Study|Adverse Event|1
7565928|NCT02299336|26307421|P1|Overall Study|Withdrawal by Subject|11
7565929|NCT02299206|26307456|P1|Overall Study|Withdrawal by Subject|1
7565930|NCT02299206|26307456|P1|Overall Study|Lost to Follow-up|1
7565931|NCT02299167|26307464|P1|Overall Study|patients were excluded from the study|11
7565932|NCT02299076|26307539|P2|Overall Study|Fraudulent Entries|14
7565933|NCT02299076|26307540|P1|Overall Study|Fraudulent Entries|20
7565934|NCT02298946|26307561|P2|Overall Study|Unevaluable|1
7565935|NCT02298946|26307562|P1|Overall Study|Unevaluable|2
7565936|NCT02298946|26307561|P2|Overall Study|Did not receive treatment|0
7565937|NCT02298946|26307562|P1|Overall Study|Did not receive treatment|2
7565938|NCT02298868|26307590|P1|Overall Study|Patient underwent transplant|1
7565939|NCT02298868|26307590|P1|Overall Study|Death|1
7565940|NCT02298868|26307590|P1|Overall Study|Adverse Event|1
7565941|NCT02298192|26307672|P2|Overall Study|Adverse Event|2
7565942|NCT02298192|26307673|P1|Overall Study|Adverse Event|6
7565943|NCT02298192|26307672|P2|Overall Study|Lost to Follow-up|1
7565944|NCT02298192|26307673|P1|Overall Study|Lost to Follow-up|2
7565945|NCT02298192|26307672|P2|Overall Study|Withdrawal by Subject|1
7565946|NCT02298192|26307673|P1|Overall Study|Withdrawal by Subject|6
7565947|NCT02298192|26307672|P2|Overall Study|Withdrawal criteria|0
7565948|NCT02298192|26307673|P1|Overall Study|Withdrawal criteria|2
7565949|NCT02298192|26307672|P2|Overall Study|Unclassified|2
7565950|NCT02298192|26307673|P1|Overall Study|Unclassified|3
7565951|NCT02298179|26307697|P12|Overall Study|Lost to Follow-up|0
7565952|NCT02298179|26307698|P11|Overall Study|Lost to Follow-up|0
7565953|NCT02298179|26307699|P10|Overall Study|Lost to Follow-up|0
7565954|NCT02298179|26307700|P9|Overall Study|Lost to Follow-up|0
7565955|NCT02298179|26307701|P8|Overall Study|Lost to Follow-up|1
7565956|NCT02298179|26307702|P7|Overall Study|Lost to Follow-up|0
7565957|NCT02298179|26307703|P6|Overall Study|Lost to Follow-up|0
7565958|NCT02298179|26307704|P5|Overall Study|Lost to Follow-up|0
7565959|NCT02298179|26307705|P4|Overall Study|Lost to Follow-up|0
7565960|NCT02298179|26307706|P3|Overall Study|Lost to Follow-up|1
7565961|NCT02298179|26307707|P2|Overall Study|Lost to Follow-up|0
7565962|NCT02298179|26307708|P1|Overall Study|Lost to Follow-up|0
7565966|NCT02297841|26307984|P1|Overall Study|Protocol Violation|7
7565967|NCT02297841|26307984|P1|Overall Study|Withdrawal by Subject|1
7565968|NCT02297815|26307990|P2|Overall Study|Lost to Follow-up|140
7565969|NCT02297815|26307991|P1|Overall Study|Lost to Follow-up|236
7565970|NCT02297516|26308009|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
7565971|NCT02297516|26308010|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
7565972|NCT02297516|26308009|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
7565973|NCT02297516|26308010|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
7565974|NCT02297516|26308009|P2|Single Treatment Phase (6 Months)|Medical reason|0
7565975|NCT02297516|26308010|P1|Single Treatment Phase (6 Months)|Medical reason|1
7565976|NCT02297503|26308031|P2|Overall Study|Medical reason|1
7565977|NCT02297503|26308032|P1|Overall Study|Medical reason|0
7565978|NCT02297503|26308031|P2|Overall Study|Lost to Follow-up|1
7565979|NCT02297503|26308032|P1|Overall Study|Lost to Follow-up|0
7565980|NCT02297503|26308031|P2|Overall Study|Pregnancy|1
7565981|NCT02297503|26308032|P1|Overall Study|Pregnancy|0
7565982|NCT02297503|26308031|P2|Overall Study|Protocol Violation|0
7565983|NCT02297503|26308032|P1|Overall Study|Protocol Violation|1
7565984|NCT02297503|26308031|P2|Overall Study|Withdrawal by Subject|1
7565985|NCT02297503|26308032|P1|Overall Study|Withdrawal by Subject|1
7565986|NCT02297412|26308059|P2|Overall Study|Canceled|1
7565987|NCT02297412|26308060|P1|Overall Study|Canceled|1
7565988|NCT02296931|26308121|P2|Overall Study|Protocol Violation|2
7565989|NCT02296931|26308122|P1|Overall Study|Protocol Violation|0
7565990|NCT02296892|26308131|P3|Overall Study|Lost to Follow-up|1
7565991|NCT02296892|26308132|P2|Overall Study|Lost to Follow-up|0
7565992|NCT02296892|26308133|P1|Overall Study|Lost to Follow-up|5
7565993|NCT02296892|26308131|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
7565994|NCT02296892|26308132|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
7565995|NCT02296892|26308133|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
7565996|NCT02296840|26308169|P2|Overall Study|Lost to Follow-up|17
7565997|NCT02296840|26308170|P1|Overall Study|Lost to Follow-up|6
7565998|NCT02296840|26308169|P2|Overall Study|Protocol Violation|1
7565999|NCT02296840|26308170|P1|Overall Study|Protocol Violation|2
7566000|NCT02296840|26308169|P2|Overall Study|Adverse Event|1
7566001|NCT02296840|26308170|P1|Overall Study|Adverse Event|1
7566002|NCT02296476|26308278|P3|Overall Study|Disease Progression|2
7566003|NCT02296476|26308279|P2|Overall Study|Disease Progression|4
7566004|NCT02296476|26308280|P1|Overall Study|Disease Progression|6
7566005|NCT02296424|26308335|P4|Part 2|Lost to Follow-up|0
7566006|NCT02296424|26308336|P3|Part 2|Lost to Follow-up|1
7566007|NCT02296424|26308337|P2|Part 2|Lost to Follow-up|0
7566008|NCT02296424|26308338|P1|Part 2|Lost to Follow-up|0
7566009|NCT02296424|26308335|P4|Part 2|Adverse Event|0
7566010|NCT02296424|26308336|P3|Part 2|Adverse Event|1
7566011|NCT02296424|26308337|P2|Part 2|Adverse Event|0
7566012|NCT02296424|26308338|P1|Part 2|Adverse Event|0
7566013|NCT02296424|26308335|P4|Part 2|Lack of Efficacy|0
7566014|NCT02296424|26308336|P3|Part 2|Lack of Efficacy|1
7566015|NCT02296424|26308337|P2|Part 2|Lack of Efficacy|0
7566016|NCT02296424|26308338|P1|Part 2|Lack of Efficacy|0
7566017|NCT02296424|26308335|P4|Part 1|16 directly started part II|0
7566018|NCT02296424|26308336|P3|Part 1|16 directly started part II|0
7566019|NCT02296424|26308337|P2|Part 1|16 directly started part II|0
7566020|NCT02296424|26308338|P1|Part 1|16 directly started part II|16
7566021|NCT02296424|26308335|P4|Part 1|Lack of Efficacy|0
7566022|NCT02296424|26308336|P3|Part 1|Lack of Efficacy|0
7566023|NCT02296424|26308337|P2|Part 1|Lack of Efficacy|17
7566024|NCT02296424|26308338|P1|Part 1|Lack of Efficacy|5
7566025|NCT02296424|26308335|P4|Part 1|Adverse Event|0
7566026|NCT02296424|26308336|P3|Part 1|Adverse Event|0
7566027|NCT02296424|26308337|P2|Part 1|Adverse Event|11
7566028|NCT02296424|26308338|P1|Part 1|Adverse Event|2
7566029|NCT02296424|26308335|P4|Part 1|Study terminated by sponsor|0
7566030|NCT02296424|26308336|P3|Part 1|Study terminated by sponsor|0
7566031|NCT02296424|26308337|P2|Part 1|Study terminated by sponsor|1
7566032|NCT02296424|26308338|P1|Part 1|Study terminated by sponsor|0
7566033|NCT02296424|26308335|P4|Part 1|Withdrawal by Subject|0
7566034|NCT02296424|26308336|P3|Part 1|Withdrawal by Subject|0
7566035|NCT02296424|26308337|P2|Part 1|Withdrawal by Subject|2
7566036|NCT02296424|26308338|P1|Part 1|Withdrawal by Subject|0
7566037|NCT02296424|26308335|P4|Part 1|Protocol Violation|0
7566038|NCT02296424|26308336|P3|Part 1|Protocol Violation|0
7566039|NCT02296424|26308337|P2|Part 1|Protocol Violation|1
7566040|NCT02296424|26308338|P1|Part 1|Protocol Violation|0
7566041|NCT02296424|26308335|P4|Part 1|New therapy for study indication|0
7566042|NCT02296424|26308336|P3|Part 1|New therapy for study indication|0
7566043|NCT02296424|26308337|P2|Part 1|New therapy for study indication|1
7566044|NCT02296424|26308338|P1|Part 1|New therapy for study indication|0
7566045|NCT02296320|26308363|P3|Overall Study|Not - specified|1
7566046|NCT02296320|26308364|P2|Overall Study|Not - specified|0
7566047|NCT02296320|26308365|P1|Overall Study|Not - specified|0
7566048|NCT02296320|26308363|P3|Overall Study|Not treated|0
7566049|NCT02296320|26308364|P2|Overall Study|Not treated|0
7566050|NCT02296320|26308365|P1|Overall Study|Not treated|2
7566051|NCT02296320|26308363|P3|Overall Study|Lost to Follow-up|7
7566052|NCT02296320|26308364|P2|Overall Study|Lost to Follow-up|2
7566053|NCT02296320|26308365|P1|Overall Study|Lost to Follow-up|5
7566054|NCT02296320|26308363|P3|Overall Study|Death|27
7566055|NCT02296320|26308364|P2|Overall Study|Death|3
7566056|NCT02296320|26308365|P1|Overall Study|Death|24
7566057|NCT02296320|26308363|P3|Overall Study|Withdrawal by Subject|2
7566058|NCT02296320|26308364|P2|Overall Study|Withdrawal by Subject|0
7566059|NCT02296320|26308365|P1|Overall Study|Withdrawal by Subject|4
7566060|NCT02296242|26308404|P5|Overall Study|Lack of Efficacy|3
7566061|NCT02296242|26308405|P4|Overall Study|Lack of Efficacy|0
7566062|NCT02296242|26308406|P3|Overall Study|Lack of Efficacy|0
7566063|NCT02296242|26308407|P2|Overall Study|Lack of Efficacy|0
7566064|NCT02296242|26308408|P1|Overall Study|Lack of Efficacy|0
7566065|NCT02296242|26308404|P5|Overall Study|Adverse Event|0
7566066|NCT02296242|26308405|P4|Overall Study|Adverse Event|1
7566067|NCT02296242|26308406|P3|Overall Study|Adverse Event|0
7566068|NCT02296242|26308407|P2|Overall Study|Adverse Event|0
7566069|NCT02296242|26308408|P1|Overall Study|Adverse Event|0
7566070|NCT02296242|26308404|P5|Overall Study|Alternative Treatment|0
7566071|NCT02296242|26308405|P4|Overall Study|Alternative Treatment|1
7566072|NCT02296242|26308406|P3|Overall Study|Alternative Treatment|0
7566073|NCT02296242|26308407|P2|Overall Study|Alternative Treatment|0
7566074|NCT02296242|26308408|P1|Overall Study|Alternative Treatment|0
7566075|NCT02296242|26308404|P5|Overall Study|Physician Decision|0
7566076|NCT02296242|26308405|P4|Overall Study|Physician Decision|1
7566077|NCT02296242|26308406|P3|Overall Study|Physician Decision|0
7566078|NCT02296242|26308407|P2|Overall Study|Physician Decision|1
7566079|NCT02296242|26308408|P1|Overall Study|Physician Decision|0
7566080|NCT02296242|26308404|P5|Overall Study|Screened for Other Protocol|0
7566081|NCT02296242|26308405|P4|Overall Study|Screened for Other Protocol|0
7566082|NCT02296242|26308406|P3|Overall Study|Screened for Other Protocol|0
7566083|NCT02296242|26308407|P2|Overall Study|Screened for Other Protocol|1
7566084|NCT02296242|26308408|P1|Overall Study|Screened for Other Protocol|0
7566085|NCT02296242|26308404|P5|Overall Study|Need for Hydroxyurea|0
7566086|NCT02296242|26308405|P4|Overall Study|Need for Hydroxyurea|0
7566087|NCT02296242|26308406|P3|Overall Study|Need for Hydroxyurea|0
7566088|NCT02296242|26308407|P2|Overall Study|Need for Hydroxyurea|0
7566089|NCT02296242|26308408|P1|Overall Study|Need for Hydroxyurea|2
7566090|NCT02296242|26308404|P5|Overall Study|Lost to Follow-up|0
7566091|NCT02296242|26308405|P4|Overall Study|Lost to Follow-up|0
7566092|NCT02296242|26308406|P3|Overall Study|Lost to Follow-up|0
7566093|NCT02296242|26308407|P2|Overall Study|Lost to Follow-up|0
7566094|NCT02296242|26308408|P1|Overall Study|Lost to Follow-up|1
7566095|NCT02296242|26308404|P5|Overall Study|At Least 3 Drug Interruptions|1
7566096|NCT02296242|26308405|P4|Overall Study|At Least 3 Drug Interruptions|1
7566097|NCT02296242|26308406|P3|Overall Study|At Least 3 Drug Interruptions|1
7566098|NCT02296242|26308407|P2|Overall Study|At Least 3 Drug Interruptions|0
7566099|NCT02296242|26308408|P1|Overall Study|At Least 3 Drug Interruptions|0
7566100|NCT02296242|26308404|P5|Overall Study|Patient Condition Changed|1
7566101|NCT02296242|26308405|P4|Overall Study|Patient Condition Changed|0
7566102|NCT02296242|26308406|P3|Overall Study|Patient Condition Changed|2
7566103|NCT02296242|26308407|P2|Overall Study|Patient Condition Changed|0
7566104|NCT02296242|26308408|P1|Overall Study|Patient Condition Changed|0
7566105|NCT02296242|26308404|P5|Overall Study|Unacceptable Toxicity|1
7566106|NCT02296242|26308405|P4|Overall Study|Unacceptable Toxicity|0
7566107|NCT02296242|26308406|P3|Overall Study|Unacceptable Toxicity|0
7566108|NCT02296242|26308407|P2|Overall Study|Unacceptable Toxicity|0
7566109|NCT02296242|26308408|P1|Overall Study|Unacceptable Toxicity|0
7566110|NCT02296242|26308404|P5|Overall Study|Disease Progression|11
7566111|NCT02296242|26308405|P4|Overall Study|Disease Progression|8
7566112|NCT02296242|26308406|P3|Overall Study|Disease Progression|2
7566113|NCT02296242|26308407|P2|Overall Study|Disease Progression|3
7566114|NCT02296242|26308408|P1|Overall Study|Disease Progression|1
7566115|NCT02296242|26308404|P5|Overall Study|Withdrawal by Subject|3
7566116|NCT02296242|26308405|P4|Overall Study|Withdrawal by Subject|1
7566117|NCT02296242|26308406|P3|Overall Study|Withdrawal by Subject|1
7566118|NCT02296242|26308407|P2|Overall Study|Withdrawal by Subject|0
7566119|NCT02296242|26308408|P1|Overall Study|Withdrawal by Subject|0
7566120|NCT02296242|26308404|P5|Overall Study|Death|1
7566121|NCT02296242|26308405|P4|Overall Study|Death|1
7566122|NCT02296242|26308406|P3|Overall Study|Death|1
7566123|NCT02296242|26308407|P2|Overall Study|Death|1
7566124|NCT02296242|26308408|P1|Overall Study|Death|1
7566125|NCT02296190|26308436|P6|Overall Study|Lab result not available in time|0
7566126|NCT02296190|26308437|P5|Overall Study|Lab result not available in time|0
7566127|NCT02296190|26308438|P4|Overall Study|Lab result not available in time|0
7566128|NCT02296190|26308439|P3|Overall Study|Lab result not available in time|0
7566129|NCT02296190|26308440|P2|Overall Study|Lab result not available in time|0
7566130|NCT02296190|26308441|P1|Overall Study|Lab result not available in time|1
7566131|NCT02296190|26308436|P6|Overall Study|Failed PSVT with mechanism of AVNRT|0
7566132|NCT02296190|26308437|P5|Overall Study|Failed PSVT with mechanism of AVNRT|0
7566133|NCT02296190|26308438|P4|Overall Study|Failed PSVT with mechanism of AVNRT|0
7566134|NCT02296190|26308439|P3|Overall Study|Failed PSVT with mechanism of AVNRT|0
7566135|NCT02296190|26308440|P2|Overall Study|Failed PSVT with mechanism of AVNRT|1
7566136|NCT02296190|26308441|P1|Overall Study|Failed PSVT with mechanism of AVNRT|0
7566137|NCT02296190|26308436|P6|Overall Study|Patient on antiarrhythmic medication|0
7566138|NCT02296190|26308437|P5|Overall Study|Patient on antiarrhythmic medication|0
7566139|NCT02296190|26308438|P4|Overall Study|Patient on antiarrhythmic medication|0
7566140|NCT02296190|26308439|P3|Overall Study|Patient on antiarrhythmic medication|0
7566141|NCT02296190|26308440|P2|Overall Study|Patient on antiarrhythmic medication|0
7566142|NCT02296190|26308441|P1|Overall Study|Patient on antiarrhythmic medication|1
7566143|NCT02296190|26308436|P6|Overall Study|Atrial Tachycardia induced not PSVT|0
7566144|NCT02296190|26308437|P5|Overall Study|Atrial Tachycardia induced not PSVT|0
7566145|NCT02296190|26308438|P4|Overall Study|Atrial Tachycardia induced not PSVT|0
7566146|NCT02296190|26308439|P3|Overall Study|Atrial Tachycardia induced not PSVT|1
7566147|NCT02296190|26308440|P2|Overall Study|Atrial Tachycardia induced not PSVT|1
7566148|NCT02296190|26308441|P1|Overall Study|Atrial Tachycardia induced not PSVT|0
7566149|NCT02296190|26308436|P6|Overall Study|Blood pressure <100 after sedation|0
7566150|NCT02296190|26308437|P5|Overall Study|Blood pressure <100 after sedation|0
7566151|NCT02296190|26308438|P4|Overall Study|Blood pressure <100 after sedation|1
7566152|NCT02296190|26308439|P3|Overall Study|Blood pressure <100 after sedation|0
7566153|NCT02296190|26308440|P2|Overall Study|Blood pressure <100 after sedation|0
7566154|NCT02296190|26308441|P1|Overall Study|Blood pressure <100 after sedation|0
7566155|NCT02296190|26308436|P6|Overall Study|Patient with Atrial Tachycardia|0
7566156|NCT02296190|26308437|P5|Overall Study|Patient with Atrial Tachycardia|0
7566157|NCT02296190|26308438|P4|Overall Study|Patient with Atrial Tachycardia|1
7566158|NCT02296190|26308439|P3|Overall Study|Patient with Atrial Tachycardia|0
7566159|NCT02296190|26308440|P2|Overall Study|Patient with Atrial Tachycardia|0
7566160|NCT02296190|26308441|P1|Overall Study|Patient with Atrial Tachycardia|0
7566161|NCT02296190|26308436|P6|Overall Study|Patient was given Propofol|0
7566162|NCT02296190|26308437|P5|Overall Study|Patient was given Propofol|0
7566163|NCT02296190|26308438|P4|Overall Study|Patient was given Propofol|1
7566164|NCT02296190|26308439|P3|Overall Study|Patient was given Propofol|0
7566165|NCT02296190|26308440|P2|Overall Study|Patient was given Propofol|1
7566166|NCT02296190|26308441|P1|Overall Study|Patient was given Propofol|0
7566167|NCT02296190|26308436|P6|Overall Study|PSVT < 5 minutes|0
7566168|NCT02296190|26308437|P5|Overall Study|PSVT < 5 minutes|5
7566169|NCT02296190|26308438|P4|Overall Study|PSVT < 5 minutes|6
7566170|NCT02296190|26308439|P3|Overall Study|PSVT < 5 minutes|6
7566171|NCT02296190|26308440|P2|Overall Study|PSVT < 5 minutes|6
7566172|NCT02296190|26308441|P1|Overall Study|PSVT < 5 minutes|5
7566173|NCT02296190|26308436|P6|Overall Study|Withdrawal by Subject|0
7566174|NCT02296190|26308437|P5|Overall Study|Withdrawal by Subject|0
7566175|NCT02296190|26308438|P4|Overall Study|Withdrawal by Subject|0
7566176|NCT02296190|26308439|P3|Overall Study|Withdrawal by Subject|0
7566177|NCT02296190|26308440|P2|Overall Study|Withdrawal by Subject|1
7566178|NCT02296190|26308441|P1|Overall Study|Withdrawal by Subject|0
7566179|NCT02296190|26308436|P6|Overall Study|Physician Decision|0
7566180|NCT02296190|26308437|P5|Overall Study|Physician Decision|2
7566181|NCT02296190|26308438|P4|Overall Study|Physician Decision|1
7566182|NCT02296190|26308439|P3|Overall Study|Physician Decision|0
7566183|NCT02296190|26308440|P2|Overall Study|Physician Decision|1
7566184|NCT02296190|26308441|P1|Overall Study|Physician Decision|1
7566185|NCT02296190|26308436|P6|Overall Study|Failure to induce PSVT|0
7566186|NCT02296190|26308437|P5|Overall Study|Failure to induce PSVT|8
7566187|NCT02296190|26308438|P4|Overall Study|Failure to induce PSVT|13
7566188|NCT02296190|26308439|P3|Overall Study|Failure to induce PSVT|5
7566189|NCT02296190|26308440|P2|Overall Study|Failure to induce PSVT|10
7566190|NCT02296190|26308441|P1|Overall Study|Failure to induce PSVT|6
7566191|NCT02296190|26308436|P6|Overall Study|Lost to Follow-up|0
7566192|NCT02296190|26308437|P5|Overall Study|Lost to Follow-up|1
7566193|NCT02296190|26308438|P4|Overall Study|Lost to Follow-up|0
7566194|NCT02296190|26308439|P3|Overall Study|Lost to Follow-up|0
7566195|NCT02296190|26308440|P2|Overall Study|Lost to Follow-up|0
7566196|NCT02296190|26308441|P1|Overall Study|Lost to Follow-up|0
7566197|NCT02296138|26308460|P2|Overall Study|Other than specified|13
7566198|NCT02296138|26308461|P1|Overall Study|Other than specified|15
7566199|NCT02296138|26308460|P2|Overall Study|Patients with data irregularities|11
7566200|NCT02296138|26308461|P1|Overall Study|Patients with data irregularities|10
7566201|NCT02296138|26308460|P2|Overall Study|Not Treated|1
7566202|NCT02296138|26308461|P1|Overall Study|Not Treated|1
7566203|NCT02296138|26308460|P2|Overall Study|Withdrawal by Subject|131
7566204|NCT02296138|26308461|P1|Overall Study|Withdrawal by Subject|184
7566205|NCT02296138|26308460|P2|Overall Study|Lost to Follow-up|12
7566206|NCT02296138|26308461|P1|Overall Study|Lost to Follow-up|9
7566207|NCT02296138|26308460|P2|Overall Study|Protocol Violation|36
7566208|NCT02296138|26308461|P1|Overall Study|Protocol Violation|35
7566209|NCT02296138|26308460|P2|Overall Study|Lack of Efficacy|37
7566210|NCT02296138|26308461|P1|Overall Study|Lack of Efficacy|59
7566211|NCT02296138|26308460|P2|Overall Study|Adverse Event|259
7566212|NCT02296138|26308461|P1|Overall Study|Adverse Event|348
7566213|NCT02296125|26308477|P4|Overall Study|Any reason not specifically recorded|0
7566214|NCT02296125|26308478|P3|Overall Study|Any reason not specifically recorded|2
7566215|NCT02296125|26308479|P2|Overall Study|Any reason not specifically recorded|4
7566216|NCT02296125|26308480|P1|Overall Study|Any reason not specifically recorded|6
7566217|NCT02296125|26308477|P4|Overall Study|Condition under investigation worsened|56
7566218|NCT02296125|26308478|P3|Overall Study|Condition under investigation worsened|39
7566219|NCT02296125|26308479|P2|Overall Study|Condition under investigation worsened|199
7566220|NCT02296125|26308480|P1|Overall Study|Condition under investigation worsened|153
7566221|NCT02296125|26308477|P4|Overall Study|Severe non-compliance to protocol|0
7566222|NCT02296125|26308478|P3|Overall Study|Severe non-compliance to protocol|0
7566223|NCT02296125|26308479|P2|Overall Study|Severe non-compliance to protocol|1
7566224|NCT02296125|26308480|P1|Overall Study|Severe non-compliance to protocol|0
7566225|NCT02296125|26308477|P4|Overall Study|Adverse Event|4
7566226|NCT02296125|26308478|P3|Overall Study|Adverse Event|9
7566227|NCT02296125|26308479|P2|Overall Study|Adverse Event|52
7566228|NCT02296125|26308480|P1|Overall Study|Adverse Event|41
7566229|NCT02296125|26308477|P4|Overall Study|Withdrawal by Subject|2
7566230|NCT02296125|26308478|P3|Overall Study|Withdrawal by Subject|6
7566231|NCT02296125|26308479|P2|Overall Study|Withdrawal by Subject|8
7566232|NCT02296125|26308480|P1|Overall Study|Withdrawal by Subject|18
7566233|NCT02296112|26308532|P1|Overall Study|Began an alternate therapy|1
7566234|NCT02296112|26308532|P1|Overall Study|Toxicity|1
7566235|NCT02296112|26308532|P1|Overall Study|Disease progression|7
7566236|NCT02295995|26308574|P2|Overall Study|Lost to Follow-up|1
7566237|NCT02295995|26308575|P1|Overall Study|Lost to Follow-up|5
7566238|NCT02295774|26308586|P1|Overall Study|Withdrawal by Subject|2
7566239|NCT02295774|26308586|P1|Overall Study|Physician Decision|1
7566240|NCT02295644|26308626|P4|Overall Study|Did not meet inclusion criterion|2
7566241|NCT02295644|26308627|P3|Overall Study|Did not meet inclusion criterion|1
7566242|NCT02295644|26308628|P2|Overall Study|Did not meet inclusion criterion|0
7566243|NCT02295644|26308629|P1|Overall Study|Did not meet inclusion criterion|0
7566244|NCT02295280|26308678|P2|Overall Study|Adverse Event|1
7566245|NCT02295280|26308679|P1|Overall Study|Adverse Event|0
7566246|NCT02295020|26308687|P2|Overall Study|Withdrawal by Subject|2
7566247|NCT02295020|26308688|P1|Overall Study|Withdrawal by Subject|3
7566248|NCT02295020|26308687|P2|Overall Study|Adverse Event|1
7566249|NCT02295020|26308688|P1|Overall Study|Adverse Event|0
7566250|NCT02294981|26308718|P1|Overall Study|Lost to Follow-up|1
7566251|NCT02294786|26308724|P2|Overall Study|Death|3
7566252|NCT02294786|26308725|P1|Overall Study|Death|2
7566253|NCT02294786|26308724|P2|Overall Study|Adverse Event|1
7566254|NCT02294786|26308725|P1|Overall Study|Adverse Event|1
7566255|NCT02294786|26308724|P2|Overall Study|Protocol Violation|0
7566256|NCT02294786|26308725|P1|Overall Study|Protocol Violation|1
7566257|NCT02294786|26308724|P2|Overall Study|Lost to Follow-up|2
7566258|NCT02294786|26308725|P1|Overall Study|Lost to Follow-up|1
7566259|NCT02294786|26308724|P2|Overall Study|Physician Decision|7
7566260|NCT02294786|26308725|P1|Overall Study|Physician Decision|6
7566261|NCT02294786|26308724|P2|Overall Study|Withdrawal by Subject|1
7566262|NCT02294786|26308725|P1|Overall Study|Withdrawal by Subject|0
7566263|NCT02294773|26308772|P2|Overall Study|Withdrawal by Subject|2
7566264|NCT02294773|26308773|P1|Overall Study|Withdrawal by Subject|0
7566265|NCT02294734|26308789|P2|Overall Study|Withdrawal by Subject|2
7566266|NCT02294734|26308790|P1|Overall Study|Withdrawal by Subject|4
7566267|NCT02294734|26308789|P2|Overall Study|Physician Decision|1
7566268|NCT02294734|26308790|P1|Overall Study|Physician Decision|2
7566269|NCT02294734|26308789|P2|Overall Study|Lost to Follow-up|0
7566270|NCT02294734|26308790|P1|Overall Study|Lost to Follow-up|2
7566271|NCT02294734|26308789|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
7566272|NCT02294734|26308790|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
7566273|NCT02294734|26308789|P2|Overall Study|Adverse Event|5
7566274|NCT02294734|26308790|P1|Overall Study|Adverse Event|5
7566275|NCT02294682|26308842|P2|Overall Study|Could not swallow pills|0
7566276|NCT02294682|26308843|P1|Overall Study|Could not swallow pills|1
7566277|NCT02294604|26308983|P3|Overall Study|Culture contamination|0
7566278|NCT02294604|26308984|P2|Overall Study|Culture contamination|2
7566279|NCT02294604|26308985|P1|Overall Study|Culture contamination|1
7566280|NCT02294604|26308983|P3|Overall Study|Did not provide samples for culture|0
7566281|NCT02294604|26308984|P2|Overall Study|Did not provide samples for culture|1
7566282|NCT02294604|26308985|P1|Overall Study|Did not provide samples for culture|0
7566283|NCT02294474|26309004|P2|Overall Study|Other than specified above|12
7566284|NCT02294474|26309005|P1|Overall Study|Other than specified above|12
7566285|NCT02294474|26309004|P2|Overall Study|Protocol Violation|2
7566286|NCT02294474|26309005|P1|Overall Study|Protocol Violation|4
7566287|NCT02294474|26309004|P2|Overall Study|Lack of Efficacy|1
7566288|NCT02294474|26309005|P1|Overall Study|Lack of Efficacy|2
7566289|NCT02294474|26309004|P2|Overall Study|Adverse Event|7
7566290|NCT02294474|26309005|P1|Overall Study|Adverse Event|7
7566303|NCT02294396|26309086|P4|Overall Study|Miscellaneous|2
7566304|NCT02294396|26309087|P3|Overall Study|Miscellaneous|5
7566305|NCT02294396|26309088|P2|Overall Study|Miscellaneous|0
7566306|NCT02294396|26309089|P1|Overall Study|Miscellaneous|2
7566307|NCT02294396|26309086|P4|Overall Study|Protocol Deviation|1
7566308|NCT02294396|26309087|P3|Overall Study|Protocol Deviation|2
7566309|NCT02294396|26309088|P2|Overall Study|Protocol Deviation|2
7566310|NCT02294396|26309089|P1|Overall Study|Protocol Deviation|3
7566311|NCT02294396|26309086|P4|Overall Study|Lost to Follow-up|1
7566312|NCT02294396|26309087|P3|Overall Study|Lost to Follow-up|1
7566313|NCT02294396|26309088|P2|Overall Study|Lost to Follow-up|0
7566314|NCT02294396|26309089|P1|Overall Study|Lost to Follow-up|0
7566315|NCT02294396|26309086|P4|Overall Study|Withdrawal by Subject|8
7566316|NCT02294396|26309087|P3|Overall Study|Withdrawal by Subject|6
7566317|NCT02294396|26309088|P2|Overall Study|Withdrawal by Subject|6
7566318|NCT02294396|26309089|P1|Overall Study|Withdrawal by Subject|8
7566319|NCT02294396|26309086|P4|Overall Study|Electrocardiogram adviser's judgment|1
7566320|NCT02294396|26309087|P3|Overall Study|Electrocardiogram adviser's judgment|0
7566321|NCT02294396|26309088|P2|Overall Study|Electrocardiogram adviser's judgment|0
7566322|NCT02294396|26309089|P1|Overall Study|Electrocardiogram adviser's judgment|1
7566323|NCT02294396|26309086|P4|Overall Study|Adverse Event|24
7566324|NCT02294396|26309087|P3|Overall Study|Adverse Event|21
7566325|NCT02294396|26309088|P2|Overall Study|Adverse Event|25
7566326|NCT02294396|26309089|P1|Overall Study|Adverse Event|26
7566327|NCT02294318|26309161|P2|Overall Study|Not exposed to intervention|2
7566328|NCT02294318|26309162|P1|Overall Study|Not exposed to intervention|0
7566329|NCT02294318|26309161|P2|Overall Study|Worsening of drinking|0
7566330|NCT02294318|26309162|P1|Overall Study|Worsening of drinking|3
7566331|NCT02294227|26309181|P3|Overall Study|Adverse Event|2
7566332|NCT02294227|26309182|P2|Overall Study|Adverse Event|8
7566333|NCT02294227|26309183|P1|Overall Study|Adverse Event|6
7566334|NCT02294227|26309181|P3|Overall Study|Lack of Efficacy|8
7566335|NCT02294227|26309182|P2|Overall Study|Lack of Efficacy|12
7566336|NCT02294227|26309183|P1|Overall Study|Lack of Efficacy|11
7566337|NCT02294227|26309181|P3|Overall Study|Lost to Follow-up|0
7566338|NCT02294227|26309182|P2|Overall Study|Lost to Follow-up|0
7566339|NCT02294227|26309183|P1|Overall Study|Lost to Follow-up|1
7566340|NCT02294227|26309181|P3|Overall Study|Physician Decision|1
7566341|NCT02294227|26309182|P2|Overall Study|Physician Decision|2
7566342|NCT02294227|26309183|P1|Overall Study|Physician Decision|1
7566343|NCT02294227|26309181|P3|Overall Study|Subject/Guardian Decision|7
7566344|NCT02294227|26309182|P2|Overall Study|Subject/Guardian Decision|3
7566345|NCT02294227|26309183|P1|Overall Study|Subject/Guardian Decision|6
7566346|NCT02294227|26309181|P3|Overall Study|Death|1
7566347|NCT02294227|26309182|P2|Overall Study|Death|0
7566348|NCT02294227|26309183|P1|Overall Study|Death|0
7566349|NCT02294175|26309209|P2|Overall Study|wound healed|2
7566350|NCT02294175|26309210|P1|Overall Study|wound healed|0
7566351|NCT02294175|26309209|P2|Overall Study|Lost to Follow-up|1
7566352|NCT02294175|26309210|P1|Overall Study|Lost to Follow-up|0
7566353|NCT02294175|26309209|P2|Overall Study|Protocol Violation|0
7566354|NCT02294175|26309210|P1|Overall Study|Protocol Violation|1
7566355|NCT02294175|26309209|P2|Overall Study|pt taking excluded medication|1
7566356|NCT02294175|26309210|P1|Overall Study|pt taking excluded medication|3
7566357|NCT02294175|26309209|P2|Overall Study|Withdrawal by Subject|2
7566358|NCT02294175|26309210|P1|Overall Study|Withdrawal by Subject|1
7566359|NCT02294058|26309237|P3|Overall Study|Miscellaneous|1
7566360|NCT02294058|26309238|P2|Overall Study|Miscellaneous|1
7566361|NCT02294058|26309239|P1|Overall Study|Miscellaneous|4
7566362|NCT02294058|26309237|P3|Overall Study|Physician Decision|0
7566363|NCT02294058|26309238|P2|Overall Study|Physician Decision|1
7566364|NCT02294058|26309239|P1|Overall Study|Physician Decision|2
7566365|NCT02294058|26309237|P3|Overall Study|Withdrawal by Subject|13
7566366|NCT02294058|26309238|P2|Overall Study|Withdrawal by Subject|14
7566367|NCT02294058|26309239|P1|Overall Study|Withdrawal by Subject|10
7566368|NCT02294058|26309237|P3|Overall Study|Lost to Follow-up|2
7566369|NCT02294058|26309238|P2|Overall Study|Lost to Follow-up|0
7566370|NCT02294058|26309239|P1|Overall Study|Lost to Follow-up|1
7566371|NCT02294058|26309237|P3|Overall Study|Lack of Efficacy|0
7566372|NCT02294058|26309238|P2|Overall Study|Lack of Efficacy|3
7566373|NCT02294058|26309239|P1|Overall Study|Lack of Efficacy|3
7566374|NCT02294058|26309237|P3|Overall Study|Adverse Event|13
7566375|NCT02294058|26309238|P2|Overall Study|Adverse Event|7
7566376|NCT02294058|26309239|P1|Overall Study|Adverse Event|16
7566377|NCT02294019|26309277|P1|Overall Study|Withdrawal by Subject|1
7566378|NCT02294019|26309277|P1|Overall Study|Other|1
7566379|NCT02294019|26309277|P1|Overall Study|Lost to Follow-up|31
7566380|NCT02294019|26309277|P1|Overall Study|Protocol Violation|68
7566381|NCT02294019|26309277|P1|Overall Study|Adverse Event|2
7566382|NCT02293993|26309286|P4|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7566383|NCT02293993|26309287|P3|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7566384|NCT02293993|26309288|P2|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
7566385|NCT02293993|26309289|P1|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7566386|NCT02293993|26309286|P4|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
7566387|NCT02293993|26309287|P3|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
7566388|NCT02293993|26309288|P2|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7566389|NCT02293993|26309289|P1|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7566390|NCT02293993|26309286|P4|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7566391|NCT02293993|26309287|P3|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
7566392|NCT02293993|26309288|P2|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7566393|NCT02293993|26309289|P1|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7566394|NCT02293993|26309286|P4|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7566395|NCT02293993|26309287|P3|Course ≥2 (Extended Treatment Period)|Physician Decision|1
7566396|NCT02293993|26309288|P2|Course ≥2 (Extended Treatment Period)|Physician Decision|2
7566397|NCT02293993|26309289|P1|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7566398|NCT02293993|26309286|P4|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7566399|NCT02293993|26309287|P3|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7566400|NCT02293993|26309288|P2|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7566401|NCT02293993|26309289|P1|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7566402|NCT02293902|26309334|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7566403|NCT02293902|26309335|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7566404|NCT02293902|26309336|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7566405|NCT02293902|26309337|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7566406|NCT02293902|26309338|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7566407|NCT02293902|26309334|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
7566408|NCT02293902|26309335|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7566409|NCT02293902|26309336|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7566410|NCT02293902|26309337|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
7566411|NCT02293902|26309338|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
7566412|NCT02293902|26309334|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7566413|NCT02293902|26309335|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7566414|NCT02293902|26309336|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7566415|NCT02293902|26309337|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7566416|NCT02293902|26309338|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
7566417|NCT02293902|26309334|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7566418|NCT02293902|26309335|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7566419|NCT02293902|26309336|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
7566420|NCT02293902|26309337|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
7566421|NCT02293902|26309338|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
7566422|NCT02293902|26309334|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
7566423|NCT02293902|26309335|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
7566424|NCT02293902|26309336|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
7566425|NCT02293902|26309337|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
7566426|NCT02293902|26309338|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
7566427|NCT02293863|26309400|P3|Overall Study|Reason Not Specified|2
7566428|NCT02293863|26309401|P2|Overall Study|Reason Not Specified|2
7566429|NCT02293863|26309402|P1|Overall Study|Reason Not Specified|0
7566430|NCT02293863|26309400|P3|Overall Study|Withdrawal by Subject|1
7566431|NCT02293863|26309401|P2|Overall Study|Withdrawal by Subject|3
7566432|NCT02293863|26309402|P1|Overall Study|Withdrawal by Subject|3
7566433|NCT02293863|26309400|P3|Overall Study|Lost to Follow-up|2
7566434|NCT02293863|26309401|P2|Overall Study|Lost to Follow-up|2
7566435|NCT02293863|26309402|P1|Overall Study|Lost to Follow-up|2
7566436|NCT02293863|26309400|P3|Overall Study|Death|4
7566437|NCT02293863|26309401|P2|Overall Study|Death|6
7566438|NCT02293863|26309402|P1|Overall Study|Death|4
7566439|NCT02293837|26309469|P4|Overall Study|Participant ill and could not be infused|0
7566440|NCT02293837|26309470|P3|Overall Study|Participant ill and could not be infused|1
7566441|NCT02293837|26309471|P2|Overall Study|Participant ill and could not be infused|0
7566442|NCT02293837|26309472|P1|Overall Study|Participant ill and could not be infused|0
7566443|NCT02293837|26309469|P4|Overall Study|COVID-19 Related|0
7566444|NCT02293837|26309470|P3|Overall Study|COVID-19 Related|0
7566445|NCT02293837|26309471|P2|Overall Study|COVID-19 Related|1
7566446|NCT02293837|26309472|P1|Overall Study|COVID-19 Related|1
7566447|NCT02293837|26309469|P4|Overall Study|Withdrawal by Subject|1
7566448|NCT02293837|26309470|P3|Overall Study|Withdrawal by Subject|2
7566449|NCT02293837|26309471|P2|Overall Study|Withdrawal by Subject|1
7566450|NCT02293837|26309472|P1|Overall Study|Withdrawal by Subject|2
7566451|NCT02293837|26309469|P4|Overall Study|Lost to Follow-up|0
7566452|NCT02293837|26309470|P3|Overall Study|Lost to Follow-up|1
7566453|NCT02293837|26309471|P2|Overall Study|Lost to Follow-up|2
7566454|NCT02293837|26309472|P1|Overall Study|Lost to Follow-up|0
7566455|NCT02293538|26309548|P2|Overall Study|Withdrawal by Subject|1
7566456|NCT02293538|26309549|P1|Overall Study|Withdrawal by Subject|0
7566457|NCT02293538|26309548|P2|Overall Study|Lost to Follow-up|0
7566458|NCT02293538|26309549|P1|Overall Study|Lost to Follow-up|1
7566459|NCT02293538|26309548|P2|Overall Study|Adverse Event|1
7566460|NCT02293538|26309549|P1|Overall Study|Adverse Event|0
7566461|NCT02293499|26309582|P3|15 Month Follow Up|Lost to Follow-up|7
7566462|NCT02293499|26309583|P2|15 Month Follow Up|Lost to Follow-up|22
7566463|NCT02293499|26309584|P1|15 Month Follow Up|Lost to Follow-up|22
7566464|NCT02293499|26309582|P3|12 Month Follow Up|Withdrawal by Subject|0
7566465|NCT02293499|26309583|P2|12 Month Follow Up|Withdrawal by Subject|1
7566466|NCT02293499|26309584|P1|12 Month Follow Up|Withdrawal by Subject|0
7566467|NCT02293499|26309582|P3|12 Month Follow Up|Lost to Follow-up|6
7566468|NCT02293499|26309583|P2|12 Month Follow Up|Lost to Follow-up|25
7566469|NCT02293499|26309584|P1|12 Month Follow Up|Lost to Follow-up|26
7566470|NCT02293499|26309582|P3|9 Month Follow Up|Lost to Follow-up|4
7566471|NCT02293499|26309583|P2|9 Month Follow Up|Lost to Follow-up|28
7566472|NCT02293499|26309584|P1|9 Month Follow Up|Lost to Follow-up|24
7566473|NCT02293499|26309582|P3|9 Month Follow Up|Withdrawal by Subject|0
7566474|NCT02293499|26309583|P2|9 Month Follow Up|Withdrawal by Subject|0
7566475|NCT02293499|26309584|P1|9 Month Follow Up|Withdrawal by Subject|2
7566476|NCT02293499|26309582|P3|6 Month Follow Up|Withdrawal by Subject|1
7566477|NCT02293499|26309583|P2|6 Month Follow Up|Withdrawal by Subject|0
7566478|NCT02293499|26309584|P1|6 Month Follow Up|Withdrawal by Subject|0
7566479|NCT02293499|26309582|P3|6 Month Follow Up|Lost to Follow-up|6
7566480|NCT02293499|26309583|P2|6 Month Follow Up|Lost to Follow-up|27
7566481|NCT02293499|26309584|P1|6 Month Follow Up|Lost to Follow-up|17
7566482|NCT02293499|26309582|P3|3 Month Follow Up|Lost to Follow-up|6
7566483|NCT02293499|26309583|P2|3 Month Follow Up|Lost to Follow-up|15
7566484|NCT02293499|26309584|P1|3 Month Follow Up|Lost to Follow-up|14
7566485|NCT02293499|26309582|P3|3 Month Follow Up|Withdrawal by Subject|4
7566486|NCT02293499|26309583|P2|3 Month Follow Up|Withdrawal by Subject|0
7566487|NCT02293499|26309584|P1|3 Month Follow Up|Withdrawal by Subject|1
7566488|NCT02293499|26309582|P3|Intervention - Camp|these are those not showing up at camp|4
7566489|NCT02293499|26309583|P2|Intervention - Camp|these are those not showing up at camp|28
7566490|NCT02293499|26309584|P1|Intervention - Camp|these are those not showing up at camp|24
7566491|NCT02293499|26309582|P3|Intervention - Camp|Withdrawal by Subject|2
7566492|NCT02293499|26309583|P2|Intervention - Camp|Withdrawal by Subject|6
7566493|NCT02293499|26309584|P1|Intervention - Camp|Withdrawal by Subject|3
7566494|NCT02293499|26309582|P3|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
7566495|NCT02293499|26309583|P2|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7566496|NCT02293499|26309584|P1|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7566497|NCT02293460|26309616|P1|Overall Study|Withdrawal by Subject|1
7566498|NCT02293460|26309616|P1|Overall Study|Adverse Event|2
7566499|NCT02293460|26309616|P1|Overall Study|Lack of Efficacy|2
7566500|NCT02293460|26309616|P1|Overall Study|Protocol Violation|1
7566501|NCT02293395|26309622|P2|Overall Study|Withdrawal by Subject|7
7566502|NCT02293395|26309623|P1|Overall Study|Withdrawal by Subject|8
7566503|NCT02293395|26309622|P2|Overall Study|Lost to Follow-up|0
7566504|NCT02293395|26309623|P1|Overall Study|Lost to Follow-up|1
7566505|NCT02292927|26309653|P2|Overall Study|Protocol Violation|7
7566506|NCT02292927|26309654|P1|Overall Study|Protocol Violation|13
7566507|NCT02292849|26309671|P3|Overall Study|Physician Decision|0
7566508|NCT02292849|26309672|P2|Overall Study|Physician Decision|0
7566509|NCT02292849|26309673|P1|Overall Study|Physician Decision|4
7566510|NCT02292849|26309671|P3|Overall Study|Lost to Follow-up|2
7566511|NCT02292849|26309672|P2|Overall Study|Lost to Follow-up|2
7566512|NCT02292849|26309673|P1|Overall Study|Lost to Follow-up|0
7566513|NCT02292784|26309684|P3|Overall Study|Withdrawal by Subject|3
7566514|NCT02292784|26309685|P2|Overall Study|Withdrawal by Subject|3
7566515|NCT02292784|26309686|P1|Overall Study|Withdrawal by Subject|0
7566516|NCT02292784|26309684|P3|Overall Study|Lost to Follow-up|18
7566517|NCT02292784|26309685|P2|Overall Study|Lost to Follow-up|17
7566518|NCT02292784|26309686|P1|Overall Study|Lost to Follow-up|1
7566519|NCT02292771|26309753|P2|Overall Study|Lost to Follow-up|1
7566520|NCT02292771|26309754|P1|Overall Study|Lost to Follow-up|2
7566521|NCT02292771|26309753|P2|Overall Study|Withdrawal by Subject|1
7566522|NCT02292771|26309754|P1|Overall Study|Withdrawal by Subject|2
7566523|NCT02292719|26309877|P6|Overall Study|Subject enrolled in new study.|0
7566524|NCT02292719|26309878|P5|Overall Study|Subject enrolled in new study.|0
7566525|NCT02292719|26309879|P4|Overall Study|Subject enrolled in new study.|0
7566526|NCT02292719|26309880|P3|Overall Study|Subject enrolled in new study.|1
7566527|NCT02292719|26309881|P2|Overall Study|Subject enrolled in new study.|0
7566528|NCT02292719|26309882|P1|Overall Study|Subject enrolled in new study.|0
7566529|NCT02292719|26309877|P6|Overall Study|Withdrawal by Subject|0
7566530|NCT02292719|26309878|P5|Overall Study|Withdrawal by Subject|1
7566531|NCT02292719|26309879|P4|Overall Study|Withdrawal by Subject|1
7566532|NCT02292719|26309880|P3|Overall Study|Withdrawal by Subject|0
7566533|NCT02292719|26309881|P2|Overall Study|Withdrawal by Subject|0
7566534|NCT02292719|26309882|P1|Overall Study|Withdrawal by Subject|0
7566535|NCT02292446|26310081|P1|Overall Study|Withdrawal by Subject|3
7566536|NCT02292446|26310081|P1|Overall Study|Subject/guardian decision|2
7566537|NCT02292446|26310081|P1|Overall Study|Disease progression|2
7566538|NCT02292446|26310081|P1|Overall Study|Death|1
7566539|NCT02292446|26310081|P1|Overall Study|Adverse Event|12
7566540|NCT02292212|26310170|P1|ViE Phase|Protocol Violation|2
7566541|NCT02292212|26310170|P1|ViE Phase|Withdrawal by Subject|1
7566542|NCT02291913|26310239|P1|Overall Study|Protocol Violation|1
7566543|NCT02291913|26310239|P1|Overall Study|Withdrawal by Subject|1
7566544|NCT02291913|26310239|P1|Overall Study|Physician Decision|1
7566545|NCT02291913|26310239|P1|Overall Study|Death|2
7566546|NCT02291913|26310239|P1|Overall Study|Adverse Event|11
7566547|NCT02291913|26310239|P1|Overall Study|Progressive Disease|32
7566548|NCT02291861|26310252|P4|Overall Study|Other|1
7566549|NCT02291861|26310253|P3|Overall Study|Other|0
7566550|NCT02291861|26310254|P2|Overall Study|Other|0
7566551|NCT02291861|26310255|P1|Overall Study|Other|0
7566552|NCT02291861|26310252|P4|Overall Study|Lost to Follow-up|0
7566553|NCT02291861|26310253|P3|Overall Study|Lost to Follow-up|4
7566554|NCT02291861|26310254|P2|Overall Study|Lost to Follow-up|1
7566555|NCT02291861|26310255|P1|Overall Study|Lost to Follow-up|2
7566556|NCT02291861|26310252|P4|Overall Study|Noncompliance|1
7566557|NCT02291861|26310253|P3|Overall Study|Noncompliance|2
7566558|NCT02291861|26310254|P2|Overall Study|Noncompliance|1
7566559|NCT02291861|26310255|P1|Overall Study|Noncompliance|1
7566560|NCT02291861|26310252|P4|Overall Study|Withdrawal by Subject|4
7566561|NCT02291861|26310253|P3|Overall Study|Withdrawal by Subject|1
7566562|NCT02291861|26310254|P2|Overall Study|Withdrawal by Subject|2
7566563|NCT02291861|26310255|P1|Overall Study|Withdrawal by Subject|1
7566564|NCT02291861|26310252|P4|Overall Study|Protocol Violation|1
7566565|NCT02291861|26310253|P3|Overall Study|Protocol Violation|0
7566566|NCT02291861|26310254|P2|Overall Study|Protocol Violation|0
7566567|NCT02291861|26310255|P1|Overall Study|Protocol Violation|1
7566568|NCT02291861|26310252|P4|Overall Study|Death|1
7566569|NCT02291861|26310253|P3|Overall Study|Death|1
7566570|NCT02291861|26310254|P2|Overall Study|Death|0
7566571|NCT02291861|26310255|P1|Overall Study|Death|0
7566572|NCT02291861|26310252|P4|Overall Study|Adverse Event|2
7566573|NCT02291861|26310253|P3|Overall Study|Adverse Event|1
7566574|NCT02291861|26310254|P2|Overall Study|Adverse Event|4
7566575|NCT02291861|26310255|P1|Overall Study|Adverse Event|2
7566576|NCT02291679|26310318|P3|Overall Study|Other|2
7566577|NCT02291679|26310319|P2|Overall Study|Other|4
7566578|NCT02291679|26310320|P1|Overall Study|Other|2
7566579|NCT02291679|26310318|P3|Overall Study|Insufficient Therapeutic Response|7
7566580|NCT02291679|26310319|P2|Overall Study|Insufficient Therapeutic Response|5
7566581|NCT02291679|26310320|P1|Overall Study|Insufficient Therapeutic Response|5
7566582|NCT02291679|26310318|P3|Overall Study|Lost to Follow-up|9
7566583|NCT02291679|26310319|P2|Overall Study|Lost to Follow-up|10
7566584|NCT02291679|26310320|P1|Overall Study|Lost to Follow-up|12
7566585|NCT02291679|26310318|P3|Overall Study|Withdrew Consent|15
7566586|NCT02291679|26310319|P2|Overall Study|Withdrew Consent|10
7566587|NCT02291679|26310320|P1|Overall Study|Withdrew Consent|18
7566588|NCT02291679|26310318|P3|Overall Study|Protocol Violation|7
7566589|NCT02291679|26310319|P2|Overall Study|Protocol Violation|1
7566590|NCT02291679|26310320|P1|Overall Study|Protocol Violation|5
7566591|NCT02291679|26310318|P3|Overall Study|Adverse Event|19
7566592|NCT02291679|26310319|P2|Overall Study|Adverse Event|12
7566593|NCT02291679|26310320|P1|Overall Study|Adverse Event|2
7566594|NCT02291614|26310360|P11|Overall Study|Death|0
7566595|NCT02291614|26310361|P10|Overall Study|Death|0
7566596|NCT02291614|26310362|P9|Overall Study|Death|0
7566597|NCT02291614|26310363|P8|Overall Study|Death|0
7566598|NCT02291614|26310364|P7|Overall Study|Death|1
7566599|NCT02291614|26310365|P6|Overall Study|Death|1
7566600|NCT02291614|26310366|P5|Overall Study|Death|1
7566601|NCT02291614|26310367|P4|Overall Study|Death|0
7566602|NCT02291614|26310368|P3|Overall Study|Death|1
7566603|NCT02291614|26310369|P2|Overall Study|Death|0
7566604|NCT02291614|26310370|P1|Overall Study|Death|0
7566605|NCT02291614|26310360|P11|Overall Study|Decision by sponsor|0
7566606|NCT02291614|26310361|P10|Overall Study|Decision by sponsor|0
7566607|NCT02291614|26310362|P9|Overall Study|Decision by sponsor|0
7566608|NCT02291614|26310363|P8|Overall Study|Decision by sponsor|0
7566609|NCT02291614|26310364|P7|Overall Study|Decision by sponsor|0
7566610|NCT02291614|26310365|P6|Overall Study|Decision by sponsor|0
7566611|NCT02291614|26310366|P5|Overall Study|Decision by sponsor|0
7566612|NCT02291614|26310367|P4|Overall Study|Decision by sponsor|1
7566613|NCT02291614|26310368|P3|Overall Study|Decision by sponsor|0
7566614|NCT02291614|26310369|P2|Overall Study|Decision by sponsor|0
7566615|NCT02291614|26310370|P1|Overall Study|Decision by sponsor|0
7566616|NCT02291614|26310360|P11|Overall Study|Withdrawal by Subject|2
7566617|NCT02291614|26310361|P10|Overall Study|Withdrawal by Subject|2
7566618|NCT02291614|26310362|P9|Overall Study|Withdrawal by Subject|0
7566619|NCT02291614|26310363|P8|Overall Study|Withdrawal by Subject|0
7566620|NCT02291614|26310364|P7|Overall Study|Withdrawal by Subject|0
7566621|NCT02291614|26310365|P6|Overall Study|Withdrawal by Subject|0
7566622|NCT02291614|26310366|P5|Overall Study|Withdrawal by Subject|0
7566623|NCT02291614|26310367|P4|Overall Study|Withdrawal by Subject|0
7566624|NCT02291614|26310368|P3|Overall Study|Withdrawal by Subject|0
7566625|NCT02291614|26310369|P2|Overall Study|Withdrawal by Subject|1
7566626|NCT02291614|26310370|P1|Overall Study|Withdrawal by Subject|0
7566627|NCT02291614|26310360|P11|Overall Study|Lost to Follow-up|0
7566628|NCT02291614|26310361|P10|Overall Study|Lost to Follow-up|0
7566629|NCT02291614|26310362|P9|Overall Study|Lost to Follow-up|0
7566630|NCT02291614|26310363|P8|Overall Study|Lost to Follow-up|1
7566631|NCT02291614|26310364|P7|Overall Study|Lost to Follow-up|0
7566632|NCT02291614|26310365|P6|Overall Study|Lost to Follow-up|0
7566633|NCT02291614|26310366|P5|Overall Study|Lost to Follow-up|0
7566634|NCT02291614|26310367|P4|Overall Study|Lost to Follow-up|0
7566635|NCT02291614|26310368|P3|Overall Study|Lost to Follow-up|0
7566636|NCT02291614|26310369|P2|Overall Study|Lost to Follow-up|0
7566637|NCT02291614|26310370|P1|Overall Study|Lost to Follow-up|0
7566638|NCT02291601|26310548|P3|Groin|Did not qualify|177
7566639|NCT02291601|26310549|P2|Groin|Did not qualify|30
7566640|NCT02291601|26310550|P1|Groin|Did not qualify|183
7566641|NCT02291601|26310548|P3|Abdomen|Did not qualify|339
7566642|NCT02291601|26310549|P2|Abdomen|Did not qualify|54
7566643|NCT02291601|26310550|P1|Abdomen|Did not qualify|333
7566644|NCT02291549|26310563|P2|Overall Study|Withdrawal by Subject|1
7566645|NCT02291549|26310564|P1|Overall Study|Withdrawal by Subject|0
7566646|NCT02291549|26310563|P2|Overall Study|Lost to Follow-up|0
7566647|NCT02291549|26310564|P1|Overall Study|Lost to Follow-up|1
7566648|NCT02291510|26310586|P4|Overall Study|Adverse Event|1
7566649|NCT02291510|26310587|P3|Overall Study|Adverse Event|0
7566650|NCT02291510|26310588|P2|Overall Study|Adverse Event|0
7566651|NCT02291510|26310589|P1|Overall Study|Adverse Event|0
7566652|NCT02291419|26310605|P2|Overall Study|Early study termination|5
7566653|NCT02291419|26310606|P1|Overall Study|Early study termination|1
7566654|NCT02291289|26310655|P12|Maintenance Treatment Phase|No Treatment Received|0
7566655|NCT02291289|26310656|P11|Maintenance Treatment Phase|No Treatment Received|1
7566656|NCT02291289|26310657|P10|Maintenance Treatment Phase|No Treatment Received|0
7566657|NCT02291289|26310658|P9|Maintenance Treatment Phase|No Treatment Received|0
7566658|NCT02291289|26310659|P8|Maintenance Treatment Phase|No Treatment Received|0
7566659|NCT02291289|26310660|P7|Maintenance Treatment Phase|No Treatment Received|0
7566660|NCT02291289|26310661|P6|Maintenance Treatment Phase|No Treatment Received|5
7566661|NCT02291289|26310662|P5|Maintenance Treatment Phase|No Treatment Received|4
7566662|NCT02291289|26310663|P4|Maintenance Treatment Phase|No Treatment Received|0
7566663|NCT02291289|26310664|P3|Maintenance Treatment Phase|No Treatment Received|2
7566664|NCT02291289|26310665|P2|Maintenance Treatment Phase|No Treatment Received|0
7566665|NCT02291289|26310666|P1|Maintenance Treatment Phase|No Treatment Received|0
7566666|NCT02291289|26310655|P12|Maintenance Treatment Phase|Multiple Reasons|0
7566667|NCT02291289|26310656|P11|Maintenance Treatment Phase|Multiple Reasons|0
7566668|NCT02291289|26310657|P10|Maintenance Treatment Phase|Multiple Reasons|0
7566669|NCT02291289|26310658|P9|Maintenance Treatment Phase|Multiple Reasons|0
7566670|NCT02291289|26310659|P8|Maintenance Treatment Phase|Multiple Reasons|0
7566671|NCT02291289|26310660|P7|Maintenance Treatment Phase|Multiple Reasons|0
7566672|NCT02291289|26310661|P6|Maintenance Treatment Phase|Multiple Reasons|1
7566673|NCT02291289|26310662|P5|Maintenance Treatment Phase|Multiple Reasons|4
7566674|NCT02291289|26310663|P4|Maintenance Treatment Phase|Multiple Reasons|0
7566675|NCT02291289|26310664|P3|Maintenance Treatment Phase|Multiple Reasons|0
7566676|NCT02291289|26310665|P2|Maintenance Treatment Phase|Multiple Reasons|0
7566677|NCT02291289|26310666|P1|Maintenance Treatment Phase|Multiple Reasons|0
7566678|NCT02291289|26310655|P12|Maintenance Treatment Phase|Physician Decision|1
7566679|NCT02291289|26310656|P11|Maintenance Treatment Phase|Physician Decision|0
7566680|NCT02291289|26310657|P10|Maintenance Treatment Phase|Physician Decision|0
7566681|NCT02291289|26310658|P9|Maintenance Treatment Phase|Physician Decision|0
7566682|NCT02291289|26310659|P8|Maintenance Treatment Phase|Physician Decision|0
7566683|NCT02291289|26310660|P7|Maintenance Treatment Phase|Physician Decision|0
7566684|NCT02291289|26310661|P6|Maintenance Treatment Phase|Physician Decision|0
7566685|NCT02291289|26310662|P5|Maintenance Treatment Phase|Physician Decision|2
7566686|NCT02291289|26310663|P4|Maintenance Treatment Phase|Physician Decision|0
7566687|NCT02291289|26310664|P3|Maintenance Treatment Phase|Physician Decision|0
7566688|NCT02291289|26310665|P2|Maintenance Treatment Phase|Physician Decision|0
7566689|NCT02291289|26310666|P1|Maintenance Treatment Phase|Physician Decision|0
7566690|NCT02291289|26310655|P12|Maintenance Treatment Phase|Other|0
7566691|NCT02291289|26310656|P11|Maintenance Treatment Phase|Other|0
7566692|NCT02291289|26310657|P10|Maintenance Treatment Phase|Other|0
7566693|NCT02291289|26310658|P9|Maintenance Treatment Phase|Other|1
7566694|NCT02291289|26310659|P8|Maintenance Treatment Phase|Other|0
7566695|NCT02291289|26310660|P7|Maintenance Treatment Phase|Other|0
7566696|NCT02291289|26310661|P6|Maintenance Treatment Phase|Other|8
7566697|NCT02291289|26310662|P5|Maintenance Treatment Phase|Other|29
7566698|NCT02291289|26310663|P4|Maintenance Treatment Phase|Other|0
7566699|NCT02291289|26310664|P3|Maintenance Treatment Phase|Other|1
7566700|NCT02291289|26310665|P2|Maintenance Treatment Phase|Other|0
7566701|NCT02291289|26310666|P1|Maintenance Treatment Phase|Other|0
7566702|NCT02291289|26310655|P12|Maintenance Treatment Phase|Lost to Follow-up|1
7566703|NCT02291289|26310656|P11|Maintenance Treatment Phase|Lost to Follow-up|2
7566704|NCT02291289|26310657|P10|Maintenance Treatment Phase|Lost to Follow-up|0
7566705|NCT02291289|26310658|P9|Maintenance Treatment Phase|Lost to Follow-up|0
7566706|NCT02291289|26310659|P8|Maintenance Treatment Phase|Lost to Follow-up|1
7566789|NCT02291029|26310761|P3|Overall Study|Adverse Event|0
7566707|NCT02291289|26310660|P7|Maintenance Treatment Phase|Lost to Follow-up|0
7566708|NCT02291289|26310661|P6|Maintenance Treatment Phase|Lost to Follow-up|3
7566709|NCT02291289|26310662|P5|Maintenance Treatment Phase|Lost to Follow-up|12
7566710|NCT02291289|26310663|P4|Maintenance Treatment Phase|Lost to Follow-up|0
7566711|NCT02291289|26310664|P3|Maintenance Treatment Phase|Lost to Follow-up|0
7566712|NCT02291289|26310665|P2|Maintenance Treatment Phase|Lost to Follow-up|0
7566713|NCT02291289|26310666|P1|Maintenance Treatment Phase|Lost to Follow-up|0
7566714|NCT02291289|26310655|P12|Maintenance Treatment Phase|Adverse Event|0
7566715|NCT02291289|26310656|P11|Maintenance Treatment Phase|Adverse Event|0
7566716|NCT02291289|26310657|P10|Maintenance Treatment Phase|Adverse Event|0
7566717|NCT02291289|26310658|P9|Maintenance Treatment Phase|Adverse Event|0
7566718|NCT02291289|26310659|P8|Maintenance Treatment Phase|Adverse Event|0
7566719|NCT02291289|26310660|P7|Maintenance Treatment Phase|Adverse Event|0
7566720|NCT02291289|26310661|P6|Maintenance Treatment Phase|Adverse Event|0
7566721|NCT02291289|26310662|P5|Maintenance Treatment Phase|Adverse Event|1
7566722|NCT02291289|26310663|P4|Maintenance Treatment Phase|Adverse Event|0
7566723|NCT02291289|26310664|P3|Maintenance Treatment Phase|Adverse Event|0
7566724|NCT02291289|26310665|P2|Maintenance Treatment Phase|Adverse Event|0
7566725|NCT02291289|26310666|P1|Maintenance Treatment Phase|Adverse Event|0
7566726|NCT02291289|26310655|P12|Maintenance Treatment Phase|Death|11
7566727|NCT02291289|26310656|P11|Maintenance Treatment Phase|Death|26
7566728|NCT02291289|26310657|P10|Maintenance Treatment Phase|Death|0
7566729|NCT02291289|26310658|P9|Maintenance Treatment Phase|Death|1
7566730|NCT02291289|26310659|P8|Maintenance Treatment Phase|Death|1
7566731|NCT02291289|26310660|P7|Maintenance Treatment Phase|Death|0
7566732|NCT02291289|26310661|P6|Maintenance Treatment Phase|Death|100
7566733|NCT02291289|26310662|P5|Maintenance Treatment Phase|Death|185
7566734|NCT02291289|26310663|P4|Maintenance Treatment Phase|Death|0
7566735|NCT02291289|26310664|P3|Maintenance Treatment Phase|Death|13
7566736|NCT02291289|26310665|P2|Maintenance Treatment Phase|Death|23
7566737|NCT02291289|26310666|P1|Maintenance Treatment Phase|Death|0
7566738|NCT02291289|26310655|P12|Maintenance Treatment Phase|Protocol Violation|0
7566739|NCT02291289|26310656|P11|Maintenance Treatment Phase|Protocol Violation|0
7566740|NCT02291289|26310657|P10|Maintenance Treatment Phase|Protocol Violation|0
7566741|NCT02291289|26310658|P9|Maintenance Treatment Phase|Protocol Violation|0
7566742|NCT02291289|26310659|P8|Maintenance Treatment Phase|Protocol Violation|0
7566743|NCT02291289|26310660|P7|Maintenance Treatment Phase|Protocol Violation|0
7566744|NCT02291289|26310661|P6|Maintenance Treatment Phase|Protocol Violation|1
7566745|NCT02291289|26310662|P5|Maintenance Treatment Phase|Protocol Violation|2
7566746|NCT02291289|26310663|P4|Maintenance Treatment Phase|Protocol Violation|0
7566747|NCT02291289|26310664|P3|Maintenance Treatment Phase|Protocol Violation|0
7566748|NCT02291289|26310665|P2|Maintenance Treatment Phase|Protocol Violation|1
7566749|NCT02291289|26310666|P1|Maintenance Treatment Phase|Protocol Violation|0
7566750|NCT02291289|26310655|P12|Maintenance Treatment Phase|Withdrawal by Subject|3
7566751|NCT02291289|26310656|P11|Maintenance Treatment Phase|Withdrawal by Subject|2
7566752|NCT02291289|26310657|P10|Maintenance Treatment Phase|Withdrawal by Subject|0
7566753|NCT02291289|26310658|P9|Maintenance Treatment Phase|Withdrawal by Subject|0
7566754|NCT02291289|26310659|P8|Maintenance Treatment Phase|Withdrawal by Subject|0
7566755|NCT02291289|26310660|P7|Maintenance Treatment Phase|Withdrawal by Subject|0
7566756|NCT02291289|26310661|P6|Maintenance Treatment Phase|Withdrawal by Subject|11
7566757|NCT02291289|26310662|P5|Maintenance Treatment Phase|Withdrawal by Subject|13
7566758|NCT02291289|26310663|P4|Maintenance Treatment Phase|Withdrawal by Subject|0
7566759|NCT02291289|26310664|P3|Maintenance Treatment Phase|Withdrawal by Subject|0
7566760|NCT02291289|26310665|P2|Maintenance Treatment Phase|Withdrawal by Subject|0
7566761|NCT02291289|26310666|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
7566762|NCT02291289|26310655|P12|Induction Treatment|Not Dosed|0
7566763|NCT02291289|26310656|P11|Induction Treatment|Not Dosed|0
7566764|NCT02291289|26310657|P10|Induction Treatment|Not Dosed|1
7566765|NCT02291289|26310658|P9|Induction Treatment|Not Dosed|0
7566766|NCT02291289|26310659|P8|Induction Treatment|Not Dosed|0
7566767|NCT02291289|26310660|P7|Induction Treatment|Not Dosed|0
7566768|NCT02291289|26310661|P6|Induction Treatment|Not Dosed|0
7566769|NCT02291289|26310662|P5|Induction Treatment|Not Dosed|0
7566770|NCT02291289|26310663|P4|Induction Treatment|Not Dosed|9
7566771|NCT02291289|26310664|P3|Induction Treatment|Not Dosed|0
7566772|NCT02291289|26310665|P2|Induction Treatment|Not Dosed|0
7566773|NCT02291289|26310666|P1|Induction Treatment|Not Dosed|2
7566774|NCT02291237|26310730|P2|Overall Study|Subject Required Prohibited Medication|0
7566775|NCT02291237|26310731|P1|Overall Study|Subject Required Prohibited Medication|2
7566776|NCT02291237|26310730|P2|Overall Study|Lost to Follow-up|2
7566777|NCT02291237|26310731|P1|Overall Study|Lost to Follow-up|0
7566778|NCT02291237|26310730|P2|Overall Study|Withdrew Consent|11
7566779|NCT02291237|26310731|P1|Overall Study|Withdrew Consent|11
7566780|NCT02291237|26310730|P2|Overall Study|Investigator's Discretion|3
7566781|NCT02291237|26310731|P1|Overall Study|Investigator's Discretion|0
7566782|NCT02291237|26310730|P2|Overall Study|Adverse Event|3
7566783|NCT02291237|26310731|P1|Overall Study|Adverse Event|1
7566784|NCT02291237|26310730|P2|Overall Study|Study Terminated by Sponsor|67
7566785|NCT02291237|26310731|P1|Overall Study|Study Terminated by Sponsor|72
7566786|NCT02291029|26310758|P6|Overall Study|Adverse Event|0
7566787|NCT02291029|26310759|P5|Overall Study|Adverse Event|0
7566788|NCT02291029|26310760|P4|Overall Study|Adverse Event|0
7566790|NCT02291029|26310762|P2|Overall Study|Adverse Event|1
7566791|NCT02291029|26310763|P1|Overall Study|Adverse Event|0
7566792|NCT02291029|26310758|P6|Overall Study|Withdrawal by Subject|0
7566793|NCT02291029|26310759|P5|Overall Study|Withdrawal by Subject|0
7566794|NCT02291029|26310760|P4|Overall Study|Withdrawal by Subject|0
7566795|NCT02291029|26310761|P3|Overall Study|Withdrawal by Subject|1
7566796|NCT02291029|26310762|P2|Overall Study|Withdrawal by Subject|0
7566797|NCT02291029|26310763|P1|Overall Study|Withdrawal by Subject|0
7566798|NCT02290925|26310834|P2|Second Period of 3 Months|insulin started|1
7566799|NCT02290925|26310835|P1|Second Period of 3 Months|insulin started|0
7566800|NCT02290925|26310834|P2|Second Period of 3 Months|Lost to Follow-up|3
7566801|NCT02290925|26310835|P1|Second Period of 3 Months|Lost to Follow-up|1
7566802|NCT02290925|26310834|P2|First Period of Three Months|Insulin Started|1
7566803|NCT02290925|26310835|P1|First Period of Three Months|Insulin Started|1
7566804|NCT02290925|26310834|P2|First Period of Three Months|Death|0
7566805|NCT02290925|26310835|P1|First Period of Three Months|Death|1
7566806|NCT02290925|26310834|P2|First Period of Three Months|Lost to Follow-up|1
7566807|NCT02290925|26310835|P1|First Period of Three Months|Lost to Follow-up|2
7566808|NCT02290873|26310850|P3|Overall Study|Protocol Violation|1
7566809|NCT02290873|26310851|P2|Overall Study|Protocol Violation|0
7566810|NCT02290873|26310852|P1|Overall Study|Protocol Violation|0
7566811|NCT02290873|26310850|P3|Overall Study|Esophagogastroduodenoscopy was added|0
7566812|NCT02290873|26310851|P2|Overall Study|Esophagogastroduodenoscopy was added|0
7566813|NCT02290873|26310852|P1|Overall Study|Esophagogastroduodenoscopy was added|1
7566814|NCT02290873|26310850|P3|Overall Study|Nellcor device error|0
7566815|NCT02290873|26310851|P2|Overall Study|Nellcor device error|0
7566816|NCT02290873|26310852|P1|Overall Study|Nellcor device error|1
7566817|NCT02290873|26310850|P3|Overall Study|Withdrawal by Subject|1
7566818|NCT02290873|26310851|P2|Overall Study|Withdrawal by Subject|1
7566819|NCT02290873|26310852|P1|Overall Study|Withdrawal by Subject|0
7566820|NCT02290821|26310871|P2|Overall Study|Lost to Follow-up|2
7566821|NCT02290821|26310872|P1|Overall Study|Lost to Follow-up|3
7566822|NCT02290821|26310871|P2|Overall Study|Unable or unwilling to cooperate with|0
7566823|NCT02290821|26310872|P1|Overall Study|Unable or unwilling to cooperate with|2
7566824|NCT02290821|26310871|P2|Overall Study|Withdrawal by Subject|1
7566825|NCT02290821|26310872|P1|Overall Study|Withdrawal by Subject|1
7566826|NCT02290691|26310880|P2|Overall Study|Lost to Follow-up|7
7566827|NCT02290691|26310881|P1|Overall Study|Lost to Follow-up|7
7566828|NCT02290691|26310880|P2|Overall Study|Withdrawal by Subject|1
7566829|NCT02290691|26310881|P1|Overall Study|Withdrawal by Subject|1
7566830|NCT02290691|26310880|P2|Overall Study|Noncompliance|1
7566831|NCT02290691|26310881|P1|Overall Study|Noncompliance|0
7566832|NCT02290431|26310994|P1|Overall Study|Physician Decision|2
7566833|NCT02290431|26310994|P1|Overall Study|Study terminated by Sponsor|1
7566834|NCT02290431|26310994|P1|Overall Study|Progressive disease|4
7566835|NCT02290431|26310994|P1|Overall Study|Adverse Event|20
7566836|NCT02290405|26311015|P2|Overall Study|Withdrawal by Subject|0
7566837|NCT02290405|26311016|P1|Overall Study|Withdrawal by Subject|1
7566838|NCT02290340|26311026|P4|Overall Study|Other|1
7566839|NCT02290340|26311027|P3|Overall Study|Other|0
7566840|NCT02290340|26311028|P2|Overall Study|Other|0
7566841|NCT02290340|26311029|P1|Overall Study|Other|1
7566842|NCT02290340|26311026|P4|Overall Study|Withdrawal by Subject|0
7566843|NCT02290340|26311027|P3|Overall Study|Withdrawal by Subject|0
7566844|NCT02290340|26311028|P2|Overall Study|Withdrawal by Subject|0
7566845|NCT02290340|26311029|P1|Overall Study|Withdrawal by Subject|1
7566846|NCT02290340|26311026|P4|Overall Study|Lost to Follow-up|1
7566847|NCT02290340|26311027|P3|Overall Study|Lost to Follow-up|0
7566848|NCT02290340|26311028|P2|Overall Study|Lost to Follow-up|0
7566849|NCT02290340|26311029|P1|Overall Study|Lost to Follow-up|0
7566850|NCT02290223|26311074|P2|12 Months|Refusal|1
7566851|NCT02290223|26311075|P1|12 Months|Refusal|0
7566852|NCT02290223|26311074|P2|12 Months|Lost to Follow-up|10
7566853|NCT02290223|26311075|P1|12 Months|Lost to Follow-up|16
7566854|NCT02290223|26311074|P2|6 Months|deceased (not related to study)|0
7566855|NCT02290223|26311075|P1|6 Months|deceased (not related to study)|2
7566856|NCT02290223|26311074|P2|6 Months|Withdrawal by Subject|0
7566857|NCT02290223|26311075|P1|6 Months|Withdrawal by Subject|5
7566858|NCT02290223|26311074|P2|6 Months|Lost to Follow-up|6
7566859|NCT02290223|26311075|P1|6 Months|Lost to Follow-up|9
7566860|NCT02290028|26311169|P1|Overall Study|Planned study completion at 12 months|257
7566861|NCT02290028|26311169|P1|Overall Study|Transition to EP PASSION|1295
7566862|NCT02290028|26311169|P1|Overall Study|Miscellaneous|10
7566863|NCT02290028|26311169|P1|Overall Study|Lost to Follow-up|34
7566864|NCT02290028|26311169|P1|Overall Study|Study site closure|44
7566865|NCT02290028|26311169|P1|Overall Study|Withdrawal by Subject|52
7566866|NCT02290028|26311169|P1|Overall Study|Sentus lead or required CRT-D explanted|55
7566867|NCT02290028|26311169|P1|Overall Study|No longer under care of study physician|76
7566868|NCT02290028|26311169|P1|Overall Study|Sentus lead or required CRT-D was not implanted|186
7566869|NCT02290028|26311169|P1|Overall Study|Death|217
7566870|NCT02289963|26311208|P2|Overall Study|Other than specified above|2
7566871|NCT02289963|26311209|P1|Overall Study|Other than specified above|0
7566872|NCT02289963|26311208|P2|Overall Study|End treatment visit outside visit window|4
7566873|NCT02289963|26311209|P1|Overall Study|End treatment visit outside visit window|0
7566874|NCT02289963|26311208|P2|Overall Study|Last injection missed|2
7566875|NCT02289963|26311209|P1|Overall Study|Last injection missed|2
7566876|NCT02289963|26311208|P2|Overall Study|Withdrawal by Subject|0
7566877|NCT02289963|26311209|P1|Overall Study|Withdrawal by Subject|1
7566878|NCT02289963|26311208|P2|Overall Study|Poor compliance to protocol|0
7566879|NCT02289963|26311209|P1|Overall Study|Poor compliance to protocol|1
7566880|NCT02289963|26311208|P2|Overall Study|Adverse Event|2
7566881|NCT02289963|26311209|P1|Overall Study|Adverse Event|1
7566882|NCT02289950|26311259|P2|Overall Study|Not Treated|1
7566883|NCT02289950|26311260|P1|Overall Study|Not Treated|2
7566884|NCT02289950|26311259|P2|Overall Study|Other|2
7566885|NCT02289950|26311260|P1|Overall Study|Other|5
7566886|NCT02289950|26311259|P2|Overall Study|Death|1
7566887|NCT02289950|26311260|P1|Overall Study|Death|1
7566888|NCT02289950|26311259|P2|Overall Study|Adverse Event|3
7566889|NCT02289950|26311260|P1|Overall Study|Adverse Event|11
7566890|NCT02289950|26311259|P2|Overall Study|Test article held for greater than 28 days|1
7566891|NCT02289950|26311260|P1|Overall Study|Test article held for greater than 28 days|0
7566892|NCT02289950|26311259|P2|Overall Study|Withdrawal by Subject|3
7566893|NCT02289950|26311260|P1|Overall Study|Withdrawal by Subject|1
7566894|NCT02289950|26311259|P2|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
7566895|NCT02289950|26311260|P1|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
7566896|NCT02289950|26311259|P2|Overall Study|Physician Decision|3
7566897|NCT02289950|26311260|P1|Overall Study|Physician Decision|9
7566898|NCT02289950|26311259|P2|Overall Study|Lost to Follow-up|0
7566899|NCT02289950|26311260|P1|Overall Study|Lost to Follow-up|1
7566900|NCT02289950|26311259|P2|Overall Study|Progressive disease by Clinical Assessment|4
7566901|NCT02289950|26311260|P1|Overall Study|Progressive disease by Clinical Assessment|4
7566902|NCT02289950|26311259|P2|Overall Study|Progressive disease by RECIST 1.1|52
7566903|NCT02289950|26311260|P1|Overall Study|Progressive disease by RECIST 1.1|99
7566904|NCT02289898|26311279|P3|Overall Study|Other|10
7566905|NCT02289898|26311280|P2|Overall Study|Other|7
7566906|NCT02289898|26311281|P1|Overall Study|Other|8
7566907|NCT02289898|26311279|P3|Overall Study|Use of another anticancer therapy|1
7566908|NCT02289898|26311280|P2|Overall Study|Use of another anticancer therapy|0
7566909|NCT02289898|26311281|P1|Overall Study|Use of another anticancer therapy|0
7566910|NCT02289898|26311279|P3|Overall Study|Disease progression|34
7566911|NCT02289898|26311280|P2|Overall Study|Disease progression|28
7566912|NCT02289898|26311281|P1|Overall Study|Disease progression|34
7566913|NCT02289898|26311279|P3|Overall Study|Adverse Event|5
7566914|NCT02289898|26311280|P2|Overall Study|Adverse Event|5
7566915|NCT02289898|26311281|P1|Overall Study|Adverse Event|3
7566916|NCT02289898|26311279|P3|Overall Study|Withdrawal by Subject|1
7566917|NCT02289898|26311280|P2|Overall Study|Withdrawal by Subject|4
7566918|NCT02289898|26311281|P1|Overall Study|Withdrawal by Subject|0
7566919|NCT02289898|26311279|P3|Overall Study|Physician Decision|2
7566920|NCT02289898|26311280|P2|Overall Study|Physician Decision|5
7566921|NCT02289898|26311281|P1|Overall Study|Physician Decision|2
7566922|NCT02289898|26311279|P3|Overall Study|Death|3
7566923|NCT02289898|26311280|P2|Overall Study|Death|4
7566924|NCT02289898|26311281|P1|Overall Study|Death|5
7566925|NCT02289833|26311290|P2|Overall Study|Death|16
7566926|NCT02289833|26311291|P1|Overall Study|Death|23
7566927|NCT02289833|26311290|P2|Overall Study|Lost to Follow-up|0
7566928|NCT02289833|26311291|P1|Overall Study|Lost to Follow-up|4
7566929|NCT02289833|26311290|P2|Overall Study|Study discontinuation|1
7566930|NCT02289833|26311291|P1|Overall Study|Study discontinuation|0
7566931|NCT02289820|26311327|P7|Overall Study|withdrawal of consent|0
7566932|NCT02289820|26311328|P6|Overall Study|withdrawal of consent|0
7566933|NCT02289820|26311329|P5|Overall Study|withdrawal of consent|0
7566934|NCT02289820|26311330|P4|Overall Study|withdrawal of consent|0
7566935|NCT02289820|26311331|P3|Overall Study|withdrawal of consent|0
7566936|NCT02289820|26311332|P2|Overall Study|withdrawal of consent|1
7566937|NCT02289820|26311333|P1|Overall Study|withdrawal of consent|0
7566938|NCT02289820|26311327|P7|Overall Study|Lost to Follow-up|1
7566939|NCT02289820|26311328|P6|Overall Study|Lost to Follow-up|1
7566940|NCT02289820|26311329|P5|Overall Study|Lost to Follow-up|0
7566941|NCT02289820|26311330|P4|Overall Study|Lost to Follow-up|1
7566942|NCT02289820|26311331|P3|Overall Study|Lost to Follow-up|3
7566943|NCT02289820|26311332|P2|Overall Study|Lost to Follow-up|0
7566944|NCT02289820|26311333|P1|Overall Study|Lost to Follow-up|0
7566945|NCT02289820|26311327|P7|Overall Study|Death|0
7566946|NCT02289820|26311328|P6|Overall Study|Death|0
7566947|NCT02289820|26311329|P5|Overall Study|Death|0
7566948|NCT02289820|26311330|P4|Overall Study|Death|0
7566949|NCT02289820|26311331|P3|Overall Study|Death|1
7566950|NCT02289820|26311332|P2|Overall Study|Death|0
7566951|NCT02289820|26311333|P1|Overall Study|Death|0
7566952|NCT02289820|26311327|P7|Overall Study|Withdrawal by Subject|1
7566953|NCT02289820|26311328|P6|Overall Study|Withdrawal by Subject|0
7566954|NCT02289820|26311329|P5|Overall Study|Withdrawal by Subject|0
7566955|NCT02289820|26311330|P4|Overall Study|Withdrawal by Subject|1
7566956|NCT02289820|26311331|P3|Overall Study|Withdrawal by Subject|2
7566957|NCT02289820|26311332|P2|Overall Study|Withdrawal by Subject|1
7566958|NCT02289820|26311333|P1|Overall Study|Withdrawal by Subject|2
7566959|NCT02289742|26311451|P4|Third Wear Period|Reason not given|1
7566960|NCT02289742|26311452|P3|Third Wear Period|Reason not given|0
7566961|NCT02289742|26311453|P2|Third Wear Period|Reason not given|0
7566962|NCT02289742|26311454|P1|Third Wear Period|Reason not given|0
7566963|NCT02289742|26311451|P4|Third Wear Period|Adverse Event|0
7566964|NCT02289742|26311452|P3|Third Wear Period|Adverse Event|0
7566965|NCT02289742|26311453|P2|Third Wear Period|Adverse Event|1
7566966|NCT02289742|26311454|P1|Third Wear Period|Adverse Event|0
7566967|NCT02289742|26311451|P4|First Wear Period|Other prior to treatment|1
7566968|NCT02289742|26311452|P3|First Wear Period|Other prior to treatment|0
7566969|NCT02289742|26311453|P2|First Wear Period|Other prior to treatment|0
7566970|NCT02289742|26311454|P1|First Wear Period|Other prior to treatment|0
7566971|NCT02289742|26311451|P4|First Wear Period|Adverse Event|0
7566972|NCT02289742|26311452|P3|First Wear Period|Adverse Event|1
7566973|NCT02289742|26311453|P2|First Wear Period|Adverse Event|0
7566974|NCT02289742|26311454|P1|First Wear Period|Adverse Event|0
7566975|NCT02289742|26311451|P4|First Wear Period|Adverse event prior to treatment|0
7566976|NCT02289742|26311452|P3|First Wear Period|Adverse event prior to treatment|0
7566977|NCT02289742|26311453|P2|First Wear Period|Adverse event prior to treatment|1
7566978|NCT02289742|26311454|P1|First Wear Period|Adverse event prior to treatment|0
7566979|NCT02289729|26311471|P1|Overall Study|Death|1
7566980|NCT02289729|26311471|P1|Overall Study|Withdrawal by Subject|1
7566981|NCT02289729|26311471|P1|Overall Study|Very Narrow Therapeutic Margin|1
7566982|NCT02289729|26311471|P1|Overall Study|Lack of Efficacy|3
7566983|NCT02289690|26311535|P10|Overall Study|Other|1
7566984|NCT02289690|26311536|P9|Overall Study|Other|3
7566985|NCT02289690|26311537|P8|Overall Study|Other|2
7566986|NCT02289690|26311538|P7|Overall Study|Other|1
7566987|NCT02289690|26311539|P6|Overall Study|Other|0
7566988|NCT02289690|26311540|P5|Overall Study|Other|1
7566989|NCT02289690|26311541|P4|Overall Study|Other|1
7566990|NCT02289690|26311542|P3|Overall Study|Other|0
7566991|NCT02289690|26311543|P2|Overall Study|Other|0
7566992|NCT02289690|26311544|P1|Overall Study|Other|0
7566993|NCT02289690|26311535|P10|Overall Study|Sponsor Discontinued Study|15
7566994|NCT02289690|26311536|P9|Overall Study|Sponsor Discontinued Study|7
7566995|NCT02289690|26311537|P8|Overall Study|Sponsor Discontinued Study|9
7566996|NCT02289690|26311538|P7|Overall Study|Sponsor Discontinued Study|0
7566997|NCT02289690|26311539|P6|Overall Study|Sponsor Discontinued Study|0
7566998|NCT02289690|26311540|P5|Overall Study|Sponsor Discontinued Study|0
7566999|NCT02289690|26311541|P4|Overall Study|Sponsor Discontinued Study|0
7567000|NCT02289690|26311542|P3|Overall Study|Sponsor Discontinued Study|0
7567001|NCT02289690|26311543|P2|Overall Study|Sponsor Discontinued Study|0
7567002|NCT02289690|26311544|P1|Overall Study|Sponsor Discontinued Study|0
7567003|NCT02289690|26311535|P10|Overall Study|Death|41
7567004|NCT02289690|26311536|P9|Overall Study|Death|45
7567005|NCT02289690|26311537|P8|Overall Study|Death|49
7567006|NCT02289690|26311538|P7|Overall Study|Death|0
7567007|NCT02289690|26311539|P6|Overall Study|Death|0
7567008|NCT02289690|26311540|P5|Overall Study|Death|0
7567009|NCT02289690|26311541|P4|Overall Study|Death|0
7567010|NCT02289690|26311542|P3|Overall Study|Death|0
7567011|NCT02289690|26311543|P2|Overall Study|Death|0
7567012|NCT02289690|26311544|P1|Overall Study|Death|0
7567013|NCT02289690|26311535|P10|Overall Study|Lost to Follow-up|2
7567014|NCT02289690|26311536|P9|Overall Study|Lost to Follow-up|0
7567015|NCT02289690|26311537|P8|Overall Study|Lost to Follow-up|1
7567016|NCT02289690|26311538|P7|Overall Study|Lost to Follow-up|0
7567017|NCT02289690|26311539|P6|Overall Study|Lost to Follow-up|0
7567018|NCT02289690|26311540|P5|Overall Study|Lost to Follow-up|0
7567019|NCT02289690|26311541|P4|Overall Study|Lost to Follow-up|0
7567020|NCT02289690|26311542|P3|Overall Study|Lost to Follow-up|0
7567021|NCT02289690|26311543|P2|Overall Study|Lost to Follow-up|0
7567022|NCT02289690|26311544|P1|Overall Study|Lost to Follow-up|0
7567023|NCT02289690|26311535|P10|Overall Study|Progressive Disease, Per Protocol|0
7567024|NCT02289690|26311536|P9|Overall Study|Progressive Disease, Per Protocol|0
7567025|NCT02289690|26311537|P8|Overall Study|Progressive Disease, Per Protocol|0
7567026|NCT02289690|26311538|P7|Overall Study|Progressive Disease, Per Protocol|2
7567027|NCT02289690|26311539|P6|Overall Study|Progressive Disease, Per Protocol|13
7567028|NCT02289690|26311540|P5|Overall Study|Progressive Disease, Per Protocol|5
7567029|NCT02289690|26311541|P4|Overall Study|Progressive Disease, Per Protocol|2
7567030|NCT02289690|26311542|P3|Overall Study|Progressive Disease, Per Protocol|3
7567031|NCT02289690|26311543|P2|Overall Study|Progressive Disease, Per Protocol|2
7567032|NCT02289690|26311544|P1|Overall Study|Progressive Disease, Per Protocol|3
7567033|NCT02289690|26311535|P10|Overall Study|Withdrawal by Subject|2
7567034|NCT02289690|26311536|P9|Overall Study|Withdrawal by Subject|4
7567035|NCT02289690|26311537|P8|Overall Study|Withdrawal by Subject|0
7567036|NCT02289690|26311538|P7|Overall Study|Withdrawal by Subject|0
7567037|NCT02289690|26311539|P6|Overall Study|Withdrawal by Subject|1
7567038|NCT02289690|26311540|P5|Overall Study|Withdrawal by Subject|1
7567039|NCT02289690|26311541|P4|Overall Study|Withdrawal by Subject|0
7567040|NCT02289690|26311542|P3|Overall Study|Withdrawal by Subject|0
7567041|NCT02289690|26311543|P2|Overall Study|Withdrawal by Subject|0
7567042|NCT02289690|26311544|P1|Overall Study|Withdrawal by Subject|1
7567043|NCT02289690|26311535|P10|Overall Study|Adverse Event Related to Progression|0
7567044|NCT02289690|26311536|P9|Overall Study|Adverse Event Related to Progression|0
7567045|NCT02289690|26311537|P8|Overall Study|Adverse Event Related to Progression|0
7567046|NCT02289690|26311538|P7|Overall Study|Adverse Event Related to Progression|1
7567047|NCT02289690|26311539|P6|Overall Study|Adverse Event Related to Progression|0
7567048|NCT02289690|26311540|P5|Overall Study|Adverse Event Related to Progression|1
7567049|NCT02289690|26311541|P4|Overall Study|Adverse Event Related to Progression|0
7567050|NCT02289690|26311542|P3|Overall Study|Adverse Event Related to Progression|1
7567051|NCT02289690|26311543|P2|Overall Study|Adverse Event Related to Progression|1
7567206|NCT02288559|26311821|P3|Overall Study|Withdrawal by Subject|2
7567052|NCT02289690|26311544|P1|Overall Study|Adverse Event Related to Progression|0
7567053|NCT02289469|26311632|P2|Overall Study|Unable to match a control|0
7567054|NCT02289469|26311633|P1|Overall Study|Unable to match a control|6
7567055|NCT02289456|26311641|P1|Monotherapy Period|Miscellaneous|1
7567056|NCT02289456|26311641|P1|Monotherapy Period|Study Terminated by Sponsor|2
7567057|NCT02289456|26311641|P1|Monotherapy Period|Withdrawal by Subject|2
7567058|NCT02289456|26311641|P1|Monotherapy Period|Symptomatic Deterioration|1
7567059|NCT02289456|26311641|P1|Monotherapy Period|Progressive Disease (PD)|8
7567060|NCT02289456|26311641|P1|Monotherapy Period|Adverse Event|1
7567061|NCT02289456|26311641|P1|Monotherapy Period|Death|1
7567062|NCT02289456|26311641|P1|Induction Period|Miscellaneous|1
7567063|NCT02289456|26311641|P1|Induction Period|Withdrawal by Subject|2
7567064|NCT02289456|26311641|P1|Induction Period|Symptomatic Deterioration|4
7567065|NCT02289456|26311641|P1|Induction Period|Progressive Disease (PD)|4
7567066|NCT02289456|26311641|P1|Induction Period|Adverse Event|11
7567067|NCT02289456|26311641|P1|Induction Period|Death|2
7567068|NCT02289417|26311664|P9|Extension Phase Weeks 52-104|Miscellaneous|0
7567069|NCT02289417|26311665|P8|Extension Phase Weeks 52-104|Miscellaneous|1
7567070|NCT02289417|26311666|P7|Extension Phase Weeks 52-104|Miscellaneous|0
7567071|NCT02289417|26311667|P6|Extension Phase Weeks 52-104|Miscellaneous|0
7567072|NCT02289417|26311668|P5|Extension Phase Weeks 52-104|Miscellaneous|0
7567073|NCT02289417|26311669|P4|Extension Phase Weeks 52-104|Miscellaneous|0
7567074|NCT02289417|26311670|P3|Extension Phase Weeks 52-104|Miscellaneous|0
7567075|NCT02289417|26311671|P2|Extension Phase Weeks 52-104|Miscellaneous|0
7567076|NCT02289417|26311672|P1|Extension Phase Weeks 52-104|Miscellaneous|0
7567077|NCT02289417|26311664|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
7567078|NCT02289417|26311665|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
7567079|NCT02289417|26311666|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567080|NCT02289417|26311667|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567081|NCT02289417|26311668|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567082|NCT02289417|26311669|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567083|NCT02289417|26311670|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567084|NCT02289417|26311671|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567085|NCT02289417|26311672|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7567086|NCT02289417|26311664|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
7567087|NCT02289417|26311665|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
7567088|NCT02289417|26311666|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567089|NCT02289417|26311667|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567090|NCT02289417|26311668|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567091|NCT02289417|26311669|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567092|NCT02289417|26311670|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567093|NCT02289417|26311671|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567094|NCT02289417|26311672|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
7567095|NCT02289417|26311664|P9|Extension Phase Weeks 52-104|Adverse Event|3
7567096|NCT02289417|26311665|P8|Extension Phase Weeks 52-104|Adverse Event|2
7567097|NCT02289417|26311666|P7|Extension Phase Weeks 52-104|Adverse Event|0
7567098|NCT02289417|26311667|P6|Extension Phase Weeks 52-104|Adverse Event|0
7567099|NCT02289417|26311668|P5|Extension Phase Weeks 52-104|Adverse Event|0
7567100|NCT02289417|26311669|P4|Extension Phase Weeks 52-104|Adverse Event|0
7567101|NCT02289417|26311670|P3|Extension Phase Weeks 52-104|Adverse Event|0
7567102|NCT02289417|26311671|P2|Extension Phase Weeks 52-104|Adverse Event|0
7567103|NCT02289417|26311672|P1|Extension Phase Weeks 52-104|Adverse Event|0
7567104|NCT02289417|26311664|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567105|NCT02289417|26311665|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567106|NCT02289417|26311666|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7567107|NCT02289417|26311667|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567108|NCT02289417|26311668|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567109|NCT02289417|26311669|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7567110|NCT02289417|26311670|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567111|NCT02289417|26311671|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567112|NCT02289417|26311672|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7567113|NCT02289417|26311664|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567114|NCT02289417|26311665|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567115|NCT02289417|26311666|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
7567116|NCT02289417|26311667|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567117|NCT02289417|26311668|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567118|NCT02289417|26311669|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567119|NCT02289417|26311670|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567120|NCT02289417|26311671|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567121|NCT02289417|26311672|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7567122|NCT02289417|26311664|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7567123|NCT02289417|26311665|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7567124|NCT02289417|26311666|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7567125|NCT02289417|26311667|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7567126|NCT02289417|26311668|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7567127|NCT02289417|26311669|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7567128|NCT02289417|26311670|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7567129|NCT02289417|26311671|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7567130|NCT02289417|26311672|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7567131|NCT02289417|26311664|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7567132|NCT02289417|26311665|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7567133|NCT02289417|26311666|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7567134|NCT02289417|26311667|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
7567135|NCT02289417|26311668|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
7567136|NCT02289417|26311669|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
7567137|NCT02289417|26311670|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
7567138|NCT02289417|26311671|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
7567139|NCT02289417|26311672|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7567140|NCT02289417|26311664|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567141|NCT02289417|26311665|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567142|NCT02289417|26311666|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567143|NCT02289417|26311667|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567144|NCT02289417|26311668|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567145|NCT02289417|26311669|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567146|NCT02289417|26311670|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
7567147|NCT02289417|26311671|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567148|NCT02289417|26311672|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
7567149|NCT02289417|26311664|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
7567150|NCT02289417|26311665|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
7567151|NCT02289417|26311666|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
7567152|NCT02289417|26311667|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
7567153|NCT02289417|26311668|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
7567154|NCT02289417|26311669|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
7567155|NCT02289417|26311670|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
7567156|NCT02289417|26311671|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
7567157|NCT02289417|26311672|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
7567158|NCT02289417|26311664|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567159|NCT02289417|26311665|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567160|NCT02289417|26311666|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567161|NCT02289417|26311667|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567162|NCT02289417|26311668|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567163|NCT02289417|26311669|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567164|NCT02289417|26311670|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567165|NCT02289417|26311671|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7567166|NCT02289417|26311672|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
7567167|NCT02289417|26311664|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567168|NCT02289417|26311665|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567169|NCT02289417|26311666|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567170|NCT02289417|26311667|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567171|NCT02289417|26311668|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567172|NCT02289417|26311669|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567173|NCT02289417|26311670|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567174|NCT02289417|26311671|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
7567175|NCT02289417|26311672|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7567176|NCT02289417|26311664|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7567177|NCT02289417|26311665|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7567178|NCT02289417|26311666|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7567179|NCT02289417|26311667|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7567180|NCT02289417|26311668|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7567181|NCT02289417|26311669|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7567182|NCT02289417|26311670|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
7567183|NCT02289417|26311671|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
7567184|NCT02289417|26311672|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
7567185|NCT02289417|26311664|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567186|NCT02289417|26311665|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567187|NCT02289417|26311666|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567188|NCT02289417|26311667|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567189|NCT02289417|26311668|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567190|NCT02289417|26311669|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567191|NCT02289417|26311670|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
7567192|NCT02289417|26311671|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7567193|NCT02289417|26311672|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
7567194|NCT02289352|26311721|P3|Overall Study|Withdrawal by Subject|0
7567195|NCT02289352|26311722|P2|Overall Study|Withdrawal by Subject|1
7567196|NCT02289352|26311723|P1|Overall Study|Withdrawal by Subject|1
7567197|NCT02289079|26311790|P2|Overall Study|Lost to Follow-up|1
7567198|NCT02289079|26311791|P1|Overall Study|Lost to Follow-up|0
7567199|NCT02289079|26311790|P2|Overall Study|Physician Decision|0
7567200|NCT02289079|26311791|P1|Overall Study|Physician Decision|2
7567201|NCT02288559|26311820|P4|Overall Study|Reason Not Specified|0
7567202|NCT02288559|26311821|P3|Overall Study|Reason Not Specified|3
7567203|NCT02288559|26311822|P2|Overall Study|Reason Not Specified|0
7567204|NCT02288559|26311823|P1|Overall Study|Reason Not Specified|0
7567205|NCT02288559|26311820|P4|Overall Study|Withdrawal by Subject|1
7567207|NCT02288559|26311822|P2|Overall Study|Withdrawal by Subject|0
7567208|NCT02288559|26311823|P1|Overall Study|Withdrawal by Subject|0
7567209|NCT02288559|26311820|P4|Overall Study|Lost to Follow-up|1
7567210|NCT02288559|26311821|P3|Overall Study|Lost to Follow-up|0
7567211|NCT02288559|26311822|P2|Overall Study|Lost to Follow-up|0
7567212|NCT02288559|26311823|P1|Overall Study|Lost to Follow-up|0
7567213|NCT02288559|26311820|P4|Overall Study|Death|0
7567214|NCT02288559|26311821|P3|Overall Study|Death|1
7567215|NCT02288559|26311822|P2|Overall Study|Death|0
7567216|NCT02288559|26311823|P1|Overall Study|Death|0
7567217|NCT02288559|26311820|P4|Overall Study|Adverse Event|0
7567218|NCT02288559|26311821|P3|Overall Study|Adverse Event|5
7567219|NCT02288559|26311822|P2|Overall Study|Adverse Event|1
7567220|NCT02288559|26311823|P1|Overall Study|Adverse Event|1
7567221|NCT02288325|26311887|P3|Double-blind Treatment Period|Multiple Reasons|2
7567222|NCT02288325|26311888|P2|Double-blind Treatment Period|Multiple Reasons|8
7567223|NCT02288325|26311889|P1|Double-blind Treatment Period|Multiple Reasons|0
7567224|NCT02288325|26311887|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
7567225|NCT02288325|26311888|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
7567226|NCT02288325|26311889|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
7567227|NCT02288325|26311887|P3|Double-blind Treatment Period|Protocol Violation|2
7567228|NCT02288325|26311888|P2|Double-blind Treatment Period|Protocol Violation|1
7567229|NCT02288325|26311889|P1|Double-blind Treatment Period|Protocol Violation|0
7567230|NCT02288325|26311887|P3|Double-blind Treatment Period|Lost to Follow-up|5
7567231|NCT02288325|26311888|P2|Double-blind Treatment Period|Lost to Follow-up|4
7567232|NCT02288325|26311889|P1|Double-blind Treatment Period|Lost to Follow-up|0
7567233|NCT02288325|26311887|P3|Double-blind Treatment Period|Withdrawal of Consent|8
7567234|NCT02288325|26311888|P2|Double-blind Treatment Period|Withdrawal of Consent|8
7567235|NCT02288325|26311889|P1|Double-blind Treatment Period|Withdrawal of Consent|0
7567236|NCT02288325|26311887|P3|Double-blind Treatment Period|Adverse Event|5
7567237|NCT02288325|26311888|P2|Double-blind Treatment Period|Adverse Event|2
7567238|NCT02288325|26311889|P1|Double-blind Treatment Period|Adverse Event|0
7567239|NCT02288325|26311887|P3|Stabilization Period|Reason not Specified|0
7567240|NCT02288325|26311888|P2|Stabilization Period|Reason not Specified|0
7567241|NCT02288325|26311889|P1|Stabilization Period|Reason not Specified|15
7567242|NCT02288325|26311887|P3|Stabilization Period|Non-Compliance With Study Drug|0
7567243|NCT02288325|26311888|P2|Stabilization Period|Non-Compliance With Study Drug|0
7567244|NCT02288325|26311889|P1|Stabilization Period|Non-Compliance With Study Drug|5
7567245|NCT02288325|26311887|P3|Stabilization Period|Protocol Violation|0
7567246|NCT02288325|26311888|P2|Stabilization Period|Protocol Violation|0
7567247|NCT02288325|26311889|P1|Stabilization Period|Protocol Violation|8
7567248|NCT02288325|26311887|P3|Stabilization Period|Lost to Follow-up|0
7567249|NCT02288325|26311888|P2|Stabilization Period|Lost to Follow-up|0
7567250|NCT02288325|26311889|P1|Stabilization Period|Lost to Follow-up|12
7567251|NCT02288325|26311887|P3|Stabilization Period|Withdrawal of Consent|0
7567252|NCT02288325|26311888|P2|Stabilization Period|Withdrawal of Consent|0
7567253|NCT02288325|26311889|P1|Stabilization Period|Withdrawal of Consent|23
7567254|NCT02288325|26311887|P3|Stabilization Period|Lack of Efficacy|0
7567255|NCT02288325|26311888|P2|Stabilization Period|Lack of Efficacy|0
7567256|NCT02288325|26311889|P1|Stabilization Period|Lack of Efficacy|22
7567257|NCT02288325|26311887|P3|Stabilization Period|Adverse Event|0
7567258|NCT02288325|26311888|P2|Stabilization Period|Adverse Event|0
7567259|NCT02288325|26311889|P1|Stabilization Period|Adverse Event|13
7567260|NCT02288325|26311887|P3|Run-in Period|Reason not Specified|0
7567261|NCT02288325|26311888|P2|Run-in Period|Reason not Specified|0
7567262|NCT02288325|26311889|P1|Run-in Period|Reason not Specified|8
7567263|NCT02288325|26311887|P3|Run-in Period|Non-Compliance With Study Drug|0
7567264|NCT02288325|26311888|P2|Run-in Period|Non-Compliance With Study Drug|0
7567265|NCT02288325|26311889|P1|Run-in Period|Non-Compliance With Study Drug|3
7567266|NCT02288325|26311887|P3|Run-in Period|Protocol Violation|0
7567267|NCT02288325|26311888|P2|Run-in Period|Protocol Violation|0
7567268|NCT02288325|26311889|P1|Run-in Period|Protocol Violation|17
7567269|NCT02288325|26311887|P3|Run-in Period|Lost to Follow-up|0
7567270|NCT02288325|26311888|P2|Run-in Period|Lost to Follow-up|0
7567271|NCT02288325|26311889|P1|Run-in Period|Lost to Follow-up|25
7567272|NCT02288325|26311887|P3|Run-in Period|Withdrawal of Consent|0
7567273|NCT02288325|26311888|P2|Run-in Period|Withdrawal of Consent|0
7567274|NCT02288325|26311889|P1|Run-in Period|Withdrawal of Consent|28
7567275|NCT02288325|26311887|P3|Run-in Period|Lack of Efficacy|0
7567276|NCT02288325|26311888|P2|Run-in Period|Lack of Efficacy|0
7567277|NCT02288325|26311889|P1|Run-in Period|Lack of Efficacy|16
7567278|NCT02288325|26311887|P3|Run-in Period|Adverse Event|0
7567279|NCT02288325|26311888|P2|Run-in Period|Adverse Event|0
7567280|NCT02288325|26311889|P1|Run-in Period|Adverse Event|48
7567281|NCT02288312|26311899|P3|Overall Study|Pregnancy|0
7567282|NCT02288312|26311900|P2|Overall Study|Pregnancy|0
7567283|NCT02288312|26311901|P1|Overall Study|Pregnancy|1
7567284|NCT02288182|26311941|P2|Overall Study|Lost to Follow-up|1
7567285|NCT02288182|26311942|P1|Overall Study|Lost to Follow-up|0
7567286|NCT02288182|26311941|P2|Overall Study|Adverse Event|1
7567287|NCT02288182|26311942|P1|Overall Study|Adverse Event|0
7567288|NCT02288091|26311991|P1|Overall Study|Screen fail|7
7567289|NCT02288091|26311991|P1|Overall Study|Lost to Follow-up|1
7567290|NCT02287922|26312003|P4|Overall Study|Other|0
7567291|NCT02287922|26312004|P3|Overall Study|Other|2
7567292|NCT02287922|26312005|P2|Overall Study|Other|0
7567293|NCT02287922|26312006|P1|Overall Study|Other|1
7567294|NCT02287922|26312003|P4|Overall Study|Sponsor's decision|1
7567295|NCT02287922|26312004|P3|Overall Study|Sponsor's decision|0
7567296|NCT02287922|26312005|P2|Overall Study|Sponsor's decision|0
7567297|NCT02287922|26312006|P1|Overall Study|Sponsor's decision|0
7567298|NCT02287922|26312003|P4|Overall Study|Lost to Follow-up|0
7567299|NCT02287922|26312004|P3|Overall Study|Lost to Follow-up|1
7567300|NCT02287922|26312005|P2|Overall Study|Lost to Follow-up|0
7567301|NCT02287922|26312006|P1|Overall Study|Lost to Follow-up|0
7567302|NCT02287922|26312003|P4|Overall Study|Withdrawal by Subject|2
7567303|NCT02287922|26312004|P3|Overall Study|Withdrawal by Subject|1
7567304|NCT02287922|26312005|P2|Overall Study|Withdrawal by Subject|1
7567305|NCT02287922|26312006|P1|Overall Study|Withdrawal by Subject|1
7567306|NCT02287922|26312003|P4|Overall Study|Adverse Event|4
7567307|NCT02287922|26312004|P3|Overall Study|Adverse Event|3
7567308|NCT02287922|26312005|P2|Overall Study|Adverse Event|1
7567309|NCT02287922|26312006|P1|Overall Study|Adverse Event|1
7567310|NCT02287896|26312114|P2|Second Injection Visit|Withdrawal by Subject|1
7567311|NCT02287896|26312115|P1|Second Injection Visit|Withdrawal by Subject|0
7567312|NCT02287883|26312133|P2|Overall Study|Non-response to survey|237
7567313|NCT02287883|26312134|P1|Overall Study|Non-response to survey|229
7567314|NCT02287883|26312133|P2|Overall Study|No longer eligible|182
7567315|NCT02287883|26312134|P1|Overall Study|No longer eligible|222
7567316|NCT02287883|26312133|P2|Overall Study|Death|7
7567317|NCT02287883|26312134|P1|Overall Study|Death|8
7567318|NCT02287623|26312345|P2|Overall Study|Protocol Violation|1
7567319|NCT02287623|26312346|P1|Overall Study|Protocol Violation|0
7567320|NCT02287610|26312362|P1|Overall Study|Excluded-investigator non-responsiveness|5
7567321|NCT02287610|26312362|P1|Overall Study|Withdrawal by Subject|8
7567322|NCT02287610|26312362|P1|Overall Study|Lost to Follow-up|3
7567323|NCT02287584|26312398|P6|the Open-label Phase|other reasons|6
7567324|NCT02287584|26312399|P5|the Open-label Phase|other reasons|6
7567325|NCT02287584|26312400|P4|the Open-label Phase|other reasons|3
7567326|NCT02287584|26312401|P3|the Open-label Phase|other reasons|0
7567327|NCT02287584|26312402|P2|the Open-label Phase|other reasons|0
7567328|NCT02287584|26312403|P1|the Open-label Phase|other reasons|0
7567329|NCT02287584|26312398|P6|the Open-label Phase|non-compliance|1
7567330|NCT02287584|26312399|P5|the Open-label Phase|non-compliance|5
7567331|NCT02287584|26312400|P4|the Open-label Phase|non-compliance|2
7567332|NCT02287584|26312401|P3|the Open-label Phase|non-compliance|0
7567333|NCT02287584|26312402|P2|the Open-label Phase|non-compliance|0
7567334|NCT02287584|26312403|P1|the Open-label Phase|non-compliance|0
7567335|NCT02287584|26312398|P6|the Open-label Phase|Withdrawal by Subject|21
7567336|NCT02287584|26312399|P5|the Open-label Phase|Withdrawal by Subject|29
7567337|NCT02287584|26312400|P4|the Open-label Phase|Withdrawal by Subject|18
7567338|NCT02287584|26312401|P3|the Open-label Phase|Withdrawal by Subject|0
7567339|NCT02287584|26312402|P2|the Open-label Phase|Withdrawal by Subject|0
7567340|NCT02287584|26312403|P1|the Open-label Phase|Withdrawal by Subject|0
7567341|NCT02287584|26312398|P6|the Open-label Phase|Lost to Follow-up|2
7567342|NCT02287584|26312399|P5|the Open-label Phase|Lost to Follow-up|1
7567343|NCT02287584|26312400|P4|the Open-label Phase|Lost to Follow-up|4
7567344|NCT02287584|26312401|P3|the Open-label Phase|Lost to Follow-up|0
7567345|NCT02287584|26312402|P2|the Open-label Phase|Lost to Follow-up|0
7567346|NCT02287584|26312403|P1|the Open-label Phase|Lost to Follow-up|0
7567347|NCT02287584|26312398|P6|the Open-label Phase|Lack of Efficacy|7
7567348|NCT02287584|26312399|P5|the Open-label Phase|Lack of Efficacy|3
7567349|NCT02287584|26312400|P4|the Open-label Phase|Lack of Efficacy|8
7567350|NCT02287584|26312401|P3|the Open-label Phase|Lack of Efficacy|0
7567351|NCT02287584|26312402|P2|the Open-label Phase|Lack of Efficacy|0
7567352|NCT02287584|26312403|P1|the Open-label Phase|Lack of Efficacy|0
7567353|NCT02287584|26312398|P6|the Open-label Phase|Adverse Event|16
7567354|NCT02287584|26312399|P5|the Open-label Phase|Adverse Event|12
7567355|NCT02287584|26312400|P4|the Open-label Phase|Adverse Event|15
7567356|NCT02287584|26312401|P3|the Open-label Phase|Adverse Event|0
7567357|NCT02287584|26312402|P2|the Open-label Phase|Adverse Event|0
7567358|NCT02287584|26312403|P1|the Open-label Phase|Adverse Event|0
7567359|NCT02287584|26312398|P6|the Open-label Phase|Did not receive drug|4
7567360|NCT02287584|26312399|P5|the Open-label Phase|Did not receive drug|6
7567361|NCT02287584|26312400|P4|the Open-label Phase|Did not receive drug|7
7567362|NCT02287584|26312401|P3|the Open-label Phase|Did not receive drug|0
7567363|NCT02287584|26312402|P2|the Open-label Phase|Did not receive drug|0
7567364|NCT02287584|26312403|P1|the Open-label Phase|Did not receive drug|0
7567365|NCT02287584|26312398|P6|the Double-blind Phase|other reasons|0
7567366|NCT02287584|26312399|P5|the Double-blind Phase|other reasons|0
7567367|NCT02287584|26312400|P4|the Double-blind Phase|other reasons|0
7567368|NCT02287584|26312401|P3|the Double-blind Phase|other reasons|1
7567369|NCT02287584|26312402|P2|the Double-blind Phase|other reasons|0
7567370|NCT02287584|26312403|P1|the Double-blind Phase|other reasons|0
7567371|NCT02287584|26312398|P6|the Double-blind Phase|Protocol Violation|0
7567372|NCT02287584|26312399|P5|the Double-blind Phase|Protocol Violation|0
7567373|NCT02287584|26312400|P4|the Double-blind Phase|Protocol Violation|0
7567374|NCT02287584|26312401|P3|the Double-blind Phase|Protocol Violation|0
7567375|NCT02287584|26312402|P2|the Double-blind Phase|Protocol Violation|3
7567376|NCT02287584|26312403|P1|the Double-blind Phase|Protocol Violation|0
7567377|NCT02287584|26312398|P6|the Double-blind Phase|Pregnancy|0
7567378|NCT02287584|26312399|P5|the Double-blind Phase|Pregnancy|0
7567379|NCT02287584|26312400|P4|the Double-blind Phase|Pregnancy|0
7567380|NCT02287584|26312401|P3|the Double-blind Phase|Pregnancy|0
7567381|NCT02287584|26312402|P2|the Double-blind Phase|Pregnancy|1
7567382|NCT02287584|26312403|P1|the Double-blind Phase|Pregnancy|0
7567383|NCT02287584|26312398|P6|the Double-blind Phase|Withdrawal by Subject|0
7567384|NCT02287584|26312399|P5|the Double-blind Phase|Withdrawal by Subject|0
7567385|NCT02287584|26312400|P4|the Double-blind Phase|Withdrawal by Subject|0
7567386|NCT02287584|26312401|P3|the Double-blind Phase|Withdrawal by Subject|11
7567387|NCT02287584|26312402|P2|the Double-blind Phase|Withdrawal by Subject|17
7567388|NCT02287584|26312403|P1|the Double-blind Phase|Withdrawal by Subject|17
7567389|NCT02287584|26312398|P6|the Double-blind Phase|Lost to Follow-up|0
7567390|NCT02287584|26312399|P5|the Double-blind Phase|Lost to Follow-up|0
7567391|NCT02287584|26312400|P4|the Double-blind Phase|Lost to Follow-up|0
7567392|NCT02287584|26312401|P3|the Double-blind Phase|Lost to Follow-up|1
7567393|NCT02287584|26312402|P2|the Double-blind Phase|Lost to Follow-up|1
7567394|NCT02287584|26312403|P1|the Double-blind Phase|Lost to Follow-up|0
7567395|NCT02287584|26312398|P6|the Double-blind Phase|Lack of Efficacy|0
7567396|NCT02287584|26312399|P5|the Double-blind Phase|Lack of Efficacy|0
7567397|NCT02287584|26312400|P4|the Double-blind Phase|Lack of Efficacy|0
7567398|NCT02287584|26312401|P3|the Double-blind Phase|Lack of Efficacy|8
7567399|NCT02287584|26312402|P2|the Double-blind Phase|Lack of Efficacy|8
7567400|NCT02287584|26312403|P1|the Double-blind Phase|Lack of Efficacy|18
7567401|NCT02287584|26312398|P6|the Double-blind Phase|Adverse Event|0
7567402|NCT02287584|26312399|P5|the Double-blind Phase|Adverse Event|0
7567403|NCT02287584|26312400|P4|the Double-blind Phase|Adverse Event|0
7567404|NCT02287584|26312401|P3|the Double-blind Phase|Adverse Event|12
7567405|NCT02287584|26312402|P2|the Double-blind Phase|Adverse Event|17
7567406|NCT02287584|26312403|P1|the Double-blind Phase|Adverse Event|17
7567407|NCT02287467|26312437|P2|Overall Study|Protocol Violation|9
7567408|NCT02287467|26312438|P1|Overall Study|Protocol Violation|12
7567409|NCT02287402|26312486|P1|Follow-up|Voluntary Withdrawal|2
7567410|NCT02287402|26312486|P1|Follow-up|Lost to Follow-up|1
7567411|NCT02287402|26312486|P1|Treatment Period|Voluntary Withdrawal|10
7567412|NCT02287402|26312486|P1|Treatment Period|Adverse Event|17
7567413|NCT02287038|26312591|P2|Overall Study|Abnormal ECG after starting medication|0
7567414|NCT02287038|26312592|P1|Overall Study|Abnormal ECG after starting medication|1
7567415|NCT02287038|26312591|P2|Overall Study|Nausea after starting medication|0
7567416|NCT02287038|26312592|P1|Overall Study|Nausea after starting medication|1
7567417|NCT02287038|26312591|P2|Overall Study|Anxiety after starting medication|1
7567418|NCT02287038|26312592|P1|Overall Study|Anxiety after starting medication|0
7567419|NCT02287038|26312591|P2|Overall Study|Stopped attending appointments|2
7567420|NCT02287038|26312592|P1|Overall Study|Stopped attending appointments|3
7567421|NCT02287025|26312602|P2|Overall Study|Screening failed|1
7567422|NCT02287025|26312603|P1|Overall Study|Screening failed|1
7567423|NCT02287025|26312602|P2|Overall Study|Withdrawal by Subject|2
7567424|NCT02287025|26312603|P1|Overall Study|Withdrawal by Subject|2
7567425|NCT02287025|26312602|P2|Overall Study|Adverse Event|4
7567426|NCT02287025|26312603|P1|Overall Study|Adverse Event|2
7567427|NCT02287025|26312602|P2|Overall Study|Progression of disease|2
7567428|NCT02287025|26312603|P1|Overall Study|Progression of disease|3
7567429|NCT02287025|26312602|P2|Overall Study|Not treated|0
7567430|NCT02287025|26312603|P1|Overall Study|Not treated|2
7567431|NCT02286960|26312614|P2|Overall Study|Lost to Follow-up|3
7567432|NCT02286960|26312615|P1|Overall Study|Lost to Follow-up|3
7567433|NCT02286947|26312627|P1|Overall Study|Withdrawal by Subject|2
7567434|NCT02286895|26312673|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
7567435|NCT02286895|26312674|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
7567436|NCT02286895|26312673|P2|Assessed for Measles Seroconversion|Missing measurement|3
7567437|NCT02286895|26312674|P1|Assessed for Measles Seroconversion|Missing measurement|6
7567438|NCT02286895|26312673|P2|Assessed for Measles Seroconversion|Protocol Violation|4
7567439|NCT02286895|26312674|P1|Assessed for Measles Seroconversion|Protocol Violation|1
7567440|NCT02286843|26312716|P1|Overall Study|Withdrawal by Subject|1
7567441|NCT02286843|26312716|P1|Overall Study|Protocol Violation|1
7567442|NCT02286843|26312716|P1|Overall Study|Not Treated|4
7567443|NCT02286713|26312738|P2|Six Month Follow-Up|Lost to Follow-up|27
7567444|NCT02286713|26312739|P1|Six Month Follow-Up|Lost to Follow-up|30
7567445|NCT02286713|26312738|P2|Six Month Follow-Up|Death|0
7567446|NCT02286713|26312739|P1|Six Month Follow-Up|Death|2
7567447|NCT02286713|26312738|P2|Three Month Follow-Up|Withdrawal by Subject|1
7567448|NCT02286713|26312739|P1|Three Month Follow-Up|Withdrawal by Subject|1
7567449|NCT02286713|26312738|P2|Three Month Follow-Up|Lost to Follow-up|24
7567450|NCT02286713|26312739|P1|Three Month Follow-Up|Lost to Follow-up|26
7567451|NCT02286713|26312738|P2|Three Month Follow-Up|Death|1
7567452|NCT02286713|26312739|P1|Three Month Follow-Up|Death|1
7567453|NCT02286713|26312738|P2|One Week Follow-Up|Withdrawal by Subject|3
7567454|NCT02286713|26312739|P1|One Week Follow-Up|Withdrawal by Subject|6
7567455|NCT02286713|26312738|P2|One Week Follow-Up|Lost to Follow-up|21
7567456|NCT02286713|26312739|P1|One Week Follow-Up|Lost to Follow-up|17
7567457|NCT02286713|26312738|P2|One Week Follow-Up|Death|0
7567458|NCT02286713|26312739|P1|One Week Follow-Up|Death|1
7567459|NCT02286466|26312920|P2|Overall Study|Declined Clinician Assessment|1
7567460|NCT02286466|26312921|P1|Overall Study|Declined Clinician Assessment|0
7567461|NCT02286466|26312920|P2|Overall Study|Lost to Follow-up|4
7567462|NCT02286466|26312921|P1|Overall Study|Lost to Follow-up|1
7567463|NCT02286466|26312920|P2|Overall Study|Withdrawal by Subject|2
7567464|NCT02286466|26312921|P1|Overall Study|Withdrawal by Subject|5
7567465|NCT02286466|26312920|P2|Overall Study|Death|3
7567466|NCT02286466|26312921|P1|Overall Study|Death|1
7567467|NCT02286193|26312933|P1|Overall Study|Referred: Declined service|38
7567468|NCT02286193|26312933|P1|Overall Study|Referred: unable to reach/resource sent|104
7567469|NCT02286193|26312933|P1|Overall Study|Referred: CRS unable to make contact|62
7567470|NCT02286102|26312940|P2|Overall Study|Screen Failure|1
7567471|NCT02286102|26312941|P1|Overall Study|Screen Failure|1
7567472|NCT02285998|26312953|P2|Overall Study|Other Reasons|10
7567473|NCT02285998|26312954|P1|Overall Study|Other Reasons|7
7567474|NCT02285998|26312953|P2|Overall Study|Withdrawal by Subject|61
7567475|NCT02285998|26312954|P1|Overall Study|Withdrawal by Subject|53
7567476|NCT02285998|26312953|P2|Overall Study|Lost to Follow-up|172
7567477|NCT02285998|26312954|P1|Overall Study|Lost to Follow-up|176
7567478|NCT02285998|26312953|P2|Overall Study|Physician Decision|2
7567479|NCT02285998|26312954|P1|Overall Study|Physician Decision|1
7567480|NCT02285998|26312953|P2|Overall Study|Adverse Event|8
7567481|NCT02285998|26312954|P1|Overall Study|Adverse Event|9
7567482|NCT02285920|26312982|P4|Overall Study|Death|1
7567483|NCT02285920|26312983|P3|Overall Study|Death|2
7567484|NCT02285920|26312984|P2|Overall Study|Death|0
7567485|NCT02285920|26312985|P1|Overall Study|Death|2
7567486|NCT02285920|26312982|P4|Overall Study|Dialysis discontinuation|0
7567487|NCT02285920|26312983|P3|Overall Study|Dialysis discontinuation|0
7567488|NCT02285920|26312984|P2|Overall Study|Dialysis discontinuation|1
7567489|NCT02285920|26312985|P1|Overall Study|Dialysis discontinuation|0
7567490|NCT02285920|26312982|P4|Overall Study|Transfer to non-participating unit|0
7567491|NCT02285920|26312983|P3|Overall Study|Transfer to non-participating unit|0
7567492|NCT02285920|26312984|P2|Overall Study|Transfer to non-participating unit|1
7567493|NCT02285920|26312985|P1|Overall Study|Transfer to non-participating unit|0
7567494|NCT02285920|26312982|P4|Overall Study|Change to peritoneal dialysis|0
7567495|NCT02285920|26312983|P3|Overall Study|Change to peritoneal dialysis|1
7567496|NCT02285920|26312984|P2|Overall Study|Change to peritoneal dialysis|0
7567497|NCT02285920|26312985|P1|Overall Study|Change to peritoneal dialysis|0
7567498|NCT02285920|26312982|P4|Overall Study|Kidney transplantation|0
7567499|NCT02285920|26312983|P3|Overall Study|Kidney transplantation|2
7567500|NCT02285920|26312984|P2|Overall Study|Kidney transplantation|2
7567501|NCT02285920|26312985|P1|Overall Study|Kidney transplantation|2
7567502|NCT02285855|26313075|P2|Overall Study|Withdrawal by Subject|1
7567503|NCT02285855|26313076|P1|Overall Study|Withdrawal by Subject|2
7567504|NCT02285777|26313084|P2|Overall Study|Lost to Follow-up|2
7567505|NCT02285777|26313085|P1|Overall Study|Lost to Follow-up|4
7567506|NCT02285777|26313084|P2|Overall Study|Withdrawal by Subject|1
7567507|NCT02285777|26313085|P1|Overall Study|Withdrawal by Subject|1
7567508|NCT02285361|26313166|P1|Overall Study|Consented prior to the contract date|1
7567509|NCT02285361|26313166|P1|Overall Study|Not taken GIOTRIF|2
7567510|NCT02285361|26313166|P1|Overall Study|Lost to Follow-up|5
7567511|NCT02285361|26313166|P1|Overall Study|Protocol Violation|43
7567512|NCT02285270|26313184|P1|Overall Study|Determined to be ineligible|1
7567513|NCT02285270|26313184|P1|Overall Study|Physician Decision|3
7567514|NCT02285270|26313184|P1|Overall Study|Lost to Follow-up|1
7567515|NCT02285153|26313192|P2|Overall Study|Adverse Event|0
7567516|NCT02285153|26313193|P1|Overall Study|Adverse Event|1
7567517|NCT02285114|26313208|P3|Overall Study|Still on study|2
7567518|NCT02285114|26313209|P2|Overall Study|Still on study|5
7567519|NCT02285114|26313210|P1|Overall Study|Still on study|21
7567520|NCT02285114|26313208|P3|Overall Study|Enrolled but not treated|0
7567521|NCT02285114|26313209|P2|Overall Study|Enrolled but not treated|0
7567522|NCT02285114|26313210|P1|Overall Study|Enrolled but not treated|1
7567523|NCT02285114|26313208|P3|Overall Study|Withdrew Consent|1
7567524|NCT02285114|26313209|P2|Overall Study|Withdrew Consent|0
7567525|NCT02285114|26313210|P1|Overall Study|Withdrew Consent|0
7567526|NCT02285114|26313208|P3|Overall Study|Investigator's Discretion|0
7567527|NCT02285114|26313209|P2|Overall Study|Investigator's Discretion|2
7567528|NCT02285114|26313210|P1|Overall Study|Investigator's Discretion|0
7567529|NCT02285062|26313275|P2|Overall Study|Lost to Follow-up|5
7567530|NCT02285062|26313276|P1|Overall Study|Lost to Follow-up|8
7567531|NCT02285062|26313275|P2|Overall Study|Death|62
7567532|NCT02285062|26313276|P1|Overall Study|Death|58
7567533|NCT02285062|26313275|P2|Overall Study|Withdrawal by Subject|17
7567534|NCT02285062|26313276|P1|Overall Study|Withdrawal by Subject|12
7567535|NCT02285010|26313324|P2|Overall Study|Not spinal anesthesia|1
7567536|NCT02285010|26313325|P1|Overall Study|Not spinal anesthesia|3
7567537|NCT02285010|26313324|P2|Overall Study|not abdominal hysterectomy|0
7567538|NCT02285010|26313325|P1|Overall Study|not abdominal hysterectomy|2
7567539|NCT02284906|26313342|P3|Overall Study|Reason not Specified|0
7567540|NCT02284906|26313343|P2|Overall Study|Reason not Specified|1
7567541|NCT02284906|26313344|P1|Overall Study|Reason not Specified|1
7567542|NCT02284906|26313342|P3|Overall Study|Study Termination|14
7567543|NCT02284906|26313343|P2|Overall Study|Study Termination|11
7567544|NCT02284906|26313344|P1|Overall Study|Study Termination|0
7567545|NCT02284906|26313342|P3|Overall Study|Voluntary Withdrawal|5
7567546|NCT02284906|26313343|P2|Overall Study|Voluntary Withdrawal|4
7567547|NCT02284906|26313344|P1|Overall Study|Voluntary Withdrawal|2
7567548|NCT02284906|26313342|P3|Overall Study|Major Protocol Deviation|0
7567549|NCT02284906|26313343|P2|Overall Study|Major Protocol Deviation|1
7567550|NCT02284906|26313344|P1|Overall Study|Major Protocol Deviation|0
7567551|NCT02284906|26313342|P3|Overall Study|Pretreatment Event/Adverse Event|0
7567552|NCT02284906|26313343|P2|Overall Study|Pretreatment Event/Adverse Event|1
7567553|NCT02284906|26313344|P1|Overall Study|Pretreatment Event/Adverse Event|0
7567554|NCT02284893|26313357|P2|52 Week (Long Term)|Non-Compliance|3
7567555|NCT02284893|26313358|P1|52 Week (Long Term)|Non-Compliance|2
7567556|NCT02284893|26313357|P2|52 Week (Long Term)|Lost to Follow-up|2
7567557|NCT02284893|26313358|P1|52 Week (Long Term)|Lost to Follow-up|2
7567558|NCT02284893|26313357|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
7567559|NCT02284893|26313358|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
7567560|NCT02284893|26313357|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
7567561|NCT02284893|26313358|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
7567562|NCT02284893|26313357|P2|52 Week (Long Term)|Adverse Event|1
7567563|NCT02284893|26313358|P1|52 Week (Long Term)|Adverse Event|3
7567564|NCT02284893|26313357|P2|26 Week (Short Term)|Other|1
7567565|NCT02284893|26313358|P1|26 Week (Short Term)|Other|1
7567566|NCT02284893|26313357|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
7567567|NCT02284893|26313358|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
7567568|NCT02284893|26313357|P2|26 Week (Short Term)|Lost to Follow-up|1
7567569|NCT02284893|26313358|P1|26 Week (Short Term)|Lost to Follow-up|3
7567570|NCT02284893|26313357|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
7567571|NCT02284893|26313358|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
7567572|NCT02284893|26313357|P2|26 Week (Short Term)|Discontinuation by the subject|2
7567573|NCT02284893|26313358|P1|26 Week (Short Term)|Discontinuation by the subject|2
7567574|NCT02284893|26313357|P2|26 Week (Short Term)|Adverse Event|9
7567575|NCT02284893|26313358|P1|26 Week (Short Term)|Adverse Event|1
7567576|NCT02284568|26313435|P3|Overall Study|Withdrew before taking study drug|0
7567577|NCT02284568|26313436|P2|Overall Study|Withdrew before taking study drug|1
7567578|NCT02284568|26313437|P1|Overall Study|Withdrew before taking study drug|0
7567579|NCT02284568|26313435|P3|Overall Study|Other|0
7567580|NCT02284568|26313436|P2|Overall Study|Other|2
7567581|NCT02284568|26313437|P1|Overall Study|Other|1
7567582|NCT02284568|26313435|P3|Overall Study|Lack of Efficacy|0
7567583|NCT02284568|26313436|P2|Overall Study|Lack of Efficacy|7
7567584|NCT02284568|26313437|P1|Overall Study|Lack of Efficacy|4
7567585|NCT02284568|26313435|P3|Overall Study|Lost to Follow-up|0
7567586|NCT02284568|26313436|P2|Overall Study|Lost to Follow-up|3
7567587|NCT02284568|26313437|P1|Overall Study|Lost to Follow-up|0
7567588|NCT02284568|26313435|P3|Overall Study|Sponsor requested patient stop treatment|90
7567589|NCT02284568|26313436|P2|Overall Study|Sponsor requested patient stop treatment|0
7567590|NCT02284568|26313437|P1|Overall Study|Sponsor requested patient stop treatment|0
7567591|NCT02284568|26313435|P3|Overall Study|Protocol Violation|0
7567592|NCT02284568|26313436|P2|Overall Study|Protocol Violation|1
7567593|NCT02284568|26313437|P1|Overall Study|Protocol Violation|0
7567594|NCT02284568|26313435|P3|Overall Study|Noncompliance|0
7567595|NCT02284568|26313436|P2|Overall Study|Noncompliance|0
7567596|NCT02284568|26313437|P1|Overall Study|Noncompliance|1
7567597|NCT02284568|26313435|P3|Overall Study|Noncompliance with study drug admin|0
7567598|NCT02284568|26313436|P2|Overall Study|Noncompliance with study drug admin|2
7567599|NCT02284568|26313437|P1|Overall Study|Noncompliance with study drug admin|1
7567600|NCT02284568|26313435|P3|Overall Study|Withdrawal by Subject|1
7567601|NCT02284568|26313436|P2|Overall Study|Withdrawal by Subject|21
7567602|NCT02284568|26313437|P1|Overall Study|Withdrawal by Subject|22
7567603|NCT02284568|26313435|P3|Overall Study|Adverse Event|4
7567604|NCT02284568|26313436|P2|Overall Study|Adverse Event|9
7567605|NCT02284568|26313437|P1|Overall Study|Adverse Event|2
7567606|NCT02284373|26313531|P3|Overall Study|Lost to Follow-up|0
7567607|NCT02284373|26313532|P2|Overall Study|Lost to Follow-up|1
7567608|NCT02284373|26313533|P1|Overall Study|Lost to Follow-up|0
7567609|NCT02284373|26313531|P3|Overall Study|Other|0
7567610|NCT02284373|26313532|P2|Overall Study|Other|1
7567611|NCT02284373|26313533|P1|Overall Study|Other|0
7567612|NCT02284373|26313531|P3|Overall Study|Withdrawal by Subject|0
7567613|NCT02284373|26313532|P2|Overall Study|Withdrawal by Subject|1
7567614|NCT02284373|26313533|P1|Overall Study|Withdrawal by Subject|0
7567615|NCT02284347|26313541|P1|Overall Study|Withdrawn prior to treatment|1
7567616|NCT02284347|26313541|P1|Overall Study|Lost to Follow-up|2
7567617|NCT02284243|26313549|P2|Overall Study|Adverse Event|0
7567618|NCT02284243|26313550|P1|Overall Study|Adverse Event|1
7567619|NCT02284243|26313549|P2|Overall Study|Lack of Efficacy|3
7567620|NCT02284243|26313550|P1|Overall Study|Lack of Efficacy|3
7567621|NCT02284178|26313570|P2|Overall Study|Met exclusion criteria|54
7567622|NCT02284178|26313571|P1|Overall Study|Met exclusion criteria|49
7567623|NCT02284009|26313625|P2|Overall Study|Withdrawal by Subject|5
7567624|NCT02284009|26313626|P1|Overall Study|Withdrawal by Subject|2
7567625|NCT02284009|26313625|P2|Overall Study|Physician Decision|2
7567626|NCT02284009|26313626|P1|Overall Study|Physician Decision|0
7567627|NCT02284009|26313625|P2|Overall Study|Lost to Follow-up|3
7567628|NCT02284009|26313626|P1|Overall Study|Lost to Follow-up|1
7567629|NCT02284009|26313625|P2|Overall Study|Adverse Event|0
7567630|NCT02284009|26313626|P1|Overall Study|Adverse Event|3
7567631|NCT02283788|26313725|P4|Overall Study|Withdrawal by Subject|1
7567632|NCT02283788|26313726|P3|Overall Study|Withdrawal by Subject|0
7567633|NCT02283788|26313727|P2|Overall Study|Withdrawal by Subject|1
7567634|NCT02283788|26313728|P1|Overall Study|Withdrawal by Subject|0
7567635|NCT02283788|26313725|P4|Overall Study|Adverse Event|1
7567636|NCT02283788|26313726|P3|Overall Study|Adverse Event|5
7567637|NCT02283788|26313727|P2|Overall Study|Adverse Event|3
7567638|NCT02283788|26313728|P1|Overall Study|Adverse Event|1
7567639|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Physician Decision|2
7567640|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Physician Decision|1
7567641|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
7567642|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
7567643|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
7567644|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
7567645|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
7567646|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
7567647|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
7567648|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
7567649|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7567650|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7567651|NCT02283762|26313740|P2|Long-term Extension Phase (LTE)|Adverse Event|6
7567652|NCT02283762|26313741|P1|Long-term Extension Phase (LTE)|Adverse Event|2
7567653|NCT02283762|26313740|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
7567654|NCT02283762|26313741|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
7567655|NCT02283762|26313740|P2|Main Treatment Phase (MT)|Pregnancy|1
7567656|NCT02283762|26313741|P1|Main Treatment Phase (MT)|Pregnancy|0
7567657|NCT02283762|26313740|P2|Main Treatment Phase (MT)|Physician Decision|1
7567658|NCT02283762|26313741|P1|Main Treatment Phase (MT)|Physician Decision|1
7567659|NCT02283762|26313740|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
7567660|NCT02283762|26313741|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
7567661|NCT02283762|26313740|P2|Main Treatment Phase (MT)|Adverse Event|9
7567662|NCT02283762|26313741|P1|Main Treatment Phase (MT)|Adverse Event|9
7567663|NCT02283658|26313765|P1|Overall Study|Withdrawal by Subject|1
7567664|NCT02283411|26313787|P1|Overall Study|Screen Failed|28
7567665|NCT02283411|26313787|P1|Overall Study|Withdrawal by Subject|3
7567666|NCT02283268|26313826|P1|Overall Study|Withdrawal by Subject|1
7567667|NCT02282982|26313887|P1|Overall Study|Other, not specified|18
7567668|NCT02282982|26313887|P1|Overall Study|Palivizumab is ended|11
7567669|NCT02282982|26313887|P1|Overall Study|Lack of product|156
7567670|NCT02282982|26313887|P1|Overall Study|Death|4
7567671|NCT02282982|26313887|P1|Overall Study|Withdrew consent|2
7567672|NCT02282982|26313887|P1|Overall Study|Lost to Follow-up|15
7567673|NCT02282813|26313915|P3|Overall Study|Administrative reasons|0
7567674|NCT02282813|26313916|P2|Overall Study|Administrative reasons|1
7567675|NCT02282813|26313917|P1|Overall Study|Administrative reasons|0
7567676|NCT02282813|26313915|P3|Overall Study|Lack of Efficacy|0
7567677|NCT02282813|26313916|P2|Overall Study|Lack of Efficacy|0
7567678|NCT02282813|26313917|P1|Overall Study|Lack of Efficacy|1
7567679|NCT02282813|26313915|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
7567680|NCT02282813|26313916|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
7567681|NCT02282813|26313917|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
7567682|NCT02282813|26313915|P3|Overall Study|Lost to Follow-up|1
7567683|NCT02282813|26313916|P2|Overall Study|Lost to Follow-up|0
7567684|NCT02282813|26313917|P1|Overall Study|Lost to Follow-up|2
7567685|NCT02282813|26313915|P3|Overall Study|Physician Decision|1
7567686|NCT02282813|26313916|P2|Overall Study|Physician Decision|3
7567687|NCT02282813|26313917|P1|Overall Study|Physician Decision|0
7567688|NCT02282813|26313915|P3|Overall Study|Subject non-compliance|0
7567689|NCT02282813|26313916|P2|Overall Study|Subject non-compliance|4
7567690|NCT02282813|26313917|P1|Overall Study|Subject non-compliance|1
7567691|NCT02282813|26313915|P3|Overall Study|Adverse Event|1
7567692|NCT02282813|26313916|P2|Overall Study|Adverse Event|10
7567693|NCT02282813|26313917|P1|Overall Study|Adverse Event|3
7567694|NCT02282813|26313915|P3|Overall Study|Withdrawal by Subject|0
7567695|NCT02282813|26313916|P2|Overall Study|Withdrawal by Subject|5
7567696|NCT02282813|26313917|P1|Overall Study|Withdrawal by Subject|4
7567697|NCT02282631|26313963|P2|Overall Study|Lost to Follow-up|0
7567698|NCT02282631|26313964|P1|Overall Study|Lost to Follow-up|2
7567699|NCT02282605|26314005|P3|Overall Study|negative SA result on Day -1|0
7567700|NCT02282605|26314006|P2|Overall Study|negative SA result on Day -1|0
7567701|NCT02282605|26314007|P1|Overall Study|negative SA result on Day -1|3
7567702|NCT02282527|26314029|P2|Overall Study|Lack of home health aid|0
7567703|NCT02282527|26314030|P1|Overall Study|Lack of home health aid|1
7567704|NCT02282527|26314029|P2|Overall Study|Lost to Follow-up|1
7567705|NCT02282527|26314030|P1|Overall Study|Lost to Follow-up|0
7567706|NCT02282293|26314053|P2|Overall Study|Moved out of study area|1
7567707|NCT02282293|26314054|P1|Overall Study|Moved out of study area|0
7567708|NCT02282293|26314053|P2|Overall Study|Unable to comply with study procedures|0
7567709|NCT02282293|26314054|P1|Overall Study|Unable to comply with study procedures|1
7567710|NCT02282293|26314053|P2|Overall Study|Lost to Follow-up|2
7567711|NCT02282293|26314054|P1|Overall Study|Lost to Follow-up|2
7567712|NCT02282163|26314072|P1|Overall Study|Protocol Violation|1
7567713|NCT02282020|26314104|P2|Overall Study|Withdrew Consent Prior to Dosing|12
7567714|NCT02282020|26314105|P1|Overall Study|Withdrew Consent Prior to Dosing|0
7567715|NCT02282020|26314104|P2|Overall Study|Developed Discontinuation Criteria|3
7567716|NCT02282020|26314105|P1|Overall Study|Developed Discontinuation Criteria|1
7567717|NCT02282020|26314104|P2|Overall Study|Severe Non-compliance to Protocol|0
7567718|NCT02282020|26314105|P1|Overall Study|Severe Non-compliance to Protocol|1
7567719|NCT02282020|26314104|P2|Overall Study|Miscellaneous|17
7567720|NCT02282020|26314105|P1|Overall Study|Miscellaneous|4
7567721|NCT02282020|26314104|P2|Overall Study|Withdrawal by Subject|10
7567722|NCT02282020|26314105|P1|Overall Study|Withdrawal by Subject|5
7567723|NCT02282020|26314104|P2|Overall Study|Adverse Event|15
7567724|NCT02282020|26314105|P1|Overall Study|Adverse Event|13
7567725|NCT02282020|26314104|P2|Overall Study|Objective Disease Progression|30
7567726|NCT02282020|26314105|P1|Overall Study|Objective Disease Progression|111
7567727|NCT02281955|26314150|P1|Overall Study|Death|1
7567728|NCT02281773|26314173|P5|Overall Study|Other Reason|1
7567729|NCT02281773|26314174|P4|Overall Study|Other Reason|3
7567730|NCT02281773|26314175|P3|Overall Study|Other Reason|2
7567731|NCT02281773|26314176|P2|Overall Study|Other Reason|4
7567732|NCT02281773|26314177|P1|Overall Study|Other Reason|0
7567733|NCT02281773|26314173|P5|Overall Study|Withdrawal by Subject|8
7567734|NCT02281773|26314174|P4|Overall Study|Withdrawal by Subject|6
7567735|NCT02281773|26314175|P3|Overall Study|Withdrawal by Subject|6
7567736|NCT02281773|26314176|P2|Overall Study|Withdrawal by Subject|8
7567737|NCT02281773|26314177|P1|Overall Study|Withdrawal by Subject|2
7567738|NCT02281773|26314173|P5|Overall Study|Lost to Follow-up|10
7567739|NCT02281773|26314174|P4|Overall Study|Lost to Follow-up|2
7567740|NCT02281773|26314175|P3|Overall Study|Lost to Follow-up|6
7567741|NCT02281773|26314176|P2|Overall Study|Lost to Follow-up|2
7567742|NCT02281773|26314177|P1|Overall Study|Lost to Follow-up|2
7567743|NCT02281773|26314173|P5|Overall Study|Protocol Violation|2
7567744|NCT02281773|26314174|P4|Overall Study|Protocol Violation|2
7567745|NCT02281773|26314175|P3|Overall Study|Protocol Violation|0
7567746|NCT02281773|26314176|P2|Overall Study|Protocol Violation|0
7567747|NCT02281773|26314177|P1|Overall Study|Protocol Violation|1
7567748|NCT02281773|26314173|P5|Overall Study|Adverse Event|9
7567749|NCT02281773|26314174|P4|Overall Study|Adverse Event|8
7567750|NCT02281773|26314175|P3|Overall Study|Adverse Event|4
7567751|NCT02281773|26314176|P2|Overall Study|Adverse Event|1
7567752|NCT02281773|26314177|P1|Overall Study|Adverse Event|6
7567753|NCT02281760|26314234|P1|Overall Study|Withdrawal by Subject|1
7567754|NCT02281552|26314275|P2|Overall Study|Adverse Event|9
7567755|NCT02281552|26314276|P1|Overall Study|Adverse Event|3
7567756|NCT02281552|26314275|P2|Overall Study|Insufficient clinical response|1
7567757|NCT02281552|26314276|P1|Overall Study|Insufficient clinical response|0
7567758|NCT02281552|26314275|P2|Overall Study|Medication error|0
7567759|NCT02281552|26314276|P1|Overall Study|Medication error|1
7567760|NCT02281357|26314416|P2|Overall Study|Withdrawal by Subject|3
7567761|NCT02281357|26314417|P1|Overall Study|Withdrawal by Subject|4
7567762|NCT02281357|26314416|P2|Overall Study|Lost to Follow-up|0
7567763|NCT02281357|26314417|P1|Overall Study|Lost to Follow-up|1
7567764|NCT02281357|26314416|P2|Overall Study|Adverse Event|1
7567765|NCT02281357|26314417|P1|Overall Study|Adverse Event|2
7567766|NCT02281318|26314436|P2|Overall Study|Withdrawal by Subject|2
7567767|NCT02281318|26314437|P1|Overall Study|Withdrawal by Subject|6
7567768|NCT02281318|26314436|P2|Overall Study|Physician Decision|0
7567769|NCT02281318|26314437|P1|Overall Study|Physician Decision|2
7567770|NCT02281318|26314436|P2|Overall Study|Lost to Follow-up|1
7567771|NCT02281318|26314437|P1|Overall Study|Lost to Follow-up|2
7567772|NCT02281318|26314436|P2|Overall Study|Lack of Efficacy|0
7567773|NCT02281318|26314437|P1|Overall Study|Lack of Efficacy|2
7567774|NCT02281318|26314436|P2|Overall Study|Adverse Event|2
7567775|NCT02281318|26314437|P1|Overall Study|Adverse Event|2
7567776|NCT02281084|26314485|P4|Overall Study|Physician Decision|0
7567777|NCT02281084|26314486|P3|Overall Study|Physician Decision|1
7567778|NCT02281084|26314487|P2|Overall Study|Physician Decision|0
7567779|NCT02281084|26314488|P1|Overall Study|Physician Decision|0
7567780|NCT02281084|26314485|P4|Overall Study|Death|5
7567781|NCT02281084|26314486|P3|Overall Study|Death|3
7567782|NCT02281084|26314487|P2|Overall Study|Death|16
7567783|NCT02281084|26314488|P1|Overall Study|Death|20
7567784|NCT02281084|26314485|P4|Overall Study|Withdrawal by Subject|0
7567785|NCT02281084|26314486|P3|Overall Study|Withdrawal by Subject|0
7567786|NCT02281084|26314487|P2|Overall Study|Withdrawal by Subject|2
7567787|NCT02281084|26314488|P1|Overall Study|Withdrawal by Subject|1
7567788|NCT02281084|26314485|P4|Overall Study|Adverse Event|0
7567789|NCT02281084|26314486|P3|Overall Study|Adverse Event|0
7567790|NCT02281084|26314487|P2|Overall Study|Adverse Event|0
7567791|NCT02281084|26314488|P1|Overall Study|Adverse Event|1
7567792|NCT02280863|26314544|P2|Integrated Platform|Met stopping criteria|1
7567793|NCT02280863|26314545|P1|Integrated Platform|Met stopping criteria|0
7567794|NCT02280499|26314629|P1|Overall Study|Adverse Event|5
7567795|NCT02280499|26314629|P1|Overall Study|Lost to Follow-up|42
7567796|NCT02280499|26314629|P1|Overall Study|Death|14
7567797|NCT02280473|26314637|P2|Overall Study|Lost to Follow-up|1
7567798|NCT02280473|26314638|P1|Overall Study|Lost to Follow-up|0
7567799|NCT02280473|26314637|P2|Overall Study|Lack of Efficacy|1
7567800|NCT02280473|26314638|P1|Overall Study|Lack of Efficacy|0
7567801|NCT02280473|26314637|P2|Overall Study|Adverse Event|1
7567802|NCT02280473|26314638|P1|Overall Study|Adverse Event|1
7567803|NCT02280421|26314654|P2|Washout (2 Weeks)|Withdrawal by Subject|0
7567804|NCT02280421|26314655|P1|Washout (2 Weeks)|Withdrawal by Subject|1
7567805|NCT02280421|26314654|P2|Washout (2 Weeks)|Adverse Event|1
7567806|NCT02280421|26314655|P1|Washout (2 Weeks)|Adverse Event|0
7567807|NCT02280408|26314721|P4|Overall Study|Lost to Follow-up|0
7567808|NCT02280408|26314722|P3|Overall Study|Lost to Follow-up|0
7567809|NCT02280408|26314723|P2|Overall Study|Lost to Follow-up|2
7567810|NCT02280408|26314724|P1|Overall Study|Lost to Follow-up|0
7567811|NCT02280304|26314796|P2|Overall Study|Lost to Follow-up|8
7567812|NCT02280304|26314797|P1|Overall Study|Lost to Follow-up|7
7567813|NCT02280291|26314818|P4|Overall Study|Other|0
7567814|NCT02280291|26314819|P3|Overall Study|Other|0
7567815|NCT02280291|26314820|P2|Overall Study|Other|1
7567816|NCT02280291|26314821|P1|Overall Study|Other|1
7567817|NCT02280291|26314818|P4|Overall Study|Protocol Violation|0
7567818|NCT02280291|26314819|P3|Overall Study|Protocol Violation|0
7567819|NCT02280291|26314820|P2|Overall Study|Protocol Violation|0
7567820|NCT02280291|26314821|P1|Overall Study|Protocol Violation|1
7567821|NCT02280291|26314818|P4|Overall Study|Lost to Follow-up|8
7567822|NCT02280291|26314819|P3|Overall Study|Lost to Follow-up|3
7567823|NCT02280291|26314820|P2|Overall Study|Lost to Follow-up|1
7567824|NCT02280291|26314821|P1|Overall Study|Lost to Follow-up|2
7567825|NCT02280187|26314862|P1|Overall Study|Lost to Follow-up|218
7567826|NCT02280096|26314890|P2|Overall Study|Lack of attachment|1
7567827|NCT02280096|26314891|P1|Overall Study|Lack of attachment|0
7567828|NCT02280096|26314890|P2|Overall Study|Functional neurological disorder|0
7567829|NCT02280096|26314891|P1|Overall Study|Functional neurological disorder|1
7567830|NCT02280096|26314890|P2|Overall Study|Pregnancy|0
7567831|NCT02280096|26314891|P1|Overall Study|Pregnancy|1
7567832|NCT02280044|26314921|P2|Overall Study|Planned alternate|2
7567833|NCT02280044|26314922|P1|Overall Study|Planned alternate|0
7567834|NCT02279862|26314932|P2|Overall Study|Withdrawal by Subject|0
7567835|NCT02279862|26314933|P1|Overall Study|Withdrawal by Subject|1
7567836|NCT02279862|26314932|P2|Overall Study|Other|2
7567837|NCT02279862|26314933|P1|Overall Study|Other|1
7567838|NCT02279862|26314932|P2|Overall Study|Study closed by sponsor|13
7567839|NCT02279862|26314933|P1|Overall Study|Study closed by sponsor|16
7567840|NCT02279862|26314932|P2|Overall Study|Disease progression|2
7567841|NCT02279862|26314933|P1|Overall Study|Disease progression|5
7567842|NCT02279862|26314932|P2|Overall Study|Administrative reason by sponsor|1
7567843|NCT02279862|26314933|P1|Overall Study|Administrative reason by sponsor|0
7567844|NCT02279862|26314932|P2|Overall Study|No longer meets criteria|1
7567845|NCT02279862|26314933|P1|Overall Study|No longer meets criteria|0
7567846|NCT02279862|26314932|P2|Overall Study|Study drug toxicity|6
7567847|NCT02279862|26314933|P1|Overall Study|Study drug toxicity|3
7567848|NCT02279732|26314951|P2|Overall Study|Other|3
7567849|NCT02279732|26314952|P1|Overall Study|Other|3
7567850|NCT02279732|26314951|P2|Overall Study|Other|67
7567851|NCT02279732|26314952|P1|Overall Study|Other|53
7567852|NCT02279732|26314951|P2|Overall Study|Subject Requested to Discontinue|1
7567853|NCT02279732|26314952|P1|Overall Study|Subject Requested to Discontinue|0
7567854|NCT02279732|26314951|P2|Overall Study|Maximum Clinical Benefit|0
7567855|NCT02279732|26314952|P1|Overall Study|Maximum Clinical Benefit|1
7567856|NCT02279732|26314951|P2|Overall Study|Lost to Follow-up|1
7567857|NCT02279732|26314952|P1|Overall Study|Lost to Follow-up|0
7567858|NCT02279732|26314951|P2|Overall Study|Study Drug Toxicity|0
7567859|NCT02279732|26314952|P1|Overall Study|Study Drug Toxicity|2
7567860|NCT02279732|26314951|P2|Overall Study|Administrative Reason By Sponsor|2
7567861|NCT02279732|26314952|P1|Overall Study|Administrative Reason By Sponsor|0
7567862|NCT02279732|26314951|P2|Overall Study|Adverse Event|2
7567863|NCT02279732|26314952|P1|Overall Study|Adverse Event|1
7567864|NCT02279732|26314951|P2|Overall Study|Withdrawal by Subject|7
7567865|NCT02279732|26314952|P1|Overall Study|Withdrawal by Subject|2
7567866|NCT02279732|26314951|P2|Overall Study|Disease Progression|3
7567867|NCT02279732|26314952|P1|Overall Study|Disease Progression|13
7567868|NCT02279732|26314951|P2|Overall Study|Death|20
7567869|NCT02279732|26314952|P1|Overall Study|Death|23
7567870|NCT02279719|26314969|P7|Overall Study|Patients randomized but never treated|3
7567871|NCT02279719|26314970|P6|Overall Study|Patients randomized but never treated|0
7567872|NCT02279719|26314971|P5|Overall Study|Patients randomized but never treated|3
7567873|NCT02279719|26314972|P4|Overall Study|Patients randomized but never treated|0
7567874|NCT02279719|26314973|P3|Overall Study|Patients randomized but never treated|0
7567875|NCT02279719|26314974|P2|Overall Study|Patients randomized but never treated|0
7567876|NCT02279719|26314975|P1|Overall Study|Patients randomized but never treated|0
7567877|NCT02279524|26315097|P3|Overall Study|Bariatric surgery|0
7567878|NCT02279524|26315098|P2|Overall Study|Bariatric surgery|0
7567879|NCT02279524|26315099|P1|Overall Study|Bariatric surgery|1
7567880|NCT02279524|26315097|P3|Overall Study|Disallowed medication|2
7567881|NCT02279524|26315098|P2|Overall Study|Disallowed medication|1
7567882|NCT02279524|26315099|P1|Overall Study|Disallowed medication|1
7567883|NCT02279524|26315097|P3|Overall Study|Lost to Follow-up|0
7567884|NCT02279524|26315098|P2|Overall Study|Lost to Follow-up|1
7567885|NCT02279524|26315099|P1|Overall Study|Lost to Follow-up|1
7567886|NCT02279524|26315097|P3|Overall Study|Adverse Event|2
7567887|NCT02279524|26315098|P2|Overall Study|Adverse Event|3
7567888|NCT02279524|26315099|P1|Overall Study|Adverse Event|4
7567889|NCT02279524|26315097|P3|Overall Study|Withdrawal by Subject|3
7567890|NCT02279524|26315098|P2|Overall Study|Withdrawal by Subject|6
7567891|NCT02279524|26315099|P1|Overall Study|Withdrawal by Subject|3
7567892|NCT02279498|26315130|P2|Overall Study|Undefined|1
7567893|NCT02279498|26315131|P1|Overall Study|Undefined|2
7567894|NCT02279498|26315130|P2|Overall Study|Withdrawal by Subject|2
7567895|NCT02279498|26315131|P1|Overall Study|Withdrawal by Subject|9
7567896|NCT02279498|26315130|P2|Overall Study|Lost to Follow-up|1
7567897|NCT02279498|26315131|P1|Overall Study|Lost to Follow-up|0
7567898|NCT02279498|26315130|P2|Overall Study|Lack of Efficacy|0
7567899|NCT02279498|26315131|P1|Overall Study|Lack of Efficacy|4
7567900|NCT02279498|26315130|P2|Overall Study|Adverse Event|0
7567901|NCT02279498|26315131|P1|Overall Study|Adverse Event|3
7567902|NCT02279420|26315140|P1|Overall Study|Lost to Follow-up|23
7567903|NCT02279407|26315148|P4|Overall Study|Adverse Event|0
7567904|NCT02279407|26315149|P3|Overall Study|Adverse Event|2
7567905|NCT02279407|26315150|P2|Overall Study|Adverse Event|1
7567906|NCT02279407|26315151|P1|Overall Study|Adverse Event|1
7567907|NCT02279407|26315148|P4|Overall Study|Withdrawal by Subject|1
7567908|NCT02279407|26315149|P3|Overall Study|Withdrawal by Subject|1
7567909|NCT02279407|26315150|P2|Overall Study|Withdrawal by Subject|0
7567910|NCT02279407|26315151|P1|Overall Study|Withdrawal by Subject|1
7567911|NCT02279407|26315148|P4|Overall Study|Couldn't swallow IP; noncompliance|0
7567912|NCT02279407|26315149|P3|Overall Study|Couldn't swallow IP; noncompliance|2
7567913|NCT02279407|26315150|P2|Overall Study|Couldn't swallow IP; noncompliance|0
7567914|NCT02279407|26315151|P1|Overall Study|Couldn't swallow IP; noncompliance|0
7567915|NCT02279173|26315162|P1|Overall Study|Lost to Follow-up|3
7567916|NCT02279173|26315162|P1|Overall Study|Decision by Sponsor|4
7567917|NCT02279173|26315162|P1|Overall Study|Withdrawal by Subject|20
7567918|NCT02279173|26315162|P1|Overall Study|Protocol-specified Criteria|67
7567919|NCT02279043|26315222|P3|Overall Study|Lost to Follow-up|0
7567920|NCT02279043|26315223|P2|Overall Study|Lost to Follow-up|88
7567921|NCT02279043|26315224|P1|Overall Study|Lost to Follow-up|46
7567922|NCT02279043|26315222|P3|Overall Study|Post-rand. exclusion - not eligible|0
7567923|NCT02279043|26315223|P2|Overall Study|Post-rand. exclusion - not eligible|1
7567924|NCT02279043|26315224|P1|Overall Study|Post-rand. exclusion - not eligible|1
7567925|NCT02278952|26315254|P1|Overall Study|Insufficient Sample|6
7567926|NCT02278939|26315266|P2|Overall Study|family emergency unable to commit|0
7567927|NCT02278939|26315267|P1|Overall Study|family emergency unable to commit|2
7567928|NCT02278939|26315266|P2|Overall Study|death in family|0
7567929|NCT02278939|26315267|P1|Overall Study|death in family|1
7567930|NCT02278939|26315266|P2|Overall Study|Lost to Follow-up|1
7567931|NCT02278939|26315267|P1|Overall Study|Lost to Follow-up|1
7567932|NCT02278939|26315266|P2|Overall Study|lack of time|0
7567933|NCT02278939|26315267|P1|Overall Study|lack of time|1
7567934|NCT02278614|26315295|P2|Overall Study|left eye was not eligible|0
7567935|NCT02278614|26315296|P1|Overall Study|left eye was not eligible|1
7567936|NCT02278614|26315295|P2|Overall Study|Adverse Event|0
7567937|NCT02278614|26315296|P1|Overall Study|Adverse Event|1
7567938|NCT02278614|26315295|P2|Overall Study|Withdrawal by Subject|5
7567939|NCT02278614|26315296|P1|Overall Study|Withdrawal by Subject|3
7567940|NCT02278471|26315330|P2|Overall Study|Withdrawal by Subject|3
7567941|NCT02278471|26315331|P1|Overall Study|Withdrawal by Subject|0
7567942|NCT02278471|26315330|P2|Overall Study|Death|2
7567943|NCT02278471|26315331|P1|Overall Study|Death|2
7567944|NCT02278471|26315330|P2|Overall Study|Lost to Follow-up|15
7567945|NCT02278471|26315331|P1|Overall Study|Lost to Follow-up|6
7567946|NCT02278367|26315355|P2|Overall Study|Withdrawal by Subject|0
7567947|NCT02278367|26315356|P1|Overall Study|Withdrawal by Subject|5
7567948|NCT02278367|26315355|P2|Overall Study|Physician Decision|0
7567949|NCT02278367|26315356|P1|Overall Study|Physician Decision|5
7567950|NCT02278354|26315366|P2|Overall Study|<10 professional fights|0
7567951|NCT02278354|26315367|P1|Overall Study|<10 professional fights|2
7567952|NCT02278354|26315366|P2|Overall Study|Withdrawal by Subject|1
7567953|NCT02278354|26315367|P1|Overall Study|Withdrawal by Subject|0
7567954|NCT02278354|26315366|P2|Overall Study|Lost to Follow-up|2
7567955|NCT02278354|26315367|P1|Overall Study|Lost to Follow-up|2
7567956|NCT02278341|26315381|P2|Overall Study|Miscellaneous|14
7567957|NCT02278341|26315382|P1|Overall Study|Miscellaneous|15
7567958|NCT02278341|26315381|P2|Overall Study|Physician Decision|1
7567959|NCT02278341|26315382|P1|Overall Study|Physician Decision|1
7567960|NCT02278341|26315381|P2|Overall Study|Lost to Follow-up|1
7567961|NCT02278341|26315382|P1|Overall Study|Lost to Follow-up|0
7567962|NCT02278341|26315381|P2|Overall Study|Withdrawal by Subject|19
7567963|NCT02278341|26315382|P1|Overall Study|Withdrawal by Subject|30
7567964|NCT02278341|26315381|P2|Overall Study|Death|56
7567965|NCT02278341|26315382|P1|Overall Study|Death|68
7567966|NCT02278341|26315381|P2|Overall Study|Adverse Event|0
7567967|NCT02278341|26315382|P1|Overall Study|Adverse Event|3
7567968|NCT02278341|26315381|P2|Overall Study|Randomized but never received study drug|1
7567969|NCT02278341|26315382|P1|Overall Study|Randomized but never received study drug|1
7567970|NCT02278328|26315476|P3|Neuropsych Screening|incomplete consent|2
7567971|NCT02278328|26315477|P2|Neuropsych Screening|incomplete consent|0
7567972|NCT02278328|26315478|P1|Neuropsych Screening|incomplete consent|0
7567973|NCT02278328|26315476|P3|Neuropsych Screening|Withdrawal by Subject|0
7567974|NCT02278328|26315477|P2|Neuropsych Screening|Withdrawal by Subject|1
7567975|NCT02278328|26315478|P1|Neuropsych Screening|Withdrawal by Subject|0
7567976|NCT02278328|26315476|P3|Neuropsych Screening|found ineligible on neuropsych|0
7567977|NCT02278328|26315477|P2|Neuropsych Screening|found ineligible on neuropsych|0
7567978|NCT02278328|26315478|P1|Neuropsych Screening|found ineligible on neuropsych|1
7567979|NCT02278263|26315512|P3|Overall Study|Protocol Violation|9
7567980|NCT02278263|26315513|P2|Overall Study|Protocol Violation|0
7567981|NCT02278263|26315514|P1|Overall Study|Protocol Violation|7
7567982|NCT02278120|26315559|P2|Overall Study|Protocol Violation|2
7567983|NCT02278120|26315560|P1|Overall Study|Protocol Violation|0
7567984|NCT02278120|26315559|P2|Overall Study|Lost to Follow-up|0
7567985|NCT02278120|26315560|P1|Overall Study|Lost to Follow-up|2
7567986|NCT02278120|26315559|P2|Overall Study|Death|3
7567987|NCT02278120|26315560|P1|Overall Study|Death|3
7567988|NCT02278120|26315559|P2|Overall Study|Physician Decision|19
7567989|NCT02278120|26315560|P1|Overall Study|Physician Decision|8
7567990|NCT02278120|26315559|P2|Overall Study|Adverse Event|10
7567991|NCT02278120|26315560|P1|Overall Study|Adverse Event|12
7567992|NCT02278120|26315559|P2|Overall Study|Patient/guardian decision|8
7567993|NCT02278120|26315560|P1|Overall Study|Patient/guardian decision|14
7567994|NCT02278120|26315559|P2|Overall Study|Progressive disease|174
7567995|NCT02278120|26315560|P1|Overall Study|Progressive disease|122
7567996|NCT02278003|26315576|P2|Overall Study|Recognition task improperly completed|0
7567997|NCT02278003|26315577|P1|Overall Study|Recognition task improperly completed|7
7567998|NCT02278003|26315576|P2|Overall Study|Not Treated|0
7567999|NCT02278003|26315577|P1|Overall Study|Not Treated|1
7568000|NCT02278003|26315576|P2|Overall Study|Withdrawal by Subject|0
7568001|NCT02278003|26315577|P1|Overall Study|Withdrawal by Subject|11
7568002|NCT02277990|26315587|P2|Overall Study|Had other reason|32
7568003|NCT02277990|26315588|P1|Overall Study|Had other reason|26
7568004|NCT02277990|26315587|P2|Overall Study|Lost to Follow-up|69
7568005|NCT02277990|26315588|P1|Overall Study|Lost to Follow-up|66
7568006|NCT02277990|26315587|P2|Overall Study|Physician Decision|34
7568007|NCT02277990|26315588|P1|Overall Study|Physician Decision|40
7568008|NCT02277990|26315587|P2|Overall Study|Withdrawal by Subject|53
7568009|NCT02277990|26315588|P1|Overall Study|Withdrawal by Subject|64
7568010|NCT02277990|26315587|P2|Overall Study|Death|188
7568011|NCT02277990|26315588|P1|Overall Study|Death|170
7568012|NCT02277769|26315616|P3|Overall Study|Other than specified above|5
7568013|NCT02277769|26315617|P2|Overall Study|Other than specified above|8
7568014|NCT02277769|26315618|P1|Overall Study|Other than specified above|12
7568015|NCT02277769|26315616|P3|Overall Study|Adverse Event|4
7568016|NCT02277769|26315617|P2|Overall Study|Adverse Event|2
7568017|NCT02277769|26315618|P1|Overall Study|Adverse Event|14
7568018|NCT02277769|26315616|P3|Overall Study|Lack of Efficacy|4
7568019|NCT02277769|26315617|P2|Overall Study|Lack of Efficacy|0
7568020|NCT02277769|26315618|P1|Overall Study|Lack of Efficacy|17
7568021|NCT02277769|26315616|P3|Overall Study|Protocol Violation|5
7568022|NCT02277769|26315617|P2|Overall Study|Protocol Violation|3
7568023|NCT02277769|26315618|P1|Overall Study|Protocol Violation|3
7568024|NCT02277743|26315689|P3|Overall Study|Other than specified above|16
7568025|NCT02277743|26315690|P2|Overall Study|Other than specified above|5
7568026|NCT02277743|26315691|P1|Overall Study|Other than specified above|18
7568027|NCT02277743|26315689|P3|Overall Study|Lack of Efficacy|3
7568028|NCT02277743|26315690|P2|Overall Study|Lack of Efficacy|4
7568029|NCT02277743|26315691|P1|Overall Study|Lack of Efficacy|11
7568030|NCT02277743|26315689|P3|Overall Study|Adverse Event|6
7568031|NCT02277743|26315690|P2|Overall Study|Adverse Event|6
7568032|NCT02277743|26315691|P1|Overall Study|Adverse Event|10
7568033|NCT02277743|26315689|P3|Overall Study|Protocol Violation|1
7568034|NCT02277743|26315690|P2|Overall Study|Protocol Violation|1
7568035|NCT02277743|26315691|P1|Overall Study|Protocol Violation|1
7568036|NCT02277691|26315759|P1|Overall Study|Used Other Antihypertensive Drug|1
7568037|NCT02277691|26315759|P1|Overall Study|Lack of Efficacy|5
7568038|NCT02277691|26315759|P1|Overall Study|Voluntary Withdrawal|7
7568039|NCT02277691|26315759|P1|Overall Study|Pretreatment Event/Adverse Event|33
7568045|NCT02277119|26315840|P3|Overall Study|Protocol Violation|7
7568046|NCT02277119|26315841|P2|Overall Study|Protocol Violation|3
7568047|NCT02277119|26315842|P1|Overall Study|Protocol Violation|2
7568048|NCT02277119|26315840|P3|Overall Study|Lack of Efficacy|1
7568049|NCT02277119|26315841|P2|Overall Study|Lack of Efficacy|1
7568050|NCT02277119|26315842|P1|Overall Study|Lack of Efficacy|1
7568051|NCT02276872|26315880|P3|Overall Study|Adverse Event|0
7568052|NCT02276872|26315881|P2|Overall Study|Adverse Event|0
7568053|NCT02276872|26315882|P1|Overall Study|Adverse Event|1
7568054|NCT02276807|26315958|P2|Overall Study|Lost to Follow-up|10
7568055|NCT02276807|26315959|P1|Overall Study|Lost to Follow-up|10
7568056|NCT02276807|26315958|P2|Overall Study|Withdrawal by Subject|7
7568057|NCT02276807|26315959|P1|Overall Study|Withdrawal by Subject|8
7568058|NCT02276612|26315994|P2|Overall Study|Lost to Follow-up|0
7568059|NCT02276612|26315995|P1|Overall Study|Lost to Follow-up|1
7568060|NCT02276612|26315994|P2|Overall Study|Withdrew Consent|0
7568061|NCT02276612|26315995|P1|Overall Study|Withdrew Consent|1
7568062|NCT02276612|26315994|P2|Overall Study|Pregnancy|0
7568063|NCT02276612|26315995|P1|Overall Study|Pregnancy|1
7568064|NCT02276612|26315994|P2|Overall Study|Death|0
7568065|NCT02276612|26315995|P1|Overall Study|Death|1
7568066|NCT02276560|26316018|P3|Overall Study|Adverse Event|0
7568067|NCT02276560|26316019|P2|Overall Study|Adverse Event|0
7568068|NCT02276560|26316020|P1|Overall Study|Adverse Event|1
7568069|NCT02276547|26316028|P1|Overall Study|Explant|2
7568070|NCT02276547|26316028|P1|Overall Study|Death|2
7568071|NCT02276482|26316034|P2|Overall Study|Reason not specified|1
7568072|NCT02276482|26316035|P1|Overall Study|Reason not specified|0
7568073|NCT02276482|26316034|P2|Overall Study|Gram-negative infection|0
7568074|NCT02276482|26316035|P1|Overall Study|Gram-negative infection|1
7568075|NCT02276482|26316034|P2|Overall Study|Withdrawal by Subject|0
7568076|NCT02276482|26316035|P1|Overall Study|Withdrawal by Subject|1
7568077|NCT02276482|26316034|P2|Overall Study|Adverse Event|0
7568078|NCT02276482|26316035|P1|Overall Study|Adverse Event|1
7568079|NCT02276222|26316170|P2|Overall Study|subject withdrew after randomization|0
7568080|NCT02276222|26316171|P1|Overall Study|subject withdrew after randomization|1
7568081|NCT02276222|26316170|P2|Overall Study|sheduling conflict|0
7568082|NCT02276222|26316171|P1|Overall Study|sheduling conflict|1
7568083|NCT02276222|26316170|P2|Overall Study|Physician Decision|1
7568084|NCT02276222|26316171|P1|Overall Study|Physician Decision|2
7568085|NCT02276222|26316170|P2|Overall Study|Lost to Follow-up|5
7568086|NCT02276222|26316171|P1|Overall Study|Lost to Follow-up|15
7568087|NCT02276222|26316170|P2|Overall Study|sponsor decision|3
7568088|NCT02276222|26316171|P1|Overall Study|sponsor decision|0
7568089|NCT02276222|26316170|P2|Overall Study|non compliance with study medication|2
7568090|NCT02276222|26316171|P1|Overall Study|non compliance with study medication|6
7568091|NCT02276222|26316170|P2|Overall Study|Withdrawal by Subject|33
7568092|NCT02276222|26316171|P1|Overall Study|Withdrawal by Subject|79
7568093|NCT02276222|26316170|P2|Overall Study|Protocol Violation|2
7568094|NCT02276222|26316171|P1|Overall Study|Protocol Violation|3
7568095|NCT02276222|26316170|P2|Overall Study|Lack of Efficacy|3
7568096|NCT02276222|26316171|P1|Overall Study|Lack of Efficacy|13
7568097|NCT02276222|26316170|P2|Overall Study|Death|4
7568098|NCT02276222|26316171|P1|Overall Study|Death|3
7568099|NCT02276222|26316170|P2|Overall Study|Adverse Event|11
7568100|NCT02276222|26316171|P1|Overall Study|Adverse Event|62
7568101|NCT02276053|26316195|P1|Overall Study|Patient needs to increase baseline AED|1
7568102|NCT02276053|26316195|P1|Overall Study|Patient does not meet selection criteria|3
7568103|NCT02276053|26316195|P1|Overall Study|Withdrawal by Subject|1
7568104|NCT02276053|26316195|P1|Overall Study|Lack of Efficacy|2
7568105|NCT02276053|26316195|P1|Overall Study|Adverse Event|5
7568106|NCT02276053|26316195|P1|Overall Study|Death|2
7568107|NCT02276040|26316211|P1|Overall Study|Physician Decision|15
7568108|NCT02276027|26316219|P4|Overall Study|Adverse Event|2
7568109|NCT02276027|26316220|P3|Overall Study|Adverse Event|8
7568110|NCT02276027|26316221|P2|Overall Study|Adverse Event|2
7568111|NCT02276027|26316222|P1|Overall Study|Adverse Event|0
7568112|NCT02276027|26316219|P4|Overall Study|Subject/guardian decision|3
7568113|NCT02276027|26316220|P3|Overall Study|Subject/guardian decision|0
7568114|NCT02276027|26316221|P2|Overall Study|Subject/guardian decision|1
7568115|NCT02276027|26316222|P1|Overall Study|Subject/guardian decision|0
7568116|NCT02276027|26316219|P4|Overall Study|Progressive disease|14
7568117|NCT02276027|26316220|P3|Overall Study|Progressive disease|12
7568118|NCT02276027|26316221|P2|Overall Study|Progressive disease|13
7568119|NCT02276027|26316222|P1|Overall Study|Progressive disease|1
7568120|NCT02276027|26316219|P4|Overall Study|Physician Decision|1
7568121|NCT02276027|26316220|P3|Overall Study|Physician Decision|0
7568122|NCT02276027|26316221|P2|Overall Study|Physician Decision|0
7568123|NCT02276027|26316222|P1|Overall Study|Physician Decision|0
7568124|NCT02276027|26316219|P4|Overall Study|Death|2
7568125|NCT02276027|26316220|P3|Overall Study|Death|0
7568126|NCT02276027|26316221|P2|Overall Study|Death|0
7568127|NCT02276027|26316222|P1|Overall Study|Death|1
7568128|NCT02275819|26316271|P2|Overall Study|Adverse Event|1
7568129|NCT02275819|26316272|P1|Overall Study|Adverse Event|0
7568130|NCT02275780|26316288|P2|Extension Study: up to 192 Weeks|Ongoing|233
7568131|NCT02275780|26316289|P1|Extension Study: up to 192 Weeks|Ongoing|260
7568132|NCT02275780|26316288|P2|Base Study: 96 Weeks|Randomized not treated|1
7568133|NCT02275780|26316289|P1|Base Study: 96 Weeks|Randomized not treated|2
7568134|NCT02275780|26316288|P2|Base Study: 96 Weeks|Pregnancy|1
7568135|NCT02275780|26316289|P1|Base Study: 96 Weeks|Pregnancy|2
7568136|NCT02275780|26316288|P2|Base Study: 96 Weeks|Physician Decision|4
7568137|NCT02275780|26316289|P1|Base Study: 96 Weeks|Physician Decision|2
7568138|NCT02275780|26316288|P2|Base Study: 96 Weeks|Noncompliance with drug|6
7568139|NCT02275780|26316289|P1|Base Study: 96 Weeks|Noncompliance with drug|9
7568140|NCT02275780|26316288|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
7568141|NCT02275780|26316289|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
7568142|NCT02275780|26316288|P2|Base Study: 96 Weeks|Protocol Violation|6
7568143|NCT02275780|26316289|P1|Base Study: 96 Weeks|Protocol Violation|1
7568144|NCT02275780|26316288|P2|Base Study: 96 Weeks|Lost to Follow-up|24
7568145|NCT02275780|26316289|P1|Base Study: 96 Weeks|Lost to Follow-up|28
7568146|NCT02275780|26316288|P2|Base Study: 96 Weeks|Lack of Efficacy|32
7568147|NCT02275780|26316289|P1|Base Study: 96 Weeks|Lack of Efficacy|21
7568148|NCT02275780|26316288|P2|Base Study: 96 Weeks|Death|1
7568149|NCT02275780|26316289|P1|Base Study: 96 Weeks|Death|3
7568150|NCT02275780|26316288|P2|Base Study: 96 Weeks|Adverse Event|14
7568151|NCT02275780|26316289|P1|Base Study: 96 Weeks|Adverse Event|6
7568152|NCT02275611|26316345|P4|Inpatient Withdrawal|Withdrawal by Subject|0
7568153|NCT02275611|26316346|P3|Inpatient Withdrawal|Withdrawal by Subject|0
7568154|NCT02275611|26316347|P2|Inpatient Withdrawal|Withdrawal by Subject|0
7568155|NCT02275611|26316348|P1|Inpatient Withdrawal|Withdrawal by Subject|1
7568156|NCT02275546|26316360|P2|Treatment Period 2|Protocol Violation|1
7568157|NCT02275546|26316361|P1|Treatment Period 2|Protocol Violation|0
7568158|NCT02275546|26316360|P2|Treatment Period 2|Withdrawal by Subject|1
7568159|NCT02275546|26316361|P1|Treatment Period 2|Withdrawal by Subject|2
7568160|NCT02275481|26316371|P2|Overall Study|Physician Decision|1
7568161|NCT02275481|26316372|P1|Overall Study|Physician Decision|0
7568162|NCT02275481|26316371|P2|Overall Study|all other reasons combined|1
7568163|NCT02275481|26316372|P1|Overall Study|all other reasons combined|2
7568164|NCT02275481|26316371|P2|Overall Study|Withdrawal by Subject|0
7568165|NCT02275481|26316372|P1|Overall Study|Withdrawal by Subject|3
7568166|NCT02275481|26316371|P2|Overall Study|Lost to Follow-up|0
7568167|NCT02275481|26316372|P1|Overall Study|Lost to Follow-up|2
7568168|NCT02275481|26316371|P2|Overall Study|Death|1
7568169|NCT02275481|26316372|P1|Overall Study|Death|2
7568170|NCT02275364|26316378|P2|Period 1|Other reason|0
7568171|NCT02275364|26316379|P1|Period 1|Other reason|1
7568172|NCT02275364|26316378|P2|Period 1|Withdrawal by Subject|0
7568173|NCT02275364|26316379|P1|Period 1|Withdrawal by Subject|1
7568174|NCT02275338|26316408|P1|Overall Study|Does not meet entry criteria|1
7568175|NCT02275338|26316408|P1|Overall Study|Reason not specified|5
7568176|NCT02275338|26316408|P1|Overall Study|Ineligible to start Phase 2|4
7568177|NCT02275338|26316408|P1|Overall Study|Disease progression (death)|1
7568178|NCT02275338|26316408|P1|Overall Study|Withdrawal by Subject|4
7568179|NCT02275338|26316408|P1|Overall Study|Lack of Efficacy|3
7568180|NCT02275338|26316408|P1|Overall Study|Adverse Event|15
7568181|NCT02275117|26316457|P5|Overall Study|Other|2
7568182|NCT02275117|26316458|P4|Overall Study|Other|0
7568183|NCT02275117|26316459|P3|Overall Study|Other|0
7568184|NCT02275117|26316460|P2|Overall Study|Other|0
7568185|NCT02275117|26316461|P1|Overall Study|Other|1
7568186|NCT02275117|26316457|P5|Overall Study|Study Burden|7
7568187|NCT02275117|26316458|P4|Overall Study|Study Burden|5
7568188|NCT02275117|26316459|P3|Overall Study|Study Burden|7
7568189|NCT02275117|26316460|P2|Overall Study|Study Burden|4
7568190|NCT02275117|26316461|P1|Overall Study|Study Burden|5
7568191|NCT02275117|26316457|P5|Overall Study|Worsening of Study Indication|0
7568192|NCT02275117|26316458|P4|Overall Study|Worsening of Study Indication|0
7568193|NCT02275117|26316459|P3|Overall Study|Worsening of Study Indication|2
7568194|NCT02275117|26316460|P2|Overall Study|Worsening of Study Indication|1
7568195|NCT02275117|26316461|P1|Overall Study|Worsening of Study Indication|0
7568196|NCT02275117|26316457|P5|Overall Study|Terminated by Sponsor|4
7568197|NCT02275117|26316458|P4|Overall Study|Terminated by Sponsor|6
7568198|NCT02275117|26316459|P3|Overall Study|Terminated by Sponsor|4
7568199|NCT02275117|26316460|P2|Overall Study|Terminated by Sponsor|4
7568200|NCT02275117|26316461|P1|Overall Study|Terminated by Sponsor|4
7568201|NCT02275117|26316457|P5|Overall Study|Withdrawal by Subject|3
7568202|NCT02275117|26316458|P4|Overall Study|Withdrawal by Subject|3
7568203|NCT02275117|26316459|P3|Overall Study|Withdrawal by Subject|7
7568204|NCT02275117|26316460|P2|Overall Study|Withdrawal by Subject|4
7568205|NCT02275117|26316461|P1|Overall Study|Withdrawal by Subject|6
7568206|NCT02275117|26316457|P5|Overall Study|Protocol Violation|0
7568207|NCT02275117|26316458|P4|Overall Study|Protocol Violation|1
7568208|NCT02275117|26316459|P3|Overall Study|Protocol Violation|1
7568209|NCT02275117|26316460|P2|Overall Study|Protocol Violation|0
7568210|NCT02275117|26316461|P1|Overall Study|Protocol Violation|1
7568211|NCT02275117|26316457|P5|Overall Study|Physician Decision|1
7568212|NCT02275117|26316458|P4|Overall Study|Physician Decision|0
7568213|NCT02275117|26316459|P3|Overall Study|Physician Decision|1
7568214|NCT02275117|26316460|P2|Overall Study|Physician Decision|1
7568215|NCT02275117|26316461|P1|Overall Study|Physician Decision|0
7568216|NCT02275117|26316457|P5|Overall Study|Lost to Follow-up|8
7568217|NCT02275117|26316458|P4|Overall Study|Lost to Follow-up|16
7568218|NCT02275117|26316459|P3|Overall Study|Lost to Follow-up|15
7568219|NCT02275117|26316460|P2|Overall Study|Lost to Follow-up|16
7568220|NCT02275117|26316461|P1|Overall Study|Lost to Follow-up|11
7568221|NCT02275117|26316457|P5|Overall Study|Lack of Efficacy|10
7568222|NCT02275117|26316458|P4|Overall Study|Lack of Efficacy|2
7568223|NCT02275117|26316459|P3|Overall Study|Lack of Efficacy|5
7568224|NCT02275117|26316460|P2|Overall Study|Lack of Efficacy|7
7568225|NCT02275117|26316461|P1|Overall Study|Lack of Efficacy|6
7568226|NCT02275117|26316457|P5|Overall Study|Adverse Event|1
7568227|NCT02275117|26316458|P4|Overall Study|Adverse Event|0
7568228|NCT02275117|26316459|P3|Overall Study|Adverse Event|0
7568229|NCT02275117|26316460|P2|Overall Study|Adverse Event|0
7568230|NCT02275117|26316461|P1|Overall Study|Adverse Event|0
7568231|NCT02275065|26316573|P5|Overall Study|Randomized but not treated|0
7568232|NCT02275065|26316574|P4|Overall Study|Randomized but not treated|1
7568233|NCT02275065|26316575|P3|Overall Study|Randomized but not treated|1
7568234|NCT02275065|26316576|P2|Overall Study|Randomized but not treated|0
7568235|NCT02275065|26316577|P1|Overall Study|Randomized but not treated|1
7568236|NCT02275052|26316658|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
7568237|NCT02275052|26316659|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7568238|NCT02275052|26316660|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7568239|NCT02275052|26316661|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7568240|NCT02275052|26316658|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
7568241|NCT02275052|26316659|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7568242|NCT02275052|26316660|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7568243|NCT02275052|26316661|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7568244|NCT02275052|26316658|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
7568245|NCT02275052|26316659|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7568246|NCT02275052|26316660|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7568247|NCT02275052|26316661|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7568248|NCT02275052|26316658|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
7568249|NCT02275052|26316659|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
7568250|NCT02275052|26316660|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7568251|NCT02275052|26316661|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7568252|NCT02275052|26316658|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
7568253|NCT02275052|26316659|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
7568254|NCT02275052|26316660|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
7568255|NCT02275052|26316661|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
7568256|NCT02275052|26316658|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
7568257|NCT02275052|26316659|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
7568258|NCT02275052|26316660|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
7568259|NCT02275052|26316661|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
7568260|NCT02275052|26316658|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7568261|NCT02275052|26316659|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7568262|NCT02275052|26316660|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7568263|NCT02275052|26316661|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
7568264|NCT02275052|26316658|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7568265|NCT02275052|26316659|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7568266|NCT02275052|26316660|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7568267|NCT02275052|26316661|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
7568268|NCT02275052|26316658|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7568269|NCT02275052|26316659|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7568270|NCT02275052|26316660|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
7568271|NCT02275052|26316661|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
7568272|NCT02275052|26316658|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7568273|NCT02275052|26316659|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7568274|NCT02275052|26316660|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
7568275|NCT02275052|26316661|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7568276|NCT02275052|26316658|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7568277|NCT02275052|26316659|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7568278|NCT02275052|26316660|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7568279|NCT02275052|26316661|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7568280|NCT02275026|26316673|P1|Overall Study|Scanner failure|1
7568281|NCT02275026|26316673|P1|Overall Study|Lost to Follow-up|2
7568282|NCT02275026|26316673|P1|Overall Study|Ineligible after MRI findings|1
7568283|NCT02275026|26316673|P1|Overall Study|MRI malfunction precluded testing|1
7568284|NCT02275026|26316673|P1|Overall Study|Ineligible due to medical history|13
7568285|NCT02275026|26316673|P1|Overall Study|Withdrawal by Subject|4
7568286|NCT02275026|26316673|P1|Overall Study|Ineligible after cognitive baseline testing|11
7568287|NCT02274948|26316686|P2|Overall Study|Left the area|3
7568288|NCT02274948|26316687|P1|Overall Study|Left the area|4
7568289|NCT02274948|26316686|P2|Overall Study|Stopped on family Practitioner advice|5
7568290|NCT02274948|26316687|P1|Overall Study|Stopped on family Practitioner advice|2
7568291|NCT02274948|26316686|P2|Overall Study|Withdrawal by Subject|58
7568292|NCT02274948|26316687|P1|Overall Study|Withdrawal by Subject|64
7568293|NCT02274948|26316686|P2|Overall Study|Lost to Follow-up|25
7568294|NCT02274948|26316687|P1|Overall Study|Lost to Follow-up|28
7568295|NCT02274857|26316730|P2|Overall Study|Other|0
7568296|NCT02274857|26316731|P1|Overall Study|Other|2
7568297|NCT02274857|26316730|P2|Overall Study|Withdrawal by Subject|2
7568298|NCT02274857|26316731|P1|Overall Study|Withdrawal by Subject|11
7568299|NCT02274857|26316730|P2|Overall Study|Trial screen failure|2
7568300|NCT02274857|26316731|P1|Overall Study|Trial screen failure|0
7568301|NCT02274857|26316730|P2|Overall Study|Physician Decision|0
7568302|NCT02274857|26316731|P1|Overall Study|Physician Decision|2
7568303|NCT02274857|26316730|P2|Overall Study|Lost to Follow-up|0
7568304|NCT02274857|26316731|P1|Overall Study|Lost to Follow-up|3
7568305|NCT02274857|26316730|P2|Overall Study|Death|2
7568306|NCT02274857|26316731|P1|Overall Study|Death|1
7568307|NCT02274857|26316730|P2|Overall Study|Adverse Event|0
7568308|NCT02274857|26316731|P1|Overall Study|Adverse Event|1
7568309|NCT02274792|26316783|P1|Overall Study|Sponsor Decision|2
7568310|NCT02274792|26316783|P1|Overall Study|Protocol Specified Criteria|2
7568311|NCT02274792|26316783|P1|Overall Study|Lost to Follow-up|8
7568312|NCT02274792|26316783|P1|Overall Study|Withdrawal by Subject|13
7568313|NCT02274766|26316793|P2|Overall Study|Adverse Event|1
7568314|NCT02274766|26316794|P1|Overall Study|Adverse Event|0
7568315|NCT02274766|26316793|P2|Overall Study|Subject Unwilling to Proceed|1
7568316|NCT02274766|26316794|P1|Overall Study|Subject Unwilling to Proceed|0
7568317|NCT02274766|26316793|P2|Overall Study|Did Not Receive Study Drug|1
7568318|NCT02274766|26316794|P1|Overall Study|Did Not Receive Study Drug|1
7568319|NCT02274766|26316793|P2|Overall Study|Withdrawal by Subject|6
7568320|NCT02274766|26316794|P1|Overall Study|Withdrawal by Subject|3
7568321|NCT02274558|26316861|P3|Overall Study|Physician Decision|1
7568322|NCT02274558|26316862|P2|Overall Study|Physician Decision|2
7568323|NCT02274558|26316863|P1|Overall Study|Physician Decision|0
7568324|NCT02274558|26316861|P3|Overall Study|Lost to Follow-up|1
7568325|NCT02274558|26316862|P2|Overall Study|Lost to Follow-up|1
7568326|NCT02274558|26316863|P1|Overall Study|Lost to Follow-up|2
7568327|NCT02274558|26316861|P3|Overall Study|Death|1
7568328|NCT02274558|26316862|P2|Overall Study|Death|0
7568329|NCT02274558|26316863|P1|Overall Study|Death|0
7568330|NCT02274558|26316861|P3|Overall Study|Withdrawal by Subject|4
7568331|NCT02274558|26316862|P2|Overall Study|Withdrawal by Subject|5
7568332|NCT02274558|26316863|P1|Overall Study|Withdrawal by Subject|1
7568333|NCT02274558|26316861|P3|Overall Study|Non-compliance|0
7568334|NCT02274558|26316862|P2|Overall Study|Non-compliance|1
7568335|NCT02274558|26316863|P1|Overall Study|Non-compliance|2
7568336|NCT02274558|26316861|P3|Overall Study|Adverse Event|2
7568337|NCT02274558|26316862|P2|Overall Study|Adverse Event|4
7568338|NCT02274558|26316863|P1|Overall Study|Adverse Event|2
7568339|NCT02274493|26316877|P1|Overall Study|Withdrawal by Subject|1
7568340|NCT02274311|26316884|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
7568341|NCT02274038|26316890|P1|Overall Study|Death|1
7568342|NCT02273973|26316900|P2|Overall Study|Reason not specified|1
7568343|NCT02273973|26316901|P1|Overall Study|Reason not specified|0
7568344|NCT02273973|26316900|P2|Overall Study|Physician Decision|1
7568345|NCT02273973|26316901|P1|Overall Study|Physician Decision|0
7568346|NCT02273973|26316900|P2|Overall Study|Lost to Follow-up|1
7568347|NCT02273973|26316901|P1|Overall Study|Lost to Follow-up|0
7568348|NCT02273973|26316900|P2|Overall Study|Progression of disease|2
7568349|NCT02273973|26316901|P1|Overall Study|Progression of disease|0
7568350|NCT02273973|26316900|P2|Overall Study|Protocol Violation|0
7568351|NCT02273973|26316901|P1|Overall Study|Protocol Violation|1
7568352|NCT02273973|26316900|P2|Overall Study|Non-compliance|0
7568353|NCT02273973|26316901|P1|Overall Study|Non-compliance|1
7568354|NCT02273973|26316900|P2|Overall Study|Death|0
7568355|NCT02273973|26316901|P1|Overall Study|Death|1
7568356|NCT02273973|26316900|P2|Overall Study|Withdrawal by Subject|3
7568357|NCT02273973|26316901|P1|Overall Study|Withdrawal by Subject|2
7568358|NCT02273973|26316900|P2|Overall Study|Adverse Event|0
7568359|NCT02273973|26316901|P1|Overall Study|Adverse Event|4
7568360|NCT02273960|26316945|P4|Long Term Extension|Death|1
7568361|NCT02273960|26316946|P3|Long Term Extension|Death|0
7568362|NCT02273960|26316947|P2|Long Term Extension|Death|0
7568363|NCT02273960|26316948|P1|Long Term Extension|Death|0
7568364|NCT02273960|26316945|P4|Short Term Period|ST complete, not entering LTE|5
7568365|NCT02273960|26316946|P3|Short Term Period|ST complete, not entering LTE|4
7568366|NCT02273960|26316947|P2|Short Term Period|ST complete, not entering LTE|6
7568367|NCT02273960|26316948|P1|Short Term Period|ST complete, not entering LTE|4
7568368|NCT02273960|26316945|P4|Short Term Period|Lack of Efficacy|1
7568369|NCT02273960|26316946|P3|Short Term Period|Lack of Efficacy|0
7568370|NCT02273960|26316947|P2|Short Term Period|Lack of Efficacy|0
7568371|NCT02273960|26316948|P1|Short Term Period|Lack of Efficacy|0
7568372|NCT02273960|26316945|P4|Short Term Period|Lost to Follow-up|0
7568373|NCT02273960|26316946|P3|Short Term Period|Lost to Follow-up|0
7568374|NCT02273960|26316947|P2|Short Term Period|Lost to Follow-up|0
7568375|NCT02273960|26316948|P1|Short Term Period|Lost to Follow-up|1
7568376|NCT02273908|26316992|P2|Overall Study|Withdrawal by Subject|2
7568377|NCT02273908|26316993|P1|Overall Study|Withdrawal by Subject|4
7568378|NCT02273908|26316992|P2|Overall Study|Did not meet entrance criteria|2
7568379|NCT02273908|26316993|P1|Overall Study|Did not meet entrance criteria|3
7568380|NCT02273908|26316992|P2|Overall Study|Lost to Follow-up|1
7568381|NCT02273908|26316993|P1|Overall Study|Lost to Follow-up|10
7568382|NCT02273908|26316992|P2|Overall Study|Adverse Event|0
7568383|NCT02273908|26316993|P1|Overall Study|Adverse Event|16
7568384|NCT02273752|26317015|P1|Overall Study|Trial was terminated early|2
7568385|NCT02273739|26317030|P4|Overall Study|Physician Decision|1
7568386|NCT02273739|26317031|P3|Overall Study|Physician Decision|0
7568387|NCT02273739|26317032|P2|Overall Study|Physician Decision|0
7568388|NCT02273739|26317033|P1|Overall Study|Physician Decision|0
7568389|NCT02273739|26317030|P4|Overall Study|Withdrawal by Subject|1
7568390|NCT02273739|26317031|P3|Overall Study|Withdrawal by Subject|2
7568391|NCT02273739|26317032|P2|Overall Study|Withdrawal by Subject|0
7568392|NCT02273739|26317033|P1|Overall Study|Withdrawal by Subject|0
7568393|NCT02273739|26317030|P4|Overall Study|Adverse Event|1
7568394|NCT02273739|26317031|P3|Overall Study|Adverse Event|0
7568395|NCT02273739|26317032|P2|Overall Study|Adverse Event|0
7568396|NCT02273739|26317033|P1|Overall Study|Adverse Event|0
7568397|NCT02273739|26317030|P4|Overall Study|Death|2
7568398|NCT02273739|26317031|P3|Overall Study|Death|0
7568399|NCT02273739|26317032|P2|Overall Study|Death|0
7568400|NCT02273739|26317033|P1|Overall Study|Death|0
7568401|NCT02273739|26317030|P4|Overall Study|Progression of Disease|2
7568402|NCT02273739|26317031|P3|Overall Study|Progression of Disease|5
7568403|NCT02273739|26317032|P2|Overall Study|Progression of Disease|4
7568404|NCT02273739|26317033|P1|Overall Study|Progression of Disease|3
7568405|NCT02273596|26317123|P1|Extension Period|Protocol Deviation|1
7568406|NCT02273596|26317123|P1|Extension Period|Lost to Follow-up|1
7568407|NCT02273596|26317123|P1|Extension Period|Participant Withdrew for Personal Reasons|1
7568408|NCT02273596|26317123|P1|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
7568409|NCT02273596|26317123|P1|24-Week Treatment Period|Protocol Deviation|1
7568410|NCT02273596|26317123|P1|24-Week Treatment Period|Physician Decision|1
7568411|NCT02273596|26317123|P1|24-Week Treatment Period|Participant was unable to Come|1
7568412|NCT02273596|26317123|P1|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
7568413|NCT02273596|26317123|P1|24-Week Treatment Period|Adverse Event|3
7568414|NCT02273180|26317235|P2|Overall Study|Other than specified above|10
7568415|NCT02273180|26317236|P1|Overall Study|Other than specified above|21
7568416|NCT02273180|26317235|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
7568417|NCT02273180|26317236|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
7568418|NCT02273180|26317235|P2|Overall Study|Randomized but not treated|0
7568419|NCT02273180|26317236|P1|Overall Study|Randomized but not treated|1
7568420|NCT02273180|26317235|P2|Overall Study|Protocol Violation|7
7568421|NCT02273180|26317236|P1|Overall Study|Protocol Violation|1
7568422|NCT02273180|26317235|P2|Overall Study|Lack of Efficacy|0
7568423|NCT02273180|26317236|P1|Overall Study|Lack of Efficacy|1
7568424|NCT02273180|26317235|P2|Overall Study|Adverse Event|2
7568425|NCT02273180|26317236|P1|Overall Study|Adverse Event|2
7568426|NCT02273167|26317261|P3|Overall Study|Various|8
7568427|NCT02273167|26317262|P2|Overall Study|Various|9
7568428|NCT02273167|26317263|P1|Overall Study|Various|10
7568429|NCT02273167|26317261|P3|Overall Study|Withdrawal by Subject|11
7568430|NCT02273167|26317262|P2|Overall Study|Withdrawal by Subject|12
7568431|NCT02273167|26317263|P1|Overall Study|Withdrawal by Subject|10
7568432|NCT02273167|26317261|P3|Overall Study|Lost to Follow-up|1
7568433|NCT02273167|26317262|P2|Overall Study|Lost to Follow-up|1
7568434|NCT02273167|26317263|P1|Overall Study|Lost to Follow-up|0
7568435|NCT02273167|26317261|P3|Overall Study|Protocol Violation|1
7568436|NCT02273167|26317262|P2|Overall Study|Protocol Violation|1
7568437|NCT02273167|26317263|P1|Overall Study|Protocol Violation|3
7568438|NCT02273167|26317261|P3|Overall Study|Adverse Event|0
7568439|NCT02273167|26317262|P2|Overall Study|Adverse Event|0
7568440|NCT02273167|26317263|P1|Overall Study|Adverse Event|1
7568441|NCT02273141|26317288|P2|Overall Study|Various|6
7568442|NCT02273141|26317289|P1|Overall Study|Various|6
7568443|NCT02273141|26317288|P2|Overall Study|Withdrawal by Subject|15
7568444|NCT02273141|26317289|P1|Overall Study|Withdrawal by Subject|10
7568445|NCT02273141|26317288|P2|Overall Study|Lost to Follow-up|3
7568446|NCT02273141|26317289|P1|Overall Study|Lost to Follow-up|1
7568447|NCT02273141|26317288|P2|Overall Study|Adverse Event|1
7568448|NCT02273141|26317289|P1|Overall Study|Adverse Event|0
7568449|NCT02273050|26317362|P3|Overall Study|Protocol Violation|4
7568450|NCT02273050|26317363|P2|Overall Study|Protocol Violation|1
7568451|NCT02273050|26317364|P1|Overall Study|Protocol Violation|3
7568452|NCT02273050|26317362|P3|Overall Study|Lost to Follow-up|3
7568453|NCT02273050|26317363|P2|Overall Study|Lost to Follow-up|2
7568454|NCT02273050|26317364|P1|Overall Study|Lost to Follow-up|0
7568455|NCT02273050|26317362|P3|Overall Study|Withdrawal by Subject|16
7568456|NCT02273050|26317363|P2|Overall Study|Withdrawal by Subject|14
7568457|NCT02273050|26317364|P1|Overall Study|Withdrawal by Subject|17
7568458|NCT02273050|26317362|P3|Overall Study|Lack of Efficacy|1
7568459|NCT02273050|26317363|P2|Overall Study|Lack of Efficacy|1
7568460|NCT02273050|26317364|P1|Overall Study|Lack of Efficacy|0
7568461|NCT02273050|26317362|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
7568462|NCT02273050|26317363|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
7568463|NCT02273050|26317364|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
7568464|NCT02273050|26317362|P3|Overall Study|Death|1
7568465|NCT02273050|26317363|P2|Overall Study|Death|0
7568466|NCT02273050|26317364|P1|Overall Study|Death|0
7568467|NCT02273050|26317362|P3|Overall Study|Adverse Event|3
7568468|NCT02273050|26317363|P2|Overall Study|Adverse Event|3
7568469|NCT02273050|26317364|P1|Overall Study|Adverse Event|4
7568470|NCT02273037|26317392|P2|Overall Study|Other complication|0
7568471|NCT02273037|26317393|P1|Overall Study|Other complication|2
7568472|NCT02273037|26317392|P2|Overall Study|Multiple delivery|2
7568473|NCT02273037|26317393|P1|Overall Study|Multiple delivery|2
7568474|NCT02273037|26317392|P2|Overall Study|Breech delivery|3
7568475|NCT02273037|26317393|P1|Overall Study|Breech delivery|2
7568476|NCT02273037|26317392|P2|Overall Study|Delivered before monitoring initiated|3
7568477|NCT02273037|26317393|P1|Overall Study|Delivered before monitoring initiated|1
7568478|NCT02273037|26317392|P2|Overall Study|Lost to Follow-up|0
7568479|NCT02273037|26317393|P1|Overall Study|Lost to Follow-up|1
7568480|NCT02272985|26317403|P1|Overall Study|kidney transplantation|1
7568481|NCT02272985|26317403|P1|Overall Study|hip fracture|1
7568482|NCT02272985|26317403|P1|Overall Study|Withdrawal by Subject|1
7568483|NCT02272842|26317410|P2|Overall Study|Withdrawal by Subject|2
7568484|NCT02272842|26317411|P1|Overall Study|Withdrawal by Subject|8
7568485|NCT02272842|26317410|P2|Overall Study|Lost to Follow-up|8
7568486|NCT02272842|26317411|P1|Overall Study|Lost to Follow-up|8
7568487|NCT02272816|26317423|P1|Overall Study|Adverse Event|1
7568488|NCT02272803|26317431|P2|Overall Study|Withdrawal by Subject|0
7568489|NCT02272803|26317432|P1|Overall Study|Withdrawal by Subject|1
7568490|NCT02272803|26317431|P2|Overall Study|Poor/non-compliance|1
7568491|NCT02272803|26317432|P1|Overall Study|Poor/non-compliance|0
7568492|NCT02272803|26317431|P2|Overall Study|Subject moved to care facility|1
7568493|NCT02272803|26317432|P1|Overall Study|Subject moved to care facility|0
7568494|NCT02272803|26317431|P2|Overall Study|Maximum clinical benefit|1
7568495|NCT02272803|26317432|P1|Overall Study|Maximum clinical benefit|1
7568496|NCT02272803|26317431|P2|Overall Study|Subj request to discontinue study trt|4
7568497|NCT02272803|26317432|P1|Overall Study|Subj request to discontinue study trt|1
7568498|NCT02272803|26317431|P2|Overall Study|Study drug toxicity|4
7568499|NCT02272803|26317432|P1|Overall Study|Study drug toxicity|1
7568500|NCT02272803|26317431|P2|Overall Study|Adverse Event unrelated to study drug|4
7568501|NCT02272803|26317432|P1|Overall Study|Adverse Event unrelated to study drug|1
7568502|NCT02272803|26317431|P2|Overall Study|Disease progression|2
7568503|NCT02272803|26317432|P1|Overall Study|Disease progression|4
7568504|NCT02272790|26317449|P6|Overall Study|Physician Decision|0
7568505|NCT02272790|26317450|P5|Overall Study|Physician Decision|0
7568506|NCT02272790|26317451|P4|Overall Study|Physician Decision|0
7568507|NCT02272790|26317452|P3|Overall Study|Physician Decision|0
7568508|NCT02272790|26317453|P2|Overall Study|Physician Decision|1
7568509|NCT02272790|26317454|P1|Overall Study|Physician Decision|0
7568510|NCT02272777|26317590|P2|Overall Study|Other|0
7568511|NCT02272777|26317591|P1|Overall Study|Other|2
7568512|NCT02272777|26317590|P2|Overall Study|Lost to Follow-up|0
7568513|NCT02272777|26317591|P1|Overall Study|Lost to Follow-up|2
7568514|NCT02272777|26317590|P2|Overall Study|Withdrawal by Subject|3
7568515|NCT02272777|26317591|P1|Overall Study|Withdrawal by Subject|0
7568516|NCT02272777|26317590|P2|Overall Study|Adverse Event|1
7568517|NCT02272777|26317591|P1|Overall Study|Adverse Event|0
7568518|NCT02272725|26317599|P2|Overall Study|equipment malfunction|0
7568519|NCT02272725|26317600|P1|Overall Study|equipment malfunction|2
7568520|NCT02272634|26317618|P3|Overall Study|Withdrawal by Subject|0
7568521|NCT02272634|26317619|P2|Overall Study|Withdrawal by Subject|1
7568522|NCT02272634|26317620|P1|Overall Study|Withdrawal by Subject|0
7568523|NCT02272634|26317618|P3|Overall Study|Protocol Violation|1
7568524|NCT02272634|26317619|P2|Overall Study|Protocol Violation|0
7568525|NCT02272634|26317620|P1|Overall Study|Protocol Violation|0
7568526|NCT02272634|26317618|P3|Overall Study|Adverse Event|0
7568527|NCT02272634|26317619|P2|Overall Study|Adverse Event|0
7568528|NCT02272634|26317620|P1|Overall Study|Adverse Event|1
7568529|NCT02272413|26317684|P2|Post-switch Period|Other than listed|5
7568530|NCT02272413|26317685|P1|Post-switch Period|Other than listed|4
7568531|NCT02272413|26317684|P2|Post-switch Period|Study terminated by sponsor|11
7568532|NCT02272413|26317685|P1|Post-switch Period|Study terminated by sponsor|8
7568533|NCT02272413|26317684|P2|Post-switch Period|Progressive disease|21
7568534|NCT02272413|26317685|P1|Post-switch Period|Progressive disease|21
7568535|NCT02272413|26317684|P2|Post-switch Period|Physician Decision|1
7568536|NCT02272413|26317685|P1|Post-switch Period|Physician Decision|1
7568537|NCT02272413|26317684|P2|Post-switch Period|Withdrawal by Subject|2
7568538|NCT02272413|26317685|P1|Post-switch Period|Withdrawal by Subject|1
7568539|NCT02272413|26317684|P2|Post-switch Period|Death|2
7568540|NCT02272413|26317685|P1|Post-switch Period|Death|3
7568541|NCT02272413|26317684|P2|Post-switch Period|Adverse Event|4
7568542|NCT02272413|26317685|P1|Post-switch Period|Adverse Event|4
7568543|NCT02272413|26317684|P2|Pre-switch Period|Other than listed|11
7568544|NCT02272413|26317685|P1|Pre-switch Period|Other than listed|10
7568545|NCT02272413|26317684|P2|Pre-switch Period|Protocol Violation|0
7568546|NCT02272413|26317685|P1|Pre-switch Period|Protocol Violation|1
7568547|NCT02272413|26317684|P2|Pre-switch Period|Lost to Follow-up|2
7568548|NCT02272413|26317685|P1|Pre-switch Period|Lost to Follow-up|0
7568549|NCT02272413|26317684|P2|Pre-switch Period|Progressive disease|173
7568550|NCT02272413|26317685|P1|Pre-switch Period|Progressive disease|185
7568551|NCT02272413|26317684|P2|Pre-switch Period|Physician Decision|18
7568552|NCT02272413|26317685|P1|Pre-switch Period|Physician Decision|6
7568553|NCT02272413|26317684|P2|Pre-switch Period|Withdrawal by Subject|15
7568554|NCT02272413|26317685|P1|Pre-switch Period|Withdrawal by Subject|27
7568555|NCT02272413|26317684|P2|Pre-switch Period|Death|26
7568556|NCT02272413|26317685|P1|Pre-switch Period|Death|26
7568557|NCT02272413|26317684|P2|Pre-switch Period|Adverse Event|37
7568558|NCT02272413|26317685|P1|Pre-switch Period|Adverse Event|38
7568559|NCT02272413|26317684|P2|Randomized Through Treatment Start|Not treated|5
7568560|NCT02272413|26317685|P1|Randomized Through Treatment Start|Not treated|3
7568561|NCT02271984|26317716|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568562|NCT02271984|26317717|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568563|NCT02271984|26317718|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568564|NCT02271984|26317719|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568565|NCT02271984|26317720|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7568566|NCT02271984|26317721|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568567|NCT02271984|26317722|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7568568|NCT02271984|26317723|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568569|NCT02271984|26317724|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568570|NCT02271984|26317725|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568571|NCT02271984|26317726|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568572|NCT02271984|26317727|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7568573|NCT02271945|26317816|P2|Overall Study|Other|1
7568574|NCT02271945|26317817|P1|Overall Study|Other|1
7568575|NCT02271945|26317816|P2|Overall Study|Withdrawal by Subject|1
7568576|NCT02271945|26317817|P1|Overall Study|Withdrawal by Subject|1
7568577|NCT02271945|26317816|P2|Overall Study|Death|3
7568578|NCT02271945|26317817|P1|Overall Study|Death|3
7568579|NCT02271880|26317860|P2|Overall Study|Premature discontinuation of study|4
7568580|NCT02271880|26317861|P1|Overall Study|Premature discontinuation of study|3
7568581|NCT02271854|26317891|P1|Overall Study|Lost to Follow-up|1
7568582|NCT02271854|26317891|P1|Overall Study|Unable or unwilling to cooperate with st|1
7568583|NCT02271854|26317891|P1|Overall Study|Withdrawal by Subject|2
7568584|NCT02271594|26317933|P2|Overall Study|Study closed; recruiting failure|12
7568585|NCT02271594|26317934|P1|Overall Study|Study closed; recruiting failure|19
7568586|NCT02271529|26317948|P1|Overall Study|Withdrawal by Subject|1
7568587|NCT02270983|26318069|P3|Overall Study|moved away from study site|0
7568588|NCT02270983|26318070|P2|Overall Study|moved away from study site|1
7568589|NCT02270983|26318071|P1|Overall Study|moved away from study site|0
7568590|NCT02270983|26318069|P3|Overall Study|study procedure non-compliance|0
7568591|NCT02270983|26318070|P2|Overall Study|study procedure non-compliance|0
7568592|NCT02270983|26318071|P1|Overall Study|study procedure non-compliance|1
7568593|NCT02270983|26318069|P3|Overall Study|family emergency|0
7568594|NCT02270983|26318070|P2|Overall Study|family emergency|1
7568595|NCT02270983|26318071|P1|Overall Study|family emergency|0
7568596|NCT02270983|26318069|P3|Overall Study|Protocol Violation|1
7568597|NCT02270983|26318070|P2|Overall Study|Protocol Violation|1
7568598|NCT02270983|26318071|P1|Overall Study|Protocol Violation|1
7568599|NCT02270983|26318069|P3|Overall Study|Lost to Follow-up|2
7568600|NCT02270983|26318070|P2|Overall Study|Lost to Follow-up|1
7568601|NCT02270983|26318071|P1|Overall Study|Lost to Follow-up|1
7568602|NCT02270983|26318069|P3|Overall Study|Withdrawal by Subject|2
7568603|NCT02270983|26318070|P2|Overall Study|Withdrawal by Subject|0
7568604|NCT02270983|26318071|P1|Overall Study|Withdrawal by Subject|1
7568605|NCT02270983|26318069|P3|Overall Study|Lack of Efficacy|1
7568606|NCT02270983|26318070|P2|Overall Study|Lack of Efficacy|1
7568607|NCT02270983|26318071|P1|Overall Study|Lack of Efficacy|2
7568608|NCT02270983|26318069|P3|Overall Study|Adverse Event|6
7568609|NCT02270983|26318070|P2|Overall Study|Adverse Event|2
7568610|NCT02270983|26318071|P1|Overall Study|Adverse Event|3
7568611|NCT02270957|26318096|P2|Overall Study|Adverse Event|0
7568612|NCT02270957|26318097|P1|Overall Study|Adverse Event|2
7568613|NCT02270957|26318096|P2|Overall Study|Lack of Efficacy|4
7568614|NCT02270957|26318097|P1|Overall Study|Lack of Efficacy|2
7568615|NCT02270944|26318109|P2|Overall Study|Withdrawal by Subject|1
7568616|NCT02270944|26318110|P1|Overall Study|Withdrawal by Subject|2
7568617|NCT02270944|26318109|P2|Overall Study|Lost to Follow-up|4
7568618|NCT02270944|26318110|P1|Overall Study|Lost to Follow-up|9
7568619|NCT02270736|26318129|P5|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7568620|NCT02270736|26318130|P4|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
7568621|NCT02270736|26318131|P3|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7568622|NCT02270736|26318132|P2|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7568623|NCT02270736|26318133|P1|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7568624|NCT02270736|26318129|P5|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7568625|NCT02270736|26318130|P4|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
7568626|NCT02270736|26318131|P3|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7568627|NCT02270736|26318132|P2|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7568628|NCT02270736|26318133|P1|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7568629|NCT02270736|26318129|P5|OLEX Period (up to 48 Weeks)|Adverse Event|0
7568630|NCT02270736|26318130|P4|OLEX Period (up to 48 Weeks)|Adverse Event|4
7568631|NCT02270736|26318131|P3|OLEX Period (up to 48 Weeks)|Adverse Event|0
7568632|NCT02270736|26318132|P2|OLEX Period (up to 48 Weeks)|Adverse Event|0
7568633|NCT02270736|26318133|P1|OLEX Period (up to 48 Weeks)|Adverse Event|0
7568634|NCT02270736|26318129|P5|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7568635|NCT02270736|26318130|P4|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
7568636|NCT02270736|26318131|P3|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7568637|NCT02270736|26318132|P2|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7568638|NCT02270736|26318133|P1|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7568639|NCT02270736|26318129|P5|OLEX Period (up to 48 Weeks)|Physician Decision|0
7568640|NCT02270736|26318130|P4|OLEX Period (up to 48 Weeks)|Physician Decision|1
7568641|NCT02270736|26318131|P3|OLEX Period (up to 48 Weeks)|Physician Decision|0
7568642|NCT02270736|26318132|P2|OLEX Period (up to 48 Weeks)|Physician Decision|0
7568643|NCT02270736|26318133|P1|OLEX Period (up to 48 Weeks)|Physician Decision|0
7568644|NCT02270736|26318129|P5|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7568645|NCT02270736|26318130|P4|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7568646|NCT02270736|26318131|P3|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
7568647|NCT02270736|26318132|P2|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7568648|NCT02270736|26318133|P1|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7568649|NCT02270736|26318129|P5|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7568650|NCT02270736|26318130|P4|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7568651|NCT02270736|26318131|P3|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7568652|NCT02270736|26318132|P2|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
7568653|NCT02270736|26318133|P1|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7568654|NCT02270736|26318129|P5|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7568655|NCT02270736|26318130|P4|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7568656|NCT02270736|26318131|P3|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
7568657|NCT02270736|26318132|P2|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7568658|NCT02270736|26318133|P1|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
7568659|NCT02270736|26318129|P5|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7568660|NCT02270736|26318130|P4|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7568661|NCT02270736|26318131|P3|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7568662|NCT02270736|26318132|P2|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
7568663|NCT02270736|26318133|P1|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7568664|NCT02270684|26318175|P2|Overall Study|Study terminated|0
7568665|NCT02270684|26318176|P1|Overall Study|Study terminated|1
7568666|NCT02270684|26318175|P2|Overall Study|Lost to Follow-up|3
7568667|NCT02270684|26318176|P1|Overall Study|Lost to Follow-up|0
7568668|NCT02270671|26318184|P2|Overall Study|Lost to Follow-up|1
7568669|NCT02270671|26318185|P1|Overall Study|Lost to Follow-up|2
7568670|NCT02270671|26318184|P2|Overall Study|Missed Post-intervention Data Collection|2
7568671|NCT02270671|26318185|P1|Overall Study|Missed Post-intervention Data Collection|2
7568672|NCT02270671|26318184|P2|Overall Study|Protocol Violation|1
7568673|NCT02270671|26318185|P1|Overall Study|Protocol Violation|0
7568674|NCT02270671|26318184|P2|Overall Study|Withdrawal by Subject|1
7568675|NCT02270671|26318185|P1|Overall Study|Withdrawal by Subject|1
7568676|NCT02270515|26318210|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
7568677|NCT02270515|26318210|P1|Intervention Period 3: 12-18 Months|Death|3
7568678|NCT02270515|26318210|P1|Intervention Period 3: 12-18 Months|Received transplant|2
7568679|NCT02270515|26318210|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
7568680|NCT02270515|26318210|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
7568681|NCT02270515|26318210|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
7568682|NCT02270515|26318210|P1|Intervention Period 2: 6-12 Months|Death|5
7568683|NCT02270515|26318210|P1|Intervention Period 2: 6-12 Months|Received transplant|1
7568684|NCT02270515|26318210|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
7568685|NCT02270515|26318210|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
7568686|NCT02270515|26318210|P1|Intervention Period 1: 0-6 Months|Death|7
7568687|NCT02270515|26318210|P1|Intervention Period 1: 0-6 Months|Received transplant|3
7568688|NCT02270515|26318210|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
7568689|NCT02270515|26318210|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
7568690|NCT02270242|26318238|P2|Overall Study|Physician Decision|1
7568691|NCT02270242|26318239|P1|Overall Study|Physician Decision|0
7568692|NCT02270242|26318238|P2|Overall Study|Lost to Follow-up|27
7568693|NCT02270242|26318239|P1|Overall Study|Lost to Follow-up|41
7568694|NCT02270242|26318238|P2|Overall Study|Withdrawal by Subject|25
7568695|NCT02270242|26318239|P1|Overall Study|Withdrawal by Subject|18
7568696|NCT02269943|26318280|P2|Follow-Up Survival Period|Alive|8
7568697|NCT02269943|26318281|P1|Follow-Up Survival Period|Alive|2
7568698|NCT02269943|26318280|P2|Follow-Up Survival Period|Lost to Follow-up|2
7568699|NCT02269943|26318281|P1|Follow-Up Survival Period|Lost to Follow-up|0
7568700|NCT02269943|26318280|P2|Follow-Up Survival Period|Death|16
7568701|NCT02269943|26318281|P1|Follow-Up Survival Period|Death|3
7568702|NCT02269943|26318280|P2|Treatment Period|Symptomatic Deterioration|2
7568703|NCT02269943|26318281|P1|Treatment Period|Symptomatic Deterioration|0
7568704|NCT02269943|26318280|P2|Treatment Period|Progressive Disease|17
7568705|NCT02269943|26318281|P1|Treatment Period|Progressive Disease|5
7568706|NCT02269943|26318280|P2|Treatment Period|Adverse Event|10
7568707|NCT02269943|26318281|P1|Treatment Period|Adverse Event|1
7568708|NCT02269943|26318280|P2|Treatment Period|Death|1
7568709|NCT02269943|26318281|P1|Treatment Period|Death|0
7568710|NCT02269917|26318311|P2|Overall Study|Randomized but not treated|5
7568711|NCT02269917|26318312|P1|Overall Study|Randomized but not treated|3
7568712|NCT02269917|26318311|P2|Overall Study|Non-compliance with study drug|0
7568713|NCT02269917|26318312|P1|Overall Study|Non-compliance with study drug|2
7568714|NCT02269917|26318311|P2|Overall Study|Adverse Event|4
7568715|NCT02269917|26318312|P1|Overall Study|Adverse Event|11
7568716|NCT02269917|26318311|P2|Overall Study|Withdrawal by Subject|8
7568717|NCT02269917|26318312|P1|Overall Study|Withdrawal by Subject|9
7568718|NCT02269917|26318311|P2|Overall Study|Other|3
7568719|NCT02269917|26318312|P1|Overall Study|Other|6
7568720|NCT02269917|26318311|P2|Overall Study|Ongoing|360
7568721|NCT02269917|26318312|P1|Overall Study|Ongoing|731
7568722|NCT02269917|26318311|P2|Overall Study|Lost to Follow-up|3
7568723|NCT02269917|26318312|P1|Overall Study|Lost to Follow-up|4
7568724|NCT02269787|26318365|P2|Overall Study|Incapacitated|1
7568725|NCT02269787|26318366|P1|Overall Study|Incapacitated|0
7568726|NCT02269787|26318365|P2|Overall Study|Death|3
7568727|NCT02269787|26318366|P1|Overall Study|Death|2
7568728|NCT02269787|26318365|P2|Overall Study|Lost to Follow-up|6
7568729|NCT02269787|26318366|P1|Overall Study|Lost to Follow-up|20
7568730|NCT02269709|26318372|P1|Six Month Follow-up|Lost to Follow-up|12
7568731|NCT02269709|26318372|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
7568732|NCT02269709|26318372|P1|Time of Enrollment|Withdrawal by Subject|3
7568733|NCT02269657|26318377|P1|Overall Study|Protocol Violation|3
7568734|NCT02269475|26318414|P2|Overall Study|Withdrawal by Subject|1
7568735|NCT02269475|26318415|P1|Overall Study|Withdrawal by Subject|0
7568736|NCT02269475|26318414|P2|Overall Study|Meet Exclusion Criteria No. 17|0
7568737|NCT02269475|26318415|P1|Overall Study|Meet Exclusion Criteria No. 17|3
7568738|NCT02269423|26318430|P4|Overall Study|Discontinued due to change in residence|1
7568739|NCT02269423|26318431|P3|Overall Study|Discontinued due to change in residence|0
7568740|NCT02269423|26318432|P2|Overall Study|Discontinued due to change in residence|1
7568741|NCT02269423|26318433|P1|Overall Study|Discontinued due to change in residence|0
7568742|NCT02269241|26318495|P1|Overall Study|Screening failures|546
7568743|NCT02269241|26318495|P1|Overall Study|Several reasons not classified|53
7568744|NCT02269241|26318495|P1|Overall Study|At the specific request of the sponsor|20
7568745|NCT02269241|26318495|P1|Overall Study|Adverse Event|113
7568746|NCT02269241|26318495|P1|Overall Study|Development of an exclusion criteria|16
7568747|NCT02269241|26318495|P1|Overall Study|Wish for pregnancy|5
7568748|NCT02269241|26318495|P1|Overall Study|Pregnancy|15
7568749|NCT02269241|26318495|P1|Overall Study|Physician Decision|7
7568750|NCT02269241|26318495|P1|Overall Study|Protocol Violation|1
7568751|NCT02269241|26318495|P1|Overall Study|Withdrawal by Subject|155
7568752|NCT02269241|26318495|P1|Overall Study|Lost to Follow-up|269
7568753|NCT02269163|26318509|P2|Overall Study|Physician Decision|1
7568754|NCT02269163|26318510|P1|Overall Study|Physician Decision|0
7568755|NCT02269163|26318509|P2|Overall Study|Withdrawal by Subject|3
7568756|NCT02269163|26318510|P1|Overall Study|Withdrawal by Subject|0
7568757|NCT02269163|26318509|P2|Overall Study|Other|2
7568758|NCT02269163|26318510|P1|Overall Study|Other|2
7568759|NCT02269163|26318509|P2|Overall Study|Major protocol violation|1
7568760|NCT02269163|26318510|P1|Overall Study|Major protocol violation|0
7568761|NCT02269163|26318509|P2|Overall Study|Lost to Follow-up|0
7568762|NCT02269163|26318510|P1|Overall Study|Lost to Follow-up|1
7568763|NCT02269124|26318524|P2|Overall Study|Withdrawal by Subject|2
7568764|NCT02269124|26318525|P1|Overall Study|Withdrawal by Subject|0
7568765|NCT02269124|26318524|P2|Overall Study|Lost to Follow-up|0
7568766|NCT02269124|26318525|P1|Overall Study|Lost to Follow-up|1
7568767|NCT02269098|26318541|P2|Overall Study|Lost to Follow-up|9
7568768|NCT02269098|26318542|P1|Overall Study|Lost to Follow-up|14
7568769|NCT02268864|26318603|P3|Overall Study|Death|0
7568770|NCT02268864|26318604|P2|Overall Study|Death|1
7568771|NCT02268864|26318605|P1|Overall Study|Death|0
7568772|NCT02268864|26318603|P3|Overall Study|Withdrawal by Subject|0
7568773|NCT02268864|26318604|P2|Overall Study|Withdrawal by Subject|0
7568774|NCT02268864|26318605|P1|Overall Study|Withdrawal by Subject|2
7568775|NCT02268851|26318633|P6|Overall Study|Co-Morbid Condition|1
7568776|NCT02268851|26318634|P5|Overall Study|Co-Morbid Condition|1
7568777|NCT02268851|26318635|P4|Overall Study|Co-Morbid Condition|0
7568778|NCT02268851|26318636|P3|Overall Study|Co-Morbid Condition|0
7568779|NCT02268851|26318637|P2|Overall Study|Co-Morbid Condition|0
7568780|NCT02268851|26318638|P1|Overall Study|Co-Morbid Condition|0
7568781|NCT02268851|26318633|P6|Overall Study|Patient Compliance|1
7568782|NCT02268851|26318634|P5|Overall Study|Patient Compliance|1
7568783|NCT02268851|26318635|P4|Overall Study|Patient Compliance|0
7568784|NCT02268851|26318636|P3|Overall Study|Patient Compliance|0
7568785|NCT02268851|26318637|P2|Overall Study|Patient Compliance|0
7568786|NCT02268851|26318638|P1|Overall Study|Patient Compliance|0
7568787|NCT02268851|26318633|P6|Overall Study|Physician Decision|1
7568788|NCT02268851|26318634|P5|Overall Study|Physician Decision|0
7568789|NCT02268851|26318635|P4|Overall Study|Physician Decision|0
7568790|NCT02268851|26318636|P3|Overall Study|Physician Decision|1
7568791|NCT02268851|26318637|P2|Overall Study|Physician Decision|0
7568792|NCT02268851|26318638|P1|Overall Study|Physician Decision|0
7568793|NCT02268851|26318633|P6|Overall Study|Progressive Disease|4
7568794|NCT02268851|26318634|P5|Overall Study|Progressive Disease|1
7568795|NCT02268851|26318635|P4|Overall Study|Progressive Disease|0
7568796|NCT02268851|26318636|P3|Overall Study|Progressive Disease|0
7568797|NCT02268851|26318637|P2|Overall Study|Progressive Disease|3
7568798|NCT02268851|26318638|P1|Overall Study|Progressive Disease|1
7568799|NCT02268851|26318633|P6|Overall Study|Withdrawal by Subject|1
7568800|NCT02268851|26318634|P5|Overall Study|Withdrawal by Subject|0
7568801|NCT02268851|26318635|P4|Overall Study|Withdrawal by Subject|2
7568802|NCT02268851|26318636|P3|Overall Study|Withdrawal by Subject|0
7568803|NCT02268851|26318637|P2|Overall Study|Withdrawal by Subject|0
7568804|NCT02268851|26318638|P1|Overall Study|Withdrawal by Subject|0
7568805|NCT02268851|26318633|P6|Overall Study|Adverse Event|2
7568806|NCT02268851|26318634|P5|Overall Study|Adverse Event|2
7568807|NCT02268851|26318635|P4|Overall Study|Adverse Event|0
7568808|NCT02268851|26318636|P3|Overall Study|Adverse Event|0
7568809|NCT02268851|26318637|P2|Overall Study|Adverse Event|0
7568810|NCT02268851|26318638|P1|Overall Study|Adverse Event|0
7568811|NCT02268851|26318633|P6|Overall Study|Death|1
7568812|NCT02268851|26318634|P5|Overall Study|Death|2
7568813|NCT02268851|26318635|P4|Overall Study|Death|1
7568814|NCT02268851|26318636|P3|Overall Study|Death|0
7568815|NCT02268851|26318637|P2|Overall Study|Death|0
7568816|NCT02268851|26318638|P1|Overall Study|Death|0
7568817|NCT02268812|26318656|P4|Overall Study|Other|3
7568818|NCT02268812|26318657|P3|Overall Study|Other|1
7568819|NCT02268812|26318658|P2|Overall Study|Other|4
7568820|NCT02268812|26318659|P1|Overall Study|Other|5
7568821|NCT02268812|26318656|P4|Overall Study|Physician Decision|1
7568822|NCT02268812|26318657|P3|Overall Study|Physician Decision|0
7568823|NCT02268812|26318658|P2|Overall Study|Physician Decision|1
7568824|NCT02268812|26318659|P1|Overall Study|Physician Decision|3
7568825|NCT02268812|26318656|P4|Overall Study|Withdrawal by Subject|0
7568826|NCT02268812|26318657|P3|Overall Study|Withdrawal by Subject|0
7568827|NCT02268812|26318658|P2|Overall Study|Withdrawal by Subject|1
7568828|NCT02268812|26318659|P1|Overall Study|Withdrawal by Subject|0
7568829|NCT02268812|26318656|P4|Overall Study|Protocol deviation|0
7568830|NCT02268812|26318657|P3|Overall Study|Protocol deviation|1
7568831|NCT02268812|26318658|P2|Overall Study|Protocol deviation|0
7568832|NCT02268812|26318659|P1|Overall Study|Protocol deviation|0
7568833|NCT02268812|26318656|P4|Overall Study|Adverse Event|10
7568834|NCT02268812|26318657|P3|Overall Study|Adverse Event|7
7568835|NCT02268812|26318658|P2|Overall Study|Adverse Event|26
7568836|NCT02268812|26318659|P1|Overall Study|Adverse Event|8
7568837|NCT02268786|26318691|P2|Overall Study|Protocol Violation|0
7568838|NCT02268786|26318692|P1|Overall Study|Protocol Violation|1
7568839|NCT02268786|26318691|P2|Overall Study|Thaw Failure|4
7568840|NCT02268786|26318692|P1|Overall Study|Thaw Failure|6
7568841|NCT02268786|26318691|P2|Overall Study|Withdrawal by Subject|14
7568842|NCT02268786|26318692|P1|Overall Study|Withdrawal by Subject|7
7568843|NCT02268786|26318691|P2|Overall Study|No Euploid Embryos available|0
7568844|NCT02268786|26318692|P1|Overall Study|No Euploid Embryos available|42
7568845|NCT02268526|26318701|P3|Overall Study|Subject/guardian decision|3
7568846|NCT02268526|26318702|P2|Overall Study|Subject/guardian decision|7
7568847|NCT02268526|26318703|P1|Overall Study|Subject/guardian decision|0
7568848|NCT02268526|26318701|P3|Overall Study|Physician Decision|1
7568849|NCT02268526|26318702|P2|Overall Study|Physician Decision|0
7568850|NCT02268526|26318703|P1|Overall Study|Physician Decision|0
7568851|NCT02268526|26318701|P3|Overall Study|protocol deviation|0
7568852|NCT02268526|26318702|P2|Overall Study|protocol deviation|1
7568853|NCT02268526|26318703|P1|Overall Study|protocol deviation|0
7568854|NCT02268526|26318701|P3|Overall Study|Death|0
7568855|NCT02268526|26318702|P2|Overall Study|Death|11
7568856|NCT02268526|26318703|P1|Overall Study|Death|1
7568857|NCT02268526|26318701|P3|Overall Study|Adverse Event|1
7568858|NCT02268526|26318702|P2|Overall Study|Adverse Event|2
7568859|NCT02268526|26318703|P1|Overall Study|Adverse Event|0
7568860|NCT02268396|26318741|P1|Overall Study|2 Subjects no Day 29 Assessment|2
7568861|NCT02268396|26318741|P1|Overall Study|Protocol-Specified Criteria|2
7568862|NCT02268396|26318741|P1|Overall Study|Lost to Follow-up|2
7568863|NCT02268396|26318741|P1|Overall Study|Withdrawal by Subject|1
7568864|NCT02268396|26318741|P1|Overall Study|Administrative|2
7568865|NCT02268396|26318741|P1|Overall Study|Adverse Event|3
7568866|NCT02268214|26318753|P3|Overall Study|Not entering long-term period|5
7568867|NCT02268214|26318754|P2|Overall Study|Not entering long-term period|3
7568868|NCT02268214|26318755|P1|Overall Study|Not entering long-term period|2
7568869|NCT02268214|26318753|P3|Overall Study|Other reasons|3
7568870|NCT02268214|26318754|P2|Overall Study|Other reasons|3
7568871|NCT02268214|26318755|P1|Overall Study|Other reasons|7
7568872|NCT02268214|26318753|P3|Overall Study|Poor/non-compliance|2
7568873|NCT02268214|26318754|P2|Overall Study|Poor/non-compliance|1
7568874|NCT02268214|26318755|P1|Overall Study|Poor/non-compliance|2
7568875|NCT02268214|26318753|P3|Overall Study|Subject request to discontinue treatment|6
7568876|NCT02268214|26318754|P2|Overall Study|Subject request to discontinue treatment|8
7568877|NCT02268214|26318755|P1|Overall Study|Subject request to discontinue treatment|10
7568878|NCT02268214|26318753|P3|Overall Study|Withdrawal by Subject|10
7568879|NCT02268214|26318754|P2|Overall Study|Withdrawal by Subject|5
7568880|NCT02268214|26318755|P1|Overall Study|Withdrawal by Subject|4
7568881|NCT02268214|26318753|P3|Overall Study|Adverse Event|9
7568882|NCT02268214|26318754|P2|Overall Study|Adverse Event|14
7568883|NCT02268214|26318755|P1|Overall Study|Adverse Event|11
7568884|NCT02268214|26318753|P3|Overall Study|Lack of Efficacy|2
7568885|NCT02268214|26318754|P2|Overall Study|Lack of Efficacy|0
7568886|NCT02268214|26318755|P1|Overall Study|Lack of Efficacy|1
7568887|NCT02268214|26318753|P3|Overall Study|Lost to Follow-up|4
7568888|NCT02268214|26318754|P2|Overall Study|Lost to Follow-up|3
7568889|NCT02268214|26318755|P1|Overall Study|Lost to Follow-up|3
7568890|NCT02268214|26318753|P3|Overall Study|Pregnancy|1
7568891|NCT02268214|26318754|P2|Overall Study|Pregnancy|2
7568892|NCT02268214|26318755|P1|Overall Study|Pregnancy|2
7568893|NCT02268214|26318753|P3|Overall Study|Subject no longer meets study criteria|0
7568894|NCT02268214|26318754|P2|Overall Study|Subject no longer meets study criteria|2
7568895|NCT02268214|26318755|P1|Overall Study|Subject no longer meets study criteria|0
7568896|NCT02268084|26318800|P2|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
7568897|NCT02268084|26318801|P1|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
7568898|NCT02268084|26318800|P2|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
7568899|NCT02268084|26318801|P1|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
7568900|NCT02268058|26318825|P4|Overall Study|Protocol Violation|0
7568901|NCT02268058|26318826|P3|Overall Study|Protocol Violation|0
7568902|NCT02268058|26318827|P2|Overall Study|Protocol Violation|0
7568903|NCT02268058|26318828|P1|Overall Study|Protocol Violation|1
7568904|NCT02268045|26318852|P2|Overall Study|Protocol Violation|1
7568905|NCT02268045|26318853|P1|Overall Study|Protocol Violation|1
7568906|NCT02268045|26318852|P2|Overall Study|Physician Decision|1
7568907|NCT02268045|26318853|P1|Overall Study|Physician Decision|0
7568908|NCT02268045|26318852|P2|Overall Study|Withdrawal by Subject|6
7568909|NCT02268045|26318853|P1|Overall Study|Withdrawal by Subject|2
7568910|NCT02268045|26318852|P2|Overall Study|Adverse Event|7
7568911|NCT02268045|26318853|P1|Overall Study|Adverse Event|7
7568912|NCT02268045|26318852|P2|Overall Study|Disease Progression|1
7568913|NCT02268045|26318853|P1|Overall Study|Disease Progression|2
7568914|NCT02268045|26318852|P2|Overall Study|Death|4
7568915|NCT02268045|26318853|P1|Overall Study|Death|4
7568916|NCT02267824|26318895|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
7568917|NCT02267824|26318896|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
7568918|NCT02267824|26318895|P2|Overall Study|Protocol Violation|0
7568919|NCT02267824|26318896|P1|Overall Study|Protocol Violation|3
7568920|NCT02267824|26318895|P2|Overall Study|Lost to Follow-up|0
7568921|NCT02267824|26318896|P1|Overall Study|Lost to Follow-up|4
7568922|NCT02267824|26318895|P2|Overall Study|Pregnancy|1
7568923|NCT02267824|26318896|P1|Overall Study|Pregnancy|1
7568924|NCT02267746|26318941|P3|Overall Study|Miscellaneous|1
7568925|NCT02267746|26318942|P2|Overall Study|Miscellaneous|0
7568926|NCT02267746|26318943|P1|Overall Study|Miscellaneous|1
7568927|NCT02267746|26318941|P3|Overall Study|Protocol Violation|1
7568928|NCT02267746|26318942|P2|Overall Study|Protocol Violation|2
7568929|NCT02267746|26318943|P1|Overall Study|Protocol Violation|1
7568930|NCT02267746|26318941|P3|Overall Study|Lack of Efficacy|15
7568931|NCT02267746|26318942|P2|Overall Study|Lack of Efficacy|11
7568932|NCT02267746|26318943|P1|Overall Study|Lack of Efficacy|11
7568933|NCT02267746|26318941|P3|Overall Study|Protocol Violation|3
7568934|NCT02267746|26318942|P2|Overall Study|Protocol Violation|7
7568935|NCT02267746|26318943|P1|Overall Study|Protocol Violation|8
7568936|NCT02267746|26318941|P3|Overall Study|Adverse Event|1
7568937|NCT02267746|26318942|P2|Overall Study|Adverse Event|2
7568938|NCT02267746|26318943|P1|Overall Study|Adverse Event|0
7568939|NCT02267317|26319053|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7568940|NCT02267317|26319054|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7568941|NCT02267317|26319055|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7568942|NCT02267317|26319056|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7568943|NCT02267317|26319057|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7568944|NCT02267317|26319058|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
7568945|NCT02267317|26319053|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7568946|NCT02267317|26319054|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7568947|NCT02267317|26319055|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7568948|NCT02267317|26319056|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7568949|NCT02267317|26319057|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7568950|NCT02267317|26319058|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
7568951|NCT02267278|26319108|P1|Overall Study|prescribed prohibited medication|1
7568952|NCT02267278|26319108|P1|Overall Study|Developed new cancer diagnoses|2
7568953|NCT02267278|26319108|P1|Overall Study|transformation to acute leukemia (AML)|1
7568954|NCT02267278|26319108|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
7568955|NCT02267187|26319132|P1|Overall Study|Screen fail|3
7568956|NCT02267187|26319132|P1|Overall Study|Physician Decision|2
7568957|NCT02267135|26319140|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
7568958|NCT02267135|26319141|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
7568959|NCT02267135|26319140|P2|Period 2 (Randomized Set)|Adverse Event|0
7568960|NCT02267135|26319141|P1|Period 2 (Randomized Set)|Adverse Event|2
7568961|NCT02267135|26319140|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
7568962|NCT02267135|26319141|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
7568963|NCT02267135|26319140|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
7568964|NCT02267135|26319141|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
7568965|NCT02267135|26319140|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
7568966|NCT02267135|26319141|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
7568995|NCT02266875|26319222|P2|Overall Study|Lost to Follow-up|0
7568996|NCT02266875|26319223|P1|Overall Study|Lost to Follow-up|2
7568997|NCT02266875|26319222|P2|Overall Study|Withdrawal by Subject|0
7568998|NCT02266875|26319223|P1|Overall Study|Withdrawal by Subject|9
7568999|NCT02266706|26319288|P9|Overall Study|Enrollment in another study|0
7569000|NCT02266706|26319289|P8|Overall Study|Enrollment in another study|0
7569001|NCT02266706|26319290|P7|Overall Study|Enrollment in another study|0
7569002|NCT02266706|26319291|P6|Overall Study|Enrollment in another study|0
7569003|NCT02266706|26319292|P5|Overall Study|Enrollment in another study|0
7569004|NCT02266706|26319293|P4|Overall Study|Enrollment in another study|1
7569005|NCT02266706|26319294|P3|Overall Study|Enrollment in another study|0
7569006|NCT02266706|26319295|P2|Overall Study|Enrollment in another study|0
7569007|NCT02266706|26319296|P1|Overall Study|Enrollment in another study|0
7569008|NCT02266706|26319288|P9|Overall Study|Screen failure|0
7569009|NCT02266706|26319289|P8|Overall Study|Screen failure|0
7569010|NCT02266706|26319290|P7|Overall Study|Screen failure|1
7569011|NCT02266706|26319291|P6|Overall Study|Screen failure|1
7569012|NCT02266706|26319292|P5|Overall Study|Screen failure|0
7569013|NCT02266706|26319293|P4|Overall Study|Screen failure|0
7569014|NCT02266706|26319294|P3|Overall Study|Screen failure|0
7569015|NCT02266706|26319295|P2|Overall Study|Screen failure|0
7569016|NCT02266706|26319296|P1|Overall Study|Screen failure|0
7569017|NCT02266706|26319288|P9|Overall Study|Withdrawal by Subject|0
7569018|NCT02266706|26319289|P8|Overall Study|Withdrawal by Subject|0
7569019|NCT02266706|26319290|P7|Overall Study|Withdrawal by Subject|0
7569020|NCT02266706|26319291|P6|Overall Study|Withdrawal by Subject|1
7569021|NCT02266706|26319292|P5|Overall Study|Withdrawal by Subject|0
7569022|NCT02266706|26319293|P4|Overall Study|Withdrawal by Subject|0
7569023|NCT02266706|26319294|P3|Overall Study|Withdrawal by Subject|1
7569024|NCT02266706|26319295|P2|Overall Study|Withdrawal by Subject|1
7569025|NCT02266706|26319296|P1|Overall Study|Withdrawal by Subject|0
7569026|NCT02266433|26319527|P2|Overall Study|Withdrawal by Subject|7
7569027|NCT02266433|26319528|P1|Overall Study|Withdrawal by Subject|5
7569028|NCT02266433|26319527|P2|Overall Study|Lost to Follow-up|46
7569029|NCT02266433|26319528|P1|Overall Study|Lost to Follow-up|54
7569030|NCT02266381|26319645|P3|Overall Study|Physician Decision|4
7569031|NCT02266381|26319646|P2|Overall Study|Physician Decision|5
7569032|NCT02266381|26319647|P1|Overall Study|Physician Decision|3
7569033|NCT02266225|26319697|P1|Overall Study|Withdrawal by Subject|13
7569034|NCT02266225|26319697|P1|Overall Study|Death|1
7569035|NCT02266225|26319697|P1|Overall Study|Lost to Follow-up|2
7569036|NCT02266147|26319722|P4|PART 2: Dose Expansion|Study Terminated by Sponsor|8
7569037|NCT02266147|26319723|P3|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7569038|NCT02266147|26319724|P2|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7569039|NCT02266147|26319725|P1|PART 2: Dose Expansion|Study Terminated by Sponsor|6
7569040|NCT02266147|26319722|P4|PART 2: Dose Expansion|Lack of Efficacy|1
7569041|NCT02266147|26319723|P3|PART 2: Dose Expansion|Lack of Efficacy|0
7569042|NCT02266147|26319724|P2|PART 2: Dose Expansion|Lack of Efficacy|0
7569043|NCT02266147|26319725|P1|PART 2: Dose Expansion|Lack of Efficacy|1
7569044|NCT02266147|26319722|P4|PART 1: Dose Escalation|Other|0
7569045|NCT02266147|26319723|P3|PART 1: Dose Escalation|Other|0
7569046|NCT02266147|26319724|P2|PART 1: Dose Escalation|Other|1
7569047|NCT02266147|26319725|P1|PART 1: Dose Escalation|Other|1
7569048|NCT02266147|26319722|P4|PART 1: Dose Escalation|Study Terminated by Sponsor|3
7569049|NCT02266147|26319723|P3|PART 1: Dose Escalation|Study Terminated by Sponsor|1
7569050|NCT02266147|26319724|P2|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7569051|NCT02266147|26319725|P1|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7569052|NCT02266147|26319722|P4|PART 1: Dose Escalation|Lack of Efficacy|1
7569053|NCT02266147|26319723|P3|PART 1: Dose Escalation|Lack of Efficacy|1
7569054|NCT02266147|26319724|P2|PART 1: Dose Escalation|Lack of Efficacy|2
7569055|NCT02266147|26319725|P1|PART 1: Dose Escalation|Lack of Efficacy|0
7569056|NCT02266147|26319722|P4|PART 1: Dose Escalation|Physician Decision|0
7569057|NCT02266147|26319723|P3|PART 1: Dose Escalation|Physician Decision|1
7569058|NCT02266147|26319724|P2|PART 1: Dose Escalation|Physician Decision|0
7569059|NCT02266147|26319725|P1|PART 1: Dose Escalation|Physician Decision|0
7569060|NCT02266004|26319768|P1|Overall Study|Physician Decision|1
7569061|NCT02266004|26319768|P1|Overall Study|unrelated adverse event|1
7569062|NCT02265952|26319806|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
7569063|NCT02265952|26319807|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7569064|NCT02265952|26319806|P2|Open Label Extension (OLE) Period|Physician Decision|7
7569065|NCT02265952|26319807|P1|Open Label Extension (OLE) Period|Physician Decision|0
7569066|NCT02265796|26319863|P2|Overall Study|Withdrawal by Subject|1
7569067|NCT02265796|26319864|P1|Overall Study|Withdrawal by Subject|1
7569068|NCT02265796|26319863|P2|Overall Study|started on excluded medication|0
7569069|NCT02265796|26319864|P1|Overall Study|started on excluded medication|1
7569070|NCT02265796|26319863|P2|Overall Study|Death|0
7569071|NCT02265796|26319864|P1|Overall Study|Death|1
7569072|NCT02265744|26319883|P5|Overall Study|Pregnancy|0
7569073|NCT02265744|26319884|P4|Overall Study|Pregnancy|1
7569074|NCT02265744|26319885|P3|Overall Study|Pregnancy|1
7569075|NCT02265744|26319886|P2|Overall Study|Pregnancy|2
7569076|NCT02265744|26319887|P1|Overall Study|Pregnancy|1
7569077|NCT02265744|26319883|P5|Overall Study|Subject no longer meets study criteria|1
7569078|NCT02265744|26319884|P4|Overall Study|Subject no longer meets study criteria|0
7569079|NCT02265744|26319885|P3|Overall Study|Subject no longer meets study criteria|0
7569080|NCT02265744|26319886|P2|Overall Study|Subject no longer meets study criteria|0
7569081|NCT02265744|26319887|P1|Overall Study|Subject no longer meets study criteria|0
7569082|NCT02265744|26319883|P5|Overall Study|Administrative reason by sponsor|3
7569083|NCT02265744|26319884|P4|Overall Study|Administrative reason by sponsor|3
7569084|NCT02265744|26319885|P3|Overall Study|Administrative reason by sponsor|2
7569085|NCT02265744|26319886|P2|Overall Study|Administrative reason by sponsor|2
7569086|NCT02265744|26319887|P1|Overall Study|Administrative reason by sponsor|3
7569087|NCT02265744|26319883|P5|Overall Study|Reason not provided by Investigator|0
7569088|NCT02265744|26319884|P4|Overall Study|Reason not provided by Investigator|2
7569089|NCT02265744|26319885|P3|Overall Study|Reason not provided by Investigator|0
7569090|NCT02265744|26319886|P2|Overall Study|Reason not provided by Investigator|0
7569091|NCT02265744|26319887|P1|Overall Study|Reason not provided by Investigator|1
7569092|NCT02265744|26319883|P5|Overall Study|Lack of Efficacy|5
7569093|NCT02265744|26319884|P4|Overall Study|Lack of Efficacy|4
7569094|NCT02265744|26319885|P3|Overall Study|Lack of Efficacy|3
7569095|NCT02265744|26319886|P2|Overall Study|Lack of Efficacy|4
7569096|NCT02265744|26319887|P1|Overall Study|Lack of Efficacy|2
7569097|NCT02265744|26319883|P5|Overall Study|Adverse Event|2
7569098|NCT02265744|26319884|P4|Overall Study|Adverse Event|8
7569099|NCT02265744|26319885|P3|Overall Study|Adverse Event|9
7569100|NCT02265744|26319886|P2|Overall Study|Adverse Event|4
7569101|NCT02265744|26319887|P1|Overall Study|Adverse Event|8
7569102|NCT02265744|26319883|P5|Overall Study|Participant request to discontinue|0
7569103|NCT02265744|26319884|P4|Overall Study|Participant request to discontinue|0
7569104|NCT02265744|26319885|P3|Overall Study|Participant request to discontinue|2
7569105|NCT02265744|26319886|P2|Overall Study|Participant request to discontinue|2
7569106|NCT02265744|26319887|P1|Overall Study|Participant request to discontinue|2
7569107|NCT02265744|26319883|P5|Overall Study|Withdrawal by Subject|0
7569108|NCT02265744|26319884|P4|Overall Study|Withdrawal by Subject|2
7569109|NCT02265744|26319885|P3|Overall Study|Withdrawal by Subject|0
7569110|NCT02265744|26319886|P2|Overall Study|Withdrawal by Subject|0
7569111|NCT02265744|26319887|P1|Overall Study|Withdrawal by Subject|2
7569112|NCT02265744|26319883|P5|Overall Study|Death|0
7569113|NCT02265744|26319884|P4|Overall Study|Death|2
7569114|NCT02265744|26319885|P3|Overall Study|Death|0
7569115|NCT02265744|26319886|P2|Overall Study|Death|0
7569116|NCT02265744|26319887|P1|Overall Study|Death|0
7569117|NCT02265744|26319883|P5|Overall Study|Lost to Follow-up|0
7569118|NCT02265744|26319884|P4|Overall Study|Lost to Follow-up|1
7569119|NCT02265744|26319885|P3|Overall Study|Lost to Follow-up|0
7569120|NCT02265744|26319886|P2|Overall Study|Lost to Follow-up|0
7569121|NCT02265744|26319887|P1|Overall Study|Lost to Follow-up|0
7569122|NCT02265744|26319883|P5|Overall Study|Poor/Non-compliance|2
7569123|NCT02265744|26319884|P4|Overall Study|Poor/Non-compliance|0
7569124|NCT02265744|26319885|P3|Overall Study|Poor/Non-compliance|0
7569125|NCT02265744|26319886|P2|Overall Study|Poor/Non-compliance|1
7569126|NCT02265744|26319887|P1|Overall Study|Poor/Non-compliance|1
7569127|NCT02265705|26320066|P7|Follow-up Period|Withdrawal by Subject|1
7569128|NCT02265705|26320067|P6|Follow-up Period|Withdrawal by Subject|0
7569129|NCT02265705|26320068|P5|Follow-up Period|Withdrawal by Subject|0
7569130|NCT02265705|26320069|P4|Follow-up Period|Withdrawal by Subject|0
7569131|NCT02265705|26320070|P3|Follow-up Period|Withdrawal by Subject|0
7569132|NCT02265705|26320071|P2|Follow-up Period|Withdrawal by Subject|0
7569133|NCT02265705|26320072|P1|Follow-up Period|Withdrawal by Subject|0
7569134|NCT02265705|26320066|P7|Follow-up Period|Physician Decision|1
7569135|NCT02265705|26320067|P6|Follow-up Period|Physician Decision|0
7569136|NCT02265705|26320068|P5|Follow-up Period|Physician Decision|0
7569137|NCT02265705|26320069|P4|Follow-up Period|Physician Decision|0
7569138|NCT02265705|26320070|P3|Follow-up Period|Physician Decision|0
7569139|NCT02265705|26320071|P2|Follow-up Period|Physician Decision|0
7569140|NCT02265705|26320072|P1|Follow-up Period|Physician Decision|0
7569141|NCT02265705|26320066|P7|Follow-up Period|Adverse Event|3
7569142|NCT02265705|26320067|P6|Follow-up Period|Adverse Event|0
7569143|NCT02265705|26320068|P5|Follow-up Period|Adverse Event|0
7569144|NCT02265705|26320069|P4|Follow-up Period|Adverse Event|0
7569145|NCT02265705|26320070|P3|Follow-up Period|Adverse Event|0
7569146|NCT02265705|26320071|P2|Follow-up Period|Adverse Event|0
7569147|NCT02265705|26320072|P1|Follow-up Period|Adverse Event|0
7569148|NCT02265705|26320066|P7|Follow-up Period|Sponsor Decision|6
7569149|NCT02265705|26320067|P6|Follow-up Period|Sponsor Decision|1
7569150|NCT02265705|26320068|P5|Follow-up Period|Sponsor Decision|0
7569151|NCT02265705|26320069|P4|Follow-up Period|Sponsor Decision|0
7569152|NCT02265705|26320070|P3|Follow-up Period|Sponsor Decision|0
7569153|NCT02265705|26320071|P2|Follow-up Period|Sponsor Decision|0
7569154|NCT02265705|26320072|P1|Follow-up Period|Sponsor Decision|0
7569155|NCT02265705|26320066|P7|Open Label Period|Withdrawal by Subject|0
7569156|NCT02265705|26320067|P6|Open Label Period|Withdrawal by Subject|0
7569157|NCT02265705|26320068|P5|Open Label Period|Withdrawal by Subject|2
7569158|NCT02265705|26320069|P4|Open Label Period|Withdrawal by Subject|0
7569159|NCT02265705|26320070|P3|Open Label Period|Withdrawal by Subject|0
7569160|NCT02265705|26320071|P2|Open Label Period|Withdrawal by Subject|0
7569161|NCT02265705|26320072|P1|Open Label Period|Withdrawal by Subject|0
7569162|NCT02265705|26320066|P7|Open Label Period|Physician Decision|0
7569163|NCT02265705|26320067|P6|Open Label Period|Physician Decision|0
7569164|NCT02265705|26320068|P5|Open Label Period|Physician Decision|1
7569165|NCT02265705|26320069|P4|Open Label Period|Physician Decision|0
7569166|NCT02265705|26320070|P3|Open Label Period|Physician Decision|0
7569167|NCT02265705|26320071|P2|Open Label Period|Physician Decision|0
7569168|NCT02265705|26320072|P1|Open Label Period|Physician Decision|0
7569169|NCT02265705|26320066|P7|Open Label Period|Adverse Event|0
7569170|NCT02265705|26320067|P6|Open Label Period|Adverse Event|0
7569171|NCT02265705|26320068|P5|Open Label Period|Adverse Event|2
7569172|NCT02265705|26320069|P4|Open Label Period|Adverse Event|2
7569173|NCT02265705|26320070|P3|Open Label Period|Adverse Event|0
7569174|NCT02265705|26320071|P2|Open Label Period|Adverse Event|0
7569175|NCT02265705|26320072|P1|Open Label Period|Adverse Event|0
7569176|NCT02265705|26320066|P7|Rescue Period|Lack of Efficacy|0
7569177|NCT02265705|26320067|P6|Rescue Period|Lack of Efficacy|0
7569178|NCT02265705|26320068|P5|Rescue Period|Lack of Efficacy|0
7569179|NCT02265705|26320069|P4|Rescue Period|Lack of Efficacy|0
7569180|NCT02265705|26320070|P3|Rescue Period|Lack of Efficacy|1
7569181|NCT02265705|26320071|P2|Rescue Period|Lack of Efficacy|0
7569182|NCT02265705|26320072|P1|Rescue Period|Lack of Efficacy|0
7569183|NCT02265705|26320066|P7|Rescue Period|Death|0
7569184|NCT02265705|26320067|P6|Rescue Period|Death|0
7569185|NCT02265705|26320068|P5|Rescue Period|Death|0
7569186|NCT02265705|26320069|P4|Rescue Period|Death|0
7569187|NCT02265705|26320070|P3|Rescue Period|Death|1
7569188|NCT02265705|26320071|P2|Rescue Period|Death|0
7569189|NCT02265705|26320072|P1|Rescue Period|Death|0
7569190|NCT02265705|26320066|P7|Rescue Period|Withdrawal by Subject|0
7569191|NCT02265705|26320067|P6|Rescue Period|Withdrawal by Subject|0
7569192|NCT02265705|26320068|P5|Rescue Period|Withdrawal by Subject|0
7569193|NCT02265705|26320069|P4|Rescue Period|Withdrawal by Subject|0
7569194|NCT02265705|26320070|P3|Rescue Period|Withdrawal by Subject|1
7569195|NCT02265705|26320071|P2|Rescue Period|Withdrawal by Subject|0
7569196|NCT02265705|26320072|P1|Rescue Period|Withdrawal by Subject|0
7569197|NCT02265705|26320066|P7|Treatment Period Week 0-24|Lack of Efficacy|0
7569198|NCT02265705|26320067|P6|Treatment Period Week 0-24|Lack of Efficacy|0
7569199|NCT02265705|26320068|P5|Treatment Period Week 0-24|Lack of Efficacy|0
7569200|NCT02265705|26320069|P4|Treatment Period Week 0-24|Lack of Efficacy|0
7569201|NCT02265705|26320070|P3|Treatment Period Week 0-24|Lack of Efficacy|0
7569202|NCT02265705|26320071|P2|Treatment Period Week 0-24|Lack of Efficacy|1
7569203|NCT02265705|26320072|P1|Treatment Period Week 0-24|Lack of Efficacy|0
7569204|NCT02265705|26320066|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
7569205|NCT02265705|26320067|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
7569206|NCT02265705|26320068|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
7569207|NCT02265705|26320069|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
7569208|NCT02265705|26320070|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
7569209|NCT02265705|26320071|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
7569210|NCT02265705|26320072|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
7569211|NCT02265705|26320066|P7|Treatment Period Week 0-24|Physician Decision|0
7569212|NCT02265705|26320067|P6|Treatment Period Week 0-24|Physician Decision|0
7569213|NCT02265705|26320068|P5|Treatment Period Week 0-24|Physician Decision|0
7569214|NCT02265705|26320069|P4|Treatment Period Week 0-24|Physician Decision|0
7569215|NCT02265705|26320070|P3|Treatment Period Week 0-24|Physician Decision|0
7569216|NCT02265705|26320071|P2|Treatment Period Week 0-24|Physician Decision|0
7569217|NCT02265705|26320072|P1|Treatment Period Week 0-24|Physician Decision|1
7569218|NCT02265705|26320066|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
7569219|NCT02265705|26320067|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
7569220|NCT02265705|26320068|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
7569221|NCT02265705|26320069|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
7569222|NCT02265705|26320070|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
7569223|NCT02265705|26320071|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
7569224|NCT02265705|26320072|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
7569225|NCT02265705|26320066|P7|Treatment Period Week 0-24|Adverse Event|0
7569226|NCT02265705|26320067|P6|Treatment Period Week 0-24|Adverse Event|0
7569227|NCT02265705|26320068|P5|Treatment Period Week 0-24|Adverse Event|0
7569228|NCT02265705|26320069|P4|Treatment Period Week 0-24|Adverse Event|0
7569229|NCT02265705|26320070|P3|Treatment Period Week 0-24|Adverse Event|0
7569230|NCT02265705|26320071|P2|Treatment Period Week 0-24|Adverse Event|2
7569231|NCT02265705|26320072|P1|Treatment Period Week 0-24|Adverse Event|3
7569232|NCT02265510|26320111|P14|Overall Study|Study Terminated by Sponsor|2
7569233|NCT02265510|26320112|P13|Overall Study|Study Terminated by Sponsor|1
7569234|NCT02265510|26320113|P12|Overall Study|Study Terminated by Sponsor|4
7569235|NCT02265510|26320114|P11|Overall Study|Study Terminated by Sponsor|1
7569236|NCT02265510|26320115|P10|Overall Study|Study Terminated by Sponsor|2
7569237|NCT02265510|26320116|P9|Overall Study|Study Terminated by Sponsor|1
7569238|NCT02265510|26320117|P8|Overall Study|Study Terminated by Sponsor|1
7569239|NCT02265510|26320118|P7|Overall Study|Study Terminated by Sponsor|1
7569240|NCT02265510|26320119|P6|Overall Study|Study Terminated by Sponsor|1
7569241|NCT02265510|26320120|P5|Overall Study|Study Terminated by Sponsor|0
7569242|NCT02265510|26320121|P4|Overall Study|Study Terminated by Sponsor|0
7569243|NCT02265510|26320122|P3|Overall Study|Study Terminated by Sponsor|0
7569244|NCT02265510|26320123|P2|Overall Study|Study Terminated by Sponsor|0
7569245|NCT02265510|26320124|P1|Overall Study|Study Terminated by Sponsor|0
7569246|NCT02265510|26320111|P14|Overall Study|Other|0
7569247|NCT02265510|26320112|P13|Overall Study|Other|0
7569248|NCT02265510|26320113|P12|Overall Study|Other|0
7569249|NCT02265510|26320114|P11|Overall Study|Other|0
7569250|NCT02265510|26320115|P10|Overall Study|Other|0
7569251|NCT02265510|26320116|P9|Overall Study|Other|0
7569252|NCT02265510|26320117|P8|Overall Study|Other|0
7569253|NCT02265510|26320118|P7|Overall Study|Other|0
7569254|NCT02265510|26320119|P6|Overall Study|Other|0
7569255|NCT02265510|26320120|P5|Overall Study|Other|0
7569256|NCT02265510|26320121|P4|Overall Study|Other|0
7569257|NCT02265510|26320122|P3|Overall Study|Other|0
7569258|NCT02265510|26320123|P2|Overall Study|Other|1
7569259|NCT02265510|26320124|P1|Overall Study|Other|0
7569260|NCT02265510|26320111|P14|Overall Study|Lost to Follow-up|2
7569261|NCT02265510|26320112|P13|Overall Study|Lost to Follow-up|0
7569262|NCT02265510|26320113|P12|Overall Study|Lost to Follow-up|0
7569263|NCT02265510|26320114|P11|Overall Study|Lost to Follow-up|0
7569264|NCT02265510|26320115|P10|Overall Study|Lost to Follow-up|2
7569265|NCT02265510|26320116|P9|Overall Study|Lost to Follow-up|0
7569266|NCT02265510|26320117|P8|Overall Study|Lost to Follow-up|0
7569267|NCT02265510|26320118|P7|Overall Study|Lost to Follow-up|0
7569268|NCT02265510|26320119|P6|Overall Study|Lost to Follow-up|0
7569269|NCT02265510|26320120|P5|Overall Study|Lost to Follow-up|1
7569270|NCT02265510|26320121|P4|Overall Study|Lost to Follow-up|0
7569271|NCT02265510|26320122|P3|Overall Study|Lost to Follow-up|0
7569272|NCT02265510|26320123|P2|Overall Study|Lost to Follow-up|0
7569273|NCT02265510|26320124|P1|Overall Study|Lost to Follow-up|0
7569274|NCT02265510|26320111|P14|Overall Study|Death|6
7569275|NCT02265510|26320112|P13|Overall Study|Death|7
7569276|NCT02265510|26320113|P12|Overall Study|Death|12
7569277|NCT02265510|26320114|P11|Overall Study|Death|4
7569278|NCT02265510|26320115|P10|Overall Study|Death|3
7569279|NCT02265510|26320116|P9|Overall Study|Death|3
7569280|NCT02265510|26320117|P8|Overall Study|Death|1
7569281|NCT02265510|26320118|P7|Overall Study|Death|2
7569282|NCT02265510|26320119|P6|Overall Study|Death|3
7569283|NCT02265510|26320120|P5|Overall Study|Death|1
7569284|NCT02265510|26320121|P4|Overall Study|Death|2
7569285|NCT02265510|26320122|P3|Overall Study|Death|2
7569286|NCT02265510|26320123|P2|Overall Study|Death|0
7569287|NCT02265510|26320124|P1|Overall Study|Death|2
7569288|NCT02265510|26320111|P14|Overall Study|Disease Progression|0
7569289|NCT02265510|26320112|P13|Overall Study|Disease Progression|0
7569290|NCT02265510|26320113|P12|Overall Study|Disease Progression|0
7569291|NCT02265510|26320114|P11|Overall Study|Disease Progression|0
7569292|NCT02265510|26320115|P10|Overall Study|Disease Progression|0
7569293|NCT02265510|26320116|P9|Overall Study|Disease Progression|0
7569294|NCT02265510|26320117|P8|Overall Study|Disease Progression|0
7569295|NCT02265510|26320118|P7|Overall Study|Disease Progression|0
7569296|NCT02265510|26320119|P6|Overall Study|Disease Progression|0
7569297|NCT02265510|26320120|P5|Overall Study|Disease Progression|1
7569298|NCT02265510|26320121|P4|Overall Study|Disease Progression|1
7569299|NCT02265510|26320122|P3|Overall Study|Disease Progression|2
7569300|NCT02265510|26320123|P2|Overall Study|Disease Progression|1
7569301|NCT02265510|26320124|P1|Overall Study|Disease Progression|0
7569302|NCT02265510|26320111|P14|Overall Study|Withdrawal by Subject|0
7569303|NCT02265510|26320112|P13|Overall Study|Withdrawal by Subject|1
7569304|NCT02265510|26320113|P12|Overall Study|Withdrawal by Subject|0
7569305|NCT02265510|26320114|P11|Overall Study|Withdrawal by Subject|0
7569306|NCT02265510|26320115|P10|Overall Study|Withdrawal by Subject|0
7569307|NCT02265510|26320116|P9|Overall Study|Withdrawal by Subject|0
7569308|NCT02265510|26320117|P8|Overall Study|Withdrawal by Subject|2
7569309|NCT02265510|26320118|P7|Overall Study|Withdrawal by Subject|0
7569310|NCT02265510|26320119|P6|Overall Study|Withdrawal by Subject|2
7569311|NCT02265510|26320120|P5|Overall Study|Withdrawal by Subject|0
7569312|NCT02265510|26320121|P4|Overall Study|Withdrawal by Subject|1
7569313|NCT02265510|26320122|P3|Overall Study|Withdrawal by Subject|2
7569314|NCT02265510|26320123|P2|Overall Study|Withdrawal by Subject|1
7569315|NCT02265510|26320124|P1|Overall Study|Withdrawal by Subject|1
7569316|NCT02265237|26320224|P4|As Treated (Overall Study)|Other|1
7569317|NCT02265237|26320225|P3|As Treated (Overall Study)|Other|3
7569318|NCT02265237|26320226|P2|As Treated (Overall Study)|Other|0
7569319|NCT02265237|26320227|P1|As Treated (Overall Study)|Other|2
7569320|NCT02265237|26320224|P4|As Treated (Overall Study)|Lost to Follow-up|0
7569321|NCT02265237|26320225|P3|As Treated (Overall Study)|Lost to Follow-up|6
7569322|NCT02265237|26320226|P2|As Treated (Overall Study)|Lost to Follow-up|2
7569323|NCT02265237|26320227|P1|As Treated (Overall Study)|Lost to Follow-up|1
7569324|NCT02265237|26320224|P4|As Treated (Overall Study)|Withdrawal by Subject|0
7569325|NCT02265237|26320225|P3|As Treated (Overall Study)|Withdrawal by Subject|1
7569326|NCT02265237|26320226|P2|As Treated (Overall Study)|Withdrawal by Subject|0
7569327|NCT02265237|26320227|P1|As Treated (Overall Study)|Withdrawal by Subject|1
7569328|NCT02265237|26320224|P4|As Treated (Overall Study)|Adverse Event|0
7569329|NCT02265237|26320225|P3|As Treated (Overall Study)|Adverse Event|0
7569330|NCT02265237|26320226|P2|As Treated (Overall Study)|Adverse Event|1
7569331|NCT02265237|26320227|P1|As Treated (Overall Study)|Adverse Event|1
7569332|NCT02264990|26320248|P2|Overall Study|Other|1
7569333|NCT02264990|26320249|P1|Overall Study|Other|0
7569334|NCT02264990|26320248|P2|Overall Study|Lost to Follow-up|3
7569335|NCT02264990|26320249|P1|Overall Study|Lost to Follow-up|1
7569336|NCT02264990|26320248|P2|Overall Study|Withdrawal by Subject|5
7569337|NCT02264990|26320249|P1|Overall Study|Withdrawal by Subject|4
7569338|NCT02264990|26320248|P2|Overall Study|Death|250
7569339|NCT02264990|26320249|P1|Overall Study|Death|255
7569340|NCT02264977|26320265|P1|Overall Study|Physician Decision|1
7569341|NCT02264977|26320265|P1|Overall Study|Withdrawal by Subject|1
7569342|NCT02264977|26320265|P1|Overall Study|Death|3
7569343|NCT02264821|26320276|P3|Overall Study|Protocol Violation|6
7569344|NCT02264821|26320277|P2|Overall Study|Protocol Violation|3
7569345|NCT02264821|26320278|P1|Overall Study|Protocol Violation|1
7569346|NCT02264639|26320294|P5|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
7569347|NCT02264639|26320295|P4|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7569348|NCT02264639|26320296|P3|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7569349|NCT02264639|26320297|P2|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7569350|NCT02264639|26320298|P1|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7569351|NCT02264639|26320294|P5|Overall Study|Pregnancy (during multiple-dose phase)|0
7569352|NCT02264639|26320295|P4|Overall Study|Pregnancy (during multiple-dose phase)|0
7569353|NCT02264639|26320296|P3|Overall Study|Pregnancy (during multiple-dose phase)|1
7569354|NCT02264639|26320297|P2|Overall Study|Pregnancy (during multiple-dose phase)|0
7569355|NCT02264639|26320298|P1|Overall Study|Pregnancy (during multiple-dose phase)|0
7569356|NCT02264639|26320294|P5|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7569357|NCT02264639|26320295|P4|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7569358|NCT02264639|26320296|P3|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7569359|NCT02264639|26320297|P2|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7569360|NCT02264639|26320298|P1|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
7569361|NCT02264639|26320294|P5|Overall Study|Death (after completing single-dose phase)|0
7569362|NCT02264639|26320295|P4|Overall Study|Death (after completing single-dose phase)|0
7569363|NCT02264639|26320296|P3|Overall Study|Death (after completing single-dose phase)|0
7569364|NCT02264639|26320297|P2|Overall Study|Death (after completing single-dose phase)|0
7569365|NCT02264639|26320298|P1|Overall Study|Death (after completing single-dose phase)|1
7569366|NCT02264574|26320316|P2|Overall Study|Other, Not Specified|3
7569367|NCT02264574|26320317|P1|Overall Study|Other, Not Specified|0
7569368|NCT02264574|26320316|P2|Overall Study|Withdrawal by Subject|6
7569369|NCT02264574|26320317|P1|Overall Study|Withdrawal by Subject|8
7569370|NCT02264574|26320316|P2|Overall Study|Death|21
7569371|NCT02264574|26320317|P1|Overall Study|Death|21
7569372|NCT02263547|26320413|P1|Overall Study|Lost to Follow-up|2
7569373|NCT02263547|26320413|P1|Overall Study|Adverse Event|1
7569374|NCT02263365|26320420|P2|Overall Study|Physician Decision|18
7569375|NCT02263365|26320421|P1|Overall Study|Physician Decision|22
7569376|NCT02263326|26320435|P2|Overall Study|Lost to Follow-up|1
7569377|NCT02263326|26320436|P1|Overall Study|Lost to Follow-up|1
7569378|NCT02263079|26320509|P3|Overall Study|Withdrawal by Subject|0
7569379|NCT02263079|26320510|P2|Overall Study|Withdrawal by Subject|8
7569380|NCT02263079|26320511|P1|Overall Study|Withdrawal by Subject|2
7569381|NCT02263079|26320509|P3|Overall Study|Physician Decision|0
7569382|NCT02263079|26320510|P2|Overall Study|Physician Decision|0
7569383|NCT02263079|26320511|P1|Overall Study|Physician Decision|1
7569384|NCT02262754|26320582|P3|Overall Study|Other|2
7569385|NCT02262754|26320583|P2|Overall Study|Other|0
7569386|NCT02262754|26320584|P1|Overall Study|Other|4
7569387|NCT02262754|26320582|P3|Overall Study|Withdrawal by Subject|1
7569388|NCT02262754|26320583|P2|Overall Study|Withdrawal by Subject|0
7569389|NCT02262754|26320584|P1|Overall Study|Withdrawal by Subject|1
7569390|NCT02262754|26320582|P3|Overall Study|Protocol Violation|0
7569391|NCT02262754|26320583|P2|Overall Study|Protocol Violation|0
7569392|NCT02262754|26320584|P1|Overall Study|Protocol Violation|1
7569393|NCT02262754|26320582|P3|Overall Study|Study terminated by sponsor|4
7569394|NCT02262754|26320583|P2|Overall Study|Study terminated by sponsor|4
7569395|NCT02262754|26320584|P1|Overall Study|Study terminated by sponsor|5
7569396|NCT02262754|26320582|P3|Overall Study|No longer meets eligibility criteria|0
7569397|NCT02262754|26320583|P2|Overall Study|No longer meets eligibility criteria|1
7569398|NCT02262754|26320584|P1|Overall Study|No longer meets eligibility criteria|0
7569399|NCT02262754|26320582|P3|Overall Study|Lost to Follow-up|1
7569400|NCT02262754|26320583|P2|Overall Study|Lost to Follow-up|0
7569401|NCT02262754|26320584|P1|Overall Study|Lost to Follow-up|0
7569402|NCT02262754|26320582|P3|Overall Study|Lack of Efficacy|1
7569403|NCT02262754|26320583|P2|Overall Study|Lack of Efficacy|0
7569404|NCT02262754|26320584|P1|Overall Study|Lack of Efficacy|2
7569405|NCT02262754|26320582|P3|Overall Study|Adverse Event|0
7569406|NCT02262754|26320583|P2|Overall Study|Adverse Event|4
7569407|NCT02262754|26320584|P1|Overall Study|Adverse Event|3
7569408|NCT02262728|26320659|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
7569409|NCT02262728|26320660|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
7569410|NCT02262728|26320659|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
7569411|NCT02262728|26320660|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
7569412|NCT02262728|26320659|P2|Follow-up Phase (3 Years)|Death|1
7569413|NCT02262728|26320660|P1|Follow-up Phase (3 Years)|Death|0
7569414|NCT02262377|26320697|P2|Overall Study|Withdrawal by Subject|0
7569415|NCT02262377|26320698|P1|Overall Study|Withdrawal by Subject|4
7569416|NCT02262377|26320697|P2|Overall Study|Found ineligible after enrollment|0
7569417|NCT02262377|26320698|P1|Overall Study|Found ineligible after enrollment|3
7569418|NCT02262377|26320697|P2|Overall Study|Lost to Follow-up|6
7569419|NCT02262377|26320698|P1|Overall Study|Lost to Follow-up|5
7569420|NCT02262364|26320713|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
7569421|NCT02262260|26320722|P2|Overall Study|Protocol deviation|5
7569422|NCT02262260|26320723|P1|Overall Study|Protocol deviation|2
7569423|NCT02262260|26320722|P2|Overall Study|Lost to Follow-up|2
7569424|NCT02262260|26320723|P1|Overall Study|Lost to Follow-up|1
7569425|NCT02262260|26320722|P2|Overall Study|Withdrawal of consent|2
7569426|NCT02262260|26320723|P1|Overall Study|Withdrawal of consent|4
7569427|NCT02262260|26320722|P2|Overall Study|Adverse Event|1
7569428|NCT02262260|26320723|P1|Overall Study|Adverse Event|4
7569429|NCT02261974|26320792|P2|Overall Study|Adverse Event|0
7569430|NCT02261974|26320793|P1|Overall Study|Adverse Event|1
7569431|NCT02261974|26320792|P2|Overall Study|Lost to Follow-up|0
7569432|NCT02261974|26320793|P1|Overall Study|Lost to Follow-up|2
7569433|NCT02261974|26320792|P2|Overall Study|Received partial treatment; FU to 1 mo|1
7569434|NCT02261974|26320793|P1|Overall Study|Received partial treatment; FU to 1 mo|3
7569435|NCT02261974|26320792|P2|Overall Study|Missed treatment cut-off date|3
7569436|NCT02261974|26320793|P1|Overall Study|Missed treatment cut-off date|6
7569437|NCT02261974|26320792|P2|Overall Study|Pregnancy|1
7569438|NCT02261974|26320793|P1|Overall Study|Pregnancy|0
7569439|NCT02261974|26320792|P2|Overall Study|Withdrawal by Subject|2
7569440|NCT02261974|26320793|P1|Overall Study|Withdrawal by Subject|3
7569441|NCT02261493|26320980|P3|Overall Study|Adverse Event|0
7569442|NCT02261493|26320981|P2|Overall Study|Adverse Event|1
7569443|NCT02261493|26320982|P1|Overall Study|Adverse Event|0
7569444|NCT02261493|26320980|P3|Overall Study|Lack of Efficacy|0
7569445|NCT02261493|26320981|P2|Overall Study|Lack of Efficacy|1
7569446|NCT02261493|26320982|P1|Overall Study|Lack of Efficacy|0
7569447|NCT02261493|26320980|P3|Overall Study|Pregnancy|0
7569448|NCT02261493|26320981|P2|Overall Study|Pregnancy|2
7569449|NCT02261493|26320982|P1|Overall Study|Pregnancy|1
7569450|NCT02261493|26320980|P3|Overall Study|Lost to Follow-up|8
7569451|NCT02261493|26320981|P2|Overall Study|Lost to Follow-up|27
7569452|NCT02261493|26320982|P1|Overall Study|Lost to Follow-up|14
7569453|NCT02261493|26320980|P3|Overall Study|Personal Reasons|16
7569454|NCT02261493|26320981|P2|Overall Study|Personal Reasons|14
7569455|NCT02261493|26320982|P1|Overall Study|Personal Reasons|14
7569456|NCT02261493|26320980|P3|Overall Study|Protocol Violation|0
7569457|NCT02261493|26320981|P2|Overall Study|Protocol Violation|0
7569458|NCT02261493|26320982|P1|Overall Study|Protocol Violation|1
7569459|NCT02261493|26320980|P3|Overall Study|Undisclosed alcohol abuse|0
7569460|NCT02261493|26320981|P2|Overall Study|Undisclosed alcohol abuse|1
7569461|NCT02261493|26320982|P1|Overall Study|Undisclosed alcohol abuse|0
7569462|NCT02261493|26320980|P3|Overall Study|Physician Decision|0
7569463|NCT02261493|26320981|P2|Overall Study|Physician Decision|1
7569464|NCT02261493|26320982|P1|Overall Study|Physician Decision|0
7569465|NCT02261493|26320980|P3|Overall Study|Noncompliance|2
7569466|NCT02261493|26320981|P2|Overall Study|Noncompliance|0
7569467|NCT02261493|26320982|P1|Overall Study|Noncompliance|0
7569468|NCT02261467|26321010|P2|Overall Study|Adverse Event|1
7569469|NCT02261467|26321011|P1|Overall Study|Adverse Event|1
7569470|NCT02261467|26321010|P2|Overall Study|Lost to Follow-up|13
7569471|NCT02261467|26321011|P1|Overall Study|Lost to Follow-up|2
7569472|NCT02261467|26321010|P2|Overall Study|Personal Reasons|22
7569473|NCT02261467|26321011|P1|Overall Study|Personal Reasons|17
7569474|NCT02261467|26321010|P2|Overall Study|Protocol Violation|1
7569475|NCT02261467|26321011|P1|Overall Study|Protocol Violation|0
7569476|NCT02261467|26321010|P2|Overall Study|Enrolled in Error|0
7569477|NCT02261467|26321011|P1|Overall Study|Enrolled in Error|1
7569478|NCT02260986|26321053|P3|Overall Study|Pregnancy|0
7569479|NCT02260986|26321054|P2|Overall Study|Pregnancy|0
7569480|NCT02260986|26321055|P1|Overall Study|Pregnancy|2
7569481|NCT02260986|26321053|P3|Overall Study|Lost to Follow-up|3
7569482|NCT02260986|26321054|P2|Overall Study|Lost to Follow-up|0
7569483|NCT02260986|26321055|P1|Overall Study|Lost to Follow-up|4
7569484|NCT02260986|26321053|P3|Overall Study|Lack of investigation product supply|1
7569485|NCT02260986|26321054|P2|Overall Study|Lack of investigation product supply|0
7569486|NCT02260986|26321055|P1|Overall Study|Lack of investigation product supply|2
7569487|NCT02260986|26321053|P3|Overall Study|Incorrect randomization|0
7569488|NCT02260986|26321054|P2|Overall Study|Incorrect randomization|1
7569489|NCT02260986|26321055|P1|Overall Study|Incorrect randomization|0
7569490|NCT02260986|26321053|P3|Overall Study|Withdrawal by Subject|9
7569491|NCT02260986|26321054|P2|Overall Study|Withdrawal by Subject|4
7569492|NCT02260986|26321055|P1|Overall Study|Withdrawal by Subject|17
7569493|NCT02260986|26321053|P3|Overall Study|Car accident|1
7569494|NCT02260986|26321054|P2|Overall Study|Car accident|0
7569495|NCT02260986|26321055|P1|Overall Study|Car accident|0
7569496|NCT02260986|26321053|P3|Overall Study|Protocol Violation|16
7569497|NCT02260986|26321054|P2|Overall Study|Protocol Violation|5
7569498|NCT02260986|26321055|P1|Overall Study|Protocol Violation|14
7569499|NCT02260986|26321053|P3|Overall Study|Lack of Efficacy|0
7569500|NCT02260986|26321054|P2|Overall Study|Lack of Efficacy|3
7569501|NCT02260986|26321055|P1|Overall Study|Lack of Efficacy|27
7569502|NCT02260986|26321053|P3|Overall Study|Adverse Event|11
7569503|NCT02260986|26321054|P2|Overall Study|Adverse Event|0
7569504|NCT02260986|26321055|P1|Overall Study|Adverse Event|24
7569505|NCT02260934|26321173|P2|Overall Study|Site error|1
7569506|NCT02260934|26321174|P1|Overall Study|Site error|0
7569507|NCT02260934|26321173|P2|Overall Study|Participant Relocated|0
7569508|NCT02260934|26321174|P1|Overall Study|Participant Relocated|1
7569509|NCT02260934|26321173|P2|Overall Study|Withdrawal by Subject|2
7569510|NCT02260934|26321174|P1|Overall Study|Withdrawal by Subject|0
7569511|NCT02260934|26321173|P2|Overall Study|Lost to Follow-up|1
7569512|NCT02260934|26321174|P1|Overall Study|Lost to Follow-up|2
7569513|NCT02260921|26321212|P2|Overall Study|Prohibited Treatment for Knee Pain|0
7569514|NCT02260921|26321213|P1|Overall Study|Prohibited Treatment for Knee Pain|4
7569515|NCT02260921|26321212|P2|Overall Study|Death|0
7569516|NCT02260921|26321213|P1|Overall Study|Death|1
7569517|NCT02260921|26321212|P2|Overall Study|Withdraw Consent|1
7569518|NCT02260921|26321213|P1|Overall Study|Withdraw Consent|4
7569519|NCT02260921|26321212|P2|Overall Study|Lost to Follow-up|3
7569520|NCT02260921|26321213|P1|Overall Study|Lost to Follow-up|4
7569521|NCT02260921|26321212|P2|Overall Study|Adverse Event|0
7569522|NCT02260921|26321213|P1|Overall Study|Adverse Event|1
7569523|NCT02260882|26321237|P2|Overall Study|Protocol Violation|1
7569524|NCT02260882|26321238|P1|Overall Study|Protocol Violation|0
7569525|NCT02260817|26321262|P2|Overall Study|Protocol Violation|14
7569526|NCT02260817|26321263|P1|Overall Study|Protocol Violation|0
7569527|NCT02260817|26321262|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
7569528|NCT02260817|26321263|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
7569529|NCT02260817|26321262|P2|Overall Study|Observation, no biopsy|1
7569530|NCT02260817|26321263|P1|Overall Study|Observation, no biopsy|0
7569531|NCT02260817|26321262|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
7569532|NCT02260817|26321263|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
7569533|NCT02260817|26321262|P2|Overall Study|Lost to Follow-up|14
7569534|NCT02260817|26321263|P1|Overall Study|Lost to Follow-up|0
7569535|NCT02260804|26321311|P2|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
7569536|NCT02260804|26321312|P1|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
7569537|NCT02260804|26321311|P2|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
7569538|NCT02260804|26321312|P1|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
7569539|NCT02260804|26321311|P2|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
7569540|NCT02260804|26321312|P1|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
7569541|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
7569542|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
7569543|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Death|1
7569544|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Death|0
7569545|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
7569546|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
7569547|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
7569548|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
7569549|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Physician Decision|3
7569550|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Physician Decision|1
7569551|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Adverse Event|1
7569552|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Adverse Event|3
7569553|NCT02260804|26321311|P2|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
7569554|NCT02260804|26321312|P1|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
7569555|NCT02260804|26321311|P2|Induction Study Period|Protocol Violation|0
7569556|NCT02260804|26321312|P1|Induction Study Period|Protocol Violation|2
7569557|NCT02260791|26321334|P2|Overall Study|Protocol deviation|3
7569558|NCT02260791|26321335|P1|Overall Study|Protocol deviation|2
7569559|NCT02260791|26321334|P2|Overall Study|Screen failure|1
7569560|NCT02260791|26321335|P1|Overall Study|Screen failure|0
7569561|NCT02260791|26321334|P2|Overall Study|Withdrawal by Subject|16
7569562|NCT02260791|26321335|P1|Overall Study|Withdrawal by Subject|11
7569563|NCT02260791|26321334|P2|Overall Study|Death|0
7569564|NCT02260791|26321335|P1|Overall Study|Death|1
7569565|NCT02260791|26321334|P2|Overall Study|Adverse Event|9
7569566|NCT02260791|26321335|P1|Overall Study|Adverse Event|13
7569567|NCT02260791|26321334|P2|Overall Study|Lack of Efficacy|1
7569568|NCT02260791|26321335|P1|Overall Study|Lack of Efficacy|2
7569569|NCT02260791|26321334|P2|Overall Study|Lost to Follow-up|4
7569570|NCT02260791|26321335|P1|Overall Study|Lost to Follow-up|4
7569571|NCT02260648|26321374|P3|Overall Study|Discontinue Due to Study Termination|7
7569572|NCT02260648|26321375|P2|Overall Study|Discontinue Due to Study Termination|12
7569573|NCT02260648|26321376|P1|Overall Study|Discontinue Due to Study Termination|13
7569574|NCT02260648|26321374|P3|Overall Study|Protocol Violation|0
7569575|NCT02260648|26321375|P2|Overall Study|Protocol Violation|0
7569576|NCT02260648|26321376|P1|Overall Study|Protocol Violation|1
7569577|NCT02260648|26321374|P3|Overall Study|Withdrawal by Subject|0
7569578|NCT02260648|26321375|P2|Overall Study|Withdrawal by Subject|1
7569579|NCT02260648|26321376|P1|Overall Study|Withdrawal by Subject|1
7569580|NCT02260648|26321374|P3|Overall Study|Adverse Event|1
7569581|NCT02260648|26321375|P2|Overall Study|Adverse Event|0
7569582|NCT02260648|26321376|P1|Overall Study|Adverse Event|3
7569583|NCT02260635|26321404|P2|Open-Label Extension|Withdrawal by Subject|0
7569584|NCT02260635|26321405|P1|Open-Label Extension|Withdrawal by Subject|1
7569585|NCT02260635|26321404|P2|Open-Label Extension|Study Termination|25
7569586|NCT02260635|26321405|P1|Open-Label Extension|Study Termination|25
7569587|NCT02260635|26321404|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
7569588|NCT02260635|26321405|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
7569589|NCT02260492|26321491|P3|Overall Study|Withdrawal by Subject|2
7569590|NCT02260492|26321492|P2|Overall Study|Withdrawal by Subject|2
7569591|NCT02260492|26321493|P1|Overall Study|Withdrawal by Subject|3
7569592|NCT02260492|26321491|P3|Overall Study|Physician Decision|1
7569593|NCT02260492|26321492|P2|Overall Study|Physician Decision|0
7569594|NCT02260492|26321493|P1|Overall Study|Physician Decision|2
7569595|NCT02260492|26321491|P3|Overall Study|Lost to Follow-up|0
7569596|NCT02260492|26321492|P2|Overall Study|Lost to Follow-up|9
7569597|NCT02260492|26321493|P1|Overall Study|Lost to Follow-up|12
7569598|NCT02260492|26321491|P3|Overall Study|Death|0
7569599|NCT02260492|26321492|P2|Overall Study|Death|1
7569600|NCT02260492|26321493|P1|Overall Study|Death|0
7569601|NCT02260492|26321491|P3|Overall Study|Adverse Event|2
7569602|NCT02260492|26321492|P2|Overall Study|Adverse Event|1
7569603|NCT02260492|26321493|P1|Overall Study|Adverse Event|6
7569604|NCT02260388|26321526|P4|Overall Study|Lost to Follow-up|4
7569605|NCT02260388|26321527|P3|Overall Study|Lost to Follow-up|3
7569606|NCT02260388|26321528|P2|Overall Study|Lost to Follow-up|8
7569607|NCT02260388|26321529|P1|Overall Study|Lost to Follow-up|2
7569608|NCT02260258|26321557|P2|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
7569609|NCT02260258|26321558|P1|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
7569610|NCT02260180|26321580|P3|Overall Study|Adverse Event|1
7569611|NCT02260180|26321581|P2|Overall Study|Adverse Event|0
7569612|NCT02260180|26321582|P1|Overall Study|Adverse Event|2
7569613|NCT02260154|26321593|P1|Overall Study|Screening failure|2
7569614|NCT02259582|26321633|P3|Overall Study|Lack of Subject Adherence to Protocol|1
7569615|NCT02259582|26321634|P2|Overall Study|Lack of Subject Adherence to Protocol|1
7569616|NCT02259582|26321635|P1|Overall Study|Lack of Subject Adherence to Protocol|1
7569617|NCT02259582|26321633|P3|Overall Study|Disease progression|17
7569618|NCT02259582|26321634|P2|Overall Study|Disease progression|15
7569619|NCT02259582|26321635|P1|Overall Study|Disease progression|14
7569620|NCT02259582|26321633|P3|Overall Study|Withdrawal by Subject|1
7569621|NCT02259582|26321634|P2|Overall Study|Withdrawal by Subject|0
7569622|NCT02259582|26321635|P1|Overall Study|Withdrawal by Subject|0
7569623|NCT02259582|26321633|P3|Overall Study|Adverse Event|1
7569624|NCT02259582|26321634|P2|Overall Study|Adverse Event|0
7569625|NCT02259582|26321635|P1|Overall Study|Adverse Event|1
7569626|NCT02259582|26321633|P3|Overall Study|Death|1
7569627|NCT02259582|26321634|P2|Overall Study|Death|0
7569628|NCT02259582|26321635|P1|Overall Study|Death|0
7569629|NCT02259582|26321633|P3|Overall Study|Physician Decision|0
7569630|NCT02259582|26321634|P2|Overall Study|Physician Decision|1
7569631|NCT02259582|26321635|P1|Overall Study|Physician Decision|0
7569632|NCT02259400|26321645|P2|Overall Study|Death|2
7569633|NCT02259400|26321646|P1|Overall Study|Death|0
7569634|NCT02259348|26321678|P1|Overall Study|Death|4
7569635|NCT02259348|26321678|P1|Overall Study|Donors|6
7569636|NCT02259231|26321697|P7|Overall Study|Sponsor termination of study|1
7569637|NCT02259231|26321698|P6|Overall Study|Sponsor termination of study|1
7569638|NCT02259231|26321699|P5|Overall Study|Sponsor termination of study|2
7569639|NCT02259231|26321700|P4|Overall Study|Sponsor termination of study|1
7569640|NCT02259231|26321701|P3|Overall Study|Sponsor termination of study|0
7569641|NCT02259231|26321702|P2|Overall Study|Sponsor termination of study|0
7569642|NCT02259231|26321703|P1|Overall Study|Sponsor termination of study|1
7569643|NCT02259231|26321697|P7|Overall Study|Progressive Disease|4
7569644|NCT02259231|26321698|P6|Overall Study|Progressive Disease|5
7569645|NCT02259231|26321699|P5|Overall Study|Progressive Disease|4
7569646|NCT02259231|26321700|P4|Overall Study|Progressive Disease|5
7569647|NCT02259231|26321701|P3|Overall Study|Progressive Disease|4
7569648|NCT02259231|26321702|P2|Overall Study|Progressive Disease|5
7569649|NCT02259231|26321703|P1|Overall Study|Progressive Disease|4
7569650|NCT02259231|26321697|P7|Overall Study|Adverse Event|0
7569651|NCT02259231|26321698|P6|Overall Study|Adverse Event|0
7569652|NCT02259231|26321699|P5|Overall Study|Adverse Event|0
7569653|NCT02259231|26321700|P4|Overall Study|Adverse Event|0
7569654|NCT02259231|26321701|P3|Overall Study|Adverse Event|2
7569655|NCT02259231|26321702|P2|Overall Study|Adverse Event|1
7569656|NCT02259231|26321703|P1|Overall Study|Adverse Event|1
7569657|NCT02259114|26321724|P5|Overall Study|Not Treated|0
7569658|NCT02259114|26321725|P4|Overall Study|Not Treated|0
7569659|NCT02259114|26321726|P3|Overall Study|Not Treated|0
7569660|NCT02259114|26321727|P2|Overall Study|Not Treated|0
7569661|NCT02259114|26321728|P1|Overall Study|Not Treated|1
7569662|NCT02259114|26321724|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
7569663|NCT02259114|26321725|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
7569664|NCT02259114|26321726|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
7569665|NCT02259114|26321727|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
7569666|NCT02259114|26321728|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
7569667|NCT02259114|26321724|P5|Overall Study|Withdrawal by Subject|0
7569668|NCT02259114|26321725|P4|Overall Study|Withdrawal by Subject|1
7569669|NCT02259114|26321726|P3|Overall Study|Withdrawal by Subject|1
7569670|NCT02259114|26321727|P2|Overall Study|Withdrawal by Subject|0
7569671|NCT02259114|26321728|P1|Overall Study|Withdrawal by Subject|0
7569672|NCT02259114|26321724|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7569673|NCT02259114|26321725|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7569674|NCT02259114|26321726|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
7569675|NCT02259114|26321727|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7569676|NCT02259114|26321728|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7569677|NCT02259114|26321724|P5|Overall Study|Death|0
7569678|NCT02259114|26321725|P4|Overall Study|Death|0
7569679|NCT02259114|26321726|P3|Overall Study|Death|1
7569680|NCT02259114|26321727|P2|Overall Study|Death|0
7569681|NCT02259114|26321728|P1|Overall Study|Death|3
7569682|NCT02259114|26321724|P5|Overall Study|Adverse Event|1
7569683|NCT02259114|26321725|P4|Overall Study|Adverse Event|0
7569684|NCT02259114|26321726|P3|Overall Study|Adverse Event|0
7569685|NCT02259114|26321727|P2|Overall Study|Adverse Event|1
7569686|NCT02259114|26321728|P1|Overall Study|Adverse Event|2
7569687|NCT02259114|26321724|P5|Overall Study|Progressive Disease|5
7569688|NCT02259114|26321725|P4|Overall Study|Progressive Disease|2
7569689|NCT02259114|26321726|P3|Overall Study|Progressive Disease|10
7569690|NCT02259114|26321727|P2|Overall Study|Progressive Disease|2
7569691|NCT02259114|26321728|P1|Overall Study|Progressive Disease|14
7569692|NCT02259088|26321787|P2|Overall Study|Subject/guardian decision|8
7569693|NCT02259088|26321788|P1|Overall Study|Subject/guardian decision|8
7569694|NCT02259088|26321787|P2|Overall Study|Protocol deviation|0
7569695|NCT02259088|26321788|P1|Overall Study|Protocol deviation|5
7569696|NCT02259088|26321787|P2|Overall Study|Physician Decision|2
7569697|NCT02259088|26321788|P1|Overall Study|Physician Decision|5
7569698|NCT02259088|26321787|P2|Overall Study|Death|0
7569699|NCT02259088|26321788|P1|Overall Study|Death|2
7569700|NCT02259088|26321787|P2|Overall Study|Lost to Follow-up|0
7569701|NCT02259088|26321788|P1|Overall Study|Lost to Follow-up|2
7569702|NCT02259088|26321787|P2|Overall Study|Adverse Event|4
7569703|NCT02259088|26321788|P1|Overall Study|Adverse Event|6
7569704|NCT02259010|26321833|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
7569705|NCT02258659|26321858|P1|Overall Study|Withdrawal by Subject|1
7569706|NCT02258542|26321875|P4|Overall Study|Eligibility criteria not fulfilled|0
7569707|NCT02258542|26321876|P3|Overall Study|Eligibility criteria not fulfilled|0
7569708|NCT02258542|26321877|P2|Overall Study|Eligibility criteria not fulfilled|2
7569709|NCT02258542|26321878|P1|Overall Study|Eligibility criteria not fulfilled|0
7569710|NCT02258542|26321875|P4|Overall Study|Protocol Violation|0
7569711|NCT02258542|26321876|P3|Overall Study|Protocol Violation|0
7569712|NCT02258542|26321877|P2|Overall Study|Protocol Violation|2
7569713|NCT02258542|26321878|P1|Overall Study|Protocol Violation|1
7569714|NCT02258542|26321875|P4|Overall Study|Adverse Event|0
7569715|NCT02258542|26321876|P3|Overall Study|Adverse Event|0
7569716|NCT02258542|26321877|P2|Overall Study|Adverse Event|4
7569717|NCT02258542|26321878|P1|Overall Study|Adverse Event|3
7569718|NCT02258542|26321875|P4|Overall Study|Death|1
7569719|NCT02258542|26321876|P3|Overall Study|Death|0
7569720|NCT02258542|26321877|P2|Overall Study|Death|4
7569721|NCT02258542|26321878|P1|Overall Study|Death|5
7569722|NCT02258542|26321875|P4|Overall Study|Lost to Follow-up|2
7569723|NCT02258542|26321876|P3|Overall Study|Lost to Follow-up|1
7569724|NCT02258542|26321877|P2|Overall Study|Lost to Follow-up|12
7569725|NCT02258542|26321878|P1|Overall Study|Lost to Follow-up|5
7569726|NCT02258542|26321875|P4|Overall Study|Withdrawal by Subject|1
7569727|NCT02258542|26321876|P3|Overall Study|Withdrawal by Subject|7
7569728|NCT02258542|26321877|P2|Overall Study|Withdrawal by Subject|20
7569729|NCT02258542|26321878|P1|Overall Study|Withdrawal by Subject|20
7569730|NCT02258542|26321875|P4|Overall Study|study specific discount. criteria|0
7569731|NCT02258542|26321876|P3|Overall Study|study specific discount. criteria|0
7569732|NCT02258542|26321877|P2|Overall Study|study specific discount. criteria|1
7569733|NCT02258542|26321878|P1|Overall Study|study specific discount. criteria|1
7569734|NCT02258542|26321875|P4|Overall Study|eg. not made to the visit|1
7569735|NCT02258542|26321876|P3|Overall Study|eg. not made to the visit|0
7569736|NCT02258542|26321877|P2|Overall Study|eg. not made to the visit|4
7569737|NCT02258542|26321878|P1|Overall Study|eg. not made to the visit|7
7569738|NCT02258529|26322102|P1|Overall Study|Adverse Event|1
7569739|NCT02258529|26322102|P1|Overall Study|Study Terminated by Sponsor|9
7569740|NCT02258464|26322134|P2|Overall Study|AE related to clinical PD|0
7569741|NCT02258464|26322135|P1|Overall Study|AE related to clinical PD|1
7569742|NCT02258464|26322134|P2|Overall Study|Withdrawal by Subject|4
7569743|NCT02258464|26322135|P1|Overall Study|Withdrawal by Subject|5
7569744|NCT02258464|26322134|P2|Overall Study|AE not related to clinical PD|3
7569745|NCT02258464|26322135|P1|Overall Study|AE not related to clinical PD|1
7569746|NCT02258464|26322134|P2|Overall Study|Study drug never administered|1
7569747|NCT02258464|26322135|P1|Overall Study|Study drug never administered|1
7569748|NCT02258464|26322134|P2|Overall Study|Progressive disease (PD)|17
7569749|NCT02258464|26322135|P1|Overall Study|Progressive disease (PD)|9
7569750|NCT02258334|26322216|P4|Overall Study|Adverse Event|0
7569751|NCT02258334|26322217|P3|Overall Study|Adverse Event|0
7569752|NCT02258334|26322218|P2|Overall Study|Adverse Event|0
7569753|NCT02258334|26322219|P1|Overall Study|Adverse Event|1
7569754|NCT02258074|26322282|P4|Overall Study|Withdrawal by Subject|0
7569755|NCT02258074|26322283|P3|Overall Study|Withdrawal by Subject|0
7569756|NCT02258074|26322284|P2|Overall Study|Withdrawal by Subject|0
7569757|NCT02258074|26322285|P1|Overall Study|Withdrawal by Subject|1
7569758|NCT02257918|26322345|P3|Overall Study|Pregnancy|1
7569759|NCT02257918|26322346|P2|Overall Study|Pregnancy|0
7569760|NCT02257918|26322347|P1|Overall Study|Pregnancy|0
7569761|NCT02257918|26322345|P3|Overall Study|Withdrawal by Subject|1
7569762|NCT02257918|26322346|P2|Overall Study|Withdrawal by Subject|0
7569763|NCT02257918|26322347|P1|Overall Study|Withdrawal by Subject|0
7569764|NCT02257918|26322345|P3|Overall Study|Lost to Follow-up|0
7569765|NCT02257918|26322346|P2|Overall Study|Lost to Follow-up|1
7569766|NCT02257918|26322347|P1|Overall Study|Lost to Follow-up|4
7569767|NCT02257736|26322399|P2|Overall Study|Randomized, not treated|2
7569768|NCT02257736|26322400|P1|Overall Study|Randomized, not treated|1
7569769|NCT02257736|26322399|P2|Overall Study|Other|7
7569770|NCT02257736|26322400|P1|Overall Study|Other|1
7569771|NCT02257736|26322399|P2|Overall Study|Protocol Violation|0
7569772|NCT02257736|26322400|P1|Overall Study|Protocol Violation|1
7569773|NCT02257736|26322399|P2|Overall Study|Non-Compliance with study drug|2
7569774|NCT02257736|26322400|P1|Overall Study|Non-Compliance with study drug|1
7569775|NCT02257736|26322399|P2|Overall Study|Physician Decision|9
7569776|NCT02257736|26322400|P1|Overall Study|Physician Decision|5
7569777|NCT02257736|26322399|P2|Overall Study|Death|6
7569778|NCT02257736|26322400|P1|Overall Study|Death|11
7569779|NCT02257736|26322399|P2|Overall Study|Withdrawal by Subject|38
7569780|NCT02257736|26322400|P1|Overall Study|Withdrawal by Subject|21
7569781|NCT02257736|26322399|P2|Overall Study|Adverse Event|56
7569782|NCT02257736|26322400|P1|Overall Study|Adverse Event|45
7569783|NCT02257736|26322399|P2|Overall Study|Progressive disease|327
7569784|NCT02257736|26322400|P1|Overall Study|Progressive disease|365
7569785|NCT02257684|26322414|P1|Overall Study|Sponsor's Decision|1
7569786|NCT02257684|26322414|P1|Overall Study|Lack of Efficacy|1
7569787|NCT02257684|26322414|P1|Overall Study|Adverse Event|2
7569788|NCT02257632|26322424|P2|Overall Study|Adverse Event|2
7569789|NCT02257632|26322425|P1|Overall Study|Adverse Event|1
7569790|NCT02257632|26322424|P2|Overall Study|Withdrawal by Subject|1
7569791|NCT02257632|26322425|P1|Overall Study|Withdrawal by Subject|0
7569792|NCT02257528|26322465|P1|Overall Study|Never received study treatment|1
7569793|NCT02257489|26322481|P9|Overall Study|Withdrawal by Subject|0
7569794|NCT02257489|26322482|P8|Overall Study|Withdrawal by Subject|0
7569795|NCT02257489|26322483|P7|Overall Study|Withdrawal by Subject|0
7569796|NCT02257489|26322484|P6|Overall Study|Withdrawal by Subject|0
7569797|NCT02257489|26322485|P5|Overall Study|Withdrawal by Subject|0
7569798|NCT02257489|26322486|P4|Overall Study|Withdrawal by Subject|1
7569799|NCT02257489|26322487|P3|Overall Study|Withdrawal by Subject|0
7569800|NCT02257489|26322488|P2|Overall Study|Withdrawal by Subject|0
7569801|NCT02257489|26322489|P1|Overall Study|Withdrawal by Subject|0
7569802|NCT02257385|26322525|P2|Overall Study|Withdrawal by Subject|4
7569803|NCT02257385|26322526|P1|Overall Study|Withdrawal by Subject|4
7569804|NCT02257385|26322525|P2|Overall Study|Lost to Follow-up|1
7569805|NCT02257385|26322526|P1|Overall Study|Lost to Follow-up|0
7569806|NCT02257385|26322525|P2|Overall Study|Protocol Violation|7
7569807|NCT02257385|26322526|P1|Overall Study|Protocol Violation|5
7569808|NCT02257385|26322525|P2|Overall Study|Lack of Efficacy|2
7569809|NCT02257385|26322526|P1|Overall Study|Lack of Efficacy|1
7569810|NCT02257385|26322525|P2|Overall Study|Adverse Event|8
7569811|NCT02257385|26322526|P1|Overall Study|Adverse Event|12
7569812|NCT02257372|26322536|P2|Overall Study|Withdrew consent|0
7569813|NCT02257372|26322537|P1|Overall Study|Withdrew consent|1
7569814|NCT02257372|26322536|P2|Overall Study|Lost to Follow-up|1
7569815|NCT02257372|26322537|P1|Overall Study|Lost to Follow-up|0
7569816|NCT02257372|26322536|P2|Overall Study|Protocol Violation|1
7569817|NCT02257372|26322537|P1|Overall Study|Protocol Violation|1
7569818|NCT02257372|26322536|P2|Overall Study|Lack of Efficacy|1
7569819|NCT02257372|26322537|P1|Overall Study|Lack of Efficacy|2
7569820|NCT02257372|26322536|P2|Overall Study|Adverse Event|7
7569821|NCT02257372|26322537|P1|Overall Study|Adverse Event|3
7569822|NCT02256982|26322599|P2|Overall Study|Disease Progression|1
7569823|NCT02256982|26322600|P1|Overall Study|Disease Progression|0
7569824|NCT02256969|26322609|P3|Overall Study|Screenfailed or withdrew|1
7569825|NCT02256969|26322610|P2|Overall Study|Screenfailed or withdrew|1
7569826|NCT02256969|26322611|P1|Overall Study|Screenfailed or withdrew|2
7569827|NCT02256917|26322628|P1|Prophylactic Treatment Phase II|Discontinued medication|1
7569828|NCT02256917|26322628|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
7569829|NCT02256917|26322628|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
7569830|NCT02256917|26322628|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
7569831|NCT02256917|26322628|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
7569832|NCT02256891|26322649|P2|Overall Study|Equipment Malfunction|1
7569833|NCT02256891|26322650|P1|Overall Study|Equipment Malfunction|0
7569834|NCT02256891|26322649|P2|Overall Study|Screen Fail|4
7569835|NCT02256891|26322650|P1|Overall Study|Screen Fail|5
7569836|NCT02256891|26322649|P2|Overall Study|Physician Decision|3
7569837|NCT02256891|26322650|P1|Overall Study|Physician Decision|7
7569838|NCT02256891|26322649|P2|Overall Study|Lost to Follow-up|3
7569839|NCT02256891|26322650|P1|Overall Study|Lost to Follow-up|0
7569840|NCT02256891|26322649|P2|Overall Study|Death|2
7569841|NCT02256891|26322650|P1|Overall Study|Death|0
7569842|NCT02256839|26322676|P2|Overall Study|Did not meet Eligibility Criteria|3
7569843|NCT02256839|26322677|P1|Overall Study|Did not meet Eligibility Criteria|2
7569844|NCT02256631|26322690|P7|Overall Study|Unable to get to clinic|2
7569845|NCT02256631|26322691|P6|Overall Study|Unable to get to clinic|1
7569846|NCT02256631|26322692|P5|Overall Study|Unable to get to clinic|0
7569847|NCT02256631|26322693|P4|Overall Study|Unable to get to clinic|1
7569848|NCT02256631|26322694|P3|Overall Study|Unable to get to clinic|0
7569849|NCT02256631|26322695|P2|Overall Study|Unable to get to clinic|2
7569850|NCT02256631|26322696|P1|Overall Study|Unable to get to clinic|0
7569851|NCT02256631|26322690|P7|Overall Study|Withdrawal by Subject|1
7569852|NCT02256631|26322691|P6|Overall Study|Withdrawal by Subject|0
7569853|NCT02256631|26322692|P5|Overall Study|Withdrawal by Subject|1
7569854|NCT02256631|26322693|P4|Overall Study|Withdrawal by Subject|1
7569855|NCT02256631|26322694|P3|Overall Study|Withdrawal by Subject|0
7569856|NCT02256631|26322695|P2|Overall Study|Withdrawal by Subject|0
7569857|NCT02256631|26322696|P1|Overall Study|Withdrawal by Subject|0
7569858|NCT02256631|26322690|P7|Overall Study|Lost to Follow-up|1
7569859|NCT02256631|26322691|P6|Overall Study|Lost to Follow-up|1
7569860|NCT02256631|26322692|P5|Overall Study|Lost to Follow-up|0
7569861|NCT02256631|26322693|P4|Overall Study|Lost to Follow-up|2
7569862|NCT02256631|26322694|P3|Overall Study|Lost to Follow-up|0
7569863|NCT02256631|26322695|P2|Overall Study|Lost to Follow-up|1
7569864|NCT02256631|26322696|P1|Overall Study|Lost to Follow-up|1
7569865|NCT02256553|26322763|P1|Period III|Adverse Event|3
7569866|NCT02256553|26322763|P1|Period II|Subject Moved|1
7569867|NCT02256553|26322763|P1|Period II|Adverse Event|1
7569868|NCT02256553|26322763|P1|Period I|Protocol Violation|1
7569869|NCT02256553|26322763|P1|Period I|Adverse Event|5
7569870|NCT02256540|26322772|P3|Overall Study|Back pain preventing exercise|1
7569871|NCT02256540|26322773|P2|Overall Study|Back pain preventing exercise|0
7569872|NCT02256540|26322774|P1|Overall Study|Back pain preventing exercise|0
7569873|NCT02256540|26322772|P3|Overall Study|Withdrawal by Subject|1
7569874|NCT02256540|26322773|P2|Overall Study|Withdrawal by Subject|1
7569875|NCT02256540|26322774|P1|Overall Study|Withdrawal by Subject|0
7569876|NCT02256488|26322792|P4|Overall Study|Withdrawal by Subject|2
7569877|NCT02256488|26322793|P3|Overall Study|Withdrawal by Subject|0
7569878|NCT02256488|26322794|P2|Overall Study|Withdrawal by Subject|0
7569879|NCT02256488|26322795|P1|Overall Study|Withdrawal by Subject|1
7569880|NCT02256488|26322792|P4|Overall Study|OTHER|1
7569881|NCT02256488|26322793|P3|Overall Study|OTHER|1
7569882|NCT02256488|26322794|P2|Overall Study|OTHER|0
7569883|NCT02256488|26322795|P1|Overall Study|OTHER|1
7569884|NCT02256488|26322792|P4|Overall Study|Lost to Follow-up|3
7569885|NCT02256488|26322793|P3|Overall Study|Lost to Follow-up|9
7569886|NCT02256488|26322794|P2|Overall Study|Lost to Follow-up|6
7569887|NCT02256488|26322795|P1|Overall Study|Lost to Follow-up|6
7569888|NCT02256436|26322811|P2|Overall Study|Did Not Continue on Extension Study|12
7569889|NCT02256436|26322812|P1|Overall Study|Did Not Continue on Extension Study|8
7569890|NCT02256436|26322811|P2|Overall Study|Transferred to Extension Study|23
7569891|NCT02256436|26322812|P1|Overall Study|Transferred to Extension Study|11
7569892|NCT02256436|26322811|P2|Overall Study|Withdrawal by Subject|10
7569893|NCT02256436|26322812|P1|Overall Study|Withdrawal by Subject|26
7569894|NCT02256436|26322811|P2|Overall Study|Protocol Violation|1
7569895|NCT02256436|26322812|P1|Overall Study|Protocol Violation|0
7569896|NCT02256436|26322811|P2|Overall Study|Physician Decision|0
7569897|NCT02256436|26322812|P1|Overall Study|Physician Decision|1
7569898|NCT02256436|26322811|P2|Overall Study|Lost to Follow-up|2
7569899|NCT02256436|26322812|P1|Overall Study|Lost to Follow-up|1
7569900|NCT02256436|26322811|P2|Overall Study|Death|208
7569901|NCT02256436|26322812|P1|Overall Study|Death|216
7569902|NCT02256436|26322811|P2|Overall Study|Adverse Event|14
7569903|NCT02256436|26322812|P1|Overall Study|Adverse Event|9
7569904|NCT02256384|26322857|P1|Overall Study|Equipment not capturing data|2
7569905|NCT02256384|26322857|P1|Overall Study|Withdrawal by Subject|12
7569906|NCT02256267|26322890|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
7569907|NCT02256267|26322890|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
7569908|NCT02255981|26322963|P1|Overall Study|Withdrawal by Subject|1
7569909|NCT02255981|26322963|P1|Overall Study|Lost to Follow-up|3
7569910|NCT02255760|26322978|P5|Overall Study|Lost to Follow-up|0
7569911|NCT02255760|26322979|P4|Overall Study|Lost to Follow-up|0
7569912|NCT02255760|26322980|P3|Overall Study|Lost to Follow-up|0
7569913|NCT02255760|26322981|P2|Overall Study|Lost to Follow-up|1
7569914|NCT02255760|26322982|P1|Overall Study|Lost to Follow-up|0
7569915|NCT02255656|26323034|P1|Overall Study|Other|126
7569916|NCT02255656|26323034|P1|Overall Study|Due to Coronavirus Disease (Covid-19)|300
7569917|NCT02255656|26323034|P1|Overall Study|Lost to Follow-up|30
7569918|NCT02255656|26323034|P1|Overall Study|Poor compliance to protocol|3
7569919|NCT02255656|26323034|P1|Overall Study|Adverse Event|11
7569920|NCT02255565|26323126|P3|Overall Study|Withdrawal by Subject|0
7569921|NCT02255565|26323127|P2|Overall Study|Withdrawal by Subject|1
7569922|NCT02255565|26323128|P1|Overall Study|Withdrawal by Subject|0
7569923|NCT02255552|26323189|P2|Overall Study|Withdrawal by Subject|4
7569924|NCT02255552|26323190|P1|Overall Study|Withdrawal by Subject|1
7569925|NCT02255552|26323189|P2|Overall Study|Participants enrolled into another study|11
7569926|NCT02255552|26323190|P1|Overall Study|Participants enrolled into another study|0
7569927|NCT02255500|26323217|P2|Overall Study|Withdrawal by Subject|0
7569928|NCT02255500|26323218|P1|Overall Study|Withdrawal by Subject|1
7569929|NCT02255474|26323237|P3|Overall Study|Withdrawal by Subject|0
7569930|NCT02255474|26323238|P2|Overall Study|Withdrawal by Subject|1
7569931|NCT02255474|26323239|P1|Overall Study|Withdrawal by Subject|1
7569932|NCT02255474|26323237|P3|Overall Study|Lost to Follow-up|3
7569933|NCT02255474|26323238|P2|Overall Study|Lost to Follow-up|1
7569934|NCT02255474|26323239|P1|Overall Study|Lost to Follow-up|1
7569935|NCT02255461|26323261|P5|Overall Study|Not meet dose reduction BSA requirement|0
7569936|NCT02255461|26323262|P4|Overall Study|Not meet dose reduction BSA requirement|0
7569937|NCT02255461|26323263|P3|Overall Study|Not meet dose reduction BSA requirement|0
7569938|NCT02255461|26323264|P2|Overall Study|Not meet dose reduction BSA requirement|1
7569939|NCT02255461|26323265|P1|Overall Study|Not meet dose reduction BSA requirement|0
7569940|NCT02255461|26323261|P5|Overall Study|Withdrawal by Subject|1
7569941|NCT02255461|26323262|P4|Overall Study|Withdrawal by Subject|0
7569942|NCT02255461|26323263|P3|Overall Study|Withdrawal by Subject|1
7569943|NCT02255461|26323264|P2|Overall Study|Withdrawal by Subject|0
7569944|NCT02255461|26323265|P1|Overall Study|Withdrawal by Subject|0
7569945|NCT02255461|26323261|P5|Overall Study|Adverse Event|1
7569946|NCT02255461|26323262|P4|Overall Study|Adverse Event|0
7569947|NCT02255461|26323263|P3|Overall Study|Adverse Event|0
7569948|NCT02255461|26323264|P2|Overall Study|Adverse Event|1
7569949|NCT02255461|26323265|P1|Overall Study|Adverse Event|0
7569950|NCT02255422|26323344|P7|Overall Study|Lost to Follow-up|0
7569951|NCT02255422|26323345|P6|Overall Study|Lost to Follow-up|0
7569952|NCT02255422|26323346|P5|Overall Study|Lost to Follow-up|0
7569953|NCT02255422|26323347|P4|Overall Study|Lost to Follow-up|0
7569954|NCT02255422|26323348|P3|Overall Study|Lost to Follow-up|1
7569955|NCT02255422|26323349|P2|Overall Study|Lost to Follow-up|0
7569956|NCT02255422|26323350|P1|Overall Study|Lost to Follow-up|0
7569957|NCT02255422|26323344|P7|Overall Study|Withdrawal by Subject|2
7569958|NCT02255422|26323345|P6|Overall Study|Withdrawal by Subject|0
7569959|NCT02255422|26323346|P5|Overall Study|Withdrawal by Subject|0
7569960|NCT02255422|26323347|P4|Overall Study|Withdrawal by Subject|0
7569961|NCT02255422|26323348|P3|Overall Study|Withdrawal by Subject|0
7569962|NCT02255422|26323349|P2|Overall Study|Withdrawal by Subject|0
7569963|NCT02255422|26323350|P1|Overall Study|Withdrawal by Subject|0
7569964|NCT02255279|26323384|P2|Overall Study|Withdrawal by Subject|6
7569965|NCT02255279|26323385|P1|Overall Study|Withdrawal by Subject|3
7569966|NCT02255279|26323384|P2|Overall Study|Protocol Violation|1
7569967|NCT02255279|26323385|P1|Overall Study|Protocol Violation|0
7569968|NCT02255279|26323384|P2|Overall Study|Lost to Follow-up|2
7569969|NCT02255279|26323385|P1|Overall Study|Lost to Follow-up|2
7569970|NCT02255149|26323438|P1|Overall Study|Implant Failure|1
7569971|NCT02255149|26323438|P1|Overall Study|Withdrawal by PI|1
7569972|NCT02255149|26323438|P1|Overall Study|Withdrawal by Subject|1
7569973|NCT02255149|26323438|P1|Overall Study|Lost to Follow-up|2
7569974|NCT02255097|26323454|P1|Overall Study|Treatment Ongoing|36
7569975|NCT02255097|26323454|P1|Overall Study|Allocated but not treated|1
7569976|NCT02255097|26323454|P1|Overall Study|Withdrawal by Subject|2
7569977|NCT02255097|26323454|P1|Overall Study|Progressive Disease|80
7569978|NCT02255097|26323454|P1|Overall Study|Physician Decision|1
7569979|NCT02255097|26323454|P1|Overall Study|Lost to Follow-up|1
7569980|NCT02255097|26323454|P1|Overall Study|Death|2
7569981|NCT02255097|26323454|P1|Overall Study|Excluded Medication|1
7569982|NCT02255097|26323454|P1|Overall Study|Complete Response|1
7569983|NCT02255097|26323454|P1|Overall Study|Clinical Progression|23
7569984|NCT02255097|26323454|P1|Overall Study|Adverse Event|24
7569985|NCT02254772|26323484|P1|Overall Study|Withdrawal by Subject|1
7569986|NCT02254772|26323484|P1|Overall Study|Ineligible|1
7569987|NCT02254681|26323490|P1|Overall Study|Lack of Efficacy|6
7569988|NCT02254551|26323500|P1|Dose Escalation|Dose-limiting toxicity|2
7569989|NCT02254551|26323500|P1|Dose Escalation|Physician Decision|1
7569990|NCT02254486|26323510|P2|Overall Study|Various|12
7569991|NCT02254486|26323511|P1|Overall Study|Various|12
7569992|NCT02254486|26323510|P2|Overall Study|GFR<60mL/min|21
7569993|NCT02254486|26323511|P1|Overall Study|GFR<60mL/min|16
7569994|NCT02254486|26323510|P2|Overall Study|Withdrawal by Subject|15
7569995|NCT02254486|26323511|P1|Overall Study|Withdrawal by Subject|17
7569996|NCT02254486|26323510|P2|Overall Study|Protocol Violation|2
7569997|NCT02254486|26323511|P1|Overall Study|Protocol Violation|1
7569998|NCT02254486|26323510|P2|Overall Study|Lost to Follow-up|4
7569999|NCT02254486|26323511|P1|Overall Study|Lost to Follow-up|2
7570000|NCT02254486|26323510|P2|Overall Study|Lack of Efficacy|0
7570001|NCT02254486|26323511|P1|Overall Study|Lack of Efficacy|1
7570002|NCT02254486|26323510|P2|Overall Study|Adverse Event|1
7570003|NCT02254486|26323511|P1|Overall Study|Adverse Event|1
7570004|NCT02254460|26323550|P2|Overall Study|Adverse Event|0
7570005|NCT02254460|26323551|P1|Overall Study|Adverse Event|1
7570006|NCT02254421|26323559|P2|Overall Study|Withdrew Consent|1
7570007|NCT02254421|26323560|P1|Overall Study|Withdrew Consent|1
7570008|NCT02254421|26323559|P2|Overall Study|Death|2
7570009|NCT02254421|26323560|P1|Overall Study|Death|0
7570010|NCT02254421|26323559|P2|Overall Study|Randomized but Not Treated|0
7570011|NCT02254421|26323560|P1|Overall Study|Randomized but Not Treated|1
7570012|NCT02254408|26323574|P2|Overall Study|Lost to Follow-up|0
7570013|NCT02254408|26323575|P1|Overall Study|Lost to Follow-up|1
7570014|NCT02254408|26323574|P2|Overall Study|Withdrawal by Subject|3
7570015|NCT02254408|26323575|P1|Overall Study|Withdrawal by Subject|3
7570016|NCT02254408|26323574|P2|Overall Study|Investigator's Discretion|1
7570017|NCT02254408|26323575|P1|Overall Study|Investigator's Discretion|0
7570018|NCT02254408|26323574|P2|Overall Study|Death|3
7570019|NCT02254408|26323575|P1|Overall Study|Death|2
7570020|NCT02254408|26323574|P2|Overall Study|Adverse Event|0
7570021|NCT02254408|26323575|P1|Overall Study|Adverse Event|1
7570022|NCT02254408|26323574|P2|Overall Study|Randomized But Not Treated|3
7570023|NCT02254408|26323575|P1|Overall Study|Randomized But Not Treated|1
7570024|NCT02254304|26323587|P2|Overall Study|Personal decision|0
7570025|NCT02254304|26323588|P1|Overall Study|Personal decision|1
7570026|NCT02254304|26323587|P2|Overall Study|Personal causes|1
7570027|NCT02254304|26323588|P1|Overall Study|Personal causes|4
7570028|NCT02254304|26323587|P2|Overall Study|Injection site pain and Injection fear|0
7570029|NCT02254304|26323588|P1|Overall Study|Injection site pain and Injection fear|1
7570030|NCT02254304|26323587|P2|Overall Study|Withdrawal by Subject|0
7570031|NCT02254304|26323588|P1|Overall Study|Withdrawal by Subject|3
7570032|NCT02254304|26323587|P2|Overall Study|Protocol Violation|0
7570033|NCT02254304|26323588|P1|Overall Study|Protocol Violation|1
7570034|NCT02254304|26323587|P2|Overall Study|Lost to Follow-up|2
7570035|NCT02254304|26323588|P1|Overall Study|Lost to Follow-up|2
7570036|NCT02254304|26323587|P2|Overall Study|Adverse Event|1
7570037|NCT02254304|26323588|P1|Overall Study|Adverse Event|2
7570038|NCT02254291|26323648|P3|Overall Study|Missing follow-up information|1
7570039|NCT02254291|26323649|P2|Overall Study|Missing follow-up information|0
7570040|NCT02254291|26323650|P1|Overall Study|Missing follow-up information|0
7570041|NCT02254291|26323648|P3|Overall Study|Withdrawal by Subject|1
7570042|NCT02254291|26323649|P2|Overall Study|Withdrawal by Subject|3
7570043|NCT02254291|26323650|P1|Overall Study|Withdrawal by Subject|0
7570046|NCT02253992|26323728|P3|Overall Study|Other|1
7570047|NCT02253992|26323729|P2|Overall Study|Other|0
7570048|NCT02253992|26323730|P1|Overall Study|Other|0
7570049|NCT02253992|26323728|P3|Overall Study|Completed treatment as per protocol|22
7570050|NCT02253992|26323729|P2|Overall Study|Completed treatment as per protocol|1
7570051|NCT02253992|26323730|P1|Overall Study|Completed treatment as per protocol|0
7570052|NCT02253992|26323728|P3|Overall Study|Subject discontinued study drug|1
7570053|NCT02253992|26323729|P2|Overall Study|Subject discontinued study drug|0
7570054|NCT02253992|26323730|P1|Overall Study|Subject discontinued study drug|1
7570055|NCT02253992|26323728|P3|Overall Study|Death|1
7570056|NCT02253992|26323729|P2|Overall Study|Death|0
7570057|NCT02253992|26323730|P1|Overall Study|Death|0
7570058|NCT02253992|26323728|P3|Overall Study|Adverse Event|8
7570059|NCT02253992|26323729|P2|Overall Study|Adverse Event|0
7570060|NCT02253992|26323730|P1|Overall Study|Adverse Event|0
7570061|NCT02253992|26323728|P3|Overall Study|Withdrawal by Subject|3
7570062|NCT02253992|26323729|P2|Overall Study|Withdrawal by Subject|0
7570063|NCT02253992|26323730|P1|Overall Study|Withdrawal by Subject|0
7570064|NCT02253992|26323728|P3|Overall Study|Disease progression|98
7570065|NCT02253992|26323729|P2|Overall Study|Disease progression|3
7570066|NCT02253992|26323730|P1|Overall Study|Disease progression|4
7570067|NCT02253992|26323728|P3|Overall Study|Study drug toxicity|10
7570068|NCT02253992|26323729|P2|Overall Study|Study drug toxicity|0
7570069|NCT02253992|26323730|P1|Overall Study|Study drug toxicity|1
7570070|NCT02253654|26323796|P2|Overall Study|Did Not Receive Study Treatment|1
7570071|NCT02253654|26323797|P1|Overall Study|Did Not Receive Study Treatment|4
7570072|NCT02253654|26323796|P2|Overall Study|Death|7
7570073|NCT02253654|26323797|P1|Overall Study|Death|4
7570074|NCT02253654|26323796|P2|Overall Study|Lost to Follow-up|5
7570075|NCT02253654|26323797|P1|Overall Study|Lost to Follow-up|2
7570076|NCT02253654|26323796|P2|Overall Study|Decision by Sponsor|1
7570077|NCT02253654|26323797|P1|Overall Study|Decision by Sponsor|1
7570078|NCT02253654|26323796|P2|Overall Study|Withdrawal by Subject|4
7570079|NCT02253654|26323797|P1|Overall Study|Withdrawal by Subject|12
7570080|NCT02253433|26323823|P2|Overall Study|Medical or Other Concerns|2
7570081|NCT02253433|26323824|P1|Overall Study|Medical or Other Concerns|1
7570082|NCT02253433|26323823|P2|Overall Study|Too Busy|4
7570083|NCT02253433|26323824|P1|Overall Study|Too Busy|0
7570084|NCT02253433|26323823|P2|Overall Study|Unstable Housing/Homeless|7
7570085|NCT02253433|26323824|P1|Overall Study|Unstable Housing/Homeless|0
7570086|NCT02253433|26323823|P2|Overall Study|Uncomfortable with home visitors|3
7570087|NCT02253433|26323824|P1|Overall Study|Uncomfortable with home visitors|0
7570088|NCT02253433|26323823|P2|Overall Study|Out of Study Area|7
7570089|NCT02253433|26323824|P1|Overall Study|Out of Study Area|2
7570090|NCT02253433|26323823|P2|Overall Study|No Longer Interested|15
7570091|NCT02253433|26323824|P1|Overall Study|No Longer Interested|3
7570092|NCT02253433|26323823|P2|Overall Study|Death|1
7570093|NCT02253433|26323824|P1|Overall Study|Death|1
7570094|NCT02253433|26323823|P2|Overall Study|Unable to Contact|16
7570095|NCT02253433|26323824|P1|Overall Study|Unable to Contact|9
7570096|NCT02253316|26323841|P3|Maintenance|Still receiving active treatment|59
7570097|NCT02253316|26323842|P2|Maintenance|Still receiving active treatment|37
7570098|NCT02253316|26323843|P1|Maintenance|Still receiving active treatment|0
7570099|NCT02253316|26323841|P3|Maintenance|Adverse Event|11
7570100|NCT02253316|26323842|P2|Maintenance|Adverse Event|7
7570101|NCT02253316|26323843|P1|Maintenance|Adverse Event|0
7570102|NCT02253316|26323841|P3|Maintenance|Secondary Malignancy|5
7570103|NCT02253316|26323842|P2|Maintenance|Secondary Malignancy|1
7570104|NCT02253316|26323843|P1|Maintenance|Secondary Malignancy|0
7570105|NCT02253316|26323841|P3|Maintenance|Non-Compliance|0
7570106|NCT02253316|26323842|P2|Maintenance|Non-Compliance|1
7570107|NCT02253316|26323843|P1|Maintenance|Non-Compliance|0
7570108|NCT02253316|26323841|P3|Maintenance|Physician Decision|1
7570109|NCT02253316|26323842|P2|Maintenance|Physician Decision|2
7570110|NCT02253316|26323843|P1|Maintenance|Physician Decision|0
7570111|NCT02253316|26323841|P3|Maintenance|Patient Withdrew Logistical Concerns|5
7570112|NCT02253316|26323842|P2|Maintenance|Patient Withdrew Logistical Concerns|4
7570113|NCT02253316|26323843|P1|Maintenance|Patient Withdrew Logistical Concerns|0
7570114|NCT02253316|26323841|P3|Maintenance|Ineligible|0
7570115|NCT02253316|26323842|P2|Maintenance|Ineligible|1
7570116|NCT02253316|26323843|P1|Maintenance|Ineligible|0
7570117|NCT02253316|26323841|P3|Consolidation|Adverse Event|0
7570118|NCT02253316|26323842|P2|Consolidation|Adverse Event|0
7570119|NCT02253316|26323843|P1|Consolidation|Adverse Event|7
7570120|NCT02253316|26323841|P3|Consolidation|Secondary Malignancy|0
7570121|NCT02253316|26323842|P2|Consolidation|Secondary Malignancy|0
7570122|NCT02253316|26323843|P1|Consolidation|Secondary Malignancy|2
7570123|NCT02253316|26323841|P3|Consolidation|Patient Withdrew Logistical Concerns|0
7570124|NCT02253316|26323842|P2|Consolidation|Patient Withdrew Logistical Concerns|0
7570125|NCT02253316|26323843|P1|Consolidation|Patient Withdrew Logistical Concerns|2
7570126|NCT02253316|26323841|P3|Consolidation|Non-Compliance|0
7570127|NCT02253316|26323842|P2|Consolidation|Non-Compliance|0
7570128|NCT02253316|26323843|P1|Consolidation|Non-Compliance|1
7570129|NCT02253316|26323841|P3|Consolidation|Progression|0
7570130|NCT02253316|26323842|P2|Consolidation|Progression|0
7570131|NCT02253316|26323843|P1|Consolidation|Progression|5
7570132|NCT02253147|26324102|P1|Overall Study|Withdrawal by Subject|1
7570133|NCT02253147|26324102|P1|Overall Study|Lost to Follow-up|2
7570134|NCT02253147|26324102|P1|Overall Study|Conditional re-treatment at W52|5
7570135|NCT02253147|26324102|P1|Overall Study|Did not consent to study extension|9
7570136|NCT02253147|26324102|P1|Overall Study|Protocol Violation|30
7570137|NCT02252965|26324136|P2|Overall Study|Other|5
7570138|NCT02252965|26324137|P1|Overall Study|Other|4
7570139|NCT02252965|26324136|P2|Overall Study|Withdrawal by Subject|9
7570140|NCT02252965|26324137|P1|Overall Study|Withdrawal by Subject|7
7570141|NCT02252965|26324136|P2|Overall Study|Lack of Efficacy|2
7570142|NCT02252965|26324137|P1|Overall Study|Lack of Efficacy|0
7570143|NCT02252965|26324136|P2|Overall Study|Protocol Violation|5
7570144|NCT02252965|26324137|P1|Overall Study|Protocol Violation|4
7570145|NCT02252965|26324136|P2|Overall Study|Lost to Follow-up|8
7570146|NCT02252965|26324137|P1|Overall Study|Lost to Follow-up|16
7570147|NCT02252965|26324136|P2|Overall Study|Adverse Event|14
7570148|NCT02252965|26324137|P1|Overall Study|Adverse Event|9
7570149|NCT02252939|26324164|P1|Overall Study|Lost to Follow-up|3
7570150|NCT02252588|26324205|P2|Overall Study|Withdrawal by Subject|0
7570151|NCT02252588|26324206|P1|Overall Study|Withdrawal by Subject|4
7570152|NCT02252536|26324234|P2|Overall Study|Lost to Follow-up|3
7570153|NCT02252536|26324235|P1|Overall Study|Lost to Follow-up|5
7570154|NCT02252406|26324296|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
7570155|NCT02252406|26324297|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
7570156|NCT02252406|26324296|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7570157|NCT02252406|26324297|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7570158|NCT02252406|26324296|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
7570159|NCT02252406|26324297|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
7570160|NCT02252406|26324296|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
7570161|NCT02252406|26324297|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
7570162|NCT02252406|26324296|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
7570163|NCT02252406|26324297|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
7570164|NCT02252211|26324355|P3|Overall Study|Serious Adverse Event During Screening|1
7570165|NCT02252211|26324356|P2|Overall Study|Serious Adverse Event During Screening|0
7570166|NCT02252211|26324357|P1|Overall Study|Serious Adverse Event During Screening|1
7570167|NCT02252211|26324355|P3|Overall Study|Withdrawal by Subject|0
7570168|NCT02252211|26324356|P2|Overall Study|Withdrawal by Subject|0
7570169|NCT02252211|26324357|P1|Overall Study|Withdrawal by Subject|1
7570170|NCT02252211|26324355|P3|Overall Study|Progressive disease|0
7570171|NCT02252211|26324356|P2|Overall Study|Progressive disease|2
7570172|NCT02252211|26324357|P1|Overall Study|Progressive disease|3
7570173|NCT02252211|26324355|P3|Overall Study|Adverse Event|0
7570174|NCT02252211|26324356|P2|Overall Study|Adverse Event|1
7570175|NCT02252211|26324357|P1|Overall Study|Adverse Event|0
7570176|NCT02252172|26324394|P2|Overall Study|Ongoing|298
7570177|NCT02252172|26324395|P1|Overall Study|Ongoing|276
7570178|NCT02252172|26324394|P2|Overall Study|Lost to Follow-up|1
7570179|NCT02252172|26324395|P1|Overall Study|Lost to Follow-up|3
7570180|NCT02252146|26324407|P1|Overall Study|Inability to travel to study site|1
7570181|NCT02252146|26324407|P1|Overall Study|Entered hospice care|1
7570182|NCT02252146|26324407|P1|Overall Study|Lack of Efficacy|4
7570183|NCT02252042|26324448|P2|Overall Study|Ongoing in study|35
7570184|NCT02252042|26324449|P1|Overall Study|Ongoing in study|64
7570185|NCT02252042|26324448|P2|Overall Study|Withdrawal by Subject|20
7570186|NCT02252042|26324449|P1|Overall Study|Withdrawal by Subject|13
7570187|NCT02252042|26324448|P2|Overall Study|Physician Decision|1
7570188|NCT02252042|26324449|P1|Overall Study|Physician Decision|0
7570189|NCT02252042|26324448|P2|Overall Study|Death|192
7570190|NCT02252042|26324449|P1|Overall Study|Death|170
7570191|NCT02252016|26324489|P2|Overall Study|Withdrawal by Subject|2
7570192|NCT02252016|26324490|P1|Overall Study|Withdrawal by Subject|0
7570193|NCT02252016|26324489|P2|Overall Study|Physician Decision|0
7570194|NCT02252016|26324490|P1|Overall Study|Physician Decision|1
7570195|NCT02252016|26324489|P2|Overall Study|Lost to Follow-up|1
7570196|NCT02252016|26324490|P1|Overall Study|Lost to Follow-up|2
7570197|NCT02251990|26324504|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
7570198|NCT02251990|26324505|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
7570199|NCT02251990|26324504|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
7570200|NCT02251990|26324505|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
7570201|NCT02251990|26324504|P2|Period 1 (Double-blind [DB])|Not Treated|0
7570202|NCT02251990|26324505|P1|Period 1 (Double-blind [DB])|Not Treated|1
7570203|NCT02251990|26324504|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
7570204|NCT02251990|26324505|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
7570205|NCT02251990|26324504|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
7570206|NCT02251990|26324505|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
7570207|NCT02251990|26324504|P2|Period 1 (Double-blind [DB])|Adverse Event|1
7570208|NCT02251990|26324505|P1|Period 1 (Double-blind [DB])|Adverse Event|1
7570209|NCT02251912|26324533|P2|Overall Study|Adverse Event|2
7570210|NCT02251912|26324534|P1|Overall Study|Adverse Event|0
7570211|NCT02251912|26324533|P2|Overall Study|Withdrawal by Subject|3
7570212|NCT02251912|26324534|P1|Overall Study|Withdrawal by Subject|2
7570213|NCT02251743|26324563|P2|Overall Study|Withdrawal by Subject|1
7570214|NCT02251743|26324564|P1|Overall Study|Withdrawal by Subject|1
7570215|NCT02251717|26324572|P2|Overall Study|Withdrew Consent|0
7570216|NCT02251717|26324573|P1|Overall Study|Withdrew Consent|1
7570217|NCT02251717|26324572|P2|Overall Study|Adverse Event|1
7570218|NCT02251717|26324573|P1|Overall Study|Adverse Event|0
7570219|NCT02251652|26324585|P1|Overall Study|Withdrawal by Subject|1
7570220|NCT02251275|26324652|P5|Overall Study|Withdrawal by Subject|0
7570221|NCT02251275|26324653|P4|Overall Study|Withdrawal by Subject|1
7570222|NCT02251275|26324654|P3|Overall Study|Withdrawal by Subject|35
7570223|NCT02251275|26324655|P2|Overall Study|Withdrawal by Subject|51
7570224|NCT02251275|26324656|P1|Overall Study|Withdrawal by Subject|25
7570225|NCT02251275|26324652|P5|Overall Study|Protocol Deviation|0
7570226|NCT02251275|26324653|P4|Overall Study|Protocol Deviation|0
7570227|NCT02251275|26324654|P3|Overall Study|Protocol Deviation|1
7570228|NCT02251275|26324655|P2|Overall Study|Protocol Deviation|0
7570229|NCT02251275|26324656|P1|Overall Study|Protocol Deviation|0
7570230|NCT02251275|26324652|P5|Overall Study|Physician Decision|1
7570231|NCT02251275|26324653|P4|Overall Study|Physician Decision|0
7570232|NCT02251275|26324654|P3|Overall Study|Physician Decision|26
7570233|NCT02251275|26324655|P2|Overall Study|Physician Decision|30
7570234|NCT02251275|26324656|P1|Overall Study|Physician Decision|19
7570235|NCT02251275|26324652|P5|Overall Study|Lost to Follow-up|0
7570236|NCT02251275|26324653|P4|Overall Study|Lost to Follow-up|0
7570237|NCT02251275|26324654|P3|Overall Study|Lost to Follow-up|4
7570238|NCT02251275|26324655|P2|Overall Study|Lost to Follow-up|6
7570239|NCT02251275|26324656|P1|Overall Study|Lost to Follow-up|5
7570240|NCT02251275|26324652|P5|Overall Study|Adverse Event|0
7570241|NCT02251275|26324653|P4|Overall Study|Adverse Event|0
7570242|NCT02251275|26324654|P3|Overall Study|Adverse Event|28
7570243|NCT02251275|26324655|P2|Overall Study|Adverse Event|60
7570244|NCT02251275|26324656|P1|Overall Study|Adverse Event|23
7570245|NCT02250651|26324718|P3|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7570246|NCT02250651|26324719|P2|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7570247|NCT02250651|26324720|P1|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
7570248|NCT02250651|26324718|P3|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7570249|NCT02250651|26324719|P2|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
7570250|NCT02250651|26324720|P1|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7570251|NCT02250651|26324718|P3|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7570252|NCT02250651|26324719|P2|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
7570253|NCT02250651|26324720|P1|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7570254|NCT02250651|26324718|P3|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7570255|NCT02250651|26324719|P2|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7570256|NCT02250651|26324720|P1|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
7570257|NCT02250651|26324718|P3|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7570258|NCT02250651|26324719|P2|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
7570259|NCT02250651|26324720|P1|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7570260|NCT02250651|26324718|P3|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7570261|NCT02250651|26324719|P2|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
7570262|NCT02250651|26324720|P1|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7570263|NCT02250651|26324718|P3|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7570264|NCT02250651|26324719|P2|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
7570265|NCT02250651|26324720|P1|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7570266|NCT02250651|26324718|P3|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
7570267|NCT02250651|26324719|P2|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7570268|NCT02250651|26324720|P1|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7570269|NCT02250651|26324718|P3|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
7570270|NCT02250651|26324719|P2|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
7570271|NCT02250651|26324720|P1|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
7570272|NCT02250651|26324718|P3|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
7570273|NCT02250651|26324719|P2|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
7570274|NCT02250651|26324720|P1|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
7570275|NCT02250651|26324718|P3|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
7570276|NCT02250651|26324719|P2|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7570277|NCT02250651|26324720|P1|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7570278|NCT02250651|26324718|P3|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7570279|NCT02250651|26324719|P2|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7570280|NCT02250651|26324720|P1|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
7570281|NCT02250651|26324718|P3|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
7570282|NCT02250651|26324719|P2|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
7570283|NCT02250651|26324720|P1|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
7570284|NCT02250651|26324718|P3|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7570285|NCT02250651|26324719|P2|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7570286|NCT02250651|26324720|P1|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
7570287|NCT02250651|26324718|P3|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7570288|NCT02250651|26324719|P2|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7570289|NCT02250651|26324720|P1|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
7570290|NCT02250443|26324794|P1|Overall Study|Adverse Event|3
7570291|NCT02250443|26324794|P1|Overall Study|Administrative problems|7
7570292|NCT02250326|26324823|P3|Follow-Up Period|Lost to Follow-up|3
7570293|NCT02250326|26324824|P2|Follow-Up Period|Lost to Follow-up|1
7570294|NCT02250326|26324825|P1|Follow-Up Period|Lost to Follow-up|1
7570295|NCT02250326|26324823|P3|Follow-Up Period|Unknown or Missing|3
7570296|NCT02250326|26324824|P2|Follow-Up Period|Unknown or Missing|3
7570297|NCT02250326|26324825|P1|Follow-Up Period|Unknown or Missing|2
7570298|NCT02250326|26324823|P3|Follow-Up Period|Death|32
7570299|NCT02250326|26324824|P2|Follow-Up Period|Death|26
7570300|NCT02250326|26324825|P1|Follow-Up Period|Death|46
7570301|NCT02250326|26324823|P3|Treatment Period|Randomized or assigned; not treated|1
7570302|NCT02250326|26324824|P2|Treatment Period|Randomized or assigned; not treated|1
7570303|NCT02250326|26324825|P1|Treatment Period|Randomized or assigned; not treated|2
7570304|NCT02250326|26324823|P3|Treatment Period|Miscellaneous|7
7570305|NCT02250326|26324824|P2|Treatment Period|Miscellaneous|2
7570306|NCT02250326|26324825|P1|Treatment Period|Miscellaneous|8
7570307|NCT02250326|26324823|P3|Treatment Period|Withdrawal by Subject|4
7570308|NCT02250326|26324824|P2|Treatment Period|Withdrawal by Subject|5
7570309|NCT02250326|26324825|P1|Treatment Period|Withdrawal by Subject|11
7570310|NCT02250326|26324823|P3|Treatment Period|Symptomatic Deterioration|10
7570311|NCT02250326|26324824|P2|Treatment Period|Symptomatic Deterioration|4
7570312|NCT02250326|26324825|P1|Treatment Period|Symptomatic Deterioration|9
7570313|NCT02250326|26324823|P3|Treatment Period|Progressive Disease|45
7570314|NCT02250326|26324824|P2|Treatment Period|Progressive Disease|36
7570315|NCT02250326|26324825|P1|Treatment Period|Progressive Disease|42
7570316|NCT02250326|26324823|P3|Treatment Period|Adverse Event|8
7570317|NCT02250326|26324824|P2|Treatment Period|Adverse Event|4
7570318|NCT02250326|26324825|P1|Treatment Period|Adverse Event|8
7570319|NCT02250326|26324823|P3|Treatment Period|Death|2
7570320|NCT02250326|26324824|P2|Treatment Period|Death|12
7570321|NCT02250326|26324825|P1|Treatment Period|Death|1
7570322|NCT02250274|26324858|P2|Overall Study|Insufficient blood draw amount|6
7570323|NCT02250274|26324859|P1|Overall Study|Insufficient blood draw amount|7
7570324|NCT02250183|26324875|P1|Overall Study|Lost to Follow-up|1
7570325|NCT02250183|26324875|P1|Overall Study|Adverse Event|5
7570326|NCT02250183|26324875|P1|Overall Study|Withdrawal by Subject|2
7570327|NCT02249949|26324897|P1|Overall Study|Cancelled prior to treatment|2
7570328|NCT02249832|26324904|P1|Overall Study|Lost to Follow-up|10
7570329|NCT02249832|26324904|P1|Overall Study|Withdrawal by Subject|3
7570330|NCT02249767|26324948|P3|Overall Study|Did not use medication|8
7570331|NCT02249767|26324949|P2|Overall Study|Did not use medication|9
7570332|NCT02249767|26324950|P1|Overall Study|Did not use medication|8
7570333|NCT02249182|26325016|P5|Treatment Phase|Lost to Follow-up|0
7570334|NCT02249182|26325017|P4|Treatment Phase|Lost to Follow-up|0
7570335|NCT02249182|26325018|P3|Treatment Phase|Lost to Follow-up|0
7570336|NCT02249182|26325019|P2|Treatment Phase|Lost to Follow-up|0
7570337|NCT02249182|26325020|P1|Treatment Phase|Lost to Follow-up|4
7570338|NCT02249091|26325146|P2|Overall Study|Refractory AML|1
7570339|NCT02249091|26325147|P1|Overall Study|Refractory AML|1
7570340|NCT02249091|26325146|P2|Overall Study|CR with subsequent donor lymphocyte infusion|0
7570341|NCT02249091|26325147|P1|Overall Study|CR with subsequent donor lymphocyte infusion|1
7570342|NCT02249091|26325146|P2|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
7570343|NCT02249091|26325147|P1|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
7570344|NCT02249091|26325146|P2|Overall Study|Stable disease with following SCT|1
7570345|NCT02249091|26325147|P1|Overall Study|Stable disease with following SCT|0
7570346|NCT02249091|26325146|P2|Overall Study|Adverse Event|0
7570347|NCT02249091|26325147|P1|Overall Study|Adverse Event|1
7570348|NCT02249091|26325146|P2|Overall Study|Death|4
7570349|NCT02249091|26325147|P1|Overall Study|Death|3
7570350|NCT02249091|26325146|P2|Overall Study|Withdrawal by Subject|2
7570351|NCT02249091|26325147|P1|Overall Study|Withdrawal by Subject|2
7570352|NCT02249091|26325146|P2|Overall Study|Physician Decision|1
7570353|NCT02249091|26325147|P1|Overall Study|Physician Decision|4
7570354|NCT02249091|26325146|P2|Overall Study|Lack of Efficacy|3
7570355|NCT02249091|26325147|P1|Overall Study|Lack of Efficacy|8
7570356|NCT02248974|26325193|P2|1-Month Follow-Up|Lost to Follow-up|3
7570357|NCT02248974|26325194|P1|1-Month Follow-Up|Lost to Follow-up|2
7570358|NCT02248974|26325193|P2|1-Week Follow-Up|Lost to Follow-up|8
7570359|NCT02248974|26325194|P1|1-Week Follow-Up|Lost to Follow-up|0
7570360|NCT02248974|26325193|P2|1-Week Follow-Up|Withdrawal by Subject|2
7570361|NCT02248974|26325194|P1|1-Week Follow-Up|Withdrawal by Subject|0
7570362|NCT02248974|26325193|P2|1-Week Follow-Up|Timing: implanted before survey|2
7570363|NCT02248974|26325194|P1|1-Week Follow-Up|Timing: implanted before survey|0
7570364|NCT02248974|26325193|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
7570365|NCT02248974|26325194|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
7570366|NCT02248974|26325193|P2|1-Week Follow-Up|Excluded because of age|1
7570367|NCT02248974|26325194|P1|1-Week Follow-Up|Excluded because of age|0
7570368|NCT02248974|26325193|P2|1-Week Follow-Up|Death|1
7570369|NCT02248974|26325194|P1|1-Week Follow-Up|Death|1
7570370|NCT02248974|26325193|P2|1-Week Follow-Up|Cognitive Difficulty|0
7570371|NCT02248974|26325194|P1|1-Week Follow-Up|Cognitive Difficulty|1
7570372|NCT02248974|26325193|P2|1-Week Follow-Up|Transferred to another facility|0
7570373|NCT02248974|26325194|P1|1-Week Follow-Up|Transferred to another facility|1
7570374|NCT02248974|26325193|P2|1-Week Follow-Up|Enrolled in another study|1
7570375|NCT02248974|26325194|P1|1-Week Follow-Up|Enrolled in another study|1
7570376|NCT02248974|26325193|P2|1-Week Follow-Up|Became ineligible for LVAD|1
7570377|NCT02248974|26325194|P1|1-Week Follow-Up|Became ineligible for LVAD|4
7570378|NCT02248974|26325193|P2|1-Day Follow-Up|Enrolled in another study|0
7570379|NCT02248974|26325194|P1|1-Day Follow-Up|Enrolled in another study|1
7570380|NCT02248974|26325193|P2|1-Day Follow-Up|Withdrawal by Subject|0
7570381|NCT02248974|26325194|P1|1-Day Follow-Up|Withdrawal by Subject|5
7570382|NCT02248974|26325193|P2|1-Day Follow-Up|Lost to Follow-up|0
7570383|NCT02248974|26325194|P1|1-Day Follow-Up|Lost to Follow-up|4
7570384|NCT02248961|26325272|P2|Overall Study|Unmet inclusion/exclusion criteria|0
7570385|NCT02248961|26325273|P1|Overall Study|Unmet inclusion/exclusion criteria|1
7570386|NCT02248961|26325272|P2|Overall Study|Withdrawal by Subject|2
7570387|NCT02248961|26325273|P1|Overall Study|Withdrawal by Subject|1
7570388|NCT02248961|26325272|P2|Overall Study|Adverse Event|0
7570389|NCT02248961|26325273|P1|Overall Study|Adverse Event|1
7570390|NCT02248857|26325308|P3|6 Month|Death|0
7570391|NCT02248857|26325309|P2|6 Month|Death|0
7570392|NCT02248857|26325310|P1|6 Month|Death|1
7570393|NCT02248857|26325308|P3|6 Month|Withdrawal by Subject|2
7570394|NCT02248857|26325309|P2|6 Month|Withdrawal by Subject|2
7570395|NCT02248857|26325310|P1|6 Month|Withdrawal by Subject|0
7570396|NCT02248857|26325308|P3|6 Month|Partially completed, unable to finish|0
7570397|NCT02248857|26325309|P2|6 Month|Partially completed, unable to finish|1
7570398|NCT02248857|26325310|P1|6 Month|Partially completed, unable to finish|0
7570399|NCT02248857|26325308|P3|6 Month|Lost to Follow-up|15
7570400|NCT02248857|26325309|P2|6 Month|Lost to Follow-up|26
7570401|NCT02248857|26325310|P1|6 Month|Lost to Follow-up|27
7570402|NCT02248857|26325308|P3|3 Month|Partially completed, unable to finish|1
7570403|NCT02248857|26325309|P2|3 Month|Partially completed, unable to finish|2
7570404|NCT02248857|26325310|P1|3 Month|Partially completed, unable to finish|2
7570405|NCT02248857|26325308|P3|3 Month|Unable to reach for 3 month|26
7570406|NCT02248857|26325309|P2|3 Month|Unable to reach for 3 month|29
7570407|NCT02248857|26325310|P1|3 Month|Unable to reach for 3 month|35
7570408|NCT02248857|26325308|P3|3 Month|Withdrawal by Subject|4
7570409|NCT02248857|26325309|P2|3 Month|Withdrawal by Subject|3
7570410|NCT02248857|26325310|P1|3 Month|Withdrawal by Subject|9
7570411|NCT02248818|26325347|P9|Randomised Study|Administrative - randomization error|0
7570412|NCT02248818|26325348|P8|Randomised Study|Administrative - randomization error|0
7570413|NCT02248818|26325349|P7|Randomised Study|Administrative - randomization error|0
7570414|NCT02248818|26325350|P6|Randomised Study|Administrative - randomization error|8
7570415|NCT02248818|26325351|P5|Randomised Study|Administrative - randomization error|0
7570416|NCT02248818|26325352|P4|Randomised Study|Administrative - randomization error|0
7570417|NCT02248818|26325353|P3|Randomised Study|Administrative - randomization error|0
7570418|NCT02248818|26325354|P2|Randomised Study|Administrative - randomization error|0
7570419|NCT02248818|26325355|P1|Randomised Study|Administrative - randomization error|0
7570420|NCT02248818|26325347|P9|Screening|Lost to Follow-up|7
7570421|NCT02248818|26325348|P8|Screening|Lost to Follow-up|0
7570422|NCT02248818|26325349|P7|Screening|Lost to Follow-up|0
7570423|NCT02248818|26325350|P6|Screening|Lost to Follow-up|0
7570424|NCT02248818|26325351|P5|Screening|Lost to Follow-up|0
7570425|NCT02248818|26325352|P4|Screening|Lost to Follow-up|0
7570426|NCT02248818|26325353|P3|Screening|Lost to Follow-up|0
7570427|NCT02248818|26325354|P2|Screening|Lost to Follow-up|0
7570428|NCT02248818|26325355|P1|Screening|Lost to Follow-up|0
7570429|NCT02248818|26325347|P9|Screening|Withdrawal by Subject|6
7570430|NCT02248818|26325348|P8|Screening|Withdrawal by Subject|0
7570431|NCT02248818|26325349|P7|Screening|Withdrawal by Subject|0
7570432|NCT02248818|26325350|P6|Screening|Withdrawal by Subject|0
7570433|NCT02248818|26325351|P5|Screening|Withdrawal by Subject|0
7570434|NCT02248818|26325352|P4|Screening|Withdrawal by Subject|0
7570435|NCT02248818|26325353|P3|Screening|Withdrawal by Subject|0
7570436|NCT02248818|26325354|P2|Screening|Withdrawal by Subject|0
7570437|NCT02248818|26325355|P1|Screening|Withdrawal by Subject|0
7570438|NCT02248818|26325347|P9|Screening|Physician Decision|73
7570439|NCT02248818|26325348|P8|Screening|Physician Decision|0
7570440|NCT02248818|26325349|P7|Screening|Physician Decision|0
7570441|NCT02248818|26325350|P6|Screening|Physician Decision|0
7570442|NCT02248818|26325351|P5|Screening|Physician Decision|0
7570443|NCT02248818|26325352|P4|Screening|Physician Decision|0
7570444|NCT02248818|26325353|P3|Screening|Physician Decision|0
7570445|NCT02248818|26325354|P2|Screening|Physician Decision|0
7570446|NCT02248818|26325355|P1|Screening|Physician Decision|0
7570447|NCT02248818|26325347|P9|Screening|Study fully enrolled|14
7570448|NCT02248818|26325348|P8|Screening|Study fully enrolled|0
7570449|NCT02248818|26325349|P7|Screening|Study fully enrolled|0
7570450|NCT02248818|26325350|P6|Screening|Study fully enrolled|0
7570451|NCT02248818|26325351|P5|Screening|Study fully enrolled|0
7570452|NCT02248818|26325352|P4|Screening|Study fully enrolled|0
7570453|NCT02248818|26325353|P3|Screening|Study fully enrolled|0
7570454|NCT02248818|26325354|P2|Screening|Study fully enrolled|0
7570455|NCT02248818|26325355|P1|Screening|Study fully enrolled|0
7570456|NCT02248818|26325347|P9|Screening|Protocol Violation|7
7570457|NCT02248818|26325348|P8|Screening|Protocol Violation|0
7570458|NCT02248818|26325349|P7|Screening|Protocol Violation|0
7570459|NCT02248818|26325350|P6|Screening|Protocol Violation|0
7570460|NCT02248818|26325351|P5|Screening|Protocol Violation|0
7570461|NCT02248818|26325352|P4|Screening|Protocol Violation|0
7570462|NCT02248818|26325353|P3|Screening|Protocol Violation|0
7570463|NCT02248818|26325354|P2|Screening|Protocol Violation|0
7570464|NCT02248818|26325355|P1|Screening|Protocol Violation|0
7570465|NCT02248675|26325570|P2|Overall Study|Lost to Follow-up|1
7570466|NCT02248675|26325571|P1|Overall Study|Lost to Follow-up|3
7570467|NCT02248649|26325598|P2|Overall Study|Lost to Follow-up|10
7570468|NCT02248649|26325599|P1|Overall Study|Lost to Follow-up|14
7570469|NCT02248649|26325598|P2|Overall Study|Death|11
7570470|NCT02248649|26325599|P1|Overall Study|Death|7
7570471|NCT02248480|26325643|P2|Overall Study|Other:Physician Decision|1
7570472|NCT02248480|26325644|P1|Overall Study|Other:Physician Decision|0
7570473|NCT02248480|26325643|P2|Overall Study|Entry Criteria Not Met|1
7570474|NCT02248480|26325644|P1|Overall Study|Entry Criteria Not Met|0
7570475|NCT02248480|26325643|P2|Overall Study|Withdrawal by Subject|4
7570476|NCT02248480|26325644|P1|Overall Study|Withdrawal by Subject|2
7570477|NCT02248480|26325643|P2|Overall Study|Adverse Event|2
7570478|NCT02248480|26325644|P1|Overall Study|Adverse Event|11
7570479|NCT02248480|26325643|P2|Overall Study|Lack of Efficacy|6
7570480|NCT02248480|26325644|P1|Overall Study|Lack of Efficacy|4
7570481|NCT02247960|26325711|P2|Catheter Removed|Lost to Follow-up|10
7570482|NCT02247960|26325712|P1|Catheter Removed|Lost to Follow-up|7
7570483|NCT02247960|26325711|P2|Patient Consent and Randomization|Withdrawal by Subject|4
7570484|NCT02247960|26325712|P1|Patient Consent and Randomization|Withdrawal by Subject|0
7570485|NCT02247960|26325711|P2|Patient Consent and Randomization|Physician Decision|2
7570486|NCT02247960|26325712|P1|Patient Consent and Randomization|Physician Decision|2
7570487|NCT02247804|26325725|P3|Treatment Period 3|Reason not Specified|3
7570488|NCT02247804|26325726|P2|Treatment Period 3|Reason not Specified|1
7570489|NCT02247804|26325727|P1|Treatment Period 3|Reason not Specified|2
7570490|NCT02247804|26325725|P3|Treatment Period 3|Personal Reasons|2
7570491|NCT02247804|26325726|P2|Treatment Period 3|Personal Reasons|3
7570492|NCT02247804|26325727|P1|Treatment Period 3|Personal Reasons|4
7570493|NCT02247804|26325725|P3|Treatment Period 3|Lost to Follow-up|2
7570494|NCT02247804|26325726|P2|Treatment Period 3|Lost to Follow-up|2
7570495|NCT02247804|26325727|P1|Treatment Period 3|Lost to Follow-up|1
7570496|NCT02247804|26325725|P3|Treatment Period 3|Lack of Efficacy|0
7570497|NCT02247804|26325726|P2|Treatment Period 3|Lack of Efficacy|1
7570498|NCT02247804|26325727|P1|Treatment Period 3|Lack of Efficacy|0
7570499|NCT02247804|26325725|P3|Treatment Period 3|Adverse Event|3
7570500|NCT02247804|26325726|P2|Treatment Period 3|Adverse Event|3
7570501|NCT02247804|26325727|P1|Treatment Period 3|Adverse Event|4
7570502|NCT02247804|26325725|P3|Treatment Period 2|Reason not Specified|2
7570503|NCT02247804|26325726|P2|Treatment Period 2|Reason not Specified|0
7570504|NCT02247804|26325727|P1|Treatment Period 2|Reason not Specified|0
7570505|NCT02247804|26325725|P3|Treatment Period 2|Personal Reasons|1
7570506|NCT02247804|26325726|P2|Treatment Period 2|Personal Reasons|1
7570507|NCT02247804|26325727|P1|Treatment Period 2|Personal Reasons|2
7570508|NCT02247804|26325725|P3|Treatment Period 2|Lost to Follow-up|1
7570509|NCT02247804|26325726|P2|Treatment Period 2|Lost to Follow-up|1
7570510|NCT02247804|26325727|P1|Treatment Period 2|Lost to Follow-up|0
7570511|NCT02247804|26325725|P3|Treatment Period 2|Lack of Efficacy|1
7570512|NCT02247804|26325726|P2|Treatment Period 2|Lack of Efficacy|0
7570513|NCT02247804|26325727|P1|Treatment Period 2|Lack of Efficacy|0
7570514|NCT02247804|26325725|P3|Treatment Period 2|Adverse Event|3
7570515|NCT02247804|26325726|P2|Treatment Period 2|Adverse Event|3
7570516|NCT02247804|26325727|P1|Treatment Period 2|Adverse Event|6
7570517|NCT02247804|26325725|P3|Treatment Period 1|Randomized but not Treated|1
7570518|NCT02247804|26325726|P2|Treatment Period 1|Randomized but not Treated|1
7570519|NCT02247804|26325727|P1|Treatment Period 1|Randomized but not Treated|5
7570520|NCT02247804|26325725|P3|Treatment Period 1|Protocol Deviation|1
7570521|NCT02247804|26325726|P2|Treatment Period 1|Protocol Deviation|0
7570522|NCT02247804|26325727|P1|Treatment Period 1|Protocol Deviation|0
7570523|NCT02247804|26325725|P3|Treatment Period 1|Personal Reasons|2
7570524|NCT02247804|26325726|P2|Treatment Period 1|Personal Reasons|1
7570525|NCT02247804|26325727|P1|Treatment Period 1|Personal Reasons|7
7570526|NCT02247804|26325725|P3|Treatment Period 1|Lost to Follow-up|2
7570527|NCT02247804|26325726|P2|Treatment Period 1|Lost to Follow-up|0
7570528|NCT02247804|26325727|P1|Treatment Period 1|Lost to Follow-up|1
7570529|NCT02247804|26325725|P3|Treatment Period 1|Lack of Efficacy|2
7570530|NCT02247804|26325726|P2|Treatment Period 1|Lack of Efficacy|0
7570531|NCT02247804|26325727|P1|Treatment Period 1|Lack of Efficacy|0
7570532|NCT02247804|26325725|P3|Treatment Period 1|Adverse Event|0
7570533|NCT02247804|26325726|P2|Treatment Period 1|Adverse Event|2
7570534|NCT02247804|26325727|P1|Treatment Period 1|Adverse Event|9
7570535|NCT02247531|26325785|P3|Overall Study|Unspecified Reason|4
7570536|NCT02247531|26325786|P2|Overall Study|Unspecified Reason|3
7570537|NCT02247531|26325787|P1|Overall Study|Unspecified Reason|2
7570538|NCT02247531|26325785|P3|Overall Study|Physician Decision|2
7570539|NCT02247531|26325786|P2|Overall Study|Physician Decision|2
7570540|NCT02247531|26325787|P1|Overall Study|Physician Decision|0
7570541|NCT02247531|26325785|P3|Overall Study|Study Terminated by Sponsor|62
7570542|NCT02247531|26325786|P2|Overall Study|Study Terminated by Sponsor|66
7570543|NCT02247531|26325787|P1|Overall Study|Study Terminated by Sponsor|64
7570544|NCT02247531|26325785|P3|Overall Study|Withdrawal by Subject|25
7570545|NCT02247531|26325786|P2|Overall Study|Withdrawal by Subject|31
7570546|NCT02247531|26325787|P1|Overall Study|Withdrawal by Subject|26
7570547|NCT02247531|26325785|P3|Overall Study|Non-compliance|0
7570548|NCT02247531|26325786|P2|Overall Study|Non-compliance|2
7570549|NCT02247531|26325787|P1|Overall Study|Non-compliance|2
7570550|NCT02247531|26325785|P3|Overall Study|Lost to Follow-up|3
7570551|NCT02247531|26325786|P2|Overall Study|Lost to Follow-up|8
7570552|NCT02247531|26325787|P1|Overall Study|Lost to Follow-up|1
7570553|NCT02247531|26325785|P3|Overall Study|Death|5
7570554|NCT02247531|26325786|P2|Overall Study|Death|9
7570555|NCT02247531|26325787|P1|Overall Study|Death|8
7570556|NCT02247531|26325785|P3|Overall Study|Adverse Event|9
7570557|NCT02247531|26325786|P2|Overall Study|Adverse Event|4
7570558|NCT02247531|26325787|P1|Overall Study|Adverse Event|3
7570559|NCT02247479|26325837|P3|Overall Study|Unspecified Reason|2
7570560|NCT02247479|26325838|P2|Overall Study|Unspecified Reason|5
7570561|NCT02247479|26325839|P1|Overall Study|Unspecified Reason|2
7570562|NCT02247479|26325837|P3|Overall Study|Physician Decision|2
7570563|NCT02247479|26325838|P2|Overall Study|Physician Decision|0
7570564|NCT02247479|26325839|P1|Overall Study|Physician Decision|1
7570565|NCT02247479|26325837|P3|Overall Study|Study Terminated by Sponsor|94
7570566|NCT02247479|26325838|P2|Overall Study|Study Terminated by Sponsor|88
7570567|NCT02247479|26325839|P1|Overall Study|Study Terminated by Sponsor|98
7570568|NCT02247479|26325837|P3|Overall Study|Withdrawal by Subject|24
7570569|NCT02247479|26325838|P2|Overall Study|Withdrawal by Subject|29
7570570|NCT02247479|26325839|P1|Overall Study|Withdrawal by Subject|25
7570571|NCT02247479|26325837|P3|Overall Study|Non-compliance|1
7570572|NCT02247479|26325838|P2|Overall Study|Non-compliance|0
7570573|NCT02247479|26325839|P1|Overall Study|Non-compliance|0
7570574|NCT02247479|26325837|P3|Overall Study|Lost to Follow-up|1
7570575|NCT02247479|26325838|P2|Overall Study|Lost to Follow-up|3
7570576|NCT02247479|26325839|P1|Overall Study|Lost to Follow-up|3
7570577|NCT02247479|26325837|P3|Overall Study|Death|6
7570578|NCT02247479|26325838|P2|Overall Study|Death|4
7570579|NCT02247479|26325839|P1|Overall Study|Death|5
7570580|NCT02247479|26325837|P3|Overall Study|Adverse Event|8
7570581|NCT02247479|26325838|P2|Overall Study|Adverse Event|9
7570582|NCT02247479|26325839|P1|Overall Study|Adverse Event|8
7570583|NCT02247466|26325888|P2|Overall Study|Procedure changed to open surgery|3
7570584|NCT02247466|26325889|P1|Overall Study|Procedure changed to open surgery|0
7570585|NCT02247440|26325907|P1|Overall Study|Lack of Efficacy|3
7570586|NCT02247440|26325907|P1|Overall Study|Withdrawal by Subject|1
7570587|NCT02247401|26325920|P3|Overall Study|Lost to Follow-up|1
7570588|NCT02247401|26325921|P2|Overall Study|Lost to Follow-up|1
7570589|NCT02247401|26325922|P1|Overall Study|Lost to Follow-up|1
7570590|NCT02247401|26325920|P3|Overall Study|Withdrawal by Subject|1
7570591|NCT02247401|26325921|P2|Overall Study|Withdrawal by Subject|1
7570592|NCT02247401|26325922|P1|Overall Study|Withdrawal by Subject|4
7570593|NCT02247401|26325920|P3|Overall Study|Adverse Event|0
7570594|NCT02247401|26325921|P2|Overall Study|Adverse Event|0
7570595|NCT02247401|26325922|P1|Overall Study|Adverse Event|1
7570596|NCT02247011|26325982|P1|Overall Study|Poor quality of radiological results|125
7570597|NCT02246998|26326003|P4|Overall Study|Randomized but Never Dosed|1
7570598|NCT02246998|26326004|P3|Overall Study|Randomized but Never Dosed|2
7570599|NCT02246998|26326005|P2|Overall Study|Randomized but Never Dosed|2
7570600|NCT02246998|26326006|P1|Overall Study|Randomized but Never Dosed|1
7570601|NCT02246998|26326003|P4|Overall Study|Lost to Follow-up|1
7570602|NCT02246998|26326004|P3|Overall Study|Lost to Follow-up|0
7570603|NCT02246998|26326005|P2|Overall Study|Lost to Follow-up|0
7570604|NCT02246998|26326006|P1|Overall Study|Lost to Follow-up|1
7570605|NCT02246998|26326003|P4|Overall Study|Adverse Event|0
7570606|NCT02246998|26326004|P3|Overall Study|Adverse Event|1
7570607|NCT02246998|26326005|P2|Overall Study|Adverse Event|1
7570608|NCT02246998|26326006|P1|Overall Study|Adverse Event|0
7570609|NCT02246777|26326116|P1|Overall Study|Change of residence|1
7570610|NCT02246777|26326116|P1|Overall Study|Adverse Event|2
7570611|NCT02246764|26326132|P3|Overall Study|Protocol Violation|1
7570612|NCT02246764|26326133|P2|Overall Study|Protocol Violation|1
7570613|NCT02246764|26326134|P1|Overall Study|Protocol Violation|2
7570614|NCT02246764|26326132|P3|Overall Study|Physician Decision|1
7570615|NCT02246764|26326133|P2|Overall Study|Physician Decision|2
7570616|NCT02246764|26326134|P1|Overall Study|Physician Decision|0
7570617|NCT02246764|26326132|P3|Overall Study|Disallowed Concomitant Medication|0
7570618|NCT02246764|26326133|P2|Overall Study|Disallowed Concomitant Medication|0
7570619|NCT02246764|26326134|P1|Overall Study|Disallowed Concomitant Medication|1
7570620|NCT02246764|26326132|P3|Overall Study|Withdrawal by Subject|1
7570621|NCT02246764|26326133|P2|Overall Study|Withdrawal by Subject|0
7570622|NCT02246764|26326134|P1|Overall Study|Withdrawal by Subject|0
7570623|NCT02246764|26326132|P3|Overall Study|Adverse Event|1
7570624|NCT02246764|26326133|P2|Overall Study|Adverse Event|29
7570625|NCT02246764|26326134|P1|Overall Study|Adverse Event|15
7570626|NCT02246673|26326147|P5|Overall Study|Protocol Violation|0
7570627|NCT02246673|26326148|P4|Overall Study|Protocol Violation|1
7570628|NCT02246673|26326149|P3|Overall Study|Protocol Violation|0
7570629|NCT02246673|26326150|P2|Overall Study|Protocol Violation|0
7570630|NCT02246673|26326151|P1|Overall Study|Protocol Violation|0
7570631|NCT02246673|26326147|P5|Overall Study|Lost to Follow-up|0
7570632|NCT02246673|26326148|P4|Overall Study|Lost to Follow-up|1
7570633|NCT02246673|26326149|P3|Overall Study|Lost to Follow-up|0
7570634|NCT02246673|26326150|P2|Overall Study|Lost to Follow-up|0
7570635|NCT02246673|26326151|P1|Overall Study|Lost to Follow-up|0
7570636|NCT02246673|26326147|P5|Overall Study|Withdrawal by Subject|1
7570637|NCT02246673|26326148|P4|Overall Study|Withdrawal by Subject|0
7570638|NCT02246673|26326149|P3|Overall Study|Withdrawal by Subject|0
7570639|NCT02246673|26326150|P2|Overall Study|Withdrawal by Subject|0
7570640|NCT02246673|26326151|P1|Overall Study|Withdrawal by Subject|0
7570641|NCT02246673|26326147|P5|Overall Study|Sponsor Decision|0
7570642|NCT02246673|26326148|P4|Overall Study|Sponsor Decision|0
7570643|NCT02246673|26326149|P3|Overall Study|Sponsor Decision|0
7570644|NCT02246673|26326150|P2|Overall Study|Sponsor Decision|0
7570645|NCT02246673|26326151|P1|Overall Study|Sponsor Decision|1
7570646|NCT02246660|26326259|P3|Overall Study|Death|1
7570647|NCT02246660|26326260|P2|Overall Study|Death|0
7570648|NCT02246660|26326261|P1|Overall Study|Death|0
7570649|NCT02246660|26326259|P3|Overall Study|Withdrawal by Subject|0
7570650|NCT02246660|26326260|P2|Overall Study|Withdrawal by Subject|1
7570651|NCT02246660|26326261|P1|Overall Study|Withdrawal by Subject|0
7570652|NCT02246647|26326271|P2|Overall Study|Withdrawal by Subject|1
7570653|NCT02246647|26326272|P1|Overall Study|Withdrawal by Subject|1
7570654|NCT02246621|26326306|P2|Overall Study|On Study Treatment/ Follow Up|119
7570655|NCT02246621|26326307|P1|Overall Study|On Study Treatment/ Follow Up|236
7570656|NCT02246621|26326306|P2|Overall Study|Lost to Follow-up|0
7570657|NCT02246621|26326307|P1|Overall Study|Lost to Follow-up|1
7570658|NCT02246621|26326306|P2|Overall Study|Withdrawal by Subject|16
7570659|NCT02246621|26326307|P1|Overall Study|Withdrawal by Subject|28
7570660|NCT02246582|26326344|P2|Overall Study|Withdrawal by Subject|4
7570661|NCT02246582|26326345|P1|Overall Study|Withdrawal by Subject|3
7570662|NCT02246478|26326355|P4|Multiple-dose Phase|Protocol Violation|1
7570663|NCT02246478|26326356|P3|Multiple-dose Phase|Protocol Violation|0
7570664|NCT02246478|26326357|P2|Multiple-dose Phase|Protocol Violation|0
7570665|NCT02246478|26326358|P1|Multiple-dose Phase|Protocol Violation|1
7570666|NCT02246439|26326384|P2|Overall Study|Withdrawal by Subject|0
7570667|NCT02246439|26326385|P1|Overall Study|Withdrawal by Subject|1
7570668|NCT02246439|26326384|P2|Overall Study|Unkonwn|3
7570669|NCT02246439|26326385|P1|Overall Study|Unkonwn|1
7570670|NCT02246439|26326384|P2|Overall Study|Physician Decision|1
7570671|NCT02246439|26326385|P1|Overall Study|Physician Decision|0
7570672|NCT02246439|26326384|P2|Overall Study|Protocol Violation|2
7570673|NCT02246439|26326385|P1|Overall Study|Protocol Violation|0
7570674|NCT02246439|26326384|P2|Overall Study|Lost to Follow-up|5
7570675|NCT02246439|26326385|P1|Overall Study|Lost to Follow-up|7
7570676|NCT02246439|26326384|P2|Overall Study|Adverse Event|0
7570677|NCT02246439|26326385|P1|Overall Study|Adverse Event|3
7570678|NCT02246218|26326517|P2|Overall Study|Lost to Follow-up|0
7570679|NCT02246218|26326518|P1|Overall Study|Lost to Follow-up|1
7570680|NCT02246218|26326517|P2|Overall Study|Adverse Event|1
7570681|NCT02246218|26326518|P1|Overall Study|Adverse Event|1
7570682|NCT02246218|26326517|P2|Overall Study|Stopping Rule: Liver Transplant|4
7570683|NCT02246218|26326518|P1|Overall Study|Stopping Rule: Liver Transplant|2
7570684|NCT02246218|26326517|P2|Overall Study|Withdrawal by Parent/Guardian|1
7570685|NCT02246218|26326518|P1|Overall Study|Withdrawal by Parent/Guardian|0
7570686|NCT02246166|26326578|P2|Overall Study|Protocol Violation|0
7570687|NCT02246166|26326579|P1|Overall Study|Protocol Violation|1
7570688|NCT02246114|26326615|P2|Overall Study|miscarriage|0
7570689|NCT02246114|26326616|P1|Overall Study|miscarriage|1
7570690|NCT02245737|26326678|P3|Overall Study|Sponsor Decision|432
7570691|NCT02245737|26326679|P2|Overall Study|Sponsor Decision|430
7570692|NCT02245737|26326680|P1|Overall Study|Sponsor Decision|445
7570693|NCT02245737|26326678|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
7570694|NCT02245737|26326679|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
7570695|NCT02245737|26326680|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
7570696|NCT02245737|26326678|P3|Overall Study|Withdrawal by Subject|44
7570697|NCT02245737|26326679|P2|Overall Study|Withdrawal by Subject|41
7570698|NCT02245737|26326680|P1|Overall Study|Withdrawal by Subject|40
7570699|NCT02245737|26326678|P3|Overall Study|Protocol Violation|3
7570700|NCT02245737|26326679|P2|Overall Study|Protocol Violation|2
7570701|NCT02245737|26326680|P1|Overall Study|Protocol Violation|3
7570702|NCT02245737|26326678|P3|Overall Study|Physician Decision|6
7570703|NCT02245737|26326679|P2|Overall Study|Physician Decision|3
7570704|NCT02245737|26326680|P1|Overall Study|Physician Decision|6
7570705|NCT02245737|26326678|P3|Overall Study|Other-determined by Investigator|10
7570706|NCT02245737|26326679|P2|Overall Study|Other-determined by Investigator|10
7570707|NCT02245737|26326680|P1|Overall Study|Other-determined by Investigator|9
7570708|NCT02245737|26326678|P3|Overall Study|Lost to Follow-up|4
7570709|NCT02245737|26326679|P2|Overall Study|Lost to Follow-up|5
7570710|NCT02245737|26326680|P1|Overall Study|Lost to Follow-up|2
7570711|NCT02245737|26326678|P3|Overall Study|Initiation of Symptomatic AD medication|0
7570712|NCT02245737|26326679|P2|Overall Study|Initiation of Symptomatic AD medication|0
7570713|NCT02245737|26326680|P1|Overall Study|Initiation of Symptomatic AD medication|2
7570714|NCT02245737|26326678|P3|Overall Study|Eligibility Criteria No Longer Met|4
7570715|NCT02245737|26326679|P2|Overall Study|Eligibility Criteria No Longer Met|4
7570716|NCT02245737|26326680|P1|Overall Study|Eligibility Criteria No Longer Met|2
7570717|NCT02245737|26326678|P3|Overall Study|Death|4
7570718|NCT02245737|26326679|P2|Overall Study|Death|4
7570719|NCT02245737|26326680|P1|Overall Study|Death|2
7570720|NCT02245737|26326678|P3|Overall Study|Condition Worsened|9
7570721|NCT02245737|26326679|P2|Overall Study|Condition Worsened|10
7570722|NCT02245737|26326680|P1|Overall Study|Condition Worsened|9
7570723|NCT02245737|26326678|P3|Overall Study|Adverse Event|33
7570724|NCT02245737|26326679|P2|Overall Study|Adverse Event|26
7570725|NCT02245737|26326680|P1|Overall Study|Adverse Event|23
7570726|NCT02245672|26326738|P3|Overall Study|Randomized in error (not treated)|0
7570727|NCT02245672|26326739|P2|Overall Study|Randomized in error (not treated)|1
7570728|NCT02245672|26326740|P1|Overall Study|Randomized in error (not treated)|0
7570729|NCT02245672|26326738|P3|Overall Study|Withdrawal by Subject|0
7570730|NCT02245672|26326739|P2|Overall Study|Withdrawal by Subject|3
7570731|NCT02245672|26326740|P1|Overall Study|Withdrawal by Subject|6
7570732|NCT02245672|26326738|P3|Overall Study|Lost to Follow-up|1
7570733|NCT02245672|26326739|P2|Overall Study|Lost to Follow-up|5
7570734|NCT02245672|26326740|P1|Overall Study|Lost to Follow-up|3
7570735|NCT02245672|26326738|P3|Overall Study|Adverse Event|4
7570736|NCT02245672|26326739|P2|Overall Study|Adverse Event|4
7570737|NCT02245672|26326740|P1|Overall Study|Adverse Event|4
7570738|NCT02245620|26326759|P2|Overall Study|Physician Decision|1
7570739|NCT02245620|26326760|P1|Overall Study|Physician Decision|1
7570740|NCT02245568|26326772|P1|Overall Study|Lost to Follow-up|5
7570741|NCT02245568|26326772|P1|Overall Study|Intolerance/dosing issues/interruption|5
7570742|NCT02245568|26326772|P1|Overall Study|Worsening dementia/caregiver withdrawal|6
7570743|NCT02245568|26326772|P1|Overall Study|Blue staining|6
7570744|NCT02245568|26326772|P1|Overall Study|Death|9
7570745|NCT02245568|26326772|P1|Overall Study|Non-compliance with study drug|11
7570746|NCT02245568|26326772|P1|Overall Study|Physician Decision|14
7570747|NCT02245568|26326772|P1|Overall Study|Missing (Site closure)|16
7570748|NCT02245568|26326772|P1|Overall Study|Withdrawal by Legal Representative|31
7570749|NCT02245568|26326772|P1|Overall Study|Withdrawal by Subject|77
7570750|NCT02245568|26326772|P1|Overall Study|Withdrawal by Caregiver|85
7570751|NCT02245568|26326772|P1|Overall Study|Lack of Efficacy|98
7570752|NCT02245568|26326772|P1|Overall Study|Adverse Event|144
7570753|NCT02245568|26326772|P1|Overall Study|Study terminated by Sponsor|346
7570754|NCT02245412|26326794|P3|Follow-Up Period|Other - Terminated by Sponsor|1
7570755|NCT02245412|26326795|P2|Follow-Up Period|Other - Terminated by Sponsor|0
7570756|NCT02245412|26326796|P1|Follow-Up Period|Other - Terminated by Sponsor|0
7570757|NCT02245412|26326794|P3|Follow-Up Period|Physician Decision|0
7570758|NCT02245412|26326795|P2|Follow-Up Period|Physician Decision|0
7570759|NCT02245412|26326796|P1|Follow-Up Period|Physician Decision|1
7570760|NCT02245412|26326794|P3|Follow-Up Period|Death|1
7570761|NCT02245412|26326795|P2|Follow-Up Period|Death|2
7570762|NCT02245412|26326796|P1|Follow-Up Period|Death|4
7570763|NCT02245412|26326794|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
7570764|NCT02245412|26326795|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
7570765|NCT02245412|26326796|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
7570766|NCT02245412|26326794|P3|Treatment Period|Withdrawal by Subject|0
7570767|NCT02245412|26326795|P2|Treatment Period|Withdrawal by Subject|1
7570768|NCT02245412|26326796|P1|Treatment Period|Withdrawal by Subject|2
7570769|NCT02245412|26326794|P3|Treatment Period|Physician Decision|0
7570770|NCT02245412|26326795|P2|Treatment Period|Physician Decision|1
7570771|NCT02245412|26326796|P1|Treatment Period|Physician Decision|1
7570772|NCT02245412|26326794|P3|Treatment Period|Death|0
7570773|NCT02245412|26326795|P2|Treatment Period|Death|1
7570774|NCT02245412|26326796|P1|Treatment Period|Death|1
7570775|NCT02244996|26326843|P2|Overall Study|Lack of Efficacy|6
7570776|NCT02244996|26326844|P1|Overall Study|Lack of Efficacy|2
7570777|NCT02244957|26326858|P2|Overall Study|Lack of Efficacy|0
7570778|NCT02244957|26326859|P1|Overall Study|Lack of Efficacy|1
7570779|NCT02244944|26326903|P1|Overall Study|Study Terminated|1
7570780|NCT02244944|26326903|P1|Overall Study|Withdrawal by Subject|1
7570781|NCT02244619|26326934|P2|Overall Study|Did not receive study intervention|21
7570782|NCT02244619|26326935|P1|Overall Study|Did not receive study intervention|8
7570783|NCT02244580|26326953|P1|Overall Study|No cancer tissues available|241
7570784|NCT02244424|26326963|P2|Overall Study|Lost to Follow-up|10
7570785|NCT02244424|26326964|P1|Overall Study|Lost to Follow-up|20
7570786|NCT02243696|26326983|P1|Overall Study|Study Terminated for EP PASSION|961
7570787|NCT02243696|26326983|P1|Overall Study|Subject Withdrawn by Investigator|273
7570788|NCT02243696|26326983|P1|Overall Study|Subject No Longer has Study System|42
7570789|NCT02243696|26326983|P1|Overall Study|Lost to Follow-up|57
7570790|NCT02243696|26326983|P1|Overall Study|Withdrawal by Subject|79
7570791|NCT02243696|26326983|P1|Overall Study|Death|282
7570792|NCT02243605|26326995|P2|Stage 2 - Final Analysis Population|Progression|1
7570793|NCT02243605|26326996|P1|Stage 2 - Final Analysis Population|Progression|0
7570794|NCT02243605|26326995|P2|Stage 2 - Final Analysis Population|Adverse Event|1
7570795|NCT02243605|26326996|P1|Stage 2 - Final Analysis Population|Adverse Event|1
7570796|NCT02243605|26326995|P2|Stage 2 - Final Analysis Population|Protocol Violation|1
7570797|NCT02243605|26326996|P1|Stage 2 - Final Analysis Population|Protocol Violation|5
7570798|NCT02243605|26326995|P2|Stage 1 - Interim Analysis Population|Adverse Event|0
7570799|NCT02243605|26326996|P1|Stage 1 - Interim Analysis Population|Adverse Event|1
7570800|NCT02243605|26326995|P2|Stage 1 - Interim Analysis Population|Protocol Violation|1
7570801|NCT02243605|26326996|P1|Stage 1 - Interim Analysis Population|Protocol Violation|1
7570802|NCT02243371|26327030|P2|Overall Study|Withdrawal by Subject|2
7570803|NCT02243371|26327031|P1|Overall Study|Withdrawal by Subject|0
7570804|NCT02243371|26327030|P2|Overall Study|Lack of Clinical Benefit|1
7570805|NCT02243371|26327031|P1|Overall Study|Lack of Clinical Benefit|0
7570806|NCT02243371|26327030|P2|Overall Study|Adverse Event (unrelated)|1
7570807|NCT02243371|26327031|P1|Overall Study|Adverse Event (unrelated)|0
7570808|NCT02243371|26327030|P2|Overall Study|Death (unrelated)|4
7570809|NCT02243371|26327031|P1|Overall Study|Death (unrelated)|2
7570810|NCT02243371|26327030|P2|Overall Study|Progressive Disease (clinic & radio)|24
7570811|NCT02243371|26327031|P1|Overall Study|Progressive Disease (clinic & radio)|35
7570812|NCT02243306|26327051|P2|Overall Study|Physician Decision|1
7570813|NCT02243306|26327052|P1|Overall Study|Physician Decision|0
7570814|NCT02243306|26327051|P2|Overall Study|Other: Reached stopping criteria|1
7570815|NCT02243306|26327052|P1|Overall Study|Other: Reached stopping criteria|0
7570816|NCT02243306|26327051|P2|Overall Study|Adverse Event|1
7570817|NCT02243306|26327052|P1|Overall Study|Adverse Event|0
7570818|NCT02243293|26327127|P22|Overall Study|Randomized but did'nt receive study drug|0
7570819|NCT02243293|26327128|P21|Overall Study|Randomized but did'nt receive study drug|0
7570820|NCT02243293|26327129|P20|Overall Study|Randomized but did'nt receive study drug|1
7570821|NCT02243293|26327130|P19|Overall Study|Randomized but did'nt receive study drug|0
7570822|NCT02243293|26327131|P18|Overall Study|Randomized but did'nt receive study drug|0
7570823|NCT02243293|26327132|P17|Overall Study|Randomized but did'nt receive study drug|0
7570824|NCT02243293|26327133|P16|Overall Study|Randomized but did'nt receive study drug|0
7570825|NCT02243293|26327134|P15|Overall Study|Randomized but did'nt receive study drug|0
7570826|NCT02243293|26327135|P14|Overall Study|Randomized but did'nt receive study drug|0
7570827|NCT02243293|26327136|P13|Overall Study|Randomized but did'nt receive study drug|0
7570828|NCT02243293|26327137|P12|Overall Study|Randomized but did'nt receive study drug|0
7570829|NCT02243293|26327138|P11|Overall Study|Randomized but did'nt receive study drug|0
7570830|NCT02243293|26327139|P10|Overall Study|Randomized but did'nt receive study drug|1
7570831|NCT02243293|26327140|P9|Overall Study|Randomized but did'nt receive study drug|0
7570832|NCT02243293|26327141|P8|Overall Study|Randomized but did'nt receive study drug|0
7570833|NCT02243293|26327142|P7|Overall Study|Randomized but did'nt receive study drug|0
7570834|NCT02243293|26327143|P6|Overall Study|Randomized but did'nt receive study drug|0
7570835|NCT02243293|26327144|P5|Overall Study|Randomized but did'nt receive study drug|1
7570836|NCT02243293|26327145|P4|Overall Study|Randomized but did'nt receive study drug|0
7570837|NCT02243293|26327146|P3|Overall Study|Randomized but did'nt receive study drug|0
7570838|NCT02243293|26327147|P2|Overall Study|Randomized but did'nt receive study drug|0
7570839|NCT02243293|26327148|P1|Overall Study|Randomized but did'nt receive study drug|0
7570840|NCT02243293|26327127|P22|Overall Study|Enrolled into a Re-treatment Study|0
7570841|NCT02243293|26327128|P21|Overall Study|Enrolled into a Re-treatment Study|0
7570842|NCT02243293|26327129|P20|Overall Study|Enrolled into a Re-treatment Study|0
7570843|NCT02243293|26327130|P19|Overall Study|Enrolled into a Re-treatment Study|0
7570844|NCT02243293|26327131|P18|Overall Study|Enrolled into a Re-treatment Study|0
7570845|NCT02243293|26327132|P17|Overall Study|Enrolled into a Re-treatment Study|0
7570846|NCT02243293|26327133|P16|Overall Study|Enrolled into a Re-treatment Study|0
7570847|NCT02243293|26327134|P15|Overall Study|Enrolled into a Re-treatment Study|1
7570848|NCT02243293|26327135|P14|Overall Study|Enrolled into a Re-treatment Study|0
7570849|NCT02243293|26327136|P13|Overall Study|Enrolled into a Re-treatment Study|0
7570850|NCT02243293|26327137|P12|Overall Study|Enrolled into a Re-treatment Study|0
7570851|NCT02243293|26327138|P11|Overall Study|Enrolled into a Re-treatment Study|0
7570852|NCT02243293|26327139|P10|Overall Study|Enrolled into a Re-treatment Study|0
7570853|NCT02243293|26327140|P9|Overall Study|Enrolled into a Re-treatment Study|0
7570854|NCT02243293|26327141|P8|Overall Study|Enrolled into a Re-treatment Study|0
7570855|NCT02243293|26327142|P7|Overall Study|Enrolled into a Re-treatment Study|0
7570856|NCT02243293|26327143|P6|Overall Study|Enrolled into a Re-treatment Study|0
7570857|NCT02243293|26327144|P5|Overall Study|Enrolled into a Re-treatment Study|0
7570858|NCT02243293|26327145|P4|Overall Study|Enrolled into a Re-treatment Study|0
7570859|NCT02243293|26327146|P3|Overall Study|Enrolled into a Re-treatment Study|0
7570860|NCT02243293|26327147|P2|Overall Study|Enrolled into a Re-treatment Study|0
7570861|NCT02243293|26327148|P1|Overall Study|Enrolled into a Re-treatment Study|0
7570862|NCT02243293|26327127|P22|Overall Study|Lost to Follow-up|2
7570863|NCT02243293|26327128|P21|Overall Study|Lost to Follow-up|1
7570864|NCT02243293|26327129|P20|Overall Study|Lost to Follow-up|0
7570865|NCT02243293|26327130|P19|Overall Study|Lost to Follow-up|0
7570866|NCT02243293|26327131|P18|Overall Study|Lost to Follow-up|1
7570867|NCT02243293|26327132|P17|Overall Study|Lost to Follow-up|3
7570868|NCT02243293|26327133|P16|Overall Study|Lost to Follow-up|0
7570869|NCT02243293|26327134|P15|Overall Study|Lost to Follow-up|0
7570870|NCT02243293|26327135|P14|Overall Study|Lost to Follow-up|0
7570871|NCT02243293|26327136|P13|Overall Study|Lost to Follow-up|0
7570872|NCT02243293|26327137|P12|Overall Study|Lost to Follow-up|2
7570873|NCT02243293|26327138|P11|Overall Study|Lost to Follow-up|0
7570874|NCT02243293|26327139|P10|Overall Study|Lost to Follow-up|0
7570875|NCT02243293|26327140|P9|Overall Study|Lost to Follow-up|0
7570876|NCT02243293|26327141|P8|Overall Study|Lost to Follow-up|0
7570877|NCT02243293|26327142|P7|Overall Study|Lost to Follow-up|3
7570878|NCT02243293|26327143|P6|Overall Study|Lost to Follow-up|0
7570879|NCT02243293|26327144|P5|Overall Study|Lost to Follow-up|0
7570880|NCT02243293|26327145|P4|Overall Study|Lost to Follow-up|1
7570881|NCT02243293|26327146|P3|Overall Study|Lost to Follow-up|1
7570882|NCT02243293|26327147|P2|Overall Study|Lost to Follow-up|1
7570883|NCT02243293|26327148|P1|Overall Study|Lost to Follow-up|0
7570884|NCT02243293|26327127|P22|Overall Study|Withdrawal by Subject|1
7570885|NCT02243293|26327128|P21|Overall Study|Withdrawal by Subject|0
7570886|NCT02243293|26327129|P20|Overall Study|Withdrawal by Subject|0
7570887|NCT02243293|26327130|P19|Overall Study|Withdrawal by Subject|0
7570888|NCT02243293|26327131|P18|Overall Study|Withdrawal by Subject|0
7570889|NCT02243293|26327132|P17|Overall Study|Withdrawal by Subject|0
7570890|NCT02243293|26327133|P16|Overall Study|Withdrawal by Subject|0
7570891|NCT02243293|26327134|P15|Overall Study|Withdrawal by Subject|0
7570892|NCT02243293|26327135|P14|Overall Study|Withdrawal by Subject|0
7570893|NCT02243293|26327136|P13|Overall Study|Withdrawal by Subject|0
7570894|NCT02243293|26327137|P12|Overall Study|Withdrawal by Subject|1
7570895|NCT02243293|26327138|P11|Overall Study|Withdrawal by Subject|0
7570896|NCT02243293|26327139|P10|Overall Study|Withdrawal by Subject|1
7570897|NCT02243293|26327140|P9|Overall Study|Withdrawal by Subject|0
7570898|NCT02243293|26327141|P8|Overall Study|Withdrawal by Subject|0
7570899|NCT02243293|26327142|P7|Overall Study|Withdrawal by Subject|0
7570900|NCT02243293|26327143|P6|Overall Study|Withdrawal by Subject|0
7570901|NCT02243293|26327144|P5|Overall Study|Withdrawal by Subject|0
7570902|NCT02243293|26327145|P4|Overall Study|Withdrawal by Subject|0
7570903|NCT02243293|26327146|P3|Overall Study|Withdrawal by Subject|0
7570904|NCT02243293|26327147|P2|Overall Study|Withdrawal by Subject|0
7570905|NCT02243293|26327148|P1|Overall Study|Withdrawal by Subject|1
7570906|NCT02243293|26327127|P22|Overall Study|Adverse Event|0
7570907|NCT02243293|26327128|P21|Overall Study|Adverse Event|1
7570908|NCT02243293|26327129|P20|Overall Study|Adverse Event|0
7570909|NCT02243293|26327130|P19|Overall Study|Adverse Event|0
7570910|NCT02243293|26327131|P18|Overall Study|Adverse Event|0
7570911|NCT02243293|26327132|P17|Overall Study|Adverse Event|0
7570912|NCT02243293|26327133|P16|Overall Study|Adverse Event|1
7570913|NCT02243293|26327134|P15|Overall Study|Adverse Event|0
7570914|NCT02243293|26327135|P14|Overall Study|Adverse Event|0
7570915|NCT02243293|26327136|P13|Overall Study|Adverse Event|0
7570916|NCT02243293|26327137|P12|Overall Study|Adverse Event|0
7570917|NCT02243293|26327138|P11|Overall Study|Adverse Event|0
7570918|NCT02243293|26327139|P10|Overall Study|Adverse Event|0
7570919|NCT02243293|26327140|P9|Overall Study|Adverse Event|0
7570920|NCT02243293|26327141|P8|Overall Study|Adverse Event|0
7570921|NCT02243293|26327142|P7|Overall Study|Adverse Event|0
7570922|NCT02243293|26327143|P6|Overall Study|Adverse Event|0
7570923|NCT02243293|26327144|P5|Overall Study|Adverse Event|0
7570924|NCT02243293|26327145|P4|Overall Study|Adverse Event|0
7570925|NCT02243293|26327146|P3|Overall Study|Adverse Event|0
7570926|NCT02243293|26327147|P2|Overall Study|Adverse Event|0
7570927|NCT02243293|26327148|P1|Overall Study|Adverse Event|1
7570928|NCT02243280|26327247|P11|Treated|Lost to Follow-up|2
7570929|NCT02243280|26327248|P10|Treated|Lost to Follow-up|0
7570930|NCT02243280|26327249|P9|Treated|Lost to Follow-up|1
7570931|NCT02243280|26327250|P8|Treated|Lost to Follow-up|0
7570932|NCT02243280|26327251|P7|Treated|Lost to Follow-up|0
7570933|NCT02243280|26327252|P6|Treated|Lost to Follow-up|0
7570934|NCT02243280|26327253|P5|Treated|Lost to Follow-up|0
7570935|NCT02243280|26327254|P4|Treated|Lost to Follow-up|0
7570936|NCT02243280|26327255|P3|Treated|Lost to Follow-up|0
7570937|NCT02243280|26327256|P2|Treated|Lost to Follow-up|0
7570938|NCT02243280|26327257|P1|Treated|Lost to Follow-up|0
7570939|NCT02243280|26327247|P11|Treated|Adverse Event|1
7570940|NCT02243280|26327248|P10|Treated|Adverse Event|0
7570941|NCT02243280|26327249|P9|Treated|Adverse Event|0
7570942|NCT02243280|26327250|P8|Treated|Adverse Event|0
7570943|NCT02243280|26327251|P7|Treated|Adverse Event|0
7570944|NCT02243280|26327252|P6|Treated|Adverse Event|0
7570945|NCT02243280|26327253|P5|Treated|Adverse Event|0
7570946|NCT02243280|26327254|P4|Treated|Adverse Event|0
7570947|NCT02243280|26327255|P3|Treated|Adverse Event|0
7570948|NCT02243280|26327256|P2|Treated|Adverse Event|0
7570949|NCT02243280|26327257|P1|Treated|Adverse Event|1
7570950|NCT02243202|26327312|P4|Overall Study|Randomized but not received treatment|1
7570951|NCT02243202|26327313|P3|Overall Study|Randomized but not received treatment|0
7570952|NCT02243202|26327314|P2|Overall Study|Randomized but not received treatment|0
7570953|NCT02243202|26327315|P1|Overall Study|Randomized but not received treatment|0
7570954|NCT02243202|26327312|P4|Overall Study|Other|2
7570955|NCT02243202|26327313|P3|Overall Study|Other|1
7570956|NCT02243202|26327314|P2|Overall Study|Other|3
7570957|NCT02243202|26327315|P1|Overall Study|Other|1
7570958|NCT02243202|26327312|P4|Overall Study|Withdrawal by Subject|4
7570959|NCT02243202|26327313|P3|Overall Study|Withdrawal by Subject|4
7570960|NCT02243202|26327314|P2|Overall Study|Withdrawal by Subject|6
7570961|NCT02243202|26327315|P1|Overall Study|Withdrawal by Subject|7
7570962|NCT02243202|26327312|P4|Overall Study|Protocol Violation|1
7570963|NCT02243202|26327313|P3|Overall Study|Protocol Violation|2
7570964|NCT02243202|26327314|P2|Overall Study|Protocol Violation|1
7570965|NCT02243202|26327315|P1|Overall Study|Protocol Violation|3
7570966|NCT02243202|26327312|P4|Overall Study|Lost to Follow-up|11
7570967|NCT02243202|26327313|P3|Overall Study|Lost to Follow-up|14
7570968|NCT02243202|26327314|P2|Overall Study|Lost to Follow-up|9
7570969|NCT02243202|26327315|P1|Overall Study|Lost to Follow-up|9
7570970|NCT02243202|26327312|P4|Overall Study|Adverse Event|4
7570971|NCT02243202|26327313|P3|Overall Study|Adverse Event|10
7570972|NCT02243202|26327314|P2|Overall Study|Adverse Event|6
7570973|NCT02243202|26327315|P1|Overall Study|Adverse Event|5
7570974|NCT02243176|26327351|P2|Overall Study|Adverse Event|2
7570975|NCT02243176|26327352|P1|Overall Study|Adverse Event|2
7570976|NCT02243176|26327351|P2|Overall Study|Withdrawal by Subject|7
7570977|NCT02243176|26327352|P1|Overall Study|Withdrawal by Subject|8
7570978|NCT02243176|26327351|P2|Overall Study|Protocol Violation|1
7570979|NCT02243176|26327352|P1|Overall Study|Protocol Violation|2
7570980|NCT02243176|26327351|P2|Overall Study|protocol specified withdrawal critera|3
7570981|NCT02243176|26327352|P1|Overall Study|protocol specified withdrawal critera|1
7570982|NCT02243176|26327351|P2|Overall Study|Other reason|2
7570983|NCT02243176|26327352|P1|Overall Study|Other reason|1
7570984|NCT02243046|26327377|P3|Overall Study|Lost to Follow-up|4
7570985|NCT02243046|26327378|P2|Overall Study|Lost to Follow-up|1
7570986|NCT02243046|26327379|P1|Overall Study|Lost to Follow-up|1
7570987|NCT02242981|26327443|P1|Overall Study|Withdrawal by Subject|1
7570988|NCT02242942|26327454|P3|Overall Study|On-going in Study|11
7570989|NCT02242942|26327455|P2|Overall Study|On-going in Study|186
7570990|NCT02242942|26327456|P1|Overall Study|On-going in Study|190
7570991|NCT02242942|26327454|P3|Overall Study|Withdrawal by Subject|0
7570992|NCT02242942|26327455|P2|Overall Study|Withdrawal by Subject|10
7570993|NCT02242942|26327456|P1|Overall Study|Withdrawal by Subject|8
7570994|NCT02242942|26327454|P3|Overall Study|Physician Decision|0
7570995|NCT02242942|26327455|P2|Overall Study|Physician Decision|0
7570996|NCT02242942|26327456|P1|Overall Study|Physician Decision|1
7570997|NCT02242942|26327454|P3|Overall Study|Death|2
7570998|NCT02242942|26327455|P2|Overall Study|Death|20
7570999|NCT02242942|26327456|P1|Overall Study|Death|17
7571000|NCT02242903|26327490|P7|Overall Study|Withdrawal by Subject|0
7571001|NCT02242903|26327491|P6|Overall Study|Withdrawal by Subject|0
7571002|NCT02242903|26327492|P5|Overall Study|Withdrawal by Subject|0
7571003|NCT02242903|26327493|P4|Overall Study|Withdrawal by Subject|0
7571004|NCT02242903|26327494|P3|Overall Study|Withdrawal by Subject|0
7571005|NCT02242903|26327495|P2|Overall Study|Withdrawal by Subject|0
7571006|NCT02242903|26327496|P1|Overall Study|Withdrawal by Subject|1
7571007|NCT02242643|26327526|P2|Overall Study|Withdrawal by subject at Visit 2|1
7571008|NCT02242643|26327527|P1|Overall Study|Withdrawal by subject at Visit 2|0
7571009|NCT02242643|26327526|P2|Overall Study|Language barrier|0
7571010|NCT02242643|26327527|P1|Overall Study|Language barrier|1
7571011|NCT02242643|26327526|P2|Overall Study|Protocol requirements not followed|0
7571012|NCT02242643|26327527|P1|Overall Study|Protocol requirements not followed|1
7571013|NCT02242643|26327526|P2|Overall Study|Consent withdrawal by parent|0
7571014|NCT02242643|26327527|P1|Overall Study|Consent withdrawal by parent|1
7571015|NCT02242643|26327526|P2|Overall Study|Non-compliance|0
7571016|NCT02242643|26327527|P1|Overall Study|Non-compliance|1
7571017|NCT02242643|26327526|P2|Overall Study|Child placed in foster care by family|1
7571018|NCT02242643|26327527|P1|Overall Study|Child placed in foster care by family|0
7571019|NCT02242643|26327526|P2|Overall Study|Lost to Follow-up|61
7571020|NCT02242643|26327527|P1|Overall Study|Lost to Follow-up|54
7571021|NCT02242643|26327526|P2|Overall Study|Migrated/moved from study area|3
7571022|NCT02242643|26327527|P1|Overall Study|Migrated/moved from study area|1
7571023|NCT02242643|26327526|P2|Overall Study|Withdrawal by Subject|10
7571024|NCT02242643|26327527|P1|Overall Study|Withdrawal by Subject|15
7571025|NCT02242643|26327526|P2|Overall Study|Protocol Violation|2
7571026|NCT02242643|26327527|P1|Overall Study|Protocol Violation|1
7571027|NCT02242487|26327593|P2|Overall Study|Withdrawal by Subject|19
7571028|NCT02242487|26327594|P1|Overall Study|Withdrawal by Subject|37
7571029|NCT02242487|26327593|P2|Overall Study|Other - Miscellaneous|6
7571030|NCT02242487|26327594|P1|Overall Study|Other - Miscellaneous|4
7571031|NCT02242487|26327593|P2|Overall Study|Lost to Follow-up|1
7571032|NCT02242487|26327594|P1|Overall Study|Lost to Follow-up|2
7571033|NCT02242487|26327593|P2|Overall Study|Protocol Violation|0
7571034|NCT02242487|26327594|P1|Overall Study|Protocol Violation|2
7571035|NCT02242487|26327593|P2|Overall Study|Lack of Efficacy|6
7571036|NCT02242487|26327594|P1|Overall Study|Lack of Efficacy|4
7571037|NCT02242487|26327593|P2|Overall Study|Adverse Event|15
7571038|NCT02242487|26327594|P1|Overall Study|Adverse Event|13
7571039|NCT02242305|26327610|P2|Overall Study|Lost to Follow-up|0
7571040|NCT02242305|26327611|P1|Overall Study|Lost to Follow-up|2
7571041|NCT02242305|26327610|P2|Overall Study|Subject withdraws inform consent|4
7571042|NCT02242305|26327611|P1|Overall Study|Subject withdraws inform consent|0
7571043|NCT02242305|26327610|P2|Overall Study|Non-compliance dosing regimen or visit|2
7571044|NCT02242305|26327611|P1|Overall Study|Non-compliance dosing regimen or visit|2
7571045|NCT02242305|26327610|P2|Overall Study|Adverse Event|0
7571046|NCT02242305|26327611|P1|Overall Study|Adverse Event|1
7571047|NCT02242305|26327610|P2|Overall Study|Without spasm-like pain during 3 weeks|4
7571048|NCT02242305|26327611|P1|Overall Study|Without spasm-like pain during 3 weeks|1
7571049|NCT02242201|26327632|P3|Overall Study|preoperative opioid consumption|0
7571050|NCT02242201|26327633|P2|Overall Study|preoperative opioid consumption|1
7571051|NCT02242201|26327634|P1|Overall Study|preoperative opioid consumption|0
7571052|NCT02242201|26327632|P3|Overall Study|postponed surgery|1
7571053|NCT02242201|26327633|P2|Overall Study|postponed surgery|0
7571054|NCT02242201|26327634|P1|Overall Study|postponed surgery|0
7571055|NCT02242201|26327632|P3|Overall Study|changed surgical procedure|0
7571056|NCT02242201|26327633|P2|Overall Study|changed surgical procedure|0
7571057|NCT02242201|26327634|P1|Overall Study|changed surgical procedure|1
7571058|NCT02242201|26327632|P3|Overall Study|planned post-op anticoagulation|0
7571059|NCT02242201|26327633|P2|Overall Study|planned post-op anticoagulation|0
7571060|NCT02242201|26327634|P1|Overall Study|planned post-op anticoagulation|1
7571061|NCT02242201|26327632|P3|Overall Study|preoperative identified neuropathy|0
7571062|NCT02242201|26327633|P2|Overall Study|preoperative identified neuropathy|0
7571063|NCT02242201|26327634|P1|Overall Study|preoperative identified neuropathy|2
7571064|NCT02242045|26327666|P1|Overall Study|Initiated another anti-cancer or experimental therapy|2
7571065|NCT02242045|26327666|P1|Overall Study|Unable to tolerate rechallenge with idelalisib|1
7571066|NCT02242045|26327666|P1|Overall Study|Progressive Disease|2
7571067|NCT02242045|26327666|P1|Overall Study|Investigator's Discretion|1
7571068|NCT02241889|26327709|P6|Overall Study|Withdrawal by Subject|1
7571069|NCT02241889|26327710|P5|Overall Study|Withdrawal by Subject|0
7571070|NCT02241889|26327711|P4|Overall Study|Withdrawal by Subject|0
7571071|NCT02241889|26327712|P3|Overall Study|Withdrawal by Subject|0
7571072|NCT02241889|26327713|P2|Overall Study|Withdrawal by Subject|0
7571073|NCT02241889|26327714|P1|Overall Study|Withdrawal by Subject|0
7571074|NCT02241889|26327709|P6|Overall Study|device issues|0
7571075|NCT02241889|26327710|P5|Overall Study|device issues|0
7571076|NCT02241889|26327711|P4|Overall Study|device issues|0
7571077|NCT02241889|26327712|P3|Overall Study|device issues|1
7571078|NCT02241889|26327713|P2|Overall Study|device issues|0
7571079|NCT02241889|26327714|P1|Overall Study|device issues|0
7571080|NCT02241785|26327749|P1|Overall Study|Adverse Event|1
7571081|NCT02241785|26327749|P1|Overall Study|Lost to Follow-up|2
7571082|NCT02241785|26327749|P1|Overall Study|Withdrawal by Subject|1
7571083|NCT02241785|26327749|P1|Overall Study|Sponsor Termination|43
7571084|NCT02241733|26327759|P2|Overall Study|Death|2
7571085|NCT02241733|26327760|P1|Overall Study|Death|0
7571086|NCT02241733|26327759|P2|Overall Study|Withdrawal by Subject|2
7571087|NCT02241733|26327760|P1|Overall Study|Withdrawal by Subject|0
7571088|NCT02241733|26327759|P2|Overall Study|Physician Decision|2
7571089|NCT02241733|26327760|P1|Overall Study|Physician Decision|6
7571090|NCT02241733|26327759|P2|Overall Study|Lost to Follow-up|4
7571091|NCT02241733|26327760|P1|Overall Study|Lost to Follow-up|9
7571092|NCT02241551|26327799|P2|Overall Study|Adverse Event|0
7571093|NCT02241551|26327800|P1|Overall Study|Adverse Event|1
7571094|NCT02241512|26327822|P2|Overall Study|Pump malfunction, drug not delivered|0
7571095|NCT02241512|26327823|P1|Overall Study|Pump malfunction, drug not delivered|1
7571096|NCT02241343|26327839|P1|Overall Study|Adverse Event|1
7571097|NCT02241187|26327844|P1|Overall Study|Protocol closed due to lack of accrual.|2
7571098|NCT02240706|26327876|P7|Overall Study|Insurance billing concerns|0
7571099|NCT02240706|26327877|P6|Overall Study|Insurance billing concerns|0
7571100|NCT02240706|26327878|P5|Overall Study|Insurance billing concerns|0
7571101|NCT02240706|26327879|P4|Overall Study|Insurance billing concerns|1
7571102|NCT02240706|26327880|P3|Overall Study|Insurance billing concerns|0
7571103|NCT02240706|26327881|P2|Overall Study|Insurance billing concerns|0
7571104|NCT02240706|26327882|P1|Overall Study|Insurance billing concerns|0
7571105|NCT02240706|26327876|P7|Overall Study|Refused to continue taking medication|0
7571106|NCT02240706|26327877|P6|Overall Study|Refused to continue taking medication|0
7571107|NCT02240706|26327878|P5|Overall Study|Refused to continue taking medication|2
7571108|NCT02240706|26327879|P4|Overall Study|Refused to continue taking medication|1
7571109|NCT02240706|26327880|P3|Overall Study|Refused to continue taking medication|3
7571110|NCT02240706|26327881|P2|Overall Study|Refused to continue taking medication|1
7571111|NCT02240706|26327882|P1|Overall Study|Refused to continue taking medication|0
7571112|NCT02240706|26327876|P7|Overall Study|Dose limiting toxicity|0
7571113|NCT02240706|26327877|P6|Overall Study|Dose limiting toxicity|0
7571114|NCT02240706|26327878|P5|Overall Study|Dose limiting toxicity|1
7571115|NCT02240706|26327879|P4|Overall Study|Dose limiting toxicity|0
7571116|NCT02240706|26327880|P3|Overall Study|Dose limiting toxicity|0
7571117|NCT02240706|26327881|P2|Overall Study|Dose limiting toxicity|0
7571118|NCT02240706|26327882|P1|Overall Study|Dose limiting toxicity|0
7571119|NCT02240706|26327876|P7|Overall Study|Progressive disease|0
7571120|NCT02240706|26327877|P6|Overall Study|Progressive disease|0
7571121|NCT02240706|26327878|P5|Overall Study|Progressive disease|1
7571122|NCT02240706|26327879|P4|Overall Study|Progressive disease|0
7571123|NCT02240706|26327880|P3|Overall Study|Progressive disease|0
7571124|NCT02240706|26327881|P2|Overall Study|Progressive disease|0
7571125|NCT02240706|26327882|P1|Overall Study|Progressive disease|0
7571126|NCT02240706|26327876|P7|Overall Study|Adverse Event|0
7571127|NCT02240706|26327877|P6|Overall Study|Adverse Event|0
7571128|NCT02240706|26327878|P5|Overall Study|Adverse Event|2
7571129|NCT02240706|26327879|P4|Overall Study|Adverse Event|0
7571130|NCT02240706|26327880|P3|Overall Study|Adverse Event|1
7571131|NCT02240706|26327881|P2|Overall Study|Adverse Event|0
7571132|NCT02240706|26327882|P1|Overall Study|Adverse Event|1
7571133|NCT02240706|26327876|P7|Overall Study|Lack of Efficacy|0
7571134|NCT02240706|26327877|P6|Overall Study|Lack of Efficacy|0
7571135|NCT02240706|26327878|P5|Overall Study|Lack of Efficacy|5
7571136|NCT02240706|26327879|P4|Overall Study|Lack of Efficacy|2
7571137|NCT02240706|26327880|P3|Overall Study|Lack of Efficacy|2
7571138|NCT02240706|26327881|P2|Overall Study|Lack of Efficacy|2
7571139|NCT02240706|26327882|P1|Overall Study|Lack of Efficacy|2
7571140|NCT02240693|26327942|P5|Overall Study|Other than specified|0
7571141|NCT02240693|26327943|P4|Overall Study|Other than specified|0
7571142|NCT02240693|26327944|P3|Overall Study|Other than specified|2
7571143|NCT02240693|26327945|P2|Overall Study|Other than specified|0
7571144|NCT02240693|26327946|P1|Overall Study|Other than specified|0
7571145|NCT02240693|26327942|P5|Overall Study|Withdrawal by Subject|0
7571146|NCT02240693|26327943|P4|Overall Study|Withdrawal by Subject|1
7571147|NCT02240693|26327944|P3|Overall Study|Withdrawal by Subject|2
7571148|NCT02240693|26327945|P2|Overall Study|Withdrawal by Subject|0
7571149|NCT02240693|26327946|P1|Overall Study|Withdrawal by Subject|0
7571150|NCT02240693|26327942|P5|Overall Study|Adverse Event|1
7571151|NCT02240693|26327943|P4|Overall Study|Adverse Event|0
7571152|NCT02240693|26327944|P3|Overall Study|Adverse Event|0
7571153|NCT02240693|26327945|P2|Overall Study|Adverse Event|0
7571154|NCT02240693|26327946|P1|Overall Study|Adverse Event|0
7571155|NCT02240680|26327982|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7571156|NCT02240680|26327983|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
7571157|NCT02240680|26327984|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7571158|NCT02240680|26327985|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7571159|NCT02240680|26327982|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7571160|NCT02240680|26327983|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
7571161|NCT02240680|26327984|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7571162|NCT02240680|26327985|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7571163|NCT02240680|26327982|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
7571164|NCT02240680|26327983|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
7571165|NCT02240680|26327984|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7571166|NCT02240680|26327985|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7571167|NCT02240680|26327982|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
7571168|NCT02240680|26327983|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
7571169|NCT02240680|26327984|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
7571170|NCT02240680|26327985|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
7571171|NCT02240680|26327982|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7571172|NCT02240680|26327983|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7571173|NCT02240680|26327984|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
7571174|NCT02240680|26327985|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
7571175|NCT02240680|26327982|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7571176|NCT02240680|26327983|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7571177|NCT02240680|26327984|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7571178|NCT02240680|26327985|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
7571179|NCT02240680|26327982|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7571180|NCT02240680|26327983|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7571181|NCT02240680|26327984|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
7571182|NCT02240680|26327985|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
7571183|NCT02240680|26327982|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
7571184|NCT02240680|26327983|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
7571185|NCT02240680|26327984|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
7571186|NCT02240680|26327985|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
7571187|NCT02240628|26328039|P2|Overall Study|Physician Decision|5
7571188|NCT02240628|26328040|P1|Overall Study|Physician Decision|6
7571189|NCT02240368|26328074|P3|Overall Study|Entropy failed to detect more than 50%|1
7571190|NCT02240368|26328075|P2|Overall Study|Entropy failed to detect more than 50%|0
7571191|NCT02240368|26328076|P1|Overall Study|Entropy failed to detect more than 50%|0
7571192|NCT02240368|26328074|P3|Overall Study|Surgery lasted less then 20 minutes|0
7571193|NCT02240368|26328075|P2|Overall Study|Surgery lasted less then 20 minutes|0
7571194|NCT02240368|26328076|P1|Overall Study|Surgery lasted less then 20 minutes|1
7571195|NCT02240121|26328108|P2|Overall Study|Other than specified|3
7571196|NCT02240121|26328109|P1|Overall Study|Other than specified|1
7571197|NCT02240121|26328108|P2|Overall Study|Lost to Follow-up|4
7571198|NCT02240121|26328109|P1|Overall Study|Lost to Follow-up|3
7571199|NCT02240121|26328108|P2|Overall Study|Withdrawal by Subject|2
7571200|NCT02240121|26328109|P1|Overall Study|Withdrawal by Subject|6
7571201|NCT02240121|26328108|P2|Overall Study|Adverse Event|4
7571202|NCT02240121|26328109|P1|Overall Study|Adverse Event|2
7571203|NCT02240121|26328108|P2|Overall Study|Pregnancy|0
7571204|NCT02240121|26328109|P1|Overall Study|Pregnancy|1
7571205|NCT02240121|26328108|P2|Overall Study|Site closed|1
7571206|NCT02240121|26328109|P1|Overall Study|Site closed|1
7571207|NCT02240121|26328108|P2|Overall Study|Lack of Efficacy|3
7571208|NCT02240121|26328109|P1|Overall Study|Lack of Efficacy|2
7571209|NCT02240121|26328108|P2|Overall Study|Change in protocol interpretation|0
7571210|NCT02240121|26328109|P1|Overall Study|Change in protocol interpretation|1
7571211|NCT02240121|26328108|P2|Overall Study|Physician Decision|1
7571212|NCT02240121|26328109|P1|Overall Study|Physician Decision|0
7571213|NCT02240121|26328108|P2|Overall Study|Protocol Violation|2
7571214|NCT02240121|26328109|P1|Overall Study|Protocol Violation|1
7571215|NCT02240108|26328137|P2|Overall Study|StudyTerminated by Sponsor|1
7571216|NCT02240108|26328138|P1|Overall Study|StudyTerminated by Sponsor|0
7571217|NCT02240108|26328137|P2|Overall Study|Withdrawal by Subject|9
7571218|NCT02240108|26328138|P1|Overall Study|Withdrawal by Subject|4
7571219|NCT02240108|26328137|P2|Overall Study|Pregnancy|0
7571220|NCT02240108|26328138|P1|Overall Study|Pregnancy|1
7571221|NCT02240108|26328137|P2|Overall Study|Adverse Event|9
7571222|NCT02240108|26328138|P1|Overall Study|Adverse Event|1
7571223|NCT02240108|26328137|P2|Overall Study|Other than specified|6
7571224|NCT02240108|26328138|P1|Overall Study|Other than specified|8
7571225|NCT02239978|26328193|P2|Overall Study|Withdrawal by Subject|0
7571226|NCT02239978|26328194|P1|Overall Study|Withdrawal by Subject|2
7571227|NCT02239939|26328211|P2|Overall Study|Lost to Follow-up|1
7571228|NCT02239939|26328212|P1|Overall Study|Lost to Follow-up|0
7571229|NCT02239939|26328211|P2|Overall Study|Withdrawal by Subject|1
7571230|NCT02239939|26328212|P1|Overall Study|Withdrawal by Subject|1
7571231|NCT02239939|26328211|P2|Overall Study|Adverse Event|0
7571232|NCT02239939|26328212|P1|Overall Study|Adverse Event|1
7571233|NCT02239926|26328228|P2|Overall Study|Withdrawal by Subject|1
7571234|NCT02239926|26328229|P1|Overall Study|Withdrawal by Subject|0
7571235|NCT02239692|26328291|P2|Overall Study|Other reason|0
7571236|NCT02239692|26328292|P1|Overall Study|Other reason|1
7571237|NCT02239692|26328291|P2|Overall Study|Withdrawal by Subject|5
7571238|NCT02239692|26328292|P1|Overall Study|Withdrawal by Subject|3
7571239|NCT02239692|26328291|P2|Overall Study|Lost to Follow-up|4
7571240|NCT02239692|26328292|P1|Overall Study|Lost to Follow-up|1
7571241|NCT02239692|26328291|P2|Overall Study|Physician Decision|1
7571242|NCT02239692|26328292|P1|Overall Study|Physician Decision|0
7571243|NCT02239692|26328291|P2|Overall Study|Adverse Event|1
7571244|NCT02239692|26328292|P1|Overall Study|Adverse Event|0
7571245|NCT02239692|26328291|P2|Overall Study|Incomplete colonoscopy|2
7571246|NCT02239692|26328292|P1|Overall Study|Incomplete colonoscopy|1
7571247|NCT02239679|26328311|P3|Overall Study|Withdrawal by Subject|1
7571248|NCT02239679|26328312|P2|Overall Study|Withdrawal by Subject|3
7571249|NCT02239679|26328313|P1|Overall Study|Withdrawal by Subject|2
7571250|NCT02239679|26328311|P3|Overall Study|Lost to Follow-up|0
7571251|NCT02239679|26328312|P2|Overall Study|Lost to Follow-up|0
7571252|NCT02239679|26328313|P1|Overall Study|Lost to Follow-up|1
7571253|NCT02239640|26328525|P1|Overall Study|Death|142
7571254|NCT02239640|26328525|P1|Overall Study|Lost to Follow-up|72
7571255|NCT02239640|26328525|P1|Overall Study|Withdrawal by Subject|3
7571256|NCT02239601|26328552|P2|Overall Study|Protocol Violation|2
7571257|NCT02239601|26328553|P1|Overall Study|Protocol Violation|4
7571258|NCT02239601|26328552|P2|Overall Study|Withdrawal by Subject|4
7571259|NCT02239601|26328553|P1|Overall Study|Withdrawal by Subject|3
7571260|NCT02239536|26328606|P2|Overall Study|Non-neoplastic polyp|17
7571261|NCT02239536|26328607|P1|Overall Study|Non-neoplastic polyp|23
7571262|NCT02239510|26328617|P2|Overall Study|Lost to Follow-up|1
7571263|NCT02239510|26328618|P1|Overall Study|Lost to Follow-up|2
7571264|NCT02239328|26328640|P1|Overall Study|Equipment or website malfunction|2
7571265|NCT02239328|26328640|P1|Overall Study|Benign disease noted at time of surgery|6
7571266|NCT02239263|26328663|P1|Overall Study|Protocol Violation|6
7571267|NCT02239224|26328673|P4|Overall Study|Administrative|1
7571268|NCT02239224|26328674|P3|Overall Study|Administrative|3
7571269|NCT02239224|26328675|P2|Overall Study|Administrative|0
7571270|NCT02239224|26328676|P1|Overall Study|Administrative|0
7571271|NCT02239120|26328732|P2|Overall Study|Lost to Follow-up|14
7571272|NCT02239120|26328733|P1|Overall Study|Lost to Follow-up|19
7571273|NCT02239120|26328732|P2|Overall Study|Death|58
7571274|NCT02239120|26328733|P1|Overall Study|Death|56
7571275|NCT02239094|26328757|P1|Overall Study|Remitted before started|1
7571276|NCT02239094|26328757|P1|Overall Study|Withdrawal by Subject|1
7571277|NCT02238483|26328812|P2|Overall Study|Illness in family member|0
7571278|NCT02238483|26328813|P1|Overall Study|Illness in family member|1
7571279|NCT02238483|26328812|P2|Overall Study|Completion status not recorded|1
7571280|NCT02238483|26328813|P1|Overall Study|Completion status not recorded|1
7571281|NCT02238483|26328812|P2|Overall Study|Withdrawn due to physician decision|0
7571282|NCT02238483|26328813|P1|Overall Study|Withdrawn due to physician decision|1
7571283|NCT02238483|26328812|P2|Overall Study|Adverse Event|3
7571284|NCT02238483|26328813|P1|Overall Study|Adverse Event|7
7571285|NCT02238483|26328812|P2|Overall Study|Death|0
7571286|NCT02238483|26328813|P1|Overall Study|Death|1
7571287|NCT02238483|26328812|P2|Overall Study|Protocol Violation|2
7571288|NCT02238483|26328813|P1|Overall Study|Protocol Violation|1
7571289|NCT02238483|26328812|P2|Overall Study|Lost to Follow-up|1
7571290|NCT02238483|26328813|P1|Overall Study|Lost to Follow-up|1
7571291|NCT02238483|26328812|P2|Overall Study|Withdrawal by Subject|7
7571292|NCT02238483|26328813|P1|Overall Study|Withdrawal by Subject|2
7571293|NCT02238379|26328851|P2|Overall Study|Lost to Follow-up|0
7571294|NCT02238379|26328852|P1|Overall Study|Lost to Follow-up|1
7571295|NCT02238080|26328878|P1|Overall Study|Other|4
7571296|NCT02238080|26328878|P1|Overall Study|Withdrawal by Subject|2
7571297|NCT02238080|26328878|P1|Overall Study|Treatment interrupted|6
7571298|NCT02238080|26328878|P1|Overall Study|Death|13
7571299|NCT02238067|26328892|P1|Overall Study|Not completed survey at Month 6|45
7571300|NCT02237911|26328980|P3|Overall Study|Lost to Follow-up|1
7571301|NCT02237911|26328981|P2|Overall Study|Lost to Follow-up|1
7571302|NCT02237911|26328982|P1|Overall Study|Lost to Follow-up|3
7571303|NCT02237911|26328980|P3|Overall Study|Withdrawal by Subject|2
7571304|NCT02237911|26328981|P2|Overall Study|Withdrawal by Subject|7
7571305|NCT02237911|26328982|P1|Overall Study|Withdrawal by Subject|4
7571306|NCT02237196|26329035|P4|Overall Study|Site Error|2
7571307|NCT02237196|26329036|P3|Overall Study|Site Error|0
7571308|NCT02237196|26329037|P2|Overall Study|Site Error|2
7571309|NCT02237196|26329038|P1|Overall Study|Site Error|1
7571310|NCT02237196|26329035|P4|Overall Study|Withdrawal by Subject|1
7571311|NCT02237196|26329036|P3|Overall Study|Withdrawal by Subject|4
7571312|NCT02237196|26329037|P2|Overall Study|Withdrawal by Subject|1
7571313|NCT02237196|26329038|P1|Overall Study|Withdrawal by Subject|1
7571314|NCT02237196|26329035|P4|Overall Study|Pregnancy|1
7571315|NCT02237196|26329036|P3|Overall Study|Pregnancy|1
7571316|NCT02237196|26329037|P2|Overall Study|Pregnancy|0
7571317|NCT02237196|26329038|P1|Overall Study|Pregnancy|0
7571318|NCT02237196|26329035|P4|Overall Study|Physician Decision|1
7571319|NCT02237196|26329036|P3|Overall Study|Physician Decision|0
7571320|NCT02237196|26329037|P2|Overall Study|Physician Decision|0
7571321|NCT02237196|26329038|P1|Overall Study|Physician Decision|2
7571322|NCT02237196|26329035|P4|Overall Study|Lost to Follow-up|6
7571323|NCT02237196|26329036|P3|Overall Study|Lost to Follow-up|4
7571324|NCT02237196|26329037|P2|Overall Study|Lost to Follow-up|2
7571325|NCT02237196|26329038|P1|Overall Study|Lost to Follow-up|4
7571326|NCT02237196|26329035|P4|Overall Study|Adverse Event|0
7571327|NCT02237196|26329036|P3|Overall Study|Adverse Event|1
7571328|NCT02237196|26329037|P2|Overall Study|Adverse Event|1
7571329|NCT02237196|26329038|P1|Overall Study|Adverse Event|0
7571330|NCT02237157|26329080|P4|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7571331|NCT02237157|26329081|P3|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7571332|NCT02237157|26329082|P2|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7571333|NCT02237157|26329083|P1|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
7571334|NCT02237157|26329080|P4|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7571335|NCT02237157|26329081|P3|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7571336|NCT02237157|26329082|P2|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7571337|NCT02237157|26329083|P1|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
7571338|NCT02237118|26329092|P2|Overall Study|consent withdrawn|0
7571339|NCT02237118|26329093|P1|Overall Study|consent withdrawn|1
7571340|NCT02237118|26329092|P2|Overall Study|Protocol Violation|1
7571341|NCT02237118|26329093|P1|Overall Study|Protocol Violation|0
7571342|NCT02237001|26329124|P1|Overall Study|Incarceration|1
7571343|NCT02237001|26329124|P1|Overall Study|Re-operation|4
7571344|NCT02237001|26329124|P1|Overall Study|Eligibility criteria/Late Screen Failure|3
7571345|NCT02237001|26329124|P1|Overall Study|Withdrawal by Subject|1
7571346|NCT02237001|26329124|P1|Overall Study|Lost to Follow-up|2
7571347|NCT02236988|26329140|P4|Overall Study|Unable to Comply with Study Visits|2
7571348|NCT02236988|26329141|P3|Overall Study|Unable to Comply with Study Visits|0
7571349|NCT02236988|26329142|P2|Overall Study|Unable to Comply with Study Visits|0
7571350|NCT02236988|26329143|P1|Overall Study|Unable to Comply with Study Visits|0
7571351|NCT02236988|26329140|P4|Overall Study|Lost to Follow-up|1
7571352|NCT02236988|26329141|P3|Overall Study|Lost to Follow-up|0
7571353|NCT02236988|26329142|P2|Overall Study|Lost to Follow-up|0
7571354|NCT02236988|26329143|P1|Overall Study|Lost to Follow-up|0
7571355|NCT02236611|26329324|P2|Overall Study|Withdrew consent|4
7571356|NCT02236611|26329325|P1|Overall Study|Withdrew consent|9
7571357|NCT02236611|26329324|P2|Overall Study|Protocol deviation|5
7571358|NCT02236611|26329325|P1|Overall Study|Protocol deviation|3
7571359|NCT02236611|26329324|P2|Overall Study|Lost to Follow-up|2
7571360|NCT02236611|26329325|P1|Overall Study|Lost to Follow-up|0
7571361|NCT02236611|26329324|P2|Overall Study|Lack of Efficacy|7
7571362|NCT02236611|26329325|P1|Overall Study|Lack of Efficacy|4
7571363|NCT02236611|26329324|P2|Overall Study|Adverse Event|16
7571364|NCT02236611|26329325|P1|Overall Study|Adverse Event|10
7571365|NCT02236598|26329333|P2|Overall Study|Withdrawal by Subject|1
7571366|NCT02236598|26329334|P1|Overall Study|Withdrawal by Subject|0
7571367|NCT02236598|26329333|P2|Overall Study|Adverse Event|1
7571368|NCT02236598|26329334|P1|Overall Study|Adverse Event|0
7571369|NCT02236559|26329348|P2|Overall Study|Withdrawal by Subject|0
7571370|NCT02236559|26329349|P1|Overall Study|Withdrawal by Subject|1
7571371|NCT02236559|26329348|P2|Overall Study|Physician Decision|1
7571372|NCT02236559|26329349|P1|Overall Study|Physician Decision|1
7571373|NCT02236559|26329348|P2|Overall Study|Subject Did Not Consent|2
7571374|NCT02236559|26329349|P1|Overall Study|Subject Did Not Consent|4
7571375|NCT02236559|26329348|P2|Overall Study|Did not Meet Inclusion|3
7571376|NCT02236559|26329349|P1|Overall Study|Did not Meet Inclusion|3
7571377|NCT02236559|26329348|P2|Overall Study|Met Exclusion|6
7571378|NCT02236559|26329349|P1|Overall Study|Met Exclusion|3
7571379|NCT02236520|26329386|P4|Overall Study|Pregnancy|0
7571380|NCT02236520|26329387|P3|Overall Study|Pregnancy|0
7571381|NCT02236520|26329388|P2|Overall Study|Pregnancy|0
7571382|NCT02236520|26329389|P1|Overall Study|Pregnancy|1
7571383|NCT02236520|26329386|P4|Overall Study|Withdrawal by Subject|1
7571384|NCT02236520|26329387|P3|Overall Study|Withdrawal by Subject|0
7571385|NCT02236520|26329388|P2|Overall Study|Withdrawal by Subject|0
7571386|NCT02236520|26329389|P1|Overall Study|Withdrawal by Subject|1
7571387|NCT02236520|26329386|P4|Overall Study|Physician Decision|0
7571388|NCT02236520|26329387|P3|Overall Study|Physician Decision|0
7571389|NCT02236520|26329388|P2|Overall Study|Physician Decision|5
7571390|NCT02236520|26329389|P1|Overall Study|Physician Decision|0
7571391|NCT02236130|26329416|P2|Overall Study|Lost to Follow-up|12
7571392|NCT02236130|26329417|P1|Overall Study|Lost to Follow-up|7
7571393|NCT02235454|26329467|P1|Overall Study|Withdrawal by Subject|2
7571394|NCT02235311|26329473|P2|Overall Study|Protocol Violation|1
7571395|NCT02235311|26329474|P1|Overall Study|Protocol Violation|0
7571396|NCT02235311|26329473|P2|Overall Study|Lost to Follow-up|1
7571397|NCT02235311|26329474|P1|Overall Study|Lost to Follow-up|0
7571398|NCT02235298|26329488|P2|Overall Study|Withdrawal by Subject|1
7571399|NCT02235298|26329489|P1|Overall Study|Withdrawal by Subject|0
7571400|NCT02235298|26329488|P2|Overall Study|Adverse Event|2
7571401|NCT02235298|26329489|P1|Overall Study|Adverse Event|2
7571402|NCT02235298|26329488|P2|Overall Study|Lost to Follow-up|5
7571403|NCT02235298|26329489|P1|Overall Study|Lost to Follow-up|6
7571404|NCT02235077|26329503|P2|Overall Study|Physician Decision|1
7571405|NCT02235077|26329504|P1|Overall Study|Physician Decision|0
7571406|NCT02235077|26329503|P2|Overall Study|Withdrawal by Subject|5
7571407|NCT02235077|26329504|P1|Overall Study|Withdrawal by Subject|8
7571408|NCT02235077|26329503|P2|Overall Study|Lost to Follow-up|6
7571409|NCT02235077|26329504|P1|Overall Study|Lost to Follow-up|5
7571410|NCT02235077|26329503|P2|Overall Study|Death|7
7571411|NCT02235077|26329504|P1|Overall Study|Death|5
7571412|NCT02234843|26329569|P10|Overall Study|Lost to Follow-up|0
7571413|NCT02234843|26329570|P9|Overall Study|Lost to Follow-up|0
7571414|NCT02234843|26329571|P8|Overall Study|Lost to Follow-up|0
7571415|NCT02234843|26329572|P7|Overall Study|Lost to Follow-up|1
7571416|NCT02234843|26329573|P6|Overall Study|Lost to Follow-up|0
7571417|NCT02234843|26329574|P5|Overall Study|Lost to Follow-up|0
7571418|NCT02234843|26329575|P4|Overall Study|Lost to Follow-up|0
7571419|NCT02234843|26329576|P3|Overall Study|Lost to Follow-up|0
7571420|NCT02234843|26329577|P2|Overall Study|Lost to Follow-up|1
7571421|NCT02234843|26329578|P1|Overall Study|Lost to Follow-up|0
7571422|NCT02234843|26329569|P10|Overall Study|Non-compliance with study drug|0
7571423|NCT02234843|26329570|P9|Overall Study|Non-compliance with study drug|0
7571424|NCT02234843|26329571|P8|Overall Study|Non-compliance with study drug|0
7571425|NCT02234843|26329572|P7|Overall Study|Non-compliance with study drug|1
7571426|NCT02234843|26329573|P6|Overall Study|Non-compliance with study drug|1
7571427|NCT02234843|26329574|P5|Overall Study|Non-compliance with study drug|0
7571428|NCT02234843|26329575|P4|Overall Study|Non-compliance with study drug|0
7571429|NCT02234843|26329576|P3|Overall Study|Non-compliance with study drug|0
7571430|NCT02234843|26329577|P2|Overall Study|Non-compliance with study drug|0
7571431|NCT02234843|26329578|P1|Overall Study|Non-compliance with study drug|1
7571432|NCT02234843|26329569|P10|Overall Study|Adverse Event|0
7571433|NCT02234843|26329570|P9|Overall Study|Adverse Event|1
7571434|NCT02234843|26329571|P8|Overall Study|Adverse Event|0
7571435|NCT02234843|26329572|P7|Overall Study|Adverse Event|0
7571436|NCT02234843|26329573|P6|Overall Study|Adverse Event|1
7571437|NCT02234843|26329574|P5|Overall Study|Adverse Event|2
7571438|NCT02234843|26329575|P4|Overall Study|Adverse Event|3
7571439|NCT02234843|26329576|P3|Overall Study|Adverse Event|1
7571440|NCT02234843|26329577|P2|Overall Study|Adverse Event|1
7571441|NCT02234843|26329578|P1|Overall Study|Adverse Event|5
7571442|NCT02234843|26329569|P10|Overall Study|Physician Decision|0
7571443|NCT02234843|26329570|P9|Overall Study|Physician Decision|0
7571444|NCT02234843|26329571|P8|Overall Study|Physician Decision|1
7571445|NCT02234843|26329572|P7|Overall Study|Physician Decision|0
7571446|NCT02234843|26329573|P6|Overall Study|Physician Decision|0
7571447|NCT02234843|26329574|P5|Overall Study|Physician Decision|0
7571448|NCT02234843|26329575|P4|Overall Study|Physician Decision|1
7571449|NCT02234843|26329576|P3|Overall Study|Physician Decision|0
7571450|NCT02234843|26329577|P2|Overall Study|Physician Decision|1
7571451|NCT02234843|26329578|P1|Overall Study|Physician Decision|4
7571452|NCT02234843|26329569|P10|Overall Study|Other|0
7571453|NCT02234843|26329570|P9|Overall Study|Other|0
7571454|NCT02234843|26329571|P8|Overall Study|Other|1
7571455|NCT02234843|26329572|P7|Overall Study|Other|0
7571456|NCT02234843|26329573|P6|Overall Study|Other|1
7571457|NCT02234843|26329574|P5|Overall Study|Other|0
7571458|NCT02234843|26329575|P4|Overall Study|Other|1
7571459|NCT02234843|26329576|P3|Overall Study|Other|0
7571460|NCT02234843|26329577|P2|Overall Study|Other|2
7571461|NCT02234843|26329578|P1|Overall Study|Other|0
7571462|NCT02234843|26329569|P10|Overall Study|Recovery|0
7571463|NCT02234843|26329570|P9|Overall Study|Recovery|0
7571464|NCT02234843|26329571|P8|Overall Study|Recovery|0
7571465|NCT02234843|26329572|P7|Overall Study|Recovery|0
7571466|NCT02234843|26329573|P6|Overall Study|Recovery|0
7571467|NCT02234843|26329574|P5|Overall Study|Recovery|0
7571468|NCT02234843|26329575|P4|Overall Study|Recovery|0
7571469|NCT02234843|26329576|P3|Overall Study|Recovery|0
7571470|NCT02234843|26329577|P2|Overall Study|Recovery|0
7571471|NCT02234843|26329578|P1|Overall Study|Recovery|1
7571472|NCT02234843|26329569|P10|Overall Study|Withdrawal by Subject|0
7571473|NCT02234843|26329570|P9|Overall Study|Withdrawal by Subject|0
7571474|NCT02234843|26329571|P8|Overall Study|Withdrawal by Subject|0
7571475|NCT02234843|26329572|P7|Overall Study|Withdrawal by Subject|0
7571476|NCT02234843|26329573|P6|Overall Study|Withdrawal by Subject|7
7571477|NCT02234843|26329574|P5|Overall Study|Withdrawal by Subject|0
7571478|NCT02234843|26329575|P4|Overall Study|Withdrawal by Subject|0
7571479|NCT02234843|26329576|P3|Overall Study|Withdrawal by Subject|1
7571480|NCT02234843|26329577|P2|Overall Study|Withdrawal by Subject|1
7571481|NCT02234843|26329578|P1|Overall Study|Withdrawal by Subject|5
7571482|NCT02234843|26329569|P10|Overall Study|Patient convenience|0
7571483|NCT02234843|26329570|P9|Overall Study|Patient convenience|0
7571484|NCT02234843|26329571|P8|Overall Study|Patient convenience|0
7571485|NCT02234843|26329572|P7|Overall Study|Patient convenience|0
7571486|NCT02234843|26329573|P6|Overall Study|Patient convenience|1
7571487|NCT02234843|26329574|P5|Overall Study|Patient convenience|0
7571488|NCT02234843|26329575|P4|Overall Study|Patient convenience|0
7571489|NCT02234843|26329576|P3|Overall Study|Patient convenience|0
7571490|NCT02234843|26329577|P2|Overall Study|Patient convenience|0
7571491|NCT02234843|26329578|P1|Overall Study|Patient convenience|2
7571492|NCT02234843|26329569|P10|Overall Study|Efficacy outcome reached|0
7571493|NCT02234843|26329570|P9|Overall Study|Efficacy outcome reached|0
7571494|NCT02234843|26329571|P8|Overall Study|Efficacy outcome reached|0
7571495|NCT02234843|26329572|P7|Overall Study|Efficacy outcome reached|0
7571496|NCT02234843|26329573|P6|Overall Study|Efficacy outcome reached|2
7571497|NCT02234843|26329574|P5|Overall Study|Efficacy outcome reached|0
7571498|NCT02234843|26329575|P4|Overall Study|Efficacy outcome reached|0
7571499|NCT02234843|26329576|P3|Overall Study|Efficacy outcome reached|0
7571500|NCT02234843|26329577|P2|Overall Study|Efficacy outcome reached|0
7571501|NCT02234843|26329578|P1|Overall Study|Efficacy outcome reached|2
7571502|NCT02234843|26329569|P10|Overall Study|Protocol Violation|0
7571503|NCT02234843|26329570|P9|Overall Study|Protocol Violation|0
7571504|NCT02234843|26329571|P8|Overall Study|Protocol Violation|0
7571505|NCT02234843|26329572|P7|Overall Study|Protocol Violation|0
7571506|NCT02234843|26329573|P6|Overall Study|Protocol Violation|0
7571507|NCT02234843|26329574|P5|Overall Study|Protocol Violation|0
7571508|NCT02234843|26329575|P4|Overall Study|Protocol Violation|0
7571509|NCT02234843|26329576|P3|Overall Study|Protocol Violation|1
7571510|NCT02234843|26329577|P2|Overall Study|Protocol Violation|0
7571511|NCT02234843|26329578|P1|Overall Study|Protocol Violation|1
7571512|NCT02234843|26329569|P10|Overall Study|Death|0
7571513|NCT02234843|26329570|P9|Overall Study|Death|0
7571514|NCT02234843|26329571|P8|Overall Study|Death|0
7571515|NCT02234843|26329572|P7|Overall Study|Death|0
7571516|NCT02234843|26329573|P6|Overall Study|Death|0
7571517|NCT02234843|26329574|P5|Overall Study|Death|0
7571518|NCT02234843|26329575|P4|Overall Study|Death|0
7571519|NCT02234843|26329576|P3|Overall Study|Death|0
7571520|NCT02234843|26329577|P2|Overall Study|Death|0
7571521|NCT02234843|26329578|P1|Overall Study|Death|1
7571522|NCT02234622|26329736|P2|Overall Study|Lost to Follow-up|14
7571523|NCT02234622|26329737|P1|Overall Study|Lost to Follow-up|27
7571524|NCT02234622|26329736|P2|Overall Study|Withdrawal by Subject|22
7571525|NCT02234622|26329737|P1|Overall Study|Withdrawal by Subject|16
7571526|NCT02234596|26329755|P1|Overall Study|Participant not treated|2
7571527|NCT02234583|26329763|P2|Overall Study|Other|97
7571528|NCT02234583|26329764|P1|Overall Study|Other|39
7571529|NCT02234583|26329763|P2|Overall Study|Protocol Violation|42
7571530|NCT02234583|26329764|P1|Overall Study|Protocol Violation|35
7571531|NCT02234583|26329763|P2|Overall Study|Lack of Efficacy|103
7571532|NCT02234583|26329764|P1|Overall Study|Lack of Efficacy|58
7571533|NCT02234583|26329763|P2|Overall Study|Lost to Follow-up|1
7571534|NCT02234583|26329764|P1|Overall Study|Lost to Follow-up|0
7571535|NCT02234583|26329763|P2|Overall Study|Withdrawal by Subject|157
7571536|NCT02234583|26329764|P1|Overall Study|Withdrawal by Subject|109
7571537|NCT02234583|26329763|P2|Overall Study|Adverse Event|156
7571538|NCT02234583|26329764|P1|Overall Study|Adverse Event|172
7571539|NCT02234479|26329883|P2|Overall Study|Withdrawal by Subject|3
7571540|NCT02234479|26329884|P1|Overall Study|Withdrawal by Subject|1
7571541|NCT02234362|26329894|P1|Overall Study|Withdrawal by Subject|3
7571542|NCT02234362|26329894|P1|Overall Study|Lost to Follow-up|6
7571543|NCT02234362|26329894|P1|Overall Study|Not eligible after first screening visit|17
7571544|NCT02234323|26329911|P1|All Treated|Other|7
7571545|NCT02234323|26329911|P1|All Treated|Exceeded lab value limit|2
7571546|NCT02234323|26329911|P1|All Treated|Lack of Efficacy|3
7571547|NCT02234323|26329911|P1|All Treated|Physician Decision|5
7571548|NCT02234323|26329911|P1|All Treated|Death|1
7571549|NCT02234323|26329911|P1|All Enrolled|Not Treated: Exceeded lab value limit|1
7571550|NCT02234323|26329911|P1|All Enrolled|Not Treated:Consent withdrawn by subject|2
7571551|NCT02234323|26329911|P1|All Enrolled|Not Treated: Completed study in database|2
7571552|NCT02234310|26329924|P1|Overall Study|Withdrawal by Subject|2
7571553|NCT02234310|26329924|P1|Overall Study|Eligibility Criteria not fulfilled|2
7571554|NCT02234310|26329924|P1|Overall Study|Adverse Event|1
7571555|NCT02234310|26329924|P1|Overall Study|Physician Decision|1
7571556|NCT02234284|26329938|P2|Overall Study|Lost to Follow-up|7
7571557|NCT02234284|26329939|P1|Overall Study|Lost to Follow-up|20
7571558|NCT02234284|26329938|P2|Overall Study|Withdrawal by Subject|0
7571559|NCT02234284|26329939|P1|Overall Study|Withdrawal by Subject|1
7571560|NCT02234284|26329938|P2|Overall Study|Death|2
7571561|NCT02234284|26329939|P1|Overall Study|Death|4
7571562|NCT02234141|26329998|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
7571563|NCT02234141|26329999|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
7571564|NCT02234141|26330000|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
7571565|NCT02234141|26330001|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
7571566|NCT02234141|26330002|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
7571567|NCT02234141|26330003|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
7571568|NCT02234141|26330004|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
7571569|NCT02234141|26329998|P7|Long-Term Treatment Period|Withdrew Consent|0
7571570|NCT02234141|26329999|P6|Long-Term Treatment Period|Withdrew Consent|0
7571571|NCT02234141|26330000|P5|Long-Term Treatment Period|Withdrew Consent|0
7571572|NCT02234141|26330001|P4|Long-Term Treatment Period|Withdrew Consent|0
7571573|NCT02234141|26330002|P3|Long-Term Treatment Period|Withdrew Consent|1
7571574|NCT02234141|26330003|P2|Long-Term Treatment Period|Withdrew Consent|1
7571575|NCT02234141|26330004|P1|Long-Term Treatment Period|Withdrew Consent|0
7571576|NCT02234141|26329998|P7|Long-Term Treatment Period|Adverse Event|1
7571577|NCT02234141|26329999|P6|Long-Term Treatment Period|Adverse Event|1
7571578|NCT02234141|26330000|P5|Long-Term Treatment Period|Adverse Event|1
7571579|NCT02234141|26330001|P4|Long-Term Treatment Period|Adverse Event|0
7571580|NCT02234141|26330002|P3|Long-Term Treatment Period|Adverse Event|5
7571581|NCT02234141|26330003|P2|Long-Term Treatment Period|Adverse Event|0
7571582|NCT02234141|26330004|P1|Long-Term Treatment Period|Adverse Event|4
7571583|NCT02234141|26329998|P7|Long-Term Treatment Period|Investigator's discretion|1
7571584|NCT02234141|26329999|P6|Long-Term Treatment Period|Investigator's discretion|0
7571585|NCT02234141|26330000|P5|Long-Term Treatment Period|Investigator's discretion|0
7571586|NCT02234141|26330001|P4|Long-Term Treatment Period|Investigator's discretion|0
7571587|NCT02234141|26330002|P3|Long-Term Treatment Period|Investigator's discretion|2
7571588|NCT02234141|26330003|P2|Long-Term Treatment Period|Investigator's discretion|3
7571589|NCT02234141|26330004|P1|Long-Term Treatment Period|Investigator's discretion|1
7571590|NCT02234141|26329998|P7|Long-Term Treatment Period|Death|0
7571591|NCT02234141|26329999|P6|Long-Term Treatment Period|Death|1
7571592|NCT02234141|26330000|P5|Long-Term Treatment Period|Death|0
7571593|NCT02234141|26330001|P4|Long-Term Treatment Period|Death|0
7571594|NCT02234141|26330002|P3|Long-Term Treatment Period|Death|0
7571595|NCT02234141|26330003|P2|Long-Term Treatment Period|Death|0
7571596|NCT02234141|26330004|P1|Long-Term Treatment Period|Death|0
7571597|NCT02234141|26329998|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
7571598|NCT02234141|26329999|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
7571599|NCT02234141|26330000|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
7571600|NCT02234141|26330001|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
7571601|NCT02234141|26330002|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
7571602|NCT02234141|26330003|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
7571603|NCT02234141|26330004|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
7571604|NCT02234141|26329998|P7|Treatment Period (24 Weeks)|Adverse Event|0
7571605|NCT02234141|26329999|P6|Treatment Period (24 Weeks)|Adverse Event|0
7571606|NCT02234141|26330000|P5|Treatment Period (24 Weeks)|Adverse Event|0
7571607|NCT02234141|26330001|P4|Treatment Period (24 Weeks)|Adverse Event|3
7571608|NCT02234141|26330002|P3|Treatment Period (24 Weeks)|Adverse Event|2
7571609|NCT02234141|26330003|P2|Treatment Period (24 Weeks)|Adverse Event|1
7571610|NCT02234141|26330004|P1|Treatment Period (24 Weeks)|Adverse Event|3
7571611|NCT02234141|26329998|P7|Treatment Period (24 Weeks)|Death|0
7571612|NCT02234141|26329999|P6|Treatment Period (24 Weeks)|Death|0
7571613|NCT02234141|26330000|P5|Treatment Period (24 Weeks)|Death|0
7571614|NCT02234141|26330001|P4|Treatment Period (24 Weeks)|Death|1
7571615|NCT02234141|26330002|P3|Treatment Period (24 Weeks)|Death|0
7571616|NCT02234141|26330003|P2|Treatment Period (24 Weeks)|Death|2
7571617|NCT02234141|26330004|P1|Treatment Period (24 Weeks)|Death|1
7571618|NCT02234141|26329998|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
7571619|NCT02234141|26329999|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
7571620|NCT02234141|26330000|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
7571621|NCT02234141|26330001|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
7571622|NCT02234141|26330002|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
7571623|NCT02234141|26330003|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
7571624|NCT02234141|26330004|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
7571625|NCT02234141|26329998|P7|Treatment Period (24 Weeks)|Protocol Violation|0
7571626|NCT02234141|26329999|P6|Treatment Period (24 Weeks)|Protocol Violation|0
7571627|NCT02234141|26330000|P5|Treatment Period (24 Weeks)|Protocol Violation|0
7571628|NCT02234141|26330001|P4|Treatment Period (24 Weeks)|Protocol Violation|1
7571629|NCT02234141|26330002|P3|Treatment Period (24 Weeks)|Protocol Violation|0
7571630|NCT02234141|26330003|P2|Treatment Period (24 Weeks)|Protocol Violation|0
7571631|NCT02234141|26330004|P1|Treatment Period (24 Weeks)|Protocol Violation|0
7571632|NCT02234063|26330109|P2|Overall Study|Withdrawal by Subject|1
7571633|NCT02234063|26330110|P1|Overall Study|Withdrawal by Subject|20
7571634|NCT02234063|26330109|P2|Overall Study|Lost to Follow-up|42
7571635|NCT02234063|26330110|P1|Overall Study|Lost to Follow-up|235
7571636|NCT02233946|26330184|P2|12-month Follow-up|Lost to Follow-up|11
7571637|NCT02233946|26330185|P1|12-month Follow-up|Lost to Follow-up|28
7571638|NCT02233946|26330184|P2|9-month Follow-up|Lost to Follow-up|11
7571639|NCT02233946|26330185|P1|9-month Follow-up|Lost to Follow-up|20
7571640|NCT02233946|26330184|P2|6-months Follow-up|Lost to Follow-up|2
7571641|NCT02233946|26330185|P1|6-months Follow-up|Lost to Follow-up|21
7571642|NCT02233946|26330184|P2|3-months Follow-up|Lost to Follow-up|29
7571643|NCT02233946|26330185|P1|3-months Follow-up|Lost to Follow-up|53
7571644|NCT02233946|26330184|P2|Baseline|Withdrawal by Subject|0
7571645|NCT02233946|26330185|P1|Baseline|Withdrawal by Subject|2
7571646|NCT02233803|26330204|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
7571647|NCT02233803|26330205|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
7571648|NCT02233803|26330204|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
7571649|NCT02233803|26330205|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
7571650|NCT02233803|26330204|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
7571651|NCT02233803|26330205|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
7571652|NCT02233803|26330204|P2|Washout Period (4-Wks)|Physician Decision|0
7571653|NCT02233803|26330205|P1|Washout Period (4-Wks)|Physician Decision|1
7571654|NCT02233803|26330204|P2|Washout Period (4-Wks)|Lost to Follow-up|1
7571655|NCT02233803|26330205|P1|Washout Period (4-Wks)|Lost to Follow-up|0
7571656|NCT02233803|26330204|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
7571657|NCT02233803|26330205|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
7571658|NCT02233803|26330204|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
7571659|NCT02233803|26330205|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
7571660|NCT02233803|26330204|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
7571661|NCT02233803|26330205|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
7571662|NCT02233803|26330204|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
7571663|NCT02233803|26330205|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
7571664|NCT02233738|26330238|P2|Overall Study|Did not return after Baseline|2
7571665|NCT02233738|26330239|P1|Overall Study|Did not return after Baseline|3
7571666|NCT02233738|26330238|P2|Overall Study|Withdrawal by Subject|1
7571667|NCT02233738|26330239|P1|Overall Study|Withdrawal by Subject|0
7571668|NCT02233738|26330238|P2|Overall Study|Death|1
7571669|NCT02233738|26330239|P1|Overall Study|Death|0
7571670|NCT02233738|26330238|P2|Overall Study|Lost to Follow-up|12
7571671|NCT02233738|26330239|P1|Overall Study|Lost to Follow-up|5
7571672|NCT02233647|26330409|P1|Overall Study|Adverse Event|1
7571673|NCT02233543|26330438|P2|Period 2|COPD exacerbation|0
7571674|NCT02233543|26330439|P1|Period 2|COPD exacerbation|1
7571675|NCT02233543|26330438|P2|Period 2|Participant required other treatment.|1
7571676|NCT02233543|26330439|P1|Period 2|Participant required other treatment.|0
7571677|NCT02233543|26330438|P2|Period 2|Adverse Event|0
7571678|NCT02233543|26330439|P1|Period 2|Adverse Event|1
7571679|NCT02233543|26330438|P2|Period 1|Participants required other treatment.|3
7571680|NCT02233543|26330439|P1|Period 1|Participants required other treatment.|2
7571681|NCT02233543|26330438|P2|Period 1|Withdrawal by Subject|0
7571682|NCT02233543|26330439|P1|Period 1|Withdrawal by Subject|1
7571683|NCT02233413|26330502|P2|Overall Study|Withdrawal by Subject|5
7571684|NCT02233413|26330503|P1|Overall Study|Withdrawal by Subject|4
7571685|NCT02233413|26330502|P2|Overall Study|Lost to Follow-up|9
7571686|NCT02233413|26330503|P1|Overall Study|Lost to Follow-up|7
7571687|NCT02233309|26330515|P1|Overall Study|Physician Decision|5
7571688|NCT02232984|26330549|P1|Overall Study|Protocol Violation|1
7571689|NCT02232984|26330549|P1|Overall Study|not disclosed by site|7
7571690|NCT02232984|26330549|P1|Overall Study|Device implant unsuccessful|53
7571691|NCT02232984|26330549|P1|Overall Study|Investigator withdrawal|10
7571692|NCT02232984|26330549|P1|Overall Study|Death|1
7571693|NCT02232984|26330549|P1|Overall Study|Withdrawal by Subject|5
7571694|NCT02232893|26330560|P2|Overall Study|Other|3
7571695|NCT02232893|26330561|P1|Overall Study|Other|0
7571696|NCT02232893|26330560|P2|Overall Study|Developed exclusion criteria|1
7571697|NCT02232893|26330561|P1|Overall Study|Developed exclusion criteria|0
7571698|NCT02232893|26330560|P2|Overall Study|Sponsor request early termination|1
7571699|NCT02232893|26330561|P1|Overall Study|Sponsor request early termination|0
7571700|NCT02232893|26330560|P2|Overall Study|Adverse Event|1
7571701|NCT02232893|26330561|P1|Overall Study|Adverse Event|0
7571702|NCT02232893|26330560|P2|Overall Study|Withdrawal by Subject|1
7571703|NCT02232893|26330561|P1|Overall Study|Withdrawal by Subject|4
7571704|NCT02232880|26330567|P1|Overall Study|study stopped prior to randomization|1
7571705|NCT02232802|26330576|P2|Period 1|Adverse Event|1
7571706|NCT02232802|26330577|P1|Period 1|Adverse Event|1
7571707|NCT02232802|26330576|P2|Period 1|Sponsor request|0
7571708|NCT02232802|26330577|P1|Period 1|Sponsor request|1
7571709|NCT02232698|26330643|P2|Overall Study|Withdrawal by Subject|11
7571710|NCT02232698|26330644|P1|Overall Study|Withdrawal by Subject|0
7571711|NCT02232698|26330643|P2|Overall Study|Allocated to control group|3
7571712|NCT02232698|26330644|P1|Overall Study|Allocated to control group|0
7571713|NCT02232698|26330643|P2|Overall Study|Non-compliance with study device|4
7571714|NCT02232698|26330644|P1|Overall Study|Non-compliance with study device|1
7571715|NCT02232698|26330643|P2|Overall Study|Had device-associated symptoms|0
7571716|NCT02232698|26330644|P1|Overall Study|Had device-associated symptoms|7
7571717|NCT02232698|26330643|P2|Overall Study|Met exclusion criteria|1
7571718|NCT02232698|26330644|P1|Overall Study|Met exclusion criteria|1
7571719|NCT02232698|26330643|P2|Overall Study|Pregnancy|1
7571720|NCT02232698|26330644|P1|Overall Study|Pregnancy|1
7571721|NCT02232425|26330667|P2|Overall Study|Lack of Efficacy|0
7571722|NCT02232425|26330668|P1|Overall Study|Lack of Efficacy|1
7571723|NCT02232425|26330667|P2|Overall Study|Withdrawal by Subject|6
7571724|NCT02232425|26330668|P1|Overall Study|Withdrawal by Subject|5
7571725|NCT02232425|26330667|P2|Overall Study|Adverse Event|0
7571726|NCT02232425|26330668|P1|Overall Study|Adverse Event|2
7571727|NCT02232425|26330667|P2|Overall Study|Lost to Follow-up|2
7571728|NCT02232425|26330668|P1|Overall Study|Lost to Follow-up|6
7571729|NCT02232243|26330714|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7571730|NCT02232243|26330715|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
7571731|NCT02232243|26330716|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7571732|NCT02232178|26330728|P3|Overall Study|surgical complication|0
7571733|NCT02232178|26330729|P2|Overall Study|surgical complication|0
7571734|NCT02232178|26330730|P1|Overall Study|surgical complication|1
7571735|NCT02232178|26330728|P3|Overall Study|ineligibility|1
7571736|NCT02232178|26330729|P2|Overall Study|ineligibility|0
7571737|NCT02232178|26330730|P1|Overall Study|ineligibility|0
7571738|NCT02232178|26330728|P3|Overall Study|Lost to Follow-up|0
7571739|NCT02232178|26330729|P2|Overall Study|Lost to Follow-up|1
7571740|NCT02232178|26330730|P1|Overall Study|Lost to Follow-up|0
7571741|NCT02232087|26330758|P6|Overall Study|Adverse Event|0
7571742|NCT02232087|26330759|P5|Overall Study|Adverse Event|1
7571743|NCT02232087|26330760|P4|Overall Study|Adverse Event|0
7571744|NCT02232087|26330761|P3|Overall Study|Adverse Event|0
7571745|NCT02232087|26330762|P2|Overall Study|Adverse Event|0
7571746|NCT02232087|26330763|P1|Overall Study|Adverse Event|0
7571747|NCT02232087|26330758|P6|Overall Study|protocol stop criteria|0
7571748|NCT02232087|26330759|P5|Overall Study|protocol stop criteria|0
7571749|NCT02232087|26330760|P4|Overall Study|protocol stop criteria|1
7571750|NCT02232087|26330761|P3|Overall Study|protocol stop criteria|0
7571751|NCT02232087|26330762|P2|Overall Study|protocol stop criteria|1
7571752|NCT02232087|26330763|P1|Overall Study|protocol stop criteria|0
7571753|NCT02232087|26330758|P6|Overall Study|poor inhalation technique|2
7571754|NCT02232087|26330759|P5|Overall Study|poor inhalation technique|0
7571755|NCT02232087|26330760|P4|Overall Study|poor inhalation technique|0
7571756|NCT02232087|26330761|P3|Overall Study|poor inhalation technique|0
7571757|NCT02232087|26330762|P2|Overall Study|poor inhalation technique|1
7571758|NCT02232087|26330763|P1|Overall Study|poor inhalation technique|0
7571759|NCT02232087|26330758|P6|Overall Study|Withdrawal by Subject|1
7571760|NCT02232087|26330759|P5|Overall Study|Withdrawal by Subject|0
7571761|NCT02232087|26330760|P4|Overall Study|Withdrawal by Subject|0
7571762|NCT02232087|26330761|P3|Overall Study|Withdrawal by Subject|0
7571763|NCT02232087|26330762|P2|Overall Study|Withdrawal by Subject|0
7571764|NCT02232087|26330763|P1|Overall Study|Withdrawal by Subject|2
7571765|NCT02232074|26330799|P2|Overall Study|deemed ineligible|1
7571766|NCT02232074|26330800|P1|Overall Study|deemed ineligible|0
7571767|NCT02232074|26330799|P2|Overall Study|No legal concerns at baseline|41
7571768|NCT02232074|26330800|P1|Overall Study|No legal concerns at baseline|36
7571769|NCT02232074|26330799|P2|Overall Study|Withdrawal by Subject|3
7571770|NCT02232074|26330800|P1|Overall Study|Withdrawal by Subject|5
7571771|NCT02232061|26330846|P1|Overall Study|Withdrawal by Subject|1
7571772|NCT02232061|26330846|P1|Overall Study|Administrative problems|1
7571773|NCT02231918|26330871|P3|Overall Study|Adverse Event|1
7571774|NCT02231918|26330872|P2|Overall Study|Adverse Event|0
7571775|NCT02231918|26330873|P1|Overall Study|Adverse Event|0
7571776|NCT02231918|26330871|P3|Overall Study|Withdrawal by Subject|0
7571777|NCT02231918|26330872|P2|Overall Study|Withdrawal by Subject|1
7571778|NCT02231918|26330873|P1|Overall Study|Withdrawal by Subject|0
7571779|NCT02231892|26330938|P3|Overall Study|Could not find reliable motor hotspot|1
7571780|NCT02231892|26330939|P2|Overall Study|Could not find reliable motor hotspot|0
7571781|NCT02231892|26330940|P1|Overall Study|Could not find reliable motor hotspot|0
7571782|NCT02231892|26330938|P3|Overall Study|Could not find motor threshold|1
7571783|NCT02231892|26330939|P2|Overall Study|Could not find motor threshold|0
7571784|NCT02231892|26330940|P1|Overall Study|Could not find motor threshold|2
7571785|NCT02231892|26330938|P3|Overall Study|Participant motor threshold was >83%|9
7571786|NCT02231892|26330939|P2|Overall Study|Participant motor threshold was >83%|0
7571787|NCT02231892|26330940|P1|Overall Study|Participant motor threshold was >83%|0
7571788|NCT02231892|26330938|P3|Overall Study|Motor activity when stimulating ante ACC|12
7571789|NCT02231892|26330939|P2|Overall Study|Motor activity when stimulating ante ACC|7
7571790|NCT02231892|26330940|P1|Overall Study|Motor activity when stimulating ante ACC|4
7571791|NCT02231892|26330938|P3|Overall Study|Physician Decision|4
7571792|NCT02231892|26330939|P2|Overall Study|Physician Decision|2
7571793|NCT02231892|26330940|P1|Overall Study|Physician Decision|0
7571794|NCT02231892|26330938|P3|Overall Study|Withdrawal by Subject|15
7571795|NCT02231892|26330939|P2|Overall Study|Withdrawal by Subject|3
7571796|NCT02231892|26330940|P1|Overall Study|Withdrawal by Subject|4
7571797|NCT02231892|26330938|P3|Overall Study|Lost to Follow-up|3
7571798|NCT02231892|26330939|P2|Overall Study|Lost to Follow-up|0
7571799|NCT02231892|26330940|P1|Overall Study|Lost to Follow-up|1
7571800|NCT02231762|26330957|P4|Maintenance Phase|Adverse Event|2
7571801|NCT02231762|26330958|P3|Maintenance Phase|Adverse Event|1
7571802|NCT02231762|26330959|P2|Maintenance Phase|Adverse Event|0
7571803|NCT02231762|26330960|P1|Maintenance Phase|Adverse Event|0
7571804|NCT02231762|26330957|P4|Maintenance Phase|Disease progression|3
7571805|NCT02231762|26330958|P3|Maintenance Phase|Disease progression|4
7571806|NCT02231762|26330959|P2|Maintenance Phase|Disease progression|3
7571807|NCT02231762|26330960|P1|Maintenance Phase|Disease progression|0
7571808|NCT02231762|26330957|P4|Combination Phase|Protocol Violation|0
7571809|NCT02231762|26330958|P3|Combination Phase|Protocol Violation|0
7571810|NCT02231762|26330959|P2|Combination Phase|Protocol Violation|0
7571811|NCT02231762|26330960|P1|Combination Phase|Protocol Violation|1
7571812|NCT02231762|26330957|P4|Combination Phase|Did not meet inclusion criteria|0
7571813|NCT02231762|26330958|P3|Combination Phase|Did not meet inclusion criteria|0
7571814|NCT02231762|26330959|P2|Combination Phase|Did not meet inclusion criteria|0
7571815|NCT02231762|26330960|P1|Combination Phase|Did not meet inclusion criteria|1
7571816|NCT02231762|26330957|P4|Combination Phase|Disease Progression|0
7571817|NCT02231762|26330958|P3|Combination Phase|Disease Progression|0
7571818|NCT02231762|26330959|P2|Combination Phase|Disease Progression|0
7571819|NCT02231762|26330960|P1|Combination Phase|Disease Progression|6
7571820|NCT02231762|26330957|P4|Combination Phase|Withdrawal by Subject|0
7571821|NCT02231762|26330958|P3|Combination Phase|Withdrawal by Subject|0
7571822|NCT02231762|26330959|P2|Combination Phase|Withdrawal by Subject|0
7571823|NCT02231762|26330960|P1|Combination Phase|Withdrawal by Subject|2
7571824|NCT02231762|26330957|P4|Combination Phase|Adverse Event|0
7571825|NCT02231762|26330958|P3|Combination Phase|Adverse Event|0
7571826|NCT02231762|26330959|P2|Combination Phase|Adverse Event|0
7571827|NCT02231762|26330960|P1|Combination Phase|Adverse Event|10
7571852|NCT02231580|26331012|P2|Overall Study|Adverse Event|0
7571853|NCT02231580|26331013|P1|Overall Study|Adverse Event|5
7571854|NCT02231164|26331130|P2|Overall Study|Withdrawal by Subject|2
7571855|NCT02231164|26331131|P1|Overall Study|Withdrawal by Subject|1
7571856|NCT02231164|26331130|P2|Overall Study|Lack of Efficacy|3
7571857|NCT02231164|26331131|P1|Overall Study|Lack of Efficacy|4
7571858|NCT02231164|26331130|P2|Overall Study|Adverse Event|1
7571859|NCT02231164|26331131|P1|Overall Study|Adverse Event|1
7571860|NCT02230956|26331170|P3|Overall Study|Other Miscellaneous Reason|2
7571861|NCT02230956|26331171|P2|Overall Study|Other Miscellaneous Reason|1
7571862|NCT02230956|26331172|P1|Overall Study|Other Miscellaneous Reason|0
7571863|NCT02230956|26331170|P3|Overall Study|Protocol Violation|1
7571864|NCT02230956|26331171|P2|Overall Study|Protocol Violation|1
7571865|NCT02230956|26331172|P1|Overall Study|Protocol Violation|0
7571866|NCT02230956|26331170|P3|Overall Study|Personal Reasons|1
7571867|NCT02230956|26331171|P2|Overall Study|Personal Reasons|1
7571868|NCT02230956|26331172|P1|Overall Study|Personal Reasons|2
7571869|NCT02230956|26331170|P3|Overall Study|Lost to Follow-up|2
7571870|NCT02230956|26331171|P2|Overall Study|Lost to Follow-up|1
7571871|NCT02230956|26331172|P1|Overall Study|Lost to Follow-up|1
7571872|NCT02230956|26331170|P3|Overall Study|Lack of Efficacy|1
7571873|NCT02230956|26331171|P2|Overall Study|Lack of Efficacy|1
7571874|NCT02230956|26331172|P1|Overall Study|Lack of Efficacy|1
7571875|NCT02230956|26331170|P3|Overall Study|Adverse Event|0
7571876|NCT02230956|26331171|P2|Overall Study|Adverse Event|1
7571877|NCT02230956|26331172|P1|Overall Study|Adverse Event|1
7571878|NCT02230904|26331194|P2|Overall Study|Safety follow up could not take place|1
7571879|NCT02230904|26331195|P1|Overall Study|Safety follow up could not take place|0
7571880|NCT02230683|26331247|P1|Overall Study|Adverse Event|1
7571881|NCT02230670|26331264|P2|Overall Study|Progression to Child-Pugh C|2
7571882|NCT02230670|26331265|P1|Overall Study|Progression to Child-Pugh C|1
7571883|NCT02230670|26331264|P2|Overall Study|Protocol Violation|1
7571884|NCT02230670|26331265|P1|Overall Study|Protocol Violation|0
7571885|NCT02230670|26331264|P2|Overall Study|Physician Decision|1
7571886|NCT02230670|26331265|P1|Overall Study|Physician Decision|0
7571887|NCT02230670|26331264|P2|Overall Study|Withdrawal by Subject|2
7571888|NCT02230670|26331265|P1|Overall Study|Withdrawal by Subject|2
7571889|NCT02230670|26331264|P2|Overall Study|Adverse Event|2
7571890|NCT02230670|26331265|P1|Overall Study|Adverse Event|1
7571891|NCT02230527|26331351|P2|Overall Study|Other|0
7571892|NCT02230527|26331352|P1|Overall Study|Other|1
7571893|NCT02230527|26331351|P2|Overall Study|Lost to Follow-up|1
7571894|NCT02230527|26331352|P1|Overall Study|Lost to Follow-up|2
7571895|NCT02230527|26331351|P2|Overall Study|Death|0
7571896|NCT02230527|26331352|P1|Overall Study|Death|1
7571897|NCT02230527|26331351|P2|Overall Study|Withdrawal by Subject|1
7571898|NCT02230527|26331352|P1|Overall Study|Withdrawal by Subject|1
7571899|NCT02230384|26331360|P2|Phase 2 - Switch|Adverse Event|0
7571900|NCT02230384|26331361|P1|Phase 2 - Switch|Adverse Event|2
7571901|NCT02230384|26331360|P2|Phase 2 - Switch|Lost to Follow-up|0
7571902|NCT02230384|26331361|P1|Phase 2 - Switch|Lost to Follow-up|1
7571903|NCT02230384|26331360|P2|Phase 2 - Switch|Withdrawal by Subject|1
7571904|NCT02230384|26331361|P1|Phase 2 - Switch|Withdrawal by Subject|0
7571905|NCT02230384|26331360|P2|Phase 1|Physician Decision|1
7571906|NCT02230384|26331361|P1|Phase 1|Physician Decision|0
7571907|NCT02230384|26331360|P2|Phase 1|Lost to Follow-up|0
7571908|NCT02230384|26331361|P1|Phase 1|Lost to Follow-up|1
7571909|NCT02230332|26331381|P2|Overall Study|Protocol Violation|0
7571910|NCT02230332|26331382|P1|Overall Study|Protocol Violation|1
7571911|NCT02230332|26331381|P2|Overall Study|Lost to Follow-up|0
7571912|NCT02230332|26331382|P1|Overall Study|Lost to Follow-up|1
7571913|NCT02230332|26331381|P2|Overall Study|Adverse Event|1
7571914|NCT02230332|26331382|P1|Overall Study|Adverse Event|2
7571915|NCT02230306|26331398|P1|Overall Study|Did not receive study treatment|1
7571916|NCT02230085|26331409|P1|Overall Study|Withdrawal by Subject|3
7571917|NCT02230085|26331409|P1|Overall Study|Physician Decision|1
7571918|NCT02229864|26331413|P1|Overall Study|Lost to Follow-up|1
7571919|NCT02229864|26331413|P1|Overall Study|Death|2
7571920|NCT02229851|26331437|P7|Extension Phase (Open-label Phase)|Death|1
7571921|NCT02229851|26331438|P6|Extension Phase (Open-label Phase)|Death|1
7571922|NCT02229851|26331439|P5|Extension Phase (Open-label Phase)|Death|0
7571923|NCT02229851|26331440|P4|Extension Phase (Open-label Phase)|Death|1
7571924|NCT02229851|26331441|P3|Extension Phase (Open-label Phase)|Death|0
7571925|NCT02229851|26331442|P2|Extension Phase (Open-label Phase)|Death|0
7571926|NCT02229851|26331443|P1|Extension Phase (Open-label Phase)|Death|0
7571927|NCT02229851|26331437|P7|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7571928|NCT02229851|26331438|P6|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
7571929|NCT02229851|26331439|P5|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
7571930|NCT02229851|26331440|P4|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7571931|NCT02229851|26331441|P3|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7571932|NCT02229851|26331442|P2|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7572263|NCT02225587|26333349|P2|Overall Study|Participant Moved|0
7571933|NCT02229851|26331443|P1|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7571934|NCT02229851|26331437|P7|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7571935|NCT02229851|26331438|P6|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7571936|NCT02229851|26331439|P5|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7571937|NCT02229851|26331440|P4|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7571938|NCT02229851|26331441|P3|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7571939|NCT02229851|26331442|P2|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7571940|NCT02229851|26331443|P1|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7571941|NCT02229851|26331437|P7|Main Phase (Double-blind Phase)|Death|0
7571942|NCT02229851|26331438|P6|Main Phase (Double-blind Phase)|Death|0
7571943|NCT02229851|26331439|P5|Main Phase (Double-blind Phase)|Death|0
7571944|NCT02229851|26331440|P4|Main Phase (Double-blind Phase)|Death|0
7571945|NCT02229851|26331441|P3|Main Phase (Double-blind Phase)|Death|0
7571946|NCT02229851|26331442|P2|Main Phase (Double-blind Phase)|Death|1
7571947|NCT02229851|26331443|P1|Main Phase (Double-blind Phase)|Death|1
7571948|NCT02229851|26331437|P7|Main Phase (Double-blind Phase)|Protocol Violation|0
7571949|NCT02229851|26331438|P6|Main Phase (Double-blind Phase)|Protocol Violation|0
7571950|NCT02229851|26331439|P5|Main Phase (Double-blind Phase)|Protocol Violation|0
7571951|NCT02229851|26331440|P4|Main Phase (Double-blind Phase)|Protocol Violation|0
7571952|NCT02229851|26331441|P3|Main Phase (Double-blind Phase)|Protocol Violation|2
7571953|NCT02229851|26331442|P2|Main Phase (Double-blind Phase)|Protocol Violation|0
7571954|NCT02229851|26331443|P1|Main Phase (Double-blind Phase)|Protocol Violation|0
7571955|NCT02229851|26331437|P7|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7571956|NCT02229851|26331438|P6|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7571957|NCT02229851|26331439|P5|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7571958|NCT02229851|26331440|P4|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7571959|NCT02229851|26331441|P3|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7571960|NCT02229851|26331442|P2|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
7571961|NCT02229851|26331443|P1|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7571962|NCT02229851|26331437|P7|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7571963|NCT02229851|26331438|P6|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7571964|NCT02229851|26331439|P5|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7571965|NCT02229851|26331440|P4|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7571966|NCT02229851|26331441|P3|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7571967|NCT02229851|26331442|P2|Main Phase (Double-blind Phase)|Lost to Follow-up|1
7571968|NCT02229851|26331443|P1|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7571969|NCT02229851|26331437|P7|Main Phase (Double-blind Phase)|Unclassified|0
7571970|NCT02229851|26331438|P6|Main Phase (Double-blind Phase)|Unclassified|0
7571971|NCT02229851|26331439|P5|Main Phase (Double-blind Phase)|Unclassified|0
7571972|NCT02229851|26331440|P4|Main Phase (Double-blind Phase)|Unclassified|0
7571973|NCT02229851|26331441|P3|Main Phase (Double-blind Phase)|Unclassified|0
7571974|NCT02229851|26331442|P2|Main Phase (Double-blind Phase)|Unclassified|2
7571975|NCT02229851|26331443|P1|Main Phase (Double-blind Phase)|Unclassified|1
7571976|NCT02229552|26331875|P1|2-Year Follow up|Lost to Follow-up|17
7571977|NCT02229552|26331875|P1|2-Year Follow up|Withdrawal by Subject|9
7571978|NCT02229552|26331875|P1|1-year Follow up|Lost to Follow-up|18
7571979|NCT02229552|26331875|P1|1-year Follow up|Withdrawal by Subject|7
7571980|NCT02229552|26331875|P1|Baseline|Withdrawal by Subject|6
7571981|NCT02229539|26331882|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
7571982|NCT02229539|26331883|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
7571983|NCT02229539|26331884|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
7571984|NCT02229539|26331882|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
7571985|NCT02229539|26331883|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7571986|NCT02229539|26331884|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7571987|NCT02229539|26331882|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7571988|NCT02229539|26331883|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7571989|NCT02229539|26331884|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
7571990|NCT02229539|26331882|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7571991|NCT02229539|26331883|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7571992|NCT02229539|26331884|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
7571993|NCT02229539|26331882|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
7571994|NCT02229539|26331883|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7571995|NCT02229539|26331884|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7571996|NCT02229539|26331882|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
7571997|NCT02229539|26331883|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
7571998|NCT02229539|26331884|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
7571999|NCT02229539|26331882|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
7572000|NCT02229539|26331883|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7572001|NCT02229539|26331884|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7572002|NCT02229539|26331882|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
7572003|NCT02229539|26331883|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7572004|NCT02229539|26331884|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7572005|NCT02229539|26331882|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7572006|NCT02229539|26331883|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
7572007|NCT02229539|26331884|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7572008|NCT02229396|26332015|P3|Overall Study|Withdrew; No Record on Termination Page|1
7572009|NCT02229396|26332016|P2|Overall Study|Withdrew; No Record on Termination Page|0
7572010|NCT02229396|26332017|P1|Overall Study|Withdrew; No Record on Termination Page|2
7572011|NCT02229396|26332015|P3|Overall Study|Study-Specific Withdrawal Criteria|3
7572012|NCT02229396|26332016|P2|Overall Study|Study-Specific Withdrawal Criteria|1
7572013|NCT02229396|26332017|P1|Overall Study|Study-Specific Withdrawal Criteria|0
7572014|NCT02229396|26332015|P3|Overall Study|Withdrawal by Subject|41
7572015|NCT02229396|26332016|P2|Overall Study|Withdrawal by Subject|28
7572016|NCT02229396|26332017|P1|Overall Study|Withdrawal by Subject|42
7572017|NCT02229396|26332015|P3|Overall Study|Other|15
7572018|NCT02229396|26332016|P2|Overall Study|Other|18
7572019|NCT02229396|26332017|P1|Overall Study|Other|10
7572020|NCT02229396|26332015|P3|Overall Study|Patient Incorrectly Randomized|1
7572021|NCT02229396|26332016|P2|Overall Study|Patient Incorrectly Randomized|0
7572022|NCT02229396|26332017|P1|Overall Study|Patient Incorrectly Randomized|0
7572023|NCT02229396|26332015|P3|Overall Study|Protocol Violation|0
7572024|NCT02229396|26332016|P2|Overall Study|Protocol Violation|1
7572025|NCT02229396|26332017|P1|Overall Study|Protocol Violation|2
7572026|NCT02229396|26332015|P3|Overall Study|Lost to Follow-up|21
7572027|NCT02229396|26332016|P2|Overall Study|Lost to Follow-up|14
7572028|NCT02229396|26332017|P1|Overall Study|Lost to Follow-up|14
7572029|NCT02229396|26332015|P3|Overall Study|Death|1
7572030|NCT02229396|26332016|P2|Overall Study|Death|3
7572031|NCT02229396|26332017|P1|Overall Study|Death|2
7572032|NCT02229396|26332015|P3|Overall Study|Adverse Event|12
7572033|NCT02229396|26332016|P2|Overall Study|Adverse Event|12
7572034|NCT02229396|26332017|P1|Overall Study|Adverse Event|6
7572035|NCT02229383|26332048|P2|Overall Study|Other|8
7572036|NCT02229383|26332049|P1|Overall Study|Other|3
7572037|NCT02229383|26332048|P2|Overall Study|Did not receive treatment|0
7572038|NCT02229383|26332049|P1|Overall Study|Did not receive treatment|1
7572039|NCT02229383|26332048|P2|Overall Study|Withdrawal by Subject|6
7572040|NCT02229383|26332049|P1|Overall Study|Withdrawal by Subject|4
7572041|NCT02229383|26332048|P2|Overall Study|Lost to Follow-up|3
7572042|NCT02229383|26332049|P1|Overall Study|Lost to Follow-up|5
7572043|NCT02229383|26332048|P2|Overall Study|Death|1
7572044|NCT02229383|26332049|P1|Overall Study|Death|0
7572045|NCT02229383|26332048|P2|Overall Study|Adverse Event|4
7572046|NCT02229383|26332049|P1|Overall Study|Adverse Event|7
7572047|NCT02229227|26332074|P2|Overall Study|Physician Decision|12
7572048|NCT02229227|26332075|P1|Overall Study|Physician Decision|5
7572049|NCT02229227|26332074|P2|Overall Study|Other|1
7572050|NCT02229227|26332075|P1|Overall Study|Other|0
7572051|NCT02229227|26332074|P2|Overall Study|Withdrawal by Subject|12
7572052|NCT02229227|26332075|P1|Overall Study|Withdrawal by Subject|8
7572053|NCT02229227|26332074|P2|Overall Study|Study terminated by sponsor|11
7572054|NCT02229227|26332075|P1|Overall Study|Study terminated by sponsor|11
7572055|NCT02229227|26332074|P2|Overall Study|Lost to Follow-up|3
7572056|NCT02229227|26332075|P1|Overall Study|Lost to Follow-up|3
7572057|NCT02229227|26332074|P2|Overall Study|Protocol defined stopping criteria|3
7572058|NCT02229227|26332075|P1|Overall Study|Protocol defined stopping criteria|1
7572059|NCT02229227|26332074|P2|Overall Study|Protocol Violation|8
7572060|NCT02229227|26332075|P1|Overall Study|Protocol Violation|6
7572061|NCT02229227|26332074|P2|Overall Study|Lack of Efficacy|3
7572062|NCT02229227|26332075|P1|Overall Study|Lack of Efficacy|3
7572063|NCT02229227|26332074|P2|Overall Study|Adverse Event|9
7572064|NCT02229227|26332075|P1|Overall Study|Adverse Event|14
7572065|NCT02229214|26332160|P2|Overall Study|Withdrawal by Subject|0
7572066|NCT02229214|26332161|P1|Overall Study|Withdrawal by Subject|4
7572067|NCT02229214|26332160|P2|Overall Study|Adverse Event|0
7572068|NCT02229214|26332161|P1|Overall Study|Adverse Event|2
7572069|NCT02228980|26332185|P4|Overall Study|Withdrawal by Subject|3
7572070|NCT02228980|26332186|P3|Overall Study|Withdrawal by Subject|2
7572071|NCT02228980|26332187|P2|Overall Study|Withdrawal by Subject|3
7572072|NCT02228980|26332188|P1|Overall Study|Withdrawal by Subject|3
7572073|NCT02228980|26332185|P4|Overall Study|Protocol Violation|0
7572074|NCT02228980|26332186|P3|Overall Study|Protocol Violation|0
7572075|NCT02228980|26332187|P2|Overall Study|Protocol Violation|0
7572076|NCT02228980|26332188|P1|Overall Study|Protocol Violation|7
7572077|NCT02228980|26332185|P4|Overall Study|Adverse Event|0
7572078|NCT02228980|26332186|P3|Overall Study|Adverse Event|0
7572079|NCT02228980|26332187|P2|Overall Study|Adverse Event|0
7572080|NCT02228980|26332188|P1|Overall Study|Adverse Event|14
7572081|NCT02228967|26332212|P2|Overall Study|Withdrawal by Subject|18
7572082|NCT02228967|26332213|P1|Overall Study|Withdrawal by Subject|13
7572083|NCT02228967|26332212|P2|Overall Study|Lost to Follow-up|142
7572084|NCT02228967|26332213|P1|Overall Study|Lost to Follow-up|146
7572085|NCT02228720|26332274|P1|Open Label - Day 30|Lost to Follow-up|1
7572086|NCT02228590|26332297|P1|Overall Study|Withdrawal by Subject|1
7572087|NCT02228564|26332310|P1|Overall Study|Other|6
7572088|NCT02228564|26332310|P1|Overall Study|Lost to Follow-up|17
7572089|NCT02228564|26332310|P1|Overall Study|Physician Decision|5
7572090|NCT02228564|26332310|P1|Overall Study|Death|11
7572091|NCT02228564|26332310|P1|Overall Study|Withdrawal by Subject|10
7572092|NCT02228460|26332334|P1|Overall Study|Lost to Follow-up|1
7572093|NCT02228460|26332334|P1|Overall Study|Adverse Event|1
7572094|NCT02228395|26332378|P3|First Intervention Period|Unable to comply with study dates|1
7572095|NCT02228395|26332379|P2|First Intervention Period|Unable to comply with study dates|1
7572096|NCT02228395|26332380|P1|First Intervention Period|Unable to comply with study dates|0
7572097|NCT02228395|26332378|P3|First Intervention Period|No longer willing to participate|0
7572098|NCT02228395|26332379|P2|First Intervention Period|No longer willing to participate|0
7572099|NCT02228395|26332380|P1|First Intervention Period|No longer willing to participate|1
7572100|NCT02228096|26332466|P1|Overall Study|Enrolled, not infused|11
7572101|NCT02228096|26332466|P1|Overall Study|New therapy for study indication|1
7572102|NCT02228096|26332466|P1|Overall Study|Subject/guardian decision|2
7572103|NCT02228096|26332466|P1|Overall Study|Physician Decision|3
7572104|NCT02228096|26332466|P1|Overall Study|Death|12
7572105|NCT02228096|26332466|P1|Overall Study|Lack of Efficacy|18
7572106|NCT02228096|26332466|P1|Overall Study|Study terminated by Sponsor|24
7572107|NCT02227875|26332568|P2|Overall Study|Lost to Follow-up|10
7572108|NCT02227875|26332569|P1|Overall Study|Lost to Follow-up|10
7572109|NCT02227875|26332568|P2|Overall Study|Withdrawal by Subject|13
7572110|NCT02227875|26332569|P1|Overall Study|Withdrawal by Subject|12
7572111|NCT02227875|26332568|P2|Overall Study|Adverse Event|0
7572112|NCT02227875|26332569|P1|Overall Study|Adverse Event|3
7572113|NCT02227875|26332568|P2|Overall Study|Physician Decision|0
7572114|NCT02227875|26332569|P1|Overall Study|Physician Decision|1
7572115|NCT02227875|26332568|P2|Overall Study|Other|3
7572116|NCT02227875|26332569|P1|Overall Study|Other|1
7572117|NCT02227875|26332568|P2|Overall Study|Protocol Violation|7
7572118|NCT02227875|26332569|P1|Overall Study|Protocol Violation|10
7572119|NCT02227862|26332589|P2|Overall Study|Lost to Follow-up|2
7572120|NCT02227862|26332590|P1|Overall Study|Lost to Follow-up|1
7572121|NCT02227862|26332589|P2|Overall Study|Withdrawal by Subject|6
7572122|NCT02227862|26332590|P1|Overall Study|Withdrawal by Subject|7
7572123|NCT02227862|26332589|P2|Overall Study|Adverse Event|3
7572124|NCT02227862|26332590|P1|Overall Study|Adverse Event|4
7572125|NCT02227862|26332589|P2|Overall Study|Other|2
7572126|NCT02227862|26332590|P1|Overall Study|Other|0
7572127|NCT02227862|26332589|P2|Overall Study|Protocol Violation|9
7572128|NCT02227862|26332590|P1|Overall Study|Protocol Violation|7
7572129|NCT02227849|26332620|P1|Overall Study|Withdrawal by Subject|3
7572130|NCT02227849|26332620|P1|Overall Study|Physician Decision|1
7572131|NCT02227849|26332620|P1|Overall Study|Adverse Event|4
7572132|NCT02227784|26332651|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
7572133|NCT02227784|26332652|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7572134|NCT02227784|26332653|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7572135|NCT02227784|26332654|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7572136|NCT02227784|26332655|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7572137|NCT02227784|26332651|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
7572138|NCT02227784|26332652|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7572139|NCT02227784|26332653|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7572140|NCT02227784|26332654|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7572141|NCT02227784|26332655|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7572142|NCT02227784|26332651|P5|Open-Label Extension Phase (OLE)|Death|1
7572143|NCT02227784|26332652|P4|Open-Label Extension Phase (OLE)|Death|0
7572144|NCT02227784|26332653|P3|Open-Label Extension Phase (OLE)|Death|0
7572145|NCT02227784|26332654|P2|Open-Label Extension Phase (OLE)|Death|0
7572146|NCT02227784|26332655|P1|Open-Label Extension Phase (OLE)|Death|0
7572147|NCT02227784|26332651|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
7572148|NCT02227784|26332652|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
7572149|NCT02227784|26332653|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
7572150|NCT02227784|26332654|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
7572151|NCT02227784|26332655|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
7572152|NCT02227784|26332651|P5|Double-Blind Phase|Withdrawal by Subject|0
7572153|NCT02227784|26332652|P4|Double-Blind Phase|Withdrawal by Subject|2
7572154|NCT02227784|26332653|P3|Double-Blind Phase|Withdrawal by Subject|5
7572155|NCT02227784|26332654|P2|Double-Blind Phase|Withdrawal by Subject|1
7572156|NCT02227784|26332655|P1|Double-Blind Phase|Withdrawal by Subject|2
7572157|NCT02227784|26332651|P5|Double-Blind Phase|Sponsor Decision|0
7572158|NCT02227784|26332652|P4|Double-Blind Phase|Sponsor Decision|32
7572159|NCT02227784|26332653|P3|Double-Blind Phase|Sponsor Decision|14
7572160|NCT02227784|26332654|P2|Double-Blind Phase|Sponsor Decision|15
7572161|NCT02227784|26332655|P1|Double-Blind Phase|Sponsor Decision|34
7572162|NCT02227784|26332651|P5|Double-Blind Phase|Protocol Violation|0
7572163|NCT02227784|26332652|P4|Double-Blind Phase|Protocol Violation|1
7572164|NCT02227784|26332653|P3|Double-Blind Phase|Protocol Violation|1
7572165|NCT02227784|26332654|P2|Double-Blind Phase|Protocol Violation|0
7572166|NCT02227784|26332655|P1|Double-Blind Phase|Protocol Violation|0
7572167|NCT02227784|26332651|P5|Double-Blind Phase|Physician Decision|0
7572168|NCT02227784|26332652|P4|Double-Blind Phase|Physician Decision|1
7572169|NCT02227784|26332653|P3|Double-Blind Phase|Physician Decision|0
7572170|NCT02227784|26332654|P2|Double-Blind Phase|Physician Decision|0
7572171|NCT02227784|26332655|P1|Double-Blind Phase|Physician Decision|1
7572172|NCT02227784|26332651|P5|Double-Blind Phase|Adverse Event|0
7572173|NCT02227784|26332652|P4|Double-Blind Phase|Adverse Event|3
7572174|NCT02227784|26332653|P3|Double-Blind Phase|Adverse Event|1
7572175|NCT02227784|26332654|P2|Double-Blind Phase|Adverse Event|2
7572176|NCT02227784|26332655|P1|Double-Blind Phase|Adverse Event|3
7572177|NCT02227446|26332834|P2|Overall Study|Withdrawal by Subject|5
7572178|NCT02227446|26332835|P1|Overall Study|Withdrawal by Subject|4
7575540|NCT02187744|26346756|P1|Study|Other|2
7572179|NCT02227446|26332834|P2|Overall Study|not eligible post randomization|29
7572180|NCT02227446|26332835|P1|Overall Study|not eligible post randomization|18
7572181|NCT02227368|26332843|P2|Overall Study|Adverse Event|0
7572182|NCT02227368|26332844|P1|Overall Study|Adverse Event|1
7572183|NCT02227368|26332843|P2|Overall Study|Lost to Follow-up|0
7572184|NCT02227368|26332844|P1|Overall Study|Lost to Follow-up|1
7572185|NCT02227368|26332843|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
7572186|NCT02227368|26332844|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
7572201|NCT02227199|26332968|P3|Overall Study|Adverse Event|3
7572202|NCT02227199|26332969|P2|Overall Study|Adverse Event|0
7572203|NCT02227199|26332970|P1|Overall Study|Adverse Event|0
7572204|NCT02227199|26332968|P3|Overall Study|Physician Decision|1
7572205|NCT02227199|26332969|P2|Overall Study|Physician Decision|0
7572206|NCT02227199|26332970|P1|Overall Study|Physician Decision|0
7572207|NCT02227147|26332987|P2|Follow-up Period|Other|5
7572208|NCT02227147|26332988|P1|Follow-up Period|Other|3
7572209|NCT02227147|26332987|P2|Controlled Treatment Period|Other|0
7572210|NCT02227147|26332988|P1|Controlled Treatment Period|Other|2
7572211|NCT02227147|26332987|P2|Controlled Treatment Period|Adverse Event|3
7572212|NCT02227147|26332988|P1|Controlled Treatment Period|Adverse Event|4
7572213|NCT02227108|26333015|P1|Overall Study|Adverse Event|6
7572214|NCT02227108|26333015|P1|Overall Study|Investigator discretion|1
7572215|NCT02227108|26333015|P1|Overall Study|Initiation of alternative therapy|2
7572216|NCT02227108|26333015|P1|Overall Study|Progressive disease|17
7572217|NCT02227108|26333015|P1|Overall Study|Other|3
7572218|NCT02227108|26333015|P1|Overall Study|Did not receive treatment|2
7572219|NCT02226653|26333069|P2|Treatment Period 5 Fed State|Adverse Event|1
7572220|NCT02226653|26333070|P1|Treatment Period 5 Fed State|Adverse Event|0
7572221|NCT02226653|26333069|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
7572222|NCT02226653|26333070|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
7572223|NCT02226562|26333094|P2|Overall Study|Lost to Follow-up|1
7572224|NCT02226562|26333095|P1|Overall Study|Lost to Follow-up|0
7572225|NCT02226549|26333113|P2|Overall Study|Lost to Follow-up|1
7572226|NCT02226549|26333114|P1|Overall Study|Lost to Follow-up|0
7572227|NCT02226549|26333113|P2|Overall Study|Randomized but Never Treated|0
7572228|NCT02226549|26333114|P1|Overall Study|Randomized but Never Treated|1
7572229|NCT02226198|26333124|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7572230|NCT02226198|26333125|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
7572231|NCT02226198|26333126|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7572232|NCT02226198|26333124|P3|Lead-in Phase|Protocol Violation|0
7572233|NCT02226198|26333125|P2|Lead-in Phase|Protocol Violation|0
7572234|NCT02226198|26333126|P1|Lead-in Phase|Protocol Violation|1
7572235|NCT02226172|26333199|P1|Overall Study|Adverse Event|6
7572236|NCT02226172|26333199|P1|Overall Study|Study terminated by sponsor|1
7572237|NCT02226172|26333199|P1|Overall Study|Death|1
7572238|NCT02226172|26333199|P1|Overall Study|Other|5
7572239|NCT02226172|26333199|P1|Overall Study|Participant refused further follow-up|4
7572240|NCT02226120|26333263|P1|Overall Study|missing treatment disposition pages|2
7572241|NCT02226120|26333263|P1|Overall Study|Protocol deviation|1
7572242|NCT02226120|26333263|P1|Overall Study|Non-compliance with study drug|10
7572243|NCT02226120|26333263|P1|Overall Study|Withdrawal by parent/guardian|36
7572244|NCT02226120|26333263|P1|Overall Study|Physician Decision|21
7572245|NCT02226120|26333263|P1|Overall Study|Lost to Follow-up|13
7572246|NCT02226120|26333263|P1|Overall Study|Technical problems|4
7572247|NCT02226120|26333263|P1|Overall Study|Study terminated by sponsor|1
7572248|NCT02226120|26333263|P1|Overall Study|Death|172
7572249|NCT02226120|26333263|P1|Overall Study|Adverse Event|60
7572250|NCT02226003|26333270|P3|Overall Study|Withdrawal by Subject|3
7572251|NCT02226003|26333271|P2|Overall Study|Withdrawal by Subject|0
7572252|NCT02226003|26333272|P1|Overall Study|Withdrawal by Subject|0
7572253|NCT02226003|26333270|P3|Overall Study|Lost to Follow-up|3
7572254|NCT02226003|26333271|P2|Overall Study|Lost to Follow-up|1
7572255|NCT02226003|26333272|P1|Overall Study|Lost to Follow-up|2
7572256|NCT02225743|26333328|P1|Overall Study|Withdrawal by Subject|18
7572257|NCT02225665|26333334|P2|Overall Study|Subject restarted HAART prior to month 18.|1
7572258|NCT02225665|26333335|P1|Overall Study|Subject restarted HAART prior to month 18.|0
7572259|NCT02225665|26333334|P2|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
7572260|NCT02225665|26333335|P1|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
7572261|NCT02225587|26333349|P2|Overall Study|Withdrawal by Subject|28
7572262|NCT02225587|26333350|P1|Overall Study|Withdrawal by Subject|13
7572264|NCT02225587|26333350|P1|Overall Study|Participant Moved|1
7572265|NCT02225587|26333349|P2|Overall Study|Protocol Violation|0
7572266|NCT02225587|26333350|P1|Overall Study|Protocol Violation|1
7572267|NCT02225587|26333349|P2|Overall Study|Physician Decision|0
7572268|NCT02225587|26333350|P1|Overall Study|Physician Decision|2
7572269|NCT02225587|26333349|P2|Overall Study|Non-Compliance With Study Drug|0
7572270|NCT02225587|26333350|P1|Overall Study|Non-Compliance With Study Drug|1
7572271|NCT02225587|26333349|P2|Overall Study|Lost to Follow-up|5
7572272|NCT02225587|26333350|P1|Overall Study|Lost to Follow-up|5
7572273|NCT02225587|26333349|P2|Overall Study|Adverse Event|5
7572274|NCT02225587|26333350|P1|Overall Study|Adverse Event|5
7572275|NCT02225353|26333379|P3|Overall Study|Protocol Violation|12
7572276|NCT02225353|26333380|P2|Overall Study|Protocol Violation|5
7572277|NCT02225353|26333381|P1|Overall Study|Protocol Violation|4
7572278|NCT02225353|26333379|P3|Overall Study|Lost to Follow-up|3
7572279|NCT02225353|26333380|P2|Overall Study|Lost to Follow-up|1
7572280|NCT02225353|26333381|P1|Overall Study|Lost to Follow-up|0
7572281|NCT02225223|26333406|P2|Overall Study|Withdrawal by Subject|2
7572282|NCT02225223|26333407|P1|Overall Study|Withdrawal by Subject|2
7572283|NCT02225223|26333406|P2|Overall Study|Physician Decision|0
7572284|NCT02225223|26333407|P1|Overall Study|Physician Decision|1
7572285|NCT02225223|26333406|P2|Overall Study|Other|2
7572286|NCT02225223|26333407|P1|Overall Study|Other|1
7572287|NCT02225223|26333406|P2|Overall Study|Lost to Follow-up|0
7572288|NCT02225223|26333407|P1|Overall Study|Lost to Follow-up|5
7572289|NCT02225223|26333406|P2|Overall Study|Death|1
7572290|NCT02225223|26333407|P1|Overall Study|Death|10
7572291|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
7572292|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
7572293|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
7572294|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
7572295|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
7572296|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
7572297|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
7572298|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
7572299|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
7572300|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
7572301|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Death|0
7572302|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Death|1
7572303|NCT02224846|26333435|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
7572304|NCT02224846|26333436|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
7572305|NCT02224846|26333435|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
7572306|NCT02224846|26333436|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
7572307|NCT02224846|26333435|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
7572308|NCT02224846|26333436|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
7572309|NCT02224846|26333435|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
7572310|NCT02224846|26333436|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
7572311|NCT02224846|26333435|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
7572312|NCT02224846|26333436|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
7572313|NCT02224846|26333435|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
7572314|NCT02224846|26333436|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
7572315|NCT02224846|26333435|P2|Period 1 (Month 3)|Sponsor Decision|1
7572316|NCT02224846|26333436|P1|Period 1 (Month 3)|Sponsor Decision|2
7572317|NCT02224846|26333435|P2|Period 1 (Month 3)|Withdrawal by Subject|18
7572318|NCT02224846|26333436|P1|Period 1 (Month 3)|Withdrawal by Subject|8
7572319|NCT02224846|26333435|P2|Period 1 (Month 3)|Protocol Violation|8
7572320|NCT02224846|26333436|P1|Period 1 (Month 3)|Protocol Violation|4
7572321|NCT02224846|26333435|P2|Period 1 (Month 3)|Lost to Follow-up|8
7572322|NCT02224846|26333436|P1|Period 1 (Month 3)|Lost to Follow-up|3
7572323|NCT02224846|26333435|P2|Period 1 (Month 3)|Adverse Event|1
7572324|NCT02224846|26333436|P1|Period 1 (Month 3)|Adverse Event|2
7572325|NCT02224755|26333466|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
7572326|NCT02224755|26333467|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
7572327|NCT02224755|26333466|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
7572328|NCT02224755|26333467|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
7572329|NCT02224755|26333466|P2|Two Year Follow up Post-implant|Heart transplant|119
7572330|NCT02224755|26333467|P1|Two Year Follow up Post-implant|Heart transplant|137
7572331|NCT02224755|26333466|P2|Two Year Follow up Post-implant|Death|98
7572332|NCT02224755|26333467|P1|Two Year Follow up Post-implant|Death|103
7572333|NCT02224755|26333466|P2|Randomization to Device Implant|Withdrawn prior to implant|1
7572334|NCT02224755|26333467|P1|Randomization to Device Implant|Withdrawn prior to implant|7
7572335|NCT02224703|26333502|P3|Overall Study|Lack of Efficacy|0
7572336|NCT02224703|26333503|P2|Overall Study|Lack of Efficacy|0
7572337|NCT02224703|26333504|P1|Overall Study|Lack of Efficacy|1
7572338|NCT02224703|26333502|P3|Overall Study|Withdrawn by parent/guardian|0
7572339|NCT02224703|26333503|P2|Overall Study|Withdrawn by parent/guardian|1
7572340|NCT02224703|26333504|P1|Overall Study|Withdrawn by parent/guardian|0
7572341|NCT02224703|26333502|P3|Overall Study|Advised by medical monitor|0
7572342|NCT02224703|26333503|P2|Overall Study|Advised by medical monitor|0
7572343|NCT02224703|26333504|P1|Overall Study|Advised by medical monitor|1
7572344|NCT02224703|26333502|P3|Overall Study|Withdrawn by investigator|0
7572345|NCT02224703|26333503|P2|Overall Study|Withdrawn by investigator|0
7572346|NCT02224703|26333504|P1|Overall Study|Withdrawn by investigator|1
7572347|NCT02224703|26333502|P3|Overall Study|Adverse Event|0
7572348|NCT02224703|26333503|P2|Overall Study|Adverse Event|5
7572349|NCT02224703|26333504|P1|Overall Study|Adverse Event|0
7572350|NCT02224690|26333523|P2|Overall Study|Did not meet eligibility criteria|0
7572351|NCT02224690|26333524|P1|Overall Study|Did not meet eligibility criteria|1
7572352|NCT02224690|26333523|P2|Overall Study|Use of G-tube|0
7572353|NCT02224690|26333524|P1|Overall Study|Use of G-tube|1
7572354|NCT02224690|26333523|P2|Overall Study|Met Withdrawal Criteria|0
7572355|NCT02224690|26333524|P1|Overall Study|Met Withdrawal Criteria|4
7572356|NCT02224690|26333523|P2|Overall Study|Adverse Event|1
7572357|NCT02224690|26333524|P1|Overall Study|Adverse Event|8
7572358|NCT02224664|26333536|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
7572359|NCT02224664|26333537|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
7572360|NCT02224664|26333538|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7572361|NCT02224664|26333539|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7572362|NCT02224664|26333540|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7572363|NCT02224664|26333536|P5|Dose Escalation Period (21 Days)|Adverse Event|7
7572364|NCT02224664|26333537|P4|Dose Escalation Period (21 Days)|Adverse Event|2
7572365|NCT02224664|26333538|P3|Dose Escalation Period (21 Days)|Adverse Event|2
7572366|NCT02224664|26333539|P2|Dose Escalation Period (21 Days)|Adverse Event|0
7572367|NCT02224664|26333540|P1|Dose Escalation Period (21 Days)|Adverse Event|0
7572368|NCT02224664|26333536|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7572369|NCT02224664|26333537|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7572370|NCT02224664|26333538|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7572371|NCT02224664|26333539|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7572372|NCT02224664|26333540|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
7572373|NCT02224638|26333622|P2|Overall Study|Adverse Event|1
7572374|NCT02224638|26333623|P1|Overall Study|Adverse Event|1
7572375|NCT02224625|26333631|P1|Sensitization|Adverse Event|55
7572376|NCT02224625|26333631|P1|Irritation|Adverse Event|6
7572377|NCT02224599|26333652|P1|Overall Study|Progression of Disease|1
7572378|NCT02224599|26333652|P1|Overall Study|Physician Decision|1
7572379|NCT02224560|26333661|P3|Overall Study|Withdrawn by Investigator|0
7572380|NCT02224560|26333662|P2|Overall Study|Withdrawn by Investigator|1
7572381|NCT02224560|26333663|P1|Overall Study|Withdrawn by Investigator|1
7572382|NCT02224560|26333661|P3|Overall Study|Adverse Event|1
7572383|NCT02224560|26333662|P2|Overall Study|Adverse Event|1
7572384|NCT02224560|26333663|P1|Overall Study|Adverse Event|4
7572385|NCT02224560|26333661|P3|Overall Study|Met Withdrawal Criteria|0
7572386|NCT02224560|26333662|P2|Overall Study|Met Withdrawal Criteria|0
7572387|NCT02224560|26333663|P1|Overall Study|Met Withdrawal Criteria|1
7572388|NCT02224560|26333661|P3|Overall Study|Withdrawal by Subject|1
7572389|NCT02224560|26333662|P2|Overall Study|Withdrawal by Subject|0
7572390|NCT02224560|26333663|P1|Overall Study|Withdrawal by Subject|2
7572391|NCT02224560|26333661|P3|Overall Study|Protocol Deviation|0
7572392|NCT02224560|26333662|P2|Overall Study|Protocol Deviation|0
7572393|NCT02224560|26333663|P1|Overall Study|Protocol Deviation|1
7572394|NCT02224274|26333732|P2|Overall Study|Death|0
7572395|NCT02224274|26333733|P1|Overall Study|Death|1
7572396|NCT02224157|26333745|P2|Overall Study|Adverse Event|3
7572397|NCT02224157|26333746|P1|Overall Study|Adverse Event|1
7572398|NCT02224157|26333745|P2|Overall Study|Death|1
7572399|NCT02224157|26333746|P1|Overall Study|Death|1
7572400|NCT02224157|26333745|P2|Overall Study|Lost to Follow-up|35
7572401|NCT02224157|26333746|P1|Overall Study|Lost to Follow-up|27
7572402|NCT02224157|26333745|P2|Overall Study|Eligibility criteria not fulfilled|8
7572403|NCT02224157|26333746|P1|Overall Study|Eligibility criteria not fulfilled|4
7572404|NCT02224157|26333745|P2|Overall Study|Prematurely closed site|2
7572405|NCT02224157|26333746|P1|Overall Study|Prematurely closed site|4
7572406|NCT02224157|26333745|P2|Overall Study|Subject decision|50
7572407|NCT02224157|26333746|P1|Overall Study|Subject decision|58
7572408|NCT02224157|26333745|P2|Overall Study|Other|10
7572409|NCT02224157|26333746|P1|Overall Study|Other|13
7572410|NCT02224157|26333745|P2|Overall Study|Severe non-compliance to protocol|2
7572411|NCT02224157|26333746|P1|Overall Study|Severe non-compliance to protocol|2
7572412|NCT02224053|26333770|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
7572413|NCT02224053|26333770|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
7572414|NCT02224053|26333770|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
7572415|NCT02224053|26333770|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
7572416|NCT02224053|26333770|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
7572417|NCT02223858|26333816|P2|Overall Study|Refused|9
7572418|NCT02223858|26333817|P1|Overall Study|Refused|9
7572419|NCT02223858|26333816|P2|Overall Study|Withdrawal by Subject|5
7572420|NCT02223858|26333817|P1|Overall Study|Withdrawal by Subject|8
7572421|NCT02223858|26333816|P2|Overall Study|Lost to Follow-up|11
7572422|NCT02223858|26333817|P1|Overall Study|Lost to Follow-up|6
7572423|NCT02223858|26333816|P2|Overall Study|Death|1
7572424|NCT02223858|26333817|P1|Overall Study|Death|1
7572425|NCT02223793|26333830|P3|Overall Study|Moved/studycenter unable to participate|8
7572426|NCT02223793|26333831|P2|Overall Study|Moved/studycenter unable to participate|6
7572427|NCT02223793|26333832|P1|Overall Study|Moved/studycenter unable to participate|4
7572428|NCT02223793|26333830|P3|Overall Study|Withdrawal by Subject|3
7572429|NCT02223793|26333831|P2|Overall Study|Withdrawal by Subject|2
7572430|NCT02223793|26333832|P1|Overall Study|Withdrawal by Subject|3
7572431|NCT02223793|26333830|P3|Overall Study|Lost to Follow-up|2
7572432|NCT02223793|26333831|P2|Overall Study|Lost to Follow-up|1
7572433|NCT02223793|26333832|P1|Overall Study|Lost to Follow-up|10
7572434|NCT02223754|26333845|P2|Period 2|Test Article No Longer Available|1
7572435|NCT02223754|26333846|P1|Period 2|Test Article No Longer Available|0
7572436|NCT02223754|26333845|P2|Period 2|Lost to Follow-up|0
7572437|NCT02223754|26333846|P1|Period 2|Lost to Follow-up|1
7572438|NCT02223754|26333845|P2|Period 2|Lens Discomfort|1
7572439|NCT02223754|26333846|P1|Period 2|Lens Discomfort|1
7572440|NCT02223754|26333845|P2|Period 2|Protocol Violation|0
7572441|NCT02223754|26333846|P1|Period 2|Protocol Violation|1
7572442|NCT02223754|26333845|P2|Period 2|Adverse Event|1
7572443|NCT02223754|26333846|P1|Period 2|Adverse Event|0
7572444|NCT02223754|26333845|P2|Period 1|Unsatisfactory Visual Response|1
7572445|NCT02223754|26333846|P1|Period 1|Unsatisfactory Visual Response|0
7572446|NCT02223754|26333845|P2|Period 1|Test Article No Longer Available|5
7572447|NCT02223754|26333846|P1|Period 1|Test Article No Longer Available|1
7572448|NCT02223754|26333845|P2|Period 1|Withdrawal by Subject|4
7572449|NCT02223754|26333846|P1|Period 1|Withdrawal by Subject|0
7572450|NCT02223754|26333845|P2|Period 1|Protocol Violation|4
7572451|NCT02223754|26333846|P1|Period 1|Protocol Violation|2
7572452|NCT02223754|26333845|P2|Period 1|Lost to Follow-up|1
7572453|NCT02223754|26333846|P1|Period 1|Lost to Follow-up|0
7572454|NCT02223754|26333845|P2|Period 1|Adverse Event|0
7572455|NCT02223754|26333846|P1|Period 1|Adverse Event|1
7572456|NCT02223715|26333866|P1|Overall Study|Lost to Follow-up|73
7572457|NCT02223715|26333866|P1|Overall Study|Death|31
7572458|NCT02223390|26334009|P2|Overall Study|Lost to Follow-up|4
7572459|NCT02223390|26334010|P1|Overall Study|Lost to Follow-up|9
7572460|NCT02223364|26334021|P3|Overall Study|Physician Decision|0
7572461|NCT02223364|26334022|P2|Overall Study|Physician Decision|0
7572462|NCT02223364|26334023|P1|Overall Study|Physician Decision|1
7572463|NCT02223364|26334021|P3|Overall Study|subject expired before surgery|0
7572464|NCT02223364|26334022|P2|Overall Study|subject expired before surgery|0
7572465|NCT02223364|26334023|P1|Overall Study|subject expired before surgery|1
7572466|NCT02223364|26334021|P3|Overall Study|Protocol Violation|3
7572467|NCT02223364|26334022|P2|Overall Study|Protocol Violation|0
7572468|NCT02223364|26334023|P1|Overall Study|Protocol Violation|3
7572469|NCT02222922|26334189|P9|Overall Study|Participant refused further follow-up|3
7572470|NCT02222922|26334190|P8|Overall Study|Participant refused further follow-up|0
7572471|NCT02222922|26334191|P7|Overall Study|Participant refused further follow-up|0
7572472|NCT02222922|26334192|P6|Overall Study|Participant refused further follow-up|0
7572473|NCT02222922|26334193|P5|Overall Study|Participant refused further follow-up|6
7572474|NCT02222922|26334194|P4|Overall Study|Participant refused further follow-up|1
7572475|NCT02222922|26334195|P3|Overall Study|Participant refused further follow-up|0
7572476|NCT02222922|26334196|P2|Overall Study|Participant refused further follow-up|0
7572477|NCT02222922|26334197|P1|Overall Study|Participant refused further follow-up|1
7572478|NCT02222922|26334189|P9|Overall Study|Other|1
7572479|NCT02222922|26334190|P8|Overall Study|Other|4
7572480|NCT02222922|26334191|P7|Overall Study|Other|2
7572481|NCT02222922|26334192|P6|Overall Study|Other|2
7572482|NCT02222922|26334193|P5|Overall Study|Other|10
7572483|NCT02222922|26334194|P4|Overall Study|Other|2
7572484|NCT02222922|26334195|P3|Overall Study|Other|0
7572485|NCT02222922|26334196|P2|Overall Study|Other|0
7572486|NCT02222922|26334197|P1|Overall Study|Other|0
7572487|NCT02222922|26334189|P9|Overall Study|Lost to Follow-up|0
7572488|NCT02222922|26334190|P8|Overall Study|Lost to Follow-up|0
7572489|NCT02222922|26334191|P7|Overall Study|Lost to Follow-up|0
7572490|NCT02222922|26334192|P6|Overall Study|Lost to Follow-up|1
7572491|NCT02222922|26334193|P5|Overall Study|Lost to Follow-up|9
7572492|NCT02222922|26334194|P4|Overall Study|Lost to Follow-up|0
7572493|NCT02222922|26334195|P3|Overall Study|Lost to Follow-up|1
7572494|NCT02222922|26334196|P2|Overall Study|Lost to Follow-up|0
7572495|NCT02222922|26334197|P1|Overall Study|Lost to Follow-up|0
7572496|NCT02222922|26334189|P9|Overall Study|Death|2
7572497|NCT02222922|26334190|P8|Overall Study|Death|0
7572498|NCT02222922|26334191|P7|Overall Study|Death|0
7572499|NCT02222922|26334192|P6|Overall Study|Death|0
7572500|NCT02222922|26334193|P5|Overall Study|Death|13
7572501|NCT02222922|26334194|P4|Overall Study|Death|0
7572502|NCT02222922|26334195|P3|Overall Study|Death|0
7572503|NCT02222922|26334196|P2|Overall Study|Death|0
7572504|NCT02222922|26334197|P1|Overall Study|Death|0
7572505|NCT02222896|26334545|P3|Groin|Did not qualify|40
7572506|NCT02222896|26334546|P2|Groin|Did not qualify|9
7572507|NCT02222896|26334547|P1|Groin|Did not qualify|43
7572508|NCT02222896|26334545|P3|Abdomen|Did not qualify|32
7572509|NCT02222896|26334546|P2|Abdomen|Did not qualify|10
7572510|NCT02222896|26334547|P1|Abdomen|Did not qualify|34
7572511|NCT02222818|26334577|P2|Period 1|Eligibility criteria not met|3
7572512|NCT02222818|26334578|P1|Period 1|Eligibility criteria not met|0
7572513|NCT02222714|26334590|P5|Overall Study|Withdrawal by Subject|1
7572514|NCT02222714|26334591|P4|Overall Study|Withdrawal by Subject|0
7572515|NCT02222714|26334592|P3|Overall Study|Withdrawal by Subject|1
7572516|NCT02222714|26334593|P2|Overall Study|Withdrawal by Subject|0
7572517|NCT02222714|26334594|P1|Overall Study|Withdrawal by Subject|0
7572518|NCT02222714|26334590|P5|Overall Study|Death|6
7572519|NCT02222714|26334591|P4|Overall Study|Death|4
7572520|NCT02222714|26334592|P3|Overall Study|Death|3
7572521|NCT02222714|26334593|P2|Overall Study|Death|2
7572522|NCT02222714|26334594|P1|Overall Study|Death|0
7572523|NCT02222688|26334640|P7|Overall Study|Disease progression|0
7572524|NCT02222688|26334641|P6|Overall Study|Disease progression|0
7572525|NCT02222688|26334642|P5|Overall Study|Disease progression|0
7572526|NCT02222688|26334643|P4|Overall Study|Disease progression|0
7572527|NCT02222688|26334644|P3|Overall Study|Disease progression|0
7572528|NCT02222688|26334645|P2|Overall Study|Disease progression|0
7572529|NCT02222688|26334646|P1|Overall Study|Disease progression|1
7572530|NCT02222688|26334640|P7|Overall Study|Withdrawal by Subject|1
7572531|NCT02222688|26334641|P6|Overall Study|Withdrawal by Subject|0
7572532|NCT02222688|26334642|P5|Overall Study|Withdrawal by Subject|1
7572533|NCT02222688|26334643|P4|Overall Study|Withdrawal by Subject|2
7572534|NCT02222688|26334644|P3|Overall Study|Withdrawal by Subject|0
7572535|NCT02222688|26334645|P2|Overall Study|Withdrawal by Subject|0
7572536|NCT02222688|26334646|P1|Overall Study|Withdrawal by Subject|0
7572537|NCT02222558|26334709|P6|Period 3|Withdrawal by Subject|1
7572538|NCT02222558|26334710|P5|Period 3|Withdrawal by Subject|0
7572539|NCT02222558|26334711|P4|Period 3|Withdrawal by Subject|0
7572540|NCT02222558|26334712|P3|Period 3|Withdrawal by Subject|0
7572541|NCT02222558|26334713|P2|Period 3|Withdrawal by Subject|0
7572542|NCT02222558|26334714|P1|Period 3|Withdrawal by Subject|0
7572543|NCT02222558|26334709|P6|Period 1: Single Dose|Withdrawal by Subject|0
7572544|NCT02222558|26334710|P5|Period 1: Single Dose|Withdrawal by Subject|0
7572545|NCT02222558|26334711|P4|Period 1: Single Dose|Withdrawal by Subject|0
7572546|NCT02222558|26334712|P3|Period 1: Single Dose|Withdrawal by Subject|0
7572547|NCT02222558|26334713|P2|Period 1: Single Dose|Withdrawal by Subject|0
7572548|NCT02222558|26334714|P1|Period 1: Single Dose|Withdrawal by Subject|4
7572549|NCT02222493|26334730|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
7572550|NCT02222493|26334731|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
7572551|NCT02222493|26334730|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
7572552|NCT02222493|26334731|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
7572553|NCT02222493|26334730|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
7572554|NCT02222493|26334731|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
7572555|NCT02222493|26334730|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
7572556|NCT02222493|26334731|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
7572557|NCT02222493|26334730|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
7572558|NCT02222493|26334731|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
7572559|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
7572560|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
7572561|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7572562|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7572563|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
7572564|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
7572565|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
7572566|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
7572567|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
7572568|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
7572569|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
7572570|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
7572571|NCT02222493|26334730|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
7572572|NCT02222493|26334731|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
7572573|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
7572574|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
7572575|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
7572576|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
7572577|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
7572578|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
7572579|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
7572580|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
7572581|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
7572582|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
7572583|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
7572584|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
7572585|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
7572586|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
7572587|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
7572588|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
7572589|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
7572590|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
7572591|NCT02222493|26334730|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7572592|NCT02222493|26334731|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7572593|NCT02222246|26334882|P2|Overall Study|Physician Decision|1
7572594|NCT02222246|26334883|P1|Overall Study|Physician Decision|0
7572595|NCT02222246|26334882|P2|Overall Study|No Emergency Department Visits|26
7572596|NCT02222246|26334883|P1|Overall Study|No Emergency Department Visits|27
7572597|NCT02222207|26334911|P1|Overall Study|Adverse Event|1
7572598|NCT02222207|26334911|P1|Overall Study|Other reasons|2
7572599|NCT02222207|26334911|P1|Overall Study|Death|1
7572600|NCT02221882|26334958|P6|Overall Study|Death|0
7572601|NCT02221882|26334959|P5|Overall Study|Death|0
7572602|NCT02221882|26334960|P4|Overall Study|Death|0
7572603|NCT02221882|26334961|P3|Overall Study|Death|0
7572604|NCT02221882|26334962|P2|Overall Study|Death|1
7572605|NCT02221882|26334963|P1|Overall Study|Death|0
7572606|NCT02221882|26334958|P6|Overall Study|Withdrawal by Subject|2
7572607|NCT02221882|26334959|P5|Overall Study|Withdrawal by Subject|2
7572608|NCT02221882|26334960|P4|Overall Study|Withdrawal by Subject|2
7572609|NCT02221882|26334961|P3|Overall Study|Withdrawal by Subject|4
7572610|NCT02221882|26334962|P2|Overall Study|Withdrawal by Subject|0
7572611|NCT02221882|26334963|P1|Overall Study|Withdrawal by Subject|0
7572612|NCT02221674|26335045|P3|Overall Study|Lost to Follow-up|0
7572613|NCT02221674|26335046|P2|Overall Study|Lost to Follow-up|0
7572614|NCT02221674|26335047|P1|Overall Study|Lost to Follow-up|1
7572615|NCT02221648|26335063|P2|Overall Study|Withdrawal by Subject|3
7572616|NCT02221648|26335064|P1|Overall Study|Withdrawal by Subject|3
7572617|NCT02221284|26335093|P1|Overall Study|Protocol Deviation|5
7572618|NCT02221284|26335093|P1|Overall Study|Case Report Forms Uncollected|56
7572619|NCT02221037|26335142|P4|Overall Study|Physician Decision|0
7572620|NCT02221037|26335143|P3|Overall Study|Physician Decision|1
7572621|NCT02221037|26335144|P2|Overall Study|Physician Decision|0
7572622|NCT02221037|26335145|P1|Overall Study|Physician Decision|0
7572623|NCT02220998|26335231|P2|Overall Study|Lost to Follow-up|4
7572624|NCT02220998|26335232|P1|Overall Study|Lost to Follow-up|4
7572625|NCT02220998|26335231|P2|Overall Study|Lack of Efficacy|5
7572626|NCT02220998|26335232|P1|Overall Study|Lack of Efficacy|0
7572627|NCT02220998|26335231|P2|Overall Study|Death|0
7572628|NCT02220998|26335232|P1|Overall Study|Death|2
7572629|NCT02220998|26335231|P2|Overall Study|Randomized but Never Treated|2
7572630|NCT02220998|26335232|P1|Overall Study|Randomized but Never Treated|1
7572631|NCT02220920|26335250|P2|Overall Study|Conflict with the stopping criteria|2
7572632|NCT02220920|26335251|P1|Overall Study|Conflict with the stopping criteria|1
7572633|NCT02220920|26335250|P2|Overall Study|Withdrawal by Subject|0
7572634|NCT02220920|26335251|P1|Overall Study|Withdrawal by Subject|1
7572635|NCT02220920|26335250|P2|Overall Study|Lack of Efficacy|1
7572636|NCT02220920|26335251|P1|Overall Study|Lack of Efficacy|0
7572637|NCT02220920|26335250|P2|Overall Study|Adverse Event|0
7572638|NCT02220920|26335251|P1|Overall Study|Adverse Event|1
7572639|NCT02220907|26335265|P1|Overall Study|Conflict with the stopping criteria|1
7572640|NCT02220907|26335265|P1|Overall Study|Withdrawal by Subject|2
7572641|NCT02220907|26335265|P1|Overall Study|Physician Decision|1
7572642|NCT02220907|26335265|P1|Overall Study|Adverse Event|7
7572643|NCT02220894|26335274|P2|Overall Study|Ongoing in Study|183
7572644|NCT02220894|26335275|P1|Overall Study|Ongoing in Study|265
7572645|NCT02220894|26335274|P2|Overall Study|Withdrawal by Subject|13
7572646|NCT02220894|26335275|P1|Overall Study|Withdrawal by Subject|2
7572647|NCT02220894|26335274|P2|Overall Study|Withdrawal by Parent/Guardian|1
7572648|NCT02220894|26335275|P1|Overall Study|Withdrawal by Parent/Guardian|0
7572649|NCT02220894|26335274|P2|Overall Study|Lost to Follow-up|2
7572650|NCT02220894|26335275|P1|Overall Study|Lost to Follow-up|0
7572651|NCT02220894|26335274|P2|Overall Study|Death|368
7572652|NCT02220894|26335275|P1|Overall Study|Death|252
7572653|NCT02220894|26335274|P2|Overall Study|Adverse Event|70
7572654|NCT02220894|26335275|P1|Overall Study|Adverse Event|118
7572655|NCT02220855|26335301|P1|Overall Study|Withdrawal by Subject|1
7572656|NCT02220855|26335301|P1|Overall Study|Disease Progression|5
7572657|NCT02220855|26335301|P1|Overall Study|Adverse Event|8
7572658|NCT02220764|26335311|P2|Overall Study|Death|0
7572659|NCT02220764|26335312|P1|Overall Study|Death|1
7572660|NCT02220764|26335311|P2|Overall Study|Lost to Follow-up|1
7572661|NCT02220764|26335312|P1|Overall Study|Lost to Follow-up|3
7572662|NCT02220725|26335326|P4|Overall Study|Withdrawal by Subject|1
7572663|NCT02220725|26335327|P3|Overall Study|Withdrawal by Subject|0
7572664|NCT02220725|26335328|P2|Overall Study|Withdrawal by Subject|0
7572665|NCT02220725|26335329|P1|Overall Study|Withdrawal by Subject|0
7572666|NCT02220725|26335326|P4|Overall Study|Lost to Follow-up|1
7572667|NCT02220725|26335327|P3|Overall Study|Lost to Follow-up|0
7572668|NCT02220725|26335328|P2|Overall Study|Lost to Follow-up|0
7572669|NCT02220725|26335329|P1|Overall Study|Lost to Follow-up|0
7572670|NCT02220712|26335357|P1|Overall Study|Exacerbation of symptoms of an underlying disease|1
7572671|NCT02220712|26335357|P1|Overall Study|Withdrawal by Subject|2
7572672|NCT02220712|26335357|P1|Overall Study|Adverse Event|1
7572673|NCT02220205|26335367|P2|Overall Study|Withdrawal by Subject|0
7572674|NCT02220205|26335368|P1|Overall Study|Withdrawal by Subject|1
7572675|NCT02219932|26335393|P2|Overall Study|Adverse Event|21
7572676|NCT02219932|26335394|P1|Overall Study|Adverse Event|23
7572677|NCT02219932|26335393|P2|Overall Study|Lost to Follow-up|2
7572678|NCT02219932|26335394|P1|Overall Study|Lost to Follow-up|4
7572679|NCT02219932|26335393|P2|Overall Study|Pregnancy|0
7572680|NCT02219932|26335394|P1|Overall Study|Pregnancy|1
7572681|NCT02219932|26335393|P2|Overall Study|Protocol Violation|6
7572682|NCT02219932|26335394|P1|Overall Study|Protocol Violation|10
7572683|NCT02219932|26335393|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
7572684|NCT02219932|26335394|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
7572685|NCT02219932|26335393|P2|Overall Study|Consent Withdrawn|7
7572686|NCT02219932|26335394|P1|Overall Study|Consent Withdrawn|11
7572687|NCT02219932|26335393|P2|Overall Study|Investigator Decision|1
7572688|NCT02219932|26335394|P1|Overall Study|Investigator Decision|0
7572689|NCT02219932|26335393|P2|Overall Study|Death|1
7572690|NCT02219932|26335394|P1|Overall Study|Death|1
7572691|NCT02219932|26335393|P2|Overall Study|Other|11
7572692|NCT02219932|26335394|P1|Overall Study|Other|5
7572693|NCT02219685|26335471|P2|Blinded Treatment Phase|Withdrew Consent|0
7572694|NCT02219685|26335472|P1|Blinded Treatment Phase|Withdrew Consent|1
7572695|NCT02219685|26335471|P2|Blinded Treatment Phase|Lost to Follow-up|0
7572696|NCT02219685|26335472|P1|Blinded Treatment Phase|Lost to Follow-up|1
7572697|NCT02219477|26335578|P3|Overall Study|Withdrawal by Subject|0
7572698|NCT02219477|26335579|P2|Overall Study|Withdrawal by Subject|1
7572699|NCT02219477|26335580|P1|Overall Study|Withdrawal by Subject|0
7572700|NCT02219477|26335578|P3|Overall Study|Adverse Event|1
7572701|NCT02219477|26335579|P2|Overall Study|Adverse Event|1
7572702|NCT02219477|26335580|P1|Overall Study|Adverse Event|0
7572703|NCT02219464|26335608|P2|Overall Study|catheter malfunction|0
7572704|NCT02219464|26335609|P1|Overall Study|catheter malfunction|1
7572705|NCT02219464|26335608|P2|Overall Study|case cancelled|0
7572706|NCT02219464|26335609|P1|Overall Study|case cancelled|1
7572707|NCT02219464|26335608|P2|Overall Study|Withdrawal by Subject|0
7572708|NCT02219464|26335609|P1|Overall Study|Withdrawal by Subject|1
7572709|NCT02219334|26335632|P2|Overall Study|Protocol Violation|3
7572710|NCT02219334|26335633|P1|Overall Study|Protocol Violation|7
7572711|NCT02219334|26335632|P2|Overall Study|Withdrawal by Subject|0
7572712|NCT02219334|26335633|P1|Overall Study|Withdrawal by Subject|1
7572713|NCT02219308|26335656|P2|Overall Study|Withdrawal by Subject|2
7572714|NCT02219308|26335657|P1|Overall Study|Withdrawal by Subject|1
7572715|NCT02219087|26335817|P2|Overall Study|Randomization envelope pulled out of seq|1
7572716|NCT02219087|26335818|P1|Overall Study|Randomization envelope pulled out of seq|0
7572717|NCT02219048|26335838|P2|Overall Study|Other|1
7572718|NCT02219048|26335839|P1|Overall Study|Other|0
7572719|NCT02219048|26335838|P2|Overall Study|Withdrawal by Subject|0
7572720|NCT02219048|26335839|P1|Overall Study|Withdrawal by Subject|2
7572721|NCT02219048|26335838|P2|Overall Study|Study terminated by sponsor|15
7572722|NCT02219048|26335839|P1|Overall Study|Study terminated by sponsor|16
7572723|NCT02219048|26335838|P2|Overall Study|No longer meets eligibility criteria|0
7572724|NCT02219048|26335839|P1|Overall Study|No longer meets eligibility criteria|1
7572725|NCT02219048|26335838|P2|Overall Study|Adverse Event|5
7572726|NCT02219048|26335839|P1|Overall Study|Adverse Event|2
7572727|NCT02219009|26335865|P2|Overall Study|Physician Decision|1
7572728|NCT02219009|26335866|P1|Overall Study|Physician Decision|0
7572729|NCT02219009|26335865|P2|Overall Study|Protocol deviation|0
7572730|NCT02219009|26335866|P1|Overall Study|Protocol deviation|1
7572731|NCT02219009|26335865|P2|Overall Study|Lost to Follow-up|2
7572732|NCT02219009|26335866|P1|Overall Study|Lost to Follow-up|2
7572733|NCT02219009|26335865|P2|Overall Study|Adverse Event|4
7572734|NCT02219009|26335866|P1|Overall Study|Adverse Event|2
7572735|NCT02219009|26335865|P2|Overall Study|Withdrawal by Subject|1
7572736|NCT02219009|26335866|P1|Overall Study|Withdrawal by Subject|5
7572737|NCT02218736|26335878|P2|Overall Study|Protocol Violation|0
7572738|NCT02218736|26335879|P1|Overall Study|Protocol Violation|2
7572739|NCT02218736|26335878|P2|Overall Study|Withdrawal by Subject|9
7572740|NCT02218736|26335879|P1|Overall Study|Withdrawal by Subject|10
7572741|NCT02218697|26335891|P2|Overall Study|Withdrawal by Subject|3
7572742|NCT02218697|26335892|P1|Overall Study|Withdrawal by Subject|2
7572743|NCT02218697|26335891|P2|Overall Study|Unwilling to be vaccinated in left arm|1
7572744|NCT02218697|26335892|P1|Overall Study|Unwilling to be vaccinated in left arm|0
7572745|NCT02218697|26335891|P2|Overall Study|Adverse Event|2
7572746|NCT02218697|26335892|P1|Overall Study|Adverse Event|0
7572747|NCT02218541|26335932|P2|Overall Study|Implant Failure|1
7572748|NCT02218541|26335933|P1|Overall Study|Implant Failure|4
7572749|NCT02218541|26335932|P2|Overall Study|Lost to Follow-up|1
7572750|NCT02218541|26335933|P1|Overall Study|Lost to Follow-up|2
7572751|NCT02218489|26335945|P2|Overall Study|Lost to Follow-up|0
7572752|NCT02218489|26335946|P1|Overall Study|Lost to Follow-up|1
7572753|NCT02218489|26335945|P2|Overall Study|Withdrawal by Subject|3
7572754|NCT02218489|26335946|P1|Overall Study|Withdrawal by Subject|4
7572755|NCT02218372|26335998|P2|Overall Study|Withdrawal by Parent/Guardian|1
7572756|NCT02218372|26335999|P1|Overall Study|Withdrawal by Parent/Guardian|0
7572757|NCT02218372|26335998|P2|Overall Study|Randomized but did not receive treatment|3
7572758|NCT02218372|26335999|P1|Overall Study|Randomized but did not receive treatment|2
7572759|NCT02218372|26335998|P2|Overall Study|Miscellaneous|1
7572760|NCT02218372|26335999|P1|Overall Study|Miscellaneous|2
7572761|NCT02218372|26335998|P2|Overall Study|Adverse Event|1
7572762|NCT02218372|26335999|P1|Overall Study|Adverse Event|1
7572763|NCT02218268|26336079|P2|24 Hour Washout|Physician Decision|9
7572764|NCT02218268|26336080|P1|24 Hour Washout|Physician Decision|11
7572765|NCT02218216|26336092|P3|Overall Study|Study terminated before completed|0
7572766|NCT02218216|26336093|P2|Overall Study|Study terminated before completed|0
7572767|NCT02218216|26336094|P1|Overall Study|Study terminated before completed|6
7572768|NCT02218008|26336147|P6|Stage 2 (S2)|Lost to Follow-up|1
7572769|NCT02218008|26336148|P5|Stage 2 (S2)|Lost to Follow-up|0
7572770|NCT02218008|26336149|P4|Stage 2 (S2)|Lost to Follow-up|0
7572771|NCT02218008|26336150|P3|Stage 2 (S2)|Lost to Follow-up|0
7572772|NCT02218008|26336151|P2|Stage 2 (S2)|Lost to Follow-up|0
7572773|NCT02218008|26336152|P1|Stage 2 (S2)|Lost to Follow-up|0
7572774|NCT02218008|26336147|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7572775|NCT02218008|26336148|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7572776|NCT02218008|26336149|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
7572777|NCT02218008|26336150|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7572778|NCT02218008|26336151|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7572779|NCT02218008|26336152|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7572780|NCT02218008|26336147|P6|Stage 2 (S2)|Lack of Efficacy|2
7572781|NCT02218008|26336148|P5|Stage 2 (S2)|Lack of Efficacy|0
7572782|NCT02218008|26336149|P4|Stage 2 (S2)|Lack of Efficacy|0
7572783|NCT02218008|26336150|P3|Stage 2 (S2)|Lack of Efficacy|0
7572784|NCT02218008|26336151|P2|Stage 2 (S2)|Lack of Efficacy|0
7572785|NCT02218008|26336152|P1|Stage 2 (S2)|Lack of Efficacy|0
7572786|NCT02218008|26336147|P6|Stage 2 (S2)|Withdrawal by Subject|0
7572787|NCT02218008|26336148|P5|Stage 2 (S2)|Withdrawal by Subject|1
7572788|NCT02218008|26336149|P4|Stage 2 (S2)|Withdrawal by Subject|1
7572789|NCT02218008|26336150|P3|Stage 2 (S2)|Withdrawal by Subject|0
7572790|NCT02218008|26336151|P2|Stage 2 (S2)|Withdrawal by Subject|0
7572791|NCT02218008|26336152|P1|Stage 2 (S2)|Withdrawal by Subject|0
7572792|NCT02218008|26336147|P6|Stage 2 (S2)|Adverse Event|3
7572793|NCT02218008|26336148|P5|Stage 2 (S2)|Adverse Event|3
7572794|NCT02218008|26336149|P4|Stage 2 (S2)|Adverse Event|2
7572795|NCT02218008|26336150|P3|Stage 2 (S2)|Adverse Event|0
7572796|NCT02218008|26336151|P2|Stage 2 (S2)|Adverse Event|0
7572797|NCT02218008|26336152|P1|Stage 2 (S2)|Adverse Event|0
7572798|NCT02218008|26336147|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7572799|NCT02218008|26336148|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7572800|NCT02218008|26336149|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7572801|NCT02218008|26336150|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7572802|NCT02218008|26336151|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7572803|NCT02218008|26336152|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
7572804|NCT02218008|26336147|P6|Stage 1 (S1)|Protocol Violation|0
7572805|NCT02218008|26336148|P5|Stage 1 (S1)|Protocol Violation|0
7572806|NCT02218008|26336149|P4|Stage 1 (S1)|Protocol Violation|0
7572807|NCT02218008|26336150|P3|Stage 1 (S1)|Protocol Violation|1
7572808|NCT02218008|26336151|P2|Stage 1 (S1)|Protocol Violation|0
7572809|NCT02218008|26336152|P1|Stage 1 (S1)|Protocol Violation|0
7572810|NCT02218008|26336147|P6|Stage 1 (S1)|Pregnancy|0
7572811|NCT02218008|26336148|P5|Stage 1 (S1)|Pregnancy|0
7572812|NCT02218008|26336149|P4|Stage 1 (S1)|Pregnancy|0
7572813|NCT02218008|26336150|P3|Stage 1 (S1)|Pregnancy|1
7572814|NCT02218008|26336151|P2|Stage 1 (S1)|Pregnancy|0
7572815|NCT02218008|26336152|P1|Stage 1 (S1)|Pregnancy|0
7572816|NCT02218008|26336147|P6|Stage 1 (S1)|Non-compliance; drug use|0
7572817|NCT02218008|26336148|P5|Stage 1 (S1)|Non-compliance; drug use|0
7572818|NCT02218008|26336149|P4|Stage 1 (S1)|Non-compliance; drug use|0
7572819|NCT02218008|26336150|P3|Stage 1 (S1)|Non-compliance; drug use|0
7572820|NCT02218008|26336151|P2|Stage 1 (S1)|Non-compliance; drug use|0
7572821|NCT02218008|26336152|P1|Stage 1 (S1)|Non-compliance; drug use|1
7572822|NCT02218008|26336147|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
7572823|NCT02218008|26336148|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
7572824|NCT02218008|26336149|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
7572825|NCT02218008|26336150|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
7572826|NCT02218008|26336151|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
7572827|NCT02218008|26336152|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
7572828|NCT02218008|26336147|P6|Stage 1 (S1)|Lost to Follow-up|0
7572829|NCT02218008|26336148|P5|Stage 1 (S1)|Lost to Follow-up|0
7572830|NCT02218008|26336149|P4|Stage 1 (S1)|Lost to Follow-up|0
7572831|NCT02218008|26336150|P3|Stage 1 (S1)|Lost to Follow-up|1
7572832|NCT02218008|26336151|P2|Stage 1 (S1)|Lost to Follow-up|0
7572833|NCT02218008|26336152|P1|Stage 1 (S1)|Lost to Follow-up|3
7572834|NCT02218008|26336147|P6|Stage 1 (S1)|Lack of Efficacy|0
7572835|NCT02218008|26336148|P5|Stage 1 (S1)|Lack of Efficacy|0
7572836|NCT02218008|26336149|P4|Stage 1 (S1)|Lack of Efficacy|0
7572837|NCT02218008|26336150|P3|Stage 1 (S1)|Lack of Efficacy|0
7572838|NCT02218008|26336151|P2|Stage 1 (S1)|Lack of Efficacy|0
7572839|NCT02218008|26336152|P1|Stage 1 (S1)|Lack of Efficacy|3
7572840|NCT02218008|26336147|P6|Stage 1 (S1)|Withdrawal by Subject|0
7572841|NCT02218008|26336148|P5|Stage 1 (S1)|Withdrawal by Subject|0
7572842|NCT02218008|26336149|P4|Stage 1 (S1)|Withdrawal by Subject|0
7572843|NCT02218008|26336150|P3|Stage 1 (S1)|Withdrawal by Subject|1
7572844|NCT02218008|26336151|P2|Stage 1 (S1)|Withdrawal by Subject|1
7572845|NCT02218008|26336152|P1|Stage 1 (S1)|Withdrawal by Subject|6
7572846|NCT02218008|26336147|P6|Stage 1 (S1)|Adverse Event|0
7572847|NCT02218008|26336148|P5|Stage 1 (S1)|Adverse Event|0
7572848|NCT02218008|26336149|P4|Stage 1 (S1)|Adverse Event|0
7572849|NCT02218008|26336150|P3|Stage 1 (S1)|Adverse Event|11
7572850|NCT02218008|26336151|P2|Stage 1 (S1)|Adverse Event|5
7572851|NCT02218008|26336152|P1|Stage 1 (S1)|Adverse Event|6
7572852|NCT02217982|26336198|P2|Overall Study|Adverse Event|1
7572853|NCT02217982|26336199|P1|Overall Study|Adverse Event|0
7572854|NCT02217982|26336198|P2|Overall Study|Trial discontinued|0
7572855|NCT02217982|26336199|P1|Overall Study|Trial discontinued|1
7572856|NCT02217878|26336282|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
7572857|NCT02217878|26336283|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
7572858|NCT02217878|26336282|P2|Overall Study|required morphine due to chest pain|2
7572859|NCT02217878|26336283|P1|Overall Study|required morphine due to chest pain|1
7572860|NCT02217566|26336381|P1|Overall Study|Early study termination|6
7572861|NCT02217566|26336381|P1|Overall Study|Death|3
7572862|NCT02217566|26336381|P1|Overall Study|Lost to Follow-up|2
7572863|NCT02217527|26336392|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
7572864|NCT02217527|26336393|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
7572865|NCT02217527|26336392|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
7572866|NCT02217527|26336393|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
7572867|NCT02217501|26336405|P2|Overall Study|Death|4
7572868|NCT02217501|26336406|P1|Overall Study|Death|3
7572869|NCT02217475|26336417|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
7572870|NCT02217475|26336418|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7572871|NCT02217475|26336419|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7572872|NCT02217475|26336417|P3|Treatment Period 2 (Year 2)|Physician Decision|2
7572873|NCT02217475|26336418|P2|Treatment Period 2 (Year 2)|Physician Decision|0
7572874|NCT02217475|26336419|P1|Treatment Period 2 (Year 2)|Physician Decision|0
7572875|NCT02217475|26336417|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7572876|NCT02217475|26336418|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
7572877|NCT02217475|26336419|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7572878|NCT02217475|26336417|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
7572879|NCT02217475|26336418|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
7572880|NCT02217475|26336419|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
7572881|NCT02217475|26336417|P3|Treatment Period 2 (Year 2)|Adverse Event|5
7572882|NCT02217475|26336418|P2|Treatment Period 2 (Year 2)|Adverse Event|1
7572883|NCT02217475|26336419|P1|Treatment Period 2 (Year 2)|Adverse Event|0
7572884|NCT02217475|26336417|P3|Discontinued After Period 1|Physician Decision|1
7572885|NCT02217475|26336418|P2|Discontinued After Period 1|Physician Decision|0
7572886|NCT02217475|26336419|P1|Discontinued After Period 1|Physician Decision|0
7572887|NCT02217475|26336417|P3|Discontinued After Period 1|Participant Withdrew Consent|2
7572888|NCT02217475|26336418|P2|Discontinued After Period 1|Participant Withdrew Consent|1
7572889|NCT02217475|26336419|P1|Discontinued After Period 1|Participant Withdrew Consent|1
7572890|NCT02217475|26336417|P3|Discontinued After Period 1|Adverse Event|0
7572891|NCT02217475|26336418|P2|Discontinued After Period 1|Adverse Event|2
7572892|NCT02217475|26336419|P1|Discontinued After Period 1|Adverse Event|1
7572893|NCT02217475|26336417|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
7572894|NCT02217475|26336418|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7572895|NCT02217475|26336419|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7572896|NCT02217475|26336417|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
7572897|NCT02217475|26336418|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
7572898|NCT02217475|26336419|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
7572899|NCT02217475|26336417|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7572900|NCT02217475|26336418|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7572901|NCT02217475|26336419|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
7572902|NCT02217475|26336417|P3|Treatment Period 1 (Year 1)|Adverse Event|9
7572903|NCT02217475|26336418|P2|Treatment Period 1 (Year 1)|Adverse Event|5
7572904|NCT02217475|26336419|P1|Treatment Period 1 (Year 1)|Adverse Event|4
7572905|NCT02217475|26336417|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7572906|NCT02217475|26336418|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
7572907|NCT02217475|26336419|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7572908|NCT02217436|26336536|P2|Overall Study|Incomplete data|1
7572909|NCT02217436|26336537|P1|Overall Study|Incomplete data|0
7572910|NCT02217436|26336536|P2|Overall Study|Protocol Violation|1
7572911|NCT02217436|26336537|P1|Overall Study|Protocol Violation|1
7572912|NCT02217410|26336548|P3|Overall Study|Physician Decision|0
7572913|NCT02217410|26336549|P2|Overall Study|Physician Decision|3
7572914|NCT02217410|26336550|P1|Overall Study|Physician Decision|1
7572915|NCT02217410|26336548|P3|Overall Study|Lack of Efficacy|0
7572916|NCT02217410|26336549|P2|Overall Study|Lack of Efficacy|1
7572917|NCT02217410|26336550|P1|Overall Study|Lack of Efficacy|0
7572918|NCT02217410|26336548|P3|Overall Study|Lost to Follow-up|1
7572919|NCT02217410|26336549|P2|Overall Study|Lost to Follow-up|0
7572920|NCT02217410|26336550|P1|Overall Study|Lost to Follow-up|0
7572921|NCT02217410|26336548|P3|Overall Study|Withdrawal by Subject|2
7572922|NCT02217410|26336549|P2|Overall Study|Withdrawal by Subject|0
7572923|NCT02217410|26336550|P1|Overall Study|Withdrawal by Subject|0
7572924|NCT02217410|26336548|P3|Overall Study|Graft Loss|2
7572925|NCT02217410|26336549|P2|Overall Study|Graft Loss|0
7572926|NCT02217410|26336550|P1|Overall Study|Graft Loss|0
7572927|NCT02217332|26336573|P1|Overall Study|Lost to Follow-up|1
7572928|NCT02217332|26336573|P1|Overall Study|Withdrawal by Subject|1
7572929|NCT02217332|26336573|P1|Overall Study|Protocol Violation (eligibility)|1
7572930|NCT02217332|26336573|P1|Overall Study|Dose interruption >1 month|1
7572931|NCT02217332|26336573|P1|Overall Study|Adverse Event|3
7572932|NCT02217280|26336584|P1|Overall Study|Post-consent sceen fail|2
7572933|NCT02217280|26336584|P1|Overall Study|Withdrawal by Subject|2
7572934|NCT02216812|26336600|P2|Overall Study|Lost to Follow-up|5
7572935|NCT02216812|26336601|P1|Overall Study|Lost to Follow-up|10
7572936|NCT02216773|26336617|P2|Overall Study|Abandoned|3
7572937|NCT02216773|26336618|P1|Overall Study|Abandoned|4
7572938|NCT02216773|26336617|P2|Overall Study|Insufficient FLRV|0
7572939|NCT02216773|26336618|P1|Overall Study|Insufficient FLRV|4
7572940|NCT02216773|26336617|P2|Overall Study|Disease progression|2
7572941|NCT02216773|26336618|P1|Overall Study|Disease progression|4
7572942|NCT02216591|26336639|P2|Overall Study|Lost to Follow-up|1
7572943|NCT02216591|26336640|P1|Overall Study|Lost to Follow-up|0
7572944|NCT02216526|26336653|P3|Overall Study|Hospitalization|3
7572945|NCT02216526|26336654|P2|Overall Study|Hospitalization|1
7572946|NCT02216526|26336655|P1|Overall Study|Hospitalization|2
7572947|NCT02216526|26336653|P3|Overall Study|Protocol Violation|2
7572948|NCT02216526|26336654|P2|Overall Study|Protocol Violation|0
7572949|NCT02216526|26336655|P1|Overall Study|Protocol Violation|2
7572950|NCT02216526|26336653|P3|Overall Study|Death|3
7572951|NCT02216526|26336654|P2|Overall Study|Death|1
7572952|NCT02216526|26336655|P1|Overall Study|Death|0
7572953|NCT02216526|26336653|P3|Overall Study|Adverse Event|0
7572954|NCT02216526|26336654|P2|Overall Study|Adverse Event|1
7572955|NCT02216526|26336655|P1|Overall Study|Adverse Event|1
7572956|NCT02216357|26336773|P2|Overall Study|Inclusion or exclusion criteria not met|1
7572957|NCT02216357|26336774|P1|Overall Study|Inclusion or exclusion criteria not met|2
7572958|NCT02216214|26336800|P2|Overall Study|Miscellaneous|1
7572959|NCT02216214|26336801|P1|Overall Study|Miscellaneous|1
7572960|NCT02216214|26336800|P2|Overall Study|Study Terminated By Sponsor|1
7572961|NCT02216214|26336801|P1|Overall Study|Study Terminated By Sponsor|0
7572962|NCT02216214|26336800|P2|Overall Study|Withdrawal by Subject|20
7572963|NCT02216214|26336801|P1|Overall Study|Withdrawal by Subject|22
7572964|NCT02216214|26336800|P2|Overall Study|Protocol Violation|2
7572965|NCT02216214|26336801|P1|Overall Study|Protocol Violation|4
7572966|NCT02216214|26336800|P2|Overall Study|Lost to Follow-up|2
7572967|NCT02216214|26336801|P1|Overall Study|Lost to Follow-up|3
7572968|NCT02216214|26336800|P2|Overall Study|Lack of Efficacy|2
7572969|NCT02216214|26336801|P1|Overall Study|Lack of Efficacy|2
7572970|NCT02216214|26336800|P2|Overall Study|Adverse Event|8
7572971|NCT02216214|26336801|P1|Overall Study|Adverse Event|10
7572972|NCT02216214|26336800|P2|Overall Study|Randomized Never Received Study Drug|0
7572973|NCT02216214|26336801|P1|Overall Study|Randomized Never Received Study Drug|1
7572974|NCT02216123|26336872|P2|Overall Study|Withdrawal by Subject|0
7572975|NCT02216123|26336873|P1|Overall Study|Withdrawal by Subject|2
7572976|NCT02216123|26336872|P2|Overall Study|Lost to Follow-up|2
7572977|NCT02216123|26336873|P1|Overall Study|Lost to Follow-up|4
7572978|NCT02216071|26336964|P2|Overall Study|Other|2
7572979|NCT02216071|26336965|P1|Overall Study|Other|2
7572980|NCT02216071|26336964|P2|Overall Study|Protocol Violation|5
7572981|NCT02216071|26336965|P1|Overall Study|Protocol Violation|3
7572982|NCT02216071|26336964|P2|Overall Study|Lost to Follow-up|3
7572983|NCT02216071|26336965|P1|Overall Study|Lost to Follow-up|3
7572984|NCT02216071|26336964|P2|Overall Study|Withdrawal by Subject|2
7572985|NCT02216071|26336965|P1|Overall Study|Withdrawal by Subject|7
7572986|NCT02215967|26336979|P4|Overall Study|Patient did not get CAR T-Cells|0
7572987|NCT02215967|26336980|P3|Overall Study|Patient did not get CAR T-Cells|1
7572988|NCT02215967|26336981|P2|Overall Study|Patient did not get CAR T-Cells|0
7572989|NCT02215967|26336982|P1|Overall Study|Patient did not get CAR T-Cells|0
7572990|NCT02215967|26336979|P4|Overall Study|Patient became ineligible for treatment|3
7572991|NCT02215967|26336980|P3|Overall Study|Patient became ineligible for treatment|0
7572992|NCT02215967|26336981|P2|Overall Study|Patient became ineligible for treatment|0
7572993|NCT02215967|26336982|P1|Overall Study|Patient became ineligible for treatment|0
7572994|NCT02215954|26337003|P3|Overall Study|Not exposed|3
7572995|NCT02215954|26337004|P2|Overall Study|Not exposed|1
7572996|NCT02215954|26337005|P1|Overall Study|Not exposed|1
7572997|NCT02215954|26337003|P3|Overall Study|Withdrawal by Subject|2
7572998|NCT02215954|26337004|P2|Overall Study|Withdrawal by Subject|0
7572999|NCT02215954|26337005|P1|Overall Study|Withdrawal by Subject|0
7573000|NCT02215954|26337003|P3|Overall Study|Adverse Event|1
7573001|NCT02215954|26337004|P2|Overall Study|Adverse Event|0
7573002|NCT02215954|26337005|P1|Overall Study|Adverse Event|0
7573003|NCT02215616|26337029|P4|Overall Study|Other than specified|1
7573004|NCT02215616|26337030|P3|Overall Study|Other than specified|1
7573005|NCT02215616|26337031|P2|Overall Study|Other than specified|0
7573006|NCT02215616|26337032|P1|Overall Study|Other than specified|1
7573007|NCT02215616|26337029|P4|Overall Study|Lost to Follow-up|1
7573008|NCT02215616|26337030|P3|Overall Study|Lost to Follow-up|0
7573009|NCT02215616|26337031|P2|Overall Study|Lost to Follow-up|1
7573010|NCT02215616|26337032|P1|Overall Study|Lost to Follow-up|1
7573011|NCT02215616|26337029|P4|Overall Study|Protocol Violation|0
7573012|NCT02215616|26337030|P3|Overall Study|Protocol Violation|0
7573013|NCT02215616|26337031|P2|Overall Study|Protocol Violation|2
7573014|NCT02215616|26337032|P1|Overall Study|Protocol Violation|0
7573015|NCT02215616|26337029|P4|Overall Study|Non-compliance|0
7573016|NCT02215616|26337030|P3|Overall Study|Non-compliance|1
7573017|NCT02215616|26337031|P2|Overall Study|Non-compliance|2
7573018|NCT02215616|26337032|P1|Overall Study|Non-compliance|0
7573019|NCT02215616|26337029|P4|Overall Study|Withdrawal by Subject|5
7573020|NCT02215616|26337030|P3|Overall Study|Withdrawal by Subject|2
7573021|NCT02215616|26337031|P2|Overall Study|Withdrawal by Subject|8
7573022|NCT02215616|26337032|P1|Overall Study|Withdrawal by Subject|1
7573023|NCT02215616|26337029|P4|Overall Study|Adverse Event|2
7573024|NCT02215616|26337030|P3|Overall Study|Adverse Event|9
7573025|NCT02215616|26337031|P2|Overall Study|Adverse Event|4
7573026|NCT02215616|26337032|P1|Overall Study|Adverse Event|7
7573027|NCT02215616|26337029|P4|Overall Study|Death|0
7573028|NCT02215616|26337030|P3|Overall Study|Death|0
7573029|NCT02215616|26337031|P2|Overall Study|Death|0
7573030|NCT02215616|26337032|P1|Overall Study|Death|1
7573031|NCT02215616|26337029|P4|Overall Study|Sponsor requested to stop study drug|4
7573032|NCT02215616|26337030|P3|Overall Study|Sponsor requested to stop study drug|1
7573033|NCT02215616|26337031|P2|Overall Study|Sponsor requested to stop study drug|0
7573034|NCT02215616|26337032|P1|Overall Study|Sponsor requested to stop study drug|0
7573035|NCT02215252|26337054|P3|Overall Study|Other|1
7573036|NCT02215252|26337055|P2|Overall Study|Other|1
7573037|NCT02215252|26337056|P1|Overall Study|Other|0
7573038|NCT02215252|26337054|P3|Overall Study|Withdrawal by Subject|0
7573039|NCT02215252|26337055|P2|Overall Study|Withdrawal by Subject|0
7573040|NCT02215252|26337056|P1|Overall Study|Withdrawal by Subject|1
7573041|NCT02215252|26337054|P3|Overall Study|Protocol Violation|0
7573042|NCT02215252|26337055|P2|Overall Study|Protocol Violation|1
7573043|NCT02215252|26337056|P1|Overall Study|Protocol Violation|0
7573044|NCT02215252|26337054|P3|Overall Study|Does not Meet Entrance Criteria|0
7573045|NCT02215252|26337055|P2|Overall Study|Does not Meet Entrance Criteria|1
7573046|NCT02215252|26337056|P1|Overall Study|Does not Meet Entrance Criteria|0
7573047|NCT02215252|26337054|P3|Overall Study|Lost to Follow-up|1
7573048|NCT02215252|26337055|P2|Overall Study|Lost to Follow-up|0
7573049|NCT02215252|26337056|P1|Overall Study|Lost to Follow-up|0
7573050|NCT02215252|26337054|P3|Overall Study|Adverse Event|2
7573051|NCT02215252|26337055|P2|Overall Study|Adverse Event|5
7573052|NCT02215252|26337056|P1|Overall Study|Adverse Event|1
7573053|NCT02215096|26337144|P5|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7573054|NCT02215096|26337145|P4|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7573055|NCT02215096|26337146|P3|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7573056|NCT02215096|26337147|P2|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
7573057|NCT02215096|26337148|P1|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7573058|NCT02215096|26337144|P5|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7573059|NCT02215096|26337145|P4|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
7573060|NCT02215096|26337146|P3|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7573061|NCT02215096|26337147|P2|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7573062|NCT02215096|26337148|P1|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7573063|NCT02215096|26337144|P5|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
7573064|NCT02215096|26337145|P4|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7573065|NCT02215096|26337146|P3|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7573066|NCT02215096|26337147|P2|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7573067|NCT02215096|26337148|P1|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7573068|NCT02215096|26337144|P5|Run-In Period (Up to Week 2)|Adverse Event|0
7573069|NCT02215096|26337145|P4|Run-In Period (Up to Week 2)|Adverse Event|0
7573070|NCT02215096|26337146|P3|Run-In Period (Up to Week 2)|Adverse Event|0
7573071|NCT02215096|26337147|P2|Run-In Period (Up to Week 2)|Adverse Event|0
7573072|NCT02215096|26337148|P1|Run-In Period (Up to Week 2)|Adverse Event|1
7573073|NCT02214225|26337310|P3|Overall Study|randomized in error, not vaccinated|1
7573074|NCT02214225|26337311|P2|Overall Study|randomized in error, not vaccinated|1
7573075|NCT02214225|26337312|P1|Overall Study|randomized in error, not vaccinated|2
7573076|NCT02214225|26337310|P3|Overall Study|Death|1
7573077|NCT02214225|26337311|P2|Overall Study|Death|0
7573078|NCT02214225|26337312|P1|Overall Study|Death|5
7573079|NCT02214225|26337310|P3|Overall Study|Withdrawal by Subject|2
7573080|NCT02214225|26337311|P2|Overall Study|Withdrawal by Subject|0
7573081|NCT02214225|26337312|P1|Overall Study|Withdrawal by Subject|2
7573082|NCT02214225|26337310|P3|Overall Study|Lost to Follow-up|18
7573083|NCT02214225|26337311|P2|Overall Study|Lost to Follow-up|18
7573084|NCT02214225|26337312|P1|Overall Study|Lost to Follow-up|46
7573085|NCT02214186|26337371|P2|Overall Study|Protocol Violation|1
7573086|NCT02214186|26337372|P1|Overall Study|Protocol Violation|1
7573087|NCT02214186|26337371|P2|Overall Study|Lost to Follow-up|1
7573088|NCT02214186|26337372|P1|Overall Study|Lost to Follow-up|1
7573089|NCT02214121|26337440|P3|Part B|Lost to Follow-up|1
7573090|NCT02214121|26337441|P2|Part B|Lost to Follow-up|0
7573091|NCT02214121|26337442|P1|Part B|Lost to Follow-up|0
7573092|NCT02214121|26337440|P3|Part B|Dev. of study-specific withdrawal crit.|0
7573093|NCT02214121|26337441|P2|Part B|Dev. of study-specific withdrawal crit.|2
7573094|NCT02214121|26337442|P1|Part B|Dev. of study-specific withdrawal crit.|0
7573095|NCT02214121|26337440|P3|Part B|Patient decision|0
7573096|NCT02214121|26337441|P2|Part B|Patient decision|1
7573097|NCT02214121|26337442|P1|Part B|Patient decision|0
7573098|NCT02214121|26337440|P3|Part A|Other|0
7573099|NCT02214121|26337441|P2|Part A|Other|0
7573100|NCT02214121|26337442|P1|Part A|Other|1
7573101|NCT02214121|26337440|P3|Part A|Dev. of study-specific withdrawal crit.|0
7573102|NCT02214121|26337441|P2|Part A|Dev. of study-specific withdrawal crit.|0
7573103|NCT02214121|26337442|P1|Part A|Dev. of study-specific withdrawal crit.|4
7573104|NCT02214121|26337440|P3|Part A|Patient decision|0
7573105|NCT02214121|26337441|P2|Part A|Patient decision|0
7573106|NCT02214121|26337442|P1|Part A|Patient decision|2
7573107|NCT02213666|26337551|P1|Overall Study|Withdrawal by Subject|1
7573108|NCT02213510|26337557|P2|Overall Study|Lost to Follow-up|0
7573109|NCT02213510|26337558|P1|Overall Study|Lost to Follow-up|1
7573110|NCT02213510|26337557|P2|Overall Study|Death|1
7573111|NCT02213510|26337558|P1|Overall Study|Death|0
7573112|NCT02213458|26337586|P2|Overall Study|Withdrawal by Subject|8
7573113|NCT02213458|26337587|P1|Overall Study|Withdrawal by Subject|26
7573114|NCT02213458|26337586|P2|Overall Study|Lost to Follow-up|2
7573115|NCT02213458|26337587|P1|Overall Study|Lost to Follow-up|2
7573116|NCT02213458|26337586|P2|Overall Study|Refused re-consent|0
7573117|NCT02213458|26337587|P1|Overall Study|Refused re-consent|6
7573118|NCT02213458|26337586|P2|Overall Study|No longer meets criteria: patient moved out of state|0
7573119|NCT02213458|26337587|P1|Overall Study|No longer meets criteria: patient moved out of state|10
7573120|NCT02213458|26337586|P2|Overall Study|No longer meets criteria: caregiver too sick to participate|0
7573121|NCT02213458|26337587|P1|Overall Study|No longer meets criteria: caregiver too sick to participate|2
7573122|NCT02213458|26337586|P2|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
7573123|NCT02213458|26337587|P1|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
7573124|NCT02213458|26337586|P2|Overall Study|No longer meets criteria: caregiver deceased|0
7573125|NCT02213458|26337587|P1|Overall Study|No longer meets criteria: caregiver deceased|4
7573126|NCT02213380|26337604|P2|Per-protocol Analysis|Protocol Violation|36
7573127|NCT02213380|26337605|P1|Per-protocol Analysis|Protocol Violation|32
7573128|NCT02213380|26337604|P2|Underwent Randomization|Not treated|3
7573129|NCT02213380|26337605|P1|Underwent Randomization|Not treated|3
7573130|NCT02213380|26337604|P2|Underwent Randomization|Withdrawal by Subject|0
7573131|NCT02213380|26337605|P1|Underwent Randomization|Withdrawal by Subject|2
7573132|NCT02213263|26337654|P2|Overall Study|Adverse Event|3
7573133|NCT02213263|26337655|P1|Overall Study|Adverse Event|1
7573134|NCT02213263|26337654|P2|Overall Study|Protocol Violation|1
7573135|NCT02213263|26337655|P1|Overall Study|Protocol Violation|0
7573136|NCT02213263|26337654|P2|Overall Study|Progressive disease|14
7573137|NCT02213263|26337655|P1|Overall Study|Progressive disease|20
7573138|NCT02213263|26337654|P2|Overall Study|No longer willing to participate|4
7573139|NCT02213263|26337655|P1|Overall Study|No longer willing to participate|3
7573140|NCT02213263|26337654|P2|Overall Study|Lost to Follow-up|1
7573141|NCT02213263|26337655|P1|Overall Study|Lost to Follow-up|0
7573142|NCT02213263|26337654|P2|Overall Study|Insufficient clinical response|3
7573143|NCT02213263|26337655|P1|Overall Study|Insufficient clinical response|4
7573144|NCT02213198|26337723|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
7573145|NCT02213198|26337724|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
7573146|NCT02213198|26337723|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
7573147|NCT02213198|26337724|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
7573148|NCT02213198|26337723|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
7573149|NCT02213198|26337724|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
7573150|NCT02213198|26337723|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
7573151|NCT02213198|26337724|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
7573152|NCT02213198|26337723|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
7573153|NCT02213198|26337724|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
7573154|NCT02213198|26337723|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7573155|NCT02213198|26337724|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7573156|NCT02213198|26337723|P2|Baseline|incarcerated,violent|1
7573157|NCT02213198|26337724|P1|Baseline|incarcerated,violent|0
7573158|NCT02213198|26337723|P2|Baseline|Lost to Follow-up|21
7573159|NCT02213198|26337724|P1|Baseline|Lost to Follow-up|40
7573160|NCT02213198|26337723|P2|Baseline|transferred out of clinic|9
7573161|NCT02213198|26337724|P1|Baseline|transferred out of clinic|7
7573162|NCT02213198|26337723|P2|Baseline|Withdrawal by Subject|11
7573163|NCT02213198|26337724|P1|Baseline|Withdrawal by Subject|34
7573164|NCT02213198|26337723|P2|Baseline|No show for intake|9
7573165|NCT02213198|26337724|P1|Baseline|No show for intake|7
7573166|NCT02213133|26337735|P3|Overall Study|Other|0
7573167|NCT02213133|26337736|P2|Overall Study|Other|0
7573168|NCT02213133|26337737|P1|Overall Study|Other|5
7573169|NCT02213133|26337735|P3|Overall Study|Death|1
7573170|NCT02213133|26337736|P2|Overall Study|Death|2
7573171|NCT02213133|26337737|P1|Overall Study|Death|16
7573172|NCT02213133|26337735|P3|Overall Study|Adverse Event (AE)|0
7573173|NCT02213133|26337736|P2|Overall Study|Adverse Event (AE)|0
7573174|NCT02213133|26337737|P1|Overall Study|Adverse Event (AE)|1
7573175|NCT02213133|26337735|P3|Overall Study|Disease progression|0
7573176|NCT02213133|26337736|P2|Overall Study|Disease progression|2
7573177|NCT02213133|26337737|P1|Overall Study|Disease progression|11
7573178|NCT02213133|26337735|P3|Overall Study|Participant withdrew informed consent|2
7573179|NCT02213133|26337736|P2|Overall Study|Participant withdrew informed consent|1
7573180|NCT02213133|26337737|P1|Overall Study|Participant withdrew informed consent|2
7573181|NCT02213133|26337735|P3|Overall Study|Participant discontinued study therapy|0
7573182|NCT02213133|26337736|P2|Overall Study|Participant discontinued study therapy|0
7573183|NCT02213133|26337737|P1|Overall Study|Participant discontinued study therapy|2
7573184|NCT02213094|26337753|P2|Overall Study|Adverse Event|0
7573185|NCT02213094|26337754|P1|Overall Study|Adverse Event|1
7573186|NCT02213055|26337784|P2|Overall Study|Did not Return to School|0
7573187|NCT02213055|26337785|P1|Overall Study|Did not Return to School|5
7573188|NCT02213055|26337784|P2|Overall Study|Did not meet Inclusion Criteria|0
7573189|NCT02213055|26337785|P1|Overall Study|Did not meet Inclusion Criteria|6
7573190|NCT02213055|26337784|P2|Overall Study|Had another Treatment during the Study|0
7573191|NCT02213055|26337785|P1|Overall Study|Had another Treatment during the Study|3
7573192|NCT02213055|26337784|P2|Overall Study|Did not have Live Lice|0
7573193|NCT02213055|26337785|P1|Overall Study|Did not have Live Lice|8
7573194|NCT02213055|26337784|P2|Overall Study|Documentation Issue during Study|0
7573195|NCT02213055|26337785|P1|Overall Study|Documentation Issue during Study|10
7573196|NCT02213055|26337784|P2|Overall Study|Documentation Issue at Enrollment|0
7573197|NCT02213055|26337785|P1|Overall Study|Documentation Issue at Enrollment|1
7573198|NCT02213055|26337784|P2|Overall Study|Protocol was not Followed during Study|0
7573199|NCT02213055|26337785|P1|Overall Study|Protocol was not Followed during Study|1
7573200|NCT02213055|26337784|P2|Overall Study|Protocol was not Followed at Enrollment|0
7573201|NCT02213055|26337785|P1|Overall Study|Protocol was not Followed at Enrollment|5
7573202|NCT02213042|26337794|P3|Overall Study|Investigator discretion|1
7573203|NCT02213042|26337795|P2|Overall Study|Investigator discretion|0
7573204|NCT02213042|26337796|P1|Overall Study|Investigator discretion|0
7573205|NCT02213042|26337794|P3|Overall Study|Protocol Violation|0
7573206|NCT02213042|26337795|P2|Overall Study|Protocol Violation|0
7573207|NCT02213042|26337796|P1|Overall Study|Protocol Violation|1
7573208|NCT02213042|26337794|P3|Overall Study|Withdrawal by Subject|1
7573209|NCT02213042|26337795|P2|Overall Study|Withdrawal by Subject|1
7573210|NCT02213042|26337796|P1|Overall Study|Withdrawal by Subject|0
7573211|NCT02213042|26337794|P3|Overall Study|Adverse Event|0
7573212|NCT02213042|26337795|P2|Overall Study|Adverse Event|1
7573213|NCT02213042|26337796|P1|Overall Study|Adverse Event|2
7573214|NCT02213042|26337794|P3|Overall Study|Disease progression (incl. death due to disease progression)|8
7573215|NCT02213042|26337795|P2|Overall Study|Disease progression (incl. death due to disease progression)|13
7573216|NCT02213042|26337796|P1|Overall Study|Disease progression (incl. death due to disease progression)|14
7573217|NCT02212730|26337847|P2|Overall Study|Disease progression prior to RCC surgery|1
7573218|NCT02212730|26337848|P1|Overall Study|Disease progression prior to RCC surgery|0
7573219|NCT02212730|26337847|P2|Overall Study|Withdrawal by Subject|0
7573220|NCT02212730|26337848|P1|Overall Study|Withdrawal by Subject|1
7573221|NCT02212730|26337847|P2|Overall Study|Tumor not of the required cell histology|0
7573222|NCT02212730|26337848|P1|Overall Study|Tumor not of the required cell histology|1
7573223|NCT02212678|26337870|P1|Overall Study|Adverse Event|1
7573224|NCT02212457|26337890|P6|Overall Study|Other|1
7573225|NCT02212457|26337891|P5|Overall Study|Other|0
7573226|NCT02212457|26337892|P4|Overall Study|Other|1
7573227|NCT02212457|26337893|P3|Overall Study|Other|2
7573228|NCT02212457|26337894|P2|Overall Study|Other|1
7573229|NCT02212457|26337895|P1|Overall Study|Other|2
7573230|NCT02212457|26337890|P6|Overall Study|Protocol Violation|3
7573231|NCT02212457|26337891|P5|Overall Study|Protocol Violation|2
7573232|NCT02212457|26337892|P4|Overall Study|Protocol Violation|1
7573233|NCT02212457|26337893|P3|Overall Study|Protocol Violation|0
7573234|NCT02212457|26337894|P2|Overall Study|Protocol Violation|1
7573235|NCT02212457|26337895|P1|Overall Study|Protocol Violation|2
7573236|NCT02212457|26337890|P6|Overall Study|Lost to Follow-up|4
7573237|NCT02212457|26337891|P5|Overall Study|Lost to Follow-up|8
7573238|NCT02212457|26337892|P4|Overall Study|Lost to Follow-up|1
7573239|NCT02212457|26337893|P3|Overall Study|Lost to Follow-up|4
7573240|NCT02212457|26337894|P2|Overall Study|Lost to Follow-up|7
7573241|NCT02212457|26337895|P1|Overall Study|Lost to Follow-up|6
7573242|NCT02212457|26337890|P6|Overall Study|Withdrawal by Subject|4
7573243|NCT02212457|26337891|P5|Overall Study|Withdrawal by Subject|5
7573244|NCT02212457|26337892|P4|Overall Study|Withdrawal by Subject|6
7573245|NCT02212457|26337893|P3|Overall Study|Withdrawal by Subject|8
7573246|NCT02212457|26337894|P2|Overall Study|Withdrawal by Subject|10
7573247|NCT02212457|26337895|P1|Overall Study|Withdrawal by Subject|8
7573248|NCT02212457|26337890|P6|Overall Study|Adverse Event|1
7573249|NCT02212457|26337891|P5|Overall Study|Adverse Event|0
7573250|NCT02212457|26337892|P4|Overall Study|Adverse Event|2
7573251|NCT02212457|26337893|P3|Overall Study|Adverse Event|2
7573252|NCT02212457|26337894|P2|Overall Study|Adverse Event|2
7573253|NCT02212457|26337895|P1|Overall Study|Adverse Event|1
7573254|NCT02212379|26338019|P1|From Week 48 to Week 96|Withdrawal by Subject|2
7573255|NCT02212379|26338019|P1|From Week 48 to Week 96|Adverse Event|1
7573256|NCT02212379|26338019|P1|From Week 48 to Week 96|Lack of Efficacy|1
7573257|NCT02212379|26338019|P1|From Baseline to Week 48|Withdrawal by Subject|1
7573258|NCT02212379|26338019|P1|From Baseline to Week 48|Adverse Event|7
7573259|NCT02212379|26338019|P1|From Baseline to Week 48|Lack of Efficacy|1
7573260|NCT02212301|26338050|P2|Period 1|Lost to Follow-up|1
7573261|NCT02212301|26338051|P1|Period 1|Lost to Follow-up|0
7573262|NCT02212197|26338062|P3|Overall Study|Need for radiotherapy|0
7573263|NCT02212197|26338063|P2|Overall Study|Need for radiotherapy|0
7573264|NCT02212197|26338064|P1|Overall Study|Need for radiotherapy|1
7573265|NCT02211638|26338117|P1|Overall Study|Protocol Violation|692
7573266|NCT02211638|26338117|P1|Overall Study|Case Report Forms Uncollected|291
7573267|NCT02211313|26338168|P2|Overall Study|No Follow up Questionnaires|1
7573268|NCT02211313|26338169|P1|Overall Study|No Follow up Questionnaires|1
7573269|NCT02211313|26338168|P2|Overall Study|Treatment Failure|2
7573270|NCT02211313|26338169|P1|Overall Study|Treatment Failure|5
7573271|NCT02211261|26338186|P11|Overall Study|Lost to Follow-up|0
7573272|NCT02211261|26338187|P10|Overall Study|Lost to Follow-up|0
7573273|NCT02211261|26338188|P9|Overall Study|Lost to Follow-up|0
7573274|NCT02211261|26338189|P8|Overall Study|Lost to Follow-up|1
7573275|NCT02211261|26338190|P7|Overall Study|Lost to Follow-up|0
7573276|NCT02211261|26338191|P6|Overall Study|Lost to Follow-up|0
7573277|NCT02211261|26338192|P5|Overall Study|Lost to Follow-up|0
7573278|NCT02211261|26338193|P4|Overall Study|Lost to Follow-up|0
7573279|NCT02211261|26338194|P3|Overall Study|Lost to Follow-up|0
7573280|NCT02211261|26338195|P2|Overall Study|Lost to Follow-up|0
7573281|NCT02211261|26338196|P1|Overall Study|Lost to Follow-up|0
7573282|NCT02211261|26338186|P11|Overall Study|Other|0
7573283|NCT02211261|26338187|P10|Overall Study|Other|2
7573284|NCT02211261|26338188|P9|Overall Study|Other|0
7573285|NCT02211261|26338189|P8|Overall Study|Other|0
7573286|NCT02211261|26338190|P7|Overall Study|Other|0
7573287|NCT02211261|26338191|P6|Overall Study|Other|1
7573288|NCT02211261|26338192|P5|Overall Study|Other|0
7573289|NCT02211261|26338193|P4|Overall Study|Other|0
7573290|NCT02211261|26338194|P3|Overall Study|Other|0
7573291|NCT02211261|26338195|P2|Overall Study|Other|0
7573292|NCT02211261|26338196|P1|Overall Study|Other|0
7573293|NCT02211261|26338186|P11|Overall Study|Withdrawal by Subject|0
7573294|NCT02211261|26338187|P10|Overall Study|Withdrawal by Subject|0
7573295|NCT02211261|26338188|P9|Overall Study|Withdrawal by Subject|0
7573296|NCT02211261|26338189|P8|Overall Study|Withdrawal by Subject|0
7573297|NCT02211261|26338190|P7|Overall Study|Withdrawal by Subject|0
7573298|NCT02211261|26338191|P6|Overall Study|Withdrawal by Subject|0
7573299|NCT02211261|26338192|P5|Overall Study|Withdrawal by Subject|2
7573300|NCT02211261|26338193|P4|Overall Study|Withdrawal by Subject|0
7573301|NCT02211261|26338194|P3|Overall Study|Withdrawal by Subject|1
7573302|NCT02211261|26338195|P2|Overall Study|Withdrawal by Subject|0
7573303|NCT02211261|26338196|P1|Overall Study|Withdrawal by Subject|0
7573304|NCT02211131|26338319|P2|Overall Study|Continuing on Study|60
7573305|NCT02211131|26338320|P1|Overall Study|Continuing on Study|49
7573306|NCT02211131|26338319|P2|Overall Study|Withdrawal by Subject|4
7573307|NCT02211131|26338320|P1|Overall Study|Withdrawal by Subject|3
7573308|NCT02211131|26338319|P2|Overall Study|Decision by Sponsor|1
7573309|NCT02211131|26338320|P1|Overall Study|Decision by Sponsor|1
7573310|NCT02211131|26338319|P2|Overall Study|Lost to Follow-up|0
7573311|NCT02211131|26338320|P1|Overall Study|Lost to Follow-up|1
7573312|NCT02211131|26338319|P2|Overall Study|Death|11
7573313|NCT02211131|26338320|P1|Overall Study|Death|20
7573314|NCT02211014|26338354|P2|Overall Study|In agreement with patient, no benefit|1
7573315|NCT02211014|26338355|P1|Overall Study|In agreement with patient, no benefit|0
7573316|NCT02211014|26338354|P2|Overall Study|Withdrawal by Subject|1
7573317|NCT02211014|26338355|P1|Overall Study|Withdrawal by Subject|0
7573318|NCT02211014|26338354|P2|Overall Study|Started another cancer therapy|0
7573319|NCT02211014|26338355|P1|Overall Study|Started another cancer therapy|1
7573320|NCT02211014|26338354|P2|Overall Study|Physician Decision|2
7573321|NCT02211014|26338355|P1|Overall Study|Physician Decision|1
7573322|NCT02211014|26338354|P2|Overall Study|Adverse Event|2
7573323|NCT02211014|26338355|P1|Overall Study|Adverse Event|0
7573324|NCT02210780|26338381|P2|Overall Study|Other than specified above|1
7573325|NCT02210780|26338382|P1|Overall Study|Other than specified above|0
7573326|NCT02210780|26338381|P2|Overall Study|Protocol Violation|0
7573327|NCT02210780|26338382|P1|Overall Study|Protocol Violation|1
7573328|NCT02210780|26338381|P2|Overall Study|Physician Decision|0
7573329|NCT02210780|26338382|P1|Overall Study|Physician Decision|1
7573330|NCT02210780|26338381|P2|Overall Study|Withdrawal by Subject|1
7573331|NCT02210780|26338382|P1|Overall Study|Withdrawal by Subject|1
7573332|NCT02210780|26338381|P2|Overall Study|Lost to Follow-up|1
7573333|NCT02210780|26338382|P1|Overall Study|Lost to Follow-up|2
7573334|NCT02210780|26338381|P2|Overall Study|Adverse Event|5
7573335|NCT02210780|26338382|P1|Overall Study|Adverse Event|0
7573336|NCT02210689|26338411|P3|Overall Study|Other|8
7573337|NCT02210689|26338412|P2|Overall Study|Other|21
7573338|NCT02210689|26338413|P1|Overall Study|Other|25
7573339|NCT02210689|26338411|P3|Overall Study|Negative Nugent score at baseline|2
7573340|NCT02210689|26338412|P2|Overall Study|Negative Nugent score at baseline|2
7573341|NCT02210689|26338413|P1|Overall Study|Negative Nugent score at baseline|6
7573342|NCT02210689|26338411|P3|Overall Study|Prohibited medication|1
7573343|NCT02210689|26338412|P2|Overall Study|Prohibited medication|8
7573344|NCT02210689|26338413|P1|Overall Study|Prohibited medication|2
7573345|NCT02210689|26338411|P3|Overall Study|Lack of Efficacy|5
7573346|NCT02210689|26338412|P2|Overall Study|Lack of Efficacy|1
7573347|NCT02210689|26338413|P1|Overall Study|Lack of Efficacy|0
7573348|NCT02210689|26338411|P3|Overall Study|Pregnancy|0
7573349|NCT02210689|26338412|P2|Overall Study|Pregnancy|1
7573350|NCT02210689|26338413|P1|Overall Study|Pregnancy|0
7573351|NCT02210689|26338411|P3|Overall Study|Lost to Follow-up|5
7573352|NCT02210689|26338412|P2|Overall Study|Lost to Follow-up|9
7573353|NCT02210689|26338413|P1|Overall Study|Lost to Follow-up|11
7573354|NCT02210689|26338411|P3|Overall Study|Protocol Violation|0
7573355|NCT02210689|26338412|P2|Overall Study|Protocol Violation|0
7573356|NCT02210689|26338413|P1|Overall Study|Protocol Violation|1
7573357|NCT02210689|26338411|P3|Overall Study|Adverse Event|0
7573358|NCT02210689|26338412|P2|Overall Study|Adverse Event|1
7573359|NCT02210689|26338413|P1|Overall Study|Adverse Event|0
7573360|NCT02210689|26338411|P3|Overall Study|Withdrawal by Subject|2
7573361|NCT02210689|26338412|P2|Overall Study|Withdrawal by Subject|4
7573362|NCT02210689|26338413|P1|Overall Study|Withdrawal by Subject|7
7573363|NCT02210221|26338470|P1|Overall Study|Withdrawal by Subject|43
7573364|NCT02210221|26338470|P1|Overall Study|Lack of Efficacy|7
7573365|NCT02210208|26338485|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
7573366|NCT02210208|26338485|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
7573367|NCT02210208|26338485|P1|Period A (Graft Site)|Withdrawal by Subject|1
7573368|NCT02210091|26338505|P2|Overall Study|Withdrawal by Sponsor|1
7573369|NCT02210091|26338506|P1|Overall Study|Withdrawal by Sponsor|0
7573370|NCT02210091|26338505|P2|Overall Study|Physician Decision|1
7573371|NCT02210091|26338506|P1|Overall Study|Physician Decision|0
7573372|NCT02210000|26338593|P2|Overall Study|Physician Decision|1
7573373|NCT02210000|26338594|P1|Overall Study|Physician Decision|0
7573374|NCT02210000|26338593|P2|Overall Study|Lost to Follow-up|2
7573375|NCT02210000|26338594|P1|Overall Study|Lost to Follow-up|0
7573376|NCT02210000|26338593|P2|Overall Study|Adverse Event|5
7573377|NCT02210000|26338594|P1|Overall Study|Adverse Event|1
7573378|NCT02210000|26338593|P2|Overall Study|Withdrawal by Subject|1
7573379|NCT02210000|26338594|P1|Overall Study|Withdrawal by Subject|7
7573380|NCT02210000|26338593|P2|Overall Study|Study Terminated|12
7573381|NCT02210000|26338594|P1|Overall Study|Study Terminated|11
7573382|NCT02209766|26338641|P5|Overall Study|Withdrawal by Subject|0
7573383|NCT02209766|26338642|P4|Overall Study|Withdrawal by Subject|1
7573384|NCT02209766|26338643|P3|Overall Study|Withdrawal by Subject|0
7573385|NCT02209766|26338644|P2|Overall Study|Withdrawal by Subject|0
7573386|NCT02209766|26338645|P1|Overall Study|Withdrawal by Subject|0
7573387|NCT02209597|26338704|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
7573388|NCT02209597|26338704|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
7573389|NCT02209597|26338704|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
7573390|NCT02209597|26338704|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
7573391|NCT02209506|26338749|P5|Overall Study|Withdrawal by Subject|1
7573392|NCT02209506|26338750|P4|Overall Study|Withdrawal by Subject|0
7573393|NCT02209506|26338751|P3|Overall Study|Withdrawal by Subject|0
7573394|NCT02209506|26338752|P2|Overall Study|Withdrawal by Subject|0
7573395|NCT02209506|26338753|P1|Overall Study|Withdrawal by Subject|0
7573396|NCT02209454|26338828|P2|Second Period|Adverse Event|0
7573397|NCT02209454|26338829|P1|Second Period|Adverse Event|1
7573398|NCT02209181|26338879|P4|Overall Study|Withdrawal by Subject|0
7573399|NCT02209181|26338880|P3|Overall Study|Withdrawal by Subject|0
7573400|NCT02209181|26338881|P2|Overall Study|Withdrawal by Subject|1
7573401|NCT02209181|26338882|P1|Overall Study|Withdrawal by Subject|0
7573402|NCT02209181|26338879|P4|Overall Study|Adverse Event|0
7573403|NCT02209181|26338880|P3|Overall Study|Adverse Event|1
7573404|NCT02209181|26338881|P2|Overall Study|Adverse Event|0
7573405|NCT02209181|26338882|P1|Overall Study|Adverse Event|1
7573406|NCT02208999|26339053|P1|Overall Study|Lost to Follow-up|1
7573407|NCT02208843|26339075|P1|Overall Study|Switched to commercial afatinib|20
7573408|NCT02208843|26339075|P1|Overall Study|Withdrawal by Subject|1
7573409|NCT02208843|26339075|P1|Overall Study|Protocol Violation|1
7573410|NCT02208843|26339075|P1|Overall Study|Adverse Event|12
7573411|NCT02208843|26339075|P1|Overall Study|Progression disease according to RECIST|24
7573412|NCT02208843|26339075|P1|Overall Study|Clinical symptoms of progression|2
7573413|NCT02208089|26339165|P2|Overall Study|Lost to Follow-up|0
7573414|NCT02208089|26339166|P1|Overall Study|Lost to Follow-up|6
7573415|NCT02208089|26339165|P2|Overall Study|Withdrawal by Subject|0
7573416|NCT02208089|26339166|P1|Overall Study|Withdrawal by Subject|1
7573417|NCT02208063|26339182|P2|Overall Study|Lost to Follow-up|0
7573418|NCT02208063|26339183|P1|Overall Study|Lost to Follow-up|1
7573419|NCT02208063|26339182|P2|Overall Study|Withdrawal by Subject|2
7573420|NCT02208063|26339183|P1|Overall Study|Withdrawal by Subject|5
7573421|NCT02208063|26339182|P2|Overall Study|Not Specified in report|4
7573422|NCT02208063|26339183|P1|Overall Study|Not Specified in report|3
7573423|NCT02208063|26339182|P2|Overall Study|Death|5
7573424|NCT02208063|26339183|P1|Overall Study|Death|3
7573425|NCT02208050|26339197|P2|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
7573426|NCT02208050|26339198|P1|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
7573427|NCT02207946|26339285|P2|Overall Study|Adverse Event|1
7573428|NCT02207946|26339286|P1|Overall Study|Adverse Event|0
7573429|NCT02207946|26339285|P2|Overall Study|Lost to Follow-up|0
7573430|NCT02207946|26339286|P1|Overall Study|Lost to Follow-up|1
7573431|NCT02207907|26339304|P2|Overall Study|Pregnancy|1
7573432|NCT02207907|26339305|P1|Overall Study|Pregnancy|0
7573433|NCT02207907|26339304|P2|Overall Study|Did not meet study criteria|0
7573434|NCT02207907|26339305|P1|Overall Study|Did not meet study criteria|3
7573435|NCT02207907|26339304|P2|Overall Study|Withdrawal by Subject|6
7573436|NCT02207907|26339305|P1|Overall Study|Withdrawal by Subject|5
7573437|NCT02207907|26339304|P2|Overall Study|Lost to Follow-up|1
7573438|NCT02207907|26339305|P1|Overall Study|Lost to Follow-up|3
7573439|NCT02207829|26339323|P2|Overall Study|Withdrew consent|14
7573440|NCT02207829|26339324|P1|Overall Study|Withdrew consent|18
7573441|NCT02207829|26339323|P2|Overall Study|Protocol deviation|4
7573442|NCT02207829|26339324|P1|Overall Study|Protocol deviation|5
7573443|NCT02207829|26339323|P2|Overall Study|Lost to Follow-up|2
7573444|NCT02207829|26339324|P1|Overall Study|Lost to Follow-up|2
7573445|NCT02207829|26339323|P2|Overall Study|Lack of Efficacy|5
7573446|NCT02207829|26339324|P1|Overall Study|Lack of Efficacy|7
7573447|NCT02207829|26339323|P2|Overall Study|Adverse Event|9
7573448|NCT02207829|26339324|P1|Overall Study|Adverse Event|10
7573449|NCT02207816|26339333|P3|Overall Study|Other|4
7573450|NCT02207816|26339334|P2|Overall Study|Other|2
7573451|NCT02207816|26339335|P1|Overall Study|Other|1
7573452|NCT02207816|26339333|P3|Overall Study|Lost to Follow-up|1
7573453|NCT02207816|26339334|P2|Overall Study|Lost to Follow-up|9
7573454|NCT02207816|26339335|P1|Overall Study|Lost to Follow-up|3
7573455|NCT02207816|26339333|P3|Overall Study|Migrated/Moved From Study Area|51
7573456|NCT02207816|26339334|P2|Overall Study|Migrated/Moved From Study Area|60
7573457|NCT02207816|26339335|P1|Overall Study|Migrated/Moved From Study Area|41
7573458|NCT02207816|26339333|P3|Overall Study|Withdrawal by Subject|7
7573459|NCT02207816|26339334|P2|Overall Study|Withdrawal by Subject|9
7573460|NCT02207816|26339335|P1|Overall Study|Withdrawal by Subject|4
7573461|NCT02207816|26339333|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
7573462|NCT02207816|26339334|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
7573463|NCT02207816|26339335|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
7573464|NCT02207816|26339333|P3|Overall Study|Serious Adverse Event|2
7573465|NCT02207816|26339334|P2|Overall Study|Serious Adverse Event|5
7573466|NCT02207816|26339335|P1|Overall Study|Serious Adverse Event|0
7573467|NCT02207725|26339493|P4|Overall Study|Did Not Receive Treatment|1
7573468|NCT02207725|26339494|P3|Overall Study|Did Not Receive Treatment|1
7573469|NCT02207725|26339495|P2|Overall Study|Did Not Receive Treatment|1
7573470|NCT02207725|26339496|P1|Overall Study|Did Not Receive Treatment|0
7573471|NCT02207634|26339526|P2|Overall Study|Lost to Follow-up|0
7573472|NCT02207634|26339527|P1|Overall Study|Lost to Follow-up|1
7573473|NCT02207634|26339526|P2|Overall Study|Withdrawal by Subject|31
7573474|NCT02207634|26339527|P1|Overall Study|Withdrawal by Subject|21
7573475|NCT02207621|26339542|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
7573476|NCT02207621|26339543|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
7573477|NCT02207621|26339544|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
7573478|NCT02207621|26339542|P3|Overall Study|Death|0
7573479|NCT02207621|26339543|P2|Overall Study|Death|0
7573480|NCT02207621|26339544|P1|Overall Study|Death|2
7573481|NCT02207621|26339542|P3|Overall Study|Protocol Violation|6
7573482|NCT02207621|26339543|P2|Overall Study|Protocol Violation|10
7573483|NCT02207621|26339544|P1|Overall Study|Protocol Violation|4
7573484|NCT02207621|26339542|P3|Overall Study|Physician Decision|2
7573485|NCT02207621|26339543|P2|Overall Study|Physician Decision|2
7573486|NCT02207621|26339544|P1|Overall Study|Physician Decision|1
7573487|NCT02207621|26339542|P3|Overall Study|Disallowed Concurrent Medication|2
7573488|NCT02207621|26339543|P2|Overall Study|Disallowed Concurrent Medication|5
7573489|NCT02207621|26339544|P1|Overall Study|Disallowed Concurrent Medication|2
7573490|NCT02207621|26339542|P3|Overall Study|Lack of Efficacy|4
7573491|NCT02207621|26339543|P2|Overall Study|Lack of Efficacy|2
7573492|NCT02207621|26339544|P1|Overall Study|Lack of Efficacy|10
7573493|NCT02207621|26339542|P3|Overall Study|Lost to Follow-up|3
7573494|NCT02207621|26339543|P2|Overall Study|Lost to Follow-up|0
7573495|NCT02207621|26339544|P1|Overall Study|Lost to Follow-up|1
7573496|NCT02207621|26339542|P3|Overall Study|Non-Compliant|1
7573497|NCT02207621|26339543|P2|Overall Study|Non-Compliant|3
7573498|NCT02207621|26339544|P1|Overall Study|Non-Compliant|3
7573499|NCT02207621|26339542|P3|Overall Study|Withdrawal by Subject|13
7573500|NCT02207621|26339543|P2|Overall Study|Withdrawal by Subject|9
7573501|NCT02207621|26339544|P1|Overall Study|Withdrawal by Subject|9
7573502|NCT02207621|26339542|P3|Overall Study|Adverse Event|132
7573503|NCT02207621|26339543|P2|Overall Study|Adverse Event|15
7573504|NCT02207621|26339544|P1|Overall Study|Adverse Event|71
7573505|NCT02207608|26339557|P2|Overall Study|Adverse Event|0
7573506|NCT02207608|26339558|P1|Overall Study|Adverse Event|1
7573507|NCT02207556|26339584|P2|Overall Study|Death|5
7573508|NCT02207556|26339585|P1|Overall Study|Death|0
7573509|NCT02207556|26339584|P2|Overall Study|Withdrawal by Subject|0
7573510|NCT02207556|26339585|P1|Overall Study|Withdrawal by Subject|1
7573511|NCT02207556|26339584|P2|Overall Study|Physician Decision|0
7573512|NCT02207556|26339585|P1|Overall Study|Physician Decision|1
7573513|NCT02207530|26339598|P1|Overall Study|Adverse Event|8
7573514|NCT02207530|26339598|P1|Overall Study|Patient decision to stop study treatment|5
7573515|NCT02207530|26339598|P1|Overall Study|Worsening condition under investigation|78
7573516|NCT02207491|26339612|P2|Overall Study|Protocol Violation|5
7573517|NCT02207491|26339613|P1|Overall Study|Protocol Violation|3
7573518|NCT02207491|26339612|P2|Overall Study|Physician Decision|0
7573519|NCT02207491|26339613|P1|Overall Study|Physician Decision|2
7573520|NCT02207491|26339612|P2|Overall Study|Lack of Efficacy|0
7573521|NCT02207491|26339613|P1|Overall Study|Lack of Efficacy|3
7573522|NCT02207491|26339612|P2|Overall Study|Lost to Follow-up|1
7573523|NCT02207491|26339613|P1|Overall Study|Lost to Follow-up|0
7573524|NCT02207491|26339612|P2|Overall Study|Non-compliant|1
7573525|NCT02207491|26339613|P1|Overall Study|Non-compliant|0
7573526|NCT02207491|26339612|P2|Overall Study|Withdrawal by Subject|2
7573527|NCT02207491|26339613|P1|Overall Study|Withdrawal by Subject|3
7573528|NCT02207491|26339612|P2|Overall Study|Adverse Event|4
7573529|NCT02207491|26339613|P1|Overall Study|Adverse Event|20
7573530|NCT02207413|26339638|P6|Overall Study|Migrated/moved from study area|0
7573531|NCT02207413|26339639|P5|Overall Study|Migrated/moved from study area|1
7573532|NCT02207413|26339640|P4|Overall Study|Migrated/moved from study area|0
7573533|NCT02207413|26339641|P3|Overall Study|Migrated/moved from study area|0
7573534|NCT02207413|26339642|P2|Overall Study|Migrated/moved from study area|0
7573535|NCT02207413|26339643|P1|Overall Study|Migrated/moved from study area|0
7573536|NCT02207413|26339638|P6|Overall Study|Adverse Event|1
7573537|NCT02207413|26339639|P5|Overall Study|Adverse Event|2
7573538|NCT02207413|26339640|P4|Overall Study|Adverse Event|0
7573539|NCT02207413|26339641|P3|Overall Study|Adverse Event|0
7573540|NCT02207413|26339642|P2|Overall Study|Adverse Event|0
7573541|NCT02207413|26339643|P1|Overall Study|Adverse Event|0
7573542|NCT02207413|26339638|P6|Overall Study|Lost to Follow-up|5
7573543|NCT02207413|26339639|P5|Overall Study|Lost to Follow-up|1
7573544|NCT02207413|26339640|P4|Overall Study|Lost to Follow-up|1
7573545|NCT02207413|26339641|P3|Overall Study|Lost to Follow-up|0
7573546|NCT02207413|26339642|P2|Overall Study|Lost to Follow-up|0
7573547|NCT02207413|26339643|P1|Overall Study|Lost to Follow-up|0
7573548|NCT02207413|26339638|P6|Overall Study|Withdrawal by Subject|7
7573549|NCT02207413|26339639|P5|Overall Study|Withdrawal by Subject|3
7573550|NCT02207413|26339640|P4|Overall Study|Withdrawal by Subject|0
7573551|NCT02207413|26339641|P3|Overall Study|Withdrawal by Subject|0
7573552|NCT02207413|26339642|P2|Overall Study|Withdrawal by Subject|0
7573553|NCT02207413|26339643|P1|Overall Study|Withdrawal by Subject|1
7573554|NCT02207400|26339739|P2|Overall Study|Positive Urine Pregnancy Test|1
7573555|NCT02207400|26339740|P1|Overall Study|Positive Urine Pregnancy Test|0
7573556|NCT02207400|26339739|P2|Overall Study|Withdrawal by Subject|4
7573557|NCT02207400|26339740|P1|Overall Study|Withdrawal by Subject|8
7573558|NCT02207400|26339739|P2|Overall Study|Protocol Violation|1
7573559|NCT02207400|26339740|P1|Overall Study|Protocol Violation|1
7573560|NCT02207400|26339739|P2|Overall Study|Lost to Follow-up|7
7573561|NCT02207400|26339740|P1|Overall Study|Lost to Follow-up|6
7573562|NCT02207400|26339739|P2|Overall Study|Adverse Event|1
7573563|NCT02207400|26339740|P1|Overall Study|Adverse Event|1
7573564|NCT02207374|26339761|P3|Overall Study|Missing follow-up information|1
7573565|NCT02207374|26339762|P2|Overall Study|Missing follow-up information|1
7573566|NCT02207374|26339763|P1|Overall Study|Missing follow-up information|0
7573567|NCT02207374|26339761|P3|Overall Study|Death|1
7573568|NCT02207374|26339762|P2|Overall Study|Death|0
7573569|NCT02207374|26339763|P1|Overall Study|Death|1
7573570|NCT02207374|26339761|P3|Overall Study|Withdrawal by Subject|4
7573571|NCT02207374|26339762|P2|Overall Study|Withdrawal by Subject|9
7573572|NCT02207374|26339763|P1|Overall Study|Withdrawal by Subject|5
7573573|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Pregnancy|2
7573574|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573575|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573576|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573577|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573578|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573579|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573580|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573581|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573582|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573583|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Pregnancy|0
7573584|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Other|19
7573585|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Other|0
7573586|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Other|8
7573587|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Other|0
7573588|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Other|0
7573589|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Other|0
7573590|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Other|0
7573591|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Other|0
7573592|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Other|0
7573593|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Other|0
7573594|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Other|0
7573595|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Death|1
7573596|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Death|0
7573597|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Death|1
7573598|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Death|0
7573599|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Death|0
7573600|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Death|0
7573601|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Death|0
7573602|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Death|0
7573603|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Death|0
7573604|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Death|0
7573605|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Death|0
7573606|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Adverse Event|21
7573607|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573608|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Adverse Event|12
7573609|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573610|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573611|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573612|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573613|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573614|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573615|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573616|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Adverse Event|0
7573617|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
7573618|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573619|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
7573620|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573621|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573622|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573623|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573624|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573625|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573626|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573627|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7573628|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
7573629|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573630|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
7573631|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573632|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573633|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573634|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573635|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573636|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573637|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573638|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7573639|NCT02207244|26339827|P11|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
7573640|NCT02207244|26339828|P10|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573641|NCT02207244|26339829|P9|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
7573642|NCT02207244|26339830|P8|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573643|NCT02207244|26339831|P7|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573644|NCT02207244|26339832|P6|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573645|NCT02207244|26339833|P5|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573646|NCT02207244|26339834|P4|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573647|NCT02207244|26339835|P3|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573648|NCT02207244|26339836|P2|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573649|NCT02207244|26339837|P1|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7573650|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573651|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573652|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573653|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573654|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
7573655|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573656|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573657|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573658|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573659|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573660|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7573661|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Other|0
7573662|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Other|0
7573663|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Other|0
7573664|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Other|2
7573665|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Other|0
7573666|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Other|0
7573667|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Other|0
7573668|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Other|0
7573669|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Other|0
7573670|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Other|0
7573671|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Other|0
7573672|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573673|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573674|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
7573675|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573676|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573677|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573678|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573679|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573680|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573681|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573682|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7573683|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573684|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573685|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7573686|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7573687|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573688|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573689|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573690|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573691|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573692|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573693|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7573694|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573695|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7573696|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7573697|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
7573698|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7573699|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573700|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573701|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573702|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573703|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573704|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7573705|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573706|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7573707|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573708|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
7573709|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7573710|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573711|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573712|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573713|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573714|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573715|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7573716|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573717|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7573718|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7573719|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
7573720|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
7573721|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573722|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573723|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573724|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573725|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573726|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7573727|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573728|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573729|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573730|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
7573731|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573732|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573733|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573734|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573735|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573736|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573737|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7573738|NCT02207244|26339827|P11|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573739|NCT02207244|26339828|P10|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
7573740|NCT02207244|26339829|P9|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
7573741|NCT02207244|26339830|P8|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
7573742|NCT02207244|26339831|P7|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
7573743|NCT02207244|26339832|P6|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573744|NCT02207244|26339833|P5|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573745|NCT02207244|26339834|P4|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573746|NCT02207244|26339835|P3|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573747|NCT02207244|26339836|P2|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573748|NCT02207244|26339837|P1|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7573749|NCT02207244|26339827|P11|Placebo Crossover and ACP: Week 16-28|Other|0
7573750|NCT02207244|26339828|P10|Placebo Crossover and ACP: Week 16-28|Other|0
7573751|NCT02207244|26339829|P9|Placebo Crossover and ACP: Week 16-28|Other|0
7573752|NCT02207244|26339830|P8|Placebo Crossover and ACP: Week 16-28|Other|0
7573753|NCT02207244|26339831|P7|Placebo Crossover and ACP: Week 16-28|Other|0
7573754|NCT02207244|26339832|P6|Placebo Crossover and ACP: Week 16-28|Other|0
7573755|NCT02207244|26339833|P5|Placebo Crossover and ACP: Week 16-28|Other|0
7573756|NCT02207244|26339834|P4|Placebo Crossover and ACP: Week 16-28|Other|1
7573757|NCT02207244|26339835|P3|Placebo Crossover and ACP: Week 16-28|Other|0
7573758|NCT02207244|26339836|P2|Placebo Crossover and ACP: Week 16-28|Other|0
7573759|NCT02207244|26339837|P1|Placebo Crossover and ACP: Week 16-28|Other|0
7573760|NCT02207244|26339827|P11|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573761|NCT02207244|26339828|P10|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573762|NCT02207244|26339829|P9|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573763|NCT02207244|26339830|P8|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573764|NCT02207244|26339831|P7|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573765|NCT02207244|26339832|P6|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7573766|NCT02207244|26339833|P5|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573767|NCT02207244|26339834|P4|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7573768|NCT02207244|26339835|P3|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573769|NCT02207244|26339836|P2|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573770|NCT02207244|26339837|P1|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7573771|NCT02207244|26339827|P11|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573772|NCT02207244|26339828|P10|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573773|NCT02207244|26339829|P9|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573774|NCT02207244|26339830|P8|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573775|NCT02207244|26339831|P7|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573776|NCT02207244|26339832|P6|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
7573777|NCT02207244|26339833|P5|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7573778|NCT02207244|26339834|P4|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7573779|NCT02207244|26339835|P3|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573780|NCT02207244|26339836|P2|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573781|NCT02207244|26339837|P1|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7573782|NCT02207244|26339827|P11|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573783|NCT02207244|26339828|P10|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573784|NCT02207244|26339829|P9|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573785|NCT02207244|26339830|P8|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573786|NCT02207244|26339831|P7|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573787|NCT02207244|26339832|P6|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7573788|NCT02207244|26339833|P5|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7573789|NCT02207244|26339834|P4|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
7573790|NCT02207244|26339835|P3|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573791|NCT02207244|26339836|P2|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573792|NCT02207244|26339837|P1|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7573793|NCT02207244|26339827|P11|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573794|NCT02207244|26339828|P10|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573795|NCT02207244|26339829|P9|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573796|NCT02207244|26339830|P8|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573797|NCT02207244|26339831|P7|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573798|NCT02207244|26339832|P6|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
7573799|NCT02207244|26339833|P5|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573800|NCT02207244|26339834|P4|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573801|NCT02207244|26339835|P3|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573802|NCT02207244|26339836|P2|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573803|NCT02207244|26339837|P1|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7573804|NCT02207244|26339827|P11|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573805|NCT02207244|26339828|P10|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573806|NCT02207244|26339829|P9|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573807|NCT02207244|26339830|P8|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573808|NCT02207244|26339831|P7|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573809|NCT02207244|26339832|P6|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
7573810|NCT02207244|26339833|P5|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
7573811|NCT02207244|26339834|P4|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573812|NCT02207244|26339835|P3|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573813|NCT02207244|26339836|P2|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573814|NCT02207244|26339837|P1|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7573815|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|OTHER|0
7573816|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|OTHER|0
7573817|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|OTHER|0
7573818|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|OTHER|0
7573819|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|OTHER|0
7573820|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|OTHER|0
7573821|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|OTHER|0
7573822|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|OTHER|0
7573823|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|OTHER|0
7573824|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|OTHER|1
7573825|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|OTHER|0
7573826|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573827|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573828|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573829|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573830|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573831|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573832|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573833|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573834|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|Noncompliance|2
7573835|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|Noncompliance|1
7573836|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|Noncompliance|0
7573837|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573838|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573839|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573840|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573841|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573842|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573843|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573844|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7573845|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7573846|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|Protocol Violation|3
7573847|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7573848|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573849|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573850|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573851|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573852|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573853|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573854|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573855|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573856|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7573857|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
7573858|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
7573859|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573860|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573861|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573862|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573863|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573864|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573865|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573866|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7573867|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
7573868|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
7573869|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
7573870|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573871|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573872|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573873|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573874|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573875|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573876|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573877|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573878|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
7573879|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7573880|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
7573881|NCT02207244|26339827|P11|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573882|NCT02207244|26339828|P10|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573883|NCT02207244|26339829|P9|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573884|NCT02207244|26339830|P8|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573885|NCT02207244|26339831|P7|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573886|NCT02207244|26339832|P6|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573887|NCT02207244|26339833|P5|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573888|NCT02207244|26339834|P4|Placebo Controlled Period: Week 0-16|Adverse Event|0
7573889|NCT02207244|26339835|P3|Placebo Controlled Period: Week 0-16|Adverse Event|4
7573890|NCT02207244|26339836|P2|Placebo Controlled Period: Week 0-16|Adverse Event|9
7573891|NCT02207244|26339837|P1|Placebo Controlled Period: Week 0-16|Adverse Event|2
7573892|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Other|11
7573893|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Other|4
7573894|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Other|0
7573895|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Other|0
7573896|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
7573897|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
7573898|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7573899|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7573900|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
7573901|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
7573902|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7573903|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7573904|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
7573905|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
7573906|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7573907|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7573908|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
7573909|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
7573910|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7573911|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7573912|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Death|3
7573913|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Death|1
7573914|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Death|0
7573915|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Death|0
7573916|NCT02207231|26339892|P4|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
7573917|NCT02207231|26339893|P3|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
7573918|NCT02207231|26339894|P2|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7573919|NCT02207231|26339895|P1|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7573920|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Other|0
7573921|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Other|3
7573922|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Other|2
7573923|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Other|0
7573924|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Noncompliance|0
7573925|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Noncompliance|3
7573926|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Noncompliance|3
7573927|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Noncompliance|0
7573928|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7573929|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7573930|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
7573931|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7573932|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
7573933|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
7573934|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
7573935|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
7573936|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
7573937|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
7573938|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
7573939|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
7573940|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7573941|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
7573942|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
7573943|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7573944|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Pregnancy|0
7573945|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
7573946|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
7573947|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
7573948|NCT02207231|26339892|P4|Active Controlled Period: Week 16 - 48|Adverse Event|0
7573949|NCT02207231|26339893|P3|Active Controlled Period: Week 16 - 48|Adverse Event|10
7573950|NCT02207231|26339894|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
7573951|NCT02207231|26339895|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
7573952|NCT02207231|26339892|P4|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7573953|NCT02207231|26339893|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
7573954|NCT02207231|26339894|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
7573955|NCT02207231|26339895|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7573956|NCT02207231|26339892|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7573957|NCT02207231|26339893|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
7573958|NCT02207231|26339894|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7573959|NCT02207231|26339895|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7573960|NCT02207231|26339892|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7573961|NCT02207231|26339893|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
7573962|NCT02207231|26339894|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7573963|NCT02207231|26339895|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
7573964|NCT02207231|26339892|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
7573965|NCT02207231|26339893|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7573966|NCT02207231|26339894|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7573967|NCT02207231|26339895|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7573968|NCT02207231|26339892|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7573969|NCT02207231|26339893|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
7573970|NCT02207231|26339894|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7573971|NCT02207231|26339895|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
7573972|NCT02207231|26339892|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
7573973|NCT02207231|26339893|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7573974|NCT02207231|26339894|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
7573975|NCT02207231|26339895|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7573976|NCT02207088|26339941|P1|Overall Study|Adverse Event|2
7573977|NCT02206828|26339947|P1|Overall Study|Lost to Follow-up|7
7573978|NCT02206685|26339985|P2|Overall Study|Protocol Violation|2
7573979|NCT02206685|26339986|P1|Overall Study|Protocol Violation|2
7573980|NCT02206685|26339985|P2|Overall Study|Withdrawal by Subject|2
7573981|NCT02206685|26339986|P1|Overall Study|Withdrawal by Subject|1
7573982|NCT02206685|26339985|P2|Overall Study|Surgery cancelled/changed|3
7573983|NCT02206685|26339986|P1|Overall Study|Surgery cancelled/changed|2
7573984|NCT02206620|26339994|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
7573985|NCT02206620|26339995|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
7573986|NCT02206620|26339994|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7573987|NCT02206620|26339995|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7573988|NCT02206607|26340011|P5|Second Intervention Period|Insufficient Clinical Response|0
7573989|NCT02206607|26340012|P4|Second Intervention Period|Insufficient Clinical Response|1
7573990|NCT02206607|26340013|P3|Second Intervention Period|Insufficient Clinical Response|0
7573991|NCT02206607|26340014|P2|Second Intervention Period|Insufficient Clinical Response|0
7573992|NCT02206607|26340015|P1|Second Intervention Period|Insufficient Clinical Response|0
7573993|NCT02206607|26340011|P5|Open-Label Run-In|Withdrawal by Subject|0
7573994|NCT02206607|26340012|P4|Open-Label Run-In|Withdrawal by Subject|0
7573995|NCT02206607|26340013|P3|Open-Label Run-In|Withdrawal by Subject|0
7573996|NCT02206607|26340014|P2|Open-Label Run-In|Withdrawal by Subject|0
7573997|NCT02206607|26340015|P1|Open-Label Run-In|Withdrawal by Subject|3
7573998|NCT02206152|26340078|P1|Pre-Randomization|Withdrawal by Subject|2
7573999|NCT02206061|26340087|P3|Overall Study|Lost to Follow-up|20
7574000|NCT02206061|26340088|P2|Overall Study|Lost to Follow-up|7
7574001|NCT02206061|26340089|P1|Overall Study|Lost to Follow-up|14
7574002|NCT02206061|26340087|P3|Overall Study|Withdrawal by Subject|1
7574003|NCT02206061|26340088|P2|Overall Study|Withdrawal by Subject|7
7574004|NCT02206061|26340089|P1|Overall Study|Withdrawal by Subject|4
7574005|NCT02205814|26340118|P4|Overall Study|not compliant with study procedures|0
7574006|NCT02205814|26340119|P3|Overall Study|not compliant with study procedures|1
7574007|NCT02205814|26340120|P2|Overall Study|not compliant with study procedures|0
7574008|NCT02205814|26340121|P1|Overall Study|not compliant with study procedures|0
7574009|NCT02205814|26340118|P4|Overall Study|Withdrawal by Subject|1
7574010|NCT02205814|26340119|P3|Overall Study|Withdrawal by Subject|2
7574011|NCT02205814|26340120|P2|Overall Study|Withdrawal by Subject|1
7574012|NCT02205814|26340121|P1|Overall Study|Withdrawal by Subject|0
7574013|NCT02205814|26340118|P4|Overall Study|Protocol Violation|1
7574014|NCT02205814|26340119|P3|Overall Study|Protocol Violation|0
7574015|NCT02205814|26340120|P2|Overall Study|Protocol Violation|0
7574016|NCT02205814|26340121|P1|Overall Study|Protocol Violation|1
7574017|NCT02205814|26340118|P4|Overall Study|Physician Decision|0
7574018|NCT02205814|26340119|P3|Overall Study|Physician Decision|1
7574019|NCT02205814|26340120|P2|Overall Study|Physician Decision|0
7574020|NCT02205814|26340121|P1|Overall Study|Physician Decision|0
7574021|NCT02205814|26340118|P4|Overall Study|Lack of Efficacy|1
7574022|NCT02205814|26340119|P3|Overall Study|Lack of Efficacy|1
7574023|NCT02205814|26340120|P2|Overall Study|Lack of Efficacy|0
7574024|NCT02205814|26340121|P1|Overall Study|Lack of Efficacy|1
7574025|NCT02205814|26340118|P4|Overall Study|Lost to Follow-up|1
7574026|NCT02205814|26340119|P3|Overall Study|Lost to Follow-up|0
7574027|NCT02205814|26340120|P2|Overall Study|Lost to Follow-up|0
7574028|NCT02205814|26340121|P1|Overall Study|Lost to Follow-up|0
7574029|NCT02205476|26340174|P2|Overall Study|Study termination by Sponsor|3
7574030|NCT02205476|26340175|P1|Overall Study|Study termination by Sponsor|7
7574031|NCT02205333|26340214|P9|Overall Study|Withdrawal by Subject|0
7574032|NCT02205333|26340215|P8|Overall Study|Withdrawal by Subject|0
7574033|NCT02205333|26340216|P7|Overall Study|Withdrawal by Subject|2
7574034|NCT02205333|26340217|P6|Overall Study|Withdrawal by Subject|0
7574035|NCT02205333|26340218|P5|Overall Study|Withdrawal by Subject|0
7574036|NCT02205333|26340219|P4|Overall Study|Withdrawal by Subject|1
7574037|NCT02205333|26340220|P3|Overall Study|Withdrawal by Subject|0
7574038|NCT02205333|26340221|P2|Overall Study|Withdrawal by Subject|0
7574039|NCT02205333|26340222|P1|Overall Study|Withdrawal by Subject|1
7574040|NCT02205333|26340214|P9|Overall Study|Death|0
7574041|NCT02205333|26340215|P8|Overall Study|Death|2
7574042|NCT02205333|26340216|P7|Overall Study|Death|3
7574043|NCT02205333|26340217|P6|Overall Study|Death|3
7574044|NCT02205333|26340218|P5|Overall Study|Death|5
7574045|NCT02205333|26340219|P4|Overall Study|Death|6
7574046|NCT02205333|26340220|P3|Overall Study|Death|2
7574047|NCT02205333|26340221|P2|Overall Study|Death|6
7574048|NCT02205333|26340222|P1|Overall Study|Death|5
7574049|NCT02204982|26340421|P2|Overall Study|Termination of Study bySponsor|1
7574050|NCT02204982|26340422|P1|Overall Study|Termination of Study bySponsor|0
7574051|NCT02204982|26340421|P2|Overall Study|Protocol-Specified Disease Progression|4
7574052|NCT02204982|26340422|P1|Overall Study|Protocol-Specified Disease Progression|0
7574053|NCT02204982|26340421|P2|Overall Study|Physician Decision|2
7574054|NCT02204982|26340422|P1|Overall Study|Physician Decision|0
7574055|NCT02204982|26340421|P2|Overall Study|Adverse Event and Investigator decision|0
7574056|NCT02204982|26340422|P1|Overall Study|Adverse Event and Investigator decision|1
7574057|NCT02204982|26340421|P2|Overall Study|Adverse Event|0
7574058|NCT02204982|26340422|P1|Overall Study|Adverse Event|1
7574059|NCT02204982|26340421|P2|Overall Study|Withdrawal by Subject|0
7574060|NCT02204982|26340422|P1|Overall Study|Withdrawal by Subject|1
7574061|NCT02204982|26340421|P2|Overall Study|Patient ineligible-medical monitor|0
7574062|NCT02204982|26340422|P1|Overall Study|Patient ineligible-medical monitor|1
7574063|NCT02204917|26340430|P1|Overall Study|Protocol Violation|1
7574064|NCT02204579|26340467|P1|Overall Study|Screen failures|2
7574065|NCT02204449|26340525|P2|Overall Study|Withdrawal by Subject|1
7574066|NCT02204449|26340526|P1|Overall Study|Withdrawal by Subject|0
7574067|NCT02204449|26340525|P2|Overall Study|Death|1
7574068|NCT02204449|26340526|P1|Overall Study|Death|0
7574069|NCT02204449|26340525|P2|Overall Study|Lost to Follow-up|9
7574070|NCT02204449|26340526|P1|Overall Study|Lost to Follow-up|7
7574071|NCT02204410|26340536|P1|Overall Study|Withdrawal by Subject|3
7574072|NCT02204410|26340536|P1|Overall Study|Protocol Violation|1
7574073|NCT02204410|26340536|P1|Overall Study|Physician Decision|2
7574074|NCT02204410|26340536|P1|Overall Study|Lost to Follow-up|5
7574075|NCT02204371|26340541|P1|Overall Study|Adverse Event|1
7574076|NCT02204319|26340564|P1|Overall Study|Withdrawal by Subject|2
7574077|NCT02204319|26340564|P1|Overall Study|Pregnancy|1
7574078|NCT02204293|26340572|P6|LTE Phase|Study Suspended|7
7574079|NCT02204293|26340573|P5|LTE Phase|Study Suspended|0
7574080|NCT02204293|26340574|P4|LTE Phase|Study Suspended|0
7574081|NCT02204293|26340575|P3|LTE Phase|Study Suspended|0
7574082|NCT02204293|26340576|P2|LTE Phase|Study Suspended|0
7574083|NCT02204293|26340577|P1|LTE Phase|Study Suspended|0
7574084|NCT02204293|26340572|P6|Core Study Part I|Physician Decision|0
7574085|NCT02204293|26340573|P5|Core Study Part I|Physician Decision|0
7574086|NCT02204293|26340574|P4|Core Study Part I|Physician Decision|0
7574087|NCT02204293|26340575|P3|Core Study Part I|Physician Decision|0
7574088|NCT02204293|26340576|P2|Core Study Part I|Physician Decision|3
7574089|NCT02204293|26340577|P1|Core Study Part I|Physician Decision|0
7574090|NCT02204293|26340572|P6|Core Study Part I|Adverse Event|0
7574091|NCT02204293|26340573|P5|Core Study Part I|Adverse Event|0
7574092|NCT02204293|26340574|P4|Core Study Part I|Adverse Event|0
7574093|NCT02204293|26340575|P3|Core Study Part I|Adverse Event|0
7574094|NCT02204293|26340576|P2|Core Study Part I|Adverse Event|0
7574095|NCT02204293|26340577|P1|Core Study Part I|Adverse Event|1
7574096|NCT02204293|26340572|P6|Core Study Part I|Met one or more exclusion criteria|0
7574097|NCT02204293|26340573|P5|Core Study Part I|Met one or more exclusion criteria|0
7574098|NCT02204293|26340574|P4|Core Study Part I|Met one or more exclusion criteria|0
7574099|NCT02204293|26340575|P3|Core Study Part I|Met one or more exclusion criteria|0
7574100|NCT02204293|26340576|P2|Core Study Part I|Met one or more exclusion criteria|0
7574101|NCT02204293|26340577|P1|Core Study Part I|Met one or more exclusion criteria|1
7574102|NCT02204007|26340698|P2|Overall Study|Surgery Canceled|1
7574103|NCT02204007|26340699|P1|Overall Study|Surgery Canceled|1
7574104|NCT02203916|26340710|P3|Overall Study|Reason Not Specified|1
7574105|NCT02203916|26340711|P2|Overall Study|Reason Not Specified|2
7574106|NCT02203916|26340712|P1|Overall Study|Reason Not Specified|0
7574107|NCT02203916|26340710|P3|Overall Study|Lack of Efficacy|0
7574108|NCT02203916|26340711|P2|Overall Study|Lack of Efficacy|0
7574109|NCT02203916|26340712|P1|Overall Study|Lack of Efficacy|3
7574110|NCT02203916|26340710|P3|Overall Study|Voluntary Withdrawal|8
7574111|NCT02203916|26340711|P2|Overall Study|Voluntary Withdrawal|3
7574112|NCT02203916|26340712|P1|Overall Study|Voluntary Withdrawal|3
7574113|NCT02203916|26340710|P3|Overall Study|Lost to Follow-up|0
7574114|NCT02203916|26340711|P2|Overall Study|Lost to Follow-up|1
7574115|NCT02203916|26340712|P1|Overall Study|Lost to Follow-up|0
7574116|NCT02203916|26340710|P3|Overall Study|Major Protocol Deviation|0
7574117|NCT02203916|26340711|P2|Overall Study|Major Protocol Deviation|1
7574118|NCT02203916|26340712|P1|Overall Study|Major Protocol Deviation|1
7574119|NCT02203916|26340710|P3|Overall Study|Pretreatment Event/Adverse Event|2
7574120|NCT02203916|26340711|P2|Overall Study|Pretreatment Event/Adverse Event|3
7574121|NCT02203916|26340712|P1|Overall Study|Pretreatment Event/Adverse Event|1
7574122|NCT02203851|26340732|P1|Overall Study|Other|1
7574123|NCT02203851|26340732|P1|Overall Study|Withdrawal by Subject|6
7574124|NCT02203851|26340732|P1|Overall Study|Lost to Follow-up|4
7574125|NCT02203838|26340770|P4|Overall Study|Other|0
7574126|NCT02203838|26340771|P3|Overall Study|Other|0
7574127|NCT02203838|26340772|P2|Overall Study|Other|0
7574128|NCT02203838|26340773|P1|Overall Study|Other|1
7574129|NCT02203838|26340770|P4|Overall Study|Physician Decision|3
7574130|NCT02203838|26340771|P3|Overall Study|Physician Decision|2
7574131|NCT02203838|26340772|P2|Overall Study|Physician Decision|0
7574132|NCT02203838|26340773|P1|Overall Study|Physician Decision|27
7574133|NCT02203838|26340770|P4|Overall Study|Withdrawal by Subject|11
7574134|NCT02203838|26340771|P3|Overall Study|Withdrawal by Subject|8
7574135|NCT02203838|26340772|P2|Overall Study|Withdrawal by Subject|10
7574136|NCT02203838|26340773|P1|Overall Study|Withdrawal by Subject|83
7574137|NCT02203838|26340770|P4|Overall Study|Protocol Violation|0
7574138|NCT02203838|26340771|P3|Overall Study|Protocol Violation|0
7574139|NCT02203838|26340772|P2|Overall Study|Protocol Violation|3
7574140|NCT02203838|26340773|P1|Overall Study|Protocol Violation|7
7574141|NCT02203838|26340770|P4|Overall Study|Lost to Follow-up|1
7574142|NCT02203838|26340771|P3|Overall Study|Lost to Follow-up|2
7574143|NCT02203838|26340772|P2|Overall Study|Lost to Follow-up|3
7574144|NCT02203838|26340773|P1|Overall Study|Lost to Follow-up|39
7574145|NCT02203838|26340770|P4|Overall Study|Adverse Event|2
7574146|NCT02203838|26340771|P3|Overall Study|Adverse Event|3
7574147|NCT02203838|26340772|P2|Overall Study|Adverse Event|6
7574148|NCT02203838|26340773|P1|Overall Study|Adverse Event|46
7574149|NCT02203838|26340770|P4|Overall Study|Lack of Efficacy|1
7574150|NCT02203838|26340771|P3|Overall Study|Lack of Efficacy|1
7574151|NCT02203838|26340772|P2|Overall Study|Lack of Efficacy|0
7574152|NCT02203838|26340773|P1|Overall Study|Lack of Efficacy|7
7574153|NCT02203721|26340853|P2|Overall Study|Illness|1
7574154|NCT02203721|26340854|P1|Overall Study|Illness|0
7574155|NCT02203721|26340853|P2|Overall Study|Death|2
7574156|NCT02203721|26340854|P1|Overall Study|Death|0
7574157|NCT02203721|26340853|P2|Overall Study|Lost to Follow-up|0
7574158|NCT02203721|26340854|P1|Overall Study|Lost to Follow-up|1
7574159|NCT02203591|26340943|P8|Overall Study|Discontinued early due to compromised test sites|1
7574160|NCT02203591|26340944|P7|Overall Study|Discontinued early due to compromised test sites|0
7574161|NCT02203591|26340945|P6|Overall Study|Discontinued early due to compromised test sites|0
7574162|NCT02203591|26340946|P5|Overall Study|Discontinued early due to compromised test sites|1
7574163|NCT02203591|26340947|P4|Overall Study|Discontinued early due to compromised test sites|0
7574164|NCT02203591|26340948|P3|Overall Study|Discontinued early due to compromised test sites|1
7574165|NCT02203591|26340949|P2|Overall Study|Discontinued early due to compromised test sites|1
7574166|NCT02203591|26340950|P1|Overall Study|Discontinued early due to compromised test sites|0
7574167|NCT02203591|26340943|P8|Overall Study|Did not meet treatment day baseline|12
7574168|NCT02203591|26340944|P7|Overall Study|Did not meet treatment day baseline|29
7574169|NCT02203591|26340945|P6|Overall Study|Did not meet treatment day baseline|35
7574170|NCT02203591|26340946|P5|Overall Study|Did not meet treatment day baseline|33
7574171|NCT02203591|26340947|P4|Overall Study|Did not meet treatment day baseline|45
7574172|NCT02203591|26340948|P3|Overall Study|Did not meet treatment day baseline|150
7574173|NCT02203591|26340949|P2|Overall Study|Did not meet treatment day baseline|141
7574174|NCT02203591|26340950|P1|Overall Study|Did not meet treatment day baseline|147
7574175|NCT02203357|26341054|P3|Overall Study|Lost to Follow-up|70
7574176|NCT02203357|26341055|P2|Overall Study|Lost to Follow-up|66
7574177|NCT02203357|26341056|P1|Overall Study|Lost to Follow-up|58
7574178|NCT02203331|26341079|P6|Overall Study|Lost to Follow-up|0
7574179|NCT02203331|26341080|P5|Overall Study|Lost to Follow-up|1
7574180|NCT02203331|26341081|P4|Overall Study|Lost to Follow-up|0
7574181|NCT02203331|26341082|P3|Overall Study|Lost to Follow-up|0
7574182|NCT02203331|26341083|P2|Overall Study|Lost to Follow-up|0
7574183|NCT02203331|26341084|P1|Overall Study|Lost to Follow-up|0
7574184|NCT02203331|26341079|P6|Overall Study|Protocol Violation|0
7574185|NCT02203331|26341080|P5|Overall Study|Protocol Violation|1
7574186|NCT02203331|26341081|P4|Overall Study|Protocol Violation|1
7574187|NCT02203331|26341082|P3|Overall Study|Protocol Violation|0
7574188|NCT02203331|26341083|P2|Overall Study|Protocol Violation|2
7574189|NCT02203331|26341084|P1|Overall Study|Protocol Violation|0
7574190|NCT02203331|26341079|P6|Overall Study|Lack of Efficacy|1
7574191|NCT02203331|26341080|P5|Overall Study|Lack of Efficacy|0
7574192|NCT02203331|26341081|P4|Overall Study|Lack of Efficacy|0
7574193|NCT02203331|26341082|P3|Overall Study|Lack of Efficacy|1
7574194|NCT02203331|26341083|P2|Overall Study|Lack of Efficacy|2
7574195|NCT02203331|26341084|P1|Overall Study|Lack of Efficacy|0
7574196|NCT02203331|26341079|P6|Overall Study|Other Reasons|0
7574197|NCT02203331|26341080|P5|Overall Study|Other Reasons|0
7574198|NCT02203331|26341081|P4|Overall Study|Other Reasons|2
7574199|NCT02203331|26341082|P3|Overall Study|Other Reasons|0
7574200|NCT02203331|26341083|P2|Overall Study|Other Reasons|2
7574201|NCT02203331|26341084|P1|Overall Study|Other Reasons|1
7574202|NCT02203331|26341079|P6|Overall Study|Adverse Event|3
7574203|NCT02203331|26341080|P5|Overall Study|Adverse Event|3
7574204|NCT02203331|26341081|P4|Overall Study|Adverse Event|4
7574205|NCT02203331|26341082|P3|Overall Study|Adverse Event|3
7574206|NCT02203331|26341083|P2|Overall Study|Adverse Event|8
7574207|NCT02203331|26341084|P1|Overall Study|Adverse Event|4
7574208|NCT02203331|26341079|P6|Overall Study|Withdrawal by Subject|3
7574209|NCT02203331|26341080|P5|Overall Study|Withdrawal by Subject|0
7574210|NCT02203331|26341081|P4|Overall Study|Withdrawal by Subject|0
7574211|NCT02203331|26341082|P3|Overall Study|Withdrawal by Subject|1
7574212|NCT02203331|26341083|P2|Overall Study|Withdrawal by Subject|0
7574213|NCT02203331|26341084|P1|Overall Study|Withdrawal by Subject|1
7574214|NCT02203331|26341079|P6|Overall Study|Pregnancy|0
7574215|NCT02203331|26341080|P5|Overall Study|Pregnancy|2
7574216|NCT02203331|26341081|P4|Overall Study|Pregnancy|0
7574217|NCT02203331|26341082|P3|Overall Study|Pregnancy|0
7574218|NCT02203331|26341083|P2|Overall Study|Pregnancy|0
7574219|NCT02203331|26341084|P1|Overall Study|Pregnancy|1
7574220|NCT02203149|26341143|P5|Part 2|Adverse Event|1
7574221|NCT02203149|26341144|P4|Part 2|Adverse Event|1
7574222|NCT02203149|26341145|P3|Part 2|Adverse Event|0
7574223|NCT02203149|26341146|P2|Part 2|Adverse Event|0
7574224|NCT02203149|26341147|P1|Part 2|Adverse Event|0
7574225|NCT02203149|26341143|P5|Part 2|Withdrawal by Subject|0
7574226|NCT02203149|26341144|P4|Part 2|Withdrawal by Subject|1
7574227|NCT02203149|26341145|P3|Part 2|Withdrawal by Subject|0
7574228|NCT02203149|26341146|P2|Part 2|Withdrawal by Subject|0
7574229|NCT02203149|26341147|P1|Part 2|Withdrawal by Subject|0
7574230|NCT02203149|26341143|P5|Part 2|Death|0
7574231|NCT02203149|26341144|P4|Part 2|Death|1
7574232|NCT02203149|26341145|P3|Part 2|Death|1
7574233|NCT02203149|26341146|P2|Part 2|Death|0
7574234|NCT02203149|26341147|P1|Part 2|Death|0
7574235|NCT02203149|26341143|P5|Part 1|Adverse Event|0
7574236|NCT02203149|26341144|P4|Part 1|Adverse Event|0
7574237|NCT02203149|26341145|P3|Part 1|Adverse Event|0
7574238|NCT02203149|26341146|P2|Part 1|Adverse Event|1
7574239|NCT02203149|26341147|P1|Part 1|Adverse Event|0
7574240|NCT02203071|26341182|P2|Overall Study|Lost to Follow-up|1
7574241|NCT02203071|26341183|P1|Overall Study|Lost to Follow-up|3
7574242|NCT02203032|26341199|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
7574243|NCT02203032|26341200|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
7574244|NCT02203032|26341201|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
7574245|NCT02203032|26341202|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
7574246|NCT02203032|26341199|P4|Blinded Phase (Week 16 to Week 44)|Death|1
7574247|NCT02203032|26341200|P3|Blinded Phase (Week 16 to Week 44)|Death|0
7574248|NCT02203032|26341201|P2|Blinded Phase (Week 16 to Week 44)|Death|0
7574249|NCT02203032|26341202|P1|Blinded Phase (Week 16 to Week 44)|Death|0
7574250|NCT02203032|26341199|P4|Blinded Phase (Week 16 to Week 44)|Other|15
7574251|NCT02203032|26341200|P3|Blinded Phase (Week 16 to Week 44)|Other|1
7574252|NCT02203032|26341201|P2|Blinded Phase (Week 16 to Week 44)|Other|4
7574253|NCT02203032|26341202|P1|Blinded Phase (Week 16 to Week 44)|Other|0
7574254|NCT02203032|26341199|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
7574255|NCT02203032|26341200|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
7574256|NCT02203032|26341201|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
7574257|NCT02203032|26341202|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
7574258|NCT02203032|26341199|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
7574259|NCT02203032|26341200|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
7574260|NCT02203032|26341201|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
7574261|NCT02203032|26341202|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
7574262|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7574263|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7574264|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7574265|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
7574266|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
7574267|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
7574268|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
7574269|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
7574270|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7574271|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7574272|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7574273|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
7574274|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7574275|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7574276|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7574277|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
7574278|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7574279|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7574280|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7574281|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
7574282|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7574283|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7574284|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7574285|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
7574286|NCT02203032|26341199|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7574287|NCT02203032|26341200|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7574288|NCT02203032|26341201|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7574289|NCT02203032|26341202|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
7574290|NCT02202980|26341245|P14|Overall Study|Withdrew Consent|0
7574291|NCT02202980|26341246|P13|Overall Study|Withdrew Consent|0
7574292|NCT02202980|26341247|P12|Overall Study|Withdrew Consent|0
7574293|NCT02202980|26341248|P11|Overall Study|Withdrew Consent|0
7574294|NCT02202980|26341249|P10|Overall Study|Withdrew Consent|0
7574295|NCT02202980|26341250|P9|Overall Study|Withdrew Consent|1
7574296|NCT02202980|26341251|P8|Overall Study|Withdrew Consent|0
7574297|NCT02202980|26341252|P7|Overall Study|Withdrew Consent|0
7574298|NCT02202980|26341253|P6|Overall Study|Withdrew Consent|0
7574299|NCT02202980|26341254|P5|Overall Study|Withdrew Consent|0
7574300|NCT02202980|26341255|P4|Overall Study|Withdrew Consent|0
7574301|NCT02202980|26341256|P3|Overall Study|Withdrew Consent|2
7574302|NCT02202980|26341257|P2|Overall Study|Withdrew Consent|1
7574303|NCT02202980|26341258|P1|Overall Study|Withdrew Consent|0
7574304|NCT02202980|26341245|P14|Overall Study|Lost to Follow-up|0
7574305|NCT02202980|26341246|P13|Overall Study|Lost to Follow-up|1
7574306|NCT02202980|26341247|P12|Overall Study|Lost to Follow-up|0
7574307|NCT02202980|26341248|P11|Overall Study|Lost to Follow-up|0
7574308|NCT02202980|26341249|P10|Overall Study|Lost to Follow-up|0
7574309|NCT02202980|26341250|P9|Overall Study|Lost to Follow-up|1
7574310|NCT02202980|26341251|P8|Overall Study|Lost to Follow-up|1
7574311|NCT02202980|26341252|P7|Overall Study|Lost to Follow-up|0
7574312|NCT02202980|26341253|P6|Overall Study|Lost to Follow-up|0
7574313|NCT02202980|26341254|P5|Overall Study|Lost to Follow-up|0
7574314|NCT02202980|26341255|P4|Overall Study|Lost to Follow-up|1
7574315|NCT02202980|26341256|P3|Overall Study|Lost to Follow-up|1
7574316|NCT02202980|26341257|P2|Overall Study|Lost to Follow-up|1
7574317|NCT02202980|26341258|P1|Overall Study|Lost to Follow-up|0
7574318|NCT02202980|26341245|P14|Overall Study|Protocol Violation|0
7574319|NCT02202980|26341246|P13|Overall Study|Protocol Violation|0
7574320|NCT02202980|26341247|P12|Overall Study|Protocol Violation|0
7574321|NCT02202980|26341248|P11|Overall Study|Protocol Violation|0
7574322|NCT02202980|26341249|P10|Overall Study|Protocol Violation|0
7574323|NCT02202980|26341250|P9|Overall Study|Protocol Violation|0
7574324|NCT02202980|26341251|P8|Overall Study|Protocol Violation|0
7574325|NCT02202980|26341252|P7|Overall Study|Protocol Violation|0
7574326|NCT02202980|26341253|P6|Overall Study|Protocol Violation|0
7574327|NCT02202980|26341254|P5|Overall Study|Protocol Violation|3
7574328|NCT02202980|26341255|P4|Overall Study|Protocol Violation|3
7574329|NCT02202980|26341256|P3|Overall Study|Protocol Violation|0
7574330|NCT02202980|26341257|P2|Overall Study|Protocol Violation|0
7574331|NCT02202980|26341258|P1|Overall Study|Protocol Violation|0
7574332|NCT02202980|26341245|P14|Overall Study|Lack of Efficacy|0
7574333|NCT02202980|26341246|P13|Overall Study|Lack of Efficacy|10
7574334|NCT02202980|26341247|P12|Overall Study|Lack of Efficacy|3
7574335|NCT02202980|26341248|P11|Overall Study|Lack of Efficacy|0
7574336|NCT02202980|26341249|P10|Overall Study|Lack of Efficacy|0
7574337|NCT02202980|26341250|P9|Overall Study|Lack of Efficacy|2
7574338|NCT02202980|26341251|P8|Overall Study|Lack of Efficacy|2
7574339|NCT02202980|26341252|P7|Overall Study|Lack of Efficacy|11
7574340|NCT02202980|26341253|P6|Overall Study|Lack of Efficacy|1
7574341|NCT02202980|26341254|P5|Overall Study|Lack of Efficacy|3
7574342|NCT02202980|26341255|P4|Overall Study|Lack of Efficacy|0
7574343|NCT02202980|26341256|P3|Overall Study|Lack of Efficacy|7
7574344|NCT02202980|26341257|P2|Overall Study|Lack of Efficacy|0
7574345|NCT02202980|26341258|P1|Overall Study|Lack of Efficacy|1
7574346|NCT02202850|26341346|P2|Overall Study|Lost to Follow-up|1
7574347|NCT02202850|26341347|P1|Overall Study|Lost to Follow-up|7
7574348|NCT02202850|26341346|P2|Overall Study|Enbrel treatment discontinued|3
7574349|NCT02202850|26341347|P1|Overall Study|Enbrel treatment discontinued|15
7574350|NCT02202850|26341346|P2|Overall Study|Other|2
7574351|NCT02202850|26341347|P1|Overall Study|Other|2
7574352|NCT02202837|26341399|P2|Overall Study|Lost to Follow-up|1
7574353|NCT02202837|26341400|P1|Overall Study|Lost to Follow-up|7
7574354|NCT02202837|26341399|P2|Overall Study|Other|0
7574355|NCT02202837|26341400|P1|Overall Study|Other|10
7574356|NCT02202837|26341399|P2|Overall Study|Enbrel treatment discontinued|4
7574357|NCT02202837|26341400|P1|Overall Study|Enbrel treatment discontinued|36
7574358|NCT02202785|26341451|P3|Overall Study|Reason not Specified|13
7574359|NCT02202785|26341452|P2|Overall Study|Reason not Specified|7
7574360|NCT02202785|26341453|P1|Overall Study|Reason not Specified|10
7574361|NCT02202785|26341451|P3|Overall Study|Lost to Follow-up|0
7574362|NCT02202785|26341452|P2|Overall Study|Lost to Follow-up|1
7574363|NCT02202785|26341453|P1|Overall Study|Lost to Follow-up|0
7574364|NCT02202785|26341451|P3|Overall Study|Withdrawal by Subject|0
7574365|NCT02202785|26341452|P2|Overall Study|Withdrawal by Subject|1
7574366|NCT02202785|26341453|P1|Overall Study|Withdrawal by Subject|0
7574367|NCT02202785|26341451|P3|Overall Study|Study Terminated by Sponsor|4
7574368|NCT02202785|26341452|P2|Overall Study|Study Terminated by Sponsor|6
7574369|NCT02202785|26341453|P1|Overall Study|Study Terminated by Sponsor|1
7574370|NCT02202759|26341490|P3|Overall Study|Reason not Specified|10
7574371|NCT02202759|26341491|P2|Overall Study|Reason not Specified|11
7574372|NCT02202759|26341492|P1|Overall Study|Reason not Specified|4
7574373|NCT02202759|26341490|P3|Overall Study|Withdrawal by Subject|1
7574374|NCT02202759|26341491|P2|Overall Study|Withdrawal by Subject|1
7574375|NCT02202759|26341492|P1|Overall Study|Withdrawal by Subject|2
7574376|NCT02202759|26341490|P3|Overall Study|Study Terminated by Sponsor|3
7574377|NCT02202759|26341491|P2|Overall Study|Study Terminated by Sponsor|3
7574378|NCT02202759|26341492|P1|Overall Study|Study Terminated by Sponsor|3
7574379|NCT02202616|26341559|P1|Overall Study|Unsatisfactory therapeutic effect|1
7574380|NCT02202616|26341559|P1|Overall Study|Abnormal test procedure result|1
7574381|NCT02202616|26341559|P1|Overall Study|Administrative problems|6
7574382|NCT02202616|26341559|P1|Overall Study|Lost to Follow-up|6
7574383|NCT02202616|26341559|P1|Overall Study|Patient withdrew consent|12
7574384|NCT02202616|26341559|P1|Overall Study|Protocol deviation|18
7574385|NCT02202616|26341559|P1|Overall Study|Adverse Event|32
7574386|NCT02202616|26341559|P1|Overall Study|Screen failed|24
7574387|NCT02202551|26341574|P4|Overall Study|eGFR<50mL/min/m2|1
7574388|NCT02202551|26341575|P3|Overall Study|eGFR<50mL/min/m2|0
7574389|NCT02202551|26341576|P2|Overall Study|eGFR<50mL/min/m2|2
7574390|NCT02202551|26341577|P1|Overall Study|eGFR<50mL/min/m2|2
7574391|NCT02202551|26341574|P4|Overall Study|Subject consent withdrawn|2
7574392|NCT02202551|26341575|P3|Overall Study|Subject consent withdrawn|1
7574393|NCT02202551|26341576|P2|Overall Study|Subject consent withdrawn|3
7574394|NCT02202551|26341577|P1|Overall Study|Subject consent withdrawn|0
7574395|NCT02202551|26341574|P4|Overall Study|Subject unwilling to proceed|5
7574396|NCT02202551|26341575|P3|Overall Study|Subject unwilling to proceed|3
7574397|NCT02202551|26341576|P2|Overall Study|Subject unwilling to proceed|5
7574398|NCT02202551|26341577|P1|Overall Study|Subject unwilling to proceed|1
7574399|NCT02202551|26341574|P4|Overall Study|Sponsor's decision|0
7574400|NCT02202551|26341575|P3|Overall Study|Sponsor's decision|0
7574401|NCT02202551|26341576|P2|Overall Study|Sponsor's decision|0
7574402|NCT02202551|26341577|P1|Overall Study|Sponsor's decision|2
7574403|NCT02202551|26341574|P4|Overall Study|Protocol Violation|0
7574404|NCT02202551|26341575|P3|Overall Study|Protocol Violation|0
7574405|NCT02202551|26341576|P2|Overall Study|Protocol Violation|1
7574406|NCT02202551|26341577|P1|Overall Study|Protocol Violation|0
7574407|NCT02202551|26341574|P4|Overall Study|Worsening Dyskinesia|1
7574408|NCT02202551|26341575|P3|Overall Study|Worsening Dyskinesia|0
7574409|NCT02202551|26341576|P2|Overall Study|Worsening Dyskinesia|0
7574410|NCT02202551|26341577|P1|Overall Study|Worsening Dyskinesia|0
7574411|NCT02202551|26341574|P4|Overall Study|Unable to complete visits per protocol|0
7574412|NCT02202551|26341575|P3|Overall Study|Unable to complete visits per protocol|0
7574413|NCT02202551|26341576|P2|Overall Study|Unable to complete visits per protocol|0
7574414|NCT02202551|26341577|P1|Overall Study|Unable to complete visits per protocol|1
7574415|NCT02202551|26341574|P4|Overall Study|Site closure|1
7574416|NCT02202551|26341575|P3|Overall Study|Site closure|0
7574417|NCT02202551|26341576|P2|Overall Study|Site closure|0
7574418|NCT02202551|26341577|P1|Overall Study|Site closure|3
7574419|NCT02202551|26341574|P4|Overall Study|Physician Decision|0
7574420|NCT02202551|26341575|P3|Overall Study|Physician Decision|0
7574421|NCT02202551|26341576|P2|Overall Study|Physician Decision|0
7574422|NCT02202551|26341577|P1|Overall Study|Physician Decision|1
7574423|NCT02202551|26341574|P4|Overall Study|Lack of Efficacy|0
7574424|NCT02202551|26341575|P3|Overall Study|Lack of Efficacy|0
7574425|NCT02202551|26341576|P2|Overall Study|Lack of Efficacy|1
7574426|NCT02202551|26341577|P1|Overall Study|Lack of Efficacy|0
7574427|NCT02202551|26341574|P4|Overall Study|Dyskinesia upon taper|0
7574428|NCT02202551|26341575|P3|Overall Study|Dyskinesia upon taper|0
7574429|NCT02202551|26341576|P2|Overall Study|Dyskinesia upon taper|0
7574430|NCT02202551|26341577|P1|Overall Study|Dyskinesia upon taper|1
7574431|NCT02202551|26341574|P4|Overall Study|DBS surgery|0
7574432|NCT02202551|26341575|P3|Overall Study|DBS surgery|0
7574433|NCT02202551|26341576|P2|Overall Study|DBS surgery|0
7574434|NCT02202551|26341577|P1|Overall Study|DBS surgery|3
7574435|NCT02202551|26341574|P4|Overall Study|Subject moved away|0
7574436|NCT02202551|26341575|P3|Overall Study|Subject moved away|0
7574437|NCT02202551|26341576|P2|Overall Study|Subject moved away|1
7574438|NCT02202551|26341577|P1|Overall Study|Subject moved away|0
7574439|NCT02202551|26341574|P4|Overall Study|Needed to take excluded medication|1
7574440|NCT02202551|26341575|P3|Overall Study|Needed to take excluded medication|0
7574441|NCT02202551|26341576|P2|Overall Study|Needed to take excluded medication|2
7574442|NCT02202551|26341577|P1|Overall Study|Needed to take excluded medication|0
7574443|NCT02202551|26341574|P4|Overall Study|Lost to Follow-up|1
7574444|NCT02202551|26341575|P3|Overall Study|Lost to Follow-up|0
7574445|NCT02202551|26341576|P2|Overall Study|Lost to Follow-up|1
7574446|NCT02202551|26341577|P1|Overall Study|Lost to Follow-up|0
7574447|NCT02202551|26341574|P4|Overall Study|Death|1
7574448|NCT02202551|26341575|P3|Overall Study|Death|1
7574449|NCT02202551|26341576|P2|Overall Study|Death|2
7574450|NCT02202551|26341577|P1|Overall Study|Death|3
7574451|NCT02202551|26341574|P4|Overall Study|Adverse Event|9
7574452|NCT02202551|26341575|P3|Overall Study|Adverse Event|5
7574453|NCT02202551|26341576|P2|Overall Study|Adverse Event|19
7574454|NCT02202551|26341577|P1|Overall Study|Adverse Event|8
7574455|NCT02202538|26341595|P1|Overall Study|Investigator Decision|1
7574456|NCT02202538|26341595|P1|Overall Study|Did not meet all inclusion criteria|2
7574457|NCT02202538|26341595|P1|Overall Study|Withdrawal by Subject|5
7574458|NCT02202499|26341609|P3|Overall Study|Auto accident|0
7574459|NCT02202499|26341610|P2|Overall Study|Auto accident|0
7574460|NCT02202499|26341611|P1|Overall Study|Auto accident|1
7574461|NCT02202499|26341609|P3|Overall Study|Declined before randomization|0
7574462|NCT02202499|26341610|P2|Overall Study|Declined before randomization|0
7574463|NCT02202499|26341611|P1|Overall Study|Declined before randomization|1
7574464|NCT02202499|26341609|P3|Overall Study|Moved from area|1
7574465|NCT02202499|26341610|P2|Overall Study|Moved from area|0
7574466|NCT02202499|26341611|P1|Overall Study|Moved from area|0
7574467|NCT02202499|26341609|P3|Overall Study|Cancer diagnosis|1
7574468|NCT02202499|26341610|P2|Overall Study|Cancer diagnosis|0
7574469|NCT02202499|26341611|P1|Overall Study|Cancer diagnosis|0
7574470|NCT02202434|26341638|P4|Overall Study|Other|1
7574471|NCT02202434|26341639|P3|Overall Study|Other|0
7574472|NCT02202434|26341640|P2|Overall Study|Other|0
7574473|NCT02202434|26341641|P1|Overall Study|Other|1
7574474|NCT02202434|26341638|P4|Overall Study|Visit Missed|5
7574475|NCT02202434|26341639|P3|Overall Study|Visit Missed|0
7574476|NCT02202434|26341640|P2|Overall Study|Visit Missed|12
7574477|NCT02202434|26341641|P1|Overall Study|Visit Missed|21
7574478|NCT02202434|26341638|P4|Overall Study|Completed Study|0
7574479|NCT02202434|26341639|P3|Overall Study|Completed Study|0
7574480|NCT02202434|26341640|P2|Overall Study|Completed Study|0
7574481|NCT02202434|26341641|P1|Overall Study|Completed Study|1
7574482|NCT02202434|26341638|P4|Overall Study|Withdrawal by Subject|4
7574483|NCT02202434|26341639|P3|Overall Study|Withdrawal by Subject|1
7574484|NCT02202434|26341640|P2|Overall Study|Withdrawal by Subject|14
7574485|NCT02202434|26341641|P1|Overall Study|Withdrawal by Subject|13
7574486|NCT02202434|26341638|P4|Overall Study|Physician Decision|0
7574487|NCT02202434|26341639|P3|Overall Study|Physician Decision|0
7574488|NCT02202434|26341640|P2|Overall Study|Physician Decision|3
7574489|NCT02202434|26341641|P1|Overall Study|Physician Decision|2
7574490|NCT02202434|26341638|P4|Overall Study|Lost to Follow-up|0
7574491|NCT02202434|26341639|P3|Overall Study|Lost to Follow-up|1
7574492|NCT02202434|26341640|P2|Overall Study|Lost to Follow-up|1
7574493|NCT02202434|26341641|P1|Overall Study|Lost to Follow-up|1
7574494|NCT02202434|26341638|P4|Overall Study|Death|27
7574495|NCT02202434|26341639|P3|Overall Study|Death|13
7574496|NCT02202434|26341640|P2|Overall Study|Death|39
7574497|NCT02202434|26341641|P1|Overall Study|Death|70
7574498|NCT02202317|26341765|P1|Overall Study|Lost to Follow-up|1
7574499|NCT02202161|26341792|P8|Overall Study|Withdrawal by Subject|0
7574500|NCT02202161|26341793|P7|Overall Study|Withdrawal by Subject|0
7574501|NCT02202161|26341794|P6|Overall Study|Withdrawal by Subject|0
7574502|NCT02202161|26341795|P5|Overall Study|Withdrawal by Subject|1
7574503|NCT02202161|26341796|P4|Overall Study|Withdrawal by Subject|0
7574504|NCT02202161|26341797|P3|Overall Study|Withdrawal by Subject|0
7574505|NCT02202161|26341798|P2|Overall Study|Withdrawal by Subject|0
7574506|NCT02202161|26341799|P1|Overall Study|Withdrawal by Subject|0
7574507|NCT02202161|26341792|P8|Overall Study|Physician Decision|3
7574508|NCT02202161|26341793|P7|Overall Study|Physician Decision|0
7574509|NCT02202161|26341794|P6|Overall Study|Physician Decision|0
7574510|NCT02202161|26341795|P5|Overall Study|Physician Decision|0
7574511|NCT02202161|26341796|P4|Overall Study|Physician Decision|0
7574512|NCT02202161|26341797|P3|Overall Study|Physician Decision|0
7574513|NCT02202161|26341798|P2|Overall Study|Physician Decision|0
7574514|NCT02202161|26341799|P1|Overall Study|Physician Decision|0
7574515|NCT02202161|26341792|P8|Overall Study|Did not meet continuation criteria|3
7574516|NCT02202161|26341793|P7|Overall Study|Did not meet continuation criteria|0
7574517|NCT02202161|26341794|P6|Overall Study|Did not meet continuation criteria|0
7574518|NCT02202161|26341795|P5|Overall Study|Did not meet continuation criteria|0
7574519|NCT02202161|26341796|P4|Overall Study|Did not meet continuation criteria|0
7574520|NCT02202161|26341797|P3|Overall Study|Did not meet continuation criteria|0
7574521|NCT02202161|26341798|P2|Overall Study|Did not meet continuation criteria|0
7574522|NCT02202161|26341799|P1|Overall Study|Did not meet continuation criteria|0
7574523|NCT02202161|26341792|P8|Overall Study|Adverse Event|0
7574524|NCT02202161|26341793|P7|Overall Study|Adverse Event|0
7574525|NCT02202161|26341794|P6|Overall Study|Adverse Event|1
7574526|NCT02202161|26341795|P5|Overall Study|Adverse Event|0
7574527|NCT02202161|26341796|P4|Overall Study|Adverse Event|0
7574528|NCT02202161|26341797|P3|Overall Study|Adverse Event|0
7574529|NCT02202161|26341798|P2|Overall Study|Adverse Event|1
7574530|NCT02202161|26341799|P1|Overall Study|Adverse Event|1
7574531|NCT02202109|26341959|P2|Overall Study|Withdrawal by Subject|0
7574532|NCT02202109|26341960|P1|Overall Study|Withdrawal by Subject|2
7574533|NCT02202109|26341959|P2|Overall Study|Lost to Follow-up|87
7574534|NCT02202109|26341960|P1|Overall Study|Lost to Follow-up|88
7574535|NCT02202031|26341977|P2|Overall Study|Intolerance/Lack of Improvement|0
7574536|NCT02202031|26341978|P1|Overall Study|Intolerance/Lack of Improvement|3
7574537|NCT02202031|26341977|P2|Overall Study|Illness/Medical Reason|2
7574538|NCT02202031|26341978|P1|Overall Study|Illness/Medical Reason|0
7574539|NCT02202031|26341977|P2|Overall Study|Too Busy|3
7574540|NCT02202031|26341978|P1|Overall Study|Too Busy|1
7574541|NCT02202031|26341977|P2|Overall Study|Lost to Follow-up|0
7574542|NCT02202031|26341978|P1|Overall Study|Lost to Follow-up|1
7574543|NCT02201953|26342026|P2|Overall Study|Death|3
7574544|NCT02201953|26342027|P1|Overall Study|Death|0
7574545|NCT02201953|26342026|P2|Overall Study|Adverse Event|5
7574546|NCT02201953|26342027|P1|Overall Study|Adverse Event|0
7574547|NCT02201953|26342026|P2|Overall Study|Withdrew Consent|5
7574548|NCT02201953|26342027|P1|Overall Study|Withdrew Consent|2
7574549|NCT02201953|26342026|P2|Overall Study|Lost to Follow-up|8
7574550|NCT02201953|26342027|P1|Overall Study|Lost to Follow-up|8
7574551|NCT02201953|26342026|P2|Overall Study|Lack of Efficacy|30
7574552|NCT02201953|26342027|P1|Overall Study|Lack of Efficacy|9
7574553|NCT02201953|26342026|P2|Overall Study|Randomized but Never Treated|5
7574554|NCT02201953|26342027|P1|Overall Study|Randomized but Never Treated|1
7574555|NCT02201940|26342045|P2|Overall Study|Adverse Event|1
7574556|NCT02201940|26342046|P1|Overall Study|Adverse Event|0
7574557|NCT02201940|26342045|P2|Overall Study|Death|0
7574558|NCT02201940|26342046|P1|Overall Study|Death|1
7574559|NCT02201940|26342045|P2|Overall Study|Investigator's Discretion|1
7574560|NCT02201940|26342046|P1|Overall Study|Investigator's Discretion|1
7574561|NCT02201940|26342045|P2|Overall Study|Withdrew Consent|1
7574562|NCT02201940|26342046|P1|Overall Study|Withdrew Consent|2
7574563|NCT02201940|26342045|P2|Overall Study|Lost to Follow-up|0
7574564|NCT02201940|26342046|P1|Overall Study|Lost to Follow-up|5
7574565|NCT02201940|26342045|P2|Overall Study|Lack of Efficacy|113
7574566|NCT02201940|26342046|P1|Overall Study|Lack of Efficacy|2
7574567|NCT02201940|26342045|P2|Overall Study|Randomized/Enrolled but Never Treated|0
7574568|NCT02201940|26342046|P1|Overall Study|Randomized/Enrolled but Never Treated|1
7574569|NCT02201901|26342065|P3|Overall Study|Adverse Event|0
7574570|NCT02201901|26342066|P2|Overall Study|Adverse Event|1
7574571|NCT02201901|26342067|P1|Overall Study|Adverse Event|1
7574572|NCT02201901|26342065|P3|Overall Study|Withdrew Consent|2
7574573|NCT02201901|26342066|P2|Overall Study|Withdrew Consent|0
7574574|NCT02201901|26342067|P1|Overall Study|Withdrew Consent|2
7574575|NCT02201901|26342065|P3|Overall Study|Lost to Follow-up|2
7574576|NCT02201901|26342066|P2|Overall Study|Lost to Follow-up|3
7574577|NCT02201901|26342067|P1|Overall Study|Lost to Follow-up|2
7574578|NCT02201901|26342065|P3|Overall Study|Death|3
7574579|NCT02201901|26342066|P2|Overall Study|Death|3
7574580|NCT02201901|26342067|P1|Overall Study|Death|3
7574581|NCT02201901|26342065|P3|Overall Study|Lack of Efficacy|6
7574582|NCT02201901|26342066|P2|Overall Study|Lack of Efficacy|1
7574583|NCT02201901|26342067|P1|Overall Study|Lack of Efficacy|7
7574584|NCT02201901|26342065|P3|Overall Study|Randomized but never treated|0
7574585|NCT02201901|26342066|P2|Overall Study|Randomized but never treated|1
7574586|NCT02201901|26342067|P1|Overall Study|Randomized but never treated|0
7574587|NCT02201784|26342098|P2|Overall Study|Failure to achieve adequate block|0
7574588|NCT02201784|26342099|P1|Overall Study|Failure to achieve adequate block|2
7574589|NCT02201771|26342116|P3|Overall Study|Protocol Violation|10
7574590|NCT02201771|26342117|P2|Overall Study|Protocol Violation|8
7574591|NCT02201771|26342118|P1|Overall Study|Protocol Violation|10
7574592|NCT02201771|26342116|P3|Overall Study|Death|0
7574593|NCT02201771|26342117|P2|Overall Study|Death|2
7574594|NCT02201771|26342118|P1|Overall Study|Death|3
7574595|NCT02201524|26342145|P4|Overall Study|Other|0
7574596|NCT02201524|26342146|P3|Overall Study|Other|0
7574597|NCT02201524|26342147|P2|Overall Study|Other|1
7574598|NCT02201524|26342148|P1|Overall Study|Other|1
7574599|NCT02201524|26342145|P4|Overall Study|Withdrawal by Subject|1
7574600|NCT02201524|26342146|P3|Overall Study|Withdrawal by Subject|1
7574601|NCT02201524|26342147|P2|Overall Study|Withdrawal by Subject|0
7574602|NCT02201524|26342148|P1|Overall Study|Withdrawal by Subject|0
7574603|NCT02201524|26342145|P4|Overall Study|Protocol Violation|1
7574604|NCT02201524|26342146|P3|Overall Study|Protocol Violation|0
7574605|NCT02201524|26342147|P2|Overall Study|Protocol Violation|0
7574606|NCT02201524|26342148|P1|Overall Study|Protocol Violation|0
7574607|NCT02201524|26342145|P4|Overall Study|No longer meets eligibility criteria|2
7574608|NCT02201524|26342146|P3|Overall Study|No longer meets eligibility criteria|0
7574609|NCT02201524|26342147|P2|Overall Study|No longer meets eligibility criteria|0
7574610|NCT02201524|26342148|P1|Overall Study|No longer meets eligibility criteria|0
7574611|NCT02201524|26342145|P4|Overall Study|Lost to Follow-up|0
7574612|NCT02201524|26342146|P3|Overall Study|Lost to Follow-up|2
7574613|NCT02201524|26342147|P2|Overall Study|Lost to Follow-up|0
7574614|NCT02201524|26342148|P1|Overall Study|Lost to Follow-up|0
7574615|NCT02201524|26342145|P4|Overall Study|Insufficient clinical response|0
7574616|NCT02201524|26342146|P3|Overall Study|Insufficient clinical response|0
7574617|NCT02201524|26342147|P2|Overall Study|Insufficient clinical response|0
7574618|NCT02201524|26342148|P1|Overall Study|Insufficient clinical response|1
7574619|NCT02201524|26342145|P4|Overall Study|Adverse Event|0
7574620|NCT02201524|26342146|P3|Overall Study|Adverse Event|1
7574621|NCT02201524|26342147|P2|Overall Study|Adverse Event|2
7574622|NCT02201524|26342148|P1|Overall Study|Adverse Event|0
7574623|NCT02201472|26342230|P1|Overall Study|Lack of Efficacy|2
7574624|NCT02201329|26342277|P1|Overall Study|Withdrawal by Subject|2
7574625|NCT02201329|26342277|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
7574626|NCT02201290|26342285|P1|Overall Study|Adverse Event|1
7574627|NCT02201290|26342285|P1|Overall Study|Lack of Efficacy|2
7574628|NCT02201290|26342285|P1|Overall Study|Withdrawal by Subject|2
7574629|NCT02201277|26342291|P2|Overall Study|Physician Decision|0
7574630|NCT02201277|26342292|P1|Overall Study|Physician Decision|1
7574631|NCT02201277|26342291|P2|Overall Study|Failed retrieval|0
7574632|NCT02201277|26342292|P1|Overall Study|Failed retrieval|1
7574633|NCT02201277|26342291|P2|Overall Study|Lost to Follow-up|1
7574634|NCT02201277|26342292|P1|Overall Study|Lost to Follow-up|2
7574635|NCT02201277|26342291|P2|Overall Study|Death|4
7574636|NCT02201277|26342292|P1|Overall Study|Death|3
7574637|NCT02201251|26342314|P2|Overall Study|Withdrawal by Subject|1
7574638|NCT02201251|26342315|P1|Overall Study|Withdrawal by Subject|2
7574639|NCT02201251|26342314|P2|Overall Study|Noncompliance with Study Drug|1
7574640|NCT02201251|26342315|P1|Overall Study|Noncompliance with Study Drug|0
7574641|NCT02201251|26342314|P2|Overall Study|Protocol Violation|0
7574642|NCT02201251|26342315|P1|Overall Study|Protocol Violation|1
7574643|NCT02201251|26342314|P2|Overall Study|Adverse Event|1
7574644|NCT02201251|26342315|P1|Overall Study|Adverse Event|1
7574651|NCT02200770|26342477|P2|Open-label Period (OLP)|Participants ongoing|162
7574652|NCT02200770|26342478|P1|Open-label Period (OLP)|Participants ongoing|51
7574653|NCT02200770|26342477|P2|Randomized-controlled Period (RCP)|Other|2
7574654|NCT02200770|26342478|P1|Randomized-controlled Period (RCP)|Other|1
7574655|NCT02200770|26342477|P2|Randomized-controlled Period (RCP)|Not treated|1
7574656|NCT02200770|26342478|P1|Randomized-controlled Period (RCP)|Not treated|0
7574657|NCT02200770|26342477|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7574658|NCT02200770|26342478|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7574659|NCT02200770|26342477|P2|Randomized-controlled Period (RCP)|Adverse Event|2
7574660|NCT02200770|26342478|P1|Randomized-controlled Period (RCP)|Adverse Event|0
7574661|NCT02200614|26342509|P2|Open Label|Protocol deviation|1
7574662|NCT02200614|26342510|P1|Open Label|Protocol deviation|1
7574663|NCT02200614|26342509|P2|Open Label|Personal reason|3
7574664|NCT02200614|26342510|P1|Open Label|Personal reason|29
7574665|NCT02200614|26342509|P2|Open Label|Other reason|1
7574666|NCT02200614|26342510|P1|Open Label|Other reason|6
7574667|NCT02200614|26342509|P2|Open Label|Metastasis by local reading|10
7574668|NCT02200614|26342510|P1|Open Label|Metastasis by local reading|58
7574669|NCT02200614|26342509|P2|Open Label|Judgment of the investigator|0
7574670|NCT02200614|26342510|P1|Open Label|Judgment of the investigator|15
7574671|NCT02200614|26342509|P2|Open Label|Confirmed metastasis|0
7574672|NCT02200614|26342510|P1|Open Label|Confirmed metastasis|1
7574673|NCT02200614|26342509|P2|Open Label|Adverse Event|8
7574674|NCT02200614|26342510|P1|Open Label|Adverse Event|15
7574675|NCT02200614|26342509|P2|Double Blind Treatment|Not treated|0
7574676|NCT02200614|26342510|P1|Double Blind Treatment|Not treated|1
7574677|NCT02200614|26342509|P2|Double Blind Treatment|Protocol deviation|7
7574678|NCT02200614|26342510|P1|Double Blind Treatment|Protocol deviation|14
7574679|NCT02200614|26342509|P2|Double Blind Treatment|Personal reason|85
7574680|NCT02200614|26342510|P1|Double Blind Treatment|Personal reason|77
7574681|NCT02200614|26342509|P2|Double Blind Treatment|Other reason|2
7574682|NCT02200614|26342510|P1|Double Blind Treatment|Other reason|6
7574683|NCT02200614|26342509|P2|Double Blind Treatment|Metastasis by local reading|3
7574684|NCT02200614|26342510|P1|Double Blind Treatment|Metastasis by local reading|1
7574685|NCT02200614|26342509|P2|Double Blind Treatment|Judgment of the investigator|99
7574686|NCT02200614|26342510|P1|Double Blind Treatment|Judgment of the investigator|60
7574687|NCT02200614|26342509|P2|Double Blind Treatment|Confirmed metastasis|140
7574688|NCT02200614|26342510|P1|Double Blind Treatment|Confirmed metastasis|119
7574689|NCT02200614|26342509|P2|Double Blind Treatment|Adverse Event|48
7574690|NCT02200614|26342510|P1|Double Blind Treatment|Adverse Event|86
7574691|NCT02200510|26342559|P2|Overall Study|potential COI - joined study team|0
7574692|NCT02200510|26342560|P1|Overall Study|potential COI - joined study team|1
7574693|NCT02200510|26342559|P2|Overall Study|Lost to Follow-up|1
7574694|NCT02200510|26342560|P1|Overall Study|Lost to Follow-up|7
7574695|NCT02200510|26342559|P2|Overall Study|Protocol Violation|1
7574696|NCT02200510|26342560|P1|Overall Study|Protocol Violation|0
7574697|NCT02200510|26342559|P2|Overall Study|Death|1
7574698|NCT02200510|26342560|P1|Overall Study|Death|1
7574699|NCT02200445|26342573|P3|Overall Study|Adverse Event|0
7574700|NCT02200445|26342574|P2|Overall Study|Adverse Event|2
7574701|NCT02200445|26342575|P1|Overall Study|Adverse Event|0
7574702|NCT02200445|26342573|P3|Overall Study|Lack of Efficacy|2
7574703|NCT02200445|26342574|P2|Overall Study|Lack of Efficacy|2
7574704|NCT02200445|26342575|P1|Overall Study|Lack of Efficacy|1
7574705|NCT02200211|26342604|P4|Overall Study|Withdrawal by Subject|0
7574706|NCT02200211|26342605|P3|Overall Study|Withdrawal by Subject|0
7574707|NCT02200211|26342606|P2|Overall Study|Withdrawal by Subject|0
7574708|NCT02200211|26342607|P1|Overall Study|Withdrawal by Subject|1
7574709|NCT02200211|26342604|P4|Overall Study|Lost to Follow-up|2
7574710|NCT02200211|26342605|P3|Overall Study|Lost to Follow-up|1
7574711|NCT02200211|26342606|P2|Overall Study|Lost to Follow-up|7
7574712|NCT02200211|26342607|P1|Overall Study|Lost to Follow-up|7
7574713|NCT02200042|26342720|P2|Overall Study|Withdrawal by Subject|1
7574714|NCT02200042|26342721|P1|Overall Study|Withdrawal by Subject|0
7574715|NCT02199795|26342750|P2|Overall Study|withdrew due to shoulder pain|0
7574716|NCT02199795|26342751|P1|Overall Study|withdrew due to shoulder pain|1
7574717|NCT02199795|26342750|P2|Overall Study|no longer met inclusion criteria|0
7574718|NCT02199795|26342751|P1|Overall Study|no longer met inclusion criteria|1
7574719|NCT02199691|26342785|P4|Overall Study|Lost to Follow-up|10
7574720|NCT02199691|26342786|P3|Overall Study|Lost to Follow-up|9
7574721|NCT02199691|26342787|P2|Overall Study|Lost to Follow-up|1
7574722|NCT02199691|26342788|P1|Overall Study|Lost to Follow-up|2
7574723|NCT02199691|26342785|P4|Overall Study|Withdrawal by Subject|13
7574724|NCT02199691|26342786|P3|Overall Study|Withdrawal by Subject|12
7574725|NCT02199691|26342787|P2|Overall Study|Withdrawal by Subject|3
7574726|NCT02199691|26342788|P1|Overall Study|Withdrawal by Subject|5
7574727|NCT02199691|26342785|P4|Overall Study|Protocol Violation|7
7574728|NCT02199691|26342786|P3|Overall Study|Protocol Violation|6
7574729|NCT02199691|26342787|P2|Overall Study|Protocol Violation|3
7574730|NCT02199691|26342788|P1|Overall Study|Protocol Violation|3
7574731|NCT02199509|26342830|P2|Overall Study|Misunderstood titration schedule|0
7574732|NCT02199509|26342831|P1|Overall Study|Misunderstood titration schedule|1
7574733|NCT02199509|26342830|P2|Overall Study|Suicidal Ideation|1
7574734|NCT02199509|26342831|P1|Overall Study|Suicidal Ideation|0
7574735|NCT02199314|26342854|P1|Overall Study|Physician Decision|10
7574736|NCT02199314|26342854|P1|Overall Study|Withdrawal by Subject|6
7574737|NCT02199080|26342881|P1|Overall Study|Protocol Violation|12
7574738|NCT02199028|26342906|P2|Week 3|Adverse Event|0
7574739|NCT02199028|26342907|P1|Week 3|Adverse Event|1
7574740|NCT02199028|26342906|P2|Week 1|Adverse Event|0
7574741|NCT02199028|26342907|P1|Week 1|Adverse Event|1
7574742|NCT02198963|26342916|P1|Overall Study|Withdrawal by Subject|6
7574743|NCT02198963|26342916|P1|Overall Study|Adverse Event|1
7574744|NCT02198794|26342940|P3|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
7574745|NCT02198794|26342941|P2|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
7574746|NCT02198794|26342942|P1|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
7574747|NCT02198794|26342940|P3|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
7574748|NCT02198794|26342941|P2|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
7574749|NCT02198794|26342942|P1|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
7574750|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7574751|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7574752|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
7574753|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7574754|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7574755|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Protocol deviation|1
7574756|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Study terminated|0
7574757|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Study terminated|0
7574758|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Study terminated|1
7574759|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Other than specified|0
7574760|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Other than specified|0
7574761|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Other than specified|5
7574762|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7574763|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7574764|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
7574765|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Death|0
7574766|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Death|0
7574767|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Death|8
7574768|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7574769|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7574770|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
7574771|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7574772|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7574773|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
7574774|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Adverse Event|0
7574775|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Adverse Event|0
7574776|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Adverse Event|33
7574777|NCT02198794|26342940|P3|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7574778|NCT02198794|26342941|P2|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7574779|NCT02198794|26342942|P1|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
7574780|NCT02198651|26342958|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7574781|NCT02198651|26342959|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
7574782|NCT02198651|26342960|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7574783|NCT02198651|26342961|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7574784|NCT02198651|26342962|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7574785|NCT02198651|26342958|P5|Open-label Rescue Period|Withdrew consent|0
7574786|NCT02198651|26342959|P4|Open-label Rescue Period|Withdrew consent|2
7574787|NCT02198651|26342960|P3|Open-label Rescue Period|Withdrew consent|0
7574788|NCT02198651|26342961|P2|Open-label Rescue Period|Withdrew consent|0
7574789|NCT02198651|26342962|P1|Open-label Rescue Period|Withdrew consent|0
7574790|NCT02198651|26342958|P5|Double-blind Period|Other, not specified|0
7574791|NCT02198651|26342959|P4|Double-blind Period|Other, not specified|0
7574792|NCT02198651|26342960|P3|Double-blind Period|Other, not specified|1
7574793|NCT02198651|26342961|P2|Double-blind Period|Other, not specified|4
7574794|NCT02198651|26342962|P1|Double-blind Period|Other, not specified|0
7574795|NCT02198651|26342958|P5|Double-blind Period|Adverse Event|0
7574796|NCT02198651|26342959|P4|Double-blind Period|Adverse Event|0
7574797|NCT02198651|26342960|P3|Double-blind Period|Adverse Event|0
7574798|NCT02198651|26342961|P2|Double-blind Period|Adverse Event|1
7574799|NCT02198651|26342962|P1|Double-blind Period|Adverse Event|0
7574800|NCT02198651|26342958|P5|Double-blind Period|Withdrew consent|0
7574801|NCT02198651|26342959|P4|Double-blind Period|Withdrew consent|0
7574802|NCT02198651|26342960|P3|Double-blind Period|Withdrew consent|0
7574803|NCT02198651|26342961|P2|Double-blind Period|Withdrew consent|4
7574804|NCT02198651|26342962|P1|Double-blind Period|Withdrew consent|0
7574805|NCT02198651|26342958|P5|Lead-in Period|Other, not specified|0
7574806|NCT02198651|26342959|P4|Lead-in Period|Other, not specified|0
7574807|NCT02198651|26342960|P3|Lead-in Period|Other, not specified|0
7574808|NCT02198651|26342961|P2|Lead-in Period|Other, not specified|0
7574809|NCT02198651|26342962|P1|Lead-in Period|Other, not specified|22
7574810|NCT02198651|26342958|P5|Lead-in Period|Adverse Event|0
7574811|NCT02198651|26342959|P4|Lead-in Period|Adverse Event|0
7574812|NCT02198651|26342960|P3|Lead-in Period|Adverse Event|0
7574813|NCT02198651|26342961|P2|Lead-in Period|Adverse Event|0
7574814|NCT02198651|26342962|P1|Lead-in Period|Adverse Event|2
7574815|NCT02198651|26342958|P5|Lead-in Period|Withdrew consent|0
7574816|NCT02198651|26342959|P4|Lead-in Period|Withdrew consent|0
7574817|NCT02198651|26342960|P3|Lead-in Period|Withdrew consent|0
7574818|NCT02198651|26342961|P2|Lead-in Period|Withdrew consent|0
7574819|NCT02198651|26342962|P1|Lead-in Period|Withdrew consent|13
7574820|NCT02198235|26343063|P3|Overall Study|Lost to Follow-up|2
7574821|NCT02198235|26343064|P2|Overall Study|Lost to Follow-up|2
7574822|NCT02198235|26343065|P1|Overall Study|Lost to Follow-up|3
7574823|NCT02198040|26343085|P3|Overall Study|Withdrawal by Subject|1
7574824|NCT02198040|26343086|P2|Overall Study|Withdrawal by Subject|0
7574825|NCT02198040|26343087|P1|Overall Study|Withdrawal by Subject|0
7574826|NCT02198040|26343085|P3|Overall Study|Work reasons|0
7574827|NCT02198040|26343086|P2|Overall Study|Work reasons|1
7574828|NCT02198040|26343087|P1|Overall Study|Work reasons|0
7574829|NCT02197897|26343113|P1|Overall Study|not eligible|1
7574830|NCT02197806|26343121|P4|Overall Study|Adverse Event|1
7574831|NCT02197806|26343122|P3|Overall Study|Adverse Event|0
7574832|NCT02197806|26343123|P2|Overall Study|Adverse Event|1
7574833|NCT02197806|26343124|P1|Overall Study|Adverse Event|0
7574834|NCT02197572|26343139|P1|Overall Study|Reason Not Specified|4
7574835|NCT02197572|26343139|P1|Overall Study|Adverse Event|3
7574836|NCT02197572|26343139|P1|Overall Study|Withdrawal by Subject|9
7574837|NCT02197572|26343139|P1|Overall Study|Progressive Disease|28
7574838|NCT02197520|26343156|P2|Period 2|Withdrawal by Subject|0
7574839|NCT02197520|26343157|P1|Period 2|Withdrawal by Subject|1
7574840|NCT02197520|26343156|P2|Period 2|Adverse Event|2
7574841|NCT02197520|26343157|P1|Period 2|Adverse Event|0
7574842|NCT02197520|26343156|P2|Period 1|Withdrawal by Subject|0
7574843|NCT02197520|26343157|P1|Period 1|Withdrawal by Subject|1
7574844|NCT02197416|26343204|P3|Overall Study|Adverse Event|1
7574845|NCT02197416|26343205|P2|Overall Study|Adverse Event|0
7574846|NCT02197416|26343206|P1|Overall Study|Adverse Event|0
7574847|NCT02197416|26343204|P3|Overall Study|Protocol Violation|1
7574848|NCT02197416|26343205|P2|Overall Study|Protocol Violation|0
7574849|NCT02197416|26343206|P1|Overall Study|Protocol Violation|1
7574850|NCT02197416|26343204|P3|Overall Study|Withdrawal by Subject|1
7574851|NCT02197416|26343205|P2|Overall Study|Withdrawal by Subject|2
7574852|NCT02197416|26343206|P1|Overall Study|Withdrawal by Subject|0
7574853|NCT02197416|26343204|P3|Overall Study|Other reasons|5
7574854|NCT02197416|26343205|P2|Overall Study|Other reasons|2
7574855|NCT02197416|26343206|P1|Overall Study|Other reasons|0
7574856|NCT02197377|26343244|P2|Overall Study|Insertion Failure|3
7574857|NCT02197377|26343245|P1|Overall Study|Insertion Failure|0
7574858|NCT02197247|26343266|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
7574859|NCT02197247|26343266|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
7574860|NCT02197247|26343266|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
7574861|NCT02197247|26343266|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
7574862|NCT02197247|26343266|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
7574863|NCT02197247|26343266|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
7574864|NCT02197247|26343266|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
7574865|NCT02197247|26343266|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
7574866|NCT02197234|26343311|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
7574867|NCT02197234|26343311|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
7574868|NCT02197234|26343311|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
7574869|NCT02197234|26343311|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
7574870|NCT02197234|26343311|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
7574871|NCT02197234|26343311|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
7574872|NCT02197234|26343311|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
7574873|NCT02197130|26343333|P3|Overall Study|Other|3
7574874|NCT02197130|26343334|P2|Overall Study|Other|0
7574875|NCT02197130|26343335|P1|Overall Study|Other|1
7574876|NCT02197130|26343333|P3|Overall Study|Withdrawal by Subject|4
7574877|NCT02197130|26343334|P2|Overall Study|Withdrawal by Subject|3
7574878|NCT02197130|26343335|P1|Overall Study|Withdrawal by Subject|0
7574879|NCT02197130|26343333|P3|Overall Study|Does not meet entrance criteria|1
7574880|NCT02197130|26343334|P2|Overall Study|Does not meet entrance criteria|0
7574881|NCT02197130|26343335|P1|Overall Study|Does not meet entrance criteria|0
7574882|NCT02197130|26343333|P3|Overall Study|Lost to Follow-up|1
7574883|NCT02197130|26343334|P2|Overall Study|Lost to Follow-up|0
7574884|NCT02197130|26343335|P1|Overall Study|Lost to Follow-up|2
7574885|NCT02197130|26343333|P3|Overall Study|Death|0
7574886|NCT02197130|26343334|P2|Overall Study|Death|1
7574887|NCT02197130|26343335|P1|Overall Study|Death|0
7574888|NCT02197130|26343333|P3|Overall Study|Adverse Event|23
7574889|NCT02197130|26343334|P2|Overall Study|Adverse Event|4
7574890|NCT02197130|26343335|P1|Overall Study|Adverse Event|13
7574891|NCT02196714|26343581|P4|Overall Study|Protocol Violation|0
7574892|NCT02196714|26343582|P3|Overall Study|Protocol Violation|1
7574893|NCT02196714|26343583|P2|Overall Study|Protocol Violation|0
7574894|NCT02196714|26343584|P1|Overall Study|Protocol Violation|0
7574895|NCT02196701|26343706|P1|Overall Study|Non-adherence to Protocol|1
7574896|NCT02196701|26343706|P1|Overall Study|Lost to Follow-up|1
7574897|NCT02196701|26343706|P1|Overall Study|Adverse Event|1
7574898|NCT02196675|26343780|P3|Overall Study|Death|1
7574899|NCT02196675|26343781|P2|Overall Study|Death|0
7574900|NCT02196675|26343782|P1|Overall Study|Death|0
7574901|NCT02196675|26343780|P3|Overall Study|Protocol Violation|0
7574902|NCT02196675|26343781|P2|Overall Study|Protocol Violation|1
7574903|NCT02196675|26343782|P1|Overall Study|Protocol Violation|0
7574904|NCT02196675|26343780|P3|Overall Study|Intra-operative surgical exclusion|0
7574905|NCT02196675|26343781|P2|Overall Study|Intra-operative surgical exclusion|1
7574906|NCT02196675|26343782|P1|Overall Study|Intra-operative surgical exclusion|1
7574907|NCT02196675|26343780|P3|Overall Study|Withdrawal by Subject|0
7574908|NCT02196675|26343781|P2|Overall Study|Withdrawal by Subject|0
7574909|NCT02196675|26343782|P1|Overall Study|Withdrawal by Subject|1
7574910|NCT02196558|26343805|P3|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7574911|NCT02196558|26343806|P2|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7574912|NCT02196558|26343807|P1|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7574913|NCT02196558|26343805|P3|Extension Phase (40 Weeks)|Adverse Event|0
7574914|NCT02196558|26343806|P2|Extension Phase (40 Weeks)|Adverse Event|2
7574915|NCT02196558|26343807|P1|Extension Phase (40 Weeks)|Adverse Event|1
7574916|NCT02196558|26343805|P3|Treatment Phase (12 Weeks)|Progression of Disease|1
7574917|NCT02196558|26343806|P2|Treatment Phase (12 Weeks)|Progression of Disease|0
7574918|NCT02196558|26343807|P1|Treatment Phase (12 Weeks)|Progression of Disease|0
7574919|NCT02196558|26343805|P3|Treatment Phase (12 Weeks)|Participant Choice|1
7574920|NCT02196558|26343806|P2|Treatment Phase (12 Weeks)|Participant Choice|1
7574921|NCT02196558|26343807|P1|Treatment Phase (12 Weeks)|Participant Choice|0
7574922|NCT02196558|26343805|P3|Treatment Phase (12 Weeks)|Adverse Event|0
7574923|NCT02196558|26343806|P2|Treatment Phase (12 Weeks)|Adverse Event|2
7574924|NCT02196558|26343807|P1|Treatment Phase (12 Weeks)|Adverse Event|0
7574925|NCT02196506|26343823|P4|Phase A+|Participant withdrawn by investigator|1
7574926|NCT02196506|26343824|P3|Phase A+|Participant withdrawn by investigator|0
7574927|NCT02196506|26343825|P2|Phase A+|Participant withdrawn by investigator|0
7574928|NCT02196506|26343826|P1|Phase A+|Participant withdrawn by investigator|0
7574929|NCT02196506|26343823|P4|Phase A+|Lost to Follow-up|6
7574930|NCT02196506|26343824|P3|Phase A+|Lost to Follow-up|0
7574931|NCT02196506|26343825|P2|Phase A+|Lost to Follow-up|0
7574932|NCT02196506|26343826|P1|Phase A+|Lost to Follow-up|0
7574933|NCT02196506|26343823|P4|Phase A+|Adverse Event|1
7574934|NCT02196506|26343824|P3|Phase A+|Adverse Event|0
7574935|NCT02196506|26343825|P2|Phase A+|Adverse Event|0
7574936|NCT02196506|26343826|P1|Phase A+|Adverse Event|0
7574937|NCT02196506|26343823|P4|Phase A+|Withdrawal by Participant|5
7574938|NCT02196506|26343824|P3|Phase A+|Withdrawal by Participant|0
7574939|NCT02196506|26343825|P2|Phase A+|Withdrawal by Participant|0
7574940|NCT02196506|26343826|P1|Phase A+|Withdrawal by Participant|0
7574941|NCT02196506|26343823|P4|Phase A+|Participant Met Withdrawal Criteria|1
7574942|NCT02196506|26343824|P3|Phase A+|Participant Met Withdrawal Criteria|0
7574943|NCT02196506|26343825|P2|Phase A+|Participant Met Withdrawal Criteria|0
7574944|NCT02196506|26343826|P1|Phase A+|Participant Met Withdrawal Criteria|0
7574945|NCT02196506|26343823|P4|Phase B|Lost to Follow-up|0
7574946|NCT02196506|26343824|P3|Phase B|Lost to Follow-up|1
7574947|NCT02196506|26343825|P2|Phase B|Lost to Follow-up|2
7574948|NCT02196506|26343826|P1|Phase B|Lost to Follow-up|0
7574949|NCT02196506|26343823|P4|Phase B|Adverse Event|0
7574950|NCT02196506|26343824|P3|Phase B|Adverse Event|1
7574951|NCT02196506|26343825|P2|Phase B|Adverse Event|4
7574952|NCT02196506|26343826|P1|Phase B|Adverse Event|0
7574953|NCT02196506|26343823|P4|Phase B|Withdrawal by Participant|0
7574954|NCT02196506|26343824|P3|Phase B|Withdrawal by Participant|1
7574955|NCT02196506|26343825|P2|Phase B|Withdrawal by Participant|8
7574956|NCT02196506|26343826|P1|Phase B|Withdrawal by Participant|0
7574957|NCT02196506|26343823|P4|Phase B|Lack of Efficacy|0
7574958|NCT02196506|26343824|P3|Phase B|Lack of Efficacy|2
7574959|NCT02196506|26343825|P2|Phase B|Lack of Efficacy|1
7574960|NCT02196506|26343826|P1|Phase B|Lack of Efficacy|0
7574961|NCT02196506|26343823|P4|Phase B|Participant Met Withdrawal Criteria|0
7574962|NCT02196506|26343824|P3|Phase B|Participant Met Withdrawal Criteria|1
7574963|NCT02196506|26343825|P2|Phase B|Participant Met Withdrawal Criteria|0
7574964|NCT02196506|26343826|P1|Phase B|Participant Met Withdrawal Criteria|0
7574965|NCT02196506|26343823|P4|Phase A|Participant withdrawn by investigator|0
7574966|NCT02196506|26343824|P3|Phase A|Participant withdrawn by investigator|0
7574967|NCT02196506|26343825|P2|Phase A|Participant withdrawn by investigator|0
7574968|NCT02196506|26343826|P1|Phase A|Participant withdrawn by investigator|10
7574969|NCT02196506|26343823|P4|Phase A|Protocol deviation|0
7574970|NCT02196506|26343824|P3|Phase A|Protocol deviation|0
7574971|NCT02196506|26343825|P2|Phase A|Protocol deviation|0
7574972|NCT02196506|26343826|P1|Phase A|Protocol deviation|12
7574973|NCT02196506|26343823|P4|Phase A|Lost to Follow-up|0
7574974|NCT02196506|26343824|P3|Phase A|Lost to Follow-up|0
7574975|NCT02196506|26343825|P2|Phase A|Lost to Follow-up|0
7574976|NCT02196506|26343826|P1|Phase A|Lost to Follow-up|9
7574977|NCT02196506|26343823|P4|Phase A|Adverse Event|0
7574978|NCT02196506|26343824|P3|Phase A|Adverse Event|0
7574979|NCT02196506|26343825|P2|Phase A|Adverse Event|0
7574980|NCT02196506|26343826|P1|Phase A|Adverse Event|22
7574981|NCT02196506|26343823|P4|Phase A|Withdrawal by Subject|0
7574982|NCT02196506|26343824|P3|Phase A|Withdrawal by Subject|0
7574983|NCT02196506|26343825|P2|Phase A|Withdrawal by Subject|0
7574984|NCT02196506|26343826|P1|Phase A|Withdrawal by Subject|34
7574985|NCT02196506|26343823|P4|Phase A|Participant Met Withdrawal Criteria|0
7574986|NCT02196506|26343824|P3|Phase A|Participant Met Withdrawal Criteria|0
7574987|NCT02196506|26343825|P2|Phase A|Participant Met Withdrawal Criteria|0
7574988|NCT02196506|26343826|P1|Phase A|Participant Met Withdrawal Criteria|34
7574989|NCT02196324|26343840|P2|Overall Study|Other|0
7574990|NCT02196324|26343841|P1|Overall Study|Other|1
7574991|NCT02196324|26343840|P2|Overall Study|Occurrence of an Exclusion Criterion|1
7574992|NCT02196324|26343841|P1|Overall Study|Occurrence of an Exclusion Criterion|0
7574993|NCT02196324|26343840|P2|Overall Study|Adverse Event or Serious Adverse Event|3
7574994|NCT02196324|26343841|P1|Overall Study|Adverse Event or Serious Adverse Event|6
7574995|NCT02196324|26343840|P2|Overall Study|Withdrawal by Subject|4
7574996|NCT02196324|26343841|P1|Overall Study|Withdrawal by Subject|8
7574997|NCT02196259|26343882|P3|Overall Study|Partial data analysis|0
7574998|NCT02196259|26343883|P2|Overall Study|Partial data analysis|3
7574999|NCT02196259|26343884|P1|Overall Study|Partial data analysis|0
7575000|NCT02196259|26343882|P3|Overall Study|Researcher choice|1
7575001|NCT02196259|26343883|P2|Overall Study|Researcher choice|0
7575002|NCT02196259|26343884|P1|Overall Study|Researcher choice|0
7575003|NCT02196077|26343912|P1|Overall Study|Protocol Violation|24
7575004|NCT02196077|26343912|P1|Overall Study|Lost to Follow-up|3
7575005|NCT02196077|26343912|P1|Overall Study|Physician Decision|1
7575006|NCT02196077|26343912|P1|Overall Study|Withdrawal by Subject|14
7575007|NCT02196077|26343912|P1|Overall Study|Lack of Efficacy|1
7575008|NCT02196077|26343912|P1|Overall Study|Adverse Event|4
7575009|NCT02196038|26343961|P2|Overall Study|Lost to Follow-up|0
7575010|NCT02196038|26343962|P1|Overall Study|Lost to Follow-up|1
7575011|NCT02196038|26343961|P2|Overall Study|Withdrawal by Subject|1
7575012|NCT02196038|26343962|P1|Overall Study|Withdrawal by Subject|0
7575013|NCT02196038|26343961|P2|Overall Study|Death|21
7575014|NCT02196038|26343962|P1|Overall Study|Death|16
7575015|NCT02195986|26343973|P3|Overall Study|Non-compliance|0
7575016|NCT02195986|26343974|P2|Overall Study|Non-compliance|1
7575017|NCT02195986|26343975|P1|Overall Study|Non-compliance|0
7575018|NCT02195986|26343973|P3|Overall Study|Protocol Violation|1
7575019|NCT02195986|26343974|P2|Overall Study|Protocol Violation|1
7575020|NCT02195986|26343975|P1|Overall Study|Protocol Violation|0
7575021|NCT02195986|26343973|P3|Overall Study|Family Emergency|1
7575022|NCT02195986|26343974|P2|Overall Study|Family Emergency|0
7575023|NCT02195986|26343975|P1|Overall Study|Family Emergency|0
7575024|NCT02195986|26343973|P3|Overall Study|Withdrawal by Subject|0
7575025|NCT02195986|26343974|P2|Overall Study|Withdrawal by Subject|3
7575026|NCT02195986|26343975|P1|Overall Study|Withdrawal by Subject|0
7575027|NCT02195986|26343973|P3|Overall Study|Adverse Event|0
7575028|NCT02195986|26343974|P2|Overall Study|Adverse Event|0
7575029|NCT02195986|26343975|P1|Overall Study|Adverse Event|3
7575030|NCT02195869|26344055|P1|Overall Study|Noncompliance with study drug|2
7575031|NCT02195869|26344055|P1|Overall Study|Study Terminated by Sponsor|7
7575032|NCT02195869|26344055|P1|Overall Study|Physician Decision|4
7575033|NCT02195869|26344055|P1|Overall Study|Withdrawal by Subject|7
7575034|NCT02195869|26344055|P1|Overall Study|Adverse Event|15
7575035|NCT02195869|26344055|P1|Overall Study|Malignancy Progression/relapse|2
7575036|NCT02195869|26344055|P1|Overall Study|cGVHD Progression|5
7575037|NCT02195700|26344077|P2|Overall Study|Lost to Follow-up|1
7575038|NCT02195700|26344078|P1|Overall Study|Lost to Follow-up|1
7575039|NCT02195700|26344077|P2|Overall Study|Withdrawal by Subject|2
7575040|NCT02195700|26344078|P1|Overall Study|Withdrawal by Subject|3
7575041|NCT02195700|26344077|P2|Overall Study|Adverse Event|2
7575042|NCT02195700|26344078|P1|Overall Study|Adverse Event|1
7575043|NCT02195700|26344077|P2|Overall Study|Noncompliance|0
7575044|NCT02195700|26344078|P1|Overall Study|Noncompliance|1
7575045|NCT02195700|26344077|P2|Overall Study|Protocol Violation|2
7575046|NCT02195700|26344078|P1|Overall Study|Protocol Violation|0
7575047|NCT02195687|26344100|P2|Overall Study|Lost to Follow-up|1
7575048|NCT02195687|26344101|P1|Overall Study|Lost to Follow-up|4
7575049|NCT02195687|26344100|P2|Overall Study|Personal Reasons|1
7575050|NCT02195687|26344101|P1|Overall Study|Personal Reasons|1
7575051|NCT02195583|26344126|P1|Overall Study|Other Reason|2
7575052|NCT02195583|26344126|P1|Overall Study|Adverse Event|2
7575053|NCT02195583|26344126|P1|Overall Study|Withdrawal by Subject|4
7575054|NCT02195583|26344126|P1|Overall Study|Lost to Follow-up|1
7575055|NCT02195531|26344161|P3|Overall Study|Withdrawal by Subject|1
7575056|NCT02195531|26344162|P2|Overall Study|Withdrawal by Subject|1
7575057|NCT02195531|26344163|P1|Overall Study|Withdrawal by Subject|1
7575058|NCT02195518|26344188|P1|Overall Study|Lost to Follow-up|1
7575059|NCT02195518|26344188|P1|Overall Study|Withdrawal by Subject|1
7575060|NCT02195518|26344188|P1|Overall Study|Pregnancy|2
7575061|NCT02195518|26344188|P1|Overall Study|Protocol Violation|4
7575062|NCT02195518|26344188|P1|Overall Study|Adverse Event|1
7575075|NCT02195427|26344250|P2|Overall Study|Conditional re-treatment at W52|1
7575076|NCT02195427|26344251|P1|Overall Study|Conditional re-treatment at W52|2
7575077|NCT02195427|26344250|P2|Overall Study|Protocol Violation|14
7575078|NCT02195427|26344251|P1|Overall Study|Protocol Violation|7
7575079|NCT02195427|26344250|P2|Overall Study|Lost to Follow-up|1
7575080|NCT02195427|26344251|P1|Overall Study|Lost to Follow-up|0
7575081|NCT02195427|26344250|P2|Overall Study|Withdrawal by Subject|2
7575082|NCT02195427|26344251|P1|Overall Study|Withdrawal by Subject|4
7575083|NCT02195427|26344250|P2|Overall Study|Did not consent to study extension|9
7575084|NCT02195427|26344251|P1|Overall Study|Did not consent to study extension|13
7575085|NCT02195011|26344616|P2|Overall Study|Withdrawal by Subject|0
7575086|NCT02195011|26344617|P1|Overall Study|Withdrawal by Subject|3
7575087|NCT02195011|26344616|P2|Overall Study|Progressive Disease|1
7575088|NCT02195011|26344617|P1|Overall Study|Progressive Disease|18
7575089|NCT02195011|26344616|P2|Overall Study|Adverse Event|0
7575090|NCT02195011|26344617|P1|Overall Study|Adverse Event|4
7575091|NCT02194998|26344633|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7575092|NCT02194998|26344634|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7575093|NCT02194998|26344635|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7575094|NCT02194998|26344636|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7575095|NCT02194998|26344633|P4|On-HCV Treatment|Did not pick up study medication|0
7575096|NCT02194998|26344634|P3|On-HCV Treatment|Did not pick up study medication|0
7575097|NCT02194998|26344635|P2|On-HCV Treatment|Did not pick up study medication|1
7575098|NCT02194998|26344636|P1|On-HCV Treatment|Did not pick up study medication|0
7575099|NCT02194985|26344698|P1|Overall Study|Withdrawal by Subject|2
7575100|NCT02194985|26344698|P1|Overall Study|Lost to Follow-up|1
7575101|NCT02194985|26344698|P1|Overall Study|Physician Decision|4
7575102|NCT02194985|26344698|P1|Overall Study|Met Protocol Defined Stopping Criteria|3
7575103|NCT02194985|26344698|P1|Overall Study|Adverse Event|1
7575104|NCT02194933|26344712|P2|Overall Study|Lack of Efficacy|2
7575105|NCT02194933|26344713|P1|Overall Study|Lack of Efficacy|1
7575106|NCT02194933|26344712|P2|Overall Study|Withdrawal by Subject|2
7575107|NCT02194933|26344713|P1|Overall Study|Withdrawal by Subject|0
7575108|NCT02194933|26344712|P2|Overall Study|Participant met withdrawal criteria|3
7575109|NCT02194933|26344713|P1|Overall Study|Participant met withdrawal criteria|1
7575110|NCT02194933|26344712|P2|Overall Study|Lost to Follow-up|2
7575111|NCT02194933|26344713|P1|Overall Study|Lost to Follow-up|1
7575112|NCT02194699|26344767|P2|With Potential to Receive 52 Weeks of IP|Other|16
7575113|NCT02194699|26344768|P1|With Potential to Receive 52 Weeks of IP|Other|24
7575114|NCT02194699|26344767|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
7575115|NCT02194699|26344768|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
7575116|NCT02194699|26344767|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7575117|NCT02194699|26344768|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7575118|NCT02194699|26344767|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
7575119|NCT02194699|26344768|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
7575120|NCT02194699|26344767|P2|With Potential to Receive 52 Weeks of IP|Death|3
7575121|NCT02194699|26344768|P1|With Potential to Receive 52 Weeks of IP|Death|1
7575122|NCT02194699|26344767|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
7575123|NCT02194699|26344768|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
7575124|NCT02194699|26344767|P2|Randomised|Duplicate patient|1
7575125|NCT02194699|26344768|P1|Randomised|Duplicate patient|2
7575126|NCT02194699|26344767|P2|Randomised|Without potential for 52 weeks of IP|5
7575127|NCT02194699|26344768|P1|Randomised|Without potential for 52 weeks of IP|5
7575128|NCT02194699|26344767|P2|Randomised|Did not receive treatment|5
7575129|NCT02194699|26344768|P1|Randomised|Did not receive treatment|1
7575130|NCT02194621|26344876|P3|Overall Study|Withdrawal by Subject|7
7575131|NCT02194621|26344877|P2|Overall Study|Withdrawal by Subject|4
7575132|NCT02194621|26344878|P1|Overall Study|Withdrawal by Subject|4
7575133|NCT02194621|26344876|P3|Overall Study|6 withdrew prior to randomization|2
7575134|NCT02194621|26344877|P2|Overall Study|6 withdrew prior to randomization|2
7575135|NCT02194621|26344878|P1|Overall Study|6 withdrew prior to randomization|2
7575136|NCT02194465|26344902|P7|Overall Study|Discontinued follow-up period|0
7575137|NCT02194465|26344903|P6|Overall Study|Discontinued follow-up period|0
7575138|NCT02194465|26344904|P5|Overall Study|Discontinued follow-up period|2
7575139|NCT02194465|26344905|P4|Overall Study|Discontinued follow-up period|0
7575140|NCT02194465|26344906|P3|Overall Study|Discontinued follow-up period|1
7575141|NCT02194465|26344907|P2|Overall Study|Discontinued follow-up period|2
7575142|NCT02194465|26344908|P1|Overall Study|Discontinued follow-up period|0
7575143|NCT02194465|26344902|P7|Overall Study|Withdrawal by Subject|2
7575144|NCT02194465|26344903|P6|Overall Study|Withdrawal by Subject|1
7575145|NCT02194465|26344904|P5|Overall Study|Withdrawal by Subject|2
7575146|NCT02194465|26344905|P4|Overall Study|Withdrawal by Subject|2
7575147|NCT02194465|26344906|P3|Overall Study|Withdrawal by Subject|1
7575148|NCT02194465|26344907|P2|Overall Study|Withdrawal by Subject|3
7575149|NCT02194465|26344908|P1|Overall Study|Withdrawal by Subject|1
7575150|NCT02194465|26344902|P7|Overall Study|Protocol Violation|0
7575151|NCT02194465|26344903|P6|Overall Study|Protocol Violation|0
7575152|NCT02194465|26344904|P5|Overall Study|Protocol Violation|1
7575153|NCT02194465|26344905|P4|Overall Study|Protocol Violation|1
7575154|NCT02194465|26344906|P3|Overall Study|Protocol Violation|2
7575155|NCT02194465|26344907|P2|Overall Study|Protocol Violation|1
7575156|NCT02194465|26344908|P1|Overall Study|Protocol Violation|1
7575157|NCT02194465|26344902|P7|Overall Study|Physician Decision|0
7575158|NCT02194465|26344903|P6|Overall Study|Physician Decision|0
7575159|NCT02194465|26344904|P5|Overall Study|Physician Decision|0
7575160|NCT02194465|26344905|P4|Overall Study|Physician Decision|0
7575161|NCT02194465|26344906|P3|Overall Study|Physician Decision|0
7575162|NCT02194465|26344907|P2|Overall Study|Physician Decision|0
7575163|NCT02194465|26344908|P1|Overall Study|Physician Decision|1
7575164|NCT02194465|26344902|P7|Overall Study|Lost to Follow-up|0
7575165|NCT02194465|26344903|P6|Overall Study|Lost to Follow-up|1
7575166|NCT02194465|26344904|P5|Overall Study|Lost to Follow-up|0
7575167|NCT02194465|26344905|P4|Overall Study|Lost to Follow-up|1
7575168|NCT02194465|26344906|P3|Overall Study|Lost to Follow-up|0
7575169|NCT02194465|26344907|P2|Overall Study|Lost to Follow-up|0
7575170|NCT02194465|26344908|P1|Overall Study|Lost to Follow-up|0
7575171|NCT02194465|26344902|P7|Overall Study|Adverse Event|0
7575172|NCT02194465|26344903|P6|Overall Study|Adverse Event|2
7575173|NCT02194465|26344904|P5|Overall Study|Adverse Event|4
7575174|NCT02194465|26344905|P4|Overall Study|Adverse Event|4
7575175|NCT02194465|26344906|P3|Overall Study|Adverse Event|4
7575176|NCT02194465|26344907|P2|Overall Study|Adverse Event|1
7575177|NCT02194465|26344908|P1|Overall Study|Adverse Event|6
7575178|NCT02194062|26344969|P3|Overall Study|Lost to Follow-up|5
7575179|NCT02194062|26344970|P2|Overall Study|Lost to Follow-up|2
7575180|NCT02194062|26344971|P1|Overall Study|Lost to Follow-up|2
7575181|NCT02193880|26344982|P1|Overall Study|patients did not collect enough HPC|3
7575182|NCT02193867|26344987|P1|Overall Study|Sponsor Study Termination|2
7575183|NCT02193867|26344987|P1|Overall Study|Death|2
7575184|NCT02193828|26345005|P4|Overall Study|Withdrawal by Subject|1
7575185|NCT02193828|26345006|P3|Overall Study|Withdrawal by Subject|1
7575186|NCT02193828|26345007|P2|Overall Study|Withdrawal by Subject|0
7575187|NCT02193828|26345008|P1|Overall Study|Withdrawal by Subject|0
7575188|NCT02193776|26345085|P4|Overall Study|Adverse event/Specific toxicity|2
7575189|NCT02193776|26345086|P3|Overall Study|Adverse event/Specific toxicity|2
7575190|NCT02193776|26345087|P2|Overall Study|Adverse event/Specific toxicity|5
7575191|NCT02193776|26345088|P1|Overall Study|Adverse event/Specific toxicity|5
7575192|NCT02193776|26345085|P4|Overall Study|Death|0
7575193|NCT02193776|26345086|P3|Overall Study|Death|0
7575194|NCT02193776|26345087|P2|Overall Study|Death|0
7575195|NCT02193776|26345088|P1|Overall Study|Death|1
7575196|NCT02193776|26345085|P4|Overall Study|Investigator/Sponsor decision|0
7575197|NCT02193776|26345086|P3|Overall Study|Investigator/Sponsor decision|0
7575198|NCT02193776|26345087|P2|Overall Study|Investigator/Sponsor decision|1
7575199|NCT02193776|26345088|P1|Overall Study|Investigator/Sponsor decision|1
7575200|NCT02193776|26345085|P4|Overall Study|Failure to comply with protocol|0
7575201|NCT02193776|26345086|P3|Overall Study|Failure to comply with protocol|0
7575202|NCT02193776|26345087|P2|Overall Study|Failure to comply with protocol|1
7575203|NCT02193776|26345088|P1|Overall Study|Failure to comply with protocol|0
7575204|NCT02193776|26345085|P4|Overall Study|Consent withdrawn|0
7575205|NCT02193776|26345086|P3|Overall Study|Consent withdrawn|0
7575206|NCT02193776|26345087|P2|Overall Study|Consent withdrawn|0
7575207|NCT02193776|26345088|P1|Overall Study|Consent withdrawn|1
7575208|NCT02193178|26345120|P1|Overall Study|Dry eyes|1
7575209|NCT02193178|26345120|P1|Overall Study|Lost to Follow-up|1
7575210|NCT02193165|26345170|P3|6 Week Product Use|Lost to Follow-up|0
7575211|NCT02193165|26345171|P2|6 Week Product Use|Lost to Follow-up|1
7575212|NCT02193165|26345172|P1|6 Week Product Use|Lost to Follow-up|0
7575213|NCT02193165|26345170|P3|4 Week Product Use|Lost to Follow-up|1
7575214|NCT02193165|26345171|P2|4 Week Product Use|Lost to Follow-up|1
7575215|NCT02193165|26345172|P1|4 Week Product Use|Lost to Follow-up|1
7575216|NCT02193087|26345207|P4|Overall Study|Did Not Receive Any Vaccination|1
7575217|NCT02193087|26345208|P3|Overall Study|Did Not Receive Any Vaccination|0
7575218|NCT02193087|26345209|P2|Overall Study|Did Not Receive Any Vaccination|3
7575219|NCT02193087|26345210|P1|Overall Study|Did Not Receive Any Vaccination|2
7575220|NCT02193087|26345207|P4|Overall Study|Other Reason Not Specified|9
7575221|NCT02193087|26345208|P3|Overall Study|Other Reason Not Specified|1
7575222|NCT02193087|26345209|P2|Overall Study|Other Reason Not Specified|2
7575223|NCT02193087|26345210|P1|Overall Study|Other Reason Not Specified|7
7575224|NCT02193087|26345207|P4|Overall Study|Withdrawal by Subject|19
7575225|NCT02193087|26345208|P3|Overall Study|Withdrawal by Subject|1
7575226|NCT02193087|26345209|P2|Overall Study|Withdrawal by Subject|3
7575227|NCT02193087|26345210|P1|Overall Study|Withdrawal by Subject|10
7575228|NCT02193087|26345207|P4|Overall Study|Protocol Violation|2
7575229|NCT02193087|26345208|P3|Overall Study|Protocol Violation|1
7575230|NCT02193087|26345209|P2|Overall Study|Protocol Violation|0
7575231|NCT02193087|26345210|P1|Overall Study|Protocol Violation|2
7575232|NCT02193087|26345207|P4|Overall Study|Lost to Follow-up|37
7575233|NCT02193087|26345208|P3|Overall Study|Lost to Follow-up|4
7575234|NCT02193087|26345209|P2|Overall Study|Lost to Follow-up|6
7575235|NCT02193087|26345210|P1|Overall Study|Lost to Follow-up|14
7575236|NCT02193087|26345207|P4|Overall Study|Adverse Event|11
7575237|NCT02193087|26345208|P3|Overall Study|Adverse Event|0
7575238|NCT02193087|26345209|P2|Overall Study|Adverse Event|0
7575239|NCT02193087|26345210|P1|Overall Study|Adverse Event|2
7575240|NCT02193074|26345255|P2|Overall Study|Adverse Event|13
7575241|NCT02193074|26345256|P1|Overall Study|Adverse Event|16
7575242|NCT02193074|26345255|P2|Overall Study|Withdrawal by Subject|2
7575243|NCT02193074|26345256|P1|Overall Study|Withdrawal by Subject|1
7575244|NCT02192970|26345290|P2|Overall Study|Lost to Follow-up|0
7575245|NCT02192970|26345291|P1|Overall Study|Lost to Follow-up|6
7575246|NCT02192905|26345299|P1|Overall Study|Lost to Follow-up|1
7575247|NCT02192606|26345367|P2|Overall Study|3D equipment rep unable to join|1
7575248|NCT02192606|26345368|P1|Overall Study|3D equipment rep unable to join|0
7575249|NCT02192606|26345367|P2|Overall Study|Physician Decision|2
7575250|NCT02192606|26345368|P1|Overall Study|Physician Decision|1
7575251|NCT02192606|26345367|P2|Overall Study|surgery type was changed|1
7575252|NCT02192606|26345368|P1|Overall Study|surgery type was changed|1
7575253|NCT02192190|26345416|P6|Overall Study|Inadequate Pain Relief|0
7575254|NCT02192190|26345417|P5|Overall Study|Inadequate Pain Relief|0
7575255|NCT02192190|26345418|P4|Overall Study|Inadequate Pain Relief|0
7575256|NCT02192190|26345419|P3|Overall Study|Inadequate Pain Relief|1
7575257|NCT02192190|26345420|P2|Overall Study|Inadequate Pain Relief|1
7575258|NCT02192190|26345421|P1|Overall Study|Inadequate Pain Relief|0
7575259|NCT02192190|26345416|P6|Overall Study|Positive Drug Screen|0
7575260|NCT02192190|26345417|P5|Overall Study|Positive Drug Screen|0
7575261|NCT02192190|26345418|P4|Overall Study|Positive Drug Screen|1
7575262|NCT02192190|26345419|P3|Overall Study|Positive Drug Screen|0
7575263|NCT02192190|26345420|P2|Overall Study|Positive Drug Screen|0
7575264|NCT02192190|26345421|P1|Overall Study|Positive Drug Screen|0
7575265|NCT02192190|26345416|P6|Overall Study|Could not Keep Visit Schedule|0
7575266|NCT02192190|26345417|P5|Overall Study|Could not Keep Visit Schedule|0
7575267|NCT02192190|26345418|P4|Overall Study|Could not Keep Visit Schedule|0
7575268|NCT02192190|26345419|P3|Overall Study|Could not Keep Visit Schedule|0
7575269|NCT02192190|26345420|P2|Overall Study|Could not Keep Visit Schedule|0
7575270|NCT02192190|26345421|P1|Overall Study|Could not Keep Visit Schedule|1
7575271|NCT02192190|26345416|P6|Overall Study|Withdrawal by Subject|3
7575272|NCT02192190|26345417|P5|Overall Study|Withdrawal by Subject|5
7575273|NCT02192190|26345418|P4|Overall Study|Withdrawal by Subject|1
7575274|NCT02192190|26345419|P3|Overall Study|Withdrawal by Subject|2
7575275|NCT02192190|26345420|P2|Overall Study|Withdrawal by Subject|1
7575276|NCT02192190|26345421|P1|Overall Study|Withdrawal by Subject|4
7575277|NCT02192190|26345416|P6|Overall Study|Terminated by Sponsor|23
7575278|NCT02192190|26345417|P5|Overall Study|Terminated by Sponsor|21
7575279|NCT02192190|26345418|P4|Overall Study|Terminated by Sponsor|23
7575280|NCT02192190|26345419|P3|Overall Study|Terminated by Sponsor|20
7575281|NCT02192190|26345420|P2|Overall Study|Terminated by Sponsor|23
7575282|NCT02192190|26345421|P1|Overall Study|Terminated by Sponsor|43
7575283|NCT02192190|26345416|P6|Overall Study|Physician Decision|0
7575284|NCT02192190|26345417|P5|Overall Study|Physician Decision|0
7575285|NCT02192190|26345418|P4|Overall Study|Physician Decision|0
7575286|NCT02192190|26345419|P3|Overall Study|Physician Decision|0
7575287|NCT02192190|26345420|P2|Overall Study|Physician Decision|0
7575288|NCT02192190|26345421|P1|Overall Study|Physician Decision|2
7575289|NCT02192190|26345416|P6|Overall Study|Lost to Follow-up|3
7575290|NCT02192190|26345417|P5|Overall Study|Lost to Follow-up|4
7575291|NCT02192190|26345418|P4|Overall Study|Lost to Follow-up|1
7575292|NCT02192190|26345419|P3|Overall Study|Lost to Follow-up|2
7575293|NCT02192190|26345420|P2|Overall Study|Lost to Follow-up|3
7575294|NCT02192190|26345421|P1|Overall Study|Lost to Follow-up|3
7575295|NCT02192190|26345416|P6|Overall Study|Adverse Event|0
7575296|NCT02192190|26345417|P5|Overall Study|Adverse Event|0
7575297|NCT02192190|26345418|P4|Overall Study|Adverse Event|0
7575298|NCT02192190|26345419|P3|Overall Study|Adverse Event|0
7575299|NCT02192190|26345420|P2|Overall Study|Adverse Event|1
7575300|NCT02192190|26345421|P1|Overall Study|Adverse Event|1
7575301|NCT02192164|26345465|P1|Overall Study|Did not meet the exclusion criteria|1
7575302|NCT02192164|26345465|P1|Overall Study|Physician Decision|4
7575303|NCT02192164|26345465|P1|Overall Study|Withdrawal by Subject|1
7575304|NCT02192164|26345465|P1|Overall Study|Other|8
7575305|NCT02192099|26345481|P1|Overall Study|Miscellaneous Reasons|5
7575306|NCT02192099|26345481|P1|Overall Study|Withdrawal by Subject|11
7575307|NCT02192099|26345481|P1|Overall Study|Study Terminated by Sponsor|32
7575308|NCT02192099|26345481|P1|Overall Study|Protocol Violation|8
7575309|NCT02192099|26345481|P1|Overall Study|Pregnancy|1
7575310|NCT02192099|26345481|P1|Overall Study|Physician Decision|1
7575311|NCT02192099|26345481|P1|Overall Study|Lost to Follow-up|2
7575312|NCT02192099|26345481|P1|Overall Study|Adverse Event|1
7575313|NCT02191618|26345510|P1|Overall Study|Missed Visit|4
7575314|NCT02191618|26345510|P1|Overall Study|Withdrawal by Subject|3
7575315|NCT02191605|26345520|P5|Overall Study|Lost to Follow-up|4
7575316|NCT02191605|26345521|P4|Overall Study|Lost to Follow-up|3
7575317|NCT02191605|26345522|P3|Overall Study|Lost to Follow-up|7
7575318|NCT02191605|26345523|P2|Overall Study|Lost to Follow-up|4
7575319|NCT02191605|26345524|P1|Overall Study|Lost to Follow-up|9
7575320|NCT02191579|26345543|P2|Treatment 2|Multiple Reasons Specified|25
7575321|NCT02191579|26345544|P1|Treatment 2|Multiple Reasons Specified|0
7575322|NCT02191579|26345543|P2|Treatment 1|Multiple Reasons Specified|58
7575323|NCT02191579|26345544|P1|Treatment 1|Multiple Reasons Specified|27
7575324|NCT02191397|26345558|P2|Overall Study|Withdrawal by Subject|27
7575325|NCT02191397|26345559|P1|Overall Study|Withdrawal by Subject|22
7575326|NCT02191397|26345558|P2|Overall Study|Physician Decision|3
7575327|NCT02191397|26345559|P1|Overall Study|Physician Decision|8
7575328|NCT02191397|26345558|P2|Overall Study|Lost to Follow-up|11
7575329|NCT02191397|26345559|P1|Overall Study|Lost to Follow-up|10
7575330|NCT02191397|26345558|P2|Overall Study|Met protocol-defined stopping criteria|4
7575331|NCT02191397|26345559|P1|Overall Study|Met protocol-defined stopping criteria|5
7575332|NCT02191397|26345558|P2|Overall Study|Protocol Violation|3
7575333|NCT02191397|26345559|P1|Overall Study|Protocol Violation|0
7575334|NCT02191397|26345558|P2|Overall Study|Lack of Efficacy|5
7575335|NCT02191397|26345559|P1|Overall Study|Lack of Efficacy|10
7575336|NCT02191397|26345558|P2|Overall Study|Adverse Event|17
7575337|NCT02191397|26345559|P1|Overall Study|Adverse Event|28
7575338|NCT02191267|26345620|P3|Overall Study|Withdrawal by Subject|0
7575339|NCT02191267|26345621|P2|Overall Study|Withdrawal by Subject|0
7575340|NCT02191267|26345622|P1|Overall Study|Withdrawal by Subject|1
7575341|NCT02191137|26345633|P1|Follow-up|Adverse Event|1
7575342|NCT02191137|26345633|P1|Follow-up|Ongoing/unknown|2
7575343|NCT02191137|26345633|P1|Follow-up|Lost to Follow-up|2
7575344|NCT02191137|26345633|P1|Treatment|Other|1
7575345|NCT02191137|26345633|P1|Treatment|Adverse Event|2
7575346|NCT02191137|26345633|P1|Treatment|Withdrawal by Subject|3
7575347|NCT02191137|26345633|P1|Treatment|Death|4
7575348|NCT02191046|26345663|P2|Overall Study|low compliance|1
7575349|NCT02191046|26345664|P1|Overall Study|low compliance|5
7575350|NCT02190721|26345771|P3|Overall Study|Patient was out of the city|0
7575351|NCT02190721|26345772|P2|Overall Study|Patient was out of the city|1
7575352|NCT02190721|26345773|P1|Overall Study|Patient was out of the city|0
7575353|NCT02190604|26345896|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575354|NCT02190604|26345897|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575355|NCT02190604|26345898|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575356|NCT02190604|26345899|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575357|NCT02190604|26345900|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575358|NCT02190604|26345901|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
7575359|NCT02190604|26345902|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575360|NCT02190604|26345903|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575361|NCT02190604|26345904|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575362|NCT02190604|26345905|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575363|NCT02190604|26345906|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575364|NCT02190604|26345907|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575365|NCT02190604|26345908|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575366|NCT02190604|26345909|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575367|NCT02190604|26345910|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575368|NCT02190604|26345911|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575369|NCT02190604|26345912|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575370|NCT02190604|26345913|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575371|NCT02190604|26345914|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7575372|NCT02190604|26345896|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575373|NCT02190604|26345897|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575374|NCT02190604|26345898|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575375|NCT02190604|26345899|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575376|NCT02190604|26345900|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
7575377|NCT02190604|26345901|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575378|NCT02190604|26345902|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575379|NCT02190604|26345903|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575380|NCT02190604|26345904|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575381|NCT02190604|26345905|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575382|NCT02190604|26345906|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575383|NCT02190604|26345907|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575384|NCT02190604|26345908|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575385|NCT02190604|26345909|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575386|NCT02190604|26345910|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575387|NCT02190604|26345911|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575388|NCT02190604|26345912|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575389|NCT02190604|26345913|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575390|NCT02190604|26345914|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7575391|NCT02190591|26346105|P2|Overall Study|face presentation so she was ineligible|1
7575392|NCT02190591|26346106|P1|Overall Study|face presentation so she was ineligible|0
7575393|NCT02190591|26346105|P2|Overall Study|did not use peanut ball as instructed|2
7575394|NCT02190591|26346106|P1|Overall Study|did not use peanut ball as instructed|0
7575395|NCT02190591|26346105|P2|Overall Study|Protocol Violation|0
7575396|NCT02190591|26346106|P1|Overall Study|Protocol Violation|1
7575397|NCT02190591|26346105|P2|Overall Study|Withdrawal by Subject|8
7575398|NCT02190591|26346106|P1|Overall Study|Withdrawal by Subject|1
7575399|NCT02190435|26346129|P2|Overall Study|3 consented screen fails|0
7575400|NCT02190435|26346130|P1|Overall Study|3 consented screen fails|3
7575401|NCT02190435|26346129|P2|Overall Study|First 12 patients were lead-ins|0
7575402|NCT02190435|26346130|P1|Overall Study|First 12 patients were lead-ins|12
7575403|NCT02190279|26346141|P3|Overall Study|Screening failure|1
7575404|NCT02190279|26346142|P2|Overall Study|Screening failure|0
7575405|NCT02190279|26346143|P1|Overall Study|Screening failure|0
7575406|NCT02190279|26346141|P3|Overall Study|Refused further treatment|1
7575407|NCT02190279|26346142|P2|Overall Study|Refused further treatment|0
7575408|NCT02190279|26346143|P1|Overall Study|Refused further treatment|0
7575409|NCT02190279|26346141|P3|Overall Study|Lost to Follow-up|0
7575410|NCT02190279|26346142|P2|Overall Study|Lost to Follow-up|0
7575411|NCT02190279|26346143|P1|Overall Study|Lost to Follow-up|2
7575412|NCT02190279|26346141|P3|Overall Study|Withdrawal consent|1
7575413|NCT02190279|26346142|P2|Overall Study|Withdrawal consent|0
7575414|NCT02190279|26346143|P1|Overall Study|Withdrawal consent|1
7575415|NCT02189941|26346182|P3|Overall Study|Non-compliance|1
7575416|NCT02189941|26346183|P2|Overall Study|Non-compliance|0
7575417|NCT02189941|26346184|P1|Overall Study|Non-compliance|0
7575418|NCT02189863|26346229|P2|First 2 Weeks|Motion Sickness|2
7575419|NCT02189863|26346230|P1|First 2 Weeks|Motion Sickness|4
7575420|NCT02189837|26346254|P4|Overall Study|Sponsor Decision|1
7575421|NCT02189837|26346255|P3|Overall Study|Sponsor Decision|0
7575422|NCT02189837|26346256|P2|Overall Study|Sponsor Decision|0
7575423|NCT02189837|26346257|P1|Overall Study|Sponsor Decision|0
7575424|NCT02189837|26346254|P4|Overall Study|Withdrawal by Subject|1
7575425|NCT02189837|26346255|P3|Overall Study|Withdrawal by Subject|3
7575426|NCT02189837|26346256|P2|Overall Study|Withdrawal by Subject|1
7575427|NCT02189837|26346257|P1|Overall Study|Withdrawal by Subject|2
7575428|NCT02189759|26346287|P4|Overall Study|Lost to Follow-up|5
7575429|NCT02189759|26346288|P3|Overall Study|Lost to Follow-up|2
7575430|NCT02189759|26346289|P2|Overall Study|Lost to Follow-up|0
7575431|NCT02189759|26346290|P1|Overall Study|Lost to Follow-up|0
7575432|NCT02189473|26346326|P2|Overall Study|Lost to Follow-up|2
7575433|NCT02189473|26346327|P1|Overall Study|Lost to Follow-up|1
7575434|NCT02189473|26346326|P2|Overall Study|Death|23
7575435|NCT02189473|26346327|P1|Overall Study|Death|22
7575436|NCT02189252|26346375|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7575437|NCT02189252|26346376|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7575438|NCT02189252|26346377|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
7575439|NCT02189252|26346378|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7575440|NCT02189252|26346375|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7575441|NCT02189252|26346376|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7575442|NCT02189252|26346377|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
7575443|NCT02189252|26346378|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7575444|NCT02188849|26346446|P2|Overall Study|Lost to Follow-up|8
7575445|NCT02188849|26346447|P1|Overall Study|Lost to Follow-up|3
7575446|NCT02188784|26346461|P2|Overall Study|Physician Decision|3
7575447|NCT02188784|26346462|P1|Overall Study|Physician Decision|2
7575448|NCT02188784|26346461|P2|Overall Study|Withdrawal by Subject|9
7575449|NCT02188784|26346462|P1|Overall Study|Withdrawal by Subject|3
7575450|NCT02188784|26346461|P2|Overall Study|Lost to Follow-up|0
7575451|NCT02188784|26346462|P1|Overall Study|Lost to Follow-up|1
7575452|NCT02188784|26346461|P2|Overall Study|Death|1
7575453|NCT02188784|26346462|P1|Overall Study|Death|3
7575454|NCT02188719|26346482|P4|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7575455|NCT02188719|26346483|P3|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7575456|NCT02188719|26346484|P2|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
7575457|NCT02188719|26346485|P1|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7575458|NCT02188589|26346509|P1|Overall Study|Withdrawal by Subject|5
7575459|NCT02188485|26346528|P2|Overall Study|PI withdrew, lack of capacity|2
7575460|NCT02188485|26346529|P1|Overall Study|PI withdrew, lack of capacity|0
7575461|NCT02188485|26346528|P2|Overall Study|Withdrawal by Subject|1
7575462|NCT02188485|26346529|P1|Overall Study|Withdrawal by Subject|2
7575463|NCT02188459|26346541|P2|Overall Study|Early Termination|3
7575464|NCT02188459|26346542|P1|Overall Study|Early Termination|0
7575465|NCT02188459|26346541|P2|Overall Study|Lost to Follow-up|4
7575466|NCT02188459|26346542|P1|Overall Study|Lost to Follow-up|3
7575467|NCT02188303|26346568|P8|Overall Study|Dose Termination Criteria Met|4
7575468|NCT02188303|26346569|P7|Overall Study|Dose Termination Criteria Met|2
7575469|NCT02188303|26346570|P6|Overall Study|Dose Termination Criteria Met|0
7575470|NCT02188303|26346571|P5|Overall Study|Dose Termination Criteria Met|0
7575471|NCT02188303|26346572|P4|Overall Study|Dose Termination Criteria Met|0
7575472|NCT02188303|26346573|P3|Overall Study|Dose Termination Criteria Met|0
7575473|NCT02188303|26346574|P2|Overall Study|Dose Termination Criteria Met|0
7575474|NCT02188303|26346575|P1|Overall Study|Dose Termination Criteria Met|0
7575475|NCT02188303|26346568|P8|Overall Study|Adverse Event|2
7575476|NCT02188303|26346569|P7|Overall Study|Adverse Event|0
7575477|NCT02188303|26346570|P6|Overall Study|Adverse Event|2
7575478|NCT02188303|26346571|P5|Overall Study|Adverse Event|0
7575479|NCT02188303|26346572|P4|Overall Study|Adverse Event|0
7575480|NCT02188303|26346573|P3|Overall Study|Adverse Event|0
7575481|NCT02188303|26346574|P2|Overall Study|Adverse Event|0
7575482|NCT02188303|26346575|P1|Overall Study|Adverse Event|0
7575483|NCT02188160|26346605|P2|Overall Study|Use of an excluded medication|1
7575484|NCT02188160|26346606|P1|Overall Study|Use of an excluded medication|0
7575485|NCT02188160|26346605|P2|Overall Study|Adverse Event|0
7575486|NCT02188160|26346606|P1|Overall Study|Adverse Event|1
7575487|NCT02187861|26346635|P4|Overall Study|Other|1
7575488|NCT02187861|26346636|P3|Overall Study|Other|7
7575489|NCT02187861|26346637|P2|Overall Study|Other|1
7575490|NCT02187861|26346638|P1|Overall Study|Other|0
7575491|NCT02187861|26346635|P4|Overall Study|Withdrawal by Subject|3
7575492|NCT02187861|26346636|P3|Overall Study|Withdrawal by Subject|3
7575493|NCT02187861|26346637|P2|Overall Study|Withdrawal by Subject|0
7575494|NCT02187861|26346638|P1|Overall Study|Withdrawal by Subject|0
7575495|NCT02187861|26346635|P4|Overall Study|Progressive Disease|22
7575496|NCT02187861|26346636|P3|Overall Study|Progressive Disease|19
7575497|NCT02187861|26346637|P2|Overall Study|Progressive Disease|42
7575498|NCT02187861|26346638|P1|Overall Study|Progressive Disease|4
7575499|NCT02187861|26346635|P4|Overall Study|Physician Decision|3
7575500|NCT02187861|26346636|P3|Overall Study|Physician Decision|0
7575501|NCT02187861|26346637|P2|Overall Study|Physician Decision|1
7575502|NCT02187861|26346638|P1|Overall Study|Physician Decision|0
7575503|NCT02187861|26346635|P4|Overall Study|Death|2
7575504|NCT02187861|26346636|P3|Overall Study|Death|1
7575505|NCT02187861|26346637|P2|Overall Study|Death|3
7575506|NCT02187861|26346638|P1|Overall Study|Death|0
7575507|NCT02187861|26346635|P4|Overall Study|Adverse Event|1
7575508|NCT02187861|26346636|P3|Overall Study|Adverse Event|2
7575509|NCT02187861|26346637|P2|Overall Study|Adverse Event|1
7575510|NCT02187861|26346638|P1|Overall Study|Adverse Event|2
7575511|NCT02187809|26346734|P1|Overall Study|The study was terminated|3
7575512|NCT02187783|26346744|P1|Overall Study|Study terminated by sponsor|1
7575513|NCT02187783|26346744|P1|Overall Study|Withdrawal by Subject|9
7575514|NCT02187783|26346744|P1|Overall Study|Physician Decision|2
7575515|NCT02187783|26346744|P1|Overall Study|Protocol Violation|3
7575516|NCT02187783|26346744|P1|Overall Study|Progressive disease|80
7575517|NCT02187783|26346744|P1|Overall Study|Death|3
7575518|NCT02187783|26346744|P1|Overall Study|Adverse Event|8
7575519|NCT02187744|26346755|P2|Treatment|Participant refused continued treatment|1
7575520|NCT02187744|26346756|P1|Treatment|Participant refused continued treatment|1
7575521|NCT02187744|26346755|P2|Treatment|Other|0
7575522|NCT02187744|26346756|P1|Treatment|Other|2
7575523|NCT02187744|26346755|P2|Treatment|Lost to Follow-up|1
7575524|NCT02187744|26346756|P1|Treatment|Lost to Follow-up|0
7575525|NCT02187744|26346755|P2|Treatment|Related adverse event, not serious|2
7575526|NCT02187744|26346756|P1|Treatment|Related adverse event, not serious|0
7575527|NCT02187744|26346755|P2|Treatment|Related adverse event, serious non-fatal|1
7575528|NCT02187744|26346756|P1|Treatment|Related adverse event, serious non-fatal|0
7575529|NCT02187744|26346755|P2|Treatment|Death|0
7575530|NCT02187744|26346756|P1|Treatment|Death|1
7575531|NCT02187744|26346755|P2|Study|Related adverse event, serious non-fatal|1
7575532|NCT02187744|26346756|P1|Study|Related adverse event, serious non-fatal|0
7575533|NCT02187744|26346755|P2|Study|Death|0
7575534|NCT02187744|26346756|P1|Study|Death|1
7575535|NCT02187744|26346755|P2|Study|Related adverse event, not serious|2
7575536|NCT02187744|26346756|P1|Study|Related adverse event, not serious|0
7575537|NCT02187744|26346755|P2|Study|Lost to Follow-up|2
7575538|NCT02187744|26346756|P1|Study|Lost to Follow-up|0
7575539|NCT02187744|26346755|P2|Study|Other|1
7575541|NCT02187744|26346755|P2|Study|Participant refused further follow-up|0
7575542|NCT02187744|26346756|P1|Study|Participant refused further follow-up|1
7575543|NCT02187471|26346776|P4|Overall Study|Other|4
7575544|NCT02187471|26346777|P3|Overall Study|Other|3
7575545|NCT02187471|26346778|P2|Overall Study|Other|5
7575546|NCT02187471|26346779|P1|Overall Study|Other|7
7575547|NCT02187471|26346776|P4|Overall Study|Withdrawal by Subject|24
7575548|NCT02187471|26346777|P3|Overall Study|Withdrawal by Subject|22
7575549|NCT02187471|26346778|P2|Overall Study|Withdrawal by Subject|29
7575550|NCT02187471|26346779|P1|Overall Study|Withdrawal by Subject|23
7575551|NCT02187471|26346776|P4|Overall Study|Adverse Event|36
7575552|NCT02187471|26346777|P3|Overall Study|Adverse Event|44
7575553|NCT02187471|26346778|P2|Overall Study|Adverse Event|34
7575554|NCT02187471|26346779|P1|Overall Study|Adverse Event|24
7575555|NCT02187471|26346776|P4|Overall Study|Lack of Efficacy|11
7575556|NCT02187471|26346777|P3|Overall Study|Lack of Efficacy|13
7575557|NCT02187471|26346778|P2|Overall Study|Lack of Efficacy|9
7575558|NCT02187471|26346779|P1|Overall Study|Lack of Efficacy|18
7575559|NCT02187471|26346776|P4|Overall Study|Missing|1
7575560|NCT02187471|26346777|P3|Overall Study|Missing|0
7575561|NCT02187471|26346778|P2|Overall Study|Missing|0
7575562|NCT02187471|26346779|P1|Overall Study|Missing|0
7575563|NCT02187471|26346776|P4|Overall Study|Protocol Violation|4
7575564|NCT02187471|26346777|P3|Overall Study|Protocol Violation|4
7575565|NCT02187471|26346778|P2|Overall Study|Protocol Violation|5
7575566|NCT02187471|26346779|P1|Overall Study|Protocol Violation|4
7575567|NCT02187172|26346835|P2|Overall Study|Physician Decision|1
7575568|NCT02187172|26346836|P1|Overall Study|Physician Decision|1
7575569|NCT02187172|26346835|P2|Overall Study|Adverse Event|1
7575570|NCT02187172|26346836|P1|Overall Study|Adverse Event|0
7575571|NCT02187172|26346835|P2|Overall Study|Lack of Efficacy|2
7575572|NCT02187172|26346836|P1|Overall Study|Lack of Efficacy|1
7575573|NCT02187172|26346835|P2|Overall Study|Lost to Follow-up|2
7575574|NCT02187172|26346836|P1|Overall Study|Lost to Follow-up|1
7575575|NCT02187159|26347004|P4|Overall Study|Other|9
7575576|NCT02187159|26347005|P3|Overall Study|Other|3
7575577|NCT02187159|26347006|P2|Overall Study|Other|7
7575578|NCT02187159|26347007|P1|Overall Study|Other|3
7575579|NCT02187159|26347004|P4|Overall Study|Withdrawal by Subject|26
7575580|NCT02187159|26347005|P3|Overall Study|Withdrawal by Subject|25
7575581|NCT02187159|26347006|P2|Overall Study|Withdrawal by Subject|28
7575582|NCT02187159|26347007|P1|Overall Study|Withdrawal by Subject|24
7575583|NCT02187159|26347004|P4|Overall Study|Adverse Event|50
7575584|NCT02187159|26347005|P3|Overall Study|Adverse Event|42
7575585|NCT02187159|26347006|P2|Overall Study|Adverse Event|33
7575586|NCT02187159|26347007|P1|Overall Study|Adverse Event|28
7575587|NCT02187159|26347004|P4|Overall Study|Lack of Efficacy|7
7575588|NCT02187159|26347005|P3|Overall Study|Lack of Efficacy|4
7575589|NCT02187159|26347006|P2|Overall Study|Lack of Efficacy|5
7575590|NCT02187159|26347007|P1|Overall Study|Lack of Efficacy|10
7575591|NCT02187159|26347004|P4|Overall Study|Protocol Violation|4
7575592|NCT02187159|26347005|P3|Overall Study|Protocol Violation|3
7575593|NCT02187159|26347006|P2|Overall Study|Protocol Violation|6
7575594|NCT02187159|26347007|P1|Overall Study|Protocol Violation|4
7575595|NCT02187055|26347064|P3|Overall Study|Death|0
7575596|NCT02187055|26347065|P2|Overall Study|Death|0
7575597|NCT02187055|26347066|P1|Overall Study|Death|2
7575598|NCT02187055|26347064|P3|Overall Study|Adverse Event|36
7575599|NCT02187055|26347065|P2|Overall Study|Adverse Event|26
7575600|NCT02187055|26347066|P1|Overall Study|Adverse Event|21
7575601|NCT02187055|26347064|P3|Overall Study|Withdrawal by Subject|11
7575602|NCT02187055|26347065|P2|Overall Study|Withdrawal by Subject|11
7575603|NCT02187055|26347066|P1|Overall Study|Withdrawal by Subject|11
7575604|NCT02187055|26347064|P3|Overall Study|Pregnancy|0
7575605|NCT02187055|26347065|P2|Overall Study|Pregnancy|1
7575606|NCT02187055|26347066|P1|Overall Study|Pregnancy|3
7575607|NCT02187055|26347064|P3|Overall Study|Protocol Violation|4
7575608|NCT02187055|26347065|P2|Overall Study|Protocol Violation|9
7575609|NCT02187055|26347066|P1|Overall Study|Protocol Violation|9
7575610|NCT02187055|26347064|P3|Overall Study|Other|3
7575611|NCT02187055|26347065|P2|Overall Study|Other|6
7575612|NCT02187055|26347066|P1|Overall Study|Other|5
7575613|NCT02187055|26347064|P3|Overall Study|No longer willing to participate|10
7575614|NCT02187055|26347065|P2|Overall Study|No longer willing to participate|8
7575615|NCT02187055|26347066|P1|Overall Study|No longer willing to participate|6
7575616|NCT02187055|26347064|P3|Overall Study|No longer meets eligibility criteria|0
7575617|NCT02187055|26347065|P2|Overall Study|No longer meets eligibility criteria|2
7575618|NCT02187055|26347066|P1|Overall Study|No longer meets eligibility criteria|0
7575619|NCT02187055|26347064|P3|Overall Study|Lost to Follow-up|3
7575620|NCT02187055|26347065|P2|Overall Study|Lost to Follow-up|7
7575621|NCT02187055|26347066|P1|Overall Study|Lost to Follow-up|2
7575622|NCT02187055|26347064|P3|Overall Study|Lack of Efficacy|7
7575623|NCT02187055|26347065|P2|Overall Study|Lack of Efficacy|3
7575624|NCT02187055|26347066|P1|Overall Study|Lack of Efficacy|10
7575625|NCT02187042|26347166|P2|Overall Study|Progressive disease|8
7575626|NCT02187042|26347167|P1|Overall Study|Progressive disease|4
7575627|NCT02187042|26347166|P2|Overall Study|Doctor choice|0
7575628|NCT02187042|26347167|P1|Overall Study|Doctor choice|1
7575629|NCT02187042|26347166|P2|Overall Study|Participant choice|0
7575630|NCT02187042|26347167|P1|Overall Study|Participant choice|1
7575631|NCT02187042|26347166|P2|Overall Study|Toxicity|5
7575632|NCT02187042|26347167|P1|Overall Study|Toxicity|6
7575633|NCT02187042|26347166|P2|Overall Study|Death|1
7575634|NCT02187042|26347167|P1|Overall Study|Death|1
7575635|NCT02187029|26347213|P4|Overall Study|Withdrawal by Subject|0
7575636|NCT02187029|26347214|P3|Overall Study|Withdrawal by Subject|0
7575637|NCT02187029|26347215|P2|Overall Study|Withdrawal by Subject|0
7575638|NCT02187029|26347216|P1|Overall Study|Withdrawal by Subject|1
7575639|NCT02187029|26347213|P4|Overall Study|Study Terminated by Sponsor|3
7575640|NCT02187029|26347214|P3|Overall Study|Study Terminated by Sponsor|10
7575641|NCT02187029|26347215|P2|Overall Study|Study Terminated by Sponsor|0
7575642|NCT02187029|26347216|P1|Overall Study|Study Terminated by Sponsor|0
7575643|NCT02187029|26347213|P4|Overall Study|Adverse Event|0
7575644|NCT02187029|26347214|P3|Overall Study|Adverse Event|1
7575645|NCT02187029|26347215|P2|Overall Study|Adverse Event|1
7575646|NCT02187029|26347216|P1|Overall Study|Adverse Event|0
7575647|NCT02186873|26347338|P2|Overall Study|Withdrawal by Subject|2
7575648|NCT02186873|26347339|P1|Overall Study|Withdrawal by Subject|7
7575649|NCT02186873|26347338|P2|Overall Study|Lost to Follow-up|2
7575650|NCT02186873|26347339|P1|Overall Study|Lost to Follow-up|1
7575651|NCT02186873|26347338|P2|Overall Study|Lack of Efficacy|1
7575652|NCT02186873|26347339|P1|Overall Study|Lack of Efficacy|0
7575653|NCT02186873|26347338|P2|Overall Study|Adverse Event|3
7575654|NCT02186873|26347339|P1|Overall Study|Adverse Event|1
7575655|NCT02186847|26347364|P2|Overall Study|Protocol Violation|0
7575656|NCT02186847|26347365|P1|Overall Study|Protocol Violation|3
7575657|NCT02186834|26347379|P6|Treatment at RP2D|Died prior to treatment|1
7575658|NCT02186834|26347380|P5|Treatment at RP2D|Died prior to treatment|0
7575659|NCT02186834|26347381|P4|Treatment at RP2D|Died prior to treatment|0
7575660|NCT02186834|26347382|P3|Treatment at RP2D|Died prior to treatment|0
7575661|NCT02186834|26347383|P2|Treatment at RP2D|Died prior to treatment|0
7575662|NCT02186834|26347384|P1|Treatment at RP2D|Died prior to treatment|0
7575663|NCT02186834|26347379|P6|Dose Escalation|Death|0
7575664|NCT02186834|26347380|P5|Dose Escalation|Death|0
7575665|NCT02186834|26347381|P4|Dose Escalation|Death|1
7575666|NCT02186834|26347382|P3|Dose Escalation|Death|0
7575667|NCT02186834|26347383|P2|Dose Escalation|Death|0
7575668|NCT02186834|26347384|P1|Dose Escalation|Death|0
7575669|NCT02186821|26347395|P1|Overall Study|Study terminated by sponsor|2
7575670|NCT02186821|26347395|P1|Overall Study|Physician Decision|1
7575671|NCT02186821|26347395|P1|Overall Study|Protocol Violation|1
7575672|NCT02186821|26347395|P1|Overall Study|Disease progression|32
7575673|NCT02186821|26347395|P1|Overall Study|Death|2
7575674|NCT02186821|26347395|P1|Overall Study|Adverse Event|9
7575675|NCT02186652|26347430|P2|Overall Study|Lost to Follow-up|0
7575676|NCT02186652|26347431|P1|Overall Study|Lost to Follow-up|2
7575677|NCT02186561|26347464|P1|1- Year Post Index Procedure Visit|Missed|1
7575678|NCT02186561|26347464|P1|1- Year Post Index Procedure Visit|Death|1
7575679|NCT02186561|26347464|P1|30-Day Post Index Procedure Visit|Death|1
7575680|NCT02186561|26347464|P1|Enrollment|Investigator Withdrew Consent|1
7575681|NCT02186561|26347464|P1|Enrollment|Withdrawal by Subject|2
7575682|NCT02186561|26347464|P1|Enrollment|Insurance Denial|2
7575683|NCT02186561|26347464|P1|Enrollment|Enrollment Cap Reached|5
7575684|NCT02186561|26347464|P1|Enrollment|Did Not Meet Inclusion Criteria|46
7575685|NCT02186301|26347484|P3|Overall Study|Other|1
7575686|NCT02186301|26347485|P2|Overall Study|Other|0
7575687|NCT02186301|26347486|P1|Overall Study|Other|0
7575688|NCT02186301|26347484|P3|Overall Study|Missing|2
7575689|NCT02186301|26347485|P2|Overall Study|Missing|0
7575690|NCT02186301|26347486|P1|Overall Study|Missing|0
7575691|NCT02186301|26347484|P3|Overall Study|Protocol Deviation|0
7575692|NCT02186301|26347485|P2|Overall Study|Protocol Deviation|2
7575693|NCT02186301|26347486|P1|Overall Study|Protocol Deviation|0
7575694|NCT02186301|26347484|P3|Overall Study|Study Terminated by Sponsor|11
7575695|NCT02186301|26347485|P2|Overall Study|Study Terminated by Sponsor|0
7575696|NCT02186301|26347486|P1|Overall Study|Study Terminated by Sponsor|1
7575697|NCT02186301|26347484|P3|Overall Study|Physician Decision|1
7575698|NCT02186301|26347485|P2|Overall Study|Physician Decision|0
7575699|NCT02186301|26347486|P1|Overall Study|Physician Decision|1
7575700|NCT02186301|26347484|P3|Overall Study|Withdrawal by Subject|3
7575701|NCT02186301|26347485|P2|Overall Study|Withdrawal by Subject|1
7575702|NCT02186301|26347486|P1|Overall Study|Withdrawal by Subject|5
7575703|NCT02186301|26347484|P3|Overall Study|Death|0
7575704|NCT02186301|26347485|P2|Overall Study|Death|0
7575705|NCT02186301|26347486|P1|Overall Study|Death|1
7575706|NCT02186301|26347484|P3|Overall Study|Adverse Event|5
7575707|NCT02186301|26347485|P2|Overall Study|Adverse Event|5
7575708|NCT02186301|26347486|P1|Overall Study|Adverse Event|5
7575709|NCT02186301|26347484|P3|Overall Study|Progressive Disease|27
7575710|NCT02186301|26347485|P2|Overall Study|Progressive Disease|22
7575711|NCT02186301|26347486|P1|Overall Study|Progressive Disease|7
7575712|NCT02186223|26347502|P1|Overall Study|Device in place less than 48 hours|9
7575713|NCT02186223|26347502|P1|Overall Study|Death|3
7575714|NCT02186223|26347502|P1|Overall Study|Unable to obtain femoral access|3
7575715|NCT02186223|26347502|P1|Overall Study|Not eligible for device placement|6
7575716|NCT02186171|26347524|P2|Overall Study|Protocol-specified Criteria|2
7575717|NCT02186171|26347525|P1|Overall Study|Protocol-specified Criteria|0
7575718|NCT02186171|26347524|P2|Overall Study|Death|2
7575719|NCT02186171|26347525|P1|Overall Study|Death|1
7575720|NCT02186171|26347524|P2|Overall Study|Lost to Follow-up|2
7575721|NCT02186171|26347525|P1|Overall Study|Lost to Follow-up|2
7575722|NCT02186171|26347524|P2|Overall Study|Withdrawal by Subject|9
7575723|NCT02186171|26347525|P1|Overall Study|Withdrawal by Subject|1
7575724|NCT02186015|26347543|P2|Overall Study|Physician Decision|0
7575725|NCT02186015|26347544|P1|Overall Study|Physician Decision|1
7575726|NCT02185794|26347570|P6|Overall Study|Lost to Follow-up|1
7575727|NCT02185794|26347571|P5|Overall Study|Lost to Follow-up|0
7575728|NCT02185794|26347572|P4|Overall Study|Lost to Follow-up|3
7575729|NCT02185794|26347573|P3|Overall Study|Lost to Follow-up|2
7575730|NCT02185794|26347574|P2|Overall Study|Lost to Follow-up|2
7575731|NCT02185794|26347575|P1|Overall Study|Lost to Follow-up|1
7575732|NCT02185794|26347570|P6|Overall Study|Withdrew Consent|0
7575733|NCT02185794|26347571|P5|Overall Study|Withdrew Consent|0
7575734|NCT02185794|26347572|P4|Overall Study|Withdrew Consent|2
7575735|NCT02185794|26347573|P3|Overall Study|Withdrew Consent|10
7575736|NCT02185794|26347574|P2|Overall Study|Withdrew Consent|5
7575737|NCT02185794|26347575|P1|Overall Study|Withdrew Consent|2
7575738|NCT02185794|26347570|P6|Overall Study|Investigator's Discretion|15
7575739|NCT02185794|26347571|P5|Overall Study|Investigator's Discretion|2
7575740|NCT02185794|26347572|P4|Overall Study|Investigator's Discretion|2
7575741|NCT02185794|26347573|P3|Overall Study|Investigator's Discretion|1
7575742|NCT02185794|26347574|P2|Overall Study|Investigator's Discretion|0
7575743|NCT02185794|26347575|P1|Overall Study|Investigator's Discretion|1
7575744|NCT02185794|26347570|P6|Overall Study|Enrolled but Never Dosed|0
7575745|NCT02185794|26347571|P5|Overall Study|Enrolled but Never Dosed|1
7575746|NCT02185794|26347572|P4|Overall Study|Enrolled but Never Dosed|1
7575747|NCT02185794|26347573|P3|Overall Study|Enrolled but Never Dosed|3
7575748|NCT02185794|26347574|P2|Overall Study|Enrolled but Never Dosed|6
7575749|NCT02185794|26347575|P1|Overall Study|Enrolled but Never Dosed|1
7575750|NCT02185534|26347668|P6|First Washout Period|Protocol Violation|1
7575751|NCT02185534|26347669|P5|First Washout Period|Protocol Violation|0
7575752|NCT02185534|26347670|P4|First Washout Period|Protocol Violation|0
7575753|NCT02185534|26347671|P3|First Washout Period|Protocol Violation|0
7575754|NCT02185534|26347672|P2|First Washout Period|Protocol Violation|0
7575755|NCT02185534|26347673|P1|First Washout Period|Protocol Violation|0
7575756|NCT02185534|26347668|P6|First Washout Period|Withdrawal by Subject|0
7575757|NCT02185534|26347669|P5|First Washout Period|Withdrawal by Subject|1
7575758|NCT02185534|26347670|P4|First Washout Period|Withdrawal by Subject|0
7575759|NCT02185534|26347671|P3|First Washout Period|Withdrawal by Subject|0
7575760|NCT02185534|26347672|P2|First Washout Period|Withdrawal by Subject|0
7575761|NCT02185534|26347673|P1|First Washout Period|Withdrawal by Subject|1
7575762|NCT02185534|26347668|P6|First Period|Withdrawal by Subject|0
7575763|NCT02185534|26347669|P5|First Period|Withdrawal by Subject|0
7575764|NCT02185534|26347670|P4|First Period|Withdrawal by Subject|1
7575765|NCT02185534|26347671|P3|First Period|Withdrawal by Subject|0
7575766|NCT02185534|26347672|P2|First Period|Withdrawal by Subject|0
7575767|NCT02185534|26347673|P1|First Period|Withdrawal by Subject|0
7575768|NCT02185521|26347688|P1|Overall Study|Protocol Violation|1
7575769|NCT02185521|26347688|P1|Overall Study|Withdrawal by Subject|1
7575770|NCT02185053|26347781|P3|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
7575771|NCT02185053|26347782|P2|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7575772|NCT02185053|26347783|P1|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7575773|NCT02185053|26347781|P3|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
7575774|NCT02185053|26347782|P2|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7575775|NCT02185053|26347783|P1|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7575776|NCT02185053|26347781|P3|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7575777|NCT02185053|26347782|P2|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
7575778|NCT02185053|26347783|P1|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7575779|NCT02185053|26347781|P3|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7575780|NCT02185053|26347782|P2|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
7575781|NCT02185053|26347783|P1|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7575782|NCT02185053|26347781|P3|Donepezil Dose Escalation Phase|Adverse Event|0
7575783|NCT02185053|26347782|P2|Donepezil Dose Escalation Phase|Adverse Event|1
7575784|NCT02185053|26347783|P1|Donepezil Dose Escalation Phase|Adverse Event|0
7575785|NCT02185053|26347781|P3|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7575786|NCT02185053|26347782|P2|Donepezil Dose Escalation Phase|Cardiac symptoms|1
7575787|NCT02185053|26347783|P1|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7575788|NCT02185053|26347781|P3|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7575789|NCT02185053|26347782|P2|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7575790|NCT02185053|26347783|P1|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
7575791|NCT02185053|26347781|P3|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7575792|NCT02185053|26347782|P2|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7575793|NCT02185053|26347783|P1|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
7575794|NCT02185040|26347797|P7|Active Treatment Extension Phase|Lost to Follow-up|2
7575795|NCT02185040|26347798|P6|Active Treatment Extension Phase|Lost to Follow-up|0
7575796|NCT02185040|26347799|P5|Active Treatment Extension Phase|Lost to Follow-up|0
7575797|NCT02185040|26347800|P4|Active Treatment Extension Phase|Lost to Follow-up|0
7575798|NCT02185040|26347801|P3|Active Treatment Extension Phase|Lost to Follow-up|0
7575799|NCT02185040|26347802|P2|Active Treatment Extension Phase|Lost to Follow-up|0
7575800|NCT02185040|26347803|P1|Active Treatment Extension Phase|Lost to Follow-up|0
7575883|NCT02184572|26347956|P2|Overall Study|Lost to Follow-up|21
7575801|NCT02185040|26347797|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
7575802|NCT02185040|26347798|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
7575803|NCT02185040|26347799|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
7575804|NCT02185040|26347800|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
7575805|NCT02185040|26347801|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
7575806|NCT02185040|26347802|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
7575807|NCT02185040|26347803|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
7575808|NCT02185040|26347797|P7|Active Treatment Extension Phase|Adverse Event|4
7575809|NCT02185040|26347798|P6|Active Treatment Extension Phase|Adverse Event|1
7575810|NCT02185040|26347799|P5|Active Treatment Extension Phase|Adverse Event|0
7575811|NCT02185040|26347800|P4|Active Treatment Extension Phase|Adverse Event|0
7575812|NCT02185040|26347801|P3|Active Treatment Extension Phase|Adverse Event|0
7575813|NCT02185040|26347802|P2|Active Treatment Extension Phase|Adverse Event|0
7575814|NCT02185040|26347803|P1|Active Treatment Extension Phase|Adverse Event|0
7575815|NCT02185040|26347797|P7|Active Treatment Extension Phase|Miscellaneous|0
7575816|NCT02185040|26347798|P6|Active Treatment Extension Phase|Miscellaneous|1
7575817|NCT02185040|26347799|P5|Active Treatment Extension Phase|Miscellaneous|0
7575818|NCT02185040|26347800|P4|Active Treatment Extension Phase|Miscellaneous|0
7575819|NCT02185040|26347801|P3|Active Treatment Extension Phase|Miscellaneous|0
7575820|NCT02185040|26347802|P2|Active Treatment Extension Phase|Miscellaneous|0
7575821|NCT02185040|26347803|P1|Active Treatment Extension Phase|Miscellaneous|0
7575822|NCT02185040|26347797|P7|Part 1 Treatment Phase|Lost to Follow-up|0
7575823|NCT02185040|26347798|P6|Part 1 Treatment Phase|Lost to Follow-up|0
7575824|NCT02185040|26347799|P5|Part 1 Treatment Phase|Lost to Follow-up|0
7575825|NCT02185040|26347800|P4|Part 1 Treatment Phase|Lost to Follow-up|0
7575826|NCT02185040|26347801|P3|Part 1 Treatment Phase|Lost to Follow-up|0
7575827|NCT02185040|26347802|P2|Part 1 Treatment Phase|Lost to Follow-up|1
7575828|NCT02185040|26347803|P1|Part 1 Treatment Phase|Lost to Follow-up|0
7575829|NCT02185040|26347797|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
7575830|NCT02185040|26347798|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
7575831|NCT02185040|26347799|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
7575832|NCT02185040|26347800|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
7575833|NCT02185040|26347801|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
7575834|NCT02185040|26347802|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
7575835|NCT02185040|26347803|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
7575836|NCT02185040|26347797|P7|Part 1 Treatment Phase|Adverse Event|0
7575837|NCT02185040|26347798|P6|Part 1 Treatment Phase|Adverse Event|0
7575838|NCT02185040|26347799|P5|Part 1 Treatment Phase|Adverse Event|3
7575839|NCT02185040|26347800|P4|Part 1 Treatment Phase|Adverse Event|2
7575840|NCT02185040|26347801|P3|Part 1 Treatment Phase|Adverse Event|0
7575841|NCT02185040|26347802|P2|Part 1 Treatment Phase|Adverse Event|0
7575842|NCT02185040|26347803|P1|Part 1 Treatment Phase|Adverse Event|1
7575843|NCT02185040|26347797|P7|Part 1 Treatment Phase|Miscellaneous|0
7575844|NCT02185040|26347798|P6|Part 1 Treatment Phase|Miscellaneous|0
7575845|NCT02185040|26347799|P5|Part 1 Treatment Phase|Miscellaneous|0
7575846|NCT02185040|26347800|P4|Part 1 Treatment Phase|Miscellaneous|0
7575847|NCT02185040|26347801|P3|Part 1 Treatment Phase|Miscellaneous|1
7575848|NCT02185040|26347802|P2|Part 1 Treatment Phase|Miscellaneous|0
7575849|NCT02185040|26347803|P1|Part 1 Treatment Phase|Miscellaneous|0
7575850|NCT02185014|26347857|P1|Overall Study|Other|4
7575851|NCT02185014|26347857|P1|Overall Study|Subject Noncompliance|1
7575852|NCT02185014|26347857|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
7575853|NCT02185014|26347857|P1|Overall Study|Lack of Efficacy|14
7575854|NCT02185014|26347857|P1|Overall Study|Lost to Follow-up|4
7575855|NCT02185014|26347857|P1|Overall Study|Withdrew Consent|8
7575856|NCT02185014|26347857|P1|Overall Study|Adverse Event|18
7575857|NCT02184988|26347861|P1|Overall Study|Lost to Follow-up|32
7575858|NCT02184988|26347861|P1|Overall Study|various other reasons|9
7575859|NCT02184988|26347861|P1|Overall Study|work scheduling issues|4
7575860|NCT02184988|26347861|P1|Overall Study|moving away/travelling/unable to complet|6
7575861|NCT02184988|26347861|P1|Overall Study|Adverse Event|2
7575862|NCT02184988|26347861|P1|Overall Study|Pregnancy|2
7575863|NCT02184611|26347919|P2|Overall Study|Protocol defined stopping criteria|1
7575864|NCT02184611|26347920|P1|Overall Study|Protocol defined stopping criteria|0
7575865|NCT02184611|26347919|P2|Overall Study|Protocol Violation|1
7575866|NCT02184611|26347920|P1|Overall Study|Protocol Violation|1
7575867|NCT02184611|26347919|P2|Overall Study|Adverse Event|5
7575868|NCT02184611|26347920|P1|Overall Study|Adverse Event|4
7575869|NCT02184611|26347919|P2|Overall Study|Withdrawal by Subject|6
7575870|NCT02184611|26347920|P1|Overall Study|Withdrawal by Subject|5
7575871|NCT02184611|26347919|P2|Overall Study|Lack of Efficacy|15
7575872|NCT02184611|26347920|P1|Overall Study|Lack of Efficacy|11
7575873|NCT02184572|26347956|P2|Overall Study|Withdrawal by Subject|9
7575874|NCT02184572|26347957|P1|Overall Study|Withdrawal by Subject|14
7575875|NCT02184572|26347956|P2|Overall Study|Traveling Outside The Country|0
7575876|NCT02184572|26347957|P1|Overall Study|Traveling Outside The Country|1
7575877|NCT02184572|26347956|P2|Overall Study|2nd blooddraw & diary card incomplete|0
7575878|NCT02184572|26347957|P1|Overall Study|2nd blooddraw & diary card incomplete|1
7575879|NCT02184572|26347956|P2|Overall Study|Loss Of Kaiser Insurance|0
7575880|NCT02184572|26347957|P1|Overall Study|Loss Of Kaiser Insurance|1
7575881|NCT02184572|26347956|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
7575882|NCT02184572|26347957|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
7575884|NCT02184572|26347957|P1|Overall Study|Lost to Follow-up|29
7575885|NCT02184455|26348027|P1|Overall Study|Lost to Follow-up|1
7575886|NCT02184442|26348038|P2|Overall Study|Withdrawal by Subject|11
7575887|NCT02184442|26348039|P1|Overall Study|Withdrawal by Subject|3
7575888|NCT02184442|26348038|P2|Overall Study|Death|65
7575889|NCT02184442|26348039|P1|Overall Study|Death|61
7575890|NCT02184195|26348059|P2|Overall Study|Other|2
7575891|NCT02184195|26348060|P1|Overall Study|Other|0
7575892|NCT02184195|26348059|P2|Overall Study|Lost to Follow-up|2
7575893|NCT02184195|26348060|P1|Overall Study|Lost to Follow-up|0
7575894|NCT02184195|26348059|P2|Overall Study|Death|29
7575895|NCT02184195|26348060|P1|Overall Study|Death|40
7575896|NCT02184195|26348059|P2|Overall Study|Eligibility criteria not fulfilled|1
7575897|NCT02184195|26348060|P1|Overall Study|Eligibility criteria not fulfilled|0
7575898|NCT02184195|26348059|P2|Overall Study|Patient decision|1
7575899|NCT02184195|26348060|P1|Overall Study|Patient decision|3
7575900|NCT02184143|26348097|P2|Overall Study|Death|0
7575901|NCT02184143|26348098|P1|Overall Study|Death|1
7575902|NCT02184143|26348097|P2|Overall Study|Lost to Follow-up|3
7575903|NCT02184143|26348098|P1|Overall Study|Lost to Follow-up|5
7575904|NCT02184143|26348097|P2|Overall Study|Withdrawal by Subject|4
7575905|NCT02184143|26348098|P1|Overall Study|Withdrawal by Subject|4
7575906|NCT02183675|26348127|P6|Treatment Period 2 (10 Days)|Adverse Event|2
7575907|NCT02183675|26348128|P5|Treatment Period 2 (10 Days)|Adverse Event|0
7575908|NCT02183675|26348129|P4|Treatment Period 2 (10 Days)|Adverse Event|0
7575909|NCT02183675|26348130|P3|Treatment Period 2 (10 Days)|Adverse Event|0
7575910|NCT02183675|26348131|P2|Treatment Period 2 (10 Days)|Adverse Event|0
7575911|NCT02183675|26348132|P1|Treatment Period 2 (10 Days)|Adverse Event|0
7575912|NCT02183519|26348156|P2|Overall Study|Did not respond to cough inducter|3
7575913|NCT02183519|26348157|P1|Overall Study|Did not respond to cough inducter|0
7575914|NCT02183519|26348156|P2|Overall Study|computer error|0
7575915|NCT02183519|26348157|P1|Overall Study|computer error|3
7575916|NCT02182999|26348165|P2|Overall Study|Physician Decision|0
7575917|NCT02182999|26348166|P1|Overall Study|Physician Decision|1
7575918|NCT02182999|26348165|P2|Overall Study|Adverse Event|3
7575919|NCT02182999|26348166|P1|Overall Study|Adverse Event|4
7575920|NCT02182973|26348182|P2|Overall Study|Withdrawal by Subject|0
7575921|NCT02182973|26348183|P1|Overall Study|Withdrawal by Subject|3
7575922|NCT02182947|26348193|P1|Overall Study|Failed screening activities|8
7575923|NCT02182947|26348193|P1|Overall Study|Lost to Follow-up|3
7575924|NCT02182947|26348193|P1|Overall Study|Withdrawal by Subject|7
7575925|NCT02182895|26348206|P2|Overall Study|Discharged from hospital within 24 hours|4
7575926|NCT02182895|26348207|P1|Overall Study|Discharged from hospital within 24 hours|2
7575927|NCT02182843|26348227|P1|Overall Study|Adverse Event|1
7575928|NCT02182843|26348227|P1|Overall Study|Lost to Follow-up|2
7575929|NCT02182843|26348227|P1|Overall Study|Withdrawal by Subject|7
7575930|NCT02182830|26348234|P2|Overall Study|Lost to Follow-up|3
7575931|NCT02182830|26348235|P1|Overall Study|Lost to Follow-up|3
7575932|NCT02182830|26348234|P2|Overall Study|Consent withdrawn|8
7575933|NCT02182830|26348235|P1|Overall Study|Consent withdrawn|8
7575934|NCT02182830|26348234|P2|Overall Study|Trial stopped, reason missing|3
7575935|NCT02182830|26348235|P1|Overall Study|Trial stopped, reason missing|3
7575936|NCT02182830|26348234|P2|Overall Study|Not Treated|1
7575937|NCT02182830|26348235|P1|Overall Study|Not Treated|1
7575938|NCT02182440|26348280|P4|Overall Study|different, e.g adm other hospital|10
7575939|NCT02182440|26348281|P3|Overall Study|different, e.g adm other hospital|3
7575940|NCT02182440|26348282|P2|Overall Study|different, e.g adm other hospital|3
7575941|NCT02182440|26348283|P1|Overall Study|different, e.g adm other hospital|12
7575942|NCT02182440|26348280|P4|Overall Study|Withdrawal by Subject|4
7575943|NCT02182440|26348281|P3|Overall Study|Withdrawal by Subject|3
7575944|NCT02182440|26348282|P2|Overall Study|Withdrawal by Subject|1
7575945|NCT02182440|26348283|P1|Overall Study|Withdrawal by Subject|1
7575946|NCT02182440|26348280|P4|Overall Study|Physician Decision|0
7575947|NCT02182440|26348281|P3|Overall Study|Physician Decision|0
7575948|NCT02182440|26348282|P2|Overall Study|Physician Decision|0
7575949|NCT02182440|26348283|P1|Overall Study|Physician Decision|1
7575950|NCT02182440|26348280|P4|Overall Study|Protocol Violation|0
7575951|NCT02182440|26348281|P3|Overall Study|Protocol Violation|0
7575952|NCT02182440|26348282|P2|Overall Study|Protocol Violation|1
7575953|NCT02182440|26348283|P1|Overall Study|Protocol Violation|0
7575954|NCT02182440|26348280|P4|Overall Study|Death|16
7575955|NCT02182440|26348281|P3|Overall Study|Death|5
7575956|NCT02182440|26348282|P2|Overall Study|Death|8
7575957|NCT02182440|26348283|P1|Overall Study|Death|31
7575958|NCT02182440|26348280|P4|Overall Study|Adverse Event|0
7575959|NCT02182440|26348281|P3|Overall Study|Adverse Event|0
7575960|NCT02182440|26348282|P2|Overall Study|Adverse Event|1
7575961|NCT02182440|26348283|P1|Overall Study|Adverse Event|0
7575962|NCT02181842|26348322|P1|Overall Study|Case Report Forms Uncollected|2
7575963|NCT02181816|26348345|P1|Overall Study|Protocol Deviation|21
7575964|NCT02181816|26348345|P1|Overall Study|Case Report Forms Uncollected|38
7575965|NCT02181803|26348360|P9|Overall Study|Adverse Event|0
7575966|NCT02181803|26348361|P8|Overall Study|Adverse Event|0
7575967|NCT02181803|26348362|P7|Overall Study|Adverse Event|1
7575968|NCT02181803|26348363|P6|Overall Study|Adverse Event|0
7575969|NCT02181803|26348364|P5|Overall Study|Adverse Event|0
7575970|NCT02181803|26348365|P4|Overall Study|Adverse Event|1
7575971|NCT02181803|26348366|P3|Overall Study|Adverse Event|0
7575972|NCT02181803|26348367|P2|Overall Study|Adverse Event|2
7575973|NCT02181803|26348368|P1|Overall Study|Adverse Event|0
7575974|NCT02181803|26348360|P9|Overall Study|Physician Decision|0
7575975|NCT02181803|26348361|P8|Overall Study|Physician Decision|1
7575976|NCT02181803|26348362|P7|Overall Study|Physician Decision|0
7575977|NCT02181803|26348363|P6|Overall Study|Physician Decision|0
7575978|NCT02181803|26348364|P5|Overall Study|Physician Decision|0
7575979|NCT02181803|26348365|P4|Overall Study|Physician Decision|1
7575980|NCT02181803|26348366|P3|Overall Study|Physician Decision|0
7575981|NCT02181803|26348367|P2|Overall Study|Physician Decision|0
7575982|NCT02181803|26348368|P1|Overall Study|Physician Decision|0
7575983|NCT02181803|26348360|P9|Overall Study|Withdrawal by Subject|0
7575984|NCT02181803|26348361|P8|Overall Study|Withdrawal by Subject|0
7575985|NCT02181803|26348362|P7|Overall Study|Withdrawal by Subject|0
7575986|NCT02181803|26348363|P6|Overall Study|Withdrawal by Subject|0
7575987|NCT02181803|26348364|P5|Overall Study|Withdrawal by Subject|0
7575988|NCT02181803|26348365|P4|Overall Study|Withdrawal by Subject|0
7575989|NCT02181803|26348366|P3|Overall Study|Withdrawal by Subject|0
7575990|NCT02181803|26348367|P2|Overall Study|Withdrawal by Subject|2
7575991|NCT02181803|26348368|P1|Overall Study|Withdrawal by Subject|0
7575992|NCT02181790|26348519|P2|Overall Study|study terminated|0
7575993|NCT02181790|26348520|P1|Overall Study|study terminated|2
7575994|NCT02181738|26348532|P4|Overall Study|Patient Return to Home Country|0
7575995|NCT02181738|26348533|P3|Overall Study|Patient Return to Home Country|0
7575996|NCT02181738|26348534|P2|Overall Study|Patient Return to Home Country|1
7575997|NCT02181738|26348535|P1|Overall Study|Patient Return to Home Country|0
7575998|NCT02181738|26348532|P4|Overall Study|Lost to Follow-up|0
7575999|NCT02181738|26348533|P3|Overall Study|Lost to Follow-up|2
7576000|NCT02181738|26348534|P2|Overall Study|Lost to Follow-up|4
7576001|NCT02181738|26348535|P1|Overall Study|Lost to Follow-up|0
7576002|NCT02181738|26348532|P4|Overall Study|Subject Withdrew Consent|1
7576003|NCT02181738|26348533|P3|Overall Study|Subject Withdrew Consent|2
7576004|NCT02181738|26348534|P2|Overall Study|Subject Withdrew Consent|3
7576005|NCT02181738|26348535|P1|Overall Study|Subject Withdrew Consent|1
7576006|NCT02181738|26348532|P4|Overall Study|Death|1
7576007|NCT02181738|26348533|P3|Overall Study|Death|6
7576008|NCT02181738|26348534|P2|Overall Study|Death|1
7576009|NCT02181738|26348535|P1|Overall Study|Death|1
7576010|NCT02181673|26348576|P3|Week 24-Week 60|Physician Decision|1
7576011|NCT02181673|26348577|P2|Week 24-Week 60|Physician Decision|0
7576012|NCT02181673|26348578|P1|Week 24-Week 60|Physician Decision|0
7576013|NCT02181673|26348576|P3|Week 24-Week 60|Lost to Follow-up|1
7576014|NCT02181673|26348577|P2|Week 24-Week 60|Lost to Follow-up|0
7576015|NCT02181673|26348578|P1|Week 24-Week 60|Lost to Follow-up|0
7576016|NCT02181673|26348576|P3|Week 24-Week 60|Lack of Efficacy|1
7576017|NCT02181673|26348577|P2|Week 24-Week 60|Lack of Efficacy|0
7576018|NCT02181673|26348578|P1|Week 24-Week 60|Lack of Efficacy|0
7576019|NCT02181673|26348576|P3|Week 24-Week 60|Pregnancy|1
7576020|NCT02181673|26348577|P2|Week 24-Week 60|Pregnancy|0
7576021|NCT02181673|26348578|P1|Week 24-Week 60|Pregnancy|0
7576022|NCT02181673|26348576|P3|Week 24-Week 60|Withdrawal by Subject|2
7576023|NCT02181673|26348577|P2|Week 24-Week 60|Withdrawal by Subject|2
7576024|NCT02181673|26348578|P1|Week 24-Week 60|Withdrawal by Subject|0
7576025|NCT02181673|26348576|P3|Week 24-Week 60|Other|1
7576026|NCT02181673|26348577|P2|Week 24-Week 60|Other|2
7576027|NCT02181673|26348578|P1|Week 24-Week 60|Other|0
7576028|NCT02181673|26348576|P3|Week 24-Week 60|Adverse Event|10
7576029|NCT02181673|26348577|P2|Week 24-Week 60|Adverse Event|4
7576030|NCT02181673|26348578|P1|Week 24-Week 60|Adverse Event|0
7576031|NCT02181673|26348576|P3|Up to Week 24|Randomized not Treated|1
7576032|NCT02181673|26348577|P2|Up to Week 24|Randomized not Treated|0
7576033|NCT02181673|26348578|P1|Up to Week 24|Randomized not Treated|0
7576034|NCT02181673|26348576|P3|Up to Week 24|Other|3
7576035|NCT02181673|26348577|P2|Up to Week 24|Other|0
7576036|NCT02181673|26348578|P1|Up to Week 24|Other|2
7576037|NCT02181673|26348576|P3|Up to Week 24|Withdrawal by Subject|1
7576038|NCT02181673|26348577|P2|Up to Week 24|Withdrawal by Subject|0
7576039|NCT02181673|26348578|P1|Up to Week 24|Withdrawal by Subject|10
7576040|NCT02181673|26348576|P3|Up to Week 24|Physician Decision|3
7576041|NCT02181673|26348577|P2|Up to Week 24|Physician Decision|0
7576042|NCT02181673|26348578|P1|Up to Week 24|Physician Decision|0
7576043|NCT02181673|26348576|P3|Up to Week 24|Lost to Follow-up|0
7576044|NCT02181673|26348577|P2|Up to Week 24|Lost to Follow-up|0
7576045|NCT02181673|26348578|P1|Up to Week 24|Lost to Follow-up|1
7576046|NCT02181673|26348576|P3|Up to Week 24|Lack of Efficacy|0
7576047|NCT02181673|26348577|P2|Up to Week 24|Lack of Efficacy|0
7576048|NCT02181673|26348578|P1|Up to Week 24|Lack of Efficacy|1
7576049|NCT02181673|26348576|P3|Up to Week 24|Death|0
7576050|NCT02181673|26348577|P2|Up to Week 24|Death|0
7576051|NCT02181673|26348578|P1|Up to Week 24|Death|1
7576052|NCT02181673|26348576|P3|Up to Week 24|Adverse Event|3
7576053|NCT02181673|26348577|P2|Up to Week 24|Adverse Event|0
7576054|NCT02181673|26348578|P1|Up to Week 24|Adverse Event|2
7576055|NCT02181634|26348605|P1|Overall Study|Patient opted to proceed to surgery|1
7576056|NCT02181634|26348605|P1|Overall Study|Symptomatic progression|1
7576057|NCT02181634|26348605|P1|Overall Study|Max number of dose reduction|1
7576058|NCT02181634|26348605|P1|Overall Study|Ineligible|1
7576059|NCT02181634|26348605|P1|Overall Study|Treatment delayed greater than 4 weeks|3
7576060|NCT02181634|26348605|P1|Overall Study|Death|2
7576061|NCT02181634|26348605|P1|Overall Study|Withdrawal by Subject|5
7576062|NCT02181634|26348605|P1|Overall Study|Physician Decision|8
7576063|NCT02181634|26348605|P1|Overall Study|Adverse Event|17
7576064|NCT02181634|26348605|P1|Overall Study|Lack of Efficacy|33
7576065|NCT02181556|26348616|P1|Overall Study|Withdrawal by Subject|1
7576066|NCT02181504|26348660|P3|Overall Study|Adverse Event|1
7576067|NCT02181504|26348661|P2|Overall Study|Adverse Event|1
7576068|NCT02181504|26348662|P1|Overall Study|Adverse Event|1
7576069|NCT02181413|26348701|P2|Overall Study|Lost to Follow-up|1
7576070|NCT02181413|26348702|P1|Overall Study|Lost to Follow-up|0
7576071|NCT02181413|26348701|P2|Overall Study|Ongoing Study Treatment|1
7576072|NCT02181413|26348702|P1|Overall Study|Ongoing Study Treatment|0
7576073|NCT02181413|26348701|P2|Overall Study|Reason Not Specified|20
7576074|NCT02181413|26348702|P1|Overall Study|Reason Not Specified|19
7576075|NCT02181413|26348701|P2|Overall Study|Withdrawal by Subject|8
7576076|NCT02181413|26348702|P1|Overall Study|Withdrawal by Subject|5
7576077|NCT02181413|26348701|P2|Overall Study|Progressive Disease|143
7576078|NCT02181413|26348702|P1|Overall Study|Progressive Disease|121
7576079|NCT02181413|26348701|P2|Overall Study|Adverse Event|24
7576080|NCT02181413|26348702|P1|Overall Study|Adverse Event|7
7576081|NCT02181296|26348747|P2|Overall Study|Lost to Follow-up|6
7576082|NCT02181296|26348748|P1|Overall Study|Lost to Follow-up|7
7576083|NCT02180867|26348870|P7|Overall Study|Refusal of further protocol therapy|0
7576084|NCT02180867|26348871|P6|Overall Study|Refusal of further protocol therapy|0
7576085|NCT02180867|26348872|P5|Overall Study|Refusal of further protocol therapy|4
7576086|NCT02180867|26348873|P4|Overall Study|Refusal of further protocol therapy|6
7576087|NCT02180867|26348874|P3|Overall Study|Refusal of further protocol therapy|2
7576088|NCT02180867|26348875|P2|Overall Study|Refusal of further protocol therapy|0
7576089|NCT02180867|26348876|P1|Overall Study|Refusal of further protocol therapy|1
7576090|NCT02180867|26348870|P7|Overall Study|Repeat Eligibility Studies|0
7576091|NCT02180867|26348871|P6|Overall Study|Repeat Eligibility Studies|0
7576092|NCT02180867|26348872|P5|Overall Study|Repeat Eligibility Studies|1
7576093|NCT02180867|26348873|P4|Overall Study|Repeat Eligibility Studies|0
7576094|NCT02180867|26348874|P3|Overall Study|Repeat Eligibility Studies|0
7576095|NCT02180867|26348875|P2|Overall Study|Repeat Eligibility Studies|0
7576096|NCT02180867|26348876|P1|Overall Study|Repeat Eligibility Studies|0
7576097|NCT02180867|26348870|P7|Overall Study|Ineligible|0
7576098|NCT02180867|26348871|P6|Overall Study|Ineligible|0
7576099|NCT02180867|26348872|P5|Overall Study|Ineligible|5
7576100|NCT02180867|26348873|P4|Overall Study|Ineligible|3
7576101|NCT02180867|26348874|P3|Overall Study|Ineligible|0
7576102|NCT02180867|26348875|P2|Overall Study|Ineligible|2
7576103|NCT02180867|26348876|P1|Overall Study|Ineligible|1
7576104|NCT02180867|26348870|P7|Overall Study|Withdrawal by Subject|0
7576105|NCT02180867|26348871|P6|Overall Study|Withdrawal by Subject|0
7576106|NCT02180867|26348872|P5|Overall Study|Withdrawal by Subject|1
7576107|NCT02180867|26348873|P4|Overall Study|Withdrawal by Subject|1
7576108|NCT02180867|26348874|P3|Overall Study|Withdrawal by Subject|0
7576109|NCT02180867|26348875|P2|Overall Study|Withdrawal by Subject|0
7576110|NCT02180867|26348876|P1|Overall Study|Withdrawal by Subject|0
7576111|NCT02180867|26348870|P7|Overall Study|Physician Decision|4
7576112|NCT02180867|26348871|P6|Overall Study|Physician Decision|3
7576113|NCT02180867|26348872|P5|Overall Study|Physician Decision|9
7576114|NCT02180867|26348873|P4|Overall Study|Physician Decision|10
7576115|NCT02180867|26348874|P3|Overall Study|Physician Decision|1
7576116|NCT02180867|26348875|P2|Overall Study|Physician Decision|3
7576117|NCT02180867|26348876|P1|Overall Study|Physician Decision|1
7576118|NCT02180867|26348870|P7|Overall Study|Lack of Efficacy|1
7576119|NCT02180867|26348871|P6|Overall Study|Lack of Efficacy|0
7576120|NCT02180867|26348872|P5|Overall Study|Lack of Efficacy|6
7576121|NCT02180867|26348873|P4|Overall Study|Lack of Efficacy|1
7576122|NCT02180867|26348874|P3|Overall Study|Lack of Efficacy|0
7576123|NCT02180867|26348875|P2|Overall Study|Lack of Efficacy|2
7576124|NCT02180867|26348876|P1|Overall Study|Lack of Efficacy|0
7576125|NCT02180867|26348870|P7|Overall Study|Death|0
7576126|NCT02180867|26348871|P6|Overall Study|Death|0
7576127|NCT02180867|26348872|P5|Overall Study|Death|1
7576128|NCT02180867|26348873|P4|Overall Study|Death|0
7576129|NCT02180867|26348874|P3|Overall Study|Death|0
7576130|NCT02180867|26348875|P2|Overall Study|Death|0
7576131|NCT02180867|26348876|P1|Overall Study|Death|0
7576132|NCT02180867|26348870|P7|Overall Study|Adverse Event|0
7576133|NCT02180867|26348871|P6|Overall Study|Adverse Event|0
7576134|NCT02180867|26348872|P5|Overall Study|Adverse Event|0
7576135|NCT02180867|26348873|P4|Overall Study|Adverse Event|5
7576136|NCT02180867|26348874|P3|Overall Study|Adverse Event|1
7576137|NCT02180867|26348875|P2|Overall Study|Adverse Event|4
7576138|NCT02180867|26348876|P1|Overall Study|Adverse Event|3
7576139|NCT02180724|26348932|P2|Overall Study|Ongoing Study|11
7576140|NCT02180724|26348933|P1|Overall Study|Ongoing Study|78
7576141|NCT02180724|26348932|P2|Overall Study|Withdrawal by Subject|2
7576142|NCT02180724|26348933|P1|Overall Study|Withdrawal by Subject|1
7576143|NCT02180724|26348932|P2|Overall Study|Lost to Follow-up|0
7576144|NCT02180724|26348933|P1|Overall Study|Lost to Follow-up|1
7576145|NCT02180724|26348932|P2|Overall Study|Death|1
7576146|NCT02180724|26348933|P1|Overall Study|Death|12
7576147|NCT02180672|26348947|P2|Overall Study|Lost to Follow-up|7
7576148|NCT02180672|26348948|P1|Overall Study|Lost to Follow-up|5
7576149|NCT02180659|26348974|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
7576150|NCT02180659|26348975|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
7576151|NCT02180659|26348974|P2|Overall Study|Withdrawal by Subject|2
7576152|NCT02180659|26348975|P1|Overall Study|Withdrawal by Subject|0
7576153|NCT02180659|26348974|P2|Overall Study|Subject incarcerated during conduct|0
7576154|NCT02180659|26348975|P1|Overall Study|Subject incarcerated during conduct|1
7576155|NCT02180659|26348974|P2|Overall Study|Lost to Follow-up|2
7576156|NCT02180659|26348975|P1|Overall Study|Lost to Follow-up|4
7576157|NCT02180659|26348974|P2|Overall Study|Adverse Event|0
7576158|NCT02180659|26348975|P1|Overall Study|Adverse Event|1
7576159|NCT02180438|26349010|P1|Overall Study|Lost to Follow-up|1
7576160|NCT02180217|26349033|P3|Overall Study|Unsatisfactory therapeutic effect|0
7576161|NCT02180217|26349034|P2|Overall Study|Unsatisfactory therapeutic effect|0
7576162|NCT02180217|26349035|P1|Overall Study|Unsatisfactory therapeutic effect|1
7576163|NCT02180217|26349033|P3|Overall Study|Physician Decision|6
7576164|NCT02180217|26349034|P2|Overall Study|Physician Decision|1
7576165|NCT02180217|26349035|P1|Overall Study|Physician Decision|1
7576166|NCT02180217|26349033|P3|Overall Study|Subject/Guardian decision|6
7576167|NCT02180217|26349034|P2|Overall Study|Subject/Guardian decision|3
7576168|NCT02180217|26349035|P1|Overall Study|Subject/Guardian decision|5
7576169|NCT02180217|26349033|P3|Overall Study|Withdrawal by Subject|4
7576170|NCT02180217|26349034|P2|Overall Study|Withdrawal by Subject|1
7576171|NCT02180217|26349035|P1|Overall Study|Withdrawal by Subject|1
7576172|NCT02180217|26349033|P3|Overall Study|Death|0
7576173|NCT02180217|26349034|P2|Overall Study|Death|1
7576174|NCT02180217|26349035|P1|Overall Study|Death|1
7576175|NCT02180217|26349033|P3|Overall Study|Adverse Event|22
7576176|NCT02180217|26349034|P2|Overall Study|Adverse Event|2
7576177|NCT02180217|26349035|P1|Overall Study|Adverse Event|3
7576178|NCT02180165|26349109|P4|Overall Study|Withdrawal by Subject|1
7576179|NCT02180165|26349110|P3|Overall Study|Withdrawal by Subject|2
7576180|NCT02180165|26349111|P2|Overall Study|Withdrawal by Subject|0
7576181|NCT02180165|26349112|P1|Overall Study|Withdrawal by Subject|3
7576182|NCT02180165|26349109|P4|Overall Study|Physician Decision|0
7576183|NCT02180165|26349110|P3|Overall Study|Physician Decision|5
7576184|NCT02180165|26349111|P2|Overall Study|Physician Decision|0
7576185|NCT02180165|26349112|P1|Overall Study|Physician Decision|1
7576186|NCT02180165|26349109|P4|Overall Study|Lack of Efficacy|2
7576187|NCT02180165|26349110|P3|Overall Study|Lack of Efficacy|3
7576188|NCT02180165|26349111|P2|Overall Study|Lack of Efficacy|1
7576189|NCT02180165|26349112|P1|Overall Study|Lack of Efficacy|0
7576190|NCT02180165|26349109|P4|Overall Study|Adverse Event|3
7576191|NCT02180165|26349110|P3|Overall Study|Adverse Event|18
7576192|NCT02180165|26349111|P2|Overall Study|Adverse Event|0
7576193|NCT02180165|26349112|P1|Overall Study|Adverse Event|7
7576194|NCT02180165|26349109|P4|Overall Study|Not Treated|0
7576195|NCT02180165|26349110|P3|Overall Study|Not Treated|1
7576196|NCT02180165|26349111|P2|Overall Study|Not Treated|0
7576197|NCT02180165|26349112|P1|Overall Study|Not Treated|0
7576198|NCT02180061|26349211|P2|Overall Study|Physician Decision|0
7576199|NCT02180061|26349212|P1|Overall Study|Physician Decision|1
7576200|NCT02180061|26349211|P2|Overall Study|Progressive Disease|5
7576201|NCT02180061|26349212|P1|Overall Study|Progressive Disease|15
7576202|NCT02180061|26349211|P2|Overall Study|Clinical Progression|1
7576203|NCT02180061|26349212|P1|Overall Study|Clinical Progression|5
7576204|NCT02180061|26349211|P2|Overall Study|Adverse Event|2
7576205|NCT02180061|26349212|P1|Overall Study|Adverse Event|4
7576206|NCT02179918|26349231|P5|Overall Study|Subject refused further follow-up|1
7576207|NCT02179918|26349232|P4|Overall Study|Subject refused further follow-up|0
7576208|NCT02179918|26349233|P3|Overall Study|Subject refused further follow-up|0
7576209|NCT02179918|26349234|P2|Overall Study|Subject refused further follow-up|1
7576210|NCT02179918|26349235|P1|Overall Study|Subject refused further follow-up|0
7576211|NCT02179918|26349231|P5|Overall Study|Other|1
7576212|NCT02179918|26349232|P4|Overall Study|Other|0
7576213|NCT02179918|26349233|P3|Overall Study|Other|0
7576214|NCT02179918|26349234|P2|Overall Study|Other|1
7576215|NCT02179918|26349235|P1|Overall Study|Other|0
7576216|NCT02179918|26349231|P5|Overall Study|Progressive Disease|6
7576217|NCT02179918|26349232|P4|Overall Study|Progressive Disease|2
7576218|NCT02179918|26349233|P3|Overall Study|Progressive Disease|1
7576219|NCT02179918|26349234|P2|Overall Study|Progressive Disease|1
7576220|NCT02179918|26349235|P1|Overall Study|Progressive Disease|4
7576221|NCT02179918|26349231|P5|Overall Study|Lost to Follow-up|0
7576222|NCT02179918|26349232|P4|Overall Study|Lost to Follow-up|0
7576223|NCT02179918|26349233|P3|Overall Study|Lost to Follow-up|1
7576224|NCT02179918|26349234|P2|Overall Study|Lost to Follow-up|0
7576225|NCT02179918|26349235|P1|Overall Study|Lost to Follow-up|0
7576226|NCT02179918|26349231|P5|Overall Study|Death|0
7576227|NCT02179918|26349232|P4|Overall Study|Death|1
7576228|NCT02179918|26349233|P3|Overall Study|Death|0
7576229|NCT02179918|26349234|P2|Overall Study|Death|0
7576230|NCT02179918|26349235|P1|Overall Study|Death|0
7576231|NCT02179515|26349427|P3|Overall Study|Disease progression on study|8
7576232|NCT02179515|26349428|P2|Overall Study|Disease progression on study|11
7576233|NCT02179515|26349429|P1|Overall Study|Disease progression on study|2
7576234|NCT02179515|26349427|P3|Overall Study|refused further treatment|4
7576235|NCT02179515|26349428|P2|Overall Study|refused further treatment|3
7576236|NCT02179515|26349429|P1|Overall Study|refused further treatment|0
7576237|NCT02179515|26349427|P3|Overall Study|Death|1
7576238|NCT02179515|26349428|P2|Overall Study|Death|1
7576239|NCT02179515|26349429|P1|Overall Study|Death|0
7576240|NCT02179515|26349427|P3|Overall Study|switched to alternative treatment|1
7576241|NCT02179515|26349428|P2|Overall Study|switched to alternative treatment|1
7576242|NCT02179515|26349429|P1|Overall Study|switched to alternative treatment|0
7576243|NCT02179398|26349492|P2|Overall Study|Lost to Follow-up|1
7576244|NCT02179398|26349493|P1|Overall Study|Lost to Follow-up|0
7576245|NCT02179398|26349492|P2|Overall Study|Lack of obligatory data|3
7576246|NCT02179398|26349493|P1|Overall Study|Lack of obligatory data|3
7576247|NCT02179190|26349511|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
7576248|NCT02179190|26349511|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
7576249|NCT02179190|26349511|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
7576250|NCT02179190|26349511|P1|Follow-Up Post Barrel VRD Implanted|Death|3
7576251|NCT02179190|26349511|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
7576252|NCT02179190|26349511|P1|Enrollment|Exit Prior to Device Attempt|11
7576253|NCT02179177|26349524|P2|Overall Study|Withdrawal by Subject|1
7576254|NCT02179177|26349525|P1|Overall Study|Withdrawal by Subject|1
7576255|NCT02179177|26349524|P2|Overall Study|Lost to Follow-up|1
7576256|NCT02179177|26349525|P1|Overall Study|Lost to Follow-up|1
7576257|NCT02178995|26349565|P9|Open Label|Adverse Event|0
7576258|NCT02178995|26349566|P8|Open Label|Adverse Event|0
7576259|NCT02178995|26349567|P7|Open Label|Adverse Event|0
7576260|NCT02178995|26349568|P6|Open Label|Adverse Event|0
7576261|NCT02178995|26349569|P5|Open Label|Adverse Event|0
7576262|NCT02178995|26349570|P4|Open Label|Adverse Event|0
7576263|NCT02178995|26349571|P3|Open Label|Adverse Event|0
7576264|NCT02178995|26349572|P2|Open Label|Adverse Event|0
7576265|NCT02178995|26349573|P1|Open Label|Adverse Event|2
7576266|NCT02178995|26349565|P9|Double Blind|Lost to Follow-up|0
7576267|NCT02178995|26349566|P8|Double Blind|Lost to Follow-up|1
7576268|NCT02178995|26349567|P7|Double Blind|Lost to Follow-up|0
7576269|NCT02178995|26349568|P6|Double Blind|Lost to Follow-up|0
7576270|NCT02178995|26349569|P5|Double Blind|Lost to Follow-up|0
7576271|NCT02178995|26349570|P4|Double Blind|Lost to Follow-up|0
7576272|NCT02178995|26349571|P3|Double Blind|Lost to Follow-up|0
7576273|NCT02178995|26349572|P2|Double Blind|Lost to Follow-up|1
7576274|NCT02178995|26349573|P1|Double Blind|Lost to Follow-up|0
7576275|NCT02178995|26349565|P9|Double Blind|Adverse Event|1
7576276|NCT02178995|26349566|P8|Double Blind|Adverse Event|1
7576277|NCT02178995|26349567|P7|Double Blind|Adverse Event|0
7576278|NCT02178995|26349568|P6|Double Blind|Adverse Event|1
7576279|NCT02178995|26349569|P5|Double Blind|Adverse Event|0
7576280|NCT02178995|26349570|P4|Double Blind|Adverse Event|0
7576281|NCT02178995|26349571|P3|Double Blind|Adverse Event|0
7576282|NCT02178995|26349572|P2|Double Blind|Adverse Event|0
7576283|NCT02178995|26349573|P1|Double Blind|Adverse Event|0
7576284|NCT02178956|26349646|P2|Overall Study|Various Reasons|5
7576285|NCT02178956|26349647|P1|Overall Study|Various Reasons|3
7576286|NCT02178956|26349646|P2|Overall Study|Withdrawal by Subject|11
7576287|NCT02178956|26349647|P1|Overall Study|Withdrawal by Subject|15
7576288|NCT02178956|26349646|P2|Overall Study|Sponsor terminated study|58
7576289|NCT02178956|26349647|P1|Overall Study|Sponsor terminated study|49
7576290|NCT02178956|26349646|P2|Overall Study|Lost to Follow-up|4
7576291|NCT02178956|26349647|P1|Overall Study|Lost to Follow-up|4
7576292|NCT02178787|26349698|P2|Overall Study|Physician Decision|0
7576293|NCT02178787|26349699|P1|Overall Study|Physician Decision|1
7576294|NCT02178787|26349698|P2|Overall Study|No TCD window|7
7576295|NCT02178787|26349699|P1|Overall Study|No TCD window|3
7576296|NCT02178787|26349698|P2|Overall Study|Withdrawal by Subject|2
7576297|NCT02178787|26349699|P1|Overall Study|Withdrawal by Subject|0
7576298|NCT02178787|26349698|P2|Overall Study|Lost to Follow-up|0
7576299|NCT02178787|26349699|P1|Overall Study|Lost to Follow-up|1
7576300|NCT02178722|26349712|P5|Overall Study|Participants Ongoing in study|74
7576301|NCT02178722|26349713|P4|Overall Study|Participants Ongoing in study|2
7576302|NCT02178722|26349714|P3|Overall Study|Participants Ongoing in study|4
7576303|NCT02178722|26349715|P2|Overall Study|Participants Ongoing in study|1
7576304|NCT02178722|26349716|P1|Overall Study|Participants Ongoing in study|1
7576305|NCT02178722|26349712|P5|Overall Study|Other Unspecified|1
7576306|NCT02178722|26349713|P4|Overall Study|Other Unspecified|0
7576307|NCT02178722|26349714|P3|Overall Study|Other Unspecified|0
7576308|NCT02178722|26349715|P2|Overall Study|Other Unspecified|0
7576309|NCT02178722|26349716|P1|Overall Study|Other Unspecified|0
7576310|NCT02178722|26349712|P5|Overall Study|Physician Decision|2
7576311|NCT02178722|26349713|P4|Overall Study|Physician Decision|0
7576312|NCT02178722|26349714|P3|Overall Study|Physician Decision|0
7576313|NCT02178722|26349715|P2|Overall Study|Physician Decision|0
7576314|NCT02178722|26349716|P1|Overall Study|Physician Decision|0
7576315|NCT02178722|26349712|P5|Overall Study|Participant trial terminated by sponsor|65
7576316|NCT02178722|26349713|P4|Overall Study|Participant trial terminated by sponsor|3
7576317|NCT02178722|26349714|P3|Overall Study|Participant trial terminated by sponsor|2
7576318|NCT02178722|26349715|P2|Overall Study|Participant trial terminated by sponsor|6
7576319|NCT02178722|26349716|P1|Overall Study|Participant trial terminated by sponsor|1
7576320|NCT02178722|26349712|P5|Overall Study|Lost to Follow-up|11
7576321|NCT02178722|26349713|P4|Overall Study|Lost to Follow-up|2
7576322|NCT02178722|26349714|P3|Overall Study|Lost to Follow-up|0
7576323|NCT02178722|26349715|P2|Overall Study|Lost to Follow-up|0
7576324|NCT02178722|26349716|P1|Overall Study|Lost to Follow-up|0
7576325|NCT02178722|26349712|P5|Overall Study|Death|199
7576326|NCT02178722|26349713|P4|Overall Study|Death|11
7576327|NCT02178722|26349714|P3|Overall Study|Death|12
7576328|NCT02178722|26349715|P2|Overall Study|Death|13
7576329|NCT02178722|26349716|P1|Overall Study|Death|2
7576330|NCT02178722|26349712|P5|Overall Study|Participant decision|30
7576331|NCT02178722|26349713|P4|Overall Study|Participant decision|2
7576332|NCT02178722|26349714|P3|Overall Study|Participant decision|0
7576333|NCT02178722|26349715|P2|Overall Study|Participant decision|0
7576334|NCT02178722|26349716|P1|Overall Study|Participant decision|0
7576335|NCT02178709|26349728|P1|Overall Study|Disease Progression|5
7576336|NCT02178709|26349728|P1|Overall Study|Physician Decision|2
7576337|NCT02178709|26349728|P1|Overall Study|Withdrawal by Subject|2
7576338|NCT02178709|26349728|P1|Overall Study|Death|2
7576339|NCT02178709|26349728|P1|Overall Study|Adverse Event|5
7576340|NCT02178592|26349755|P2|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
7576341|NCT02178592|26349756|P1|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
7576342|NCT02178592|26349755|P2|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
7576343|NCT02178592|26349756|P1|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
7576344|NCT02178592|26349755|P2|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
7576345|NCT02178592|26349756|P1|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
7576346|NCT02178592|26349755|P2|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
7576347|NCT02178592|26349756|P1|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
7576348|NCT02178592|26349755|P2|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
7576349|NCT02178592|26349756|P1|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
7576350|NCT02178592|26349755|P2|OLE Phase (Week 52 to Week 252)|Adverse Event|0
7576351|NCT02178592|26349756|P1|OLE Phase (Week 52 to Week 252)|Adverse Event|1
7576352|NCT02178592|26349755|P2|Randomized Phase (Up to Week 52)|Physician Decision|0
7576353|NCT02178592|26349756|P1|Randomized Phase (Up to Week 52)|Physician Decision|1
7576354|NCT02178592|26349755|P2|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
7576355|NCT02178592|26349756|P1|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
7576356|NCT02178592|26349755|P2|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
7576357|NCT02178592|26349756|P1|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
7576358|NCT02178592|26349755|P2|Randomized Phase (Up to Week 52)|Protocol Violation|2
7576359|NCT02178592|26349756|P1|Randomized Phase (Up to Week 52)|Protocol Violation|3
7576360|NCT02178592|26349755|P2|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7576361|NCT02178592|26349756|P1|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7576362|NCT02178592|26349755|P2|Randomized Phase (Up to Week 52)|Adverse Event|2
7576363|NCT02178592|26349756|P1|Randomized Phase (Up to Week 52)|Adverse Event|0
7576364|NCT02178553|26349798|P2|Overall Study|Technical problem with injection|3
7576365|NCT02178553|26349799|P1|Overall Study|Technical problem with injection|1
7576366|NCT02178553|26349798|P2|Overall Study|Physician Decision|4
7576367|NCT02178553|26349799|P1|Overall Study|Physician Decision|0
7576368|NCT02178553|26349798|P2|Overall Study|Did not proceed to open thoracotomy|3
7576369|NCT02178553|26349799|P1|Overall Study|Did not proceed to open thoracotomy|7
7576370|NCT02178475|26349818|P1|Overall Study|Protocol-specified Criteria|99
7576371|NCT02178475|26349818|P1|Overall Study|Death|13
7576372|NCT02178475|26349818|P1|Overall Study|Lost to Follow-up|10
7576373|NCT02178475|26349818|P1|Overall Study|Withdrawal by Subject|7
7576374|NCT02178358|26349841|P3|Overall Study|On study treatment at study conclusion|2
7576375|NCT02178358|26349842|P2|Overall Study|On study treatment at study conclusion|1
7576376|NCT02178358|26349843|P1|Overall Study|On study treatment at study conclusion|0
7576377|NCT02178358|26349841|P3|Overall Study|Withdrawal by Subject|2
7576378|NCT02178358|26349842|P2|Overall Study|Withdrawal by Subject|2
7576379|NCT02178358|26349843|P1|Overall Study|Withdrawal by Subject|0
7576380|NCT02178059|26349875|P2|Washout|Physician Decision|0
7576381|NCT02178059|26349876|P1|Washout|Physician Decision|1
7576382|NCT02177942|26349894|P2|Overall Study|Withdrawal by Subject|81
7576383|NCT02177942|26349895|P1|Overall Study|Withdrawal by Subject|71
7576384|NCT02177942|26349894|P2|Overall Study|Protocol Violation|6
7576385|NCT02177942|26349895|P1|Overall Study|Protocol Violation|4
7576386|NCT02177942|26349894|P2|Overall Study|Lost to Follow-up|1
7576387|NCT02177942|26349895|P1|Overall Study|Lost to Follow-up|1
7576388|NCT02177942|26349894|P2|Overall Study|Adverse Event|0
7576389|NCT02177942|26349895|P1|Overall Study|Adverse Event|1
7576390|NCT02177838|26349917|P1|Overall Study|Death|1
7576391|NCT02177838|26349917|P1|Overall Study|Physician Decision|1
7576392|NCT02177838|26349917|P1|Overall Study|Withdrawal by Subject|1
7576393|NCT02177812|26349932|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
7576394|NCT02177812|26349933|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
7576395|NCT02177812|26349934|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
7576396|NCT02177812|26349935|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
7576397|NCT02177812|26349936|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
7576398|NCT02177812|26349937|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
7576399|NCT02177812|26349938|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
7576400|NCT02177812|26349939|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
7576401|NCT02177812|26349940|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
7576402|NCT02177812|26349932|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576403|NCT02177812|26349933|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576404|NCT02177812|26349934|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
7576405|NCT02177812|26349935|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
7576406|NCT02177812|26349936|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576407|NCT02177812|26349937|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576408|NCT02177812|26349938|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576409|NCT02177812|26349939|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576410|NCT02177812|26349940|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
7576411|NCT02177812|26349932|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7576412|NCT02177812|26349933|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7576413|NCT02177812|26349934|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
7576414|NCT02177812|26349935|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7576415|NCT02177812|26349936|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7576416|NCT02177812|26349937|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7576417|NCT02177812|26349938|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7576418|NCT02177812|26349939|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7576419|NCT02177812|26349940|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7576420|NCT02177786|26350157|P4|Overall Study|Missing study completion status|0
7576421|NCT02177786|26350158|P3|Overall Study|Missing study completion status|0
7576422|NCT02177786|26350159|P2|Overall Study|Missing study completion status|1
7576423|NCT02177786|26350160|P1|Overall Study|Missing study completion status|0
7576424|NCT02177786|26350157|P4|Overall Study|Progressive Disease|0
7576425|NCT02177786|26350158|P3|Overall Study|Progressive Disease|0
7576426|NCT02177786|26350159|P2|Overall Study|Progressive Disease|1
7576427|NCT02177786|26350160|P1|Overall Study|Progressive Disease|0
7576428|NCT02177786|26350157|P4|Overall Study|Protocol Violation|0
7576429|NCT02177786|26350158|P3|Overall Study|Protocol Violation|2
7576430|NCT02177786|26350159|P2|Overall Study|Protocol Violation|0
7576431|NCT02177786|26350160|P1|Overall Study|Protocol Violation|0
7576432|NCT02177786|26350157|P4|Overall Study|Non-Compliance with Study Drug|1
7576433|NCT02177786|26350158|P3|Overall Study|Non-Compliance with Study Drug|0
7576434|NCT02177786|26350159|P2|Overall Study|Non-Compliance with Study Drug|1
7576435|NCT02177786|26350160|P1|Overall Study|Non-Compliance with Study Drug|0
7576436|NCT02177786|26350157|P4|Overall Study|Lost to Follow-up|2
7576437|NCT02177786|26350158|P3|Overall Study|Lost to Follow-up|2
7576438|NCT02177786|26350159|P2|Overall Study|Lost to Follow-up|0
7576439|NCT02177786|26350160|P1|Overall Study|Lost to Follow-up|0
7576440|NCT02177786|26350157|P4|Overall Study|Death|1
7576441|NCT02177786|26350158|P3|Overall Study|Death|1
7576442|NCT02177786|26350159|P2|Overall Study|Death|1
7576443|NCT02177786|26350160|P1|Overall Study|Death|1
7576444|NCT02177786|26350157|P4|Overall Study|Adverse Event|3
7576445|NCT02177786|26350158|P3|Overall Study|Adverse Event|2
7576446|NCT02177786|26350159|P2|Overall Study|Adverse Event|1
7576447|NCT02177786|26350160|P1|Overall Study|Adverse Event|1
7576448|NCT02177786|26350157|P4|Overall Study|Progression to End Stage Renal Disease|1
7576449|NCT02177786|26350158|P3|Overall Study|Progression to End Stage Renal Disease|2
7576450|NCT02177786|26350159|P2|Overall Study|Progression to End Stage Renal Disease|3
7576451|NCT02177786|26350160|P1|Overall Study|Progression to End Stage Renal Disease|2
7576452|NCT02177786|26350157|P4|Overall Study|Withdrew Consent|5
7576453|NCT02177786|26350158|P3|Overall Study|Withdrew Consent|9
7576454|NCT02177786|26350159|P2|Overall Study|Withdrew Consent|6
7576455|NCT02177786|26350160|P1|Overall Study|Withdrew Consent|2
7576456|NCT02177266|26350183|P2|Overall Study|Withdrawal by Subject|0
7576457|NCT02177266|26350184|P1|Overall Study|Withdrawal by Subject|1
7576458|NCT02177266|26350183|P2|Overall Study|Adverse Event|1
7576459|NCT02177266|26350184|P1|Overall Study|Adverse Event|0
7576460|NCT02177136|26350206|P4|LTSE Phase|Participant Moved|1
7576461|NCT02177136|26350207|P3|LTSE Phase|Participant Moved|0
7576462|NCT02177136|26350208|P2|LTSE Phase|Participant Moved|0
7576463|NCT02177136|26350209|P1|LTSE Phase|Participant Moved|0
7576464|NCT02177136|26350206|P4|LTSE Phase|Lost to Follow-up|1
7576465|NCT02177136|26350207|P3|LTSE Phase|Lost to Follow-up|0
7576466|NCT02177136|26350208|P2|LTSE Phase|Lost to Follow-up|0
7576467|NCT02177136|26350209|P1|LTSE Phase|Lost to Follow-up|0
7576468|NCT02177136|26350206|P4|LTSE Phase|Physician Decision|2
7576469|NCT02177136|26350207|P3|LTSE Phase|Physician Decision|0
7576470|NCT02177136|26350208|P2|LTSE Phase|Physician Decision|0
7576471|NCT02177136|26350209|P1|LTSE Phase|Physician Decision|0
7576472|NCT02177136|26350206|P4|LTSE Phase|Discontinued Due to Pruritus|4
7576473|NCT02177136|26350207|P3|LTSE Phase|Discontinued Due to Pruritus|0
7576474|NCT02177136|26350208|P2|LTSE Phase|Discontinued Due to Pruritus|0
7576475|NCT02177136|26350209|P1|LTSE Phase|Discontinued Due to Pruritus|0
7576476|NCT02177136|26350206|P4|LTSE Phase|Adverse Event|10
7576477|NCT02177136|26350207|P3|LTSE Phase|Adverse Event|0
7576478|NCT02177136|26350208|P2|LTSE Phase|Adverse Event|0
7576479|NCT02177136|26350209|P1|LTSE Phase|Adverse Event|0
7576480|NCT02177136|26350206|P4|LTSE Phase|Withdrawal by Subject|6
7576481|NCT02177136|26350207|P3|LTSE Phase|Withdrawal by Subject|0
7576482|NCT02177136|26350208|P2|LTSE Phase|Withdrawal by Subject|0
7576483|NCT02177136|26350209|P1|LTSE Phase|Withdrawal by Subject|0
7576484|NCT02177136|26350206|P4|DB Phase|Withdrew Consent Prior to Dosing|0
7576485|NCT02177136|26350207|P3|DB Phase|Withdrew Consent Prior to Dosing|0
7576486|NCT02177136|26350208|P2|DB Phase|Withdrew Consent Prior to Dosing|0
7576487|NCT02177136|26350209|P1|DB Phase|Withdrew Consent Prior to Dosing|1
7576488|NCT02177136|26350206|P4|DB Phase|Protocol Violation|0
7576489|NCT02177136|26350207|P3|DB Phase|Protocol Violation|1
7576490|NCT02177136|26350208|P2|DB Phase|Protocol Violation|0
7576491|NCT02177136|26350209|P1|DB Phase|Protocol Violation|0
7576492|NCT02177136|26350206|P4|DB Phase|Adverse Event|0
7576493|NCT02177136|26350207|P3|DB Phase|Adverse Event|3
7576494|NCT02177136|26350208|P2|DB Phase|Adverse Event|2
7576495|NCT02177136|26350209|P1|DB Phase|Adverse Event|3
7576496|NCT02177136|26350206|P4|DB Phase|Discontinued Due to Pruritus|0
7576497|NCT02177136|26350207|P3|DB Phase|Discontinued Due to Pruritus|0
7576498|NCT02177136|26350208|P2|DB Phase|Discontinued Due to Pruritus|3
7576499|NCT02177136|26350209|P1|DB Phase|Discontinued Due to Pruritus|1
7576500|NCT02177136|26350206|P4|DB Phase|Withdrawal by Subject|0
7576501|NCT02177136|26350207|P3|DB Phase|Withdrawal by Subject|0
7576502|NCT02177136|26350208|P2|DB Phase|Withdrawal by Subject|0
7576503|NCT02177136|26350209|P1|DB Phase|Withdrawal by Subject|2
7576504|NCT02177123|26350256|P1|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
7576505|NCT02177123|26350256|P1|Overall Study|Other|1
7576506|NCT02177123|26350256|P1|Overall Study|Death|1
7576507|NCT02177123|26350256|P1|Overall Study|Excluded for medical reasons|2
7576508|NCT02177123|26350256|P1|Overall Study|Excluded by Sponsor - other reason|2
7576509|NCT02177123|26350256|P1|Overall Study|Physician Decision|3
7576510|NCT02177123|26350256|P1|Overall Study|Adverse Event|4
7576511|NCT02177123|26350256|P1|Overall Study|Withdrawal by Subject|4
7576512|NCT02177123|26350256|P1|Overall Study|Lost to Follow-up|6
7576513|NCT02177032|26350267|P4|Overall Study|Withdrawal by Subject|0
7576514|NCT02177032|26350268|P3|Overall Study|Withdrawal by Subject|1
7576515|NCT02177032|26350269|P2|Overall Study|Withdrawal by Subject|0
7576516|NCT02177032|26350270|P1|Overall Study|Withdrawal by Subject|1
7576517|NCT02177032|26350267|P4|Overall Study|OTHER|0
7576518|NCT02177032|26350268|P3|Overall Study|OTHER|1
7576519|NCT02177032|26350269|P2|Overall Study|OTHER|0
7576520|NCT02177032|26350270|P1|Overall Study|OTHER|2
7576521|NCT02177032|26350267|P4|Overall Study|Lost to Follow-up|0
7576522|NCT02177032|26350268|P3|Overall Study|Lost to Follow-up|0
7576523|NCT02177032|26350269|P2|Overall Study|Lost to Follow-up|2
7576524|NCT02177032|26350270|P1|Overall Study|Lost to Follow-up|0
7576525|NCT02177032|26350267|P4|Overall Study|ADMINISTRATIVE REASON|0
7576526|NCT02177032|26350268|P3|Overall Study|ADMINISTRATIVE REASON|1
7576527|NCT02177032|26350269|P2|Overall Study|ADMINISTRATIVE REASON|0
7576528|NCT02177032|26350270|P1|Overall Study|ADMINISTRATIVE REASON|2
7576529|NCT02176928|26350306|P2|Overall Study|Lost to Follow-up|4
7576530|NCT02176928|26350307|P1|Overall Study|Lost to Follow-up|2
7576531|NCT02176655|26350317|P1|Overall Study|Subjects did not treat|6
7576532|NCT02176642|26350340|P2|Overall Study|Withdrawal by Subject|1
7576533|NCT02176642|26350341|P1|Overall Study|Withdrawal by Subject|0
7576534|NCT02176525|26350371|P8|Overall Study|not treated|0
7576535|NCT02176525|26350372|P7|Overall Study|not treated|0
7576536|NCT02176525|26350373|P6|Overall Study|not treated|1
7576537|NCT02176525|26350374|P5|Overall Study|not treated|0
7576538|NCT02176525|26350375|P4|Overall Study|not treated|0
7576539|NCT02176525|26350376|P3|Overall Study|not treated|0
7576540|NCT02176525|26350377|P2|Overall Study|not treated|0
7576541|NCT02176525|26350378|P1|Overall Study|not treated|1
7576542|NCT02176525|26350371|P8|Overall Study|Adverse Event|0
7576543|NCT02176525|26350372|P7|Overall Study|Adverse Event|1
7576544|NCT02176525|26350373|P6|Overall Study|Adverse Event|0
7576545|NCT02176525|26350374|P5|Overall Study|Adverse Event|1
7576546|NCT02176525|26350375|P4|Overall Study|Adverse Event|1
7576547|NCT02176525|26350376|P3|Overall Study|Adverse Event|0
7576548|NCT02176525|26350377|P2|Overall Study|Adverse Event|0
7576549|NCT02176525|26350378|P1|Overall Study|Adverse Event|0
7576550|NCT02176421|26350594|P1|Overall Study|Adverse Event|1
7576551|NCT02176421|26350594|P1|Overall Study|Lost to Follow-up|4
7576552|NCT02176356|26350635|P1|Overall Study|Other Miscellaneous Reasons|2
7576553|NCT02176356|26350635|P1|Overall Study|Personal Reasons|3
7576554|NCT02176356|26350635|P1|Overall Study|Lost to Follow-up|4
7576555|NCT02176356|26350635|P1|Overall Study|Screen Failure|14
7576556|NCT02176291|26350665|P2|Overall Study|Withdrawal by Subject|0
7576557|NCT02176291|26350666|P1|Overall Study|Withdrawal by Subject|2
7576558|NCT02176291|26350665|P2|Overall Study|non compliance with protocol|0
7576559|NCT02176291|26350666|P1|Overall Study|non compliance with protocol|2
7576560|NCT02176291|26350665|P2|Overall Study|Death|0
7576561|NCT02176291|26350666|P1|Overall Study|Death|1
7576562|NCT02176226|26350674|P1|Overall Study|Withdrew prior to treatment|6
7576563|NCT02176226|26350674|P1|Overall Study|Lost to Follow-up|3
7576564|NCT02176018|26350700|P2|Overall Study|Withdrawal by Subject|2
7576565|NCT02176018|26350701|P1|Overall Study|Withdrawal by Subject|1
7576566|NCT02176018|26350700|P2|Overall Study|Protocol Violation|1
7576567|NCT02176018|26350701|P1|Overall Study|Protocol Violation|1
7576568|NCT02176018|26350700|P2|Overall Study|Lost to Follow-up|1
7576569|NCT02176018|26350701|P1|Overall Study|Lost to Follow-up|3
7576570|NCT02176018|26350700|P2|Overall Study|Adverse Event|2
7576571|NCT02176018|26350701|P1|Overall Study|Adverse Event|0
7576572|NCT02175966|26350785|P2|Follow-up Period|Lack of Efficacy|6
7576573|NCT02175966|26350786|P1|Follow-up Period|Lack of Efficacy|10
7576574|NCT02175771|26350814|P9|Treatment Period|Other|0
7576575|NCT02175771|26350815|P8|Treatment Period|Other|2
7576576|NCT02175771|26350816|P7|Treatment Period|Other|0
7576577|NCT02175771|26350817|P6|Treatment Period|Other|0
7576578|NCT02175771|26350818|P5|Treatment Period|Other|1
7576579|NCT02175771|26350819|P4|Treatment Period|Other|3
7576580|NCT02175771|26350820|P3|Treatment Period|Other|0
7576581|NCT02175771|26350821|P2|Treatment Period|Other|1
7576582|NCT02175771|26350822|P1|Treatment Period|Other|0
7576583|NCT02175771|26350814|P9|Treatment Period|Lack of Efficacy|0
7576584|NCT02175771|26350815|P8|Treatment Period|Lack of Efficacy|1
7576585|NCT02175771|26350816|P7|Treatment Period|Lack of Efficacy|0
7576586|NCT02175771|26350817|P6|Treatment Period|Lack of Efficacy|1
7576587|NCT02175771|26350818|P5|Treatment Period|Lack of Efficacy|0
7576588|NCT02175771|26350819|P4|Treatment Period|Lack of Efficacy|0
7576589|NCT02175771|26350820|P3|Treatment Period|Lack of Efficacy|0
7576590|NCT02175771|26350821|P2|Treatment Period|Lack of Efficacy|0
7576591|NCT02175771|26350822|P1|Treatment Period|Lack of Efficacy|0
7576592|NCT02175771|26350814|P9|Treatment Period|Lost to Follow-up|2
7576593|NCT02175771|26350815|P8|Treatment Period|Lost to Follow-up|2
7576594|NCT02175771|26350816|P7|Treatment Period|Lost to Follow-up|1
7576595|NCT02175771|26350817|P6|Treatment Period|Lost to Follow-up|2
7576596|NCT02175771|26350818|P5|Treatment Period|Lost to Follow-up|1
7576597|NCT02175771|26350819|P4|Treatment Period|Lost to Follow-up|3
7576598|NCT02175771|26350820|P3|Treatment Period|Lost to Follow-up|1
7576599|NCT02175771|26350821|P2|Treatment Period|Lost to Follow-up|3
7576600|NCT02175771|26350822|P1|Treatment Period|Lost to Follow-up|0
7576601|NCT02175771|26350814|P9|Treatment Period|Disease progression|0
7576602|NCT02175771|26350815|P8|Treatment Period|Disease progression|2
7576603|NCT02175771|26350816|P7|Treatment Period|Disease progression|0
7576604|NCT02175771|26350817|P6|Treatment Period|Disease progression|0
7576605|NCT02175771|26350818|P5|Treatment Period|Disease progression|0
7576606|NCT02175771|26350819|P4|Treatment Period|Disease progression|0
7576607|NCT02175771|26350820|P3|Treatment Period|Disease progression|0
7576608|NCT02175771|26350821|P2|Treatment Period|Disease progression|0
7576609|NCT02175771|26350822|P1|Treatment Period|Disease progression|0
7576610|NCT02175771|26350814|P9|Treatment Period|Protocol Violation|0
7576611|NCT02175771|26350815|P8|Treatment Period|Protocol Violation|1
7576612|NCT02175771|26350816|P7|Treatment Period|Protocol Violation|0
7576613|NCT02175771|26350817|P6|Treatment Period|Protocol Violation|0
7576614|NCT02175771|26350818|P5|Treatment Period|Protocol Violation|0
7576615|NCT02175771|26350819|P4|Treatment Period|Protocol Violation|0
7576616|NCT02175771|26350820|P3|Treatment Period|Protocol Violation|0
7576617|NCT02175771|26350821|P2|Treatment Period|Protocol Violation|0
7576618|NCT02175771|26350822|P1|Treatment Period|Protocol Violation|0
7576619|NCT02175771|26350814|P9|Treatment Period|Noncompliance|1
7576620|NCT02175771|26350815|P8|Treatment Period|Noncompliance|0
7576621|NCT02175771|26350816|P7|Treatment Period|Noncompliance|0
7576622|NCT02175771|26350817|P6|Treatment Period|Noncompliance|0
7576623|NCT02175771|26350818|P5|Treatment Period|Noncompliance|0
7576624|NCT02175771|26350819|P4|Treatment Period|Noncompliance|0
7576625|NCT02175771|26350820|P3|Treatment Period|Noncompliance|2
7576626|NCT02175771|26350821|P2|Treatment Period|Noncompliance|1
7576627|NCT02175771|26350822|P1|Treatment Period|Noncompliance|0
7576628|NCT02175771|26350814|P9|Treatment Period|Withdrawal by Subject|2
7576629|NCT02175771|26350815|P8|Treatment Period|Withdrawal by Subject|9
7576630|NCT02175771|26350816|P7|Treatment Period|Withdrawal by Subject|2
7576631|NCT02175771|26350817|P6|Treatment Period|Withdrawal by Subject|4
7576632|NCT02175771|26350818|P5|Treatment Period|Withdrawal by Subject|2
7576633|NCT02175771|26350819|P4|Treatment Period|Withdrawal by Subject|6
7576634|NCT02175771|26350820|P3|Treatment Period|Withdrawal by Subject|3
7576635|NCT02175771|26350821|P2|Treatment Period|Withdrawal by Subject|9
7576636|NCT02175771|26350822|P1|Treatment Period|Withdrawal by Subject|0
7576637|NCT02175771|26350814|P9|Treatment Period|Adverse Event|1
7576638|NCT02175771|26350815|P8|Treatment Period|Adverse Event|0
7576639|NCT02175771|26350816|P7|Treatment Period|Adverse Event|2
7576640|NCT02175771|26350817|P6|Treatment Period|Adverse Event|3
7576641|NCT02175771|26350818|P5|Treatment Period|Adverse Event|1
7576642|NCT02175771|26350819|P4|Treatment Period|Adverse Event|1
7576643|NCT02175771|26350820|P3|Treatment Period|Adverse Event|1
7576644|NCT02175771|26350821|P2|Treatment Period|Adverse Event|2
7576645|NCT02175771|26350822|P1|Treatment Period|Adverse Event|0
7576646|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Other|0
7576647|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Other|0
7576648|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Other|0
7576649|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Other|0
7576650|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Other|0
7576651|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Other|0
7576652|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Other|0
7576653|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Other|0
7576654|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Other|8
7576655|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576656|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576657|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576658|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576659|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576660|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576661|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576662|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7576663|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7576664|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576665|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576666|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576667|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576668|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576669|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576670|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576671|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7576672|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
7576673|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Adverse Event|0
7576674|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Adverse Event|0
7576675|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Adverse Event|0
7576676|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Adverse Event|0
7576677|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Adverse Event|0
7576678|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Adverse Event|0
7576679|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Adverse Event|0
7576680|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Adverse Event|0
7576681|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Adverse Event|9
7576682|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576683|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576684|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576685|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576686|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576687|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576688|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576689|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7576690|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
7576691|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576692|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576693|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576694|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576695|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576696|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576697|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576698|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7576699|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
7576700|NCT02175771|26350814|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576701|NCT02175771|26350815|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576702|NCT02175771|26350816|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576703|NCT02175771|26350817|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576704|NCT02175771|26350818|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576705|NCT02175771|26350819|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576706|NCT02175771|26350820|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576707|NCT02175771|26350821|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7576708|NCT02175771|26350822|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
7576709|NCT02175758|26350886|P6|Treatment Phase|Adverse Event|0
7576710|NCT02175758|26350887|P5|Treatment Phase|Adverse Event|1
7576711|NCT02175758|26350888|P4|Treatment Phase|Adverse Event|0
7576712|NCT02175758|26350889|P3|Treatment Phase|Adverse Event|0
7576713|NCT02175758|26350890|P2|Treatment Phase|Adverse Event|0
7576714|NCT02175758|26350891|P1|Treatment Phase|Adverse Event|0
7576715|NCT02175758|26350886|P6|Treatment Phase|Lost to Follow-up|0
7576716|NCT02175758|26350887|P5|Treatment Phase|Lost to Follow-up|0
7576717|NCT02175758|26350888|P4|Treatment Phase|Lost to Follow-up|0
7576718|NCT02175758|26350889|P3|Treatment Phase|Lost to Follow-up|0
7576719|NCT02175758|26350890|P2|Treatment Phase|Lost to Follow-up|1
7576720|NCT02175758|26350891|P1|Treatment Phase|Lost to Follow-up|0
7576721|NCT02175745|26350994|P1|Overall Study|Not Eligible|1
7576722|NCT02175641|26351001|P2|Overall Study|Developed Contraindicated Condition|0
7576723|NCT02175641|26351002|P1|Overall Study|Developed Contraindicated Condition|8
7576724|NCT02175641|26351001|P2|Overall Study|Discharged from Supportive Housing Agenc|15
7576725|NCT02175641|26351002|P1|Overall Study|Discharged from Supportive Housing Agenc|13
7576726|NCT02175641|26351001|P2|Overall Study|Withdrawal by Subject|4
7576727|NCT02175641|26351002|P1|Overall Study|Withdrawal by Subject|7
7576728|NCT02175641|26351001|P2|Overall Study|Lost to Follow-up|4
7576729|NCT02175641|26351002|P1|Overall Study|Lost to Follow-up|4
7576730|NCT02175641|26351001|P2|Overall Study|Death|4
7576731|NCT02175641|26351002|P1|Overall Study|Death|3
7576732|NCT02175368|26351056|P1|Overall Study|Lost to Follow-up|1
7576733|NCT02175277|26351061|P1|Overall Study|Protocol-specified Criteria|1
7576734|NCT02175225|26351067|P2|Overall Study|Study drug not administered|2
7576735|NCT02175225|26351068|P1|Overall Study|Study drug not administered|1
7576736|NCT02175225|26351067|P2|Overall Study|Lost to Follow-up|7
7576737|NCT02175225|26351068|P1|Overall Study|Lost to Follow-up|6
7576738|NCT02175225|26351067|P2|Overall Study|Withdrawal by Subject|2
7576739|NCT02175225|26351068|P1|Overall Study|Withdrawal by Subject|1
7576740|NCT02175199|26351119|P2|Overall Study|Sponsor Decision|0
7576741|NCT02175199|26351120|P1|Overall Study|Sponsor Decision|1
7576742|NCT02175199|26351119|P2|Overall Study|Randomized in Error|0
7576743|NCT02175199|26351120|P1|Overall Study|Randomized in Error|1
7576744|NCT02175199|26351119|P2|Overall Study|Withdrawal by Subject|5
7576745|NCT02175199|26351120|P1|Overall Study|Withdrawal by Subject|1
7576746|NCT02175121|26351134|P5|Overall Study|Time issues|0
7576747|NCT02175121|26351135|P4|Overall Study|Time issues|0
7576748|NCT02175121|26351136|P3|Overall Study|Time issues|1
7576749|NCT02175121|26351137|P2|Overall Study|Time issues|0
7576750|NCT02175121|26351138|P1|Overall Study|Time issues|0
7576751|NCT02175121|26351134|P5|Overall Study|Schedule conflict|0
7576752|NCT02175121|26351135|P4|Overall Study|Schedule conflict|0
7576753|NCT02175121|26351136|P3|Overall Study|Schedule conflict|1
7576754|NCT02175121|26351137|P2|Overall Study|Schedule conflict|0
7576755|NCT02175121|26351138|P1|Overall Study|Schedule conflict|0
7576756|NCT02175121|26351134|P5|Overall Study|Personal emergency|1
7576757|NCT02175121|26351135|P4|Overall Study|Personal emergency|0
7576758|NCT02175121|26351136|P3|Overall Study|Personal emergency|0
7576759|NCT02175121|26351137|P2|Overall Study|Personal emergency|0
7576760|NCT02175121|26351138|P1|Overall Study|Personal emergency|0
7576761|NCT02175121|26351134|P5|Overall Study|Lost to Follow-up|0
7576762|NCT02175121|26351135|P4|Overall Study|Lost to Follow-up|1
7576763|NCT02175121|26351136|P3|Overall Study|Lost to Follow-up|0
7576764|NCT02175121|26351137|P2|Overall Study|Lost to Follow-up|1
7576765|NCT02175121|26351138|P1|Overall Study|Lost to Follow-up|0
7576766|NCT02175121|26351134|P5|Overall Study|Lack of Efficacy|0
7576767|NCT02175121|26351135|P4|Overall Study|Lack of Efficacy|0
7576768|NCT02175121|26351136|P3|Overall Study|Lack of Efficacy|0
7576769|NCT02175121|26351137|P2|Overall Study|Lack of Efficacy|0
7576770|NCT02175121|26351138|P1|Overall Study|Lack of Efficacy|1
7576771|NCT02174861|26351276|P1|Overall Study|Lost to Follow-up|26
7576772|NCT02174861|26351276|P1|Overall Study|Withdrawal by Subject|124
7576773|NCT02174861|26351276|P1|Overall Study|Decision by sponsor|8
7576774|NCT02174848|26351290|P2|Overall Study|Unable to comply with study requirements|0
7576775|NCT02174848|26351291|P1|Overall Study|Unable to comply with study requirements|1
7576776|NCT02174848|26351290|P2|Overall Study|Worsening of disease|1
7576777|NCT02174848|26351291|P1|Overall Study|Worsening of disease|1
7576778|NCT02174848|26351290|P2|Overall Study|Lost to Follow-up|1
7576779|NCT02174848|26351291|P1|Overall Study|Lost to Follow-up|0
7576780|NCT02174848|26351290|P2|Overall Study|Withdrawal by Subject|3
7576781|NCT02174848|26351291|P1|Overall Study|Withdrawal by Subject|3
7576782|NCT02174848|26351290|P2|Overall Study|Adverse Event|1
7576783|NCT02174848|26351291|P1|Overall Study|Adverse Event|2
7576784|NCT02174731|26351308|P2|Overall Study|Missing|0
7576785|NCT02174731|26351309|P1|Overall Study|Missing|2
7576786|NCT02174731|26351308|P2|Overall Study|Incorrect enrolment before randomization|1
7576787|NCT02174731|26351309|P1|Overall Study|Incorrect enrolment before randomization|0
7576788|NCT02174731|26351308|P2|Overall Study|Participant decision|64
7576789|NCT02174731|26351309|P1|Overall Study|Participant decision|67
7576790|NCT02174627|26351331|P2|Overall Study|Participant decision|128
7576791|NCT02174627|26351332|P1|Overall Study|Participant decision|84
7576792|NCT02174627|26351331|P2|Overall Study|Incorrect enrolment before randomization|1
7576793|NCT02174627|26351332|P1|Overall Study|Incorrect enrolment before randomization|0
7576794|NCT02174627|26351331|P2|Overall Study|Missing|1
7576795|NCT02174627|26351332|P1|Overall Study|Missing|0
7576796|NCT02174562|26351360|P2|Overall Study|Lost to Follow-up|3
7576797|NCT02174562|26351361|P1|Overall Study|Lost to Follow-up|0
7576798|NCT02174562|26351360|P2|Overall Study|Death|0
7576799|NCT02174562|26351361|P1|Overall Study|Death|2
7576800|NCT02174562|26351360|P2|Overall Study|Withdrawal by Subject|2
7576801|NCT02174562|26351361|P1|Overall Study|Withdrawal by Subject|7
7576802|NCT02174523|26351371|P2|Overall Study|Withdrawal by Subject|0
7576803|NCT02174523|26351372|P1|Overall Study|Withdrawal by Subject|1
7576804|NCT02174276|26351457|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
7576805|NCT02174276|26351458|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7576806|NCT02174276|26351459|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
7576807|NCT02174276|26351460|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7576808|NCT02174276|26351457|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
7576809|NCT02174276|26351458|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
7576810|NCT02174276|26351459|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
7576811|NCT02174276|26351460|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
7576812|NCT02174276|26351457|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7576813|NCT02174276|26351458|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
7576814|NCT02174276|26351459|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7576815|NCT02174276|26351460|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7576816|NCT02174276|26351457|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7576817|NCT02174276|26351458|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
7576818|NCT02174276|26351459|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
7576819|NCT02174276|26351460|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7576820|NCT02174276|26351457|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7576821|NCT02174276|26351458|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
7576822|NCT02174276|26351459|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7576823|NCT02174276|26351460|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7576824|NCT02174276|26351457|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7576825|NCT02174276|26351458|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7576826|NCT02174276|26351459|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7576827|NCT02174276|26351460|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
7576828|NCT02173769|26351567|P1|Overall Study|Protocol Violation|4
7576829|NCT02173704|26351580|P2|Overall Study|Withdrawal by Subject|4
7576830|NCT02173704|26351581|P1|Overall Study|Withdrawal by Subject|9
7576831|NCT02173704|26351580|P2|Overall Study|Protocol Violation|0
7576832|NCT02173704|26351581|P1|Overall Study|Protocol Violation|1
7576833|NCT02173704|26351580|P2|Overall Study|Other|0
7576834|NCT02173704|26351581|P1|Overall Study|Other|1
7576835|NCT02173704|26351580|P2|Overall Study|Lost to Follow-up|0
7576836|NCT02173704|26351581|P1|Overall Study|Lost to Follow-up|1
7576837|NCT02173704|26351580|P2|Overall Study|Adverse Event|0
7576838|NCT02173704|26351581|P1|Overall Study|Adverse Event|1
7576839|NCT02173548|26351609|P2|Overall Study|Withdrawal by Subject|0
7576840|NCT02173548|26351610|P1|Overall Study|Withdrawal by Subject|1
7576841|NCT02173548|26351609|P2|Overall Study|Lost to Follow-up|2
7576842|NCT02173548|26351610|P1|Overall Study|Lost to Follow-up|0
7576843|NCT02173379|26351742|P2|Overall Study|Death|22
7576844|NCT02173379|26351743|P1|Overall Study|Death|22
7576845|NCT02173379|26351742|P2|Overall Study|Physician Decision|4
7576846|NCT02173379|26351743|P1|Overall Study|Physician Decision|7
7576847|NCT02173379|26351742|P2|Overall Study|Withdrawal by Subject|17
7576848|NCT02173379|26351743|P1|Overall Study|Withdrawal by Subject|14
7576849|NCT02173379|26351742|P2|Overall Study|Lost to Follow-up|34
7576850|NCT02173379|26351743|P1|Overall Study|Lost to Follow-up|48
7576851|NCT02173158|26351987|P1|Efficacy Phase|Adverse Event|1
7576852|NCT02173054|26352004|P3|Overall Study|Withdrawal by Subject|1
7576853|NCT02173054|26352005|P2|Overall Study|Withdrawal by Subject|0
7576854|NCT02173054|26352006|P1|Overall Study|Withdrawal by Subject|0
7576855|NCT02173054|26352004|P3|Overall Study|lack of compliance|0
7576856|NCT02173054|26352005|P2|Overall Study|lack of compliance|0
7576857|NCT02173054|26352006|P1|Overall Study|lack of compliance|1
7576858|NCT02172911|26352028|P2|Overall Study|Loss of insurance coverage|0
7576859|NCT02172911|26352029|P1|Overall Study|Loss of insurance coverage|1
7576860|NCT02172911|26352028|P2|Overall Study|Progression of Disease|1
7576861|NCT02172911|26352029|P1|Overall Study|Progression of Disease|0
7576862|NCT02172911|26352028|P2|Overall Study|Serious Adverse Event|1
7576863|NCT02172911|26352029|P1|Overall Study|Serious Adverse Event|0
7576864|NCT02172664|26352103|P2|Overall Study|Moved out of area|1
7576865|NCT02172664|26352104|P1|Overall Study|Moved out of area|1
7576866|NCT02172664|26352103|P2|Overall Study|Death|1
7576867|NCT02172664|26352104|P1|Overall Study|Death|1
7576868|NCT02172664|26352103|P2|Overall Study|Lost to Follow-up|4
7576869|NCT02172664|26352104|P1|Overall Study|Lost to Follow-up|4
7576870|NCT02172625|26352113|P2|Overall Study|car accident|1
7576871|NCT02172625|26352114|P1|Overall Study|car accident|0
7576872|NCT02172625|26352113|P2|Overall Study|Pregnancy|1
7576873|NCT02172625|26352114|P1|Overall Study|Pregnancy|0
7576874|NCT02172625|26352113|P2|Overall Study|Adverse Event|1
7576875|NCT02172625|26352114|P1|Overall Study|Adverse Event|0
7576876|NCT02172040|26352136|P4|Overall Study|Family emergency abroad|1
7576877|NCT02172040|26352137|P3|Overall Study|Family emergency abroad|0
7576878|NCT02172040|26352138|P2|Overall Study|Family emergency abroad|0
7576879|NCT02172040|26352139|P1|Overall Study|Family emergency abroad|0
7576880|NCT02172040|26352136|P4|Overall Study|Not available for Day 13 & 14 visits|0
7576881|NCT02172040|26352137|P3|Overall Study|Not available for Day 13 & 14 visits|1
7576882|NCT02172040|26352138|P2|Overall Study|Not available for Day 13 & 14 visits|0
7576883|NCT02172040|26352139|P1|Overall Study|Not available for Day 13 & 14 visits|0
7576884|NCT02172040|26352136|P4|Overall Study|Withdrawal by Subject|0
7576885|NCT02172040|26352137|P3|Overall Study|Withdrawal by Subject|1
7576886|NCT02172040|26352138|P2|Overall Study|Withdrawal by Subject|0
7576887|NCT02172040|26352139|P1|Overall Study|Withdrawal by Subject|0
7576888|NCT02172040|26352136|P4|Overall Study|Protocol Violation|0
7576889|NCT02172040|26352137|P3|Overall Study|Protocol Violation|0
7576890|NCT02172040|26352138|P2|Overall Study|Protocol Violation|1
7576891|NCT02172040|26352139|P1|Overall Study|Protocol Violation|0
7576892|NCT02172040|26352136|P4|Overall Study|Adverse Event|0
7576893|NCT02172040|26352137|P3|Overall Study|Adverse Event|0
7576894|NCT02172040|26352138|P2|Overall Study|Adverse Event|2
7576895|NCT02172040|26352139|P1|Overall Study|Adverse Event|0
7576896|NCT02171429|26352301|P3|Overall Study|Death|1
7576897|NCT02171429|26352302|P2|Overall Study|Death|0
7576898|NCT02171429|26352303|P1|Overall Study|Death|0
7576899|NCT02171429|26352301|P3|Overall Study|Lost to Follow-up|0
7576900|NCT02171429|26352302|P2|Overall Study|Lost to Follow-up|1
7576901|NCT02171429|26352303|P1|Overall Study|Lost to Follow-up|0
7576902|NCT02171429|26352301|P3|Overall Study|Withdrawal by Subject|1
7576903|NCT02171429|26352302|P2|Overall Study|Withdrawal by Subject|1
7576904|NCT02171429|26352303|P1|Overall Study|Withdrawal by Subject|1
7576905|NCT02171429|26352301|P3|Overall Study|Physician Decision|1
7576906|NCT02171429|26352302|P2|Overall Study|Physician Decision|0
7576907|NCT02171429|26352303|P1|Overall Study|Physician Decision|0
7576908|NCT02171429|26352301|P3|Overall Study|Non-Compliance|1
7576909|NCT02171429|26352302|P2|Overall Study|Non-Compliance|0
7576910|NCT02171429|26352303|P1|Overall Study|Non-Compliance|0
7576911|NCT02171429|26352301|P3|Overall Study|Other|1
7576912|NCT02171429|26352302|P2|Overall Study|Other|1
7576913|NCT02171429|26352303|P1|Overall Study|Other|0
7576914|NCT02171260|26352380|P4|Overall Study|Evidence of progressive disease|4
7576915|NCT02171260|26352381|P3|Overall Study|Evidence of progressive disease|4
7576916|NCT02171260|26352382|P2|Overall Study|Evidence of progressive disease|6
7576917|NCT02171260|26352383|P1|Overall Study|Evidence of progressive disease|4
7576918|NCT02171260|26352380|P4|Overall Study|Withdrawal by Subject|0
7576919|NCT02171260|26352381|P3|Overall Study|Withdrawal by Subject|0
7576920|NCT02171260|26352382|P2|Overall Study|Withdrawal by Subject|0
7576921|NCT02171260|26352383|P1|Overall Study|Withdrawal by Subject|1
7576922|NCT02171260|26352380|P4|Overall Study|Physician Decision|0
7576923|NCT02171260|26352381|P3|Overall Study|Physician Decision|1
7576924|NCT02171260|26352382|P2|Overall Study|Physician Decision|0
7576925|NCT02171260|26352383|P1|Overall Study|Physician Decision|1
7576926|NCT02171260|26352380|P4|Overall Study|Death|1
7576927|NCT02171260|26352381|P3|Overall Study|Death|0
7576928|NCT02171260|26352382|P2|Overall Study|Death|0
7576929|NCT02171260|26352383|P1|Overall Study|Death|0
7576930|NCT02171130|26352519|P1|Overall Study|Met Exclusion Criteria|1
7576931|NCT02171130|26352519|P1|Overall Study|Lost to Follow-up|1
7576932|NCT02171130|26352519|P1|Overall Study|Physician Decision|1
7576933|NCT02171130|26352519|P1|Overall Study|Withdrawal by Subject|3
7576934|NCT02171130|26352519|P1|Overall Study|Discontinued; Site Termination|5
7576935|NCT02171130|26352519|P1|Overall Study|Discontinued; Clinical Material Issue|16
7576936|NCT02171130|26352519|P1|Overall Study|Death|1
7576937|NCT02171065|26352530|P3|Overall Study|Lost to Follow-up|1
7576938|NCT02171065|26352531|P2|Overall Study|Lost to Follow-up|0
7576939|NCT02171065|26352532|P1|Overall Study|Lost to Follow-up|0
7576940|NCT02171065|26352530|P3|Overall Study|Withdrawal by Subject|0
7576941|NCT02171065|26352531|P2|Overall Study|Withdrawal by Subject|0
7576942|NCT02171065|26352532|P1|Overall Study|Withdrawal by Subject|1
7576943|NCT02170779|26352575|P2|Overall Study|Lost to Follow-up|1
7576944|NCT02170779|26352576|P1|Overall Study|Lost to Follow-up|0
7576945|NCT02170779|26352575|P2|Overall Study|Withdrawal by Subject|0
7576946|NCT02170779|26352576|P1|Overall Study|Withdrawal by Subject|1
7576947|NCT02170727|26352600|P2|Overall Study|Withdrawal by Subject|0
7576948|NCT02170727|26352601|P1|Overall Study|Withdrawal by Subject|2
7576949|NCT02170727|26352600|P2|Overall Study|Lost to Follow-up|0
7576950|NCT02170727|26352601|P1|Overall Study|Lost to Follow-up|1
7576951|NCT02170688|26352632|P5|Overall Study|Physician Decision|0
7576952|NCT02170688|26352633|P4|Overall Study|Physician Decision|0
7576953|NCT02170688|26352634|P3|Overall Study|Physician Decision|1
7576954|NCT02170688|26352635|P2|Overall Study|Physician Decision|0
7576955|NCT02170688|26352636|P1|Overall Study|Physician Decision|0
7576956|NCT02170688|26352632|P5|Overall Study|Full dose not received|0
7576957|NCT02170688|26352633|P4|Overall Study|Full dose not received|0
7576958|NCT02170688|26352634|P3|Overall Study|Full dose not received|0
7576959|NCT02170688|26352635|P2|Overall Study|Full dose not received|1
7576960|NCT02170688|26352636|P1|Overall Study|Full dose not received|0
7576961|NCT02170688|26352632|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
7576962|NCT02170688|26352633|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
7576963|NCT02170688|26352634|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
7576964|NCT02170688|26352635|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
7576965|NCT02170688|26352636|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
7576966|NCT02170389|26352722|P1|Overall Study|Study terminated prior to start of treat|1
7576967|NCT02170298|26352787|P2|Overall Study|unblinded, rerandomized to intervention|0
7576968|NCT02170298|26352788|P1|Overall Study|unblinded, rerandomized to intervention|1
7576969|NCT02170298|26352787|P2|Overall Study|Withdrawal by Subject|1
7576970|NCT02170298|26352788|P1|Overall Study|Withdrawal by Subject|0
7576971|NCT02170207|26352825|P1|Overall Study|Case report forms unavailable|5
7576972|NCT02170077|26352836|P3|Overall Study|Exacerbation of seizures|1
7576973|NCT02170077|26352837|P2|Overall Study|Exacerbation of seizures|2
7576974|NCT02170077|26352838|P1|Overall Study|Exacerbation of seizures|0
7576975|NCT02170077|26352836|P3|Overall Study|Exclusion criteria|5
7576976|NCT02170077|26352837|P2|Overall Study|Exclusion criteria|2
7576977|NCT02170077|26352838|P1|Overall Study|Exclusion criteria|2
7576978|NCT02170077|26352836|P3|Overall Study|Lost to Follow-up|0
7576979|NCT02170077|26352837|P2|Overall Study|Lost to Follow-up|1
7576980|NCT02170077|26352838|P1|Overall Study|Lost to Follow-up|0
7576981|NCT02170077|26352836|P3|Overall Study|Adverse Event|4
7576982|NCT02170077|26352837|P2|Overall Study|Adverse Event|4
7576983|NCT02170077|26352838|P1|Overall Study|Adverse Event|4
7576984|NCT02170077|26352836|P3|Overall Study|Withdrawal by Subject|2
7576985|NCT02170077|26352837|P2|Overall Study|Withdrawal by Subject|4
7576986|NCT02170077|26352838|P1|Overall Study|Withdrawal by Subject|3
7576987|NCT02170064|26352849|P3|Overall Study|Physician Decision|0
7576988|NCT02170064|26352850|P2|Overall Study|Physician Decision|1
7576989|NCT02170064|26352851|P1|Overall Study|Physician Decision|1
7576990|NCT02170064|26352849|P3|Overall Study|Withdrawal by Subject|1
7576991|NCT02170064|26352850|P2|Overall Study|Withdrawal by Subject|1
7576992|NCT02170064|26352851|P1|Overall Study|Withdrawal by Subject|5
7576993|NCT02170051|26352867|P2|Overall Study|Lost to Follow-up|3
7576994|NCT02170051|26352868|P1|Overall Study|Lost to Follow-up|1
7576995|NCT02170051|26352867|P2|Overall Study|Withdrawal by Subject|10
7576996|NCT02170051|26352868|P1|Overall Study|Withdrawal by Subject|10
7576997|NCT02170025|26352890|P2|Overall Study|Adverse Event|0
7576998|NCT02170025|26352891|P1|Overall Study|Adverse Event|2
7576999|NCT02169830|26352936|P3|Third Intervention (8 Weeks)|Withdrawal by Subject|0
7577000|NCT02169830|26352937|P2|Third Intervention (8 Weeks)|Withdrawal by Subject|1
7577001|NCT02169830|26352938|P1|Third Intervention (8 Weeks)|Withdrawal by Subject|0
7577002|NCT02169830|26352936|P3|Third Intervention (8 Weeks)|Lost to Follow-up|0
7577003|NCT02169830|26352937|P2|Third Intervention (8 Weeks)|Lost to Follow-up|1
7577004|NCT02169830|26352938|P1|Third Intervention (8 Weeks)|Lost to Follow-up|0
7577005|NCT02169830|26352936|P3|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7577006|NCT02169830|26352937|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|5
7577007|NCT02169830|26352938|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7577008|NCT02169830|26352936|P3|Second Intervention (8 Weeks)|Lost to Follow-up|0
7577009|NCT02169830|26352937|P2|Second Intervention (8 Weeks)|Lost to Follow-up|0
7577010|NCT02169830|26352938|P1|Second Intervention (8 Weeks)|Lost to Follow-up|1
7577011|NCT02169830|26352936|P3|Diet Intervention (4 Weeks)|Lost to Follow-up|1
7577012|NCT02169830|26352937|P2|Diet Intervention (4 Weeks)|Lost to Follow-up|0
7577013|NCT02169830|26352938|P1|Diet Intervention (4 Weeks)|Lost to Follow-up|0
7577014|NCT02169791|26352946|P1|Overall Study|patient withdrew consent|1
7577015|NCT02169791|26352946|P1|Overall Study|Death|6
7577016|NCT02169739|26352957|P2|Overall Study|Lost to Follow-up|4
7577017|NCT02169739|26352958|P1|Overall Study|Lost to Follow-up|0
7577018|NCT02169674|26352969|P2|Overall Study|Lost to Follow-up|1
7577019|NCT02169674|26352970|P1|Overall Study|Lost to Follow-up|0
7577020|NCT02169674|26352969|P2|Overall Study|Seroprotected|76
7577021|NCT02169674|26352970|P1|Overall Study|Seroprotected|30
7577022|NCT02169674|26352969|P2|Overall Study|Withdrawal by Subject|1
7577023|NCT02169674|26352970|P1|Overall Study|Withdrawal by Subject|2
7577024|NCT02169505|26352984|P1|Overall Study|Withdrawal by Subject|1
7577025|NCT02169414|26353112|P4|Overall Study|Adverse Event|0
7577026|NCT02169414|26353113|P3|Overall Study|Adverse Event|0
7577027|NCT02169414|26353114|P2|Overall Study|Adverse Event|1
7577028|NCT02169414|26353115|P1|Overall Study|Adverse Event|0
7577029|NCT02169414|26353112|P4|Overall Study|Withdrawal by Subject|0
7577030|NCT02169414|26353113|P3|Overall Study|Withdrawal by Subject|0
7577031|NCT02169414|26353114|P2|Overall Study|Withdrawal by Subject|0
7577032|NCT02169414|26353115|P1|Overall Study|Withdrawal by Subject|1
7577033|NCT02169336|26353156|P3|Overall Study|Subject declined to continue dosing|1
7577034|NCT02169336|26353157|P2|Overall Study|Subject declined to continue dosing|0
7577035|NCT02169336|26353158|P1|Overall Study|Subject declined to continue dosing|0
7577036|NCT02169336|26353156|P3|Overall Study|Physician Decision|1
7577037|NCT02169336|26353157|P2|Overall Study|Physician Decision|0
7577038|NCT02169336|26353158|P1|Overall Study|Physician Decision|0
7577039|NCT02169336|26353156|P3|Overall Study|Withdrawal by Subject|0
7577040|NCT02169336|26353157|P2|Overall Study|Withdrawal by Subject|0
7577041|NCT02169336|26353158|P1|Overall Study|Withdrawal by Subject|1
7577042|NCT02169336|26353156|P3|Overall Study|Adverse Event|1
7577043|NCT02169336|26353157|P2|Overall Study|Adverse Event|3
7577044|NCT02169336|26353158|P1|Overall Study|Adverse Event|2
7577045|NCT02169336|26353156|P3|Overall Study|Lack of Efficacy|0
7577046|NCT02169336|26353157|P2|Overall Study|Lack of Efficacy|1
7577047|NCT02169336|26353158|P1|Overall Study|Lack of Efficacy|1
7577048|NCT02169284|26353168|P2|Overall Study|Physician Decision|1
7577049|NCT02169284|26353169|P1|Overall Study|Physician Decision|0
7577050|NCT02169271|26353195|P2|Overall Study|Protocol Violation|2
7577051|NCT02169271|26353196|P1|Overall Study|Protocol Violation|1
7577052|NCT02169219|26353218|P1|Overall Study|Lack of Efficacy|6
7577053|NCT02168946|26353262|P2|Overall Study|Subject unable to come back for visits|0
7577054|NCT02168946|26353263|P1|Overall Study|Subject unable to come back for visits|1
7577055|NCT02168946|26353262|P2|Overall Study|Lost to Follow-up|0
7577056|NCT02168946|26353263|P1|Overall Study|Lost to Follow-up|3
7577057|NCT02168946|26353262|P2|Overall Study|Adverse Event|5
7577058|NCT02168946|26353263|P1|Overall Study|Adverse Event|8
7577059|NCT02168842|26353322|P2|Overall Study|Physician Decision|2
7577060|NCT02168842|26353323|P1|Overall Study|Physician Decision|1
7577061|NCT02168842|26353322|P2|Overall Study|Death|1
7577062|NCT02168842|26353323|P1|Overall Study|Death|2
7577063|NCT02168842|26353322|P2|Overall Study|Lost to Follow-up|2
7577064|NCT02168842|26353323|P1|Overall Study|Lost to Follow-up|0
7577065|NCT02168842|26353322|P2|Overall Study|Withdrawal by Subject|3
7577066|NCT02168842|26353323|P1|Overall Study|Withdrawal by Subject|5
7577067|NCT02168816|26353381|P2|Overall Study|Lost to Follow-up|2
7577068|NCT02168816|26353382|P1|Overall Study|Lost to Follow-up|2
7577069|NCT02168803|26353393|P3|Overall Study|Sponsor Decision|1
7577070|NCT02168803|26353394|P2|Overall Study|Sponsor Decision|0
7577071|NCT02168803|26353395|P1|Overall Study|Sponsor Decision|0
7577072|NCT02168803|26353393|P3|Overall Study|Death|1
7577073|NCT02168803|26353394|P2|Overall Study|Death|0
7577074|NCT02168803|26353395|P1|Overall Study|Death|0
7577075|NCT02168803|26353393|P3|Overall Study|Adverse Event|1
7577076|NCT02168803|26353394|P2|Overall Study|Adverse Event|1
7577077|NCT02168803|26353395|P1|Overall Study|Adverse Event|0
7577078|NCT02168803|26353393|P3|Overall Study|Physician Decision|0
7577079|NCT02168803|26353394|P2|Overall Study|Physician Decision|1
7577080|NCT02168803|26353395|P1|Overall Study|Physician Decision|0
7577081|NCT02168803|26353393|P3|Overall Study|Withdrawal by Subject|2
7577082|NCT02168803|26353394|P2|Overall Study|Withdrawal by Subject|1
7577083|NCT02168803|26353395|P1|Overall Study|Withdrawal by Subject|1
7577084|NCT02168803|26353393|P3|Overall Study|Lost to Follow-up|1
7577085|NCT02168803|26353394|P2|Overall Study|Lost to Follow-up|0
7577086|NCT02168803|26353395|P1|Overall Study|Lost to Follow-up|1
7577087|NCT02168777|26353425|P3|Overall Study|Other reason|0
7577088|NCT02168777|26353426|P2|Overall Study|Other reason|1
7577089|NCT02168777|26353427|P1|Overall Study|Other reason|0
7577090|NCT02168777|26353425|P3|Overall Study|Clinical disease progression|2
7577091|NCT02168777|26353426|P2|Overall Study|Clinical disease progression|1
7577092|NCT02168777|26353427|P1|Overall Study|Clinical disease progression|0
7577093|NCT02168777|26353425|P3|Overall Study|Radiological disease progression|5
7577094|NCT02168777|26353426|P2|Overall Study|Radiological disease progression|5
7577095|NCT02168777|26353427|P1|Overall Study|Radiological disease progression|0
7577096|NCT02168777|26353425|P3|Overall Study|Disease recurrence|1
7577097|NCT02168777|26353426|P2|Overall Study|Disease recurrence|0
7577098|NCT02168777|26353427|P1|Overall Study|Disease recurrence|0
7577099|NCT02168777|26353425|P3|Overall Study|Adverse Event|1
7577100|NCT02168777|26353426|P2|Overall Study|Adverse Event|0
7577101|NCT02168777|26353427|P1|Overall Study|Adverse Event|1
7577102|NCT02168777|26353425|P3|Overall Study|Withdrawal by Subject|2
7577103|NCT02168777|26353426|P2|Overall Study|Withdrawal by Subject|0
7577104|NCT02168777|26353427|P1|Overall Study|Withdrawal by Subject|1
7577105|NCT02168491|26353523|P1|Overall Study|Withdrawal by Subject|1
7577106|NCT02168478|26353529|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
7577107|NCT02168478|26353529|P1|Overall Study|Did Not Consent to Participation|2
7577108|NCT02168478|26353529|P1|Overall Study|Withdrawal by Subject|1
7577109|NCT02168439|26353535|P2|Overall Study|Protocol Violation|2
7577110|NCT02168439|26353536|P1|Overall Study|Protocol Violation|0
7577111|NCT02168387|26353554|P2|Overall Study|Death|0
7577112|NCT02168387|26353555|P1|Overall Study|Death|1
7577113|NCT02168387|26353554|P2|Overall Study|Planned exubation|3
7577114|NCT02168387|26353555|P1|Overall Study|Planned exubation|6
7577115|NCT02168270|26353587|P1|Overall Study|Lack of Efficacy|4
7577116|NCT02168101|26353614|P3|Overall Study|Death|1
7577117|NCT02168101|26353615|P2|Overall Study|Death|2
7577118|NCT02168101|26353616|P1|Overall Study|Death|2
7577119|NCT02167893|26353686|P1|Overall Study|Case report forms not collected|68
7577120|NCT02167893|26353686|P1|Overall Study|Investigator health reasons|10
7577121|NCT02167893|26353686|P1|Overall Study|Investigator transferred|85
7577122|NCT02167594|26353721|P3|Overall Study|Death|0
7577123|NCT02167594|26353722|P2|Overall Study|Death|1
7577124|NCT02167594|26353723|P1|Overall Study|Death|0
7577125|NCT02167594|26353721|P3|Overall Study|Withdrawal by Subject|0
7577126|NCT02167594|26353722|P2|Overall Study|Withdrawal by Subject|0
7577127|NCT02167594|26353723|P1|Overall Study|Withdrawal by Subject|2
7577128|NCT02167451|26353732|P1|Overall Study|Withdrawal by Subject|1
7577129|NCT02167256|26353749|P2|Overall Study|Study partner unable to participate|0
7577130|NCT02167256|26353750|P1|Overall Study|Study partner unable to participate|1
7577131|NCT02167256|26353749|P2|Overall Study|non-compliance|0
7577132|NCT02167256|26353750|P1|Overall Study|non-compliance|3
7577133|NCT02167256|26353749|P2|Overall Study|Withdrawal by Subject|4
7577134|NCT02167256|26353750|P1|Overall Study|Withdrawal by Subject|4
7577135|NCT02167256|26353749|P2|Overall Study|Adverse Event|6
7577136|NCT02167256|26353750|P1|Overall Study|Adverse Event|13
7577137|NCT02167139|26353783|P4|Transition-extension|Lost to Follow-up|0
7577138|NCT02167139|26353784|P3|Transition-extension|Lost to Follow-up|0
7577139|NCT02167139|26353785|P2|Transition-extension|Lost to Follow-up|0
7577140|NCT02167139|26353786|P1|Transition-extension|Lost to Follow-up|1
7577141|NCT02167139|26353783|P4|Transition-extension|Other|0
7577142|NCT02167139|26353784|P3|Transition-extension|Other|1
7577143|NCT02167139|26353785|P2|Transition-extension|Other|0
7577144|NCT02167139|26353786|P1|Transition-extension|Other|1
7577145|NCT02167139|26353783|P4|Transition-extension|Lack of Efficacy|1
7577146|NCT02167139|26353784|P3|Transition-extension|Lack of Efficacy|1
7577147|NCT02167139|26353785|P2|Transition-extension|Lack of Efficacy|0
7577148|NCT02167139|26353786|P1|Transition-extension|Lack of Efficacy|0
7577149|NCT02167139|26353783|P4|Transition-extension|Withdrawal by Subject|1
7577150|NCT02167139|26353784|P3|Transition-extension|Withdrawal by Subject|4
7577151|NCT02167139|26353785|P2|Transition-extension|Withdrawal by Subject|0
7577152|NCT02167139|26353786|P1|Transition-extension|Withdrawal by Subject|2
7577153|NCT02167139|26353783|P4|Transition-extension|Adverse Event|3
7577154|NCT02167139|26353784|P3|Transition-extension|Adverse Event|2
7577155|NCT02167139|26353785|P2|Transition-extension|Adverse Event|0
7577156|NCT02167139|26353786|P1|Transition-extension|Adverse Event|2
7577157|NCT02167139|26353783|P4|Randomised, Double-blind|Other|0
7577158|NCT02167139|26353784|P3|Randomised, Double-blind|Other|0
7577159|NCT02167139|26353785|P2|Randomised, Double-blind|Other|0
7577160|NCT02167139|26353786|P1|Randomised, Double-blind|Other|3
7577161|NCT02167139|26353783|P4|Randomised, Double-blind|Lack of Efficacy|0
7577162|NCT02167139|26353784|P3|Randomised, Double-blind|Lack of Efficacy|0
7577163|NCT02167139|26353785|P2|Randomised, Double-blind|Lack of Efficacy|2
7577164|NCT02167139|26353786|P1|Randomised, Double-blind|Lack of Efficacy|1
7577165|NCT02167139|26353783|P4|Randomised, Double-blind|Adverse Event|0
7577166|NCT02167139|26353784|P3|Randomised, Double-blind|Adverse Event|0
7577167|NCT02167139|26353785|P2|Randomised, Double-blind|Adverse Event|9
7577168|NCT02167139|26353786|P1|Randomised, Double-blind|Adverse Event|2
7577169|NCT02167139|26353783|P4|Randomised, Double-blind|Withdrawal by Subject|0
7577170|NCT02167139|26353784|P3|Randomised, Double-blind|Withdrawal by Subject|0
7577171|NCT02167139|26353785|P2|Randomised, Double-blind|Withdrawal by Subject|8
7577172|NCT02167139|26353786|P1|Randomised, Double-blind|Withdrawal by Subject|11
7577173|NCT02167035|26353821|P2|Overall Study|Randomized to incorrect Study Medication|1
7577174|NCT02167035|26353822|P1|Overall Study|Randomized to incorrect Study Medication|0
7577175|NCT02167035|26353821|P2|Overall Study|Lost to Follow-up|3
7577176|NCT02167035|26353822|P1|Overall Study|Lost to Follow-up|3
7577177|NCT02167035|26353821|P2|Overall Study|Adverse Event|2
7577178|NCT02167035|26353822|P1|Overall Study|Adverse Event|2
7577179|NCT02166697|26353830|P1|Overall Study|Protocol Violation|347
7577180|NCT02166606|26353839|P1|Overall Study|Enrolled after End of Enrollment|4
7577181|NCT02166606|26353839|P1|Overall Study|Device upgrade|1
7577182|NCT02166606|26353839|P1|Overall Study|Physician Decision|1
7577183|NCT02166606|26353839|P1|Overall Study|Withdrawal by Subject|1
7577184|NCT02166606|26353839|P1|Overall Study|Lost to Follow-up|30
7577185|NCT02166606|26353839|P1|Overall Study|Protocol Violation|7
7577186|NCT02166606|26353839|P1|Overall Study|Death|31
7577187|NCT02166606|26353839|P1|Overall Study|Adverse Event|3
7577188|NCT02166476|26353846|P2|Overall Study|Unable to Come for Visit|3
7577189|NCT02166476|26353847|P1|Overall Study|Unable to Come for Visit|0
7577190|NCT02166476|26353846|P2|Overall Study|Physician Decision|0
7577191|NCT02166476|26353847|P1|Overall Study|Physician Decision|1
7577192|NCT02166476|26353846|P2|Overall Study|Lost to Follow-up|10
7577193|NCT02166476|26353847|P1|Overall Study|Lost to Follow-up|5
7577194|NCT02166476|26353846|P2|Overall Study|Adverse Event|3
7577195|NCT02166476|26353847|P1|Overall Study|Adverse Event|3
7577196|NCT02166476|26353846|P2|Overall Study|Withdrawal by Subject|7
7577197|NCT02166476|26353847|P1|Overall Study|Withdrawal by Subject|5
7577198|NCT02166333|26353893|P6|Stage 2|Lost to Follow-up|6
7577199|NCT02166333|26353894|P5|Stage 2|Lost to Follow-up|3
7577200|NCT02166333|26353895|P4|Stage 2|Lost to Follow-up|9
7577201|NCT02166333|26353896|P3|Stage 2|Lost to Follow-up|11
7577202|NCT02166333|26353897|P2|Stage 2|Lost to Follow-up|4
7577203|NCT02166333|26353898|P1|Stage 2|Lost to Follow-up|23
7577204|NCT02166333|26353893|P6|Stage 2|Death|1
7577205|NCT02166333|26353894|P5|Stage 2|Death|0
7577206|NCT02166333|26353895|P4|Stage 2|Death|0
7577207|NCT02166333|26353896|P3|Stage 2|Death|1
7577208|NCT02166333|26353897|P2|Stage 2|Death|2
7577209|NCT02166333|26353898|P1|Stage 2|Death|4
7577210|NCT02166333|26353893|P6|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
7577211|NCT02166333|26353894|P5|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
7577212|NCT02166333|26353895|P4|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7577213|NCT02166333|26353896|P3|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
7577214|NCT02166333|26353897|P2|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7577215|NCT02166333|26353898|P1|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
7577216|NCT02166333|26353893|P6|Stage 1|Lost to Follow-up|3
7577217|NCT02166333|26353894|P5|Stage 1|Lost to Follow-up|3
7577218|NCT02166333|26353895|P4|Stage 1|Lost to Follow-up|0
7577219|NCT02166333|26353896|P3|Stage 1|Lost to Follow-up|6
7577220|NCT02166333|26353897|P2|Stage 1|Lost to Follow-up|0
7577221|NCT02166333|26353898|P1|Stage 1|Lost to Follow-up|12
7577222|NCT02166333|26353893|P6|Stage 1|Death|2
7577223|NCT02166333|26353894|P5|Stage 1|Death|3
7577224|NCT02166333|26353895|P4|Stage 1|Death|0
7577225|NCT02166333|26353896|P3|Stage 1|Death|2
7577226|NCT02166333|26353897|P2|Stage 1|Death|0
7577227|NCT02166333|26353898|P1|Stage 1|Death|4
7577228|NCT02166333|26353893|P6|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
7577229|NCT02166333|26353894|P5|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
7577230|NCT02166333|26353895|P4|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7577231|NCT02166333|26353896|P3|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7577232|NCT02166333|26353897|P2|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7577233|NCT02166333|26353898|P1|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
7577234|NCT02166047|26353922|P12|Overall Study|Adverse Event|0
7577235|NCT02166047|26353923|P11|Overall Study|Adverse Event|2
7577236|NCT02166047|26353924|P10|Overall Study|Adverse Event|0
7577237|NCT02166047|26353925|P9|Overall Study|Adverse Event|0
7577238|NCT02166047|26353926|P8|Overall Study|Adverse Event|0
7577239|NCT02166047|26353927|P7|Overall Study|Adverse Event|1
7577240|NCT02166047|26353928|P6|Overall Study|Adverse Event|0
7577241|NCT02166047|26353929|P5|Overall Study|Adverse Event|1
7577242|NCT02166047|26353930|P4|Overall Study|Adverse Event|0
7577243|NCT02166047|26353931|P3|Overall Study|Adverse Event|0
7577244|NCT02166047|26353932|P2|Overall Study|Adverse Event|0
7577245|NCT02166047|26353933|P1|Overall Study|Adverse Event|0
7577246|NCT02166047|26353922|P12|Overall Study|Withdrawal by Participant|0
7577247|NCT02166047|26353923|P11|Overall Study|Withdrawal by Participant|0
7577248|NCT02166047|26353924|P10|Overall Study|Withdrawal by Participant|0
7577249|NCT02166047|26353925|P9|Overall Study|Withdrawal by Participant|0
7577250|NCT02166047|26353926|P8|Overall Study|Withdrawal by Participant|0
7577251|NCT02166047|26353927|P7|Overall Study|Withdrawal by Participant|1
7577252|NCT02166047|26353928|P6|Overall Study|Withdrawal by Participant|0
7577253|NCT02166047|26353929|P5|Overall Study|Withdrawal by Participant|0
7577254|NCT02166047|26353930|P4|Overall Study|Withdrawal by Participant|0
7577255|NCT02166047|26353931|P3|Overall Study|Withdrawal by Participant|2
7577256|NCT02166047|26353932|P2|Overall Study|Withdrawal by Participant|1
7577257|NCT02166047|26353933|P1|Overall Study|Withdrawal by Participant|0
7577258|NCT02165826|26354100|P3|Down-Titration Period|Reason Not Specified|2
7577259|NCT02165826|26354101|P2|Down-Titration Period|Reason Not Specified|0
7577260|NCT02165826|26354102|P1|Down-Titration Period|Reason Not Specified|1
7577261|NCT02165826|26354100|P3|Down-Titration Period|Voluntary Withdrawal|2
7577262|NCT02165826|26354101|P2|Down-Titration Period|Voluntary Withdrawal|1
7577263|NCT02165826|26354102|P1|Down-Titration Period|Voluntary Withdrawal|2
7577264|NCT02165826|26354100|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
7577265|NCT02165826|26354101|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
7577266|NCT02165826|26354102|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
7577267|NCT02165826|26354100|P3|Main Treatment Period|Did Not Receive Study Drug|0
7577268|NCT02165826|26354101|P2|Main Treatment Period|Did Not Receive Study Drug|2
7577269|NCT02165826|26354102|P1|Main Treatment Period|Did Not Receive Study Drug|0
7577270|NCT02165826|26354100|P3|Main Treatment Period|Reason Not Specified|16
7577271|NCT02165826|26354101|P2|Main Treatment Period|Reason Not Specified|5
7577272|NCT02165826|26354102|P1|Main Treatment Period|Reason Not Specified|8
7577273|NCT02165826|26354100|P3|Main Treatment Period|Lack of Efficacy|0
7577274|NCT02165826|26354101|P2|Main Treatment Period|Lack of Efficacy|0
7577275|NCT02165826|26354102|P1|Main Treatment Period|Lack of Efficacy|2
7577276|NCT02165826|26354100|P3|Main Treatment Period|Voluntary Withdrawal|21
7577277|NCT02165826|26354101|P2|Main Treatment Period|Voluntary Withdrawal|23
7577278|NCT02165826|26354102|P1|Main Treatment Period|Voluntary Withdrawal|23
7577279|NCT02165826|26354100|P3|Main Treatment Period|Lost to Follow-up|1
7577280|NCT02165826|26354101|P2|Main Treatment Period|Lost to Follow-up|2
7577281|NCT02165826|26354102|P1|Main Treatment Period|Lost to Follow-up|4
7577282|NCT02165826|26354100|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
7577283|NCT02165826|26354101|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
7577284|NCT02165826|26354102|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
7577285|NCT02165826|26354100|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
7577286|NCT02165826|26354101|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
7577287|NCT02165826|26354102|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
7577288|NCT02165735|26354170|P2|Overall Study|Protocol Violation|1
7577289|NCT02165735|26354171|P1|Overall Study|Protocol Violation|0
7577290|NCT02165735|26354170|P2|Overall Study|Participant indicated lack of time|3
7577291|NCT02165735|26354171|P1|Overall Study|Participant indicated lack of time|1
7577292|NCT02165735|26354170|P2|Overall Study|Withdrawal by Subject|0
7577293|NCT02165735|26354171|P1|Overall Study|Withdrawal by Subject|3
7577294|NCT02165735|26354170|P2|Overall Study|Lost to Follow-up|10
7577295|NCT02165735|26354171|P1|Overall Study|Lost to Follow-up|12
7577296|NCT02165397|26354245|P3|Overall Study|Other, Not Specified|1
7577297|NCT02165397|26354246|P2|Overall Study|Other, Not Specified|0
7577298|NCT02165397|26354247|P1|Overall Study|Other, Not Specified|0
7577299|NCT02165397|26354245|P3|Overall Study|Withdrawal by Subject|1
7577300|NCT02165397|26354246|P2|Overall Study|Withdrawal by Subject|6
7577301|NCT02165397|26354247|P1|Overall Study|Withdrawal by Subject|6
7577302|NCT02165397|26354245|P3|Overall Study|Lost to Follow-up|0
7577303|NCT02165397|26354246|P2|Overall Study|Lost to Follow-up|3
7577304|NCT02165397|26354247|P1|Overall Study|Lost to Follow-up|1
7577305|NCT02165397|26354245|P3|Overall Study|Death|8
7577306|NCT02165397|26354246|P2|Overall Study|Death|10
7577307|NCT02165397|26354247|P1|Overall Study|Death|7
7577308|NCT02165215|26354278|P3|Maintenance Phase|Adverse Event|1
7577309|NCT02165215|26354279|P2|Maintenance Phase|Adverse Event|1
7577310|NCT02165215|26354280|P1|Maintenance Phase|Adverse Event|0
7577311|NCT02165215|26354278|P3|Maintenance Phase|Lost to Follow-up|0
7577312|NCT02165215|26354279|P2|Maintenance Phase|Lost to Follow-up|2
7577313|NCT02165215|26354280|P1|Maintenance Phase|Lost to Follow-up|0
7577314|NCT02165215|26354278|P3|Maintenance Phase|Multiple reasons|1
7577315|NCT02165215|26354279|P2|Maintenance Phase|Multiple reasons|2
7577316|NCT02165215|26354280|P1|Maintenance Phase|Multiple reasons|0
7577317|NCT02165215|26354278|P3|Maintenance Phase|Withdrawal by Subject|3
7577318|NCT02165215|26354279|P2|Maintenance Phase|Withdrawal by Subject|7
7577319|NCT02165215|26354280|P1|Maintenance Phase|Withdrawal by Subject|0
7577320|NCT02165215|26354278|P3|Induction Phase|Lost to Follow-up|0
7577321|NCT02165215|26354279|P2|Induction Phase|Lost to Follow-up|0
7577322|NCT02165215|26354280|P1|Induction Phase|Lost to Follow-up|6
7577323|NCT02165215|26354278|P3|Induction Phase|Non-Compliance|0
7577324|NCT02165215|26354279|P2|Induction Phase|Non-Compliance|0
7577325|NCT02165215|26354280|P1|Induction Phase|Non-Compliance|2
7577326|NCT02165215|26354278|P3|Induction Phase|Lack of Efficacy|0
7577327|NCT02165215|26354279|P2|Induction Phase|Lack of Efficacy|0
7577328|NCT02165215|26354280|P1|Induction Phase|Lack of Efficacy|2
7577329|NCT02165215|26354278|P3|Induction Phase|Physician Decision|0
7577330|NCT02165215|26354279|P2|Induction Phase|Physician Decision|0
7577331|NCT02165215|26354280|P1|Induction Phase|Physician Decision|1
7577332|NCT02165215|26354278|P3|Induction Phase|Protocol Violation|0
7577333|NCT02165215|26354279|P2|Induction Phase|Protocol Violation|0
7577334|NCT02165215|26354280|P1|Induction Phase|Protocol Violation|1
7577335|NCT02165215|26354278|P3|Induction Phase|Withdrawal by Subject|0
7577336|NCT02165215|26354279|P2|Induction Phase|Withdrawal by Subject|0
7577337|NCT02165215|26354280|P1|Induction Phase|Withdrawal by Subject|10
7577338|NCT02165215|26354278|P3|Induction Phase|Adverse Event|0
7577339|NCT02165215|26354279|P2|Induction Phase|Adverse Event|0
7577340|NCT02165215|26354280|P1|Induction Phase|Adverse Event|1
7577341|NCT02165202|26354338|P2|Injection Phase|Participant unwilling to comply|0
7577342|NCT02165202|26354339|P1|Injection Phase|Participant unwilling to comply|1
7577343|NCT02165202|26354338|P2|Injection Phase|No longer interested|1
7577344|NCT02165202|26354339|P1|Injection Phase|No longer interested|0
7577345|NCT02165202|26354338|P2|Injection Phase|Study Product related Toxicity|0
7577346|NCT02165202|26354339|P1|Injection Phase|Study Product related Toxicity|1
7577347|NCT02165202|26354338|P2|Injection Phase|End of Study|1
7577348|NCT02165202|26354339|P1|Injection Phase|End of Study|2
7577349|NCT02165202|26354338|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
7577350|NCT02165202|26354339|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
7577351|NCT02165202|26354338|P2|Injection Phase|Unable to attend within Visit Window|0
7577352|NCT02165202|26354339|P1|Injection Phase|Unable to attend within Visit Window|1
7577353|NCT02165202|26354338|P2|Injection Phase|Reactive HIV or HIV Suspected|2
7577354|NCT02165202|26354339|P1|Injection Phase|Reactive HIV or HIV Suspected|0
7577355|NCT02165202|26354338|P2|Injection Phase|Abnormal Lab Value|1
7577356|NCT02165202|26354339|P1|Injection Phase|Abnormal Lab Value|5
7577357|NCT02165202|26354338|P2|Oral Phase|Abnormal EKG|1
7577358|NCT02165202|26354339|P1|Oral Phase|Abnormal EKG|0
7577359|NCT02165202|26354338|P2|Oral Phase|Relocated, no follow-up planned|0
7577360|NCT02165202|26354339|P1|Oral Phase|Relocated, no follow-up planned|1
7577361|NCT02165202|26354338|P2|Oral Phase|CMC advised termination|0
7577362|NCT02165202|26354339|P1|Oral Phase|CMC advised termination|1
7577363|NCT02165202|26354338|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
7577364|NCT02165202|26354339|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
7577365|NCT02165202|26354338|P2|Oral Phase|Clinical reasons|0
7577366|NCT02165202|26354339|P1|Oral Phase|Clinical reasons|1
7577367|NCT02165202|26354338|P2|Oral Phase|Unable to contact Participant|1
7577368|NCT02165202|26354339|P1|Oral Phase|Unable to contact Participant|1
7577369|NCT02165202|26354338|P2|Oral Phase|Study product Related Toxicity|0
7577370|NCT02165202|26354339|P1|Oral Phase|Study product Related Toxicity|1
7577371|NCT02165202|26354338|P2|Oral Phase|Refused further participation|1
7577372|NCT02165202|26354339|P1|Oral Phase|Refused further participation|5
7577373|NCT02164981|26354376|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7577374|NCT02164981|26354377|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
7577375|NCT02164981|26354378|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7577376|NCT02164981|26354376|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
7577377|NCT02164981|26354377|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
7577378|NCT02164981|26354378|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
7577379|NCT02164981|26354376|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7577380|NCT02164981|26354377|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
7577381|NCT02164981|26354378|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7577382|NCT02164981|26354376|P3|Started|Adverse Event|0
7577383|NCT02164981|26354377|P2|Started|Adverse Event|2
7577384|NCT02164981|26354378|P1|Started|Adverse Event|1
7577385|NCT02164981|26354376|P3|Started|Protocol Violation|0
7577386|NCT02164981|26354377|P2|Started|Protocol Violation|0
7577387|NCT02164981|26354378|P1|Started|Protocol Violation|2
7577388|NCT02164981|26354376|P3|Started|Withdrawal by Subject|0
7577389|NCT02164981|26354377|P2|Started|Withdrawal by Subject|1
7577390|NCT02164981|26354378|P1|Started|Withdrawal by Subject|2
7577391|NCT02164929|26354451|P4|Overall Study|Failed regional block|0
7577392|NCT02164929|26354452|P3|Overall Study|Failed regional block|1
7577393|NCT02164929|26354453|P2|Overall Study|Failed regional block|0
7577394|NCT02164929|26354454|P1|Overall Study|Failed regional block|0
7577395|NCT02164929|26354451|P4|Overall Study|Converted to open procedure|2
7577396|NCT02164929|26354452|P3|Overall Study|Converted to open procedure|0
7577397|NCT02164929|26354453|P2|Overall Study|Converted to open procedure|0
7577398|NCT02164929|26354454|P1|Overall Study|Converted to open procedure|1
7577399|NCT02164916|26354498|P2|Overall Study|Not eligible|5
7577400|NCT02164916|26354499|P1|Overall Study|Not eligible|2
7577401|NCT02164916|26354498|P2|Overall Study|Reason under review|6
7577402|NCT02164916|26354499|P1|Overall Study|Reason under review|1
7577403|NCT02164916|26354498|P2|Overall Study|Not protocol specified|1
7577404|NCT02164916|26354499|P1|Overall Study|Not protocol specified|5
7577405|NCT02164916|26354498|P2|Overall Study|Progression|26
7577406|NCT02164916|26354499|P1|Overall Study|Progression|37
7577407|NCT02164916|26354498|P2|Overall Study|Refusal unrelated to adverse event|7
7577408|NCT02164916|26354499|P1|Overall Study|Refusal unrelated to adverse event|3
7577409|NCT02164916|26354498|P2|Overall Study|Death|1
7577410|NCT02164916|26354499|P1|Overall Study|Death|1
7577411|NCT02164916|26354498|P2|Overall Study|Adverse Event|8
7577412|NCT02164916|26354499|P1|Overall Study|Adverse Event|3
7577413|NCT02164864|26354519|P3|Overall Study|Other than stated|14
7577414|NCT02164864|26354520|P2|Overall Study|Other than stated|4
7577415|NCT02164864|26354521|P1|Overall Study|Other than stated|3
7577416|NCT02164864|26354519|P3|Overall Study|Consent withdrawn, not due to AE|56
7577417|NCT02164864|26354520|P2|Overall Study|Consent withdrawn, not due to AE|8
7577418|NCT02164864|26354521|P1|Overall Study|Consent withdrawn, not due to AE|21
7577419|NCT02164864|26354519|P3|Overall Study|Lost to Follow-up|2
7577420|NCT02164864|26354520|P2|Overall Study|Lost to Follow-up|3
7577421|NCT02164864|26354521|P1|Overall Study|Lost to Follow-up|4
7577422|NCT02164864|26354519|P3|Overall Study|Protocol Violation|1
7577423|NCT02164864|26354520|P2|Overall Study|Protocol Violation|4
7577424|NCT02164864|26354521|P1|Overall Study|Protocol Violation|2
7577425|NCT02164864|26354519|P3|Overall Study|Other Adverse Event (AE)|49
7577426|NCT02164864|26354520|P2|Overall Study|Other Adverse Event (AE)|32
7577427|NCT02164864|26354521|P1|Overall Study|Other Adverse Event (AE)|52
7577428|NCT02164864|26354519|P3|Overall Study|Other pre-existing disease worsening|9
7577429|NCT02164864|26354520|P2|Overall Study|Other pre-existing disease worsening|4
7577430|NCT02164864|26354521|P1|Overall Study|Other pre-existing disease worsening|6
7577431|NCT02164864|26354519|P3|Overall Study|Trial disease worsening|1
7577432|NCT02164864|26354520|P2|Overall Study|Trial disease worsening|5
7577433|NCT02164864|26354521|P1|Overall Study|Trial disease worsening|7
7577434|NCT02164539|26354596|P7|Treatment Phase C (1 Week)|Physician Decision|1
7577435|NCT02164539|26354597|P6|Treatment Phase C (1 Week)|Physician Decision|0
7577436|NCT02164539|26354598|P5|Treatment Phase C (1 Week)|Physician Decision|0
7577437|NCT02164539|26354599|P4|Treatment Phase C (1 Week)|Physician Decision|0
7577438|NCT02164539|26354600|P3|Treatment Phase C (1 Week)|Physician Decision|0
7577439|NCT02164539|26354601|P2|Treatment Phase C (1 Week)|Physician Decision|0
7577440|NCT02164539|26354602|P1|Treatment Phase C (1 Week)|Physician Decision|0
7577441|NCT02164539|26354596|P7|Treatment Phase C (1 Week)|Adverse Event|1
7577442|NCT02164539|26354597|P6|Treatment Phase C (1 Week)|Adverse Event|0
7577443|NCT02164539|26354598|P5|Treatment Phase C (1 Week)|Adverse Event|0
7577444|NCT02164539|26354599|P4|Treatment Phase C (1 Week)|Adverse Event|0
7577445|NCT02164539|26354600|P3|Treatment Phase C (1 Week)|Adverse Event|0
7577446|NCT02164539|26354601|P2|Treatment Phase C (1 Week)|Adverse Event|0
7577447|NCT02164539|26354602|P1|Treatment Phase C (1 Week)|Adverse Event|0
7577448|NCT02164539|26354596|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7577449|NCT02164539|26354597|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7577450|NCT02164539|26354598|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7577451|NCT02164539|26354599|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7577452|NCT02164539|26354600|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7577453|NCT02164539|26354601|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7577454|NCT02164539|26354602|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
7577455|NCT02164539|26354596|P7|Treatment Phase B (1 Week)|Physician Decision|1
7577456|NCT02164539|26354597|P6|Treatment Phase B (1 Week)|Physician Decision|0
7577457|NCT02164539|26354598|P5|Treatment Phase B (1 Week)|Physician Decision|1
7577458|NCT02164539|26354599|P4|Treatment Phase B (1 Week)|Physician Decision|0
7577459|NCT02164539|26354600|P3|Treatment Phase B (1 Week)|Physician Decision|0
7577460|NCT02164539|26354601|P2|Treatment Phase B (1 Week)|Physician Decision|0
7577461|NCT02164539|26354602|P1|Treatment Phase B (1 Week)|Physician Decision|0
7577462|NCT02164539|26354596|P7|Treatment Phase B (1 Week)|Adverse Event|0
7577463|NCT02164539|26354597|P6|Treatment Phase B (1 Week)|Adverse Event|0
7577464|NCT02164539|26354598|P5|Treatment Phase B (1 Week)|Adverse Event|2
7577465|NCT02164539|26354599|P4|Treatment Phase B (1 Week)|Adverse Event|0
7577466|NCT02164539|26354600|P3|Treatment Phase B (1 Week)|Adverse Event|0
7577467|NCT02164539|26354601|P2|Treatment Phase B (1 Week)|Adverse Event|0
7577468|NCT02164539|26354602|P1|Treatment Phase B (1 Week)|Adverse Event|0
7577469|NCT02164539|26354596|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7577470|NCT02164539|26354597|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7577471|NCT02164539|26354598|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
7577472|NCT02164539|26354599|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7577473|NCT02164539|26354600|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7577474|NCT02164539|26354601|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7577475|NCT02164539|26354602|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7577476|NCT02164513|26354650|P3|Overall Study|Other: Reason not provided by site|0
7577477|NCT02164513|26354651|P2|Overall Study|Other: Reason not provided by site|0
7577478|NCT02164513|26354652|P1|Overall Study|Other: Reason not provided by site|1
7577479|NCT02164513|26354650|P3|Overall Study|Withdrawal by Subject|130
7577480|NCT02164513|26354651|P2|Overall Study|Withdrawal by Subject|261
7577481|NCT02164513|26354652|P1|Overall Study|Withdrawal by Subject|192
7577482|NCT02164513|26354650|P3|Overall Study|Physician Decision|28
7577483|NCT02164513|26354651|P2|Overall Study|Physician Decision|57
7577484|NCT02164513|26354652|P1|Overall Study|Physician Decision|47
7577485|NCT02164513|26354650|P3|Overall Study|Lost to Follow-up|22
7577486|NCT02164513|26354651|P2|Overall Study|Lost to Follow-up|36
7577487|NCT02164513|26354652|P1|Overall Study|Lost to Follow-up|30
7577488|NCT02164513|26354650|P3|Overall Study|Other: Study Closed or terminated|4
7577489|NCT02164513|26354651|P2|Overall Study|Other: Study Closed or terminated|2
7577490|NCT02164513|26354652|P1|Overall Study|Other: Study Closed or terminated|5
7577491|NCT02164513|26354650|P3|Overall Study|Adverse Event|111
7577492|NCT02164513|26354651|P2|Overall Study|Adverse Event|180
7577493|NCT02164513|26354652|P1|Overall Study|Adverse Event|162
7577494|NCT02164383|26354702|P2|Overall Study|Lost to Follow-up|0
7577495|NCT02164383|26354703|P1|Overall Study|Lost to Follow-up|1
7577496|NCT02164318|26354713|P4|Overall Study|Withdrawal by Subject|1
7577497|NCT02164318|26354714|P3|Overall Study|Withdrawal by Subject|0
7577498|NCT02164318|26354715|P2|Overall Study|Withdrawal by Subject|1
7577499|NCT02164318|26354716|P1|Overall Study|Withdrawal by Subject|0
7577500|NCT02163993|26354751|P5|Post-treatment Period|Withdrawal by Subject|2
7577501|NCT02163993|26354752|P4|Post-treatment Period|Withdrawal by Subject|1
7577502|NCT02163993|26354753|P3|Post-treatment Period|Withdrawal by Subject|0
7577503|NCT02163993|26354754|P2|Post-treatment Period|Withdrawal by Subject|4
7577504|NCT02163993|26354755|P1|Post-treatment Period|Withdrawal by Subject|2
7577505|NCT02163993|26354751|P5|Post-treatment Period|Protocol Violation|1
7577506|NCT02163993|26354752|P4|Post-treatment Period|Protocol Violation|0
7577507|NCT02163993|26354753|P3|Post-treatment Period|Protocol Violation|0
7577508|NCT02163993|26354754|P2|Post-treatment Period|Protocol Violation|0
7577509|NCT02163993|26354755|P1|Post-treatment Period|Protocol Violation|0
7577510|NCT02163993|26354751|P5|Post-treatment Period|Lost to Follow-up|0
7577511|NCT02163993|26354752|P4|Post-treatment Period|Lost to Follow-up|1
7577512|NCT02163993|26354753|P3|Post-treatment Period|Lost to Follow-up|3
7577513|NCT02163993|26354754|P2|Post-treatment Period|Lost to Follow-up|2
7577514|NCT02163993|26354755|P1|Post-treatment Period|Lost to Follow-up|2
7577515|NCT02163993|26354751|P5|Post-treatment Period|Adverse Event|0
7577516|NCT02163993|26354752|P4|Post-treatment Period|Adverse Event|0
7577517|NCT02163993|26354753|P3|Post-treatment Period|Adverse Event|1
7577518|NCT02163993|26354754|P2|Post-treatment Period|Adverse Event|0
7577519|NCT02163993|26354755|P1|Post-treatment Period|Adverse Event|0
7577520|NCT02163993|26354751|P5|Treatment Period|Not treated|2
7577521|NCT02163993|26354752|P4|Treatment Period|Not treated|1
7577522|NCT02163993|26354753|P3|Treatment Period|Not treated|0
7577523|NCT02163993|26354754|P2|Treatment Period|Not treated|0
7577524|NCT02163993|26354755|P1|Treatment Period|Not treated|1
7577525|NCT02163993|26354751|P5|Treatment Period|Withdrawal by Subject|1
7577526|NCT02163993|26354752|P4|Treatment Period|Withdrawal by Subject|4
7577527|NCT02163993|26354753|P3|Treatment Period|Withdrawal by Subject|1
7577528|NCT02163993|26354754|P2|Treatment Period|Withdrawal by Subject|4
7577529|NCT02163993|26354755|P1|Treatment Period|Withdrawal by Subject|6
7577530|NCT02163993|26354751|P5|Treatment Period|Protocol Violation|2
7577531|NCT02163993|26354752|P4|Treatment Period|Protocol Violation|1
7577532|NCT02163993|26354753|P3|Treatment Period|Protocol Violation|0
7577533|NCT02163993|26354754|P2|Treatment Period|Protocol Violation|1
7577534|NCT02163993|26354755|P1|Treatment Period|Protocol Violation|2
7577535|NCT02163993|26354751|P5|Treatment Period|Physician Decision|0
7577536|NCT02163993|26354752|P4|Treatment Period|Physician Decision|0
7577537|NCT02163993|26354753|P3|Treatment Period|Physician Decision|0
7577538|NCT02163993|26354754|P2|Treatment Period|Physician Decision|0
7577539|NCT02163993|26354755|P1|Treatment Period|Physician Decision|1
7577540|NCT02163993|26354751|P5|Treatment Period|Lost to Follow-up|1
7577541|NCT02163993|26354752|P4|Treatment Period|Lost to Follow-up|3
7577542|NCT02163993|26354753|P3|Treatment Period|Lost to Follow-up|1
7577543|NCT02163993|26354754|P2|Treatment Period|Lost to Follow-up|3
7577544|NCT02163993|26354755|P1|Treatment Period|Lost to Follow-up|2
7577545|NCT02163993|26354751|P5|Treatment Period|Adverse Event|1
7577546|NCT02163993|26354752|P4|Treatment Period|Adverse Event|0
7577547|NCT02163993|26354753|P3|Treatment Period|Adverse Event|0
7577548|NCT02163993|26354754|P2|Treatment Period|Adverse Event|1
7577549|NCT02163993|26354755|P1|Treatment Period|Adverse Event|0
7577550|NCT02163915|26354858|P5|Overall Study|Physician Decision|0
7577551|NCT02163915|26354859|P4|Overall Study|Physician Decision|1
7577552|NCT02163915|26354860|P3|Overall Study|Physician Decision|0
7577553|NCT02163915|26354861|P2|Overall Study|Physician Decision|0
7577554|NCT02163915|26354862|P1|Overall Study|Physician Decision|0
7577555|NCT02163915|26354858|P5|Overall Study|Study termination|2
7577556|NCT02163915|26354859|P4|Overall Study|Study termination|0
7577557|NCT02163915|26354860|P3|Overall Study|Study termination|0
7577558|NCT02163915|26354861|P2|Overall Study|Study termination|0
7577559|NCT02163915|26354862|P1|Overall Study|Study termination|1
7577560|NCT02163915|26354858|P5|Overall Study|Withdrawal by Subject|2
7577561|NCT02163915|26354859|P4|Overall Study|Withdrawal by Subject|2
7577562|NCT02163915|26354860|P3|Overall Study|Withdrawal by Subject|2
7577563|NCT02163915|26354861|P2|Overall Study|Withdrawal by Subject|0
7577564|NCT02163915|26354862|P1|Overall Study|Withdrawal by Subject|2
7577565|NCT02163902|26354917|P2|Overall Study|Administrative Decision|2
7577566|NCT02163902|26354918|P1|Overall Study|Administrative Decision|2
7577567|NCT02163902|26354917|P2|Overall Study|Lost to Follow-up|7
7577568|NCT02163902|26354918|P1|Overall Study|Lost to Follow-up|6
7577569|NCT02163902|26354917|P2|Overall Study|Subject's Request|4
7577570|NCT02163902|26354918|P1|Overall Study|Subject's Request|3
7577571|NCT02163759|26354996|P3|Overall Study|Death|1
7577572|NCT02163759|26354997|P2|Overall Study|Death|0
7577573|NCT02163759|26354998|P1|Overall Study|Death|0
7577574|NCT02163759|26354996|P3|Overall Study|Adverse Event|1
7577575|NCT02163759|26354997|P2|Overall Study|Adverse Event|0
7577576|NCT02163759|26354998|P1|Overall Study|Adverse Event|0
7577577|NCT02163759|26354996|P3|Overall Study|Withdrawal by Subject|1
7577578|NCT02163759|26354997|P2|Overall Study|Withdrawal by Subject|5
7577579|NCT02163759|26354998|P1|Overall Study|Withdrawal by Subject|1
7577580|NCT02163733|26355073|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
7577581|NCT02163733|26355074|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
7577582|NCT02163733|26355075|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
7577583|NCT02163733|26355073|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
7577584|NCT02163733|26355074|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
7577585|NCT02163733|26355075|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
7577586|NCT02163538|26355177|P2|Overall Study|Physician Decision|1
7577587|NCT02163538|26355178|P1|Overall Study|Physician Decision|0
7577588|NCT02163538|26355177|P2|Overall Study|Protocol Violation|0
7577589|NCT02163538|26355178|P1|Overall Study|Protocol Violation|1
7577590|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Various reasons|16
7577591|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
7577592|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Subject Compliance|17
7577593|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Death|8
7577594|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Protocol Violation|2
7577595|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
7577596|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Physician Decision|8
7577597|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
7577598|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
7577599|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
7577600|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Hypokalemia|9
7577601|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
7577602|NCT02163499|26355194|P1|Extended Dosing Phase: ZS|Adverse Event|51
7577603|NCT02163499|26355194|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
7577604|NCT02163499|26355194|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
7577605|NCT02163499|26355194|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
7577606|NCT02163499|26355194|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
7577607|NCT02163499|26355194|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
7577608|NCT02163447|26355222|P3|Overall Study|Became HIV infected at time of delivery|0
7577609|NCT02163447|26355223|P2|Overall Study|Became HIV infected at time of delivery|0
7577610|NCT02163447|26355224|P1|Overall Study|Became HIV infected at time of delivery|1
7577611|NCT02163447|26355222|P3|Overall Study|Moved out of study area|2
7577612|NCT02163447|26355223|P2|Overall Study|Moved out of study area|3
7577613|NCT02163447|26355224|P1|Overall Study|Moved out of study area|2
7577614|NCT02163447|26355222|P3|Overall Study|Lost to Follow-up|0
7577615|NCT02163447|26355223|P2|Overall Study|Lost to Follow-up|3
7577616|NCT02163447|26355224|P1|Overall Study|Lost to Follow-up|1
7577617|NCT02163447|26355222|P3|Overall Study|Withdrawal by Subject|1
7577618|NCT02163447|26355223|P2|Overall Study|Withdrawal by Subject|0
7577619|NCT02163447|26355224|P1|Overall Study|Withdrawal by Subject|2
7577620|NCT02163395|26355318|P1|Overall Study|Adverse Event|1
7577621|NCT02163395|26355318|P1|Overall Study|Lost to Follow-up|3
7577622|NCT02163395|26355318|P1|Overall Study|Withdrawal by Subject|1
7577623|NCT02163187|26355327|P2|Overall Study|Progressive disease|0
7577624|NCT02163187|26355328|P1|Overall Study|Progressive disease|1
7577625|NCT02163187|26355327|P2|Overall Study|Device removed|0
7577626|NCT02163187|26355328|P1|Overall Study|Device removed|1
7577627|NCT02163057|26355338|P2|Overall Study|Progression of Disease|2
7577628|NCT02163057|26355339|P1|Overall Study|Progression of Disease|1
7577629|NCT02163057|26355338|P2|Overall Study|Participant Significant Noncompliance|1
7577630|NCT02163057|26355339|P1|Overall Study|Participant Significant Noncompliance|0
7577631|NCT02163057|26355338|P2|Overall Study|Participant Refusal to Continue|2
7577632|NCT02163057|26355339|P1|Overall Study|Participant Refusal to Continue|2
7577633|NCT02162862|26355386|P3|Overall Study|Subject did not feel the med was needed|4
7577634|NCT02162862|26355387|P2|Overall Study|Subject did not feel the med was needed|0
7577635|NCT02162862|26355388|P1|Overall Study|Subject did not feel the med was needed|0
7577636|NCT02162862|26355386|P3|Overall Study|Lost to Follow-up|0
7577637|NCT02162862|26355387|P2|Overall Study|Lost to Follow-up|11
7577638|NCT02162862|26355388|P1|Overall Study|Lost to Follow-up|0
7577639|NCT02162771|26355401|P2|Maintenance Study Period (Part 2)|Stable Disease|1
7577640|NCT02162771|26355402|P1|Maintenance Study Period (Part 2)|Stable Disease|0
7577641|NCT02162771|26355401|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
7577642|NCT02162771|26355402|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
7577643|NCT02162771|26355401|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
7577644|NCT02162771|26355402|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
7577645|NCT02162771|26355401|P2|Maintenance Study Period (Part 2)|Death|1
7577646|NCT02162771|26355402|P1|Maintenance Study Period (Part 2)|Death|2
7577647|NCT02162771|26355401|P2|Maintenance Study Period (Part 2)|Adverse Event|3
7577648|NCT02162771|26355402|P1|Maintenance Study Period (Part 2)|Adverse Event|3
7577649|NCT02162771|26355401|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
7577650|NCT02162771|26355402|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
7577651|NCT02162771|26355401|P2|Core Study Period (Part 2)|Death|0
7577652|NCT02162771|26355402|P1|Core Study Period (Part 2)|Death|1
7577653|NCT02162771|26355401|P2|Core Study Period (Part 2)|Physician Decision|2
7577654|NCT02162771|26355402|P1|Core Study Period (Part 2)|Physician Decision|0
7577655|NCT02162771|26355401|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
7577656|NCT02162771|26355402|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
7577657|NCT02162771|26355401|P2|Core Study Period (Part 2)|Adverse Event|1
7577658|NCT02162771|26355402|P1|Core Study Period (Part 2)|Adverse Event|4
7577659|NCT02162771|26355401|P2|Core Study Period (Part 2)|Progressive Disease|3
7577660|NCT02162771|26355402|P1|Core Study Period (Part 2)|Progressive Disease|2
7577661|NCT02162758|26355416|P2|Overall Study|Study termination|1
7577662|NCT02162758|26355417|P1|Overall Study|Study termination|0
7577663|NCT02162719|26355431|P2|Overall Study|Discontinuation of Overall Survival Follow-up|10
7577664|NCT02162719|26355432|P1|Overall Study|Discontinuation of Overall Survival Follow-up|10
7577665|NCT02162719|26355431|P2|Overall Study|Withdrawal by Subject|2
7577666|NCT02162719|26355432|P1|Overall Study|Withdrawal by Subject|8
7577667|NCT02162719|26355431|P2|Overall Study|Disease Progression|1
7577668|NCT02162719|26355432|P1|Overall Study|Disease Progression|2
7577669|NCT02162719|26355431|P2|Overall Study|Lost to Follow-up|3
7577670|NCT02162719|26355432|P1|Overall Study|Lost to Follow-up|1
7577671|NCT02162719|26355431|P2|Overall Study|Death|46
7577672|NCT02162719|26355432|P1|Overall Study|Death|41
7577673|NCT02161757|26355597|P3|Treatment Through Study Completion|Death|1
7577674|NCT02161757|26355598|P2|Treatment Through Study Completion|Death|1
7577675|NCT02161757|26355599|P1|Treatment Through Study Completion|Death|2
7577676|NCT02161757|26355597|P3|Treatment Through Study Completion|Other|12
7577677|NCT02161757|26355598|P2|Treatment Through Study Completion|Other|19
7577678|NCT02161757|26355599|P1|Treatment Through Study Completion|Other|20
7577679|NCT02161757|26355597|P3|Treatment Through Study Completion|Lost to Follow-up|4
7577680|NCT02161757|26355598|P2|Treatment Through Study Completion|Lost to Follow-up|2
7577681|NCT02161757|26355599|P1|Treatment Through Study Completion|Lost to Follow-up|7
7577682|NCT02161757|26355597|P3|Treatment Through Study Completion|Withdrawal by Subject|20
7577683|NCT02161757|26355598|P2|Treatment Through Study Completion|Withdrawal by Subject|19
7577684|NCT02161757|26355599|P1|Treatment Through Study Completion|Withdrawal by Subject|27
7577685|NCT02161757|26355597|P3|Treatment Through Study Completion|Protocol Violation|2
7577686|NCT02161757|26355598|P2|Treatment Through Study Completion|Protocol Violation|1
7577687|NCT02161757|26355599|P1|Treatment Through Study Completion|Protocol Violation|0
7577688|NCT02161757|26355597|P3|Treatment Through Study Completion|Adverse Event|0
7577689|NCT02161757|26355598|P2|Treatment Through Study Completion|Adverse Event|1
7577690|NCT02161757|26355599|P1|Treatment Through Study Completion|Adverse Event|1
7577691|NCT02161757|26355597|P3|Randomised Through Start Treatment|Did not receive treatment|0
7577692|NCT02161757|26355598|P2|Randomised Through Start Treatment|Did not receive treatment|2
7577693|NCT02161757|26355599|P1|Randomised Through Start Treatment|Did not receive treatment|3
7577694|NCT02161731|26355657|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
7577695|NCT02161731|26355658|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
7577696|NCT02161731|26355657|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
7577697|NCT02161731|26355658|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
7577698|NCT02161718|26355677|P3|Post- Randomization Period|Relocation|0
7577699|NCT02161718|26355678|P2|Post- Randomization Period|Relocation|3
7577700|NCT02161718|26355679|P1|Post- Randomization Period|Relocation|0
7577701|NCT02161718|26355677|P3|Post- Randomization Period|Received prohibitive treatment|2
7577702|NCT02161718|26355678|P2|Post- Randomization Period|Received prohibitive treatment|1
7577703|NCT02161718|26355679|P1|Post- Randomization Period|Received prohibitive treatment|0
7577704|NCT02161718|26355677|P3|Post- Randomization Period|Non-compliance with study procedures|4
7577705|NCT02161718|26355678|P2|Post- Randomization Period|Non-compliance with study procedures|2
7577706|NCT02161718|26355679|P1|Post- Randomization Period|Non-compliance with study procedures|0
7577707|NCT02161718|26355677|P3|Post- Randomization Period|Lack of Efficacy|1
7577708|NCT02161718|26355678|P2|Post- Randomization Period|Lack of Efficacy|0
7577709|NCT02161718|26355679|P1|Post- Randomization Period|Lack of Efficacy|0
7577710|NCT02161718|26355677|P3|Post- Randomization Period|Protocol Violation|3
7577711|NCT02161718|26355678|P2|Post- Randomization Period|Protocol Violation|2
7577712|NCT02161718|26355679|P1|Post- Randomization Period|Protocol Violation|0
7577713|NCT02161718|26355677|P3|Post- Randomization Period|Physician Decision|4
7577714|NCT02161718|26355678|P2|Post- Randomization Period|Physician Decision|2
7577715|NCT02161718|26355679|P1|Post- Randomization Period|Physician Decision|0
7577716|NCT02161718|26355677|P3|Post- Randomization Period|Non- compliance with study drug|2
7577717|NCT02161718|26355678|P2|Post- Randomization Period|Non- compliance with study drug|8
7577718|NCT02161718|26355679|P1|Post- Randomization Period|Non- compliance with study drug|0
7577719|NCT02161718|26355677|P3|Post- Randomization Period|Adverse Event|10
7577720|NCT02161718|26355678|P2|Post- Randomization Period|Adverse Event|9
7577721|NCT02161718|26355679|P1|Post- Randomization Period|Adverse Event|0
7577722|NCT02161718|26355677|P3|Post- Randomization Period|Lost to Follow-up|15
7577723|NCT02161718|26355678|P2|Post- Randomization Period|Lost to Follow-up|9
7577724|NCT02161718|26355679|P1|Post- Randomization Period|Lost to Follow-up|0
7577725|NCT02161718|26355677|P3|Post- Randomization Period|Withdrawal by Subject|18
7577726|NCT02161718|26355678|P2|Post- Randomization Period|Withdrawal by Subject|23
7577727|NCT02161718|26355679|P1|Post- Randomization Period|Withdrawal by Subject|0
7577728|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7577729|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7577730|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
7577731|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7577732|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7577733|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Lost to Follow-up|3
7577734|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7577735|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7577736|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
7577737|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Adverse Event|0
7577738|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Adverse Event|0
7577739|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Adverse Event|3
7577740|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7577741|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7577742|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Lack of Efficacy|1
7577743|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7577744|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7577745|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
7577746|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Physician Decision|0
7577747|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Physician Decision|0
7577748|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Physician Decision|1
7577749|NCT02161718|26355677|P3|Open-Label ALKS 3831 Period|Protocol Violation|0
7577750|NCT02161718|26355678|P2|Open-Label ALKS 3831 Period|Protocol Violation|0
7577751|NCT02161718|26355679|P1|Open-Label ALKS 3831 Period|Protocol Violation|2
7577752|NCT02161575|26355701|P1|Overall Study|Adverse Event|2
7577753|NCT02161575|26355701|P1|Overall Study|Lack of Efficacy|1
7577754|NCT02161575|26355701|P1|Overall Study|Protocol Violation|8
7577755|NCT02161562|26355721|P2|Overall Study|Participant moved out of province|0
7577756|NCT02161562|26355722|P1|Overall Study|Participant moved out of province|1
7577757|NCT02161562|26355721|P2|Overall Study|Withdrew due to being out of the country|0
7577758|NCT02161562|26355722|P1|Overall Study|Withdrew due to being out of the country|1
7577759|NCT02161562|26355721|P2|Overall Study|Participant moved back to home country|0
7577760|NCT02161562|26355722|P1|Overall Study|Participant moved back to home country|1
7577761|NCT02161562|26355721|P2|Overall Study|Adverse Event|1
7577762|NCT02161562|26355722|P1|Overall Study|Adverse Event|1
7577763|NCT02161562|26355721|P2|Overall Study|Lack of Efficacy|1
7577764|NCT02161562|26355722|P1|Overall Study|Lack of Efficacy|4
7577765|NCT02161562|26355721|P2|Overall Study|Lost to Follow-up|1
7577766|NCT02161562|26355722|P1|Overall Study|Lost to Follow-up|3
7577767|NCT02161562|26355721|P2|Overall Study|Pregnancy|2
7577768|NCT02161562|26355722|P1|Overall Study|Pregnancy|1
7577769|NCT02161562|26355721|P2|Overall Study|Protocol Violation|4
7577770|NCT02161562|26355722|P1|Overall Study|Protocol Violation|9
7577771|NCT02161562|26355721|P2|Overall Study|Withdrawal by Subject|8
7577772|NCT02161562|26355722|P1|Overall Study|Withdrawal by Subject|5
7577773|NCT02161549|26355750|P2|Overall Study|Physician Decision|2
7577774|NCT02161549|26355751|P1|Overall Study|Physician Decision|6
7577775|NCT02161458|26355799|P4|Overall Study|Lost to Follow-up|0
7577776|NCT02161458|26355800|P3|Overall Study|Lost to Follow-up|1
7577777|NCT02161458|26355801|P2|Overall Study|Lost to Follow-up|2
7577778|NCT02161458|26355802|P1|Overall Study|Lost to Follow-up|0
7577779|NCT02161458|26355799|P4|Overall Study|Withdrawal by Subject|0
7577780|NCT02161458|26355800|P3|Overall Study|Withdrawal by Subject|4
7577781|NCT02161458|26355801|P2|Overall Study|Withdrawal by Subject|4
7577782|NCT02161458|26355802|P1|Overall Study|Withdrawal by Subject|0
7577783|NCT02161406|26355814|P2|Overall Study|relocation|1
7577784|NCT02161406|26355815|P1|Overall Study|relocation|0
7577785|NCT02161406|26355814|P2|Overall Study|Lack of Efficacy|1
7577786|NCT02161406|26355815|P1|Overall Study|Lack of Efficacy|1
7577787|NCT02161406|26355814|P2|Overall Study|investigator withdrew subject|1
7577788|NCT02161406|26355815|P1|Overall Study|investigator withdrew subject|3
7577789|NCT02161406|26355814|P2|Overall Study|Withdrawal by Subject|4
7577790|NCT02161406|26355815|P1|Overall Study|Withdrawal by Subject|2
7577791|NCT02161406|26355814|P2|Overall Study|Lost to Follow-up|1
7577792|NCT02161406|26355815|P1|Overall Study|Lost to Follow-up|2
7577793|NCT02161406|26355814|P2|Overall Study|Death|1
7577794|NCT02161406|26355815|P1|Overall Study|Death|2
7577795|NCT02161185|26355889|P1|Treatment Phase|Administrative/Other|7
7577796|NCT02161146|26355899|P5|Overall Study|Other Miscellaneous Reasons|0
7577797|NCT02161146|26355900|P4|Overall Study|Other Miscellaneous Reasons|0
7577798|NCT02161146|26355901|P3|Overall Study|Other Miscellaneous Reasons|0
7577799|NCT02161146|26355902|P2|Overall Study|Other Miscellaneous Reasons|1
7577800|NCT02161146|26355903|P1|Overall Study|Other Miscellaneous Reasons|0
7577801|NCT02161146|26355899|P5|Overall Study|Personal Reasons|1
7577802|NCT02161146|26355900|P4|Overall Study|Personal Reasons|2
7577803|NCT02161146|26355901|P3|Overall Study|Personal Reasons|0
7577804|NCT02161146|26355902|P2|Overall Study|Personal Reasons|1
7577805|NCT02161146|26355903|P1|Overall Study|Personal Reasons|0
7577806|NCT02161146|26355899|P5|Overall Study|Lost to Follow-up|0
7577807|NCT02161146|26355900|P4|Overall Study|Lost to Follow-up|0
7577808|NCT02161146|26355901|P3|Overall Study|Lost to Follow-up|0
7577809|NCT02161146|26355902|P2|Overall Study|Lost to Follow-up|1
7577810|NCT02161146|26355903|P1|Overall Study|Lost to Follow-up|0
7577811|NCT02161146|26355899|P5|Overall Study|Adverse Event|0
7577812|NCT02161146|26355900|P4|Overall Study|Adverse Event|1
7577813|NCT02161146|26355901|P3|Overall Study|Adverse Event|0
7577814|NCT02161146|26355902|P2|Overall Study|Adverse Event|1
7577815|NCT02161146|26355903|P1|Overall Study|Adverse Event|1
7577816|NCT02161016|26355939|P1|Overall Study|withdrawn by IRB|1
7577817|NCT02160977|26355970|P2|Six Months After Surgery|Lost to Follow-up|1
7577818|NCT02160977|26355971|P1|Six Months After Surgery|Lost to Follow-up|2
7577819|NCT02160977|26355970|P2|Three Months After Surgery|Lost to Follow-up|2
7577820|NCT02160977|26355971|P1|Three Months After Surgery|Lost to Follow-up|0
7577821|NCT02160977|26355970|P2|Six Weeks After Surgery|Lost to Follow-up|0
7577822|NCT02160977|26355971|P1|Six Weeks After Surgery|Lost to Follow-up|1
7577823|NCT02160899|26355987|P6|Overall Study|Adverse Event or Serious Adverse Event|0
7577824|NCT02160899|26355988|P5|Overall Study|Adverse Event or Serious Adverse Event|2
7577825|NCT02160899|26355989|P4|Overall Study|Adverse Event or Serious Adverse Event|1
7577826|NCT02160899|26355990|P3|Overall Study|Adverse Event or Serious Adverse Event|0
7577827|NCT02160899|26355991|P2|Overall Study|Adverse Event or Serious Adverse Event|1
7577828|NCT02160899|26355992|P1|Overall Study|Adverse Event or Serious Adverse Event|0
7577829|NCT02160782|26356051|P5|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
7577830|NCT02160782|26356052|P4|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7577831|NCT02160782|26356053|P3|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7577832|NCT02160782|26356054|P2|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7577833|NCT02160782|26356055|P1|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7577834|NCT02160782|26356051|P5|Long-term Extension Period: Maralixibat|Adverse Event|3
7577835|NCT02160782|26356052|P4|Long-term Extension Period: Maralixibat|Adverse Event|0
7577836|NCT02160782|26356053|P3|Long-term Extension Period: Maralixibat|Adverse Event|0
7577837|NCT02160782|26356054|P2|Long-term Extension Period: Maralixibat|Adverse Event|0
7577838|NCT02160782|26356055|P1|Long-term Extension Period: Maralixibat|Adverse Event|0
7577839|NCT02160782|26356051|P5|Long-term Extension Period: Maralixibat|Physician Decision|1
7577840|NCT02160782|26356052|P4|Long-term Extension Period: Maralixibat|Physician Decision|0
7577841|NCT02160782|26356053|P3|Long-term Extension Period: Maralixibat|Physician Decision|0
7577842|NCT02160782|26356054|P2|Long-term Extension Period: Maralixibat|Physician Decision|0
7577843|NCT02160782|26356055|P1|Long-term Extension Period: Maralixibat|Physician Decision|0
7577844|NCT02160782|26356051|P5|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
7577845|NCT02160782|26356052|P4|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7577846|NCT02160782|26356053|P3|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7577847|NCT02160782|26356054|P2|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7577848|NCT02160782|26356055|P1|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7577849|NCT02160782|26356051|P5|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7577850|NCT02160782|26356052|P4|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
7577851|NCT02160782|26356053|P3|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7577852|NCT02160782|26356054|P2|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7577853|NCT02160782|26356055|P1|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7577854|NCT02160782|26356051|P5|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7577855|NCT02160782|26356052|P4|After Randomized Withdrawal: Maralixibat|Adverse Event|1
7577856|NCT02160782|26356053|P3|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7577857|NCT02160782|26356054|P2|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7577858|NCT02160782|26356055|P1|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7577859|NCT02160782|26356051|P5|Open-label Period: Maralixibat|Adverse Event|0
7577860|NCT02160782|26356052|P4|Open-label Period: Maralixibat|Adverse Event|0
7577861|NCT02160782|26356053|P3|Open-label Period: Maralixibat|Adverse Event|0
7577862|NCT02160782|26356054|P2|Open-label Period: Maralixibat|Adverse Event|0
7577863|NCT02160782|26356055|P1|Open-label Period: Maralixibat|Adverse Event|2
7577864|NCT02160626|26356094|P3|Overall Study|Withdrawal by Subject|0
7577865|NCT02160626|26356095|P2|Overall Study|Withdrawal by Subject|1
7577866|NCT02160626|26356096|P1|Overall Study|Withdrawal by Subject|0
7577867|NCT02160626|26356094|P3|Overall Study|Schedule not conducive to study visits|1
7577868|NCT02160626|26356095|P2|Overall Study|Schedule not conducive to study visits|0
7577869|NCT02160626|26356096|P1|Overall Study|Schedule not conducive to study visits|0
7577870|NCT02160626|26356094|P3|Overall Study|Adverse Event|0
7577871|NCT02160626|26356095|P2|Overall Study|Adverse Event|0
7577872|NCT02160626|26356096|P1|Overall Study|Adverse Event|1
7577873|NCT02160314|26356119|P2|Overall Study|Lost to Follow-up|1
7577874|NCT02160314|26356120|P1|Overall Study|Lost to Follow-up|0
7577875|NCT02160314|26356119|P2|Overall Study|Withdrawal by Subject|2
7577876|NCT02160314|26356120|P1|Overall Study|Withdrawal by Subject|1
7577877|NCT02160314|26356119|P2|Overall Study|Protocol Violation|4
7577878|NCT02160314|26356120|P1|Overall Study|Protocol Violation|0
7577879|NCT02160314|26356119|P2|Overall Study|Adverse Event|6
7577880|NCT02160314|26356120|P1|Overall Study|Adverse Event|0
7577881|NCT02160145|26356155|P3|Randomized Double-blind Period|Physician Decision|5
7577882|NCT02160145|26356156|P2|Randomized Double-blind Period|Physician Decision|7
7577883|NCT02160145|26356157|P1|Randomized Double-blind Period|Physician Decision|0
7577884|NCT02160145|26356155|P3|Randomized Double-blind Period|Lost to Follow-up|3
7577885|NCT02160145|26356156|P2|Randomized Double-blind Period|Lost to Follow-up|1
7577886|NCT02160145|26356157|P1|Randomized Double-blind Period|Lost to Follow-up|0
7577887|NCT02160145|26356155|P3|Randomized Double-blind Period|Subject decision|20
7577888|NCT02160145|26356156|P2|Randomized Double-blind Period|Subject decision|21
7577889|NCT02160145|26356157|P1|Randomized Double-blind Period|Subject decision|0
7577890|NCT02160145|26356155|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7577891|NCT02160145|26356156|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7577892|NCT02160145|26356157|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
7577893|NCT02160145|26356155|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
7577894|NCT02160145|26356156|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
7577895|NCT02160145|26356157|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
7577896|NCT02160041|26356170|P1|Overall Study|study terminated by by sponsor|1
7577897|NCT02160041|26356170|P1|Overall Study|Withdrawal by Subject|8
7577898|NCT02160041|26356170|P1|Overall Study|Physician Decision|3
7577899|NCT02160041|26356170|P1|Overall Study|non-compliance with study|1
7577900|NCT02160041|26356170|P1|Overall Study|Protocol Violation|1
7577901|NCT02160041|26356170|P1|Overall Study|disease progression|57
7577902|NCT02160041|26356170|P1|Overall Study|Death|2
7577903|NCT02160041|26356170|P1|Overall Study|Adverse Event|11
7577904|NCT02160002|26356182|P2|Overall Study|Withdrawal by Subject|1
7577905|NCT02160002|26356183|P1|Overall Study|Withdrawal by Subject|2
7577906|NCT02159950|26356230|P2|Overall Study|Progression|1
7577907|NCT02159950|26356231|P1|Overall Study|Progression|0
7577908|NCT02159950|26356230|P2|Overall Study|Adverse Event|1
7577909|NCT02159950|26356231|P1|Overall Study|Adverse Event|0
7577910|NCT02159807|26356295|P3|Overall Study|elevated blood pressure|1
7577911|NCT02159807|26356296|P2|Overall Study|elevated blood pressure|0
7577912|NCT02159807|26356297|P1|Overall Study|elevated blood pressure|0
7577913|NCT02159807|26356295|P3|Overall Study|No CSF|1
7577914|NCT02159807|26356296|P2|Overall Study|No CSF|1
7577915|NCT02159807|26356297|P1|Overall Study|No CSF|1
7577916|NCT02159807|26356295|P3|Overall Study|Adverse Event|1
7577917|NCT02159807|26356296|P2|Overall Study|Adverse Event|0
7577918|NCT02159807|26356297|P1|Overall Study|Adverse Event|0
7577919|NCT02159729|26356318|P2|Overall Study|Other Unspecified|1
7577920|NCT02159729|26356319|P1|Overall Study|Other Unspecified|3
7577921|NCT02159729|26356318|P2|Overall Study|Non compliance|0
7577922|NCT02159729|26356319|P1|Overall Study|Non compliance|2
7577923|NCT02159729|26356318|P2|Overall Study|Lost to Follow-up|9
7577924|NCT02159729|26356319|P1|Overall Study|Lost to Follow-up|24
7577925|NCT02159729|26356318|P2|Overall Study|Subject's Request|10
7577926|NCT02159729|26356319|P1|Overall Study|Subject's Request|13
7577927|NCT02159729|26356318|P2|Overall Study|Adverse Event|1
7577928|NCT02159729|26356319|P1|Overall Study|Adverse Event|0
7577929|NCT02159521|26356346|P1|Overall Study|Other than specified|1
7577930|NCT02159521|26356346|P1|Overall Study|Death|1
7577931|NCT02159521|26356346|P1|Overall Study|Lost to Follow-up|6
7577932|NCT02159521|26356346|P1|Overall Study|Withdrawal by Subject|7
7577933|NCT02159521|26356346|P1|Overall Study|Enrolled but not treated|3
7577934|NCT02159482|26356367|P1|Overall Study|Physician Decision|3
7577935|NCT02159482|26356367|P1|Overall Study|Withdrawal by Subject|2
7577936|NCT02159469|26356372|P1|Overall Study|Multiple|29
7577937|NCT02159469|26356372|P1|Overall Study|Other|1
7577938|NCT02159469|26356372|P1|Overall Study|Met Stopping Criteria|3
7577939|NCT02159469|26356372|P1|Overall Study|Sponsor's request|2
7577940|NCT02159469|26356372|P1|Overall Study|Lost to Follow-up|1
7577941|NCT02159469|26356372|P1|Overall Study|Withdrawal by Subject|9
7577942|NCT02159469|26356372|P1|Overall Study|Non-compliance|2
7577943|NCT02159469|26356372|P1|Overall Study|Adverse Event|5
7577944|NCT02159469|26356372|P1|Overall Study|Missing Completion status|1
7577945|NCT02159365|26356377|P1|Overall Study|Lost to Follow-up|1
7577946|NCT02159365|26356377|P1|Overall Study|Death|1
7577947|NCT02159365|26356377|P1|Overall Study|Subject withdrew consent|3
7577948|NCT02159365|26356377|P1|Overall Study|Subject request to discontinue treatment|3
7577949|NCT02159365|26356377|P1|Overall Study|Maximum clinical benefit|3
7577950|NCT02159365|26356377|P1|Overall Study|Study drug toxicity|7
7577951|NCT02159365|26356377|P1|Overall Study|Adverse Event unrelated to study drug|9
7577952|NCT02159365|26356377|P1|Overall Study|Administrative reason by Sponsor|9
7577953|NCT02159365|26356377|P1|Overall Study|Other reasons|11
7577954|NCT02159365|26356377|P1|Overall Study|Disease Progression|23
7577955|NCT02159352|26356384|P2|Overall Study|Withdrawal by Subject|1
7577956|NCT02159352|26356385|P1|Overall Study|Withdrawal by Subject|0
7577957|NCT02159352|26356384|P2|Overall Study|Adverse Event|1
7577958|NCT02159352|26356385|P1|Overall Study|Adverse Event|3
7577959|NCT02159183|26356437|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
7577960|NCT02159183|26356438|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
7577961|NCT02159183|26356437|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
7577962|NCT02159183|26356438|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
7577963|NCT02159183|26356437|P2|Analysis After the 36 Months Follow-up|Death|1
7577964|NCT02159183|26356438|P1|Analysis After the 36 Months Follow-up|Death|0
7577965|NCT02159183|26356437|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
7577966|NCT02159183|26356438|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
7577967|NCT02159183|26356437|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
7577968|NCT02159183|26356438|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
7577969|NCT02159053|26356511|P3|Overall Study|Participants/guardian decision|6
7577970|NCT02159053|26356512|P2|Overall Study|Participants/guardian decision|10
7577971|NCT02159053|26356513|P1|Overall Study|Participants/guardian decision|8
7577972|NCT02159053|26356511|P3|Overall Study|Adverse Event|5
7577973|NCT02159053|26356512|P2|Overall Study|Adverse Event|6
7577974|NCT02159053|26356513|P1|Overall Study|Adverse Event|7
7577975|NCT02159053|26356511|P3|Overall Study|Lack of Efficacy|7
7577976|NCT02159053|26356512|P2|Overall Study|Lack of Efficacy|4
7577977|NCT02159053|26356513|P1|Overall Study|Lack of Efficacy|3
7577978|NCT02159053|26356511|P3|Overall Study|Physician Decision|1
7577979|NCT02159053|26356512|P2|Overall Study|Physician Decision|1
7577980|NCT02159053|26356513|P1|Overall Study|Physician Decision|0
7577981|NCT02159053|26356511|P3|Overall Study|Death|1
7577982|NCT02159053|26356512|P2|Overall Study|Death|0
7577983|NCT02159053|26356513|P1|Overall Study|Death|2
7577984|NCT02159040|26356550|P1|Overall Study|Death|1
7577985|NCT02158975|26356563|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
7577986|NCT02158949|26356573|P2|Overall Study|Lost to Follow-up|11
7577987|NCT02158949|26356574|P1|Overall Study|Lost to Follow-up|5
7577988|NCT02158949|26356573|P2|Overall Study|Withdrawal by Subject|0
7577989|NCT02158949|26356574|P1|Overall Study|Withdrawal by Subject|1
7577990|NCT02158936|26356590|P2|Overall Study|Lost to Follow-up|1
7577991|NCT02158936|26356591|P1|Overall Study|Lost to Follow-up|0
7577992|NCT02158936|26356590|P2|Overall Study|Physician Decision|13
7577993|NCT02158936|26356591|P1|Overall Study|Physician Decision|15
7577994|NCT02158936|26356590|P2|Overall Study|Withdrawal by Subject|16
7577995|NCT02158936|26356591|P1|Overall Study|Withdrawal by Subject|15
7577996|NCT02158936|26356590|P2|Overall Study|Adverse Event|24
7577997|NCT02158936|26356591|P1|Overall Study|Adverse Event|39
7577998|NCT02158936|26356590|P2|Overall Study|Azacitidine tx discontinued|46
7577999|NCT02158936|26356591|P1|Overall Study|Azacitidine tx discontinued|53
7578000|NCT02158936|26356590|P2|Overall Study|Study closed/ terminated|77
7578001|NCT02158936|26356591|P1|Overall Study|Study closed/ terminated|57
7578002|NCT02158884|26356633|P1|12 Month Assessment|Missed SMFA|17
7578003|NCT02158884|26356633|P1|6 Month Assessment|Missed SMFA|20
7578004|NCT02158884|26356633|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
7578005|NCT02158884|26356633|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
7578006|NCT02158884|26356633|P1|Baseline Assessment|Missed SMFA|1
7578007|NCT02158884|26356633|P1|Baseline Assessment|Missed performance assessment|3
7578008|NCT02158806|26356668|P2|Overall Study|Transferred to palliative care|1
7578009|NCT02158806|26356669|P1|Overall Study|Transferred to palliative care|0
7578010|NCT02158806|26356668|P2|Overall Study|Moved out of area|1
7578011|NCT02158806|26356669|P1|Overall Study|Moved out of area|0
7578012|NCT02158806|26356668|P2|Overall Study|Lost to Follow-up|3
7578013|NCT02158806|26356669|P1|Overall Study|Lost to Follow-up|0
7578014|NCT02158806|26356668|P2|Overall Study|Withdrawal by Subject|0
7578015|NCT02158806|26356669|P1|Overall Study|Withdrawal by Subject|2
7578016|NCT02158806|26356668|P2|Overall Study|Death|0
7578017|NCT02158806|26356669|P1|Overall Study|Death|2
7578018|NCT02158728|26356689|P1|Overall Study|no qualified dataset|24
7578019|NCT02158728|26356689|P1|Overall Study|no procedure according to CIP done|3
7578020|NCT02158663|26356695|P2|Overall Study|Withdrawal by Subject|4
7578021|NCT02158663|26356696|P1|Overall Study|Withdrawal by Subject|5
7578022|NCT02158546|26356719|P4|Overall Study|Site Excluded|4
7578023|NCT02158546|26356720|P3|Overall Study|Site Excluded|3
7578024|NCT02158546|26356721|P2|Overall Study|Site Excluded|5
7578025|NCT02158546|26356722|P1|Overall Study|Site Excluded|5
7578026|NCT02158546|26356719|P4|Overall Study|Lost to Follow-up|1
7578027|NCT02158546|26356720|P3|Overall Study|Lost to Follow-up|0
7578028|NCT02158546|26356721|P2|Overall Study|Lost to Follow-up|4
7578029|NCT02158546|26356722|P1|Overall Study|Lost to Follow-up|5
7578030|NCT02158546|26356719|P4|Overall Study|Withdrawal by Subject|0
7578031|NCT02158546|26356720|P3|Overall Study|Withdrawal by Subject|1
7578032|NCT02158546|26356721|P2|Overall Study|Withdrawal by Subject|2
7578033|NCT02158546|26356722|P1|Overall Study|Withdrawal by Subject|6
7578034|NCT02158546|26356719|P4|Overall Study|Adverse Event|0
7578035|NCT02158546|26356720|P3|Overall Study|Adverse Event|0
7578036|NCT02158546|26356721|P2|Overall Study|Adverse Event|2
7578037|NCT02158546|26356722|P1|Overall Study|Adverse Event|2
7578038|NCT02158546|26356719|P4|Overall Study|Lack of Efficacy|0
7578039|NCT02158546|26356720|P3|Overall Study|Lack of Efficacy|0
7578040|NCT02158546|26356721|P2|Overall Study|Lack of Efficacy|1
7578041|NCT02158546|26356722|P1|Overall Study|Lack of Efficacy|1
7578042|NCT02158546|26356719|P4|Overall Study|Failure to meet eligibility criteria|0
7578043|NCT02158546|26356720|P3|Overall Study|Failure to meet eligibility criteria|0
7578044|NCT02158546|26356721|P2|Overall Study|Failure to meet eligibility criteria|1
7578045|NCT02158546|26356722|P1|Overall Study|Failure to meet eligibility criteria|0
7578046|NCT02158546|26356719|P4|Overall Study|Non-compliance|1
7578047|NCT02158546|26356720|P3|Overall Study|Non-compliance|0
7578048|NCT02158546|26356721|P2|Overall Study|Non-compliance|1
7578049|NCT02158546|26356722|P1|Overall Study|Non-compliance|0
7578050|NCT02158546|26356719|P4|Overall Study|Physician Decision|0
7578051|NCT02158546|26356720|P3|Overall Study|Physician Decision|0
7578052|NCT02158546|26356721|P2|Overall Study|Physician Decision|1
7578053|NCT02158546|26356722|P1|Overall Study|Physician Decision|0
7578054|NCT02158533|26356741|P6|Stage 2|Non-adherence with study visits|1
7578055|NCT02158533|26356742|P5|Stage 2|Non-adherence with study visits|0
7578056|NCT02158533|26356743|P4|Stage 2|Non-adherence with study visits|0
7578057|NCT02158533|26356744|P3|Stage 2|Non-adherence with study visits|0
7578058|NCT02158533|26356745|P2|Stage 2|Non-adherence with study visits|0
7578059|NCT02158533|26356746|P1|Stage 2|Non-adherence with study visits|0
7578060|NCT02158533|26356741|P6|Stage 2|Psychiatrist decision to try new tx|0
7578061|NCT02158533|26356742|P5|Stage 2|Psychiatrist decision to try new tx|0
7578062|NCT02158533|26356743|P4|Stage 2|Psychiatrist decision to try new tx|1
7578063|NCT02158533|26356744|P3|Stage 2|Psychiatrist decision to try new tx|0
7578064|NCT02158533|26356745|P2|Stage 2|Psychiatrist decision to try new tx|0
7578065|NCT02158533|26356746|P1|Stage 2|Psychiatrist decision to try new tx|0
7578066|NCT02158533|26356741|P6|Stage 2|Pregnancy|0
7578067|NCT02158533|26356742|P5|Stage 2|Pregnancy|0
7578068|NCT02158533|26356743|P4|Stage 2|Pregnancy|1
7578069|NCT02158533|26356744|P3|Stage 2|Pregnancy|0
7578070|NCT02158533|26356745|P2|Stage 2|Pregnancy|0
7578071|NCT02158533|26356746|P1|Stage 2|Pregnancy|0
7578072|NCT02158533|26356741|P6|Stage 2|Physician Decision|0
7578073|NCT02158533|26356742|P5|Stage 2|Physician Decision|1
7578074|NCT02158533|26356743|P4|Stage 2|Physician Decision|0
7578075|NCT02158533|26356744|P3|Stage 2|Physician Decision|0
7578076|NCT02158533|26356745|P2|Stage 2|Physician Decision|0
7578077|NCT02158533|26356746|P1|Stage 2|Physician Decision|0
7578078|NCT02158533|26356741|P6|Stage 2|Withdrawal by Subject|2
7578079|NCT02158533|26356742|P5|Stage 2|Withdrawal by Subject|1
7578080|NCT02158533|26356743|P4|Stage 2|Withdrawal by Subject|0
7578081|NCT02158533|26356744|P3|Stage 2|Withdrawal by Subject|0
7578082|NCT02158533|26356745|P2|Stage 2|Withdrawal by Subject|0
7578083|NCT02158533|26356746|P1|Stage 2|Withdrawal by Subject|0
7578084|NCT02158533|26356741|P6|Stage 2|Lost to Follow-up|2
7578085|NCT02158533|26356742|P5|Stage 2|Lost to Follow-up|1
7578086|NCT02158533|26356743|P4|Stage 2|Lost to Follow-up|1
7578087|NCT02158533|26356744|P3|Stage 2|Lost to Follow-up|0
7578088|NCT02158533|26356745|P2|Stage 2|Lost to Follow-up|0
7578089|NCT02158533|26356746|P1|Stage 2|Lost to Follow-up|0
7578090|NCT02158533|26356741|P6|Stage 2|Lack of Efficacy|0
7578091|NCT02158533|26356742|P5|Stage 2|Lack of Efficacy|1
7578092|NCT02158533|26356743|P4|Stage 2|Lack of Efficacy|0
7578093|NCT02158533|26356744|P3|Stage 2|Lack of Efficacy|0
7578094|NCT02158533|26356745|P2|Stage 2|Lack of Efficacy|0
7578095|NCT02158533|26356746|P1|Stage 2|Lack of Efficacy|0
7578096|NCT02158533|26356741|P6|Stage 2|Adverse Event|1
7578097|NCT02158533|26356742|P5|Stage 2|Adverse Event|0
7578098|NCT02158533|26356743|P4|Stage 2|Adverse Event|0
7578099|NCT02158533|26356744|P3|Stage 2|Adverse Event|0
7578100|NCT02158533|26356745|P2|Stage 2|Adverse Event|0
7578101|NCT02158533|26356746|P1|Stage 2|Adverse Event|0
7578102|NCT02158533|26356741|P6|Stage 1|Non-compliance with study visits|0
7578103|NCT02158533|26356742|P5|Stage 1|Non-compliance with study visits|0
7578104|NCT02158533|26356743|P4|Stage 1|Non-compliance with study visits|0
7578105|NCT02158533|26356744|P3|Stage 1|Non-compliance with study visits|0
7578106|NCT02158533|26356745|P2|Stage 1|Non-compliance with study visits|0
7578107|NCT02158533|26356746|P1|Stage 1|Non-compliance with study visits|1
7578108|NCT02158533|26356741|P6|Stage 1|Failure to Meet Eligibility Criteria|0
7578109|NCT02158533|26356742|P5|Stage 1|Failure to Meet Eligibility Criteria|0
7578110|NCT02158533|26356743|P4|Stage 1|Failure to Meet Eligibility Criteria|0
7578111|NCT02158533|26356744|P3|Stage 1|Failure to Meet Eligibility Criteria|0
7578112|NCT02158533|26356745|P2|Stage 1|Failure to Meet Eligibility Criteria|1
7578113|NCT02158533|26356746|P1|Stage 1|Failure to Meet Eligibility Criteria|0
7578114|NCT02158533|26356741|P6|Stage 1|Lost to Follow-up|0
7578115|NCT02158533|26356742|P5|Stage 1|Lost to Follow-up|0
7578116|NCT02158533|26356743|P4|Stage 1|Lost to Follow-up|0
7578117|NCT02158533|26356744|P3|Stage 1|Lost to Follow-up|0
7578118|NCT02158533|26356745|P2|Stage 1|Lost to Follow-up|1
7578119|NCT02158533|26356746|P1|Stage 1|Lost to Follow-up|3
7578120|NCT02158533|26356741|P6|Stage 1|Lack of Efficacy|0
7578121|NCT02158533|26356742|P5|Stage 1|Lack of Efficacy|0
7578122|NCT02158533|26356743|P4|Stage 1|Lack of Efficacy|0
7578123|NCT02158533|26356744|P3|Stage 1|Lack of Efficacy|0
7578124|NCT02158533|26356745|P2|Stage 1|Lack of Efficacy|0
7578125|NCT02158533|26356746|P1|Stage 1|Lack of Efficacy|1
7578126|NCT02158533|26356741|P6|Stage 1|Withdrawal by Subject|0
7578127|NCT02158533|26356742|P5|Stage 1|Withdrawal by Subject|0
7578128|NCT02158533|26356743|P4|Stage 1|Withdrawal by Subject|0
7578129|NCT02158533|26356744|P3|Stage 1|Withdrawal by Subject|1
7578130|NCT02158533|26356745|P2|Stage 1|Withdrawal by Subject|2
7578131|NCT02158533|26356746|P1|Stage 1|Withdrawal by Subject|3
7578132|NCT02158533|26356741|P6|Stage 1|Adverse Event|0
7578133|NCT02158533|26356742|P5|Stage 1|Adverse Event|0
7578134|NCT02158533|26356743|P4|Stage 1|Adverse Event|0
7578135|NCT02158533|26356744|P3|Stage 1|Adverse Event|7
7578136|NCT02158533|26356745|P2|Stage 1|Adverse Event|4
7578137|NCT02158533|26356746|P1|Stage 1|Adverse Event|6
7578138|NCT02158442|26356822|P2|Overall Study|Perfusion staff not available|0
7578139|NCT02158442|26356823|P1|Overall Study|Perfusion staff not available|1
7578140|NCT02158442|26356822|P2|Overall Study|Withdrawal by Subject|0
7578141|NCT02158442|26356823|P1|Overall Study|Withdrawal by Subject|1
7578142|NCT02158364|26356829|P1|Overall Study|Protocol Deviation|50
7578143|NCT02158364|26356829|P1|Overall Study|Case report forms uncollected|10
7578144|NCT02158247|26356847|P1|Overall Study|Invisible vocal cords|5
7578145|NCT02158091|26356866|P3|Overall Study|DLT|0
7578146|NCT02158091|26356867|P2|Overall Study|DLT|1
7578147|NCT02158091|26356868|P1|Overall Study|DLT|2
7578148|NCT02158039|26356876|P1|Overall Study|Screen Failure|9
7578149|NCT02158039|26356876|P1|Overall Study|Withdrawal by Subject|1
7578150|NCT02157948|26356883|P2|Overall Study|Decision by Sponsor|1
7578151|NCT02157948|26356884|P1|Overall Study|Decision by Sponsor|0
7578152|NCT02157948|26356883|P2|Overall Study|Protocol Specified Criteria|1
7578153|NCT02157948|26356884|P1|Overall Study|Protocol Specified Criteria|2
7578154|NCT02157948|26356883|P2|Overall Study|Lost to Follow-up|2
7578155|NCT02157948|26356884|P1|Overall Study|Lost to Follow-up|3
7578156|NCT02157948|26356883|P2|Overall Study|Withdrawal by Subject|5
7578157|NCT02157948|26356884|P1|Overall Study|Withdrawal by Subject|4
7578158|NCT02157935|26356896|P2|Overall Study|Adverse Event|5
7578159|NCT02157935|26356897|P1|Overall Study|Adverse Event|3
7578160|NCT02157935|26356896|P2|Overall Study|Death|4
7578161|NCT02157935|26356897|P1|Overall Study|Death|4
7578162|NCT02157935|26356896|P2|Overall Study|Lack of Efficacy|1
7578163|NCT02157935|26356897|P1|Overall Study|Lack of Efficacy|0
7578164|NCT02157935|26356896|P2|Overall Study|Other|12
7578165|NCT02157935|26356897|P1|Overall Study|Other|5
7578166|NCT02157935|26356896|P2|Overall Study|Progressive disease|2
7578167|NCT02157935|26356897|P1|Overall Study|Progressive disease|0
7578168|NCT02157935|26356896|P2|Overall Study|Protocol Violation|0
7578169|NCT02157935|26356897|P1|Overall Study|Protocol Violation|1
7578170|NCT02157935|26356896|P2|Overall Study|Screen failure|2
7578171|NCT02157935|26356897|P1|Overall Study|Screen failure|1
7578172|NCT02157935|26356896|P2|Overall Study|Withdrawal by Subject|39
7578173|NCT02157935|26356897|P1|Overall Study|Withdrawal by Subject|25
7578174|NCT02157883|26356923|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
7578175|NCT02157883|26356923|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
7578176|NCT02157883|26356923|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
7578177|NCT02157883|26356923|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
7578178|NCT02157883|26356923|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
7578179|NCT02157779|26356954|P2|Overall Study|Legal issue|0
7578180|NCT02157779|26356955|P1|Overall Study|Legal issue|1
7578181|NCT02157779|26356954|P2|Overall Study|Medical|0
7578182|NCT02157779|26356955|P1|Overall Study|Medical|1
7578183|NCT02157779|26356954|P2|Overall Study|Moved|0
7578184|NCT02157779|26356955|P1|Overall Study|Moved|1
7578185|NCT02157779|26356954|P2|Overall Study|No response to outreach after Baseline|1
7578186|NCT02157779|26356955|P1|Overall Study|No response to outreach after Baseline|1
7578187|NCT02157779|26356954|P2|Overall Study|Stopped attending, reason unknown|7
7578188|NCT02157779|26356955|P1|Overall Study|Stopped attending, reason unknown|11
7578189|NCT02157779|26356954|P2|Overall Study|Logistical|3
7578190|NCT02157779|26356955|P1|Overall Study|Logistical|9
7578191|NCT02157519|26356989|P2|Overall Study|Lost to Follow-up|0
7578192|NCT02157519|26356990|P1|Overall Study|Lost to Follow-up|1
7578193|NCT02157519|26356989|P2|Overall Study|Withdrawal by Subject|0
7578194|NCT02157519|26356990|P1|Overall Study|Withdrawal by Subject|7
7578195|NCT02157519|26356989|P2|Overall Study|Death|1
7578196|NCT02157519|26356990|P1|Overall Study|Death|3
7578197|NCT02157506|26357013|P5|Overall Study|Lost to Follow-up|0
7578198|NCT02157506|26357014|P4|Overall Study|Lost to Follow-up|0
7578199|NCT02157506|26357015|P3|Overall Study|Lost to Follow-up|1
7578200|NCT02157506|26357016|P2|Overall Study|Lost to Follow-up|0
7578201|NCT02157506|26357017|P1|Overall Study|Lost to Follow-up|0
7578202|NCT02157506|26357013|P5|Overall Study|Adverse Event|0
7578203|NCT02157506|26357014|P4|Overall Study|Adverse Event|0
7578204|NCT02157506|26357015|P3|Overall Study|Adverse Event|0
7578205|NCT02157506|26357016|P2|Overall Study|Adverse Event|1
7578206|NCT02157506|26357017|P1|Overall Study|Adverse Event|0
7578207|NCT02157376|26357076|P2|Overall Study|Investigator's misjudgement|2
7578208|NCT02157376|26357077|P1|Overall Study|Investigator's misjudgement|1
7578209|NCT02157376|26357076|P2|Overall Study|Not treated|3
7578210|NCT02157376|26357077|P1|Overall Study|Not treated|8
7578211|NCT02157376|26357076|P2|Overall Study|Withdrawal by Subject|8
7578212|NCT02157376|26357077|P1|Overall Study|Withdrawal by Subject|3
7578213|NCT02157376|26357076|P2|Overall Study|Eligibility criteria not fulfilled|1
7578214|NCT02157376|26357077|P1|Overall Study|Eligibility criteria not fulfilled|0
7578215|NCT02157376|26357076|P2|Overall Study|Death|4
7578216|NCT02157376|26357077|P1|Overall Study|Death|10
7578217|NCT02157298|26357087|P2|Overall Study|Withdrawal by Subject|0
7578218|NCT02157298|26357088|P1|Overall Study|Withdrawal by Subject|1
7578219|NCT02157298|26357087|P2|Overall Study|Poor/Non-compliance|0
7578220|NCT02157298|26357088|P1|Overall Study|Poor/Non-compliance|1
7578221|NCT02157298|26357087|P2|Overall Study|Subject no longer meets study criteria|2
7578222|NCT02157298|26357088|P1|Overall Study|Subject no longer meets study criteria|1
7578223|NCT02157298|26357087|P2|Overall Study|Adverse Event|0
7578224|NCT02157298|26357088|P1|Overall Study|Adverse Event|1
7578225|NCT02157116|26357127|P1|Overall Study|Failed Screening|2
7578226|NCT02157116|26357127|P1|Overall Study|Physician Decision|3
7578227|NCT02157116|26357127|P1|Overall Study|Withdrawal by Subject|4
7578228|NCT02156804|26357153|P1|Overall Study|Withdrawal by Subject|1
7578229|NCT02156492|26357195|P3|Period 3|Adverse Event|0
7578230|NCT02156492|26357196|P2|Period 3|Adverse Event|1
7578231|NCT02156492|26357197|P1|Period 3|Adverse Event|0
7578232|NCT02156492|26357195|P3|Period 1|No Reason Given|0
7578233|NCT02156492|26357196|P2|Period 1|No Reason Given|1
7578234|NCT02156492|26357197|P1|Period 1|No Reason Given|0
7578235|NCT02156466|26357223|P5|Overall Study|Quantiferon Positivity|0
7578236|NCT02156466|26357224|P4|Overall Study|Quantiferon Positivity|1
7578237|NCT02156466|26357225|P3|Overall Study|Quantiferon Positivity|0
7578238|NCT02156466|26357226|P2|Overall Study|Quantiferon Positivity|0
7578239|NCT02156466|26357227|P1|Overall Study|Quantiferon Positivity|0
7578240|NCT02156466|26357223|P5|Overall Study|Adverse Event|0
7578241|NCT02156466|26357224|P4|Overall Study|Adverse Event|1
7578242|NCT02156466|26357225|P3|Overall Study|Adverse Event|1
7578243|NCT02156466|26357226|P2|Overall Study|Adverse Event|0
7578244|NCT02156466|26357227|P1|Overall Study|Adverse Event|0
7578245|NCT02156271|26357408|P2|Overall Study|Physician Decision|3
7578246|NCT02156271|26357409|P1|Overall Study|Physician Decision|4
7578247|NCT02156076|26357489|P4|Follow-up Period|Withdrawal by Subject|0
7578248|NCT02156076|26357490|P3|Follow-up Period|Withdrawal by Subject|0
7578249|NCT02156076|26357491|P2|Follow-up Period|Withdrawal by Subject|0
7578250|NCT02156076|26357492|P1|Follow-up Period|Withdrawal by Subject|1
7578251|NCT02156076|26357489|P4|Treatment Period|Adverse Event|1
7578252|NCT02156076|26357490|P3|Treatment Period|Adverse Event|0
7578253|NCT02156076|26357491|P2|Treatment Period|Adverse Event|0
7578254|NCT02156076|26357492|P1|Treatment Period|Adverse Event|0
7578255|NCT02156076|26357489|P4|Treatment Period|Subject request to discontinue treatment|0
7578256|NCT02156076|26357490|P3|Treatment Period|Subject request to discontinue treatment|0
7578257|NCT02156076|26357491|P2|Treatment Period|Subject request to discontinue treatment|1
7578258|NCT02156076|26357492|P1|Treatment Period|Subject request to discontinue treatment|0
7578259|NCT02156076|26357489|P4|Treatment Period|Withdrawal by Subject|0
7578260|NCT02156076|26357490|P3|Treatment Period|Withdrawal by Subject|1
7578261|NCT02156076|26357491|P2|Treatment Period|Withdrawal by Subject|0
7578262|NCT02156076|26357492|P1|Treatment Period|Withdrawal by Subject|0
7578263|NCT02156076|26357489|P4|Treatment Period|Lost to Follow-up|1
7578264|NCT02156076|26357490|P3|Treatment Period|Lost to Follow-up|0
7578265|NCT02156076|26357491|P2|Treatment Period|Lost to Follow-up|0
7578266|NCT02156076|26357492|P1|Treatment Period|Lost to Follow-up|0
7578267|NCT02156076|26357489|P4|Treatment Period|Poor/non-compliance|0
7578268|NCT02156076|26357490|P3|Treatment Period|Poor/non-compliance|0
7578269|NCT02156076|26357491|P2|Treatment Period|Poor/non-compliance|1
7578270|NCT02156076|26357492|P1|Treatment Period|Poor/non-compliance|0
7578271|NCT02156076|26357489|P4|Treatment Period|no longer meets study criteria|0
7578272|NCT02156076|26357490|P3|Treatment Period|no longer meets study criteria|1
7578273|NCT02156076|26357491|P2|Treatment Period|no longer meets study criteria|0
7578274|NCT02156076|26357492|P1|Treatment Period|no longer meets study criteria|0
7578275|NCT02155985|26357549|P3|Overall Study|Lost to Follow-up|0
7578276|NCT02155985|26357550|P2|Overall Study|Lost to Follow-up|0
7578277|NCT02155985|26357551|P1|Overall Study|Lost to Follow-up|1
7578278|NCT02155985|26357549|P3|Overall Study|Withdrawal by Subject|1
7578279|NCT02155985|26357550|P2|Overall Study|Withdrawal by Subject|0
7578280|NCT02155985|26357551|P1|Overall Study|Withdrawal by Subject|0
7578281|NCT02155881|26357618|P2|Overall Study|Inappropriately randomized|2
7578282|NCT02155881|26357619|P1|Overall Study|Inappropriately randomized|2
7578283|NCT02155881|26357618|P2|Overall Study|Withdrawal by Subject|2
7578284|NCT02155881|26357619|P1|Overall Study|Withdrawal by Subject|0
7578285|NCT02155829|26357641|P2|Overall Study|Protocol Violation|0
7578286|NCT02155829|26357642|P1|Overall Study|Protocol Violation|2
7578287|NCT02155829|26357641|P2|Overall Study|Withdrawal by Subject|3
7578288|NCT02155829|26357642|P1|Overall Study|Withdrawal by Subject|3
7578289|NCT02155829|26357641|P2|Overall Study|Adverse Event|0
7578290|NCT02155829|26357642|P1|Overall Study|Adverse Event|1
7578291|NCT02155738|26357664|P4|Overall Study|Missing critical information|1
7578292|NCT02155738|26357665|P3|Overall Study|Missing critical information|0
7578293|NCT02155738|26357666|P2|Overall Study|Missing critical information|0
7578294|NCT02155738|26357667|P1|Overall Study|Missing critical information|1
7578305|NCT02155660|26357715|P4|Overall Study|Withdrawal by Subject|21
7578306|NCT02155660|26357716|P3|Overall Study|Withdrawal by Subject|24
7578307|NCT02155660|26357717|P2|Overall Study|Withdrawal by Subject|31
7578308|NCT02155660|26357718|P1|Overall Study|Withdrawal by Subject|28
7578309|NCT02155660|26357715|P4|Overall Study|Death|19
7578310|NCT02155660|26357716|P3|Overall Study|Death|17
7578311|NCT02155660|26357717|P2|Overall Study|Death|19
7578312|NCT02155660|26357718|P1|Overall Study|Death|17
7578313|NCT02155660|26357715|P4|Overall Study|Lost to Follow-up|8
7578314|NCT02155660|26357716|P3|Overall Study|Lost to Follow-up|5
7578315|NCT02155660|26357717|P2|Overall Study|Lost to Follow-up|6
7578316|NCT02155660|26357718|P1|Overall Study|Lost to Follow-up|3
7578317|NCT02155660|26357715|P4|Overall Study|Adverse Event|1
7578318|NCT02155660|26357716|P3|Overall Study|Adverse Event|3
7578319|NCT02155660|26357717|P2|Overall Study|Adverse Event|6
7578320|NCT02155660|26357718|P1|Overall Study|Adverse Event|2
7578321|NCT02155660|26357715|P4|Overall Study|Severe non-compliance|1
7578322|NCT02155660|26357716|P3|Overall Study|Severe non-compliance|0
7578323|NCT02155660|26357717|P2|Overall Study|Severe non-compliance|4
7578324|NCT02155660|26357718|P1|Overall Study|Severe non-compliance|0
7578325|NCT02155660|26357715|P4|Overall Study|Study-specific withdrawal criteria|1
7578326|NCT02155660|26357716|P3|Overall Study|Study-specific withdrawal criteria|1
7578327|NCT02155660|26357717|P2|Overall Study|Study-specific withdrawal criteria|1
7578328|NCT02155660|26357718|P1|Overall Study|Study-specific withdrawal criteria|0
7578329|NCT02155660|26357715|P4|Overall Study|Other Reason|10
7578330|NCT02155660|26357716|P3|Overall Study|Other Reason|10
7578331|NCT02155660|26357717|P2|Overall Study|Other Reason|6
7578332|NCT02155660|26357718|P1|Overall Study|Other Reason|8
7578333|NCT02155647|26357801|P2|Overall Study|Off-Treatment, but follow up ongoing|26
7578334|NCT02155647|26357802|P1|Overall Study|Off-Treatment, but follow up ongoing|15
7578335|NCT02155647|26357801|P2|Overall Study|Still on Treatment|26
7578336|NCT02155647|26357802|P1|Overall Study|Still on Treatment|26
7578337|NCT02155608|26357830|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7578338|NCT02155608|26357831|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7578339|NCT02155608|26357830|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
7578340|NCT02155608|26357831|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
7578341|NCT02155322|26357928|P1|Overall Study|Withdrawal by Subject|4
7578342|NCT02155322|26357928|P1|Overall Study|Relapse/Recurrence|8
7578343|NCT02155322|26357928|P1|Overall Study|Physician Decision|1
7578344|NCT02155322|26357928|P1|Overall Study|Adverse Event|1
7578345|NCT02155309|26357935|P3|Overall Study|Protocol Violation|1
7578346|NCT02155309|26357936|P2|Overall Study|Protocol Violation|0
7578347|NCT02155309|26357937|P1|Overall Study|Protocol Violation|0
7578348|NCT02155283|26357944|P1|Overall Study|Protocol Violation|3
7578349|NCT02155283|26357944|P1|Overall Study|Withdrawal by Subject|1
7578350|NCT02155283|26357944|P1|Overall Study|Lost to Follow-up|3
7578351|NCT02154581|26358124|P2|Overall Study|Lost to Follow-up|8
7578352|NCT02154581|26358125|P1|Overall Study|Lost to Follow-up|7
7578353|NCT02154425|26358150|P1|Screening Period|Adverse Event|1
7578354|NCT02154347|26358195|P2|Open-label Period|Withdrawal by Subject|1
7578355|NCT02154347|26358196|P1|Open-label Period|Withdrawal by Subject|0
7578356|NCT02154347|26358195|P2|Open-label Period|Protocol Violation|1
7578357|NCT02154347|26358196|P1|Open-label Period|Protocol Violation|0
7578358|NCT02154347|26358195|P2|Open-label Period|Lack of Efficacy|19
7578359|NCT02154347|26358196|P1|Open-label Period|Lack of Efficacy|4
7578360|NCT02154347|26358195|P2|Open-label Period|Adverse Event|4
7578361|NCT02154347|26358196|P1|Open-label Period|Adverse Event|3
7578362|NCT02154347|26358195|P2|Double-blind Period|Withdrawal by Subject|1
7578363|NCT02154347|26358196|P1|Double-blind Period|Withdrawal by Subject|1
7578364|NCT02154347|26358195|P2|Double-blind Period|Physician Decision|1
7578365|NCT02154347|26358196|P1|Double-blind Period|Physician Decision|0
7578366|NCT02154347|26358195|P2|Double-blind Period|Lack of Efficacy|0
7578367|NCT02154347|26358196|P1|Double-blind Period|Lack of Efficacy|1
7578368|NCT02154347|26358195|P2|Double-blind Period|Adverse Event|2
7578369|NCT02154347|26358196|P1|Double-blind Period|Adverse Event|1
7578370|NCT02154139|26358219|P1|Overall Study|Investigator transferred|3
7578371|NCT02154139|26358219|P1|Overall Study|Other|2
7578372|NCT02154139|26358219|P1|Overall Study|Injection not administered|2
7578373|NCT02154087|26358227|P1|Overall Study|Study Termination|1
7578374|NCT02154061|26358233|P2|Overall Study|enrolled but not vaccinated|0
7578375|NCT02154061|26358234|P1|Overall Study|enrolled but not vaccinated|1
7578376|NCT02154061|26358233|P2|Overall Study|Pregnancy|0
7578377|NCT02154061|26358234|P1|Overall Study|Pregnancy|1
7578378|NCT02153918|26358281|P1|Overall Study|Refused further treatment|1
7578379|NCT02153905|26358292|P2|Overall Study|Death|0
7578380|NCT02153905|26358293|P1|Overall Study|Death|1
7578381|NCT02153827|26358311|P2|Overall Study|Lost to Follow-up|9
7578382|NCT02153827|26358312|P1|Overall Study|Lost to Follow-up|3
7578383|NCT02153788|26358328|P2|Overall Study|Physician Decision|1
7578384|NCT02153788|26358329|P1|Overall Study|Physician Decision|2
7578385|NCT02153736|26358349|P2|Overall Study|Withdrawal by Subject|1
7578386|NCT02153736|26358350|P1|Overall Study|Withdrawal by Subject|0
7578387|NCT02153736|26358349|P2|Overall Study|Death|1
7578388|NCT02153736|26358350|P1|Overall Study|Death|0
7578389|NCT02153736|26358349|P2|Overall Study|Medical status change made ineligible|0
7578390|NCT02153736|26358350|P1|Overall Study|Medical status change made ineligible|1
7578391|NCT02153736|26358349|P2|Overall Study|Lost to Follow-up|0
7578392|NCT02153736|26358350|P1|Overall Study|Lost to Follow-up|1
7578393|NCT02153398|26358577|P5|Overall Study|Adverse Event|0
7578394|NCT02153398|26358578|P4|Overall Study|Adverse Event|1
7578395|NCT02153398|26358579|P3|Overall Study|Adverse Event|1
7578396|NCT02153398|26358580|P2|Overall Study|Adverse Event|0
7578397|NCT02153398|26358581|P1|Overall Study|Adverse Event|0
7578398|NCT02153398|26358577|P5|Overall Study|Withdrawal by Subject|0
7578399|NCT02153398|26358578|P4|Overall Study|Withdrawal by Subject|0
7578400|NCT02153398|26358579|P3|Overall Study|Withdrawal by Subject|0
7578401|NCT02153398|26358580|P2|Overall Study|Withdrawal by Subject|0
7578402|NCT02153398|26358581|P1|Overall Study|Withdrawal by Subject|1
7578403|NCT02153359|26358703|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
7578404|NCT02153359|26358704|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
7578405|NCT02153346|26358738|P1|Overall Study|Lost to Follow-up|11
7578406|NCT02153112|26358755|P10|Overall Study|Reason not Specified|1
7578407|NCT02153112|26358756|P9|Overall Study|Reason not Specified|1
7578408|NCT02153112|26358757|P8|Overall Study|Reason not Specified|0
7578409|NCT02153112|26358758|P7|Overall Study|Reason not Specified|0
7578410|NCT02153112|26358759|P6|Overall Study|Reason not Specified|0
7578411|NCT02153112|26358760|P5|Overall Study|Reason not Specified|0
7578412|NCT02153112|26358761|P4|Overall Study|Reason not Specified|0
7578413|NCT02153112|26358762|P3|Overall Study|Reason not Specified|0
7578414|NCT02153112|26358763|P2|Overall Study|Reason not Specified|0
7578415|NCT02153112|26358764|P1|Overall Study|Reason not Specified|0
7578416|NCT02153112|26358755|P10|Overall Study|Withdrawal by Subject|12
7578417|NCT02153112|26358756|P9|Overall Study|Withdrawal by Subject|13
7578418|NCT02153112|26358757|P8|Overall Study|Withdrawal by Subject|2
7578419|NCT02153112|26358758|P7|Overall Study|Withdrawal by Subject|7
7578420|NCT02153112|26358759|P6|Overall Study|Withdrawal by Subject|1
7578421|NCT02153112|26358760|P5|Overall Study|Withdrawal by Subject|1
7578422|NCT02153112|26358761|P4|Overall Study|Withdrawal by Subject|2
7578423|NCT02153112|26358762|P3|Overall Study|Withdrawal by Subject|2
7578424|NCT02153112|26358763|P2|Overall Study|Withdrawal by Subject|1
7578425|NCT02153112|26358764|P1|Overall Study|Withdrawal by Subject|3
7578426|NCT02153112|26358755|P10|Overall Study|Lost to Follow-up|1
7578427|NCT02153112|26358756|P9|Overall Study|Lost to Follow-up|1
7578428|NCT02153112|26358757|P8|Overall Study|Lost to Follow-up|0
7578429|NCT02153112|26358758|P7|Overall Study|Lost to Follow-up|1
7578430|NCT02153112|26358759|P6|Overall Study|Lost to Follow-up|1
7578431|NCT02153112|26358760|P5|Overall Study|Lost to Follow-up|2
7578432|NCT02153112|26358761|P4|Overall Study|Lost to Follow-up|0
7578433|NCT02153112|26358762|P3|Overall Study|Lost to Follow-up|0
7578434|NCT02153112|26358763|P2|Overall Study|Lost to Follow-up|1
7578435|NCT02153112|26358764|P1|Overall Study|Lost to Follow-up|1
7578436|NCT02153112|26358755|P10|Overall Study|Adverse Event|0
7578437|NCT02153112|26358756|P9|Overall Study|Adverse Event|0
7578438|NCT02153112|26358757|P8|Overall Study|Adverse Event|0
7578439|NCT02153112|26358758|P7|Overall Study|Adverse Event|0
7578440|NCT02153112|26358759|P6|Overall Study|Adverse Event|0
7578441|NCT02153112|26358760|P5|Overall Study|Adverse Event|0
7578442|NCT02153112|26358761|P4|Overall Study|Adverse Event|0
7578443|NCT02153112|26358762|P3|Overall Study|Adverse Event|1
7578444|NCT02153112|26358763|P2|Overall Study|Adverse Event|0
7578445|NCT02153112|26358764|P1|Overall Study|Adverse Event|0
7578446|NCT02153086|26359103|P1|Overall Study|Other|2
7578447|NCT02153086|26359103|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
7578448|NCT02153073|26359117|P1|Overall Study|Protocol Deviation|68
7578449|NCT02153073|26359117|P1|Overall Study|Case Report Forms Uncollected|230
7578450|NCT02152761|26359145|P4|Epoch: Post-treatment Follow-up Epoch|Death|1
7578451|NCT02152761|26359146|P3|Epoch: Post-treatment Follow-up Epoch|Death|0
7578452|NCT02152761|26359147|P2|Epoch: Post-treatment Follow-up Epoch|Death|0
7578453|NCT02152761|26359148|P1|Epoch: Post-treatment Follow-up Epoch|Death|1
7578454|NCT02152761|26359145|P4|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7578455|NCT02152761|26359146|P3|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7578456|NCT02152761|26359147|P2|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7578457|NCT02152761|26359148|P1|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
7578458|NCT02152761|26359145|P4|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7578459|NCT02152761|26359146|P3|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7578460|NCT02152761|26359147|P2|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
7578461|NCT02152761|26359148|P1|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
7578462|NCT02152761|26359145|P4|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7578463|NCT02152761|26359146|P3|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
7578464|NCT02152761|26359147|P2|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
7578465|NCT02152761|26359148|P1|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7578466|NCT02152761|26359145|P4|Epoch: Treatment Epoch|Non-compliance with treatment|0
7578467|NCT02152761|26359146|P3|Epoch: Treatment Epoch|Non-compliance with treatment|0
7578468|NCT02152761|26359147|P2|Epoch: Treatment Epoch|Non-compliance with treatment|1
7578469|NCT02152761|26359148|P1|Epoch: Treatment Epoch|Non-compliance with treatment|1
7578470|NCT02152761|26359145|P4|Epoch: Treatment Epoch|Death|0
7578471|NCT02152761|26359146|P3|Epoch: Treatment Epoch|Death|1
7578472|NCT02152761|26359147|P2|Epoch: Treatment Epoch|Death|3
7578473|NCT02152761|26359148|P1|Epoch: Treatment Epoch|Death|0
7578474|NCT02152761|26359145|P4|Epoch: Treatment Epoch|Adverse Event|2
7578475|NCT02152761|26359146|P3|Epoch: Treatment Epoch|Adverse Event|1
7578476|NCT02152761|26359147|P2|Epoch: Treatment Epoch|Adverse Event|6
7578477|NCT02152761|26359148|P1|Epoch: Treatment Epoch|Adverse Event|3
7578478|NCT02152761|26359145|P4|Epoch: Treatment Epoch|Withdrawal by Subject|5
7578479|NCT02152761|26359146|P3|Epoch: Treatment Epoch|Withdrawal by Subject|3
7578480|NCT02152761|26359147|P2|Epoch: Treatment Epoch|Withdrawal by Subject|8
7578481|NCT02152761|26359148|P1|Epoch: Treatment Epoch|Withdrawal by Subject|7
7578482|NCT02152761|26359145|P4|Epoch: Treatment Epoch|Lost to Follow-up|0
7578483|NCT02152761|26359146|P3|Epoch: Treatment Epoch|Lost to Follow-up|0
7578484|NCT02152761|26359147|P2|Epoch: Treatment Epoch|Lost to Follow-up|2
7578485|NCT02152761|26359148|P1|Epoch: Treatment Epoch|Lost to Follow-up|0
7578486|NCT02152761|26359145|P4|Epoch: Treatment Epoch|Technical problems|1
7578487|NCT02152761|26359146|P3|Epoch: Treatment Epoch|Technical problems|0
7578488|NCT02152761|26359147|P2|Epoch: Treatment Epoch|Technical problems|0
7578489|NCT02152761|26359148|P1|Epoch: Treatment Epoch|Technical problems|0
7578490|NCT02152631|26359188|P2|Overall Study|On Treatment|3
7578491|NCT02152631|26359189|P1|Overall Study|On Treatment|19
7578492|NCT02152631|26359188|P2|Overall Study|Lost to Follow-up|1
7578493|NCT02152631|26359189|P1|Overall Study|Lost to Follow-up|0
7578494|NCT02152631|26359188|P2|Overall Study|Physician Decision|2
7578495|NCT02152631|26359189|P1|Overall Study|Physician Decision|1
7578496|NCT02152631|26359188|P2|Overall Study|Noncompliance with study drug|0
7578497|NCT02152631|26359189|P1|Overall Study|Noncompliance with study drug|1
7578498|NCT02152631|26359188|P2|Overall Study|Withdrawal by Subject|16
7578499|NCT02152631|26359189|P1|Overall Study|Withdrawal by Subject|13
7578500|NCT02152631|26359188|P2|Overall Study|Adverse Event|4
7578501|NCT02152631|26359189|P1|Overall Study|Adverse Event|32
7578502|NCT02152605|26359208|P2|Overall Study|Withdrew consent|2
7578503|NCT02152605|26359209|P1|Overall Study|Withdrew consent|4
7578504|NCT02152605|26359208|P2|Overall Study|Lost to Follow-up|0
7578505|NCT02152605|26359209|P1|Overall Study|Lost to Follow-up|1
7578506|NCT02152605|26359208|P2|Overall Study|Protocol deviation|4
7578507|NCT02152605|26359209|P1|Overall Study|Protocol deviation|1
7578508|NCT02152605|26359208|P2|Overall Study|Lack of Efficacy|4
7578509|NCT02152605|26359209|P1|Overall Study|Lack of Efficacy|7
7578510|NCT02152605|26359208|P2|Overall Study|Adverse Event|8
7578511|NCT02152605|26359209|P1|Overall Study|Adverse Event|6
7578512|NCT02152566|26359219|P1|Overall Study|Withdrawal by Subject|2
7578513|NCT02152566|26359219|P1|Overall Study|Lost to Follow-up|1
7578514|NCT02152384|26359242|P2|Period 1|Adverse Event|1
7578515|NCT02152384|26359243|P1|Period 1|Adverse Event|1
7578516|NCT02152384|26359242|P2|Period 1|Withdrawal by Subject|1
7578517|NCT02152384|26359243|P1|Period 1|Withdrawal by Subject|0
7578518|NCT02152371|26359263|P2|Overall Study|Reason Not Given|1
7578519|NCT02152371|26359264|P1|Overall Study|Reason Not Given|0
7578520|NCT02152371|26359263|P2|Overall Study|Physician Decision|2
7578521|NCT02152371|26359264|P1|Overall Study|Physician Decision|0
7578522|NCT02152371|26359263|P2|Overall Study|Lack of Efficacy|1
7578523|NCT02152371|26359264|P1|Overall Study|Lack of Efficacy|0
7578524|NCT02152371|26359263|P2|Overall Study|Lost to Follow-up|0
7578525|NCT02152371|26359264|P1|Overall Study|Lost to Follow-up|1
7578526|NCT02152371|26359263|P2|Overall Study|Protocol Violation|3
7578527|NCT02152371|26359264|P1|Overall Study|Protocol Violation|2
7578528|NCT02152371|26359263|P2|Overall Study|Withdrawal by Subject|7
7578529|NCT02152371|26359264|P1|Overall Study|Withdrawal by Subject|3
7578530|NCT02152371|26359263|P2|Overall Study|Adverse Event|2
7578531|NCT02152371|26359264|P1|Overall Study|Adverse Event|6
7578532|NCT02152345|26359302|P2|Overall Study|Withdrawal by Subject|1
7578533|NCT02152345|26359303|P1|Overall Study|Withdrawal by Subject|2
7578534|NCT02152345|26359302|P2|Overall Study|Case Cancellations|4
7578535|NCT02152345|26359303|P1|Overall Study|Case Cancellations|2
7578536|NCT02152163|26359317|P2|Overall Study|Physician Decision|13
7578537|NCT02152163|26359318|P1|Overall Study|Physician Decision|12
7578538|NCT02152137|26359324|P1|Overall Study|Originally assigned to Arm B|3
7578539|NCT02152137|26359324|P1|Overall Study|Withdrawal by Subject|1
7578540|NCT02152007|26359345|P1|Overall Study|Withdrawal by Subject|1
7578541|NCT02151981|26359406|P2|Overall Study|Study terminated|1
7578542|NCT02151981|26359407|P1|Overall Study|Study terminated|0
7578543|NCT02151981|26359406|P2|Overall Study|Unwilling to continue to follow up visit|1
7578544|NCT02151981|26359407|P1|Overall Study|Unwilling to continue to follow up visit|0
7578545|NCT02151981|26359406|P2|Overall Study|Patient had no clinical benefit|0
7578546|NCT02151981|26359407|P1|Overall Study|Patient had no clinical benefit|1
7578547|NCT02151981|26359406|P2|Overall Study|Eligibility criteria not fulfilled|1
7578548|NCT02151981|26359407|P1|Overall Study|Eligibility criteria not fulfilled|0
7578549|NCT02151981|26359406|P2|Overall Study|Ongoing Study at Data Cut-off|27
7578550|NCT02151981|26359407|P1|Overall Study|Ongoing Study at Data Cut-off|60
7578551|NCT02151981|26359406|P2|Overall Study|Withdrawal by Subject|21
7578552|NCT02151981|26359407|P1|Overall Study|Withdrawal by Subject|27
7578553|NCT02151981|26359406|P2|Overall Study|Lost to Follow-up|1
7578554|NCT02151981|26359407|P1|Overall Study|Lost to Follow-up|7
7578555|NCT02151981|26359406|P2|Overall Study|Death|88
7578556|NCT02151981|26359407|P1|Overall Study|Death|184
7578557|NCT02151903|26359429|P2|Overall Study|Progressive disease|1
7578558|NCT02151903|26359430|P1|Overall Study|Progressive disease|2
7578559|NCT02151903|26359429|P2|Overall Study|Withdrawal by Subject|0
7578560|NCT02151903|26359430|P1|Overall Study|Withdrawal by Subject|1
7578561|NCT02151851|26359467|P2|Overall Study|Adverse Event|28
7578562|NCT02151851|26359468|P1|Overall Study|Adverse Event|6
7578563|NCT02151851|26359467|P2|Overall Study|Subject entered into study in error|1
7578564|NCT02151851|26359468|P1|Overall Study|Subject entered into study in error|0
7578565|NCT02151851|26359467|P2|Overall Study|Low compliance to study visits|1
7578566|NCT02151851|26359468|P1|Overall Study|Low compliance to study visits|0
7578567|NCT02151851|26359467|P2|Overall Study|Medical impairment|0
7578568|NCT02151851|26359468|P1|Overall Study|Medical impairment|1
7578569|NCT02151851|26359467|P2|Overall Study|Withdrawal by Subject|5
7578570|NCT02151851|26359468|P1|Overall Study|Withdrawal by Subject|2
7578571|NCT02151851|26359467|P2|Overall Study|Protocol Violation|1
7578572|NCT02151851|26359468|P1|Overall Study|Protocol Violation|0
7578573|NCT02151851|26359467|P2|Overall Study|Lack of Efficacy|94
7578574|NCT02151851|26359468|P1|Overall Study|Lack of Efficacy|67
7578575|NCT02151786|26359480|P1|Overall Study|Unavailability of Information|8
7578576|NCT02151786|26359480|P1|Overall Study|Randomized, not Treated|1
7578577|NCT02151786|26359480|P1|Overall Study|Outside the Contract Period|1
7578578|NCT02151786|26359480|P1|Overall Study|Unavailability of Case Report Form|26
7578579|NCT02151773|26359491|P1|Overall Study|Protocol Deviation|64
7578580|NCT02151682|26359498|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
7578581|NCT02151682|26359499|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7578582|NCT02151682|26359500|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7578583|NCT02151682|26359501|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7578584|NCT02151682|26359502|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7578585|NCT02151682|26359503|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7578586|NCT02151682|26359498|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
7578587|NCT02151682|26359499|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7578588|NCT02151682|26359500|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7578589|NCT02151682|26359501|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7578590|NCT02151682|26359502|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7578591|NCT02151682|26359503|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7578592|NCT02151682|26359498|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
7578593|NCT02151682|26359499|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
7578594|NCT02151682|26359500|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
7578595|NCT02151682|26359501|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
7578596|NCT02151682|26359502|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
7578597|NCT02151682|26359503|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
7578598|NCT02151682|26359498|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
7578599|NCT02151682|26359499|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7578600|NCT02151682|26359500|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7578601|NCT02151682|26359501|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7578602|NCT02151682|26359502|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7578603|NCT02151682|26359503|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7578604|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7578605|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7578606|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7578607|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
7578608|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7578609|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7578610|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Various other|0
7578611|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Various other|0
7578612|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Various other|0
7578613|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Various other|6
7578614|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Various other|0
7578615|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Various other|0
7578616|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Missing|0
7578617|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Missing|0
7578618|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Missing|1
7578619|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Missing|0
7578620|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Missing|0
7578621|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Missing|0
7578622|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
7578623|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
7578624|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
7578625|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
7578626|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
7578627|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
7578628|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7578629|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7578630|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7578631|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
7578632|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7578633|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7578634|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7578635|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7578636|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7578637|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
7578638|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7578639|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7578640|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7578641|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7578642|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7578643|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7578644|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7578645|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7578646|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Death|0
7578647|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Death|0
7578648|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Death|2
7578649|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Death|0
7578650|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Death|0
7578651|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Death|0
7578652|NCT02151682|26359498|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
7578653|NCT02151682|26359499|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
7578654|NCT02151682|26359500|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
7578655|NCT02151682|26359501|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
7578656|NCT02151682|26359502|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
7578657|NCT02151682|26359503|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
7578658|NCT02151682|26359498|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7578659|NCT02151682|26359499|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7578660|NCT02151682|26359500|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7578661|NCT02151682|26359501|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7578662|NCT02151682|26359502|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7578663|NCT02151682|26359503|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
7578664|NCT02151682|26359498|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7578665|NCT02151682|26359499|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7578666|NCT02151682|26359500|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7578667|NCT02151682|26359501|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7578668|NCT02151682|26359502|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7578669|NCT02151682|26359503|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7578670|NCT02151682|26359498|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7578671|NCT02151682|26359499|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7578672|NCT02151682|26359500|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7578673|NCT02151682|26359501|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7578674|NCT02151682|26359502|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
7578675|NCT02151682|26359503|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7578676|NCT02151682|26359498|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7578677|NCT02151682|26359499|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7578678|NCT02151682|26359500|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7578679|NCT02151682|26359501|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7578680|NCT02151682|26359502|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
7578681|NCT02151682|26359503|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7578682|NCT02151682|26359498|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7578683|NCT02151682|26359499|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7578684|NCT02151682|26359500|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7578685|NCT02151682|26359501|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7578686|NCT02151682|26359502|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
7578687|NCT02151682|26359503|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7578688|NCT02151643|26359553|P5|Overall Study|High Ferritin levels|1
7578689|NCT02151643|26359554|P4|Overall Study|High Ferritin levels|2
7578690|NCT02151643|26359555|P3|Overall Study|High Ferritin levels|2
7578691|NCT02151643|26359556|P2|Overall Study|High Ferritin levels|3
7578692|NCT02151643|26359557|P1|Overall Study|High Ferritin levels|3
7578693|NCT02151643|26359553|P5|Overall Study|Hyperphosphataemia|1
7578694|NCT02151643|26359554|P4|Overall Study|Hyperphosphataemia|0
7578695|NCT02151643|26359555|P3|Overall Study|Hyperphosphataemia|0
7578696|NCT02151643|26359556|P2|Overall Study|Hyperphosphataemia|0
7578697|NCT02151643|26359557|P1|Overall Study|Hyperphosphataemia|1
7578698|NCT02151643|26359553|P5|Overall Study|Withdrawal by Subject|1
7578699|NCT02151643|26359554|P4|Overall Study|Withdrawal by Subject|1
7578700|NCT02151643|26359555|P3|Overall Study|Withdrawal by Subject|1
7578701|NCT02151643|26359556|P2|Overall Study|Withdrawal by Subject|1
7578702|NCT02151643|26359557|P1|Overall Study|Withdrawal by Subject|0
7578703|NCT02151643|26359553|P5|Overall Study|Adverse Event|0
7578704|NCT02151643|26359554|P4|Overall Study|Adverse Event|4
7578705|NCT02151643|26359555|P3|Overall Study|Adverse Event|1
7578706|NCT02151643|26359556|P2|Overall Study|Adverse Event|0
7578707|NCT02151643|26359557|P1|Overall Study|Adverse Event|2
7578708|NCT02151591|26359596|P2|Overall Study|Lost to Follow-up|3
7578709|NCT02151591|26359597|P1|Overall Study|Lost to Follow-up|6
7578710|NCT02151461|26359668|P4|Overall Study|Treatment discontinuation|0
7578711|NCT02151461|26359669|P3|Overall Study|Treatment discontinuation|1
7578712|NCT02151461|26359670|P2|Overall Study|Treatment discontinuation|0
7578713|NCT02151461|26359671|P1|Overall Study|Treatment discontinuation|0
7578714|NCT02151461|26359668|P4|Overall Study|Withdrawal by Subject|1
7578715|NCT02151461|26359669|P3|Overall Study|Withdrawal by Subject|1
7578716|NCT02151461|26359670|P2|Overall Study|Withdrawal by Subject|0
7578717|NCT02151461|26359671|P1|Overall Study|Withdrawal by Subject|1
7578718|NCT02151461|26359668|P4|Overall Study|Lost to Follow-up|1
7578719|NCT02151461|26359669|P3|Overall Study|Lost to Follow-up|1
7578720|NCT02151461|26359670|P2|Overall Study|Lost to Follow-up|0
7578721|NCT02151461|26359671|P1|Overall Study|Lost to Follow-up|0
7578722|NCT02151461|26359668|P4|Overall Study|Adverse Event|2
7578723|NCT02151461|26359669|P3|Overall Study|Adverse Event|0
7578724|NCT02151461|26359670|P2|Overall Study|Adverse Event|1
7578725|NCT02151461|26359671|P1|Overall Study|Adverse Event|5
7578726|NCT02151266|26359803|P3|Overall Study|Not able to exercise|4
7578727|NCT02151266|26359804|P2|Overall Study|Not able to exercise|5
7578728|NCT02151266|26359805|P1|Overall Study|Not able to exercise|4
7578729|NCT02151266|26359803|P3|Overall Study|Did NOT receive intervention|2
7578730|NCT02151266|26359804|P2|Overall Study|Did NOT receive intervention|6
7578731|NCT02151266|26359805|P1|Overall Study|Did NOT receive intervention|3
7578732|NCT02151266|26359803|P3|Overall Study|Lost to Follow-up|1
7578733|NCT02151266|26359804|P2|Overall Study|Lost to Follow-up|4
7578734|NCT02151266|26359805|P1|Overall Study|Lost to Follow-up|1
7578735|NCT02151149|26359848|P2|Follow-Up Period|Death|34
7578736|NCT02151149|26359849|P1|Follow-Up Period|Death|37
7578737|NCT02151149|26359848|P2|Follow-Up Period|Lost to Follow-up|3
7578738|NCT02151149|26359849|P1|Follow-Up Period|Lost to Follow-up|2
7578739|NCT02151149|26359848|P2|Treatment Period|Participants randomized but not treated|2
7578740|NCT02151149|26359849|P1|Treatment Period|Participants randomized but not treated|3
7578741|NCT02151149|26359848|P2|Treatment Period|Miscellaneous|7
7578742|NCT02151149|26359849|P1|Treatment Period|Miscellaneous|8
7578743|NCT02151149|26359848|P2|Treatment Period|Withdrawal by Subject|11
7578744|NCT02151149|26359849|P1|Treatment Period|Withdrawal by Subject|13
7578745|NCT02151149|26359848|P2|Treatment Period|Symptomatic Deterioration|10
7578746|NCT02151149|26359849|P1|Treatment Period|Symptomatic Deterioration|2
7578747|NCT02151149|26359848|P2|Treatment Period|Progressive Disease|24
7578748|NCT02151149|26359849|P1|Treatment Period|Progressive Disease|25
7578749|NCT02151149|26359848|P2|Treatment Period|Adverse Event|14
7578750|NCT02151149|26359849|P1|Treatment Period|Adverse Event|17
7578751|NCT02151149|26359848|P2|Treatment Period|Death|3
7578752|NCT02151149|26359849|P1|Treatment Period|Death|2
7578753|NCT02151110|26359881|P8|Overall Study|Lost to Follow-up|2
7578754|NCT02151110|26359882|P7|Overall Study|Lost to Follow-up|0
7578755|NCT02151110|26359883|P6|Overall Study|Lost to Follow-up|0
7578756|NCT02151110|26359884|P5|Overall Study|Lost to Follow-up|0
7578757|NCT02151110|26359885|P4|Overall Study|Lost to Follow-up|0
7578758|NCT02151110|26359886|P3|Overall Study|Lost to Follow-up|0
7578759|NCT02151110|26359887|P2|Overall Study|Lost to Follow-up|0
7578760|NCT02151110|26359888|P1|Overall Study|Lost to Follow-up|0
7578761|NCT02151110|26359881|P8|Overall Study|Withdrawal by Subject|1
7578762|NCT02151110|26359882|P7|Overall Study|Withdrawal by Subject|0
7578763|NCT02151110|26359883|P6|Overall Study|Withdrawal by Subject|0
7578764|NCT02151110|26359884|P5|Overall Study|Withdrawal by Subject|0
7578765|NCT02151110|26359885|P4|Overall Study|Withdrawal by Subject|0
7578766|NCT02151110|26359886|P3|Overall Study|Withdrawal by Subject|0
7578767|NCT02151110|26359887|P2|Overall Study|Withdrawal by Subject|0
7578768|NCT02151110|26359888|P1|Overall Study|Withdrawal by Subject|0
7578769|NCT02151058|26359981|P3|Overall Study|Lost to Follow-up|2
7578770|NCT02151058|26359982|P2|Overall Study|Lost to Follow-up|0
7578771|NCT02151058|26359983|P1|Overall Study|Lost to Follow-up|1
7578772|NCT02151058|26359981|P3|Overall Study|Withdrawal by Subject|3
7578773|NCT02151058|26359982|P2|Overall Study|Withdrawal by Subject|1
7578774|NCT02151058|26359983|P1|Overall Study|Withdrawal by Subject|1
7578775|NCT02150954|26360017|P2|Overall Study|Protocol Violation|0
7578776|NCT02150954|26360018|P1|Overall Study|Protocol Violation|1
7578777|NCT02150863|26360043|P3|Overall Study|Lost to Follow-up|0
7578778|NCT02150863|26360044|P2|Overall Study|Lost to Follow-up|1
7578779|NCT02150863|26360045|P1|Overall Study|Lost to Follow-up|0
7578780|NCT02150343|26360291|P4|Overall Study|Other|2
7578781|NCT02150343|26360292|P3|Overall Study|Other|0
7578782|NCT02150343|26360293|P2|Overall Study|Other|6
7578783|NCT02150343|26360294|P1|Overall Study|Other|2
7578784|NCT02150343|26360291|P4|Overall Study|Lost to Follow-up|3
7578785|NCT02150343|26360292|P3|Overall Study|Lost to Follow-up|2
7578786|NCT02150343|26360293|P2|Overall Study|Lost to Follow-up|4
7578787|NCT02150343|26360294|P1|Overall Study|Lost to Follow-up|4
7578788|NCT02150343|26360291|P4|Overall Study|Withdrawal by Subject|4
7578789|NCT02150343|26360292|P3|Overall Study|Withdrawal by Subject|9
7578790|NCT02150343|26360293|P2|Overall Study|Withdrawal by Subject|10
7578791|NCT02150343|26360294|P1|Overall Study|Withdrawal by Subject|13
7578792|NCT02150343|26360291|P4|Overall Study|Adverse Event|1
7578793|NCT02150343|26360292|P3|Overall Study|Adverse Event|1
7578794|NCT02150343|26360293|P2|Overall Study|Adverse Event|0
7578795|NCT02150343|26360294|P1|Overall Study|Adverse Event|2
7578796|NCT02150213|26360332|P1|Overall Study|Withdrawal by Subject|1
7578797|NCT02150213|26360332|P1|Overall Study|Lost to Follow-up|1
7578798|NCT02150057|26360351|P2|Overall Study|Lost to Follow-up|4
7578799|NCT02150057|26360352|P1|Overall Study|Lost to Follow-up|6
7578800|NCT02149875|26360367|P3|Overall Study|Physician Decision|2
7578801|NCT02149875|26360368|P2|Overall Study|Physician Decision|2
7578802|NCT02149875|26360369|P1|Overall Study|Physician Decision|1
7578803|NCT02149875|26360367|P3|Overall Study|Withdrawal by Subject|2
7578804|NCT02149875|26360368|P2|Overall Study|Withdrawal by Subject|2
7578805|NCT02149875|26360369|P1|Overall Study|Withdrawal by Subject|3
7578806|NCT02149875|26360367|P3|Overall Study|Lost to Follow-up|5
7578807|NCT02149875|26360368|P2|Overall Study|Lost to Follow-up|4
7578808|NCT02149875|26360369|P1|Overall Study|Lost to Follow-up|3
7578809|NCT02149836|26360380|P1|Overall Study|Withdrawal by Subject|1
7578810|NCT02149810|26360389|P2|Overall Study|Withdrawal by Subject|1
7578811|NCT02149810|26360390|P1|Overall Study|Withdrawal by Subject|5
7578812|NCT02149810|26360389|P2|Overall Study|Lost to Follow-up|1
7578813|NCT02149810|26360390|P1|Overall Study|Lost to Follow-up|2
7578814|NCT02149810|26360389|P2|Overall Study|Physician Decision|2
7578815|NCT02149810|26360390|P1|Overall Study|Physician Decision|1
7578816|NCT02149420|26360434|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7578817|NCT02149420|26360435|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7578818|NCT02149420|26360436|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
7578819|NCT02149420|26360434|P3|Core Study|Administrative problems|2
7578820|NCT02149420|26360435|P2|Core Study|Administrative problems|1
7578821|NCT02149420|26360436|P1|Core Study|Administrative problems|0
7578822|NCT02149264|26360512|P1|Overall Study|Protocol Violation|1
7578823|NCT02149264|26360512|P1|Overall Study|Physician Decision|3
7578824|NCT02149264|26360512|P1|Overall Study|Adverse Event|7
7578825|NCT02149264|26360512|P1|Overall Study|Withdrawal by Subject|9
7578826|NCT02149199|26360528|P3|Overall Study|Adverse Event|9
7578827|NCT02149199|26360529|P2|Overall Study|Adverse Event|15
7578828|NCT02149199|26360530|P1|Overall Study|Adverse Event|6
7578829|NCT02149199|26360528|P3|Overall Study|Death|1
7578830|NCT02149199|26360529|P2|Overall Study|Death|0
7578831|NCT02149199|26360530|P1|Overall Study|Death|0
7578832|NCT02149199|26360528|P3|Overall Study|Lost to Follow-up|11
7578833|NCT02149199|26360529|P2|Overall Study|Lost to Follow-up|12
7578834|NCT02149199|26360530|P1|Overall Study|Lost to Follow-up|3
7578835|NCT02149199|26360528|P3|Overall Study|Protocol Violation|15
7578836|NCT02149199|26360529|P2|Overall Study|Protocol Violation|13
7578837|NCT02149199|26360530|P1|Overall Study|Protocol Violation|16
7578838|NCT02149199|26360528|P3|Overall Study|Withdrawal by Subject|77
7578839|NCT02149199|26360529|P2|Overall Study|Withdrawal by Subject|93
7578840|NCT02149199|26360530|P1|Overall Study|Withdrawal by Subject|75
7578841|NCT02149199|26360528|P3|Overall Study|Eligibility criteria not fulfilled|8
7578842|NCT02149199|26360529|P2|Overall Study|Eligibility criteria not fulfilled|14
7578843|NCT02149199|26360530|P1|Overall Study|Eligibility criteria not fulfilled|9
7578844|NCT02149199|26360528|P3|Overall Study|Other|20
7578845|NCT02149199|26360529|P2|Overall Study|Other|25
7578846|NCT02149199|26360530|P1|Overall Study|Other|20
7578847|NCT02149199|26360528|P3|Overall Study|Study specific withdrawal criteria|6
7578848|NCT02149199|26360529|P2|Overall Study|Study specific withdrawal criteria|21
7578849|NCT02149199|26360530|P1|Overall Study|Study specific withdrawal criteria|4
7578850|NCT02149108|26360609|P2|Overall Study|Lost to Follow-up|0
7578851|NCT02149108|26360610|P1|Overall Study|Lost to Follow-up|1
7578852|NCT02149108|26360609|P2|Overall Study|Refusal to continue trial medication|11
7578853|NCT02149108|26360610|P1|Overall Study|Refusal to continue trial medication|15
7578854|NCT02149108|26360609|P2|Overall Study|Other not defined above|2
7578855|NCT02149108|26360610|P1|Overall Study|Other not defined above|0
7578856|NCT02149108|26360609|P2|Overall Study|Other Adverse Event (AE)|18
7578857|NCT02149108|26360610|P1|Overall Study|Other Adverse Event (AE)|8
7578858|NCT02149108|26360609|P2|Overall Study|Worsening/adverse event cancer disease|32
7578859|NCT02149108|26360610|P1|Overall Study|Worsening/adverse event cancer disease|31
7578860|NCT02149108|26360609|P2|Overall Study|Progressive Disease (PD)|318
7578861|NCT02149108|26360610|P1|Overall Study|Progressive Disease (PD)|324
7578862|NCT02149108|26360609|P2|Overall Study|Not treated|2
7578863|NCT02149108|26360610|P1|Overall Study|Not treated|1
7578864|NCT02148952|26360624|P2|Follow-Up|Withdrawal by Subject|48
7578865|NCT02148952|26360625|P1|Follow-Up|Withdrawal by Subject|46
7578866|NCT02148952|26360624|P2|Follow-Up|Lost to Follow-up|231
7578867|NCT02148952|26360625|P1|Follow-Up|Lost to Follow-up|219
7578868|NCT02148952|26360624|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
7578869|NCT02148952|26360625|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
7578870|NCT02148952|26360624|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
7578871|NCT02148952|26360625|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
7578872|NCT02148718|26360708|P1|Overall Study|Discontinued Study Prematurely|5
7578873|NCT02148718|26360708|P1|Overall Study|Protocol Violation|26
7578874|NCT02148445|26360756|P2|Overall Study|Death|3
7578875|NCT02148445|26360757|P1|Overall Study|Death|1
7578876|NCT02148250|26360808|P2|Screening|Withdrawal by Subject|0
7578877|NCT02148250|26360809|P1|Screening|Withdrawal by Subject|5
7578878|NCT02148211|26360823|P1|Overall Study|Lost to Follow-up|352
7578879|NCT02148133|26360832|P1|Overall Study|Protocol-defined stopping criteria|2
7578880|NCT02148133|26360832|P1|Overall Study|Protocol deviation|1
7578881|NCT02148133|26360832|P1|Overall Study|Lack of Efficacy|1
7578882|NCT02148133|26360832|P1|Overall Study|Investigator discretion|1
7578883|NCT02147691|26360981|P2|Overall Study|Lost to Follow-up|1
7578884|NCT02147691|26360982|P1|Overall Study|Lost to Follow-up|0
7578885|NCT02147691|26360981|P2|Overall Study|Adverse Event|0
7578886|NCT02147691|26360982|P1|Overall Study|Adverse Event|2
7578887|NCT02147691|26360981|P2|Overall Study|Withdrawal by Subject|0
7578888|NCT02147691|26360982|P1|Overall Study|Withdrawal by Subject|2
7578889|NCT02147626|26361028|P2|Overall Study|Withdrawal by Subject|1
7578890|NCT02147626|26361029|P1|Overall Study|Withdrawal by Subject|0
7578891|NCT02147626|26361028|P2|Overall Study|Pregnancy|2
7578892|NCT02147626|26361029|P1|Overall Study|Pregnancy|1
7578893|NCT02147626|26361028|P2|Overall Study|Lost to Follow-up|4
7578894|NCT02147626|26361029|P1|Overall Study|Lost to Follow-up|4
7578895|NCT02147587|26361062|P2|Overall Study|Lack of Efficacy|1
7578896|NCT02147587|26361063|P1|Overall Study|Lack of Efficacy|2
7578897|NCT02147587|26361062|P2|Overall Study|Adverse Event|4
7578898|NCT02147587|26361063|P1|Overall Study|Adverse Event|9
7578899|NCT02147561|26361083|P1|Overall Study|Subjects who didn't receive BOTOX|1
7578900|NCT02147561|26361083|P1|Overall Study|Lost to Follow-up|3
7578901|NCT02147353|26361104|P2|Overall Study|medication noncompliance|0
7578902|NCT02147353|26361105|P1|Overall Study|medication noncompliance|3
7578903|NCT02147353|26361104|P2|Overall Study|unable to make visits|0
7578904|NCT02147353|26361105|P1|Overall Study|unable to make visits|4
7578905|NCT02147353|26361104|P2|Overall Study|Lost to Follow-up|0
7578906|NCT02147353|26361105|P1|Overall Study|Lost to Follow-up|2
7578907|NCT02147288|26361138|P10|Overall Study|complications from concurrent hernia rep|0
7578908|NCT02147288|26361139|P9|Overall Study|complications from concurrent hernia rep|0
7578909|NCT02147288|26361140|P8|Overall Study|complications from concurrent hernia rep|0
7578910|NCT02147288|26361141|P7|Overall Study|complications from concurrent hernia rep|0
7578911|NCT02147288|26361142|P6|Overall Study|complications from concurrent hernia rep|0
7578912|NCT02147288|26361143|P5|Overall Study|complications from concurrent hernia rep|0
7578913|NCT02147288|26361144|P4|Overall Study|complications from concurrent hernia rep|0
7578914|NCT02147288|26361145|P3|Overall Study|complications from concurrent hernia rep|0
7578915|NCT02147288|26361146|P2|Overall Study|complications from concurrent hernia rep|1
7578916|NCT02147288|26361147|P1|Overall Study|complications from concurrent hernia rep|0
7578917|NCT02147288|26361138|P10|Overall Study|post-operative hematoma|0
7578918|NCT02147288|26361139|P9|Overall Study|post-operative hematoma|0
7578919|NCT02147288|26361140|P8|Overall Study|post-operative hematoma|0
7578920|NCT02147288|26361141|P7|Overall Study|post-operative hematoma|0
7578921|NCT02147288|26361142|P6|Overall Study|post-operative hematoma|0
7578922|NCT02147288|26361143|P5|Overall Study|post-operative hematoma|0
7578923|NCT02147288|26361144|P4|Overall Study|post-operative hematoma|0
7578924|NCT02147288|26361145|P3|Overall Study|post-operative hematoma|0
7578925|NCT02147288|26361146|P2|Overall Study|post-operative hematoma|1
7578926|NCT02147288|26361147|P1|Overall Study|post-operative hematoma|1
7578927|NCT02147197|26361156|P3|Overall Study|Other Miscellaneous Reasons|3
7578928|NCT02147197|26361157|P2|Overall Study|Other Miscellaneous Reasons|0
7578929|NCT02147197|26361158|P1|Overall Study|Other Miscellaneous Reasons|1
7578930|NCT02147197|26361156|P3|Overall Study|Protocol Violation|3
7578931|NCT02147197|26361157|P2|Overall Study|Protocol Violation|0
7578932|NCT02147197|26361158|P1|Overall Study|Protocol Violation|1
7578933|NCT02147197|26361156|P3|Overall Study|Lost to Follow-up|1
7578934|NCT02147197|26361157|P2|Overall Study|Lost to Follow-up|3
7578935|NCT02147197|26361158|P1|Overall Study|Lost to Follow-up|2
7578936|NCT02147197|26361156|P3|Overall Study|Withdrawal of Consent|2
7578937|NCT02147197|26361157|P2|Overall Study|Withdrawal of Consent|3
7578938|NCT02147197|26361158|P1|Overall Study|Withdrawal of Consent|4
7578939|NCT02147197|26361156|P3|Overall Study|Adverse Event|0
7578940|NCT02147197|26361157|P2|Overall Study|Adverse Event|0
7578941|NCT02147197|26361158|P1|Overall Study|Adverse Event|1
7578942|NCT02147184|26361177|P2|Overall Study|Other|0
7578943|NCT02147184|26361178|P1|Overall Study|Other|1
7578944|NCT02147184|26361177|P2|Overall Study|Physician Decision|2
7578945|NCT02147184|26361178|P1|Overall Study|Physician Decision|0
7578946|NCT02147184|26361177|P2|Overall Study|Moved out of state|3
7578947|NCT02147184|26361178|P1|Overall Study|Moved out of state|3
7578948|NCT02147184|26361177|P2|Overall Study|Pregnancy|0
7578949|NCT02147184|26361178|P1|Overall Study|Pregnancy|6
7578950|NCT02147184|26361177|P2|Overall Study|Study Burden|7
7578951|NCT02147184|26361178|P1|Overall Study|Study Burden|11
7578952|NCT02147184|26361177|P2|Overall Study|Lost to Follow-up|15
7578953|NCT02147184|26361178|P1|Overall Study|Lost to Follow-up|28
7578954|NCT02147158|26361202|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7578955|NCT02147158|26361203|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7578956|NCT02147158|26361204|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
7578957|NCT02147158|26361205|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7578958|NCT02147158|26361206|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
7578959|NCT02147158|26361207|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7578960|NCT02147158|26361202|P6|Off-Treatment Interval 2|Protocol Violation|0
7578961|NCT02147158|26361203|P5|Off-Treatment Interval 2|Protocol Violation|0
7578962|NCT02147158|26361204|P4|Off-Treatment Interval 2|Protocol Violation|1
7578963|NCT02147158|26361205|P3|Off-Treatment Interval 2|Protocol Violation|0
7578964|NCT02147158|26361206|P2|Off-Treatment Interval 2|Protocol Violation|0
7578965|NCT02147158|26361207|P1|Off-Treatment Interval 2|Protocol Violation|0
7578966|NCT02147158|26361202|P6|Off-Treatment Interval 2|Lost to Follow-up|2
7578967|NCT02147158|26361203|P5|Off-Treatment Interval 2|Lost to Follow-up|2
7578968|NCT02147158|26361204|P4|Off-Treatment Interval 2|Lost to Follow-up|2
7578969|NCT02147158|26361205|P3|Off-Treatment Interval 2|Lost to Follow-up|3
7578970|NCT02147158|26361206|P2|Off-Treatment Interval 2|Lost to Follow-up|0
7578971|NCT02147158|26361207|P1|Off-Treatment Interval 2|Lost to Follow-up|0
7578972|NCT02147158|26361202|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
7578973|NCT02147158|26361203|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
7578974|NCT02147158|26361204|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
7578975|NCT02147158|26361205|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
7578976|NCT02147158|26361206|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
7578977|NCT02147158|26361207|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
7578978|NCT02147158|26361202|P6|Off-Treatment Interval 2|Lack of Efficacy|0
7578979|NCT02147158|26361203|P5|Off-Treatment Interval 2|Lack of Efficacy|0
7578980|NCT02147158|26361204|P4|Off-Treatment Interval 2|Lack of Efficacy|0
7578981|NCT02147158|26361205|P3|Off-Treatment Interval 2|Lack of Efficacy|1
7578982|NCT02147158|26361206|P2|Off-Treatment Interval 2|Lack of Efficacy|1
7578983|NCT02147158|26361207|P1|Off-Treatment Interval 2|Lack of Efficacy|0
7578984|NCT02147158|26361202|P6|Treatment Course 2|Lost to Follow-up|1
7578985|NCT02147158|26361203|P5|Treatment Course 2|Lost to Follow-up|0
7578986|NCT02147158|26361204|P4|Treatment Course 2|Lost to Follow-up|1
7578987|NCT02147158|26361205|P3|Treatment Course 2|Lost to Follow-up|1
7578988|NCT02147158|26361206|P2|Treatment Course 2|Lost to Follow-up|0
7578989|NCT02147158|26361207|P1|Treatment Course 2|Lost to Follow-up|1
7578990|NCT02147158|26361202|P6|Treatment Course 2|Withdrawal of Consent|0
7578991|NCT02147158|26361203|P5|Treatment Course 2|Withdrawal of Consent|0
7578992|NCT02147158|26361204|P4|Treatment Course 2|Withdrawal of Consent|3
7578993|NCT02147158|26361205|P3|Treatment Course 2|Withdrawal of Consent|2
7578994|NCT02147158|26361206|P2|Treatment Course 2|Withdrawal of Consent|1
7578995|NCT02147158|26361207|P1|Treatment Course 2|Withdrawal of Consent|0
7578996|NCT02147158|26361202|P6|Treatment Course 2|Adverse Event|1
7578997|NCT02147158|26361203|P5|Treatment Course 2|Adverse Event|0
7578998|NCT02147158|26361204|P4|Treatment Course 2|Adverse Event|1
7578999|NCT02147158|26361205|P3|Treatment Course 2|Adverse Event|2
7579000|NCT02147158|26361206|P2|Treatment Course 2|Adverse Event|4
7579001|NCT02147158|26361207|P1|Treatment Course 2|Adverse Event|0
7579002|NCT02147158|26361202|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7579003|NCT02147158|26361203|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7579004|NCT02147158|26361204|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7579005|NCT02147158|26361205|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
7579006|NCT02147158|26361206|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7579007|NCT02147158|26361207|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7579008|NCT02147158|26361202|P6|Off-Treatment Interval 1|Lack of Efficacy|0
7579009|NCT02147158|26361203|P5|Off-Treatment Interval 1|Lack of Efficacy|1
7579010|NCT02147158|26361204|P4|Off-Treatment Interval 1|Lack of Efficacy|0
7579011|NCT02147158|26361205|P3|Off-Treatment Interval 1|Lack of Efficacy|2
7579012|NCT02147158|26361206|P2|Off-Treatment Interval 1|Lack of Efficacy|0
7579013|NCT02147158|26361207|P1|Off-Treatment Interval 1|Lack of Efficacy|0
7579014|NCT02147158|26361202|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
7579015|NCT02147158|26361203|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
7579016|NCT02147158|26361204|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
7579017|NCT02147158|26361205|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
7579018|NCT02147158|26361206|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
7579019|NCT02147158|26361207|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
7579020|NCT02147158|26361202|P6|Off-Treatment Interval 1|Protocol Violation|0
7579021|NCT02147158|26361203|P5|Off-Treatment Interval 1|Protocol Violation|1
7579022|NCT02147158|26361204|P4|Off-Treatment Interval 1|Protocol Violation|0
7579023|NCT02147158|26361205|P3|Off-Treatment Interval 1|Protocol Violation|2
7579024|NCT02147158|26361206|P2|Off-Treatment Interval 1|Protocol Violation|0
7579025|NCT02147158|26361207|P1|Off-Treatment Interval 1|Protocol Violation|1
7579026|NCT02147158|26361202|P6|Off-Treatment Interval 1|Lost to Follow-up|2
7579027|NCT02147158|26361203|P5|Off-Treatment Interval 1|Lost to Follow-up|4
7579028|NCT02147158|26361204|P4|Off-Treatment Interval 1|Lost to Follow-up|2
7579029|NCT02147158|26361205|P3|Off-Treatment Interval 1|Lost to Follow-up|3
7579030|NCT02147158|26361206|P2|Off-Treatment Interval 1|Lost to Follow-up|1
7579031|NCT02147158|26361207|P1|Off-Treatment Interval 1|Lost to Follow-up|2
7579032|NCT02147158|26361202|P6|Off-Treatment Interval 1|Adverse Event|0
7579033|NCT02147158|26361203|P5|Off-Treatment Interval 1|Adverse Event|0
7579034|NCT02147158|26361204|P4|Off-Treatment Interval 1|Adverse Event|1
7579035|NCT02147158|26361205|P3|Off-Treatment Interval 1|Adverse Event|0
7579036|NCT02147158|26361206|P2|Off-Treatment Interval 1|Adverse Event|0
7579037|NCT02147158|26361207|P1|Off-Treatment Interval 1|Adverse Event|1
7579038|NCT02147158|26361202|P6|Treatment Course 1|Withdrawal of Consent|2
7579039|NCT02147158|26361203|P5|Treatment Course 1|Withdrawal of Consent|3
7579040|NCT02147158|26361204|P4|Treatment Course 1|Withdrawal of Consent|5
7579041|NCT02147158|26361205|P3|Treatment Course 1|Withdrawal of Consent|1
7579042|NCT02147158|26361206|P2|Treatment Course 1|Withdrawal of Consent|1
7579043|NCT02147158|26361207|P1|Treatment Course 1|Withdrawal of Consent|1
7579044|NCT02147158|26361202|P6|Treatment Course 1|Protocol Violation|0
7579045|NCT02147158|26361203|P5|Treatment Course 1|Protocol Violation|0
7579046|NCT02147158|26361204|P4|Treatment Course 1|Protocol Violation|1
7579047|NCT02147158|26361205|P3|Treatment Course 1|Protocol Violation|1
7579048|NCT02147158|26361206|P2|Treatment Course 1|Protocol Violation|0
7579049|NCT02147158|26361207|P1|Treatment Course 1|Protocol Violation|0
7579050|NCT02147158|26361202|P6|Treatment Course 1|Lost to Follow-up|4
7579051|NCT02147158|26361203|P5|Treatment Course 1|Lost to Follow-up|2
7579052|NCT02147158|26361204|P4|Treatment Course 1|Lost to Follow-up|3
7579053|NCT02147158|26361205|P3|Treatment Course 1|Lost to Follow-up|3
7579054|NCT02147158|26361206|P2|Treatment Course 1|Lost to Follow-up|4
7579055|NCT02147158|26361207|P1|Treatment Course 1|Lost to Follow-up|2
7579056|NCT02147158|26361202|P6|Treatment Course 1|Adverse Event|2
7579057|NCT02147158|26361203|P5|Treatment Course 1|Adverse Event|1
7579058|NCT02147158|26361204|P4|Treatment Course 1|Adverse Event|4
7579059|NCT02147158|26361205|P3|Treatment Course 1|Adverse Event|3
7579060|NCT02147158|26361206|P2|Treatment Course 1|Adverse Event|4
7579061|NCT02147158|26361207|P1|Treatment Course 1|Adverse Event|1
7579062|NCT02147132|26361236|P4|Overall Study|Lost to Follow-up|0
7579063|NCT02147132|26361237|P3|Overall Study|Lost to Follow-up|0
7579064|NCT02147132|26361238|P2|Overall Study|Lost to Follow-up|0
7579065|NCT02147132|26361239|P1|Overall Study|Lost to Follow-up|1
7579066|NCT02147093|26361259|P2|Period 2|Protocol Violation|0
7579067|NCT02147093|26361260|P1|Period 2|Protocol Violation|2
7579068|NCT02147093|26361259|P2|Period 1|Lost to Follow-up|1
7579069|NCT02147093|26361260|P1|Period 1|Lost to Follow-up|0
7579070|NCT02147067|26361270|P2|Overall Study|Withdrawal by Subject|2
7579071|NCT02147067|26361271|P1|Overall Study|Withdrawal by Subject|2
7579072|NCT02146833|26361297|P1|Overall Study|No longer consented to study treatment|1
7579073|NCT02146833|26361297|P1|Overall Study|Death|10
7579074|NCT02146599|26361309|P1|Overall Study|Failed to meet inclusion criteria|5
7579075|NCT02146430|26361326|P4|Overall Study|Withdrawal by Subject|34
7579076|NCT02146430|26361327|P3|Overall Study|Withdrawal by Subject|30
7579077|NCT02146430|26361328|P2|Overall Study|Withdrawal by Subject|29
7579078|NCT02146430|26361329|P1|Overall Study|Withdrawal by Subject|27
7579079|NCT02146430|26361326|P4|Overall Study|Reason missing or not reported|5
7579080|NCT02146430|26361327|P3|Overall Study|Reason missing or not reported|4
7579081|NCT02146430|26361328|P2|Overall Study|Reason missing or not reported|3
7579082|NCT02146430|26361329|P1|Overall Study|Reason missing or not reported|2
7579083|NCT02146430|26361326|P4|Overall Study|Adverse Event|49
7579084|NCT02146430|26361327|P3|Overall Study|Adverse Event|32
7579085|NCT02146430|26361328|P2|Overall Study|Adverse Event|40
7579086|NCT02146430|26361329|P1|Overall Study|Adverse Event|20
7579087|NCT02146430|26361326|P4|Overall Study|Lack of Efficacy|5
7579088|NCT02146430|26361327|P3|Overall Study|Lack of Efficacy|8
7579089|NCT02146430|26361328|P2|Overall Study|Lack of Efficacy|11
7579090|NCT02146430|26361329|P1|Overall Study|Lack of Efficacy|13
7579091|NCT02146430|26361326|P4|Overall Study|Protocol Violation|6
7579092|NCT02146430|26361327|P3|Overall Study|Protocol Violation|8
7579093|NCT02146430|26361328|P2|Overall Study|Protocol Violation|4
7579094|NCT02146430|26361329|P1|Overall Study|Protocol Violation|5
7579095|NCT02146365|26361389|P8|Overall Study|Other|0
7579096|NCT02146365|26361390|P7|Overall Study|Other|0
7579097|NCT02146365|26361391|P6|Overall Study|Other|0
7579098|NCT02146365|26361392|P5|Overall Study|Other|0
7579099|NCT02146365|26361393|P4|Overall Study|Other|1
7579100|NCT02146365|26361394|P3|Overall Study|Other|2
7579101|NCT02146365|26361395|P2|Overall Study|Other|0
7579102|NCT02146365|26361396|P1|Overall Study|Other|1
7579103|NCT02146365|26361389|P8|Overall Study|Unable to Comply with Protocol|0
7579104|NCT02146365|26361390|P7|Overall Study|Unable to Comply with Protocol|0
7579105|NCT02146365|26361391|P6|Overall Study|Unable to Comply with Protocol|0
7579106|NCT02146365|26361392|P5|Overall Study|Unable to Comply with Protocol|0
7579107|NCT02146365|26361393|P4|Overall Study|Unable to Comply with Protocol|0
7579108|NCT02146365|26361394|P3|Overall Study|Unable to Comply with Protocol|1
7579109|NCT02146365|26361395|P2|Overall Study|Unable to Comply with Protocol|1
7579110|NCT02146365|26361396|P1|Overall Study|Unable to Comply with Protocol|0
7579111|NCT02146365|26361389|P8|Overall Study|Withdrawal by Subject|0
7579112|NCT02146365|26361390|P7|Overall Study|Withdrawal by Subject|0
7579113|NCT02146365|26361391|P6|Overall Study|Withdrawal by Subject|0
7579114|NCT02146365|26361392|P5|Overall Study|Withdrawal by Subject|1
7579115|NCT02146365|26361393|P4|Overall Study|Withdrawal by Subject|5
7579116|NCT02146365|26361394|P3|Overall Study|Withdrawal by Subject|1
7579117|NCT02146365|26361395|P2|Overall Study|Withdrawal by Subject|2
7579118|NCT02146365|26361396|P1|Overall Study|Withdrawal by Subject|1
7579119|NCT02146365|26361389|P8|Overall Study|Lost to Follow-up|1
7579120|NCT02146365|26361390|P7|Overall Study|Lost to Follow-up|0
7579121|NCT02146365|26361391|P6|Overall Study|Lost to Follow-up|1
7579122|NCT02146365|26361392|P5|Overall Study|Lost to Follow-up|1
7579123|NCT02146365|26361393|P4|Overall Study|Lost to Follow-up|3
7579124|NCT02146365|26361394|P3|Overall Study|Lost to Follow-up|3
7579125|NCT02146365|26361395|P2|Overall Study|Lost to Follow-up|1
7579126|NCT02146365|26361396|P1|Overall Study|Lost to Follow-up|2
7579127|NCT02146352|26361522|P1|Overall Study|Patient entered hospice care|1
7579128|NCT02146352|26361522|P1|Overall Study|Death|1
7579129|NCT02146326|26361540|P4|Overall Study|Unable to complete interview|6
7579130|NCT02146326|26361541|P3|Overall Study|Unable to complete interview|10
7579131|NCT02146326|26361542|P2|Overall Study|Unable to complete interview|0
7579132|NCT02146326|26361543|P1|Overall Study|Unable to complete interview|0
7579133|NCT02146326|26361540|P4|Overall Study|Death|4
7579134|NCT02146326|26361541|P3|Overall Study|Death|4
7579135|NCT02146326|26361542|P2|Overall Study|Death|0
7579136|NCT02146326|26361543|P1|Overall Study|Death|0
7579137|NCT02146326|26361540|P4|Overall Study|Incarcerated|8
7579138|NCT02146326|26361541|P3|Overall Study|Incarcerated|3
7579139|NCT02146326|26361542|P2|Overall Study|Incarcerated|0
7579140|NCT02146326|26361543|P1|Overall Study|Incarcerated|0
7579141|NCT02146326|26361540|P4|Overall Study|Separated from mental health center|0
7579142|NCT02146326|26361541|P3|Overall Study|Separated from mental health center|0
7579143|NCT02146326|26361542|P2|Overall Study|Separated from mental health center|33
7579144|NCT02146326|26361543|P1|Overall Study|Separated from mental health center|23
7579145|NCT02146326|26361540|P4|Overall Study|Withdrawal by Subject|11
7579146|NCT02146326|26361541|P3|Overall Study|Withdrawal by Subject|15
7579147|NCT02146326|26361542|P2|Overall Study|Withdrawal by Subject|1
7579148|NCT02146326|26361543|P1|Overall Study|Withdrawal by Subject|2
7579149|NCT02146326|26361540|P4|Overall Study|Lost to Follow-up|19
7579150|NCT02146326|26361541|P3|Overall Study|Lost to Follow-up|11
7579151|NCT02146326|26361542|P2|Overall Study|Lost to Follow-up|3
7579152|NCT02146326|26361543|P1|Overall Study|Lost to Follow-up|3
7579153|NCT02146274|26361705|P1|Overall Study|Protocol Violation|73
7579154|NCT02146248|26361712|P1|Overall Study|Withdrawal by Subject|2
7579155|NCT02146131|26361722|P2|Overall Study|Physician Decision|56
7579156|NCT02146131|26361723|P1|Overall Study|Physician Decision|61
7579157|NCT02146105|26361729|P1|Overall Study|Withdrawal by Subject|5
7579158|NCT02146105|26361729|P1|Overall Study|Adverse Event|1
7579159|NCT02145468|26361780|P2|Overall Study|Withdrawal by Subject|8
7579160|NCT02145468|26361781|P1|Overall Study|Withdrawal by Subject|5
7579161|NCT02145429|26361839|P2|Overall Study|Withdrawal by Subject|3
7579162|NCT02145429|26361840|P1|Overall Study|Withdrawal by Subject|8
7579163|NCT02145429|26361839|P2|Overall Study|Lost to Follow-up|3
7579164|NCT02145429|26361840|P1|Overall Study|Lost to Follow-up|4
7579165|NCT02145429|26361839|P2|Overall Study|Death|5
7579166|NCT02145429|26361840|P1|Overall Study|Death|4
7579167|NCT02145390|26361871|P1|Overall Study|Withdrawal by Subject|1
7579168|NCT02145182|26361920|P2|Overall Study|Withdrawal by Subject|4
7579169|NCT02145182|26361921|P1|Overall Study|Withdrawal by Subject|5
7579170|NCT02145182|26361920|P2|Overall Study|Pre-transplant Withdrawal|2
7579171|NCT02145182|26361921|P1|Overall Study|Pre-transplant Withdrawal|0
7579172|NCT02145182|26361920|P2|Overall Study|Lost to Follow-up|2
7579173|NCT02145182|26361921|P1|Overall Study|Lost to Follow-up|2
7579174|NCT02145182|26361920|P2|Overall Study|Death|7
7579175|NCT02145182|26361921|P1|Overall Study|Death|7
7579176|NCT02145182|26361920|P2|Overall Study|Adverse Event|1
7579177|NCT02145182|26361921|P1|Overall Study|Adverse Event|4
7579178|NCT02145156|26361954|P3|Overall Study|No match to vaccination records|41
7579179|NCT02145156|26361955|P2|Overall Study|No match to vaccination records|52
7579180|NCT02145156|26361956|P1|Overall Study|No match to vaccination records|60
7579181|NCT02145078|26361997|P1|Overall Study|Reason not given|3
7579182|NCT02145078|26361997|P1|Overall Study|Death|1
7579183|NCT02145026|26362014|P1|Overall Study|Physician Decision|4
7579184|NCT02145026|26362014|P1|Overall Study|Withdrawal by Subject|2
7579185|NCT02145026|26362014|P1|Overall Study|Death|4
7579186|NCT02145026|26362014|P1|Overall Study|Adverse Event|2
7579187|NCT02144701|26362045|P2|Overall Study|development of relapse, GVHD or death|3
7579188|NCT02144701|26362046|P1|Overall Study|development of relapse, GVHD or death|9
7579189|NCT02144610|26362073|P2|Overall Study|Other|1
7579190|NCT02144610|26362074|P1|Overall Study|Other|0
7579191|NCT02144610|26362073|P2|Overall Study|Study Discontinuation by Sponsor|14
7579192|NCT02144610|26362074|P1|Overall Study|Study Discontinuation by Sponsor|19
7579193|NCT02144610|26362073|P2|Overall Study|Death|2
7579194|NCT02144610|26362074|P1|Overall Study|Death|2
7579195|NCT02144610|26362073|P2|Overall Study|Withdrawal by Subject|5
7579196|NCT02144610|26362074|P1|Overall Study|Withdrawal by Subject|1
7579197|NCT02144610|26362073|P2|Overall Study|Physician Decision|0
7579198|NCT02144610|26362074|P1|Overall Study|Physician Decision|1
7579199|NCT02144337|26362140|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
7579200|NCT02144337|26362141|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
7579201|NCT02144337|26362140|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
7579202|NCT02144337|26362141|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
7579203|NCT02144337|26362140|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
7579204|NCT02144337|26362141|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
7579205|NCT02144337|26362140|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
7579206|NCT02144337|26362141|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
7579207|NCT02144337|26362140|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7579208|NCT02144337|26362141|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7579209|NCT02144285|26362161|P10|Overall Study|Withdrawal by Subject|0
7579210|NCT02144285|26362162|P9|Overall Study|Withdrawal by Subject|0
7579211|NCT02144285|26362163|P8|Overall Study|Withdrawal by Subject|0
7579212|NCT02144285|26362164|P7|Overall Study|Withdrawal by Subject|0
7579213|NCT02144285|26362165|P6|Overall Study|Withdrawal by Subject|0
7579214|NCT02144285|26362166|P5|Overall Study|Withdrawal by Subject|1
7579215|NCT02144285|26362167|P4|Overall Study|Withdrawal by Subject|0
7579216|NCT02144285|26362168|P3|Overall Study|Withdrawal by Subject|0
7579217|NCT02144285|26362169|P2|Overall Study|Withdrawal by Subject|0
7579218|NCT02144285|26362170|P1|Overall Study|Withdrawal by Subject|0
7579219|NCT02144220|26362296|P1|Overall Study|Protocol Violation|1
7579220|NCT02144220|26362296|P1|Overall Study|Withdrawal by Subject|2
7579221|NCT02144220|26362296|P1|Overall Study|Physician Decision|3
7579222|NCT02144220|26362296|P1|Overall Study|Lack of Efficacy|4
7579223|NCT02144220|26362296|P1|Overall Study|technology incompatibility|9
7579224|NCT02144077|26362315|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
7579225|NCT02144077|26362316|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
7579226|NCT02144077|26362315|P2|Overall Study|Death|1
7579227|NCT02144077|26362316|P1|Overall Study|Death|0
7579228|NCT02144077|26362315|P2|Overall Study|Protocol Violation|2
7579229|NCT02144077|26362316|P1|Overall Study|Protocol Violation|1
7579230|NCT02144077|26362315|P2|Overall Study|Lost to Follow-up|2
7579231|NCT02144077|26362316|P1|Overall Study|Lost to Follow-up|2
7579232|NCT02144077|26362315|P2|Overall Study|Adverse Event|3
7579233|NCT02144077|26362316|P1|Overall Study|Adverse Event|2
7579234|NCT02144077|26362315|P2|Overall Study|Withdrawal by Subject|3
7579235|NCT02144077|26362316|P1|Overall Study|Withdrawal by Subject|3
7579236|NCT02144012|26362334|P2|Overall Study|Other|0
7579237|NCT02144012|26362335|P1|Overall Study|Other|3
7579238|NCT02144012|26362334|P2|Overall Study|Study Terminated by Sponsor|12
7579239|NCT02144012|26362335|P1|Overall Study|Study Terminated by Sponsor|18
7579240|NCT02144012|26362334|P2|Overall Study|Withdrawal by Subject|3
7579241|NCT02144012|26362335|P1|Overall Study|Withdrawal by Subject|11
7579242|NCT02144012|26362334|P2|Overall Study|Death|0
7579243|NCT02144012|26362335|P1|Overall Study|Death|1
7579244|NCT02144012|26362334|P2|Overall Study|Adverse Event|0
7579245|NCT02144012|26362335|P1|Overall Study|Adverse Event|1
7579246|NCT02143947|26362376|P2|Overall Study|Lost to Follow-up|2
7579247|NCT02143947|26362377|P1|Overall Study|Lost to Follow-up|4
7579248|NCT02143843|26362389|P1|Overall Study|Withdrawal by Subject|2
7579249|NCT02143843|26362389|P1|Overall Study|Lack of Efficacy|2
7579250|NCT02143843|26362389|P1|Overall Study|Adverse Event|8
7579251|NCT02143778|26362394|P1|Overall Study|Device malfunction|1
7579252|NCT02143778|26362394|P1|Overall Study|Withdrawal by Subject|2
7579253|NCT02143713|26362403|P4|Post-treatment Follow-up (12 Months)|Other|7
7579254|NCT02143713|26362404|P3|Post-treatment Follow-up (12 Months)|Other|7
7579255|NCT02143713|26362405|P2|Post-treatment Follow-up (12 Months)|Other|4
7579256|NCT02143713|26362406|P1|Post-treatment Follow-up (12 Months)|Other|3
7579257|NCT02143713|26362403|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7579258|NCT02143713|26362404|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7579259|NCT02143713|26362405|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7579260|NCT02143713|26362406|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7579261|NCT02143713|26362403|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
7579262|NCT02143713|26362404|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7579263|NCT02143713|26362405|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7579264|NCT02143713|26362406|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
7579265|NCT02143713|26362403|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7579266|NCT02143713|26362404|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
7579267|NCT02143713|26362405|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7579268|NCT02143713|26362406|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
7579269|NCT02143713|26362403|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
7579270|NCT02143713|26362404|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
7579271|NCT02143713|26362405|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
7579272|NCT02143713|26362406|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
7579273|NCT02143713|26362403|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
7579274|NCT02143713|26362404|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7579275|NCT02143713|26362405|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
7579276|NCT02143713|26362406|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7579277|NCT02143713|26362403|P4|Treatment Period (6 Months)|Lack of Efficacy|1
7579278|NCT02143713|26362404|P3|Treatment Period (6 Months)|Lack of Efficacy|0
7579279|NCT02143713|26362405|P2|Treatment Period (6 Months)|Lack of Efficacy|0
7579280|NCT02143713|26362406|P1|Treatment Period (6 Months)|Lack of Efficacy|1
7579281|NCT02143713|26362403|P4|Treatment Period (6 Months)|Exclusionary Medication|0
7579282|NCT02143713|26362404|P3|Treatment Period (6 Months)|Exclusionary Medication|0
7579283|NCT02143713|26362405|P2|Treatment Period (6 Months)|Exclusionary Medication|0
7579284|NCT02143713|26362406|P1|Treatment Period (6 Months)|Exclusionary Medication|2
7579285|NCT02143713|26362403|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
7579286|NCT02143713|26362404|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7579287|NCT02143713|26362405|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7579288|NCT02143713|26362406|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7579289|NCT02143713|26362403|P4|Treatment Period (6 Months)|Other|2
7579290|NCT02143713|26362404|P3|Treatment Period (6 Months)|Other|3
7579291|NCT02143713|26362405|P2|Treatment Period (6 Months)|Other|0
7579292|NCT02143713|26362406|P1|Treatment Period (6 Months)|Other|3
7579293|NCT02143713|26362403|P4|Treatment Period (6 Months)|Non-compliance|3
7579294|NCT02143713|26362404|P3|Treatment Period (6 Months)|Non-compliance|0
7579295|NCT02143713|26362405|P2|Treatment Period (6 Months)|Non-compliance|0
7579296|NCT02143713|26362406|P1|Treatment Period (6 Months)|Non-compliance|1
7579297|NCT02143713|26362403|P4|Treatment Period (6 Months)|Pregnancy|0
7579298|NCT02143713|26362404|P3|Treatment Period (6 Months)|Pregnancy|2
7579299|NCT02143713|26362405|P2|Treatment Period (6 Months)|Pregnancy|2
7579300|NCT02143713|26362406|P1|Treatment Period (6 Months)|Pregnancy|0
7579301|NCT02143713|26362403|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7579302|NCT02143713|26362404|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7579303|NCT02143713|26362405|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7579304|NCT02143713|26362406|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7579305|NCT02143713|26362403|P4|Treatment Period (6 Months)|Lost to Follow-up|3
7579306|NCT02143713|26362404|P3|Treatment Period (6 Months)|Lost to Follow-up|4
7579307|NCT02143713|26362405|P2|Treatment Period (6 Months)|Lost to Follow-up|0
7579308|NCT02143713|26362406|P1|Treatment Period (6 Months)|Lost to Follow-up|3
7579309|NCT02143713|26362403|P4|Treatment Period (6 Months)|Adverse Event|9
7579310|NCT02143713|26362404|P3|Treatment Period (6 Months)|Adverse Event|8
7579311|NCT02143713|26362405|P2|Treatment Period (6 Months)|Adverse Event|8
7579312|NCT02143713|26362406|P1|Treatment Period (6 Months)|Adverse Event|7
7579313|NCT02143713|26362403|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
7579314|NCT02143713|26362404|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
7579315|NCT02143713|26362405|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
7579316|NCT02143713|26362406|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
7579317|NCT02143583|26362500|P3|Overall Study|husband illness|1
7579318|NCT02143583|26362501|P2|Overall Study|husband illness|0
7579319|NCT02143583|26362502|P1|Overall Study|husband illness|0
7579320|NCT02143583|26362500|P3|Overall Study|Withdrawal by Subject|1
7579321|NCT02143583|26362501|P2|Overall Study|Withdrawal by Subject|0
7579322|NCT02143583|26362502|P1|Overall Study|Withdrawal by Subject|1
7579323|NCT02143141|26362525|P2|Overall Study|pain scores at 24 hours not collected|0
7579324|NCT02143141|26362526|P1|Overall Study|pain scores at 24 hours not collected|1
7579325|NCT02143102|26362538|P2|Overall Study|Lost to Follow-up|0
7579326|NCT02143102|26362539|P1|Overall Study|Lost to Follow-up|11
7579327|NCT02143024|26362549|P2|Overall Study|Withdrawal by Subject|0
7579328|NCT02143024|26362550|P1|Overall Study|Withdrawal by Subject|1
7579329|NCT02143024|26362549|P2|Overall Study|Lost to Follow-up|1
7579330|NCT02143024|26362550|P1|Overall Study|Lost to Follow-up|1
7579331|NCT02142894|26362556|P1|Overall Study|Protocol Violation|8
7579332|NCT02142738|26362562|P2|Overall Study|Ongoing in Study|82
7579333|NCT02142738|26362563|P1|Overall Study|Ongoing in Study|107
7579334|NCT02142738|26362562|P2|Overall Study|Withdrawal by Subject|5
7579335|NCT02142738|26362563|P1|Overall Study|Withdrawal by Subject|5
7579336|NCT02142738|26362562|P2|Overall Study|Progressive Disease|1
7579337|NCT02142738|26362563|P1|Overall Study|Progressive Disease|0
7579338|NCT02142738|26362562|P2|Overall Study|Death|55
7579339|NCT02142738|26362563|P1|Overall Study|Death|33
7579340|NCT02142738|26362562|P2|Overall Study|Adverse Event|8
7579341|NCT02142738|26362563|P1|Overall Study|Adverse Event|9
7579342|NCT02142712|26362576|P4|Overall Study|Lost to Follow-up|0
7579343|NCT02142712|26362577|P3|Overall Study|Lost to Follow-up|1
7579344|NCT02142712|26362578|P2|Overall Study|Lost to Follow-up|1
7579345|NCT02142712|26362579|P1|Overall Study|Lost to Follow-up|1
7579346|NCT02142504|26362607|P3|Overall Study|Reason Not Specified|4
7579347|NCT02142504|26362608|P2|Overall Study|Reason Not Specified|5
7579348|NCT02142504|26362609|P1|Overall Study|Reason Not Specified|4
7579349|NCT02142504|26362607|P3|Overall Study|Physician Decision|3
7579350|NCT02142504|26362608|P2|Overall Study|Physician Decision|1
7579351|NCT02142504|26362609|P1|Overall Study|Physician Decision|0
7579352|NCT02142504|26362607|P3|Overall Study|Pregnancy|2
7579353|NCT02142504|26362608|P2|Overall Study|Pregnancy|4
7579354|NCT02142504|26362609|P1|Overall Study|Pregnancy|4
7579355|NCT02142504|26362607|P3|Overall Study|Withdrawal by Subject|11
7579356|NCT02142504|26362608|P2|Overall Study|Withdrawal by Subject|9
7579357|NCT02142504|26362609|P1|Overall Study|Withdrawal by Subject|7
7579358|NCT02142504|26362607|P3|Overall Study|Lost to Follow-up|17
7579359|NCT02142504|26362608|P2|Overall Study|Lost to Follow-up|19
7579360|NCT02142504|26362609|P1|Overall Study|Lost to Follow-up|12
7579361|NCT02142504|26362607|P3|Overall Study|Adverse Event|4
7579362|NCT02142504|26362608|P2|Overall Study|Adverse Event|3
7579363|NCT02142504|26362609|P1|Overall Study|Adverse Event|2
7579364|NCT02142504|26362607|P3|Overall Study|Protocol Violation|2
7579365|NCT02142504|26362608|P2|Overall Study|Protocol Violation|1
7579366|NCT02142504|26362609|P1|Overall Study|Protocol Violation|2
7579367|NCT02142387|26362697|P2|Overall Study|occurred not at home|2474
7579368|NCT02142387|26362698|P1|Overall Study|occurred not at home|298
7579369|NCT02142387|26362697|P2|Overall Study|incomplete data|9
7579370|NCT02142387|26362698|P1|Overall Study|incomplete data|1
7579371|NCT02142387|26362697|P2|Overall Study|witnessed by paramedic|917
7579372|NCT02142387|26362698|P1|Overall Study|witnessed by paramedic|139
7579373|NCT02142387|26362697|P2|Overall Study|CPR not performed|473
7579374|NCT02142387|26362698|P1|Overall Study|CPR not performed|74
7579375|NCT02142387|26362697|P2|Overall Study|non-cardiac etiology|3431
7579376|NCT02142387|26362698|P1|Overall Study|non-cardiac etiology|504
7579377|NCT02142387|26362697|P2|Overall Study|<19 years old|326
7579378|NCT02142387|26362698|P1|Overall Study|<19 years old|49
7579379|NCT02142283|26362811|P2|Overall Study|Withdrawal by Subject|3
7579380|NCT02142283|26362812|P1|Overall Study|Withdrawal by Subject|1
7579381|NCT02142283|26362811|P2|Overall Study|Death|18
7579382|NCT02142283|26362812|P1|Overall Study|Death|20
7579383|NCT02141997|26362921|P4|Overall Study|Other|0
7579384|NCT02141997|26362922|P3|Overall Study|Other|0
7579385|NCT02141997|26362923|P2|Overall Study|Other|4
7579386|NCT02141997|26362924|P1|Overall Study|Other|1
7579387|NCT02141997|26362921|P4|Overall Study|Withdrew consent|0
7579388|NCT02141997|26362922|P3|Overall Study|Withdrew consent|3
7579389|NCT02141997|26362923|P2|Overall Study|Withdrew consent|0
7579390|NCT02141997|26362924|P1|Overall Study|Withdrew consent|1
7579391|NCT02141997|26362921|P4|Overall Study|Participant noncompliance|0
7579392|NCT02141997|26362922|P3|Overall Study|Participant noncompliance|0
7579393|NCT02141997|26362923|P2|Overall Study|Participant noncompliance|0
7579394|NCT02141997|26362924|P1|Overall Study|Participant noncompliance|1
7579395|NCT02141997|26362921|P4|Overall Study|Adverse Event|1
7579396|NCT02141997|26362922|P3|Overall Study|Adverse Event|0
7579397|NCT02141997|26362923|P2|Overall Study|Adverse Event|2
7579398|NCT02141997|26362924|P1|Overall Study|Adverse Event|0
7579399|NCT02141984|26362962|P1|Overall Study|Lack of Efficacy|2
7579400|NCT02141854|26362981|P6|Treatment Period|Lost to Follow-up|1
7579401|NCT02141854|26362982|P5|Treatment Period|Lost to Follow-up|0
7579402|NCT02141854|26362983|P4|Treatment Period|Lost to Follow-up|1
7579403|NCT02141854|26362984|P3|Treatment Period|Lost to Follow-up|1
7579404|NCT02141854|26362985|P2|Treatment Period|Lost to Follow-up|1
7579405|NCT02141854|26362986|P1|Treatment Period|Lost to Follow-up|0
7579406|NCT02141854|26362981|P6|Treatment Period|Disease progression|18
7579407|NCT02141854|26362982|P5|Treatment Period|Disease progression|0
7579408|NCT02141854|26362983|P4|Treatment Period|Disease progression|3
7579409|NCT02141854|26362984|P3|Treatment Period|Disease progression|1
7579410|NCT02141854|26362985|P2|Treatment Period|Disease progression|2
7579411|NCT02141854|26362986|P1|Treatment Period|Disease progression|0
7579412|NCT02141854|26362981|P6|Treatment Period|Withdrawal by Subject|7
7579413|NCT02141854|26362982|P5|Treatment Period|Withdrawal by Subject|4
7579414|NCT02141854|26362983|P4|Treatment Period|Withdrawal by Subject|3
7579415|NCT02141854|26362984|P3|Treatment Period|Withdrawal by Subject|3
7579416|NCT02141854|26362985|P2|Treatment Period|Withdrawal by Subject|2
7579417|NCT02141854|26362986|P1|Treatment Period|Withdrawal by Subject|0
7579418|NCT02141854|26362981|P6|Treatment Period|Adverse Event|2
7579419|NCT02141854|26362982|P5|Treatment Period|Adverse Event|2
7579420|NCT02141854|26362983|P4|Treatment Period|Adverse Event|0
7579421|NCT02141854|26362984|P3|Treatment Period|Adverse Event|2
7579422|NCT02141854|26362985|P2|Treatment Period|Adverse Event|2
7579423|NCT02141854|26362986|P1|Treatment Period|Adverse Event|0
7579424|NCT02141854|26362981|P6|Treatment Period|Other|2
7579425|NCT02141854|26362982|P5|Treatment Period|Other|1
7579426|NCT02141854|26362983|P4|Treatment Period|Other|0
7579427|NCT02141854|26362984|P3|Treatment Period|Other|2
7579428|NCT02141854|26362985|P2|Treatment Period|Other|1
7579429|NCT02141854|26362986|P1|Treatment Period|Other|0
7579430|NCT02141854|26362981|P6|Treatment Period|Pregnancy|0
7579431|NCT02141854|26362982|P5|Treatment Period|Pregnancy|0
7579432|NCT02141854|26362983|P4|Treatment Period|Pregnancy|0
7579433|NCT02141854|26362984|P3|Treatment Period|Pregnancy|0
7579434|NCT02141854|26362985|P2|Treatment Period|Pregnancy|1
7579435|NCT02141854|26362986|P1|Treatment Period|Pregnancy|0
7579436|NCT02141854|26362981|P6|Treatment Period|Lack of Efficacy|7
7579437|NCT02141854|26362982|P5|Treatment Period|Lack of Efficacy|1
7579438|NCT02141854|26362983|P4|Treatment Period|Lack of Efficacy|1
7579439|NCT02141854|26362984|P3|Treatment Period|Lack of Efficacy|0
7579440|NCT02141854|26362985|P2|Treatment Period|Lack of Efficacy|0
7579441|NCT02141854|26362986|P1|Treatment Period|Lack of Efficacy|0
7579442|NCT02141854|26362981|P6|Treatment Period|Noncompliance|0
7579443|NCT02141854|26362982|P5|Treatment Period|Noncompliance|0
7579444|NCT02141854|26362983|P4|Treatment Period|Noncompliance|1
7579445|NCT02141854|26362984|P3|Treatment Period|Noncompliance|0
7579446|NCT02141854|26362985|P2|Treatment Period|Noncompliance|0
7579447|NCT02141854|26362986|P1|Treatment Period|Noncompliance|0
7579448|NCT02141854|26362981|P6|Treatment Period|Protocol Violation|1
7579449|NCT02141854|26362982|P5|Treatment Period|Protocol Violation|2
7579450|NCT02141854|26362983|P4|Treatment Period|Protocol Violation|2
7579451|NCT02141854|26362984|P3|Treatment Period|Protocol Violation|0
7579452|NCT02141854|26362985|P2|Treatment Period|Protocol Violation|1
7579453|NCT02141854|26362986|P1|Treatment Period|Protocol Violation|0
7579454|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579455|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579456|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579457|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579458|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579459|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7579460|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579461|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579462|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579463|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579464|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579465|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
7579466|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Adverse Event|0
7579467|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Adverse Event|0
7579468|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Adverse Event|0
7579469|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Adverse Event|0
7579470|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Adverse Event|0
7579471|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Adverse Event|10
7579472|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Other|0
7579473|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Other|0
7579474|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Other|0
7579475|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Other|0
7579476|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Other|0
7579477|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Other|14
7579478|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579479|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579480|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579481|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579482|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579483|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
7579484|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579485|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579486|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579487|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579488|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579489|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
7579490|NCT02141854|26362981|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579491|NCT02141854|26362982|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579492|NCT02141854|26362983|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579493|NCT02141854|26362984|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579494|NCT02141854|26362985|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579495|NCT02141854|26362986|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
7579496|NCT02141672|26363041|P3|Overall Study|refused to follow-up|1
7579497|NCT02141672|26363042|P2|Overall Study|refused to follow-up|0
7579498|NCT02141672|26363043|P1|Overall Study|refused to follow-up|1
7579499|NCT02141672|26363041|P3|Overall Study|Withdrawal by Subject|5
7579500|NCT02141672|26363042|P2|Overall Study|Withdrawal by Subject|2
7579501|NCT02141672|26363043|P1|Overall Study|Withdrawal by Subject|3
7579502|NCT02141672|26363041|P3|Overall Study|Protocol Violation|1
7579503|NCT02141672|26363042|P2|Overall Study|Protocol Violation|0
7579504|NCT02141672|26363043|P1|Overall Study|Protocol Violation|0
7579505|NCT02141672|26363041|P3|Overall Study|Physician Decision|5
7579506|NCT02141672|26363042|P2|Overall Study|Physician Decision|2
7579507|NCT02141672|26363043|P1|Overall Study|Physician Decision|1
7579508|NCT02141672|26363041|P3|Overall Study|Lost to Follow-up|3
7579509|NCT02141672|26363042|P2|Overall Study|Lost to Follow-up|1
7579510|NCT02141672|26363043|P1|Overall Study|Lost to Follow-up|1
7579511|NCT02141672|26363041|P3|Overall Study|Lack of Efficacy|2
7579512|NCT02141672|26363042|P2|Overall Study|Lack of Efficacy|0
7579513|NCT02141672|26363043|P1|Overall Study|Lack of Efficacy|0
7579514|NCT02141672|26363041|P3|Overall Study|Death|1
7579515|NCT02141672|26363042|P2|Overall Study|Death|2
7579516|NCT02141672|26363043|P1|Overall Study|Death|10
7579517|NCT02141672|26363041|P3|Overall Study|Adverse Event|0
7579518|NCT02141672|26363042|P2|Overall Study|Adverse Event|1
7579519|NCT02141672|26363043|P1|Overall Study|Adverse Event|0
7579520|NCT02141659|26363105|P6|Overall Study|Pretreatment Event/ Adverse Event|1
7579521|NCT02141659|26363106|P5|Overall Study|Pretreatment Event/ Adverse Event|2
7579522|NCT02141659|26363107|P4|Overall Study|Pretreatment Event/ Adverse Event|0
7579523|NCT02141659|26363108|P3|Overall Study|Pretreatment Event/ Adverse Event|0
7579524|NCT02141659|26363109|P2|Overall Study|Pretreatment Event/ Adverse Event|0
7579525|NCT02141659|26363110|P1|Overall Study|Pretreatment Event/ Adverse Event|0
7579526|NCT02141659|26363105|P6|Overall Study|Lack of Efficacy|1
7579527|NCT02141659|26363106|P5|Overall Study|Lack of Efficacy|0
7579528|NCT02141659|26363107|P4|Overall Study|Lack of Efficacy|0
7579529|NCT02141659|26363108|P3|Overall Study|Lack of Efficacy|0
7579530|NCT02141659|26363109|P2|Overall Study|Lack of Efficacy|0
7579531|NCT02141659|26363110|P1|Overall Study|Lack of Efficacy|0
7579532|NCT02141659|26363105|P6|Overall Study|Major Protocol Deviation|0
7579533|NCT02141659|26363106|P5|Overall Study|Major Protocol Deviation|0
7579534|NCT02141659|26363107|P4|Overall Study|Major Protocol Deviation|0
7579535|NCT02141659|26363108|P3|Overall Study|Major Protocol Deviation|0
7579536|NCT02141659|26363109|P2|Overall Study|Major Protocol Deviation|1
7579537|NCT02141659|26363110|P1|Overall Study|Major Protocol Deviation|0
7579538|NCT02141633|26363166|P2|Overall Study|Physician Decision|0
7579539|NCT02141633|26363167|P1|Overall Study|Physician Decision|1
7579540|NCT02141620|26363175|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
7579541|NCT02141620|26363176|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
7579542|NCT02141516|26363268|P3|Overall Study|Other|0
7579543|NCT02141516|26363269|P2|Overall Study|Other|3
7579544|NCT02141516|26363270|P1|Overall Study|Other|0
7579545|NCT02141516|26363268|P3|Overall Study|Lost to Follow-up|0
7579546|NCT02141516|26363269|P2|Overall Study|Lost to Follow-up|1
7579547|NCT02141516|26363270|P1|Overall Study|Lost to Follow-up|0
7579548|NCT02141516|26363268|P3|Overall Study|Adverse Event|0
7579549|NCT02141516|26363269|P2|Overall Study|Adverse Event|1
7579550|NCT02141516|26363270|P1|Overall Study|Adverse Event|0
7579551|NCT02141490|26363321|P3|Overall Study|Screening failures|0
7579552|NCT02141490|26363322|P2|Overall Study|Screening failures|0
7579553|NCT02141490|26363323|P1|Overall Study|Screening failures|4
7579554|NCT02141399|26363368|P1|Overall Study|Failure to meet eligibility criteria|14
7579555|NCT02141399|26363368|P1|Overall Study|Withdrawal by Subject|238
7579556|NCT02141399|26363368|P1|Overall Study|Protocol Violation|38
7579557|NCT02141399|26363368|P1|Overall Study|Pregnancy|3
7579558|NCT02141399|26363368|P1|Overall Study|Physician Decision|17
7579559|NCT02141399|26363368|P1|Overall Study|Other|45
7579560|NCT02141399|26363368|P1|Overall Study|Non-compliance with study drug|18
7579561|NCT02141399|26363368|P1|Overall Study|Lost to Follow-up|151
7579562|NCT02141399|26363368|P1|Overall Study|Lack of Efficacy|62
7579563|NCT02141399|26363368|P1|Overall Study|Adverse Event|158
7579564|NCT02141360|26363374|P3|Overall Study|Study Terminated before Visit|0
7579565|NCT02141360|26363375|P2|Overall Study|Study Terminated before Visit|0
7579566|NCT02141360|26363376|P1|Overall Study|Study Terminated before Visit|1
7579567|NCT02141360|26363374|P3|Overall Study|Withdrawal by Subject|0
7579568|NCT02141360|26363375|P2|Overall Study|Withdrawal by Subject|0
7579569|NCT02141360|26363376|P1|Overall Study|Withdrawal by Subject|6
7579570|NCT02141295|26363387|P3|Overall Study|Withdrawal by Subject|4
7579571|NCT02141295|26363388|P2|Overall Study|Withdrawal by Subject|9
7579572|NCT02141295|26363389|P1|Overall Study|Withdrawal by Subject|0
7579573|NCT02141295|26363387|P3|Overall Study|Reason not specified|10
7579574|NCT02141295|26363388|P2|Overall Study|Reason not specified|9
7579575|NCT02141295|26363389|P1|Overall Study|Reason not specified|0
7579576|NCT02141295|26363387|P3|Overall Study|Progressive disease|50
7579577|NCT02141295|26363388|P2|Overall Study|Progressive disease|32
7579578|NCT02141295|26363389|P1|Overall Study|Progressive disease|3
7579579|NCT02141295|26363387|P3|Overall Study|Non-compliance|0
7579580|NCT02141295|26363388|P2|Overall Study|Non-compliance|1
7579581|NCT02141295|26363389|P1|Overall Study|Non-compliance|0
7579582|NCT02141295|26363387|P3|Overall Study|Study terminated by sponsor|6
7579583|NCT02141295|26363388|P2|Overall Study|Study terminated by sponsor|6
7579584|NCT02141295|26363389|P1|Overall Study|Study terminated by sponsor|0
7579585|NCT02141295|26363387|P3|Overall Study|Physician Decision|14
7579586|NCT02141295|26363388|P2|Overall Study|Physician Decision|19
7579587|NCT02141295|26363389|P1|Overall Study|Physician Decision|2
7579588|NCT02141295|26363387|P3|Overall Study|Adverse Event|11
7579589|NCT02141295|26363388|P2|Overall Study|Adverse Event|18
7579590|NCT02141295|26363389|P1|Overall Study|Adverse Event|1
7579591|NCT02141217|26363425|P2|Overall Study|Surgical Intervention|1
7579592|NCT02141217|26363426|P1|Overall Study|Surgical Intervention|1
7579593|NCT02141217|26363425|P2|Overall Study|Physician Decision|0
7579594|NCT02141217|26363426|P1|Overall Study|Physician Decision|1
7579595|NCT02141217|26363425|P2|Overall Study|Lost to Follow-up|1
7579596|NCT02141217|26363426|P1|Overall Study|Lost to Follow-up|1
7579597|NCT02141217|26363425|P2|Overall Study|Withdrawal by Subject|0
7579598|NCT02141217|26363426|P1|Overall Study|Withdrawal by Subject|6
7579599|NCT02141217|26363425|P2|Overall Study|Protocol Violation|4
7579600|NCT02141217|26363426|P1|Overall Study|Protocol Violation|1
7579601|NCT02141217|26363425|P2|Overall Study|Adverse Event|2
7579602|NCT02141217|26363426|P1|Overall Study|Adverse Event|1
7579603|NCT02141204|26363446|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
7579604|NCT02141204|26363447|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
7579605|NCT02141204|26363446|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
7579606|NCT02141204|26363447|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7579607|NCT02141204|26363446|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
7579608|NCT02141204|26363447|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
7579609|NCT02141204|26363446|P2|Overall Study|Lost to Follow-up|1
7579610|NCT02141204|26363447|P1|Overall Study|Lost to Follow-up|2
7579611|NCT02140970|26363463|P2|Overall Study|Did not meet inclusion criteria|1
7579612|NCT02140970|26363464|P1|Overall Study|Did not meet inclusion criteria|0
7579613|NCT02140970|26363463|P2|Overall Study|Misplaced consent, subject withdrawn|0
7579614|NCT02140970|26363464|P1|Overall Study|Misplaced consent, subject withdrawn|1
7579615|NCT02140970|26363463|P2|Overall Study|Lost to Follow-up|2
7579616|NCT02140970|26363464|P1|Overall Study|Lost to Follow-up|1
7579617|NCT02140775|26363520|P2|Overall Study|Withdrawal by Subject|7
7579618|NCT02140775|26363521|P1|Overall Study|Withdrawal by Subject|30
7579619|NCT02140762|26363533|P2|Overall Study|Other|1
7579620|NCT02140762|26363534|P1|Overall Study|Other|0
7579621|NCT02140762|26363533|P2|Overall Study|Withdrawal by Subject|4
7579622|NCT02140762|26363534|P1|Overall Study|Withdrawal by Subject|6
7579623|NCT02140762|26363533|P2|Overall Study|Protocol Violation|1
7579624|NCT02140762|26363534|P1|Overall Study|Protocol Violation|1
7579625|NCT02140762|26363533|P2|Overall Study|Lost to Follow-up|5
7579626|NCT02140762|26363534|P1|Overall Study|Lost to Follow-up|9
7579627|NCT02140762|26363533|P2|Overall Study|Adverse Event|1
7579628|NCT02140762|26363534|P1|Overall Study|Adverse Event|1
7579629|NCT02140645|26363600|P6|Overall Study|Not linked|70896
7579630|NCT02140645|26363601|P5|Overall Study|Not linked|3286
7579631|NCT02140645|26363602|P4|Overall Study|Not linked|13833
7579632|NCT02140645|26363603|P3|Overall Study|Not linked|4236
7579633|NCT02140645|26363604|P2|Overall Study|Not linked|61654
7579634|NCT02140645|26363605|P1|Overall Study|Not linked|5489
7579635|NCT02140567|26363703|P1|Overall Study|Problems with recording equipment|6
7579636|NCT02140411|26363708|P1|Overall Study|Adverse Event|1
7579637|NCT02140164|26363728|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
7579638|NCT02140060|26363749|P6|Overall Study|Lack of Efficacy|0
7579639|NCT02140060|26363750|P5|Overall Study|Lack of Efficacy|0
7579640|NCT02140060|26363751|P4|Overall Study|Lack of Efficacy|1
7579641|NCT02140060|26363752|P3|Overall Study|Lack of Efficacy|0
7579642|NCT02140060|26363753|P2|Overall Study|Lack of Efficacy|0
7579643|NCT02140060|26363754|P1|Overall Study|Lack of Efficacy|0
7579644|NCT02140060|26363749|P6|Overall Study|Adverse Event|1
7579645|NCT02140060|26363750|P5|Overall Study|Adverse Event|1
7579646|NCT02140060|26363751|P4|Overall Study|Adverse Event|1
7579647|NCT02140060|26363752|P3|Overall Study|Adverse Event|0
7579648|NCT02140060|26363753|P2|Overall Study|Adverse Event|0
7579649|NCT02140060|26363754|P1|Overall Study|Adverse Event|0
7579650|NCT02139982|26363779|P10|Overall Study|Lack of Efficacy|0
7579651|NCT02139982|26363780|P9|Overall Study|Lack of Efficacy|0
7579652|NCT02139982|26363781|P8|Overall Study|Lack of Efficacy|0
7579653|NCT02139982|26363782|P7|Overall Study|Lack of Efficacy|0
7579654|NCT02139982|26363783|P6|Overall Study|Lack of Efficacy|0
7579655|NCT02139982|26363784|P5|Overall Study|Lack of Efficacy|0
7579656|NCT02139982|26363785|P4|Overall Study|Lack of Efficacy|1
7579657|NCT02139982|26363786|P3|Overall Study|Lack of Efficacy|0
7579658|NCT02139982|26363787|P2|Overall Study|Lack of Efficacy|1
7579659|NCT02139982|26363788|P1|Overall Study|Lack of Efficacy|0
7579660|NCT02139943|26363852|P3|Overall Study|eGFR Withdrawal Criteria|1
7579661|NCT02139943|26363853|P2|Overall Study|eGFR Withdrawal Criteria|0
7579662|NCT02139943|26363854|P1|Overall Study|eGFR Withdrawal Criteria|0
7579663|NCT02139943|26363852|P3|Overall Study|Participant in Poor Compliance|1
7579664|NCT02139943|26363853|P2|Overall Study|Participant in Poor Compliance|0
7579665|NCT02139943|26363854|P1|Overall Study|Participant in Poor Compliance|1
7579666|NCT02139943|26363852|P3|Overall Study|Participant wishes to discontinue|0
7579667|NCT02139943|26363853|P2|Overall Study|Participant wishes to discontinue|0
7579668|NCT02139943|26363854|P1|Overall Study|Participant wishes to discontinue|2
7579669|NCT02139943|26363852|P3|Overall Study|Other|1
7579670|NCT02139943|26363853|P2|Overall Study|Other|0
7579671|NCT02139943|26363854|P1|Overall Study|Other|0
7579672|NCT02139943|26363852|P3|Overall Study|Withdrawal by Subject|0
7579673|NCT02139943|26363853|P2|Overall Study|Withdrawal by Subject|3
7579674|NCT02139943|26363854|P1|Overall Study|Withdrawal by Subject|4
7579675|NCT02139943|26363852|P3|Overall Study|Lost to Follow-up|2
7579676|NCT02139943|26363853|P2|Overall Study|Lost to Follow-up|2
7579677|NCT02139943|26363854|P1|Overall Study|Lost to Follow-up|3
7579678|NCT02139943|26363852|P3|Overall Study|Adverse Event|2
7579679|NCT02139943|26363853|P2|Overall Study|Adverse Event|1
7579680|NCT02139943|26363854|P1|Overall Study|Adverse Event|0
7579681|NCT02139826|26363874|P1|Overall Study|Adverse Event|1
7579682|NCT02139644|26363919|P6|Treatment Period|Other|1
7579683|NCT02139644|26363920|P5|Treatment Period|Other|0
7579684|NCT02139644|26363921|P4|Treatment Period|Other|1
7579685|NCT02139644|26363922|P3|Treatment Period|Other|1
7579686|NCT02139644|26363923|P2|Treatment Period|Other|3
7579687|NCT02139644|26363924|P1|Treatment Period|Other|0
7579688|NCT02139644|26363919|P6|Treatment Period|Lack of Efficacy|4
7579689|NCT02139644|26363920|P5|Treatment Period|Lack of Efficacy|1
7579690|NCT02139644|26363921|P4|Treatment Period|Lack of Efficacy|0
7579691|NCT02139644|26363922|P3|Treatment Period|Lack of Efficacy|1
7579692|NCT02139644|26363923|P2|Treatment Period|Lack of Efficacy|0
7579693|NCT02139644|26363924|P1|Treatment Period|Lack of Efficacy|0
7579694|NCT02139644|26363919|P6|Treatment Period|Lost to Follow-up|1
7579695|NCT02139644|26363920|P5|Treatment Period|Lost to Follow-up|1
7579696|NCT02139644|26363921|P4|Treatment Period|Lost to Follow-up|1
7579697|NCT02139644|26363922|P3|Treatment Period|Lost to Follow-up|1
7579698|NCT02139644|26363923|P2|Treatment Period|Lost to Follow-up|0
7579699|NCT02139644|26363924|P1|Treatment Period|Lost to Follow-up|0
7579700|NCT02139644|26363919|P6|Treatment Period|Disease progression|2
7579701|NCT02139644|26363920|P5|Treatment Period|Disease progression|1
7579702|NCT02139644|26363921|P4|Treatment Period|Disease progression|1
7579703|NCT02139644|26363922|P3|Treatment Period|Disease progression|0
7579704|NCT02139644|26363923|P2|Treatment Period|Disease progression|0
7579705|NCT02139644|26363924|P1|Treatment Period|Disease progression|0
7579706|NCT02139644|26363919|P6|Treatment Period|Protocol Violation|1
7579707|NCT02139644|26363920|P5|Treatment Period|Protocol Violation|1
7579708|NCT02139644|26363921|P4|Treatment Period|Protocol Violation|1
7579709|NCT02139644|26363922|P3|Treatment Period|Protocol Violation|0
7579710|NCT02139644|26363923|P2|Treatment Period|Protocol Violation|0
7579711|NCT02139644|26363924|P1|Treatment Period|Protocol Violation|0
7579712|NCT02139644|26363919|P6|Treatment Period|Non-compliance|0
7579713|NCT02139644|26363920|P5|Treatment Period|Non-compliance|0
7579714|NCT02139644|26363921|P4|Treatment Period|Non-compliance|1
7579715|NCT02139644|26363922|P3|Treatment Period|Non-compliance|0
7579716|NCT02139644|26363923|P2|Treatment Period|Non-compliance|0
7579717|NCT02139644|26363924|P1|Treatment Period|Non-compliance|0
7579718|NCT02139644|26363919|P6|Treatment Period|Withdrawal by Subject|2
7579719|NCT02139644|26363920|P5|Treatment Period|Withdrawal by Subject|3
7579720|NCT02139644|26363921|P4|Treatment Period|Withdrawal by Subject|2
7579721|NCT02139644|26363922|P3|Treatment Period|Withdrawal by Subject|2
7579722|NCT02139644|26363923|P2|Treatment Period|Withdrawal by Subject|0
7579723|NCT02139644|26363924|P1|Treatment Period|Withdrawal by Subject|0
7579724|NCT02139644|26363919|P6|Treatment Period|Adverse Event|6
7579725|NCT02139644|26363920|P5|Treatment Period|Adverse Event|1
7579726|NCT02139644|26363921|P4|Treatment Period|Adverse Event|2
7579727|NCT02139644|26363922|P3|Treatment Period|Adverse Event|3
7579728|NCT02139644|26363923|P2|Treatment Period|Adverse Event|0
7579729|NCT02139644|26363924|P1|Treatment Period|Adverse Event|0
7579730|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Other|0
7579731|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Other|0
7579732|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Other|0
7579733|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Other|0
7579734|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Other|0
7579735|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Other|6
7579736|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Adverse Event|0
7579737|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Adverse Event|0
7579738|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Adverse Event|0
7579739|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Adverse Event|0
7579740|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Adverse Event|0
7579741|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Adverse Event|3
7579742|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579743|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579744|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579745|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579746|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7579747|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
7579748|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579749|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579750|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579751|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579752|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7579753|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
7579754|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579755|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579756|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579757|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579758|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7579759|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
7579760|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579761|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579762|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579763|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579764|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7579765|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
7579766|NCT02139644|26363919|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579767|NCT02139644|26363920|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579768|NCT02139644|26363921|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579769|NCT02139644|26363922|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579770|NCT02139644|26363923|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7579771|NCT02139644|26363924|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
7579772|NCT02139592|26363976|P1|Overall Study|Case Report Forms Uncollected|8
7579773|NCT02139306|26364002|P2|Overall Study|Protocol Violation|0
7579774|NCT02139306|26364003|P1|Overall Study|Protocol Violation|4
7579775|NCT02139306|26364002|P2|Overall Study|Other Unspecified|3
7579776|NCT02139306|26364003|P1|Overall Study|Other Unspecified|2
7579777|NCT02139306|26364002|P2|Overall Study|Physician Decision|1
7579778|NCT02139306|26364003|P1|Overall Study|Physician Decision|0
7579779|NCT02139306|26364002|P2|Overall Study|Adverse Event|4
7579780|NCT02139306|26364003|P1|Overall Study|Adverse Event|3
7579781|NCT02139306|26364002|P2|Overall Study|Withdrawal by Subject|6
7579782|NCT02139306|26364003|P1|Overall Study|Withdrawal by Subject|4
7579783|NCT02139280|26364029|P2|Overall Study|No longer eligible|0
7579784|NCT02139280|26364030|P1|Overall Study|No longer eligible|2
7579785|NCT02139124|26364094|P5|Overall Study|Lost to Follow-up|4
7579786|NCT02139124|26364095|P4|Overall Study|Lost to Follow-up|5
7579787|NCT02139124|26364096|P3|Overall Study|Lost to Follow-up|0
7579788|NCT02139124|26364097|P2|Overall Study|Lost to Follow-up|2
7579789|NCT02139124|26364098|P1|Overall Study|Lost to Follow-up|3
7579790|NCT02139124|26364094|P5|Overall Study|subject moved|0
7579791|NCT02139124|26364095|P4|Overall Study|subject moved|0
7579792|NCT02139124|26364096|P3|Overall Study|subject moved|0
7579793|NCT02139124|26364097|P2|Overall Study|subject moved|0
7579794|NCT02139124|26364098|P1|Overall Study|subject moved|1
7579795|NCT02139124|26364094|P5|Overall Study|incarceration|0
7579796|NCT02139124|26364095|P4|Overall Study|incarceration|0
7579797|NCT02139124|26364096|P3|Overall Study|incarceration|1
7579798|NCT02139124|26364097|P2|Overall Study|incarceration|0
7579799|NCT02139124|26364098|P1|Overall Study|incarceration|0
7579800|NCT02139124|26364094|P5|Overall Study|non-compliant|0
7579801|NCT02139124|26364095|P4|Overall Study|non-compliant|2
7579802|NCT02139124|26364096|P3|Overall Study|non-compliant|0
7579803|NCT02139124|26364097|P2|Overall Study|non-compliant|0
7579804|NCT02139124|26364098|P1|Overall Study|non-compliant|1
7579805|NCT02139124|26364094|P5|Overall Study|Protocol Violation|1
7579806|NCT02139124|26364095|P4|Overall Study|Protocol Violation|1
7579807|NCT02139124|26364096|P3|Overall Study|Protocol Violation|0
7579808|NCT02139124|26364097|P2|Overall Study|Protocol Violation|0
7579809|NCT02139124|26364098|P1|Overall Study|Protocol Violation|0
7579810|NCT02139124|26364094|P5|Overall Study|Withdrawal by Subject|3
7579811|NCT02139124|26364095|P4|Overall Study|Withdrawal by Subject|2
7579812|NCT02139124|26364096|P3|Overall Study|Withdrawal by Subject|2
7579813|NCT02139124|26364097|P2|Overall Study|Withdrawal by Subject|2
7579814|NCT02139124|26364098|P1|Overall Study|Withdrawal by Subject|2
7579815|NCT02139124|26364094|P5|Overall Study|Adverse Event|5
7579816|NCT02139124|26364095|P4|Overall Study|Adverse Event|2
7579817|NCT02139124|26364096|P3|Overall Study|Adverse Event|1
7579818|NCT02139124|26364097|P2|Overall Study|Adverse Event|0
7579819|NCT02139124|26364098|P1|Overall Study|Adverse Event|2
7579820|NCT02139046|26364115|P5|Overall Study|Other Miscellaneous Reasons|12
7579821|NCT02139046|26364116|P4|Overall Study|Other Miscellaneous Reasons|9
7579822|NCT02139046|26364117|P3|Overall Study|Other Miscellaneous Reasons|4
7579823|NCT02139046|26364118|P2|Overall Study|Other Miscellaneous Reasons|9
7579824|NCT02139046|26364119|P1|Overall Study|Other Miscellaneous Reasons|10
7579825|NCT02139046|26364115|P5|Overall Study|Withdrawal due to a Gout Flare|1
7579826|NCT02139046|26364116|P4|Overall Study|Withdrawal due to a Gout Flare|0
7579827|NCT02139046|26364117|P3|Overall Study|Withdrawal due to a Gout Flare|1
7579828|NCT02139046|26364118|P2|Overall Study|Withdrawal due to a Gout Flare|1
7579829|NCT02139046|26364119|P1|Overall Study|Withdrawal due to a Gout Flare|1
7579830|NCT02139046|26364115|P5|Overall Study|Lack of Efficacy|2
7579831|NCT02139046|26364116|P4|Overall Study|Lack of Efficacy|1
7579832|NCT02139046|26364117|P3|Overall Study|Lack of Efficacy|2
7579833|NCT02139046|26364118|P2|Overall Study|Lack of Efficacy|1
7579834|NCT02139046|26364119|P1|Overall Study|Lack of Efficacy|0
7579835|NCT02139046|26364115|P5|Overall Study|Voluntary Withdrawal|16
7579836|NCT02139046|26364116|P4|Overall Study|Voluntary Withdrawal|15
7579837|NCT02139046|26364117|P3|Overall Study|Voluntary Withdrawal|10
7579838|NCT02139046|26364118|P2|Overall Study|Voluntary Withdrawal|8
7579839|NCT02139046|26364119|P1|Overall Study|Voluntary Withdrawal|20
7579840|NCT02139046|26364115|P5|Overall Study|Lost to Follow-up|13
7579841|NCT02139046|26364116|P4|Overall Study|Lost to Follow-up|18
7579842|NCT02139046|26364117|P3|Overall Study|Lost to Follow-up|16
7579843|NCT02139046|26364118|P2|Overall Study|Lost to Follow-up|16
7579844|NCT02139046|26364119|P1|Overall Study|Lost to Follow-up|13
7579845|NCT02139046|26364115|P5|Overall Study|Major Protocol Deviation|6
7579846|NCT02139046|26364116|P4|Overall Study|Major Protocol Deviation|12
7579847|NCT02139046|26364117|P3|Overall Study|Major Protocol Deviation|16
7579848|NCT02139046|26364118|P2|Overall Study|Major Protocol Deviation|10
7579849|NCT02139046|26364119|P1|Overall Study|Major Protocol Deviation|9
7579850|NCT02139046|26364115|P5|Overall Study|Pretreatment Event/Adverse Event|7
7579851|NCT02139046|26364116|P4|Overall Study|Pretreatment Event/Adverse Event|13
7579852|NCT02139046|26364117|P3|Overall Study|Pretreatment Event/Adverse Event|10
7579853|NCT02139046|26364118|P2|Overall Study|Pretreatment Event/Adverse Event|9
7579854|NCT02139046|26364119|P1|Overall Study|Pretreatment Event/Adverse Event|9
7579855|NCT02138916|26364160|P3|Overall Study|Adverse Event|3
7579856|NCT02138916|26364161|P2|Overall Study|Adverse Event|4
7579857|NCT02138916|26364162|P1|Overall Study|Adverse Event|4
7579858|NCT02138916|26364160|P3|Overall Study|Lost to Follow-up|3
7579859|NCT02138916|26364161|P2|Overall Study|Lost to Follow-up|2
7579860|NCT02138916|26364162|P1|Overall Study|Lost to Follow-up|4
7579861|NCT02138916|26364160|P3|Overall Study|Severe non-compliance|1
7579862|NCT02138916|26364161|P2|Overall Study|Severe non-compliance|2
7579863|NCT02138916|26364162|P1|Overall Study|Severe non-compliance|1
7579864|NCT02138916|26364160|P3|Overall Study|incorrect enrolment|0
7579865|NCT02138916|26364161|P2|Overall Study|incorrect enrolment|1
7579866|NCT02138916|26364162|P1|Overall Study|incorrect enrolment|1
7579867|NCT02138916|26364160|P3|Overall Study|Study specific withdrawal criteria|1
7579868|NCT02138916|26364161|P2|Overall Study|Study specific withdrawal criteria|0
7579869|NCT02138916|26364162|P1|Overall Study|Study specific withdrawal criteria|0
7579870|NCT02138916|26364160|P3|Overall Study|Withdrawal by Subject|32
7579871|NCT02138916|26364161|P2|Overall Study|Withdrawal by Subject|31
7579872|NCT02138916|26364162|P1|Overall Study|Withdrawal by Subject|27
7579873|NCT02138916|26364160|P3|Overall Study|Death|12
7579874|NCT02138916|26364161|P2|Overall Study|Death|11
7579875|NCT02138916|26364162|P1|Overall Study|Death|14
7579876|NCT02138916|26364160|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
7579877|NCT02138916|26364161|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
7579878|NCT02138916|26364162|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
7579879|NCT02138890|26364225|P2|Overall Study|Adverse Event|0
7579880|NCT02138890|26364226|P1|Overall Study|Adverse Event|1
7579881|NCT02138838|26364268|P2|Overall Study|Withdrawal by Subject|5
7579882|NCT02138838|26364269|P1|Overall Study|Withdrawal by Subject|1
7579883|NCT02138838|26364268|P2|Overall Study|Study Closure|6
7579884|NCT02138838|26364269|P1|Overall Study|Study Closure|7
7579885|NCT02138825|26364287|P2|Safety Follow-up|withdrawn due to lung transplant|1
7579886|NCT02138825|26364288|P1|Safety Follow-up|withdrawn due to lung transplant|0
7579887|NCT02138825|26364287|P2|Safety Follow-up|treatment unblinded|1
7579888|NCT02138825|26364288|P1|Safety Follow-up|treatment unblinded|0
7579889|NCT02138825|26364287|P2|Safety Follow-up|too unwell to attend the visit|1
7579890|NCT02138825|26364288|P1|Safety Follow-up|too unwell to attend the visit|0
7579891|NCT02138825|26364287|P2|Safety Follow-up|progressive disease|2
7579892|NCT02138825|26364288|P1|Safety Follow-up|progressive disease|0
7579893|NCT02138825|26364287|P2|Safety Follow-up|logistical difficulties|1
7579894|NCT02138825|26364288|P1|Safety Follow-up|logistical difficulties|0
7579895|NCT02138825|26364287|P2|Safety Follow-up|withdrawal by PI|0
7579896|NCT02138825|26364288|P1|Safety Follow-up|withdrawal by PI|1
7579897|NCT02138825|26364287|P2|Safety Follow-up|clinic worsening|0
7579898|NCT02138825|26364288|P1|Safety Follow-up|clinic worsening|1
7579899|NCT02138825|26364287|P2|Safety Follow-up|Withdrawal by Subject|3
7579900|NCT02138825|26364288|P1|Safety Follow-up|Withdrawal by Subject|5
7579901|NCT02138825|26364287|P2|Safety Follow-up|Death|5
7579902|NCT02138825|26364288|P1|Safety Follow-up|Death|11
7579903|NCT02138825|26364287|P2|Safety Follow-up|Adverse Event|3
7579904|NCT02138825|26364288|P1|Safety Follow-up|Adverse Event|4
7579905|NCT02138825|26364287|P2|Long-term Extension|Study termination by sponsor|38
7579906|NCT02138825|26364288|P1|Long-term Extension|Study termination by sponsor|32
7579907|NCT02138825|26364287|P2|Main Study Treatment|Medical decision|0
7579908|NCT02138825|26364288|P1|Main Study Treatment|Medical decision|1
7579909|NCT02138825|26364287|P2|Main Study Treatment|Withdrawal by Subject|1
7579910|NCT02138825|26364288|P1|Main Study Treatment|Withdrawal by Subject|3
7579911|NCT02138825|26364287|P2|Main Study Treatment|Study terminated by sponsor|9
7579912|NCT02138825|26364288|P1|Main Study Treatment|Study terminated by sponsor|10
7579913|NCT02138825|26364287|P2|Main Study Treatment|Sponsor decision|18
7579914|NCT02138825|26364288|P1|Main Study Treatment|Sponsor decision|12
7579915|NCT02138825|26364287|P2|Main Study Treatment|Protocol Violation|2
7579916|NCT02138825|26364288|P1|Main Study Treatment|Protocol Violation|2
7579917|NCT02138825|26364287|P2|Main Study Treatment|Death|2
7579918|NCT02138825|26364288|P1|Main Study Treatment|Death|1
7579919|NCT02138825|26364287|P2|Main Study Treatment|Adverse Event|3
7579920|NCT02138825|26364288|P1|Main Study Treatment|Adverse Event|11
7579921|NCT02138786|26364305|P3|Overall Study|Non-Compliance|1
7579922|NCT02138786|26364306|P2|Overall Study|Non-Compliance|0
7579923|NCT02138786|26364307|P1|Overall Study|Non-Compliance|0
7579924|NCT02138786|26364305|P3|Overall Study|Sponsor Terminated Study|1
7579925|NCT02138786|26364306|P2|Overall Study|Sponsor Terminated Study|1
7579926|NCT02138786|26364307|P1|Overall Study|Sponsor Terminated Study|0
7579927|NCT02138786|26364305|P3|Overall Study|Patient's Wish|0
7579928|NCT02138786|26364306|P2|Overall Study|Patient's Wish|2
7579929|NCT02138786|26364307|P1|Overall Study|Patient's Wish|0
7579930|NCT02138786|26364305|P3|Overall Study|Withdrawal by Subject|0
7579931|NCT02138786|26364306|P2|Overall Study|Withdrawal by Subject|2
7579932|NCT02138786|26364307|P1|Overall Study|Withdrawal by Subject|1
7579933|NCT02138786|26364305|P3|Overall Study|Disease Progression|3
7579934|NCT02138786|26364306|P2|Overall Study|Disease Progression|1
7579935|NCT02138786|26364307|P1|Overall Study|Disease Progression|1
7579936|NCT02138786|26364305|P3|Overall Study|Death|2
7579937|NCT02138786|26364306|P2|Overall Study|Death|7
7579938|NCT02138786|26364307|P1|Overall Study|Death|1
7579939|NCT02138786|26364305|P3|Overall Study|Adverse Event|1
7579940|NCT02138786|26364306|P2|Overall Study|Adverse Event|2
7579941|NCT02138786|26364307|P1|Overall Study|Adverse Event|0
7579942|NCT02138747|26364324|P4|Treatment Period 2|Other - Miscellaneous|0
7579943|NCT02138747|26364325|P3|Treatment Period 2|Other - Miscellaneous|0
7579944|NCT02138747|26364326|P2|Treatment Period 2|Other - Miscellaneous|0
7579945|NCT02138747|26364327|P1|Treatment Period 2|Other - Miscellaneous|3
7579946|NCT02138747|26364324|P4|Treatment Period 2|Withdrawal by Subject|2
7579947|NCT02138747|26364325|P3|Treatment Period 2|Withdrawal by Subject|1
7579948|NCT02138747|26364326|P2|Treatment Period 2|Withdrawal by Subject|4
7579949|NCT02138747|26364327|P1|Treatment Period 2|Withdrawal by Subject|5
7579950|NCT02138747|26364324|P4|Treatment Period 2|Protocol Violation|0
7579951|NCT02138747|26364325|P3|Treatment Period 2|Protocol Violation|0
7579952|NCT02138747|26364326|P2|Treatment Period 2|Protocol Violation|0
7579953|NCT02138747|26364327|P1|Treatment Period 2|Protocol Violation|1
7579954|NCT02138747|26364324|P4|Treatment Period 2|Lost to Follow-up|0
7579955|NCT02138747|26364325|P3|Treatment Period 2|Lost to Follow-up|0
7579956|NCT02138747|26364326|P2|Treatment Period 2|Lost to Follow-up|0
7579957|NCT02138747|26364327|P1|Treatment Period 2|Lost to Follow-up|2
7579958|NCT02138747|26364324|P4|Treatment Period 2|Adverse Event|1
7579959|NCT02138747|26364325|P3|Treatment Period 2|Adverse Event|1
7579960|NCT02138747|26364326|P2|Treatment Period 2|Adverse Event|3
7579961|NCT02138747|26364327|P1|Treatment Period 2|Adverse Event|6
7579962|NCT02138747|26364324|P4|Treatment Period 1|Other - Miscellaneous|0
7579963|NCT02138747|26364325|P3|Treatment Period 1|Other - Miscellaneous|0
7579964|NCT02138747|26364326|P2|Treatment Period 1|Other - Miscellaneous|4
7579965|NCT02138747|26364327|P1|Treatment Period 1|Other - Miscellaneous|2
7579966|NCT02138747|26364324|P4|Treatment Period 1|Withdrawal by Subject|3
7579967|NCT02138747|26364325|P3|Treatment Period 1|Withdrawal by Subject|1
7579968|NCT02138747|26364326|P2|Treatment Period 1|Withdrawal by Subject|4
7579969|NCT02138747|26364327|P1|Treatment Period 1|Withdrawal by Subject|8
7579970|NCT02138747|26364324|P4|Treatment Period 1|Protocol Violation|0
7579971|NCT02138747|26364325|P3|Treatment Period 1|Protocol Violation|0
7579972|NCT02138747|26364326|P2|Treatment Period 1|Protocol Violation|2
7579973|NCT02138747|26364327|P1|Treatment Period 1|Protocol Violation|0
7579974|NCT02138747|26364324|P4|Treatment Period 1|Lost to Follow-up|0
7579975|NCT02138747|26364325|P3|Treatment Period 1|Lost to Follow-up|1
7579976|NCT02138747|26364326|P2|Treatment Period 1|Lost to Follow-up|1
7579977|NCT02138747|26364327|P1|Treatment Period 1|Lost to Follow-up|0
7579978|NCT02138747|26364324|P4|Treatment Period 1|Adverse Event|1
7579979|NCT02138747|26364325|P3|Treatment Period 1|Adverse Event|2
7579980|NCT02138747|26364326|P2|Treatment Period 1|Adverse Event|14
7579981|NCT02138747|26364327|P1|Treatment Period 1|Adverse Event|10
7579982|NCT02138253|26364401|P2|Overall Study|Withdrawal by Subject|0
7579983|NCT02138253|26364402|P1|Overall Study|Withdrawal by Subject|1
7579984|NCT02138253|26364401|P2|Overall Study|Non compliance|0
7579985|NCT02138253|26364402|P1|Overall Study|Non compliance|1
7579986|NCT02138253|26364401|P2|Overall Study|Physician Decision|0
7579987|NCT02138253|26364402|P1|Overall Study|Physician Decision|2
7579988|NCT02138253|26364401|P2|Overall Study|Lost to Follow-up|1
7579989|NCT02138253|26364402|P1|Overall Study|Lost to Follow-up|2
7579990|NCT02138253|26364401|P2|Overall Study|Adverse Event|3
7579991|NCT02138253|26364402|P1|Overall Study|Adverse Event|3
7579992|NCT02138214|26364477|P3|Overall Study|Screen Failure|0
7579993|NCT02138214|26364478|P2|Overall Study|Screen Failure|1
7579994|NCT02138214|26364479|P1|Overall Study|Screen Failure|0
7579995|NCT02138214|26364477|P3|Overall Study|Lost to Follow-up|4
7579996|NCT02138214|26364478|P2|Overall Study|Lost to Follow-up|2
7579997|NCT02138214|26364479|P1|Overall Study|Lost to Follow-up|0
7579998|NCT02138214|26364477|P3|Overall Study|Withdrawal by Subject|0
7579999|NCT02138214|26364478|P2|Overall Study|Withdrawal by Subject|1
7580000|NCT02138214|26364479|P1|Overall Study|Withdrawal by Subject|0
7580001|NCT02138136|26364500|P1|Overall Study|Withdrawn by Sponsor|5
7580002|NCT02138136|26364500|P1|Overall Study|Lost to Follow-up|32
7580003|NCT02138136|26364500|P1|Overall Study|Withdrawal by Subject|36
7580004|NCT02138136|26364500|P1|Overall Study|Adverse Event|18
7580005|NCT02138136|26364500|P1|Overall Study|Pregnancy|2
7580006|NCT02138136|26364500|P1|Overall Study|Lack of Efficacy|35
7580007|NCT02138136|26364500|P1|Overall Study|Physician Decision|7
7580008|NCT02138136|26364500|P1|Overall Study|Protocol Violation|4
7580009|NCT02138110|26364507|P1|Overall Scaffold Implantation|Death|3
7580010|NCT02138110|26364507|P1|Enrolled for Scaffold Implantation|Physician Decision|1
7580011|NCT02137837|26364740|P3|Overall Study|Not protocol specified|3
7580012|NCT02137837|26364741|P2|Overall Study|Not protocol specified|1
7580013|NCT02137837|26364742|P1|Overall Study|Not protocol specified|2
7580014|NCT02137837|26364740|P3|Overall Study|Progression/relapse|7
7580015|NCT02137837|26364741|P2|Overall Study|Progression/relapse|7
7580016|NCT02137837|26364742|P1|Overall Study|Progression/relapse|9
7580017|NCT02137837|26364740|P3|Overall Study|Refusal unrelated to adverse event|1
7580018|NCT02137837|26364741|P2|Overall Study|Refusal unrelated to adverse event|2
7580019|NCT02137837|26364742|P1|Overall Study|Refusal unrelated to adverse event|2
7580020|NCT02137837|26364740|P3|Overall Study|Adverse Event|1
7580021|NCT02137837|26364741|P2|Overall Study|Adverse Event|2
7580022|NCT02137837|26364742|P1|Overall Study|Adverse Event|0
7580023|NCT02137785|26364770|P2|Overall Study|subject moved out of state|0
7580024|NCT02137785|26364771|P1|Overall Study|subject moved out of state|1
7580025|NCT02137785|26364770|P2|Overall Study|Withdrawal by Subject|4
7580026|NCT02137785|26364771|P1|Overall Study|Withdrawal by Subject|1
7580027|NCT02137785|26364770|P2|Overall Study|Lost to Follow-up|0
7580028|NCT02137785|26364771|P1|Overall Study|Lost to Follow-up|1
7580029|NCT02137772|26364879|P2|Overall Study|Not treated|2
7580030|NCT02137772|26364880|P1|Overall Study|Not treated|3
7580031|NCT02137772|26364879|P2|Overall Study|Non-compliance with study drug|0
7580032|NCT02137772|26364880|P1|Overall Study|Non-compliance with study drug|1
7580033|NCT02137772|26364879|P2|Overall Study|Withdrawal by Subject|17
7580034|NCT02137772|26364880|P1|Overall Study|Withdrawal by Subject|28
7580035|NCT02137772|26364879|P2|Overall Study|Physician Decision|5
7580036|NCT02137772|26364880|P1|Overall Study|Physician Decision|15
7580037|NCT02137772|26364879|P2|Overall Study|Lost to Follow-up|4
7580038|NCT02137772|26364880|P1|Overall Study|Lost to Follow-up|8
7580039|NCT02137772|26364879|P2|Overall Study|Death|44
7580040|NCT02137772|26364880|P1|Overall Study|Death|71
7580041|NCT02137772|26364879|P2|Overall Study|Adverse Event|3
7580042|NCT02137772|26364880|P1|Overall Study|Adverse Event|6
7580043|NCT02137369|26365167|P2|Overall Study|Moved away|0
7580044|NCT02137369|26365168|P1|Overall Study|Moved away|2
7580045|NCT02137369|26365167|P2|Overall Study|Lost to Follow-up|0
7580046|NCT02137369|26365168|P1|Overall Study|Lost to Follow-up|1
7580047|NCT02137369|26365167|P2|Overall Study|Adverse Event|0
7580048|NCT02137369|26365168|P1|Overall Study|Adverse Event|2
7580049|NCT02137369|26365167|P2|Overall Study|Withdrawal by Subject|2
7580050|NCT02137369|26365168|P1|Overall Study|Withdrawal by Subject|3
7580051|NCT02137239|26365178|P2|Overall Study|Adverse Event|2
7580052|NCT02137239|26365179|P1|Overall Study|Adverse Event|2
7580053|NCT02137239|26365178|P2|Overall Study|Withdrew Consent|1
7580054|NCT02137239|26365179|P1|Overall Study|Withdrew Consent|1
7580055|NCT02137239|26365178|P2|Overall Study|Discontinued Study Treatment|3
7580056|NCT02137239|26365179|P1|Overall Study|Discontinued Study Treatment|0
7580057|NCT02137226|26365241|P5|Period 2 (Re - Randomization)|Other Reason|1
7580058|NCT02137226|26365242|P4|Period 2 (Re - Randomization)|Other Reason|1
7580059|NCT02137226|26365243|P3|Period 2 (Re - Randomization)|Other Reason|1
7580060|NCT02137226|26365244|P2|Period 2 (Re - Randomization)|Other Reason|0
7580061|NCT02137226|26365245|P1|Period 2 (Re - Randomization)|Other Reason|0
7580062|NCT02137226|26365241|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
7580063|NCT02137226|26365242|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
7580064|NCT02137226|26365243|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
7580065|NCT02137226|26365244|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
7580066|NCT02137226|26365245|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
7580067|NCT02137226|26365241|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
7580068|NCT02137226|26365242|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
7580069|NCT02137226|26365243|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
7580070|NCT02137226|26365244|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
7580071|NCT02137226|26365245|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
7580072|NCT02137226|26365241|P5|Period 2 (Re - Randomization)|Physician Decision|0
7580073|NCT02137226|26365242|P4|Period 2 (Re - Randomization)|Physician Decision|1
7580074|NCT02137226|26365243|P3|Period 2 (Re - Randomization)|Physician Decision|0
7580075|NCT02137226|26365244|P2|Period 2 (Re - Randomization)|Physician Decision|0
7580076|NCT02137226|26365245|P1|Period 2 (Re - Randomization)|Physician Decision|0
7580077|NCT02137226|26365241|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
7580078|NCT02137226|26365242|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
7580079|NCT02137226|26365243|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
7580080|NCT02137226|26365244|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7580081|NCT02137226|26365245|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7580082|NCT02137226|26365241|P5|Period 2 (Re - Randomization)|Adverse Event|4
7580083|NCT02137226|26365242|P4|Period 2 (Re - Randomization)|Adverse Event|1
7580084|NCT02137226|26365243|P3|Period 2 (Re - Randomization)|Adverse Event|3
7580085|NCT02137226|26365244|P2|Period 2 (Re - Randomization)|Adverse Event|0
7580086|NCT02137226|26365245|P1|Period 2 (Re - Randomization)|Adverse Event|0
7580087|NCT02137226|26365241|P5|Period 1 (Initial Randomization)|Other Reason|0
7580088|NCT02137226|26365242|P4|Period 1 (Initial Randomization)|Other Reason|0
7580089|NCT02137226|26365243|P3|Period 1 (Initial Randomization)|Other Reason|0
7580090|NCT02137226|26365244|P2|Period 1 (Initial Randomization)|Other Reason|3
7580091|NCT02137226|26365245|P1|Period 1 (Initial Randomization)|Other Reason|1
7580092|NCT02137226|26365241|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
7580093|NCT02137226|26365242|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
7580094|NCT02137226|26365243|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
7580095|NCT02137226|26365244|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
7580096|NCT02137226|26365245|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
7580097|NCT02137226|26365241|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
7580098|NCT02137226|26365242|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
7580099|NCT02137226|26365243|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
7580100|NCT02137226|26365244|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
7580101|NCT02137226|26365245|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
7580102|NCT02137226|26365241|P5|Period 1 (Initial Randomization)|Physician Decision|0
7580103|NCT02137226|26365242|P4|Period 1 (Initial Randomization)|Physician Decision|0
7580104|NCT02137226|26365243|P3|Period 1 (Initial Randomization)|Physician Decision|0
7580105|NCT02137226|26365244|P2|Period 1 (Initial Randomization)|Physician Decision|3
7580106|NCT02137226|26365245|P1|Period 1 (Initial Randomization)|Physician Decision|1
7580107|NCT02137226|26365241|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7580108|NCT02137226|26365242|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7580109|NCT02137226|26365243|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7580110|NCT02137226|26365244|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
7580111|NCT02137226|26365245|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
7580112|NCT02137226|26365241|P5|Period 1 (Initial Randomization)|Adverse Event|0
7580113|NCT02137226|26365242|P4|Period 1 (Initial Randomization)|Adverse Event|0
7580114|NCT02137226|26365243|P3|Period 1 (Initial Randomization)|Adverse Event|0
7580115|NCT02137226|26365244|P2|Period 1 (Initial Randomization)|Adverse Event|3
7580116|NCT02137226|26365245|P1|Period 1 (Initial Randomization)|Adverse Event|3
7580117|NCT02136914|26365263|P2|Overall Study|Death|1
7580118|NCT02136914|26365264|P1|Overall Study|Death|0
7580119|NCT02136914|26365263|P2|Overall Study|Lack of Efficacy|0
7580120|NCT02136914|26365264|P1|Overall Study|Lack of Efficacy|1
7580121|NCT02136914|26365263|P2|Overall Study|Did Not Receive Study Drug|0
7580122|NCT02136914|26365264|P1|Overall Study|Did Not Receive Study Drug|2
7580123|NCT02136914|26365263|P2|Overall Study|Lost to Follow-up|1
7580124|NCT02136914|26365264|P1|Overall Study|Lost to Follow-up|1
7580125|NCT02136914|26365263|P2|Overall Study|Subject Unwilling to Proceed|2
7580126|NCT02136914|26365264|P1|Overall Study|Subject Unwilling to Proceed|7
7580127|NCT02136914|26365263|P2|Overall Study|Withdrawal by Subject|10
7580128|NCT02136914|26365264|P1|Overall Study|Withdrawal by Subject|3
7580129|NCT02136914|26365263|P2|Overall Study|Sponsor's Decision to Stop the Study|7
7580130|NCT02136914|26365264|P1|Overall Study|Sponsor's Decision to Stop the Study|7
7580131|NCT02136680|26365284|P2|Overall Study|Study ended before interview due|3
7580132|NCT02136680|26365285|P1|Overall Study|Study ended before interview due|6
7580133|NCT02136680|26365284|P2|Overall Study|Unable to schedule|16
7580134|NCT02136680|26365285|P1|Overall Study|Unable to schedule|17
7580135|NCT02136680|26365284|P2|Overall Study|Moved away|4
7580136|NCT02136680|26365285|P1|Overall Study|Moved away|5
7580137|NCT02136680|26365284|P2|Overall Study|No longer receiving care at clinic|5
7580138|NCT02136680|26365285|P1|Overall Study|No longer receiving care at clinic|3
7580139|NCT02136680|26365284|P2|Overall Study|No Longer Interested|1
7580140|NCT02136680|26365285|P1|Overall Study|No Longer Interested|1
7580141|NCT02136576|26365302|P3|Overall Study|Lost to Follow-up|0
7580142|NCT02136576|26365303|P2|Overall Study|Lost to Follow-up|0
7580143|NCT02136576|26365304|P1|Overall Study|Lost to Follow-up|2
7580144|NCT02136134|26365373|P2|Overall Study|Subjects randomized but not treated|8
7580145|NCT02136134|26365374|P1|Overall Study|Subjects randomized but not treated|10
7580146|NCT02136134|26365373|P2|Overall Study|Ongoing|207
7580147|NCT02136134|26365374|P1|Overall Study|Ongoing|185
7580148|NCT02136134|26365373|P2|Overall Study|Other|3
7580149|NCT02136134|26365374|P1|Overall Study|Other|3
7580150|NCT02136134|26365373|P2|Overall Study|Withdrawal by Subject|4
7580151|NCT02136134|26365374|P1|Overall Study|Withdrawal by Subject|14
7580152|NCT02136134|26365373|P2|Overall Study|Death|29
7580153|NCT02136134|26365374|P1|Overall Study|Death|35
7580154|NCT02136069|26365392|P2|Overall Study|Withdrawal by Subject|11
7580155|NCT02136069|26365393|P1|Overall Study|Withdrawal by Subject|10
7580156|NCT02136069|26365392|P2|Overall Study|Physician Decision|4
7580157|NCT02136069|26365393|P1|Overall Study|Physician Decision|5
7580158|NCT02136069|26365392|P2|Overall Study|Non-Compliance|0
7580159|NCT02136069|26365393|P1|Overall Study|Non-Compliance|1
7580160|NCT02136069|26365392|P2|Overall Study|Lost to Follow-up|0
7580161|NCT02136069|26365393|P1|Overall Study|Lost to Follow-up|1
7580162|NCT02136069|26365392|P2|Overall Study|Lack of Efficacy|4
7580163|NCT02136069|26365393|P1|Overall Study|Lack of Efficacy|10
7580164|NCT02136069|26365392|P2|Overall Study|Death|1
7580165|NCT02136069|26365393|P1|Overall Study|Death|0
7580166|NCT02136069|26365392|P2|Overall Study|Adverse Event|8
7580167|NCT02136069|26365393|P1|Overall Study|Adverse Event|6
7580168|NCT02136069|26365392|P2|Overall Study|UC flare-up|0
7580169|NCT02136069|26365393|P1|Overall Study|UC flare-up|1
7580170|NCT02135848|26365485|P2|Overall Study|Withdrawal by Subject|1
7580171|NCT02135848|26365486|P1|Overall Study|Withdrawal by Subject|1
7580172|NCT02135848|26365485|P2|Overall Study|Adverse Event|0
7580173|NCT02135848|26365486|P1|Overall Study|Adverse Event|2
7580174|NCT02135692|26365544|P1|Overall Study|Withdrawal by Subject|15
7580175|NCT02135692|26365544|P1|Overall Study|Lost to Follow-up|4
7580176|NCT02135692|26365544|P1|Overall Study|Study closed/terminated|153
7580177|NCT02135692|26365544|P1|Overall Study|Product commercially available|159
7580178|NCT02135692|26365544|P1|Overall Study|Subject met Liver Stopping Criteria|1
7580179|NCT02135692|26365544|P1|Overall Study|Protocol Violation|2
7580180|NCT02135692|26365544|P1|Overall Study|Lack of Efficacy|2
7580181|NCT02135692|26365544|P1|Overall Study|Adverse Event|3
7580182|NCT02135614|26365586|P2|Overall Study|Lost to Follow-up|0
7580183|NCT02135614|26365587|P1|Overall Study|Lost to Follow-up|3
7580184|NCT02135614|26365586|P2|Overall Study|Withdrew Consent|2
7580185|NCT02135614|26365587|P1|Overall Study|Withdrew Consent|2
7580186|NCT02135614|26365586|P2|Overall Study|Investigator's Discretion|1
7580187|NCT02135614|26365587|P1|Overall Study|Investigator's Discretion|0
7580188|NCT02135614|26365586|P2|Overall Study|Death|0
7580189|NCT02135614|26365587|P1|Overall Study|Death|1
7580190|NCT02135614|26365586|P2|Overall Study|Adverse Event|1
7580191|NCT02135614|26365587|P1|Overall Study|Adverse Event|0
7580192|NCT02135614|26365586|P2|Overall Study|Randomized but Not Treated|1
7580193|NCT02135614|26365587|P1|Overall Study|Randomized but Not Treated|2
7580194|NCT02135445|26365601|P2|Overall Study|Withdrawal by Subject|0
7580195|NCT02135445|26365602|P1|Overall Study|Withdrawal by Subject|1
7580196|NCT02135445|26365601|P2|Overall Study|Lost to Follow-up|0
7580197|NCT02135445|26365602|P1|Overall Study|Lost to Follow-up|1
7580198|NCT02135107|26365687|P4|Maintenance Therapy Period|Other|8
7580199|NCT02135107|26365688|P3|Maintenance Therapy Period|Other|7
7580200|NCT02135107|26365689|P2|Maintenance Therapy Period|Other|0
7580201|NCT02135107|26365690|P1|Maintenance Therapy Period|Other|0
7580202|NCT02135107|26365687|P4|Maintenance Therapy Period|Pregnancy|1
7580203|NCT02135107|26365688|P3|Maintenance Therapy Period|Pregnancy|0
7580204|NCT02135107|26365689|P2|Maintenance Therapy Period|Pregnancy|0
7580205|NCT02135107|26365690|P1|Maintenance Therapy Period|Pregnancy|0
7580206|NCT02135107|26365687|P4|Maintenance Therapy Period|Withdrawal by Subject|4
7580207|NCT02135107|26365688|P3|Maintenance Therapy Period|Withdrawal by Subject|5
7580208|NCT02135107|26365689|P2|Maintenance Therapy Period|Withdrawal by Subject|0
7580209|NCT02135107|26365690|P1|Maintenance Therapy Period|Withdrawal by Subject|0
7580210|NCT02135107|26365687|P4|Maintenance Therapy Period|Adverse Event|7
7580211|NCT02135107|26365688|P3|Maintenance Therapy Period|Adverse Event|3
7580212|NCT02135107|26365689|P2|Maintenance Therapy Period|Adverse Event|0
7580213|NCT02135107|26365690|P1|Maintenance Therapy Period|Adverse Event|0
7580214|NCT02135107|26365687|P4|Treatment Period|Other|0
7580215|NCT02135107|26365688|P3|Treatment Period|Other|0
7580216|NCT02135107|26365689|P2|Treatment Period|Other|24
7580217|NCT02135107|26365690|P1|Treatment Period|Other|115
7580218|NCT02135107|26365687|P4|Treatment Period|Pregnancy|0
7580219|NCT02135107|26365688|P3|Treatment Period|Pregnancy|0
7580220|NCT02135107|26365689|P2|Treatment Period|Pregnancy|0
7580221|NCT02135107|26365690|P1|Treatment Period|Pregnancy|1
7580222|NCT02135107|26365687|P4|Treatment Period|Adverse Event|0
7580223|NCT02135107|26365688|P3|Treatment Period|Adverse Event|0
7580224|NCT02135107|26365689|P2|Treatment Period|Adverse Event|2
7580225|NCT02135107|26365690|P1|Treatment Period|Adverse Event|5
7580226|NCT02135107|26365687|P4|Treatment Period|Withdrawal by Subject|0
7580227|NCT02135107|26365688|P3|Treatment Period|Withdrawal by Subject|0
7580228|NCT02135107|26365689|P2|Treatment Period|Withdrawal by Subject|0
7580229|NCT02135107|26365690|P1|Treatment Period|Withdrawal by Subject|11
7580230|NCT02135029|26365736|P3|Overall Study|Death|0
7580231|NCT02135029|26365737|P2|Overall Study|Death|1
7580232|NCT02135029|26365738|P1|Overall Study|Death|0
7580233|NCT02135029|26365736|P3|Overall Study|Other|0
7580234|NCT02135029|26365737|P2|Overall Study|Other|1
7580235|NCT02135029|26365738|P1|Overall Study|Other|0
7580236|NCT02135029|26365736|P3|Overall Study|Withdrawal by Subject|1
7580237|NCT02135029|26365737|P2|Overall Study|Withdrawal by Subject|0
7580238|NCT02135029|26365738|P1|Overall Study|Withdrawal by Subject|2
7580239|NCT02135029|26365736|P3|Overall Study|Lost to Follow-up|0
7580240|NCT02135029|26365737|P2|Overall Study|Lost to Follow-up|1
7580241|NCT02135029|26365738|P1|Overall Study|Lost to Follow-up|0
7580242|NCT02135029|26365736|P3|Overall Study|Adverse Event|2
7580243|NCT02135029|26365737|P2|Overall Study|Adverse Event|2
7580244|NCT02135029|26365738|P1|Overall Study|Adverse Event|2
7580245|NCT02134977|26365843|P1|Overall Study|Protocol Deviation|102
7580246|NCT02134925|26365877|P2|Overall Study|Cancel|6
7580247|NCT02134925|26365878|P1|Overall Study|Cancel|1
7580248|NCT02134925|26365877|P2|Overall Study|Withdrawal by Subject|0
7580249|NCT02134925|26365878|P1|Overall Study|Withdrawal by Subject|1
7580250|NCT02134587|26365932|P1|Overall Study|Did not completed all meetings|30
7580251|NCT02134353|26365948|P2|Overall Study|Other - Patient's Choice|1
7580252|NCT02134353|26365949|P1|Overall Study|Other - Patient's Choice|0
7580253|NCT02134353|26365948|P2|Overall Study|Relocation|0
7580254|NCT02134353|26365949|P1|Overall Study|Relocation|1
7580255|NCT02134353|26365948|P2|Overall Study|Pregnancy|1
7580256|NCT02134353|26365949|P1|Overall Study|Pregnancy|0
7580257|NCT02134353|26365948|P2|Overall Study|Death|1
7580258|NCT02134353|26365949|P1|Overall Study|Death|0
7580259|NCT02134353|26365948|P2|Overall Study|Withdrawal by Subject|13
7580260|NCT02134353|26365949|P1|Overall Study|Withdrawal by Subject|12
7580261|NCT02134353|26365948|P2|Overall Study|Lack of Efficacy|1
7580262|NCT02134353|26365949|P1|Overall Study|Lack of Efficacy|2
7580263|NCT02134353|26365948|P2|Overall Study|Lost to Follow-up|1
7580264|NCT02134353|26365949|P1|Overall Study|Lost to Follow-up|1
7580265|NCT02134353|26365948|P2|Overall Study|Adverse Event|6
7580266|NCT02134353|26365949|P1|Overall Study|Adverse Event|10
7580267|NCT02134028|26366104|P8|Overall Study|Adverse Event|2
7580268|NCT02134028|26366105|P7|Overall Study|Adverse Event|1
7580269|NCT02134028|26366106|P6|Overall Study|Adverse Event|5
7580270|NCT02134028|26366107|P5|Overall Study|Adverse Event|4
7580271|NCT02134028|26366108|P4|Overall Study|Adverse Event|32
7580272|NCT02134028|26366109|P3|Overall Study|Adverse Event|13
7580273|NCT02134028|26366110|P2|Overall Study|Adverse Event|19
7580274|NCT02134028|26366111|P1|Overall Study|Adverse Event|3
7580275|NCT02134028|26366104|P8|Overall Study|Other unspecified|1
7580276|NCT02134028|26366105|P7|Overall Study|Other unspecified|2
7580277|NCT02134028|26366106|P6|Overall Study|Other unspecified|6
7580278|NCT02134028|26366107|P5|Overall Study|Other unspecified|8
7580279|NCT02134028|26366108|P4|Overall Study|Other unspecified|64
7580280|NCT02134028|26366109|P3|Overall Study|Other unspecified|33
7580281|NCT02134028|26366110|P2|Overall Study|Other unspecified|22
7580282|NCT02134028|26366111|P1|Overall Study|Other unspecified|4
7580283|NCT02134028|26366104|P8|Overall Study|Poor compliance to protocol|0
7580284|NCT02134028|26366105|P7|Overall Study|Poor compliance to protocol|0
7580285|NCT02134028|26366106|P6|Overall Study|Poor compliance to protocol|1
7580286|NCT02134028|26366107|P5|Overall Study|Poor compliance to protocol|1
7580287|NCT02134028|26366108|P4|Overall Study|Poor compliance to protocol|7
7580288|NCT02134028|26366109|P3|Overall Study|Poor compliance to protocol|3
7580289|NCT02134028|26366110|P2|Overall Study|Poor compliance to protocol|1
7580290|NCT02134028|26366111|P1|Overall Study|Poor compliance to protocol|1
7580291|NCT02134028|26366104|P8|Overall Study|Lack of Efficacy|0
7580292|NCT02134028|26366105|P7|Overall Study|Lack of Efficacy|1
7580293|NCT02134028|26366106|P6|Overall Study|Lack of Efficacy|2
7580294|NCT02134028|26366107|P5|Overall Study|Lack of Efficacy|1
7580295|NCT02134028|26366108|P4|Overall Study|Lack of Efficacy|2
7580296|NCT02134028|26366109|P3|Overall Study|Lack of Efficacy|3
7580297|NCT02134028|26366110|P2|Overall Study|Lack of Efficacy|0
7580298|NCT02134028|26366111|P1|Overall Study|Lack of Efficacy|1
7580299|NCT02134015|26366269|P2|Overall Study|Withdrawal by Subject|7
7580300|NCT02134015|26366270|P1|Overall Study|Withdrawal by Subject|3
7580301|NCT02134015|26366269|P2|Overall Study|Adverse Event|10
7580302|NCT02134015|26366270|P1|Overall Study|Adverse Event|9
7580303|NCT02134015|26366269|P2|Overall Study|Study terminated by sponsor|3
7580304|NCT02134015|26366270|P1|Overall Study|Study terminated by sponsor|2
7580305|NCT02134015|26366269|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
7580306|NCT02134015|26366270|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
7580307|NCT02134015|26366269|P2|Overall Study|Clinical progression|7
7580308|NCT02134015|26366270|P1|Overall Study|Clinical progression|14
7580309|NCT02134015|26366269|P2|Overall Study|Reason not provided|2
7580310|NCT02134015|26366270|P1|Overall Study|Reason not provided|1
7580311|NCT02134015|26366269|P2|Overall Study|Death|1
7580312|NCT02134015|26366270|P1|Overall Study|Death|2
7580313|NCT02134015|26366269|P2|Overall Study|Protocol Violation|1
7580314|NCT02134015|26366270|P1|Overall Study|Protocol Violation|0
7580315|NCT02133742|26366306|P1|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
7580316|NCT02133742|26366306|P1|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
7580317|NCT02133742|26366306|P1|Period 2:Dose Expansion Phase (1344days)|Death|13
7580318|NCT02133742|26366306|P1|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
7580319|NCT02133742|26366306|P1|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
7580320|NCT02133664|26366335|P2|Overall Study|Adverse Event|6
7580321|NCT02133664|26366336|P1|Overall Study|Adverse Event|3
7580322|NCT02133664|26366335|P2|Overall Study|Lost to Follow-up|1
7580323|NCT02133664|26366336|P1|Overall Study|Lost to Follow-up|2
7580324|NCT02133508|26366352|P1|Overall Study|Lost to Follow-up|2
7580325|NCT02133508|26366352|P1|Overall Study|Death|12
7580326|NCT02133508|26366352|P1|Overall Study|Decision of Investigator or Sponsor|1
7580327|NCT02133352|26366360|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
7580328|NCT02133131|26366391|P7|Overall Study|Protocol Violation|1
7580329|NCT02133131|26366392|P6|Overall Study|Protocol Violation|0
7580330|NCT02133131|26366393|P5|Overall Study|Protocol Violation|0
7580331|NCT02133131|26366394|P4|Overall Study|Protocol Violation|0
7580332|NCT02133131|26366395|P3|Overall Study|Protocol Violation|0
7580333|NCT02133131|26366396|P2|Overall Study|Protocol Violation|0
7580334|NCT02133131|26366397|P1|Overall Study|Protocol Violation|0
7580335|NCT02133131|26366391|P7|Overall Study|Ongoing in study|11
7580336|NCT02133131|26366392|P6|Overall Study|Ongoing in study|14
7580337|NCT02133131|26366393|P5|Overall Study|Ongoing in study|15
7580338|NCT02133131|26366394|P4|Overall Study|Ongoing in study|0
7580339|NCT02133131|26366395|P3|Overall Study|Ongoing in study|0
7580340|NCT02133131|26366396|P2|Overall Study|Ongoing in study|0
7580341|NCT02133131|26366397|P1|Overall Study|Ongoing in study|0
7580342|NCT02133131|26366391|P7|Overall Study|Status not recorded|0
7580343|NCT02133131|26366392|P6|Overall Study|Status not recorded|0
7580344|NCT02133131|26366393|P5|Overall Study|Status not recorded|0
7580345|NCT02133131|26366394|P4|Overall Study|Status not recorded|4
7580346|NCT02133131|26366395|P3|Overall Study|Status not recorded|1
7580347|NCT02133131|26366396|P2|Overall Study|Status not recorded|5
7580348|NCT02133131|26366397|P1|Overall Study|Status not recorded|4
7580349|NCT02133131|26366391|P7|Overall Study|Lost to Follow-up|0
7580350|NCT02133131|26366392|P6|Overall Study|Lost to Follow-up|0
7580351|NCT02133131|26366393|P5|Overall Study|Lost to Follow-up|0
7580352|NCT02133131|26366394|P4|Overall Study|Lost to Follow-up|1
7580353|NCT02133131|26366395|P3|Overall Study|Lost to Follow-up|0
7580354|NCT02133131|26366396|P2|Overall Study|Lost to Follow-up|0
7580355|NCT02133131|26366397|P1|Overall Study|Lost to Follow-up|1
7580356|NCT02133131|26366391|P7|Overall Study|Adverse Event|0
7580357|NCT02133131|26366392|P6|Overall Study|Adverse Event|0
7580358|NCT02133131|26366393|P5|Overall Study|Adverse Event|0
7580359|NCT02133131|26366394|P4|Overall Study|Adverse Event|1
7580360|NCT02133131|26366395|P3|Overall Study|Adverse Event|0
7580361|NCT02133131|26366396|P2|Overall Study|Adverse Event|0
7580362|NCT02133131|26366397|P1|Overall Study|Adverse Event|0
7580363|NCT02133001|26366451|P2|Follow-Up Phase (Day 26-81)|Other|1
7580364|NCT02133001|26366452|P1|Follow-Up Phase (Day 26-81)|Other|0
7580365|NCT02133001|26366451|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7580366|NCT02133001|26366452|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7580367|NCT02133001|26366451|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7580368|NCT02133001|26366452|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7580369|NCT02133001|26366451|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
7580370|NCT02133001|26366452|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
7580371|NCT02133001|26366451|P2|Double Blind (Day 1-25)|Other|2
7580372|NCT02133001|26366452|P1|Double Blind (Day 1-25)|Other|2
7580373|NCT02133001|26366451|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
7580374|NCT02133001|26366452|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
7580375|NCT02133001|26366451|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
7580376|NCT02133001|26366452|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
7580377|NCT02133001|26366451|P2|Double Blind (Day 1-25)|Adverse Event|5
7580378|NCT02133001|26366452|P1|Double Blind (Day 1-25)|Adverse Event|1
7580379|NCT02132949|26366500|P2|Overall Study|Reason Unspecified|1
7580380|NCT02132949|26366501|P1|Overall Study|Reason Unspecified|0
7580381|NCT02132949|26366500|P2|Overall Study|Withdrew Prior to Treatment|2
7580382|NCT02132949|26366501|P1|Overall Study|Withdrew Prior to Treatment|1
7580383|NCT02132949|26366500|P2|Overall Study|Adverse Event|1
7580384|NCT02132949|26366501|P1|Overall Study|Adverse Event|2
7580385|NCT02132949|26366500|P2|Overall Study|Disease Progression|0
7580386|NCT02132949|26366501|P1|Overall Study|Disease Progression|3
7580387|NCT02132949|26366500|P2|Overall Study|Physician Decision|1
7580388|NCT02132949|26366501|P1|Overall Study|Physician Decision|3
7580389|NCT02132949|26366500|P2|Overall Study|Noncompliance|1
7580390|NCT02132949|26366501|P1|Overall Study|Noncompliance|5
7580391|NCT02132949|26366500|P2|Overall Study|Withdrawal by Subject|5
7580392|NCT02132949|26366501|P1|Overall Study|Withdrawal by Subject|6
7580393|NCT02132949|26366500|P2|Overall Study|Lost to Follow-up|4
7580394|NCT02132949|26366501|P1|Overall Study|Lost to Follow-up|14
7580395|NCT02132949|26366500|P2|Overall Study|Death|13
7580396|NCT02132949|26366501|P1|Overall Study|Death|7
7580397|NCT02132767|26366619|P2|Overall Study|Lost to Follow-up|4
7580398|NCT02132767|26366620|P1|Overall Study|Lost to Follow-up|4
7580399|NCT02132767|26366619|P2|Overall Study|Withdrawal by Subject|9
7580400|NCT02132767|26366620|P1|Overall Study|Withdrawal by Subject|10
7580401|NCT02132767|26366619|P2|Overall Study|Death|2
7580402|NCT02132767|26366620|P1|Overall Study|Death|3
7580403|NCT02132754|26366674|P34|Overall Study|Withdrawal by Subject|2
7580404|NCT02132754|26366675|P33|Overall Study|Withdrawal by Subject|0
7580405|NCT02132754|26366676|P32|Overall Study|Withdrawal by Subject|1
7580406|NCT02132754|26366677|P31|Overall Study|Withdrawal by Subject|0
7580407|NCT02132754|26366678|P30|Overall Study|Withdrawal by Subject|0
7580408|NCT02132754|26366679|P29|Overall Study|Withdrawal by Subject|0
7580409|NCT02132754|26366680|P28|Overall Study|Withdrawal by Subject|1
7580410|NCT02132754|26366681|P27|Overall Study|Withdrawal by Subject|0
7580411|NCT02132754|26366682|P26|Overall Study|Withdrawal by Subject|0
7580412|NCT02132754|26366683|P25|Overall Study|Withdrawal by Subject|1
7580413|NCT02132754|26366684|P24|Overall Study|Withdrawal by Subject|0
7580414|NCT02132754|26366685|P23|Overall Study|Withdrawal by Subject|0
7580415|NCT02132754|26366686|P22|Overall Study|Withdrawal by Subject|0
7580416|NCT02132754|26366687|P21|Overall Study|Withdrawal by Subject|1
7580417|NCT02132754|26366688|P20|Overall Study|Withdrawal by Subject|0
7580418|NCT02132754|26366689|P19|Overall Study|Withdrawal by Subject|0
7580419|NCT02132754|26366690|P18|Overall Study|Withdrawal by Subject|0
7580420|NCT02132754|26366691|P17|Overall Study|Withdrawal by Subject|1
7580421|NCT02132754|26366692|P16|Overall Study|Withdrawal by Subject|2
7580422|NCT02132754|26366693|P15|Overall Study|Withdrawal by Subject|1
7580423|NCT02132754|26366694|P14|Overall Study|Withdrawal by Subject|0
7580424|NCT02132754|26366695|P13|Overall Study|Withdrawal by Subject|1
7580425|NCT02132754|26366696|P12|Overall Study|Withdrawal by Subject|0
7580426|NCT02132754|26366697|P11|Overall Study|Withdrawal by Subject|0
7580427|NCT02132754|26366698|P10|Overall Study|Withdrawal by Subject|1
7580428|NCT02132754|26366699|P9|Overall Study|Withdrawal by Subject|0
7580429|NCT02132754|26366700|P8|Overall Study|Withdrawal by Subject|0
7580430|NCT02132754|26366701|P7|Overall Study|Withdrawal by Subject|0
7580431|NCT02132754|26366702|P6|Overall Study|Withdrawal by Subject|0
7580432|NCT02132754|26366703|P5|Overall Study|Withdrawal by Subject|0
7580433|NCT02132754|26366704|P4|Overall Study|Withdrawal by Subject|0
7580434|NCT02132754|26366705|P3|Overall Study|Withdrawal by Subject|0
7580435|NCT02132754|26366706|P2|Overall Study|Withdrawal by Subject|0
7580436|NCT02132754|26366707|P1|Overall Study|Withdrawal by Subject|0
7580437|NCT02132754|26366674|P34|Overall Study|Transferred to Extension Study|6
7580438|NCT02132754|26366675|P33|Overall Study|Transferred to Extension Study|0
7580439|NCT02132754|26366676|P32|Overall Study|Transferred to Extension Study|0
7580440|NCT02132754|26366677|P31|Overall Study|Transferred to Extension Study|0
7580441|NCT02132754|26366678|P30|Overall Study|Transferred to Extension Study|0
7580442|NCT02132754|26366679|P29|Overall Study|Transferred to Extension Study|0
7580443|NCT02132754|26366680|P28|Overall Study|Transferred to Extension Study|0
7580444|NCT02132754|26366681|P27|Overall Study|Transferred to Extension Study|0
7580445|NCT02132754|26366682|P26|Overall Study|Transferred to Extension Study|0
7580446|NCT02132754|26366683|P25|Overall Study|Transferred to Extension Study|0
7580447|NCT02132754|26366684|P24|Overall Study|Transferred to Extension Study|0
7580448|NCT02132754|26366685|P23|Overall Study|Transferred to Extension Study|0
7580449|NCT02132754|26366686|P22|Overall Study|Transferred to Extension Study|0
7580450|NCT02132754|26366687|P21|Overall Study|Transferred to Extension Study|0
7580451|NCT02132754|26366688|P20|Overall Study|Transferred to Extension Study|0
7580452|NCT02132754|26366689|P19|Overall Study|Transferred to Extension Study|0
7580453|NCT02132754|26366690|P18|Overall Study|Transferred to Extension Study|0
7580454|NCT02132754|26366691|P17|Overall Study|Transferred to Extension Study|0
7580455|NCT02132754|26366692|P16|Overall Study|Transferred to Extension Study|0
7580456|NCT02132754|26366693|P15|Overall Study|Transferred to Extension Study|0
7580457|NCT02132754|26366694|P14|Overall Study|Transferred to Extension Study|0
7580458|NCT02132754|26366695|P13|Overall Study|Transferred to Extension Study|0
7580459|NCT02132754|26366696|P12|Overall Study|Transferred to Extension Study|0
7580460|NCT02132754|26366697|P11|Overall Study|Transferred to Extension Study|0
7580461|NCT02132754|26366698|P10|Overall Study|Transferred to Extension Study|0
7580462|NCT02132754|26366699|P9|Overall Study|Transferred to Extension Study|0
7580463|NCT02132754|26366700|P8|Overall Study|Transferred to Extension Study|0
7580464|NCT02132754|26366701|P7|Overall Study|Transferred to Extension Study|0
7580465|NCT02132754|26366702|P6|Overall Study|Transferred to Extension Study|0
7580466|NCT02132754|26366703|P5|Overall Study|Transferred to Extension Study|0
7580467|NCT02132754|26366704|P4|Overall Study|Transferred to Extension Study|0
7580468|NCT02132754|26366705|P3|Overall Study|Transferred to Extension Study|0
7580469|NCT02132754|26366706|P2|Overall Study|Transferred to Extension Study|0
7580470|NCT02132754|26366707|P1|Overall Study|Transferred to Extension Study|0
7580471|NCT02132754|26366674|P34|Overall Study|Screen Failure|0
7580472|NCT02132754|26366675|P33|Overall Study|Screen Failure|0
7580473|NCT02132754|26366676|P32|Overall Study|Screen Failure|0
7580474|NCT02132754|26366677|P31|Overall Study|Screen Failure|0
7580475|NCT02132754|26366678|P30|Overall Study|Screen Failure|0
7580476|NCT02132754|26366679|P29|Overall Study|Screen Failure|0
7580477|NCT02132754|26366680|P28|Overall Study|Screen Failure|0
7580478|NCT02132754|26366681|P27|Overall Study|Screen Failure|0
7580479|NCT02132754|26366682|P26|Overall Study|Screen Failure|0
7580480|NCT02132754|26366683|P25|Overall Study|Screen Failure|0
7580481|NCT02132754|26366684|P24|Overall Study|Screen Failure|0
7580482|NCT02132754|26366685|P23|Overall Study|Screen Failure|0
7580483|NCT02132754|26366686|P22|Overall Study|Screen Failure|1
7580484|NCT02132754|26366687|P21|Overall Study|Screen Failure|0
7580485|NCT02132754|26366688|P20|Overall Study|Screen Failure|1
7580486|NCT02132754|26366689|P19|Overall Study|Screen Failure|0
7580487|NCT02132754|26366690|P18|Overall Study|Screen Failure|0
7580488|NCT02132754|26366691|P17|Overall Study|Screen Failure|0
7580489|NCT02132754|26366692|P16|Overall Study|Screen Failure|0
7580490|NCT02132754|26366693|P15|Overall Study|Screen Failure|0
7580491|NCT02132754|26366694|P14|Overall Study|Screen Failure|0
7580492|NCT02132754|26366695|P13|Overall Study|Screen Failure|0
7580493|NCT02132754|26366696|P12|Overall Study|Screen Failure|0
7580494|NCT02132754|26366697|P11|Overall Study|Screen Failure|0
7580495|NCT02132754|26366698|P10|Overall Study|Screen Failure|0
7580496|NCT02132754|26366699|P9|Overall Study|Screen Failure|0
7580497|NCT02132754|26366700|P8|Overall Study|Screen Failure|0
7580498|NCT02132754|26366701|P7|Overall Study|Screen Failure|0
7580499|NCT02132754|26366702|P6|Overall Study|Screen Failure|0
7580500|NCT02132754|26366703|P5|Overall Study|Screen Failure|0
7580501|NCT02132754|26366704|P4|Overall Study|Screen Failure|0
7580502|NCT02132754|26366705|P3|Overall Study|Screen Failure|0
7580503|NCT02132754|26366706|P2|Overall Study|Screen Failure|0
7580504|NCT02132754|26366707|P1|Overall Study|Screen Failure|0
7580505|NCT02132754|26366674|P34|Overall Study|Progressive Disease|6
7580506|NCT02132754|26366675|P33|Overall Study|Progressive Disease|3
7580507|NCT02132754|26366676|P32|Overall Study|Progressive Disease|1
7580508|NCT02132754|26366677|P31|Overall Study|Progressive Disease|1
7580509|NCT02132754|26366678|P30|Overall Study|Progressive Disease|3
7580510|NCT02132754|26366679|P29|Overall Study|Progressive Disease|2
7580511|NCT02132754|26366680|P28|Overall Study|Progressive Disease|1
7580512|NCT02132754|26366681|P27|Overall Study|Progressive Disease|2
7580513|NCT02132754|26366682|P26|Overall Study|Progressive Disease|1
7580514|NCT02132754|26366683|P25|Overall Study|Progressive Disease|0
7580515|NCT02132754|26366684|P24|Overall Study|Progressive Disease|3
7580516|NCT02132754|26366685|P23|Overall Study|Progressive Disease|2
7580517|NCT02132754|26366686|P22|Overall Study|Progressive Disease|3
7580518|NCT02132754|26366687|P21|Overall Study|Progressive Disease|1
7580519|NCT02132754|26366688|P20|Overall Study|Progressive Disease|1
7580520|NCT02132754|26366689|P19|Overall Study|Progressive Disease|3
7580521|NCT02132754|26366690|P18|Overall Study|Progressive Disease|1
7580522|NCT02132754|26366691|P17|Overall Study|Progressive Disease|2
7580523|NCT02132754|26366692|P16|Overall Study|Progressive Disease|1
7580524|NCT02132754|26366693|P15|Overall Study|Progressive Disease|2
7580525|NCT02132754|26366694|P14|Overall Study|Progressive Disease|3
7580526|NCT02132754|26366695|P13|Overall Study|Progressive Disease|2
7580527|NCT02132754|26366696|P12|Overall Study|Progressive Disease|2
7580528|NCT02132754|26366697|P11|Overall Study|Progressive Disease|3
7580529|NCT02132754|26366698|P10|Overall Study|Progressive Disease|3
7580530|NCT02132754|26366699|P9|Overall Study|Progressive Disease|1
7580531|NCT02132754|26366700|P8|Overall Study|Progressive Disease|1
7580532|NCT02132754|26366701|P7|Overall Study|Progressive Disease|1
7580533|NCT02132754|26366702|P6|Overall Study|Progressive Disease|1
7580534|NCT02132754|26366703|P5|Overall Study|Progressive Disease|1
7580535|NCT02132754|26366704|P4|Overall Study|Progressive Disease|1
7580536|NCT02132754|26366705|P3|Overall Study|Progressive Disease|1
7580537|NCT02132754|26366706|P2|Overall Study|Progressive Disease|1
7580538|NCT02132754|26366707|P1|Overall Study|Progressive Disease|1
7580539|NCT02132754|26366674|P34|Overall Study|Physician Decision|3
7580540|NCT02132754|26366675|P33|Overall Study|Physician Decision|0
7580541|NCT02132754|26366676|P32|Overall Study|Physician Decision|1
7580542|NCT02132754|26366677|P31|Overall Study|Physician Decision|0
7580543|NCT02132754|26366678|P30|Overall Study|Physician Decision|0
7580544|NCT02132754|26366679|P29|Overall Study|Physician Decision|0
7580545|NCT02132754|26366680|P28|Overall Study|Physician Decision|0
7580546|NCT02132754|26366681|P27|Overall Study|Physician Decision|0
7580547|NCT02132754|26366682|P26|Overall Study|Physician Decision|0
7580548|NCT02132754|26366683|P25|Overall Study|Physician Decision|1
7580549|NCT02132754|26366684|P24|Overall Study|Physician Decision|0
7580550|NCT02132754|26366685|P23|Overall Study|Physician Decision|0
7580551|NCT02132754|26366686|P22|Overall Study|Physician Decision|0
7580552|NCT02132754|26366687|P21|Overall Study|Physician Decision|0
7580553|NCT02132754|26366688|P20|Overall Study|Physician Decision|0
7580554|NCT02132754|26366689|P19|Overall Study|Physician Decision|0
7580555|NCT02132754|26366690|P18|Overall Study|Physician Decision|0
7580556|NCT02132754|26366691|P17|Overall Study|Physician Decision|0
7580557|NCT02132754|26366692|P16|Overall Study|Physician Decision|1
7580558|NCT02132754|26366693|P15|Overall Study|Physician Decision|0
7580559|NCT02132754|26366694|P14|Overall Study|Physician Decision|0
7580560|NCT02132754|26366695|P13|Overall Study|Physician Decision|1
7580561|NCT02132754|26366696|P12|Overall Study|Physician Decision|1
7580562|NCT02132754|26366697|P11|Overall Study|Physician Decision|0
7580563|NCT02132754|26366698|P10|Overall Study|Physician Decision|1
7580564|NCT02132754|26366699|P9|Overall Study|Physician Decision|0
7580565|NCT02132754|26366700|P8|Overall Study|Physician Decision|0
7580566|NCT02132754|26366701|P7|Overall Study|Physician Decision|0
7580567|NCT02132754|26366702|P6|Overall Study|Physician Decision|0
7580568|NCT02132754|26366703|P5|Overall Study|Physician Decision|0
7580569|NCT02132754|26366704|P4|Overall Study|Physician Decision|0
7580570|NCT02132754|26366705|P3|Overall Study|Physician Decision|0
7580571|NCT02132754|26366706|P2|Overall Study|Physician Decision|0
7580572|NCT02132754|26366707|P1|Overall Study|Physician Decision|0
7580573|NCT02132754|26366674|P34|Overall Study|Excluded Medication|1
7580574|NCT02132754|26366675|P33|Overall Study|Excluded Medication|0
7580575|NCT02132754|26366676|P32|Overall Study|Excluded Medication|0
7580576|NCT02132754|26366677|P31|Overall Study|Excluded Medication|0
7580577|NCT02132754|26366678|P30|Overall Study|Excluded Medication|0
7580578|NCT02132754|26366679|P29|Overall Study|Excluded Medication|0
7580579|NCT02132754|26366680|P28|Overall Study|Excluded Medication|0
7580580|NCT02132754|26366681|P27|Overall Study|Excluded Medication|0
7580581|NCT02132754|26366682|P26|Overall Study|Excluded Medication|0
7580582|NCT02132754|26366683|P25|Overall Study|Excluded Medication|0
7580583|NCT02132754|26366684|P24|Overall Study|Excluded Medication|0
7580584|NCT02132754|26366685|P23|Overall Study|Excluded Medication|0
7580585|NCT02132754|26366686|P22|Overall Study|Excluded Medication|0
7580586|NCT02132754|26366687|P21|Overall Study|Excluded Medication|1
7580587|NCT02132754|26366688|P20|Overall Study|Excluded Medication|0
7580588|NCT02132754|26366689|P19|Overall Study|Excluded Medication|0
7580589|NCT02132754|26366690|P18|Overall Study|Excluded Medication|0
7580590|NCT02132754|26366691|P17|Overall Study|Excluded Medication|0
7580591|NCT02132754|26366692|P16|Overall Study|Excluded Medication|0
7580592|NCT02132754|26366693|P15|Overall Study|Excluded Medication|0
7580593|NCT02132754|26366694|P14|Overall Study|Excluded Medication|0
7580594|NCT02132754|26366695|P13|Overall Study|Excluded Medication|0
7580595|NCT02132754|26366696|P12|Overall Study|Excluded Medication|0
7580596|NCT02132754|26366697|P11|Overall Study|Excluded Medication|0
7580597|NCT02132754|26366698|P10|Overall Study|Excluded Medication|0
7580598|NCT02132754|26366699|P9|Overall Study|Excluded Medication|0
7580599|NCT02132754|26366700|P8|Overall Study|Excluded Medication|0
7580600|NCT02132754|26366701|P7|Overall Study|Excluded Medication|0
7580601|NCT02132754|26366702|P6|Overall Study|Excluded Medication|0
7580602|NCT02132754|26366703|P5|Overall Study|Excluded Medication|0
7580603|NCT02132754|26366704|P4|Overall Study|Excluded Medication|0
7580604|NCT02132754|26366705|P3|Overall Study|Excluded Medication|0
7580605|NCT02132754|26366706|P2|Overall Study|Excluded Medication|0
7580606|NCT02132754|26366707|P1|Overall Study|Excluded Medication|0
7580607|NCT02132754|26366674|P34|Overall Study|Death|2
7580608|NCT02132754|26366675|P33|Overall Study|Death|0
7580609|NCT02132754|26366676|P32|Overall Study|Death|0
7580610|NCT02132754|26366677|P31|Overall Study|Death|0
7580611|NCT02132754|26366678|P30|Overall Study|Death|0
7580612|NCT02132754|26366679|P29|Overall Study|Death|0
7580613|NCT02132754|26366680|P28|Overall Study|Death|0
7580614|NCT02132754|26366681|P27|Overall Study|Death|1
7580615|NCT02132754|26366682|P26|Overall Study|Death|0
7580616|NCT02132754|26366683|P25|Overall Study|Death|0
7580617|NCT02132754|26366684|P24|Overall Study|Death|0
7580618|NCT02132754|26366685|P23|Overall Study|Death|0
7580619|NCT02132754|26366686|P22|Overall Study|Death|1
7580620|NCT02132754|26366687|P21|Overall Study|Death|0
7580621|NCT02132754|26366688|P20|Overall Study|Death|1
7580622|NCT02132754|26366689|P19|Overall Study|Death|0
7580623|NCT02132754|26366690|P18|Overall Study|Death|0
7580624|NCT02132754|26366691|P17|Overall Study|Death|0
7580625|NCT02132754|26366692|P16|Overall Study|Death|1
7580626|NCT02132754|26366693|P15|Overall Study|Death|0
7580627|NCT02132754|26366694|P14|Overall Study|Death|0
7580628|NCT02132754|26366695|P13|Overall Study|Death|0
7580629|NCT02132754|26366696|P12|Overall Study|Death|0
7580630|NCT02132754|26366697|P11|Overall Study|Death|0
7580631|NCT02132754|26366698|P10|Overall Study|Death|0
7580632|NCT02132754|26366699|P9|Overall Study|Death|0
7580633|NCT02132754|26366700|P8|Overall Study|Death|0
7580634|NCT02132754|26366701|P7|Overall Study|Death|0
7580635|NCT02132754|26366702|P6|Overall Study|Death|0
7580636|NCT02132754|26366703|P5|Overall Study|Death|0
7580637|NCT02132754|26366704|P4|Overall Study|Death|0
7580638|NCT02132754|26366705|P3|Overall Study|Death|0
7580639|NCT02132754|26366706|P2|Overall Study|Death|0
7580640|NCT02132754|26366707|P1|Overall Study|Death|0
7580641|NCT02132754|26366674|P34|Overall Study|Clinical Progression|2
7580642|NCT02132754|26366675|P33|Overall Study|Clinical Progression|0
7580643|NCT02132754|26366676|P32|Overall Study|Clinical Progression|0
7580644|NCT02132754|26366677|P31|Overall Study|Clinical Progression|1
7580645|NCT02132754|26366678|P30|Overall Study|Clinical Progression|0
7580646|NCT02132754|26366679|P29|Overall Study|Clinical Progression|1
7580647|NCT02132754|26366680|P28|Overall Study|Clinical Progression|1
7580648|NCT02132754|26366681|P27|Overall Study|Clinical Progression|0
7580649|NCT02132754|26366682|P26|Overall Study|Clinical Progression|1
7580650|NCT02132754|26366683|P25|Overall Study|Clinical Progression|1
7580651|NCT02132754|26366684|P24|Overall Study|Clinical Progression|0
7580652|NCT02132754|26366685|P23|Overall Study|Clinical Progression|1
7580653|NCT02132754|26366686|P22|Overall Study|Clinical Progression|0
7580654|NCT02132754|26366687|P21|Overall Study|Clinical Progression|0
7580655|NCT02132754|26366688|P20|Overall Study|Clinical Progression|1
7580656|NCT02132754|26366689|P19|Overall Study|Clinical Progression|0
7580657|NCT02132754|26366690|P18|Overall Study|Clinical Progression|1
7580658|NCT02132754|26366691|P17|Overall Study|Clinical Progression|1
7580659|NCT02132754|26366692|P16|Overall Study|Clinical Progression|0
7580660|NCT02132754|26366693|P15|Overall Study|Clinical Progression|0
7580661|NCT02132754|26366694|P14|Overall Study|Clinical Progression|0
7580662|NCT02132754|26366695|P13|Overall Study|Clinical Progression|0
7580663|NCT02132754|26366696|P12|Overall Study|Clinical Progression|0
7580664|NCT02132754|26366697|P11|Overall Study|Clinical Progression|0
7580665|NCT02132754|26366698|P10|Overall Study|Clinical Progression|1
7580666|NCT02132754|26366699|P9|Overall Study|Clinical Progression|0
7580667|NCT02132754|26366700|P8|Overall Study|Clinical Progression|0
7580668|NCT02132754|26366701|P7|Overall Study|Clinical Progression|0
7580669|NCT02132754|26366702|P6|Overall Study|Clinical Progression|0
7580670|NCT02132754|26366703|P5|Overall Study|Clinical Progression|0
7580671|NCT02132754|26366704|P4|Overall Study|Clinical Progression|0
7580672|NCT02132754|26366705|P3|Overall Study|Clinical Progression|0
7580673|NCT02132754|26366706|P2|Overall Study|Clinical Progression|0
7580674|NCT02132754|26366707|P1|Overall Study|Clinical Progression|0
7580675|NCT02132754|26366674|P34|Overall Study|Adverse Event|1
7580676|NCT02132754|26366675|P33|Overall Study|Adverse Event|1
7580677|NCT02132754|26366676|P32|Overall Study|Adverse Event|0
7580678|NCT02132754|26366677|P31|Overall Study|Adverse Event|1
7580679|NCT02132754|26366678|P30|Overall Study|Adverse Event|0
7580680|NCT02132754|26366679|P29|Overall Study|Adverse Event|0
7580681|NCT02132754|26366680|P28|Overall Study|Adverse Event|0
7580682|NCT02132754|26366681|P27|Overall Study|Adverse Event|1
7580683|NCT02132754|26366682|P26|Overall Study|Adverse Event|1
7580684|NCT02132754|26366683|P25|Overall Study|Adverse Event|0
7580685|NCT02132754|26366684|P24|Overall Study|Adverse Event|0
7580686|NCT02132754|26366685|P23|Overall Study|Adverse Event|0
7580687|NCT02132754|26366686|P22|Overall Study|Adverse Event|0
7580688|NCT02132754|26366687|P21|Overall Study|Adverse Event|0
7580689|NCT02132754|26366688|P20|Overall Study|Adverse Event|0
7580690|NCT02132754|26366689|P19|Overall Study|Adverse Event|0
7580691|NCT02132754|26366690|P18|Overall Study|Adverse Event|1
7580692|NCT02132754|26366691|P17|Overall Study|Adverse Event|0
7580693|NCT02132754|26366692|P16|Overall Study|Adverse Event|0
7580694|NCT02132754|26366693|P15|Overall Study|Adverse Event|0
7580695|NCT02132754|26366694|P14|Overall Study|Adverse Event|0
7580696|NCT02132754|26366695|P13|Overall Study|Adverse Event|0
7580697|NCT02132754|26366696|P12|Overall Study|Adverse Event|0
7580698|NCT02132754|26366697|P11|Overall Study|Adverse Event|0
7580699|NCT02132754|26366698|P10|Overall Study|Adverse Event|0
7580700|NCT02132754|26366699|P9|Overall Study|Adverse Event|0
7580701|NCT02132754|26366700|P8|Overall Study|Adverse Event|0
7580702|NCT02132754|26366701|P7|Overall Study|Adverse Event|0
7580703|NCT02132754|26366702|P6|Overall Study|Adverse Event|0
7580704|NCT02132754|26366703|P5|Overall Study|Adverse Event|0
7580705|NCT02132754|26366704|P4|Overall Study|Adverse Event|0
7580706|NCT02132754|26366705|P3|Overall Study|Adverse Event|0
7580707|NCT02132754|26366706|P2|Overall Study|Adverse Event|0
7580708|NCT02132754|26366707|P1|Overall Study|Adverse Event|0
7580709|NCT02132637|26367475|P2|Study Period 2 (Crossover)|Physician Decision|0
7580710|NCT02132637|26367476|P1|Study Period 2 (Crossover)|Physician Decision|2
7580711|NCT02132637|26367475|P2|Study Period 2 (Crossover)|Adverse Event|1
7580712|NCT02132637|26367476|P1|Study Period 2 (Crossover)|Adverse Event|0
7580713|NCT02132637|26367475|P2|Study Period 1|Physician Decision|0
7580714|NCT02132637|26367476|P1|Study Period 1|Physician Decision|1
7580715|NCT02132637|26367475|P2|Study Period 1|Withdrawal by Subject|4
7580716|NCT02132637|26367476|P1|Study Period 1|Withdrawal by Subject|0
7580717|NCT02132611|26367500|P1|Overall Study|Death|2
7580718|NCT02132312|26367563|P2|Overall Study|Lost to Follow-up|1
7580719|NCT02132312|26367564|P1|Overall Study|Lost to Follow-up|2
7580720|NCT02132312|26367563|P2|Overall Study|Withdrawal by Subject|0
7580721|NCT02132312|26367564|P1|Overall Study|Withdrawal by Subject|1
7580722|NCT02132312|26367563|P2|Overall Study|Protocol Violation|1
7580723|NCT02132312|26367564|P1|Overall Study|Protocol Violation|0
7580724|NCT02132312|26367563|P2|Overall Study|Physician Decision|1
7580725|NCT02132312|26367564|P1|Overall Study|Physician Decision|1
7580726|NCT02132312|26367563|P2|Overall Study|Adverse Event|0
7580727|NCT02132312|26367564|P1|Overall Study|Adverse Event|2
7580728|NCT02132247|26367576|P2|Overall Study|Protocol Violation|0
7580729|NCT02132247|26367577|P1|Overall Study|Protocol Violation|1
7580730|NCT02132195|26367592|P3|Rescue Therapy|Adverse Event|2
7580731|NCT02132195|26367593|P2|Rescue Therapy|Adverse Event|0
7580732|NCT02132195|26367594|P1|Rescue Therapy|Adverse Event|0
7580733|NCT02132195|26367592|P3|Rescue Therapy|Withdrawal by Subject|1
7580734|NCT02132195|26367593|P2|Rescue Therapy|Withdrawal by Subject|0
7580735|NCT02132195|26367594|P1|Rescue Therapy|Withdrawal by Subject|0
7580736|NCT02132195|26367592|P3|Rescue Therapy|Physician Decision|1
7580737|NCT02132195|26367593|P2|Rescue Therapy|Physician Decision|0
7580738|NCT02132195|26367594|P1|Rescue Therapy|Physician Decision|0
7580739|NCT02132195|26367592|P3|Rescue Therapy|Relapsed|7
7580740|NCT02132195|26367593|P2|Rescue Therapy|Relapsed|0
7580741|NCT02132195|26367594|P1|Rescue Therapy|Relapsed|0
7580742|NCT02132195|26367592|P3|Initial Assignment|Relapsed|0
7580743|NCT02132195|26367593|P2|Initial Assignment|Relapsed|0
7580744|NCT02132195|26367594|P1|Initial Assignment|Relapsed|14
7580745|NCT02132130|26367627|P4|Overall Study|Withdrawal by Subject|1
7580746|NCT02132130|26367628|P3|Overall Study|Withdrawal by Subject|0
7580747|NCT02132130|26367629|P2|Overall Study|Withdrawal by Subject|0
7580748|NCT02132130|26367630|P1|Overall Study|Withdrawal by Subject|0
7580749|NCT02132130|26367627|P4|Overall Study|Lost to Follow-up|0
7580750|NCT02132130|26367628|P3|Overall Study|Lost to Follow-up|0
7580751|NCT02132130|26367629|P2|Overall Study|Lost to Follow-up|2
7580752|NCT02132130|26367630|P1|Overall Study|Lost to Follow-up|0
7580753|NCT02132117|26367683|P2|Overall Study|Other Miscellaneous Reasons|0
7580754|NCT02132117|26367684|P1|Overall Study|Other Miscellaneous Reasons|2
7580755|NCT02132117|26367683|P2|Overall Study|Personal Reasons|2
7580756|NCT02132117|26367684|P1|Overall Study|Personal Reasons|1
7580757|NCT02132117|26367683|P2|Overall Study|Lost to Follow-up|2
7580758|NCT02132117|26367684|P1|Overall Study|Lost to Follow-up|2
7580759|NCT02132117|26367683|P2|Overall Study|Adverse Event|1
7580760|NCT02132117|26367684|P1|Overall Study|Adverse Event|6
7580761|NCT02131766|26367700|P1|Overall Study|Withdrawal by Subject|4
7580762|NCT02131662|26367716|P5|Overall Study|Not treated|3
7580763|NCT02131662|26367717|P4|Overall Study|Not treated|2
7580764|NCT02131662|26367718|P3|Overall Study|Not treated|2
7580765|NCT02131662|26367719|P2|Overall Study|Not treated|0
7580766|NCT02131662|26367720|P1|Overall Study|Not treated|2
7580767|NCT02131662|26367716|P5|Overall Study|Lost to Follow-up|0
7580768|NCT02131662|26367717|P4|Overall Study|Lost to Follow-up|9
7580769|NCT02131662|26367718|P3|Overall Study|Lost to Follow-up|0
7580770|NCT02131662|26367719|P2|Overall Study|Lost to Follow-up|3
7580771|NCT02131662|26367720|P1|Overall Study|Lost to Follow-up|1
7580772|NCT02131662|26367716|P5|Overall Study|Withdrawal by Subject|6
7580773|NCT02131662|26367717|P4|Overall Study|Withdrawal by Subject|5
7580774|NCT02131662|26367718|P3|Overall Study|Withdrawal by Subject|1
7580775|NCT02131662|26367719|P2|Overall Study|Withdrawal by Subject|5
7580776|NCT02131662|26367720|P1|Overall Study|Withdrawal by Subject|1
7580777|NCT02131662|26367716|P5|Overall Study|Lack of Efficacy|1
7580778|NCT02131662|26367717|P4|Overall Study|Lack of Efficacy|0
7580779|NCT02131662|26367718|P3|Overall Study|Lack of Efficacy|0
7580780|NCT02131662|26367719|P2|Overall Study|Lack of Efficacy|0
7580781|NCT02131662|26367720|P1|Overall Study|Lack of Efficacy|1
7580782|NCT02131662|26367716|P5|Overall Study|Wish for pregnancy|1
7580783|NCT02131662|26367717|P4|Overall Study|Wish for pregnancy|0
7580784|NCT02131662|26367718|P3|Overall Study|Wish for pregnancy|0
7580785|NCT02131662|26367719|P2|Overall Study|Wish for pregnancy|0
7580786|NCT02131662|26367720|P1|Overall Study|Wish for pregnancy|0
7580787|NCT02131662|26367716|P5|Overall Study|Pregnancy|0
7580788|NCT02131662|26367717|P4|Overall Study|Pregnancy|1
7580789|NCT02131662|26367718|P3|Overall Study|Pregnancy|0
7580790|NCT02131662|26367719|P2|Overall Study|Pregnancy|1
7580791|NCT02131662|26367720|P1|Overall Study|Pregnancy|0
7580792|NCT02131662|26367716|P5|Overall Study|Adverse Event|3
7580793|NCT02131662|26367717|P4|Overall Study|Adverse Event|1
7580794|NCT02131662|26367718|P3|Overall Study|Adverse Event|1
7580795|NCT02131662|26367719|P2|Overall Study|Adverse Event|1
7580796|NCT02131662|26367720|P1|Overall Study|Adverse Event|0
7580797|NCT02131662|26367716|P5|Overall Study|Other|4
7580798|NCT02131662|26367717|P4|Overall Study|Other|3
7580799|NCT02131662|26367718|P3|Overall Study|Other|3
7580800|NCT02131662|26367719|P2|Overall Study|Other|4
7580801|NCT02131662|26367720|P1|Overall Study|Other|2
7580802|NCT02131662|26367716|P5|Overall Study|Protocol Violation|0
7580803|NCT02131662|26367717|P4|Overall Study|Protocol Violation|0
7580804|NCT02131662|26367718|P3|Overall Study|Protocol Violation|0
7580805|NCT02131662|26367719|P2|Overall Study|Protocol Violation|0
7580806|NCT02131662|26367720|P1|Overall Study|Protocol Violation|1
7580807|NCT02131636|26367766|P2|Overall Study|Adverse Event|1
7580808|NCT02131636|26367767|P1|Overall Study|Adverse Event|4
7580809|NCT02131636|26367766|P2|Overall Study|Lost to Follow-up|0
7580810|NCT02131636|26367767|P1|Overall Study|Lost to Follow-up|4
7580811|NCT02131636|26367766|P2|Overall Study|Personal Reasons|4
7580812|NCT02131636|26367767|P1|Overall Study|Personal Reasons|4
7580813|NCT02131532|26367783|P1|Overall Study|Other health conditions|2
7580814|NCT02131532|26367783|P1|Overall Study|Physician Decision|1
7580815|NCT02131532|26367783|P1|Overall Study|Withdrawal by Subject|1
7580816|NCT02131324|26367875|P2|Overall Study|Lost to Follow-up|1
7580817|NCT02131324|26367876|P1|Overall Study|Lost to Follow-up|1
7580818|NCT02131324|26367875|P2|Overall Study|Withdrawal by Subject|2
7580819|NCT02131324|26367876|P1|Overall Study|Withdrawal by Subject|1
7580820|NCT02131311|26367882|P1|Overall Study|Lost to Follow-up|1
7580821|NCT02131311|26367882|P1|Overall Study|Protocol Violation|1
7580822|NCT02131311|26367882|P1|Overall Study|Adverse Event|2
7580823|NCT02131272|26367894|P2|Overall Study|Withdrawal Criteria|0
7580824|NCT02131272|26367895|P1|Overall Study|Withdrawal Criteria|1
7580825|NCT02131272|26367894|P2|Overall Study|Withdrawal by Subject|1
7580826|NCT02131272|26367895|P1|Overall Study|Withdrawal by Subject|0
7580827|NCT02131272|26367894|P2|Overall Study|Withdrawal by parent|1
7580828|NCT02131272|26367895|P1|Overall Study|Withdrawal by parent|0
7580829|NCT02131259|26367913|P1|Overall Study|Missing|3
7580830|NCT02131259|26367913|P1|Overall Study|Progressive disease/AE/other|1
7580831|NCT02131259|26367913|P1|Overall Study|AE/other|1
7580832|NCT02131259|26367913|P1|Overall Study|AE/lost to follow-up|1
7580833|NCT02131259|26367913|P1|Overall Study|Progressive disease/other|2
7580834|NCT02131259|26367913|P1|Overall Study|Progressive disease/relocation|1
7580835|NCT02131259|26367913|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
7580836|NCT02131259|26367913|P1|Overall Study|Other|63
7580837|NCT02131259|26367913|P1|Overall Study|Relocation|32
7580838|NCT02131259|26367913|P1|Overall Study|Lost to Follow-up|7
7580839|NCT02131259|26367913|P1|Overall Study|Adverse Event|341
7580840|NCT02131259|26367913|P1|Overall Study|Progressive disease|751
7580841|NCT02131233|26367920|P2|Overall Study|Withdrawal by Subject|11
7580842|NCT02131233|26367921|P1|Overall Study|Withdrawal by Subject|18
7580843|NCT02131233|26367920|P2|Overall Study|Pregnancy|0
7580844|NCT02131233|26367921|P1|Overall Study|Pregnancy|4
7580845|NCT02131233|26367920|P2|Overall Study|Physician Decision|0
7580846|NCT02131233|26367921|P1|Overall Study|Physician Decision|7
7580847|NCT02131233|26367920|P2|Overall Study|Non-Compliance With Study Drug|5
7580848|NCT02131233|26367921|P1|Overall Study|Non-Compliance With Study Drug|8
7580849|NCT02131233|26367920|P2|Overall Study|Lost to Follow-up|13
7580850|NCT02131233|26367921|P1|Overall Study|Lost to Follow-up|14
7580851|NCT02131233|26367920|P2|Overall Study|Lack of Efficacy|3
7580852|NCT02131233|26367921|P1|Overall Study|Lack of Efficacy|6
7580853|NCT02131233|26367920|P2|Overall Study|Death|1
7580854|NCT02131233|26367921|P1|Overall Study|Death|0
7580855|NCT02131233|26367920|P2|Overall Study|Adverse Event|6
7580856|NCT02131233|26367921|P1|Overall Study|Adverse Event|7
7580857|NCT02131233|26367920|P2|Overall Study|Not Treated|3
7580858|NCT02131233|26367921|P1|Overall Study|Not Treated|2
7580859|NCT02131155|26367955|P2|Overall Study|Study early termination|10
7580860|NCT02131155|26367956|P1|Overall Study|Study early termination|20
7580861|NCT02131155|26367955|P2|Overall Study|Refused to continue study medication|0
7580862|NCT02131155|26367956|P1|Overall Study|Refused to continue study medication|1
7580863|NCT02131155|26367955|P2|Overall Study|Primary tumour recurrence|1
7580864|NCT02131155|26367956|P1|Overall Study|Primary tumour recurrence|2
7580865|NCT02131155|26367955|P2|Overall Study|Treatment completed|0
7580866|NCT02131155|26367956|P1|Overall Study|Treatment completed|1
7580867|NCT02131155|26367955|P2|Overall Study|Adverse Event|0
7580868|NCT02131155|26367956|P1|Overall Study|Adverse Event|1
7580869|NCT02131129|26367970|P2|Overall Study|Withdrawal by Subject|0
7580870|NCT02131129|26367971|P1|Overall Study|Withdrawal by Subject|1
7580871|NCT02131064|26367989|P2|Overall Study|Other|2
7580872|NCT02131064|26367990|P1|Overall Study|Other|2
7580873|NCT02131064|26367989|P2|Overall Study|Withdrawal by Subject|18
7580874|NCT02131064|26367990|P1|Overall Study|Withdrawal by Subject|14
7580875|NCT02131064|26367989|P2|Overall Study|Lost to Follow-up|8
7580876|NCT02131064|26367990|P1|Overall Study|Lost to Follow-up|4
7580877|NCT02131064|26367989|P2|Overall Study|Death|6
7580878|NCT02131064|26367990|P1|Overall Study|Death|5
7580879|NCT02130986|26368059|P2|Overall Study|Lost to Follow-up|160
7580880|NCT02130986|26368060|P1|Overall Study|Lost to Follow-up|151
7580881|NCT02130986|26368059|P2|Overall Study|Withdrawal by Subject|4
7580882|NCT02130986|26368060|P1|Overall Study|Withdrawal by Subject|4
7580883|NCT02130765|26368074|P4|Overall Study|Did not receive treatment|0
7580884|NCT02130765|26368075|P3|Overall Study|Did not receive treatment|0
7580885|NCT02130765|26368076|P2|Overall Study|Did not receive treatment|0
7580886|NCT02130765|26368077|P1|Overall Study|Did not receive treatment|4
7580887|NCT02130570|26368381|P2|Overall Study|Part of practice that discontinued study|5
7580888|NCT02130570|26368382|P1|Overall Study|Part of practice that discontinued study|0
7580889|NCT02130570|26368381|P2|Overall Study|Withdrawal by Subject|3
7580890|NCT02130570|26368382|P1|Overall Study|Withdrawal by Subject|6
7580891|NCT02130570|26368381|P2|Overall Study|Death|5
7580892|NCT02130570|26368382|P1|Overall Study|Death|3
7580893|NCT02130557|26368400|P2|Overall Study|Missing|1
7580894|NCT02130557|26368401|P1|Overall Study|Missing|2
7580895|NCT02130557|26368400|P2|Overall Study|Other|1
7580896|NCT02130557|26368401|P1|Overall Study|Other|2
7580897|NCT02130557|26368400|P2|Overall Study|Lost to Follow-up|7
7580898|NCT02130557|26368401|P1|Overall Study|Lost to Follow-up|6
7580899|NCT02130557|26368400|P2|Overall Study|Deceased|14
7580900|NCT02130557|26368401|P1|Overall Study|Deceased|14
7580901|NCT02130557|26368400|P2|Overall Study|Investigator Request|2
7580902|NCT02130557|26368401|P1|Overall Study|Investigator Request|0
7580903|NCT02130557|26368400|P2|Overall Study|Withdrawal by Subject|12
7580904|NCT02130557|26368401|P1|Overall Study|Withdrawal by Subject|12
7580905|NCT02130427|26368433|P1|Overall Study|Imaging results not interpretable|30
7580906|NCT02130297|26368437|P1|Overall Study|Lost to Follow-up|4
7580907|NCT02130284|26368443|P1|Overall Study|Screen Failure|1
7580908|NCT02130284|26368443|P1|Overall Study|Subject was screened as backup for study|3
7580909|NCT02130284|26368443|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
7580910|NCT02130284|26368443|P1|Overall Study|Subject Withdrew Consent|1
7580911|NCT02130284|26368443|P1|Overall Study|Withdrawal by Subject|3
7580912|NCT02130193|26368469|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7580913|NCT02130193|26368470|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7580914|NCT02130193|26368471|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
7580915|NCT02130193|26368469|P3|Part B: 52-week Double-blind Period|Physician Decision|1
7580916|NCT02130193|26368470|P2|Part B: 52-week Double-blind Period|Physician Decision|0
7580917|NCT02130193|26368471|P1|Part B: 52-week Double-blind Period|Physician Decision|0
7580918|NCT02130193|26368469|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
7580919|NCT02130193|26368470|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
7580920|NCT02130193|26368471|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
7580921|NCT02130193|26368469|P3|Part B: 52-week Double-blind Period|Adverse Event|3
7580922|NCT02130193|26368470|P2|Part B: 52-week Double-blind Period|Adverse Event|5
7580923|NCT02130193|26368471|P1|Part B: 52-week Double-blind Period|Adverse Event|0
7580924|NCT02130024|26368552|P2|Overall Study|Subject Withdrew Consent|14
7580925|NCT02130024|26368553|P1|Overall Study|Subject Withdrew Consent|6
7580926|NCT02130024|26368552|P2|Overall Study|Site Administration Problems|0
7580927|NCT02130024|26368553|P1|Overall Study|Site Administration Problems|1
7580928|NCT02130024|26368552|P2|Overall Study|Protocol Deviation|0
7580929|NCT02130024|26368553|P1|Overall Study|Protocol Deviation|4
7580930|NCT02130024|26368552|P2|Overall Study|Physician Decision|3
7580931|NCT02130024|26368553|P1|Overall Study|Physician Decision|1
7580932|NCT02130024|26368552|P2|Overall Study|Lost to Follow-up|1
7580933|NCT02130024|26368553|P1|Overall Study|Lost to Follow-up|1
7580934|NCT02130024|26368552|P2|Overall Study|Death|2
7580935|NCT02130024|26368553|P1|Overall Study|Death|2
7580936|NCT02130024|26368552|P2|Overall Study|Adverse Event|11
7580937|NCT02130024|26368553|P1|Overall Study|Adverse Event|10
7580938|NCT02129803|26368587|P2|Overall Study|Withdrawal by Subject|1
7580939|NCT02129803|26368588|P1|Overall Study|Withdrawal by Subject|1
7580940|NCT02129803|26368587|P2|Overall Study|Morning headache|1
7580941|NCT02129803|26368588|P1|Overall Study|Morning headache|0
7580942|NCT02129803|26368587|P2|Overall Study|Difficulty sleeping|0
7580943|NCT02129803|26368588|P1|Overall Study|Difficulty sleeping|1
7580944|NCT02129803|26368587|P2|Overall Study|Physician Decision|1
7580945|NCT02129803|26368588|P1|Overall Study|Physician Decision|0
7580946|NCT02129803|26368587|P2|Overall Study|Protocol Violation|0
7580947|NCT02129803|26368588|P1|Overall Study|Protocol Violation|4
7580948|NCT02129777|26368601|P7|Open-Label Period|Study Termination|39
7580949|NCT02129777|26368602|P6|Open-Label Period|Study Termination|10
7580950|NCT02129777|26368603|P5|Open-Label Period|Study Termination|0
7580951|NCT02129777|26368604|P4|Open-Label Period|Study Termination|0
7580952|NCT02129777|26368605|P3|Open-Label Period|Study Termination|0
7580953|NCT02129777|26368606|P2|Open-Label Period|Study Termination|0
7580954|NCT02129777|26368607|P1|Open-Label Period|Study Termination|0
7580955|NCT02129777|26368601|P7|Open-Label Period|Withdrawal by Subject|3
7580956|NCT02129777|26368602|P6|Open-Label Period|Withdrawal by Subject|1
7580957|NCT02129777|26368603|P5|Open-Label Period|Withdrawal by Subject|0
7580958|NCT02129777|26368604|P4|Open-Label Period|Withdrawal by Subject|0
7580959|NCT02129777|26368605|P3|Open-Label Period|Withdrawal by Subject|0
7580960|NCT02129777|26368606|P2|Open-Label Period|Withdrawal by Subject|0
7580961|NCT02129777|26368607|P1|Open-Label Period|Withdrawal by Subject|0
7580962|NCT02129777|26368601|P7|Open-Label Period|Lost to Follow-up|1
7580963|NCT02129777|26368602|P6|Open-Label Period|Lost to Follow-up|1
7580964|NCT02129777|26368603|P5|Open-Label Period|Lost to Follow-up|0
7580965|NCT02129777|26368604|P4|Open-Label Period|Lost to Follow-up|0
7580966|NCT02129777|26368605|P3|Open-Label Period|Lost to Follow-up|0
7580967|NCT02129777|26368606|P2|Open-Label Period|Lost to Follow-up|0
7580968|NCT02129777|26368607|P1|Open-Label Period|Lost to Follow-up|0
7580969|NCT02129777|26368601|P7|Open-Label Period|Lack of Efficacy|5
7580970|NCT02129777|26368602|P6|Open-Label Period|Lack of Efficacy|0
7580971|NCT02129777|26368603|P5|Open-Label Period|Lack of Efficacy|0
7580972|NCT02129777|26368604|P4|Open-Label Period|Lack of Efficacy|0
7580973|NCT02129777|26368605|P3|Open-Label Period|Lack of Efficacy|0
7580974|NCT02129777|26368606|P2|Open-Label Period|Lack of Efficacy|0
7580975|NCT02129777|26368607|P1|Open-Label Period|Lack of Efficacy|0
7580976|NCT02129777|26368601|P7|Double-Blind Period|Other|0
7580977|NCT02129777|26368602|P6|Double-Blind Period|Other|0
7580978|NCT02129777|26368603|P5|Double-Blind Period|Other|0
7580979|NCT02129777|26368604|P4|Double-Blind Period|Other|0
7580980|NCT02129777|26368605|P3|Double-Blind Period|Other|0
7580981|NCT02129777|26368606|P2|Double-Blind Period|Other|2
7580982|NCT02129777|26368607|P1|Double-Blind Period|Other|1
7580983|NCT02129777|26368601|P7|Double-Blind Period|Lack of Efficacy|0
7580984|NCT02129777|26368602|P6|Double-Blind Period|Lack of Efficacy|0
7580985|NCT02129777|26368603|P5|Double-Blind Period|Lack of Efficacy|2
7580986|NCT02129777|26368604|P4|Double-Blind Period|Lack of Efficacy|3
7580987|NCT02129777|26368605|P3|Double-Blind Period|Lack of Efficacy|0
7580988|NCT02129777|26368606|P2|Double-Blind Period|Lack of Efficacy|1
7580989|NCT02129777|26368607|P1|Double-Blind Period|Lack of Efficacy|3
7580990|NCT02129777|26368601|P7|Double-Blind Period|Pregnancy|0
7580991|NCT02129777|26368602|P6|Double-Blind Period|Pregnancy|0
7580992|NCT02129777|26368603|P5|Double-Blind Period|Pregnancy|1
7580993|NCT02129777|26368604|P4|Double-Blind Period|Pregnancy|0
7580994|NCT02129777|26368605|P3|Double-Blind Period|Pregnancy|0
7580995|NCT02129777|26368606|P2|Double-Blind Period|Pregnancy|0
7580996|NCT02129777|26368607|P1|Double-Blind Period|Pregnancy|0
7580997|NCT02129777|26368601|P7|Double-Blind Period|Withdrawal by Subject|0
7580998|NCT02129777|26368602|P6|Double-Blind Period|Withdrawal by Subject|0
7580999|NCT02129777|26368603|P5|Double-Blind Period|Withdrawal by Subject|3
7581000|NCT02129777|26368604|P4|Double-Blind Period|Withdrawal by Subject|2
7581001|NCT02129777|26368605|P3|Double-Blind Period|Withdrawal by Subject|3
7581002|NCT02129777|26368606|P2|Double-Blind Period|Withdrawal by Subject|4
7581003|NCT02129777|26368607|P1|Double-Blind Period|Withdrawal by Subject|2
7581004|NCT02129777|26368601|P7|Double-Blind Period|Lost to Follow-up|0
7581005|NCT02129777|26368602|P6|Double-Blind Period|Lost to Follow-up|0
7581006|NCT02129777|26368603|P5|Double-Blind Period|Lost to Follow-up|0
7581007|NCT02129777|26368604|P4|Double-Blind Period|Lost to Follow-up|2
7581008|NCT02129777|26368605|P3|Double-Blind Period|Lost to Follow-up|1
7581009|NCT02129777|26368606|P2|Double-Blind Period|Lost to Follow-up|1
7581010|NCT02129777|26368607|P1|Double-Blind Period|Lost to Follow-up|1
7581011|NCT02129777|26368601|P7|Double-Blind Period|Adverse Event|0
7581012|NCT02129777|26368602|P6|Double-Blind Period|Adverse Event|0
7581013|NCT02129777|26368603|P5|Double-Blind Period|Adverse Event|1
7581014|NCT02129777|26368604|P4|Double-Blind Period|Adverse Event|0
7581015|NCT02129777|26368605|P3|Double-Blind Period|Adverse Event|0
7581016|NCT02129777|26368606|P2|Double-Blind Period|Adverse Event|0
7581017|NCT02129777|26368607|P1|Double-Blind Period|Adverse Event|0
7581018|NCT02129608|26368774|P3|Overall Study|Withdrawal by Subject|2
7581019|NCT02129608|26368775|P2|Overall Study|Withdrawal by Subject|0
7581020|NCT02129608|26368776|P1|Overall Study|Withdrawal by Subject|0
7581021|NCT02129608|26368774|P3|Overall Study|Lost to Follow-up|1
7581022|NCT02129608|26368775|P2|Overall Study|Lost to Follow-up|1
7581023|NCT02129608|26368776|P1|Overall Study|Lost to Follow-up|0
7581024|NCT02129205|26368875|P10|Overall Study|Other|0
7581025|NCT02129205|26368876|P9|Overall Study|Other|1
7581026|NCT02129205|26368877|P8|Overall Study|Other|2
7581027|NCT02129205|26368878|P7|Overall Study|Other|3
7581028|NCT02129205|26368879|P6|Overall Study|Other|3
7581029|NCT02129205|26368880|P5|Overall Study|Other|2
7581030|NCT02129205|26368881|P4|Overall Study|Other|0
7581031|NCT02129205|26368882|P3|Overall Study|Other|0
7581032|NCT02129205|26368883|P2|Overall Study|Other|0
7581033|NCT02129205|26368884|P1|Overall Study|Other|1
7581034|NCT02129205|26368875|P10|Overall Study|Withdrawal by Subject|0
7581035|NCT02129205|26368876|P9|Overall Study|Withdrawal by Subject|1
7581036|NCT02129205|26368877|P8|Overall Study|Withdrawal by Subject|0
7581037|NCT02129205|26368878|P7|Overall Study|Withdrawal by Subject|1
7581038|NCT02129205|26368879|P6|Overall Study|Withdrawal by Subject|1
7581039|NCT02129205|26368880|P5|Overall Study|Withdrawal by Subject|1
7581040|NCT02129205|26368881|P4|Overall Study|Withdrawal by Subject|0
7581041|NCT02129205|26368882|P3|Overall Study|Withdrawal by Subject|0
7581042|NCT02129205|26368883|P2|Overall Study|Withdrawal by Subject|0
7581043|NCT02129205|26368884|P1|Overall Study|Withdrawal by Subject|0
7581044|NCT02129192|26369037|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
7581045|NCT02129192|26369038|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
7581046|NCT02129062|26369055|P1|Overall Study|Disease Progression|2
7581047|NCT02129062|26369055|P1|Overall Study|Death|1
7581048|NCT02128997|26369062|P2|Overall Study|Lost to Follow-up|11
7581049|NCT02128997|26369063|P1|Overall Study|Lost to Follow-up|6
7581050|NCT02128932|26369078|P3|Overall Study|No reason for withdrawal|7
7581051|NCT02128932|26369079|P2|Overall Study|No reason for withdrawal|11
7581052|NCT02128932|26369080|P1|Overall Study|No reason for withdrawal|12
7581053|NCT02128932|26369078|P3|Overall Study|Lost to Follow-up|1
7581054|NCT02128932|26369079|P2|Overall Study|Lost to Follow-up|1
7581055|NCT02128932|26369080|P1|Overall Study|Lost to Follow-up|2
7581056|NCT02128932|26369078|P3|Overall Study|Death|2
7581057|NCT02128932|26369079|P2|Overall Study|Death|0
7581058|NCT02128932|26369080|P1|Overall Study|Death|2
7581059|NCT02128932|26369078|P3|Overall Study|Withdrawal by Subject|8
7581060|NCT02128932|26369079|P2|Overall Study|Withdrawal by Subject|7
7581061|NCT02128932|26369080|P1|Overall Study|Withdrawal by Subject|11
7581062|NCT02128763|26369141|P2|Overall Study|Lost to Follow-up|16
7581063|NCT02128763|26369142|P1|Overall Study|Lost to Follow-up|19
7581064|NCT02128763|26369141|P2|Overall Study|Death|0
7581065|NCT02128763|26369142|P1|Overall Study|Death|1
7581066|NCT02128724|26369188|P4|Overall Study|Withdrawal by Subject|1
7581067|NCT02128724|26369189|P3|Overall Study|Withdrawal by Subject|0
7581068|NCT02128724|26369190|P2|Overall Study|Withdrawal by Subject|0
7581069|NCT02128724|26369191|P1|Overall Study|Withdrawal by Subject|0
7581070|NCT02128724|26369188|P4|Overall Study|Physician Decision|2
7581071|NCT02128724|26369189|P3|Overall Study|Physician Decision|0
7581072|NCT02128724|26369190|P2|Overall Study|Physician Decision|0
7581073|NCT02128724|26369191|P1|Overall Study|Physician Decision|0
7581074|NCT02128724|26369188|P4|Overall Study|Adverse Event|0
7581075|NCT02128724|26369189|P3|Overall Study|Adverse Event|0
7581076|NCT02128724|26369190|P2|Overall Study|Adverse Event|1
7581077|NCT02128724|26369191|P1|Overall Study|Adverse Event|0
7581078|NCT02128724|26369188|P4|Overall Study|Death|0
7581079|NCT02128724|26369189|P3|Overall Study|Death|0
7581080|NCT02128724|26369190|P2|Overall Study|Death|0
7581081|NCT02128724|26369191|P1|Overall Study|Death|1
7581082|NCT02128542|26369246|P2|Overall Study|Withdrew Consent|0
7581083|NCT02128542|26369247|P1|Overall Study|Withdrew Consent|1
7581084|NCT02128542|26369246|P2|Overall Study|Lost to Follow-up|0
7581085|NCT02128542|26369247|P1|Overall Study|Lost to Follow-up|3
7581086|NCT02128490|26369265|P5|Overall Study|Other Miscellaneous Reasons|1
7581087|NCT02128490|26369266|P4|Overall Study|Other Miscellaneous Reasons|1
7581088|NCT02128490|26369267|P3|Overall Study|Other Miscellaneous Reasons|2
7581089|NCT02128490|26369268|P2|Overall Study|Other Miscellaneous Reasons|0
7581090|NCT02128490|26369269|P1|Overall Study|Other Miscellaneous Reasons|0
7581091|NCT02128490|26369265|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
7581092|NCT02128490|26369266|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
7581093|NCT02128490|26369267|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
7581094|NCT02128490|26369268|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
7581095|NCT02128490|26369269|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
7581096|NCT02128490|26369265|P5|Overall Study|Lack of Efficacy|0
7581097|NCT02128490|26369266|P4|Overall Study|Lack of Efficacy|0
7581098|NCT02128490|26369267|P3|Overall Study|Lack of Efficacy|0
7581099|NCT02128490|26369268|P2|Overall Study|Lack of Efficacy|1
7581100|NCT02128490|26369269|P1|Overall Study|Lack of Efficacy|0
7581101|NCT02128490|26369265|P5|Overall Study|Voluntary Withdrawal|2
7581102|NCT02128490|26369266|P4|Overall Study|Voluntary Withdrawal|1
7581103|NCT02128490|26369267|P3|Overall Study|Voluntary Withdrawal|1
7581104|NCT02128490|26369268|P2|Overall Study|Voluntary Withdrawal|3
7581105|NCT02128490|26369269|P1|Overall Study|Voluntary Withdrawal|3
7581106|NCT02128490|26369265|P5|Overall Study|Lost to Follow-up|1
7581107|NCT02128490|26369266|P4|Overall Study|Lost to Follow-up|1
7581108|NCT02128490|26369267|P3|Overall Study|Lost to Follow-up|1
7581109|NCT02128490|26369268|P2|Overall Study|Lost to Follow-up|0
7581110|NCT02128490|26369269|P1|Overall Study|Lost to Follow-up|0
7581111|NCT02128490|26369265|P5|Overall Study|Major Protocol Deviation|2
7581112|NCT02128490|26369266|P4|Overall Study|Major Protocol Deviation|2
7581113|NCT02128490|26369267|P3|Overall Study|Major Protocol Deviation|0
7581114|NCT02128490|26369268|P2|Overall Study|Major Protocol Deviation|2
7581115|NCT02128490|26369269|P1|Overall Study|Major Protocol Deviation|1
7581116|NCT02128490|26369265|P5|Overall Study|Pretreatment Event/Adverse Event|0
7581117|NCT02128490|26369266|P4|Overall Study|Pretreatment Event/Adverse Event|1
7581118|NCT02128490|26369267|P3|Overall Study|Pretreatment Event/Adverse Event|1
7581119|NCT02128490|26369268|P2|Overall Study|Pretreatment Event/Adverse Event|0
7581120|NCT02128490|26369269|P1|Overall Study|Pretreatment Event/Adverse Event|1
7581121|NCT02128269|26369291|P1|Treatment Period|Physician Decision|1
7581122|NCT02128269|26369291|P1|Treatment Period|Adverse Event|1
7581123|NCT02128217|26369301|P2|Overall Study|Lost to Follow-up|1
7581124|NCT02128217|26369302|P1|Overall Study|Lost to Follow-up|0
7581125|NCT02127970|26369350|P2|Overall Study|Subject Withdrew Consent|3
7581126|NCT02127970|26369351|P1|Overall Study|Subject Withdrew Consent|5
7581127|NCT02127970|26369350|P2|Overall Study|Pregnancy|1
7581128|NCT02127970|26369351|P1|Overall Study|Pregnancy|0
7581129|NCT02127970|26369350|P2|Overall Study|Reason not Specified|7
7581130|NCT02127970|26369351|P1|Overall Study|Reason not Specified|4
7581131|NCT02127970|26369350|P2|Overall Study|Lost to Follow-up|14
7581132|NCT02127970|26369351|P1|Overall Study|Lost to Follow-up|14
7581133|NCT02127970|26369350|P2|Overall Study|Death|1
7581134|NCT02127970|26369351|P1|Overall Study|Death|1
7581135|NCT02127970|26369350|P2|Overall Study|Adverse Event|1
7581136|NCT02127970|26369351|P1|Overall Study|Adverse Event|2
7581137|NCT02127931|26369373|P1|Overall Study|Glitch in Game|1
7581138|NCT02127372|26369499|P2|Overall Study|Withdrawal by Subject|0
7581139|NCT02127372|26369500|P1|Overall Study|Withdrawal by Subject|1
7581140|NCT02127307|26369510|P1|Overall Study|Other than specified above|169
7581141|NCT02127307|26369510|P1|Overall Study|Death|101
7581142|NCT02127307|26369510|P1|Overall Study|Lost to Follow-up|2
7581143|NCT02127307|26369510|P1|Overall Study|Protocol Violation|36
7581144|NCT02127281|26369516|P2|Overall Study|Lost to Follow-up|0
7581145|NCT02127281|26369517|P1|Overall Study|Lost to Follow-up|1
7581146|NCT02127125|26369552|P9|Overall Study|Physician Decision|0
7581147|NCT02127125|26369553|P8|Overall Study|Physician Decision|0
7581148|NCT02127125|26369554|P7|Overall Study|Physician Decision|0
7581149|NCT02127125|26369555|P6|Overall Study|Physician Decision|2
7581150|NCT02127125|26369556|P5|Overall Study|Physician Decision|1
7581151|NCT02127125|26369557|P4|Overall Study|Physician Decision|0
7581152|NCT02127125|26369558|P3|Overall Study|Physician Decision|1
7581153|NCT02127125|26369559|P2|Overall Study|Physician Decision|0
7581154|NCT02127125|26369560|P1|Overall Study|Physician Decision|0
7581155|NCT02127125|26369552|P9|Overall Study|Withdrawal by Subject|0
7581156|NCT02127125|26369553|P8|Overall Study|Withdrawal by Subject|0
7581157|NCT02127125|26369554|P7|Overall Study|Withdrawal by Subject|0
7581158|NCT02127125|26369555|P6|Overall Study|Withdrawal by Subject|0
7581159|NCT02127125|26369556|P5|Overall Study|Withdrawal by Subject|0
7581160|NCT02127125|26369557|P4|Overall Study|Withdrawal by Subject|1
7581161|NCT02127125|26369558|P3|Overall Study|Withdrawal by Subject|0
7581162|NCT02127125|26369559|P2|Overall Study|Withdrawal by Subject|0
7581163|NCT02127125|26369560|P1|Overall Study|Withdrawal by Subject|0
7581164|NCT02127125|26369552|P9|Overall Study|Lost to Follow-up|0
7581165|NCT02127125|26369553|P8|Overall Study|Lost to Follow-up|0
7581166|NCT02127125|26369554|P7|Overall Study|Lost to Follow-up|0
7581167|NCT02127125|26369555|P6|Overall Study|Lost to Follow-up|1
7581168|NCT02127125|26369556|P5|Overall Study|Lost to Follow-up|2
7581169|NCT02127125|26369557|P4|Overall Study|Lost to Follow-up|0
7581170|NCT02127125|26369558|P3|Overall Study|Lost to Follow-up|0
7581171|NCT02127125|26369559|P2|Overall Study|Lost to Follow-up|0
7581172|NCT02127125|26369560|P1|Overall Study|Lost to Follow-up|0
7581173|NCT02126969|26369600|P2|Overall Study|Withdrawal by Subject|2
7581174|NCT02126969|26369601|P1|Overall Study|Withdrawal by Subject|1
7581175|NCT02126839|26369632|P2|Overall Study|Other|5
7581176|NCT02126839|26369633|P1|Overall Study|Other|5
7581177|NCT02126839|26369632|P2|Overall Study|Lost to Follow-up|4
7581178|NCT02126839|26369633|P1|Overall Study|Lost to Follow-up|1
7581179|NCT02126839|26369632|P2|Overall Study|Sponsor request|1
7581180|NCT02126839|26369633|P1|Overall Study|Sponsor request|0
7581181|NCT02126839|26369632|P2|Overall Study|Protocol Violation|3
7581182|NCT02126839|26369633|P1|Overall Study|Protocol Violation|2
7581183|NCT02126839|26369632|P2|Overall Study|Withdrawal by parent/guardian|0
7581184|NCT02126839|26369633|P1|Overall Study|Withdrawal by parent/guardian|1
7581185|NCT02126839|26369632|P2|Overall Study|Withdrawal by Subject|0
7581186|NCT02126839|26369633|P1|Overall Study|Withdrawal by Subject|1
7581187|NCT02126839|26369632|P2|Overall Study|Adverse Event|1
7581188|NCT02126839|26369633|P1|Overall Study|Adverse Event|0
7581189|NCT02126826|26369650|P7|Overall Study|Withdrawal by Subject|0
7581190|NCT02126826|26369651|P6|Overall Study|Withdrawal by Subject|0
7581191|NCT02126826|26369652|P5|Overall Study|Withdrawal by Subject|0
7581192|NCT02126826|26369653|P4|Overall Study|Withdrawal by Subject|1
7581193|NCT02126826|26369654|P3|Overall Study|Withdrawal by Subject|0
7581194|NCT02126826|26369655|P2|Overall Study|Withdrawal by Subject|0
7581195|NCT02126826|26369656|P1|Overall Study|Withdrawal by Subject|0
7581196|NCT02126670|26369724|P4|Overall Study|Withdrawal by Subject|1
7581197|NCT02126670|26369725|P3|Overall Study|Withdrawal by Subject|0
7581198|NCT02126670|26369726|P2|Overall Study|Withdrawal by Subject|0
7581199|NCT02126670|26369727|P1|Overall Study|Withdrawal by Subject|1
7581200|NCT02125877|26369779|P2|Overall Study|Adverse Event|4
7581201|NCT02125877|26369780|P1|Overall Study|Adverse Event|6
7581202|NCT02125877|26369779|P2|Overall Study|Protocol deviation|1
7581203|NCT02125877|26369780|P1|Overall Study|Protocol deviation|4
7581204|NCT02125877|26369779|P2|Overall Study|Withdrawal by Subject|1
7581205|NCT02125877|26369780|P1|Overall Study|Withdrawal by Subject|2
7581206|NCT02125877|26369779|P2|Overall Study|Participant/guardian decision|2
7581207|NCT02125877|26369780|P1|Overall Study|Participant/guardian decision|0
7581208|NCT02125877|26369779|P2|Overall Study|Administrative problems|1
7581209|NCT02125877|26369780|P1|Overall Study|Administrative problems|0
7581210|NCT02125877|26369779|P2|Overall Study|Death|1
7581211|NCT02125877|26369780|P1|Overall Study|Death|0
7581212|NCT02125877|26369779|P2|Overall Study|Physician Decision|0
7581213|NCT02125877|26369780|P1|Overall Study|Physician Decision|1
7581214|NCT02125838|26369810|P2|Overall Study|Lost to Follow-up|4
7581215|NCT02125838|26369811|P1|Overall Study|Lost to Follow-up|4
7581216|NCT02125734|26369829|P2|Period 2|Adverse Event|1
7581217|NCT02125734|26369830|P1|Period 2|Adverse Event|0
7581218|NCT02125604|26369844|P1|Overall Study|Adverse Event|20
7581219|NCT02125604|26369844|P1|Overall Study|Consent Withdrawn|4
7581220|NCT02125604|26369844|P1|Overall Study|Lost to Follow-up|2
7581221|NCT02125604|26369844|P1|Overall Study|Investigator Decision|1
7581222|NCT02125604|26369844|P1|Overall Study|Other|4
7581223|NCT02125461|26369860|P2|Overall Study|Death|115
7581224|NCT02125461|26369861|P1|Overall Study|Death|180
7581225|NCT02125461|26369860|P2|Overall Study|Lost to Follow-up|0
7581226|NCT02125461|26369861|P1|Overall Study|Lost to Follow-up|1
7581227|NCT02125461|26369860|P2|Overall Study|Withdrawal by Subject|14
7581228|NCT02125461|26369861|P1|Overall Study|Withdrawal by Subject|22
7581229|NCT02125331|26369892|P2|Overall Study|screen failure|0
7581230|NCT02125331|26369893|P1|Overall Study|screen failure|2
7581231|NCT02125331|26369892|P2|Overall Study|technical problem|0
7581232|NCT02125331|26369893|P1|Overall Study|technical problem|2
7581233|NCT02125331|26369892|P2|Overall Study|Protocol Violation|0
7581234|NCT02125331|26369893|P1|Overall Study|Protocol Violation|1
7581235|NCT02125279|26369925|P1|Overall Study|Lost to Follow-up|4
7581236|NCT02125279|26369925|P1|Overall Study|Protocol Violation|1
7581237|NCT02125279|26369925|P1|Overall Study|Withdrawal by Subject|6
7581238|NCT02125279|26369925|P1|Overall Study|Lack of Efficacy|2
7581239|NCT02124811|26369969|P2|Overall Study|Withdrawal by Subject|0
7581240|NCT02124811|26369970|P1|Overall Study|Withdrawal by Subject|1
7581241|NCT02124811|26369969|P2|Overall Study|Early termination|2
7581242|NCT02124811|26369970|P1|Overall Study|Early termination|2
7581243|NCT02124798|26369986|P1|Overall Study|Lost to Follow-up|1
7581244|NCT02124798|26369986|P1|Overall Study|Adverse Event|3
7581245|NCT02124772|26370005|P13|Overall Study|Other|0
7581246|NCT02124772|26370006|P12|Overall Study|Other|1
7581247|NCT02124772|26370007|P11|Overall Study|Other|1
7581248|NCT02124772|26370008|P10|Overall Study|Other|1
7581249|NCT02124772|26370009|P9|Overall Study|Other|1
7581250|NCT02124772|26370010|P8|Overall Study|Other|1
7581251|NCT02124772|26370011|P7|Overall Study|Other|4
7581252|NCT02124772|26370012|P6|Overall Study|Other|3
7581253|NCT02124772|26370013|P5|Overall Study|Other|4
7581254|NCT02124772|26370014|P4|Overall Study|Other|5
7581255|NCT02124772|26370015|P3|Overall Study|Other|2
7581256|NCT02124772|26370016|P2|Overall Study|Other|7
7581257|NCT02124772|26370017|P1|Overall Study|Other|0
7581258|NCT02124772|26370005|P13|Overall Study|Progressive disease|0
7581259|NCT02124772|26370006|P12|Overall Study|Progressive disease|0
7581260|NCT02124772|26370007|P11|Overall Study|Progressive disease|0
7581261|NCT02124772|26370008|P10|Overall Study|Progressive disease|0
7581262|NCT02124772|26370009|P9|Overall Study|Progressive disease|0
7581263|NCT02124772|26370010|P8|Overall Study|Progressive disease|1
7581264|NCT02124772|26370011|P7|Overall Study|Progressive disease|1
7581265|NCT02124772|26370012|P6|Overall Study|Progressive disease|0
7581266|NCT02124772|26370013|P5|Overall Study|Progressive disease|0
7581267|NCT02124772|26370014|P4|Overall Study|Progressive disease|0
7581268|NCT02124772|26370015|P3|Overall Study|Progressive disease|0
7581269|NCT02124772|26370016|P2|Overall Study|Progressive disease|0
7581270|NCT02124772|26370017|P1|Overall Study|Progressive disease|0
7581271|NCT02124772|26370005|P13|Overall Study|Investigator discretion|0
7581272|NCT02124772|26370006|P12|Overall Study|Investigator discretion|1
7581273|NCT02124772|26370007|P11|Overall Study|Investigator discretion|0
7581274|NCT02124772|26370008|P10|Overall Study|Investigator discretion|1
7581275|NCT02124772|26370009|P9|Overall Study|Investigator discretion|0
7581276|NCT02124772|26370010|P8|Overall Study|Investigator discretion|0
7581277|NCT02124772|26370011|P7|Overall Study|Investigator discretion|1
7581278|NCT02124772|26370012|P6|Overall Study|Investigator discretion|0
7581279|NCT02124772|26370013|P5|Overall Study|Investigator discretion|1
7581280|NCT02124772|26370014|P4|Overall Study|Investigator discretion|1
7581281|NCT02124772|26370015|P3|Overall Study|Investigator discretion|2
7581282|NCT02124772|26370016|P2|Overall Study|Investigator discretion|2
7581283|NCT02124772|26370017|P1|Overall Study|Investigator discretion|0
7581284|NCT02124772|26370005|P13|Overall Study|Withdrawal consent|0
7581285|NCT02124772|26370006|P12|Overall Study|Withdrawal consent|1
7581286|NCT02124772|26370007|P11|Overall Study|Withdrawal consent|0
7581287|NCT02124772|26370008|P10|Overall Study|Withdrawal consent|1
7581288|NCT02124772|26370009|P9|Overall Study|Withdrawal consent|0
7581289|NCT02124772|26370010|P8|Overall Study|Withdrawal consent|0
7581290|NCT02124772|26370011|P7|Overall Study|Withdrawal consent|1
7581291|NCT02124772|26370012|P6|Overall Study|Withdrawal consent|1
7581292|NCT02124772|26370013|P5|Overall Study|Withdrawal consent|0
7581293|NCT02124772|26370014|P4|Overall Study|Withdrawal consent|1
7581294|NCT02124772|26370015|P3|Overall Study|Withdrawal consent|1
7581295|NCT02124772|26370016|P2|Overall Study|Withdrawal consent|1
7581296|NCT02124772|26370017|P1|Overall Study|Withdrawal consent|0
7581297|NCT02124772|26370005|P13|Overall Study|Adverse Event|1
7581298|NCT02124772|26370006|P12|Overall Study|Adverse Event|3
7581299|NCT02124772|26370007|P11|Overall Study|Adverse Event|1
7581300|NCT02124772|26370008|P10|Overall Study|Adverse Event|3
7581301|NCT02124772|26370009|P9|Overall Study|Adverse Event|0
7581302|NCT02124772|26370010|P8|Overall Study|Adverse Event|5
7581303|NCT02124772|26370011|P7|Overall Study|Adverse Event|1
7581304|NCT02124772|26370012|P6|Overall Study|Adverse Event|1
7581305|NCT02124772|26370013|P5|Overall Study|Adverse Event|2
7581306|NCT02124772|26370014|P4|Overall Study|Adverse Event|5
7581307|NCT02124772|26370015|P3|Overall Study|Adverse Event|1
7581308|NCT02124772|26370016|P2|Overall Study|Adverse Event|4
7581309|NCT02124772|26370017|P1|Overall Study|Adverse Event|1
7581310|NCT02124772|26370005|P13|Overall Study|Lack of Efficacy|1
7581311|NCT02124772|26370006|P12|Overall Study|Lack of Efficacy|0
7581312|NCT02124772|26370007|P11|Overall Study|Lack of Efficacy|0
7581313|NCT02124772|26370008|P10|Overall Study|Lack of Efficacy|1
7581314|NCT02124772|26370009|P9|Overall Study|Lack of Efficacy|0
7581315|NCT02124772|26370010|P8|Overall Study|Lack of Efficacy|2
7581316|NCT02124772|26370011|P7|Overall Study|Lack of Efficacy|0
7581317|NCT02124772|26370012|P6|Overall Study|Lack of Efficacy|3
7581318|NCT02124772|26370013|P5|Overall Study|Lack of Efficacy|2
7581319|NCT02124772|26370014|P4|Overall Study|Lack of Efficacy|1
7581320|NCT02124772|26370015|P3|Overall Study|Lack of Efficacy|0
7581321|NCT02124772|26370016|P2|Overall Study|Lack of Efficacy|0
7581322|NCT02124772|26370017|P1|Overall Study|Lack of Efficacy|2
7581323|NCT02124759|26370259|P3|Overall Study|Screen Fail|3
7581324|NCT02124759|26370260|P2|Overall Study|Screen Fail|2
7581325|NCT02124759|26370261|P1|Overall Study|Screen Fail|2
7581326|NCT02124759|26370259|P3|Overall Study|Withdrawal by Subject|1
7581327|NCT02124759|26370260|P2|Overall Study|Withdrawal by Subject|1
7581328|NCT02124759|26370261|P1|Overall Study|Withdrawal by Subject|3
7581329|NCT02124746|26370281|P3|Overall Study|Disease Progression|4
7581330|NCT02124746|26370282|P2|Overall Study|Disease Progression|6
7581331|NCT02124746|26370283|P1|Overall Study|Disease Progression|3
7581332|NCT02124746|26370281|P3|Overall Study|Study Terminated by Sponsor|6
7581333|NCT02124746|26370282|P2|Overall Study|Study Terminated by Sponsor|0
7581334|NCT02124746|26370283|P1|Overall Study|Study Terminated by Sponsor|0
7581335|NCT02124746|26370281|P3|Overall Study|Withdrawal by Subject|0
7581336|NCT02124746|26370282|P2|Overall Study|Withdrawal by Subject|3
7581337|NCT02124746|26370283|P1|Overall Study|Withdrawal by Subject|3
7581338|NCT02124746|26370281|P3|Overall Study|Non-Compliance with Study Drug|0
7581339|NCT02124746|26370282|P2|Overall Study|Non-Compliance with Study Drug|1
7581340|NCT02124746|26370283|P1|Overall Study|Non-Compliance with Study Drug|0
7581341|NCT02124746|26370281|P3|Overall Study|Physician Decision|5
7581342|NCT02124746|26370282|P2|Overall Study|Physician Decision|4
7581343|NCT02124746|26370283|P1|Overall Study|Physician Decision|6
7581344|NCT02124746|26370281|P3|Overall Study|Lack of Efficacy|2
7581345|NCT02124746|26370282|P2|Overall Study|Lack of Efficacy|2
7581346|NCT02124746|26370283|P1|Overall Study|Lack of Efficacy|3
7581347|NCT02124746|26370281|P3|Overall Study|Death|3
7581348|NCT02124746|26370282|P2|Overall Study|Death|1
7581349|NCT02124746|26370283|P1|Overall Study|Death|2
7581350|NCT02124746|26370281|P3|Overall Study|Adverse Event|2
7581351|NCT02124746|26370282|P2|Overall Study|Adverse Event|1
7581352|NCT02124746|26370283|P1|Overall Study|Adverse Event|2
7581353|NCT02124707|26370324|P1|Overall Study|Death|1
7581354|NCT02124707|26370324|P1|Overall Study|Physician Decision|1
7581355|NCT02124707|26370324|P1|Overall Study|Adverse Event|5
7581356|NCT02124564|26370338|P1|Treatment Period|Withdrawal by Subject|2
7581357|NCT02124564|26370338|P1|Treatment Period|Lack of Efficacy|3
7581358|NCT02124564|26370338|P1|Treatment Period|Adverse Event|2
7581359|NCT02124265|26370403|P1|Overall Study|Adverse Event|1
7581360|NCT02124161|26370409|P2|Overall Study|Lost to Follow-up|4
7581361|NCT02124161|26370410|P1|Overall Study|Lost to Follow-up|3
7581362|NCT02124161|26370409|P2|Overall Study|No longer meets eligibility criteria|4
7581363|NCT02124161|26370410|P1|Overall Study|No longer meets eligibility criteria|5
7581364|NCT02124161|26370409|P2|Overall Study|Does not meet entrance criteria|3
7581365|NCT02124161|26370410|P1|Overall Study|Does not meet entrance criteria|2
7581366|NCT02124161|26370409|P2|Overall Study|Adverse Event|0
7581367|NCT02124161|26370410|P1|Overall Study|Adverse Event|2
7581368|NCT02124161|26370409|P2|Overall Study|Withdrawal by Subject|2
7581369|NCT02124161|26370410|P1|Overall Study|Withdrawal by Subject|1
7581370|NCT02124161|26370409|P2|Overall Study|Protocol Violation|1
7581371|NCT02124161|26370410|P1|Overall Study|Protocol Violation|2
7581372|NCT02124161|26370409|P2|Overall Study|Death|0
7581373|NCT02124161|26370410|P1|Overall Study|Death|1
7581374|NCT02124161|26370409|P2|Overall Study|Other unspecified|1
7581375|NCT02124161|26370410|P1|Overall Study|Other unspecified|0
7581376|NCT02123966|26370485|P1|Overall Study|Intercurrent Illness|1
7581377|NCT02123797|26370519|P5|6-month Follow up (Cumulative Counts)|Relocation|0
7581378|NCT02123797|26370520|P4|6-month Follow up (Cumulative Counts)|Relocation|0
7581379|NCT02123797|26370521|P3|6-month Follow up (Cumulative Counts)|Relocation|0
7581380|NCT02123797|26370522|P2|6-month Follow up (Cumulative Counts)|Relocation|2
7581381|NCT02123797|26370523|P1|6-month Follow up (Cumulative Counts)|Relocation|0
7581382|NCT02123797|26370519|P5|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7581383|NCT02123797|26370520|P4|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7581384|NCT02123797|26370521|P3|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7581385|NCT02123797|26370522|P2|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
7581386|NCT02123797|26370523|P1|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
7581387|NCT02123797|26370519|P5|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7581388|NCT02123797|26370520|P4|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
7581389|NCT02123797|26370521|P3|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
7581390|NCT02123797|26370522|P2|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
7581391|NCT02123797|26370523|P1|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7581392|NCT02123797|26370519|P5|6-month Follow up (Cumulative Counts)|Death|0
7581393|NCT02123797|26370520|P4|6-month Follow up (Cumulative Counts)|Death|0
7581394|NCT02123797|26370521|P3|6-month Follow up (Cumulative Counts)|Death|0
7581395|NCT02123797|26370522|P2|6-month Follow up (Cumulative Counts)|Death|97
7581396|NCT02123797|26370523|P1|6-month Follow up (Cumulative Counts)|Death|51
7581397|NCT02123797|26370519|P5|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7581398|NCT02123797|26370520|P4|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7581399|NCT02123797|26370521|P3|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7581400|NCT02123797|26370522|P2|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
7581401|NCT02123797|26370523|P1|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
7581402|NCT02123797|26370519|P5|3-month Follow up (Cumulative Counts)|Relocation|0
7581403|NCT02123797|26370520|P4|3-month Follow up (Cumulative Counts)|Relocation|0
7581404|NCT02123797|26370521|P3|3-month Follow up (Cumulative Counts)|Relocation|0
7581405|NCT02123797|26370522|P2|3-month Follow up (Cumulative Counts)|Relocation|1
7581406|NCT02123797|26370523|P1|3-month Follow up (Cumulative Counts)|Relocation|0
7581407|NCT02123797|26370519|P5|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7581408|NCT02123797|26370520|P4|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7581409|NCT02123797|26370521|P3|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7581410|NCT02123797|26370522|P2|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
7581411|NCT02123797|26370523|P1|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
7581412|NCT02123797|26370519|P5|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7581413|NCT02123797|26370520|P4|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
7581414|NCT02123797|26370521|P3|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
7581415|NCT02123797|26370522|P2|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
7581416|NCT02123797|26370523|P1|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
7581417|NCT02123797|26370519|P5|3-month Follow up (Cumulative Counts)|Death|0
7581418|NCT02123797|26370520|P4|3-month Follow up (Cumulative Counts)|Death|0
7581419|NCT02123797|26370521|P3|3-month Follow up (Cumulative Counts)|Death|0
7581420|NCT02123797|26370522|P2|3-month Follow up (Cumulative Counts)|Death|57
7581421|NCT02123797|26370523|P1|3-month Follow up (Cumulative Counts)|Death|33
7581422|NCT02123797|26370519|P5|Baseline Intervention|Other Disease|0
7581423|NCT02123797|26370520|P4|Baseline Intervention|Other Disease|0
7581424|NCT02123797|26370521|P3|Baseline Intervention|Other Disease|0
7581425|NCT02123797|26370522|P2|Baseline Intervention|Other Disease|0
7581426|NCT02123797|26370523|P1|Baseline Intervention|Other Disease|3
7581427|NCT02123797|26370519|P5|Baseline Intervention|Lost to Follow-up|0
7581428|NCT02123797|26370520|P4|Baseline Intervention|Lost to Follow-up|0
7581429|NCT02123797|26370521|P3|Baseline Intervention|Lost to Follow-up|0
7581430|NCT02123797|26370522|P2|Baseline Intervention|Lost to Follow-up|5
7581431|NCT02123797|26370523|P1|Baseline Intervention|Lost to Follow-up|0
7581432|NCT02123797|26370519|P5|Baseline Intervention|Out of window for initial survey|0
7581433|NCT02123797|26370520|P4|Baseline Intervention|Out of window for initial survey|0
7581434|NCT02123797|26370521|P3|Baseline Intervention|Out of window for initial survey|0
7581435|NCT02123797|26370522|P2|Baseline Intervention|Out of window for initial survey|13
7581436|NCT02123797|26370523|P1|Baseline Intervention|Out of window for initial survey|6
7581437|NCT02123797|26370519|P5|Baseline Intervention|Relocation|0
7581438|NCT02123797|26370520|P4|Baseline Intervention|Relocation|0
7581439|NCT02123797|26370521|P3|Baseline Intervention|Relocation|0
7581440|NCT02123797|26370522|P2|Baseline Intervention|Relocation|0
7581441|NCT02123797|26370523|P1|Baseline Intervention|Relocation|2
7581442|NCT02123797|26370519|P5|Baseline Intervention|Withdrawal by Subject|0
7581443|NCT02123797|26370520|P4|Baseline Intervention|Withdrawal by Subject|0
7581444|NCT02123797|26370521|P3|Baseline Intervention|Withdrawal by Subject|0
7581445|NCT02123797|26370522|P2|Baseline Intervention|Withdrawal by Subject|8
7581446|NCT02123797|26370523|P1|Baseline Intervention|Withdrawal by Subject|2
7581447|NCT02123797|26370519|P5|Baseline Intervention|Death|0
7581448|NCT02123797|26370520|P4|Baseline Intervention|Death|0
7581449|NCT02123797|26370521|P3|Baseline Intervention|Death|0
7581450|NCT02123797|26370522|P2|Baseline Intervention|Death|16
7581451|NCT02123797|26370523|P1|Baseline Intervention|Death|9
7581452|NCT02123576|26370632|P2|Overall Study|Adverse Event|0
7581453|NCT02123576|26370633|P1|Overall Study|Adverse Event|1
7581454|NCT02123511|26370651|P2|Overall Study|Ineligible|1
7581455|NCT02123511|26370652|P1|Overall Study|Ineligible|0
7581456|NCT02123511|26370651|P2|Overall Study|Incomplete data|3
7581457|NCT02123511|26370652|P1|Overall Study|Incomplete data|1
7581458|NCT02123511|26370651|P2|Overall Study|Cancelled treatment|0
7581459|NCT02123511|26370652|P1|Overall Study|Cancelled treatment|1
7581460|NCT02123472|26370687|P2|Period 2 (7 Days)|Withdrawal by Subject|1
7581461|NCT02123472|26370688|P1|Period 2 (7 Days)|Withdrawal by Subject|0
7581462|NCT02123459|26370698|P2|Washout Period (1 Day)|Adverse Event|0
7581463|NCT02123459|26370699|P1|Washout Period (1 Day)|Adverse Event|1
7581464|NCT02123446|26370709|P2|Washout Period (1 Day)|Physician Decision|0
7581465|NCT02123446|26370710|P1|Washout Period (1 Day)|Physician Decision|1
7581466|NCT02123251|26370751|P2|Overall Study|Switched Managed Care Organization (MCO)|4
7581467|NCT02123251|26370752|P1|Overall Study|Switched Managed Care Organization (MCO)|4
7581468|NCT02123251|26370751|P2|Overall Study|Lost Medicaid eligibility|22
7581469|NCT02123251|26370752|P1|Overall Study|Lost Medicaid eligibility|29
7581470|NCT02123251|26370751|P2|Overall Study|Withdrawal by Subject|3
7581471|NCT02123251|26370752|P1|Overall Study|Withdrawal by Subject|0
7581472|NCT02123251|26370751|P2|Overall Study|Death|1
7581473|NCT02123251|26370752|P1|Overall Study|Death|1
7581474|NCT02123134|26370778|P2|Overall Study|Administrative decision|1
7581475|NCT02123134|26370779|P1|Overall Study|Administrative decision|0
7581476|NCT02123134|26370778|P2|Overall Study|Withdrawal of consent|2
7581477|NCT02123134|26370779|P1|Overall Study|Withdrawal of consent|3
7581478|NCT02122887|26370836|P2|Overall Study|Withdrawal by Subject|2
7581479|NCT02122887|26370837|P1|Overall Study|Withdrawal by Subject|20
7581480|NCT02122783|26370875|P2|Overall Study|Adverse Event|1
7581481|NCT02122783|26370876|P1|Overall Study|Adverse Event|0
7581482|NCT02122770|26370898|P6|Part B: Standard of Care|Progressive Disease|8
7581483|NCT02122770|26370899|P5|Part B: Standard of Care|Progressive Disease|10
7581484|NCT02122770|26370900|P4|Part B: Standard of Care|Progressive Disease|0
7581485|NCT02122770|26370901|P3|Part B: Standard of Care|Progressive Disease|0
7581486|NCT02122770|26370902|P2|Part B: Standard of Care|Progressive Disease|0
7581487|NCT02122770|26370903|P1|Part B: Standard of Care|Progressive Disease|0
7581488|NCT02122770|26370898|P6|Part B: Standard of Care|Symptomatic Deterioration|0
7581489|NCT02122770|26370899|P5|Part B: Standard of Care|Symptomatic Deterioration|5
7581490|NCT02122770|26370900|P4|Part B: Standard of Care|Symptomatic Deterioration|0
7581491|NCT02122770|26370901|P3|Part B: Standard of Care|Symptomatic Deterioration|0
7581492|NCT02122770|26370902|P2|Part B: Standard of Care|Symptomatic Deterioration|0
7581493|NCT02122770|26370903|P1|Part B: Standard of Care|Symptomatic Deterioration|0
7581494|NCT02122770|26370898|P6|Part B: Standard of Care|Withdrawal by Subject|2
7581495|NCT02122770|26370899|P5|Part B: Standard of Care|Withdrawal by Subject|4
7581496|NCT02122770|26370900|P4|Part B: Standard of Care|Withdrawal by Subject|0
7581497|NCT02122770|26370901|P3|Part B: Standard of Care|Withdrawal by Subject|0
7581498|NCT02122770|26370902|P2|Part B: Standard of Care|Withdrawal by Subject|0
7581499|NCT02122770|26370903|P1|Part B: Standard of Care|Withdrawal by Subject|0
7581500|NCT02122770|26370898|P6|Part B: Standard of Care|Other|2
7581501|NCT02122770|26370899|P5|Part B: Standard of Care|Other|0
7581502|NCT02122770|26370900|P4|Part B: Standard of Care|Other|0
7581503|NCT02122770|26370901|P3|Part B: Standard of Care|Other|0
7581504|NCT02122770|26370902|P2|Part B: Standard of Care|Other|0
7581505|NCT02122770|26370903|P1|Part B: Standard of Care|Other|0
7581506|NCT02122770|26370898|P6|Part B: Standard of Care|Adverse Event|1
7581507|NCT02122770|26370899|P5|Part B: Standard of Care|Adverse Event|4
7581508|NCT02122770|26370900|P4|Part B: Standard of Care|Adverse Event|0
7581509|NCT02122770|26370901|P3|Part B: Standard of Care|Adverse Event|0
7581510|NCT02122770|26370902|P2|Part B: Standard of Care|Adverse Event|0
7581511|NCT02122770|26370903|P1|Part B: Standard of Care|Adverse Event|0
7581512|NCT02122770|26370898|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7581513|NCT02122770|26370899|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7581514|NCT02122770|26370900|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7581515|NCT02122770|26370901|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7581516|NCT02122770|26370902|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
7581517|NCT02122770|26370903|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7581518|NCT02122770|26370898|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7581519|NCT02122770|26370899|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7581520|NCT02122770|26370900|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7581521|NCT02122770|26370901|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7581522|NCT02122770|26370902|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
7581523|NCT02122770|26370903|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7581524|NCT02122770|26370898|P6|Part A: Drug-drug Interaction 2|Other|0
7581525|NCT02122770|26370899|P5|Part A: Drug-drug Interaction 2|Other|0
7581526|NCT02122770|26370900|P4|Part A: Drug-drug Interaction 2|Other|0
7581527|NCT02122770|26370901|P3|Part A: Drug-drug Interaction 2|Other|1
7581528|NCT02122770|26370902|P2|Part A: Drug-drug Interaction 2|Other|0
7581529|NCT02122770|26370903|P1|Part A: Drug-drug Interaction 2|Other|0
7581530|NCT02122770|26370898|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
7581531|NCT02122770|26370899|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
7581532|NCT02122770|26370900|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
7581533|NCT02122770|26370901|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
7581534|NCT02122770|26370902|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
7581535|NCT02122770|26370903|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
7581536|NCT02122380|26371023|P2|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
7581537|NCT02122380|26371024|P1|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
7581538|NCT02122380|26371023|P2|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
7581539|NCT02122380|26371024|P1|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
7581540|NCT02122380|26371023|P2|Washout (8 Weeks)|Lost to Follow-up|0
7581541|NCT02122380|26371024|P1|Washout (8 Weeks)|Lost to Follow-up|1
7581542|NCT02122380|26371023|P2|First Intervention (30 Days)|Physician Decision|1
7581543|NCT02122380|26371024|P1|First Intervention (30 Days)|Physician Decision|0
7581544|NCT02122380|26371023|P2|First Intervention (30 Days)|Adverse Event|0
7581545|NCT02122380|26371024|P1|First Intervention (30 Days)|Adverse Event|1
7581546|NCT02122146|26371063|P8|Part 1: Dose Escalation|Other|2
7581547|NCT02122146|26371064|P7|Part 1: Dose Escalation|Other|1
7581548|NCT02122146|26371065|P6|Part 1: Dose Escalation|Other|1
7581549|NCT02122146|26371066|P5|Part 1: Dose Escalation|Other|0
7581550|NCT02122146|26371067|P4|Part 1: Dose Escalation|Other|0
7581551|NCT02122146|26371068|P3|Part 1: Dose Escalation|Other|0
7581552|NCT02122146|26371069|P2|Part 1: Dose Escalation|Other|0
7581553|NCT02122146|26371070|P1|Part 1: Dose Escalation|Other|1
7581554|NCT02122146|26371063|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
7581555|NCT02122146|26371064|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
7581556|NCT02122146|26371065|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
7581557|NCT02122146|26371066|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
7581558|NCT02122146|26371067|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
7581559|NCT02122146|26371068|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
7581560|NCT02122146|26371069|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
7581561|NCT02122146|26371070|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
7581562|NCT02122146|26371063|P8|Part 1: Dose Escalation|Lost to Follow-up|0
7581563|NCT02122146|26371064|P7|Part 1: Dose Escalation|Lost to Follow-up|0
7581564|NCT02122146|26371065|P6|Part 1: Dose Escalation|Lost to Follow-up|0
7581565|NCT02122146|26371066|P5|Part 1: Dose Escalation|Lost to Follow-up|1
7581566|NCT02122146|26371067|P4|Part 1: Dose Escalation|Lost to Follow-up|0
7581567|NCT02122146|26371068|P3|Part 1: Dose Escalation|Lost to Follow-up|1
7581568|NCT02122146|26371069|P2|Part 1: Dose Escalation|Lost to Follow-up|0
7581569|NCT02122146|26371070|P1|Part 1: Dose Escalation|Lost to Follow-up|0
7581570|NCT02122146|26371063|P8|Part 1: Dose Escalation|Death|0
7581571|NCT02122146|26371064|P7|Part 1: Dose Escalation|Death|0
7581572|NCT02122146|26371065|P6|Part 1: Dose Escalation|Death|0
7581573|NCT02122146|26371066|P5|Part 1: Dose Escalation|Death|0
7581574|NCT02122146|26371067|P4|Part 1: Dose Escalation|Death|0
7581575|NCT02122146|26371068|P3|Part 1: Dose Escalation|Death|1
7581576|NCT02122146|26371069|P2|Part 1: Dose Escalation|Death|1
7581577|NCT02122146|26371070|P1|Part 1: Dose Escalation|Death|0
7581578|NCT02121847|26371344|P1|Overall Study|Adverse Event|2
7581579|NCT02121847|26371344|P1|Overall Study|Administrative Reasons|1
7581580|NCT02121834|26371370|P7|Overall Study|Lost to Follow-up|0
7581581|NCT02121834|26371371|P6|Overall Study|Lost to Follow-up|0
7581582|NCT02121834|26371372|P5|Overall Study|Lost to Follow-up|0
7581583|NCT02121834|26371373|P4|Overall Study|Lost to Follow-up|0
7581584|NCT02121834|26371374|P3|Overall Study|Lost to Follow-up|1
7581585|NCT02121834|26371375|P2|Overall Study|Lost to Follow-up|0
7581586|NCT02121834|26371376|P1|Overall Study|Lost to Follow-up|0
7581587|NCT02121834|26371370|P7|Overall Study|Withdrawal by Subject|0
7581588|NCT02121834|26371371|P6|Overall Study|Withdrawal by Subject|0
7581589|NCT02121834|26371372|P5|Overall Study|Withdrawal by Subject|0
7581590|NCT02121834|26371373|P4|Overall Study|Withdrawal by Subject|0
7581591|NCT02121834|26371374|P3|Overall Study|Withdrawal by Subject|1
7581592|NCT02121834|26371375|P2|Overall Study|Withdrawal by Subject|1
7581593|NCT02121834|26371376|P1|Overall Study|Withdrawal by Subject|0
7581594|NCT02121834|26371370|P7|Overall Study|Protocol Violation|0
7581595|NCT02121834|26371371|P6|Overall Study|Protocol Violation|0
7581596|NCT02121834|26371372|P5|Overall Study|Protocol Violation|0
7581597|NCT02121834|26371373|P4|Overall Study|Protocol Violation|0
7581598|NCT02121834|26371374|P3|Overall Study|Protocol Violation|0
7581599|NCT02121834|26371375|P2|Overall Study|Protocol Violation|1
7581600|NCT02121834|26371376|P1|Overall Study|Protocol Violation|0
7581601|NCT02121808|26371402|P1|Overall Study|Technical problem|3
7581602|NCT02121795|26371413|P2|Open-Label Phase|Lost to Follow-up|0
7581603|NCT02121795|26371414|P1|Open-Label Phase|Lost to Follow-up|1
7581604|NCT02121795|26371413|P2|Open-Label Phase|Withdrawal by Subject|2
7581605|NCT02121795|26371414|P1|Open-Label Phase|Withdrawal by Subject|3
7581606|NCT02121795|26371413|P2|Open-Label Phase|Physician Decision|8
7581607|NCT02121795|26371414|P1|Open-Label Phase|Physician Decision|8
7581608|NCT02121795|26371413|P2|Double-Blind Phase|Death|1
7581609|NCT02121795|26371414|P1|Double-Blind Phase|Death|1
7581610|NCT02121795|26371413|P2|Double-Blind Phase|Protocol Violation|3
7581611|NCT02121795|26371414|P1|Double-Blind Phase|Protocol Violation|0
7581612|NCT02121795|26371413|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
7581613|NCT02121795|26371414|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
7581614|NCT02121795|26371413|P2|Double-Blind Phase|Adverse Event|0
7581615|NCT02121795|26371414|P1|Double-Blind Phase|Adverse Event|5
7581616|NCT02121795|26371413|P2|Double-Blind Phase|Physician Decision|5
7581617|NCT02121795|26371414|P1|Double-Blind Phase|Physician Decision|2
7581618|NCT02121795|26371413|P2|Double-Blind Phase|Lost to Follow-up|4
7581619|NCT02121795|26371414|P1|Double-Blind Phase|Lost to Follow-up|7
7581620|NCT02121795|26371413|P2|Double-Blind Phase|Withdrawal by Subject|16
7581621|NCT02121795|26371414|P1|Double-Blind Phase|Withdrawal by Subject|19
7581622|NCT02121795|26371413|P2|Double-Blind Phase|Randomized but Never Treated|4
7581623|NCT02121795|26371414|P1|Double-Blind Phase|Randomized but Never Treated|1
7581624|NCT02121756|26371442|P2|Overall Study|Physician Decision|1
7581625|NCT02121756|26371443|P1|Overall Study|Physician Decision|2
7581626|NCT02121756|26371442|P2|Overall Study|Protocol Violation|1
7581627|NCT02121756|26371443|P1|Overall Study|Protocol Violation|1
7581628|NCT02121756|26371442|P2|Overall Study|Adverse Event|0
7581629|NCT02121756|26371443|P1|Overall Study|Adverse Event|3
7581630|NCT02121535|26371480|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
7581631|NCT02121535|26371481|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
7581632|NCT02121535|26371480|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
7581633|NCT02121535|26371481|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
7581634|NCT02121522|26371504|P1|Overall Study|Adverse Event|1
7581635|NCT02121509|26371511|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
7581636|NCT02121509|26371512|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
7581637|NCT02121509|26371513|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
7581638|NCT02121509|26371514|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
7581639|NCT02121509|26371511|P4|Washout Period (35 Days)|Withdrawal by Subject|0
7581640|NCT02121509|26371512|P3|Washout Period (35 Days)|Withdrawal by Subject|0
7581641|NCT02121509|26371513|P2|Washout Period (35 Days)|Withdrawal by Subject|3
7581642|NCT02121509|26371514|P1|Washout Period (35 Days)|Withdrawal by Subject|0
7581643|NCT02121509|26371511|P4|Washout Period (35 Days)|Adverse Event|0
7581644|NCT02121509|26371512|P3|Washout Period (35 Days)|Adverse Event|0
7581645|NCT02121509|26371513|P2|Washout Period (35 Days)|Adverse Event|1
7581646|NCT02121509|26371514|P1|Washout Period (35 Days)|Adverse Event|1
7581647|NCT02121392|26371585|P2|After Placement of AC Block vs Sham|Lost to Follow-up|1
7581648|NCT02121392|26371586|P1|After Placement of AC Block vs Sham|Lost to Follow-up|0
7581649|NCT02121392|26371585|P2|After Placement of AC Block vs Sham|Protocol Violation|2
7581650|NCT02121392|26371586|P1|After Placement of AC Block vs Sham|Protocol Violation|3
7581651|NCT02121392|26371585|P2|Prior to Intervention|Withdrawal by Subject|6
7581652|NCT02121392|26371586|P1|Prior to Intervention|Withdrawal by Subject|8
7581653|NCT02121392|26371585|P2|Prior to Intervention|Protocol Violation|35
7581654|NCT02121392|26371586|P1|Prior to Intervention|Protocol Violation|40
7581655|NCT02121301|26371611|P3|Overall Study|Protocol Violation|1
7581656|NCT02121301|26371612|P2|Overall Study|Protocol Violation|4
7581657|NCT02121301|26371613|P1|Overall Study|Protocol Violation|1
7581658|NCT02121262|26371626|P2|Overall Study|Consent Withdrawn|0
7581659|NCT02121262|26371627|P1|Overall Study|Consent Withdrawn|1
7581660|NCT02121262|26371626|P2|Overall Study|Participant was Deemed Unsuitable|0
7581661|NCT02121262|26371627|P1|Overall Study|Participant was Deemed Unsuitable|1
7581662|NCT02121262|26371626|P2|Overall Study|Participant Dropped-out|1
7581663|NCT02121262|26371627|P1|Overall Study|Participant Dropped-out|0
7581664|NCT02121262|26371626|P2|Overall Study|Protocol Violation|1
7581665|NCT02121262|26371627|P1|Overall Study|Protocol Violation|1
7581666|NCT02121262|26371626|P2|Overall Study|Personal Reasons|5
7581667|NCT02121262|26371627|P1|Overall Study|Personal Reasons|19
7581668|NCT02121262|26371626|P2|Overall Study|Lack of Efficacy|0
7581669|NCT02121262|26371627|P1|Overall Study|Lack of Efficacy|3
7581670|NCT02121262|26371626|P2|Overall Study|Adverse Event|3
7581671|NCT02121262|26371627|P1|Overall Study|Adverse Event|6
7581672|NCT02121210|26371641|P2|Overall Study|Other than specified above|2
7581673|NCT02121210|26371642|P1|Overall Study|Other than specified above|0
7581674|NCT02121210|26371641|P2|Overall Study|Lack of Efficacy|0
7581675|NCT02121210|26371642|P1|Overall Study|Lack of Efficacy|2
7581676|NCT02121210|26371641|P2|Overall Study|Adverse Event|7
7581677|NCT02121210|26371642|P1|Overall Study|Adverse Event|5
7581678|NCT02121002|26371668|P3|Overall Study|Others|1
7581679|NCT02121002|26371669|P2|Overall Study|Others|0
7581680|NCT02121002|26371670|P1|Overall Study|Others|1
7581681|NCT02121002|26371668|P3|Overall Study|Concomitant therapy|1
7581682|NCT02121002|26371669|P2|Overall Study|Concomitant therapy|1
7581683|NCT02121002|26371670|P1|Overall Study|Concomitant therapy|0
7581684|NCT02121002|26371668|P3|Overall Study|Protocol Violation|4
7581685|NCT02121002|26371669|P2|Overall Study|Protocol Violation|2
7581686|NCT02121002|26371670|P1|Overall Study|Protocol Violation|1
7581687|NCT02121002|26371668|P3|Overall Study|Withdrawal by Subject|4
7581688|NCT02121002|26371669|P2|Overall Study|Withdrawal by Subject|1
7581689|NCT02121002|26371670|P1|Overall Study|Withdrawal by Subject|3
7581690|NCT02121002|26371668|P3|Overall Study|Physician Decision|0
7581691|NCT02121002|26371669|P2|Overall Study|Physician Decision|0
7581692|NCT02121002|26371670|P1|Overall Study|Physician Decision|2
7581693|NCT02120950|26371680|P3|Overall Study|Lost to Follow-up|1
7581694|NCT02120950|26371681|P2|Overall Study|Lost to Follow-up|2
7581695|NCT02120950|26371682|P1|Overall Study|Lost to Follow-up|0
7581696|NCT02120950|26371680|P3|Overall Study|Other reasons|1
7581697|NCT02120950|26371681|P2|Overall Study|Other reasons|4
7581698|NCT02120950|26371682|P1|Overall Study|Other reasons|5
7581699|NCT02120950|26371680|P3|Overall Study|Protocol Violation|7
7581700|NCT02120950|26371681|P2|Overall Study|Protocol Violation|1
7581701|NCT02120950|26371682|P1|Overall Study|Protocol Violation|1
7581702|NCT02120950|26371680|P3|Overall Study|Withdrawal by Subject|2
7581703|NCT02120950|26371681|P2|Overall Study|Withdrawal by Subject|3
7581704|NCT02120950|26371682|P1|Overall Study|Withdrawal by Subject|6
7581705|NCT02120950|26371680|P3|Overall Study|Death|1
7581706|NCT02120950|26371681|P2|Overall Study|Death|0
7581707|NCT02120950|26371682|P1|Overall Study|Death|3
7581708|NCT02120950|26371680|P3|Overall Study|Adverse Event|3
7581709|NCT02120950|26371681|P2|Overall Study|Adverse Event|4
7581710|NCT02120950|26371682|P1|Overall Study|Adverse Event|5
7581711|NCT02120924|26371718|P3|Overall Study|Compliance with IP|1
7581712|NCT02120924|26371719|P2|Overall Study|Compliance with IP|1
7581713|NCT02120924|26371720|P1|Overall Study|Compliance with IP|5
7581714|NCT02120924|26371718|P3|Overall Study|Death|0
7581715|NCT02120924|26371719|P2|Overall Study|Death|0
7581716|NCT02120924|26371720|P1|Overall Study|Death|1
7581717|NCT02120924|26371718|P3|Overall Study|Physician Decision|1
7581718|NCT02120924|26371719|P2|Overall Study|Physician Decision|1
7581719|NCT02120924|26371720|P1|Overall Study|Physician Decision|0
7581720|NCT02120924|26371718|P3|Overall Study|Protocol Violation|2
7581721|NCT02120924|26371719|P2|Overall Study|Protocol Violation|7
7581722|NCT02120924|26371720|P1|Overall Study|Protocol Violation|3
7581723|NCT02120924|26371718|P3|Overall Study|Pregnancy|0
7581724|NCT02120924|26371719|P2|Overall Study|Pregnancy|0
7581725|NCT02120924|26371720|P1|Overall Study|Pregnancy|2
7581726|NCT02120924|26371718|P3|Overall Study|Lost to Follow-up|11
7581727|NCT02120924|26371719|P2|Overall Study|Lost to Follow-up|14
7581728|NCT02120924|26371720|P1|Overall Study|Lost to Follow-up|14
7581729|NCT02120924|26371718|P3|Overall Study|Withdrawal by Subject|8
7581730|NCT02120924|26371719|P2|Overall Study|Withdrawal by Subject|20
7581731|NCT02120924|26371720|P1|Overall Study|Withdrawal by Subject|16
7581732|NCT02120924|26371718|P3|Overall Study|Adverse Event|3
7581733|NCT02120924|26371719|P2|Overall Study|Adverse Event|1
7581734|NCT02120924|26371720|P1|Overall Study|Adverse Event|0
7581735|NCT02120924|26371718|P3|Overall Study|Lack of Efficacy|3
7581736|NCT02120924|26371719|P2|Overall Study|Lack of Efficacy|2
7581737|NCT02120924|26371720|P1|Overall Study|Lack of Efficacy|1
7581738|NCT02120898|26371734|P3|Overall Study|Lost to Follow-up|1
7581739|NCT02120898|26371735|P2|Overall Study|Lost to Follow-up|0
7581740|NCT02120898|26371736|P1|Overall Study|Lost to Follow-up|0
7581741|NCT02120898|26371734|P3|Overall Study|Protocol Violation|0
7581742|NCT02120898|26371735|P2|Overall Study|Protocol Violation|2
7581743|NCT02120898|26371736|P1|Overall Study|Protocol Violation|1
7581744|NCT02120898|26371734|P3|Overall Study|Adverse Event|1
7581745|NCT02120898|26371735|P2|Overall Study|Adverse Event|2
7581746|NCT02120898|26371736|P1|Overall Study|Adverse Event|1
7581747|NCT02120898|26371734|P3|Overall Study|Non-compliance with study drug|0
7581748|NCT02120898|26371735|P2|Overall Study|Non-compliance with study drug|0
7581749|NCT02120898|26371736|P1|Overall Study|Non-compliance with study drug|3
7581750|NCT02120898|26371734|P3|Overall Study|Withdrawal by Subject|2
7581751|NCT02120898|26371735|P2|Overall Study|Withdrawal by Subject|2
7581752|NCT02120898|26371736|P1|Overall Study|Withdrawal by Subject|4
7581753|NCT02120833|26371758|P2|Overall Study|Lost to Follow-up|1
7581754|NCT02120833|26371759|P1|Overall Study|Lost to Follow-up|1
7581755|NCT02120833|26371758|P2|Overall Study|Withdrawal by Subject|0
7581756|NCT02120833|26371759|P1|Overall Study|Withdrawal by Subject|2
7581757|NCT02120833|26371758|P2|Overall Study|Adverse Event|0
7581758|NCT02120833|26371759|P1|Overall Study|Adverse Event|1
7581759|NCT02120794|26371913|P1|Overall Study|Due to insurance coverage|1
7581760|NCT02120794|26371913|P1|Overall Study|Physician Decision|4
7581761|NCT02120794|26371913|P1|Overall Study|Adverse Event|10
7581762|NCT02120794|26371913|P1|Overall Study|Withdrawal by Subject|43
7581763|NCT02120781|26371922|P2|Overall Study|Completion not documented|1
7581764|NCT02120781|26371923|P1|Overall Study|Completion not documented|2
7581765|NCT02120781|26371922|P2|Overall Study|Physician Decision|0
7581766|NCT02120781|26371923|P1|Overall Study|Physician Decision|2
7581767|NCT02120664|26371960|P5|Overall Study|Withdrawal by Subject|0
7581768|NCT02120664|26371961|P4|Overall Study|Withdrawal by Subject|1
7581769|NCT02120664|26371962|P3|Overall Study|Withdrawal by Subject|0
7581770|NCT02120664|26371963|P2|Overall Study|Withdrawal by Subject|0
7581771|NCT02120664|26371964|P1|Overall Study|Withdrawal by Subject|0
7581772|NCT02120625|26371982|P1|Overall Study|Physician Decision|2
7581773|NCT02120456|26371998|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
7581774|NCT02120456|26371999|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581775|NCT02120456|26372000|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581776|NCT02120456|26372001|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581777|NCT02120456|26372002|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581778|NCT02120456|26372003|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581779|NCT02120456|26372004|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581780|NCT02120456|26372005|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581781|NCT02120456|26372006|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7581782|NCT02120456|26371998|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
7581783|NCT02120456|26371999|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
7581784|NCT02120456|26372000|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
7581785|NCT02120456|26372001|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
7581786|NCT02120456|26372002|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
7581787|NCT02120456|26372003|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
7581788|NCT02120456|26372004|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
7581789|NCT02120456|26372005|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
7581790|NCT02120456|26372006|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
7581791|NCT02120456|26371998|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
7581792|NCT02120456|26371999|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
7581793|NCT02120456|26372000|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
7581794|NCT02120456|26372001|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
7581795|NCT02120456|26372002|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
7581796|NCT02120456|26372003|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
7581797|NCT02120456|26372004|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
7581798|NCT02120456|26372005|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
7581799|NCT02120456|26372006|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
7581800|NCT02120417|26372040|P2|Overall Study|Other unspecified|4
7581801|NCT02120417|26372041|P1|Overall Study|Other unspecified|5
7581802|NCT02120417|26372040|P2|Overall Study|Physician Decision|3
7581803|NCT02120417|26372041|P1|Overall Study|Physician Decision|2
7581804|NCT02120417|26372040|P2|Overall Study|Noncompliance with study treatment|2
7581805|NCT02120417|26372041|P1|Overall Study|Noncompliance with study treatment|0
7581806|NCT02120417|26372040|P2|Overall Study|Disease progression|45
7581807|NCT02120417|26372041|P1|Overall Study|Disease progression|41
7581808|NCT02120417|26372040|P2|Overall Study|Participant decision|4
7581809|NCT02120417|26372041|P1|Overall Study|Participant decision|4
7581810|NCT02120417|26372040|P2|Overall Study|Adverse Event|9
7581811|NCT02120417|26372041|P1|Overall Study|Adverse Event|3
7581812|NCT02120417|26372040|P2|Overall Study|Death|1
7581813|NCT02120417|26372041|P1|Overall Study|Death|5
7581814|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
7581815|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
7581816|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
7581817|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
7581818|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
7581819|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
7581820|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
7581821|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
7581822|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Lost to Follow-up|1
7581823|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7581824|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7581825|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7581826|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
7581827|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
7581828|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
7581829|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
7581830|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Protocol Violation|0
7581831|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Protocol Violation|2
7581832|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Protocol Violation|0
7581833|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Protocol Violation|0
7581834|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Lack of Efficacy|1
7581835|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Lack of Efficacy|0
7581836|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Lack of Efficacy|1
7581837|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Lack of Efficacy|0
7581838|NCT02120352|26372059|P4|Maintenance Period (32 Weeks)|Adverse Event|1
7581839|NCT02120352|26372060|P3|Maintenance Period (32 Weeks)|Adverse Event|6
7581840|NCT02120352|26372061|P2|Maintenance Period (32 Weeks)|Adverse Event|0
7581841|NCT02120352|26372062|P1|Maintenance Period (32 Weeks)|Adverse Event|0
7581842|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Physician Decision|0
7581843|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Physician Decision|0
7581844|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Physician Decision|0
7581845|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Physician Decision|1
7581846|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Withdrawal by Subject|0
7581847|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Withdrawal by Subject|0
7581848|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Withdrawal by Subject|0
7581849|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Withdrawal by Subject|5
7581850|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Lost to Follow-up|0
7581851|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Lost to Follow-up|0
7581852|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Lost to Follow-up|0
7581853|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Lost to Follow-up|2
7581854|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7581855|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7581856|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7581857|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
7581858|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Protocol Violation|0
7581859|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Protocol Violation|0
7581860|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Protocol Violation|0
7581861|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Protocol Violation|2
7581862|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Lack of Efficacy|0
7581863|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Lack of Efficacy|0
7581864|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Lack of Efficacy|0
7581865|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Lack of Efficacy|5
7581866|NCT02120352|26372059|P4|Induction Period (20 Weeks)|Adverse Event|0
7581867|NCT02120352|26372060|P3|Induction Period (20 Weeks)|Adverse Event|0
7581868|NCT02120352|26372061|P2|Induction Period (20 Weeks)|Adverse Event|0
7581869|NCT02120352|26372062|P1|Induction Period (20 Weeks)|Adverse Event|3
7581870|NCT02120300|26372213|P4|Overall Study|Lost to Follow-up|0
7581871|NCT02120300|26372214|P3|Overall Study|Lost to Follow-up|0
7581872|NCT02120300|26372215|P2|Overall Study|Lost to Follow-up|0
7581873|NCT02120300|26372216|P1|Overall Study|Lost to Follow-up|1
7581874|NCT02120300|26372213|P4|Overall Study|Lack of Efficacy|1
7581875|NCT02120300|26372214|P3|Overall Study|Lack of Efficacy|0
7581876|NCT02120300|26372215|P2|Overall Study|Lack of Efficacy|0
7581877|NCT02120300|26372216|P1|Overall Study|Lack of Efficacy|0
7581878|NCT02120300|26372213|P4|Overall Study|Enrolled but Never Treated|0
7581879|NCT02120300|26372214|P3|Overall Study|Enrolled but Never Treated|0
7581880|NCT02120300|26372215|P2|Overall Study|Enrolled but Never Treated|0
7581881|NCT02120300|26372216|P1|Overall Study|Enrolled but Never Treated|2
7581882|NCT02120157|26372287|P2|Overall Study|Graft Failure before Day 100|0
7581883|NCT02120157|26372288|P1|Overall Study|Graft Failure before Day 100|2
7581884|NCT02120157|26372287|P2|Overall Study|Death|2
7581885|NCT02120157|26372288|P1|Overall Study|Death|4
7581886|NCT02120027|26372298|P2|Overall Study|Withdrawal by Subject|25
7581887|NCT02120027|26372299|P1|Overall Study|Withdrawal by Subject|33
7581888|NCT02120027|26372298|P2|Overall Study|Study terminated by Sponsor|47
7581889|NCT02120027|26372299|P1|Overall Study|Study terminated by Sponsor|45
7581890|NCT02120027|26372298|P2|Overall Study|Protocol Violation|21
7581891|NCT02120027|26372299|P1|Overall Study|Protocol Violation|18
7581892|NCT02120027|26372298|P2|Overall Study|Physician Decision|3
7581893|NCT02120027|26372299|P1|Overall Study|Physician Decision|4
7581894|NCT02120027|26372298|P2|Overall Study|Other|0
7581895|NCT02120027|26372299|P1|Overall Study|Other|4
7581896|NCT02120027|26372298|P2|Overall Study|Lost to Follow-up|13
7581897|NCT02120027|26372299|P1|Overall Study|Lost to Follow-up|5
7581898|NCT02120027|26372298|P2|Overall Study|Lack of Efficacy|5
7581899|NCT02120027|26372299|P1|Overall Study|Lack of Efficacy|3
7581900|NCT02120027|26372298|P2|Overall Study|Adverse Event|5
7581901|NCT02120027|26372299|P1|Overall Study|Adverse Event|4
7581902|NCT02119936|26372324|P1|Overall Study|Lost to Follow-up|10
7581903|NCT02119819|26372360|P6|Overall Study|Left the city to get a job|0
7581904|NCT02119819|26372361|P5|Overall Study|Left the city to get a job|0
7581905|NCT02119819|26372362|P4|Overall Study|Left the city to get a job|1
7581906|NCT02119819|26372363|P3|Overall Study|Left the city to get a job|0
7581907|NCT02119819|26372364|P2|Overall Study|Left the city to get a job|0
7581908|NCT02119819|26372365|P1|Overall Study|Left the city to get a job|0
7581909|NCT02119819|26372360|P6|Overall Study|Protocol Violation|0
7581910|NCT02119819|26372361|P5|Overall Study|Protocol Violation|0
7581911|NCT02119819|26372362|P4|Overall Study|Protocol Violation|1
7581912|NCT02119819|26372363|P3|Overall Study|Protocol Violation|0
7581913|NCT02119819|26372364|P2|Overall Study|Protocol Violation|0
7581914|NCT02119819|26372365|P1|Overall Study|Protocol Violation|0
7581915|NCT02119819|26372360|P6|Overall Study|Jury Duty|0
7581916|NCT02119819|26372361|P5|Overall Study|Jury Duty|0
7581917|NCT02119819|26372362|P4|Overall Study|Jury Duty|0
7581918|NCT02119819|26372363|P3|Overall Study|Jury Duty|1
7581919|NCT02119819|26372364|P2|Overall Study|Jury Duty|0
7581920|NCT02119819|26372365|P1|Overall Study|Jury Duty|0
7581921|NCT02119819|26372360|P6|Overall Study|Withdrawal by Subject|10
7581922|NCT02119819|26372361|P5|Overall Study|Withdrawal by Subject|6
7581923|NCT02119819|26372362|P4|Overall Study|Withdrawal by Subject|0
7581924|NCT02119819|26372363|P3|Overall Study|Withdrawal by Subject|0
7581925|NCT02119819|26372364|P2|Overall Study|Withdrawal by Subject|3
7581926|NCT02119819|26372365|P1|Overall Study|Withdrawal by Subject|5
7581927|NCT02119819|26372360|P6|Overall Study|Physician Decision|1
7581928|NCT02119819|26372361|P5|Overall Study|Physician Decision|0
7581929|NCT02119819|26372362|P4|Overall Study|Physician Decision|0
7581930|NCT02119819|26372363|P3|Overall Study|Physician Decision|0
7581931|NCT02119819|26372364|P2|Overall Study|Physician Decision|1
7581932|NCT02119819|26372365|P1|Overall Study|Physician Decision|1
7581933|NCT02119819|26372360|P6|Overall Study|Lost to Follow-up|2
7581934|NCT02119819|26372361|P5|Overall Study|Lost to Follow-up|1
7581935|NCT02119819|26372362|P4|Overall Study|Lost to Follow-up|2
7581936|NCT02119819|26372363|P3|Overall Study|Lost to Follow-up|1
7581937|NCT02119819|26372364|P2|Overall Study|Lost to Follow-up|0
7581938|NCT02119819|26372365|P1|Overall Study|Lost to Follow-up|0
7581939|NCT02119819|26372360|P6|Overall Study|Lack of Efficacy|1
7581940|NCT02119819|26372361|P5|Overall Study|Lack of Efficacy|0
7581941|NCT02119819|26372362|P4|Overall Study|Lack of Efficacy|0
7581942|NCT02119819|26372363|P3|Overall Study|Lack of Efficacy|0
7581943|NCT02119819|26372364|P2|Overall Study|Lack of Efficacy|0
7581944|NCT02119819|26372365|P1|Overall Study|Lack of Efficacy|0
7581945|NCT02119819|26372360|P6|Overall Study|Adverse Event|1
7581946|NCT02119819|26372361|P5|Overall Study|Adverse Event|0
7581947|NCT02119819|26372362|P4|Overall Study|Adverse Event|3
7581948|NCT02119819|26372363|P3|Overall Study|Adverse Event|2
7581949|NCT02119819|26372364|P2|Overall Study|Adverse Event|1
7581950|NCT02119819|26372365|P1|Overall Study|Adverse Event|3
7581951|NCT02119676|26372463|P4|Overall Study|Did not receive study med|5
7581952|NCT02119676|26372464|P3|Overall Study|Did not receive study med|4
7581953|NCT02119676|26372465|P2|Overall Study|Did not receive study med|2
7581954|NCT02119676|26372466|P1|Overall Study|Did not receive study med|2
7581955|NCT02119676|26372463|P4|Overall Study|Other, unspecified|4
7581956|NCT02119676|26372464|P3|Overall Study|Other, unspecified|3
7581957|NCT02119676|26372465|P2|Overall Study|Other, unspecified|1
7581958|NCT02119676|26372466|P1|Overall Study|Other, unspecified|2
7581959|NCT02119676|26372463|P4|Overall Study|Protocol deviation|0
7581960|NCT02119676|26372464|P3|Overall Study|Protocol deviation|1
7581961|NCT02119676|26372465|P2|Overall Study|Protocol deviation|0
7581962|NCT02119676|26372466|P1|Overall Study|Protocol deviation|0
7581963|NCT02119676|26372463|P4|Overall Study|Lost to Follow-up|0
7581964|NCT02119676|26372464|P3|Overall Study|Lost to Follow-up|1
7581965|NCT02119676|26372465|P2|Overall Study|Lost to Follow-up|0
7581966|NCT02119676|26372466|P1|Overall Study|Lost to Follow-up|0
7581967|NCT02119676|26372463|P4|Overall Study|Noncompliance|0
7581968|NCT02119676|26372464|P3|Overall Study|Noncompliance|0
7581969|NCT02119676|26372465|P2|Overall Study|Noncompliance|1
7581970|NCT02119676|26372466|P1|Overall Study|Noncompliance|0
7581971|NCT02119676|26372463|P4|Overall Study|Death|1
7581972|NCT02119676|26372464|P3|Overall Study|Death|2
7581973|NCT02119676|26372465|P2|Overall Study|Death|3
7581974|NCT02119676|26372466|P1|Overall Study|Death|9
7581975|NCT02119676|26372463|P4|Overall Study|Physician Decision|2
7581976|NCT02119676|26372464|P3|Overall Study|Physician Decision|3
7581977|NCT02119676|26372465|P2|Overall Study|Physician Decision|2
7581978|NCT02119676|26372466|P1|Overall Study|Physician Decision|4
7581979|NCT02119676|26372463|P4|Overall Study|Patient decision, inc. consent withdrawn|6
7581980|NCT02119676|26372464|P3|Overall Study|Patient decision, inc. consent withdrawn|5
7581981|NCT02119676|26372465|P2|Overall Study|Patient decision, inc. consent withdrawn|5
7581982|NCT02119676|26372466|P1|Overall Study|Patient decision, inc. consent withdrawn|4
7581983|NCT02119676|26372463|P4|Overall Study|Disease progression|73
7581984|NCT02119676|26372464|P3|Overall Study|Disease progression|68
7581985|NCT02119676|26372465|P2|Overall Study|Disease progression|55
7581986|NCT02119676|26372466|P1|Overall Study|Disease progression|53
7581987|NCT02119676|26372463|P4|Overall Study|Adverse Event|10
7581988|NCT02119676|26372464|P3|Overall Study|Adverse Event|10
7581989|NCT02119676|26372465|P2|Overall Study|Adverse Event|17
7581990|NCT02119676|26372466|P1|Overall Study|Adverse Event|9
7581991|NCT02119663|26372498|P2|Overall Study|Study Terminated by the Sponsor|4
7581992|NCT02119663|26372499|P1|Overall Study|Study Terminated by the Sponsor|3
7581993|NCT02119663|26372498|P2|Overall Study|Subject decision|1
7581994|NCT02119663|26372499|P1|Overall Study|Subject decision|0
7581995|NCT02119663|26372498|P2|Overall Study|Other unspecified|0
7581996|NCT02119663|26372499|P1|Overall Study|Other unspecified|2
7581997|NCT02119663|26372498|P2|Overall Study|Physician Decision|2
7581998|NCT02119663|26372499|P1|Overall Study|Physician Decision|1
7581999|NCT02119663|26372498|P2|Overall Study|Death|2
7582000|NCT02119663|26372499|P1|Overall Study|Death|3
7582001|NCT02119663|26372498|P2|Overall Study|Adverse Event|5
7582002|NCT02119663|26372499|P1|Overall Study|Adverse Event|5
7582003|NCT02119663|26372498|P2|Overall Study|Disease progression|27
7582004|NCT02119663|26372499|P1|Overall Study|Disease progression|26
7582005|NCT02119650|26372517|P2|Overall Study|Multiple reasons for termination|1
7582006|NCT02119650|26372518|P1|Overall Study|Multiple reasons for termination|2
7582007|NCT02119650|26372517|P2|Overall Study|Physician Decision|2
7582008|NCT02119650|26372518|P1|Overall Study|Physician Decision|0
7582009|NCT02119650|26372517|P2|Overall Study|Study terminated by the sponsor|0
7582010|NCT02119650|26372518|P1|Overall Study|Study terminated by the sponsor|1
7582011|NCT02119650|26372517|P2|Overall Study|Noncompliance with study treatment|1
7582012|NCT02119650|26372518|P1|Overall Study|Noncompliance with study treatment|1
7582013|NCT02119650|26372517|P2|Overall Study|Death|1
7582014|NCT02119650|26372518|P1|Overall Study|Death|5
7582015|NCT02119650|26372517|P2|Overall Study|Disease progression|14
7582016|NCT02119650|26372518|P1|Overall Study|Disease progression|11
7582017|NCT02119650|26372517|P2|Overall Study|Subject decision|3
7582018|NCT02119650|26372518|P1|Overall Study|Subject decision|2
7582019|NCT02119650|26372517|P2|Overall Study|Adverse Event|4
7582020|NCT02119650|26372518|P1|Overall Study|Adverse Event|3
7582021|NCT02119325|26372568|P2|Washout Period 1|Adverse Event|1
7582022|NCT02119325|26372569|P1|Washout Period 1|Adverse Event|0
7582023|NCT02119299|26372613|P1|Overall Study|Pregnancy|1
7582024|NCT02119299|26372613|P1|Overall Study|Lack of Efficacy|1
7582025|NCT02119299|26372613|P1|Overall Study|Withdrawal by Subject|7
7582026|NCT02119286|26372627|P3|Overall Study|Withdrawal by Subject|0
7582027|NCT02119286|26372628|P2|Overall Study|Withdrawal by Subject|1
7582028|NCT02119286|26372629|P1|Overall Study|Withdrawal by Subject|4
7582029|NCT02119286|26372627|P3|Overall Study|Lost to Follow-up|1
7582030|NCT02119286|26372628|P2|Overall Study|Lost to Follow-up|0
7582031|NCT02119286|26372629|P1|Overall Study|Lost to Follow-up|2
7582032|NCT02119286|26372627|P3|Overall Study|Lack of Efficacy|4
7582033|NCT02119286|26372628|P2|Overall Study|Lack of Efficacy|3
7582034|NCT02119286|26372629|P1|Overall Study|Lack of Efficacy|11
7582035|NCT02119286|26372627|P3|Overall Study|Adverse Event|2
7582036|NCT02119286|26372628|P2|Overall Study|Adverse Event|7
7582037|NCT02119286|26372629|P1|Overall Study|Adverse Event|9
7582038|NCT02119260|26372647|P7|Overall Study|Withdrew consent|0
7582039|NCT02119260|26372648|P6|Overall Study|Withdrew consent|0
7582040|NCT02119260|26372649|P5|Overall Study|Withdrew consent|0
7582041|NCT02119260|26372650|P4|Overall Study|Withdrew consent|0
7582042|NCT02119260|26372651|P3|Overall Study|Withdrew consent|1
7582043|NCT02119260|26372652|P2|Overall Study|Withdrew consent|1
7582044|NCT02119260|26372653|P1|Overall Study|Withdrew consent|0
7582045|NCT02119260|26372647|P7|Overall Study|Adverse Event|0
7582046|NCT02119260|26372648|P6|Overall Study|Adverse Event|0
7582047|NCT02119260|26372649|P5|Overall Study|Adverse Event|0
7582048|NCT02119260|26372650|P4|Overall Study|Adverse Event|0
7582049|NCT02119260|26372651|P3|Overall Study|Adverse Event|0
7582050|NCT02119260|26372652|P2|Overall Study|Adverse Event|0
7582051|NCT02119260|26372653|P1|Overall Study|Adverse Event|1
7582052|NCT02119156|26372726|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
7582053|NCT02119156|26372727|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
7582054|NCT02119156|26372728|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
7582055|NCT02119156|26372726|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7582056|NCT02119156|26372727|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7582057|NCT02119156|26372728|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
7582058|NCT02119156|26372726|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
7582059|NCT02119156|26372727|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
7582060|NCT02119156|26372728|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
7582061|NCT02119156|26372726|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7582062|NCT02119156|26372727|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7582063|NCT02119156|26372728|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
7582064|NCT02119156|26372726|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
7582065|NCT02119156|26372727|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7582066|NCT02119156|26372728|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7582067|NCT02119104|26372786|P1|Overall Study|Protocol Violation|16
7582068|NCT02119026|26372792|P2|2nd-line Treatment|Adverse Event|1
7582069|NCT02119026|26372793|P1|2nd-line Treatment|Adverse Event|4
7582070|NCT02119026|26372792|P2|2nd-line Treatment|Withdrawal by Subject|1
7582071|NCT02119026|26372793|P1|2nd-line Treatment|Withdrawal by Subject|3
7582072|NCT02119026|26372792|P2|2nd-line Treatment|Lost to Follow-up|0
7582073|NCT02119026|26372793|P1|2nd-line Treatment|Lost to Follow-up|2
7582074|NCT02119026|26372792|P2|1st-line Treatment|Death|1
7582075|NCT02119026|26372793|P1|1st-line Treatment|Death|2
7582076|NCT02119026|26372792|P2|1st-line Treatment|Surgery of metastases|1
7582077|NCT02119026|26372793|P1|1st-line Treatment|Surgery of metastases|2
7582078|NCT02119026|26372792|P2|1st-line Treatment|Patient condition or compliance|4
7582079|NCT02119026|26372793|P1|1st-line Treatment|Patient condition or compliance|6
7582080|NCT02119026|26372792|P2|1st-line Treatment|Withdrawal by Subject|10
7582081|NCT02119026|26372793|P1|1st-line Treatment|Withdrawal by Subject|4
7582082|NCT02119026|26372792|P2|1st-line Treatment|Physician Decision|8
7582083|NCT02119026|26372793|P1|1st-line Treatment|Physician Decision|3
7582084|NCT02119026|26372792|P2|1st-line Treatment|Adverse Event|14
7582085|NCT02119026|26372793|P1|1st-line Treatment|Adverse Event|9
7582086|NCT02118961|26372817|P2|Overall Study|Withdrawal by Subject|0
7582087|NCT02118961|26372818|P1|Overall Study|Withdrawal by Subject|1
7582088|NCT02118896|26372846|P10|Overall Study|Miscellaneous|0
7582089|NCT02118896|26372847|P9|Overall Study|Miscellaneous|0
7582090|NCT02118896|26372848|P8|Overall Study|Miscellaneous|0
7582091|NCT02118896|26372849|P7|Overall Study|Miscellaneous|0
7582092|NCT02118896|26372850|P6|Overall Study|Miscellaneous|4
7582093|NCT02118896|26372851|P5|Overall Study|Miscellaneous|0
7582094|NCT02118896|26372852|P4|Overall Study|Miscellaneous|2
7582095|NCT02118896|26372853|P3|Overall Study|Miscellaneous|0
7582096|NCT02118896|26372854|P2|Overall Study|Miscellaneous|2
7582097|NCT02118896|26372855|P1|Overall Study|Miscellaneous|1
7582098|NCT02118896|26372846|P10|Overall Study|Prohibited medication|0
7582099|NCT02118896|26372847|P9|Overall Study|Prohibited medication|0
7582100|NCT02118896|26372848|P8|Overall Study|Prohibited medication|0
7582101|NCT02118896|26372849|P7|Overall Study|Prohibited medication|0
7582102|NCT02118896|26372850|P6|Overall Study|Prohibited medication|3
7582103|NCT02118896|26372851|P5|Overall Study|Prohibited medication|1
7582104|NCT02118896|26372852|P4|Overall Study|Prohibited medication|0
7582105|NCT02118896|26372853|P3|Overall Study|Prohibited medication|0
7582106|NCT02118896|26372854|P2|Overall Study|Prohibited medication|0
7582107|NCT02118896|26372855|P1|Overall Study|Prohibited medication|0
7582108|NCT02118896|26372846|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
7582109|NCT02118896|26372847|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
7582110|NCT02118896|26372848|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
7582111|NCT02118896|26372849|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
7582112|NCT02118896|26372850|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
7582113|NCT02118896|26372851|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
7582114|NCT02118896|26372852|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
7582115|NCT02118896|26372853|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
7582116|NCT02118896|26372854|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
7582117|NCT02118896|26372855|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
7582118|NCT02118896|26372846|P10|Overall Study|Lost to Follow-up|0
7582119|NCT02118896|26372847|P9|Overall Study|Lost to Follow-up|0
7582120|NCT02118896|26372848|P8|Overall Study|Lost to Follow-up|0
7582121|NCT02118896|26372849|P7|Overall Study|Lost to Follow-up|0
7582122|NCT02118896|26372850|P6|Overall Study|Lost to Follow-up|1
7582123|NCT02118896|26372851|P5|Overall Study|Lost to Follow-up|2
7582124|NCT02118896|26372852|P4|Overall Study|Lost to Follow-up|0
7582125|NCT02118896|26372853|P3|Overall Study|Lost to Follow-up|1
7582126|NCT02118896|26372854|P2|Overall Study|Lost to Follow-up|2
7582127|NCT02118896|26372855|P1|Overall Study|Lost to Follow-up|1
7582128|NCT02118896|26372846|P10|Overall Study|Pregnancy|0
7582129|NCT02118896|26372847|P9|Overall Study|Pregnancy|0
7582130|NCT02118896|26372848|P8|Overall Study|Pregnancy|0
7582131|NCT02118896|26372849|P7|Overall Study|Pregnancy|1
7582132|NCT02118896|26372850|P6|Overall Study|Pregnancy|3
7582133|NCT02118896|26372851|P5|Overall Study|Pregnancy|1
7582134|NCT02118896|26372852|P4|Overall Study|Pregnancy|0
7582135|NCT02118896|26372853|P3|Overall Study|Pregnancy|0
7582136|NCT02118896|26372854|P2|Overall Study|Pregnancy|1
7582137|NCT02118896|26372855|P1|Overall Study|Pregnancy|1
7582138|NCT02118896|26372846|P10|Overall Study|Non-compliance|0
7582139|NCT02118896|26372847|P9|Overall Study|Non-compliance|0
7582140|NCT02118896|26372848|P8|Overall Study|Non-compliance|1
7582141|NCT02118896|26372849|P7|Overall Study|Non-compliance|0
7582142|NCT02118896|26372850|P6|Overall Study|Non-compliance|1
7582143|NCT02118896|26372851|P5|Overall Study|Non-compliance|0
7582144|NCT02118896|26372852|P4|Overall Study|Non-compliance|5
7582145|NCT02118896|26372853|P3|Overall Study|Non-compliance|1
7582146|NCT02118896|26372854|P2|Overall Study|Non-compliance|1
7582147|NCT02118896|26372855|P1|Overall Study|Non-compliance|2
7582148|NCT02118896|26372846|P10|Overall Study|Consent withdrawn|0
7582149|NCT02118896|26372847|P9|Overall Study|Consent withdrawn|0
7582150|NCT02118896|26372848|P8|Overall Study|Consent withdrawn|0
7582151|NCT02118896|26372849|P7|Overall Study|Consent withdrawn|0
7582152|NCT02118896|26372850|P6|Overall Study|Consent withdrawn|4
7582153|NCT02118896|26372851|P5|Overall Study|Consent withdrawn|1
7582154|NCT02118896|26372852|P4|Overall Study|Consent withdrawn|4
7582155|NCT02118896|26372853|P3|Overall Study|Consent withdrawn|3
7582156|NCT02118896|26372854|P2|Overall Study|Consent withdrawn|0
7582157|NCT02118896|26372855|P1|Overall Study|Consent withdrawn|2
7582158|NCT02118896|26372846|P10|Overall Study|Adverse Event|0
7582159|NCT02118896|26372847|P9|Overall Study|Adverse Event|4
7582160|NCT02118896|26372848|P8|Overall Study|Adverse Event|1
7582161|NCT02118896|26372849|P7|Overall Study|Adverse Event|1
7582162|NCT02118896|26372850|P6|Overall Study|Adverse Event|9
7582163|NCT02118896|26372851|P5|Overall Study|Adverse Event|5
7582164|NCT02118896|26372852|P4|Overall Study|Adverse Event|5
7582165|NCT02118896|26372853|P3|Overall Study|Adverse Event|4
7582166|NCT02118896|26372854|P2|Overall Study|Adverse Event|4
7582167|NCT02118896|26372855|P1|Overall Study|Adverse Event|5
7582168|NCT02118896|26372846|P10|Overall Study|Death|0
7582169|NCT02118896|26372847|P9|Overall Study|Death|0
7582170|NCT02118896|26372848|P8|Overall Study|Death|0
7582171|NCT02118896|26372849|P7|Overall Study|Death|0
7582172|NCT02118896|26372850|P6|Overall Study|Death|1
7582173|NCT02118896|26372851|P5|Overall Study|Death|3
7582174|NCT02118896|26372852|P4|Overall Study|Death|6
7582175|NCT02118896|26372853|P3|Overall Study|Death|4
7582176|NCT02118896|26372854|P2|Overall Study|Death|0
7582177|NCT02118896|26372855|P1|Overall Study|Death|4
7582178|NCT02118792|26372945|P2|Overall Study|Randomised but not treated|0
7582179|NCT02118792|26372946|P1|Overall Study|Randomised but not treated|1
7582180|NCT02118792|26372945|P2|Overall Study|Other|6
7582181|NCT02118792|26372946|P1|Overall Study|Other|1
7582182|NCT02118792|26372945|P2|Overall Study|Withdrawal by parent/guardian|20
7582183|NCT02118792|26372946|P1|Overall Study|Withdrawal by parent/guardian|14
7582184|NCT02118792|26372945|P2|Overall Study|Adverse Event|4
7582185|NCT02118792|26372946|P1|Overall Study|Adverse Event|5
7582186|NCT02118792|26372945|P2|Overall Study|Lost to Follow-up|4
7582187|NCT02118792|26372946|P1|Overall Study|Lost to Follow-up|4
7582188|NCT02118792|26372945|P2|Overall Study|Withdrawal by Subject|3
7582189|NCT02118792|26372946|P1|Overall Study|Withdrawal by Subject|6
7582190|NCT02118766|26372988|P2|Overall Study|Other|1
7582191|NCT02118766|26372989|P1|Overall Study|Other|3
7582192|NCT02118766|26372988|P2|Overall Study|Withdrawal by parent/guardian|18
7582193|NCT02118766|26372989|P1|Overall Study|Withdrawal by parent/guardian|12
7582194|NCT02118766|26372988|P2|Overall Study|Lost to Follow-up|4
7582195|NCT02118766|26372989|P1|Overall Study|Lost to Follow-up|5
7582196|NCT02118766|26372988|P2|Overall Study|Withdrawal by Subject|6
7582197|NCT02118766|26372989|P1|Overall Study|Withdrawal by Subject|3
7582198|NCT02118766|26372988|P2|Overall Study|Adverse Event|2
7582199|NCT02118766|26372989|P1|Overall Study|Adverse Event|7
7582200|NCT02118714|26373011|P1|Overall Study|Protocol Violation|1
7582201|NCT02118714|26373011|P1|Overall Study|Lost to Follow-up|2
7582202|NCT02118597|26373036|P1|Overall Study|Investigator's decision|1
7582203|NCT02118597|26373036|P1|Overall Study|Serious Adverse Event|1
7582204|NCT02118597|26373036|P1|Overall Study|Sponsor terminated the study|14
7582205|NCT02118428|26373067|P3|Overall Study|Screen Failure or Became Inelegible|1
7582206|NCT02118428|26373068|P2|Overall Study|Screen Failure or Became Inelegible|0
7582207|NCT02118428|26373069|P1|Overall Study|Screen Failure or Became Inelegible|1
7582208|NCT02118428|26373067|P3|Overall Study|Lost to Follow-up|0
7582209|NCT02118428|26373068|P2|Overall Study|Lost to Follow-up|1
7582210|NCT02118428|26373069|P1|Overall Study|Lost to Follow-up|3
7582211|NCT02118428|26373067|P3|Overall Study|Death|0
7582212|NCT02118428|26373068|P2|Overall Study|Death|5
7582213|NCT02118428|26373069|P1|Overall Study|Death|7
7582214|NCT02118428|26373067|P3|Overall Study|Withdrawal by Subject|0
7582215|NCT02118428|26373068|P2|Overall Study|Withdrawal by Subject|2
7582216|NCT02118428|26373069|P1|Overall Study|Withdrawal by Subject|2
7582217|NCT02118428|26373067|P3|Overall Study|Physician Decision|0
7582218|NCT02118428|26373068|P2|Overall Study|Physician Decision|1
7582219|NCT02118428|26373069|P1|Overall Study|Physician Decision|0
7582220|NCT02118337|26373116|P9|Overall Study|Death|4
7582221|NCT02118337|26373117|P8|Overall Study|Death|9
7582222|NCT02118337|26373118|P7|Overall Study|Death|2
7582223|NCT02118337|26373119|P6|Overall Study|Death|1
7582224|NCT02118337|26373120|P5|Overall Study|Death|5
7582225|NCT02118337|26373121|P4|Overall Study|Death|2
7582226|NCT02118337|26373122|P3|Overall Study|Death|1
7582227|NCT02118337|26373123|P2|Overall Study|Death|2
7582228|NCT02118337|26373124|P1|Overall Study|Death|2
7582229|NCT02118337|26373116|P9|Overall Study|Withdrawal by Subject|2
7582230|NCT02118337|26373117|P8|Overall Study|Withdrawal by Subject|4
7582231|NCT02118337|26373118|P7|Overall Study|Withdrawal by Subject|1
7582232|NCT02118337|26373119|P6|Overall Study|Withdrawal by Subject|2
7582233|NCT02118337|26373120|P5|Overall Study|Withdrawal by Subject|2
7582234|NCT02118337|26373121|P4|Overall Study|Withdrawal by Subject|1
7582235|NCT02118337|26373122|P3|Overall Study|Withdrawal by Subject|2
7582236|NCT02118337|26373123|P2|Overall Study|Withdrawal by Subject|3
7582237|NCT02118337|26373124|P1|Overall Study|Withdrawal by Subject|1
7582238|NCT02118337|26373116|P9|Overall Study|Lost to Follow-up|0
7582239|NCT02118337|26373117|P8|Overall Study|Lost to Follow-up|1
7582240|NCT02118337|26373118|P7|Overall Study|Lost to Follow-up|0
7582241|NCT02118337|26373119|P6|Overall Study|Lost to Follow-up|0
7582242|NCT02118337|26373120|P5|Overall Study|Lost to Follow-up|0
7582243|NCT02118337|26373121|P4|Overall Study|Lost to Follow-up|0
7582244|NCT02118337|26373122|P3|Overall Study|Lost to Follow-up|0
7582245|NCT02118337|26373123|P2|Overall Study|Lost to Follow-up|0
7582246|NCT02118337|26373124|P1|Overall Study|Lost to Follow-up|0
7582247|NCT02118337|26373116|P9|Overall Study|Other|15
7582248|NCT02118337|26373117|P8|Overall Study|Other|28
7582249|NCT02118337|26373118|P7|Overall Study|Other|1
7582250|NCT02118337|26373119|P6|Overall Study|Other|3
7582251|NCT02118337|26373120|P5|Overall Study|Other|2
7582252|NCT02118337|26373121|P4|Overall Study|Other|0
7582253|NCT02118337|26373122|P3|Overall Study|Other|0
7582254|NCT02118337|26373123|P2|Overall Study|Other|0
7582255|NCT02118337|26373124|P1|Overall Study|Other|1
7582256|NCT02118012|26373281|P2|Overall Study|Physician Decision|1
7582257|NCT02118012|26373282|P1|Overall Study|Physician Decision|0
7582258|NCT02118012|26373281|P2|Overall Study|Adverse Event|1
7582259|NCT02118012|26373282|P1|Overall Study|Adverse Event|0
7582260|NCT02117713|26373324|P1|Long Term Follow-up Treatment|Non-Compliance with study drug|1
7582261|NCT02117713|26373324|P1|Long Term Follow-up Treatment|Progressive Disease|2
7582262|NCT02117713|26373324|P1|Long Term Follow-up Treatment|Adverse Event|3
7582263|NCT02117713|26373324|P1|Week 48|Did not consent to Protocol Amendment 4|2
7582264|NCT02117713|26373324|P1|Week 48|Withdrawal by caregiver|2
7582265|NCT02117713|26373324|P1|Week 48|Adverse Event|4
7582266|NCT02117687|26373351|P2|Overall Study|Other Reasons|1
7582267|NCT02117687|26373352|P1|Overall Study|Other Reasons|1
7582268|NCT02117687|26373351|P2|Overall Study|Adverse Event|2
7582269|NCT02117687|26373352|P1|Overall Study|Adverse Event|0
7582270|NCT02117687|26373351|P2|Overall Study|Lost to Follow-up|1
7582271|NCT02117687|26373352|P1|Overall Study|Lost to Follow-up|0
7582272|NCT02117648|26373384|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
7582273|NCT02117648|26373384|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
7582274|NCT02117648|26373384|P1|Abemaciclib Safety-Extension Phase|Death|3
7582275|NCT02117648|26373384|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
7582276|NCT02117648|26373384|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
7582277|NCT02117648|26373384|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
7582278|NCT02117648|26373384|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
7582279|NCT02117648|26373384|P1|Abemaciclib + Clarithromycin Period 2|Death|1
7582280|NCT02117648|26373384|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
7582281|NCT02117648|26373384|P1|Abemaciclib Alone Period 1|Adverse Event|1
7582282|NCT02117648|26373384|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
7582283|NCT02117570|26373397|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7582284|NCT02117570|26373398|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
7582285|NCT02117570|26373399|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7582286|NCT02117570|26373397|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7582287|NCT02117570|26373398|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7582288|NCT02117570|26373399|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
7582289|NCT02117570|26373397|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
7582290|NCT02117570|26373398|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7582291|NCT02117570|26373399|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7582292|NCT02117570|26373397|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
7582293|NCT02117570|26373398|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
7582294|NCT02117570|26373399|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
7582295|NCT02117570|26373397|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
7582296|NCT02117570|26373398|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7582297|NCT02117570|26373399|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7582298|NCT02117570|26373397|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
7582299|NCT02117570|26373398|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7582300|NCT02117570|26373399|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7582301|NCT02117570|26373397|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
7582302|NCT02117570|26373398|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
7582303|NCT02117570|26373399|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
7582304|NCT02117544|26373449|P2|Period 1|Lost to follow-up (prior to treatment)|0
7582305|NCT02117544|26373450|P1|Period 1|Lost to follow-up (prior to treatment)|2
7582306|NCT02117479|26373465|P2|Overall Study|Other unspecified|7
7582307|NCT02117479|26373466|P1|Overall Study|Other unspecified|11
7582308|NCT02117479|26373465|P2|Overall Study|Physician Decision|2
7582309|NCT02117479|26373466|P1|Overall Study|Physician Decision|7
7582310|NCT02117479|26373465|P2|Overall Study|Study terminated by the sponsor|6
7582311|NCT02117479|26373466|P1|Overall Study|Study terminated by the sponsor|4
7582312|NCT02117479|26373465|P2|Overall Study|Noncompliance with study treatment|0
7582313|NCT02117479|26373466|P1|Overall Study|Noncompliance with study treatment|1
7582314|NCT02117479|26373465|P2|Overall Study|Disease progression|108
7582315|NCT02117479|26373466|P1|Overall Study|Disease progression|104
7582316|NCT02117479|26373465|P2|Overall Study|Subject decision|9
7582317|NCT02117479|26373466|P1|Overall Study|Subject decision|8
7582318|NCT02117479|26373465|P2|Overall Study|Adverse Event|16
7582319|NCT02117479|26373466|P1|Overall Study|Adverse Event|8
7582320|NCT02117479|26373465|P2|Overall Study|Death|8
7582321|NCT02117479|26373466|P1|Overall Study|Death|13
7582322|NCT02117427|26373485|P3|Overall Study|Death|0
7582323|NCT02117427|26373486|P2|Overall Study|Death|1
7582324|NCT02117427|26373487|P1|Overall Study|Death|0
7582325|NCT02117427|26373485|P3|Overall Study|No longer meets inclusion criteria|0
7582326|NCT02117427|26373486|P2|Overall Study|No longer meets inclusion criteria|1
7582327|NCT02117427|26373487|P1|Overall Study|No longer meets inclusion criteria|0
7582328|NCT02117427|26373485|P3|Overall Study|Physician Decision|0
7582329|NCT02117427|26373486|P2|Overall Study|Physician Decision|2
7582330|NCT02117427|26373487|P1|Overall Study|Physician Decision|0
7582331|NCT02117427|26373485|P3|Overall Study|Permanent need for exogenous ESA Tx|0
7582332|NCT02117427|26373486|P2|Overall Study|Permanent need for exogenous ESA Tx|1
7582333|NCT02117427|26373487|P1|Overall Study|Permanent need for exogenous ESA Tx|3
7582334|NCT02117427|26373485|P3|Overall Study|Permanent need for exogenous EPO Tx|0
7582335|NCT02117427|26373486|P2|Overall Study|Permanent need for exogenous EPO Tx|0
7582336|NCT02117427|26373487|P1|Overall Study|Permanent need for exogenous EPO Tx|2
7582337|NCT02117414|26373497|P2|Overall Study|Withdrawal by Subject|4
7582338|NCT02117414|26373498|P1|Overall Study|Withdrawal by Subject|10
7582339|NCT02117414|26373497|P2|Overall Study|Death|2
7582340|NCT02117414|26373498|P1|Overall Study|Death|5
7582341|NCT02117349|26373518|P2|Overall Study|Death|0
7582342|NCT02117349|26373519|P1|Overall Study|Death|1
7582343|NCT02117349|26373518|P2|Overall Study|Lost to Follow-up|1
7582344|NCT02117349|26373519|P1|Overall Study|Lost to Follow-up|1
7582345|NCT02117349|26373518|P2|Overall Study|Withdrawal by Subject|0
7582346|NCT02117349|26373519|P1|Overall Study|Withdrawal by Subject|1
7582347|NCT02117050|26373555|P1|Overall Study|Subject Enrolled but not Dosed|1
7582348|NCT02117024|26373569|P2|Overall Study|Physician Decision|2
7582349|NCT02117024|26373570|P1|Overall Study|Physician Decision|0
7582350|NCT02117024|26373569|P2|Overall Study|Patient took treatment break|1
7582351|NCT02117024|26373570|P1|Overall Study|Patient took treatment break|0
7582352|NCT02117024|26373569|P2|Overall Study|Patient returned to primary oncologist|1
7582353|NCT02117024|26373570|P1|Overall Study|Patient returned to primary oncologist|0
7582354|NCT02117024|26373569|P2|Overall Study|Randomized in Error|0
7582355|NCT02117024|26373570|P1|Overall Study|Randomized in Error|1
7582356|NCT02117024|26373569|P2|Overall Study|Adverse Event|2
7582357|NCT02117024|26373570|P1|Overall Study|Adverse Event|1
7582358|NCT02117024|26373569|P2|Overall Study|Protocol Violation|0
7582359|NCT02117024|26373570|P1|Overall Study|Protocol Violation|1
7582360|NCT02117024|26373569|P2|Overall Study|Withdrawal by Subject|1
7582361|NCT02117024|26373570|P1|Overall Study|Withdrawal by Subject|3
7582362|NCT02117024|26373569|P2|Overall Study|Death|0
7582363|NCT02117024|26373570|P1|Overall Study|Death|5
7582364|NCT02117024|26373569|P2|Overall Study|Significant Clinical Progression|4
7582365|NCT02117024|26373570|P1|Overall Study|Significant Clinical Progression|7
7582366|NCT02117024|26373569|P2|Overall Study|Progressive Disease|9
7582367|NCT02117024|26373570|P1|Overall Study|Progressive Disease|26
7582368|NCT02116972|26373597|P3|Overall Study|scheduling conflicts and relocation|6
7582369|NCT02116972|26373598|P2|Overall Study|scheduling conflicts and relocation|3
7582370|NCT02116972|26373599|P1|Overall Study|scheduling conflicts and relocation|3
7582371|NCT02116972|26373597|P3|Overall Study|Lack of Efficacy|5
7582372|NCT02116972|26373598|P2|Overall Study|Lack of Efficacy|6
7582373|NCT02116972|26373599|P1|Overall Study|Lack of Efficacy|6
7582374|NCT02116972|26373597|P3|Overall Study|Lost to Follow-up|1
7582375|NCT02116972|26373598|P2|Overall Study|Lost to Follow-up|3
7582376|NCT02116972|26373599|P1|Overall Study|Lost to Follow-up|4
7582377|NCT02116972|26373597|P3|Overall Study|Protocol Violation|1
7582378|NCT02116972|26373598|P2|Overall Study|Protocol Violation|0
7582379|NCT02116972|26373599|P1|Overall Study|Protocol Violation|1
7582380|NCT02116972|26373597|P3|Overall Study|Withdrawal by Subject|5
7582381|NCT02116972|26373598|P2|Overall Study|Withdrawal by Subject|1
7582382|NCT02116972|26373599|P1|Overall Study|Withdrawal by Subject|1
7582383|NCT02116972|26373597|P3|Overall Study|Adverse Event|1
7582384|NCT02116972|26373598|P2|Overall Study|Adverse Event|4
7582385|NCT02116972|26373599|P1|Overall Study|Adverse Event|4
7582386|NCT02116803|26373631|P2|Overall Study|Death|0
7582387|NCT02116803|26373632|P1|Overall Study|Death|1
7582388|NCT02116803|26373631|P2|Overall Study|Study terminated by sponsor|1
7582389|NCT02116803|26373632|P1|Overall Study|Study terminated by sponsor|2
7582390|NCT02116803|26373631|P2|Overall Study|Progressive disease|0
7582391|NCT02116803|26373632|P1|Overall Study|Progressive disease|4
7582392|NCT02116803|26373631|P2|Overall Study|Physician Decision|0
7582393|NCT02116803|26373632|P1|Overall Study|Physician Decision|1
7582394|NCT02116803|26373631|P2|Overall Study|Adverse Event|1
7582395|NCT02116803|26373632|P1|Overall Study|Adverse Event|2
7582396|NCT02116777|26373645|P7|Overall Study|Withdrawal by Subject|0
7582397|NCT02116777|26373646|P6|Overall Study|Withdrawal by Subject|0
7582398|NCT02116777|26373647|P5|Overall Study|Withdrawal by Subject|0
7582399|NCT02116777|26373648|P4|Overall Study|Withdrawal by Subject|1
7582400|NCT02116777|26373649|P3|Overall Study|Withdrawal by Subject|0
7582401|NCT02116777|26373650|P2|Overall Study|Withdrawal by Subject|0
7582402|NCT02116777|26373651|P1|Overall Study|Withdrawal by Subject|0
7582403|NCT02116777|26373645|P7|Overall Study|Protocol Violation|0
7582404|NCT02116777|26373646|P6|Overall Study|Protocol Violation|0
7582405|NCT02116777|26373647|P5|Overall Study|Protocol Violation|0
7582406|NCT02116777|26373648|P4|Overall Study|Protocol Violation|1
7582407|NCT02116777|26373649|P3|Overall Study|Protocol Violation|0
7582408|NCT02116777|26373650|P2|Overall Study|Protocol Violation|0
7582409|NCT02116777|26373651|P1|Overall Study|Protocol Violation|0
7582410|NCT02116777|26373645|P7|Overall Study|Physician Decision|0
7582411|NCT02116777|26373646|P6|Overall Study|Physician Decision|0
7582412|NCT02116777|26373647|P5|Overall Study|Physician Decision|0
7582413|NCT02116777|26373648|P4|Overall Study|Physician Decision|2
7582414|NCT02116777|26373649|P3|Overall Study|Physician Decision|0
7582415|NCT02116777|26373650|P2|Overall Study|Physician Decision|0
7582416|NCT02116777|26373651|P1|Overall Study|Physician Decision|0
7582417|NCT02116777|26373645|P7|Overall Study|Lack of Efficacy|9
7582418|NCT02116777|26373646|P6|Overall Study|Lack of Efficacy|1
7582419|NCT02116777|26373647|P5|Overall Study|Lack of Efficacy|4
7582420|NCT02116777|26373648|P4|Overall Study|Lack of Efficacy|8
7582421|NCT02116777|26373649|P3|Overall Study|Lack of Efficacy|3
7582422|NCT02116777|26373650|P2|Overall Study|Lack of Efficacy|3
7582423|NCT02116777|26373651|P1|Overall Study|Lack of Efficacy|3
7582424|NCT02116777|26373645|P7|Overall Study|Death|0
7582425|NCT02116777|26373646|P6|Overall Study|Death|0
7582426|NCT02116777|26373647|P5|Overall Study|Death|0
7582427|NCT02116777|26373648|P4|Overall Study|Death|1
7582428|NCT02116777|26373649|P3|Overall Study|Death|0
7582429|NCT02116777|26373650|P2|Overall Study|Death|0
7582430|NCT02116777|26373651|P1|Overall Study|Death|0
7582431|NCT02116777|26373645|P7|Overall Study|Adverse Event|0
7582432|NCT02116777|26373646|P6|Overall Study|Adverse Event|2
7582433|NCT02116777|26373647|P5|Overall Study|Adverse Event|2
7582434|NCT02116777|26373648|P4|Overall Study|Adverse Event|0
7582435|NCT02116777|26373649|P3|Overall Study|Adverse Event|0
7582436|NCT02116777|26373650|P2|Overall Study|Adverse Event|0
7582437|NCT02116777|26373651|P1|Overall Study|Adverse Event|0
7582438|NCT02116660|26373693|P2|Overall Study|Organization reason|0
7582439|NCT02116660|26373694|P1|Overall Study|Organization reason|1
7582440|NCT02116660|26373693|P2|Overall Study|Withdrawal by Subject|2
7582441|NCT02116660|26373694|P1|Overall Study|Withdrawal by Subject|0
7582442|NCT02116660|26373693|P2|Overall Study|Adverse Event|1
7582443|NCT02116660|26373694|P1|Overall Study|Adverse Event|1
7582444|NCT02116660|26373693|P2|Overall Study|Deteriorating renal function|1
7582445|NCT02116660|26373694|P1|Overall Study|Deteriorating renal function|0
7582446|NCT02116621|26373738|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
7582447|NCT02116621|26373739|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
7582448|NCT02116621|26373738|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
7582449|NCT02116621|26373739|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
7582450|NCT02116621|26373738|P2|Twelve Month Follow-up|Lost to Follow-up|1
7582451|NCT02116621|26373739|P1|Twelve Month Follow-up|Lost to Follow-up|0
7582452|NCT02116621|26373738|P2|Twelve Month Follow-up|Withdrawal by Subject|0
7582453|NCT02116621|26373739|P1|Twelve Month Follow-up|Withdrawal by Subject|1
7582454|NCT02116621|26373738|P2|Six Month Follow-up|Did not complete follow-up survey|1
7582455|NCT02116621|26373739|P1|Six Month Follow-up|Did not complete follow-up survey|1
7582456|NCT02116621|26373738|P2|Six Month Follow-up|Lost to Follow-up|1
7582457|NCT02116621|26373739|P1|Six Month Follow-up|Lost to Follow-up|2
7582458|NCT02116621|26373738|P2|Six Month Follow-up|Withdrawal by Subject|1
7582459|NCT02116621|26373739|P1|Six Month Follow-up|Withdrawal by Subject|1
7582460|NCT02116621|26373738|P2|Three Month Follow-up|Did not complete follow-up survey|4
7582461|NCT02116621|26373739|P1|Three Month Follow-up|Did not complete follow-up survey|14
7582462|NCT02116621|26373738|P2|Three Month Follow-up|Lost to Follow-up|1
7582463|NCT02116621|26373739|P1|Three Month Follow-up|Lost to Follow-up|0
7582464|NCT02116621|26373738|P2|Three Month Follow-up|Withdrawal by Subject|1
7582465|NCT02116621|26373739|P1|Three Month Follow-up|Withdrawal by Subject|4
7582466|NCT02116621|26373738|P2|Three Month Follow-up|Death|1
7582467|NCT02116621|26373739|P1|Three Month Follow-up|Death|1
7582468|NCT02116621|26373738|P2|Baseline|Withdrawal by Subject|4
7582469|NCT02116621|26373739|P1|Baseline|Withdrawal by Subject|0
7582470|NCT02116608|26373830|P3|Overall Study|Death|0
7582471|NCT02116608|26373831|P2|Overall Study|Death|1
7582472|NCT02116608|26373832|P1|Overall Study|Death|0
7582473|NCT02116608|26373830|P3|Overall Study|Physician Decision|0
7582474|NCT02116608|26373831|P2|Overall Study|Physician Decision|1
7582475|NCT02116608|26373832|P1|Overall Study|Physician Decision|0
7582476|NCT02116608|26373830|P3|Overall Study|Lost to Follow-up|1
7582477|NCT02116608|26373831|P2|Overall Study|Lost to Follow-up|0
7582478|NCT02116608|26373832|P1|Overall Study|Lost to Follow-up|0
7582479|NCT02116582|26373846|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
7582480|NCT02116582|26373846|P1|Overall Study|Lost to Follow-up|1
7582481|NCT02116582|26373846|P1|Overall Study|Other: Miscellaneous|11
7582482|NCT02116582|26373846|P1|Overall Study|Withdrawal by Subject|8
7582483|NCT02116582|26373846|P1|Overall Study|Protocol Violation|3
7582484|NCT02116582|26373846|P1|Overall Study|Progressive Disease|148
7582485|NCT02116582|26373846|P1|Overall Study|Death|9
7582486|NCT02116582|26373846|P1|Overall Study|Adverse Event|22
7582487|NCT02116582|26373846|P1|Overall Study|Enrolled but Never Received Study Drug|1
7582488|NCT02116530|26373856|P2|Overall Study|Other Medical Problems|2
7582489|NCT02116530|26373857|P1|Overall Study|Other Medical Problems|2
7582490|NCT02116530|26373856|P2|Overall Study|Lost to Follow-up|0
7582491|NCT02116530|26373857|P1|Overall Study|Lost to Follow-up|1
7582492|NCT02116530|26373856|P2|Overall Study|Physician Decision|0
7582493|NCT02116530|26373857|P1|Overall Study|Physician Decision|1
7582494|NCT02116530|26373856|P2|Overall Study|Adverse Event|0
7582495|NCT02116530|26373857|P1|Overall Study|Adverse Event|4
7582496|NCT02116530|26373856|P2|Overall Study|Withdrawal by Subject|2
7582497|NCT02116530|26373857|P1|Overall Study|Withdrawal by Subject|1
7582498|NCT02116361|26373875|P4|Overall Study|Investigator Decision - Relapse|5
7582499|NCT02116361|26373876|P3|Overall Study|Investigator Decision - Relapse|8
7582500|NCT02116361|26373877|P2|Overall Study|Investigator Decision - Relapse|7
7582501|NCT02116361|26373878|P1|Overall Study|Investigator Decision - Relapse|9
7582502|NCT02116361|26373875|P4|Overall Study|Personal Reasons|9
7582503|NCT02116361|26373876|P3|Overall Study|Personal Reasons|4
7582504|NCT02116361|26373877|P2|Overall Study|Personal Reasons|6
7582505|NCT02116361|26373878|P1|Overall Study|Personal Reasons|6
7582506|NCT02116361|26373875|P4|Overall Study|Lost to Follow-up|5
7582507|NCT02116361|26373876|P3|Overall Study|Lost to Follow-up|7
7582508|NCT02116361|26373877|P2|Overall Study|Lost to Follow-up|5
7582509|NCT02116361|26373878|P1|Overall Study|Lost to Follow-up|4
7582510|NCT02116361|26373875|P4|Overall Study|Lack of Efficacy|3
7582511|NCT02116361|26373876|P3|Overall Study|Lack of Efficacy|4
7582512|NCT02116361|26373877|P2|Overall Study|Lack of Efficacy|7
7582513|NCT02116361|26373878|P1|Overall Study|Lack of Efficacy|5
7582514|NCT02116361|26373875|P4|Overall Study|Other Reasons|3
7582515|NCT02116361|26373876|P3|Overall Study|Other Reasons|3
7582516|NCT02116361|26373877|P2|Overall Study|Other Reasons|3
7582517|NCT02116361|26373878|P1|Overall Study|Other Reasons|3
7582518|NCT02116361|26373875|P4|Overall Study|Adverse Event|3
7582519|NCT02116361|26373876|P3|Overall Study|Adverse Event|0
7582520|NCT02116361|26373877|P2|Overall Study|Adverse Event|0
7582521|NCT02116361|26373878|P1|Overall Study|Adverse Event|1
7582522|NCT02116361|26373875|P4|Overall Study|Physician Decision|0
7582523|NCT02116361|26373876|P3|Overall Study|Physician Decision|0
7582524|NCT02116361|26373877|P2|Overall Study|Physician Decision|3
7582525|NCT02116361|26373878|P1|Overall Study|Physician Decision|2
7582526|NCT02116361|26373875|P4|Overall Study|Protocol Violation|2
7582527|NCT02116361|26373876|P3|Overall Study|Protocol Violation|0
7582528|NCT02116361|26373877|P2|Overall Study|Protocol Violation|0
7582529|NCT02116361|26373878|P1|Overall Study|Protocol Violation|1
7582530|NCT02116361|26373875|P4|Overall Study|Pregnancy|1
7582531|NCT02116361|26373876|P3|Overall Study|Pregnancy|0
7582532|NCT02116361|26373877|P2|Overall Study|Pregnancy|0
7582533|NCT02116361|26373878|P1|Overall Study|Pregnancy|0
7582534|NCT02116309|26373915|P2|Overall Study|Lost to Follow-up|1
7582535|NCT02116309|26373916|P1|Overall Study|Lost to Follow-up|0
7582536|NCT02116205|26373928|P4|Overall Study|Exclusion criteria|0
7582537|NCT02116205|26373929|P3|Overall Study|Exclusion criteria|1
7582538|NCT02116205|26373930|P2|Overall Study|Exclusion criteria|0
7582539|NCT02116205|26373931|P1|Overall Study|Exclusion criteria|0
7582540|NCT02116205|26373928|P4|Overall Study|Physician Decision|1
7582541|NCT02116205|26373929|P3|Overall Study|Physician Decision|1
7582542|NCT02116205|26373930|P2|Overall Study|Physician Decision|1
7582543|NCT02116205|26373931|P1|Overall Study|Physician Decision|0
7582544|NCT02116205|26373928|P4|Overall Study|Lost to Follow-up|2
7582545|NCT02116205|26373929|P3|Overall Study|Lost to Follow-up|1
7582546|NCT02116205|26373930|P2|Overall Study|Lost to Follow-up|2
7582547|NCT02116205|26373931|P1|Overall Study|Lost to Follow-up|0
7582548|NCT02116205|26373928|P4|Overall Study|Withdrawal by Subject|3
7582549|NCT02116205|26373929|P3|Overall Study|Withdrawal by Subject|1
7582550|NCT02116205|26373930|P2|Overall Study|Withdrawal by Subject|4
7582551|NCT02116205|26373931|P1|Overall Study|Withdrawal by Subject|2
7582552|NCT02115815|26373973|P7|Overall Study|Missed appointment, randomized in error|0
7582553|NCT02115815|26373974|P6|Overall Study|Missed appointment, randomized in error|1
7582554|NCT02115815|26373975|P5|Overall Study|Missed appointment, randomized in error|0
7582555|NCT02115815|26373976|P4|Overall Study|Missed appointment, randomized in error|0
7582556|NCT02115815|26373977|P3|Overall Study|Missed appointment, randomized in error|0
7582557|NCT02115815|26373978|P2|Overall Study|Missed appointment, randomized in error|0
7582558|NCT02115815|26373979|P1|Overall Study|Missed appointment, randomized in error|0
7582559|NCT02115815|26373973|P7|Overall Study|Not enough drug to dose participant|0
7582560|NCT02115815|26373974|P6|Overall Study|Not enough drug to dose participant|1
7582561|NCT02115815|26373975|P5|Overall Study|Not enough drug to dose participant|0
7582562|NCT02115815|26373976|P4|Overall Study|Not enough drug to dose participant|0
7582563|NCT02115815|26373977|P3|Overall Study|Not enough drug to dose participant|0
7582564|NCT02115815|26373978|P2|Overall Study|Not enough drug to dose participant|0
7582565|NCT02115815|26373979|P1|Overall Study|Not enough drug to dose participant|0
7582566|NCT02115815|26373973|P7|Overall Study|Withdrawal by Subject|0
7582567|NCT02115815|26373974|P6|Overall Study|Withdrawal by Subject|0
7582568|NCT02115815|26373975|P5|Overall Study|Withdrawal by Subject|0
7582569|NCT02115815|26373976|P4|Overall Study|Withdrawal by Subject|0
7582570|NCT02115815|26373977|P3|Overall Study|Withdrawal by Subject|0
7582571|NCT02115815|26373978|P2|Overall Study|Withdrawal by Subject|0
7582572|NCT02115815|26373979|P1|Overall Study|Withdrawal by Subject|2
7582573|NCT02115607|26374121|P1|Overall Study|Withdrawal by Subject|1
7582574|NCT02115386|26374147|P1|Overall Study|Administrative - trial was terminated|6
7582575|NCT02115386|26374147|P1|Overall Study|Protocol Violation|1
7582576|NCT02115321|26374250|P2|Overall Study|Death|0
7582577|NCT02115321|26374251|P1|Overall Study|Death|1
7582578|NCT02115308|26374273|P2|Overall Study|Safety Screening|2
7582579|NCT02115308|26374274|P1|Overall Study|Safety Screening|2
7582580|NCT02115269|26374290|P1|Overall Study|Didn't take study drug|2
7582581|NCT02115269|26374290|P1|Overall Study|Withdrawal by Subject|2
7582582|NCT02115269|26374290|P1|Overall Study|Moved to another city|7
7582583|NCT02115269|26374290|P1|Overall Study|Did not complete patient diary|3
7582584|NCT02115269|26374290|P1|Overall Study|Lost to Follow-up|43
7582585|NCT02115256|26374310|P2|Overall Study|Withdrawal by Subject|1
7582586|NCT02115256|26374311|P1|Overall Study|Withdrawal by Subject|0
7582587|NCT02115139|26374323|P1|Overall Study|treatment discontinuation|6
7582588|NCT02115139|26374323|P1|Overall Study|Protocol Violation|1
7582589|NCT02115113|26374333|P3|Participants Randomized|Death|0
7582590|NCT02115113|26374334|P2|Participants Randomized|Death|0
7582591|NCT02115113|26374335|P1|Participants Randomized|Death|1
7582592|NCT02115113|26374333|P3|Participants Randomized|Lost to Follow-up|0
7582593|NCT02115113|26374334|P2|Participants Randomized|Lost to Follow-up|0
7582594|NCT02115113|26374335|P1|Participants Randomized|Lost to Follow-up|1
7582595|NCT02115113|26374333|P3|Participants in Run-in Period|Withdrawal by Subject|3
7582596|NCT02115113|26374334|P2|Participants in Run-in Period|Withdrawal by Subject|0
7582597|NCT02115113|26374335|P1|Participants in Run-in Period|Withdrawal by Subject|0
7582598|NCT02115113|26374333|P3|Participants in Run-in Period|Lost to Follow-up|5
7582599|NCT02115113|26374334|P2|Participants in Run-in Period|Lost to Follow-up|0
7582600|NCT02115113|26374335|P1|Participants in Run-in Period|Lost to Follow-up|0
7582601|NCT02115113|26374333|P3|Participants in Run-in Period|Administrative problems|1
7582602|NCT02115113|26374334|P2|Participants in Run-in Period|Administrative problems|0
7582603|NCT02115113|26374335|P1|Participants in Run-in Period|Administrative problems|0
7582604|NCT02115113|26374333|P3|Participants in Run-in Period|Death|1
7582605|NCT02115113|26374334|P2|Participants in Run-in Period|Death|0
7582606|NCT02115113|26374335|P1|Participants in Run-in Period|Death|0
7582607|NCT02114931|26374367|P2|Overall Study|Other|1
7582608|NCT02114931|26374368|P1|Overall Study|Other|2
7582609|NCT02114931|26374367|P2|Overall Study|Physician Decision|2
7582610|NCT02114931|26374368|P1|Overall Study|Physician Decision|1
7582611|NCT02114931|26374367|P2|Overall Study|Lost to Follow-up|3
7582612|NCT02114931|26374368|P1|Overall Study|Lost to Follow-up|3
7582613|NCT02114931|26374367|P2|Overall Study|Adverse Event|6
7582614|NCT02114931|26374368|P1|Overall Study|Adverse Event|4
7582615|NCT02114931|26374367|P2|Overall Study|Withdrawal by Subject|18
7582616|NCT02114931|26374368|P1|Overall Study|Withdrawal by Subject|15
7582617|NCT02114892|26374384|P2|Overall Study|Lost to Follow-up|2
7582618|NCT02114892|26374385|P1|Overall Study|Lost to Follow-up|1
7582619|NCT02114879|26374421|P2|Overall Study|Physician Decision|2
7582620|NCT02114879|26374422|P1|Overall Study|Physician Decision|0
7582621|NCT02114879|26374421|P2|Overall Study|Lost to Follow-up|6
7582622|NCT02114879|26374422|P1|Overall Study|Lost to Follow-up|4
7582623|NCT02114879|26374421|P2|Overall Study|Death|11
7582624|NCT02114879|26374422|P1|Overall Study|Death|6
7582625|NCT02114879|26374421|P2|Overall Study|Withdrawal by Subject|5
7582626|NCT02114879|26374422|P1|Overall Study|Withdrawal by Subject|9
7582627|NCT02114697|26374463|P2|Overall Study|Study terminated|4
7582628|NCT02114697|26374464|P1|Overall Study|Study terminated|5
7582629|NCT02114684|26374472|P2|Overall Study|Patient Incarcerated|0
7582630|NCT02114684|26374473|P1|Overall Study|Patient Incarcerated|1
7582631|NCT02114684|26374472|P2|Overall Study|Rifampicin resistant on culture|1
7582632|NCT02114684|26374473|P1|Overall Study|Rifampicin resistant on culture|0
7582633|NCT02114684|26374472|P2|Overall Study|Relocation|1
7582634|NCT02114684|26374473|P1|Overall Study|Relocation|3
7582635|NCT02114684|26374472|P2|Overall Study|Withdrawal by Subject|2
7582636|NCT02114684|26374473|P1|Overall Study|Withdrawal by Subject|1
7582637|NCT02114684|26374472|P2|Overall Study|Lost to Follow-up|2
7582638|NCT02114684|26374473|P1|Overall Study|Lost to Follow-up|1
7582639|NCT02114684|26374472|P2|Overall Study|Death|4
7582640|NCT02114684|26374473|P1|Overall Study|Death|6
7582641|NCT02114606|26374489|P1|Overall Study|Unable to swallow Cytosponge|6
7582642|NCT02114515|26374499|P2|Overall Study|Other|61
7582643|NCT02114515|26374500|P1|Overall Study|Other|65
7582644|NCT02114515|26374499|P2|Overall Study|Withdrawal by Subject|22
7582645|NCT02114515|26374500|P1|Overall Study|Withdrawal by Subject|4
7582646|NCT02114515|26374499|P2|Overall Study|Death|12
7582647|NCT02114515|26374500|P1|Overall Study|Death|12
7582648|NCT02114515|26374499|P2|Overall Study|Lost to Follow-up|55
7582649|NCT02114515|26374500|P1|Overall Study|Lost to Follow-up|52
7582650|NCT02114385|26374546|P2|Overall Study|Lost to Follow-up|6
7582651|NCT02114385|26374547|P1|Overall Study|Lost to Follow-up|0
7582652|NCT02114385|26374546|P2|Overall Study|Withdrawal by Subject|2
7582653|NCT02114385|26374547|P1|Overall Study|Withdrawal by Subject|3
7582654|NCT02114268|26374588|P6|Overall Study|Withdrawn by site due to noncompliance|0
7582655|NCT02114268|26374589|P5|Overall Study|Withdrawn by site due to noncompliance|0
7582656|NCT02114268|26374590|P4|Overall Study|Withdrawn by site due to noncompliance|0
7582657|NCT02114268|26374591|P3|Overall Study|Withdrawn by site due to noncompliance|0
7582658|NCT02114268|26374592|P2|Overall Study|Withdrawn by site due to noncompliance|0
7582659|NCT02114268|26374593|P1|Overall Study|Withdrawn by site due to noncompliance|1
7582660|NCT02114268|26374588|P6|Overall Study|Withdrawal by Subject|1
7582661|NCT02114268|26374589|P5|Overall Study|Withdrawal by Subject|0
7582662|NCT02114268|26374590|P4|Overall Study|Withdrawal by Subject|0
7582663|NCT02114268|26374591|P3|Overall Study|Withdrawal by Subject|0
7582664|NCT02114268|26374592|P2|Overall Study|Withdrawal by Subject|0
7582665|NCT02114268|26374593|P1|Overall Study|Withdrawal by Subject|1
7582666|NCT02114268|26374588|P6|Overall Study|Lost to Follow-up|2
7582667|NCT02114268|26374589|P5|Overall Study|Lost to Follow-up|0
7582668|NCT02114268|26374590|P4|Overall Study|Lost to Follow-up|0
7582669|NCT02114268|26374591|P3|Overall Study|Lost to Follow-up|1
7582670|NCT02114268|26374592|P2|Overall Study|Lost to Follow-up|1
7582671|NCT02114268|26374593|P1|Overall Study|Lost to Follow-up|4
7582672|NCT02114203|26374662|P3|Overall Study|Withdrawal by Subject|0
7582673|NCT02114203|26374663|P2|Overall Study|Withdrawal by Subject|1
7582674|NCT02114203|26374664|P1|Overall Study|Withdrawal by Subject|0
7582675|NCT02114203|26374662|P3|Overall Study|Adverse Event|0
7582676|NCT02114203|26374663|P2|Overall Study|Adverse Event|1
7582677|NCT02114203|26374664|P1|Overall Study|Adverse Event|0
7582678|NCT02114177|26374698|P2|Overall Study|Other|1
7582679|NCT02114177|26374699|P1|Overall Study|Other|2
7582680|NCT02114177|26374698|P2|Overall Study|Withdrawal by Subject|1
7582681|NCT02114177|26374699|P1|Overall Study|Withdrawal by Subject|6
7582682|NCT02114177|26374698|P2|Overall Study|Lost to Follow-up|2
7582683|NCT02114177|26374699|P1|Overall Study|Lost to Follow-up|1
7582684|NCT02114151|26374723|P1|Overall Study|Withdrawal by Subject|5
7582685|NCT02114151|26374723|P1|Overall Study|Lost to Follow-up|1
7582686|NCT02114151|26374723|P1|Overall Study|Death|1
7582687|NCT02113956|26374740|P2|3 Month Post-intervention|Lost to Follow-up|2
7582688|NCT02113956|26374741|P1|3 Month Post-intervention|Lost to Follow-up|4
7582689|NCT02113956|26374740|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
7582690|NCT02113956|26374741|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
7582691|NCT02113956|26374740|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
7582692|NCT02113956|26374741|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
7582693|NCT02113579|26374775|P2|Overall Study|Lost to Follow-up|2
7582694|NCT02113579|26374776|P1|Overall Study|Lost to Follow-up|6
7582695|NCT02113579|26374775|P2|Overall Study|Withdrawal by Subject|2
7582696|NCT02113579|26374776|P1|Overall Study|Withdrawal by Subject|3
7582697|NCT02113579|26374775|P2|Overall Study|Adverse Event|0
7582698|NCT02113579|26374776|P1|Overall Study|Adverse Event|1
7582699|NCT02113449|26374800|P1|Overall Study|Adverse Event|4
7582700|NCT02113436|26374816|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
7582701|NCT02113436|26374817|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
7582702|NCT02113436|26374818|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
7582703|NCT02113436|26374819|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
7582704|NCT02113436|26374816|P4|Period 2: 16 Weeks|Physician Decision|0
7582705|NCT02113436|26374817|P3|Period 2: 16 Weeks|Physician Decision|2
7582706|NCT02113436|26374818|P2|Period 2: 16 Weeks|Physician Decision|0
7582707|NCT02113436|26374819|P1|Period 2: 16 Weeks|Physician Decision|0
7582708|NCT02113436|26374816|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
7582709|NCT02113436|26374817|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
7582710|NCT02113436|26374818|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7582711|NCT02113436|26374819|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7582712|NCT02113436|26374816|P4|Period 2: 16 Weeks|Adverse Event|5
7582713|NCT02113436|26374817|P3|Period 2: 16 Weeks|Adverse Event|4
7582714|NCT02113436|26374818|P2|Period 2: 16 Weeks|Adverse Event|0
7582715|NCT02113436|26374819|P1|Period 2: 16 Weeks|Adverse Event|0
7582716|NCT02113436|26374816|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
7582717|NCT02113436|26374817|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
7582718|NCT02113436|26374818|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
7582719|NCT02113436|26374819|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
7582720|NCT02113436|26374816|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7582721|NCT02113436|26374817|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7582722|NCT02113436|26374818|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
7582723|NCT02113436|26374819|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
7582724|NCT02113436|26374816|P4|Period 1: 8 Weeks|Protocol Violation|0
7582725|NCT02113436|26374817|P3|Period 1: 8 Weeks|Protocol Violation|0
7582726|NCT02113436|26374818|P2|Period 1: 8 Weeks|Protocol Violation|0
7582727|NCT02113436|26374819|P1|Period 1: 8 Weeks|Protocol Violation|1
7582728|NCT02113436|26374816|P4|Period 1: 8 Weeks|Adverse Event|0
7582729|NCT02113436|26374817|P3|Period 1: 8 Weeks|Adverse Event|0
7582730|NCT02113436|26374818|P2|Period 1: 8 Weeks|Adverse Event|0
7582731|NCT02113436|26374819|P1|Period 1: 8 Weeks|Adverse Event|1
7582732|NCT02113189|26374925|P3|Overall Study|Lost to follow up|3
7582733|NCT02113189|26374926|P2|Overall Study|Lost to follow up|1
7582734|NCT02113189|26374927|P1|Overall Study|Lost to follow up|2
7582735|NCT02113124|26374943|P2|Overall Study|Unable to retrieve blood sample|1
7582736|NCT02113124|26374944|P1|Overall Study|Unable to retrieve blood sample|1
7582737|NCT02113007|26374950|P1|Overall Study|Progressive disease|2
7582738|NCT02112994|26374956|P3|Overall Study|Withdrawal by Subject|1
7582739|NCT02112994|26374957|P2|Overall Study|Withdrawal by Subject|0
7582740|NCT02112994|26374958|P1|Overall Study|Withdrawal by Subject|0
7582741|NCT02112994|26374956|P3|Overall Study|Liver Transplant|0
7582742|NCT02112994|26374957|P2|Overall Study|Liver Transplant|1
7582743|NCT02112994|26374958|P1|Overall Study|Liver Transplant|0
7582744|NCT02112994|26374956|P3|Overall Study|Pregnancy|1
7582745|NCT02112994|26374957|P2|Overall Study|Pregnancy|1
7582746|NCT02112994|26374958|P1|Overall Study|Pregnancy|0
7582747|NCT02112994|26374956|P3|Overall Study|Progressive Disease|1
7582748|NCT02112994|26374957|P2|Overall Study|Progressive Disease|0
7582749|NCT02112994|26374958|P1|Overall Study|Progressive Disease|0
7582750|NCT02112877|26374976|P2|Overall Study|Visit Missed|6
7582751|NCT02112877|26374977|P1|Overall Study|Visit Missed|1
7582752|NCT02112877|26374976|P2|Overall Study|Withdrawal by Subject|7
7582753|NCT02112877|26374977|P1|Overall Study|Withdrawal by Subject|1
7582754|NCT02112448|26375067|P2|Overall Study|required heparin so could not use ketoro|0
7582755|NCT02112448|26375068|P1|Overall Study|required heparin so could not use ketoro|1
7582756|NCT02112448|26375067|P2|Overall Study|Physician Decision|6
7582757|NCT02112448|26375068|P1|Overall Study|Physician Decision|4
7582758|NCT02112448|26375067|P2|Overall Study|Protocol Violation|2
7582759|NCT02112448|26375068|P1|Overall Study|Protocol Violation|1
7582760|NCT02112448|26375067|P2|Overall Study|lab values precluding use of ketorolac|2
7582761|NCT02112448|26375068|P1|Overall Study|lab values precluding use of ketorolac|2
7582762|NCT02112045|26375101|P2|Overall Study|Withdrawal by Subject|0
7582763|NCT02112045|26375102|P1|Overall Study|Withdrawal by Subject|1
7582764|NCT02111993|26375122|P2|Overall Study|Physician Decision|4
7582765|NCT02111993|26375123|P1|Overall Study|Physician Decision|5
7582766|NCT02111811|26375164|P2|Follow up Period (Aim 2)|Death|0
7582767|NCT02111811|26375165|P1|Follow up Period (Aim 2)|Death|2
7582768|NCT02111811|26375164|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
7582769|NCT02111811|26375165|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
7582770|NCT02111811|26375164|P2|Treatment Phase|Death|0
7582771|NCT02111811|26375165|P1|Treatment Phase|Death|2
7582772|NCT02111811|26375164|P2|Treatment Phase|Lost to Follow-up|18
7582773|NCT02111811|26375165|P1|Treatment Phase|Lost to Follow-up|22
7582774|NCT02111785|26375199|P4|Overall Study|Death|0
7582775|NCT02111785|26375200|P3|Overall Study|Death|0
7582776|NCT02111785|26375201|P2|Overall Study|Death|1
7582777|NCT02111785|26375202|P1|Overall Study|Death|0
7582778|NCT02111603|26375264|P1|Overall Study|Withdrawal by Subject|1
7582779|NCT02111577|26375275|P2|Overall Study|Lost to Follow-up|10
7582780|NCT02111577|26375276|P1|Overall Study|Lost to Follow-up|19
7582781|NCT02111577|26375275|P2|Overall Study|Disease progression|1
7582782|NCT02111577|26375276|P1|Overall Study|Disease progression|0
7582783|NCT02111577|26375275|P2|Overall Study|Withdrawal by Subject|23
7582784|NCT02111577|26375276|P1|Overall Study|Withdrawal by Subject|51
7582785|NCT02111577|26375275|P2|Overall Study|Adverse Event|1
7582786|NCT02111577|26375276|P1|Overall Study|Adverse Event|1
7582787|NCT02111577|26375275|P2|Overall Study|Medical monitor's decision (active hepatitis B)|0
7582788|NCT02111577|26375276|P1|Overall Study|Medical monitor's decision (active hepatitis B)|1
7582789|NCT02111577|26375275|P2|Overall Study|Death|254
7582790|NCT02111577|26375276|P1|Overall Study|Death|518
7582791|NCT02111577|26375275|P2|Overall Study|Failure to produce study treatment|0
7582792|NCT02111577|26375276|P1|Overall Study|Failure to produce study treatment|6
7582793|NCT02111577|26375275|P2|Overall Study|Unable to tolerate leukapheresis|0
7582794|NCT02111577|26375276|P1|Overall Study|Unable to tolerate leukapheresis|1
7582795|NCT02111577|26375275|P2|Overall Study|Protocol Violation|0
7582796|NCT02111577|26375276|P1|Overall Study|Protocol Violation|2
7582797|NCT02111564|26375312|P2|Overall Study|Withdrawal by Subject|20
7582798|NCT02111564|26375313|P1|Overall Study|Withdrawal by Subject|20
7582799|NCT02111564|26375312|P2|Overall Study|Lost to Follow-up|3
7582800|NCT02111564|26375313|P1|Overall Study|Lost to Follow-up|2
7582801|NCT02111564|26375312|P2|Overall Study|Death|120
7582802|NCT02111564|26375313|P1|Overall Study|Death|109
7582803|NCT02111369|26375352|P1|Overall Study|Withdrawal by Subject|1
7582804|NCT02111369|26375352|P1|Overall Study|Lost to Follow-up|2
7582805|NCT02111213|26375376|P2|Overall Study|Lost to Follow-up|4
7582806|NCT02111213|26375377|P1|Overall Study|Lost to Follow-up|3
7582807|NCT02111213|26375376|P2|Overall Study|Withdrawal by Subject|2
7582808|NCT02111213|26375377|P1|Overall Study|Withdrawal by Subject|3
7582809|NCT02111174|26375425|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
7582810|NCT02111174|26375426|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
7582811|NCT02111174|26375425|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
7582812|NCT02111174|26375426|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
7582813|NCT02111174|26375425|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
7582814|NCT02111174|26375426|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
7582815|NCT02111174|26375425|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
7582816|NCT02111174|26375426|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
7582817|NCT02111096|26375455|P3|Overall Study|Withdrawal by Subject|8
7582818|NCT02111096|26375456|P2|Overall Study|Withdrawal by Subject|2
7582819|NCT02111096|26375457|P1|Overall Study|Withdrawal by Subject|4
7582820|NCT02111096|26375455|P3|Overall Study|Terminated by Sponsor|54
7582821|NCT02111096|26375456|P2|Overall Study|Terminated by Sponsor|35
7582822|NCT02111096|26375457|P1|Overall Study|Terminated by Sponsor|53
7582823|NCT02111096|26375455|P3|Overall Study|Protocol Violation|1
7582824|NCT02111096|26375456|P2|Overall Study|Protocol Violation|0
7582825|NCT02111096|26375457|P1|Overall Study|Protocol Violation|1
7582826|NCT02111096|26375455|P3|Overall Study|Physician Decision|0
7582827|NCT02111096|26375456|P2|Overall Study|Physician Decision|1
7582828|NCT02111096|26375457|P1|Overall Study|Physician Decision|0
7582829|NCT02111096|26375455|P3|Overall Study|Lost to Follow Up|1
7582830|NCT02111096|26375456|P2|Overall Study|Lost to Follow Up|1
7582831|NCT02111096|26375457|P1|Overall Study|Lost to Follow Up|1
7582832|NCT02111096|26375455|P3|Overall Study|Non-Compliance with Study Drug|0
7582833|NCT02111096|26375456|P2|Overall Study|Non-Compliance with Study Drug|1
7582834|NCT02111096|26375457|P1|Overall Study|Non-Compliance with Study Drug|1
7582835|NCT02111096|26375455|P3|Overall Study|Adverse Event|2
7582836|NCT02111096|26375456|P2|Overall Study|Adverse Event|1
7582837|NCT02111096|26375457|P1|Overall Study|Adverse Event|4
7582838|NCT02111083|26375505|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
7582839|NCT02111083|26375506|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
7582840|NCT02110901|26375526|P2|Overall Study|received a kidney transplant|0
7582841|NCT02110901|26375527|P1|Overall Study|received a kidney transplant|5
7582842|NCT02110901|26375526|P2|Overall Study|Withdrawal by Subject|3
7582843|NCT02110901|26375527|P1|Overall Study|Withdrawal by Subject|7
7582844|NCT02110901|26375526|P2|Overall Study|Lost to Follow-up|8
7582845|NCT02110901|26375527|P1|Overall Study|Lost to Follow-up|12
7582846|NCT02110901|26375526|P2|Overall Study|Death|3
7582847|NCT02110901|26375527|P1|Overall Study|Death|6
7582848|NCT02110732|26375562|P2|Overall Study|Lost to Follow-up|1
7582849|NCT02110732|26375563|P1|Overall Study|Lost to Follow-up|1
7582850|NCT02110732|26375562|P2|Overall Study|Physician Decision|2
7582851|NCT02110732|26375563|P1|Overall Study|Physician Decision|5
7582852|NCT02110706|26375575|P2|Overall Study|Patients who didn't receive 2nd infusion|1
7582853|NCT02110706|26375576|P1|Overall Study|Patients who didn't receive 2nd infusion|3
7582854|NCT02110706|26375575|P2|Overall Study|Adverse Event|3
7582855|NCT02110706|26375576|P1|Overall Study|Adverse Event|2
7582856|NCT02110693|26375588|P2|Overall Study|Other|0
7582857|NCT02110693|26375589|P1|Overall Study|Other|1
7582858|NCT02110693|26375588|P2|Overall Study|technical difficulties|4
7582859|NCT02110693|26375589|P1|Overall Study|technical difficulties|6
7582860|NCT02110693|26375588|P2|Overall Study|skipped assessment|18
7582861|NCT02110693|26375589|P1|Overall Study|skipped assessment|15
7582862|NCT02110693|26375588|P2|Overall Study|Withdrawal by Subject|7
7582863|NCT02110693|26375589|P1|Overall Study|Withdrawal by Subject|6
7582864|NCT02110238|26375670|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
7582865|NCT02110238|26375671|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
7582866|NCT02110238|26375670|P2|14 Week Blinded Extension Phase|Protocol Violation|3
7582867|NCT02110238|26375671|P1|14 Week Blinded Extension Phase|Protocol Violation|2
7582868|NCT02110238|26375670|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
7582869|NCT02110238|26375671|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
7582870|NCT02110238|26375670|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
7582871|NCT02110238|26375671|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
7582872|NCT02110238|26375670|P2|14 Week Blinded Extension Phase|Adverse Event|1
7582873|NCT02110238|26375671|P1|14 Week Blinded Extension Phase|Adverse Event|1
7582874|NCT02110238|26375670|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
7582875|NCT02110238|26375671|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
7582876|NCT02110238|26375670|P2|12 Week Pivotal Phase|Protocol Violation|1
7582877|NCT02110238|26375671|P1|12 Week Pivotal Phase|Protocol Violation|0
7582878|NCT02110238|26375670|P2|12 Week Pivotal Phase|Physician Decision|2
7582879|NCT02110238|26375671|P1|12 Week Pivotal Phase|Physician Decision|0
7582880|NCT02110238|26375670|P2|12 Week Pivotal Phase|Lost to Follow-up|0
7582881|NCT02110238|26375671|P1|12 Week Pivotal Phase|Lost to Follow-up|2
7582882|NCT02110238|26375670|P2|12 Week Pivotal Phase|Lack of Efficacy|3
7582883|NCT02110238|26375671|P1|12 Week Pivotal Phase|Lack of Efficacy|2
7582884|NCT02110238|26375670|P2|12 Week Pivotal Phase|Adverse Event|0
7582885|NCT02110238|26375671|P1|12 Week Pivotal Phase|Adverse Event|3
7582886|NCT02110225|26375680|P3|Overall Study|Lost to Follow-up|0
7582887|NCT02110225|26375681|P2|Overall Study|Lost to Follow-up|1
7582888|NCT02110225|26375682|P1|Overall Study|Lost to Follow-up|0
7582889|NCT02109562|26375833|P3|Overall Study|Physician Decision|5
7582890|NCT02109562|26375834|P2|Overall Study|Physician Decision|4
7582891|NCT02109562|26375835|P1|Overall Study|Physician Decision|3
7582892|NCT02109562|26375833|P3|Overall Study|Withdrawal by Subject|21
7582893|NCT02109562|26375834|P2|Overall Study|Withdrawal by Subject|25
7582894|NCT02109562|26375835|P1|Overall Study|Withdrawal by Subject|20
7582895|NCT02109562|26375833|P3|Overall Study|Protocol Violation|1
7582896|NCT02109562|26375834|P2|Overall Study|Protocol Violation|3
7582897|NCT02109562|26375835|P1|Overall Study|Protocol Violation|0
7582898|NCT02109562|26375833|P3|Overall Study|Lost to Follow-up|1
7582899|NCT02109562|26375834|P2|Overall Study|Lost to Follow-up|0
7582900|NCT02109562|26375835|P1|Overall Study|Lost to Follow-up|1
7582901|NCT02109562|26375833|P3|Overall Study|Adverse Event|3
7582902|NCT02109562|26375834|P2|Overall Study|Adverse Event|2
7582903|NCT02109562|26375835|P1|Overall Study|Adverse Event|0
7582904|NCT02109562|26375833|P3|Overall Study|Insufficient clinical response|4
7582905|NCT02109562|26375834|P2|Overall Study|Insufficient clinical response|0
7582906|NCT02109562|26375835|P1|Overall Study|Insufficient clinical response|2
7582907|NCT02109484|26375862|P8|Overall Study|Moved away from study area|1
7582908|NCT02109484|26375863|P7|Overall Study|Moved away from study area|1
7582909|NCT02109484|26375864|P6|Overall Study|Moved away from study area|0
7582910|NCT02109484|26375865|P5|Overall Study|Moved away from study area|0
7582911|NCT02109484|26375866|P4|Overall Study|Moved away from study area|0
7582912|NCT02109484|26375867|P3|Overall Study|Moved away from study area|0
7582913|NCT02109484|26375868|P2|Overall Study|Moved away from study area|0
7582914|NCT02109484|26375869|P1|Overall Study|Moved away from study area|0
7582915|NCT02109484|26375862|P8|Overall Study|Death|2
7582916|NCT02109484|26375863|P7|Overall Study|Death|0
7582917|NCT02109484|26375864|P6|Overall Study|Death|0
7582918|NCT02109484|26375865|P5|Overall Study|Death|0
7582919|NCT02109484|26375866|P4|Overall Study|Death|0
7582920|NCT02109484|26375867|P3|Overall Study|Death|0
7582921|NCT02109484|26375868|P2|Overall Study|Death|0
7582922|NCT02109484|26375869|P1|Overall Study|Death|0
7582923|NCT02109484|26375862|P8|Overall Study|Physician Decision|0
7582924|NCT02109484|26375863|P7|Overall Study|Physician Decision|0
7582925|NCT02109484|26375864|P6|Overall Study|Physician Decision|0
7582926|NCT02109484|26375865|P5|Overall Study|Physician Decision|2
7582927|NCT02109484|26375866|P4|Overall Study|Physician Decision|0
7582928|NCT02109484|26375867|P3|Overall Study|Physician Decision|0
7582929|NCT02109484|26375868|P2|Overall Study|Physician Decision|0
7582930|NCT02109484|26375869|P1|Overall Study|Physician Decision|0
7582931|NCT02109484|26375862|P8|Overall Study|Withdrawal by Subject|0
7582932|NCT02109484|26375863|P7|Overall Study|Withdrawal by Subject|1
7582933|NCT02109484|26375864|P6|Overall Study|Withdrawal by Subject|1
7582934|NCT02109484|26375865|P5|Overall Study|Withdrawal by Subject|1
7582935|NCT02109484|26375866|P4|Overall Study|Withdrawal by Subject|0
7582936|NCT02109484|26375867|P3|Overall Study|Withdrawal by Subject|0
7582937|NCT02109484|26375868|P2|Overall Study|Withdrawal by Subject|0
7582938|NCT02109484|26375869|P1|Overall Study|Withdrawal by Subject|0
7582939|NCT02109484|26375862|P8|Overall Study|Lost to Follow-up|0
7582940|NCT02109484|26375863|P7|Overall Study|Lost to Follow-up|1
7582941|NCT02109484|26375864|P6|Overall Study|Lost to Follow-up|0
7582942|NCT02109484|26375865|P5|Overall Study|Lost to Follow-up|1
7582943|NCT02109484|26375866|P4|Overall Study|Lost to Follow-up|1
7582944|NCT02109484|26375867|P3|Overall Study|Lost to Follow-up|0
7582945|NCT02109484|26375868|P2|Overall Study|Lost to Follow-up|0
7582946|NCT02109484|26375869|P1|Overall Study|Lost to Follow-up|0
7582947|NCT02109445|26375925|P1|Overall Study|Adverse Event|1
7582948|NCT02109445|26375925|P1|Overall Study|Symptomatic deterioration|2
7582949|NCT02109432|26375958|P1|Overall Study|Withdrawal by Subject|1
7582950|NCT02109172|26375968|P6|Overall Study|Death|0
7582951|NCT02109172|26375969|P5|Overall Study|Death|1
7582952|NCT02109172|26375970|P4|Overall Study|Death|0
7582953|NCT02109172|26375971|P3|Overall Study|Death|0
7582954|NCT02109172|26375972|P2|Overall Study|Death|0
7582955|NCT02109172|26375973|P1|Overall Study|Death|0
7582956|NCT02109172|26375968|P6|Overall Study|Adverse Event|1
7582957|NCT02109172|26375969|P5|Overall Study|Adverse Event|0
7582958|NCT02109172|26375970|P4|Overall Study|Adverse Event|0
7582959|NCT02109172|26375971|P3|Overall Study|Adverse Event|1
7582960|NCT02109172|26375972|P2|Overall Study|Adverse Event|0
7582961|NCT02109172|26375973|P1|Overall Study|Adverse Event|0
7582962|NCT02109172|26375968|P6|Overall Study|Withdrawal by Subject|0
7582963|NCT02109172|26375969|P5|Overall Study|Withdrawal by Subject|0
7582964|NCT02109172|26375970|P4|Overall Study|Withdrawal by Subject|1
7582965|NCT02109172|26375971|P3|Overall Study|Withdrawal by Subject|0
7582966|NCT02109172|26375972|P2|Overall Study|Withdrawal by Subject|0
7582967|NCT02109172|26375973|P1|Overall Study|Withdrawal by Subject|1
7582968|NCT02109133|26375994|P2|Overall Study|Lost to Follow-up|0
7582969|NCT02109133|26375995|P1|Overall Study|Lost to Follow-up|1
7582970|NCT02109107|26376007|P1|Overall Study|Lost to Follow-up|2
7582971|NCT02109042|26376014|P1|Overall Study|Sponsor Decision|15
7582972|NCT02109029|26376023|P6|Part B|Adverse Event|1
7582973|NCT02109029|26376024|P5|Part B|Adverse Event|1
7582974|NCT02109029|26376025|P4|Part B|Adverse Event|0
7582975|NCT02109029|26376026|P3|Part B|Adverse Event|0
7582976|NCT02109029|26376027|P2|Part B|Adverse Event|0
7582977|NCT02109029|26376028|P1|Part B|Adverse Event|0
7582978|NCT02108964|26376065|P8|Overall Study|Subject/Guardian decision|1
7582979|NCT02108964|26376066|P7|Overall Study|Subject/Guardian decision|1
7582980|NCT02108964|26376067|P6|Overall Study|Subject/Guardian decision|0
7582981|NCT02108964|26376068|P5|Overall Study|Subject/Guardian decision|2
7582982|NCT02108964|26376069|P4|Overall Study|Subject/Guardian decision|0
7582983|NCT02108964|26376070|P3|Overall Study|Subject/Guardian decision|3
7582984|NCT02108964|26376071|P2|Overall Study|Subject/Guardian decision|1
7582985|NCT02108964|26376072|P1|Overall Study|Subject/Guardian decision|0
7582986|NCT02108964|26376065|P8|Overall Study|Death|1
7582987|NCT02108964|26376066|P7|Overall Study|Death|0
7582988|NCT02108964|26376067|P6|Overall Study|Death|0
7582989|NCT02108964|26376068|P5|Overall Study|Death|3
7582990|NCT02108964|26376069|P4|Overall Study|Death|0
7582991|NCT02108964|26376070|P3|Overall Study|Death|2
7582992|NCT02108964|26376071|P2|Overall Study|Death|1
7582993|NCT02108964|26376072|P1|Overall Study|Death|1
7582994|NCT02108964|26376065|P8|Overall Study|Adverse Event|1
7582995|NCT02108964|26376066|P7|Overall Study|Adverse Event|3
7582996|NCT02108964|26376067|P6|Overall Study|Adverse Event|0
7582997|NCT02108964|26376068|P5|Overall Study|Adverse Event|1
7582998|NCT02108964|26376069|P4|Overall Study|Adverse Event|0
7582999|NCT02108964|26376070|P3|Overall Study|Adverse Event|4
7583000|NCT02108964|26376071|P2|Overall Study|Adverse Event|0
7583001|NCT02108964|26376072|P1|Overall Study|Adverse Event|0
7583002|NCT02108964|26376065|P8|Overall Study|Physician Decision|0
7583003|NCT02108964|26376066|P7|Overall Study|Physician Decision|0
7583004|NCT02108964|26376067|P6|Overall Study|Physician Decision|0
7583005|NCT02108964|26376068|P5|Overall Study|Physician Decision|1
7583006|NCT02108964|26376069|P4|Overall Study|Physician Decision|0
7583007|NCT02108964|26376070|P3|Overall Study|Physician Decision|6
7583008|NCT02108964|26376071|P2|Overall Study|Physician Decision|5
7583009|NCT02108964|26376072|P1|Overall Study|Physician Decision|1
7583010|NCT02108964|26376065|P8|Overall Study|Progressive disease|9
7583011|NCT02108964|26376066|P7|Overall Study|Progressive disease|7
7583012|NCT02108964|26376067|P6|Overall Study|Progressive disease|5
7583013|NCT02108964|26376068|P5|Overall Study|Progressive disease|18
7583014|NCT02108964|26376069|P4|Overall Study|Progressive disease|6
7583015|NCT02108964|26376070|P3|Overall Study|Progressive disease|50
7583016|NCT02108964|26376071|P2|Overall Study|Progressive disease|25
7583017|NCT02108964|26376072|P1|Overall Study|Progressive disease|12
7583018|NCT02108951|26376091|P1|Overall Study|Study Terminated by Sponsor|14
7583019|NCT02108951|26376091|P1|Overall Study|Patient's/guardian's decision|1
7583020|NCT02108951|26376091|P1|Overall Study|Lost to Follow-up|1
7583021|NCT02108912|26376110|P2|Overall Study|high blood pressure|0
7583022|NCT02108912|26376111|P1|Overall Study|high blood pressure|1
7583023|NCT02108912|26376110|P2|Overall Study|lack of transportation|0
7583024|NCT02108912|26376111|P1|Overall Study|lack of transportation|1
7583025|NCT02108912|26376110|P2|Overall Study|Lost to Follow-up|1
7583026|NCT02108912|26376111|P1|Overall Study|Lost to Follow-up|1
7583031|NCT02108600|26376169|P2|Overall Study|Lost to Follow-up|1
7583032|NCT02108600|26376170|P1|Overall Study|Lost to Follow-up|1
7583033|NCT02108600|26376169|P2|Overall Study|Withdrawal by Subject|0
7583034|NCT02108600|26376170|P1|Overall Study|Withdrawal by Subject|2
7583035|NCT02108262|26376228|P4|Overall Study|Missed IV due to pharmacy error|0
7583036|NCT02108262|26376229|P3|Overall Study|Missed IV due to pharmacy error|1
7583037|NCT02108262|26376230|P2|Overall Study|Missed IV due to pharmacy error|0
7583038|NCT02108262|26376231|P1|Overall Study|Missed IV due to pharmacy error|0
7583039|NCT02108262|26376228|P4|Overall Study|Patient decision|14
7583040|NCT02108262|26376229|P3|Overall Study|Patient decision|9
7583041|NCT02108262|26376230|P2|Overall Study|Patient decision|7
7583042|NCT02108262|26376231|P1|Overall Study|Patient decision|0
7583043|NCT02108262|26376228|P4|Overall Study|Vacation|0
7583044|NCT02108262|26376229|P3|Overall Study|Vacation|0
7583045|NCT02108262|26376230|P2|Overall Study|Vacation|1
7583046|NCT02108262|26376231|P1|Overall Study|Vacation|0
7583047|NCT02108262|26376228|P4|Overall Study|Patient did not want another infusion|2
7583048|NCT02108262|26376229|P3|Overall Study|Patient did not want another infusion|3
7583049|NCT02108262|26376230|P2|Overall Study|Patient did not want another infusion|3
7583050|NCT02108262|26376231|P1|Overall Study|Patient did not want another infusion|0
7583051|NCT02108262|26376228|P4|Overall Study|Patient unable to come to site/attend visit|6
7583052|NCT02108262|26376229|P3|Overall Study|Patient unable to come to site/attend visit|11
7583053|NCT02108262|26376230|P2|Overall Study|Patient unable to come to site/attend visit|6
7583054|NCT02108262|26376231|P1|Overall Study|Patient unable to come to site/attend visit|0
7583055|NCT02108262|26376228|P4|Overall Study|Unable to contact patient|2
7583056|NCT02108262|26376229|P3|Overall Study|Unable to contact patient|1
7583057|NCT02108262|26376230|P2|Overall Study|Unable to contact patient|3
7583058|NCT02108262|26376231|P1|Overall Study|Unable to contact patient|0
7583059|NCT02108262|26376228|P4|Overall Study|Due to key hepatic values|0
7583060|NCT02108262|26376229|P3|Overall Study|Due to key hepatic values|0
7583061|NCT02108262|26376230|P2|Overall Study|Due to key hepatic values|1
7583062|NCT02108262|26376231|P1|Overall Study|Due to key hepatic values|0
7583063|NCT02108262|26376228|P4|Overall Study|Withdrawal by Subject|4
7583064|NCT02108262|26376229|P3|Overall Study|Withdrawal by Subject|3
7583065|NCT02108262|26376230|P2|Overall Study|Withdrawal by Subject|7
7583066|NCT02108262|26376231|P1|Overall Study|Withdrawal by Subject|0
7583067|NCT02108262|26376228|P4|Overall Study|Physician Decision|0
7583068|NCT02108262|26376229|P3|Overall Study|Physician Decision|2
7583069|NCT02108262|26376230|P2|Overall Study|Physician Decision|0
7583070|NCT02108262|26376231|P1|Overall Study|Physician Decision|0
7583071|NCT02108262|26376228|P4|Overall Study|Lost to Follow-up|0
7583072|NCT02108262|26376229|P3|Overall Study|Lost to Follow-up|1
7583073|NCT02108262|26376230|P2|Overall Study|Lost to Follow-up|0
7583074|NCT02108262|26376231|P1|Overall Study|Lost to Follow-up|0
7583075|NCT02108262|26376228|P4|Overall Study|Death|1
7583076|NCT02108262|26376229|P3|Overall Study|Death|2
7583077|NCT02108262|26376230|P2|Overall Study|Death|2
7583078|NCT02108262|26376231|P1|Overall Study|Death|0
7583079|NCT02108262|26376228|P4|Overall Study|Adverse Event|12
7583080|NCT02108262|26376229|P3|Overall Study|Adverse Event|6
7583081|NCT02108262|26376230|P2|Overall Study|Adverse Event|11
7583082|NCT02108262|26376231|P1|Overall Study|Adverse Event|0
7583083|NCT02108262|26376228|P4|Overall Study|Distance to center|0
7583084|NCT02108262|26376229|P3|Overall Study|Distance to center|1
7583085|NCT02108262|26376230|P2|Overall Study|Distance to center|1
7583086|NCT02108262|26376231|P1|Overall Study|Distance to center|0
7583087|NCT02108262|26376228|P4|Overall Study|Randomized by error/screen failure|0
7583088|NCT02108262|26376229|P3|Overall Study|Randomized by error/screen failure|1
7583089|NCT02108262|26376230|P2|Overall Study|Randomized by error/screen failure|0
7583090|NCT02108262|26376231|P1|Overall Study|Randomized by error/screen failure|0
7583091|NCT02108262|26376228|P4|Overall Study|Non-compliance|1
7583092|NCT02108262|26376229|P3|Overall Study|Non-compliance|1
7583093|NCT02108262|26376230|P2|Overall Study|Non-compliance|2
7583094|NCT02108262|26376231|P1|Overall Study|Non-compliance|0
7583095|NCT02107898|26376556|P2|Overall Study|Randomized but not treated|1
7583096|NCT02107898|26376557|P1|Overall Study|Randomized but not treated|0
7583097|NCT02107898|26376556|P2|Overall Study|Consent withdrawn by participant|1
7583098|NCT02107898|26376557|P1|Overall Study|Consent withdrawn by participant|2
7583099|NCT02107898|26376556|P2|Overall Study|Participant moved|2
7583100|NCT02107898|26376557|P1|Overall Study|Participant moved|0
7583101|NCT02107898|26376556|P2|Overall Study|Poor compliance to protocol|1
7583102|NCT02107898|26376557|P1|Overall Study|Poor compliance to protocol|0
7583103|NCT02107898|26376556|P2|Overall Study|Adverse Event|7
7583104|NCT02107898|26376557|P1|Overall Study|Adverse Event|4
7583105|NCT02107859|26376609|P1|Overall Study|Other than specified|3
7583106|NCT02107859|26376609|P1|Overall Study|Study closure|41
7583107|NCT02107859|26376609|P1|Overall Study|Adverse Event|3
7583108|NCT02107859|26376609|P1|Overall Study|Withdrawal by Subject|14
7583109|NCT02107703|26376625|P2|Overall Study|On study treatment/follow up|152
7583110|NCT02107703|26376626|P1|Overall Study|On study treatment/follow up|319
7583111|NCT02107703|26376625|P2|Overall Study|Lost to Follow-up|4
7583112|NCT02107703|26376626|P1|Overall Study|Lost to Follow-up|6
7583113|NCT02107703|26376625|P2|Overall Study|Withdrawal by Subject|19
7583114|NCT02107703|26376626|P1|Overall Study|Withdrawal by Subject|36
7583115|NCT02107482|26376658|P1|Overall Study|Lack of Efficacy|1
7583116|NCT02107482|26376658|P1|Overall Study|Lost to Follow-up|1
7583117|NCT02107482|26376658|P1|Overall Study|inconveinence|2
7583118|NCT02107443|26376666|P2|Overall Study|Withdrawal: Personal Issues|3
7583119|NCT02107443|26376667|P1|Overall Study|Withdrawal: Personal Issues|0
7583120|NCT02107443|26376666|P2|Overall Study|Withdrawal: Disease Progression|2
7583121|NCT02107443|26376667|P1|Overall Study|Withdrawal: Disease Progression|4
7583122|NCT02107443|26376666|P2|Overall Study|Withdrawal: Other Medical|5
7583123|NCT02107443|26376667|P1|Overall Study|Withdrawal: Other Medical|9
7583124|NCT02107443|26376666|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
7583125|NCT02107443|26376667|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
7583126|NCT02107443|26376666|P2|Overall Study|Withdrawal: Too Time Consuming|6
7583127|NCT02107443|26376667|P1|Overall Study|Withdrawal: Too Time Consuming|3
7583128|NCT02107443|26376666|P2|Overall Study|Withdrawal: Too Many Forms|1
7583129|NCT02107443|26376667|P1|Overall Study|Withdrawal: Too Many Forms|3
7583130|NCT02107443|26376666|P2|Overall Study|Withdrawal: Changed MD/Facility|3
7583131|NCT02107443|26376667|P1|Overall Study|Withdrawal: Changed MD/Facility|1
7583132|NCT02107443|26376666|P2|Overall Study|Withdrawal: Changed Mind|0
7583133|NCT02107443|26376667|P1|Overall Study|Withdrawal: Changed Mind|2
7583134|NCT02107443|26376666|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
7583135|NCT02107443|26376667|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
7583136|NCT02107443|26376666|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
7583137|NCT02107443|26376667|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
7583138|NCT02107443|26376666|P2|Overall Study|Registered but Not Eligible|1
7583139|NCT02107443|26376667|P1|Overall Study|Registered but Not Eligible|0
7583140|NCT02107443|26376666|P2|Overall Study|Study Protocol Violation|1
7583141|NCT02107443|26376667|P1|Overall Study|Study Protocol Violation|3
7583142|NCT02107443|26376666|P2|Overall Study|Death|30
7583143|NCT02107443|26376667|P1|Overall Study|Death|42
7583144|NCT02107313|26376720|P2|Overall Study|One participant did not do the FED cohor|1
7583145|NCT02107313|26376721|P1|Overall Study|One participant did not do the FED cohor|0
7583146|NCT02107274|26376742|P2|Control Phase|Adverse Event|1
7583147|NCT02107274|26376743|P1|Control Phase|Adverse Event|0
7583148|NCT02107274|26376742|P2|Control Phase|Death|0
7583149|NCT02107274|26376743|P1|Control Phase|Death|2
7583150|NCT02107274|26376742|P2|Control Phase|Lost to Follow-up|1
7583151|NCT02107274|26376743|P1|Control Phase|Lost to Follow-up|1
7583152|NCT02107274|26376742|P2|Treatment vs. Placebo|Lost to Follow-up|2
7583153|NCT02107274|26376743|P1|Treatment vs. Placebo|Lost to Follow-up|0
7583154|NCT02107274|26376742|P2|Treatment vs. Placebo|Adverse Event|0
7583155|NCT02107274|26376743|P1|Treatment vs. Placebo|Adverse Event|3
7583156|NCT02107196|26376757|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
7583157|NCT02107196|26376758|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
7583158|NCT02107196|26376757|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
7583159|NCT02107196|26376758|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
7583160|NCT02107196|26376757|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7583161|NCT02107196|26376758|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7583162|NCT02107196|26376757|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
7583163|NCT02107196|26376758|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
7583164|NCT02107196|26376757|P2|12-week Treatment Period|Reason Missing|8
7583165|NCT02107196|26376758|P1|12-week Treatment Period|Reason Missing|11
7583166|NCT02107196|26376757|P2|12-week Treatment Period|Protocol Violation|8
7583167|NCT02107196|26376758|P1|12-week Treatment Period|Protocol Violation|7
7583168|NCT02107196|26376757|P2|12-week Treatment Period|Withdrawal by Subject|12
7583169|NCT02107196|26376758|P1|12-week Treatment Period|Withdrawal by Subject|15
7583170|NCT02107196|26376757|P2|12-week Treatment Period|Physician Decision|1
7583171|NCT02107196|26376758|P1|12-week Treatment Period|Physician Decision|0
7583172|NCT02107196|26376757|P2|12-week Treatment Period|Lost to Follow-up|6
7583173|NCT02107196|26376758|P1|12-week Treatment Period|Lost to Follow-up|3
7583174|NCT02107196|26376757|P2|12-week Treatment Period|Lack of Efficacy|1
7583175|NCT02107196|26376758|P1|12-week Treatment Period|Lack of Efficacy|2
7583176|NCT02107196|26376757|P2|12-week Treatment Period|Adverse Event|3
7583177|NCT02107196|26376758|P1|12-week Treatment Period|Adverse Event|6
7583178|NCT02107131|26376786|P2|Overall Study|Protocol Violation|4
7583179|NCT02107131|26376787|P1|Overall Study|Protocol Violation|0
7583180|NCT02107131|26376786|P2|Overall Study|Death|1
7583181|NCT02107131|26376787|P1|Overall Study|Death|0
7583182|NCT02107131|26376786|P2|Overall Study|mental instability|0
7583183|NCT02107131|26376787|P1|Overall Study|mental instability|1
7583184|NCT02107131|26376786|P2|Overall Study|Withdrawal by Subject|0
7583185|NCT02107131|26376787|P1|Overall Study|Withdrawal by Subject|2
7583186|NCT02107131|26376786|P2|Overall Study|Physician Decision|0
7583187|NCT02107131|26376787|P1|Overall Study|Physician Decision|1
7583188|NCT02107131|26376786|P2|Overall Study|Lost to Follow-up|4
7583189|NCT02107131|26376787|P1|Overall Study|Lost to Follow-up|4
7583190|NCT02107092|26376799|P1|Overall Study|Expected progression of CKD|12
7583191|NCT02107092|26376799|P1|Overall Study|Adverse Event|7
7583192|NCT02107092|26376799|P1|Overall Study|Withdrawal by Subject|9
7583193|NCT02107092|26376799|P1|Overall Study|Lost to Follow-up|2
7583194|NCT02107092|26376799|P1|Overall Study|Physician Decision|3
7583195|NCT02107092|26376799|P1|Overall Study|Met ECG withdrawal criteria|3
7583196|NCT02107092|26376799|P1|Overall Study|Hypo-or hyperkalemia|2
7583197|NCT02107092|26376799|P1|Overall Study|Subject compliance|3
7583198|NCT02107092|26376799|P1|Overall Study|Miscellaneous|3
7583199|NCT02107014|26376804|P1|Overall Study|Withdrew before drug: moving interstate|1
7583200|NCT02106975|26376874|P2|Overall Study|Death|39
7583201|NCT02106975|26376875|P1|Overall Study|Death|25
7583202|NCT02106923|26376935|P6|Overall Study|Protocol Violation|1
7583203|NCT02106923|26376936|P5|Overall Study|Protocol Violation|0
7583204|NCT02106923|26376937|P4|Overall Study|Protocol Violation|0
7583205|NCT02106923|26376938|P3|Overall Study|Protocol Violation|0
7583206|NCT02106923|26376939|P2|Overall Study|Protocol Violation|0
7583207|NCT02106923|26376940|P1|Overall Study|Protocol Violation|0
7583208|NCT02106910|26376986|P2|Overall Study|Lost to Follow-up|1
7583209|NCT02106910|26376987|P1|Overall Study|Lost to Follow-up|1
7583210|NCT02106884|26377003|P2|Overall Study|Change of diagnosis/exclusion|1
7583211|NCT02106884|26377004|P1|Overall Study|Change of diagnosis/exclusion|0
7583212|NCT02106832|26377028|P4|Overall Study|Technical problems|0
7583213|NCT02106832|26377029|P3|Overall Study|Technical problems|0
7583214|NCT02106832|26377030|P2|Overall Study|Technical problems|1
7583215|NCT02106832|26377031|P1|Overall Study|Technical problems|0
7583216|NCT02106832|26377028|P4|Overall Study|Withdrawal by Subject|7
7583217|NCT02106832|26377029|P3|Overall Study|Withdrawal by Subject|10
7583218|NCT02106832|26377030|P2|Overall Study|Withdrawal by Subject|17
7583219|NCT02106832|26377031|P1|Overall Study|Withdrawal by Subject|17
7583220|NCT02106832|26377028|P4|Overall Study|Protocol Violation|1
7583221|NCT02106832|26377029|P3|Overall Study|Protocol Violation|0
7583222|NCT02106832|26377030|P2|Overall Study|Protocol Violation|0
7583223|NCT02106832|26377031|P1|Overall Study|Protocol Violation|0
7583224|NCT02106832|26377028|P4|Overall Study|Physician Decision|0
7583225|NCT02106832|26377029|P3|Overall Study|Physician Decision|0
7583226|NCT02106832|26377030|P2|Overall Study|Physician Decision|0
7583227|NCT02106832|26377031|P1|Overall Study|Physician Decision|1
7583228|NCT02106832|26377028|P4|Overall Study|Lost to Follow-up|3
7583229|NCT02106832|26377029|P3|Overall Study|Lost to Follow-up|1
7583230|NCT02106832|26377030|P2|Overall Study|Lost to Follow-up|1
7583231|NCT02106832|26377031|P1|Overall Study|Lost to Follow-up|0
7583232|NCT02106832|26377028|P4|Overall Study|Deterioration of general conditions|0
7583233|NCT02106832|26377029|P3|Overall Study|Deterioration of general conditions|1
7583234|NCT02106832|26377030|P2|Overall Study|Deterioration of general conditions|0
7583235|NCT02106832|26377031|P1|Overall Study|Deterioration of general conditions|0
7583236|NCT02106832|26377028|P4|Overall Study|Death|4
7583237|NCT02106832|26377029|P3|Overall Study|Death|1
7583238|NCT02106832|26377030|P2|Overall Study|Death|4
7583239|NCT02106832|26377031|P1|Overall Study|Death|4
7583240|NCT02106832|26377028|P4|Overall Study|Adverse Event|0
7583241|NCT02106832|26377029|P3|Overall Study|Adverse Event|3
7583242|NCT02106832|26377030|P2|Overall Study|Adverse Event|2
7583243|NCT02106832|26377031|P1|Overall Study|Adverse Event|1
7583244|NCT02106455|26377098|P1|Overall Study|Protocol Deviation|2
7583245|NCT02106455|26377098|P1|Overall Study|Case Report Form Uncollected|6
7583246|NCT02106442|26377112|P1|Overall Study|Protocol Deviation|30
7583247|NCT02106442|26377112|P1|Overall Study|Case Report Forms Uncollected|7
7583248|NCT02106403|26377130|P6|Follow-Up Visit 3|Other Reason|1
7583249|NCT02106403|26377131|P5|Follow-Up Visit 3|Other Reason|0
7583250|NCT02106403|26377132|P4|Follow-Up Visit 3|Other Reason|0
7583251|NCT02106403|26377133|P3|Follow-Up Visit 3|Other Reason|0
7583252|NCT02106403|26377134|P2|Follow-Up Visit 3|Other Reason|0
7583253|NCT02106403|26377135|P1|Follow-Up Visit 3|Other Reason|0
7583254|NCT02106390|26377158|P3|Overall Study|Protocol Violation|0
7583255|NCT02106390|26377159|P2|Overall Study|Protocol Violation|1
7583256|NCT02106390|26377160|P1|Overall Study|Protocol Violation|0
7583257|NCT02106390|26377158|P3|Overall Study|Adverse Event|1
7583258|NCT02106390|26377159|P2|Overall Study|Adverse Event|2
7583259|NCT02106390|26377160|P1|Overall Study|Adverse Event|0
7583260|NCT02106390|26377158|P3|Overall Study|Other: Unspecified|2
7583261|NCT02106390|26377159|P2|Overall Study|Other: Unspecified|4
7583262|NCT02106390|26377160|P1|Overall Study|Other: Unspecified|1
7583263|NCT02106390|26377158|P3|Overall Study|Other: Administrative Reason|12
7583264|NCT02106390|26377159|P2|Overall Study|Other: Administrative Reason|5
7583265|NCT02106390|26377160|P1|Overall Study|Other: Administrative Reason|8
7583266|NCT02106390|26377158|P3|Overall Study|Lost to Follow-up|13
7583267|NCT02106390|26377159|P2|Overall Study|Lost to Follow-up|20
7583268|NCT02106390|26377160|P1|Overall Study|Lost to Follow-up|25
7583269|NCT02106390|26377158|P3|Overall Study|Withdrawal by Subject|15
7583270|NCT02106390|26377159|P2|Overall Study|Withdrawal by Subject|16
7583271|NCT02106390|26377160|P1|Overall Study|Withdrawal by Subject|15
7583272|NCT02106351|26377237|P3|Treatment Cycle 4|Other|0
7583273|NCT02106351|26377238|P2|Treatment Cycle 4|Other|1
7583274|NCT02106351|26377239|P1|Treatment Cycle 4|Other|0
7583275|NCT02106351|26377237|P3|Treatment Cycle 4|Consent withdrawn|2
7583276|NCT02106351|26377238|P2|Treatment Cycle 4|Consent withdrawn|0
7583277|NCT02106351|26377239|P1|Treatment Cycle 4|Consent withdrawn|0
7583278|NCT02106351|26377237|P3|Treatment Cycle 3|Other|3
7583279|NCT02106351|26377238|P2|Treatment Cycle 3|Other|2
7583280|NCT02106351|26377239|P1|Treatment Cycle 3|Other|0
7583281|NCT02106351|26377237|P3|Treatment Cycle 3|Lost to Follow-up|0
7583282|NCT02106351|26377238|P2|Treatment Cycle 3|Lost to Follow-up|1
7583283|NCT02106351|26377239|P1|Treatment Cycle 3|Lost to Follow-up|0
7583284|NCT02106351|26377237|P3|Treatment Cycle 3|Consent withdrawn|2
7583285|NCT02106351|26377238|P2|Treatment Cycle 3|Consent withdrawn|0
7583286|NCT02106351|26377239|P1|Treatment Cycle 3|Consent withdrawn|0
7583287|NCT02106351|26377237|P3|Treatment Cycle 3|Adverse Event|0
7583288|NCT02106351|26377238|P2|Treatment Cycle 3|Adverse Event|1
7583289|NCT02106351|26377239|P1|Treatment Cycle 3|Adverse Event|0
7583290|NCT02106351|26377237|P3|Treatment Cycle 2|Other|2
7583291|NCT02106351|26377238|P2|Treatment Cycle 2|Other|2
7583292|NCT02106351|26377239|P1|Treatment Cycle 2|Other|0
7583293|NCT02106351|26377237|P3|Treatment Cycle 2|Consent withdrawn|1
7583294|NCT02106351|26377238|P2|Treatment Cycle 2|Consent withdrawn|1
7583295|NCT02106351|26377239|P1|Treatment Cycle 2|Consent withdrawn|0
7583296|NCT02106351|26377237|P3|Treatment Cycle 2|Adverse Event|0
7583297|NCT02106351|26377238|P2|Treatment Cycle 2|Adverse Event|2
7583298|NCT02106351|26377239|P1|Treatment Cycle 2|Adverse Event|0
7583299|NCT02106351|26377237|P3|Treatment Cycle 1|Randomised but not treated|1
7583300|NCT02106351|26377238|P2|Treatment Cycle 1|Randomised but not treated|0
7583301|NCT02106351|26377239|P1|Treatment Cycle 1|Randomised but not treated|1
7583302|NCT02106351|26377237|P3|Treatment Cycle 1|Other|1
7583303|NCT02106351|26377238|P2|Treatment Cycle 1|Other|3
7583304|NCT02106351|26377239|P1|Treatment Cycle 1|Other|0
7583305|NCT02106351|26377237|P3|Treatment Cycle 1|Lost to Follow-up|0
7583306|NCT02106351|26377238|P2|Treatment Cycle 1|Lost to Follow-up|0
7583307|NCT02106351|26377239|P1|Treatment Cycle 1|Lost to Follow-up|1
7583308|NCT02106351|26377237|P3|Treatment Cycle 1|Consent withdrawn|2
7583309|NCT02106351|26377238|P2|Treatment Cycle 1|Consent withdrawn|0
7583310|NCT02106351|26377239|P1|Treatment Cycle 1|Consent withdrawn|1
7583311|NCT02106351|26377237|P3|Treatment Cycle 1|Adverse Event|0
7583312|NCT02106351|26377238|P2|Treatment Cycle 1|Adverse Event|0
7583313|NCT02106351|26377239|P1|Treatment Cycle 1|Adverse Event|2
7583314|NCT02106325|26377282|P2|Phase 3|Lost to Follow-up|1
7583315|NCT02106325|26377283|P1|Phase 3|Lost to Follow-up|2
7583316|NCT02106325|26377282|P2|Phase 2|Lost to Follow-up|3
7583317|NCT02106325|26377283|P1|Phase 2|Lost to Follow-up|2
7583318|NCT02106325|26377282|P2|Phase 1|Lost to Follow-up|2
7583319|NCT02106325|26377283|P1|Phase 1|Lost to Follow-up|2
7583320|NCT02106195|26377305|P1|Overall Study|Protocol Violation|1
7583321|NCT02106195|26377305|P1|Overall Study|Adverse Event|2
7583322|NCT02106156|26377324|P3|Overall Study|Relocation/Change of Physician|0
7583323|NCT02106156|26377325|P2|Overall Study|Relocation/Change of Physician|1
7583324|NCT02106156|26377326|P1|Overall Study|Relocation/Change of Physician|40
7583325|NCT02106156|26377324|P3|Overall Study|Hospitalization/Surgical Intervention|0
7583326|NCT02106156|26377325|P2|Overall Study|Hospitalization/Surgical Intervention|0
7583327|NCT02106156|26377326|P1|Overall Study|Hospitalization/Surgical Intervention|6
7583328|NCT02106156|26377324|P3|Overall Study|Change of Laboratory Parameter|0
7583329|NCT02106156|26377325|P2|Overall Study|Change of Laboratory Parameter|0
7583330|NCT02106156|26377326|P1|Overall Study|Change of Laboratory Parameter|10
7583331|NCT02106156|26377324|P3|Overall Study|Unplanned Event|0
7583332|NCT02106156|26377325|P2|Overall Study|Unplanned Event|2
7583333|NCT02106156|26377326|P1|Overall Study|Unplanned Event|82
7583334|NCT02106156|26377324|P3|Overall Study|Lost to Follow-up|0
7583335|NCT02106156|26377325|P2|Overall Study|Lost to Follow-up|8
7583336|NCT02106156|26377326|P1|Overall Study|Lost to Follow-up|451
7583337|NCT02106156|26377324|P3|Overall Study|Patients Request|0
7583338|NCT02106156|26377325|P2|Overall Study|Patients Request|9
7583339|NCT02106156|26377326|P1|Overall Study|Patients Request|307
7583340|NCT02106156|26377324|P3|Overall Study|Lack of Compliance|0
7583341|NCT02106156|26377325|P2|Overall Study|Lack of Compliance|7
7583342|NCT02106156|26377326|P1|Overall Study|Lack of Compliance|211
7583343|NCT02106156|26377324|P3|Overall Study|Concomitant Disease|0
7583344|NCT02106156|26377325|P2|Overall Study|Concomitant Disease|2
7583345|NCT02106156|26377326|P1|Overall Study|Concomitant Disease|74
7583346|NCT02106156|26377324|P3|Overall Study|Lack of Virological Response|0
7583347|NCT02106156|26377325|P2|Overall Study|Lack of Virological Response|8
7583348|NCT02106156|26377326|P1|Overall Study|Lack of Virological Response|1044
7583349|NCT02106156|26377324|P3|Overall Study|Lack of Tolerability|0
7583350|NCT02106156|26377325|P2|Overall Study|Lack of Tolerability|3
7583351|NCT02106156|26377326|P1|Overall Study|Lack of Tolerability|305
7583352|NCT02106156|26377324|P3|Overall Study|Patient Died|0
7583353|NCT02106156|26377325|P2|Overall Study|Patient Died|0
7583354|NCT02106156|26377326|P1|Overall Study|Patient Died|19
7583355|NCT02105987|26377372|P6|Continuation Phase|Protocol Violation|0
7583356|NCT02105987|26377373|P5|Continuation Phase|Protocol Violation|1
7583357|NCT02105987|26377374|P4|Continuation Phase|Protocol Violation|0
7583358|NCT02105987|26377375|P3|Continuation Phase|Protocol Violation|0
7583359|NCT02105987|26377376|P2|Continuation Phase|Protocol Violation|0
7583360|NCT02105987|26377377|P1|Continuation Phase|Protocol Violation|0
7583361|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
7583362|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
7583363|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
7583364|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
7583365|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
7583366|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
7583367|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7583368|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7583369|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
7583370|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7583371|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7583372|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7583373|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
7583374|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
7583375|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
7583376|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
7583377|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
7583378|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
7583379|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7583380|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7583381|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
7583382|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
7583383|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7583384|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7583385|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583386|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583387|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
7583388|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
7583389|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583390|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583391|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
7583392|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
7583393|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
7583394|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
7583395|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
7583396|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
7583397|NCT02105987|26377372|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
7583398|NCT02105987|26377373|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
7583399|NCT02105987|26377374|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
7583400|NCT02105987|26377375|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
7583401|NCT02105987|26377376|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
7583402|NCT02105987|26377377|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
7583403|NCT02105987|26377372|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7583404|NCT02105987|26377373|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7583405|NCT02105987|26377374|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7583406|NCT02105987|26377375|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7583407|NCT02105987|26377376|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
7583408|NCT02105987|26377377|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7583409|NCT02105987|26377372|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
7583410|NCT02105987|26377373|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
7583411|NCT02105987|26377374|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
7583412|NCT02105987|26377375|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
7583413|NCT02105987|26377376|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
7583414|NCT02105987|26377377|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
7583415|NCT02105987|26377372|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7583416|NCT02105987|26377373|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7583417|NCT02105987|26377374|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7583418|NCT02105987|26377375|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7583419|NCT02105987|26377376|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7583420|NCT02105987|26377377|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7583421|NCT02105987|26377372|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583422|NCT02105987|26377373|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583423|NCT02105987|26377374|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583424|NCT02105987|26377375|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7583425|NCT02105987|26377376|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
7583426|NCT02105987|26377377|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
7583427|NCT02105987|26377372|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
7583428|NCT02105987|26377373|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
7583429|NCT02105987|26377374|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
7583430|NCT02105987|26377375|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
7583431|NCT02105987|26377376|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
7583432|NCT02105987|26377377|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
7583433|NCT02105987|26377372|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
7583434|NCT02105987|26377373|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
7583435|NCT02105987|26377374|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
7583436|NCT02105987|26377375|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
7583437|NCT02105987|26377376|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
7583438|NCT02105987|26377377|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
7583439|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
7583440|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
7583441|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
7583442|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
7583443|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
7583444|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
7583445|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
7583446|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7583447|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7583448|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
7583449|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
7583450|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
7583451|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
7583452|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
7583453|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
7583454|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
7583455|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
7583456|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
7583457|NCT02105974|26377431|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
7583458|NCT02105974|26377432|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
7583459|NCT02105974|26377433|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
7583460|NCT02105974|26377431|P3|2 Week Run-in Period|Investigator discretion|0
7583461|NCT02105974|26377432|P2|2 Week Run-in Period|Investigator discretion|0
7583462|NCT02105974|26377433|P1|2 Week Run-in Period|Investigator discretion|8
7583463|NCT02105974|26377431|P3|2 Week Run-in Period|Withdrew consent|0
7583464|NCT02105974|26377432|P2|2 Week Run-in Period|Withdrew consent|0
7583465|NCT02105974|26377433|P1|2 Week Run-in Period|Withdrew consent|23
7583466|NCT02105974|26377431|P3|2 Week Run-in Period|Lost to Follow-up|0
7583467|NCT02105974|26377432|P2|2 Week Run-in Period|Lost to Follow-up|0
7583468|NCT02105974|26377433|P1|2 Week Run-in Period|Lost to Follow-up|2
7583469|NCT02105974|26377431|P3|2 Week Run-in Period|Study closed/terminated|0
7583470|NCT02105974|26377432|P2|2 Week Run-in Period|Study closed/terminated|0
7583471|NCT02105974|26377433|P1|2 Week Run-in Period|Study closed/terminated|1
7583472|NCT02105974|26377431|P3|2 Week Run-in Period|Adverse Event|0
7583473|NCT02105974|26377432|P2|2 Week Run-in Period|Adverse Event|0
7583474|NCT02105974|26377433|P1|2 Week Run-in Period|Adverse Event|6
7583475|NCT02105974|26377431|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7583476|NCT02105974|26377432|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7583477|NCT02105974|26377433|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
7583478|NCT02105974|26377431|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
7583479|NCT02105974|26377432|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
7583480|NCT02105974|26377433|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
7583481|NCT02105961|26377446|P3|Overall Study|Withdrawal by Subject|11
7583482|NCT02105961|26377447|P2|Overall Study|Withdrawal by Subject|7
7583483|NCT02105961|26377448|P1|Overall Study|Withdrawal by Subject|15
7583484|NCT02105961|26377446|P3|Overall Study|Physician Decision|2
7583485|NCT02105961|26377447|P2|Overall Study|Physician Decision|3
7583486|NCT02105961|26377448|P1|Overall Study|Physician Decision|3
7583487|NCT02105961|26377446|P3|Overall Study|Lost to Follow-up|1
7583488|NCT02105961|26377447|P2|Overall Study|Lost to Follow-up|0
7583489|NCT02105961|26377448|P1|Overall Study|Lost to Follow-up|2
7583490|NCT02105961|26377446|P3|Overall Study|Lack of Efficacy|3
7583491|NCT02105961|26377447|P2|Overall Study|Lack of Efficacy|0
7583492|NCT02105961|26377448|P1|Overall Study|Lack of Efficacy|3
7583493|NCT02105961|26377446|P3|Overall Study|Adverse Event|13
7583494|NCT02105961|26377447|P2|Overall Study|Adverse Event|7
7583495|NCT02105961|26377448|P1|Overall Study|Adverse Event|18
7583496|NCT02105948|26377472|P4|Overall Study|Withdrawal by Subject|11
7583497|NCT02105948|26377473|P3|Overall Study|Withdrawal by Subject|10
7583498|NCT02105948|26377474|P2|Overall Study|Withdrawal by Subject|10
7583499|NCT02105948|26377475|P1|Overall Study|Withdrawal by Subject|15
7583500|NCT02105948|26377472|P4|Overall Study|Physician Decision|2
7583501|NCT02105948|26377473|P3|Overall Study|Physician Decision|2
7583502|NCT02105948|26377474|P2|Overall Study|Physician Decision|2
7583503|NCT02105948|26377475|P1|Overall Study|Physician Decision|2
7583504|NCT02105948|26377472|P4|Overall Study|Lost to Follow-up|1
7583505|NCT02105948|26377473|P3|Overall Study|Lost to Follow-up|2
7583506|NCT02105948|26377474|P2|Overall Study|Lost to Follow-up|0
7583507|NCT02105948|26377475|P1|Overall Study|Lost to Follow-up|0
7583508|NCT02105948|26377472|P4|Overall Study|Lack of Efficacy|2
7583509|NCT02105948|26377473|P3|Overall Study|Lack of Efficacy|3
7583510|NCT02105948|26377474|P2|Overall Study|Lack of Efficacy|1
7583511|NCT02105948|26377475|P1|Overall Study|Lack of Efficacy|0
7583512|NCT02105948|26377472|P4|Overall Study|Adverse Event|11
7583513|NCT02105948|26377473|P3|Overall Study|Adverse Event|11
7583514|NCT02105948|26377474|P2|Overall Study|Adverse Event|7
7583515|NCT02105948|26377475|P1|Overall Study|Adverse Event|10
7583516|NCT02105701|26377516|P4|Overall Study|Death|0
7583517|NCT02105701|26377517|P3|Overall Study|Death|0
7583518|NCT02105701|26377518|P2|Overall Study|Death|0
7583519|NCT02105701|26377519|P1|Overall Study|Death|1
7583520|NCT02105701|26377516|P4|Overall Study|Withdrawal by Subject|1
7583521|NCT02105701|26377517|P3|Overall Study|Withdrawal by Subject|0
7583522|NCT02105701|26377518|P2|Overall Study|Withdrawal by Subject|1
7583523|NCT02105701|26377519|P1|Overall Study|Withdrawal by Subject|2
7583524|NCT02105701|26377516|P4|Overall Study|Protocol Violation|0
7583525|NCT02105701|26377517|P3|Overall Study|Protocol Violation|1
7583526|NCT02105701|26377518|P2|Overall Study|Protocol Violation|0
7583527|NCT02105701|26377519|P1|Overall Study|Protocol Violation|0
7583528|NCT02105701|26377516|P4|Overall Study|Lost to Follow-up|1
7583529|NCT02105701|26377517|P3|Overall Study|Lost to Follow-up|2
7583530|NCT02105701|26377518|P2|Overall Study|Lost to Follow-up|0
7583531|NCT02105701|26377519|P1|Overall Study|Lost to Follow-up|1
7583532|NCT02105688|26377543|P2|Part B: Observational Follow-up|Physician Decision|1
7583533|NCT02105688|26377544|P1|Part B: Observational Follow-up|Physician Decision|3
7583534|NCT02105688|26377543|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
7583535|NCT02105688|26377544|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
7583536|NCT02105688|26377543|P2|Part B: Observational Follow-up|Lost to Follow-up|15
7583537|NCT02105688|26377544|P1|Part B: Observational Follow-up|Lost to Follow-up|23
7583538|NCT02105688|26377543|P2|Part B: Observational Follow-up|Death|1
7583539|NCT02105688|26377544|P1|Part B: Observational Follow-up|Death|2
7583540|NCT02105688|26377543|P2|Part A: Double-Blind|Withdrawal by Subject|2
7583541|NCT02105688|26377544|P1|Part A: Double-Blind|Withdrawal by Subject|4
7583542|NCT02105688|26377543|P2|Part A: Double-Blind|Status Unknown|2
7583543|NCT02105688|26377544|P1|Part A: Double-Blind|Status Unknown|0
7583544|NCT02105688|26377543|P2|Part A: Double-Blind|Physician Decision|1
7583545|NCT02105688|26377544|P1|Part A: Double-Blind|Physician Decision|0
7583546|NCT02105688|26377543|P2|Part A: Double-Blind|Lost to Follow-up|11
7583547|NCT02105688|26377544|P1|Part A: Double-Blind|Lost to Follow-up|15
7583548|NCT02105688|26377543|P2|Part A: Double-Blind|Death|1
7583549|NCT02105688|26377544|P1|Part A: Double-Blind|Death|0
7583550|NCT02105688|26377543|P2|Part A: Double-Blind|Adverse Event|0
7583551|NCT02105688|26377544|P1|Part A: Double-Blind|Adverse Event|1
7583552|NCT02105662|26377557|P1|Overall Study|Withdrawal by Subject|1
7583553|NCT02105662|26377557|P1|Overall Study|Lost to Follow-up|5
7583554|NCT02105636|26377566|P2|Overall Study|Not Reported|0
7583555|NCT02105636|26377567|P1|Overall Study|Not Reported|3
7583556|NCT02105636|26377566|P2|Overall Study|Reason Not Specified|2
7583557|NCT02105636|26377567|P1|Overall Study|Reason Not Specified|0
7583558|NCT02105636|26377566|P2|Overall Study|Poor/Non-compliance|1
7583559|NCT02105636|26377567|P1|Overall Study|Poor/Non-compliance|0
7583560|NCT02105636|26377566|P2|Overall Study|Maximum Clinical Benefit|1
7583561|NCT02105636|26377567|P1|Overall Study|Maximum Clinical Benefit|1
7583562|NCT02105636|26377566|P2|Overall Study|Subject Withdrew Consent|1
7583563|NCT02105636|26377567|P1|Overall Study|Subject Withdrew Consent|4
7583564|NCT02105636|26377566|P2|Overall Study|Subject Request to Discontinue Treatment|6
7583565|NCT02105636|26377567|P1|Overall Study|Subject Request to Discontinue Treatment|4
7583566|NCT02105636|26377566|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
7583567|NCT02105636|26377567|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
7583568|NCT02105636|26377566|P2|Overall Study|Study Drug Toxicity|11
7583569|NCT02105636|26377567|P1|Overall Study|Study Drug Toxicity|9
7583570|NCT02105636|26377566|P2|Overall Study|Disease Progression|83
7583571|NCT02105636|26377567|P1|Overall Study|Disease Progression|162
7583572|NCT02105467|26377610|P2|Period 3|Lost to Follow-up|1
7583573|NCT02105467|26377611|P1|Period 3|Lost to Follow-up|0
7583574|NCT02105467|26377610|P2|Period 2|Withdrawal by Subject|2
7583575|NCT02105467|26377611|P1|Period 2|Withdrawal by Subject|0
7583576|NCT02105467|26377610|P2|Period 2|Death|0
7583577|NCT02105467|26377611|P1|Period 2|Death|1
7583578|NCT02105467|26377610|P2|Period 2|Lost to Follow-up|0
7583579|NCT02105467|26377611|P1|Period 2|Lost to Follow-up|1
7583580|NCT02105467|26377610|P2|Period 1|Death|0
7583581|NCT02105467|26377611|P1|Period 1|Death|1
7583582|NCT02105467|26377610|P2|Period 1|Lost to Follow-up|0
7583583|NCT02105467|26377611|P1|Period 1|Lost to Follow-up|1
7583584|NCT02105454|26377623|P1|Overall Study|Withdrawal by Subject|1
7583585|NCT02105285|26377735|P3|Overall Study|Withdrawal by Subject|0
7583586|NCT02105285|26377736|P2|Overall Study|Withdrawal by Subject|0
7583587|NCT02105285|26377737|P1|Overall Study|Withdrawal by Subject|1
7583588|NCT02105285|26377735|P3|Overall Study|Protocol Violation|0
7583589|NCT02105285|26377736|P2|Overall Study|Protocol Violation|1
7583590|NCT02105285|26377737|P1|Overall Study|Protocol Violation|0
7583591|NCT02105285|26377735|P3|Overall Study|Adverse Event|0
7583592|NCT02105285|26377736|P2|Overall Study|Adverse Event|1
7583593|NCT02105285|26377737|P1|Overall Study|Adverse Event|1
7583594|NCT02105272|26377756|P2|Overall Study|Withdrawal by Subject|0
7583595|NCT02105272|26377757|P1|Overall Study|Withdrawal by Subject|2
7583596|NCT02105272|26377756|P2|Overall Study|Protocol Violation|0
7583597|NCT02105272|26377757|P1|Overall Study|Protocol Violation|2
7583598|NCT02105272|26377756|P2|Overall Study|Physician Decision|1
7583599|NCT02105272|26377757|P1|Overall Study|Physician Decision|0
7583600|NCT02105272|26377756|P2|Overall Study|Adverse Event|2
7583601|NCT02105272|26377757|P1|Overall Study|Adverse Event|1
7583602|NCT02105116|26377786|P1|Overall Study|Death|1
7583603|NCT02105116|26377786|P1|Overall Study|not eligible for step 2 of trial|5
7583604|NCT02105012|26377793|P1|Overall Study|Lack of Efficacy|1
7583605|NCT02105012|26377793|P1|Overall Study|Adverse Event|1
7583606|NCT02105012|26377793|P1|Overall Study|Physician Decision|3
7583607|NCT02105012|26377793|P1|Overall Study|Protocol Violation|4
7583608|NCT02105012|26377793|P1|Overall Study|Lost to Follow-up|4
7583609|NCT02105012|26377793|P1|Overall Study|Protocol Specified Criteria|9
7583610|NCT02105012|26377793|P1|Overall Study|Withdrawal by Subject|11
7583611|NCT02104947|26377827|P2|Overall Study|Other than stated above|3
7583612|NCT02104947|26377828|P1|Overall Study|Other than stated above|2
7583613|NCT02104947|26377827|P2|Overall Study|Adverse Event|38
7583614|NCT02104947|26377828|P1|Overall Study|Adverse Event|57
7583615|NCT02104947|26377827|P2|Overall Study|Protocol Violation|8
7583616|NCT02104947|26377828|P1|Overall Study|Protocol Violation|6
7583617|NCT02104947|26377827|P2|Overall Study|Lost to Follow-up|4
7583618|NCT02104947|26377828|P1|Overall Study|Lost to Follow-up|4
7583619|NCT02104947|26377827|P2|Overall Study|Withdrawal by Subject|3
7583620|NCT02104947|26377828|P1|Overall Study|Withdrawal by Subject|10
7583621|NCT02104895|26377846|P2|Overall Study|Withdrawal by Subject|14
7583622|NCT02104895|26377847|P1|Overall Study|Withdrawal by Subject|0
7583623|NCT02104817|26377887|P2|Overall Study|Other reasons|135
7583624|NCT02104817|26377888|P1|Overall Study|Other reasons|128
7583625|NCT02104817|26377887|P2|Overall Study|Withdrawal by Subject|78
7583626|NCT02104817|26377888|P1|Overall Study|Withdrawal by Subject|111
7583627|NCT02104817|26377887|P2|Overall Study|Study terminated by sponsor|5901
7583628|NCT02104817|26377888|P1|Overall Study|Study terminated by sponsor|5854
7583629|NCT02104817|26377887|P2|Overall Study|Protocol Violation|1
7583630|NCT02104817|26377888|P1|Overall Study|Protocol Violation|0
7583631|NCT02104817|26377887|P2|Overall Study|Lost to Follow-up|2
7583632|NCT02104817|26377888|P1|Overall Study|Lost to Follow-up|3
7583633|NCT02104817|26377887|P2|Overall Study|Death|330
7583634|NCT02104817|26377888|P1|Overall Study|Death|363
7583635|NCT02104804|26377922|P2|Overall Study|Withdrawal by Subject|12
7583636|NCT02104804|26377923|P1|Overall Study|Withdrawal by Subject|4
7583637|NCT02104804|26377922|P2|Overall Study|Adverse Event|3
7583638|NCT02104804|26377923|P1|Overall Study|Adverse Event|4
7583639|NCT02104804|26377922|P2|Overall Study|Protocol Violation|1
7583640|NCT02104804|26377923|P1|Overall Study|Protocol Violation|0
7583641|NCT02104804|26377922|P2|Overall Study|Other listed|1
7583642|NCT02104804|26377923|P1|Overall Study|Other listed|2
7583643|NCT02104804|26377922|P2|Overall Study|Study specific discontinuation criteria|1
7583644|NCT02104804|26377923|P1|Overall Study|Study specific discontinuation criteria|6
7583645|NCT02104804|26377922|P2|Overall Study|Did not take study medication|1
7583646|NCT02104804|26377923|P1|Overall Study|Did not take study medication|0
7583647|NCT02104765|26377946|P7|Overall Study|Withdrawal by Subject|1
7583648|NCT02104765|26377947|P6|Overall Study|Withdrawal by Subject|0
7583649|NCT02104765|26377948|P5|Overall Study|Withdrawal by Subject|1
7583650|NCT02104765|26377949|P4|Overall Study|Withdrawal by Subject|1
7583651|NCT02104765|26377950|P3|Overall Study|Withdrawal by Subject|0
7583652|NCT02104765|26377951|P2|Overall Study|Withdrawal by Subject|0
7583653|NCT02104765|26377952|P1|Overall Study|Withdrawal by Subject|0
7583654|NCT02104765|26377946|P7|Overall Study|Lost to Follow-up|0
7583655|NCT02104765|26377947|P6|Overall Study|Lost to Follow-up|0
7583656|NCT02104765|26377948|P5|Overall Study|Lost to Follow-up|0
7583657|NCT02104765|26377949|P4|Overall Study|Lost to Follow-up|0
7583658|NCT02104765|26377950|P3|Overall Study|Lost to Follow-up|1
7583659|NCT02104765|26377951|P2|Overall Study|Lost to Follow-up|0
7583660|NCT02104765|26377952|P1|Overall Study|Lost to Follow-up|0
7583661|NCT02104752|26377980|P2|Overall Study|Weight gain; unrelated anxiety|2
7583662|NCT02104752|26377981|P1|Overall Study|Weight gain; unrelated anxiety|0
7583663|NCT02104752|26377980|P2|Overall Study|Withdrawal by Subject|0
7583664|NCT02104752|26377981|P1|Overall Study|Withdrawal by Subject|1
7583665|NCT02104583|26378064|P5|Overall Study|Randomized but Never Treated|0
7583666|NCT02104583|26378065|P4|Overall Study|Randomized but Never Treated|1
7583667|NCT02104583|26378066|P3|Overall Study|Randomized but Never Treated|0
7583668|NCT02104583|26378067|P2|Overall Study|Randomized but Never Treated|0
7583669|NCT02104583|26378068|P1|Overall Study|Randomized but Never Treated|0
7583670|NCT02104583|26378064|P5|Overall Study|Lost to Follow-up|0
7583671|NCT02104583|26378065|P4|Overall Study|Lost to Follow-up|0
7583672|NCT02104583|26378066|P3|Overall Study|Lost to Follow-up|0
7583673|NCT02104583|26378067|P2|Overall Study|Lost to Follow-up|0
7583674|NCT02104583|26378068|P1|Overall Study|Lost to Follow-up|1
7583675|NCT02104583|26378064|P5|Overall Study|Adverse Event|1
7583676|NCT02104583|26378065|P4|Overall Study|Adverse Event|6
7583677|NCT02104583|26378066|P3|Overall Study|Adverse Event|6
7583678|NCT02104583|26378067|P2|Overall Study|Adverse Event|3
7583679|NCT02104583|26378068|P1|Overall Study|Adverse Event|3
7583680|NCT02104583|26378064|P5|Overall Study|Protocol Violation|0
7583681|NCT02104583|26378065|P4|Overall Study|Protocol Violation|0
7583682|NCT02104583|26378066|P3|Overall Study|Protocol Violation|1
7583683|NCT02104583|26378067|P2|Overall Study|Protocol Violation|0
7583684|NCT02104583|26378068|P1|Overall Study|Protocol Violation|0
7583685|NCT02104583|26378064|P5|Overall Study|Investigator's Discretion|0
7583686|NCT02104583|26378065|P4|Overall Study|Investigator's Discretion|0
7583687|NCT02104583|26378066|P3|Overall Study|Investigator's Discretion|0
7583688|NCT02104583|26378067|P2|Overall Study|Investigator's Discretion|0
7583689|NCT02104583|26378068|P1|Overall Study|Investigator's Discretion|1
7583690|NCT02104583|26378064|P5|Overall Study|Withdrew Consent|1
7583691|NCT02104583|26378065|P4|Overall Study|Withdrew Consent|2
7583692|NCT02104583|26378066|P3|Overall Study|Withdrew Consent|0
7583693|NCT02104583|26378067|P2|Overall Study|Withdrew Consent|2
7583694|NCT02104583|26378068|P1|Overall Study|Withdrew Consent|3
7583695|NCT02104583|26378064|P5|Overall Study|Subject required prohibited medication|1
7583696|NCT02104583|26378065|P4|Overall Study|Subject required prohibited medication|0
7583697|NCT02104583|26378066|P3|Overall Study|Subject required prohibited medication|1
7583698|NCT02104583|26378067|P2|Overall Study|Subject required prohibited medication|1
7583699|NCT02104583|26378068|P1|Overall Study|Subject required prohibited medication|0
7583700|NCT02104583|26378064|P5|Overall Study|Subject required cardiac ablation|4
7583701|NCT02104583|26378065|P4|Overall Study|Subject required cardiac ablation|5
7583702|NCT02104583|26378066|P3|Overall Study|Subject required cardiac ablation|4
7583703|NCT02104583|26378067|P2|Overall Study|Subject required cardiac ablation|4
7583704|NCT02104583|26378068|P1|Overall Study|Subject required cardiac ablation|6
7583705|NCT02104583|26378064|P5|Overall Study|Death|5
7583706|NCT02104583|26378065|P4|Overall Study|Death|3
7583707|NCT02104583|26378066|P3|Overall Study|Death|3
7583708|NCT02104583|26378067|P2|Overall Study|Death|1
7583709|NCT02104583|26378068|P1|Overall Study|Death|2
7583710|NCT02104583|26378064|P5|Overall Study|New ICD or CRT-D implanted|0
7583711|NCT02104583|26378065|P4|Overall Study|New ICD or CRT-D implanted|0
7583712|NCT02104583|26378066|P3|Overall Study|New ICD or CRT-D implanted|1
7583713|NCT02104583|26378067|P2|Overall Study|New ICD or CRT-D implanted|0
7583714|NCT02104583|26378068|P1|Overall Study|New ICD or CRT-D implanted|2
7583715|NCT02104557|26378129|P1|Overall Study|Discontinuation of contraception|9
7583716|NCT02104557|26378129|P1|Overall Study|Refusal of administration due to unknown reasons|69
7583717|NCT02104557|26378129|P1|Overall Study|Withdrawal consent|2
7583718|NCT02104557|26378129|P1|Overall Study|Discontinuation due to no pain|1
7583719|NCT02104557|26378129|P1|Overall Study|Change to other contraception methods|5
7583720|NCT02104557|26378129|P1|Overall Study|Other|17
7583721|NCT02104557|26378129|P1|Overall Study|Administered Sayana prior to the contract|1
7583722|NCT02104557|26378129|P1|Overall Study|No longer met inclusion/exclusion criteria|1
7583723|NCT02104557|26378129|P1|Overall Study|Violated the usage and dosage|14
7583724|NCT02104557|26378129|P1|Overall Study|Lost to Follow-up|34
7583725|NCT02104557|26378129|P1|Overall Study|Adverse Event|24
7583726|NCT02104505|26378144|P2|Second Intervention (14 Days)|Adverse Event|0
7583727|NCT02104505|26378145|P1|Second Intervention (14 Days)|Adverse Event|2
7583728|NCT02104505|26378144|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
7583729|NCT02104505|26378145|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
7583730|NCT02104505|26378144|P2|First Intervention (14 Days)|exclusionary condition|1
7583731|NCT02104505|26378145|P1|First Intervention (14 Days)|exclusionary condition|0
7583732|NCT02104505|26378144|P2|First Intervention (14 Days)|Lost to Follow-up|1
7583733|NCT02104505|26378145|P1|First Intervention (14 Days)|Lost to Follow-up|0
7583734|NCT02104505|26378144|P2|First Intervention (14 Days)|Withdrawal by Subject|1
7583735|NCT02104505|26378145|P1|First Intervention (14 Days)|Withdrawal by Subject|0
7583736|NCT02104505|26378144|P2|First Intervention (14 Days)|Adverse Event|0
7583737|NCT02104505|26378145|P1|First Intervention (14 Days)|Adverse Event|2
7583738|NCT02104180|26378217|P2|Overall Study|Protocol Violation|0
7583739|NCT02104180|26378218|P1|Overall Study|Protocol Violation|1
7583740|NCT02103478|26378259|P9|Overall Study|Other|2
7583741|NCT02103478|26378260|P8|Overall Study|Other|4
7583742|NCT02103478|26378261|P7|Overall Study|Other|8
7583743|NCT02103478|26378262|P6|Overall Study|Other|8
7583744|NCT02103478|26378263|P5|Overall Study|Other|3
7583745|NCT02103478|26378264|P4|Overall Study|Other|0
7583746|NCT02103478|26378265|P3|Overall Study|Other|2
7583747|NCT02103478|26378266|P2|Overall Study|Other|3
7583748|NCT02103478|26378267|P1|Overall Study|Other|1
7583749|NCT02103478|26378259|P9|Overall Study|Lost to Follow-up|0
7583750|NCT02103478|26378260|P8|Overall Study|Lost to Follow-up|1
7583751|NCT02103478|26378261|P7|Overall Study|Lost to Follow-up|0
7583752|NCT02103478|26378262|P6|Overall Study|Lost to Follow-up|0
7583753|NCT02103478|26378263|P5|Overall Study|Lost to Follow-up|0
7583754|NCT02103478|26378264|P4|Overall Study|Lost to Follow-up|0
7583755|NCT02103478|26378265|P3|Overall Study|Lost to Follow-up|0
7583756|NCT02103478|26378266|P2|Overall Study|Lost to Follow-up|0
7583757|NCT02103478|26378267|P1|Overall Study|Lost to Follow-up|0
7583758|NCT02103478|26378259|P9|Overall Study|Withdrawal by Subject|0
7583759|NCT02103478|26378260|P8|Overall Study|Withdrawal by Subject|1
7583760|NCT02103478|26378261|P7|Overall Study|Withdrawal by Subject|1
7583761|NCT02103478|26378262|P6|Overall Study|Withdrawal by Subject|0
7583762|NCT02103478|26378263|P5|Overall Study|Withdrawal by Subject|0
7583763|NCT02103478|26378264|P4|Overall Study|Withdrawal by Subject|4
7583764|NCT02103478|26378265|P3|Overall Study|Withdrawal by Subject|0
7583765|NCT02103478|26378266|P2|Overall Study|Withdrawal by Subject|0
7583766|NCT02103478|26378267|P1|Overall Study|Withdrawal by Subject|2
7583767|NCT02103478|26378259|P9|Overall Study|Progressive Disease|1
7583768|NCT02103478|26378260|P8|Overall Study|Progressive Disease|0
7583769|NCT02103478|26378261|P7|Overall Study|Progressive Disease|2
7583770|NCT02103478|26378262|P6|Overall Study|Progressive Disease|1
7583771|NCT02103478|26378263|P5|Overall Study|Progressive Disease|9
7583772|NCT02103478|26378264|P4|Overall Study|Progressive Disease|0
7583773|NCT02103478|26378265|P3|Overall Study|Progressive Disease|2
7583774|NCT02103478|26378266|P2|Overall Study|Progressive Disease|1
7583775|NCT02103478|26378267|P1|Overall Study|Progressive Disease|2
7583776|NCT02103478|26378259|P9|Overall Study|Death|11
7583777|NCT02103478|26378260|P8|Overall Study|Death|10
7583778|NCT02103478|26378261|P7|Overall Study|Death|14
7583779|NCT02103478|26378262|P6|Overall Study|Death|15
7583780|NCT02103478|26378263|P5|Overall Study|Death|5
7583781|NCT02103478|26378264|P4|Overall Study|Death|1
7583782|NCT02103478|26378265|P3|Overall Study|Death|1
7583783|NCT02103478|26378266|P2|Overall Study|Death|2
7583784|NCT02103478|26378267|P1|Overall Study|Death|2
7583785|NCT02103478|26378259|P9|Overall Study|Adverse Event|0
7583786|NCT02103478|26378260|P8|Overall Study|Adverse Event|0
7583787|NCT02103478|26378261|P7|Overall Study|Adverse Event|0
7583788|NCT02103478|26378262|P6|Overall Study|Adverse Event|1
7583789|NCT02103478|26378263|P5|Overall Study|Adverse Event|2
7583790|NCT02103478|26378264|P4|Overall Study|Adverse Event|1
7583791|NCT02103478|26378265|P3|Overall Study|Adverse Event|1
7583792|NCT02103478|26378266|P2|Overall Study|Adverse Event|0
7583793|NCT02103478|26378267|P1|Overall Study|Adverse Event|0
7583794|NCT02103439|26378376|P2|Overall Study|Withdrawal by Subject|1
7583795|NCT02103439|26378377|P1|Overall Study|Withdrawal by Subject|3
7583796|NCT02103439|26378376|P2|Overall Study|Adverse Event|2
7583797|NCT02103439|26378377|P1|Overall Study|Adverse Event|0
7583798|NCT02103062|26378551|P2|Overall Study|Death|1
7583799|NCT02103062|26378552|P1|Overall Study|Death|0
7583800|NCT02103062|26378551|P2|Overall Study|Progressive Disease|20
7583801|NCT02103062|26378552|P1|Overall Study|Progressive Disease|17
7583802|NCT02103062|26378551|P2|Overall Study|Adverse Event|2
7583803|NCT02103062|26378552|P1|Overall Study|Adverse Event|1
7583804|NCT02102724|26378645|P2|Overall Study|surgery for brain aneurysm|1
7583805|NCT02102724|26378646|P1|Overall Study|surgery for brain aneurysm|1
7583806|NCT02102724|26378645|P2|Overall Study|Lost to Follow-up|0
7583807|NCT02102724|26378646|P1|Overall Study|Lost to Follow-up|1
7583808|NCT02102490|26378652|P1|Overall Study|Lost to Follow-up|1
7583809|NCT02102490|26378652|P1|Overall Study|Death|6
7583810|NCT02102464|26378666|P3|Randomized Study|Withdrawal by Subject|0
7583811|NCT02102464|26378667|P2|Randomized Study|Withdrawal by Subject|1
7583812|NCT02102464|26378668|P1|Randomized Study|Withdrawal by Subject|0
7583813|NCT02102399|26378687|P2|Overall Study|Withdrawal by Subject|4
7583814|NCT02102399|26378688|P1|Overall Study|Withdrawal by Subject|6
7583815|NCT02102204|26378758|P1|Overall Study|Ongoing|5
7583816|NCT02102204|26378758|P1|Overall Study|Sponsor Decision|5
7583817|NCT02102204|26378758|P1|Overall Study|Lost to Follow-up|65
7583818|NCT02102204|26378758|P1|Overall Study|Death|92
7583819|NCT02102204|26378758|P1|Overall Study|Withdrawal by Subject|137
7583820|NCT02101983|26378778|P2|Overall Study|Physician Decision|0
7583821|NCT02101983|26378779|P1|Overall Study|Physician Decision|1
7583822|NCT02101554|26378825|P3|Overall Study|Withdrawl by Parents/Guardians|0
7583823|NCT02101554|26378826|P2|Overall Study|Withdrawl by Parents/Guardians|0
7583824|NCT02101554|26378827|P1|Overall Study|Withdrawl by Parents/Guardians|1
7583825|NCT02101554|26378825|P3|Overall Study|Lost to Follow-up|0
7583826|NCT02101554|26378826|P2|Overall Study|Lost to Follow-up|1
7583827|NCT02101554|26378827|P1|Overall Study|Lost to Follow-up|0
7583828|NCT02101554|26378825|P3|Overall Study|Adverse Event|1
7583829|NCT02101554|26378826|P2|Overall Study|Adverse Event|1
7583830|NCT02101554|26378827|P1|Overall Study|Adverse Event|2
7583831|NCT02101554|26378825|P3|Overall Study|Insufficient Clinical Response|0
7583832|NCT02101554|26378826|P2|Overall Study|Insufficient Clinical Response|2
7583833|NCT02101554|26378827|P1|Overall Study|Insufficient Clinical Response|0
7583834|NCT02101554|26378825|P3|Overall Study|Protocol Violation|0
7583835|NCT02101554|26378826|P2|Overall Study|Protocol Violation|1
7583836|NCT02101554|26378827|P1|Overall Study|Protocol Violation|0
7583837|NCT02101359|26378980|P2|Overall Study|Protocol Violation|2
7583838|NCT02101359|26378981|P1|Overall Study|Protocol Violation|0
7583839|NCT02101359|26378980|P2|Overall Study|Lost to Follow-up|0
7583840|NCT02101359|26378981|P1|Overall Study|Lost to Follow-up|1
7583841|NCT02101359|26378980|P2|Overall Study|Withdrawal by Subject|4
7583842|NCT02101359|26378981|P1|Overall Study|Withdrawal by Subject|5
7583843|NCT02101359|26378980|P2|Overall Study|Not included|13
7583844|NCT02101359|26378981|P1|Overall Study|Not included|23
7583845|NCT02101294|26378987|P1|Overall Study|Lost to Follow-up|6
7583846|NCT02101294|26378987|P1|Overall Study|Withdrawal by Subject|5
7583847|NCT02101281|26378996|P2|Overall Study|Adverse Event|1
7583848|NCT02101281|26378997|P1|Overall Study|Adverse Event|0
7583849|NCT02101112|26379050|P6|Overall Study|Withdrawal by Subject|0
7583850|NCT02101112|26379051|P5|Overall Study|Withdrawal by Subject|1
7583851|NCT02101112|26379052|P4|Overall Study|Withdrawal by Subject|0
7583852|NCT02101112|26379053|P3|Overall Study|Withdrawal by Subject|0
7583853|NCT02101112|26379054|P2|Overall Study|Withdrawal by Subject|0
7583854|NCT02101112|26379055|P1|Overall Study|Withdrawal by Subject|0
7583855|NCT02101112|26379050|P6|Overall Study|Adverse Event|0
7583856|NCT02101112|26379051|P5|Overall Study|Adverse Event|0
7583857|NCT02101112|26379052|P4|Overall Study|Adverse Event|0
7583858|NCT02101112|26379053|P3|Overall Study|Adverse Event|1
7583859|NCT02101112|26379054|P2|Overall Study|Adverse Event|0
7583860|NCT02101112|26379055|P1|Overall Study|Adverse Event|0
7583861|NCT02101060|26379082|P2|Overall Study|Lost to Follow-up|3
7583862|NCT02101060|26379083|P1|Overall Study|Lost to Follow-up|3
7583863|NCT02101060|26379082|P2|Overall Study|Withdrawal by Subject|1
7583864|NCT02101060|26379083|P1|Overall Study|Withdrawal by Subject|1
7583865|NCT02101060|26379082|P2|Overall Study|Adverse Event|0
7583866|NCT02101060|26379083|P1|Overall Study|Adverse Event|1
7583867|NCT02101034|26379098|P5|Overall Study|Enrolled but did not start treatment|0
7583868|NCT02101034|26379099|P4|Overall Study|Enrolled but did not start treatment|0
7583869|NCT02101034|26379100|P3|Overall Study|Enrolled but did not start treatment|1
7583870|NCT02101034|26379101|P2|Overall Study|Enrolled but did not start treatment|0
7583871|NCT02101034|26379102|P1|Overall Study|Enrolled but did not start treatment|0
7583872|NCT02101021|26379133|P5|Overall Study|Study Terminated by Sponsor|1
7583873|NCT02101021|26379134|P4|Overall Study|Study Terminated by Sponsor|1
7583874|NCT02101021|26379135|P3|Overall Study|Study Terminated by Sponsor|1
7583875|NCT02101021|26379136|P2|Overall Study|Study Terminated by Sponsor|0
7583876|NCT02101021|26379137|P1|Overall Study|Study Terminated by Sponsor|1
7583877|NCT02101021|26379133|P5|Overall Study|Lost to Follow-up|0
7583878|NCT02101021|26379134|P4|Overall Study|Lost to Follow-up|0
7583879|NCT02101021|26379135|P3|Overall Study|Lost to Follow-up|0
7583880|NCT02101021|26379136|P2|Overall Study|Lost to Follow-up|0
7583881|NCT02101021|26379137|P1|Overall Study|Lost to Follow-up|1
7583882|NCT02101021|26379133|P5|Overall Study|Withdrew Consent from study|0
7583883|NCT02101021|26379134|P4|Overall Study|Withdrew Consent from study|2
7583884|NCT02101021|26379135|P3|Overall Study|Withdrew Consent from study|0
7583885|NCT02101021|26379136|P2|Overall Study|Withdrew Consent from study|1
7583886|NCT02101021|26379137|P1|Overall Study|Withdrew Consent from study|1
7583887|NCT02101021|26379133|P5|Overall Study|Death|3
7583888|NCT02101021|26379134|P4|Overall Study|Death|0
7583889|NCT02101021|26379135|P3|Overall Study|Death|6
7583890|NCT02101021|26379136|P2|Overall Study|Death|3
7583891|NCT02101021|26379137|P1|Overall Study|Death|4
7583892|NCT02100969|26379184|P1|Overall Study|Did not pass screening phase|1
7583893|NCT02100839|26379203|P2|Multiple Ascending Dose|Withdrawal by Subject|0
7583894|NCT02100839|26379204|P1|Multiple Ascending Dose|Withdrawal by Subject|2
7583895|NCT02100839|26379203|P2|Multiple Ascending Dose|Adverse Event|0
7583896|NCT02100839|26379204|P1|Multiple Ascending Dose|Adverse Event|2
7583897|NCT02100813|26379235|P8|Overall Study|Adverse Event|1
7583898|NCT02100813|26379236|P7|Overall Study|Adverse Event|0
7583899|NCT02100813|26379237|P6|Overall Study|Adverse Event|0
7583900|NCT02100813|26379238|P5|Overall Study|Adverse Event|0
7583901|NCT02100813|26379239|P4|Overall Study|Adverse Event|0
7583902|NCT02100813|26379240|P3|Overall Study|Adverse Event|0
7583903|NCT02100813|26379241|P2|Overall Study|Adverse Event|0
7583904|NCT02100813|26379242|P1|Overall Study|Adverse Event|0
7583905|NCT02100696|26379321|P6|Maintenance Phase|Multiple Reasons|1
7583906|NCT02100696|26379322|P5|Maintenance Phase|Multiple Reasons|2
7583907|NCT02100696|26379323|P4|Maintenance Phase|Multiple Reasons|0
7583908|NCT02100696|26379324|P3|Maintenance Phase|Multiple Reasons|0
7583909|NCT02100696|26379325|P2|Maintenance Phase|Multiple Reasons|0
7583910|NCT02100696|26379326|P1|Maintenance Phase|Multiple Reasons|0
7583911|NCT02100696|26379321|P6|Maintenance Phase|Physician Decision|0
7583912|NCT02100696|26379322|P5|Maintenance Phase|Physician Decision|1
7583913|NCT02100696|26379323|P4|Maintenance Phase|Physician Decision|0
7583914|NCT02100696|26379324|P3|Maintenance Phase|Physician Decision|0
7583915|NCT02100696|26379325|P2|Maintenance Phase|Physician Decision|0
7583916|NCT02100696|26379326|P1|Maintenance Phase|Physician Decision|0
7583917|NCT02100696|26379321|P6|Maintenance Phase|Withdrawal by Subject|2
7583918|NCT02100696|26379322|P5|Maintenance Phase|Withdrawal by Subject|4
7583919|NCT02100696|26379323|P4|Maintenance Phase|Withdrawal by Subject|1
7583920|NCT02100696|26379324|P3|Maintenance Phase|Withdrawal by Subject|0
7583921|NCT02100696|26379325|P2|Maintenance Phase|Withdrawal by Subject|0
7583922|NCT02100696|26379326|P1|Maintenance Phase|Withdrawal by Subject|0
7583923|NCT02100696|26379321|P6|Maintenance Phase|Protocol Violation|0
7583924|NCT02100696|26379322|P5|Maintenance Phase|Protocol Violation|1
7583925|NCT02100696|26379323|P4|Maintenance Phase|Protocol Violation|0
7583926|NCT02100696|26379324|P3|Maintenance Phase|Protocol Violation|0
7583927|NCT02100696|26379325|P2|Maintenance Phase|Protocol Violation|0
7583928|NCT02100696|26379326|P1|Maintenance Phase|Protocol Violation|0
7583929|NCT02100696|26379321|P6|Maintenance Phase|Lost to Follow-up|0
7583930|NCT02100696|26379322|P5|Maintenance Phase|Lost to Follow-up|1
7583931|NCT02100696|26379323|P4|Maintenance Phase|Lost to Follow-up|0
7583932|NCT02100696|26379324|P3|Maintenance Phase|Lost to Follow-up|0
7583933|NCT02100696|26379325|P2|Maintenance Phase|Lost to Follow-up|0
7583934|NCT02100696|26379326|P1|Maintenance Phase|Lost to Follow-up|0
7583935|NCT02100696|26379321|P6|Maintenance Phase|Adverse Event|2
7583936|NCT02100696|26379322|P5|Maintenance Phase|Adverse Event|0
7583937|NCT02100696|26379323|P4|Maintenance Phase|Adverse Event|0
7583938|NCT02100696|26379324|P3|Maintenance Phase|Adverse Event|0
7583939|NCT02100696|26379325|P2|Maintenance Phase|Adverse Event|0
7583940|NCT02100696|26379326|P1|Maintenance Phase|Adverse Event|0
7583941|NCT02100696|26379321|P6|Induction Phase|Multiple Reasons|0
7583942|NCT02100696|26379322|P5|Induction Phase|Multiple Reasons|0
7583943|NCT02100696|26379323|P4|Induction Phase|Multiple Reasons|0
7583944|NCT02100696|26379324|P3|Induction Phase|Multiple Reasons|8
7583945|NCT02100696|26379325|P2|Induction Phase|Multiple Reasons|2
7583946|NCT02100696|26379326|P1|Induction Phase|Multiple Reasons|5
7583947|NCT02100696|26379321|P6|Induction Phase|Physician Decision|0
7583948|NCT02100696|26379322|P5|Induction Phase|Physician Decision|0
7583949|NCT02100696|26379323|P4|Induction Phase|Physician Decision|0
7583950|NCT02100696|26379324|P3|Induction Phase|Physician Decision|2
7583951|NCT02100696|26379325|P2|Induction Phase|Physician Decision|0
7583952|NCT02100696|26379326|P1|Induction Phase|Physician Decision|1
7583953|NCT02100696|26379321|P6|Induction Phase|Withdrawal by Subject|0
7583954|NCT02100696|26379322|P5|Induction Phase|Withdrawal by Subject|0
7583955|NCT02100696|26379323|P4|Induction Phase|Withdrawal by Subject|0
7583956|NCT02100696|26379324|P3|Induction Phase|Withdrawal by Subject|13
7583957|NCT02100696|26379325|P2|Induction Phase|Withdrawal by Subject|2
7583958|NCT02100696|26379326|P1|Induction Phase|Withdrawal by Subject|8
7583959|NCT02100696|26379321|P6|Induction Phase|Protocol Violation|0
7583960|NCT02100696|26379322|P5|Induction Phase|Protocol Violation|0
7583961|NCT02100696|26379323|P4|Induction Phase|Protocol Violation|0
7583962|NCT02100696|26379324|P3|Induction Phase|Protocol Violation|1
7583963|NCT02100696|26379325|P2|Induction Phase|Protocol Violation|1
7583964|NCT02100696|26379326|P1|Induction Phase|Protocol Violation|0
7583965|NCT02100696|26379321|P6|Induction Phase|Lost to Follow-up|0
7583966|NCT02100696|26379322|P5|Induction Phase|Lost to Follow-up|0
7583967|NCT02100696|26379323|P4|Induction Phase|Lost to Follow-up|0
7583968|NCT02100696|26379324|P3|Induction Phase|Lost to Follow-up|1
7583969|NCT02100696|26379325|P2|Induction Phase|Lost to Follow-up|0
7583970|NCT02100696|26379326|P1|Induction Phase|Lost to Follow-up|1
7583971|NCT02100696|26379321|P6|Induction Phase|Adverse Event|0
7583972|NCT02100696|26379322|P5|Induction Phase|Adverse Event|0
7583973|NCT02100696|26379323|P4|Induction Phase|Adverse Event|0
7583974|NCT02100696|26379324|P3|Induction Phase|Adverse Event|1
7583975|NCT02100696|26379325|P2|Induction Phase|Adverse Event|0
7583976|NCT02100696|26379326|P1|Induction Phase|Adverse Event|0
7583977|NCT02100670|26379433|P4|Overall Study|Withdrawal by Subject|0
7583978|NCT02100670|26379434|P3|Overall Study|Withdrawal by Subject|0
7583979|NCT02100670|26379435|P2|Overall Study|Withdrawal by Subject|0
7583980|NCT02100670|26379436|P1|Overall Study|Withdrawal by Subject|1
7583981|NCT02100670|26379433|P4|Overall Study|Physician Decision|0
7583982|NCT02100670|26379434|P3|Overall Study|Physician Decision|0
7583983|NCT02100670|26379435|P2|Overall Study|Physician Decision|1
7583984|NCT02100670|26379436|P1|Overall Study|Physician Decision|0
7583985|NCT02100670|26379433|P4|Overall Study|Poor Efficacy|0
7583986|NCT02100670|26379434|P3|Overall Study|Poor Efficacy|0
7583987|NCT02100670|26379435|P2|Overall Study|Poor Efficacy|1
7583988|NCT02100670|26379436|P1|Overall Study|Poor Efficacy|0
7583989|NCT02100670|26379433|P4|Overall Study|No swelling no pain|0
7583990|NCT02100670|26379434|P3|Overall Study|No swelling no pain|0
7583991|NCT02100670|26379435|P2|Overall Study|No swelling no pain|0
7583992|NCT02100670|26379436|P1|Overall Study|No swelling no pain|1
7583993|NCT02100670|26379433|P4|Overall Study|Withdrawal of Consent|0
7583994|NCT02100670|26379434|P3|Overall Study|Withdrawal of Consent|1
7583995|NCT02100670|26379435|P2|Overall Study|Withdrawal of Consent|1
7583996|NCT02100670|26379436|P1|Overall Study|Withdrawal of Consent|0
7583997|NCT02100670|26379433|P4|Overall Study|Protocol Violation|1
7583998|NCT02100670|26379434|P3|Overall Study|Protocol Violation|0
7583999|NCT02100670|26379435|P2|Overall Study|Protocol Violation|1
7584000|NCT02100670|26379436|P1|Overall Study|Protocol Violation|0
7584001|NCT02100670|26379433|P4|Overall Study|Lost to Follow-up|0
7584002|NCT02100670|26379434|P3|Overall Study|Lost to Follow-up|0
7584003|NCT02100670|26379435|P2|Overall Study|Lost to Follow-up|0
7584004|NCT02100670|26379436|P1|Overall Study|Lost to Follow-up|1
7584005|NCT02100670|26379433|P4|Overall Study|Adverse Event|0
7584006|NCT02100670|26379434|P3|Overall Study|Adverse Event|3
7584007|NCT02100670|26379435|P2|Overall Study|Adverse Event|3
7584008|NCT02100670|26379436|P1|Overall Study|Adverse Event|10
7584009|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Withdrawal by Subject|3
7584010|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7584011|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7584012|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Treatment-related adverse event|3
7584013|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7584014|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7584015|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Never were treated|3
7584016|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Never were treated|0
7584017|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Never were treated|0
7584018|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Physician Decision|1
7584019|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Physician Decision|0
7584020|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Physician Decision|0
7584021|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
7584022|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7584023|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7584024|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Death|1
7584025|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Death|0
7584026|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Death|0
7584027|NCT02100657|26379499|P3|Cohort 3: Dose Level 3|Progressive disease|15
7584028|NCT02100657|26379500|P2|Cohort 3: Dose Level 3|Progressive disease|0
7584029|NCT02100657|26379501|P1|Cohort 3: Dose Level 3|Progressive disease|0
7584030|NCT02100657|26379499|P3|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7584031|NCT02100657|26379500|P2|Cohort 2: Dose Level 2|Treatment-related adverse event|1
7584032|NCT02100657|26379501|P1|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7584033|NCT02100657|26379499|P3|Cohort 2: Dose Level 2|Physician Decision|0
7584034|NCT02100657|26379500|P2|Cohort 2: Dose Level 2|Physician Decision|1
7584035|NCT02100657|26379501|P1|Cohort 2: Dose Level 2|Physician Decision|0
7584036|NCT02100657|26379499|P3|Cohort 2: Dose Level 2|Progressive disease|0
7584037|NCT02100657|26379500|P2|Cohort 2: Dose Level 2|Progressive disease|2
7584038|NCT02100657|26379501|P1|Cohort 2: Dose Level 2|Progressive disease|0
7584039|NCT02100657|26379499|P3|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7584040|NCT02100657|26379500|P2|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7584041|NCT02100657|26379501|P1|Cohort 1: Dose Level 1|Withdrawal by Subject|1
7584042|NCT02100657|26379499|P3|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7584043|NCT02100657|26379500|P2|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7584044|NCT02100657|26379501|P1|Cohort 1: Dose Level 1|Treatment-related adverse event|1
7584045|NCT02100657|26379499|P3|Cohort 1: Dose Level 1|Progressive disease|0
7584046|NCT02100657|26379500|P2|Cohort 1: Dose Level 1|Progressive disease|0
7584047|NCT02100657|26379501|P1|Cohort 1: Dose Level 1|Progressive disease|6
7584048|NCT02100644|26379539|P3|LTG Escalation Phase|Withdrawal by Subject|0
7584049|NCT02100644|26379540|P2|LTG Escalation Phase|Withdrawal by Subject|0
7584050|NCT02100644|26379541|P1|LTG Escalation Phase|Withdrawal by Subject|3
7584051|NCT02100644|26379539|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7584052|NCT02100644|26379540|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7584053|NCT02100644|26379541|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
7584054|NCT02100644|26379539|P3|LTG Escalation Phase|Adverse Event|0
7584055|NCT02100644|26379540|P2|LTG Escalation Phase|Adverse Event|0
7584056|NCT02100644|26379541|P1|LTG Escalation Phase|Adverse Event|9
7584057|NCT02100631|26379554|P3|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7584058|NCT02100631|26379555|P2|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7584059|NCT02100631|26379556|P1|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
7584060|NCT02100631|26379554|P3|Overall Study|Lost to Follow-up|0
7584061|NCT02100631|26379555|P2|Overall Study|Lost to Follow-up|4
7584062|NCT02100631|26379556|P1|Overall Study|Lost to Follow-up|3
7584063|NCT02100631|26379554|P3|Overall Study|Withdrawal by Subject|0
7584064|NCT02100631|26379555|P2|Overall Study|Withdrawal by Subject|0
7584065|NCT02100631|26379556|P1|Overall Study|Withdrawal by Subject|1
7584066|NCT02100514|26379589|P5|Extension Period|Withdrew consent|0
7584067|NCT02100514|26379590|P4|Extension Period|Withdrew consent|0
7584068|NCT02100514|26379591|P3|Extension Period|Withdrew consent|2
7584069|NCT02100514|26379592|P2|Extension Period|Withdrew consent|0
7584070|NCT02100514|26379593|P1|Extension Period|Withdrew consent|0
7584071|NCT02100514|26379589|P5|Treatment Period|Other|0
7584072|NCT02100514|26379590|P4|Treatment Period|Other|0
7584073|NCT02100514|26379591|P3|Treatment Period|Other|0
7584074|NCT02100514|26379592|P2|Treatment Period|Other|11
7584075|NCT02100514|26379593|P1|Treatment Period|Other|9
7584076|NCT02100514|26379589|P5|Treatment Period|Withdrawal by Subject|0
7584077|NCT02100514|26379590|P4|Treatment Period|Withdrawal by Subject|0
7584078|NCT02100514|26379591|P3|Treatment Period|Withdrawal by Subject|0
7584079|NCT02100514|26379592|P2|Treatment Period|Withdrawal by Subject|37
7584080|NCT02100514|26379593|P1|Treatment Period|Withdrawal by Subject|12
7584081|NCT02100514|26379589|P5|Treatment Period|Protocol Violation|0
7584082|NCT02100514|26379590|P4|Treatment Period|Protocol Violation|0
7584083|NCT02100514|26379591|P3|Treatment Period|Protocol Violation|0
7584084|NCT02100514|26379592|P2|Treatment Period|Protocol Violation|1
7584085|NCT02100514|26379593|P1|Treatment Period|Protocol Violation|1
7584086|NCT02100514|26379589|P5|Treatment Period|Did Not Meet Entrance Criteria|0
7584087|NCT02100514|26379590|P4|Treatment Period|Did Not Meet Entrance Criteria|0
7584088|NCT02100514|26379591|P3|Treatment Period|Did Not Meet Entrance Criteria|0
7584089|NCT02100514|26379592|P2|Treatment Period|Did Not Meet Entrance Criteria|1
7584090|NCT02100514|26379593|P1|Treatment Period|Did Not Meet Entrance Criteria|0
7584091|NCT02100514|26379589|P5|Treatment Period|Lost to Follow-up|0
7584092|NCT02100514|26379590|P4|Treatment Period|Lost to Follow-up|0
7584093|NCT02100514|26379591|P3|Treatment Period|Lost to Follow-up|0
7584094|NCT02100514|26379592|P2|Treatment Period|Lost to Follow-up|17
7584095|NCT02100514|26379593|P1|Treatment Period|Lost to Follow-up|5
7584096|NCT02100514|26379589|P5|Treatment Period|Death|0
7584097|NCT02100514|26379590|P4|Treatment Period|Death|0
7584098|NCT02100514|26379591|P3|Treatment Period|Death|0
7584099|NCT02100514|26379592|P2|Treatment Period|Death|2
7584100|NCT02100514|26379593|P1|Treatment Period|Death|2
7584101|NCT02100514|26379589|P5|Treatment Period|Adverse Event|0
7584102|NCT02100514|26379590|P4|Treatment Period|Adverse Event|0
7584103|NCT02100514|26379591|P3|Treatment Period|Adverse Event|0
7584104|NCT02100514|26379592|P2|Treatment Period|Adverse Event|5
7584105|NCT02100514|26379593|P1|Treatment Period|Adverse Event|0
7584106|NCT02100475|26379661|P2|Overall Study|Withdrawal criteria|0
7584107|NCT02100475|26379662|P1|Overall Study|Withdrawal criteria|1
7584108|NCT02100475|26379661|P2|Overall Study|Unclassified|2
7584109|NCT02100475|26379662|P1|Overall Study|Unclassified|1
7584110|NCT02100319|26379693|P1|Overall Study|Protocol Deviation|5
7584111|NCT02100319|26379693|P1|Overall Study|Case Report Forms Uncollected|11
7584112|NCT02100228|26379721|P2|Overall Study|Death|1
7584113|NCT02100228|26379722|P1|Overall Study|Death|1
7584114|NCT02100228|26379721|P2|Overall Study|Adverse Event|12
7584115|NCT02100228|26379722|P1|Overall Study|Adverse Event|16
7584116|NCT02100228|26379721|P2|Overall Study|Withdrawal by Subject|37
7584117|NCT02100228|26379722|P1|Overall Study|Withdrawal by Subject|27
7584118|NCT02100228|26379721|P2|Overall Study|Lost to Follow-up|1
7584119|NCT02100228|26379722|P1|Overall Study|Lost to Follow-up|0
7584120|NCT02100228|26379721|P2|Overall Study|Non-compliance|3
7584121|NCT02100228|26379722|P1|Overall Study|Non-compliance|0
7584122|NCT02100228|26379721|P2|Overall Study|Inclusion/Exclusion criteria not met|16
7584123|NCT02100228|26379722|P1|Overall Study|Inclusion/Exclusion criteria not met|12
7584124|NCT02100228|26379721|P2|Overall Study|Administrative reason|1
7584125|NCT02100228|26379722|P1|Overall Study|Administrative reason|0
7584126|NCT02100228|26379721|P2|Overall Study|Other|19
7584127|NCT02100228|26379722|P1|Overall Study|Other|19
7584128|NCT02100124|26379758|P3|Overall Study|Withdrawal by Subject|0
7584129|NCT02100124|26379759|P2|Overall Study|Withdrawal by Subject|0
7584130|NCT02100124|26379760|P1|Overall Study|Withdrawal by Subject|1
7584131|NCT02100124|26379758|P3|Overall Study|Lost to Follow-up|3
7584132|NCT02100124|26379759|P2|Overall Study|Lost to Follow-up|11
7584133|NCT02100124|26379760|P1|Overall Study|Lost to Follow-up|5
7584134|NCT02099838|26379817|P2|Overall Study|Withdrawal by Subject|1
7584135|NCT02099838|26379818|P1|Overall Study|Withdrawal by Subject|0
7584136|NCT02099838|26379817|P2|Overall Study|Lost to Follow-up|1
7584137|NCT02099838|26379818|P1|Overall Study|Lost to Follow-up|3
7584138|NCT02099838|26379817|P2|Overall Study|Death|0
7584139|NCT02099838|26379818|P1|Overall Study|Death|1
7584140|NCT02099708|26379905|P1|Overall Study|Other|29
7584141|NCT02099708|26379905|P1|Overall Study|Lost to Follow-up|141
7584142|NCT02099708|26379905|P1|Overall Study|Data Not Available|30
7584143|NCT02099682|26379916|P1|Overall Study|Other|29
7584144|NCT02099682|26379916|P1|Overall Study|Lost to Follow-up|31
7584145|NCT02099682|26379916|P1|Overall Study|Data Not Available|51
7584146|NCT02099344|26379942|P2|Overall Study|Physician Decision|0
7584147|NCT02099344|26379943|P1|Overall Study|Physician Decision|1
7584148|NCT02099110|26379980|P5|Overall Study|Physician Decision|1
7584149|NCT02099110|26379981|P4|Overall Study|Physician Decision|2
7584150|NCT02099110|26379982|P3|Overall Study|Physician Decision|1
7584151|NCT02099110|26379983|P2|Overall Study|Physician Decision|0
7584152|NCT02099110|26379984|P1|Overall Study|Physician Decision|3
7584153|NCT02099110|26379980|P5|Overall Study|Non-compliance with study drug|1
7584154|NCT02099110|26379981|P4|Overall Study|Non-compliance with study drug|0
7584155|NCT02099110|26379982|P3|Overall Study|Non-compliance with study drug|0
7584156|NCT02099110|26379983|P2|Overall Study|Non-compliance with study drug|0
7584157|NCT02099110|26379984|P1|Overall Study|Non-compliance with study drug|2
7584158|NCT02099110|26379980|P5|Overall Study|Screen failure|1
7584159|NCT02099110|26379981|P4|Overall Study|Screen failure|0
7584160|NCT02099110|26379982|P3|Overall Study|Screen failure|0
7584161|NCT02099110|26379983|P2|Overall Study|Screen failure|0
7584162|NCT02099110|26379984|P1|Overall Study|Screen failure|0
7584163|NCT02099110|26379980|P5|Overall Study|Death|0
7584164|NCT02099110|26379981|P4|Overall Study|Death|0
7584165|NCT02099110|26379982|P3|Overall Study|Death|0
7584166|NCT02099110|26379983|P2|Overall Study|Death|1
7584167|NCT02099110|26379984|P1|Overall Study|Death|0
7584168|NCT02099110|26379980|P5|Overall Study|Lost to Follow-up|6
7584169|NCT02099110|26379981|P4|Overall Study|Lost to Follow-up|5
7584170|NCT02099110|26379982|P3|Overall Study|Lost to Follow-up|11
7584171|NCT02099110|26379983|P2|Overall Study|Lost to Follow-up|12
7584172|NCT02099110|26379984|P1|Overall Study|Lost to Follow-up|6
7584173|NCT02099110|26379980|P5|Overall Study|Adverse Event|2
7584174|NCT02099110|26379981|P4|Overall Study|Adverse Event|3
7584175|NCT02099110|26379982|P3|Overall Study|Adverse Event|2
7584176|NCT02099110|26379983|P2|Overall Study|Adverse Event|5
7584177|NCT02099110|26379984|P1|Overall Study|Adverse Event|3
7584178|NCT02099110|26379980|P5|Overall Study|Withdrawal by Subject|13
7584179|NCT02099110|26379981|P4|Overall Study|Withdrawal by Subject|9
7584180|NCT02099110|26379982|P3|Overall Study|Withdrawal by Subject|13
7584181|NCT02099110|26379983|P2|Overall Study|Withdrawal by Subject|11
7584182|NCT02099110|26379984|P1|Overall Study|Withdrawal by Subject|7
7584183|NCT02099110|26379980|P5|Overall Study|Participant moved|2
7584184|NCT02099110|26379981|P4|Overall Study|Participant moved|0
7584185|NCT02099110|26379982|P3|Overall Study|Participant moved|1
7584186|NCT02099110|26379983|P2|Overall Study|Participant moved|1
7584187|NCT02099110|26379984|P1|Overall Study|Participant moved|1
7584188|NCT02099110|26379980|P5|Overall Study|Protocol Violation|1
7584189|NCT02099110|26379981|P4|Overall Study|Protocol Violation|3
7584190|NCT02099110|26379982|P3|Overall Study|Protocol Violation|0
7584191|NCT02099110|26379983|P2|Overall Study|Protocol Violation|1
7584192|NCT02099110|26379984|P1|Overall Study|Protocol Violation|2
7584193|NCT02098746|26380085|P1|Overall Study|Data Not Available After Treatment|1
7584194|NCT02098746|26380085|P1|Overall Study|Enrolled 15 Days After the First Dose|1
7584195|NCT02098746|26380085|P1|Overall Study|Other Miscellaneous Reasons|1
7584196|NCT02098746|26380085|P1|Overall Study|Changes of Investigator|2
7584197|NCT02098733|26380093|P1|Overall Study|Lost to Follow-up|5
7584198|NCT02098733|26380093|P1|Overall Study|Data Not Available|5
7584199|NCT02098395|26380107|P4|Overall Study|Unclassified|2
7584200|NCT02098395|26380108|P3|Overall Study|Unclassified|3
7584201|NCT02098395|26380109|P2|Overall Study|Unclassified|0
7584202|NCT02098395|26380110|P1|Overall Study|Unclassified|0
7584203|NCT02098395|26380107|P4|Overall Study|Lost to Follow-up|3
7584204|NCT02098395|26380108|P3|Overall Study|Lost to Follow-up|0
7584205|NCT02098395|26380109|P2|Overall Study|Lost to Follow-up|1
7584206|NCT02098395|26380110|P1|Overall Study|Lost to Follow-up|2
7584207|NCT02098395|26380107|P4|Overall Study|Adverse Event|2
7584208|NCT02098395|26380108|P3|Overall Study|Adverse Event|34
7584209|NCT02098395|26380109|P2|Overall Study|Adverse Event|19
7584210|NCT02098395|26380110|P1|Overall Study|Adverse Event|12
7584211|NCT02098395|26380107|P4|Overall Study|Withdrawal by Subject|13
7584212|NCT02098395|26380108|P3|Overall Study|Withdrawal by Subject|5
7584213|NCT02098395|26380109|P2|Overall Study|Withdrawal by Subject|10
7584214|NCT02098395|26380110|P1|Overall Study|Withdrawal by Subject|10
7584215|NCT02098395|26380107|P4|Overall Study|Protocol Violation|7
7584216|NCT02098395|26380108|P3|Overall Study|Protocol Violation|0
7584217|NCT02098395|26380109|P2|Overall Study|Protocol Violation|2
7584218|NCT02098395|26380110|P1|Overall Study|Protocol Violation|2
7584219|NCT02098369|26380131|P3|Overall Study|Other|1
7584220|NCT02098369|26380132|P2|Overall Study|Other|2
7584221|NCT02098369|26380133|P1|Overall Study|Other|0
7584222|NCT02098369|26380131|P3|Overall Study|Death|1
7584223|NCT02098369|26380132|P2|Overall Study|Death|1
7584224|NCT02098369|26380133|P1|Overall Study|Death|1
7584225|NCT02098369|26380131|P3|Overall Study|Lost to Follow-up|3
7584226|NCT02098369|26380132|P2|Overall Study|Lost to Follow-up|1
7584227|NCT02098369|26380133|P1|Overall Study|Lost to Follow-up|5
7584228|NCT02098369|26380131|P3|Overall Study|Withdrawal by Subject|0
7584229|NCT02098369|26380132|P2|Overall Study|Withdrawal by Subject|5
7584230|NCT02098369|26380133|P1|Overall Study|Withdrawal by Subject|1
7584231|NCT02098109|26380171|P2|Overall Study|Protocol Violation|0
7584232|NCT02098109|26380172|P1|Overall Study|Protocol Violation|3
7584233|NCT02097823|26380250|P2|Overall Study|Withdrawal by Subject|1
7584234|NCT02097823|26380251|P1|Overall Study|Withdrawal by Subject|1
7584235|NCT02097745|26380266|P1|Overall Study|Reason Not Specified|96
7584236|NCT02097745|26380266|P1|Overall Study|Administrative/Other|27
7584237|NCT02097745|26380266|P1|Overall Study|Failure to Return|14
7584238|NCT02097745|26380266|P1|Overall Study|Death|16
7584239|NCT02097745|26380266|P1|Overall Study|Adverse Event|25
7584240|NCT02097719|26380306|P2|Overall Study|Adverse Event|0
7584241|NCT02097719|26380307|P1|Overall Study|Adverse Event|2
7584242|NCT02097719|26380306|P2|Overall Study|Lost to Follow-up|1
7584243|NCT02097719|26380307|P1|Overall Study|Lost to Follow-up|0
7584244|NCT02097719|26380306|P2|Overall Study|Subject Withdrew Consent|0
7584245|NCT02097719|26380307|P1|Overall Study|Subject Withdrew Consent|1
7584246|NCT02097472|26380381|P8|Received Vaccination 2|Adverse Event|0
7584247|NCT02097472|26380382|P7|Received Vaccination 2|Adverse Event|1
7584248|NCT02097472|26380383|P6|Received Vaccination 2|Adverse Event|0
7584249|NCT02097472|26380384|P5|Received Vaccination 2|Adverse Event|0
7584250|NCT02097472|26380385|P4|Received Vaccination 2|Adverse Event|0
7584251|NCT02097472|26380386|P3|Received Vaccination 2|Adverse Event|0
7584252|NCT02097472|26380387|P2|Received Vaccination 2|Adverse Event|0
7584253|NCT02097472|26380388|P1|Received Vaccination 2|Adverse Event|0
7584254|NCT02097420|26380809|P1|Overall Study|Not reached 12-month visit|7
7584255|NCT02097420|26380809|P1|Overall Study|Device explanted|3
7584256|NCT02097420|26380809|P1|Overall Study|Death|4
7584257|NCT02097290|26380832|P1|Overall Study|Attempt|8
7584258|NCT02097290|26380832|P1|Overall Study|Total Withdrawals|3
7584259|NCT02097290|26380832|P1|Overall Study|Death|6
7584260|NCT02097277|26380847|P5|Overall Study|Adverse Event|0
7584261|NCT02097277|26380848|P4|Overall Study|Adverse Event|2
7584262|NCT02097277|26380849|P3|Overall Study|Adverse Event|1
7584263|NCT02097277|26380850|P2|Overall Study|Adverse Event|0
7584264|NCT02097277|26380851|P1|Overall Study|Adverse Event|0
7584265|NCT02097277|26380847|P5|Overall Study|Withdrawal by Subject|0
7584266|NCT02097277|26380848|P4|Overall Study|Withdrawal by Subject|1
7584267|NCT02097277|26380849|P3|Overall Study|Withdrawal by Subject|0
7584268|NCT02097277|26380850|P2|Overall Study|Withdrawal by Subject|1
7584269|NCT02097277|26380851|P1|Overall Study|Withdrawal by Subject|2
7584270|NCT02097277|26380847|P5|Overall Study|Lost to Follow-up|0
7584271|NCT02097277|26380848|P4|Overall Study|Lost to Follow-up|0
7584272|NCT02097277|26380849|P3|Overall Study|Lost to Follow-up|1
7584273|NCT02097277|26380850|P2|Overall Study|Lost to Follow-up|1
7584274|NCT02097277|26380851|P1|Overall Study|Lost to Follow-up|0
7584275|NCT02097277|26380847|P5|Overall Study|Subject request to discontinue treatment|1
7584276|NCT02097277|26380848|P4|Overall Study|Subject request to discontinue treatment|0
7584277|NCT02097277|26380849|P3|Overall Study|Subject request to discontinue treatment|0
7584278|NCT02097277|26380850|P2|Overall Study|Subject request to discontinue treatment|0
7584279|NCT02097277|26380851|P1|Overall Study|Subject request to discontinue treatment|0
7584280|NCT02097277|26380847|P5|Overall Study|Subject no longer meets study criteria|0
7584281|NCT02097277|26380848|P4|Overall Study|Subject no longer meets study criteria|1
7584282|NCT02097277|26380849|P3|Overall Study|Subject no longer meets study criteria|0
7584283|NCT02097277|26380850|P2|Overall Study|Subject no longer meets study criteria|1
7584284|NCT02097277|26380851|P1|Overall Study|Subject no longer meets study criteria|0
7584285|NCT02097238|26380934|P1|Overall Study|Progressive Disease|17
7584286|NCT02097238|26380934|P1|Overall Study|Physician Decision|1
7584287|NCT02097238|26380934|P1|Overall Study|Death|1
7584288|NCT02097134|26380943|P1|Overall Study|Refusal of Further Protocol Therapy|1
7584289|NCT02097134|26380943|P1|Overall Study|Progressive Disease|3
7584290|NCT02097134|26380943|P1|Overall Study|Non-Protocol Therapy|1
7584291|NCT02097134|26380943|P1|Overall Study|Physician Decision|4
7584292|NCT02097108|26380951|P1|Overall Study|patient was abroad for 6 months|1
7584293|NCT02097108|26380951|P1|Overall Study|Adverse Event|1
7584294|NCT02097056|26380958|P1|Overall Study|Other|2
7584295|NCT02097056|26380958|P1|Overall Study|Adverse Event|37
7584296|NCT02097056|26380958|P1|Overall Study|Lost to Follow-up|2
7584297|NCT02097056|26380958|P1|Overall Study|Withdrawal by Subject|15
7584298|NCT02097056|26380958|P1|Overall Study|Protocol Violation|2
7584299|NCT02097030|26380966|P2|First Intervention (3 Days)|Visual Acuity|1
7584300|NCT02097030|26380967|P1|First Intervention (3 Days)|Visual Acuity|0
7584301|NCT02097030|26380966|P2|First Intervention (3 Days)|Lost to Follow-up|0
7584302|NCT02097030|26380967|P1|First Intervention (3 Days)|Lost to Follow-up|1
7584303|NCT02096952|26381028|P1|Overall Study|Adverse Event|1
7584304|NCT02096900|26381034|P2|Overall Study|Surgery cancelled- medication received|1
7584305|NCT02096900|26381035|P1|Overall Study|Surgery cancelled- medication received|1
7584306|NCT02096900|26381034|P2|Overall Study|Did not receive medication|1
7584307|NCT02096900|26381035|P1|Overall Study|Did not receive medication|3
7584308|NCT02096835|26381087|P3|Overall Study|Lost to Follow-up|1
7584309|NCT02096835|26381088|P2|Overall Study|Lost to Follow-up|0
7584310|NCT02096835|26381089|P1|Overall Study|Lost to Follow-up|1
7584311|NCT02096835|26381087|P3|Overall Study|converted to open procedures|0
7584312|NCT02096835|26381088|P2|Overall Study|converted to open procedures|0
7584313|NCT02096835|26381089|P1|Overall Study|converted to open procedures|1
7584314|NCT02096835|26381087|P3|Overall Study|Withdrawal by Subject|0
7584315|NCT02096835|26381088|P2|Overall Study|Withdrawal by Subject|0
7584316|NCT02096835|26381089|P1|Overall Study|Withdrawal by Subject|1
7584317|NCT02096744|26381106|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
7584318|NCT02096744|26381107|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
7584319|NCT02096744|26381106|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
7584320|NCT02096744|26381107|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
7584321|NCT02096744|26381106|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
7584322|NCT02096744|26381107|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
7584323|NCT02096705|26381161|P2|Follow-up|Subjects not reporting status|2
7584324|NCT02096705|26381162|P1|Follow-up|Subjects not reporting status|1
7584325|NCT02096705|26381161|P2|Follow-up|Adverse Event|2
7584326|NCT02096705|26381162|P1|Follow-up|Adverse Event|2
7584327|NCT02096705|26381161|P2|Follow-up|Withdrawal by Subject|0
7584328|NCT02096705|26381162|P1|Follow-up|Withdrawal by Subject|1
7584329|NCT02096705|26381161|P2|Treatment|Other|1
7584330|NCT02096705|26381162|P1|Treatment|Other|1
7584331|NCT02096705|26381161|P2|Treatment|Withdrawal by Subject|0
7584332|NCT02096705|26381162|P1|Treatment|Withdrawal by Subject|1
7584333|NCT02096705|26381161|P2|Treatment|Subject request to discontinue treatment|1
7584334|NCT02096705|26381162|P1|Treatment|Subject request to discontinue treatment|1
7584335|NCT02096705|26381161|P2|Treatment|Adverse Event|3
7584336|NCT02096705|26381162|P1|Treatment|Adverse Event|6
7584337|NCT02096588|26381205|P2|Overall Study|Withdrawal by Subject|1
7584338|NCT02096588|26381206|P1|Overall Study|Withdrawal by Subject|0
7584339|NCT02096588|26381205|P2|Overall Study|Lack of Efficacy|0
7584340|NCT02096588|26381206|P1|Overall Study|Lack of Efficacy|2
7584341|NCT02096471|26381232|P1|Overall Study|Non-Compliant|2
7584342|NCT02096471|26381232|P1|Overall Study|Withdrawal by Subject|3
7584343|NCT02096471|26381232|P1|Overall Study|Lack of Efficacy|7
7584344|NCT02096471|26381232|P1|Overall Study|Adverse Event|1
7584345|NCT02096263|26381259|P3|Overall Study|Withdrawal by Subject|8
7584346|NCT02096263|26381260|P2|Overall Study|Withdrawal by Subject|7
7584347|NCT02096263|26381261|P1|Overall Study|Withdrawal by Subject|5
7584348|NCT02096263|26381259|P3|Overall Study|Protocol Violation|8
7584349|NCT02096263|26381260|P2|Overall Study|Protocol Violation|2
7584350|NCT02096263|26381261|P1|Overall Study|Protocol Violation|7
7584351|NCT02096263|26381259|P3|Overall Study|Sponsor study termination|1
7584352|NCT02096263|26381260|P2|Overall Study|Sponsor study termination|0
7584353|NCT02096263|26381261|P1|Overall Study|Sponsor study termination|0
7584354|NCT02096263|26381259|P3|Overall Study|Other|6
7584355|NCT02096263|26381260|P2|Overall Study|Other|9
7584356|NCT02096263|26381261|P1|Overall Study|Other|7
7584357|NCT02096263|26381259|P3|Overall Study|Lost to Follow-up|15
7584358|NCT02096263|26381260|P2|Overall Study|Lost to Follow-up|18
7584359|NCT02096263|26381261|P1|Overall Study|Lost to Follow-up|14
7584360|NCT02096263|26381259|P3|Overall Study|Adverse Event|1
7584361|NCT02096263|26381260|P2|Overall Study|Adverse Event|0
7584362|NCT02096263|26381261|P1|Overall Study|Adverse Event|1
7584363|NCT02096042|26381449|P3|Overall Study|Disease Progression|0
7584364|NCT02096042|26381450|P2|Overall Study|Disease Progression|0
7584365|NCT02096042|26381451|P1|Overall Study|Disease Progression|1
7584366|NCT02096003|26381473|P2|Overall Study|additional surgery|1
7584367|NCT02096003|26381474|P1|Overall Study|additional surgery|2
7584368|NCT02096003|26381473|P2|Overall Study|Protocol Violation|2
7584369|NCT02096003|26381474|P1|Overall Study|Protocol Violation|0
7584370|NCT02095951|26381490|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
7584371|NCT02095951|26381491|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
7584372|NCT02095873|26381511|P2|Second Intervention (8 Weeks)|Protocol Violation|0
7584373|NCT02095873|26381512|P1|Second Intervention (8 Weeks)|Protocol Violation|1
7584374|NCT02095873|26381511|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7584375|NCT02095873|26381512|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7584376|NCT02095873|26381511|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
7584377|NCT02095873|26381512|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
7584378|NCT02095691|26381524|P1|Overall Study|Physician Decision|1
7584379|NCT02095678|26381543|P2|Overall Study|No Visible Lesion or Pathological Finding|0
7584380|NCT02095678|26381544|P1|Overall Study|No Visible Lesion or Pathological Finding|4
7584381|NCT02095678|26381543|P2|Overall Study|Malignant lesions not HCC nor Metastatic|1
7584382|NCT02095678|26381544|P1|Overall Study|Malignant lesions not HCC nor Metastatic|1
7584383|NCT02095678|26381543|P2|Overall Study|No Confirmed Diagnosis|3
7584384|NCT02095678|26381544|P1|Overall Study|No Confirmed Diagnosis|0
7584385|NCT02095678|26381543|P2|Overall Study|lesion impacted by previous treatment|1
7584386|NCT02095678|26381544|P1|Overall Study|lesion impacted by previous treatment|1
7584387|NCT02095678|26381543|P2|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
7584388|NCT02095678|26381544|P1|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
7584389|NCT02095678|26381543|P2|Overall Study|Withdrawal by Subject|1
7584390|NCT02095678|26381544|P1|Overall Study|Withdrawal by Subject|0
7584391|NCT02095535|26381576|P1|Recruitment|Protocol Violation|2
7584392|NCT02095223|26381598|P2|Overall Study|Withdrawal by Subject|0
7584393|NCT02095223|26381599|P1|Overall Study|Withdrawal by Subject|1
7584394|NCT02095197|26381609|P2|Overall Study|Lost to Follow-up|3
7584395|NCT02095197|26381610|P1|Overall Study|Lost to Follow-up|0
7584396|NCT02095158|26381622|P1|Overall Study|Other Miscellaneous Reasons|1
7584397|NCT02095158|26381622|P1|Overall Study|Protocol Violation|1
7584398|NCT02095158|26381622|P1|Overall Study|Personal Reasons|35
7584399|NCT02095158|26381622|P1|Overall Study|Lost to Follow-up|20
7584400|NCT02095158|26381622|P1|Overall Study|Pregnancy|1
7584401|NCT02095158|26381622|P1|Overall Study|Lack of Efficacy|3
7584402|NCT02095158|26381622|P1|Overall Study|Adverse Event|14
7584403|NCT02095145|26381629|P2|Overall Study|Withdrawal by Subject|0
7584404|NCT02095145|26381630|P1|Overall Study|Withdrawal by Subject|1
7584405|NCT02095106|26381676|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
7584406|NCT02095106|26381677|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
7584407|NCT02094937|26381693|P4|12 Weeks in Period 2|Randomized incorrectly|0
7584408|NCT02094937|26381694|P3|12 Weeks in Period 2|Randomized incorrectly|0
7584409|NCT02094937|26381695|P2|12 Weeks in Period 2|Randomized incorrectly|1
7584410|NCT02094937|26381696|P1|12 Weeks in Period 2|Randomized incorrectly|0
7584411|NCT02094937|26381693|P4|12 Weeks in Period 2|Withdrawal by Subject|0
7584412|NCT02094937|26381694|P3|12 Weeks in Period 2|Withdrawal by Subject|2
7584413|NCT02094937|26381695|P2|12 Weeks in Period 2|Withdrawal by Subject|2
7584414|NCT02094937|26381696|P1|12 Weeks in Period 2|Withdrawal by Subject|0
7584415|NCT02094937|26381693|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
7584416|NCT02094937|26381694|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
7584417|NCT02094937|26381695|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
7584418|NCT02094937|26381696|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
7584419|NCT02094937|26381693|P4|12 Weeks in Period 2|Lack of Efficacy|0
7584420|NCT02094937|26381694|P3|12 Weeks in Period 2|Lack of Efficacy|0
7584421|NCT02094937|26381695|P2|12 Weeks in Period 2|Lack of Efficacy|1
7584422|NCT02094937|26381696|P1|12 Weeks in Period 2|Lack of Efficacy|0
7584423|NCT02094937|26381693|P4|12 Weeks in Period 2|Adverse Event|1
7584424|NCT02094937|26381694|P3|12 Weeks in Period 2|Adverse Event|4
7584425|NCT02094937|26381695|P2|12 Weeks in Period 2|Adverse Event|2
7584426|NCT02094937|26381696|P1|12 Weeks in Period 2|Adverse Event|0
7584427|NCT02094937|26381693|P4|8 Weeks in Period 1|Withdrawal by Subject|0
7584428|NCT02094937|26381694|P3|8 Weeks in Period 1|Withdrawal by Subject|0
7584429|NCT02094937|26381695|P2|8 Weeks in Period 1|Withdrawal by Subject|0
7584430|NCT02094937|26381696|P1|8 Weeks in Period 1|Withdrawal by Subject|4
7584431|NCT02094937|26381693|P4|8 Weeks in Period 1|Physician Decision|0
7584432|NCT02094937|26381694|P3|8 Weeks in Period 1|Physician Decision|0
7584433|NCT02094937|26381695|P2|8 Weeks in Period 1|Physician Decision|0
7584434|NCT02094937|26381696|P1|8 Weeks in Period 1|Physician Decision|1
7584435|NCT02094937|26381693|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
7584436|NCT02094937|26381694|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
7584437|NCT02094937|26381695|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
7584438|NCT02094937|26381696|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
7584439|NCT02094937|26381693|P4|8 Weeks in Period 1|Protocol Violation|0
7584440|NCT02094937|26381694|P3|8 Weeks in Period 1|Protocol Violation|0
7584441|NCT02094937|26381695|P2|8 Weeks in Period 1|Protocol Violation|0
7584442|NCT02094937|26381696|P1|8 Weeks in Period 1|Protocol Violation|2
7584443|NCT02094937|26381693|P4|8 Weeks in Period 1|Lack of Efficacy|0
7584444|NCT02094937|26381694|P3|8 Weeks in Period 1|Lack of Efficacy|0
7584445|NCT02094937|26381695|P2|8 Weeks in Period 1|Lack of Efficacy|0
7584446|NCT02094937|26381696|P1|8 Weeks in Period 1|Lack of Efficacy|3
7584447|NCT02094937|26381693|P4|8 Weeks in Period 1|Adverse Event|0
7584448|NCT02094937|26381694|P3|8 Weeks in Period 1|Adverse Event|0
7584449|NCT02094937|26381695|P2|8 Weeks in Period 1|Adverse Event|0
7584450|NCT02094937|26381696|P1|8 Weeks in Period 1|Adverse Event|9
7584451|NCT02094898|26381726|P1|Overall Study|Lack of Efficacy|1
7584452|NCT02094898|26381726|P1|Overall Study|Adverse Event|2
7584453|NCT02094898|26381726|P1|Overall Study|Clinical Worsening|2
7584454|NCT02094885|26381773|P2|Overall Study|Withdrawn due to age|0
7584455|NCT02094885|26381774|P1|Overall Study|Withdrawn due to age|1
7584456|NCT02094885|26381773|P2|Overall Study|Death|5
7584457|NCT02094885|26381774|P1|Overall Study|Death|1
7584458|NCT02094677|26381822|P2|Overall Study|Screening|1
7584459|NCT02094677|26381823|P1|Overall Study|Screening|3
7584460|NCT02094612|26381902|P2|Overall Study|Never started ADHD medication|23
7584461|NCT02094612|26381903|P1|Overall Study|Never started ADHD medication|32
7584462|NCT02094612|26381902|P2|Overall Study|Lost to Follow-up|47
7584463|NCT02094612|26381903|P1|Overall Study|Lost to Follow-up|47
7584464|NCT02094573|26381956|P2|Overall Study|Randomized but not Treated|0
7584465|NCT02094573|26381957|P1|Overall Study|Randomized but not Treated|3
7584466|NCT02094573|26381956|P2|Overall Study|Withdrawal by Subject|8
7584467|NCT02094573|26381957|P1|Overall Study|Withdrawal by Subject|6
7584468|NCT02094573|26381956|P2|Overall Study|Site Terminated by Sponsor|17
7584469|NCT02094573|26381957|P1|Overall Study|Site Terminated by Sponsor|10
7584470|NCT02094573|26381956|P2|Overall Study|Physician Decision|4
7584471|NCT02094573|26381957|P1|Overall Study|Physician Decision|4
7584472|NCT02094573|26381956|P2|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
7584473|NCT02094573|26381957|P1|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
7584474|NCT02094573|26381956|P2|Overall Study|Non-compliance with Study Drug|1
7584475|NCT02094573|26381957|P1|Overall Study|Non-compliance with Study Drug|1
7584476|NCT02094573|26381956|P2|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
7584477|NCT02094573|26381957|P1|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
7584478|NCT02094573|26381956|P2|Overall Study|Death|3
7584479|NCT02094573|26381957|P1|Overall Study|Death|11
7584480|NCT02094573|26381956|P2|Overall Study|Clinical Progressive Disease|13
7584481|NCT02094573|26381957|P1|Overall Study|Clinical Progressive Disease|9
7584482|NCT02094573|26381956|P2|Overall Study|Adverse Event|14
7584483|NCT02094573|26381957|P1|Overall Study|Adverse Event|4
7584484|NCT02094417|26382025|P4|Overall Study|Withdrawal by Subject|3
7584485|NCT02094417|26382026|P3|Overall Study|Withdrawal by Subject|1
7584486|NCT02094417|26382027|P2|Overall Study|Withdrawal by Subject|2
7584487|NCT02094417|26382028|P1|Overall Study|Withdrawal by Subject|1
7584488|NCT02094417|26382025|P4|Overall Study|Unable to conduct observations or assess|0
7584489|NCT02094417|26382026|P3|Overall Study|Unable to conduct observations or assess|0
7584490|NCT02094417|26382027|P2|Overall Study|Unable to conduct observations or assess|1
7584491|NCT02094417|26382028|P1|Overall Study|Unable to conduct observations or assess|0
7584492|NCT02094417|26382025|P4|Overall Study|No responder|3
7584493|NCT02094417|26382026|P3|Overall Study|No responder|4
7584494|NCT02094417|26382027|P2|Overall Study|No responder|4
7584495|NCT02094417|26382028|P1|Overall Study|No responder|4
7584496|NCT02094417|26382025|P4|Overall Study|Eligibility criteria|0
7584497|NCT02094417|26382026|P3|Overall Study|Eligibility criteria|0
7584498|NCT02094417|26382027|P2|Overall Study|Eligibility criteria|1
7584499|NCT02094417|26382028|P1|Overall Study|Eligibility criteria|0
7584500|NCT02094417|26382025|P4|Overall Study|Adverse Event|1
7584501|NCT02094417|26382026|P3|Overall Study|Adverse Event|0
7584502|NCT02094417|26382027|P2|Overall Study|Adverse Event|0
7584503|NCT02094417|26382028|P1|Overall Study|Adverse Event|0
7584504|NCT02094300|26382080|P1|Overall Study|Still be eligible for follow-up|3
7584505|NCT02094300|26382080|P1|Overall Study|Lost to Follow-up|10
7584506|NCT02094300|26382080|P1|Overall Study|Death|7
7584507|NCT02094261|26382084|P1|Overall Study|Ongoing Study at Data Cut-off|181
7584508|NCT02094261|26382084|P1|Overall Study|Withdrawal by Subject|4
7584509|NCT02094261|26382084|P1|Overall Study|Lost to Follow-up|1
7584510|NCT02094261|26382084|P1|Overall Study|Death|24
7584511|NCT02093923|26382153|P5|Overall Study|Screen failure after randomization|0
7584512|NCT02093923|26382154|P4|Overall Study|Screen failure after randomization|1
7584513|NCT02093923|26382155|P3|Overall Study|Screen failure after randomization|0
7584514|NCT02093923|26382156|P2|Overall Study|Screen failure after randomization|0
7584515|NCT02093923|26382157|P1|Overall Study|Screen failure after randomization|0
7584516|NCT02093923|26382153|P5|Overall Study|Lost to Follow-up|0
7584517|NCT02093923|26382154|P4|Overall Study|Lost to Follow-up|1
7584518|NCT02093923|26382155|P3|Overall Study|Lost to Follow-up|0
7584519|NCT02093923|26382156|P2|Overall Study|Lost to Follow-up|0
7584520|NCT02093923|26382157|P1|Overall Study|Lost to Follow-up|0
7584521|NCT02093897|26382209|P1|Overall Study|Adverse event, non-fatal|1
7584522|NCT02093897|26382209|P1|Overall Study|Planned age group closure - no's reached|17
7584523|NCT02093897|26382209|P1|Overall Study|Physician Decision|1
7584524|NCT02093689|26382325|P3|Overall Study|Physician Decision|0
7584525|NCT02093689|26382326|P2|Overall Study|Physician Decision|0
7584526|NCT02093689|26382327|P1|Overall Study|Physician Decision|4
7584527|NCT02093663|26382333|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
7584528|NCT02093663|26382334|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7584529|NCT02093663|26382335|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7584530|NCT02093663|26382336|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7584531|NCT02093663|26382337|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7584532|NCT02093663|26382333|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7584533|NCT02093663|26382334|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7584534|NCT02093663|26382335|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7584535|NCT02093663|26382336|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7584536|NCT02093663|26382337|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7584537|NCT02093663|26382333|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
7584538|NCT02093663|26382334|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
7584539|NCT02093663|26382335|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7584540|NCT02093663|26382336|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7584541|NCT02093663|26382337|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7584542|NCT02093663|26382333|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
7584543|NCT02093663|26382334|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
7584544|NCT02093663|26382335|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7584545|NCT02093663|26382336|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7584546|NCT02093663|26382337|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7584547|NCT02093663|26382333|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7584548|NCT02093663|26382334|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7584549|NCT02093663|26382335|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
7584550|NCT02093663|26382336|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7584551|NCT02093663|26382337|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7584552|NCT02093663|26382333|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7584553|NCT02093663|26382334|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7584554|NCT02093663|26382335|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
7584555|NCT02093663|26382336|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7584556|NCT02093663|26382337|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7584557|NCT02093663|26382333|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7584558|NCT02093663|26382334|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7584559|NCT02093663|26382335|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7584560|NCT02093663|26382336|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
7584561|NCT02093663|26382337|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
7584562|NCT02093663|26382333|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7584563|NCT02093663|26382334|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7584564|NCT02093663|26382335|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7584565|NCT02093663|26382336|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7584566|NCT02093663|26382337|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
7584567|NCT02093663|26382333|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7584568|NCT02093663|26382334|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7584569|NCT02093663|26382335|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7584570|NCT02093663|26382336|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7584571|NCT02093663|26382337|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
7584572|NCT02093520|26382366|P2|Overall Study|Not treated|22
7584573|NCT02093520|26382367|P1|Overall Study|Not treated|6
7584574|NCT02093390|26382379|P2|Overall Study|Withdrawal by Subject|1
7584575|NCT02093390|26382380|P1|Overall Study|Withdrawal by Subject|0
7584576|NCT02093351|26382419|P4|Part B|Death|1
7584577|NCT02093351|26382420|P3|Part B|Death|0
7584578|NCT02093351|26382421|P2|Part B|Death|0
7584579|NCT02093351|26382422|P1|Part B|Death|0
7584580|NCT02093351|26382419|P4|Part B|Adverse Event|2
7584581|NCT02093351|26382420|P3|Part B|Adverse Event|0
7584582|NCT02093351|26382421|P2|Part B|Adverse Event|0
7584583|NCT02093351|26382422|P1|Part B|Adverse Event|0
7584584|NCT02093351|26382419|P4|Part B|Condition under investigation worsened|39
7584585|NCT02093351|26382420|P3|Part B|Condition under investigation worsened|0
7584586|NCT02093351|26382421|P2|Part B|Condition under investigation worsened|0
7584587|NCT02093351|26382422|P1|Part B|Condition under investigation worsened|0
7584588|NCT02093351|26382419|P4|Part B|Lack of therapeutic response|12
7584589|NCT02093351|26382420|P3|Part B|Lack of therapeutic response|0
7584590|NCT02093351|26382421|P2|Part B|Lack of therapeutic response|0
7584591|NCT02093351|26382422|P1|Part B|Lack of therapeutic response|0
7584592|NCT02093351|26382419|P4|Part B|Adverse event + disease progression|1
7584593|NCT02093351|26382420|P3|Part B|Adverse event + disease progression|0
7584594|NCT02093351|26382421|P2|Part B|Adverse event + disease progression|0
7584595|NCT02093351|26382422|P1|Part B|Adverse event + disease progression|0
7584596|NCT02093351|26382419|P4|Part B|Complete response|1
7584597|NCT02093351|26382420|P3|Part B|Complete response|0
7584598|NCT02093351|26382421|P2|Part B|Complete response|0
7584599|NCT02093351|26382422|P1|Part B|Complete response|0
7584600|NCT02093351|26382419|P4|Part B|Disease progression|4
7584601|NCT02093351|26382420|P3|Part B|Disease progression|0
7584602|NCT02093351|26382421|P2|Part B|Disease progression|0
7584603|NCT02093351|26382422|P1|Part B|Disease progression|0
7584604|NCT02093351|26382419|P4|Part B|Patient decision|3
7584605|NCT02093351|26382420|P3|Part B|Patient decision|0
7584606|NCT02093351|26382421|P2|Part B|Patient decision|0
7584607|NCT02093351|26382422|P1|Part B|Patient decision|0
7584608|NCT02093351|26382419|P4|Part A|Death|0
7584609|NCT02093351|26382420|P3|Part A|Death|0
7584610|NCT02093351|26382421|P2|Part A|Death|1
7584611|NCT02093351|26382422|P1|Part A|Death|0
7584612|NCT02093351|26382419|P4|Part A|Condition under investigation worsened|0
7584613|NCT02093351|26382420|P3|Part A|Condition under investigation worsened|2
7584704|NCT02092467|26382683|P1|Overall Study|Lost to Follow-up|38
7584614|NCT02093351|26382421|P2|Part A|Condition under investigation worsened|0
7584615|NCT02093351|26382422|P1|Part A|Condition under investigation worsened|2
7584616|NCT02093351|26382419|P4|Part A|Adverse Event|0
7584617|NCT02093351|26382420|P3|Part A|Adverse Event|1
7584618|NCT02093351|26382421|P2|Part A|Adverse Event|1
7584619|NCT02093351|26382422|P1|Part A|Adverse Event|0
7584620|NCT02093221|26382479|P5|Overall Study|Study termination|7
7584621|NCT02093221|26382480|P4|Overall Study|Study termination|6
7584622|NCT02093221|26382481|P3|Overall Study|Study termination|4
7584623|NCT02093221|26382482|P2|Overall Study|Study termination|5
7584624|NCT02093221|26382483|P1|Overall Study|Study termination|6
7584625|NCT02093221|26382479|P5|Overall Study|Protocol Violation|0
7584626|NCT02093221|26382480|P4|Overall Study|Protocol Violation|0
7584627|NCT02093221|26382481|P3|Overall Study|Protocol Violation|0
7584628|NCT02093221|26382482|P2|Overall Study|Protocol Violation|1
7584629|NCT02093221|26382483|P1|Overall Study|Protocol Violation|0
7584630|NCT02093221|26382479|P5|Overall Study|Death|0
7584631|NCT02093221|26382480|P4|Overall Study|Death|0
7584632|NCT02093221|26382481|P3|Overall Study|Death|0
7584633|NCT02093221|26382482|P2|Overall Study|Death|1
7584634|NCT02093221|26382483|P1|Overall Study|Death|0
7584635|NCT02093221|26382479|P5|Overall Study|Lost to Follow-up|0
7584636|NCT02093221|26382480|P4|Overall Study|Lost to Follow-up|1
7584637|NCT02093221|26382481|P3|Overall Study|Lost to Follow-up|1
7584638|NCT02093221|26382482|P2|Overall Study|Lost to Follow-up|0
7584639|NCT02093221|26382483|P1|Overall Study|Lost to Follow-up|2
7584640|NCT02093221|26382479|P5|Overall Study|Withdrawal by Subject|1
7584641|NCT02093221|26382480|P4|Overall Study|Withdrawal by Subject|1
7584642|NCT02093221|26382481|P3|Overall Study|Withdrawal by Subject|4
7584643|NCT02093221|26382482|P2|Overall Study|Withdrawal by Subject|1
7584644|NCT02093221|26382483|P1|Overall Study|Withdrawal by Subject|1
7584645|NCT02093221|26382479|P5|Overall Study|Adverse Event|0
7584646|NCT02093221|26382480|P4|Overall Study|Adverse Event|0
7584647|NCT02093221|26382481|P3|Overall Study|Adverse Event|0
7584648|NCT02093221|26382482|P2|Overall Study|Adverse Event|0
7584649|NCT02093221|26382483|P1|Overall Study|Adverse Event|1
7584650|NCT02093026|26382520|P1|Overall Study|Other|157
7584651|NCT02093026|26382520|P1|Overall Study|Death|10
7584652|NCT02093026|26382520|P1|Overall Study|Adverse Event|26
7584653|NCT02092961|26382565|P3|Overall Study|Adverse Event|0
7584654|NCT02092961|26382566|P2|Overall Study|Adverse Event|4
7584655|NCT02092961|26382567|P1|Overall Study|Adverse Event|2
7584656|NCT02092961|26382565|P3|Overall Study|Dev. of study specific discont. criteria|0
7584657|NCT02092961|26382566|P2|Overall Study|Dev. of study specific discont. criteria|0
7584658|NCT02092961|26382567|P1|Overall Study|Dev. of study specific discont. criteria|3
7584659|NCT02092961|26382565|P3|Overall Study|Lack of therapeutic response|3
7584660|NCT02092961|26382566|P2|Overall Study|Lack of therapeutic response|1
7584661|NCT02092961|26382567|P1|Overall Study|Lack of therapeutic response|2
7584662|NCT02092961|26382565|P3|Overall Study|Study stopped|12
7584663|NCT02092961|26382566|P2|Overall Study|Study stopped|9
7584664|NCT02092961|26382567|P1|Overall Study|Study stopped|13
7584665|NCT02092961|26382565|P3|Overall Study|Not reported|1
7584666|NCT02092961|26382566|P2|Overall Study|Not reported|0
7584667|NCT02092961|26382567|P1|Overall Study|Not reported|1
7584668|NCT02092909|26382592|P4|Overall Study|Miscellaneous|1
7584669|NCT02092909|26382593|P3|Overall Study|Miscellaneous|2
7584670|NCT02092909|26382594|P2|Overall Study|Miscellaneous|1
7584671|NCT02092909|26382595|P1|Overall Study|Miscellaneous|1
7584672|NCT02092909|26382592|P4|Overall Study|Study terminated by Sponsor|2
7584673|NCT02092909|26382593|P3|Overall Study|Study terminated by Sponsor|0
7584674|NCT02092909|26382594|P2|Overall Study|Study terminated by Sponsor|0
7584675|NCT02092909|26382595|P1|Overall Study|Study terminated by Sponsor|0
7584676|NCT02092909|26382592|P4|Overall Study|Withdrawal by Subject|1
7584677|NCT02092909|26382593|P3|Overall Study|Withdrawal by Subject|2
7584678|NCT02092909|26382594|P2|Overall Study|Withdrawal by Subject|0
7584679|NCT02092909|26382595|P1|Overall Study|Withdrawal by Subject|0
7584680|NCT02092909|26382592|P4|Overall Study|Lack of Efficacy|0
7584681|NCT02092909|26382593|P3|Overall Study|Lack of Efficacy|1
7584682|NCT02092909|26382594|P2|Overall Study|Lack of Efficacy|2
7584683|NCT02092909|26382595|P1|Overall Study|Lack of Efficacy|0
7584684|NCT02092909|26382592|P4|Overall Study|Adverse Event|2
7584685|NCT02092909|26382593|P3|Overall Study|Adverse Event|4
7584686|NCT02092909|26382594|P2|Overall Study|Adverse Event|0
7584687|NCT02092909|26382595|P1|Overall Study|Adverse Event|0
7584688|NCT02092662|26382636|P2|Overall Study|Lost to Follow-up|0
7584689|NCT02092662|26382637|P1|Overall Study|Lost to Follow-up|13
7584690|NCT02092467|26382681|P3|Overall Study|Randomized but not treated|7
7584691|NCT02092467|26382682|P2|Overall Study|Randomized but not treated|1
7584692|NCT02092467|26382683|P1|Overall Study|Randomized but not treated|2
7584693|NCT02092467|26382681|P3|Overall Study|Withdrawal by Subject|289
7584694|NCT02092467|26382682|P2|Overall Study|Withdrawal by Subject|327
7584695|NCT02092467|26382683|P1|Overall Study|Withdrawal by Subject|282
7584696|NCT02092467|26382681|P3|Overall Study|Other|24
7584697|NCT02092467|26382682|P2|Overall Study|Other|30
7584698|NCT02092467|26382683|P1|Overall Study|Other|32
7584699|NCT02092467|26382681|P3|Overall Study|Global Deterioration of Health Status|0
7584700|NCT02092467|26382682|P2|Overall Study|Global Deterioration of Health Status|0
7584701|NCT02092467|26382683|P1|Overall Study|Global Deterioration of Health Status|1
7584702|NCT02092467|26382681|P3|Overall Study|Lost to Follow-up|40
7584703|NCT02092467|26382682|P2|Overall Study|Lost to Follow-up|35
7584705|NCT02092467|26382681|P3|Overall Study|Death|38
7584706|NCT02092467|26382682|P2|Overall Study|Death|66
7584707|NCT02092467|26382683|P1|Overall Study|Death|49
7584708|NCT02092389|26382780|P1|Overall Study|Other|5
7584709|NCT02092389|26382780|P1|Overall Study|Adverse Event|1
7584710|NCT02092350|26382792|P2|Overall Study|Withdrawal by Subject|2
7584711|NCT02092350|26382793|P1|Overall Study|Withdrawal by Subject|2
7584712|NCT02092350|26382792|P2|Overall Study|Screen Failure|0
7584713|NCT02092350|26382793|P1|Overall Study|Screen Failure|1
7584714|NCT02092350|26382792|P2|Overall Study|Physician Decision|1
7584715|NCT02092350|26382793|P1|Overall Study|Physician Decision|1
7584716|NCT02092350|26382792|P2|Overall Study|Protocol Violation|0
7584717|NCT02092350|26382793|P1|Overall Study|Protocol Violation|1
7584718|NCT02092350|26382792|P2|Overall Study|Lost to Follow-up|1
7584719|NCT02092350|26382793|P1|Overall Study|Lost to Follow-up|3
7584720|NCT02092350|26382792|P2|Overall Study|Death|5
7584721|NCT02092350|26382793|P1|Overall Study|Death|2
7584722|NCT02092350|26382792|P2|Overall Study|Adverse Event|3
7584723|NCT02092350|26382793|P1|Overall Study|Adverse Event|0
7584724|NCT02092324|26382810|P1|Overall Study|Misdiagnosis|2
7584725|NCT02092324|26382810|P1|Overall Study|Physician Decision|7
7584726|NCT02092324|26382810|P1|Overall Study|Proceed to Transplant|3
7584727|NCT02092324|26382810|P1|Overall Study|Lack of Efficacy|6
7584728|NCT02092324|26382810|P1|Overall Study|Adverse Event|1
7584729|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
7584730|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
7584731|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
7584732|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Protocol Violation|11
7584733|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Pregnancy|1
7584734|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Physician Decision|10
7584735|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
7584736|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
7584737|NCT02092285|26382846|P1|Maintenance Phase & Follow-up|Adverse Event|22
7584738|NCT02092285|26382846|P1|Induction Phase|Lack of Efficacy|14
7584739|NCT02092285|26382846|P1|Induction Phase|Withdrawal by Subject|2
7584740|NCT02092285|26382846|P1|Induction Phase|Relapse/Recurrence|7
7584741|NCT02092285|26382846|P1|Induction Phase|Pregnancy|1
7584742|NCT02092285|26382846|P1|Induction Phase|Physician Decision|4
7584743|NCT02092285|26382846|P1|Induction Phase|Adverse Event|7
7584744|NCT02092220|26382850|P2|Period 2|Nausea, Anxiety, Inconvenience|1
7584745|NCT02092220|26382851|P1|Period 2|Nausea, Anxiety, Inconvenience|0
7584746|NCT02092220|26382850|P2|Period 2|Severe Hypoglycaemia|0
7584747|NCT02092220|26382851|P1|Period 2|Severe Hypoglycaemia|1
7584748|NCT02092220|26382850|P2|Period 1|Unrelated Illness|2
7584749|NCT02092220|26382851|P1|Period 1|Unrelated Illness|0
7584750|NCT02092116|26382945|P2|Overall Study|Adverse Event|1
7584751|NCT02092116|26382946|P1|Overall Study|Adverse Event|0
7584752|NCT02092116|26382945|P2|Overall Study|Withdrawal by Subject|3
7584753|NCT02092116|26382946|P1|Overall Study|Withdrawal by Subject|0
7584754|NCT02092025|26382955|P1|Overall Study|Protocol Deviation|24
7584755|NCT02092025|26382955|P1|Overall Study|Case Report Forms Uncollected|44
7584756|NCT02091986|26382964|P3|Overall Study|Adverse Event|2
7584757|NCT02091986|26382965|P2|Overall Study|Adverse Event|0
7584758|NCT02091986|26382966|P1|Overall Study|Adverse Event|0
7584759|NCT02091986|26382964|P3|Overall Study|Withdrawal by Subject|3
7584760|NCT02091986|26382965|P2|Overall Study|Withdrawal by Subject|8
7584761|NCT02091986|26382966|P1|Overall Study|Withdrawal by Subject|4
7584762|NCT02091986|26382964|P3|Overall Study|Lost to Follow-up|0
7584763|NCT02091986|26382965|P2|Overall Study|Lost to Follow-up|0
7584764|NCT02091986|26382966|P1|Overall Study|Lost to Follow-up|1
7584765|NCT02091986|26382964|P3|Overall Study|7 rand in error 1 patient decision|3
7584766|NCT02091986|26382965|P2|Overall Study|7 rand in error 1 patient decision|3
7584767|NCT02091986|26382966|P1|Overall Study|7 rand in error 1 patient decision|2
7584768|NCT02091960|26383013|P1|Overall Study|On Study at Data Cut-off|12
7584769|NCT02091960|26383013|P1|Overall Study|Miscellaneous Reasons|31
7584770|NCT02091960|26383013|P1|Overall Study|Withdrawal by Subject|1
7584771|NCT02091960|26383013|P1|Overall Study|Death|7
7584772|NCT02091921|26383024|P1|Overall Study|Adverse Event|3
7584773|NCT02091869|26383033|P2|Overall Study|Withdrawal by Subject|3
7584774|NCT02091869|26383034|P1|Overall Study|Withdrawal by Subject|0
7584775|NCT02091752|26383075|P1|Overall Study|Adverse Event|1
7584776|NCT02091752|26383075|P1|Overall Study|Study terminated by Sponsor|2
7584777|NCT02091739|26383089|P5|EP: 48 Weeks|Withdrawal by Subject|6
7584778|NCT02091739|26383090|P4|EP: 48 Weeks|Withdrawal by Subject|2
7584779|NCT02091739|26383091|P3|EP: 48 Weeks|Withdrawal by Subject|0
7584780|NCT02091739|26383092|P2|EP: 48 Weeks|Withdrawal by Subject|0
7584781|NCT02091739|26383093|P1|EP: 48 Weeks|Withdrawal by Subject|0
7584782|NCT02091739|26383089|P5|EP: 48 Weeks|Adverse Event|6
7584783|NCT02091739|26383090|P4|EP: 48 Weeks|Adverse Event|2
7584784|NCT02091739|26383091|P3|EP: 48 Weeks|Adverse Event|0
7584785|NCT02091739|26383092|P2|EP: 48 Weeks|Adverse Event|0
7584786|NCT02091739|26383093|P1|EP: 48 Weeks|Adverse Event|0
7584787|NCT02091739|26383089|P5|EP: 48 Weeks|Death|2
7584788|NCT02091739|26383090|P4|EP: 48 Weeks|Death|3
7584789|NCT02091739|26383091|P3|EP: 48 Weeks|Death|0
7584790|NCT02091739|26383092|P2|EP: 48 Weeks|Death|0
7584791|NCT02091739|26383093|P1|EP: 48 Weeks|Death|0
7584792|NCT02091739|26383089|P5|EP: 48 Weeks|Other|0
7584793|NCT02091739|26383090|P4|EP: 48 Weeks|Other|1
7584794|NCT02091739|26383091|P3|EP: 48 Weeks|Other|0
7584795|NCT02091739|26383092|P2|EP: 48 Weeks|Other|0
7584796|NCT02091739|26383093|P1|EP: 48 Weeks|Other|0
7584797|NCT02091739|26383089|P5|MP: 16 Weeks|Lost to Follow-up|0
7584798|NCT02091739|26383090|P4|MP: 16 Weeks|Lost to Follow-up|0
7584799|NCT02091739|26383091|P3|MP: 16 Weeks|Lost to Follow-up|1
7584800|NCT02091739|26383092|P2|MP: 16 Weeks|Lost to Follow-up|0
7584801|NCT02091739|26383093|P1|MP: 16 Weeks|Lost to Follow-up|0
7584802|NCT02091739|26383089|P5|MP: 16 Weeks|Withdrawal by Subject|0
7584803|NCT02091739|26383090|P4|MP: 16 Weeks|Withdrawal by Subject|0
7584804|NCT02091739|26383091|P3|MP: 16 Weeks|Withdrawal by Subject|0
7584805|NCT02091739|26383092|P2|MP: 16 Weeks|Withdrawal by Subject|4
7584806|NCT02091739|26383093|P1|MP: 16 Weeks|Withdrawal by Subject|3
7584807|NCT02091739|26383089|P5|MP: 16 Weeks|Adverse Event|0
7584808|NCT02091739|26383090|P4|MP: 16 Weeks|Adverse Event|0
7584809|NCT02091739|26383091|P3|MP: 16 Weeks|Adverse Event|1
7584810|NCT02091739|26383092|P2|MP: 16 Weeks|Adverse Event|1
7584811|NCT02091739|26383093|P1|MP: 16 Weeks|Adverse Event|1
7584812|NCT02091726|26383112|P1|Overall Study|Lost to Follow-up|6
7584813|NCT02091440|26383135|P1|Overall Study|Death|2
7584814|NCT02091414|26383145|P1|Overall Study|Death|2
7584815|NCT02091414|26383145|P1|Overall Study|Withdrawal by Subject|2
7584816|NCT02091375|26383159|P2|Overall Study|Withdrawn by the investigator|0
7584817|NCT02091375|26383160|P1|Overall Study|Withdrawn by the investigator|1
7584818|NCT02091375|26383159|P2|Overall Study|Withdrawal by Subject|1
7584819|NCT02091375|26383160|P1|Overall Study|Withdrawal by Subject|0
7584820|NCT02091375|26383159|P2|Overall Study|Lost to Follow-up|1
7584821|NCT02091375|26383160|P1|Overall Study|Lost to Follow-up|0
7584822|NCT02091375|26383159|P2|Overall Study|Adverse Event|1
7584823|NCT02091375|26383160|P1|Overall Study|Adverse Event|8
7584824|NCT02091362|26383190|P2|Period 2|Withdrawal by Subject|1
7584825|NCT02091362|26383191|P1|Period 2|Withdrawal by Subject|1
7584826|NCT02091362|26383190|P2|Period 2|Lost to Follow-up|1
7584827|NCT02091362|26383191|P1|Period 2|Lost to Follow-up|0
7584828|NCT02091362|26383190|P2|Period 2|Adverse Event|0
7584829|NCT02091362|26383191|P1|Period 2|Adverse Event|1
7584830|NCT02091362|26383190|P2|Wash-out|Withdrawal by Subject|2
7584831|NCT02091362|26383191|P1|Wash-out|Withdrawal by Subject|0
7584832|NCT02091362|26383190|P2|Wash-out|Lost to Follow-up|1
7584833|NCT02091362|26383191|P1|Wash-out|Lost to Follow-up|1
7584834|NCT02091362|26383190|P2|Period 1|Adverse Event|0
7584835|NCT02091362|26383191|P1|Period 1|Adverse Event|2
7584836|NCT02091362|26383190|P2|Period 1|Lost to Follow-up|1
7584837|NCT02091362|26383191|P1|Period 1|Lost to Follow-up|0
7584838|NCT02091362|26383190|P2|Period 1|Withdrawal by Subject|3
7584839|NCT02091362|26383191|P1|Period 1|Withdrawal by Subject|2
7584840|NCT02091362|26383190|P2|Period 1|Protocol Violation|0
7584841|NCT02091362|26383191|P1|Period 1|Protocol Violation|1
7584842|NCT02091284|26383213|P2|Overall Study|unreliable data|0
7584843|NCT02091284|26383214|P1|Overall Study|unreliable data|1
7584844|NCT02091284|26383213|P2|Overall Study|Withdrawal by Subject|1
7584845|NCT02091284|26383214|P1|Overall Study|Withdrawal by Subject|2
7584846|NCT02091206|26383236|P4|Taper Period|Lost to Follow-up|1
7584847|NCT02091206|26383237|P3|Taper Period|Lost to Follow-up|0
7584848|NCT02091206|26383238|P2|Taper Period|Lost to Follow-up|0
7584849|NCT02091206|26383239|P1|Taper Period|Lost to Follow-up|0
7584850|NCT02091206|26383236|P4|Taper Period|Participant refused study drug|1
7584851|NCT02091206|26383237|P3|Taper Period|Participant refused study drug|0
7584852|NCT02091206|26383238|P2|Taper Period|Participant refused study drug|0
7584853|NCT02091206|26383239|P1|Taper Period|Participant refused study drug|1
7584854|NCT02091206|26383236|P4|Treatment Period|Met withdrawal criteria|0
7584855|NCT02091206|26383237|P3|Treatment Period|Met withdrawal criteria|1
7584856|NCT02091206|26383238|P2|Treatment Period|Met withdrawal criteria|0
7584857|NCT02091206|26383239|P1|Treatment Period|Met withdrawal criteria|0
7584858|NCT02091206|26383236|P4|Treatment Period|Adverse Event|0
7584859|NCT02091206|26383237|P3|Treatment Period|Adverse Event|0
7584860|NCT02091206|26383238|P2|Treatment Period|Adverse Event|1
7584861|NCT02091206|26383239|P1|Treatment Period|Adverse Event|0
7584862|NCT02091167|26383258|P2|Overall Study|Lost to Follow-up|2
7584863|NCT02091167|26383259|P1|Overall Study|Lost to Follow-up|0
7584864|NCT02091089|26383275|P1|Overall Study|Lost to Follow-up|2
7584865|NCT02090959|26383283|P1|Overall Study|Other than specified|2
7584866|NCT02090959|26383283|P1|Overall Study|Switched to commercial supply|88
7584867|NCT02090959|26383283|P1|Overall Study|Entered in to other study|34
7584868|NCT02090959|26383283|P1|Overall Study|Move to medical need program|3
7584869|NCT02090959|26383283|P1|Overall Study|Transfer for compassionate use medicine|4
7584870|NCT02090959|26383283|P1|Overall Study|Enrolled but not treated|1
7584871|NCT02090959|26383283|P1|Overall Study|Study termination|6
7584872|NCT02090959|26383283|P1|Overall Study|Investigator decision|2
7584873|NCT02090959|26383283|P1|Overall Study|Adverse Event|1
7584874|NCT02090959|26383283|P1|Overall Study|Withdrawal by Subject|10
7584875|NCT02090855|26383310|P1|Overall Study|no evaluable Standard of Truth results|2
7584876|NCT02090764|26383323|P2|Overall Study|Lost to Follow-up|2
7584877|NCT02090764|26383324|P1|Overall Study|Lost to Follow-up|2
7584878|NCT02090764|26383323|P2|Overall Study|Intercurrent illness and other|1
7584879|NCT02090764|26383324|P1|Overall Study|Intercurrent illness and other|1
7584880|NCT02090764|26383323|P2|Overall Study|Withdrawal by Subject|1
7584881|NCT02090764|26383324|P1|Overall Study|Withdrawal by Subject|2
7584882|NCT02090764|26383323|P2|Overall Study|Lack of Efficacy|13
7584883|NCT02090764|26383324|P1|Overall Study|Lack of Efficacy|0
7584884|NCT02090764|26383323|P2|Overall Study|Adverse Event|3
7584885|NCT02090764|26383324|P1|Overall Study|Adverse Event|1
7584886|NCT02090725|26383330|P1|Overall Study|participants moved from area|3
7584887|NCT02090725|26383330|P1|Overall Study|Withdrawal by Subject|1
7584888|NCT02090634|26383336|P2|Overall Study|Adverse Event|0
7584889|NCT02090634|26383337|P1|Overall Study|Adverse Event|2
7584890|NCT02090634|26383336|P2|Overall Study|Protocol Violation|1
7584891|NCT02090634|26383337|P1|Overall Study|Protocol Violation|3
7584892|NCT02090634|26383336|P2|Overall Study|Death|1
7584893|NCT02090634|26383337|P1|Overall Study|Death|0
7584894|NCT02090634|26383336|P2|Overall Study|Lost to Follow-up|1
7584895|NCT02090634|26383337|P1|Overall Study|Lost to Follow-up|0
7584896|NCT02090426|26383347|P2|Overall Study|Lost to Follow-up|6
7584897|NCT02090426|26383348|P1|Overall Study|Lost to Follow-up|12
7584898|NCT02090413|26383379|P3|Overall Study|Lost to Follow-up|0
7584899|NCT02090413|26383380|P2|Overall Study|Lost to Follow-up|1
7584900|NCT02090413|26383381|P1|Overall Study|Lost to Follow-up|1
7584901|NCT02090413|26383379|P3|Overall Study|Other|0
7584902|NCT02090413|26383380|P2|Overall Study|Other|1
7584903|NCT02090413|26383381|P1|Overall Study|Other|2
7584904|NCT02090413|26383379|P3|Overall Study|Investigator Decision|0
7584905|NCT02090413|26383380|P2|Overall Study|Investigator Decision|1
7584906|NCT02090413|26383381|P1|Overall Study|Investigator Decision|1
7584907|NCT02090413|26383379|P3|Overall Study|Withdrawal by Subject|2
7584908|NCT02090413|26383380|P2|Overall Study|Withdrawal by Subject|2
7584909|NCT02090413|26383381|P1|Overall Study|Withdrawal by Subject|2
7584910|NCT02090413|26383379|P3|Overall Study|Flushing event|1
7584911|NCT02090413|26383380|P2|Overall Study|Flushing event|0
7584912|NCT02090413|26383381|P1|Overall Study|Flushing event|2
7584913|NCT02090413|26383379|P3|Overall Study|Adverse Event|20
7584914|NCT02090413|26383380|P2|Overall Study|Adverse Event|15
7584915|NCT02090413|26383381|P1|Overall Study|Adverse Event|11
7584916|NCT02090283|26383458|P3|Overall Study|Protocol Violation|0
7584917|NCT02090283|26383459|P2|Overall Study|Protocol Violation|0
7584918|NCT02090283|26383460|P1|Overall Study|Protocol Violation|2
7584919|NCT02090283|26383458|P3|Overall Study|Adverse Event|0
7584920|NCT02090283|26383459|P2|Overall Study|Adverse Event|1
7584921|NCT02090283|26383460|P1|Overall Study|Adverse Event|1
7584922|NCT02090283|26383458|P3|Overall Study|Lost to Follow-up|3
7584923|NCT02090283|26383459|P2|Overall Study|Lost to Follow-up|2
7584924|NCT02090283|26383460|P1|Overall Study|Lost to Follow-up|2
7584925|NCT02090283|26383458|P3|Overall Study|Sponsor Terminated Study|1
7584926|NCT02090283|26383459|P2|Overall Study|Sponsor Terminated Study|6
7584927|NCT02090283|26383460|P1|Overall Study|Sponsor Terminated Study|6
7584928|NCT02090283|26383458|P3|Overall Study|Withdrawal by Subject|6
7584929|NCT02090283|26383459|P2|Overall Study|Withdrawal by Subject|6
7584930|NCT02090283|26383460|P1|Overall Study|Withdrawal by Subject|6
7584931|NCT02089997|26383494|P1|Overall Study|Protocol Violation|147
7584932|NCT02089997|26383494|P1|Overall Study|Case report forms uncollected|99
7584933|NCT02089737|26383509|P1|Overall Study|Not treated|1
7584934|NCT02089737|26383509|P1|Overall Study|Survey form not completed|5
7584935|NCT02089347|26383559|P2|Overall Study|Protocol Violation|0
7584936|NCT02089347|26383560|P1|Overall Study|Protocol Violation|1
7584937|NCT02089334|26383586|P4|Overall Study|Physician Decision|1
7584938|NCT02089334|26383587|P3|Overall Study|Physician Decision|1
7584939|NCT02089334|26383588|P2|Overall Study|Physician Decision|0
7584940|NCT02089334|26383589|P1|Overall Study|Physician Decision|0
7584941|NCT02089334|26383586|P4|Overall Study|Progressive disease|2
7584942|NCT02089334|26383587|P3|Overall Study|Progressive disease|0
7584943|NCT02089334|26383588|P2|Overall Study|Progressive disease|0
7584944|NCT02089334|26383589|P1|Overall Study|Progressive disease|0
7584945|NCT02089334|26383586|P4|Overall Study|Adverse Event|2
7584946|NCT02089334|26383587|P3|Overall Study|Adverse Event|0
7584947|NCT02089334|26383588|P2|Overall Study|Adverse Event|0
7584948|NCT02089334|26383589|P1|Overall Study|Adverse Event|0
7584949|NCT02089334|26383586|P4|Overall Study|Withdrawal by Subject|2
7584950|NCT02089334|26383587|P3|Overall Study|Withdrawal by Subject|0
7584951|NCT02089334|26383588|P2|Overall Study|Withdrawal by Subject|0
7584952|NCT02089334|26383589|P1|Overall Study|Withdrawal by Subject|0
7584953|NCT02089230|26383609|P3|Overall Study|Seeking Alternative Therapy|4
7584954|NCT02089230|26383610|P2|Overall Study|Seeking Alternative Therapy|0
7584955|NCT02089230|26383611|P1|Overall Study|Seeking Alternative Therapy|0
7584956|NCT02089230|26383609|P3|Overall Study|Death|2
7584957|NCT02089230|26383610|P2|Overall Study|Death|0
7584958|NCT02089230|26383611|P1|Overall Study|Death|0
7584959|NCT02088957|26383642|P2|Overall Study|Lack of Efficacy|0
7584960|NCT02088957|26383643|P1|Overall Study|Lack of Efficacy|1
7584961|NCT02088905|26383661|P2|Overall Study|Withdrawal by Subject|1
7584962|NCT02088905|26383662|P1|Overall Study|Withdrawal by Subject|5
7584963|NCT02088697|26383695|P2|Wash-out Period (at Least 10 Days)|Adverse Event|0
7584964|NCT02088697|26383696|P1|Wash-out Period (at Least 10 Days)|Adverse Event|1
7584965|NCT02088697|26383695|P2|Period I|Physician Decision|4
7584966|NCT02088697|26383696|P1|Period I|Physician Decision|1
7584967|NCT02088541|26383709|P5|Overall Study|Other|1
7584968|NCT02088541|26383710|P4|Overall Study|Other|1
7584969|NCT02088541|26383711|P3|Overall Study|Other|3
7584970|NCT02088541|26383712|P2|Overall Study|Other|1
7584971|NCT02088541|26383713|P1|Overall Study|Other|2
7584972|NCT02088541|26383709|P5|Overall Study|Withdrawal by Subject|10
7584973|NCT02088541|26383710|P4|Overall Study|Withdrawal by Subject|7
7584974|NCT02088541|26383711|P3|Overall Study|Withdrawal by Subject|9
7584975|NCT02088541|26383712|P2|Overall Study|Withdrawal by Subject|2
7584976|NCT02088541|26383713|P1|Overall Study|Withdrawal by Subject|3
7584977|NCT02088541|26383709|P5|Overall Study|Study terminated by sponsor|6
7584978|NCT02088541|26383710|P4|Overall Study|Study terminated by sponsor|2
7584979|NCT02088541|26383711|P3|Overall Study|Study terminated by sponsor|12
7584980|NCT02088541|26383712|P2|Overall Study|Study terminated by sponsor|1
7584981|NCT02088541|26383713|P1|Overall Study|Study terminated by sponsor|1
7584982|NCT02088541|26383709|P5|Overall Study|Disease progression|1
7584983|NCT02088541|26383710|P4|Overall Study|Disease progression|3
7584984|NCT02088541|26383711|P3|Overall Study|Disease progression|2
7584985|NCT02088541|26383712|P2|Overall Study|Disease progression|1
7584986|NCT02088541|26383713|P1|Overall Study|Disease progression|7
7584987|NCT02088541|26383709|P5|Overall Study|Physician Decision|2
7584988|NCT02088541|26383710|P4|Overall Study|Physician Decision|0
7584989|NCT02088541|26383711|P3|Overall Study|Physician Decision|2
7584990|NCT02088541|26383712|P2|Overall Study|Physician Decision|1
7584991|NCT02088541|26383713|P1|Overall Study|Physician Decision|2
7584992|NCT02088541|26383709|P5|Overall Study|Lost to Follow-up|0
7584993|NCT02088541|26383710|P4|Overall Study|Lost to Follow-up|0
7584994|NCT02088541|26383711|P3|Overall Study|Lost to Follow-up|1
7584995|NCT02088541|26383712|P2|Overall Study|Lost to Follow-up|0
7584996|NCT02088541|26383713|P1|Overall Study|Lost to Follow-up|2
7584997|NCT02088541|26383709|P5|Overall Study|Death|38
7584998|NCT02088541|26383710|P4|Overall Study|Death|28
7584999|NCT02088541|26383711|P3|Overall Study|Death|85
7585000|NCT02088541|26383712|P2|Overall Study|Death|21
7585001|NCT02088541|26383713|P1|Overall Study|Death|51
7585002|NCT02088541|26383709|P5|Overall Study|Adverse Event|0
7585003|NCT02088541|26383710|P4|Overall Study|Adverse Event|3
7585004|NCT02088541|26383711|P3|Overall Study|Adverse Event|3
7585005|NCT02088541|26383712|P2|Overall Study|Adverse Event|0
7585006|NCT02088541|26383713|P1|Overall Study|Adverse Event|3
7585007|NCT02088177|26383784|P1|Overall Study|Lost to Follow-up|3
7585008|NCT02088073|26383794|P5|Maintanance Phase|Subject compliance|0
7585009|NCT02088073|26383795|P4|Maintanance Phase|Subject compliance|0
7585010|NCT02088073|26383796|P3|Maintanance Phase|Subject compliance|0
7585011|NCT02088073|26383797|P2|Maintanance Phase|Subject compliance|1
7585012|NCT02088073|26383798|P1|Maintanance Phase|Subject compliance|0
7585013|NCT02088073|26383794|P5|Maintanance Phase|Met ECG withdrawal criteria|2
7585014|NCT02088073|26383795|P4|Maintanance Phase|Met ECG withdrawal criteria|0
7585015|NCT02088073|26383796|P3|Maintanance Phase|Met ECG withdrawal criteria|1
7585016|NCT02088073|26383797|P2|Maintanance Phase|Met ECG withdrawal criteria|0
7585017|NCT02088073|26383798|P1|Maintanance Phase|Met ECG withdrawal criteria|0
7585018|NCT02088073|26383794|P5|Maintanance Phase|Miscellaneous|1
7585019|NCT02088073|26383795|P4|Maintanance Phase|Miscellaneous|2
7585020|NCT02088073|26383796|P3|Maintanance Phase|Miscellaneous|1
7585021|NCT02088073|26383797|P2|Maintanance Phase|Miscellaneous|2
7585022|NCT02088073|26383798|P1|Maintanance Phase|Miscellaneous|0
7585023|NCT02088073|26383794|P5|Maintanance Phase|Hypo- or hyperkalemia|1
7585024|NCT02088073|26383795|P4|Maintanance Phase|Hypo- or hyperkalemia|3
7585025|NCT02088073|26383796|P3|Maintanance Phase|Hypo- or hyperkalemia|0
7585026|NCT02088073|26383797|P2|Maintanance Phase|Hypo- or hyperkalemia|3
7585027|NCT02088073|26383798|P1|Maintanance Phase|Hypo- or hyperkalemia|0
7585028|NCT02088073|26383794|P5|Maintanance Phase|Sponsor's decision|1
7585029|NCT02088073|26383795|P4|Maintanance Phase|Sponsor's decision|2
7585030|NCT02088073|26383796|P3|Maintanance Phase|Sponsor's decision|0
7585031|NCT02088073|26383797|P2|Maintanance Phase|Sponsor's decision|2
7585032|NCT02088073|26383798|P1|Maintanance Phase|Sponsor's decision|0
7585033|NCT02088073|26383794|P5|Maintanance Phase|Physician Decision|1
7585034|NCT02088073|26383795|P4|Maintanance Phase|Physician Decision|0
7585035|NCT02088073|26383796|P3|Maintanance Phase|Physician Decision|0
7585036|NCT02088073|26383797|P2|Maintanance Phase|Physician Decision|0
7585037|NCT02088073|26383798|P1|Maintanance Phase|Physician Decision|0
7585038|NCT02088073|26383794|P5|Maintanance Phase|Adverse Event|1
7585039|NCT02088073|26383795|P4|Maintanance Phase|Adverse Event|0
7585040|NCT02088073|26383796|P3|Maintanance Phase|Adverse Event|3
7585041|NCT02088073|26383797|P2|Maintanance Phase|Adverse Event|0
7585042|NCT02088073|26383798|P1|Maintanance Phase|Adverse Event|0
7585043|NCT02088073|26383794|P5|Maintanance Phase|Withdrawal by Subject|0
7585044|NCT02088073|26383795|P4|Maintanance Phase|Withdrawal by Subject|0
7585045|NCT02088073|26383796|P3|Maintanance Phase|Withdrawal by Subject|0
7585046|NCT02088073|26383797|P2|Maintanance Phase|Withdrawal by Subject|2
7585047|NCT02088073|26383798|P1|Maintanance Phase|Withdrawal by Subject|0
7585048|NCT02088073|26383794|P5|Acute Phase|Hyperkalemia|0
7585049|NCT02088073|26383795|P4|Acute Phase|Hyperkalemia|0
7585050|NCT02088073|26383796|P3|Acute Phase|Hyperkalemia|0
7585051|NCT02088073|26383797|P2|Acute Phase|Hyperkalemia|0
7585052|NCT02088073|26383798|P1|Acute Phase|Hyperkalemia|2
7585053|NCT02088073|26383794|P5|Acute Phase|Withdrawal by Subject|0
7585054|NCT02088073|26383795|P4|Acute Phase|Withdrawal by Subject|0
7585055|NCT02088073|26383796|P3|Acute Phase|Withdrawal by Subject|0
7585056|NCT02088073|26383797|P2|Acute Phase|Withdrawal by Subject|0
7585057|NCT02088073|26383798|P1|Acute Phase|Withdrawal by Subject|5
7585058|NCT02088047|26383852|P2|Overall Study|Withdrawal by Subject|0
7585059|NCT02088047|26383853|P1|Overall Study|Withdrawal by Subject|1
7585060|NCT02088034|26383862|P3|Overall Study|Pregnancy|2
7585061|NCT02088034|26383863|P2|Overall Study|Pregnancy|1
7585062|NCT02088034|26383864|P1|Overall Study|Pregnancy|2
7585063|NCT02088034|26383862|P3|Overall Study|Lost to Follow-up|0
7585064|NCT02088034|26383863|P2|Overall Study|Lost to Follow-up|1
7585065|NCT02088034|26383864|P1|Overall Study|Lost to Follow-up|1
7585066|NCT02087943|26383894|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
7585067|NCT02087943|26383895|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
7585068|NCT02087943|26383896|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
7585069|NCT02087943|26383897|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
7585070|NCT02087943|26383898|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
7585071|NCT02087943|26383894|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
7585072|NCT02087943|26383895|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7585073|NCT02087943|26383896|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7585074|NCT02087943|26383897|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7585075|NCT02087943|26383898|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7585076|NCT02087943|26383894|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7585077|NCT02087943|26383895|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7585078|NCT02087943|26383896|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
7585079|NCT02087943|26383897|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7585080|NCT02087943|26383898|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7585081|NCT02087943|26383894|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7585082|NCT02087943|26383895|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7585083|NCT02087943|26383896|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7585084|NCT02087943|26383897|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
7585085|NCT02087943|26383898|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7585086|NCT02087943|26383894|P5|Active Treatment Phase Week 12-24|Adverse Event|1
7585087|NCT02087943|26383895|P4|Active Treatment Phase Week 12-24|Adverse Event|0
7585088|NCT02087943|26383896|P3|Active Treatment Phase Week 12-24|Adverse Event|2
7585089|NCT02087943|26383897|P2|Active Treatment Phase Week 12-24|Adverse Event|1
7585090|NCT02087943|26383898|P1|Active Treatment Phase Week 12-24|Adverse Event|0
7585091|NCT02087943|26383894|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7585092|NCT02087943|26383895|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7585093|NCT02087943|26383896|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7585094|NCT02087943|26383897|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
7585095|NCT02087943|26383898|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7585096|NCT02087943|26383894|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7585097|NCT02087943|26383895|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7585098|NCT02087943|26383896|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7585099|NCT02087943|26383897|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7585100|NCT02087943|26383898|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7585101|NCT02087943|26383894|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7585102|NCT02087943|26383895|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7585103|NCT02087943|26383896|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7585104|NCT02087943|26383897|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7585105|NCT02087943|26383898|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
7585106|NCT02087943|26383894|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7585107|NCT02087943|26383895|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7585108|NCT02087943|26383896|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
7585109|NCT02087943|26383897|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
7585110|NCT02087943|26383898|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
7585111|NCT02087943|26383894|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7585112|NCT02087943|26383895|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7585113|NCT02087943|26383896|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
7585114|NCT02087943|26383897|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
7585115|NCT02087943|26383898|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
7585116|NCT02087904|26383926|P4|Overall Study|Lost to Follow-up|2
7585117|NCT02087904|26383927|P3|Overall Study|Lost to Follow-up|2
7585118|NCT02087904|26383928|P2|Overall Study|Lost to Follow-up|4
7585119|NCT02087904|26383929|P1|Overall Study|Lost to Follow-up|0
7585120|NCT02087904|26383926|P4|Overall Study|Withdrawal by Subject|4
7585121|NCT02087904|26383927|P3|Overall Study|Withdrawal by Subject|7
7585122|NCT02087904|26383928|P2|Overall Study|Withdrawal by Subject|3
7585123|NCT02087904|26383929|P1|Overall Study|Withdrawal by Subject|8
7585124|NCT02087904|26383926|P4|Overall Study|Other|4
7585125|NCT02087904|26383927|P3|Overall Study|Other|4
7585126|NCT02087904|26383928|P2|Overall Study|Other|2
7585127|NCT02087904|26383929|P1|Overall Study|Other|6
7585128|NCT02087904|26383926|P4|Overall Study|Lack of Efficacy|2
7585129|NCT02087904|26383927|P3|Overall Study|Lack of Efficacy|3
7585130|NCT02087904|26383928|P2|Overall Study|Lack of Efficacy|6
7585131|NCT02087904|26383929|P1|Overall Study|Lack of Efficacy|3
7585132|NCT02087904|26383926|P4|Overall Study|Adverse Event|12
7585133|NCT02087904|26383927|P3|Overall Study|Adverse Event|4
7585134|NCT02087904|26383928|P2|Overall Study|Adverse Event|4
7585135|NCT02087904|26383929|P1|Overall Study|Adverse Event|8
7585136|NCT02087904|26383926|P4|Overall Study|Did Not Receive Study Drug|1
7585137|NCT02087904|26383927|P3|Overall Study|Did Not Receive Study Drug|2
7585138|NCT02087904|26383928|P2|Overall Study|Did Not Receive Study Drug|0
7585139|NCT02087904|26383929|P1|Overall Study|Did Not Receive Study Drug|0
7585140|NCT02087774|26384045|P2|Overall Study|Were absent day of data collection|20
7585141|NCT02087774|26384046|P1|Overall Study|Were absent day of data collection|8
7585142|NCT02087670|26384066|P2|Overall Study|Withdrawal by Subject|2
7585143|NCT02087670|26384067|P1|Overall Study|Withdrawal by Subject|3
7585144|NCT02087423|26384103|P3|Overall Study|Terminated from study at final DCO|25
7585145|NCT02087423|26384104|P2|Overall Study|Terminated from study at final DCO|36
7585146|NCT02087423|26384105|P1|Overall Study|Terminated from study at final DCO|23
7585147|NCT02087423|26384103|P3|Overall Study|Lost to Follow-up|0
7585148|NCT02087423|26384104|P2|Overall Study|Lost to Follow-up|2
7585149|NCT02087423|26384105|P1|Overall Study|Lost to Follow-up|0
7585150|NCT02087423|26384103|P3|Overall Study|Death|40
7585151|NCT02087423|26384104|P2|Overall Study|Death|207
7585152|NCT02087423|26384105|P1|Overall Study|Death|68
7585153|NCT02087423|26384103|P3|Overall Study|Withdrawal by Subject|3
7585154|NCT02087423|26384104|P2|Overall Study|Withdrawal by Subject|20
7585155|NCT02087423|26384105|P1|Overall Study|Withdrawal by Subject|20
7585156|NCT02087241|26384152|P4|Overall Study|Study Terminated by Sponsor|4
7585157|NCT02087241|26384153|P3|Overall Study|Study Terminated by Sponsor|0
7585158|NCT02087241|26384154|P2|Overall Study|Study Terminated by Sponsor|2
7585159|NCT02087241|26384155|P1|Overall Study|Study Terminated by Sponsor|0
7585160|NCT02087241|26384152|P4|Overall Study|Progressive Disease|1
7585161|NCT02087241|26384153|P3|Overall Study|Progressive Disease|0
7585162|NCT02087241|26384154|P2|Overall Study|Progressive Disease|0
7585163|NCT02087241|26384155|P1|Overall Study|Progressive Disease|0
7585164|NCT02087241|26384152|P4|Overall Study|Withdrawal by Subject|1
7585165|NCT02087241|26384153|P3|Overall Study|Withdrawal by Subject|0
7585166|NCT02087241|26384154|P2|Overall Study|Withdrawal by Subject|0
7585167|NCT02087241|26384155|P1|Overall Study|Withdrawal by Subject|1
7585168|NCT02087241|26384152|P4|Overall Study|Death|1
7585169|NCT02087241|26384153|P3|Overall Study|Death|1
7585170|NCT02087241|26384154|P2|Overall Study|Death|1
7585171|NCT02087241|26384155|P1|Overall Study|Death|2
7585172|NCT02087176|26384181|P1|Overall Study|Study Terminated by Sponsor|2
7585173|NCT02087176|26384181|P1|Overall Study|Censored|19
7585174|NCT02087176|26384181|P1|Overall Study|Death|10
7585175|NCT02087176|26384181|P1|Overall Study|Withdrawal by Subject|1
7585176|NCT02087150|26384194|P3|Overall Study|Pt moved out of town|0
7585177|NCT02087150|26384195|P2|Overall Study|Pt moved out of town|1
7585178|NCT02087150|26384196|P1|Overall Study|Pt moved out of town|0
7585179|NCT02087150|26384194|P3|Overall Study|Other|0
7585180|NCT02087150|26384195|P2|Overall Study|Other|0
7585181|NCT02087150|26384196|P1|Overall Study|Other|1
7585182|NCT02087150|26384194|P3|Overall Study|F/U not completed w/in study window|1
7585183|NCT02087150|26384195|P2|Overall Study|F/U not completed w/in study window|0
7585184|NCT02087150|26384196|P1|Overall Study|F/U not completed w/in study window|0
7585185|NCT02087150|26384194|P3|Overall Study|Procedure not done|0
7585186|NCT02087150|26384195|P2|Overall Study|Procedure not done|13
7585187|NCT02087150|26384196|P1|Overall Study|Procedure not done|1
7585188|NCT02087150|26384194|P3|Overall Study|Physician Decision|0
7585189|NCT02087150|26384195|P2|Overall Study|Physician Decision|1
7585190|NCT02087150|26384196|P1|Overall Study|Physician Decision|0
7585191|NCT02087150|26384194|P3|Overall Study|Withdrawal by Subject|3
7585192|NCT02087150|26384195|P2|Overall Study|Withdrawal by Subject|5
7585193|NCT02087150|26384196|P1|Overall Study|Withdrawal by Subject|2
7585194|NCT02087150|26384194|P3|Overall Study|Lost to Follow-up|7
7585195|NCT02087150|26384195|P2|Overall Study|Lost to Follow-up|13
7585196|NCT02087150|26384196|P1|Overall Study|Lost to Follow-up|6
7585197|NCT02087150|26384194|P3|Overall Study|Death|0
7585198|NCT02087150|26384195|P2|Overall Study|Death|1
7585199|NCT02087150|26384196|P1|Overall Study|Death|0
7585200|NCT02087085|26384215|P2|Overall Study|Other Miscellaneous Reasons|4
7585201|NCT02087085|26384216|P1|Overall Study|Other Miscellaneous Reasons|3
7585202|NCT02087085|26384215|P2|Overall Study|Study Terminated by Sponsor|80
7585203|NCT02087085|26384216|P1|Overall Study|Study Terminated by Sponsor|87
7585204|NCT02087085|26384215|P2|Overall Study|Protocol Violation|0
7585205|NCT02087085|26384216|P1|Overall Study|Protocol Violation|1
7585206|NCT02087085|26384215|P2|Overall Study|Withdrawal by Subject|11
7585207|NCT02087085|26384216|P1|Overall Study|Withdrawal by Subject|9
7585208|NCT02087085|26384215|P2|Overall Study|Lost to Follow-up|4
7585209|NCT02087085|26384216|P1|Overall Study|Lost to Follow-up|6
7585210|NCT02087085|26384215|P2|Overall Study|Lack of Efficacy|3
7585211|NCT02087085|26384216|P1|Overall Study|Lack of Efficacy|4
7585212|NCT02087085|26384215|P2|Overall Study|Adverse Event|14
7585213|NCT02087085|26384216|P1|Overall Study|Adverse Event|10
7585214|NCT02087059|26384226|P1|Overall Study|Lost to Follow-up|1
7585215|NCT02087059|26384226|P1|Overall Study|Adverse Event|5
7585216|NCT02087059|26384226|P1|Overall Study|Disease Progression|1
7585217|NCT02087046|26384234|P1|Overall Study|Physician Decision|1
7585218|NCT02087046|26384234|P1|Overall Study|Withdrawal by Subject|2
7585219|NCT02087046|26384234|P1|Overall Study|Lost to Follow-up|3
7585220|NCT02087046|26384234|P1|Overall Study|Death|1
7585221|NCT02087046|26384234|P1|Overall Study|Adverse Event|4
7585222|NCT02086968|26384306|P2|Overall Study|Withdrawal by Subject|4
7585223|NCT02086968|26384307|P1|Overall Study|Withdrawal by Subject|1
7585224|NCT02086968|26384306|P2|Overall Study|Physician Decision|0
7585225|NCT02086968|26384307|P1|Overall Study|Physician Decision|4
7585226|NCT02086968|26384306|P2|Overall Study|Study drug received outside protocol|1
7585227|NCT02086968|26384307|P1|Overall Study|Study drug received outside protocol|0
7585228|NCT02086968|26384306|P2|Overall Study|Lost to Follow-up|3
7585229|NCT02086968|26384307|P1|Overall Study|Lost to Follow-up|2
7585230|NCT02086968|26384306|P2|Overall Study|Adverse Event|5
7585231|NCT02086968|26384307|P1|Overall Study|Adverse Event|1
7585232|NCT02086591|26384361|P1|Overall Study|protocol terminated|3
7585233|NCT02086591|26384361|P1|Overall Study|Withdrawal by Subject|1
7585234|NCT02086591|26384361|P1|Overall Study|Adverse Event|1
7585235|NCT02086565|26384369|P2|Overall Study|withdrawn by research team|2
7585236|NCT02086565|26384370|P1|Overall Study|withdrawn by research team|2
7585237|NCT02086565|26384369|P2|Overall Study|Death|2
7585238|NCT02086565|26384370|P1|Overall Study|Death|3
7585239|NCT02086565|26384369|P2|Overall Study|Withdrawal by Subject|1
7585240|NCT02086565|26384370|P1|Overall Study|Withdrawal by Subject|2
7585241|NCT02086565|26384369|P2|Overall Study|Lost to Follow-up|7
7585242|NCT02086565|26384370|P1|Overall Study|Lost to Follow-up|9
7585243|NCT02086552|26384384|P1|Overall Study|Withdrawal by Subject|1
7585244|NCT02086162|26384433|P2|Overall Study|Death|0
7585245|NCT02086162|26384434|P1|Overall Study|Death|1
7585246|NCT02086162|26384433|P2|Overall Study|Lost to Follow-up|2
7585247|NCT02086162|26384434|P1|Overall Study|Lost to Follow-up|4
7585248|NCT02086162|26384433|P2|Overall Study|moved|1
7585249|NCT02086162|26384434|P1|Overall Study|moved|1
7585250|NCT02086162|26384433|P2|Overall Study|Withdrawal by Subject|4
7585251|NCT02086162|26384434|P1|Overall Study|Withdrawal by Subject|4
7585252|NCT02086110|26384446|P2|Overall Study|Withdrawal by Subject|1
7585253|NCT02086110|26384447|P1|Overall Study|Withdrawal by Subject|1
7585254|NCT02085785|26384462|P2|Overall Study|Lost to Follow-up|1
7585255|NCT02085785|26384463|P1|Overall Study|Lost to Follow-up|0
7585256|NCT02085785|26384462|P2|Overall Study|Withdrawal by Subject|1
7585257|NCT02085785|26384463|P1|Overall Study|Withdrawal by Subject|2
7585267|NCT02085252|26384633|P2|Overall Study|Reason Unknown|1
7585268|NCT02085252|26384634|P1|Overall Study|Reason Unknown|0
7585269|NCT02085252|26384633|P2|Overall Study|Reason Not Specified|1
7585270|NCT02085252|26384634|P1|Overall Study|Reason Not Specified|0
7585271|NCT02085252|26384633|P2|Overall Study|Discontinuation Due to Patient Decision|1
7585272|NCT02085252|26384634|P1|Overall Study|Discontinuation Due to Patient Decision|0
7585273|NCT02085252|26384633|P2|Overall Study|Adverse Event|1
7585274|NCT02085252|26384634|P1|Overall Study|Adverse Event|0
7585275|NCT02085252|26384633|P2|Overall Study|Withdrawal of Consent|0
7585276|NCT02085252|26384634|P1|Overall Study|Withdrawal of Consent|1
7585277|NCT02085161|26384658|P4|Overall Study|Other Reason|1
7585278|NCT02085161|26384659|P3|Overall Study|Other Reason|1
7585279|NCT02085161|26384660|P2|Overall Study|Other Reason|0
7585280|NCT02085161|26384661|P1|Overall Study|Other Reason|1
7585281|NCT02085161|26384658|P4|Overall Study|Withdrawal by Subject|3
7585282|NCT02085161|26384659|P3|Overall Study|Withdrawal by Subject|0
7585283|NCT02085161|26384660|P2|Overall Study|Withdrawal by Subject|4
7585284|NCT02085161|26384661|P1|Overall Study|Withdrawal by Subject|2
7585285|NCT02085161|26384658|P4|Overall Study|Protocol Violation|1
7585286|NCT02085161|26384659|P3|Overall Study|Protocol Violation|0
7585287|NCT02085161|26384660|P2|Overall Study|Protocol Violation|1
7585288|NCT02085161|26384661|P1|Overall Study|Protocol Violation|0
7585289|NCT02085161|26384658|P4|Overall Study|Adverse Event|5
7585290|NCT02085161|26384659|P3|Overall Study|Adverse Event|4
7585291|NCT02085161|26384660|P2|Overall Study|Adverse Event|5
7585292|NCT02085161|26384661|P1|Overall Study|Adverse Event|8
7585293|NCT02085161|26384658|P4|Overall Study|Not Treated|0
7585294|NCT02085161|26384659|P3|Overall Study|Not Treated|0
7585295|NCT02085161|26384660|P2|Overall Study|Not Treated|0
7585296|NCT02085161|26384661|P1|Overall Study|Not Treated|1
7585297|NCT02085135|26384702|P2|Overall Study|Lack of Efficacy|0
7585298|NCT02085135|26384703|P1|Overall Study|Lack of Efficacy|2
7585299|NCT02085135|26384702|P2|Overall Study|Withdrawal by Subject|0
7585300|NCT02085135|26384703|P1|Overall Study|Withdrawal by Subject|3
7585301|NCT02085135|26384702|P2|Overall Study|Lost to Follow-up|2
7585302|NCT02085135|26384703|P1|Overall Study|Lost to Follow-up|2
7585303|NCT02085135|26384702|P2|Overall Study|Adverse Event|7
7585304|NCT02085135|26384703|P1|Overall Study|Adverse Event|4
7585305|NCT02084238|26384784|P1|Overall Study|Lost to Follow-up|2
7585306|NCT02084134|26384809|P2|Overall Study|Death|1
7585307|NCT02084134|26384810|P1|Overall Study|Death|0
7585308|NCT02084134|26384809|P2|Overall Study|Protocol Violation|2
7585309|NCT02084134|26384810|P1|Overall Study|Protocol Violation|4
7585310|NCT02084082|26384820|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7585311|NCT02084082|26384821|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7585312|NCT02084082|26384822|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7585313|NCT02084082|26384823|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7585314|NCT02084082|26384820|P4|Washout Period 1 (35 Days)|Adverse Event|1
7585315|NCT02084082|26384821|P3|Washout Period 1 (35 Days)|Adverse Event|1
7585316|NCT02084082|26384822|P2|Washout Period 1 (35 Days)|Adverse Event|0
7585317|NCT02084082|26384823|P1|Washout Period 1 (35 Days)|Adverse Event|0
7585318|NCT02084056|26384864|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7585319|NCT02084056|26384865|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7585407|NCT02082977|26385315|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
7585320|NCT02084056|26384866|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7585321|NCT02084056|26384867|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7585322|NCT02084056|26384864|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7585323|NCT02084056|26384865|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7585324|NCT02084056|26384866|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7585325|NCT02084056|26384867|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7585326|NCT02083965|26384899|P2|Treatment Period|Other|0
7585327|NCT02083965|26384900|P1|Treatment Period|Other|1
7585328|NCT02083926|26384958|P2|Overall Study|Withdrawal by Subject|0
7585329|NCT02083926|26384959|P1|Overall Study|Withdrawal by Subject|1
7585330|NCT02083783|26384993|P2|Overall Study|Withdrawal by Subject|0
7585331|NCT02083783|26384994|P1|Overall Study|Withdrawal by Subject|1
7585332|NCT02083653|26385026|P3|Overall Study|Reason Missing|4
7585333|NCT02083653|26385027|P2|Overall Study|Reason Missing|0
7585334|NCT02083653|26385028|P1|Overall Study|Reason Missing|0
7585335|NCT02083653|26385026|P3|Overall Study|Other Events|2
7585336|NCT02083653|26385027|P2|Overall Study|Other Events|2
7585337|NCT02083653|26385028|P1|Overall Study|Other Events|0
7585338|NCT02083653|26385026|P3|Overall Study|Withdrawal by Subject|2
7585339|NCT02083653|26385027|P2|Overall Study|Withdrawal by Subject|1
7585340|NCT02083653|26385028|P1|Overall Study|Withdrawal by Subject|2
7585341|NCT02083653|26385026|P3|Overall Study|Progressive Disease|63
7585342|NCT02083653|26385027|P2|Overall Study|Progressive Disease|73
7585343|NCT02083653|26385028|P1|Overall Study|Progressive Disease|65
7585344|NCT02083653|26385026|P3|Overall Study|Death|2
7585345|NCT02083653|26385027|P2|Overall Study|Death|2
7585346|NCT02083653|26385028|P1|Overall Study|Death|2
7585347|NCT02083653|26385026|P3|Overall Study|Lost to Follow-up|0
7585348|NCT02083653|26385027|P2|Overall Study|Lost to Follow-up|0
7585349|NCT02083653|26385028|P1|Overall Study|Lost to Follow-up|1
7585350|NCT02083653|26385026|P3|Overall Study|Adverse Event|4
7585351|NCT02083653|26385027|P2|Overall Study|Adverse Event|5
7585352|NCT02083653|26385028|P1|Overall Study|Adverse Event|12
7585353|NCT02083653|26385026|P3|Overall Study|Randomized but not Treated|7
7585354|NCT02083653|26385027|P2|Overall Study|Randomized but not Treated|2
7585355|NCT02083653|26385028|P1|Overall Study|Randomized but not Treated|0
7585356|NCT02083380|26385096|P3|Overall Study|Other|6
7585357|NCT02083380|26385097|P2|Overall Study|Other|4
7585358|NCT02083380|26385098|P1|Overall Study|Other|8
7585359|NCT02083380|26385096|P3|Overall Study|Lost to Follow-up|3
7585360|NCT02083380|26385097|P2|Overall Study|Lost to Follow-up|3
7585361|NCT02083380|26385098|P1|Overall Study|Lost to Follow-up|5
7585362|NCT02083380|26385096|P3|Overall Study|Adverse Event|1
7585363|NCT02083380|26385097|P2|Overall Study|Adverse Event|0
7585364|NCT02083380|26385098|P1|Overall Study|Adverse Event|0
7585365|NCT02083380|26385096|P3|Overall Study|Physician Decision|3
7585366|NCT02083380|26385097|P2|Overall Study|Physician Decision|6
7585367|NCT02083380|26385098|P1|Overall Study|Physician Decision|1
7585368|NCT02083380|26385096|P3|Overall Study|Withdrawal by Subject|7
7585369|NCT02083380|26385097|P2|Overall Study|Withdrawal by Subject|3
7585370|NCT02083380|26385098|P1|Overall Study|Withdrawal by Subject|9
7585371|NCT02083380|26385096|P3|Overall Study|Lack of Efficacy|64
7585372|NCT02083380|26385097|P2|Overall Study|Lack of Efficacy|79
7585373|NCT02083380|26385098|P1|Overall Study|Lack of Efficacy|68
7585374|NCT02083354|26385191|P1|Overall Study|Disease progression|32
7585375|NCT02083354|26385191|P1|Overall Study|Withdrawal by Subject|5
7585376|NCT02083354|26385191|P1|Overall Study|Adverse Event|3
7585377|NCT02083354|26385191|P1|Overall Study|Lost to Follow-up|1
7585378|NCT02083185|26385207|P3|Overall Study|Did not Receive Study Drug|0
7585379|NCT02083185|26385208|P2|Overall Study|Did not Receive Study Drug|2
7585380|NCT02083185|26385209|P1|Overall Study|Did not Receive Study Drug|0
7585381|NCT02083185|26385207|P3|Overall Study|Study Terminated by Sponsor|0
7585382|NCT02083185|26385208|P2|Overall Study|Study Terminated by Sponsor|1
7585383|NCT02083185|26385209|P1|Overall Study|Study Terminated by Sponsor|0
7585384|NCT02083185|26385207|P3|Overall Study|Reason not Specified|5
7585385|NCT02083185|26385208|P2|Overall Study|Reason not Specified|6
7585386|NCT02083185|26385209|P1|Overall Study|Reason not Specified|9
7585387|NCT02083185|26385207|P3|Overall Study|Death|1
7585388|NCT02083185|26385208|P2|Overall Study|Death|2
7585389|NCT02083185|26385209|P1|Overall Study|Death|2
7585390|NCT02083185|26385207|P3|Overall Study|Withdrawal by Subject|1
7585391|NCT02083185|26385208|P2|Overall Study|Withdrawal by Subject|15
7585392|NCT02083185|26385209|P1|Overall Study|Withdrawal by Subject|9
7585393|NCT02083185|26385207|P3|Overall Study|Lost to Follow-up|0
7585394|NCT02083185|26385208|P2|Overall Study|Lost to Follow-up|3
7585395|NCT02083185|26385209|P1|Overall Study|Lost to Follow-up|0
7585396|NCT02082977|26385314|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585397|NCT02082977|26385315|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585398|NCT02082977|26385316|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
7585399|NCT02082977|26385317|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585400|NCT02082977|26385318|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585401|NCT02082977|26385319|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585402|NCT02082977|26385320|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585403|NCT02082977|26385321|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585404|NCT02082977|26385322|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585405|NCT02082977|26385323|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7585406|NCT02082977|26385314|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
7585408|NCT02082977|26385316|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
7585409|NCT02082977|26385317|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
7585410|NCT02082977|26385318|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
7585411|NCT02082977|26385319|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
7585412|NCT02082977|26385320|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
7585413|NCT02082977|26385321|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
7585414|NCT02082977|26385322|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
7585415|NCT02082977|26385323|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
7585416|NCT02082977|26385314|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585417|NCT02082977|26385315|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585418|NCT02082977|26385316|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585419|NCT02082977|26385317|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585420|NCT02082977|26385318|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
7585421|NCT02082977|26385319|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585422|NCT02082977|26385320|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585423|NCT02082977|26385321|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585424|NCT02082977|26385322|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585425|NCT02082977|26385323|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7585426|NCT02082977|26385314|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585427|NCT02082977|26385315|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585428|NCT02082977|26385316|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
7585429|NCT02082977|26385317|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585430|NCT02082977|26385318|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585431|NCT02082977|26385319|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585432|NCT02082977|26385320|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585433|NCT02082977|26385321|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585434|NCT02082977|26385322|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585435|NCT02082977|26385323|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7585436|NCT02082977|26385314|P10|Part 1 (Up to 3.2 Years)|Death|0
7585437|NCT02082977|26385315|P9|Part 1 (Up to 3.2 Years)|Death|1
7585438|NCT02082977|26385316|P8|Part 1 (Up to 3.2 Years)|Death|0
7585439|NCT02082977|26385317|P7|Part 1 (Up to 3.2 Years)|Death|2
7585440|NCT02082977|26385318|P6|Part 1 (Up to 3.2 Years)|Death|1
7585441|NCT02082977|26385319|P5|Part 1 (Up to 3.2 Years)|Death|0
7585442|NCT02082977|26385320|P4|Part 1 (Up to 3.2 Years)|Death|0
7585443|NCT02082977|26385321|P3|Part 1 (Up to 3.2 Years)|Death|0
7585444|NCT02082977|26385322|P2|Part 1 (Up to 3.2 Years)|Death|0
7585445|NCT02082977|26385323|P1|Part 1 (Up to 3.2 Years)|Death|1
7585446|NCT02082912|26385577|P2|Overall Study|Physician Decision|1
7585447|NCT02082912|26385578|P1|Overall Study|Physician Decision|0
7585448|NCT02082522|26385639|P2|Overall Study|Chemotherapy change|3
7585449|NCT02082522|26385640|P1|Overall Study|Chemotherapy change|1
7585450|NCT02082522|26385639|P2|Overall Study|Disease progression|2
7585451|NCT02082522|26385640|P1|Overall Study|Disease progression|2
7585452|NCT02082522|26385639|P2|Overall Study|Physician Decision|1
7585453|NCT02082522|26385640|P1|Overall Study|Physician Decision|3
7585454|NCT02082522|26385639|P2|Overall Study|Lost to Follow-up|0
7585455|NCT02082522|26385640|P1|Overall Study|Lost to Follow-up|1
7585456|NCT02082522|26385639|P2|Overall Study|Death|0
7585457|NCT02082522|26385640|P1|Overall Study|Death|1
7585458|NCT02082522|26385639|P2|Overall Study|Withdrawal by Subject|4
7585459|NCT02082522|26385640|P1|Overall Study|Withdrawal by Subject|2
7585460|NCT02082522|26385639|P2|Overall Study|Sponsor termination|3
7585461|NCT02082522|26385640|P1|Overall Study|Sponsor termination|5
7585462|NCT02082483|26385690|P2|Overall Study|Death|3
7585463|NCT02082483|26385691|P1|Overall Study|Death|2
7585464|NCT02082483|26385690|P2|Overall Study|Physician Decision|1
7585465|NCT02082483|26385691|P1|Overall Study|Physician Decision|1
7585466|NCT02082483|26385690|P2|Overall Study|Withdrawal by Subject|1
7585467|NCT02082483|26385691|P1|Overall Study|Withdrawal by Subject|2
7585468|NCT02082483|26385690|P2|Overall Study|Lost to Follow-up|1
7585469|NCT02082483|26385691|P1|Overall Study|Lost to Follow-up|1
7585470|NCT02082340|26385743|P2|Overall Study|Lost to Follow-up|1
7585471|NCT02082340|26385744|P1|Overall Study|Lost to Follow-up|1
7585472|NCT02082262|26385754|P1|Overall Study|Adverse Event|48
7585473|NCT02082262|26385754|P1|Overall Study|Withdrawal by Subject|3
7585474|NCT02082210|26385764|P6|Overall Study|Physician Decision|0
7585475|NCT02082210|26385765|P5|Overall Study|Physician Decision|0
7585476|NCT02082210|26385766|P4|Overall Study|Physician Decision|1
7585477|NCT02082210|26385767|P3|Overall Study|Physician Decision|1
7585478|NCT02082210|26385768|P2|Overall Study|Physician Decision|0
7585479|NCT02082210|26385769|P1|Overall Study|Physician Decision|0
7585480|NCT02082210|26385764|P6|Overall Study|No Post-Baseline Tumor Assesment|0
7585481|NCT02082210|26385765|P5|Overall Study|No Post-Baseline Tumor Assesment|0
7585482|NCT02082210|26385766|P4|Overall Study|No Post-Baseline Tumor Assesment|2
7585483|NCT02082210|26385767|P3|Overall Study|No Post-Baseline Tumor Assesment|1
7585484|NCT02082210|26385768|P2|Overall Study|No Post-Baseline Tumor Assesment|0
7585485|NCT02082210|26385769|P1|Overall Study|No Post-Baseline Tumor Assesment|0
7585486|NCT02082210|26385764|P6|Overall Study|Clinical Progression|0
7585487|NCT02082210|26385765|P5|Overall Study|Clinical Progression|0
7585488|NCT02082210|26385766|P4|Overall Study|Clinical Progression|1
7585489|NCT02082210|26385767|P3|Overall Study|Clinical Progression|0
7585490|NCT02082210|26385768|P2|Overall Study|Clinical Progression|0
7585491|NCT02082210|26385769|P1|Overall Study|Clinical Progression|0
7585492|NCT02082210|26385764|P6|Overall Study|Withdrawal by Subject|2
7585493|NCT02082210|26385765|P5|Overall Study|Withdrawal by Subject|2
7585494|NCT02082210|26385766|P4|Overall Study|Withdrawal by Subject|1
7585495|NCT02082210|26385767|P3|Overall Study|Withdrawal by Subject|0
7585496|NCT02082210|26385768|P2|Overall Study|Withdrawal by Subject|0
7585497|NCT02082210|26385769|P1|Overall Study|Withdrawal by Subject|0
7585498|NCT02082210|26385764|P6|Overall Study|Death|0
7585499|NCT02082210|26385765|P5|Overall Study|Death|1
7585500|NCT02082210|26385766|P4|Overall Study|Death|1
7585501|NCT02082210|26385767|P3|Overall Study|Death|1
7585502|NCT02082210|26385768|P2|Overall Study|Death|0
7585503|NCT02082210|26385769|P1|Overall Study|Death|0
7585504|NCT02082184|26385817|P2|Overall Study|Subject non-compliance|1
7585505|NCT02082184|26385818|P1|Overall Study|Subject non-compliance|0
7585506|NCT02082184|26385817|P2|Overall Study|Lost to Follow-up|2
7585507|NCT02082184|26385818|P1|Overall Study|Lost to Follow-up|0
7585508|NCT02082184|26385817|P2|Overall Study|Protocol Violation|6
7585509|NCT02082184|26385818|P1|Overall Study|Protocol Violation|0
7585510|NCT02082184|26385817|P2|Overall Study|Withdrawal by Subject|2
7585511|NCT02082184|26385818|P1|Overall Study|Withdrawal by Subject|3
7585512|NCT02082184|26385817|P2|Overall Study|Device associated symptoms|0
7585513|NCT02082184|26385818|P1|Overall Study|Device associated symptoms|5
7585514|NCT02082184|26385817|P2|Overall Study|Medical diagnosis|2
7585515|NCT02082184|26385818|P1|Overall Study|Medical diagnosis|1
7585516|NCT02082184|26385817|P2|Overall Study|Adverse Event|0
7585517|NCT02082184|26385818|P1|Overall Study|Adverse Event|1
7585518|NCT02082158|26385843|P6|Overall Study|Failed Fit-testing|7
7585519|NCT02082158|26385844|P5|Overall Study|Failed Fit-testing|3
7585520|NCT02082158|26385845|P4|Overall Study|Failed Fit-testing|4
7585521|NCT02082158|26385846|P3|Overall Study|Failed Fit-testing|14
7585522|NCT02082158|26385847|P2|Overall Study|Failed Fit-testing|8
7585523|NCT02082158|26385848|P1|Overall Study|Failed Fit-testing|8
7585524|NCT02082158|26385843|P6|Overall Study|Withdrawal by Subject|0
7585525|NCT02082158|26385844|P5|Overall Study|Withdrawal by Subject|1
7585526|NCT02082158|26385845|P4|Overall Study|Withdrawal by Subject|0
7585527|NCT02082158|26385846|P3|Overall Study|Withdrawal by Subject|0
7585528|NCT02082158|26385847|P2|Overall Study|Withdrawal by Subject|0
7585529|NCT02082158|26385848|P1|Overall Study|Withdrawal by Subject|0
7585530|NCT02081859|26385978|P2|Overall Study|Other reasons|0
7585531|NCT02081859|26385979|P1|Overall Study|Other reasons|2
7585532|NCT02081859|26385978|P2|Overall Study|< 4 embryos|23
7585533|NCT02081859|26385979|P1|Overall Study|< 4 embryos|27
7585534|NCT02081859|26385978|P2|Overall Study|Unanticipated freeze all cycle|6
7585535|NCT02081859|26385979|P1|Overall Study|Unanticipated freeze all cycle|2
7585536|NCT02081859|26385978|P2|Overall Study|No sperm|0
7585537|NCT02081859|26385979|P1|Overall Study|No sperm|1
7585538|NCT02081859|26385978|P2|Overall Study|No fertilization|2
7585539|NCT02081859|26385979|P1|Overall Study|No fertilization|2
7585540|NCT02081846|26385989|P2|Overall Study|invalid consent|0
7585541|NCT02081846|26385990|P1|Overall Study|invalid consent|1
7585542|NCT02081846|26385989|P2|Overall Study|Withdrawal by Subject|0
7585543|NCT02081846|26385990|P1|Overall Study|Withdrawal by Subject|1
7585544|NCT02081690|26386159|P1|Overall Study|Withdrawal by Subject|1
7585545|NCT02081690|26386159|P1|Overall Study|Physician Decision|3
7585546|NCT02081690|26386159|P1|Overall Study|Death|3
7585547|NCT02081677|26386170|P4|Overall Study|Unsatisfactory Lens Fitting|0
7585548|NCT02081677|26386171|P3|Overall Study|Unsatisfactory Lens Fitting|0
7585549|NCT02081677|26386172|P2|Overall Study|Unsatisfactory Lens Fitting|1
7585550|NCT02081677|26386173|P1|Overall Study|Unsatisfactory Lens Fitting|0
7585551|NCT02081677|26386170|P4|Overall Study|Not comfortable with lens care system|0
7585552|NCT02081677|26386171|P3|Overall Study|Not comfortable with lens care system|0
7585553|NCT02081677|26386172|P2|Overall Study|Not comfortable with lens care system|0
7585554|NCT02081677|26386173|P1|Overall Study|Not comfortable with lens care system|1
7585555|NCT02081677|26386170|P4|Overall Study|No Longer Meets Eligibility Criteria|0
7585556|NCT02081677|26386171|P3|Overall Study|No Longer Meets Eligibility Criteria|1
7585557|NCT02081677|26386172|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7585558|NCT02081677|26386173|P1|Overall Study|No Longer Meets Eligibility Criteria|0
7585559|NCT02081677|26386170|P4|Overall Study|Adverse Event|0
7585560|NCT02081677|26386171|P3|Overall Study|Adverse Event|1
7585561|NCT02081677|26386172|P2|Overall Study|Adverse Event|0
7585562|NCT02081677|26386173|P1|Overall Study|Adverse Event|0
7585563|NCT02081599|26386278|P2|Period 2：Open-label Period|Withdrawal by Subject|0
7585564|NCT02081599|26386279|P1|Period 2：Open-label Period|Withdrawal by Subject|2
7585565|NCT02081599|26386278|P2|Period 2：Open-label Period|Physician Decision|0
7585566|NCT02081599|26386279|P1|Period 2：Open-label Period|Physician Decision|1
7585567|NCT02081599|26386278|P2|Period 2：Open-label Period|Lack of Efficacy|4
7585568|NCT02081599|26386279|P1|Period 2：Open-label Period|Lack of Efficacy|2
7585569|NCT02081599|26386278|P2|Period 2：Open-label Period|Adverse Event|0
7585570|NCT02081599|26386279|P1|Period 2：Open-label Period|Adverse Event|1
7585571|NCT02081599|26386278|P2|Period 1：Double-blind Period|stopping criteria|0
7585572|NCT02081599|26386279|P1|Period 1：Double-blind Period|stopping criteria|1
7585573|NCT02081599|26386278|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
7585574|NCT02081599|26386279|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
7585575|NCT02081599|26386278|P2|Period 1：Double-blind Period|Protocol Violation|1
7585576|NCT02081599|26386279|P1|Period 1：Double-blind Period|Protocol Violation|0
7585577|NCT02081599|26386278|P2|Period 1：Double-blind Period|Physician Decision|0
7585578|NCT02081599|26386279|P1|Period 1：Double-blind Period|Physician Decision|1
7585579|NCT02081599|26386278|P2|Period 1：Double-blind Period|Lack of Efficacy|1
7585580|NCT02081599|26386279|P1|Period 1：Double-blind Period|Lack of Efficacy|2
7585581|NCT02081599|26386278|P2|Period 1：Double-blind Period|Adverse Event|0
7585582|NCT02081599|26386279|P1|Period 1：Double-blind Period|Adverse Event|3
7585583|NCT02081586|26386297|P4|Overall Study|Head injury not related to study|0
7585584|NCT02081586|26386298|P3|Overall Study|Head injury not related to study|1
7585585|NCT02081586|26386299|P2|Overall Study|Head injury not related to study|0
7585586|NCT02081586|26386300|P1|Overall Study|Head injury not related to study|0
7585587|NCT02081586|26386297|P4|Overall Study|Lost to Follow-up|1
7585588|NCT02081586|26386298|P3|Overall Study|Lost to Follow-up|0
7585589|NCT02081586|26386299|P2|Overall Study|Lost to Follow-up|1
7585590|NCT02081586|26386300|P1|Overall Study|Lost to Follow-up|0
7585591|NCT02081534|26386343|P7|Overall Study|Lost to Follow-up|0
7585592|NCT02081534|26386344|P6|Overall Study|Lost to Follow-up|1
7585593|NCT02081534|26386345|P5|Overall Study|Lost to Follow-up|1
7585594|NCT02081534|26386346|P4|Overall Study|Lost to Follow-up|2
7585595|NCT02081534|26386347|P3|Overall Study|Lost to Follow-up|0
7585596|NCT02081534|26386348|P2|Overall Study|Lost to Follow-up|0
7585597|NCT02081534|26386349|P1|Overall Study|Lost to Follow-up|0
7585598|NCT02081534|26386343|P7|Overall Study|Protocol Violation|1
7585599|NCT02081534|26386344|P6|Overall Study|Protocol Violation|0
7585600|NCT02081534|26386345|P5|Overall Study|Protocol Violation|0
7585601|NCT02081534|26386346|P4|Overall Study|Protocol Violation|0
7585602|NCT02081534|26386347|P3|Overall Study|Protocol Violation|0
7585603|NCT02081534|26386348|P2|Overall Study|Protocol Violation|3
7585604|NCT02081534|26386349|P1|Overall Study|Protocol Violation|0
7585605|NCT02081534|26386343|P7|Overall Study|Withdrawal by Subject|1
7585606|NCT02081534|26386344|P6|Overall Study|Withdrawal by Subject|0
7585607|NCT02081534|26386345|P5|Overall Study|Withdrawal by Subject|1
7585608|NCT02081534|26386346|P4|Overall Study|Withdrawal by Subject|1
7585609|NCT02081534|26386347|P3|Overall Study|Withdrawal by Subject|1
7585610|NCT02081534|26386348|P2|Overall Study|Withdrawal by Subject|1
7585611|NCT02081534|26386349|P1|Overall Study|Withdrawal by Subject|0
7585612|NCT02081534|26386343|P7|Overall Study|Adverse Event|2
7585613|NCT02081534|26386344|P6|Overall Study|Adverse Event|8
7585614|NCT02081534|26386345|P5|Overall Study|Adverse Event|2
7585615|NCT02081534|26386346|P4|Overall Study|Adverse Event|10
7585616|NCT02081534|26386347|P3|Overall Study|Adverse Event|3
7585617|NCT02081534|26386348|P2|Overall Study|Adverse Event|4
7585618|NCT02081534|26386349|P1|Overall Study|Adverse Event|5
7585619|NCT02081417|26386402|P2|Overall Study|Did not start treatment|21
7585620|NCT02081417|26386403|P1|Overall Study|Did not start treatment|17
7585621|NCT02081417|26386402|P2|Overall Study|Admitted to Residential Treatment|0
7585622|NCT02081417|26386403|P1|Overall Study|Admitted to Residential Treatment|2
7585623|NCT02081417|26386402|P2|Overall Study|Withdrawal by Subject|0
7585624|NCT02081417|26386403|P1|Overall Study|Withdrawal by Subject|4
7585625|NCT02081417|26386402|P2|Overall Study|Death|3
7585626|NCT02081417|26386403|P1|Overall Study|Death|4
7585627|NCT02081417|26386402|P2|Overall Study|Incarcerated|2
7585628|NCT02081417|26386403|P1|Overall Study|Incarcerated|2
7585629|NCT02081417|26386402|P2|Overall Study|Moved Away|2
7585630|NCT02081417|26386403|P1|Overall Study|Moved Away|1
7585631|NCT02081417|26386402|P2|Overall Study|Lost to Follow-up|23
7585632|NCT02081417|26386403|P1|Overall Study|Lost to Follow-up|26
7585633|NCT02081391|26386423|P4|24-hour Treatment and Trial Completion|Further reasons|0
7585634|NCT02081391|26386424|P3|24-hour Treatment and Trial Completion|Further reasons|0
7585635|NCT02081391|26386425|P2|24-hour Treatment and Trial Completion|Further reasons|4
7585636|NCT02081391|26386426|P1|24-hour Treatment and Trial Completion|Further reasons|3
7585637|NCT02081391|26386423|P4|24-hour Treatment and Trial Completion|Technical Problems|0
7585638|NCT02081391|26386424|P3|24-hour Treatment and Trial Completion|Technical Problems|0
7585639|NCT02081391|26386425|P2|24-hour Treatment and Trial Completion|Technical Problems|1
7585640|NCT02081391|26386426|P1|24-hour Treatment and Trial Completion|Technical Problems|1
7585641|NCT02081391|26386423|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
7585642|NCT02081391|26386424|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
7585643|NCT02081391|26386425|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
7585644|NCT02081391|26386426|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
7585645|NCT02081391|26386423|P4|24-hour Treatment and Trial Completion|Adverse Event|0
7585646|NCT02081391|26386424|P3|24-hour Treatment and Trial Completion|Adverse Event|0
7585647|NCT02081391|26386425|P2|24-hour Treatment and Trial Completion|Adverse Event|0
7585648|NCT02081391|26386426|P1|24-hour Treatment and Trial Completion|Adverse Event|1
7585649|NCT02081391|26386423|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7585650|NCT02081391|26386424|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7585651|NCT02081391|26386425|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
7585652|NCT02081391|26386426|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
7585653|NCT02081391|26386423|P4|24-hour Treatment and Trial Completion|Physician Decision|0
7585654|NCT02081391|26386424|P3|24-hour Treatment and Trial Completion|Physician Decision|0
7585655|NCT02081391|26386425|P2|24-hour Treatment and Trial Completion|Physician Decision|5
7585656|NCT02081391|26386426|P1|24-hour Treatment and Trial Completion|Physician Decision|10
7585657|NCT02081391|26386423|P4|12-hour Treatment|Further reasons|0
7585658|NCT02081391|26386424|P3|12-hour Treatment|Further reasons|0
7585659|NCT02081391|26386425|P2|12-hour Treatment|Further reasons|1
7585660|NCT02081391|26386426|P1|12-hour Treatment|Further reasons|2
7585661|NCT02081391|26386423|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
7585662|NCT02081391|26386424|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
7585663|NCT02081391|26386425|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
7585664|NCT02081391|26386426|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
7585665|NCT02081391|26386423|P4|12-hour Treatment|Adverse Event|0
7585666|NCT02081391|26386424|P3|12-hour Treatment|Adverse Event|0
7585667|NCT02081391|26386425|P2|12-hour Treatment|Adverse Event|2
7585668|NCT02081391|26386426|P1|12-hour Treatment|Adverse Event|4
7585669|NCT02081391|26386423|P4|12-hour Treatment|Lack of Efficacy|0
7585670|NCT02081391|26386424|P3|12-hour Treatment|Lack of Efficacy|0
7585671|NCT02081391|26386425|P2|12-hour Treatment|Lack of Efficacy|0
7585672|NCT02081391|26386426|P1|12-hour Treatment|Lack of Efficacy|3
7585673|NCT02081391|26386423|P4|12-hour Treatment|Physician Decision|0
7585674|NCT02081391|26386424|P3|12-hour Treatment|Physician Decision|0
7585675|NCT02081391|26386425|P2|12-hour Treatment|Physician Decision|1
7585676|NCT02081391|26386426|P1|12-hour Treatment|Physician Decision|4
7585677|NCT02081391|26386423|P4|12-hour Treatment|Withdrawal by Subject|0
7585678|NCT02081391|26386424|P3|12-hour Treatment|Withdrawal by Subject|0
7585679|NCT02081391|26386425|P2|12-hour Treatment|Withdrawal by Subject|2
7585680|NCT02081391|26386426|P1|12-hour Treatment|Withdrawal by Subject|3
7585681|NCT02081196|26386518|P1|Overall Study|Lost to Follow-up|1
7585682|NCT02081183|26386529|P2|Overall Study|Other|3
7585683|NCT02081183|26386530|P1|Overall Study|Other|3
7585684|NCT02081183|26386529|P2|Overall Study|Protocol Violation|0
7585685|NCT02081183|26386530|P1|Overall Study|Protocol Violation|1
7585686|NCT02081183|26386529|P2|Overall Study|Lost to Follow-up|1
7585687|NCT02081183|26386530|P1|Overall Study|Lost to Follow-up|0
7585688|NCT02081079|26386546|P2|Overall Study|Lost to Follow-up|0
7585689|NCT02081079|26386547|P1|Overall Study|Lost to Follow-up|1
7585690|NCT02081079|26386546|P2|Overall Study|Lack of Efficacy|2
7585691|NCT02081079|26386547|P1|Overall Study|Lack of Efficacy|3
7585692|NCT02081001|26386620|P12|Overall Study|Adverse Event|0
7585693|NCT02081001|26386621|P11|Overall Study|Adverse Event|0
7585694|NCT02081001|26386622|P10|Overall Study|Adverse Event|0
7585695|NCT02081001|26386623|P9|Overall Study|Adverse Event|0
7585696|NCT02081001|26386624|P8|Overall Study|Adverse Event|0
7585697|NCT02081001|26386625|P7|Overall Study|Adverse Event|0
7585698|NCT02081001|26386626|P6|Overall Study|Adverse Event|0
7585699|NCT02081001|26386627|P5|Overall Study|Adverse Event|1
7585700|NCT02081001|26386628|P4|Overall Study|Adverse Event|0
7585701|NCT02081001|26386629|P3|Overall Study|Adverse Event|0
7585702|NCT02081001|26386630|P2|Overall Study|Adverse Event|0
7585703|NCT02081001|26386631|P1|Overall Study|Adverse Event|0
7585704|NCT02080871|26386695|P1|Overall Study|Lost to Follow-up|1
7585705|NCT02080871|26386695|P1|Overall Study|Death|1
7585706|NCT02080832|26386779|P3|Overall Study|Lost to Follow-up|2
7585707|NCT02080832|26386780|P2|Overall Study|Lost to Follow-up|2
7585708|NCT02080832|26386781|P1|Overall Study|Lost to Follow-up|0
7585709|NCT02080832|26386779|P3|Overall Study|Excluded from analysis by MRI|14
7585710|NCT02080832|26386780|P2|Overall Study|Excluded from analysis by MRI|10
7585711|NCT02080832|26386781|P1|Overall Study|Excluded from analysis by MRI|9
7585712|NCT02080481|26386853|P2|Overall Study|Never received a block.|0
7585713|NCT02080481|26386854|P1|Overall Study|Never received a block.|1
7585714|NCT02080403|26387002|P2|Overall Study|Withdrawal by Subject|1
7585715|NCT02080403|26387003|P1|Overall Study|Withdrawal by Subject|5
7585716|NCT02080403|26387002|P2|Overall Study|Protocol Violation|7
7585717|NCT02080403|26387003|P1|Overall Study|Protocol Violation|3
7585718|NCT02080403|26387002|P2|Overall Study|Pregnancy|1
7585719|NCT02080403|26387003|P1|Overall Study|Pregnancy|0
7585720|NCT02080403|26387002|P2|Overall Study|Lost to Follow-up|0
7585721|NCT02080403|26387003|P1|Overall Study|Lost to Follow-up|2
7585722|NCT02080403|26387002|P2|Overall Study|Death|2
7585723|NCT02080403|26387003|P1|Overall Study|Death|0
7585724|NCT02080403|26387002|P2|Overall Study|Adverse Event|1
7585725|NCT02080403|26387003|P1|Overall Study|Adverse Event|5
7585726|NCT02080364|26387019|P4|Treatment Period|Other|16
7585727|NCT02080364|26387020|P3|Treatment Period|Other|21
7585728|NCT02080364|26387021|P2|Treatment Period|Other|12
7585729|NCT02080364|26387022|P1|Treatment Period|Other|14
7585730|NCT02080364|26387019|P4|Treatment Period|Study Terminated by Sponsor|183
7585731|NCT02080364|26387020|P3|Treatment Period|Study Terminated by Sponsor|180
7585732|NCT02080364|26387021|P2|Treatment Period|Study Terminated by Sponsor|0
7585733|NCT02080364|26387022|P1|Treatment Period|Study Terminated by Sponsor|0
7585734|NCT02080364|26387019|P4|Treatment Period|Withdrawal by Subject|10
7585735|NCT02080364|26387020|P3|Treatment Period|Withdrawal by Subject|15
7585736|NCT02080364|26387021|P2|Treatment Period|Withdrawal by Subject|16
7585737|NCT02080364|26387022|P1|Treatment Period|Withdrawal by Subject|16
7585738|NCT02080364|26387019|P4|Treatment Period|Protocol Violation|1
7585739|NCT02080364|26387020|P3|Treatment Period|Protocol Violation|5
7585740|NCT02080364|26387021|P2|Treatment Period|Protocol Violation|3
7585741|NCT02080364|26387022|P1|Treatment Period|Protocol Violation|5
7585742|NCT02080364|26387019|P4|Treatment Period|Lost to Follow-up|0
7585743|NCT02080364|26387020|P3|Treatment Period|Lost to Follow-up|5
7585744|NCT02080364|26387021|P2|Treatment Period|Lost to Follow-up|3
7585745|NCT02080364|26387022|P1|Treatment Period|Lost to Follow-up|2
7585746|NCT02080364|26387019|P4|Treatment Period|Adverse Event|14
7585747|NCT02080364|26387020|P3|Treatment Period|Adverse Event|11
7585748|NCT02080364|26387021|P2|Treatment Period|Adverse Event|15
7585749|NCT02080364|26387022|P1|Treatment Period|Adverse Event|10
7585750|NCT02080364|26387019|P4|Baseline Period|Other|0
7585751|NCT02080364|26387020|P3|Baseline Period|Other|1
7585752|NCT02080364|26387021|P2|Baseline Period|Other|1
7585753|NCT02080364|26387022|P1|Baseline Period|Other|0
7585754|NCT02080364|26387019|P4|Baseline Period|Protocol Violation|0
7585755|NCT02080364|26387020|P3|Baseline Period|Protocol Violation|0
7585756|NCT02080364|26387021|P2|Baseline Period|Protocol Violation|1
7585757|NCT02080364|26387022|P1|Baseline Period|Protocol Violation|2
7585758|NCT02080260|26387102|P1|Overall Study|Withdrawal by Subject|1
7585759|NCT02080260|26387102|P1|Overall Study|Death|18
7585760|NCT02080221|26387110|P1|Overall Study|Clinical Progression of Disease|1
7585761|NCT02080221|26387110|P1|Overall Study|Withdrawal by Subject|1
7585762|NCT02080091|26387124|P1|Overall Study|Other|1
7585763|NCT02080091|26387124|P1|Overall Study|Withdrawal by Subject|1
7585764|NCT02080091|26387124|P1|Overall Study|Death|1
7585765|NCT02080091|26387124|P1|Overall Study|Study Terminated|22
7585766|NCT02079909|26387152|P3|Overall Study|Relocation etc.|3
7585767|NCT02079909|26387153|P2|Overall Study|Relocation etc.|2
7585768|NCT02079909|26387154|P1|Overall Study|Relocation etc.|2
7585769|NCT02079909|26387152|P3|Overall Study|Physician Decision|1
7585770|NCT02079909|26387153|P2|Overall Study|Physician Decision|1
7585771|NCT02079909|26387154|P1|Overall Study|Physician Decision|0
7585772|NCT02079909|26387152|P3|Overall Study|Protocol Violation|1
7585773|NCT02079909|26387153|P2|Overall Study|Protocol Violation|1
7585774|NCT02079909|26387154|P1|Overall Study|Protocol Violation|0
7585775|NCT02079909|26387152|P3|Overall Study|Lack of Efficacy|1
7585776|NCT02079909|26387153|P2|Overall Study|Lack of Efficacy|0
7585777|NCT02079909|26387154|P1|Overall Study|Lack of Efficacy|0
7585778|NCT02079909|26387152|P3|Overall Study|Death|0
7585779|NCT02079909|26387153|P2|Overall Study|Death|2
7585780|NCT02079909|26387154|P1|Overall Study|Death|2
7585781|NCT02079909|26387152|P3|Overall Study|Lost to Follow-up|1
7585782|NCT02079909|26387153|P2|Overall Study|Lost to Follow-up|3
7585783|NCT02079909|26387154|P1|Overall Study|Lost to Follow-up|2
7585784|NCT02079909|26387152|P3|Overall Study|Withdrawal by Subject|4
7585785|NCT02079909|26387153|P2|Overall Study|Withdrawal by Subject|17
7585786|NCT02079909|26387154|P1|Overall Study|Withdrawal by Subject|9
7585787|NCT02079909|26387152|P3|Overall Study|Adverse Event|7
7585788|NCT02079909|26387153|P2|Overall Study|Adverse Event|23
7585789|NCT02079909|26387154|P1|Overall Study|Adverse Event|23
7585790|NCT02079844|26387171|P3|Treatment Period 2|Voluntary Withdrawal|0
7585791|NCT02079844|26387172|P2|Treatment Period 2|Voluntary Withdrawal|1
7585792|NCT02079844|26387173|P1|Treatment Period 2|Voluntary Withdrawal|0
7585793|NCT02079844|26387171|P3|Treatment Period 1|Voluntary Withdrawal|2
7585794|NCT02079844|26387172|P2|Treatment Period 1|Voluntary Withdrawal|0
7585795|NCT02079844|26387173|P1|Treatment Period 1|Voluntary Withdrawal|0
7585796|NCT02079805|26387231|P2|Overall Study|Voluntary Withdrawal|1
7585797|NCT02079805|26387232|P1|Overall Study|Voluntary Withdrawal|0
7585798|NCT02079805|26387231|P2|Overall Study|Pretreatment Event/Adverse Event|1
7585799|NCT02079805|26387232|P1|Overall Study|Pretreatment Event/Adverse Event|0
7585800|NCT02079766|26387252|P2|Overall Study|Withdrawal by Subject|0
7585801|NCT02079766|26387253|P1|Overall Study|Withdrawal by Subject|1
7585802|NCT02079766|26387252|P2|Overall Study|Physician Decision|0
7585803|NCT02079766|26387253|P1|Overall Study|Physician Decision|1
7585804|NCT02079649|26387264|P4|Overall Study|Randomization error (prior to treatment)|0
7585805|NCT02079649|26387265|P3|Overall Study|Randomization error (prior to treatment)|1
7585806|NCT02079649|26387266|P2|Overall Study|Randomization error (prior to treatment)|0
7585807|NCT02079649|26387267|P1|Overall Study|Randomization error (prior to treatment)|1
7585808|NCT02079649|26387264|P4|Overall Study|Withdrawal by Subject|1
7585809|NCT02079649|26387265|P3|Overall Study|Withdrawal by Subject|0
7585810|NCT02079649|26387266|P2|Overall Study|Withdrawal by Subject|0
7585811|NCT02079649|26387267|P1|Overall Study|Withdrawal by Subject|0
7585812|NCT02079649|26387264|P4|Overall Study|Lost to Follow-up|1
7585813|NCT02079649|26387265|P3|Overall Study|Lost to Follow-up|0
7585814|NCT02079649|26387266|P2|Overall Study|Lost to Follow-up|0
7585815|NCT02079649|26387267|P1|Overall Study|Lost to Follow-up|0
7585816|NCT02079636|26387297|P15|Overall Study|Lost to Follow-up|0
7585817|NCT02079636|26387298|P14|Overall Study|Lost to Follow-up|0
7585818|NCT02079636|26387299|P13|Overall Study|Lost to Follow-up|0
7585819|NCT02079636|26387300|P12|Overall Study|Lost to Follow-up|0
7585820|NCT02079636|26387301|P11|Overall Study|Lost to Follow-up|0
7585821|NCT02079636|26387302|P10|Overall Study|Lost to Follow-up|0
7585822|NCT02079636|26387303|P9|Overall Study|Lost to Follow-up|0
7585823|NCT02079636|26387304|P8|Overall Study|Lost to Follow-up|1
7585824|NCT02079636|26387305|P7|Overall Study|Lost to Follow-up|0
7585825|NCT02079636|26387306|P6|Overall Study|Lost to Follow-up|0
7585826|NCT02079636|26387307|P5|Overall Study|Lost to Follow-up|0
7585827|NCT02079636|26387308|P4|Overall Study|Lost to Follow-up|0
7585828|NCT02079636|26387309|P3|Overall Study|Lost to Follow-up|0
7585829|NCT02079636|26387310|P2|Overall Study|Lost to Follow-up|0
7585830|NCT02079636|26387311|P1|Overall Study|Lost to Follow-up|0
7585831|NCT02079636|26387297|P15|Overall Study|Physician Decision|1
7585832|NCT02079636|26387298|P14|Overall Study|Physician Decision|0
7585833|NCT02079636|26387299|P13|Overall Study|Physician Decision|0
7585834|NCT02079636|26387300|P12|Overall Study|Physician Decision|0
7585835|NCT02079636|26387301|P11|Overall Study|Physician Decision|1
7585836|NCT02079636|26387302|P10|Overall Study|Physician Decision|1
7585837|NCT02079636|26387303|P9|Overall Study|Physician Decision|0
7585838|NCT02079636|26387304|P8|Overall Study|Physician Decision|0
7585839|NCT02079636|26387305|P7|Overall Study|Physician Decision|0
7585840|NCT02079636|26387306|P6|Overall Study|Physician Decision|1
7585841|NCT02079636|26387307|P5|Overall Study|Physician Decision|0
7585842|NCT02079636|26387308|P4|Overall Study|Physician Decision|0
7585843|NCT02079636|26387309|P3|Overall Study|Physician Decision|0
7585844|NCT02079636|26387310|P2|Overall Study|Physician Decision|0
7585845|NCT02079636|26387311|P1|Overall Study|Physician Decision|0
7585846|NCT02079636|26387297|P15|Overall Study|Withdrawal by Subject|2
7585847|NCT02079636|26387298|P14|Overall Study|Withdrawal by Subject|0
7585848|NCT02079636|26387299|P13|Overall Study|Withdrawal by Subject|1
7585849|NCT02079636|26387300|P12|Overall Study|Withdrawal by Subject|1
7585850|NCT02079636|26387301|P11|Overall Study|Withdrawal by Subject|1
7585851|NCT02079636|26387302|P10|Overall Study|Withdrawal by Subject|2
7585852|NCT02079636|26387303|P9|Overall Study|Withdrawal by Subject|0
7585853|NCT02079636|26387304|P8|Overall Study|Withdrawal by Subject|0
7585854|NCT02079636|26387305|P7|Overall Study|Withdrawal by Subject|0
7585855|NCT02079636|26387306|P6|Overall Study|Withdrawal by Subject|1
7585856|NCT02079636|26387307|P5|Overall Study|Withdrawal by Subject|0
7585857|NCT02079636|26387308|P4|Overall Study|Withdrawal by Subject|4
7585858|NCT02079636|26387309|P3|Overall Study|Withdrawal by Subject|0
7585859|NCT02079636|26387310|P2|Overall Study|Withdrawal by Subject|0
7585860|NCT02079636|26387311|P1|Overall Study|Withdrawal by Subject|0
7585861|NCT02079636|26387297|P15|Overall Study|Progressive disease|0
7585862|NCT02079636|26387298|P14|Overall Study|Progressive disease|0
7585863|NCT02079636|26387299|P13|Overall Study|Progressive disease|1
7585864|NCT02079636|26387300|P12|Overall Study|Progressive disease|0
7585865|NCT02079636|26387301|P11|Overall Study|Progressive disease|0
7585866|NCT02079636|26387302|P10|Overall Study|Progressive disease|0
7585867|NCT02079636|26387303|P9|Overall Study|Progressive disease|0
7585868|NCT02079636|26387304|P8|Overall Study|Progressive disease|0
7585869|NCT02079636|26387305|P7|Overall Study|Progressive disease|0
7585870|NCT02079636|26387306|P6|Overall Study|Progressive disease|0
7585871|NCT02079636|26387307|P5|Overall Study|Progressive disease|0
7585872|NCT02079636|26387308|P4|Overall Study|Progressive disease|2
7585873|NCT02079636|26387309|P3|Overall Study|Progressive disease|0
7585874|NCT02079636|26387310|P2|Overall Study|Progressive disease|0
7585875|NCT02079636|26387311|P1|Overall Study|Progressive disease|0
7585876|NCT02079636|26387297|P15|Overall Study|Adverse Event|0
7585877|NCT02079636|26387298|P14|Overall Study|Adverse Event|0
7585878|NCT02079636|26387299|P13|Overall Study|Adverse Event|0
7585879|NCT02079636|26387300|P12|Overall Study|Adverse Event|0
7585880|NCT02079636|26387301|P11|Overall Study|Adverse Event|0
7585881|NCT02079636|26387302|P10|Overall Study|Adverse Event|0
7585882|NCT02079636|26387303|P9|Overall Study|Adverse Event|0
7585883|NCT02079636|26387304|P8|Overall Study|Adverse Event|0
7585884|NCT02079636|26387305|P7|Overall Study|Adverse Event|0
7585885|NCT02079636|26387306|P6|Overall Study|Adverse Event|2
7585886|NCT02079636|26387307|P5|Overall Study|Adverse Event|1
7585887|NCT02079636|26387308|P4|Overall Study|Adverse Event|1
7585888|NCT02079636|26387309|P3|Overall Study|Adverse Event|0
7585889|NCT02079636|26387310|P2|Overall Study|Adverse Event|1
7585890|NCT02079636|26387311|P1|Overall Study|Adverse Event|1
7585891|NCT02079636|26387297|P15|Overall Study|Death|2
7585892|NCT02079636|26387298|P14|Overall Study|Death|0
7585893|NCT02079636|26387299|P13|Overall Study|Death|1
7585894|NCT02079636|26387300|P12|Overall Study|Death|1
7585895|NCT02079636|26387301|P11|Overall Study|Death|0
7585896|NCT02079636|26387302|P10|Overall Study|Death|0
7585897|NCT02079636|26387303|P9|Overall Study|Death|0
7585898|NCT02079636|26387304|P8|Overall Study|Death|0
7585899|NCT02079636|26387305|P7|Overall Study|Death|1
7585900|NCT02079636|26387306|P6|Overall Study|Death|2
7585901|NCT02079636|26387307|P5|Overall Study|Death|1
7585902|NCT02079636|26387308|P4|Overall Study|Death|5
7585903|NCT02079636|26387309|P3|Overall Study|Death|0
7585904|NCT02079636|26387310|P2|Overall Study|Death|1
7585905|NCT02079636|26387311|P1|Overall Study|Death|2
7585906|NCT02079610|26387422|P2|Overall Study|Withdrawal by Subject|1
7585907|NCT02079610|26387423|P1|Overall Study|Withdrawal by Subject|1
7585908|NCT02079532|26387433|P1|Overall Study|Other|3
7585909|NCT02079532|26387433|P1|Overall Study|Inclusion into ReFIRST|3
7585910|NCT02079532|26387433|P1|Overall Study|Administrative problems|1
7585911|NCT02079532|26387433|P1|Overall Study|Withdrawal by Subject|1
7585912|NCT02079532|26387433|P1|Overall Study|Protocol Violation|3
7585913|NCT02079532|26387433|P1|Overall Study|Lack of Efficacy|9
7585914|NCT02079532|26387433|P1|Overall Study|Additional or changed therapy|2
7585915|NCT02079532|26387433|P1|Overall Study|Adverse Event|7
7585916|NCT02079519|26387455|P1|Overall Study|Adverse Event|1
7585917|NCT02079519|26387455|P1|Overall Study|Disease Progression|9
7585918|NCT02079246|26387468|P2|OLEX-MEM|Other: Moved to nursing home|3
7585919|NCT02079246|26387469|P1|OLEX-MEM|Other: Moved to nursing home|0
7585920|NCT02079246|26387468|P2|OLEX-MEM|Lost to Follow-up|1
7585921|NCT02079246|26387469|P1|OLEX-MEM|Lost to Follow-up|0
7585922|NCT02079246|26387468|P2|OLEX-MEM|Protocol Violation|2
7585923|NCT02079246|26387469|P1|OLEX-MEM|Protocol Violation|0
7585924|NCT02079246|26387468|P2|OLEX-MEM|Withdrawal by Subject|7
7585925|NCT02079246|26387469|P1|OLEX-MEM|Withdrawal by Subject|0
7585926|NCT02079246|26387468|P2|OLEX-MEM|Adverse Event|6
7585927|NCT02079246|26387469|P1|OLEX-MEM|Adverse Event|0
7585928|NCT02079246|26387468|P2|OLEX|Other: Withdrawal of caregiver consent|0
7585929|NCT02079246|26387469|P1|OLEX|Other: Withdrawal of caregiver consent|1
7585930|NCT02079246|26387468|P2|OLEX|Other: Moved to nursing home|0
7585931|NCT02079246|26387469|P1|OLEX|Other: Moved to nursing home|1
7585932|NCT02079246|26387468|P2|OLEX|Other: Worsening of condition|0
7585933|NCT02079246|26387469|P1|OLEX|Other: Worsening of condition|1
7585934|NCT02079246|26387468|P2|OLEX|Other: Coordinator decision|0
7585935|NCT02079246|26387469|P1|OLEX|Other: Coordinator decision|1
7585936|NCT02079246|26387468|P2|OLEX|Other: Caregiver unavailable|0
7585937|NCT02079246|26387469|P1|OLEX|Other: Caregiver unavailable|3
7585938|NCT02079246|26387468|P2|OLEX|Other: Insufficient compliance|0
7585939|NCT02079246|26387469|P1|OLEX|Other: Insufficient compliance|2
7585940|NCT02079246|26387468|P2|OLEX|Other: Disallowed medication|0
7585941|NCT02079246|26387469|P1|OLEX|Other: Disallowed medication|8
7585942|NCT02079246|26387468|P2|OLEX|Results of the lead-in studies|0
7585943|NCT02079246|26387469|P1|OLEX|Results of the lead-in studies|58
7585944|NCT02079246|26387468|P2|OLEX|Lack of Efficacy|0
7585945|NCT02079246|26387469|P1|OLEX|Lack of Efficacy|3
7585946|NCT02079246|26387468|P2|OLEX|Protocol Violation|0
7585947|NCT02079246|26387469|P1|OLEX|Protocol Violation|6
7585948|NCT02079246|26387468|P2|OLEX|Lost to Follow-up|0
7585949|NCT02079246|26387469|P1|OLEX|Lost to Follow-up|6
7585950|NCT02079246|26387468|P2|OLEX|Withdrawal by Subject|0
7585951|NCT02079246|26387469|P1|OLEX|Withdrawal by Subject|60
7585952|NCT02079246|26387468|P2|OLEX|Adverse Event|0
7585953|NCT02079246|26387469|P1|OLEX|Adverse Event|66
7585954|NCT02079246|26387468|P2|OLEX|Death|0
7585955|NCT02079246|26387469|P1|OLEX|Death|11
7585956|NCT02079246|26387468|P2|OLEX|Withdrawal before treatment|0
7585957|NCT02079246|26387469|P1|OLEX|Withdrawal before treatment|1
7585958|NCT02079077|26387488|P2|Overall Study|Became STIs Positive|2
7585959|NCT02079077|26387489|P1|Overall Study|Became STIs Positive|1
7585960|NCT02079077|26387488|P2|Overall Study|Lost to Follow-up|7
7585961|NCT02079077|26387489|P1|Overall Study|Lost to Follow-up|5
7585962|NCT02079038|26387499|P2|Completed 6 Months|Lost to Follow-up|1
7585963|NCT02079038|26387500|P1|Completed 6 Months|Lost to Follow-up|2
7585964|NCT02079038|26387499|P2|Modified Intent to Treat Population|Death|0
7585965|NCT02079038|26387500|P1|Modified Intent to Treat Population|Death|1
7585966|NCT02079038|26387499|P2|Modified Intent to Treat Population|Withdrawal by Subject|5
7585967|NCT02079038|26387500|P1|Modified Intent to Treat Population|Withdrawal by Subject|6
7585968|NCT02078960|26387521|P3|Follow-up Period|Lost to Follow-up|0
7585969|NCT02078960|26387522|P2|Follow-up Period|Lost to Follow-up|1
7585970|NCT02078960|26387523|P1|Follow-up Period|Lost to Follow-up|0
7585971|NCT02078960|26387521|P3|Follow-up Period|Death|0
7585972|NCT02078960|26387522|P2|Follow-up Period|Death|0
7585973|NCT02078960|26387523|P1|Follow-up Period|Death|2
7585974|NCT02078960|26387521|P3|Treatment Period|Death|1
7585975|NCT02078960|26387522|P2|Treatment Period|Death|0
7585976|NCT02078960|26387523|P1|Treatment Period|Death|0
7585977|NCT02078960|26387521|P3|Treatment Period|Adverse Event|0
7585978|NCT02078960|26387522|P2|Treatment Period|Adverse Event|0
7585979|NCT02078960|26387523|P1|Treatment Period|Adverse Event|1
7585980|NCT02078960|26387521|P3|Treatment Period|Withdrawal by Subject|1
7585981|NCT02078960|26387522|P2|Treatment Period|Withdrawal by Subject|1
7585982|NCT02078960|26387523|P1|Treatment Period|Withdrawal by Subject|0
7585983|NCT02078960|26387521|P3|Treatment Period|Disease progression - blast phase|0
7585984|NCT02078960|26387522|P2|Treatment Period|Disease progression - blast phase|0
7585985|NCT02078960|26387523|P1|Treatment Period|Disease progression - blast phase|1
7585986|NCT02078960|26387521|P3|Treatment Period|Disease progression - accelerated phase|0
7585987|NCT02078960|26387522|P2|Treatment Period|Disease progression - accelerated phase|1
7585988|NCT02078960|26387523|P1|Treatment Period|Disease progression - accelerated phase|0
7585989|NCT02078960|26387521|P3|Treatment Period|Lack of Efficacy|0
7585990|NCT02078960|26387522|P2|Treatment Period|Lack of Efficacy|1
7585991|NCT02078960|26387523|P1|Treatment Period|Lack of Efficacy|0
7585992|NCT02078960|26387521|P3|Treatment Period|Other|1
7585993|NCT02078960|26387522|P2|Treatment Period|Other|0
7585994|NCT02078960|26387523|P1|Treatment Period|Other|0
7585995|NCT02078817|26387557|P1|Overall Study|Withdrawal by Subject|1
7585996|NCT02078752|26387579|P10|Overall Study|Study terminated by sponsor|5
7585997|NCT02078752|26387580|P9|Overall Study|Study terminated by sponsor|0
7585998|NCT02078752|26387581|P8|Overall Study|Study terminated by sponsor|0
7585999|NCT02078752|26387582|P7|Overall Study|Study terminated by sponsor|0
7586000|NCT02078752|26387583|P6|Overall Study|Study terminated by sponsor|0
7586001|NCT02078752|26387584|P5|Overall Study|Study terminated by sponsor|0
7586002|NCT02078752|26387585|P4|Overall Study|Study terminated by sponsor|0
7586003|NCT02078752|26387586|P3|Overall Study|Study terminated by sponsor|0
7586004|NCT02078752|26387587|P2|Overall Study|Study terminated by sponsor|0
7586005|NCT02078752|26387588|P1|Overall Study|Study terminated by sponsor|0
7586006|NCT02078752|26387579|P10|Overall Study|Other|0
7586007|NCT02078752|26387580|P9|Overall Study|Other|0
7586008|NCT02078752|26387581|P8|Overall Study|Other|1
7586009|NCT02078752|26387582|P7|Overall Study|Other|0
7586010|NCT02078752|26387583|P6|Overall Study|Other|0
7586011|NCT02078752|26387584|P5|Overall Study|Other|1
7586012|NCT02078752|26387585|P4|Overall Study|Other|0
7586013|NCT02078752|26387586|P3|Overall Study|Other|0
7586014|NCT02078752|26387587|P2|Overall Study|Other|3
7586015|NCT02078752|26387588|P1|Overall Study|Other|0
7586016|NCT02078752|26387579|P10|Overall Study|Withdrawal by Subject|1
7586017|NCT02078752|26387580|P9|Overall Study|Withdrawal by Subject|0
7586018|NCT02078752|26387581|P8|Overall Study|Withdrawal by Subject|1
7586019|NCT02078752|26387582|P7|Overall Study|Withdrawal by Subject|2
7586020|NCT02078752|26387583|P6|Overall Study|Withdrawal by Subject|3
7586021|NCT02078752|26387584|P5|Overall Study|Withdrawal by Subject|0
7586022|NCT02078752|26387585|P4|Overall Study|Withdrawal by Subject|1
7586023|NCT02078752|26387586|P3|Overall Study|Withdrawal by Subject|1
7586024|NCT02078752|26387587|P2|Overall Study|Withdrawal by Subject|1
7586025|NCT02078752|26387588|P1|Overall Study|Withdrawal by Subject|1
7586026|NCT02078752|26387579|P10|Overall Study|Lost to Follow-up|0
7586027|NCT02078752|26387580|P9|Overall Study|Lost to Follow-up|0
7586028|NCT02078752|26387581|P8|Overall Study|Lost to Follow-up|0
7586029|NCT02078752|26387582|P7|Overall Study|Lost to Follow-up|0
7586030|NCT02078752|26387583|P6|Overall Study|Lost to Follow-up|0
7586031|NCT02078752|26387584|P5|Overall Study|Lost to Follow-up|0
7586032|NCT02078752|26387585|P4|Overall Study|Lost to Follow-up|1
7586033|NCT02078752|26387586|P3|Overall Study|Lost to Follow-up|0
7586034|NCT02078752|26387587|P2|Overall Study|Lost to Follow-up|0
7586035|NCT02078752|26387588|P1|Overall Study|Lost to Follow-up|1
7586036|NCT02078752|26387579|P10|Overall Study|Death|4
7586037|NCT02078752|26387580|P9|Overall Study|Death|0
7586038|NCT02078752|26387581|P8|Overall Study|Death|1
7586039|NCT02078752|26387582|P7|Overall Study|Death|0
7586040|NCT02078752|26387583|P6|Overall Study|Death|1
7586041|NCT02078752|26387584|P5|Overall Study|Death|0
7586042|NCT02078752|26387585|P4|Overall Study|Death|0
7586043|NCT02078752|26387586|P3|Overall Study|Death|0
7586044|NCT02078752|26387587|P2|Overall Study|Death|3
7586045|NCT02078752|26387588|P1|Overall Study|Death|0
7586046|NCT02078713|26387873|P4|Overall Study|Enrolled twice|0
7586047|NCT02078713|26387874|P3|Overall Study|Enrolled twice|0
7586048|NCT02078713|26387875|P2|Overall Study|Enrolled twice|1
7586049|NCT02078713|26387876|P1|Overall Study|Enrolled twice|0
7586050|NCT02078713|26387873|P4|Overall Study|Pregnant at baseline|0
7586051|NCT02078713|26387874|P3|Overall Study|Pregnant at baseline|0
7586052|NCT02078713|26387875|P2|Overall Study|Pregnant at baseline|5
7586053|NCT02078713|26387876|P1|Overall Study|Pregnant at baseline|3
7586054|NCT02078713|26387873|P4|Overall Study|Lost to Follow-up|0
7586055|NCT02078713|26387874|P3|Overall Study|Lost to Follow-up|0
7586056|NCT02078713|26387875|P2|Overall Study|Lost to Follow-up|55
7586057|NCT02078713|26387876|P1|Overall Study|Lost to Follow-up|49
7586058|NCT02078219|26388002|P5|Overall Study|Adverse Event|0
7586059|NCT02078219|26388003|P4|Overall Study|Adverse Event|1
7586060|NCT02078219|26388004|P3|Overall Study|Adverse Event|3
7586061|NCT02078219|26388005|P2|Overall Study|Adverse Event|1
7586062|NCT02078219|26388006|P1|Overall Study|Adverse Event|1
7586063|NCT02078219|26388002|P5|Overall Study|Death|0
7586064|NCT02078219|26388003|P4|Overall Study|Death|1
7586065|NCT02078219|26388004|P3|Overall Study|Death|0
7586066|NCT02078219|26388005|P2|Overall Study|Death|0
7586067|NCT02078219|26388006|P1|Overall Study|Death|0
7586068|NCT02078219|26388002|P5|Overall Study|Protocol Violation|0
7586069|NCT02078219|26388003|P4|Overall Study|Protocol Violation|1
7586070|NCT02078219|26388004|P3|Overall Study|Protocol Violation|0
7586071|NCT02078219|26388005|P2|Overall Study|Protocol Violation|0
7586072|NCT02078219|26388006|P1|Overall Study|Protocol Violation|0
7586073|NCT02078219|26388002|P5|Overall Study|Withdrawal by Subject|1
7586074|NCT02078219|26388003|P4|Overall Study|Withdrawal by Subject|1
7586075|NCT02078219|26388004|P3|Overall Study|Withdrawal by Subject|0
7586076|NCT02078219|26388005|P2|Overall Study|Withdrawal by Subject|1
7586077|NCT02078219|26388006|P1|Overall Study|Withdrawal by Subject|0
7586078|NCT02078219|26388002|P5|Overall Study|Other|1
7586079|NCT02078219|26388003|P4|Overall Study|Other|0
7586080|NCT02078219|26388004|P3|Overall Study|Other|3
7586081|NCT02078219|26388005|P2|Overall Study|Other|2
7586082|NCT02078219|26388006|P1|Overall Study|Other|2
7586083|NCT02078102|26388056|P2|Overall Study|Physician Decision|1
7586084|NCT02078102|26388057|P1|Overall Study|Physician Decision|0
7586085|NCT02078102|26388056|P2|Overall Study|Withdrawal by Subject|0
7586086|NCT02078102|26388057|P1|Overall Study|Withdrawal by Subject|1
7586087|NCT02078102|26388056|P2|Overall Study|Adverse Event|0
7586088|NCT02078102|26388057|P1|Overall Study|Adverse Event|1
7586089|NCT02077465|26388071|P2|Overall Study|Lost to Follow-up|0
7586090|NCT02077465|26388072|P1|Overall Study|Lost to Follow-up|1
7586091|NCT02077465|26388071|P2|Overall Study|Withdrew Consent|1
7586092|NCT02077465|26388072|P1|Overall Study|Withdrew Consent|0
7586093|NCT02077374|26388095|P2|Overall Study|Protocol Violation|1
7586094|NCT02077374|26388096|P1|Overall Study|Protocol Violation|0
7586095|NCT02077374|26388095|P2|Overall Study|Withdrawal by Subject|1
7586096|NCT02077374|26388096|P1|Overall Study|Withdrawal by Subject|0
7586097|NCT02077140|26388117|P5|Overall Study|Withdrawal by Subject|2
7586098|NCT02077140|26388118|P4|Overall Study|Withdrawal by Subject|2
7586099|NCT02077140|26388119|P3|Overall Study|Withdrawal by Subject|0
7586100|NCT02077140|26388120|P2|Overall Study|Withdrawal by Subject|1
7586101|NCT02077140|26388121|P1|Overall Study|Withdrawal by Subject|0
7586102|NCT02077140|26388117|P5|Overall Study|Lost to Follow-up|3
7586103|NCT02077140|26388118|P4|Overall Study|Lost to Follow-up|2
7586104|NCT02077140|26388119|P3|Overall Study|Lost to Follow-up|2
7586105|NCT02077140|26388120|P2|Overall Study|Lost to Follow-up|1
7586106|NCT02077140|26388121|P1|Overall Study|Lost to Follow-up|4
7586107|NCT02076334|26388410|P4|Overall Study|muscle soreness|1
7586108|NCT02076334|26388411|P3|Overall Study|muscle soreness|0
7586109|NCT02076334|26388412|P2|Overall Study|muscle soreness|0
7586110|NCT02076334|26388413|P1|Overall Study|muscle soreness|0
7586111|NCT02076334|26388410|P4|Overall Study|Lost to Follow-up|0
7586112|NCT02076334|26388411|P3|Overall Study|Lost to Follow-up|1
7586113|NCT02076334|26388412|P2|Overall Study|Lost to Follow-up|1
7586114|NCT02076334|26388413|P1|Overall Study|Lost to Follow-up|0
7586115|NCT02076334|26388410|P4|Overall Study|Protocol Violation|0
7586116|NCT02076334|26388411|P3|Overall Study|Protocol Violation|0
7586117|NCT02076334|26388412|P2|Overall Study|Protocol Violation|0
7586118|NCT02076334|26388413|P1|Overall Study|Protocol Violation|1
7586119|NCT02076178|26388446|P2|Injection Phase|Lost to Follow-up|1
7586120|NCT02076178|26388447|P1|Injection Phase|Lost to Follow-up|0
7586121|NCT02076178|26388446|P2|Injection Phase|Physician Decision|3
7586122|NCT02076178|26388447|P1|Injection Phase|Physician Decision|0
7586123|NCT02076178|26388446|P2|Injection Phase|Withdrawal by Subject|3
7586124|NCT02076178|26388447|P1|Injection Phase|Withdrawal by Subject|0
7586125|NCT02076178|26388446|P2|Injection Phase|Protocol defined stopping criteria|0
7586126|NCT02076178|26388447|P1|Injection Phase|Protocol defined stopping criteria|1
7586127|NCT02076178|26388446|P2|Oral Phase|Physician Decision|1
7586128|NCT02076178|26388447|P1|Oral Phase|Physician Decision|0
7586129|NCT02076178|26388446|P2|Oral Phase|Withdrawal by Subject|4
7586130|NCT02076178|26388447|P1|Oral Phase|Withdrawal by Subject|0
7586131|NCT02076178|26388446|P2|Oral Phase|Adverse Event|7
7586132|NCT02076178|26388447|P1|Oral Phase|Adverse Event|0
7586133|NCT02076165|26388481|P2|Overall Study|Refused follow-up assessment|1
7586134|NCT02076165|26388482|P1|Overall Study|Refused follow-up assessment|1
7586135|NCT02076165|26388481|P2|Overall Study|Lost to Follow-up|5
7586136|NCT02076165|26388482|P1|Overall Study|Lost to Follow-up|7
7586137|NCT02076113|26388519|P2|Overall Study|Death|3
7586138|NCT02076113|26388520|P1|Overall Study|Death|1
7586139|NCT02076113|26388519|P2|Overall Study|Withdrawal by Subject|3
7586140|NCT02076113|26388520|P1|Overall Study|Withdrawal by Subject|2
7586141|NCT02076113|26388519|P2|Overall Study|Lost to Follow-up|1
7586142|NCT02076113|26388520|P1|Overall Study|Lost to Follow-up|4
7586143|NCT02076022|26388597|P2|Overall Study|Withdrawal by Subject|0
7586144|NCT02076022|26388598|P1|Overall Study|Withdrawal by Subject|2
7586157|NCT02075840|26388633|P2|Overall Study|Ongoing at CCOD|82
7586158|NCT02075840|26388634|P1|Overall Study|Ongoing at CCOD|99
7586159|NCT02075840|26388633|P2|Overall Study|Physician Decision|3
7586160|NCT02075840|26388634|P1|Overall Study|Physician Decision|1
7586161|NCT02075840|26388633|P2|Overall Study|Lost to Follow-up|2
7586162|NCT02075840|26388634|P1|Overall Study|Lost to Follow-up|3
7586163|NCT02075840|26388633|P2|Overall Study|Death|40
7586164|NCT02075840|26388634|P1|Overall Study|Death|35
7586165|NCT02075840|26388633|P2|Overall Study|Adverse Event|2
7586166|NCT02075840|26388634|P1|Overall Study|Adverse Event|0
7586167|NCT02075840|26388633|P2|Overall Study|Reason not specified|0
7586168|NCT02075840|26388634|P1|Overall Study|Reason not specified|1
7586169|NCT02075840|26388633|P2|Overall Study|Withdrawal by Subject|22
7586170|NCT02075840|26388634|P1|Overall Study|Withdrawal by Subject|13
7586171|NCT02075658|26388690|P2|Overall Study|Physician Decision|2
7586172|NCT02075658|26388691|P1|Overall Study|Physician Decision|2
7586173|NCT02075632|26388701|P2|Overall Study|Withdrawal by Subject|1
7586174|NCT02075632|26388702|P1|Overall Study|Withdrawal by Subject|0
7586175|NCT02075632|26388701|P2|Overall Study|Lost to Follow-up|3
7586176|NCT02075632|26388702|P1|Overall Study|Lost to Follow-up|0
7586177|NCT02075632|26388701|P2|Overall Study|Adverse Event|1
7586178|NCT02075632|26388702|P1|Overall Study|Adverse Event|1
7586179|NCT02075606|26388712|P1|Overall Study|Increasing Symptoms|1
7586180|NCT02075606|26388712|P1|Overall Study|Symptom management|1
7586181|NCT02075606|26388712|P1|Overall Study|Investigator's decision|1
7586182|NCT02075606|26388712|P1|Overall Study|Death|1
7586183|NCT02075606|26388712|P1|Overall Study|Withdrawal by Subject|1
7586184|NCT02075606|26388712|P1|Overall Study|Adverse Event|5
7586185|NCT02075554|26388734|P1|Overall Study|Physician Decision|3
7586186|NCT02075554|26388734|P1|Overall Study|Withdrawal by Subject|5
7586187|NCT02075554|26388734|P1|Overall Study|Lost to Follow-up|7
7586188|NCT02075541|26388743|P2|Overall Study|Other- unable to perform study procedure|0
7586189|NCT02075541|26388744|P1|Overall Study|Other- unable to perform study procedure|1
7586190|NCT02075541|26388743|P2|Overall Study|Sponsor study termination|1
7586191|NCT02075541|26388744|P1|Overall Study|Sponsor study termination|0
7586192|NCT02075541|26388743|P2|Overall Study|Withdrawal by Subject|3
7586193|NCT02075541|26388744|P1|Overall Study|Withdrawal by Subject|1
7586194|NCT02075541|26388743|P2|Overall Study|Protocol Violation|0
7586195|NCT02075541|26388744|P1|Overall Study|Protocol Violation|1
7586196|NCT02075541|26388743|P2|Overall Study|Serious Adverse Event|4
7586197|NCT02075541|26388744|P1|Overall Study|Serious Adverse Event|1
7586198|NCT02075515|26388793|P3|Overall Study|Lost to Follow-up|6
7586199|NCT02075515|26388794|P2|Overall Study|Lost to Follow-up|3
7586200|NCT02075515|26388795|P1|Overall Study|Lost to Follow-up|1
7586201|NCT02075515|26388793|P3|Overall Study|Withdrawal by Subject|1
7586202|NCT02075515|26388794|P2|Overall Study|Withdrawal by Subject|0
7586203|NCT02075515|26388795|P1|Overall Study|Withdrawal by Subject|2
7586204|NCT02075515|26388793|P3|Overall Study|Non-Serious Adverse Event|0
7586205|NCT02075515|26388794|P2|Overall Study|Non-Serious Adverse Event|1
7586206|NCT02075515|26388795|P1|Overall Study|Non-Serious Adverse Event|0
7586207|NCT02075515|26388793|P3|Overall Study|Serious Adverse Event|1
7586208|NCT02075515|26388794|P2|Overall Study|Serious Adverse Event|1
7586209|NCT02075515|26388795|P1|Overall Study|Serious Adverse Event|1
7586210|NCT02075476|26388832|P2|Overall Study|Lost to Follow-up|3
7586211|NCT02075476|26388833|P1|Overall Study|Lost to Follow-up|1
7586212|NCT02075476|26388832|P2|Overall Study|Death|2
7586213|NCT02075476|26388833|P1|Overall Study|Death|2
7586214|NCT02075463|26388843|P1|Overall Study|Withdrawal by Subject|1
7586215|NCT02075463|26388843|P1|Overall Study|Par. reached stopping criteria|4
7586216|NCT02075463|26388843|P1|Overall Study|Adverse Event|3
7586217|NCT02075320|26388893|P1|Overall Study|Withdrawal by Subject|2
7586218|NCT02075255|26388903|P3|Overall Study|Death|0
7586219|NCT02075255|26388904|P2|Overall Study|Death|2
7586220|NCT02075255|26388905|P1|Overall Study|Death|0
7586221|NCT02075255|26388903|P3|Overall Study|Adverse Event|1
7586222|NCT02075255|26388904|P2|Overall Study|Adverse Event|0
7586223|NCT02075255|26388905|P1|Overall Study|Adverse Event|0
7586224|NCT02075255|26388903|P3|Overall Study|Lost to Follow-up|1
7586225|NCT02075255|26388904|P2|Overall Study|Lost to Follow-up|0
7586226|NCT02075255|26388905|P1|Overall Study|Lost to Follow-up|0
7586227|NCT02075255|26388903|P3|Overall Study|Withdrawal by Subject|0
7586228|NCT02075255|26388904|P2|Overall Study|Withdrawal by Subject|1
7586229|NCT02075255|26388905|P1|Overall Study|Withdrawal by Subject|4
7586230|NCT02075255|26388903|P3|Overall Study|Study specific withdrawal criteria|1
7586231|NCT02075255|26388904|P2|Overall Study|Study specific withdrawal criteria|1
7586232|NCT02075255|26388905|P1|Overall Study|Study specific withdrawal criteria|0
7586233|NCT02075203|26389015|P3|Overall Study|participant refused to use contraception|0
7586234|NCT02075203|26389016|P2|Overall Study|participant refused to use contraception|0
7586235|NCT02075203|26389017|P1|Overall Study|participant refused to use contraception|1
7586236|NCT02075203|26389015|P3|Overall Study|Adverse Event|0
7586237|NCT02075203|26389016|P2|Overall Study|Adverse Event|0
7586238|NCT02075203|26389017|P1|Overall Study|Adverse Event|1
7586239|NCT02075203|26389015|P3|Overall Study|Withdrawal by Subject|1
7586240|NCT02075203|26389016|P2|Overall Study|Withdrawal by Subject|0
7586241|NCT02075203|26389017|P1|Overall Study|Withdrawal by Subject|1
7586242|NCT02075073|26389058|P3|Overall Study|Withdrawal by Subject|0
7586243|NCT02075073|26389059|P2|Overall Study|Withdrawal by Subject|1
7586244|NCT02075073|26389060|P1|Overall Study|Withdrawal by Subject|0
7586245|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
7586246|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
7586247|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Other|2
7586248|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Other|1
7586249|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Screen Failure|0
7586250|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Screen Failure|1
7586251|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
7586252|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
7586253|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Lost to Follow-up|1
7586254|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Lost to Follow-up|0
7586255|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7586256|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7586257|NCT02075047|26389079|P2|Follow up Phase (5 Weeks)|Adverse Event|4
7586258|NCT02075047|26389080|P1|Follow up Phase (5 Weeks)|Adverse Event|14
7586259|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
7586260|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
7586261|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Other|1
7586262|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Other|1
7586263|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Screen Failure|0
7586264|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Screen Failure|1
7586265|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
7586266|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
7586267|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Lost to Follow-up|1
7586268|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Lost to Follow-up|0
7586269|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7586270|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7586271|NCT02075047|26389079|P2|Treatment Phase (4 Weeks)|Adverse Event|4
7586272|NCT02075047|26389080|P1|Treatment Phase (4 Weeks)|Adverse Event|14
7586273|NCT02075008|26389129|P1|Overall Study|Study terminated by Sponsor|159
7586274|NCT02075008|26389129|P1|Overall Study|Withdrawal by Subject|6
7586275|NCT02075008|26389129|P1|Overall Study|Adverse Event|5
7586276|NCT02075008|26389129|P1|Overall Study|Death|1
7586277|NCT02075008|26389129|P1|Overall Study|Lack of Efficacy|1
7586278|NCT02075008|26389129|P1|Overall Study|Lost to Follow-up|1
7586279|NCT02075008|26389129|P1|Overall Study|Physician Decision|1
7586280|NCT02075008|26389129|P1|Overall Study|Pregnancy|1
7586281|NCT02075008|26389129|P1|Overall Study|Technical problems|1
7586282|NCT02074982|26389152|P2|Overall Study|Death|2
7586283|NCT02074982|26389153|P1|Overall Study|Death|0
7586284|NCT02074982|26389152|P2|Overall Study|Subject/guardian decision|24
7586285|NCT02074982|26389153|P1|Overall Study|Subject/guardian decision|15
7586286|NCT02074982|26389152|P2|Overall Study|Technical problems|2
7586287|NCT02074982|26389153|P1|Overall Study|Technical problems|0
7586288|NCT02074982|26389152|P2|Overall Study|Protocol deviation|3
7586289|NCT02074982|26389153|P1|Overall Study|Protocol deviation|4
7586290|NCT02074982|26389152|P2|Overall Study|Pregnancy|2
7586291|NCT02074982|26389153|P1|Overall Study|Pregnancy|1
7586292|NCT02074982|26389152|P2|Overall Study|Physician Decision|1
7586293|NCT02074982|26389153|P1|Overall Study|Physician Decision|1
7586294|NCT02074982|26389152|P2|Overall Study|Non-compliance with study treatment|2
7586295|NCT02074982|26389153|P1|Overall Study|Non-compliance with study treatment|0
7586296|NCT02074982|26389152|P2|Overall Study|Lost to Follow-up|10
7586297|NCT02074982|26389153|P1|Overall Study|Lost to Follow-up|9
7586298|NCT02074982|26389152|P2|Overall Study|Lack of Efficacy|1
7586299|NCT02074982|26389153|P1|Overall Study|Lack of Efficacy|6
7586300|NCT02074982|26389152|P2|Overall Study|Adverse Event|7
7586301|NCT02074982|26389153|P1|Overall Study|Adverse Event|15
7586302|NCT02074553|26389200|P8|Washout Period 3|Physician Decision|1
7586303|NCT02074553|26389201|P7|Washout Period 3|Physician Decision|0
7586304|NCT02074553|26389202|P6|Washout Period 3|Physician Decision|0
7586305|NCT02074553|26389203|P5|Washout Period 3|Physician Decision|0
7586306|NCT02074553|26389204|P4|Washout Period 3|Physician Decision|0
7586307|NCT02074553|26389205|P3|Washout Period 3|Physician Decision|0
7586308|NCT02074553|26389206|P2|Washout Period 3|Physician Decision|0
7586309|NCT02074553|26389207|P1|Washout Period 3|Physician Decision|0
7586310|NCT02074553|26389200|P8|Washout Period 2|Lost to Follow-up|0
7586311|NCT02074553|26389201|P7|Washout Period 2|Lost to Follow-up|0
7586312|NCT02074553|26389202|P6|Washout Period 2|Lost to Follow-up|0
7586313|NCT02074553|26389203|P5|Washout Period 2|Lost to Follow-up|0
7586314|NCT02074553|26389204|P4|Washout Period 2|Lost to Follow-up|0
7586315|NCT02074553|26389205|P3|Washout Period 2|Lost to Follow-up|1
7586316|NCT02074553|26389206|P2|Washout Period 2|Lost to Follow-up|0
7586317|NCT02074553|26389207|P1|Washout Period 2|Lost to Follow-up|0
7586318|NCT02074553|26389200|P8|Washout Period 2|Physician Decision|0
7586319|NCT02074553|26389201|P7|Washout Period 2|Physician Decision|0
7586320|NCT02074553|26389202|P6|Washout Period 2|Physician Decision|1
7586321|NCT02074553|26389203|P5|Washout Period 2|Physician Decision|0
7586322|NCT02074553|26389204|P4|Washout Period 2|Physician Decision|0
7586323|NCT02074553|26389205|P3|Washout Period 2|Physician Decision|0
7586324|NCT02074553|26389206|P2|Washout Period 2|Physician Decision|0
7586325|NCT02074553|26389207|P1|Washout Period 2|Physician Decision|0
7586326|NCT02074553|26389200|P8|Washout Period 2|Adverse Event|0
7586327|NCT02074553|26389201|P7|Washout Period 2|Adverse Event|1
7586328|NCT02074553|26389202|P6|Washout Period 2|Adverse Event|0
7586329|NCT02074553|26389203|P5|Washout Period 2|Adverse Event|0
7586330|NCT02074553|26389204|P4|Washout Period 2|Adverse Event|0
7586331|NCT02074553|26389205|P3|Washout Period 2|Adverse Event|0
7586332|NCT02074553|26389206|P2|Washout Period 2|Adverse Event|0
7586333|NCT02074553|26389207|P1|Washout Period 2|Adverse Event|0
7586334|NCT02074553|26389200|P8|Washout Period 1|Other|0
7586335|NCT02074553|26389201|P7|Washout Period 1|Other|0
7586336|NCT02074553|26389202|P6|Washout Period 1|Other|1
7586337|NCT02074553|26389203|P5|Washout Period 1|Other|0
7586338|NCT02074553|26389204|P4|Washout Period 1|Other|0
7586339|NCT02074553|26389205|P3|Washout Period 1|Other|0
7586340|NCT02074553|26389206|P2|Washout Period 1|Other|0
7586341|NCT02074553|26389207|P1|Washout Period 1|Other|0
7586342|NCT02074553|26389200|P8|Washout Period 1|Physician Decision|0
7586343|NCT02074553|26389201|P7|Washout Period 1|Physician Decision|0
7586344|NCT02074553|26389202|P6|Washout Period 1|Physician Decision|0
7586345|NCT02074553|26389203|P5|Washout Period 1|Physician Decision|0
7586346|NCT02074553|26389204|P4|Washout Period 1|Physician Decision|1
7586347|NCT02074553|26389205|P3|Washout Period 1|Physician Decision|0
7586348|NCT02074553|26389206|P2|Washout Period 1|Physician Decision|0
7586349|NCT02074553|26389207|P1|Washout Period 1|Physician Decision|0
7586350|NCT02074553|26389200|P8|Washout Period 1|Adverse Event|0
7586351|NCT02074553|26389201|P7|Washout Period 1|Adverse Event|0
7586352|NCT02074553|26389202|P6|Washout Period 1|Adverse Event|0
7586353|NCT02074553|26389203|P5|Washout Period 1|Adverse Event|0
7586354|NCT02074553|26389204|P4|Washout Period 1|Adverse Event|0
7586355|NCT02074553|26389205|P3|Washout Period 1|Adverse Event|0
7586356|NCT02074553|26389206|P2|Washout Period 1|Adverse Event|0
7586357|NCT02074553|26389207|P1|Washout Period 1|Adverse Event|1
7586358|NCT02074553|26389200|P8|Intervention Period 1|Family Emergency|0
7586359|NCT02074553|26389201|P7|Intervention Period 1|Family Emergency|0
7586360|NCT02074553|26389202|P6|Intervention Period 1|Family Emergency|0
7586361|NCT02074553|26389203|P5|Intervention Period 1|Family Emergency|0
7586362|NCT02074553|26389204|P4|Intervention Period 1|Family Emergency|1
7586363|NCT02074553|26389205|P3|Intervention Period 1|Family Emergency|0
7586364|NCT02074553|26389206|P2|Intervention Period 1|Family Emergency|0
7586365|NCT02074553|26389207|P1|Intervention Period 1|Family Emergency|0
7586366|NCT02074514|26389389|P2|Overall Study|Withdrew Consent|1
7586367|NCT02074514|26389390|P1|Overall Study|Withdrew Consent|0
7586368|NCT02074514|26389389|P2|Overall Study|Lost to Follow-up|1
7586369|NCT02074514|26389390|P1|Overall Study|Lost to Follow-up|0
7586370|NCT02074514|26389389|P2|Overall Study|Lack of Efficacy|2
7586371|NCT02074514|26389390|P1|Overall Study|Lack of Efficacy|3
7586372|NCT02074059|26389531|P6|Overall Study|Death|1
7586373|NCT02074059|26389532|P5|Overall Study|Death|1
7586374|NCT02074059|26389533|P4|Overall Study|Death|0
7586375|NCT02074059|26389534|P3|Overall Study|Death|0
7586376|NCT02074059|26389535|P2|Overall Study|Death|0
7586377|NCT02074059|26389536|P1|Overall Study|Death|0
7586378|NCT02073929|26389580|P2|Overall Study|Withdrawal by Subject|1
7586379|NCT02073929|26389581|P1|Overall Study|Withdrawal by Subject|0
7586380|NCT02073929|26389580|P2|Overall Study|Adverse Event|1
7586381|NCT02073929|26389581|P1|Overall Study|Adverse Event|2
7586382|NCT02073929|26389580|P2|Overall Study|Lost to Follow-up|1
7586383|NCT02073929|26389581|P1|Overall Study|Lost to Follow-up|2
7586384|NCT02073682|26389618|P2|Overall Study|ID: Benefit/Risk Judgment|46
7586385|NCT02073682|26389619|P1|Overall Study|ID: Benefit/Risk Judgment|32
7586386|NCT02073682|26389618|P2|Overall Study|Lost to Follow-up|1
7586387|NCT02073682|26389619|P1|Overall Study|Lost to Follow-up|1
7586388|NCT02073682|26389618|P2|Overall Study|PD: Inconvenience of Dosing|78
7586389|NCT02073682|26389619|P1|Overall Study|PD: Inconvenience of Dosing|21
7586390|NCT02073682|26389618|P2|Overall Study|No reason provided|9
7586391|NCT02073682|26389619|P1|Overall Study|No reason provided|11
7586392|NCT02073682|26389618|P2|Overall Study|Adverse Event|62
7586393|NCT02073682|26389619|P1|Overall Study|Adverse Event|79
7586394|NCT02073682|26389618|P2|Overall Study|Protocol Violation|0
7586395|NCT02073682|26389619|P1|Overall Study|Protocol Violation|1
7586396|NCT02073682|26389618|P2|Overall Study|Cancer Progression|33
7586397|NCT02073682|26389619|P1|Overall Study|Cancer Progression|53
7586398|NCT02073682|26389618|P2|Overall Study|Start of New Chemotherapy Regimen|3
7586399|NCT02073682|26389619|P1|Overall Study|Start of New Chemotherapy Regimen|6
7586400|NCT02073682|26389618|P2|Overall Study|Withdrawal by Subject|8
7586401|NCT02073682|26389619|P1|Overall Study|Withdrawal by Subject|6
7586402|NCT02073682|26389618|P2|Overall Study|Surgery/Medical Procedure|1
7586403|NCT02073682|26389619|P1|Overall Study|Surgery/Medical Procedure|3
7586404|NCT02073682|26389618|P2|Overall Study|Platelet Count <50,000/mL|2
7586405|NCT02073682|26389619|P1|Overall Study|Platelet Count <50,000/mL|1
7586406|NCT02073682|26389618|P2|Overall Study|Prohibited Concomitant Medication Use|1
7586407|NCT02073682|26389619|P1|Overall Study|Prohibited Concomitant Medication Use|0
7586408|NCT02073682|26389618|P2|Overall Study|ID: Palliative Treatment Only|7
7586409|NCT02073682|26389619|P1|Overall Study|ID: Palliative Treatment Only|10
7586410|NCT02073682|26389618|P2|Overall Study|ID: Patient Noncompliance|2
7586411|NCT02073682|26389619|P1|Overall Study|ID: Patient Noncompliance|1
7586412|NCT02073682|26389618|P2|Overall Study|Cancer Cured|15
7586413|NCT02073682|26389619|P1|Overall Study|Cancer Cured|10
7586414|NCT02073682|26389618|P2|Overall Study|Death|100
7586415|NCT02073682|26389619|P1|Overall Study|Death|86
7586416|NCT02073682|26389618|P2|Overall Study|Low Creatinine Clearance|2
7586417|NCT02073682|26389619|P1|Overall Study|Low Creatinine Clearance|1
7586418|NCT02073656|26389637|P1|Primary Study|Withdrew Consent|1
7586419|NCT02073656|26389637|P1|Primary Study|Death|1
7586420|NCT02073656|26389637|P1|Primary Study|Lost to Follow-up|6
7586421|NCT02073643|26389653|P1|Overall Study|Lost to Follow-up|24
7586422|NCT02073565|26389664|P2|Cohort C|Lost to Follow-up|2
7586423|NCT02073565|26389665|P1|Cohort C|Lost to Follow-up|0
7586424|NCT02073565|26389664|P2|Cohort C|Withdrawal by Subject|2
7586425|NCT02073565|26389665|P1|Cohort C|Withdrawal by Subject|0
7586426|NCT02073565|26389664|P2|Cohort B|Withdrawal by Subject|2
7586427|NCT02073565|26389665|P1|Cohort B|Withdrawal by Subject|1
7586428|NCT02073565|26389664|P2|Cohort A|Withdrawal by Subject|0
7586429|NCT02073565|26389665|P1|Cohort A|Withdrawal by Subject|1
7586430|NCT02073279|26389766|P2|Open-label Extension Period|On-going in Study|13
7586431|NCT02073279|26389767|P1|Open-label Extension Period|On-going in Study|14
7586432|NCT02073279|26389766|P2|Open-label Extension Period|Reason Not Specified|1
7586433|NCT02073279|26389767|P1|Open-label Extension Period|Reason Not Specified|1
7586434|NCT02073279|26389766|P2|Open-label Extension Period|Withdrawal by Subject|1
7586435|NCT02073279|26389767|P1|Open-label Extension Period|Withdrawal by Subject|1
7586436|NCT02073279|26389766|P2|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
7586437|NCT02073279|26389767|P1|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
7586438|NCT02073279|26389766|P2|Open-label Extension Period|Lack of Efficacy|0
7586439|NCT02073279|26389767|P1|Open-label Extension Period|Lack of Efficacy|1
7586440|NCT02073279|26389766|P2|Double-blind Period|On-going in Study|40
7586441|NCT02073279|26389767|P1|Double-blind Period|On-going in Study|11
7586442|NCT02073279|26389766|P2|Double-blind Period|Refused Treatment/Did Not Cooperate|1
7586443|NCT02073279|26389767|P1|Double-blind Period|Refused Treatment/Did Not Cooperate|0
7586444|NCT02073279|26389766|P2|Double-blind Period|Reason Not Specified|2
7586445|NCT02073279|26389767|P1|Double-blind Period|Reason Not Specified|1
7586446|NCT02073279|26389766|P2|Double-blind Period|Withdrawal by Subject|2
7586447|NCT02073279|26389767|P1|Double-blind Period|Withdrawal by Subject|2
7586448|NCT02073279|26389766|P2|Double-blind Period|Protocol Deviation|1
7586449|NCT02073279|26389767|P1|Double-blind Period|Protocol Deviation|0
7586450|NCT02073279|26389766|P2|Double-blind Period|Adverse Event|1
7586451|NCT02073279|26389767|P1|Double-blind Period|Adverse Event|1
7586452|NCT02072980|26389870|P2|Period 2, Second Wear|Adverse Event|1
7586453|NCT02072980|26389871|P1|Period 2, Second Wear|Adverse Event|0
7586454|NCT02072941|26389879|P2|Overall Study|Removed by Study Staff|2
7586455|NCT02072941|26389880|P1|Overall Study|Removed by Study Staff|2
7586456|NCT02072941|26389879|P2|Overall Study|Death|2
7586457|NCT02072941|26389880|P1|Overall Study|Death|3
7586458|NCT02072941|26389879|P2|Overall Study|Lost to Follow-up|4
7586459|NCT02072941|26389880|P1|Overall Study|Lost to Follow-up|4
7586460|NCT02072941|26389879|P2|Overall Study|Withdrawal by Subject|21
7586461|NCT02072941|26389880|P1|Overall Study|Withdrawal by Subject|29
7586462|NCT02072824|26389895|P3|Overall Study|Adverse Event|1
7586463|NCT02072824|26389896|P2|Overall Study|Adverse Event|0
7586464|NCT02072824|26389897|P1|Overall Study|Adverse Event|0
7586465|NCT02072824|26389895|P3|Overall Study|Medication error|0
7586466|NCT02072824|26389896|P2|Overall Study|Medication error|1
7586467|NCT02072824|26389897|P1|Overall Study|Medication error|0
7586468|NCT02072824|26389895|P3|Overall Study|No longer willing to participate|1
7586469|NCT02072824|26389896|P2|Overall Study|No longer willing to participate|0
7586470|NCT02072824|26389897|P1|Overall Study|No longer willing to participate|1
7586471|NCT02072824|26389895|P3|Overall Study|Insufficient clinical response|1
7586472|NCT02072824|26389896|P2|Overall Study|Insufficient clinical response|0
7586473|NCT02072824|26389897|P1|Overall Study|Insufficient clinical response|1
7586474|NCT02072668|26389932|P2|Second Intervention|Lost to Follow-up|0
7586475|NCT02072668|26389933|P1|Second Intervention|Lost to Follow-up|1
7586476|NCT02072434|26389973|P2|Overall Study|Lost to Follow-up|1
7586477|NCT02072434|26389974|P1|Overall Study|Lost to Follow-up|0
7586478|NCT02072434|26389973|P2|Overall Study|Other|29
7586479|NCT02072434|26389974|P1|Overall Study|Other|14
7586480|NCT02072434|26389973|P2|Overall Study|Withdrawal by Subject|29
7586481|NCT02072434|26389974|P1|Overall Study|Withdrawal by Subject|17
7586482|NCT02072434|26389973|P2|Overall Study|Adverse Event|6
7586483|NCT02072434|26389974|P1|Overall Study|Adverse Event|7
7586484|NCT02072434|26389973|P2|Overall Study|Adverse event, serious fatal|6
7586485|NCT02072434|26389974|P1|Overall Study|Adverse event, serious fatal|1
7586486|NCT02072434|26389973|P2|Overall Study|Physician Decision|10
7586487|NCT02072434|26389974|P1|Overall Study|Physician Decision|5
7586488|NCT02072434|26389973|P2|Overall Study|Protocol Violation|9
7586489|NCT02072434|26389974|P1|Overall Study|Protocol Violation|10
7586490|NCT02072226|26389994|P2|Overall Study|Patient Withdrawal of Consent|0
7586491|NCT02072226|26389995|P1|Overall Study|Patient Withdrawal of Consent|1
7586492|NCT02072226|26389994|P2|Overall Study|Death|0
7586493|NCT02072226|26389995|P1|Overall Study|Death|1
7586494|NCT02072226|26389994|P2|Overall Study|Patient Non-compliance|3
7586495|NCT02072226|26389995|P1|Overall Study|Patient Non-compliance|2
7586496|NCT02072226|26389994|P2|Overall Study|Lost to Follow-up|7
7586497|NCT02072226|26389995|P1|Overall Study|Lost to Follow-up|11
7586498|NCT02072174|26390025|P2|Overall Study|Non-compliance with protocol requirement|0
7586499|NCT02072174|26390026|P1|Overall Study|Non-compliance with protocol requirement|2
7586500|NCT02072174|26390025|P2|Overall Study|Physician Decision|1
7586501|NCT02072174|26390026|P1|Overall Study|Physician Decision|0
7586502|NCT02072174|26390025|P2|Overall Study|Protocol Violation|23
7586503|NCT02072174|26390026|P1|Overall Study|Protocol Violation|16
7586504|NCT02072174|26390025|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
7586505|NCT02072174|26390026|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
7586506|NCT02072096|26390050|P2|Overall Study|Lost to Follow-up|0
7586507|NCT02072096|26390051|P1|Overall Study|Lost to Follow-up|1
7586508|NCT02072096|26390050|P2|Overall Study|Study Terminated by Sponsor|30
7586509|NCT02072096|26390051|P1|Overall Study|Study Terminated by Sponsor|43
7586510|NCT02072096|26390050|P2|Overall Study|Physician Decision|1
7586511|NCT02072096|26390051|P1|Overall Study|Physician Decision|0
7586512|NCT02072096|26390050|P2|Overall Study|Death|0
7586513|NCT02072096|26390051|P1|Overall Study|Death|2
7586514|NCT02072096|26390050|P2|Overall Study|No Reason Provided|2
7586515|NCT02072096|26390051|P1|Overall Study|No Reason Provided|4
7586516|NCT02072096|26390050|P2|Overall Study|Adverse Event|2
7586517|NCT02072096|26390051|P1|Overall Study|Adverse Event|5
7586518|NCT02072096|26390050|P2|Overall Study|Withdrawal by Subject|7
7586519|NCT02072096|26390051|P1|Overall Study|Withdrawal by Subject|5
7586520|NCT02072096|26390050|P2|Overall Study|Protocol Violation|7
7586521|NCT02072096|26390051|P1|Overall Study|Protocol Violation|7
7586522|NCT02072096|26390050|P2|Overall Study|Lack of Efficacy|29
7586523|NCT02072096|26390051|P1|Overall Study|Lack of Efficacy|18
7586524|NCT02071849|26390102|P1|2-year Extended Follow-up|Adverse Event|1
7586525|NCT02071849|26390102|P1|6-month Primary Endpoint|Adverse Event|1
7586526|NCT02071849|26390102|P1|6-month Primary Endpoint|Did not receive device|4
7586527|NCT02071771|26390168|P2|Period 1: First 10 Days|Unavailable lens power|0
7586528|NCT02071771|26390169|P1|Period 1: First 10 Days|Unavailable lens power|1
7586529|NCT02071771|26390168|P2|Period 1: First 10 Days|Unacceptable lens fit|0
7586530|NCT02071771|26390169|P1|Period 1: First 10 Days|Unacceptable lens fit|1
7586531|NCT02071706|26390177|P1|Overall Study|Withdrawal by Subject|2
7586532|NCT02071706|26390177|P1|Overall Study|Adverse Event|1
7586533|NCT02071290|26390193|P2|Overall Study|Physician Decision|1
7586534|NCT02071290|26390194|P1|Overall Study|Physician Decision|0
7586535|NCT02071290|26390193|P2|Overall Study|Protocol Violation|5
7586536|NCT02071290|26390194|P1|Overall Study|Protocol Violation|3
7586537|NCT02071290|26390193|P2|Overall Study|Withdrawal by Subject|1
7586538|NCT02071290|26390194|P1|Overall Study|Withdrawal by Subject|0
7586539|NCT02071290|26390193|P2|Overall Study|Death|0
7586540|NCT02071290|26390194|P1|Overall Study|Death|1
7586541|NCT02071225|26390248|P1|Overall Study|Death|25
7586542|NCT02071225|26390248|P1|Overall Study|Lost to Follow-up|2
7586543|NCT02071225|26390248|P1|Overall Study|Protocol Deviation|1
7586544|NCT02071225|26390248|P1|Overall Study|Withdrawal of Consent|2
7586545|NCT02071082|26390323|P2|Overall Study|Lost to Follow-up|1
7586546|NCT02071082|26390324|P1|Overall Study|Lost to Follow-up|1
7586547|NCT02071082|26390323|P2|Overall Study|Withdrew Consent|4
7586548|NCT02071082|26390324|P1|Overall Study|Withdrew Consent|0
7586549|NCT02071082|26390323|P2|Overall Study|Adverse Event|1
7586550|NCT02071082|26390324|P1|Overall Study|Adverse Event|0
7586551|NCT02071082|26390323|P2|Overall Study|Enrolled and Never Treated|1
7586552|NCT02071082|26390324|P1|Overall Study|Enrolled and Never Treated|1
7586553|NCT02070991|26390354|P2|Overall Study|Withdrawal by Subject|0
7586554|NCT02070991|26390355|P1|Overall Study|Withdrawal by Subject|1
7586555|NCT02070991|26390354|P2|Overall Study|Death|0
7586556|NCT02070991|26390355|P1|Overall Study|Death|2
7586557|NCT02070978|26390378|P3|Overall Study|Terminated by Sponsor|39
7586558|NCT02070978|26390379|P2|Overall Study|Terminated by Sponsor|40
7586559|NCT02070978|26390380|P1|Overall Study|Terminated by Sponsor|33
7586560|NCT02070978|26390378|P3|Overall Study|Un-specified|2
7586561|NCT02070978|26390379|P2|Overall Study|Un-specified|2
7586562|NCT02070978|26390380|P1|Overall Study|Un-specified|3
7586563|NCT02070978|26390378|P3|Overall Study|Death|2
7586564|NCT02070978|26390379|P2|Overall Study|Death|0
7586565|NCT02070978|26390380|P1|Overall Study|Death|0
7586566|NCT02070978|26390378|P3|Overall Study|Lack of Efficacy|0
7586567|NCT02070978|26390379|P2|Overall Study|Lack of Efficacy|1
7586568|NCT02070978|26390380|P1|Overall Study|Lack of Efficacy|0
7586569|NCT02070978|26390378|P3|Overall Study|Protocol Violation|3
7586570|NCT02070978|26390379|P2|Overall Study|Protocol Violation|0
7586571|NCT02070978|26390380|P1|Overall Study|Protocol Violation|1
7586572|NCT02070978|26390378|P3|Overall Study|Withdrawal by Subject|3
7586573|NCT02070978|26390379|P2|Overall Study|Withdrawal by Subject|5
7586574|NCT02070978|26390380|P1|Overall Study|Withdrawal by Subject|3
7586575|NCT02070978|26390378|P3|Overall Study|Lost to Follow-up|4
7586576|NCT02070978|26390379|P2|Overall Study|Lost to Follow-up|3
7586577|NCT02070978|26390380|P1|Overall Study|Lost to Follow-up|1
7586578|NCT02070978|26390378|P3|Overall Study|Adverse Event|0
7586579|NCT02070978|26390379|P2|Overall Study|Adverse Event|2
7586580|NCT02070978|26390380|P1|Overall Study|Adverse Event|6
7586581|NCT02070965|26390442|P3|Overall Study|Subject moved|0
7586582|NCT02070965|26390443|P2|Overall Study|Subject moved|0
7586583|NCT02070965|26390444|P1|Overall Study|Subject moved|1
7586584|NCT02070965|26390442|P3|Overall Study|Withdrawal by Subject|1
7586585|NCT02070965|26390443|P2|Overall Study|Withdrawal by Subject|1
7586586|NCT02070965|26390444|P1|Overall Study|Withdrawal by Subject|1
7586587|NCT02070965|26390442|P3|Overall Study|Lost to Follow-up|0
7586588|NCT02070965|26390443|P2|Overall Study|Lost to Follow-up|1
7586589|NCT02070965|26390444|P1|Overall Study|Lost to Follow-up|0
7586590|NCT02070757|26390454|P2|Overall Study|Discharged from Study Hospital|2
7586591|NCT02070757|26390455|P1|Overall Study|Discharged from Study Hospital|2
7586592|NCT02070757|26390454|P2|Overall Study|Investigator Decision|2
7586593|NCT02070757|26390455|P1|Overall Study|Investigator Decision|0
7586594|NCT02070757|26390454|P2|Overall Study|Withdrawal by Subject|3
7586595|NCT02070757|26390455|P1|Overall Study|Withdrawal by Subject|1
7586596|NCT02070757|26390454|P2|Overall Study|Protocol Violation|4
7586597|NCT02070757|26390455|P1|Overall Study|Protocol Violation|0
7586598|NCT02070757|26390454|P2|Overall Study|Lost to Follow-up|4
7586599|NCT02070757|26390455|P1|Overall Study|Lost to Follow-up|7
7586600|NCT02070757|26390454|P2|Overall Study|Adverse Event|99
7586601|NCT02070757|26390455|P1|Overall Study|Adverse Event|107
7586602|NCT02070744|26390489|P5|OLE Phase (48 Weeks)|Other|1
7586603|NCT02070744|26390490|P4|OLE Phase (48 Weeks)|Other|0
7586604|NCT02070744|26390491|P3|OLE Phase (48 Weeks)|Other|0
7586605|NCT02070744|26390492|P2|OLE Phase (48 Weeks)|Other|0
7586606|NCT02070744|26390493|P1|OLE Phase (48 Weeks)|Other|0
7586607|NCT02070744|26390489|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
7586608|NCT02070744|26390490|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7586609|NCT02070744|26390491|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7586610|NCT02070744|26390492|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7586611|NCT02070744|26390493|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7586612|NCT02070744|26390489|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
7586613|NCT02070744|26390490|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
7586614|NCT02070744|26390491|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
7586615|NCT02070744|26390492|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
7586616|NCT02070744|26390493|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
7586617|NCT02070588|26390576|P3|Overall Study|Adverse Event|0
7586618|NCT02070588|26390577|P2|Overall Study|Adverse Event|0
7586619|NCT02070588|26390578|P1|Overall Study|Adverse Event|1
7586620|NCT02070588|26390576|P3|Overall Study|Writhdrawal due to early termination|0
7586621|NCT02070588|26390577|P2|Overall Study|Writhdrawal due to early termination|0
7586622|NCT02070588|26390578|P1|Overall Study|Writhdrawal due to early termination|9
7586623|NCT02070588|26390576|P3|Overall Study|Withdrawal by Subject|0
7586624|NCT02070588|26390577|P2|Overall Study|Withdrawal by Subject|1
7586625|NCT02070588|26390578|P1|Overall Study|Withdrawal by Subject|29
7586626|NCT02070484|26390594|P2|Overall Study|Withdrawal by Subject|0
7586627|NCT02070484|26390595|P1|Overall Study|Withdrawal by Subject|1
7586628|NCT02070380|26390617|P4|Second Injection|Protocol Violation|5
7586629|NCT02070380|26390618|P3|Second Injection|Protocol Violation|1
7586630|NCT02070380|26390619|P2|Second Injection|Protocol Violation|1
7586631|NCT02070380|26390620|P1|Second Injection|Protocol Violation|0
7586632|NCT02070380|26390617|P4|Second Injection|Image sets missing or technically inadeq|0
7586633|NCT02070380|26390618|P3|Second Injection|Image sets missing or technically inadeq|0
7586634|NCT02070380|26390619|P2|Second Injection|Image sets missing or technically inadeq|1
7586635|NCT02070380|26390620|P1|Second Injection|Image sets missing or technically inadeq|0
7586636|NCT02070380|26390617|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
7586637|NCT02070380|26390618|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
7586638|NCT02070380|26390619|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
7586639|NCT02070380|26390620|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
7586640|NCT02069392|26390762|P2|Overall Study|Withdrawal by Subject|2
7586641|NCT02069392|26390763|P1|Overall Study|Withdrawal by Subject|4
7586642|NCT02069379|26390787|P4|Second Treatment Arm|Lost to Follow-up|0
7586643|NCT02069379|26390788|P3|Second Treatment Arm|Lost to Follow-up|1
7586644|NCT02069379|26390789|P2|Second Treatment Arm|Lost to Follow-up|0
7586645|NCT02069379|26390790|P1|Second Treatment Arm|Lost to Follow-up|0
7586646|NCT02069379|26390787|P4|Washout Period (4 Weeks)|Unrelated event|0
7586647|NCT02069379|26390788|P3|Washout Period (4 Weeks)|Unrelated event|0
7586648|NCT02069379|26390789|P2|Washout Period (4 Weeks)|Unrelated event|1
7586649|NCT02069379|26390790|P1|Washout Period (4 Weeks)|Unrelated event|0
7586650|NCT02069379|26390787|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
7586651|NCT02069379|26390788|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
7586652|NCT02069379|26390789|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
7586653|NCT02069379|26390790|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
7586654|NCT02069379|26390787|P4|First Treatment Arm|Lost to Follow-up|0
7586655|NCT02069379|26390788|P3|First Treatment Arm|Lost to Follow-up|1
7586656|NCT02069379|26390789|P2|First Treatment Arm|Lost to Follow-up|1
7586657|NCT02069379|26390790|P1|First Treatment Arm|Lost to Follow-up|0
7586658|NCT02069379|26390787|P4|Baseline Measurements|Ineligible based on initial assessments|2
7586659|NCT02069379|26390788|P3|Baseline Measurements|Ineligible based on initial assessments|0
7586660|NCT02069379|26390789|P2|Baseline Measurements|Ineligible based on initial assessments|0
7586661|NCT02069379|26390790|P1|Baseline Measurements|Ineligible based on initial assessments|2
7586662|NCT02069379|26390787|P4|Baseline Measurements|Lost to Follow-up|0
7586663|NCT02069379|26390788|P3|Baseline Measurements|Lost to Follow-up|0
7586664|NCT02069379|26390789|P2|Baseline Measurements|Lost to Follow-up|0
7586665|NCT02069379|26390790|P1|Baseline Measurements|Lost to Follow-up|1
7586666|NCT02069093|26390877|P1|Overall Study|Adverse Event|10
7586667|NCT02069093|26390877|P1|Overall Study|Abnormal laboratory values|1
7586668|NCT02069093|26390877|P1|Overall Study|Withdrawal by Subject|2
7586669|NCT02069093|26390877|P1|Overall Study|Administrative problems|1
7586670|NCT02069093|26390877|P1|Overall Study|Death|1
7586671|NCT02069093|26390877|P1|Overall Study|New cancer therapy|1
7586672|NCT02069093|26390877|P1|Overall Study|Disease progression|14
7586673|NCT02069015|26390896|P2|Overall Study|Withdrawal by Subject|1
7586674|NCT02069015|26390897|P1|Overall Study|Withdrawal by Subject|1
7586675|NCT02069015|26390896|P2|Overall Study|Lost to Follow-up|32
7586676|NCT02069015|26390897|P1|Overall Study|Lost to Follow-up|39
7586677|NCT02068885|26390907|P3|Overall Study|Withdrew|8
7586678|NCT02068885|26390908|P2|Overall Study|Withdrew|5
7586679|NCT02068885|26390909|P1|Overall Study|Withdrew|3
7586680|NCT02068768|26391038|P1|Overall Study|Early Termination by Sponsor|2
7586681|NCT02068768|26391038|P1|Overall Study|Lost to Follow-up|5
7586682|NCT02068599|26391106|P3|Overall Study|Noncompliance|1
7586683|NCT02068599|26391107|P2|Overall Study|Noncompliance|0
7586684|NCT02068599|26391108|P1|Overall Study|Noncompliance|0
7586685|NCT02068599|26391106|P3|Overall Study|Lack of Efficacy|3
7586686|NCT02068599|26391107|P2|Overall Study|Lack of Efficacy|0
7586687|NCT02068599|26391108|P1|Overall Study|Lack of Efficacy|0
7586688|NCT02068599|26391106|P3|Overall Study|Lost to Follow-up|0
7586689|NCT02068599|26391107|P2|Overall Study|Lost to Follow-up|0
7586690|NCT02068599|26391108|P1|Overall Study|Lost to Follow-up|1
7586691|NCT02068599|26391106|P3|Overall Study|Protocol Violation|3
7586692|NCT02068599|26391107|P2|Overall Study|Protocol Violation|2
7586693|NCT02068599|26391108|P1|Overall Study|Protocol Violation|4
7586694|NCT02068599|26391106|P3|Overall Study|Withdrawal by Subject|5
7586695|NCT02068599|26391107|P2|Overall Study|Withdrawal by Subject|7
7586696|NCT02068599|26391108|P1|Overall Study|Withdrawal by Subject|2
7586697|NCT02068599|26391106|P3|Overall Study|Adverse Event|1
7586698|NCT02068599|26391107|P2|Overall Study|Adverse Event|1
7586699|NCT02068599|26391108|P1|Overall Study|Adverse Event|4
7586700|NCT02068547|26391148|P2|Overall Study|Physician Decision|0
7586701|NCT02068547|26391149|P1|Overall Study|Physician Decision|1
7586702|NCT02068547|26391148|P2|Overall Study|Lost to Follow-up|3
7586703|NCT02068547|26391149|P1|Overall Study|Lost to Follow-up|3
7586704|NCT02068508|26391159|P1|Overall Study|Protocol Violation|4
7586705|NCT02068508|26391159|P1|Overall Study|Patient did not visit the study site|1
7586706|NCT02068508|26391159|P1|Overall Study|Case report forms uncollected|27
7586707|NCT02068495|26391169|P1|Overall Study|Protocol Deviation|49
7586708|NCT02068495|26391169|P1|Overall Study|Case Report Forms Uncollected|60
7586709|NCT02068443|26391181|P3|Overall Study|Other Reason Not Specified|0
7586710|NCT02068443|26391182|P2|Overall Study|Other Reason Not Specified|0
7586711|NCT02068443|26391183|P1|Overall Study|Other Reason Not Specified|1
7586712|NCT02068443|26391181|P3|Overall Study|Lack of Efficacy|0
7586713|NCT02068443|26391182|P2|Overall Study|Lack of Efficacy|1
7586714|NCT02068443|26391183|P1|Overall Study|Lack of Efficacy|2
7586715|NCT02068443|26391181|P3|Overall Study|Voluntary Withdrawal|1
7586716|NCT02068443|26391182|P2|Overall Study|Voluntary Withdrawal|0
7586717|NCT02068443|26391183|P1|Overall Study|Voluntary Withdrawal|4
7586718|NCT02068443|26391181|P3|Overall Study|Pretreatment Event/Adverse Event|2
7586719|NCT02068443|26391182|P2|Overall Study|Pretreatment Event/Adverse Event|5
7586720|NCT02068443|26391183|P1|Overall Study|Pretreatment Event/Adverse Event|0
7586721|NCT02068222|26391218|P1|Overall Study|Lost to Follow-up|1
7586722|NCT02067728|26391274|P2|6 Month Measurements|Unable to attend|97
7586723|NCT02067728|26391275|P1|6 Month Measurements|Unable to attend|114
7586724|NCT02067728|26391274|P2|6 Month Follow up Survey|Lost to Follow-up|60
7586725|NCT02067728|26391275|P1|6 Month Follow up Survey|Lost to Follow-up|48
7586726|NCT02067728|26391274|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
7586727|NCT02067728|26391275|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
7586728|NCT02067676|26391309|P6|Overall Study|Withdrawal by Subject|0
7586729|NCT02067676|26391310|P5|Overall Study|Withdrawal by Subject|0
7586730|NCT02067676|26391311|P4|Overall Study|Withdrawal by Subject|0
7586731|NCT02067676|26391312|P3|Overall Study|Withdrawal by Subject|0
7586732|NCT02067676|26391313|P2|Overall Study|Withdrawal by Subject|0
7586733|NCT02067676|26391314|P1|Overall Study|Withdrawal by Subject|1
7586734|NCT02067663|26391354|P2|Overall Study|Lost to Follow-up|14
7586735|NCT02067663|26391355|P1|Overall Study|Lost to Follow-up|13
7586736|NCT02067533|26391454|P2|Overall Study|Lost to Follow-up|2
7586737|NCT02067533|26391455|P1|Overall Study|Lost to Follow-up|4
7586738|NCT02067104|26391506|P2|Overall Study|Study termination due to low accrual|5
7586739|NCT02067104|26391507|P1|Overall Study|Study termination due to low accrual|4
7586740|NCT02066922|26391536|P1|Overall Study|Adverse Event|1
7586741|NCT02066467|26391605|P1|Overall Study|Not defined|4
7586742|NCT02066467|26391605|P1|Overall Study|Physician Decision|2
7586743|NCT02066467|26391605|P1|Overall Study|Withdrawal by Subject|16
7586744|NCT02066467|26391605|P1|Overall Study|Adverse Event|20
7586745|NCT02066467|26391605|P1|Overall Study|Lost to Follow-up|51
7586746|NCT02066467|26391605|P1|Overall Study|Death|54
7586747|NCT02066467|26391605|P1|Overall Study|Consent ineligible|1
7586748|NCT02066467|26391605|P1|Overall Study|Attempted to implant withoput success|43
7586749|NCT02066467|26391605|P1|Overall Study|Did not undergo implant procedure|24
7586750|NCT02066415|26391614|P3|Overall Study|Lost to Follow-up|2
7586751|NCT02066415|26391615|P2|Overall Study|Lost to Follow-up|2
7586752|NCT02066415|26391616|P1|Overall Study|Lost to Follow-up|7
7586753|NCT02066415|26391614|P3|Overall Study|Withdrawal by Subject|4
7586754|NCT02066415|26391615|P2|Overall Study|Withdrawal by Subject|1
7586755|NCT02066415|26391616|P1|Overall Study|Withdrawal by Subject|9
7586756|NCT02066415|26391614|P3|Overall Study|Decision by Sponsor|2
7586757|NCT02066415|26391615|P2|Overall Study|Decision by Sponsor|4
7586758|NCT02066415|26391616|P1|Overall Study|Decision by Sponsor|5
7586759|NCT02066402|26391641|P2|Overall Study|Protocol driven decision point|1
7586760|NCT02066402|26391642|P1|Overall Study|Protocol driven decision point|0
7586761|NCT02066402|26391641|P2|Overall Study|Progressive disease-clinical progression|1
7586762|NCT02066402|26391642|P1|Overall Study|Progressive disease-clinical progression|0
7586763|NCT02066402|26391641|P2|Overall Study|Withdrawal by Subject|11
7586764|NCT02066402|26391642|P1|Overall Study|Withdrawal by Subject|14
7586765|NCT02066402|26391641|P2|Overall Study|Lost to Follow-up|8
7586766|NCT02066402|26391642|P1|Overall Study|Lost to Follow-up|11
7586767|NCT02066402|26391641|P2|Overall Study|Adverse Event|2
7586768|NCT02066402|26391642|P1|Overall Study|Adverse Event|1
7586769|NCT02066389|26391674|P6|Overall Study|Randomized in Error|1
7586770|NCT02066389|26391675|P5|Overall Study|Randomized in Error|0
7586771|NCT02066389|26391676|P4|Overall Study|Randomized in Error|0
7586772|NCT02066389|26391677|P3|Overall Study|Randomized in Error|0
7586773|NCT02066389|26391678|P2|Overall Study|Randomized in Error|0
7586774|NCT02066389|26391679|P1|Overall Study|Randomized in Error|0
7586775|NCT02066389|26391674|P6|Overall Study|Lost to Follow-up|1
7586776|NCT02066389|26391675|P5|Overall Study|Lost to Follow-up|1
7586777|NCT02066389|26391676|P4|Overall Study|Lost to Follow-up|1
7586778|NCT02066389|26391677|P3|Overall Study|Lost to Follow-up|0
7586779|NCT02066389|26391678|P2|Overall Study|Lost to Follow-up|0
7586780|NCT02066389|26391679|P1|Overall Study|Lost to Follow-up|0
7586781|NCT02066389|26391674|P6|Overall Study|Withdrawal by Subject|2
7586782|NCT02066389|26391675|P5|Overall Study|Withdrawal by Subject|1
7586783|NCT02066389|26391676|P4|Overall Study|Withdrawal by Subject|1
7586784|NCT02066389|26391677|P3|Overall Study|Withdrawal by Subject|5
7586785|NCT02066389|26391678|P2|Overall Study|Withdrawal by Subject|0
7586786|NCT02066389|26391679|P1|Overall Study|Withdrawal by Subject|4
7586787|NCT02066389|26391674|P6|Overall Study|Adverse Event|1
7586788|NCT02066389|26391675|P5|Overall Study|Adverse Event|5
7586789|NCT02066389|26391676|P4|Overall Study|Adverse Event|1
7586790|NCT02066389|26391677|P3|Overall Study|Adverse Event|1
7586791|NCT02066389|26391678|P2|Overall Study|Adverse Event|1
7586792|NCT02066389|26391679|P1|Overall Study|Adverse Event|1
7586793|NCT02066311|26391729|P1|Overall Study|Withdrawal by Subject|1
7586794|NCT02066311|26391729|P1|Overall Study|Adverse Event|4
7586795|NCT02066298|26391739|P6|Overall Study|Physician Decision|0
7586796|NCT02066298|26391740|P5|Overall Study|Physician Decision|1
7586797|NCT02066298|26391741|P4|Overall Study|Physician Decision|0
7586798|NCT02066298|26391742|P3|Overall Study|Physician Decision|1
7586799|NCT02066298|26391743|P2|Overall Study|Physician Decision|0
7586800|NCT02066298|26391744|P1|Overall Study|Physician Decision|0
7586801|NCT02066298|26391739|P6|Overall Study|Withdrawal by Subject|8
7586802|NCT02066298|26391740|P5|Overall Study|Withdrawal by Subject|5
7586803|NCT02066298|26391741|P4|Overall Study|Withdrawal by Subject|4
7586804|NCT02066298|26391742|P3|Overall Study|Withdrawal by Subject|6
7586805|NCT02066298|26391743|P2|Overall Study|Withdrawal by Subject|6
7586806|NCT02066298|26391744|P1|Overall Study|Withdrawal by Subject|6
7586807|NCT02066298|26391739|P6|Overall Study|Lost to Follow-up|4
7586808|NCT02066298|26391740|P5|Overall Study|Lost to Follow-up|3
7586809|NCT02066298|26391741|P4|Overall Study|Lost to Follow-up|2
7586810|NCT02066298|26391742|P3|Overall Study|Lost to Follow-up|3
7586811|NCT02066298|26391743|P2|Overall Study|Lost to Follow-up|2
7586812|NCT02066298|26391744|P1|Overall Study|Lost to Follow-up|3
7586813|NCT02066233|26391768|P2|EG Scan II (Day 1)|difficulty intubating subject|6
7586814|NCT02066233|26391769|P1|EG Scan II (Day 1)|difficulty intubating subject|6
7586815|NCT02066181|26391779|P2|Overall Study|Withdrawal by Subject|1
7586816|NCT02066181|26391780|P1|Overall Study|Withdrawal by Subject|1
7586817|NCT02066129|26391802|P2|Overall Study|Physician Decision|1
7586818|NCT02066129|26391803|P1|Overall Study|Physician Decision|1
7586819|NCT02066129|26391802|P2|Overall Study|Lack of Efficacy|10
7586820|NCT02066129|26391803|P1|Overall Study|Lack of Efficacy|8
7586821|NCT02066129|26391802|P2|Overall Study|Withdrawal by Subject|10
7586822|NCT02066129|26391803|P1|Overall Study|Withdrawal by Subject|7
7586823|NCT02066129|26391802|P2|Overall Study|Lost to Follow-up|12
7586824|NCT02066129|26391803|P1|Overall Study|Lost to Follow-up|13
7586825|NCT02066051|26391817|P1|Overall Study|Subject developed active GVHD|1
7586826|NCT02065895|26391822|P6|Overall Study|Scheduling conflicts|0
7586827|NCT02065895|26391823|P5|Overall Study|Scheduling conflicts|0
7586828|NCT02065895|26391824|P4|Overall Study|Scheduling conflicts|0
7586829|NCT02065895|26391825|P3|Overall Study|Scheduling conflicts|0
7586830|NCT02065895|26391826|P2|Overall Study|Scheduling conflicts|1
7586831|NCT02065895|26391827|P1|Overall Study|Scheduling conflicts|0
7586832|NCT02065895|26391822|P6|Overall Study|Protocol Violation|0
7586833|NCT02065895|26391823|P5|Overall Study|Protocol Violation|0
7586834|NCT02065895|26391824|P4|Overall Study|Protocol Violation|1
7586835|NCT02065895|26391825|P3|Overall Study|Protocol Violation|0
7586836|NCT02065895|26391826|P2|Overall Study|Protocol Violation|0
7586837|NCT02065895|26391827|P1|Overall Study|Protocol Violation|1
7586838|NCT02065791|26391846|P2|Overall Study|Lost to Follow-up|9
7586839|NCT02065791|26391847|P1|Overall Study|Lost to Follow-up|13
7586840|NCT02065791|26391846|P2|Overall Study|Withdrawal by Subject|5
7586841|NCT02065791|26391847|P1|Overall Study|Withdrawal by Subject|11
7586842|NCT02065791|26391846|P2|Overall Study|Closed Site|1
7586843|NCT02065791|26391847|P1|Overall Study|Closed Site|1
7586844|NCT02065713|26391869|P2|Overall Study|Unsatisfactory therapeutic effect|0
7586845|NCT02065713|26391870|P1|Overall Study|Unsatisfactory therapeutic effect|1
7586846|NCT02065713|26391869|P2|Overall Study|Adverse Event|1
7586847|NCT02065713|26391870|P1|Overall Study|Adverse Event|0
7586848|NCT02065622|26391901|P5|Maintenance Study|Unknown Reason|0
7586849|NCT02065622|26391902|P4|Maintenance Study|Unknown Reason|1
7586850|NCT02065622|26391903|P3|Maintenance Study|Unknown Reason|0
7586851|NCT02065622|26391904|P2|Maintenance Study|Unknown Reason|0
7586852|NCT02065622|26391905|P1|Maintenance Study|Unknown Reason|0
7586853|NCT02065622|26391901|P5|Maintenance Study|Other, Not Specified|2
7586854|NCT02065622|26391902|P4|Maintenance Study|Other, Not Specified|14
7586855|NCT02065622|26391903|P3|Maintenance Study|Other, Not Specified|6
7586856|NCT02065622|26391904|P2|Maintenance Study|Other, Not Specified|0
7586857|NCT02065622|26391905|P1|Maintenance Study|Other, Not Specified|0
7586858|NCT02065622|26391901|P5|Maintenance Study|Subject Non-Compliance|2
7586859|NCT02065622|26391902|P4|Maintenance Study|Subject Non-Compliance|3
7586860|NCT02065622|26391903|P3|Maintenance Study|Subject Non-Compliance|1
7586861|NCT02065622|26391904|P2|Maintenance Study|Subject Non-Compliance|0
7586862|NCT02065622|26391905|P1|Maintenance Study|Subject Non-Compliance|0
7586863|NCT02065622|26391901|P5|Maintenance Study|Requires Alternative/Prohibited Therapy|4
7586864|NCT02065622|26391902|P4|Maintenance Study|Requires Alternative/Prohibited Therapy|3
7586865|NCT02065622|26391903|P3|Maintenance Study|Requires Alternative/Prohibited Therapy|7
7586866|NCT02065622|26391904|P2|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7586867|NCT02065622|26391905|P1|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7586868|NCT02065622|26391901|P5|Maintenance Study|Lack of Efficacy|19
7586869|NCT02065622|26391902|P4|Maintenance Study|Lack of Efficacy|55
7586870|NCT02065622|26391903|P3|Maintenance Study|Lack of Efficacy|70
7586871|NCT02065622|26391904|P2|Maintenance Study|Lack of Efficacy|0
7586872|NCT02065622|26391905|P1|Maintenance Study|Lack of Efficacy|0
7586873|NCT02065622|26391901|P5|Maintenance Study|Lost to Follow-up|1
7586874|NCT02065622|26391902|P4|Maintenance Study|Lost to Follow-up|1
7586875|NCT02065622|26391903|P3|Maintenance Study|Lost to Follow-up|4
7586876|NCT02065622|26391904|P2|Maintenance Study|Lost to Follow-up|0
7586877|NCT02065622|26391905|P1|Maintenance Study|Lost to Follow-up|0
7586878|NCT02065622|26391901|P5|Maintenance Study|Withdrawal by Subject|7
7586879|NCT02065622|26391902|P4|Maintenance Study|Withdrawal by Subject|5
7586880|NCT02065622|26391903|P3|Maintenance Study|Withdrawal by Subject|11
7586881|NCT02065622|26391904|P2|Maintenance Study|Withdrawal by Subject|0
7586882|NCT02065622|26391905|P1|Maintenance Study|Withdrawal by Subject|0
7586883|NCT02065622|26391901|P5|Maintenance Study|Adverse Event|11
7586884|NCT02065622|26391902|P4|Maintenance Study|Adverse Event|22
7586885|NCT02065622|26391903|P3|Maintenance Study|Adverse Event|25
7586886|NCT02065622|26391904|P2|Maintenance Study|Adverse Event|0
7586887|NCT02065622|26391905|P1|Maintenance Study|Adverse Event|0
7586888|NCT02065622|26391901|P5|Induction Study|Other, Not Specified|0
7586889|NCT02065622|26391902|P4|Induction Study|Other, Not Specified|0
7586890|NCT02065622|26391903|P3|Induction Study|Other, Not Specified|0
7586891|NCT02065622|26391904|P2|Induction Study|Other, Not Specified|2
7586892|NCT02065622|26391905|P1|Induction Study|Other, Not Specified|3
7586893|NCT02065622|26391901|P5|Induction Study|Subject Noncompliance|0
7586894|NCT02065622|26391902|P4|Induction Study|Subject Noncompliance|0
7586895|NCT02065622|26391903|P3|Induction Study|Subject Noncompliance|0
7586896|NCT02065622|26391904|P2|Induction Study|Subject Noncompliance|1
7586897|NCT02065622|26391905|P1|Induction Study|Subject Noncompliance|1
7586898|NCT02065622|26391901|P5|Induction Study|Requires Alternative/Prohibited Therapy|0
7586899|NCT02065622|26391902|P4|Induction Study|Requires Alternative/Prohibited Therapy|0
7586900|NCT02065622|26391903|P3|Induction Study|Requires Alternative/Prohibited Therapy|0
7586901|NCT02065622|26391904|P2|Induction Study|Requires Alternative/Prohibited Therapy|5
7586902|NCT02065622|26391905|P1|Induction Study|Requires Alternative/Prohibited Therapy|4
7586903|NCT02065622|26391901|P5|Induction Study|Lack of Efficacy|0
7586904|NCT02065622|26391902|P4|Induction Study|Lack of Efficacy|0
7586905|NCT02065622|26391903|P3|Induction Study|Lack of Efficacy|0
7586906|NCT02065622|26391904|P2|Induction Study|Lack of Efficacy|27
7586907|NCT02065622|26391905|P1|Induction Study|Lack of Efficacy|22
7586908|NCT02065622|26391901|P5|Induction Study|Lost to Follow-up|0
7586909|NCT02065622|26391902|P4|Induction Study|Lost to Follow-up|0
7586910|NCT02065622|26391903|P3|Induction Study|Lost to Follow-up|0
7586911|NCT02065622|26391904|P2|Induction Study|Lost to Follow-up|0
7586912|NCT02065622|26391905|P1|Induction Study|Lost to Follow-up|1
7586913|NCT02065622|26391901|P5|Induction Study|Withdrawal by Subject|0
7586914|NCT02065622|26391902|P4|Induction Study|Withdrawal by Subject|0
7586915|NCT02065622|26391903|P3|Induction Study|Withdrawal by Subject|0
7586916|NCT02065622|26391904|P2|Induction Study|Withdrawal by Subject|5
7586917|NCT02065622|26391905|P1|Induction Study|Withdrawal by Subject|3
7586918|NCT02065622|26391901|P5|Induction Study|Adverse Event|0
7586919|NCT02065622|26391902|P4|Induction Study|Adverse Event|0
7586920|NCT02065622|26391903|P3|Induction Study|Adverse Event|0
7586921|NCT02065622|26391904|P2|Induction Study|Adverse Event|19
7586922|NCT02065622|26391905|P1|Induction Study|Adverse Event|13
7586923|NCT02065570|26392006|P4|Maintenance Study|Other, Not Specified|5
7586924|NCT02065570|26392007|P3|Maintenance Study|Other, Not Specified|11
7586925|NCT02065570|26392008|P2|Maintenance Study|Other, Not Specified|0
7586926|NCT02065570|26392009|P1|Maintenance Study|Other, Not Specified|0
7586927|NCT02065570|26392006|P4|Maintenance Study|Lost to Follow-up|2
7586928|NCT02065570|26392007|P3|Maintenance Study|Lost to Follow-up|2
7586929|NCT02065570|26392008|P2|Maintenance Study|Lost to Follow-up|0
7586930|NCT02065570|26392009|P1|Maintenance Study|Lost to Follow-up|0
7586931|NCT02065570|26392006|P4|Maintenance Study|Withdrawal by Subject|4
7586932|NCT02065570|26392007|P3|Maintenance Study|Withdrawal by Subject|1
7586933|NCT02065570|26392008|P2|Maintenance Study|Withdrawal by Subject|0
7586934|NCT02065570|26392009|P1|Maintenance Study|Withdrawal by Subject|0
7586935|NCT02065570|26392006|P4|Maintenance Study|Adverse Event|8
7586936|NCT02065570|26392007|P3|Maintenance Study|Adverse Event|8
7586937|NCT02065570|26392008|P2|Maintenance Study|Adverse Event|0
7586938|NCT02065570|26392009|P1|Maintenance Study|Adverse Event|0
7586939|NCT02065570|26392006|P4|Induction Study|Other, Not Specified|0
7586940|NCT02065570|26392007|P3|Induction Study|Other, Not Specified|0
7586941|NCT02065570|26392008|P2|Induction Study|Other, Not Specified|5
7586942|NCT02065570|26392009|P1|Induction Study|Other, Not Specified|6
7586943|NCT02065570|26392006|P4|Induction Study|Lost to Follow-up|0
7586944|NCT02065570|26392007|P3|Induction Study|Lost to Follow-up|0
7586945|NCT02065570|26392008|P2|Induction Study|Lost to Follow-up|1
7586946|NCT02065570|26392009|P1|Induction Study|Lost to Follow-up|1
7586947|NCT02065570|26392006|P4|Induction Study|Withdrawal by Subject|0
7586948|NCT02065570|26392007|P3|Induction Study|Withdrawal by Subject|0
7586949|NCT02065570|26392008|P2|Induction Study|Withdrawal by Subject|3
7586950|NCT02065570|26392009|P1|Induction Study|Withdrawal by Subject|2
7586951|NCT02065570|26392006|P4|Induction Study|Adverse Event|0
7586952|NCT02065570|26392007|P3|Induction Study|Adverse Event|0
7586953|NCT02065570|26392008|P2|Induction Study|Adverse Event|12
7586954|NCT02065570|26392009|P1|Induction Study|Adverse Event|5
7586955|NCT02065557|26392056|P6|Maintenance Period|Subject Non-Compliance|1
7586956|NCT02065557|26392057|P5|Maintenance Period|Subject Non-Compliance|0
7586957|NCT02065557|26392058|P4|Maintenance Period|Subject Non-Compliance|0
7586958|NCT02065557|26392059|P3|Maintenance Period|Subject Non-Compliance|0
7586959|NCT02065557|26392060|P2|Maintenance Period|Subject Non-Compliance|0
7586960|NCT02065557|26392061|P1|Maintenance Period|Subject Non-Compliance|0
7586961|NCT02065557|26392056|P6|Maintenance Period|Lack of Efficacy|2
7586962|NCT02065557|26392057|P5|Maintenance Period|Lack of Efficacy|5
7586963|NCT02065557|26392058|P4|Maintenance Period|Lack of Efficacy|0
7586964|NCT02065557|26392059|P3|Maintenance Period|Lack of Efficacy|0
7586965|NCT02065557|26392060|P2|Maintenance Period|Lack of Efficacy|0
7586966|NCT02065557|26392061|P1|Maintenance Period|Lack of Efficacy|0
7586967|NCT02065557|26392056|P6|Maintenance Period|Withdrawal by Subject|1
7586968|NCT02065557|26392057|P5|Maintenance Period|Withdrawal by Subject|2
7586969|NCT02065557|26392058|P4|Maintenance Period|Withdrawal by Subject|0
7586970|NCT02065557|26392059|P3|Maintenance Period|Withdrawal by Subject|0
7586971|NCT02065557|26392060|P2|Maintenance Period|Withdrawal by Subject|0
7586972|NCT02065557|26392061|P1|Maintenance Period|Withdrawal by Subject|0
7586973|NCT02065557|26392056|P6|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7586974|NCT02065557|26392057|P5|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7586975|NCT02065557|26392058|P4|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7586976|NCT02065557|26392059|P3|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7586977|NCT02065557|26392060|P2|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7586978|NCT02065557|26392061|P1|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7586979|NCT02065557|26392056|P6|Induction Period|Adverse Event|0
7586980|NCT02065557|26392057|P5|Induction Period|Adverse Event|0
7586981|NCT02065557|26392058|P4|Induction Period|Adverse Event|0
7586982|NCT02065557|26392059|P3|Induction Period|Adverse Event|0
7586983|NCT02065557|26392060|P2|Induction Period|Adverse Event|1
7586984|NCT02065557|26392061|P1|Induction Period|Adverse Event|1
7586985|NCT02065557|26392056|P6|Induction Period|Non-Responder at Week 8|0
7586986|NCT02065557|26392057|P5|Induction Period|Non-Responder at Week 8|0
7586987|NCT02065557|26392058|P4|Induction Period|Non-Responder at Week 8|0
7586988|NCT02065557|26392059|P3|Induction Period|Non-Responder at Week 8|0
7586989|NCT02065557|26392060|P2|Induction Period|Non-Responder at Week 8|4
7586990|NCT02065557|26392061|P1|Induction Period|Non-Responder at Week 8|4
7586991|NCT02065557|26392056|P6|Induction Period|Requires Alternative/Prohibited Therapy|0
7586992|NCT02065557|26392057|P5|Induction Period|Requires Alternative/Prohibited Therapy|0
7586993|NCT02065557|26392058|P4|Induction Period|Requires Alternative/Prohibited Therapy|0
7586994|NCT02065557|26392059|P3|Induction Period|Requires Alternative/Prohibited Therapy|1
7586995|NCT02065557|26392060|P2|Induction Period|Requires Alternative/Prohibited Therapy|1
7586996|NCT02065557|26392061|P1|Induction Period|Requires Alternative/Prohibited Therapy|1
7586997|NCT02065557|26392056|P6|Induction Period|Lack of Efficacy|0
7586998|NCT02065557|26392057|P5|Induction Period|Lack of Efficacy|0
7586999|NCT02065557|26392058|P4|Induction Period|Lack of Efficacy|0
7587000|NCT02065557|26392059|P3|Induction Period|Lack of Efficacy|1
7587001|NCT02065557|26392060|P2|Induction Period|Lack of Efficacy|1
7587002|NCT02065557|26392061|P1|Induction Period|Lack of Efficacy|2
7587003|NCT02065557|26392056|P6|Induction Period|Withdrawal by Subject|0
7587004|NCT02065557|26392057|P5|Induction Period|Withdrawal by Subject|0
7587005|NCT02065557|26392058|P4|Induction Period|Withdrawal by Subject|0
7587006|NCT02065557|26392059|P3|Induction Period|Withdrawal by Subject|0
7587007|NCT02065557|26392060|P2|Induction Period|Withdrawal by Subject|1
7587008|NCT02065557|26392061|P1|Induction Period|Withdrawal by Subject|2
7587009|NCT02065518|26392122|P4|Overall Study|Withdrawal by Subject|2
7587010|NCT02065518|26392123|P3|Overall Study|Withdrawal by Subject|9
7587011|NCT02065518|26392124|P2|Overall Study|Withdrawal by Subject|4
7587012|NCT02065518|26392125|P1|Overall Study|Withdrawal by Subject|3
7587013|NCT02065518|26392122|P4|Overall Study|Lost to Follow-up|3
7587014|NCT02065518|26392123|P3|Overall Study|Lost to Follow-up|0
7587015|NCT02065518|26392124|P2|Overall Study|Lost to Follow-up|4
7587016|NCT02065518|26392125|P1|Overall Study|Lost to Follow-up|3
7587017|NCT02065336|26392200|P10|Extension Phase|Study Terminated by Sponsor|8
7587018|NCT02065336|26392201|P9|Extension Phase|Study Terminated by Sponsor|2
7587019|NCT02065336|26392202|P8|Extension Phase|Study Terminated by Sponsor|0
7587020|NCT02065336|26392203|P7|Extension Phase|Study Terminated by Sponsor|0
7587021|NCT02065336|26392204|P6|Extension Phase|Study Terminated by Sponsor|0
7587022|NCT02065336|26392205|P5|Extension Phase|Study Terminated by Sponsor|0
7587023|NCT02065336|26392206|P4|Extension Phase|Study Terminated by Sponsor|0
7587024|NCT02065336|26392207|P3|Extension Phase|Study Terminated by Sponsor|0
7587025|NCT02065336|26392208|P2|Extension Phase|Study Terminated by Sponsor|0
7587026|NCT02065336|26392209|P1|Extension Phase|Study Terminated by Sponsor|0
7587027|NCT02065245|26392308|P7|Infusion 3|Lost to Follow-up|0
7587028|NCT02065245|26392309|P6|Infusion 3|Lost to Follow-up|0
7587029|NCT02065245|26392310|P5|Infusion 3|Lost to Follow-up|0
7587030|NCT02065245|26392311|P4|Infusion 3|Lost to Follow-up|0
7587031|NCT02065245|26392312|P3|Infusion 3|Lost to Follow-up|0
7587032|NCT02065245|26392313|P2|Infusion 3|Lost to Follow-up|1
7587033|NCT02065245|26392314|P1|Infusion 3|Lost to Follow-up|1
7587034|NCT02065245|26392308|P7|Infusion 2|Death|1
7587035|NCT02065245|26392309|P6|Infusion 2|Death|0
7587036|NCT02065245|26392310|P5|Infusion 2|Death|0
7587037|NCT02065245|26392311|P4|Infusion 2|Death|0
7587038|NCT02065245|26392312|P3|Infusion 2|Death|0
7587039|NCT02065245|26392313|P2|Infusion 2|Death|0
7587040|NCT02065245|26392314|P1|Infusion 2|Death|0
7587041|NCT02065245|26392308|P7|Infusion 1|Death|0
7587042|NCT02065245|26392309|P6|Infusion 1|Death|0
7587043|NCT02065245|26392310|P5|Infusion 1|Death|1
7587044|NCT02065245|26392311|P4|Infusion 1|Death|0
7587045|NCT02065245|26392312|P3|Infusion 1|Death|1
7587046|NCT02065245|26392313|P2|Infusion 1|Death|0
7587047|NCT02065245|26392314|P1|Infusion 1|Death|0
7587048|NCT02065245|26392308|P7|Infusion 1|Lost to Follow-up|1
7587049|NCT02065245|26392309|P6|Infusion 1|Lost to Follow-up|0
7587050|NCT02065245|26392310|P5|Infusion 1|Lost to Follow-up|0
7587051|NCT02065245|26392311|P4|Infusion 1|Lost to Follow-up|0
7587052|NCT02065245|26392312|P3|Infusion 1|Lost to Follow-up|0
7587053|NCT02065245|26392313|P2|Infusion 1|Lost to Follow-up|0
7587054|NCT02065245|26392314|P1|Infusion 1|Lost to Follow-up|0
7587055|NCT02064920|26392515|P2|Overall Study|Withdrawal by Subject|3
7587056|NCT02064920|26392516|P1|Overall Study|Withdrawal by Subject|1
7587057|NCT02064920|26392515|P2|Overall Study|Technical Problems|1
7587058|NCT02064920|26392516|P1|Overall Study|Technical Problems|0
7587059|NCT02064920|26392515|P2|Overall Study|Physician Decision|1
7587060|NCT02064920|26392516|P1|Overall Study|Physician Decision|0
7587061|NCT02064920|26392515|P2|Overall Study|Adverse Event|4
7587062|NCT02064920|26392516|P1|Overall Study|Adverse Event|0
7587063|NCT02064894|26392546|P3|Overall Study|Withdrawal by Subject|115
7587064|NCT02064894|26392547|P2|Overall Study|Withdrawal by Subject|102
7587065|NCT02064894|26392548|P1|Overall Study|Withdrawal by Subject|43
7587066|NCT02064868|26392561|P2|Overall Study|Technical Problems or Missing|2
7587067|NCT02064868|26392562|P1|Overall Study|Technical Problems or Missing|5
7587068|NCT02064868|26392561|P2|Overall Study|Withdrawal by Subject|3
7587069|NCT02064868|26392562|P1|Overall Study|Withdrawal by Subject|14
7587070|NCT02064868|26392561|P2|Overall Study|Physician Decision|0
7587071|NCT02064868|26392562|P1|Overall Study|Physician Decision|1
7587072|NCT02064868|26392561|P2|Overall Study|Lost to Follow-up|8
7587073|NCT02064868|26392562|P1|Overall Study|Lost to Follow-up|14
7587074|NCT02064816|26392629|P2|Overall Study|Other|3
7587075|NCT02064816|26392630|P1|Overall Study|Other|1
7587076|NCT02064816|26392629|P2|Overall Study|Therapeutic failure|1
7587077|NCT02064816|26392630|P1|Overall Study|Therapeutic failure|0
7587078|NCT02064816|26392629|P2|Overall Study|Lost to Follow-up|1
7587079|NCT02064816|26392630|P1|Overall Study|Lost to Follow-up|2
7587080|NCT02064816|26392629|P2|Overall Study|Withdrawal by Subject|1
7587081|NCT02064816|26392630|P1|Overall Study|Withdrawal by Subject|2
7587082|NCT02064816|26392629|P2|Overall Study|Adverse Event|2
7587083|NCT02064816|26392630|P1|Overall Study|Adverse Event|3
7587084|NCT02064439|26392676|P3|Overall Study|Other|7
7587085|NCT02064439|26392677|P2|Overall Study|Other|2
7587086|NCT02064439|26392678|P1|Overall Study|Other|2
7587087|NCT02064439|26392676|P3|Overall Study|Safety outcome reached|10
7587088|NCT02064439|26392677|P2|Overall Study|Safety outcome reached|20
7587089|NCT02064439|26392678|P1|Overall Study|Safety outcome reached|12
7587090|NCT02064439|26392676|P3|Overall Study|Efficacy outcome reached|57
7587091|NCT02064439|26392677|P2|Overall Study|Efficacy outcome reached|16
7587092|NCT02064439|26392678|P1|Overall Study|Efficacy outcome reached|18
7587093|NCT02064439|26392676|P3|Overall Study|Logistical difficulties|2
7587094|NCT02064439|26392677|P2|Overall Study|Logistical difficulties|5
7587095|NCT02064439|26392678|P1|Overall Study|Logistical difficulties|6
7587096|NCT02064439|26392676|P3|Overall Study|Physician Decision|1
7587097|NCT02064439|26392677|P2|Overall Study|Physician Decision|1
7587098|NCT02064439|26392678|P1|Overall Study|Physician Decision|0
7587099|NCT02064439|26392676|P3|Overall Study|Non-compliance with study medication|23
7587100|NCT02064439|26392677|P2|Overall Study|Non-compliance with study medication|19
7587101|NCT02064439|26392678|P1|Overall Study|Non-compliance with study medication|21
7587102|NCT02064439|26392676|P3|Overall Study|Lost to Follow-up|4
7587103|NCT02064439|26392677|P2|Overall Study|Lost to Follow-up|3
7587104|NCT02064439|26392678|P1|Overall Study|Lost to Follow-up|1
7587105|NCT02064439|26392676|P3|Overall Study|Protocol Violation|3
7587106|NCT02064439|26392677|P2|Overall Study|Protocol Violation|5
7587107|NCT02064439|26392678|P1|Overall Study|Protocol Violation|3
7587108|NCT02064439|26392676|P3|Overall Study|Withdrawal by Subject|26
7587109|NCT02064439|26392677|P2|Overall Study|Withdrawal by Subject|18
7587110|NCT02064439|26392678|P1|Overall Study|Withdrawal by Subject|29
7587111|NCT02064439|26392676|P3|Overall Study|Death|3
7587112|NCT02064439|26392677|P2|Overall Study|Death|2
7587113|NCT02064439|26392678|P1|Overall Study|Death|0
7587114|NCT02064439|26392676|P3|Overall Study|Adverse Event|46
7587115|NCT02064439|26392677|P2|Overall Study|Adverse Event|47
7587116|NCT02064439|26392678|P1|Overall Study|Adverse Event|51
7587117|NCT02064387|26392707|P12|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587118|NCT02064387|26392708|P11|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
7587119|NCT02064387|26392709|P10|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587120|NCT02064387|26392710|P9|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587121|NCT02064387|26392711|P8|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587122|NCT02064387|26392712|P7|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587123|NCT02064387|26392713|P6|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587124|NCT02064387|26392714|P5|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587125|NCT02064387|26392715|P4|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587126|NCT02064387|26392716|P3|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587127|NCT02064387|26392717|P2|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587128|NCT02064387|26392718|P1|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7587129|NCT02064387|26392707|P12|Part 2 Max 35 Months Followup Duration|Death|3
7587130|NCT02064387|26392708|P11|Part 2 Max 35 Months Followup Duration|Death|5
7587131|NCT02064387|26392709|P10|Part 2 Max 35 Months Followup Duration|Death|0
7587132|NCT02064387|26392710|P9|Part 2 Max 35 Months Followup Duration|Death|0
7587133|NCT02064387|26392711|P8|Part 2 Max 35 Months Followup Duration|Death|0
7587134|NCT02064387|26392712|P7|Part 2 Max 35 Months Followup Duration|Death|0
7587135|NCT02064387|26392713|P6|Part 2 Max 35 Months Followup Duration|Death|0
7587136|NCT02064387|26392714|P5|Part 2 Max 35 Months Followup Duration|Death|0
7587137|NCT02064387|26392715|P4|Part 2 Max 35 Months Followup Duration|Death|0
7587138|NCT02064387|26392716|P3|Part 2 Max 35 Months Followup Duration|Death|0
7587139|NCT02064387|26392717|P2|Part 2 Max 35 Months Followup Duration|Death|0
7587140|NCT02064387|26392718|P1|Part 2 Max 35 Months Followup Duration|Death|0
7587141|NCT02064387|26392707|P12|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587142|NCT02064387|26392708|P11|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587299|NCT02063217|26393487|P1|Overall Study|Withdrawal by Subject|1
7587143|NCT02064387|26392709|P10|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587144|NCT02064387|26392710|P9|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
7587145|NCT02064387|26392711|P8|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587146|NCT02064387|26392712|P7|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587147|NCT02064387|26392713|P6|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587148|NCT02064387|26392714|P5|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587149|NCT02064387|26392715|P4|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587150|NCT02064387|26392716|P3|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587151|NCT02064387|26392717|P2|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587152|NCT02064387|26392718|P1|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7587153|NCT02064387|26392707|P12|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587154|NCT02064387|26392708|P11|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587155|NCT02064387|26392709|P10|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587156|NCT02064387|26392710|P9|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587157|NCT02064387|26392711|P8|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
7587158|NCT02064387|26392712|P7|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587159|NCT02064387|26392713|P6|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587160|NCT02064387|26392714|P5|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587161|NCT02064387|26392715|P4|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587162|NCT02064387|26392716|P3|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587163|NCT02064387|26392717|P2|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587164|NCT02064387|26392718|P1|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7587165|NCT02064387|26392707|P12|Part 1 Max 23.5 Months Followup Duration|Death|0
7587166|NCT02064387|26392708|P11|Part 1 Max 23.5 Months Followup Duration|Death|0
7587167|NCT02064387|26392709|P10|Part 1 Max 23.5 Months Followup Duration|Death|1
7587168|NCT02064387|26392710|P9|Part 1 Max 23.5 Months Followup Duration|Death|0
7587169|NCT02064387|26392711|P8|Part 1 Max 23.5 Months Followup Duration|Death|1
7587170|NCT02064387|26392712|P7|Part 1 Max 23.5 Months Followup Duration|Death|0
7587171|NCT02064387|26392713|P6|Part 1 Max 23.5 Months Followup Duration|Death|0
7587172|NCT02064387|26392714|P5|Part 1 Max 23.5 Months Followup Duration|Death|0
7587173|NCT02064387|26392715|P4|Part 1 Max 23.5 Months Followup Duration|Death|0
7587174|NCT02064387|26392716|P3|Part 1 Max 23.5 Months Followup Duration|Death|0
7587175|NCT02064387|26392717|P2|Part 1 Max 23.5 Months Followup Duration|Death|0
7587176|NCT02064387|26392718|P1|Part 1 Max 23.5 Months Followup Duration|Death|0
7587177|NCT02064231|26393047|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7587178|NCT02064231|26393048|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7587179|NCT02064231|26393049|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7587180|NCT02064231|26393050|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7587181|NCT02064231|26393047|P4|First Test Period (Test A or Test C)|Adverse Event|0
7587182|NCT02064231|26393048|P3|First Test Period (Test A or Test C)|Adverse Event|1
7587183|NCT02064231|26393049|P2|First Test Period (Test A or Test C)|Adverse Event|0
7587184|NCT02064231|26393050|P1|First Test Period (Test A or Test C)|Adverse Event|1
7587185|NCT02064231|26393047|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7587186|NCT02064231|26393048|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7587187|NCT02064231|26393049|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7587188|NCT02064231|26393050|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7587189|NCT02064231|26393047|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
7587190|NCT02064231|26393048|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
7587191|NCT02064231|26393049|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
7587192|NCT02064231|26393050|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
7587193|NCT02064205|26393062|P1|Overall Study|Withdrawal by Subject|1
7587194|NCT02064166|26393080|P2|Overall Study|Adverse Event|0
7587195|NCT02064166|26393081|P1|Overall Study|Adverse Event|1
7587196|NCT02063984|26393111|P2|Overall Study|Lost to Follow-up|5
7587197|NCT02063984|26393112|P1|Overall Study|Lost to Follow-up|6
7587198|NCT02063880|26393134|P2|Overall Study|Ineligible|2
7587199|NCT02063880|26393135|P1|Overall Study|Ineligible|0
7587200|NCT02063880|26393134|P2|Overall Study|Lost to Follow-up|7
7587201|NCT02063880|26393135|P1|Overall Study|Lost to Follow-up|7
7587202|NCT02063880|26393134|P2|Overall Study|Death|18
7587203|NCT02063880|26393135|P1|Overall Study|Death|21
7587204|NCT02063854|26393173|P7|Overall Study|Did Not Receive Study Drug|0
7587205|NCT02063854|26393174|P6|Overall Study|Did Not Receive Study Drug|1
7587206|NCT02063854|26393175|P5|Overall Study|Did Not Receive Study Drug|0
7587207|NCT02063854|26393176|P4|Overall Study|Did Not Receive Study Drug|0
7587208|NCT02063854|26393177|P3|Overall Study|Did Not Receive Study Drug|0
7587209|NCT02063854|26393178|P2|Overall Study|Did Not Receive Study Drug|0
7587210|NCT02063854|26393179|P1|Overall Study|Did Not Receive Study Drug|0
7587211|NCT02063854|26393173|P7|Overall Study|Reason Not Specified|0
7587212|NCT02063854|26393174|P6|Overall Study|Reason Not Specified|0
7587213|NCT02063854|26393175|P5|Overall Study|Reason Not Specified|0
7587214|NCT02063854|26393176|P4|Overall Study|Reason Not Specified|0
7587215|NCT02063854|26393177|P3|Overall Study|Reason Not Specified|0
7587216|NCT02063854|26393178|P2|Overall Study|Reason Not Specified|0
7587217|NCT02063854|26393179|P1|Overall Study|Reason Not Specified|1
7587218|NCT02063854|26393173|P7|Overall Study|Surgical Dental Work Performed/Planned|1
7587219|NCT02063854|26393174|P6|Overall Study|Surgical Dental Work Performed/Planned|6
7587220|NCT02063854|26393175|P5|Overall Study|Surgical Dental Work Performed/Planned|1
7587221|NCT02063854|26393176|P4|Overall Study|Surgical Dental Work Performed/Planned|1
7587222|NCT02063854|26393177|P3|Overall Study|Surgical Dental Work Performed/Planned|6
7587223|NCT02063854|26393178|P2|Overall Study|Surgical Dental Work Performed/Planned|2
7587224|NCT02063854|26393179|P1|Overall Study|Surgical Dental Work Performed/Planned|5
7587225|NCT02063854|26393173|P7|Overall Study|Voluntary Withdrawal|1
7587226|NCT02063854|26393174|P6|Overall Study|Voluntary Withdrawal|6
7587227|NCT02063854|26393175|P5|Overall Study|Voluntary Withdrawal|3
7587228|NCT02063854|26393176|P4|Overall Study|Voluntary Withdrawal|1
7587229|NCT02063854|26393177|P3|Overall Study|Voluntary Withdrawal|8
7587230|NCT02063854|26393178|P2|Overall Study|Voluntary Withdrawal|0
7587231|NCT02063854|26393179|P1|Overall Study|Voluntary Withdrawal|2
7587232|NCT02063854|26393173|P7|Overall Study|Major Protocol Deviation|0
7587233|NCT02063854|26393174|P6|Overall Study|Major Protocol Deviation|0
7587234|NCT02063854|26393175|P5|Overall Study|Major Protocol Deviation|0
7587235|NCT02063854|26393176|P4|Overall Study|Major Protocol Deviation|0
7587236|NCT02063854|26393177|P3|Overall Study|Major Protocol Deviation|3
7587237|NCT02063854|26393178|P2|Overall Study|Major Protocol Deviation|0
7587238|NCT02063854|26393179|P1|Overall Study|Major Protocol Deviation|0
7587239|NCT02063854|26393173|P7|Overall Study|Pretreatment Event/Adverse Event|4
7587240|NCT02063854|26393174|P6|Overall Study|Pretreatment Event/Adverse Event|18
7587241|NCT02063854|26393175|P5|Overall Study|Pretreatment Event/Adverse Event|7
7587242|NCT02063854|26393176|P4|Overall Study|Pretreatment Event/Adverse Event|8
7587243|NCT02063854|26393177|P3|Overall Study|Pretreatment Event/Adverse Event|13
7587244|NCT02063854|26393178|P2|Overall Study|Pretreatment Event/Adverse Event|10
7587245|NCT02063854|26393179|P1|Overall Study|Pretreatment Event/Adverse Event|13
7587246|NCT02063828|26393264|P3|Overall Study|Death|1
7587247|NCT02063828|26393265|P2|Overall Study|Death|0
7587248|NCT02063828|26393266|P1|Overall Study|Death|0
7587249|NCT02063828|26393264|P3|Overall Study|Withdrawal by Subject|3
7587250|NCT02063828|26393265|P2|Overall Study|Withdrawal by Subject|6
7587251|NCT02063828|26393266|P1|Overall Study|Withdrawal by Subject|4
7587252|NCT02063737|26393285|P2|Overall Study|Lost to Follow-up|4
7587253|NCT02063737|26393286|P1|Overall Study|Lost to Follow-up|11
7587254|NCT02063724|26393318|P1|Overall Study|Disease progression|1
7587255|NCT02063698|26393326|P2|Overall Study|did not complete booklet for days 2-8|2
7587256|NCT02063698|26393327|P1|Overall Study|did not complete booklet for days 2-8|1
7587257|NCT02063672|26393351|P2|Overall Study|Withdrawal by Subject|2
7587258|NCT02063672|26393352|P1|Overall Study|Withdrawal by Subject|2
7587259|NCT02063672|26393351|P2|Overall Study|Lost to Follow-up|3
7587260|NCT02063672|26393352|P1|Overall Study|Lost to Follow-up|1
7587261|NCT02063672|26393351|P2|Overall Study|Death|3
7587262|NCT02063672|26393352|P1|Overall Study|Death|5
7587263|NCT02063672|26393351|P2|Overall Study|Ongoing Follow-up|14
7587264|NCT02063672|26393352|P1|Overall Study|Ongoing Follow-up|27
7587265|NCT02063659|26393399|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
7587266|NCT02063659|26393400|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
7587267|NCT02063659|26393401|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
7587268|NCT02063659|26393402|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
7587269|NCT02063659|26393399|P4|Open-Label Extension Period (OLE)|Adverse Event|7
7587270|NCT02063659|26393400|P3|Open-Label Extension Period (OLE)|Adverse Event|0
7587271|NCT02063659|26393401|P2|Open-Label Extension Period (OLE)|Adverse Event|0
7587272|NCT02063659|26393402|P1|Open-Label Extension Period (OLE)|Adverse Event|0
7587273|NCT02063659|26393399|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
7587274|NCT02063659|26393400|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7587275|NCT02063659|26393401|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7587276|NCT02063659|26393402|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7587277|NCT02063659|26393399|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7587278|NCT02063659|26393400|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7587279|NCT02063659|26393401|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7587280|NCT02063659|26393402|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7587281|NCT02063659|26393399|P4|Open-Label Extension Period (OLE)|Physician Decision|1
7587282|NCT02063659|26393400|P3|Open-Label Extension Period (OLE)|Physician Decision|0
7587283|NCT02063659|26393401|P2|Open-Label Extension Period (OLE)|Physician Decision|0
7587284|NCT02063659|26393402|P1|Open-Label Extension Period (OLE)|Physician Decision|0
7587285|NCT02063659|26393399|P4|Double-Blind Treatment Period|Withdrawal of consent|0
7587286|NCT02063659|26393400|P3|Double-Blind Treatment Period|Withdrawal of consent|3
7587287|NCT02063659|26393401|P2|Double-Blind Treatment Period|Withdrawal of consent|1
7587288|NCT02063659|26393402|P1|Double-Blind Treatment Period|Withdrawal of consent|0
7587289|NCT02063659|26393399|P4|Double-Blind Treatment Period|Physician Decision|0
7587290|NCT02063659|26393400|P3|Double-Blind Treatment Period|Physician Decision|0
7587291|NCT02063659|26393401|P2|Double-Blind Treatment Period|Physician Decision|0
7587292|NCT02063659|26393402|P1|Double-Blind Treatment Period|Physician Decision|1
7587293|NCT02063659|26393399|P4|Double-Blind Treatment Period|Adverse Event|0
7587294|NCT02063659|26393400|P3|Double-Blind Treatment Period|Adverse Event|0
7587295|NCT02063659|26393401|P2|Double-Blind Treatment Period|Adverse Event|2
7587296|NCT02063659|26393402|P1|Double-Blind Treatment Period|Adverse Event|1
7587297|NCT02063217|26393485|P3|Overall Study|Withdrawal by Subject|0
7587298|NCT02063217|26393486|P2|Overall Study|Withdrawal by Subject|0
7587300|NCT02062879|26393563|P2|Overall Study|Withdrawal by Subject|1
7587301|NCT02062879|26393564|P1|Overall Study|Withdrawal by Subject|4
7587302|NCT02062658|26393600|P1|Overall Study|Lack of Efficacy|1
7587303|NCT02062658|26393600|P1|Overall Study|Withdrawal by Subject|1
7587304|NCT02062645|26393604|P1|Overall Study|Lost to Follow-up|5
7587305|NCT02062645|26393604|P1|Overall Study|Protocol Violation|8
7587306|NCT02062645|26393604|P1|Overall Study|Adverse Event|2
7587307|NCT02062632|26393612|P1|Overall Study|No treatment data|1
7587308|NCT02062450|26393695|P1|Overall Study|No follow-up visit|124
7587309|NCT02062437|26393709|P1|Overall Study|Pt. couldn't come due to med. condition|1
7587310|NCT02062437|26393709|P1|Overall Study|Death|2
7587311|NCT02062437|26393709|P1|Overall Study|Patient not available for the 2y visit|18
7587312|NCT02062437|26393709|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
7587313|NCT02062398|26393718|P1|Overall Study|Implant removal|1
7587314|NCT02062385|26393730|P4|Overall Study|Lost to Follow-up|0
7587315|NCT02062385|26393731|P3|Overall Study|Lost to Follow-up|1
7587316|NCT02062385|26393732|P2|Overall Study|Lost to Follow-up|0
7587317|NCT02062385|26393733|P1|Overall Study|Lost to Follow-up|0
7587318|NCT02062385|26393730|P4|Overall Study|Death|1
7587319|NCT02062385|26393731|P3|Overall Study|Death|0
7587320|NCT02062385|26393732|P2|Overall Study|Death|0
7587321|NCT02062385|26393733|P1|Overall Study|Death|0
7587322|NCT02062385|26393730|P4|Overall Study|Withdrawn by parent/guardian|8
7587323|NCT02062385|26393731|P3|Overall Study|Withdrawn by parent/guardian|9
7587324|NCT02062385|26393732|P2|Overall Study|Withdrawn by parent/guardian|41
7587325|NCT02062385|26393733|P1|Overall Study|Withdrawn by parent/guardian|46
7587326|NCT02062385|26393730|P4|Overall Study|Moved|0
7587327|NCT02062385|26393731|P3|Overall Study|Moved|1
7587328|NCT02062385|26393732|P2|Overall Study|Moved|11
7587329|NCT02062385|26393733|P1|Overall Study|Moved|10
7587330|NCT02062385|26393730|P4|Overall Study|Incomplete EPI by database lock|0
7587331|NCT02062385|26393731|P3|Overall Study|Incomplete EPI by database lock|0
7587332|NCT02062385|26393732|P2|Overall Study|Incomplete EPI by database lock|0
7587333|NCT02062385|26393733|P1|Overall Study|Incomplete EPI by database lock|2
7587334|NCT02062385|26393730|P4|Overall Study|Protocol Violation|0
7587335|NCT02062385|26393731|P3|Overall Study|Protocol Violation|0
7587336|NCT02062385|26393732|P2|Overall Study|Protocol Violation|0
7587337|NCT02062385|26393733|P1|Overall Study|Protocol Violation|1
7587338|NCT02062385|26393730|P4|Overall Study|Adverse Event|0
7587339|NCT02062385|26393731|P3|Overall Study|Adverse Event|1
7587340|NCT02062385|26393732|P2|Overall Study|Adverse Event|13
7587341|NCT02062385|26393733|P1|Overall Study|Adverse Event|19
7587342|NCT02062151|26393777|P1|Overall Study|screen failure|1
7587343|NCT02061813|26393817|P1|Overall Study|Protocol Violation|2
7587344|NCT02061813|26393817|P1|Overall Study|Withdrawal by Subject|1
7587345|NCT02061592|26393948|P2|Period 2|Lost to Follow-up|1
7587346|NCT02061592|26393949|P1|Period 2|Lost to Follow-up|0
7587347|NCT02061592|26393948|P2|Period 1|Protocol Violation|0
7587348|NCT02061592|26393949|P1|Period 1|Protocol Violation|1
7587349|NCT02061592|26393948|P2|Period 1|Withdrawal by Subject|0
7587350|NCT02061592|26393949|P1|Period 1|Withdrawal by Subject|1
7587351|NCT02061540|26393961|P1|Overall Study|Withdrawal by Subject|2
7587352|NCT02061540|26393961|P1|Overall Study|Adverse Event|2
7587353|NCT02061280|26394143|P2|Overall Study|Lost to Follow-up|1
7587354|NCT02061280|26394144|P1|Overall Study|Lost to Follow-up|5
7587355|NCT02061280|26394143|P2|Overall Study|Withdrawal by Subject|2
7587356|NCT02061280|26394144|P1|Overall Study|Withdrawal by Subject|1
7587357|NCT02061280|26394143|P2|Overall Study|moved out of state|1
7587358|NCT02061280|26394144|P1|Overall Study|moved out of state|0
7587359|NCT02061280|26394143|P2|Overall Study|Protocol Violation|8
7587360|NCT02061280|26394144|P1|Overall Study|Protocol Violation|12
7587361|NCT02061202|26394176|P2|Overall Study|Lost to Follow-up|1
7587362|NCT02061202|26394177|P1|Overall Study|Lost to Follow-up|1
7587363|NCT02060903|26394203|P2|Overall Study|Withdrawal by Subject|7
7587364|NCT02060903|26394204|P1|Overall Study|Withdrawal by Subject|0
7587365|NCT02060903|26394203|P2|Overall Study|Lost to Follow-up|0
7587366|NCT02060903|26394204|P1|Overall Study|Lost to Follow-up|4
7587367|NCT02060383|26394325|P5|Extension Phase|Protocol Violation|1
7587368|NCT02060383|26394326|P4|Extension Phase|Protocol Violation|0
7587369|NCT02060383|26394327|P3|Extension Phase|Protocol Violation|0
7587370|NCT02060383|26394328|P2|Extension Phase|Protocol Violation|0
7587371|NCT02060383|26394329|P1|Extension Phase|Protocol Violation|0
7587372|NCT02060383|26394325|P5|Extension Phase|Death|1
7587373|NCT02060383|26394326|P4|Extension Phase|Death|0
7587374|NCT02060383|26394327|P3|Extension Phase|Death|1
7587375|NCT02060383|26394328|P2|Extension Phase|Death|0
7587376|NCT02060383|26394329|P1|Extension Phase|Death|0
7587377|NCT02060383|26394325|P5|Extension Phase|Administrative problems|0
7587378|NCT02060383|26394326|P4|Extension Phase|Administrative problems|0
7587379|NCT02060383|26394327|P3|Extension Phase|Administrative problems|0
7587380|NCT02060383|26394328|P2|Extension Phase|Administrative problems|0
7587381|NCT02060383|26394329|P1|Extension Phase|Administrative problems|1
7587382|NCT02060383|26394325|P5|Extension Phase|Withdrawal by Subject|2
7587383|NCT02060383|26394326|P4|Extension Phase|Withdrawal by Subject|0
7587384|NCT02060383|26394327|P3|Extension Phase|Withdrawal by Subject|0
7587385|NCT02060383|26394328|P2|Extension Phase|Withdrawal by Subject|1
7587386|NCT02060383|26394329|P1|Extension Phase|Withdrawal by Subject|0
7587387|NCT02060383|26394325|P5|Extension Phase|Adverse Event|1
7587388|NCT02060383|26394326|P4|Extension Phase|Adverse Event|0
7587389|NCT02060383|26394327|P3|Extension Phase|Adverse Event|2
7587390|NCT02060383|26394328|P2|Extension Phase|Adverse Event|1
7587391|NCT02060383|26394329|P1|Extension Phase|Adverse Event|1
7587392|NCT02060383|26394325|P5|Extension Phase|Unsatisfactory therapeutic effect|2
7587393|NCT02060383|26394326|P4|Extension Phase|Unsatisfactory therapeutic effect|2
7587394|NCT02060383|26394327|P3|Extension Phase|Unsatisfactory therapeutic effect|0
7587395|NCT02060383|26394328|P2|Extension Phase|Unsatisfactory therapeutic effect|1
7587396|NCT02060383|26394329|P1|Extension Phase|Unsatisfactory therapeutic effect|1
7587397|NCT02060383|26394325|P5|Core Phase|Withdrawal by Subject|2
7587398|NCT02060383|26394326|P4|Core Phase|Withdrawal by Subject|4
7587399|NCT02060383|26394327|P3|Core Phase|Withdrawal by Subject|0
7587400|NCT02060383|26394328|P2|Core Phase|Withdrawal by Subject|0
7587401|NCT02060383|26394329|P1|Core Phase|Withdrawal by Subject|0
7587402|NCT02060383|26394325|P5|Core Phase|Protocol Violation|0
7587403|NCT02060383|26394326|P4|Core Phase|Protocol Violation|1
7587404|NCT02060383|26394327|P3|Core Phase|Protocol Violation|0
7587405|NCT02060383|26394328|P2|Core Phase|Protocol Violation|0
7587406|NCT02060383|26394329|P1|Core Phase|Protocol Violation|0
7587407|NCT02060383|26394325|P5|Core Phase|Administrative problems|0
7587408|NCT02060383|26394326|P4|Core Phase|Administrative problems|0
7587409|NCT02060383|26394327|P3|Core Phase|Administrative problems|0
7587410|NCT02060383|26394328|P2|Core Phase|Administrative problems|1
7587411|NCT02060383|26394329|P1|Core Phase|Administrative problems|0
7587412|NCT02060383|26394325|P5|Core Phase|Adverse Event|6
7587413|NCT02060383|26394326|P4|Core Phase|Adverse Event|2
7587414|NCT02060383|26394327|P3|Core Phase|Adverse Event|0
7587415|NCT02060383|26394328|P2|Core Phase|Adverse Event|0
7587416|NCT02060383|26394329|P1|Core Phase|Adverse Event|2
7587417|NCT02060383|26394325|P5|Core Phase|Unsatisfactory therapeutic effect|0
7587418|NCT02060383|26394326|P4|Core Phase|Unsatisfactory therapeutic effect|0
7587419|NCT02060383|26394327|P3|Core Phase|Unsatisfactory therapeutic effect|0
7587420|NCT02060383|26394328|P2|Core Phase|Unsatisfactory therapeutic effect|5
7587421|NCT02060383|26394329|P1|Core Phase|Unsatisfactory therapeutic effect|1
7587422|NCT02060370|26394355|P1|Overall Study|Physician Decision|1
7587423|NCT02059980|26394396|P2|Overall Study|Lost to Follow-up|1
7587424|NCT02059980|26394397|P1|Overall Study|Lost to Follow-up|2
7587425|NCT02059434|26394549|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
7587426|NCT02059434|26394550|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587427|NCT02059434|26394551|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587428|NCT02059434|26394552|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587429|NCT02059434|26394553|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587430|NCT02059434|26394554|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587431|NCT02059434|26394555|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587432|NCT02059434|26394556|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587433|NCT02059434|26394557|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7587434|NCT02059434|26394549|P9|Washout Between Periods 7 and 8|Adverse Event|1
7587435|NCT02059434|26394550|P8|Washout Between Periods 7 and 8|Adverse Event|0
7587436|NCT02059434|26394551|P7|Washout Between Periods 7 and 8|Adverse Event|0
7587437|NCT02059434|26394552|P6|Washout Between Periods 7 and 8|Adverse Event|0
7587438|NCT02059434|26394553|P5|Washout Between Periods 7 and 8|Adverse Event|0
7587439|NCT02059434|26394554|P4|Washout Between Periods 7 and 8|Adverse Event|0
7587440|NCT02059434|26394555|P3|Washout Between Periods 7 and 8|Adverse Event|0
7587441|NCT02059434|26394556|P2|Washout Between Periods 7 and 8|Adverse Event|0
7587442|NCT02059434|26394557|P1|Washout Between Periods 7 and 8|Adverse Event|0
7587443|NCT02059434|26394549|P9|Washout Between Periods 6 and 7|Physician Decision|1
7587444|NCT02059434|26394550|P8|Washout Between Periods 6 and 7|Physician Decision|0
7587445|NCT02059434|26394551|P7|Washout Between Periods 6 and 7|Physician Decision|0
7587446|NCT02059434|26394552|P6|Washout Between Periods 6 and 7|Physician Decision|0
7587447|NCT02059434|26394553|P5|Washout Between Periods 6 and 7|Physician Decision|0
7587448|NCT02059434|26394554|P4|Washout Between Periods 6 and 7|Physician Decision|0
7587449|NCT02059434|26394555|P3|Washout Between Periods 6 and 7|Physician Decision|0
7587450|NCT02059434|26394556|P2|Washout Between Periods 6 and 7|Physician Decision|0
7587451|NCT02059434|26394557|P1|Washout Between Periods 6 and 7|Physician Decision|0
7587452|NCT02059434|26394549|P9|Washout Between Periods 4 and 5|Adverse Event|1
7587453|NCT02059434|26394550|P8|Washout Between Periods 4 and 5|Adverse Event|0
7587454|NCT02059434|26394551|P7|Washout Between Periods 4 and 5|Adverse Event|0
7587455|NCT02059434|26394552|P6|Washout Between Periods 4 and 5|Adverse Event|0
7587456|NCT02059434|26394553|P5|Washout Between Periods 4 and 5|Adverse Event|0
7587457|NCT02059434|26394554|P4|Washout Between Periods 4 and 5|Adverse Event|0
7587458|NCT02059434|26394555|P3|Washout Between Periods 4 and 5|Adverse Event|0
7587459|NCT02059434|26394556|P2|Washout Between Periods 4 and 5|Adverse Event|0
7587460|NCT02059434|26394557|P1|Washout Between Periods 4 and 5|Adverse Event|0
7587461|NCT02059434|26394549|P9|Washout Between Periods 1 and 2|Physician Decision|0
7587462|NCT02059434|26394550|P8|Washout Between Periods 1 and 2|Physician Decision|1
7587463|NCT02059434|26394551|P7|Washout Between Periods 1 and 2|Physician Decision|0
7587464|NCT02059434|26394552|P6|Washout Between Periods 1 and 2|Physician Decision|0
7587465|NCT02059434|26394553|P5|Washout Between Periods 1 and 2|Physician Decision|0
7587466|NCT02059434|26394554|P4|Washout Between Periods 1 and 2|Physician Decision|0
7587467|NCT02059434|26394555|P3|Washout Between Periods 1 and 2|Physician Decision|0
7587468|NCT02059434|26394556|P2|Washout Between Periods 1 and 2|Physician Decision|0
7587469|NCT02059434|26394557|P1|Washout Between Periods 1 and 2|Physician Decision|0
7587470|NCT02059408|26394622|P3|Overall Study|Did not get tested|358
7587471|NCT02059408|26394623|P2|Overall Study|Did not get tested|330
7587472|NCT02059408|26394624|P1|Overall Study|Did not get tested|0
7587473|NCT02059395|26394643|P2|Overall Study|Lost to Follow-up|4
7587474|NCT02059395|26394644|P1|Overall Study|Lost to Follow-up|2
7587475|NCT02059291|26394659|P25|Epoch 4|Lack of Efficacy|0
7587476|NCT02059291|26394660|P24|Epoch 4|Lack of Efficacy|1
7587477|NCT02059291|26394661|P23|Epoch 4|Lack of Efficacy|0
7587478|NCT02059291|26394662|P22|Epoch 4|Lack of Efficacy|0
7587479|NCT02059291|26394663|P21|Epoch 4|Lack of Efficacy|0
7587480|NCT02059291|26394664|P20|Epoch 4|Lack of Efficacy|0
7587481|NCT02059291|26394665|P19|Epoch 4|Lack of Efficacy|0
7587482|NCT02059291|26394666|P18|Epoch 4|Lack of Efficacy|0
7587483|NCT02059291|26394667|P17|Epoch 4|Lack of Efficacy|0
7587484|NCT02059291|26394668|P16|Epoch 4|Lack of Efficacy|0
7587485|NCT02059291|26394669|P15|Epoch 4|Lack of Efficacy|0
7587486|NCT02059291|26394670|P14|Epoch 4|Lack of Efficacy|0
7587487|NCT02059291|26394671|P13|Epoch 4|Lack of Efficacy|0
7587488|NCT02059291|26394672|P12|Epoch 4|Lack of Efficacy|0
7587489|NCT02059291|26394673|P11|Epoch 4|Lack of Efficacy|0
7587490|NCT02059291|26394674|P10|Epoch 4|Lack of Efficacy|0
7587491|NCT02059291|26394675|P9|Epoch 4|Lack of Efficacy|0
7587492|NCT02059291|26394676|P8|Epoch 4|Lack of Efficacy|0
7587493|NCT02059291|26394677|P7|Epoch 4|Lack of Efficacy|0
7587494|NCT02059291|26394678|P6|Epoch 4|Lack of Efficacy|0
7587495|NCT02059291|26394679|P5|Epoch 4|Lack of Efficacy|0
7587496|NCT02059291|26394680|P4|Epoch 4|Lack of Efficacy|0
7587497|NCT02059291|26394681|P3|Epoch 4|Lack of Efficacy|0
7587498|NCT02059291|26394682|P2|Epoch 4|Lack of Efficacy|0
7587499|NCT02059291|26394683|P1|Epoch 4|Lack of Efficacy|0
7587500|NCT02059291|26394659|P25|Epoch 4|Withdrawal by Subject|0
7587501|NCT02059291|26394660|P24|Epoch 4|Withdrawal by Subject|0
7587502|NCT02059291|26394661|P23|Epoch 4|Withdrawal by Subject|0
7587503|NCT02059291|26394662|P22|Epoch 4|Withdrawal by Subject|0
7587504|NCT02059291|26394663|P21|Epoch 4|Withdrawal by Subject|1
7587505|NCT02059291|26394664|P20|Epoch 4|Withdrawal by Subject|0
7587506|NCT02059291|26394665|P19|Epoch 4|Withdrawal by Subject|0
7587507|NCT02059291|26394666|P18|Epoch 4|Withdrawal by Subject|0
7587508|NCT02059291|26394667|P17|Epoch 4|Withdrawal by Subject|0
7587509|NCT02059291|26394668|P16|Epoch 4|Withdrawal by Subject|0
7587510|NCT02059291|26394669|P15|Epoch 4|Withdrawal by Subject|0
7587511|NCT02059291|26394670|P14|Epoch 4|Withdrawal by Subject|0
7587512|NCT02059291|26394671|P13|Epoch 4|Withdrawal by Subject|0
7587513|NCT02059291|26394672|P12|Epoch 4|Withdrawal by Subject|0
7587514|NCT02059291|26394673|P11|Epoch 4|Withdrawal by Subject|0
7587515|NCT02059291|26394674|P10|Epoch 4|Withdrawal by Subject|0
7587516|NCT02059291|26394675|P9|Epoch 4|Withdrawal by Subject|0
7587517|NCT02059291|26394676|P8|Epoch 4|Withdrawal by Subject|0
7587518|NCT02059291|26394677|P7|Epoch 4|Withdrawal by Subject|0
7587519|NCT02059291|26394678|P6|Epoch 4|Withdrawal by Subject|0
7587520|NCT02059291|26394679|P5|Epoch 4|Withdrawal by Subject|0
7587521|NCT02059291|26394680|P4|Epoch 4|Withdrawal by Subject|0
7587522|NCT02059291|26394681|P3|Epoch 4|Withdrawal by Subject|0
7587523|NCT02059291|26394682|P2|Epoch 4|Withdrawal by Subject|0
7587524|NCT02059291|26394683|P1|Epoch 4|Withdrawal by Subject|0
7587525|NCT02059291|26394659|P25|Epoch 4|Pregnancy|0
7587526|NCT02059291|26394660|P24|Epoch 4|Pregnancy|0
7587527|NCT02059291|26394661|P23|Epoch 4|Pregnancy|0
7587528|NCT02059291|26394662|P22|Epoch 4|Pregnancy|0
7587529|NCT02059291|26394663|P21|Epoch 4|Pregnancy|0
7587530|NCT02059291|26394664|P20|Epoch 4|Pregnancy|0
7587531|NCT02059291|26394665|P19|Epoch 4|Pregnancy|0
7587532|NCT02059291|26394666|P18|Epoch 4|Pregnancy|0
7587533|NCT02059291|26394667|P17|Epoch 4|Pregnancy|1
7587534|NCT02059291|26394668|P16|Epoch 4|Pregnancy|0
7587535|NCT02059291|26394669|P15|Epoch 4|Pregnancy|0
7587536|NCT02059291|26394670|P14|Epoch 4|Pregnancy|0
7587537|NCT02059291|26394671|P13|Epoch 4|Pregnancy|0
7587538|NCT02059291|26394672|P12|Epoch 4|Pregnancy|0
7587539|NCT02059291|26394673|P11|Epoch 4|Pregnancy|0
7587540|NCT02059291|26394674|P10|Epoch 4|Pregnancy|0
7587541|NCT02059291|26394675|P9|Epoch 4|Pregnancy|0
7587542|NCT02059291|26394676|P8|Epoch 4|Pregnancy|0
7587543|NCT02059291|26394677|P7|Epoch 4|Pregnancy|0
7587544|NCT02059291|26394678|P6|Epoch 4|Pregnancy|0
7587545|NCT02059291|26394679|P5|Epoch 4|Pregnancy|0
7587546|NCT02059291|26394680|P4|Epoch 4|Pregnancy|0
7587547|NCT02059291|26394681|P3|Epoch 4|Pregnancy|0
7587548|NCT02059291|26394682|P2|Epoch 4|Pregnancy|0
7587549|NCT02059291|26394683|P1|Epoch 4|Pregnancy|0
7587550|NCT02059291|26394659|P25|Epoch 4|Adverse Event|0
7587551|NCT02059291|26394660|P24|Epoch 4|Adverse Event|0
7587552|NCT02059291|26394661|P23|Epoch 4|Adverse Event|1
7587553|NCT02059291|26394662|P22|Epoch 4|Adverse Event|0
7587554|NCT02059291|26394663|P21|Epoch 4|Adverse Event|0
7587555|NCT02059291|26394664|P20|Epoch 4|Adverse Event|0
7587556|NCT02059291|26394665|P19|Epoch 4|Adverse Event|0
7587557|NCT02059291|26394666|P18|Epoch 4|Adverse Event|0
7587558|NCT02059291|26394667|P17|Epoch 4|Adverse Event|1
7587559|NCT02059291|26394668|P16|Epoch 4|Adverse Event|0
7587560|NCT02059291|26394669|P15|Epoch 4|Adverse Event|0
7587561|NCT02059291|26394670|P14|Epoch 4|Adverse Event|0
7587562|NCT02059291|26394671|P13|Epoch 4|Adverse Event|0
7587563|NCT02059291|26394672|P12|Epoch 4|Adverse Event|0
7587564|NCT02059291|26394673|P11|Epoch 4|Adverse Event|0
7587565|NCT02059291|26394674|P10|Epoch 4|Adverse Event|0
7587566|NCT02059291|26394675|P9|Epoch 4|Adverse Event|0
7587567|NCT02059291|26394676|P8|Epoch 4|Adverse Event|0
7587568|NCT02059291|26394677|P7|Epoch 4|Adverse Event|0
7587569|NCT02059291|26394678|P6|Epoch 4|Adverse Event|0
7587570|NCT02059291|26394679|P5|Epoch 4|Adverse Event|0
7587571|NCT02059291|26394680|P4|Epoch 4|Adverse Event|0
7587572|NCT02059291|26394681|P3|Epoch 4|Adverse Event|0
7587573|NCT02059291|26394682|P2|Epoch 4|Adverse Event|0
7587574|NCT02059291|26394683|P1|Epoch 4|Adverse Event|0
7587575|NCT02059291|26394659|P25|Epoch 3|Withdrawal by Subject|0
7587576|NCT02059291|26394660|P24|Epoch 3|Withdrawal by Subject|0
7587577|NCT02059291|26394661|P23|Epoch 3|Withdrawal by Subject|0
7587578|NCT02059291|26394662|P22|Epoch 3|Withdrawal by Subject|0
7587579|NCT02059291|26394663|P21|Epoch 3|Withdrawal by Subject|0
7587580|NCT02059291|26394664|P20|Epoch 3|Withdrawal by Subject|0
7587581|NCT02059291|26394665|P19|Epoch 3|Withdrawal by Subject|0
7587582|NCT02059291|26394666|P18|Epoch 3|Withdrawal by Subject|0
7587583|NCT02059291|26394667|P17|Epoch 3|Withdrawal by Subject|0
7587584|NCT02059291|26394668|P16|Epoch 3|Withdrawal by Subject|1
7587585|NCT02059291|26394669|P15|Epoch 3|Withdrawal by Subject|0
7587586|NCT02059291|26394670|P14|Epoch 3|Withdrawal by Subject|0
7587587|NCT02059291|26394671|P13|Epoch 3|Withdrawal by Subject|0
7587588|NCT02059291|26394672|P12|Epoch 3|Withdrawal by Subject|0
7587589|NCT02059291|26394673|P11|Epoch 3|Withdrawal by Subject|0
7587590|NCT02059291|26394674|P10|Epoch 3|Withdrawal by Subject|0
7587591|NCT02059291|26394675|P9|Epoch 3|Withdrawal by Subject|0
7587592|NCT02059291|26394676|P8|Epoch 3|Withdrawal by Subject|0
7587593|NCT02059291|26394677|P7|Epoch 3|Withdrawal by Subject|0
7587594|NCT02059291|26394678|P6|Epoch 3|Withdrawal by Subject|0
7587595|NCT02059291|26394679|P5|Epoch 3|Withdrawal by Subject|0
7587596|NCT02059291|26394680|P4|Epoch 3|Withdrawal by Subject|0
7587597|NCT02059291|26394681|P3|Epoch 3|Withdrawal by Subject|0
7587598|NCT02059291|26394682|P2|Epoch 3|Withdrawal by Subject|0
7587599|NCT02059291|26394683|P1|Epoch 3|Withdrawal by Subject|0
7587600|NCT02059291|26394659|P25|Epoch 3|Lack of Efficacy|0
7587601|NCT02059291|26394660|P24|Epoch 3|Lack of Efficacy|0
7587602|NCT02059291|26394661|P23|Epoch 3|Lack of Efficacy|0
7587603|NCT02059291|26394662|P22|Epoch 3|Lack of Efficacy|0
7587604|NCT02059291|26394663|P21|Epoch 3|Lack of Efficacy|0
7587605|NCT02059291|26394664|P20|Epoch 3|Lack of Efficacy|0
7587606|NCT02059291|26394665|P19|Epoch 3|Lack of Efficacy|0
7587607|NCT02059291|26394666|P18|Epoch 3|Lack of Efficacy|0
7587608|NCT02059291|26394667|P17|Epoch 3|Lack of Efficacy|0
7587609|NCT02059291|26394668|P16|Epoch 3|Lack of Efficacy|3
7587610|NCT02059291|26394669|P15|Epoch 3|Lack of Efficacy|0
7587611|NCT02059291|26394670|P14|Epoch 3|Lack of Efficacy|0
7587612|NCT02059291|26394671|P13|Epoch 3|Lack of Efficacy|0
7587613|NCT02059291|26394672|P12|Epoch 3|Lack of Efficacy|0
7587614|NCT02059291|26394673|P11|Epoch 3|Lack of Efficacy|0
7587615|NCT02059291|26394674|P10|Epoch 3|Lack of Efficacy|0
7587616|NCT02059291|26394675|P9|Epoch 3|Lack of Efficacy|0
7587617|NCT02059291|26394676|P8|Epoch 3|Lack of Efficacy|0
7587618|NCT02059291|26394677|P7|Epoch 3|Lack of Efficacy|0
7587619|NCT02059291|26394678|P6|Epoch 3|Lack of Efficacy|0
7587620|NCT02059291|26394679|P5|Epoch 3|Lack of Efficacy|0
7587621|NCT02059291|26394680|P4|Epoch 3|Lack of Efficacy|0
7587622|NCT02059291|26394681|P3|Epoch 3|Lack of Efficacy|0
7587623|NCT02059291|26394682|P2|Epoch 3|Lack of Efficacy|0
7587624|NCT02059291|26394683|P1|Epoch 3|Lack of Efficacy|0
7587625|NCT02059291|26394659|P25|Epoch 3|Adverse Event|0
7587626|NCT02059291|26394660|P24|Epoch 3|Adverse Event|0
7587627|NCT02059291|26394661|P23|Epoch 3|Adverse Event|0
7587628|NCT02059291|26394662|P22|Epoch 3|Adverse Event|0
7587629|NCT02059291|26394663|P21|Epoch 3|Adverse Event|0
7587630|NCT02059291|26394664|P20|Epoch 3|Adverse Event|0
7587631|NCT02059291|26394665|P19|Epoch 3|Adverse Event|0
7587632|NCT02059291|26394666|P18|Epoch 3|Adverse Event|0
7587633|NCT02059291|26394667|P17|Epoch 3|Adverse Event|0
7587634|NCT02059291|26394668|P16|Epoch 3|Adverse Event|1
7587635|NCT02059291|26394669|P15|Epoch 3|Adverse Event|0
7587636|NCT02059291|26394670|P14|Epoch 3|Adverse Event|0
7587637|NCT02059291|26394671|P13|Epoch 3|Adverse Event|0
7587638|NCT02059291|26394672|P12|Epoch 3|Adverse Event|0
7587639|NCT02059291|26394673|P11|Epoch 3|Adverse Event|0
7587640|NCT02059291|26394674|P10|Epoch 3|Adverse Event|0
7587641|NCT02059291|26394675|P9|Epoch 3|Adverse Event|0
7587642|NCT02059291|26394676|P8|Epoch 3|Adverse Event|0
7587643|NCT02059291|26394677|P7|Epoch 3|Adverse Event|0
7587644|NCT02059291|26394678|P6|Epoch 3|Adverse Event|0
7587645|NCT02059291|26394679|P5|Epoch 3|Adverse Event|0
7587646|NCT02059291|26394680|P4|Epoch 3|Adverse Event|0
7587647|NCT02059291|26394681|P3|Epoch 3|Adverse Event|0
7587648|NCT02059291|26394682|P2|Epoch 3|Adverse Event|0
7587649|NCT02059291|26394683|P1|Epoch 3|Adverse Event|0
7587650|NCT02059291|26394659|P25|Epoch 3|Physician Decision|0
7587651|NCT02059291|26394660|P24|Epoch 3|Physician Decision|0
7587652|NCT02059291|26394661|P23|Epoch 3|Physician Decision|0
7587653|NCT02059291|26394662|P22|Epoch 3|Physician Decision|0
7587654|NCT02059291|26394663|P21|Epoch 3|Physician Decision|0
7587655|NCT02059291|26394664|P20|Epoch 3|Physician Decision|0
7587656|NCT02059291|26394665|P19|Epoch 3|Physician Decision|0
7587657|NCT02059291|26394666|P18|Epoch 3|Physician Decision|0
7587658|NCT02059291|26394667|P17|Epoch 3|Physician Decision|0
7587659|NCT02059291|26394668|P16|Epoch 3|Physician Decision|1
7587660|NCT02059291|26394669|P15|Epoch 3|Physician Decision|0
7587661|NCT02059291|26394670|P14|Epoch 3|Physician Decision|1
7587662|NCT02059291|26394671|P13|Epoch 3|Physician Decision|0
7587663|NCT02059291|26394672|P12|Epoch 3|Physician Decision|0
7587664|NCT02059291|26394673|P11|Epoch 3|Physician Decision|0
7587665|NCT02059291|26394674|P10|Epoch 3|Physician Decision|0
7587666|NCT02059291|26394675|P9|Epoch 3|Physician Decision|0
7587667|NCT02059291|26394676|P8|Epoch 3|Physician Decision|0
7587668|NCT02059291|26394677|P7|Epoch 3|Physician Decision|0
7587669|NCT02059291|26394678|P6|Epoch 3|Physician Decision|0
7587670|NCT02059291|26394679|P5|Epoch 3|Physician Decision|0
7587671|NCT02059291|26394680|P4|Epoch 3|Physician Decision|0
7587672|NCT02059291|26394681|P3|Epoch 3|Physician Decision|0
7587673|NCT02059291|26394682|P2|Epoch 3|Physician Decision|0
7587674|NCT02059291|26394683|P1|Epoch 3|Physician Decision|0
7587675|NCT02059291|26394659|P25|Epoch 2|Withdrawal by Subject|0
7587676|NCT02059291|26394660|P24|Epoch 2|Withdrawal by Subject|0
7587677|NCT02059291|26394661|P23|Epoch 2|Withdrawal by Subject|0
7587678|NCT02059291|26394662|P22|Epoch 2|Withdrawal by Subject|0
7587679|NCT02059291|26394663|P21|Epoch 2|Withdrawal by Subject|0
7587680|NCT02059291|26394664|P20|Epoch 2|Withdrawal by Subject|0
7587681|NCT02059291|26394665|P19|Epoch 2|Withdrawal by Subject|0
7587682|NCT02059291|26394666|P18|Epoch 2|Withdrawal by Subject|0
7587683|NCT02059291|26394667|P17|Epoch 2|Withdrawal by Subject|0
7587684|NCT02059291|26394668|P16|Epoch 2|Withdrawal by Subject|0
7587685|NCT02059291|26394669|P15|Epoch 2|Withdrawal by Subject|0
7587686|NCT02059291|26394670|P14|Epoch 2|Withdrawal by Subject|0
7587687|NCT02059291|26394671|P13|Epoch 2|Withdrawal by Subject|0
7587688|NCT02059291|26394672|P12|Epoch 2|Withdrawal by Subject|0
7587689|NCT02059291|26394673|P11|Epoch 2|Withdrawal by Subject|0
7587690|NCT02059291|26394674|P10|Epoch 2|Withdrawal by Subject|0
7587691|NCT02059291|26394675|P9|Epoch 2|Withdrawal by Subject|1
7587692|NCT02059291|26394676|P8|Epoch 2|Withdrawal by Subject|0
7587693|NCT02059291|26394677|P7|Epoch 2|Withdrawal by Subject|0
7587694|NCT02059291|26394678|P6|Epoch 2|Withdrawal by Subject|1
7587695|NCT02059291|26394679|P5|Epoch 2|Withdrawal by Subject|0
7587696|NCT02059291|26394680|P4|Epoch 2|Withdrawal by Subject|0
7587697|NCT02059291|26394681|P3|Epoch 2|Withdrawal by Subject|0
7587698|NCT02059291|26394682|P2|Epoch 2|Withdrawal by Subject|1
7587699|NCT02059291|26394683|P1|Epoch 2|Withdrawal by Subject|0
7587700|NCT02059291|26394659|P25|Epoch 2|Adverse Event|0
7587701|NCT02059291|26394660|P24|Epoch 2|Adverse Event|0
7587702|NCT02059291|26394661|P23|Epoch 2|Adverse Event|0
7587703|NCT02059291|26394662|P22|Epoch 2|Adverse Event|0
7587704|NCT02059291|26394663|P21|Epoch 2|Adverse Event|0
7587705|NCT02059291|26394664|P20|Epoch 2|Adverse Event|0
7587706|NCT02059291|26394665|P19|Epoch 2|Adverse Event|0
7587707|NCT02059291|26394666|P18|Epoch 2|Adverse Event|0
7587708|NCT02059291|26394667|P17|Epoch 2|Adverse Event|0
7587709|NCT02059291|26394668|P16|Epoch 2|Adverse Event|0
7587710|NCT02059291|26394669|P15|Epoch 2|Adverse Event|0
7587711|NCT02059291|26394670|P14|Epoch 2|Adverse Event|0
7587712|NCT02059291|26394671|P13|Epoch 2|Adverse Event|0
7587713|NCT02059291|26394672|P12|Epoch 2|Adverse Event|0
7587714|NCT02059291|26394673|P11|Epoch 2|Adverse Event|0
7587715|NCT02059291|26394674|P10|Epoch 2|Adverse Event|0
7587716|NCT02059291|26394675|P9|Epoch 2|Adverse Event|1
7587717|NCT02059291|26394676|P8|Epoch 2|Adverse Event|1
7587718|NCT02059291|26394677|P7|Epoch 2|Adverse Event|0
7587719|NCT02059291|26394678|P6|Epoch 2|Adverse Event|0
7587720|NCT02059291|26394679|P5|Epoch 2|Adverse Event|0
7587721|NCT02059291|26394680|P4|Epoch 2|Adverse Event|1
7587722|NCT02059291|26394681|P3|Epoch 2|Adverse Event|1
7587723|NCT02059291|26394682|P2|Epoch 2|Adverse Event|0
7587724|NCT02059291|26394683|P1|Epoch 2|Adverse Event|0
7587725|NCT02059291|26394659|P25|Epoch 2|Lack of Efficacy|0
7587726|NCT02059291|26394660|P24|Epoch 2|Lack of Efficacy|0
7587727|NCT02059291|26394661|P23|Epoch 2|Lack of Efficacy|0
7587728|NCT02059291|26394662|P22|Epoch 2|Lack of Efficacy|0
7587729|NCT02059291|26394663|P21|Epoch 2|Lack of Efficacy|0
7587730|NCT02059291|26394664|P20|Epoch 2|Lack of Efficacy|0
7587731|NCT02059291|26394665|P19|Epoch 2|Lack of Efficacy|0
7587732|NCT02059291|26394666|P18|Epoch 2|Lack of Efficacy|0
7587733|NCT02059291|26394667|P17|Epoch 2|Lack of Efficacy|0
7587734|NCT02059291|26394668|P16|Epoch 2|Lack of Efficacy|0
7587735|NCT02059291|26394669|P15|Epoch 2|Lack of Efficacy|0
7587736|NCT02059291|26394670|P14|Epoch 2|Lack of Efficacy|0
7587737|NCT02059291|26394671|P13|Epoch 2|Lack of Efficacy|0
7587738|NCT02059291|26394672|P12|Epoch 2|Lack of Efficacy|0
7587739|NCT02059291|26394673|P11|Epoch 2|Lack of Efficacy|0
7587740|NCT02059291|26394674|P10|Epoch 2|Lack of Efficacy|0
7587741|NCT02059291|26394675|P9|Epoch 2|Lack of Efficacy|0
7587742|NCT02059291|26394676|P8|Epoch 2|Lack of Efficacy|0
7587743|NCT02059291|26394677|P7|Epoch 2|Lack of Efficacy|0
7587744|NCT02059291|26394678|P6|Epoch 2|Lack of Efficacy|1
7587745|NCT02059291|26394679|P5|Epoch 2|Lack of Efficacy|0
7587746|NCT02059291|26394680|P4|Epoch 2|Lack of Efficacy|1
7587747|NCT02059291|26394681|P3|Epoch 2|Lack of Efficacy|0
7587748|NCT02059291|26394682|P2|Epoch 2|Lack of Efficacy|0
7587749|NCT02059291|26394683|P1|Epoch 2|Lack of Efficacy|0
7587750|NCT02059278|26394737|P2|Overall Study|Ran out of IP and decided to discontinue|0
7587751|NCT02059278|26394738|P1|Overall Study|Ran out of IP and decided to discontinue|1
7587752|NCT02059278|26394737|P2|Overall Study|Withdrawal by Subject|3
7587753|NCT02059278|26394738|P1|Overall Study|Withdrawal by Subject|0
7587754|NCT02059278|26394737|P2|Overall Study|Lost to Follow-up|0
7587755|NCT02059278|26394738|P1|Overall Study|Lost to Follow-up|1
7587756|NCT02059278|26394737|P2|Overall Study|Adverse Event|1
7587757|NCT02059278|26394738|P1|Overall Study|Adverse Event|1
7587758|NCT02059265|26394752|P1|Overall Study|Ineligible|4
7587759|NCT02059239|26394762|P2|Overall Study|Physician Decision|0
7587760|NCT02059239|26394763|P1|Overall Study|Physician Decision|1
7587761|NCT02059239|26394762|P2|Overall Study|Progressive Disease after Bendamustine|3
7587762|NCT02059239|26394763|P1|Overall Study|Progressive Disease after Bendamustine|1
7587763|NCT02059187|26394812|P2|Overall Study|Withdrawal by Subject|8
7587764|NCT02059187|26394813|P1|Overall Study|Withdrawal by Subject|12
7587765|NCT02059187|26394812|P2|Overall Study|Protocol Violation|0
7587766|NCT02059187|26394813|P1|Overall Study|Protocol Violation|1
7587767|NCT02059187|26394812|P2|Overall Study|Physician Decision|2
7587768|NCT02059187|26394813|P1|Overall Study|Physician Decision|1
7587769|NCT02059187|26394812|P2|Overall Study|Non-compliance with study drug|0
7587770|NCT02059187|26394813|P1|Overall Study|Non-compliance with study drug|1
7587771|NCT02059187|26394812|P2|Overall Study|Lost to Follow-up|8
7587772|NCT02059187|26394813|P1|Overall Study|Lost to Follow-up|9
7587773|NCT02059187|26394812|P2|Overall Study|Death|1
7587774|NCT02059187|26394813|P1|Overall Study|Death|1
7587775|NCT02059187|26394812|P2|Overall Study|Adverse Event|3
7587776|NCT02059187|26394813|P1|Overall Study|Adverse Event|0
7587777|NCT02059174|26394839|P2|Period 3|Physician Decision|0
7587778|NCT02059174|26394840|P1|Period 3|Physician Decision|1
7587779|NCT02059174|26394839|P2|Period 2|Protocol Violation|0
7587780|NCT02059174|26394840|P1|Period 2|Protocol Violation|1
7587781|NCT02059174|26394839|P2|Period 2|Withdrawal by Subject|2
7587782|NCT02059174|26394840|P1|Period 2|Withdrawal by Subject|0
7587783|NCT02059174|26394839|P2|Period 1|Withdrawal by Subject|2
7587784|NCT02059174|26394840|P1|Period 1|Withdrawal by Subject|0
7587785|NCT02059161|26394864|P2|Overall Study|Non-compliance with study drug|2
7587786|NCT02059161|26394865|P1|Overall Study|Non-compliance with study drug|6
7587787|NCT02059161|26394864|P2|Overall Study|Randomized in error, no study drug|1
7587788|NCT02059161|26394865|P1|Overall Study|Randomized in error, no study drug|0
7587789|NCT02059161|26394864|P2|Overall Study|Withdrawal by Subject|13
7587790|NCT02059161|26394865|P1|Overall Study|Withdrawal by Subject|16
7587791|NCT02059161|26394864|P2|Overall Study|Protocol Violation|1
7587792|NCT02059161|26394865|P1|Overall Study|Protocol Violation|1
7587793|NCT02059161|26394864|P2|Overall Study|Physician Decision|4
7587794|NCT02059161|26394865|P1|Overall Study|Physician Decision|4
7587795|NCT02059161|26394864|P2|Overall Study|Lost to Follow-up|12
7587796|NCT02059161|26394865|P1|Overall Study|Lost to Follow-up|20
7587797|NCT02059161|26394864|P2|Overall Study|Adverse Event|6
7587798|NCT02059161|26394865|P1|Overall Study|Adverse Event|2
7587799|NCT02059161|26394864|P2|Overall Study|Pregnancy|2
7587800|NCT02059161|26394865|P1|Overall Study|Pregnancy|0
7587801|NCT02059148|26394925|P6|Treatment 1|Protocol Violation|1
7587802|NCT02059148|26394926|P5|Treatment 1|Protocol Violation|0
7587803|NCT02059148|26394927|P4|Treatment 1|Protocol Violation|0
7587804|NCT02059148|26394928|P3|Treatment 1|Protocol Violation|0
7587805|NCT02059148|26394929|P2|Treatment 1|Protocol Violation|0
7587806|NCT02059148|26394930|P1|Treatment 1|Protocol Violation|0
7587807|NCT02059135|26394949|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
7587808|NCT02059135|26394950|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
7587809|NCT02059135|26394949|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
7587810|NCT02059135|26394950|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
7587811|NCT02059135|26394949|P2|Neonatal Follow-up (Safety Population)|Death|2
7587812|NCT02059135|26394950|P1|Neonatal Follow-up (Safety Population)|Death|3
7587813|NCT02059135|26394949|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
7587814|NCT02059135|26394950|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
7587815|NCT02059135|26394949|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
7587816|NCT02059135|26394950|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
7587817|NCT02059135|26394949|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
7587818|NCT02059135|26394950|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
7587819|NCT02059135|26394949|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
7587820|NCT02059135|26394950|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
7587821|NCT02059135|26394949|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
7587822|NCT02059135|26394950|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
7587823|NCT02059005|26394986|P2|Overall Study|Inpatient|1
7587824|NCT02059005|26394987|P1|Overall Study|Inpatient|0
7587825|NCT02059005|26394986|P2|Overall Study|Incarceration|1
7587826|NCT02059005|26394987|P1|Overall Study|Incarceration|0
7587827|NCT02059005|26394986|P2|Overall Study|Lost to Follow-up|19
7587828|NCT02059005|26394987|P1|Overall Study|Lost to Follow-up|19
7587829|NCT02059005|26394986|P2|Overall Study|Death|3
7587830|NCT02059005|26394987|P1|Overall Study|Death|1
7587831|NCT02058992|26394997|P1|Overall Study|CRF Uncollected|20
7587832|NCT02058992|26394997|P1|Overall Study|Protocol Violation|92
7587833|NCT02058992|26394997|P1|Overall Study|Lost to Follow-up|4
7587834|NCT02058966|26395006|P1|First Intervention|Withdrawal by Subject|1
7587835|NCT02058966|26395006|P1|Open-Label Methamphetamine|Adverse Event|1
7587836|NCT02058940|26395033|P1|Overall Study|Discharged from Critical Care Unit|1
7587837|NCT02058849|26395057|P2|Overall Study|Withdrawal by Subject|0
7587838|NCT02058849|26395058|P1|Overall Study|Withdrawal by Subject|4
7587839|NCT02058849|26395057|P2|Overall Study|Lost to Follow-up|0
7587840|NCT02058849|26395058|P1|Overall Study|Lost to Follow-up|1
7587841|NCT02058849|26395057|P2|Overall Study|Death|0
7587842|NCT02058849|26395058|P1|Overall Study|Death|1
7587843|NCT02058849|26395057|P2|Overall Study|Hospitalization|1
7587844|NCT02058849|26395058|P1|Overall Study|Hospitalization|1
7587845|NCT02058836|26395086|P2|Overall Study|Withdrawal by Subject|1
7587846|NCT02058836|26395087|P1|Overall Study|Withdrawal by Subject|1
7587847|NCT02058628|26395117|P2|Overall Study|Non compliance|0
7587848|NCT02058628|26395118|P1|Overall Study|Non compliance|1
7587849|NCT02058628|26395117|P2|Overall Study|A lot of time for study for participant|0
7587850|NCT02058628|26395118|P1|Overall Study|A lot of time for study for participant|1
7587851|NCT02058628|26395117|P2|Overall Study|The visit date was not in timeline|1
7587852|NCT02058628|26395118|P1|Overall Study|The visit date was not in timeline|0
7587853|NCT02058628|26395117|P2|Overall Study|Not in time schedule|1
7587854|NCT02058628|26395118|P1|Overall Study|Not in time schedule|0
7587855|NCT02058628|26395117|P2|Overall Study|Lost to Follow-up|4
7587856|NCT02058628|26395118|P1|Overall Study|Lost to Follow-up|2
7587857|NCT02058628|26395117|P2|Overall Study|Withdrawal by Subject|2
7587858|NCT02058628|26395118|P1|Overall Study|Withdrawal by Subject|2
7587859|NCT02058628|26395117|P2|Overall Study|Adverse Event|0
7587860|NCT02058628|26395118|P1|Overall Study|Adverse Event|1
7587861|NCT02058589|26395150|P2|Overall Study|Withdrawal by Subject|1
7587862|NCT02058589|26395151|P1|Overall Study|Withdrawal by Subject|0
7587863|NCT02058589|26395150|P2|Overall Study|Non-Serious Adverse Event|0
7587864|NCT02058589|26395151|P1|Overall Study|Non-Serious Adverse Event|1
7587865|NCT02058589|26395150|P2|Overall Study|Serious Adverse Event|1
7587866|NCT02058589|26395151|P1|Overall Study|Serious Adverse Event|1
7587867|NCT02058563|26395193|P2|Overall Study|Other (patient incarcerated)|1
7587868|NCT02058563|26395194|P1|Overall Study|Other (patient incarcerated)|0
7587869|NCT02058563|26395193|P2|Overall Study|Consent Withdrawal|1
7587870|NCT02058563|26395194|P1|Overall Study|Consent Withdrawal|1
7587871|NCT02058563|26395193|P2|Overall Study|Other (vaccinated later as new subject)|0
7587872|NCT02058563|26395194|P1|Overall Study|Other (vaccinated later as new subject)|1
7587873|NCT02058563|26395193|P2|Overall Study|Lost to Follow-up|22
7587874|NCT02058563|26395194|P1|Overall Study|Lost to Follow-up|26
7587875|NCT02058537|26395230|P1|Overall Study|Withdrawal by Subject|1
7587876|NCT02058498|26395241|P1|Overall Study|Withdrawal by Subject|4
7587877|NCT02058368|26395249|P2|Overall Study|Withdrawal by Subject|26
7587878|NCT02058368|26395250|P1|Overall Study|Withdrawal by Subject|22
7587879|NCT02058368|26395249|P2|Overall Study|Physician Decision|3
7587880|NCT02058368|26395250|P1|Overall Study|Physician Decision|2
7587881|NCT02058368|26395249|P2|Overall Study|Lost to Follow-up|0
7587882|NCT02058368|26395250|P1|Overall Study|Lost to Follow-up|2
7587883|NCT02058368|26395249|P2|Overall Study|Protocol Violation|4
7587884|NCT02058368|26395250|P1|Overall Study|Protocol Violation|0
7587885|NCT02058368|26395249|P2|Overall Study|Lack of Efficacy|1
7587886|NCT02058368|26395250|P1|Overall Study|Lack of Efficacy|0
7587887|NCT02058368|26395249|P2|Overall Study|Adverse Event|20
7587888|NCT02058368|26395250|P1|Overall Study|Adverse Event|15
7587889|NCT02058290|26395302|P2|Overall Study|Withdrawal by Subject|1
7587890|NCT02058290|26395303|P1|Overall Study|Withdrawal by Subject|0
7587891|NCT02058290|26395302|P2|Overall Study|Didn't meet intraoperative criteria|7
7587892|NCT02058290|26395303|P1|Overall Study|Didn't meet intraoperative criteria|8
7587893|NCT02058290|26395302|P2|Overall Study|Physician Decision|0
7587894|NCT02058290|26395303|P1|Overall Study|Physician Decision|1
7587895|NCT02058290|26395302|P2|Overall Study|Protocol Violation|1
7587896|NCT02058290|26395303|P1|Overall Study|Protocol Violation|2
7587897|NCT02058160|26395330|P2|Overall Study|Other than specified above|6
7587898|NCT02058160|26395331|P1|Overall Study|Other than specified above|12
7587899|NCT02058160|26395330|P2|Overall Study|Lost to Follow-up|0
7587900|NCT02058160|26395331|P1|Overall Study|Lost to Follow-up|1
7587901|NCT02058160|26395330|P2|Overall Study|Adverse Event|3
7587902|NCT02058160|26395331|P1|Overall Study|Adverse Event|12
7587903|NCT02058160|26395330|P2|Overall Study|Poor compliance to protocol|1
7587904|NCT02058160|26395331|P1|Overall Study|Poor compliance to protocol|4
7587905|NCT02058160|26395330|P2|Overall Study|Randomized but not treated|4
7587906|NCT02058160|26395331|P1|Overall Study|Randomized but not treated|2
7587907|NCT02058147|26395368|P3|Overall Study|Other than specified|0
7587908|NCT02058147|26395369|P2|Overall Study|Other than specified|9
7587909|NCT02058147|26395370|P1|Overall Study|Other than specified|8
7587910|NCT02058147|26395368|P3|Overall Study|Poor compliance to protocol|4
7587911|NCT02058147|26395369|P2|Overall Study|Poor compliance to protocol|9
7587912|NCT02058147|26395370|P1|Overall Study|Poor compliance to protocol|8
7587913|NCT02058147|26395368|P3|Overall Study|Lack of Efficacy|3
7587914|NCT02058147|26395369|P2|Overall Study|Lack of Efficacy|0
7587915|NCT02058147|26395370|P1|Overall Study|Lack of Efficacy|1
7587916|NCT02058147|26395368|P3|Overall Study|Adverse Event|21
7587917|NCT02058147|26395369|P2|Overall Study|Adverse Event|9
7587918|NCT02058147|26395370|P1|Overall Study|Adverse Event|12
7587919|NCT02058147|26395368|P3|Overall Study|Randomized but not treated|1
7587920|NCT02058147|26395369|P2|Overall Study|Randomized but not treated|0
7587921|NCT02058147|26395370|P1|Overall Study|Randomized but not treated|0
7587922|NCT02058108|26395421|P2|Overall Study|Protocol Violation|1
7587923|NCT02058108|26395422|P1|Overall Study|Protocol Violation|0
7587924|NCT02058108|26395421|P2|Overall Study|Administrative problems|3
7587925|NCT02058108|26395422|P1|Overall Study|Administrative problems|3
7587926|NCT02058108|26395421|P2|Overall Study|Withdrawal by Subject|0
7587927|NCT02058108|26395422|P1|Overall Study|Withdrawal by Subject|1
7587928|NCT02058108|26395421|P2|Overall Study|No longer requires study drug|1
7587929|NCT02058108|26395422|P1|Overall Study|No longer requires study drug|0
7587930|NCT02058108|26395421|P2|Overall Study|Unsatisfactory therapeutic effect|4
7587931|NCT02058108|26395422|P1|Overall Study|Unsatisfactory therapeutic effect|37
7587932|NCT02058108|26395421|P2|Overall Study|Abnormal Laboratory Values|1
7587933|NCT02058108|26395422|P1|Overall Study|Abnormal Laboratory Values|0
7587934|NCT02058095|26395448|P2|Overall Study|Adverse Event|0
7587935|NCT02058095|26395449|P1|Overall Study|Adverse Event|1
7587936|NCT02058069|26395459|P1|Overall Study|Withdrawal by Subject|6
7587937|NCT02058069|26395459|P1|Overall Study|Exclusion due to implant size|5
7587938|NCT02057874|26395518|P1|Overall Study|participant did not return for scan|1
7587939|NCT02057835|26395536|P10|Overall Study|Withdrawal by Subject|0
7587940|NCT02057835|26395537|P9|Overall Study|Withdrawal by Subject|0
7587941|NCT02057835|26395538|P8|Overall Study|Withdrawal by Subject|0
7587942|NCT02057835|26395539|P7|Overall Study|Withdrawal by Subject|0
7587943|NCT02057835|26395540|P6|Overall Study|Withdrawal by Subject|0
7587944|NCT02057835|26395541|P5|Overall Study|Withdrawal by Subject|0
7587945|NCT02057835|26395542|P4|Overall Study|Withdrawal by Subject|0
7587946|NCT02057835|26395543|P3|Overall Study|Withdrawal by Subject|0
7587947|NCT02057835|26395544|P2|Overall Study|Withdrawal by Subject|2
7587948|NCT02057835|26395545|P1|Overall Study|Withdrawal by Subject|0
7587949|NCT02057757|26395624|P2|Overall Study|Non-compliance|0
7587950|NCT02057757|26395625|P1|Overall Study|Non-compliance|1
7587951|NCT02057757|26395624|P2|Overall Study|Lost to Follow-up|3
7587952|NCT02057757|26395625|P1|Overall Study|Lost to Follow-up|8
7587953|NCT02057757|26395624|P2|Overall Study|Death|0
7587954|NCT02057757|26395625|P1|Overall Study|Death|2
7587955|NCT02057757|26395624|P2|Overall Study|Withdrawal by Subject|5
7587956|NCT02057757|26395625|P1|Overall Study|Withdrawal by Subject|3
7587957|NCT02057718|26395677|P2|Optional Follow-up Treatment Period|Liver Transplant|2
7587958|NCT02057718|26395678|P1|Optional Follow-up Treatment Period|Liver Transplant|0
7587959|NCT02057718|26395677|P2|Optional Follow-up Treatment Period|Adverse Event|2
7587960|NCT02057718|26395678|P1|Optional Follow-up Treatment Period|Adverse Event|1
7587961|NCT02057718|26395677|P2|Optional Follow-up Treatment Period|Progressive disease|1
7587962|NCT02057718|26395678|P1|Optional Follow-up Treatment Period|Progressive disease|0
7587963|NCT02057718|26395677|P2|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
7587964|NCT02057718|26395678|P1|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
7587965|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Liver Transplant|1
7587966|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Liver Transplant|0
7587967|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
7587968|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
7587969|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7587970|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7587971|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Adverse Event|3
7587972|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Adverse Event|0
7587973|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
7587974|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
7587975|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Physician Decision|0
7587976|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Physician Decision|1
7587977|NCT02057718|26395677|P2|Completed Study Treatment Through Wk. 72|Progressive disease|2
7587978|NCT02057718|26395678|P1|Completed Study Treatment Through Wk. 72|Progressive disease|0
7587979|NCT02057692|26395703|P4|Overall Study|Lost to Follow-up|1
7587980|NCT02057692|26395704|P3|Overall Study|Lost to Follow-up|0
7587981|NCT02057692|26395705|P2|Overall Study|Lost to Follow-up|0
7587982|NCT02057692|26395706|P1|Overall Study|Lost to Follow-up|0
7587983|NCT02057692|26395703|P4|Overall Study|Adverse Event|0
7587984|NCT02057692|26395704|P3|Overall Study|Adverse Event|0
7587985|NCT02057692|26395705|P2|Overall Study|Adverse Event|0
7587986|NCT02057692|26395706|P1|Overall Study|Adverse Event|1
7587987|NCT02057666|26395736|P2|Open-Label Treatment Period|Sponsor's request|4
7587988|NCT02057666|26395737|P1|Open-Label Treatment Period|Sponsor's request|0
7587989|NCT02057666|26395736|P2|Open-Label Treatment Period|Symptomatic disease progression|1
7587990|NCT02057666|26395737|P1|Open-Label Treatment Period|Symptomatic disease progression|0
7587991|NCT02057666|26395736|P2|Open-Label Treatment Period|Poor tolerability|1
7587992|NCT02057666|26395737|P1|Open-Label Treatment Period|Poor tolerability|0
7587993|NCT02057666|26395736|P2|Double Blind Treatment Period|Sponsor's request|34
7587994|NCT02057666|26395737|P1|Double Blind Treatment Period|Sponsor's request|70
7587995|NCT02057666|26395736|P2|Double Blind Treatment Period|Subject planning to withdraw|0
7587996|NCT02057666|26395737|P1|Double Blind Treatment Period|Subject planning to withdraw|1
7587997|NCT02057666|26395736|P2|Double Blind Treatment Period|Progressive disease for bone lesion|0
7587998|NCT02057666|26395737|P1|Double Blind Treatment Period|Progressive disease for bone lesion|1
7587999|NCT02057666|26395736|P2|Double Blind Treatment Period|Physician Decision|0
7588000|NCT02057666|26395737|P1|Double Blind Treatment Period|Physician Decision|1
7588001|NCT02057666|26395736|P2|Double Blind Treatment Period|Symptomatic disease progression|3
7588002|NCT02057666|26395737|P1|Double Blind Treatment Period|Symptomatic disease progression|8
7588003|NCT02057666|26395736|P2|Double Blind Treatment Period|Poor tolerability|2
7588004|NCT02057666|26395737|P1|Double Blind Treatment Period|Poor tolerability|7
7588005|NCT02057666|26395736|P2|Double Blind Treatment Period|Withdrawal by Subject|5
7588006|NCT02057666|26395737|P1|Double Blind Treatment Period|Withdrawal by Subject|8
7588007|NCT02057575|26395771|P4|Overall Study|Protocol Violation|0
7588008|NCT02057575|26395772|P3|Overall Study|Protocol Violation|0
7588009|NCT02057575|26395773|P2|Overall Study|Protocol Violation|1
7588010|NCT02057575|26395774|P1|Overall Study|Protocol Violation|0
7588011|NCT02057575|26395771|P4|Overall Study|Dissallowed Concurrent Medication|0
7588012|NCT02057575|26395772|P3|Overall Study|Dissallowed Concurrent Medication|0
7588013|NCT02057575|26395773|P2|Overall Study|Dissallowed Concurrent Medication|1
7588014|NCT02057575|26395774|P1|Overall Study|Dissallowed Concurrent Medication|0
7588015|NCT02057575|26395771|P4|Overall Study|Withdrawal by Subject|0
7588016|NCT02057575|26395772|P3|Overall Study|Withdrawal by Subject|0
7588017|NCT02057575|26395773|P2|Overall Study|Withdrawal by Subject|0
7588018|NCT02057575|26395774|P1|Overall Study|Withdrawal by Subject|1
7588019|NCT02057575|26395771|P4|Overall Study|Adverse Event|1
7588020|NCT02057575|26395772|P3|Overall Study|Adverse Event|0
7588021|NCT02057575|26395773|P2|Overall Study|Adverse Event|2
7588022|NCT02057575|26395774|P1|Overall Study|Adverse Event|0
7588023|NCT02057549|26395786|P2|Overall Study|Withdrawal by Subject|0
7588024|NCT02057549|26395787|P1|Overall Study|Withdrawal by Subject|1
7588025|NCT02057549|26395786|P2|Overall Study|Physician Decision|0
7588026|NCT02057549|26395787|P1|Overall Study|Physician Decision|1
7588027|NCT02057549|26395786|P2|Overall Study|Lost to Follow-up|0
7588028|NCT02057549|26395787|P1|Overall Study|Lost to Follow-up|1
7588029|NCT02057523|26395807|P1|Overall Study|Lack of Efficacy|1
7588030|NCT02057523|26395807|P1|Overall Study|Withdrawal by Subject|1
7588031|NCT02057458|26395812|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7588032|NCT02057458|26395813|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7588033|NCT02057458|26395814|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
7588034|NCT02057458|26395812|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7588035|NCT02057458|26395813|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7588036|NCT02057458|26395814|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
7588037|NCT02057458|26395812|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
7588038|NCT02057458|26395813|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
7588039|NCT02057458|26395814|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
7588040|NCT02057406|26395852|P3|Overall Study|Patient transportation issues|1
7588041|NCT02057406|26395853|P2|Overall Study|Patient transportation issues|0
7588042|NCT02057406|26395854|P1|Overall Study|Patient transportation issues|0
7588043|NCT02057406|26395852|P3|Overall Study|Protocol Violation|0
7588044|NCT02057406|26395853|P2|Overall Study|Protocol Violation|1
7588045|NCT02057406|26395854|P1|Overall Study|Protocol Violation|0
7588046|NCT02057406|26395852|P3|Overall Study|Death|0
7588047|NCT02057406|26395853|P2|Overall Study|Death|0
7588048|NCT02057406|26395854|P1|Overall Study|Death|1
7588049|NCT02057406|26395852|P3|Overall Study|Lost to Follow-up|1
7588050|NCT02057406|26395853|P2|Overall Study|Lost to Follow-up|0
7588051|NCT02057406|26395854|P1|Overall Study|Lost to Follow-up|0
7588052|NCT02057406|26395852|P3|Overall Study|Withdrawal by Subject|0
7588053|NCT02057406|26395853|P2|Overall Study|Withdrawal by Subject|2
7588054|NCT02057406|26395854|P1|Overall Study|Withdrawal by Subject|0
7588055|NCT02057406|26395852|P3|Overall Study|Physician Decision|2
7588056|NCT02057406|26395853|P2|Overall Study|Physician Decision|0
7588057|NCT02057406|26395854|P1|Overall Study|Physician Decision|0
7588058|NCT02057393|26395865|P1|Overall Study|Patient did not meet criteria|1
7588059|NCT02057393|26395865|P1|Overall Study|Withdrawal by Subject|1
7588060|NCT02057250|26395886|P5|Extension Phase|Other than specified above|7
7588061|NCT02057250|26395887|P4|Extension Phase|Other than specified above|0
7588062|NCT02057250|26395888|P3|Extension Phase|Other than specified above|0
7588063|NCT02057250|26395889|P2|Extension Phase|Other than specified above|0
7588064|NCT02057250|26395890|P1|Extension Phase|Other than specified above|0
7588065|NCT02057250|26395886|P5|Extension Phase|Entered in this period but not treated|4
7588066|NCT02057250|26395887|P4|Extension Phase|Entered in this period but not treated|0
7588067|NCT02057250|26395888|P3|Extension Phase|Entered in this period but not treated|0
7588068|NCT02057250|26395889|P2|Extension Phase|Entered in this period but not treated|0
7588069|NCT02057250|26395890|P1|Extension Phase|Entered in this period but not treated|0
7588070|NCT02057250|26395886|P5|Extension Phase|Lack of Efficacy|10
7588071|NCT02057250|26395887|P4|Extension Phase|Lack of Efficacy|0
7588072|NCT02057250|26395888|P3|Extension Phase|Lack of Efficacy|0
7588073|NCT02057250|26395889|P2|Extension Phase|Lack of Efficacy|0
7588074|NCT02057250|26395890|P1|Extension Phase|Lack of Efficacy|0
7588075|NCT02057250|26395886|P5|Extension Phase|Adverse Event|15
7588076|NCT02057250|26395887|P4|Extension Phase|Adverse Event|0
7588077|NCT02057250|26395888|P3|Extension Phase|Adverse Event|0
7588078|NCT02057250|26395889|P2|Extension Phase|Adverse Event|0
7588079|NCT02057250|26395890|P1|Extension Phase|Adverse Event|0
7588080|NCT02057250|26395886|P5|AID Assessment Phase|Other than specified above|0
7588081|NCT02057250|26395887|P4|AID Assessment Phase|Other than specified above|1
7588082|NCT02057250|26395888|P3|AID Assessment Phase|Other than specified above|1
7588083|NCT02057250|26395889|P2|AID Assessment Phase|Other than specified above|1
7588084|NCT02057250|26395890|P1|AID Assessment Phase|Other than specified above|1
7588085|NCT02057250|26395886|P5|AID Assessment Phase|Adverse Event|0
7588086|NCT02057250|26395887|P4|AID Assessment Phase|Adverse Event|1
7588087|NCT02057250|26395888|P3|AID Assessment Phase|Adverse Event|6
7588088|NCT02057250|26395889|P2|AID Assessment Phase|Adverse Event|2
7588089|NCT02057250|26395890|P1|AID Assessment Phase|Adverse Event|3
7588090|NCT02057198|26395911|P3|Overall Study|Discharged early; lost to followup|0
7588091|NCT02057198|26395912|P2|Overall Study|Discharged early; lost to followup|1
7588092|NCT02057198|26395913|P1|Overall Study|Discharged early; lost to followup|0
7588093|NCT02057198|26395911|P3|Overall Study|Death|1
7588094|NCT02057198|26395912|P2|Overall Study|Death|0
7588095|NCT02057198|26395913|P1|Overall Study|Death|0
7588096|NCT02057068|26395949|P2|Overall Study|Lost to Follow-up|2
7588097|NCT02057068|26395950|P1|Overall Study|Lost to Follow-up|2
7588098|NCT02057068|26395949|P2|Overall Study|Carepartner (CP) Health|2
7588099|NCT02057068|26395950|P1|Overall Study|Carepartner (CP) Health|4
7588100|NCT02057068|26395949|P2|Overall Study|Caregiver (CG) Health|2
7588101|NCT02057068|26395950|P1|Overall Study|Caregiver (CG) Health|0
7588102|NCT02057068|26395949|P2|Overall Study|Withdrawal by Subject|2
7588103|NCT02057068|26395950|P1|Overall Study|Withdrawal by Subject|2
7588104|NCT02056834|26395979|P1|Overall Study|Lost to Follow-up|7
7588105|NCT02056652|26396000|P2|Overall Study|Lost to Follow-up|3
7588106|NCT02056652|26396001|P1|Overall Study|Lost to Follow-up|0
7588107|NCT02056652|26396000|P2|Overall Study|Withdrawal by Subject|0
7588108|NCT02056652|26396001|P1|Overall Study|Withdrawal by Subject|1
7588109|NCT02056626|26396038|P4|Overall Study|patient did not follow directions|0
7588110|NCT02056626|26396039|P3|Overall Study|patient did not follow directions|0
7588111|NCT02056626|26396040|P2|Overall Study|patient did not follow directions|1
7588112|NCT02056626|26396041|P1|Overall Study|patient did not follow directions|3
7588113|NCT02056392|26396076|P6|Overall Study|Withdrawal by Subject|0
7588114|NCT02056392|26396077|P5|Overall Study|Withdrawal by Subject|1
7588115|NCT02056392|26396078|P4|Overall Study|Withdrawal by Subject|0
7588116|NCT02056392|26396079|P3|Overall Study|Withdrawal by Subject|0
7588117|NCT02056392|26396080|P2|Overall Study|Withdrawal by Subject|0
7588118|NCT02056392|26396081|P1|Overall Study|Withdrawal by Subject|1
7588119|NCT02056392|26396076|P6|Overall Study|Protocol Violation|0
7588120|NCT02056392|26396077|P5|Overall Study|Protocol Violation|0
7588121|NCT02056392|26396078|P4|Overall Study|Protocol Violation|0
7588122|NCT02056392|26396079|P3|Overall Study|Protocol Violation|1
7588123|NCT02056392|26396080|P2|Overall Study|Protocol Violation|0
7588124|NCT02056392|26396081|P1|Overall Study|Protocol Violation|1
7588125|NCT02056392|26396076|P6|Overall Study|Lost to Follow-up|0
7588126|NCT02056392|26396077|P5|Overall Study|Lost to Follow-up|0
7588127|NCT02056392|26396078|P4|Overall Study|Lost to Follow-up|0
7588128|NCT02056392|26396079|P3|Overall Study|Lost to Follow-up|2
7588129|NCT02056392|26396080|P2|Overall Study|Lost to Follow-up|1
7588130|NCT02056392|26396081|P1|Overall Study|Lost to Follow-up|0
7588131|NCT02056340|26396118|P2|Overall Study|Withdrawal by Subject|6
7588132|NCT02056340|26396119|P1|Overall Study|Withdrawal by Subject|2
7588133|NCT02056340|26396118|P2|Overall Study|Lost to Follow-up|5
7588134|NCT02056340|26396119|P1|Overall Study|Lost to Follow-up|5
7588135|NCT02056301|26396129|P2|Overall Study|Issues with epidural|3
7588136|NCT02056301|26396130|P1|Overall Study|Issues with epidural|0
7588137|NCT02056301|26396129|P2|Overall Study|Withdrawal by Subject|1
7588138|NCT02056301|26396130|P1|Overall Study|Withdrawal by Subject|0
7588139|NCT02056301|26396129|P2|Overall Study|Surgical complications req. 2nd surgery|0
7588140|NCT02056301|26396130|P1|Overall Study|Surgical complications req. 2nd surgery|1
7588141|NCT02056301|26396129|P2|Overall Study|Protocol Violation|2
7588142|NCT02056301|26396130|P1|Overall Study|Protocol Violation|1
7588143|NCT02056288|26396142|P2|48-Hour Post-Discharge Data|Did not return diary|20
7588144|NCT02056288|26396143|P1|48-Hour Post-Discharge Data|Did not return diary|14
7588145|NCT02056288|26396142|P2|In-Hospital Data|Physician Decision|0
7588146|NCT02056288|26396143|P1|In-Hospital Data|Physician Decision|1
7588147|NCT02056288|26396142|P2|In-Hospital Data|Protocol Violation|0
7588148|NCT02056288|26396143|P1|In-Hospital Data|Protocol Violation|3
7588149|NCT02056288|26396142|P2|In-Hospital Data|Surgery cancelled|0
7588150|NCT02056288|26396143|P1|In-Hospital Data|Surgery cancelled|1
7588151|NCT02055976|26396181|P9|Overall Study|Lost to Follow-up|0
7588152|NCT02055976|26396182|P8|Overall Study|Lost to Follow-up|0
7588153|NCT02055976|26396183|P7|Overall Study|Lost to Follow-up|0
7588154|NCT02055976|26396184|P6|Overall Study|Lost to Follow-up|0
7588155|NCT02055976|26396185|P5|Overall Study|Lost to Follow-up|0
7588156|NCT02055976|26396186|P4|Overall Study|Lost to Follow-up|1
7588157|NCT02055976|26396187|P3|Overall Study|Lost to Follow-up|0
7588158|NCT02055976|26396188|P2|Overall Study|Lost to Follow-up|0
7588159|NCT02055976|26396189|P1|Overall Study|Lost to Follow-up|0
7588160|NCT02055976|26396181|P9|Overall Study|Does not meet entrance criteria|0
7588161|NCT02055976|26396182|P8|Overall Study|Does not meet entrance criteria|0
7588162|NCT02055976|26396183|P7|Overall Study|Does not meet entrance criteria|1
7588163|NCT02055976|26396184|P6|Overall Study|Does not meet entrance criteria|0
7588164|NCT02055976|26396185|P5|Overall Study|Does not meet entrance criteria|0
7588165|NCT02055976|26396186|P4|Overall Study|Does not meet entrance criteria|0
7588166|NCT02055976|26396187|P3|Overall Study|Does not meet entrance criteria|0
7588167|NCT02055976|26396188|P2|Overall Study|Does not meet entrance criteria|0
7588168|NCT02055976|26396189|P1|Overall Study|Does not meet entrance criteria|0
7588169|NCT02055976|26396181|P9|Overall Study|Adverse Event|0
7588170|NCT02055976|26396182|P8|Overall Study|Adverse Event|0
7588171|NCT02055976|26396183|P7|Overall Study|Adverse Event|1
7588172|NCT02055976|26396184|P6|Overall Study|Adverse Event|1
7588173|NCT02055976|26396185|P5|Overall Study|Adverse Event|0
7588174|NCT02055976|26396186|P4|Overall Study|Adverse Event|0
7588175|NCT02055976|26396187|P3|Overall Study|Adverse Event|0
7588176|NCT02055976|26396188|P2|Overall Study|Adverse Event|0
7588177|NCT02055976|26396189|P1|Overall Study|Adverse Event|0
7588178|NCT02055976|26396181|P9|Overall Study|Other|0
7588179|NCT02055976|26396182|P8|Overall Study|Other|0
7588180|NCT02055976|26396183|P7|Overall Study|Other|0
7588181|NCT02055976|26396184|P6|Overall Study|Other|0
7588182|NCT02055976|26396185|P5|Overall Study|Other|0
7588183|NCT02055976|26396186|P4|Overall Study|Other|0
7588184|NCT02055976|26396187|P3|Overall Study|Other|1
7588185|NCT02055976|26396188|P2|Overall Study|Other|0
7588186|NCT02055976|26396189|P1|Overall Study|Other|0
7588187|NCT02055898|26396610|P2|First Intervention (5 Days)|Withdrawal by Subject|1
7588188|NCT02055898|26396611|P1|First Intervention (5 Days)|Withdrawal by Subject|0
7588189|NCT02055898|26396610|P2|First Intervention (5 Days)|Physician Decision|0
7588190|NCT02055898|26396611|P1|First Intervention (5 Days)|Physician Decision|2
7588191|NCT02055820|26396633|P10|Phase II: Expansion|Withdrawal by Subject|0
7588192|NCT02055820|26396634|P9|Phase II: Expansion|Withdrawal by Subject|0
7588193|NCT02055820|26396635|P8|Phase II: Expansion|Withdrawal by Subject|0
7588194|NCT02055820|26396636|P7|Phase II: Expansion|Withdrawal by Subject|0
7588195|NCT02055820|26396637|P6|Phase II: Expansion|Withdrawal by Subject|0
7588196|NCT02055820|26396638|P5|Phase II: Expansion|Withdrawal by Subject|12
7588197|NCT02055820|26396639|P4|Phase II: Expansion|Withdrawal by Subject|0
7588198|NCT02055820|26396640|P3|Phase II: Expansion|Withdrawal by Subject|0
7588199|NCT02055820|26396641|P2|Phase II: Expansion|Withdrawal by Subject|0
7588200|NCT02055820|26396642|P1|Phase II: Expansion|Withdrawal by Subject|0
7588201|NCT02055820|26396633|P10|Phase II: Expansion|Lost to Follow-up|0
7588202|NCT02055820|26396634|P9|Phase II: Expansion|Lost to Follow-up|0
7588203|NCT02055820|26396635|P8|Phase II: Expansion|Lost to Follow-up|0
7588204|NCT02055820|26396636|P7|Phase II: Expansion|Lost to Follow-up|0
7588205|NCT02055820|26396637|P6|Phase II: Expansion|Lost to Follow-up|0
7588206|NCT02055820|26396638|P5|Phase II: Expansion|Lost to Follow-up|4
7588207|NCT02055820|26396639|P4|Phase II: Expansion|Lost to Follow-up|0
7588208|NCT02055820|26396640|P3|Phase II: Expansion|Lost to Follow-up|0
7588209|NCT02055820|26396641|P2|Phase II: Expansion|Lost to Follow-up|0
7588210|NCT02055820|26396642|P1|Phase II: Expansion|Lost to Follow-up|0
7588211|NCT02055820|26396633|P10|Phase II: Expansion|Death|0
7588212|NCT02055820|26396634|P9|Phase II: Expansion|Death|0
7588213|NCT02055820|26396635|P8|Phase II: Expansion|Death|0
7588214|NCT02055820|26396636|P7|Phase II: Expansion|Death|0
7588215|NCT02055820|26396637|P6|Phase II: Expansion|Death|0
7588216|NCT02055820|26396638|P5|Phase II: Expansion|Death|33
7588217|NCT02055820|26396639|P4|Phase II: Expansion|Death|0
7588218|NCT02055820|26396640|P3|Phase II: Expansion|Death|0
7588219|NCT02055820|26396641|P2|Phase II: Expansion|Death|0
7588220|NCT02055820|26396642|P1|Phase II: Expansion|Death|0
7588221|NCT02055820|26396633|P10|Phase I: Dose-Finding|Lost to Follow-up|0
7588222|NCT02055820|26396634|P9|Phase I: Dose-Finding|Lost to Follow-up|0
7588223|NCT02055820|26396635|P8|Phase I: Dose-Finding|Lost to Follow-up|0
7588224|NCT02055820|26396636|P7|Phase I: Dose-Finding|Lost to Follow-up|1
7588225|NCT02055820|26396637|P6|Phase I: Dose-Finding|Lost to Follow-up|0
7588226|NCT02055820|26396638|P5|Phase I: Dose-Finding|Lost to Follow-up|0
7588227|NCT02055820|26396639|P4|Phase I: Dose-Finding|Lost to Follow-up|1
7588228|NCT02055820|26396640|P3|Phase I: Dose-Finding|Lost to Follow-up|0
7588229|NCT02055820|26396641|P2|Phase I: Dose-Finding|Lost to Follow-up|0
7588230|NCT02055820|26396642|P1|Phase I: Dose-Finding|Lost to Follow-up|0
7588231|NCT02055820|26396633|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
7588232|NCT02055820|26396634|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
7588233|NCT02055820|26396635|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
7588234|NCT02055820|26396636|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
7588235|NCT02055820|26396637|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
7588236|NCT02055820|26396638|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
7588237|NCT02055820|26396639|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
7588238|NCT02055820|26396640|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
7588239|NCT02055820|26396641|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
7588240|NCT02055820|26396642|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
7588241|NCT02055820|26396633|P10|Phase I: Dose-Finding|Death|0
7588242|NCT02055820|26396634|P9|Phase I: Dose-Finding|Death|0
7588243|NCT02055820|26396635|P8|Phase I: Dose-Finding|Death|0
7588244|NCT02055820|26396636|P7|Phase I: Dose-Finding|Death|1
7588245|NCT02055820|26396637|P6|Phase I: Dose-Finding|Death|1
7588246|NCT02055820|26396638|P5|Phase I: Dose-Finding|Death|0
7588247|NCT02055820|26396639|P4|Phase I: Dose-Finding|Death|2
7588248|NCT02055820|26396640|P3|Phase I: Dose-Finding|Death|1
7588249|NCT02055820|26396641|P2|Phase I: Dose-Finding|Death|0
7588250|NCT02055820|26396642|P1|Phase I: Dose-Finding|Death|1
7588251|NCT02055547|26396753|P19|Overall Study|Lost to Follow-up|0
7588252|NCT02055547|26396754|P18|Overall Study|Lost to Follow-up|0
7588253|NCT02055547|26396755|P17|Overall Study|Lost to Follow-up|0
7588254|NCT02055547|26396756|P16|Overall Study|Lost to Follow-up|0
7588255|NCT02055547|26396757|P15|Overall Study|Lost to Follow-up|0
7588256|NCT02055547|26396758|P14|Overall Study|Lost to Follow-up|0
7588257|NCT02055547|26396759|P13|Overall Study|Lost to Follow-up|0
7588258|NCT02055547|26396760|P12|Overall Study|Lost to Follow-up|0
7588259|NCT02055547|26396761|P11|Overall Study|Lost to Follow-up|0
7588260|NCT02055547|26396762|P10|Overall Study|Lost to Follow-up|0
7588261|NCT02055547|26396763|P9|Overall Study|Lost to Follow-up|0
7588262|NCT02055547|26396764|P8|Overall Study|Lost to Follow-up|0
7588263|NCT02055547|26396765|P7|Overall Study|Lost to Follow-up|0
7588264|NCT02055547|26396766|P6|Overall Study|Lost to Follow-up|0
7588265|NCT02055547|26396767|P5|Overall Study|Lost to Follow-up|0
7588266|NCT02055547|26396768|P4|Overall Study|Lost to Follow-up|0
7588267|NCT02055547|26396769|P3|Overall Study|Lost to Follow-up|1
7588268|NCT02055547|26396770|P2|Overall Study|Lost to Follow-up|0
7588269|NCT02055547|26396771|P1|Overall Study|Lost to Follow-up|0
7588270|NCT02055547|26396753|P19|Overall Study|Withdrawal by Subject|0
7588271|NCT02055547|26396754|P18|Overall Study|Withdrawal by Subject|0
7588272|NCT02055547|26396755|P17|Overall Study|Withdrawal by Subject|0
7588273|NCT02055547|26396756|P16|Overall Study|Withdrawal by Subject|1
7588274|NCT02055547|26396757|P15|Overall Study|Withdrawal by Subject|0
7588275|NCT02055547|26396758|P14|Overall Study|Withdrawal by Subject|1
7588276|NCT02055547|26396759|P13|Overall Study|Withdrawal by Subject|0
7588277|NCT02055547|26396760|P12|Overall Study|Withdrawal by Subject|0
7588278|NCT02055547|26396761|P11|Overall Study|Withdrawal by Subject|0
7588279|NCT02055547|26396762|P10|Overall Study|Withdrawal by Subject|0
7588280|NCT02055547|26396763|P9|Overall Study|Withdrawal by Subject|1
7588281|NCT02055547|26396764|P8|Overall Study|Withdrawal by Subject|0
7588282|NCT02055547|26396765|P7|Overall Study|Withdrawal by Subject|0
7588283|NCT02055547|26396766|P6|Overall Study|Withdrawal by Subject|1
7588284|NCT02055547|26396767|P5|Overall Study|Withdrawal by Subject|0
7588285|NCT02055547|26396768|P4|Overall Study|Withdrawal by Subject|0
7588286|NCT02055547|26396769|P3|Overall Study|Withdrawal by Subject|0
7588287|NCT02055547|26396770|P2|Overall Study|Withdrawal by Subject|0
7588288|NCT02055547|26396771|P1|Overall Study|Withdrawal by Subject|0
7588289|NCT02055547|26396753|P19|Overall Study|Adverse Event|0
7588290|NCT02055547|26396754|P18|Overall Study|Adverse Event|0
7588291|NCT02055547|26396755|P17|Overall Study|Adverse Event|0
7588292|NCT02055547|26396756|P16|Overall Study|Adverse Event|0
7588293|NCT02055547|26396757|P15|Overall Study|Adverse Event|0
7588294|NCT02055547|26396758|P14|Overall Study|Adverse Event|0
7588295|NCT02055547|26396759|P13|Overall Study|Adverse Event|0
7588296|NCT02055547|26396760|P12|Overall Study|Adverse Event|0
7588297|NCT02055547|26396761|P11|Overall Study|Adverse Event|0
7588298|NCT02055547|26396762|P10|Overall Study|Adverse Event|0
7588299|NCT02055547|26396763|P9|Overall Study|Adverse Event|1
7588300|NCT02055547|26396764|P8|Overall Study|Adverse Event|0
7588301|NCT02055547|26396765|P7|Overall Study|Adverse Event|1
7588302|NCT02055547|26396766|P6|Overall Study|Adverse Event|0
7588303|NCT02055547|26396767|P5|Overall Study|Adverse Event|0
7588304|NCT02055547|26396768|P4|Overall Study|Adverse Event|0
7588305|NCT02055547|26396769|P3|Overall Study|Adverse Event|0
7588306|NCT02055547|26396770|P2|Overall Study|Adverse Event|0
7588307|NCT02055547|26396771|P1|Overall Study|Adverse Event|0
7588308|NCT02055547|26396753|P19|Overall Study|Physician Decision|0
7588309|NCT02055547|26396754|P18|Overall Study|Physician Decision|0
7588310|NCT02055547|26396755|P17|Overall Study|Physician Decision|0
7588311|NCT02055547|26396756|P16|Overall Study|Physician Decision|0
7588312|NCT02055547|26396757|P15|Overall Study|Physician Decision|0
7588313|NCT02055547|26396758|P14|Overall Study|Physician Decision|0
7588314|NCT02055547|26396759|P13|Overall Study|Physician Decision|0
7588315|NCT02055547|26396760|P12|Overall Study|Physician Decision|0
7588316|NCT02055547|26396761|P11|Overall Study|Physician Decision|1
7588317|NCT02055547|26396762|P10|Overall Study|Physician Decision|1
7588318|NCT02055547|26396763|P9|Overall Study|Physician Decision|0
7588319|NCT02055547|26396764|P8|Overall Study|Physician Decision|0
7588320|NCT02055547|26396765|P7|Overall Study|Physician Decision|0
7588321|NCT02055547|26396766|P6|Overall Study|Physician Decision|0
7588322|NCT02055547|26396767|P5|Overall Study|Physician Decision|1
7588323|NCT02055547|26396768|P4|Overall Study|Physician Decision|0
7588324|NCT02055547|26396769|P3|Overall Study|Physician Decision|1
7588325|NCT02055547|26396770|P2|Overall Study|Physician Decision|1
7588326|NCT02055547|26396771|P1|Overall Study|Physician Decision|0
7588327|NCT02055547|26396753|P19|Overall Study|Protocol Violation|0
7588328|NCT02055547|26396754|P18|Overall Study|Protocol Violation|0
7588329|NCT02055547|26396755|P17|Overall Study|Protocol Violation|0
7588330|NCT02055547|26396756|P16|Overall Study|Protocol Violation|0
7588331|NCT02055547|26396757|P15|Overall Study|Protocol Violation|0
7588332|NCT02055547|26396758|P14|Overall Study|Protocol Violation|0
7588333|NCT02055547|26396759|P13|Overall Study|Protocol Violation|0
7588334|NCT02055547|26396760|P12|Overall Study|Protocol Violation|0
7588335|NCT02055547|26396761|P11|Overall Study|Protocol Violation|0
7588336|NCT02055547|26396762|P10|Overall Study|Protocol Violation|0
7588337|NCT02055547|26396763|P9|Overall Study|Protocol Violation|0
7588338|NCT02055547|26396764|P8|Overall Study|Protocol Violation|0
7588339|NCT02055547|26396765|P7|Overall Study|Protocol Violation|1
7588340|NCT02055547|26396766|P6|Overall Study|Protocol Violation|0
7588341|NCT02055547|26396767|P5|Overall Study|Protocol Violation|0
7588342|NCT02055547|26396768|P4|Overall Study|Protocol Violation|0
7588343|NCT02055547|26396769|P3|Overall Study|Protocol Violation|1
7588344|NCT02055547|26396770|P2|Overall Study|Protocol Violation|0
7588345|NCT02055547|26396771|P1|Overall Study|Protocol Violation|0
7588346|NCT02055365|26396940|P1|Overall Study|Prematurely Withdrawn|1
7588347|NCT02055352|26396953|P2|Overall Study|Reason unknown|5
7588348|NCT02055352|26396954|P1|Overall Study|Reason unknown|1
7588349|NCT02055352|26396953|P2|Overall Study|Withdrawal of informed consent|0
7588350|NCT02055352|26396954|P1|Overall Study|Withdrawal of informed consent|1
7588351|NCT02055352|26396953|P2|Overall Study|AE, study drug would be detrimental|3
7588352|NCT02055352|26396954|P1|Overall Study|AE, study drug would be detrimental|1
7588353|NCT02055352|26396953|P2|Overall Study|Use of prohibited treatment|3
7588354|NCT02055352|26396954|P1|Overall Study|Use of prohibited treatment|0
7588355|NCT02055352|26396953|P2|Overall Study|Patient decision|1
7588356|NCT02055352|26396954|P1|Overall Study|Patient decision|1
7588357|NCT02055352|26396953|P2|Overall Study|Death|2
7588358|NCT02055352|26396954|P1|Overall Study|Death|1
7588359|NCT02055352|26396953|P2|Overall Study|Poor compliance|1
7588360|NCT02055352|26396954|P1|Overall Study|Poor compliance|1
7588361|NCT02055352|26396953|P2|Overall Study|Non-eligible|1
7588362|NCT02055352|26396954|P1|Overall Study|Non-eligible|0
7588363|NCT02055352|26396953|P2|Overall Study|Adverse Event|1
7588364|NCT02055352|26396954|P1|Overall Study|Adverse Event|0
7588365|NCT02055157|26396972|P4|18-month Extension|Subject discontinued due to NeedlePhobia|0
7588366|NCT02055157|26396973|P3|18-month Extension|Subject discontinued due to NeedlePhobia|0
7588367|NCT02055157|26396974|P2|18-month Extension|Subject discontinued due to NeedlePhobia|0
7588368|NCT02055157|26396975|P1|18-month Extension|Subject discontinued due to NeedlePhobia|1
7588369|NCT02055157|26396972|P4|18-month Extension|Investigator decision|0
7588370|NCT02055157|26396973|P3|18-month Extension|Investigator decision|0
7588371|NCT02055157|26396974|P2|18-month Extension|Investigator decision|1
7588372|NCT02055157|26396975|P1|18-month Extension|Investigator decision|0
7588373|NCT02055157|26396972|P4|Initial 6 Months|Consent withdrawn by subject|0
7588374|NCT02055157|26396973|P3|Initial 6 Months|Consent withdrawn by subject|0
7588375|NCT02055157|26396974|P2|Initial 6 Months|Consent withdrawn by subject|0
7588376|NCT02055157|26396975|P1|Initial 6 Months|Consent withdrawn by subject|1
7588377|NCT02055157|26396972|P4|Initial 6 Months|Adverse Event|1
7588378|NCT02055157|26396973|P3|Initial 6 Months|Adverse Event|0
7588379|NCT02055157|26396974|P2|Initial 6 Months|Adverse Event|0
7588380|NCT02055157|26396975|P1|Initial 6 Months|Adverse Event|0
7588381|NCT02055157|26396972|P4|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7588382|NCT02055157|26396973|P3|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7588383|NCT02055157|26396974|P2|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
7588384|NCT02055157|26396975|P1|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7588385|NCT02055118|26397055|P3|Overall Study|Withdrawal by Subject|0
7588386|NCT02055118|26397056|P2|Overall Study|Withdrawal by Subject|2
7588387|NCT02055118|26397057|P1|Overall Study|Withdrawal by Subject|0
7588388|NCT02054910|26397127|P2|Overall Study|Lost to Follow-up|1
7588389|NCT02054910|26397128|P1|Overall Study|Lost to Follow-up|4
7588390|NCT02054897|26397147|P3|Overall Study|Randomized but not exposed|0
7588391|NCT02054897|26397148|P2|Overall Study|Randomized but not exposed|0
7588392|NCT02054897|26397149|P1|Overall Study|Randomized but not exposed|1
7588393|NCT02054897|26397147|P3|Overall Study|Lost to Follow-up|7
7588394|NCT02054897|26397148|P2|Overall Study|Lost to Follow-up|2
7588395|NCT02054897|26397149|P1|Overall Study|Lost to Follow-up|4
7588396|NCT02054897|26397147|P3|Overall Study|Missing follow-up information|3
7588397|NCT02054897|26397148|P2|Overall Study|Missing follow-up information|5
7588398|NCT02054897|26397149|P1|Overall Study|Missing follow-up information|3
7588399|NCT02054897|26397147|P3|Overall Study|Withdrawal by Subject|2
7588400|NCT02054897|26397148|P2|Overall Study|Withdrawal by Subject|0
7588401|NCT02054897|26397149|P1|Overall Study|Withdrawal by Subject|2
7588402|NCT02054715|26397196|P2|Follow-up 2|Treatment Change or Delay|0
7588403|NCT02054715|26397197|P1|Follow-up 2|Treatment Change or Delay|1
7588404|NCT02054715|26397196|P2|Follow-up 2|No Reason|0
7588405|NCT02054715|26397197|P1|Follow-up 2|No Reason|2
7588406|NCT02054715|26397196|P2|Follow-up 2|Changed Mind|1
7588407|NCT02054715|26397197|P1|Follow-up 2|Changed Mind|0
7588408|NCT02054715|26397196|P2|Follow-up 2|Changed MD/Facility|1
7588409|NCT02054715|26397197|P1|Follow-up 2|Changed MD/Facility|0
7588410|NCT02054715|26397196|P2|Follow-up 2|Hospitalization|2
7588411|NCT02054715|26397197|P1|Follow-up 2|Hospitalization|0
7588412|NCT02054715|26397196|P2|Follow-up 2|Death|3
7588413|NCT02054715|26397197|P1|Follow-up 2|Death|3
7588414|NCT02054715|26397196|P2|Follow-up 2|Ineligible|5
7588415|NCT02054715|26397197|P1|Follow-up 2|Ineligible|4
7588416|NCT02054715|26397196|P2|Follow-up 2|Followup Not Completed|4
7588417|NCT02054715|26397197|P1|Follow-up 2|Followup Not Completed|3
7588418|NCT02054715|26397196|P2|Follow-up 2|Refused|2
7588419|NCT02054715|26397197|P1|Follow-up 2|Refused|3
7588420|NCT02054715|26397196|P2|Follow-up 2|Lost to Followup|1
7588421|NCT02054715|26397197|P1|Follow-up 2|Lost to Followup|3
7588422|NCT02054715|26397196|P2|Baseline/Follow-up 1|Changed Mind|0
7588423|NCT02054715|26397197|P1|Baseline/Follow-up 1|Changed Mind|1
7588424|NCT02054715|26397196|P2|Baseline/Follow-up 1|Hospitalization|0
7588425|NCT02054715|26397197|P1|Baseline/Follow-up 1|Hospitalization|1
7588426|NCT02054715|26397196|P2|Baseline/Follow-up 1|Ineligible|0
7588427|NCT02054715|26397197|P1|Baseline/Follow-up 1|Ineligible|3
7588428|NCT02054715|26397196|P2|Baseline/Follow-up 1|Overwhelmed|0
7588429|NCT02054715|26397197|P1|Baseline/Follow-up 1|Overwhelmed|2
7588430|NCT02054715|26397196|P2|Baseline/Follow-up 1|No Reason|1
7588431|NCT02054715|26397197|P1|Baseline/Follow-up 1|No Reason|0
7588432|NCT02054715|26397196|P2|Baseline/Follow-up 1|Disliked Procedure|1
7588433|NCT02054715|26397197|P1|Baseline/Follow-up 1|Disliked Procedure|0
7588434|NCT02054715|26397196|P2|Baseline/Follow-up 1|Changed MD/Facility|1
7588435|NCT02054715|26397197|P1|Baseline/Follow-up 1|Changed MD/Facility|0
7588436|NCT02054715|26397196|P2|Baseline/Follow-up 1|Medical|1
7588437|NCT02054715|26397197|P1|Baseline/Follow-up 1|Medical|0
7588438|NCT02054715|26397196|P2|Baseline/Follow-up 1|Refused|3
7588439|NCT02054715|26397197|P1|Baseline/Follow-up 1|Refused|1
7588440|NCT02054702|26397211|P2|Overall Study|Withdrawal by Subject|4
7588441|NCT02054702|26397212|P1|Overall Study|Withdrawal by Subject|14
7588442|NCT02054702|26397211|P2|Overall Study|Physician Decision|1
7588443|NCT02054702|26397212|P1|Overall Study|Physician Decision|0
7588444|NCT02054702|26397211|P2|Overall Study|Met Withdrawal Criteria|1
7588445|NCT02054702|26397212|P1|Overall Study|Met Withdrawal Criteria|4
7588446|NCT02054702|26397211|P2|Overall Study|Adverse Event|1
7588447|NCT02054702|26397212|P1|Overall Study|Adverse Event|3
7588448|NCT02054702|26397211|P2|Overall Study|Lost to Follow-up|5
7588449|NCT02054702|26397212|P1|Overall Study|Lost to Follow-up|3
7588450|NCT02054520|26397269|P6|Overall Study|Study terminated by Sponsor|0
7588451|NCT02054520|26397270|P5|Overall Study|Study terminated by Sponsor|0
7588452|NCT02054520|26397271|P4|Overall Study|Study terminated by Sponsor|1
7588453|NCT02054520|26397272|P3|Overall Study|Study terminated by Sponsor|2
7588454|NCT02054520|26397273|P2|Overall Study|Study terminated by Sponsor|0
7588455|NCT02054520|26397274|P1|Overall Study|Study terminated by Sponsor|0
7588456|NCT02054520|26397269|P6|Overall Study|Physician Decision|1
7588457|NCT02054520|26397270|P5|Overall Study|Physician Decision|0
7588458|NCT02054520|26397271|P4|Overall Study|Physician Decision|1
7588459|NCT02054520|26397272|P3|Overall Study|Physician Decision|0
7588460|NCT02054520|26397273|P2|Overall Study|Physician Decision|1
7588461|NCT02054520|26397274|P1|Overall Study|Physician Decision|0
7588462|NCT02054520|26397269|P6|Overall Study|Withdrawal by Subject|0
7588463|NCT02054520|26397270|P5|Overall Study|Withdrawal by Subject|1
7588464|NCT02054520|26397271|P4|Overall Study|Withdrawal by Subject|2
7588465|NCT02054520|26397272|P3|Overall Study|Withdrawal by Subject|0
7588466|NCT02054520|26397273|P2|Overall Study|Withdrawal by Subject|0
7588467|NCT02054520|26397274|P1|Overall Study|Withdrawal by Subject|1
7588468|NCT02054520|26397269|P6|Overall Study|Lack of Efficacy|2
7588469|NCT02054520|26397270|P5|Overall Study|Lack of Efficacy|3
7588470|NCT02054520|26397271|P4|Overall Study|Lack of Efficacy|1
7588471|NCT02054520|26397272|P3|Overall Study|Lack of Efficacy|2
7588472|NCT02054520|26397273|P2|Overall Study|Lack of Efficacy|0
7588473|NCT02054520|26397274|P1|Overall Study|Lack of Efficacy|7
7588474|NCT02054520|26397269|P6|Overall Study|Adverse Event|0
7588475|NCT02054520|26397270|P5|Overall Study|Adverse Event|1
7588476|NCT02054520|26397271|P4|Overall Study|Adverse Event|1
7588477|NCT02054520|26397272|P3|Overall Study|Adverse Event|2
7588478|NCT02054520|26397273|P2|Overall Study|Adverse Event|4
7588479|NCT02054520|26397274|P1|Overall Study|Adverse Event|1
7588480|NCT02054481|26397298|P4|Overall Study|Other reason|0
7588481|NCT02054481|26397299|P3|Overall Study|Other reason|2
7588482|NCT02054481|26397300|P2|Overall Study|Other reason|1
7588483|NCT02054481|26397301|P1|Overall Study|Other reason|2
7588484|NCT02054481|26397298|P4|Overall Study|Lost to Follow-up|0
7588485|NCT02054481|26397299|P3|Overall Study|Lost to Follow-up|0
7588486|NCT02054481|26397300|P2|Overall Study|Lost to Follow-up|0
7588487|NCT02054481|26397301|P1|Overall Study|Lost to Follow-up|1
7588488|NCT02054481|26397298|P4|Overall Study|Adverse Event|1
7588489|NCT02054481|26397299|P3|Overall Study|Adverse Event|0
7588490|NCT02054481|26397300|P2|Overall Study|Adverse Event|1
7588491|NCT02054481|26397301|P1|Overall Study|Adverse Event|1
7588492|NCT02054325|26397362|P2|Overall Study|Lost to Follow-up|5
7588493|NCT02054325|26397363|P1|Overall Study|Lost to Follow-up|8
7588494|NCT02054130|26397390|P4|Overall Study|Missed dose|10
7588495|NCT02054130|26397391|P3|Overall Study|Missed dose|7
7588496|NCT02054130|26397392|P2|Overall Study|Missed dose|6
7588497|NCT02054130|26397393|P1|Overall Study|Missed dose|4
7588498|NCT02054130|26397390|P4|Overall Study|Lost to Follow-up|2
7588499|NCT02054130|26397391|P3|Overall Study|Lost to Follow-up|1
7588500|NCT02054130|26397392|P2|Overall Study|Lost to Follow-up|0
7588501|NCT02054130|26397393|P1|Overall Study|Lost to Follow-up|0
7588502|NCT02054130|26397390|P4|Overall Study|Death|0
7588503|NCT02054130|26397391|P3|Overall Study|Death|0
7588504|NCT02054130|26397392|P2|Overall Study|Death|1
7588505|NCT02054130|26397393|P1|Overall Study|Death|0
7588506|NCT02054130|26397390|P4|Overall Study|Withdrawal by Subject|10
7588507|NCT02054130|26397391|P3|Overall Study|Withdrawal by Subject|7
7588508|NCT02054130|26397392|P2|Overall Study|Withdrawal by Subject|4
7588509|NCT02054130|26397393|P1|Overall Study|Withdrawal by Subject|4
7588510|NCT02053753|26397487|P2|Overall Study|Lost to Follow-up|3
7588511|NCT02053753|26397488|P1|Overall Study|Lost to Follow-up|4
7588512|NCT02053753|26397487|P2|Overall Study|Decision by Sponsor|1
7588513|NCT02053753|26397488|P1|Overall Study|Decision by Sponsor|1
7588514|NCT02053753|26397487|P2|Overall Study|Withdrawal by Subject|4
7588515|NCT02053753|26397488|P1|Overall Study|Withdrawal by Subject|2
7588516|NCT02053610|26397512|P2|Overall Study|Violation of Selection Criteria|0
7588517|NCT02053610|26397513|P1|Overall Study|Violation of Selection Criteria|1
7588518|NCT02053610|26397512|P2|Overall Study|Insufficient Therapeutic Response|1
7588519|NCT02053610|26397513|P1|Overall Study|Insufficient Therapeutic Response|1
7588520|NCT02053610|26397512|P2|Overall Study|Did not Receive Treatment|2
7588521|NCT02053610|26397513|P1|Overall Study|Did not Receive Treatment|4
7588522|NCT02053610|26397512|P2|Overall Study|Refused treatment/Did not cooperate|3
7588523|NCT02053610|26397513|P1|Overall Study|Refused treatment/Did not cooperate|1
7588524|NCT02053610|26397512|P2|Overall Study|Disease Progression|3
7588525|NCT02053610|26397513|P1|Overall Study|Disease Progression|2
7588526|NCT02053610|26397512|P2|Overall Study|Administrative/Other|1
7588527|NCT02053610|26397513|P1|Overall Study|Administrative/Other|1
7588528|NCT02053610|26397512|P2|Overall Study|Death|5
7588529|NCT02053610|26397513|P1|Overall Study|Death|5
7588530|NCT02053610|26397512|P2|Overall Study|Withdrew Consent|9
7588531|NCT02053610|26397513|P1|Overall Study|Withdrew Consent|2
7588532|NCT02053610|26397512|P2|Overall Study|Adverse Event/Intercurrent Illness|43
7588533|NCT02053610|26397513|P1|Overall Study|Adverse Event/Intercurrent Illness|25
7588534|NCT02053493|26397545|P2|Overall Study|Withdrawal by Subject|1
7588535|NCT02053493|26397546|P1|Overall Study|Withdrawal by Subject|1
7588536|NCT02053168|26397612|P1|Overall Study|Lost to Follow-up|1
7588537|NCT02053168|26397612|P1|Overall Study|Physician Decision|1
7588538|NCT02053168|26397612|P1|Overall Study|Withdrawal by Subject|1
7588539|NCT02052596|26397696|P2|Safety Phase|Lost due to Crohn's disease|1
7588540|NCT02052596|26397697|P1|Safety Phase|Lost due to Crohn's disease|0
7588541|NCT02052596|26397696|P2|Safety Phase|Enrolled in error|0
7588542|NCT02052596|26397697|P1|Safety Phase|Enrolled in error|1
7588543|NCT02052596|26397696|P2|Safety Phase|Withdrawal by Subject|11
7588544|NCT02052596|26397697|P1|Safety Phase|Withdrawal by Subject|8
7588545|NCT02052596|26397696|P2|Safety Phase|Protocol Violation|2
7588546|NCT02052596|26397697|P1|Safety Phase|Protocol Violation|1
7588547|NCT02052596|26397696|P2|Safety Phase|Lost to Follow-up|18
7588548|NCT02052596|26397697|P1|Safety Phase|Lost to Follow-up|11
7588549|NCT02052596|26397696|P2|Safety Phase|Adverse Event|3
7588550|NCT02052596|26397697|P1|Safety Phase|Adverse Event|6
7588551|NCT02052596|26397696|P2|Active Phase|Lost due to Crohn's disease|1
7588552|NCT02052596|26397697|P1|Active Phase|Lost due to Crohn's disease|0
7588553|NCT02052596|26397696|P2|Active Phase|Enrolled in error|0
7588554|NCT02052596|26397697|P1|Active Phase|Enrolled in error|1
7588555|NCT02052596|26397696|P2|Active Phase|Withdrawal by Subject|4
7588556|NCT02052596|26397697|P1|Active Phase|Withdrawal by Subject|3
7588557|NCT02052596|26397696|P2|Active Phase|Protocol Violation|2
7588558|NCT02052596|26397697|P1|Active Phase|Protocol Violation|1
7588559|NCT02052596|26397696|P2|Active Phase|Lost to Follow-up|11
7588560|NCT02052596|26397697|P1|Active Phase|Lost to Follow-up|8
7588561|NCT02052596|26397696|P2|Active Phase|Adverse Event|2
7588562|NCT02052596|26397697|P1|Active Phase|Adverse Event|3
7588563|NCT02052466|26397762|P1|Overall Study|Acromial fracture|1
7588564|NCT02052466|26397762|P1|Overall Study|Withdrawal by Subject|1
7588565|NCT02052440|26397779|P2|Overall Study|Withdrawal by Subject|1
7588566|NCT02052440|26397780|P1|Overall Study|Withdrawal by Subject|0
7588567|NCT02052414|26397792|P1|Overall Study|Withdrawal by Subject|3
7588568|NCT02052414|26397792|P1|Overall Study|Lack of Efficacy|2
7588569|NCT02052414|26397792|P1|Overall Study|Adverse Event|12
7588570|NCT02052310|26397802|P2|Overall Study|Protocol Violation|6
7588571|NCT02052310|26397803|P1|Overall Study|Protocol Violation|1
7588572|NCT02052310|26397802|P2|Overall Study|Lost to Follow-up|2
7588573|NCT02052310|26397803|P1|Overall Study|Lost to Follow-up|4
7588574|NCT02052310|26397802|P2|Overall Study|Site Terminated by Sponsor|13
7588575|NCT02052310|26397803|P1|Overall Study|Site Terminated by Sponsor|5
7588576|NCT02052310|26397802|P2|Overall Study|Lack of Efficacy|1
7588577|NCT02052310|26397803|P1|Overall Study|Lack of Efficacy|6
7588578|NCT02052310|26397802|P2|Overall Study|Physician Decision|7
7588579|NCT02052310|26397803|P1|Overall Study|Physician Decision|14
7588580|NCT02052310|26397802|P2|Overall Study|Kidney Transplant|29
7588581|NCT02052310|26397803|P1|Overall Study|Kidney Transplant|23
7588582|NCT02052310|26397802|P2|Overall Study|Adverse Event|22
7588583|NCT02052310|26397803|P1|Overall Study|Adverse Event|29
7588584|NCT02052310|26397802|P2|Overall Study|Other than specified|29
7588585|NCT02052310|26397803|P1|Overall Study|Other than specified|32
7588586|NCT02052310|26397802|P2|Overall Study|Withdrawal by Subject|49
7588587|NCT02052310|26397803|P1|Overall Study|Withdrawal by Subject|37
7588588|NCT02052310|26397802|P2|Overall Study|Death|54
7588589|NCT02052310|26397803|P1|Overall Study|Death|64
7588590|NCT02052011|26397862|P2|Overall Study|Withdrawal by Subject|2
7588591|NCT02052011|26397863|P1|Overall Study|Withdrawal by Subject|1
7588592|NCT02052011|26397862|P2|Overall Study|Lost to Follow-up|0
7588593|NCT02052011|26397863|P1|Overall Study|Lost to Follow-up|3
7588594|NCT02051764|26397920|P2|Overall Study|Study terminated by sponsor|7
7588595|NCT02051764|26397921|P1|Overall Study|Study terminated by sponsor|0
7588596|NCT02051296|26398027|P2|Overall Study|withdraw prior to treatment|7
7588597|NCT02051296|26398028|P1|Overall Study|withdraw prior to treatment|7
7588598|NCT02051296|26398027|P2|Overall Study|Lost to Follow-up|2
7588599|NCT02051296|26398028|P1|Overall Study|Lost to Follow-up|1
7588600|NCT02050373|26398079|P2|Overall Study|Death|3
7588601|NCT02050373|26398080|P1|Overall Study|Death|3
7588602|NCT02050373|26398079|P2|Overall Study|Adverse Event|7
7588603|NCT02050373|26398080|P1|Overall Study|Adverse Event|4
7588604|NCT02050321|26398099|P1|Overall Study|Adverse Event|1
7588605|NCT02050321|26398099|P1|Overall Study|Withdrawal by Subject|1
7588606|NCT02050048|26398115|P2|Overall Study|Ineligible after ERCP|1
7588607|NCT02050048|26398116|P1|Overall Study|Ineligible after ERCP|4
7588608|NCT02050048|26398115|P2|Overall Study|Death|0
7588609|NCT02050048|26398116|P1|Overall Study|Death|1
7588610|NCT02050048|26398115|P2|Overall Study|Lost to Follow-up|1
7588611|NCT02050048|26398116|P1|Overall Study|Lost to Follow-up|0
7588612|NCT02049957|26398131|P9|Overall Study|Physician Decision|0
7588613|NCT02049957|26398132|P8|Overall Study|Physician Decision|0
7588614|NCT02049957|26398133|P7|Overall Study|Physician Decision|0
7588615|NCT02049957|26398134|P6|Overall Study|Physician Decision|1
7588616|NCT02049957|26398135|P5|Overall Study|Physician Decision|0
7588617|NCT02049957|26398136|P4|Overall Study|Physician Decision|0
7588618|NCT02049957|26398137|P3|Overall Study|Physician Decision|0
7588619|NCT02049957|26398138|P2|Overall Study|Physician Decision|0
7588620|NCT02049957|26398139|P1|Overall Study|Physician Decision|0
7588621|NCT02049957|26398131|P9|Overall Study|Withdrawal by Subject|1
7588622|NCT02049957|26398132|P8|Overall Study|Withdrawal by Subject|3
7588623|NCT02049957|26398133|P7|Overall Study|Withdrawal by Subject|0
7588624|NCT02049957|26398134|P6|Overall Study|Withdrawal by Subject|2
7588625|NCT02049957|26398135|P5|Overall Study|Withdrawal by Subject|0
7588626|NCT02049957|26398136|P4|Overall Study|Withdrawal by Subject|1
7588627|NCT02049957|26398137|P3|Overall Study|Withdrawal by Subject|0
7588628|NCT02049957|26398138|P2|Overall Study|Withdrawal by Subject|0
7588629|NCT02049957|26398139|P1|Overall Study|Withdrawal by Subject|0
7588630|NCT02049957|26398131|P9|Overall Study|Study Terminated by Sponsor|0
7588631|NCT02049957|26398132|P8|Overall Study|Study Terminated by Sponsor|0
7588632|NCT02049957|26398133|P7|Overall Study|Study Terminated by Sponsor|1
7588633|NCT02049957|26398134|P6|Overall Study|Study Terminated by Sponsor|0
7588634|NCT02049957|26398135|P5|Overall Study|Study Terminated by Sponsor|0
7588635|NCT02049957|26398136|P4|Overall Study|Study Terminated by Sponsor|0
7588636|NCT02049957|26398137|P3|Overall Study|Study Terminated by Sponsor|0
7588637|NCT02049957|26398138|P2|Overall Study|Study Terminated by Sponsor|1
7588638|NCT02049957|26398139|P1|Overall Study|Study Terminated by Sponsor|0
7588639|NCT02049957|26398131|P9|Overall Study|Adverse Event|1
7588640|NCT02049957|26398132|P8|Overall Study|Adverse Event|6
7588641|NCT02049957|26398133|P7|Overall Study|Adverse Event|0
7588642|NCT02049957|26398134|P6|Overall Study|Adverse Event|5
7588643|NCT02049957|26398135|P5|Overall Study|Adverse Event|0
7588644|NCT02049957|26398136|P4|Overall Study|Adverse Event|0
7588645|NCT02049957|26398137|P3|Overall Study|Adverse Event|1
7588646|NCT02049957|26398138|P2|Overall Study|Adverse Event|1
7588647|NCT02049957|26398139|P1|Overall Study|Adverse Event|1
7588648|NCT02049957|26398131|P9|Overall Study|Progressive Disease|6
7588649|NCT02049957|26398132|P8|Overall Study|Progressive Disease|26
7588650|NCT02049957|26398133|P7|Overall Study|Progressive Disease|7
7588651|NCT02049957|26398134|P6|Overall Study|Progressive Disease|35
7588652|NCT02049957|26398135|P5|Overall Study|Progressive Disease|6
7588653|NCT02049957|26398136|P4|Overall Study|Progressive Disease|2
7588654|NCT02049957|26398137|P3|Overall Study|Progressive Disease|2
7588655|NCT02049957|26398138|P2|Overall Study|Progressive Disease|4
7588656|NCT02049957|26398139|P1|Overall Study|Progressive Disease|5
7588657|NCT02049944|26398204|P1|Overall Study|Protocol Violation|2
7588658|NCT02049866|26398233|P1|Overall Study|Withdrawal by Subject|1
7588659|NCT02049814|26398239|P2|Overall Study|Voluntary withdrawal|8
7588660|NCT02049814|26398240|P1|Overall Study|Voluntary withdrawal|9
7588661|NCT02049814|26398239|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
7588662|NCT02049814|26398240|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
7588663|NCT02049814|26398239|P2|Overall Study|Study Termination|1
7588664|NCT02049814|26398240|P1|Overall Study|Study Termination|0
7588665|NCT02049814|26398239|P2|Overall Study|Serious Protocol Violation|7
7588666|NCT02049814|26398240|P1|Overall Study|Serious Protocol Violation|5
7588667|NCT02049814|26398239|P2|Overall Study|Lost to Follow-up|3
7588668|NCT02049814|26398240|P1|Overall Study|Lost to Follow-up|2
7588669|NCT02049814|26398239|P2|Overall Study|Pregnancy|0
7588670|NCT02049814|26398240|P1|Overall Study|Pregnancy|1
7588671|NCT02049814|26398239|P2|Overall Study|Reason not Specified|3
7588672|NCT02049814|26398240|P1|Overall Study|Reason not Specified|4
7588673|NCT02049450|26398289|P1|Overall Study|Patients/guardian decision|1
7588674|NCT02049450|26398289|P1|Overall Study|Withdrawal by Subject|1
7588675|NCT02049450|26398289|P1|Overall Study|Adverse Event|2
7588676|NCT02049437|26398305|P2|Period 1|Adverse Event|0
7588677|NCT02049437|26398306|P1|Period 1|Adverse Event|1
7588678|NCT02049437|26398305|P2|Period 1|Adverse Event|1
7588679|NCT02049437|26398306|P1|Period 1|Adverse Event|1
7588680|NCT02048904|26398351|P1|Overall Study|Physician Decision|70
7588681|NCT02048904|26398351|P1|Overall Study|Withdrawal by Subject|7
7588682|NCT02048826|26398385|P2|Overall Study|Withdrawal by Subject|0
7588683|NCT02048826|26398386|P1|Overall Study|Withdrawal by Subject|1
7588684|NCT02048722|26398396|P1|Follow up for 5 Years|Still in follow up|4
7588685|NCT02048722|26398396|P1|Follow up for 5 Years|Withdrawal by Subject|3
7588686|NCT02048722|26398396|P1|Follow up for 5 Years|Death|22
7588687|NCT02048722|26398396|P1|Reached 1st Response/Continued Treatment|Progressive Disease|10
7588688|NCT02048722|26398396|P1|2 Cycles of Treatment|Progressive Disease|2
7588689|NCT02048722|26398396|P1|2 Cycles of Treatment|Withdrawal by Subject|4
7588690|NCT02048722|26398396|P1|2 Cycles of Treatment|Adverse Event|2
7588691|NCT02048241|26398419|P2|Overall Study|Withdrawal by Subject|1
7588692|NCT02048241|26398420|P1|Overall Study|Withdrawal by Subject|0
7588693|NCT02048072|26398426|P1|Overall Study|Lost to Follow-up|1
7588694|NCT02048072|26398426|P1|Overall Study|Adverse Event|3
7588695|NCT02047903|26398465|P1|Overall Study|Not Treated|9
7588696|NCT02047903|26398465|P1|Overall Study|Reason not listed|6
7588697|NCT02047903|26398465|P1|Overall Study|Lost to Follow-up|4
7588698|NCT02047903|26398465|P1|Overall Study|Withdrawal by Subject|16
7588699|NCT02047903|26398465|P1|Overall Study|Serious adverse event|10
7588700|NCT02047903|26398465|P1|Overall Study|Adverse Event|14
7588701|NCT02047734|26398485|P3|Overall Study|Did Not Receive Study Drug|1
7588702|NCT02047734|26398486|P2|Overall Study|Did Not Receive Study Drug|4
7588703|NCT02047734|26398487|P1|Overall Study|Did Not Receive Study Drug|2
7588704|NCT02047734|26398485|P3|Overall Study|Miscellaneous|6
7588705|NCT02047734|26398486|P2|Overall Study|Miscellaneous|4
7588706|NCT02047734|26398487|P1|Overall Study|Miscellaneous|2
7588707|NCT02047734|26398485|P3|Overall Study|Physician Decision|5
7588708|NCT02047734|26398486|P2|Overall Study|Physician Decision|6
7588709|NCT02047734|26398487|P1|Overall Study|Physician Decision|7
7588710|NCT02047734|26398485|P3|Overall Study|Withdrawal by Subject|19
7588711|NCT02047734|26398486|P2|Overall Study|Withdrawal by Subject|31
7588712|NCT02047734|26398487|P1|Overall Study|Withdrawal by Subject|30
7588713|NCT02047734|26398485|P3|Overall Study|Death|0
7588714|NCT02047734|26398486|P2|Overall Study|Death|1
7588715|NCT02047734|26398487|P1|Overall Study|Death|0
7588716|NCT02047734|26398485|P3|Overall Study|Lost to Follow-up|0
7588717|NCT02047734|26398486|P2|Overall Study|Lost to Follow-up|4
7588718|NCT02047734|26398487|P1|Overall Study|Lost to Follow-up|1
7588719|NCT02047734|26398485|P3|Overall Study|Protocol Violation|1
7588720|NCT02047734|26398486|P2|Overall Study|Protocol Violation|1
7588721|NCT02047734|26398487|P1|Overall Study|Protocol Violation|3
7588722|NCT02047734|26398485|P3|Overall Study|Lack of Efficacy|1
7588723|NCT02047734|26398486|P2|Overall Study|Lack of Efficacy|5
7588724|NCT02047734|26398487|P1|Overall Study|Lack of Efficacy|4
7588725|NCT02047734|26398485|P3|Overall Study|Adverse Event|13
7588726|NCT02047734|26398486|P2|Overall Study|Adverse Event|13
7588727|NCT02047734|26398487|P1|Overall Study|Adverse Event|18
7588728|NCT02047604|26398543|P6|Overall Study|Withdrawal by Subject|1
7588729|NCT02047604|26398544|P5|Overall Study|Withdrawal by Subject|1
7588730|NCT02047604|26398545|P4|Overall Study|Withdrawal by Subject|0
7588731|NCT02047604|26398546|P3|Overall Study|Withdrawal by Subject|0
7588732|NCT02047604|26398547|P2|Overall Study|Withdrawal by Subject|0
7588733|NCT02047604|26398548|P1|Overall Study|Withdrawal by Subject|0
7588734|NCT02047253|26398615|P1|Overall Study|Lost to Follow-up|8
7588735|NCT02047227|26398625|P2|Overall Study|Other|9
7588736|NCT02047227|26398626|P1|Overall Study|Other|10
7588737|NCT02047227|26398625|P2|Overall Study|All embryos discarded|11
7588738|NCT02047227|26398626|P1|Overall Study|All embryos discarded|12
7588739|NCT02047227|26398625|P2|Overall Study|Intention to freeze all embryos|0
7588740|NCT02047227|26398626|P1|Overall Study|Intention to freeze all embryos|1
7588741|NCT02047227|26398625|P2|Overall Study|No fertilization|51
7588742|NCT02047227|26398626|P1|Overall Study|No fertilization|61
7588743|NCT02047227|26398625|P2|Overall Study|No oocytes retrieved|20
7588744|NCT02047227|26398626|P1|Overall Study|No oocytes retrieved|21
7588745|NCT02047227|26398625|P2|Overall Study|Lack of ovarian response to stimulation|32
7588746|NCT02047227|26398626|P1|Overall Study|Lack of ovarian response to stimulation|35
7588747|NCT02047227|26398625|P2|Overall Study|Spontaneous pregnancy|0
7588748|NCT02047227|26398626|P1|Overall Study|Spontaneous pregnancy|1
7588749|NCT02047227|26398625|P2|Overall Study|Protocol Violation|0
7588750|NCT02047227|26398626|P1|Overall Study|Protocol Violation|1
7588751|NCT02047227|26398625|P2|Overall Study|Lost to Follow-up|3
7588752|NCT02047227|26398626|P1|Overall Study|Lost to Follow-up|0
7588753|NCT02047227|26398625|P2|Overall Study|Adverse Event|4
7588754|NCT02047227|26398626|P1|Overall Study|Adverse Event|2
7588755|NCT02047110|26398646|P4|OLE Treatment Period|Other than specified|0
7588756|NCT02047110|26398647|P3|OLE Treatment Period|Other than specified|1
7588757|NCT02047110|26398648|P2|OLE Treatment Period|Other than specified|0
7588758|NCT02047110|26398649|P1|OLE Treatment Period|Other than specified|0
7588759|NCT02047110|26398646|P4|Escape Treatment Period|Other than specified|1
7588760|NCT02047110|26398647|P3|Escape Treatment Period|Other than specified|0
7588761|NCT02047110|26398648|P2|Escape Treatment Period|Other than specified|2
7588762|NCT02047110|26398649|P1|Escape Treatment Period|Other than specified|1
7588763|NCT02047110|26398646|P4|Escape Treatment Period|Adverse Event|0
7588764|NCT02047110|26398647|P3|Escape Treatment Period|Adverse Event|2
7588765|NCT02047110|26398648|P2|Escape Treatment Period|Adverse Event|2
7588766|NCT02047110|26398649|P1|Escape Treatment Period|Adverse Event|1
7588767|NCT02047110|26398646|P4|Escape Treatment Period|Withdrawal by Subject|1
7588768|NCT02047110|26398647|P3|Escape Treatment Period|Withdrawal by Subject|1
7588769|NCT02047110|26398648|P2|Escape Treatment Period|Withdrawal by Subject|2
7588770|NCT02047110|26398649|P1|Escape Treatment Period|Withdrawal by Subject|1
7588771|NCT02047110|26398646|P4|DB (Week 12 up to Week 24)|Other than specified|0
7588772|NCT02047110|26398647|P3|DB (Week 12 up to Week 24)|Other than specified|1
7588773|NCT02047110|26398648|P2|DB (Week 12 up to Week 24)|Other than specified|1
7588774|NCT02047110|26398649|P1|DB (Week 12 up to Week 24)|Other than specified|0
7588775|NCT02047110|26398646|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7588776|NCT02047110|26398647|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7588777|NCT02047110|26398648|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
7588778|NCT02047110|26398649|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7588779|NCT02047110|26398646|P4|DB Treatment Period up to Week 24|Other than specified|1
7588780|NCT02047110|26398647|P3|DB Treatment Period up to Week 24|Other than specified|3
7588781|NCT02047110|26398648|P2|DB Treatment Period up to Week 24|Other than specified|2
7588782|NCT02047110|26398649|P1|DB Treatment Period up to Week 24|Other than specified|1
7588783|NCT02047110|26398646|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7588784|NCT02047110|26398647|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7588785|NCT02047110|26398648|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7588786|NCT02047110|26398649|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7588787|NCT02047110|26398646|P4|DB Treatment Period up to Week 24|Protocol Violation|0
7588788|NCT02047110|26398647|P3|DB Treatment Period up to Week 24|Protocol Violation|0
7588789|NCT02047110|26398648|P2|DB Treatment Period up to Week 24|Protocol Violation|0
7588790|NCT02047110|26398649|P1|DB Treatment Period up to Week 24|Protocol Violation|1
7588791|NCT02047110|26398646|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
7588792|NCT02047110|26398647|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
7588793|NCT02047110|26398648|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
7588794|NCT02047110|26398649|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
7588795|NCT02047110|26398646|P4|DB Treatment Period up to Week 24|Adverse Event|0
7588796|NCT02047110|26398647|P3|DB Treatment Period up to Week 24|Adverse Event|0
7588797|NCT02047110|26398648|P2|DB Treatment Period up to Week 24|Adverse Event|0
7588798|NCT02047110|26398649|P1|DB Treatment Period up to Week 24|Adverse Event|1
7588799|NCT02047045|26398692|P2|Follow-up Period (24 Weeks)|Adverse Event|1
7588800|NCT02047045|26398693|P1|Follow-up Period (24 Weeks)|Adverse Event|1
7588801|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|for safety considerations|1
7588802|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|for safety considerations|0
7588803|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|refused to take drugs|5
7588804|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|refused to take drugs|0
7588805|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|no reason was given|0
7588806|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|no reason was given|1
7588807|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|moved far away out of work|0
7588808|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|moved far away out of work|3
7588809|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|5
7588810|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|3
7588811|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|Lost to Follow-up|3
7588812|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
7588813|NCT02047045|26398692|P2|Treatment Period (8 Weeks )|Adverse Event|1
7588814|NCT02047045|26398693|P1|Treatment Period (8 Weeks )|Adverse Event|3
7588815|NCT02047045|26398692|P2|Baseline|Withdrawal by Subject|2
7588816|NCT02047045|26398693|P1|Baseline|Withdrawal by Subject|3
7588817|NCT02046993|26398757|P2|Overall Study|Lost to Follow-up|1
7588818|NCT02046993|26398758|P1|Overall Study|Lost to Follow-up|1
7588819|NCT02046993|26398757|P2|Overall Study|Withdrawal by Subject|10
7588820|NCT02046993|26398758|P1|Overall Study|Withdrawal by Subject|2
7588821|NCT02046616|26398830|P1|8-Week FU Period|Lost to Follow-up|1
7588822|NCT02046616|26398830|P1|24-Week Treatment Period|Other|1
7588823|NCT02046616|26398830|P1|24-Week Treatment Period|Physician Decision|3
7588824|NCT02046616|26398830|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
7588825|NCT02046616|26398830|P1|24-Week Treatment Period|Any Other Adverse Event|13
7588826|NCT02046616|26398830|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
7588827|NCT02046603|26398852|P2|Overall Study|Adverse Event|1
7588828|NCT02046603|26398853|P1|Overall Study|Adverse Event|0
7588829|NCT02046603|26398852|P2|Overall Study|Death|1
7588830|NCT02046603|26398853|P1|Overall Study|Death|0
7588831|NCT02046603|26398852|P2|Overall Study|Lost to Follow-up|2
7588832|NCT02046603|26398853|P1|Overall Study|Lost to Follow-up|1
7588833|NCT02046603|26398852|P2|Overall Study|Physician Decision|1
7588834|NCT02046603|26398853|P1|Overall Study|Physician Decision|2
7588835|NCT02046603|26398852|P2|Overall Study|Participant/legal guardian decision|3
7588836|NCT02046603|26398853|P1|Overall Study|Participant/legal guardian decision|1
7588837|NCT02046603|26398852|P2|Overall Study|Protocol Violation|1
7588838|NCT02046603|26398853|P1|Overall Study|Protocol Violation|0
7588839|NCT02046603|26398852|P2|Overall Study|Other|66
7588840|NCT02046603|26398853|P1|Overall Study|Other|11
7588841|NCT02046564|26398932|P2|Overall Study|Subject met withdrawal criteria|5
7588842|NCT02046564|26398933|P1|Overall Study|Subject met withdrawal criteria|2
7588843|NCT02046564|26398932|P2|Overall Study|Withdrawal by Subject|10
7588844|NCT02046564|26398933|P1|Overall Study|Withdrawal by Subject|4
7588845|NCT02046564|26398932|P2|Overall Study|Protocol Violation|1
7588846|NCT02046564|26398933|P1|Overall Study|Protocol Violation|3
7588847|NCT02046564|26398932|P2|Overall Study|Physician Decision|1
7588848|NCT02046564|26398933|P1|Overall Study|Physician Decision|0
7588849|NCT02046564|26398932|P2|Overall Study|Adverse Event|3
7588850|NCT02046564|26398933|P1|Overall Study|Adverse Event|6
7588851|NCT02046369|26398981|P2|Overall Study|non compliance|0
7588852|NCT02046369|26398982|P1|Overall Study|non compliance|1
7588853|NCT02046369|26398981|P2|Overall Study|never received study drug|1
7588854|NCT02046369|26398982|P1|Overall Study|never received study drug|0
7588855|NCT02046369|26398981|P2|Overall Study|Withdrawal by Subject|6
7588856|NCT02046369|26398982|P1|Overall Study|Withdrawal by Subject|3
7588857|NCT02046369|26398981|P2|Overall Study|Protocol Violation|2
7588858|NCT02046369|26398982|P1|Overall Study|Protocol Violation|1
7588859|NCT02046369|26398981|P2|Overall Study|Lost to Follow-up|3
7588860|NCT02046369|26398982|P1|Overall Study|Lost to Follow-up|3
7588861|NCT02046369|26398981|P2|Overall Study|Lack of Efficacy|3
7588862|NCT02046369|26398982|P1|Overall Study|Lack of Efficacy|3
7588863|NCT02046369|26398981|P2|Overall Study|Adverse Event|3
7588864|NCT02046369|26398982|P1|Overall Study|Adverse Event|3
7588865|NCT02046226|26399026|P1|Overall Study|Lost to Follow-up|7
7588866|NCT02046174|26399072|P2|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
7588867|NCT02046174|26399073|P1|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
7588868|NCT02046148|26399160|P2|Overall Study|Withdrawal by Subject|2
7588869|NCT02046148|26399161|P1|Overall Study|Withdrawal by Subject|0
7588870|NCT02046148|26399160|P2|Overall Study|Lost to Follow-up|1
7588871|NCT02046148|26399161|P1|Overall Study|Lost to Follow-up|1
7588872|NCT02046122|26399238|P1|Overall Study|Withdrawal by Subject|1
7588873|NCT02046122|26399238|P1|Overall Study|Physician Decision|8
7588874|NCT02046070|26399252|P3|Overall Study|Reason not Specified|6
7588875|NCT02046070|26399253|P2|Overall Study|Reason not Specified|4
7588876|NCT02046070|26399254|P1|Overall Study|Reason not Specified|4
7588877|NCT02046070|26399252|P3|Overall Study|Study Terminated by Sponsor|1
7588878|NCT02046070|26399253|P2|Overall Study|Study Terminated by Sponsor|1
7588879|NCT02046070|26399254|P1|Overall Study|Study Terminated by Sponsor|1
7588880|NCT02046070|26399252|P3|Overall Study|Withdrawal by Subject|6
7588881|NCT02046070|26399253|P2|Overall Study|Withdrawal by Subject|2
7588882|NCT02046070|26399254|P1|Overall Study|Withdrawal by Subject|1
7588883|NCT02046070|26399252|P3|Overall Study|Adverse Event|17
7588884|NCT02046070|26399253|P2|Overall Study|Adverse Event|10
7588885|NCT02046070|26399254|P1|Overall Study|Adverse Event|8
7588886|NCT02046070|26399252|P3|Overall Study|Progressive Disease|40
7588887|NCT02046070|26399253|P2|Overall Study|Progressive Disease|11
7588888|NCT02046070|26399254|P1|Overall Study|Progressive Disease|18
7588889|NCT02045979|26399314|P3|Overall Study|not specified above|0
7588890|NCT02045979|26399315|P2|Overall Study|not specified above|1
7588891|NCT02045979|26399316|P1|Overall Study|not specified above|0
7588892|NCT02045979|26399314|P3|Overall Study|Informed Consent Withdrawn|1
7588893|NCT02045979|26399315|P2|Overall Study|Informed Consent Withdrawn|0
7588894|NCT02045979|26399316|P1|Overall Study|Informed Consent Withdrawn|2
7588895|NCT02045875|26399353|P2|Overall Study|Withdrawal by Subject|3
7588896|NCT02045875|26399354|P1|Overall Study|Withdrawal by Subject|4
7588897|NCT02045875|26399353|P2|Overall Study|Lost to Follow-up|0
7588898|NCT02045875|26399354|P1|Overall Study|Lost to Follow-up|3
7588899|NCT02045862|26399365|P3|Overall Study|Lost to Follow-up|6
7588900|NCT02045862|26399366|P2|Overall Study|Lost to Follow-up|2
7588901|NCT02045862|26399367|P1|Overall Study|Lost to Follow-up|1
7588902|NCT02045862|26399365|P3|Overall Study|Adverse Event|27
7588903|NCT02045862|26399366|P2|Overall Study|Adverse Event|5
7588904|NCT02045862|26399367|P1|Overall Study|Adverse Event|7
7588905|NCT02045862|26399365|P3|Overall Study|Randomized but not Received Study Drug|8
7588906|NCT02045862|26399366|P2|Overall Study|Randomized but not Received Study Drug|2
7588907|NCT02045862|26399367|P1|Overall Study|Randomized but not Received Study Drug|0
7588908|NCT02045862|26399365|P3|Overall Study|Lack of Efficacy|13
7588909|NCT02045862|26399366|P2|Overall Study|Lack of Efficacy|4
7588910|NCT02045862|26399367|P1|Overall Study|Lack of Efficacy|8
7588911|NCT02045862|26399365|P3|Overall Study|Protocol Violation|6
7588912|NCT02045862|26399366|P2|Overall Study|Protocol Violation|0
7588913|NCT02045862|26399367|P1|Overall Study|Protocol Violation|0
7588914|NCT02045862|26399365|P3|Overall Study|Withdrawal by Patient|57
7588915|NCT02045862|26399366|P2|Overall Study|Withdrawal by Patient|27
7588916|NCT02045862|26399367|P1|Overall Study|Withdrawal by Patient|18
7588917|NCT02045862|26399365|P3|Overall Study|Miscellaneous|8
7588918|NCT02045862|26399366|P2|Overall Study|Miscellaneous|0
7588919|NCT02045862|26399367|P1|Overall Study|Miscellaneous|5
7588920|NCT02045862|26399365|P3|Overall Study|Death|1
7588921|NCT02045862|26399366|P2|Overall Study|Death|0
7588922|NCT02045862|26399367|P1|Overall Study|Death|0
7588923|NCT02045836|26399548|P2|Overall Study|Migrated from study area|2
7588924|NCT02045836|26399549|P1|Overall Study|Migrated from study area|0
7588925|NCT02045836|26399548|P2|Overall Study|Lost to Follow-up|7
7588926|NCT02045836|26399549|P1|Overall Study|Lost to Follow-up|4
7588927|NCT02045836|26399548|P2|Overall Study|Withdrawal by Subject|1
7588928|NCT02045836|26399549|P1|Overall Study|Withdrawal by Subject|1
7588929|NCT02045836|26399548|P2|Overall Study|Adverse Event|4
7588930|NCT02045836|26399549|P1|Overall Study|Adverse Event|4
7588931|NCT02045797|26399583|P3|Overall Study|Withdrawal by Subject|0
7588932|NCT02045797|26399584|P2|Overall Study|Withdrawal by Subject|2
7588933|NCT02045797|26399585|P1|Overall Study|Withdrawal by Subject|1
7588934|NCT02045797|26399583|P3|Overall Study|Physician Decision|0
7588935|NCT02045797|26399584|P2|Overall Study|Physician Decision|1
7588936|NCT02045797|26399585|P1|Overall Study|Physician Decision|0
7588937|NCT02045797|26399583|P3|Overall Study|Lost to Follow-up|1
7588938|NCT02045797|26399584|P2|Overall Study|Lost to Follow-up|3
7588939|NCT02045797|26399585|P1|Overall Study|Lost to Follow-up|2
7588940|NCT02045797|26399583|P3|Overall Study|Lack of Efficacy|0
7588941|NCT02045797|26399584|P2|Overall Study|Lack of Efficacy|0
7588942|NCT02045797|26399585|P1|Overall Study|Lack of Efficacy|1
7588943|NCT02045797|26399583|P3|Overall Study|Adverse Event|0
7588944|NCT02045797|26399584|P2|Overall Study|Adverse Event|1
7588945|NCT02045797|26399585|P1|Overall Study|Adverse Event|3
7588946|NCT02045732|26399730|P2|Overall Study|At the discretion of the investigator|1
7588947|NCT02045732|26399731|P1|Overall Study|At the discretion of the investigator|1
7588948|NCT02045433|26399768|P1|Overall Study|Withdrawal by Subject|1
7588949|NCT02045212|26399821|P2|Overall Study|Finished 13 weeks, chose not to extend|0
7588950|NCT02045212|26399822|P1|Overall Study|Finished 13 weeks, chose not to extend|1
7588951|NCT02045212|26399821|P2|Overall Study|Withdrawal by Subject|0
7588952|NCT02045212|26399822|P1|Overall Study|Withdrawal by Subject|1
7588953|NCT02045212|26399821|P2|Overall Study|Adverse Event|1
7588954|NCT02045212|26399822|P1|Overall Study|Adverse Event|0
7588955|NCT02045095|26399887|P7|Overall Study|Adverse Event|0
7588956|NCT02045095|26399888|P6|Overall Study|Adverse Event|2
7588957|NCT02045095|26399889|P5|Overall Study|Adverse Event|0
7588958|NCT02045095|26399890|P4|Overall Study|Adverse Event|0
7588959|NCT02045095|26399891|P3|Overall Study|Adverse Event|1
7588960|NCT02045095|26399892|P2|Overall Study|Adverse Event|1
7588961|NCT02045095|26399893|P1|Overall Study|Adverse Event|0
7588962|NCT02045095|26399887|P7|Overall Study|Withdrawal by Subject|0
7588963|NCT02045095|26399888|P6|Overall Study|Withdrawal by Subject|0
7588964|NCT02045095|26399889|P5|Overall Study|Withdrawal by Subject|3
7588965|NCT02045095|26399890|P4|Overall Study|Withdrawal by Subject|0
7588966|NCT02045095|26399891|P3|Overall Study|Withdrawal by Subject|0
7588967|NCT02045095|26399892|P2|Overall Study|Withdrawal by Subject|0
7588968|NCT02045095|26399893|P1|Overall Study|Withdrawal by Subject|0
7588969|NCT02045095|26399887|P7|Overall Study|Progressive Disease|1
7588970|NCT02045095|26399888|P6|Overall Study|Progressive Disease|4
7588971|NCT02045095|26399889|P5|Overall Study|Progressive Disease|2
7588972|NCT02045095|26399890|P4|Overall Study|Progressive Disease|4
7588973|NCT02045095|26399891|P3|Overall Study|Progressive Disease|2
7588974|NCT02045095|26399892|P2|Overall Study|Progressive Disease|3
7588975|NCT02045095|26399893|P1|Overall Study|Progressive Disease|3
7588976|NCT02045095|26399887|P7|Overall Study|Other|0
7588977|NCT02045095|26399888|P6|Overall Study|Other|2
7588978|NCT02045095|26399889|P5|Overall Study|Other|0
7588979|NCT02045095|26399890|P4|Overall Study|Other|0
7588980|NCT02045095|26399891|P3|Overall Study|Other|1
7588981|NCT02045095|26399892|P2|Overall Study|Other|0
7588982|NCT02045095|26399893|P1|Overall Study|Other|0
7588983|NCT02044874|26400051|P3|Overall Study|Other|8
7588984|NCT02044874|26400052|P2|Overall Study|Other|3
7588985|NCT02044874|26400053|P1|Overall Study|Other|7
7588986|NCT02044874|26400051|P3|Overall Study|Sponsor Decision|1
7588987|NCT02044874|26400052|P2|Overall Study|Sponsor Decision|1
7588988|NCT02044874|26400053|P1|Overall Study|Sponsor Decision|0
7588989|NCT02044874|26400051|P3|Overall Study|Lost to Follow-up|21
7588990|NCT02044874|26400052|P2|Overall Study|Lost to Follow-up|27
7588991|NCT02044874|26400053|P1|Overall Study|Lost to Follow-up|10
7588992|NCT02044874|26400051|P3|Overall Study|Physician Decision|1
7588993|NCT02044874|26400052|P2|Overall Study|Physician Decision|2
7588994|NCT02044874|26400053|P1|Overall Study|Physician Decision|0
7588995|NCT02044874|26400051|P3|Overall Study|Withdrawal by Subject|23
7588996|NCT02044874|26400052|P2|Overall Study|Withdrawal by Subject|16
7588997|NCT02044874|26400053|P1|Overall Study|Withdrawal by Subject|8
7588998|NCT02044874|26400051|P3|Overall Study|Adverse Event|6
7588999|NCT02044874|26400052|P2|Overall Study|Adverse Event|6
7589000|NCT02044874|26400053|P1|Overall Study|Adverse Event|5
7589001|NCT02044848|26400075|P2|Overall Study|Administrative Problems|3
7589002|NCT02044848|26400076|P1|Overall Study|Administrative Problems|2
7589003|NCT02044822|26400082|P1|Overall Study|Lost to Follow-up|1
7589004|NCT02044822|26400082|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
7589005|NCT02044822|26400082|P1|Overall Study|Withdrew Consent|3
7589006|NCT02044822|26400082|P1|Overall Study|Investigator's Discretion|10
7589007|NCT02044822|26400082|P1|Overall Study|Study Terminated by Sponsor|77
7589008|NCT02044510|26400124|P2|Overall Study|Adverse Event|2
7589009|NCT02044510|26400125|P1|Overall Study|Adverse Event|1
7589010|NCT02044458|26400133|P2|Overall Study|Protocol Violation|8
7589011|NCT02044458|26400134|P1|Overall Study|Protocol Violation|3
7589012|NCT02044302|26400220|P2|Overall Study|study terminated|0
7589013|NCT02044302|26400221|P1|Overall Study|study terminated|2
7589014|NCT02044159|26400229|P2|Overall Study|Nurse declined to give study drug|0
7589015|NCT02044159|26400230|P1|Overall Study|Nurse declined to give study drug|1
7589016|NCT02044159|26400229|P2|Overall Study|No longer eligible, drug not given|0
7589017|NCT02044159|26400230|P1|Overall Study|No longer eligible, drug not given|1
7589018|NCT02044159|26400229|P2|Overall Study|Consent declined (deferred consent)|4
7589019|NCT02044159|26400230|P1|Overall Study|Consent declined (deferred consent)|2
7589020|NCT02044094|26400243|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
7589021|NCT02044094|26400243|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
7589022|NCT02044094|26400243|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
7589023|NCT02044094|26400243|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
7589024|NCT02044094|26400243|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
7589025|NCT02044094|26400243|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
7589026|NCT02044094|26400243|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
7589027|NCT02044094|26400243|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
7589028|NCT02043938|26400300|P1|Overall Study|Investigator decision|1
7589029|NCT02043938|26400300|P1|Overall Study|No show by subject|1
7589030|NCT02043938|26400300|P1|Overall Study|Unable to place EEG sensors on patient|1
7589031|NCT02043938|26400300|P1|Overall Study|Withdrawal by Subject|7
7589032|NCT02043899|26400310|P1|Overall Study|Treatment delayed|1
7589033|NCT02043899|26400310|P1|Overall Study|Clinical progression necessitating urgent treatment|1
7589034|NCT02043899|26400310|P1|Overall Study|Temporary halt due to out of specification radioactivity|2
7589035|NCT02043899|26400310|P1|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
7589036|NCT02043899|26400310|P1|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
7589037|NCT02043899|26400310|P1|Overall Study|Withdrawal by Subject|2
7589038|NCT02043899|26400310|P1|Overall Study|Physician Decision|1
7589039|NCT02043899|26400310|P1|Overall Study|Adverse Event|3
7589040|NCT02043782|26400361|P6|Period 1|Adverse Event|0
7589041|NCT02043782|26400362|P5|Period 1|Adverse Event|0
7589042|NCT02043782|26400363|P4|Period 1|Adverse Event|0
7589043|NCT02043782|26400364|P3|Period 1|Adverse Event|1
7589044|NCT02043782|26400365|P2|Period 1|Adverse Event|0
7589045|NCT02043782|26400366|P1|Period 1|Adverse Event|0
7589066|NCT02043548|26400462|P2|Overall Study|Adverse Event|1
7589067|NCT02043548|26400463|P1|Overall Study|Adverse Event|0
7589068|NCT02043548|26400462|P2|Overall Study|Lack of Efficacy|0
7589069|NCT02043548|26400463|P1|Overall Study|Lack of Efficacy|1
7589070|NCT02043509|26400481|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
7589071|NCT02043509|26400482|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
7589072|NCT02043509|26400481|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
7589073|NCT02043509|26400482|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
7589074|NCT02043509|26400481|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
7589075|NCT02043509|26400482|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
7589076|NCT02043509|26400481|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
7589077|NCT02043509|26400482|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
7589078|NCT02043366|26400570|P6|Overall Study|Lost to Follow-up|2
7589079|NCT02043366|26400571|P5|Overall Study|Lost to Follow-up|2
7589080|NCT02043366|26400572|P4|Overall Study|Lost to Follow-up|2
7589081|NCT02043366|26400573|P3|Overall Study|Lost to Follow-up|2
7589082|NCT02043366|26400574|P2|Overall Study|Lost to Follow-up|2
7589083|NCT02043366|26400575|P1|Overall Study|Lost to Follow-up|2
7589084|NCT02043301|26400598|P3|Overall Study|Discontinued|0
7589085|NCT02043301|26400599|P2|Overall Study|Discontinued|1
7589086|NCT02043301|26400600|P1|Overall Study|Discontinued|0
7589087|NCT02043132|26400697|P2|Overall Study|screen failures|8
7589088|NCT02043132|26400698|P1|Overall Study|screen failures|4
7589089|NCT02043132|26400697|P2|Overall Study|Lost to Follow-up|1
7589090|NCT02043132|26400698|P1|Overall Study|Lost to Follow-up|1
7589091|NCT02043015|26400718|P1|Overall Study|Incarceration|1
7589092|NCT02043015|26400718|P1|Overall Study|Participant moved away from study city|4
7589093|NCT02043015|26400718|P1|Overall Study|Removed once target enrollment reached|15
7589094|NCT02043015|26400718|P1|Overall Study|Withdrawal by Subject|4
7589095|NCT02043015|26400718|P1|Overall Study|Lost to Follow-up|4
7589096|NCT02042950|26400731|P1|Overall Study|Progressive Disease|4
7589097|NCT02042924|26400737|P1|Overall Study|Early Death|1
7589098|NCT02042443|26400785|P2|Overall Study|Not eligible/not analyzable|6
7589099|NCT02042443|26400786|P1|Overall Study|Not eligible/not analyzable|3
7589100|NCT02042443|26400785|P2|Overall Study|not protocol specified|1
7589101|NCT02042443|26400786|P1|Overall Study|not protocol specified|1
7589102|NCT02042443|26400785|P2|Overall Study|Progression|17
7589103|NCT02042443|26400786|P1|Overall Study|Progression|21
7589104|NCT02042443|26400785|P2|Overall Study|Withdrawal by Subject|1
7589105|NCT02042443|26400786|P1|Overall Study|Withdrawal by Subject|0
7589106|NCT02042443|26400785|P2|Overall Study|Adverse Event|1
7589107|NCT02042443|26400786|P1|Overall Study|Adverse Event|2
7589108|NCT02042404|26400798|P2|Overall Study|Inability to meet time requirements|0
7589109|NCT02042404|26400799|P1|Overall Study|Inability to meet time requirements|1
7589110|NCT02042404|26400798|P2|Overall Study|Unrelated Adverse Event|0
7589111|NCT02042404|26400799|P1|Overall Study|Unrelated Adverse Event|3
7589112|NCT02042404|26400798|P2|Overall Study|Death|0
7589113|NCT02042404|26400799|P1|Overall Study|Death|1
7589114|NCT02042183|26400817|P2|Overall Study|Lost to Follow-up|2
7589115|NCT02042183|26400818|P1|Overall Study|Lost to Follow-up|9
7589116|NCT02042183|26400817|P2|Overall Study|Site Terminated by Sponsor|1
7589117|NCT02042183|26400818|P1|Overall Study|Site Terminated by Sponsor|2
7589118|NCT02042183|26400817|P2|Overall Study|Withdrawal by Subject|16
7589119|NCT02042183|26400818|P1|Overall Study|Withdrawal by Subject|21
7589120|NCT02042183|26400817|P2|Overall Study|Other|3
7589121|NCT02042183|26400818|P1|Overall Study|Other|3
7589122|NCT02042183|26400817|P2|Overall Study|Adverse Event|6
7589123|NCT02042183|26400818|P1|Overall Study|Adverse Event|17
7589124|NCT02042183|26400817|P2|Overall Study|Non-compliance with Study Drug|3
7589125|NCT02042183|26400818|P1|Overall Study|Non-compliance with Study Drug|2
7589126|NCT02042183|26400817|P2|Overall Study|Lack of Efficacy|3
7589127|NCT02042183|26400818|P1|Overall Study|Lack of Efficacy|4
7589128|NCT02042183|26400817|P2|Overall Study|Physician Decision|2
7589129|NCT02042183|26400818|P1|Overall Study|Physician Decision|7
7589130|NCT02042014|26400848|P1|Overall Study|Physician Decision|7
7589131|NCT02042014|26400848|P1|Overall Study|Adverse Event|1
7589132|NCT02041962|26400854|P2|Overall Study|Withdrawal by Subject|11
7589133|NCT02041962|26400855|P1|Overall Study|Withdrawal by Subject|0
7589134|NCT02041962|26400854|P2|Overall Study|Lost to Follow-up|32
7589135|NCT02041962|26400855|P1|Overall Study|Lost to Follow-up|37
7589136|NCT02041962|26400854|P2|Overall Study|Death|1
7589137|NCT02041962|26400855|P1|Overall Study|Death|1
7589138|NCT02041962|26400854|P2|Overall Study|Lost Aetna Coverage|40
7589139|NCT02041962|26400855|P1|Overall Study|Lost Aetna Coverage|43
7589140|NCT02041923|26400865|P2|Overall Study|Lost to Follow-up|30
7589141|NCT02041923|26400866|P1|Overall Study|Lost to Follow-up|26
7589142|NCT02041702|26400880|P2|Overall Study|Cardiac Resynchronization Therapy|0
7589143|NCT02041702|26400881|P1|Overall Study|Cardiac Resynchronization Therapy|1
7589144|NCT02041702|26400880|P2|Overall Study|Patient not confirmed as MRI compatible|0
7589145|NCT02041702|26400881|P1|Overall Study|Patient not confirmed as MRI compatible|1
7589146|NCT02041702|26400880|P2|Overall Study|Withdrawal by Subject|3
7589147|NCT02041702|26400881|P1|Overall Study|Withdrawal by Subject|4
7589148|NCT02041702|26400880|P2|Overall Study|Death|0
7589149|NCT02041702|26400881|P1|Overall Study|Death|4
7589150|NCT02041702|26400880|P2|Overall Study|Lost to Follow-up|6
7589151|NCT02041702|26400881|P1|Overall Study|Lost to Follow-up|1
7589152|NCT02041533|26400896|P2|Overall Study|Randomized, not treated|7
7589153|NCT02041533|26400897|P1|Overall Study|Randomized, not treated|4
7589154|NCT02041533|26400896|P2|Overall Study|Completed max number of chemo cycles|29
7589155|NCT02041533|26400897|P1|Overall Study|Completed max number of chemo cycles|0
7589156|NCT02041533|26400896|P2|Overall Study|Other reasons|1
7589157|NCT02041533|26400897|P1|Overall Study|Other reasons|0
7589158|NCT02041533|26400896|P2|Overall Study|Poor/non-compliance|0
7589159|NCT02041533|26400897|P1|Overall Study|Poor/non-compliance|1
7589160|NCT02041533|26400896|P2|Overall Study|Maximum clinical benefit|18
7589161|NCT02041533|26400897|P1|Overall Study|Maximum clinical benefit|0
7589162|NCT02041533|26400896|P2|Overall Study|Withdrawal by Subject|1
7589163|NCT02041533|26400897|P1|Overall Study|Withdrawal by Subject|2
7589164|NCT02041533|26400896|P2|Overall Study|Subject request to discontinue treatment|9
7589165|NCT02041533|26400897|P1|Overall Study|Subject request to discontinue treatment|5
7589166|NCT02041533|26400896|P2|Overall Study|Adverse Event unrelated to study drug|21
7589167|NCT02041533|26400897|P1|Overall Study|Adverse Event unrelated to study drug|20
7589168|NCT02041533|26400896|P2|Overall Study|Death|0
7589169|NCT02041533|26400897|P1|Overall Study|Death|1
7589170|NCT02041533|26400896|P2|Overall Study|Study drug toxicity|30
7589171|NCT02041533|26400897|P1|Overall Study|Study drug toxicity|27
7589172|NCT02041533|26400896|P2|Overall Study|Disease Progression|142
7589173|NCT02041533|26400897|P1|Overall Study|Disease Progression|168
7589174|NCT02041520|26400919|P2|Overall Study|Hypothiroidism identified during follow-|1
7589175|NCT02041520|26400920|P1|Overall Study|Hypothiroidism identified during follow-|0
7589176|NCT02041520|26400919|P2|Overall Study|Lost to Follow-up|1
7589177|NCT02041520|26400920|P1|Overall Study|Lost to Follow-up|0
7589178|NCT02041520|26400919|P2|Overall Study|Protocol Violation|0
7589179|NCT02041520|26400920|P1|Overall Study|Protocol Violation|1
7589180|NCT02041520|26400919|P2|Overall Study|Withdrawal by Subject|4
7589181|NCT02041520|26400920|P1|Overall Study|Withdrawal by Subject|3
7589182|NCT02041520|26400919|P2|Overall Study|Adverse Event|1
7589183|NCT02041520|26400920|P1|Overall Study|Adverse Event|2
7589184|NCT02041494|26400942|P2|Overall Study|study terminated|11
7589185|NCT02041494|26400943|P1|Overall Study|study terminated|16
7589186|NCT02041494|26400942|P2|Overall Study|Lost to Follow-up|6
7589187|NCT02041494|26400943|P1|Overall Study|Lost to Follow-up|2
7589188|NCT02041494|26400942|P2|Overall Study|Death|3
7589189|NCT02041494|26400943|P1|Overall Study|Death|1
7589190|NCT02041429|26400959|P4|Overall Study|On Maintenance Therapy|2
7589191|NCT02041429|26400960|P3|Overall Study|On Maintenance Therapy|0
7589192|NCT02041429|26400961|P2|Overall Study|On Maintenance Therapy|0
7589193|NCT02041429|26400962|P1|Overall Study|On Maintenance Therapy|1
7589194|NCT02041429|26400959|P4|Overall Study|Withdrawal by Subject|0
7589195|NCT02041429|26400960|P3|Overall Study|Withdrawal by Subject|0
7589196|NCT02041429|26400961|P2|Overall Study|Withdrawal by Subject|1
7589197|NCT02041429|26400962|P1|Overall Study|Withdrawal by Subject|0
7589198|NCT02041429|26400959|P4|Overall Study|Toxicity|2
7589199|NCT02041429|26400960|P3|Overall Study|Toxicity|4
7589200|NCT02041429|26400961|P2|Overall Study|Toxicity|1
7589201|NCT02041429|26400962|P1|Overall Study|Toxicity|0
7589202|NCT02041429|26400959|P4|Overall Study|Progressive Disease|2
7589203|NCT02041429|26400960|P3|Overall Study|Progressive Disease|3
7589204|NCT02041429|26400961|P2|Overall Study|Progressive Disease|2
7589205|NCT02041429|26400962|P1|Overall Study|Progressive Disease|2
7589206|NCT02041299|26401014|P2|Overall Study|Patient stopped dosing on unknown date|0
7589207|NCT02041299|26401015|P1|Overall Study|Patient stopped dosing on unknown date|1
7589208|NCT02041299|26401014|P2|Overall Study|Required bone marrow transplant|1
7589209|NCT02041299|26401015|P1|Overall Study|Required bone marrow transplant|0
7589210|NCT02041299|26401014|P2|Overall Study|Termination of the study|3
7589211|NCT02041299|26401015|P1|Overall Study|Termination of the study|7
7589212|NCT02041299|26401014|P2|Overall Study|Protocol Violation|4
7589213|NCT02041299|26401015|P1|Overall Study|Protocol Violation|11
7589214|NCT02041299|26401014|P2|Overall Study|Withdrawal by Subject|7
7589215|NCT02041299|26401015|P1|Overall Study|Withdrawal by Subject|13
7589216|NCT02041299|26401014|P2|Overall Study|Physician Decision|1
7589217|NCT02041299|26401015|P1|Overall Study|Physician Decision|1
7589218|NCT02041299|26401014|P2|Overall Study|Lost to Follow-up|1
7589219|NCT02041299|26401015|P1|Overall Study|Lost to Follow-up|4
7589220|NCT02041299|26401014|P2|Overall Study|Adverse Event|3
7589221|NCT02041299|26401015|P1|Overall Study|Adverse Event|9
7589222|NCT02041286|26401027|P1|Overall Study|Adverse Event|1
7589223|NCT02041104|26401062|P2|Overall Study|discomfort during OGTT|3
7589224|NCT02041104|26401063|P1|Overall Study|discomfort during OGTT|0
7589225|NCT02041104|26401062|P2|Overall Study|Lost to Follow-up|4
7589226|NCT02041104|26401063|P1|Overall Study|Lost to Follow-up|1
7589227|NCT02041091|26401103|P2|Optional Safety Extension Period|Lost to Follow-up|3
7589228|NCT02041091|26401104|P1|Optional Safety Extension Period|Lost to Follow-up|2
7589229|NCT02041091|26401103|P2|Optional Safety Extension Period|Sponsor Decision|74
7589230|NCT02041091|26401104|P1|Optional Safety Extension Period|Sponsor Decision|70
7589231|NCT02041091|26401103|P2|Optional Safety Extension Period|Physician Decision|1
7589232|NCT02041091|26401104|P1|Optional Safety Extension Period|Physician Decision|2
7589233|NCT02041091|26401103|P2|Optional Safety Extension Period|Protocol Violation|0
7589234|NCT02041091|26401104|P1|Optional Safety Extension Period|Protocol Violation|2
7589235|NCT02041091|26401103|P2|Optional Safety Extension Period|Withdrawal by Subject|2
7589236|NCT02041091|26401104|P1|Optional Safety Extension Period|Withdrawal by Subject|5
7589237|NCT02041091|26401103|P2|Optional Safety Extension Period|Adverse Event|2
7589238|NCT02041091|26401104|P1|Optional Safety Extension Period|Adverse Event|4
7589239|NCT02041091|26401103|P2|Treatment|Lost to Follow-up|0
7589240|NCT02041091|26401104|P1|Treatment|Lost to Follow-up|1
7589241|NCT02041091|26401103|P2|Treatment|Sponsor Decision|16
7589242|NCT02041091|26401104|P1|Treatment|Sponsor Decision|15
7589243|NCT02041091|26401103|P2|Treatment|Physician Decision|0
7589244|NCT02041091|26401104|P1|Treatment|Physician Decision|1
7589245|NCT02041091|26401103|P2|Treatment|Withdrawal by Subject|4
7589246|NCT02041091|26401104|P1|Treatment|Withdrawal by Subject|2
7589247|NCT02041091|26401103|P2|Treatment|Adverse Event|3
7589248|NCT02041091|26401104|P1|Treatment|Adverse Event|3
7589249|NCT02040870|26401126|P1|Overall Study|Death|13
7589250|NCT02040870|26401126|P1|Overall Study|Lost to Follow-up|3
7589251|NCT02040870|26401126|P1|Overall Study|Subject/guardian decision|10
7589252|NCT02040870|26401126|P1|Overall Study|Physician Decision|6
7589253|NCT02040870|26401126|P1|Overall Study|Progressive disease|58
7589254|NCT02040870|26401126|P1|Overall Study|Adverse Event|7
7589255|NCT02040870|26401126|P1|Overall Study|Completed treatment phase|6
7589256|NCT02040857|26401147|P1|Overall Study|ineligible|1
7589257|NCT02040857|26401147|P1|Overall Study|recurrence|4
7589258|NCT02040857|26401147|P1|Overall Study|Lost to Follow-up|2
7589259|NCT02040857|26401147|P1|Overall Study|patient non-compliance|3
7589260|NCT02040857|26401147|P1|Overall Study|Withdrawal by Subject|31
7589261|NCT02040857|26401147|P1|Overall Study|Physician Decision|5
7589262|NCT02040857|26401147|P1|Overall Study|Adverse Event|14
7589263|NCT02040844|26401160|P3|Overall Study|Concomitant medication|1
7589264|NCT02040844|26401161|P2|Overall Study|Concomitant medication|3
7589265|NCT02040844|26401162|P1|Overall Study|Concomitant medication|1
7589266|NCT02040844|26401160|P3|Overall Study|Non-specified|5
7589267|NCT02040844|26401161|P2|Overall Study|Non-specified|2
7589268|NCT02040844|26401162|P1|Overall Study|Non-specified|8
7589269|NCT02040844|26401160|P3|Overall Study|Missing|2
7589270|NCT02040844|26401161|P2|Overall Study|Missing|3
7589271|NCT02040844|26401162|P1|Overall Study|Missing|13
7589272|NCT02040844|26401160|P3|Overall Study|Lost to Follow-up|13
7589273|NCT02040844|26401161|P2|Overall Study|Lost to Follow-up|9
7589274|NCT02040844|26401162|P1|Overall Study|Lost to Follow-up|12
7589275|NCT02040844|26401160|P3|Overall Study|Withdrawal by Subject|25
7589276|NCT02040844|26401161|P2|Overall Study|Withdrawal by Subject|22
7589277|NCT02040844|26401162|P1|Overall Study|Withdrawal by Subject|16
7589278|NCT02040844|26401160|P3|Overall Study|Adverse Event|1
7589279|NCT02040844|26401161|P2|Overall Study|Adverse Event|0
7589280|NCT02040844|26401162|P1|Overall Study|Adverse Event|0
7589281|NCT02040805|26401187|P2|Overall Study|Withdrawal by Subject|41
7589282|NCT02040805|26401188|P1|Overall Study|Withdrawal by Subject|28
7589283|NCT02040805|26401187|P2|Overall Study|Lost to Follow-up|9
7589284|NCT02040805|26401188|P1|Overall Study|Lost to Follow-up|14
7589285|NCT02040779|26401224|P3|Overall Study|Lack of Efficacy|0
7589286|NCT02040779|26401225|P2|Overall Study|Lack of Efficacy|2
7589287|NCT02040779|26401226|P1|Overall Study|Lack of Efficacy|4
7589288|NCT02040779|26401224|P3|Overall Study|Lost to Follow-up|1
7589289|NCT02040779|26401225|P2|Overall Study|Lost to Follow-up|2
7589290|NCT02040779|26401226|P1|Overall Study|Lost to Follow-up|1
7589291|NCT02040779|26401224|P3|Overall Study|Protocol Violation|0
7589292|NCT02040779|26401225|P2|Overall Study|Protocol Violation|1
7589293|NCT02040779|26401226|P1|Overall Study|Protocol Violation|2
7589294|NCT02040779|26401224|P3|Overall Study|Non-compliance|0
7589295|NCT02040779|26401225|P2|Overall Study|Non-compliance|1
7589296|NCT02040779|26401226|P1|Overall Study|Non-compliance|0
7589297|NCT02040779|26401224|P3|Overall Study|Withdrawal by Subject|3
7589298|NCT02040779|26401225|P2|Overall Study|Withdrawal by Subject|1
7589299|NCT02040779|26401226|P1|Overall Study|Withdrawal by Subject|4
7589300|NCT02040779|26401224|P3|Overall Study|Adverse Event|0
7589301|NCT02040779|26401225|P2|Overall Study|Adverse Event|0
7589302|NCT02040779|26401226|P1|Overall Study|Adverse Event|1
7589303|NCT02040766|26401266|P5|Overall Study|Lack of Efficacy|5
7589304|NCT02040766|26401267|P4|Overall Study|Lack of Efficacy|6
7589305|NCT02040766|26401268|P3|Overall Study|Lack of Efficacy|4
7589306|NCT02040766|26401269|P2|Overall Study|Lack of Efficacy|3
7589307|NCT02040766|26401270|P1|Overall Study|Lack of Efficacy|6
7589308|NCT02040766|26401266|P5|Overall Study|Not reported|0
7589309|NCT02040766|26401267|P4|Overall Study|Not reported|0
7589310|NCT02040766|26401268|P3|Overall Study|Not reported|0
7589311|NCT02040766|26401269|P2|Overall Study|Not reported|0
7589312|NCT02040766|26401270|P1|Overall Study|Not reported|1
7589313|NCT02040766|26401266|P5|Overall Study|Lost to Follow-up|4
7589314|NCT02040766|26401267|P4|Overall Study|Lost to Follow-up|1
7589315|NCT02040766|26401268|P3|Overall Study|Lost to Follow-up|3
7589316|NCT02040766|26401269|P2|Overall Study|Lost to Follow-up|1
7589317|NCT02040766|26401270|P1|Overall Study|Lost to Follow-up|4
7589318|NCT02040766|26401266|P5|Overall Study|Protocol Violation|0
7589319|NCT02040766|26401267|P4|Overall Study|Protocol Violation|3
7589320|NCT02040766|26401268|P3|Overall Study|Protocol Violation|2
7589321|NCT02040766|26401269|P2|Overall Study|Protocol Violation|1
7589322|NCT02040766|26401270|P1|Overall Study|Protocol Violation|2
7589323|NCT02040766|26401266|P5|Overall Study|Non-compliance|0
7589324|NCT02040766|26401267|P4|Overall Study|Non-compliance|0
7589325|NCT02040766|26401268|P3|Overall Study|Non-compliance|0
7589326|NCT02040766|26401269|P2|Overall Study|Non-compliance|1
7589327|NCT02040766|26401270|P1|Overall Study|Non-compliance|0
7589328|NCT02040766|26401266|P5|Overall Study|Withdrawal by Subject|2
7589329|NCT02040766|26401267|P4|Overall Study|Withdrawal by Subject|3
7589330|NCT02040766|26401268|P3|Overall Study|Withdrawal by Subject|2
7589331|NCT02040766|26401269|P2|Overall Study|Withdrawal by Subject|3
7589332|NCT02040766|26401270|P1|Overall Study|Withdrawal by Subject|4
7589333|NCT02040766|26401266|P5|Overall Study|Adverse Event|2
7589334|NCT02040766|26401267|P4|Overall Study|Adverse Event|0
7589335|NCT02040766|26401268|P3|Overall Study|Adverse Event|1
7589336|NCT02040766|26401269|P2|Overall Study|Adverse Event|1
7589337|NCT02040766|26401270|P1|Overall Study|Adverse Event|1
7589338|NCT02040584|26401323|P2|Overall Study|Immunosuppressant/prohibited med use|10
7589339|NCT02040584|26401324|P1|Overall Study|Immunosuppressant/prohibited med use|7
7589340|NCT02040584|26401323|P2|Overall Study|Transplant rejection/retransplant|1
7589341|NCT02040584|26401324|P1|Overall Study|Transplant rejection/retransplant|0
7589342|NCT02040584|26401323|P2|Overall Study|Death|3
7589343|NCT02040584|26401324|P1|Overall Study|Death|6
7589344|NCT02040584|26401323|P2|Overall Study|Unsatisfactory therapeutic effect|1
7589345|NCT02040584|26401324|P1|Overall Study|Unsatisfactory therapeutic effect|0
7589346|NCT02040584|26401323|P2|Overall Study|Protocol Violation|11
7589347|NCT02040584|26401324|P1|Overall Study|Protocol Violation|9
7589348|NCT02040584|26401323|P2|Overall Study|Adverse Event|6
7589349|NCT02040584|26401324|P1|Overall Study|Adverse Event|13
7589350|NCT02040532|26401357|P1|Overall Study|Withdrawal by Subject|3
7589351|NCT02040532|26401357|P1|Overall Study|Adverse Event|4
7589352|NCT02040532|26401357|P1|Overall Study|Physician Decision|4
7589353|NCT02040532|26401357|P1|Overall Study|Lost to Follow-up|1
7589354|NCT02040428|26401370|P2|Overall Study|Withdrawal by Subject|1
7589355|NCT02040428|26401371|P1|Overall Study|Withdrawal by Subject|1
7589356|NCT02040428|26401370|P2|Overall Study|Death|3
7589357|NCT02040428|26401371|P1|Overall Study|Death|4
7589358|NCT02040259|26401398|P1|Overall Study|Withdrawal by Subject|4
7589359|NCT02040259|26401398|P1|Overall Study|Assessment not completed|3
7589360|NCT02040259|26401398|P1|Overall Study|Lost to Follow-up|76
7589361|NCT02040259|26401398|P1|Overall Study|Death|280
7589362|NCT02040090|26401416|P2|Overall Study|Lost to Follow-up|1
7589363|NCT02040090|26401417|P1|Overall Study|Lost to Follow-up|0
7589364|NCT02040090|26401416|P2|Overall Study|Withdrawal by Subject|1
7589365|NCT02040090|26401417|P1|Overall Study|Withdrawal by Subject|0
7589366|NCT02040090|26401416|P2|Overall Study|Physician Decision|0
7589367|NCT02040090|26401417|P1|Overall Study|Physician Decision|1
7589368|NCT02040090|26401416|P2|Overall Study|Adverse Event|0
7589369|NCT02040090|26401417|P1|Overall Study|Adverse Event|2
7589370|NCT02039908|26401481|P4|Phase 2-School Year|Withdrawal by Subject|5
7589371|NCT02039908|26401482|P3|Phase 2-School Year|Withdrawal by Subject|8
7589372|NCT02039908|26401483|P2|Phase 2-School Year|Withdrawal by Subject|0
7589373|NCT02039908|26401484|P1|Phase 2-School Year|Withdrawal by Subject|0
7589374|NCT02039908|26401481|P4|Phase 2-School Year|Protocol Violation|0
7589375|NCT02039908|26401482|P3|Phase 2-School Year|Protocol Violation|3
7589376|NCT02039908|26401483|P2|Phase 2-School Year|Protocol Violation|0
7589377|NCT02039908|26401484|P1|Phase 2-School Year|Protocol Violation|0
7589378|NCT02039908|26401481|P4|Phase 2-School Year|Lost to Follow-up|3
7589379|NCT02039908|26401482|P3|Phase 2-School Year|Lost to Follow-up|1
7589380|NCT02039908|26401483|P2|Phase 2-School Year|Lost to Follow-up|0
7589381|NCT02039908|26401484|P1|Phase 2-School Year|Lost to Follow-up|0
7589382|NCT02039908|26401481|P4|Phase 1-Summer|Protocol Violation|0
7589383|NCT02039908|26401482|P3|Phase 1-Summer|Protocol Violation|0
7589384|NCT02039908|26401483|P2|Phase 1-Summer|Protocol Violation|0
7589385|NCT02039908|26401484|P1|Phase 1-Summer|Protocol Violation|6
7589386|NCT02039908|26401481|P4|Phase 1-Summer|Withdrawal by Subject|0
7589387|NCT02039908|26401482|P3|Phase 1-Summer|Withdrawal by Subject|0
7589388|NCT02039908|26401483|P2|Phase 1-Summer|Withdrawal by Subject|6
7589389|NCT02039908|26401484|P1|Phase 1-Summer|Withdrawal by Subject|7
7589390|NCT02039856|26401498|P2|Overall Study|Withdrawal by Subject|618
7589391|NCT02039856|26401499|P1|Overall Study|Withdrawal by Subject|1573
7589392|NCT02039856|26401498|P2|Overall Study|Lost to Follow-up|206
7589393|NCT02039856|26401499|P1|Overall Study|Lost to Follow-up|388
7589394|NCT02039856|26401498|P2|Overall Study|Partial survey completion|26
7589395|NCT02039856|26401499|P1|Overall Study|Partial survey completion|61
7589396|NCT02039856|26401498|P2|Overall Study|Death|3
7589397|NCT02039856|26401499|P1|Overall Study|Death|5
7589398|NCT02039778|26401531|P1|Overall Study|Never started the protocol treatment|1
7589399|NCT02039778|26401531|P1|Overall Study|Withdrawal by Subject|1
7589400|NCT02039778|26401531|P1|Overall Study|Death|2
7589401|NCT02039687|26401554|P4|Overall Study|treatment assignment could not be confir|0
7589402|NCT02039687|26401555|P3|Overall Study|treatment assignment could not be confir|2
7589403|NCT02039687|26401556|P2|Overall Study|treatment assignment could not be confir|0
7589404|NCT02039687|26401557|P1|Overall Study|treatment assignment could not be confir|0
7589405|NCT02039687|26401554|P4|Overall Study|Withdrawal by Subject|0
7589406|NCT02039687|26401555|P3|Overall Study|Withdrawal by Subject|0
7589407|NCT02039687|26401556|P2|Overall Study|Withdrawal by Subject|1
7589408|NCT02039687|26401557|P1|Overall Study|Withdrawal by Subject|0
7589409|NCT02039687|26401554|P4|Overall Study|Adverse Event|0
7589410|NCT02039687|26401555|P3|Overall Study|Adverse Event|1
7589411|NCT02039687|26401556|P2|Overall Study|Adverse Event|0
7589412|NCT02039687|26401557|P1|Overall Study|Adverse Event|0
7589413|NCT02039674|26401597|P14|Overall Study|Ongoing in Study|3
7589414|NCT02039674|26401598|P13|Overall Study|Ongoing in Study|33
7589415|NCT02039674|26401599|P12|Overall Study|Ongoing in Study|34
7589416|NCT02039674|26401600|P11|Overall Study|Ongoing in Study|1
7589417|NCT02039674|26401601|P10|Overall Study|Ongoing in Study|6
7589418|NCT02039674|26401602|P9|Overall Study|Ongoing in Study|1
7589419|NCT02039674|26401603|P8|Overall Study|Ongoing in Study|0
7589420|NCT02039674|26401604|P7|Overall Study|Ongoing in Study|2
7589421|NCT02039674|26401605|P6|Overall Study|Ongoing in Study|1
7589422|NCT02039674|26401606|P5|Overall Study|Ongoing in Study|3
7589423|NCT02039674|26401607|P4|Overall Study|Ongoing in Study|2
7589424|NCT02039674|26401608|P3|Overall Study|Ongoing in Study|3
7589425|NCT02039674|26401609|P2|Overall Study|Ongoing in Study|2
7589426|NCT02039674|26401610|P1|Overall Study|Ongoing in Study|5
7589427|NCT02039674|26401597|P14|Overall Study|Withdrawal by Subject|2
7589428|NCT02039674|26401598|P13|Overall Study|Withdrawal by Subject|5
7589429|NCT02039674|26401599|P12|Overall Study|Withdrawal by Subject|3
7589430|NCT02039674|26401600|P11|Overall Study|Withdrawal by Subject|1
7589431|NCT02039674|26401601|P10|Overall Study|Withdrawal by Subject|2
7589432|NCT02039674|26401602|P9|Overall Study|Withdrawal by Subject|0
7589433|NCT02039674|26401603|P8|Overall Study|Withdrawal by Subject|0
7589434|NCT02039674|26401604|P7|Overall Study|Withdrawal by Subject|0
7589435|NCT02039674|26401605|P6|Overall Study|Withdrawal by Subject|0
7589436|NCT02039674|26401606|P5|Overall Study|Withdrawal by Subject|1
7589437|NCT02039674|26401607|P4|Overall Study|Withdrawal by Subject|0
7589438|NCT02039674|26401608|P3|Overall Study|Withdrawal by Subject|1
7589439|NCT02039674|26401609|P2|Overall Study|Withdrawal by Subject|2
7589440|NCT02039674|26401610|P1|Overall Study|Withdrawal by Subject|0
7589441|NCT02039674|26401597|P14|Overall Study|Progressive Disease|16
7589442|NCT02039674|26401598|P13|Overall Study|Progressive Disease|18
7589443|NCT02039674|26401599|P12|Overall Study|Progressive Disease|17
7589444|NCT02039674|26401600|P11|Overall Study|Progressive Disease|0
7589445|NCT02039674|26401601|P10|Overall Study|Progressive Disease|2
7589446|NCT02039674|26401602|P9|Overall Study|Progressive Disease|7
7589447|NCT02039674|26401603|P8|Overall Study|Progressive Disease|3
7589448|NCT02039674|26401604|P7|Overall Study|Progressive Disease|1
7589449|NCT02039674|26401605|P6|Overall Study|Progressive Disease|10
7589450|NCT02039674|26401606|P5|Overall Study|Progressive Disease|8
7589451|NCT02039674|26401607|P4|Overall Study|Progressive Disease|7
7589452|NCT02039674|26401608|P3|Overall Study|Progressive Disease|6
7589453|NCT02039674|26401609|P2|Overall Study|Progressive Disease|7
7589454|NCT02039674|26401610|P1|Overall Study|Progressive Disease|6
7589455|NCT02039674|26401597|P14|Overall Study|Physician Decision|0
7589456|NCT02039674|26401598|P13|Overall Study|Physician Decision|0
7589457|NCT02039674|26401599|P12|Overall Study|Physician Decision|1
7589458|NCT02039674|26401600|P11|Overall Study|Physician Decision|0
7589459|NCT02039674|26401601|P10|Overall Study|Physician Decision|0
7589460|NCT02039674|26401602|P9|Overall Study|Physician Decision|0
7589461|NCT02039674|26401603|P8|Overall Study|Physician Decision|0
7589462|NCT02039674|26401604|P7|Overall Study|Physician Decision|0
7589463|NCT02039674|26401605|P6|Overall Study|Physician Decision|0
7589464|NCT02039674|26401606|P5|Overall Study|Physician Decision|0
7589465|NCT02039674|26401607|P4|Overall Study|Physician Decision|0
7589466|NCT02039674|26401608|P3|Overall Study|Physician Decision|0
7589467|NCT02039674|26401609|P2|Overall Study|Physician Decision|0
7589468|NCT02039674|26401610|P1|Overall Study|Physician Decision|0
7589469|NCT02039674|26401597|P14|Overall Study|Lost to Follow-up|0
7589470|NCT02039674|26401598|P13|Overall Study|Lost to Follow-up|1
7589471|NCT02039674|26401599|P12|Overall Study|Lost to Follow-up|0
7589472|NCT02039674|26401600|P11|Overall Study|Lost to Follow-up|0
7589473|NCT02039674|26401601|P10|Overall Study|Lost to Follow-up|0
7589474|NCT02039674|26401602|P9|Overall Study|Lost to Follow-up|0
7589475|NCT02039674|26401603|P8|Overall Study|Lost to Follow-up|0
7589476|NCT02039674|26401604|P7|Overall Study|Lost to Follow-up|0
7589477|NCT02039674|26401605|P6|Overall Study|Lost to Follow-up|0
7589478|NCT02039674|26401606|P5|Overall Study|Lost to Follow-up|0
7589479|NCT02039674|26401607|P4|Overall Study|Lost to Follow-up|0
7589480|NCT02039674|26401608|P3|Overall Study|Lost to Follow-up|0
7589481|NCT02039674|26401609|P2|Overall Study|Lost to Follow-up|0
7589482|NCT02039674|26401610|P1|Overall Study|Lost to Follow-up|0
7589483|NCT02039674|26401597|P14|Overall Study|Excluded Medication|3
7589484|NCT02039674|26401598|P13|Overall Study|Excluded Medication|4
7589485|NCT02039674|26401599|P12|Overall Study|Excluded Medication|2
7589486|NCT02039674|26401600|P11|Overall Study|Excluded Medication|4
7589487|NCT02039674|26401601|P10|Overall Study|Excluded Medication|2
7589488|NCT02039674|26401602|P9|Overall Study|Excluded Medication|2
7589489|NCT02039674|26401603|P8|Overall Study|Excluded Medication|0
7589490|NCT02039674|26401604|P7|Overall Study|Excluded Medication|0
7589491|NCT02039674|26401605|P6|Overall Study|Excluded Medication|1
7589492|NCT02039674|26401606|P5|Overall Study|Excluded Medication|0
7589493|NCT02039674|26401607|P4|Overall Study|Excluded Medication|1
7589494|NCT02039674|26401608|P3|Overall Study|Excluded Medication|0
7589495|NCT02039674|26401609|P2|Overall Study|Excluded Medication|1
7589496|NCT02039674|26401610|P1|Overall Study|Excluded Medication|1
7589497|NCT02039674|26401597|P14|Overall Study|Death|8
7589498|NCT02039674|26401598|P13|Overall Study|Death|0
7589499|NCT02039674|26401599|P12|Overall Study|Death|1
7589500|NCT02039674|26401600|P11|Overall Study|Death|1
7589501|NCT02039674|26401601|P10|Overall Study|Death|0
7589502|NCT02039674|26401602|P9|Overall Study|Death|0
7589503|NCT02039674|26401603|P8|Overall Study|Death|0
7589504|NCT02039674|26401604|P7|Overall Study|Death|0
7589505|NCT02039674|26401605|P6|Overall Study|Death|0
7589506|NCT02039674|26401606|P5|Overall Study|Death|0
7589507|NCT02039674|26401607|P4|Overall Study|Death|2
7589508|NCT02039674|26401608|P3|Overall Study|Death|1
7589509|NCT02039674|26401609|P2|Overall Study|Death|0
7589510|NCT02039674|26401610|P1|Overall Study|Death|0
7589511|NCT02039674|26401597|P14|Overall Study|Adverse Event|1
7589512|NCT02039674|26401598|P13|Overall Study|Adverse Event|2
7589513|NCT02039674|26401599|P12|Overall Study|Adverse Event|2
7589514|NCT02039674|26401600|P11|Overall Study|Adverse Event|0
7589515|NCT02039674|26401601|P10|Overall Study|Adverse Event|0
7589516|NCT02039674|26401602|P9|Overall Study|Adverse Event|2
7589517|NCT02039674|26401603|P8|Overall Study|Adverse Event|0
7589518|NCT02039674|26401604|P7|Overall Study|Adverse Event|0
7589519|NCT02039674|26401605|P6|Overall Study|Adverse Event|0
7589520|NCT02039674|26401606|P5|Overall Study|Adverse Event|0
7589521|NCT02039674|26401607|P4|Overall Study|Adverse Event|1
7589522|NCT02039674|26401608|P3|Overall Study|Adverse Event|1
7589523|NCT02039674|26401609|P2|Overall Study|Adverse Event|0
7589524|NCT02039674|26401610|P1|Overall Study|Adverse Event|0
7589525|NCT02039505|26401652|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
7589526|NCT02039505|26401653|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7589527|NCT02039505|26401654|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7589528|NCT02039505|26401655|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7589529|NCT02039505|26401656|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7589530|NCT02039505|26401657|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7589531|NCT02039505|26401658|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7589532|NCT02039505|26401652|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
7589533|NCT02039505|26401653|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7589534|NCT02039505|26401654|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7589535|NCT02039505|26401655|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7589536|NCT02039505|26401656|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7589537|NCT02039505|26401657|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7589538|NCT02039505|26401658|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7589539|NCT02039505|26401652|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
7589540|NCT02039505|26401653|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7589541|NCT02039505|26401654|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7589542|NCT02039505|26401655|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7589543|NCT02039505|26401656|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7589544|NCT02039505|26401657|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7589545|NCT02039505|26401658|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7589546|NCT02039505|26401652|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
7589547|NCT02039505|26401653|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7589548|NCT02039505|26401654|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7589549|NCT02039505|26401655|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7589550|NCT02039505|26401656|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7589551|NCT02039505|26401657|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7589552|NCT02039505|26401658|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7589553|NCT02039505|26401652|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7589554|NCT02039505|26401653|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7589555|NCT02039505|26401654|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7589556|NCT02039505|26401655|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
7589557|NCT02039505|26401656|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7589558|NCT02039505|26401657|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7589559|NCT02039505|26401658|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7589560|NCT02039505|26401652|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7589561|NCT02039505|26401653|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
7589562|NCT02039505|26401654|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
7589563|NCT02039505|26401655|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
7589564|NCT02039505|26401656|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7589565|NCT02039505|26401657|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7589566|NCT02039505|26401658|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7589567|NCT02039505|26401652|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7589568|NCT02039505|26401653|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7589569|NCT02039505|26401654|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7589570|NCT02039505|26401655|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
7589571|NCT02039505|26401656|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7589572|NCT02039505|26401657|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7589573|NCT02039505|26401658|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7589574|NCT02039505|26401652|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7589575|NCT02039505|26401653|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
7589576|NCT02039505|26401654|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
7589577|NCT02039505|26401655|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
7589578|NCT02039505|26401656|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7589579|NCT02039505|26401657|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7589580|NCT02039505|26401658|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7589581|NCT02039505|26401652|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7589582|NCT02039505|26401653|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7589583|NCT02039505|26401654|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7589584|NCT02039505|26401655|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7589585|NCT02039505|26401656|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7589586|NCT02039505|26401657|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7589587|NCT02039505|26401658|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
7589588|NCT02039505|26401652|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7589589|NCT02039505|26401653|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7589590|NCT02039505|26401654|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7589591|NCT02039505|26401655|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7589592|NCT02039505|26401656|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
7589593|NCT02039505|26401657|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7589594|NCT02039505|26401658|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7589595|NCT02039505|26401652|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7589596|NCT02039505|26401653|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7589597|NCT02039505|26401654|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7589598|NCT02039505|26401655|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7589599|NCT02039505|26401656|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
7589600|NCT02039505|26401657|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
7589601|NCT02039505|26401658|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
7589602|NCT02039427|26401734|P4|Overall Study|Steroid Use|0
7589603|NCT02039427|26401735|P3|Overall Study|Steroid Use|0
7589604|NCT02039427|26401736|P2|Overall Study|Steroid Use|0
7589605|NCT02039427|26401737|P1|Overall Study|Steroid Use|1
7589606|NCT02039427|26401734|P4|Overall Study|Loss of follow - up|4
7589607|NCT02039427|26401735|P3|Overall Study|Loss of follow - up|2
7589608|NCT02039427|26401736|P2|Overall Study|Loss of follow - up|0
7589609|NCT02039427|26401737|P1|Overall Study|Loss of follow - up|1
7589610|NCT02039427|26401734|P4|Overall Study|Cancellation of surgery|0
7589611|NCT02039427|26401735|P3|Overall Study|Cancellation of surgery|1
7589612|NCT02039427|26401736|P2|Overall Study|Cancellation of surgery|0
7589613|NCT02039427|26401737|P1|Overall Study|Cancellation of surgery|0
7589614|NCT02039427|26401734|P4|Overall Study|Withdrawal on concent|1
7589615|NCT02039427|26401735|P3|Overall Study|Withdrawal on concent|0
7589616|NCT02039427|26401736|P2|Overall Study|Withdrawal on concent|0
7589617|NCT02039427|26401737|P1|Overall Study|Withdrawal on concent|0
7589618|NCT02039427|26401734|P4|Overall Study|Duration of surgery > 3h|0
7589619|NCT02039427|26401735|P3|Overall Study|Duration of surgery > 3h|0
7589620|NCT02039427|26401736|P2|Overall Study|Duration of surgery > 3h|1
7589621|NCT02039427|26401737|P1|Overall Study|Duration of surgery > 3h|1
7589622|NCT02039414|26401757|P2|Overall Study|Protocol Violation|1
7589623|NCT02039414|26401758|P1|Overall Study|Protocol Violation|3
7589624|NCT02039414|26401757|P2|Overall Study|Lost to Follow-up|0
7589625|NCT02039414|26401758|P1|Overall Study|Lost to Follow-up|2
7589626|NCT02039414|26401757|P2|Overall Study|Delivered|1
7589627|NCT02039414|26401758|P1|Overall Study|Delivered|1
7589628|NCT02039375|26401770|P1|Overall Study|Lost to Follow-up|2
7589629|NCT02039219|26401781|P2|Follow up|Adverse Event|1
7589630|NCT02039219|26401782|P1|Follow up|Adverse Event|0
7589631|NCT02039219|26401781|P2|Treatment|Death|0
7589632|NCT02039219|26401782|P1|Treatment|Death|1
7589633|NCT02039219|26401781|P2|Treatment|Protocol Violation|0
7589634|NCT02039219|26401782|P1|Treatment|Protocol Violation|1
7589635|NCT02039219|26401781|P2|Treatment|Lost to Follow-up|1
7589636|NCT02039219|26401782|P1|Treatment|Lost to Follow-up|0
7589637|NCT02039219|26401781|P2|Treatment|Physician Decision|0
7589638|NCT02039219|26401782|P1|Treatment|Physician Decision|1
7589639|NCT02039219|26401781|P2|Treatment|Adverse Event|1
7589640|NCT02039219|26401782|P1|Treatment|Adverse Event|0
7589641|NCT02039219|26401781|P2|Treatment|Withdrawal by Subject|0
7589642|NCT02039219|26401782|P1|Treatment|Withdrawal by Subject|1
7589643|NCT02038959|26401831|P2|Overall Study|Withdrawal by Subject|8
7589644|NCT02038959|26401832|P1|Overall Study|Withdrawal by Subject|6
7589645|NCT02038946|26401858|P1|Overall Study|Other reasons|1
7589646|NCT02038946|26401858|P1|Overall Study|Lost to Follow-up|2
7589647|NCT02038946|26401858|P1|Overall Study|Withdrawal by Subject|3
7589648|NCT02038946|26401858|P1|Overall Study|Death|5
7589649|NCT02038933|26401869|P1|Overall Study|Other reasons|2
7589650|NCT02038933|26401869|P1|Overall Study|Lost to Follow-up|1
7589651|NCT02038933|26401869|P1|Overall Study|Participant request to discontinue treatment|2
7589652|NCT02038933|26401869|P1|Overall Study|Adverse event unrelated to study drug|6
7589653|NCT02038933|26401869|P1|Overall Study|Study drug toxicity|6
7589654|NCT02038933|26401869|P1|Overall Study|Disease progression|104
7589655|NCT02038920|26401890|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
7589656|NCT02038920|26401891|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7589657|NCT02038920|26401892|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7589658|NCT02038920|26401893|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7589659|NCT02038920|26401894|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7589660|NCT02038920|26401895|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7589661|NCT02038920|26401890|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
7589662|NCT02038920|26401891|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7589663|NCT02038920|26401892|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7589664|NCT02038920|26401893|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7589665|NCT02038920|26401894|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7589666|NCT02038920|26401895|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7589667|NCT02038920|26401890|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
7589668|NCT02038920|26401891|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7589669|NCT02038920|26401892|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7589670|NCT02038920|26401893|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7589671|NCT02038920|26401894|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7589672|NCT02038920|26401895|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7589673|NCT02038920|26401890|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
7589674|NCT02038920|26401891|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7589675|NCT02038920|26401892|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7589676|NCT02038920|26401893|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7589677|NCT02038920|26401894|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7589678|NCT02038920|26401895|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7589679|NCT02038920|26401890|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
7589680|NCT02038920|26401891|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7589681|NCT02038920|26401892|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7589682|NCT02038920|26401893|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7589683|NCT02038920|26401894|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7589684|NCT02038920|26401895|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7589685|NCT02038920|26401890|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
7589686|NCT02038920|26401891|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7589687|NCT02038920|26401892|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7589688|NCT02038920|26401893|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7589689|NCT02038920|26401894|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7589690|NCT02038920|26401895|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7589691|NCT02038920|26401890|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7589692|NCT02038920|26401891|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
7589693|NCT02038920|26401892|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
7589694|NCT02038920|26401893|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
7589695|NCT02038920|26401894|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7589696|NCT02038920|26401895|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7589697|NCT02038920|26401890|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7589698|NCT02038920|26401891|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7589699|NCT02038920|26401892|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7589700|NCT02038920|26401893|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
7589701|NCT02038920|26401894|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7589702|NCT02038920|26401895|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7589703|NCT02038920|26401890|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7589704|NCT02038920|26401891|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7589705|NCT02038920|26401892|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
7589706|NCT02038920|26401893|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7589707|NCT02038920|26401894|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7589708|NCT02038920|26401895|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7589709|NCT02038920|26401890|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7589710|NCT02038920|26401891|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7589711|NCT02038920|26401892|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7589712|NCT02038920|26401893|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7589713|NCT02038920|26401894|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7589714|NCT02038920|26401895|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7589715|NCT02038920|26401890|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7589716|NCT02038920|26401891|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7589717|NCT02038920|26401892|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7589718|NCT02038920|26401893|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7589719|NCT02038920|26401894|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7589720|NCT02038920|26401895|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
7589721|NCT02038920|26401890|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7589722|NCT02038920|26401891|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7589723|NCT02038920|26401892|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7589724|NCT02038920|26401893|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7589725|NCT02038920|26401894|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
7589726|NCT02038920|26401895|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
7589727|NCT02038907|26401972|P14|Overall Study|Withdrawal by Subject|0
7589728|NCT02038907|26401973|P13|Overall Study|Withdrawal by Subject|0
7589729|NCT02038907|26401974|P12|Overall Study|Withdrawal by Subject|0
7589730|NCT02038907|26401975|P11|Overall Study|Withdrawal by Subject|1
7589731|NCT02038907|26401976|P10|Overall Study|Withdrawal by Subject|0
7589732|NCT02038907|26401977|P9|Overall Study|Withdrawal by Subject|0
7589733|NCT02038907|26401978|P8|Overall Study|Withdrawal by Subject|0
7589734|NCT02038907|26401979|P7|Overall Study|Withdrawal by Subject|0
7589735|NCT02038907|26401980|P6|Overall Study|Withdrawal by Subject|0
7589736|NCT02038907|26401981|P5|Overall Study|Withdrawal by Subject|0
7589737|NCT02038907|26401982|P4|Overall Study|Withdrawal by Subject|0
7589738|NCT02038907|26401983|P3|Overall Study|Withdrawal by Subject|0
7589739|NCT02038907|26401984|P2|Overall Study|Withdrawal by Subject|0
7589740|NCT02038907|26401985|P1|Overall Study|Withdrawal by Subject|0
7589741|NCT02038907|26401972|P14|Overall Study|Protocol Violation|0
7589742|NCT02038907|26401973|P13|Overall Study|Protocol Violation|0
7589743|NCT02038907|26401974|P12|Overall Study|Protocol Violation|0
7589744|NCT02038907|26401975|P11|Overall Study|Protocol Violation|1
7589745|NCT02038907|26401976|P10|Overall Study|Protocol Violation|0
7589746|NCT02038907|26401977|P9|Overall Study|Protocol Violation|0
7589747|NCT02038907|26401978|P8|Overall Study|Protocol Violation|0
7589748|NCT02038907|26401979|P7|Overall Study|Protocol Violation|0
7589749|NCT02038907|26401980|P6|Overall Study|Protocol Violation|0
7589750|NCT02038907|26401981|P5|Overall Study|Protocol Violation|0
7589751|NCT02038907|26401982|P4|Overall Study|Protocol Violation|0
7589752|NCT02038907|26401983|P3|Overall Study|Protocol Violation|0
7589753|NCT02038907|26401984|P2|Overall Study|Protocol Violation|0
7589754|NCT02038907|26401985|P1|Overall Study|Protocol Violation|0
7589755|NCT02038881|26402536|P3|Overall Study|incarcerated|0
7589756|NCT02038881|26402537|P2|Overall Study|incarcerated|0
7589757|NCT02038881|26402538|P1|Overall Study|incarcerated|1
7589758|NCT02038881|26402536|P3|Overall Study|Lost to Follow-up|0
7589759|NCT02038881|26402537|P2|Overall Study|Lost to Follow-up|0
7589760|NCT02038881|26402538|P1|Overall Study|Lost to Follow-up|2
7589761|NCT02038881|26402536|P3|Overall Study|Withdrawal by Subject|1
7589762|NCT02038881|26402537|P2|Overall Study|Withdrawal by Subject|0
7589763|NCT02038881|26402538|P1|Overall Study|Withdrawal by Subject|0
7589764|NCT02038829|26402611|P12|Treatment Period 6|Adverse Event|0
7589765|NCT02038829|26402612|P11|Treatment Period 6|Adverse Event|0
7589766|NCT02038829|26402613|P10|Treatment Period 6|Adverse Event|0
7589767|NCT02038829|26402614|P9|Treatment Period 6|Adverse Event|0
7589768|NCT02038829|26402615|P8|Treatment Period 6|Adverse Event|0
7589769|NCT02038829|26402616|P7|Treatment Period 6|Adverse Event|0
7589770|NCT02038829|26402617|P6|Treatment Period 6|Adverse Event|0
7589771|NCT02038829|26402618|P5|Treatment Period 6|Adverse Event|0
7589772|NCT02038829|26402619|P4|Treatment Period 6|Adverse Event|0
7589773|NCT02038829|26402620|P3|Treatment Period 6|Adverse Event|1
7589774|NCT02038829|26402621|P2|Treatment Period 6|Adverse Event|0
7589775|NCT02038829|26402622|P1|Treatment Period 6|Adverse Event|0
7589776|NCT02038829|26402611|P12|Washout Period 4|Adverse Event|0
7589777|NCT02038829|26402612|P11|Washout Period 4|Adverse Event|0
7589778|NCT02038829|26402613|P10|Washout Period 4|Adverse Event|0
7589779|NCT02038829|26402614|P9|Washout Period 4|Adverse Event|0
7589780|NCT02038829|26402615|P8|Washout Period 4|Adverse Event|0
7589781|NCT02038829|26402616|P7|Washout Period 4|Adverse Event|1
7589782|NCT02038829|26402617|P6|Washout Period 4|Adverse Event|0
7589783|NCT02038829|26402618|P5|Washout Period 4|Adverse Event|0
7589784|NCT02038829|26402619|P4|Washout Period 4|Adverse Event|0
7589785|NCT02038829|26402620|P3|Washout Period 4|Adverse Event|0
7589786|NCT02038829|26402621|P2|Washout Period 4|Adverse Event|0
7589787|NCT02038829|26402622|P1|Washout Period 4|Adverse Event|0
7589788|NCT02038829|26402611|P12|Treatment Period 4|Adverse Event|0
7589789|NCT02038829|26402612|P11|Treatment Period 4|Adverse Event|0
7589790|NCT02038829|26402613|P10|Treatment Period 4|Adverse Event|0
7589791|NCT02038829|26402614|P9|Treatment Period 4|Adverse Event|0
7589792|NCT02038829|26402615|P8|Treatment Period 4|Adverse Event|0
7589793|NCT02038829|26402616|P7|Treatment Period 4|Adverse Event|0
7589794|NCT02038829|26402617|P6|Treatment Period 4|Adverse Event|0
7589795|NCT02038829|26402618|P5|Treatment Period 4|Adverse Event|0
7589796|NCT02038829|26402619|P4|Treatment Period 4|Adverse Event|0
7589797|NCT02038829|26402620|P3|Treatment Period 4|Adverse Event|0
7589798|NCT02038829|26402621|P2|Treatment Period 4|Adverse Event|1
7589799|NCT02038829|26402622|P1|Treatment Period 4|Adverse Event|0
7589800|NCT02038829|26402611|P12|Washout Period 2|Withdrawal by Subject|0
7589801|NCT02038829|26402612|P11|Washout Period 2|Withdrawal by Subject|0
7589802|NCT02038829|26402613|P10|Washout Period 2|Withdrawal by Subject|0
7589803|NCT02038829|26402614|P9|Washout Period 2|Withdrawal by Subject|0
7589804|NCT02038829|26402615|P8|Washout Period 2|Withdrawal by Subject|0
7589805|NCT02038829|26402616|P7|Washout Period 2|Withdrawal by Subject|0
7589806|NCT02038829|26402617|P6|Washout Period 2|Withdrawal by Subject|1
7589807|NCT02038829|26402618|P5|Washout Period 2|Withdrawal by Subject|0
7589808|NCT02038829|26402619|P4|Washout Period 2|Withdrawal by Subject|0
7589809|NCT02038829|26402620|P3|Washout Period 2|Withdrawal by Subject|0
7589810|NCT02038829|26402621|P2|Washout Period 2|Withdrawal by Subject|0
7589811|NCT02038829|26402622|P1|Washout Period 2|Withdrawal by Subject|0
7589812|NCT02038829|26402611|P12|Washout Period 2|Adverse Event|0
7589813|NCT02038829|26402612|P11|Washout Period 2|Adverse Event|0
7589814|NCT02038829|26402613|P10|Washout Period 2|Adverse Event|0
7589815|NCT02038829|26402614|P9|Washout Period 2|Adverse Event|1
7589816|NCT02038829|26402615|P8|Washout Period 2|Adverse Event|0
7589817|NCT02038829|26402616|P7|Washout Period 2|Adverse Event|0
7589818|NCT02038829|26402617|P6|Washout Period 2|Adverse Event|0
7589819|NCT02038829|26402618|P5|Washout Period 2|Adverse Event|0
7589820|NCT02038829|26402619|P4|Washout Period 2|Adverse Event|0
7589821|NCT02038829|26402620|P3|Washout Period 2|Adverse Event|0
7589822|NCT02038829|26402621|P2|Washout Period 2|Adverse Event|0
7589823|NCT02038829|26402622|P1|Washout Period 2|Adverse Event|0
7589824|NCT02038829|26402611|P12|Treatment Period 2|Withdrawal by Subject|0
7589825|NCT02038829|26402612|P11|Treatment Period 2|Withdrawal by Subject|0
7589826|NCT02038829|26402613|P10|Treatment Period 2|Withdrawal by Subject|0
7589827|NCT02038829|26402614|P9|Treatment Period 2|Withdrawal by Subject|0
7589828|NCT02038829|26402615|P8|Treatment Period 2|Withdrawal by Subject|0
7589829|NCT02038829|26402616|P7|Treatment Period 2|Withdrawal by Subject|0
7589830|NCT02038829|26402617|P6|Treatment Period 2|Withdrawal by Subject|0
7589831|NCT02038829|26402618|P5|Treatment Period 2|Withdrawal by Subject|0
7589832|NCT02038829|26402619|P4|Treatment Period 2|Withdrawal by Subject|0
7589833|NCT02038829|26402620|P3|Treatment Period 2|Withdrawal by Subject|0
7589834|NCT02038829|26402621|P2|Treatment Period 2|Withdrawal by Subject|0
7589835|NCT02038829|26402622|P1|Treatment Period 2|Withdrawal by Subject|1
7589836|NCT02038829|26402611|P12|Treatment Period 2|Adverse Event|0
7589837|NCT02038829|26402612|P11|Treatment Period 2|Adverse Event|1
7589838|NCT02038829|26402613|P10|Treatment Period 2|Adverse Event|0
7589839|NCT02038829|26402614|P9|Treatment Period 2|Adverse Event|0
7589840|NCT02038829|26402615|P8|Treatment Period 2|Adverse Event|0
7589841|NCT02038829|26402616|P7|Treatment Period 2|Adverse Event|0
7589842|NCT02038829|26402617|P6|Treatment Period 2|Adverse Event|0
7589843|NCT02038829|26402618|P5|Treatment Period 2|Adverse Event|0
7589844|NCT02038829|26402619|P4|Treatment Period 2|Adverse Event|0
7589845|NCT02038829|26402620|P3|Treatment Period 2|Adverse Event|0
7589846|NCT02038829|26402621|P2|Treatment Period 2|Adverse Event|0
7589847|NCT02038829|26402622|P1|Treatment Period 2|Adverse Event|0
7589848|NCT02038829|26402611|P12|Washout Period 1|Death|0
7589849|NCT02038829|26402612|P11|Washout Period 1|Death|0
7589850|NCT02038829|26402613|P10|Washout Period 1|Death|0
7589851|NCT02038829|26402614|P9|Washout Period 1|Death|0
7589852|NCT02038829|26402615|P8|Washout Period 1|Death|0
7589853|NCT02038829|26402616|P7|Washout Period 1|Death|0
7589854|NCT02038829|26402617|P6|Washout Period 1|Death|0
7589855|NCT02038829|26402618|P5|Washout Period 1|Death|1
7589856|NCT02038829|26402619|P4|Washout Period 1|Death|0
7589857|NCT02038829|26402620|P3|Washout Period 1|Death|0
7589858|NCT02038829|26402621|P2|Washout Period 1|Death|0
7589859|NCT02038829|26402622|P1|Washout Period 1|Death|0
7589860|NCT02038790|26402656|P2|Day 0 - First Treatment|Withdrawal by Subject|1
7589861|NCT02038790|26402657|P1|Day 0 - First Treatment|Withdrawal by Subject|1
7589862|NCT02038764|26402693|P5|Overall Study|Other|0
7589863|NCT02038764|26402694|P4|Overall Study|Other|0
7589864|NCT02038764|26402695|P3|Overall Study|Other|1
7589865|NCT02038764|26402696|P2|Overall Study|Other|0
7589866|NCT02038764|26402697|P1|Overall Study|Other|1
7589867|NCT02038764|26402693|P5|Overall Study|Withdrawal by Subject|1
7589868|NCT02038764|26402694|P4|Overall Study|Withdrawal by Subject|0
7589869|NCT02038764|26402695|P3|Overall Study|Withdrawal by Subject|0
7589870|NCT02038764|26402696|P2|Overall Study|Withdrawal by Subject|0
7589871|NCT02038764|26402697|P1|Overall Study|Withdrawal by Subject|0
7589872|NCT02038764|26402693|P5|Overall Study|Lost to Follow-up|0
7589873|NCT02038764|26402694|P4|Overall Study|Lost to Follow-up|0
7589874|NCT02038764|26402695|P3|Overall Study|Lost to Follow-up|0
7589875|NCT02038764|26402696|P2|Overall Study|Lost to Follow-up|1
7589876|NCT02038764|26402697|P1|Overall Study|Lost to Follow-up|0
7589877|NCT02038764|26402693|P5|Overall Study|Adverse Event|0
7589878|NCT02038764|26402694|P4|Overall Study|Adverse Event|0
7589879|NCT02038764|26402695|P3|Overall Study|Adverse Event|1
7589880|NCT02038764|26402696|P2|Overall Study|Adverse Event|0
7589881|NCT02038764|26402697|P1|Overall Study|Adverse Event|0
7589882|NCT02038647|26402799|P2|Overall Study|Ongoing at Datacut|10
7589883|NCT02038647|26402800|P1|Overall Study|Ongoing at Datacut|9
7589884|NCT02038647|26402799|P2|Overall Study|Not Reported|1
7589885|NCT02038647|26402800|P1|Overall Study|Not Reported|0
7589886|NCT02038647|26402799|P2|Overall Study|Withdrawal by Subject|2
7589887|NCT02038647|26402800|P1|Overall Study|Withdrawal by Subject|5
7589888|NCT02038647|26402799|P2|Overall Study|Symptomatic Deterioration|7
7589889|NCT02038647|26402800|P1|Overall Study|Symptomatic Deterioration|7
7589890|NCT02038647|26402799|P2|Overall Study|Adverse Event|10
7589891|NCT02038647|26402800|P1|Overall Study|Adverse Event|18
7589892|NCT02038647|26402799|P2|Overall Study|Progressive Disease|59
7589893|NCT02038647|26402800|P1|Overall Study|Progressive Disease|50
7589894|NCT02038543|26402863|P4|Overall Study|Withdrawal by Subject|1
7589895|NCT02038543|26402864|P3|Overall Study|Withdrawal by Subject|0
7589896|NCT02038543|26402865|P2|Overall Study|Withdrawal by Subject|0
7589897|NCT02038543|26402866|P1|Overall Study|Withdrawal by Subject|0
7589898|NCT02038543|26402863|P4|Overall Study|Screen Failure|1
7589899|NCT02038543|26402864|P3|Overall Study|Screen Failure|0
7589900|NCT02038543|26402865|P2|Overall Study|Screen Failure|0
7589901|NCT02038543|26402866|P1|Overall Study|Screen Failure|0
7589902|NCT02038153|26402902|P1|Overall Study|Withdrawal by Subject|1
7589903|NCT02038075|26402909|P2|Overall Study|Withdrawal by Subject|0
7589904|NCT02038075|26402910|P1|Overall Study|Withdrawal by Subject|3
7589905|NCT02038049|26402918|P2|Overall Study|Lost to Follow-up|0
7589906|NCT02038049|26402919|P1|Overall Study|Lost to Follow-up|1
7589907|NCT02038036|26402943|P2|Crossover Period|Physician Decision|2
7589908|NCT02038036|26402944|P1|Crossover Period|Physician Decision|0
7589909|NCT02038036|26402943|P2|Crossover Period|Lost to Follow-up|1
7589910|NCT02038036|26402944|P1|Crossover Period|Lost to Follow-up|0
7589911|NCT02038036|26402943|P2|Crossover Period|Disease progression|3
7589912|NCT02038036|26402944|P1|Crossover Period|Disease progression|0
7589913|NCT02038036|26402943|P2|Crossover Period|Death|2
7589914|NCT02038036|26402944|P1|Crossover Period|Death|0
7589915|NCT02038036|26402943|P2|Crossover Period|Adverse Event|9
7589916|NCT02038036|26402944|P1|Crossover Period|Adverse Event|0
7589917|NCT02038036|26402943|P2|Crossover Period|Withdrawal by Subject|3
7589918|NCT02038036|26402944|P1|Crossover Period|Withdrawal by Subject|0
7589919|NCT02038036|26402943|P2|Core Study|Withdrawal by Subject|1
7589920|NCT02038036|26402944|P1|Core Study|Withdrawal by Subject|3
7589921|NCT02038036|26402943|P2|Core Study|Subject/guardian decision|1
7589922|NCT02038036|26402944|P1|Core Study|Subject/guardian decision|0
7589923|NCT02038036|26402943|P2|Core Study|Physician Decision|1
7589924|NCT02038036|26402944|P1|Core Study|Physician Decision|2
7589925|NCT02038036|26402943|P2|Core Study|Lost to Follow-up|1
7589926|NCT02038036|26402944|P1|Core Study|Lost to Follow-up|0
7589927|NCT02038036|26402943|P2|Core Study|Disease progression|2
7589928|NCT02038036|26402944|P1|Core Study|Disease progression|2
7589929|NCT02038036|26402943|P2|Core Study|Death|1
7589930|NCT02038036|26402944|P1|Core Study|Death|1
7589931|NCT02038036|26402943|P2|Core Study|Adverse Event|7
7589932|NCT02038036|26402944|P1|Core Study|Adverse Event|7
7589933|NCT02038010|26403000|P4|Follow Up|Other|0
7589934|NCT02038010|26403001|P3|Follow Up|Other|0
7589935|NCT02038010|26403002|P2|Follow Up|Other|0
7589936|NCT02038010|26403003|P1|Follow Up|Other|3
7589937|NCT02038010|26403000|P4|Follow Up|Death|0
7589938|NCT02038010|26403001|P3|Follow Up|Death|0
7589939|NCT02038010|26403002|P2|Follow Up|Death|3
7589940|NCT02038010|26403003|P1|Follow Up|Death|4
7589941|NCT02038010|26403000|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7589942|NCT02038010|26403001|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7589943|NCT02038010|26403002|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7589944|NCT02038010|26403003|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7589945|NCT02038010|26403000|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7589946|NCT02038010|26403001|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7589947|NCT02038010|26403002|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
7589948|NCT02038010|26403003|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7589949|NCT02038010|26403000|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7589950|NCT02038010|26403001|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7589951|NCT02038010|26403002|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7589952|NCT02038010|26403003|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
7589953|NCT02038010|26403000|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7589954|NCT02038010|26403001|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7589955|NCT02038010|26403002|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
7589956|NCT02038010|26403003|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7589957|NCT02037984|26403030|P8|Overall Study|Withdrawal by Subject|1
7589958|NCT02037984|26403031|P7|Overall Study|Withdrawal by Subject|0
7589959|NCT02037984|26403032|P6|Overall Study|Withdrawal by Subject|3
7589960|NCT02037984|26403033|P5|Overall Study|Withdrawal by Subject|1
7589961|NCT02037984|26403034|P4|Overall Study|Withdrawal by Subject|1
7589962|NCT02037984|26403035|P3|Overall Study|Withdrawal by Subject|0
7589963|NCT02037984|26403036|P2|Overall Study|Withdrawal by Subject|0
7589964|NCT02037984|26403037|P1|Overall Study|Withdrawal by Subject|0
7589965|NCT02037984|26403030|P8|Overall Study|Withdrawal by Parent/Guardian|2
7589966|NCT02037984|26403031|P7|Overall Study|Withdrawal by Parent/Guardian|4
7589967|NCT02037984|26403032|P6|Overall Study|Withdrawal by Parent/Guardian|1
7589968|NCT02037984|26403033|P5|Overall Study|Withdrawal by Parent/Guardian|5
7589969|NCT02037984|26403034|P4|Overall Study|Withdrawal by Parent/Guardian|2
7589970|NCT02037984|26403035|P3|Overall Study|Withdrawal by Parent/Guardian|3
7589971|NCT02037984|26403036|P2|Overall Study|Withdrawal by Parent/Guardian|0
7589972|NCT02037984|26403037|P1|Overall Study|Withdrawal by Parent/Guardian|0
7589973|NCT02037984|26403030|P8|Overall Study|Technical Problems|2
7589974|NCT02037984|26403031|P7|Overall Study|Technical Problems|4
7589975|NCT02037984|26403032|P6|Overall Study|Technical Problems|3
7589976|NCT02037984|26403033|P5|Overall Study|Technical Problems|2
7589977|NCT02037984|26403034|P4|Overall Study|Technical Problems|3
7589978|NCT02037984|26403035|P3|Overall Study|Technical Problems|3
7589979|NCT02037984|26403036|P2|Overall Study|Technical Problems|0
7589980|NCT02037984|26403037|P1|Overall Study|Technical Problems|0
7589981|NCT02037984|26403030|P8|Overall Study|Protocol Violation|0
7589982|NCT02037984|26403031|P7|Overall Study|Protocol Violation|2
7589983|NCT02037984|26403032|P6|Overall Study|Protocol Violation|1
7589984|NCT02037984|26403033|P5|Overall Study|Protocol Violation|0
7589985|NCT02037984|26403034|P4|Overall Study|Protocol Violation|0
7589986|NCT02037984|26403035|P3|Overall Study|Protocol Violation|0
7589987|NCT02037984|26403036|P2|Overall Study|Protocol Violation|0
7589988|NCT02037984|26403037|P1|Overall Study|Protocol Violation|0
7589989|NCT02037984|26403030|P8|Overall Study|Physician Decision|0
7589990|NCT02037984|26403031|P7|Overall Study|Physician Decision|1
7589991|NCT02037984|26403032|P6|Overall Study|Physician Decision|0
7589992|NCT02037984|26403033|P5|Overall Study|Physician Decision|0
7589993|NCT02037984|26403034|P4|Overall Study|Physician Decision|0
7589994|NCT02037984|26403035|P3|Overall Study|Physician Decision|0
7589995|NCT02037984|26403036|P2|Overall Study|Physician Decision|0
7589996|NCT02037984|26403037|P1|Overall Study|Physician Decision|0
7589997|NCT02037984|26403030|P8|Overall Study|Lost to Follow-up|4
7589998|NCT02037984|26403031|P7|Overall Study|Lost to Follow-up|2
7589999|NCT02037984|26403032|P6|Overall Study|Lost to Follow-up|2
7590000|NCT02037984|26403033|P5|Overall Study|Lost to Follow-up|2
7590001|NCT02037984|26403034|P4|Overall Study|Lost to Follow-up|5
7590002|NCT02037984|26403035|P3|Overall Study|Lost to Follow-up|3
7590003|NCT02037984|26403036|P2|Overall Study|Lost to Follow-up|0
7590004|NCT02037984|26403037|P1|Overall Study|Lost to Follow-up|1
7590005|NCT02037984|26403030|P8|Overall Study|Lack of Efficacy|3
7590006|NCT02037984|26403031|P7|Overall Study|Lack of Efficacy|4
7590007|NCT02037984|26403032|P6|Overall Study|Lack of Efficacy|2
7590008|NCT02037984|26403033|P5|Overall Study|Lack of Efficacy|2
7590009|NCT02037984|26403034|P4|Overall Study|Lack of Efficacy|10
7590010|NCT02037984|26403035|P3|Overall Study|Lack of Efficacy|3
7590011|NCT02037984|26403036|P2|Overall Study|Lack of Efficacy|0
7590012|NCT02037984|26403037|P1|Overall Study|Lack of Efficacy|0
7590013|NCT02037568|26403182|P2|Overall Study|Patient did not receive transplant|1
7590014|NCT02037568|26403183|P1|Overall Study|Patient did not receive transplant|0
7590015|NCT02037568|26403182|P2|Overall Study|Screen Failure|1
7590016|NCT02037568|26403183|P1|Overall Study|Screen Failure|3
7590017|NCT02037568|26403182|P2|Overall Study|Lost to Follow-up|13
7590018|NCT02037568|26403183|P1|Overall Study|Lost to Follow-up|16
7590019|NCT02037568|26403182|P2|Overall Study|Withdrawal by Subject|24
7590020|NCT02037568|26403183|P1|Overall Study|Withdrawal by Subject|17
7590021|NCT02037477|26403218|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7590022|NCT02037477|26403219|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
7590023|NCT02037477|26403220|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7590024|NCT02037477|26403221|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7590025|NCT02037295|26403316|P4|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7590026|NCT02037295|26403317|P3|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7590027|NCT02037295|26403318|P2|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7590028|NCT02037295|26403319|P1|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7590029|NCT02037256|26403341|P2|Overall Study|Withdrawn prior to Velcade|2
7590030|NCT02037256|26403342|P1|Overall Study|Withdrawn prior to Velcade|0
7590031|NCT02037256|26403341|P2|Overall Study|Protocol Violation|1
7590032|NCT02037256|26403342|P1|Overall Study|Protocol Violation|0
7590033|NCT02037165|26403386|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
7590034|NCT02037165|26403387|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7590035|NCT02037165|26403388|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7590036|NCT02037165|26403389|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7590037|NCT02037165|26403390|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7590038|NCT02036970|26403456|P10|Part 2: Week 16 Onwards|Progressive Disease|2
7590039|NCT02036970|26403457|P9|Part 2: Week 16 Onwards|Progressive Disease|0
7590040|NCT02036970|26403458|P8|Part 2: Week 16 Onwards|Progressive Disease|0
7590041|NCT02036970|26403459|P7|Part 2: Week 16 Onwards|Progressive Disease|0
7590042|NCT02036970|26403460|P6|Part 2: Week 16 Onwards|Progressive Disease|0
7590043|NCT02036970|26403461|P5|Part 2: Week 16 Onwards|Progressive Disease|0
7590044|NCT02036970|26403462|P4|Part 2: Week 16 Onwards|Progressive Disease|1
7590045|NCT02036970|26403463|P3|Part 2: Week 16 Onwards|Progressive Disease|1
7590046|NCT02036970|26403464|P2|Part 2: Week 16 Onwards|Progressive Disease|2
7590047|NCT02036970|26403465|P1|Part 2: Week 16 Onwards|Progressive Disease|0
7590048|NCT02036970|26403456|P10|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590049|NCT02036970|26403457|P9|Part 2: Week 16 Onwards|Withdrawal by Subject|3
7590050|NCT02036970|26403458|P8|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590051|NCT02036970|26403459|P7|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590052|NCT02036970|26403460|P6|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590053|NCT02036970|26403461|P5|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590054|NCT02036970|26403462|P4|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590055|NCT02036970|26403463|P3|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7590056|NCT02036970|26403464|P2|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7590057|NCT02036970|26403465|P1|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7590058|NCT02036970|26403456|P10|Part 2: Week 16 Onwards|Protocol Violation|0
7590059|NCT02036970|26403457|P9|Part 2: Week 16 Onwards|Protocol Violation|0
7590060|NCT02036970|26403458|P8|Part 2: Week 16 Onwards|Protocol Violation|1
7590061|NCT02036970|26403459|P7|Part 2: Week 16 Onwards|Protocol Violation|0
7590062|NCT02036970|26403460|P6|Part 2: Week 16 Onwards|Protocol Violation|0
7590063|NCT02036970|26403461|P5|Part 2: Week 16 Onwards|Protocol Violation|0
7590064|NCT02036970|26403462|P4|Part 2: Week 16 Onwards|Protocol Violation|0
7590065|NCT02036970|26403463|P3|Part 2: Week 16 Onwards|Protocol Violation|0
7590066|NCT02036970|26403464|P2|Part 2: Week 16 Onwards|Protocol Violation|0
7590067|NCT02036970|26403465|P1|Part 2: Week 16 Onwards|Protocol Violation|0
7590068|NCT02036970|26403456|P10|Part 2: Week 16 Onwards|Adverse Event|3
7590069|NCT02036970|26403457|P9|Part 2: Week 16 Onwards|Adverse Event|6
7590070|NCT02036970|26403458|P8|Part 2: Week 16 Onwards|Adverse Event|0
7590071|NCT02036970|26403459|P7|Part 2: Week 16 Onwards|Adverse Event|1
7590072|NCT02036970|26403460|P6|Part 2: Week 16 Onwards|Adverse Event|0
7590073|NCT02036970|26403461|P5|Part 2: Week 16 Onwards|Adverse Event|1
7590074|NCT02036970|26403462|P4|Part 2: Week 16 Onwards|Adverse Event|1
7590075|NCT02036970|26403463|P3|Part 2: Week 16 Onwards|Adverse Event|1
7590076|NCT02036970|26403464|P2|Part 2: Week 16 Onwards|Adverse Event|2
7590077|NCT02036970|26403465|P1|Part 2: Week 16 Onwards|Adverse Event|0
7590078|NCT02036970|26403456|P10|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590079|NCT02036970|26403457|P9|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590080|NCT02036970|26403458|P8|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590081|NCT02036970|26403459|P7|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590082|NCT02036970|26403460|P6|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590083|NCT02036970|26403461|P5|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590084|NCT02036970|26403462|P4|Part 1: Day 1 Through Week 16|Progressive Disease|1
7590085|NCT02036970|26403463|P3|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590086|NCT02036970|26403464|P2|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590087|NCT02036970|26403465|P1|Part 1: Day 1 Through Week 16|Progressive Disease|0
7590088|NCT02036970|26403456|P10|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
7590089|NCT02036970|26403457|P9|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
7590090|NCT02036970|26403458|P8|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590091|NCT02036970|26403459|P7|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590092|NCT02036970|26403460|P6|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590093|NCT02036970|26403461|P5|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
7590094|NCT02036970|26403462|P4|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590095|NCT02036970|26403463|P3|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590096|NCT02036970|26403464|P2|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590097|NCT02036970|26403465|P1|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7590098|NCT02036970|26403456|P10|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590099|NCT02036970|26403457|P9|Part 1: Day 1 Through Week 16|Protocol Violation|2
7590100|NCT02036970|26403458|P8|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590101|NCT02036970|26403459|P7|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590102|NCT02036970|26403460|P6|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590103|NCT02036970|26403461|P5|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590104|NCT02036970|26403462|P4|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590105|NCT02036970|26403463|P3|Part 1: Day 1 Through Week 16|Protocol Violation|1
7590106|NCT02036970|26403464|P2|Part 1: Day 1 Through Week 16|Protocol Violation|0
7590107|NCT02036970|26403465|P1|Part 1: Day 1 Through Week 16|Protocol Violation|1
7590108|NCT02036970|26403456|P10|Part 1: Day 1 Through Week 16|Death|0
7590109|NCT02036970|26403457|P9|Part 1: Day 1 Through Week 16|Death|1
7590110|NCT02036970|26403458|P8|Part 1: Day 1 Through Week 16|Death|0
7590111|NCT02036970|26403459|P7|Part 1: Day 1 Through Week 16|Death|0
7590112|NCT02036970|26403460|P6|Part 1: Day 1 Through Week 16|Death|0
7590113|NCT02036970|26403461|P5|Part 1: Day 1 Through Week 16|Death|0
7590114|NCT02036970|26403462|P4|Part 1: Day 1 Through Week 16|Death|0
7590115|NCT02036970|26403463|P3|Part 1: Day 1 Through Week 16|Death|0
7590116|NCT02036970|26403464|P2|Part 1: Day 1 Through Week 16|Death|0
7590117|NCT02036970|26403465|P1|Part 1: Day 1 Through Week 16|Death|0
7590118|NCT02036970|26403456|P10|Part 1: Day 1 Through Week 16|Adverse Event|1
7590119|NCT02036970|26403457|P9|Part 1: Day 1 Through Week 16|Adverse Event|3
7590120|NCT02036970|26403458|P8|Part 1: Day 1 Through Week 16|Adverse Event|1
7590121|NCT02036970|26403459|P7|Part 1: Day 1 Through Week 16|Adverse Event|0
7590122|NCT02036970|26403460|P6|Part 1: Day 1 Through Week 16|Adverse Event|1
7590123|NCT02036970|26403461|P5|Part 1: Day 1 Through Week 16|Adverse Event|0
7590124|NCT02036970|26403462|P4|Part 1: Day 1 Through Week 16|Adverse Event|2
7590125|NCT02036970|26403463|P3|Part 1: Day 1 Through Week 16|Adverse Event|3
7590126|NCT02036970|26403464|P2|Part 1: Day 1 Through Week 16|Adverse Event|0
7590127|NCT02036970|26403465|P1|Part 1: Day 1 Through Week 16|Adverse Event|0
7590128|NCT02036853|26403499|P2|Overall Study|Withdrawal by Subject|1
7590129|NCT02036853|26403500|P1|Overall Study|Withdrawal by Subject|0
7590130|NCT02036853|26403499|P2|Overall Study|Physician Decision|1
7590131|NCT02036853|26403500|P1|Overall Study|Physician Decision|0
7590132|NCT02036853|26403499|P2|Overall Study|Lack of Efficacy|2
7590133|NCT02036853|26403500|P1|Overall Study|Lack of Efficacy|0
7590134|NCT02036853|26403499|P2|Overall Study|Adverse Event|2
7590135|NCT02036853|26403500|P1|Overall Study|Adverse Event|0
7590136|NCT02036775|26403524|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
7590137|NCT02036775|26403525|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7590138|NCT02036775|26403526|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7590139|NCT02036775|26403527|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7590140|NCT02036775|26403528|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7590141|NCT02036775|26403529|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7590142|NCT02036645|26403579|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590143|NCT02036645|26403580|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590144|NCT02036645|26403581|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590145|NCT02036645|26403582|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590146|NCT02036645|26403583|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590147|NCT02036645|26403584|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590148|NCT02036645|26403585|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590149|NCT02036645|26403586|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590150|NCT02036645|26403587|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
7590151|NCT02036645|26403588|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590152|NCT02036645|26403589|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590153|NCT02036645|26403590|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7590154|NCT02036645|26403579|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590155|NCT02036645|26403580|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590156|NCT02036645|26403581|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590157|NCT02036645|26403582|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590158|NCT02036645|26403583|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590159|NCT02036645|26403584|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
7590160|NCT02036645|26403585|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590161|NCT02036645|26403586|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590162|NCT02036645|26403587|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590163|NCT02036645|26403588|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590164|NCT02036645|26403589|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590165|NCT02036645|26403590|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7590166|NCT02036580|26403695|P3|Overall Study|Adverse Event|0
7590167|NCT02036580|26403696|P2|Overall Study|Adverse Event|0
7590168|NCT02036580|26403697|P1|Overall Study|Adverse Event|1
7590169|NCT02036580|26403695|P3|Overall Study|Withdrawal by Subject|0
7590170|NCT02036580|26403696|P2|Overall Study|Withdrawal by Subject|1
7590171|NCT02036580|26403697|P1|Overall Study|Withdrawal by Subject|0
7590172|NCT02036515|26403718|P3|Overall Study|Hyperglycemia|1
7590173|NCT02036515|26403719|P2|Overall Study|Hyperglycemia|0
7590174|NCT02036515|26403720|P1|Overall Study|Hyperglycemia|0
7590175|NCT02036515|26403718|P3|Overall Study|Withdrawal by Subject|9
7590176|NCT02036515|26403719|P2|Overall Study|Withdrawal by Subject|7
7590177|NCT02036515|26403720|P1|Overall Study|Withdrawal by Subject|4
7590178|NCT02036515|26403718|P3|Overall Study|Screen failure|0
7590179|NCT02036515|26403719|P2|Overall Study|Screen failure|2
7590180|NCT02036515|26403720|P1|Overall Study|Screen failure|0
7590181|NCT02036515|26403718|P3|Overall Study|Non-compliance with study drug|2
7590182|NCT02036515|26403719|P2|Overall Study|Non-compliance with study drug|0
7590183|NCT02036515|26403720|P1|Overall Study|Non-compliance with study drug|0
7590184|NCT02036515|26403718|P3|Overall Study|Lost to Follow-up|0
7590185|NCT02036515|26403719|P2|Overall Study|Lost to Follow-up|2
7590186|NCT02036515|26403720|P1|Overall Study|Lost to Follow-up|0
7590187|NCT02036515|26403718|P3|Overall Study|Adverse Event|2
7590188|NCT02036515|26403719|P2|Overall Study|Adverse Event|1
7590189|NCT02036515|26403720|P1|Overall Study|Adverse Event|1
7590190|NCT02036502|26403805|P8|Part 3:Dose Expansion|Not Treated|0
7590191|NCT02036502|26403806|P7|Part 3:Dose Expansion|Not Treated|0
7590192|NCT02036502|26403807|P6|Part 3:Dose Expansion|Not Treated|2
7590193|NCT02036502|26403808|P5|Part 3:Dose Expansion|Not Treated|0
7590194|NCT02036502|26403809|P4|Part 3:Dose Expansion|Not Treated|0
7590195|NCT02036502|26403810|P3|Part 3:Dose Expansion|Not Treated|0
7590196|NCT02036502|26403811|P2|Part 3:Dose Expansion|Not Treated|0
7590197|NCT02036502|26403812|P1|Part 3:Dose Expansion|Not Treated|0
7590198|NCT02036502|26403805|P8|Part 3:Dose Expansion|Withdrawal by Subject|2
7590199|NCT02036502|26403806|P7|Part 3:Dose Expansion|Withdrawal by Subject|1
7590200|NCT02036502|26403807|P6|Part 3:Dose Expansion|Withdrawal by Subject|4
7590201|NCT02036502|26403808|P5|Part 3:Dose Expansion|Withdrawal by Subject|0
7590202|NCT02036502|26403809|P4|Part 3:Dose Expansion|Withdrawal by Subject|0
7590203|NCT02036502|26403810|P3|Part 3:Dose Expansion|Withdrawal by Subject|0
7590204|NCT02036502|26403811|P2|Part 3:Dose Expansion|Withdrawal by Subject|0
7590205|NCT02036502|26403812|P1|Part 3:Dose Expansion|Withdrawal by Subject|0
7590206|NCT02036502|26403805|P8|Part 3:Dose Expansion|Study Terminated by Sponsor|2
7590207|NCT02036502|26403806|P7|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7590208|NCT02036502|26403807|P6|Part 3:Dose Expansion|Study Terminated by Sponsor|11
7590209|NCT02036502|26403808|P5|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7590210|NCT02036502|26403809|P4|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7590211|NCT02036502|26403810|P3|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7590212|NCT02036502|26403811|P2|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7590213|NCT02036502|26403812|P1|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7590214|NCT02036502|26403805|P8|Part 3:Dose Expansion|Progressive Disease|0
7590215|NCT02036502|26403806|P7|Part 3:Dose Expansion|Progressive Disease|0
7590216|NCT02036502|26403807|P6|Part 3:Dose Expansion|Progressive Disease|1
7590217|NCT02036502|26403808|P5|Part 3:Dose Expansion|Progressive Disease|0
7590218|NCT02036502|26403809|P4|Part 3:Dose Expansion|Progressive Disease|0
7590219|NCT02036502|26403810|P3|Part 3:Dose Expansion|Progressive Disease|0
7590220|NCT02036502|26403811|P2|Part 3:Dose Expansion|Progressive Disease|0
7590221|NCT02036502|26403812|P1|Part 3:Dose Expansion|Progressive Disease|0
7590222|NCT02036502|26403805|P8|Part 3:Dose Expansion|Physician Decision|0
7590223|NCT02036502|26403806|P7|Part 3:Dose Expansion|Physician Decision|0
7590224|NCT02036502|26403807|P6|Part 3:Dose Expansion|Physician Decision|1
7590225|NCT02036502|26403808|P5|Part 3:Dose Expansion|Physician Decision|0
7590226|NCT02036502|26403809|P4|Part 3:Dose Expansion|Physician Decision|0
7590227|NCT02036502|26403810|P3|Part 3:Dose Expansion|Physician Decision|0
7590228|NCT02036502|26403811|P2|Part 3:Dose Expansion|Physician Decision|0
7590229|NCT02036502|26403812|P1|Part 3:Dose Expansion|Physician Decision|0
7590230|NCT02036502|26403805|P8|Part 3:Dose Expansion|Lost to Follow-up|1
7590231|NCT02036502|26403806|P7|Part 3:Dose Expansion|Lost to Follow-up|0
7590232|NCT02036502|26403807|P6|Part 3:Dose Expansion|Lost to Follow-up|0
7590233|NCT02036502|26403808|P5|Part 3:Dose Expansion|Lost to Follow-up|0
7590234|NCT02036502|26403809|P4|Part 3:Dose Expansion|Lost to Follow-up|0
7590235|NCT02036502|26403810|P3|Part 3:Dose Expansion|Lost to Follow-up|0
7590236|NCT02036502|26403811|P2|Part 3:Dose Expansion|Lost to Follow-up|0
7590237|NCT02036502|26403812|P1|Part 3:Dose Expansion|Lost to Follow-up|0
7590238|NCT02036502|26403805|P8|Part 3:Dose Expansion|Death|3
7590239|NCT02036502|26403806|P7|Part 3:Dose Expansion|Death|0
7590240|NCT02036502|26403807|P6|Part 3:Dose Expansion|Death|24
7590241|NCT02036502|26403808|P5|Part 3:Dose Expansion|Death|0
7590242|NCT02036502|26403809|P4|Part 3:Dose Expansion|Death|0
7590243|NCT02036502|26403810|P3|Part 3:Dose Expansion|Death|0
7590244|NCT02036502|26403811|P2|Part 3:Dose Expansion|Death|0
7590245|NCT02036502|26403812|P1|Part 3:Dose Expansion|Death|0
7590246|NCT02036502|26403805|P8|Part 3:Dose Expansion|Adverse Event|2
7590247|NCT02036502|26403806|P7|Part 3:Dose Expansion|Adverse Event|0
7590248|NCT02036502|26403807|P6|Part 3:Dose Expansion|Adverse Event|4
7590249|NCT02036502|26403808|P5|Part 3:Dose Expansion|Adverse Event|0
7590250|NCT02036502|26403809|P4|Part 3:Dose Expansion|Adverse Event|0
7590251|NCT02036502|26403810|P3|Part 3:Dose Expansion|Adverse Event|0
7590252|NCT02036502|26403811|P2|Part 3:Dose Expansion|Adverse Event|0
7590253|NCT02036502|26403812|P1|Part 3:Dose Expansion|Adverse Event|0
7590254|NCT02036502|26403805|P8|Part 2:Dose Confirmation|Not treated|0
7590255|NCT02036502|26403806|P7|Part 2:Dose Confirmation|Not treated|0
7590256|NCT02036502|26403807|P6|Part 2:Dose Confirmation|Not treated|0
7590257|NCT02036502|26403808|P5|Part 2:Dose Confirmation|Not treated|0
7590258|NCT02036502|26403809|P4|Part 2:Dose Confirmation|Not treated|1
7590259|NCT02036502|26403810|P3|Part 2:Dose Confirmation|Not treated|0
7590260|NCT02036502|26403811|P2|Part 2:Dose Confirmation|Not treated|0
7590261|NCT02036502|26403812|P1|Part 2:Dose Confirmation|Not treated|0
7590262|NCT02036502|26403805|P8|Part 2:Dose Confirmation|Death|0
7590263|NCT02036502|26403806|P7|Part 2:Dose Confirmation|Death|0
7590264|NCT02036502|26403807|P6|Part 2:Dose Confirmation|Death|0
7590265|NCT02036502|26403808|P5|Part 2:Dose Confirmation|Death|0
7590266|NCT02036502|26403809|P4|Part 2:Dose Confirmation|Death|0
7590267|NCT02036502|26403810|P3|Part 2:Dose Confirmation|Death|1
7590268|NCT02036502|26403811|P2|Part 2:Dose Confirmation|Death|0
7590269|NCT02036502|26403812|P1|Part 2:Dose Confirmation|Death|0
7590270|NCT02036502|26403805|P8|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590271|NCT02036502|26403806|P7|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590272|NCT02036502|26403807|P6|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590273|NCT02036502|26403808|P5|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590274|NCT02036502|26403809|P4|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590275|NCT02036502|26403810|P3|Part 2:Dose Confirmation|Withdrawal by Subject|3
7590276|NCT02036502|26403811|P2|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590277|NCT02036502|26403812|P1|Part 2:Dose Confirmation|Withdrawal by Subject|0
7590278|NCT02036502|26403805|P8|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7590279|NCT02036502|26403806|P7|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7590280|NCT02036502|26403807|P6|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7590281|NCT02036502|26403808|P5|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7590282|NCT02036502|26403809|P4|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7590283|NCT02036502|26403810|P3|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
7590284|NCT02036502|26403811|P2|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7590285|NCT02036502|26403812|P1|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7590286|NCT02036502|26403805|P8|Part 1:Dose Determination/Escalation|Not treated|0
7590287|NCT02036502|26403806|P7|Part 1:Dose Determination/Escalation|Not treated|0
7590288|NCT02036502|26403807|P6|Part 1:Dose Determination/Escalation|Not treated|0
7590289|NCT02036502|26403808|P5|Part 1:Dose Determination/Escalation|Not treated|0
7590290|NCT02036502|26403809|P4|Part 1:Dose Determination/Escalation|Not treated|0
7590291|NCT02036502|26403810|P3|Part 1:Dose Determination/Escalation|Not treated|0
7590292|NCT02036502|26403811|P2|Part 1:Dose Determination/Escalation|Not treated|1
7590293|NCT02036502|26403812|P1|Part 1:Dose Determination/Escalation|Not treated|0
7590294|NCT02036502|26403805|P8|Part 1:Dose Determination/Escalation|Adverse Event|0
7590295|NCT02036502|26403806|P7|Part 1:Dose Determination/Escalation|Adverse Event|0
7590296|NCT02036502|26403807|P6|Part 1:Dose Determination/Escalation|Adverse Event|0
7590297|NCT02036502|26403808|P5|Part 1:Dose Determination/Escalation|Adverse Event|0
7590298|NCT02036502|26403809|P4|Part 1:Dose Determination/Escalation|Adverse Event|0
7590299|NCT02036502|26403810|P3|Part 1:Dose Determination/Escalation|Adverse Event|0
7590300|NCT02036502|26403811|P2|Part 1:Dose Determination/Escalation|Adverse Event|1
7590301|NCT02036502|26403812|P1|Part 1:Dose Determination/Escalation|Adverse Event|0
7590302|NCT02036502|26403805|P8|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590303|NCT02036502|26403806|P7|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590304|NCT02036502|26403807|P6|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590305|NCT02036502|26403808|P5|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590306|NCT02036502|26403809|P4|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590307|NCT02036502|26403810|P3|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590308|NCT02036502|26403811|P2|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7590309|NCT02036502|26403812|P1|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
7590310|NCT02036502|26403805|P8|Part 1:Dose Determination/Escalation|Death|0
7590311|NCT02036502|26403806|P7|Part 1:Dose Determination/Escalation|Death|0
7590312|NCT02036502|26403807|P6|Part 1:Dose Determination/Escalation|Death|0
7590313|NCT02036502|26403808|P5|Part 1:Dose Determination/Escalation|Death|0
7590314|NCT02036502|26403809|P4|Part 1:Dose Determination/Escalation|Death|0
7590315|NCT02036502|26403810|P3|Part 1:Dose Determination/Escalation|Death|0
7590316|NCT02036502|26403811|P2|Part 1:Dose Determination/Escalation|Death|2
7590317|NCT02036502|26403812|P1|Part 1:Dose Determination/Escalation|Death|3
7590318|NCT02036294|26403930|P2|Overall Study|Withdrawal by Subject|3
7590319|NCT02036294|26403931|P1|Overall Study|Withdrawal by Subject|2
7590320|NCT02036294|26403930|P2|Overall Study|Death|8
7590321|NCT02036294|26403931|P1|Overall Study|Death|7
7590322|NCT02035748|26403947|P1|Overall Study|Progressive Disease|1
7590323|NCT02035748|26403947|P1|Overall Study|Withdrawal by Subject|6
7590324|NCT02035748|26403947|P1|Overall Study|Physician Decision|3
7590325|NCT02035748|26403947|P1|Overall Study|Lost to Follow-up|2
7590326|NCT02035748|26403947|P1|Overall Study|Death|3
7590327|NCT02035748|26403947|P1|Overall Study|Adverse Event|5
7590328|NCT02035696|26403961|P4|Overall Study|Withdrawal by Subject|1
7590329|NCT02035696|26403962|P3|Overall Study|Withdrawal by Subject|2
7590330|NCT02035696|26403963|P2|Overall Study|Withdrawal by Subject|0
7590331|NCT02035696|26403964|P1|Overall Study|Withdrawal by Subject|3
7590332|NCT02035696|26403961|P4|Overall Study|Lost to Follow-up|2
7590333|NCT02035696|26403962|P3|Overall Study|Lost to Follow-up|1
7590334|NCT02035696|26403963|P2|Overall Study|Lost to Follow-up|3
7590335|NCT02035696|26403964|P1|Overall Study|Lost to Follow-up|0
7590336|NCT02035553|26404020|P2|Overall Study|Other Reason|4
7590337|NCT02035553|26404021|P1|Overall Study|Other Reason|0
7590338|NCT02035553|26404020|P2|Overall Study|Lost to Follow-up|1
7590339|NCT02035553|26404021|P1|Overall Study|Lost to Follow-up|0
7590340|NCT02035553|26404020|P2|Overall Study|Non-compliance with Study Drug|1
7590341|NCT02035553|26404021|P1|Overall Study|Non-compliance with Study Drug|0
7590342|NCT02035553|26404020|P2|Overall Study|Withdrawal by Subject|7
7590343|NCT02035553|26404021|P1|Overall Study|Withdrawal by Subject|4
7590344|NCT02035553|26404020|P2|Overall Study|Lack of Efficacy|1
7590345|NCT02035553|26404021|P1|Overall Study|Lack of Efficacy|1
7590346|NCT02035553|26404020|P2|Overall Study|Physician Decision|2
7590347|NCT02035553|26404021|P1|Overall Study|Physician Decision|3
7590348|NCT02035553|26404020|P2|Overall Study|Adverse Event|6
7590349|NCT02035553|26404021|P1|Overall Study|Adverse Event|10
7590350|NCT02035553|26404020|P2|Overall Study|Death (See All-Cause Mortality Table)|1
7590351|NCT02035553|26404021|P1|Overall Study|Death (See All-Cause Mortality Table)|0
7590352|NCT02035475|26404027|P1|Overall Study|Equipment Error|1
7590353|NCT02035475|26404027|P1|Overall Study|Physician Decision|1
7590354|NCT02035475|26404027|P1|Overall Study|Withdrawal by Subject|4
7590355|NCT02035332|26404038|P1|Overall Study|Procedure Aborted due to Uterine Width|1
7590356|NCT02035267|26404048|P4|Overall Study|Other unspecified|0
7590357|NCT02035267|26404049|P3|Overall Study|Other unspecified|0
7590358|NCT02035267|26404050|P2|Overall Study|Other unspecified|1
7590359|NCT02035267|26404051|P1|Overall Study|Other unspecified|0
7590360|NCT02035267|26404048|P4|Overall Study|Lost to Follow-up|1
7590361|NCT02035267|26404049|P3|Overall Study|Lost to Follow-up|0
7590362|NCT02035267|26404050|P2|Overall Study|Lost to Follow-up|0
7590363|NCT02035267|26404051|P1|Overall Study|Lost to Follow-up|0
7590364|NCT02035267|26404048|P4|Overall Study|Adverse Event|0
7590365|NCT02035267|26404049|P3|Overall Study|Adverse Event|1
7590366|NCT02035267|26404050|P2|Overall Study|Adverse Event|0
7590367|NCT02035267|26404051|P1|Overall Study|Adverse Event|0
7590368|NCT02035267|26404048|P4|Overall Study|Withdrawal consent-subject convenience|0
7590369|NCT02035267|26404049|P3|Overall Study|Withdrawal consent-subject convenience|1
7590370|NCT02035267|26404050|P2|Overall Study|Withdrawal consent-subject convenience|0
7590371|NCT02035267|26404051|P1|Overall Study|Withdrawal consent-subject convenience|0
7590372|NCT02035202|26404082|P3|Overall Study|Lost to Follow-up|2
7590373|NCT02035202|26404083|P2|Overall Study|Lost to Follow-up|16
7590374|NCT02035202|26404084|P1|Overall Study|Lost to Follow-up|8
7590375|NCT02034916|26404100|P2|Overall Study|Study terminated by sponsor|5
7590376|NCT02034916|26404101|P1|Overall Study|Study terminated by sponsor|4
7590377|NCT02034916|26404100|P2|Overall Study|Lost to Follow-up|1
7590378|NCT02034916|26404101|P1|Overall Study|Lost to Follow-up|4
7590379|NCT02034916|26404100|P2|Overall Study|Withdrawal by Subject|1
7590380|NCT02034916|26404101|P1|Overall Study|Withdrawal by Subject|2
7590381|NCT02034916|26404100|P2|Overall Study|Death|28
7590382|NCT02034916|26404101|P1|Overall Study|Death|39
7590383|NCT02034877|26404138|P2|Overall Study|No Longer Willing to Participate|3
7590384|NCT02034877|26404139|P1|Overall Study|No Longer Willing to Participate|0
7590385|NCT02034877|26404138|P2|Overall Study|Lost to Follow-up|3
7590386|NCT02034877|26404139|P1|Overall Study|Lost to Follow-up|0
7590387|NCT02034799|26404157|P2|Overall Study|Death|1
7590388|NCT02034799|26404158|P1|Overall Study|Death|2
7590389|NCT02034799|26404157|P2|Overall Study|Lost to Follow-up|1
7590390|NCT02034799|26404158|P1|Overall Study|Lost to Follow-up|0
7590391|NCT02034799|26404157|P2|Overall Study|Withdrawal by Subject|2
7590392|NCT02034799|26404158|P1|Overall Study|Withdrawal by Subject|0
7590393|NCT02034708|26404172|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
7590394|NCT02034708|26404173|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
7590395|NCT02034708|26404172|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7590396|NCT02034708|26404173|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7590397|NCT02034708|26404172|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
7590398|NCT02034708|26404173|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
7590399|NCT02034708|26404172|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
7590400|NCT02034708|26404173|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
7590401|NCT02034591|26404184|P6|Overall Study|Withdrawal by Subject|0
7590402|NCT02034591|26404185|P5|Overall Study|Withdrawal by Subject|1
7590403|NCT02034591|26404186|P4|Overall Study|Withdrawal by Subject|0
7590404|NCT02034591|26404187|P3|Overall Study|Withdrawal by Subject|0
7590405|NCT02034591|26404188|P2|Overall Study|Withdrawal by Subject|0
7590406|NCT02034591|26404189|P1|Overall Study|Withdrawal by Subject|0
7590407|NCT02034565|26404244|P2|Overall Study|Adverse Event|0
7590408|NCT02034565|26404245|P1|Overall Study|Adverse Event|1
7590409|NCT02034552|26404262|P3|Overall Study|Clinical progression|9
7590410|NCT02034552|26404263|P2|Overall Study|Clinical progression|7
7590411|NCT02034552|26404264|P1|Overall Study|Clinical progression|5
7590412|NCT02034552|26404262|P3|Overall Study|Non-compliance with study drug|1
7590413|NCT02034552|26404263|P2|Overall Study|Non-compliance with study drug|0
7590414|NCT02034552|26404264|P1|Overall Study|Non-compliance with study drug|0
7590415|NCT02034552|26404262|P3|Overall Study|Withdrawal by Subject|1
7590416|NCT02034552|26404263|P2|Overall Study|Withdrawal by Subject|1
7590417|NCT02034552|26404264|P1|Overall Study|Withdrawal by Subject|2
7590418|NCT02034552|26404262|P3|Overall Study|AE associated with disease progression|0
7590419|NCT02034552|26404263|P2|Overall Study|AE associated with disease progression|1
7590420|NCT02034552|26404264|P1|Overall Study|AE associated with disease progression|0
7590421|NCT02034552|26404262|P3|Overall Study|AE not assoc. with disease progression|2
7590422|NCT02034552|26404263|P2|Overall Study|AE not assoc. with disease progression|4
7590423|NCT02034552|26404264|P1|Overall Study|AE not assoc. with disease progression|1
7590424|NCT02034552|26404262|P3|Overall Study|Radiological progression|4
7590425|NCT02034552|26404263|P2|Overall Study|Radiological progression|5
7590426|NCT02034552|26404264|P1|Overall Study|Radiological progression|3
7590427|NCT02034552|26404262|P3|Overall Study|Never treated|0
7590428|NCT02034552|26404263|P2|Overall Study|Never treated|2
7590429|NCT02034552|26404264|P1|Overall Study|Never treated|3
7590430|NCT02034513|26404295|P2|Overall Study|Unclassified|1
7590431|NCT02034513|26404296|P1|Overall Study|Unclassified|0
7590432|NCT02034513|26404295|P2|Overall Study|Withdrawal by Subject|25
7590433|NCT02034513|26404296|P1|Overall Study|Withdrawal by Subject|25
7590434|NCT02034513|26404295|P2|Overall Study|Protocol Violation|10
7590435|NCT02034513|26404296|P1|Overall Study|Protocol Violation|7
7590436|NCT02034513|26404295|P2|Overall Study|Pregnancy|3
7590437|NCT02034513|26404296|P1|Overall Study|Pregnancy|0
7590438|NCT02034513|26404295|P2|Overall Study|Lost to Follow-up|7
7590439|NCT02034513|26404296|P1|Overall Study|Lost to Follow-up|6
7590440|NCT02034513|26404295|P2|Overall Study|Lack of Efficacy|1
7590441|NCT02034513|26404296|P1|Overall Study|Lack of Efficacy|0
7590442|NCT02034513|26404295|P2|Overall Study|Adverse Event|10
7590443|NCT02034513|26404296|P1|Overall Study|Adverse Event|11
7590444|NCT02034474|26404314|P2|Overall Study|Withdrawal by Subject|2
7590445|NCT02034474|26404315|P1|Overall Study|Withdrawal by Subject|1
7590446|NCT02034474|26404314|P2|Overall Study|Adverse Event|2
7590447|NCT02034474|26404315|P1|Overall Study|Adverse Event|3
7590448|NCT02034435|26404327|P4|Overall Study|Inadequate IV access|1
7590449|NCT02034435|26404328|P3|Overall Study|Inadequate IV access|0
7590450|NCT02034435|26404329|P2|Overall Study|Inadequate IV access|0
7590451|NCT02034435|26404330|P1|Overall Study|Inadequate IV access|1
7590452|NCT02034435|26404327|P4|Overall Study|Illness|0
7590453|NCT02034435|26404328|P3|Overall Study|Illness|0
7590454|NCT02034435|26404329|P2|Overall Study|Illness|2
7590455|NCT02034435|26404330|P1|Overall Study|Illness|0
7590456|NCT02034435|26404327|P4|Overall Study|Withdrawal by Subject|0
7590457|NCT02034435|26404328|P3|Overall Study|Withdrawal by Subject|0
7590458|NCT02034435|26404329|P2|Overall Study|Withdrawal by Subject|0
7590459|NCT02034435|26404330|P1|Overall Study|Withdrawal by Subject|1
7590460|NCT02034162|26404350|P3|Double-blind|Withdrawal by Subject|0
7590461|NCT02034162|26404351|P2|Double-blind|Withdrawal by Subject|7
7590462|NCT02034162|26404352|P1|Double-blind|Withdrawal by Subject|5
7590463|NCT02034162|26404350|P3|Double-blind|Protocol Violation|0
7590464|NCT02034162|26404351|P2|Double-blind|Protocol Violation|1
7590465|NCT02034162|26404352|P1|Double-blind|Protocol Violation|0
7590466|NCT02034162|26404350|P3|Double-blind|Physician Decision|0
7590467|NCT02034162|26404351|P2|Double-blind|Physician Decision|0
7590468|NCT02034162|26404352|P1|Double-blind|Physician Decision|1
7590469|NCT02034162|26404350|P3|Double-blind|Lost to Follow-up|0
7590470|NCT02034162|26404351|P2|Double-blind|Lost to Follow-up|0
7590471|NCT02034162|26404352|P1|Double-blind|Lost to Follow-up|3
7590472|NCT02034123|26404398|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590473|NCT02034123|26404399|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590474|NCT02034123|26404400|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590475|NCT02034123|26404401|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590476|NCT02034123|26404402|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590477|NCT02034123|26404403|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590478|NCT02034123|26404404|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590479|NCT02034123|26404405|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590480|NCT02034123|26404406|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590481|NCT02034123|26404407|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590482|NCT02034123|26404408|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590483|NCT02034123|26404409|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590484|NCT02034123|26404410|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590485|NCT02034123|26404411|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7590486|NCT02034123|26404412|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7590487|NCT02034123|26404413|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590488|NCT02034123|26404414|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590489|NCT02034123|26404415|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7590490|NCT02034123|26404398|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590491|NCT02034123|26404399|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590492|NCT02034123|26404400|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590493|NCT02034123|26404401|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590494|NCT02034123|26404402|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590495|NCT02034123|26404403|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590496|NCT02034123|26404404|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590497|NCT02034123|26404405|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590498|NCT02034123|26404406|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590499|NCT02034123|26404407|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
7590500|NCT02034123|26404408|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590501|NCT02034123|26404409|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590502|NCT02034123|26404410|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590503|NCT02034123|26404411|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590504|NCT02034123|26404412|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590505|NCT02034123|26404413|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590506|NCT02034123|26404414|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590507|NCT02034123|26404415|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7590508|NCT02034123|26404398|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590509|NCT02034123|26404399|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590510|NCT02034123|26404400|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590511|NCT02034123|26404401|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590512|NCT02034123|26404402|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590513|NCT02034123|26404403|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590514|NCT02034123|26404404|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590515|NCT02034123|26404405|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590516|NCT02034123|26404406|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590517|NCT02034123|26404407|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590518|NCT02034123|26404408|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590519|NCT02034123|26404409|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590520|NCT02034123|26404410|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590521|NCT02034123|26404411|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590522|NCT02034123|26404412|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
7590523|NCT02034123|26404413|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590524|NCT02034123|26404414|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590525|NCT02034123|26404415|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7590526|NCT02034123|26404398|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590527|NCT02034123|26404399|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590528|NCT02034123|26404400|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590529|NCT02034123|26404401|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590530|NCT02034123|26404402|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590531|NCT02034123|26404403|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590532|NCT02034123|26404404|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590533|NCT02034123|26404405|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590534|NCT02034123|26404406|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590535|NCT02034123|26404407|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7590536|NCT02034123|26404408|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7590537|NCT02034123|26404409|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590538|NCT02034123|26404410|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590539|NCT02034123|26404411|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7590540|NCT02034123|26404412|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590541|NCT02034123|26404413|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590542|NCT02034123|26404414|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590543|NCT02034123|26404415|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7590544|NCT02034058|26404734|P1|Overall Study|Death|3
7590545|NCT02034006|26404755|P1|Overall Study|Pregnancy|1
7590546|NCT02034006|26404755|P1|Overall Study|Death|1
7590547|NCT02034006|26404755|P1|Overall Study|Lost to Follow-up|5
7590548|NCT02034006|26404755|P1|Overall Study|Withdrawal by Subject|7
7590549|NCT02033889|26404806|P3|Overall Study|Withdrawal by Subject|13
7590550|NCT02033889|26404807|P2|Overall Study|Withdrawal by Subject|10
7590551|NCT02033889|26404808|P1|Overall Study|Withdrawal by Subject|18
7590552|NCT02033889|26404806|P3|Overall Study|Participant moved|0
7590553|NCT02033889|26404807|P2|Overall Study|Participant moved|1
7590554|NCT02033889|26404808|P1|Overall Study|Participant moved|0
7590555|NCT02033889|26404806|P3|Overall Study|Physician Decision|1
7590556|NCT02033889|26404807|P2|Overall Study|Physician Decision|1
7590557|NCT02033889|26404808|P1|Overall Study|Physician Decision|0
7590558|NCT02033889|26404806|P3|Overall Study|Non-Compliance With Study Drug|0
7590559|NCT02033889|26404807|P2|Overall Study|Non-Compliance With Study Drug|0
7590560|NCT02033889|26404808|P1|Overall Study|Non-Compliance With Study Drug|1
7590561|NCT02033889|26404806|P3|Overall Study|Lost to Follow-up|6
7590562|NCT02033889|26404807|P2|Overall Study|Lost to Follow-up|5
7590563|NCT02033889|26404808|P1|Overall Study|Lost to Follow-up|8
7590564|NCT02033889|26404806|P3|Overall Study|Excluded Medication|0
7590565|NCT02033889|26404807|P2|Overall Study|Excluded Medication|1
7590566|NCT02033889|26404808|P1|Overall Study|Excluded Medication|1
7590567|NCT02033889|26404806|P3|Overall Study|Death|2
7590568|NCT02033889|26404807|P2|Overall Study|Death|1
7590569|NCT02033889|26404808|P1|Overall Study|Death|3
7590570|NCT02033889|26404806|P3|Overall Study|Adverse Event|3
7590571|NCT02033889|26404807|P2|Overall Study|Adverse Event|1
7590572|NCT02033889|26404808|P1|Overall Study|Adverse Event|3
7590573|NCT02033850|26404985|P2|Overall Study|unrelated medical reason|1
7590574|NCT02033850|26404986|P1|Overall Study|unrelated medical reason|1
7590575|NCT02033850|26404985|P2|Overall Study|Death|0
7590576|NCT02033850|26404986|P1|Overall Study|Death|1
7590577|NCT02033759|26405010|P2|Overall Study|Protocol Violation|1
7590578|NCT02033759|26405011|P1|Overall Study|Protocol Violation|1
7590579|NCT02033759|26405010|P2|Overall Study|Withdrawal by Subject|1
7590580|NCT02033759|26405011|P1|Overall Study|Withdrawal by Subject|2
7590581|NCT02033369|26405092|P2|Overall Study|Protocol Violation|0
7590582|NCT02033369|26405093|P1|Overall Study|Protocol Violation|2
7590583|NCT02033369|26405092|P2|Overall Study|Lost to Follow-up|0
7590584|NCT02033369|26405093|P1|Overall Study|Lost to Follow-up|1
7590585|NCT02033369|26405092|P2|Overall Study|Withdrawal by Subject|1
7590586|NCT02033369|26405093|P1|Overall Study|Withdrawal by Subject|1
7590587|NCT02033369|26405092|P2|Overall Study|Not a good demographic match|2
7590588|NCT02033369|26405093|P1|Overall Study|Not a good demographic match|0
7590589|NCT02033369|26405092|P2|Overall Study|Physician Decision|2
7590590|NCT02033369|26405093|P1|Overall Study|Physician Decision|1
7590591|NCT02032901|26405187|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
7590592|NCT02032901|26405188|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
7590593|NCT02032901|26405187|P2|Treatment Period (12 Weeks)|Pregnancy|0
7590594|NCT02032901|26405188|P1|Treatment Period (12 Weeks)|Pregnancy|1
7590595|NCT02032888|26405212|P3|Follow-up Period|Other|0
7590596|NCT02032888|26405213|P2|Follow-up Period|Other|0
7590597|NCT02032888|26405214|P1|Follow-up Period|Other|1
7590598|NCT02032888|26405212|P3|Follow-up Period|Death|0
7590599|NCT02032888|26405213|P2|Follow-up Period|Death|1
7590600|NCT02032888|26405214|P1|Follow-up Period|Death|1
7590601|NCT02032888|26405212|P3|Follow-up Period|Lost to Follow-up|0
7590602|NCT02032888|26405213|P2|Follow-up Period|Lost to Follow-up|1
7590603|NCT02032888|26405214|P1|Follow-up Period|Lost to Follow-up|1
7590604|NCT02032888|26405212|P3|Treatment Period|Other|0
7590605|NCT02032888|26405213|P2|Treatment Period|Other|1
7590606|NCT02032888|26405214|P1|Treatment Period|Other|1
7590607|NCT02032888|26405212|P3|Treatment Period|Poor compliance/noncompliance|0
7590608|NCT02032888|26405213|P2|Treatment Period|Poor compliance/noncompliance|1
7590609|NCT02032888|26405214|P1|Treatment Period|Poor compliance/noncompliance|1
7590610|NCT02032875|26405245|P2|Follow-up Period|Virologic Relapse|10
7590611|NCT02032875|26405246|P1|Follow-up Period|Virologic Relapse|3
7590612|NCT02032875|26405245|P2|Follow-up Period|Death|1
7590613|NCT02032875|26405246|P1|Follow-up Period|Death|0
7590614|NCT02032875|26405245|P2|Treatment Period|Liver transplant, Treatment extension|3
7590615|NCT02032875|26405246|P1|Treatment Period|Liver transplant, Treatment extension|0
7590616|NCT02032875|26405245|P2|Treatment Period|Liver transplant, No extension needed|1
7590617|NCT02032875|26405246|P1|Treatment Period|Liver transplant, No extension needed|0
7590618|NCT02032875|26405245|P2|Treatment Period|Adverse Event|0
7590619|NCT02032875|26405246|P1|Treatment Period|Adverse Event|1
7590620|NCT02032706|26405289|P1|Overall Study|Protocol Violation|1
7590621|NCT02032706|26405289|P1|Overall Study|Did not qualify|5
7590622|NCT02032407|26405472|P1|Overall Study|Other Miscellaneous Reasons|2
7590623|NCT02032407|26405472|P1|Overall Study|Pregnancy|1
7590624|NCT02032407|26405472|P1|Overall Study|Lost to Follow-up|2
7590625|NCT02032238|26405485|P2|Overall Study|Lost to Follow-up|0
7590626|NCT02032238|26405486|P1|Overall Study|Lost to Follow-up|2
7590627|NCT02032173|26405525|P1|Overall Study|Discontinuation due to sponsor decision|31
7590628|NCT02031679|26405551|P2|Overall Study|Lack of Efficacy|1
7590629|NCT02031679|26405552|P1|Overall Study|Lack of Efficacy|0
7590630|NCT02031679|26405551|P2|Overall Study|Protocol Violation|1
7590631|NCT02031679|26405552|P1|Overall Study|Protocol Violation|0
7590632|NCT02031640|26405567|P6|Double-blind Treatment Period|Lost to Follow-up|0
7590633|NCT02031640|26405568|P5|Double-blind Treatment Period|Lost to Follow-up|1
7590634|NCT02031640|26405569|P4|Double-blind Treatment Period|Lost to Follow-up|0
7590635|NCT02031640|26405570|P3|Double-blind Treatment Period|Lost to Follow-up|0
7590636|NCT02031640|26405571|P2|Double-blind Treatment Period|Lost to Follow-up|3
7590637|NCT02031640|26405572|P1|Double-blind Treatment Period|Lost to Follow-up|0
7590638|NCT02031640|26405567|P6|Double-blind Treatment Period|Withdrawal by Subject|1
7590639|NCT02031640|26405568|P5|Double-blind Treatment Period|Withdrawal by Subject|1
7590640|NCT02031640|26405569|P4|Double-blind Treatment Period|Withdrawal by Subject|1
7590641|NCT02031640|26405570|P3|Double-blind Treatment Period|Withdrawal by Subject|3
7590642|NCT02031640|26405571|P2|Double-blind Treatment Period|Withdrawal by Subject|2
7590643|NCT02031640|26405572|P1|Double-blind Treatment Period|Withdrawal by Subject|0
7590644|NCT02031640|26405567|P6|Double-blind Treatment Period|Adverse Event|0
7590645|NCT02031640|26405568|P5|Double-blind Treatment Period|Adverse Event|0
7590646|NCT02031640|26405569|P4|Double-blind Treatment Period|Adverse Event|2
7590647|NCT02031640|26405570|P3|Double-blind Treatment Period|Adverse Event|0
7590648|NCT02031640|26405571|P2|Double-blind Treatment Period|Adverse Event|0
7590649|NCT02031640|26405572|P1|Double-blind Treatment Period|Adverse Event|0
7590650|NCT02031640|26405567|P6|Double-blind Treatment Period|Non-compliance|0
7590651|NCT02031640|26405568|P5|Double-blind Treatment Period|Non-compliance|1
7590652|NCT02031640|26405569|P4|Double-blind Treatment Period|Non-compliance|1
7590653|NCT02031640|26405570|P3|Double-blind Treatment Period|Non-compliance|0
7590654|NCT02031640|26405571|P2|Double-blind Treatment Period|Non-compliance|1
7590655|NCT02031640|26405572|P1|Double-blind Treatment Period|Non-compliance|0
7590656|NCT02031640|26405567|P6|Double-blind Treatment Period|Lack of Efficacy|1
7590657|NCT02031640|26405568|P5|Double-blind Treatment Period|Lack of Efficacy|5
7590658|NCT02031640|26405569|P4|Double-blind Treatment Period|Lack of Efficacy|2
7590659|NCT02031640|26405570|P3|Double-blind Treatment Period|Lack of Efficacy|3
7590660|NCT02031640|26405571|P2|Double-blind Treatment Period|Lack of Efficacy|14
7590661|NCT02031640|26405572|P1|Double-blind Treatment Period|Lack of Efficacy|0
7590662|NCT02031640|26405567|P6|Double-blind Treatment Period|Protocol deviation|1
7590663|NCT02031640|26405568|P5|Double-blind Treatment Period|Protocol deviation|3
7590664|NCT02031640|26405569|P4|Double-blind Treatment Period|Protocol deviation|1
7590665|NCT02031640|26405570|P3|Double-blind Treatment Period|Protocol deviation|0
7590666|NCT02031640|26405571|P2|Double-blind Treatment Period|Protocol deviation|2
7590667|NCT02031640|26405572|P1|Double-blind Treatment Period|Protocol deviation|0
7590668|NCT02031640|26405567|P6|Run-In Period|Various administrative reasons|0
7590669|NCT02031640|26405568|P5|Run-In Period|Various administrative reasons|0
7590670|NCT02031640|26405569|P4|Run-In Period|Various administrative reasons|0
7590671|NCT02031640|26405570|P3|Run-In Period|Various administrative reasons|0
7590672|NCT02031640|26405571|P2|Run-In Period|Various administrative reasons|0
7590673|NCT02031640|26405572|P1|Run-In Period|Various administrative reasons|17
7590674|NCT02031640|26405567|P6|Run-In Period|Randomization criteria not met|0
7590675|NCT02031640|26405568|P5|Run-In Period|Randomization criteria not met|0
7590676|NCT02031640|26405569|P4|Run-In Period|Randomization criteria not met|0
7590677|NCT02031640|26405570|P3|Run-In Period|Randomization criteria not met|0
7590678|NCT02031640|26405571|P2|Run-In Period|Randomization criteria not met|0
7590679|NCT02031640|26405572|P1|Run-In Period|Randomization criteria not met|85
7590680|NCT02031640|26405567|P6|Run-In Period|Exclusion criteria met|0
7590681|NCT02031640|26405568|P5|Run-In Period|Exclusion criteria met|0
7590682|NCT02031640|26405569|P4|Run-In Period|Exclusion criteria met|0
7590683|NCT02031640|26405570|P3|Run-In Period|Exclusion criteria met|0
7590684|NCT02031640|26405571|P2|Run-In Period|Exclusion criteria met|0
7590685|NCT02031640|26405572|P1|Run-In Period|Exclusion criteria met|8
7590686|NCT02031640|26405567|P6|Run-In Period|Inclusion criteria not met|0
7590687|NCT02031640|26405568|P5|Run-In Period|Inclusion criteria not met|0
7590688|NCT02031640|26405569|P4|Run-In Period|Inclusion criteria not met|0
7590689|NCT02031640|26405570|P3|Run-In Period|Inclusion criteria not met|0
7590690|NCT02031640|26405571|P2|Run-In Period|Inclusion criteria not met|0
7590691|NCT02031640|26405572|P1|Run-In Period|Inclusion criteria not met|38
7590692|NCT02031640|26405567|P6|Run-In Period|Withdrawal by Subject|0
7590693|NCT02031640|26405568|P5|Run-In Period|Withdrawal by Subject|0
7590694|NCT02031640|26405569|P4|Run-In Period|Withdrawal by Subject|0
7590695|NCT02031640|26405570|P3|Run-In Period|Withdrawal by Subject|0
7590696|NCT02031640|26405571|P2|Run-In Period|Withdrawal by Subject|0
7590697|NCT02031640|26405572|P1|Run-In Period|Withdrawal by Subject|17
7590698|NCT02031640|26405567|P6|Run-In Period|Adverse Event|0
7590699|NCT02031640|26405568|P5|Run-In Period|Adverse Event|0
7590700|NCT02031640|26405569|P4|Run-In Period|Adverse Event|0
7590701|NCT02031640|26405570|P3|Run-In Period|Adverse Event|0
7590702|NCT02031640|26405571|P2|Run-In Period|Adverse Event|0
7590703|NCT02031640|26405572|P1|Run-In Period|Adverse Event|4
7590704|NCT02031640|26405567|P6|Screening Period|Enrollment closed|0
7590705|NCT02031640|26405568|P5|Screening Period|Enrollment closed|0
7590706|NCT02031640|26405569|P4|Screening Period|Enrollment closed|0
7590707|NCT02031640|26405570|P3|Screening Period|Enrollment closed|0
7590708|NCT02031640|26405571|P2|Screening Period|Enrollment closed|0
7590709|NCT02031640|26405572|P1|Screening Period|Enrollment closed|26
7590710|NCT02031640|26405567|P6|Screening Period|Lost to Follow-up|0
7590711|NCT02031640|26405568|P5|Screening Period|Lost to Follow-up|0
7590712|NCT02031640|26405569|P4|Screening Period|Lost to Follow-up|0
7590713|NCT02031640|26405570|P3|Screening Period|Lost to Follow-up|0
7590714|NCT02031640|26405571|P2|Screening Period|Lost to Follow-up|0
7590715|NCT02031640|26405572|P1|Screening Period|Lost to Follow-up|14
7590716|NCT02031640|26405567|P6|Screening Period|Exclusion criteria met|0
7590717|NCT02031640|26405568|P5|Screening Period|Exclusion criteria met|0
7590718|NCT02031640|26405569|P4|Screening Period|Exclusion criteria met|0
7590719|NCT02031640|26405570|P3|Screening Period|Exclusion criteria met|0
7590720|NCT02031640|26405571|P2|Screening Period|Exclusion criteria met|0
7590721|NCT02031640|26405572|P1|Screening Period|Exclusion criteria met|30
7590722|NCT02031640|26405567|P6|Screening Period|Inclusion criteria not met|0
7590723|NCT02031640|26405568|P5|Screening Period|Inclusion criteria not met|0
7590724|NCT02031640|26405569|P4|Screening Period|Inclusion criteria not met|0
7590725|NCT02031640|26405570|P3|Screening Period|Inclusion criteria not met|0
7590726|NCT02031640|26405571|P2|Screening Period|Inclusion criteria not met|0
7590727|NCT02031640|26405572|P1|Screening Period|Inclusion criteria not met|312
7590728|NCT02031640|26405567|P6|Screening Period|Withdrawal by Subject|0
7590729|NCT02031640|26405568|P5|Screening Period|Withdrawal by Subject|0
7590730|NCT02031640|26405569|P4|Screening Period|Withdrawal by Subject|0
7590731|NCT02031640|26405570|P3|Screening Period|Withdrawal by Subject|0
7590732|NCT02031640|26405571|P2|Screening Period|Withdrawal by Subject|0
7590733|NCT02031640|26405572|P1|Screening Period|Withdrawal by Subject|29
7590734|NCT02031640|26405567|P6|Screening Period|Adverse Event|0
7590735|NCT02031640|26405568|P5|Screening Period|Adverse Event|0
7590736|NCT02031640|26405569|P4|Screening Period|Adverse Event|0
7590737|NCT02031640|26405570|P3|Screening Period|Adverse Event|0
7590738|NCT02031640|26405571|P2|Screening Period|Adverse Event|0
7590739|NCT02031640|26405572|P1|Screening Period|Adverse Event|1
7590740|NCT02031536|26405660|P2|Overall Study|ineligible|0
7590741|NCT02031536|26405661|P1|Overall Study|ineligible|1
7590742|NCT02031471|26405669|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
7590743|NCT02031471|26405669|P1|Long Term Extension (LTE) Period|Adverse Event|1
7590744|NCT02031471|26405669|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
7590745|NCT02031471|26405669|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
7590746|NCT02031471|26405669|P1|24 Week Treatment Period|Protocol Violation|1
7590747|NCT02031471|26405669|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
7590748|NCT02031471|26405669|P1|24 Week Treatment Period|Adverse Event|6
7590749|NCT02031458|26405702|P3|Baseline to May 8, 2015|Lost to Follow-up|2
7590750|NCT02031458|26405703|P2|Baseline to May 8, 2015|Lost to Follow-up|1
7590751|NCT02031458|26405704|P1|Baseline to May 8, 2015|Lost to Follow-up|1
7590752|NCT02031458|26405702|P3|Baseline to May 8, 2015|On Treatment|73
7590753|NCT02031458|26405703|P2|Baseline to May 8, 2015|On Treatment|81
7590754|NCT02031458|26405704|P1|Baseline to May 8, 2015|On Treatment|43
7590755|NCT02031458|26405702|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
7590756|NCT02031458|26405703|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
7590757|NCT02031458|26405704|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
7590758|NCT02031458|26405702|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
7590759|NCT02031458|26405703|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
7590760|NCT02031458|26405704|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
7590761|NCT02031458|26405702|P3|Baseline to May 8, 2015|Unknown Reason|2
7590762|NCT02031458|26405703|P2|Baseline to May 8, 2015|Unknown Reason|1
7590763|NCT02031458|26405704|P1|Baseline to May 8, 2015|Unknown Reason|0
7590764|NCT02031458|26405702|P3|Baseline to May 8, 2015|Physician Decision|0
7590765|NCT02031458|26405703|P2|Baseline to May 8, 2015|Physician Decision|1
7590766|NCT02031458|26405704|P1|Baseline to May 8, 2015|Physician Decision|0
7590767|NCT02031458|26405702|P3|Baseline to May 8, 2015|Protocol Violation|0
7590768|NCT02031458|26405703|P2|Baseline to May 8, 2015|Protocol Violation|4
7590769|NCT02031458|26405704|P1|Baseline to May 8, 2015|Protocol Violation|7
7590770|NCT02031458|26405702|P3|Baseline to May 8, 2015|Death|100
7590771|NCT02031458|26405703|P2|Baseline to May 8, 2015|Death|87
7590772|NCT02031458|26405704|P1|Baseline to May 8, 2015|Death|36
7590773|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
7590774|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
7590775|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
7590776|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
7590777|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
7590778|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
7590779|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
7590780|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
7590781|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
7590782|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
7590783|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
7590784|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
7590785|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7590786|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7590787|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
7590788|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
7590789|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
7590790|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
7590791|NCT02031458|26405702|P3|May 8, 2015 to January 11, 2019|Death|198
7590792|NCT02031458|26405703|P2|May 8, 2015 to January 11, 2019|Death|193
7590793|NCT02031458|26405704|P1|May 8, 2015 to January 11, 2019|Death|89
7590794|NCT02031432|26405798|P1|Overall Study|Death|10
7590795|NCT02031432|26405798|P1|Overall Study|Inclusion/Exclusion criteria not met|5
7590796|NCT02031432|26405798|P1|Overall Study|Lost to Follow-up|1
7590797|NCT02031432|26405798|P1|Overall Study|Withdrawal by Subject|5
7590798|NCT02031432|26405798|P1|Overall Study|Adverse Event|8
7590799|NCT02031432|26405798|P1|Overall Study|Withdrawn as forbidden meds required|1
7590800|NCT02031432|26405798|P1|Overall Study|Cancer Progression|2
7590801|NCT02031432|26405798|P1|Overall Study|Lack of Efficacy|5
7590802|NCT02031432|26405798|P1|Overall Study|Protocol Violation|1
7590803|NCT02031302|26405825|P2|Overall Study|Lost to Follow-up|0
7590804|NCT02031302|26405826|P1|Overall Study|Lost to Follow-up|4
7590805|NCT02031302|26405825|P2|Overall Study|Missed Follow Up|0
7590806|NCT02031302|26405826|P1|Overall Study|Missed Follow Up|27
7590807|NCT02031302|26405825|P2|Overall Study|Not treated with study valve system|0
7590808|NCT02031302|26405826|P1|Overall Study|Not treated with study valve system|18
7590809|NCT02031302|26405825|P2|Overall Study|Death|0
7590810|NCT02031302|26405826|P1|Overall Study|Death|115
7590811|NCT02031276|26405847|P3|Period 3 Open-label Risankizumab SC|Other|1
7590812|NCT02031276|26405848|P2|Period 3 Open-label Risankizumab SC|Other|0
7590813|NCT02031276|26405849|P1|Period 3 Open-label Risankizumab SC|Other|0
7590814|NCT02031276|26405847|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7590815|NCT02031276|26405848|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7590816|NCT02031276|26405849|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7590817|NCT02031276|26405847|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7590818|NCT02031276|26405848|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7590819|NCT02031276|26405849|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
7590820|NCT02031276|26405847|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
7590821|NCT02031276|26405848|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
7590822|NCT02031276|26405849|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
7590823|NCT02031276|26405847|P3|Period 2 Open-label Risankizumab IV|Other|1
7590824|NCT02031276|26405848|P2|Period 2 Open-label Risankizumab IV|Other|2
7590825|NCT02031276|26405849|P1|Period 2 Open-label Risankizumab IV|Other|0
7590826|NCT02031276|26405847|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7590827|NCT02031276|26405848|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7590828|NCT02031276|26405849|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
7590829|NCT02031276|26405847|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
7590830|NCT02031276|26405848|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
7590831|NCT02031276|26405849|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
7590832|NCT02031276|26405847|P3|Period 1 Double-blind IV|Other|0
7590833|NCT02031276|26405848|P2|Period 1 Double-blind IV|Other|1
7590834|NCT02031276|26405849|P1|Period 1 Double-blind IV|Other|0
7590835|NCT02031276|26405847|P3|Period 1 Double-blind IV|Adverse Event|1
7590836|NCT02031276|26405848|P2|Period 1 Double-blind IV|Adverse Event|5
7590837|NCT02031276|26405849|P1|Period 1 Double-blind IV|Adverse Event|6
7590838|NCT02031237|26405883|P3|Overall Study|Alternate Treatment Given|3
7590839|NCT02031237|26405884|P2|Overall Study|Alternate Treatment Given|0
7590840|NCT02031237|26405885|P1|Overall Study|Alternate Treatment Given|0
7590841|NCT02031237|26405883|P3|Overall Study|Protocol Violation|0
7590842|NCT02031237|26405884|P2|Overall Study|Protocol Violation|6
7590843|NCT02031237|26405885|P1|Overall Study|Protocol Violation|2
7590844|NCT02031237|26405883|P3|Overall Study|Withdrawal by Subject|0
7590845|NCT02031237|26405884|P2|Overall Study|Withdrawal by Subject|2
7590846|NCT02031237|26405885|P1|Overall Study|Withdrawal by Subject|2
7590847|NCT02031237|26405883|P3|Overall Study|Physician Decision|0
7590848|NCT02031237|26405884|P2|Overall Study|Physician Decision|1
7590849|NCT02031237|26405885|P1|Overall Study|Physician Decision|0
7590850|NCT02031237|26405883|P3|Overall Study|Death|0
7590851|NCT02031237|26405884|P2|Overall Study|Death|5
7590852|NCT02031237|26405885|P1|Overall Study|Death|1
7590853|NCT02031146|26405894|P7|Overall Study|Did not meet criteria for inclusion in data analysis|5
7590854|NCT02031146|26405895|P6|Overall Study|Did not meet criteria for inclusion in data analysis|4
7590855|NCT02031146|26405896|P5|Overall Study|Did not meet criteria for inclusion in data analysis|26
7590856|NCT02031146|26405897|P4|Overall Study|Did not meet criteria for inclusion in data analysis|100
7590857|NCT02031146|26405898|P3|Overall Study|Did not meet criteria for inclusion in data analysis|0
7590858|NCT02031146|26405899|P2|Overall Study|Did not meet criteria for inclusion in data analysis|0
7590859|NCT02031146|26405900|P1|Overall Study|Did not meet criteria for inclusion in data analysis|0
7590860|NCT02030847|26405923|P1|Overall Study|Withdrawal by Subject|1
7590861|NCT02030847|26405923|P1|Overall Study|Physician Decision|3
7590862|NCT02030847|26405923|P1|Overall Study|New Cancer Therapy|8
7590863|NCT02030847|26405923|P1|Overall Study|Disease Progression|15
7590864|NCT02030847|26405923|P1|Overall Study|Death|10
7590865|NCT02030834|26405931|P3|Overall Study|Lack of funding|0
7590866|NCT02030834|26405932|P2|Overall Study|Lack of funding|0
7590867|NCT02030834|26405933|P1|Overall Study|Lack of funding|1
7590868|NCT02030834|26405931|P3|Overall Study|Withdrawal by Subject|0
7590869|NCT02030834|26405932|P2|Overall Study|Withdrawal by Subject|0
7590870|NCT02030834|26405933|P1|Overall Study|Withdrawal by Subject|1
7590871|NCT02030834|26405931|P3|Overall Study|Lost to Follow-up|0
7590872|NCT02030834|26405932|P2|Overall Study|Lost to Follow-up|0
7590873|NCT02030834|26405933|P1|Overall Study|Lost to Follow-up|1
7590874|NCT02030834|26405931|P3|Overall Study|Disease progression|2
7590875|NCT02030834|26405932|P2|Overall Study|Disease progression|0
7590876|NCT02030834|26405933|P1|Overall Study|Disease progression|2
7590877|NCT02030834|26405931|P3|Overall Study|Manufacturing failure|1
7590878|NCT02030834|26405932|P2|Overall Study|Manufacturing failure|0
7590879|NCT02030834|26405933|P1|Overall Study|Manufacturing failure|2
7590880|NCT02030834|26405931|P3|Overall Study|Death|0
7590881|NCT02030834|26405932|P2|Overall Study|Death|0
7590882|NCT02030834|26405933|P1|Overall Study|Death|4
7590883|NCT02030821|26405945|P4|Overall Study|Physician Decision|2
7590884|NCT02030821|26405946|P3|Overall Study|Physician Decision|5
7590885|NCT02030821|26405947|P2|Overall Study|Physician Decision|2
7590886|NCT02030821|26405948|P1|Overall Study|Physician Decision|2
7590887|NCT02030600|26405976|P2|Treatment Period 2|Unclassified|0
7590888|NCT02030600|26405977|P1|Treatment Period 2|Unclassified|1
7590889|NCT02030600|26405976|P2|Treatment Period 2|Withdrawal by Subject|9
7590890|NCT02030600|26405977|P1|Treatment Period 2|Withdrawal by Subject|13
7590891|NCT02030600|26405976|P2|Treatment Period 2|Protocol Violation|2
7590892|NCT02030600|26405977|P1|Treatment Period 2|Protocol Violation|1
7590893|NCT02030600|26405976|P2|Treatment Period 2|Lost to Follow-up|2
7590894|NCT02030600|26405977|P1|Treatment Period 2|Lost to Follow-up|4
7590895|NCT02030600|26405976|P2|Treatment Period 2|Lack of Efficacy|1
7590896|NCT02030600|26405977|P1|Treatment Period 2|Lack of Efficacy|2
7590897|NCT02030600|26405976|P2|Treatment Period 2|Adverse Event|4
7590898|NCT02030600|26405977|P1|Treatment Period 2|Adverse Event|4
7590899|NCT02030600|26405976|P2|Treatment Period 1|Unclassified|0
7590900|NCT02030600|26405977|P1|Treatment Period 1|Unclassified|1
7590901|NCT02030600|26405976|P2|Treatment Period 1|Casebook Unsigned|0
7590902|NCT02030600|26405977|P1|Treatment Period 1|Casebook Unsigned|1
7590903|NCT02030600|26405976|P2|Treatment Period 1|Withdrawal by Subject|17
7590904|NCT02030600|26405977|P1|Treatment Period 1|Withdrawal by Subject|13
7590905|NCT02030600|26405976|P2|Treatment Period 1|Protocol Violation|17
7590906|NCT02030600|26405977|P1|Treatment Period 1|Protocol Violation|22
7590907|NCT02030600|26405976|P2|Treatment Period 1|Lost to Follow-up|3
7590908|NCT02030600|26405977|P1|Treatment Period 1|Lost to Follow-up|11
7590909|NCT02030600|26405976|P2|Treatment Period 1|Lack of Efficacy|1
7590910|NCT02030600|26405977|P1|Treatment Period 1|Lack of Efficacy|0
7590911|NCT02030600|26405976|P2|Treatment Period 1|Adverse Event|7
7590912|NCT02030600|26405977|P1|Treatment Period 1|Adverse Event|5
7590913|NCT02030535|26405998|P1|Washout Period 1 (21 Days)|Adverse Event|1
7590914|NCT02030405|26406066|P1|Overall Study|Lost to Follow-up|1
7590915|NCT02030405|26406066|P1|Overall Study|Withdrawal by Subject|1
7590916|NCT02030119|26406092|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
7590917|NCT02030119|26406093|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
7590918|NCT02030119|26406094|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
7590919|NCT02030119|26406095|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
7590920|NCT02030119|26406092|P4|Overall Study|Withdrawal by Subject|3
7590921|NCT02030119|26406093|P3|Overall Study|Withdrawal by Subject|5
7590922|NCT02030119|26406094|P2|Overall Study|Withdrawal by Subject|1
7590923|NCT02030119|26406095|P1|Overall Study|Withdrawal by Subject|3
7590924|NCT02030041|26406133|P3|Overall Study|Withdrawal by Subject|1
7590925|NCT02030041|26406134|P2|Overall Study|Withdrawal by Subject|2
7590926|NCT02030041|26406135|P1|Overall Study|Withdrawal by Subject|2
7590927|NCT02030015|26406146|P1|Overall Study|Death|13
7590928|NCT02030015|26406146|P1|Overall Study|Withdrawal by Subject|3
7590929|NCT02030002|26406151|P1|Follow-up|Lost to Follow-up|2
7590930|NCT02030002|26406151|P1|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
7590931|NCT02030002|26406151|P1|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
7590932|NCT02029989|26406165|P2|Overall Study|Protocol Violation|0
7590933|NCT02029989|26406166|P1|Overall Study|Protocol Violation|1
7590934|NCT02029989|26406165|P2|Overall Study|Death|1
7590935|NCT02029989|26406166|P1|Overall Study|Death|0
7590936|NCT02029989|26406165|P2|Overall Study|Lost to Follow-up|7
7590937|NCT02029989|26406166|P1|Overall Study|Lost to Follow-up|9
7590938|NCT02029989|26406165|P2|Overall Study|Physician Decision|0
7590939|NCT02029989|26406166|P1|Overall Study|Physician Decision|2
7590940|NCT02029989|26406165|P2|Overall Study|Change of location|3
7590941|NCT02029989|26406166|P1|Overall Study|Change of location|2
7590942|NCT02029989|26406165|P2|Overall Study|Withdrawal: Fear of needles|0
7590943|NCT02029989|26406166|P1|Overall Study|Withdrawal: Fear of needles|1
7590944|NCT02029989|26406165|P2|Overall Study|Withdrawal by Subject|0
7590945|NCT02029989|26406166|P1|Overall Study|Withdrawal by Subject|1
7590946|NCT02029976|26406174|P2|YR-2 Follow Up vs Baseline|Moved from area|2
7590947|NCT02029976|26406175|P1|YR-2 Follow Up vs Baseline|Moved from area|0
7590948|NCT02029976|26406174|P2|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7590949|NCT02029976|26406175|P1|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7590950|NCT02029976|26406174|P2|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
7590951|NCT02029976|26406175|P1|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
7590952|NCT02029976|26406174|P2|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
7590953|NCT02029976|26406175|P1|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
7590954|NCT02029846|26406204|P2|Overall Study|n=1 each arm|1
7590955|NCT02029846|26406205|P1|Overall Study|n=1 each arm|1
7590956|NCT02029638|26406243|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
7590957|NCT02029638|26406244|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
7590958|NCT02029638|26406245|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
7590959|NCT02029638|26406243|P3|Overall Study|Death|1
7590960|NCT02029638|26406244|P2|Overall Study|Death|0
7590961|NCT02029638|26406245|P1|Overall Study|Death|0
7590962|NCT02029521|26406274|P2|Overall Study|Withdrawal by Subject|1
7590963|NCT02029521|26406275|P1|Overall Study|Withdrawal by Subject|1
7590964|NCT02029521|26406274|P2|Overall Study|Protocol Violation|0
7590965|NCT02029521|26406275|P1|Overall Study|Protocol Violation|1
7590966|NCT02029417|26406373|P1|Overall Study|Adverse Event|1
7590967|NCT02029417|26406373|P1|Overall Study|Death|1
7590968|NCT02029274|26406382|P4|Overall Study|Adverse Event|2
7590969|NCT02029274|26406383|P3|Overall Study|Adverse Event|2
7590970|NCT02029274|26406384|P2|Overall Study|Adverse Event|0
7590971|NCT02029274|26406385|P1|Overall Study|Adverse Event|1
7590972|NCT02029235|26406417|P2|Overall Study|Non-compliance with study meds or diary|1
7590973|NCT02029235|26406418|P1|Overall Study|Non-compliance with study meds or diary|4
7590974|NCT02028884|26406450|P2|Open-label Extension Period|On-going in Study|14
7590975|NCT02028884|26406451|P1|Open-label Extension Period|On-going in Study|19
7590976|NCT02028884|26406450|P2|Open-label Extension Period|Withdrawal by Subject|2
7590977|NCT02028884|26406451|P1|Open-label Extension Period|Withdrawal by Subject|0
7590978|NCT02028884|26406450|P2|Open-label Extension Period|Non-Compliance With Study Drug|1
7590979|NCT02028884|26406451|P1|Open-label Extension Period|Non-Compliance With Study Drug|0
7590980|NCT02028884|26406450|P2|Open-label Extension Period|Lack of Efficacy|0
7590981|NCT02028884|26406451|P1|Open-label Extension Period|Lack of Efficacy|3
7590982|NCT02028884|26406450|P2|Open-label Extension Period|Adverse Event|1
7590983|NCT02028884|26406451|P1|Open-label Extension Period|Adverse Event|2
7590984|NCT02028884|26406450|P2|Double-blind Period|On-going in Study|20
7590985|NCT02028884|26406451|P1|Double-blind Period|On-going in Study|8
7590986|NCT02028884|26406450|P2|Double-blind Period|Withdrawal by Subject|0
7590987|NCT02028884|26406451|P1|Double-blind Period|Withdrawal by Subject|2
7590988|NCT02028884|26406450|P2|Double-blind Period|Non-Compliance With Study Drug|0
7590989|NCT02028884|26406451|P1|Double-blind Period|Non-Compliance With Study Drug|2
7590990|NCT02028884|26406450|P2|Double-blind Period|Eligibility Violation|0
7590991|NCT02028884|26406451|P1|Double-blind Period|Eligibility Violation|1
7590992|NCT02028884|26406450|P2|Double-blind Period|Adverse Event|3
7590993|NCT02028884|26406451|P1|Double-blind Period|Adverse Event|5
7590994|NCT02028871|26406521|P2|Overall Study|Current Illness|0
7590995|NCT02028871|26406522|P1|Overall Study|Current Illness|1
7590996|NCT02028871|26406521|P2|Overall Study|IV placement difficulty|0
7590997|NCT02028871|26406522|P1|Overall Study|IV placement difficulty|1
7590998|NCT02028871|26406521|P2|Overall Study|Withdrawal by Subject|2
7590999|NCT02028871|26406522|P1|Overall Study|Withdrawal by Subject|1
7591000|NCT02028871|26406521|P2|Overall Study|Positive urine drug screen|1
7591001|NCT02028871|26406522|P1|Overall Study|Positive urine drug screen|1
7591002|NCT02028767|26406619|P2|Treatment Period 2|Reason other than those specified above|0
7591003|NCT02028767|26406620|P1|Treatment Period 2|Reason other than those specified above|1
7591004|NCT02028767|26406619|P2|Treatment Period 2|Non compliant with protocol|0
7591005|NCT02028767|26406620|P1|Treatment Period 2|Non compliant with protocol|1
7591006|NCT02028715|26406653|P2|Overall Study|Did not complete satisfaction surveys|2
7591007|NCT02028715|26406654|P1|Overall Study|Did not complete satisfaction surveys|2
7591008|NCT02028715|26406653|P2|Overall Study|Physician Decision|0
7591009|NCT02028715|26406654|P1|Overall Study|Physician Decision|1
7591010|NCT02028715|26406653|P2|Overall Study|Adverse Event|2
7591011|NCT02028715|26406654|P1|Overall Study|Adverse Event|2
7591012|NCT02028182|26406893|P1|Overall Study|Protocol Violation|2
7591013|NCT02028169|26406899|P1|Overall Study|Concomitant Medication Usage|1
7591014|NCT02028169|26406899|P1|Overall Study|Cessation of Drug|1
7591015|NCT02028169|26406899|P1|Overall Study|Adverse Event|1
7591016|NCT02028169|26406899|P1|Overall Study|Withdrawal by Subject|2
7591017|NCT02028169|26406899|P1|Overall Study|Lack of Efficacy|2
7591018|NCT02028169|26406899|P1|Overall Study|Lost to Follow-up|21
7591019|NCT02028065|26406925|P3|Treatment Through Study Completion|Adverse Event|5
7591020|NCT02028065|26406926|P2|Treatment Through Study Completion|Adverse Event|3
7591021|NCT02028065|26406927|P1|Treatment Through Study Completion|Adverse Event|3
7591022|NCT02028065|26406925|P3|Treatment Through Study Completion|Withdrawal by Subject|3
7591023|NCT02028065|26406926|P2|Treatment Through Study Completion|Withdrawal by Subject|4
7591024|NCT02028065|26406927|P1|Treatment Through Study Completion|Withdrawal by Subject|5
7591025|NCT02028065|26406925|P3|Treatment Through Study Completion|Protocol Violation|0
7591026|NCT02028065|26406926|P2|Treatment Through Study Completion|Protocol Violation|4
7591027|NCT02028065|26406927|P1|Treatment Through Study Completion|Protocol Violation|1
7591028|NCT02028065|26406925|P3|Treatment Through Study Completion|Physician Decision|0
7591029|NCT02028065|26406926|P2|Treatment Through Study Completion|Physician Decision|0
7591030|NCT02028065|26406927|P1|Treatment Through Study Completion|Physician Decision|1
7591031|NCT02028065|26406925|P3|Treatment Through Study Completion|Lost to Follow-up|6
7591032|NCT02028065|26406926|P2|Treatment Through Study Completion|Lost to Follow-up|4
7591033|NCT02028065|26406927|P1|Treatment Through Study Completion|Lost to Follow-up|2
7591034|NCT02028065|26406925|P3|Randomization Through Start Treatment|Not treated|3
7591035|NCT02028065|26406926|P2|Randomization Through Start Treatment|Not treated|3
7591036|NCT02028065|26406927|P1|Randomization Through Start Treatment|Not treated|1
7591037|NCT02027844|26406954|P3|Overall Study|Incomlete data|0
7591038|NCT02027844|26406955|P2|Overall Study|Incomlete data|0
7591039|NCT02027844|26406956|P1|Overall Study|Incomlete data|2
7591040|NCT02027844|26406954|P3|Overall Study|Protocol Violation|0
7591041|NCT02027844|26406955|P2|Overall Study|Protocol Violation|2
7591042|NCT02027844|26406956|P1|Overall Study|Protocol Violation|0
7591043|NCT02027844|26406954|P3|Overall Study|Lost to Follow-up|1
7591044|NCT02027844|26406955|P2|Overall Study|Lost to Follow-up|2
7591045|NCT02027844|26406956|P1|Overall Study|Lost to Follow-up|0
7591046|NCT02027844|26406954|P3|Overall Study|Withdrawal by Subject|1
7591047|NCT02027844|26406955|P2|Overall Study|Withdrawal by Subject|2
7591048|NCT02027844|26406956|P1|Overall Study|Withdrawal by Subject|3
7591049|NCT02027701|26406973|P1|Overall Study|Withdrawal by Subject|3
7591050|NCT02027701|26406973|P1|Overall Study|Physician Decision|2
7591051|NCT02027701|26406973|P1|Overall Study|Lack of Efficacy|8
7591052|NCT02027701|26406973|P1|Overall Study|Adverse Event|3
7591053|NCT02027623|26406991|P2|Overall Study|Withdrawal by Subject|9
7591054|NCT02027623|26406992|P1|Overall Study|Withdrawal by Subject|6
7591055|NCT02027623|26406991|P2|Overall Study|Lost to Follow-up|3
7591056|NCT02027623|26406992|P1|Overall Study|Lost to Follow-up|3
7591057|NCT02027558|26407088|P2|Overall Study|Refused assessment|0
7591058|NCT02027558|26407089|P1|Overall Study|Refused assessment|3
7591059|NCT02027558|26407088|P2|Overall Study|Lost to Follow-up|1
7591060|NCT02027558|26407089|P1|Overall Study|Lost to Follow-up|4
7591061|NCT02027558|26407088|P2|Overall Study|Withdrawal by Subject|0
7591062|NCT02027558|26407089|P1|Overall Study|Withdrawal by Subject|2
7591063|NCT02027558|26407088|P2|Overall Study|Death|1
7591064|NCT02027558|26407089|P1|Overall Study|Death|0
7591065|NCT02027545|26407107|P2|Overall Study|Failed to attend study visit|0
7591066|NCT02027545|26407108|P1|Overall Study|Failed to attend study visit|2
7591067|NCT02027545|26407107|P2|Overall Study|Failed to sign HIPAA|2
7591068|NCT02027545|26407108|P1|Overall Study|Failed to sign HIPAA|0
7591069|NCT02027428|26407120|P3|Survival Follow-up|Lost to Follow-up|1
7591070|NCT02027428|26407121|P2|Survival Follow-up|Lost to Follow-up|1
7591071|NCT02027428|26407122|P1|Survival Follow-up|Lost to Follow-up|0
7591072|NCT02027428|26407120|P3|Survival Follow-up|Death|45
7591073|NCT02027428|26407121|P2|Survival Follow-up|Death|78
7591074|NCT02027428|26407122|P1|Survival Follow-up|Death|0
7591075|NCT02027428|26407120|P3|Maintenance|Other|3
7591076|NCT02027428|26407121|P2|Maintenance|Other|6
7591077|NCT02027428|26407122|P1|Maintenance|Other|0
7591078|NCT02027428|26407120|P3|Maintenance|Protocol Violation|1
7591079|NCT02027428|26407121|P2|Maintenance|Protocol Violation|0
7591080|NCT02027428|26407122|P1|Maintenance|Protocol Violation|0
7591081|NCT02027428|26407120|P3|Maintenance|Withdrawal by Subject|5
7591082|NCT02027428|26407121|P2|Maintenance|Withdrawal by Subject|6
7591083|NCT02027428|26407122|P1|Maintenance|Withdrawal by Subject|0
7591084|NCT02027428|26407120|P3|Maintenance|Symptomatic deterioration|1
7591085|NCT02027428|26407121|P2|Maintenance|Symptomatic deterioration|4
7591086|NCT02027428|26407122|P1|Maintenance|Symptomatic deterioration|0
7591087|NCT02027428|26407120|P3|Maintenance|Progressive disease|47
7591088|NCT02027428|26407121|P2|Maintenance|Progressive disease|84
7591089|NCT02027428|26407122|P1|Maintenance|Progressive disease|0
7591090|NCT02027428|26407120|P3|Maintenance|Adverse Event|1
7591091|NCT02027428|26407121|P2|Maintenance|Adverse Event|21
7591092|NCT02027428|26407122|P1|Maintenance|Adverse Event|0
7591093|NCT02027428|26407120|P3|Maintenance|Death|2
7591094|NCT02027428|26407121|P2|Maintenance|Death|3
7591095|NCT02027428|26407122|P1|Maintenance|Death|0
7591096|NCT02027428|26407120|P3|Induction|Induction Treatment Ongoing|0
7591097|NCT02027428|26407121|P2|Induction|Induction Treatment Ongoing|0
7591098|NCT02027428|26407122|P1|Induction|Induction Treatment Ongoing|4
7591099|NCT02027428|26407120|P3|Induction|Miscellaneous|0
7591100|NCT02027428|26407121|P2|Induction|Miscellaneous|0
7591101|NCT02027428|26407122|P1|Induction|Miscellaneous|14
7591102|NCT02027428|26407120|P3|Induction|Protocol Violation|0
7591103|NCT02027428|26407121|P2|Induction|Protocol Violation|0
7591104|NCT02027428|26407122|P1|Induction|Protocol Violation|1
7591105|NCT02027428|26407120|P3|Induction|Study terminated by sponsor|0
7591106|NCT02027428|26407121|P2|Induction|Study terminated by sponsor|0
7591107|NCT02027428|26407122|P1|Induction|Study terminated by sponsor|12
7591108|NCT02027428|26407120|P3|Induction|Symptomatic deterioration|0
7591109|NCT02027428|26407121|P2|Induction|Symptomatic deterioration|0
7591110|NCT02027428|26407122|P1|Induction|Symptomatic deterioration|16
7591111|NCT02027428|26407120|P3|Induction|Death|0
7591112|NCT02027428|26407121|P2|Induction|Death|0
7591113|NCT02027428|26407122|P1|Induction|Death|21
7591114|NCT02027428|26407120|P3|Induction|Withdrawal by Subject|0
7591115|NCT02027428|26407121|P2|Induction|Withdrawal by Subject|0
7591116|NCT02027428|26407122|P1|Induction|Withdrawal by Subject|22
7591117|NCT02027428|26407120|P3|Induction|Adverse Event|0
7591118|NCT02027428|26407121|P2|Induction|Adverse Event|0
7591119|NCT02027428|26407122|P1|Induction|Adverse Event|51
7591120|NCT02027428|26407120|P3|Induction|Progressive disease|0
7591121|NCT02027428|26407121|P2|Induction|Progressive disease|0
7591122|NCT02027428|26407122|P1|Induction|Progressive disease|77
7591123|NCT02027428|26407120|P3|Induction|Never treated|0
7591124|NCT02027428|26407121|P2|Induction|Never treated|0
7591125|NCT02027428|26407122|P1|Induction|Never treated|7
7591126|NCT02027402|26407160|P2|Overall Study|Withdrawal by Subject|1
7591127|NCT02027402|26407161|P1|Overall Study|Withdrawal by Subject|4
7591128|NCT02027376|26407173|P3|Overall Study|Death|0
7591129|NCT02027376|26407174|P2|Overall Study|Death|0
7591130|NCT02027376|26407175|P1|Overall Study|Death|1
7591131|NCT02027311|26407201|P2|Overall Study|Protocol Violation|2
7591132|NCT02027311|26407202|P1|Overall Study|Protocol Violation|3
7591133|NCT02027025|26407222|P3|Overall Study|Sponsor's decision|0
7591134|NCT02027025|26407223|P2|Overall Study|Sponsor's decision|1
7591135|NCT02027025|26407224|P1|Overall Study|Sponsor's decision|0
7591136|NCT02027025|26407222|P3|Overall Study|Withdrawal by Subject|0
7591137|NCT02027025|26407223|P2|Overall Study|Withdrawal by Subject|1
7591138|NCT02027025|26407224|P1|Overall Study|Withdrawal by Subject|0
7591139|NCT02027025|26407222|P3|Overall Study|Lost to Follow-up|0
7591140|NCT02027025|26407223|P2|Overall Study|Lost to Follow-up|2
7591141|NCT02027025|26407224|P1|Overall Study|Lost to Follow-up|0
7591142|NCT02027025|26407222|P3|Overall Study|Protocol Violation|0
7591143|NCT02027025|26407223|P2|Overall Study|Protocol Violation|0
7591144|NCT02027025|26407224|P1|Overall Study|Protocol Violation|1
7591145|NCT02027025|26407222|P3|Overall Study|Adverse Event|1
7591146|NCT02027025|26407223|P2|Overall Study|Adverse Event|1
7591147|NCT02027025|26407224|P1|Overall Study|Adverse Event|0
7591148|NCT02026258|26407287|P2|Recieved Allocated Intervention|Lost to Follow-up|1
7591149|NCT02026258|26407288|P1|Recieved Allocated Intervention|Lost to Follow-up|0
7591150|NCT02026258|26407287|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
7591151|NCT02026258|26407288|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
7591152|NCT02026258|26407287|P2|Randomized|Presence of periodontal disease|1
7591153|NCT02026258|26407288|P1|Randomized|Presence of periodontal disease|1
7591154|NCT02026258|26407287|P2|Randomized|Change in treatment plan|0
7591155|NCT02026258|26407288|P1|Randomized|Change in treatment plan|1
7591156|NCT02026258|26407287|P2|Randomized|Did not start treatment|1
7591157|NCT02026258|26407288|P1|Randomized|Did not start treatment|2
7591158|NCT02026141|26407322|P2|Overall Study|Protocol Violation|1
7591159|NCT02026141|26407323|P1|Overall Study|Protocol Violation|0
7591160|NCT02026063|26407331|P2|Overall Study|Reason not Specified|7
7591161|NCT02026063|26407332|P1|Overall Study|Reason not Specified|2
7591162|NCT02026063|26407331|P2|Overall Study|Lost to Follow-up|1
7591163|NCT02026063|26407332|P1|Overall Study|Lost to Follow-up|0
7591164|NCT02026063|26407331|P2|Overall Study|Lack of Efficacy|4
7591165|NCT02026063|26407332|P1|Overall Study|Lack of Efficacy|0
7591166|NCT02026063|26407331|P2|Overall Study|Adverse Event|20
7591167|NCT02026063|26407332|P1|Overall Study|Adverse Event|5
7591168|NCT02026063|26407331|P2|Overall Study|Withdrawal of Consent|6
7591169|NCT02026063|26407332|P1|Overall Study|Withdrawal of Consent|1
7591170|NCT02026063|26407331|P2|Overall Study|Noncompliance with Study Drug|1
7591171|NCT02026063|26407332|P1|Overall Study|Noncompliance with Study Drug|1
7591172|NCT02026063|26407331|P2|Overall Study|Physician Decision|10
7591173|NCT02026063|26407332|P1|Overall Study|Physician Decision|0
7591174|NCT02026011|26407344|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
7591175|NCT02026011|26407345|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
7591176|NCT02026011|26407344|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
7591177|NCT02026011|26407345|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
7591178|NCT02026011|26407344|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
7591179|NCT02026011|26407345|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
7591180|NCT02026011|26407344|P2|Allocation 1 (First Set of Medication)|Side Effects|0
7591181|NCT02026011|26407345|P1|Allocation 1 (First Set of Medication)|Side Effects|6
7591182|NCT02025985|26407374|P5|Overall Study|Death|17
7591183|NCT02025985|26407375|P4|Overall Study|Death|20
7591184|NCT02025985|26407376|P3|Overall Study|Death|23
7591185|NCT02025985|26407377|P2|Overall Study|Death|20
7591186|NCT02025985|26407378|P1|Overall Study|Death|21
7591187|NCT02025985|26407374|P5|Overall Study|Termination of study by Sponsor|3
7591188|NCT02025985|26407375|P4|Overall Study|Termination of study by Sponsor|1
7591189|NCT02025985|26407376|P3|Overall Study|Termination of study by Sponsor|1
7591190|NCT02025985|26407377|P2|Overall Study|Termination of study by Sponsor|3
7591191|NCT02025985|26407378|P1|Overall Study|Termination of study by Sponsor|4
7591192|NCT02025985|26407374|P5|Overall Study|Consent withdrawn|0
7591193|NCT02025985|26407375|P4|Overall Study|Consent withdrawn|0
7591194|NCT02025985|26407376|P3|Overall Study|Consent withdrawn|1
7591195|NCT02025985|26407377|P2|Overall Study|Consent withdrawn|0
7591196|NCT02025985|26407378|P1|Overall Study|Consent withdrawn|0
7591197|NCT02025907|26407438|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
7591198|NCT02025907|26407439|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
7591199|NCT02025907|26407438|P2|Overall Study|Adverse Event|1
7591200|NCT02025907|26407439|P1|Overall Study|Adverse Event|3
7591201|NCT02025907|26407438|P2|Overall Study|Lost to Follow-up|2
7591202|NCT02025907|26407439|P1|Overall Study|Lost to Follow-up|2
7591203|NCT02025907|26407438|P2|Overall Study|Physician Decision|0
7591204|NCT02025907|26407439|P1|Overall Study|Physician Decision|2
7591205|NCT02025907|26407438|P2|Overall Study|Protocol Violation|0
7591206|NCT02025907|26407439|P1|Overall Study|Protocol Violation|2
7591207|NCT02025907|26407438|P2|Overall Study|Withdrawal by Subject|8
7591208|NCT02025907|26407439|P1|Overall Study|Withdrawal by Subject|15
7591209|NCT02025907|26407438|P2|Overall Study|Lack of Efficacy|0
7591210|NCT02025907|26407439|P1|Overall Study|Lack of Efficacy|1
7591211|NCT02025751|26407467|P2|Overall Study|Withdrawal by Subject|1
7591212|NCT02025751|26407468|P1|Overall Study|Withdrawal by Subject|0
7591213|NCT02025751|26407467|P2|Overall Study|Physician Decision|1
7591214|NCT02025751|26407468|P1|Overall Study|Physician Decision|0
7591215|NCT02025751|26407467|P2|Overall Study|Adverse Event|1
7591216|NCT02025751|26407468|P1|Overall Study|Adverse Event|0
7591217|NCT02025751|26407467|P2|Overall Study|Lost to Follow-up|0
7591218|NCT02025751|26407468|P1|Overall Study|Lost to Follow-up|1
7591219|NCT02025725|26407476|P2|Overall Study|Post-dose QTcB > 270 msec|1
7591220|NCT02025725|26407477|P1|Overall Study|Post-dose QTcB > 270 msec|0
7591221|NCT02025725|26407476|P2|Overall Study|Withdrawal by Subject|2
7591222|NCT02025725|26407477|P1|Overall Study|Withdrawal by Subject|3
7591223|NCT02025725|26407476|P2|Overall Study|Protocol Violation|1
7591224|NCT02025725|26407477|P1|Overall Study|Protocol Violation|1
7591225|NCT02025725|26407476|P2|Overall Study|Lost to Follow-up|0
7591226|NCT02025725|26407477|P1|Overall Study|Lost to Follow-up|2
7591227|NCT02025725|26407476|P2|Overall Study|Adverse Event|0
7591228|NCT02025725|26407477|P1|Overall Study|Adverse Event|5
7591229|NCT02025621|26407529|P2|Overall Study|Surgery initiated before infusion|3
7591230|NCT02025621|26407530|P1|Overall Study|Surgery initiated before infusion|3
7591231|NCT02025621|26407529|P2|Overall Study|No longer eligible|15
7591232|NCT02025621|26407530|P1|Overall Study|No longer eligible|10
7591233|NCT02025621|26407529|P2|Overall Study|Death|1
7591234|NCT02025621|26407530|P1|Overall Study|Death|0
7591235|NCT02025621|26407529|P2|Overall Study|Withdrawal by Subject|0
7591236|NCT02025621|26407530|P1|Overall Study|Withdrawal by Subject|1
7591237|NCT02025530|26407550|P2|Overall Study|No longer met elligibility criteria|1
7591238|NCT02025530|26407551|P1|Overall Study|No longer met elligibility criteria|5
7591239|NCT02025205|26407597|P2|Overall Study|Death|1
7591240|NCT02025205|26407598|P1|Overall Study|Death|0
7591241|NCT02025205|26407597|P2|Overall Study|Protocol Violation|1
7591242|NCT02025205|26407598|P1|Overall Study|Protocol Violation|2
7591243|NCT02025205|26407597|P2|Overall Study|Withdrawal by Subject|1
7591244|NCT02025205|26407598|P1|Overall Study|Withdrawal by Subject|1
7591245|NCT02025179|26407642|P3|Overall Study|Lost to Follow-up|1
7591246|NCT02025179|26407643|P2|Overall Study|Lost to Follow-up|0
7591247|NCT02025179|26407644|P1|Overall Study|Lost to Follow-up|0
7591248|NCT02024971|26407694|P1|Overall Study|Lost to Follow-up|6
7591249|NCT02024971|26407694|P1|Overall Study|Data Not Available|30
7591250|NCT02024932|26407707|P6|Overall Study|Abnormal laboratory value|0
7591251|NCT02024932|26407708|P5|Overall Study|Abnormal laboratory value|0
7591252|NCT02024932|26407709|P4|Overall Study|Abnormal laboratory value|2
7591253|NCT02024932|26407710|P3|Overall Study|Abnormal laboratory value|0
7591254|NCT02024932|26407711|P2|Overall Study|Abnormal laboratory value|0
7591255|NCT02024932|26407712|P1|Overall Study|Abnormal laboratory value|0
7591256|NCT02024932|26407707|P6|Overall Study|Adverse Event|0
7591257|NCT02024932|26407708|P5|Overall Study|Adverse Event|2
7591258|NCT02024932|26407709|P4|Overall Study|Adverse Event|0
7591259|NCT02024932|26407710|P3|Overall Study|Adverse Event|0
7591260|NCT02024932|26407711|P2|Overall Study|Adverse Event|3
7591261|NCT02024932|26407712|P1|Overall Study|Adverse Event|2
7591262|NCT02024867|26407771|P2|Overall Study|Lost to Follow-up|4
7591263|NCT02024867|26407772|P1|Overall Study|Lost to Follow-up|6
7591264|NCT02024867|26407771|P2|Overall Study|Protocol Violation|3
7591265|NCT02024867|26407772|P1|Overall Study|Protocol Violation|3
7591266|NCT02024750|26407790|P2|Overall Study|Withdrawal by Subject|1
7591267|NCT02024750|26407791|P1|Overall Study|Withdrawal by Subject|2
7591268|NCT02024698|26407827|P2|First Intervention (7 Days)|Withdrawal by Subject|1
7591269|NCT02024698|26407828|P1|First Intervention (7 Days)|Withdrawal by Subject|0
7591270|NCT02024555|26407923|P2|Overall Study|Withdrawal by Subject|1
7591271|NCT02024555|26407924|P1|Overall Study|Withdrawal by Subject|5
7591272|NCT02024555|26407923|P2|Overall Study|Lost to Follow-up|1
7591273|NCT02024555|26407924|P1|Overall Study|Lost to Follow-up|1
7591274|NCT02023879|26408078|P3|Extension Open Label Treatment|Other than specified above|2
7591275|NCT02023879|26408079|P2|Extension Open Label Treatment|Other than specified above|7
7591276|NCT02023879|26408080|P1|Extension Open Label Treatment|Other than specified above|2
7591277|NCT02023879|26408078|P3|Extension Open Label Treatment|Participant moved|0
7591278|NCT02023879|26408079|P2|Extension Open Label Treatment|Participant moved|2
7591279|NCT02023879|26408080|P1|Extension Open Label Treatment|Participant moved|1
7591280|NCT02023879|26408078|P3|Extension Open Label Treatment|Poor compliance to protocol|0
7591281|NCT02023879|26408079|P2|Extension Open Label Treatment|Poor compliance to protocol|1
7591282|NCT02023879|26408080|P1|Extension Open Label Treatment|Poor compliance to protocol|1
7591283|NCT02023879|26408078|P3|Extension Open Label Treatment|Adverse Event|3
7591284|NCT02023879|26408079|P2|Extension Open Label Treatment|Adverse Event|7
7591285|NCT02023879|26408080|P1|Extension Open Label Treatment|Adverse Event|1
7591286|NCT02023879|26408078|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7591287|NCT02023879|26408079|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
7591288|NCT02023879|26408080|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7591289|NCT02023879|26408078|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7591290|NCT02023879|26408079|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7591291|NCT02023879|26408080|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
7591292|NCT02023879|26408078|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7591293|NCT02023879|26408079|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
7591294|NCT02023879|26408080|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7591295|NCT02023879|26408078|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7591296|NCT02023879|26408079|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
7591297|NCT02023879|26408080|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7591298|NCT02023879|26408078|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
7591299|NCT02023879|26408079|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
7591300|NCT02023879|26408080|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
7591301|NCT02023879|26408078|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
7591302|NCT02023879|26408079|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7591303|NCT02023879|26408080|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7591304|NCT02023866|26408169|P1|Overall Study|Withdrawal by Subject|1
7591305|NCT02023866|26408169|P1|Overall Study|Adverse Event|3
7591306|NCT02023866|26408169|P1|Overall Study|Non-compliance|2
7591307|NCT02023697|26408191|P3|Long-term Follow-up Period|Other unspecified|5
7591308|NCT02023697|26408192|P2|Long-term Follow-up Period|Other unspecified|3
7591309|NCT02023697|26408193|P1|Long-term Follow-up Period|Other unspecified|6
7591310|NCT02023697|26408191|P3|Long-term Follow-up Period|Technical problems|1
7591311|NCT02023697|26408192|P2|Long-term Follow-up Period|Technical problems|0
7591312|NCT02023697|26408193|P1|Long-term Follow-up Period|Technical problems|0
7591313|NCT02023697|26408191|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
7591314|NCT02023697|26408192|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
7591315|NCT02023697|26408193|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
7591316|NCT02023697|26408191|P3|Long-term Follow-up Period|Lost to Follow-up|1
7591317|NCT02023697|26408192|P2|Long-term Follow-up Period|Lost to Follow-up|0
7591318|NCT02023697|26408193|P1|Long-term Follow-up Period|Lost to Follow-up|1
7591319|NCT02023697|26408191|P3|Long-term Follow-up Period|Withdrawal by Subject|0
7591320|NCT02023697|26408192|P2|Long-term Follow-up Period|Withdrawal by Subject|3
7591321|NCT02023697|26408193|P1|Long-term Follow-up Period|Withdrawal by Subject|6
7591322|NCT02023697|26408191|P3|Long-term Follow-up Period|Death|4
7591323|NCT02023697|26408192|P2|Long-term Follow-up Period|Death|6
7591324|NCT02023697|26408193|P1|Long-term Follow-up Period|Death|9
7591325|NCT02023697|26408191|P3|Active Follow-up Period|Death|87
7591326|NCT02023697|26408192|P2|Active Follow-up Period|Death|82
7591327|NCT02023697|26408193|P1|Active Follow-up Period|Death|83
7591328|NCT02023697|26408191|P3|Active Follow-up Period|Radiological progression|1
7591329|NCT02023697|26408192|P2|Active Follow-up Period|Radiological progression|0
7591330|NCT02023697|26408193|P1|Active Follow-up Period|Radiological progression|0
7591331|NCT02023697|26408191|P3|Active Follow-up Period|Clinical progression|1
7591332|NCT02023697|26408192|P2|Active Follow-up Period|Clinical progression|2
7591333|NCT02023697|26408193|P1|Active Follow-up Period|Clinical progression|0
7591334|NCT02023697|26408191|P3|Active Follow-up Period|Other unspecified|1
7591335|NCT02023697|26408192|P2|Active Follow-up Period|Other unspecified|0
7591336|NCT02023697|26408193|P1|Active Follow-up Period|Other unspecified|2
7591337|NCT02023697|26408191|P3|Active Follow-up Period|Deterioration of general condition|1
7591338|NCT02023697|26408192|P2|Active Follow-up Period|Deterioration of general condition|1
7591339|NCT02023697|26408193|P1|Active Follow-up Period|Deterioration of general condition|1
7591340|NCT02023697|26408191|P3|Active Follow-up Period|Lost to Follow-up|1
7591341|NCT02023697|26408192|P2|Active Follow-up Period|Lost to Follow-up|1
7591342|NCT02023697|26408193|P1|Active Follow-up Period|Lost to Follow-up|1
7591343|NCT02023697|26408191|P3|Active Follow-up Period|Withdrawal by Subject|7
7591344|NCT02023697|26408192|P2|Active Follow-up Period|Withdrawal by Subject|13
7591345|NCT02023697|26408193|P1|Active Follow-up Period|Withdrawal by Subject|5
7591346|NCT02023697|26408191|P3|Treatment Period|Physician Decision|1
7591347|NCT02023697|26408192|P2|Treatment Period|Physician Decision|0
7591348|NCT02023697|26408193|P1|Treatment Period|Physician Decision|0
7591349|NCT02023697|26408191|P3|Treatment Period|Safety outcome reached|0
7591350|NCT02023697|26408192|P2|Treatment Period|Safety outcome reached|1
7591351|NCT02023697|26408193|P1|Treatment Period|Safety outcome reached|0
7591352|NCT02023697|26408191|P3|Treatment Period|Withdrawal by Subject|13
7591353|NCT02023697|26408192|P2|Treatment Period|Withdrawal by Subject|5
7591354|NCT02023697|26408193|P1|Treatment Period|Withdrawal by Subject|4
7591355|NCT02023697|26408191|P3|Treatment Period|Clinical progression|28
7591356|NCT02023697|26408192|P2|Treatment Period|Clinical progression|8
7591357|NCT02023697|26408193|P1|Treatment Period|Clinical progression|10
7591358|NCT02023697|26408191|P3|Treatment Period|Logistical difficulties|1
7591359|NCT02023697|26408192|P2|Treatment Period|Logistical difficulties|1
7591360|NCT02023697|26408193|P1|Treatment Period|Logistical difficulties|1
7591361|NCT02023697|26408191|P3|Treatment Period|Adverse Event|23
7591362|NCT02023697|26408192|P2|Treatment Period|Adverse Event|25
7591363|NCT02023697|26408193|P1|Treatment Period|Adverse Event|13
7591364|NCT02023697|26408191|P3|Treatment Period|Never Treated|10
7591365|NCT02023697|26408192|P2|Treatment Period|Never Treated|6
7591366|NCT02023697|26408193|P1|Treatment Period|Never Treated|5
7591367|NCT02023697|26408191|P3|Treatment Period|Radiological progression|26
7591368|NCT02023697|26408192|P2|Treatment Period|Radiological progression|17
7591369|NCT02023697|26408193|P1|Treatment Period|Radiological progression|13
7591370|NCT02023268|26408317|P2|Overall Study|Withdrawal by Subject|1
7591371|NCT02023268|26408318|P1|Overall Study|Withdrawal by Subject|0
7591372|NCT02023268|26408317|P2|Overall Study|Adverse Event|2
7591373|NCT02023268|26408318|P1|Overall Study|Adverse Event|0
7591374|NCT02023268|26408317|P2|Overall Study|Lack of Efficacy|1
7591375|NCT02023268|26408318|P1|Overall Study|Lack of Efficacy|0
7591376|NCT02023242|26408326|P2|Overall Study|Death|1
7591377|NCT02023242|26408327|P1|Overall Study|Death|0
7591378|NCT02023242|26408326|P2|Overall Study|Lost to Follow-up|1
7591379|NCT02023242|26408327|P1|Overall Study|Lost to Follow-up|3
7591380|NCT02023151|26408341|P1|Overall Study|Lost to Follow-up|4
7591381|NCT02023112|26408411|P2|Overall Study|Withdrawal by Subject|1
7591382|NCT02023112|26408412|P1|Overall Study|Withdrawal by Subject|2
7591383|NCT02023099|26408433|P3|Overall Study|Non-treatment-emergent Fatal AE|1
7591384|NCT02023099|26408434|P2|Overall Study|Non-treatment-emergent Fatal AE|0
7591385|NCT02023099|26408435|P1|Overall Study|Non-treatment-emergent Fatal AE|0
7591386|NCT02023099|26408433|P3|Overall Study|Withdrawn Consent|1
7591387|NCT02023099|26408434|P2|Overall Study|Withdrawn Consent|0
7591388|NCT02023099|26408435|P1|Overall Study|Withdrawn Consent|3
7591389|NCT02023099|26408433|P3|Overall Study|Non-fatal Adverse Event (AE)|1
7591390|NCT02023099|26408434|P2|Overall Study|Non-fatal Adverse Event (AE)|0
7591391|NCT02023099|26408435|P1|Overall Study|Non-fatal Adverse Event (AE)|0
7591392|NCT02022748|26408458|P3|Overall Study|Withdrawal by Subject|0
7591393|NCT02022748|26408459|P2|Overall Study|Withdrawal by Subject|1
7591394|NCT02022748|26408460|P1|Overall Study|Withdrawal by Subject|0
7591395|NCT02022748|26408458|P3|Overall Study|Adverse Event|0
7591396|NCT02022748|26408459|P2|Overall Study|Adverse Event|1
7591397|NCT02022748|26408460|P1|Overall Study|Adverse Event|1
7591398|NCT02022670|26408508|P3|Overall Study|Adverse Event|1
7591399|NCT02022670|26408509|P2|Overall Study|Adverse Event|0
7591400|NCT02022670|26408510|P1|Overall Study|Adverse Event|1
7591401|NCT02022657|26408524|P6|Overall Study|Physician Decision|1
7591402|NCT02022657|26408525|P5|Overall Study|Physician Decision|0
7591403|NCT02022657|26408526|P4|Overall Study|Physician Decision|0
7591404|NCT02022657|26408527|P3|Overall Study|Physician Decision|0
7591405|NCT02022657|26408528|P2|Overall Study|Physician Decision|0
7591406|NCT02022657|26408529|P1|Overall Study|Physician Decision|0
7591407|NCT02022657|26408524|P6|Overall Study|Withdrawal by Subject|0
7591408|NCT02022657|26408525|P5|Overall Study|Withdrawal by Subject|0
7591409|NCT02022657|26408526|P4|Overall Study|Withdrawal by Subject|0
7591410|NCT02022657|26408527|P3|Overall Study|Withdrawal by Subject|1
7591411|NCT02022657|26408528|P2|Overall Study|Withdrawal by Subject|0
7591412|NCT02022657|26408529|P1|Overall Study|Withdrawal by Subject|2
7591413|NCT02022033|26408594|P1|Overall Study|Physician Decision|1
7591414|NCT02022007|26408608|P3|Overall Study|Noncompliant|1
7591415|NCT02022007|26408609|P2|Overall Study|Noncompliant|0
7591416|NCT02022007|26408610|P1|Overall Study|Noncompliant|0
7591417|NCT02022007|26408608|P3|Overall Study|Withdrawal by Subject|1
7591418|NCT02022007|26408609|P2|Overall Study|Withdrawal by Subject|1
7591419|NCT02022007|26408610|P1|Overall Study|Withdrawal by Subject|1
7591420|NCT02021812|26408688|P1|Overall Study|Still in study|6
7591421|NCT02021812|26408688|P1|Overall Study|Refuse to return, COVD 19, in hospice, and didn't return for visit|4
7591422|NCT02021812|26408688|P1|Overall Study|Lost to Follow-up|1
7591423|NCT02021812|26408688|P1|Overall Study|Withdrawal by Subject|3
7591424|NCT02021812|26408688|P1|Overall Study|Death|8
7591425|NCT02021656|26408707|P1|Overall Study|Withdrew Consent|2
7591426|NCT02021656|26408707|P1|Overall Study|Lost to Follow-up|1
7591427|NCT02021656|26408707|P1|Overall Study|Lack of Efficacy|2
7591428|NCT02021656|26408707|P1|Overall Study|Adverse Event|1
7591429|NCT02021643|26408727|P4|Overall Study|Withdrew Consent|0
7591430|NCT02021643|26408728|P3|Overall Study|Withdrew Consent|0
7591431|NCT02021643|26408729|P2|Overall Study|Withdrew Consent|1
7591432|NCT02021643|26408730|P1|Overall Study|Withdrew Consent|0
7591433|NCT02021643|26408727|P4|Overall Study|Lost to Follow-up|0
7591434|NCT02021643|26408728|P3|Overall Study|Lost to Follow-up|0
7591435|NCT02021643|26408729|P2|Overall Study|Lost to Follow-up|1
7591436|NCT02021643|26408730|P1|Overall Study|Lost to Follow-up|0
7591437|NCT02021643|26408727|P4|Overall Study|Lack of Efficacy|12
7591438|NCT02021643|26408728|P3|Overall Study|Lack of Efficacy|0
7591439|NCT02021643|26408729|P2|Overall Study|Lack of Efficacy|6
7591440|NCT02021643|26408730|P1|Overall Study|Lack of Efficacy|7
7591441|NCT02021643|26408727|P4|Overall Study|Investigator's Discretion|0
7591442|NCT02021643|26408728|P3|Overall Study|Investigator's Discretion|0
7591443|NCT02021643|26408729|P2|Overall Study|Investigator's Discretion|0
7591444|NCT02021643|26408730|P1|Overall Study|Investigator's Discretion|1
7591445|NCT02021643|26408727|P4|Overall Study|Death|0
7591446|NCT02021643|26408728|P3|Overall Study|Death|0
7591447|NCT02021643|26408729|P2|Overall Study|Death|1
7591448|NCT02021643|26408730|P1|Overall Study|Death|0
7591449|NCT02021643|26408727|P4|Overall Study|Adverse Event|0
7591450|NCT02021643|26408728|P3|Overall Study|Adverse Event|0
7591451|NCT02021643|26408729|P2|Overall Study|Adverse Event|1
7591452|NCT02021643|26408730|P1|Overall Study|Adverse Event|0
7591453|NCT02021643|26408727|P4|Overall Study|Enrolled but Never Treated|0
7591454|NCT02021643|26408728|P3|Overall Study|Enrolled but Never Treated|0
7591455|NCT02021643|26408729|P2|Overall Study|Enrolled but Never Treated|0
7591456|NCT02021643|26408730|P1|Overall Study|Enrolled but Never Treated|1
7591457|NCT02021565|26408772|P2|3-month Follow-up|Protocol Violation|2
7591458|NCT02021565|26408773|P1|3-month Follow-up|Protocol Violation|3
7591459|NCT02021565|26408772|P2|3-month Follow-up|Withdrawal by Subject|0
7591460|NCT02021565|26408773|P1|3-month Follow-up|Withdrawal by Subject|4
7591461|NCT02021565|26408772|P2|3-month Follow-up|Death|0
7591462|NCT02021565|26408773|P1|3-month Follow-up|Death|3
7591463|NCT02021565|26408772|P2|Baseline Through Intervention|Lost to Follow-up|2
7591464|NCT02021565|26408773|P1|Baseline Through Intervention|Lost to Follow-up|4
7591465|NCT02021565|26408772|P2|Baseline Through Intervention|Protocol Violation|7
7591466|NCT02021565|26408773|P1|Baseline Through Intervention|Protocol Violation|0
7591467|NCT02021565|26408772|P2|Baseline Through Intervention|Withdrawal by Subject|8
7591468|NCT02021565|26408773|P1|Baseline Through Intervention|Withdrawal by Subject|8
7591469|NCT02021565|26408772|P2|Baseline Through Intervention|Death|1
7591470|NCT02021565|26408773|P1|Baseline Through Intervention|Death|0
7591471|NCT02021331|26408793|P2|Overall Study|Adverse Event|2
7591472|NCT02021331|26408794|P1|Overall Study|Adverse Event|0
7591473|NCT02021318|26408806|P2|Overall Study|Miscellaneous|3
7591474|NCT02021318|26408807|P1|Overall Study|Miscellaneous|2
7591475|NCT02021318|26408806|P2|Overall Study|Physician Decision|3
7591476|NCT02021318|26408807|P1|Overall Study|Physician Decision|3
7591477|NCT02021318|26408806|P2|Overall Study|Withdrawal by Subject|18
7591478|NCT02021318|26408807|P1|Overall Study|Withdrawal by Subject|30
7591479|NCT02021318|26408806|P2|Overall Study|Progressive Disease|1
7591480|NCT02021318|26408807|P1|Overall Study|Progressive Disease|0
7591481|NCT02021318|26408806|P2|Overall Study|Lost to Follow-up|3
7591482|NCT02021318|26408807|P1|Overall Study|Lost to Follow-up|3
7591483|NCT02021318|26408806|P2|Overall Study|Death|34
7591484|NCT02021318|26408807|P1|Overall Study|Death|33
7591485|NCT02021318|26408806|P2|Overall Study|Adverse Event|1
7591486|NCT02021318|26408807|P1|Overall Study|Adverse Event|2
7591487|NCT02021292|26408935|P2|Overall Study|Death|1
7591488|NCT02021292|26408936|P1|Overall Study|Death|0
7591489|NCT02021292|26408935|P2|Overall Study|Lost to Follow-up|1
7591490|NCT02021292|26408936|P1|Overall Study|Lost to Follow-up|0
7591491|NCT02021292|26408935|P2|Overall Study|Physician Decision|1
7591492|NCT02021292|26408936|P1|Overall Study|Physician Decision|0
7591493|NCT02020967|26408968|P1|Overall Study|Withdrawal by Subject|51
7591494|NCT02020941|26408978|P1|Overall Study|Disease Progression|4
7591495|NCT02020941|26408978|P1|Overall Study|Withdrawal by Subject|1
7591496|NCT02020941|26408978|P1|Overall Study|Physician Decision|2
7591497|NCT02020941|26408978|P1|Overall Study|Adverse Event|1
7591498|NCT02020889|26408989|P2|Overall Study|Withdrawal by Subject|2
7591499|NCT02020889|26408990|P1|Overall Study|Withdrawal by Subject|3
7591500|NCT02020889|26408989|P2|Overall Study|Physician Decision|0
7591501|NCT02020889|26408990|P1|Overall Study|Physician Decision|2
7591502|NCT02020889|26408989|P2|Overall Study|Lost to Follow-up|0
7591503|NCT02020889|26408990|P1|Overall Study|Lost to Follow-up|1
7591504|NCT02020889|26408989|P2|Overall Study|Lack of Efficacy|0
7591505|NCT02020889|26408990|P1|Overall Study|Lack of Efficacy|1
7591506|NCT02020889|26408989|P2|Overall Study|Adverse Event|1
7591507|NCT02020889|26408990|P1|Overall Study|Adverse Event|0
7591508|NCT02020863|26409044|P1|Overall Study|Team chose not to place an a line|1
7591509|NCT02020863|26409044|P1|Overall Study|Discovery of Metastatic disease|4
7591510|NCT02020616|26409074|P7|Overall Study|Lack of Efficacy|0
7591511|NCT02020616|26409075|P6|Overall Study|Lack of Efficacy|0
7591512|NCT02020616|26409076|P5|Overall Study|Lack of Efficacy|1
7591513|NCT02020616|26409077|P4|Overall Study|Lack of Efficacy|0
7591514|NCT02020616|26409078|P3|Overall Study|Lack of Efficacy|0
7591515|NCT02020616|26409079|P2|Overall Study|Lack of Efficacy|0
7591516|NCT02020616|26409080|P1|Overall Study|Lack of Efficacy|0
7591517|NCT02020616|26409074|P7|Overall Study|Randomized in Error|0
7591518|NCT02020616|26409075|P6|Overall Study|Randomized in Error|0
7591519|NCT02020616|26409076|P5|Overall Study|Randomized in Error|0
7591520|NCT02020616|26409077|P4|Overall Study|Randomized in Error|1
7591521|NCT02020616|26409078|P3|Overall Study|Randomized in Error|0
7591522|NCT02020616|26409079|P2|Overall Study|Randomized in Error|0
7591523|NCT02020616|26409080|P1|Overall Study|Randomized in Error|0
7591524|NCT02020616|26409074|P7|Overall Study|Early Termination Criteria Met|0
7591525|NCT02020616|26409075|P6|Overall Study|Early Termination Criteria Met|1
7591526|NCT02020616|26409076|P5|Overall Study|Early Termination Criteria Met|0
7591527|NCT02020616|26409077|P4|Overall Study|Early Termination Criteria Met|0
7591528|NCT02020616|26409078|P3|Overall Study|Early Termination Criteria Met|1
7591529|NCT02020616|26409079|P2|Overall Study|Early Termination Criteria Met|0
7591530|NCT02020616|26409080|P1|Overall Study|Early Termination Criteria Met|0
7591531|NCT02020616|26409074|P7|Overall Study|Lost to Follow-up|0
7591532|NCT02020616|26409075|P6|Overall Study|Lost to Follow-up|1
7591533|NCT02020616|26409076|P5|Overall Study|Lost to Follow-up|1
7591534|NCT02020616|26409077|P4|Overall Study|Lost to Follow-up|1
7591535|NCT02020616|26409078|P3|Overall Study|Lost to Follow-up|0
7591536|NCT02020616|26409079|P2|Overall Study|Lost to Follow-up|1
7591537|NCT02020616|26409080|P1|Overall Study|Lost to Follow-up|0
7591538|NCT02020616|26409074|P7|Overall Study|Withdrawal by Subject|1
7591539|NCT02020616|26409075|P6|Overall Study|Withdrawal by Subject|1
7591540|NCT02020616|26409076|P5|Overall Study|Withdrawal by Subject|0
7591541|NCT02020616|26409077|P4|Overall Study|Withdrawal by Subject|0
7591542|NCT02020616|26409078|P3|Overall Study|Withdrawal by Subject|1
7591543|NCT02020616|26409079|P2|Overall Study|Withdrawal by Subject|0
7591544|NCT02020616|26409080|P1|Overall Study|Withdrawal by Subject|0
7591545|NCT02020616|26409074|P7|Overall Study|Physician Decision|2
7591546|NCT02020616|26409075|P6|Overall Study|Physician Decision|1
7591547|NCT02020616|26409076|P5|Overall Study|Physician Decision|0
7591548|NCT02020616|26409077|P4|Overall Study|Physician Decision|0
7591549|NCT02020616|26409078|P3|Overall Study|Physician Decision|0
7591550|NCT02020616|26409079|P2|Overall Study|Physician Decision|0
7591551|NCT02020616|26409080|P1|Overall Study|Physician Decision|0
7591552|NCT02020616|26409074|P7|Overall Study|Adverse Event|1
7591553|NCT02020616|26409075|P6|Overall Study|Adverse Event|1
7591554|NCT02020616|26409076|P5|Overall Study|Adverse Event|0
7591555|NCT02020616|26409077|P4|Overall Study|Adverse Event|0
7591556|NCT02020616|26409078|P3|Overall Study|Adverse Event|0
7591557|NCT02020616|26409079|P2|Overall Study|Adverse Event|0
7591558|NCT02020616|26409080|P1|Overall Study|Adverse Event|0
7591559|NCT02020577|26409177|P2|Overall Study|Other than stated above|1
7591560|NCT02020577|26409178|P1|Overall Study|Other than stated above|0
7591561|NCT02020577|26409177|P2|Overall Study|Withdrawal by Subject|1
7591562|NCT02020577|26409178|P1|Overall Study|Withdrawal by Subject|0
7591563|NCT02020577|26409177|P2|Overall Study|Other AE or clinical progression|15
7591564|NCT02020577|26409178|P1|Overall Study|Other AE or clinical progression|0
7591565|NCT02020577|26409177|P2|Overall Study|Progressive disease|38
7591566|NCT02020577|26409178|P1|Overall Study|Progressive disease|3
7591567|NCT02020512|26409205|P1|Overall Study|Protocol Violation|4
7591568|NCT02020512|26409205|P1|Overall Study|Lost to Follow-up|3
7591569|NCT02020512|26409205|P1|Overall Study|Adverse Event|1
7591570|NCT02020031|26409290|P2|Overall Study|Physician Decision|1
7591571|NCT02020031|26409291|P1|Overall Study|Physician Decision|1
7591572|NCT02019979|26409312|P1|Overall Study|study terminated|14
7591573|NCT02019927|26409328|P6|Overall Study|Lost to Follow-up|1
7591574|NCT02019927|26409329|P5|Overall Study|Lost to Follow-up|3
7591575|NCT02019927|26409330|P4|Overall Study|Lost to Follow-up|2
7591576|NCT02019927|26409331|P3|Overall Study|Lost to Follow-up|1
7591577|NCT02019927|26409332|P2|Overall Study|Lost to Follow-up|4
7591578|NCT02019927|26409333|P1|Overall Study|Lost to Follow-up|2
7591579|NCT02019719|26409455|P5|Overall Study|Physician Decision|0
7591580|NCT02019719|26409456|P4|Overall Study|Physician Decision|0
7591581|NCT02019719|26409457|P3|Overall Study|Physician Decision|0
7591582|NCT02019719|26409458|P2|Overall Study|Physician Decision|0
7591583|NCT02019719|26409459|P1|Overall Study|Physician Decision|2
7591584|NCT02019719|26409455|P5|Overall Study|Protocol defined stopping criteria|1
7591585|NCT02019719|26409456|P4|Overall Study|Protocol defined stopping criteria|1
7591586|NCT02019719|26409457|P3|Overall Study|Protocol defined stopping criteria|0
7591587|NCT02019719|26409458|P2|Overall Study|Protocol defined stopping criteria|0
7591588|NCT02019719|26409459|P1|Overall Study|Protocol defined stopping criteria|2
7591589|NCT02019719|26409455|P5|Overall Study|Protocol Violation|0
7591590|NCT02019719|26409456|P4|Overall Study|Protocol Violation|0
7591591|NCT02019719|26409457|P3|Overall Study|Protocol Violation|0
7591592|NCT02019719|26409458|P2|Overall Study|Protocol Violation|1
7591593|NCT02019719|26409459|P1|Overall Study|Protocol Violation|1
7591594|NCT02019719|26409455|P5|Overall Study|Adverse Event|1
7591595|NCT02019719|26409456|P4|Overall Study|Adverse Event|1
7591596|NCT02019719|26409457|P3|Overall Study|Adverse Event|0
7591597|NCT02019719|26409458|P2|Overall Study|Adverse Event|0
7591598|NCT02019719|26409459|P1|Overall Study|Adverse Event|1
7591599|NCT02019667|26409556|P2|2nd Intervention (6 Months)|Physician Decision|1
7591600|NCT02019667|26409557|P1|2nd Intervention (6 Months)|Physician Decision|0
7591601|NCT02019667|26409556|P2|2nd Intervention (6 Months)|Adverse Event|1
7591602|NCT02019667|26409557|P1|2nd Intervention (6 Months)|Adverse Event|0
7591603|NCT02019667|26409556|P2|First Intervention (6 Months)|Adverse Event|1
7591604|NCT02019667|26409557|P1|First Intervention (6 Months)|Adverse Event|0
7591605|NCT02019602|26409577|P2|Screening Period|Adverse Event|0
7591606|NCT02019602|26409578|P1|Screening Period|Adverse Event|1
7591607|NCT02019602|26409577|P2|Screening Period|Ineligibility|0
7591608|NCT02019602|26409578|P1|Screening Period|Ineligibility|4
7591609|NCT02019550|26409607|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
7591610|NCT02019550|26409608|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
7591611|NCT02019472|26409649|P3|Overall Study|Other|6
7591612|NCT02019472|26409650|P2|Overall Study|Other|8
7591613|NCT02019472|26409651|P1|Overall Study|Other|3
7591614|NCT02019472|26409649|P3|Overall Study|Withdrawal by Subject|11
7591615|NCT02019472|26409650|P2|Overall Study|Withdrawal by Subject|10
7591616|NCT02019472|26409651|P1|Overall Study|Withdrawal by Subject|11
7591617|NCT02019472|26409649|P3|Overall Study|Pregnancy|2
7591618|NCT02019472|26409650|P2|Overall Study|Pregnancy|2
7591619|NCT02019472|26409651|P1|Overall Study|Pregnancy|1
7591620|NCT02019472|26409649|P3|Overall Study|Physician Decision|0
7591621|NCT02019472|26409650|P2|Overall Study|Physician Decision|2
7591622|NCT02019472|26409651|P1|Overall Study|Physician Decision|1
7591623|NCT02019472|26409649|P3|Overall Study|Lost to Follow-up|1
7591624|NCT02019472|26409650|P2|Overall Study|Lost to Follow-up|2
7591625|NCT02019472|26409651|P1|Overall Study|Lost to Follow-up|0
7591626|NCT02019472|26409649|P3|Overall Study|Lack of Efficacy|4
7591627|NCT02019472|26409650|P2|Overall Study|Lack of Efficacy|4
7591628|NCT02019472|26409651|P1|Overall Study|Lack of Efficacy|7
7591629|NCT02019472|26409649|P3|Overall Study|Death|1
7591630|NCT02019472|26409650|P2|Overall Study|Death|1
7591631|NCT02019472|26409651|P1|Overall Study|Death|0
7591632|NCT02019472|26409649|P3|Overall Study|Adverse Event|17
7591633|NCT02019472|26409650|P2|Overall Study|Adverse Event|23
7591634|NCT02019472|26409651|P1|Overall Study|Adverse Event|14
7591635|NCT02019420|26409674|P2|Overall Study|Transferred to other care facility|1
7591636|NCT02019420|26409675|P1|Overall Study|Transferred to other care facility|1
7591637|NCT02019420|26409674|P2|Overall Study|Death|99
7591638|NCT02019420|26409675|P1|Overall Study|Death|104
7591639|NCT02019420|26409674|P2|Overall Study|At request of sponsor or investigator|1
7591640|NCT02019420|26409675|P1|Overall Study|At request of sponsor or investigator|0
7591641|NCT02019420|26409674|P2|Overall Study|Withdrawal by Subject|3
7591642|NCT02019420|26409675|P1|Overall Study|Withdrawal by Subject|1
7591643|NCT02019420|26409674|P2|Overall Study|Did not receive study drug|2
7591644|NCT02019420|26409675|P1|Overall Study|Did not receive study drug|2
7591645|NCT02019277|26409703|P1|Overall Study|Adverse Event|1
7591646|NCT02019277|26409703|P1|Overall Study|Did no Cooperate|1
7591647|NCT02019277|26409703|P1|Overall Study|Death|7
7591648|NCT02019277|26409703|P1|Overall Study|Withdrawal by Subject|3
7591649|NCT02019264|26409722|P2|Overall Study|Missing|11
7591650|NCT02019264|26409723|P1|Overall Study|Missing|14
7591651|NCT02019264|26409722|P2|Overall Study|Administrative reason|28
7591652|NCT02019264|26409723|P1|Overall Study|Administrative reason|36
7591653|NCT02019264|26409722|P2|Overall Study|Withdrawal by Subject|117
7591654|NCT02019264|26409723|P1|Overall Study|Withdrawal by Subject|142
7591655|NCT02019264|26409722|P2|Overall Study|Lost to Follow-up|47
7591656|NCT02019264|26409723|P1|Overall Study|Lost to Follow-up|50
7591657|NCT02019264|26409722|P2|Overall Study|Not treated|4
7591658|NCT02019264|26409723|P1|Overall Study|Not treated|6
7591659|NCT02019108|26409759|P2|Overall Study|Lost to Follow-up|7
7591660|NCT02019108|26409760|P1|Overall Study|Lost to Follow-up|5
7591661|NCT02018887|26409802|P11|Part C: Cohort 8 Overall|Physician Decision|1
7591662|NCT02018887|26409803|P10|Part C: Cohort 8 Overall|Physician Decision|0
7591663|NCT02018887|26409804|P9|Part C: Cohort 8 Overall|Physician Decision|2
7591664|NCT02018887|26409805|P8|Part C: Cohort 8 Overall|Physician Decision|0
7591665|NCT02018887|26409806|P7|Part C: Cohort 8 Overall|Physician Decision|0
7591666|NCT02018887|26409807|P6|Part C: Cohort 8 Overall|Physician Decision|0
7591667|NCT02018887|26409808|P5|Part C: Cohort 8 Overall|Physician Decision|0
7591668|NCT02018887|26409809|P4|Part C: Cohort 8 Overall|Physician Decision|0
7591669|NCT02018887|26409810|P3|Part C: Cohort 8 Overall|Physician Decision|0
7591670|NCT02018887|26409811|P2|Part C: Cohort 8 Overall|Physician Decision|0
7591671|NCT02018887|26409812|P1|Part C: Cohort 8 Overall|Physician Decision|0
7591672|NCT02018887|26409802|P11|Part C: Cohort 8 Overall|Adverse Event|0
7591673|NCT02018887|26409803|P10|Part C: Cohort 8 Overall|Adverse Event|3
7591674|NCT02018887|26409804|P9|Part C: Cohort 8 Overall|Adverse Event|1
7591675|NCT02018887|26409805|P8|Part C: Cohort 8 Overall|Adverse Event|0
7591676|NCT02018887|26409806|P7|Part C: Cohort 8 Overall|Adverse Event|0
7591677|NCT02018887|26409807|P6|Part C: Cohort 8 Overall|Adverse Event|0
7591678|NCT02018887|26409808|P5|Part C: Cohort 8 Overall|Adverse Event|0
7591679|NCT02018887|26409809|P4|Part C: Cohort 8 Overall|Adverse Event|0
7591680|NCT02018887|26409810|P3|Part C: Cohort 8 Overall|Adverse Event|0
7591681|NCT02018887|26409811|P2|Part C: Cohort 8 Overall|Adverse Event|0
7591682|NCT02018887|26409812|P1|Part C: Cohort 8 Overall|Adverse Event|0
7591683|NCT02018887|26409802|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591684|NCT02018887|26409803|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591685|NCT02018887|26409804|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591686|NCT02018887|26409805|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
7591687|NCT02018887|26409806|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
7591688|NCT02018887|26409807|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591689|NCT02018887|26409808|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
7591690|NCT02018887|26409809|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591691|NCT02018887|26409810|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591692|NCT02018887|26409811|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591693|NCT02018887|26409812|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
7591694|NCT02018887|26409802|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591695|NCT02018887|26409803|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591696|NCT02018887|26409804|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591697|NCT02018887|26409805|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591698|NCT02018887|26409806|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591699|NCT02018887|26409807|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591700|NCT02018887|26409808|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591701|NCT02018887|26409809|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591702|NCT02018887|26409810|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591703|NCT02018887|26409811|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7591704|NCT02018887|26409812|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
7591705|NCT02018822|26409901|P3|Overall Study|Lost to Follow-up|5
7591706|NCT02018822|26409902|P2|Overall Study|Lost to Follow-up|6
7591707|NCT02018822|26409903|P1|Overall Study|Lost to Follow-up|6
7591708|NCT02018822|26409901|P3|Overall Study|Physician Decision|1
7591709|NCT02018822|26409902|P2|Overall Study|Physician Decision|1
7591710|NCT02018822|26409903|P1|Overall Study|Physician Decision|0
7591711|NCT02018822|26409901|P3|Overall Study|filling replaced by crown|0
7591712|NCT02018822|26409902|P2|Overall Study|filling replaced by crown|1
7591713|NCT02018822|26409903|P1|Overall Study|filling replaced by crown|0
7591714|NCT02018562|26409983|P2|Overall Study|Discharged prior to study completion|0
7591715|NCT02018562|26409984|P1|Overall Study|Discharged prior to study completion|1
7591716|NCT02018562|26409983|P2|Overall Study|Withdrawal by Subject|0
7591717|NCT02018562|26409984|P1|Overall Study|Withdrawal by Subject|2
7591718|NCT02018458|26410002|P1|Overall Study|Death|4
7591719|NCT02018042|26410029|P1|Overall Study|Withdrawal by Subject|1
7591720|NCT02017964|26410035|P1|Overall Study|Patient deemed ineligible|1
7591721|NCT02017899|26410049|P6|Overall Study|Withdrawal by Subject|0
7591722|NCT02017899|26410050|P5|Overall Study|Withdrawal by Subject|1
7591723|NCT02017899|26410051|P4|Overall Study|Withdrawal by Subject|1
7591724|NCT02017899|26410052|P3|Overall Study|Withdrawal by Subject|0
7591725|NCT02017899|26410053|P2|Overall Study|Withdrawal by Subject|0
7591726|NCT02017899|26410054|P1|Overall Study|Withdrawal by Subject|0
7591727|NCT02017860|26410128|P1|Overall Study|Withdrawal by Subject|1
7591728|NCT02017860|26410128|P1|Overall Study|Adverse Event|1
7591729|NCT02017535|26410147|P4|Overall Study|Withdrawal by Subject|0
7591730|NCT02017535|26410148|P3|Overall Study|Withdrawal by Subject|0
7591731|NCT02017535|26410149|P2|Overall Study|Withdrawal by Subject|0
7591732|NCT02017535|26410150|P1|Overall Study|Withdrawal by Subject|1
7591733|NCT02017522|26410172|P1|Overall Study|Withdrawal by Subject|1
7591734|NCT02017223|26410218|P1|Overall Study|Algorithm problems|2
7591735|NCT02017171|26410264|P2|Overall Study|Miscellaneous|3
7591736|NCT02017171|26410265|P1|Overall Study|Miscellaneous|2
7591737|NCT02017171|26410264|P2|Overall Study|ESKD|2
7591738|NCT02017171|26410265|P1|Overall Study|ESKD|6
7591739|NCT02017171|26410264|P2|Overall Study|Lost to Follow-up|20
7591740|NCT02017171|26410265|P1|Overall Study|Lost to Follow-up|21
7591741|NCT02017171|26410264|P2|Overall Study|Withdrawal by Subject|17
7591742|NCT02017171|26410265|P1|Overall Study|Withdrawal by Subject|23
7591743|NCT02017171|26410264|P2|Overall Study|Death|4
7591744|NCT02017171|26410265|P1|Overall Study|Death|10
7591745|NCT02017015|26410298|P1|Overall Study|Physician Decision|2
7591746|NCT02017015|26410298|P1|Overall Study|Non-compliance with study drug|2
7591747|NCT02017015|26410298|P1|Overall Study|Progressive Disease|31
7591748|NCT02017015|26410298|P1|Overall Study|Death|4
7591749|NCT02017015|26410298|P1|Overall Study|Withdrawal by Subject|21
7591750|NCT02017015|26410298|P1|Overall Study|Adverse Event|9
7591751|NCT02016898|26410323|P2|Overall Study|Lost to Follow-up|4
7591752|NCT02016898|26410324|P1|Overall Study|Lost to Follow-up|4
7591753|NCT02016898|26410323|P2|Overall Study|Death|1
7591754|NCT02016898|26410324|P1|Overall Study|Death|1
7591755|NCT02016755|26410378|P1|Overall Study|Death|2
7591756|NCT02016755|26410378|P1|Overall Study|Physician Decision|1
7591757|NCT02016755|26410378|P1|Overall Study|Adverse Event|2
7591758|NCT02016755|26410378|P1|Overall Study|Major amputation of index limb|2
7591759|NCT02016716|26410397|P3|Overall Study|Lost to Follow-up|1
7591760|NCT02016716|26410398|P2|Overall Study|Lost to Follow-up|2
7591761|NCT02016716|26410399|P1|Overall Study|Lost to Follow-up|1
7591762|NCT02016716|26410397|P3|Overall Study|Protocol-specified Criteria|0
7591763|NCT02016716|26410398|P2|Overall Study|Protocol-specified Criteria|1
7591764|NCT02016716|26410399|P1|Overall Study|Protocol-specified Criteria|0
7591765|NCT02016716|26410397|P3|Overall Study|Withdrawal by Subject|5
7591766|NCT02016716|26410398|P2|Overall Study|Withdrawal by Subject|5
7591767|NCT02016716|26410399|P1|Overall Study|Withdrawal by Subject|5
7591768|NCT02016690|26410420|P1|Overall Study|Hospitalized for RSV at study start|3
7591769|NCT02016690|26410420|P1|Overall Study|Did not meet inclusion criteria|13
7591770|NCT02016690|26410420|P1|Overall Study|Excluded from SAS: Ineligible for study|2
7591771|NCT02016690|26410420|P1|Overall Study|Excluded from SAS: Early treatment|2
7591772|NCT02016690|26410420|P1|Overall Study|Excluded from SAS: Duplication|2
7591773|NCT02016690|26410420|P1|Overall Study|Excluded from SAS: Enrollment violation|2
7591774|NCT02016625|26410433|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
7591775|NCT02016625|26410434|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
7591776|NCT02016625|26410433|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
7591777|NCT02016625|26410434|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
7591778|NCT02016625|26410433|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
7591779|NCT02016625|26410434|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
7591780|NCT02016482|26410522|P2|Period B|Required Alternative/Prohibited Therapy|2
7591781|NCT02016482|26410523|P1|Period B|Required Alternative/Prohibited Therapy|0
7591782|NCT02016482|26410522|P2|Period B|Other|0
7591783|NCT02016482|26410523|P1|Period B|Other|4
7591784|NCT02016482|26410522|P2|Period B|Lack of Efficacy|4
7591785|NCT02016482|26410523|P1|Period B|Lack of Efficacy|6
7591786|NCT02016482|26410522|P2|Period B|Lost to Follow-up|0
7591787|NCT02016482|26410523|P1|Period B|Lost to Follow-up|2
7591788|NCT02016482|26410522|P2|Period B|Withdrawal by Subject|1
7591789|NCT02016482|26410523|P1|Period B|Withdrawal by Subject|1
7591790|NCT02016482|26410522|P2|Period A|Required Alternative/Prohibited Therapy|1
7591791|NCT02016482|26410523|P1|Period A|Required Alternative/Prohibited Therapy|0
7591792|NCT02016482|26410522|P2|Period A|Protocol Violation|1
7591793|NCT02016482|26410523|P1|Period A|Protocol Violation|0
7591794|NCT02016482|26410522|P2|Period A|Other|0
7591795|NCT02016482|26410523|P1|Period A|Other|3
7591796|NCT02016482|26410522|P2|Period A|Lack of Efficacy|1
7591797|NCT02016482|26410523|P1|Period A|Lack of Efficacy|2
7591798|NCT02016482|26410522|P2|Period A|Lost to Follow-up|3
7591799|NCT02016482|26410523|P1|Period A|Lost to Follow-up|3
7591800|NCT02016482|26410522|P2|Period A|Withdrawal by Subject|4
7591801|NCT02016482|26410523|P1|Period A|Withdrawal by Subject|3
7591802|NCT02016482|26410522|P2|Period A|Adverse Event|5
7591803|NCT02016482|26410523|P1|Period A|Adverse Event|3
7591804|NCT02016300|26410613|P2|Overall Study|Lost to Follow-up|3
7591805|NCT02016300|26410614|P1|Overall Study|Lost to Follow-up|0
7591806|NCT02016183|26410645|P1|Overall Study|Protocol Violation|52
7591807|NCT02016183|26410645|P1|Overall Study|Case Report Forms Uncollected|13
7591808|NCT02016170|26410655|P3|Overall Study|Protocol Violation|0
7591809|NCT02016170|26410656|P2|Overall Study|Protocol Violation|0
7591810|NCT02016170|26410657|P1|Overall Study|Protocol Violation|1
7591811|NCT02016170|26410655|P3|Overall Study|Adverse Event|0
7591812|NCT02016170|26410656|P2|Overall Study|Adverse Event|1
7591813|NCT02016170|26410657|P1|Overall Study|Adverse Event|1
7591814|NCT02016105|26410668|P6|EXTENSION PERIOD|Lost to Follow-up|2
7591815|NCT02016105|26410669|P5|EXTENSION PERIOD|Lost to Follow-up|0
7591816|NCT02016105|26410670|P4|EXTENSION PERIOD|Lost to Follow-up|0
7591817|NCT02016105|26410671|P3|EXTENSION PERIOD|Lost to Follow-up|0
7591818|NCT02016105|26410672|P2|EXTENSION PERIOD|Lost to Follow-up|0
7591819|NCT02016105|26410673|P1|EXTENSION PERIOD|Lost to Follow-up|0
7591820|NCT02016105|26410668|P6|EXTENSION PERIOD|Non-compliance with study indication|0
7591821|NCT02016105|26410669|P5|EXTENSION PERIOD|Non-compliance with study indication|1
7591822|NCT02016105|26410670|P4|EXTENSION PERIOD|Non-compliance with study indication|0
7591823|NCT02016105|26410671|P3|EXTENSION PERIOD|Non-compliance with study indication|0
7591824|NCT02016105|26410672|P2|EXTENSION PERIOD|Non-compliance with study indication|0
7591825|NCT02016105|26410673|P1|EXTENSION PERIOD|Non-compliance with study indication|0
7591826|NCT02016105|26410668|P6|EXTENSION PERIOD|Withdrawal by Subject|2
7591827|NCT02016105|26410669|P5|EXTENSION PERIOD|Withdrawal by Subject|2
7591828|NCT02016105|26410670|P4|EXTENSION PERIOD|Withdrawal by Subject|2
7591829|NCT02016105|26410671|P3|EXTENSION PERIOD|Withdrawal by Subject|2
7591830|NCT02016105|26410672|P2|EXTENSION PERIOD|Withdrawal by Subject|0
7591831|NCT02016105|26410673|P1|EXTENSION PERIOD|Withdrawal by Subject|0
7591832|NCT02016105|26410668|P6|EXTENSION PERIOD|Adverse Event|0
7591833|NCT02016105|26410669|P5|EXTENSION PERIOD|Adverse Event|1
7591834|NCT02016105|26410670|P4|EXTENSION PERIOD|Adverse Event|0
7591835|NCT02016105|26410671|P3|EXTENSION PERIOD|Adverse Event|2
7591836|NCT02016105|26410672|P2|EXTENSION PERIOD|Adverse Event|0
7591837|NCT02016105|26410673|P1|EXTENSION PERIOD|Adverse Event|0
7591838|NCT02016105|26410668|P6|EXTENSION PERIOD|Lack of Efficacy|1
7591839|NCT02016105|26410669|P5|EXTENSION PERIOD|Lack of Efficacy|1
7591840|NCT02016105|26410670|P4|EXTENSION PERIOD|Lack of Efficacy|3
7591841|NCT02016105|26410671|P3|EXTENSION PERIOD|Lack of Efficacy|1
7591842|NCT02016105|26410672|P2|EXTENSION PERIOD|Lack of Efficacy|0
7591843|NCT02016105|26410673|P1|EXTENSION PERIOD|Lack of Efficacy|0
7591844|NCT02016105|26410668|P6|EXTENSION PERIOD|New therapy for study indication|1
7591845|NCT02016105|26410669|P5|EXTENSION PERIOD|New therapy for study indication|1
7591846|NCT02016105|26410670|P4|EXTENSION PERIOD|New therapy for study indication|0
7591847|NCT02016105|26410671|P3|EXTENSION PERIOD|New therapy for study indication|0
7591848|NCT02016105|26410672|P2|EXTENSION PERIOD|New therapy for study indication|0
7591849|NCT02016105|26410673|P1|EXTENSION PERIOD|New therapy for study indication|0
7591850|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
7591851|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
7591852|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
7591853|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
7591854|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
7591855|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
7591856|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
7591857|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
7591858|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
7591859|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
7591860|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
7591861|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
7591862|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Adverse Event|1
7591863|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Adverse Event|0
7591864|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Adverse Event|4
7591865|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Adverse Event|0
7591866|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Adverse Event|0
7591867|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Adverse Event|0
7591868|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Death|1
7591869|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Death|0
7591870|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Death|0
7591871|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Death|0
7591872|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Death|0
7591873|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Death|0
7591874|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Pregnancy|1
7591875|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Pregnancy|0
7591876|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Pregnancy|0
7591877|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Pregnancy|0
7591878|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Pregnancy|0
7591879|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Pregnancy|0
7591880|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
7591881|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
7591882|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
7591883|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
7591884|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
7591885|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
7591886|NCT02016105|26410668|P6|TREATMENT PERIOD 2|Non compliance study medication|1
7591887|NCT02016105|26410669|P5|TREATMENT PERIOD 2|Non compliance study medication|0
7591888|NCT02016105|26410670|P4|TREATMENT PERIOD 2|Non compliance study medication|0
7591889|NCT02016105|26410671|P3|TREATMENT PERIOD 2|Non compliance study medication|0
7591890|NCT02016105|26410672|P2|TREATMENT PERIOD 2|Non compliance study medication|0
7591891|NCT02016105|26410673|P1|TREATMENT PERIOD 2|Non compliance study medication|0
7591892|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
7591893|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
7591894|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
7591895|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
7591896|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
7591897|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
7591898|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
7591899|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
7591900|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
7591901|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
7591902|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
7591903|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
7591904|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Adverse Event|0
7591905|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Adverse Event|0
7591906|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Adverse Event|0
7591907|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Adverse Event|0
7591908|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Adverse Event|5
7591909|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Adverse Event|3
7591910|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Pregnancy|0
7591911|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Pregnancy|0
7591912|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Pregnancy|0
7591913|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Pregnancy|0
7591914|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Pregnancy|1
7591915|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Pregnancy|0
7591916|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
7591917|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
7591918|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
7591919|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
7591920|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
7591921|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
7591922|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Physician Decision|0
7591923|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Physician Decision|0
7591924|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Physician Decision|0
7591925|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Physician Decision|0
7591926|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Physician Decision|2
7591927|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Physician Decision|0
7591928|NCT02016105|26410668|P6|TREATMENT PERIOD 1|Protocol Violation|0
7591929|NCT02016105|26410669|P5|TREATMENT PERIOD 1|Protocol Violation|0
7591930|NCT02016105|26410670|P4|TREATMENT PERIOD 1|Protocol Violation|0
7591931|NCT02016105|26410671|P3|TREATMENT PERIOD 1|Protocol Violation|0
7591932|NCT02016105|26410672|P2|TREATMENT PERIOD 1|Protocol Violation|8
7591933|NCT02016105|26410673|P1|TREATMENT PERIOD 1|Protocol Violation|2
7591938|NCT02015793|26410764|P2|Overall Study|Withdrawal by Subject|1
7591939|NCT02015793|26410765|P1|Overall Study|Withdrawal by Subject|1
7591940|NCT02015793|26410764|P2|Overall Study|Adverse Event|3
7591941|NCT02015793|26410765|P1|Overall Study|Adverse Event|3
7591942|NCT02015754|26410795|P1|Overall Study|Lost to Follow-up|1
7591943|NCT02015754|26410795|P1|Overall Study|Change in treatment modality|5
7591944|NCT02015754|26410795|P1|Overall Study|Disease progression|5
7591945|NCT02015676|26410815|P3|Overall Study|Disease progression|1
7591946|NCT02015676|26410816|P2|Overall Study|Disease progression|1
7591947|NCT02015676|26410817|P1|Overall Study|Disease progression|3
7591948|NCT02015676|26410815|P3|Overall Study|Death|0
7591949|NCT02015676|26410816|P2|Overall Study|Death|1
7591950|NCT02015676|26410817|P1|Overall Study|Death|0
7591951|NCT02015676|26410815|P3|Overall Study|Administrative reasons|1
7591952|NCT02015676|26410816|P2|Overall Study|Administrative reasons|3
7591953|NCT02015676|26410817|P1|Overall Study|Administrative reasons|0
7591954|NCT02015676|26410815|P3|Overall Study|Withdrawal by Subject|1
7591955|NCT02015676|26410816|P2|Overall Study|Withdrawal by Subject|7
7591956|NCT02015676|26410817|P1|Overall Study|Withdrawal by Subject|1
7591957|NCT02015676|26410815|P3|Overall Study|Protocol Violation|0
7591958|NCT02015676|26410816|P2|Overall Study|Protocol Violation|0
7591959|NCT02015676|26410817|P1|Overall Study|Protocol Violation|1
7591960|NCT02015676|26410815|P3|Overall Study|Lack of Efficacy|0
7591961|NCT02015676|26410816|P2|Overall Study|Lack of Efficacy|4
7591962|NCT02015676|26410817|P1|Overall Study|Lack of Efficacy|2
7591963|NCT02015676|26410815|P3|Overall Study|Adverse Event|0
7591964|NCT02015676|26410816|P2|Overall Study|Adverse Event|18
7591965|NCT02015676|26410817|P1|Overall Study|Adverse Event|2
7591966|NCT02015663|26410833|P2|Overall Study|Administrative problems|11
7591967|NCT02015663|26410834|P1|Overall Study|Administrative problems|10
7591968|NCT02015663|26410833|P2|Overall Study|Adverse Event|0
7591969|NCT02015663|26410834|P1|Overall Study|Adverse Event|3
7591970|NCT02015663|26410833|P2|Overall Study|Protocol Violation|1
7591971|NCT02015663|26410834|P1|Overall Study|Protocol Violation|0
7591972|NCT02015663|26410833|P2|Overall Study|Withdrawal by Subject|0
7591973|NCT02015663|26410834|P1|Overall Study|Withdrawal by Subject|1
7591974|NCT02015663|26410833|P2|Overall Study|unsatisfactory therapeutic effect|0
7591975|NCT02015663|26410834|P1|Overall Study|unsatisfactory therapeutic effect|1
7591976|NCT02015637|26410865|P2|Overall Study|Did not take study drug|0
7591977|NCT02015637|26410866|P1|Overall Study|Did not take study drug|2
7591978|NCT02015637|26410865|P2|Overall Study|Adverse Event|0
7591979|NCT02015637|26410866|P1|Overall Study|Adverse Event|3
7591980|NCT02015637|26410865|P2|Overall Study|Lost to Follow-up|5
7591981|NCT02015637|26410866|P1|Overall Study|Lost to Follow-up|3
7591982|NCT02015546|26410877|P3|Overall Study|Screem Failure|3
7591983|NCT02015546|26410878|P2|Overall Study|Screem Failure|1
7591984|NCT02015546|26410879|P1|Overall Study|Screem Failure|2
7591985|NCT02015546|26410877|P3|Overall Study|Withdrawal by Subject|1
7591986|NCT02015546|26410878|P2|Overall Study|Withdrawal by Subject|1
7591987|NCT02015546|26410879|P1|Overall Study|Withdrawal by Subject|1
7591988|NCT02015520|26410915|P4|Overall Study|Subject no Longer Meets Study Criteria|0
7591989|NCT02015520|26410916|P3|Overall Study|Subject no Longer Meets Study Criteria|0
7591990|NCT02015520|26410917|P2|Overall Study|Subject no Longer Meets Study Criteria|1
7591991|NCT02015520|26410918|P1|Overall Study|Subject no Longer Meets Study Criteria|0
7591992|NCT02015520|26410915|P4|Overall Study|Subject Request to Discontinue Study Treatment|1
7591993|NCT02015520|26410916|P3|Overall Study|Subject Request to Discontinue Study Treatment|2
7591994|NCT02015520|26410917|P2|Overall Study|Subject Request to Discontinue Study Treatment|1
7591995|NCT02015520|26410918|P1|Overall Study|Subject Request to Discontinue Study Treatment|1
7591996|NCT02015520|26410915|P4|Overall Study|Lost to Follow-up|0
7591997|NCT02015520|26410916|P3|Overall Study|Lost to Follow-up|1
7591998|NCT02015520|26410917|P2|Overall Study|Lost to Follow-up|0
7591999|NCT02015520|26410918|P1|Overall Study|Lost to Follow-up|0
7592000|NCT02015520|26410915|P4|Overall Study|Death|0
7592001|NCT02015520|26410916|P3|Overall Study|Death|0
7592002|NCT02015520|26410917|P2|Overall Study|Death|0
7592003|NCT02015520|26410918|P1|Overall Study|Death|1
7592004|NCT02015520|26410915|P4|Overall Study|Withdrawal by Subject|0
7592005|NCT02015520|26410916|P3|Overall Study|Withdrawal by Subject|1
7592006|NCT02015520|26410917|P2|Overall Study|Withdrawal by Subject|2
7592007|NCT02015520|26410918|P1|Overall Study|Withdrawal by Subject|2
7592008|NCT02015520|26410915|P4|Overall Study|Adverse Event|1
7592009|NCT02015520|26410916|P3|Overall Study|Adverse Event|0
7592010|NCT02015520|26410917|P2|Overall Study|Adverse Event|0
7592011|NCT02015520|26410918|P1|Overall Study|Adverse Event|0
7592012|NCT02015520|26410915|P4|Overall Study|Lack of Efficacy|2
7592013|NCT02015520|26410916|P3|Overall Study|Lack of Efficacy|3
7592014|NCT02015520|26410917|P2|Overall Study|Lack of Efficacy|0
7592015|NCT02015520|26410918|P1|Overall Study|Lack of Efficacy|1
7592016|NCT02015481|26410956|P1|Overall Study|Death|1
7592017|NCT02015390|26410974|P2|Overall Study|Physician Decision|1
7592018|NCT02015390|26410975|P1|Overall Study|Physician Decision|0
7592019|NCT02015390|26410974|P2|Overall Study|Adverse Event|3
7592020|NCT02015390|26410975|P1|Overall Study|Adverse Event|0
7592021|NCT02015390|26410974|P2|Overall Study|Lost to Follow-up|0
7592022|NCT02015390|26410975|P1|Overall Study|Lost to Follow-up|1
7592023|NCT02015221|26411012|P2|Overall Study|Lost to Follow-up|0
7592024|NCT02015221|26411013|P1|Overall Study|Lost to Follow-up|1
7592025|NCT02015221|26411012|P2|Overall Study|Withdrawal by Subject|6
7592026|NCT02015221|26411013|P1|Overall Study|Withdrawal by Subject|8
7592027|NCT02015195|26411026|P7|Overall Study|Adverse Event|0
7592028|NCT02015195|26411027|P6|Overall Study|Adverse Event|0
7592029|NCT02015195|26411028|P5|Overall Study|Adverse Event|0
7592030|NCT02015195|26411029|P4|Overall Study|Adverse Event|1
7592031|NCT02015195|26411030|P3|Overall Study|Adverse Event|0
7592032|NCT02015195|26411031|P2|Overall Study|Adverse Event|0
7592033|NCT02015195|26411032|P1|Overall Study|Adverse Event|0
7592034|NCT02015104|26411055|P2|Overall Study|Withdrew consent prior to treatment|1
7592035|NCT02015104|26411056|P1|Overall Study|Withdrew consent prior to treatment|0
7592036|NCT02015104|26411055|P2|Overall Study|Withdrew consent after first dose drug|0
7592037|NCT02015104|26411056|P1|Overall Study|Withdrew consent after first dose drug|1
7592038|NCT02015065|26411073|P3|Overall Study|Death on study|1
7592039|NCT02015065|26411074|P2|Overall Study|Death on study|2
7592040|NCT02015065|26411075|P1|Overall Study|Death on study|1
7592041|NCT02015039|26411097|P2|Overall Study|Not eligible|1
7592042|NCT02015039|26411098|P1|Overall Study|Not eligible|0
7592043|NCT02014740|26411118|P2|Overall Study|Withdrawal by Subject|1
7592044|NCT02014740|26411119|P1|Overall Study|Withdrawal by Subject|2
7592045|NCT02014740|26411118|P2|Overall Study|Lost to Follow-up|4
7592046|NCT02014740|26411119|P1|Overall Study|Lost to Follow-up|4
7592047|NCT02014597|26411127|P2|Overall Study|Unable to record log contrast sensitivity|1
7592048|NCT02014597|26411128|P1|Overall Study|Unable to record log contrast sensitivity|2
7592049|NCT02014584|26411144|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7592050|NCT02014584|26411145|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
7592051|NCT02014584|26411146|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7592052|NCT02014584|26411147|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7592053|NCT02014584|26411148|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7592054|NCT02014584|26411149|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7592055|NCT02014584|26411144|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7592056|NCT02014584|26411145|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7592057|NCT02014584|26411146|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
7592058|NCT02014584|26411147|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
7592059|NCT02014584|26411148|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7592060|NCT02014584|26411149|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7592061|NCT02014584|26411144|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7592062|NCT02014584|26411145|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7592063|NCT02014584|26411146|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7592064|NCT02014584|26411147|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
7592065|NCT02014584|26411148|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7592066|NCT02014584|26411149|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7592067|NCT02014584|26411144|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7592068|NCT02014584|26411145|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7592069|NCT02014584|26411146|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7592070|NCT02014584|26411147|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7592071|NCT02014584|26411148|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
7592072|NCT02014584|26411149|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
7592073|NCT02014584|26411144|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
7592074|NCT02014584|26411145|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
7592075|NCT02014584|26411146|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
7592076|NCT02014584|26411147|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
7592077|NCT02014584|26411148|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
7592078|NCT02014584|26411149|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
7592079|NCT02014558|26411279|P13|Overall Study|Miscellaneous|1
7592080|NCT02014558|26411280|P12|Overall Study|Miscellaneous|11
7592081|NCT02014558|26411281|P11|Overall Study|Miscellaneous|12
7592082|NCT02014558|26411282|P10|Overall Study|Miscellaneous|3
7592083|NCT02014558|26411283|P9|Overall Study|Miscellaneous|1
7592084|NCT02014558|26411284|P8|Overall Study|Miscellaneous|1
7592085|NCT02014558|26411285|P7|Overall Study|Miscellaneous|0
7592086|NCT02014558|26411286|P6|Overall Study|Miscellaneous|1
7592087|NCT02014558|26411287|P5|Overall Study|Miscellaneous|0
7592088|NCT02014558|26411288|P4|Overall Study|Miscellaneous|1
7592089|NCT02014558|26411289|P3|Overall Study|Miscellaneous|1
7592090|NCT02014558|26411290|P2|Overall Study|Miscellaneous|1
7592091|NCT02014558|26411291|P1|Overall Study|Miscellaneous|2
7592092|NCT02014558|26411279|P13|Overall Study|Withdrawal by Subject|0
7592093|NCT02014558|26411280|P12|Overall Study|Withdrawal by Subject|10
7592094|NCT02014558|26411281|P11|Overall Study|Withdrawal by Subject|6
7592095|NCT02014558|26411282|P10|Overall Study|Withdrawal by Subject|2
7592096|NCT02014558|26411283|P9|Overall Study|Withdrawal by Subject|0
7592097|NCT02014558|26411284|P8|Overall Study|Withdrawal by Subject|0
7592098|NCT02014558|26411285|P7|Overall Study|Withdrawal by Subject|0
7592099|NCT02014558|26411286|P6|Overall Study|Withdrawal by Subject|0
7592100|NCT02014558|26411287|P5|Overall Study|Withdrawal by Subject|1
7592101|NCT02014558|26411288|P4|Overall Study|Withdrawal by Subject|0
7592102|NCT02014558|26411289|P3|Overall Study|Withdrawal by Subject|0
7592103|NCT02014558|26411290|P2|Overall Study|Withdrawal by Subject|0
7592104|NCT02014558|26411291|P1|Overall Study|Withdrawal by Subject|0
7592105|NCT02014558|26411279|P13|Overall Study|Progressive Disease|6
7592106|NCT02014558|26411280|P12|Overall Study|Progressive Disease|31
7592107|NCT02014558|26411281|P11|Overall Study|Progressive Disease|22
7592108|NCT02014558|26411282|P10|Overall Study|Progressive Disease|6
7592109|NCT02014558|26411283|P9|Overall Study|Progressive Disease|5
7592110|NCT02014558|26411284|P8|Overall Study|Progressive Disease|6
7592111|NCT02014558|26411285|P7|Overall Study|Progressive Disease|1
7592112|NCT02014558|26411286|P6|Overall Study|Progressive Disease|2
7592113|NCT02014558|26411287|P5|Overall Study|Progressive Disease|1
7592114|NCT02014558|26411288|P4|Overall Study|Progressive Disease|1
7592115|NCT02014558|26411289|P3|Overall Study|Progressive Disease|1
7592116|NCT02014558|26411290|P2|Overall Study|Progressive Disease|0
7592117|NCT02014558|26411291|P1|Overall Study|Progressive Disease|1
7592118|NCT02014558|26411279|P13|Overall Study|Lost to Follow-up|0
7592119|NCT02014558|26411280|P12|Overall Study|Lost to Follow-up|0
7592120|NCT02014558|26411281|P11|Overall Study|Lost to Follow-up|1
7592121|NCT02014558|26411282|P10|Overall Study|Lost to Follow-up|0
7592122|NCT02014558|26411283|P9|Overall Study|Lost to Follow-up|0
7592123|NCT02014558|26411284|P8|Overall Study|Lost to Follow-up|0
7592124|NCT02014558|26411285|P7|Overall Study|Lost to Follow-up|0
7592125|NCT02014558|26411286|P6|Overall Study|Lost to Follow-up|0
7592126|NCT02014558|26411287|P5|Overall Study|Lost to Follow-up|0
7592127|NCT02014558|26411288|P4|Overall Study|Lost to Follow-up|0
7592128|NCT02014558|26411289|P3|Overall Study|Lost to Follow-up|0
7592129|NCT02014558|26411290|P2|Overall Study|Lost to Follow-up|0
7592130|NCT02014558|26411291|P1|Overall Study|Lost to Follow-up|0
7592131|NCT02014558|26411279|P13|Overall Study|Lack of Efficacy|5
7592132|NCT02014558|26411280|P12|Overall Study|Lack of Efficacy|8
7592133|NCT02014558|26411281|P11|Overall Study|Lack of Efficacy|16
7592134|NCT02014558|26411282|P10|Overall Study|Lack of Efficacy|3
7592135|NCT02014558|26411283|P9|Overall Study|Lack of Efficacy|3
7592136|NCT02014558|26411284|P8|Overall Study|Lack of Efficacy|3
7592137|NCT02014558|26411285|P7|Overall Study|Lack of Efficacy|1
7592138|NCT02014558|26411286|P6|Overall Study|Lack of Efficacy|0
7592139|NCT02014558|26411287|P5|Overall Study|Lack of Efficacy|0
7592140|NCT02014558|26411288|P4|Overall Study|Lack of Efficacy|1
7592141|NCT02014558|26411289|P3|Overall Study|Lack of Efficacy|1
7592142|NCT02014558|26411290|P2|Overall Study|Lack of Efficacy|2
7592143|NCT02014558|26411291|P1|Overall Study|Lack of Efficacy|1
7592144|NCT02014558|26411279|P13|Overall Study|Death|2
7592145|NCT02014558|26411280|P12|Overall Study|Death|19
7592146|NCT02014558|26411281|P11|Overall Study|Death|5
7592147|NCT02014558|26411282|P10|Overall Study|Death|5
7592148|NCT02014558|26411283|P9|Overall Study|Death|2
7592149|NCT02014558|26411284|P8|Overall Study|Death|1
7592150|NCT02014558|26411285|P7|Overall Study|Death|1
7592151|NCT02014558|26411286|P6|Overall Study|Death|0
7592152|NCT02014558|26411287|P5|Overall Study|Death|0
7592153|NCT02014558|26411288|P4|Overall Study|Death|0
7592154|NCT02014558|26411289|P3|Overall Study|Death|0
7592155|NCT02014558|26411290|P2|Overall Study|Death|0
7592156|NCT02014558|26411291|P1|Overall Study|Death|1
7592157|NCT02014558|26411279|P13|Overall Study|Adverse Event|3
7592158|NCT02014558|26411280|P12|Overall Study|Adverse Event|21
7592159|NCT02014558|26411281|P11|Overall Study|Adverse Event|5
7592160|NCT02014558|26411282|P10|Overall Study|Adverse Event|2
7592161|NCT02014558|26411283|P9|Overall Study|Adverse Event|2
7592162|NCT02014558|26411284|P8|Overall Study|Adverse Event|0
7592163|NCT02014558|26411285|P7|Overall Study|Adverse Event|0
7592164|NCT02014558|26411286|P6|Overall Study|Adverse Event|0
7592165|NCT02014558|26411287|P5|Overall Study|Adverse Event|1
7592166|NCT02014558|26411288|P4|Overall Study|Adverse Event|0
7592167|NCT02014558|26411289|P3|Overall Study|Adverse Event|0
7592168|NCT02014558|26411290|P2|Overall Study|Adverse Event|0
7592169|NCT02014558|26411291|P1|Overall Study|Adverse Event|0
7592170|NCT02014558|26411279|P13|Overall Study|Never Received Study Drug|0
7592171|NCT02014558|26411280|P12|Overall Study|Never Received Study Drug|2
7592172|NCT02014558|26411281|P11|Overall Study|Never Received Study Drug|2
7592173|NCT02014558|26411282|P10|Overall Study|Never Received Study Drug|0
7592174|NCT02014558|26411283|P9|Overall Study|Never Received Study Drug|2
7592175|NCT02014558|26411284|P8|Overall Study|Never Received Study Drug|0
7592176|NCT02014558|26411285|P7|Overall Study|Never Received Study Drug|1
7592177|NCT02014558|26411286|P6|Overall Study|Never Received Study Drug|0
7592178|NCT02014558|26411287|P5|Overall Study|Never Received Study Drug|1
7592179|NCT02014558|26411288|P4|Overall Study|Never Received Study Drug|0
7592180|NCT02014558|26411289|P3|Overall Study|Never Received Study Drug|0
7592181|NCT02014558|26411290|P2|Overall Study|Never Received Study Drug|0
7592182|NCT02014558|26411291|P1|Overall Study|Never Received Study Drug|0
7592183|NCT02014480|26411656|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
7592184|NCT02014480|26411657|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7592185|NCT02014480|26411658|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7592186|NCT02014480|26411659|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7592187|NCT02014480|26411660|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7592188|NCT02014480|26411661|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7592189|NCT02014480|26411656|P6|Treatment Period 3 (14 Days)|Adverse Event|1
7592190|NCT02014480|26411657|P5|Treatment Period 3 (14 Days)|Adverse Event|0
7592191|NCT02014480|26411658|P4|Treatment Period 3 (14 Days)|Adverse Event|0
7592192|NCT02014480|26411659|P3|Treatment Period 3 (14 Days)|Adverse Event|1
7592193|NCT02014480|26411660|P2|Treatment Period 3 (14 Days)|Adverse Event|0
7592194|NCT02014480|26411661|P1|Treatment Period 3 (14 Days)|Adverse Event|0
7592195|NCT02014480|26411656|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7592196|NCT02014480|26411657|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7592197|NCT02014480|26411658|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7592198|NCT02014480|26411659|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7592199|NCT02014480|26411660|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7592200|NCT02014480|26411661|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7592201|NCT02014480|26411656|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
7592202|NCT02014480|26411657|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
7592203|NCT02014480|26411658|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
7592204|NCT02014480|26411659|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
7592205|NCT02014480|26411660|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
7592206|NCT02014480|26411661|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
7592207|NCT02014480|26411656|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7592208|NCT02014480|26411657|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7592209|NCT02014480|26411658|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7592210|NCT02014480|26411659|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7592211|NCT02014480|26411660|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7592212|NCT02014480|26411661|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7592213|NCT02014480|26411656|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7592214|NCT02014480|26411657|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7592215|NCT02014480|26411658|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7592216|NCT02014480|26411659|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7592217|NCT02014480|26411660|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7592218|NCT02014480|26411661|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7592219|NCT02014480|26411656|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7592220|NCT02014480|26411657|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7592221|NCT02014480|26411658|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7592222|NCT02014480|26411659|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
7592223|NCT02014480|26411660|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7592224|NCT02014480|26411661|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7592225|NCT02014467|26411680|P2|Overall Study|Withdrawal by Subject|4
7592226|NCT02014467|26411681|P1|Overall Study|Withdrawal by Subject|16
7592227|NCT02014467|26411680|P2|Overall Study|Physician Decision|3
7592228|NCT02014467|26411681|P1|Overall Study|Physician Decision|2
7592229|NCT02014467|26411680|P2|Overall Study|Protocol Violation|0
7592230|NCT02014467|26411681|P1|Overall Study|Protocol Violation|3
7592231|NCT02014467|26411680|P2|Overall Study|Adverse Event|0
7592232|NCT02014467|26411681|P1|Overall Study|Adverse Event|4
7592233|NCT02014441|26411741|P1|Overall Study|Withdrawal by Subject|12
7592234|NCT02014402|26411837|P4|Overall Study|Lost to Follow-up|2
7592235|NCT02014402|26411838|P3|Overall Study|Lost to Follow-up|1
7592236|NCT02014402|26411839|P2|Overall Study|Lost to Follow-up|0
7592237|NCT02014402|26411840|P1|Overall Study|Lost to Follow-up|0
7592238|NCT02014402|26411837|P4|Overall Study|Subject did not have transportation|0
7592239|NCT02014402|26411838|P3|Overall Study|Subject did not have transportation|0
7592240|NCT02014402|26411839|P2|Overall Study|Subject did not have transportation|1
7592241|NCT02014402|26411840|P1|Overall Study|Subject did not have transportation|0
7592242|NCT02014402|26411837|P4|Overall Study|Withdrawal by Subject|1
7592243|NCT02014402|26411838|P3|Overall Study|Withdrawal by Subject|2
7592244|NCT02014402|26411839|P2|Overall Study|Withdrawal by Subject|2
7592245|NCT02014402|26411840|P1|Overall Study|Withdrawal by Subject|1
7592246|NCT02014402|26411837|P4|Overall Study|Adverse Event|0
7592247|NCT02014402|26411838|P3|Overall Study|Adverse Event|0
7592248|NCT02014402|26411839|P2|Overall Study|Adverse Event|0
7592249|NCT02014402|26411840|P1|Overall Study|Adverse Event|1
7592250|NCT02014376|26411870|P3|Overall Study|Lost to Follow-up|0
7592251|NCT02014376|26411871|P2|Overall Study|Lost to Follow-up|0
7592252|NCT02014376|26411872|P1|Overall Study|Lost to Follow-up|2
7592253|NCT02014376|26411870|P3|Overall Study|Adverse Event|0
7592254|NCT02014376|26411871|P2|Overall Study|Adverse Event|1
7592255|NCT02014376|26411872|P1|Overall Study|Adverse Event|1
7592256|NCT02014272|26411908|P2|Intervention Period 1|Adverse Event|1
7592257|NCT02014272|26411909|P1|Intervention Period 1|Adverse Event|0
7592258|NCT02014272|26411908|P2|Intervention Period 1|Withdrawal by Subject|0
7592259|NCT02014272|26411909|P1|Intervention Period 1|Withdrawal by Subject|1
7592260|NCT02014116|26411958|P9|Overall Study|Physician Decision|1
7592261|NCT02014116|26411959|P8|Overall Study|Physician Decision|0
7592262|NCT02014116|26411960|P7|Overall Study|Physician Decision|0
7592263|NCT02014116|26411961|P6|Overall Study|Physician Decision|0
7592264|NCT02014116|26411962|P5|Overall Study|Physician Decision|0
7592265|NCT02014116|26411963|P4|Overall Study|Physician Decision|0
7592266|NCT02014116|26411964|P3|Overall Study|Physician Decision|0
7592267|NCT02014116|26411965|P2|Overall Study|Physician Decision|0
7592268|NCT02014116|26411966|P1|Overall Study|Physician Decision|0
7592269|NCT02014116|26411958|P9|Overall Study|Withdrawal Caregiver Decision|0
7592270|NCT02014116|26411959|P8|Overall Study|Withdrawal Caregiver Decision|0
7592271|NCT02014116|26411960|P7|Overall Study|Withdrawal Caregiver Decision|0
7592272|NCT02014116|26411961|P6|Overall Study|Withdrawal Caregiver Decision|1
7592273|NCT02014116|26411962|P5|Overall Study|Withdrawal Caregiver Decision|0
7592274|NCT02014116|26411963|P4|Overall Study|Withdrawal Caregiver Decision|0
7592275|NCT02014116|26411964|P3|Overall Study|Withdrawal Caregiver Decision|0
7592276|NCT02014116|26411965|P2|Overall Study|Withdrawal Caregiver Decision|0
7592277|NCT02014116|26411966|P1|Overall Study|Withdrawal Caregiver Decision|0
7592278|NCT02014116|26411958|P9|Overall Study|Withdrawal by Subject|0
7592279|NCT02014116|26411959|P8|Overall Study|Withdrawal by Subject|0
7592280|NCT02014116|26411960|P7|Overall Study|Withdrawal by Subject|0
7592281|NCT02014116|26411961|P6|Overall Study|Withdrawal by Subject|1
7592282|NCT02014116|26411962|P5|Overall Study|Withdrawal by Subject|0
7592283|NCT02014116|26411963|P4|Overall Study|Withdrawal by Subject|1
7592284|NCT02014116|26411964|P3|Overall Study|Withdrawal by Subject|1
7592285|NCT02014116|26411965|P2|Overall Study|Withdrawal by Subject|0
7592286|NCT02014116|26411966|P1|Overall Study|Withdrawal by Subject|0
7592287|NCT02014116|26411958|P9|Overall Study|Death|1
7592288|NCT02014116|26411959|P8|Overall Study|Death|1
7592289|NCT02014116|26411960|P7|Overall Study|Death|0
7592290|NCT02014116|26411961|P6|Overall Study|Death|0
7592291|NCT02014116|26411962|P5|Overall Study|Death|0
7592292|NCT02014116|26411963|P4|Overall Study|Death|0
7592293|NCT02014116|26411964|P3|Overall Study|Death|0
7592294|NCT02014116|26411965|P2|Overall Study|Death|0
7592295|NCT02014116|26411966|P1|Overall Study|Death|0
7592296|NCT02014116|26411958|P9|Overall Study|Lost to Follow-up|1
7592297|NCT02014116|26411959|P8|Overall Study|Lost to Follow-up|0
7592298|NCT02014116|26411960|P7|Overall Study|Lost to Follow-up|0
7592299|NCT02014116|26411961|P6|Overall Study|Lost to Follow-up|1
7592300|NCT02014116|26411962|P5|Overall Study|Lost to Follow-up|0
7592301|NCT02014116|26411963|P4|Overall Study|Lost to Follow-up|0
7592302|NCT02014116|26411964|P3|Overall Study|Lost to Follow-up|0
7592303|NCT02014116|26411965|P2|Overall Study|Lost to Follow-up|0
7592304|NCT02014116|26411966|P1|Overall Study|Lost to Follow-up|0
7592305|NCT02014116|26411958|P9|Overall Study|Adverse Event|0
7592306|NCT02014116|26411959|P8|Overall Study|Adverse Event|1
7592307|NCT02014116|26411960|P7|Overall Study|Adverse Event|0
7592308|NCT02014116|26411961|P6|Overall Study|Adverse Event|0
7592309|NCT02014116|26411962|P5|Overall Study|Adverse Event|1
7592310|NCT02014116|26411963|P4|Overall Study|Adverse Event|0
7592311|NCT02014116|26411964|P3|Overall Study|Adverse Event|0
7592312|NCT02014116|26411965|P2|Overall Study|Adverse Event|0
7592313|NCT02014116|26411966|P1|Overall Study|Adverse Event|0
7592314|NCT02014116|26411958|P9|Overall Study|Progressive Disease|7
7592315|NCT02014116|26411959|P8|Overall Study|Progressive Disease|3
7592316|NCT02014116|26411960|P7|Overall Study|Progressive Disease|1
7592317|NCT02014116|26411961|P6|Overall Study|Progressive Disease|13
7592318|NCT02014116|26411962|P5|Overall Study|Progressive Disease|1
7592319|NCT02014116|26411963|P4|Overall Study|Progressive Disease|6
7592320|NCT02014116|26411964|P3|Overall Study|Progressive Disease|2
7592321|NCT02014116|26411965|P2|Overall Study|Progressive Disease|4
7592322|NCT02014116|26411966|P1|Overall Study|Progressive Disease|3
7592323|NCT02013830|26412031|P1|Overall Study|Refused treatment|1
7592414|NCT02013206|26412369|P1|Overall Study|Patient refusal|2
7592324|NCT02013830|26412031|P1|Overall Study|Insufficient therapeutic response|25
7592325|NCT02013830|26412031|P1|Overall Study|Death|1
7592326|NCT02013830|26412031|P1|Overall Study|Adverse Event|3
7592327|NCT02013817|26412042|P1|Overall Study|Other|9
7592328|NCT02013817|26412042|P1|Overall Study|Death|2
7592329|NCT02013817|26412042|P1|Overall Study|Withdrawal by Subject|4
7592330|NCT02013817|26412042|P1|Overall Study|Adverse Event|12
7592331|NCT02013791|26412060|P9|Period 1|Other Miscellaneous Reasons|0
7592332|NCT02013791|26412061|P8|Period 1|Other Miscellaneous Reasons|0
7592333|NCT02013791|26412062|P7|Period 1|Other Miscellaneous Reasons|0
7592334|NCT02013791|26412063|P6|Period 1|Other Miscellaneous Reasons|0
7592335|NCT02013791|26412064|P5|Period 1|Other Miscellaneous Reasons|0
7592336|NCT02013791|26412065|P4|Period 1|Other Miscellaneous Reasons|0
7592337|NCT02013791|26412066|P3|Period 1|Other Miscellaneous Reasons|0
7592338|NCT02013791|26412067|P2|Period 1|Other Miscellaneous Reasons|2
7592339|NCT02013791|26412068|P1|Period 1|Other Miscellaneous Reasons|0
7592340|NCT02013791|26412060|P9|Period 1|Lost to Follow-up|0
7592341|NCT02013791|26412061|P8|Period 1|Lost to Follow-up|1
7592342|NCT02013791|26412062|P7|Period 1|Lost to Follow-up|1
7592343|NCT02013791|26412063|P6|Period 1|Lost to Follow-up|0
7592344|NCT02013791|26412064|P5|Period 1|Lost to Follow-up|0
7592345|NCT02013791|26412065|P4|Period 1|Lost to Follow-up|1
7592346|NCT02013791|26412066|P3|Period 1|Lost to Follow-up|0
7592347|NCT02013791|26412067|P2|Period 1|Lost to Follow-up|0
7592348|NCT02013791|26412068|P1|Period 1|Lost to Follow-up|0
7592349|NCT02013778|26412089|P1|Overall Study|Adverse Event|1
7592350|NCT02013778|26412089|P1|Overall Study|Physician Decision|1
7592351|NCT02013778|26412089|P1|Overall Study|Withdrawal by Subject|1
7592352|NCT02013778|26412089|P1|Overall Study|Death|4
7592353|NCT02013765|26412093|P1|Overall Study|Trial was terminated by sponsor|1
7592354|NCT02013687|26412107|P4|Overall Study|Missed visits due to patient travel|0
7592355|NCT02013687|26412108|P3|Overall Study|Missed visits due to patient travel|1
7592356|NCT02013687|26412109|P2|Overall Study|Missed visits due to patient travel|0
7592357|NCT02013687|26412110|P1|Overall Study|Missed visits due to patient travel|0
7592358|NCT02013687|26412107|P4|Overall Study|Withdrawal by Subject|1
7592359|NCT02013687|26412108|P3|Overall Study|Withdrawal by Subject|0
7592360|NCT02013687|26412109|P2|Overall Study|Withdrawal by Subject|0
7592361|NCT02013687|26412110|P1|Overall Study|Withdrawal by Subject|0
7592362|NCT02013687|26412107|P4|Overall Study|Protocol Violation|1
7592363|NCT02013687|26412108|P3|Overall Study|Protocol Violation|0
7592364|NCT02013687|26412109|P2|Overall Study|Protocol Violation|0
7592365|NCT02013687|26412110|P1|Overall Study|Protocol Violation|0
7592366|NCT02013687|26412107|P4|Overall Study|Lost to Follow-up|0
7592367|NCT02013687|26412108|P3|Overall Study|Lost to Follow-up|1
7592368|NCT02013687|26412109|P2|Overall Study|Lost to Follow-up|0
7592369|NCT02013687|26412110|P1|Overall Study|Lost to Follow-up|0
7592370|NCT02013674|26412142|P2|Overall Study|Lost to Follow-up|0
7592371|NCT02013674|26412143|P1|Overall Study|Lost to Follow-up|1
7592372|NCT02013674|26412142|P2|Overall Study|Death|1
7592373|NCT02013674|26412143|P1|Overall Study|Death|0
7592374|NCT02013622|26412193|P1|Overall Study|Lack of Efficacy|1
7592375|NCT02013622|26412193|P1|Overall Study|Protocol Deviation|1
7592376|NCT02013622|26412193|P1|Overall Study|Withdrawal by Subject|6
7592377|NCT02013622|26412193|P1|Overall Study|Met Withdrawal Criteria|3
7592378|NCT02013622|26412193|P1|Overall Study|Adverse Event|3
7592379|NCT02013622|26412193|P1|Overall Study|Lost to Follow-up|10
7592380|NCT02013609|26412213|P1|Overall Study|Met Withdrawal Criteria|3
7592381|NCT02013609|26412213|P1|Overall Study|Adverse Event|3
7592382|NCT02013609|26412213|P1|Overall Study|Lost to Follow-up|3
7592383|NCT02013609|26412213|P1|Overall Study|Withdrawal by Subject|9
7592384|NCT02013544|26412238|P2|Overall Study|Entry criteria not met/non-compliance|3
7592385|NCT02013544|26412239|P1|Overall Study|Entry criteria not met/non-compliance|2
7592386|NCT02013544|26412238|P2|Overall Study|Physician Decision|1
7592387|NCT02013544|26412239|P1|Overall Study|Physician Decision|0
7592388|NCT02013544|26412238|P2|Overall Study|Withdrawal by Subject|8
7592389|NCT02013544|26412239|P1|Overall Study|Withdrawal by Subject|2
7592390|NCT02013544|26412238|P2|Overall Study|Lost to Follow-up|3
7592391|NCT02013544|26412239|P1|Overall Study|Lost to Follow-up|2
7592392|NCT02013544|26412238|P2|Overall Study|Adverse Event|5
7592393|NCT02013544|26412239|P1|Overall Study|Adverse Event|5
7592394|NCT02013531|26412261|P1|Overall Study|Withdrawal by Subject|1
7592395|NCT02013531|26412261|P1|Overall Study|Met Withdrawal Criteria|1
7592396|NCT02013531|26412261|P1|Overall Study|Lost to Follow-up|3
7592397|NCT02013388|26412297|P8|Overall Study|work emergency|0
7592398|NCT02013388|26412298|P7|Overall Study|work emergency|0
7592399|NCT02013388|26412299|P6|Overall Study|work emergency|0
7592400|NCT02013388|26412300|P5|Overall Study|work emergency|1
7592401|NCT02013388|26412301|P4|Overall Study|work emergency|0
7592402|NCT02013388|26412302|P3|Overall Study|work emergency|0
7592403|NCT02013388|26412303|P2|Overall Study|work emergency|0
7592404|NCT02013388|26412304|P1|Overall Study|work emergency|1
7592405|NCT02013375|26412338|P1|Overall Study|Did not engraft|1
7592406|NCT02013375|26412338|P1|Overall Study|Did not engraft|1
7592407|NCT02013206|26412368|P2|Overall Study|Other reasons off treatment|2
7592408|NCT02013206|26412369|P1|Overall Study|Other reasons off treatment|5
7592409|NCT02013206|26412368|P2|Overall Study|Death|2
7592410|NCT02013206|26412369|P1|Overall Study|Death|1
7592411|NCT02013206|26412368|P2|Overall Study|Patient non-compliance|0
7592412|NCT02013206|26412369|P1|Overall Study|Patient non-compliance|1
7592413|NCT02013206|26412368|P2|Overall Study|Patient refusal|0
7592415|NCT02013206|26412368|P2|Overall Study|Adverse Event|0
7592416|NCT02013206|26412369|P1|Overall Study|Adverse Event|1
7592417|NCT02013206|26412368|P2|Overall Study|Symptomatic deterioration|1
7592418|NCT02013206|26412369|P1|Overall Study|Symptomatic deterioration|3
7592419|NCT02013206|26412368|P2|Overall Study|Progressive disease (PD)|17
7592420|NCT02013206|26412369|P1|Overall Study|Progressive disease (PD)|14
7592421|NCT02013167|26412400|P2|Overall Study|Death|160
7592422|NCT02013167|26412401|P1|Overall Study|Death|85
7592423|NCT02013167|26412400|P2|Overall Study|Lost to Follow-up|1
7592424|NCT02013167|26412401|P1|Overall Study|Lost to Follow-up|0
7592425|NCT02013167|26412400|P2|Overall Study|Sponsor Decision|3
7592426|NCT02013167|26412401|P1|Overall Study|Sponsor Decision|1
7592427|NCT02013167|26412400|P2|Overall Study|Withdrawal by Subject|14
7592428|NCT02013167|26412401|P1|Overall Study|Withdrawal by Subject|15
7592429|NCT02013037|26412477|P1|Overall Study|Transplanted without DSA|2
7592430|NCT02013037|26412477|P1|Overall Study|Awaiting Transplantation|7
7592431|NCT02013037|26412477|P1|Overall Study|Withdrawal by Subject|1
7592432|NCT02013037|26412477|P1|Overall Study|Death|6
7592433|NCT02012959|26412488|P5|Treatment Phase A|Adverse Event|0
7592434|NCT02012959|26412489|P4|Treatment Phase A|Adverse Event|0
7592435|NCT02012959|26412490|P3|Treatment Phase A|Adverse Event|0
7592436|NCT02012959|26412491|P2|Treatment Phase A|Adverse Event|0
7592437|NCT02012959|26412492|P1|Treatment Phase A|Adverse Event|2
7592438|NCT02012686|26412505|P2|Overall Study|electrocardiography monitoring noise|1
7592439|NCT02012686|26412506|P1|Overall Study|electrocardiography monitoring noise|0
7592440|NCT02012686|26412505|P2|Overall Study|muscle contraction|1
7592441|NCT02012686|26412506|P1|Overall Study|muscle contraction|0
7592442|NCT02012491|26412568|P2|Overall Study|Withdrawal by Subject|0
7592443|NCT02012491|26412569|P1|Overall Study|Withdrawal by Subject|1
7592444|NCT02012491|26412568|P2|Overall Study|Protocol Violation|1
7592445|NCT02012491|26412569|P1|Overall Study|Protocol Violation|0
7592446|NCT02012491|26412568|P2|Overall Study|Lost to Follow-up|0
7592447|NCT02012491|26412569|P1|Overall Study|Lost to Follow-up|1
7592448|NCT02012452|26412587|P2|Overall Study|Withdrawal by Subject|0
7592449|NCT02012452|26412588|P1|Overall Study|Withdrawal by Subject|4
7592450|NCT02012452|26412587|P2|Overall Study|Lost to Follow-up|1
7592451|NCT02012452|26412588|P1|Overall Study|Lost to Follow-up|2
7592452|NCT02012218|26412631|P5|Overall Study|Protocol Deviation|0
7592453|NCT02012218|26412632|P4|Overall Study|Protocol Deviation|0
7592454|NCT02012218|26412633|P3|Overall Study|Protocol Deviation|0
7592455|NCT02012218|26412634|P2|Overall Study|Protocol Deviation|0
7592456|NCT02012218|26412635|P1|Overall Study|Protocol Deviation|1
7592457|NCT02012218|26412631|P5|Overall Study|Protocol Specified|0
7592458|NCT02012218|26412632|P4|Overall Study|Protocol Specified|0
7592459|NCT02012218|26412633|P3|Overall Study|Protocol Specified|0
7592460|NCT02012218|26412634|P2|Overall Study|Protocol Specified|0
7592461|NCT02012218|26412635|P1|Overall Study|Protocol Specified|1
7592462|NCT02012218|26412631|P5|Overall Study|Lost to Follow-up|0
7592463|NCT02012218|26412632|P4|Overall Study|Lost to Follow-up|0
7592464|NCT02012218|26412633|P3|Overall Study|Lost to Follow-up|1
7592465|NCT02012218|26412634|P2|Overall Study|Lost to Follow-up|1
7592466|NCT02012218|26412635|P1|Overall Study|Lost to Follow-up|0
7592467|NCT02012218|26412631|P5|Overall Study|Adverse Event|0
7592468|NCT02012218|26412632|P4|Overall Study|Adverse Event|1
7592469|NCT02012218|26412633|P3|Overall Study|Adverse Event|0
7592470|NCT02012218|26412634|P2|Overall Study|Adverse Event|0
7592471|NCT02012218|26412635|P1|Overall Study|Adverse Event|1
7592472|NCT02012218|26412631|P5|Overall Study|Withdrawal by Subject|1
7592473|NCT02012218|26412632|P4|Overall Study|Withdrawal by Subject|1
7592474|NCT02012218|26412633|P3|Overall Study|Withdrawal by Subject|1
7592475|NCT02012218|26412634|P2|Overall Study|Withdrawal by Subject|0
7592476|NCT02012218|26412635|P1|Overall Study|Withdrawal by Subject|1
7592477|NCT02011945|26412659|P3|Overall Study|Sub-Optimal Response to dasatinib|0
7592478|NCT02011945|26412660|P2|Overall Study|Sub-Optimal Response to dasatinib|0
7592479|NCT02011945|26412661|P1|Overall Study|Sub-Optimal Response to dasatinib|1
7592480|NCT02011945|26412659|P3|Overall Study|Proceeded to stem cell transplant|1
7592481|NCT02011945|26412660|P2|Overall Study|Proceeded to stem cell transplant|0
7592482|NCT02011945|26412661|P1|Overall Study|Proceeded to stem cell transplant|0
7592483|NCT02011945|26412659|P3|Overall Study|No Longer Meets Study Criteria|0
7592484|NCT02011945|26412660|P2|Overall Study|No Longer Meets Study Criteria|0
7592485|NCT02011945|26412661|P1|Overall Study|No Longer Meets Study Criteria|1
7592486|NCT02011945|26412659|P3|Overall Study|Treatment Failure|6
7592487|NCT02011945|26412660|P2|Overall Study|Treatment Failure|7
7592488|NCT02011945|26412661|P1|Overall Study|Treatment Failure|0
7592489|NCT02011945|26412659|P3|Overall Study|Study Drug Toxicity|1
7592490|NCT02011945|26412660|P2|Overall Study|Study Drug Toxicity|0
7592491|NCT02011945|26412661|P1|Overall Study|Study Drug Toxicity|0
7592492|NCT02011945|26412659|P3|Overall Study|Adverse Event unrelated to Drug|1
7592493|NCT02011945|26412660|P2|Overall Study|Adverse Event unrelated to Drug|2
7592494|NCT02011945|26412661|P1|Overall Study|Adverse Event unrelated to Drug|0
7592495|NCT02011945|26412659|P3|Overall Study|Participant requested to Discontinue|1
7592496|NCT02011945|26412660|P2|Overall Study|Participant requested to Discontinue|1
7592497|NCT02011945|26412661|P1|Overall Study|Participant requested to Discontinue|0
7592498|NCT02011893|26412738|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
7592499|NCT02011893|26412739|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7592500|NCT02011893|26412740|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7592501|NCT02011893|26412738|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
7592502|NCT02011893|26412739|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7592503|NCT02011893|26412740|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7592504|NCT02011893|26412738|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
7592505|NCT02011893|26412739|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7592506|NCT02011893|26412740|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7592507|NCT02011893|26412738|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
7592508|NCT02011893|26412739|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
7592509|NCT02011893|26412740|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
7592510|NCT02011893|26412738|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7592511|NCT02011893|26412739|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7592512|NCT02011893|26412740|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
7592513|NCT02011893|26412738|P3|Enrollment to Randomization|Screening Failure|0
7592514|NCT02011893|26412739|P2|Enrollment to Randomization|Screening Failure|0
7592515|NCT02011893|26412740|P1|Enrollment to Randomization|Screening Failure|29
7592516|NCT02011893|26412738|P3|Enrollment to Randomization|Withdrawal by Subject|0
7592517|NCT02011893|26412739|P2|Enrollment to Randomization|Withdrawal by Subject|0
7592518|NCT02011893|26412740|P1|Enrollment to Randomization|Withdrawal by Subject|21
7592519|NCT02011893|26412738|P3|Enrollment to Randomization|Physician Decision|0
7592520|NCT02011893|26412739|P2|Enrollment to Randomization|Physician Decision|0
7592521|NCT02011893|26412740|P1|Enrollment to Randomization|Physician Decision|10
7592522|NCT02011893|26412738|P3|Enrollment to Randomization|Adverse Event|0
7592523|NCT02011893|26412739|P2|Enrollment to Randomization|Adverse Event|0
7592524|NCT02011893|26412740|P1|Enrollment to Randomization|Adverse Event|2
7592525|NCT02011542|26412751|P1|Overall Study|Physician Decision|1
7592526|NCT02011386|26412882|P1|Overall Study|Lack of Efficacy|3
7592527|NCT02011386|26412882|P1|Overall Study|Non-compliance|2
7592528|NCT02011113|26412896|P1|Overall Study|Study terminated by sponsor|11
7592529|NCT02011113|26412896|P1|Overall Study|Investigator's judgement- DP|3
7592530|NCT02011113|26412896|P1|Overall Study|Insufficient effect of Pomalidomide|1
7592531|NCT02011113|26412896|P1|Overall Study|Death|1
7592532|NCT02011113|26412896|P1|Overall Study|Disease Progression (DP)|16
7592533|NCT02011113|26412896|P1|Overall Study|Adverse Event|4
7592534|NCT02010775|26412928|P5|Overall Study|Personal Reasons|4
7592535|NCT02010775|26412929|P4|Overall Study|Personal Reasons|2
7592536|NCT02010775|26412930|P3|Overall Study|Personal Reasons|1
7592537|NCT02010775|26412931|P2|Overall Study|Personal Reasons|3
7592538|NCT02010775|26412932|P1|Overall Study|Personal Reasons|3
7592539|NCT02010775|26412928|P5|Overall Study|Lost to Follow-up|1
7592540|NCT02010775|26412929|P4|Overall Study|Lost to Follow-up|1
7592541|NCT02010775|26412930|P3|Overall Study|Lost to Follow-up|0
7592542|NCT02010775|26412931|P2|Overall Study|Lost to Follow-up|0
7592543|NCT02010775|26412932|P1|Overall Study|Lost to Follow-up|2
7592544|NCT02010775|26412928|P5|Overall Study|Pregnancy|0
7592545|NCT02010775|26412929|P4|Overall Study|Pregnancy|0
7592546|NCT02010775|26412930|P3|Overall Study|Pregnancy|2
7592547|NCT02010775|26412931|P2|Overall Study|Pregnancy|0
7592548|NCT02010775|26412932|P1|Overall Study|Pregnancy|0
7592549|NCT02010775|26412928|P5|Overall Study|Adverse Event|1
7592550|NCT02010775|26412929|P4|Overall Study|Adverse Event|0
7592551|NCT02010775|26412930|P3|Overall Study|Adverse Event|0
7592552|NCT02010775|26412931|P2|Overall Study|Adverse Event|0
7592553|NCT02010775|26412932|P1|Overall Study|Adverse Event|0
7592554|NCT02010684|26412973|P2|Overall Study|Withdrawal by Subject|5
7592555|NCT02010684|26412974|P1|Overall Study|Withdrawal by Subject|4
7592556|NCT02010684|26412973|P2|Overall Study|Lost to Follow-up|18
7592557|NCT02010684|26412974|P1|Overall Study|Lost to Follow-up|8
7592558|NCT02010632|26412996|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
7592559|NCT02010632|26412997|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
7592560|NCT02010567|26413008|P5|Overall Study|Adverse Event|1
7592561|NCT02010567|26413009|P4|Overall Study|Adverse Event|0
7592562|NCT02010567|26413010|P3|Overall Study|Adverse Event|1
7592563|NCT02010567|26413011|P2|Overall Study|Adverse Event|0
7592564|NCT02010567|26413012|P1|Overall Study|Adverse Event|0
7592565|NCT02010255|26413068|P14|Overall Study|Randomized but Not Treated|1
7592566|NCT02010255|26413069|P13|Overall Study|Randomized but Not Treated|0
7592567|NCT02010255|26413070|P12|Overall Study|Randomized but Not Treated|0
7592568|NCT02010255|26413071|P11|Overall Study|Randomized but Not Treated|0
7592569|NCT02010255|26413072|P10|Overall Study|Randomized but Not Treated|0
7592570|NCT02010255|26413073|P9|Overall Study|Randomized but Not Treated|0
7592571|NCT02010255|26413074|P8|Overall Study|Randomized but Not Treated|0
7592572|NCT02010255|26413075|P7|Overall Study|Randomized but Not Treated|0
7592573|NCT02010255|26413076|P6|Overall Study|Randomized but Not Treated|0
7592574|NCT02010255|26413077|P5|Overall Study|Randomized but Not Treated|0
7592575|NCT02010255|26413078|P4|Overall Study|Randomized but Not Treated|0
7592576|NCT02010255|26413079|P3|Overall Study|Randomized but Not Treated|0
7592577|NCT02010255|26413080|P2|Overall Study|Randomized but Not Treated|0
7592578|NCT02010255|26413081|P1|Overall Study|Randomized but Not Treated|0
7592579|NCT02010255|26413068|P14|Overall Study|Lost to Follow-up|0
7592580|NCT02010255|26413069|P13|Overall Study|Lost to Follow-up|0
7592581|NCT02010255|26413070|P12|Overall Study|Lost to Follow-up|0
7592582|NCT02010255|26413071|P11|Overall Study|Lost to Follow-up|0
7592583|NCT02010255|26413072|P10|Overall Study|Lost to Follow-up|0
7592584|NCT02010255|26413073|P9|Overall Study|Lost to Follow-up|0
7592585|NCT02010255|26413074|P8|Overall Study|Lost to Follow-up|0
7592586|NCT02010255|26413075|P7|Overall Study|Lost to Follow-up|0
7592587|NCT02010255|26413076|P6|Overall Study|Lost to Follow-up|0
7592588|NCT02010255|26413077|P5|Overall Study|Lost to Follow-up|1
7592589|NCT02010255|26413078|P4|Overall Study|Lost to Follow-up|0
7592590|NCT02010255|26413079|P3|Overall Study|Lost to Follow-up|1
7592591|NCT02010255|26413080|P2|Overall Study|Lost to Follow-up|0
7592592|NCT02010255|26413081|P1|Overall Study|Lost to Follow-up|0
7592593|NCT02010255|26413068|P14|Overall Study|Adverse Event|0
7592594|NCT02010255|26413069|P13|Overall Study|Adverse Event|0
7592595|NCT02010255|26413070|P12|Overall Study|Adverse Event|0
7592596|NCT02010255|26413071|P11|Overall Study|Adverse Event|0
7592597|NCT02010255|26413072|P10|Overall Study|Adverse Event|0
7592598|NCT02010255|26413073|P9|Overall Study|Adverse Event|0
7592599|NCT02010255|26413074|P8|Overall Study|Adverse Event|0
7592600|NCT02010255|26413075|P7|Overall Study|Adverse Event|0
7592601|NCT02010255|26413076|P6|Overall Study|Adverse Event|0
7592602|NCT02010255|26413077|P5|Overall Study|Adverse Event|0
7592603|NCT02010255|26413078|P4|Overall Study|Adverse Event|0
7592604|NCT02010255|26413079|P3|Overall Study|Adverse Event|0
7592605|NCT02010255|26413080|P2|Overall Study|Adverse Event|0
7592606|NCT02010255|26413081|P1|Overall Study|Adverse Event|1
7592607|NCT02010255|26413068|P14|Overall Study|Withdrew Consent|0
7592608|NCT02010255|26413069|P13|Overall Study|Withdrew Consent|0
7592609|NCT02010255|26413070|P12|Overall Study|Withdrew Consent|0
7592610|NCT02010255|26413071|P11|Overall Study|Withdrew Consent|0
7592611|NCT02010255|26413072|P10|Overall Study|Withdrew Consent|0
7592612|NCT02010255|26413073|P9|Overall Study|Withdrew Consent|0
7592613|NCT02010255|26413074|P8|Overall Study|Withdrew Consent|0
7592614|NCT02010255|26413075|P7|Overall Study|Withdrew Consent|0
7592615|NCT02010255|26413076|P6|Overall Study|Withdrew Consent|0
7592616|NCT02010255|26413077|P5|Overall Study|Withdrew Consent|0
7592617|NCT02010255|26413078|P4|Overall Study|Withdrew Consent|1
7592618|NCT02010255|26413079|P3|Overall Study|Withdrew Consent|0
7592619|NCT02010255|26413080|P2|Overall Study|Withdrew Consent|0
7592620|NCT02010255|26413081|P1|Overall Study|Withdrew Consent|1
7592621|NCT02010255|26413068|P14|Overall Study|Lack of Efficacy|0
7592622|NCT02010255|26413069|P13|Overall Study|Lack of Efficacy|0
7592623|NCT02010255|26413070|P12|Overall Study|Lack of Efficacy|0
7592624|NCT02010255|26413071|P11|Overall Study|Lack of Efficacy|1
7592625|NCT02010255|26413072|P10|Overall Study|Lack of Efficacy|0
7592626|NCT02010255|26413073|P9|Overall Study|Lack of Efficacy|0
7592627|NCT02010255|26413074|P8|Overall Study|Lack of Efficacy|0
7592628|NCT02010255|26413075|P7|Overall Study|Lack of Efficacy|0
7592629|NCT02010255|26413076|P6|Overall Study|Lack of Efficacy|0
7592630|NCT02010255|26413077|P5|Overall Study|Lack of Efficacy|1
7592631|NCT02010255|26413078|P4|Overall Study|Lack of Efficacy|1
7592632|NCT02010255|26413079|P3|Overall Study|Lack of Efficacy|2
7592633|NCT02010255|26413080|P2|Overall Study|Lack of Efficacy|1
7592634|NCT02010255|26413081|P1|Overall Study|Lack of Efficacy|4
7592635|NCT02010255|26413068|P14|Overall Study|Death|0
7592636|NCT02010255|26413069|P13|Overall Study|Death|0
7592637|NCT02010255|26413070|P12|Overall Study|Death|1
7592638|NCT02010255|26413071|P11|Overall Study|Death|1
7592639|NCT02010255|26413072|P10|Overall Study|Death|0
7592640|NCT02010255|26413073|P9|Overall Study|Death|1
7592641|NCT02010255|26413074|P8|Overall Study|Death|1
7592642|NCT02010255|26413075|P7|Overall Study|Death|1
7592643|NCT02010255|26413076|P6|Overall Study|Death|0
7592644|NCT02010255|26413077|P5|Overall Study|Death|2
7592645|NCT02010255|26413078|P4|Overall Study|Death|4
7592646|NCT02010255|26413079|P3|Overall Study|Death|4
7592647|NCT02010255|26413080|P2|Overall Study|Death|1
7592648|NCT02010255|26413081|P1|Overall Study|Death|0
7592649|NCT02009930|26413526|P1|Overall Study|withdrawn|5
7592650|NCT02009878|26413551|P3|Overall Study|Participant Met Withdrawal Criteria|0
7592651|NCT02009878|26413552|P2|Overall Study|Participant Met Withdrawal Criteria|1
7592652|NCT02009878|26413553|P1|Overall Study|Participant Met Withdrawal Criteria|0
7592653|NCT02009865|26413587|P2|Overall Study|Withdrawal by Subject|1
7592654|NCT02009865|26413588|P1|Overall Study|Withdrawal by Subject|1
7592655|NCT02009865|26413587|P2|Overall Study|Protocol Violation|2
7592656|NCT02009865|26413588|P1|Overall Study|Protocol Violation|0
7592657|NCT02009865|26413587|P2|Overall Study|Adverse Event|2
7592658|NCT02009865|26413588|P1|Overall Study|Adverse Event|0
7592659|NCT02009722|26413604|P2|Overall Study|Did not receive intervention|1
7592660|NCT02009722|26413605|P1|Overall Study|Did not receive intervention|0
7592661|NCT02009722|26413604|P2|Overall Study|Protocol Violation|2
7592662|NCT02009722|26413605|P1|Overall Study|Protocol Violation|1
7592663|NCT02009696|26413629|P1|Overall Study|Withdrawal by Subject|2
7592664|NCT02009332|26413652|P6|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
7592665|NCT02009332|26413653|P5|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7592666|NCT02009332|26413654|P4|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7592667|NCT02009332|26413655|P3|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7592668|NCT02009332|26413656|P2|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7592669|NCT02009332|26413657|P1|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7592670|NCT02009332|26413652|P6|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7592671|NCT02009332|26413653|P5|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
7592672|NCT02009332|26413654|P4|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7592751|NCT02008890|26413813|P4|Extension Period|Adverse Event|0
7592673|NCT02009332|26413655|P3|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7592674|NCT02009332|26413656|P2|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7592675|NCT02009332|26413657|P1|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7592676|NCT02009332|26413652|P6|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7592677|NCT02009332|26413653|P5|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7592678|NCT02009332|26413654|P4|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7592679|NCT02009332|26413655|P3|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7592680|NCT02009332|26413656|P2|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
7592681|NCT02009332|26413657|P1|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7592682|NCT02009163|26413676|P3|Randomized-withdrawal Period|Other|5
7592683|NCT02009163|26413677|P2|Randomized-withdrawal Period|Other|9
7592684|NCT02009163|26413678|P1|Randomized-withdrawal Period|Other|0
7592685|NCT02009163|26413676|P3|Randomized-withdrawal Period|Pregnancy|2
7592686|NCT02009163|26413677|P2|Randomized-withdrawal Period|Pregnancy|0
7592687|NCT02009163|26413678|P1|Randomized-withdrawal Period|Pregnancy|0
7592688|NCT02009163|26413676|P3|Randomized-withdrawal Period|Protocol Violation|2
7592689|NCT02009163|26413677|P2|Randomized-withdrawal Period|Protocol Violation|1
7592690|NCT02009163|26413678|P1|Randomized-withdrawal Period|Protocol Violation|0
7592691|NCT02009163|26413676|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
7592692|NCT02009163|26413677|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
7592693|NCT02009163|26413678|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
7592694|NCT02009163|26413676|P3|Randomized-withdrawal Period|Adverse Event|6
7592695|NCT02009163|26413677|P2|Randomized-withdrawal Period|Adverse Event|0
7592696|NCT02009163|26413678|P1|Randomized-withdrawal Period|Adverse Event|0
7592697|NCT02009163|26413676|P3|Randomized-withdrawal Period|Lost to Follow-up|6
7592698|NCT02009163|26413677|P2|Randomized-withdrawal Period|Lost to Follow-up|13
7592699|NCT02009163|26413678|P1|Randomized-withdrawal Period|Lost to Follow-up|0
7592700|NCT02009163|26413676|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
7592701|NCT02009163|26413677|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
7592702|NCT02009163|26413678|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
7592703|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Other|0
7592704|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Other|0
7592705|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Other|13
7592706|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Pregnancy|0
7592707|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Pregnancy|0
7592708|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Pregnancy|1
7592709|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Protocol Violation|0
7592710|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Protocol Violation|0
7592711|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Protocol Violation|10
7592712|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
7592713|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
7592714|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
7592715|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Adverse Event|0
7592716|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Adverse Event|0
7592717|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Adverse Event|22
7592718|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7592719|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7592720|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
7592721|NCT02009163|26413676|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7592722|NCT02009163|26413677|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7592723|NCT02009163|26413678|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
7592724|NCT02009046|26413713|P2|Overall Study|Lost to Follow-up|206
7592725|NCT02009046|26413714|P1|Overall Study|Lost to Follow-up|256
7592726|NCT02008916|26413774|P3|Week 16 - 156|Physician Decision|0
7592727|NCT02008916|26413775|P2|Week 16 - 156|Physician Decision|1
7592728|NCT02008916|26413776|P1|Week 16 - 156|Physician Decision|0
7592729|NCT02008916|26413774|P3|Week 16 - 156|Pregnancy|0
7592730|NCT02008916|26413775|P2|Week 16 - 156|Pregnancy|1
7592731|NCT02008916|26413776|P1|Week 16 - 156|Pregnancy|0
7592732|NCT02008916|26413774|P3|Week 16 - 156|Lack of Efficacy|2
7592733|NCT02008916|26413775|P2|Week 16 - 156|Lack of Efficacy|5
7592734|NCT02008916|26413776|P1|Week 16 - 156|Lack of Efficacy|3
7592735|NCT02008916|26413774|P3|Week 16 - 156|Lost to Follow-up|0
7592736|NCT02008916|26413775|P2|Week 16 - 156|Lost to Follow-up|0
7592737|NCT02008916|26413776|P1|Week 16 - 156|Lost to Follow-up|5
7592738|NCT02008916|26413774|P3|Week 16 - 156|No longer requires treatment|0
7592739|NCT02008916|26413775|P2|Week 16 - 156|No longer requires treatment|1
7592740|NCT02008916|26413776|P1|Week 16 - 156|No longer requires treatment|0
7592741|NCT02008916|26413774|P3|Week 16 - 156|Withdrawal by Subject|5
7592742|NCT02008916|26413775|P2|Week 16 - 156|Withdrawal by Subject|3
7592743|NCT02008916|26413776|P1|Week 16 - 156|Withdrawal by Subject|7
7592744|NCT02008916|26413774|P3|Week 16 - 156|Adverse Event|3
7592745|NCT02008916|26413775|P2|Week 16 - 156|Adverse Event|2
7592746|NCT02008916|26413776|P1|Week 16 - 156|Adverse Event|4
7592747|NCT02008916|26413774|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
7592748|NCT02008916|26413775|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
7592749|NCT02008916|26413776|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
7592750|NCT02008890|26413812|P5|Extension Period|Adverse Event|2
7592752|NCT02008890|26413814|P3|Extension Period|Adverse Event|0
7592753|NCT02008890|26413815|P2|Extension Period|Adverse Event|3
7592754|NCT02008890|26413816|P1|Extension Period|Adverse Event|1
7592755|NCT02008890|26413812|P5|Extension Period|Lost to Follow-up|0
7592756|NCT02008890|26413813|P4|Extension Period|Lost to Follow-up|0
7592757|NCT02008890|26413814|P3|Extension Period|Lost to Follow-up|0
7592758|NCT02008890|26413815|P2|Extension Period|Lost to Follow-up|0
7592759|NCT02008890|26413816|P1|Extension Period|Lost to Follow-up|1
7592760|NCT02008890|26413812|P5|Extension Period|Withdrawal by Subject|2
7592761|NCT02008890|26413813|P4|Extension Period|Withdrawal by Subject|4
7592762|NCT02008890|26413814|P3|Extension Period|Withdrawal by Subject|0
7592763|NCT02008890|26413815|P2|Extension Period|Withdrawal by Subject|2
7592764|NCT02008890|26413816|P1|Extension Period|Withdrawal by Subject|3
7592765|NCT02008890|26413812|P5|Period 2|Lost to Follow-up|0
7592766|NCT02008890|26413813|P4|Period 2|Lost to Follow-up|0
7592767|NCT02008890|26413814|P3|Period 2|Lost to Follow-up|1
7592768|NCT02008890|26413815|P2|Period 2|Lost to Follow-up|0
7592769|NCT02008890|26413816|P1|Period 2|Lost to Follow-up|0
7592770|NCT02008890|26413812|P5|Period 2|Physician Decision|1
7592771|NCT02008890|26413813|P4|Period 2|Physician Decision|2
7592772|NCT02008890|26413814|P3|Period 2|Physician Decision|0
7592773|NCT02008890|26413815|P2|Period 2|Physician Decision|0
7592774|NCT02008890|26413816|P1|Period 2|Physician Decision|4
7592775|NCT02008890|26413812|P5|Period 2|Withdrawal by Subject|2
7592776|NCT02008890|26413813|P4|Period 2|Withdrawal by Subject|7
7592777|NCT02008890|26413814|P3|Period 2|Withdrawal by Subject|0
7592778|NCT02008890|26413815|P2|Period 2|Withdrawal by Subject|8
7592779|NCT02008890|26413816|P1|Period 2|Withdrawal by Subject|11
7592780|NCT02008890|26413812|P5|Period 2|Adverse Event|5
7592781|NCT02008890|26413813|P4|Period 2|Adverse Event|5
7592782|NCT02008890|26413814|P3|Period 2|Adverse Event|0
7592783|NCT02008890|26413815|P2|Period 2|Adverse Event|7
7592784|NCT02008890|26413816|P1|Period 2|Adverse Event|12
7592785|NCT02008890|26413812|P5|Period 1|Adverse Event|0
7592786|NCT02008890|26413813|P4|Period 1|Adverse Event|0
7592787|NCT02008890|26413814|P3|Period 1|Adverse Event|6
7592788|NCT02008890|26413815|P2|Period 1|Adverse Event|8
7592789|NCT02008890|26413816|P1|Period 1|Adverse Event|6
7592790|NCT02008890|26413812|P5|Period 1|Physician Decision|0
7592791|NCT02008890|26413813|P4|Period 1|Physician Decision|0
7592792|NCT02008890|26413814|P3|Period 1|Physician Decision|1
7592793|NCT02008890|26413815|P2|Period 1|Physician Decision|0
7592794|NCT02008890|26413816|P1|Period 1|Physician Decision|1
7592795|NCT02008890|26413812|P5|Period 1|Pregnancy|0
7592796|NCT02008890|26413813|P4|Period 1|Pregnancy|0
7592797|NCT02008890|26413814|P3|Period 1|Pregnancy|0
7592798|NCT02008890|26413815|P2|Period 1|Pregnancy|0
7592799|NCT02008890|26413816|P1|Period 1|Pregnancy|1
7592800|NCT02008890|26413812|P5|Period 1|Withdrawal by Subject|0
7592801|NCT02008890|26413813|P4|Period 1|Withdrawal by Subject|0
7592802|NCT02008890|26413814|P3|Period 1|Withdrawal by Subject|5
7592803|NCT02008890|26413815|P2|Period 1|Withdrawal by Subject|7
7592804|NCT02008890|26413816|P1|Period 1|Withdrawal by Subject|7
7592805|NCT02008877|26413852|P3|Overall Study|Inevaluable|0
7592806|NCT02008877|26413853|P2|Overall Study|Inevaluable|1
7592807|NCT02008877|26413854|P1|Overall Study|Inevaluable|0
7592808|NCT02008773|26413873|P4|Overall Study|Lost to Follow-up|2
7592809|NCT02008773|26413874|P3|Overall Study|Lost to Follow-up|3
7592810|NCT02008773|26413875|P2|Overall Study|Lost to Follow-up|1
7592811|NCT02008773|26413876|P1|Overall Study|Lost to Follow-up|0
7592812|NCT02008773|26413873|P4|Overall Study|Withdrawal by Subject|6
7592813|NCT02008773|26413874|P3|Overall Study|Withdrawal by Subject|7
7592814|NCT02008773|26413875|P2|Overall Study|Withdrawal by Subject|4
7592815|NCT02008773|26413876|P1|Overall Study|Withdrawal by Subject|8
7592816|NCT02008773|26413873|P4|Overall Study|Medication Non-compliance|2
7592817|NCT02008773|26413874|P3|Overall Study|Medication Non-compliance|3
7592818|NCT02008773|26413875|P2|Overall Study|Medication Non-compliance|1
7592819|NCT02008773|26413876|P1|Overall Study|Medication Non-compliance|2
7592820|NCT02008773|26413873|P4|Overall Study|Adverse Event|2
7592821|NCT02008773|26413874|P3|Overall Study|Adverse Event|1
7592822|NCT02008773|26413875|P2|Overall Study|Adverse Event|3
7592823|NCT02008773|26413876|P1|Overall Study|Adverse Event|3
7592824|NCT02008565|26413942|P4|Overall Study|Protocol Violation|0
7592825|NCT02008565|26413943|P3|Overall Study|Protocol Violation|2
7592826|NCT02008565|26413944|P2|Overall Study|Protocol Violation|1
7592827|NCT02008565|26413945|P1|Overall Study|Protocol Violation|1
7592828|NCT02008526|26414006|P3|Overall Study|Lost to Follow-up|6
7592829|NCT02008526|26414007|P2|Overall Study|Lost to Follow-up|9
7592830|NCT02008526|26414008|P1|Overall Study|Lost to Follow-up|5
7592831|NCT02008526|26414006|P3|Overall Study|Withdrawal by Subject|2
7592832|NCT02008526|26414007|P2|Overall Study|Withdrawal by Subject|3
7592833|NCT02008526|26414008|P1|Overall Study|Withdrawal by Subject|3
7592834|NCT02008526|26414006|P3|Overall Study|Death|1
7592835|NCT02008526|26414007|P2|Overall Study|Death|2
7592836|NCT02008526|26414008|P1|Overall Study|Death|0
7592837|NCT02008396|26414021|P2|Overall Study|Protocol Violation|1
7592838|NCT02008396|26414022|P1|Overall Study|Protocol Violation|0
7592839|NCT02008370|26414032|P1|Overall Study|Lost to Follow-up|7
7592840|NCT02008318|26414040|P2|Overall Study|Withdrawal by Subject|0
7592841|NCT02008318|26414041|P1|Overall Study|Withdrawal by Subject|3
7592842|NCT02008318|26414040|P2|Overall Study|Protocol Violation|1
7592843|NCT02008318|26414041|P1|Overall Study|Protocol Violation|1
7592844|NCT02008318|26414040|P2|Overall Study|Progressive Disease|0
7592845|NCT02008318|26414041|P1|Overall Study|Progressive Disease|2
7592846|NCT02008318|26414040|P2|Overall Study|Physician Decision|0
7592847|NCT02008318|26414041|P1|Overall Study|Physician Decision|2
7592848|NCT02008318|26414040|P2|Overall Study|Adverse Event|0
7592849|NCT02008318|26414041|P1|Overall Study|Adverse Event|4
7592850|NCT02008227|26414062|P2|Overall Study|Study Terminated By Sponsor|83
7592851|NCT02008227|26414063|P1|Overall Study|Study Terminated By Sponsor|44
7592852|NCT02008227|26414062|P2|Overall Study|Withdrawal by Subject|36
7592853|NCT02008227|26414063|P1|Overall Study|Withdrawal by Subject|67
7592854|NCT02008227|26414062|P2|Overall Study|Death|485
7592855|NCT02008227|26414063|P1|Overall Study|Death|494
7592856|NCT02008227|26414062|P2|Overall Study|Lost to Follow-up|9
7592857|NCT02008227|26414063|P1|Overall Study|Lost to Follow-up|7
7592858|NCT02007954|26414151|P1|Overall Study|Death|1
7592859|NCT02007954|26414151|P1|Overall Study|Disease progression and unrelated AE|1
7592860|NCT02007954|26414151|P1|Overall Study|Switch in treatment modality|2
7592861|NCT02007954|26414151|P1|Overall Study|Received liver transplant|3
7592862|NCT02007720|26414170|P2|Overall Study|patient followd less than 165 days|5
7592863|NCT02007720|26414171|P1|Overall Study|patient followd less than 165 days|11
7592864|NCT02007720|26414170|P2|Overall Study|technical problem|2
7592865|NCT02007720|26414171|P1|Overall Study|technical problem|4
7592866|NCT02007720|26414170|P2|Overall Study|study terminated by sponsor|54
7592867|NCT02007720|26414171|P1|Overall Study|study terminated by sponsor|58
7592868|NCT02007720|26414170|P2|Overall Study|Withdrawal by Subject|11
7592869|NCT02007720|26414171|P1|Overall Study|Withdrawal by Subject|9
7592870|NCT02007577|26414206|P2|Overall Study|Withdrawal by Subject|1
7592871|NCT02007577|26414207|P1|Overall Study|Withdrawal by Subject|0
7592872|NCT02007577|26414206|P2|Overall Study|Adverse Event|0
7592873|NCT02007577|26414207|P1|Overall Study|Adverse Event|1
7592874|NCT02007512|26414219|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7592875|NCT02007512|26414220|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7592876|NCT02007512|26414221|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
7592877|NCT02007512|26414222|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7592878|NCT02007512|26414219|P4|Open Label Treatment Period|Disease progression|11
7592879|NCT02007512|26414220|P3|Open Label Treatment Period|Disease progression|0
7592880|NCT02007512|26414221|P2|Open Label Treatment Period|Disease progression|17
7592881|NCT02007512|26414222|P1|Open Label Treatment Period|Disease progression|0
7592882|NCT02007512|26414219|P4|Open Label Treatment Period|Other|1
7592883|NCT02007512|26414220|P3|Open Label Treatment Period|Other|0
7592884|NCT02007512|26414221|P2|Open Label Treatment Period|Other|0
7592885|NCT02007512|26414222|P1|Open Label Treatment Period|Other|0
7592886|NCT02007512|26414219|P4|Open Label Treatment Period|Adverse Event|0
7592887|NCT02007512|26414220|P3|Open Label Treatment Period|Adverse Event|0
7592888|NCT02007512|26414221|P2|Open Label Treatment Period|Adverse Event|1
7592889|NCT02007512|26414222|P1|Open Label Treatment Period|Adverse Event|0
7592890|NCT02007512|26414219|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
7592891|NCT02007512|26414220|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
7592892|NCT02007512|26414221|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
7592893|NCT02007512|26414222|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
7592894|NCT02007512|26414219|P4|Double Blind Treatment Period|Other|2
7592895|NCT02007512|26414220|P3|Double Blind Treatment Period|Other|1
7592896|NCT02007512|26414221|P2|Double Blind Treatment Period|Other|0
7592897|NCT02007512|26414222|P1|Double Blind Treatment Period|Other|0
7592898|NCT02007512|26414219|P4|Double Blind Treatment Period|Protocol Violation|1
7592899|NCT02007512|26414220|P3|Double Blind Treatment Period|Protocol Violation|0
7592900|NCT02007512|26414221|P2|Double Blind Treatment Period|Protocol Violation|0
7592901|NCT02007512|26414222|P1|Double Blind Treatment Period|Protocol Violation|0
7592902|NCT02007512|26414219|P4|Double Blind Treatment Period|Withdrawal by Subject|3
7592903|NCT02007512|26414220|P3|Double Blind Treatment Period|Withdrawal by Subject|3
7592904|NCT02007512|26414221|P2|Double Blind Treatment Period|Withdrawal by Subject|2
7592905|NCT02007512|26414222|P1|Double Blind Treatment Period|Withdrawal by Subject|4
7592906|NCT02007512|26414219|P4|Double Blind Treatment Period|Disease progression|51
7592907|NCT02007512|26414220|P3|Double Blind Treatment Period|Disease progression|45
7592908|NCT02007512|26414221|P2|Double Blind Treatment Period|Disease progression|49
7592909|NCT02007512|26414222|P1|Double Blind Treatment Period|Disease progression|44
7592910|NCT02007512|26414219|P4|Double Blind Treatment Period|Death|0
7592911|NCT02007512|26414220|P3|Double Blind Treatment Period|Death|0
7592912|NCT02007512|26414221|P2|Double Blind Treatment Period|Death|0
7592913|NCT02007512|26414222|P1|Double Blind Treatment Period|Death|1
7592914|NCT02007512|26414219|P4|Double Blind Treatment Period|Adverse Event|2
7592915|NCT02007512|26414220|P3|Double Blind Treatment Period|Adverse Event|6
7592916|NCT02007512|26414221|P2|Double Blind Treatment Period|Adverse Event|2
7592917|NCT02007512|26414222|P1|Double Blind Treatment Period|Adverse Event|4
7592918|NCT02007434|26414300|P8|Overall Study|Non-compliance|0
7592919|NCT02007434|26414301|P7|Overall Study|Non-compliance|0
7592920|NCT02007434|26414302|P6|Overall Study|Non-compliance|0
7592921|NCT02007434|26414303|P5|Overall Study|Non-compliance|0
7592922|NCT02007434|26414304|P4|Overall Study|Non-compliance|0
7592923|NCT02007434|26414305|P3|Overall Study|Non-compliance|1
7592924|NCT02007434|26414306|P2|Overall Study|Non-compliance|0
7592925|NCT02007434|26414307|P1|Overall Study|Non-compliance|1
7592926|NCT02007434|26414300|P8|Overall Study|Lost to Follow-up|0
7592927|NCT02007434|26414301|P7|Overall Study|Lost to Follow-up|0
7592928|NCT02007434|26414302|P6|Overall Study|Lost to Follow-up|0
7592929|NCT02007434|26414303|P5|Overall Study|Lost to Follow-up|0
7592930|NCT02007434|26414304|P4|Overall Study|Lost to Follow-up|0
7592931|NCT02007434|26414305|P3|Overall Study|Lost to Follow-up|0
7592932|NCT02007434|26414306|P2|Overall Study|Lost to Follow-up|1
7592933|NCT02007434|26414307|P1|Overall Study|Lost to Follow-up|0
7592934|NCT02007278|26414438|P2|Overall Study|Mis-randomization|1
7592935|NCT02007278|26414439|P1|Overall Study|Mis-randomization|1
7592936|NCT02007278|26414438|P2|Overall Study|Incorrect medication administration|0
7592937|NCT02007278|26414439|P1|Overall Study|Incorrect medication administration|1
7592938|NCT02007278|26414438|P2|Overall Study|Ingestion of drugs not allowed in study|1
7592939|NCT02007278|26414439|P1|Overall Study|Ingestion of drugs not allowed in study|0
7592940|NCT02007278|26414438|P2|Overall Study|Failure to comply with an eligibility|1
7592941|NCT02007278|26414439|P1|Overall Study|Failure to comply with an eligibility|0
7592942|NCT02007252|26414461|P2|Overall Study|Adverse Event|4
7592943|NCT02007252|26414462|P1|Overall Study|Adverse Event|7
7592944|NCT02007252|26414461|P2|Overall Study|Abnormal laboratory value(s)|0
7592945|NCT02007252|26414462|P1|Overall Study|Abnormal laboratory value(s)|1
7592946|NCT02007252|26414461|P2|Overall Study|Administrative problems|7
7592947|NCT02007252|26414462|P1|Overall Study|Administrative problems|3
7592948|NCT02007109|26414475|P1|Overall Study|Excluded - Age<7yo|9
7592949|NCT02007109|26414475|P1|Overall Study|Diary not returned or excluded|102
7592950|NCT02007096|26414484|P2|Overall Study|no mesh placed|1
7592951|NCT02007096|26414485|P1|Overall Study|no mesh placed|0
7592952|NCT02007096|26414484|P2|Overall Study|converted to open surgery|1
7592953|NCT02007096|26414485|P1|Overall Study|converted to open surgery|1
7592954|NCT02007096|26414484|P2|Overall Study|did not follow postoperative protocol|11
7592955|NCT02007096|26414485|P1|Overall Study|did not follow postoperative protocol|8
7592956|NCT02007096|26414484|P2|Overall Study|did not inject saline|3
7592957|NCT02007096|26414485|P1|Overall Study|did not inject saline|0
7592958|NCT02007096|26414484|P2|Overall Study|medication not available|0
7592959|NCT02007096|26414485|P1|Overall Study|medication not available|2
7592960|NCT02007070|26414497|P1|Overall Study|Progressive Disease|21
7592961|NCT02007070|26414497|P1|Overall Study|Physician Decision|1
7592962|NCT02007070|26414497|P1|Overall Study|Protocol Violation|2
7592963|NCT02007070|26414497|P1|Overall Study|Death|1
7592964|NCT02007070|26414497|P1|Overall Study|Clinical Progression|4
7592965|NCT02007070|26414497|P1|Overall Study|Adverse Event|4
7592966|NCT02006979|26414518|P2|Overall Study|Protocol Violation|1
7592967|NCT02006979|26414519|P1|Overall Study|Protocol Violation|0
7592968|NCT02006979|26414518|P2|Overall Study|Withdrawal by Subject|1
7592969|NCT02006979|26414519|P1|Overall Study|Withdrawal by Subject|1
7592970|NCT02006927|26414531|P1|Overall Study|Withdrawal by Subject|1
7592971|NCT02006927|26414531|P1|Overall Study|Adverse Event|2
7592972|NCT02006758|26414570|P1|Overall Study|Other|2
7592973|NCT02006758|26414570|P1|Overall Study|Procedurally excluded|1
7592974|NCT02006758|26414570|P1|Overall Study|Withdrawal by Subject|4
7592975|NCT02006758|26414570|P1|Overall Study|Lost to Follow-up|4
7592976|NCT02006758|26414570|P1|Overall Study|Death|1
7592977|NCT02006758|26414570|P1|Overall Study|Protocol Violation|1
7592978|NCT02006732|26414601|P4|Overall Study|Withdrawal by Subject|1
7592979|NCT02006732|26414602|P3|Overall Study|Withdrawal by Subject|4
7592980|NCT02006732|26414603|P2|Overall Study|Withdrawal by Subject|0
7592981|NCT02006732|26414604|P1|Overall Study|Withdrawal by Subject|3
7592982|NCT02006732|26414601|P4|Overall Study|Lost to Follow-up|0
7592983|NCT02006732|26414602|P3|Overall Study|Lost to Follow-up|0
7592984|NCT02006732|26414603|P2|Overall Study|Lost to Follow-up|1
7592985|NCT02006732|26414604|P1|Overall Study|Lost to Follow-up|0
7592986|NCT02006732|26414601|P4|Overall Study|Protocol Violation|0
7592987|NCT02006732|26414602|P3|Overall Study|Protocol Violation|0
7592988|NCT02006732|26414603|P2|Overall Study|Protocol Violation|1
7592989|NCT02006732|26414604|P1|Overall Study|Protocol Violation|1
7592990|NCT02006732|26414601|P4|Overall Study|Lack of Efficacy|1
7592991|NCT02006732|26414602|P3|Overall Study|Lack of Efficacy|1
7592992|NCT02006732|26414603|P2|Overall Study|Lack of Efficacy|3
7592993|NCT02006732|26414604|P1|Overall Study|Lack of Efficacy|6
7592994|NCT02006732|26414601|P4|Overall Study|Adverse Event|2
7592995|NCT02006732|26414602|P3|Overall Study|Adverse Event|4
7592996|NCT02006732|26414603|P2|Overall Study|Adverse Event|7
7592997|NCT02006732|26414604|P1|Overall Study|Adverse Event|10
7592998|NCT02006719|26414644|P2|Overall Study|Other/Unknown|1
7592999|NCT02006719|26414645|P1|Overall Study|Other/Unknown|0
7593000|NCT02006719|26414644|P2|Overall Study|Adverse Event|1
7593001|NCT02006719|26414645|P1|Overall Study|Adverse Event|1
7593002|NCT02006719|26414644|P2|Overall Study|Protocol Violation|0
7593003|NCT02006719|26414645|P1|Overall Study|Protocol Violation|2
7593004|NCT02006719|26414644|P2|Overall Study|Lost to Follow-up|1
7593005|NCT02006719|26414645|P1|Overall Study|Lost to Follow-up|5
7593006|NCT02006719|26414644|P2|Overall Study|Withdrawal by Subject|2
7593007|NCT02006719|26414645|P1|Overall Study|Withdrawal by Subject|10
7593008|NCT02006706|26414675|P1|Overall Study|Lost to Follow-up|1
7593009|NCT02006693|26414682|P2|Overall Study|Patient Decision|0
7593010|NCT02006693|26414683|P1|Overall Study|Patient Decision|4
7593011|NCT02006693|26414682|P2|Overall Study|Lost to Follow-up|1
7593012|NCT02006693|26414683|P1|Overall Study|Lost to Follow-up|4
7593013|NCT02006693|26414682|P2|Overall Study|Death|2
7593014|NCT02006693|26414683|P1|Overall Study|Death|2
7593015|NCT02006693|26414682|P2|Overall Study|XEN Implant Explantation|1
7593016|NCT02006693|26414683|P1|Overall Study|XEN Implant Explantation|0
7593017|NCT02006693|26414682|P2|Overall Study|Another Glaucoma-related Surgery|1
7593018|NCT02006693|26414683|P1|Overall Study|Another Glaucoma-related Surgery|12
7593019|NCT02006693|26414682|P2|Overall Study|No Reason Specified|8
7593020|NCT02006693|26414683|P1|Overall Study|No Reason Specified|6
7593021|NCT02006667|26414695|P1|Overall Study|Withdrawal by Subject|1
7593022|NCT02006667|26414695|P1|Overall Study|Death|2
7593023|NCT02006667|26414695|P1|Overall Study|Adverse Event|3
7593024|NCT02006654|26414707|P2|Overall Study|moving out of state|1
7593025|NCT02006654|26414708|P1|Overall Study|moving out of state|0
7593026|NCT02006654|26414707|P2|Overall Study|disallowed medication|0
7593027|NCT02006654|26414708|P1|Overall Study|disallowed medication|1
7593028|NCT02006654|26414707|P2|Overall Study|mood disorder|1
7593029|NCT02006654|26414708|P1|Overall Study|mood disorder|0
7593030|NCT02006654|26414707|P2|Overall Study|faecal incontinence|1
7593031|NCT02006654|26414708|P1|Overall Study|faecal incontinence|0
7593032|NCT02006654|26414707|P2|Overall Study|worsening cognitive condition|1
7593033|NCT02006654|26414708|P1|Overall Study|worsening cognitive condition|0
7593034|NCT02006654|26414707|P2|Overall Study|insufficient compliance|0
7593035|NCT02006654|26414708|P1|Overall Study|insufficient compliance|1
7593036|NCT02006654|26414707|P2|Overall Study|patient's will|1
7593037|NCT02006654|26414708|P1|Overall Study|patient's will|2
7593038|NCT02006654|26414707|P2|Overall Study|Lost to Follow-up|0
7593039|NCT02006654|26414708|P1|Overall Study|Lost to Follow-up|1
7593040|NCT02006654|26414707|P2|Overall Study|Protocol Violation|8
7593041|NCT02006654|26414708|P1|Overall Study|Protocol Violation|5
7593042|NCT02006654|26414707|P2|Overall Study|Withdrawal by Subject|12
7593043|NCT02006654|26414708|P1|Overall Study|Withdrawal by Subject|14
7593044|NCT02006654|26414707|P2|Overall Study|Death|0
7593045|NCT02006654|26414708|P1|Overall Study|Death|1
7593046|NCT02006654|26414707|P2|Overall Study|Adverse Event|17
7593047|NCT02006654|26414708|P1|Overall Study|Adverse Event|16
7593048|NCT02006654|26414707|P2|Overall Study|Withdrawal before treatment|2
7593049|NCT02006654|26414708|P1|Overall Study|Withdrawal before treatment|4
7593050|NCT02006641|26414737|P3|Overall Study|Other reason: protocol non-compliance|1
7593051|NCT02006641|26414738|P2|Overall Study|Other reason: protocol non-compliance|0
7593052|NCT02006641|26414739|P1|Overall Study|Other reason: protocol non-compliance|0
7593053|NCT02006641|26414737|P3|Overall Study|Other reason: caregiver impossibility|1
7593054|NCT02006641|26414738|P2|Overall Study|Other reason: caregiver impossibility|0
7593055|NCT02006641|26414739|P1|Overall Study|Other reason: caregiver impossibility|0
7593056|NCT02006641|26414737|P3|Overall Study|Other reason: hospitalisation|0
7593057|NCT02006641|26414738|P2|Overall Study|Other reason: hospitalisation|1
7593058|NCT02006641|26414739|P1|Overall Study|Other reason: hospitalisation|0
7593059|NCT02006641|26414737|P3|Overall Study|Other reason: patient's wife has died|1
7593060|NCT02006641|26414738|P2|Overall Study|Other reason: patient's wife has died|0
7593061|NCT02006641|26414739|P1|Overall Study|Other reason: patient's wife has died|0
7593062|NCT02006641|26414737|P3|Overall Study|Other reason: caregiver in hospital|0
7593063|NCT02006641|26414738|P2|Overall Study|Other reason: caregiver in hospital|1
7593064|NCT02006641|26414739|P1|Overall Study|Other reason: caregiver in hospital|0
7593065|NCT02006641|26414737|P3|Overall Study|Other reason: patient has moved|1
7593066|NCT02006641|26414738|P2|Overall Study|Other reason: patient has moved|0
7593067|NCT02006641|26414739|P1|Overall Study|Other reason: patient has moved|1
7593068|NCT02006641|26414737|P3|Overall Study|Other reason:patient didn't want to come|1
7593069|NCT02006641|26414738|P2|Overall Study|Other reason:patient didn't want to come|0
7593070|NCT02006641|26414739|P1|Overall Study|Other reason:patient didn't want to come|0
7593071|NCT02006641|26414737|P3|Overall Study|Other reason: patient didn't show up|0
7593072|NCT02006641|26414738|P2|Overall Study|Other reason: patient didn't show up|0
7593073|NCT02006641|26414739|P1|Overall Study|Other reason: patient didn't show up|1
7593074|NCT02006641|26414737|P3|Overall Study|Withdrawal by Subject|11
7593075|NCT02006641|26414738|P2|Overall Study|Withdrawal by Subject|12
7593076|NCT02006641|26414739|P1|Overall Study|Withdrawal by Subject|7
7593077|NCT02006641|26414737|P3|Overall Study|Lost to Follow-up|0
7593078|NCT02006641|26414738|P2|Overall Study|Lost to Follow-up|1
7593079|NCT02006641|26414739|P1|Overall Study|Lost to Follow-up|0
7593080|NCT02006641|26414737|P3|Overall Study|Protocol Violation|2
7593081|NCT02006641|26414738|P2|Overall Study|Protocol Violation|2
7593082|NCT02006641|26414739|P1|Overall Study|Protocol Violation|0
7593083|NCT02006641|26414737|P3|Overall Study|Adverse Event|15
7593084|NCT02006641|26414738|P2|Overall Study|Adverse Event|11
7593085|NCT02006641|26414739|P1|Overall Study|Adverse Event|15
7593086|NCT02006641|26414737|P3|Overall Study|Withdrawal before treatment|3
7593087|NCT02006641|26414738|P2|Overall Study|Withdrawal before treatment|5
7593088|NCT02006641|26414739|P1|Overall Study|Withdrawal before treatment|2
7593089|NCT02006628|26414779|P2|Overall Study|Withdrawal by Subject|1
7593090|NCT02006628|26414780|P1|Overall Study|Withdrawal by Subject|2
7593091|NCT02006628|26414779|P2|Overall Study|Adverse Event|1
7593092|NCT02006628|26414780|P1|Overall Study|Adverse Event|1
7593093|NCT02006576|26414805|P3|Overall Study|Screen Failure, too sick, other|13
7593094|NCT02006576|26414806|P2|Overall Study|Screen Failure, too sick, other|1
7593095|NCT02006576|26414807|P1|Overall Study|Screen Failure, too sick, other|13
7593096|NCT02006576|26414805|P3|Overall Study|Lost to Follow-up|1
7593097|NCT02006576|26414806|P2|Overall Study|Lost to Follow-up|0
7593098|NCT02006576|26414807|P1|Overall Study|Lost to Follow-up|1
7593099|NCT02006576|26414805|P3|Overall Study|Death|1
7593100|NCT02006576|26414806|P2|Overall Study|Death|0
7593101|NCT02006576|26414807|P1|Overall Study|Death|0
7593102|NCT02006576|26414805|P3|Overall Study|Withdrawal by Subject|2
7593103|NCT02006576|26414806|P2|Overall Study|Withdrawal by Subject|6
7593104|NCT02006576|26414807|P1|Overall Study|Withdrawal by Subject|4
7593105|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Sponsor decision|0
7593106|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Sponsor decision|0
7593107|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Sponsor decision|1
7593108|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Sponsor decision|0
7593109|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Sponsor decision|0
7593110|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Withdrawal by Subject|0
7593111|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Withdrawal by Subject|0
7593112|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Withdrawal by Subject|2
7593113|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Withdrawal by Subject|1
7593114|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Withdrawal by Subject|2
7593115|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Not treated|0
7593116|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Not treated|0
7593117|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Not treated|2
7593118|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Not treated|0
7593119|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Not treated|0
7593120|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Other|0
7593121|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Other|1
7593122|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Other|0
7593123|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Other|1
7593124|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Other|0
7593125|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Adverse Event|1
7593126|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Adverse Event|1
7593127|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Adverse Event|5
7593128|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Adverse Event|4
7593129|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Adverse Event|1
7593130|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Noncompliance|0
7593131|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Noncompliance|0
7593132|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Noncompliance|0
7593133|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Noncompliance|0
7593134|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Noncompliance|1
7593135|NCT02006472|26414823|P5|Period 2 (Through Week 52)|Lack of Efficacy|1
7593136|NCT02006472|26414824|P4|Period 2 (Through Week 52)|Lack of Efficacy|1
7593137|NCT02006472|26414825|P3|Period 2 (Through Week 52)|Lack of Efficacy|0
7593138|NCT02006472|26414826|P2|Period 2 (Through Week 52)|Lack of Efficacy|0
7593139|NCT02006472|26414827|P1|Period 2 (Through Week 52)|Lack of Efficacy|1
7593140|NCT02006472|26414823|P5|Period 1 (Through Week 26)|Withdrawal by Subject|3
7593141|NCT02006472|26414824|P4|Period 1 (Through Week 26)|Withdrawal by Subject|0
7593142|NCT02006472|26414825|P3|Period 1 (Through Week 26)|Withdrawal by Subject|3
7593143|NCT02006472|26414826|P2|Period 1 (Through Week 26)|Withdrawal by Subject|9
7593144|NCT02006472|26414827|P1|Period 1 (Through Week 26)|Withdrawal by Subject|3
7593145|NCT02006472|26414823|P5|Period 1 (Through Week 26)|Adverse Event|14
7593146|NCT02006472|26414824|P4|Period 1 (Through Week 26)|Adverse Event|11
7593147|NCT02006472|26414825|P3|Period 1 (Through Week 26)|Adverse Event|11
7593148|NCT02006472|26414826|P2|Period 1 (Through Week 26)|Adverse Event|6
7593149|NCT02006472|26414827|P1|Period 1 (Through Week 26)|Adverse Event|5
7593150|NCT02006472|26414823|P5|Period 1 (Through Week 26)|Other|3
7593151|NCT02006472|26414824|P4|Period 1 (Through Week 26)|Other|2
7593152|NCT02006472|26414825|P3|Period 1 (Through Week 26)|Other|0
7593153|NCT02006472|26414826|P2|Period 1 (Through Week 26)|Other|5
7593154|NCT02006472|26414827|P1|Period 1 (Through Week 26)|Other|1
7593155|NCT02006472|26414823|P5|Period 1 (Through Week 26)|Noncompliance|0
7593156|NCT02006472|26414824|P4|Period 1 (Through Week 26)|Noncompliance|0
7593157|NCT02006472|26414825|P3|Period 1 (Through Week 26)|Noncompliance|1
7593158|NCT02006472|26414826|P2|Period 1 (Through Week 26)|Noncompliance|1
7593159|NCT02006472|26414827|P1|Period 1 (Through Week 26)|Noncompliance|2
7593160|NCT02006472|26414823|P5|Period 1 (Through Week 26)|Lack of Efficacy|0
7593161|NCT02006472|26414824|P4|Period 1 (Through Week 26)|Lack of Efficacy|0
7593162|NCT02006472|26414825|P3|Period 1 (Through Week 26)|Lack of Efficacy|1
7593163|NCT02006472|26414826|P2|Period 1 (Through Week 26)|Lack of Efficacy|0
7593164|NCT02006472|26414827|P1|Period 1 (Through Week 26)|Lack of Efficacy|0
7593165|NCT02006472|26414823|P5|Period 1 (Through Week 26)|Protocol Violation|0
7593166|NCT02006472|26414824|P4|Period 1 (Through Week 26)|Protocol Violation|1
7593167|NCT02006472|26414825|P3|Period 1 (Through Week 26)|Protocol Violation|1
7593168|NCT02006472|26414826|P2|Period 1 (Through Week 26)|Protocol Violation|1
7593169|NCT02006472|26414827|P1|Period 1 (Through Week 26)|Protocol Violation|1
7593170|NCT02006121|26414927|P2|Open Label Phase|Non-compliance with study drug|0
7593171|NCT02006121|26414928|P1|Open Label Phase|Non-compliance with study drug|3
7593172|NCT02006121|26414927|P2|Open Label Phase|Withdrawal by Subject|0
7593173|NCT02006121|26414928|P1|Open Label Phase|Withdrawal by Subject|3
7593174|NCT02006121|26414927|P2|Open Label Phase|Protocol Violation|0
7593175|NCT02006121|26414928|P1|Open Label Phase|Protocol Violation|2
7593176|NCT02006121|26414927|P2|Open Label Phase|Lack of Efficacy|0
7593177|NCT02006121|26414928|P1|Open Label Phase|Lack of Efficacy|2
7593178|NCT02006121|26414927|P2|Open Label Phase|Adverse Event|0
7593179|NCT02006121|26414928|P1|Open Label Phase|Adverse Event|15
7593180|NCT02006121|26414927|P2|Double Blind Phase|Inconvenience of infusion system|1
7593181|NCT02006121|26414928|P1|Double Blind Phase|Inconvenience of infusion system|0
7593182|NCT02006121|26414927|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
7593183|NCT02006121|26414928|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
7593184|NCT02006121|26414927|P2|Double Blind Phase|Non-compliance with study drug|3
7593185|NCT02006121|26414928|P1|Double Blind Phase|Non-compliance with study drug|1
7593186|NCT02006121|26414927|P2|Double Blind Phase|Withdrawal by Subject|4
7593187|NCT02006121|26414928|P1|Double Blind Phase|Withdrawal by Subject|3
7593188|NCT02006121|26414927|P2|Double Blind Phase|Lack of Efficacy|16
7593189|NCT02006121|26414928|P1|Double Blind Phase|Lack of Efficacy|1
7593190|NCT02006121|26414927|P2|Double Blind Phase|Adverse Event|0
7593191|NCT02006121|26414928|P1|Double Blind Phase|Adverse Event|6
7593192|NCT02005887|26414961|P2|Overall Study|Protocol Violation|2
7593193|NCT02005887|26414962|P1|Overall Study|Protocol Violation|0
7593194|NCT02005692|26414980|P1|Overall Study|Discharged earlier than anticipated|5
7593195|NCT02005692|26414980|P1|Overall Study|Withdrawal by Subject|1
7593196|NCT02005692|26414980|P1|Overall Study|Protocol Violation|1
7593197|NCT02005627|26415006|P2|Overall Study|Withdrawal by Subject|2
7593198|NCT02005627|26415007|P1|Overall Study|Withdrawal by Subject|1
7593199|NCT02005627|26415006|P2|Overall Study|Lost to Follow-up|2
7593200|NCT02005627|26415007|P1|Overall Study|Lost to Follow-up|1
7593201|NCT02005562|26415036|P2|Overall Study|Physician Decision|1
7593202|NCT02005562|26415037|P1|Overall Study|Physician Decision|0
7593203|NCT02005562|26415036|P2|Overall Study|No transplant|4
7593204|NCT02005562|26415037|P1|Overall Study|No transplant|1
7593205|NCT02005562|26415036|P2|Overall Study|Withdrawal by Subject|2
7593206|NCT02005562|26415037|P1|Overall Study|Withdrawal by Subject|2
7593207|NCT02005562|26415036|P2|Overall Study|Graft loss|6
7593208|NCT02005562|26415037|P1|Overall Study|Graft loss|7
7593209|NCT02005562|26415036|P2|Overall Study|Death|2
7593210|NCT02005562|26415037|P1|Overall Study|Death|2
7593211|NCT02005484|26415098|P1|Overall Study|Sponsor decision|1
7593212|NCT02005484|26415098|P1|Overall Study|Changed to a Different Study|1
7593213|NCT02005484|26415098|P1|Overall Study|Disease progression|1
7593214|NCT02005484|26415098|P1|Overall Study|Death|1
7593215|NCT02005471|26415110|P2|Overall Study|Withdrawal by Subject|7
7593216|NCT02005471|26415111|P1|Overall Study|Withdrawal by Subject|18
7593217|NCT02005471|26415110|P2|Overall Study|Progressive Disease|0
7593218|NCT02005471|26415111|P1|Overall Study|Progressive Disease|3
7593219|NCT02005471|26415110|P2|Overall Study|Physician Decision|1
7593220|NCT02005471|26415111|P1|Overall Study|Physician Decision|2
7593221|NCT02005471|26415110|P2|Overall Study|Lost to Follow-up|0
7593222|NCT02005471|26415111|P1|Overall Study|Lost to Follow-up|1
7593223|NCT02005471|26415110|P2|Overall Study|Death|15
7593224|NCT02005471|26415111|P1|Overall Study|Death|26
7593225|NCT02005471|26415110|P2|Overall Study|Adverse Event|0
7593226|NCT02005471|26415111|P1|Overall Study|Adverse Event|1
7593227|NCT02005471|26415110|P2|Overall Study|Ongoing in Study|171
7593228|NCT02005471|26415111|P1|Overall Study|Ongoing in Study|144
7593229|NCT02005445|26415166|P2|Overall Study|Dual study enrollment|1
7593230|NCT02005445|26415167|P1|Overall Study|Dual study enrollment|0
7593231|NCT02005276|26415190|P4|Overall Study|No longer interested|3
7593232|NCT02005276|26415191|P3|Overall Study|No longer interested|3
7593233|NCT02005276|26415192|P2|Overall Study|No longer interested|2
7593234|NCT02005276|26415193|P1|Overall Study|No longer interested|5
7593235|NCT02005250|26415209|P2|Overall Study|Lost to Follow-up|5
7593236|NCT02005250|26415210|P1|Overall Study|Lost to Follow-up|15
7593237|NCT02005211|26415223|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7593238|NCT02005211|26415224|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7593239|NCT02005211|26415225|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
7593240|NCT02005211|26415226|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7593241|NCT02005211|26415227|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7593242|NCT02005211|26415228|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7593243|NCT02005211|26415229|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7593244|NCT02005029|26415264|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
7593245|NCT02005029|26415265|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
7593246|NCT02004886|26415322|P4|Overall Study|Unable to attend future visits|0
7593247|NCT02004886|26415323|P3|Overall Study|Unable to attend future visits|0
7593248|NCT02004886|26415324|P2|Overall Study|Unable to attend future visits|0
7593249|NCT02004886|26415325|P1|Overall Study|Unable to attend future visits|1
7593250|NCT02004886|26415322|P4|Overall Study|Adverse Event|0
7593251|NCT02004886|26415323|P3|Overall Study|Adverse Event|0
7593252|NCT02004886|26415324|P2|Overall Study|Adverse Event|1
7593253|NCT02004886|26415325|P1|Overall Study|Adverse Event|0
7593254|NCT02004873|26415375|P1|Overall Study|Withdrawal by Subject|1
7593255|NCT02004873|26415375|P1|Overall Study|Death|23
7593256|NCT02004873|26415375|P1|Overall Study|Missed 6-month visit|4
7593257|NCT02004873|26415375|P1|Overall Study|Awaiting 6-month visit|390
7593258|NCT02004873|26415375|P1|Overall Study|Implant unsuccessful|6
7593259|NCT02004847|26415384|P2|Overall Study|Protocol Violation|1
7593260|NCT02004847|26415385|P1|Overall Study|Protocol Violation|1
7593261|NCT02004522|26415446|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
7593262|NCT02004522|26415447|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
7593263|NCT02004522|26415446|P2|Overall Study|Disease Progression|31
7593264|NCT02004522|26415447|P1|Overall Study|Disease Progression|35
7593265|NCT02004522|26415446|P2|Overall Study|Never Dosed|4
7593266|NCT02004522|26415447|P1|Overall Study|Never Dosed|2
7593267|NCT02004522|26415446|P2|Overall Study|Other is reason listed by PI.|1
7593268|NCT02004522|26415447|P1|Overall Study|Other is reason listed by PI.|4
7593269|NCT02004522|26415446|P2|Overall Study|Protocol Violation|0
7593270|NCT02004522|26415447|P1|Overall Study|Protocol Violation|1
7593271|NCT02004522|26415446|P2|Overall Study|Physician Decision|4
7593272|NCT02004522|26415447|P1|Overall Study|Physician Decision|3
7593273|NCT02004522|26415446|P2|Overall Study|Death|3
7593274|NCT02004522|26415447|P1|Overall Study|Death|12
7593275|NCT02004522|26415446|P2|Overall Study|Withdrawal by Subject|7
7593276|NCT02004522|26415447|P1|Overall Study|Withdrawal by Subject|13
7593277|NCT02004522|26415446|P2|Overall Study|Adverse Event|6
7593278|NCT02004522|26415447|P1|Overall Study|Adverse Event|55
7593279|NCT02004262|26415579|P6|Overall Study|Study Terminated by Sponsor|5
7593280|NCT02004262|26415580|P5|Overall Study|Study Terminated by Sponsor|1
7593281|NCT02004262|26415581|P4|Overall Study|Study Terminated by Sponsor|1
7593282|NCT02004262|26415582|P3|Overall Study|Study Terminated by Sponsor|2
7593283|NCT02004262|26415583|P2|Overall Study|Study Terminated by Sponsor|3
7593284|NCT02004262|26415584|P1|Overall Study|Study Terminated by Sponsor|4
7593285|NCT02004262|26415579|P6|Overall Study|Lost to Follow-up|0
7593286|NCT02004262|26415580|P5|Overall Study|Lost to Follow-up|0
7593287|NCT02004262|26415581|P4|Overall Study|Lost to Follow-up|0
7593288|NCT02004262|26415582|P3|Overall Study|Lost to Follow-up|0
7593289|NCT02004262|26415583|P2|Overall Study|Lost to Follow-up|1
7593290|NCT02004262|26415584|P1|Overall Study|Lost to Follow-up|1
7593291|NCT02004262|26415579|P6|Overall Study|Withdrawal by Subject|3
7593292|NCT02004262|26415580|P5|Overall Study|Withdrawal by Subject|1
7593293|NCT02004262|26415581|P4|Overall Study|Withdrawal by Subject|0
7593294|NCT02004262|26415582|P3|Overall Study|Withdrawal by Subject|4
7593295|NCT02004262|26415583|P2|Overall Study|Withdrawal by Subject|0
7593296|NCT02004262|26415584|P1|Overall Study|Withdrawal by Subject|1
7593297|NCT02004262|26415579|P6|Overall Study|Death|22
7593298|NCT02004262|26415580|P5|Overall Study|Death|29
7593299|NCT02004262|26415581|P4|Overall Study|Death|28
7593300|NCT02004262|26415582|P3|Overall Study|Death|66
7593301|NCT02004262|26415583|P2|Overall Study|Death|64
7593302|NCT02004262|26415584|P1|Overall Study|Death|67
7593303|NCT02004236|26415604|P3|Overall Study|Lack of Efficacy|16
7593304|NCT02004236|26415605|P2|Overall Study|Lack of Efficacy|0
7593305|NCT02004236|26415606|P1|Overall Study|Lack of Efficacy|0
7593306|NCT02004093|26415666|P2|Overall Study|Other|1
7593307|NCT02004093|26415667|P1|Overall Study|Other|3
7593308|NCT02004093|26415666|P2|Overall Study|Withdrawal by Subject|7
7593309|NCT02004093|26415667|P1|Overall Study|Withdrawal by Subject|3
7593310|NCT02004093|26415666|P2|Overall Study|Lost to Follow-up|1
7593311|NCT02004093|26415667|P1|Overall Study|Lost to Follow-up|0
7593312|NCT02004093|26415666|P2|Overall Study|Protocol Violation|1
7593313|NCT02004093|26415667|P1|Overall Study|Protocol Violation|0
7593314|NCT02004093|26415666|P2|Overall Study|Lack of Efficacy|62
7593315|NCT02004093|26415667|P1|Overall Study|Lack of Efficacy|66
7593316|NCT02004093|26415666|P2|Overall Study|Death|1
7593317|NCT02004093|26415667|P1|Overall Study|Death|2
7593318|NCT02003963|26415699|P2|Overall Study|Lost to Follow-up|1
7593319|NCT02003963|26415700|P1|Overall Study|Lost to Follow-up|2
7593320|NCT02003924|26415722|P3|Long-term Follow-up Phase|Other|1
7593321|NCT02003924|26415723|P2|Long-term Follow-up Phase|Other|2
7593322|NCT02003924|26415724|P1|Long-term Follow-up Phase|Other|5
7593323|NCT02003924|26415722|P3|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
7593324|NCT02003924|26415723|P2|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
7593325|NCT02003924|26415724|P1|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
7593326|NCT02003924|26415722|P3|Long-term Follow-up Phase|Lost to Follow-up|1
7593327|NCT02003924|26415723|P2|Long-term Follow-up Phase|Lost to Follow-up|6
7593328|NCT02003924|26415724|P1|Long-term Follow-up Phase|Lost to Follow-up|8
7593329|NCT02003924|26415722|P3|Long-term Follow-up Phase|Death|4
7593330|NCT02003924|26415723|P2|Long-term Follow-up Phase|Death|174
7593331|NCT02003924|26415724|P1|Long-term Follow-up Phase|Death|288
7593332|NCT02003924|26415722|P3|Open-label Phase|Other|0
7593333|NCT02003924|26415723|P2|Open-label Phase|Other|0
7593334|NCT02003924|26415724|P1|Open-label Phase|Other|7
7593335|NCT02003924|26415722|P3|Open-label Phase|Adverse Event|10
7593336|NCT02003924|26415723|P2|Open-label Phase|Adverse Event|0
7593337|NCT02003924|26415724|P1|Open-label Phase|Adverse Event|25
7593338|NCT02003924|26415722|P3|Open-label Phase|Disease Progression|5
7593339|NCT02003924|26415723|P2|Open-label Phase|Disease Progression|0
7593340|NCT02003924|26415724|P1|Open-label Phase|Disease Progression|59
7593341|NCT02003924|26415722|P3|Open-label Phase|Withdrawal Consent to Continue Treatment|1
7593342|NCT02003924|26415723|P2|Open-label Phase|Withdrawal Consent to Continue Treatment|0
7593343|NCT02003924|26415724|P1|Open-label Phase|Withdrawal Consent to Continue Treatment|9
7593344|NCT02003924|26415722|P3|Open-label Phase|Lost to Follow-up|1
7593345|NCT02003924|26415723|P2|Open-label Phase|Lost to Follow-up|0
7593346|NCT02003924|26415724|P1|Open-label Phase|Lost to Follow-up|0
7593347|NCT02003924|26415722|P3|Double-blind Phase|Other|0
7593348|NCT02003924|26415723|P2|Double-blind Phase|Other|50
7593349|NCT02003924|26415724|P1|Double-blind Phase|Other|29
7593350|NCT02003924|26415722|P3|Double-blind Phase|Randomized But not Treated|0
7593351|NCT02003924|26415723|P2|Double-blind Phase|Randomized But not Treated|3
7593352|NCT02003924|26415724|P1|Double-blind Phase|Randomized But not Treated|3
7593353|NCT02003924|26415722|P3|Double-blind Phase|Adverse Event|0
7593354|NCT02003924|26415723|P2|Double-blind Phase|Adverse Event|31
7593355|NCT02003924|26415724|P1|Double-blind Phase|Adverse Event|120
7593356|NCT02003924|26415722|P3|Double-blind Phase|Disease Progression|0
7593357|NCT02003924|26415723|P2|Double-blind Phase|Disease Progression|247
7593358|NCT02003924|26415724|P1|Double-blind Phase|Disease Progression|229
7593359|NCT02003924|26415722|P3|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
7593360|NCT02003924|26415723|P2|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
7593361|NCT02003924|26415724|P1|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
7593362|NCT02003924|26415722|P3|Double-blind Phase|Protocol Violation|0
7593363|NCT02003924|26415723|P2|Double-blind Phase|Protocol Violation|2
7593364|NCT02003924|26415724|P1|Double-blind Phase|Protocol Violation|1
7593365|NCT02003924|26415722|P3|Double-blind Phase|Lost to Follow-up|0
7593366|NCT02003924|26415723|P2|Double-blind Phase|Lost to Follow-up|1
7593367|NCT02003924|26415724|P1|Double-blind Phase|Lost to Follow-up|2
7593368|NCT02003898|26415846|P1|Overall Study|Withdrawal by Subject|52
7593369|NCT02003898|26415846|P1|Overall Study|Lost to Follow-up|12
7593370|NCT02003898|26415846|P1|Overall Study|Death|3
7593371|NCT02003638|26415855|P2|Overall Study|Withdrawal by Subject|0
7593372|NCT02003638|26415856|P1|Overall Study|Withdrawal by Subject|1
7593373|NCT02003573|26415886|P3|Overall Study|Other than specified|3
7593374|NCT02003573|26415887|P2|Overall Study|Other than specified|2
7593375|NCT02003573|26415888|P1|Overall Study|Other than specified|1
7593376|NCT02003573|26415886|P3|Overall Study|Refuse to take trial medication|1
7593377|NCT02003573|26415887|P2|Overall Study|Refuse to take trial medication|1
7593378|NCT02003573|26415888|P1|Overall Study|Refuse to take trial medication|0
7593379|NCT02003573|26415886|P3|Overall Study|Other Adverse event|1
7593380|NCT02003573|26415887|P2|Overall Study|Other Adverse event|1
7593381|NCT02003573|26415888|P1|Overall Study|Other Adverse event|0
7593382|NCT02003573|26415886|P3|Overall Study|Progressive disease|1
7593383|NCT02003573|26415887|P2|Overall Study|Progressive disease|0
7593384|NCT02003573|26415888|P1|Overall Study|Progressive disease|2
7593385|NCT02003534|26415898|P1|Overall Study|Lost to Follow-up|47
7593386|NCT02003391|26415919|P2|Overall Study|Adverse Event|0
7593387|NCT02003391|26415920|P1|Overall Study|Adverse Event|1
7593388|NCT02003391|26415919|P2|Overall Study|Protocol Violation|1
7593389|NCT02003391|26415920|P1|Overall Study|Protocol Violation|0
7593390|NCT02003391|26415919|P2|Overall Study|Withdrawal by Subject|1
7593391|NCT02003391|26415920|P1|Overall Study|Withdrawal by Subject|2
7593392|NCT02003365|26415933|P3|Overall Study|Lost to Follow-up|1
7593393|NCT02003365|26415934|P2|Overall Study|Lost to Follow-up|0
7593394|NCT02003365|26415935|P1|Overall Study|Lost to Follow-up|0
7593395|NCT02003183|26415952|P2|Overall Study|Lost to Follow-up|2
7593396|NCT02003183|26415953|P1|Overall Study|Lost to Follow-up|0
7593397|NCT02003014|26415968|P1|Overall Study|Investigator's transfer|4
7593398|NCT02003014|26415968|P1|Overall Study|Patient did not visit the study site|5
7593399|NCT02003014|26415968|P1|Overall Study|Treatment started after contract period|1
7593400|NCT02003014|26415968|P1|Overall Study|Case report forms uncollected|9
7593401|NCT02002975|26415978|P1|Overall Study|Protocol Deviation|437
7593402|NCT02002975|26415978|P1|Overall Study|Case Report Forms Uncollected|135
7593403|NCT02002884|26416006|P4|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
7593404|NCT02002884|26416007|P3|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7593405|NCT02002884|26416008|P2|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7593406|NCT02002884|26416009|P1|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7593407|NCT02002884|26416006|P4|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
7593408|NCT02002884|26416007|P3|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7593409|NCT02002884|26416008|P2|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7593410|NCT02002884|26416009|P1|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7593411|NCT02002884|26416006|P4|Open-Label Extension Period (OLEX)|Adverse Event|5
7593412|NCT02002884|26416007|P3|Open-Label Extension Period (OLEX)|Adverse Event|0
7593413|NCT02002884|26416008|P2|Open-Label Extension Period (OLEX)|Adverse Event|0
7593414|NCT02002884|26416009|P1|Open-Label Extension Period (OLEX)|Adverse Event|0
7593415|NCT02002884|26416006|P4|Open-Label Extension Period (OLEX)|Physician Decision|1
7593416|NCT02002884|26416007|P3|Open-Label Extension Period (OLEX)|Physician Decision|0
7593417|NCT02002884|26416008|P2|Open-Label Extension Period (OLEX)|Physician Decision|0
7593418|NCT02002884|26416009|P1|Open-Label Extension Period (OLEX)|Physician Decision|0
7593419|NCT02002884|26416006|P4|Open-Label Extension Period (OLEX)|Other|24
7593420|NCT02002884|26416007|P3|Open-Label Extension Period (OLEX)|Other|0
7593421|NCT02002884|26416008|P2|Open-Label Extension Period (OLEX)|Other|0
7593422|NCT02002884|26416009|P1|Open-Label Extension Period (OLEX)|Other|0
7593423|NCT02002884|26416006|P4|Main Period (MP)|Lost to Follow-up|0
7593424|NCT02002884|26416007|P3|Main Period (MP)|Lost to Follow-up|2
7593425|NCT02002884|26416008|P2|Main Period (MP)|Lost to Follow-up|0
7593426|NCT02002884|26416009|P1|Main Period (MP)|Lost to Follow-up|0
7593427|NCT02002884|26416006|P4|Main Period (MP)|Withdrawal by Subject|0
7593428|NCT02002884|26416007|P3|Main Period (MP)|Withdrawal by Subject|2
7593429|NCT02002884|26416008|P2|Main Period (MP)|Withdrawal by Subject|2
7593430|NCT02002884|26416009|P1|Main Period (MP)|Withdrawal by Subject|6
7593431|NCT02002884|26416006|P4|Main Period (MP)|Adverse Event|0
7593432|NCT02002884|26416007|P3|Main Period (MP)|Adverse Event|1
7593433|NCT02002884|26416008|P2|Main Period (MP)|Adverse Event|1
7593434|NCT02002884|26416009|P1|Main Period (MP)|Adverse Event|0
7593435|NCT02002884|26416006|P4|Main Period (MP)|Other|0
7593436|NCT02002884|26416007|P3|Main Period (MP)|Other|3
7593437|NCT02002884|26416008|P2|Main Period (MP)|Other|3
7593438|NCT02002884|26416009|P1|Main Period (MP)|Other|0
7593439|NCT02002689|26416161|P1|Overall Study|Adverse Event|3
7593440|NCT02002689|26416161|P1|Overall Study|Disease Progression|7
7593441|NCT02002533|26416180|P2|Overall Study|Lost to Follow-up|1
7593442|NCT02002533|26416181|P1|Overall Study|Lost to Follow-up|0
7593443|NCT02002533|26416180|P2|Overall Study|Adverse Event|3
7593444|NCT02002533|26416181|P1|Overall Study|Adverse Event|0
7593445|NCT02002533|26416180|P2|Overall Study|Protocol Violation|1
7593446|NCT02002533|26416181|P1|Overall Study|Protocol Violation|0
7593447|NCT02002533|26416180|P2|Overall Study|Withdrawal by Subject|13
7593448|NCT02002533|26416181|P1|Overall Study|Withdrawal by Subject|6
7593449|NCT02002221|26416221|P2|Overall Study|Patient withdrew consent|1
7593450|NCT02002221|26416222|P1|Overall Study|Patient withdrew consent|0
7593451|NCT02002221|26416221|P2|Overall Study|Unsatisfactory therapeutic effect|1
7593452|NCT02002221|26416222|P1|Overall Study|Unsatisfactory therapeutic effect|0
7593453|NCT02002221|26416221|P2|Overall Study|Adverse Event|1
7593454|NCT02002221|26416222|P1|Overall Study|Adverse Event|2
7593455|NCT02002182|26416249|P2|Overall Study|Death|0
7593456|NCT02002182|26416250|P1|Overall Study|Death|1
7593457|NCT02002182|26416249|P2|Overall Study|Health Reasons|0
7593458|NCT02002182|26416250|P1|Overall Study|Health Reasons|1
7593459|NCT02002182|26416249|P2|Overall Study|Withdraw from study|1
7593460|NCT02002182|26416250|P1|Overall Study|Withdraw from study|3
7593461|NCT02002091|26416262|P2|Screening|Death|2
7593462|NCT02002091|26416263|P1|Screening|Death|3
7593463|NCT02002091|26416262|P2|Screening|Lost to Follow-up|12
7593464|NCT02002091|26416263|P1|Screening|Lost to Follow-up|10
7593465|NCT02001987|26416298|P1|LTE Period (52 Weeks)|Other|3
7593466|NCT02001987|26416298|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
7593467|NCT02001987|26416298|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
7593468|NCT02001987|26416298|P1|LTE Period (52 Weeks)|Physician Decision|2
7593469|NCT02001987|26416298|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
7593470|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
7593471|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Protocol Violation|3
7593472|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
7593473|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Physician Decision|1
7593474|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
7593475|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Death|1
7593476|NCT02001987|26416298|P1|Core Study Period (24 Weeks)|Adverse Event|9
7593477|NCT02001974|26416375|P3|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2
7593478|NCT02001974|26416376|P2|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7593479|NCT02001974|26416377|P1|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7593480|NCT02001974|26416375|P3|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6
7593481|NCT02001974|26416376|P2|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0
7593482|NCT02001974|26416377|P1|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1
7593483|NCT02001974|26416375|P3|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4
7593484|NCT02001974|26416376|P2|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0
7593485|NCT02001974|26416377|P1|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1
7593486|NCT02001974|26416375|P3|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14
7593487|NCT02001974|26416376|P2|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3
7593488|NCT02001974|26416377|P1|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2
7593489|NCT02001688|26416490|P3|Overall Study|Adverse Event|0
7593490|NCT02001688|26416491|P2|Overall Study|Adverse Event|1
7593491|NCT02001688|26416492|P1|Overall Study|Adverse Event|0
7593492|NCT02001688|26416490|P3|Overall Study|Withdrawal by Subject|1
7593493|NCT02001688|26416491|P2|Overall Study|Withdrawal by Subject|0
7593494|NCT02001688|26416492|P1|Overall Study|Withdrawal by Subject|0
7593495|NCT02001558|26416511|P2|Overall Study|Lost to Follow-up|14
7593496|NCT02001558|26416512|P1|Overall Study|Lost to Follow-up|8
7593497|NCT02001194|26416548|P4|Follow-Up Period (13 Weeks)|No longer interested|0
7593498|NCT02001194|26416549|P3|Follow-Up Period (13 Weeks)|No longer interested|1
7593499|NCT02001194|26416550|P2|Follow-Up Period (13 Weeks)|No longer interested|2
7593500|NCT02001194|26416551|P1|Follow-Up Period (13 Weeks)|No longer interested|3
7593501|NCT02001194|26416548|P4|Intervention Period (13 Weeks)|No longer interested|2
7593502|NCT02001194|26416549|P3|Intervention Period (13 Weeks)|No longer interested|2
7593503|NCT02001194|26416550|P2|Intervention Period (13 Weeks)|No longer interested|0
7593504|NCT02001194|26416551|P1|Intervention Period (13 Weeks)|No longer interested|1
7593505|NCT02001181|26416567|P2|Overall Study|Withdrawal by Subject|1
7593506|NCT02001181|26416568|P1|Overall Study|Withdrawal by Subject|0
7593507|NCT02001181|26416567|P2|Overall Study|Lost to Follow-up|0
7593508|NCT02001181|26416568|P1|Overall Study|Lost to Follow-up|1
7593509|NCT02001181|26416567|P2|Overall Study|Adverse Event|2
7593510|NCT02001181|26416568|P1|Overall Study|Adverse Event|0
7593511|NCT02001064|26416584|P2|Overall Study|Withdrawal by Subject|1
7593512|NCT02001064|26416585|P1|Overall Study|Withdrawal by Subject|2
7593513|NCT02001051|26416597|P2|Overall Study|Deemed not eligible following enrollment|1
7593514|NCT02001051|26416598|P1|Overall Study|Deemed not eligible following enrollment|0
7593515|NCT02000921|26416650|P3|Overall Study|Physician Decision|0
7593516|NCT02000921|26416651|P2|Overall Study|Physician Decision|2
7593517|NCT02000921|26416652|P1|Overall Study|Physician Decision|0
7593518|NCT02000921|26416650|P3|Overall Study|Lost to Follow-up|5
7593519|NCT02000921|26416651|P2|Overall Study|Lost to Follow-up|4
7593520|NCT02000921|26416652|P1|Overall Study|Lost to Follow-up|2
7593521|NCT02000921|26416650|P3|Overall Study|Withdrawal by Subject|5
7593522|NCT02000921|26416651|P2|Overall Study|Withdrawal by Subject|10
7593523|NCT02000921|26416652|P1|Overall Study|Withdrawal by Subject|3
7593524|NCT02000817|26416682|P4|Overall Study|Lost to Follow-up|0
7593525|NCT02000817|26416683|P3|Overall Study|Lost to Follow-up|1
7593526|NCT02000817|26416684|P2|Overall Study|Lost to Follow-up|0
7593527|NCT02000817|26416685|P1|Overall Study|Lost to Follow-up|0
7593528|NCT02000817|26416682|P4|Overall Study|Adverse Event|0
7593529|NCT02000817|26416683|P3|Overall Study|Adverse Event|0
7593530|NCT02000817|26416684|P2|Overall Study|Adverse Event|1
7593531|NCT02000817|26416685|P1|Overall Study|Adverse Event|0
7593532|NCT02000817|26416682|P4|Overall Study|Withdrawal by Subject|0
7593533|NCT02000817|26416683|P3|Overall Study|Withdrawal by Subject|0
7593534|NCT02000817|26416684|P2|Overall Study|Withdrawal by Subject|0
7593535|NCT02000817|26416685|P1|Overall Study|Withdrawal by Subject|2
7593536|NCT02000752|26416780|P2|Overall Study|Shift Changes|5
7593537|NCT02000752|26416781|P1|Overall Study|Shift Changes|12
7593538|NCT02000752|26416780|P2|Overall Study|Dystocic delivery|8
7593539|NCT02000752|26416781|P1|Overall Study|Dystocic delivery|19
7593540|NCT02000622|26416795|P2|Overall Study|Withdrawn due to site closure|0
7593541|NCT02000622|26416796|P1|Overall Study|Withdrawn due to site closure|1
7593542|NCT02000622|26416795|P2|Overall Study|Death|73
7593543|NCT02000622|26416796|P1|Overall Study|Death|159
7593544|NCT02000622|26416795|P2|Overall Study|Lost to Follow-up|0
7593545|NCT02000622|26416796|P1|Overall Study|Lost to Follow-up|4
7593546|NCT02000622|26416795|P2|Overall Study|Withdrawal by Subject|7
7593547|NCT02000622|26416796|P1|Overall Study|Withdrawal by Subject|5
7593548|NCT02000531|26416839|P2|Overall Study|Discontinued due to data cut-off|8
7593549|NCT02000531|26416840|P1|Overall Study|Discontinued due to data cut-off|3
7593550|NCT02000531|26416839|P2|Overall Study|Lost to Follow-up|0
7593551|NCT02000531|26416840|P1|Overall Study|Lost to Follow-up|1
7593552|NCT02000440|26416848|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
7593553|NCT02000440|26416848|P1|Overall Study|Adverse Event|3
7593554|NCT02000427|26416868|P1|Overall Study|Death|22
7593555|NCT02000115|26416909|P4|Overall Study|Still on Study|53
7593556|NCT02000115|26416910|P3|Overall Study|Still on Study|0
7593557|NCT02000115|26416911|P2|Overall Study|Still on Study|0
7593558|NCT02000115|26416912|P1|Overall Study|Still on Study|0
7593559|NCT02000115|26416909|P4|Overall Study|Withdrawn on day of randomization|0
7593560|NCT02000115|26416910|P3|Overall Study|Withdrawn on day of randomization|0
7593561|NCT02000115|26416911|P2|Overall Study|Withdrawn on day of randomization|1
7593562|NCT02000115|26416912|P1|Overall Study|Withdrawn on day of randomization|0
7593563|NCT02000115|26416909|P4|Overall Study|Non-compliance|0
7593564|NCT02000115|26416910|P3|Overall Study|Non-compliance|0
7593565|NCT02000115|26416911|P2|Overall Study|Non-compliance|1
7593566|NCT02000115|26416912|P1|Overall Study|Non-compliance|2
7593567|NCT02000115|26416909|P4|Overall Study|Lost to Follow-up|0
7593568|NCT02000115|26416910|P3|Overall Study|Lost to Follow-up|0
7593569|NCT02000115|26416911|P2|Overall Study|Lost to Follow-up|1
7593570|NCT02000115|26416912|P1|Overall Study|Lost to Follow-up|0
7593571|NCT02000115|26416909|P4|Overall Study|Withdrawal by Subject|0
7593572|NCT02000115|26416910|P3|Overall Study|Withdrawal by Subject|0
7593573|NCT02000115|26416911|P2|Overall Study|Withdrawal by Subject|11
7593574|NCT02000115|26416912|P1|Overall Study|Withdrawal by Subject|11
7593575|NCT02000115|26416909|P4|Overall Study|Physician Decision|0
7593576|NCT02000115|26416910|P3|Overall Study|Physician Decision|0
7593577|NCT02000115|26416911|P2|Overall Study|Physician Decision|0
7593578|NCT02000115|26416912|P1|Overall Study|Physician Decision|2
7593579|NCT02000115|26416909|P4|Overall Study|Protocol Violation|0
7593580|NCT02000115|26416910|P3|Overall Study|Protocol Violation|0
7593581|NCT02000115|26416911|P2|Overall Study|Protocol Violation|1
7593582|NCT02000115|26416912|P1|Overall Study|Protocol Violation|2
7593583|NCT02000115|26416909|P4|Overall Study|Missed Visit|0
7593584|NCT02000115|26416910|P3|Overall Study|Missed Visit|1
7593585|NCT02000115|26416911|P2|Overall Study|Missed Visit|8
7593586|NCT02000115|26416912|P1|Overall Study|Missed Visit|6
7593587|NCT02000115|26416909|P4|Overall Study|Death|0
7593588|NCT02000115|26416910|P3|Overall Study|Death|0
7593589|NCT02000115|26416911|P2|Overall Study|Death|45
7593590|NCT02000115|26416912|P1|Overall Study|Death|56
7593591|NCT01999972|26416946|P6|Dose Expansion Part|Changed to standard of care|0
7593592|NCT01999972|26416947|P5|Dose Expansion Part|Changed to standard of care|1
7593593|NCT01999972|26416948|P4|Dose Expansion Part|Changed to standard of care|0
7593594|NCT01999972|26416949|P3|Dose Expansion Part|Changed to standard of care|0
7593595|NCT01999972|26416950|P2|Dose Expansion Part|Changed to standard of care|0
7593596|NCT01999972|26416951|P1|Dose Expansion Part|Changed to standard of care|0
7593597|NCT01999972|26416946|P6|Dose Expansion Part|Participant refused further follow-up|0
7593598|NCT01999972|26416947|P5|Dose Expansion Part|Participant refused further follow-up|4
7593599|NCT01999972|26416948|P4|Dose Expansion Part|Participant refused further follow-up|0
7593600|NCT01999972|26416949|P3|Dose Expansion Part|Participant refused further follow-up|0
7593601|NCT01999972|26416950|P2|Dose Expansion Part|Participant refused further follow-up|0
7593602|NCT01999972|26416951|P1|Dose Expansion Part|Participant refused further follow-up|0
7593603|NCT01999972|26416946|P6|Dose Expansion Part|Participant's non-compliance|1
7593604|NCT01999972|26416947|P5|Dose Expansion Part|Participant's non-compliance|0
7593605|NCT01999972|26416948|P4|Dose Expansion Part|Participant's non-compliance|0
7593606|NCT01999972|26416949|P3|Dose Expansion Part|Participant's non-compliance|0
7593607|NCT01999972|26416950|P2|Dose Expansion Part|Participant's non-compliance|0
7593608|NCT01999972|26416951|P1|Dose Expansion Part|Participant's non-compliance|0
7593609|NCT01999972|26416946|P6|Dose Expansion Part|Adverse Event|2
7593610|NCT01999972|26416947|P5|Dose Expansion Part|Adverse Event|4
7593611|NCT01999972|26416948|P4|Dose Expansion Part|Adverse Event|0
7593612|NCT01999972|26416949|P3|Dose Expansion Part|Adverse Event|0
7593613|NCT01999972|26416950|P2|Dose Expansion Part|Adverse Event|0
7593614|NCT01999972|26416951|P1|Dose Expansion Part|Adverse Event|0
7593615|NCT01999972|26416946|P6|Dose Expansion Part|Sponsor decision|0
7593616|NCT01999972|26416947|P5|Dose Expansion Part|Sponsor decision|1
7593617|NCT01999972|26416948|P4|Dose Expansion Part|Sponsor decision|0
7593618|NCT01999972|26416949|P3|Dose Expansion Part|Sponsor decision|0
7593619|NCT01999972|26416950|P2|Dose Expansion Part|Sponsor decision|0
7593620|NCT01999972|26416951|P1|Dose Expansion Part|Sponsor decision|0
7593621|NCT01999972|26416946|P6|Dose Expansion Part|Disease progression|3
7593622|NCT01999972|26416947|P5|Dose Expansion Part|Disease progression|9
7593623|NCT01999972|26416948|P4|Dose Expansion Part|Disease progression|0
7593624|NCT01999972|26416949|P3|Dose Expansion Part|Disease progression|0
7593625|NCT01999972|26416950|P2|Dose Expansion Part|Disease progression|0
7593626|NCT01999972|26416951|P1|Dose Expansion Part|Disease progression|0
7593627|NCT01999972|26416946|P6|Dose Expansion Part|Death|1
7593628|NCT01999972|26416947|P5|Dose Expansion Part|Death|2
7593629|NCT01999972|26416948|P4|Dose Expansion Part|Death|0
7593630|NCT01999972|26416949|P3|Dose Expansion Part|Death|0
7593631|NCT01999972|26416950|P2|Dose Expansion Part|Death|0
7593632|NCT01999972|26416951|P1|Dose Expansion Part|Death|0
7593633|NCT01999972|26416946|P6|Dose Escalation Part|Global deterioration of health status|0
7593634|NCT01999972|26416947|P5|Dose Escalation Part|Global deterioration of health status|0
7593635|NCT01999972|26416948|P4|Dose Escalation Part|Global deterioration of health status|1
7593636|NCT01999972|26416949|P3|Dose Escalation Part|Global deterioration of health status|0
7593637|NCT01999972|26416950|P2|Dose Escalation Part|Global deterioration of health status|0
7593638|NCT01999972|26416951|P1|Dose Escalation Part|Global deterioration of health status|1
7593639|NCT01999972|26416946|P6|Dose Escalation Part|Adverse Event|0
7593640|NCT01999972|26416947|P5|Dose Escalation Part|Adverse Event|0
7593641|NCT01999972|26416948|P4|Dose Escalation Part|Adverse Event|2
7593642|NCT01999972|26416949|P3|Dose Escalation Part|Adverse Event|0
7593643|NCT01999972|26416950|P2|Dose Escalation Part|Adverse Event|0
7593644|NCT01999972|26416951|P1|Dose Escalation Part|Adverse Event|0
7593645|NCT01999972|26416946|P6|Dose Escalation Part|Disease progression|0
7593646|NCT01999972|26416947|P5|Dose Escalation Part|Disease progression|0
7593647|NCT01999972|26416948|P4|Dose Escalation Part|Disease progression|6
7593648|NCT01999972|26416949|P3|Dose Escalation Part|Disease progression|3
7593649|NCT01999972|26416950|P2|Dose Escalation Part|Disease progression|2
7593650|NCT01999972|26416951|P1|Dose Escalation Part|Disease progression|3
7593651|NCT01999972|26416946|P6|Dose Escalation Part|Enrolled but not treated|0
7593652|NCT01999972|26416947|P5|Dose Escalation Part|Enrolled but not treated|0
7593653|NCT01999972|26416948|P4|Dose Escalation Part|Enrolled but not treated|1
7593654|NCT01999972|26416949|P3|Dose Escalation Part|Enrolled but not treated|1
7593655|NCT01999972|26416950|P2|Dose Escalation Part|Enrolled but not treated|0
7593656|NCT01999972|26416951|P1|Dose Escalation Part|Enrolled but not treated|0
7593657|NCT01999972|26416946|P6|Dose Escalation Part|Death|0
7593658|NCT01999972|26416947|P5|Dose Escalation Part|Death|0
7593659|NCT01999972|26416948|P4|Dose Escalation Part|Death|0
7593660|NCT01999972|26416949|P3|Dose Escalation Part|Death|0
7593661|NCT01999972|26416950|P2|Dose Escalation Part|Death|1
7593662|NCT01999972|26416951|P1|Dose Escalation Part|Death|0
7593663|NCT01999972|26416946|P6|Dose Escalation Part|Participant refused further follow-up|0
7593664|NCT01999972|26416947|P5|Dose Escalation Part|Participant refused further follow-up|0
7593665|NCT01999972|26416948|P4|Dose Escalation Part|Participant refused further follow-up|1
7593666|NCT01999972|26416949|P3|Dose Escalation Part|Participant refused further follow-up|1
7593667|NCT01999972|26416950|P2|Dose Escalation Part|Participant refused further follow-up|0
7593668|NCT01999972|26416951|P1|Dose Escalation Part|Participant refused further follow-up|1
7593669|NCT01999946|26417066|P3|Overall Study|Not included in primary outcome analysis|79
7593670|NCT01999946|26417067|P2|Overall Study|Not included in primary outcome analysis|0
7593671|NCT01999946|26417068|P1|Overall Study|Not included in primary outcome analysis|0
7593672|NCT01999946|26417066|P3|Overall Study|Participant not released from jail|0
7593673|NCT01999946|26417067|P2|Overall Study|Participant not released from jail|2
7593674|NCT01999946|26417068|P1|Overall Study|Participant not released from jail|2
7593675|NCT01999894|26417094|P1|Overall Study|Inclusion/exclusion criteria not met|1
7593676|NCT01999894|26417094|P1|Overall Study|Other Reason|3
7593677|NCT01999894|26417094|P1|Overall Study|Lost to Follow-up|10
7593678|NCT01999894|26417094|P1|Overall Study|Withdrawal by Subject|7
7593679|NCT01999894|26417094|P1|Overall Study|Protocol Violation|1
7593680|NCT01999894|26417094|P1|Overall Study|Lack of Efficacy|5
7593681|NCT01999894|26417094|P1|Overall Study|Adverse Event|9
7593682|NCT01999868|26417102|P3|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
7593683|NCT01999868|26417103|P2|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
7593684|NCT01999868|26417104|P1|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
7593685|NCT01999868|26417102|P3|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7593761|NCT01999218|26417309|P1|Overall Study|Study Terminated By Sponsor|7
7593686|NCT01999868|26417103|P2|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
7593687|NCT01999868|26417104|P1|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7593688|NCT01999868|26417102|P3|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
7593689|NCT01999868|26417103|P2|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
7593690|NCT01999868|26417104|P1|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
7593691|NCT01999868|26417102|P3|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
7593692|NCT01999868|26417103|P2|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
7593693|NCT01999868|26417104|P1|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
7593694|NCT01999868|26417102|P3|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7593695|NCT01999868|26417103|P2|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
7593696|NCT01999868|26417104|P1|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7593697|NCT01999868|26417102|P3|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7593698|NCT01999868|26417103|P2|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
7593699|NCT01999868|26417104|P1|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7593700|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7593701|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7593702|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
7593703|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7593704|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7593705|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
7593706|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
7593707|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
7593708|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
7593709|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
7593710|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
7593711|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
7593712|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7593713|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
7593714|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7593715|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7593716|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
7593717|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7593718|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
7593719|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
7593720|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
7593721|NCT01999868|26417102|P3|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
7593722|NCT01999868|26417103|P2|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7593723|NCT01999868|26417104|P1|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7593724|NCT01999868|26417102|P3|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
7593725|NCT01999868|26417103|P2|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7593726|NCT01999868|26417104|P1|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7593727|NCT01999465|26417155|P2|Overall Study|Protocol Violation|1
7593728|NCT01999465|26417156|P1|Overall Study|Protocol Violation|0
7593729|NCT01999465|26417155|P2|Overall Study|Lost to Follow-up|2
7593730|NCT01999465|26417156|P1|Overall Study|Lost to Follow-up|0
7593731|NCT01999335|26417204|P5|Overall Study|Discontinued before receiving treatment|2
7593732|NCT01999335|26417205|P4|Overall Study|Discontinued before receiving treatment|0
7593733|NCT01999335|26417206|P3|Overall Study|Discontinued before receiving treatment|0
7593734|NCT01999335|26417207|P2|Overall Study|Discontinued before receiving treatment|0
7593735|NCT01999335|26417208|P1|Overall Study|Discontinued before receiving treatment|0
7593736|NCT01999322|26417254|P2|Overall Study|Adverse Event|0
7593737|NCT01999322|26417255|P1|Overall Study|Adverse Event|1
7593738|NCT01999218|26417307|P3|Overall Study|Treated but excluded at 1 trial site|2
7593739|NCT01999218|26417308|P2|Overall Study|Treated but excluded at 1 trial site|5
7593740|NCT01999218|26417309|P1|Overall Study|Treated but excluded at 1 trial site|3
7593741|NCT01999218|26417307|P3|Overall Study|Adverse Event|7
7593742|NCT01999218|26417308|P2|Overall Study|Adverse Event|7
7593743|NCT01999218|26417309|P1|Overall Study|Adverse Event|9
7593744|NCT01999218|26417307|P3|Overall Study|Excluded Medication|2
7593745|NCT01999218|26417308|P2|Overall Study|Excluded Medication|1
7593746|NCT01999218|26417309|P1|Overall Study|Excluded Medication|1
7593747|NCT01999218|26417307|P3|Overall Study|Death|2
7593748|NCT01999218|26417308|P2|Overall Study|Death|1
7593749|NCT01999218|26417309|P1|Overall Study|Death|7
7593750|NCT01999218|26417307|P3|Overall Study|Creatinine/eGFR|1
7593751|NCT01999218|26417308|P2|Overall Study|Creatinine/eGFR|0
7593752|NCT01999218|26417309|P1|Overall Study|Creatinine/eGFR|0
7593753|NCT01999218|26417307|P3|Overall Study|Withdrawal by Subject|34
7593754|NCT01999218|26417308|P2|Overall Study|Withdrawal by Subject|29
7593755|NCT01999218|26417309|P1|Overall Study|Withdrawal by Subject|28
7593756|NCT01999218|26417307|P3|Overall Study|Participant moves|3
7593757|NCT01999218|26417308|P2|Overall Study|Participant moves|5
7593758|NCT01999218|26417309|P1|Overall Study|Participant moves|2
7593759|NCT01999218|26417307|P3|Overall Study|Study Terminated By Sponsor|12
7593760|NCT01999218|26417308|P2|Overall Study|Study Terminated By Sponsor|5
7593762|NCT01999218|26417307|P3|Overall Study|Screen failure|0
7593763|NCT01999218|26417308|P2|Overall Study|Screen failure|1
7593764|NCT01999218|26417309|P1|Overall Study|Screen failure|0
7593765|NCT01999218|26417307|P3|Overall Study|Protocol Violation|4
7593766|NCT01999218|26417308|P2|Overall Study|Protocol Violation|5
7593767|NCT01999218|26417309|P1|Overall Study|Protocol Violation|4
7593768|NCT01999218|26417307|P3|Overall Study|Physician Decision|6
7593769|NCT01999218|26417308|P2|Overall Study|Physician Decision|4
7593770|NCT01999218|26417309|P1|Overall Study|Physician Decision|1
7593771|NCT01999218|26417307|P3|Overall Study|Non-Compliance With Study Drug|1
7593772|NCT01999218|26417308|P2|Overall Study|Non-Compliance With Study Drug|4
7593773|NCT01999218|26417309|P1|Overall Study|Non-Compliance With Study Drug|6
7593774|NCT01999218|26417307|P3|Overall Study|Lost to Follow-up|18
7593775|NCT01999218|26417308|P2|Overall Study|Lost to Follow-up|17
7593776|NCT01999218|26417309|P1|Overall Study|Lost to Follow-up|22
7593777|NCT01999218|26417307|P3|Overall Study|Lack of Efficacy|1
7593778|NCT01999218|26417308|P2|Overall Study|Lack of Efficacy|0
7593779|NCT01999218|26417309|P1|Overall Study|Lack of Efficacy|1
7593780|NCT01999218|26417307|P3|Overall Study|Hyperglycemia|17
7593781|NCT01999218|26417308|P2|Overall Study|Hyperglycemia|17
7593782|NCT01999218|26417309|P1|Overall Study|Hyperglycemia|18
7593783|NCT01999114|26417354|P5|Overall Study|Administrative|2
7593784|NCT01999114|26417355|P4|Overall Study|Administrative|1
7593785|NCT01999114|26417356|P3|Overall Study|Administrative|1
7593786|NCT01999114|26417357|P2|Overall Study|Administrative|0
7593787|NCT01999114|26417358|P1|Overall Study|Administrative|0
7593788|NCT01999114|26417354|P5|Overall Study|Lost to Follow-up|0
7593789|NCT01999114|26417355|P4|Overall Study|Lost to Follow-up|0
7593790|NCT01999114|26417356|P3|Overall Study|Lost to Follow-up|1
7593791|NCT01999114|26417357|P2|Overall Study|Lost to Follow-up|0
7593792|NCT01999114|26417358|P1|Overall Study|Lost to Follow-up|0
7593793|NCT01999114|26417354|P5|Overall Study|Withdrawal by Subject|1
7593794|NCT01999114|26417355|P4|Overall Study|Withdrawal by Subject|0
7593795|NCT01999114|26417356|P3|Overall Study|Withdrawal by Subject|1
7593796|NCT01999114|26417357|P2|Overall Study|Withdrawal by Subject|0
7593797|NCT01999114|26417358|P1|Overall Study|Withdrawal by Subject|0
7593798|NCT01999114|26417354|P5|Overall Study|Adverse Event|1
7593799|NCT01999114|26417355|P4|Overall Study|Adverse Event|2
7593800|NCT01999114|26417356|P3|Overall Study|Adverse Event|2
7593801|NCT01999114|26417357|P2|Overall Study|Adverse Event|7
7593802|NCT01999114|26417358|P1|Overall Study|Adverse Event|8
7593803|NCT01998984|26417426|P4|Overall Study|Other|1
7593804|NCT01998984|26417427|P3|Overall Study|Other|0
7593805|NCT01998984|26417428|P2|Overall Study|Other|0
7593806|NCT01998984|26417429|P1|Overall Study|Other|0
7593807|NCT01998984|26417426|P4|Overall Study|Withdrawal by Subject|0
7593808|NCT01998984|26417427|P3|Overall Study|Withdrawal by Subject|1
7593809|NCT01998984|26417428|P2|Overall Study|Withdrawal by Subject|0
7593810|NCT01998984|26417429|P1|Overall Study|Withdrawal by Subject|0
7593811|NCT01998984|26417426|P4|Overall Study|Lost to Follow-up|1
7593812|NCT01998984|26417427|P3|Overall Study|Lost to Follow-up|0
7593813|NCT01998984|26417428|P2|Overall Study|Lost to Follow-up|1
7593814|NCT01998984|26417429|P1|Overall Study|Lost to Follow-up|0
7593815|NCT01998984|26417426|P4|Overall Study|Adverse Event|1
7593816|NCT01998984|26417427|P3|Overall Study|Adverse Event|0
7593817|NCT01998984|26417428|P2|Overall Study|Adverse Event|0
7593818|NCT01998984|26417429|P1|Overall Study|Adverse Event|0
7593819|NCT01998958|26417454|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
7593820|NCT01998958|26417455|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
7593821|NCT01998958|26417456|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
7593822|NCT01998958|26417457|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
7593823|NCT01998958|26417458|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
7593824|NCT01998958|26417459|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
7593825|NCT01998958|26417460|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
7593826|NCT01998958|26417461|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
7593827|NCT01998958|26417462|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
7593828|NCT01998958|26417463|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
7593829|NCT01998958|26417464|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
7593830|NCT01998958|26417465|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
7593831|NCT01998958|26417466|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
7593832|NCT01998958|26417467|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
7593833|NCT01998958|26417468|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
7593834|NCT01998958|26417469|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
7593835|NCT01998958|26417470|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
7593836|NCT01998958|26417471|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
7593837|NCT01998958|26417472|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
7593838|NCT01998958|26417473|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
7593839|NCT01998958|26417474|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
7593840|NCT01998958|26417475|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
7593841|NCT01998958|26417476|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
7593842|NCT01998958|26417477|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
7593843|NCT01998958|26417478|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
7593844|NCT01998958|26417479|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
7593845|NCT01998958|26417480|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
7593846|NCT01998958|26417481|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
7593924|NCT01998958|26417463|P23|Open Label Phase (Optional)|Other|5
7593847|NCT01998958|26417482|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
7593848|NCT01998958|26417483|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
7593849|NCT01998958|26417484|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
7593850|NCT01998958|26417485|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
7593851|NCT01998958|26417454|P32|Open Label Phase (Optional)|Lack of Efficacy|0
7593852|NCT01998958|26417455|P31|Open Label Phase (Optional)|Lack of Efficacy|0
7593853|NCT01998958|26417456|P30|Open Label Phase (Optional)|Lack of Efficacy|0
7593854|NCT01998958|26417457|P29|Open Label Phase (Optional)|Lack of Efficacy|0
7593855|NCT01998958|26417458|P28|Open Label Phase (Optional)|Lack of Efficacy|0
7593856|NCT01998958|26417459|P27|Open Label Phase (Optional)|Lack of Efficacy|0
7593857|NCT01998958|26417460|P26|Open Label Phase (Optional)|Lack of Efficacy|0
7593858|NCT01998958|26417461|P25|Open Label Phase (Optional)|Lack of Efficacy|0
7593859|NCT01998958|26417462|P24|Open Label Phase (Optional)|Lack of Efficacy|0
7593860|NCT01998958|26417463|P23|Open Label Phase (Optional)|Lack of Efficacy|2
7593861|NCT01998958|26417464|P22|Open Label Phase (Optional)|Lack of Efficacy|1
7593862|NCT01998958|26417465|P21|Open Label Phase (Optional)|Lack of Efficacy|0
7593863|NCT01998958|26417466|P20|Open Label Phase (Optional)|Lack of Efficacy|0
7593864|NCT01998958|26417467|P19|Open Label Phase (Optional)|Lack of Efficacy|0
7593865|NCT01998958|26417468|P18|Open Label Phase (Optional)|Lack of Efficacy|0
7593866|NCT01998958|26417469|P17|Open Label Phase (Optional)|Lack of Efficacy|0
7593867|NCT01998958|26417470|P16|Open Label Phase (Optional)|Lack of Efficacy|0
7593868|NCT01998958|26417471|P15|Open Label Phase (Optional)|Lack of Efficacy|0
7593869|NCT01998958|26417472|P14|Open Label Phase (Optional)|Lack of Efficacy|0
7593870|NCT01998958|26417473|P13|Open Label Phase (Optional)|Lack of Efficacy|0
7593871|NCT01998958|26417474|P12|Open Label Phase (Optional)|Lack of Efficacy|0
7593872|NCT01998958|26417475|P11|Open Label Phase (Optional)|Lack of Efficacy|0
7593873|NCT01998958|26417476|P10|Open Label Phase (Optional)|Lack of Efficacy|0
7593874|NCT01998958|26417477|P9|Open Label Phase (Optional)|Lack of Efficacy|0
7593875|NCT01998958|26417478|P8|Open Label Phase (Optional)|Lack of Efficacy|0
7593876|NCT01998958|26417479|P7|Open Label Phase (Optional)|Lack of Efficacy|0
7593877|NCT01998958|26417480|P6|Open Label Phase (Optional)|Lack of Efficacy|0
7593878|NCT01998958|26417481|P5|Open Label Phase (Optional)|Lack of Efficacy|0
7593879|NCT01998958|26417482|P4|Open Label Phase (Optional)|Lack of Efficacy|0
7593880|NCT01998958|26417483|P3|Open Label Phase (Optional)|Lack of Efficacy|0
7593881|NCT01998958|26417484|P2|Open Label Phase (Optional)|Lack of Efficacy|0
7593882|NCT01998958|26417485|P1|Open Label Phase (Optional)|Lack of Efficacy|0
7593883|NCT01998958|26417454|P32|Open Label Phase (Optional)|Lost to Follow-up|0
7593884|NCT01998958|26417455|P31|Open Label Phase (Optional)|Lost to Follow-up|0
7593885|NCT01998958|26417456|P30|Open Label Phase (Optional)|Lost to Follow-up|0
7593886|NCT01998958|26417457|P29|Open Label Phase (Optional)|Lost to Follow-up|0
7593887|NCT01998958|26417458|P28|Open Label Phase (Optional)|Lost to Follow-up|0
7593888|NCT01998958|26417459|P27|Open Label Phase (Optional)|Lost to Follow-up|0
7593889|NCT01998958|26417460|P26|Open Label Phase (Optional)|Lost to Follow-up|0
7593890|NCT01998958|26417461|P25|Open Label Phase (Optional)|Lost to Follow-up|0
7593891|NCT01998958|26417462|P24|Open Label Phase (Optional)|Lost to Follow-up|0
7593892|NCT01998958|26417463|P23|Open Label Phase (Optional)|Lost to Follow-up|1
7593893|NCT01998958|26417464|P22|Open Label Phase (Optional)|Lost to Follow-up|0
7593894|NCT01998958|26417465|P21|Open Label Phase (Optional)|Lost to Follow-up|0
7593895|NCT01998958|26417466|P20|Open Label Phase (Optional)|Lost to Follow-up|0
7593896|NCT01998958|26417467|P19|Open Label Phase (Optional)|Lost to Follow-up|0
7593897|NCT01998958|26417468|P18|Open Label Phase (Optional)|Lost to Follow-up|0
7593898|NCT01998958|26417469|P17|Open Label Phase (Optional)|Lost to Follow-up|0
7593899|NCT01998958|26417470|P16|Open Label Phase (Optional)|Lost to Follow-up|0
7593900|NCT01998958|26417471|P15|Open Label Phase (Optional)|Lost to Follow-up|0
7593901|NCT01998958|26417472|P14|Open Label Phase (Optional)|Lost to Follow-up|0
7593902|NCT01998958|26417473|P13|Open Label Phase (Optional)|Lost to Follow-up|0
7593903|NCT01998958|26417474|P12|Open Label Phase (Optional)|Lost to Follow-up|0
7593904|NCT01998958|26417475|P11|Open Label Phase (Optional)|Lost to Follow-up|0
7593905|NCT01998958|26417476|P10|Open Label Phase (Optional)|Lost to Follow-up|0
7593906|NCT01998958|26417477|P9|Open Label Phase (Optional)|Lost to Follow-up|0
7593907|NCT01998958|26417478|P8|Open Label Phase (Optional)|Lost to Follow-up|0
7593908|NCT01998958|26417479|P7|Open Label Phase (Optional)|Lost to Follow-up|0
7593909|NCT01998958|26417480|P6|Open Label Phase (Optional)|Lost to Follow-up|0
7593910|NCT01998958|26417481|P5|Open Label Phase (Optional)|Lost to Follow-up|0
7593911|NCT01998958|26417482|P4|Open Label Phase (Optional)|Lost to Follow-up|0
7593912|NCT01998958|26417483|P3|Open Label Phase (Optional)|Lost to Follow-up|0
7593913|NCT01998958|26417484|P2|Open Label Phase (Optional)|Lost to Follow-up|0
7593914|NCT01998958|26417485|P1|Open Label Phase (Optional)|Lost to Follow-up|0
7593915|NCT01998958|26417454|P32|Open Label Phase (Optional)|Other|0
7593916|NCT01998958|26417455|P31|Open Label Phase (Optional)|Other|0
7593917|NCT01998958|26417456|P30|Open Label Phase (Optional)|Other|0
7593918|NCT01998958|26417457|P29|Open Label Phase (Optional)|Other|0
7593919|NCT01998958|26417458|P28|Open Label Phase (Optional)|Other|0
7593920|NCT01998958|26417459|P27|Open Label Phase (Optional)|Other|0
7593921|NCT01998958|26417460|P26|Open Label Phase (Optional)|Other|0
7593922|NCT01998958|26417461|P25|Open Label Phase (Optional)|Other|0
7593923|NCT01998958|26417462|P24|Open Label Phase (Optional)|Other|1
7593925|NCT01998958|26417464|P22|Open Label Phase (Optional)|Other|0
7593926|NCT01998958|26417465|P21|Open Label Phase (Optional)|Other|0
7593927|NCT01998958|26417466|P20|Open Label Phase (Optional)|Other|0
7593928|NCT01998958|26417467|P19|Open Label Phase (Optional)|Other|0
7593929|NCT01998958|26417468|P18|Open Label Phase (Optional)|Other|0
7593930|NCT01998958|26417469|P17|Open Label Phase (Optional)|Other|0
7593931|NCT01998958|26417470|P16|Open Label Phase (Optional)|Other|0
7593932|NCT01998958|26417471|P15|Open Label Phase (Optional)|Other|0
7593933|NCT01998958|26417472|P14|Open Label Phase (Optional)|Other|0
7593934|NCT01998958|26417473|P13|Open Label Phase (Optional)|Other|0
7593935|NCT01998958|26417474|P12|Open Label Phase (Optional)|Other|0
7593936|NCT01998958|26417475|P11|Open Label Phase (Optional)|Other|0
7593937|NCT01998958|26417476|P10|Open Label Phase (Optional)|Other|0
7593938|NCT01998958|26417477|P9|Open Label Phase (Optional)|Other|0
7593939|NCT01998958|26417478|P8|Open Label Phase (Optional)|Other|0
7593940|NCT01998958|26417479|P7|Open Label Phase (Optional)|Other|0
7593941|NCT01998958|26417480|P6|Open Label Phase (Optional)|Other|0
7593942|NCT01998958|26417481|P5|Open Label Phase (Optional)|Other|0
7593943|NCT01998958|26417482|P4|Open Label Phase (Optional)|Other|0
7593944|NCT01998958|26417483|P3|Open Label Phase (Optional)|Other|0
7593945|NCT01998958|26417484|P2|Open Label Phase (Optional)|Other|0
7593946|NCT01998958|26417485|P1|Open Label Phase (Optional)|Other|0
7593947|NCT01998958|26417454|P32|Open Label Phase (Optional)|Adverse Event|0
7593948|NCT01998958|26417455|P31|Open Label Phase (Optional)|Adverse Event|0
7593949|NCT01998958|26417456|P30|Open Label Phase (Optional)|Adverse Event|0
7593950|NCT01998958|26417457|P29|Open Label Phase (Optional)|Adverse Event|0
7593951|NCT01998958|26417458|P28|Open Label Phase (Optional)|Adverse Event|0
7593952|NCT01998958|26417459|P27|Open Label Phase (Optional)|Adverse Event|0
7593953|NCT01998958|26417460|P26|Open Label Phase (Optional)|Adverse Event|0
7593954|NCT01998958|26417461|P25|Open Label Phase (Optional)|Adverse Event|0
7593955|NCT01998958|26417462|P24|Open Label Phase (Optional)|Adverse Event|1
7593956|NCT01998958|26417463|P23|Open Label Phase (Optional)|Adverse Event|0
7593957|NCT01998958|26417464|P22|Open Label Phase (Optional)|Adverse Event|0
7593958|NCT01998958|26417465|P21|Open Label Phase (Optional)|Adverse Event|0
7593959|NCT01998958|26417466|P20|Open Label Phase (Optional)|Adverse Event|0
7593960|NCT01998958|26417467|P19|Open Label Phase (Optional)|Adverse Event|0
7593961|NCT01998958|26417468|P18|Open Label Phase (Optional)|Adverse Event|0
7593962|NCT01998958|26417469|P17|Open Label Phase (Optional)|Adverse Event|0
7593963|NCT01998958|26417470|P16|Open Label Phase (Optional)|Adverse Event|0
7593964|NCT01998958|26417471|P15|Open Label Phase (Optional)|Adverse Event|0
7593965|NCT01998958|26417472|P14|Open Label Phase (Optional)|Adverse Event|0
7593966|NCT01998958|26417473|P13|Open Label Phase (Optional)|Adverse Event|0
7593967|NCT01998958|26417474|P12|Open Label Phase (Optional)|Adverse Event|0
7593968|NCT01998958|26417475|P11|Open Label Phase (Optional)|Adverse Event|0
7593969|NCT01998958|26417476|P10|Open Label Phase (Optional)|Adverse Event|0
7593970|NCT01998958|26417477|P9|Open Label Phase (Optional)|Adverse Event|0
7593971|NCT01998958|26417478|P8|Open Label Phase (Optional)|Adverse Event|0
7593972|NCT01998958|26417479|P7|Open Label Phase (Optional)|Adverse Event|0
7593973|NCT01998958|26417480|P6|Open Label Phase (Optional)|Adverse Event|0
7593974|NCT01998958|26417481|P5|Open Label Phase (Optional)|Adverse Event|0
7593975|NCT01998958|26417482|P4|Open Label Phase (Optional)|Adverse Event|0
7593976|NCT01998958|26417483|P3|Open Label Phase (Optional)|Adverse Event|0
7593977|NCT01998958|26417484|P2|Open Label Phase (Optional)|Adverse Event|0
7593978|NCT01998958|26417485|P1|Open Label Phase (Optional)|Adverse Event|0
7593979|NCT01998958|26417454|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593980|NCT01998958|26417455|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593981|NCT01998958|26417456|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593982|NCT01998958|26417457|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593983|NCT01998958|26417458|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593984|NCT01998958|26417459|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593985|NCT01998958|26417460|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593986|NCT01998958|26417461|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593987|NCT01998958|26417462|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593988|NCT01998958|26417463|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593989|NCT01998958|26417464|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593990|NCT01998958|26417465|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593991|NCT01998958|26417466|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593992|NCT01998958|26417467|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
7593993|NCT01998958|26417468|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593994|NCT01998958|26417469|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593995|NCT01998958|26417470|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593996|NCT01998958|26417471|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
7593997|NCT01998958|26417472|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593998|NCT01998958|26417473|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
7593999|NCT01998958|26417474|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594000|NCT01998958|26417475|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594001|NCT01998958|26417476|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594002|NCT01998958|26417477|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594003|NCT01998958|26417478|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594004|NCT01998958|26417479|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594005|NCT01998958|26417480|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594006|NCT01998958|26417481|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594007|NCT01998958|26417482|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594008|NCT01998958|26417483|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594009|NCT01998958|26417484|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594010|NCT01998958|26417485|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
7594011|NCT01998958|26417454|P32|Period 2 (Panel A and B)|Adverse Event|0
7594012|NCT01998958|26417455|P31|Period 2 (Panel A and B)|Adverse Event|0
7594013|NCT01998958|26417456|P30|Period 2 (Panel A and B)|Adverse Event|0
7594014|NCT01998958|26417457|P29|Period 2 (Panel A and B)|Adverse Event|0
7594015|NCT01998958|26417458|P28|Period 2 (Panel A and B)|Adverse Event|0
7594016|NCT01998958|26417459|P27|Period 2 (Panel A and B)|Adverse Event|0
7594017|NCT01998958|26417460|P26|Period 2 (Panel A and B)|Adverse Event|0
7594018|NCT01998958|26417461|P25|Period 2 (Panel A and B)|Adverse Event|0
7594019|NCT01998958|26417462|P24|Period 2 (Panel A and B)|Adverse Event|0
7594020|NCT01998958|26417463|P23|Period 2 (Panel A and B)|Adverse Event|0
7594021|NCT01998958|26417464|P22|Period 2 (Panel A and B)|Adverse Event|0
7594022|NCT01998958|26417465|P21|Period 2 (Panel A and B)|Adverse Event|0
7594023|NCT01998958|26417466|P20|Period 2 (Panel A and B)|Adverse Event|0
7594024|NCT01998958|26417467|P19|Period 2 (Panel A and B)|Adverse Event|0
7594025|NCT01998958|26417468|P18|Period 2 (Panel A and B)|Adverse Event|0
7594026|NCT01998958|26417469|P17|Period 2 (Panel A and B)|Adverse Event|0
7594027|NCT01998958|26417470|P16|Period 2 (Panel A and B)|Adverse Event|0
7594028|NCT01998958|26417471|P15|Period 2 (Panel A and B)|Adverse Event|1
7594029|NCT01998958|26417472|P14|Period 2 (Panel A and B)|Adverse Event|0
7594030|NCT01998958|26417473|P13|Period 2 (Panel A and B)|Adverse Event|0
7594031|NCT01998958|26417474|P12|Period 2 (Panel A and B)|Adverse Event|0
7594032|NCT01998958|26417475|P11|Period 2 (Panel A and B)|Adverse Event|1
7594033|NCT01998958|26417476|P10|Period 2 (Panel A and B)|Adverse Event|0
7594034|NCT01998958|26417477|P9|Period 2 (Panel A and B)|Adverse Event|0
7594035|NCT01998958|26417478|P8|Period 2 (Panel A and B)|Adverse Event|0
7594036|NCT01998958|26417479|P7|Period 2 (Panel A and B)|Adverse Event|0
7594037|NCT01998958|26417480|P6|Period 2 (Panel A and B)|Adverse Event|0
7594038|NCT01998958|26417481|P5|Period 2 (Panel A and B)|Adverse Event|0
7594039|NCT01998958|26417482|P4|Period 2 (Panel A and B)|Adverse Event|0
7594040|NCT01998958|26417483|P3|Period 2 (Panel A and B)|Adverse Event|0
7594041|NCT01998958|26417484|P2|Period 2 (Panel A and B)|Adverse Event|0
7594042|NCT01998958|26417485|P1|Period 2 (Panel A and B)|Adverse Event|0
7594043|NCT01998958|26417454|P32|Period 1 (Panel A and B)|Other|0
7594044|NCT01998958|26417455|P31|Period 1 (Panel A and B)|Other|0
7594045|NCT01998958|26417456|P30|Period 1 (Panel A and B)|Other|0
7594046|NCT01998958|26417457|P29|Period 1 (Panel A and B)|Other|0
7594047|NCT01998958|26417458|P28|Period 1 (Panel A and B)|Other|0
7594048|NCT01998958|26417459|P27|Period 1 (Panel A and B)|Other|0
7594049|NCT01998958|26417460|P26|Period 1 (Panel A and B)|Other|0
7594050|NCT01998958|26417461|P25|Period 1 (Panel A and B)|Other|0
7594051|NCT01998958|26417462|P24|Period 1 (Panel A and B)|Other|0
7594052|NCT01998958|26417463|P23|Period 1 (Panel A and B)|Other|0
7594053|NCT01998958|26417464|P22|Period 1 (Panel A and B)|Other|0
7594054|NCT01998958|26417465|P21|Period 1 (Panel A and B)|Other|0
7594055|NCT01998958|26417466|P20|Period 1 (Panel A and B)|Other|0
7594056|NCT01998958|26417467|P19|Period 1 (Panel A and B)|Other|0
7594057|NCT01998958|26417468|P18|Period 1 (Panel A and B)|Other|0
7594058|NCT01998958|26417469|P17|Period 1 (Panel A and B)|Other|0
7594059|NCT01998958|26417470|P16|Period 1 (Panel A and B)|Other|0
7594060|NCT01998958|26417471|P15|Period 1 (Panel A and B)|Other|0
7594061|NCT01998958|26417472|P14|Period 1 (Panel A and B)|Other|0
7594062|NCT01998958|26417473|P13|Period 1 (Panel A and B)|Other|0
7594063|NCT01998958|26417474|P12|Period 1 (Panel A and B)|Other|0
7594064|NCT01998958|26417475|P11|Period 1 (Panel A and B)|Other|0
7594065|NCT01998958|26417476|P10|Period 1 (Panel A and B)|Other|0
7594066|NCT01998958|26417477|P9|Period 1 (Panel A and B)|Other|0
7594067|NCT01998958|26417478|P8|Period 1 (Panel A and B)|Other|0
7594068|NCT01998958|26417479|P7|Period 1 (Panel A and B)|Other|0
7594069|NCT01998958|26417480|P6|Period 1 (Panel A and B)|Other|0
7594070|NCT01998958|26417481|P5|Period 1 (Panel A and B)|Other|0
7594071|NCT01998958|26417482|P4|Period 1 (Panel A and B)|Other|0
7594072|NCT01998958|26417483|P3|Period 1 (Panel A and B)|Other|0
7594073|NCT01998958|26417484|P2|Period 1 (Panel A and B)|Other|0
7594074|NCT01998958|26417485|P1|Period 1 (Panel A and B)|Other|1
7594075|NCT01998958|26417454|P32|Period 1 (Panel A and B)|Adverse Event|0
7594076|NCT01998958|26417455|P31|Period 1 (Panel A and B)|Adverse Event|0
7594077|NCT01998958|26417456|P30|Period 1 (Panel A and B)|Adverse Event|0
7594078|NCT01998958|26417457|P29|Period 1 (Panel A and B)|Adverse Event|0
7594079|NCT01998958|26417458|P28|Period 1 (Panel A and B)|Adverse Event|0
7594080|NCT01998958|26417459|P27|Period 1 (Panel A and B)|Adverse Event|0
7594081|NCT01998958|26417460|P26|Period 1 (Panel A and B)|Adverse Event|0
7594082|NCT01998958|26417461|P25|Period 1 (Panel A and B)|Adverse Event|0
7594083|NCT01998958|26417462|P24|Period 1 (Panel A and B)|Adverse Event|0
7594084|NCT01998958|26417463|P23|Period 1 (Panel A and B)|Adverse Event|0
7594085|NCT01998958|26417464|P22|Period 1 (Panel A and B)|Adverse Event|0
7594086|NCT01998958|26417465|P21|Period 1 (Panel A and B)|Adverse Event|0
7594087|NCT01998958|26417466|P20|Period 1 (Panel A and B)|Adverse Event|0
7594088|NCT01998958|26417467|P19|Period 1 (Panel A and B)|Adverse Event|0
7594089|NCT01998958|26417468|P18|Period 1 (Panel A and B)|Adverse Event|0
7594090|NCT01998958|26417469|P17|Period 1 (Panel A and B)|Adverse Event|0
7594091|NCT01998958|26417470|P16|Period 1 (Panel A and B)|Adverse Event|0
7594092|NCT01998958|26417471|P15|Period 1 (Panel A and B)|Adverse Event|0
7594093|NCT01998958|26417472|P14|Period 1 (Panel A and B)|Adverse Event|0
7594094|NCT01998958|26417473|P13|Period 1 (Panel A and B)|Adverse Event|0
7594095|NCT01998958|26417474|P12|Period 1 (Panel A and B)|Adverse Event|0
7594096|NCT01998958|26417475|P11|Period 1 (Panel A and B)|Adverse Event|0
7594097|NCT01998958|26417476|P10|Period 1 (Panel A and B)|Adverse Event|0
7594098|NCT01998958|26417477|P9|Period 1 (Panel A and B)|Adverse Event|0
7594099|NCT01998958|26417478|P8|Period 1 (Panel A and B)|Adverse Event|0
7594100|NCT01998958|26417479|P7|Period 1 (Panel A and B)|Adverse Event|0
7594101|NCT01998958|26417480|P6|Period 1 (Panel A and B)|Adverse Event|0
7594102|NCT01998958|26417481|P5|Period 1 (Panel A and B)|Adverse Event|0
7594103|NCT01998958|26417482|P4|Period 1 (Panel A and B)|Adverse Event|0
7594104|NCT01998958|26417483|P3|Period 1 (Panel A and B)|Adverse Event|0
7594105|NCT01998958|26417484|P2|Period 1 (Panel A and B)|Adverse Event|1
7594106|NCT01998958|26417485|P1|Period 1 (Panel A and B)|Adverse Event|0
7594107|NCT01998958|26417454|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
7594108|NCT01998958|26417455|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
7594109|NCT01998958|26417456|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
7594110|NCT01998958|26417457|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
7594111|NCT01998958|26417458|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
7594112|NCT01998958|26417459|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
7594113|NCT01998958|26417460|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
7594114|NCT01998958|26417461|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
7594115|NCT01998958|26417462|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
7594116|NCT01998958|26417463|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
7594117|NCT01998958|26417464|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
7594118|NCT01998958|26417465|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
7594119|NCT01998958|26417466|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
7594120|NCT01998958|26417467|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
7594121|NCT01998958|26417468|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
7594122|NCT01998958|26417469|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
7594123|NCT01998958|26417470|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
7594124|NCT01998958|26417471|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
7594125|NCT01998958|26417472|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
7594126|NCT01998958|26417473|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
7594127|NCT01998958|26417474|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
7594128|NCT01998958|26417475|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
7594129|NCT01998958|26417476|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
7594130|NCT01998958|26417477|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
7594131|NCT01998958|26417478|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
7594132|NCT01998958|26417479|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
7594133|NCT01998958|26417480|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
7594134|NCT01998958|26417481|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
7594135|NCT01998958|26417482|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
7594136|NCT01998958|26417483|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
7594137|NCT01998958|26417484|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
7594138|NCT01998958|26417485|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
7594139|NCT01998958|26417454|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594140|NCT01998958|26417455|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594141|NCT01998958|26417456|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594142|NCT01998958|26417457|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594143|NCT01998958|26417458|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594144|NCT01998958|26417459|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594145|NCT01998958|26417460|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594146|NCT01998958|26417461|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594147|NCT01998958|26417462|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594148|NCT01998958|26417463|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594149|NCT01998958|26417464|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594150|NCT01998958|26417465|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594151|NCT01998958|26417466|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594152|NCT01998958|26417467|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594153|NCT01998958|26417468|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594154|NCT01998958|26417469|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594155|NCT01998958|26417470|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594156|NCT01998958|26417471|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594157|NCT01998958|26417472|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594158|NCT01998958|26417473|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594159|NCT01998958|26417474|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594160|NCT01998958|26417475|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594161|NCT01998958|26417476|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594162|NCT01998958|26417477|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594163|NCT01998958|26417478|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594164|NCT01998958|26417479|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594165|NCT01998958|26417480|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594166|NCT01998958|26417481|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594167|NCT01998958|26417482|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594168|NCT01998958|26417483|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594169|NCT01998958|26417484|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
7594170|NCT01998958|26417485|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
7594171|NCT01998919|26417624|P2|Overall Study|Other|2
7594172|NCT01998919|26417625|P1|Overall Study|Other|5
7594173|NCT01998919|26417624|P2|Overall Study|Lost to Follow-up|0
7594174|NCT01998919|26417625|P1|Overall Study|Lost to Follow-up|2
7594175|NCT01998919|26417624|P2|Overall Study|Withdrawal by Subject|4
7594176|NCT01998919|26417625|P1|Overall Study|Withdrawal by Subject|2
7594177|NCT01998919|26417624|P2|Overall Study|Disease progression|22
7594178|NCT01998919|26417625|P1|Overall Study|Disease progression|31
7594179|NCT01998919|26417624|P2|Overall Study|Adverse Event|5
7594180|NCT01998919|26417625|P1|Overall Study|Adverse Event|0
7594181|NCT01998919|26417624|P2|Overall Study|Death|2
7594182|NCT01998919|26417625|P1|Overall Study|Death|2
7594183|NCT01998906|26417646|P3|Overall Study|Other|4
7594184|NCT01998906|26417647|P2|Overall Study|Other|8
7594185|NCT01998906|26417648|P1|Overall Study|Other|3
7594186|NCT01998906|26417646|P3|Overall Study|Administrative/Other|3
7594187|NCT01998906|26417647|P2|Overall Study|Administrative/Other|1
7594188|NCT01998906|26417648|P1|Overall Study|Administrative/Other|2
7594189|NCT01998906|26417646|P3|Overall Study|Withdrawal by Subject|3
7594190|NCT01998906|26417647|P2|Overall Study|Withdrawal by Subject|4
7594191|NCT01998906|26417648|P1|Overall Study|Withdrawal by Subject|1
7594192|NCT01998906|26417646|P3|Overall Study|Violation of Selection Criteria|1
7594193|NCT01998906|26417647|P2|Overall Study|Violation of Selection Criteria|0
7594194|NCT01998906|26417648|P1|Overall Study|Violation of Selection Criteria|0
7594195|NCT01998906|26417646|P3|Overall Study|Failure to return|4
7594196|NCT01998906|26417647|P2|Overall Study|Failure to return|2
7594197|NCT01998906|26417648|P1|Overall Study|Failure to return|0
7594198|NCT01998906|26417646|P3|Overall Study|Lack of Efficacy|8
7594199|NCT01998906|26417647|P2|Overall Study|Lack of Efficacy|9
7594200|NCT01998906|26417648|P1|Overall Study|Lack of Efficacy|10
7594201|NCT01998906|26417646|P3|Overall Study|Death|17
7594202|NCT01998906|26417647|P2|Overall Study|Death|30
7594203|NCT01998906|26417648|P1|Overall Study|Death|21
7594204|NCT01998906|26417646|P3|Overall Study|Participants ongoing in follow-up|58
7594205|NCT01998906|26417647|P2|Overall Study|Participants ongoing in follow-up|60
7594206|NCT01998906|26417648|P1|Overall Study|Participants ongoing in follow-up|77
7594207|NCT01998893|26417692|P1|Overall Study|Transformation to high-grade lymphoma|1
7594208|NCT01998893|26417692|P1|Overall Study|Withdrawal by Subject|1
7594209|NCT01998893|26417692|P1|Overall Study|Protocol Violation|2
7594210|NCT01998893|26417692|P1|Overall Study|Physician Decision|2
7594211|NCT01998893|26417692|P1|Overall Study|Lost to Follow-up|8
7594212|NCT01998893|26417692|P1|Overall Study|Death|1
7594213|NCT01998893|26417692|P1|Overall Study|Adverse Event|2
7594214|NCT01998880|26417704|P2|Overall Study|Did Not Receive Treatment|2
7594215|NCT01998880|26417705|P1|Overall Study|Did Not Receive Treatment|3
7594216|NCT01998880|26417704|P2|Overall Study|Violation of Selection Criteria at Entry|1
7594217|NCT01998880|26417705|P1|Overall Study|Violation of Selection Criteria at Entry|0
7594218|NCT01998880|26417704|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
7594219|NCT01998880|26417705|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
7594220|NCT01998880|26417704|P2|Overall Study|Administrative/Other|1
7594221|NCT01998880|26417705|P1|Overall Study|Administrative/Other|1
7594222|NCT01998880|26417704|P2|Overall Study|Insufficient Therapeutic Response|5
7594223|NCT01998880|26417705|P1|Overall Study|Insufficient Therapeutic Response|1
7594224|NCT01998880|26417704|P2|Overall Study|Death|6
7594225|NCT01998880|26417705|P1|Overall Study|Death|3
7594226|NCT01998880|26417704|P2|Overall Study|Withdrew Consent|1
7594227|NCT01998880|26417705|P1|Overall Study|Withdrew Consent|2
7594228|NCT01998880|26417704|P2|Overall Study|Disease Progression|8
7594229|NCT01998880|26417705|P1|Overall Study|Disease Progression|1
7594230|NCT01998880|26417704|P2|Overall Study|Adverse Events or Intercurrent Illness|16
7594231|NCT01998880|26417705|P1|Overall Study|Adverse Events or Intercurrent Illness|16
7594232|NCT01998737|26417737|P2|Overall Study|Corrupted database|0
7594233|NCT01998737|26417738|P1|Overall Study|Corrupted database|23
7594234|NCT01998633|26417750|P1|Overall Study|Death|1
7594235|NCT01998581|26417768|P2|Overall Study|Randomized but withdrew before treatment|0
7594236|NCT01998581|26417769|P1|Overall Study|Randomized but withdrew before treatment|1
7594237|NCT01998581|26417768|P2|Overall Study|Other reasons|2
7594238|NCT01998581|26417769|P1|Overall Study|Other reasons|3
7594239|NCT01998581|26417768|P2|Overall Study|Adverse Event|1
7594240|NCT01998581|26417769|P1|Overall Study|Adverse Event|1
7594241|NCT01998581|26417768|P2|Overall Study|Lost to Follow-up|4
7594242|NCT01998581|26417769|P1|Overall Study|Lost to Follow-up|12
7594243|NCT01998581|26417768|P2|Overall Study|Withdrawal by Subject|1
7594244|NCT01998581|26417769|P1|Overall Study|Withdrawal by Subject|8
7594245|NCT01998581|26417768|P2|Overall Study|Protocol Violation|0
7594246|NCT01998581|26417769|P1|Overall Study|Protocol Violation|1
7594247|NCT01998581|26417768|P2|Overall Study|Refused repeat treatment|4
7594248|NCT01998581|26417769|P1|Overall Study|Refused repeat treatment|20
7594249|NCT01998477|26417782|P2|Overall Study|Withdrawal by Subject|0
7594250|NCT01998477|26417783|P1|Overall Study|Withdrawal by Subject|6
7594251|NCT01998477|26417782|P2|Overall Study|Lost to Follow-up|5
7594252|NCT01998477|26417783|P1|Overall Study|Lost to Follow-up|4
7594253|NCT01998399|26417829|P2|Overall Study|Withdrawal by Subject|1
7594254|NCT01998399|26417830|P1|Overall Study|Withdrawal by Subject|0
7594255|NCT01998399|26417829|P2|Overall Study|Study stopped before dosing completed|3
7594256|NCT01998399|26417830|P1|Overall Study|Study stopped before dosing completed|3
7594257|NCT01998399|26417829|P2|Overall Study|Death|2
7594258|NCT01998399|26417830|P1|Overall Study|Death|4
7594259|NCT01998399|26417829|P2|Overall Study|Lost to Follow-up|3
7594260|NCT01998399|26417830|P1|Overall Study|Lost to Follow-up|1
7594261|NCT01998243|26417885|P2|Overall Study|Withdrawal by Subject|4
7594262|NCT01998243|26417886|P1|Overall Study|Withdrawal by Subject|3
7594263|NCT01998243|26417885|P2|Overall Study|Protocol Violation|2
7594264|NCT01998243|26417886|P1|Overall Study|Protocol Violation|5
7594265|NCT01998243|26417885|P2|Overall Study|Pregnancy|1
7594266|NCT01998243|26417886|P1|Overall Study|Pregnancy|0
7594267|NCT01997892|26417909|P1|Overall Study|Study completion data not recorded|35
7594268|NCT01997892|26417909|P1|Overall Study|Other|3
7594269|NCT01997892|26417909|P1|Overall Study|Renal transplant|8
7594270|NCT01997892|26417909|P1|Overall Study|Death|14
7594271|NCT01997892|26417909|P1|Overall Study|Lost to Follow-up|6
7594272|NCT01997892|26417909|P1|Overall Study|Physician Decision|2
7594273|NCT01997333|26418083|P2|Survival Follow up|Various|2
7594274|NCT01997333|26418084|P1|Survival Follow up|Various|1
7594275|NCT01997333|26418083|P2|Survival Follow up|Lost to Follow-up|6
7594276|NCT01997333|26418084|P1|Survival Follow up|Lost to Follow-up|0
7594277|NCT01997333|26418083|P2|Survival Follow up|Withdrawal by Subject|6
7594278|NCT01997333|26418084|P1|Survival Follow up|Withdrawal by Subject|15
7594279|NCT01997333|26418083|P2|Randomization and Treatment|Did not receive treatment|5
7594280|NCT01997333|26418084|P1|Randomization and Treatment|Did not receive treatment|17
7594281|NCT01997333|26418083|P2|Randomization and Treatment|Withdrawal by Subject|3
7594282|NCT01997333|26418084|P1|Randomization and Treatment|Withdrawal by Subject|6
7594283|NCT01997333|26418083|P2|Randomization and Treatment|Physician Decision|4
7594284|NCT01997333|26418084|P1|Randomization and Treatment|Physician Decision|0
7594285|NCT01997333|26418083|P2|Randomization and Treatment|Adverse Event|32
7594286|NCT01997333|26418084|P1|Randomization and Treatment|Adverse Event|10
7594287|NCT01997333|26418083|P2|Randomization and Treatment|Disease Progression|159
7594288|NCT01997333|26418084|P1|Randomization and Treatment|Disease Progression|70
7594289|NCT01997281|26418101|P2|Overall Study|Withdrawal by Subject|0
7594290|NCT01997281|26418102|P1|Overall Study|Withdrawal by Subject|1
7594291|NCT01996982|26418132|P1|Overall Study|PI/team left institution|7
7594292|NCT01996904|26418161|P2|Overall Study|Lost to Follow-up|27
7594293|NCT01996904|26418162|P1|Overall Study|Lost to Follow-up|38
7594294|NCT01996826|26418247|P2|Overall Study|Physician Decision|1
7594295|NCT01996826|26418248|P1|Overall Study|Physician Decision|1
7594296|NCT01996826|26418247|P2|Overall Study|Lost to Follow-up|2
7594297|NCT01996826|26418248|P1|Overall Study|Lost to Follow-up|6
7594298|NCT01996748|26418271|P2|Overall Study|Lost to Follow-up|1
7594299|NCT01996748|26418272|P1|Overall Study|Lost to Follow-up|4
7594300|NCT01996748|26418271|P2|Overall Study|Withdrawal by Subject|1
7594301|NCT01996748|26418272|P1|Overall Study|Withdrawal by Subject|0
7594302|NCT01996748|26418271|P2|Overall Study|Adverse Event|4
7594303|NCT01996748|26418272|P1|Overall Study|Adverse Event|1
7594304|NCT01996748|26418271|P2|Overall Study|Physician Decision|0
7594305|NCT01996748|26418272|P1|Overall Study|Physician Decision|2
7594306|NCT01996748|26418271|P2|Overall Study|Personal reason|0
7594307|NCT01996748|26418272|P1|Overall Study|Personal reason|1
7594308|NCT01996709|26418286|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
7594309|NCT01996709|26418287|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
7594310|NCT01996709|26418286|P2|Overall Study|Subject Non-Compliant|0
7594311|NCT01996709|26418287|P1|Overall Study|Subject Non-Compliant|1
7594312|NCT01996709|26418286|P2|Overall Study|Lost to Follow-up|0
7594313|NCT01996709|26418287|P1|Overall Study|Lost to Follow-up|3
7594314|NCT01996709|26418286|P2|Overall Study|Withdrawal by Subject|0
7594315|NCT01996709|26418287|P1|Overall Study|Withdrawal by Subject|1
7594316|NCT01996592|26418334|P1|Overall Study|change in mode of delivery|4
7594317|NCT01996592|26418334|P1|Overall Study|Withdrawal by Subject|5
7594318|NCT01996592|26418334|P1|Overall Study|change in surgical date|4
7594319|NCT01996592|26418334|P1|Overall Study|no response to text/no diary entry|32
7594320|NCT01996332|26418370|P1|Overall Study|Lost to Follow-up|34
7594321|NCT01996332|26418370|P1|Overall Study|Physician Decision|17
7594322|NCT01996332|26418370|P1|Overall Study|Clinical Deterioration|28
7594323|NCT01996332|26418370|P1|Overall Study|Other|20
7594324|NCT01996332|26418370|P1|Overall Study|Withdrawal by Subject|71
7594325|NCT01996332|26418370|P1|Overall Study|Protocol Violation|9
7594326|NCT01996332|26418370|P1|Overall Study|Death|264
7594327|NCT01996332|26418370|P1|Overall Study|Lack of Efficacy|1245
7594328|NCT01996332|26418370|P1|Overall Study|Adverse Event|117
7594329|NCT01996319|26418378|P2|Overall Study|Adverse Event|2
7594330|NCT01996319|26418379|P1|Overall Study|Adverse Event|2
7594331|NCT01996319|26418378|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
7594332|NCT01996319|26418379|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
7594333|NCT01996319|26418378|P2|Overall Study|Protocol Violation|0
7594334|NCT01996319|26418379|P1|Overall Study|Protocol Violation|1
7594335|NCT01996254|26418401|P3|Overall Study|Lost to Follow-up|4
7594336|NCT01996254|26418402|P2|Overall Study|Lost to Follow-up|0
7594337|NCT01996254|26418403|P1|Overall Study|Lost to Follow-up|1
7594338|NCT01996254|26418401|P3|Overall Study|Withdrawal by Subject|4
7594339|NCT01996254|26418402|P2|Overall Study|Withdrawal by Subject|3
7594340|NCT01996254|26418403|P1|Overall Study|Withdrawal by Subject|0
7594341|NCT01996254|26418401|P3|Overall Study|Change in Eligibility|0
7594342|NCT01996254|26418402|P2|Overall Study|Change in Eligibility|2
7594343|NCT01996254|26418403|P1|Overall Study|Change in Eligibility|0
7594344|NCT01996241|26418431|P2|Overall Study|Lost to Follow-up|235
7594345|NCT01996241|26418432|P1|Overall Study|Lost to Follow-up|252
7594346|NCT01996033|26418448|P1|Overall Study|Lost to Follow-up|3
7594347|NCT01996033|26418448|P1|Overall Study|Withdrawal by Subject|4
7594348|NCT01996033|26418448|P1|Overall Study|Physician Decision|1
7594349|NCT01996033|26418448|P1|Overall Study|Death|1
7594350|NCT01995838|26418468|P7|Overall Study|Other|2
7594351|NCT01995838|26418469|P6|Overall Study|Other|1
7594352|NCT01995838|26418470|P5|Overall Study|Other|1
7594353|NCT01995838|26418471|P4|Overall Study|Other|2
7594354|NCT01995838|26418472|P3|Overall Study|Other|0
7594355|NCT01995838|26418473|P2|Overall Study|Other|1
7594356|NCT01995838|26418474|P1|Overall Study|Other|3
7594357|NCT01995838|26418468|P7|Overall Study|Withdrawal by Subject|0
7594358|NCT01995838|26418469|P6|Overall Study|Withdrawal by Subject|0
7594359|NCT01995838|26418470|P5|Overall Study|Withdrawal by Subject|1
7594360|NCT01995838|26418471|P4|Overall Study|Withdrawal by Subject|0
7594361|NCT01995838|26418472|P3|Overall Study|Withdrawal by Subject|0
7594362|NCT01995838|26418473|P2|Overall Study|Withdrawal by Subject|0
7594363|NCT01995838|26418474|P1|Overall Study|Withdrawal by Subject|0
7594364|NCT01995838|26418468|P7|Overall Study|Adverse Event|1
7594365|NCT01995838|26418469|P6|Overall Study|Adverse Event|0
7594366|NCT01995838|26418470|P5|Overall Study|Adverse Event|0
7594367|NCT01995838|26418471|P4|Overall Study|Adverse Event|0
7594368|NCT01995838|26418472|P3|Overall Study|Adverse Event|0
7594369|NCT01995838|26418473|P2|Overall Study|Adverse Event|0
7594370|NCT01995838|26418474|P1|Overall Study|Adverse Event|0
7594371|NCT01995838|26418468|P7|Overall Study|Participant choice|1
7594372|NCT01995838|26418469|P6|Overall Study|Participant choice|1
7594373|NCT01995838|26418470|P5|Overall Study|Participant choice|0
7594374|NCT01995838|26418471|P4|Overall Study|Participant choice|0
7594375|NCT01995838|26418472|P3|Overall Study|Participant choice|0
7594376|NCT01995838|26418473|P2|Overall Study|Participant choice|0
7594377|NCT01995838|26418474|P1|Overall Study|Participant choice|2
7594378|NCT01995838|26418468|P7|Overall Study|Lost to Follow-up|1
7594379|NCT01995838|26418469|P6|Overall Study|Lost to Follow-up|0
7594380|NCT01995838|26418470|P5|Overall Study|Lost to Follow-up|0
7594381|NCT01995838|26418471|P4|Overall Study|Lost to Follow-up|0
7594382|NCT01995838|26418472|P3|Overall Study|Lost to Follow-up|0
7594383|NCT01995838|26418473|P2|Overall Study|Lost to Follow-up|1
7594384|NCT01995838|26418474|P1|Overall Study|Lost to Follow-up|0
7594385|NCT01995825|26418575|P2|Overall Study|Withdrawal by Subject|0
7594386|NCT01995825|26418576|P1|Overall Study|Withdrawal by Subject|1
7594387|NCT01995552|26418584|P1|Overall Study|Death|1
7594388|NCT01995552|26418584|P1|Overall Study|Lack of Efficacy|15
7594389|NCT01995552|26418584|P1|Overall Study|Protocol Violation|1
7594390|NCT01995539|26418590|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
7594391|NCT01995539|26418590|P1|Overall Study|Lost to Follow-up|5
7594392|NCT01995539|26418590|P1|Overall Study|Withdrawal by Subject|11
7594393|NCT01995539|26418590|P1|Overall Study|Withdrawal by Investigator|15
7594394|NCT01995539|26418590|P1|Overall Study|Screening Failure|1
7594395|NCT01995526|26418595|P1|Overall Study|Physician Decision|1
7594396|NCT01995513|26418603|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
7594397|NCT01995513|26418604|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
7594398|NCT01995513|26418605|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7594399|NCT01995513|26418603|P3|Double Blind Treatment Period|Disease Progression|93
7594400|NCT01995513|26418604|P2|Double Blind Treatment Period|Disease Progression|82
7594401|NCT01995513|26418605|P1|Double Blind Treatment Period|Disease Progression|0
7594402|NCT01995513|26418603|P3|Double Blind Treatment Period|Death|1
7594403|NCT01995513|26418604|P2|Double Blind Treatment Period|Death|0
7594404|NCT01995513|26418605|P1|Double Blind Treatment Period|Death|0
7594405|NCT01995513|26418603|P3|Double Blind Treatment Period|Withdrawal by Subject|6
7594406|NCT01995513|26418604|P2|Double Blind Treatment Period|Withdrawal by Subject|4
7594407|NCT01995513|26418605|P1|Double Blind Treatment Period|Withdrawal by Subject|0
7594408|NCT01995513|26418603|P3|Double Blind Treatment Period|Other|2
7594409|NCT01995513|26418604|P2|Double Blind Treatment Period|Other|1
7594410|NCT01995513|26418605|P1|Double Blind Treatment Period|Other|0
7594411|NCT01995513|26418603|P3|Double Blind Treatment Period|Adverse Event|5
7594412|NCT01995513|26418604|P2|Double Blind Treatment Period|Adverse Event|12
7594413|NCT01995513|26418605|P1|Double Blind Treatment Period|Adverse Event|0
7594414|NCT01995513|26418603|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7594415|NCT01995513|26418604|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7594416|NCT01995513|26418605|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
7594417|NCT01995513|26418603|P3|Open Label Treatment Period|Death|0
7594418|NCT01995513|26418604|P2|Open Label Treatment Period|Death|0
7594419|NCT01995513|26418605|P1|Open Label Treatment Period|Death|8
7594420|NCT01995513|26418603|P3|Open Label Treatment Period|Adverse Event|0
7594421|NCT01995513|26418604|P2|Open Label Treatment Period|Adverse Event|0
7594422|NCT01995513|26418605|P1|Open Label Treatment Period|Adverse Event|35
7594423|NCT01995513|26418603|P3|Open Label Treatment Period|No PSA response at week 13|0
7594424|NCT01995513|26418604|P2|Open Label Treatment Period|No PSA response at week 13|0
7594425|NCT01995513|26418605|P1|Open Label Treatment Period|No PSA response at week 13|43
7594426|NCT01995513|26418603|P3|Open Label Treatment Period|Disease Progression|0
7594427|NCT01995513|26418604|P2|Open Label Treatment Period|Disease Progression|0
7594428|NCT01995513|26418605|P1|Open Label Treatment Period|Disease Progression|64
7594429|NCT01995513|26418603|P3|Open Label Treatment Period|Protocol Violation|0
7594430|NCT01995513|26418604|P2|Open Label Treatment Period|Protocol Violation|0
7594431|NCT01995513|26418605|P1|Open Label Treatment Period|Protocol Violation|1
7594432|NCT01995513|26418603|P3|Open Label Treatment Period|Withdrawal by Subject|0
7594433|NCT01995513|26418604|P2|Open Label Treatment Period|Withdrawal by Subject|0
7594434|NCT01995513|26418605|P1|Open Label Treatment Period|Withdrawal by Subject|14
7594435|NCT01995513|26418603|P3|Open Label Treatment Period|Other|0
7594436|NCT01995513|26418604|P2|Open Label Treatment Period|Other|0
7594437|NCT01995513|26418605|P1|Open Label Treatment Period|Other|9
7594438|NCT01995461|26418657|P1|Overall Study|Withdrawal by Subject|2
7594439|NCT01995461|26418657|P1|Overall Study|Lost to Follow-up|2
7594440|NCT01995461|26418657|P1|Overall Study|Death|1
7594441|NCT01995357|26418663|P6|Period 5|Adverse Event|0
7594442|NCT01995357|26418664|P5|Period 5|Adverse Event|0
7594443|NCT01995357|26418665|P4|Period 5|Adverse Event|0
7594444|NCT01995357|26418666|P3|Period 5|Adverse Event|1
7594445|NCT01995357|26418667|P2|Period 5|Adverse Event|0
7594446|NCT01995357|26418668|P1|Period 5|Adverse Event|1
7594447|NCT01995357|26418663|P6|Period 5|Lack of Efficacy|0
7594448|NCT01995357|26418664|P5|Period 5|Lack of Efficacy|0
7594449|NCT01995357|26418665|P4|Period 5|Lack of Efficacy|0
7594450|NCT01995357|26418666|P3|Period 5|Lack of Efficacy|0
7594451|NCT01995357|26418667|P2|Period 5|Lack of Efficacy|0
7594452|NCT01995357|26418668|P1|Period 5|Lack of Efficacy|1
7594453|NCT01995266|26418684|P1|Overall Study|Adverse Event|2
7594454|NCT01995266|26418684|P1|Overall Study|Lack of Efficacy|6
7594455|NCT01995266|26418684|P1|Overall Study|Death|1
7594456|NCT01995201|26418699|P7|From Week 24 Until Week 48|Protocol Violation|0
7594457|NCT01995201|26418700|P6|From Week 24 Until Week 48|Protocol Violation|0
7594458|NCT01995201|26418701|P5|From Week 24 Until Week 48|Protocol Violation|2
7594459|NCT01995201|26418702|P4|From Week 24 Until Week 48|Protocol Violation|0
7594460|NCT01995201|26418703|P3|From Week 24 Until Week 48|Protocol Violation|1
7594461|NCT01995201|26418704|P2|From Week 24 Until Week 48|Protocol Violation|0
7594462|NCT01995201|26418705|P1|From Week 24 Until Week 48|Protocol Violation|0
7594463|NCT01995201|26418699|P7|From Week 24 Until Week 48|Physician Decision|0
7594464|NCT01995201|26418700|P6|From Week 24 Until Week 48|Physician Decision|0
7594465|NCT01995201|26418701|P5|From Week 24 Until Week 48|Physician Decision|1
7594466|NCT01995201|26418702|P4|From Week 24 Until Week 48|Physician Decision|0
7594467|NCT01995201|26418703|P3|From Week 24 Until Week 48|Physician Decision|0
7594468|NCT01995201|26418704|P2|From Week 24 Until Week 48|Physician Decision|0
7594469|NCT01995201|26418705|P1|From Week 24 Until Week 48|Physician Decision|0
7594470|NCT01995201|26418699|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
7594471|NCT01995201|26418700|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
7594472|NCT01995201|26418701|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
7594473|NCT01995201|26418702|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
7594474|NCT01995201|26418703|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
7594475|NCT01995201|26418704|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
7594476|NCT01995201|26418705|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
7594477|NCT01995201|26418699|P7|From Week 24 Until Week 48|Lost to Follow-up|0
7594478|NCT01995201|26418700|P6|From Week 24 Until Week 48|Lost to Follow-up|1
7594479|NCT01995201|26418701|P5|From Week 24 Until Week 48|Lost to Follow-up|1
7594480|NCT01995201|26418702|P4|From Week 24 Until Week 48|Lost to Follow-up|0
7594481|NCT01995201|26418703|P3|From Week 24 Until Week 48|Lost to Follow-up|0
7594482|NCT01995201|26418704|P2|From Week 24 Until Week 48|Lost to Follow-up|0
7594483|NCT01995201|26418705|P1|From Week 24 Until Week 48|Lost to Follow-up|0
7594484|NCT01995201|26418699|P7|From Week 24 Until Week 48|Lack of Efficacy|1
7594485|NCT01995201|26418700|P6|From Week 24 Until Week 48|Lack of Efficacy|2
7594486|NCT01995201|26418701|P5|From Week 24 Until Week 48|Lack of Efficacy|0
7594487|NCT01995201|26418702|P4|From Week 24 Until Week 48|Lack of Efficacy|0
7594488|NCT01995201|26418703|P3|From Week 24 Until Week 48|Lack of Efficacy|1
7594489|NCT01995201|26418704|P2|From Week 24 Until Week 48|Lack of Efficacy|0
7594490|NCT01995201|26418705|P1|From Week 24 Until Week 48|Lack of Efficacy|0
7594491|NCT01995201|26418699|P7|From Week 24 Until Week 48|Death|0
7594492|NCT01995201|26418700|P6|From Week 24 Until Week 48|Death|2
7594493|NCT01995201|26418701|P5|From Week 24 Until Week 48|Death|0
7594494|NCT01995201|26418702|P4|From Week 24 Until Week 48|Death|0
7594495|NCT01995201|26418703|P3|From Week 24 Until Week 48|Death|0
7594496|NCT01995201|26418704|P2|From Week 24 Until Week 48|Death|0
7594497|NCT01995201|26418705|P1|From Week 24 Until Week 48|Death|0
7594498|NCT01995201|26418699|P7|From Week 24 Until Week 48|Adverse Event|1
7594499|NCT01995201|26418700|P6|From Week 24 Until Week 48|Adverse Event|3
7594500|NCT01995201|26418701|P5|From Week 24 Until Week 48|Adverse Event|1
7594501|NCT01995201|26418702|P4|From Week 24 Until Week 48|Adverse Event|1
7594502|NCT01995201|26418703|P3|From Week 24 Until Week 48|Adverse Event|2
7594503|NCT01995201|26418704|P2|From Week 24 Until Week 48|Adverse Event|0
7594504|NCT01995201|26418705|P1|From Week 24 Until Week 48|Adverse Event|0
7594505|NCT01995201|26418699|P7|From Baseline Until Week 24|Protocol Violation|0
7594506|NCT01995201|26418700|P6|From Baseline Until Week 24|Protocol Violation|0
7594507|NCT01995201|26418701|P5|From Baseline Until Week 24|Protocol Violation|0
7594508|NCT01995201|26418702|P4|From Baseline Until Week 24|Protocol Violation|0
7594509|NCT01995201|26418703|P3|From Baseline Until Week 24|Protocol Violation|0
7594510|NCT01995201|26418704|P2|From Baseline Until Week 24|Protocol Violation|9
7594511|NCT01995201|26418705|P1|From Baseline Until Week 24|Protocol Violation|0
7594512|NCT01995201|26418699|P7|From Baseline Until Week 24|Physician Decision|0
7594513|NCT01995201|26418700|P6|From Baseline Until Week 24|Physician Decision|0
7594514|NCT01995201|26418701|P5|From Baseline Until Week 24|Physician Decision|0
7594515|NCT01995201|26418702|P4|From Baseline Until Week 24|Physician Decision|0
7594516|NCT01995201|26418703|P3|From Baseline Until Week 24|Physician Decision|0
7594517|NCT01995201|26418704|P2|From Baseline Until Week 24|Physician Decision|2
7594518|NCT01995201|26418705|P1|From Baseline Until Week 24|Physician Decision|0
7594519|NCT01995201|26418699|P7|From Baseline Until Week 24|Withdrawal by Subject|0
7594520|NCT01995201|26418700|P6|From Baseline Until Week 24|Withdrawal by Subject|0
7594521|NCT01995201|26418701|P5|From Baseline Until Week 24|Withdrawal by Subject|0
7594522|NCT01995201|26418702|P4|From Baseline Until Week 24|Withdrawal by Subject|0
7594523|NCT01995201|26418703|P3|From Baseline Until Week 24|Withdrawal by Subject|0
7594524|NCT01995201|26418704|P2|From Baseline Until Week 24|Withdrawal by Subject|8
7594525|NCT01995201|26418705|P1|From Baseline Until Week 24|Withdrawal by Subject|2
7594526|NCT01995201|26418699|P7|From Baseline Until Week 24|Lost to Follow-up|0
7594527|NCT01995201|26418700|P6|From Baseline Until Week 24|Lost to Follow-up|0
7594528|NCT01995201|26418701|P5|From Baseline Until Week 24|Lost to Follow-up|0
7594529|NCT01995201|26418702|P4|From Baseline Until Week 24|Lost to Follow-up|0
7594530|NCT01995201|26418703|P3|From Baseline Until Week 24|Lost to Follow-up|0
7594531|NCT01995201|26418704|P2|From Baseline Until Week 24|Lost to Follow-up|3
7594532|NCT01995201|26418705|P1|From Baseline Until Week 24|Lost to Follow-up|2
7594533|NCT01995201|26418699|P7|From Baseline Until Week 24|Lack of Efficacy|0
7594534|NCT01995201|26418700|P6|From Baseline Until Week 24|Lack of Efficacy|0
7594535|NCT01995201|26418701|P5|From Baseline Until Week 24|Lack of Efficacy|0
7594536|NCT01995201|26418702|P4|From Baseline Until Week 24|Lack of Efficacy|0
7594537|NCT01995201|26418703|P3|From Baseline Until Week 24|Lack of Efficacy|0
7594538|NCT01995201|26418704|P2|From Baseline Until Week 24|Lack of Efficacy|5
7594539|NCT01995201|26418705|P1|From Baseline Until Week 24|Lack of Efficacy|2
7594540|NCT01995201|26418699|P7|From Baseline Until Week 24|Death|0
7594541|NCT01995201|26418700|P6|From Baseline Until Week 24|Death|0
7594542|NCT01995201|26418701|P5|From Baseline Until Week 24|Death|0
7594543|NCT01995201|26418702|P4|From Baseline Until Week 24|Death|0
7594544|NCT01995201|26418703|P3|From Baseline Until Week 24|Death|0
7594545|NCT01995201|26418704|P2|From Baseline Until Week 24|Death|1
7594546|NCT01995201|26418705|P1|From Baseline Until Week 24|Death|0
7594547|NCT01995201|26418699|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7594548|NCT01995201|26418700|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7594549|NCT01995201|26418701|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7594550|NCT01995201|26418702|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7594551|NCT01995201|26418703|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7594552|NCT01995201|26418704|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
7594553|NCT01995201|26418705|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7594554|NCT01995201|26418699|P7|From Baseline Until Week 24|Adverse Event|0
7594555|NCT01995201|26418700|P6|From Baseline Until Week 24|Adverse Event|0
7594556|NCT01995201|26418701|P5|From Baseline Until Week 24|Adverse Event|0
7594557|NCT01995201|26418702|P4|From Baseline Until Week 24|Adverse Event|0
7594558|NCT01995201|26418703|P3|From Baseline Until Week 24|Adverse Event|0
7594559|NCT01995201|26418704|P2|From Baseline Until Week 24|Adverse Event|15
7594560|NCT01995201|26418705|P1|From Baseline Until Week 24|Adverse Event|4
7594565|NCT01995136|26418829|P1|Overall Study|Change in residence|1
7594566|NCT01995071|26418858|P12|Overall Study|Incarcerated|0
7594567|NCT01995071|26418859|P11|Overall Study|Incarcerated|0
7594568|NCT01995071|26418860|P10|Overall Study|Incarcerated|0
7594569|NCT01995071|26418861|P9|Overall Study|Incarcerated|0
7594570|NCT01995071|26418862|P8|Overall Study|Incarcerated|1
7594571|NCT01995071|26418863|P7|Overall Study|Incarcerated|0
7594572|NCT01995071|26418864|P6|Overall Study|Incarcerated|0
7594573|NCT01995071|26418865|P5|Overall Study|Incarcerated|0
7594574|NCT01995071|26418866|P4|Overall Study|Incarcerated|0
7594575|NCT01995071|26418867|P3|Overall Study|Incarcerated|0
7594576|NCT01995071|26418868|P2|Overall Study|Incarcerated|0
7594577|NCT01995071|26418869|P1|Overall Study|Incarcerated|0
7594578|NCT01995071|26418858|P12|Overall Study|Lost to Follow-up|0
7594579|NCT01995071|26418859|P11|Overall Study|Lost to Follow-up|0
7594580|NCT01995071|26418860|P10|Overall Study|Lost to Follow-up|0
7594581|NCT01995071|26418861|P9|Overall Study|Lost to Follow-up|1
7594582|NCT01995071|26418862|P8|Overall Study|Lost to Follow-up|1
7594583|NCT01995071|26418863|P7|Overall Study|Lost to Follow-up|0
7594584|NCT01995071|26418864|P6|Overall Study|Lost to Follow-up|0
7594585|NCT01995071|26418865|P5|Overall Study|Lost to Follow-up|0
7594586|NCT01995071|26418866|P4|Overall Study|Lost to Follow-up|0
7594587|NCT01995071|26418867|P3|Overall Study|Lost to Follow-up|0
7594588|NCT01995071|26418868|P2|Overall Study|Lost to Follow-up|0
7594589|NCT01995071|26418869|P1|Overall Study|Lost to Follow-up|1
7594590|NCT01995071|26418858|P12|Overall Study|Moved|0
7594591|NCT01995071|26418859|P11|Overall Study|Moved|1
7594592|NCT01995071|26418860|P10|Overall Study|Moved|0
7594593|NCT01995071|26418861|P9|Overall Study|Moved|0
7594594|NCT01995071|26418862|P8|Overall Study|Moved|0
7594595|NCT01995071|26418863|P7|Overall Study|Moved|0
7594596|NCT01995071|26418864|P6|Overall Study|Moved|0
7594597|NCT01995071|26418865|P5|Overall Study|Moved|1
7594598|NCT01995071|26418866|P4|Overall Study|Moved|0
7594599|NCT01995071|26418867|P3|Overall Study|Moved|1
7594600|NCT01995071|26418868|P2|Overall Study|Moved|0
7594601|NCT01995071|26418869|P1|Overall Study|Moved|0
7594602|NCT01995071|26418858|P12|Overall Study|Adverse Event|0
7594603|NCT01995071|26418859|P11|Overall Study|Adverse Event|0
7594604|NCT01995071|26418860|P10|Overall Study|Adverse Event|0
7594605|NCT01995071|26418861|P9|Overall Study|Adverse Event|0
7594606|NCT01995071|26418862|P8|Overall Study|Adverse Event|0
7594607|NCT01995071|26418863|P7|Overall Study|Adverse Event|1
7594608|NCT01995071|26418864|P6|Overall Study|Adverse Event|0
7594609|NCT01995071|26418865|P5|Overall Study|Adverse Event|0
7594610|NCT01995071|26418866|P4|Overall Study|Adverse Event|0
7594611|NCT01995071|26418867|P3|Overall Study|Adverse Event|0
7594612|NCT01995071|26418868|P2|Overall Study|Adverse Event|0
7594613|NCT01995071|26418869|P1|Overall Study|Adverse Event|0
7594614|NCT01994954|26419006|P2|Overall Study|6 Month Follow-up Not Complete|4
7594615|NCT01994954|26419007|P1|Overall Study|6 Month Follow-up Not Complete|5
7594616|NCT01994954|26419006|P2|Overall Study|Lost to Follow-up|10
7594617|NCT01994954|26419007|P1|Overall Study|Lost to Follow-up|8
7594618|NCT01994954|26419006|P2|Overall Study|Physician Decision|2
7594619|NCT01994954|26419007|P1|Overall Study|Physician Decision|2
7594620|NCT01994954|26419006|P2|Overall Study|Withdrawal by Subject|14
7594621|NCT01994954|26419007|P1|Overall Study|Withdrawal by Subject|9
7594622|NCT01994954|26419006|P2|Overall Study|Death|0
7594623|NCT01994954|26419007|P1|Overall Study|Death|1
7594624|NCT01994902|26419025|P2|Test Period 2|Other|3
7594625|NCT01994902|26419026|P1|Test Period 2|Other|0
7594626|NCT01994902|26419025|P2|Test Period 2|Lack of Efficacy|1
7594627|NCT01994902|26419026|P1|Test Period 2|Lack of Efficacy|0
7594628|NCT01994902|26419025|P2|Test Period 2|Withdrawal by Subject|2
7594629|NCT01994902|26419026|P1|Test Period 2|Withdrawal by Subject|0
7594630|NCT01994902|26419025|P2|Test Period 1|bag too small|0
7594631|NCT01994902|26419026|P1|Test Period 1|bag too small|1
7594632|NCT01994902|26419025|P2|Test Period 1|Lack of Efficacy|1
7594633|NCT01994902|26419026|P1|Test Period 1|Lack of Efficacy|0
7594634|NCT01994902|26419025|P2|Test Period 1|Adverse Event|1
7594635|NCT01994902|26419026|P1|Test Period 1|Adverse Event|2
7594636|NCT01994902|26419025|P2|Test Period 1|device deficiency with adverse event|1
7594637|NCT01994902|26419026|P1|Test Period 1|device deficiency with adverse event|0
7594638|NCT01994902|26419025|P2|Test Period 1|Withdrawal by Subject|0
7594639|NCT01994902|26419026|P1|Test Period 1|Withdrawal by Subject|3
7594640|NCT01994889|26419035|P3|Overall Study|Death|38
7594641|NCT01994889|26419036|P2|Overall Study|Death|25
7594642|NCT01994889|26419037|P1|Overall Study|Death|14
7594643|NCT01994889|26419035|P3|Overall Study|Protocol Violation|1
7594644|NCT01994889|26419036|P2|Overall Study|Protocol Violation|1
7594645|NCT01994889|26419037|P1|Overall Study|Protocol Violation|0
7594646|NCT01994889|26419035|P3|Overall Study|Lost to Follow-up|0
7594647|NCT01994889|26419036|P2|Overall Study|Lost to Follow-up|1
7594648|NCT01994889|26419037|P1|Overall Study|Lost to Follow-up|0
7594649|NCT01994889|26419035|P3|Overall Study|No longer willing to participate|37
7594650|NCT01994889|26419036|P2|Overall Study|No longer willing to participate|17
7594651|NCT01994889|26419037|P1|Overall Study|No longer willing to participate|8
7594652|NCT01994889|26419035|P3|Overall Study|Organ Transplantation|5
7594653|NCT01994889|26419036|P2|Overall Study|Organ Transplantation|5
7594654|NCT01994889|26419037|P1|Overall Study|Organ Transplantation|1
7594655|NCT01994889|26419035|P3|Overall Study|Cardiac Device Implantation|0
7594656|NCT01994889|26419036|P2|Overall Study|Cardiac Device Implantation|2
7594657|NCT01994889|26419037|P1|Overall Study|Cardiac Device Implantation|0
7594658|NCT01994889|26419035|P3|Overall Study|Adverse Event|11
7594659|NCT01994889|26419036|P2|Overall Study|Adverse Event|12
7594660|NCT01994889|26419037|P1|Overall Study|Adverse Event|5
7594661|NCT01994876|26419056|P2|Test Period 2|Protocol Violation|1
7594662|NCT01994876|26419057|P1|Test Period 2|Protocol Violation|0
7594663|NCT01994876|26419056|P2|Test Period 2|Adverse Event|0
7594664|NCT01994876|26419057|P1|Test Period 2|Adverse Event|1
7594665|NCT01994876|26419056|P2|Test Period 1|Adverse Event|1
7594666|NCT01994876|26419057|P1|Test Period 1|Adverse Event|0
7594667|NCT01994876|26419056|P2|Test Period 1|Withdrawal by Subject|1
7594668|NCT01994876|26419057|P1|Test Period 1|Withdrawal by Subject|0
7594669|NCT01994863|26419065|P2|Period 2|Withdrawal by Subject|1
7594670|NCT01994863|26419066|P1|Period 2|Withdrawal by Subject|1
7594671|NCT01994863|26419065|P2|Period 2|Lack of Efficacy|2
7594672|NCT01994863|26419066|P1|Period 2|Lack of Efficacy|0
7594673|NCT01994863|26419065|P2|Period 2|Adverse Event|1
7594674|NCT01994863|26419066|P1|Period 2|Adverse Event|0
7594675|NCT01994863|26419065|P2|Period 1|Lack of Efficacy|0
7594676|NCT01994863|26419066|P1|Period 1|Lack of Efficacy|1
7594677|NCT01994863|26419065|P2|Period 1|Trial stopped by sponsor|3
7594678|NCT01994863|26419066|P1|Period 1|Trial stopped by sponsor|1
7594679|NCT01994863|26419065|P2|Period 1|Withdrawal by Subject|0
7594680|NCT01994863|26419066|P1|Period 1|Withdrawal by Subject|1
7594681|NCT01994863|26419065|P2|Period 1|Adverse Event|0
7594682|NCT01994863|26419066|P1|Period 1|Adverse Event|4
7594683|NCT01994850|26419072|P1|Overall Study|Withdrawal by Subject|1
7594684|NCT01994850|26419072|P1|Overall Study|Physician Decision|1
7594685|NCT01994837|26419077|P1|Overall Study|Removed from study due to no response|1
7594686|NCT01994837|26419077|P1|Overall Study|Proceeded to transplant|1
7594687|NCT01994837|26419077|P1|Overall Study|Chose palliative care|1
7594688|NCT01994837|26419077|P1|Overall Study|Adverse event not related to progression|1
7594689|NCT01994837|26419077|P1|Overall Study|Fatal progressive disease|2
7594690|NCT01994837|26419077|P1|Overall Study|Adv event related to progressive disease|3
7594691|NCT01994837|26419077|P1|Overall Study|Progressive disease per protocol|23
7594692|NCT01994720|26419134|P2|Overall Study|Withdrawal by Subject|56
7594693|NCT01994720|26419135|P1|Overall Study|Withdrawal by Subject|46
7594694|NCT01994629|26419177|P2|Overall Study|Lost to Follow-up|3
7594695|NCT01994629|26419178|P1|Overall Study|Lost to Follow-up|0
7594696|NCT01994629|26419177|P2|Overall Study|Withdrawal by Subject|0
7594697|NCT01994629|26419178|P1|Overall Study|Withdrawal by Subject|1
7594698|NCT01994590|26419202|P1|Overall Study|Trial Terminated|1
7594699|NCT01994590|26419202|P1|Overall Study|Adverse Event|1
7594700|NCT01994395|26419232|P2|Overall Study|Withdrawal by Subject|2
7594701|NCT01994395|26419233|P1|Overall Study|Withdrawal by Subject|1
7594702|NCT01994291|26419258|P3|Overall Study|Other|0
7594703|NCT01994291|26419259|P2|Overall Study|Other|2
7594704|NCT01994291|26419260|P1|Overall Study|Other|1
7594705|NCT01994291|26419258|P3|Overall Study|Withdrawal by Subject|5
7594706|NCT01994291|26419259|P2|Overall Study|Withdrawal by Subject|3
7594707|NCT01994291|26419260|P1|Overall Study|Withdrawal by Subject|6
7594708|NCT01994291|26419258|P3|Overall Study|Protocol Violation|0
7594709|NCT01994291|26419259|P2|Overall Study|Protocol Violation|0
7594710|NCT01994291|26419260|P1|Overall Study|Protocol Violation|1
7594711|NCT01994291|26419258|P3|Overall Study|Medication error without associated AE|1
7594712|NCT01994291|26419259|P2|Overall Study|Medication error without associated AE|0
7594713|NCT01994291|26419260|P1|Overall Study|Medication error without associated AE|1
7594714|NCT01994291|26419258|P3|Overall Study|Does not meet entrance criteria|0
7594715|NCT01994291|26419259|P2|Overall Study|Does not meet entrance criteria|0
7594716|NCT01994291|26419260|P1|Overall Study|Does not meet entrance criteria|1
7594717|NCT01994291|26419258|P3|Overall Study|Lost to Follow-up|0
7594718|NCT01994291|26419259|P2|Overall Study|Lost to Follow-up|1
7594719|NCT01994291|26419260|P1|Overall Study|Lost to Follow-up|1
7594720|NCT01994291|26419258|P3|Overall Study|Adverse Event|3
7594721|NCT01994291|26419259|P2|Overall Study|Adverse Event|1
7594722|NCT01994291|26419260|P1|Overall Study|Adverse Event|4
7594723|NCT01994226|26419316|P2|Overall Study|Early Cessation of treatment|11
7594724|NCT01994226|26419317|P1|Overall Study|Early Cessation of treatment|6
7594725|NCT01994226|26419316|P2|Overall Study|Protocol Violation|10
7594726|NCT01994226|26419317|P1|Overall Study|Protocol Violation|13
7594727|NCT01993940|26419343|P2|Overall Study|Other - Miscellaneous|1
7594728|NCT01993940|26419344|P1|Overall Study|Other - Miscellaneous|1
7594729|NCT01993940|26419343|P2|Overall Study|Death|0
7594730|NCT01993940|26419344|P1|Overall Study|Death|1
7594731|NCT01993940|26419343|P2|Overall Study|Protocol Violation|8
7594732|NCT01993940|26419344|P1|Overall Study|Protocol Violation|5
7594733|NCT01993940|26419343|P2|Overall Study|Lost to Follow-up|5
7594734|NCT01993940|26419344|P1|Overall Study|Lost to Follow-up|2
7594735|NCT01993940|26419343|P2|Overall Study|Withdrawal by Subject|19
7594736|NCT01993940|26419344|P1|Overall Study|Withdrawal by Subject|15
7594737|NCT01993940|26419343|P2|Overall Study|Adverse Event|11
7594738|NCT01993940|26419344|P1|Overall Study|Adverse Event|16
7594739|NCT01993927|26419358|P1|Overall Study|Protocol Violation|11
7594740|NCT01993927|26419358|P1|Overall Study|Case Report Forms Uncollected|18
7594741|NCT01993888|26419366|P2|Overall Study|Withdrawal by Subject|1
7594742|NCT01993888|26419367|P1|Overall Study|Withdrawal by Subject|0
7594743|NCT01993888|26419366|P2|Overall Study|Lost to Follow-up|1
7594744|NCT01993888|26419367|P1|Overall Study|Lost to Follow-up|1
7594745|NCT01993888|26419366|P2|Overall Study|Death|1
7594746|NCT01993888|26419367|P1|Overall Study|Death|1
7594747|NCT01993836|26419416|P3|Overall Study|Withdrawal by Subject|5
7594748|NCT01993836|26419417|P2|Overall Study|Withdrawal by Subject|10
7594749|NCT01993836|26419418|P1|Overall Study|Withdrawal by Subject|12
7594750|NCT01993836|26419416|P3|Overall Study|Death|0
7594751|NCT01993836|26419417|P2|Overall Study|Death|2
7594752|NCT01993836|26419418|P1|Overall Study|Death|0
7594753|NCT01993836|26419416|P3|Overall Study|Physician Decision|0
7594754|NCT01993836|26419417|P2|Overall Study|Physician Decision|1
7594755|NCT01993836|26419418|P1|Overall Study|Physician Decision|2
7594756|NCT01993836|26419416|P3|Overall Study|Surgery Cancelled|0
7594757|NCT01993836|26419417|P2|Overall Study|Surgery Cancelled|0
7594758|NCT01993836|26419418|P1|Overall Study|Surgery Cancelled|3
7594759|NCT01993823|26419434|P2|Overall Study|Lost to Follow-up|4
7594760|NCT01993823|26419435|P1|Overall Study|Lost to Follow-up|1
7594761|NCT01993823|26419434|P2|Overall Study|Protocol Violation|1
7594762|NCT01993823|26419435|P1|Overall Study|Protocol Violation|0
7594763|NCT01993823|26419434|P2|Overall Study|Requested by the patient|11
7594764|NCT01993823|26419435|P1|Overall Study|Requested by the patient|6
7594765|NCT01993667|26419445|P2|Overall Study|Lost to Follow-up|2
7594766|NCT01993667|26419446|P1|Overall Study|Lost to Follow-up|2
7594767|NCT01993667|26419445|P2|Overall Study|Insufficient altitude reached|1
7594768|NCT01993667|26419446|P1|Overall Study|Insufficient altitude reached|3
7594769|NCT01993667|26419445|P2|Overall Study|Insufficient data to analyze|16
7594770|NCT01993667|26419446|P1|Overall Study|Insufficient data to analyze|16
7594771|NCT01993615|26419456|P2|Overall Study|Death|0
7594772|NCT01993615|26419457|P1|Overall Study|Death|1
7594773|NCT01993329|26419475|P6|Wash-out|Personal reasons|0
7594774|NCT01993329|26419476|P5|Wash-out|Personal reasons|0
7594775|NCT01993329|26419477|P4|Wash-out|Personal reasons|0
7594776|NCT01993329|26419478|P3|Wash-out|Personal reasons|0
7594777|NCT01993329|26419479|P2|Wash-out|Personal reasons|1
7594778|NCT01993329|26419480|P1|Wash-out|Personal reasons|0
7594779|NCT01993329|26419475|P6|Period 2|Adverse Event|1
7594780|NCT01993329|26419476|P5|Period 2|Adverse Event|0
7594781|NCT01993329|26419477|P4|Period 2|Adverse Event|0
7594782|NCT01993329|26419478|P3|Period 2|Adverse Event|0
7594783|NCT01993329|26419479|P2|Period 2|Adverse Event|0
7594784|NCT01993329|26419480|P1|Period 2|Adverse Event|0
7594785|NCT01993186|26419499|P2|Open-Label Extension Period|Subject Non-Compliance|0
7594786|NCT01993186|26419500|P1|Open-Label Extension Period|Subject Non-Compliance|1
7594787|NCT01993186|26419499|P2|Open-Label Extension Period|Withdrawal by Subject|5
7594788|NCT01993186|26419500|P1|Open-Label Extension Period|Withdrawal by Subject|4
7594789|NCT01993186|26419499|P2|Open-Label Extension Period|Principal Investigator Decision|0
7594790|NCT01993186|26419500|P1|Open-Label Extension Period|Principal Investigator Decision|1
7594791|NCT01993186|26419499|P2|Open-Label Extension Period|Adverse Event|0
7594792|NCT01993186|26419500|P1|Open-Label Extension Period|Adverse Event|1
7594793|NCT01993186|26419499|P2|Open-Label Extension Period|Other, Not Specified|1
7594794|NCT01993186|26419500|P1|Open-Label Extension Period|Other, Not Specified|0
7594795|NCT01993186|26419499|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
7594796|NCT01993186|26419500|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
7594797|NCT01993186|26419499|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7594798|NCT01993186|26419500|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|1
7594799|NCT01993030|26419577|P2|Overall Study|Adverse Event|4
7594800|NCT01993030|26419578|P1|Overall Study|Adverse Event|0
7594801|NCT01993017|26419595|P3|Overall Study|Ineligible after randomization|5
7594802|NCT01993017|26419596|P2|Overall Study|Ineligible after randomization|5
7594803|NCT01993017|26419597|P1|Overall Study|Ineligible after randomization|4
7594804|NCT01993017|26419595|P3|Overall Study|Other reasons|7
7594805|NCT01993017|26419596|P2|Overall Study|Other reasons|11
7594806|NCT01993017|26419597|P1|Overall Study|Other reasons|17
7594807|NCT01993017|26419595|P3|Overall Study|Dropped out|11
7594808|NCT01993017|26419596|P2|Overall Study|Dropped out|6
7594809|NCT01993017|26419597|P1|Overall Study|Dropped out|19
7594810|NCT01993017|26419595|P3|Overall Study|Could not be contacted|38
7594811|NCT01993017|26419596|P2|Overall Study|Could not be contacted|42
7594812|NCT01993017|26419597|P1|Overall Study|Could not be contacted|43
7594813|NCT01993017|26419595|P3|Overall Study|Death|18
7594814|NCT01993017|26419596|P2|Overall Study|Death|26
7594815|NCT01993017|26419597|P1|Overall Study|Death|23
7594816|NCT01992757|26419641|P1|Overall Study|2 patients excluded due to FFP given.|2
7594817|NCT01992653|26419654|P8|Overall Study|Disease Progression|0
7594818|NCT01992653|26419655|P7|Overall Study|Disease Progression|4
7594819|NCT01992653|26419656|P6|Overall Study|Disease Progression|0
7594820|NCT01992653|26419657|P5|Overall Study|Disease Progression|0
7594821|NCT01992653|26419658|P4|Overall Study|Disease Progression|0
7594822|NCT01992653|26419659|P3|Overall Study|Disease Progression|0
7594823|NCT01992653|26419660|P2|Overall Study|Disease Progression|0
7594824|NCT01992653|26419661|P1|Overall Study|Disease Progression|0
7594825|NCT01992653|26419654|P8|Overall Study|Study Completed|1
7594826|NCT01992653|26419655|P7|Overall Study|Study Completed|0
7594827|NCT01992653|26419656|P6|Overall Study|Study Completed|0
7594828|NCT01992653|26419657|P5|Overall Study|Study Completed|0
7594829|NCT01992653|26419658|P4|Overall Study|Study Completed|0
7594830|NCT01992653|26419659|P3|Overall Study|Study Completed|0
7594831|NCT01992653|26419660|P2|Overall Study|Study Completed|0
7594832|NCT01992653|26419661|P1|Overall Study|Study Completed|0
7594833|NCT01992653|26419654|P8|Overall Study|Lost to Follow-up|1
7594834|NCT01992653|26419655|P7|Overall Study|Lost to Follow-up|0
7594835|NCT01992653|26419656|P6|Overall Study|Lost to Follow-up|0
7594836|NCT01992653|26419657|P5|Overall Study|Lost to Follow-up|0
7594837|NCT01992653|26419658|P4|Overall Study|Lost to Follow-up|0
7594838|NCT01992653|26419659|P3|Overall Study|Lost to Follow-up|0
7594839|NCT01992653|26419660|P2|Overall Study|Lost to Follow-up|0
7594840|NCT01992653|26419661|P1|Overall Study|Lost to Follow-up|0
7594841|NCT01992653|26419654|P8|Overall Study|Death|2
7594842|NCT01992653|26419655|P7|Overall Study|Death|4
7594843|NCT01992653|26419656|P6|Overall Study|Death|0
7594844|NCT01992653|26419657|P5|Overall Study|Death|1
7594845|NCT01992653|26419658|P4|Overall Study|Death|0
7594846|NCT01992653|26419659|P3|Overall Study|Death|1
7594847|NCT01992653|26419660|P2|Overall Study|Death|0
7594848|NCT01992653|26419661|P1|Overall Study|Death|0
7594849|NCT01992549|26419887|P1|Overall Study|Product Switch to Extend Half Life|1
7594850|NCT01992549|26419887|P1|Overall Study|Serious Adverse Event|1
7594851|NCT01992549|26419887|P1|Overall Study|Lost to Follow-up|2
7594852|NCT01992536|26419907|P10|Overall Study|Withdrawal by Subject|0
7594853|NCT01992536|26419908|P9|Overall Study|Withdrawal by Subject|0
7594854|NCT01992536|26419909|P8|Overall Study|Withdrawal by Subject|0
7594855|NCT01992536|26419910|P7|Overall Study|Withdrawal by Subject|0
7594856|NCT01992536|26419911|P6|Overall Study|Withdrawal by Subject|0
7594857|NCT01992536|26419912|P5|Overall Study|Withdrawal by Subject|0
7594858|NCT01992536|26419913|P4|Overall Study|Withdrawal by Subject|2
7594859|NCT01992536|26419914|P3|Overall Study|Withdrawal by Subject|0
7594860|NCT01992536|26419915|P2|Overall Study|Withdrawal by Subject|1
7594861|NCT01992536|26419916|P1|Overall Study|Withdrawal by Subject|0
7594862|NCT01992536|26419907|P10|Overall Study|Lost to Follow-up|1
7594863|NCT01992536|26419908|P9|Overall Study|Lost to Follow-up|1
7594864|NCT01992536|26419909|P8|Overall Study|Lost to Follow-up|0
7594865|NCT01992536|26419910|P7|Overall Study|Lost to Follow-up|0
7594866|NCT01992536|26419911|P6|Overall Study|Lost to Follow-up|1
7594867|NCT01992536|26419912|P5|Overall Study|Lost to Follow-up|0
7594868|NCT01992536|26419913|P4|Overall Study|Lost to Follow-up|0
7594869|NCT01992536|26419914|P3|Overall Study|Lost to Follow-up|1
7594870|NCT01992536|26419915|P2|Overall Study|Lost to Follow-up|2
7594871|NCT01992536|26419916|P1|Overall Study|Lost to Follow-up|4
7594872|NCT01992536|26419907|P10|Overall Study|Administrative Reason|0
7594873|NCT01992536|26419908|P9|Overall Study|Administrative Reason|0
7594874|NCT01992536|26419909|P8|Overall Study|Administrative Reason|0
7594875|NCT01992536|26419910|P7|Overall Study|Administrative Reason|7
7594876|NCT01992536|26419911|P6|Overall Study|Administrative Reason|0
7594877|NCT01992536|26419912|P5|Overall Study|Administrative Reason|0
7594878|NCT01992536|26419913|P4|Overall Study|Administrative Reason|0
7594879|NCT01992536|26419914|P3|Overall Study|Administrative Reason|0
7594880|NCT01992536|26419915|P2|Overall Study|Administrative Reason|0
7594881|NCT01992536|26419916|P1|Overall Study|Administrative Reason|0
7594882|NCT01992159|26420185|P4|Overall Study|Death|0
7594883|NCT01992159|26420186|P3|Overall Study|Death|1
7594884|NCT01992159|26420187|P2|Overall Study|Death|0
7594885|NCT01992159|26420188|P1|Overall Study|Death|0
7594886|NCT01992159|26420185|P4|Overall Study|Adverse Event|1
7594887|NCT01992159|26420186|P3|Overall Study|Adverse Event|0
7594888|NCT01992159|26420187|P2|Overall Study|Adverse Event|1
7594889|NCT01992159|26420188|P1|Overall Study|Adverse Event|0
7594890|NCT01992159|26420185|P4|Overall Study|Withdrawal by Subject|3
7594891|NCT01992159|26420186|P3|Overall Study|Withdrawal by Subject|0
7594892|NCT01992159|26420187|P2|Overall Study|Withdrawal by Subject|7
7594893|NCT01992159|26420188|P1|Overall Study|Withdrawal by Subject|4
7594894|NCT01992107|26420241|P3|Overall Study|Withdrawal by Subject|8
7594895|NCT01992107|26420242|P2|Overall Study|Withdrawal by Subject|7
7594896|NCT01992107|26420243|P1|Overall Study|Withdrawal by Subject|13
7594897|NCT01992107|26420241|P3|Overall Study|noncompliance and were unavailable|2
7594898|NCT01992107|26420242|P2|Overall Study|noncompliance and were unavailable|3
7594899|NCT01992107|26420243|P1|Overall Study|noncompliance and were unavailable|7
7594900|NCT01992107|26420241|P3|Overall Study|Lost to Follow-up|26
7594901|NCT01992107|26420242|P2|Overall Study|Lost to Follow-up|22
7594902|NCT01992107|26420243|P1|Overall Study|Lost to Follow-up|46
7594903|NCT01992107|26420241|P3|Overall Study|Adverse Event|0
7594904|NCT01992107|26420242|P2|Overall Study|Adverse Event|1
7594905|NCT01992107|26420243|P1|Overall Study|Adverse Event|0
7594906|NCT01992107|26420241|P3|Overall Study|Administrative reasons|0
7594907|NCT01992107|26420242|P2|Overall Study|Administrative reasons|0
7594908|NCT01992107|26420243|P1|Overall Study|Administrative reasons|2
7594909|NCT01992094|26420299|P3|Overall Study|Withdrawal by Subject|4
7594910|NCT01992094|26420300|P2|Overall Study|Withdrawal by Subject|3
7594911|NCT01992094|26420301|P1|Overall Study|Withdrawal by Subject|7
7594912|NCT01992094|26420299|P3|Overall Study|Protocol Violation|1
7594913|NCT01992094|26420300|P2|Overall Study|Protocol Violation|0
7594914|NCT01992094|26420301|P1|Overall Study|Protocol Violation|1
7594915|NCT01992094|26420299|P3|Overall Study|OTHER|0
7594916|NCT01992094|26420300|P2|Overall Study|OTHER|0
7594917|NCT01992094|26420301|P1|Overall Study|OTHER|4
7594918|NCT01992094|26420299|P3|Overall Study|Lost to Follow-up|13
7594919|NCT01992094|26420300|P2|Overall Study|Lost to Follow-up|9
7594920|NCT01992094|26420301|P1|Overall Study|Lost to Follow-up|26
7594921|NCT01992094|26420299|P3|Overall Study|Death|2
7594922|NCT01992094|26420300|P2|Overall Study|Death|5
7594923|NCT01992094|26420301|P1|Overall Study|Death|5
7594924|NCT01992094|26420299|P3|Overall Study|Adverse Event|0
7594925|NCT01992094|26420300|P2|Overall Study|Adverse Event|0
7594926|NCT01992094|26420301|P1|Overall Study|Adverse Event|1
7594927|NCT01992094|26420299|P3|Overall Study|ADMINISTRATIVE REASON|1
7594928|NCT01992094|26420300|P2|Overall Study|ADMINISTRATIVE REASON|7
7594929|NCT01992094|26420301|P1|Overall Study|ADMINISTRATIVE REASON|6
7594930|NCT01991977|26420409|P1|Overall Study|Withdrew after start of treatment|5
7594931|NCT01991977|26420409|P1|Overall Study|Withdrew prior to receiving treatment|7
7594932|NCT01991795|26420461|P2|Overall Study|Site prematurely closed by sponsor|25
7594933|NCT01991795|26420462|P1|Overall Study|Site prematurely closed by sponsor|26
7594934|NCT01991795|26420461|P2|Overall Study|Withdrawal by Subject|94
7594935|NCT01991795|26420462|P1|Overall Study|Withdrawal by Subject|117
7594936|NCT01991795|26420461|P2|Overall Study|Lost to Follow-up|4
7594937|NCT01991795|26420462|P1|Overall Study|Lost to Follow-up|6
7594938|NCT01991743|26420488|P4|Overall Study|external cephalic version not performed|0
7594939|NCT01991743|26420489|P3|Overall Study|external cephalic version not performed|1
7594940|NCT01991743|26420490|P2|Overall Study|external cephalic version not performed|0
7594941|NCT01991743|26420491|P1|Overall Study|external cephalic version not performed|0
7594942|NCT01991483|26420536|P4|Dose Level 1000 mg|Protocol Violation|1
7594943|NCT01991483|26420537|P3|Dose Level 1000 mg|Protocol Violation|0
7594944|NCT01991483|26420538|P2|Dose Level 1000 mg|Protocol Violation|0
7594945|NCT01991483|26420539|P1|Dose Level 1000 mg|Protocol Violation|0
7594946|NCT01991483|26420536|P4|Dose Level 600 mg|Physician Decision|0
7594947|NCT01991483|26420537|P3|Dose Level 600 mg|Physician Decision|1
7594948|NCT01991483|26420538|P2|Dose Level 600 mg|Physician Decision|0
7594949|NCT01991483|26420539|P1|Dose Level 600 mg|Physician Decision|0
7594950|NCT01991483|26420536|P4|Dose Level 600 mg|Withdrawal by Subject|0
7594951|NCT01991483|26420537|P3|Dose Level 600 mg|Withdrawal by Subject|1
7594952|NCT01991483|26420538|P2|Dose Level 600 mg|Withdrawal by Subject|0
7594953|NCT01991483|26420539|P1|Dose Level 600 mg|Withdrawal by Subject|0
7594954|NCT01991470|26420605|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
7594955|NCT01991470|26420605|P1|Enlite 3 Period|Physician Decision|8
7594956|NCT01991470|26420605|P1|Enlite 3 Period|Physician Decision|2
7594957|NCT01991470|26420605|P1|Enlite 3 Period|Lost to Follow-up|1
7594958|NCT01991470|26420605|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
7594959|NCT01991470|26420605|P1|Enlite 1 Period|Adverse Event|1
7594960|NCT01991470|26420605|P1|Enlite 1 Period|Withdrawal by Subject|18
7594961|NCT01991314|26420619|P2|Overall Study|Lost to Follow-up|10
7594962|NCT01991314|26420620|P1|Overall Study|Lost to Follow-up|6
7594963|NCT01991314|26420619|P2|Overall Study|Adverse Event|1
7594964|NCT01991314|26420620|P1|Overall Study|Adverse Event|5
7594965|NCT01991197|26420640|P2|Overall Study|Withdrawal by Subject|0
7594966|NCT01991197|26420641|P1|Overall Study|Withdrawal by Subject|2
7594967|NCT01991197|26420640|P2|Overall Study|Physician Decision|2
7594968|NCT01991197|26420641|P1|Overall Study|Physician Decision|0
7594969|NCT01991197|26420640|P2|Overall Study|Lost to Follow-up|1
7594970|NCT01991197|26420641|P1|Overall Study|Lost to Follow-up|1
7594971|NCT01991067|26420679|P2|Overall Study|Lost to Follow-up|5
7594972|NCT01991067|26420680|P1|Overall Study|Lost to Follow-up|6
7594973|NCT01990950|26420690|P1|Overall Study|Withdrawal by Subject|6
7594974|NCT01990950|26420690|P1|Overall Study|Lost to Follow-up|2
7594975|NCT01990950|26420690|P1|Overall Study|Death|3
7594976|NCT01990859|26420698|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
7594977|NCT01990859|26420698|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
7594978|NCT01990768|26420833|P3|6-Month Follow-up|Patient at psychiatric hospital|0
7594979|NCT01990768|26420834|P2|6-Month Follow-up|Patient at psychiatric hospital|0
7594980|NCT01990768|26420835|P1|6-Month Follow-up|Patient at psychiatric hospital|1
7594981|NCT01990768|26420833|P3|6-Month Follow-up|Prisoner at time of follow-up|0
7594982|NCT01990768|26420834|P2|6-Month Follow-up|Prisoner at time of follow-up|2
7594983|NCT01990768|26420835|P1|6-Month Follow-up|Prisoner at time of follow-up|0
7594984|NCT01990768|26420833|P3|6-Month Follow-up|Prisoner at time of enrollment|1
7594985|NCT01990768|26420834|P2|6-Month Follow-up|Prisoner at time of enrollment|0
7594986|NCT01990768|26420835|P1|6-Month Follow-up|Prisoner at time of enrollment|0
7594987|NCT01990768|26420833|P3|6-Month Follow-up|Homeless|6
7594988|NCT01990768|26420834|P2|6-Month Follow-up|Homeless|3
7594989|NCT01990768|26420835|P1|6-Month Follow-up|Homeless|4
7594990|NCT01990768|26420833|P3|6-Month Follow-up|No contact information|5
7594991|NCT01990768|26420834|P2|6-Month Follow-up|No contact information|6
7594992|NCT01990768|26420835|P1|6-Month Follow-up|No contact information|5
7594993|NCT01990768|26420833|P3|6-Month Follow-up|Calls unreturned or refused contact|20
7594994|NCT01990768|26420834|P2|6-Month Follow-up|Calls unreturned or refused contact|15
7594995|NCT01990768|26420835|P1|6-Month Follow-up|Calls unreturned or refused contact|4
7594996|NCT01990768|26420833|P3|6-Month Follow-up|Withdrawal by Subject|26
7594997|NCT01990768|26420834|P2|6-Month Follow-up|Withdrawal by Subject|25
7594998|NCT01990768|26420835|P1|6-Month Follow-up|Withdrawal by Subject|25
7594999|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
7595000|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
7595001|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
7595002|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
7595003|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
7595004|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
7595005|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
7595006|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7595007|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7595008|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
7595009|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
7595010|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
7595011|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
7595012|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
7595013|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
7595014|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Other safety concern|3
7595015|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Other safety concern|2
7595016|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Other safety concern|4
7595017|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Required CPR|1
7595018|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Required CPR|7
7595019|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Required CPR|3
7595020|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
7595021|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7595022|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7595023|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
7595024|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
7595025|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
7595026|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
7595027|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
7595028|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
7595029|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
7595030|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
7595031|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
7595032|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
7595033|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
7595034|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
7595035|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
7595036|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
7595037|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
7595038|NCT01990768|26420833|P3|In-Hospital Study Drug Infusion|Discharged|13
7595039|NCT01990768|26420834|P2|In-Hospital Study Drug Infusion|Discharged|18
7595040|NCT01990768|26420835|P1|In-Hospital Study Drug Infusion|Discharged|19
7595041|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Unknown if completed|2
7595042|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Unknown if completed|4
7595043|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Unknown if completed|1
7595044|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
7595045|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
7595046|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
7595047|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7595048|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7595049|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
7595050|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Discharged|0
7595051|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Discharged|1
7595052|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Discharged|2
7595053|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Death|1
7595054|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Death|1
7595055|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Death|3
7595056|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Other safety concern|1
7595057|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Other safety concern|1
7595058|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Other safety concern|2
7595059|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Required CPR|0
7595060|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Required CPR|6
7595061|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Required CPR|2
7595062|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7595063|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
7595064|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7595065|NCT01990768|26420833|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
7595066|NCT01990768|26420834|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
7595067|NCT01990768|26420835|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
7595068|NCT01990768|26420833|P3|Intervention Started|Discovered to be pregnant|0
7595069|NCT01990768|26420834|P2|Intervention Started|Discovered to be pregnant|1
7595070|NCT01990768|26420835|P1|Intervention Started|Discovered to be pregnant|0
7595071|NCT01990768|26420833|P3|Intervention Started|Seizure or hx of seizure|2
7595072|NCT01990768|26420834|P2|Intervention Started|Seizure or hx of seizure|0
7595073|NCT01990768|26420835|P1|Intervention Started|Seizure or hx of seizure|0
7595074|NCT01990768|26420833|P3|Intervention Started|Required CPR|0
7595075|NCT01990768|26420834|P2|Intervention Started|Required CPR|1
7595076|NCT01990768|26420835|P1|Intervention Started|Required CPR|1
7595077|NCT01990768|26420833|P3|Intervention Started|IV lost|2
7595078|NCT01990768|26420834|P2|Intervention Started|IV lost|2
7595079|NCT01990768|26420835|P1|Intervention Started|IV lost|2
7595080|NCT01990768|26420833|P3|Intervention Started|Patient care priority|3
7595081|NCT01990768|26420834|P2|Intervention Started|Patient care priority|2
7595082|NCT01990768|26420835|P1|Intervention Started|Patient care priority|1
7595083|NCT01990768|26420833|P3|Intervention Started|Not enough time for EMS to enroll|0
7595084|NCT01990768|26420834|P2|Intervention Started|Not enough time for EMS to enroll|3
7595085|NCT01990768|26420835|P1|Intervention Started|Not enough time for EMS to enroll|4
7595086|NCT01990768|26420833|P3|Intervention Started|Patient became ineligible due to vitals|2
7595087|NCT01990768|26420834|P2|Intervention Started|Patient became ineligible due to vitals|5
7595088|NCT01990768|26420835|P1|Intervention Started|Patient became ineligible due to vitals|5
7595089|NCT01990768|26420833|P3|Intervention Started|Study drug issue or kit malfunction|7
7595090|NCT01990768|26420834|P2|Intervention Started|Study drug issue or kit malfunction|6
7595091|NCT01990768|26420835|P1|Intervention Started|Study drug issue or kit malfunction|9
7595092|NCT01990768|26420833|P3|Intervention Started|Found to be ineligible|11
7595093|NCT01990768|26420834|P2|Intervention Started|Found to be ineligible|13
7595094|NCT01990768|26420835|P1|Intervention Started|Found to be ineligible|14
7595095|NCT01990742|26420900|P2|Overall Study|Facility closed|270
7595096|NCT01990742|26420901|P1|Overall Study|Facility closed|0
7595097|NCT01990742|26420900|P2|Overall Study|Withdrawal by facility|1083
7595098|NCT01990742|26420901|P1|Overall Study|Withdrawal by facility|407
7595099|NCT01990664|26420937|P2|Overall Study|Unsatisfactory Visual Response|1
7595100|NCT01990664|26420938|P1|Overall Study|Unsatisfactory Visual Response|0
7595101|NCT01990664|26420937|P2|Overall Study|Lens Handling Difficulties|0
7595102|NCT01990664|26420938|P1|Overall Study|Lens Handling Difficulties|1
7595103|NCT01990664|26420937|P2|Overall Study|Lens Discomfort|1
7595104|NCT01990664|26420938|P1|Overall Study|Lens Discomfort|1
7595105|NCT01990664|26420937|P2|Overall Study|Protocol Violation|0
7595106|NCT01990664|26420938|P1|Overall Study|Protocol Violation|1
7595107|NCT01990664|26420937|P2|Overall Study|Withdrawal by Subject|3
7595108|NCT01990664|26420938|P1|Overall Study|Withdrawal by Subject|2
7595109|NCT01990664|26420937|P2|Overall Study|Lost to Follow-up|6
7595110|NCT01990664|26420938|P1|Overall Study|Lost to Follow-up|2
7595111|NCT01990612|26420946|P2|Overall Study|Withdrawal by Subject|2
7595112|NCT01990612|26420947|P1|Overall Study|Withdrawal by Subject|5
7595113|NCT01990612|26420946|P2|Overall Study|Lost to Follow-up|1
7595114|NCT01990612|26420947|P1|Overall Study|Lost to Follow-up|2
7595115|NCT01990573|26421028|P3|Overall Study|Physician Decision|1
7595116|NCT01990573|26421029|P2|Overall Study|Physician Decision|0
7595117|NCT01990573|26421030|P1|Overall Study|Physician Decision|0
7595118|NCT01990560|26421043|P1|Overall Study|Withdrawal by Subject|1
7595119|NCT01990534|26421057|P1|Overall Study|Lost to Follow-up|1
7595120|NCT01990534|26421057|P1|Overall Study|Reason not Specified|2
7595121|NCT01990534|26421057|P1|Overall Study|Withdrawal by Subject|3
7595122|NCT01990534|26421057|P1|Overall Study|Symptomatic Deterioration|1
7595123|NCT01990534|26421057|P1|Overall Study|Withdrawal of Informed Consent|2
7595124|NCT01990534|26421057|P1|Overall Study|Protocol Violation|1
7595125|NCT01990534|26421057|P1|Overall Study|Progressive disease|3
7595126|NCT01990534|26421057|P1|Overall Study|Death|22
7595127|NCT01990495|26421075|P2|Overall Study|Physician Decision|4
7595128|NCT01990495|26421076|P1|Overall Study|Physician Decision|5
7595129|NCT01990339|26421086|P1|Overall Study|Lost to Follow-up|861
7595130|NCT01990339|26421086|P1|Overall Study|Voluntary Withdrawal|1402
7595131|NCT01990339|26421086|P1|Overall Study|Data Not Available|49
7595132|NCT01990313|26421091|P1|Overall Study|Lost to Follow-up|1
7595133|NCT01990300|26421096|P1|Overall Study|Protocol Deviation|53
7595134|NCT01990300|26421096|P1|Overall Study|Case Report Forms Uncollected|89
7595135|NCT01990261|26421102|P1|Overall Study|Lost to Follow-up|2
7595136|NCT01990261|26421102|P1|Overall Study|Dossier not Approved|1
7595137|NCT01990261|26421102|P1|Overall Study|PD Before Treatment Start|1
7595138|NCT01990261|26421102|P1|Overall Study|Disease Progression (PD)|8
7595139|NCT01990261|26421102|P1|Overall Study|Death From other Causes|1
7595140|NCT01990261|26421102|P1|Overall Study|Death due to Disease Progression (PD)|10
7595141|NCT01990261|26421102|P1|Overall Study|Death Before Treatment Start|2
7595142|NCT01989754|26421159|P2|Overall Study|Closed Site|1
7595143|NCT01989754|26421160|P1|Overall Study|Closed Site|1
7595144|NCT01989754|26421159|P2|Overall Study|Lost to Follow-up|20
7595145|NCT01989754|26421160|P1|Overall Study|Lost to Follow-up|28
7595146|NCT01989754|26421159|P2|Overall Study|Withdrawal by Subject|14
7595147|NCT01989754|26421160|P1|Overall Study|Withdrawal by Subject|10
7595148|NCT01989689|26421172|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
7595149|NCT01989689|26421173|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
7595150|NCT01989689|26421172|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
7595151|NCT01989689|26421173|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
7595152|NCT01989676|26421185|P2|Overall Study|Other|3
7595153|NCT01989676|26421186|P1|Overall Study|Other|4
7595154|NCT01989676|26421185|P2|Overall Study|Participants terminated from study by Sponsor|30
7595155|NCT01989676|26421186|P1|Overall Study|Participants terminated from study by Sponsor|26
7595156|NCT01989676|26421185|P2|Overall Study|No longer willing to participate in study|26
7595157|NCT01989676|26421186|P1|Overall Study|No longer willing to participate in study|26
7595158|NCT01989676|26421185|P2|Overall Study|Lost to Follow-up|18
7595159|NCT01989676|26421186|P1|Overall Study|Lost to Follow-up|8
7595160|NCT01989676|26421185|P2|Overall Study|Protocol Violation|1
7595161|NCT01989676|26421186|P1|Overall Study|Protocol Violation|2
7595162|NCT01989676|26421185|P2|Overall Study|Death|60
7595163|NCT01989676|26421186|P1|Overall Study|Death|52
7595164|NCT01989572|26421212|P6|Overall Study|alternative therapy|3
7595165|NCT01989572|26421213|P5|Overall Study|alternative therapy|1
7595166|NCT01989572|26421214|P4|Overall Study|alternative therapy|0
7595167|NCT01989572|26421215|P3|Overall Study|alternative therapy|0
7595168|NCT01989572|26421216|P2|Overall Study|alternative therapy|0
7595169|NCT01989572|26421217|P1|Overall Study|alternative therapy|3
7595170|NCT01989572|26421212|P6|Overall Study|not start protocol therapy|18
7595171|NCT01989572|26421213|P5|Overall Study|not start protocol therapy|4
7595172|NCT01989572|26421214|P4|Overall Study|not start protocol therapy|3
7595173|NCT01989572|26421215|P3|Overall Study|not start protocol therapy|2
7595174|NCT01989572|26421216|P2|Overall Study|not start protocol therapy|1
7595175|NCT01989572|26421217|P1|Overall Study|not start protocol therapy|5
7595176|NCT01989572|26421212|P6|Overall Study|unknown/not specify|5
7595177|NCT01989572|26421213|P5|Overall Study|unknown/not specify|3
7595178|NCT01989572|26421214|P4|Overall Study|unknown/not specify|3
7595179|NCT01989572|26421215|P3|Overall Study|unknown/not specify|1
7595180|NCT01989572|26421216|P2|Overall Study|unknown/not specify|4
7595181|NCT01989572|26421217|P1|Overall Study|unknown/not specify|3
7595182|NCT01989572|26421212|P6|Overall Study|maximum dose reached|0
7595183|NCT01989572|26421213|P5|Overall Study|maximum dose reached|1
7595184|NCT01989572|26421214|P4|Overall Study|maximum dose reached|0
7595185|NCT01989572|26421215|P3|Overall Study|maximum dose reached|0
7595186|NCT01989572|26421216|P2|Overall Study|maximum dose reached|1
7595187|NCT01989572|26421217|P1|Overall Study|maximum dose reached|0
7595188|NCT01989572|26421212|P6|Overall Study|error|1
7595189|NCT01989572|26421213|P5|Overall Study|error|1
7595190|NCT01989572|26421214|P4|Overall Study|error|1
7595191|NCT01989572|26421215|P3|Overall Study|error|1
7595192|NCT01989572|26421216|P2|Overall Study|error|1
7595193|NCT01989572|26421217|P1|Overall Study|error|2
7595194|NCT01989572|26421212|P6|Overall Study|complicating disease|0
7595195|NCT01989572|26421213|P5|Overall Study|complicating disease|1
7595196|NCT01989572|26421214|P4|Overall Study|complicating disease|0
7595197|NCT01989572|26421215|P3|Overall Study|complicating disease|2
7595198|NCT01989572|26421216|P2|Overall Study|complicating disease|1
7595199|NCT01989572|26421217|P1|Overall Study|complicating disease|1
7595200|NCT01989572|26421212|P6|Overall Study|Withdrawal by Subject|4
7595201|NCT01989572|26421213|P5|Overall Study|Withdrawal by Subject|12
7595202|NCT01989572|26421214|P4|Overall Study|Withdrawal by Subject|1
7595203|NCT01989572|26421215|P3|Overall Study|Withdrawal by Subject|5
7595204|NCT01989572|26421216|P2|Overall Study|Withdrawal by Subject|1
7595205|NCT01989572|26421217|P1|Overall Study|Withdrawal by Subject|4
7595206|NCT01989572|26421212|P6|Overall Study|Death|0
7595207|NCT01989572|26421213|P5|Overall Study|Death|1
7595208|NCT01989572|26421214|P4|Overall Study|Death|0
7595209|NCT01989572|26421215|P3|Overall Study|Death|0
7595210|NCT01989572|26421216|P2|Overall Study|Death|0
7595211|NCT01989572|26421217|P1|Overall Study|Death|0
7595212|NCT01989572|26421212|P6|Overall Study|Adverse Event|0
7595213|NCT01989572|26421213|P5|Overall Study|Adverse Event|3
7595214|NCT01989572|26421214|P4|Overall Study|Adverse Event|0
7595215|NCT01989572|26421215|P3|Overall Study|Adverse Event|3
7595216|NCT01989572|26421216|P2|Overall Study|Adverse Event|1
7595217|NCT01989572|26421217|P1|Overall Study|Adverse Event|2
7595218|NCT01989572|26421212|P6|Overall Study|Lack of Efficacy|79
7595219|NCT01989572|26421213|P5|Overall Study|Lack of Efficacy|71
7595220|NCT01989572|26421214|P4|Overall Study|Lack of Efficacy|43
7595221|NCT01989572|26421215|P3|Overall Study|Lack of Efficacy|48
7595222|NCT01989572|26421216|P2|Overall Study|Lack of Efficacy|48
7595223|NCT01989572|26421217|P1|Overall Study|Lack of Efficacy|35
7595224|NCT01989546|26421245|P1|Overall Study|Disease progression on study|8
7595225|NCT01989546|26421245|P1|Overall Study|Clinical Progression|1
7595226|NCT01989468|26421254|P5|Overall Study|Death|0
7595227|NCT01989468|26421255|P4|Overall Study|Death|0
7595228|NCT01989468|26421256|P3|Overall Study|Death|1
7595229|NCT01989468|26421257|P2|Overall Study|Death|0
7595230|NCT01989468|26421258|P1|Overall Study|Death|3
7595231|NCT01989468|26421254|P5|Overall Study|Subject Guardian Decision|1
7595232|NCT01989468|26421255|P4|Overall Study|Subject Guardian Decision|4
7595233|NCT01989468|26421256|P3|Overall Study|Subject Guardian Decision|4
7595234|NCT01989468|26421257|P2|Overall Study|Subject Guardian Decision|6
7595235|NCT01989468|26421258|P1|Overall Study|Subject Guardian Decision|11
7595236|NCT01989468|26421254|P5|Overall Study|Technical Problems|0
7595237|NCT01989468|26421255|P4|Overall Study|Technical Problems|1
7595238|NCT01989468|26421256|P3|Overall Study|Technical Problems|3
7595239|NCT01989468|26421257|P2|Overall Study|Technical Problems|1
7595240|NCT01989468|26421258|P1|Overall Study|Technical Problems|3
7595241|NCT01989468|26421254|P5|Overall Study|Pregnancy|0
7595242|NCT01989468|26421255|P4|Overall Study|Pregnancy|0
7595243|NCT01989468|26421256|P3|Overall Study|Pregnancy|0
7595244|NCT01989468|26421257|P2|Overall Study|Pregnancy|1
7595245|NCT01989468|26421258|P1|Overall Study|Pregnancy|0
7595246|NCT01989468|26421254|P5|Overall Study|Physician Decision|0
7595247|NCT01989468|26421255|P4|Overall Study|Physician Decision|1
7595248|NCT01989468|26421256|P3|Overall Study|Physician Decision|0
7595249|NCT01989468|26421257|P2|Overall Study|Physician Decision|1
7595250|NCT01989468|26421258|P1|Overall Study|Physician Decision|4
7595251|NCT01989468|26421254|P5|Overall Study|Lost to Follow-up|1
7595252|NCT01989468|26421255|P4|Overall Study|Lost to Follow-up|1
7595253|NCT01989468|26421256|P3|Overall Study|Lost to Follow-up|0
7595254|NCT01989468|26421257|P2|Overall Study|Lost to Follow-up|2
7595255|NCT01989468|26421258|P1|Overall Study|Lost to Follow-up|5
7595256|NCT01989468|26421254|P5|Overall Study|Lack of Efficacy|2
7595257|NCT01989468|26421255|P4|Overall Study|Lack of Efficacy|4
7595258|NCT01989468|26421256|P3|Overall Study|Lack of Efficacy|7
7595259|NCT01989468|26421257|P2|Overall Study|Lack of Efficacy|11
7595260|NCT01989468|26421258|P1|Overall Study|Lack of Efficacy|11
7595261|NCT01989468|26421254|P5|Overall Study|Adverse Event|4
7595262|NCT01989468|26421255|P4|Overall Study|Adverse Event|5
7595263|NCT01989468|26421256|P3|Overall Study|Adverse Event|4
7595264|NCT01989468|26421257|P2|Overall Study|Adverse Event|15
7595265|NCT01989468|26421258|P1|Overall Study|Adverse Event|10
7595266|NCT01989455|26421300|P5|Overall Study|Technical problems with infusion|1
7595267|NCT01989455|26421301|P4|Overall Study|Technical problems with infusion|0
7595268|NCT01989455|26421302|P3|Overall Study|Technical problems with infusion|1
7595269|NCT01989455|26421303|P2|Overall Study|Technical problems with infusion|0
7595270|NCT01989455|26421304|P1|Overall Study|Technical problems with infusion|0
7595271|NCT01989455|26421300|P5|Overall Study|Withdrawal by Subject|0
7595272|NCT01989455|26421301|P4|Overall Study|Withdrawal by Subject|0
7595273|NCT01989455|26421302|P3|Overall Study|Withdrawal by Subject|0
7595274|NCT01989455|26421303|P2|Overall Study|Withdrawal by Subject|1
7595275|NCT01989455|26421304|P1|Overall Study|Withdrawal by Subject|0
7595276|NCT01989455|26421300|P5|Overall Study|Adverse Event|0
7595277|NCT01989455|26421301|P4|Overall Study|Adverse Event|0
7595278|NCT01989455|26421302|P3|Overall Study|Adverse Event|0
7595279|NCT01989455|26421303|P2|Overall Study|Adverse Event|1
7595280|NCT01989455|26421304|P1|Overall Study|Adverse Event|0
7595281|NCT01989208|26421345|P2|200 mg (7 Days)|Protocol Violation|1
7595282|NCT01989208|26421346|P1|200 mg (7 Days)|Protocol Violation|0
7595283|NCT01989169|26421374|P2|Period 2|Adverse Event|1
7595284|NCT01989169|26421375|P1|Period 2|Adverse Event|0
7595285|NCT01989156|26421388|P3|End of Study (Population at Day 90)|Employment Conflict|0
7595286|NCT01989156|26421389|P2|End of Study (Population at Day 90)|Employment Conflict|1
7595287|NCT01989156|26421390|P1|End of Study (Population at Day 90)|Employment Conflict|0
7595288|NCT01989156|26421388|P3|End of Study (Population at Day 90)|Moved out of state|0
7595289|NCT01989156|26421389|P2|End of Study (Population at Day 90)|Moved out of state|0
7595290|NCT01989156|26421390|P1|End of Study (Population at Day 90)|Moved out of state|1
7595291|NCT01989156|26421388|P3|End of Study (Population at Day 90)|Physician Decision|1
7595292|NCT01989156|26421389|P2|End of Study (Population at Day 90)|Physician Decision|0
7595293|NCT01989156|26421390|P1|End of Study (Population at Day 90)|Physician Decision|1
7595294|NCT01989156|26421388|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
7595295|NCT01989156|26421389|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
7595296|NCT01989156|26421390|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
7595297|NCT01989156|26421388|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
7595298|NCT01989156|26421389|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
7595299|NCT01989156|26421390|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
7595300|NCT01989156|26421388|P3|Confinement Period (Population at Day 5)|Adverse Event|1
7595301|NCT01989156|26421389|P2|Confinement Period (Population at Day 5)|Adverse Event|0
7595302|NCT01989156|26421390|P1|Confinement Period (Population at Day 5)|Adverse Event|0
7595303|NCT01989156|26421388|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
7595304|NCT01989156|26421389|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
7595305|NCT01989156|26421390|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
7595306|NCT01989156|26421388|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
7595307|NCT01989156|26421389|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7595308|NCT01989156|26421390|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
7595309|NCT01988779|26421450|P2|Overall Study|Protocol Violation|0
7595310|NCT01988779|26421451|P1|Overall Study|Protocol Violation|1
7595311|NCT01988779|26421450|P2|Overall Study|Withdrawal by Subject|2
7595312|NCT01988779|26421451|P1|Overall Study|Withdrawal by Subject|2
7595313|NCT01988662|26421467|P2|Overall Study|Adverse Event|1
7595314|NCT01988662|26421468|P1|Overall Study|Adverse Event|3
7595315|NCT01988662|26421467|P2|Overall Study|Subject/guardian decision|1
7595316|NCT01988662|26421468|P1|Overall Study|Subject/guardian decision|1
7595317|NCT01988493|26421490|P5|Overall Study|Ongoing|0
7595318|NCT01988493|26421491|P4|Overall Study|Ongoing|2
7595319|NCT01988493|26421492|P3|Overall Study|Ongoing|0
7595320|NCT01988493|26421493|P2|Overall Study|Ongoing|0
7595321|NCT01988493|26421494|P1|Overall Study|Ongoing|0
7595322|NCT01988493|26421490|P5|Overall Study|Randomized but not treated|1
7595323|NCT01988493|26421491|P4|Overall Study|Randomized but not treated|0
7595324|NCT01988493|26421492|P3|Overall Study|Randomized but not treated|0
7595325|NCT01988493|26421493|P2|Overall Study|Randomized but not treated|0
7595326|NCT01988493|26421494|P1|Overall Study|Randomized but not treated|0
7595327|NCT01988402|26421573|P2|Overall Study|Withdrawal by Subject|0
7595328|NCT01988402|26421574|P1|Overall Study|Withdrawal by Subject|1
7595329|NCT01988402|26421573|P2|Overall Study|Adverse Event|2
7595330|NCT01988402|26421574|P1|Overall Study|Adverse Event|1
7595331|NCT01988103|26421641|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7595332|NCT01988103|26421642|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7595333|NCT01988103|26421643|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7595334|NCT01988103|26421644|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
7595335|NCT01988103|26421645|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7595336|NCT01988103|26421641|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
7595337|NCT01988103|26421642|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7595338|NCT01988103|26421643|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
7595339|NCT01988103|26421644|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
7595340|NCT01988103|26421645|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7595341|NCT01988103|26421641|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7595342|NCT01988103|26421642|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7595343|NCT01988103|26421643|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
7595344|NCT01988103|26421644|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
7595345|NCT01988103|26421645|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7595346|NCT01988103|26421641|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
7595347|NCT01988103|26421642|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7595348|NCT01988103|26421643|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7595349|NCT01988103|26421644|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
7595350|NCT01988103|26421645|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
7595351|NCT01988103|26421641|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7595352|NCT01988103|26421642|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7595353|NCT01988103|26421643|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
7595354|NCT01988103|26421644|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
7595355|NCT01988103|26421645|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
7595356|NCT01988103|26421641|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7595357|NCT01988103|26421642|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7595358|NCT01988103|26421643|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7595359|NCT01988103|26421644|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7595360|NCT01988103|26421645|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
7595361|NCT01988103|26421641|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7595362|NCT01988103|26421642|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7595363|NCT01988103|26421643|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
7595364|NCT01988103|26421644|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
7595365|NCT01988103|26421645|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
7595366|NCT01988090|26421692|P2|Complete Study After Start|Protocol Violation|1
7595367|NCT01988090|26421693|P1|Complete Study After Start|Protocol Violation|1
7595368|NCT01988090|26421692|P2|Complete Study After Start|Withdrawal by Subject|0
7595369|NCT01988090|26421693|P1|Complete Study After Start|Withdrawal by Subject|2
7595370|NCT01988090|26421692|P2|Start Treament After Randomization|Protocol Violation|1
7595371|NCT01988090|26421693|P1|Start Treament After Randomization|Protocol Violation|0
7595372|NCT01988090|26421692|P2|Start Treament After Randomization|Withdrawal by Subject|3
7595373|NCT01988090|26421693|P1|Start Treament After Randomization|Withdrawal by Subject|2
7595374|NCT01988012|26421703|P1|Overall Study|Protocol Violation|1
7595375|NCT01988012|26421703|P1|Overall Study|Physician Decision|1
7595376|NCT01988012|26421703|P1|Overall Study|Lost to Follow-up|1
7595377|NCT01988012|26421703|P1|Overall Study|Patient Withdrawal of Consent|4
7595378|NCT01988012|26421703|P1|Overall Study|Insufficient Therapeutic Response|3
7595379|NCT01988012|26421703|P1|Overall Study|Adverse Event|5
7595380|NCT01987986|26421729|P4|Overall Study|Adverse Event|0
7595381|NCT01987986|26421730|P3|Overall Study|Adverse Event|2
7595382|NCT01987986|26421731|P2|Overall Study|Adverse Event|0
7595383|NCT01987986|26421732|P1|Overall Study|Adverse Event|1
7595384|NCT01987986|26421729|P4|Overall Study|Lost to Follow-up|0
7595385|NCT01987986|26421730|P3|Overall Study|Lost to Follow-up|0
7595386|NCT01987986|26421731|P2|Overall Study|Lost to Follow-up|0
7595387|NCT01987986|26421732|P1|Overall Study|Lost to Follow-up|1
7595388|NCT01987960|26421772|P4|Period 3|Administrative or other reason|43
7595389|NCT01987960|26421773|P3|Period 3|Administrative or other reason|0
7595390|NCT01987960|26421774|P2|Period 3|Administrative or other reason|0
7595391|NCT01987960|26421775|P1|Period 3|Administrative or other reason|0
7595392|NCT01987960|26421772|P4|Period 3|Lost to Follow-up|5
7595393|NCT01987960|26421773|P3|Period 3|Lost to Follow-up|0
7595394|NCT01987960|26421774|P2|Period 3|Lost to Follow-up|0
7595395|NCT01987960|26421775|P1|Period 3|Lost to Follow-up|0
7595396|NCT01987960|26421772|P4|Period 3|Withdrawal by Subject|9
7595397|NCT01987960|26421773|P3|Period 3|Withdrawal by Subject|0
7595398|NCT01987960|26421774|P2|Period 3|Withdrawal by Subject|0
7595399|NCT01987960|26421775|P1|Period 3|Withdrawal by Subject|0
7595400|NCT01987960|26421772|P4|Period 3|Protocol Violation|6
7595401|NCT01987960|26421773|P3|Period 3|Protocol Violation|0
7595402|NCT01987960|26421774|P2|Period 3|Protocol Violation|0
7595403|NCT01987960|26421775|P1|Period 3|Protocol Violation|0
7595404|NCT01987960|26421772|P4|Period 3|Non-compliance with IMP|1
7595405|NCT01987960|26421773|P3|Period 3|Non-compliance with IMP|0
7595406|NCT01987960|26421774|P2|Period 3|Non-compliance with IMP|0
7595407|NCT01987960|26421775|P1|Period 3|Non-compliance with IMP|0
7595408|NCT01987960|26421772|P4|Period 3|Adverse Event|7
7595409|NCT01987960|26421773|P3|Period 3|Adverse Event|0
7595410|NCT01987960|26421774|P2|Period 3|Adverse Event|0
7595411|NCT01987960|26421775|P1|Period 3|Adverse Event|0
7595412|NCT01987960|26421772|P4|Period 2|Administrative or other reason|0
7595413|NCT01987960|26421773|P3|Period 2|Administrative or other reason|7
7595414|NCT01987960|26421774|P2|Period 2|Administrative or other reason|5
7595415|NCT01987960|26421775|P1|Period 2|Administrative or other reason|0
7595416|NCT01987960|26421772|P4|Period 2|Withdrawal by Subject|0
7595417|NCT01987960|26421773|P3|Period 2|Withdrawal by Subject|1
7595418|NCT01987960|26421774|P2|Period 2|Withdrawal by Subject|0
7595419|NCT01987960|26421775|P1|Period 2|Withdrawal by Subject|0
7595420|NCT01987960|26421772|P4|Period 2|Adverse Event|0
7595421|NCT01987960|26421773|P3|Period 2|Adverse Event|1
7595422|NCT01987960|26421774|P2|Period 2|Adverse Event|0
7595423|NCT01987960|26421775|P1|Period 2|Adverse Event|0
7595424|NCT01987960|26421772|P4|Period 1|Withdrawal of consent before treatment|0
7595425|NCT01987960|26421773|P3|Period 1|Withdrawal of consent before treatment|0
7595426|NCT01987960|26421774|P2|Period 1|Withdrawal of consent before treatment|0
7595427|NCT01987960|26421775|P1|Period 1|Withdrawal of consent before treatment|4
7595428|NCT01987960|26421772|P4|Period 1|administrative or other reason|0
7595429|NCT01987960|26421773|P3|Period 1|administrative or other reason|0
7595430|NCT01987960|26421774|P2|Period 1|administrative or other reason|0
7595431|NCT01987960|26421775|P1|Period 1|administrative or other reason|75
7595432|NCT01987960|26421772|P4|Period 1|Lost to Follow-up|0
7595433|NCT01987960|26421773|P3|Period 1|Lost to Follow-up|0
7595434|NCT01987960|26421774|P2|Period 1|Lost to Follow-up|0
7595435|NCT01987960|26421775|P1|Period 1|Lost to Follow-up|40
7595436|NCT01987960|26421772|P4|Period 1|Withdrawal by Subject|0
7595437|NCT01987960|26421773|P3|Period 1|Withdrawal by Subject|0
7595438|NCT01987960|26421774|P2|Period 1|Withdrawal by Subject|0
7595439|NCT01987960|26421775|P1|Period 1|Withdrawal by Subject|21
7595440|NCT01987960|26421772|P4|Period 1|Protocol Violation|0
7595441|NCT01987960|26421773|P3|Period 1|Protocol Violation|0
7595442|NCT01987960|26421774|P2|Period 1|Protocol Violation|0
7595443|NCT01987960|26421775|P1|Period 1|Protocol Violation|12
7595444|NCT01987960|26421772|P4|Period 1|Non-compliance with IMP|0
7595445|NCT01987960|26421773|P3|Period 1|Non-compliance with IMP|0
7595446|NCT01987960|26421774|P2|Period 1|Non-compliance with IMP|0
7595447|NCT01987960|26421775|P1|Period 1|Non-compliance with IMP|6
7595448|NCT01987960|26421772|P4|Period 1|Lack of Efficacy|0
7595449|NCT01987960|26421773|P3|Period 1|Lack of Efficacy|0
7595450|NCT01987960|26421774|P2|Period 1|Lack of Efficacy|0
7595451|NCT01987960|26421775|P1|Period 1|Lack of Efficacy|4
7595452|NCT01987960|26421772|P4|Period 1|Adverse Event|0
7595453|NCT01987960|26421773|P3|Period 1|Adverse Event|0
7595454|NCT01987960|26421774|P2|Period 1|Adverse Event|0
7595455|NCT01987960|26421775|P1|Period 1|Adverse Event|24
7595456|NCT01987908|26421787|P3|Post-Treatment Observation Period|Other: Bad Veins|0
7595457|NCT01987908|26421788|P2|Post-Treatment Observation Period|Other: Bad Veins|1
7595458|NCT01987908|26421789|P1|Post-Treatment Observation Period|Other: Bad Veins|0
7595459|NCT01987908|26421787|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7595460|NCT01987908|26421788|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
7595461|NCT01987908|26421789|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7595462|NCT01987908|26421787|P3|Treatment Period|Adverse Event|1
7595463|NCT01987908|26421788|P2|Treatment Period|Adverse Event|1
7595464|NCT01987908|26421789|P1|Treatment Period|Adverse Event|0
7595465|NCT01987908|26421787|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7595466|NCT01987908|26421788|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7595467|NCT01987908|26421789|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
7595468|NCT01987908|26421787|P3|Placebo Lead-in Period|Withdrawal by Subject|0
7595469|NCT01987908|26421788|P2|Placebo Lead-in Period|Withdrawal by Subject|0
7595470|NCT01987908|26421789|P1|Placebo Lead-in Period|Withdrawal by Subject|1
7595471|NCT01987908|26421787|P3|Placebo Lead-in Period|Physician Decision|0
7595472|NCT01987908|26421788|P2|Placebo Lead-in Period|Physician Decision|0
7595473|NCT01987908|26421789|P1|Placebo Lead-in Period|Physician Decision|2
7595474|NCT01987908|26421787|P3|Placebo Lead-in Period|Adverse Event|0
7595475|NCT01987908|26421788|P2|Placebo Lead-in Period|Adverse Event|0
7595476|NCT01987908|26421789|P1|Placebo Lead-in Period|Adverse Event|2
7595477|NCT01987895|26421872|P2|Overall Study|randomized before giving IC|1
7595478|NCT01987895|26421873|P1|Overall Study|randomized before giving IC|0
7595479|NCT01987895|26421872|P2|Overall Study|Lost to Follow-up|5
7595480|NCT01987895|26421873|P1|Overall Study|Lost to Follow-up|3
7595481|NCT01987895|26421872|P2|Overall Study|Death|7
7595482|NCT01987895|26421873|P1|Overall Study|Death|7
7595483|NCT01987895|26421872|P2|Overall Study|Physician Decision|10
7595484|NCT01987895|26421873|P1|Overall Study|Physician Decision|8
7595485|NCT01987895|26421872|P2|Overall Study|Withdrawal by Subject|7
7595486|NCT01987895|26421873|P1|Overall Study|Withdrawal by Subject|12
7595487|NCT01987830|26421897|P1|Overall Study|Never received baseline scan|1
7595488|NCT01987765|26421901|P1|Overall Study|Lost to Follow-up|37
7595489|NCT01987765|26421901|P1|Overall Study|Protocol Violation|65
7595490|NCT01987609|26421911|P1|Overall Study|Adverse Event|1
7595491|NCT01987596|26421944|P2|Overall Study|Progressive Disease; missing all period|1
7595492|NCT01987596|26421945|P1|Overall Study|Progressive Disease; missing all period|0
7595493|NCT01987596|26421944|P2|Overall Study|Physician Decision|0
7595494|NCT01987596|26421945|P1|Overall Study|Physician Decision|1
7595495|NCT01987557|26421971|P3|Overall Study|Adverse Event|0
7595496|NCT01987557|26421972|P2|Overall Study|Adverse Event|2
7595497|NCT01987557|26421973|P1|Overall Study|Adverse Event|0
7595498|NCT01987557|26421971|P3|Overall Study|Withdrawal by Subject|2
7595499|NCT01987557|26421972|P2|Overall Study|Withdrawal by Subject|1
7595500|NCT01987557|26421973|P1|Overall Study|Withdrawal by Subject|2
7595501|NCT01987557|26421971|P3|Overall Study|Protocol Violation|1
7595502|NCT01987557|26421972|P2|Overall Study|Protocol Violation|0
7595503|NCT01987557|26421973|P1|Overall Study|Protocol Violation|1
7595504|NCT01987505|26421983|P1|Overall Study|Death|4
7595505|NCT01987505|26421983|P1|Overall Study|Investigator Decision|2
7595506|NCT01987505|26421983|P1|Overall Study|Lost to Follow-up|15
7595507|NCT01987505|26421983|P1|Overall Study|Other Reason|2
7595508|NCT01987505|26421983|P1|Overall Study|Withdrawal by Subject|2
7595509|NCT01987505|26421983|P1|Overall Study|Other|9
7595510|NCT01987479|26422013|P1|Overall Study|Adverse Event|7
7595511|NCT01987479|26422013|P1|Overall Study|Lost to Follow-up|1
7595512|NCT01987479|26422013|P1|Overall Study|Other|5
7595513|NCT01987479|26422013|P1|Overall Study|Participant/legal guardian decision|1
7595514|NCT01987479|26422013|P1|Overall Study|Physician Decision|2
7595515|NCT01987479|26422013|P1|Overall Study|Protocol Violation|1
7595516|NCT01987453|26422041|P3|Overall Study|Lack of Efficacy|0
7595517|NCT01987453|26422042|P2|Overall Study|Lack of Efficacy|12
7595518|NCT01987453|26422043|P1|Overall Study|Lack of Efficacy|1
7595519|NCT01987453|26422041|P3|Overall Study|Death|1
7595520|NCT01987453|26422042|P2|Overall Study|Death|0
7595521|NCT01987453|26422043|P1|Overall Study|Death|0
7595522|NCT01987427|26422069|P3|Overall Study|Other|0
7595523|NCT01987427|26422070|P2|Overall Study|Other|1
7595524|NCT01987427|26422071|P1|Overall Study|Other|1
7595525|NCT01987427|26422069|P3|Overall Study|Lack of Efficacy|0
7595526|NCT01987427|26422070|P2|Overall Study|Lack of Efficacy|0
7595527|NCT01987427|26422071|P1|Overall Study|Lack of Efficacy|1
7595528|NCT01987427|26422069|P3|Overall Study|Withdrawal by Subject|3
7595529|NCT01987427|26422070|P2|Overall Study|Withdrawal by Subject|1
7595530|NCT01987427|26422071|P1|Overall Study|Withdrawal by Subject|2
7595531|NCT01987427|26422069|P3|Overall Study|Lost to Follow-up|9
7595532|NCT01987427|26422070|P2|Overall Study|Lost to Follow-up|6
7595533|NCT01987427|26422071|P1|Overall Study|Lost to Follow-up|6
7595534|NCT01987427|26422069|P3|Overall Study|Adverse Event|8
7595535|NCT01987427|26422070|P2|Overall Study|Adverse Event|2
7595536|NCT01987427|26422071|P1|Overall Study|Adverse Event|4
7595537|NCT01987232|26422208|P5|Overall Study|Ongoing in Study|0
7595538|NCT01987232|26422209|P4|Overall Study|Ongoing in Study|1
7595539|NCT01987232|26422210|P3|Overall Study|Ongoing in Study|0
7595540|NCT01987232|26422211|P2|Overall Study|Ongoing in Study|0
7595541|NCT01987232|26422212|P1|Overall Study|Ongoing in Study|0
7595542|NCT01987102|26422301|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
7595543|NCT01987102|26422302|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
7595544|NCT01987102|26422301|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
7595545|NCT01987102|26422302|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
7595546|NCT01987102|26422301|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
7595547|NCT01987102|26422302|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
7595548|NCT01987102|26422301|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
7595549|NCT01987102|26422302|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
7595550|NCT01987102|26422301|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
7595551|NCT01987102|26422302|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
7595552|NCT01987102|26422301|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7595553|NCT01987102|26422302|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7595554|NCT01986985|26422349|P1|Overall Study|Scan not completed due to malfunction|3
7595555|NCT01986985|26422349|P1|Overall Study|Withdrawal by Subject|4
7595556|NCT01986920|26422386|P4|Placebo|Withdrawal by Subject|1
7595557|NCT01986920|26422387|P3|Placebo|Withdrawal by Subject|0
7595558|NCT01986920|26422388|P2|Placebo|Withdrawal by Subject|0
7595559|NCT01986920|26422389|P1|Placebo|Withdrawal by Subject|0
7595560|NCT01986920|26422386|P4|A-101 40%|Withdrawal by Subject|0
7595561|NCT01986920|26422387|P3|A-101 40%|Withdrawal by Subject|1
7595562|NCT01986920|26422388|P2|A-101 40%|Withdrawal by Subject|0
7595563|NCT01986920|26422389|P1|A-101 40%|Withdrawal by Subject|0
7595564|NCT01986920|26422386|P4|A-101 32.5%|Withdrawal by Subject|0
7595565|NCT01986920|26422387|P3|A-101 32.5%|Withdrawal by Subject|0
7595566|NCT01986920|26422388|P2|A-101 32.5%|Withdrawal by Subject|1
7595567|NCT01986920|26422389|P1|A-101 32.5%|Withdrawal by Subject|0
7595568|NCT01986920|26422386|P4|A- 101 25%|Withdrawal by Subject|0
7595569|NCT01986920|26422387|P3|A- 101 25%|Withdrawal by Subject|0
7595570|NCT01986920|26422388|P2|A- 101 25%|Withdrawal by Subject|0
7595571|NCT01986920|26422389|P1|A- 101 25%|Withdrawal by Subject|1
7595572|NCT01986907|26422403|P1|Overall Study|Death|9
7595573|NCT01986907|26422403|P1|Overall Study|Lost to Follow-up|38
7595574|NCT01986907|26422403|P1|Overall Study|Withdrawal by Subject|76
7595575|NCT01986907|26422403|P1|Overall Study|Protocol Violation|4
7595576|NCT01986907|26422403|P1|Overall Study|Unsatisfactory therapeutic effect|24
7595577|NCT01986907|26422403|P1|Overall Study|Adverse Event|11
7595578|NCT01986881|26422416|P3|Overall Study|Other|2
7595579|NCT01986881|26422417|P2|Overall Study|Other|2
7595580|NCT01986881|26422418|P1|Overall Study|Other|1
7595581|NCT01986881|26422416|P3|Overall Study|Subject Moved|0
7595582|NCT01986881|26422417|P2|Overall Study|Subject Moved|1
7595583|NCT01986881|26422418|P1|Overall Study|Subject Moved|0
7595584|NCT01986881|26422416|P3|Overall Study|Withdrawal by Subject|45
7595585|NCT01986881|26422417|P2|Overall Study|Withdrawal by Subject|60
7595586|NCT01986881|26422418|P1|Overall Study|Withdrawal by Subject|41
7595587|NCT01986881|26422416|P3|Overall Study|Study Site Terminated by Sponsor|3
7595588|NCT01986881|26422417|P2|Overall Study|Study Site Terminated by Sponsor|2
7595589|NCT01986881|26422418|P1|Overall Study|Study Site Terminated by Sponsor|2
7595590|NCT01986881|26422416|P3|Overall Study|Physician Decision|6
7595591|NCT01986881|26422417|P2|Overall Study|Physician Decision|4
7595592|NCT01986881|26422418|P1|Overall Study|Physician Decision|7
7595593|NCT01986881|26422416|P3|Overall Study|Lost to Follow-up|55
7595594|NCT01986881|26422417|P2|Overall Study|Lost to Follow-up|44
7595595|NCT01986881|26422418|P1|Overall Study|Lost to Follow-up|51
7595596|NCT01986881|26422416|P3|Overall Study|Death|247
7595597|NCT01986881|26422417|P2|Overall Study|Death|233
7595598|NCT01986881|26422418|P1|Overall Study|Death|228
7595599|NCT01986855|26422825|P3|Overall Study|Withdrawal by Subject|5
7595600|NCT01986855|26422826|P2|Overall Study|Withdrawal by Subject|8
7595601|NCT01986855|26422827|P1|Overall Study|Withdrawal by Subject|7
7595602|NCT01986855|26422825|P3|Overall Study|Participant Moved|2
7595603|NCT01986855|26422826|P2|Overall Study|Participant Moved|0
7595604|NCT01986855|26422827|P1|Overall Study|Participant Moved|0
7595605|NCT01986855|26422825|P3|Overall Study|Screen Failure|0
7595606|NCT01986855|26422826|P2|Overall Study|Screen Failure|1
7595607|NCT01986855|26422827|P1|Overall Study|Screen Failure|0
7595608|NCT01986855|26422825|P3|Overall Study|Lost to Follow-up|0
7595609|NCT01986855|26422826|P2|Overall Study|Lost to Follow-up|1
7595610|NCT01986855|26422827|P1|Overall Study|Lost to Follow-up|2
7595611|NCT01986855|26422825|P3|Overall Study|Death|4
7595612|NCT01986855|26422826|P2|Overall Study|Death|4
7595613|NCT01986855|26422827|P1|Overall Study|Death|3
7595614|NCT01986855|26422825|P3|Overall Study|Adverse Event|0
7595615|NCT01986855|26422826|P2|Overall Study|Adverse Event|0
7595616|NCT01986855|26422827|P1|Overall Study|Adverse Event|1
7595617|NCT01986829|26422856|P1|Overall Study|Death|1
7595618|NCT01986751|26422904|P2|Overall Study|improperly consented|2
7595619|NCT01986751|26422905|P1|Overall Study|improperly consented|10
7595620|NCT01986647|26422938|P4|Overall Study|Health|4
7595621|NCT01986647|26422939|P3|Overall Study|Health|6
7595622|NCT01986647|26422940|P2|Overall Study|Health|3
7595623|NCT01986647|26422941|P1|Overall Study|Health|5
7595624|NCT01986647|26422938|P4|Overall Study|Withdrawal by Subject|3
7595625|NCT01986647|26422939|P3|Overall Study|Withdrawal by Subject|2
7595626|NCT01986647|26422940|P2|Overall Study|Withdrawal by Subject|3
7595627|NCT01986647|26422941|P1|Overall Study|Withdrawal by Subject|1
7595628|NCT01986647|26422938|P4|Overall Study|Lost to Follow-up|4
7595629|NCT01986647|26422939|P3|Overall Study|Lost to Follow-up|4
7595630|NCT01986647|26422940|P2|Overall Study|Lost to Follow-up|1
7595631|NCT01986647|26422941|P1|Overall Study|Lost to Follow-up|4
7595632|NCT01986348|26423040|P4|Overall Study|Other-unspecified|2
7595633|NCT01986348|26423041|P3|Overall Study|Other-unspecified|0
7595634|NCT01986348|26423042|P2|Overall Study|Other-unspecified|1
7595635|NCT01986348|26423043|P1|Overall Study|Other-unspecified|0
7595636|NCT01986348|26423040|P4|Overall Study|Study Terminated by Sponsor|3
7595637|NCT01986348|26423041|P3|Overall Study|Study Terminated by Sponsor|0
7595638|NCT01986348|26423042|P2|Overall Study|Study Terminated by Sponsor|0
7595639|NCT01986348|26423043|P1|Overall Study|Study Terminated by Sponsor|0
7595640|NCT01986348|26423040|P4|Overall Study|Withdrawal by Participant|1
7595641|NCT01986348|26423041|P3|Overall Study|Withdrawal by Participant|2
7595642|NCT01986348|26423042|P2|Overall Study|Withdrawal by Participant|1
7595643|NCT01986348|26423043|P1|Overall Study|Withdrawal by Participant|0
7595644|NCT01986348|26423040|P4|Overall Study|Progressive Disease|0
7595645|NCT01986348|26423041|P3|Overall Study|Progressive Disease|2
7595646|NCT01986348|26423042|P2|Overall Study|Progressive Disease|0
7595647|NCT01986348|26423043|P1|Overall Study|Progressive Disease|0
7595648|NCT01986348|26423040|P4|Overall Study|Physician Decision|1
7595649|NCT01986348|26423041|P3|Overall Study|Physician Decision|0
7595650|NCT01986348|26423042|P2|Overall Study|Physician Decision|0
7595651|NCT01986348|26423043|P1|Overall Study|Physician Decision|0
7595652|NCT01986348|26423040|P4|Overall Study|Lost to Follow-up|2
7595653|NCT01986348|26423041|P3|Overall Study|Lost to Follow-up|0
7595654|NCT01986348|26423042|P2|Overall Study|Lost to Follow-up|0
7595655|NCT01986348|26423043|P1|Overall Study|Lost to Follow-up|0
7595656|NCT01986348|26423040|P4|Overall Study|Death|21
7595657|NCT01986348|26423041|P3|Overall Study|Death|10
7595658|NCT01986348|26423042|P2|Overall Study|Death|22
7595659|NCT01986348|26423043|P1|Overall Study|Death|8
7595660|NCT01986231|26423065|P1|Overall Study|Adverse Event|1
7595661|NCT01986140|26423072|P2|Overall Study|progression disease|1
7595662|NCT01986140|26423073|P1|Overall Study|progression disease|0
7595663|NCT01986140|26423072|P2|Overall Study|Adverse Event|1
7595664|NCT01986140|26423073|P1|Overall Study|Adverse Event|0
7595665|NCT01986140|26423072|P2|Overall Study|found not eligible|0
7595666|NCT01986140|26423073|P1|Overall Study|found not eligible|3
7595667|NCT01986140|26423072|P2|Overall Study|alternative treatment|1
7595668|NCT01986140|26423073|P1|Overall Study|alternative treatment|1
7595669|NCT01986140|26423072|P2|Overall Study|Withdrawal by Subject|25
7595670|NCT01986140|26423073|P1|Overall Study|Withdrawal by Subject|31
7595671|NCT01986114|26423079|P1|Overall Study|Other reason|7
7595672|NCT01986114|26423079|P1|Overall Study|Lost to Follow-up|5
7595673|NCT01986114|26423079|P1|Overall Study|Protocol Violation|1
7595674|NCT01986114|26423079|P1|Overall Study|Noncompliance|3
7595675|NCT01986114|26423079|P1|Overall Study|Withdrawal by Subject|58
7595676|NCT01986114|26423079|P1|Overall Study|Lack of Efficacy|23
7595677|NCT01986114|26423079|P1|Overall Study|Adverse Event|59
7595678|NCT01986062|26423118|P2|Overall Study|Withdrawal by Subject|1
7595679|NCT01986062|26423119|P1|Overall Study|Withdrawal by Subject|0
7595680|NCT01986062|26423118|P2|Overall Study|Lost to Follow-up|0
7595681|NCT01986062|26423119|P1|Overall Study|Lost to Follow-up|1
7595686|NCT01985334|26423245|P8|Overall Study|Lost to Follow-up|3
7595687|NCT01985334|26423246|P7|Overall Study|Lost to Follow-up|0
7595688|NCT01985334|26423247|P6|Overall Study|Lost to Follow-up|4
7595689|NCT01985334|26423248|P5|Overall Study|Lost to Follow-up|1
7595690|NCT01985334|26423249|P4|Overall Study|Lost to Follow-up|3
7595691|NCT01985334|26423250|P3|Overall Study|Lost to Follow-up|0
7595692|NCT01985334|26423251|P2|Overall Study|Lost to Follow-up|2
7595693|NCT01985334|26423252|P1|Overall Study|Lost to Follow-up|0
7595694|NCT01985334|26423245|P8|Overall Study|Investigator decision|4
7595695|NCT01985334|26423246|P7|Overall Study|Investigator decision|0
7595696|NCT01985334|26423247|P6|Overall Study|Investigator decision|1
7595697|NCT01985334|26423248|P5|Overall Study|Investigator decision|1
7595698|NCT01985334|26423249|P4|Overall Study|Investigator decision|7
7595699|NCT01985334|26423250|P3|Overall Study|Investigator decision|0
7595700|NCT01985334|26423251|P2|Overall Study|Investigator decision|3
7595701|NCT01985334|26423252|P1|Overall Study|Investigator decision|0
7595702|NCT01985334|26423245|P8|Overall Study|Use of prohibited treatment|0
7595703|NCT01985334|26423246|P7|Overall Study|Use of prohibited treatment|2
7595704|NCT01985334|26423247|P6|Overall Study|Use of prohibited treatment|6
7595705|NCT01985334|26423248|P5|Overall Study|Use of prohibited treatment|1
7595706|NCT01985334|26423249|P4|Overall Study|Use of prohibited treatment|2
7595707|NCT01985334|26423250|P3|Overall Study|Use of prohibited treatment|1
7595708|NCT01985334|26423251|P2|Overall Study|Use of prohibited treatment|4
7595709|NCT01985334|26423252|P1|Overall Study|Use of prohibited treatment|1
7595710|NCT01985334|26423245|P8|Overall Study|Medication non-compliance|3
7595711|NCT01985334|26423246|P7|Overall Study|Medication non-compliance|1
7595712|NCT01985334|26423247|P6|Overall Study|Medication non-compliance|3
7595713|NCT01985334|26423248|P5|Overall Study|Medication non-compliance|2
7595714|NCT01985334|26423249|P4|Overall Study|Medication non-compliance|6
7595715|NCT01985334|26423250|P3|Overall Study|Medication non-compliance|1
7595716|NCT01985334|26423251|P2|Overall Study|Medication non-compliance|4
7595717|NCT01985334|26423252|P1|Overall Study|Medication non-compliance|0
7595718|NCT01985334|26423245|P8|Overall Study|Other|2
7595719|NCT01985334|26423246|P7|Overall Study|Other|2
7595720|NCT01985334|26423247|P6|Overall Study|Other|6
7595721|NCT01985334|26423248|P5|Overall Study|Other|1
7595722|NCT01985334|26423249|P4|Overall Study|Other|10
7595723|NCT01985334|26423250|P3|Overall Study|Other|3
7595724|NCT01985334|26423251|P2|Overall Study|Other|2
7595725|NCT01985334|26423252|P1|Overall Study|Other|4
7595726|NCT01985334|26423245|P8|Overall Study|Adverse Event|15
7595727|NCT01985334|26423246|P7|Overall Study|Adverse Event|3
7595728|NCT01985334|26423247|P6|Overall Study|Adverse Event|18
7595729|NCT01985334|26423248|P5|Overall Study|Adverse Event|3
7595730|NCT01985334|26423249|P4|Overall Study|Adverse Event|26
7595731|NCT01985334|26423250|P3|Overall Study|Adverse Event|2
7595732|NCT01985334|26423251|P2|Overall Study|Adverse Event|8
7595733|NCT01985334|26423252|P1|Overall Study|Adverse Event|0
7595734|NCT01985334|26423245|P8|Overall Study|Subject withdrawal of consent|20
7595735|NCT01985334|26423246|P7|Overall Study|Subject withdrawal of consent|0
7595736|NCT01985334|26423247|P6|Overall Study|Subject withdrawal of consent|19
7595737|NCT01985334|26423248|P5|Overall Study|Subject withdrawal of consent|4
7595738|NCT01985334|26423249|P4|Overall Study|Subject withdrawal of consent|28
7595739|NCT01985334|26423250|P3|Overall Study|Subject withdrawal of consent|2
7595740|NCT01985334|26423251|P2|Overall Study|Subject withdrawal of consent|6
7595741|NCT01985334|26423252|P1|Overall Study|Subject withdrawal of consent|3
7595742|NCT01985334|26423245|P8|Overall Study|Moderate / severe COPD exacerbation|19
7595743|NCT01985334|26423246|P7|Overall Study|Moderate / severe COPD exacerbation|8
7595744|NCT01985334|26423247|P6|Overall Study|Moderate / severe COPD exacerbation|40
7595745|NCT01985334|26423248|P5|Overall Study|Moderate / severe COPD exacerbation|6
7595746|NCT01985334|26423249|P4|Overall Study|Moderate / severe COPD exacerbation|40
7595747|NCT01985334|26423250|P3|Overall Study|Moderate / severe COPD exacerbation|12
7595748|NCT01985334|26423251|P2|Overall Study|Moderate / severe COPD exacerbation|14
7595749|NCT01985334|26423252|P1|Overall Study|Moderate / severe COPD exacerbation|5
7595750|NCT01985334|26423245|P8|Overall Study|Protocol deviation|42
7595751|NCT01985334|26423246|P7|Overall Study|Protocol deviation|15
7595752|NCT01985334|26423247|P6|Overall Study|Protocol deviation|47
7595753|NCT01985334|26423248|P5|Overall Study|Protocol deviation|17
7595754|NCT01985334|26423249|P4|Overall Study|Protocol deviation|84
7595755|NCT01985334|26423250|P3|Overall Study|Protocol deviation|25
7595756|NCT01985334|26423251|P2|Overall Study|Protocol deviation|31
7595757|NCT01985334|26423252|P1|Overall Study|Protocol deviation|6
7595758|NCT01985334|26423245|P8|Overall Study|Other|7
7595759|NCT01985334|26423246|P7|Overall Study|Other|4
7595760|NCT01985334|26423247|P6|Overall Study|Other|8
7595761|NCT01985334|26423248|P5|Overall Study|Other|4
7595762|NCT01985334|26423249|P4|Overall Study|Other|17
7595763|NCT01985334|26423250|P3|Overall Study|Other|7
7595764|NCT01985334|26423251|P2|Overall Study|Other|9
7595765|NCT01985334|26423252|P1|Overall Study|Other|2
7595766|NCT01985334|26423245|P8|Overall Study|Worsening of disease|1
7595767|NCT01985334|26423246|P7|Overall Study|Worsening of disease|0
7595768|NCT01985334|26423247|P6|Overall Study|Worsening of disease|3
7595769|NCT01985334|26423248|P5|Overall Study|Worsening of disease|0
7595770|NCT01985334|26423249|P4|Overall Study|Worsening of disease|1
7595771|NCT01985334|26423250|P3|Overall Study|Worsening of disease|0
7595772|NCT01985334|26423251|P2|Overall Study|Worsening of disease|0
7595773|NCT01985334|26423252|P1|Overall Study|Worsening of disease|0
7595774|NCT01985334|26423245|P8|Overall Study|Death|2
7595775|NCT01985334|26423246|P7|Overall Study|Death|1
7595776|NCT01985334|26423247|P6|Overall Study|Death|0
7595777|NCT01985334|26423248|P5|Overall Study|Death|0
7595778|NCT01985334|26423249|P4|Overall Study|Death|3
7595779|NCT01985334|26423250|P3|Overall Study|Death|0
7595780|NCT01985334|26423251|P2|Overall Study|Death|0
7595781|NCT01985334|26423252|P1|Overall Study|Death|1
7595782|NCT01985334|26423245|P8|Overall Study|Administrative problems|3
7595783|NCT01985334|26423246|P7|Overall Study|Administrative problems|1
7595784|NCT01985334|26423247|P6|Overall Study|Administrative problems|1
7595785|NCT01985334|26423248|P5|Overall Study|Administrative problems|0
7595786|NCT01985334|26423249|P4|Overall Study|Administrative problems|2
7595787|NCT01985334|26423250|P3|Overall Study|Administrative problems|0
7595788|NCT01985334|26423251|P2|Overall Study|Administrative problems|1
7595789|NCT01985334|26423252|P1|Overall Study|Administrative problems|1
7595790|NCT01985321|26423320|P2|Overall Study|Subject treated wrong type of sore|0
7595791|NCT01985321|26423321|P1|Overall Study|Subject treated wrong type of sore|1
7595792|NCT01985321|26423320|P2|Overall Study|Lost to Follow-up|2
7595793|NCT01985321|26423321|P1|Overall Study|Lost to Follow-up|5
7595794|NCT01985321|26423320|P2|Overall Study|Withdrawal by Subject|0
7595795|NCT01985321|26423321|P1|Overall Study|Withdrawal by Subject|1
7595796|NCT01985321|26423320|P2|Overall Study|Protocol Violation|3
7595797|NCT01985321|26423321|P1|Overall Study|Protocol Violation|4
7595798|NCT01985126|26423331|P2|Overall Study|Withdrawal by Subject|7
7595799|NCT01985126|26423332|P1|Overall Study|Withdrawal by Subject|2
7595800|NCT01985126|26423331|P2|Overall Study|Study Terminated By Sponsor|22
7595801|NCT01985126|26423332|P1|Overall Study|Study Terminated By Sponsor|1
7595802|NCT01985126|26423331|P2|Overall Study|Lost to Follow-up|8
7595803|NCT01985126|26423332|P1|Overall Study|Lost to Follow-up|0
7595804|NCT01985126|26423331|P2|Overall Study|Death|69
7595805|NCT01985126|26423332|P1|Overall Study|Death|15
7595806|NCT01984892|26423350|P1|Overall Study|Progressive disease|7
7595807|NCT01984697|26423361|P5|Overall Study|Pregnancy|1
7595808|NCT01984697|26423362|P4|Overall Study|Pregnancy|0
7595809|NCT01984697|26423363|P3|Overall Study|Pregnancy|1
7595810|NCT01984697|26423364|P2|Overall Study|Pregnancy|0
7595811|NCT01984697|26423365|P1|Overall Study|Pregnancy|2
7595812|NCT01984697|26423361|P5|Overall Study|Death|0
7595813|NCT01984697|26423362|P4|Overall Study|Death|1
7595814|NCT01984697|26423363|P3|Overall Study|Death|0
7595815|NCT01984697|26423364|P2|Overall Study|Death|0
7595816|NCT01984697|26423365|P1|Overall Study|Death|0
7595817|NCT01984697|26423361|P5|Overall Study|Missed last follow-up visit|0
7595818|NCT01984697|26423362|P4|Overall Study|Missed last follow-up visit|0
7595819|NCT01984697|26423363|P3|Overall Study|Missed last follow-up visit|0
7595820|NCT01984697|26423364|P2|Overall Study|Missed last follow-up visit|0
7595821|NCT01984697|26423365|P1|Overall Study|Missed last follow-up visit|1
7595822|NCT01984697|26423361|P5|Overall Study|Withdrawal by Subject|13
7595823|NCT01984697|26423362|P4|Overall Study|Withdrawal by Subject|11
7595824|NCT01984697|26423363|P3|Overall Study|Withdrawal by Subject|13
7595825|NCT01984697|26423364|P2|Overall Study|Withdrawal by Subject|21
7595826|NCT01984697|26423365|P1|Overall Study|Withdrawal by Subject|15
7595827|NCT01984697|26423361|P5|Overall Study|Protocol Violation|0
7595828|NCT01984697|26423362|P4|Overall Study|Protocol Violation|2
7595829|NCT01984697|26423363|P3|Overall Study|Protocol Violation|3
7595830|NCT01984697|26423364|P2|Overall Study|Protocol Violation|5
7595831|NCT01984697|26423365|P1|Overall Study|Protocol Violation|8
7595832|NCT01984697|26423361|P5|Overall Study|Physician Decision|0
7595833|NCT01984697|26423362|P4|Overall Study|Physician Decision|1
7595834|NCT01984697|26423363|P3|Overall Study|Physician Decision|0
7595835|NCT01984697|26423364|P2|Overall Study|Physician Decision|0
7595836|NCT01984697|26423365|P1|Overall Study|Physician Decision|3
7595837|NCT01984697|26423361|P5|Overall Study|Lost to Follow-up|21
7595838|NCT01984697|26423362|P4|Overall Study|Lost to Follow-up|6
7595839|NCT01984697|26423363|P3|Overall Study|Lost to Follow-up|10
7595840|NCT01984697|26423364|P2|Overall Study|Lost to Follow-up|5
7595841|NCT01984697|26423365|P1|Overall Study|Lost to Follow-up|14
7595842|NCT01984697|26423361|P5|Overall Study|Adverse Event|0
7595843|NCT01984697|26423362|P4|Overall Study|Adverse Event|0
7595844|NCT01984697|26423363|P3|Overall Study|Adverse Event|2
7595845|NCT01984697|26423364|P2|Overall Study|Adverse Event|0
7595846|NCT01984697|26423365|P1|Overall Study|Adverse Event|0
7595847|NCT01984684|26423484|P2|Overall Study|Subject had inadequate IV access|1
7595848|NCT01984684|26423485|P1|Overall Study|Subject had inadequate IV access|0
7595849|NCT01984684|26423484|P2|Overall Study|Study drug not available at site|1
7595850|NCT01984684|26423485|P1|Overall Study|Study drug not available at site|1
7595851|NCT01984684|26423484|P2|Overall Study|Subject incarcerated|0
7595852|NCT01984684|26423485|P1|Overall Study|Subject incarcerated|1
7595853|NCT01984684|26423484|P2|Overall Study|Noncompliance with study drug|1
7595854|NCT01984684|26423485|P1|Overall Study|Noncompliance with study drug|2
7595855|NCT01984684|26423484|P2|Overall Study|Death|1
7595856|NCT01984684|26423485|P1|Overall Study|Death|0
7595857|NCT01984684|26423484|P2|Overall Study|Protocol Violation|2
7595858|NCT01984684|26423485|P1|Overall Study|Protocol Violation|4
7595859|NCT01984684|26423484|P2|Overall Study|Physician Decision|2
7595860|NCT01984684|26423485|P1|Overall Study|Physician Decision|4
7595861|NCT01984684|26423484|P2|Overall Study|Lack of Efficacy|6
7595862|NCT01984684|26423485|P1|Overall Study|Lack of Efficacy|3
7595863|NCT01984684|26423484|P2|Overall Study|Withdrawal by Subject|9
7595864|NCT01984684|26423485|P1|Overall Study|Withdrawal by Subject|9
7595865|NCT01984684|26423484|P2|Overall Study|Adverse Event|12
7595866|NCT01984684|26423485|P1|Overall Study|Adverse Event|8
7595867|NCT01984684|26423484|P2|Overall Study|Lost to Follow-up|24
7595868|NCT01984684|26423485|P1|Overall Study|Lost to Follow-up|25
7595869|NCT01984424|26423503|P2|Overall Study|Lost to Follow-up|1
7595870|NCT01984424|26423504|P1|Overall Study|Lost to Follow-up|0
7595871|NCT01984424|26423503|P2|Overall Study|Sponsor Decision|1
7595872|NCT01984424|26423504|P1|Overall Study|Sponsor Decision|0
7595873|NCT01984424|26423503|P2|Overall Study|Withdrawal by Subject|5
7595874|NCT01984424|26423504|P1|Overall Study|Withdrawal by Subject|3
7595875|NCT01984294|26423574|P3|Overall Study|Adverse Event|0
7595876|NCT01984294|26423575|P2|Overall Study|Adverse Event|1
7595877|NCT01984294|26423576|P1|Overall Study|Adverse Event|0
7595878|NCT01984294|26423574|P3|Overall Study|Lack of Efficacy|6
7595879|NCT01984294|26423575|P2|Overall Study|Lack of Efficacy|2
7595880|NCT01984294|26423576|P1|Overall Study|Lack of Efficacy|4
7595881|NCT01984294|26423574|P3|Overall Study|Randomized but Never Treated|1
7595882|NCT01984294|26423575|P2|Overall Study|Randomized but Never Treated|0
7595883|NCT01984294|26423576|P1|Overall Study|Randomized but Never Treated|0
7595884|NCT01984268|26423596|P1|Overall Study|Study Terminated|15
7595885|NCT01984242|26423608|P3|Overall Study|Disease Progression|1
7595886|NCT01984242|26423609|P2|Overall Study|Disease Progression|0
7595887|NCT01984242|26423610|P1|Overall Study|Disease Progression|0
7595888|NCT01984242|26423608|P3|Overall Study|Study terminated by Sponsor|34
7595889|NCT01984242|26423609|P2|Overall Study|Study terminated by Sponsor|50
7595890|NCT01984242|26423610|P1|Overall Study|Study terminated by Sponsor|38
7595891|NCT01984242|26423608|P3|Overall Study|Non-Compliance|0
7595892|NCT01984242|26423609|P2|Overall Study|Non-Compliance|0
7595893|NCT01984242|26423610|P1|Overall Study|Non-Compliance|1
7595894|NCT01984242|26423608|P3|Overall Study|Sponsor Decision|0
7595895|NCT01984242|26423609|P2|Overall Study|Sponsor Decision|0
7595896|NCT01984242|26423610|P1|Overall Study|Sponsor Decision|1
7595897|NCT01984242|26423608|P3|Overall Study|Lost to Follow-up|3
7595898|NCT01984242|26423609|P2|Overall Study|Lost to Follow-up|0
7595899|NCT01984242|26423610|P1|Overall Study|Lost to Follow-up|4
7595900|NCT01984242|26423608|P3|Overall Study|Physician Decision|1
7595901|NCT01984242|26423609|P2|Overall Study|Physician Decision|0
7595902|NCT01984242|26423610|P1|Overall Study|Physician Decision|0
7595903|NCT01984242|26423608|P3|Overall Study|Withdrawal by Subject|10
7595904|NCT01984242|26423609|P2|Overall Study|Withdrawal by Subject|3
7595905|NCT01984242|26423610|P1|Overall Study|Withdrawal by Subject|5
7595906|NCT01984242|26423608|P3|Overall Study|Death|52
7595907|NCT01984242|26423609|P2|Overall Study|Death|50
7595908|NCT01984242|26423610|P1|Overall Study|Death|52
7595909|NCT01984229|26423760|P2|Safety Follow-up Period|Lost to Follow-up|0
7595910|NCT01984229|26423761|P1|Safety Follow-up Period|Lost to Follow-up|1
7595911|NCT01984229|26423760|P2|Safety Follow-up Period|Adverse Event|1
7595912|NCT01984229|26423761|P1|Safety Follow-up Period|Adverse Event|1
7595913|NCT01984164|26423813|P2|Overall Study|Lost to Follow-up|3
7595914|NCT01984164|26423814|P1|Overall Study|Lost to Follow-up|1
7595915|NCT01984164|26423813|P2|Overall Study|Adverse Event|19
7595916|NCT01984164|26423814|P1|Overall Study|Adverse Event|5
7595917|NCT01984164|26423813|P2|Overall Study|Withdrawal by Subject|3
7595918|NCT01984164|26423814|P1|Overall Study|Withdrawal by Subject|4
7595919|NCT01983969|26423837|P3|Overall Study|Disease Progression|0
7595920|NCT01983969|26423838|P2|Overall Study|Disease Progression|1
7595921|NCT01983969|26423839|P1|Overall Study|Disease Progression|0
7595922|NCT01983930|26423853|P2|Overall Study|Adverse Event|1
7595923|NCT01983930|26423854|P1|Overall Study|Adverse Event|0
7595924|NCT01983930|26423853|P2|Overall Study|Withdrawal by Subject|8
7595925|NCT01983930|26423854|P1|Overall Study|Withdrawal by Subject|9
7595926|NCT01983683|26423928|P2|Overall Study|Sponsor Decision|1
7595927|NCT01983683|26423929|P1|Overall Study|Sponsor Decision|1
7595928|NCT01983683|26423928|P2|Overall Study|Lost to Follow-up|8
7595929|NCT01983683|26423929|P1|Overall Study|Lost to Follow-up|4
7595930|NCT01983683|26423928|P2|Overall Study|Physician Decision|9
7595931|NCT01983683|26423929|P1|Overall Study|Physician Decision|8
7595932|NCT01983683|26423928|P2|Overall Study|Death|15
7595933|NCT01983683|26423929|P1|Overall Study|Death|11
7595934|NCT01983683|26423928|P2|Overall Study|Withdrawal by Subject|18
7595935|NCT01983683|26423929|P1|Overall Study|Withdrawal by Subject|14
7595936|NCT01983293|26424016|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
7595937|NCT01983293|26424017|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
7595938|NCT01983293|26424016|P2|Overall Study|Missing 12-month visit|3
7595939|NCT01983293|26424017|P1|Overall Study|Missing 12-month visit|3
7595940|NCT01983293|26424016|P2|Overall Study|Withdrawal by Subject|15
7595941|NCT01983293|26424017|P1|Overall Study|Withdrawal by Subject|29
7595942|NCT01983254|26424025|P2|Overall Study|too ill|8
7595943|NCT01983254|26424026|P1|Overall Study|too ill|11
7595944|NCT01983254|26424025|P2|Overall Study|Lost to Follow-up|16
7595945|NCT01983254|26424026|P1|Overall Study|Lost to Follow-up|17
7595946|NCT01983254|26424025|P2|Overall Study|Death|6
7595947|NCT01983254|26424026|P1|Overall Study|Death|6
7595948|NCT01983111|26424057|P2|Overall Study|Protocol Violation|1
7595949|NCT01983111|26424058|P1|Overall Study|Protocol Violation|0
7595950|NCT01983111|26424057|P2|Overall Study|Adverse Event|0
7595951|NCT01983111|26424058|P1|Overall Study|Adverse Event|4
7595952|NCT01983111|26424057|P2|Overall Study|Withdrawal by Subject|6
7595953|NCT01983111|26424058|P1|Overall Study|Withdrawal by Subject|8
7595954|NCT01982955|26424096|P5|Overall Study|Ongoing|0
7595955|NCT01982955|26424097|P4|Overall Study|Ongoing|0
7595956|NCT01982955|26424098|P3|Overall Study|Ongoing|4
7595957|NCT01982955|26424099|P2|Overall Study|Ongoing|0
7595958|NCT01982955|26424100|P1|Overall Study|Ongoing|0
7595959|NCT01982955|26424096|P5|Overall Study|Randomized but not treated|0
7595960|NCT01982955|26424097|P4|Overall Study|Randomized but not treated|1
7595961|NCT01982955|26424098|P3|Overall Study|Randomized but not treated|0
7595962|NCT01982955|26424099|P2|Overall Study|Randomized but not treated|0
7595963|NCT01982955|26424100|P1|Overall Study|Randomized but not treated|0
7595964|NCT01982942|26424202|P2|Overall Study|Subject bedridden, rapidly declining|1
7595965|NCT01982942|26424203|P1|Overall Study|Subject bedridden, rapidly declining|0
7595966|NCT01982942|26424202|P2|Overall Study|Chose to join a stem cell trial|1
7595967|NCT01982942|26424203|P1|Overall Study|Chose to join a stem cell trial|0
7595968|NCT01982942|26424202|P2|Overall Study|MS Relapse|1
7595969|NCT01982942|26424203|P1|Overall Study|MS Relapse|0
7595970|NCT01982942|26424202|P2|Overall Study|Too many pills|0
7595971|NCT01982942|26424203|P1|Overall Study|Too many pills|1
7595972|NCT01982942|26424202|P2|Overall Study|Left geographical area|0
7595973|NCT01982942|26424203|P1|Overall Study|Left geographical area|2
7595974|NCT01982942|26424202|P2|Overall Study|Subject declined future visits|1
7595975|NCT01982942|26424203|P1|Overall Study|Subject declined future visits|0
7595976|NCT01982942|26424202|P2|Overall Study|Wanted to try therapy not permitted|0
7595977|NCT01982942|26424203|P1|Overall Study|Wanted to try therapy not permitted|1
7595978|NCT01982942|26424202|P2|Overall Study|Multiple sclerosis progression|2
7595979|NCT01982942|26424203|P1|Overall Study|Multiple sclerosis progression|3
7595980|NCT01982942|26424202|P2|Overall Study|Lost to Follow-up|3
7595981|NCT01982942|26424203|P1|Overall Study|Lost to Follow-up|4
7595982|NCT01982942|26424202|P2|Overall Study|Adverse Event|5
7595983|NCT01982942|26424203|P1|Overall Study|Adverse Event|10
7595984|NCT01982812|26424221|P2|Overall Study|Adverse Event|5
7595985|NCT01982812|26424222|P1|Overall Study|Adverse Event|0
7595986|NCT01982812|26424221|P2|Overall Study|Death|5
7595987|NCT01982812|26424222|P1|Overall Study|Death|1
7595988|NCT01982773|26424251|P2|Overall Study|Lost to Follow-up|1
7595989|NCT01982773|26424252|P1|Overall Study|Lost to Follow-up|7
7595990|NCT01982773|26424251|P2|Overall Study|Withdrawal by Subject|3
7595991|NCT01982773|26424252|P1|Overall Study|Withdrawal by Subject|1
7595992|NCT01982682|26424273|P1|Overall Study|Physician Decision|1
7595993|NCT01982448|26424293|P2|Preoperative Chemotherapy|Lost to Follow-up|1
7595994|NCT01982448|26424294|P1|Preoperative Chemotherapy|Lost to Follow-up|0
7595995|NCT01982448|26424293|P2|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
7595996|NCT01982448|26424294|P1|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
7595997|NCT01982448|26424293|P2|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
7595998|NCT01982448|26424294|P1|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
7595999|NCT01982448|26424293|P2|Preoperative Chemotherapy|Withdrawal by Subject|2
7596000|NCT01982448|26424294|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
7596001|NCT01982435|26424314|P2|Overall Study|Adverse Event|0
7596002|NCT01982435|26424315|P1|Overall Study|Adverse Event|1
7596003|NCT01982331|26424354|P2|Completed Study (Day 112)|Withdrawal by Subject|0
7596004|NCT01982331|26424355|P1|Completed Study (Day 112)|Withdrawal by Subject|2
7596005|NCT01982331|26424354|P2|Received Vaccination 2|Withdrawal by Subject|1
7596006|NCT01982331|26424355|P1|Received Vaccination 2|Withdrawal by Subject|0
7596007|NCT01982331|26424354|P2|Received Vaccination 2|Adverse Event|2
7596008|NCT01982331|26424355|P1|Received Vaccination 2|Adverse Event|1
7596009|NCT01982292|26424391|P2|Overall Study|Technical Problems|0
7596010|NCT01982292|26424392|P1|Overall Study|Technical Problems|2
7596011|NCT01982292|26424391|P2|Overall Study|Patient/Guardian Decision|1
7596012|NCT01982292|26424392|P1|Overall Study|Patient/Guardian Decision|3
7596013|NCT01982292|26424391|P2|Overall Study|Protocol Deviation|0
7596014|NCT01982292|26424392|P1|Overall Study|Protocol Deviation|1
7596015|NCT01982292|26424391|P2|Overall Study|Non-Compliance With Study Treatment|0
7596016|NCT01982292|26424392|P1|Overall Study|Non-Compliance With Study Treatment|1
7596017|NCT01982292|26424391|P2|Overall Study|Lost to Follow-up|0
7596018|NCT01982292|26424392|P1|Overall Study|Lost to Follow-up|2
7596019|NCT01982292|26424391|P2|Overall Study|Death|0
7596020|NCT01982292|26424392|P1|Overall Study|Death|1
7596021|NCT01982292|26424391|P2|Overall Study|Adverse Event|0
7596022|NCT01982292|26424392|P1|Overall Study|Adverse Event|2
7596023|NCT01982253|26424413|P3|Overall Study|Study terminated by sponsor|4
7596024|NCT01982253|26424414|P2|Overall Study|Study terminated by sponsor|4
7596025|NCT01982253|26424415|P1|Overall Study|Study terminated by sponsor|1
7596026|NCT01982253|26424413|P3|Overall Study|Withdrawal by Subject|0
7596027|NCT01982253|26424414|P2|Overall Study|Withdrawal by Subject|0
7596028|NCT01982253|26424415|P1|Overall Study|Withdrawal by Subject|1
7596029|NCT01981954|26424469|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
7596030|NCT01981954|26424469|P1|Titration Period|Protocol Deviation|1
7596031|NCT01981616|26424553|P2|Overall Study|Protocol Violation|0
7596032|NCT01981616|26424554|P1|Overall Study|Protocol Violation|1
7596033|NCT01981616|26424553|P2|Overall Study|Adverse Event|1
7596034|NCT01981616|26424554|P1|Overall Study|Adverse Event|0
7596035|NCT01981551|26424584|P1|Overall Study|Adverse Event|1
7596036|NCT01981551|26424584|P1|Overall Study|Refused further treatment|8
7596037|NCT01981473|26424594|P3|Overall Study|Received treatment for >24 months|6
7596038|NCT01981473|26424595|P2|Overall Study|Received treatment for >24 months|0
7596039|NCT01981473|26424596|P1|Overall Study|Received treatment for >24 months|2
7596040|NCT01981473|26424594|P3|Overall Study|Received treatment for < 6 months|1
7596041|NCT01981473|26424595|P2|Overall Study|Received treatment for < 6 months|0
7596042|NCT01981473|26424596|P1|Overall Study|Received treatment for < 6 months|0
7596043|NCT01981473|26424594|P3|Overall Study|Incorrect diagnosis of RA|1
7596044|NCT01981473|26424595|P2|Overall Study|Incorrect diagnosis of RA|0
7596045|NCT01981473|26424596|P1|Overall Study|Incorrect diagnosis of RA|0
7596046|NCT01981356|26424637|P2|Overall Study|Protocol Violation|0
7596047|NCT01981356|26424638|P1|Overall Study|Protocol Violation|2
7596048|NCT01981356|26424637|P2|Overall Study|Withdrawal by Subject|1
7596049|NCT01981356|26424638|P1|Overall Study|Withdrawal by Subject|1
7596050|NCT01981356|26424637|P2|Overall Study|Lost to Follow-up|1
7596051|NCT01981356|26424638|P1|Overall Study|Lost to Follow-up|4
7596052|NCT01981187|26424663|P1|Overall Study|Adverse Event|7
7596053|NCT01981187|26424663|P1|Overall Study|Disease progression|2
7596054|NCT01981187|26424663|P1|Overall Study|Physician Decision|1
7596055|NCT01981187|26424663|P1|Overall Study|Participant/guardian decision|2
7596056|NCT01981122|26424682|P2|Overall Study|Death|15
7596057|NCT01981122|26424683|P1|Overall Study|Death|14
7596058|NCT01981122|26424682|P2|Overall Study|Investigator Or Dendreon Discretion|1
7596059|NCT01981122|26424683|P1|Overall Study|Investigator Or Dendreon Discretion|0
7596060|NCT01981122|26424682|P2|Overall Study|Lost to Follow-up|1
7596061|NCT01981122|26424683|P1|Overall Study|Lost to Follow-up|0
7596062|NCT01981122|26424682|P2|Overall Study|Protocol Violation|1
7596063|NCT01981122|26424683|P1|Overall Study|Protocol Violation|0
7596064|NCT01981122|26424682|P2|Overall Study|Withdrawal by Subject|2
7596065|NCT01981122|26424683|P1|Overall Study|Withdrawal by Subject|0
7596066|NCT01981109|26424689|P1|Overall Study|No data available|2
7596067|NCT01981109|26424689|P1|Overall Study|Study Termination|100
7596068|NCT01981109|26424689|P1|Overall Study|No Discontinuation Documentation|37
7596069|NCT01981109|26424689|P1|Overall Study|Lost to Follow-up|9
7596070|NCT01981109|26424689|P1|Overall Study|Withdrawal by Subject|40
7596071|NCT01981109|26424689|P1|Overall Study|Death|36
7596072|NCT01981096|26424696|P2|Overall Study|Lost to Follow-up|0
7596073|NCT01981096|26424697|P1|Overall Study|Lost to Follow-up|2
7596074|NCT01981096|26424696|P2|Overall Study|Withdrawal by Subject|1
7596075|NCT01981096|26424697|P1|Overall Study|Withdrawal by Subject|0
7596076|NCT01981096|26424696|P2|Overall Study|Parent illness|0
7596077|NCT01981096|26424697|P1|Overall Study|Parent illness|1
7596078|NCT01980992|26424718|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
7596079|NCT01980992|26424719|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
7596080|NCT01980992|26424718|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
7596081|NCT01980992|26424719|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
7596082|NCT01980992|26424718|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
7596083|NCT01980992|26424719|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
7596084|NCT01980992|26424718|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
7596085|NCT01980992|26424719|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
7596086|NCT01980992|26424718|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7596087|NCT01980992|26424719|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7596088|NCT01980992|26424718|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
7596089|NCT01980992|26424719|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
7596090|NCT01980940|26424744|P8|Overall Study|Protocol Violation|0
7596091|NCT01980940|26424745|P7|Overall Study|Protocol Violation|0
7596092|NCT01980940|26424746|P6|Overall Study|Protocol Violation|2
7596093|NCT01980940|26424747|P5|Overall Study|Protocol Violation|0
7596094|NCT01980940|26424748|P4|Overall Study|Protocol Violation|0
7596095|NCT01980940|26424749|P3|Overall Study|Protocol Violation|0
7596096|NCT01980940|26424750|P2|Overall Study|Protocol Violation|0
7596097|NCT01980940|26424751|P1|Overall Study|Protocol Violation|0
7596098|NCT01980888|26424810|P2|Overall Study|Non-Compliance with Study Drug|2
7596099|NCT01980888|26424811|P1|Overall Study|Non-Compliance with Study Drug|3
7596100|NCT01980888|26424810|P2|Overall Study|Investigator's Discretion|3
7596101|NCT01980888|26424811|P1|Overall Study|Investigator's Discretion|8
7596102|NCT01980888|26424810|P2|Overall Study|Withdrew Consent|6
7596103|NCT01980888|26424811|P1|Overall Study|Withdrew Consent|17
7596104|NCT01980888|26424810|P2|Overall Study|Study Terminated by Sponsor|122
7596105|NCT01980888|26424811|P1|Overall Study|Study Terminated by Sponsor|116
7596106|NCT01980875|26424830|P3|Overall Study|Lost to Follow-up|1
7596107|NCT01980875|26424831|P2|Overall Study|Lost to Follow-up|0
7596108|NCT01980875|26424832|P1|Overall Study|Lost to Follow-up|0
7596109|NCT01980875|26424830|P3|Overall Study|Study Terminated by Sponsor|22
7596110|NCT01980875|26424831|P2|Overall Study|Study Terminated by Sponsor|24
7596111|NCT01980875|26424832|P1|Overall Study|Study Terminated by Sponsor|7
7596112|NCT01980875|26424830|P3|Overall Study|Withdrew Consent|1
7596113|NCT01980875|26424831|P2|Overall Study|Withdrew Consent|1
7596114|NCT01980875|26424832|P1|Overall Study|Withdrew Consent|1
7596115|NCT01980706|26424867|P3|Overall Study|miscellaneous|3
7596116|NCT01980706|26424868|P2|Overall Study|miscellaneous|5
7596117|NCT01980706|26424869|P1|Overall Study|miscellaneous|4
7596118|NCT01980706|26424867|P3|Overall Study|Lost to Follow-up|3
7596119|NCT01980706|26424868|P2|Overall Study|Lost to Follow-up|4
7596120|NCT01980706|26424869|P1|Overall Study|Lost to Follow-up|3
7596121|NCT01980706|26424867|P3|Overall Study|Adverse Event|5
7596122|NCT01980706|26424868|P2|Overall Study|Adverse Event|2
7596123|NCT01980706|26424869|P1|Overall Study|Adverse Event|1
7596124|NCT01980706|26424867|P3|Overall Study|Withdrawal by Subject|2
7596125|NCT01980706|26424868|P2|Overall Study|Withdrawal by Subject|6
7596126|NCT01980706|26424869|P1|Overall Study|Withdrawal by Subject|9
7596127|NCT01980628|26424909|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
7596128|NCT01980628|26424909|P1|Overall Study|Withdrawal by Subject|4
7596129|NCT01980628|26424909|P1|Overall Study|Physician Decision|5
7596130|NCT01980628|26424909|P1|Overall Study|Adverse Event|12
7596131|NCT01980095|26424968|P2|Overall Study|Randomized by mistake|0
7596132|NCT01980095|26424969|P1|Overall Study|Randomized by mistake|1
7596133|NCT01980095|26424968|P2|Overall Study|Study drug discontinued|0
7596134|NCT01980095|26424969|P1|Overall Study|Study drug discontinued|1
7596135|NCT01980095|26424968|P2|Overall Study|Safety issue|1
7596136|NCT01980095|26424969|P1|Overall Study|Safety issue|0
7596137|NCT01980095|26424968|P2|Overall Study|Poor compliance|0
7596138|NCT01980095|26424969|P1|Overall Study|Poor compliance|5
7596139|NCT01980095|26424968|P2|Overall Study|Withdrawal by Subject|3
7596140|NCT01980095|26424969|P1|Overall Study|Withdrawal by Subject|2
7596141|NCT01980095|26424968|P2|Overall Study|Lost to Follow-up|7
7596142|NCT01980095|26424969|P1|Overall Study|Lost to Follow-up|6
7596143|NCT01980056|26424980|P3|Overall Study|Death|0
7596144|NCT01980056|26424981|P2|Overall Study|Death|1
7596145|NCT01980056|26424982|P1|Overall Study|Death|1
7596146|NCT01979952|26424996|P2|Overall Study|Other than specified above|0
7596147|NCT01979952|26424997|P1|Overall Study|Other than specified above|1
7596148|NCT01979952|26424996|P2|Overall Study|Withdrawal by Subject|1
7596149|NCT01979952|26424997|P1|Overall Study|Withdrawal by Subject|2
7596150|NCT01979952|26424996|P2|Overall Study|Protocol Violation|0
7596151|NCT01979952|26424997|P1|Overall Study|Protocol Violation|1
7596152|NCT01979952|26424996|P2|Overall Study|Adverse Event|5
7596153|NCT01979952|26424997|P1|Overall Study|Adverse Event|4
7596154|NCT01979835|26425025|P1|Follow-up|Lost to Follow-up|32
7596155|NCT01979835|26425025|P1|Primary Outcome SA Measurment|failed insertion|18
7596156|NCT01979614|26425032|P2|Overall Study|Adverse Event|1
7596157|NCT01979614|26425033|P1|Overall Study|Adverse Event|1
7596158|NCT01979523|26425055|P2|Overall Study|Withdrawal by Subject|0
7596159|NCT01979523|26425056|P1|Overall Study|Withdrawal by Subject|1
7596160|NCT01979185|26425116|P2|Period 2|Other|1
7596161|NCT01979185|26425117|P1|Period 2|Other|0
7596162|NCT01979016|26425165|P2|Overall Study|Adverse Event|1
7596163|NCT01979016|26425166|P1|Overall Study|Adverse Event|0
7596164|NCT01979016|26425165|P2|Overall Study|Withdrawal by Subject|0
7596165|NCT01979016|26425166|P1|Overall Study|Withdrawal by Subject|2
7596166|NCT01978938|26425200|P2|Overall Study|Previously scheduled procedure|1
7596167|NCT01978938|26425201|P1|Overall Study|Previously scheduled procedure|0
7596168|NCT01978938|26425200|P2|Overall Study|Did not meet inclusion criteria|1
7596169|NCT01978938|26425201|P1|Overall Study|Did not meet inclusion criteria|0
7596170|NCT01978938|26425200|P2|Overall Study|Participant noncompliance|1
7596171|NCT01978938|26425201|P1|Overall Study|Participant noncompliance|1
7596172|NCT01978938|26425200|P2|Overall Study|Adverse Event, non-fatal|1
7596173|NCT01978938|26425201|P1|Overall Study|Adverse Event, non-fatal|2
7596174|NCT01978938|26425200|P2|Overall Study|Withdrawal by Subject|4
7596175|NCT01978938|26425201|P1|Overall Study|Withdrawal by Subject|8
7596176|NCT01978938|26425200|P2|Overall Study|Lost to Follow-up|6
7596177|NCT01978938|26425201|P1|Overall Study|Lost to Follow-up|12
7596178|NCT01978912|26425215|P4|Overall Study|Intradiscal Steroid Injection|0
7596179|NCT01978912|26425216|P3|Overall Study|Intradiscal Steroid Injection|0
7596180|NCT01978912|26425217|P2|Overall Study|Intradiscal Steroid Injection|1
7596181|NCT01978912|26425218|P1|Overall Study|Intradiscal Steroid Injection|0
7596182|NCT01978912|26425215|P4|Overall Study|Lumbar Surgery|0
7596183|NCT01978912|26425216|P3|Overall Study|Lumbar Surgery|1
7596184|NCT01978912|26425217|P2|Overall Study|Lumbar Surgery|0
7596185|NCT01978912|26425218|P1|Overall Study|Lumbar Surgery|1
7596186|NCT01978912|26425215|P4|Overall Study|Withdrawal by Subject|2
7596187|NCT01978912|26425216|P3|Overall Study|Withdrawal by Subject|2
7596188|NCT01978912|26425217|P2|Overall Study|Withdrawal by Subject|0
7596189|NCT01978912|26425218|P1|Overall Study|Withdrawal by Subject|1
7596190|NCT01978912|26425215|P4|Overall Study|Lost to Follow-up|1
7596191|NCT01978912|26425216|P3|Overall Study|Lost to Follow-up|0
7596192|NCT01978912|26425217|P2|Overall Study|Lost to Follow-up|1
7596193|NCT01978912|26425218|P1|Overall Study|Lost to Follow-up|1
7596194|NCT01978912|26425215|P4|Overall Study|Adverse Event|0
7596195|NCT01978912|26425216|P3|Overall Study|Adverse Event|0
7596196|NCT01978912|26425217|P2|Overall Study|Adverse Event|1
7596197|NCT01978912|26425218|P1|Overall Study|Adverse Event|0
7596198|NCT01978262|26425411|P1|Overall Study|Lost to Follow-up|2
7596199|NCT01978262|26425411|P1|Overall Study|Withdrawal by Subject|9
7596200|NCT01978236|26425416|P1|Overall Study|Discontinued due to study close|2
7596201|NCT01978184|26425437|P2|Overall Study|Withdrew- toxicities or physical decline|8
7596202|NCT01978184|26425438|P1|Overall Study|Withdrew- toxicities or physical decline|4
7596203|NCT01978184|26425437|P2|Overall Study|Death|0
7596204|NCT01978184|26425438|P1|Overall Study|Death|1
7596205|NCT01978184|26425437|P2|Overall Study|Noncompliance|2
7596206|NCT01978184|26425438|P1|Overall Study|Noncompliance|1
7596207|NCT01978184|26425437|P2|Overall Study|Physician Decision|3
7596208|NCT01978184|26425438|P1|Overall Study|Physician Decision|0
7596209|NCT01978184|26425437|P2|Overall Study|Other than PDA|2
7596210|NCT01978184|26425438|P1|Overall Study|Other than PDA|2
7596211|NCT01978184|26425437|P2|Overall Study|Progressive disease|5
7596212|NCT01978184|26425438|P1|Overall Study|Progressive disease|5
7596213|NCT01978145|26425464|P2|Treatment Period 2|Par. reached defined stopping criteria|5
7596214|NCT01978145|26425465|P1|Treatment Period 2|Par. reached defined stopping criteria|8
7596215|NCT01978145|26425464|P2|Treatment Period 2|Withdrawal by Subject|4
7596216|NCT01978145|26425465|P1|Treatment Period 2|Withdrawal by Subject|7
7596217|NCT01978145|26425464|P2|Treatment Period 2|Lost to Follow-up|1
7596218|NCT01978145|26425465|P1|Treatment Period 2|Lost to Follow-up|1
7596219|NCT01978145|26425464|P2|Treatment Period 2|Protocol Violation|1
7596220|NCT01978145|26425465|P1|Treatment Period 2|Protocol Violation|0
7596221|NCT01978145|26425464|P2|Treatment Period 2|Adverse Event|3
7596222|NCT01978145|26425465|P1|Treatment Period 2|Adverse Event|3
7596223|NCT01978145|26425464|P2|Washout Period 1|Par. reached defined stopping criteria|1
7596224|NCT01978145|26425465|P1|Washout Period 1|Par. reached defined stopping criteria|0
7596225|NCT01978145|26425464|P2|Washout Period 1|Withdrawal by Subject|1
7596226|NCT01978145|26425465|P1|Washout Period 1|Withdrawal by Subject|1
7596227|NCT01978145|26425464|P2|Washout Period 1|Adverse Event|1
7596228|NCT01978145|26425465|P1|Washout Period 1|Adverse Event|0
7596229|NCT01978145|26425464|P2|Treatment Period 1|Par. reached defined stopping criteria|3
7596230|NCT01978145|26425465|P1|Treatment Period 1|Par. reached defined stopping criteria|2
7596231|NCT01978145|26425464|P2|Treatment Period 1|Withdrawal by Subject|4
7596232|NCT01978145|26425465|P1|Treatment Period 1|Withdrawal by Subject|5
7596233|NCT01978145|26425464|P2|Treatment Period 1|Physician Decision|0
7596234|NCT01978145|26425465|P1|Treatment Period 1|Physician Decision|1
7596235|NCT01978145|26425464|P2|Treatment Period 1|Adverse Event|9
7596236|NCT01978145|26425465|P1|Treatment Period 1|Adverse Event|1
7596237|NCT01978119|26425481|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7596238|NCT01978119|26425482|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7596239|NCT01978119|26425481|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7596240|NCT01978119|26425482|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7596241|NCT01978119|26425481|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
7596242|NCT01978119|26425482|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
7596243|NCT01978093|26425508|P2|Overall Study|N/A for vaccine administration|1
7596244|NCT01978093|26425509|P1|Overall Study|N/A for vaccine administration|0
7596245|NCT01978093|26425508|P2|Overall Study|Child was in care of grandmother|1
7596246|NCT01978093|26425509|P1|Overall Study|Child was in care of grandmother|0
7596247|NCT01978093|26425508|P2|Overall Study|Mother lost custody of child|1
7596248|NCT01978093|26425509|P1|Overall Study|Mother lost custody of child|0
7596249|NCT01978093|26425508|P2|Overall Study|Lost kaiser health plan unable to contac|0
7596250|NCT01978093|26425509|P1|Overall Study|Lost kaiser health plan unable to contac|1
7596251|NCT01978093|26425508|P2|Overall Study|Loss of kaiser coverage|10
7596252|NCT01978093|26425509|P1|Overall Study|Loss of kaiser coverage|4
7596253|NCT01978093|26425508|P2|Overall Study|Migrated/moved from study area|13
7596254|NCT01978093|26425509|P1|Overall Study|Migrated/moved from study area|11
7596255|NCT01978093|26425508|P2|Overall Study|Lost to Follow-up|15
7596256|NCT01978093|26425509|P1|Overall Study|Lost to Follow-up|11
7596257|NCT01978093|26425508|P2|Overall Study|Withdrawal by Subject|25
7596258|NCT01978093|26425509|P1|Overall Study|Withdrawal by Subject|29
7596259|NCT01978093|26425508|P2|Overall Study|Protocol Violation|2
7596260|NCT01978093|26425509|P1|Overall Study|Protocol Violation|8
7596261|NCT01978093|26425508|P2|Overall Study|Adverse Event|5
7596262|NCT01978093|26425509|P1|Overall Study|Adverse Event|0
7596263|NCT01978093|26425508|P2|Overall Study|Death|0
7596264|NCT01978093|26425509|P1|Overall Study|Death|1
7596265|NCT01977937|26425553|P2|Overall Study|Physician Decision|1
7596266|NCT01977937|26425554|P1|Overall Study|Physician Decision|0
7596267|NCT01977937|26425553|P2|Overall Study|Adverse Event|0
7596268|NCT01977937|26425554|P1|Overall Study|Adverse Event|1
7596269|NCT01977937|26425553|P2|Overall Study|Withdrawal by Subject|1
7596270|NCT01977937|26425554|P1|Overall Study|Withdrawal by Subject|2
7596271|NCT01977898|26425564|P2|Overall Study|Non functioning catheter|1
7596272|NCT01977898|26425565|P1|Overall Study|Non functioning catheter|1
7596273|NCT01977846|26425593|P2|Total Study - Prospective|Protocol Violation|1
7596274|NCT01977846|26425594|P1|Total Study - Prospective|Protocol Violation|0
7596275|NCT01977846|26425593|P2|Total Study - Prospective|No show|1
7596276|NCT01977846|26425594|P1|Total Study - Prospective|No show|0
7596277|NCT01977846|26425593|P2|Total Study - Prospective|Not available at time of visit|5
7596278|NCT01977846|26425594|P1|Total Study - Prospective|Not available at time of visit|0
7596279|NCT01977846|26425593|P2|Total Study - Prospective|Withdrawal by Subject|13
7596280|NCT01977846|26425594|P1|Total Study - Prospective|Withdrawal by Subject|0
7596281|NCT01977846|26425593|P2|Total Study - Prospective|Lost to Follow-up|8
7596282|NCT01977846|26425594|P1|Total Study - Prospective|Lost to Follow-up|0
7596283|NCT01977846|26425593|P2|Total Study - Prospective|Death|1
7596284|NCT01977846|26425594|P1|Total Study - Prospective|Death|0
7596285|NCT01977820|26425612|P2|Overall Study|Sponsor terminated the study|1
7596286|NCT01977820|26425613|P1|Overall Study|Sponsor terminated the study|1
7596287|NCT01977794|26425621|P2|Overall Study|Other|1
7596288|NCT01977794|26425622|P1|Overall Study|Other|0
7596289|NCT01977794|26425621|P2|Overall Study|Withdrew consent|1
7596290|NCT01977794|26425622|P1|Overall Study|Withdrew consent|2
7596291|NCT01977794|26425621|P2|Overall Study|Death|1
7596292|NCT01977794|26425622|P1|Overall Study|Death|1
7596293|NCT01977794|26425621|P2|Overall Study|Protocol Violation|0
7596294|NCT01977794|26425622|P1|Overall Study|Protocol Violation|1
7596295|NCT01977794|26425621|P2|Overall Study|Lost to Follow-up|1
7596296|NCT01977794|26425622|P1|Overall Study|Lost to Follow-up|2
7596297|NCT01977794|26425621|P2|Overall Study|Adverse Event|2
7596298|NCT01977794|26425622|P1|Overall Study|Adverse Event|2
7596299|NCT01977729|26425657|P1|Overall Study|Study terminated|1
7596300|NCT01977690|26425669|P2|Overall Study|Withdrawal by Subject|4
7596301|NCT01977690|26425670|P1|Overall Study|Withdrawal by Subject|0
7596302|NCT01977677|26425679|P3|Overall Study|Unrelated Adverse Event|1
7596303|NCT01977677|26425680|P2|Overall Study|Unrelated Adverse Event|0
7596304|NCT01977677|26425681|P1|Overall Study|Unrelated Adverse Event|0
7596305|NCT01977651|26425692|P1|Post 1 Year Extension Period|Miscellaneous|49
7596306|NCT01977651|26425692|P1|Post 1 Year Extension Period|Physician Decision|4
7596307|NCT01977651|26425692|P1|Post 1 Year Extension Period|Withdrawal by Subject|13
7596308|NCT01977651|26425692|P1|Post 1 Year Extension Period|Progressive Disease|60
7596309|NCT01977651|26425692|P1|Post 1 Year Extension Period|Death|13
7596310|NCT01977651|26425692|P1|Post 1 Year Extension Period|Adverse Event|5
7596311|NCT01977651|26425692|P1|1 Year Extension Period|Miscellaneous|1
7596312|NCT01977651|26425692|P1|1 Year Extension Period|Physician Decision|6
7596313|NCT01977651|26425692|P1|1 Year Extension Period|Withdrawal by Subject|11
7596314|NCT01977651|26425692|P1|1 Year Extension Period|Progressive Disease|86
7596315|NCT01977651|26425692|P1|1 Year Extension Period|Lost to Follow-up|2
7596316|NCT01977651|26425692|P1|1 Year Extension Period|Death|10
7596317|NCT01977651|26425692|P1|1 Year Extension Period|Adverse Event|14
7596318|NCT01977651|26425692|P1|4 Month Treatment Period|Physician Decision|4
7596319|NCT01977651|26425692|P1|4 Month Treatment Period|Withdrawal by Subject|17
7596320|NCT01977651|26425692|P1|4 Month Treatment Period|Progressive Disease|43
7596321|NCT01977651|26425692|P1|4 Month Treatment Period|Death|3
7596322|NCT01977651|26425692|P1|4 Month Treatment Period|Adverse Event|34
7596323|NCT01977625|26425696|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7596324|NCT01977625|26425697|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7596325|NCT01977625|26425696|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
7596326|NCT01977625|26425697|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
7596327|NCT01977612|26425707|P2|Overall Study|Lost to Follow-up|1
7596328|NCT01977612|26425708|P1|Overall Study|Lost to Follow-up|1
7596329|NCT01977573|26425741|P4|Overall Study|Withdrawal by Subject|1
7596330|NCT01977573|26425742|P3|Overall Study|Withdrawal by Subject|1
7596331|NCT01977573|26425743|P2|Overall Study|Withdrawal by Subject|1
7596332|NCT01977573|26425744|P1|Overall Study|Withdrawal by Subject|6
7596333|NCT01977573|26425741|P4|Overall Study|Reached Defined Stopping Criteria|0
7596334|NCT01977573|26425742|P3|Overall Study|Reached Defined Stopping Criteria|1
7596335|NCT01977573|26425743|P2|Overall Study|Reached Defined Stopping Criteria|1
7596336|NCT01977573|26425744|P1|Overall Study|Reached Defined Stopping Criteria|2
7596337|NCT01977573|26425741|P4|Overall Study|Protocol Violation|0
7596338|NCT01977573|26425742|P3|Overall Study|Protocol Violation|0
7596339|NCT01977573|26425743|P2|Overall Study|Protocol Violation|1
7596340|NCT01977573|26425744|P1|Overall Study|Protocol Violation|3
7596341|NCT01977573|26425741|P4|Overall Study|Physician Decision|0
7596342|NCT01977573|26425742|P3|Overall Study|Physician Decision|0
7596343|NCT01977573|26425743|P2|Overall Study|Physician Decision|0
7596344|NCT01977573|26425744|P1|Overall Study|Physician Decision|1
7596345|NCT01977573|26425741|P4|Overall Study|Lost to Follow-up|1
7596346|NCT01977573|26425742|P3|Overall Study|Lost to Follow-up|0
7596347|NCT01977573|26425743|P2|Overall Study|Lost to Follow-up|0
7596348|NCT01977573|26425744|P1|Overall Study|Lost to Follow-up|1
7596349|NCT01977573|26425741|P4|Overall Study|Adverse Event|1
7596350|NCT01977573|26425742|P3|Overall Study|Adverse Event|2
7596351|NCT01977573|26425743|P2|Overall Study|Adverse Event|0
7596352|NCT01977573|26425744|P1|Overall Study|Adverse Event|7
7596353|NCT01977482|26425885|P6|Overall Study|Withdrawal by Subject|5
7596354|NCT01977482|26425886|P5|Overall Study|Withdrawal by Subject|1
7596355|NCT01977482|26425887|P4|Overall Study|Withdrawal by Subject|3
7596356|NCT01977482|26425888|P3|Overall Study|Withdrawal by Subject|1
7596357|NCT01977482|26425889|P2|Overall Study|Withdrawal by Subject|4
7596358|NCT01977482|26425890|P1|Overall Study|Withdrawal by Subject|2
7596359|NCT01977482|26425885|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
7596360|NCT01977482|26425886|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
7596361|NCT01977482|26425887|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
7596362|NCT01977482|26425888|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
7596363|NCT01977482|26425889|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
7596364|NCT01977482|26425890|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
7596365|NCT01977482|26425885|P6|Overall Study|Protocol Violation|0
7596366|NCT01977482|26425886|P5|Overall Study|Protocol Violation|0
7596367|NCT01977482|26425887|P4|Overall Study|Protocol Violation|0
7596368|NCT01977482|26425888|P3|Overall Study|Protocol Violation|1
7596369|NCT01977482|26425889|P2|Overall Study|Protocol Violation|0
7596370|NCT01977482|26425890|P1|Overall Study|Protocol Violation|0
7596371|NCT01977482|26425885|P6|Overall Study|Physician Decision|0
7596372|NCT01977482|26425886|P5|Overall Study|Physician Decision|0
7596373|NCT01977482|26425887|P4|Overall Study|Physician Decision|0
7596374|NCT01977482|26425888|P3|Overall Study|Physician Decision|0
7596375|NCT01977482|26425889|P2|Overall Study|Physician Decision|1
7596376|NCT01977482|26425890|P1|Overall Study|Physician Decision|0
7596377|NCT01977482|26425885|P6|Overall Study|Lost to Follow-up|0
7596378|NCT01977482|26425886|P5|Overall Study|Lost to Follow-up|0
7596379|NCT01977482|26425887|P4|Overall Study|Lost to Follow-up|0
7596380|NCT01977482|26425888|P3|Overall Study|Lost to Follow-up|0
7596381|NCT01977482|26425889|P2|Overall Study|Lost to Follow-up|0
7596382|NCT01977482|26425890|P1|Overall Study|Lost to Follow-up|1
7596383|NCT01977482|26425885|P6|Overall Study|Adverse Event|0
7596384|NCT01977482|26425886|P5|Overall Study|Adverse Event|2
7596385|NCT01977482|26425887|P4|Overall Study|Adverse Event|0
7596386|NCT01977482|26425888|P3|Overall Study|Adverse Event|1
7596387|NCT01977482|26425889|P2|Overall Study|Adverse Event|1
7596388|NCT01977482|26425890|P1|Overall Study|Adverse Event|0
7596389|NCT01977456|26426005|P1|Overall Study|Death|5
7596390|NCT01977352|26426014|P2|Overall Study|Lost to Follow-up|2
7596391|NCT01977352|26426015|P1|Overall Study|Lost to Follow-up|1
7596392|NCT01977222|26426033|P1|Overall Study|Withdrawal by Subject|1
7596393|NCT01977092|26426046|P2|Overall Study|In prison|11
7596394|NCT01977092|26426047|P1|Overall Study|In prison|3
7596395|NCT01977092|26426046|P2|Overall Study|Withdrawal by Subject|1
7596396|NCT01977092|26426047|P1|Overall Study|Withdrawal by Subject|2
7596397|NCT01977092|26426046|P2|Overall Study|Lost to Follow-up|14
7596398|NCT01977092|26426047|P1|Overall Study|Lost to Follow-up|23
7596399|NCT01977092|26426046|P2|Overall Study|Death|4
7596400|NCT01977092|26426047|P1|Overall Study|Death|3
7596401|NCT01977040|26426057|P1|Overall Study|Vasa previa not confirmed|2
7596402|NCT01976845|26426111|P3|Overall Study|Physician Decision|3
7596403|NCT01976845|26426112|P2|Overall Study|Physician Decision|8
7596404|NCT01976845|26426113|P1|Overall Study|Physician Decision|8
7596405|NCT01976806|26426138|P2|Overall Study|Withdrawal by Subject|1
7596406|NCT01976806|26426139|P1|Overall Study|Withdrawal by Subject|1
7596407|NCT01976806|26426138|P2|Overall Study|Adverse Event|1
7596408|NCT01976806|26426139|P1|Overall Study|Adverse Event|1
7596409|NCT01976806|26426138|P2|Overall Study|Lost to Follow-up|4
7596410|NCT01976806|26426139|P1|Overall Study|Lost to Follow-up|1
7596411|NCT01976741|26426177|P10|Overall Study|Adverse Event|4
7596412|NCT01976741|26426178|P9|Overall Study|Adverse Event|1
7596413|NCT01976741|26426179|P8|Overall Study|Adverse Event|8
7596414|NCT01976741|26426180|P7|Overall Study|Adverse Event|3
7596415|NCT01976741|26426181|P6|Overall Study|Adverse Event|0
7596416|NCT01976741|26426182|P5|Overall Study|Adverse Event|0
7596417|NCT01976741|26426183|P4|Overall Study|Adverse Event|0
7596418|NCT01976741|26426184|P3|Overall Study|Adverse Event|2
7596419|NCT01976741|26426185|P2|Overall Study|Adverse Event|0
7596420|NCT01976741|26426186|P1|Overall Study|Adverse Event|0
7596421|NCT01976741|26426177|P10|Overall Study|Withdrawal by Subject|0
7596422|NCT01976741|26426178|P9|Overall Study|Withdrawal by Subject|0
7596423|NCT01976741|26426179|P8|Overall Study|Withdrawal by Subject|4
7596424|NCT01976741|26426180|P7|Overall Study|Withdrawal by Subject|1
7596425|NCT01976741|26426181|P6|Overall Study|Withdrawal by Subject|0
7596426|NCT01976741|26426182|P5|Overall Study|Withdrawal by Subject|0
7596427|NCT01976741|26426183|P4|Overall Study|Withdrawal by Subject|1
7596428|NCT01976741|26426184|P3|Overall Study|Withdrawal by Subject|1
7596429|NCT01976741|26426185|P2|Overall Study|Withdrawal by Subject|0
7596430|NCT01976741|26426186|P1|Overall Study|Withdrawal by Subject|1
7596431|NCT01976728|26426493|P4|Overall Study|Subject missed multiple doses of IMP|0
7596432|NCT01976728|26426494|P3|Overall Study|Subject missed multiple doses of IMP|0
7596433|NCT01976728|26426495|P2|Overall Study|Subject missed multiple doses of IMP|0
7596434|NCT01976728|26426496|P1|Overall Study|Subject missed multiple doses of IMP|1
7596435|NCT01976663|26426571|P1|Overall Study|Lost to Follow-up|3
7596436|NCT01976663|26426571|P1|Overall Study|Adverse Event|2
7596437|NCT01976663|26426571|P1|Overall Study|Screen Failure|3
7596438|NCT01976663|26426571|P1|Overall Study|Withdrawal by Subject|4
7596439|NCT01976663|26426571|P1|Overall Study|Personal Reasons|6
7596440|NCT01976663|26426571|P1|Overall Study|Completed 18 mos but no repeat treatment|24
7596441|NCT01976624|26426590|P1|Overall Study|Participants age less than 19 years|12
7596442|NCT01976624|26426590|P1|Overall Study|Participants contraindicated|2
7596443|NCT01976507|26426618|P1|Overall Study|ablation not done, drug not given|1
7596444|NCT01976507|26426618|P1|Overall Study|Adverse Event|6
7596445|NCT01976364|26426649|P3|Sub-study (12 Months)|Adverse Event|3
7596446|NCT01976364|26426650|P2|Sub-study (12 Months)|Adverse Event|4
7596447|NCT01976364|26426651|P1|Sub-study (12 Months)|Adverse Event|0
7596448|NCT01976364|26426649|P3|Sub-study (12 Months)|Protocol Violation|1
7596449|NCT01976364|26426650|P2|Sub-study (12 Months)|Protocol Violation|1
7596450|NCT01976364|26426651|P1|Sub-study (12 Months)|Protocol Violation|0
7596451|NCT01976364|26426649|P3|Sub-study (12 Months)|Withdrawal by Subject|1
7596452|NCT01976364|26426650|P2|Sub-study (12 Months)|Withdrawal by Subject|0
7596453|NCT01976364|26426651|P1|Sub-study (12 Months)|Withdrawal by Subject|0
7596454|NCT01976364|26426649|P3|Sub-study (12 Months)|Lost to Follow-up|0
7596455|NCT01976364|26426650|P2|Sub-study (12 Months)|Lost to Follow-up|1
7596456|NCT01976364|26426651|P1|Sub-study (12 Months)|Lost to Follow-up|0
7596457|NCT01976364|26426649|P3|Main Study (36 Months)|Death|0
7596458|NCT01976364|26426650|P2|Main Study (36 Months)|Death|0
7596459|NCT01976364|26426651|P1|Main Study (36 Months)|Death|5
7596460|NCT01976364|26426649|P3|Main Study (36 Months)|Withdrawal by Subject|0
7596461|NCT01976364|26426650|P2|Main Study (36 Months)|Withdrawal by Subject|0
7596462|NCT01976364|26426651|P1|Main Study (36 Months)|Withdrawal by Subject|69
7596463|NCT01976364|26426649|P3|Main Study (36 Months)|Protocol Violation|0
7596464|NCT01976364|26426650|P2|Main Study (36 Months)|Protocol Violation|0
7596465|NCT01976364|26426651|P1|Main Study (36 Months)|Protocol Violation|13
7596466|NCT01976364|26426649|P3|Main Study (36 Months)|Lack of Efficacy|0
7596467|NCT01976364|26426650|P2|Main Study (36 Months)|Lack of Efficacy|0
7596468|NCT01976364|26426651|P1|Main Study (36 Months)|Lack of Efficacy|40
7596469|NCT01976364|26426649|P3|Main Study (36 Months)|Lost to Follow-up|0
7596470|NCT01976364|26426650|P2|Main Study (36 Months)|Lost to Follow-up|0
7596471|NCT01976364|26426651|P1|Main Study (36 Months)|Lost to Follow-up|10
7596472|NCT01976364|26426649|P3|Main Study (36 Months)|Medication error|0
7596473|NCT01976364|26426650|P2|Main Study (36 Months)|Medication error|0
7596474|NCT01976364|26426651|P1|Main Study (36 Months)|Medication error|1
7596475|NCT01976364|26426649|P3|Main Study (36 Months)|No longer met eligibility criteria|0
7596476|NCT01976364|26426650|P2|Main Study (36 Months)|No longer met eligibility criteria|0
7596477|NCT01976364|26426651|P1|Main Study (36 Months)|No longer met eligibility criteria|2
7596478|NCT01976364|26426649|P3|Main Study (36 Months)|Other|0
7596479|NCT01976364|26426650|P2|Main Study (36 Months)|Other|0
7596480|NCT01976364|26426651|P1|Main Study (36 Months)|Other|13
7596481|NCT01976364|26426649|P3|Main Study (36 Months)|Withdrawn due to pregnancy|0
7596482|NCT01976364|26426650|P2|Main Study (36 Months)|Withdrawn due to pregnancy|0
7596483|NCT01976364|26426651|P1|Main Study (36 Months)|Withdrawn due to pregnancy|5
7596484|NCT01976364|26426649|P3|Main Study (36 Months)|Adverse Event|0
7596485|NCT01976364|26426650|P2|Main Study (36 Months)|Adverse Event|0
7596486|NCT01976364|26426651|P1|Main Study (36 Months)|Adverse Event|63
7596487|NCT01976338|26426771|P2|Overall Study|Adverse Event|1
7596488|NCT01976338|26426772|P1|Overall Study|Adverse Event|5
7596489|NCT01976338|26426771|P2|Overall Study|Withdrawal by Subject|2
7596490|NCT01976338|26426772|P1|Overall Study|Withdrawal by Subject|5
7596491|NCT01976338|26426771|P2|Overall Study|Lost to Follow-up|0
7596492|NCT01976338|26426772|P1|Overall Study|Lost to Follow-up|3
7596493|NCT01976338|26426771|P2|Overall Study|Physician Decision|1
7596494|NCT01976338|26426772|P1|Overall Study|Physician Decision|0
7596495|NCT01976312|26426799|P2|Overall Study|Protocol Violation|0
7596496|NCT01976312|26426800|P1|Overall Study|Protocol Violation|2
7596497|NCT01976312|26426799|P2|Overall Study|Adverse Event|6
7596498|NCT01976312|26426800|P1|Overall Study|Adverse Event|6
7596499|NCT01976312|26426799|P2|Overall Study|Withdrawal by Subject|2
7596500|NCT01976312|26426800|P1|Overall Study|Withdrawal by Subject|7
7596501|NCT01976312|26426799|P2|Overall Study|Lost to Follow-up|0
7596502|NCT01976312|26426800|P1|Overall Study|Lost to Follow-up|2
7596503|NCT01976312|26426799|P2|Overall Study|Pregnancy|1
7596504|NCT01976312|26426800|P1|Overall Study|Pregnancy|0
7596505|NCT01976299|26426821|P2|Overall Study|See clarification above in comments|2
7596506|NCT01976299|26426822|P1|Overall Study|See clarification above in comments|9
7596507|NCT01976299|26426821|P2|Overall Study|Lost to Follow-up|1
7596508|NCT01976299|26426822|P1|Overall Study|Lost to Follow-up|7
7596509|NCT01976299|26426821|P2|Overall Study|Death|2
7596510|NCT01976299|26426822|P1|Overall Study|Death|4
7596511|NCT01976299|26426821|P2|Overall Study|Withdrawal by Subject|1
7596512|NCT01976299|26426822|P1|Overall Study|Withdrawal by Subject|3
7596513|NCT01976104|26426849|P4|Overall Study|Other|0
7596514|NCT01976104|26426850|P3|Overall Study|Other|0
7596515|NCT01976104|26426851|P2|Overall Study|Other|1
7596516|NCT01976104|26426852|P1|Overall Study|Other|0
7596517|NCT01976104|26426849|P4|Overall Study|Withdrawal by Subject|1
7596518|NCT01976104|26426850|P3|Overall Study|Withdrawal by Subject|0
7596519|NCT01976104|26426851|P2|Overall Study|Withdrawal by Subject|0
7596520|NCT01976104|26426852|P1|Overall Study|Withdrawal by Subject|3
7596521|NCT01976104|26426849|P4|Overall Study|Subject Choice|1
7596522|NCT01976104|26426850|P3|Overall Study|Subject Choice|0
7596523|NCT01976104|26426851|P2|Overall Study|Subject Choice|1
7596524|NCT01976104|26426852|P1|Overall Study|Subject Choice|0
7596525|NCT01976104|26426849|P4|Overall Study|Lost to Follow-up|1
7596526|NCT01976104|26426850|P3|Overall Study|Lost to Follow-up|1
7596527|NCT01976104|26426851|P2|Overall Study|Lost to Follow-up|0
7596528|NCT01976104|26426852|P1|Overall Study|Lost to Follow-up|3
7596529|NCT01976104|26426849|P4|Overall Study|Adverse Event|0
7596530|NCT01976104|26426850|P3|Overall Study|Adverse Event|1
7596531|NCT01976104|26426851|P2|Overall Study|Adverse Event|0
7596532|NCT01976104|26426852|P1|Overall Study|Adverse Event|0
7596533|NCT01975948|26426886|P4|Overall Study|Withdrawal by Subject|6
7596534|NCT01975948|26426887|P3|Overall Study|Withdrawal by Subject|7
7596535|NCT01975948|26426888|P2|Overall Study|Withdrawal by Subject|21
7596536|NCT01975948|26426889|P1|Overall Study|Withdrawal by Subject|17
7596537|NCT01975831|26426965|P9|Overall Study|Unable to Treat Within Protocol Windows|1
7596538|NCT01975831|26426966|P8|Overall Study|Unable to Treat Within Protocol Windows|0
7596539|NCT01975831|26426967|P7|Overall Study|Unable to Treat Within Protocol Windows|1
7596540|NCT01975831|26426968|P6|Overall Study|Unable to Treat Within Protocol Windows|0
7596541|NCT01975831|26426969|P5|Overall Study|Unable to Treat Within Protocol Windows|0
7596542|NCT01975831|26426970|P4|Overall Study|Unable to Treat Within Protocol Windows|0
7596543|NCT01975831|26426971|P3|Overall Study|Unable to Treat Within Protocol Windows|0
7596544|NCT01975831|26426972|P2|Overall Study|Unable to Treat Within Protocol Windows|0
7596545|NCT01975831|26426973|P1|Overall Study|Unable to Treat Within Protocol Windows|0
7596546|NCT01975831|26426965|P9|Overall Study|Entered Hospice|0
7596547|NCT01975831|26426966|P8|Overall Study|Entered Hospice|0
7596548|NCT01975831|26426967|P7|Overall Study|Entered Hospice|0
7596549|NCT01975831|26426968|P6|Overall Study|Entered Hospice|1
7596550|NCT01975831|26426969|P5|Overall Study|Entered Hospice|0
7596551|NCT01975831|26426970|P4|Overall Study|Entered Hospice|0
7596552|NCT01975831|26426971|P3|Overall Study|Entered Hospice|0
7596553|NCT01975831|26426972|P2|Overall Study|Entered Hospice|0
7596554|NCT01975831|26426973|P1|Overall Study|Entered Hospice|0
7596555|NCT01975831|26426965|P9|Overall Study|Initiation of Subsequent Therapy|0
7596556|NCT01975831|26426966|P8|Overall Study|Initiation of Subsequent Therapy|2
7596557|NCT01975831|26426967|P7|Overall Study|Initiation of Subsequent Therapy|0
7596558|NCT01975831|26426968|P6|Overall Study|Initiation of Subsequent Therapy|1
7596559|NCT01975831|26426969|P5|Overall Study|Initiation of Subsequent Therapy|0
7596560|NCT01975831|26426970|P4|Overall Study|Initiation of Subsequent Therapy|0
7596561|NCT01975831|26426971|P3|Overall Study|Initiation of Subsequent Therapy|0
7596562|NCT01975831|26426972|P2|Overall Study|Initiation of Subsequent Therapy|0
7596563|NCT01975831|26426973|P1|Overall Study|Initiation of Subsequent Therapy|0
7596564|NCT01975831|26426965|P9|Overall Study|Physician Decision|0
7596565|NCT01975831|26426966|P8|Overall Study|Physician Decision|1
7596566|NCT01975831|26426967|P7|Overall Study|Physician Decision|0
7596567|NCT01975831|26426968|P6|Overall Study|Physician Decision|1
7596568|NCT01975831|26426969|P5|Overall Study|Physician Decision|0
7596569|NCT01975831|26426970|P4|Overall Study|Physician Decision|0
7596570|NCT01975831|26426971|P3|Overall Study|Physician Decision|0
7596571|NCT01975831|26426972|P2|Overall Study|Physician Decision|0
7596572|NCT01975831|26426973|P1|Overall Study|Physician Decision|0
7596573|NCT01975831|26426965|P9|Overall Study|Withdrawal by Subject|0
7596574|NCT01975831|26426966|P8|Overall Study|Withdrawal by Subject|0
7596575|NCT01975831|26426967|P7|Overall Study|Withdrawal by Subject|1
7596576|NCT01975831|26426968|P6|Overall Study|Withdrawal by Subject|1
7596577|NCT01975831|26426969|P5|Overall Study|Withdrawal by Subject|3
7596578|NCT01975831|26426970|P4|Overall Study|Withdrawal by Subject|0
7596579|NCT01975831|26426971|P3|Overall Study|Withdrawal by Subject|0
7596580|NCT01975831|26426972|P2|Overall Study|Withdrawal by Subject|3
7596581|NCT01975831|26426973|P1|Overall Study|Withdrawal by Subject|0
7596582|NCT01975831|26426965|P9|Overall Study|Progressive Disease|10
7596583|NCT01975831|26426966|P8|Overall Study|Progressive Disease|8
7596584|NCT01975831|26426967|P7|Overall Study|Progressive Disease|10
7596585|NCT01975831|26426968|P6|Overall Study|Progressive Disease|9
7596586|NCT01975831|26426969|P5|Overall Study|Progressive Disease|13
7596587|NCT01975831|26426970|P4|Overall Study|Progressive Disease|4
7596588|NCT01975831|26426971|P3|Overall Study|Progressive Disease|2
7596589|NCT01975831|26426972|P2|Overall Study|Progressive Disease|3
7596590|NCT01975831|26426973|P1|Overall Study|Progressive Disease|1
7596591|NCT01975831|26426965|P9|Overall Study|Death|0
7596592|NCT01975831|26426966|P8|Overall Study|Death|0
7596593|NCT01975831|26426967|P7|Overall Study|Death|1
7596594|NCT01975831|26426968|P6|Overall Study|Death|0
7596595|NCT01975831|26426969|P5|Overall Study|Death|1
7596596|NCT01975831|26426970|P4|Overall Study|Death|0
7596597|NCT01975831|26426971|P3|Overall Study|Death|0
7596598|NCT01975831|26426972|P2|Overall Study|Death|1
7596599|NCT01975831|26426973|P1|Overall Study|Death|1
7596600|NCT01975831|26426965|P9|Overall Study|Adverse Event|1
7596601|NCT01975831|26426966|P8|Overall Study|Adverse Event|4
7596602|NCT01975831|26426967|P7|Overall Study|Adverse Event|3
7596603|NCT01975831|26426968|P6|Overall Study|Adverse Event|1
7596604|NCT01975831|26426969|P5|Overall Study|Adverse Event|1
7596605|NCT01975831|26426970|P4|Overall Study|Adverse Event|0
7596606|NCT01975831|26426971|P3|Overall Study|Adverse Event|2
7596607|NCT01975831|26426972|P2|Overall Study|Adverse Event|2
7596608|NCT01975831|26426973|P1|Overall Study|Adverse Event|1
7596609|NCT01975701|26427038|P1|Overall Study|Physician Decision|1
7596610|NCT01975701|26427038|P1|Overall Study|Death|23
7596611|NCT01975701|26427038|P1|Overall Study|Lost to Follow-up|1
7596612|NCT01975675|26427049|P4|Overall Study|Death|0
7596613|NCT01975675|26427050|P3|Overall Study|Death|0
7596614|NCT01975675|26427051|P2|Overall Study|Death|1
7596615|NCT01975675|26427052|P1|Overall Study|Death|0
7596616|NCT01975428|26427103|P2|Overall Study|Withdrawal by Subject|10
7596617|NCT01975428|26427104|P1|Overall Study|Withdrawal by Subject|3
7596618|NCT01975428|26427103|P2|Overall Study|Lost to Follow-up|4
7596619|NCT01975428|26427104|P1|Overall Study|Lost to Follow-up|17
7596620|NCT01975389|26427114|P2|Overall Study|Randomized, not treated|5
7596621|NCT01975389|26427115|P1|Overall Study|Randomized, not treated|4
7596622|NCT01975389|26427114|P2|Overall Study|Other|9
7596623|NCT01975389|26427115|P1|Overall Study|Other|6
7596624|NCT01975389|26427114|P2|Overall Study|Withdrawal by Subject|76
7596625|NCT01975389|26427115|P1|Overall Study|Withdrawal by Subject|90
7596626|NCT01975389|26427114|P2|Overall Study|Lost to Follow-up|86
7596627|NCT01975389|26427115|P1|Overall Study|Lost to Follow-up|81
7596628|NCT01975389|26427114|P2|Overall Study|Death|54
7596629|NCT01975389|26427115|P1|Overall Study|Death|61
7596630|NCT01975389|26427114|P2|Overall Study|Adverse Event|6
7596631|NCT01975389|26427115|P1|Overall Study|Adverse Event|10
7596632|NCT01975376|26427175|P2|Overall Study|Randomized, Not Treated|8
7596633|NCT01975376|26427176|P1|Overall Study|Randomized, Not Treated|16
7596634|NCT01975376|26427175|P2|Overall Study|Other|4
7596635|NCT01975376|26427176|P1|Overall Study|Other|2
7596636|NCT01975376|26427175|P2|Overall Study|Withdrew consent|62
7596637|NCT01975376|26427176|P1|Overall Study|Withdrew consent|68
7596638|NCT01975376|26427175|P2|Overall Study|Lost to Follow-up|66
7596639|NCT01975376|26427176|P1|Overall Study|Lost to Follow-up|70
7596640|NCT01975376|26427175|P2|Overall Study|Death|72
7596641|NCT01975376|26427176|P1|Overall Study|Death|65
7596642|NCT01975376|26427175|P2|Overall Study|Adverse Event|5
7596643|NCT01975376|26427176|P1|Overall Study|Adverse Event|5
7596644|NCT01975285|26427236|P2|Overall Study|Failed Block and follow up|2
7596645|NCT01975285|26427237|P1|Overall Study|Failed Block and follow up|2
7596646|NCT01975246|26427253|P2|Overall Study|Other than stated|1
7596647|NCT01975246|26427254|P1|Overall Study|Other than stated|0
7596648|NCT01975246|26427253|P2|Overall Study|Protocol Violation|0
7596649|NCT01975246|26427254|P1|Overall Study|Protocol Violation|1
7596650|NCT01975246|26427253|P2|Overall Study|Lack of Efficacy|0
7596651|NCT01975246|26427254|P1|Overall Study|Lack of Efficacy|1
7596652|NCT01975246|26427253|P2|Overall Study|Adverse Event|1
7596653|NCT01975246|26427254|P1|Overall Study|Adverse Event|2
7596654|NCT01975220|26427267|P6|Test Period 1|Not treated|0
7596655|NCT01975220|26427268|P5|Test Period 1|Not treated|0
7596656|NCT01975220|26427269|P4|Test Period 1|Not treated|0
7596657|NCT01975220|26427270|P3|Test Period 1|Not treated|0
7596658|NCT01975220|26427271|P2|Test Period 1|Not treated|1
7596659|NCT01975220|26427272|P1|Test Period 1|Not treated|0
7596660|NCT01974895|26427328|P2|Overall Study|Other (Reason unknown)|8
7596661|NCT01974895|26427329|P1|Overall Study|Other (Reason unknown)|9
7596662|NCT01974895|26427328|P2|Overall Study|Other (Missed Visit)|0
7596663|NCT01974895|26427329|P1|Overall Study|Other (Missed Visit)|1
7596664|NCT01974895|26427328|P2|Overall Study|Withdrawal by Subject|1
7596665|NCT01974895|26427329|P1|Overall Study|Withdrawal by Subject|0
7596666|NCT01974895|26427328|P2|Overall Study|Lost to Follow-up|6
7596667|NCT01974895|26427329|P1|Overall Study|Lost to Follow-up|4
7596668|NCT01974895|26427328|P2|Overall Study|Protocol Violation|0
7596669|NCT01974895|26427329|P1|Overall Study|Protocol Violation|1
7596670|NCT01974817|26427359|P1|Overall Study|Protocol Violation|2
7596671|NCT01974817|26427359|P1|Overall Study|Lost to Follow-up|2
7596672|NCT01974817|26427359|P1|Overall Study|Death|4
7596673|NCT01974752|26427365|P2|Overall Study|Other Eligibility Criteria|1
7596674|NCT01974752|26427366|P1|Overall Study|Other Eligibility Criteria|0
7596675|NCT01974752|26427365|P2|Overall Study|Withdrawal by Subject|3
7596676|NCT01974752|26427366|P1|Overall Study|Withdrawal by Subject|2
7596677|NCT01974752|26427365|P2|Overall Study|Lost to Follow-up|0
7596678|NCT01974752|26427366|P1|Overall Study|Lost to Follow-up|2
7596679|NCT01974752|26427365|P2|Overall Study|Death|11
7596680|NCT01974752|26427366|P1|Overall Study|Death|33
7596681|NCT01974323|26427794|P2|Overall Study|Adverse Event|2
7596682|NCT01974323|26427795|P1|Overall Study|Adverse Event|2
7596683|NCT01974323|26427794|P2|Overall Study|Lack of Efficacy|1
7596684|NCT01974323|26427795|P1|Overall Study|Lack of Efficacy|1
7596685|NCT01974323|26427794|P2|Overall Study|Pregnancy|1
7596686|NCT01974323|26427795|P1|Overall Study|Pregnancy|2
7596687|NCT01974323|26427794|P2|Overall Study|Lost to Follow-up|40
7596688|NCT01974323|26427795|P1|Overall Study|Lost to Follow-up|45
7596689|NCT01974323|26427794|P2|Overall Study|Personal Reasons|19
7596690|NCT01974323|26427795|P1|Overall Study|Personal Reasons|15
7596691|NCT01974323|26427794|P2|Overall Study|Protocol Violation|2
7596692|NCT01974323|26427795|P1|Overall Study|Protocol Violation|2
7596693|NCT01974323|26427794|P2|Overall Study|Other Reasons|28
7596694|NCT01974323|26427795|P1|Overall Study|Other Reasons|25
7596695|NCT01974141|26427835|P2|Overall Study|Adverse Event|5
7596696|NCT01974141|26427836|P1|Overall Study|Adverse Event|4
7596697|NCT01974141|26427835|P2|Overall Study|Lack of Efficacy|1
7596698|NCT01974141|26427836|P1|Overall Study|Lack of Efficacy|0
7596699|NCT01974141|26427835|P2|Overall Study|Pregnancy|3
7596700|NCT01974141|26427836|P1|Overall Study|Pregnancy|3
7596701|NCT01974141|26427835|P2|Overall Study|Lost to Follow-up|29
7596702|NCT01974141|26427836|P1|Overall Study|Lost to Follow-up|38
7596703|NCT01974141|26427835|P2|Overall Study|Personal Reasons|20
7596704|NCT01974141|26427836|P1|Overall Study|Personal Reasons|21
7596705|NCT01974141|26427835|P2|Overall Study|Protocol Violation|6
7596706|NCT01974141|26427836|P1|Overall Study|Protocol Violation|2
7596707|NCT01974141|26427835|P2|Overall Study|Other Reasons|18
7596708|NCT01974141|26427836|P1|Overall Study|Other Reasons|28
7596709|NCT01973998|26427891|P2|Overall Study|Death|2
7596710|NCT01973998|26427892|P1|Overall Study|Death|2
7596711|NCT01973595|26427954|P4|Washout|Withdrawal by Subject|0
7596712|NCT01973595|26427955|P3|Washout|Withdrawal by Subject|1
7596713|NCT01973595|26427956|P2|Washout|Withdrawal by Subject|0
7596714|NCT01973595|26427957|P1|Washout|Withdrawal by Subject|1
7596715|NCT01973569|26427974|P3|Overall Study|Did not receive study drug|3
7596716|NCT01973569|26427975|P2|Overall Study|Did not receive study drug|3
7596717|NCT01973569|26427976|P1|Overall Study|Did not receive study drug|6
7596718|NCT01973569|26427974|P3|Overall Study|Other|0
7596719|NCT01973569|26427975|P2|Overall Study|Other|1
7596720|NCT01973569|26427976|P1|Overall Study|Other|1
7596721|NCT01973569|26427974|P3|Overall Study|Disease progression|0
7596722|NCT01973569|26427975|P2|Overall Study|Disease progression|3
7596723|NCT01973569|26427976|P1|Overall Study|Disease progression|0
7596724|NCT01973569|26427974|P3|Overall Study|Prohibited concomitant d|0
7596725|NCT01973569|26427975|P2|Overall Study|Prohibited concomitant d|5
7596726|NCT01973569|26427976|P1|Overall Study|Prohibited concomitant d|1
7596727|NCT01973569|26427974|P3|Overall Study|Invasive dental treatment|6
7596728|NCT01973569|26427975|P2|Overall Study|Invasive dental treatment|5
7596729|NCT01973569|26427976|P1|Overall Study|Invasive dental treatment|3
7596730|NCT01973569|26427974|P3|Overall Study|Withdrawal by Subject|2
7596731|NCT01973569|26427975|P2|Overall Study|Withdrawal by Subject|5
7596732|NCT01973569|26427976|P1|Overall Study|Withdrawal by Subject|7
7596733|NCT01973569|26427974|P3|Overall Study|Protocol Violation|3
7596734|NCT01973569|26427975|P2|Overall Study|Protocol Violation|1
7596735|NCT01973569|26427976|P1|Overall Study|Protocol Violation|2
7596736|NCT01973569|26427974|P3|Overall Study|Adverse Event|4
7596737|NCT01973569|26427975|P2|Overall Study|Adverse Event|2
7596738|NCT01973569|26427976|P1|Overall Study|Adverse Event|9
7596739|NCT01973491|26428002|P1|Treatment Period (16 Weeks)|Adverse Event|1
7596740|NCT01973491|26428002|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
7596741|NCT01973491|26428002|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
7596742|NCT01973439|26428018|P1|Overall Study|PK curve incomplete|2
7596743|NCT01973439|26428018|P1|Overall Study|Vomiting after commencing once daily|1
7596744|NCT01973439|26428018|P1|Overall Study|Lost samples from one PK Day|2
7596745|NCT01973387|26428040|P2|Overall Study|Randomized, not treated|2
7596746|NCT01973387|26428041|P1|Overall Study|Randomized, not treated|2
7596747|NCT01973387|26428040|P2|Overall Study|Death|3
7596748|NCT01973387|26428041|P1|Overall Study|Death|4
7596749|NCT01973387|26428040|P2|Overall Study|Progressive disease or relapse|5
7596750|NCT01973387|26428041|P1|Overall Study|Progressive disease or relapse|16
7596751|NCT01973387|26428040|P2|Overall Study|Study terminated by sponsor|0
7596752|NCT01973387|26428041|P1|Overall Study|Study terminated by sponsor|63
7596753|NCT01973387|26428040|P2|Overall Study|Withdrawal by Subject|4
7596754|NCT01973387|26428041|P1|Overall Study|Withdrawal by Subject|7
7596755|NCT01973387|26428040|P2|Overall Study|Adverse Event|4
7596756|NCT01973387|26428041|P1|Overall Study|Adverse Event|14
7596757|NCT01973283|26428121|P1|Overall Study|Lost to Follow-up|4
7596758|NCT01973231|26428149|P2|Overall Study|Withdrawal by Subject|9
7596759|NCT01973231|26428150|P1|Overall Study|Withdrawal by Subject|7
7596760|NCT01973231|26428149|P2|Overall Study|unclassified|1
7596761|NCT01973231|26428150|P1|Overall Study|unclassified|2
7596762|NCT01973231|26428149|P2|Overall Study|Lost to Follow-up|1
7596763|NCT01973231|26428150|P1|Overall Study|Lost to Follow-up|1
7596764|NCT01973231|26428149|P2|Overall Study|Protocol Violation|1
7596765|NCT01973231|26428150|P1|Overall Study|Protocol Violation|1
7596766|NCT01973218|26428170|P2|Overall Study|Withdrawal by Subject|0
7596767|NCT01973218|26428171|P1|Overall Study|Withdrawal by Subject|1
7596768|NCT01973218|26428170|P2|Overall Study|Adverse Event|0
7596769|NCT01973218|26428171|P1|Overall Study|Adverse Event|1
7596770|NCT01972841|26428264|P6|Overall Study|Did not have end of treatment page|0
7596771|NCT01972841|26428265|P5|Overall Study|Did not have end of treatment page|1
7596772|NCT01972841|26428266|P4|Overall Study|Did not have end of treatment page|0
7596773|NCT01972841|26428267|P3|Overall Study|Did not have end of treatment page|0
7596774|NCT01972841|26428268|P2|Overall Study|Did not have end of treatment page|0
7596775|NCT01972841|26428269|P1|Overall Study|Did not have end of treatment page|0
7596776|NCT01972841|26428264|P6|Overall Study|Miscellaneous|4
7596777|NCT01972841|26428265|P5|Overall Study|Miscellaneous|0
7596778|NCT01972841|26428266|P4|Overall Study|Miscellaneous|1
7596779|NCT01972841|26428267|P3|Overall Study|Miscellaneous|4
7596780|NCT01972841|26428268|P2|Overall Study|Miscellaneous|0
7596781|NCT01972841|26428269|P1|Overall Study|Miscellaneous|0
7596782|NCT01972841|26428264|P6|Overall Study|Withdrawal by participants|34
7596783|NCT01972841|26428265|P5|Overall Study|Withdrawal by participants|33
7596784|NCT01972841|26428266|P4|Overall Study|Withdrawal by participants|16
7596785|NCT01972841|26428267|P3|Overall Study|Withdrawal by participants|23
7596786|NCT01972841|26428268|P2|Overall Study|Withdrawal by participants|27
7596787|NCT01972841|26428269|P1|Overall Study|Withdrawal by participants|21
7596788|NCT01972841|26428264|P6|Overall Study|Protocol Violation|4
7596789|NCT01972841|26428265|P5|Overall Study|Protocol Violation|9
7596790|NCT01972841|26428266|P4|Overall Study|Protocol Violation|5
7596791|NCT01972841|26428267|P3|Overall Study|Protocol Violation|3
7596792|NCT01972841|26428268|P2|Overall Study|Protocol Violation|2
7596793|NCT01972841|26428269|P1|Overall Study|Protocol Violation|2
7596794|NCT01972841|26428264|P6|Overall Study|Lost to Follow-up|3
7596795|NCT01972841|26428265|P5|Overall Study|Lost to Follow-up|9
7596796|NCT01972841|26428266|P4|Overall Study|Lost to Follow-up|2
7596797|NCT01972841|26428267|P3|Overall Study|Lost to Follow-up|4
7596798|NCT01972841|26428268|P2|Overall Study|Lost to Follow-up|2
7596799|NCT01972841|26428269|P1|Overall Study|Lost to Follow-up|4
7596800|NCT01972841|26428264|P6|Overall Study|Lack of Efficacy|1
7596801|NCT01972841|26428265|P5|Overall Study|Lack of Efficacy|4
7596802|NCT01972841|26428266|P4|Overall Study|Lack of Efficacy|2
7596803|NCT01972841|26428267|P3|Overall Study|Lack of Efficacy|0
7596804|NCT01972841|26428268|P2|Overall Study|Lack of Efficacy|0
7596805|NCT01972841|26428269|P1|Overall Study|Lack of Efficacy|1
7596806|NCT01972841|26428264|P6|Overall Study|Adverse Event|26
7596807|NCT01972841|26428265|P5|Overall Study|Adverse Event|21
7596808|NCT01972841|26428266|P4|Overall Study|Adverse Event|9
7596809|NCT01972841|26428267|P3|Overall Study|Adverse Event|12
7596810|NCT01972841|26428268|P2|Overall Study|Adverse Event|8
7596811|NCT01972841|26428269|P1|Overall Study|Adverse Event|13
7596812|NCT01972841|26428264|P6|Overall Study|Randomized but Never Received Treatment|13
7596813|NCT01972841|26428265|P5|Overall Study|Randomized but Never Received Treatment|6
7596814|NCT01972841|26428266|P4|Overall Study|Randomized but Never Received Treatment|2
7596815|NCT01972841|26428267|P3|Overall Study|Randomized but Never Received Treatment|4
7596816|NCT01972841|26428268|P2|Overall Study|Randomized but Never Received Treatment|5
7596817|NCT01972841|26428269|P1|Overall Study|Randomized but Never Received Treatment|2
7596818|NCT01972789|26428699|P2|Overall Study|Physician Decision|2
7596819|NCT01972789|26428700|P1|Overall Study|Physician Decision|3
7596820|NCT01972789|26428699|P2|Overall Study|Protocol deviation|0
7596821|NCT01972789|26428700|P1|Overall Study|Protocol deviation|1
7596822|NCT01972789|26428699|P2|Overall Study|Death|5
7596823|NCT01972789|26428700|P1|Overall Study|Death|7
7596824|NCT01972789|26428699|P2|Overall Study|Lost to Follow-up|7
7596825|NCT01972789|26428700|P1|Overall Study|Lost to Follow-up|4
7596826|NCT01972789|26428699|P2|Overall Study|Subject withdrew consent|12
7596827|NCT01972789|26428700|P1|Overall Study|Subject withdrew consent|14
7596828|NCT01972789|26428699|P2|Overall Study|Adverse Event|4
7596829|NCT01972789|26428700|P1|Overall Study|Adverse Event|11
7596830|NCT01972776|26428734|P6|Part 2|Administrative problems|7
7596831|NCT01972776|26428735|P5|Part 2|Administrative problems|10
7596832|NCT01972776|26428736|P4|Part 2|Administrative problems|0
7596833|NCT01972776|26428737|P3|Part 2|Administrative problems|0
7596834|NCT01972776|26428738|P2|Part 2|Administrative problems|0
7596835|NCT01972776|26428739|P1|Part 2|Administrative problems|0
7596836|NCT01972776|26428734|P6|Part 2|Adverse Event|0
7596837|NCT01972776|26428735|P5|Part 2|Adverse Event|3
7596838|NCT01972776|26428736|P4|Part 2|Adverse Event|0
7596839|NCT01972776|26428737|P3|Part 2|Adverse Event|0
7596840|NCT01972776|26428738|P2|Part 2|Adverse Event|0
7596841|NCT01972776|26428739|P1|Part 2|Adverse Event|0
7596842|NCT01972776|26428734|P6|Part 1|Adverse Event|0
7596843|NCT01972776|26428735|P5|Part 1|Adverse Event|0
7596844|NCT01972776|26428736|P4|Part 1|Adverse Event|1
7596845|NCT01972776|26428737|P3|Part 1|Adverse Event|1
7596846|NCT01972776|26428738|P2|Part 1|Adverse Event|0
7596847|NCT01972776|26428739|P1|Part 1|Adverse Event|0
7596848|NCT01972776|26428734|P6|Part 1|Withdrawal by Subject|0
7596849|NCT01972776|26428735|P5|Part 1|Withdrawal by Subject|0
7596850|NCT01972776|26428736|P4|Part 1|Withdrawal by Subject|0
7596851|NCT01972776|26428737|P3|Part 1|Withdrawal by Subject|1
7596852|NCT01972776|26428738|P2|Part 1|Withdrawal by Subject|0
7596853|NCT01972776|26428739|P1|Part 1|Withdrawal by Subject|0
7596854|NCT01972724|26428810|P3|Open-Label|Significant Protocol Deviation|2
7596855|NCT01972724|26428811|P2|Open-Label|Significant Protocol Deviation|0
7596856|NCT01972724|26428812|P1|Open-Label|Significant Protocol Deviation|0
7596857|NCT01972724|26428810|P3|Open-Label|Withdrew Consent|3
7596858|NCT01972724|26428811|P2|Open-Label|Withdrew Consent|0
7596859|NCT01972724|26428812|P1|Open-Label|Withdrew Consent|0
7596860|NCT01972724|26428810|P3|Double-Blind|Significant Protocol Deviation|0
7596861|NCT01972724|26428811|P2|Double-Blind|Significant Protocol Deviation|8
7596862|NCT01972724|26428812|P1|Double-Blind|Significant Protocol Deviation|5
7596863|NCT01972724|26428810|P3|Double-Blind|Withdrawal of Consent|0
7596864|NCT01972724|26428811|P2|Double-Blind|Withdrawal of Consent|1
7596865|NCT01972724|26428812|P1|Double-Blind|Withdrawal of Consent|2
7596866|NCT01972724|26428810|P3|Double-Blind|Adverse Event|0
7596867|NCT01972724|26428811|P2|Double-Blind|Adverse Event|0
7596868|NCT01972724|26428812|P1|Double-Blind|Adverse Event|1
7596869|NCT01972724|26428810|P3|Double-Blind|Rescue Criteria Met|0
7596870|NCT01972724|26428811|P2|Double-Blind|Rescue Criteria Met|0
7596871|NCT01972724|26428812|P1|Double-Blind|Rescue Criteria Met|1
7596872|NCT01972659|26428825|P2|Overall Study|problems realted to acceleromyograph|1
7596873|NCT01972659|26428826|P1|Overall Study|problems realted to acceleromyograph|2
7596874|NCT01972659|26428825|P2|Overall Study|Protocol Violation|2
7596875|NCT01972659|26428826|P1|Overall Study|Protocol Violation|2
7596876|NCT01972568|26428835|P3|Overall Study|Adverse Event|5
7596877|NCT01972568|26428836|P2|Overall Study|Adverse Event|6
7596878|NCT01972568|26428837|P1|Overall Study|Adverse Event|5
7596879|NCT01972568|26428835|P3|Overall Study|Lost to Follow-up|0
7596880|NCT01972568|26428836|P2|Overall Study|Lost to Follow-up|0
7596881|NCT01972568|26428837|P1|Overall Study|Lost to Follow-up|1
7596882|NCT01972568|26428835|P3|Overall Study|Withdrawal by Subject|7
7596883|NCT01972568|26428836|P2|Overall Study|Withdrawal by Subject|3
7596884|NCT01972568|26428837|P1|Overall Study|Withdrawal by Subject|6
7596885|NCT01972568|26428835|P3|Overall Study|Protocol Violation|2
7596886|NCT01972568|26428836|P2|Overall Study|Protocol Violation|2
7596887|NCT01972568|26428837|P1|Overall Study|Protocol Violation|1
7596888|NCT01972568|26428835|P3|Overall Study|Lack of Efficacy|2
7596889|NCT01972568|26428836|P2|Overall Study|Lack of Efficacy|1
7596890|NCT01972568|26428837|P1|Overall Study|Lack of Efficacy|0
7596891|NCT01972568|26428835|P3|Overall Study|Other events|0
7596892|NCT01972568|26428836|P2|Overall Study|Other events|0
7596893|NCT01972568|26428837|P1|Overall Study|Other events|3
7596894|NCT01972529|26428876|P4|Overall Study|Not treated|1
7596895|NCT01972529|26428877|P3|Overall Study|Not treated|2
7596896|NCT01972529|26428878|P2|Overall Study|Not treated|1
7596897|NCT01972529|26428879|P1|Overall Study|Not treated|0
7596898|NCT01972529|26428876|P4|Overall Study|Other|2
7596899|NCT01972529|26428877|P3|Overall Study|Other|0
7596900|NCT01972529|26428878|P2|Overall Study|Other|0
7596901|NCT01972529|26428879|P1|Overall Study|Other|0
7596902|NCT01972529|26428876|P4|Overall Study|Withdrawl of Consent|1
7596903|NCT01972529|26428877|P3|Overall Study|Withdrawl of Consent|0
7596904|NCT01972529|26428878|P2|Overall Study|Withdrawl of Consent|2
7596905|NCT01972529|26428879|P1|Overall Study|Withdrawl of Consent|1
7596906|NCT01972529|26428876|P4|Overall Study|Participant Choice|0
7596907|NCT01972529|26428877|P3|Overall Study|Participant Choice|0
7596908|NCT01972529|26428878|P2|Overall Study|Participant Choice|1
7596909|NCT01972529|26428879|P1|Overall Study|Participant Choice|0
7596910|NCT01972529|26428876|P4|Overall Study|Lost to Follow-up|0
7596911|NCT01972529|26428877|P3|Overall Study|Lost to Follow-up|0
7596912|NCT01972529|26428878|P2|Overall Study|Lost to Follow-up|0
7596913|NCT01972529|26428879|P1|Overall Study|Lost to Follow-up|1
7596914|NCT01972529|26428876|P4|Overall Study|Adverse Event|0
7596915|NCT01972529|26428877|P3|Overall Study|Adverse Event|0
7596916|NCT01972529|26428878|P2|Overall Study|Adverse Event|1
7596917|NCT01972529|26428879|P1|Overall Study|Adverse Event|0
7596918|NCT01972464|26428924|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7596919|NCT01972464|26428925|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7596920|NCT01972464|26428924|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
7596921|NCT01972464|26428925|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
7596922|NCT01972464|26428924|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
7596923|NCT01972464|26428925|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
7596924|NCT01972464|26428924|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
7596925|NCT01972464|26428925|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
7596926|NCT01972438|26428941|P2|Post Month 12 Study Period|Early Study Closure|4
7596927|NCT01972438|26428942|P1|Post Month 12 Study Period|Early Study Closure|3
7596928|NCT01972438|26428941|P2|Months 6-12 Study Period|Early Study Closure|2
7596929|NCT01972438|26428942|P1|Months 6-12 Study Period|Early Study Closure|2
7596930|NCT01972438|26428941|P2|Months 6-12 Study Period|Death|0
7596931|NCT01972438|26428942|P1|Months 6-12 Study Period|Death|1
7596932|NCT01972438|26428941|P2|Months 3-6 Crossover Period|Early Study Closure|1
7596933|NCT01972438|26428942|P1|Months 3-6 Crossover Period|Early Study Closure|0
7596934|NCT01972438|26428941|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
7596935|NCT01972438|26428942|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
7596936|NCT01972438|26428941|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
7596937|NCT01972438|26428942|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
7596938|NCT01972438|26428941|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
7596939|NCT01972438|26428942|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
7596940|NCT01972438|26428941|P2|Baseline-Month 3 Crossover Period|Death|0
7596941|NCT01972438|26428942|P1|Baseline-Month 3 Crossover Period|Death|1
7596942|NCT01972308|26428996|P2|Overall Study|Death|1
7596943|NCT01972308|26428997|P1|Overall Study|Death|4
7596944|NCT01972308|26428996|P2|Overall Study|Lost to Follow-up|6
7596945|NCT01972308|26428997|P1|Overall Study|Lost to Follow-up|4
7596946|NCT01972308|26428996|P2|Overall Study|Withdrawal by Subject|1
7596947|NCT01972308|26428997|P1|Overall Study|Withdrawal by Subject|0
7596984|NCT01972152|26429087|P6|Second Treatment Visit|Protocol Violation|0
7596985|NCT01972152|26429088|P5|Second Treatment Visit|Protocol Violation|0
7596986|NCT01972152|26429089|P4|Second Treatment Visit|Protocol Violation|0
7596987|NCT01972152|26429090|P3|Second Treatment Visit|Protocol Violation|0
7596988|NCT01972152|26429091|P2|Second Treatment Visit|Protocol Violation|1
7596989|NCT01972152|26429092|P1|Second Treatment Visit|Protocol Violation|0
7596990|NCT01972152|26429087|P6|First Treatment Visit|Lost to Follow-up|0
7596991|NCT01972152|26429088|P5|First Treatment Visit|Lost to Follow-up|0
7596992|NCT01972152|26429089|P4|First Treatment Visit|Lost to Follow-up|0
7596993|NCT01972152|26429090|P3|First Treatment Visit|Lost to Follow-up|0
7596994|NCT01972152|26429091|P2|First Treatment Visit|Lost to Follow-up|1
7596995|NCT01972152|26429092|P1|First Treatment Visit|Lost to Follow-up|0
7596996|NCT01972074|26429130|P3|Overall Study|Scanner Unavailable|1
7596997|NCT01972074|26429131|P2|Overall Study|Scanner Unavailable|0
7596998|NCT01972074|26429132|P1|Overall Study|Scanner Unavailable|0
7596999|NCT01972074|26429130|P3|Overall Study|Withdrawal by Subject|1
7597000|NCT01972074|26429131|P2|Overall Study|Withdrawal by Subject|1
7597001|NCT01972074|26429132|P1|Overall Study|Withdrawal by Subject|1
7597002|NCT01972074|26429130|P3|Overall Study|Lost to Follow-up|1
7597003|NCT01972074|26429131|P2|Overall Study|Lost to Follow-up|1
7597004|NCT01972074|26429132|P1|Overall Study|Lost to Follow-up|0
7597005|NCT01972074|26429130|P3|Overall Study|Lack of Efficacy|0
7597006|NCT01972074|26429131|P2|Overall Study|Lack of Efficacy|1
7597007|NCT01972074|26429132|P1|Overall Study|Lack of Efficacy|1
7597008|NCT01972074|26429130|P3|Overall Study|Adverse Event|0
7597009|NCT01972074|26429131|P2|Overall Study|Adverse Event|1
7597010|NCT01972074|26429132|P1|Overall Study|Adverse Event|4
7597011|NCT01971723|26429177|P2|Overall Study|Protocol Violation|2
7597012|NCT01971723|26429178|P1|Overall Study|Protocol Violation|1
7597013|NCT01971723|26429177|P2|Overall Study|Withdrawal by Subject|1
7597014|NCT01971723|26429178|P1|Overall Study|Withdrawal by Subject|1
7597015|NCT01971645|26429211|P3|Overall Study|Protocol Violation|1
7597016|NCT01971645|26429212|P2|Overall Study|Protocol Violation|0
7597017|NCT01971645|26429213|P1|Overall Study|Protocol Violation|0
7597018|NCT01971645|26429211|P3|Overall Study|Lost to Follow-up|1
7597019|NCT01971645|26429212|P2|Overall Study|Lost to Follow-up|0
7597020|NCT01971645|26429213|P1|Overall Study|Lost to Follow-up|1
7597021|NCT01971645|26429211|P3|Overall Study|Adverse Event|0
7597022|NCT01971645|26429212|P2|Overall Study|Adverse Event|0
7597023|NCT01971645|26429213|P1|Overall Study|Adverse Event|1
7597024|NCT01971567|26429247|P2|Overall Study|Lost to Follow-up|0
7597025|NCT01971567|26429248|P1|Overall Study|Lost to Follow-up|1
7597026|NCT01971567|26429247|P2|Overall Study|Withdrawal by Subject|2
7597027|NCT01971567|26429248|P1|Overall Study|Withdrawal by Subject|3
7597028|NCT01971554|26429274|P4|Overall Study|Lost to Follow-up|0
7597029|NCT01971554|26429275|P3|Overall Study|Lost to Follow-up|0
7597030|NCT01971554|26429276|P2|Overall Study|Lost to Follow-up|0
7597031|NCT01971554|26429277|P1|Overall Study|Lost to Follow-up|1
7597032|NCT01971476|26429314|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
7597033|NCT01971476|26429315|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
7597034|NCT01971476|26429316|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
7597035|NCT01971476|26429314|P3|Cohort 2: 12 to <18 Years|Other not defined|0
7597036|NCT01971476|26429315|P2|Cohort 2: 12 to <18 Years|Other not defined|3
7597037|NCT01971476|26429316|P1|Cohort 2: 12 to <18 Years|Other not defined|6
7597038|NCT01971476|26429314|P3|Cohort 1: 2 to <12 Years|Other not defined|6
7597039|NCT01971476|26429315|P2|Cohort 1: 2 to <12 Years|Other not defined|3
7597040|NCT01971476|26429316|P1|Cohort 1: 2 to <12 Years|Other not defined|3
7597041|NCT01971346|26429410|P1|Overall Study|Physician Decision|1
7597042|NCT01971346|26429410|P1|Overall Study|Withdrawal by Subject|2
7597043|NCT01971346|26429410|P1|Overall Study|Lost to Follow-up|2
7597044|NCT01971346|26429410|P1|Overall Study|Protocol Violation|3
7597045|NCT01971203|26429443|P2|Overall Study|Adverse Event|0
7597046|NCT01971203|26429444|P1|Overall Study|Adverse Event|1
7597047|NCT01971203|26429443|P2|Overall Study|Withdrawal by Subject|6
7597048|NCT01971203|26429444|P1|Overall Study|Withdrawal by Subject|5
7597049|NCT01971203|26429443|P2|Overall Study|Protocol Violation|2
7597050|NCT01971203|26429444|P1|Overall Study|Protocol Violation|3
7597051|NCT01970995|26429471|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
7597052|NCT01970995|26429472|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
7597053|NCT01970995|26429473|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
7597054|NCT01970995|26429471|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7597055|NCT01970995|26429472|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7597056|NCT01970995|26429473|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7597057|NCT01970982|26429496|P3|Overall Study|Withdrawal by Subject|2
7597058|NCT01970982|26429497|P2|Overall Study|Withdrawal by Subject|0
7597059|NCT01970982|26429498|P1|Overall Study|Withdrawal by Subject|0
7597060|NCT01970878|26429533|P4|Overall Study|No Completion Status|0
7597061|NCT01970878|26429534|P3|Overall Study|No Completion Status|0
7597062|NCT01970878|26429535|P2|Overall Study|No Completion Status|1
7597063|NCT01970878|26429536|P1|Overall Study|No Completion Status|0
7597064|NCT01970878|26429533|P4|Overall Study|Physician Decision|0
7597065|NCT01970878|26429534|P3|Overall Study|Physician Decision|1
7597066|NCT01970878|26429535|P2|Overall Study|Physician Decision|1
7597067|NCT01970878|26429536|P1|Overall Study|Physician Decision|0
7597068|NCT01970878|26429533|P4|Overall Study|Protocol Specified Criteria|6
7597069|NCT01970878|26429534|P3|Overall Study|Protocol Specified Criteria|3
7597070|NCT01970878|26429535|P2|Overall Study|Protocol Specified Criteria|4
7597071|NCT01970878|26429536|P1|Overall Study|Protocol Specified Criteria|10
7597072|NCT01970878|26429533|P4|Overall Study|Adverse Event|3
7597073|NCT01970878|26429534|P3|Overall Study|Adverse Event|4
7597074|NCT01970878|26429535|P2|Overall Study|Adverse Event|7
7597075|NCT01970878|26429536|P1|Overall Study|Adverse Event|12
7597076|NCT01970878|26429533|P4|Overall Study|Lack of Efficacy|0
7597077|NCT01970878|26429534|P3|Overall Study|Lack of Efficacy|2
7597078|NCT01970878|26429535|P2|Overall Study|Lack of Efficacy|1
7597079|NCT01970878|26429536|P1|Overall Study|Lack of Efficacy|2
7597080|NCT01970878|26429533|P4|Overall Study|Administrative Reasons|4
7597081|NCT01970878|26429534|P3|Overall Study|Administrative Reasons|0
7597082|NCT01970878|26429535|P2|Overall Study|Administrative Reasons|0
7597083|NCT01970878|26429536|P1|Overall Study|Administrative Reasons|1
7597084|NCT01970878|26429533|P4|Overall Study|Lost to Follow-up|4
7597085|NCT01970878|26429534|P3|Overall Study|Lost to Follow-up|2
7597086|NCT01970878|26429535|P2|Overall Study|Lost to Follow-up|3
7597087|NCT01970878|26429536|P1|Overall Study|Lost to Follow-up|1
7597088|NCT01970878|26429533|P4|Overall Study|Withdrawal by Subject|7
7597089|NCT01970878|26429534|P3|Overall Study|Withdrawal by Subject|14
7597090|NCT01970878|26429535|P2|Overall Study|Withdrawal by Subject|10
7597091|NCT01970878|26429536|P1|Overall Study|Withdrawal by Subject|11
7597092|NCT01970865|26429579|P17|Overall Study|Study ongoing|2
7597093|NCT01970865|26429580|P16|Overall Study|Study ongoing|29
7597094|NCT01970865|26429581|P15|Overall Study|Study ongoing|29
7597095|NCT01970865|26429582|P14|Overall Study|Study ongoing|41
7597096|NCT01970865|26429583|P13|Overall Study|Study ongoing|43
7597097|NCT01970865|26429584|P12|Overall Study|Study ongoing|22
7597098|NCT01970865|26429585|P11|Overall Study|Study ongoing|29
7597099|NCT01970865|26429586|P10|Overall Study|Study ongoing|3
7597100|NCT01970865|26429587|P9|Overall Study|Study ongoing|1
7597101|NCT01970865|26429588|P8|Overall Study|Study ongoing|0
7597102|NCT01970865|26429589|P7|Overall Study|Study ongoing|2
7597103|NCT01970865|26429590|P6|Overall Study|Study ongoing|0
7597104|NCT01970865|26429591|P5|Overall Study|Study ongoing|8
7597105|NCT01970865|26429592|P4|Overall Study|Study ongoing|6
7597106|NCT01970865|26429593|P3|Overall Study|Study ongoing|0
7597107|NCT01970865|26429594|P2|Overall Study|Study ongoing|2
7597108|NCT01970865|26429595|P1|Overall Study|Study ongoing|0
7597109|NCT01970865|26429579|P17|Overall Study|Other|0
7597110|NCT01970865|26429580|P16|Overall Study|Other|1
7597111|NCT01970865|26429581|P15|Overall Study|Other|0
7597112|NCT01970865|26429582|P14|Overall Study|Other|1
7597113|NCT01970865|26429583|P13|Overall Study|Other|0
7597114|NCT01970865|26429584|P12|Overall Study|Other|0
7597115|NCT01970865|26429585|P11|Overall Study|Other|0
7597116|NCT01970865|26429586|P10|Overall Study|Other|0
7597117|NCT01970865|26429587|P9|Overall Study|Other|0
7597118|NCT01970865|26429588|P8|Overall Study|Other|0
7597119|NCT01970865|26429589|P7|Overall Study|Other|0
7597120|NCT01970865|26429590|P6|Overall Study|Other|0
7597121|NCT01970865|26429591|P5|Overall Study|Other|0
7597122|NCT01970865|26429592|P4|Overall Study|Other|1
7597123|NCT01970865|26429593|P3|Overall Study|Other|0
7597124|NCT01970865|26429594|P2|Overall Study|Other|0
7597125|NCT01970865|26429595|P1|Overall Study|Other|0
7597126|NCT01970865|26429579|P17|Overall Study|Withdrawal by Subject|0
7597127|NCT01970865|26429580|P16|Overall Study|Withdrawal by Subject|7
7597128|NCT01970865|26429581|P15|Overall Study|Withdrawal by Subject|2
7597129|NCT01970865|26429582|P14|Overall Study|Withdrawal by Subject|5
7597130|NCT01970865|26429583|P13|Overall Study|Withdrawal by Subject|2
7597131|NCT01970865|26429584|P12|Overall Study|Withdrawal by Subject|1
7597132|NCT01970865|26429585|P11|Overall Study|Withdrawal by Subject|0
7597133|NCT01970865|26429586|P10|Overall Study|Withdrawal by Subject|0
7597134|NCT01970865|26429587|P9|Overall Study|Withdrawal by Subject|0
7597135|NCT01970865|26429588|P8|Overall Study|Withdrawal by Subject|0
7597136|NCT01970865|26429589|P7|Overall Study|Withdrawal by Subject|0
7597137|NCT01970865|26429590|P6|Overall Study|Withdrawal by Subject|0
7597138|NCT01970865|26429591|P5|Overall Study|Withdrawal by Subject|2
7597139|NCT01970865|26429592|P4|Overall Study|Withdrawal by Subject|1
7597140|NCT01970865|26429593|P3|Overall Study|Withdrawal by Subject|0
7597141|NCT01970865|26429594|P2|Overall Study|Withdrawal by Subject|0
7597142|NCT01970865|26429595|P1|Overall Study|Withdrawal by Subject|0
7597143|NCT01970865|26429579|P17|Overall Study|Lost to Follow-up|0
7597144|NCT01970865|26429580|P16|Overall Study|Lost to Follow-up|0
7597145|NCT01970865|26429581|P15|Overall Study|Lost to Follow-up|0
7597146|NCT01970865|26429582|P14|Overall Study|Lost to Follow-up|0
7597147|NCT01970865|26429583|P13|Overall Study|Lost to Follow-up|1
7597148|NCT01970865|26429584|P12|Overall Study|Lost to Follow-up|0
7597149|NCT01970865|26429585|P11|Overall Study|Lost to Follow-up|0
7597150|NCT01970865|26429586|P10|Overall Study|Lost to Follow-up|0
7597151|NCT01970865|26429587|P9|Overall Study|Lost to Follow-up|0
7597152|NCT01970865|26429588|P8|Overall Study|Lost to Follow-up|0
7597153|NCT01970865|26429589|P7|Overall Study|Lost to Follow-up|0
7597154|NCT01970865|26429590|P6|Overall Study|Lost to Follow-up|0
7597155|NCT01970865|26429591|P5|Overall Study|Lost to Follow-up|1
7597156|NCT01970865|26429592|P4|Overall Study|Lost to Follow-up|1
7597157|NCT01970865|26429593|P3|Overall Study|Lost to Follow-up|0
7597158|NCT01970865|26429594|P2|Overall Study|Lost to Follow-up|0
7597159|NCT01970865|26429595|P1|Overall Study|Lost to Follow-up|0
7597160|NCT01970865|26429579|P17|Overall Study|Death|1
7597161|NCT01970865|26429580|P16|Overall Study|Death|10
7597162|NCT01970865|26429581|P15|Overall Study|Death|15
7597163|NCT01970865|26429582|P14|Overall Study|Death|19
7597164|NCT01970865|26429583|P13|Overall Study|Death|14
7597165|NCT01970865|26429584|P12|Overall Study|Death|4
7597166|NCT01970865|26429585|P11|Overall Study|Death|1
7597167|NCT01970865|26429586|P10|Overall Study|Death|1
7597168|NCT01970865|26429587|P9|Overall Study|Death|2
7597169|NCT01970865|26429588|P8|Overall Study|Death|3
7597170|NCT01970865|26429589|P7|Overall Study|Death|1
7597171|NCT01970865|26429590|P6|Overall Study|Death|3
7597172|NCT01970865|26429591|P5|Overall Study|Death|6
7597173|NCT01970865|26429592|P4|Overall Study|Death|4
7597174|NCT01970865|26429593|P3|Overall Study|Death|3
7597175|NCT01970865|26429594|P2|Overall Study|Death|1
7597176|NCT01970865|26429595|P1|Overall Study|Death|3
7597177|NCT01970592|26430027|P1|Overall Study|Adverse Event|1
7597178|NCT01970592|26430027|P1|Overall Study|Physician Decision|1
7597179|NCT01970592|26430027|P1|Overall Study|Withdrawal by Subject|4
7597180|NCT01970540|26430035|P3|Overall Study|Clinical deterioration|0
7597181|NCT01970540|26430036|P2|Overall Study|Clinical deterioration|0
7597182|NCT01970540|26430037|P1|Overall Study|Clinical deterioration|1
7597183|NCT01970540|26430035|P3|Overall Study|Withdrawal by Subject|1
7597184|NCT01970540|26430036|P2|Overall Study|Withdrawal by Subject|0
7597185|NCT01970540|26430037|P1|Overall Study|Withdrawal by Subject|4
7597186|NCT01970540|26430035|P3|Overall Study|Treatment-related AE|2
7597187|NCT01970540|26430036|P2|Overall Study|Treatment-related AE|0
7597188|NCT01970540|26430037|P1|Overall Study|Treatment-related AE|4
7597189|NCT01970540|26430035|P3|Overall Study|Adverse Event|1
7597190|NCT01970540|26430036|P2|Overall Study|Adverse Event|2
7597191|NCT01970540|26430037|P1|Overall Study|Adverse Event|0
7597192|NCT01970540|26430035|P3|Overall Study|End of study|2
7597193|NCT01970540|26430036|P2|Overall Study|End of study|0
7597194|NCT01970540|26430037|P1|Overall Study|End of study|2
7597195|NCT01970540|26430035|P3|Overall Study|Clinical progression|1
7597196|NCT01970540|26430036|P2|Overall Study|Clinical progression|1
7597197|NCT01970540|26430037|P1|Overall Study|Clinical progression|0
7597198|NCT01970540|26430035|P3|Overall Study|Physician Decision|0
7597199|NCT01970540|26430036|P2|Overall Study|Physician Decision|2
7597200|NCT01970540|26430037|P1|Overall Study|Physician Decision|7
7597201|NCT01970540|26430035|P3|Overall Study|Treatment delay over protocol|1
7597202|NCT01970540|26430036|P2|Overall Study|Treatment delay over protocol|0
7597203|NCT01970540|26430037|P1|Overall Study|Treatment delay over protocol|0
7597204|NCT01970540|26430035|P3|Overall Study|Progressive disease|10
7597205|NCT01970540|26430036|P2|Overall Study|Progressive disease|23
7597206|NCT01970540|26430037|P1|Overall Study|Progressive disease|55
7597207|NCT01970540|26430035|P3|Overall Study|Non-treatment-related AE|1
7597208|NCT01970540|26430036|P2|Overall Study|Non-treatment-related AE|0
7597209|NCT01970540|26430037|P1|Overall Study|Non-treatment-related AE|0
7597210|NCT01970527|26430068|P2|Follow-up Clinic Visit|Lost to Follow-up|1
7597211|NCT01970527|26430069|P1|Follow-up Clinic Visit|Lost to Follow-up|0
7597212|NCT01970527|26430068|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
7597213|NCT01970527|26430069|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
7597214|NCT01970527|26430068|P2|Follow-up Clinic Visit|Disease progression|1
7597215|NCT01970527|26430069|P1|Follow-up Clinic Visit|Disease progression|1
7597216|NCT01970527|26430068|P2|Treatment|Death|1
7597217|NCT01970527|26430069|P1|Treatment|Death|0
7597218|NCT01970527|26430068|P2|Treatment|Participant did not tolerate Ipilimumab|1
7597219|NCT01970527|26430069|P1|Treatment|Participant did not tolerate Ipilimumab|0
7597220|NCT01970527|26430068|P2|Treatment|Disease progression|1
7597221|NCT01970527|26430069|P1|Treatment|Disease progression|0
7597222|NCT01970527|26430068|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
7597223|NCT01970527|26430069|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
7597224|NCT01970488|26430082|P5|Part 2: Post Week 16|Lost to Follow-up|2
7597225|NCT01970488|26430083|P4|Part 2: Post Week 16|Lost to Follow-up|1
7597226|NCT01970488|26430084|P3|Part 2: Post Week 16|Lost to Follow-up|1
7597227|NCT01970488|26430085|P2|Part 2: Post Week 16|Lost to Follow-up|0
7597228|NCT01970488|26430086|P1|Part 2: Post Week 16|Lost to Follow-up|0
7597229|NCT01970488|26430082|P5|Part 2: Post Week 16|Withdrawal by Subject|3
7597230|NCT01970488|26430083|P4|Part 2: Post Week 16|Withdrawal by Subject|3
7597231|NCT01970488|26430084|P3|Part 2: Post Week 16|Withdrawal by Subject|8
7597232|NCT01970488|26430085|P2|Part 2: Post Week 16|Withdrawal by Subject|0
7597233|NCT01970488|26430086|P1|Part 2: Post Week 16|Withdrawal by Subject|0
7597234|NCT01970488|26430082|P5|Part 2: Post Week 16|Adverse Event|1
7597235|NCT01970488|26430083|P4|Part 2: Post Week 16|Adverse Event|1
7597236|NCT01970488|26430084|P3|Part 2: Post Week 16|Adverse Event|5
7597237|NCT01970488|26430085|P2|Part 2: Post Week 16|Adverse Event|0
7597238|NCT01970488|26430086|P1|Part 2: Post Week 16|Adverse Event|0
7597239|NCT01970488|26430082|P5|Part 2: Post Week 16|Lack of Efficacy|1
7597240|NCT01970488|26430083|P4|Part 2: Post Week 16|Lack of Efficacy|3
7597241|NCT01970488|26430084|P3|Part 2: Post Week 16|Lack of Efficacy|2
7597242|NCT01970488|26430085|P2|Part 2: Post Week 16|Lack of Efficacy|0
7597243|NCT01970488|26430086|P1|Part 2: Post Week 16|Lack of Efficacy|0
7597244|NCT01970488|26430082|P5|Part 2: Post Week 16|Non-compliance|0
7597245|NCT01970488|26430083|P4|Part 2: Post Week 16|Non-compliance|0
7597246|NCT01970488|26430084|P3|Part 2: Post Week 16|Non-compliance|1
7597247|NCT01970488|26430085|P2|Part 2: Post Week 16|Non-compliance|0
7597248|NCT01970488|26430086|P1|Part 2: Post Week 16|Non-compliance|0
7597249|NCT01970488|26430082|P5|Part 2: Post Week 16|Physician Decision|1
7597250|NCT01970488|26430083|P4|Part 2: Post Week 16|Physician Decision|0
7597251|NCT01970488|26430084|P3|Part 2: Post Week 16|Physician Decision|0
7597252|NCT01970488|26430085|P2|Part 2: Post Week 16|Physician Decision|0
7597253|NCT01970488|26430086|P1|Part 2: Post Week 16|Physician Decision|0
7597254|NCT01970488|26430082|P5|Part 1: Through Week 16|Lost to Follow-up|0
7597255|NCT01970488|26430083|P4|Part 1: Through Week 16|Lost to Follow-up|0
7597256|NCT01970488|26430084|P3|Part 1: Through Week 16|Lost to Follow-up|0
7597257|NCT01970488|26430085|P2|Part 1: Through Week 16|Lost to Follow-up|2
7597258|NCT01970488|26430086|P1|Part 1: Through Week 16|Lost to Follow-up|0
7597259|NCT01970488|26430082|P5|Part 1: Through Week 16|Withdrawal by Subject|0
7597260|NCT01970488|26430083|P4|Part 1: Through Week 16|Withdrawal by Subject|0
7597261|NCT01970488|26430084|P3|Part 1: Through Week 16|Withdrawal by Subject|0
7597262|NCT01970488|26430085|P2|Part 1: Through Week 16|Withdrawal by Subject|2
7597263|NCT01970488|26430086|P1|Part 1: Through Week 16|Withdrawal by Subject|3
7597264|NCT01970488|26430082|P5|Part 1: Through Week 16|Adverse Event|0
7597265|NCT01970488|26430083|P4|Part 1: Through Week 16|Adverse Event|0
7597266|NCT01970488|26430084|P3|Part 1: Through Week 16|Adverse Event|0
7597267|NCT01970488|26430085|P2|Part 1: Through Week 16|Adverse Event|5
7597268|NCT01970488|26430086|P1|Part 1: Through Week 16|Adverse Event|6
7597269|NCT01970488|26430082|P5|Part 1: Through Week 16|Protocol Violation|0
7597270|NCT01970488|26430083|P4|Part 1: Through Week 16|Protocol Violation|0
7597271|NCT01970488|26430084|P3|Part 1: Through Week 16|Protocol Violation|0
7597272|NCT01970488|26430085|P2|Part 1: Through Week 16|Protocol Violation|2
7597273|NCT01970488|26430086|P1|Part 1: Through Week 16|Protocol Violation|1
7597274|NCT01970488|26430082|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
7597275|NCT01970488|26430083|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
7597276|NCT01970488|26430084|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
7597277|NCT01970488|26430085|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
7597278|NCT01970488|26430086|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
7597279|NCT01970475|26430153|P2|Overall Study|Protocol Violation|0
7597280|NCT01970475|26430154|P1|Overall Study|Protocol Violation|1
7597281|NCT01970475|26430153|P2|Overall Study|Lost to Follow-up|2
7597282|NCT01970475|26430154|P1|Overall Study|Lost to Follow-up|2
7597283|NCT01970475|26430153|P2|Overall Study|Adverse Event|3
7597284|NCT01970475|26430154|P1|Overall Study|Adverse Event|7
7597285|NCT01970475|26430153|P2|Overall Study|Withdrawal by Subject|6
7597286|NCT01970475|26430154|P1|Overall Study|Withdrawal by Subject|11
7597287|NCT01970462|26430174|P2|Overall Study|Lost to Follow-up|2
7597288|NCT01970462|26430175|P1|Overall Study|Lost to Follow-up|0
7597289|NCT01970397|26430189|P2|Overall Study|Protocol Violation|1
7597290|NCT01970397|26430190|P1|Overall Study|Protocol Violation|1
7597291|NCT01970397|26430189|P2|Overall Study|Personal Reasons|2
7597292|NCT01970397|26430190|P1|Overall Study|Personal Reasons|1
7597293|NCT01970397|26430189|P2|Overall Study|Lost to Follow-up|1
7597294|NCT01970397|26430190|P1|Overall Study|Lost to Follow-up|0
7597295|NCT01970397|26430189|P2|Overall Study|Adverse Event|1
7597296|NCT01970397|26430190|P1|Overall Study|Adverse Event|0
7597297|NCT01970371|26430203|P3|Overall Study|Lost to Follow-up|1
7597298|NCT01970371|26430204|P2|Overall Study|Lost to Follow-up|0
7597299|NCT01970371|26430205|P1|Overall Study|Lost to Follow-up|0
7597300|NCT01970371|26430203|P3|Overall Study|Death|12
7597301|NCT01970371|26430204|P2|Overall Study|Death|13
7597302|NCT01970371|26430205|P1|Overall Study|Death|8
7597303|NCT01970241|26430230|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
7597304|NCT01970241|26430231|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
7597305|NCT01970241|26430230|P2|Overall Study|Withdrawal by Subject|0
7597306|NCT01970241|26430231|P1|Overall Study|Withdrawal by Subject|2
7597307|NCT01970007|26430284|P1|Overall Study|"Other endpoint"|3
7597308|NCT01970007|26430284|P1|Overall Study|Lost to Follow-up|24
7597309|NCT01970007|26430284|P1|Overall Study|Withdrawal by Subject|23
7597310|NCT01970007|26430284|P1|Overall Study|Death|5
7597311|NCT01969851|26430298|P3|Overall Study|Sponsor decision|1
7597312|NCT01969851|26430299|P2|Overall Study|Sponsor decision|0
7597313|NCT01969851|26430300|P1|Overall Study|Sponsor decision|0
7597314|NCT01969851|26430298|P3|Overall Study|No effective dose in Titration period|1
7597315|NCT01969851|26430299|P2|Overall Study|No effective dose in Titration period|0
7597316|NCT01969851|26430300|P1|Overall Study|No effective dose in Titration period|0
7597317|NCT01969851|26430298|P3|Overall Study|Withdrawal by Subject|1
7597318|NCT01969851|26430299|P2|Overall Study|Withdrawal by Subject|0
7597319|NCT01969851|26430300|P1|Overall Study|Withdrawal by Subject|1
7597320|NCT01969851|26430298|P3|Overall Study|Lack of Efficacy|1
7597321|NCT01969851|26430299|P2|Overall Study|Lack of Efficacy|3
7597322|NCT01969851|26430300|P1|Overall Study|Lack of Efficacy|0
7597323|NCT01969851|26430298|P3|Overall Study|Adverse Event|3
7597324|NCT01969851|26430299|P2|Overall Study|Adverse Event|0
7597325|NCT01969851|26430300|P1|Overall Study|Adverse Event|0
7597326|NCT01969799|26430322|P2|Overall Study|Physician Decision|0
7597327|NCT01969799|26430323|P1|Overall Study|Physician Decision|1
7597328|NCT01969799|26430322|P2|Overall Study|Lost to Follow-up|2
7597329|NCT01969799|26430323|P1|Overall Study|Lost to Follow-up|0
7597330|NCT01969799|26430322|P2|Overall Study|Death|11
7597331|NCT01969799|26430323|P1|Overall Study|Death|16
7597332|NCT01969799|26430322|P2|Overall Study|Adverse Event|1
7597333|NCT01969799|26430323|P1|Overall Study|Adverse Event|0
7597334|NCT01969721|26430360|P4|Overall Study|Discontinued during washout periods.|2
7597335|NCT01969721|26430361|P3|Overall Study|Discontinued during washout periods.|1
7597336|NCT01969721|26430362|P2|Overall Study|Discontinued during washout periods.|1
7597337|NCT01969721|26430363|P1|Overall Study|Discontinued during washout periods.|0
7597338|NCT01969721|26430360|P4|Overall Study|Other not defined above|0
7597339|NCT01969721|26430361|P3|Overall Study|Other not defined above|0
7597340|NCT01969721|26430362|P2|Overall Study|Other not defined above|2
7597341|NCT01969721|26430363|P1|Overall Study|Other not defined above|0
7597342|NCT01969721|26430360|P4|Overall Study|Non compliant with protocol|2
7597343|NCT01969721|26430361|P3|Overall Study|Non compliant with protocol|0
7597344|NCT01969721|26430362|P2|Overall Study|Non compliant with protocol|1
7597345|NCT01969721|26430363|P1|Overall Study|Non compliant with protocol|1
7597346|NCT01969721|26430360|P4|Overall Study|Lack of Efficacy|0
7597347|NCT01969721|26430361|P3|Overall Study|Lack of Efficacy|1
7597348|NCT01969721|26430362|P2|Overall Study|Lack of Efficacy|0
7597349|NCT01969721|26430363|P1|Overall Study|Lack of Efficacy|0
7597350|NCT01969721|26430360|P4|Overall Study|Adverse Event|2
7597351|NCT01969721|26430361|P3|Overall Study|Adverse Event|3
7597352|NCT01969721|26430362|P2|Overall Study|Adverse Event|8
7597353|NCT01969721|26430363|P1|Overall Study|Adverse Event|3
7597354|NCT01969565|26430408|P1|Overall Study|Withdrawal by Subject|1
7597355|NCT01969500|26430422|P2|Overall Study|extended hospitalization|1
7597356|NCT01969500|26430423|P1|Overall Study|extended hospitalization|1
7597357|NCT01969500|26430422|P2|Overall Study|Death|1
7597358|NCT01969500|26430423|P1|Overall Study|Death|0
7597359|NCT01969084|26430544|P2|Overall Study|Adverse Event|1
7597360|NCT01969084|26430545|P1|Overall Study|Adverse Event|0
7597361|NCT01969058|26430561|P2|Overall Study|Adverse Event|0
7597362|NCT01969058|26430562|P1|Overall Study|Adverse Event|1
7597363|NCT01969058|26430561|P2|Overall Study|Withdrawal by Subject|0
7597364|NCT01969058|26430562|P1|Overall Study|Withdrawal by Subject|2
7597365|NCT01968980|26430606|P2|Overall Study|Other unspecified|2
7597366|NCT01968980|26430607|P1|Overall Study|Other unspecified|1
7597367|NCT01968980|26430606|P2|Overall Study|Withdrawal by Subject|5
7597368|NCT01968980|26430607|P1|Overall Study|Withdrawal by Subject|13
7597369|NCT01968980|26430606|P2|Overall Study|Does not meet entry criteria|3
7597370|NCT01968980|26430607|P1|Overall Study|Does not meet entry criteria|1
7597371|NCT01968980|26430606|P2|Overall Study|Adverse Event|3
7597372|NCT01968980|26430607|P1|Overall Study|Adverse Event|1
7597373|NCT01968980|26430606|P2|Overall Study|Death|1
7597374|NCT01968980|26430607|P1|Overall Study|Death|0
7597375|NCT01968967|26430669|P5|Extension Period|Withdrew Consent|5
7597376|NCT01968967|26430670|P4|Extension Period|Withdrew Consent|0
7597377|NCT01968967|26430671|P3|Extension Period|Withdrew Consent|2
7597378|NCT01968967|26430672|P2|Extension Period|Withdrew Consent|0
7597379|NCT01968967|26430673|P1|Extension Period|Withdrew Consent|0
7597380|NCT01968967|26430669|P5|Treatment Period|Randomized Not Treated|0
7597381|NCT01968967|26430670|P4|Treatment Period|Randomized Not Treated|0
7597382|NCT01968967|26430671|P3|Treatment Period|Randomized Not Treated|0
7597383|NCT01968967|26430672|P2|Treatment Period|Randomized Not Treated|5
7597384|NCT01968967|26430673|P1|Treatment Period|Randomized Not Treated|6
7597385|NCT01968967|26430669|P5|Treatment Period|Death|0
7597386|NCT01968967|26430670|P4|Treatment Period|Death|0
7597387|NCT01968967|26430671|P3|Treatment Period|Death|0
7597388|NCT01968967|26430672|P2|Treatment Period|Death|2
7597389|NCT01968967|26430673|P1|Treatment Period|Death|9
7597390|NCT01968967|26430669|P5|Treatment Period|Adverse Event|0
7597391|NCT01968967|26430670|P4|Treatment Period|Adverse Event|0
7597392|NCT01968967|26430671|P3|Treatment Period|Adverse Event|0
7597393|NCT01968967|26430672|P2|Treatment Period|Adverse Event|8
7597394|NCT01968967|26430673|P1|Treatment Period|Adverse Event|9
7597395|NCT01968967|26430669|P5|Treatment Period|Protocol Violation|0
7597396|NCT01968967|26430670|P4|Treatment Period|Protocol Violation|0
7597397|NCT01968967|26430671|P3|Treatment Period|Protocol Violation|0
7597398|NCT01968967|26430672|P2|Treatment Period|Protocol Violation|2
7597399|NCT01968967|26430673|P1|Treatment Period|Protocol Violation|1
7597400|NCT01968967|26430669|P5|Treatment Period|Lost to Follow-up|0
7597401|NCT01968967|26430670|P4|Treatment Period|Lost to Follow-up|0
7597402|NCT01968967|26430671|P3|Treatment Period|Lost to Follow-up|0
7597403|NCT01968967|26430672|P2|Treatment Period|Lost to Follow-up|31
7597404|NCT01968967|26430673|P1|Treatment Period|Lost to Follow-up|26
7597405|NCT01968967|26430669|P5|Treatment Period|Did Not Meet Entrance Criteria|0
7597406|NCT01968967|26430670|P4|Treatment Period|Did Not Meet Entrance Criteria|0
7597407|NCT01968967|26430671|P3|Treatment Period|Did Not Meet Entrance Criteria|0
7597408|NCT01968967|26430672|P2|Treatment Period|Did Not Meet Entrance Criteria|3
7597409|NCT01968967|26430673|P1|Treatment Period|Did Not Meet Entrance Criteria|2
7597410|NCT01968967|26430669|P5|Treatment Period|Withdrawal by Subject|0
7597411|NCT01968967|26430670|P4|Treatment Period|Withdrawal by Subject|0
7597412|NCT01968967|26430671|P3|Treatment Period|Withdrawal by Subject|0
7597413|NCT01968967|26430672|P2|Treatment Period|Withdrawal by Subject|61
7597414|NCT01968967|26430673|P1|Treatment Period|Withdrawal by Subject|71
7597415|NCT01968967|26430669|P5|Treatment Period|Other|0
7597416|NCT01968967|26430670|P4|Treatment Period|Other|0
7597417|NCT01968967|26430671|P3|Treatment Period|Other|0
7597418|NCT01968967|26430672|P2|Treatment Period|Other|22
7597419|NCT01968967|26430673|P1|Treatment Period|Other|22
7597420|NCT01968954|26430742|P2|Overall Study|Did not met inclusion criteria|2
7597421|NCT01968954|26430743|P1|Overall Study|Did not met inclusion criteria|0
7597422|NCT01968954|26430742|P2|Overall Study|Protocol Violation|1
7597423|NCT01968954|26430743|P1|Overall Study|Protocol Violation|0
7597424|NCT01968954|26430742|P2|Overall Study|Other|8
7597425|NCT01968954|26430743|P1|Overall Study|Other|7
7597426|NCT01968954|26430742|P2|Overall Study|Withdrawal by Subject|23
7597427|NCT01968954|26430743|P1|Overall Study|Withdrawal by Subject|20
7597428|NCT01968954|26430742|P2|Overall Study|Lost to Follow-up|4
7597429|NCT01968954|26430743|P1|Overall Study|Lost to Follow-up|6
7597430|NCT01968954|26430742|P2|Overall Study|Death|2
7597431|NCT01968954|26430743|P1|Overall Study|Death|1
7597432|NCT01968954|26430742|P2|Overall Study|Adverse Event|3
7597433|NCT01968954|26430743|P1|Overall Study|Adverse Event|6
7597434|NCT01968811|26430807|P1|Overall Study|post op.ref. of subject to other hospita|1
7597435|NCT01968811|26430807|P1|Overall Study|Protocol Violation|4
7597436|NCT01968707|26430820|P8|Overall Study|Did not meet treatment day baseline|35
7597437|NCT01968707|26430821|P7|Overall Study|Did not meet treatment day baseline|34
7597438|NCT01968707|26430822|P6|Overall Study|Did not meet treatment day baseline|11
7597439|NCT01968707|26430823|P5|Overall Study|Did not meet treatment day baseline|36
7597440|NCT01968707|26430824|P4|Overall Study|Did not meet treatment day baseline|44
7597441|NCT01968707|26430825|P3|Overall Study|Did not meet treatment day baseline|41
7597442|NCT01968707|26430826|P2|Overall Study|Did not meet treatment day baseline|12
7597443|NCT01968707|26430827|P1|Overall Study|Did not meet treatment day baseline|49
7597444|NCT01968694|26430895|P2|Washout (1 Month)|Lost to Follow-up|1
7597445|NCT01968694|26430896|P1|Washout (1 Month)|Lost to Follow-up|0
7597446|NCT01968551|26430913|P3|Extension Phase|Lost to Follow-up|1
7597447|NCT01968551|26430914|P2|Extension Phase|Lost to Follow-up|0
7597448|NCT01968551|26430915|P1|Extension Phase|Lost to Follow-up|1
7597449|NCT01968551|26430913|P3|Extension Phase|Withdrew Consent|1
7597450|NCT01968551|26430914|P2|Extension Phase|Withdrew Consent|0
7597451|NCT01968551|26430915|P1|Extension Phase|Withdrew Consent|0
7597452|NCT01968551|26430913|P3|Extension Phase|Death|0
7597453|NCT01968551|26430914|P2|Extension Phase|Death|1
7597454|NCT01968551|26430915|P1|Extension Phase|Death|0
7597455|NCT01968551|26430913|P3|Extension Phase|Adverse Event|2
7597456|NCT01968551|26430914|P2|Extension Phase|Adverse Event|0
7597457|NCT01968551|26430915|P1|Extension Phase|Adverse Event|0
7597458|NCT01968551|26430913|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
7597459|NCT01968551|26430914|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7597460|NCT01968551|26430915|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7597461|NCT01968551|26430913|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
7597462|NCT01968551|26430914|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
7597463|NCT01968551|26430915|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
7597464|NCT01968551|26430913|P3|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7597465|NCT01968551|26430914|P2|Open Label Phase (48 Weeks)|Investigator's Discretion|1
7597466|NCT01968551|26430915|P1|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7597467|NCT01968551|26430913|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
7597468|NCT01968551|26430914|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7597469|NCT01968551|26430915|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7597470|NCT01968434|26430952|P2|Overall Study|Lost to Follow-up|6
7597471|NCT01968434|26430953|P1|Overall Study|Lost to Follow-up|3
7597472|NCT01968226|26431117|P1|Overall Study|[F-18] RDG-K5 was not available|2
7597473|NCT01968213|26431123|P2|Overall Study|Ongoing|9
7597474|NCT01968213|26431124|P1|Overall Study|Ongoing|90
7597475|NCT01968070|26431166|P18|Period 2|Withdrawal by Subject|0
7597476|NCT01968070|26431167|P17|Period 2|Withdrawal by Subject|0
7597477|NCT01968070|26431168|P16|Period 2|Withdrawal by Subject|0
7597478|NCT01968070|26431169|P15|Period 2|Withdrawal by Subject|0
7597479|NCT01968070|26431170|P14|Period 2|Withdrawal by Subject|0
7597480|NCT01968070|26431171|P13|Period 2|Withdrawal by Subject|0
7597481|NCT01968070|26431172|P12|Period 2|Withdrawal by Subject|0
7597482|NCT01968070|26431173|P11|Period 2|Withdrawal by Subject|0
7597483|NCT01968070|26431174|P10|Period 2|Withdrawal by Subject|0
7597484|NCT01968070|26431175|P9|Period 2|Withdrawal by Subject|0
7597485|NCT01968070|26431176|P8|Period 2|Withdrawal by Subject|0
7597486|NCT01968070|26431177|P7|Period 2|Withdrawal by Subject|0
7597487|NCT01968070|26431178|P6|Period 2|Withdrawal by Subject|0
7597488|NCT01968070|26431179|P5|Period 2|Withdrawal by Subject|1
7597489|NCT01968070|26431180|P4|Period 2|Withdrawal by Subject|0
7597490|NCT01968070|26431181|P3|Period 2|Withdrawal by Subject|0
7597491|NCT01968070|26431182|P2|Period 2|Withdrawal by Subject|0
7597492|NCT01968070|26431183|P1|Period 2|Withdrawal by Subject|0
7597493|NCT01968070|26431166|P18|Period 1|Physician Decision|0
7597494|NCT01968070|26431167|P17|Period 1|Physician Decision|0
7597495|NCT01968070|26431168|P16|Period 1|Physician Decision|0
7597496|NCT01968070|26431169|P15|Period 1|Physician Decision|0
7597497|NCT01968070|26431170|P14|Period 1|Physician Decision|0
7597498|NCT01968070|26431171|P13|Period 1|Physician Decision|0
7597499|NCT01968070|26431172|P12|Period 1|Physician Decision|1
7597500|NCT01968070|26431173|P11|Period 1|Physician Decision|0
7597501|NCT01968070|26431174|P10|Period 1|Physician Decision|0
7597502|NCT01968070|26431175|P9|Period 1|Physician Decision|0
7597503|NCT01968070|26431176|P8|Period 1|Physician Decision|0
7597504|NCT01968070|26431177|P7|Period 1|Physician Decision|0
7597505|NCT01968070|26431178|P6|Period 1|Physician Decision|0
7597506|NCT01968070|26431179|P5|Period 1|Physician Decision|0
7597507|NCT01968070|26431180|P4|Period 1|Physician Decision|0
7597508|NCT01968070|26431181|P3|Period 1|Physician Decision|0
7597509|NCT01968070|26431182|P2|Period 1|Physician Decision|0
7597510|NCT01968070|26431183|P1|Period 1|Physician Decision|0
7597511|NCT01968070|26431166|P18|Period 1|Adverse Event|0
7597512|NCT01968070|26431167|P17|Period 1|Adverse Event|0
7597513|NCT01968070|26431168|P16|Period 1|Adverse Event|0
7597514|NCT01968070|26431169|P15|Period 1|Adverse Event|0
7597515|NCT01968070|26431170|P14|Period 1|Adverse Event|0
7597516|NCT01968070|26431171|P13|Period 1|Adverse Event|0
7597517|NCT01968070|26431172|P12|Period 1|Adverse Event|0
7597518|NCT01968070|26431173|P11|Period 1|Adverse Event|0
7597519|NCT01968070|26431174|P10|Period 1|Adverse Event|0
7597520|NCT01968070|26431175|P9|Period 1|Adverse Event|0
7597521|NCT01968070|26431176|P8|Period 1|Adverse Event|0
7597522|NCT01968070|26431177|P7|Period 1|Adverse Event|1
7597523|NCT01968070|26431178|P6|Period 1|Adverse Event|0
7597524|NCT01968070|26431179|P5|Period 1|Adverse Event|0
7597525|NCT01968070|26431180|P4|Period 1|Adverse Event|0
7597526|NCT01968070|26431181|P3|Period 1|Adverse Event|0
7597527|NCT01968070|26431182|P2|Period 1|Adverse Event|0
7597528|NCT01968070|26431183|P1|Period 1|Adverse Event|0
7597529|NCT01968070|26431166|P18|Period 1|Lost to Follow-up|0
7597530|NCT01968070|26431167|P17|Period 1|Lost to Follow-up|0
7597531|NCT01968070|26431168|P16|Period 1|Lost to Follow-up|0
7597532|NCT01968070|26431169|P15|Period 1|Lost to Follow-up|0
7597533|NCT01968070|26431170|P14|Period 1|Lost to Follow-up|0
7597534|NCT01968070|26431171|P13|Period 1|Lost to Follow-up|0
7597535|NCT01968070|26431172|P12|Period 1|Lost to Follow-up|0
7597536|NCT01968070|26431173|P11|Period 1|Lost to Follow-up|0
7597537|NCT01968070|26431174|P10|Period 1|Lost to Follow-up|0
7597538|NCT01968070|26431175|P9|Period 1|Lost to Follow-up|0
7597539|NCT01968070|26431176|P8|Period 1|Lost to Follow-up|0
7597540|NCT01968070|26431177|P7|Period 1|Lost to Follow-up|0
7597541|NCT01968070|26431178|P6|Period 1|Lost to Follow-up|0
7597542|NCT01968070|26431179|P5|Period 1|Lost to Follow-up|0
7597543|NCT01968070|26431180|P4|Period 1|Lost to Follow-up|1
7597544|NCT01968070|26431181|P3|Period 1|Lost to Follow-up|0
7597545|NCT01968070|26431182|P2|Period 1|Lost to Follow-up|0
7597546|NCT01968070|26431183|P1|Period 1|Lost to Follow-up|0
7597547|NCT01968070|26431166|P18|Period 1|Protocol Violation|0
7597548|NCT01968070|26431167|P17|Period 1|Protocol Violation|0
7597549|NCT01968070|26431168|P16|Period 1|Protocol Violation|0
7597550|NCT01968070|26431169|P15|Period 1|Protocol Violation|0
7597551|NCT01968070|26431170|P14|Period 1|Protocol Violation|0
7597552|NCT01968070|26431171|P13|Period 1|Protocol Violation|0
7597553|NCT01968070|26431172|P12|Period 1|Protocol Violation|0
7597554|NCT01968070|26431173|P11|Period 1|Protocol Violation|0
7597555|NCT01968070|26431174|P10|Period 1|Protocol Violation|0
7597556|NCT01968070|26431175|P9|Period 1|Protocol Violation|0
7597557|NCT01968070|26431176|P8|Period 1|Protocol Violation|0
7597558|NCT01968070|26431177|P7|Period 1|Protocol Violation|0
7597559|NCT01968070|26431178|P6|Period 1|Protocol Violation|0
7597560|NCT01968070|26431179|P5|Period 1|Protocol Violation|1
7597561|NCT01968070|26431180|P4|Period 1|Protocol Violation|1
7597562|NCT01968070|26431181|P3|Period 1|Protocol Violation|0
7597563|NCT01968070|26431182|P2|Period 1|Protocol Violation|0
7597564|NCT01968070|26431183|P1|Period 1|Protocol Violation|0
7597565|NCT01968070|26431166|P18|Period 1|Withdrawal by Subject|0
7597566|NCT01968070|26431167|P17|Period 1|Withdrawal by Subject|0
7597567|NCT01968070|26431168|P16|Period 1|Withdrawal by Subject|1
7597568|NCT01968070|26431169|P15|Period 1|Withdrawal by Subject|0
7597569|NCT01968070|26431170|P14|Period 1|Withdrawal by Subject|0
7597570|NCT01968070|26431171|P13|Period 1|Withdrawal by Subject|0
7597571|NCT01968070|26431172|P12|Period 1|Withdrawal by Subject|0
7597572|NCT01968070|26431173|P11|Period 1|Withdrawal by Subject|0
7597573|NCT01968070|26431174|P10|Period 1|Withdrawal by Subject|0
7597574|NCT01968070|26431175|P9|Period 1|Withdrawal by Subject|0
7597575|NCT01968070|26431176|P8|Period 1|Withdrawal by Subject|0
7597576|NCT01968070|26431177|P7|Period 1|Withdrawal by Subject|1
7597577|NCT01968070|26431178|P6|Period 1|Withdrawal by Subject|0
7597578|NCT01968070|26431179|P5|Period 1|Withdrawal by Subject|0
7597579|NCT01968070|26431180|P4|Period 1|Withdrawal by Subject|0
7597580|NCT01968070|26431181|P3|Period 1|Withdrawal by Subject|0
7597581|NCT01968070|26431182|P2|Period 1|Withdrawal by Subject|1
7597582|NCT01968070|26431183|P1|Period 1|Withdrawal by Subject|0
7597583|NCT01968031|26431254|P3|Overall Study|Prohibited concomitant medication|0
7597584|NCT01968031|26431255|P2|Overall Study|Prohibited concomitant medication|0
7597585|NCT01968031|26431256|P1|Overall Study|Prohibited concomitant medication|1
7597586|NCT01968031|26431254|P3|Overall Study|Death|1
7597587|NCT01968031|26431255|P2|Overall Study|Death|0
7597588|NCT01968031|26431256|P1|Overall Study|Death|0
7597589|NCT01968031|26431254|P3|Overall Study|Failed inclusion criteria|0
7597590|NCT01968031|26431255|P2|Overall Study|Failed inclusion criteria|2
7597591|NCT01968031|26431256|P1|Overall Study|Failed inclusion criteria|0
7597592|NCT01968031|26431254|P3|Overall Study|Noncompliance|2
7597593|NCT01968031|26431255|P2|Overall Study|Noncompliance|0
7597594|NCT01968031|26431256|P1|Overall Study|Noncompliance|0
7597595|NCT01968031|26431254|P3|Overall Study|Did not meet entry criteria|1
7597596|NCT01968031|26431255|P2|Overall Study|Did not meet entry criteria|1
7597597|NCT01968031|26431256|P1|Overall Study|Did not meet entry criteria|1
7597598|NCT01968031|26431254|P3|Overall Study|Withdrawal by Subject|3
7597599|NCT01968031|26431255|P2|Overall Study|Withdrawal by Subject|7
7597600|NCT01968031|26431256|P1|Overall Study|Withdrawal by Subject|3
7597601|NCT01968031|26431254|P3|Overall Study|Adverse Event|22
7597602|NCT01968031|26431255|P2|Overall Study|Adverse Event|10
7597603|NCT01968031|26431256|P1|Overall Study|Adverse Event|13
7597604|NCT01967940|26431300|P4|Part 2|Unknown Reason|1
7597605|NCT01967940|26431301|P3|Part 2|Unknown Reason|0
7597606|NCT01967940|26431302|P2|Part 2|Unknown Reason|0
7597607|NCT01967940|26431303|P1|Part 2|Unknown Reason|0
7597608|NCT01967940|26431300|P4|Part 2|Adverse Event|1
7597609|NCT01967940|26431301|P3|Part 2|Adverse Event|0
7597610|NCT01967940|26431302|P2|Part 2|Adverse Event|0
7597611|NCT01967940|26431303|P1|Part 2|Adverse Event|0
7597612|NCT01967940|26431300|P4|Part 2|Enrolled in Part 2 and Never Treated|1
7597613|NCT01967940|26431301|P3|Part 2|Enrolled in Part 2 and Never Treated|0
7597614|NCT01967940|26431302|P2|Part 2|Enrolled in Part 2 and Never Treated|0
7597615|NCT01967940|26431303|P1|Part 2|Enrolled in Part 2 and Never Treated|0
7597630|NCT01967823|26431410|P1|Overall Study|Died prior to completing therapy (before the six-week mark).|1
7597631|NCT01967732|26431429|P4|First Intervention (Day 1)|Poor venous access|0
7597632|NCT01967732|26431430|P3|First Intervention (Day 1)|Poor venous access|0
7597633|NCT01967732|26431431|P2|First Intervention (Day 1)|Poor venous access|1
7597634|NCT01967732|26431432|P1|First Intervention (Day 1)|Poor venous access|0
7597635|NCT01967732|26431429|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7597636|NCT01967732|26431430|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7597637|NCT01967732|26431431|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
7597638|NCT01967732|26431432|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7597639|NCT01967719|26431446|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
7597640|NCT01967719|26431447|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
7597641|NCT01967719|26431448|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
7597642|NCT01967719|26431449|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
7597643|NCT01967719|26431446|P4|First Intervention (Day 1)|Withdrawal by Subject|1
7597644|NCT01967719|26431447|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7597645|NCT01967719|26431448|P2|First Intervention (Day 1)|Withdrawal by Subject|1
7597646|NCT01967719|26431449|P1|First Intervention (Day 1)|Withdrawal by Subject|0
7597647|NCT01967706|26431464|P4|First Intervention (Day 1)|Withdrawal by Subject|0
7597648|NCT01967706|26431465|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7597649|NCT01967706|26431466|P2|First Intervention (Day 1)|Withdrawal by Subject|0
7597650|NCT01967706|26431467|P1|First Intervention (Day 1)|Withdrawal by Subject|1
7597651|NCT01967628|26431488|P2|Overall Study|Low protein concentration in sample|25
7597652|NCT01967628|26431489|P1|Overall Study|Low protein concentration in sample|20
7597653|NCT01967628|26431488|P2|Overall Study|Lost to Follow-up|0
7597654|NCT01967628|26431489|P1|Overall Study|Lost to Follow-up|1
7597655|NCT01967628|26431488|P2|Overall Study|Unable to complete bronchoscopy|6
7597656|NCT01967628|26431489|P1|Overall Study|Unable to complete bronchoscopy|4
7597657|NCT01967628|26431488|P2|Overall Study|Withdrawal by Subject|0
7597658|NCT01967628|26431489|P1|Overall Study|Withdrawal by Subject|2
7597659|NCT01967576|26431495|P1|Overall Study|Refused further treatment|1
7597660|NCT01967576|26431495|P1|Overall Study|Adverse Event|1
7597661|NCT01967576|26431495|P1|Overall Study|Study closing at site|1
7597662|NCT01967576|26431495|P1|Overall Study|Progressed/Removed from treatment|1
7597663|NCT01967576|26431495|P1|Overall Study|Withdrawal by Subject|3
7597664|NCT01967550|26431506|P2|Overall Study|Non Compliance|1
7597665|NCT01967550|26431507|P1|Overall Study|Non Compliance|0
7597666|NCT01967550|26431506|P2|Overall Study|Protocol Violation|1
7597667|NCT01967550|26431507|P1|Overall Study|Protocol Violation|2
7597668|NCT01967550|26431506|P2|Overall Study|Adverse Event|0
7597669|NCT01967550|26431507|P1|Overall Study|Adverse Event|2
7597670|NCT01967550|26431506|P2|Overall Study|Withdrawal by Subject|0
7597671|NCT01967550|26431507|P1|Overall Study|Withdrawal by Subject|1
7597672|NCT01967537|26431513|P1|Overall Study|Lost to Follow-up|6
7597673|NCT01967537|26431513|P1|Overall Study|Refuse treatment|2
7597674|NCT01967537|26431513|P1|Overall Study|Withdrawal by Subject|52
7597675|NCT01967277|26431567|P2|Overall Study|Unrelated illness|1
7597676|NCT01967277|26431568|P1|Overall Study|Unrelated illness|0
7597677|NCT01967277|26431567|P2|Overall Study|Lost to Follow-up|2
7597678|NCT01967277|26431568|P1|Overall Study|Lost to Follow-up|1
7597679|NCT01967225|26431580|P2|Overall Study|Protocol Violation|0
7597680|NCT01967225|26431581|P1|Overall Study|Protocol Violation|2
7597681|NCT01967225|26431580|P2|Overall Study|Logistical difficulties|0
7597682|NCT01967225|26431581|P1|Overall Study|Logistical difficulties|1
7597683|NCT01967225|26431580|P2|Overall Study|Protocol driven decision point|0
7597684|NCT01967225|26431581|P1|Overall Study|Protocol driven decision point|1
7597685|NCT01967225|26431580|P2|Overall Study|Switching to other therapy|0
7597686|NCT01967225|26431581|P1|Overall Study|Switching to other therapy|2
7597687|NCT01967225|26431580|P2|Overall Study|Lack of Efficacy|1
7597688|NCT01967225|26431581|P1|Overall Study|Lack of Efficacy|1
7597689|NCT01967225|26431580|P2|Overall Study|Withdrawal by Subject|1
7597690|NCT01967225|26431581|P1|Overall Study|Withdrawal by Subject|2
7597691|NCT01967225|26431580|P2|Overall Study|Adverse Event|1
7597692|NCT01967225|26431581|P1|Overall Study|Adverse Event|3
7597693|NCT01967173|26431613|P8|Overall Study|Withdrawal by Subject|12
7597694|NCT01967173|26431614|P7|Overall Study|Withdrawal by Subject|10
7597695|NCT01967173|26431615|P6|Overall Study|Withdrawal by Subject|9
7597696|NCT01967173|26431616|P5|Overall Study|Withdrawal by Subject|8
7597697|NCT01967173|26431617|P4|Overall Study|Withdrawal by Subject|7
7597698|NCT01967173|26431618|P3|Overall Study|Withdrawal by Subject|10
7597699|NCT01967173|26431619|P2|Overall Study|Withdrawal by Subject|14
7597700|NCT01967173|26431620|P1|Overall Study|Withdrawal by Subject|15
7597701|NCT01967173|26431613|P8|Overall Study|Adverse Event|1
7597702|NCT01967173|26431614|P7|Overall Study|Adverse Event|0
7597703|NCT01967173|26431615|P6|Overall Study|Adverse Event|0
7597704|NCT01967173|26431616|P5|Overall Study|Adverse Event|0
7597705|NCT01967173|26431617|P4|Overall Study|Adverse Event|0
7597706|NCT01967173|26431618|P3|Overall Study|Adverse Event|0
7597707|NCT01967173|26431619|P2|Overall Study|Adverse Event|0
7597708|NCT01967173|26431620|P1|Overall Study|Adverse Event|0
7597709|NCT01967173|26431613|P8|Overall Study|Pregnancy|1
7597710|NCT01967173|26431614|P7|Overall Study|Pregnancy|1
7597711|NCT01967173|26431615|P6|Overall Study|Pregnancy|0
7597712|NCT01967173|26431616|P5|Overall Study|Pregnancy|0
7597713|NCT01967173|26431617|P4|Overall Study|Pregnancy|0
7597714|NCT01967173|26431618|P3|Overall Study|Pregnancy|0
7597715|NCT01967173|26431619|P2|Overall Study|Pregnancy|0
7597716|NCT01967173|26431620|P1|Overall Study|Pregnancy|0
7597717|NCT01967173|26431613|P8|Overall Study|Lack of Efficacy|2
7597718|NCT01967173|26431614|P7|Overall Study|Lack of Efficacy|0
7597719|NCT01967173|26431615|P6|Overall Study|Lack of Efficacy|1
7597720|NCT01967173|26431616|P5|Overall Study|Lack of Efficacy|0
7597721|NCT01967173|26431617|P4|Overall Study|Lack of Efficacy|2
7597722|NCT01967173|26431618|P3|Overall Study|Lack of Efficacy|2
7597723|NCT01967173|26431619|P2|Overall Study|Lack of Efficacy|0
7597724|NCT01967173|26431620|P1|Overall Study|Lack of Efficacy|2
7597725|NCT01967173|26431613|P8|Overall Study|Physician Decision|0
7597726|NCT01967173|26431614|P7|Overall Study|Physician Decision|1
7597727|NCT01967173|26431615|P6|Overall Study|Physician Decision|1
7597728|NCT01967173|26431616|P5|Overall Study|Physician Decision|1
7597729|NCT01967173|26431617|P4|Overall Study|Physician Decision|1
7597730|NCT01967173|26431618|P3|Overall Study|Physician Decision|2
7597731|NCT01967173|26431619|P2|Overall Study|Physician Decision|0
7597732|NCT01967173|26431620|P1|Overall Study|Physician Decision|2
7597733|NCT01967173|26431613|P8|Overall Study|Lost to Follow-up|8
7597734|NCT01967173|26431614|P7|Overall Study|Lost to Follow-up|6
7597735|NCT01967173|26431615|P6|Overall Study|Lost to Follow-up|12
7597736|NCT01967173|26431616|P5|Overall Study|Lost to Follow-up|8
7597737|NCT01967173|26431617|P4|Overall Study|Lost to Follow-up|4
7597738|NCT01967173|26431618|P3|Overall Study|Lost to Follow-up|2
7597739|NCT01967173|26431619|P2|Overall Study|Lost to Follow-up|3
7597740|NCT01967173|26431620|P1|Overall Study|Lost to Follow-up|5
7597741|NCT01967147|26431634|P2|Overall Study|Other|5
7597742|NCT01967147|26431635|P1|Overall Study|Other|4
7597743|NCT01967147|26431634|P2|Overall Study|Non-compliance with Study Drug|3
7597744|NCT01967147|26431635|P1|Overall Study|Non-compliance with Study Drug|0
7597745|NCT01967147|26431634|P2|Overall Study|Withdrawal by Subject|4
7597746|NCT01967147|26431635|P1|Overall Study|Withdrawal by Subject|2
7597747|NCT01967147|26431634|P2|Overall Study|Lost to Follow-up|2
7597748|NCT01967147|26431635|P1|Overall Study|Lost to Follow-up|1
7597749|NCT01967147|26431634|P2|Overall Study|Lack of Efficacy|4
7597750|NCT01967147|26431635|P1|Overall Study|Lack of Efficacy|1
7597751|NCT01967147|26431634|P2|Overall Study|Adverse Event|2
7597752|NCT01967147|26431635|P1|Overall Study|Adverse Event|5
7597753|NCT01967134|26431653|P3|Overall Study|Lost to Follow-up|0
7597754|NCT01967134|26431654|P2|Overall Study|Lost to Follow-up|1
7597755|NCT01967134|26431655|P1|Overall Study|Lost to Follow-up|0
7597756|NCT01967069|26431690|P2|Overall Study|Lack of Efficacy|1
7597757|NCT01967069|26431691|P1|Overall Study|Lack of Efficacy|0
7597758|NCT01967069|26431690|P2|Overall Study|Withdrawal by Subject|3
7597759|NCT01967069|26431691|P1|Overall Study|Withdrawal by Subject|1
7597760|NCT01967069|26431690|P2|Overall Study|Lost to Follow-up|2
7597761|NCT01967069|26431691|P1|Overall Study|Lost to Follow-up|5
7597762|NCT01967069|26431690|P2|Overall Study|Adverse Event|2
7597763|NCT01967069|26431691|P1|Overall Study|Adverse Event|2
7597764|NCT01966731|26431889|P1|Overall Study|Found to be ineligible|1
7597765|NCT01966731|26431889|P1|Overall Study|Screening Failure|29
7597766|NCT01966731|26431889|P1|Overall Study|Follow up is not complete|600
7597767|NCT01966731|26431889|P1|Overall Study|Physician Decision|2
7597768|NCT01966731|26431889|P1|Overall Study|Lost to Follow-up|1
7597769|NCT01966731|26431889|P1|Overall Study|Death|2
7597770|NCT01966471|26431903|P2|Overall Study|Withdrawal by Subject|43
7597771|NCT01966471|26431904|P1|Overall Study|Withdrawal by Subject|48
7597772|NCT01966471|26431903|P2|Overall Study|Physician Decision|5
7597773|NCT01966471|26431904|P1|Overall Study|Physician Decision|5
7597774|NCT01966471|26431903|P2|Overall Study|Other|5
7597775|NCT01966471|26431904|P1|Overall Study|Other|3
7597776|NCT01966471|26431903|P2|Overall Study|Lost to Follow-up|16
7597777|NCT01966471|26431904|P1|Overall Study|Lost to Follow-up|14
7597778|NCT01966471|26431903|P2|Overall Study|Death|44
7597779|NCT01966471|26431904|P1|Overall Study|Death|33
7597780|NCT01966445|26431938|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
7597781|NCT01966445|26431939|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7597782|NCT01966445|26431940|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7597783|NCT01966445|26431941|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7597784|NCT01966445|26431942|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7597785|NCT01966445|26431943|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7597786|NCT01966445|26431944|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7597787|NCT01966445|26431938|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
7597788|NCT01966445|26431939|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7597789|NCT01966445|26431940|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7597790|NCT01966445|26431941|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7597791|NCT01966445|26431942|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7597792|NCT01966445|26431943|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7597793|NCT01966445|26431944|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7597878|NCT01965652|26432298|P1|Overall Study|Withdrawal by Subject|62
7597794|NCT01966445|26431938|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7597795|NCT01966445|26431939|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7597796|NCT01966445|26431940|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
7597797|NCT01966445|26431941|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7597798|NCT01966445|26431942|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7597799|NCT01966445|26431943|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7597800|NCT01966445|26431944|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7597801|NCT01966445|26431938|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7597802|NCT01966445|26431939|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7597803|NCT01966445|26431940|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7597804|NCT01966445|26431941|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7597805|NCT01966445|26431942|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7597806|NCT01966445|26431943|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7597807|NCT01966445|26431944|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7597808|NCT01966445|26431938|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7597809|NCT01966445|26431939|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
7597810|NCT01966445|26431940|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7597811|NCT01966445|26431941|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
7597812|NCT01966445|26431942|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7597813|NCT01966445|26431943|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7597814|NCT01966445|26431944|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7597815|NCT01966432|26432054|P3|Overall Study|SBIRT program ended|20
7597816|NCT01966432|26432055|P2|Overall Study|SBIRT program ended|8
7597817|NCT01966432|26432056|P1|Overall Study|SBIRT program ended|1
7597818|NCT01966432|26432054|P3|Overall Study|Subject Incarcerated|1
7597819|NCT01966432|26432055|P2|Overall Study|Subject Incarcerated|0
7597820|NCT01966432|26432056|P1|Overall Study|Subject Incarcerated|0
7597821|NCT01966432|26432054|P3|Overall Study|Withdrawal by Subject|0
7597822|NCT01966432|26432055|P2|Overall Study|Withdrawal by Subject|3
7597823|NCT01966432|26432056|P1|Overall Study|Withdrawal by Subject|1
7597824|NCT01966432|26432054|P3|Overall Study|Lost to Follow-up|5
7597825|NCT01966432|26432055|P2|Overall Study|Lost to Follow-up|2
7597826|NCT01966432|26432056|P1|Overall Study|Lost to Follow-up|3
7597827|NCT01966120|26432135|P2|Overall Study|Lost to Follow-up|1
7597828|NCT01966120|26432136|P1|Overall Study|Lost to Follow-up|1
7597829|NCT01966120|26432135|P2|Overall Study|Withdrawal by Subject|5
7597830|NCT01966120|26432136|P1|Overall Study|Withdrawal by Subject|0
7597831|NCT01966107|26432160|P2|Overall Study|withdrew from the study|303
7597832|NCT01966107|26432161|P1|Overall Study|withdrew from the study|272
7597833|NCT01966107|26432160|P2|Overall Study|due to study closure|186
7597834|NCT01966107|26432161|P1|Overall Study|due to study closure|164
7597835|NCT01966107|26432160|P2|Overall Study|discontinued treatment|372
7597836|NCT01966107|26432161|P1|Overall Study|discontinued treatment|345
7597837|NCT01966107|26432160|P2|Overall Study|excluded from FAS|20
7597838|NCT01966107|26432161|P1|Overall Study|excluded from FAS|21
7597839|NCT01966068|26432175|P1|Overall Study|Lost to Follow-up|81
7597840|NCT01966068|26432175|P1|Overall Study|Withdrawal by Subject|57
7597841|NCT01966042|26432180|P1|Overall Study|Death|2
7597842|NCT01966003|26432189|P2|Overall Study|Other|1
7597843|NCT01966003|26432190|P1|Overall Study|Other|1
7597844|NCT01966003|26432189|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
7597845|NCT01966003|26432190|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
7597846|NCT01966003|26432189|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
7597847|NCT01966003|26432190|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
7597848|NCT01966003|26432189|P2|Overall Study|Withdrawal by Subject|19
7597849|NCT01966003|26432190|P1|Overall Study|Withdrawal by Subject|29
7597850|NCT01966003|26432189|P2|Overall Study|Physician Decision|13
7597851|NCT01966003|26432190|P1|Overall Study|Physician Decision|12
7597852|NCT01966003|26432189|P2|Overall Study|Lost to Follow-up|3
7597853|NCT01966003|26432190|P1|Overall Study|Lost to Follow-up|4
7597854|NCT01966003|26432189|P2|Overall Study|Protocol Violation|4
7597855|NCT01966003|26432190|P1|Overall Study|Protocol Violation|6
7597856|NCT01966003|26432189|P2|Overall Study|Death|36
7597857|NCT01966003|26432190|P1|Overall Study|Death|43
7597858|NCT01965938|26432208|P2|Overall Study|Withdrawal by Subject|0
7597859|NCT01965938|26432209|P1|Overall Study|Withdrawal by Subject|1
7597860|NCT01965860|26432243|P3|Overall Study|Logistics|0
7597861|NCT01965860|26432244|P2|Overall Study|Logistics|0
7597862|NCT01965860|26432245|P1|Overall Study|Logistics|1
7597863|NCT01965860|26432243|P3|Overall Study|Pregnancy|1
7597864|NCT01965860|26432244|P2|Overall Study|Pregnancy|0
7597865|NCT01965860|26432245|P1|Overall Study|Pregnancy|1
7597866|NCT01965834|26432256|P1|Overall Study|Lack of Efficacy|4
7597867|NCT01965652|26432297|P2|Overall Study|Pregnancy|1
7597868|NCT01965652|26432298|P1|Overall Study|Pregnancy|0
7597869|NCT01965652|26432297|P2|Overall Study|Other - Miscellaneous|21
7597870|NCT01965652|26432298|P1|Overall Study|Other - Miscellaneous|18
7597871|NCT01965652|26432297|P2|Overall Study|Death|4
7597872|NCT01965652|26432298|P1|Overall Study|Death|3
7597873|NCT01965652|26432297|P2|Overall Study|Protocol Violation|38
7597874|NCT01965652|26432298|P1|Overall Study|Protocol Violation|34
7597875|NCT01965652|26432297|P2|Overall Study|Lost to Follow-up|40
7597876|NCT01965652|26432298|P1|Overall Study|Lost to Follow-up|53
7597877|NCT01965652|26432297|P2|Overall Study|Withdrawal by Subject|69
7597879|NCT01965652|26432297|P2|Overall Study|Adverse Event|37
7597880|NCT01965652|26432298|P1|Overall Study|Adverse Event|40
7597881|NCT01965600|26432328|P4|Second Intervention|Study terminated by Sponsor|2
7597882|NCT01965600|26432329|P3|Second Intervention|Study terminated by Sponsor|2
7597883|NCT01965600|26432330|P2|Second Intervention|Study terminated by Sponsor|0
7597884|NCT01965600|26432331|P1|Second Intervention|Study terminated by Sponsor|0
7597885|NCT01965600|26432328|P4|Washout Period of Approximately 15 Days|Adverse Event|1
7597886|NCT01965600|26432329|P3|Washout Period of Approximately 15 Days|Adverse Event|0
7597887|NCT01965600|26432330|P2|Washout Period of Approximately 15 Days|Adverse Event|0
7597888|NCT01965600|26432331|P1|Washout Period of Approximately 15 Days|Adverse Event|0
7597889|NCT01965600|26432328|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7597890|NCT01965600|26432329|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7597891|NCT01965600|26432330|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7597892|NCT01965600|26432331|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
7597893|NCT01965600|26432328|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7597894|NCT01965600|26432329|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7597895|NCT01965600|26432330|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
7597896|NCT01965600|26432331|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7597897|NCT01965600|26432328|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7597898|NCT01965600|26432329|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
7597899|NCT01965600|26432330|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
7597900|NCT01965600|26432331|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7597901|NCT01965535|26432388|P2|Overall Study|Lack of Efficacy|1
7597902|NCT01965535|26432389|P1|Overall Study|Lack of Efficacy|2
7597903|NCT01965431|26432403|P6|Overall Study|Other than stated above|6
7597904|NCT01965431|26432404|P5|Overall Study|Other than stated above|6
7597905|NCT01965431|26432405|P4|Overall Study|Other than stated above|6
7597906|NCT01965431|26432406|P3|Overall Study|Other than stated above|6
7597907|NCT01965431|26432407|P2|Overall Study|Other than stated above|5
7597908|NCT01965431|26432408|P1|Overall Study|Other than stated above|6
7597909|NCT01965431|26432403|P6|Overall Study|Adverse Event|0
7597910|NCT01965431|26432404|P5|Overall Study|Adverse Event|0
7597911|NCT01965431|26432405|P4|Overall Study|Adverse Event|0
7597912|NCT01965431|26432406|P3|Overall Study|Adverse Event|0
7597913|NCT01965431|26432407|P2|Overall Study|Adverse Event|1
7597914|NCT01965431|26432408|P1|Overall Study|Adverse Event|0
7597915|NCT01965327|26432432|P1|Overall Study|Physician Decision|2
7597916|NCT01965262|26432646|P2|Second Intervention (7 Days)|Poor visual acuity|0
7597917|NCT01965262|26432647|P1|Second Intervention (7 Days)|Poor visual acuity|1
7597918|NCT01965262|26432646|P2|Second Intervention (7 Days)|Poor lens fit|9
7597919|NCT01965262|26432647|P1|Second Intervention (7 Days)|Poor lens fit|0
7597920|NCT01965262|26432646|P2|Second Intervention (7 Days)|Discontinued|1
7597921|NCT01965262|26432647|P1|Second Intervention (7 Days)|Discontinued|0
7597922|NCT01965158|26432711|P2|Overall Study|Other - Miscellaneous|0
7597923|NCT01965158|26432712|P1|Overall Study|Other - Miscellaneous|3
7597924|NCT01965158|26432711|P2|Overall Study|Protocol Violation|1
7597925|NCT01965158|26432712|P1|Overall Study|Protocol Violation|1
7597926|NCT01965158|26432711|P2|Overall Study|Lost to Follow-up|5
7597927|NCT01965158|26432712|P1|Overall Study|Lost to Follow-up|7
7597928|NCT01965158|26432711|P2|Overall Study|Withdrawal by Subject|24
7597929|NCT01965158|26432712|P1|Overall Study|Withdrawal by Subject|16
7597930|NCT01965158|26432711|P2|Overall Study|Adverse Event|5
7597931|NCT01965158|26432712|P1|Overall Study|Adverse Event|14
7597932|NCT01964976|26432753|P1|Overall Study|Protocol Violation|31
7597933|NCT01964963|26432765|P1|Overall Study|Data Reliability was not Assured|5
7597934|NCT01964963|26432765|P1|Overall Study|Protocol Deviation|50
7597935|NCT01964963|26432765|P1|Overall Study|Case Report Forms Uncollected|888
7597936|NCT01964950|26432773|P1|Overall Study|Protocol Violation|25
7597937|NCT01964924|26432785|P2|Trametinib Monotherapy|Progression|0
7597938|NCT01964924|26432786|P1|Trametinib Monotherapy|Progression|19
7597939|NCT01964898|26432810|P2|Overall Study|Withdrawal by Subject|0
7597940|NCT01964898|26432811|P1|Overall Study|Withdrawal by Subject|1
7597941|NCT01964898|26432810|P2|Overall Study|Lost to Follow-up|5
7597942|NCT01964898|26432811|P1|Overall Study|Lost to Follow-up|3
7597943|NCT01964898|26432810|P2|Overall Study|did not receive the allocated interventi|1
7597944|NCT01964898|26432811|P1|Overall Study|did not receive the allocated interventi|2
7597945|NCT01964898|26432810|P2|Overall Study|ineligible post-randomization|1
7597946|NCT01964898|26432811|P1|Overall Study|ineligible post-randomization|1
7597947|NCT01964755|26432831|P1|Overall Study|Death|2
7597948|NCT01964716|26432846|P2|Overall Study|Death|0
7597949|NCT01964716|26432847|P1|Overall Study|Death|1
7597950|NCT01964716|26432846|P2|Overall Study|No longer met eligibility criteria|1
7597951|NCT01964716|26432847|P1|Overall Study|No longer met eligibility criteria|1
7597952|NCT01964716|26432846|P2|Overall Study|Lost to Follow-up|2
7597953|NCT01964716|26432847|P1|Overall Study|Lost to Follow-up|1
7597954|NCT01964716|26432846|P2|Overall Study|Withdrawal by Subject|3
7597955|NCT01964716|26432847|P1|Overall Study|Withdrawal by Subject|2
7597956|NCT01964547|26432885|P2|Overall Study|Withdrawal by Investigator|1
7597957|NCT01964547|26432886|P1|Overall Study|Withdrawal by Investigator|0
7597958|NCT01964547|26432885|P2|Overall Study|Lost to Follow-up|1
7597959|NCT01964547|26432886|P1|Overall Study|Lost to Follow-up|0
7597960|NCT01964547|26432885|P2|Overall Study|Withdrawal by Subject|7
7597961|NCT01964547|26432886|P1|Overall Study|Withdrawal by Subject|4
7597962|NCT01964547|26432885|P2|Overall Study|Adverse Event|2
7597963|NCT01964547|26432886|P1|Overall Study|Adverse Event|8
7597964|NCT01964521|26432910|P1|Overall Study|Lost to Follow-up|4
7597965|NCT01964430|26432917|P2|Overall Study|Randomized but not Treated|11
7597966|NCT01964430|26432918|P1|Overall Study|Randomized but not Treated|3
7597967|NCT01964430|26432917|P2|Overall Study|Miscellaneous|3
7597968|NCT01964430|26432918|P1|Overall Study|Miscellaneous|1
7597969|NCT01964430|26432917|P2|Overall Study|Disease Relapse|38
7597970|NCT01964430|26432918|P1|Overall Study|Disease Relapse|28
7597971|NCT01964430|26432917|P2|Overall Study|Physician Decision|4
7597972|NCT01964430|26432918|P1|Overall Study|Physician Decision|5
7597973|NCT01964430|26432917|P2|Overall Study|Protocol Deviation|1
7597974|NCT01964430|26432918|P1|Overall Study|Protocol Deviation|0
7597975|NCT01964430|26432917|P2|Overall Study|Death|3
7597976|NCT01964430|26432918|P1|Overall Study|Death|1
7597977|NCT01964430|26432917|P2|Overall Study|Withdrawal by Subject|27
7597978|NCT01964430|26432918|P1|Overall Study|Withdrawal by Subject|36
7597979|NCT01964430|26432917|P2|Overall Study|Adverse Event|37
7597980|NCT01964430|26432918|P1|Overall Study|Adverse Event|71
7597981|NCT01964378|26432930|P2|Overall Study|Other|2
7597982|NCT01964378|26432931|P1|Overall Study|Other|1
7597983|NCT01964378|26432930|P2|Overall Study|Inclusion/exclusion criteria not met|3
7597984|NCT01964378|26432931|P1|Overall Study|Inclusion/exclusion criteria not met|1
7597985|NCT01964378|26432930|P2|Overall Study|Withdrawal by Subject|5
7597986|NCT01964378|26432931|P1|Overall Study|Withdrawal by Subject|7
7597987|NCT01964378|26432930|P2|Overall Study|Lost to Follow-up|1
7597988|NCT01964378|26432931|P1|Overall Study|Lost to Follow-up|0
7597989|NCT01964378|26432930|P2|Overall Study|Protocol Violation|1
7597990|NCT01964378|26432931|P1|Overall Study|Protocol Violation|0
7597991|NCT01964378|26432930|P2|Overall Study|Lack of Efficacy|1
7597992|NCT01964378|26432931|P1|Overall Study|Lack of Efficacy|0
7597993|NCT01964378|26432930|P2|Overall Study|Adverse Event|5
7597994|NCT01964378|26432931|P1|Overall Study|Adverse Event|12
7597995|NCT01964378|26432930|P2|Overall Study|Death|2
7597996|NCT01964378|26432931|P1|Overall Study|Death|3
7597997|NCT01964378|26432930|P2|Overall Study|Disc. due to AE before first dosing|0
7597998|NCT01964378|26432931|P1|Overall Study|Disc. due to AE before first dosing|1
7597999|NCT01964378|26432930|P2|Overall Study|Disc. due to death before first dosing|1
7598000|NCT01964378|26432931|P1|Overall Study|Disc. due to death before first dosing|0
7598001|NCT01964352|26432967|P4|Overall Study|Other than stated above|2
7598002|NCT01964352|26432968|P3|Overall Study|Other than stated above|1
7598003|NCT01964352|26432969|P2|Overall Study|Other than stated above|2
7598004|NCT01964352|26432970|P1|Overall Study|Other than stated above|0
7598005|NCT01964352|26432967|P4|Overall Study|Withdrawal by Subject|0
7598006|NCT01964352|26432968|P3|Overall Study|Withdrawal by Subject|1
7598007|NCT01964352|26432969|P2|Overall Study|Withdrawal by Subject|2
7598008|NCT01964352|26432970|P1|Overall Study|Withdrawal by Subject|4
7598009|NCT01964352|26432967|P4|Overall Study|Lost to Follow-up|1
7598010|NCT01964352|26432968|P3|Overall Study|Lost to Follow-up|0
7598011|NCT01964352|26432969|P2|Overall Study|Lost to Follow-up|0
7598012|NCT01964352|26432970|P1|Overall Study|Lost to Follow-up|1
7598013|NCT01964352|26432967|P4|Overall Study|Protocol Violation|2
7598014|NCT01964352|26432968|P3|Overall Study|Protocol Violation|0
7598015|NCT01964352|26432969|P2|Overall Study|Protocol Violation|4
7598016|NCT01964352|26432970|P1|Overall Study|Protocol Violation|2
7598017|NCT01964352|26432967|P4|Overall Study|Lack of Efficacy|0
7598018|NCT01964352|26432968|P3|Overall Study|Lack of Efficacy|0
7598019|NCT01964352|26432969|P2|Overall Study|Lack of Efficacy|0
7598020|NCT01964352|26432970|P1|Overall Study|Lack of Efficacy|6
7598021|NCT01964352|26432967|P4|Overall Study|Adverse Event|3
7598022|NCT01964352|26432968|P3|Overall Study|Adverse Event|4
7598023|NCT01964352|26432969|P2|Overall Study|Adverse Event|3
7598024|NCT01964352|26432970|P1|Overall Study|Adverse Event|13
7598025|NCT01964326|26433000|P1|Overall Study|Did not meet eligibility criteria|1
7598026|NCT01964326|26433000|P1|Overall Study|Other|9
7598027|NCT01964326|26433000|P1|Overall Study|Investigator Discretion|1
7598028|NCT01964326|26433000|P1|Overall Study|Physician Decision|55
7598029|NCT01964326|26433000|P1|Overall Study|No Longer Meets Eligibility Criteria|1
7598030|NCT01964326|26433000|P1|Overall Study|Pregnancy|1
7598031|NCT01964326|26433000|P1|Overall Study|Withdrawal by Subject|87
7598032|NCT01964326|26433000|P1|Overall Study|Lost to Follow-up|88
7598033|NCT01964326|26433000|P1|Overall Study|Protocol Violation|4
7598034|NCT01964326|26433000|P1|Overall Study|Death|2
7598035|NCT01964326|26433000|P1|Overall Study|Adverse Event|48
7598036|NCT01964300|26433009|P2|Overall Study|Weight criteria not met|1
7598037|NCT01964300|26433010|P1|Overall Study|Weight criteria not met|0
7598038|NCT01964300|26433009|P2|Overall Study|Enlargement of cyst requiring drainage|0
7598039|NCT01964300|26433010|P1|Overall Study|Enlargement of cyst requiring drainage|1
7598040|NCT01964300|26433009|P2|Overall Study|To receive alternative therapy|2
7598041|NCT01964300|26433010|P1|Overall Study|To receive alternative therapy|1
7598042|NCT01964300|26433009|P2|Overall Study|Withdrawal by Subject|1
7598043|NCT01964300|26433010|P1|Overall Study|Withdrawal by Subject|0
7598044|NCT01964300|26433009|P2|Overall Study|Lack of Efficacy|5
7598045|NCT01964300|26433010|P1|Overall Study|Lack of Efficacy|3
7598046|NCT01964300|26433009|P2|Overall Study|Adverse Event|1
7598047|NCT01964300|26433010|P1|Overall Study|Adverse Event|1
7598048|NCT01964300|26433009|P2|Overall Study|Ineligible after enrollment|1
7598049|NCT01964300|26433010|P1|Overall Study|Ineligible after enrollment|0
7598050|NCT01964222|26433024|P2|Overall Study|Screening Failure|0
7598051|NCT01964222|26433025|P1|Overall Study|Screening Failure|2
7598052|NCT01964222|26433024|P2|Overall Study|Withdrawal by Subject|6
7598053|NCT01964222|26433025|P1|Overall Study|Withdrawal by Subject|6
7598054|NCT01964222|26433024|P2|Overall Study|Lost to Follow-up|5
7598055|NCT01964222|26433025|P1|Overall Study|Lost to Follow-up|7
7598056|NCT01964105|26433042|P3|Overall Study|Lost to Follow-up|0
7598057|NCT01964105|26433043|P2|Overall Study|Lost to Follow-up|13
7598058|NCT01964105|26433044|P1|Overall Study|Lost to Follow-up|2
7598059|NCT01963767|26433146|P2|Overall Study|Adverse Event|0
7598060|NCT01963767|26433147|P1|Overall Study|Adverse Event|2
7598061|NCT01963767|26433146|P2|Overall Study|Withdrawal by Subject|2
7598062|NCT01963767|26433147|P1|Overall Study|Withdrawal by Subject|4
7598063|NCT01963676|26433157|P2|Overall Study|Withdrawal by Subject|0
7598064|NCT01963676|26433158|P1|Overall Study|Withdrawal by Subject|1
7598065|NCT01963611|26433171|P5|Overall Study|Other|45
7598066|NCT01963611|26433172|P4|Overall Study|Other|45
7598067|NCT01963611|26433173|P3|Overall Study|Other|48
7598068|NCT01963611|26433174|P2|Overall Study|Other|46
7598069|NCT01963611|26433175|P1|Overall Study|Other|47
7598070|NCT01963611|26433171|P5|Overall Study|Withdrawal by Subject|3
7598071|NCT01963611|26433172|P4|Overall Study|Withdrawal by Subject|1
7598072|NCT01963611|26433173|P3|Overall Study|Withdrawal by Subject|1
7598073|NCT01963611|26433174|P2|Overall Study|Withdrawal by Subject|2
7598074|NCT01963611|26433175|P1|Overall Study|Withdrawal by Subject|3
7598075|NCT01963611|26433171|P5|Overall Study|Lack of Efficacy|0
7598076|NCT01963611|26433172|P4|Overall Study|Lack of Efficacy|1
7598077|NCT01963611|26433173|P3|Overall Study|Lack of Efficacy|0
7598078|NCT01963611|26433174|P2|Overall Study|Lack of Efficacy|0
7598079|NCT01963611|26433175|P1|Overall Study|Lack of Efficacy|0
7598080|NCT01963611|26433171|P5|Overall Study|Protocol Violation|0
7598081|NCT01963611|26433172|P4|Overall Study|Protocol Violation|1
7598082|NCT01963611|26433173|P3|Overall Study|Protocol Violation|0
7598083|NCT01963611|26433174|P2|Overall Study|Protocol Violation|0
7598084|NCT01963611|26433175|P1|Overall Study|Protocol Violation|0
7598085|NCT01963611|26433171|P5|Overall Study|Adverse Event|3
7598086|NCT01963611|26433172|P4|Overall Study|Adverse Event|4
7598087|NCT01963611|26433173|P3|Overall Study|Adverse Event|3
7598088|NCT01963611|26433174|P2|Overall Study|Adverse Event|1
7598089|NCT01963611|26433175|P1|Overall Study|Adverse Event|1
7598090|NCT01963403|26433240|P2|Overall Study|Implant removal|1
7598091|NCT01963403|26433241|P1|Overall Study|Implant removal|0
7598092|NCT01963403|26433240|P2|Overall Study|Lost to Follow-up|3
7598093|NCT01963403|26433241|P1|Overall Study|Lost to Follow-up|2
7598094|NCT01963260|26433263|P10|Overall Study|Withdrawal by Subject|0
7598095|NCT01963260|26433264|P9|Overall Study|Withdrawal by Subject|0
7598096|NCT01963260|26433265|P8|Overall Study|Withdrawal by Subject|0
7598097|NCT01963260|26433266|P7|Overall Study|Withdrawal by Subject|0
7598098|NCT01963260|26433267|P6|Overall Study|Withdrawal by Subject|0
7598099|NCT01963260|26433268|P5|Overall Study|Withdrawal by Subject|2
7598100|NCT01963260|26433269|P4|Overall Study|Withdrawal by Subject|1
7598101|NCT01963260|26433270|P3|Overall Study|Withdrawal by Subject|0
7598102|NCT01963260|26433271|P2|Overall Study|Withdrawal by Subject|0
7598103|NCT01963260|26433272|P1|Overall Study|Withdrawal by Subject|2
7598104|NCT01963117|26433386|P1|Overall Study|Death|1
7598105|NCT01962987|26433428|P3|Overall Study|Randomized in Error|2
7598106|NCT01962987|26433429|P2|Overall Study|Randomized in Error|2
7598107|NCT01962987|26433430|P1|Overall Study|Randomized in Error|4
7598108|NCT01962987|26433428|P3|Overall Study|Withdrawal by Subject|6
7598109|NCT01962987|26433429|P2|Overall Study|Withdrawal by Subject|10
7598110|NCT01962987|26433430|P1|Overall Study|Withdrawal by Subject|11
7598111|NCT01962987|26433428|P3|Overall Study|Serious Adverse Event|0
7598112|NCT01962987|26433429|P2|Overall Study|Serious Adverse Event|0
7598113|NCT01962987|26433430|P1|Overall Study|Serious Adverse Event|1
7598114|NCT01962987|26433428|P3|Overall Study|Restricted medication|1
7598115|NCT01962987|26433429|P2|Overall Study|Restricted medication|1
7598116|NCT01962987|26433430|P1|Overall Study|Restricted medication|5
7598117|NCT01962987|26433428|P3|Overall Study|Miscellaneous|2
7598118|NCT01962987|26433429|P2|Overall Study|Miscellaneous|9
7598119|NCT01962987|26433430|P1|Overall Study|Miscellaneous|1
7598120|NCT01962987|26433428|P3|Overall Study|Non compliance with dosing requirements|0
7598121|NCT01962987|26433429|P2|Overall Study|Non compliance with dosing requirements|2
7598122|NCT01962987|26433430|P1|Overall Study|Non compliance with dosing requirements|4
7598123|NCT01962987|26433428|P3|Overall Study|Lost to Follow-up|1
7598124|NCT01962987|26433429|P2|Overall Study|Lost to Follow-up|0
7598125|NCT01962987|26433430|P1|Overall Study|Lost to Follow-up|0
7598126|NCT01962987|26433428|P3|Overall Study|Adverse Event|0
7598127|NCT01962987|26433429|P2|Overall Study|Adverse Event|4
7598128|NCT01962987|26433430|P1|Overall Study|Adverse Event|4
7598129|NCT01962974|26433438|P1|Overall Study|Study termination|7
7598130|NCT01962922|26433465|P2|Extendion Portion (up to Month 6)|Physician Decision|0
7598131|NCT01962922|26433466|P1|Extendion Portion (up to Month 6)|Physician Decision|1
7598132|NCT01962922|26433465|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
7598133|NCT01962922|26433466|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
7598134|NCT01962922|26433465|P2|PK Portion Day 7|non-compliance|0
7598135|NCT01962922|26433466|P1|PK Portion Day 7|non-compliance|1
7598136|NCT01962922|26433465|P2|PK Portion Day 7|Withdrawal by Subject|0
7598137|NCT01962922|26433466|P1|PK Portion Day 7|Withdrawal by Subject|3
7598138|NCT01962896|26433488|P1|Overall Study|Lack of Efficacy|4
7598139|NCT01962493|26433610|P2|Overall Study|Withdrawal by Subject|2
7598140|NCT01962493|26433611|P1|Overall Study|Withdrawal by Subject|4
7598141|NCT01962493|26433610|P2|Overall Study|Protocol Violation|1
7598142|NCT01962493|26433611|P1|Overall Study|Protocol Violation|0
7598143|NCT01962493|26433610|P2|Overall Study|Adverse Event|2
7598144|NCT01962493|26433611|P1|Overall Study|Adverse Event|1
7598145|NCT01962441|26433634|P3|Retreatment Substudy|Lost to Follow-up|0
7598146|NCT01962441|26433635|P2|Retreatment Substudy|Lost to Follow-up|0
7598147|NCT01962441|26433636|P1|Retreatment Substudy|Lost to Follow-up|1
7598148|NCT01962441|26433634|P3|Retreatment Substudy|Lack of Efficacy|0
7598149|NCT01962441|26433635|P2|Retreatment Substudy|Lack of Efficacy|0
7598150|NCT01962441|26433636|P1|Retreatment Substudy|Lack of Efficacy|1
7598151|NCT01962441|26433634|P3|Randomized Period|Protocol Violation|0
7598152|NCT01962441|26433635|P2|Randomized Period|Protocol Violation|1
7598153|NCT01962441|26433636|P1|Randomized Period|Protocol Violation|0
7598154|NCT01962441|26433634|P3|Randomized Period|Death|2
7598155|NCT01962441|26433635|P2|Randomized Period|Death|0
7598156|NCT01962441|26433636|P1|Randomized Period|Death|0
7598157|NCT01962441|26433634|P3|Randomized Period|Adverse Event|0
7598158|NCT01962441|26433635|P2|Randomized Period|Adverse Event|1
7598159|NCT01962441|26433636|P1|Randomized Period|Adverse Event|1
7598160|NCT01962441|26433634|P3|Randomized Period|Withdrew Consent|2
7598161|NCT01962441|26433635|P2|Randomized Period|Withdrew Consent|3
7598162|NCT01962441|26433636|P1|Randomized Period|Withdrew Consent|3
7598163|NCT01962441|26433634|P3|Randomized Period|Lost to Follow-up|4
7598164|NCT01962441|26433635|P2|Randomized Period|Lost to Follow-up|4
7598165|NCT01962441|26433636|P1|Randomized Period|Lost to Follow-up|2
7598166|NCT01962441|26433634|P3|Randomized Period|Randomized but Never Treated|3
7598167|NCT01962441|26433635|P2|Randomized Period|Randomized but Never Treated|2
7598168|NCT01962441|26433636|P1|Randomized Period|Randomized but Never Treated|4
7598169|NCT01962298|26433680|P5|Overall Study|Physician Decision|1
7598170|NCT01962298|26433681|P4|Overall Study|Physician Decision|0
7598171|NCT01962298|26433682|P3|Overall Study|Physician Decision|0
7598172|NCT01962298|26433683|P2|Overall Study|Physician Decision|1
7598173|NCT01962298|26433684|P1|Overall Study|Physician Decision|0
7598174|NCT01962298|26433680|P5|Overall Study|Incorrect data recorded|0
7598175|NCT01962298|26433681|P4|Overall Study|Incorrect data recorded|0
7598176|NCT01962298|26433682|P3|Overall Study|Incorrect data recorded|0
7598177|NCT01962298|26433683|P2|Overall Study|Incorrect data recorded|1
7598178|NCT01962298|26433684|P1|Overall Study|Incorrect data recorded|0
7598179|NCT01962298|26433680|P5|Overall Study|Insufficient data|1
7598180|NCT01962298|26433681|P4|Overall Study|Insufficient data|0
7598181|NCT01962298|26433682|P3|Overall Study|Insufficient data|1
7598182|NCT01962298|26433683|P2|Overall Study|Insufficient data|2
7598183|NCT01962298|26433684|P1|Overall Study|Insufficient data|0
7598184|NCT01962298|26433680|P5|Overall Study|Data quality insufficient|4
7598185|NCT01962298|26433681|P4|Overall Study|Data quality insufficient|1
7598186|NCT01962298|26433682|P3|Overall Study|Data quality insufficient|3
7598187|NCT01962298|26433683|P2|Overall Study|Data quality insufficient|0
7598188|NCT01962298|26433684|P1|Overall Study|Data quality insufficient|2
7598189|NCT01962298|26433680|P5|Overall Study|Protocol Violation|0
7598190|NCT01962298|26433681|P4|Overall Study|Protocol Violation|1
7598191|NCT01962298|26433682|P3|Overall Study|Protocol Violation|1
7598192|NCT01962298|26433683|P2|Overall Study|Protocol Violation|0
7598193|NCT01962298|26433684|P1|Overall Study|Protocol Violation|1
7598194|NCT01962207|26433705|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
7598195|NCT01962207|26433706|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
7598196|NCT01962207|26433707|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
7598197|NCT01962207|26433708|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
7598198|NCT01962207|26433705|P4|Persistence Phase (5 Years)|Adverse Event|0
7598199|NCT01962207|26433706|P3|Persistence Phase (5 Years)|Adverse Event|1
7598200|NCT01962207|26433707|P2|Persistence Phase (5 Years)|Adverse Event|0
7598201|NCT01962207|26433708|P1|Persistence Phase (5 Years)|Adverse Event|0
7598202|NCT01962207|26433705|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
7598203|NCT01962207|26433706|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
7598204|NCT01962207|26433707|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7598205|NCT01962207|26433708|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7598206|NCT01962207|26433705|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
7598207|NCT01962207|26433706|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
7598208|NCT01962207|26433707|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
7598209|NCT01962207|26433708|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
7598210|NCT01962207|26433705|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
7598211|NCT01962207|26433706|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
7598212|NCT01962207|26433707|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
7598213|NCT01962207|26433708|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
7598214|NCT01962207|26433705|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
7598215|NCT01962207|26433706|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
7598216|NCT01962207|26433707|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
7598217|NCT01962207|26433708|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
7598218|NCT01962103|26433819|P9|Phase 2|Symptomatic Deterioration|0
7598219|NCT01962103|26433820|P8|Phase 2|Symptomatic Deterioration|2
7598220|NCT01962103|26433821|P7|Phase 2|Symptomatic Deterioration|2
7598221|NCT01962103|26433822|P6|Phase 2|Symptomatic Deterioration|0
7598222|NCT01962103|26433823|P5|Phase 2|Symptomatic Deterioration|0
7598223|NCT01962103|26433824|P4|Phase 2|Symptomatic Deterioration|0
7598224|NCT01962103|26433825|P3|Phase 2|Symptomatic Deterioration|0
7598225|NCT01962103|26433826|P2|Phase 2|Symptomatic Deterioration|0
7598226|NCT01962103|26433827|P1|Phase 2|Symptomatic Deterioration|0
7598227|NCT01962103|26433819|P9|Phase 2|Progressive Disease|11
7598228|NCT01962103|26433820|P8|Phase 2|Progressive Disease|12
7598229|NCT01962103|26433821|P7|Phase 2|Progressive Disease|11
7598230|NCT01962103|26433822|P6|Phase 2|Progressive Disease|0
7598231|NCT01962103|26433823|P5|Phase 2|Progressive Disease|0
7598232|NCT01962103|26433824|P4|Phase 2|Progressive Disease|0
7598233|NCT01962103|26433825|P3|Phase 2|Progressive Disease|0
7598234|NCT01962103|26433826|P2|Phase 2|Progressive Disease|0
7598235|NCT01962103|26433827|P1|Phase 2|Progressive Disease|0
7598236|NCT01962103|26433819|P9|Phase 2|Adverse Event|3
7598237|NCT01962103|26433820|P8|Phase 2|Adverse Event|0
7598238|NCT01962103|26433821|P7|Phase 2|Adverse Event|1
7598239|NCT01962103|26433822|P6|Phase 2|Adverse Event|0
7598240|NCT01962103|26433823|P5|Phase 2|Adverse Event|0
7598241|NCT01962103|26433824|P4|Phase 2|Adverse Event|0
7598242|NCT01962103|26433825|P3|Phase 2|Adverse Event|0
7598243|NCT01962103|26433826|P2|Phase 2|Adverse Event|0
7598244|NCT01962103|26433827|P1|Phase 2|Adverse Event|0
7598245|NCT01962103|26433819|P9|Phase 1|Miscellaneous|0
7598246|NCT01962103|26433820|P8|Phase 1|Miscellaneous|0
7598247|NCT01962103|26433821|P7|Phase 1|Miscellaneous|0
7598248|NCT01962103|26433822|P6|Phase 1|Miscellaneous|0
7598249|NCT01962103|26433823|P5|Phase 1|Miscellaneous|0
7598250|NCT01962103|26433824|P4|Phase 1|Miscellaneous|0
7598251|NCT01962103|26433825|P3|Phase 1|Miscellaneous|0
7598252|NCT01962103|26433826|P2|Phase 1|Miscellaneous|0
7598253|NCT01962103|26433827|P1|Phase 1|Miscellaneous|1
7598254|NCT01962103|26433819|P9|Phase 1|Symptomatic Deterioration|0
7598255|NCT01962103|26433820|P8|Phase 1|Symptomatic Deterioration|0
7598256|NCT01962103|26433821|P7|Phase 1|Symptomatic Deterioration|0
7598257|NCT01962103|26433822|P6|Phase 1|Symptomatic Deterioration|1
7598258|NCT01962103|26433823|P5|Phase 1|Symptomatic Deterioration|1
7598259|NCT01962103|26433824|P4|Phase 1|Symptomatic Deterioration|2
7598260|NCT01962103|26433825|P3|Phase 1|Symptomatic Deterioration|2
7598261|NCT01962103|26433826|P2|Phase 1|Symptomatic Deterioration|2
7598262|NCT01962103|26433827|P1|Phase 1|Symptomatic Deterioration|3
7598263|NCT01962103|26433819|P9|Phase 1|Physician Decision|0
7598264|NCT01962103|26433820|P8|Phase 1|Physician Decision|0
7598265|NCT01962103|26433821|P7|Phase 1|Physician Decision|0
7598266|NCT01962103|26433822|P6|Phase 1|Physician Decision|0
7598267|NCT01962103|26433823|P5|Phase 1|Physician Decision|0
7598268|NCT01962103|26433824|P4|Phase 1|Physician Decision|1
7598269|NCT01962103|26433825|P3|Phase 1|Physician Decision|0
7598270|NCT01962103|26433826|P2|Phase 1|Physician Decision|0
7598271|NCT01962103|26433827|P1|Phase 1|Physician Decision|0
7598272|NCT01962103|26433819|P9|Phase 1|Withdrawal by Parent/Guardian|0
7598273|NCT01962103|26433820|P8|Phase 1|Withdrawal by Parent/Guardian|0
7598274|NCT01962103|26433821|P7|Phase 1|Withdrawal by Parent/Guardian|0
7598275|NCT01962103|26433822|P6|Phase 1|Withdrawal by Parent/Guardian|0
7598276|NCT01962103|26433823|P5|Phase 1|Withdrawal by Parent/Guardian|0
7598277|NCT01962103|26433824|P4|Phase 1|Withdrawal by Parent/Guardian|1
7598278|NCT01962103|26433825|P3|Phase 1|Withdrawal by Parent/Guardian|2
7598279|NCT01962103|26433826|P2|Phase 1|Withdrawal by Parent/Guardian|0
7598280|NCT01962103|26433827|P1|Phase 1|Withdrawal by Parent/Guardian|0
7598281|NCT01962103|26433819|P9|Phase 1|Withdrawal by Subject|0
7598282|NCT01962103|26433820|P8|Phase 1|Withdrawal by Subject|0
7598283|NCT01962103|26433821|P7|Phase 1|Withdrawal by Subject|0
7598284|NCT01962103|26433822|P6|Phase 1|Withdrawal by Subject|0
7598285|NCT01962103|26433823|P5|Phase 1|Withdrawal by Subject|0
7598286|NCT01962103|26433824|P4|Phase 1|Withdrawal by Subject|2
7598287|NCT01962103|26433825|P3|Phase 1|Withdrawal by Subject|0
7598288|NCT01962103|26433826|P2|Phase 1|Withdrawal by Subject|0
7598289|NCT01962103|26433827|P1|Phase 1|Withdrawal by Subject|0
7598290|NCT01962103|26433819|P9|Phase 1|Progressive Disease|0
7598291|NCT01962103|26433820|P8|Phase 1|Progressive Disease|0
7598292|NCT01962103|26433821|P7|Phase 1|Progressive Disease|0
7598293|NCT01962103|26433822|P6|Phase 1|Progressive Disease|4
7598294|NCT01962103|26433823|P5|Phase 1|Progressive Disease|5
7598295|NCT01962103|26433824|P4|Phase 1|Progressive Disease|4
7598296|NCT01962103|26433825|P3|Phase 1|Progressive Disease|8
7598297|NCT01962103|26433826|P2|Phase 1|Progressive Disease|6
7598298|NCT01962103|26433827|P1|Phase 1|Progressive Disease|8
7598299|NCT01962103|26433819|P9|Phase 1|Adverse Event|0
7598300|NCT01962103|26433820|P8|Phase 1|Adverse Event|0
7598301|NCT01962103|26433821|P7|Phase 1|Adverse Event|0
7598302|NCT01962103|26433822|P6|Phase 1|Adverse Event|2
7598303|NCT01962103|26433823|P5|Phase 1|Adverse Event|2
7598304|NCT01962103|26433824|P4|Phase 1|Adverse Event|1
7598305|NCT01962103|26433825|P3|Phase 1|Adverse Event|2
7598306|NCT01962103|26433826|P2|Phase 1|Adverse Event|0
7598307|NCT01962103|26433827|P1|Phase 1|Adverse Event|4
7598308|NCT01961882|26433956|P2|Overall Study|Subject found to be ineligible for the trial after registration|0
7598309|NCT01961882|26433957|P1|Overall Study|Subject found to be ineligible for the trial after registration|1
7598310|NCT01961882|26433956|P2|Overall Study|Use of prohibited concomitant drug or therapy|2
7598311|NCT01961882|26433957|P1|Overall Study|Use of prohibited concomitant drug or therapy|2
7598312|NCT01961882|26433956|P2|Overall Study|Relapse of AML|37
7598313|NCT01961882|26433957|P1|Overall Study|Relapse of AML|39
7598314|NCT01961882|26433956|P2|Overall Study|Withdrawal by Subject|1
7598315|NCT01961882|26433957|P1|Overall Study|Withdrawal by Subject|4
7598316|NCT01961882|26433956|P2|Overall Study|Physician Decision|0
7598317|NCT01961882|26433957|P1|Overall Study|Physician Decision|1
7598318|NCT01961882|26433956|P2|Overall Study|Adverse Event|2
7598319|NCT01961882|26433957|P1|Overall Study|Adverse Event|3
7598320|NCT01961687|26433965|P1|Overall Study|Unable to meet follow-up requirements|1
7598321|NCT01961687|26433965|P1|Overall Study|Physician Decision|1
7598322|NCT01961687|26433965|P1|Overall Study|Sponsor decision|2
7598323|NCT01961687|26433965|P1|Overall Study|Moved to area without study site|2
7598324|NCT01961687|26433965|P1|Overall Study|Adverse Event|6
7598325|NCT01961687|26433965|P1|Overall Study|Withdrawal by Subject|6
7598326|NCT01961687|26433965|P1|Overall Study|Death|7
7598327|NCT01961687|26433965|P1|Overall Study|Re-operation|17
7598328|NCT01961687|26433965|P1|Overall Study|Lost to Follow-up|19
7598329|NCT01961609|26433979|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
7598330|NCT01961609|26433980|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7598331|NCT01961609|26433981|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7598332|NCT01961609|26433982|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
7598333|NCT01961609|26433979|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
7598334|NCT01961609|26433980|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7598335|NCT01961609|26433981|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
7598336|NCT01961609|26433982|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7598337|NCT01961609|26433979|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7598338|NCT01961609|26433980|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7598339|NCT01961609|26433981|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
7598340|NCT01961609|26433982|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7598341|NCT01961609|26433979|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7598342|NCT01961609|26433980|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7598343|NCT01961609|26433981|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7598344|NCT01961609|26433982|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
7598345|NCT01961609|26433979|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7598346|NCT01961609|26433980|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
7598347|NCT01961609|26433981|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7598348|NCT01961609|26433982|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7598349|NCT01961609|26433979|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
7598350|NCT01961609|26433980|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
7598351|NCT01961609|26433981|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
7598352|NCT01961609|26433982|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
7598353|NCT01961609|26433979|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7598354|NCT01961609|26433980|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
7598355|NCT01961609|26433981|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7598356|NCT01961609|26433982|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7598357|NCT01961609|26433979|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
7598358|NCT01961609|26433980|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
7598359|NCT01961609|26433981|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7598360|NCT01961609|26433982|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7598361|NCT01961609|26433979|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
7598362|NCT01961609|26433980|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
7598363|NCT01961609|26433981|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
7598364|NCT01961609|26433982|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
7598365|NCT01961609|26433979|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7598366|NCT01961609|26433980|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7598367|NCT01961609|26433981|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7598368|NCT01961609|26433982|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7598369|NCT01961609|26433979|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7598370|NCT01961609|26433980|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
7598371|NCT01961609|26433981|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7598372|NCT01961609|26433982|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
7598373|NCT01961609|26433979|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7598374|NCT01961609|26433980|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
7598375|NCT01961609|26433981|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7598376|NCT01961609|26433982|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
7598377|NCT01961609|26433979|P4|Initiation|Randomized but not treated|0
7598378|NCT01961609|26433980|P3|Initiation|Randomized but not treated|0
7598379|NCT01961609|26433981|P2|Initiation|Randomized but not treated|1
7598380|NCT01961609|26433982|P1|Initiation|Randomized but not treated|1
7598381|NCT01961609|26433979|P4|Initiation|Adverse Event|0
7598382|NCT01961609|26433980|P3|Initiation|Adverse Event|0
7598383|NCT01961609|26433981|P2|Initiation|Adverse Event|5
7598384|NCT01961609|26433982|P1|Initiation|Adverse Event|3
7598385|NCT01961609|26433979|P4|Initiation|Abnormal lab values|0
7598386|NCT01961609|26433980|P3|Initiation|Abnormal lab values|0
7598387|NCT01961609|26433981|P2|Initiation|Abnormal lab values|1
7598388|NCT01961609|26433982|P1|Initiation|Abnormal lab values|0
7598389|NCT01961609|26433979|P4|Initiation|Lack of Efficacy|0
7598390|NCT01961609|26433980|P3|Initiation|Lack of Efficacy|0
7598391|NCT01961609|26433981|P2|Initiation|Lack of Efficacy|1
7598392|NCT01961609|26433982|P1|Initiation|Lack of Efficacy|2
7598393|NCT01961609|26433979|P4|Initiation|Withdrawal by Subject|0
7598394|NCT01961609|26433980|P3|Initiation|Withdrawal by Subject|0
7598395|NCT01961609|26433981|P2|Initiation|Withdrawal by Subject|2
7598396|NCT01961609|26433982|P1|Initiation|Withdrawal by Subject|1
7598397|NCT01961609|26433979|P4|Initiation|Administrative problems|0
7598398|NCT01961609|26433980|P3|Initiation|Administrative problems|0
7598399|NCT01961609|26433981|P2|Initiation|Administrative problems|0
7598400|NCT01961609|26433982|P1|Initiation|Administrative problems|1
7598401|NCT01961609|26433979|P4|Initiation|Death|0
7598402|NCT01961609|26433980|P3|Initiation|Death|0
7598403|NCT01961609|26433981|P2|Initiation|Death|1
7598404|NCT01961609|26433982|P1|Initiation|Death|0
7598405|NCT01961609|26433979|P4|Initiation|Protocol deviation|0
7598406|NCT01961609|26433980|P3|Initiation|Protocol deviation|0
7598407|NCT01961609|26433981|P2|Initiation|Protocol deviation|0
7598408|NCT01961609|26433982|P1|Initiation|Protocol deviation|1
7598409|NCT01961609|26433979|P4|Initiation|Missing|0
7598410|NCT01961609|26433980|P3|Initiation|Missing|0
7598411|NCT01961609|26433981|P2|Initiation|Missing|2
7598412|NCT01961609|26433982|P1|Initiation|Missing|3
7598413|NCT01961544|26434034|P1|Overall Study|Aggravation of Steral Pain|1
7598414|NCT01961544|26434034|P1|Overall Study|Poor Tolerance|1
7598415|NCT01961544|26434034|P1|Overall Study|Physician Decision|2
7598416|NCT01961544|26434034|P1|Overall Study|Adverse Event|1
7598417|NCT01961544|26434034|P1|Overall Study|Withdrawal by Subject|7
7598418|NCT01961544|26434034|P1|Overall Study|Protocol Violation|1
7598419|NCT01961349|26434053|P3|Overall Study|registration error, personal reason etc|1
7598420|NCT01961349|26434054|P2|Overall Study|registration error, personal reason etc|2
7598421|NCT01961349|26434055|P1|Overall Study|registration error, personal reason etc|2
7598422|NCT01961349|26434053|P3|Overall Study|Adverse Event|1
7598423|NCT01961349|26434054|P2|Overall Study|Adverse Event|0
7598424|NCT01961349|26434055|P1|Overall Study|Adverse Event|0
7598425|NCT01961349|26434053|P3|Overall Study|Withdrawal by Subject|0
7598426|NCT01961349|26434054|P2|Overall Study|Withdrawal by Subject|4
7598427|NCT01961349|26434055|P1|Overall Study|Withdrawal by Subject|1
7598428|NCT01961323|26434066|P1|Overall Study|screen failure|34
7598429|NCT01961323|26434066|P1|Overall Study|Lost to Follow-up|8
7598430|NCT01961323|26434066|P1|Overall Study|Withdrawal by Subject|7
7598431|NCT01961297|26434074|P2|Overall Study|unconfirmed diagnosis of SD|1
7598432|NCT01961297|26434075|P1|Overall Study|unconfirmed diagnosis of SD|2
7598433|NCT01961115|26434139|P3|Overall Study|Adverse Event|1
7598434|NCT01961115|26434140|P2|Overall Study|Adverse Event|0
7598435|NCT01961115|26434141|P1|Overall Study|Adverse Event|1
7598436|NCT01961115|26434139|P3|Overall Study|Disease Progression|3
7598437|NCT01961115|26434140|P2|Overall Study|Disease Progression|0
7598438|NCT01961115|26434141|P1|Overall Study|Disease Progression|1
7598439|NCT01960998|26434184|P2|Overall Study|lost computer access|1
7598440|NCT01960998|26434185|P1|Overall Study|lost computer access|0
7598441|NCT01960998|26434184|P2|Overall Study|Withdrawal by Subject|2
7598442|NCT01960998|26434185|P1|Overall Study|Withdrawal by Subject|8
7598443|NCT01960998|26434184|P2|Overall Study|Death|1
7598444|NCT01960998|26434185|P1|Overall Study|Death|0
7598445|NCT01960998|26434184|P2|Overall Study|Lost to Follow-up|7
7598446|NCT01960998|26434185|P1|Overall Study|Lost to Follow-up|3
7598447|NCT01960907|26434215|P2|Overall Study|Withdrawal by Subject|42
7598448|NCT01960907|26434216|P1|Overall Study|Withdrawal by Subject|32
7598449|NCT01960907|26434215|P2|Overall Study|Death|3
7598450|NCT01960907|26434216|P1|Overall Study|Death|4
7598451|NCT01960855|26434231|P5|Overall Study|Lost to Follow-up|2
7598452|NCT01960855|26434232|P4|Overall Study|Lost to Follow-up|0
7598453|NCT01960855|26434233|P3|Overall Study|Lost to Follow-up|0
7598454|NCT01960855|26434234|P2|Overall Study|Lost to Follow-up|1
7598455|NCT01960855|26434235|P1|Overall Study|Lost to Follow-up|2
7598456|NCT01960855|26434231|P5|Overall Study|Consent withdrawn by subject|1
7598457|NCT01960855|26434232|P4|Overall Study|Consent withdrawn by subject|1
7598458|NCT01960855|26434233|P3|Overall Study|Consent withdrawn by subject|2
7598459|NCT01960855|26434234|P2|Overall Study|Consent withdrawn by subject|1
7598460|NCT01960855|26434235|P1|Overall Study|Consent withdrawn by subject|3
7598461|NCT01960855|26434231|P5|Overall Study|Other|0
7598462|NCT01960855|26434232|P4|Overall Study|Other|1
7598463|NCT01960855|26434233|P3|Overall Study|Other|1
7598464|NCT01960855|26434234|P2|Overall Study|Other|1
7598465|NCT01960855|26434235|P1|Overall Study|Other|2
7598466|NCT01960855|26434231|P5|Overall Study|Lack of Efficacy|0
7598467|NCT01960855|26434232|P4|Overall Study|Lack of Efficacy|0
7598468|NCT01960855|26434233|P3|Overall Study|Lack of Efficacy|0
7598469|NCT01960855|26434234|P2|Overall Study|Lack of Efficacy|1
7598470|NCT01960855|26434235|P1|Overall Study|Lack of Efficacy|1
7598471|NCT01960855|26434231|P5|Overall Study|Adverse Event|2
7598472|NCT01960855|26434232|P4|Overall Study|Adverse Event|2
7598473|NCT01960855|26434233|P3|Overall Study|Adverse Event|6
7598474|NCT01960855|26434234|P2|Overall Study|Adverse Event|0
7598475|NCT01960855|26434235|P1|Overall Study|Adverse Event|2
7598476|NCT01960855|26434231|P5|Overall Study|Subject noncompliant|0
7598477|NCT01960855|26434232|P4|Overall Study|Subject noncompliant|0
7598478|NCT01960855|26434233|P3|Overall Study|Subject noncompliant|0
7598479|NCT01960855|26434234|P2|Overall Study|Subject noncompliant|0
7598480|NCT01960855|26434235|P1|Overall Study|Subject noncompliant|1
7598481|NCT01960842|26434267|P1|Overall Study|Withdrawal by Subject|2
7598482|NCT01960842|26434267|P1|Overall Study|Adverse Event|1
7598483|NCT01960816|26434290|P1|Overall Study|Lost to Follow-up|1
7598484|NCT01960790|26434296|P1|Overall Study|Unevaluable for safety|1
7598485|NCT01960790|26434296|P1|Overall Study|Transferred to another hospital|4
7598486|NCT01960790|26434296|P1|Overall Study|Treat with Humira outside survey period|3
7598487|NCT01960790|26434296|P1|Overall Study|Survey forms could not be recovered|3
7598488|NCT01960725|26434308|P2|Overall Study|unable to obtain blood sample|2
7598489|NCT01960725|26434309|P1|Overall Study|unable to obtain blood sample|1
7598490|NCT01960725|26434308|P2|Overall Study|Withdrawal by Subject|0
7598491|NCT01960725|26434309|P1|Overall Study|Withdrawal by Subject|1
7598492|NCT01960725|26434308|P2|Overall Study|Lost to Follow-up|3
7598493|NCT01960725|26434309|P1|Overall Study|Lost to Follow-up|4
7598494|NCT01960413|26434379|P2|Overall Study|Lost to Follow-up|0
7598495|NCT01960413|26434380|P1|Overall Study|Lost to Follow-up|2
7598496|NCT01960413|26434379|P2|Overall Study|Physician Decision|0
7598497|NCT01960413|26434380|P1|Overall Study|Physician Decision|1
7598498|NCT01960413|26434379|P2|Overall Study|Withdrawal by Subject|1
7598499|NCT01960413|26434380|P1|Overall Study|Withdrawal by Subject|1
7598500|NCT01960348|26434410|P2|Overall Study|Protocol Violation|0
7598501|NCT01960348|26434411|P1|Overall Study|Protocol Violation|1
7598502|NCT01960348|26434410|P2|Overall Study|Physician Decision|1
7598503|NCT01960348|26434411|P1|Overall Study|Physician Decision|0
7598504|NCT01960348|26434410|P2|Overall Study|Withdrawal by Subject|11
7598505|NCT01960348|26434411|P1|Overall Study|Withdrawal by Subject|1
7598506|NCT01960348|26434410|P2|Overall Study|Adverse event, serious non-fatal|3
7598507|NCT01960348|26434411|P1|Overall Study|Adverse event, serious non-fatal|0
7598508|NCT01960348|26434410|P2|Overall Study|Adverse event, serious fatal|5
7598509|NCT01960348|26434411|P1|Overall Study|Adverse event, serious fatal|6
7598510|NCT01960348|26434410|P2|Overall Study|Adverse event, not serious|2
7598511|NCT01960348|26434411|P1|Overall Study|Adverse event, not serious|2
7598512|NCT01960296|26434431|P2|Overall Study|Received different procedure|3
7598513|NCT01960296|26434432|P1|Overall Study|Received different procedure|1
7598514|NCT01960296|26434431|P2|Overall Study|Postponed surgery|0
7598515|NCT01960296|26434432|P1|Overall Study|Postponed surgery|1
7598516|NCT01960257|26434452|P3|Stage 1 (1-3 Weeks)|Adverse Event|0
7598517|NCT01960257|26434453|P2|Stage 1 (1-3 Weeks)|Adverse Event|0
7598518|NCT01960257|26434454|P1|Stage 1 (1-3 Weeks)|Adverse Event|1
7598519|NCT01960257|26434452|P3|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7598520|NCT01960257|26434453|P2|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7598521|NCT01960257|26434454|P1|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
7598522|NCT01960257|26434452|P3|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7598523|NCT01960257|26434453|P2|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7598524|NCT01960257|26434454|P1|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
7598525|NCT01960140|26434464|P1|Period 2 (Days 3-18)|Adverse Event|2
7598526|NCT01960114|26434475|P2|Overall Study|Could not swallow study medication|1
7598527|NCT01960114|26434476|P1|Overall Study|Could not swallow study medication|0
7598528|NCT01960114|26434475|P2|Overall Study|Adverse Event|0
7598529|NCT01960114|26434476|P1|Overall Study|Adverse Event|1
7598530|NCT01959932|26434583|P3|Overall Study|Withdrawal by Subject|0
7598531|NCT01959932|26434584|P2|Overall Study|Withdrawal by Subject|0
7598532|NCT01959932|26434585|P1|Overall Study|Withdrawal by Subject|1
7598533|NCT01959919|26434603|P1|Overall Study|Did not meet the eligibility criteria|2
7598534|NCT01959880|26434617|P4|Overall Study|Study completed early-FDA approved|152
7598535|NCT01959880|26434618|P3|Overall Study|Study completed early-FDA approved|179
7598536|NCT01959880|26434619|P2|Overall Study|Study completed early-FDA approved|311
7598537|NCT01959880|26434620|P1|Overall Study|Study completed early-FDA approved|1003
7598538|NCT01959880|26434617|P4|Overall Study|Explantation w/o study device reimplant.|12
7598539|NCT01959880|26434618|P3|Overall Study|Explantation w/o study device reimplant.|5
7598540|NCT01959880|26434619|P2|Overall Study|Explantation w/o study device reimplant.|17
7598541|NCT01959880|26434620|P1|Overall Study|Explantation w/o study device reimplant.|22
7598542|NCT01959880|26434617|P4|Overall Study|Lost to Follow-up|8
7598543|NCT01959880|26434618|P3|Overall Study|Lost to Follow-up|15
7598544|NCT01959880|26434619|P2|Overall Study|Lost to Follow-up|18
7598545|NCT01959880|26434620|P1|Overall Study|Lost to Follow-up|95
7598546|NCT01959880|26434617|P4|Overall Study|Death|2
7598547|NCT01959880|26434618|P3|Overall Study|Death|1
7598548|NCT01959880|26434619|P2|Overall Study|Death|10
7598549|NCT01959880|26434620|P1|Overall Study|Death|1
7598550|NCT01959880|26434617|P4|Overall Study|Withdrawal by Subject|7
7598551|NCT01959880|26434618|P3|Overall Study|Withdrawal by Subject|8
7598552|NCT01959880|26434619|P2|Overall Study|Withdrawal by Subject|13
7598553|NCT01959880|26434620|P1|Overall Study|Withdrawal by Subject|11
7598554|NCT01959841|26434645|P3|Overall Study|Platelet count below on day1 or 4|11
7598555|NCT01959841|26434646|P2|Overall Study|Platelet count below on day1 or 4|15
7598556|NCT01959841|26434647|P1|Overall Study|Platelet count below on day1 or 4|11
7598557|NCT01959841|26434645|P3|Overall Study|Clinical laboratory value|6
7598558|NCT01959841|26434646|P2|Overall Study|Clinical laboratory value|6
7598559|NCT01959841|26434647|P1|Overall Study|Clinical laboratory value|2
7598560|NCT01959841|26434645|P3|Overall Study|Withdrawal by Subject|5
7598561|NCT01959841|26434646|P2|Overall Study|Withdrawal by Subject|7
7598562|NCT01959841|26434647|P1|Overall Study|Withdrawal by Subject|7
7598563|NCT01959841|26434645|P3|Overall Study|Protocol Violation|16
7598564|NCT01959841|26434646|P2|Overall Study|Protocol Violation|23
7598565|NCT01959841|26434647|P1|Overall Study|Protocol Violation|16
7598566|NCT01959841|26434645|P3|Overall Study|Physician Decision|3
7598567|NCT01959841|26434646|P2|Overall Study|Physician Decision|2
7598568|NCT01959841|26434647|P1|Overall Study|Physician Decision|0
7598569|NCT01959841|26434645|P3|Overall Study|Lost to Follow-up|0
7598570|NCT01959841|26434646|P2|Overall Study|Lost to Follow-up|1
7598571|NCT01959841|26434647|P1|Overall Study|Lost to Follow-up|1
7598572|NCT01959841|26434645|P3|Overall Study|Lack of Efficacy|0
7598573|NCT01959841|26434646|P2|Overall Study|Lack of Efficacy|0
7598574|NCT01959841|26434647|P1|Overall Study|Lack of Efficacy|5
7598575|NCT01959841|26434645|P3|Overall Study|Adverse Event|2
7598576|NCT01959841|26434646|P2|Overall Study|Adverse Event|3
7598577|NCT01959841|26434647|P1|Overall Study|Adverse Event|1
7598578|NCT01959698|26434677|P7|Overall Study|Physician Decision|3
7598579|NCT01959698|26434678|P6|Overall Study|Physician Decision|3
7598580|NCT01959698|26434679|P5|Overall Study|Physician Decision|0
7598581|NCT01959698|26434680|P4|Overall Study|Physician Decision|2
7598582|NCT01959698|26434681|P3|Overall Study|Physician Decision|1
7598583|NCT01959698|26434682|P2|Overall Study|Physician Decision|0
7598584|NCT01959698|26434683|P1|Overall Study|Physician Decision|1
7598585|NCT01959698|26434677|P7|Overall Study|Adverse Event|1
7598586|NCT01959698|26434678|P6|Overall Study|Adverse Event|0
7598587|NCT01959698|26434679|P5|Overall Study|Adverse Event|0
7598588|NCT01959698|26434680|P4|Overall Study|Adverse Event|0
7598589|NCT01959698|26434681|P3|Overall Study|Adverse Event|0
7598590|NCT01959698|26434682|P2|Overall Study|Adverse Event|0
7598591|NCT01959698|26434683|P1|Overall Study|Adverse Event|0
7598592|NCT01959672|26434719|P1|Overall Study|Death|1
7598593|NCT01959607|26434730|P4|First Intervention (Day 1)|Withdrawal by Subject|0
7598594|NCT01959607|26434731|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7598595|NCT01959607|26434732|P2|First Intervention (Day 1)|Withdrawal by Subject|1
7598596|NCT01959607|26434733|P1|First Intervention (Day 1)|Withdrawal by Subject|1
7598597|NCT01959581|26434746|P1|Overall Study|Lost to Follow-up|5
7598598|NCT01959529|26434757|P2|Overall Study|Lack of glycaemic control|1
7598599|NCT01959529|26434758|P1|Overall Study|Lack of glycaemic control|1
7598600|NCT01959529|26434757|P2|Overall Study|Hypoglycaemia|1
7598601|NCT01959529|26434758|P1|Overall Study|Hypoglycaemia|1
7598602|NCT01959529|26434757|P2|Overall Study|Other|68
7598603|NCT01959529|26434758|P1|Overall Study|Other|70
7598604|NCT01959529|26434757|P2|Overall Study|Lost to Follow-up|1
7598605|NCT01959529|26434758|P1|Overall Study|Lost to Follow-up|4
7598606|NCT01959529|26434757|P2|Overall Study|Adverse event (not hypoglycaemia)|1
7598607|NCT01959529|26434758|P1|Overall Study|Adverse event (not hypoglycaemia)|0
7598608|NCT01959516|26434770|P2|Epoch 2|Moderate or severe COPD exacerbation|1
7598609|NCT01959516|26434771|P1|Epoch 2|Moderate or severe COPD exacerbation|0
7598610|NCT01959516|26434770|P2|Epoch 2|Subject withdrew consent|0
7598611|NCT01959516|26434771|P1|Epoch 2|Subject withdrew consent|1
7598612|NCT01959516|26434770|P2|Epoch 2|unsatisfactory therapeutic effect|0
7598613|NCT01959516|26434771|P1|Epoch 2|unsatisfactory therapeutic effect|1
7598614|NCT01959516|26434770|P2|Epoch 1|Protocol deviation|1
7598615|NCT01959516|26434771|P1|Epoch 1|Protocol deviation|0
7598616|NCT01959516|26434770|P2|Epoch 1|Moderate or severe COPD exacerbation|1
7598617|NCT01959516|26434771|P1|Epoch 1|Moderate or severe COPD exacerbation|0
7598618|NCT01959516|26434770|P2|Epoch 1|Use of prohibited treatment|0
7598619|NCT01959516|26434771|P1|Epoch 1|Use of prohibited treatment|1
7598620|NCT01959516|26434770|P2|Epoch 1|Administrative problems|0
7598621|NCT01959516|26434771|P1|Epoch 1|Administrative problems|1
7598622|NCT01959516|26434770|P2|Epoch 1|Subject withdrew consent|2
7598623|NCT01959516|26434771|P1|Epoch 1|Subject withdrew consent|3
7598624|NCT01959516|26434770|P2|Epoch 1|unsatisfactory therapeutic effect|0
7598625|NCT01959516|26434771|P1|Epoch 1|unsatisfactory therapeutic effect|1
7598626|NCT01959516|26434770|P2|Epoch 1|Adverse Event|1
7598627|NCT01959516|26434771|P1|Epoch 1|Adverse Event|4
7598628|NCT01959503|26434781|P2|Overall Study|Randomized but not treated|1
7598629|NCT01959503|26434782|P1|Overall Study|Randomized but not treated|1
7598630|NCT01959503|26434781|P2|Overall Study|Death|1
7598631|NCT01959503|26434782|P1|Overall Study|Death|2
7598632|NCT01959425|26434846|P2|Overall Study|Discontinued Subjects|4
7598633|NCT01959425|26434847|P1|Overall Study|Discontinued Subjects|6
7598634|NCT01959425|26434846|P2|Overall Study|Lost to Follow-up|0
7598635|NCT01959425|26434847|P1|Overall Study|Lost to Follow-up|1
7598636|NCT01959425|26434846|P2|Overall Study|Withdrawal by Subject|4
7598637|NCT01959425|26434847|P1|Overall Study|Withdrawal by Subject|5
7598638|NCT01959412|26434867|P6|Overall Study|Adverse Event|0
7598639|NCT01959412|26434868|P5|Overall Study|Adverse Event|0
7598640|NCT01959412|26434869|P4|Overall Study|Adverse Event|1
7598641|NCT01959412|26434870|P3|Overall Study|Adverse Event|0
7598642|NCT01959412|26434871|P2|Overall Study|Adverse Event|0
7598643|NCT01959412|26434872|P1|Overall Study|Adverse Event|0
7598644|NCT01959412|26434867|P6|Overall Study|Protocol deviation|0
7598645|NCT01959412|26434868|P5|Overall Study|Protocol deviation|3
7598646|NCT01959412|26434869|P4|Overall Study|Protocol deviation|1
7598647|NCT01959412|26434870|P3|Overall Study|Protocol deviation|0
7598648|NCT01959412|26434871|P2|Overall Study|Protocol deviation|1
7598649|NCT01959412|26434872|P1|Overall Study|Protocol deviation|1
7598650|NCT01959347|26434912|P2|Overall Study|Protocol Violation|7
7598651|NCT01959347|26434913|P1|Overall Study|Protocol Violation|9
7598652|NCT01959334|26435019|P2|Third Dose|Adverse Event|1
7598653|NCT01959334|26435020|P1|Third Dose|Adverse Event|0
7598654|NCT01959334|26435019|P2|Second Dose|Adverse Event|0
7598655|NCT01959334|26435020|P1|Second Dose|Adverse Event|1
7598656|NCT01959243|26435032|P2|Overall Study|Lost to Follow-up|1
7598657|NCT01959243|26435033|P1|Overall Study|Lost to Follow-up|3
7598658|NCT01959243|26435032|P2|Overall Study|Administrative reasons|1
7598659|NCT01959243|26435033|P1|Overall Study|Administrative reasons|2
7598660|NCT01959243|26435032|P2|Overall Study|Adverse Event|2
7598661|NCT01959243|26435033|P1|Overall Study|Adverse Event|5
7598662|NCT01959243|26435032|P2|Overall Study|Investigator Decision|0
7598663|NCT01959243|26435033|P1|Overall Study|Investigator Decision|3
7598664|NCT01959230|26435045|P2|Overall Study|Withdrawal by Subject|0
7598665|NCT01959230|26435046|P1|Overall Study|Withdrawal by Subject|2
7598666|NCT01959230|26435045|P2|Overall Study|Administrative reasons|0
7598667|NCT01959230|26435046|P1|Overall Study|Administrative reasons|2
7598668|NCT01959230|26435045|P2|Overall Study|Failure to follow study procedures|1
7598669|NCT01959230|26435046|P1|Overall Study|Failure to follow study procedures|0
7598670|NCT01959165|26435069|P4|Overall Study|Welfare recipient|0
7598671|NCT01959165|26435070|P3|Overall Study|Welfare recipient|0
7598672|NCT01959165|26435071|P2|Overall Study|Welfare recipient|1
7598673|NCT01959165|26435072|P1|Overall Study|Welfare recipient|0
7598674|NCT01959165|26435069|P4|Overall Study|overdose|1
7598675|NCT01959165|26435070|P3|Overall Study|overdose|0
7598676|NCT01959165|26435071|P2|Overall Study|overdose|0
7598677|NCT01959165|26435072|P1|Overall Study|overdose|0
7598678|NCT01959165|26435069|P4|Overall Study|Lack of Efficacy|0
7598679|NCT01959165|26435070|P3|Overall Study|Lack of Efficacy|0
7598680|NCT01959165|26435071|P2|Overall Study|Lack of Efficacy|0
7598681|NCT01959165|26435072|P1|Overall Study|Lack of Efficacy|1
7598682|NCT01959165|26435069|P4|Overall Study|Adverse Event|1
7598683|NCT01959165|26435070|P3|Overall Study|Adverse Event|0
7598684|NCT01959165|26435071|P2|Overall Study|Adverse Event|0
7598685|NCT01959165|26435072|P1|Overall Study|Adverse Event|0
7598686|NCT01959139|26435098|P4|Phase II|On treatment|0
7598687|NCT01959139|26435099|P3|Phase II|On treatment|4
7598688|NCT01959139|26435100|P2|Phase II|On treatment|0
7598689|NCT01959139|26435101|P1|Phase II|On treatment|0
7598690|NCT01959139|26435098|P4|Phase II|Other/Unknown|5
7598691|NCT01959139|26435099|P3|Phase II|Other/Unknown|8
7598692|NCT01959139|26435100|P2|Phase II|Other/Unknown|0
7598693|NCT01959139|26435101|P1|Phase II|Other/Unknown|0
7598694|NCT01959139|26435098|P4|Phase II|Death|1
7598695|NCT01959139|26435099|P3|Phase II|Death|3
7598696|NCT01959139|26435100|P2|Phase II|Death|0
7598697|NCT01959139|26435101|P1|Phase II|Death|0
7598698|NCT01959139|26435098|P4|Phase II|Patient Refusal|4
7598699|NCT01959139|26435099|P3|Phase II|Patient Refusal|5
7598700|NCT01959139|26435100|P2|Phase II|Patient Refusal|0
7598701|NCT01959139|26435101|P1|Phase II|Patient Refusal|0
7598702|NCT01959139|26435098|P4|Phase II|Adverse Event|11
7598703|NCT01959139|26435099|P3|Phase II|Adverse Event|10
7598704|NCT01959139|26435100|P2|Phase II|Adverse Event|0
7598705|NCT01959139|26435101|P1|Phase II|Adverse Event|0
7598706|NCT01959139|26435098|P4|Phase II|Disease progression|34
7598707|NCT01959139|26435099|P3|Phase II|Disease progression|26
7598708|NCT01959139|26435100|P2|Phase II|Disease progression|0
7598709|NCT01959139|26435101|P1|Phase II|Disease progression|0
7598710|NCT01959035|26435134|P1|Overall Study|Other (no primary reason given)|1
7598711|NCT01959035|26435134|P1|Overall Study|Lost to Follow-up|1
7598712|NCT01959035|26435134|P1|Overall Study|Withdrawal by Subject|4
7598713|NCT01959035|26435134|P1|Overall Study|Adverse Event|5
7598714|NCT01958918|26435162|P2|Overall Study|administrative problems|2
7598715|NCT01958918|26435163|P1|Overall Study|administrative problems|0
7598716|NCT01958918|26435162|P2|Overall Study|Adverse Event|12
7598717|NCT01958918|26435163|P1|Overall Study|Adverse Event|12
7598718|NCT01958918|26435162|P2|Overall Study|Lack of Efficacy|10
7598719|NCT01958918|26435163|P1|Overall Study|Lack of Efficacy|13
7598720|NCT01958918|26435162|P2|Overall Study|Withdrawal by Subject|8
7598721|NCT01958918|26435163|P1|Overall Study|Withdrawal by Subject|13
7598722|NCT01958918|26435162|P2|Overall Study|Lost to Follow-up|7
7598723|NCT01958918|26435163|P1|Overall Study|Lost to Follow-up|4
7598724|NCT01958918|26435162|P2|Overall Study|Death|3
7598725|NCT01958918|26435163|P1|Overall Study|Death|1
7598726|NCT01958827|26435177|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
7598727|NCT01958827|26435177|P1|Overall Study|Lack of Efficacy|6
7598728|NCT01958827|26435177|P1|Overall Study|Adverse Event|3
7598729|NCT01958671|26435208|P3|Overall Study|Withdrawal by Subject|13
7598730|NCT01958671|26435209|P2|Overall Study|Withdrawal by Subject|10
7598731|NCT01958671|26435210|P1|Overall Study|Withdrawal by Subject|8
7598732|NCT01958671|26435208|P3|Overall Study|Participant moved|1
7598733|NCT01958671|26435209|P2|Overall Study|Participant moved|0
7598734|NCT01958671|26435210|P1|Overall Study|Participant moved|0
7598735|NCT01958671|26435208|P3|Overall Study|Study site terminated by sponsor|1
7598736|NCT01958671|26435209|P2|Overall Study|Study site terminated by sponsor|0
7598737|NCT01958671|26435210|P1|Overall Study|Study site terminated by sponsor|1
7598738|NCT01958671|26435208|P3|Overall Study|Protocol Violation|0
7598739|NCT01958671|26435209|P2|Overall Study|Protocol Violation|1
7598740|NCT01958671|26435210|P1|Overall Study|Protocol Violation|0
7598741|NCT01958671|26435208|P3|Overall Study|Pregnancy|1
7598742|NCT01958671|26435209|P2|Overall Study|Pregnancy|0
7598743|NCT01958671|26435210|P1|Overall Study|Pregnancy|0
7598744|NCT01958671|26435208|P3|Overall Study|Non-compliance with study drug|1
7598745|NCT01958671|26435209|P2|Overall Study|Non-compliance with study drug|1
7598746|NCT01958671|26435210|P1|Overall Study|Non-compliance with study drug|1
7598747|NCT01958671|26435208|P3|Overall Study|Lost to Follow-up|7
7598748|NCT01958671|26435209|P2|Overall Study|Lost to Follow-up|11
7598749|NCT01958671|26435210|P1|Overall Study|Lost to Follow-up|7
7598750|NCT01958671|26435208|P3|Overall Study|Hyperglycemia|2
7598751|NCT01958671|26435209|P2|Overall Study|Hyperglycemia|0
7598752|NCT01958671|26435210|P1|Overall Study|Hyperglycemia|0
7598753|NCT01958671|26435208|P3|Overall Study|Excluded medication|1
7598754|NCT01958671|26435209|P2|Overall Study|Excluded medication|0
7598755|NCT01958671|26435210|P1|Overall Study|Excluded medication|0
7598756|NCT01958671|26435208|P3|Overall Study|Death|0
7598757|NCT01958671|26435209|P2|Overall Study|Death|0
7598758|NCT01958671|26435210|P1|Overall Study|Death|1
7598759|NCT01958671|26435208|P3|Overall Study|Adverse Event|5
7598760|NCT01958671|26435209|P2|Overall Study|Adverse Event|1
7598761|NCT01958671|26435210|P1|Overall Study|Adverse Event|1
7598762|NCT01958619|26435284|P4|Overall Study|Protocol Violation|0
7598763|NCT01958619|26435285|P3|Overall Study|Protocol Violation|1
7598764|NCT01958619|26435286|P2|Overall Study|Protocol Violation|0
7598765|NCT01958619|26435287|P1|Overall Study|Protocol Violation|2
7598766|NCT01958489|26435357|P2|Period 2|Adverse Event|1
7598767|NCT01958489|26435358|P1|Period 2|Adverse Event|0
7598768|NCT01958476|26435374|P2|Overall Study|Parent requested exclusion from analysis|0
7598769|NCT01958476|26435375|P1|Overall Study|Parent requested exclusion from analysis|1
7598770|NCT01958437|26435405|P4|Overall Study|Incidental MRI findings|1
7598771|NCT01958437|26435406|P3|Overall Study|Incidental MRI findings|1
7598772|NCT01958437|26435407|P2|Overall Study|Incidental MRI findings|0
7598773|NCT01958437|26435408|P1|Overall Study|Incidental MRI findings|0
7598774|NCT01958294|26435472|P1|Overall Study|Clinical Circumstances|2
7598775|NCT01958281|26435481|P3|Overall Study|Withdrew Consent|0
7598776|NCT01958281|26435482|P2|Overall Study|Withdrew Consent|0
7598777|NCT01958281|26435483|P1|Overall Study|Withdrew Consent|1
7598778|NCT01958281|26435481|P3|Overall Study|Adverse Event|0
7598779|NCT01958281|26435482|P2|Overall Study|Adverse Event|2
7598780|NCT01958281|26435483|P1|Overall Study|Adverse Event|0
7598781|NCT01958281|26435481|P3|Overall Study|Lack of Efficacy|0
7598782|NCT01958281|26435482|P2|Overall Study|Lack of Efficacy|2
7598783|NCT01958281|26435483|P1|Overall Study|Lack of Efficacy|5
7598784|NCT01958164|26435559|P2|Overall Study|Lost to Follow-up|3
7598785|NCT01958164|26435560|P1|Overall Study|Lost to Follow-up|2
7598786|NCT01958164|26435559|P2|Overall Study|Adverse Event|2
7598787|NCT01958164|26435560|P1|Overall Study|Adverse Event|0
7598788|NCT01958125|26435575|P2|Overall Study|No headache attacks|2
7598789|NCT01958125|26435576|P1|Overall Study|No headache attacks|0
7598790|NCT01958125|26435575|P2|Overall Study|Missing diary data|6
7598791|NCT01958125|26435576|P1|Overall Study|Missing diary data|2
7598792|NCT01958060|26435639|P6|Overall Study|Not treated|0
7598793|NCT01958060|26435640|P5|Overall Study|Not treated|1
7598794|NCT01958060|26435641|P4|Overall Study|Not treated|0
7598795|NCT01958060|26435642|P3|Overall Study|Not treated|0
7598796|NCT01958060|26435643|P2|Overall Study|Not treated|0
7598797|NCT01958060|26435644|P1|Overall Study|Not treated|2
7598810|NCT01958008|26435682|P4|Overall Study|Other adverse event|0
7598811|NCT01958008|26435683|P3|Overall Study|Other adverse event|0
7598812|NCT01958008|26435684|P2|Overall Study|Other adverse event|0
7598813|NCT01958008|26435685|P1|Overall Study|Other adverse event|1
7598814|NCT01958008|26435682|P4|Overall Study|Worsening of disease under study|0
7598815|NCT01958008|26435683|P3|Overall Study|Worsening of disease under study|1
7598816|NCT01958008|26435684|P2|Overall Study|Worsening of disease under study|0
7598817|NCT01958008|26435685|P1|Overall Study|Worsening of disease under study|0
7598818|NCT01957865|26435728|P3|Overall Study|Lost to Follow-up|2
7598819|NCT01957865|26435729|P2|Overall Study|Lost to Follow-up|2
7598820|NCT01957865|26435730|P1|Overall Study|Lost to Follow-up|0
7598821|NCT01957865|26435728|P3|Overall Study|Found HIV negative|1
7598822|NCT01957865|26435729|P2|Overall Study|Found HIV negative|0
7598823|NCT01957865|26435730|P1|Overall Study|Found HIV negative|0
7598824|NCT01957787|26435741|P1|Overall Study|Local therapy, not cryoablation|6
7598825|NCT01957787|26435741|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
7598826|NCT01957787|26435741|P1|Overall Study|Index Tumor(s) Resected|2
7598827|NCT01957787|26435741|P1|Overall Study|Entered Hospice or Similar Program|2
7598828|NCT01957787|26435741|P1|Overall Study|Withdrawal by Subject|3
7598829|NCT01957787|26435741|P1|Overall Study|Lost to Follow-up|3
7598830|NCT01957787|26435741|P1|Overall Study|Death|18
7598831|NCT01957709|26435760|P1|Overall Study|Patient refused to complete post-tx bx|1
7598832|NCT01957644|26435785|P5|Overall Study|Protocol Violation|0
7598833|NCT01957644|26435786|P4|Overall Study|Protocol Violation|0
7598834|NCT01957644|26435787|P3|Overall Study|Protocol Violation|0
7598835|NCT01957644|26435788|P2|Overall Study|Protocol Violation|1
7598836|NCT01957644|26435789|P1|Overall Study|Protocol Violation|0
7598837|NCT01957644|26435785|P5|Overall Study|Withdrawal by Subject|0
7598838|NCT01957644|26435786|P4|Overall Study|Withdrawal by Subject|0
7598839|NCT01957644|26435787|P3|Overall Study|Withdrawal by Subject|0
7598840|NCT01957644|26435788|P2|Overall Study|Withdrawal by Subject|0
7598841|NCT01957644|26435789|P1|Overall Study|Withdrawal by Subject|1
7598842|NCT01957644|26435785|P5|Overall Study|Other reason|0
7598843|NCT01957644|26435786|P4|Overall Study|Other reason|1
7598844|NCT01957644|26435787|P3|Overall Study|Other reason|1
7598845|NCT01957644|26435788|P2|Overall Study|Other reason|2
7598846|NCT01957644|26435789|P1|Overall Study|Other reason|1
7598847|NCT01957644|26435785|P5|Overall Study|Progressive disease / relapse|0
7598848|NCT01957644|26435786|P4|Overall Study|Progressive disease / relapse|1
7598849|NCT01957644|26435787|P3|Overall Study|Progressive disease / relapse|0
7598850|NCT01957644|26435788|P2|Overall Study|Progressive disease / relapse|1
7598851|NCT01957644|26435789|P1|Overall Study|Progressive disease / relapse|0
7598852|NCT01957644|26435785|P5|Overall Study|Adverse Event|1
7598853|NCT01957644|26435786|P4|Overall Study|Adverse Event|0
7598854|NCT01957644|26435787|P3|Overall Study|Adverse Event|0
7598855|NCT01957644|26435788|P2|Overall Study|Adverse Event|2
7598856|NCT01957644|26435789|P1|Overall Study|Adverse Event|4
7598857|NCT01957579|26435813|P4|Overall Study|Death|0
7598858|NCT01957579|26435814|P3|Overall Study|Death|2
7598859|NCT01957579|26435815|P2|Overall Study|Death|0
7598860|NCT01957579|26435816|P1|Overall Study|Death|0
7598861|NCT01957579|26435813|P4|Overall Study|Withdrawal of concent|0
7598862|NCT01957579|26435814|P3|Overall Study|Withdrawal of concent|0
7598863|NCT01957579|26435815|P2|Overall Study|Withdrawal of concent|1
7598864|NCT01957579|26435816|P1|Overall Study|Withdrawal of concent|0
7598865|NCT01957553|26435883|P2|Test Period 2 (21 +- 1 Days)|Other|0
7598866|NCT01957553|26435884|P1|Test Period 2 (21 +- 1 Days)|Other|1
7598867|NCT01957553|26435883|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
7598868|NCT01957553|26435884|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
7598869|NCT01957553|26435883|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
7598870|NCT01957553|26435884|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
7598871|NCT01957553|26435883|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
7598872|NCT01957553|26435884|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
7598873|NCT01957553|26435883|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
7598874|NCT01957553|26435884|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
7598875|NCT01957553|26435883|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
7598876|NCT01957553|26435884|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
7598877|NCT01957553|26435883|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
7598878|NCT01957553|26435884|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
7598879|NCT01957553|26435883|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
7598880|NCT01957553|26435884|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
7598881|NCT01957553|26435883|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
7598882|NCT01957553|26435884|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
7598883|NCT01957488|26435890|P6|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7598884|NCT01957488|26435891|P5|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7598885|NCT01957488|26435892|P4|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7598886|NCT01957488|26435893|P3|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7598887|NCT01957488|26435894|P2|Test Period 3 (2 Weeks)|Lack of Efficacy|1
7598888|NCT01957488|26435895|P1|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7598889|NCT01957488|26435890|P6|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7598890|NCT01957488|26435891|P5|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7598891|NCT01957488|26435892|P4|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7598892|NCT01957488|26435893|P3|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7598893|NCT01957488|26435894|P2|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7598894|NCT01957488|26435895|P1|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
7598895|NCT01957488|26435890|P6|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
7598896|NCT01957488|26435891|P5|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7598897|NCT01957488|26435892|P4|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7598898|NCT01957488|26435893|P3|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7598899|NCT01957488|26435894|P2|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7598900|NCT01957488|26435895|P1|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7598901|NCT01957488|26435890|P6|Test Period 2 (2 Weeks)|Adverse Event|0
7598902|NCT01957488|26435891|P5|Test Period 2 (2 Weeks)|Adverse Event|2
7598903|NCT01957488|26435892|P4|Test Period 2 (2 Weeks)|Adverse Event|0
7598904|NCT01957488|26435893|P3|Test Period 2 (2 Weeks)|Adverse Event|0
7598905|NCT01957488|26435894|P2|Test Period 2 (2 Weeks)|Adverse Event|0
7598906|NCT01957488|26435895|P1|Test Period 2 (2 Weeks)|Adverse Event|0
7598907|NCT01957488|26435890|P6|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7598908|NCT01957488|26435891|P5|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7598909|NCT01957488|26435892|P4|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7598910|NCT01957488|26435893|P3|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7598911|NCT01957488|26435894|P2|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
7598912|NCT01957488|26435895|P1|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7598913|NCT01957488|26435890|P6|Test Period 2 (2 Weeks)|Other|0
7598914|NCT01957488|26435891|P5|Test Period 2 (2 Weeks)|Other|0
7598915|NCT01957488|26435892|P4|Test Period 2 (2 Weeks)|Other|0
7598916|NCT01957488|26435893|P3|Test Period 2 (2 Weeks)|Other|0
7598917|NCT01957488|26435894|P2|Test Period 2 (2 Weeks)|Other|0
7598918|NCT01957488|26435895|P1|Test Period 2 (2 Weeks)|Other|1
7598919|NCT01957488|26435890|P6|Test Period 2 (2 Weeks)|Protocol Violation|0
7598920|NCT01957488|26435891|P5|Test Period 2 (2 Weeks)|Protocol Violation|0
7598921|NCT01957488|26435892|P4|Test Period 2 (2 Weeks)|Protocol Violation|1
7598922|NCT01957488|26435893|P3|Test Period 2 (2 Weeks)|Protocol Violation|1
7598923|NCT01957488|26435894|P2|Test Period 2 (2 Weeks)|Protocol Violation|0
7598924|NCT01957488|26435895|P1|Test Period 2 (2 Weeks)|Protocol Violation|2
7598925|NCT01957488|26435890|P6|Test Period 1 (2 Weeks)|screen failure|1
7598926|NCT01957488|26435891|P5|Test Period 1 (2 Weeks)|screen failure|0
7598927|NCT01957488|26435892|P4|Test Period 1 (2 Weeks)|screen failure|0
7598928|NCT01957488|26435893|P3|Test Period 1 (2 Weeks)|screen failure|0
7598929|NCT01957488|26435894|P2|Test Period 1 (2 Weeks)|screen failure|0
7598930|NCT01957488|26435895|P1|Test Period 1 (2 Weeks)|screen failure|0
7598931|NCT01957488|26435890|P6|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7598932|NCT01957488|26435891|P5|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
7598933|NCT01957488|26435892|P4|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7598934|NCT01957488|26435893|P3|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7598935|NCT01957488|26435894|P2|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7598936|NCT01957488|26435895|P1|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7598937|NCT01957488|26435890|P6|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
7598938|NCT01957488|26435891|P5|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7598939|NCT01957488|26435892|P4|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7598940|NCT01957488|26435893|P3|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7598941|NCT01957488|26435894|P2|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7598942|NCT01957488|26435895|P1|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7598943|NCT01957488|26435890|P6|Test Period 1 (2 Weeks)|Adverse Event|0
7598944|NCT01957488|26435891|P5|Test Period 1 (2 Weeks)|Adverse Event|1
7598945|NCT01957488|26435892|P4|Test Period 1 (2 Weeks)|Adverse Event|0
7598946|NCT01957488|26435893|P3|Test Period 1 (2 Weeks)|Adverse Event|1
7598947|NCT01957488|26435894|P2|Test Period 1 (2 Weeks)|Adverse Event|1
7598948|NCT01957488|26435895|P1|Test Period 1 (2 Weeks)|Adverse Event|0
7598949|NCT01957488|26435890|P6|Test Period 1 (2 Weeks)|Protocol Violation|3
7598950|NCT01957488|26435891|P5|Test Period 1 (2 Weeks)|Protocol Violation|0
7598951|NCT01957488|26435892|P4|Test Period 1 (2 Weeks)|Protocol Violation|1
7598952|NCT01957488|26435893|P3|Test Period 1 (2 Weeks)|Protocol Violation|2
7598953|NCT01957488|26435894|P2|Test Period 1 (2 Weeks)|Protocol Violation|2
7598954|NCT01957488|26435895|P1|Test Period 1 (2 Weeks)|Protocol Violation|1
7598955|NCT01957488|26435890|P6|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7598956|NCT01957488|26435891|P5|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7598957|NCT01957488|26435892|P4|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7598958|NCT01957488|26435893|P3|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7598959|NCT01957488|26435894|P2|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7598960|NCT01957488|26435895|P1|Test Period 1 (2 Weeks)|Lost to Follow-up|2
7598961|NCT01957475|26435903|P2|Test Period 2|Adverse Event|0
7598962|NCT01957475|26435904|P1|Test Period 2|Adverse Event|1
7598963|NCT01957475|26435903|P2|Test Period 1|Lack of Efficacy|1
7598964|NCT01957475|26435904|P1|Test Period 1|Lack of Efficacy|0
7598965|NCT01957475|26435903|P2|Test Period 1|Other|0
7598966|NCT01957475|26435904|P1|Test Period 1|Other|1
7598967|NCT01957475|26435903|P2|Test Period 1|Withdrawal by Subject|0
7598968|NCT01957475|26435904|P1|Test Period 1|Withdrawal by Subject|1
7598969|NCT01957462|26435910|P2|Test Period 1|Adverse Event|0
7598970|NCT01957462|26435911|P1|Test Period 1|Adverse Event|1
7598971|NCT01957462|26435910|P2|Test Period 1|Withdrawal by Subject|0
7598972|NCT01957462|26435911|P1|Test Period 1|Withdrawal by Subject|1
7598973|NCT01957397|26435922|P2|Test Period 3|the adhesive did not work|0
7598974|NCT01957397|26435923|P1|Test Period 3|the adhesive did not work|1
7598975|NCT01957397|26435922|P2|Test Period 3|Adverse Event|2
7598976|NCT01957397|26435923|P1|Test Period 3|Adverse Event|1
7598977|NCT01957397|26435922|P2|Test Period 2|Adverse Event|1
7598978|NCT01957397|26435923|P1|Test Period 2|Adverse Event|0
7598979|NCT01957397|26435922|P2|Test Period 1|Withdrawal by Subject|0
7598980|NCT01957397|26435923|P1|Test Period 1|Withdrawal by Subject|1
7598981|NCT01957397|26435922|P2|Test Period 1|sudden leakage/small bag|1
7598982|NCT01957397|26435923|P1|Test Period 1|sudden leakage/small bag|1
7598983|NCT01957215|26435948|P2|Overall Study|Withdrawal by Subject|5
7598984|NCT01957215|26435949|P1|Overall Study|Withdrawal by Subject|7
7598985|NCT01957215|26435948|P2|Overall Study|Protocol Violation|2
7598986|NCT01957215|26435949|P1|Overall Study|Protocol Violation|1
7598987|NCT01957215|26435948|P2|Overall Study|Lost to Follow-up|3
7598988|NCT01957215|26435949|P1|Overall Study|Lost to Follow-up|3
7598989|NCT01957215|26435948|P2|Overall Study|Adverse Event|2
7598990|NCT01957215|26435949|P1|Overall Study|Adverse Event|2
7598991|NCT01957202|26435977|P18|Treatment Period 3 (8 Days)|Adverse Event|0
7598992|NCT01957202|26435978|P17|Treatment Period 3 (8 Days)|Adverse Event|1
7598993|NCT01957202|26435979|P16|Treatment Period 3 (8 Days)|Adverse Event|0
7598994|NCT01957202|26435980|P15|Treatment Period 3 (8 Days)|Adverse Event|0
7598995|NCT01957202|26435981|P14|Treatment Period 3 (8 Days)|Adverse Event|0
7598996|NCT01957202|26435982|P13|Treatment Period 3 (8 Days)|Adverse Event|0
7598997|NCT01957202|26435983|P12|Treatment Period 3 (8 Days)|Adverse Event|0
7598998|NCT01957202|26435984|P11|Treatment Period 3 (8 Days)|Adverse Event|0
7598999|NCT01957202|26435985|P10|Treatment Period 3 (8 Days)|Adverse Event|0
7599000|NCT01957202|26435986|P9|Treatment Period 3 (8 Days)|Adverse Event|0
7599001|NCT01957202|26435987|P8|Treatment Period 3 (8 Days)|Adverse Event|0
7599002|NCT01957202|26435988|P7|Treatment Period 3 (8 Days)|Adverse Event|0
7599003|NCT01957202|26435989|P6|Treatment Period 3 (8 Days)|Adverse Event|0
7599004|NCT01957202|26435990|P5|Treatment Period 3 (8 Days)|Adverse Event|0
7599005|NCT01957202|26435991|P4|Treatment Period 3 (8 Days)|Adverse Event|0
7599006|NCT01957202|26435992|P3|Treatment Period 3 (8 Days)|Adverse Event|0
7599007|NCT01957202|26435993|P2|Treatment Period 3 (8 Days)|Adverse Event|0
7599008|NCT01957202|26435994|P1|Treatment Period 3 (8 Days)|Adverse Event|0
7599009|NCT01957202|26435977|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599010|NCT01957202|26435978|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7599011|NCT01957202|26435979|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599012|NCT01957202|26435980|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599013|NCT01957202|26435981|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599014|NCT01957202|26435982|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599015|NCT01957202|26435983|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599016|NCT01957202|26435984|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599017|NCT01957202|26435985|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599018|NCT01957202|26435986|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599019|NCT01957202|26435987|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599020|NCT01957202|26435988|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599021|NCT01957202|26435989|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599022|NCT01957202|26435990|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599023|NCT01957202|26435991|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599024|NCT01957202|26435992|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599025|NCT01957202|26435993|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7599026|NCT01957202|26435994|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7599027|NCT01957163|26436019|P3|Overall Study|Withdrawal by Subject|4
7599028|NCT01957163|26436020|P2|Overall Study|Withdrawal by Subject|2
7599029|NCT01957163|26436021|P1|Overall Study|Withdrawal by Subject|4
7599030|NCT01957163|26436019|P3|Overall Study|Lost to Follow-up|0
7599031|NCT01957163|26436020|P2|Overall Study|Lost to Follow-up|1
7599032|NCT01957163|26436021|P1|Overall Study|Lost to Follow-up|0
7599033|NCT01957163|26436019|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
7599034|NCT01957163|26436020|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
7599035|NCT01957163|26436021|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
7599036|NCT01957163|26436019|P3|Overall Study|Protocol Violation|0
7599037|NCT01957163|26436020|P2|Overall Study|Protocol Violation|2
7599038|NCT01957163|26436021|P1|Overall Study|Protocol Violation|1
7599039|NCT01957163|26436019|P3|Overall Study|Lack of Efficacy|9
7599040|NCT01957163|26436020|P2|Overall Study|Lack of Efficacy|4
7599041|NCT01957163|26436021|P1|Overall Study|Lack of Efficacy|5
7599042|NCT01957163|26436019|P3|Overall Study|Adverse Event|4
7599043|NCT01957163|26436020|P2|Overall Study|Adverse Event|2
7599044|NCT01957163|26436021|P1|Overall Study|Adverse Event|5
7599045|NCT01957150|26436034|P2|Overall Study|Lack of Efficacy|11
7599046|NCT01957150|26436035|P1|Overall Study|Lack of Efficacy|11
7599047|NCT01957150|26436034|P2|Overall Study|Protocol Violation|0
7599048|NCT01957150|26436035|P1|Overall Study|Protocol Violation|1
7599049|NCT01957150|26436034|P2|Overall Study|Lost to Follow-up|4
7599050|NCT01957150|26436035|P1|Overall Study|Lost to Follow-up|4
7599051|NCT01957150|26436034|P2|Overall Study|Physician Decision|6
7599052|NCT01957150|26436035|P1|Overall Study|Physician Decision|3
7599053|NCT01957150|26436034|P2|Overall Study|Withdrawal by Subject|17
7599054|NCT01957150|26436035|P1|Overall Study|Withdrawal by Subject|13
7599055|NCT01957150|26436034|P2|Overall Study|Adverse Event|20
7599056|NCT01957150|26436035|P1|Overall Study|Adverse Event|23
7599057|NCT01957137|26436051|P1|Randomized Portion|Withdrawal by Subject|1
7599058|NCT01957137|26436051|P1|Randomized Portion|Adverse Event|1
7599059|NCT01957111|26436081|P2|Overall Study|Withdrawal by Subject|1
7599060|NCT01957111|26436082|P1|Overall Study|Withdrawal by Subject|1
7599061|NCT01956773|26436101|P2|Overall Study|Lost to Follow-up|1
7599062|NCT01956773|26436102|P1|Overall Study|Lost to Follow-up|628
7599063|NCT01956669|26436120|P7|Overall Study|Withdrawal by Subject|1
7599064|NCT01956669|26436121|P6|Overall Study|Withdrawal by Subject|0
7599065|NCT01956669|26436122|P5|Overall Study|Withdrawal by Subject|0
7599066|NCT01956669|26436123|P4|Overall Study|Withdrawal by Subject|1
7599067|NCT01956669|26436124|P3|Overall Study|Withdrawal by Subject|1
7599068|NCT01956669|26436125|P2|Overall Study|Withdrawal by Subject|0
7599069|NCT01956669|26436126|P1|Overall Study|Withdrawal by Subject|0
7599070|NCT01956669|26436120|P7|Overall Study|Physician Decision|0
7599071|NCT01956669|26436121|P6|Overall Study|Physician Decision|1
7599072|NCT01956669|26436122|P5|Overall Study|Physician Decision|0
7599073|NCT01956669|26436123|P4|Overall Study|Physician Decision|0
7599074|NCT01956669|26436124|P3|Overall Study|Physician Decision|0
7599075|NCT01956669|26436125|P2|Overall Study|Physician Decision|2
7599076|NCT01956669|26436126|P1|Overall Study|Physician Decision|0
7599077|NCT01956669|26436120|P7|Overall Study|Adverse Event|0
7599078|NCT01956669|26436121|P6|Overall Study|Adverse Event|0
7599079|NCT01956669|26436122|P5|Overall Study|Adverse Event|0
7599080|NCT01956669|26436123|P4|Overall Study|Adverse Event|1
7599081|NCT01956669|26436124|P3|Overall Study|Adverse Event|2
7599082|NCT01956669|26436125|P2|Overall Study|Adverse Event|2
7599083|NCT01956669|26436126|P1|Overall Study|Adverse Event|0
7599084|NCT01956669|26436120|P7|Overall Study|Disease Progression|5
7599085|NCT01956669|26436121|P6|Overall Study|Disease Progression|3
7599086|NCT01956669|26436122|P5|Overall Study|Disease Progression|4
7599087|NCT01956669|26436123|P4|Overall Study|Disease Progression|8
7599088|NCT01956669|26436124|P3|Overall Study|Disease Progression|7
7599089|NCT01956669|26436125|P2|Overall Study|Disease Progression|7
7599090|NCT01956669|26436126|P1|Overall Study|Disease Progression|12
7599091|NCT01956240|26436248|P2|Overall Study|Adverse Event|4
7599092|NCT01956240|26436249|P1|Overall Study|Adverse Event|17
7599093|NCT01956240|26436248|P2|Overall Study|Lost to Follow-up|20
7599094|NCT01956240|26436249|P1|Overall Study|Lost to Follow-up|6
7599095|NCT01956123|26436259|P4|COS Cycle 3|Withdrawal by Subject|1
7599096|NCT01956123|26436260|P3|COS Cycle 3|Withdrawal by Subject|0
7599097|NCT01956123|26436261|P2|COS Cycle 3|Withdrawal by Subject|0
7599098|NCT01956123|26436262|P1|COS Cycle 3|Withdrawal by Subject|0
7599099|NCT01956123|26436259|P4|COS Cycle 3|Personal Reasons|0
7599100|NCT01956123|26436260|P3|COS Cycle 3|Personal Reasons|1
7599101|NCT01956123|26436261|P2|COS Cycle 3|Personal Reasons|0
7599102|NCT01956123|26436262|P1|COS Cycle 3|Personal Reasons|0
7599103|NCT01956123|26436259|P4|COS Cycle 3|Adverse Event|0
7599104|NCT01956123|26436260|P3|COS Cycle 3|Adverse Event|3
7599105|NCT01956123|26436261|P2|COS Cycle 3|Adverse Event|0
7599106|NCT01956123|26436262|P1|COS Cycle 3|Adverse Event|0
7599107|NCT01956123|26436259|P4|COS Cycle 3|Protocol Violation|1
7599108|NCT01956123|26436260|P3|COS Cycle 3|Protocol Violation|2
7599109|NCT01956123|26436261|P2|COS Cycle 3|Protocol Violation|0
7599110|NCT01956123|26436262|P1|COS Cycle 3|Protocol Violation|0
7599111|NCT01956123|26436259|P4|COS Cycle 2|Withdrawal by Subject|0
7599112|NCT01956123|26436260|P3|COS Cycle 2|Withdrawal by Subject|0
7599113|NCT01956123|26436261|P2|COS Cycle 2|Withdrawal by Subject|0
7599114|NCT01956123|26436262|P1|COS Cycle 2|Withdrawal by Subject|1
7599115|NCT01956123|26436259|P4|COS Cycle 2|Personal Reasons|0
7599116|NCT01956123|26436260|P3|COS Cycle 2|Personal Reasons|0
7599117|NCT01956123|26436261|P2|COS Cycle 2|Personal Reasons|0
7599118|NCT01956123|26436262|P1|COS Cycle 2|Personal Reasons|2
7599119|NCT01956123|26436259|P4|COS Cycle 2|Adverse Event|0
7599120|NCT01956123|26436260|P3|COS Cycle 2|Adverse Event|0
7599121|NCT01956123|26436261|P2|COS Cycle 2|Adverse Event|4
7599122|NCT01956123|26436262|P1|COS Cycle 2|Adverse Event|3
7599123|NCT01956123|26436259|P4|COS Cycle 2|Protocol Violation|0
7599124|NCT01956123|26436260|P3|COS Cycle 2|Protocol Violation|0
7599125|NCT01956123|26436261|P2|COS Cycle 2|Protocol Violation|3
7599126|NCT01956123|26436262|P1|COS Cycle 2|Protocol Violation|8
7599127|NCT01956110|26436314|P2|Overall Study|Personal reasons|1
7599128|NCT01956110|26436315|P1|Overall Study|Personal reasons|1
7599129|NCT01956110|26436314|P2|Overall Study|Adverse Event|10
7599130|NCT01956110|26436315|P1|Overall Study|Adverse Event|9
7599131|NCT01956110|26436314|P2|Overall Study|Protocol Violation|11
7599132|NCT01956110|26436315|P1|Overall Study|Protocol Violation|25
7599133|NCT01955733|26436481|P3|Period 2|Other not defined above|2
7599134|NCT01955733|26436482|P2|Period 2|Other not defined above|2
7599135|NCT01955733|26436483|P1|Period 2|Other not defined above|0
7599136|NCT01955733|26436481|P3|Period 2|Lost to Follow-up|0
7599137|NCT01955733|26436482|P2|Period 2|Lost to Follow-up|0
7599138|NCT01955733|26436483|P1|Period 2|Lost to Follow-up|2
7599139|NCT01955733|26436481|P3|Period 2|Study terminated by sponsor|16
7599140|NCT01955733|26436482|P2|Period 2|Study terminated by sponsor|14
7599141|NCT01955733|26436483|P1|Period 2|Study terminated by sponsor|8
7599142|NCT01955733|26436481|P3|Period 2|Withdrawal by Subject|2
7599143|NCT01955733|26436482|P2|Period 2|Withdrawal by Subject|3
7599144|NCT01955733|26436483|P1|Period 2|Withdrawal by Subject|1
7599145|NCT01955733|26436481|P3|Period 2|Physician Decision|1
7599146|NCT01955733|26436482|P2|Period 2|Physician Decision|0
7599147|NCT01955733|26436483|P1|Period 2|Physician Decision|0
7599148|NCT01955733|26436481|P3|Period 2|Adverse Event|0
7599149|NCT01955733|26436482|P2|Period 2|Adverse Event|0
7599150|NCT01955733|26436483|P1|Period 2|Adverse Event|1
7599151|NCT01955733|26436481|P3|Period 1|Lost to Follow-up|0
7599152|NCT01955733|26436482|P2|Period 1|Lost to Follow-up|0
7599153|NCT01955733|26436483|P1|Period 1|Lost to Follow-up|1
7599154|NCT01955707|26436576|P2|Overall Study|Other|2
7599155|NCT01955707|26436577|P1|Overall Study|Other|4
7599156|NCT01955707|26436576|P2|Overall Study|Death|14
7599157|NCT01955707|26436577|P1|Overall Study|Death|13
7599158|NCT01955707|26436576|P2|Overall Study|Withdrawal by Subject|3
7599159|NCT01955707|26436577|P1|Overall Study|Withdrawal by Subject|0
7599160|NCT01955707|26436576|P2|Overall Study|Lost to Follow-up|1
7599161|NCT01955707|26436577|P1|Overall Study|Lost to Follow-up|2
7599162|NCT01955707|26436576|P2|Overall Study|Adverse Event|2
7599163|NCT01955707|26436577|P1|Overall Study|Adverse Event|1
7599164|NCT01955161|26436845|P3|Overall Study|Other reason: patient's will|1
7599165|NCT01955161|26436846|P2|Overall Study|Other reason: patient's will|0
7599166|NCT01955161|26436847|P1|Overall Study|Other reason: patient's will|0
7599167|NCT01955161|26436845|P3|Overall Study|Other reason: primary biliary cirrhosis|0
7599168|NCT01955161|26436846|P2|Overall Study|Other reason: primary biliary cirrhosis|0
7599169|NCT01955161|26436847|P1|Overall Study|Other reason: primary biliary cirrhosis|1
7599170|NCT01955161|26436845|P3|Overall Study|Other reason: insufficient compliance|1
7599171|NCT01955161|26436846|P2|Overall Study|Other reason: insufficient compliance|0
7599172|NCT01955161|26436847|P1|Overall Study|Other reason: insufficient compliance|0
7599173|NCT01955161|26436845|P3|Overall Study|Other reason: moved to nursing home|0
7599174|NCT01955161|26436846|P2|Overall Study|Other reason: moved to nursing home|1
7599175|NCT01955161|26436847|P1|Overall Study|Other reason: moved to nursing home|0
7599176|NCT01955161|26436845|P3|Overall Study|Other reason: caregiver unavailable|0
7599177|NCT01955161|26436846|P2|Overall Study|Other reason: caregiver unavailable|0
7599178|NCT01955161|26436847|P1|Overall Study|Other reason: caregiver unavailable|1
7599179|NCT01955161|26436845|P3|Overall Study|Other reason: disallowed medication|1
7599180|NCT01955161|26436846|P2|Overall Study|Other reason: disallowed medication|0
7599181|NCT01955161|26436847|P1|Overall Study|Other reason: disallowed medication|1
7599182|NCT01955161|26436845|P3|Overall Study|Other reason: physician decision|1
7599183|NCT01955161|26436846|P2|Overall Study|Other reason: physician decision|1
7599184|NCT01955161|26436847|P1|Overall Study|Other reason: physician decision|0
7599185|NCT01955161|26436845|P3|Overall Study|Protocol Violation|0
7599186|NCT01955161|26436846|P2|Overall Study|Protocol Violation|0
7599187|NCT01955161|26436847|P1|Overall Study|Protocol Violation|2
7599188|NCT01955161|26436845|P3|Overall Study|Withdrawal by Subject|12
7599189|NCT01955161|26436846|P2|Overall Study|Withdrawal by Subject|8
7599190|NCT01955161|26436847|P1|Overall Study|Withdrawal by Subject|9
7599191|NCT01955161|26436845|P3|Overall Study|Death|3
7599192|NCT01955161|26436846|P2|Overall Study|Death|1
7599193|NCT01955161|26436847|P1|Overall Study|Death|1
7599194|NCT01955161|26436845|P3|Overall Study|Adverse Event|15
7599195|NCT01955161|26436846|P2|Overall Study|Adverse Event|14
7599196|NCT01955161|26436847|P1|Overall Study|Adverse Event|10
7599197|NCT01955161|26436845|P3|Overall Study|Withdrawal before treatment|1
7599198|NCT01955161|26436846|P2|Overall Study|Withdrawal before treatment|0
7599199|NCT01955161|26436847|P1|Overall Study|Withdrawal before treatment|2
7599200|NCT01955122|26436887|P2|Overall Study|Physician Decision|5
7599201|NCT01955122|26436888|P1|Overall Study|Physician Decision|5
7599202|NCT01955083|26436908|P2|Overall Study|Lost to Follow-up|1
7599203|NCT01955083|26436909|P1|Overall Study|Lost to Follow-up|1
7599204|NCT01955044|26436942|P3|Overall Study|Death|0
7599205|NCT01955044|26436943|P2|Overall Study|Death|1
7599206|NCT01955044|26436944|P1|Overall Study|Death|1
7599207|NCT01955005|26436957|P2|Overall Study|Withdrawal by Subject|5
7599208|NCT01955005|26436958|P1|Overall Study|Withdrawal by Subject|3
7599209|NCT01954927|26436970|P2|Overall Study|Withdrawal by Subject|1
7599210|NCT01954927|26436971|P1|Overall Study|Withdrawal by Subject|3
7599211|NCT01954771|26436992|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
7599212|NCT01954771|26436993|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
7599213|NCT01954771|26436994|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
7599214|NCT01954771|26436992|P3|Overall Study|Missing CGMS of end-point|0
7599215|NCT01954771|26436993|P2|Overall Study|Missing CGMS of end-point|1
7599216|NCT01954771|26436994|P1|Overall Study|Missing CGMS of end-point|1
7599217|NCT01954771|26436992|P3|Overall Study|Missing HbA1c of end-point|0
7599218|NCT01954771|26436993|P2|Overall Study|Missing HbA1c of end-point|1
7599219|NCT01954771|26436994|P1|Overall Study|Missing HbA1c of end-point|1
7599220|NCT01954745|26437011|P1|Overall Study|Death|1
7599221|NCT01954745|26437011|P1|Overall Study|Adverse Event|2
7599222|NCT01954745|26437011|P1|Overall Study|Clinical Progression|5
7599223|NCT01954745|26437011|P1|Overall Study|Radiological Progression|11
7599224|NCT01954394|26437042|P2|Overall Study|Other than specified above|21
7599225|NCT01954394|26437043|P1|Overall Study|Other than specified above|10
7599226|NCT01954394|26437042|P2|Overall Study|Related to Study Drug administration|2
7599227|NCT01954394|26437043|P1|Overall Study|Related to Study Drug administration|2
7599228|NCT01954394|26437042|P2|Overall Study|Participant Moved|4
7599229|NCT01954394|26437043|P1|Overall Study|Participant Moved|0
7599230|NCT01954394|26437042|P2|Overall Study|Poor compliance to protocol|7
7599231|NCT01954394|26437043|P1|Overall Study|Poor compliance to protocol|7
7599232|NCT01954394|26437042|P2|Overall Study|Adverse Event|23
7599233|NCT01954394|26437043|P1|Overall Study|Adverse Event|10
7599234|NCT01954394|26437042|P2|Overall Study|Enrolled but not treated|0
7599235|NCT01954394|26437043|P1|Overall Study|Enrolled but not treated|1
7599236|NCT01954342|26437097|P4|Overall Study|Unreliable Data|2
7599237|NCT01954342|26437098|P3|Overall Study|Unreliable Data|0
7599238|NCT01954342|26437099|P2|Overall Study|Unreliable Data|0
7599239|NCT01954342|26437100|P1|Overall Study|Unreliable Data|0
7599240|NCT01954342|26437097|P4|Overall Study|Pre-eclampsia|4
7599241|NCT01954342|26437098|P3|Overall Study|Pre-eclampsia|0
7599242|NCT01954342|26437099|P2|Overall Study|Pre-eclampsia|0
7599243|NCT01954342|26437100|P1|Overall Study|Pre-eclampsia|0
7599244|NCT01954342|26437097|P4|Overall Study|Preterm delivery|3
7599245|NCT01954342|26437098|P3|Overall Study|Preterm delivery|0
7599246|NCT01954342|26437099|P2|Overall Study|Preterm delivery|0
7599247|NCT01954342|26437100|P1|Overall Study|Preterm delivery|0
7599248|NCT01954342|26437097|P4|Overall Study|Lost to Follow-up|5
7599249|NCT01954342|26437098|P3|Overall Study|Lost to Follow-up|0
7599250|NCT01954342|26437099|P2|Overall Study|Lost to Follow-up|0
7599251|NCT01954342|26437100|P1|Overall Study|Lost to Follow-up|0
7599252|NCT01954342|26437097|P4|Overall Study|Miscarriage|3
7599253|NCT01954342|26437098|P3|Overall Study|Miscarriage|0
7599254|NCT01954342|26437099|P2|Overall Study|Miscarriage|0
7599255|NCT01954342|26437100|P1|Overall Study|Miscarriage|0
7599256|NCT01954342|26437097|P4|Overall Study|Missing data from 13-16week study visit|1
7599257|NCT01954342|26437098|P3|Overall Study|Missing data from 13-16week study visit|0
7599258|NCT01954342|26437099|P2|Overall Study|Missing data from 13-16week study visit|0
7599259|NCT01954342|26437100|P1|Overall Study|Missing data from 13-16week study visit|0
7599260|NCT01954251|26437202|P2|Overall Study|Withdrawal by Subject|6
7599261|NCT01954251|26437203|P1|Overall Study|Withdrawal by Subject|2
7599262|NCT01954251|26437202|P2|Overall Study|Lost to Follow-up|6
7599263|NCT01954251|26437203|P1|Overall Study|Lost to Follow-up|6
7599264|NCT01954251|26437202|P2|Overall Study|Adverse Event|7
7599265|NCT01954251|26437203|P1|Overall Study|Adverse Event|5
7599266|NCT01954121|26437300|P2|Overall Study|Subject did not follow instructions|2
7599267|NCT01954121|26437301|P1|Overall Study|Subject did not follow instructions|0
7599268|NCT01954121|26437300|P2|Overall Study|Non-compliant patient|1
7599269|NCT01954121|26437301|P1|Overall Study|Non-compliant patient|1
7599270|NCT01954121|26437300|P2|Overall Study|Non-compliant with study procedures|0
7599271|NCT01954121|26437301|P1|Overall Study|Non-compliant with study procedures|1
7599272|NCT01954121|26437300|P2|Overall Study|SAE, non-fatal|4
7599273|NCT01954121|26437301|P1|Overall Study|SAE, non-fatal|1
7599274|NCT01954121|26437300|P2|Overall Study|AE, non-serious non-fatal|22
7599275|NCT01954121|26437301|P1|Overall Study|AE, non-serious non-fatal|5
7599276|NCT01954121|26437300|P2|Overall Study|AE, serious fatal|0
7599277|NCT01954121|26437301|P1|Overall Study|AE, serious fatal|1
7599278|NCT01954121|26437300|P2|Overall Study|Pregnancy|1
7599279|NCT01954121|26437301|P1|Overall Study|Pregnancy|1
7599280|NCT01954121|26437300|P2|Overall Study|Withdrawal by Subject|12
7599281|NCT01954121|26437301|P1|Overall Study|Withdrawal by Subject|18
7599282|NCT01954121|26437300|P2|Overall Study|Lost to Follow-up|6
7599283|NCT01954121|26437301|P1|Overall Study|Lost to Follow-up|5
7599284|NCT01954121|26437300|P2|Overall Study|Protocol Violation|2
7599285|NCT01954121|26437301|P1|Overall Study|Protocol Violation|0
7599286|NCT01954121|26437300|P2|Overall Study|Lack of Efficacy|41
7599287|NCT01954121|26437301|P1|Overall Study|Lack of Efficacy|94
7599288|NCT01954082|26437317|P2|Overall Study|Randomized not Treated|2
7599289|NCT01954082|26437318|P1|Overall Study|Randomized not Treated|4
7599290|NCT01954082|26437317|P2|Overall Study|Infant Moved|1
7599291|NCT01954082|26437318|P1|Overall Study|Infant Moved|0
7599292|NCT01954082|26437317|P2|Overall Study|Comfort Care|1
7599293|NCT01954082|26437318|P1|Overall Study|Comfort Care|0
7599294|NCT01954082|26437317|P2|Overall Study|Miscalculation of Final Dose Day|3
7599295|NCT01954082|26437318|P1|Overall Study|Miscalculation of Final Dose Day|0
7599296|NCT01954082|26437317|P2|Overall Study|Redirection of Care|2
7599297|NCT01954082|26437318|P1|Overall Study|Redirection of Care|0
7599298|NCT01954082|26437317|P2|Overall Study|Discontinued Early Prior to Transfer|2
7599299|NCT01954082|26437318|P1|Overall Study|Discontinued Early Prior to Transfer|3
7599300|NCT01954082|26437317|P2|Overall Study|Withdrawal by Subject|1
7599301|NCT01954082|26437318|P1|Overall Study|Withdrawal by Subject|0
7599302|NCT01954082|26437317|P2|Overall Study|Parent Decision|0
7599303|NCT01954082|26437318|P1|Overall Study|Parent Decision|1
7599304|NCT01954082|26437317|P2|Overall Study|Physician Decision|0
7599305|NCT01954082|26437318|P1|Overall Study|Physician Decision|2
7599306|NCT01954082|26437317|P2|Overall Study|Non-compliance|4
7599307|NCT01954082|26437318|P1|Overall Study|Non-compliance|6
7599308|NCT01954082|26437317|P2|Overall Study|Intolerance|1
7599309|NCT01954082|26437318|P1|Overall Study|Intolerance|0
7599310|NCT01954082|26437317|P2|Overall Study|Adverse Event|4
7599311|NCT01954082|26437318|P1|Overall Study|Adverse Event|10
7599312|NCT01954082|26437317|P2|Overall Study|Study Suspension|36
7599313|NCT01954082|26437318|P1|Overall Study|Study Suspension|42
7599314|NCT01954056|26437338|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
7599315|NCT01954056|26437339|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
7599316|NCT01954017|26437384|P3|Overall Study|All other reasons|7
7599317|NCT01954017|26437385|P2|Overall Study|All other reasons|2
7599318|NCT01954017|26437386|P1|Overall Study|All other reasons|2
7599319|NCT01954017|26437384|P3|Overall Study|Enteral intake stopped >7 days|1
7599320|NCT01954017|26437385|P2|Overall Study|Enteral intake stopped >7 days|1
7599321|NCT01954017|26437386|P1|Overall Study|Enteral intake stopped >7 days|0
7599322|NCT01954017|26437384|P3|Overall Study|Necrotizing enterocolitis|1
7599323|NCT01954017|26437385|P2|Overall Study|Necrotizing enterocolitis|0
7599324|NCT01954017|26437386|P1|Overall Study|Necrotizing enterocolitis|1
7599325|NCT01954017|26437384|P3|Overall Study|Protocol Violation|2
7599326|NCT01954017|26437385|P2|Overall Study|Protocol Violation|3
7599327|NCT01954017|26437386|P1|Overall Study|Protocol Violation|0
7599328|NCT01954017|26437384|P3|Overall Study|Withdrawal by Subject|0
7599329|NCT01954017|26437385|P2|Overall Study|Withdrawal by Subject|1
7599330|NCT01954017|26437386|P1|Overall Study|Withdrawal by Subject|0
7599331|NCT01954017|26437384|P3|Overall Study|Death|1
7599332|NCT01954017|26437385|P2|Overall Study|Death|1
7599333|NCT01954017|26437386|P1|Overall Study|Death|2
7599334|NCT01954017|26437384|P3|Overall Study|Adverse Event|1
7599335|NCT01954017|26437385|P2|Overall Study|Adverse Event|0
7599336|NCT01954017|26437386|P1|Overall Study|Adverse Event|0
7599337|NCT01953913|26437612|P1|Overall Study|Not Treated|1
7599338|NCT01953913|26437612|P1|Overall Study|Other than listed|108
7599339|NCT01953913|26437612|P1|Overall Study|Withdrawal by Subject|32
7599340|NCT01953913|26437612|P1|Overall Study|Lost to Follow-up|4
7599341|NCT01953913|26437612|P1|Overall Study|Protocol Violation|6
7599342|NCT01953913|26437612|P1|Overall Study|Adverse Event|20
7599343|NCT01953913|26437612|P1|Overall Study|Worsening of underlying cancer|22
7599344|NCT01953913|26437612|P1|Overall Study|Disease Progression|349
7599345|NCT01953783|26437664|P1|Overall Study|Progressive disease|2
7599346|NCT01953692|26437695|P9|Overall Study|Withdrawal by Subject|1
7599347|NCT01953692|26437696|P8|Overall Study|Withdrawal by Subject|1
7599348|NCT01953692|26437697|P7|Overall Study|Withdrawal by Subject|2
7599349|NCT01953692|26437698|P6|Overall Study|Withdrawal by Subject|3
7599350|NCT01953692|26437699|P5|Overall Study|Withdrawal by Subject|0
7599351|NCT01953692|26437700|P4|Overall Study|Withdrawal by Subject|2
7599352|NCT01953692|26437701|P3|Overall Study|Withdrawal by Subject|1
7599353|NCT01953692|26437702|P2|Overall Study|Withdrawal by Subject|2
7599354|NCT01953692|26437703|P1|Overall Study|Withdrawal by Subject|4
7599355|NCT01953692|26437695|P9|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599356|NCT01953692|26437696|P8|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
7599357|NCT01953692|26437697|P7|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599358|NCT01953692|26437698|P6|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599359|NCT01953692|26437699|P5|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599360|NCT01953692|26437700|P4|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599361|NCT01953692|26437701|P3|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599362|NCT01953692|26437702|P2|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599363|NCT01953692|26437703|P1|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7599364|NCT01953692|26437695|P9|Overall Study|Protocol Violation|0
7599365|NCT01953692|26437696|P8|Overall Study|Protocol Violation|1
7599366|NCT01953692|26437697|P7|Overall Study|Protocol Violation|0
7599367|NCT01953692|26437698|P6|Overall Study|Protocol Violation|0
7599368|NCT01953692|26437699|P5|Overall Study|Protocol Violation|0
7599369|NCT01953692|26437700|P4|Overall Study|Protocol Violation|0
7599370|NCT01953692|26437701|P3|Overall Study|Protocol Violation|1
7599371|NCT01953692|26437702|P2|Overall Study|Protocol Violation|2
7599372|NCT01953692|26437703|P1|Overall Study|Protocol Violation|0
7599373|NCT01953692|26437695|P9|Overall Study|Physician Decision|0
7599374|NCT01953692|26437696|P8|Overall Study|Physician Decision|1
7599375|NCT01953692|26437697|P7|Overall Study|Physician Decision|4
7599376|NCT01953692|26437698|P6|Overall Study|Physician Decision|2
7599377|NCT01953692|26437699|P5|Overall Study|Physician Decision|1
7599378|NCT01953692|26437700|P4|Overall Study|Physician Decision|2
7599379|NCT01953692|26437701|P3|Overall Study|Physician Decision|2
7599380|NCT01953692|26437702|P2|Overall Study|Physician Decision|4
7599381|NCT01953692|26437703|P1|Overall Study|Physician Decision|11
7599382|NCT01953692|26437695|P9|Overall Study|Lost to Follow-up|0
7599383|NCT01953692|26437696|P8|Overall Study|Lost to Follow-up|0
7599384|NCT01953692|26437697|P7|Overall Study|Lost to Follow-up|0
7599385|NCT01953692|26437698|P6|Overall Study|Lost to Follow-up|1
7599386|NCT01953692|26437699|P5|Overall Study|Lost to Follow-up|0
7599387|NCT01953692|26437700|P4|Overall Study|Lost to Follow-up|1
7599388|NCT01953692|26437701|P3|Overall Study|Lost to Follow-up|3
7599389|NCT01953692|26437702|P2|Overall Study|Lost to Follow-up|0
7599390|NCT01953692|26437703|P1|Overall Study|Lost to Follow-up|1
7599391|NCT01953692|26437695|P9|Overall Study|Excluded Medication|0
7599392|NCT01953692|26437696|P8|Overall Study|Excluded Medication|0
7599393|NCT01953692|26437697|P7|Overall Study|Excluded Medication|0
7599394|NCT01953692|26437698|P6|Overall Study|Excluded Medication|0
7599395|NCT01953692|26437699|P5|Overall Study|Excluded Medication|0
7599396|NCT01953692|26437700|P4|Overall Study|Excluded Medication|0
7599397|NCT01953692|26437701|P3|Overall Study|Excluded Medication|0
7599398|NCT01953692|26437702|P2|Overall Study|Excluded Medication|0
7599399|NCT01953692|26437703|P1|Overall Study|Excluded Medication|1
7599400|NCT01953692|26437695|P9|Overall Study|Death|1
7599401|NCT01953692|26437696|P8|Overall Study|Death|2
7599402|NCT01953692|26437697|P7|Overall Study|Death|6
7599403|NCT01953692|26437698|P6|Overall Study|Death|3
7599404|NCT01953692|26437699|P5|Overall Study|Death|1
7599405|NCT01953692|26437700|P4|Overall Study|Death|2
7599406|NCT01953692|26437701|P3|Overall Study|Death|2
7599407|NCT01953692|26437702|P2|Overall Study|Death|0
7599408|NCT01953692|26437703|P1|Overall Study|Death|5
7599409|NCT01953692|26437695|P9|Overall Study|Clinical Progression|3
7599410|NCT01953692|26437696|P8|Overall Study|Clinical Progression|3
7599411|NCT01953692|26437697|P7|Overall Study|Clinical Progression|20
7599412|NCT01953692|26437698|P6|Overall Study|Clinical Progression|7
7599413|NCT01953692|26437699|P5|Overall Study|Clinical Progression|0
7599414|NCT01953692|26437700|P4|Overall Study|Clinical Progression|5
7599415|NCT01953692|26437701|P3|Overall Study|Clinical Progression|7
7599416|NCT01953692|26437702|P2|Overall Study|Clinical Progression|15
7599417|NCT01953692|26437703|P1|Overall Study|Clinical Progression|0
7599418|NCT01953692|26437695|P9|Overall Study|Adverse Event|0
7599419|NCT01953692|26437696|P8|Overall Study|Adverse Event|0
7599420|NCT01953692|26437697|P7|Overall Study|Adverse Event|0
7599421|NCT01953692|26437698|P6|Overall Study|Adverse Event|2
7599422|NCT01953692|26437699|P5|Overall Study|Adverse Event|1
7599423|NCT01953692|26437700|P4|Overall Study|Adverse Event|2
7599424|NCT01953692|26437701|P3|Overall Study|Adverse Event|4
7599425|NCT01953692|26437702|P2|Overall Study|Adverse Event|2
7599426|NCT01953692|26437703|P1|Overall Study|Adverse Event|5
7599427|NCT01953601|26437807|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
7599428|NCT01953601|26437808|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
7599429|NCT01953601|26437809|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
7599430|NCT01953601|26437807|P3|Part 2 (Extension Study)|Subject moved|1
7599431|NCT01953601|26437808|P2|Part 2 (Extension Study)|Subject moved|0
7599432|NCT01953601|26437809|P1|Part 2 (Extension Study)|Subject moved|0
7599433|NCT01953601|26437807|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
7599434|NCT01953601|26437808|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
7599435|NCT01953601|26437809|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
7599436|NCT01953601|26437807|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
7599437|NCT01953601|26437808|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
7599438|NCT01953601|26437809|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
7599439|NCT01953601|26437807|P3|Part 2 (Extension Study)|Site discontinued study participation|1
7599440|NCT01953601|26437808|P2|Part 2 (Extension Study)|Site discontinued study participation|1
7599441|NCT01953601|26437809|P1|Part 2 (Extension Study)|Site discontinued study participation|0
7599442|NCT01953601|26437807|P3|Part 2 (Extension Study)|Physician Decision|2
7599443|NCT01953601|26437808|P2|Part 2 (Extension Study)|Physician Decision|0
7599444|NCT01953601|26437809|P1|Part 2 (Extension Study)|Physician Decision|2
7599445|NCT01953601|26437807|P3|Part 2 (Extension Study)|Lost to Follow-up|1
7599446|NCT01953601|26437808|P2|Part 2 (Extension Study)|Lost to Follow-up|1
7599447|NCT01953601|26437809|P1|Part 2 (Extension Study)|Lost to Follow-up|2
7599448|NCT01953601|26437807|P3|Part 2 (Extension Study)|Lack of Efficacy|0
7599449|NCT01953601|26437808|P2|Part 2 (Extension Study)|Lack of Efficacy|0
7599450|NCT01953601|26437809|P1|Part 2 (Extension Study)|Lack of Efficacy|2
7599451|NCT01953601|26437807|P3|Part 2 (Extension Study)|Death|0
7599452|NCT01953601|26437808|P2|Part 2 (Extension Study)|Death|3
7599453|NCT01953601|26437809|P1|Part 2 (Extension Study)|Death|0
7599454|NCT01953601|26437807|P3|Part 2 (Extension Study)|Adverse Event|10
7599455|NCT01953601|26437808|P2|Part 2 (Extension Study)|Adverse Event|1
7599456|NCT01953601|26437809|P1|Part 2 (Extension Study)|Adverse Event|1
7599457|NCT01953601|26437807|P3|Part 1 (Base Study)|Withdrawal by Subject|22
7599458|NCT01953601|26437808|P2|Part 1 (Base Study)|Withdrawal by Subject|23
7599459|NCT01953601|26437809|P1|Part 1 (Base Study)|Withdrawal by Subject|32
7599460|NCT01953601|26437807|P3|Part 1 (Base Study)|Subject moved|1
7599461|NCT01953601|26437808|P2|Part 1 (Base Study)|Subject moved|2
7599462|NCT01953601|26437809|P1|Part 1 (Base Study)|Subject moved|2
7599463|NCT01953601|26437807|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
7599464|NCT01953601|26437808|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
7599465|NCT01953601|26437809|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
7599466|NCT01953601|26437807|P3|Part 1 (Base Study)|Study terminated by sponsor|179
7599467|NCT01953601|26437808|P2|Part 1 (Base Study)|Study terminated by sponsor|169
7599468|NCT01953601|26437809|P1|Part 1 (Base Study)|Study terminated by sponsor|174
7599469|NCT01953601|26437807|P3|Part 1 (Base Study)|Site discontinued study participation|0
7599470|NCT01953601|26437808|P2|Part 1 (Base Study)|Site discontinued study participation|0
7599471|NCT01953601|26437809|P1|Part 1 (Base Study)|Site discontinued study participation|2
7599472|NCT01953601|26437807|P3|Part 1 (Base Study)|Screen failure|1
7599473|NCT01953601|26437808|P2|Part 1 (Base Study)|Screen failure|0
7599474|NCT01953601|26437809|P1|Part 1 (Base Study)|Screen failure|1
7599475|NCT01953601|26437807|P3|Part 1 (Base Study)|Physician Decision|4
7599476|NCT01953601|26437808|P2|Part 1 (Base Study)|Physician Decision|7
7599477|NCT01953601|26437809|P1|Part 1 (Base Study)|Physician Decision|3
7599478|NCT01953601|26437807|P3|Part 1 (Base Study)|Non-compliance with study drug|1
7599479|NCT01953601|26437808|P2|Part 1 (Base Study)|Non-compliance with study drug|3
7599480|NCT01953601|26437809|P1|Part 1 (Base Study)|Non-compliance with study drug|0
7599481|NCT01953601|26437807|P3|Part 1 (Base Study)|Lost to Follow-up|6
7599482|NCT01953601|26437808|P2|Part 1 (Base Study)|Lost to Follow-up|3
7599483|NCT01953601|26437809|P1|Part 1 (Base Study)|Lost to Follow-up|1
7599484|NCT01953601|26437807|P3|Part 1 (Base Study)|Lack of Efficacy|4
7599485|NCT01953601|26437808|P2|Part 1 (Base Study)|Lack of Efficacy|1
7599486|NCT01953601|26437809|P1|Part 1 (Base Study)|Lack of Efficacy|3
7599487|NCT01953601|26437807|P3|Part 1 (Base Study)|Death|3
7599488|NCT01953601|26437808|P2|Part 1 (Base Study)|Death|0
7599489|NCT01953601|26437809|P1|Part 1 (Base Study)|Death|2
7599490|NCT01953601|26437807|P3|Part 1 (Base Study)|Adverse Event|15
7599491|NCT01953601|26437808|P2|Part 1 (Base Study)|Adverse Event|37
7599492|NCT01953601|26437809|P1|Part 1 (Base Study)|Adverse Event|24
7599493|NCT01953354|26437880|P2|Overall Study|Disease Exacerbation|0
7599494|NCT01953354|26437881|P1|Overall Study|Disease Exacerbation|1
7599495|NCT01953354|26437880|P2|Overall Study|Decision of Sponsor|1
7599496|NCT01953354|26437881|P1|Overall Study|Decision of Sponsor|0
7599497|NCT01953354|26437880|P2|Overall Study|Withdrawal by Subject|1
7599498|NCT01953354|26437881|P1|Overall Study|Withdrawal by Subject|0
7599499|NCT01953328|26437909|P8|Overall Study|Lost to Follow-up|0
7599500|NCT01953328|26437910|P7|Overall Study|Lost to Follow-up|0
7599501|NCT01953328|26437911|P6|Overall Study|Lost to Follow-up|0
7599502|NCT01953328|26437912|P5|Overall Study|Lost to Follow-up|1
7599503|NCT01953328|26437913|P4|Overall Study|Lost to Follow-up|0
7599504|NCT01953328|26437914|P3|Overall Study|Lost to Follow-up|0
7599505|NCT01953328|26437915|P2|Overall Study|Lost to Follow-up|0
7599506|NCT01953328|26437916|P1|Overall Study|Lost to Follow-up|0
7599507|NCT01953328|26437909|P8|Overall Study|Withdrawal by Subject|0
7599508|NCT01953328|26437910|P7|Overall Study|Withdrawal by Subject|0
7599509|NCT01953328|26437911|P6|Overall Study|Withdrawal by Subject|0
7599510|NCT01953328|26437912|P5|Overall Study|Withdrawal by Subject|1
7599511|NCT01953328|26437913|P4|Overall Study|Withdrawal by Subject|0
7599512|NCT01953328|26437914|P3|Overall Study|Withdrawal by Subject|0
7599513|NCT01953328|26437915|P2|Overall Study|Withdrawal by Subject|0
7599514|NCT01953328|26437916|P1|Overall Study|Withdrawal by Subject|0
7599515|NCT01953224|26438129|P2|Overall Study|Withdrawal by Subject|2
7599516|NCT01953224|26438130|P1|Overall Study|Withdrawal by Subject|1
7599517|NCT01953224|26438129|P2|Overall Study|Lost to Follow-up|1
7599518|NCT01953224|26438130|P1|Overall Study|Lost to Follow-up|1
7599519|NCT01953003|26438179|P2|Overall Study|Withdrawal by Subject|4
7599520|NCT01953003|26438180|P1|Overall Study|Withdrawal by Subject|14
7599521|NCT01953003|26438179|P2|Overall Study|Protocol Violation|1
7599522|NCT01953003|26438180|P1|Overall Study|Protocol Violation|0
7599523|NCT01953003|26438179|P2|Overall Study|Non-related adverse events|2
7599524|NCT01953003|26438180|P1|Overall Study|Non-related adverse events|0
7599525|NCT01953003|26438179|P2|Overall Study|Related Adverse events|2
7599526|NCT01953003|26438180|P1|Overall Study|Related Adverse events|7
7599527|NCT01953003|26438179|P2|Overall Study|Progressive disease|45
7599528|NCT01953003|26438180|P1|Overall Study|Progressive disease|35
7599529|NCT01953003|26438179|P2|Overall Study|Not treated|1
7599530|NCT01953003|26438180|P1|Overall Study|Not treated|0
7599531|NCT01952834|26438186|P1|Overall Study|Adverse Event|1
7599532|NCT01952691|26438193|P1|Overall Study|Lost to Follow-up|2
7599533|NCT01952665|26438220|P2|Overall Study|Protocol Violation|1
7599534|NCT01952665|26438221|P1|Overall Study|Protocol Violation|0
7599535|NCT01952665|26438220|P2|Overall Study|Adverse Event|1
7599536|NCT01952665|26438221|P1|Overall Study|Adverse Event|2
7599537|NCT01952665|26438220|P2|Overall Study|Lost to Follow-up|2
7599538|NCT01952665|26438221|P1|Overall Study|Lost to Follow-up|1
7599539|NCT01952665|26438220|P2|Overall Study|Physician Decision|2
7599540|NCT01952665|26438221|P1|Overall Study|Physician Decision|3
7599541|NCT01952574|26438376|P7|Clinical Home Use Substudy|Decision by Sponsor|1
7599542|NCT01952574|26438377|P6|Clinical Home Use Substudy|Decision by Sponsor|2
7599543|NCT01952574|26438378|P5|Clinical Home Use Substudy|Decision by Sponsor|0
7599544|NCT01952574|26438379|P4|Clinical Home Use Substudy|Decision by Sponsor|0
7599545|NCT01952574|26438380|P3|Clinical Home Use Substudy|Decision by Sponsor|0
7599546|NCT01952574|26438381|P2|Clinical Home Use Substudy|Decision by Sponsor|0
7599547|NCT01952574|26438382|P1|Clinical Home Use Substudy|Decision by Sponsor|0
7599548|NCT01952574|26438376|P7|Clinical Home Use Substudy|Withdrawal by Subject|0
7599549|NCT01952574|26438377|P6|Clinical Home Use Substudy|Withdrawal by Subject|1
7599550|NCT01952574|26438378|P5|Clinical Home Use Substudy|Withdrawal by Subject|0
7599551|NCT01952574|26438379|P4|Clinical Home Use Substudy|Withdrawal by Subject|0
7599552|NCT01952574|26438380|P3|Clinical Home Use Substudy|Withdrawal by Subject|0
7599553|NCT01952574|26438381|P2|Clinical Home Use Substudy|Withdrawal by Subject|0
7599554|NCT01952574|26438382|P1|Clinical Home Use Substudy|Withdrawal by Subject|0
7599555|NCT01952574|26438376|P7|Open-label Treatment Phase|Death|0
7599556|NCT01952574|26438377|P6|Open-label Treatment Phase|Death|0
7599557|NCT01952574|26438378|P5|Open-label Treatment Phase|Death|1
7599558|NCT01952574|26438379|P4|Open-label Treatment Phase|Death|0
7599559|NCT01952574|26438380|P3|Open-label Treatment Phase|Death|0
7599560|NCT01952574|26438381|P2|Open-label Treatment Phase|Death|0
7599561|NCT01952574|26438382|P1|Open-label Treatment Phase|Death|0
7599562|NCT01952574|26438376|P7|Open-label Treatment Phase|Lost to Follow-up|0
7599563|NCT01952574|26438377|P6|Open-label Treatment Phase|Lost to Follow-up|0
7599564|NCT01952574|26438378|P5|Open-label Treatment Phase|Lost to Follow-up|19
7599565|NCT01952574|26438379|P4|Open-label Treatment Phase|Lost to Follow-up|0
7599566|NCT01952574|26438380|P3|Open-label Treatment Phase|Lost to Follow-up|0
7599567|NCT01952574|26438381|P2|Open-label Treatment Phase|Lost to Follow-up|0
7599568|NCT01952574|26438382|P1|Open-label Treatment Phase|Lost to Follow-up|0
7599569|NCT01952574|26438376|P7|Open-label Treatment Phase|Missing|0
7599570|NCT01952574|26438377|P6|Open-label Treatment Phase|Missing|0
7599571|NCT01952574|26438378|P5|Open-label Treatment Phase|Missing|4
7599572|NCT01952574|26438379|P4|Open-label Treatment Phase|Missing|0
7599573|NCT01952574|26438380|P3|Open-label Treatment Phase|Missing|0
7599574|NCT01952574|26438381|P2|Open-label Treatment Phase|Missing|0
7599575|NCT01952574|26438382|P1|Open-label Treatment Phase|Missing|0
7599576|NCT01952574|26438376|P7|Open-label Treatment Phase|Decision by Sponsor|0
7599577|NCT01952574|26438377|P6|Open-label Treatment Phase|Decision by Sponsor|0
7599578|NCT01952574|26438378|P5|Open-label Treatment Phase|Decision by Sponsor|17
7599579|NCT01952574|26438379|P4|Open-label Treatment Phase|Decision by Sponsor|0
7599580|NCT01952574|26438380|P3|Open-label Treatment Phase|Decision by Sponsor|0
7599581|NCT01952574|26438381|P2|Open-label Treatment Phase|Decision by Sponsor|0
7599582|NCT01952574|26438382|P1|Open-label Treatment Phase|Decision by Sponsor|0
7599583|NCT01952574|26438376|P7|Open-label Treatment Phase|Withdrawal by Subject|0
7599584|NCT01952574|26438377|P6|Open-label Treatment Phase|Withdrawal by Subject|0
7599585|NCT01952574|26438378|P5|Open-label Treatment Phase|Withdrawal by Subject|121
7599586|NCT01952574|26438379|P4|Open-label Treatment Phase|Withdrawal by Subject|0
7599587|NCT01952574|26438380|P3|Open-label Treatment Phase|Withdrawal by Subject|0
7599588|NCT01952574|26438381|P2|Open-label Treatment Phase|Withdrawal by Subject|0
7599589|NCT01952574|26438382|P1|Open-label Treatment Phase|Withdrawal by Subject|0
7599590|NCT01952574|26438376|P7|Double-blind Treatment Phase|Lost to Follow-up|0
7599591|NCT01952574|26438377|P6|Double-blind Treatment Phase|Lost to Follow-up|0
7599592|NCT01952574|26438378|P5|Double-blind Treatment Phase|Lost to Follow-up|0
7599593|NCT01952574|26438379|P4|Double-blind Treatment Phase|Lost to Follow-up|0
7599594|NCT01952574|26438380|P3|Double-blind Treatment Phase|Lost to Follow-up|1
7599595|NCT01952574|26438381|P2|Double-blind Treatment Phase|Lost to Follow-up|0
7599596|NCT01952574|26438382|P1|Double-blind Treatment Phase|Lost to Follow-up|2
7599597|NCT01952574|26438376|P7|Double-blind Treatment Phase|Sponsor Decision|0
7599598|NCT01952574|26438377|P6|Double-blind Treatment Phase|Sponsor Decision|0
7599599|NCT01952574|26438378|P5|Double-blind Treatment Phase|Sponsor Decision|0
7599600|NCT01952574|26438379|P4|Double-blind Treatment Phase|Sponsor Decision|2
7599601|NCT01952574|26438380|P3|Double-blind Treatment Phase|Sponsor Decision|5
7599602|NCT01952574|26438381|P2|Double-blind Treatment Phase|Sponsor Decision|0
7599603|NCT01952574|26438382|P1|Double-blind Treatment Phase|Sponsor Decision|6
7599604|NCT01952574|26438376|P7|Double-blind Treatment Phase|Withdrawal by Subject|0
7599605|NCT01952574|26438377|P6|Double-blind Treatment Phase|Withdrawal by Subject|0
7599606|NCT01952574|26438378|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
7599607|NCT01952574|26438379|P4|Double-blind Treatment Phase|Withdrawal by Subject|4
7599608|NCT01952574|26438380|P3|Double-blind Treatment Phase|Withdrawal by Subject|3
7599609|NCT01952574|26438381|P2|Double-blind Treatment Phase|Withdrawal by Subject|3
7599610|NCT01952574|26438382|P1|Double-blind Treatment Phase|Withdrawal by Subject|9
7599611|NCT01952366|26438506|P1|Overall Study|Withdrawal by Subject|9
7599612|NCT01952366|26438506|P1|Overall Study|Death|22
7599613|NCT01952145|26438521|P2|Overall Study|Unclassified|1
7599614|NCT01952145|26438522|P1|Overall Study|Unclassified|1
7599615|NCT01952145|26438521|P2|Overall Study|Withdrawal Criteria|11
7599616|NCT01952145|26438522|P1|Overall Study|Withdrawal Criteria|16
7599617|NCT01952145|26438521|P2|Overall Study|Adverse Event|0
7599618|NCT01952145|26438522|P1|Overall Study|Adverse Event|9
7599619|NCT01952145|26438521|P2|Overall Study|Death|1
7599620|NCT01952145|26438522|P1|Overall Study|Death|0
7599621|NCT01952145|26438521|P2|Overall Study|Protocol Violation|1
7599622|NCT01952145|26438522|P1|Overall Study|Protocol Violation|2
7599623|NCT01952080|26438536|P4|Overall Study|Protocol Non-compliance|0
7599624|NCT01952080|26438537|P3|Overall Study|Protocol Non-compliance|0
7599625|NCT01952080|26438538|P2|Overall Study|Protocol Non-compliance|1
7599626|NCT01952080|26438539|P1|Overall Study|Protocol Non-compliance|0
7599627|NCT01952080|26438536|P4|Overall Study|Withdrawal by Subject|1
7599628|NCT01952080|26438537|P3|Overall Study|Withdrawal by Subject|0
7599629|NCT01952080|26438538|P2|Overall Study|Withdrawal by Subject|0
7599630|NCT01952080|26438539|P1|Overall Study|Withdrawal by Subject|0
7599631|NCT01952054|26438585|P1|Overall Study|Physician Decision|1
7599632|NCT01952041|26438593|P2|Overall Study|Death|0
7599633|NCT01952041|26438594|P1|Overall Study|Death|1
7599634|NCT01952041|26438593|P2|Overall Study|Withdrawal by Subject|5
7599635|NCT01952041|26438594|P1|Overall Study|Withdrawal by Subject|7
7599636|NCT01952041|26438593|P2|Overall Study|Lost to Follow-up|16
7599637|NCT01952041|26438594|P1|Overall Study|Lost to Follow-up|9
7599638|NCT01952015|26438608|P1|Treatment Period 3|Physician Decision|9
7599639|NCT01952015|26438608|P1|Maintenance|Adverse Event|2
7599640|NCT01952015|26438608|P1|Induction|Protocol Violation|1
7599641|NCT01951703|26438675|P2|Second Intervention|Unsatisfactory Lens fitting|1
7599642|NCT01951703|26438676|P1|Second Intervention|Unsatisfactory Lens fitting|0
7599643|NCT01951703|26438675|P2|Second Intervention|Protocol Violation|1
7599644|NCT01951703|26438676|P1|Second Intervention|Protocol Violation|0
7599645|NCT01951703|26438675|P2|First Intervention|Physician Decision|0
7599646|NCT01951703|26438676|P1|First Intervention|Physician Decision|1
7599647|NCT01951703|26438675|P2|First Intervention|Subject was not compliant|1
7599648|NCT01951703|26438676|P1|First Intervention|Subject was not compliant|1
7599649|NCT01951703|26438675|P2|First Intervention|Withdrawal by Subject|0
7599650|NCT01951703|26438676|P1|First Intervention|Withdrawal by Subject|1
7599651|NCT01951638|26438704|P5|Follow-up Period|Adverse Event|1
7599652|NCT01951638|26438705|P4|Follow-up Period|Adverse Event|1
7599653|NCT01951638|26438706|P3|Follow-up Period|Adverse Event|2
7599654|NCT01951638|26438707|P2|Follow-up Period|Adverse Event|1
7599655|NCT01951638|26438708|P1|Follow-up Period|Adverse Event|0
7599656|NCT01951638|26438704|P5|Follow-up Period|Death|1
7599657|NCT01951638|26438705|P4|Follow-up Period|Death|4
7599658|NCT01951638|26438706|P3|Follow-up Period|Death|1
7599659|NCT01951638|26438707|P2|Follow-up Period|Death|0
7599660|NCT01951638|26438708|P1|Follow-up Period|Death|1
7599661|NCT01951638|26438704|P5|Follow-up Period|Lost to Follow-up|0
7599662|NCT01951638|26438705|P4|Follow-up Period|Lost to Follow-up|1
7599663|NCT01951638|26438706|P3|Follow-up Period|Lost to Follow-up|0
7599664|NCT01951638|26438707|P2|Follow-up Period|Lost to Follow-up|1
7599665|NCT01951638|26438708|P1|Follow-up Period|Lost to Follow-up|0
7599666|NCT01951638|26438704|P5|Follow-up Period|Withdrawal by Subject|2
7599667|NCT01951638|26438705|P4|Follow-up Period|Withdrawal by Subject|1
7599668|NCT01951638|26438706|P3|Follow-up Period|Withdrawal by Subject|2
7599669|NCT01951638|26438707|P2|Follow-up Period|Withdrawal by Subject|5
7599670|NCT01951638|26438708|P1|Follow-up Period|Withdrawal by Subject|1
7599671|NCT01951638|26438704|P5|Follow-up Period|Logistical difficulties|1
7599672|NCT01951638|26438705|P4|Follow-up Period|Logistical difficulties|0
7599673|NCT01951638|26438706|P3|Follow-up Period|Logistical difficulties|0
7599674|NCT01951638|26438707|P2|Follow-up Period|Logistical difficulties|2
7599675|NCT01951638|26438708|P1|Follow-up Period|Logistical difficulties|0
7599676|NCT01951638|26438704|P5|Follow-up Period|Protocol Violation|0
7599677|NCT01951638|26438705|P4|Follow-up Period|Protocol Violation|1
7599678|NCT01951638|26438706|P3|Follow-up Period|Protocol Violation|0
7599679|NCT01951638|26438707|P2|Follow-up Period|Protocol Violation|0
7599680|NCT01951638|26438708|P1|Follow-up Period|Protocol Violation|0
7599681|NCT01951638|26438704|P5|Treatment Period|Adverse Event|5
7599682|NCT01951638|26438705|P4|Treatment Period|Adverse Event|6
7599683|NCT01951638|26438706|P3|Treatment Period|Adverse Event|8
7599684|NCT01951638|26438707|P2|Treatment Period|Adverse Event|4
7599685|NCT01951638|26438708|P1|Treatment Period|Adverse Event|3
7599686|NCT01951638|26438704|P5|Treatment Period|Death|1
7599687|NCT01951638|26438705|P4|Treatment Period|Death|3
7599688|NCT01951638|26438706|P3|Treatment Period|Death|0
7599689|NCT01951638|26438707|P2|Treatment Period|Death|0
7599690|NCT01951638|26438708|P1|Treatment Period|Death|0
7599691|NCT01951638|26438704|P5|Treatment Period|Withdrawal by Subject|4
7599692|NCT01951638|26438705|P4|Treatment Period|Withdrawal by Subject|5
7599693|NCT01951638|26438706|P3|Treatment Period|Withdrawal by Subject|4
7599694|NCT01951638|26438707|P2|Treatment Period|Withdrawal by Subject|6
7599695|NCT01951638|26438708|P1|Treatment Period|Withdrawal by Subject|9
7599696|NCT01951638|26438704|P5|Treatment Period|Logistical difficulties|0
7599697|NCT01951638|26438705|P4|Treatment Period|Logistical difficulties|0
7599698|NCT01951638|26438706|P3|Treatment Period|Logistical difficulties|1
7599699|NCT01951638|26438707|P2|Treatment Period|Logistical difficulties|1
7599700|NCT01951638|26438708|P1|Treatment Period|Logistical difficulties|0
7599701|NCT01951638|26438704|P5|Treatment Period|Protocol-driven decision point|0
7599702|NCT01951638|26438705|P4|Treatment Period|Protocol-driven decision point|0
7599703|NCT01951638|26438706|P3|Treatment Period|Protocol-driven decision point|0
7599704|NCT01951638|26438707|P2|Treatment Period|Protocol-driven decision point|3
7599705|NCT01951638|26438708|P1|Treatment Period|Protocol-driven decision point|1
7599706|NCT01951638|26438704|P5|Treatment Period|Protocol Violation|0
7599707|NCT01951638|26438705|P4|Treatment Period|Protocol Violation|2
7599708|NCT01951638|26438706|P3|Treatment Period|Protocol Violation|0
7599709|NCT01951638|26438707|P2|Treatment Period|Protocol Violation|0
7599710|NCT01951638|26438708|P1|Treatment Period|Protocol Violation|0
7599711|NCT01951625|26438745|P5|Follow Up Period|Lost to Follow-up|1
7599712|NCT01951625|26438746|P4|Follow Up Period|Lost to Follow-up|1
7599713|NCT01951625|26438747|P3|Follow Up Period|Lost to Follow-up|0
7599714|NCT01951625|26438748|P2|Follow Up Period|Lost to Follow-up|0
7599715|NCT01951625|26438749|P1|Follow Up Period|Lost to Follow-up|1
7599716|NCT01951625|26438745|P5|Follow Up Period|Withdrawal by Subject|3
7599717|NCT01951625|26438746|P4|Follow Up Period|Withdrawal by Subject|5
7599718|NCT01951625|26438747|P3|Follow Up Period|Withdrawal by Subject|0
7599719|NCT01951625|26438748|P2|Follow Up Period|Withdrawal by Subject|1
7599720|NCT01951625|26438749|P1|Follow Up Period|Withdrawal by Subject|4
7599721|NCT01951625|26438745|P5|Follow Up Period|Adverse Event|5
7599722|NCT01951625|26438746|P4|Follow Up Period|Adverse Event|3
7599723|NCT01951625|26438747|P3|Follow Up Period|Adverse Event|2
7599724|NCT01951625|26438748|P2|Follow Up Period|Adverse Event|3
7599725|NCT01951625|26438749|P1|Follow Up Period|Adverse Event|0
7599726|NCT01951625|26438745|P5|Follow Up Period|Logistical difficulties|0
7599727|NCT01951625|26438746|P4|Follow Up Period|Logistical difficulties|0
7599728|NCT01951625|26438747|P3|Follow Up Period|Logistical difficulties|0
7599729|NCT01951625|26438748|P2|Follow Up Period|Logistical difficulties|2
7599730|NCT01951625|26438749|P1|Follow Up Period|Logistical difficulties|1
7599731|NCT01951625|26438745|P5|Follow Up Period|Death|1
7599732|NCT01951625|26438746|P4|Follow Up Period|Death|2
7599733|NCT01951625|26438747|P3|Follow Up Period|Death|2
7599734|NCT01951625|26438748|P2|Follow Up Period|Death|3
7599735|NCT01951625|26438749|P1|Follow Up Period|Death|1
7599736|NCT01951625|26438745|P5|Follow Up Period|Non-compliance with study drug|0
7599737|NCT01951625|26438746|P4|Follow Up Period|Non-compliance with study drug|0
7599738|NCT01951625|26438747|P3|Follow Up Period|Non-compliance with study drug|0
7599739|NCT01951625|26438748|P2|Follow Up Period|Non-compliance with study drug|0
7599740|NCT01951625|26438749|P1|Follow Up Period|Non-compliance with study drug|1
7599741|NCT01951625|26438745|P5|Treatment Period|Lost to Follow-up|0
7599742|NCT01951625|26438746|P4|Treatment Period|Lost to Follow-up|1
7599743|NCT01951625|26438747|P3|Treatment Period|Lost to Follow-up|0
7599744|NCT01951625|26438748|P2|Treatment Period|Lost to Follow-up|0
7599745|NCT01951625|26438749|P1|Treatment Period|Lost to Follow-up|1
7599746|NCT01951625|26438745|P5|Treatment Period|Withdrawal by Subject|3
7599747|NCT01951625|26438746|P4|Treatment Period|Withdrawal by Subject|7
7599748|NCT01951625|26438747|P3|Treatment Period|Withdrawal by Subject|1
7599749|NCT01951625|26438748|P2|Treatment Period|Withdrawal by Subject|2
7599750|NCT01951625|26438749|P1|Treatment Period|Withdrawal by Subject|5
7599751|NCT01951625|26438745|P5|Treatment Period|Adverse Event|8
7599752|NCT01951625|26438746|P4|Treatment Period|Adverse Event|8
7599753|NCT01951625|26438747|P3|Treatment Period|Adverse Event|9
7599754|NCT01951625|26438748|P2|Treatment Period|Adverse Event|10
7599755|NCT01951625|26438749|P1|Treatment Period|Adverse Event|7
7599756|NCT01951625|26438745|P5|Treatment Period|Death|2
7599757|NCT01951625|26438746|P4|Treatment Period|Death|1
7599758|NCT01951625|26438747|P3|Treatment Period|Death|2
7599759|NCT01951625|26438748|P2|Treatment Period|Death|2
7599760|NCT01951625|26438749|P1|Treatment Period|Death|3
7599761|NCT01951625|26438745|P5|Treatment Period|Non compliance with study drug|0
7599762|NCT01951625|26438746|P4|Treatment Period|Non compliance with study drug|0
7599763|NCT01951625|26438747|P3|Treatment Period|Non compliance with study drug|2
7599764|NCT01951625|26438748|P2|Treatment Period|Non compliance with study drug|2
7599765|NCT01951625|26438749|P1|Treatment Period|Non compliance with study drug|1
7599766|NCT01951625|26438745|P5|Treatment Period|Protocol driven decision point|1
7599767|NCT01951625|26438746|P4|Treatment Period|Protocol driven decision point|2
7599768|NCT01951625|26438747|P3|Treatment Period|Protocol driven decision point|0
7599769|NCT01951625|26438748|P2|Treatment Period|Protocol driven decision point|5
7599770|NCT01951625|26438749|P1|Treatment Period|Protocol driven decision point|0
7599771|NCT01951625|26438745|P5|Treatment Period|Physician Decision|1
7599772|NCT01951625|26438746|P4|Treatment Period|Physician Decision|0
7599773|NCT01951625|26438747|P3|Treatment Period|Physician Decision|0
7599774|NCT01951625|26438748|P2|Treatment Period|Physician Decision|0
7599775|NCT01951625|26438749|P1|Treatment Period|Physician Decision|0
7599776|NCT01951625|26438745|P5|Treatment Period|Protocol Violation|2
7599777|NCT01951625|26438746|P4|Treatment Period|Protocol Violation|3
7599778|NCT01951625|26438747|P3|Treatment Period|Protocol Violation|1
7599779|NCT01951625|26438748|P2|Treatment Period|Protocol Violation|0
7599780|NCT01951625|26438749|P1|Treatment Period|Protocol Violation|2
7599789|NCT01951573|26438859|P2|Washout Period|Adverse Event|1
7599790|NCT01951573|26438860|P1|Washout Period|Adverse Event|0
7599791|NCT01951417|26438870|P1|Overall Study|Lost to Follow-up|6
7599792|NCT01951417|26438870|P1|Overall Study|Protocol Violation|2
7599793|NCT01951417|26438870|P1|Overall Study|Withdrawal by Subject|1
7599794|NCT01951378|26438906|P2|Overall Study|Study Terminated-Not completed|17
7599795|NCT01951378|26438907|P1|Overall Study|Study Terminated-Not completed|23
7599796|NCT01951261|26438984|P2|Overall Study|Protocol Violation|3
7599797|NCT01951261|26438985|P1|Overall Study|Protocol Violation|4
7599798|NCT01951261|26438984|P2|Overall Study|Lost to Follow-up|3
7599799|NCT01951261|26438985|P1|Overall Study|Lost to Follow-up|4
7599800|NCT01951261|26438984|P2|Overall Study|Death|0
7599801|NCT01951261|26438985|P1|Overall Study|Death|1
7599802|NCT01951170|26439003|P1|Overall Study|Investigator decision|1
7599803|NCT01951157|26439029|P3|Overall Study|Treatment-related death|0
7599804|NCT01951157|26439030|P2|Overall Study|Treatment-related death|2
7599805|NCT01951157|26439031|P1|Overall Study|Treatment-related death|0
7599806|NCT01951157|26439029|P3|Overall Study|Consent withdrawn by subject|3
7599807|NCT01951157|26439030|P2|Overall Study|Consent withdrawn by subject|1
7599808|NCT01951157|26439031|P1|Overall Study|Consent withdrawn by subject|0
7599809|NCT01951157|26439029|P3|Overall Study|Treatment-related AE|4
7599810|NCT01951157|26439030|P2|Overall Study|Treatment-related AE|0
7599811|NCT01951157|26439031|P1|Overall Study|Treatment-related AE|2
7599812|NCT01951157|26439029|P3|Overall Study|No treated|0
7599813|NCT01951157|26439030|P2|Overall Study|No treated|1
7599814|NCT01951157|26439031|P1|Overall Study|No treated|0
7599815|NCT01951157|26439029|P3|Overall Study|Non-treatmentrelated death|2
7599816|NCT01951157|26439030|P2|Overall Study|Non-treatmentrelated death|2
7599817|NCT01951157|26439031|P1|Overall Study|Non-treatmentrelated death|2
7599818|NCT01951157|26439029|P3|Overall Study|Physician Decision|2
7599819|NCT01951157|26439030|P2|Overall Study|Physician Decision|3
7599820|NCT01951157|26439031|P1|Overall Study|Physician Decision|5
7599821|NCT01951157|26439029|P3|Overall Study|Study Termination|1
7599822|NCT01951157|26439030|P2|Overall Study|Study Termination|0
7599823|NCT01951157|26439031|P1|Overall Study|Study Termination|0
7599824|NCT01951157|26439029|P3|Overall Study|Treatment-unrelated AE|3
7599825|NCT01951157|26439030|P2|Overall Study|Treatment-unrelated AE|0
7599826|NCT01951157|26439031|P1|Overall Study|Treatment-unrelated AE|1
7599827|NCT01951157|26439029|P3|Overall Study|Progressive Disease|10
7599828|NCT01951157|26439030|P2|Overall Study|Progressive Disease|13
7599829|NCT01951157|26439031|P1|Overall Study|Progressive Disease|12
7599830|NCT01951105|26439082|P3|Overall Study|Withdrawal by Subject|1
7599831|NCT01951105|26439083|P2|Overall Study|Withdrawal by Subject|3
7599832|NCT01951105|26439084|P1|Overall Study|Withdrawal by Subject|0
7599833|NCT01951105|26439082|P3|Overall Study|Protocol Violation|1
7599834|NCT01951105|26439083|P2|Overall Study|Protocol Violation|1
7599835|NCT01951105|26439084|P1|Overall Study|Protocol Violation|1
7599836|NCT01951105|26439082|P3|Overall Study|Lost to Follow-up|0
7599837|NCT01951105|26439083|P2|Overall Study|Lost to Follow-up|1
7599838|NCT01951105|26439084|P1|Overall Study|Lost to Follow-up|0
7599839|NCT01951105|26439082|P3|Overall Study|Adverse Event|0
7599840|NCT01951105|26439083|P2|Overall Study|Adverse Event|5
7599841|NCT01951105|26439084|P1|Overall Study|Adverse Event|0
7599842|NCT01951092|26439098|P1|Overall Study|Transfer of Care|1
7599843|NCT01951092|26439098|P1|Overall Study|Incarceration|1
7599844|NCT01951092|26439098|P1|Overall Study|Lost to Follow-up|10
7599845|NCT01950819|26439111|P2|Overall Study|Lost to Follow-up|17
7599846|NCT01950819|26439112|P1|Overall Study|Lost to Follow-up|9
7599847|NCT01950819|26439111|P2|Overall Study|Pregnancy|2
7599848|NCT01950819|26439112|P1|Overall Study|Pregnancy|0
7599849|NCT01950819|26439111|P2|Overall Study|technical problems|0
7599850|NCT01950819|26439112|P1|Overall Study|technical problems|2
7599851|NCT01950819|26439111|P2|Overall Study|Subject / Gardian decision|51
7599852|NCT01950819|26439112|P1|Overall Study|Subject / Gardian decision|54
7599853|NCT01950819|26439111|P2|Overall Study|Death|34
7599854|NCT01950819|26439112|P1|Overall Study|Death|29
7599855|NCT01950819|26439111|P2|Overall Study|Graft Loss|30
7599856|NCT01950819|26439112|P1|Overall Study|Graft Loss|35
7599857|NCT01950741|26439165|P1|Overall Study|Withdrawal by Subject|1
7599858|NCT01950741|26439165|P1|Overall Study|Death|1
7599859|NCT01950741|26439165|P1|Overall Study|Lost to Follow-up|1
7599860|NCT01950364|26439180|P2|Overall Study|Protocol Violation|1
7599861|NCT01950364|26439181|P1|Overall Study|Protocol Violation|0
7599862|NCT01950364|26439180|P2|Overall Study|Withdrawal by Subject|1
7599863|NCT01950364|26439181|P1|Overall Study|Withdrawal by Subject|0
7599864|NCT01950364|26439180|P2|Overall Study|Disease Progression|2
7599865|NCT01950364|26439181|P1|Overall Study|Disease Progression|5
7599866|NCT01950364|26439180|P2|Overall Study|Stem Cell Transplant|6
7599867|NCT01950364|26439181|P1|Overall Study|Stem Cell Transplant|2
7599868|NCT01950364|26439180|P2|Overall Study|Adverse Event|0
7599869|NCT01950364|26439181|P1|Overall Study|Adverse Event|3
7599870|NCT01950273|26439303|P2|Overall Study|Other not defined above|0
7599871|NCT01950273|26439304|P1|Overall Study|Other not defined above|1
7599872|NCT01950273|26439303|P2|Overall Study|Withdrawal by Subject|0
7599873|NCT01950273|26439304|P1|Overall Study|Withdrawal by Subject|2
7599874|NCT01950273|26439303|P2|Overall Study|Protocol Violation|0
7599875|NCT01950273|26439304|P1|Overall Study|Protocol Violation|1
7599876|NCT01950169|26439340|P3|Overall Study|Death|0
7599877|NCT01950169|26439341|P2|Overall Study|Death|0
7599878|NCT01950169|26439342|P1|Overall Study|Death|1
7599879|NCT01950169|26439340|P3|Overall Study|Withdrawal by Subject|1
7599880|NCT01950169|26439341|P2|Overall Study|Withdrawal by Subject|8
7599881|NCT01950169|26439342|P1|Overall Study|Withdrawal by Subject|2
7599882|NCT01950013|26439390|P3|Overall Study|Withdrawal by Subject|0
7599883|NCT01950013|26439391|P2|Overall Study|Withdrawal by Subject|2
7599884|NCT01950013|26439392|P1|Overall Study|Withdrawal by Subject|0
7599885|NCT01949870|26439403|P1|Overall Study|Eligibility requirements not fulfilled|2
7599886|NCT01949870|26439403|P1|Overall Study|Study termination|1
7599887|NCT01949870|26439403|P1|Overall Study|Adverse Event|1
7599888|NCT01949870|26439403|P1|Overall Study|Lack of Efficacy|2
7599889|NCT01949662|26439419|P2|Overall Study|Ineligible|1
7599890|NCT01949662|26439420|P1|Overall Study|Ineligible|0
7599891|NCT01949662|26439419|P2|Overall Study|Dropped out|3
7599892|NCT01949662|26439420|P1|Overall Study|Dropped out|1
7599893|NCT01949662|26439419|P2|Overall Study|Discharged before an agitation event|3
7599894|NCT01949662|26439420|P1|Overall Study|Discharged before an agitation event|8
7599895|NCT01949662|26439419|P2|Overall Study|Death|7
7599896|NCT01949662|26439420|P1|Overall Study|Death|9
7599897|NCT01949532|26439587|P2|Overall Study|On-study at the Data Cut-off Date|3
7599898|NCT01949532|26439588|P1|Overall Study|On-study at the Data Cut-off Date|3
7599899|NCT01949480|26439658|P2|Overall Study|Physician Decision|8
7599900|NCT01949480|26439659|P1|Overall Study|Physician Decision|5
7599901|NCT01949155|26439705|P2|Overall Study|Protocol Violation|0
7599902|NCT01949155|26439706|P1|Overall Study|Protocol Violation|1
7599903|NCT01949155|26439705|P2|Overall Study|Lost to Follow-up|0
7599904|NCT01949155|26439706|P1|Overall Study|Lost to Follow-up|1
7599905|NCT01949142|26439718|P2|Overall Study|Parent changed their mind|0
7599906|NCT01949142|26439719|P1|Overall Study|Parent changed their mind|1
7599907|NCT01949142|26439718|P2|Overall Study|Lost to Follow-up|1
7599908|NCT01949142|26439719|P1|Overall Study|Lost to Follow-up|1
7599909|NCT01949142|26439718|P2|Overall Study|Withdrawal of consent|0
7599910|NCT01949142|26439719|P1|Overall Study|Withdrawal of consent|1
7599911|NCT01949116|26439731|P2|Overall Study|Withdrawal by Subject|3
7599912|NCT01949116|26439732|P1|Overall Study|Withdrawal by Subject|5
7599913|NCT01949116|26439731|P2|Overall Study|Lost to Follow-up|3
7599914|NCT01949116|26439732|P1|Overall Study|Lost to Follow-up|1
7599915|NCT01949116|26439731|P2|Overall Study|Death|0
7599916|NCT01949116|26439732|P1|Overall Study|Death|2
7599917|NCT01949090|26439769|P5|Overall Study|Lost to Follow-up|1
7599918|NCT01949090|26439770|P4|Overall Study|Lost to Follow-up|1
7599919|NCT01949090|26439771|P3|Overall Study|Lost to Follow-up|0
7599920|NCT01949090|26439772|P2|Overall Study|Lost to Follow-up|1
7599921|NCT01949090|26439773|P1|Overall Study|Lost to Follow-up|2
7599922|NCT01949090|26439769|P5|Overall Study|Protocol non-compliance|1
7599923|NCT01949090|26439770|P4|Overall Study|Protocol non-compliance|0
7599924|NCT01949090|26439771|P3|Overall Study|Protocol non-compliance|0
7599925|NCT01949090|26439772|P2|Overall Study|Protocol non-compliance|0
7599926|NCT01949090|26439773|P1|Overall Study|Protocol non-compliance|0
7599927|NCT01949090|26439769|P5|Overall Study|Withdrawal by Subject|1
7599928|NCT01949090|26439770|P4|Overall Study|Withdrawal by Subject|0
7599929|NCT01949090|26439771|P3|Overall Study|Withdrawal by Subject|0
7599930|NCT01949090|26439772|P2|Overall Study|Withdrawal by Subject|0
7599931|NCT01949090|26439773|P1|Overall Study|Withdrawal by Subject|2
7599932|NCT01949090|26439769|P5|Overall Study|Serious Adverse Event|1
7599933|NCT01949090|26439770|P4|Overall Study|Serious Adverse Event|0
7599934|NCT01949090|26439771|P3|Overall Study|Serious Adverse Event|2
7599935|NCT01949090|26439772|P2|Overall Study|Serious Adverse Event|1
7599936|NCT01949090|26439773|P1|Overall Study|Serious Adverse Event|0
7599937|NCT01949051|26439950|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7599938|NCT01949051|26439951|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7599939|NCT01949051|26439952|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7599940|NCT01949051|26439953|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
7599941|NCT01949051|26439954|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7599942|NCT01949051|26439955|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7599943|NCT01949051|26439950|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7599944|NCT01949051|26439951|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7599945|NCT01949051|26439952|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7599946|NCT01949051|26439953|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7599947|NCT01949051|26439954|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
7599948|NCT01949051|26439955|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7599949|NCT01949051|26439950|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
7599950|NCT01949051|26439951|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
7599951|NCT01949051|26439952|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
7599952|NCT01949051|26439953|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
7599953|NCT01949051|26439954|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
7599954|NCT01949051|26439955|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
7599955|NCT01949051|26439950|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7599956|NCT01949051|26439951|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7599957|NCT01949051|26439952|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7599958|NCT01949051|26439953|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7599959|NCT01949051|26439954|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7599960|NCT01949051|26439955|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7599961|NCT01949051|26439950|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
7599962|NCT01949051|26439951|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
7599963|NCT01949051|26439952|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
7599964|NCT01949051|26439953|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
7599965|NCT01949051|26439954|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
7599966|NCT01949051|26439955|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
7599967|NCT01948908|26440150|P3|Overall Study|Protocol Violation|2
7599968|NCT01948908|26440151|P2|Overall Study|Protocol Violation|0
7599969|NCT01948908|26440152|P1|Overall Study|Protocol Violation|1
7599970|NCT01948830|26440168|P2|Overall Study|Death|4
7599971|NCT01948830|26440169|P1|Overall Study|Death|3
7599972|NCT01948830|26440168|P2|Overall Study|Adverse Event|2
7599973|NCT01948830|26440169|P1|Overall Study|Adverse Event|9
7599974|NCT01948830|26440168|P2|Overall Study|Withdrawal by Subject|17
7599975|NCT01948830|26440169|P1|Overall Study|Withdrawal by Subject|14
7599976|NCT01948830|26440168|P2|Overall Study|Lost to Follow-up|4
7599977|NCT01948830|26440169|P1|Overall Study|Lost to Follow-up|5
7599978|NCT01948830|26440168|P2|Overall Study|Protocol deviation|2
7599979|NCT01948830|26440169|P1|Overall Study|Protocol deviation|1
7599980|NCT01948830|26440168|P2|Overall Study|Physician Decision|3
7599981|NCT01948830|26440169|P1|Overall Study|Physician Decision|1
7599982|NCT01948791|26440201|P1|Overall Study|Screening failure|35
7599983|NCT01948791|26440201|P1|Overall Study|Others|7
7599984|NCT01948791|26440201|P1|Overall Study|Management issues|1
7599985|NCT01948791|26440201|P1|Overall Study|Lost to Follow-up|6
7599986|NCT01948791|26440201|P1|Overall Study|Withdrawal by Subject|5
7599987|NCT01948791|26440201|P1|Overall Study|Protocol Violation|2
7599988|NCT01948791|26440201|P1|Overall Study|Lack of Efficacy|3
7599989|NCT01948791|26440201|P1|Overall Study|Adverse Event|12
7599990|NCT01948427|26440233|P5|Overall Study|Other, Not Specified|2
7599991|NCT01948427|26440234|P4|Overall Study|Other, Not Specified|0
7599992|NCT01948427|26440235|P3|Overall Study|Other, Not Specified|0
7599993|NCT01948427|26440236|P2|Overall Study|Other, Not Specified|9
7599994|NCT01948427|26440237|P1|Overall Study|Other, Not Specified|1
7599995|NCT01948427|26440233|P5|Overall Study|Withdrawal by Subject|1
7599996|NCT01948427|26440234|P4|Overall Study|Withdrawal by Subject|0
7599997|NCT01948427|26440235|P3|Overall Study|Withdrawal by Subject|0
7599998|NCT01948427|26440236|P2|Overall Study|Withdrawal by Subject|0
7599999|NCT01948427|26440237|P1|Overall Study|Withdrawal by Subject|2
7600000|NCT01948427|26440233|P5|Overall Study|Lost to Follow-up|4
7600001|NCT01948427|26440234|P4|Overall Study|Lost to Follow-up|0
7600002|NCT01948427|26440235|P3|Overall Study|Lost to Follow-up|0
7600003|NCT01948427|26440236|P2|Overall Study|Lost to Follow-up|0
7600004|NCT01948427|26440237|P1|Overall Study|Lost to Follow-up|1
7600005|NCT01948427|26440233|P5|Overall Study|Investigator Request|6
7600006|NCT01948427|26440234|P4|Overall Study|Investigator Request|0
7600007|NCT01948427|26440235|P3|Overall Study|Investigator Request|0
7600008|NCT01948427|26440236|P2|Overall Study|Investigator Request|8
7600009|NCT01948427|26440237|P1|Overall Study|Investigator Request|0
7600010|NCT01948427|26440233|P5|Overall Study|Serious Adverse Event|1
7600011|NCT01948427|26440234|P4|Overall Study|Serious Adverse Event|0
7600012|NCT01948427|26440235|P3|Overall Study|Serious Adverse Event|0
7600013|NCT01948427|26440236|P2|Overall Study|Serious Adverse Event|0
7600014|NCT01948427|26440237|P1|Overall Study|Serious Adverse Event|3
7600015|NCT01948258|26440316|P1|Overall Study|Removed from statistical analysis|2
7600016|NCT01948258|26440316|P1|Overall Study|Health Care Professional|43
7600017|NCT01948258|26440316|P1|Overall Study|Withdrawal by Subject|6
7600018|NCT01948258|26440316|P1|Overall Study|Withdrawal by SPD|8
7600019|NCT01948258|26440316|P1|Overall Study|Lost to Follow-up|27
7600020|NCT01948258|26440316|P1|Overall Study|Did not complete by cut-off date|35
7600021|NCT01948258|26440316|P1|Overall Study|Pregnancy|41
7600022|NCT01948193|26440322|P1|Overall Study|Lost to Follow-up|7
7600023|NCT01948193|26440322|P1|Overall Study|Serious event|2
7600024|NCT01948076|26440344|P2|Overall Study|Withdrawal by Subject|1
7600025|NCT01948076|26440345|P1|Overall Study|Withdrawal by Subject|0
7600026|NCT01948063|26440355|P2|Overall Study|Blood samples were accidentally thawed|0
7600027|NCT01948063|26440356|P1|Overall Study|Blood samples were accidentally thawed|1
7600028|NCT01948063|26440355|P2|Overall Study|Discovered an enrollment in other study|1
7600029|NCT01948063|26440356|P1|Overall Study|Discovered an enrollment in other study|0
7600030|NCT01948063|26440355|P2|Overall Study|Boston MCI halted research protocol|1
7600031|NCT01948063|26440356|P1|Overall Study|Boston MCI halted research protocol|0
7600032|NCT01948050|26440364|P2|Overall Study|Withdrawal by Subject|1
7600033|NCT01948050|26440365|P1|Overall Study|Withdrawal by Subject|0
7600034|NCT01947894|26440433|P3|Overall Study|Switched to other growth hormone brand|23
7600035|NCT01947894|26440434|P2|Overall Study|Switched to other growth hormone brand|8
7600036|NCT01947894|26440435|P1|Overall Study|Switched to other growth hormone brand|53
7600037|NCT01947894|26440433|P3|Overall Study|Adverse Event|0
7600038|NCT01947894|26440434|P2|Overall Study|Adverse Event|1
7600039|NCT01947894|26440435|P1|Overall Study|Adverse Event|5
7600040|NCT01947894|26440433|P3|Overall Study|Physician Decision|0
7600041|NCT01947894|26440434|P2|Overall Study|Physician Decision|0
7600042|NCT01947894|26440435|P1|Overall Study|Physician Decision|2
7600043|NCT01947894|26440433|P3|Overall Study|Death|0
7600044|NCT01947894|26440434|P2|Overall Study|Death|1
7600045|NCT01947894|26440435|P1|Overall Study|Death|12
7600046|NCT01947894|26440433|P3|Overall Study|Withdrawal by Subject|1
7600047|NCT01947894|26440434|P2|Overall Study|Withdrawal by Subject|4
7600048|NCT01947894|26440435|P1|Overall Study|Withdrawal by Subject|12
7600049|NCT01947894|26440433|P3|Overall Study|Other|3
7600050|NCT01947894|26440434|P2|Overall Study|Other|4
7600051|NCT01947894|26440435|P1|Overall Study|Other|3
7600052|NCT01947855|26440500|P3|Overall Study|Withdrawal by Subject|0
7600053|NCT01947855|26440501|P2|Overall Study|Withdrawal by Subject|0
7600054|NCT01947855|26440502|P1|Overall Study|Withdrawal by Subject|1
7600055|NCT01947582|26440537|P1|Overall Study|Withdrawal by Subject|1
7600056|NCT01947517|26440546|P2|Overall Study|Withdrawal by Subject|1
7600057|NCT01947517|26440547|P1|Overall Study|Withdrawal by Subject|1
7600058|NCT01947491|26440565|P4|Overall Study|Adverse Event|2
7600059|NCT01947491|26440566|P3|Overall Study|Adverse Event|0
7600060|NCT01947491|26440567|P2|Overall Study|Adverse Event|1
7600061|NCT01947491|26440568|P1|Overall Study|Adverse Event|0
7600062|NCT01947491|26440565|P4|Overall Study|Worsening of condition|0
7600063|NCT01947491|26440566|P3|Overall Study|Worsening of condition|0
7600064|NCT01947491|26440567|P2|Overall Study|Worsening of condition|1
7600065|NCT01947491|26440568|P1|Overall Study|Worsening of condition|0
7600066|NCT01947491|26440565|P4|Overall Study|Withdrawal by Subject|0
7600067|NCT01947491|26440566|P3|Overall Study|Withdrawal by Subject|1
7600068|NCT01947491|26440567|P2|Overall Study|Withdrawal by Subject|1
7600069|NCT01947491|26440568|P1|Overall Study|Withdrawal by Subject|1
7600070|NCT01947491|26440565|P4|Overall Study|Protocol Violation|0
7600071|NCT01947491|26440566|P3|Overall Study|Protocol Violation|0
7600072|NCT01947491|26440567|P2|Overall Study|Protocol Violation|0
7600073|NCT01947491|26440568|P1|Overall Study|Protocol Violation|1
7600074|NCT01947491|26440565|P4|Overall Study|Lack of Efficacy|1
7600075|NCT01947491|26440566|P3|Overall Study|Lack of Efficacy|0
7600076|NCT01947491|26440567|P2|Overall Study|Lack of Efficacy|0
7600077|NCT01947491|26440568|P1|Overall Study|Lack of Efficacy|1
7600078|NCT01947491|26440565|P4|Overall Study|Lost to Follow-up|2
7600079|NCT01947491|26440566|P3|Overall Study|Lost to Follow-up|1
7600080|NCT01947491|26440567|P2|Overall Study|Lost to Follow-up|3
7600081|NCT01947491|26440568|P1|Overall Study|Lost to Follow-up|5
7600082|NCT01947283|26440598|P7|Overall Study|No patients were enrolled in study|1
7600083|NCT01947283|26440599|P6|Overall Study|No patients were enrolled in study|3
7600084|NCT01947283|26440600|P5|Overall Study|No patients were enrolled in study|0
7600085|NCT01947283|26440601|P4|Overall Study|No patients were enrolled in study|0
7600086|NCT01947283|26440602|P3|Overall Study|No patients were enrolled in study|0
7600087|NCT01947283|26440603|P2|Overall Study|No patients were enrolled in study|0
7600088|NCT01947283|26440604|P1|Overall Study|No patients were enrolled in study|0
7600089|NCT01947283|26440598|P7|Overall Study|Missing Follow-up Assessment|0
7600090|NCT01947283|26440599|P6|Overall Study|Missing Follow-up Assessment|2
7600091|NCT01947283|26440600|P5|Overall Study|Missing Follow-up Assessment|0
7600092|NCT01947283|26440601|P4|Overall Study|Missing Follow-up Assessment|0
7600093|NCT01947283|26440602|P3|Overall Study|Missing Follow-up Assessment|3
7600094|NCT01947283|26440603|P2|Overall Study|Missing Follow-up Assessment|2
7600095|NCT01947283|26440604|P1|Overall Study|Missing Follow-up Assessment|2
7600096|NCT01947283|26440598|P7|Overall Study|Non-coding Clinical Recording language|0
7600097|NCT01947283|26440599|P6|Overall Study|Non-coding Clinical Recording language|0
7600098|NCT01947283|26440600|P5|Overall Study|Non-coding Clinical Recording language|0
7600099|NCT01947283|26440601|P4|Overall Study|Non-coding Clinical Recording language|1
7600100|NCT01947283|26440602|P3|Overall Study|Non-coding Clinical Recording language|0
7600101|NCT01947283|26440603|P2|Overall Study|Non-coding Clinical Recording language|0
7600102|NCT01947283|26440604|P1|Overall Study|Non-coding Clinical Recording language|0
7600103|NCT01947283|26440598|P7|Overall Study|No Clinical Recording|0
7600104|NCT01947283|26440599|P6|Overall Study|No Clinical Recording|0
7600105|NCT01947283|26440600|P5|Overall Study|No Clinical Recording|0
7600106|NCT01947283|26440601|P4|Overall Study|No Clinical Recording|10
7600107|NCT01947283|26440602|P3|Overall Study|No Clinical Recording|8
7600108|NCT01947283|26440603|P2|Overall Study|No Clinical Recording|6
7600109|NCT01947283|26440604|P1|Overall Study|No Clinical Recording|12
7600110|NCT01947283|26440598|P7|Overall Study|Withdrawal by Subject|2
7600111|NCT01947283|26440599|P6|Overall Study|Withdrawal by Subject|0
7600112|NCT01947283|26440600|P5|Overall Study|Withdrawal by Subject|0
7600113|NCT01947283|26440601|P4|Overall Study|Withdrawal by Subject|1
7600114|NCT01947283|26440602|P3|Overall Study|Withdrawal by Subject|4
7600115|NCT01947283|26440603|P2|Overall Study|Withdrawal by Subject|8
7600116|NCT01947283|26440604|P1|Overall Study|Withdrawal by Subject|10
7600117|NCT01947283|26440598|P7|Overall Study|Lost to Follow-up|5
7600118|NCT01947283|26440599|P6|Overall Study|Lost to Follow-up|2
7600119|NCT01947283|26440600|P5|Overall Study|Lost to Follow-up|0
7600120|NCT01947283|26440601|P4|Overall Study|Lost to Follow-up|5
7600121|NCT01947283|26440602|P3|Overall Study|Lost to Follow-up|5
7600122|NCT01947283|26440603|P2|Overall Study|Lost to Follow-up|6
7600123|NCT01947283|26440604|P1|Overall Study|Lost to Follow-up|4
7600124|NCT01947283|26440598|P7|Overall Study|Death|0
7600125|NCT01947283|26440599|P6|Overall Study|Death|0
7600126|NCT01947283|26440600|P5|Overall Study|Death|0
7600127|NCT01947283|26440601|P4|Overall Study|Death|0
7600128|NCT01947283|26440602|P3|Overall Study|Death|1
7600129|NCT01947283|26440603|P2|Overall Study|Death|1
7600130|NCT01947283|26440604|P1|Overall Study|Death|1
7600131|NCT01947127|26440676|P2|Overall Study|Data loss|4
7600132|NCT01947127|26440677|P1|Overall Study|Data loss|4
7600133|NCT01947127|26440676|P2|Overall Study|Withdrawal by Subject|1
7600134|NCT01947127|26440677|P1|Overall Study|Withdrawal by Subject|1
7600135|NCT01947127|26440676|P2|Overall Study|Protocol Violation|38
7600136|NCT01947127|26440677|P1|Overall Study|Protocol Violation|18
7600137|NCT01946880|26440689|P2|Overall Study|Personal and Family Issues|0
7600138|NCT01946880|26440690|P1|Overall Study|Personal and Family Issues|1
7600139|NCT01946880|26440689|P2|Overall Study|Met Primary Endpoint|0
7600140|NCT01946880|26440690|P1|Overall Study|Met Primary Endpoint|1
7600141|NCT01946880|26440689|P2|Overall Study|Withdrawal by Subject|2
7600142|NCT01946880|26440690|P1|Overall Study|Withdrawal by Subject|3
7600143|NCT01946880|26440689|P2|Overall Study|Physician Decision|1
7600144|NCT01946880|26440690|P1|Overall Study|Physician Decision|1
7600145|NCT01946880|26440689|P2|Overall Study|Lost to Follow-up|0
7600146|NCT01946880|26440690|P1|Overall Study|Lost to Follow-up|1
7600147|NCT01946802|26440766|P1|Overall Study|Protocol Violation|1
7600148|NCT01946802|26440766|P1|Overall Study|Combined septic shock|1
7600149|NCT01946802|26440766|P1|Overall Study|Withdrawal by Subject|2
7600150|NCT01946802|26440766|P1|Overall Study|Death|1
7600151|NCT01946529|26440789|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
7600152|NCT01946529|26440790|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
7600153|NCT01946529|26440791|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
7600154|NCT01946529|26440789|P3|End of Window Therapy (2 Courses)|Physician Decision|0
7600155|NCT01946529|26440790|P2|End of Window Therapy (2 Courses)|Physician Decision|1
7600156|NCT01946529|26440791|P1|End of Window Therapy (2 Courses)|Physician Decision|0
7600157|NCT01946438|26440802|P4|Overall Study|Withdrawal by Subject|0
7600158|NCT01946438|26440803|P3|Overall Study|Withdrawal by Subject|0
7600159|NCT01946438|26440804|P2|Overall Study|Withdrawal by Subject|0
7600160|NCT01946438|26440805|P1|Overall Study|Withdrawal by Subject|1
7600161|NCT01946438|26440802|P4|Overall Study|Protocol Violation|0
7600162|NCT01946438|26440803|P3|Overall Study|Protocol Violation|1
7600163|NCT01946438|26440804|P2|Overall Study|Protocol Violation|0
7600164|NCT01946438|26440805|P1|Overall Study|Protocol Violation|0
7600165|NCT01946438|26440802|P4|Overall Study|Serious Adverse event|0
7600166|NCT01946438|26440803|P3|Overall Study|Serious Adverse event|0
7600167|NCT01946438|26440804|P2|Overall Study|Serious Adverse event|0
7600168|NCT01946438|26440805|P1|Overall Study|Serious Adverse event|1
7600169|NCT01946438|26440802|P4|Overall Study|Adverse Event|1
7600170|NCT01946438|26440803|P3|Overall Study|Adverse Event|0
7600171|NCT01946438|26440804|P2|Overall Study|Adverse Event|0
7600172|NCT01946438|26440805|P1|Overall Study|Adverse Event|0
7600173|NCT01946425|26440833|P2|Overall Study|Withdrawal by Subject|0
7600174|NCT01946425|26440834|P1|Overall Study|Withdrawal by Subject|1
7600175|NCT01946425|26440833|P2|Overall Study|Protocol Violation|0
7600176|NCT01946425|26440834|P1|Overall Study|Protocol Violation|1
7600177|NCT01946412|26440848|P1|Overall Study|Difficulty in swallowing|1
7600178|NCT01946412|26440848|P1|Overall Study|Continued with commercial Kalydeco|2
7600179|NCT01946412|26440848|P1|Overall Study|Non-Compliance|1
7600180|NCT01946412|26440848|P1|Overall Study|Adverse Event|1
7600181|NCT01946282|26440873|P3|Year 3|Did not return FIT kit|30
7600182|NCT01946282|26440874|P2|Year 3|Did not return FIT kit|43
7600183|NCT01946282|26440875|P1|Year 3|Did not return FIT kit|288
7600184|NCT01946282|26440873|P3|Year 2|Did not return FIT kit|115
7600185|NCT01946282|26440874|P2|Year 2|Did not return FIT kit|131
7600186|NCT01946282|26440875|P1|Year 2|Did not return FIT kit|803
7600187|NCT01946282|26440873|P3|Year 1|Did not return FIT kit|654
7600188|NCT01946282|26440874|P2|Year 1|Did not return FIT kit|608
7600189|NCT01946282|26440875|P1|Year 1|Did not return FIT kit|4186
7600190|NCT01946204|26440908|P2|Overall Study|Other|3
7600191|NCT01946204|26440909|P1|Overall Study|Other|7
7600192|NCT01946204|26440908|P2|Overall Study|Ongoing|687
7600193|NCT01946204|26440909|P1|Overall Study|Ongoing|316
7600194|NCT01946204|26440908|P2|Overall Study|Lost to Follow-up|7
7600195|NCT01946204|26440909|P1|Overall Study|Lost to Follow-up|3
7600196|NCT01946204|26440908|P2|Overall Study|Withdrawal by Subject|50
7600197|NCT01946204|26440909|P1|Overall Study|Withdrawal by Subject|37
7600198|NCT01946204|26440908|P2|Overall Study|Death|59
7600199|NCT01946204|26440909|P1|Overall Study|Death|38
7600200|NCT01946191|26440927|P2|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
7600201|NCT01946191|26440928|P1|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
7600202|NCT01946191|26440927|P2|Follow-Up, 24-mo Endpoint|Protocol Violation|1
7600203|NCT01946191|26440928|P1|Follow-Up, 24-mo Endpoint|Protocol Violation|0
7600204|NCT01946191|26440927|P2|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
7600205|NCT01946191|26440928|P1|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
7600206|NCT01946191|26440927|P2|Allocation|Did not complete orientation|1
7600207|NCT01946191|26440928|P1|Allocation|Did not complete orientation|1
7600208|NCT01946178|26440954|P1|Overall Study|Lost to Follow-up|1
7600209|NCT01946178|26440954|P1|Overall Study|Pregnancy|1
7600210|NCT01946165|26440964|P2|Overall Study|Withdrawal by Subject|2
7600211|NCT01946165|26440965|P1|Overall Study|Withdrawal by Subject|0
7600212|NCT01946165|26440964|P2|Overall Study|Physician Decision|0
7600213|NCT01946165|26440965|P1|Overall Study|Physician Decision|2
7600214|NCT01946152|26440977|P4|Overall Study|Adverse Event|1
7600215|NCT01946152|26440978|P3|Overall Study|Adverse Event|0
7600216|NCT01946152|26440979|P2|Overall Study|Adverse Event|0
7600217|NCT01946152|26440980|P1|Overall Study|Adverse Event|0
7600218|NCT01946152|26440977|P4|Overall Study|Second malignancy|0
7600219|NCT01946152|26440978|P3|Overall Study|Second malignancy|1
7600220|NCT01946152|26440979|P2|Overall Study|Second malignancy|0
7600221|NCT01946152|26440980|P1|Overall Study|Second malignancy|0
7600222|NCT01946152|26440977|P4|Overall Study|Physician Decision|0
7600223|NCT01946152|26440978|P3|Overall Study|Physician Decision|1
7600224|NCT01946152|26440979|P2|Overall Study|Physician Decision|0
7600225|NCT01946152|26440980|P1|Overall Study|Physician Decision|0
7600226|NCT01946152|26440977|P4|Overall Study|Progression|7
7600227|NCT01946152|26440978|P3|Overall Study|Progression|4
7600228|NCT01946152|26440979|P2|Overall Study|Progression|1
7600229|NCT01946152|26440980|P1|Overall Study|Progression|0
7600230|NCT01946152|26440977|P4|Overall Study|Withdrawal by Subject|0
7600231|NCT01946152|26440978|P3|Overall Study|Withdrawal by Subject|0
7600232|NCT01946152|26440979|P2|Overall Study|Withdrawal by Subject|2
7600233|NCT01946152|26440980|P1|Overall Study|Withdrawal by Subject|0
7600234|NCT01946152|26440977|P4|Overall Study|Adverse Event|0
7600235|NCT01946152|26440978|P3|Overall Study|Adverse Event|0
7600236|NCT01946152|26440979|P2|Overall Study|Adverse Event|0
7600237|NCT01946152|26440980|P1|Overall Study|Adverse Event|1
7600238|NCT01945996|26441012|P2|Overall Study|Lost to Follow-up|5
7600239|NCT01945996|26441013|P1|Overall Study|Lost to Follow-up|3
7600240|NCT01945944|26441089|P2|Overall Study|Withdrawal by Subject|1
7600241|NCT01945944|26441090|P1|Overall Study|Withdrawal by Subject|0
7600242|NCT01945944|26441089|P2|Overall Study|Physician Decision|0
7600243|NCT01945944|26441090|P1|Overall Study|Physician Decision|1
7600244|NCT01945944|26441089|P2|Overall Study|Adverse Event|2
7600245|NCT01945944|26441090|P1|Overall Study|Adverse Event|0
7600246|NCT01945866|26441114|P2|Overall Study|Eyes did not complete or were dropped|0
7600247|NCT01945866|26441115|P1|Overall Study|Eyes did not complete or were dropped|2
7600248|NCT01945775|26441136|P2|Overall Study|Ongoing|19
7600249|NCT01945775|26441137|P1|Overall Study|Ongoing|56
7600250|NCT01945775|26441136|P2|Overall Study|Withdrawal by Subject|21
7600251|NCT01945775|26441137|P1|Overall Study|Withdrawal by Subject|10
7600252|NCT01945775|26441136|P2|Overall Study|Lost to Follow-up|7
7600253|NCT01945775|26441137|P1|Overall Study|Lost to Follow-up|11
7600254|NCT01945775|26441136|P2|Overall Study|Death|97
7600255|NCT01945775|26441137|P1|Overall Study|Death|210
7600256|NCT01945710|26441173|P7|Overall Study|Withdrawal by Subject|0
7600257|NCT01945710|26441174|P6|Overall Study|Withdrawal by Subject|0
7600258|NCT01945710|26441175|P5|Overall Study|Withdrawal by Subject|1
7600259|NCT01945710|26441176|P4|Overall Study|Withdrawal by Subject|0
7600260|NCT01945710|26441177|P3|Overall Study|Withdrawal by Subject|1
7600261|NCT01945710|26441178|P2|Overall Study|Withdrawal by Subject|1
7600262|NCT01945710|26441179|P1|Overall Study|Withdrawal by Subject|0
7600263|NCT01945710|26441173|P7|Overall Study|Other|4
7600264|NCT01945710|26441174|P6|Overall Study|Other|0
7600265|NCT01945710|26441175|P5|Overall Study|Other|1
7600266|NCT01945710|26441176|P4|Overall Study|Other|1
7600267|NCT01945710|26441177|P3|Overall Study|Other|3
7600268|NCT01945710|26441178|P2|Overall Study|Other|0
7600269|NCT01945710|26441179|P1|Overall Study|Other|2
7600270|NCT01945710|26441173|P7|Overall Study|Adverse Event|0
7600271|NCT01945710|26441174|P6|Overall Study|Adverse Event|0
7600272|NCT01945710|26441175|P5|Overall Study|Adverse Event|0
7600273|NCT01945710|26441176|P4|Overall Study|Adverse Event|0
7600274|NCT01945710|26441177|P3|Overall Study|Adverse Event|0
7600275|NCT01945710|26441178|P2|Overall Study|Adverse Event|1
7600276|NCT01945710|26441179|P1|Overall Study|Adverse Event|0
7600277|NCT01945710|26441173|P7|Overall Study|Progressive Disease|19
7600278|NCT01945710|26441174|P6|Overall Study|Progressive Disease|3
7600279|NCT01945710|26441175|P5|Overall Study|Progressive Disease|7
7600280|NCT01945710|26441176|P4|Overall Study|Progressive Disease|2
7600281|NCT01945710|26441177|P3|Overall Study|Progressive Disease|3
7600282|NCT01945710|26441178|P2|Overall Study|Progressive Disease|4
7600283|NCT01945710|26441179|P1|Overall Study|Progressive Disease|5
7600284|NCT01945593|26441298|P4|Overall Study|Other: Screen Failure|0
7600285|NCT01945593|26441299|P3|Overall Study|Other: Screen Failure|0
7600286|NCT01945593|26441300|P2|Overall Study|Other: Screen Failure|2
7600287|NCT01945593|26441301|P1|Overall Study|Other: Screen Failure|0
7600288|NCT01945593|26441298|P4|Overall Study|Other: Surgical Procedure|6
7600289|NCT01945593|26441299|P3|Overall Study|Other: Surgical Procedure|0
7600290|NCT01945593|26441300|P2|Overall Study|Other: Surgical Procedure|2
7600291|NCT01945593|26441301|P1|Overall Study|Other: Surgical Procedure|0
7600292|NCT01945593|26441298|P4|Overall Study|Other: Terminated|1
7600293|NCT01945593|26441299|P3|Overall Study|Other: Terminated|0
7600294|NCT01945593|26441300|P2|Overall Study|Other: Terminated|0
7600295|NCT01945593|26441301|P1|Overall Study|Other: Terminated|0
7600296|NCT01945593|26441298|P4|Overall Study|Death|0
7600297|NCT01945593|26441299|P3|Overall Study|Death|1
7600298|NCT01945593|26441300|P2|Overall Study|Death|0
7600299|NCT01945593|26441301|P1|Overall Study|Death|0
7600300|NCT01945593|26441298|P4|Overall Study|Protocol Violation|3
7600301|NCT01945593|26441299|P3|Overall Study|Protocol Violation|1
7600302|NCT01945593|26441300|P2|Overall Study|Protocol Violation|2
7600303|NCT01945593|26441301|P1|Overall Study|Protocol Violation|0
7600304|NCT01945593|26441298|P4|Overall Study|Withdrawal by Subject|4
7600305|NCT01945593|26441299|P3|Overall Study|Withdrawal by Subject|0
7600306|NCT01945593|26441300|P2|Overall Study|Withdrawal by Subject|2
7600307|NCT01945593|26441301|P1|Overall Study|Withdrawal by Subject|0
7600308|NCT01945593|26441298|P4|Overall Study|Physician Decision|1
7600309|NCT01945593|26441299|P3|Overall Study|Physician Decision|1
7600310|NCT01945593|26441300|P2|Overall Study|Physician Decision|0
7600311|NCT01945593|26441301|P1|Overall Study|Physician Decision|0
7600312|NCT01945593|26441298|P4|Overall Study|Adverse Event|5
7600313|NCT01945593|26441299|P3|Overall Study|Adverse Event|0
7600314|NCT01945593|26441300|P2|Overall Study|Adverse Event|0
7600315|NCT01945593|26441301|P1|Overall Study|Adverse Event|0
7600316|NCT01945580|26441383|P2|Overall Study|No data available|2
7600317|NCT01945580|26441384|P1|Overall Study|No data available|0
7600318|NCT01945580|26441383|P2|Overall Study|The patient moved.|0
7600319|NCT01945580|26441384|P1|Overall Study|The patient moved.|1
7600320|NCT01945580|26441383|P2|Overall Study|Noncompliance with 36 month visit|0
7600321|NCT01945580|26441384|P1|Overall Study|Noncompliance with 36 month visit|1
7600322|NCT01945580|26441383|P2|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
7600323|NCT01945580|26441384|P1|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
7600324|NCT01945580|26441383|P2|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
7600325|NCT01945580|26441384|P1|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
7600326|NCT01945580|26441383|P2|Overall Study|Family illness - unable to return|1
7600327|NCT01945580|26441384|P1|Overall Study|Family illness - unable to return|0
7600328|NCT01945580|26441383|P2|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
7600329|NCT01945580|26441384|P1|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
7600330|NCT01945580|26441383|P2|Overall Study|Patient moved out of state|1
7600331|NCT01945580|26441384|P1|Overall Study|Patient moved out of state|0
7600332|NCT01945580|26441383|P2|Overall Study|Death|2
7600333|NCT01945580|26441384|P1|Overall Study|Death|7
7600334|NCT01945580|26441383|P2|Overall Study|Lost to Follow-up|39
7600335|NCT01945580|26441384|P1|Overall Study|Lost to Follow-up|26
7600336|NCT01945580|26441383|P2|Overall Study|Physician Decision|2
7600337|NCT01945580|26441384|P1|Overall Study|Physician Decision|3
7600338|NCT01945580|26441383|P2|Overall Study|Withdrawal by Subject|35
7600339|NCT01945580|26441384|P1|Overall Study|Withdrawal by Subject|13
7600340|NCT01945489|26441420|P2|Cycle 2|Lost to Follow-up|1
7600341|NCT01945489|26441421|P1|Cycle 2|Lost to Follow-up|0
7600342|NCT01945489|26441420|P2|Cycle 2|Adverse Event|0
7600343|NCT01945489|26441421|P1|Cycle 2|Adverse Event|1
7600344|NCT01945489|26441420|P2|Cycle 1|Other Miscellaneous Reasons|1
7600345|NCT01945489|26441421|P1|Cycle 1|Other Miscellaneous Reasons|3
7600346|NCT01945489|26441420|P2|Cycle 1|Protocol Violation|1
7600347|NCT01945489|26441421|P1|Cycle 1|Protocol Violation|0
7600348|NCT01945489|26441420|P2|Cycle 1|Personal Reasons|2
7600349|NCT01945489|26441421|P1|Cycle 1|Personal Reasons|4
7600350|NCT01945489|26441420|P2|Cycle 1|Lost to Follow-up|0
7600351|NCT01945489|26441421|P1|Cycle 1|Lost to Follow-up|4
7600352|NCT01945489|26441420|P2|Cycle 1|Adverse Event|0
7600353|NCT01945489|26441421|P1|Cycle 1|Adverse Event|2
7600354|NCT01945281|26441475|P2|Overall Study|Technical Problems|0
7600355|NCT01945281|26441476|P1|Overall Study|Technical Problems|1
7600356|NCT01945281|26441475|P2|Overall Study|Physician Decision|1
7600357|NCT01945281|26441476|P1|Overall Study|Physician Decision|1
7600358|NCT01945281|26441475|P2|Overall Study|Death|3
7600359|NCT01945281|26441476|P1|Overall Study|Death|3
7600360|NCT01945281|26441475|P2|Overall Study|Adverse Event|0
7600361|NCT01945281|26441476|P1|Overall Study|Adverse Event|1
7600362|NCT01945242|26441488|P2|Overall Study|Physician Decision|3
7600363|NCT01945242|26441489|P1|Overall Study|Physician Decision|3
7600364|NCT01945216|26441504|P1|Overall Study|CRF not assured by investigators|5
7600365|NCT01945216|26441504|P1|Overall Study|Protocol Violation|42
7600366|NCT01945216|26441504|P1|Overall Study|Case report forms (CRF) uncollected|52
7600367|NCT01945086|26441562|P3|Overall Study|Adverse Event|1
7600368|NCT01945086|26441563|P2|Overall Study|Adverse Event|0
7600369|NCT01945086|26441564|P1|Overall Study|Adverse Event|0
7600370|NCT01945086|26441562|P3|Overall Study|Withdrawal by Subject|1
7600371|NCT01945086|26441563|P2|Overall Study|Withdrawal by Subject|0
7600372|NCT01945086|26441564|P1|Overall Study|Withdrawal by Subject|1
7600373|NCT01945034|26441608|P3|Overall Study|Protocol Violation|1
7600374|NCT01945034|26441609|P2|Overall Study|Protocol Violation|0
7600375|NCT01945034|26441610|P1|Overall Study|Protocol Violation|1
7600376|NCT01945034|26441608|P3|Overall Study|Lost to Follow-up|2
7600377|NCT01945034|26441609|P2|Overall Study|Lost to Follow-up|0
7600378|NCT01945034|26441610|P1|Overall Study|Lost to Follow-up|0
7600379|NCT01945034|26441608|P3|Overall Study|Other|3
7600380|NCT01945034|26441609|P2|Overall Study|Other|1
7600381|NCT01945034|26441610|P1|Overall Study|Other|0
7600382|NCT01945034|26441608|P3|Overall Study|Withdrawal by Subject|1
7600383|NCT01945034|26441609|P2|Overall Study|Withdrawal by Subject|3
7600384|NCT01945034|26441610|P1|Overall Study|Withdrawal by Subject|0
7600385|NCT01945034|26441608|P3|Overall Study|Medication Error|0
7600386|NCT01945034|26441609|P2|Overall Study|Medication Error|1
7600387|NCT01945034|26441610|P1|Overall Study|Medication Error|0
7600388|NCT01945021|26441660|P1|Overall Study|Death|65
7600389|NCT01945021|26441660|P1|Overall Study|Lost to Follow-up|5
7600390|NCT01945021|26441660|P1|Overall Study|Withdrawal of consent|12
7600391|NCT01945021|26441660|P1|Overall Study|Adverse Event|1
7600392|NCT01944969|26441674|P1|Overall Study|Administrative or other reasons|23
7600393|NCT01944969|26441674|P1|Overall Study|Non-compliance with IMP|1
7600394|NCT01944969|26441674|P1|Overall Study|Lack of Efficacy|1
7600395|NCT01944969|26441674|P1|Overall Study|Adverse Event|1
7600396|NCT01944839|26441707|P2|Overall Study|Subject non-compliance|3
7600397|NCT01944839|26441708|P1|Overall Study|Subject non-compliance|0
7600398|NCT01944839|26441707|P2|Overall Study|Lost to Follow-up|0
7600399|NCT01944839|26441708|P1|Overall Study|Lost to Follow-up|1
7600400|NCT01944839|26441707|P2|Overall Study|Withdrawal by Subject|17
7600401|NCT01944839|26441708|P1|Overall Study|Withdrawal by Subject|9
7600402|NCT01944839|26441707|P2|Overall Study|Adverse Event|5
7600403|NCT01944839|26441708|P1|Overall Study|Adverse Event|10
7600404|NCT01944839|26441707|P2|Overall Study|Protocol Violation|1
7600405|NCT01944839|26441708|P1|Overall Study|Protocol Violation|0
7600406|NCT01944839|26441707|P2|Overall Study|Physician Decision|2
7600407|NCT01944839|26441708|P1|Overall Study|Physician Decision|2
7600408|NCT01944774|26441717|P3|Overall Study|Lost to Follow-up|0
7600409|NCT01944774|26441718|P2|Overall Study|Lost to Follow-up|1
7600410|NCT01944774|26441719|P1|Overall Study|Lost to Follow-up|0
7600411|NCT01944774|26441717|P3|Overall Study|Lack of Efficacy|2
7600412|NCT01944774|26441718|P2|Overall Study|Lack of Efficacy|2
7600413|NCT01944774|26441719|P1|Overall Study|Lack of Efficacy|1
7600414|NCT01944774|26441717|P3|Overall Study|Adverse Event|3
7600415|NCT01944774|26441718|P2|Overall Study|Adverse Event|2
7600416|NCT01944774|26441719|P1|Overall Study|Adverse Event|3
7600417|NCT01944774|26441717|P3|Overall Study|Withdrawal by Subject|3
7600418|NCT01944774|26441718|P2|Overall Study|Withdrawal by Subject|3
7600419|NCT01944774|26441719|P1|Overall Study|Withdrawal by Subject|2
7600420|NCT01944722|26441762|P1|Overall Study|>ASCUS Cytology|1122
7600421|NCT01944722|26441762|P1|Overall Study|Unsatisfactory Cytology Result|63
7600422|NCT01944722|26441762|P1|Overall Study|NILM Subjects <30 years old|8106
7600423|NCT01944722|26441762|P1|Overall Study|Withdrawal by Subject|8
7600424|NCT01944722|26441762|P1|Overall Study|Specimens Mislabeled|2
7600425|NCT01944722|26441762|P1|Overall Study|Missing Specimens|3
7600426|NCT01944722|26441762|P1|Overall Study|Insufficient Volume for Test|1
7600427|NCT01944722|26441762|P1|Overall Study|Improper Storage/Transport|5
7600428|NCT01944722|26441762|P1|Overall Study|Specimen Shipping Issues|34
7600429|NCT01944722|26441762|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
7600430|NCT01944670|26441796|P1|Overall Study|Lost to Follow-up|2
7600431|NCT01944631|26441818|P2|Overall Study|Withdrawal by Subject|1
7600432|NCT01944631|26441819|P1|Overall Study|Withdrawal by Subject|0
7600433|NCT01944631|26441818|P2|Overall Study|Lost to Follow-up|1
7600434|NCT01944631|26441819|P1|Overall Study|Lost to Follow-up|3
7600435|NCT01944631|26441818|P2|Overall Study|Adverse Event|0
7600436|NCT01944631|26441819|P1|Overall Study|Adverse Event|1
7600437|NCT01944462|26441835|P1|PPPP Educational Program|Lost to Follow-up|60
7600438|NCT01944098|26441911|P2|Overall Study|Physician Decision|0
7600439|NCT01944098|26441912|P1|Overall Study|Physician Decision|1
7600440|NCT01944059|26441924|P1|Overall Study|Adverse Event|2
7600441|NCT01944059|26441924|P1|Overall Study|Withdrawal by Subject|1
7600442|NCT01944059|26441924|P1|Overall Study|Physician Decision|3
7600443|NCT01944059|26441924|P1|Overall Study|Lost to Follow-up|1
7600444|NCT01944046|26441935|P2|Open Label Eligible and Consented|Withdrawal by Subject|0
7600445|NCT01944046|26441936|P1|Open Label Eligible and Consented|Withdrawal by Subject|1
7600446|NCT01944046|26441935|P2|Open Label Eligible and Consented|Clinical Worsening|2
7600447|NCT01944046|26441936|P1|Open Label Eligible and Consented|Clinical Worsening|4
7600448|NCT01944046|26441935|P2|Open Label Eligible and Consented|Adverse Event|1
7600449|NCT01944046|26441936|P1|Open Label Eligible and Consented|Adverse Event|6
7600450|NCT01944046|26441935|P2|Open Label Eligible and Consented|Lost to Follow-up|5
7600451|NCT01944046|26441936|P1|Open Label Eligible and Consented|Lost to Follow-up|3
7600452|NCT01944046|26441935|P2|Randomized to DB|Did not have a postbaseline ABC SW|6
7600453|NCT01944046|26441936|P1|Randomized to DB|Did not have a postbaseline ABC SW|5
7600454|NCT01944046|26441935|P2|Randomized to DB|Did not have baseline ABC-SW|0
7600455|NCT01944046|26441936|P1|Randomized to DB|Did not have baseline ABC-SW|2
7600456|NCT01944046|26441935|P2|Randomized to DB|Physician Decision|2
7600457|NCT01944046|26441936|P1|Randomized to DB|Physician Decision|1
7600458|NCT01944046|26441935|P2|Randomized to DB|Withdrawal by Subject|4
7600459|NCT01944046|26441936|P1|Randomized to DB|Withdrawal by Subject|2
7600460|NCT01944046|26441935|P2|Randomized to DB|Lost to Follow-up|3
7600461|NCT01944046|26441936|P1|Randomized to DB|Lost to Follow-up|3
7600462|NCT01944046|26441935|P2|Randomized to DB|Clinical Worsening|2
7600463|NCT01944046|26441936|P1|Randomized to DB|Clinical Worsening|3
7600464|NCT01944046|26441935|P2|Randomized to DB|Adverse Event|2
7600465|NCT01944046|26441936|P1|Randomized to DB|Adverse Event|5
7600466|NCT01943916|26441974|P1|Overall Study|Protocol Deviation|1
7600467|NCT01943916|26441974|P1|Overall Study|No Truth Panel Review|38
7600468|NCT01943916|26441974|P1|Overall Study|Protocol Deviation No Biopsy|25
7600469|NCT01943916|26441974|P1|Overall Study|Technical Failure|39
7600470|NCT01943916|26441974|P1|Overall Study|Quality Assurance Reader Fail|130
7600471|NCT01943916|26441974|P1|Overall Study|Pilot Phase exclusion|100
7600472|NCT01943916|26441974|P1|Overall Study|Enrollment Failure|23
7600473|NCT01943916|26441974|P1|Overall Study|Technically invalid images|10
7600474|NCT01943851|26442031|P18|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
7600475|NCT01943851|26442032|P17|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
7600476|NCT01943851|26442033|P16|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
7600477|NCT01943851|26442034|P15|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600478|NCT01943851|26442035|P14|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600479|NCT01943851|26442036|P13|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600480|NCT01943851|26442037|P12|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600481|NCT01943851|26442038|P11|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600482|NCT01943851|26442039|P10|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600483|NCT01943851|26442040|P9|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600484|NCT01943851|26442041|P8|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600485|NCT01943851|26442042|P7|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600486|NCT01943851|26442043|P6|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600487|NCT01943851|26442044|P5|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600488|NCT01943851|26442045|P4|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600489|NCT01943851|26442046|P3|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600490|NCT01943851|26442047|P2|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600491|NCT01943851|26442048|P1|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7600492|NCT01943851|26442031|P18|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600493|NCT01943851|26442032|P17|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600494|NCT01943851|26442033|P16|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
7600495|NCT01943851|26442034|P15|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600496|NCT01943851|26442035|P14|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600497|NCT01943851|26442036|P13|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600498|NCT01943851|26442037|P12|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600499|NCT01943851|26442038|P11|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600500|NCT01943851|26442039|P10|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600501|NCT01943851|26442040|P9|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600502|NCT01943851|26442041|P8|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600503|NCT01943851|26442042|P7|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600504|NCT01943851|26442043|P6|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600505|NCT01943851|26442044|P5|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600506|NCT01943851|26442045|P4|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600507|NCT01943851|26442046|P3|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600508|NCT01943851|26442047|P2|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600509|NCT01943851|26442048|P1|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7600510|NCT01943851|26442031|P18|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600511|NCT01943851|26442032|P17|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600512|NCT01943851|26442033|P16|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600513|NCT01943851|26442034|P15|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600514|NCT01943851|26442035|P14|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
7600515|NCT01943851|26442036|P13|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600516|NCT01943851|26442037|P12|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600517|NCT01943851|26442038|P11|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600518|NCT01943851|26442039|P10|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600519|NCT01943851|26442040|P9|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600520|NCT01943851|26442041|P8|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600521|NCT01943851|26442042|P7|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600522|NCT01943851|26442043|P6|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600523|NCT01943851|26442044|P5|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600524|NCT01943851|26442045|P4|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600525|NCT01943851|26442046|P3|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600526|NCT01943851|26442047|P2|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600527|NCT01943851|26442048|P1|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7600528|NCT01943851|26442031|P18|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600529|NCT01943851|26442032|P17|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600530|NCT01943851|26442033|P16|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600531|NCT01943851|26442034|P15|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600532|NCT01943851|26442035|P14|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600533|NCT01943851|26442036|P13|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600534|NCT01943851|26442037|P12|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600535|NCT01943851|26442038|P11|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600536|NCT01943851|26442039|P10|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600537|NCT01943851|26442040|P9|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600538|NCT01943851|26442041|P8|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7600539|NCT01943851|26442042|P7|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600540|NCT01943851|26442043|P6|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600541|NCT01943851|26442044|P5|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7600542|NCT01943851|26442045|P4|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600543|NCT01943851|26442046|P3|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600544|NCT01943851|26442047|P2|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600545|NCT01943851|26442048|P1|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7600546|NCT01943851|26442031|P18|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600547|NCT01943851|26442032|P17|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600548|NCT01943851|26442033|P16|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600549|NCT01943851|26442034|P15|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600550|NCT01943851|26442035|P14|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600551|NCT01943851|26442036|P13|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600552|NCT01943851|26442037|P12|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600553|NCT01943851|26442038|P11|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600554|NCT01943851|26442039|P10|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600555|NCT01943851|26442040|P9|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7600556|NCT01943851|26442041|P8|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7600557|NCT01943851|26442042|P7|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7600558|NCT01943851|26442043|P6|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600559|NCT01943851|26442044|P5|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600560|NCT01943851|26442045|P4|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7600561|NCT01943851|26442046|P3|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600562|NCT01943851|26442047|P2|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600563|NCT01943851|26442048|P1|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7600564|NCT01943825|26442686|P4|Overall Study|Other than specified above|1
7600565|NCT01943825|26442687|P3|Overall Study|Other than specified above|0
7600566|NCT01943825|26442688|P2|Overall Study|Other than specified above|1
7600567|NCT01943825|26442689|P1|Overall Study|Other than specified above|0
7600568|NCT01943825|26442686|P4|Overall Study|Withdrawal by Subject|2
7600569|NCT01943825|26442687|P3|Overall Study|Withdrawal by Subject|3
7600570|NCT01943825|26442688|P2|Overall Study|Withdrawal by Subject|0
7600571|NCT01943825|26442689|P1|Overall Study|Withdrawal by Subject|1
7600572|NCT01943825|26442686|P4|Overall Study|Lost to Follow-up|8
7600573|NCT01943825|26442687|P3|Overall Study|Lost to Follow-up|12
7600574|NCT01943825|26442688|P2|Overall Study|Lost to Follow-up|3
7600575|NCT01943825|26442689|P1|Overall Study|Lost to Follow-up|9
7600576|NCT01943799|26442731|P4|Overall Study|Withdrawal by Subject|0
7600577|NCT01943799|26442732|P3|Overall Study|Withdrawal by Subject|1
7600578|NCT01943799|26442733|P2|Overall Study|Withdrawal by Subject|2
7600579|NCT01943799|26442734|P1|Overall Study|Withdrawal by Subject|4
7600580|NCT01943799|26442731|P4|Overall Study|Protocol Violation|0
7600581|NCT01943799|26442732|P3|Overall Study|Protocol Violation|0
7600582|NCT01943799|26442733|P2|Overall Study|Protocol Violation|0
7600583|NCT01943799|26442734|P1|Overall Study|Protocol Violation|1
7600584|NCT01943799|26442731|P4|Overall Study|Lost to Follow-up|0
7600585|NCT01943799|26442732|P3|Overall Study|Lost to Follow-up|1
7600586|NCT01943799|26442733|P2|Overall Study|Lost to Follow-up|1
7600587|NCT01943799|26442734|P1|Overall Study|Lost to Follow-up|0
7600588|NCT01943591|26442774|P2|Overall Study|Death|7
7600589|NCT01943591|26442775|P1|Overall Study|Death|2
7600590|NCT01943591|26442774|P2|Overall Study|Lost to Follow-up|4
7600591|NCT01943591|26442775|P1|Overall Study|Lost to Follow-up|3
7600592|NCT01943552|26442833|P2|Overall Study|Other Reasons|17
7600593|NCT01943552|26442834|P1|Overall Study|Other Reasons|16
7600594|NCT01943552|26442833|P2|Overall Study|Withdrawal by Subject|6
7600595|NCT01943552|26442834|P1|Overall Study|Withdrawal by Subject|6
7600596|NCT01943552|26442833|P2|Overall Study|Adverse Event|2
7600597|NCT01943552|26442834|P1|Overall Study|Adverse Event|3
7600598|NCT01943539|26442850|P2|Overall Study|Non-compliance with at-home intervention|0
7600599|NCT01943539|26442851|P1|Overall Study|Non-compliance with at-home intervention|4
7600600|NCT01943435|26442948|P3|6 Month Follow up|Lost to Follow-up|15
7600601|NCT01943435|26442949|P2|6 Month Follow up|Lost to Follow-up|7
7600602|NCT01943435|26442950|P1|6 Month Follow up|Lost to Follow-up|12
7600603|NCT01943435|26442948|P3|2 Month Follow up|Lost to Follow-up|0
7600604|NCT01943435|26442949|P2|2 Month Follow up|Lost to Follow-up|3
7600605|NCT01943435|26442950|P1|2 Month Follow up|Lost to Follow-up|2
7600606|NCT01943435|26442948|P3|Intervention Period|Withdrawal by Subject|4
7600607|NCT01943435|26442949|P2|Intervention Period|Withdrawal by Subject|3
7600608|NCT01943435|26442950|P1|Intervention Period|Withdrawal by Subject|3
7600609|NCT01943435|26442948|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
7600610|NCT01943435|26442949|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
7600611|NCT01943435|26442950|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
7600612|NCT01943292|26442973|P3|Overall Study|Withdrawal by Subject|0
7600613|NCT01943292|26442974|P2|Overall Study|Withdrawal by Subject|0
7600614|NCT01943292|26442975|P1|Overall Study|Withdrawal by Subject|1
7600615|NCT01942993|26443011|P1|Overall Study|Physician Decision|1
7600616|NCT01942993|26443011|P1|Overall Study|Lost to Follow-up|1
7600617|NCT01942785|26443028|P1|Overall Study|Protocol Violation|1
7600618|NCT01942785|26443028|P1|Overall Study|Withdrawal by Subject|1
7600619|NCT01942785|26443028|P1|Overall Study|Adverse Event|2
7600620|NCT01942733|26443057|P1|Overall Study|Administrative|1
7600621|NCT01942733|26443057|P1|Overall Study|Non-compliance with IMP|1
7600622|NCT01942733|26443057|P1|Overall Study|Lost to Follow-up|1
7600623|NCT01942590|26444198|P2|Overall Study|Adverse Event|0
7600624|NCT01942590|26444199|P1|Overall Study|Adverse Event|1
7600625|NCT01942590|26444198|P2|Overall Study|Withdrawal by Subject|1
7600626|NCT01942590|26444199|P1|Overall Study|Withdrawal by Subject|0
7600627|NCT01942486|26444229|P1|Overall Study|Lost to Follow-up|27
7600628|NCT01942161|26444236|P3|Overall Study|Withdrawal by Subject|1
7600629|NCT01942161|26444237|P2|Overall Study|Withdrawal by Subject|3
7600630|NCT01942161|26444238|P1|Overall Study|Withdrawal by Subject|3
7600631|NCT01942161|26444236|P3|Overall Study|Protocol Violation|0
7600632|NCT01942161|26444237|P2|Overall Study|Protocol Violation|0
7600633|NCT01942161|26444238|P1|Overall Study|Protocol Violation|1
7600634|NCT01942161|26444236|P3|Overall Study|Physician Decision|0
7600635|NCT01942161|26444237|P2|Overall Study|Physician Decision|1
7600636|NCT01942161|26444238|P1|Overall Study|Physician Decision|3
7600637|NCT01942161|26444236|P3|Overall Study|Adverse Event|5
7600638|NCT01942161|26444237|P2|Overall Study|Adverse Event|2
7600639|NCT01942161|26444238|P1|Overall Study|Adverse Event|1
7600640|NCT01942148|26444258|P1|Overall Study|Use of the prohibition medicine|1
7600641|NCT01942148|26444258|P1|Overall Study|Withdrawal by Subject|8
7600642|NCT01942148|26444258|P1|Overall Study|Protocol Violation|1
7600643|NCT01942148|26444258|P1|Overall Study|Physician Decision|11
7600644|NCT01942148|26444258|P1|Overall Study|Lack of Efficacy|2
7600645|NCT01942148|26444258|P1|Overall Study|Adverse Event|4
7600662|NCT01941940|26444304|P1|Overall Study|Other|1
7600663|NCT01941940|26444304|P1|Overall Study|Other|1
7600664|NCT01941940|26444304|P1|Overall Study|Death|1
7600665|NCT01941940|26444304|P1|Overall Study|Withdrawal by Subject|15
7600666|NCT01941940|26444304|P1|Overall Study|Physician Decision|2
7600667|NCT01941940|26444304|P1|Overall Study|Lost to Follow-up|2
7600668|NCT01941940|26444304|P1|Overall Study|Adverse Event|11
7600669|NCT01941537|26444412|P2|Overall Study|Withdrawal by Subject|1
7600670|NCT01941537|26444413|P1|Overall Study|Withdrawal by Subject|0
7600671|NCT01941537|26444412|P2|Overall Study|Adverse Event|0
7600672|NCT01941537|26444413|P1|Overall Study|Adverse Event|1
7600673|NCT01941537|26444412|P2|Overall Study|Pregnancy|0
7600674|NCT01941537|26444413|P1|Overall Study|Pregnancy|1
7600675|NCT01941537|26444412|P2|Overall Study|Lost to Follow-up|0
7600676|NCT01941537|26444413|P1|Overall Study|Lost to Follow-up|1
7600677|NCT01941537|26444412|P2|Overall Study|Lack of Efficacy|2
7600678|NCT01941537|26444413|P1|Overall Study|Lack of Efficacy|1
7600679|NCT01941498|26444425|P1|Overall Study|Relocated out of state|1
7600680|NCT01941186|26444543|P2|Follow-up|Lost to Follow-up|0
7600681|NCT01941186|26444544|P1|Follow-up|Lost to Follow-up|1
7600682|NCT01941095|26444570|P1|Overall Study|Lost to Follow-up|10
7600683|NCT01941095|26444570|P1|Overall Study|Withdrawal by Subject|17
7600684|NCT01941095|26444570|P1|Overall Study|Physician Decision|3
7600685|NCT01941095|26444570|P1|Overall Study|Adverse Event|11
7600686|NCT01941095|26444570|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
7600687|NCT01941095|26444570|P1|Overall Study|Insufficient therapeutic response|13
7600688|NCT01941030|26444595|P2|Overall Study|Withdrawal by Subject|6
7600689|NCT01941030|26444596|P1|Overall Study|Withdrawal by Subject|4
7600690|NCT01941030|26444595|P2|Overall Study|Lost to Follow-up|5
7600691|NCT01941030|26444596|P1|Overall Study|Lost to Follow-up|6
7600692|NCT01941030|26444595|P2|Overall Study|Death|2
7600693|NCT01941030|26444596|P1|Overall Study|Death|3
7600694|NCT01940939|26444618|P2|Overall Study|Withdrawal by Subject|8
7600695|NCT01940939|26444619|P1|Overall Study|Withdrawal by Subject|2
7600696|NCT01940900|26444631|P2|Overall Study|other|0
7600697|NCT01940900|26444632|P1|Overall Study|other|1
7600698|NCT01940900|26444631|P2|Overall Study|subject non-compliance|1
7600699|NCT01940900|26444632|P1|Overall Study|subject non-compliance|1
7600700|NCT01940900|26444631|P2|Overall Study|Sponsor Decision|0
7600701|NCT01940900|26444632|P1|Overall Study|Sponsor Decision|1
7600702|NCT01940900|26444631|P2|Overall Study|Lost to Follow-up|0
7600703|NCT01940900|26444632|P1|Overall Study|Lost to Follow-up|1
7600704|NCT01940900|26444631|P2|Overall Study|Withdrawal by Subject|15
7600705|NCT01940900|26444632|P1|Overall Study|Withdrawal by Subject|11
7600706|NCT01940900|26444631|P2|Overall Study|Adverse Event|15
7600707|NCT01940900|26444632|P1|Overall Study|Adverse Event|10
7600708|NCT01940900|26444631|P2|Overall Study|Physician Decision|0
7600709|NCT01940900|26444632|P1|Overall Study|Physician Decision|4
7600710|NCT01940887|26444640|P2|Year 2|Lost to Follow-up|6
7600711|NCT01940887|26444641|P1|Year 2|Lost to Follow-up|1
7600712|NCT01940887|26444640|P2|Year 2|Withdrawal by Subject|8
7600713|NCT01940887|26444641|P1|Year 2|Withdrawal by Subject|8
7600714|NCT01940887|26444640|P2|Year 2|Adverse Event|2
7600715|NCT01940887|26444641|P1|Year 2|Adverse Event|8
7600716|NCT01940887|26444640|P2|Year 2|Sponsor Decision, early termination|203
7600717|NCT01940887|26444641|P1|Year 2|Sponsor Decision, early termination|192
7600718|NCT01940887|26444640|P2|Year 2|Death|2
7600719|NCT01940887|26444641|P1|Year 2|Death|0
7600720|NCT01940887|26444640|P2|Year 2|Physician Decision|1
7600721|NCT01940887|26444641|P1|Year 2|Physician Decision|8
7600722|NCT01940887|26444640|P2|Year 1|Lost to Follow-up|1
7600723|NCT01940887|26444641|P1|Year 1|Lost to Follow-up|2
7600724|NCT01940887|26444640|P2|Year 1|Withdrawal by Subject|9
7600725|NCT01940887|26444641|P1|Year 1|Withdrawal by Subject|18
7600726|NCT01940887|26444640|P2|Year 1|Adverse Event|6
7600727|NCT01940887|26444641|P1|Year 1|Adverse Event|7
7600728|NCT01940887|26444640|P2|Year 1|Death|3
7600729|NCT01940887|26444641|P1|Year 1|Death|5
7600730|NCT01940887|26444640|P2|Year 1|Physician Decision|3
7600731|NCT01940887|26444641|P1|Year 1|Physician Decision|7
7600732|NCT01940887|26444640|P2|Year 1|Protocol Violation|1
7600733|NCT01940887|26444641|P1|Year 1|Protocol Violation|0
7600734|NCT01940705|26444651|P4|Overall Study|Withdrawal by team - hearing aid change|0
7600735|NCT01940705|26444652|P3|Overall Study|Withdrawal by team - hearing aid change|0
7600736|NCT01940705|26444653|P2|Overall Study|Withdrawal by team - hearing aid change|0
7600737|NCT01940705|26444654|P1|Overall Study|Withdrawal by team - hearing aid change|1
7600738|NCT01940705|26444651|P4|Overall Study|Intervention not given|0
7600739|NCT01940705|26444652|P3|Overall Study|Intervention not given|3
7600740|NCT01940705|26444653|P2|Overall Study|Intervention not given|3
7600741|NCT01940705|26444654|P1|Overall Study|Intervention not given|0
7600742|NCT01940705|26444651|P4|Overall Study|Withdrawal by Subject|2
7600743|NCT01940705|26444652|P3|Overall Study|Withdrawal by Subject|3
7600744|NCT01940705|26444653|P2|Overall Study|Withdrawal by Subject|2
7600745|NCT01940705|26444654|P1|Overall Study|Withdrawal by Subject|2
7600746|NCT01940705|26444651|P4|Overall Study|Lost to Follow-up|2
7600747|NCT01940705|26444652|P3|Overall Study|Lost to Follow-up|2
7600748|NCT01940705|26444653|P2|Overall Study|Lost to Follow-up|3
7600749|NCT01940705|26444654|P1|Overall Study|Lost to Follow-up|1
7600750|NCT01940497|26444718|P2|Overall Study|Administrative/Other|1
7600751|NCT01940497|26444719|P1|Overall Study|Administrative/Other|1
7600752|NCT01940497|26444718|P2|Overall Study|Withdrew Consent|2
7600753|NCT01940497|26444719|P1|Overall Study|Withdrew Consent|6
7600754|NCT01940497|26444718|P2|Overall Study|Refused Treatment|3
7600755|NCT01940497|26444719|P1|Overall Study|Refused Treatment|1
7600756|NCT01940497|26444718|P2|Overall Study|Violation of Entry Criteria|1
7600757|NCT01940497|26444719|P1|Overall Study|Violation of Entry Criteria|1
7600758|NCT01940497|26444718|P2|Overall Study|Recurrence of Disease Postsurgery|3
7600759|NCT01940497|26444719|P1|Overall Study|Recurrence of Disease Postsurgery|1
7600760|NCT01940497|26444718|P2|Overall Study|Adverse Event/Intercurrent Illness|8
7600761|NCT01940497|26444719|P1|Overall Study|Adverse Event/Intercurrent Illness|11
7600762|NCT01940484|26444760|P1|Overall Study|Adverse Event|1
7600763|NCT01940484|26444760|P1|Overall Study|Death|2
7600764|NCT01940484|26444760|P1|Overall Study|Underwent transplantation|4
7600765|NCT01940484|26444760|P1|Overall Study|Withdrawal by Subject|3
7600766|NCT01940471|26444780|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
7600767|NCT01940471|26444781|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
7600768|NCT01940471|26444780|P2|Double-Blind Phase|Still in Double-Blind Phase|270
7600769|NCT01940471|26444781|P1|Double-Blind Phase|Still in Double-Blind Phase|539
7600770|NCT01940471|26444780|P2|Double-Blind Phase|Protocol Violation|1
7600771|NCT01940471|26444781|P1|Double-Blind Phase|Protocol Violation|0
7600772|NCT01940471|26444780|P2|Double-Blind Phase|Lack of Efficacy|0
7600773|NCT01940471|26444781|P1|Double-Blind Phase|Lack of Efficacy|1
7600774|NCT01940471|26444780|P2|Double-Blind Phase|Death|0
7600775|NCT01940471|26444781|P1|Double-Blind Phase|Death|1
7600776|NCT01940471|26444780|P2|Double-Blind Phase|Protocol-Specified Criteria|0
7600777|NCT01940471|26444781|P1|Double-Blind Phase|Protocol-Specified Criteria|1
7600778|NCT01940471|26444780|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
7600779|NCT01940471|26444781|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
7600780|NCT01940471|26444780|P2|Double-Blind Phase|Investigator's Discretion|0
7600781|NCT01940471|26444781|P1|Double-Blind Phase|Investigator's Discretion|5
7600782|NCT01940471|26444780|P2|Double-Blind Phase|Pregnancy|1
7600783|NCT01940471|26444781|P1|Double-Blind Phase|Pregnancy|2
7600784|NCT01940471|26444780|P2|Double-Blind Phase|Lost to Follow-up|2
7600785|NCT01940471|26444781|P1|Double-Blind Phase|Lost to Follow-up|3
7600786|NCT01940471|26444780|P2|Double-Blind Phase|Adverse Event|2
7600787|NCT01940471|26444781|P1|Double-Blind Phase|Adverse Event|1
7600788|NCT01940471|26444780|P2|Double-Blind Phase|Withdrew Consent|7
7600789|NCT01940471|26444781|P1|Double-Blind Phase|Withdrew Consent|13
7600790|NCT01940471|26444780|P2|Double-Blind Phase|Randomized but Never Treated|1
7600791|NCT01940471|26444781|P1|Double-Blind Phase|Randomized but Never Treated|1
7600792|NCT01940354|26444799|P2|Overall Study|Withdrawal by Subject|2
7600793|NCT01940354|26444800|P1|Overall Study|Withdrawal by Subject|4
7600794|NCT01940341|26444812|P2|Open-label Extension Phase|Still on Study|1
7600795|NCT01940341|26444813|P1|Open-label Extension Phase|Still on Study|4
7600796|NCT01940341|26444812|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
7600797|NCT01940341|26444813|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
7600798|NCT01940341|26444812|P2|Double-Blind Phase|Protocol Specified Criteria|0
7600799|NCT01940341|26444813|P1|Double-Blind Phase|Protocol Specified Criteria|1
7600800|NCT01940341|26444812|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
7600801|NCT01940341|26444813|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
7600802|NCT01940341|26444812|P2|Double-Blind Phase|Investigator's Discretion|0
7600803|NCT01940341|26444813|P1|Double-Blind Phase|Investigator's Discretion|1
7600804|NCT01940341|26444812|P2|Double-Blind Phase|Pregnancy|1
7600805|NCT01940341|26444813|P1|Double-Blind Phase|Pregnancy|0
7600806|NCT01940341|26444812|P2|Double-Blind Phase|Lost to Follow-up|1
7600807|NCT01940341|26444813|P1|Double-Blind Phase|Lost to Follow-up|4
7600808|NCT01940341|26444812|P2|Double-Blind Phase|Withdrew Consent|2
7600809|NCT01940341|26444813|P1|Double-Blind Phase|Withdrew Consent|3
7600810|NCT01940341|26444812|P2|Double-Blind Phase|Adverse Event|2
7600811|NCT01940341|26444813|P1|Double-Blind Phase|Adverse Event|3
7600812|NCT01940341|26444812|P2|Double-Blind Phase|Randomized but Never Treated|1
7600813|NCT01940341|26444813|P1|Double-Blind Phase|Randomized but Never Treated|0
7600814|NCT01940120|26444863|P1|Overall Study|Withdrawal by Subject|8
7600815|NCT01940120|26444863|P1|Overall Study|Death|40
7600816|NCT01939977|26445019|P2|Overall Study|Did not receive study medication|1
7600817|NCT01939977|26445020|P1|Overall Study|Did not receive study medication|0
7600818|NCT01939977|26445019|P2|Overall Study|Did not meet inclusion criteria|0
7600819|NCT01939977|26445020|P1|Overall Study|Did not meet inclusion criteria|1
7600820|NCT01939977|26445019|P2|Overall Study|Withdrawal by Subject|2
7600821|NCT01939977|26445020|P1|Overall Study|Withdrawal by Subject|0
7600822|NCT01939977|26445019|P2|Overall Study|Physician Decision|1
7600823|NCT01939977|26445020|P1|Overall Study|Physician Decision|1
7600824|NCT01939977|26445019|P2|Overall Study|Lack of Efficacy|0
7600825|NCT01939977|26445020|P1|Overall Study|Lack of Efficacy|3
7600826|NCT01939977|26445019|P2|Overall Study|Adverse Event|3
7600827|NCT01939977|26445020|P1|Overall Study|Adverse Event|4
7600828|NCT01939899|26445067|P5|Phase 2|Disease Progression|1
7600829|NCT01939899|26445068|P4|Phase 2|Disease Progression|9
7600830|NCT01939899|26445069|P3|Phase 2|Disease Progression|0
7600831|NCT01939899|26445070|P2|Phase 2|Disease Progression|0
7600832|NCT01939899|26445071|P1|Phase 2|Disease Progression|0
7600833|NCT01939899|26445067|P5|Phase 2|Withdrawal by Subject|0
7600834|NCT01939899|26445068|P4|Phase 2|Withdrawal by Subject|2
7600835|NCT01939899|26445069|P3|Phase 2|Withdrawal by Subject|0
7600836|NCT01939899|26445070|P2|Phase 2|Withdrawal by Subject|0
7600837|NCT01939899|26445071|P1|Phase 2|Withdrawal by Subject|0
7600838|NCT01939899|26445067|P5|Lead-in Dose Finding Phase|Other|0
7600839|NCT01939899|26445068|P4|Lead-in Dose Finding Phase|Other|0
7600840|NCT01939899|26445069|P3|Lead-in Dose Finding Phase|Other|1
7600841|NCT01939899|26445070|P2|Lead-in Dose Finding Phase|Other|0
7600842|NCT01939899|26445071|P1|Lead-in Dose Finding Phase|Other|0
7600843|NCT01939899|26445067|P5|Lead-in Dose Finding Phase|Disease Progression|0
7600844|NCT01939899|26445068|P4|Lead-in Dose Finding Phase|Disease Progression|0
7600845|NCT01939899|26445069|P3|Lead-in Dose Finding Phase|Disease Progression|3
7600846|NCT01939899|26445070|P2|Lead-in Dose Finding Phase|Disease Progression|4
7600847|NCT01939899|26445071|P1|Lead-in Dose Finding Phase|Disease Progression|2
7600848|NCT01939899|26445067|P5|Lead-in Dose Finding Phase|Death|0
7600849|NCT01939899|26445068|P4|Lead-in Dose Finding Phase|Death|0
7600850|NCT01939899|26445069|P3|Lead-in Dose Finding Phase|Death|1
7600851|NCT01939899|26445070|P2|Lead-in Dose Finding Phase|Death|3
7600852|NCT01939899|26445071|P1|Lead-in Dose Finding Phase|Death|0
7600853|NCT01939548|26445118|P3|Overall Study|Did not complete follow-up|0
7600854|NCT01939548|26445119|P2|Overall Study|Did not complete follow-up|1
7600855|NCT01939548|26445120|P1|Overall Study|Did not complete follow-up|0
7600856|NCT01939548|26445118|P3|Overall Study|Participant withdrew consent|0
7600857|NCT01939548|26445119|P2|Overall Study|Participant withdrew consent|2
7600858|NCT01939548|26445120|P1|Overall Study|Participant withdrew consent|0
7600859|NCT01939548|26445118|P3|Overall Study|Participant unwilling to continue|0
7600860|NCT01939548|26445119|P2|Overall Study|Participant unwilling to continue|1
7600861|NCT01939548|26445120|P1|Overall Study|Participant unwilling to continue|0
7600862|NCT01939548|26445118|P3|Overall Study|Participant dropped|1
7600863|NCT01939548|26445119|P2|Overall Study|Participant dropped|0
7600864|NCT01939548|26445120|P1|Overall Study|Participant dropped|0
7600865|NCT01939548|26445118|P3|Overall Study|Death|1
7600866|NCT01939548|26445119|P2|Overall Study|Death|0
7600867|NCT01939548|26445120|P1|Overall Study|Death|0
7600868|NCT01939548|26445118|P3|Overall Study|Adverse Event|7
7600869|NCT01939548|26445119|P2|Overall Study|Adverse Event|9
7600870|NCT01939548|26445120|P1|Overall Study|Adverse Event|2
7600871|NCT01939548|26445118|P3|Overall Study|Lost to Follow-up|3
7600872|NCT01939548|26445119|P2|Overall Study|Lost to Follow-up|5
7600873|NCT01939548|26445120|P1|Overall Study|Lost to Follow-up|5
7600874|NCT01939548|26445118|P3|Overall Study|Protocol Violation|5
7600875|NCT01939548|26445119|P2|Overall Study|Protocol Violation|6
7600876|NCT01939548|26445120|P1|Overall Study|Protocol Violation|7
7600877|NCT01939548|26445118|P3|Overall Study|Withdrawal by Subject|1
7600878|NCT01939548|26445119|P2|Overall Study|Withdrawal by Subject|4
7600879|NCT01939548|26445120|P1|Overall Study|Withdrawal by Subject|4
7600880|NCT01939548|26445118|P3|Overall Study|Did Not Meet Entrance Criteria|0
7600881|NCT01939548|26445119|P2|Overall Study|Did Not Meet Entrance Criteria|0
7600882|NCT01939548|26445120|P1|Overall Study|Did Not Meet Entrance Criteria|1
7600883|NCT01939548|26445118|P3|Overall Study|Insufficient Clinical Response|0
7600884|NCT01939548|26445119|P2|Overall Study|Insufficient Clinical Response|0
7600885|NCT01939548|26445120|P1|Overall Study|Insufficient Clinical Response|1
7600886|NCT01939548|26445118|P3|Overall Study|Study Terminated by Sponsor|12
7600887|NCT01939548|26445119|P2|Overall Study|Study Terminated by Sponsor|19
7600888|NCT01939548|26445120|P1|Overall Study|Study Terminated by Sponsor|17
7600889|NCT01939548|26445118|P3|Overall Study|Non compliance|0
7600890|NCT01939548|26445119|P2|Overall Study|Non compliance|2
7600891|NCT01939548|26445120|P1|Overall Study|Non compliance|0
7600892|NCT01939496|26445194|P3|Overall Study|Other|1
7600893|NCT01939496|26445195|P2|Overall Study|Other|0
7600894|NCT01939496|26445196|P1|Overall Study|Other|2
7600895|NCT01939496|26445194|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
7600896|NCT01939496|26445195|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
7600897|NCT01939496|26445196|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
7600898|NCT01939496|26445194|P3|Overall Study|Withdrawal by Subject|1
7600899|NCT01939496|26445195|P2|Overall Study|Withdrawal by Subject|1
7600900|NCT01939496|26445196|P1|Overall Study|Withdrawal by Subject|0
7600901|NCT01939496|26445194|P3|Overall Study|Protocol Violation|0
7600902|NCT01939496|26445195|P2|Overall Study|Protocol Violation|0
7600903|NCT01939496|26445196|P1|Overall Study|Protocol Violation|3
7600904|NCT01939496|26445194|P3|Overall Study|Physician Decision|0
7600905|NCT01939496|26445195|P2|Overall Study|Physician Decision|0
7600906|NCT01939496|26445196|P1|Overall Study|Physician Decision|1
7600907|NCT01939496|26445194|P3|Overall Study|Lost to Follow-up|0
7600908|NCT01939496|26445195|P2|Overall Study|Lost to Follow-up|1
7600909|NCT01939496|26445196|P1|Overall Study|Lost to Follow-up|1
7600910|NCT01939496|26445194|P3|Overall Study|Adverse Event|0
7600911|NCT01939496|26445195|P2|Overall Study|Adverse Event|0
7600912|NCT01939496|26445196|P1|Overall Study|Adverse Event|2
7600913|NCT01939366|26445266|P5|Overall Study|GCP non-compliance at site|3
7600914|NCT01939366|26445267|P4|Overall Study|GCP non-compliance at site|3
7600915|NCT01939366|26445268|P3|Overall Study|GCP non-compliance at site|2
7600916|NCT01939366|26445269|P2|Overall Study|GCP non-compliance at site|3
7600917|NCT01939366|26445270|P1|Overall Study|GCP non-compliance at site|2
7600918|NCT01939366|26445266|P5|Overall Study|Sponsor decision|2
7600919|NCT01939366|26445267|P4|Overall Study|Sponsor decision|0
7600920|NCT01939366|26445268|P3|Overall Study|Sponsor decision|0
7600921|NCT01939366|26445269|P2|Overall Study|Sponsor decision|0
7600922|NCT01939366|26445270|P1|Overall Study|Sponsor decision|0
7600923|NCT01939366|26445266|P5|Overall Study|Protocol Violation|0
7600924|NCT01939366|26445267|P4|Overall Study|Protocol Violation|1
7600925|NCT01939366|26445268|P3|Overall Study|Protocol Violation|0
7600926|NCT01939366|26445269|P2|Overall Study|Protocol Violation|0
7600927|NCT01939366|26445270|P1|Overall Study|Protocol Violation|0
7600928|NCT01939366|26445266|P5|Overall Study|Other|1
7600929|NCT01939366|26445267|P4|Overall Study|Other|2
7600930|NCT01939366|26445268|P3|Overall Study|Other|2
7600931|NCT01939366|26445269|P2|Overall Study|Other|0
7600932|NCT01939366|26445270|P1|Overall Study|Other|0
7600933|NCT01939366|26445266|P5|Overall Study|Inclusion criteria not met|1
7600934|NCT01939366|26445267|P4|Overall Study|Inclusion criteria not met|0
7600935|NCT01939366|26445268|P3|Overall Study|Inclusion criteria not met|1
7600936|NCT01939366|26445269|P2|Overall Study|Inclusion criteria not met|1
7600937|NCT01939366|26445270|P1|Overall Study|Inclusion criteria not met|0
7600938|NCT01939366|26445266|P5|Overall Study|Withdrawal by Subject|3
7600939|NCT01939366|26445267|P4|Overall Study|Withdrawal by Subject|2
7600940|NCT01939366|26445268|P3|Overall Study|Withdrawal by Subject|2
7600941|NCT01939366|26445269|P2|Overall Study|Withdrawal by Subject|0
7600942|NCT01939366|26445270|P1|Overall Study|Withdrawal by Subject|1
7600943|NCT01939366|26445266|P5|Overall Study|Lost to Follow-up|0
7600944|NCT01939366|26445267|P4|Overall Study|Lost to Follow-up|0
7600945|NCT01939366|26445268|P3|Overall Study|Lost to Follow-up|0
7600946|NCT01939366|26445269|P2|Overall Study|Lost to Follow-up|1
7600947|NCT01939366|26445270|P1|Overall Study|Lost to Follow-up|1
7600948|NCT01939366|26445266|P5|Overall Study|Lack of Efficacy|3
7600949|NCT01939366|26445267|P4|Overall Study|Lack of Efficacy|1
7600950|NCT01939366|26445268|P3|Overall Study|Lack of Efficacy|1
7600951|NCT01939366|26445269|P2|Overall Study|Lack of Efficacy|1
7600952|NCT01939366|26445270|P1|Overall Study|Lack of Efficacy|2
7600953|NCT01939366|26445266|P5|Overall Study|Adverse Event|5
7600954|NCT01939366|26445267|P4|Overall Study|Adverse Event|8
7600955|NCT01939366|26445268|P3|Overall Study|Adverse Event|30
7600956|NCT01939366|26445269|P2|Overall Study|Adverse Event|17
7600957|NCT01939366|26445270|P1|Overall Study|Adverse Event|8
7600958|NCT01939314|26445284|P2|Overall Study|Lost to Follow-up|6
7600959|NCT01939314|26445285|P1|Overall Study|Lost to Follow-up|5
7600960|NCT01939314|26445284|P2|Overall Study|Pregnancy|1
7600961|NCT01939314|26445285|P1|Overall Study|Pregnancy|0
7600962|NCT01939314|26445284|P2|Overall Study|Protocol Violation|0
7600963|NCT01939314|26445285|P1|Overall Study|Protocol Violation|1
7600964|NCT01939314|26445284|P2|Overall Study|Withdrawal by Subject|1
7600965|NCT01939314|26445285|P1|Overall Study|Withdrawal by Subject|3
7600966|NCT01939223|26445319|P2|Overall Study|Withdrawal by Subject|0
7600967|NCT01939223|26445320|P1|Overall Study|Withdrawal by Subject|6
7600968|NCT01939223|26445319|P2|Overall Study|Study stopped by Sponsor|7
7600969|NCT01939223|26445320|P1|Overall Study|Study stopped by Sponsor|5
7600970|NCT01939223|26445319|P2|Overall Study|Disease recurrence (radiological)|3
7600971|NCT01939223|26445320|P1|Overall Study|Disease recurrence (radiological)|1
7600972|NCT01939223|26445319|P2|Overall Study|AE not assoc. with disease recurrence|1
7600973|NCT01939223|26445320|P1|Overall Study|AE not assoc. with disease recurrence|1
7600974|NCT01939197|26445335|P7|Overall Study|Lost to Follow-up|2
7600975|NCT01939197|26445336|P6|Overall Study|Lost to Follow-up|1
7600976|NCT01939197|26445337|P5|Overall Study|Lost to Follow-up|3
7600977|NCT01939197|26445338|P4|Overall Study|Lost to Follow-up|1
7600978|NCT01939197|26445339|P3|Overall Study|Lost to Follow-up|0
7600979|NCT01939197|26445340|P2|Overall Study|Lost to Follow-up|1
7600980|NCT01939197|26445341|P1|Overall Study|Lost to Follow-up|0
7600981|NCT01939197|26445335|P7|Overall Study|Withdrawal by Subject|0
7600982|NCT01939197|26445336|P6|Overall Study|Withdrawal by Subject|0
7600983|NCT01939197|26445337|P5|Overall Study|Withdrawal by Subject|1
7600984|NCT01939197|26445338|P4|Overall Study|Withdrawal by Subject|0
7600985|NCT01939197|26445339|P3|Overall Study|Withdrawal by Subject|0
7600986|NCT01939197|26445340|P2|Overall Study|Withdrawal by Subject|0
7600987|NCT01939197|26445341|P1|Overall Study|Withdrawal by Subject|1
7600988|NCT01939158|26445403|P4|Overall Study|Other|3
7600989|NCT01939158|26445404|P3|Overall Study|Other|4
7600990|NCT01939158|26445405|P2|Overall Study|Other|3
7600991|NCT01939158|26445406|P1|Overall Study|Other|1
7600992|NCT01939158|26445403|P4|Overall Study|No longer meets eligibility criteria|0
7600993|NCT01939158|26445404|P3|Overall Study|No longer meets eligibility criteria|1
7600994|NCT01939158|26445405|P2|Overall Study|No longer meets eligibility criteria|0
7600995|NCT01939158|26445406|P1|Overall Study|No longer meets eligibility criteria|0
7600996|NCT01939158|26445403|P4|Overall Study|Death|1
7600997|NCT01939158|26445404|P3|Overall Study|Death|1
7600998|NCT01939158|26445405|P2|Overall Study|Death|0
7600999|NCT01939158|26445406|P1|Overall Study|Death|0
7601000|NCT01939158|26445403|P4|Overall Study|Lost to Follow-up|17
7601001|NCT01939158|26445404|P3|Overall Study|Lost to Follow-up|17
7601002|NCT01939158|26445405|P2|Overall Study|Lost to Follow-up|17
7601003|NCT01939158|26445406|P1|Overall Study|Lost to Follow-up|18
7601004|NCT01939158|26445403|P4|Overall Study|Migrated/moved from study area|6
7601005|NCT01939158|26445404|P3|Overall Study|Migrated/moved from study area|3
7601006|NCT01939158|26445405|P2|Overall Study|Migrated/moved from study area|7
7601007|NCT01939158|26445406|P1|Overall Study|Migrated/moved from study area|5
7601008|NCT01939158|26445403|P4|Overall Study|Withdrawal by Subject|17
7601009|NCT01939158|26445404|P3|Overall Study|Withdrawal by Subject|15
7601010|NCT01939158|26445405|P2|Overall Study|Withdrawal by Subject|25
7601011|NCT01939158|26445406|P1|Overall Study|Withdrawal by Subject|22
7601012|NCT01939158|26445403|P4|Overall Study|Adverse Event|0
7601013|NCT01939158|26445404|P3|Overall Study|Adverse Event|0
7601014|NCT01939158|26445405|P2|Overall Study|Adverse Event|0
7601015|NCT01939158|26445406|P1|Overall Study|Adverse Event|1
7601016|NCT01939028|26445493|P1|Overall Study|Physician Decision|7
7601017|NCT01939028|26445493|P1|Overall Study|Withdrawal by Subject|5
7601018|NCT01939002|26445506|P2|Overall Study|Other|2
7601019|NCT01939002|26445507|P1|Overall Study|Other|1
7601020|NCT01939002|26445506|P2|Overall Study|Withdrawal by Subject|3
7601021|NCT01939002|26445507|P1|Overall Study|Withdrawal by Subject|5
7601022|NCT01939002|26445506|P2|Overall Study|Adverse Event|13
7601023|NCT01939002|26445507|P1|Overall Study|Adverse Event|13
7601024|NCT01938846|26445583|P3|Overall Study|Other than listed|4
7601025|NCT01938846|26445584|P2|Overall Study|Other than listed|1
7601026|NCT01938846|26445585|P1|Overall Study|Other than listed|5
7601027|NCT01938846|26445583|P3|Overall Study|Withdrawal by Subject|1
7601028|NCT01938846|26445584|P2|Overall Study|Withdrawal by Subject|2
7601029|NCT01938846|26445585|P1|Overall Study|Withdrawal by Subject|2
7601030|NCT01938846|26445583|P3|Overall Study|Adverse Event|3
7601031|NCT01938846|26445584|P2|Overall Study|Adverse Event|4
7601032|NCT01938846|26445585|P1|Overall Study|Adverse Event|8
7601033|NCT01938846|26445583|P3|Overall Study|Progressive disease|16
7601034|NCT01938846|26445584|P2|Overall Study|Progressive disease|18
7601035|NCT01938846|26445585|P1|Overall Study|Progressive disease|26
7601036|NCT01938716|26445785|P1|Overall Study|Withdrawal by Subject|2
7601037|NCT01938716|26445785|P1|Overall Study|Physician Decision|2
7601038|NCT01938625|26445808|P2|Overall Study|Adverse Event|1
7601039|NCT01938625|26445809|P1|Overall Study|Adverse Event|0
7601040|NCT01938625|26445808|P2|Overall Study|Withdrawal by Subject|1
7601041|NCT01938625|26445809|P1|Overall Study|Withdrawal by Subject|0
7601042|NCT01938573|26445829|P2|Overall Study|Operation at other hospital|0
7601043|NCT01938573|26445830|P1|Overall Study|Operation at other hospital|1
7601044|NCT01938573|26445829|P2|Overall Study|Lack of Efficacy|0
7601045|NCT01938573|26445830|P1|Overall Study|Lack of Efficacy|1
7601046|NCT01938430|26445850|P14|Overall Study|Withdrew Consent|0
7601047|NCT01938430|26445851|P13|Overall Study|Withdrew Consent|0
7601048|NCT01938430|26445852|P12|Overall Study|Withdrew Consent|0
7601049|NCT01938430|26445853|P11|Overall Study|Withdrew Consent|0
7601050|NCT01938430|26445854|P10|Overall Study|Withdrew Consent|0
7601051|NCT01938430|26445855|P9|Overall Study|Withdrew Consent|1
7601052|NCT01938430|26445856|P8|Overall Study|Withdrew Consent|0
7601053|NCT01938430|26445857|P7|Overall Study|Withdrew Consent|0
7601054|NCT01938430|26445858|P6|Overall Study|Withdrew Consent|0
7601055|NCT01938430|26445859|P5|Overall Study|Withdrew Consent|0
7601056|NCT01938430|26445860|P4|Overall Study|Withdrew Consent|0
7601057|NCT01938430|26445861|P3|Overall Study|Withdrew Consent|0
7601058|NCT01938430|26445862|P2|Overall Study|Withdrew Consent|0
7601059|NCT01938430|26445863|P1|Overall Study|Withdrew Consent|0
7601060|NCT01938430|26445850|P14|Overall Study|Lost to Follow-up|0
7601061|NCT01938430|26445851|P13|Overall Study|Lost to Follow-up|0
7601062|NCT01938430|26445852|P12|Overall Study|Lost to Follow-up|0
7601063|NCT01938430|26445853|P11|Overall Study|Lost to Follow-up|0
7601064|NCT01938430|26445854|P10|Overall Study|Lost to Follow-up|0
7601065|NCT01938430|26445855|P9|Overall Study|Lost to Follow-up|0
7601066|NCT01938430|26445856|P8|Overall Study|Lost to Follow-up|0
7601067|NCT01938430|26445857|P7|Overall Study|Lost to Follow-up|0
7601068|NCT01938430|26445858|P6|Overall Study|Lost to Follow-up|1
7601069|NCT01938430|26445859|P5|Overall Study|Lost to Follow-up|0
7601070|NCT01938430|26445860|P4|Overall Study|Lost to Follow-up|0
7601071|NCT01938430|26445861|P3|Overall Study|Lost to Follow-up|1
7601072|NCT01938430|26445862|P2|Overall Study|Lost to Follow-up|0
7601073|NCT01938430|26445863|P1|Overall Study|Lost to Follow-up|0
7601074|NCT01938430|26445850|P14|Overall Study|Lack of Efficacy|0
7601075|NCT01938430|26445851|P13|Overall Study|Lack of Efficacy|0
7601076|NCT01938430|26445852|P12|Overall Study|Lack of Efficacy|1
7601077|NCT01938430|26445853|P11|Overall Study|Lack of Efficacy|2
7601078|NCT01938430|26445854|P10|Overall Study|Lack of Efficacy|0
7601079|NCT01938430|26445855|P9|Overall Study|Lack of Efficacy|1
7601080|NCT01938430|26445856|P8|Overall Study|Lack of Efficacy|0
7601081|NCT01938430|26445857|P7|Overall Study|Lack of Efficacy|0
7601082|NCT01938430|26445858|P6|Overall Study|Lack of Efficacy|0
7601083|NCT01938430|26445859|P5|Overall Study|Lack of Efficacy|0
7601084|NCT01938430|26445860|P4|Overall Study|Lack of Efficacy|1
7601085|NCT01938430|26445861|P3|Overall Study|Lack of Efficacy|1
7601086|NCT01938430|26445862|P2|Overall Study|Lack of Efficacy|1
7601087|NCT01938430|26445863|P1|Overall Study|Lack of Efficacy|3
7601088|NCT01938430|26445850|P14|Overall Study|Investigator's Discretion|0
7601089|NCT01938430|26445851|P13|Overall Study|Investigator's Discretion|0
7601090|NCT01938430|26445852|P12|Overall Study|Investigator's Discretion|0
7601091|NCT01938430|26445853|P11|Overall Study|Investigator's Discretion|0
7601092|NCT01938430|26445854|P10|Overall Study|Investigator's Discretion|0
7601093|NCT01938430|26445855|P9|Overall Study|Investigator's Discretion|0
7601094|NCT01938430|26445856|P8|Overall Study|Investigator's Discretion|0
7601095|NCT01938430|26445857|P7|Overall Study|Investigator's Discretion|0
7601096|NCT01938430|26445858|P6|Overall Study|Investigator's Discretion|0
7601097|NCT01938430|26445859|P5|Overall Study|Investigator's Discretion|0
7601098|NCT01938430|26445860|P4|Overall Study|Investigator's Discretion|0
7601099|NCT01938430|26445861|P3|Overall Study|Investigator's Discretion|1
7601100|NCT01938430|26445862|P2|Overall Study|Investigator's Discretion|0
7601101|NCT01938430|26445863|P1|Overall Study|Investigator's Discretion|0
7601102|NCT01938430|26445850|P14|Overall Study|Death|0
7601103|NCT01938430|26445851|P13|Overall Study|Death|0
7601104|NCT01938430|26445852|P12|Overall Study|Death|0
7601105|NCT01938430|26445853|P11|Overall Study|Death|0
7601106|NCT01938430|26445854|P10|Overall Study|Death|3
7601107|NCT01938430|26445855|P9|Overall Study|Death|2
7601108|NCT01938430|26445856|P8|Overall Study|Death|1
7601109|NCT01938430|26445857|P7|Overall Study|Death|1
7601110|NCT01938430|26445858|P6|Overall Study|Death|0
7601111|NCT01938430|26445859|P5|Overall Study|Death|0
7601112|NCT01938430|26445860|P4|Overall Study|Death|1
7601113|NCT01938430|26445861|P3|Overall Study|Death|2
7601114|NCT01938430|26445862|P2|Overall Study|Death|2
7601115|NCT01938430|26445863|P1|Overall Study|Death|1
7601116|NCT01938430|26445850|P14|Overall Study|Adverse Event|0
7601117|NCT01938430|26445851|P13|Overall Study|Adverse Event|0
7601118|NCT01938430|26445852|P12|Overall Study|Adverse Event|0
7601119|NCT01938430|26445853|P11|Overall Study|Adverse Event|0
7601120|NCT01938430|26445854|P10|Overall Study|Adverse Event|0
7601121|NCT01938430|26445855|P9|Overall Study|Adverse Event|0
7601122|NCT01938430|26445856|P8|Overall Study|Adverse Event|0
7601123|NCT01938430|26445857|P7|Overall Study|Adverse Event|1
7601124|NCT01938430|26445858|P6|Overall Study|Adverse Event|0
7601125|NCT01938430|26445859|P5|Overall Study|Adverse Event|0
7601126|NCT01938430|26445860|P4|Overall Study|Adverse Event|0
7601127|NCT01938430|26445861|P3|Overall Study|Adverse Event|0
7601128|NCT01938430|26445862|P2|Overall Study|Adverse Event|0
7601129|NCT01938430|26445863|P1|Overall Study|Adverse Event|0
7601130|NCT01938430|26445850|P14|Overall Study|Randomized but Not Treated|1
7601131|NCT01938430|26445851|P13|Overall Study|Randomized but Not Treated|0
7601132|NCT01938430|26445852|P12|Overall Study|Randomized but Not Treated|0
7601133|NCT01938430|26445853|P11|Overall Study|Randomized but Not Treated|1
7601134|NCT01938430|26445854|P10|Overall Study|Randomized but Not Treated|0
7601135|NCT01938430|26445855|P9|Overall Study|Randomized but Not Treated|0
7601136|NCT01938430|26445856|P8|Overall Study|Randomized but Not Treated|0
7601137|NCT01938430|26445857|P7|Overall Study|Randomized but Not Treated|0
7601138|NCT01938430|26445858|P6|Overall Study|Randomized but Not Treated|0
7601139|NCT01938430|26445859|P5|Overall Study|Randomized but Not Treated|0
7601140|NCT01938430|26445860|P4|Overall Study|Randomized but Not Treated|0
7601141|NCT01938430|26445861|P3|Overall Study|Randomized but Not Treated|0
7601142|NCT01938430|26445862|P2|Overall Study|Randomized but Not Treated|0
7601143|NCT01938430|26445863|P1|Overall Study|Randomized but Not Treated|0
7601144|NCT01938391|26446188|P1|12 Month Follow up|Withdrawal by Subject|1
7601145|NCT01938391|26446188|P1|12 Month Follow up|Physician Decision|1
7601146|NCT01938391|26446188|P1|6 Month Follow up|Withdrawal by Subject|1
7601147|NCT01938001|26446322|P2|Overall Study|Death|26
7601148|NCT01938001|26446323|P1|Overall Study|Death|16
7601149|NCT01938001|26446322|P2|Overall Study|Lost to Follow-up|3
7601150|NCT01938001|26446323|P1|Overall Study|Lost to Follow-up|1
7601151|NCT01938001|26446322|P2|Overall Study|Participant Moved|1
7601152|NCT01938001|26446323|P1|Overall Study|Participant Moved|0
7601153|NCT01938001|26446322|P2|Overall Study|Non-compliant|0
7601154|NCT01938001|26446323|P1|Overall Study|Non-compliant|1
7601155|NCT01938001|26446322|P2|Overall Study|Withdrawal by Subject|17
7601156|NCT01938001|26446323|P1|Overall Study|Withdrawal by Subject|25
7601157|NCT01937884|26446401|P2|Overall Study|Withdrawal by Subject|0
7601158|NCT01937884|26446402|P1|Overall Study|Withdrawal by Subject|1
7601159|NCT01937871|26446425|P3|Overall Study|Entry Criteria Not Met|1
7601160|NCT01937871|26446426|P2|Overall Study|Entry Criteria Not Met|2
7601161|NCT01937871|26446427|P1|Overall Study|Entry Criteria Not Met|1
7601162|NCT01937871|26446425|P3|Overall Study|Physician Decision|0
7601163|NCT01937871|26446426|P2|Overall Study|Physician Decision|1
7601164|NCT01937871|26446427|P1|Overall Study|Physician Decision|0
7601165|NCT01937871|26446425|P3|Overall Study|Withdrawal by Subject|4
7601166|NCT01937871|26446426|P2|Overall Study|Withdrawal by Subject|6
7601167|NCT01937871|26446427|P1|Overall Study|Withdrawal by Subject|9
7601168|NCT01937871|26446425|P3|Overall Study|Lost to Follow-up|4
7601169|NCT01937871|26446426|P2|Overall Study|Lost to Follow-up|2
7601170|NCT01937871|26446427|P1|Overall Study|Lost to Follow-up|8
7601171|NCT01937871|26446425|P3|Overall Study|Adverse Event|2
7601172|NCT01937871|26446426|P2|Overall Study|Adverse Event|6
7601173|NCT01937871|26446427|P1|Overall Study|Adverse Event|6
7601174|NCT01937715|26446503|P5|Overall Study|Other|0
7601175|NCT01937715|26446504|P4|Overall Study|Other|3
7601176|NCT01937715|26446505|P3|Overall Study|Other|0
7601177|NCT01937715|26446506|P2|Overall Study|Other|0
7601178|NCT01937715|26446507|P1|Overall Study|Other|0
7601179|NCT01937715|26446503|P5|Overall Study|Withdrawal by Subject|2
7601180|NCT01937715|26446504|P4|Overall Study|Withdrawal by Subject|0
7601181|NCT01937715|26446505|P3|Overall Study|Withdrawal by Subject|0
7601182|NCT01937715|26446506|P2|Overall Study|Withdrawal by Subject|1
7601183|NCT01937715|26446507|P1|Overall Study|Withdrawal by Subject|0
7601184|NCT01937715|26446503|P5|Overall Study|Death|0
7601185|NCT01937715|26446504|P4|Overall Study|Death|1
7601186|NCT01937715|26446505|P3|Overall Study|Death|0
7601187|NCT01937715|26446506|P2|Overall Study|Death|0
7601188|NCT01937715|26446507|P1|Overall Study|Death|0
7601189|NCT01937559|26446659|P3|Overall Study|screen fail|0
7601190|NCT01937559|26446660|P2|Overall Study|screen fail|4
7601191|NCT01937559|26446661|P1|Overall Study|screen fail|2
7601192|NCT01937559|26446659|P3|Overall Study|Withdrawal by Subject|0
7601193|NCT01937559|26446660|P2|Overall Study|Withdrawal by Subject|4
7601194|NCT01937559|26446661|P1|Overall Study|Withdrawal by Subject|6
7601195|NCT01937559|26446659|P3|Overall Study|Physician Decision|0
7601196|NCT01937559|26446660|P2|Overall Study|Physician Decision|3
7601197|NCT01937559|26446661|P1|Overall Study|Physician Decision|3
7601198|NCT01937390|26446731|P1|Overall Study|Fail to return|21
7601199|NCT01937390|26446731|P1|Overall Study|Withdrawal by Subject|5
7601200|NCT01937390|26446731|P1|Overall Study|Lost to Follow-up|7
7601201|NCT01937390|26446731|P1|Overall Study|Death|2
7601202|NCT01937364|26446741|P2|Overall Study|Adverse Event|1
7601203|NCT01937364|26446742|P1|Overall Study|Adverse Event|2
7601204|NCT01937351|26446754|P2|Overall Study|Not treated w device, per protocol fail|0
7601205|NCT01937351|26446755|P1|Overall Study|Not treated w device, per protocol fail|4
7601206|NCT01937351|26446754|P2|Overall Study|Death|0
7601207|NCT01937351|26446755|P1|Overall Study|Death|1
7601208|NCT01937351|26446754|P2|Overall Study|Withdrawal by Subject|2
7601209|NCT01937351|26446755|P1|Overall Study|Withdrawal by Subject|4
7601210|NCT01937312|26446788|P2|Overall Study|Withdrawal of subject prior to treatment|1
7601211|NCT01937312|26446789|P1|Overall Study|Withdrawal of subject prior to treatment|1
7601212|NCT01937312|26446788|P2|Overall Study|Lack of Efficacy|1
7601213|NCT01937312|26446789|P1|Overall Study|Lack of Efficacy|0
7601214|NCT01937312|26446788|P2|Overall Study|Adverse Event|1
7601215|NCT01937312|26446789|P1|Overall Study|Adverse Event|10
7601216|NCT01937299|26446804|P2|Overall Study|Withdrawal by Subject|0
7601217|NCT01937299|26446805|P1|Overall Study|Withdrawal by Subject|1
7601218|NCT01937299|26446804|P2|Overall Study|Lack of Efficacy|4
7601219|NCT01937299|26446805|P1|Overall Study|Lack of Efficacy|0
7601220|NCT01937299|26446804|P2|Overall Study|Adverse Event|0
7601221|NCT01937299|26446805|P1|Overall Study|Adverse Event|13
7601222|NCT01937130|26446840|P4|Overall Study|Patient lost to FU due to death|0
7601223|NCT01937130|26446841|P3|Overall Study|Patient lost to FU due to death|0
7601224|NCT01937130|26446842|P2|Overall Study|Patient lost to FU due to death|0
7601225|NCT01937130|26446843|P1|Overall Study|Patient lost to FU due to death|2
7601226|NCT01937130|26446840|P4|Overall Study|Patients unable to swallow|0
7601227|NCT01937130|26446841|P3|Overall Study|Patients unable to swallow|0
7601228|NCT01937130|26446842|P2|Overall Study|Patients unable to swallow|1
7601229|NCT01937130|26446843|P1|Overall Study|Patients unable to swallow|0
7601230|NCT01937130|26446840|P4|Overall Study|Physician Decision|0
7601231|NCT01937130|26446841|P3|Overall Study|Physician Decision|0
7601232|NCT01937130|26446842|P2|Overall Study|Physician Decision|1
7601233|NCT01937130|26446843|P1|Overall Study|Physician Decision|0
7601234|NCT01937130|26446840|P4|Overall Study|Lost to Follow-up|0
7601235|NCT01937130|26446841|P3|Overall Study|Lost to Follow-up|2
7601236|NCT01937130|26446842|P2|Overall Study|Lost to Follow-up|0
7601237|NCT01937130|26446843|P1|Overall Study|Lost to Follow-up|2
7601238|NCT01937130|26446840|P4|Overall Study|Death|0
7601239|NCT01937130|26446841|P3|Overall Study|Death|1
7601240|NCT01937130|26446842|P2|Overall Study|Death|1
7601241|NCT01937130|26446843|P1|Overall Study|Death|1
7601242|NCT01937130|26446840|P4|Overall Study|Adverse Event|1
7601243|NCT01937130|26446841|P3|Overall Study|Adverse Event|0
7601244|NCT01937130|26446842|P2|Overall Study|Adverse Event|1
7601245|NCT01937130|26446843|P1|Overall Study|Adverse Event|0
7601246|NCT01937130|26446840|P4|Overall Study|Withdrawal by Subject|1
7601247|NCT01937130|26446841|P3|Overall Study|Withdrawal by Subject|0
7601248|NCT01937130|26446842|P2|Overall Study|Withdrawal by Subject|0
7601249|NCT01937130|26446843|P1|Overall Study|Withdrawal by Subject|0
7601250|NCT01937117|26446870|P1|Overall Study|Adverse Event|2
7601251|NCT01937117|26446870|P1|Overall Study|Physician Decision|4
7601252|NCT01937117|26446870|P1|Overall Study|Disease Progression|7
7601253|NCT01936974|26446885|P2|Overall Study|Physician Decision|5
7601254|NCT01936974|26446886|P1|Overall Study|Physician Decision|2
7601255|NCT01936948|26446896|P4|Overall Study|no 30-day follow-up data|3
7601256|NCT01936948|26446897|P3|Overall Study|no 30-day follow-up data|3
7601257|NCT01936948|26446898|P2|Overall Study|no 30-day follow-up data|3
7601258|NCT01936948|26446899|P1|Overall Study|no 30-day follow-up data|0
7601259|NCT01936870|26446933|P1|Overall Study|No Drug Administration|1
7601260|NCT01936870|26446933|P1|Overall Study|Protocol Violation|12
7601261|NCT01936870|26446933|P1|Overall Study|No Visit After Treatment|176
7601262|NCT01936857|26446949|P2|Overall Study|Other|2
7601263|NCT01936857|26446950|P1|Overall Study|Other|2
7601264|NCT01936857|26446949|P2|Overall Study|Side effect of medication|0
7601265|NCT01936857|26446950|P1|Overall Study|Side effect of medication|1
7601266|NCT01936857|26446949|P2|Overall Study|Withdrawal by Subject|0
7601267|NCT01936857|26446950|P1|Overall Study|Withdrawal by Subject|1
7601268|NCT01936857|26446949|P2|Overall Study|Moved|1
7601269|NCT01936857|26446950|P1|Overall Study|Moved|2
7601270|NCT01936857|26446949|P2|Overall Study|Death|3
7601271|NCT01936857|26446950|P1|Overall Study|Death|7
7601272|NCT01936857|26446949|P2|Overall Study|Lost to Follow-up|7
7601273|NCT01936857|26446950|P1|Overall Study|Lost to Follow-up|10
7601274|NCT01936857|26446949|P2|Overall Study|Sent to prison or 06 center|12
7601275|NCT01936857|26446950|P1|Overall Study|Sent to prison or 06 center|11
7601276|NCT01936649|26446988|P1|Overall Study|Other than specified above|5
7601277|NCT01936649|26446988|P1|Overall Study|Protocol Violation|2
7601278|NCT01936649|26446988|P1|Overall Study|Physician Decision|2
7601279|NCT01936649|26446988|P1|Overall Study|Withdrawal by Subject|4
7601280|NCT01936623|26446995|P2|Overall Study|Lost to Follow-up|5
7601281|NCT01936623|26446996|P1|Overall Study|Lost to Follow-up|0
7601282|NCT01936181|26447123|P4|Transition-extension|Withdrawal by Subject|1
7601283|NCT01936181|26447124|P3|Transition-extension|Withdrawal by Subject|2
7601284|NCT01936181|26447125|P2|Transition-extension|Withdrawal by Subject|0
7601285|NCT01936181|26447126|P1|Transition-extension|Withdrawal by Subject|7
7601286|NCT01936181|26447123|P4|Transition-extension|Physician Decision|1
7601287|NCT01936181|26447124|P3|Transition-extension|Physician Decision|0
7601288|NCT01936181|26447125|P2|Transition-extension|Physician Decision|0
7601289|NCT01936181|26447126|P1|Transition-extension|Physician Decision|2
7601290|NCT01936181|26447123|P4|Transition-extension|Lost to Follow-up|2
7601291|NCT01936181|26447124|P3|Transition-extension|Lost to Follow-up|1
7601292|NCT01936181|26447125|P2|Transition-extension|Lost to Follow-up|0
7601293|NCT01936181|26447126|P1|Transition-extension|Lost to Follow-up|3
7601294|NCT01936181|26447123|P4|Transition-extension|Adverse Event|1
7601295|NCT01936181|26447124|P3|Transition-extension|Adverse Event|3
7601296|NCT01936181|26447125|P2|Transition-extension|Adverse Event|0
7601297|NCT01936181|26447126|P1|Transition-extension|Adverse Event|3
7601298|NCT01936181|26447123|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7601299|NCT01936181|26447124|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7601300|NCT01936181|26447125|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7601301|NCT01936181|26447126|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7601302|NCT01936181|26447123|P4|Randomised, Double-blind|Withdrawal by Subject|0
7601303|NCT01936181|26447124|P3|Randomised, Double-blind|Withdrawal by Subject|0
7601304|NCT01936181|26447125|P2|Randomised, Double-blind|Withdrawal by Subject|26
7601305|NCT01936181|26447126|P1|Randomised, Double-blind|Withdrawal by Subject|23
7601306|NCT01936181|26447123|P4|Randomised, Double-blind|Physician Decision|0
7601307|NCT01936181|26447124|P3|Randomised, Double-blind|Physician Decision|0
7601308|NCT01936181|26447125|P2|Randomised, Double-blind|Physician Decision|4
7601309|NCT01936181|26447126|P1|Randomised, Double-blind|Physician Decision|4
7601310|NCT01936181|26447123|P4|Randomised, Double-blind|Pregnancy|0
7601311|NCT01936181|26447124|P3|Randomised, Double-blind|Pregnancy|0
7601312|NCT01936181|26447125|P2|Randomised, Double-blind|Pregnancy|1
7601313|NCT01936181|26447126|P1|Randomised, Double-blind|Pregnancy|0
7601314|NCT01936181|26447123|P4|Randomised, Double-blind|Lost to Follow-up|0
7601315|NCT01936181|26447124|P3|Randomised, Double-blind|Lost to Follow-up|0
7601316|NCT01936181|26447125|P2|Randomised, Double-blind|Lost to Follow-up|1
7601317|NCT01936181|26447126|P1|Randomised, Double-blind|Lost to Follow-up|0
7601318|NCT01936181|26447123|P4|Randomised, Double-blind|Lack of Efficacy|0
7601319|NCT01936181|26447124|P3|Randomised, Double-blind|Lack of Efficacy|0
7601320|NCT01936181|26447125|P2|Randomised, Double-blind|Lack of Efficacy|6
7601321|NCT01936181|26447126|P1|Randomised, Double-blind|Lack of Efficacy|5
7601322|NCT01936181|26447123|P4|Randomised, Double-blind|Protocol Violation|0
7601323|NCT01936181|26447124|P3|Randomised, Double-blind|Protocol Violation|0
7601324|NCT01936181|26447125|P2|Randomised, Double-blind|Protocol Violation|5
7601325|NCT01936181|26447126|P1|Randomised, Double-blind|Protocol Violation|1
7601326|NCT01936181|26447123|P4|Randomised, Double-blind|Adverse Event|0
7601327|NCT01936181|26447124|P3|Randomised, Double-blind|Adverse Event|0
7601328|NCT01936181|26447125|P2|Randomised, Double-blind|Adverse Event|21
7601329|NCT01936181|26447126|P1|Randomised, Double-blind|Adverse Event|27
7601330|NCT01935947|26447140|P3|Overall Study|Death|0
7601331|NCT01935947|26447141|P2|Overall Study|Death|0
7601332|NCT01935947|26447142|P1|Overall Study|Death|1
7601333|NCT01935947|26447140|P3|Overall Study|Diease Progression|2
7601334|NCT01935947|26447141|P2|Overall Study|Diease Progression|2
7601335|NCT01935947|26447142|P1|Overall Study|Diease Progression|2
7601336|NCT01935947|26447140|P3|Overall Study|Adverse Event|0
7601337|NCT01935947|26447141|P2|Overall Study|Adverse Event|2
7601338|NCT01935947|26447142|P1|Overall Study|Adverse Event|0
7601339|NCT01935700|26447199|P2|Overall Study|Physician Decision|0
7601340|NCT01935700|26447200|P1|Overall Study|Physician Decision|4
7601341|NCT01935700|26447199|P2|Overall Study|Withdrawal by Subject|0
7601342|NCT01935700|26447200|P1|Overall Study|Withdrawal by Subject|1
7601343|NCT01934972|26447244|P2|Overall Study|Withdrawal by Subject|6
7601344|NCT01934972|26447245|P1|Overall Study|Withdrawal by Subject|9
7601345|NCT01934894|26447275|P2|Overall Study|Progressive Disease|2
7601346|NCT01934894|26447276|P1|Overall Study|Progressive Disease|3
7601347|NCT01934894|26447275|P2|Overall Study|Withdrawal by Subject|1
7601348|NCT01934894|26447276|P1|Overall Study|Withdrawal by Subject|0
7601349|NCT01934894|26447275|P2|Overall Study|Death|0
7601350|NCT01934894|26447276|P1|Overall Study|Death|2
7601351|NCT01934894|26447275|P2|Overall Study|Adverse Event|2
7601352|NCT01934894|26447276|P1|Overall Study|Adverse Event|1
7601353|NCT01934790|26447291|P1|Active Follow up|Other reason|1
7601354|NCT01934790|26447291|P1|Active Follow up|Progressive disease|1
7601355|NCT01934790|26447291|P1|Active Follow up|Physician Decision|2
7601356|NCT01934790|26447291|P1|Active Follow up|Death|20
7601357|NCT01934790|26447291|P1|Treatment|Study drug never administered|1
7601358|NCT01934790|26447291|P1|Treatment|Withdrawal by Subject|2
7601359|NCT01934790|26447291|P1|Treatment|Radiological progression|4
7601360|NCT01934790|26447291|P1|Treatment|Clinical progression|6
7601361|NCT01934790|26447291|P1|Treatment|Adverse Event|3
7601362|NCT01934556|26447349|P3|Overall Study|Death|2
7601363|NCT01934556|26447350|P2|Overall Study|Death|5
7601364|NCT01934556|26447351|P1|Overall Study|Death|1
7601365|NCT01934556|26447349|P3|Overall Study|Lost to Follow-up|7
7601366|NCT01934556|26447350|P2|Overall Study|Lost to Follow-up|10
7601367|NCT01934556|26447351|P1|Overall Study|Lost to Follow-up|4
7601368|NCT01934556|26447349|P3|Overall Study|Withdrawal by Subject|1
7601369|NCT01934556|26447350|P2|Overall Study|Withdrawal by Subject|1
7601370|NCT01934556|26447351|P1|Overall Study|Withdrawal by Subject|0
7601371|NCT01934504|26447395|P4|Overall Study|Study Terminated by Sponsor|5
7601372|NCT01934504|26447396|P3|Overall Study|Study Terminated by Sponsor|5
7601373|NCT01934504|26447397|P2|Overall Study|Study Terminated by Sponsor|0
7601374|NCT01934504|26447398|P1|Overall Study|Study Terminated by Sponsor|1
7601375|NCT01934504|26447395|P4|Overall Study|Protocol Deviation|2
7601376|NCT01934504|26447396|P3|Overall Study|Protocol Deviation|0
7601377|NCT01934504|26447397|P2|Overall Study|Protocol Deviation|0
7601378|NCT01934504|26447398|P1|Overall Study|Protocol Deviation|0
7601379|NCT01934218|26447431|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
7601380|NCT01934218|26447432|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
7601381|NCT01934218|26447431|P2|Open-Label Phase|Noncompliance with Study Protocol|2
7601382|NCT01934218|26447432|P1|Open-Label Phase|Noncompliance with Study Protocol|4
7601383|NCT01934218|26447431|P2|Open-Label Phase|Withdrawal by Subject|11
7601384|NCT01934218|26447432|P1|Open-Label Phase|Withdrawal by Subject|13
7601385|NCT01934218|26447431|P2|Open-Label Phase|Protocol Violation|0
7601386|NCT01934218|26447432|P1|Open-Label Phase|Protocol Violation|1
7601387|NCT01934218|26447431|P2|Open-Label Phase|Physician Decision|0
7601388|NCT01934218|26447432|P1|Open-Label Phase|Physician Decision|1
7601389|NCT01934218|26447431|P2|Open-Label Phase|Lost to Follow-up|2
7601390|NCT01934218|26447432|P1|Open-Label Phase|Lost to Follow-up|4
7601391|NCT01934218|26447431|P2|Open-Label Phase|Lack of Efficacy|4
7601392|NCT01934218|26447432|P1|Open-Label Phase|Lack of Efficacy|1
7601393|NCT01934218|26447431|P2|Open-Label Phase|Adverse Event|4
7601394|NCT01934218|26447432|P1|Open-Label Phase|Adverse Event|2
7601395|NCT01934218|26447431|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
7601396|NCT01934218|26447432|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
7601397|NCT01934218|26447431|P2|Double-blind Phase|Noncompliance with Study Protocol|8
7601398|NCT01934218|26447432|P1|Double-blind Phase|Noncompliance with Study Protocol|5
7601399|NCT01934218|26447431|P2|Double-blind Phase|Withdrawal by Subject|13
7601400|NCT01934218|26447432|P1|Double-blind Phase|Withdrawal by Subject|16
7601401|NCT01934218|26447431|P2|Double-blind Phase|Protocol Violation|0
7601402|NCT01934218|26447432|P1|Double-blind Phase|Protocol Violation|4
7601403|NCT01934218|26447431|P2|Double-blind Phase|Physician Decision|2
7601404|NCT01934218|26447432|P1|Double-blind Phase|Physician Decision|1
7601405|NCT01934218|26447431|P2|Double-blind Phase|Lost to Follow-up|14
7601406|NCT01934218|26447432|P1|Double-blind Phase|Lost to Follow-up|7
7601407|NCT01934218|26447431|P2|Double-blind Phase|Lack of Efficacy|7
7601408|NCT01934218|26447432|P1|Double-blind Phase|Lack of Efficacy|6
7601409|NCT01934218|26447431|P2|Double-blind Phase|Adverse Event|8
7601410|NCT01934218|26447432|P1|Double-blind Phase|Adverse Event|8
7601411|NCT01934192|26447443|P4|Overall Study|Physician Decision|0
7601412|NCT01934192|26447444|P3|Overall Study|Physician Decision|0
7601413|NCT01934192|26447445|P2|Overall Study|Physician Decision|2
7601414|NCT01934192|26447446|P1|Overall Study|Physician Decision|3
7601415|NCT01934192|26447443|P4|Overall Study|Other: reached stopping criteria|0
7601416|NCT01934192|26447444|P3|Overall Study|Other: reached stopping criteria|1
7601417|NCT01934192|26447445|P2|Overall Study|Other: reached stopping criteria|5
7601418|NCT01934192|26447446|P1|Overall Study|Other: reached stopping criteria|6
7601419|NCT01934192|26447443|P4|Overall Study|Protocol Violation|1
7601420|NCT01934192|26447444|P3|Overall Study|Protocol Violation|0
7601421|NCT01934192|26447445|P2|Overall Study|Protocol Violation|0
7601422|NCT01934192|26447446|P1|Overall Study|Protocol Violation|0
7601423|NCT01934140|26447582|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
7601424|NCT01934140|26447583|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
7601425|NCT01934140|26447582|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
7601426|NCT01934140|26447583|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
7601427|NCT01934140|26447582|P2|Booster Phase (6 Months)|Lost to Follow-up|0
7601428|NCT01934140|26447583|P1|Booster Phase (6 Months)|Lost to Follow-up|1
7601429|NCT01934140|26447582|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
7601430|NCT01934140|26447583|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
7601431|NCT01934140|26447582|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
7601432|NCT01934140|26447583|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
7601433|NCT01934140|26447582|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
7601434|NCT01934140|26447583|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
7601435|NCT01934140|26447582|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
7601436|NCT01934140|26447583|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
7601437|NCT01934140|26447582|P2|Persistence Phase (Year 6-10)|Other|6
7601438|NCT01934140|26447583|P1|Persistence Phase (Year 6-10)|Other|24
7601439|NCT01934010|26447634|P3|Overall Study|Lost to Follow-up|0
7601440|NCT01934010|26447635|P2|Overall Study|Lost to Follow-up|4
7601441|NCT01934010|26447636|P1|Overall Study|Lost to Follow-up|7
7601442|NCT01934010|26447634|P3|Overall Study|Withdrawal by Subject|2
7601443|NCT01934010|26447635|P2|Overall Study|Withdrawal by Subject|6
7601444|NCT01934010|26447636|P1|Overall Study|Withdrawal by Subject|15
7601445|NCT01934010|26447634|P3|Overall Study|Adverse Event|0
7601446|NCT01934010|26447635|P2|Overall Study|Adverse Event|1
7601447|NCT01934010|26447636|P1|Overall Study|Adverse Event|1
7601448|NCT01933932|26447678|P2|Overall Study|Eligibility criteria not fulfilled|1
7601449|NCT01933932|26447679|P1|Overall Study|Eligibility criteria not fulfilled|0
7601450|NCT01933932|26447678|P2|Overall Study|Withdrawal by Subject|14
7601451|NCT01933932|26447679|P1|Overall Study|Withdrawal by Subject|11
7601452|NCT01933932|26447678|P2|Overall Study|Death|163
7601453|NCT01933932|26447679|P1|Overall Study|Death|173
7601454|NCT01933919|26447697|P2|Open-label Long-term Phase|Other|2
7601455|NCT01933919|26447698|P1|Open-label Long-term Phase|Other|1
7601456|NCT01933919|26447697|P2|Open-label Long-term Phase|Lost to Follow-up|0
7601457|NCT01933919|26447698|P1|Open-label Long-term Phase|Lost to Follow-up|1
7601458|NCT01933919|26447697|P2|Open-label Long-term Phase|Withdrawal by Subject|4
7601459|NCT01933919|26447698|P1|Open-label Long-term Phase|Withdrawal by Subject|3
7601460|NCT01933919|26447697|P2|Open-label Long-term Phase|Adverse Event|0
7601461|NCT01933919|26447698|P1|Open-label Long-term Phase|Adverse Event|2
7601462|NCT01933919|26447697|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
7601463|NCT01933919|26447698|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
7601464|NCT01933919|26447697|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
7601465|NCT01933919|26447698|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
7601466|NCT01933919|26447697|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
7601467|NCT01933919|26447698|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
7601468|NCT01933880|26447734|P2|Overall Study|Protocol Violation|0
7601469|NCT01933880|26447735|P1|Overall Study|Protocol Violation|1
7601470|NCT01933880|26447734|P2|Overall Study|Other|0
7601471|NCT01933880|26447735|P1|Overall Study|Other|4
7601472|NCT01933880|26447734|P2|Overall Study|Followup exceeded 4 days to visit window|0
7601473|NCT01933880|26447735|P1|Overall Study|Followup exceeded 4 days to visit window|19
7601474|NCT01933880|26447734|P2|Overall Study|Concomitant medication Interference|1
7601475|NCT01933880|26447735|P1|Overall Study|Concomitant medication Interference|0
7601476|NCT01933880|26447734|P2|Overall Study|Lack of Efficacy|0
7601477|NCT01933880|26447735|P1|Overall Study|Lack of Efficacy|1
7601478|NCT01933880|26447734|P2|Overall Study|Withdrawal by Subject|0
7601479|NCT01933880|26447735|P1|Overall Study|Withdrawal by Subject|5
7601480|NCT01933789|26447809|P9|Overall Study|Became Ineligible|0
7601481|NCT01933789|26447810|P8|Overall Study|Became Ineligible|6
7601482|NCT01933789|26447811|P7|Overall Study|Became Ineligible|13
7601483|NCT01933789|26447812|P6|Overall Study|Became Ineligible|10
7601484|NCT01933789|26447813|P5|Overall Study|Became Ineligible|13
7601485|NCT01933789|26447814|P4|Overall Study|Became Ineligible|0
7601486|NCT01933789|26447815|P3|Overall Study|Became Ineligible|0
7601487|NCT01933789|26447816|P2|Overall Study|Became Ineligible|0
7601488|NCT01933789|26447817|P1|Overall Study|Became Ineligible|4
7601489|NCT01933789|26447809|P9|Overall Study|Withdrawal by Subject|0
7601490|NCT01933789|26447810|P8|Overall Study|Withdrawal by Subject|4
7601491|NCT01933789|26447811|P7|Overall Study|Withdrawal by Subject|1
7601492|NCT01933789|26447812|P6|Overall Study|Withdrawal by Subject|16
7601493|NCT01933789|26447813|P5|Overall Study|Withdrawal by Subject|17
7601494|NCT01933789|26447814|P4|Overall Study|Withdrawal by Subject|0
7601495|NCT01933789|26447815|P3|Overall Study|Withdrawal by Subject|0
7601496|NCT01933789|26447816|P2|Overall Study|Withdrawal by Subject|1
7601497|NCT01933789|26447817|P1|Overall Study|Withdrawal by Subject|2
7601498|NCT01933789|26447809|P9|Overall Study|Lost to Follow-up|0
7601499|NCT01933789|26447810|P8|Overall Study|Lost to Follow-up|4
7601500|NCT01933789|26447811|P7|Overall Study|Lost to Follow-up|1
7601501|NCT01933789|26447812|P6|Overall Study|Lost to Follow-up|9
7601502|NCT01933789|26447813|P5|Overall Study|Lost to Follow-up|8
7601503|NCT01933789|26447814|P4|Overall Study|Lost to Follow-up|1
7601504|NCT01933789|26447815|P3|Overall Study|Lost to Follow-up|0
7601505|NCT01933789|26447816|P2|Overall Study|Lost to Follow-up|0
7601506|NCT01933789|26447817|P1|Overall Study|Lost to Follow-up|0
7601507|NCT01933789|26447809|P9|Overall Study|Death|0
7601508|NCT01933789|26447810|P8|Overall Study|Death|0
7601509|NCT01933789|26447811|P7|Overall Study|Death|0
7601510|NCT01933789|26447812|P6|Overall Study|Death|32
7601511|NCT01933789|26447813|P5|Overall Study|Death|21
7601512|NCT01933789|26447814|P4|Overall Study|Death|0
7601513|NCT01933789|26447815|P3|Overall Study|Death|0
7601514|NCT01933789|26447816|P2|Overall Study|Death|0
7601515|NCT01933789|26447817|P1|Overall Study|Death|0
7601516|NCT01933672|26448127|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7601517|NCT01933672|26448128|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7601518|NCT01933672|26448129|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7601519|NCT01933672|26448130|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7601520|NCT01933672|26448131|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7601521|NCT01933672|26448132|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
7601522|NCT01933672|26448133|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7601523|NCT01933672|26448127|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7601524|NCT01933672|26448128|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7601525|NCT01933672|26448129|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7601526|NCT01933672|26448130|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
7601527|NCT01933672|26448131|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7601528|NCT01933672|26448132|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7601529|NCT01933672|26448133|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7601530|NCT01933672|26448127|P7|Second Intervention Period (12-16 Days)|Other|0
7601531|NCT01933672|26448128|P6|Second Intervention Period (12-16 Days)|Other|0
7601532|NCT01933672|26448129|P5|Second Intervention Period (12-16 Days)|Other|0
7601533|NCT01933672|26448130|P4|Second Intervention Period (12-16 Days)|Other|0
7601534|NCT01933672|26448131|P3|Second Intervention Period (12-16 Days)|Other|1
7601535|NCT01933672|26448132|P2|Second Intervention Period (12-16 Days)|Other|1
7601536|NCT01933672|26448133|P1|Second Intervention Period (12-16 Days)|Other|0
7601537|NCT01933672|26448127|P7|First Intervention Period (12-16 Days)|Other|0
7601538|NCT01933672|26448128|P6|First Intervention Period (12-16 Days)|Other|1
7601539|NCT01933672|26448129|P5|First Intervention Period (12-16 Days)|Other|0
7601540|NCT01933672|26448130|P4|First Intervention Period (12-16 Days)|Other|0
7601541|NCT01933672|26448131|P3|First Intervention Period (12-16 Days)|Other|1
7601542|NCT01933672|26448132|P2|First Intervention Period (12-16 Days)|Other|0
7601543|NCT01933672|26448133|P1|First Intervention Period (12-16 Days)|Other|0
7601544|NCT01933672|26448127|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7601545|NCT01933672|26448128|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7601546|NCT01933672|26448129|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
7601547|NCT01933672|26448130|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7601548|NCT01933672|26448131|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7601549|NCT01933672|26448132|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7601550|NCT01933672|26448133|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7601551|NCT01933672|26448127|P7|Metformin Run-in Period|Other|0
7601552|NCT01933672|26448128|P6|Metformin Run-in Period|Other|0
7601553|NCT01933672|26448129|P5|Metformin Run-in Period|Other|0
7601554|NCT01933672|26448130|P4|Metformin Run-in Period|Other|0
7601555|NCT01933672|26448131|P3|Metformin Run-in Period|Other|0
7601556|NCT01933672|26448132|P2|Metformin Run-in Period|Other|0
7601557|NCT01933672|26448133|P1|Metformin Run-in Period|Other|5
7601558|NCT01933672|26448127|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
7601559|NCT01933672|26448128|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
7601560|NCT01933672|26448129|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
7601561|NCT01933672|26448130|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
7601562|NCT01933672|26448131|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
7601563|NCT01933672|26448132|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
7601564|NCT01933672|26448133|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
7601565|NCT01933672|26448127|P7|Metformin Run-in Period|Adverse Event|0
7601566|NCT01933672|26448128|P6|Metformin Run-in Period|Adverse Event|0
7601567|NCT01933672|26448129|P5|Metformin Run-in Period|Adverse Event|0
7601568|NCT01933672|26448130|P4|Metformin Run-in Period|Adverse Event|0
7601569|NCT01933672|26448131|P3|Metformin Run-in Period|Adverse Event|0
7601570|NCT01933672|26448132|P2|Metformin Run-in Period|Adverse Event|0
7601571|NCT01933672|26448133|P1|Metformin Run-in Period|Adverse Event|1
7601572|NCT01933594|26448185|P6|Overall Study|Ineligible for subsequent study step|0
7601573|NCT01933594|26448186|P5|Overall Study|Ineligible for subsequent study step|1
7601574|NCT01933594|26448187|P4|Overall Study|Ineligible for subsequent study step|0
7601575|NCT01933594|26448188|P3|Overall Study|Ineligible for subsequent study step|0
7601576|NCT01933594|26448189|P2|Overall Study|Ineligible for subsequent study step|0
7601577|NCT01933594|26448190|P1|Overall Study|Ineligible for subsequent study step|0
7601578|NCT01933594|26448185|P6|Overall Study|Lost to Follow-up|0
7601579|NCT01933594|26448186|P5|Overall Study|Lost to Follow-up|1
7601580|NCT01933594|26448187|P4|Overall Study|Lost to Follow-up|0
7601581|NCT01933594|26448188|P3|Overall Study|Lost to Follow-up|0
7601582|NCT01933594|26448189|P2|Overall Study|Lost to Follow-up|0
7601583|NCT01933594|26448190|P1|Overall Study|Lost to Follow-up|1
7601584|NCT01933334|26448324|P2|Overall Study|Withdrawal by Subject|1
7601585|NCT01933334|26448325|P1|Overall Study|Withdrawal by Subject|0
7601586|NCT01933334|26448324|P2|Overall Study|Adverse Event|1
7601587|NCT01933334|26448325|P1|Overall Study|Adverse Event|5
7601588|NCT01933217|26448354|P2|Randomization (4 Weeks)|Lost to Follow-up|1
7601589|NCT01933217|26448355|P1|Randomization (4 Weeks)|Lost to Follow-up|1
7601590|NCT01933217|26448354|P2|Randomization (4 Weeks)|Withdrawal by Subject|3
7601591|NCT01933217|26448355|P1|Randomization (4 Weeks)|Withdrawal by Subject|1
7601592|NCT01933113|26448367|P1|Overall Study|Fractured nonfunctioning lead.|1
7601593|NCT01933048|26448373|P2|Overall Study|unknown reasons|1
7601594|NCT01933048|26448374|P1|Overall Study|unknown reasons|1
7601595|NCT01933048|26448373|P2|Overall Study|Physician Decision|0
7601596|NCT01933048|26448374|P1|Overall Study|Physician Decision|1
7601597|NCT01933048|26448373|P2|Overall Study|Protocol Violation|8
7601598|NCT01933048|26448374|P1|Overall Study|Protocol Violation|7
7601599|NCT01933048|26448373|P2|Overall Study|personal reasons|1
7601600|NCT01933048|26448374|P1|Overall Study|personal reasons|1
7601601|NCT01933048|26448373|P2|Overall Study|Lost to Follow-up|18
7601602|NCT01933048|26448374|P1|Overall Study|Lost to Follow-up|15
7601603|NCT01932996|26448389|P2|Overall Study|Protocol Violation|0
7601604|NCT01932996|26448390|P1|Overall Study|Protocol Violation|2
7601605|NCT01932970|26448400|P1|Overall Study|Protocol Specified Criteria|10
7601606|NCT01932970|26448400|P1|Overall Study|Lost to Follow-up|2
7601607|NCT01932970|26448400|P1|Overall Study|Death|1
7601608|NCT01932970|26448400|P1|Overall Study|Withdrawal by Subject|5
7601609|NCT01932788|26448410|P2|Overall Study|Withdrawal by Subject|5
7601610|NCT01932788|26448411|P1|Overall Study|Withdrawal by Subject|0
7601611|NCT01932788|26448410|P2|Overall Study|Lack of Efficacy|0
7601612|NCT01932788|26448411|P1|Overall Study|Lack of Efficacy|2
7601613|NCT01932788|26448410|P2|Overall Study|Lost to Follow-up|46
7601614|NCT01932788|26448411|P1|Overall Study|Lost to Follow-up|18
7601615|NCT01932788|26448410|P2|Overall Study|Protocol Violation|0
7601616|NCT01932788|26448411|P1|Overall Study|Protocol Violation|18
7601617|NCT01932762|26448421|P4|Overall Study|Physician Decision|0
7601618|NCT01932762|26448422|P3|Overall Study|Physician Decision|0
7601619|NCT01932762|26448423|P2|Overall Study|Physician Decision|0
7601620|NCT01932762|26448424|P1|Overall Study|Physician Decision|1
7601621|NCT01932762|26448421|P4|Overall Study|Lost to Follow-up|1
7601622|NCT01932762|26448422|P3|Overall Study|Lost to Follow-up|0
7601623|NCT01932762|26448423|P2|Overall Study|Lost to Follow-up|0
7601624|NCT01932762|26448424|P1|Overall Study|Lost to Follow-up|4
7601625|NCT01932762|26448421|P4|Overall Study|Withdrawal by Subject|0
7601626|NCT01932762|26448422|P3|Overall Study|Withdrawal by Subject|0
7601627|NCT01932762|26448423|P2|Overall Study|Withdrawal by Subject|2
7601628|NCT01932762|26448424|P1|Overall Study|Withdrawal by Subject|1
7601629|NCT01932697|26448460|P2|Overall Study|Ineligible|0
7601630|NCT01932697|26448461|P1|Overall Study|Ineligible|1
7601631|NCT01932697|26448460|P2|Overall Study|Received a different amount of tx|0
7601632|NCT01932697|26448461|P1|Overall Study|Received a different amount of tx|1
7601633|NCT01932437|26448528|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
7601634|NCT01932437|26448529|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7601635|NCT01932437|26448530|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7601636|NCT01932437|26448531|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7601637|NCT01932437|26448532|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7601638|NCT01932437|26448533|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7601639|NCT01932294|26448583|P1|Overall Study|Transferred to other hospitals|12
7601640|NCT01932294|26448583|P1|Overall Study|Heart Transplantation|16
7601641|NCT01932294|26448583|P1|Overall Study|VAD Implantation|20
7601642|NCT01932294|26448583|P1|Overall Study|Lost to Follow-up|8
7601643|NCT01932294|26448583|P1|Overall Study|Death|43
7601644|NCT01931995|26448658|P2|First Intervention (1 Day)|Lost to Follow-up|1
7601645|NCT01931995|26448659|P1|First Intervention (1 Day)|Lost to Follow-up|1
7601646|NCT01931995|26448658|P2|First Intervention (1 Day)|Physician Decision|1
7601647|NCT01931995|26448659|P1|First Intervention (1 Day)|Physician Decision|1
7601648|NCT01931995|26448658|P2|First Intervention (1 Day)|Withdrawal by Subject|2
7601649|NCT01931995|26448659|P1|First Intervention (1 Day)|Withdrawal by Subject|2
7601650|NCT01931956|26448671|P4|Overall Study|Not due|0
7601651|NCT01931956|26448672|P3|Overall Study|Not due|21
7601652|NCT01931956|26448673|P2|Overall Study|Not due|0
7601653|NCT01931956|26448674|P1|Overall Study|Not due|0
7601654|NCT01931956|26448671|P4|Overall Study|Expected|0
7601655|NCT01931956|26448672|P3|Overall Study|Expected|6
7601656|NCT01931956|26448673|P2|Overall Study|Expected|0
7601657|NCT01931956|26448674|P1|Overall Study|Expected|2
7601658|NCT01931956|26448671|P4|Overall Study|Lost to Follow-up|7
7601659|NCT01931956|26448672|P3|Overall Study|Lost to Follow-up|11
7601660|NCT01931956|26448673|P2|Overall Study|Lost to Follow-up|0
7601661|NCT01931956|26448674|P1|Overall Study|Lost to Follow-up|2
7601662|NCT01931956|26448671|P4|Overall Study|Withdrawal by Subject|30
7601663|NCT01931956|26448672|P3|Overall Study|Withdrawal by Subject|70
7601664|NCT01931956|26448673|P2|Overall Study|Withdrawal by Subject|0
7601665|NCT01931956|26448674|P1|Overall Study|Withdrawal by Subject|5
7601666|NCT01931956|26448671|P4|Overall Study|Death|96
7601667|NCT01931956|26448672|P3|Overall Study|Death|379
7601668|NCT01931956|26448673|P2|Overall Study|Death|7
7601669|NCT01931956|26448674|P1|Overall Study|Death|42
7601670|NCT01931865|26449041|P1|Overall Study|Withdrawal by Subject|2
7601671|NCT01931865|26449041|P1|Overall Study|Lost to Follow-up|2
7601672|NCT01931839|26449054|P7|Overall Study|Other|0
7601673|NCT01931839|26449055|P6|Overall Study|Other|0
7601674|NCT01931839|26449056|P5|Overall Study|Other|0
7601675|NCT01931839|26449057|P4|Overall Study|Other|0
7601676|NCT01931839|26449058|P3|Overall Study|Other|6
7601677|NCT01931839|26449059|P2|Overall Study|Other|2
7601678|NCT01931839|26449060|P1|Overall Study|Other|4
7601679|NCT01931839|26449054|P7|Overall Study|Lost to Follow-up|0
7601680|NCT01931839|26449055|P6|Overall Study|Lost to Follow-up|0
7601681|NCT01931839|26449056|P5|Overall Study|Lost to Follow-up|0
7601682|NCT01931839|26449057|P4|Overall Study|Lost to Follow-up|5
7601683|NCT01931839|26449058|P3|Overall Study|Lost to Follow-up|4
7601684|NCT01931839|26449059|P2|Overall Study|Lost to Follow-up|2
7601685|NCT01931839|26449060|P1|Overall Study|Lost to Follow-up|1
7601686|NCT01931839|26449054|P7|Overall Study|Other non-compliance|0
7601687|NCT01931839|26449055|P6|Overall Study|Other non-compliance|3
7601688|NCT01931839|26449056|P5|Overall Study|Other non-compliance|0
7601689|NCT01931839|26449057|P4|Overall Study|Other non-compliance|3
7601690|NCT01931839|26449058|P3|Overall Study|Other non-compliance|12
7601691|NCT01931839|26449059|P2|Overall Study|Other non-compliance|9
7601692|NCT01931839|26449060|P1|Overall Study|Other non-compliance|15
7601693|NCT01931839|26449054|P7|Overall Study|Withdrawal of consent (not due to AE)|2
7601694|NCT01931839|26449055|P6|Overall Study|Withdrawal of consent (not due to AE)|2
7601695|NCT01931839|26449056|P5|Overall Study|Withdrawal of consent (not due to AE)|0
7601696|NCT01931839|26449057|P4|Overall Study|Withdrawal of consent (not due to AE)|3
7601697|NCT01931839|26449058|P3|Overall Study|Withdrawal of consent (not due to AE)|13
7601698|NCT01931839|26449059|P2|Overall Study|Withdrawal of consent (not due to AE)|8
7601699|NCT01931839|26449060|P1|Overall Study|Withdrawal of consent (not due to AE)|11
7601700|NCT01931839|26449054|P7|Overall Study|Adverse Event|1
7601701|NCT01931839|26449055|P6|Overall Study|Adverse Event|0
7601702|NCT01931839|26449056|P5|Overall Study|Adverse Event|0
7601703|NCT01931839|26449057|P4|Overall Study|Adverse Event|3
7601704|NCT01931839|26449058|P3|Overall Study|Adverse Event|1
7601705|NCT01931839|26449059|P2|Overall Study|Adverse Event|4
7601706|NCT01931839|26449060|P1|Overall Study|Adverse Event|9
7601707|NCT01931839|26449054|P7|Overall Study|Withdrawal of consent|0
7601708|NCT01931839|26449055|P6|Overall Study|Withdrawal of consent|0
7601709|NCT01931839|26449056|P5|Overall Study|Withdrawal of consent|1
7601710|NCT01931839|26449057|P4|Overall Study|Withdrawal of consent|0
7601711|NCT01931839|26449058|P3|Overall Study|Withdrawal of consent|0
7601712|NCT01931839|26449059|P2|Overall Study|Withdrawal of consent|0
7601713|NCT01931839|26449060|P1|Overall Study|Withdrawal of consent|0
7601714|NCT01931839|26449054|P7|Overall Study|Physician Decision|1
7601715|NCT01931839|26449055|P6|Overall Study|Physician Decision|0
7601716|NCT01931839|26449056|P5|Overall Study|Physician Decision|0
7601717|NCT01931839|26449057|P4|Overall Study|Physician Decision|0
7601718|NCT01931839|26449058|P3|Overall Study|Physician Decision|1
7601719|NCT01931839|26449059|P2|Overall Study|Physician Decision|0
7601720|NCT01931839|26449060|P1|Overall Study|Physician Decision|1
7601721|NCT01931839|26449054|P7|Overall Study|Death|0
7601722|NCT01931839|26449055|P6|Overall Study|Death|0
7601723|NCT01931839|26449056|P5|Overall Study|Death|0
7601724|NCT01931839|26449057|P4|Overall Study|Death|0
7601725|NCT01931839|26449058|P3|Overall Study|Death|2
7601726|NCT01931839|26449059|P2|Overall Study|Death|1
7601727|NCT01931839|26449060|P1|Overall Study|Death|0
7601728|NCT01931735|26449132|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
7601729|NCT01931735|26449133|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
7601730|NCT01931735|26449134|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
7601731|NCT01931735|26449135|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
7601732|NCT01931735|26449132|P4|Observational Non-Randomized Phase|Adverse Event|1
7601733|NCT01931735|26449133|P3|Observational Non-Randomized Phase|Adverse Event|0
7601734|NCT01931735|26449134|P2|Observational Non-Randomized Phase|Adverse Event|0
7601735|NCT01931735|26449135|P1|Observational Non-Randomized Phase|Adverse Event|0
7601736|NCT01931735|26449132|P4|Randomized Phase|Lost to Follow-up|0
7601737|NCT01931735|26449133|P3|Randomized Phase|Lost to Follow-up|5
7601738|NCT01931735|26449134|P2|Randomized Phase|Lost to Follow-up|2
7601739|NCT01931735|26449135|P1|Randomized Phase|Lost to Follow-up|2
7601740|NCT01931670|26449182|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
7601741|NCT01931670|26449183|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7601742|NCT01931670|26449184|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7601743|NCT01931670|26449182|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
7601744|NCT01931670|26449183|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
7601745|NCT01931670|26449184|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
7601746|NCT01931670|26449182|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
7601747|NCT01931670|26449183|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
7601748|NCT01931670|26449184|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
7601749|NCT01931670|26449182|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
7601750|NCT01931670|26449183|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7601751|NCT01931670|26449184|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7601752|NCT01931670|26449182|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
7601753|NCT01931670|26449183|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
7601754|NCT01931670|26449184|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
7601755|NCT01931670|26449182|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7601756|NCT01931670|26449183|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7601757|NCT01931670|26449184|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
7601758|NCT01931670|26449182|P3|Treatment Period|Lost to Follow-up|7
7601759|NCT01931670|26449183|P2|Treatment Period|Lost to Follow-up|5
7601760|NCT01931670|26449184|P1|Treatment Period|Lost to Follow-up|19
7601761|NCT01931670|26449182|P3|Treatment Period|Consent Withdrawn by Subject|7
7601762|NCT01931670|26449183|P2|Treatment Period|Consent Withdrawn by Subject|12
7601763|NCT01931670|26449184|P1|Treatment Period|Consent Withdrawn by Subject|17
7601764|NCT01931670|26449182|P3|Treatment Period|Other|2
7601765|NCT01931670|26449183|P2|Treatment Period|Other|7
7601766|NCT01931670|26449184|P1|Treatment Period|Other|8
7601767|NCT01931670|26449182|P3|Treatment Period|Pregnancy|0
7601768|NCT01931670|26449183|P2|Treatment Period|Pregnancy|2
7601769|NCT01931670|26449184|P1|Treatment Period|Pregnancy|7
7601770|NCT01931670|26449182|P3|Treatment Period|Lack of Efficacy|2
7601771|NCT01931670|26449183|P2|Treatment Period|Lack of Efficacy|2
7601772|NCT01931670|26449184|P1|Treatment Period|Lack of Efficacy|11
7601773|NCT01931670|26449182|P3|Treatment Period|Adverse Event|21
7601774|NCT01931670|26449183|P2|Treatment Period|Adverse Event|8
7601775|NCT01931670|26449184|P1|Treatment Period|Adverse Event|19
7601776|NCT01931670|26449182|P3|Treatment Period|Subject Noncompliant|5
7601777|NCT01931670|26449183|P2|Treatment Period|Subject Noncompliant|9
7601778|NCT01931670|26449184|P1|Treatment Period|Subject Noncompliant|4
7601779|NCT01931670|26449182|P3|Treatment Period|Surgery/Invasive Intervention|0
7601780|NCT01931670|26449183|P2|Treatment Period|Surgery/Invasive Intervention|2
7601781|NCT01931670|26449184|P1|Treatment Period|Surgery/Invasive Intervention|4
7601782|NCT01931670|26449182|P3|Treatment Period|Exclusionary Medication Received|1
7601783|NCT01931670|26449183|P2|Treatment Period|Exclusionary Medication Received|1
7601784|NCT01931670|26449184|P1|Treatment Period|Exclusionary Medication Received|1
7601785|NCT01931566|26449285|P3|Overall Study|Missing|1
7601786|NCT01931566|26449286|P2|Overall Study|Missing|0
7601787|NCT01931566|26449287|P1|Overall Study|Missing|0
7601788|NCT01931566|26449285|P3|Overall Study|Reason Not Specified|53
7601789|NCT01931566|26449286|P2|Overall Study|Reason Not Specified|47
7601790|NCT01931566|26449287|P1|Overall Study|Reason Not Specified|11
7601791|NCT01931566|26449285|P3|Overall Study|Study Termination|1037
7601792|NCT01931566|26449286|P2|Overall Study|Study Termination|968
7601793|NCT01931566|26449287|P1|Overall Study|Study Termination|289
7601794|NCT01931566|26449285|P3|Overall Study|Voluntary Withdrawal|225
7601795|NCT01931566|26449286|P2|Overall Study|Voluntary Withdrawal|245
7601796|NCT01931566|26449287|P1|Overall Study|Voluntary Withdrawal|78
7601797|NCT01931566|26449285|P3|Overall Study|Lost to Follow-up|23
7601798|NCT01931566|26449286|P2|Overall Study|Lost to Follow-up|26
7601799|NCT01931566|26449287|P1|Overall Study|Lost to Follow-up|3
7601800|NCT01931566|26449285|P3|Overall Study|Major Protocol Deviation|21
7601801|NCT01931566|26449286|P2|Overall Study|Major Protocol Deviation|14
7601802|NCT01931566|26449287|P1|Overall Study|Major Protocol Deviation|5
7601803|NCT01931566|26449285|P3|Overall Study|Adverse Event|132
7601804|NCT01931566|26449286|P2|Overall Study|Adverse Event|167
7601805|NCT01931566|26449287|P1|Overall Study|Adverse Event|37
7601806|NCT01931566|26449285|P3|Overall Study|Randomized But Not Treated|14
7601807|NCT01931566|26449286|P2|Overall Study|Randomized But Not Treated|9
7601808|NCT01931566|26449287|P1|Overall Study|Randomized But Not Treated|6
7601809|NCT01931475|26449325|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7601810|NCT01931475|26449326|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7601811|NCT01931475|26449325|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
7601812|NCT01931475|26449326|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
7601813|NCT01931475|26449325|P2|Period 2: Extension Treatment Phase|Physician Decision|1
7601814|NCT01931475|26449326|P1|Period 2: Extension Treatment Phase|Physician Decision|1
7601815|NCT01931475|26449325|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
7601816|NCT01931475|26449326|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
7601817|NCT01931475|26449325|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
7601818|NCT01931475|26449326|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
7601819|NCT01931475|26449325|P2|Period 2: Extension Treatment Phase|Adverse Event|8
7601820|NCT01931475|26449326|P1|Period 2: Extension Treatment Phase|Adverse Event|0
7601821|NCT01931475|26449325|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
7601822|NCT01931475|26449326|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
7601823|NCT01931475|26449325|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
7601824|NCT01931475|26449326|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
7601825|NCT01931475|26449325|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
7601826|NCT01931475|26449326|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
7601827|NCT01931475|26449325|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
7601828|NCT01931475|26449326|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
7601829|NCT01931475|26449325|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
7601830|NCT01931475|26449326|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
7601831|NCT01931462|26449353|P1|Overall Study|Withdrawal by Subject|1
7601832|NCT01931397|26449364|P1|Overall Study|moved out of state|1
7601833|NCT01931397|26449364|P1|Overall Study|Withdrawal by Subject|8
7601834|NCT01931397|26449364|P1|Overall Study|Physician Decision|2
7601835|NCT01931202|26449376|P3|Overall Study|Lost to Follow-up|2
7601836|NCT01931202|26449377|P2|Overall Study|Lost to Follow-up|5
7601837|NCT01931202|26449378|P1|Overall Study|Lost to Follow-up|0
7601838|NCT01931202|26449376|P3|Overall Study|Withdrawal by Subject|2
7601839|NCT01931202|26449377|P2|Overall Study|Withdrawal by Subject|0
7601840|NCT01931202|26449378|P1|Overall Study|Withdrawal by Subject|0
7601841|NCT01931150|26449428|P2|Overall Study|Withdrawal by Subject|2
7601842|NCT01931150|26449429|P1|Overall Study|Withdrawal by Subject|1
7601843|NCT01931098|26449437|P2|Overall Study|Refused further treatment|1
7601844|NCT01931098|26449438|P1|Overall Study|Refused further treatment|0
7601845|NCT01931098|26449437|P2|Overall Study|Unable to begin trmt:active infection|1
7601846|NCT01931098|26449438|P1|Overall Study|Unable to begin trmt:active infection|0
7601847|NCT01931098|26449437|P2|Overall Study|Enrolled in different protocol|1
7601848|NCT01931098|26449438|P1|Overall Study|Enrolled in different protocol|0
7601849|NCT01931098|26449437|P2|Overall Study|Withdrawal by Subject|1
7601850|NCT01931098|26449438|P1|Overall Study|Withdrawal by Subject|0
7601851|NCT01931059|26449454|P2|Day3|Lost to Follow-up|0
7601852|NCT01931059|26449455|P1|Day3|Lost to Follow-up|1
7601853|NCT01931059|26449454|P2|Day 1|Pregnancy|1
7601854|NCT01931059|26449455|P1|Day 1|Pregnancy|0
7601855|NCT01930890|26449471|P4|Overall Study|Adverse Event|0
7601856|NCT01930890|26449472|P3|Overall Study|Adverse Event|0
7601857|NCT01930890|26449473|P2|Overall Study|Adverse Event|1
7601858|NCT01930890|26449474|P1|Overall Study|Adverse Event|0
7601859|NCT01930890|26449471|P4|Overall Study|Consent Withdrawn|1
7601860|NCT01930890|26449472|P3|Overall Study|Consent Withdrawn|0
7601861|NCT01930890|26449473|P2|Overall Study|Consent Withdrawn|3
7601862|NCT01930890|26449474|P1|Overall Study|Consent Withdrawn|0
7601863|NCT01930890|26449471|P4|Overall Study|Investigator Decision|0
7601864|NCT01930890|26449472|P3|Overall Study|Investigator Decision|0
7601865|NCT01930890|26449473|P2|Overall Study|Investigator Decision|1
7601866|NCT01930890|26449474|P1|Overall Study|Investigator Decision|0
7601867|NCT01930890|26449471|P4|Overall Study|Death|1
7601868|NCT01930890|26449472|P3|Overall Study|Death|0
7601869|NCT01930890|26449473|P2|Overall Study|Death|0
7601870|NCT01930890|26449474|P1|Overall Study|Death|0
7601871|NCT01930890|26449471|P4|Overall Study|Study Termination|25
7601872|NCT01930890|26449472|P3|Overall Study|Study Termination|13
7601873|NCT01930890|26449473|P2|Overall Study|Study Termination|28
7601874|NCT01930890|26449474|P1|Overall Study|Study Termination|14
7601875|NCT01930799|26449488|P1|Overall Study|Lost to Follow-up|5
7601876|NCT01930799|26449488|P1|Overall Study|Withdrawal by Subject|3
7601877|NCT01930214|26449627|P3|Overall Study|Physician Decision|0
7601878|NCT01930214|26449628|P2|Overall Study|Physician Decision|0
7601879|NCT01930214|26449629|P1|Overall Study|Physician Decision|2
7601880|NCT01930214|26449627|P3|Overall Study|Voluntary withdrawal of infomed consent|2
7601881|NCT01930214|26449628|P2|Overall Study|Voluntary withdrawal of infomed consent|4
7601882|NCT01930214|26449629|P1|Overall Study|Voluntary withdrawal of infomed consent|2
7601883|NCT01930214|26449627|P3|Overall Study|Lost to Follow-up|12
7601884|NCT01930214|26449628|P2|Overall Study|Lost to Follow-up|13
7601885|NCT01930214|26449629|P1|Overall Study|Lost to Follow-up|12
7601886|NCT01930214|26449627|P3|Overall Study|Death|11
7601887|NCT01930214|26449628|P2|Overall Study|Death|4
7601888|NCT01930214|26449629|P1|Overall Study|Death|4
7601889|NCT01930188|26449649|P3|Overall Study|Withdrawal by Subject|8
7601890|NCT01930188|26449650|P2|Overall Study|Withdrawal by Subject|11
7601891|NCT01930188|26449651|P1|Overall Study|Withdrawal by Subject|9
7601892|NCT01930188|26449649|P3|Overall Study|Death|3
7601893|NCT01930188|26449650|P2|Overall Study|Death|1
7601894|NCT01930188|26449651|P1|Overall Study|Death|2
7601895|NCT01930188|26449649|P3|Overall Study|Lost to Follow-up|2
7601896|NCT01930188|26449650|P2|Overall Study|Lost to Follow-up|2
7601897|NCT01930188|26449651|P1|Overall Study|Lost to Follow-up|5
7601898|NCT01930188|26449649|P3|Overall Study|Missing follow-up information|3
7601899|NCT01930188|26449650|P2|Overall Study|Missing follow-up information|2
7601900|NCT01930188|26449651|P1|Overall Study|Missing follow-up information|2
7601901|NCT01930188|26449649|P3|Overall Study|unclassified|3
7601902|NCT01930188|26449650|P2|Overall Study|unclassified|5
7601903|NCT01930188|26449651|P1|Overall Study|unclassified|4
7601904|NCT01930175|26449678|P3|Core Study|Adverse Event|1
7601905|NCT01930175|26449679|P2|Core Study|Adverse Event|0
7601906|NCT01930175|26449680|P1|Core Study|Adverse Event|0
7601907|NCT01930175|26449678|P3|Core Study|Lost to Follow-up|0
7601908|NCT01930175|26449679|P2|Core Study|Lost to Follow-up|1
7601909|NCT01930175|26449680|P1|Core Study|Lost to Follow-up|0
7601910|NCT01930162|26449710|P1|Overall Study|Death|1
7601911|NCT01930162|26449710|P1|Overall Study|Abnormal test procedure result(s)|4
7601912|NCT01930045|26449746|P6|Pause (up to 37 Days)|Protocol Violation|1
7601913|NCT01930045|26449747|P5|Pause (up to 37 Days)|Protocol Violation|0
7601914|NCT01930045|26449748|P4|Pause (up to 37 Days)|Protocol Violation|0
7601915|NCT01930045|26449749|P3|Pause (up to 37 Days)|Protocol Violation|0
7601916|NCT01930045|26449750|P2|Pause (up to 37 Days)|Protocol Violation|0
7601917|NCT01930045|26449751|P1|Pause (up to 37 Days)|Protocol Violation|0
7601918|NCT01930045|26449746|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
7601919|NCT01930045|26449747|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
7601920|NCT01930045|26449748|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
7601921|NCT01930045|26449749|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
7601922|NCT01930045|26449750|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
7601923|NCT01930045|26449751|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
7601924|NCT01929993|26449778|P2|Overall Study|Absent CIN, invasion present or artifact|22
7601925|NCT01929993|26449779|P1|Overall Study|Absent CIN, invasion present or artifact|26
7601926|NCT01929993|26449778|P2|Overall Study|Protocol Violation|6
7601927|NCT01929993|26449779|P1|Overall Study|Protocol Violation|4
7601928|NCT01929980|26449785|P1|Overall Study|Physician Decision|1
7601929|NCT01929876|26449793|P1|Period 2|Non-Compliance|1
7601930|NCT01929863|26449806|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
7601931|NCT01929863|26449807|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
7601932|NCT01929863|26449806|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
7601933|NCT01929863|26449807|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
7601934|NCT01929863|26449806|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
7601935|NCT01929863|26449807|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
7601936|NCT01929707|26449862|P8|Intervention Period 2|Withdrawal by Subject|0
7601937|NCT01929707|26449863|P7|Intervention Period 2|Withdrawal by Subject|0
7601938|NCT01929707|26449864|P6|Intervention Period 2|Withdrawal by Subject|2
7601939|NCT01929707|26449865|P5|Intervention Period 2|Withdrawal by Subject|0
7601940|NCT01929707|26449866|P4|Intervention Period 2|Withdrawal by Subject|0
7601941|NCT01929707|26449867|P3|Intervention Period 2|Withdrawal by Subject|0
7601942|NCT01929707|26449868|P2|Intervention Period 2|Withdrawal by Subject|0
7601943|NCT01929707|26449869|P1|Intervention Period 2|Withdrawal by Subject|0
7601944|NCT01929707|26449862|P8|Intervention Period 1|Withdrawal by Subject|0
7601945|NCT01929707|26449863|P7|Intervention Period 1|Withdrawal by Subject|0
7601946|NCT01929707|26449864|P6|Intervention Period 1|Withdrawal by Subject|0
7601947|NCT01929707|26449865|P5|Intervention Period 1|Withdrawal by Subject|0
7601948|NCT01929707|26449866|P4|Intervention Period 1|Withdrawal by Subject|2
7601949|NCT01929707|26449867|P3|Intervention Period 1|Withdrawal by Subject|0
7601950|NCT01929707|26449868|P2|Intervention Period 1|Withdrawal by Subject|0
7601951|NCT01929707|26449869|P1|Intervention Period 1|Withdrawal by Subject|0
7601952|NCT01929707|26449862|P8|Intervention Period 1|Lost to Follow-up|0
7601953|NCT01929707|26449863|P7|Intervention Period 1|Lost to Follow-up|0
7601954|NCT01929707|26449864|P6|Intervention Period 1|Lost to Follow-up|0
7601955|NCT01929707|26449865|P5|Intervention Period 1|Lost to Follow-up|0
7601956|NCT01929707|26449866|P4|Intervention Period 1|Lost to Follow-up|1
7601957|NCT01929707|26449867|P3|Intervention Period 1|Lost to Follow-up|0
7601958|NCT01929707|26449868|P2|Intervention Period 1|Lost to Follow-up|0
7601959|NCT01929707|26449869|P1|Intervention Period 1|Lost to Follow-up|0
7601960|NCT01929681|26449901|P2|Overall Study|Physician Decision|1
7601961|NCT01929681|26449902|P1|Overall Study|Physician Decision|1
7601962|NCT01929681|26449901|P2|Overall Study|Withdrawal by Subject|0
7601963|NCT01929681|26449902|P1|Overall Study|Withdrawal by Subject|1
7601964|NCT01929408|26449956|P1|Overall Study|received HCT as initial treatment|8
7601965|NCT01929395|26449964|P3|Overall Study|Screen Fail|1
7601966|NCT01929395|26449965|P2|Overall Study|Screen Fail|0
7601967|NCT01929395|26449966|P1|Overall Study|Screen Fail|0
7601968|NCT01929395|26449964|P3|Overall Study|Withdrawal by Subject|0
7601969|NCT01929395|26449965|P2|Overall Study|Withdrawal by Subject|1
7601970|NCT01929395|26449966|P1|Overall Study|Withdrawal by Subject|0
7601971|NCT01929395|26449964|P3|Overall Study|Did not complete - non-related toxicity|0
7601972|NCT01929395|26449965|P2|Overall Study|Did not complete - non-related toxicity|0
7601973|NCT01929395|26449966|P1|Overall Study|Did not complete - non-related toxicity|1
7601974|NCT01929343|26449979|P3|Overall Study|Withdrawal by Subject|0
7601975|NCT01929343|26449980|P2|Overall Study|Withdrawal by Subject|0
7601976|NCT01929343|26449981|P1|Overall Study|Withdrawal by Subject|1
7601977|NCT01929343|26449979|P3|Overall Study|Physician Decision|0
7601978|NCT01929343|26449980|P2|Overall Study|Physician Decision|2
7601979|NCT01929343|26449981|P1|Overall Study|Physician Decision|0
7601980|NCT01929317|26450009|P2|Long-term Phase|Study Closed/Terminated|3
7601981|NCT01929317|26450010|P1|Long-term Phase|Study Closed/Terminated|5
7601982|NCT01929317|26450009|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
7601983|NCT01929317|26450010|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
7601984|NCT01929317|26450009|P2|Long-term Phase|Protocol Violation|0
7601985|NCT01929317|26450010|P1|Long-term Phase|Protocol Violation|1
7601986|NCT01929317|26450009|P2|Long-term Phase|Withdrawal by Subject|0
7601987|NCT01929317|26450010|P1|Long-term Phase|Withdrawal by Subject|4
7601988|NCT01929317|26450009|P2|Long-term Phase|Physician Decision|0
7601989|NCT01929317|26450010|P1|Long-term Phase|Physician Decision|3
7601990|NCT01929317|26450009|P2|Long-term Phase|Adverse Event|1
7601991|NCT01929317|26450010|P1|Long-term Phase|Adverse Event|5
7601992|NCT01929317|26450009|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
7601993|NCT01929317|26450010|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
7601994|NCT01929317|26450009|P2|Dose Increase Effect Verification Phase|Physician Decision|0
7601995|NCT01929317|26450010|P1|Dose Increase Effect Verification Phase|Physician Decision|1
7602083|NCT01928719|26450634|P2|Overall Study|Adverse Event|0
7601996|NCT01929317|26450009|P2|Dose Increase Effect Verification Phase|Adverse Event|1
7601997|NCT01929317|26450010|P1|Dose Increase Effect Verification Phase|Adverse Event|5
7601998|NCT01929226|26450085|P2|Overall Study|Withdrawal by Subject|1
7601999|NCT01929226|26450086|P1|Overall Study|Withdrawal by Subject|1
7602000|NCT01929226|26450085|P2|Overall Study|Lost to Follow-up|0
7602001|NCT01929226|26450086|P1|Overall Study|Lost to Follow-up|4
7602002|NCT01929135|26450112|P2|Overall Study|Lost to Follow-up|1
7602003|NCT01929135|26450113|P1|Overall Study|Lost to Follow-up|1
7602004|NCT01929109|26450132|P5|Period 1 (All Groups)|Deviation from protocol|0
7602005|NCT01929109|26450133|P4|Period 1 (All Groups)|Deviation from protocol|0
7602006|NCT01929109|26450134|P3|Period 1 (All Groups)|Deviation from protocol|1
7602007|NCT01929109|26450135|P2|Period 1 (All Groups)|Deviation from protocol|0
7602008|NCT01929109|26450136|P1|Period 1 (All Groups)|Deviation from protocol|0
7602009|NCT01929083|26450155|P2|Intervention 2|Adverse Event|1
7602010|NCT01929083|26450156|P1|Intervention 2|Adverse Event|0
7602011|NCT01929083|26450155|P2|Intervention 1|Nonadherent to study medications|0
7602012|NCT01929083|26450156|P1|Intervention 1|Nonadherent to study medications|1
7602013|NCT01929083|26450155|P2|Intervention 1|Lost to Follow-up|0
7602014|NCT01929083|26450156|P1|Intervention 1|Lost to Follow-up|2
7602015|NCT01929044|26450193|P2|Overall Study|Not Treated|3
7602016|NCT01929044|26450194|P1|Overall Study|Not Treated|1
7602017|NCT01929044|26450193|P2|Overall Study|Protocol Violation|14
7602018|NCT01929044|26450194|P1|Overall Study|Protocol Violation|9
7602019|NCT01929044|26450193|P2|Overall Study|Adverse Event|0
7602020|NCT01929044|26450194|P1|Overall Study|Adverse Event|1
7602021|NCT01929031|26450216|P6|Overall Study|Reason other than specified above|0
7602022|NCT01929031|26450217|P5|Overall Study|Reason other than specified above|1
7602023|NCT01929031|26450218|P4|Overall Study|Reason other than specified above|0
7602024|NCT01929031|26450219|P3|Overall Study|Reason other than specified above|0
7602025|NCT01929031|26450220|P2|Overall Study|Reason other than specified above|1
7602026|NCT01929031|26450221|P1|Overall Study|Reason other than specified above|0
7602027|NCT01929031|26450216|P6|Overall Study|Protocol Violation|1
7602028|NCT01929031|26450217|P5|Overall Study|Protocol Violation|0
7602029|NCT01929031|26450218|P4|Overall Study|Protocol Violation|0
7602030|NCT01929031|26450219|P3|Overall Study|Protocol Violation|0
7602031|NCT01929031|26450220|P2|Overall Study|Protocol Violation|0
7602032|NCT01929031|26450221|P1|Overall Study|Protocol Violation|1
7602033|NCT01929031|26450216|P6|Overall Study|Adverse Event|0
7602034|NCT01929031|26450217|P5|Overall Study|Adverse Event|0
7602035|NCT01929031|26450218|P4|Overall Study|Adverse Event|0
7602036|NCT01929031|26450219|P3|Overall Study|Adverse Event|1
7602037|NCT01929031|26450220|P2|Overall Study|Adverse Event|1
7602038|NCT01929031|26450221|P1|Overall Study|Adverse Event|3
7602039|NCT01929018|26450245|P2|Overall Study|Hospitalization|1
7602040|NCT01929018|26450246|P1|Overall Study|Hospitalization|0
7602041|NCT01929018|26450245|P2|Overall Study|Lost to Follow-up|0
7602042|NCT01929018|26450246|P1|Overall Study|Lost to Follow-up|1
7602043|NCT01928940|26450270|P2|Overall Study|Adverse Event|1
7602044|NCT01928940|26450271|P1|Overall Study|Adverse Event|0
7602045|NCT01928927|26450314|P2|Overall Study|Withdrawal by Subject|1
7602046|NCT01928927|26450315|P1|Overall Study|Withdrawal by Subject|1
7602047|NCT01928927|26450314|P2|Overall Study|Lost to Follow-up|0
7602048|NCT01928927|26450315|P1|Overall Study|Lost to Follow-up|1
7602049|NCT01928862|26450456|P5|Overall Study|Lost to Follow-up|1
7602050|NCT01928862|26450457|P4|Overall Study|Lost to Follow-up|0
7602051|NCT01928862|26450458|P3|Overall Study|Lost to Follow-up|0
7602052|NCT01928862|26450459|P2|Overall Study|Lost to Follow-up|0
7602053|NCT01928862|26450460|P1|Overall Study|Lost to Follow-up|1
7602054|NCT01928771|26450534|P3|Overall Study|Severe Non-Compliance to Protocol|2
7602055|NCT01928771|26450535|P2|Overall Study|Severe Non-Compliance to Protocol|2
7602056|NCT01928771|26450536|P1|Overall Study|Severe Non-Compliance to Protocol|4
7602057|NCT01928771|26450534|P3|Overall Study|Other Reasons|14
7602058|NCT01928771|26450535|P2|Overall Study|Other Reasons|9
7602059|NCT01928771|26450536|P1|Overall Study|Other Reasons|9
7602060|NCT01928771|26450534|P3|Overall Study|Study-Specific Withdrawal Criteria|1
7602061|NCT01928771|26450535|P2|Overall Study|Study-Specific Withdrawal Criteria|1
7602062|NCT01928771|26450536|P1|Overall Study|Study-Specific Withdrawal Criteria|0
7602063|NCT01928771|26450534|P3|Overall Study|Withdrawal by Subject|17
7602064|NCT01928771|26450535|P2|Overall Study|Withdrawal by Subject|15
7602065|NCT01928771|26450536|P1|Overall Study|Withdrawal by Subject|20
7602066|NCT01928771|26450534|P3|Overall Study|Lost to Follow-up|3
7602067|NCT01928771|26450535|P2|Overall Study|Lost to Follow-up|6
7602068|NCT01928771|26450536|P1|Overall Study|Lost to Follow-up|5
7602069|NCT01928771|26450534|P3|Overall Study|Death|2
7602070|NCT01928771|26450535|P2|Overall Study|Death|2
7602071|NCT01928771|26450536|P1|Overall Study|Death|2
7602072|NCT01928771|26450534|P3|Overall Study|Adverse Event|1
7602073|NCT01928771|26450535|P2|Overall Study|Adverse Event|5
7602074|NCT01928771|26450536|P1|Overall Study|Adverse Event|6
7602075|NCT01928758|26450615|P2|Overall Study|Protocol Violation|4
7602076|NCT01928758|26450616|P1|Overall Study|Protocol Violation|3
7602077|NCT01928758|26450615|P2|Overall Study|Adverse Event|5
7602078|NCT01928758|26450616|P1|Overall Study|Adverse Event|3
7602079|NCT01928758|26450615|P2|Overall Study|Withdrawal by Subject|2
7602080|NCT01928758|26450616|P1|Overall Study|Withdrawal by Subject|5
7602081|NCT01928758|26450615|P2|Overall Study|Lost to Follow-up|9
7602082|NCT01928758|26450616|P1|Overall Study|Lost to Follow-up|14
7602084|NCT01928719|26450635|P1|Overall Study|Adverse Event|1
7602085|NCT01928719|26450634|P2|Overall Study|Protocol Violation|1
7602086|NCT01928719|26450635|P1|Overall Study|Protocol Violation|3
7602087|NCT01928719|26450634|P2|Overall Study|Withdrawal by Subject|7
7602088|NCT01928719|26450635|P1|Overall Study|Withdrawal by Subject|22
7602089|NCT01928719|26450634|P2|Overall Study|Lost to Follow-up|11
7602090|NCT01928719|26450635|P1|Overall Study|Lost to Follow-up|26
7602091|NCT01928615|26450687|P1|Overall Study|Study Terminated by Sponsor|2
7602092|NCT01928485|26450733|P2|Overall Study|Physician Decision|1
7602093|NCT01928485|26450734|P1|Overall Study|Physician Decision|0
7602094|NCT01928472|26450786|P4|Overall Study|Unclassified|0
7602095|NCT01928472|26450787|P3|Overall Study|Unclassified|1
7602096|NCT01928472|26450788|P2|Overall Study|Unclassified|0
7602097|NCT01928472|26450789|P1|Overall Study|Unclassified|0
7602098|NCT01928472|26450786|P4|Overall Study|Administrative Reason|0
7602099|NCT01928472|26450787|P3|Overall Study|Administrative Reason|0
7602100|NCT01928472|26450788|P2|Overall Study|Administrative Reason|1
7602101|NCT01928472|26450789|P1|Overall Study|Administrative Reason|2
7602102|NCT01928472|26450786|P4|Overall Study|Lost to Follow-up|0
7602103|NCT01928472|26450787|P3|Overall Study|Lost to Follow-up|4
7602104|NCT01928472|26450788|P2|Overall Study|Lost to Follow-up|3
7602105|NCT01928472|26450789|P1|Overall Study|Lost to Follow-up|2
7602106|NCT01928472|26450786|P4|Overall Study|Withdrawal by Subject|2
7602107|NCT01928472|26450787|P3|Overall Study|Withdrawal by Subject|1
7602108|NCT01928472|26450788|P2|Overall Study|Withdrawal by Subject|4
7602109|NCT01928472|26450789|P1|Overall Study|Withdrawal by Subject|4
7602110|NCT01928472|26450786|P4|Overall Study|Death|0
7602111|NCT01928472|26450787|P3|Overall Study|Death|1
7602112|NCT01928472|26450788|P2|Overall Study|Death|0
7602113|NCT01928472|26450789|P1|Overall Study|Death|0
7602114|NCT01928433|26450872|P3|Overall Study|Other reasons|4
7602115|NCT01928433|26450873|P2|Overall Study|Other reasons|3
7602116|NCT01928433|26450874|P1|Overall Study|Other reasons|3
7602117|NCT01928433|26450872|P3|Overall Study|Lost to Follow-up|3
7602118|NCT01928433|26450873|P2|Overall Study|Lost to Follow-up|2
7602119|NCT01928433|26450874|P1|Overall Study|Lost to Follow-up|0
7602120|NCT01928433|26450872|P3|Overall Study|Negative screening urine culture|10
7602121|NCT01928433|26450873|P2|Overall Study|Negative screening urine culture|6
7602122|NCT01928433|26450874|P1|Overall Study|Negative screening urine culture|7
7602123|NCT01928433|26450872|P3|Overall Study|Withdrawal by Subject|0
7602124|NCT01928433|26450873|P2|Overall Study|Withdrawal by Subject|4
7602125|NCT01928433|26450874|P1|Overall Study|Withdrawal by Subject|0
7602126|NCT01928433|26450872|P3|Overall Study|Lack of Efficacy|4
7602127|NCT01928433|26450873|P2|Overall Study|Lack of Efficacy|4
7602128|NCT01928433|26450874|P1|Overall Study|Lack of Efficacy|5
7602129|NCT01928433|26450872|P3|Overall Study|Protocol Violation|2
7602130|NCT01928433|26450873|P2|Overall Study|Protocol Violation|0
7602131|NCT01928433|26450874|P1|Overall Study|Protocol Violation|0
7602132|NCT01928433|26450872|P3|Overall Study|Adverse Event|5
7602133|NCT01928433|26450873|P2|Overall Study|Adverse Event|2
7602134|NCT01928433|26450874|P1|Overall Study|Adverse Event|5
7602457|NCT01928381|26450990|P7|Part 2 - Post Third Intervention|Protocol Violation|0
7602458|NCT01928381|26450991|P6|Part 2 - Post Third Intervention|Protocol Violation|0
7602459|NCT01928381|26450992|P5|Part 2 - Post Third Intervention|Protocol Violation|0
7602460|NCT01928381|26450993|P4|Part 2 - Post Third Intervention|Protocol Violation|0
7602461|NCT01928381|26450994|P3|Part 2 - Post Third Intervention|Protocol Violation|1
7602462|NCT01928381|26450995|P2|Part 2 - Post Third Intervention|Protocol Violation|0
7602463|NCT01928381|26450996|P1|Part 2 - Post Third Intervention|Protocol Violation|0
7602464|NCT01928381|26450990|P7|Part 2 - Second Intervention|Lost to Follow-up|0
7602465|NCT01928381|26450991|P6|Part 2 - Second Intervention|Lost to Follow-up|0
7602466|NCT01928381|26450992|P5|Part 2 - Second Intervention|Lost to Follow-up|0
7602467|NCT01928381|26450993|P4|Part 2 - Second Intervention|Lost to Follow-up|1
7602468|NCT01928381|26450994|P3|Part 2 - Second Intervention|Lost to Follow-up|0
7602469|NCT01928381|26450995|P2|Part 2 - Second Intervention|Lost to Follow-up|1
7602470|NCT01928381|26450996|P1|Part 2 - Second Intervention|Lost to Follow-up|0
7602471|NCT01928381|26450990|P7|Washout First Intervention|Protocol Violation|0
7602472|NCT01928381|26450991|P6|Washout First Intervention|Protocol Violation|0
7602473|NCT01928381|26450992|P5|Washout First Intervention|Protocol Violation|1
7602474|NCT01928381|26450993|P4|Washout First Intervention|Protocol Violation|0
7602475|NCT01928381|26450994|P3|Washout First Intervention|Protocol Violation|0
7602476|NCT01928381|26450995|P2|Washout First Intervention|Protocol Violation|0
7602477|NCT01928381|26450996|P1|Washout First Intervention|Protocol Violation|0
7602478|NCT01928381|26450990|P7|Part 2 - First Intervention|Lost to Follow-up|0
7602479|NCT01928381|26450991|P6|Part 2 - First Intervention|Lost to Follow-up|0
7602480|NCT01928381|26450992|P5|Part 2 - First Intervention|Lost to Follow-up|0
7602481|NCT01928381|26450993|P4|Part 2 - First Intervention|Lost to Follow-up|1
7602482|NCT01928381|26450994|P3|Part 2 - First Intervention|Lost to Follow-up|0
7602483|NCT01928381|26450995|P2|Part 2 - First Intervention|Lost to Follow-up|0
7602484|NCT01928381|26450996|P1|Part 2 - First Intervention|Lost to Follow-up|0
7602485|NCT01928381|26450990|P7|Part 2 - First Intervention|Eligibility criterion not met|1
7602486|NCT01928381|26450991|P6|Part 2 - First Intervention|Eligibility criterion not met|1
7602487|NCT01928381|26450992|P5|Part 2 - First Intervention|Eligibility criterion not met|0
7602488|NCT01928381|26450993|P4|Part 2 - First Intervention|Eligibility criterion not met|0
7602489|NCT01928381|26450994|P3|Part 2 - First Intervention|Eligibility criterion not met|0
7602490|NCT01928381|26450995|P2|Part 2 - First Intervention|Eligibility criterion not met|0
7602491|NCT01928381|26450996|P1|Part 2 - First Intervention|Eligibility criterion not met|0
7602492|NCT01928381|26450990|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
7602493|NCT01928381|26450991|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
7602494|NCT01928381|26450992|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
7602495|NCT01928381|26450993|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
7602496|NCT01928381|26450994|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
7602497|NCT01928381|26450995|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
7602498|NCT01928381|26450996|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
7602499|NCT01928381|26450990|P7|Part 2 - First Intervention|Withdrawal by Subject|0
7602500|NCT01928381|26450991|P6|Part 2 - First Intervention|Withdrawal by Subject|0
7602501|NCT01928381|26450992|P5|Part 2 - First Intervention|Withdrawal by Subject|0
7602502|NCT01928381|26450993|P4|Part 2 - First Intervention|Withdrawal by Subject|0
7602503|NCT01928381|26450994|P3|Part 2 - First Intervention|Withdrawal by Subject|1
7602504|NCT01928381|26450995|P2|Part 2 - First Intervention|Withdrawal by Subject|0
7602505|NCT01928381|26450996|P1|Part 2 - First Intervention|Withdrawal by Subject|0
7602506|NCT01928381|26450990|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7602507|NCT01928381|26450991|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7602508|NCT01928381|26450992|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7602509|NCT01928381|26450993|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7602510|NCT01928381|26450994|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7602511|NCT01928381|26450995|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7602512|NCT01928381|26450996|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
7602513|NCT01928381|26450990|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7602514|NCT01928381|26450991|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7602515|NCT01928381|26450992|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7602516|NCT01928381|26450993|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7602517|NCT01928381|26450994|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7602518|NCT01928381|26450995|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7602519|NCT01928381|26450996|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
7602520|NCT01928381|26450990|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7602521|NCT01928381|26450991|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7602522|NCT01928381|26450992|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7602523|NCT01928381|26450993|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7602524|NCT01928381|26450994|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7602525|NCT01928381|26450995|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7602526|NCT01928381|26450996|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
7602527|NCT01928381|26450990|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7602528|NCT01928381|26450991|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7602529|NCT01928381|26450992|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7602530|NCT01928381|26450993|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7602531|NCT01928381|26450994|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7602532|NCT01928381|26450995|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7602533|NCT01928381|26450996|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
7602534|NCT01928381|26450990|P7|Part 1 - Pain Training|Protocol Violation|0
7602535|NCT01928381|26450991|P6|Part 1 - Pain Training|Protocol Violation|0
7602536|NCT01928381|26450992|P5|Part 1 - Pain Training|Protocol Violation|0
7602537|NCT01928381|26450993|P4|Part 1 - Pain Training|Protocol Violation|0
7602538|NCT01928381|26450994|P3|Part 1 - Pain Training|Protocol Violation|0
7602539|NCT01928381|26450995|P2|Part 1 - Pain Training|Protocol Violation|0
7602540|NCT01928381|26450996|P1|Part 1 - Pain Training|Protocol Violation|1
7602541|NCT01928381|26450990|P7|Part 1 - Pain Training|Lost to Follow-up|0
7602542|NCT01928381|26450991|P6|Part 1 - Pain Training|Lost to Follow-up|0
7602543|NCT01928381|26450992|P5|Part 1 - Pain Training|Lost to Follow-up|0
7602544|NCT01928381|26450993|P4|Part 1 - Pain Training|Lost to Follow-up|0
7602545|NCT01928381|26450994|P3|Part 1 - Pain Training|Lost to Follow-up|0
7602546|NCT01928381|26450995|P2|Part 1 - Pain Training|Lost to Follow-up|0
7602547|NCT01928381|26450996|P1|Part 1 - Pain Training|Lost to Follow-up|4
7602548|NCT01928381|26450990|P7|Part 1 - Pain Training|Withdrawal by Subject|0
7602549|NCT01928381|26450991|P6|Part 1 - Pain Training|Withdrawal by Subject|0
7602550|NCT01928381|26450992|P5|Part 1 - Pain Training|Withdrawal by Subject|0
7602551|NCT01928381|26450993|P4|Part 1 - Pain Training|Withdrawal by Subject|0
7602552|NCT01928381|26450994|P3|Part 1 - Pain Training|Withdrawal by Subject|0
7602553|NCT01928381|26450995|P2|Part 1 - Pain Training|Withdrawal by Subject|0
7602554|NCT01928381|26450996|P1|Part 1 - Pain Training|Withdrawal by Subject|1
7602555|NCT01928381|26450990|P7|Part 1 - Pain Training|Pain training criteria not met|0
7602556|NCT01928381|26450991|P6|Part 1 - Pain Training|Pain training criteria not met|0
7602557|NCT01928381|26450992|P5|Part 1 - Pain Training|Pain training criteria not met|0
7602558|NCT01928381|26450993|P4|Part 1 - Pain Training|Pain training criteria not met|0
7602559|NCT01928381|26450994|P3|Part 1 - Pain Training|Pain training criteria not met|0
7602560|NCT01928381|26450995|P2|Part 1 - Pain Training|Pain training criteria not met|0
7602561|NCT01928381|26450996|P1|Part 1 - Pain Training|Pain training criteria not met|29
7602562|NCT01928381|26450990|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7602563|NCT01928381|26450991|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7602564|NCT01928381|26450992|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7602565|NCT01928381|26450993|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7602566|NCT01928381|26450994|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7602567|NCT01928381|26450995|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7602568|NCT01928381|26450996|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
7602569|NCT01928329|26451011|P2|Overall Study|Physician Decision|1
7602570|NCT01928329|26451012|P1|Overall Study|Physician Decision|1
7602571|NCT01928329|26451011|P2|Overall Study|Withdrawal by Subject|5
7602572|NCT01928329|26451012|P1|Overall Study|Withdrawal by Subject|1
7602573|NCT01928329|26451011|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
7602574|NCT01928329|26451012|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
7602575|NCT01928329|26451011|P2|Overall Study|Adverse Event|3
7602576|NCT01928329|26451012|P1|Overall Study|Adverse Event|5
7602577|NCT01928329|26451011|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
7602578|NCT01928329|26451012|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
7602579|NCT01928329|26451011|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
7602580|NCT01928329|26451012|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
7602581|NCT01928225|26451047|P2|Overall Study|Lost to Follow-up|3
7602582|NCT01928225|26451048|P1|Overall Study|Lost to Follow-up|1
7602583|NCT01928225|26451047|P2|Overall Study|basaloid cervical cancer|0
7602584|NCT01928225|26451048|P1|Overall Study|basaloid cervical cancer|1
7602585|NCT01928225|26451047|P2|Overall Study|Pregnancy|0
7602586|NCT01928225|26451048|P1|Overall Study|Pregnancy|1
7602587|NCT01928082|26451079|P1|Overall Study|Study terminated.|1
7602588|NCT01927861|26451113|P2|Extension Phase (104 Weeks)|Unclassified|1
7602589|NCT01927861|26451114|P1|Extension Phase (104 Weeks)|Unclassified|0
7602590|NCT01927861|26451113|P2|Extension Phase (104 Weeks)|Adverse Event|2
7602591|NCT01927861|26451114|P1|Extension Phase (104 Weeks)|Adverse Event|0
7602592|NCT01927757|26451252|P1|Overall Study|Ethical Reasons|4
7602593|NCT01927757|26451252|P1|Overall Study|Other|1
7602594|NCT01927757|26451252|P1|Overall Study|Decision by Sponsor|2
7602595|NCT01927757|26451252|P1|Overall Study|Lost to Follow-up|2
7602596|NCT01927757|26451252|P1|Overall Study|Withdrawal by Subject|14
7602597|NCT01927627|26451274|P1|Overall Study|Financial Concerns|1
7602598|NCT01927627|26451274|P1|Overall Study|Lack of Efficacy|1
7602599|NCT01927627|26451274|P1|Overall Study|Adverse Event|3
7602600|NCT01927562|26451287|P1|Overall Study|Physician Decision|5
7602601|NCT01927562|26451287|P1|Overall Study|Withdrawal by Subject|3
7602602|NCT01927562|26451287|P1|Overall Study|Lost to Follow-up|30
7602603|NCT01927497|26451293|P2|Overall Study|Protocol Violation|0
7602604|NCT01927497|26451294|P1|Overall Study|Protocol Violation|2
7602605|NCT01927497|26451293|P2|Overall Study|Death|1
7602606|NCT01927497|26451294|P1|Overall Study|Death|0
7602607|NCT01927419|26451302|P2|Overall Study|Not reported|0
7602608|NCT01927419|26451303|P1|Overall Study|Not reported|1
7602609|NCT01927419|26451302|P2|Overall Study|Other|1
7602610|NCT01927419|26451303|P1|Overall Study|Other|2
7602611|NCT01927419|26451302|P2|Overall Study|Withdrawal by Subject|1
7602612|NCT01927419|26451303|P1|Overall Study|Withdrawal by Subject|3
7602613|NCT01927419|26451302|P2|Overall Study|Adverse event unrelated to study drug|1
7602614|NCT01927419|26451303|P1|Overall Study|Adverse event unrelated to study drug|6
7602615|NCT01927419|26451302|P2|Overall Study|Death|1
7602616|NCT01927419|26451303|P1|Overall Study|Death|0
7602617|NCT01927419|26451302|P2|Overall Study|Study drug toxicity|7
7602618|NCT01927419|26451303|P1|Overall Study|Study drug toxicity|43
7602619|NCT01927419|26451302|P2|Overall Study|Disease progression|17
7602620|NCT01927419|26451303|P1|Overall Study|Disease progression|15
7602621|NCT01927367|26451321|P2|Overall Study|No baseline data|1
7602622|NCT01927367|26451322|P1|Overall Study|No baseline data|0
7602623|NCT01927367|26451321|P2|Overall Study|Withdrawal by Subject|4
7602624|NCT01927367|26451322|P1|Overall Study|Withdrawal by Subject|7
7602625|NCT01927341|26451341|P5|Phase 2|Follow-up completed|2
7602626|NCT01927341|26451342|P4|Phase 2|Follow-up completed|5
7602627|NCT01927341|26451343|P3|Phase 2|Follow-up completed|3
7602628|NCT01927341|26451344|P2|Phase 2|Follow-up completed|6
7602629|NCT01927341|26451345|P1|Phase 2|Follow-up completed|0
7602630|NCT01927341|26451341|P5|Phase 2|Disease progression|0
7602631|NCT01927341|26451342|P4|Phase 2|Disease progression|1
7602632|NCT01927341|26451343|P3|Phase 2|Disease progression|1
7602633|NCT01927341|26451344|P2|Phase 2|Disease progression|1
7602634|NCT01927341|26451345|P1|Phase 2|Disease progression|0
7602635|NCT01927341|26451341|P5|Phase 2|New cancer therapy|1
7602636|NCT01927341|26451342|P4|Phase 2|New cancer therapy|4
7602637|NCT01927341|26451343|P3|Phase 2|New cancer therapy|0
7602638|NCT01927341|26451344|P2|Phase 2|New cancer therapy|1
7602639|NCT01927341|26451345|P1|Phase 2|New cancer therapy|0
7602640|NCT01927341|26451341|P5|Phase 2|Death|2
7602641|NCT01927341|26451342|P4|Phase 2|Death|3
7602642|NCT01927341|26451343|P3|Phase 2|Death|0
7602643|NCT01927341|26451344|P2|Phase 2|Death|4
7602644|NCT01927341|26451345|P1|Phase 2|Death|0
7602645|NCT01927341|26451341|P5|Phase 2|Participant withdrew consent|3
7602646|NCT01927341|26451342|P4|Phase 2|Participant withdrew consent|2
7602647|NCT01927341|26451343|P3|Phase 2|Participant withdrew consent|1
7602648|NCT01927341|26451344|P2|Phase 2|Participant withdrew consent|2
7602649|NCT01927341|26451345|P1|Phase 2|Participant withdrew consent|0
7602650|NCT01927341|26451341|P5|Phase 2|Lost to Follow-up|0
7602651|NCT01927341|26451342|P4|Phase 2|Lost to Follow-up|0
7602652|NCT01927341|26451343|P3|Phase 2|Lost to Follow-up|0
7602653|NCT01927341|26451344|P2|Phase 2|Lost to Follow-up|1
7602654|NCT01927341|26451345|P1|Phase 2|Lost to Follow-up|0
7602655|NCT01927341|26451341|P5|Phase 1b|Follow-up completed|0
7602656|NCT01927341|26451342|P4|Phase 1b|Follow-up completed|0
7602657|NCT01927341|26451343|P3|Phase 1b|Follow-up completed|0
7602658|NCT01927341|26451344|P2|Phase 1b|Follow-up completed|0
7602659|NCT01927341|26451345|P1|Phase 1b|Follow-up completed|7
7602660|NCT01927341|26451341|P5|Phase 1b|Death|0
7602661|NCT01927341|26451342|P4|Phase 1b|Death|0
7602662|NCT01927341|26451343|P3|Phase 1b|Death|0
7602663|NCT01927341|26451344|P2|Phase 1b|Death|0
7602664|NCT01927341|26451345|P1|Phase 1b|Death|2
7602665|NCT01927341|26451341|P5|Phase 1b|Lost to Follow-up|0
7602666|NCT01927341|26451342|P4|Phase 1b|Lost to Follow-up|0
7602667|NCT01927341|26451343|P3|Phase 1b|Lost to Follow-up|0
7602668|NCT01927341|26451344|P2|Phase 1b|Lost to Follow-up|0
7602669|NCT01927341|26451345|P1|Phase 1b|Lost to Follow-up|1
7602670|NCT01927055|26451416|P3|Double-Blind|Extended Vacation|0
7602671|NCT01927055|26451417|P2|Double-Blind|Extended Vacation|1
7602672|NCT01927055|26451418|P1|Double-Blind|Extended Vacation|0
7602673|NCT01927055|26451416|P3|Double-Blind|Supine Hypertension|1
7602674|NCT01927055|26451417|P2|Double-Blind|Supine Hypertension|0
7602675|NCT01927055|26451418|P1|Double-Blind|Supine Hypertension|0
7602676|NCT01927055|26451416|P3|Double-Blind|Study Stopped|7
7602677|NCT01927055|26451417|P2|Double-Blind|Study Stopped|7
7602678|NCT01927055|26451418|P1|Double-Blind|Study Stopped|0
7602679|NCT01927055|26451416|P3|Double-Blind|Withdrawal by Subject|3
7602680|NCT01927055|26451417|P2|Double-Blind|Withdrawal by Subject|2
7602681|NCT01927055|26451418|P1|Double-Blind|Withdrawal by Subject|0
7602682|NCT01927055|26451416|P3|Double-Blind|Protocol Violation|1
7602683|NCT01927055|26451417|P2|Double-Blind|Protocol Violation|0
7602684|NCT01927055|26451418|P1|Double-Blind|Protocol Violation|0
7602685|NCT01927055|26451416|P3|Double-Blind|Adverse Event|1
7602686|NCT01927055|26451417|P2|Double-Blind|Adverse Event|1
7602687|NCT01927055|26451418|P1|Double-Blind|Adverse Event|0
7602688|NCT01927055|26451416|P3|Open-label|Difficulty attending study visits|0
7602689|NCT01927055|26451417|P2|Open-label|Difficulty attending study visits|0
7602690|NCT01927055|26451418|P1|Open-label|Difficulty attending study visits|1
7602691|NCT01927055|26451416|P3|Open-label|Supine Hypertension|0
7602692|NCT01927055|26451417|P2|Open-label|Supine Hypertension|0
7602693|NCT01927055|26451418|P1|Open-label|Supine Hypertension|4
7602694|NCT01927055|26451416|P3|Open-label|Study Stopped|0
7602695|NCT01927055|26451417|P2|Open-label|Study Stopped|0
7602696|NCT01927055|26451418|P1|Open-label|Study Stopped|4
7602697|NCT01927055|26451416|P3|Open-label|Withdrawal by Subject|0
7602698|NCT01927055|26451417|P2|Open-label|Withdrawal by Subject|0
7602699|NCT01927055|26451418|P1|Open-label|Withdrawal by Subject|1
7602700|NCT01927055|26451416|P3|Open-label|Adverse Event|0
7602701|NCT01927055|26451417|P2|Open-label|Adverse Event|0
7602702|NCT01927055|26451418|P1|Open-label|Adverse Event|6
7602703|NCT01926886|26451436|P2|Overall Study|Did not cooperate|0
7602704|NCT01926886|26451437|P1|Overall Study|Did not cooperate|1
7602705|NCT01926886|26451436|P2|Overall Study|Death|0
7602706|NCT01926886|26451437|P1|Overall Study|Death|1
7602707|NCT01926886|26451436|P2|Overall Study|Progression of disease|0
7602708|NCT01926886|26451437|P1|Overall Study|Progression of disease|2
7602709|NCT01926886|26451436|P2|Overall Study|Recurrence of disease|0
7602710|NCT01926886|26451437|P1|Overall Study|Recurrence of disease|1
7602711|NCT01926886|26451436|P2|Overall Study|Failure to return|0
7602712|NCT01926886|26451437|P1|Overall Study|Failure to return|3
7602713|NCT01926886|26451436|P2|Overall Study|Withdrawal by Subject|0
7602714|NCT01926886|26451437|P1|Overall Study|Withdrawal by Subject|15
7602715|NCT01926886|26451436|P2|Overall Study|Disease progression/recurrence|0
7602716|NCT01926886|26451437|P1|Overall Study|Disease progression/recurrence|4
7602717|NCT01926886|26451436|P2|Overall Study|Adverse event/intercurrent illness|0
7602718|NCT01926886|26451437|P1|Overall Study|Adverse event/intercurrent illness|4
7602719|NCT01926886|26451436|P2|Overall Study|Administrative/other|0
7602720|NCT01926886|26451437|P1|Overall Study|Administrative/other|1
7602721|NCT01926782|26451456|P6|Overall Study|Related to study drug administration|2
7602722|NCT01926782|26451457|P5|Overall Study|Related to study drug administration|0
7602723|NCT01926782|26451458|P4|Overall Study|Related to study drug administration|0
7602724|NCT01926782|26451459|P3|Overall Study|Related to study drug administration|0
7602725|NCT01926782|26451460|P2|Overall Study|Related to study drug administration|0
7602726|NCT01926782|26451461|P1|Overall Study|Related to study drug administration|0
7602727|NCT01926782|26451456|P6|Overall Study|Withdrawal by Subject|5
7602728|NCT01926782|26451457|P5|Overall Study|Withdrawal by Subject|0
7602729|NCT01926782|26451458|P4|Overall Study|Withdrawal by Subject|1
7602730|NCT01926782|26451459|P3|Overall Study|Withdrawal by Subject|8
7602731|NCT01926782|26451460|P2|Overall Study|Withdrawal by Subject|1
7602732|NCT01926782|26451461|P1|Overall Study|Withdrawal by Subject|6
7602733|NCT01926782|26451456|P6|Overall Study|Randomized and not treated|0
7602734|NCT01926782|26451457|P5|Overall Study|Randomized and not treated|0
7602735|NCT01926782|26451458|P4|Overall Study|Randomized and not treated|1
7602736|NCT01926782|26451459|P3|Overall Study|Randomized and not treated|0
7602737|NCT01926782|26451460|P2|Overall Study|Randomized and not treated|0
7602738|NCT01926782|26451461|P1|Overall Study|Randomized and not treated|0
7602739|NCT01926782|26451456|P6|Overall Study|Poor compliance to protocol|6
7602740|NCT01926782|26451457|P5|Overall Study|Poor compliance to protocol|1
7602741|NCT01926782|26451458|P4|Overall Study|Poor compliance to protocol|0
7602742|NCT01926782|26451459|P3|Overall Study|Poor compliance to protocol|8
7602743|NCT01926782|26451460|P2|Overall Study|Poor compliance to protocol|3
7602744|NCT01926782|26451461|P1|Overall Study|Poor compliance to protocol|5
7602745|NCT01926782|26451456|P6|Overall Study|Adverse Event|14
7602746|NCT01926782|26451457|P5|Overall Study|Adverse Event|3
7602747|NCT01926782|26451458|P4|Overall Study|Adverse Event|4
7602748|NCT01926782|26451459|P3|Overall Study|Adverse Event|17
7602749|NCT01926782|26451460|P2|Overall Study|Adverse Event|4
7602750|NCT01926782|26451461|P1|Overall Study|Adverse Event|13
7602751|NCT01926782|26451456|P6|Overall Study|Other than specified|11
7602752|NCT01926782|26451457|P5|Overall Study|Other than specified|4
7602753|NCT01926782|26451458|P4|Overall Study|Other than specified|12
7602754|NCT01926782|26451459|P3|Overall Study|Other than specified|5
7602755|NCT01926782|26451460|P2|Overall Study|Other than specified|3
7602756|NCT01926782|26451461|P1|Overall Study|Other than specified|2
7602757|NCT01926782|26451456|P6|Overall Study|Physician Decision|0
7602758|NCT01926782|26451457|P5|Overall Study|Physician Decision|0
7602759|NCT01926782|26451458|P4|Overall Study|Physician Decision|1
7602760|NCT01926782|26451459|P3|Overall Study|Physician Decision|1
7602761|NCT01926782|26451460|P2|Overall Study|Physician Decision|2
7602762|NCT01926782|26451461|P1|Overall Study|Physician Decision|0
7602763|NCT01926782|26451456|P6|Overall Study|Participant moved|3
7602764|NCT01926782|26451457|P5|Overall Study|Participant moved|0
7602765|NCT01926782|26451458|P4|Overall Study|Participant moved|1
7602766|NCT01926782|26451459|P3|Overall Study|Participant moved|1
7602767|NCT01926782|26451460|P2|Overall Study|Participant moved|0
7602768|NCT01926782|26451461|P1|Overall Study|Participant moved|2
7602769|NCT01926626|26451610|P1|Overall Study|Lost to Follow-up|7
7602770|NCT01926626|26451610|P1|Overall Study|Withdrawal by Subject|15
7602771|NCT01926509|26451624|P4|Overall Study|vital sign met discontinuation criteria|0
7602772|NCT01926509|26451625|P3|Overall Study|vital sign met discontinuation criteria|0
7602773|NCT01926509|26451626|P2|Overall Study|vital sign met discontinuation criteria|0
7602774|NCT01926509|26451627|P1|Overall Study|vital sign met discontinuation criteria|1
7602775|NCT01926444|26451667|P4|Overall Study|Colonoscopy not performed|2
7602776|NCT01926444|26451668|P3|Overall Study|Colonoscopy not performed|4
7602777|NCT01926444|26451669|P2|Overall Study|Colonoscopy not performed|0
7602778|NCT01926444|26451670|P1|Overall Study|Colonoscopy not performed|0
7602779|NCT01926119|26451712|P1|Overall Study|Withdrawal by Subject|1
7602780|NCT01926028|26451725|P3|Overall Study|Non compliance or other reasons|0
7602781|NCT01926028|26451726|P2|Overall Study|Non compliance or other reasons|2
7602782|NCT01926028|26451727|P1|Overall Study|Non compliance or other reasons|4
7602783|NCT01926028|26451725|P3|Overall Study|Withdrawal by Subject|2
7602784|NCT01926028|26451726|P2|Overall Study|Withdrawal by Subject|9
7602785|NCT01926028|26451727|P1|Overall Study|Withdrawal by Subject|9
7602786|NCT01926028|26451725|P3|Overall Study|Physician Decision|0
7602787|NCT01926028|26451726|P2|Overall Study|Physician Decision|5
7602788|NCT01926028|26451727|P1|Overall Study|Physician Decision|1
7602789|NCT01926028|26451725|P3|Overall Study|Lost to Follow-up|0
7602790|NCT01926028|26451726|P2|Overall Study|Lost to Follow-up|6
7602791|NCT01926028|26451727|P1|Overall Study|Lost to Follow-up|7
7602792|NCT01926015|26451763|P2|Overall Study|Randomized not treated|0
7602793|NCT01926015|26451764|P1|Overall Study|Randomized not treated|2
7602794|NCT01926015|26451763|P2|Overall Study|Withdrawal by parent/guardian|1
7602795|NCT01926015|26451764|P1|Overall Study|Withdrawal by parent/guardian|0
7602796|NCT01925989|26451796|P3|Period 1|Withdrawal by Subject|0
7602797|NCT01925989|26451797|P2|Period 1|Withdrawal by Subject|1
7602798|NCT01925989|26451798|P1|Period 1|Withdrawal by Subject|0
7602799|NCT01925989|26451796|P3|Period 1|Sponsor Decision|0
7602800|NCT01925989|26451797|P2|Period 1|Sponsor Decision|1
7602801|NCT01925989|26451798|P1|Period 1|Sponsor Decision|1
7602802|NCT01925950|26451818|P2|Part 2|Withdrawal by Subject|0
7602803|NCT01925950|26451819|P1|Part 2|Withdrawal by Subject|1
7602804|NCT01925768|26451838|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
7602805|NCT01925768|26451839|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
7602806|NCT01925768|26451838|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
7602807|NCT01925768|26451839|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
7602808|NCT01925768|26451838|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
7602809|NCT01925768|26451839|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
7602810|NCT01925768|26451838|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
7602811|NCT01925768|26451839|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
7602812|NCT01925768|26451838|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7602813|NCT01925768|26451839|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7602814|NCT01925768|26451838|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
7602815|NCT01925768|26451839|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
7602816|NCT01925768|26451838|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7602817|NCT01925768|26451839|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7602818|NCT01925768|26451838|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7602819|NCT01925768|26451839|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7602820|NCT01925768|26451838|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7602821|NCT01925768|26451839|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7602822|NCT01925768|26451838|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
7602823|NCT01925768|26451839|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7602824|NCT01925768|26451838|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7602825|NCT01925768|26451839|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7602826|NCT01925703|26451887|P1|Overall Study|Discharge prior to full iron repletion|1
7602827|NCT01925703|26451887|P1|Overall Study|Lost to Follow-up|2
7602828|NCT01925703|26451887|P1|Overall Study|Physician Decision|1
7602829|NCT01925612|26451905|P5|Overall Study|Adverse Event|2
7602830|NCT01925612|26451906|P4|Overall Study|Adverse Event|1
7602831|NCT01925612|26451907|P3|Overall Study|Adverse Event|0
7602832|NCT01925612|26451908|P2|Overall Study|Adverse Event|3
7602833|NCT01925612|26451909|P1|Overall Study|Adverse Event|3
7602834|NCT01925612|26451905|P5|Overall Study|Progressive Disease|0
7602835|NCT01925612|26451906|P4|Overall Study|Progressive Disease|0
7602836|NCT01925612|26451907|P3|Overall Study|Progressive Disease|1
7602837|NCT01925612|26451908|P2|Overall Study|Progressive Disease|1
7602838|NCT01925612|26451909|P1|Overall Study|Progressive Disease|1
7602839|NCT01925417|26451959|P1|Overall Study|Death|1
7602840|NCT01925417|26451959|P1|Overall Study|Withdrawal by Subject|2
7602841|NCT01925339|26451990|P2|Overall Study|Adverse Event|0
7602842|NCT01925339|26451991|P1|Overall Study|Adverse Event|2
7602843|NCT01925274|26452002|P3|Overall Study|Protocol amendment|6
7602844|NCT01925274|26452003|P2|Overall Study|Protocol amendment|3
7602845|NCT01925274|26452004|P1|Overall Study|Protocol amendment|1
7602846|NCT01925274|26452002|P3|Overall Study|Study terminated by sponsor|0
7602847|NCT01925274|26452003|P2|Overall Study|Study terminated by sponsor|0
7602848|NCT01925274|26452004|P1|Overall Study|Study terminated by sponsor|4
7602849|NCT01925274|26452002|P3|Overall Study|Withdrawal by Subject|0
7602850|NCT01925274|26452003|P2|Overall Study|Withdrawal by Subject|2
7602851|NCT01925274|26452004|P1|Overall Study|Withdrawal by Subject|1
7602852|NCT01925274|26452002|P3|Overall Study|Lost to Follow-up|0
7602853|NCT01925274|26452003|P2|Overall Study|Lost to Follow-up|1
7602854|NCT01925274|26452004|P1|Overall Study|Lost to Follow-up|0
7602855|NCT01925274|26452002|P3|Overall Study|Death|0
7602856|NCT01925274|26452003|P2|Overall Study|Death|0
7602857|NCT01925274|26452004|P1|Overall Study|Death|1
7602858|NCT01925209|26452085|P4|Follow-up|Withdrawal by Subject|2
7602859|NCT01925209|26452086|P3|Follow-up|Withdrawal by Subject|0
7602860|NCT01925209|26452087|P2|Follow-up|Withdrawal by Subject|2
7602861|NCT01925209|26452088|P1|Follow-up|Withdrawal by Subject|0
7602862|NCT01925209|26452085|P4|Follow-up|Non-compliance with study treatment|1
7602863|NCT01925209|26452086|P3|Follow-up|Non-compliance with study treatment|0
7602864|NCT01925209|26452087|P2|Follow-up|Non-compliance with study treatment|0
7602865|NCT01925209|26452088|P1|Follow-up|Non-compliance with study treatment|0
7602866|NCT01925209|26452085|P4|Follow-up|Physician Decision|0
7602867|NCT01925209|26452086|P3|Follow-up|Physician Decision|1
7602868|NCT01925209|26452087|P2|Follow-up|Physician Decision|0
7602869|NCT01925209|26452088|P1|Follow-up|Physician Decision|0
7602870|NCT01925209|26452085|P4|Follow-up|Adverse Event|1
7602871|NCT01925209|26452086|P3|Follow-up|Adverse Event|0
7602872|NCT01925209|26452087|P2|Follow-up|Adverse Event|4
7602873|NCT01925209|26452088|P1|Follow-up|Adverse Event|1
7602874|NCT01925209|26452085|P4|Maintenance Treatment Epoch|Adverse Event|0
7602875|NCT01925209|26452086|P3|Maintenance Treatment Epoch|Adverse Event|1
7602876|NCT01925209|26452087|P2|Maintenance Treatment Epoch|Adverse Event|0
7602877|NCT01925209|26452088|P1|Maintenance Treatment Epoch|Adverse Event|0
7602878|NCT01925209|26452085|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
7602879|NCT01925209|26452086|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
7602880|NCT01925209|26452087|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
7602881|NCT01925209|26452088|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
7602882|NCT01925209|26452085|P4|Treatment Epoch|Adverse Event|1
7602883|NCT01925209|26452086|P3|Treatment Epoch|Adverse Event|3
7602884|NCT01925209|26452087|P2|Treatment Epoch|Adverse Event|5
7602885|NCT01925209|26452088|P1|Treatment Epoch|Adverse Event|3
7602886|NCT01925209|26452085|P4|Treatment Epoch|Withdrawal by Subject|2
7602887|NCT01925209|26452086|P3|Treatment Epoch|Withdrawal by Subject|3
7602888|NCT01925209|26452087|P2|Treatment Epoch|Withdrawal by Subject|3
7602889|NCT01925209|26452088|P1|Treatment Epoch|Withdrawal by Subject|4
7602890|NCT01925209|26452085|P4|Treatment Epoch|Protocol deviation|1
7602891|NCT01925209|26452086|P3|Treatment Epoch|Protocol deviation|1
7602892|NCT01925209|26452087|P2|Treatment Epoch|Protocol deviation|0
7602893|NCT01925209|26452088|P1|Treatment Epoch|Protocol deviation|0
7602894|NCT01925209|26452085|P4|Treatment Epoch|Death|0
7602895|NCT01925209|26452086|P3|Treatment Epoch|Death|0
7602896|NCT01925209|26452087|P2|Treatment Epoch|Death|0
7602897|NCT01925209|26452088|P1|Treatment Epoch|Death|1
7602898|NCT01925209|26452085|P4|Treatment Epoch|Non-compliance with study treatment|1
7602899|NCT01925209|26452086|P3|Treatment Epoch|Non-compliance with study treatment|0
7602900|NCT01925209|26452087|P2|Treatment Epoch|Non-compliance with study treatment|0
7602901|NCT01925209|26452088|P1|Treatment Epoch|Non-compliance with study treatment|0
7602902|NCT01925209|26452085|P4|Treatment Epoch|Physician Decision|0
7602903|NCT01925209|26452086|P3|Treatment Epoch|Physician Decision|0
7602904|NCT01925209|26452087|P2|Treatment Epoch|Physician Decision|0
7602905|NCT01925209|26452088|P1|Treatment Epoch|Physician Decision|1
7602906|NCT01925183|26452120|P2|Overall Study|Adverse Event|0
7602907|NCT01925183|26452121|P1|Overall Study|Adverse Event|1
7602908|NCT01925170|26452129|P1|Overall Study|Unverified cancer status|53
7602909|NCT01925014|26452160|P2|Overall Study|Withdrawal by Subject|13
7602910|NCT01925014|26452161|P1|Overall Study|Withdrawal by Subject|5
7602911|NCT01925014|26452160|P2|Overall Study|Inappropriate enrollment|6
7602912|NCT01925014|26452161|P1|Overall Study|Inappropriate enrollment|4
7602913|NCT01924845|26452236|P1|Overall Study|Protocol Violation|1
7602914|NCT01924845|26452236|P1|Overall Study|Withdrawal by Subject|2
7602915|NCT01924845|26452236|P1|Overall Study|Adverse Event|3
7602916|NCT01924806|26452246|P2|Overall Study|Physician Decision|1
7602917|NCT01924806|26452247|P1|Overall Study|Physician Decision|2
7602918|NCT01924767|26452264|P5|Overall Study|Adverse Event|0
7602919|NCT01924767|26452265|P4|Overall Study|Adverse Event|0
7602920|NCT01924767|26452266|P3|Overall Study|Adverse Event|1
7602921|NCT01924767|26452267|P2|Overall Study|Adverse Event|0
7602922|NCT01924767|26452268|P1|Overall Study|Adverse Event|1
7602923|NCT01924754|26452371|P3|Overall Study|Pregnancy|2
7602924|NCT01924754|26452372|P2|Overall Study|Pregnancy|1
7602925|NCT01924754|26452373|P1|Overall Study|Pregnancy|0
7602926|NCT01924754|26452371|P3|Overall Study|Lost to Follow-up|1
7602927|NCT01924754|26452372|P2|Overall Study|Lost to Follow-up|2
7602928|NCT01924754|26452373|P1|Overall Study|Lost to Follow-up|1
7602929|NCT01924689|26452413|P6|Overall Study|Other|0
7602930|NCT01924689|26452414|P5|Overall Study|Other|1
7602931|NCT01924689|26452415|P4|Overall Study|Other|0
7602932|NCT01924689|26452416|P3|Overall Study|Other|0
7602933|NCT01924689|26452417|P2|Overall Study|Other|0
7602934|NCT01924689|26452418|P1|Overall Study|Other|0
7602935|NCT01924689|26452413|P6|Overall Study|Withdrawal of consent|0
7602936|NCT01924689|26452414|P5|Overall Study|Withdrawal of consent|0
7602937|NCT01924689|26452415|P4|Overall Study|Withdrawal of consent|1
7602938|NCT01924689|26452416|P3|Overall Study|Withdrawal of consent|1
7602939|NCT01924689|26452417|P2|Overall Study|Withdrawal of consent|0
7602940|NCT01924689|26452418|P1|Overall Study|Withdrawal of consent|0
7602941|NCT01924689|26452413|P6|Overall Study|New therapy or study|0
7602942|NCT01924689|26452414|P5|Overall Study|New therapy or study|2
7602943|NCT01924689|26452415|P4|Overall Study|New therapy or study|4
7602944|NCT01924689|26452416|P3|Overall Study|New therapy or study|1
7602945|NCT01924689|26452417|P2|Overall Study|New therapy or study|2
7602946|NCT01924689|26452418|P1|Overall Study|New therapy or study|3
7602947|NCT01924689|26452413|P6|Overall Study|Disease progression|2
7602948|NCT01924689|26452414|P5|Overall Study|Disease progression|3
7602949|NCT01924689|26452415|P4|Overall Study|Disease progression|0
7602950|NCT01924689|26452416|P3|Overall Study|Disease progression|2
7602951|NCT01924689|26452417|P2|Overall Study|Disease progression|0
7602952|NCT01924689|26452418|P1|Overall Study|Disease progression|0
7602953|NCT01924689|26452413|P6|Overall Study|Death|0
7602954|NCT01924689|26452414|P5|Overall Study|Death|0
7602955|NCT01924689|26452415|P4|Overall Study|Death|1
7602956|NCT01924689|26452416|P3|Overall Study|Death|0
7602957|NCT01924689|26452417|P2|Overall Study|Death|1
7602958|NCT01924689|26452418|P1|Overall Study|Death|0
7602959|NCT01924533|26452492|P2|Overall Study|Other Eligibility criteria|1
7602960|NCT01924533|26452493|P1|Overall Study|Other Eligibility criteria|1
7602961|NCT01924533|26452492|P2|Overall Study|Withdrawal by Subject|3
7602962|NCT01924533|26452493|P1|Overall Study|Withdrawal by Subject|7
7602963|NCT01924533|26452492|P2|Overall Study|Lost to Follow-up|1
7602964|NCT01924533|26452493|P1|Overall Study|Lost to Follow-up|0
7602965|NCT01924533|26452492|P2|Overall Study|Death|200
7602966|NCT01924533|26452493|P1|Overall Study|Death|181
7602967|NCT01924429|26452534|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
7602968|NCT01924429|26452535|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
7602969|NCT01924364|26452578|P1|Overall Study|Physician Decision|3
7602970|NCT01924299|26452595|P2|Period 2|Adverse Event|1
7602971|NCT01924299|26452596|P1|Period 2|Adverse Event|0
7602972|NCT01924299|26452595|P2|Period 2|Withdrawal by Subject|0
7602973|NCT01924299|26452596|P1|Period 2|Withdrawal by Subject|1
7602974|NCT01924182|26452618|P2|Overall Study|Withdrawal by Subject|0
7602975|NCT01924182|26452619|P1|Overall Study|Withdrawal by Subject|1
7602976|NCT01923896|26452660|P2|Overall Study|Adverse Event|0
7602977|NCT01923896|26452661|P1|Overall Study|Adverse Event|1
7602978|NCT01923740|26452684|P2|Overall Study|Withdrawal by Subject|0
7602979|NCT01923740|26452685|P1|Overall Study|Withdrawal by Subject|2
7602980|NCT01923740|26452684|P2|Overall Study|Lost to Follow-up|9
7602981|NCT01923740|26452685|P1|Overall Study|Lost to Follow-up|4
7602982|NCT01923467|26453110|P1|Overall Study|Subject non-interest|479
7602983|NCT01923467|26453110|P1|Overall Study|Lost to Follow-up|62
7602984|NCT01923428|26453118|P4|Overall Study|Lack of Efficacy|1
7602985|NCT01923428|26453119|P3|Overall Study|Lack of Efficacy|1
7602986|NCT01923428|26453120|P2|Overall Study|Lack of Efficacy|0
7602987|NCT01923428|26453121|P1|Overall Study|Lack of Efficacy|0
7602988|NCT01923428|26453118|P4|Overall Study|Non Compliance to treatment|1
7602989|NCT01923428|26453119|P3|Overall Study|Non Compliance to treatment|0
7602990|NCT01923428|26453120|P2|Overall Study|Non Compliance to treatment|2
7602991|NCT01923428|26453121|P1|Overall Study|Non Compliance to treatment|1
7602992|NCT01923428|26453118|P4|Overall Study|Protocol Violation|1
7602993|NCT01923428|26453119|P3|Overall Study|Protocol Violation|2
7602994|NCT01923428|26453120|P2|Overall Study|Protocol Violation|0
7602995|NCT01923428|26453121|P1|Overall Study|Protocol Violation|3
7602996|NCT01923428|26453118|P4|Overall Study|Lost to Follow-up|0
7602997|NCT01923428|26453119|P3|Overall Study|Lost to Follow-up|5
7602998|NCT01923428|26453120|P2|Overall Study|Lost to Follow-up|1
7602999|NCT01923428|26453121|P1|Overall Study|Lost to Follow-up|2
7603000|NCT01923428|26453118|P4|Overall Study|Withdrawal by Subject|4
7603001|NCT01923428|26453119|P3|Overall Study|Withdrawal by Subject|0
7603002|NCT01923428|26453120|P2|Overall Study|Withdrawal by Subject|3
7603003|NCT01923428|26453121|P1|Overall Study|Withdrawal by Subject|5
7603004|NCT01923428|26453118|P4|Overall Study|Adverse Event|3
7603005|NCT01923428|26453119|P3|Overall Study|Adverse Event|3
7603006|NCT01923428|26453120|P2|Overall Study|Adverse Event|6
7603007|NCT01923428|26453121|P1|Overall Study|Adverse Event|8
7603008|NCT01923389|26453133|P2|Overall Study|Protocol Violation|0
7603009|NCT01923389|26453134|P1|Overall Study|Protocol Violation|1
7603010|NCT01923363|26453156|P1|Overall Study|Protocol Violation|1
7603011|NCT01923311|26453165|P2|Overall Study|Study Terminated by Sponsor|0
7603012|NCT01923311|26453166|P1|Overall Study|Study Terminated by Sponsor|12
7603013|NCT01923311|26453165|P2|Overall Study|Withdrew Consent|0
7603014|NCT01923311|26453166|P1|Overall Study|Withdrew Consent|1
7603015|NCT01923311|26453165|P2|Overall Study|Non-Compliance with Study Drug|1
7603016|NCT01923311|26453166|P1|Overall Study|Non-Compliance with Study Drug|2
7603017|NCT01923311|26453165|P2|Overall Study|Investigator's Discretion|0
7603018|NCT01923311|26453166|P1|Overall Study|Investigator's Discretion|1
7603019|NCT01923311|26453165|P2|Overall Study|Pregnancy|0
7603020|NCT01923311|26453166|P1|Overall Study|Pregnancy|1
7603021|NCT01923285|26453211|P2|Overall Study|Withdrawal by Subject|6
7603022|NCT01923285|26453212|P1|Overall Study|Withdrawal by Subject|7
7603023|NCT01923181|26453233|P9|Overall Study|Lost to Follow-up|1
7603024|NCT01923181|26453234|P8|Overall Study|Lost to Follow-up|3
7603025|NCT01923181|26453235|P7|Overall Study|Lost to Follow-up|3
7603026|NCT01923181|26453236|P6|Overall Study|Lost to Follow-up|1
7603027|NCT01923181|26453237|P5|Overall Study|Lost to Follow-up|2
7603028|NCT01923181|26453238|P4|Overall Study|Lost to Follow-up|1
7603029|NCT01923181|26453239|P3|Overall Study|Lost to Follow-up|2
7603030|NCT01923181|26453240|P2|Overall Study|Lost to Follow-up|3
7603031|NCT01923181|26453241|P1|Overall Study|Lost to Follow-up|0
7603032|NCT01923181|26453233|P9|Overall Study|Other|0
7603033|NCT01923181|26453234|P8|Overall Study|Other|0
7603034|NCT01923181|26453235|P7|Overall Study|Other|0
7603035|NCT01923181|26453236|P6|Overall Study|Other|0
7603036|NCT01923181|26453237|P5|Overall Study|Other|0
7603037|NCT01923181|26453238|P4|Overall Study|Other|1
7603038|NCT01923181|26453239|P3|Overall Study|Other|0
7603039|NCT01923181|26453240|P2|Overall Study|Other|0
7603040|NCT01923181|26453241|P1|Overall Study|Other|1
7603041|NCT01923181|26453233|P9|Overall Study|Withdrawal by Subject|1
7603042|NCT01923181|26453234|P8|Overall Study|Withdrawal by Subject|3
7603043|NCT01923181|26453235|P7|Overall Study|Withdrawal by Subject|4
7603044|NCT01923181|26453236|P6|Overall Study|Withdrawal by Subject|2
7603045|NCT01923181|26453237|P5|Overall Study|Withdrawal by Subject|4
7603046|NCT01923181|26453238|P4|Overall Study|Withdrawal by Subject|1
7603047|NCT01923181|26453239|P3|Overall Study|Withdrawal by Subject|0
7603048|NCT01923181|26453240|P2|Overall Study|Withdrawal by Subject|1
7603049|NCT01923181|26453241|P1|Overall Study|Withdrawal by Subject|0
7603050|NCT01923181|26453233|P9|Overall Study|Protocol Violation|1
7603051|NCT01923181|26453234|P8|Overall Study|Protocol Violation|2
7603052|NCT01923181|26453235|P7|Overall Study|Protocol Violation|1
7603053|NCT01923181|26453236|P6|Overall Study|Protocol Violation|1
7603054|NCT01923181|26453237|P5|Overall Study|Protocol Violation|2
7603055|NCT01923181|26453238|P4|Overall Study|Protocol Violation|2
7603056|NCT01923181|26453239|P3|Overall Study|Protocol Violation|0
7603057|NCT01923181|26453240|P2|Overall Study|Protocol Violation|2
7603058|NCT01923181|26453241|P1|Overall Study|Protocol Violation|2
7603059|NCT01923168|26453319|P3|Overall Study|Death|1
7603060|NCT01923168|26453320|P2|Overall Study|Death|0
7603061|NCT01923168|26453321|P1|Overall Study|Death|0
7603062|NCT01923168|26453319|P3|Overall Study|Progressive disease|7
7603063|NCT01923168|26453320|P2|Overall Study|Progressive disease|3
7603064|NCT01923168|26453321|P1|Overall Study|Progressive disease|4
7603065|NCT01923168|26453319|P3|Overall Study|Physician Decision|5
7603066|NCT01923168|26453320|P2|Overall Study|Physician Decision|9
7603067|NCT01923168|26453321|P1|Overall Study|Physician Decision|6
7603068|NCT01923168|26453319|P3|Overall Study|Adverse Event|0
7603069|NCT01923168|26453320|P2|Overall Study|Adverse Event|12
7603070|NCT01923168|26453321|P1|Overall Study|Adverse Event|12
7603071|NCT01923168|26453319|P3|Overall Study|Subject/guardian decision|4
7603072|NCT01923168|26453320|P2|Overall Study|Subject/guardian decision|14
7603073|NCT01923168|26453321|P1|Overall Study|Subject/guardian decision|14
7603074|NCT01923168|26453319|P3|Overall Study|Protocol Violation|0
7603075|NCT01923168|26453320|P2|Overall Study|Protocol Violation|1
7603076|NCT01923168|26453321|P1|Overall Study|Protocol Violation|1
7603077|NCT01922934|26453404|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
7603078|NCT01922934|26453405|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
7603079|NCT01922934|26453404|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
7603080|NCT01922934|26453405|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
7603081|NCT01922934|26453404|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
7603082|NCT01922934|26453405|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
7603083|NCT01922934|26453404|P2|Eligible Patients|Did not meet inclusion criteria|81
7603084|NCT01922934|26453405|P1|Eligible Patients|Did not meet inclusion criteria|36
7603085|NCT01922934|26453404|P2|Eligible Patients|Physician Decision|0
7603086|NCT01922934|26453405|P1|Eligible Patients|Physician Decision|17
7603087|NCT01922934|26453404|P2|Eligible Patients|Death|7
7603088|NCT01922934|26453405|P1|Eligible Patients|Death|0
7603089|NCT01922739|26453417|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
7603090|NCT01922739|26453417|P1|Open-label Treatment Period|Physician Decision|1
7603091|NCT01922739|26453417|P1|Open-label Treatment Period|Lost to Follow-up|2
7603092|NCT01922739|26453417|P1|Open-label Treatment Period|Noncompliance to study procedures|1
7603093|NCT01922739|26453417|P1|Open-label Treatment Period|Pregnancy|1
7603094|NCT01922739|26453417|P1|Open-label Treatment Period|Protocol Violation|5
7603095|NCT01922739|26453417|P1|Open-label Treatment Period|Noncompliance to study medication|3
7603096|NCT01922739|26453417|P1|Open-label Treatment Period|Withdrawal by Subject|14
7603097|NCT01922739|26453417|P1|Open-label Treatment Period|Adverse Event|6
7603098|NCT01922739|26453417|P1|Titration/Adjustment Period|Lack of Efficacy|3
7603186|NCT01921517|26453998|P1|Overall Study|Newly diagnosed health concern|2
7603099|NCT01922739|26453417|P1|Titration/Adjustment Period|Lost to Follow-up|1
7603100|NCT01922739|26453417|P1|Titration/Adjustment Period|Withdrawal by Subject|5
7603101|NCT01922739|26453417|P1|Titration/Adjustment Period|Adverse Event|3
7603102|NCT01922349|26453446|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
7603103|NCT01922349|26453447|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
7603104|NCT01922349|26453448|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
7603105|NCT01922349|26453449|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
7603106|NCT01922271|26453578|P2|WASHOUT Period|Withdrawal by Subject|0
7603107|NCT01922271|26453579|P1|WASHOUT Period|Withdrawal by Subject|1
7603108|NCT01922258|26453599|P2|Overall Study|Withdrawal by participant|5
7603109|NCT01922258|26453600|P1|Overall Study|Withdrawal by participant|5
7603110|NCT01922258|26453599|P2|Overall Study|Withdrawn by the Investigator|4
7603111|NCT01922258|26453600|P1|Overall Study|Withdrawn by the Investigator|1
7603112|NCT01922258|26453599|P2|Overall Study|Met Withdrawal Criteria|4
7603113|NCT01922258|26453600|P1|Overall Study|Met Withdrawal Criteria|0
7603114|NCT01922258|26453599|P2|Overall Study|Adverse Event|2
7603115|NCT01922258|26453600|P1|Overall Study|Adverse Event|9
7603116|NCT01922258|26453599|P2|Overall Study|Lost to Follow-up|1
7603117|NCT01922258|26453600|P1|Overall Study|Lost to Follow-up|1
7603118|NCT01922102|26453632|P3|Overall Study|Administrative problems|0
7603119|NCT01922102|26453633|P2|Overall Study|Administrative problems|2
7603120|NCT01922102|26453634|P1|Overall Study|Administrative problems|0
7603121|NCT01922102|26453632|P3|Overall Study|Lost to Follow-up|0
7603122|NCT01922102|26453633|P2|Overall Study|Lost to Follow-up|0
7603123|NCT01922102|26453634|P1|Overall Study|Lost to Follow-up|1
7603124|NCT01922102|26453632|P3|Overall Study|Adverse Event|0
7603125|NCT01922102|26453633|P2|Overall Study|Adverse Event|2
7603126|NCT01922102|26453634|P1|Overall Study|Adverse Event|1
7603127|NCT01922102|26453632|P3|Overall Study|Physician Decision|1
7603128|NCT01922102|26453633|P2|Overall Study|Physician Decision|2
7603129|NCT01922102|26453634|P1|Overall Study|Physician Decision|0
7603130|NCT01922102|26453632|P3|Overall Study|Withdrawal by Subject|7
7603131|NCT01922102|26453633|P2|Overall Study|Withdrawal by Subject|3
7603132|NCT01922102|26453634|P1|Overall Study|Withdrawal by Subject|7
7603133|NCT01922089|26453670|P2|Overall Study|Lost to Follow-up|1
7603134|NCT01922089|26453671|P1|Overall Study|Lost to Follow-up|0
7603135|NCT01922089|26453670|P2|Overall Study|Death|1
7603136|NCT01922089|26453671|P1|Overall Study|Death|2
7603137|NCT01922089|26453670|P2|Overall Study|Physician Decision|3
7603138|NCT01922089|26453671|P1|Overall Study|Physician Decision|2
7603139|NCT01922089|26453670|P2|Overall Study|administrative problems|1
7603140|NCT01922089|26453671|P1|Overall Study|administrative problems|4
7603141|NCT01922089|26453670|P2|Overall Study|Withdrawal by Subject|4
7603142|NCT01922089|26453671|P1|Overall Study|Withdrawal by Subject|3
7603143|NCT01922089|26453670|P2|Overall Study|Protocol Deviation|7
7603144|NCT01922089|26453671|P1|Overall Study|Protocol Deviation|10
7603145|NCT01922089|26453670|P2|Overall Study|Adverse Event|13
7603146|NCT01922089|26453671|P1|Overall Study|Adverse Event|18
7603147|NCT01922037|26453748|P2|Overall Study|Other unspecified|66
7603148|NCT01922037|26453749|P1|Overall Study|Other unspecified|2
7603149|NCT01922037|26453748|P2|Overall Study|Investigator/Sponsor decision|4
7603150|NCT01922037|26453749|P1|Overall Study|Investigator/Sponsor decision|1
7603151|NCT01922037|26453748|P2|Overall Study|Participant non-compliance|46
7603152|NCT01922037|26453749|P1|Overall Study|Participant non-compliance|4
7603153|NCT01922037|26453748|P2|Overall Study|Pregnancy|2
7603154|NCT01922037|26453749|P1|Overall Study|Pregnancy|0
7603155|NCT01922037|26453748|P2|Overall Study|Death|5
7603156|NCT01922037|26453749|P1|Overall Study|Death|0
7603157|NCT01922037|26453748|P2|Overall Study|Adverse Event|7
7603158|NCT01922037|26453749|P1|Overall Study|Adverse Event|1
7603159|NCT01922037|26453748|P2|Overall Study|Withdrawal by Subject|44
7603160|NCT01922037|26453749|P1|Overall Study|Withdrawal by Subject|2
7603161|NCT01922011|26453852|P2|Overall Study|Randomized in error|0
7603162|NCT01922011|26453853|P1|Overall Study|Randomized in error|1
7603163|NCT01922011|26453852|P2|Overall Study|Lack of willing home health agency|0
7603164|NCT01922011|26453853|P1|Overall Study|Lack of willing home health agency|1
7603165|NCT01922011|26453852|P2|Overall Study|Not Treated|0
7603166|NCT01922011|26453853|P1|Overall Study|Not Treated|1
7603167|NCT01922011|26453852|P2|Overall Study|Missed Test-of-Cure Visit|2
7603168|NCT01922011|26453853|P1|Overall Study|Missed Test-of-Cure Visit|0
7603169|NCT01922011|26453852|P2|Overall Study|Lost to Follow-up|1
7603170|NCT01922011|26453853|P1|Overall Study|Lost to Follow-up|0
7603171|NCT01922011|26453852|P2|Overall Study|Parent/Guardian Decision|0
7603172|NCT01922011|26453853|P1|Overall Study|Parent/Guardian Decision|3
7603173|NCT01922011|26453852|P2|Overall Study|Physician Decision|1
7603174|NCT01922011|26453853|P1|Overall Study|Physician Decision|0
7603175|NCT01922011|26453852|P2|Overall Study|Protocol Violation|1
7603176|NCT01922011|26453853|P1|Overall Study|Protocol Violation|0
7603177|NCT01921829|26453920|P2|Overall Study|Withdrawal by Subject|1
7603178|NCT01921829|26453921|P1|Overall Study|Withdrawal by Subject|0
7603179|NCT01921517|26453997|P2|Overall Study|Subject missed final imaging|4
7603180|NCT01921517|26453998|P1|Overall Study|Subject missed final imaging|1
7603181|NCT01921517|26453997|P2|Overall Study|Withdrawal by Subject|3
7603182|NCT01921517|26453998|P1|Overall Study|Withdrawal by Subject|7
7603183|NCT01921517|26453997|P2|Overall Study|Physician Decision|2
7603184|NCT01921517|26453998|P1|Overall Study|Physician Decision|0
7603185|NCT01921517|26453997|P2|Overall Study|Newly diagnosed health concern|0
7603187|NCT01921517|26453997|P2|Overall Study|Lost to Follow-up|0
7603188|NCT01921517|26453998|P1|Overall Study|Lost to Follow-up|5
7603189|NCT01921387|26454009|P1|Overall Study|Adverse Event|1
7603190|NCT01921348|26454018|P2|Overall Study|Lost to Follow-up|2
7603191|NCT01921348|26454019|P1|Overall Study|Lost to Follow-up|0
7603192|NCT01921348|26454018|P2|Overall Study|Withdrawal by Subject|0
7603193|NCT01921348|26454019|P1|Overall Study|Withdrawal by Subject|1
7603194|NCT01921270|26454048|P1|Overall Study|Withdrawal by Subject|1
7603195|NCT01921257|26454064|P1|Overall Study|Withdrawal by Subject|1
7603196|NCT01921257|26454064|P1|Overall Study|Protocol Violation|1
7603197|NCT01921257|26454064|P1|Overall Study|Adverse Event|1
7603198|NCT01921218|26454071|P2|Overall Study|Kidney transplant|1
7603199|NCT01921218|26454072|P1|Overall Study|Kidney transplant|1
7603200|NCT01921218|26454071|P2|Overall Study|Withdrawal by Subject|2
7603201|NCT01921218|26454072|P1|Overall Study|Withdrawal by Subject|0
7603202|NCT01921218|26454071|P2|Overall Study|Death|1
7603203|NCT01921218|26454072|P1|Overall Study|Death|2
7603204|NCT01921205|26454088|P2|Overall Study|Non Compliance Of Child|1
7603205|NCT01921205|26454089|P1|Overall Study|Non Compliance Of Child|0
7603206|NCT01921205|26454088|P2|Overall Study|Non Compliance Of The Parent|1
7603207|NCT01921205|26454089|P1|Overall Study|Non Compliance Of The Parent|0
7603208|NCT01921205|26454088|P2|Overall Study|The Excessive Use Of Rescue Medication|1
7603209|NCT01921205|26454089|P1|Overall Study|The Excessive Use Of Rescue Medication|0
7603210|NCT01921205|26454088|P2|Overall Study|Use Of Prohibited Medication|1
7603211|NCT01921205|26454089|P1|Overall Study|Use Of Prohibited Medication|0
7603212|NCT01921205|26454088|P2|Overall Study|Withdrawal by Subject|5
7603213|NCT01921205|26454089|P1|Overall Study|Withdrawal by Subject|6
7603214|NCT01921205|26454088|P2|Overall Study|Lost to Follow-up|1
7603215|NCT01921205|26454089|P1|Overall Study|Lost to Follow-up|1
7603216|NCT01921205|26454088|P2|Overall Study|Protocol Violation|3
7603217|NCT01921205|26454089|P1|Overall Study|Protocol Violation|1
7603218|NCT01921205|26454088|P2|Overall Study|Lack of Efficacy|0
7603219|NCT01921205|26454089|P1|Overall Study|Lack of Efficacy|1
7603220|NCT01921205|26454088|P2|Overall Study|Adverse Event|7
7603221|NCT01921205|26454089|P1|Overall Study|Adverse Event|12
7603222|NCT01921179|26454119|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
7603223|NCT01921179|26454120|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
7603224|NCT01921179|26454119|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7603225|NCT01921179|26454120|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7603226|NCT01921101|26454157|P2|Overall Study|Death|6
7603227|NCT01921101|26454158|P1|Overall Study|Death|16
7603228|NCT01920958|26454166|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
7603229|NCT01920893|26454184|P2|Overall Study|Lack of Efficacy|0
7603230|NCT01920893|26454185|P1|Overall Study|Lack of Efficacy|2
7603231|NCT01920893|26454184|P2|Overall Study|Adverse Event|2
7603232|NCT01920893|26454185|P1|Overall Study|Adverse Event|5
7603233|NCT01920854|26454218|P7|Overall Study|Withdrawal by Subject|1
7603234|NCT01920854|26454219|P6|Overall Study|Withdrawal by Subject|0
7603235|NCT01920854|26454220|P5|Overall Study|Withdrawal by Subject|1
7603236|NCT01920854|26454221|P4|Overall Study|Withdrawal by Subject|0
7603237|NCT01920854|26454222|P3|Overall Study|Withdrawal by Subject|0
7603238|NCT01920854|26454223|P2|Overall Study|Withdrawal by Subject|0
7603239|NCT01920854|26454224|P1|Overall Study|Withdrawal by Subject|1
7603240|NCT01920711|26454384|P2|Overall Study|Withdrawal by Subject|3
7603241|NCT01920711|26454385|P1|Overall Study|Withdrawal by Subject|4
7603242|NCT01920711|26454384|P2|Overall Study|Lost to Follow-up|14
7603243|NCT01920711|26454385|P1|Overall Study|Lost to Follow-up|13
7603244|NCT01920711|26454384|P2|Overall Study|Death|356
7603245|NCT01920711|26454385|P1|Overall Study|Death|347
7603246|NCT01920594|26454402|P2|Overall Study|Investigator discretion|1
7603247|NCT01920594|26454403|P1|Overall Study|Investigator discretion|0
7603248|NCT01920594|26454402|P2|Overall Study|Recovery|0
7603249|NCT01920594|26454403|P1|Overall Study|Recovery|2
7603250|NCT01920594|26454402|P2|Overall Study|Lost to Follow-up|0
7603251|NCT01920594|26454403|P1|Overall Study|Lost to Follow-up|1
7603252|NCT01920594|26454402|P2|Overall Study|Adverse Event|2
7603253|NCT01920594|26454403|P1|Overall Study|Adverse Event|4
7603254|NCT01920568|26454453|P2|Overall Study|Death due to disease progression|12
7603255|NCT01920568|26454454|P1|Overall Study|Death due to disease progression|25
7603256|NCT01920568|26454453|P2|Overall Study|Withdrawal by Subject|55
7603257|NCT01920568|26454454|P1|Overall Study|Withdrawal by Subject|79
7603258|NCT01920568|26454453|P2|Overall Study|Physician Decision|4
7603259|NCT01920568|26454454|P1|Overall Study|Physician Decision|13
7603260|NCT01920568|26454453|P2|Overall Study|Lost to Follow-up|2
7603261|NCT01920568|26454454|P1|Overall Study|Lost to Follow-up|2
7603262|NCT01920568|26454453|P2|Overall Study|Protocol Violation|3
7603263|NCT01920568|26454454|P1|Overall Study|Protocol Violation|5
7603264|NCT01920568|26454453|P2|Overall Study|Adverse Event|8
7603265|NCT01920568|26454454|P1|Overall Study|Adverse Event|27
7603266|NCT01920555|26454480|P5|Overall Study|Lost to Follow-up|0
7603267|NCT01920555|26454481|P4|Overall Study|Lost to Follow-up|1
7603268|NCT01920555|26454482|P3|Overall Study|Lost to Follow-up|0
7603269|NCT01920555|26454483|P2|Overall Study|Lost to Follow-up|1
7603270|NCT01920555|26454484|P1|Overall Study|Lost to Follow-up|0
7603271|NCT01920555|26454480|P5|Overall Study|Travel Difficulties|1
7603272|NCT01920555|26454481|P4|Overall Study|Travel Difficulties|0
7603273|NCT01920555|26454482|P3|Overall Study|Travel Difficulties|0
7603274|NCT01920555|26454483|P2|Overall Study|Travel Difficulties|1
7603275|NCT01920555|26454484|P1|Overall Study|Travel Difficulties|1
7603276|NCT01920555|26454480|P5|Overall Study|Lack of Efficacy|0
7603277|NCT01920555|26454481|P4|Overall Study|Lack of Efficacy|0
7603278|NCT01920555|26454482|P3|Overall Study|Lack of Efficacy|0
7603279|NCT01920555|26454483|P2|Overall Study|Lack of Efficacy|0
7603280|NCT01920555|26454484|P1|Overall Study|Lack of Efficacy|2
7603281|NCT01920555|26454480|P5|Overall Study|Physician Decision|0
7603282|NCT01920555|26454481|P4|Overall Study|Physician Decision|2
7603283|NCT01920555|26454482|P3|Overall Study|Physician Decision|1
7603284|NCT01920555|26454483|P2|Overall Study|Physician Decision|2
7603285|NCT01920555|26454484|P1|Overall Study|Physician Decision|1
7603286|NCT01920477|26454543|P2|Overall Study|Withdrawal by Subject|1
7603287|NCT01920477|26454544|P1|Overall Study|Withdrawal by Subject|0
7603288|NCT01920477|26454543|P2|Overall Study|Study closed/terminated|15
7603289|NCT01920477|26454544|P1|Overall Study|Study closed/terminated|14
7603290|NCT01920477|26454543|P2|Overall Study|Lack of Efficacy|0
7603291|NCT01920477|26454544|P1|Overall Study|Lack of Efficacy|1
7603292|NCT01920477|26454543|P2|Overall Study|Adverse Event|1
7603293|NCT01920477|26454544|P1|Overall Study|Adverse Event|0
7603294|NCT01920178|26454593|P2|Overall Study|Lost to Follow-up|1
7603295|NCT01920178|26454594|P1|Overall Study|Lost to Follow-up|2
7603296|NCT01920152|26454606|P2|Overall Study|Withdrawal by Subject|2
7603297|NCT01920152|26454607|P1|Overall Study|Withdrawal by Subject|1
7603298|NCT01920061|26454663|P20|Overall Study|Participant refused further follow-up|0
7603299|NCT01920061|26454664|P19|Overall Study|Participant refused further follow-up|0
7603300|NCT01920061|26454665|P18|Overall Study|Participant refused further follow-up|1
7603301|NCT01920061|26454666|P17|Overall Study|Participant refused further follow-up|1
7603302|NCT01920061|26454667|P16|Overall Study|Participant refused further follow-up|2
7603303|NCT01920061|26454668|P15|Overall Study|Participant refused further follow-up|1
7603304|NCT01920061|26454669|P14|Overall Study|Participant refused further follow-up|0
7603305|NCT01920061|26454670|P13|Overall Study|Participant refused further follow-up|1
7603306|NCT01920061|26454671|P12|Overall Study|Participant refused further follow-up|0
7603307|NCT01920061|26454672|P11|Overall Study|Participant refused further follow-up|1
7603308|NCT01920061|26454673|P10|Overall Study|Participant refused further follow-up|0
7603309|NCT01920061|26454674|P9|Overall Study|Participant refused further follow-up|1
7603310|NCT01920061|26454675|P8|Overall Study|Participant refused further follow-up|0
7603311|NCT01920061|26454676|P7|Overall Study|Participant refused further follow-up|0
7603312|NCT01920061|26454677|P6|Overall Study|Participant refused further follow-up|1
7603313|NCT01920061|26454678|P5|Overall Study|Participant refused further follow-up|1
7603314|NCT01920061|26454679|P4|Overall Study|Participant refused further follow-up|0
7603315|NCT01920061|26454680|P3|Overall Study|Participant refused further follow-up|0
7603316|NCT01920061|26454681|P2|Overall Study|Participant refused further follow-up|0
7603317|NCT01920061|26454682|P1|Overall Study|Participant refused further follow-up|0
7603318|NCT01920061|26454663|P20|Overall Study|Other|1
7603319|NCT01920061|26454664|P19|Overall Study|Other|1
7603320|NCT01920061|26454665|P18|Overall Study|Other|0
7603321|NCT01920061|26454666|P17|Overall Study|Other|1
7603322|NCT01920061|26454667|P16|Overall Study|Other|1
7603323|NCT01920061|26454668|P15|Overall Study|Other|0
7603324|NCT01920061|26454669|P14|Overall Study|Other|4
7603325|NCT01920061|26454670|P13|Overall Study|Other|1
7603326|NCT01920061|26454671|P12|Overall Study|Other|2
7603327|NCT01920061|26454672|P11|Overall Study|Other|1
7603328|NCT01920061|26454673|P10|Overall Study|Other|1
7603329|NCT01920061|26454674|P9|Overall Study|Other|0
7603330|NCT01920061|26454675|P8|Overall Study|Other|0
7603331|NCT01920061|26454676|P7|Overall Study|Other|0
7603332|NCT01920061|26454677|P6|Overall Study|Other|1
7603333|NCT01920061|26454678|P5|Overall Study|Other|0
7603334|NCT01920061|26454679|P4|Overall Study|Other|1
7603335|NCT01920061|26454680|P3|Overall Study|Other|2
7603336|NCT01920061|26454681|P2|Overall Study|Other|1
7603337|NCT01920061|26454682|P1|Overall Study|Other|1
7603338|NCT01920061|26454663|P20|Overall Study|Lost to Follow-up|3
7603339|NCT01920061|26454664|P19|Overall Study|Lost to Follow-up|4
7603340|NCT01920061|26454665|P18|Overall Study|Lost to Follow-up|1
7603341|NCT01920061|26454666|P17|Overall Study|Lost to Follow-up|0
7603342|NCT01920061|26454667|P16|Overall Study|Lost to Follow-up|0
7603343|NCT01920061|26454668|P15|Overall Study|Lost to Follow-up|0
7603344|NCT01920061|26454669|P14|Overall Study|Lost to Follow-up|0
7603345|NCT01920061|26454670|P13|Overall Study|Lost to Follow-up|0
7603346|NCT01920061|26454671|P12|Overall Study|Lost to Follow-up|0
7603347|NCT01920061|26454672|P11|Overall Study|Lost to Follow-up|3
7603348|NCT01920061|26454673|P10|Overall Study|Lost to Follow-up|0
7603349|NCT01920061|26454674|P9|Overall Study|Lost to Follow-up|0
7603350|NCT01920061|26454675|P8|Overall Study|Lost to Follow-up|0
7603351|NCT01920061|26454676|P7|Overall Study|Lost to Follow-up|1
7603352|NCT01920061|26454677|P6|Overall Study|Lost to Follow-up|0
7603353|NCT01920061|26454678|P5|Overall Study|Lost to Follow-up|0
7603354|NCT01920061|26454679|P4|Overall Study|Lost to Follow-up|0
7603355|NCT01920061|26454680|P3|Overall Study|Lost to Follow-up|0
7603356|NCT01920061|26454681|P2|Overall Study|Lost to Follow-up|2
7603357|NCT01920061|26454682|P1|Overall Study|Lost to Follow-up|0
7603358|NCT01920061|26454663|P20|Overall Study|Death|0
7603359|NCT01920061|26454664|P19|Overall Study|Death|1
7603360|NCT01920061|26454665|P18|Overall Study|Death|0
7603361|NCT01920061|26454666|P17|Overall Study|Death|0
7603362|NCT01920061|26454667|P16|Overall Study|Death|0
7603363|NCT01920061|26454668|P15|Overall Study|Death|0
7603364|NCT01920061|26454669|P14|Overall Study|Death|2
7603365|NCT01920061|26454670|P13|Overall Study|Death|0
7603366|NCT01920061|26454671|P12|Overall Study|Death|1
7603367|NCT01920061|26454672|P11|Overall Study|Death|0
7603368|NCT01920061|26454673|P10|Overall Study|Death|1
7603369|NCT01920061|26454674|P9|Overall Study|Death|0
7603370|NCT01920061|26454675|P8|Overall Study|Death|1
7603371|NCT01920061|26454676|P7|Overall Study|Death|0
7603372|NCT01920061|26454677|P6|Overall Study|Death|0
7603373|NCT01920061|26454678|P5|Overall Study|Death|1
7603374|NCT01920061|26454679|P4|Overall Study|Death|1
7603375|NCT01920061|26454680|P3|Overall Study|Death|0
7603376|NCT01920061|26454681|P2|Overall Study|Death|1
7603377|NCT01920061|26454682|P1|Overall Study|Death|1
7603378|NCT01919970|26455191|P2|Overall Study|Withdrawal by Subject|0
7603379|NCT01919970|26455192|P1|Overall Study|Withdrawal by Subject|3
7603380|NCT01919814|26455200|P2|Overall Study|Withdrawal by Subject|0
7603381|NCT01919814|26455201|P1|Overall Study|Withdrawal by Subject|1
7603382|NCT01919814|26455200|P2|Overall Study|Protocol Violation|0
7603383|NCT01919814|26455201|P1|Overall Study|Protocol Violation|1
7603384|NCT01919814|26455200|P2|Overall Study|Adverse Event|0
7603385|NCT01919814|26455201|P1|Overall Study|Adverse Event|1
7603386|NCT01919801|26455213|P2|Overall Study|Other|1
7603387|NCT01919801|26455214|P1|Overall Study|Other|0
7603388|NCT01919801|26455213|P2|Overall Study|Lost to Follow-up|1
7603389|NCT01919801|26455214|P1|Overall Study|Lost to Follow-up|0
7603390|NCT01919801|26455213|P2|Overall Study|Physician Decision|1
7603391|NCT01919801|26455214|P1|Overall Study|Physician Decision|0
7603392|NCT01919801|26455213|P2|Overall Study|Withdrawal by Subject|0
7603393|NCT01919801|26455214|P1|Overall Study|Withdrawal by Subject|1
7603394|NCT01919723|26455239|P2|Overall Study|Blood Samples Hemolyzed|2
7603395|NCT01919723|26455240|P1|Overall Study|Blood Samples Hemolyzed|2
7603396|NCT01919411|26455313|P2|Overall Study|Protocol Violation|1
7603397|NCT01919411|26455314|P1|Overall Study|Protocol Violation|2
7603398|NCT01919411|26455313|P2|Overall Study|Physician Decision|0
7603399|NCT01919411|26455314|P1|Overall Study|Physician Decision|1
7603400|NCT01919411|26455313|P2|Overall Study|Lost to Follow-up|4
7603401|NCT01919411|26455314|P1|Overall Study|Lost to Follow-up|2
7603402|NCT01919398|26455333|P3|Overall Study|Progressive Disease|4
7603403|NCT01919398|26455334|P2|Overall Study|Progressive Disease|0
7603404|NCT01919398|26455335|P1|Overall Study|Progressive Disease|0
7603405|NCT01919307|26455355|P1|Overall Study|Withdrawal by Subject|9
7603406|NCT01919229|26455365|P3|Overall Study|Subject/guardian decision|1
7603407|NCT01919229|26455366|P2|Overall Study|Subject/guardian decision|0
7603408|NCT01919229|26455367|P1|Overall Study|Subject/guardian decision|0
7603409|NCT01919190|26455411|P2|Overall Study|Intra-op findings, etc.|0
7603410|NCT01919190|26455412|P1|Overall Study|Intra-op findings, etc.|3
7603411|NCT01919164|26455433|P5|Overall Study|Other Un-specified|15
7603412|NCT01919164|26455434|P4|Overall Study|Other Un-specified|7
7603413|NCT01919164|26455435|P3|Overall Study|Other Un-specified|8
7603414|NCT01919164|26455436|P2|Overall Study|Other Un-specified|9
7603415|NCT01919164|26455437|P1|Overall Study|Other Un-specified|13
7603416|NCT01919164|26455433|P5|Overall Study|Withdrew consent|9
7603417|NCT01919164|26455434|P4|Overall Study|Withdrew consent|14
7603418|NCT01919164|26455435|P3|Overall Study|Withdrew consent|14
7603419|NCT01919164|26455436|P2|Overall Study|Withdrew consent|13
7603420|NCT01919164|26455437|P1|Overall Study|Withdrew consent|13
7603421|NCT01919164|26455433|P5|Overall Study|Disease progression|1
7603422|NCT01919164|26455434|P4|Overall Study|Disease progression|2
7603423|NCT01919164|26455435|P3|Overall Study|Disease progression|1
7603424|NCT01919164|26455436|P2|Overall Study|Disease progression|2
7603425|NCT01919164|26455437|P1|Overall Study|Disease progression|2
7603426|NCT01919164|26455433|P5|Overall Study|Protocol Violation|2
7603427|NCT01919164|26455434|P4|Overall Study|Protocol Violation|2
7603428|NCT01919164|26455435|P3|Overall Study|Protocol Violation|3
7603429|NCT01919164|26455436|P2|Overall Study|Protocol Violation|0
7603430|NCT01919164|26455437|P1|Overall Study|Protocol Violation|6
7603431|NCT01919164|26455433|P5|Overall Study|Death|0
7603432|NCT01919164|26455434|P4|Overall Study|Death|0
7603433|NCT01919164|26455435|P3|Overall Study|Death|0
7603434|NCT01919164|26455436|P2|Overall Study|Death|0
7603435|NCT01919164|26455437|P1|Overall Study|Death|1
7603436|NCT01919164|26455433|P5|Overall Study|Lost to Follow-up|4
7603437|NCT01919164|26455434|P4|Overall Study|Lost to Follow-up|0
7603438|NCT01919164|26455435|P3|Overall Study|Lost to Follow-up|2
7603439|NCT01919164|26455436|P2|Overall Study|Lost to Follow-up|2
7603440|NCT01919164|26455437|P1|Overall Study|Lost to Follow-up|2
7603441|NCT01919164|26455433|P5|Overall Study|Adverse Event|2
7603442|NCT01919164|26455434|P4|Overall Study|Adverse Event|3
7603443|NCT01919164|26455435|P3|Overall Study|Adverse Event|9
7603444|NCT01919164|26455436|P2|Overall Study|Adverse Event|4
7603445|NCT01919164|26455437|P1|Overall Study|Adverse Event|6
7603446|NCT01919112|26455492|P3|Secondary Analysis-day 30|Lost to Follow-up|0
7603447|NCT01919112|26455493|P2|Secondary Analysis-day 30|Lost to Follow-up|0
7603448|NCT01919112|26455494|P1|Secondary Analysis-day 30|Lost to Follow-up|1
7603449|NCT01919112|26455492|P3|Secondary Analysis-day 30|Death|1
7603450|NCT01919112|26455493|P2|Secondary Analysis-day 30|Death|1
7603451|NCT01919112|26455494|P1|Secondary Analysis-day 30|Death|1
7603452|NCT01918774|26455553|P1|Overall Study|Lost to Follow-up|1
7603453|NCT01918774|26455553|P1|Overall Study|Lost prior to first CBTw session|4
7603454|NCT01918371|26455577|P2|Overall Study|Missing Data|1
7603455|NCT01918371|26455578|P1|Overall Study|Missing Data|1
7603456|NCT01918332|26455656|P4|Overall Study|lipid result by central lab did not meet|0
7603457|NCT01918332|26455657|P3|Overall Study|lipid result by central lab did not meet|1
7603458|NCT01918332|26455658|P2|Overall Study|lipid result by central lab did not meet|0
7603459|NCT01918332|26455659|P1|Overall Study|lipid result by central lab did not meet|0
7603460|NCT01918332|26455656|P4|Overall Study|Protocol Violation|3
7603461|NCT01918332|26455657|P3|Overall Study|Protocol Violation|6
7603462|NCT01918332|26455658|P2|Overall Study|Protocol Violation|2
7603463|NCT01918332|26455659|P1|Overall Study|Protocol Violation|6
7603464|NCT01918332|26455656|P4|Overall Study|Withdrawal by Subject|3
7603465|NCT01918332|26455657|P3|Overall Study|Withdrawal by Subject|2
7603466|NCT01918332|26455658|P2|Overall Study|Withdrawal by Subject|3
7603467|NCT01918332|26455659|P1|Overall Study|Withdrawal by Subject|2
7603468|NCT01918332|26455656|P4|Overall Study|Adverse Event|1
7603469|NCT01918332|26455657|P3|Overall Study|Adverse Event|0
7603470|NCT01918332|26455658|P2|Overall Study|Adverse Event|0
7603471|NCT01918332|26455659|P1|Overall Study|Adverse Event|0
7603472|NCT01918306|26455671|P4|Overall Study|progress disease, crossover|0
7603473|NCT01918306|26455672|P3|Overall Study|progress disease, crossover|1
7603474|NCT01918306|26455673|P2|Overall Study|progress disease, crossover|0
7603475|NCT01918306|26455674|P1|Overall Study|progress disease, crossover|0
7603476|NCT01918306|26455671|P4|Overall Study|Lack of Efficacy|0
7603477|NCT01918306|26455672|P3|Overall Study|Lack of Efficacy|0
7603478|NCT01918306|26455673|P2|Overall Study|Lack of Efficacy|0
7603479|NCT01918306|26455674|P1|Overall Study|Lack of Efficacy|1
7603480|NCT01918306|26455671|P4|Overall Study|neutropenia|0
7603481|NCT01918306|26455672|P3|Overall Study|neutropenia|0
7603482|NCT01918306|26455673|P2|Overall Study|neutropenia|0
7603483|NCT01918306|26455674|P1|Overall Study|neutropenia|1
7603484|NCT01918306|26455671|P4|Overall Study|Withdrawal by Subject|2
7603485|NCT01918306|26455672|P3|Overall Study|Withdrawal by Subject|0
7603486|NCT01918306|26455673|P2|Overall Study|Withdrawal by Subject|0
7603487|NCT01918306|26455674|P1|Overall Study|Withdrawal by Subject|0
7603488|NCT01918306|26455671|P4|Overall Study|progresive disease|1
7603489|NCT01918306|26455672|P3|Overall Study|progresive disease|1
7603490|NCT01918306|26455673|P2|Overall Study|progresive disease|0
7603491|NCT01918306|26455674|P1|Overall Study|progresive disease|4
7603492|NCT01918085|26455705|P2|Test Period 1: Strata Strip|Adverse Event|1
7603493|NCT01918085|26455706|P1|Test Period 1: Strata Strip|Adverse Event|0
7603494|NCT01918033|26455730|P3|Overall Study|Withdrawal by Subject|0
7603495|NCT01918033|26455731|P2|Overall Study|Withdrawal by Subject|1
7603496|NCT01918033|26455732|P1|Overall Study|Withdrawal by Subject|2
7603497|NCT01918033|26455730|P3|Overall Study|Protocol Violation|1
7603498|NCT01918033|26455731|P2|Overall Study|Protocol Violation|0
7603499|NCT01918033|26455732|P1|Overall Study|Protocol Violation|2
7603500|NCT01918033|26455730|P3|Overall Study|Lost to Follow-up|0
7603501|NCT01918033|26455731|P2|Overall Study|Lost to Follow-up|1
7603502|NCT01918033|26455732|P1|Overall Study|Lost to Follow-up|0
7603503|NCT01918033|26455730|P3|Overall Study|Adverse Event|2
7603504|NCT01918033|26455731|P2|Overall Study|Adverse Event|0
7603505|NCT01918033|26455732|P1|Overall Study|Adverse Event|1
7603506|NCT01917968|26455772|P2|Overall Study|No Data Available|2
7603507|NCT01917968|26455773|P1|Overall Study|No Data Available|0
7603508|NCT01917968|26455772|P2|Overall Study|Change in Family Circumstances|1
7603509|NCT01917968|26455773|P1|Overall Study|Change in Family Circumstances|0
7603510|NCT01917968|26455772|P2|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
7603511|NCT01917968|26455773|P1|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
7603512|NCT01917968|26455772|P2|Overall Study|36M Missed Visit|2
7603513|NCT01917968|26455773|P1|Overall Study|36M Missed Visit|3
7603514|NCT01917968|26455772|P2|Overall Study|Subject Relocation|1
7603515|NCT01917968|26455773|P1|Overall Study|Subject Relocation|5
7603516|NCT01917968|26455772|P2|Overall Study|Withdrawal by Subject|35
7603517|NCT01917968|26455773|P1|Overall Study|Withdrawal by Subject|20
7603518|NCT01917968|26455772|P2|Overall Study|Physician Decision|2
7603519|NCT01917968|26455773|P1|Overall Study|Physician Decision|1
7603520|NCT01917968|26455772|P2|Overall Study|Lost to Follow-up|39
7603521|NCT01917968|26455773|P1|Overall Study|Lost to Follow-up|21
7603522|NCT01917968|26455772|P2|Overall Study|Death|2
7603523|NCT01917968|26455773|P1|Overall Study|Death|3
7603524|NCT01917747|26455834|P2|Overall Study|Lost to Follow-up|9
7603525|NCT01917747|26455835|P1|Overall Study|Lost to Follow-up|18
7603526|NCT01917747|26455834|P2|Overall Study|Withdrawal by Subject|2
7603527|NCT01917747|26455835|P1|Overall Study|Withdrawal by Subject|1
7603528|NCT01917656|26455864|P2|Overall Study|Lost to Follow-up|4
7603529|NCT01917656|26455865|P1|Overall Study|Lost to Follow-up|3
7603530|NCT01917656|26455864|P2|Overall Study|Withdrawal by Subject|3
7603531|NCT01917656|26455865|P1|Overall Study|Withdrawal by Subject|4
7603532|NCT01917656|26455864|P2|Overall Study|Unclassified|3
7603533|NCT01917656|26455865|P1|Overall Study|Unclassified|0
7603534|NCT01917656|26455864|P2|Overall Study|Withdrawal criteria|14
7603535|NCT01917656|26455865|P1|Overall Study|Withdrawal criteria|8
7603536|NCT01917656|26455864|P2|Overall Study|Adverse Event|0
7603537|NCT01917656|26455865|P1|Overall Study|Adverse Event|11
7603538|NCT01917526|26455891|P2|Overall Study|Protocol Violation|1
7603539|NCT01917526|26455892|P1|Overall Study|Protocol Violation|1
7603540|NCT01917344|26455909|P1|Overall Study|Withdrawal by Subject|1
7603541|NCT01917318|26455915|P2|First Treatment|Withdrawal by Subject|1
7603542|NCT01917318|26455916|P1|First Treatment|Withdrawal by Subject|0
7603543|NCT01917084|26455962|P1|Overall Study|Withdrawal by Subject|1
7603544|NCT01917006|26455975|P8|Open-label Period|Lost to Follow-up|1
7603545|NCT01917006|26455976|P7|Open-label Period|Lost to Follow-up|0
7603546|NCT01917006|26455977|P6|Open-label Period|Lost to Follow-up|0
7603547|NCT01917006|26455978|P5|Open-label Period|Lost to Follow-up|0
7603548|NCT01917006|26455979|P4|Open-label Period|Lost to Follow-up|0
7603549|NCT01917006|26455980|P3|Open-label Period|Lost to Follow-up|0
7603550|NCT01917006|26455981|P2|Open-label Period|Lost to Follow-up|0
7603551|NCT01917006|26455982|P1|Open-label Period|Lost to Follow-up|0
7603552|NCT01917006|26455975|P8|Open-label Period|Adverse Event|1
7603553|NCT01917006|26455976|P7|Open-label Period|Adverse Event|0
7603554|NCT01917006|26455977|P6|Open-label Period|Adverse Event|0
7603555|NCT01917006|26455978|P5|Open-label Period|Adverse Event|0
7603556|NCT01917006|26455979|P4|Open-label Period|Adverse Event|0
7603557|NCT01917006|26455980|P3|Open-label Period|Adverse Event|0
7603558|NCT01917006|26455981|P2|Open-label Period|Adverse Event|0
7603559|NCT01917006|26455982|P1|Open-label Period|Adverse Event|0
7603560|NCT01917006|26455975|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603561|NCT01917006|26455976|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
7603562|NCT01917006|26455977|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603563|NCT01917006|26455978|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603564|NCT01917006|26455979|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603565|NCT01917006|26455980|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603566|NCT01917006|26455981|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603567|NCT01917006|26455982|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
7603568|NCT01917006|26455975|P8|Randomized-treatment Period|Protocol Violation|0
7603569|NCT01917006|26455976|P7|Randomized-treatment Period|Protocol Violation|0
7603570|NCT01917006|26455977|P6|Randomized-treatment Period|Protocol Violation|0
7603571|NCT01917006|26455978|P5|Randomized-treatment Period|Protocol Violation|0
7603572|NCT01917006|26455979|P4|Randomized-treatment Period|Protocol Violation|0
7603573|NCT01917006|26455980|P3|Randomized-treatment Period|Protocol Violation|0
7603574|NCT01917006|26455981|P2|Randomized-treatment Period|Protocol Violation|0
7603575|NCT01917006|26455982|P1|Randomized-treatment Period|Protocol Violation|1
7603576|NCT01917006|26455975|P8|Randomized-treatment Period|Personal Reasons|0
7603577|NCT01917006|26455976|P7|Randomized-treatment Period|Personal Reasons|0
7603578|NCT01917006|26455977|P6|Randomized-treatment Period|Personal Reasons|1
7603579|NCT01917006|26455978|P5|Randomized-treatment Period|Personal Reasons|0
7603580|NCT01917006|26455979|P4|Randomized-treatment Period|Personal Reasons|0
7603581|NCT01917006|26455980|P3|Randomized-treatment Period|Personal Reasons|0
7603582|NCT01917006|26455981|P2|Randomized-treatment Period|Personal Reasons|0
7603583|NCT01917006|26455982|P1|Randomized-treatment Period|Personal Reasons|0
7603584|NCT01917006|26455975|P8|Randomized-treatment Period|Lost to Follow-up|0
7603585|NCT01917006|26455976|P7|Randomized-treatment Period|Lost to Follow-up|0
7603586|NCT01917006|26455977|P6|Randomized-treatment Period|Lost to Follow-up|0
7603587|NCT01917006|26455978|P5|Randomized-treatment Period|Lost to Follow-up|0
7603588|NCT01917006|26455979|P4|Randomized-treatment Period|Lost to Follow-up|1
7603589|NCT01917006|26455980|P3|Randomized-treatment Period|Lost to Follow-up|0
7603590|NCT01917006|26455981|P2|Randomized-treatment Period|Lost to Follow-up|0
7603591|NCT01917006|26455982|P1|Randomized-treatment Period|Lost to Follow-up|1
7603592|NCT01916980|26456015|P2|Overall Study|Withdrawal by Subject|0
7603593|NCT01916980|26456016|P1|Overall Study|Withdrawal by Subject|1
7603594|NCT01916980|26456015|P2|Overall Study|Lack of Efficacy|2
7603595|NCT01916980|26456016|P1|Overall Study|Lack of Efficacy|2
7603596|NCT01916980|26456015|P2|Overall Study|Adverse Event|2
7603597|NCT01916980|26456016|P1|Overall Study|Adverse Event|4
7603598|NCT01916967|26456035|P3|Overall Study|Protocol Violation|0
7603599|NCT01916967|26456036|P2|Overall Study|Protocol Violation|1
7603600|NCT01916967|26456037|P1|Overall Study|Protocol Violation|0
7603601|NCT01916967|26456035|P3|Overall Study|Physician Decision|1
7603602|NCT01916967|26456036|P2|Overall Study|Physician Decision|0
7603603|NCT01916967|26456037|P1|Overall Study|Physician Decision|0
7603604|NCT01916967|26456035|P3|Overall Study|Lack of Efficacy|6
7603605|NCT01916967|26456036|P2|Overall Study|Lack of Efficacy|0
7603606|NCT01916967|26456037|P1|Overall Study|Lack of Efficacy|0
7603607|NCT01916967|26456035|P3|Overall Study|Adverse Event|2
7603608|NCT01916967|26456036|P2|Overall Study|Adverse Event|0
7603609|NCT01916967|26456037|P1|Overall Study|Adverse Event|0
7603610|NCT01916824|26456093|P2|Overall Study|Withdrawal by Subject|3
7603611|NCT01916824|26456094|P1|Overall Study|Withdrawal by Subject|2
7603612|NCT01916824|26456093|P2|Overall Study|Physician Decision|0
7603613|NCT01916824|26456094|P1|Overall Study|Physician Decision|2
7603614|NCT01916824|26456093|P2|Overall Study|Lost to Follow-up|6
7603615|NCT01916824|26456094|P1|Overall Study|Lost to Follow-up|3
7603616|NCT01916304|26456176|P1|Overall Study|Screening failure|17
7603617|NCT01916226|26456188|P4|Overall Study|Physician Decision|1
7603618|NCT01916226|26456189|P3|Overall Study|Physician Decision|0
7603619|NCT01916226|26456190|P2|Overall Study|Physician Decision|0
7603620|NCT01916226|26456191|P1|Overall Study|Physician Decision|0
7603621|NCT01916226|26456188|P4|Overall Study|Protocol Violation|1
7603622|NCT01916226|26456189|P3|Overall Study|Protocol Violation|0
7603623|NCT01916226|26456190|P2|Overall Study|Protocol Violation|1
7603624|NCT01916226|26456191|P1|Overall Study|Protocol Violation|0
7603625|NCT01916226|26456188|P4|Overall Study|Lack of Efficacy|1
7603626|NCT01916226|26456189|P3|Overall Study|Lack of Efficacy|2
7603627|NCT01916226|26456190|P2|Overall Study|Lack of Efficacy|0
7603628|NCT01916226|26456191|P1|Overall Study|Lack of Efficacy|0
7603629|NCT01916226|26456188|P4|Overall Study|Adverse Event|1
7603630|NCT01916226|26456189|P3|Overall Study|Adverse Event|1
7603631|NCT01916226|26456190|P2|Overall Study|Adverse Event|0
7603632|NCT01916226|26456191|P1|Overall Study|Adverse Event|1
7603633|NCT01916109|26456225|P1|Overall Study|Withdrawal by Subject|1
7603634|NCT01915940|26456231|P3|Treatment Period|Other Miscellaneous Reasons|0
7603635|NCT01915940|26456232|P2|Treatment Period|Other Miscellaneous Reasons|1
7603636|NCT01915940|26456233|P1|Treatment Period|Other Miscellaneous Reasons|0
7603637|NCT01915940|26456231|P3|Treatment Period|Adverse Event|1
7603638|NCT01915940|26456232|P2|Treatment Period|Adverse Event|9
7603639|NCT01915940|26456233|P1|Treatment Period|Adverse Event|0
7603640|NCT01915940|26456231|P3|Treatment Period|Decision of Participant|3
7603641|NCT01915940|26456232|P2|Treatment Period|Decision of Participant|1
7603642|NCT01915940|26456233|P1|Treatment Period|Decision of Participant|0
7603643|NCT01915940|26456231|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
7603644|NCT01915940|26456232|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
7603645|NCT01915940|26456233|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
7603646|NCT01915914|26456249|P4|Follow-up Phase|Physician Decision|1
7603647|NCT01915914|26456250|P3|Follow-up Phase|Physician Decision|0
7603648|NCT01915914|26456251|P2|Follow-up Phase|Physician Decision|0
7603649|NCT01915914|26456252|P1|Follow-up Phase|Physician Decision|0
7603650|NCT01915914|26456249|P4|Follow-up Phase|Withdrawal by Subject|1
7603651|NCT01915914|26456250|P3|Follow-up Phase|Withdrawal by Subject|0
7603652|NCT01915914|26456251|P2|Follow-up Phase|Withdrawal by Subject|0
7603653|NCT01915914|26456252|P1|Follow-up Phase|Withdrawal by Subject|0
7603654|NCT01915914|26456249|P4|Maintenance Phase|Missing|0
7603655|NCT01915914|26456250|P3|Maintenance Phase|Missing|0
7603656|NCT01915914|26456251|P2|Maintenance Phase|Missing|1
7603657|NCT01915914|26456252|P1|Maintenance Phase|Missing|0
7603658|NCT01915914|26456249|P4|Maintenance Phase|Lost to Follow-up|0
7603659|NCT01915914|26456250|P3|Maintenance Phase|Lost to Follow-up|1
7603660|NCT01915914|26456251|P2|Maintenance Phase|Lost to Follow-up|4
7603661|NCT01915914|26456252|P1|Maintenance Phase|Lost to Follow-up|0
7603662|NCT01915914|26456249|P4|Maintenance Phase|Withdrawal by Subject|0
7603663|NCT01915914|26456250|P3|Maintenance Phase|Withdrawal by Subject|1
7603664|NCT01915914|26456251|P2|Maintenance Phase|Withdrawal by Subject|1
7603665|NCT01915914|26456252|P1|Maintenance Phase|Withdrawal by Subject|0
7603666|NCT01915914|26456249|P4|Acute Phase|Missing|0
7603667|NCT01915914|26456250|P3|Acute Phase|Missing|0
7603668|NCT01915914|26456251|P2|Acute Phase|Missing|0
7603669|NCT01915914|26456252|P1|Acute Phase|Missing|1
7603670|NCT01915914|26456249|P4|Acute Phase|"Not Achieved treatment success"|0
7603671|NCT01915914|26456250|P3|Acute Phase|"Not Achieved treatment success"|0
7603672|NCT01915914|26456251|P2|Acute Phase|"Not Achieved treatment success"|0
7603673|NCT01915914|26456252|P1|Acute Phase|"Not Achieved treatment success"|1
7603674|NCT01915914|26456249|P4|Acute Phase|Accepted Other Topic Therapies|0
7603675|NCT01915914|26456250|P3|Acute Phase|Accepted Other Topic Therapies|0
7603676|NCT01915914|26456251|P2|Acute Phase|Accepted Other Topic Therapies|0
7603677|NCT01915914|26456252|P1|Acute Phase|Accepted Other Topic Therapies|1
7603678|NCT01915914|26456249|P4|Acute Phase|Physician Decision|0
7603679|NCT01915914|26456250|P3|Acute Phase|Physician Decision|0
7603680|NCT01915914|26456251|P2|Acute Phase|Physician Decision|0
7603681|NCT01915914|26456252|P1|Acute Phase|Physician Decision|1
7603682|NCT01915914|26456249|P4|Acute Phase|Lost to Follow-up|0
7603683|NCT01915914|26456250|P3|Acute Phase|Lost to Follow-up|0
7603684|NCT01915914|26456251|P2|Acute Phase|Lost to Follow-up|0
7603685|NCT01915914|26456252|P1|Acute Phase|Lost to Follow-up|4
7603686|NCT01915914|26456249|P4|Acute Phase|Withdrawal by Subject|0
7603687|NCT01915914|26456250|P3|Acute Phase|Withdrawal by Subject|0
7603688|NCT01915914|26456251|P2|Acute Phase|Withdrawal by Subject|0
7603689|NCT01915914|26456252|P1|Acute Phase|Withdrawal by Subject|4
7603690|NCT01915849|26456284|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7603691|NCT01915849|26456285|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7603692|NCT01915849|26456286|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7603693|NCT01915849|26456287|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7603694|NCT01915849|26456284|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
7603695|NCT01915849|26456285|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
7603696|NCT01915849|26456286|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
7603697|NCT01915849|26456287|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
7603698|NCT01915771|26456310|P1|Day 15|Withdrawal by Subject|1
7603699|NCT01915771|26456310|P1|Day 1|Withdrawal by Subject|1
7603700|NCT01915732|26456334|P2|Overall Study|Poor Conscious Effect|1
7603701|NCT01915732|26456335|P1|Overall Study|Poor Conscious Effect|0
7603702|NCT01915732|26456334|P2|Overall Study|Improper Facial Procedure|1
7603703|NCT01915732|26456335|P1|Overall Study|Improper Facial Procedure|0
7603704|NCT01915732|26456334|P2|Overall Study|Job Transfer|1
7603705|NCT01915732|26456335|P1|Overall Study|Job Transfer|0
7603706|NCT01915732|26456334|P2|Overall Study|Par. Refused to Hospital Visits|1
7603707|NCT01915732|26456335|P1|Overall Study|Par. Refused to Hospital Visits|0
7603708|NCT01915732|26456334|P2|Overall Study|Par. not Willing to Continue Treatment|1
7603709|NCT01915732|26456335|P1|Overall Study|Par. not Willing to Continue Treatment|0
7603710|NCT01915732|26456334|P2|Overall Study|Got Well|1
7603711|NCT01915732|26456335|P1|Overall Study|Got Well|0
7603712|NCT01915732|26456334|P2|Overall Study|Par. Unable to Come to the Hospital|1
7603713|NCT01915732|26456335|P1|Overall Study|Par. Unable to Come to the Hospital|0
7603714|NCT01915732|26456334|P2|Overall Study|Poor Perceived Efficacy|0
7603715|NCT01915732|26456335|P1|Overall Study|Poor Perceived Efficacy|1
7603716|NCT01915732|26456334|P2|Overall Study|Pregnancy|0
7603717|NCT01915732|26456335|P1|Overall Study|Pregnancy|1
7603718|NCT01915732|26456334|P2|Overall Study|Recovered|0
7603719|NCT01915732|26456335|P1|Overall Study|Recovered|1
7603720|NCT01915732|26456334|P2|Overall Study|Drug Release Error|0
7603721|NCT01915732|26456335|P1|Overall Study|Drug Release Error|1
7603722|NCT01915732|26456334|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
7603723|NCT01915732|26456335|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
7603724|NCT01915732|26456334|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
7603725|NCT01915732|26456335|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
7603726|NCT01915732|26456334|P2|Overall Study|Lost to Follow-up|26
7603727|NCT01915732|26456335|P1|Overall Study|Lost to Follow-up|22
7603728|NCT01915732|26456334|P2|Overall Study|Lack of Efficacy|11
7603729|NCT01915732|26456335|P1|Overall Study|Lack of Efficacy|6
7603730|NCT01915732|26456334|P2|Overall Study|Protocol Violation|5
7603731|NCT01915732|26456335|P1|Overall Study|Protocol Violation|5
7603732|NCT01915732|26456334|P2|Overall Study|Adverse Event|4
7603733|NCT01915732|26456335|P1|Overall Study|Adverse Event|12
7603734|NCT01915732|26456334|P2|Overall Study|Failure to Meet Randomization Criteria|0
7603735|NCT01915732|26456335|P1|Overall Study|Failure to Meet Randomization Criteria|1
7603736|NCT01915732|26456334|P2|Overall Study|Withdrawal by Subject|18
7603737|NCT01915732|26456335|P1|Overall Study|Withdrawal by Subject|18
7603738|NCT01915498|26456388|P19|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
7603739|NCT01915498|26456389|P18|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603740|NCT01915498|26456390|P17|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603741|NCT01915498|26456391|P16|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603742|NCT01915498|26456392|P15|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603743|NCT01915498|26456393|P14|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603744|NCT01915498|26456394|P13|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603745|NCT01915498|26456395|P12|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603746|NCT01915498|26456396|P11|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603747|NCT01915498|26456397|P10|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603748|NCT01915498|26456398|P9|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603749|NCT01915498|26456399|P8|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603750|NCT01915498|26456400|P7|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603751|NCT01915498|26456401|P6|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603752|NCT01915498|26456402|P5|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603753|NCT01915498|26456403|P4|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603754|NCT01915498|26456404|P3|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603755|NCT01915498|26456405|P2|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603756|NCT01915498|26456406|P1|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7603757|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603758|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7603759|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7603760|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7603761|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7603762|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7603763|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603764|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603765|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603766|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7603767|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603768|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603769|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603770|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7603771|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603772|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603773|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603774|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603775|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7603776|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603777|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
7603778|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603779|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603780|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7603781|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603782|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603783|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603784|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603785|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603786|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603787|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603788|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603789|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7603790|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603791|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603792|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603793|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7603794|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7603795|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603796|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7603797|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7603798|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603799|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603800|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7603801|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603802|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603803|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7603804|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603805|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603806|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603807|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603808|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603809|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603810|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603811|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603812|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603813|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7603814|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603815|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
7603816|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7603817|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7603818|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
7603819|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
7603820|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7603821|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603822|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7603823|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603824|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603825|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603826|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7603827|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603828|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603829|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7603830|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7603831|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7603832|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7603833|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603834|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
7603835|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
7603836|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603837|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603838|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603839|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603840|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603841|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603842|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603843|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603844|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603845|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603846|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603847|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603848|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603849|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
7603850|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7603851|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7603852|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603853|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603854|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603855|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603856|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603857|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603858|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603859|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603860|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603861|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7603862|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603863|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603864|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603865|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603866|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7603867|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603868|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603869|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603870|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7603871|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7603872|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Death|16
7603873|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Death|3
7603874|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7603875|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7603876|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7603877|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7603878|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7603879|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7603880|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7603881|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7603882|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7603883|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7603884|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7603885|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7603886|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7603887|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7603888|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7603889|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7603890|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603891|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603892|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603893|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603894|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603895|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603896|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603897|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603898|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
7603899|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603900|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603901|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603902|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603903|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603904|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603905|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603906|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603907|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603908|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7603909|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
7603910|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
7603911|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
7603912|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
7603913|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
7603914|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
7603915|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7603916|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7603917|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7603918|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
7603919|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7603920|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
7603921|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7603922|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7603923|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7603924|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7603925|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7603926|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7603927|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
7603928|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7603929|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
7603930|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7603931|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7603932|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603933|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7603934|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7603935|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603936|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603937|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7603938|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603939|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7603940|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603941|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7603942|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7603943|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603944|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7603945|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7603946|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7603947|NCT01915498|26456388|P19|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603948|NCT01915498|26456389|P18|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7603949|NCT01915498|26456390|P17|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7603950|NCT01915498|26456391|P16|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7603951|NCT01915498|26456392|P15|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7603952|NCT01915498|26456393|P14|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7603953|NCT01915498|26456394|P13|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7603954|NCT01915498|26456395|P12|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603955|NCT01915498|26456396|P11|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603956|NCT01915498|26456397|P10|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7603957|NCT01915498|26456398|P9|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603958|NCT01915498|26456399|P8|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603959|NCT01915498|26456400|P7|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603960|NCT01915498|26456401|P6|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603961|NCT01915498|26456402|P5|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7603962|NCT01915498|26456403|P4|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7603963|NCT01915498|26456404|P3|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603964|NCT01915498|26456405|P2|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603965|NCT01915498|26456406|P1|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7603966|NCT01915303|26456930|P1|Extension Phase|Protocol Violation|1
7603967|NCT01915303|26456930|P1|Extension Phase|Death|1
7603968|NCT01915303|26456930|P1|Extension Phase|Adverse Event|3
7603969|NCT01915303|26456930|P1|Extension Phase|Withdrawal by Subject|4
7603970|NCT01915303|26456930|P1|Extension Phase|Unsatisfactory therapeutic effect|8
7603971|NCT01915303|26456930|P1|Core Phase|Withdrawal by Subject|1
7603972|NCT01915303|26456930|P1|Core Phase|Abnormal lab value|1
7603973|NCT01915303|26456930|P1|Core Phase|Protocol Violation|2
7603974|NCT01915303|26456930|P1|Core Phase|Death|2
7603975|NCT01915303|26456930|P1|Core Phase|Unsatisfactory therapeutic effect|3
7603976|NCT01915303|26456930|P1|Core Phase|Adverse Event|7
7603977|NCT01915095|26457004|P5|Overall Study|Some subjects were unable to commit to the training study.|6
7603978|NCT01915095|26457005|P4|Overall Study|Some subjects were unable to commit to the training study.|4
7603979|NCT01915095|26457006|P3|Overall Study|Some subjects were unable to commit to the training study.|0
7603980|NCT01915095|26457007|P2|Overall Study|Some subjects were unable to commit to the training study.|0
7603981|NCT01915095|26457008|P1|Overall Study|Some subjects were unable to commit to the training study.|0
7603982|NCT01914926|26457031|P2|Overall Study|uncooperative, agitated and removed|1
7603983|NCT01914926|26457032|P1|Overall Study|uncooperative, agitated and removed|0
7603984|NCT01914926|26457031|P2|Overall Study|Adverse Event|0
7603985|NCT01914926|26457032|P1|Overall Study|Adverse Event|1
7603986|NCT01914757|26457041|P3|Overall Study|Other reasons|4
7603987|NCT01914757|26457042|P2|Overall Study|Other reasons|9
7603988|NCT01914757|26457043|P1|Overall Study|Other reasons|5
7603989|NCT01914757|26457041|P3|Overall Study|Eligibility criteria not fulfilled|2
7603990|NCT01914757|26457042|P2|Overall Study|Eligibility criteria not fulfilled|0
7603991|NCT01914757|26457043|P1|Overall Study|Eligibility criteria not fulfilled|2
7603992|NCT01914757|26457041|P3|Overall Study|Study specific withdrawal criteria|0
7603993|NCT01914757|26457042|P2|Overall Study|Study specific withdrawal criteria|1
7603994|NCT01914757|26457043|P1|Overall Study|Study specific withdrawal criteria|0
7603995|NCT01914757|26457041|P3|Overall Study|Adverse Event|4
7603996|NCT01914757|26457042|P2|Overall Study|Adverse Event|3
7603997|NCT01914757|26457043|P1|Overall Study|Adverse Event|4
7603998|NCT01914757|26457041|P3|Overall Study|Death|1
7603999|NCT01914757|26457042|P2|Overall Study|Death|2
7604000|NCT01914757|26457043|P1|Overall Study|Death|2
7604001|NCT01914757|26457041|P3|Overall Study|Withdrawal by Subject|19
7604002|NCT01914757|26457042|P2|Overall Study|Withdrawal by Subject|27
7604003|NCT01914757|26457043|P1|Overall Study|Withdrawal by Subject|15
7604004|NCT01914757|26457041|P3|Overall Study|Lost to Follow-up|6
7604005|NCT01914757|26457042|P2|Overall Study|Lost to Follow-up|8
7604006|NCT01914757|26457043|P1|Overall Study|Lost to Follow-up|5
7604007|NCT01914757|26457041|P3|Overall Study|Severe non-compliance to protocol|2
7604008|NCT01914757|26457042|P2|Overall Study|Severe non-compliance to protocol|1
7604009|NCT01914757|26457043|P1|Overall Study|Severe non-compliance to protocol|3
7604010|NCT01914679|26457117|P1|Overall Study|Sponsor terminated study|4
7604011|NCT01914679|26457117|P1|Overall Study|Lack of Efficacy|1
7604012|NCT01914666|26457124|P3|Treatment Period|Physician Decision|2
7604013|NCT01914666|26457125|P2|Treatment Period|Physician Decision|0
7604014|NCT01914666|26457126|P1|Treatment Period|Physician Decision|0
7604015|NCT01914666|26457124|P3|Treatment Period|Withdrawal by Subject|2
7604016|NCT01914666|26457125|P2|Treatment Period|Withdrawal by Subject|2
7604017|NCT01914666|26457126|P1|Treatment Period|Withdrawal by Subject|3
7604018|NCT01914666|26457124|P3|Treatment Period|Adverse Event|2
7604019|NCT01914666|26457125|P2|Treatment Period|Adverse Event|4
7604020|NCT01914666|26457126|P1|Treatment Period|Adverse Event|10
7604021|NCT01914666|26457124|P3|Treatment Period|Lack of Efficacy|2
7604022|NCT01914666|26457125|P2|Treatment Period|Lack of Efficacy|0
7604023|NCT01914666|26457126|P1|Treatment Period|Lack of Efficacy|0
7604024|NCT01914393|26457169|P3|Overall Study|subject never dosed|1
7604025|NCT01914393|26457170|P2|Overall Study|subject never dosed|0
7604026|NCT01914393|26457171|P1|Overall Study|subject never dosed|0
7604027|NCT01914393|26457169|P3|Overall Study|Lost to Follow-up|19
7604028|NCT01914393|26457170|P2|Overall Study|Lost to Follow-up|6
7604029|NCT01914393|26457171|P1|Overall Study|Lost to Follow-up|12
7604030|NCT01914393|26457169|P3|Overall Study|Withdrawal by Subject|47
7604031|NCT01914393|26457170|P2|Overall Study|Withdrawal by Subject|20
7604032|NCT01914393|26457171|P1|Overall Study|Withdrawal by Subject|38
7604033|NCT01914393|26457169|P3|Overall Study|Adverse Event|31
7604034|NCT01914393|26457170|P2|Overall Study|Adverse Event|18
7604035|NCT01914393|26457171|P1|Overall Study|Adverse Event|29
7604036|NCT01914393|26457169|P3|Overall Study|no reason given|16
7604037|NCT01914393|26457170|P2|Overall Study|no reason given|8
7604038|NCT01914393|26457171|P1|Overall Study|no reason given|14
7604039|NCT01914393|26457169|P3|Overall Study|Lack of Efficacy|5
7604040|NCT01914393|26457170|P2|Overall Study|Lack of Efficacy|16
7604041|NCT01914393|26457171|P1|Overall Study|Lack of Efficacy|11
7604042|NCT01914393|26457169|P3|Overall Study|Protocol Violation|19
7604043|NCT01914393|26457170|P2|Overall Study|Protocol Violation|3
7604044|NCT01914393|26457171|P1|Overall Study|Protocol Violation|11
7604045|NCT01913639|26457239|P1|Overall Study|Not Eligible|3
7604046|NCT01913483|26457305|P2|Overall Study|Death|17
7604047|NCT01913483|26457306|P1|Overall Study|Death|14
7604048|NCT01913483|26457305|P2|Overall Study|Lost to Follow-up|3
7604049|NCT01913483|26457306|P1|Overall Study|Lost to Follow-up|6
7604050|NCT01913483|26457305|P2|Overall Study|Withdrawal by Subject|2
7604051|NCT01913483|26457306|P1|Overall Study|Withdrawal by Subject|1
7604052|NCT01913470|26457318|P2|Overall Study|Withdrawal by Subject|1
7604053|NCT01913470|26457319|P1|Overall Study|Withdrawal by Subject|0
7604054|NCT01913470|26457318|P2|Overall Study|Physician Decision|1
7604055|NCT01913470|26457319|P1|Overall Study|Physician Decision|0
7604056|NCT01913470|26457318|P2|Overall Study|Lost to Follow-up|1
7604057|NCT01913470|26457319|P1|Overall Study|Lost to Follow-up|0
7604058|NCT01913405|26457337|P1|Overall Study|Adverse Event|1
7604059|NCT01913405|26457337|P1|Overall Study|Withdrawal by Subject|1
7604060|NCT01913353|26457393|P2|Overall Study|multiple reasons|7
7604061|NCT01913353|26457394|P1|Overall Study|multiple reasons|10
7604062|NCT01913353|26457393|P2|Overall Study|Withdrawal by Subject|6
7604063|NCT01913353|26457394|P1|Overall Study|Withdrawal by Subject|20
7604064|NCT01913353|26457393|P2|Overall Study|Physician Decision|2
7604065|NCT01913353|26457394|P1|Overall Study|Physician Decision|0
7604066|NCT01913353|26457393|P2|Overall Study|Adverse Event|0
7604067|NCT01913353|26457394|P1|Overall Study|Adverse Event|2
7604068|NCT01913340|26457464|P2|Overall Study|Lost to Follow-up|1
7604069|NCT01913340|26457465|P1|Overall Study|Lost to Follow-up|1
7604070|NCT01913340|26457464|P2|Overall Study|Death|5
7604071|NCT01913340|26457465|P1|Overall Study|Death|2
7604072|NCT01913327|26457489|P2|Overall Study|Withdrawal by Subject|1
7604073|NCT01913327|26457490|P1|Overall Study|Withdrawal by Subject|0
7604074|NCT01913041|26457515|P1|Overall Study|Physician Decision|1
7604075|NCT01913041|26457515|P1|Overall Study|Withdrawal by Subject|3
7604076|NCT01913041|26457515|P1|Overall Study|Protocol Violation|35
7604077|NCT01912963|26457522|P3|Overall Study|Sought treatment locally|0
7604078|NCT01912963|26457523|P2|Overall Study|Sought treatment locally|1
7604079|NCT01912963|26457524|P1|Overall Study|Sought treatment locally|0
7604080|NCT01912963|26457522|P3|Overall Study|Withdrawal by Subject|0
7604081|NCT01912963|26457523|P2|Overall Study|Withdrawal by Subject|1
7604082|NCT01912963|26457524|P1|Overall Study|Withdrawal by Subject|0
7604083|NCT01912963|26457522|P3|Overall Study|Adverse Event|1
7604084|NCT01912963|26457523|P2|Overall Study|Adverse Event|1
7604085|NCT01912963|26457524|P1|Overall Study|Adverse Event|0
7604086|NCT01912963|26457522|P3|Overall Study|Disease Progression (not RECIST1.1)|1
7604087|NCT01912963|26457523|P2|Overall Study|Disease Progression (not RECIST1.1)|7
7604088|NCT01912963|26457524|P1|Overall Study|Disease Progression (not RECIST1.1)|0
7604089|NCT01912963|26457522|P3|Overall Study|Disease Progression (RECIST1.1)|5
7604090|NCT01912963|26457523|P2|Overall Study|Disease Progression (RECIST1.1)|9
7604091|NCT01912963|26457524|P1|Overall Study|Disease Progression (RECIST1.1)|6
7604092|NCT01912872|26457547|P4|Overall Study|Missing|1
7604093|NCT01912872|26457548|P3|Overall Study|Missing|0
7604094|NCT01912872|26457549|P2|Overall Study|Missing|0
7604095|NCT01912872|26457550|P1|Overall Study|Missing|0
7604096|NCT01912872|26457547|P4|Overall Study|Withdrawal of study medication|2
7604097|NCT01912872|26457548|P3|Overall Study|Withdrawal of study medication|0
7604098|NCT01912872|26457549|P2|Overall Study|Withdrawal of study medication|0
7604099|NCT01912872|26457550|P1|Overall Study|Withdrawal of study medication|0
7604100|NCT01912872|26457547|P4|Overall Study|Unsatisfactory therapeutic effect|2
7604101|NCT01912872|26457548|P3|Overall Study|Unsatisfactory therapeutic effect|0
7604102|NCT01912872|26457549|P2|Overall Study|Unsatisfactory therapeutic effect|0
7604103|NCT01912872|26457550|P1|Overall Study|Unsatisfactory therapeutic effect|0
7604104|NCT01912872|26457547|P4|Overall Study|Protocol Violation|0
7604105|NCT01912872|26457548|P3|Overall Study|Protocol Violation|1
7604106|NCT01912872|26457549|P2|Overall Study|Protocol Violation|0
7604107|NCT01912872|26457550|P1|Overall Study|Protocol Violation|0
7604108|NCT01912872|26457547|P4|Overall Study|Non-compliance with lab inc/exclusion|1
7604109|NCT01912872|26457548|P3|Overall Study|Non-compliance with lab inc/exclusion|0
7604110|NCT01912872|26457549|P2|Overall Study|Non-compliance with lab inc/exclusion|0
7604111|NCT01912872|26457550|P1|Overall Study|Non-compliance with lab inc/exclusion|0
7604112|NCT01912872|26457547|P4|Overall Study|Informed consent withdrawn|1
7604113|NCT01912872|26457548|P3|Overall Study|Informed consent withdrawn|1
7604114|NCT01912872|26457549|P2|Overall Study|Informed consent withdrawn|0
7604115|NCT01912872|26457550|P1|Overall Study|Informed consent withdrawn|0
7604116|NCT01912872|26457547|P4|Overall Study|Other unspecified|0
7604117|NCT01912872|26457548|P3|Overall Study|Other unspecified|3
7604118|NCT01912872|26457549|P2|Overall Study|Other unspecified|1
7604119|NCT01912872|26457550|P1|Overall Study|Other unspecified|3
7604120|NCT01912872|26457547|P4|Overall Study|Lost to Follow-up|5
7604121|NCT01912872|26457548|P3|Overall Study|Lost to Follow-up|5
7604122|NCT01912872|26457549|P2|Overall Study|Lost to Follow-up|3
7604123|NCT01912872|26457550|P1|Overall Study|Lost to Follow-up|2
7604124|NCT01912781|26457594|P2|Overall Study|Withdrawal by Subject|0
7604125|NCT01912781|26457595|P1|Overall Study|Withdrawal by Subject|2
7604126|NCT01912768|26457626|P2|Overall Study|Randomized in error|0
7604127|NCT01912768|26457627|P1|Overall Study|Randomized in error|1
7604128|NCT01912768|26457626|P2|Overall Study|Withdrawal by Subject|3
7604129|NCT01912768|26457627|P1|Overall Study|Withdrawal by Subject|5
7604130|NCT01912768|26457626|P2|Overall Study|Lost to Follow-up|1
7604131|NCT01912768|26457627|P1|Overall Study|Lost to Follow-up|2
7604132|NCT01912768|26457626|P2|Overall Study|Adverse Event|0
7604133|NCT01912768|26457627|P1|Overall Study|Adverse Event|2
7604134|NCT01912729|26457658|P2|Overall Study|Withdrawal by Subject|1
7604135|NCT01912729|26457659|P1|Overall Study|Withdrawal by Subject|0
7604136|NCT01912612|26457682|P3|Overall Study|Study design change|3
7604137|NCT01912612|26457683|P2|Overall Study|Study design change|0
7604138|NCT01912612|26457684|P1|Overall Study|Study design change|0
7604139|NCT01912612|26457682|P3|Overall Study|Withdrew consent|0
7604140|NCT01912612|26457683|P2|Overall Study|Withdrew consent|0
7604141|NCT01912612|26457684|P1|Overall Study|Withdrew consent|1
7604142|NCT01912612|26457682|P3|Overall Study|Adverse Event|0
7604143|NCT01912612|26457683|P2|Overall Study|Adverse Event|0
7604144|NCT01912612|26457684|P1|Overall Study|Adverse Event|4
7604145|NCT01912599|26457728|P2|Overall Study|Withdrawal by Subject|1
7604146|NCT01912599|26457729|P1|Overall Study|Withdrawal by Subject|0
7604147|NCT01912456|26457754|P4|Period 2|Adverse Event|1
7604148|NCT01912456|26457755|P3|Period 2|Adverse Event|0
7604149|NCT01912456|26457756|P2|Period 2|Adverse Event|0
7604150|NCT01912456|26457757|P1|Period 2|Adverse Event|0
7604151|NCT01912456|26457754|P4|Period 2|Lack of Efficacy|0
7604152|NCT01912456|26457755|P3|Period 2|Lack of Efficacy|0
7604153|NCT01912456|26457756|P2|Period 2|Lack of Efficacy|2
7604154|NCT01912456|26457757|P1|Period 2|Lack of Efficacy|0
7604155|NCT01912456|26457754|P4|Period 1|Withdrawal by Subject|1
7604156|NCT01912456|26457755|P3|Period 1|Withdrawal by Subject|1
7604157|NCT01912456|26457756|P2|Period 1|Withdrawal by Subject|1
7604158|NCT01912456|26457757|P1|Period 1|Withdrawal by Subject|0
7604159|NCT01912456|26457754|P4|Period 1|Adverse Event|1
7604160|NCT01912456|26457755|P3|Period 1|Adverse Event|0
7604161|NCT01912456|26457756|P2|Period 1|Adverse Event|0
7604162|NCT01912456|26457757|P1|Period 1|Adverse Event|1
7604163|NCT01912456|26457754|P4|Period 1|non-compliance|1
7604164|NCT01912456|26457755|P3|Period 1|non-compliance|0
7604165|NCT01912456|26457756|P2|Period 1|non-compliance|0
7604166|NCT01912456|26457757|P1|Period 1|non-compliance|1
7604167|NCT01912456|26457754|P4|Period 1|Physician Decision|0
7604168|NCT01912456|26457755|P3|Period 1|Physician Decision|1
7604169|NCT01912456|26457756|P2|Period 1|Physician Decision|0
7604170|NCT01912456|26457757|P1|Period 1|Physician Decision|0
7604171|NCT01912404|26457791|P2|Overall Study|Due to personal reasons|0
7604172|NCT01912404|26457792|P1|Overall Study|Due to personal reasons|1
7604173|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
7604174|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
7604175|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
7604176|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
7604177|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7604178|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7604179|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
7604180|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7604181|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7604182|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
7604183|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7604184|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7604185|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
7604186|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7604187|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7604188|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7604189|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7604190|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
7604191|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7604192|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7604193|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
7604194|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
7604195|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
7604196|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
7604197|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7604198|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7604199|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
7604200|NCT01912339|26457805|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7604201|NCT01912339|26457806|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7604202|NCT01912339|26457807|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
7604203|NCT01912339|26457805|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7604204|NCT01912339|26457806|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7604205|NCT01912339|26457807|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
7604206|NCT01912339|26457805|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
7604207|NCT01912339|26457806|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
7604208|NCT01912339|26457807|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
7604209|NCT01912339|26457805|P3|Blinded (0 to 3 Months)|Declined to participate|0
7604210|NCT01912339|26457806|P2|Blinded (0 to 3 Months)|Declined to participate|0
7604211|NCT01912339|26457807|P1|Blinded (0 to 3 Months)|Declined to participate|1
7604212|NCT01912287|26457824|P3|Overall Study|Scheduling/change in availability|8
7604213|NCT01912287|26457825|P2|Overall Study|Scheduling/change in availability|10
7604214|NCT01912287|26457826|P1|Overall Study|Scheduling/change in availability|17
7604215|NCT01912287|26457824|P3|Overall Study|Missed Assesment|1
7604216|NCT01912287|26457825|P2|Overall Study|Missed Assesment|1
7604217|NCT01912287|26457826|P1|Overall Study|Missed Assesment|1
7604218|NCT01912287|26457824|P3|Overall Study|Uknown reason - subject drop out|3
7604219|NCT01912287|26457825|P2|Overall Study|Uknown reason - subject drop out|7
7604220|NCT01912287|26457826|P1|Overall Study|Uknown reason - subject drop out|5
7604221|NCT01912287|26457824|P3|Overall Study|Lost Interest|0
7604222|NCT01912287|26457825|P2|Overall Study|Lost Interest|0
7604223|NCT01912287|26457826|P1|Overall Study|Lost Interest|1
7604224|NCT01912287|26457824|P3|Overall Study|Life circumstances|0
7604225|NCT01912287|26457825|P2|Overall Study|Life circumstances|2
7604226|NCT01912287|26457826|P1|Overall Study|Life circumstances|4
7604227|NCT01912287|26457824|P3|Overall Study|Felt treatment no longer needed|0
7604228|NCT01912287|26457825|P2|Overall Study|Felt treatment no longer needed|1
7604229|NCT01912287|26457826|P1|Overall Study|Felt treatment no longer needed|0
7604230|NCT01912287|26457824|P3|Overall Study|Dissatisfaction with assigned treatment|1
7604231|NCT01912287|26457825|P2|Overall Study|Dissatisfaction with assigned treatment|2
7604232|NCT01912287|26457826|P1|Overall Study|Dissatisfaction with assigned treatment|4
7604233|NCT01912287|26457824|P3|Overall Study|No-show|1
7604234|NCT01912287|26457825|P2|Overall Study|No-show|0
7604235|NCT01912287|26457826|P1|Overall Study|No-show|0
7604236|NCT01912287|26457824|P3|Overall Study|Ineligible|1
7604237|NCT01912287|26457825|P2|Overall Study|Ineligible|0
7604238|NCT01912287|26457826|P1|Overall Study|Ineligible|1
7604239|NCT01912222|26457847|P3|Part B: Treatment Period|Withdrawal by Subject|2
7604240|NCT01912222|26457848|P2|Part B: Treatment Period|Withdrawal by Subject|1
7604241|NCT01912222|26457849|P1|Part B: Treatment Period|Withdrawal by Subject|2
7604242|NCT01912222|26457847|P3|Part B: Treatment Period|Adverse Event|3
7604243|NCT01912222|26457848|P2|Part B: Treatment Period|Adverse Event|2
7604244|NCT01912222|26457849|P1|Part B: Treatment Period|Adverse Event|1
7604245|NCT01912222|26457847|P3|Part B: Treatment Period|Progressive disease|15
7604246|NCT01912222|26457848|P2|Part B: Treatment Period|Progressive disease|12
7604247|NCT01912222|26457849|P1|Part B: Treatment Period|Progressive disease|10
7604248|NCT01912222|26457847|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7604249|NCT01912222|26457848|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7604250|NCT01912222|26457849|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
7604251|NCT01911845|26457907|P1|Overall Study|Other (not specified)|3
7604252|NCT01911845|26457907|P1|Overall Study|Lost to Follow-up|1
7604253|NCT01911845|26457907|P1|Overall Study|Adverse Event|2
7604254|NCT01911819|26457924|P3|Overall Study|Withdrawal by Subject|0
7604255|NCT01911819|26457925|P2|Overall Study|Withdrawal by Subject|1
7604256|NCT01911819|26457926|P1|Overall Study|Withdrawal by Subject|1
7604257|NCT01911819|26457924|P3|Overall Study|Adverse Event|0
7604258|NCT01911819|26457925|P2|Overall Study|Adverse Event|1
7604259|NCT01911819|26457926|P1|Overall Study|Adverse Event|0
7604260|NCT01911793|26457939|P2|Overall Study|Physician Decision|5
7604261|NCT01911793|26457940|P1|Overall Study|Physician Decision|1
7604262|NCT01911780|26457964|P2|Extension Period (52 Weeks)|Personal reason|1
7604263|NCT01911780|26457965|P1|Extension Period (52 Weeks)|Personal reason|1
7604264|NCT01911780|26457964|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
7604265|NCT01911780|26457965|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
7604266|NCT01911780|26457964|P2|Extension Period (52 Weeks)|Adverse Event|0
7604267|NCT01911780|26457965|P1|Extension Period (52 Weeks)|Adverse Event|3
7604268|NCT01911780|26457964|P2|Double-blind Period (8 Weeks)|Personal reason|0
7604269|NCT01911780|26457965|P1|Double-blind Period (8 Weeks)|Personal reason|1
7604270|NCT01911780|26457964|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7604271|NCT01911780|26457965|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7604272|NCT01911780|26457964|P2|Double-blind Period (8 Weeks)|Adverse Event|2
7604273|NCT01911780|26457965|P1|Double-blind Period (8 Weeks)|Adverse Event|1
7604274|NCT01911546|26457999|P1|Overall Study|Everolimus was discontinued|5
7604275|NCT01911546|26457999|P1|Overall Study|Lost to Follow-up|1
7604276|NCT01911442|26458009|P3|Overall Study|Mother's Work Schedule|0
7604277|NCT01911442|26458010|P2|Overall Study|Mother's Work Schedule|1
7604278|NCT01911442|26458011|P1|Overall Study|Mother's Work Schedule|0
7604279|NCT01911442|26458009|P3|Overall Study|Withdrawal by Subject|6
7604280|NCT01911442|26458010|P2|Overall Study|Withdrawal by Subject|0
7604281|NCT01911442|26458011|P1|Overall Study|Withdrawal by Subject|1
7604282|NCT01911442|26458009|P3|Overall Study|Lost to Follow-up|1
7604283|NCT01911442|26458010|P2|Overall Study|Lost to Follow-up|0
7604284|NCT01911442|26458011|P1|Overall Study|Lost to Follow-up|2
7604285|NCT01911442|26458009|P3|Overall Study|Lack of Efficacy|1
7604286|NCT01911442|26458010|P2|Overall Study|Lack of Efficacy|1
7604287|NCT01911442|26458011|P1|Overall Study|Lack of Efficacy|1
7604288|NCT01911442|26458009|P3|Overall Study|Adverse Event|4
7604289|NCT01911442|26458010|P2|Overall Study|Adverse Event|2
7604290|NCT01911442|26458011|P1|Overall Study|Adverse Event|2
7604291|NCT01911429|26458040|P3|Overall Study|subject left study|0
7604292|NCT01911429|26458041|P2|Overall Study|subject left study|0
7604293|NCT01911429|26458042|P1|Overall Study|subject left study|1
7604294|NCT01911429|26458040|P3|Overall Study|Accidental randomization|1
7604295|NCT01911429|26458041|P2|Overall Study|Accidental randomization|0
7604296|NCT01911429|26458042|P1|Overall Study|Accidental randomization|0
7604297|NCT01911429|26458040|P3|Overall Study|Withdrawal by Subject|4
7604298|NCT01911429|26458041|P2|Overall Study|Withdrawal by Subject|5
7604299|NCT01911429|26458042|P1|Overall Study|Withdrawal by Subject|5
7604300|NCT01911429|26458040|P3|Overall Study|Protocol Violation|1
7604301|NCT01911429|26458041|P2|Overall Study|Protocol Violation|0
7604302|NCT01911429|26458042|P1|Overall Study|Protocol Violation|0
7604303|NCT01911429|26458040|P3|Overall Study|Lost to Follow-up|1
7604304|NCT01911429|26458041|P2|Overall Study|Lost to Follow-up|0
7604305|NCT01911429|26458042|P1|Overall Study|Lost to Follow-up|0
7604306|NCT01911429|26458040|P3|Overall Study|Lack of Efficacy|4
7604307|NCT01911429|26458041|P2|Overall Study|Lack of Efficacy|2
7604308|NCT01911429|26458042|P1|Overall Study|Lack of Efficacy|1
7604309|NCT01911429|26458040|P3|Overall Study|Adverse Event|9
7604310|NCT01911429|26458041|P2|Overall Study|Adverse Event|3
7604311|NCT01911429|26458042|P1|Overall Study|Adverse Event|5
7604312|NCT01911273|26458134|P2|Overall Study|Withdrawal by Subject|2
7604313|NCT01911273|26458135|P1|Overall Study|Withdrawal by Subject|0
7604314|NCT01911273|26458134|P2|Overall Study|Progression of Disease|0
7604315|NCT01911273|26458135|P1|Overall Study|Progression of Disease|1
7604316|NCT01911260|26458169|P4|Follow-up Period|transference or evasion of school|12
7604317|NCT01911260|26458170|P3|Follow-up Period|transference or evasion of school|15
7604318|NCT01911260|26458171|P2|Follow-up Period|transference or evasion of school|20
7604319|NCT01911260|26458172|P1|Follow-up Period|transference or evasion of school|13
7604320|NCT01911260|26458169|P4|Supplementation Period|less than 12 weeks supplementation|2
7604321|NCT01911260|26458170|P3|Supplementation Period|less than 12 weeks supplementation|1
7604322|NCT01911260|26458171|P2|Supplementation Period|less than 12 weeks supplementation|3
7604323|NCT01911260|26458172|P1|Supplementation Period|less than 12 weeks supplementation|0
7604324|NCT01911260|26458169|P4|Supplementation Period|refused to receive supplement|0
7604325|NCT01911260|26458170|P3|Supplementation Period|refused to receive supplement|1
7604326|NCT01911260|26458171|P2|Supplementation Period|refused to receive supplement|0
7604327|NCT01911260|26458172|P1|Supplementation Period|refused to receive supplement|1
7604328|NCT01911260|26458169|P4|Supplementation Period|Adverse Event|0
7604329|NCT01911260|26458170|P3|Supplementation Period|Adverse Event|1
7604330|NCT01911260|26458171|P2|Supplementation Period|Adverse Event|0
7604331|NCT01911260|26458172|P1|Supplementation Period|Adverse Event|2
7604332|NCT01911260|26458169|P4|Supplementation Period|transference or evasion of school|6
7604333|NCT01911260|26458170|P3|Supplementation Period|transference or evasion of school|7
7604334|NCT01911260|26458171|P2|Supplementation Period|transference or evasion of school|9
7604335|NCT01911260|26458172|P1|Supplementation Period|transference or evasion of school|7
7604336|NCT01910519|26458258|P2|Overall Study|Adverse Event|0
7604337|NCT01910519|26458259|P1|Overall Study|Adverse Event|2
7604338|NCT01910519|26458258|P2|Overall Study|Withdrawal by Subject|0
7604339|NCT01910519|26458259|P1|Overall Study|Withdrawal by Subject|2
7604340|NCT01910441|26458285|P2|Overall Study|Physician Decision|1
7604341|NCT01910441|26458286|P1|Overall Study|Physician Decision|0
7604342|NCT01910441|26458285|P2|Overall Study|Adverse Event|0
7604343|NCT01910441|26458286|P1|Overall Study|Adverse Event|1
7604344|NCT01910441|26458285|P2|Overall Study|Non-compliance|1
7604345|NCT01910441|26458286|P1|Overall Study|Non-compliance|0
7604346|NCT01910441|26458285|P2|Overall Study|Withdrawal by Subject|1
7604347|NCT01910441|26458286|P1|Overall Study|Withdrawal by Subject|0
7604348|NCT01910441|26458285|P2|Overall Study|Lost to Follow-up|5
7604349|NCT01910441|26458286|P1|Overall Study|Lost to Follow-up|6
7604350|NCT01910441|26458285|P2|Overall Study|Sponsor decision|2
7604351|NCT01910441|26458286|P1|Overall Study|Sponsor decision|0
7604352|NCT01910402|26458294|P2|Continuation Phase|Withdrawal by Subject|0
7604353|NCT01910402|26458295|P1|Continuation Phase|Withdrawal by Subject|2
7604354|NCT01910402|26458294|P2|Continuation Phase|Protocol Violation|0
7604355|NCT01910402|26458295|P1|Continuation Phase|Protocol Violation|3
7604356|NCT01910402|26458294|P2|Continuation Phase|Adverse Event|0
7604357|NCT01910402|26458295|P1|Continuation Phase|Adverse Event|1
7604358|NCT01910402|26458294|P2|Continuation Phase|Ongoing|0
7604359|NCT01910402|26458295|P1|Continuation Phase|Ongoing|84
7604360|NCT01910402|26458294|P2|Randomized Phase|Withdrawal by Subject|7
7604361|NCT01910402|26458295|P1|Randomized Phase|Withdrawal by Subject|5
7604362|NCT01910402|26458294|P2|Randomized Phase|Protocol Violation|13
7604363|NCT01910402|26458295|P1|Randomized Phase|Protocol Violation|10
7604364|NCT01910402|26458294|P2|Randomized Phase|Lost to Follow-up|13
7604365|NCT01910402|26458295|P1|Randomized Phase|Lost to Follow-up|11
7604366|NCT01910402|26458294|P2|Randomized Phase|Lack of Efficacy|4
7604367|NCT01910402|26458295|P1|Randomized Phase|Lack of Efficacy|5
7604368|NCT01910402|26458294|P2|Randomized Phase|Physician Decision|0
7604369|NCT01910402|26458295|P1|Randomized Phase|Physician Decision|1
7604370|NCT01910402|26458294|P2|Randomized Phase|Adverse Event|18
7604371|NCT01910402|26458295|P1|Randomized Phase|Adverse Event|10
7604372|NCT01910389|26458365|P2|Overall Study|Study Closed|8
7604373|NCT01910389|26458366|P1|Overall Study|Study Closed|13
7604374|NCT01910389|26458365|P2|Overall Study|Withdrawal by Subject|0
7604375|NCT01910389|26458366|P1|Overall Study|Withdrawal by Subject|2
7604376|NCT01910298|26458409|P2|Overall Study|Other Miscellaneous Reasons|2
7604377|NCT01910298|26458410|P1|Overall Study|Other Miscellaneous Reasons|0
7604378|NCT01910298|26458409|P2|Overall Study|Study Terminated by Sponsor|17
7604379|NCT01910298|26458410|P1|Overall Study|Study Terminated by Sponsor|1
7604380|NCT01910298|26458409|P2|Overall Study|Lost to Follow-up|1
7604381|NCT01910298|26458410|P1|Overall Study|Lost to Follow-up|1
7604382|NCT01910298|26458409|P2|Overall Study|Protocol Deviation|5
7604383|NCT01910298|26458410|P1|Overall Study|Protocol Deviation|0
7604384|NCT01910298|26458409|P2|Overall Study|Withdrawal by Subject|7
7604385|NCT01910298|26458410|P1|Overall Study|Withdrawal by Subject|2
7604386|NCT01910298|26458409|P2|Overall Study|Adverse Event|0
7604387|NCT01910298|26458410|P1|Overall Study|Adverse Event|1
7604388|NCT01910181|26458428|P1|Overall Study|Study Terminated by Sponsor|6
7604389|NCT01910181|26458428|P1|Overall Study|Lost to Follow-up|3
7604390|NCT01910181|26458428|P1|Overall Study|Death|37
7604391|NCT01910129|26458455|P3|Randomized Phase 3|Withdrawal by Subject|0
7604392|NCT01910129|26458456|P2|Randomized Phase 3|Withdrawal by Subject|1
7604393|NCT01910129|26458457|P1|Randomized Phase 3|Withdrawal by Subject|0
7604394|NCT01910129|26458455|P3|Randomized Phase 2|Withdrawal by Subject|0
7604395|NCT01910129|26458456|P2|Randomized Phase 2|Withdrawal by Subject|1
7604396|NCT01910129|26458457|P1|Randomized Phase 2|Withdrawal by Subject|2
7604397|NCT01910116|26458481|P2|Overall Study|incomplete data|1
7604398|NCT01910116|26458482|P1|Overall Study|incomplete data|0
7604399|NCT01910116|26458481|P2|Overall Study|uncertain allocation|3
7604400|NCT01910116|26458482|P1|Overall Study|uncertain allocation|1
7604401|NCT01910116|26458481|P2|Overall Study|Withdrawal by Subject|3
7604402|NCT01910116|26458482|P1|Overall Study|Withdrawal by Subject|8
7604403|NCT01910116|26458481|P2|Overall Study|Protocol Violation|2
7604404|NCT01910116|26458482|P1|Overall Study|Protocol Violation|1
7604405|NCT01910116|26458481|P2|Overall Study|Lost to Follow-up|0
7604406|NCT01910116|26458482|P1|Overall Study|Lost to Follow-up|1
7604407|NCT01910116|26458481|P2|Overall Study|Lack of Efficacy|4
7604408|NCT01910116|26458482|P1|Overall Study|Lack of Efficacy|3
7604409|NCT01910116|26458481|P2|Overall Study|Adverse Event|3
7604410|NCT01910116|26458482|P1|Overall Study|Adverse Event|0
7604411|NCT01909973|26458569|P2|Overall Study|Lost to Follow-up|0
7604412|NCT01909973|26458570|P1|Overall Study|Lost to Follow-up|1
7604413|NCT01909804|26458590|P12|Overall Study|Protocol Violation|1
7604414|NCT01909804|26458591|P11|Overall Study|Protocol Violation|0
7604415|NCT01909804|26458592|P10|Overall Study|Protocol Violation|0
7604416|NCT01909804|26458593|P9|Overall Study|Protocol Violation|0
7604417|NCT01909804|26458594|P8|Overall Study|Protocol Violation|0
7604418|NCT01909804|26458595|P7|Overall Study|Protocol Violation|0
7604419|NCT01909804|26458596|P6|Overall Study|Protocol Violation|0
7604420|NCT01909804|26458597|P5|Overall Study|Protocol Violation|0
7604421|NCT01909804|26458598|P4|Overall Study|Protocol Violation|0
7604422|NCT01909804|26458599|P3|Overall Study|Protocol Violation|0
7604423|NCT01909804|26458600|P2|Overall Study|Protocol Violation|0
7604424|NCT01909804|26458601|P1|Overall Study|Protocol Violation|0
7604425|NCT01909804|26458590|P12|Overall Study|Withdrew Consent|0
7604426|NCT01909804|26458591|P11|Overall Study|Withdrew Consent|0
7604427|NCT01909804|26458592|P10|Overall Study|Withdrew Consent|0
7604428|NCT01909804|26458593|P9|Overall Study|Withdrew Consent|0
7604429|NCT01909804|26458594|P8|Overall Study|Withdrew Consent|0
7604430|NCT01909804|26458595|P7|Overall Study|Withdrew Consent|0
7604431|NCT01909804|26458596|P6|Overall Study|Withdrew Consent|1
7604432|NCT01909804|26458597|P5|Overall Study|Withdrew Consent|1
7604433|NCT01909804|26458598|P4|Overall Study|Withdrew Consent|0
7604434|NCT01909804|26458599|P3|Overall Study|Withdrew Consent|0
7604435|NCT01909804|26458600|P2|Overall Study|Withdrew Consent|0
7604436|NCT01909804|26458601|P1|Overall Study|Withdrew Consent|0
7604437|NCT01909804|26458590|P12|Overall Study|Lack of Efficacy|1
7604438|NCT01909804|26458591|P11|Overall Study|Lack of Efficacy|0
7604439|NCT01909804|26458592|P10|Overall Study|Lack of Efficacy|1
7604440|NCT01909804|26458593|P9|Overall Study|Lack of Efficacy|0
7604441|NCT01909804|26458594|P8|Overall Study|Lack of Efficacy|1
7604442|NCT01909804|26458595|P7|Overall Study|Lack of Efficacy|1
7604443|NCT01909804|26458596|P6|Overall Study|Lack of Efficacy|3
7604444|NCT01909804|26458597|P5|Overall Study|Lack of Efficacy|7
7604445|NCT01909804|26458598|P4|Overall Study|Lack of Efficacy|0
7604446|NCT01909804|26458599|P3|Overall Study|Lack of Efficacy|0
7604447|NCT01909804|26458600|P2|Overall Study|Lack of Efficacy|1
7604448|NCT01909804|26458601|P1|Overall Study|Lack of Efficacy|4
7604449|NCT01909804|26458590|P12|Overall Study|Death|0
7604450|NCT01909804|26458591|P11|Overall Study|Death|1
7604451|NCT01909804|26458592|P10|Overall Study|Death|0
7604452|NCT01909804|26458593|P9|Overall Study|Death|0
7604453|NCT01909804|26458594|P8|Overall Study|Death|0
7604454|NCT01909804|26458595|P7|Overall Study|Death|0
7604455|NCT01909804|26458596|P6|Overall Study|Death|0
7604456|NCT01909804|26458597|P5|Overall Study|Death|0
7604457|NCT01909804|26458598|P4|Overall Study|Death|0
7604458|NCT01909804|26458599|P3|Overall Study|Death|0
7604459|NCT01909804|26458600|P2|Overall Study|Death|0
7604460|NCT01909804|26458601|P1|Overall Study|Death|0
7604461|NCT01909804|26458590|P12|Overall Study|Randomized but Never Treated|1
7604462|NCT01909804|26458591|P11|Overall Study|Randomized but Never Treated|0
7604463|NCT01909804|26458592|P10|Overall Study|Randomized but Never Treated|0
7604464|NCT01909804|26458593|P9|Overall Study|Randomized but Never Treated|0
7604465|NCT01909804|26458594|P8|Overall Study|Randomized but Never Treated|0
7604466|NCT01909804|26458595|P7|Overall Study|Randomized but Never Treated|1
7604467|NCT01909804|26458596|P6|Overall Study|Randomized but Never Treated|0
7604468|NCT01909804|26458597|P5|Overall Study|Randomized but Never Treated|0
7604469|NCT01909804|26458598|P4|Overall Study|Randomized but Never Treated|0
7604470|NCT01909804|26458599|P3|Overall Study|Randomized but Never Treated|0
7604471|NCT01909804|26458600|P2|Overall Study|Randomized but Never Treated|0
7604472|NCT01909804|26458601|P1|Overall Study|Randomized but Never Treated|0
7604473|NCT01909791|26458650|P3|Overall Study|Missed Visit|1
7604474|NCT01909791|26458651|P2|Overall Study|Missed Visit|0
7604475|NCT01909791|26458652|P1|Overall Study|Missed Visit|2
7604476|NCT01909791|26458650|P3|Overall Study|Lost to Follow-up|10
7604477|NCT01909791|26458651|P2|Overall Study|Lost to Follow-up|11
7604478|NCT01909791|26458652|P1|Overall Study|Lost to Follow-up|5
7604479|NCT01909791|26458650|P3|Overall Study|Withdrawal by Subject|13
7604480|NCT01909791|26458651|P2|Overall Study|Withdrawal by Subject|9
7604481|NCT01909791|26458652|P1|Overall Study|Withdrawal by Subject|5
7604482|NCT01909791|26458650|P3|Overall Study|Death|4
7604483|NCT01909791|26458651|P2|Overall Study|Death|8
7604484|NCT01909791|26458652|P1|Overall Study|Death|9
7604485|NCT01909778|26458710|P1|Overall Study|failed screening|1
7604486|NCT01909674|26458789|P2|Overall Study|Withdrawal by Subject|2
7604487|NCT01909674|26458790|P1|Overall Study|Withdrawal by Subject|5
7604488|NCT01909466|26458809|P2|Overall Study|Lack of Efficacy|0
7604489|NCT01909466|26458810|P1|Overall Study|Lack of Efficacy|1
7604490|NCT01909466|26458809|P2|Overall Study|Withdrawal by Subject|9
7604491|NCT01909466|26458810|P1|Overall Study|Withdrawal by Subject|11
7604492|NCT01909466|26458809|P2|Overall Study|Physician Decision|0
7604493|NCT01909466|26458810|P1|Overall Study|Physician Decision|2
7604494|NCT01909466|26458809|P2|Overall Study|Met Withdrawal Criteria|3
7604495|NCT01909466|26458810|P1|Overall Study|Met Withdrawal Criteria|0
7604496|NCT01909466|26458809|P2|Overall Study|Adverse Event|4
7604497|NCT01909466|26458810|P1|Overall Study|Adverse Event|3
7604498|NCT01909466|26458809|P2|Overall Study|Lost to Follow-up|7
7604499|NCT01909466|26458810|P1|Overall Study|Lost to Follow-up|5
7604520|NCT01909336|26458989|P3|Overall Study|Physician Decision|1
7604521|NCT01909336|26458990|P2|Overall Study|Physician Decision|1
7604522|NCT01909336|26458991|P1|Overall Study|Physician Decision|0
7604523|NCT01909336|26458989|P3|Overall Study|Lost to Follow-up|2
7604524|NCT01909336|26458990|P2|Overall Study|Lost to Follow-up|2
7604525|NCT01909336|26458991|P1|Overall Study|Lost to Follow-up|4
7604526|NCT01908907|26459089|P2|Overall Study|Protocol Violation|0
7604527|NCT01908907|26459090|P1|Overall Study|Protocol Violation|1
7604528|NCT01908907|26459089|P2|Overall Study|Physician Decision|0
7604529|NCT01908907|26459090|P1|Overall Study|Physician Decision|1
7604530|NCT01908829|26459134|P3|Overall Study|Withdrawal by Subject|22
7604531|NCT01908829|26459135|P2|Overall Study|Withdrawal by Subject|29
7604532|NCT01908829|26459136|P1|Overall Study|Withdrawal by Subject|26
7604533|NCT01908829|26459134|P3|Overall Study|Lack of Efficacy|2
7604534|NCT01908829|26459135|P2|Overall Study|Lack of Efficacy|3
7604535|NCT01908829|26459136|P1|Overall Study|Lack of Efficacy|1
7604536|NCT01908829|26459134|P3|Overall Study|Protocol Violation|0
7604537|NCT01908829|26459135|P2|Overall Study|Protocol Violation|2
7604538|NCT01908829|26459136|P1|Overall Study|Protocol Violation|2
7604539|NCT01908829|26459134|P3|Overall Study|Miscellaneous|0
7604540|NCT01908829|26459135|P2|Overall Study|Miscellaneous|2
7604541|NCT01908829|26459136|P1|Overall Study|Miscellaneous|0
7604542|NCT01908829|26459134|P3|Overall Study|Discontinued (no EoT page)|0
7604543|NCT01908829|26459135|P2|Overall Study|Discontinued (no EoT page)|0
7604544|NCT01908829|26459136|P1|Overall Study|Discontinued (no EoT page)|2
7604545|NCT01908829|26459134|P3|Overall Study|Randomized no double-blind drug received|1
7604546|NCT01908829|26459135|P2|Overall Study|Randomized no double-blind drug received|0
7604547|NCT01908829|26459136|P1|Overall Study|Randomized no double-blind drug received|1
7604548|NCT01908829|26459134|P3|Overall Study|Lost to Follow-up|1
7604549|NCT01908829|26459135|P2|Overall Study|Lost to Follow-up|2
7604550|NCT01908829|26459136|P1|Overall Study|Lost to Follow-up|4
7604551|NCT01908829|26459134|P3|Overall Study|Adverse Event|13
7604552|NCT01908829|26459135|P2|Overall Study|Adverse Event|11
7604553|NCT01908829|26459136|P1|Overall Study|Adverse Event|13
7604554|NCT01908816|26459253|P4|Overall Study|Early termination|28
7604555|NCT01908816|26459254|P3|Overall Study|Early termination|43
7604556|NCT01908816|26459255|P2|Overall Study|Early termination|60
7604557|NCT01908816|26459256|P1|Overall Study|Early termination|87
7604558|NCT01908816|26459253|P4|Overall Study|Unsatisfactory therapeutic effect|0
7604559|NCT01908816|26459254|P3|Overall Study|Unsatisfactory therapeutic effect|1
7604560|NCT01908816|26459255|P2|Overall Study|Unsatisfactory therapeutic effect|13
7604561|NCT01908816|26459256|P1|Overall Study|Unsatisfactory therapeutic effect|1
7604562|NCT01908816|26459253|P4|Overall Study|Death|1
7604563|NCT01908816|26459254|P3|Overall Study|Death|7
7604564|NCT01908816|26459255|P2|Overall Study|Death|0
7604565|NCT01908816|26459256|P1|Overall Study|Death|1
7604566|NCT01908816|26459253|P4|Overall Study|Lost to Follow-up|2
7604567|NCT01908816|26459254|P3|Overall Study|Lost to Follow-up|4
7604568|NCT01908816|26459255|P2|Overall Study|Lost to Follow-up|5
7604569|NCT01908816|26459256|P1|Overall Study|Lost to Follow-up|3
7604570|NCT01908816|26459253|P4|Overall Study|Withdrawal by Subject|2
7604571|NCT01908816|26459254|P3|Overall Study|Withdrawal by Subject|2
7604572|NCT01908816|26459255|P2|Overall Study|Withdrawal by Subject|4
7604573|NCT01908816|26459256|P1|Overall Study|Withdrawal by Subject|0
7604574|NCT01908816|26459253|P4|Overall Study|Protocol deviation|1
7604575|NCT01908816|26459254|P3|Overall Study|Protocol deviation|1
7604576|NCT01908816|26459255|P2|Overall Study|Protocol deviation|2
7604577|NCT01908816|26459256|P1|Overall Study|Protocol deviation|1
7604578|NCT01908816|26459253|P4|Overall Study|Subject's no longer requires study drug|1
7604579|NCT01908816|26459254|P3|Overall Study|Subject's no longer requires study drug|0
7604580|NCT01908816|26459255|P2|Overall Study|Subject's no longer requires study drug|0
7604581|NCT01908816|26459256|P1|Overall Study|Subject's no longer requires study drug|0
7604582|NCT01908803|26459281|P2|Overall Study|Adverse Event (pre-treatment)|0
7604583|NCT01908803|26459282|P1|Overall Study|Adverse Event (pre-treatment)|1
7604584|NCT01908803|26459281|P2|Overall Study|Randomization Error|0
7604585|NCT01908803|26459282|P1|Overall Study|Randomization Error|1
7604586|NCT01908803|26459281|P2|Overall Study|Withdrawal by Subject|0
7604587|NCT01908803|26459282|P1|Overall Study|Withdrawal by Subject|1
7604588|NCT01908803|26459281|P2|Overall Study|Physician Decision|1
7604589|NCT01908803|26459282|P1|Overall Study|Physician Decision|0
7604590|NCT01908803|26459281|P2|Overall Study|Adverse Event|0
7604591|NCT01908803|26459282|P1|Overall Study|Adverse Event|1
7604592|NCT01908699|26459336|P2|Overall Study|Progressive Disease|29
7604593|NCT01908699|26459337|P1|Overall Study|Progressive Disease|30
7604594|NCT01908699|26459336|P2|Overall Study|Death|12
7604595|NCT01908699|26459337|P1|Overall Study|Death|9
7604596|NCT01908699|26459336|P2|Overall Study|Randomized in Error|0
7604597|NCT01908699|26459337|P1|Overall Study|Randomized in Error|1
7604598|NCT01908699|26459336|P2|Overall Study|Pregnancy|1
7604599|NCT01908699|26459337|P1|Overall Study|Pregnancy|0
7604600|NCT01908699|26459336|P2|Overall Study|Withdrawal by Subject|10
7604601|NCT01908699|26459337|P1|Overall Study|Withdrawal by Subject|15
7604602|NCT01908699|26459336|P2|Overall Study|Physician Decision|8
7604603|NCT01908699|26459337|P1|Overall Study|Physician Decision|8
7604604|NCT01908699|26459336|P2|Overall Study|Lost to Follow-up|4
7604605|NCT01908699|26459337|P1|Overall Study|Lost to Follow-up|2
7604606|NCT01908699|26459336|P2|Overall Study|Lack of Efficacy|2
7604607|NCT01908699|26459337|P1|Overall Study|Lack of Efficacy|2
7604608|NCT01908699|26459336|P2|Overall Study|Adverse Event|12
7604609|NCT01908699|26459337|P1|Overall Study|Adverse Event|8
7604610|NCT01908634|26459353|P1|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
7604611|NCT01908634|26459353|P1|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
7604612|NCT01908582|26459361|P1|Period 2|Withdrawal by Subject|1
7604613|NCT01908582|26459361|P1|Period 2|Physician Decision|1
7604614|NCT01908426|26459405|P2|Overall Study|No Study Treatment Given|0
7604615|NCT01908426|26459406|P1|Overall Study|No Study Treatment Given|3
7604616|NCT01908426|26459405|P2|Overall Study|Protocol Violation|0
7604617|NCT01908426|26459406|P1|Overall Study|Protocol Violation|1
7604618|NCT01908426|26459405|P2|Overall Study|Progressive Disease|152
7604619|NCT01908426|26459406|P1|Overall Study|Progressive Disease|206
7604620|NCT01908426|26459405|P2|Overall Study|Withdrawal by Subject|6
7604621|NCT01908426|26459406|P1|Overall Study|Withdrawal by Subject|11
7604622|NCT01908426|26459405|P2|Overall Study|Physician Decision|3
7604623|NCT01908426|26459406|P1|Overall Study|Physician Decision|3
7604624|NCT01908426|26459405|P2|Overall Study|Lost to Follow-up|1
7604625|NCT01908426|26459406|P1|Overall Study|Lost to Follow-up|0
7604626|NCT01908426|26459405|P2|Overall Study|Lack of Efficacy|0
7604627|NCT01908426|26459406|P1|Overall Study|Lack of Efficacy|3
7604628|NCT01908426|26459405|P2|Overall Study|Clinical Deterioration|38
7604629|NCT01908426|26459406|P1|Overall Study|Clinical Deterioration|72
7604630|NCT01908426|26459405|P2|Overall Study|Adverse Event|11
7604631|NCT01908426|26459406|P1|Overall Study|Adverse Event|98
7604632|NCT01908205|26459418|P2|Overall Study|Withdrawal by Subject|1
7604633|NCT01908205|26459419|P1|Overall Study|Withdrawal by Subject|3
7604634|NCT01908205|26459418|P2|Overall Study|Lost to Follow-up|0
7604635|NCT01908205|26459419|P1|Overall Study|Lost to Follow-up|2
7604636|NCT01908140|26459447|P2|Overall Study|Adverse Event|23
7604637|NCT01908140|26459448|P1|Overall Study|Adverse Event|22
7604638|NCT01908140|26459447|P2|Overall Study|Protocol Violation|9
7604639|NCT01908140|26459448|P1|Overall Study|Protocol Violation|8
7604640|NCT01908140|26459447|P2|Overall Study|Lost to Follow-up|6
7604641|NCT01908140|26459448|P1|Overall Study|Lost to Follow-up|1
7604642|NCT01908140|26459447|P2|Overall Study|Withdrawal by Subject|24
7604643|NCT01908140|26459448|P1|Overall Study|Withdrawal by Subject|23
7604644|NCT01908140|26459447|P2|Overall Study|Lack of Efficacy|5
7604645|NCT01908140|26459448|P1|Overall Study|Lack of Efficacy|7
7604646|NCT01908140|26459447|P2|Overall Study|Other or Progressive Disease|12
7604647|NCT01908140|26459448|P1|Overall Study|Other or Progressive Disease|5
7604648|NCT01908101|26459467|P1|Overall Study|Did not complete the first cycle|4
7604649|NCT01908101|26459467|P1|Overall Study|Incorrect Starting Dose|1
7604650|NCT01908101|26459467|P1|Overall Study|Incorrect Diagnosis|2
7604651|NCT01908101|26459467|P1|Overall Study|Withdrawal by Subject|1
7604652|NCT01908101|26459467|P1|Overall Study|Physician Decision|1
7604653|NCT01907906|26459501|P2|Overall Study|Physician Decision|1
7604654|NCT01907906|26459502|P1|Overall Study|Physician Decision|3
7604655|NCT01907906|26459501|P2|Overall Study|Withdrawal by Subject|0
7604656|NCT01907906|26459502|P1|Overall Study|Withdrawal by Subject|1
7604657|NCT01907854|26459582|P2|Overall Study|Unclassified|3
7604658|NCT01907854|26459583|P1|Overall Study|Unclassified|4
7604659|NCT01907854|26459582|P2|Overall Study|Lost to Follow-up|2
7604660|NCT01907854|26459583|P1|Overall Study|Lost to Follow-up|2
7604661|NCT01907854|26459582|P2|Overall Study|Withdrawal by Subject|7
7604662|NCT01907854|26459583|P1|Overall Study|Withdrawal by Subject|9
7604663|NCT01907854|26459582|P2|Overall Study|Protocol Violation|1
7604664|NCT01907854|26459583|P1|Overall Study|Protocol Violation|1
7604665|NCT01907828|26459603|P2|Overall Study|Participant met exclusion criteria|1
7604666|NCT01907828|26459604|P1|Overall Study|Participant met exclusion criteria|0
7604667|NCT01907828|26459603|P2|Overall Study|Participant refused 24-month follow-up|0
7604668|NCT01907828|26459604|P1|Overall Study|Participant refused 24-month follow-up|1
7604669|NCT01907828|26459603|P2|Overall Study|Lost to Follow-up|0
7604670|NCT01907828|26459604|P1|Overall Study|Lost to Follow-up|3
7604671|NCT01907828|26459603|P2|Overall Study|Withdrawal by Subject|4
7604672|NCT01907828|26459604|P1|Overall Study|Withdrawal by Subject|3
7604673|NCT01907828|26459603|P2|Overall Study|Exclusion criteria not met|1
7604674|NCT01907828|26459604|P1|Overall Study|Exclusion criteria not met|0
7604675|NCT01907815|26459632|P2|Overall Study|Withdrawal by Subject|0
7604676|NCT01907815|26459633|P1|Overall Study|Withdrawal by Subject|1
7604677|NCT01907737|26459647|P1|Overall Study|Withdrawal by Subject|1
7604678|NCT01907516|26459666|P2|First Intervention (3 Weeks)|Developed DKA during study|0
7604679|NCT01907516|26459667|P1|First Intervention (3 Weeks)|Developed DKA during study|1
7604680|NCT01907516|26459666|P2|First Intervention (3 Weeks)|Delivered before second arm|4
7604681|NCT01907516|26459667|P1|First Intervention (3 Weeks)|Delivered before second arm|3
7604682|NCT01907516|26459666|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
7604683|NCT01907516|26459667|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
7604684|NCT01907516|26459666|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
7604685|NCT01907516|26459667|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
7604686|NCT01907217|26459720|P2|Overall Study|Withdrawal by Subject|2
7604687|NCT01907217|26459721|P1|Overall Study|Withdrawal by Subject|0
7604688|NCT01907100|26459833|P4|Overall Study|Worsening/AE underlying cancer disease|8
7604689|NCT01907100|26459834|P3|Overall Study|Worsening/AE underlying cancer disease|8
7604690|NCT01907100|26459835|P2|Overall Study|Worsening/AE underlying cancer disease|0
7604691|NCT01907100|26459836|P1|Overall Study|Worsening/AE underlying cancer disease|0
7604692|NCT01907100|26459833|P4|Overall Study|Adverse event (AE)|23
7604693|NCT01907100|26459834|P3|Overall Study|Adverse event (AE)|22
7604694|NCT01907100|26459835|P2|Overall Study|Adverse event (AE)|3
7604695|NCT01907100|26459836|P1|Overall Study|Adverse event (AE)|6
7604696|NCT01907100|26459833|P4|Overall Study|Other than reasons specified|6
7604697|NCT01907100|26459834|P3|Overall Study|Other than reasons specified|10
7604698|NCT01907100|26459835|P2|Overall Study|Other than reasons specified|0
7604699|NCT01907100|26459836|P1|Overall Study|Other than reasons specified|1
7604700|NCT01907100|26459833|P4|Overall Study|Not treated|2
7604701|NCT01907100|26459834|P3|Overall Study|Not treated|1
7604702|NCT01907100|26459835|P2|Overall Study|Not treated|0
7604703|NCT01907100|26459836|P1|Overall Study|Not treated|2
7604704|NCT01907100|26459833|P4|Overall Study|Lost to Follow-up|1
7604705|NCT01907100|26459834|P3|Overall Study|Lost to Follow-up|0
7604706|NCT01907100|26459835|P2|Overall Study|Lost to Follow-up|0
7604707|NCT01907100|26459836|P1|Overall Study|Lost to Follow-up|0
7604708|NCT01907100|26459833|P4|Overall Study|Protocol Violation|1
7604709|NCT01907100|26459834|P3|Overall Study|Protocol Violation|1
7604710|NCT01907100|26459835|P2|Overall Study|Protocol Violation|0
7604711|NCT01907100|26459836|P1|Overall Study|Protocol Violation|0
7604712|NCT01907100|26459833|P4|Overall Study|Withdrawal by Subject|13
7604713|NCT01907100|26459834|P3|Overall Study|Withdrawal by Subject|10
7604714|NCT01907100|26459835|P2|Overall Study|Withdrawal by Subject|5
7604715|NCT01907100|26459836|P1|Overall Study|Withdrawal by Subject|2
7604716|NCT01907100|26459833|P4|Overall Study|PD based on modified RECIST criteria|92
7604717|NCT01907100|26459834|P3|Overall Study|PD based on modified RECIST criteria|95
7604718|NCT01907100|26459835|P2|Overall Study|PD based on modified RECIST criteria|32
7604719|NCT01907100|26459836|P1|Overall Study|PD based on modified RECIST criteria|31
7604720|NCT01907087|26459850|P1|Overall Study|Withdrawal by Subject|1
7604721|NCT01906476|26459913|P2|Overall Study|Lost to Follow-up|16
7604722|NCT01906476|26459914|P1|Overall Study|Lost to Follow-up|17
7604723|NCT01906372|26459922|P1|Overall Study|Withdrawal by Subject|2
7604724|NCT01906346|26459927|P1|Overall Study|AEs|1
7604725|NCT01906008|26459935|P2|Overall Study|Adverse Event|3
7604726|NCT01906008|26459936|P1|Overall Study|Adverse Event|0
7604727|NCT01906008|26459935|P2|Overall Study|Lack of compliance of study med|3
7604728|NCT01906008|26459936|P1|Overall Study|Lack of compliance of study med|5
7604729|NCT01906008|26459935|P2|Overall Study|Physician Decision|3
7604730|NCT01906008|26459936|P1|Overall Study|Physician Decision|3
7604731|NCT01906008|26459935|P2|Overall Study|Hospice|0
7604732|NCT01906008|26459936|P1|Overall Study|Hospice|1
7604733|NCT01906008|26459935|P2|Overall Study|Oxaliplatin stops|8
7604734|NCT01906008|26459936|P1|Overall Study|Oxaliplatin stops|10
7604735|NCT01906008|26459935|P2|Overall Study|Did not start study med|4
7604736|NCT01906008|26459936|P1|Overall Study|Did not start study med|3
7604737|NCT01906008|26459935|P2|Overall Study|Withdrawal by Subject|5
7604738|NCT01906008|26459936|P1|Overall Study|Withdrawal by Subject|1
7604739|NCT01906008|26459935|P2|Overall Study|Protocol Violation|1
7604740|NCT01906008|26459936|P1|Overall Study|Protocol Violation|0
7604741|NCT01906008|26459935|P2|Overall Study|Oxaliplatin toxicity|0
7604742|NCT01906008|26459936|P1|Overall Study|Oxaliplatin toxicity|2
7604743|NCT01906008|26459935|P2|Overall Study|Lost to Follow-up|0
7604744|NCT01906008|26459936|P1|Overall Study|Lost to Follow-up|2
7604745|NCT01905943|26459969|P1|Overall Study|Other|12
7604746|NCT01905943|26459969|P1|Overall Study|Adverse Event|3
7604747|NCT01905943|26459969|P1|Overall Study|Death|186
7604748|NCT01905943|26459969|P1|Overall Study|Investigator discretion|7
7604749|NCT01905943|26459969|P1|Overall Study|Lost to Follow-up|16
7604750|NCT01905943|26459969|P1|Overall Study|Withdrawal of consent|90
7604751|NCT01905683|26460086|P1|Overall Study|Lost to Follow-up|4
7604752|NCT01905683|26460086|P1|Overall Study|Adverse Event|4
7604753|NCT01905683|26460086|P1|Overall Study|Withdrawal by Subject|20
7604754|NCT01905683|26460086|P1|Overall Study|Lack of Efficacy|8
7604755|NCT01905683|26460086|P1|Overall Study|Physician Decision|1
7604756|NCT01905683|26460086|P1|Overall Study|Re-injection criteria not met; others|13
7604757|NCT01905683|26460086|P1|Overall Study|Protocol Violation|1
7604758|NCT01905657|26460102|P3|Overall Study|Sponsor Decision|0
7604759|NCT01905657|26460103|P2|Overall Study|Sponsor Decision|0
7604760|NCT01905657|26460104|P1|Overall Study|Sponsor Decision|1
7604761|NCT01905657|26460102|P3|Overall Study|Withdrawal by Subject|53
7604762|NCT01905657|26460103|P2|Overall Study|Withdrawal by Subject|21
7604763|NCT01905657|26460104|P1|Overall Study|Withdrawal by Subject|15
7604764|NCT01905657|26460102|P3|Overall Study|Screen Failure|0
7604765|NCT01905657|26460103|P2|Overall Study|Screen Failure|1
7604766|NCT01905657|26460104|P1|Overall Study|Screen Failure|0
7604767|NCT01905657|26460102|P3|Overall Study|Protocol Violation|1
7604768|NCT01905657|26460103|P2|Overall Study|Protocol Violation|1
7604769|NCT01905657|26460104|P1|Overall Study|Protocol Violation|2
7604770|NCT01905657|26460102|P3|Overall Study|Physician Decision|12
7604771|NCT01905657|26460103|P2|Overall Study|Physician Decision|8
7604772|NCT01905657|26460104|P1|Overall Study|Physician Decision|5
7604773|NCT01905657|26460102|P3|Overall Study|Lost to Follow-up|1
7604774|NCT01905657|26460103|P2|Overall Study|Lost to Follow-up|2
7604775|NCT01905657|26460104|P1|Overall Study|Lost to Follow-up|1
7604776|NCT01905657|26460102|P3|Overall Study|Excluded Medication|9
7604777|NCT01905657|26460103|P2|Overall Study|Excluded Medication|16
7604778|NCT01905657|26460104|P1|Overall Study|Excluded Medication|13
7604779|NCT01905657|26460102|P3|Overall Study|Death|47
7604780|NCT01905657|26460103|P2|Overall Study|Death|43
7604781|NCT01905657|26460104|P1|Overall Study|Death|40
7604782|NCT01905657|26460102|P3|Overall Study|Clinical Progression|59
7604783|NCT01905657|26460103|P2|Overall Study|Clinical Progression|78
7604784|NCT01905657|26460104|P1|Overall Study|Clinical Progression|103
7604785|NCT01905657|26460102|P3|Overall Study|Adverse Event|18
7604786|NCT01905657|26460103|P2|Overall Study|Adverse Event|17
7604787|NCT01905657|26460104|P1|Overall Study|Adverse Event|23
7604788|NCT01905592|26460132|P2|Overall Study|Withdrawal by Subject|2
7604789|NCT01905592|26460133|P1|Overall Study|Withdrawal by Subject|10
7604790|NCT01905592|26460132|P2|Overall Study|Ongoing in Study|7
7604791|NCT01905592|26460133|P1|Overall Study|Ongoing in Study|0
7604792|NCT01905592|26460132|P2|Overall Study|Not treated|3
7604793|NCT01905592|26460133|P1|Overall Study|Not treated|7
7604794|NCT01905592|26460132|P2|Overall Study|Sponsor's decision|0
7604795|NCT01905592|26460133|P1|Overall Study|Sponsor's decision|1
7604796|NCT01905592|26460132|P2|Overall Study|Protocol Violation|1
7604797|NCT01905592|26460133|P1|Overall Study|Protocol Violation|0
7604798|NCT01905592|26460132|P2|Overall Study|New anti-cancer|0
7604799|NCT01905592|26460133|P1|Overall Study|New anti-cancer|1
7604800|NCT01905592|26460132|P2|Overall Study|Physician Decision|2
7604801|NCT01905592|26460133|P1|Overall Study|Physician Decision|0
7604802|NCT01905592|26460132|P2|Overall Study|Toxicity|16
7604803|NCT01905592|26460133|P1|Overall Study|Toxicity|1
7604804|NCT01905592|26460132|P2|Overall Study|Disease Progression|104
7604805|NCT01905592|26460133|P1|Overall Study|Disease Progression|51
7604806|NCT01905553|26460147|P2|Period 2|Adverse Event|0
7604807|NCT01905553|26460148|P1|Period 2|Adverse Event|1
7604808|NCT01905540|26460162|P4|Period 3|Other|1
7604809|NCT01905540|26460163|P3|Period 3|Other|1
7604810|NCT01905540|26460164|P2|Period 3|Other|0
7604811|NCT01905540|26460165|P1|Period 3|Other|1
7604812|NCT01905267|26460231|P2|Overall Study|Physician Decision|2
7604813|NCT01905267|26460232|P1|Overall Study|Physician Decision|2
7604814|NCT01904903|26460251|P1|Overall Study|Withdrawal by Subject|1
7604815|NCT01904773|26460264|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604816|NCT01904773|26460265|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604817|NCT01904773|26460266|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604818|NCT01904773|26460267|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604819|NCT01904773|26460268|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604820|NCT01904773|26460269|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604821|NCT01904773|26460270|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604822|NCT01904773|26460271|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
7604823|NCT01904773|26460272|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7604824|NCT01904773|26460264|P9|Fifth Intervention|Adverse Event|0
7604825|NCT01904773|26460265|P8|Fifth Intervention|Adverse Event|1
7604826|NCT01904773|26460266|P7|Fifth Intervention|Adverse Event|0
7604827|NCT01904773|26460267|P6|Fifth Intervention|Adverse Event|0
7604828|NCT01904773|26460268|P5|Fifth Intervention|Adverse Event|0
7604829|NCT01904773|26460269|P4|Fifth Intervention|Adverse Event|0
7604830|NCT01904773|26460270|P3|Fifth Intervention|Adverse Event|0
7604831|NCT01904773|26460271|P2|Fifth Intervention|Adverse Event|0
7604832|NCT01904773|26460272|P1|Fifth Intervention|Adverse Event|0
7604833|NCT01904773|26460264|P9|Placebo Washout First Intervention|Condition worsened|0
7604834|NCT01904773|26460265|P8|Placebo Washout First Intervention|Condition worsened|0
7604835|NCT01904773|26460266|P7|Placebo Washout First Intervention|Condition worsened|0
7604836|NCT01904773|26460267|P6|Placebo Washout First Intervention|Condition worsened|0
7604837|NCT01904773|26460268|P5|Placebo Washout First Intervention|Condition worsened|0
7604838|NCT01904773|26460269|P4|Placebo Washout First Intervention|Condition worsened|0
7604839|NCT01904773|26460270|P3|Placebo Washout First Intervention|Condition worsened|0
7604840|NCT01904773|26460271|P2|Placebo Washout First Intervention|Condition worsened|1
7604841|NCT01904773|26460272|P1|Placebo Washout First Intervention|Condition worsened|0
7604842|NCT01904773|26460264|P9|First Intervention|Adverse Event|0
7604843|NCT01904773|26460265|P8|First Intervention|Adverse Event|0
7604844|NCT01904773|26460266|P7|First Intervention|Adverse Event|1
7604845|NCT01904773|26460267|P6|First Intervention|Adverse Event|0
7604846|NCT01904773|26460268|P5|First Intervention|Adverse Event|0
7604847|NCT01904773|26460269|P4|First Intervention|Adverse Event|0
7604848|NCT01904773|26460270|P3|First Intervention|Adverse Event|0
7604849|NCT01904773|26460271|P2|First Intervention|Adverse Event|0
7604850|NCT01904773|26460272|P1|First Intervention|Adverse Event|0
7604851|NCT01904773|26460264|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604852|NCT01904773|26460265|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604853|NCT01904773|26460266|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604854|NCT01904773|26460267|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604855|NCT01904773|26460268|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604856|NCT01904773|26460269|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604857|NCT01904773|26460270|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604858|NCT01904773|26460271|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7604949|NCT01904383|26460408|P1|Overall Study|Lost to Follow-up|674
7604859|NCT01904773|26460272|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
7604860|NCT01904773|26460264|P9|Screen|Withdrawal by Subject|0
7604861|NCT01904773|26460265|P8|Screen|Withdrawal by Subject|0
7604862|NCT01904773|26460266|P7|Screen|Withdrawal by Subject|0
7604863|NCT01904773|26460267|P6|Screen|Withdrawal by Subject|0
7604864|NCT01904773|26460268|P5|Screen|Withdrawal by Subject|0
7604865|NCT01904773|26460269|P4|Screen|Withdrawal by Subject|0
7604866|NCT01904773|26460270|P3|Screen|Withdrawal by Subject|0
7604867|NCT01904773|26460271|P2|Screen|Withdrawal by Subject|0
7604868|NCT01904773|26460272|P1|Screen|Withdrawal by Subject|1
7604869|NCT01904773|26460264|P9|Screen|Screen failure|0
7604870|NCT01904773|26460265|P8|Screen|Screen failure|0
7604871|NCT01904773|26460266|P7|Screen|Screen failure|0
7604872|NCT01904773|26460267|P6|Screen|Screen failure|0
7604873|NCT01904773|26460268|P5|Screen|Screen failure|0
7604874|NCT01904773|26460269|P4|Screen|Screen failure|0
7604875|NCT01904773|26460270|P3|Screen|Screen failure|0
7604876|NCT01904773|26460271|P2|Screen|Screen failure|0
7604877|NCT01904773|26460272|P1|Screen|Screen failure|3
7604878|NCT01904760|26460289|P2|Overall Study|Protocol Violation|0
7604879|NCT01904760|26460290|P1|Overall Study|Protocol Violation|1
7604880|NCT01904721|26460305|P7|Overall Study|Adverse Event|0
7604881|NCT01904721|26460306|P6|Overall Study|Adverse Event|1
7604882|NCT01904721|26460307|P5|Overall Study|Adverse Event|3
7604883|NCT01904721|26460308|P4|Overall Study|Adverse Event|0
7604884|NCT01904721|26460309|P3|Overall Study|Adverse Event|0
7604885|NCT01904721|26460310|P2|Overall Study|Adverse Event|0
7604886|NCT01904721|26460311|P1|Overall Study|Adverse Event|0
7604887|NCT01904721|26460305|P7|Overall Study|Lack of Efficacy|1
7604888|NCT01904721|26460306|P6|Overall Study|Lack of Efficacy|0
7604889|NCT01904721|26460307|P5|Overall Study|Lack of Efficacy|0
7604890|NCT01904721|26460308|P4|Overall Study|Lack of Efficacy|0
7604891|NCT01904721|26460309|P3|Overall Study|Lack of Efficacy|0
7604892|NCT01904721|26460310|P2|Overall Study|Lack of Efficacy|0
7604893|NCT01904721|26460311|P1|Overall Study|Lack of Efficacy|0
7604894|NCT01904721|26460305|P7|Overall Study|Lost to Follow-up|1
7604895|NCT01904721|26460306|P6|Overall Study|Lost to Follow-up|3
7604896|NCT01904721|26460307|P5|Overall Study|Lost to Follow-up|1
7604897|NCT01904721|26460308|P4|Overall Study|Lost to Follow-up|0
7604898|NCT01904721|26460309|P3|Overall Study|Lost to Follow-up|0
7604899|NCT01904721|26460310|P2|Overall Study|Lost to Follow-up|0
7604900|NCT01904721|26460311|P1|Overall Study|Lost to Follow-up|0
7604901|NCT01904721|26460305|P7|Overall Study|Personal Reasons|3
7604902|NCT01904721|26460306|P6|Overall Study|Personal Reasons|3
7604903|NCT01904721|26460307|P5|Overall Study|Personal Reasons|2
7604904|NCT01904721|26460308|P4|Overall Study|Personal Reasons|0
7604905|NCT01904721|26460309|P3|Overall Study|Personal Reasons|0
7604906|NCT01904721|26460310|P2|Overall Study|Personal Reasons|0
7604907|NCT01904721|26460311|P1|Overall Study|Personal Reasons|0
7604908|NCT01904721|26460305|P7|Overall Study|Other Reasons|2
7604909|NCT01904721|26460306|P6|Overall Study|Other Reasons|2
7604910|NCT01904721|26460307|P5|Overall Study|Other Reasons|2
7604911|NCT01904721|26460308|P4|Overall Study|Other Reasons|1
7604912|NCT01904721|26460309|P3|Overall Study|Other Reasons|1
7604913|NCT01904721|26460310|P2|Overall Study|Other Reasons|0
7604914|NCT01904721|26460311|P1|Overall Study|Other Reasons|0
7604915|NCT01904604|26460341|P3|Overall Study|Lost to Follow-up|1
7604916|NCT01904604|26460342|P2|Overall Study|Lost to Follow-up|0
7604917|NCT01904604|26460343|P1|Overall Study|Lost to Follow-up|0
7604918|NCT01904604|26460341|P3|Overall Study|Participant Relocated|1
7604919|NCT01904604|26460342|P2|Overall Study|Participant Relocated|1
7604920|NCT01904604|26460343|P1|Overall Study|Participant Relocated|1
7604921|NCT01904604|26460341|P3|Overall Study|Withdrawal by Subject|0
7604922|NCT01904604|26460342|P2|Overall Study|Withdrawal by Subject|2
7604923|NCT01904604|26460343|P1|Overall Study|Withdrawal by Subject|1
7604924|NCT01904604|26460341|P3|Overall Study|Passed Week 52 OFC|0
7604925|NCT01904604|26460342|P2|Overall Study|Passed Week 52 OFC|0
7604926|NCT01904604|26460343|P1|Overall Study|Passed Week 52 OFC|1
7604927|NCT01904604|26460341|P3|Overall Study|Unrelated illness|0
7604928|NCT01904604|26460342|P2|Overall Study|Unrelated illness|1
7604929|NCT01904604|26460343|P1|Overall Study|Unrelated illness|0
7604930|NCT01904604|26460341|P3|Overall Study|Increased syncope|0
7604931|NCT01904604|26460342|P2|Overall Study|Increased syncope|1
7604932|NCT01904604|26460343|P1|Overall Study|Increased syncope|0
7604933|NCT01904604|26460341|P3|Overall Study|Patch site reactions|0
7604934|NCT01904604|26460342|P2|Overall Study|Patch site reactions|1
7604935|NCT01904604|26460343|P1|Overall Study|Patch site reactions|1
7604936|NCT01904604|26460341|P3|Overall Study|Anxiety about OFC/Refused OFC|0
7604937|NCT01904604|26460342|P2|Overall Study|Anxiety about OFC/Refused OFC|0
7604938|NCT01904604|26460343|P1|Overall Study|Anxiety about OFC/Refused OFC|2
7604939|NCT01904604|26460341|P3|Overall Study|Non-compliance|0
7604940|NCT01904604|26460342|P2|Overall Study|Non-compliance|0
7604941|NCT01904604|26460343|P1|Overall Study|Non-compliance|1
7604942|NCT01904604|26460341|P3|Overall Study|Withdrew before receiving dosing|0
7604943|NCT01904604|26460342|P2|Overall Study|Withdrew before receiving dosing|1
7604944|NCT01904604|26460343|P1|Overall Study|Withdrew before receiving dosing|0
7604945|NCT01904383|26460408|P1|Overall Study|No patient visit after entry|54
7604946|NCT01904383|26460408|P1|Overall Study|Adverse Event|271
7604947|NCT01904383|26460408|P1|Overall Study|Improvement|141
7604948|NCT01904383|26460408|P1|Overall Study|Lack of Efficacy|370
7604950|NCT01904383|26460408|P1|Overall Study|Reason not listed|147
7604951|NCT01904383|26460408|P1|Overall Study|CRF not collected|117
7604952|NCT01904279|26460415|P2|Overall Study|Withdrawal by Subject|0
7604953|NCT01904279|26460416|P1|Overall Study|Withdrawal by Subject|1
7604954|NCT01904279|26460415|P2|Overall Study|Lack of Efficacy|3
7604955|NCT01904279|26460416|P1|Overall Study|Lack of Efficacy|2
7604956|NCT01904149|26460442|P6|Overall Study|non compliance with study drug|0
7604957|NCT01904149|26460443|P5|Overall Study|non compliance with study drug|0
7604958|NCT01904149|26460444|P4|Overall Study|non compliance with study drug|0
7604959|NCT01904149|26460445|P3|Overall Study|non compliance with study drug|0
7604960|NCT01904149|26460446|P2|Overall Study|non compliance with study drug|0
7604961|NCT01904149|26460447|P1|Overall Study|non compliance with study drug|1
7604962|NCT01904149|26460442|P6|Overall Study|Protocol Violation|0
7604963|NCT01904149|26460443|P5|Overall Study|Protocol Violation|0
7604964|NCT01904149|26460444|P4|Overall Study|Protocol Violation|0
7604965|NCT01904149|26460445|P3|Overall Study|Protocol Violation|0
7604966|NCT01904149|26460446|P2|Overall Study|Protocol Violation|1
7604967|NCT01904149|26460447|P1|Overall Study|Protocol Violation|0
7604968|NCT01904149|26460442|P6|Overall Study|Withdrawal by Subject|0
7604969|NCT01904149|26460443|P5|Overall Study|Withdrawal by Subject|1
7604970|NCT01904149|26460444|P4|Overall Study|Withdrawal by Subject|0
7604971|NCT01904149|26460445|P3|Overall Study|Withdrawal by Subject|1
7604972|NCT01904149|26460446|P2|Overall Study|Withdrawal by Subject|3
7604973|NCT01904149|26460447|P1|Overall Study|Withdrawal by Subject|1
7604974|NCT01904149|26460442|P6|Overall Study|Lack of Efficacy|1
7604975|NCT01904149|26460443|P5|Overall Study|Lack of Efficacy|3
7604976|NCT01904149|26460444|P4|Overall Study|Lack of Efficacy|3
7604977|NCT01904149|26460445|P3|Overall Study|Lack of Efficacy|1
7604978|NCT01904149|26460446|P2|Overall Study|Lack of Efficacy|3
7604979|NCT01904149|26460447|P1|Overall Study|Lack of Efficacy|0
7604980|NCT01904149|26460442|P6|Overall Study|Adverse Event|2
7604981|NCT01904149|26460443|P5|Overall Study|Adverse Event|1
7604982|NCT01904149|26460444|P4|Overall Study|Adverse Event|1
7604983|NCT01904149|26460445|P3|Overall Study|Adverse Event|0
7604984|NCT01904149|26460446|P2|Overall Study|Adverse Event|4
7604985|NCT01904149|26460447|P1|Overall Study|Adverse Event|3
7604986|NCT01904058|26460498|P4|Overall Study|Pregnancy|1
7604987|NCT01904058|26460499|P3|Overall Study|Pregnancy|0
7604988|NCT01904058|26460500|P2|Overall Study|Pregnancy|0
7604989|NCT01904058|26460501|P1|Overall Study|Pregnancy|0
7604990|NCT01904058|26460498|P4|Overall Study|Withdrawal by Subject|0
7604991|NCT01904058|26460499|P3|Overall Study|Withdrawal by Subject|1
7604992|NCT01904058|26460500|P2|Overall Study|Withdrawal by Subject|0
7604993|NCT01904058|26460501|P1|Overall Study|Withdrawal by Subject|1
7604994|NCT01904058|26460498|P4|Overall Study|Adverse Event|0
7604995|NCT01904058|26460499|P3|Overall Study|Adverse Event|0
7604996|NCT01904058|26460500|P2|Overall Study|Adverse Event|0
7604997|NCT01904058|26460501|P1|Overall Study|Adverse Event|2
7605004|NCT01903993|26460556|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
7605005|NCT01903993|26460557|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
7605006|NCT01903993|26460556|P2|Overall Study|Study Terminated by Sponsor|14
7605007|NCT01903993|26460557|P1|Overall Study|Study Terminated by Sponsor|8
7605008|NCT01903993|26460556|P2|Overall Study|Lost to Follow-up|3
7605009|NCT01903993|26460557|P1|Overall Study|Lost to Follow-up|2
7605010|NCT01903993|26460556|P2|Overall Study|Withdrawal by Subject|4
7605011|NCT01903993|26460557|P1|Overall Study|Withdrawal by Subject|15
7605012|NCT01903993|26460556|P2|Overall Study|Death|121
7605013|NCT01903993|26460557|P1|Overall Study|Death|118
7605014|NCT01903876|26460574|P2|Six-Month Follow-up Period|Lost to Follow-up|145
7605015|NCT01903876|26460575|P1|Six-Month Follow-up Period|Lost to Follow-up|91
7605016|NCT01903876|26460574|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
7605017|NCT01903876|26460575|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
7605018|NCT01903863|26460585|P2|Overall Study|Physician Decision|0
7605019|NCT01903863|26460586|P1|Overall Study|Physician Decision|2
7605020|NCT01903837|26460610|P4|Part B|Lack of Efficacy|0
7605021|NCT01903837|26460611|P3|Part B|Lack of Efficacy|0
7605022|NCT01903837|26460612|P2|Part B|Lack of Efficacy|1
7605023|NCT01903837|26460613|P1|Part B|Lack of Efficacy|0
7605024|NCT01903837|26460610|P4|Part B|Physician Decision|2
7605025|NCT01903837|26460611|P3|Part B|Physician Decision|0
7605026|NCT01903837|26460612|P2|Part B|Physician Decision|0
7605027|NCT01903837|26460613|P1|Part B|Physician Decision|1
7605028|NCT01903837|26460610|P4|Part B|Incarceration|1
7605029|NCT01903837|26460611|P3|Part B|Incarceration|0
7605030|NCT01903837|26460612|P2|Part B|Incarceration|0
7605031|NCT01903837|26460613|P1|Part B|Incarceration|2
7605032|NCT01903837|26460610|P4|Part B|Non-compliance with study drug|1
7605033|NCT01903837|26460611|P3|Part B|Non-compliance with study drug|0
7605034|NCT01903837|26460612|P2|Part B|Non-compliance with study drug|0
7605035|NCT01903837|26460613|P1|Part B|Non-compliance with study drug|2
7605036|NCT01903837|26460610|P4|Part B|Adverse Event|0
7605037|NCT01903837|26460611|P3|Part B|Adverse Event|2
7605038|NCT01903837|26460612|P2|Part B|Adverse Event|0
7605039|NCT01903837|26460613|P1|Part B|Adverse Event|3
7605040|NCT01903837|26460610|P4|Part B|Withdrawal by Subject|3
7605041|NCT01903837|26460611|P3|Part B|Withdrawal by Subject|0
7605042|NCT01903837|26460612|P2|Part B|Withdrawal by Subject|2
7605043|NCT01903837|26460613|P1|Part B|Withdrawal by Subject|1
7605044|NCT01903837|26460610|P4|Part B|Lost to Follow-up|4
7605045|NCT01903837|26460611|P3|Part B|Lost to Follow-up|3
7605046|NCT01903837|26460612|P2|Part B|Lost to Follow-up|3
7605047|NCT01903837|26460613|P1|Part B|Lost to Follow-up|0
7605048|NCT01903837|26460610|P4|Part A|Protocol Violation|0
7605049|NCT01903837|26460611|P3|Part A|Protocol Violation|0
7605050|NCT01903837|26460612|P2|Part A|Protocol Violation|1
7605051|NCT01903837|26460613|P1|Part A|Protocol Violation|1
7605052|NCT01903837|26460610|P4|Part A|Physician Decision|0
7605053|NCT01903837|26460611|P3|Part A|Physician Decision|0
7605054|NCT01903837|26460612|P2|Part A|Physician Decision|1
7605055|NCT01903837|26460613|P1|Part A|Physician Decision|1
7605056|NCT01903837|26460610|P4|Part A|Non-compliance with study drug|0
7605057|NCT01903837|26460611|P3|Part A|Non-compliance with study drug|4
7605058|NCT01903837|26460612|P2|Part A|Non-compliance with study drug|4
7605059|NCT01903837|26460613|P1|Part A|Non-compliance with study drug|1
7605060|NCT01903837|26460610|P4|Part A|Lost to Follow-up|2
7605061|NCT01903837|26460611|P3|Part A|Lost to Follow-up|7
7605062|NCT01903837|26460612|P2|Part A|Lost to Follow-up|7
7605063|NCT01903837|26460613|P1|Part A|Lost to Follow-up|9
7605064|NCT01903837|26460610|P4|Part A|Adverse Event|6
7605065|NCT01903837|26460611|P3|Part A|Adverse Event|9
7605066|NCT01903837|26460612|P2|Part A|Adverse Event|6
7605067|NCT01903837|26460613|P1|Part A|Adverse Event|3
7605068|NCT01903837|26460610|P4|Part A|Withdrawal by Subject|5
7605069|NCT01903837|26460611|P3|Part A|Withdrawal by Subject|8
7605070|NCT01903837|26460612|P2|Part A|Withdrawal by Subject|9
7605071|NCT01903837|26460613|P1|Part A|Withdrawal by Subject|4
7605072|NCT01903811|26460657|P2|Overall Study|Withdrawal by Subject|1
7605073|NCT01903811|26460658|P1|Overall Study|Withdrawal by Subject|0
7605074|NCT01903811|26460657|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
7605075|NCT01903811|26460658|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
7605076|NCT01903811|26460657|P2|Overall Study|Incomplete/discontinued prior therapy|1
7605077|NCT01903811|26460658|P1|Overall Study|Incomplete/discontinued prior therapy|1
7605078|NCT01903811|26460657|P2|Overall Study|No measurable disease|1
7605079|NCT01903811|26460658|P1|Overall Study|No measurable disease|1
7605080|NCT01903733|26460696|P4|Overall Study|Investigator request|0
7605081|NCT01903733|26460697|P3|Overall Study|Investigator request|0
7605082|NCT01903733|26460698|P2|Overall Study|Investigator request|0
7605083|NCT01903733|26460699|P1|Overall Study|Investigator request|18
7605084|NCT01903733|26460696|P4|Overall Study|Missing|0
7605085|NCT01903733|26460697|P3|Overall Study|Missing|0
7605086|NCT01903733|26460698|P2|Overall Study|Missing|0
7605087|NCT01903733|26460699|P1|Overall Study|Missing|2
7605088|NCT01903733|26460696|P4|Overall Study|Other|3
7605089|NCT01903733|26460697|P3|Overall Study|Other|12
7605090|NCT01903733|26460698|P2|Overall Study|Other|15
7605091|NCT01903733|26460699|P1|Overall Study|Other|10
7605092|NCT01903733|26460696|P4|Overall Study|Lost to Follow-up|9
7605093|NCT01903733|26460697|P3|Overall Study|Lost to Follow-up|6
7605094|NCT01903733|26460698|P2|Overall Study|Lost to Follow-up|19
7605095|NCT01903733|26460699|P1|Overall Study|Lost to Follow-up|18
7605096|NCT01903733|26460696|P4|Overall Study|Participant refused further follow-up|9
7605097|NCT01903733|26460697|P3|Overall Study|Participant refused further follow-up|13
7605098|NCT01903733|26460698|P2|Overall Study|Participant refused further follow-up|38
7605099|NCT01903733|26460699|P1|Overall Study|Participant refused further follow-up|35
7605100|NCT01903733|26460696|P4|Overall Study|Death|98
7605101|NCT01903733|26460697|P3|Overall Study|Death|30
7605102|NCT01903733|26460698|P2|Overall Study|Death|54
7605103|NCT01903733|26460699|P1|Overall Study|Death|23
7605104|NCT01903720|26460764|P1|Overall Study|Treatment with alternative drug|1
7605105|NCT01903720|26460764|P1|Overall Study|Lost to Follow-up|2
7605106|NCT01903720|26460764|P1|Overall Study|Rescinding of informed consent|2
7605107|NCT01903720|26460764|P1|Overall Study|Adverse Event|1
7605108|NCT01903720|26460764|P1|Overall Study|Inclusion / exclusion criteria not met|6
7605109|NCT01903525|26460800|P2|Overall Study|Adverse Event|1
7605110|NCT01903525|26460801|P1|Overall Study|Adverse Event|0
7605111|NCT01903525|26460800|P2|Overall Study|Lost to Follow-up|9
7605112|NCT01903525|26460801|P1|Overall Study|Lost to Follow-up|5
7605113|NCT01903460|26460817|P4|Overall Study|Adverse Event|1
7605114|NCT01903460|26460818|P3|Overall Study|Adverse Event|0
7605115|NCT01903460|26460819|P2|Overall Study|Adverse Event|0
7605116|NCT01903460|26460820|P1|Overall Study|Adverse Event|0
7605117|NCT01903434|26460837|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
7605118|NCT01903434|26460838|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
7605119|NCT01903434|26460837|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
7605120|NCT01903434|26460838|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
7605121|NCT01903356|26460846|P1|Overall Study|Violated the dosage and administration|3
7605122|NCT01903356|26460846|P1|Overall Study|Violated inclusion/exclusion criteria|5
7605123|NCT01903356|26460846|P1|Overall Study|Lost to Follow-up|7
7605124|NCT01903252|26460873|P6|Maintenance, Open-Label|Other|2
7605125|NCT01903252|26460874|P5|Maintenance, Open-Label|Other|6
7605126|NCT01903252|26460875|P4|Maintenance, Open-Label|Other|2
7605127|NCT01903252|26460876|P3|Maintenance, Open-Label|Other|0
7605128|NCT01903252|26460877|P2|Maintenance, Open-Label|Other|0
7605129|NCT01903252|26460878|P1|Maintenance, Open-Label|Other|0
7605130|NCT01903252|26460873|P6|Maintenance, Open-Label|Withdrawal by Subject|2
7605131|NCT01903252|26460874|P5|Maintenance, Open-Label|Withdrawal by Subject|6
7605132|NCT01903252|26460875|P4|Maintenance, Open-Label|Withdrawal by Subject|1
7605133|NCT01903252|26460876|P3|Maintenance, Open-Label|Withdrawal by Subject|0
7605134|NCT01903252|26460877|P2|Maintenance, Open-Label|Withdrawal by Subject|0
7605135|NCT01903252|26460878|P1|Maintenance, Open-Label|Withdrawal by Subject|0
7605136|NCT01903252|26460873|P6|Maintenance, Open-Label|Adverse Event|14
7605137|NCT01903252|26460874|P5|Maintenance, Open-Label|Adverse Event|9
7605138|NCT01903252|26460875|P4|Maintenance, Open-Label|Adverse Event|3
7605139|NCT01903252|26460876|P3|Maintenance, Open-Label|Adverse Event|0
7605140|NCT01903252|26460877|P2|Maintenance, Open-Label|Adverse Event|0
7605141|NCT01903252|26460878|P1|Maintenance, Open-Label|Adverse Event|0
7605142|NCT01903252|26460873|P6|Extended Induction, Open-Label|Physician Decision|0
7605143|NCT01903252|26460874|P5|Extended Induction, Open-Label|Physician Decision|0
7605144|NCT01903252|26460875|P4|Extended Induction, Open-Label|Physician Decision|0
7605145|NCT01903252|26460876|P3|Extended Induction, Open-Label|Physician Decision|1
7605146|NCT01903252|26460877|P2|Extended Induction, Open-Label|Physician Decision|0
7605147|NCT01903252|26460878|P1|Extended Induction, Open-Label|Physician Decision|0
7605148|NCT01903252|26460873|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
7605149|NCT01903252|26460874|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
7605150|NCT01903252|26460875|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
7605151|NCT01903252|26460876|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
7605152|NCT01903252|26460877|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
7605153|NCT01903252|26460878|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
7605154|NCT01903252|26460873|P6|Extended Induction, Open-Label|Adverse Event|0
7605155|NCT01903252|26460874|P5|Extended Induction, Open-Label|Adverse Event|0
7605156|NCT01903252|26460875|P4|Extended Induction, Open-Label|Adverse Event|0
7605157|NCT01903252|26460876|P3|Extended Induction, Open-Label|Adverse Event|17
7605158|NCT01903252|26460877|P2|Extended Induction, Open-Label|Adverse Event|0
7605159|NCT01903252|26460878|P1|Extended Induction, Open-Label|Adverse Event|0
7605160|NCT01903252|26460873|P6|Double-Blind Induction|non-compliance,|0
7605161|NCT01903252|26460874|P5|Double-Blind Induction|non-compliance,|0
7605162|NCT01903252|26460875|P4|Double-Blind Induction|non-compliance,|0
7605163|NCT01903252|26460876|P3|Double-Blind Induction|non-compliance,|0
7605164|NCT01903252|26460877|P2|Double-Blind Induction|non-compliance,|7
7605165|NCT01903252|26460878|P1|Double-Blind Induction|non-compliance,|7
7605166|NCT01903252|26460873|P6|Double-Blind Induction|Physician Decision|0
7605167|NCT01903252|26460874|P5|Double-Blind Induction|Physician Decision|0
7605168|NCT01903252|26460875|P4|Double-Blind Induction|Physician Decision|0
7605169|NCT01903252|26460876|P3|Double-Blind Induction|Physician Decision|0
7605170|NCT01903252|26460877|P2|Double-Blind Induction|Physician Decision|3
7605171|NCT01903252|26460878|P1|Double-Blind Induction|Physician Decision|2
7605172|NCT01903252|26460873|P6|Double-Blind Induction|Withdrawal by Subject|0
7605173|NCT01903252|26460874|P5|Double-Blind Induction|Withdrawal by Subject|0
7605174|NCT01903252|26460875|P4|Double-Blind Induction|Withdrawal by Subject|0
7605175|NCT01903252|26460876|P3|Double-Blind Induction|Withdrawal by Subject|0
7605176|NCT01903252|26460877|P2|Double-Blind Induction|Withdrawal by Subject|13
7605177|NCT01903252|26460878|P1|Double-Blind Induction|Withdrawal by Subject|10
7605178|NCT01903252|26460873|P6|Double-Blind Induction|Adverse Event|0
7605179|NCT01903252|26460874|P5|Double-Blind Induction|Adverse Event|0
7605180|NCT01903252|26460875|P4|Double-Blind Induction|Adverse Event|0
7605181|NCT01903252|26460876|P3|Double-Blind Induction|Adverse Event|0
7605182|NCT01903252|26460877|P2|Double-Blind Induction|Adverse Event|18
7605183|NCT01903252|26460878|P1|Double-Blind Induction|Adverse Event|20
7605184|NCT01903031|26460991|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
7605185|NCT01903031|26460992|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
7605186|NCT01903031|26460993|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
7605187|NCT01903031|26460991|P3|Overall Study|Lost to Follow-up|1
7605188|NCT01903031|26460992|P2|Overall Study|Lost to Follow-up|0
7605189|NCT01903031|26460993|P1|Overall Study|Lost to Follow-up|0
7605190|NCT01903031|26460991|P3|Overall Study|Protocol Violation|2
7605191|NCT01903031|26460992|P2|Overall Study|Protocol Violation|0
7605192|NCT01903031|26460993|P1|Overall Study|Protocol Violation|0
7605193|NCT01903031|26460991|P3|Overall Study|Withdrawal by Subject|1
7605194|NCT01903031|26460992|P2|Overall Study|Withdrawal by Subject|1
7605195|NCT01903031|26460993|P1|Overall Study|Withdrawal by Subject|0
7605196|NCT01903031|26460991|P3|Overall Study|Adverse Event|0
7605197|NCT01903031|26460992|P2|Overall Study|Adverse Event|1
7605198|NCT01903031|26460993|P1|Overall Study|Adverse Event|0
7605199|NCT01903031|26460991|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7605200|NCT01903031|26460992|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7605201|NCT01903031|26460993|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
7605202|NCT01903031|26460991|P3|Overall Study|Not Able to Attend Clinic|0
7605203|NCT01903031|26460992|P2|Overall Study|Not Able to Attend Clinic|1
7605204|NCT01903031|26460993|P1|Overall Study|Not Able to Attend Clinic|1
7605205|NCT01902966|26461049|P1|Overall Study|Withdrawal by Subject|1
7605206|NCT01902966|26461049|P1|Overall Study|Physician Decision|1
7605207|NCT01902966|26461049|P1|Overall Study|Death|1
7605208|NCT01902888|26461071|P1|Overall Study|Study Terminated|3
7605209|NCT01902628|26461085|P1|Overall Study|Lost to Follow-up|35
7605210|NCT01902628|26461085|P1|Overall Study|Adverse Event|41
7605211|NCT01902628|26461085|P1|Overall Study|Withdrawal of participant's consent|7
7605212|NCT01902303|26461113|P2|Overall Study|Did not develop a cold sore|19
7605213|NCT01902303|26461114|P1|Overall Study|Did not develop a cold sore|21
7605214|NCT01902303|26461113|P2|Overall Study|subject lost investigational product|1
7605215|NCT01902303|26461114|P1|Overall Study|subject lost investigational product|0
7605216|NCT01902303|26461113|P2|Overall Study|Protocol Violation|2
7605217|NCT01902303|26461114|P1|Overall Study|Protocol Violation|2
7605218|NCT01902303|26461113|P2|Overall Study|Lost to Follow-up|1
7605219|NCT01902303|26461114|P1|Overall Study|Lost to Follow-up|0
7605220|NCT01902303|26461113|P2|Overall Study|Adverse Event|1
7605221|NCT01902303|26461114|P1|Overall Study|Adverse Event|0
7605222|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 4|Death|1
7605223|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 4|Death|0
7605224|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 4|Death|0
7605225|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 4|Death|0
7605226|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 4|Death|0
7605227|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 4|Death|0
7605228|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
7605229|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7605230|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7605231|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7605232|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7605233|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7605234|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
7605235|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7605236|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7605237|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7605238|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7605239|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7605240|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7605241|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
7605242|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7605243|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7605244|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7605245|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7605246|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7605247|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
7605248|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7605249|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7605250|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7605251|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7605252|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7605253|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7605254|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
7605255|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7605256|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7605257|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7605258|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7605259|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7605260|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
7605261|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7605262|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7605263|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7605264|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7605265|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7605266|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7605267|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
7605268|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7605269|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7605270|NCT01902173|26461128|P6|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7605271|NCT01902173|26461129|P5|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7605272|NCT01902173|26461130|P4|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7605273|NCT01902173|26461131|P3|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
7605274|NCT01902173|26461132|P2|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7605275|NCT01902173|26461133|P1|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7605276|NCT01902173|26461128|P6|Phase 1 Doublet Regimen Cohort 2|No treated|0
7605277|NCT01902173|26461129|P5|Phase 1 Doublet Regimen Cohort 2|No treated|0
7605278|NCT01902173|26461130|P4|Phase 1 Doublet Regimen Cohort 2|No treated|0
7605279|NCT01902173|26461131|P3|Phase 1 Doublet Regimen Cohort 2|No treated|0
7605280|NCT01902173|26461132|P2|Phase 1 Doublet Regimen Cohort 2|No treated|3
7605281|NCT01902173|26461133|P1|Phase 1 Doublet Regimen Cohort 2|No treated|0
7605282|NCT01902173|26461128|P6|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7605283|NCT01902173|26461129|P5|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7605284|NCT01902173|26461130|P4|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7605285|NCT01902173|26461131|P3|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7605286|NCT01902173|26461132|P2|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
7605287|NCT01902173|26461133|P1|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7605288|NCT01902173|26461128|P6|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7605289|NCT01902173|26461129|P5|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7605290|NCT01902173|26461130|P4|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7605291|NCT01902173|26461131|P3|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7605292|NCT01902173|26461132|P2|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
7605293|NCT01902173|26461133|P1|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7605294|NCT01902173|26461128|P6|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7605295|NCT01902173|26461129|P5|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7605296|NCT01902173|26461130|P4|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7605297|NCT01902173|26461131|P3|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7605298|NCT01902173|26461132|P2|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7605299|NCT01902173|26461133|P1|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
7605300|NCT01902173|26461128|P6|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7605301|NCT01902173|26461129|P5|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7605302|NCT01902173|26461130|P4|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7605303|NCT01902173|26461131|P3|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7605304|NCT01902173|26461132|P2|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7605305|NCT01902173|26461133|P1|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
7605306|NCT01902134|26461156|P6|Overall Study|Other|0
7605307|NCT01902134|26461157|P5|Overall Study|Other|1
7605308|NCT01902134|26461158|P4|Overall Study|Other|0
7605309|NCT01902134|26461159|P3|Overall Study|Other|2
7605310|NCT01902134|26461160|P2|Overall Study|Other|1
7605311|NCT01902134|26461161|P1|Overall Study|Other|0
7605312|NCT01902134|26461156|P6|Overall Study|no compliance|0
7605313|NCT01902134|26461157|P5|Overall Study|no compliance|0
7605314|NCT01902134|26461158|P4|Overall Study|no compliance|0
7605315|NCT01902134|26461159|P3|Overall Study|no compliance|0
7605316|NCT01902134|26461160|P2|Overall Study|no compliance|0
7605317|NCT01902134|26461161|P1|Overall Study|no compliance|1
7605318|NCT01902134|26461156|P6|Overall Study|Withdrawal by Subject|4
7605319|NCT01902134|26461157|P5|Overall Study|Withdrawal by Subject|5
7605320|NCT01902134|26461158|P4|Overall Study|Withdrawal by Subject|1
7605321|NCT01902134|26461159|P3|Overall Study|Withdrawal by Subject|9
7605322|NCT01902134|26461160|P2|Overall Study|Withdrawal by Subject|8
7605323|NCT01902134|26461161|P1|Overall Study|Withdrawal by Subject|4
7605324|NCT01902134|26461156|P6|Overall Study|Protocol Violation|1
7605325|NCT01902134|26461157|P5|Overall Study|Protocol Violation|0
7605326|NCT01902134|26461158|P4|Overall Study|Protocol Violation|0
7605327|NCT01902134|26461159|P3|Overall Study|Protocol Violation|0
7605328|NCT01902134|26461160|P2|Overall Study|Protocol Violation|0
7605329|NCT01902134|26461161|P1|Overall Study|Protocol Violation|0
7605330|NCT01902134|26461156|P6|Overall Study|Physician Decision|0
7605331|NCT01902134|26461157|P5|Overall Study|Physician Decision|0
7605332|NCT01902134|26461158|P4|Overall Study|Physician Decision|0
7605333|NCT01902134|26461159|P3|Overall Study|Physician Decision|0
7605334|NCT01902134|26461160|P2|Overall Study|Physician Decision|1
7605335|NCT01902134|26461161|P1|Overall Study|Physician Decision|0
7605336|NCT01902134|26461156|P6|Overall Study|Lack of Efficacy|1
7605337|NCT01902134|26461157|P5|Overall Study|Lack of Efficacy|0
7605338|NCT01902134|26461158|P4|Overall Study|Lack of Efficacy|0
7605339|NCT01902134|26461159|P3|Overall Study|Lack of Efficacy|2
7605340|NCT01902134|26461160|P2|Overall Study|Lack of Efficacy|0
7605341|NCT01902134|26461161|P1|Overall Study|Lack of Efficacy|0
7605342|NCT01902134|26461156|P6|Overall Study|Adverse Event|3
7605343|NCT01902134|26461157|P5|Overall Study|Adverse Event|1
7605344|NCT01902134|26461158|P4|Overall Study|Adverse Event|1
7605345|NCT01902134|26461159|P3|Overall Study|Adverse Event|2
7605346|NCT01902134|26461160|P2|Overall Study|Adverse Event|1
7605347|NCT01902134|26461161|P1|Overall Study|Adverse Event|3
7605348|NCT01901874|26461198|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
7605349|NCT01901874|26461198|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
7605350|NCT01901874|26461198|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
7605351|NCT01901874|26461198|P1|1-Year (365-Day) MAE Evaluation|Death|7
7605352|NCT01901874|26461198|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
7605353|NCT01901874|26461198|P1|Screening Committee Retrospective Review|Protocol Violation|47
7605354|NCT01901848|26461213|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
7605355|NCT01901848|26461214|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
7605356|NCT01901848|26461213|P2|Randomized and Treated|Lost to Follow-up|6
7605357|NCT01901848|26461214|P1|Randomized and Treated|Lost to Follow-up|3
7605358|NCT01901653|26461265|P13|Overall Study|Alive at Study Termination by Sponsor|1
7605359|NCT01901653|26461266|P12|Overall Study|Alive at Study Termination by Sponsor|1
7605360|NCT01901653|26461267|P11|Overall Study|Alive at Study Termination by Sponsor|0
7605361|NCT01901653|26461268|P10|Overall Study|Alive at Study Termination by Sponsor|2
7605362|NCT01901653|26461269|P9|Overall Study|Alive at Study Termination by Sponsor|0
7605363|NCT01901653|26461270|P8|Overall Study|Alive at Study Termination by Sponsor|0
7605364|NCT01901653|26461271|P7|Overall Study|Alive at Study Termination by Sponsor|0
7605365|NCT01901653|26461272|P6|Overall Study|Alive at Study Termination by Sponsor|0
7605366|NCT01901653|26461273|P5|Overall Study|Alive at Study Termination by Sponsor|0
7605367|NCT01901653|26461274|P4|Overall Study|Alive at Study Termination by Sponsor|0
7605368|NCT01901653|26461275|P3|Overall Study|Alive at Study Termination by Sponsor|1
7605369|NCT01901653|26461276|P2|Overall Study|Alive at Study Termination by Sponsor|0
7605370|NCT01901653|26461277|P1|Overall Study|Alive at Study Termination by Sponsor|0
7605371|NCT01901653|26461265|P13|Overall Study|Withdrawal by Subject|0
7605372|NCT01901653|26461266|P12|Overall Study|Withdrawal by Subject|0
7605373|NCT01901653|26461267|P11|Overall Study|Withdrawal by Subject|0
7605374|NCT01901653|26461268|P10|Overall Study|Withdrawal by Subject|0
7605375|NCT01901653|26461269|P9|Overall Study|Withdrawal by Subject|0
7605376|NCT01901653|26461270|P8|Overall Study|Withdrawal by Subject|0
7605377|NCT01901653|26461271|P7|Overall Study|Withdrawal by Subject|1
7605378|NCT01901653|26461272|P6|Overall Study|Withdrawal by Subject|0
7605379|NCT01901653|26461273|P5|Overall Study|Withdrawal by Subject|0
7605380|NCT01901653|26461274|P4|Overall Study|Withdrawal by Subject|0
7605381|NCT01901653|26461275|P3|Overall Study|Withdrawal by Subject|0
7605382|NCT01901653|26461276|P2|Overall Study|Withdrawal by Subject|0
7605383|NCT01901653|26461277|P1|Overall Study|Withdrawal by Subject|0
7605384|NCT01901653|26461265|P13|Overall Study|Lost to Follow-up|0
7605385|NCT01901653|26461266|P12|Overall Study|Lost to Follow-up|0
7605386|NCT01901653|26461267|P11|Overall Study|Lost to Follow-up|0
7605387|NCT01901653|26461268|P10|Overall Study|Lost to Follow-up|0
7605388|NCT01901653|26461269|P9|Overall Study|Lost to Follow-up|0
7605389|NCT01901653|26461270|P8|Overall Study|Lost to Follow-up|1
7605390|NCT01901653|26461271|P7|Overall Study|Lost to Follow-up|0
7605391|NCT01901653|26461272|P6|Overall Study|Lost to Follow-up|1
7605392|NCT01901653|26461273|P5|Overall Study|Lost to Follow-up|0
7605393|NCT01901653|26461274|P4|Overall Study|Lost to Follow-up|0
7605394|NCT01901653|26461275|P3|Overall Study|Lost to Follow-up|2
7605395|NCT01901653|26461276|P2|Overall Study|Lost to Follow-up|0
7605396|NCT01901653|26461277|P1|Overall Study|Lost to Follow-up|1
7605397|NCT01901653|26461265|P13|Overall Study|Death|4
7605398|NCT01901653|26461266|P12|Overall Study|Death|15
7605399|NCT01901653|26461267|P11|Overall Study|Death|2
7605400|NCT01901653|26461268|P10|Overall Study|Death|16
7605401|NCT01901653|26461269|P9|Overall Study|Death|1
7605402|NCT01901653|26461270|P8|Overall Study|Death|9
7605403|NCT01901653|26461271|P7|Overall Study|Death|6
7605404|NCT01901653|26461272|P6|Overall Study|Death|2
7605405|NCT01901653|26461273|P5|Overall Study|Death|2
7605406|NCT01901653|26461274|P4|Overall Study|Death|3
7605407|NCT01901653|26461275|P3|Overall Study|Death|8
7605408|NCT01901653|26461276|P2|Overall Study|Death|1
7605409|NCT01901653|26461277|P1|Overall Study|Death|2
7605410|NCT01901614|26461321|P2|Overall Study|Screen Fail|0
7605411|NCT01901614|26461322|P1|Overall Study|Screen Fail|1
7605412|NCT01901614|26461321|P2|Overall Study|Lost to Follow-up|0
7605413|NCT01901614|26461322|P1|Overall Study|Lost to Follow-up|1
7605414|NCT01901614|26461321|P2|Overall Study|Adverse Event|1
7605415|NCT01901614|26461322|P1|Overall Study|Adverse Event|0
7605416|NCT01901432|26461357|P5|Overall Study|Patient decision to stop study drug|1
7605417|NCT01901432|26461358|P4|Overall Study|Patient decision to stop study drug|0
7605418|NCT01901432|26461359|P3|Overall Study|Patient decision to stop study drug|0
7605419|NCT01901432|26461360|P2|Overall Study|Patient decision to stop study drug|0
7605420|NCT01901432|26461361|P1|Overall Study|Patient decision to stop study drug|0
7605421|NCT01901432|26461357|P5|Overall Study|Physician Decision|2
7605422|NCT01901432|26461358|P4|Overall Study|Physician Decision|0
7605423|NCT01901432|26461359|P3|Overall Study|Physician Decision|0
7605424|NCT01901432|26461360|P2|Overall Study|Physician Decision|0
7605425|NCT01901432|26461361|P1|Overall Study|Physician Decision|0
7605426|NCT01901432|26461357|P5|Overall Study|Withdrawal by Subject|5
7605427|NCT01901432|26461358|P4|Overall Study|Withdrawal by Subject|0
7605428|NCT01901432|26461359|P3|Overall Study|Withdrawal by Subject|1
7605429|NCT01901432|26461360|P2|Overall Study|Withdrawal by Subject|0
7605430|NCT01901432|26461361|P1|Overall Study|Withdrawal by Subject|0
7605431|NCT01901432|26461357|P5|Overall Study|Adverse Event|1
7605432|NCT01901432|26461358|P4|Overall Study|Adverse Event|0
7605433|NCT01901432|26461359|P3|Overall Study|Adverse Event|1
7605434|NCT01901432|26461360|P2|Overall Study|Adverse Event|1
7605435|NCT01901432|26461361|P1|Overall Study|Adverse Event|0
7605436|NCT01901419|26461413|P2|Overall Study|unavailable researchers|3
7605437|NCT01901419|26461414|P1|Overall Study|unavailable researchers|6
7605438|NCT01901419|26461413|P2|Overall Study|Protocol Violation|6
7605439|NCT01901419|26461414|P1|Overall Study|Protocol Violation|2
7605440|NCT01901393|26461480|P2|Overall Study|Adverse Event|0
7605441|NCT01901393|26461481|P1|Overall Study|Adverse Event|1
7605442|NCT01901341|26461499|P2|Overall Study|Withdrawal by Subject|1
7605443|NCT01901341|26461500|P1|Overall Study|Withdrawal by Subject|1
7605444|NCT01901341|26461499|P2|Overall Study|Study Terminated by Sponsor|15
7605445|NCT01901341|26461500|P1|Overall Study|Study Terminated by Sponsor|13
7605446|NCT01901341|26461499|P2|Overall Study|Protocol Violation|0
7605447|NCT01901341|26461500|P1|Overall Study|Protocol Violation|2
7605448|NCT01901341|26461499|P2|Overall Study|Lost to Follow-up|1
7605449|NCT01901341|26461500|P1|Overall Study|Lost to Follow-up|0
7605450|NCT01901341|26461499|P2|Overall Study|Lack of Efficacy|2
7605451|NCT01901341|26461500|P1|Overall Study|Lack of Efficacy|0
7605452|NCT01901341|26461499|P2|Overall Study|Adverse Event|2
7605453|NCT01901341|26461500|P1|Overall Study|Adverse Event|4
7605454|NCT01901328|26461514|P2|Overall Study|Lack of Efficacy|1
7605455|NCT01901328|26461515|P1|Overall Study|Lack of Efficacy|0
7605456|NCT01901328|26461514|P2|Overall Study|Withdrawal by Subject|2
7605457|NCT01901328|26461515|P1|Overall Study|Withdrawal by Subject|1
7605458|NCT01901328|26461514|P2|Overall Study|Study Terminated by Sponsor|16
7605459|NCT01901328|26461515|P1|Overall Study|Study Terminated by Sponsor|19
7605460|NCT01901328|26461514|P2|Overall Study|Protocol Violation|1
7605461|NCT01901328|26461515|P1|Overall Study|Protocol Violation|1
7605462|NCT01901328|26461514|P2|Overall Study|Physician Decision|1
7605463|NCT01901328|26461515|P1|Overall Study|Physician Decision|0
7605464|NCT01901328|26461514|P2|Overall Study|Lost to Follow-up|0
7605465|NCT01901328|26461515|P1|Overall Study|Lost to Follow-up|1
7605466|NCT01901302|26461529|P2|Overall Study|Withdrawal by Subject|0
7605467|NCT01901302|26461530|P1|Overall Study|Withdrawal by Subject|2
7605468|NCT01901302|26461529|P2|Overall Study|Study Terminated by Sponsor|20
7605469|NCT01901302|26461530|P1|Overall Study|Study Terminated by Sponsor|23
7605470|NCT01901302|26461529|P2|Overall Study|Lack of Efficacy|2
7605471|NCT01901302|26461530|P1|Overall Study|Lack of Efficacy|0
7605472|NCT01901302|26461529|P2|Overall Study|Adverse Event|1
7605473|NCT01901302|26461530|P1|Overall Study|Adverse Event|2
7605474|NCT01901224|26461555|P1|Overall Study|study was not funded and terminated|2
7605475|NCT01901185|26461590|P1|Overall Study|Withdrawal by Subject|2
7605476|NCT01901146|26461599|P5|Adjuvant Phase|Withdrawal by Subject|4
7605477|NCT01901146|26461600|P4|Adjuvant Phase|Withdrawal by Subject|1
7605478|NCT01901146|26461601|P3|Adjuvant Phase|Withdrawal by Subject|4
7605479|NCT01901146|26461602|P2|Adjuvant Phase|Withdrawal by Subject|0
7605480|NCT01901146|26461603|P1|Adjuvant Phase|Withdrawal by Subject|0
7605481|NCT01901146|26461599|P5|Adjuvant Phase|Physician Decision|4
7605482|NCT01901146|26461600|P4|Adjuvant Phase|Physician Decision|2
7605483|NCT01901146|26461601|P3|Adjuvant Phase|Physician Decision|9
7605484|NCT01901146|26461602|P2|Adjuvant Phase|Physician Decision|0
7605485|NCT01901146|26461603|P1|Adjuvant Phase|Physician Decision|0
7605486|NCT01901146|26461599|P5|Adjuvant Phase|Disease Progression or Recurrence|3
7605487|NCT01901146|26461600|P4|Adjuvant Phase|Disease Progression or Recurrence|4
7605488|NCT01901146|26461601|P3|Adjuvant Phase|Disease Progression or Recurrence|12
7605489|NCT01901146|26461602|P2|Adjuvant Phase|Disease Progression or Recurrence|0
7605490|NCT01901146|26461603|P1|Adjuvant Phase|Disease Progression or Recurrence|0
7605491|NCT01901146|26461599|P5|Adjuvant Phase|Death|3
7605492|NCT01901146|26461600|P4|Adjuvant Phase|Death|0
7605493|NCT01901146|26461601|P3|Adjuvant Phase|Death|0
7605494|NCT01901146|26461602|P2|Adjuvant Phase|Death|0
7605495|NCT01901146|26461603|P1|Adjuvant Phase|Death|0
7605496|NCT01901146|26461599|P5|Adjuvant Phase|Other|0
7605497|NCT01901146|26461600|P4|Adjuvant Phase|Other|0
7605498|NCT01901146|26461601|P3|Adjuvant Phase|Other|1
7605499|NCT01901146|26461602|P2|Adjuvant Phase|Other|0
7605500|NCT01901146|26461603|P1|Adjuvant Phase|Other|0
7605501|NCT01901146|26461599|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7605502|NCT01901146|26461600|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7605503|NCT01901146|26461601|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7605504|NCT01901146|26461602|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
7605505|NCT01901146|26461603|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7605506|NCT01901146|26461599|P5|Neoadjuvant Phase|Withdrawal by Subject|0
7605507|NCT01901146|26461600|P4|Neoadjuvant Phase|Withdrawal by Subject|0
7605508|NCT01901146|26461601|P3|Neoadjuvant Phase|Withdrawal by Subject|0
7605509|NCT01901146|26461602|P2|Neoadjuvant Phase|Withdrawal by Subject|5
7605510|NCT01901146|26461603|P1|Neoadjuvant Phase|Withdrawal by Subject|2
7605511|NCT01901146|26461599|P5|Neoadjuvant Phase|Physician Decision|0
7605512|NCT01901146|26461600|P4|Neoadjuvant Phase|Physician Decision|0
7605513|NCT01901146|26461601|P3|Neoadjuvant Phase|Physician Decision|0
7605514|NCT01901146|26461602|P2|Neoadjuvant Phase|Physician Decision|2
7605515|NCT01901146|26461603|P1|Neoadjuvant Phase|Physician Decision|1
7605516|NCT01901146|26461599|P5|Neoadjuvant Phase|Lost to Follow-up|0
7605517|NCT01901146|26461600|P4|Neoadjuvant Phase|Lost to Follow-up|0
7605518|NCT01901146|26461601|P3|Neoadjuvant Phase|Lost to Follow-up|0
7605519|NCT01901146|26461602|P2|Neoadjuvant Phase|Lost to Follow-up|1
7605520|NCT01901146|26461603|P1|Neoadjuvant Phase|Lost to Follow-up|0
7605521|NCT01901146|26461599|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
7605522|NCT01901146|26461600|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
7605523|NCT01901146|26461601|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
7605524|NCT01901146|26461602|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
7605525|NCT01901146|26461603|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
7605526|NCT01901146|26461599|P5|Neoadjuvant Phase|Death|0
7605527|NCT01901146|26461600|P4|Neoadjuvant Phase|Death|0
7605528|NCT01901146|26461601|P3|Neoadjuvant Phase|Death|0
7605529|NCT01901146|26461602|P2|Neoadjuvant Phase|Death|2
7605530|NCT01901146|26461603|P1|Neoadjuvant Phase|Death|1
7605531|NCT01901055|26461618|P2|Week 36|Withdrawal by Subject|5
7605532|NCT01901055|26461619|P1|Week 36|Withdrawal by Subject|0
7605533|NCT01901055|26461618|P2|Week 24|Physician Decision|0
7605534|NCT01901055|26461619|P1|Week 24|Physician Decision|1
7605535|NCT01901055|26461618|P2|Week 24|Withdrawal by Subject|19
7605536|NCT01901055|26461619|P1|Week 24|Withdrawal by Subject|13
7605537|NCT01901055|26461618|P2|Week 12 Assessment|Withdrawal by Subject|4
7605538|NCT01901055|26461619|P1|Week 12 Assessment|Withdrawal by Subject|0
7605539|NCT01901055|26461618|P2|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
7605540|NCT01901055|26461619|P1|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
7605541|NCT01901055|26461618|P2|Started Protocol to Week 6|Withdrawal by Subject|1
7605542|NCT01901055|26461619|P1|Started Protocol to Week 6|Withdrawal by Subject|0
7605543|NCT01901055|26461618|P2|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
7605544|NCT01901055|26461619|P1|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
7605545|NCT01901055|26461618|P2|Started Protocol to Week 6|complains of difficulty with wearing mask|2
7605710|NCT01899053|26462160|P4|Overall Study|Protocol Violation|0
7605546|NCT01901055|26461619|P1|Started Protocol to Week 6|complains of difficulty with wearing mask|0
7605547|NCT01901055|26461618|P2|Started Protocol to Week 6|Physician Decision|1
7605548|NCT01901055|26461619|P1|Started Protocol to Week 6|Physician Decision|2
7605549|NCT01901055|26461618|P2|Randomization But Not Titrated|Physician Decision|1
7605550|NCT01901055|26461619|P1|Randomization But Not Titrated|Physician Decision|0
7605551|NCT01901055|26461618|P2|Randomization But Not Titrated|Did not come to titration study|1
7605552|NCT01901055|26461619|P1|Randomization But Not Titrated|Did not come to titration study|1
7605553|NCT01900899|26461648|P2|Overall Study|Migrated from study area|0
7605554|NCT01900899|26461649|P1|Overall Study|Migrated from study area|2
7605555|NCT01900899|26461648|P2|Overall Study|Withdrawal by Subject|1
7605556|NCT01900899|26461649|P1|Overall Study|Withdrawal by Subject|7
7605557|NCT01900730|26461675|P2|Overall Study|Screen Failure|0
7605558|NCT01900730|26461676|P1|Overall Study|Screen Failure|1
7605559|NCT01900730|26461675|P2|Overall Study|Withdrawal by Subject|0
7605560|NCT01900730|26461676|P1|Overall Study|Withdrawal by Subject|1
7605561|NCT01900665|26461700|P2|Open Label Period|Withdrawal by Subject|28
7605562|NCT01900665|26461701|P1|Open Label Period|Withdrawal by Subject|20
7605563|NCT01900665|26461700|P2|Open Label Period|Sponsor Decision|765
7605564|NCT01900665|26461701|P1|Open Label Period|Sponsor Decision|802
7605565|NCT01900665|26461700|P2|Open Label Period|Protocol Violation|1
7605566|NCT01900665|26461701|P1|Open Label Period|Protocol Violation|0
7605567|NCT01900665|26461700|P2|Open Label Period|Physician Decision|4
7605568|NCT01900665|26461701|P1|Open Label Period|Physician Decision|4
7605569|NCT01900665|26461700|P2|Open Label Period|Parent/Caregiver Decision|34
7605570|NCT01900665|26461701|P1|Open Label Period|Parent/Caregiver Decision|33
7605571|NCT01900665|26461700|P2|Open Label Period|Lost to Follow-up|1
7605572|NCT01900665|26461701|P1|Open Label Period|Lost to Follow-up|1
7605573|NCT01900665|26461700|P2|Open Label Period|Death|6
7605574|NCT01900665|26461701|P1|Open Label Period|Death|5
7605575|NCT01900665|26461700|P2|Open Label Period|Adverse Event|20
7605576|NCT01900665|26461701|P1|Open Label Period|Adverse Event|16
7605577|NCT01900665|26461700|P2|Placebo Controlled Period|Entry Criteria Not Met|9
7605578|NCT01900665|26461701|P1|Placebo Controlled Period|Entry Criteria Not Met|5
7605579|NCT01900665|26461700|P2|Placebo Controlled Period|Caregiver Decision|41
7605580|NCT01900665|26461701|P1|Placebo Controlled Period|Caregiver Decision|33
7605581|NCT01900665|26461700|P2|Placebo Controlled Period|Lost to Follow-up|0
7605582|NCT01900665|26461701|P1|Placebo Controlled Period|Lost to Follow-up|3
7605583|NCT01900665|26461700|P2|Placebo Controlled Period|Physician Decision|7
7605584|NCT01900665|26461701|P1|Placebo Controlled Period|Physician Decision|11
7605585|NCT01900665|26461700|P2|Placebo Controlled Period|Withdrawal by Subject|45
7605586|NCT01900665|26461701|P1|Placebo Controlled Period|Withdrawal by Subject|33
7605587|NCT01900665|26461700|P2|Placebo Controlled Period|Protocol Violation|7
7605588|NCT01900665|26461701|P1|Placebo Controlled Period|Protocol Violation|1
7605589|NCT01900665|26461700|P2|Placebo Controlled Period|Adverse Event|39
7605590|NCT01900665|26461701|P1|Placebo Controlled Period|Adverse Event|48
7605591|NCT01900665|26461700|P2|Placebo Controlled Period|Death|16
7605592|NCT01900665|26461701|P1|Placebo Controlled Period|Death|9
7605593|NCT01900652|26461744|P2|Overall Study|Physician Decision|1
7605594|NCT01900652|26461745|P1|Overall Study|Physician Decision|1
7605595|NCT01900652|26461744|P2|Overall Study|Adverse Event|1
7605596|NCT01900652|26461745|P1|Overall Study|Adverse Event|2
7605597|NCT01900652|26461744|P2|Overall Study|Death|0
7605598|NCT01900652|26461745|P1|Overall Study|Death|3
7605599|NCT01900652|26461744|P2|Overall Study|Consent withdrawn by subject|1
7605600|NCT01900652|26461745|P1|Overall Study|Consent withdrawn by subject|1
7605601|NCT01900652|26461744|P2|Overall Study|Progressive Disease|0
7605602|NCT01900652|26461745|P1|Overall Study|Progressive Disease|1
7605603|NCT01900626|26461781|P2|Overall Study|study was closed due to low enrollment|1
7605604|NCT01900626|26461782|P1|Overall Study|study was closed due to low enrollment|1
7605605|NCT01900444|26461861|P1|Overall Study|Lost to Follow-up|1
7605606|NCT01900444|26461861|P1|Overall Study|Protocol Violation|2
7605607|NCT01900431|26461874|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
7605608|NCT01900431|26461875|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7605609|NCT01900431|26461876|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7605610|NCT01900431|26461874|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
7605611|NCT01900431|26461875|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7605612|NCT01900431|26461876|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7605613|NCT01900431|26461874|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
7605614|NCT01900431|26461875|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
7605615|NCT01900431|26461876|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
7605616|NCT01900431|26461874|P3|Extended Treatment Period (Part B)|Other than specified above|0
7605617|NCT01900431|26461875|P2|Extended Treatment Period (Part B)|Other than specified above|1
7605618|NCT01900431|26461876|P1|Extended Treatment Period (Part B)|Other than specified above|0
7605619|NCT01900431|26461874|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
7605620|NCT01900431|26461875|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
7605621|NCT01900431|26461876|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
7605622|NCT01900431|26461874|P3|Extended Treatment Period (Part B)|Adverse Event|0
7605623|NCT01900431|26461875|P2|Extended Treatment Period (Part B)|Adverse Event|2
7605624|NCT01900431|26461876|P1|Extended Treatment Period (Part B)|Adverse Event|0
7605625|NCT01900431|26461874|P3|Principal Treatment Period (Part A)|Other than specified above|0
7605626|NCT01900431|26461875|P2|Principal Treatment Period (Part A)|Other than specified above|1
7605627|NCT01900431|26461876|P1|Principal Treatment Period (Part A)|Other than specified above|0
7605628|NCT01900431|26461874|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
7605629|NCT01900431|26461875|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
7605630|NCT01900431|26461876|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
7605631|NCT01900431|26461874|P3|Principal Treatment Period (Part A)|Adverse Event|0
7605632|NCT01900431|26461875|P2|Principal Treatment Period (Part A)|Adverse Event|3
7605633|NCT01900431|26461876|P1|Principal Treatment Period (Part A)|Adverse Event|1
7605634|NCT01900314|26461918|P2|Overall Study|Withdrawal by Subject|3
7605635|NCT01900314|26461919|P1|Overall Study|Withdrawal by Subject|3
7605636|NCT01900314|26461918|P2|Overall Study|Protocol Violation|1
7605637|NCT01900314|26461919|P1|Overall Study|Protocol Violation|0
7605638|NCT01900314|26461918|P2|Overall Study|Lost to Follow-up|0
7605639|NCT01900314|26461919|P1|Overall Study|Lost to Follow-up|1
7605640|NCT01900054|26461949|P1|Overall Study|Withdrawal by Subject|1
7605641|NCT01900054|26461949|P1|Overall Study|Physician Decision|1
7605642|NCT01899768|26461958|P1|Part B|Withdrawal by Subject|1
7605643|NCT01899768|26461958|P1|Part B|Adverse Event|1
7605644|NCT01899768|26461958|P1|Part A|Withdrawal by Subject|1
7605645|NCT01899768|26461958|P1|Part A|Adverse Event|2
7605646|NCT01899742|26462032|P2|Overall Study|Withdrawal by Subject|5
7605647|NCT01899742|26462033|P1|Overall Study|Withdrawal by Subject|9
7605648|NCT01899742|26462032|P2|Overall Study|Protocol Violation|2
7605649|NCT01899742|26462033|P1|Overall Study|Protocol Violation|2
7605650|NCT01899742|26462032|P2|Overall Study|Lack of Efficacy|5
7605651|NCT01899742|26462033|P1|Overall Study|Lack of Efficacy|1
7605652|NCT01899742|26462032|P2|Overall Study|Adverse Event|4
7605653|NCT01899742|26462033|P1|Overall Study|Adverse Event|5
7605654|NCT01899729|26462046|P5|Overall Study|Lack of Efficacy|1
7605655|NCT01899729|26462047|P4|Overall Study|Lack of Efficacy|0
7605656|NCT01899729|26462048|P3|Overall Study|Lack of Efficacy|2
7605657|NCT01899729|26462049|P2|Overall Study|Lack of Efficacy|0
7605658|NCT01899729|26462050|P1|Overall Study|Lack of Efficacy|0
7605659|NCT01899729|26462046|P5|Overall Study|Withdrawal by Subject|0
7605660|NCT01899729|26462047|P4|Overall Study|Withdrawal by Subject|0
7605661|NCT01899729|26462048|P3|Overall Study|Withdrawal by Subject|0
7605662|NCT01899729|26462049|P2|Overall Study|Withdrawal by Subject|2
7605663|NCT01899729|26462050|P1|Overall Study|Withdrawal by Subject|1
7605664|NCT01899729|26462046|P5|Overall Study|Adverse Event|1
7605665|NCT01899729|26462047|P4|Overall Study|Adverse Event|0
7605666|NCT01899729|26462048|P3|Overall Study|Adverse Event|0
7605667|NCT01899729|26462049|P2|Overall Study|Adverse Event|0
7605668|NCT01899729|26462050|P1|Overall Study|Adverse Event|1
7605669|NCT01899144|26462114|P1|Treatment Period 5|Other|1
7605670|NCT01899144|26462114|P1|Treatment Period 3|Other|2
7605671|NCT01899144|26462114|P1|Treatment Period 2|Other|1
7605672|NCT01899053|26462150|P14|Overall Study|Symptomatic Deterioration|0
7605673|NCT01899053|26462151|P13|Overall Study|Symptomatic Deterioration|2
7605674|NCT01899053|26462152|P12|Overall Study|Symptomatic Deterioration|1
7605675|NCT01899053|26462153|P11|Overall Study|Symptomatic Deterioration|0
7605676|NCT01899053|26462154|P10|Overall Study|Symptomatic Deterioration|0
7605677|NCT01899053|26462155|P9|Overall Study|Symptomatic Deterioration|0
7605678|NCT01899053|26462156|P8|Overall Study|Symptomatic Deterioration|1
7605679|NCT01899053|26462157|P7|Overall Study|Symptomatic Deterioration|0
7605680|NCT01899053|26462158|P6|Overall Study|Symptomatic Deterioration|1
7605681|NCT01899053|26462159|P5|Overall Study|Symptomatic Deterioration|0
7605682|NCT01899053|26462160|P4|Overall Study|Symptomatic Deterioration|0
7605683|NCT01899053|26462161|P3|Overall Study|Symptomatic Deterioration|0
7605684|NCT01899053|26462162|P2|Overall Study|Symptomatic Deterioration|0
7605685|NCT01899053|26462163|P1|Overall Study|Symptomatic Deterioration|0
7605686|NCT01899053|26462150|P14|Overall Study|Unsatisfactory Therapeutic Response|0
7605687|NCT01899053|26462151|P13|Overall Study|Unsatisfactory Therapeutic Response|0
7605688|NCT01899053|26462152|P12|Overall Study|Unsatisfactory Therapeutic Response|0
7605689|NCT01899053|26462153|P11|Overall Study|Unsatisfactory Therapeutic Response|1
7605690|NCT01899053|26462154|P10|Overall Study|Unsatisfactory Therapeutic Response|0
7605691|NCT01899053|26462155|P9|Overall Study|Unsatisfactory Therapeutic Response|0
7605692|NCT01899053|26462156|P8|Overall Study|Unsatisfactory Therapeutic Response|0
7605693|NCT01899053|26462157|P7|Overall Study|Unsatisfactory Therapeutic Response|0
7605694|NCT01899053|26462158|P6|Overall Study|Unsatisfactory Therapeutic Response|0
7605695|NCT01899053|26462159|P5|Overall Study|Unsatisfactory Therapeutic Response|0
7605696|NCT01899053|26462160|P4|Overall Study|Unsatisfactory Therapeutic Response|0
7605697|NCT01899053|26462161|P3|Overall Study|Unsatisfactory Therapeutic Response|0
7605698|NCT01899053|26462162|P2|Overall Study|Unsatisfactory Therapeutic Response|1
7605699|NCT01899053|26462163|P1|Overall Study|Unsatisfactory Therapeutic Response|1
7605700|NCT01899053|26462150|P14|Overall Study|Protocol Violation|0
7605701|NCT01899053|26462151|P13|Overall Study|Protocol Violation|0
7605702|NCT01899053|26462152|P12|Overall Study|Protocol Violation|0
7605703|NCT01899053|26462153|P11|Overall Study|Protocol Violation|0
7605704|NCT01899053|26462154|P10|Overall Study|Protocol Violation|0
7605705|NCT01899053|26462155|P9|Overall Study|Protocol Violation|0
7605706|NCT01899053|26462156|P8|Overall Study|Protocol Violation|0
7605707|NCT01899053|26462157|P7|Overall Study|Protocol Violation|0
7605708|NCT01899053|26462158|P6|Overall Study|Protocol Violation|0
7605709|NCT01899053|26462159|P5|Overall Study|Protocol Violation|0
7605711|NCT01899053|26462161|P3|Overall Study|Protocol Violation|1
7605712|NCT01899053|26462162|P2|Overall Study|Protocol Violation|0
7605713|NCT01899053|26462163|P1|Overall Study|Protocol Violation|0
7605714|NCT01899053|26462150|P14|Overall Study|Withdrawal by Subject|1
7605715|NCT01899053|26462151|P13|Overall Study|Withdrawal by Subject|1
7605716|NCT01899053|26462152|P12|Overall Study|Withdrawal by Subject|0
7605717|NCT01899053|26462153|P11|Overall Study|Withdrawal by Subject|0
7605718|NCT01899053|26462154|P10|Overall Study|Withdrawal by Subject|0
7605719|NCT01899053|26462155|P9|Overall Study|Withdrawal by Subject|0
7605720|NCT01899053|26462156|P8|Overall Study|Withdrawal by Subject|1
7605721|NCT01899053|26462157|P7|Overall Study|Withdrawal by Subject|0
7605722|NCT01899053|26462158|P6|Overall Study|Withdrawal by Subject|0
7605723|NCT01899053|26462159|P5|Overall Study|Withdrawal by Subject|2
7605724|NCT01899053|26462160|P4|Overall Study|Withdrawal by Subject|0
7605725|NCT01899053|26462161|P3|Overall Study|Withdrawal by Subject|2
7605726|NCT01899053|26462162|P2|Overall Study|Withdrawal by Subject|1
7605727|NCT01899053|26462163|P1|Overall Study|Withdrawal by Subject|1
7605728|NCT01899053|26462150|P14|Overall Study|Reason Not Specified|0
7605729|NCT01899053|26462151|P13|Overall Study|Reason Not Specified|1
7605730|NCT01899053|26462152|P12|Overall Study|Reason Not Specified|0
7605731|NCT01899053|26462153|P11|Overall Study|Reason Not Specified|0
7605732|NCT01899053|26462154|P10|Overall Study|Reason Not Specified|0
7605733|NCT01899053|26462155|P9|Overall Study|Reason Not Specified|0
7605734|NCT01899053|26462156|P8|Overall Study|Reason Not Specified|0
7605735|NCT01899053|26462157|P7|Overall Study|Reason Not Specified|1
7605736|NCT01899053|26462158|P6|Overall Study|Reason Not Specified|0
7605737|NCT01899053|26462159|P5|Overall Study|Reason Not Specified|0
7605738|NCT01899053|26462160|P4|Overall Study|Reason Not Specified|0
7605739|NCT01899053|26462161|P3|Overall Study|Reason Not Specified|0
7605740|NCT01899053|26462162|P2|Overall Study|Reason Not Specified|0
7605741|NCT01899053|26462163|P1|Overall Study|Reason Not Specified|0
7605742|NCT01899053|26462150|P14|Overall Study|Adverse Event|2
7605743|NCT01899053|26462151|P13|Overall Study|Adverse Event|2
7605744|NCT01899053|26462152|P12|Overall Study|Adverse Event|1
7605745|NCT01899053|26462153|P11|Overall Study|Adverse Event|3
7605746|NCT01899053|26462154|P10|Overall Study|Adverse Event|0
7605747|NCT01899053|26462155|P9|Overall Study|Adverse Event|2
7605748|NCT01899053|26462156|P8|Overall Study|Adverse Event|0
7605749|NCT01899053|26462157|P7|Overall Study|Adverse Event|1
7605750|NCT01899053|26462158|P6|Overall Study|Adverse Event|1
7605751|NCT01899053|26462159|P5|Overall Study|Adverse Event|1
7605752|NCT01899053|26462160|P4|Overall Study|Adverse Event|3
7605753|NCT01899053|26462161|P3|Overall Study|Adverse Event|1
7605754|NCT01899053|26462162|P2|Overall Study|Adverse Event|1
7605755|NCT01899053|26462163|P1|Overall Study|Adverse Event|1
7605756|NCT01899053|26462150|P14|Overall Study|Progressive Disease|17
7605757|NCT01899053|26462151|P13|Overall Study|Progressive Disease|8
7605758|NCT01899053|26462152|P12|Overall Study|Progressive Disease|5
7605759|NCT01899053|26462153|P11|Overall Study|Progressive Disease|12
7605760|NCT01899053|26462154|P10|Overall Study|Progressive Disease|3
7605761|NCT01899053|26462155|P9|Overall Study|Progressive Disease|4
7605762|NCT01899053|26462156|P8|Overall Study|Progressive Disease|1
7605763|NCT01899053|26462157|P7|Overall Study|Progressive Disease|1
7605764|NCT01899053|26462158|P6|Overall Study|Progressive Disease|1
7605765|NCT01899053|26462159|P5|Overall Study|Progressive Disease|3
7605766|NCT01899053|26462160|P4|Overall Study|Progressive Disease|0
7605767|NCT01899053|26462161|P3|Overall Study|Progressive Disease|3
7605768|NCT01899053|26462162|P2|Overall Study|Progressive Disease|0
7605769|NCT01899053|26462163|P1|Overall Study|Progressive Disease|4
7605770|NCT01898923|26462417|P2|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
7605771|NCT01898923|26462418|P1|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
7605772|NCT01898923|26462417|P2|Overall Study|Physician Decision|4
7605773|NCT01898923|26462418|P1|Overall Study|Physician Decision|3
7605774|NCT01898923|26462417|P2|Overall Study|Withdrawal by Subject|7
7605775|NCT01898923|26462418|P1|Overall Study|Withdrawal by Subject|4
7605776|NCT01898923|26462417|P2|Overall Study|Lost to Follow-up|1
7605777|NCT01898923|26462418|P1|Overall Study|Lost to Follow-up|0
7605778|NCT01898923|26462417|P2|Overall Study|Adverse Event|1
7605779|NCT01898923|26462418|P1|Overall Study|Adverse Event|3
7605780|NCT01898923|26462417|P2|Overall Study|Lack of Efficacy|6
7605781|NCT01898923|26462418|P1|Overall Study|Lack of Efficacy|5
7605782|NCT01898884|26462437|P9|Multiple Dose Period|Randomized Not Treated|1
7605783|NCT01898884|26462438|P8|Multiple Dose Period|Randomized Not Treated|0
7605784|NCT01898884|26462439|P7|Multiple Dose Period|Randomized Not Treated|0
7605785|NCT01898884|26462440|P6|Multiple Dose Period|Randomized Not Treated|0
7605786|NCT01898884|26462441|P5|Multiple Dose Period|Randomized Not Treated|0
7605787|NCT01898884|26462442|P4|Multiple Dose Period|Randomized Not Treated|0
7605788|NCT01898884|26462443|P3|Multiple Dose Period|Randomized Not Treated|0
7605789|NCT01898884|26462444|P2|Multiple Dose Period|Randomized Not Treated|0
7605790|NCT01898884|26462445|P1|Multiple Dose Period|Randomized Not Treated|0
7605791|NCT01898884|26462437|P9|Multiple Dose Period|Adverse Event|0
7605792|NCT01898884|26462438|P8|Multiple Dose Period|Adverse Event|0
7605793|NCT01898884|26462439|P7|Multiple Dose Period|Adverse Event|1
7605794|NCT01898884|26462440|P6|Multiple Dose Period|Adverse Event|0
7605795|NCT01898884|26462441|P5|Multiple Dose Period|Adverse Event|0
7605796|NCT01898884|26462442|P4|Multiple Dose Period|Adverse Event|0
7605797|NCT01898884|26462443|P3|Multiple Dose Period|Adverse Event|0
7605798|NCT01898884|26462444|P2|Multiple Dose Period|Adverse Event|0
7605799|NCT01898884|26462445|P1|Multiple Dose Period|Adverse Event|0
7605800|NCT01898806|26462595|P1|Overall Study|Physician Decision|1
7605801|NCT01898806|26462595|P1|Overall Study|Withdrawal by Subject|2
7605802|NCT01898598|26462638|P2|Overall Study|Other|1
7605803|NCT01898598|26462639|P1|Overall Study|Other|0
7605804|NCT01898598|26462638|P2|Overall Study|Lost to Follow-up|1
7605805|NCT01898598|26462639|P1|Overall Study|Lost to Follow-up|0
7605806|NCT01898598|26462638|P2|Overall Study|Withdrawal by Subject|0
7605807|NCT01898598|26462639|P1|Overall Study|Withdrawal by Subject|3
7605808|NCT01898598|26462638|P2|Overall Study|Adverse Event|0
7605809|NCT01898598|26462639|P1|Overall Study|Adverse Event|1
7605810|NCT01898442|26462658|P3|Overall Study|Patient vomited pills|1
7605811|NCT01898442|26462659|P2|Overall Study|Patient vomited pills|0
7605812|NCT01898442|26462660|P1|Overall Study|Patient vomited pills|0
7605813|NCT01898442|26462658|P3|Overall Study|Hemolysis/technical problems|2
7605814|NCT01898442|26462659|P2|Overall Study|Hemolysis/technical problems|2
7605815|NCT01898442|26462660|P1|Overall Study|Hemolysis/technical problems|1
7605816|NCT01898299|26462697|P2|Post Treatment (One Month)|Lost to Follow-up|4
7605817|NCT01898299|26462698|P1|Post Treatment (One Month)|Lost to Follow-up|3
7605818|NCT01898286|26462704|P1|Overall Study|Lost to Follow-up|1
7605819|NCT01898286|26462704|P1|Overall Study|Protocol Violation|1
7605820|NCT01898286|26462704|P1|Overall Study|Withdrawal by Subject|1
7605821|NCT01898208|26462714|P3|Overall Study|Lost to Follow-up|1
7605822|NCT01898208|26462715|P2|Overall Study|Lost to Follow-up|1
7605823|NCT01898208|26462716|P1|Overall Study|Lost to Follow-up|3
7605824|NCT01898208|26462714|P3|Overall Study|System/Technical Error|3
7605825|NCT01898208|26462715|P2|Overall Study|System/Technical Error|2
7605826|NCT01898208|26462716|P1|Overall Study|System/Technical Error|1
7605827|NCT01898208|26462714|P3|Overall Study|Non-Blood Specimens in Bottles|4
7605828|NCT01898208|26462715|P2|Overall Study|Non-Blood Specimens in Bottles|5
7605829|NCT01898208|26462716|P1|Overall Study|Non-Blood Specimens in Bottles|3
7605830|NCT01898208|26462714|P3|Overall Study|Negative Gram Stain|6
7605831|NCT01898208|26462715|P2|Overall Study|Negative Gram Stain|9
7605832|NCT01898208|26462716|P1|Overall Study|Negative Gram Stain|6
7605833|NCT01898208|26462714|P3|Overall Study|Death/comfort care within 24 hours|8
7605834|NCT01898208|26462715|P2|Overall Study|Death/comfort care within 24 hours|9
7605835|NCT01898208|26462716|P1|Overall Study|Death/comfort care within 24 hours|10
7605836|NCT01898208|26462714|P3|Overall Study|Positive blood culture|15
7605837|NCT01898208|26462715|P2|Overall Study|Positive blood culture|23
7605838|NCT01898208|26462716|P1|Overall Study|Positive blood culture|17
7605839|NCT01898195|26462763|P3|Smoking Abstinence|Did not have good measurements|36
7605840|NCT01898195|26462764|P2|Smoking Abstinence|Did not have good measurements|38
7605841|NCT01898195|26462765|P1|Smoking Abstinence|Did not have good measurements|35
7605842|NCT01898130|26462776|P1|Follow up Until PD or Death|Lost to Follow-up|1
7605843|NCT01898130|26462776|P1|Treatment|Progressive Disease|4
7605844|NCT01898130|26462776|P1|Treatment|Withdrawal by Subject|2
7605845|NCT01898091|26462791|P2|Overall Study|Withdrawal by Subject|5
7605846|NCT01898091|26462792|P1|Overall Study|Withdrawal by Subject|1
7605847|NCT01898091|26462791|P2|Overall Study|Lost to Follow-up|1
7605848|NCT01898091|26462792|P1|Overall Study|Lost to Follow-up|1
7605849|NCT01898078|26462800|P2|Overall Study|Reason not Specified|1
7605850|NCT01898078|26462801|P1|Overall Study|Reason not Specified|0
7605851|NCT01898078|26462800|P2|Overall Study|Symptomatic Deterioration|0
7605852|NCT01898078|26462801|P1|Overall Study|Symptomatic Deterioration|2
7605853|NCT01898078|26462800|P2|Overall Study|Withdrawal by Subject|1
7605854|NCT01898078|26462801|P1|Overall Study|Withdrawal by Subject|1
7605855|NCT01898078|26462800|P2|Overall Study|Adverse Event|1
7605856|NCT01898078|26462801|P1|Overall Study|Adverse Event|2
7605857|NCT01898078|26462800|P2|Overall Study|Progressive Disease|5
7605858|NCT01898078|26462801|P1|Overall Study|Progressive Disease|1
7605859|NCT01897896|26462838|P2|Overall Study|Other than specified|1
7605860|NCT01897896|26462839|P1|Overall Study|Other than specified|2
7605861|NCT01897896|26462838|P2|Overall Study|Caregiver can no longer participate|2
7605862|NCT01897896|26462839|P1|Overall Study|Caregiver can no longer participate|0
7605863|NCT01897896|26462838|P2|Overall Study|Withdrawal per Investigator's judgement|1
7605864|NCT01897896|26462839|P1|Overall Study|Withdrawal per Investigator's judgement|1
7605865|NCT01897896|26462838|P2|Overall Study|Protocol Violation|1
7605866|NCT01897896|26462839|P1|Overall Study|Protocol Violation|1
7605867|NCT01897896|26462838|P2|Overall Study|Require drug that interfere with study|4
7605868|NCT01897896|26462839|P1|Overall Study|Require drug that interfere with study|1
7605869|NCT01897896|26462838|P2|Overall Study|Withdrawal by Subject|1
7605870|NCT01897896|26462839|P1|Overall Study|Withdrawal by Subject|7
7605871|NCT01897896|26462838|P2|Overall Study|Non-compliance with study drug dosing|1
7605872|NCT01897896|26462839|P1|Overall Study|Non-compliance with study drug dosing|1
7605873|NCT01897896|26462838|P2|Overall Study|Lost to Follow-up|0
7605874|NCT01897896|26462839|P1|Overall Study|Lost to Follow-up|1
7605875|NCT01897896|26462838|P2|Overall Study|Adverse Event|1
7605876|NCT01897896|26462839|P1|Overall Study|Adverse Event|11
7605877|NCT01897896|26462838|P2|Overall Study|Death|0
7605878|NCT01897896|26462839|P1|Overall Study|Death|1
7605879|NCT01897727|26462971|P2|Overall Study|Exclusion: central sleep apnea|1
7605880|NCT01897727|26462972|P1|Overall Study|Exclusion: central sleep apnea|0
7605881|NCT01897714|26462984|P6|Phase II (MTD)|Other|0
7605882|NCT01897714|26462985|P5|Phase II (MTD)|Other|3
7605883|NCT01897714|26462986|P4|Phase II (MTD)|Other|0
7605884|NCT01897714|26462987|P3|Phase II (MTD)|Other|0
7605885|NCT01897714|26462988|P2|Phase II (MTD)|Other|0
7605886|NCT01897714|26462989|P1|Phase II (MTD)|Other|0
7605887|NCT01897714|26462984|P6|Phase II (MTD)|Study terminated with patient alive|0
7605888|NCT01897714|26462985|P5|Phase II (MTD)|Study terminated with patient alive|1
7605889|NCT01897714|26462986|P4|Phase II (MTD)|Study terminated with patient alive|0
7605890|NCT01897714|26462987|P3|Phase II (MTD)|Study terminated with patient alive|0
7605891|NCT01897714|26462988|P2|Phase II (MTD)|Study terminated with patient alive|0
7605892|NCT01897714|26462989|P1|Phase II (MTD)|Study terminated with patient alive|0
7605893|NCT01897714|26462984|P6|Phase II (MTD)|Death|10
7605894|NCT01897714|26462985|P5|Phase II (MTD)|Death|25
7605895|NCT01897714|26462986|P4|Phase II (MTD)|Death|0
7605896|NCT01897714|26462987|P3|Phase II (MTD)|Death|0
7605897|NCT01897714|26462988|P2|Phase II (MTD)|Death|0
7605898|NCT01897714|26462989|P1|Phase II (MTD)|Death|0
7605899|NCT01897714|26462984|P6|Phase II (MTD)|Lost to Follow-up|0
7605900|NCT01897714|26462985|P5|Phase II (MTD)|Lost to Follow-up|1
7605901|NCT01897714|26462986|P4|Phase II (MTD)|Lost to Follow-up|0
7605902|NCT01897714|26462987|P3|Phase II (MTD)|Lost to Follow-up|0
7605903|NCT01897714|26462988|P2|Phase II (MTD)|Lost to Follow-up|0
7605904|NCT01897714|26462989|P1|Phase II (MTD)|Lost to Follow-up|0
7605905|NCT01897714|26462984|P6|Phase II (MTD)|Withdrawal by Subject|1
7605906|NCT01897714|26462985|P5|Phase II (MTD)|Withdrawal by Subject|0
7605907|NCT01897714|26462986|P4|Phase II (MTD)|Withdrawal by Subject|0
7605908|NCT01897714|26462987|P3|Phase II (MTD)|Withdrawal by Subject|0
7605909|NCT01897714|26462988|P2|Phase II (MTD)|Withdrawal by Subject|0
7605910|NCT01897714|26462989|P1|Phase II (MTD)|Withdrawal by Subject|0
7605911|NCT01897714|26462984|P6|Phase I (Dose Escalation)|Other|0
7605912|NCT01897714|26462985|P5|Phase I (Dose Escalation)|Other|0
7605913|NCT01897714|26462986|P4|Phase I (Dose Escalation)|Other|0
7605914|NCT01897714|26462987|P3|Phase I (Dose Escalation)|Other|0
7605915|NCT01897714|26462988|P2|Phase I (Dose Escalation)|Other|1
7605916|NCT01897714|26462989|P1|Phase I (Dose Escalation)|Other|0
7605917|NCT01897714|26462984|P6|Phase I (Dose Escalation)|Adverse Event|0
7605918|NCT01897714|26462985|P5|Phase I (Dose Escalation)|Adverse Event|0
7605919|NCT01897714|26462986|P4|Phase I (Dose Escalation)|Adverse Event|3
7605920|NCT01897714|26462987|P3|Phase I (Dose Escalation)|Adverse Event|4
7605921|NCT01897714|26462988|P2|Phase I (Dose Escalation)|Adverse Event|1
7605922|NCT01897714|26462989|P1|Phase I (Dose Escalation)|Adverse Event|0
7605923|NCT01897714|26462984|P6|Phase I (Dose Escalation)|Disease progression|0
7605924|NCT01897714|26462985|P5|Phase I (Dose Escalation)|Disease progression|0
7605925|NCT01897714|26462986|P4|Phase I (Dose Escalation)|Disease progression|3
7605926|NCT01897714|26462987|P3|Phase I (Dose Escalation)|Disease progression|1
7605927|NCT01897714|26462988|P2|Phase I (Dose Escalation)|Disease progression|5
7605928|NCT01897714|26462989|P1|Phase I (Dose Escalation)|Disease progression|3
7605929|NCT01897532|26463035|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
7605930|NCT01897532|26463036|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
7605931|NCT01897532|26463035|P2|Discontinuation From Trial|Not Treated|5
7605932|NCT01897532|26463036|P1|Discontinuation From Trial|Not Treated|7
7605933|NCT01897532|26463035|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
7605934|NCT01897532|26463036|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
7605935|NCT01897532|26463035|P2|Discontinuation From Treatment|Non compliance|15
7605936|NCT01897532|26463036|P1|Discontinuation From Treatment|Non compliance|24
7605937|NCT01897532|26463035|P2|Discontinuation From Treatment|Withdrawal by Subject|281
7605938|NCT01897532|26463036|P1|Discontinuation From Treatment|Withdrawal by Subject|333
7605939|NCT01897532|26463035|P2|Discontinuation From Treatment|Other reason than specified|176
7605940|NCT01897532|26463036|P1|Discontinuation From Treatment|Other reason than specified|196
7605941|NCT01897532|26463035|P2|Discontinuation From Treatment|Not Treated|5
7605942|NCT01897532|26463036|P1|Discontinuation From Treatment|Not Treated|7
7605943|NCT01897493|26463044|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
7605944|NCT01897233|26463080|P1|Part B (24 Weeks)|Physician Decision|1
7605945|NCT01897233|26463080|P1|Part B (24 Weeks)|Withdrawal by Subject|2
7605946|NCT01897233|26463080|P1|Part B (24 Weeks)|Adverse Event|1
7605947|NCT01896986|26463132|P2|Overall Study|samples lost|23
7605948|NCT01896986|26463133|P1|Overall Study|samples lost|14
7605949|NCT01896934|26463139|P1|Overall Study|Withdrawal by Subject|1
7605950|NCT01896934|26463139|P1|Overall Study|Adverse Event|1
7605951|NCT01896895|26463152|P4|Double-blind MP|Lost to Follow-up|0
7605952|NCT01896895|26463153|P3|Double-blind MP|Lost to Follow-up|1
7605953|NCT01896895|26463154|P2|Double-blind MP|Lost to Follow-up|0
7605954|NCT01896895|26463155|P1|Double-blind MP|Lost to Follow-up|1
7605955|NCT01896895|26463152|P4|Double-blind MP|Withdrawal by Subject|0
7605956|NCT01896895|26463153|P3|Double-blind MP|Withdrawal by Subject|1
7605957|NCT01896895|26463154|P2|Double-blind MP|Withdrawal by Subject|2
7605958|NCT01896895|26463155|P1|Double-blind MP|Withdrawal by Subject|0
7605959|NCT01896895|26463152|P4|Double-blind MP|Physician Decision|0
7605960|NCT01896895|26463153|P3|Double-blind MP|Physician Decision|1
7605961|NCT01896895|26463154|P2|Double-blind MP|Physician Decision|0
7605962|NCT01896895|26463155|P1|Double-blind MP|Physician Decision|0
7605963|NCT01896869|26463172|P2|Overall Study|Lost to Follow-up|0
7605964|NCT01896869|26463173|P1|Overall Study|Lost to Follow-up|1
7605965|NCT01896869|26463172|P2|Overall Study|Withdrawal by Subject|6
7605966|NCT01896869|26463173|P1|Overall Study|Withdrawal by Subject|0
7605967|NCT01896856|26463198|P6|Overall Study|Transportation issues / Non-compliance|0
7605968|NCT01896856|26463199|P5|Overall Study|Transportation issues / Non-compliance|0
7605969|NCT01896856|26463200|P4|Overall Study|Transportation issues / Non-compliance|0
7605970|NCT01896856|26463201|P3|Overall Study|Transportation issues / Non-compliance|1
7605971|NCT01896856|26463202|P2|Overall Study|Transportation issues / Non-compliance|0
7605972|NCT01896856|26463203|P1|Overall Study|Transportation issues / Non-compliance|0
7605973|NCT01896726|26463222|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
7605974|NCT01896726|26463222|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
7605975|NCT01896700|26463237|P2|Overall Study|Withdrawal by Subject|1
7605976|NCT01896700|26463238|P1|Overall Study|Withdrawal by Subject|0
7605977|NCT01896700|26463237|P2|Overall Study|Adverse Event|5
7605978|NCT01896700|26463238|P1|Overall Study|Adverse Event|4
7605979|NCT01896557|26463269|P2|Clopidogrel + GI Protector|Reading error|3
7605980|NCT01896557|26463270|P1|Clopidogrel + GI Protector|Reading error|1
7605981|NCT01896557|26463269|P2|Clopidogrel + GI Protector|low adherence|1
7605982|NCT01896557|26463270|P1|Clopidogrel + GI Protector|low adherence|1
7605983|NCT01896557|26463269|P2|Clopidogrel Alone|Adverse Event|0
7605984|NCT01896557|26463270|P1|Clopidogrel Alone|Adverse Event|1
7605985|NCT01896297|26463307|P1|Overall Study|Died in post treatment phase|1
7605986|NCT01896271|26463312|P1|Overall Study|Physician Decision|10
7605987|NCT01896232|26463326|P2|Overall Study|Lost to Follow-up|12
7605988|NCT01896232|26463327|P1|Overall Study|Lost to Follow-up|9
7605989|NCT01896232|26463326|P2|Overall Study|Sponsor Decision|0
7605990|NCT01896232|26463327|P1|Overall Study|Sponsor Decision|2
7605991|NCT01896232|26463326|P2|Overall Study|Withdrawal by Subject|31
7605992|NCT01896232|26463327|P1|Overall Study|Withdrawal by Subject|32
7605993|NCT01896232|26463326|P2|Overall Study|Death|10
7605994|NCT01896232|26463327|P1|Overall Study|Death|6
7605995|NCT01896193|26463355|P2|Overall Study|Withdrew Consent|0
7605996|NCT01896193|26463356|P1|Overall Study|Withdrew Consent|1
7605997|NCT01896193|26463355|P2|Overall Study|Protocol Violation|1
7605998|NCT01896193|26463356|P1|Overall Study|Protocol Violation|0
7605999|NCT01896193|26463355|P2|Overall Study|Lack of Efficacy|11
7606000|NCT01896193|26463356|P1|Overall Study|Lack of Efficacy|20
7606001|NCT01896128|26463382|P2|Overall Study|Withdrawal by Subject|3
7606002|NCT01896128|26463383|P1|Overall Study|Withdrawal by Subject|3
7606003|NCT01896050|26463425|P2|Overall Study|Death|0
7606004|NCT01896050|26463426|P1|Overall Study|Death|1
7606005|NCT01896050|26463425|P2|Overall Study|Adverse Event|2
7606006|NCT01896050|26463426|P1|Overall Study|Adverse Event|37
7606007|NCT01895777|26463503|P2|Overall Study|Non-compliance with the CTP|1
7606008|NCT01895777|26463504|P1|Overall Study|Non-compliance with the CTP|2
7606009|NCT01895777|26463503|P2|Overall Study|Other reasons|2
7606010|NCT01895777|26463504|P1|Overall Study|Other reasons|3
7606011|NCT01895777|26463503|P2|Overall Study|Not treated|0
7606012|NCT01895777|26463504|P1|Overall Study|Not treated|1
7606013|NCT01895777|26463503|P2|Overall Study|Lost to Follow-up|0
7606014|NCT01895777|26463504|P1|Overall Study|Lost to Follow-up|2
7606015|NCT01895777|26463503|P2|Overall Study|Adverse Event|2
7606016|NCT01895777|26463504|P1|Overall Study|Adverse Event|1
7606017|NCT01895608|26463560|P4|Overall Study|Withdrawal by Subject|0
7606018|NCT01895608|26463561|P3|Overall Study|Withdrawal by Subject|2
7606019|NCT01895608|26463562|P2|Overall Study|Withdrawal by Subject|0
7606020|NCT01895608|26463563|P1|Overall Study|Withdrawal by Subject|0
7606021|NCT01895608|26463560|P4|Overall Study|change in health status|0
7606022|NCT01895608|26463561|P3|Overall Study|change in health status|1
7606023|NCT01895608|26463562|P2|Overall Study|change in health status|1
7606024|NCT01895608|26463563|P1|Overall Study|change in health status|0
7606025|NCT01895543|26463593|P1|Overall Study|Other (Not fulfilling above criteria)|24
7606026|NCT01895543|26463593|P1|Overall Study|Physician Decision|2
7606027|NCT01895543|26463593|P1|Overall Study|Protocol Violation|1
7606028|NCT01895543|26463593|P1|Overall Study|Subject's substantial non-compliance|6
7606029|NCT01895543|26463593|P1|Overall Study|Adverse Event|28
7606030|NCT01895543|26463593|P1|Overall Study|Lost to Follow-up|25
7606031|NCT01895543|26463593|P1|Overall Study|Withdrawal by Subject|43
7606032|NCT01895452|26463609|P2|Overall Study|Noncompliance with study drug|1
7606033|NCT01895452|26463610|P1|Overall Study|Noncompliance with study drug|0
7606034|NCT01895452|26463609|P2|Overall Study|Underlying disease|3
7606035|NCT01895452|26463610|P1|Overall Study|Underlying disease|0
7606036|NCT01895452|26463609|P2|Overall Study|Withdrawal by Subject|14
7606037|NCT01895452|26463610|P1|Overall Study|Withdrawal by Subject|2
7606038|NCT01895452|26463609|P2|Overall Study|Pregnancy|1
7606039|NCT01895452|26463610|P1|Overall Study|Pregnancy|0
7606040|NCT01895452|26463609|P2|Overall Study|Lost to Follow-up|5
7606041|NCT01895452|26463610|P1|Overall Study|Lost to Follow-up|1
7606042|NCT01895452|26463609|P2|Overall Study|Adverse Event|4
7606043|NCT01895452|26463610|P1|Overall Study|Adverse Event|1
7606044|NCT01895361|26463623|P3|Overall Study|Reasons different from categories above|4
7606045|NCT01895361|26463624|P2|Overall Study|Reasons different from categories above|3
7606046|NCT01895361|26463625|P1|Overall Study|Reasons different from categories above|7
7606047|NCT01895361|26463623|P3|Overall Study|Lack of Efficacy|0
7606048|NCT01895361|26463624|P2|Overall Study|Lack of Efficacy|1
7606049|NCT01895361|26463625|P1|Overall Study|Lack of Efficacy|0
7606050|NCT01895361|26463623|P3|Overall Study|Withdrawal by Subject|6
7606051|NCT01895361|26463624|P2|Overall Study|Withdrawal by Subject|6
7606052|NCT01895361|26463625|P1|Overall Study|Withdrawal by Subject|7
7606053|NCT01895361|26463623|P3|Overall Study|Physician Decision|2
7606054|NCT01895361|26463624|P2|Overall Study|Physician Decision|2
7606055|NCT01895361|26463625|P1|Overall Study|Physician Decision|2
7606056|NCT01895361|26463623|P3|Overall Study|Non-compliance with study|1
7606057|NCT01895361|26463624|P2|Overall Study|Non-compliance with study|3
7606058|NCT01895361|26463625|P1|Overall Study|Non-compliance with study|1
7606059|NCT01895361|26463623|P3|Overall Study|Lost to Follow-up|6
7606060|NCT01895361|26463624|P2|Overall Study|Lost to Follow-up|4
7606061|NCT01895361|26463625|P1|Overall Study|Lost to Follow-up|4
7606062|NCT01895361|26463623|P3|Overall Study|Death|2
7606063|NCT01895361|26463624|P2|Overall Study|Death|1
7606064|NCT01895361|26463625|P1|Overall Study|Death|2
7606065|NCT01895361|26463623|P3|Overall Study|Adverse Event|3
7606066|NCT01895361|26463624|P2|Overall Study|Adverse Event|1
7606067|NCT01895361|26463625|P1|Overall Study|Adverse Event|1
7606068|NCT01895335|26463654|P1|Overall Study|Other than Specified Above|44
7606069|NCT01895335|26463654|P1|Overall Study|Included But Not treated|1
7606070|NCT01895335|26463654|P1|Overall Study|Poor Compliance to Protocol|11
7606071|NCT01895335|26463654|P1|Overall Study|Lack of Efficacy|53
7606072|NCT01895335|26463654|P1|Overall Study|Adverse Event|106
7606073|NCT01895322|26463671|P1|Overall Study|Protocol Violation|10
7606074|NCT01895322|26463671|P1|Overall Study|Withdrawal by Subject|2
7606075|NCT01895322|26463671|P1|Overall Study|Adverse Event|1
7606076|NCT01895309|26463680|P2|Overall Study|Withdrawal by Subject|18
7606077|NCT01895309|26463681|P1|Overall Study|Withdrawal by Subject|9
7606078|NCT01895309|26463680|P2|Overall Study|Physician Decision|10
7606079|NCT01895309|26463681|P1|Overall Study|Physician Decision|15
7606080|NCT01895309|26463680|P2|Overall Study|Lost to Follow-up|3
7606081|NCT01895309|26463681|P1|Overall Study|Lost to Follow-up|1
7606082|NCT01895309|26463680|P2|Overall Study|Lack of Efficacy|3
7606083|NCT01895309|26463681|P1|Overall Study|Lack of Efficacy|1
7606084|NCT01895309|26463680|P2|Overall Study|Protocol Violation|0
7606085|NCT01895309|26463681|P1|Overall Study|Protocol Violation|1
7606086|NCT01895309|26463680|P2|Overall Study|Adverse Event|17
7606087|NCT01895309|26463681|P1|Overall Study|Adverse Event|13
7606088|NCT01895270|26463695|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
7606089|NCT01895270|26463696|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
7606090|NCT01895270|26463695|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
7606091|NCT01895270|26463696|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
7606092|NCT01895270|26463695|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
7606093|NCT01895270|26463696|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
7606094|NCT01895270|26463695|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
7606095|NCT01895270|26463696|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
7606096|NCT01895270|26463695|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
7606097|NCT01895270|26463696|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
7606098|NCT01895270|26463695|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
7606099|NCT01895270|26463696|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
7606100|NCT01895270|26463695|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
7606101|NCT01895270|26463696|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
7606102|NCT01895101|26463715|P3|Overall Study|coagulation disorder|0
7606103|NCT01895101|26463716|P2|Overall Study|coagulation disorder|1
7606104|NCT01895101|26463717|P1|Overall Study|coagulation disorder|0
7606105|NCT01895101|26463715|P3|Overall Study|Death|0
7606106|NCT01895101|26463716|P2|Overall Study|Death|1
7606107|NCT01895101|26463717|P1|Overall Study|Death|0
7606108|NCT01895101|26463715|P3|Overall Study|another study, enrolled in other study|0
7606109|NCT01895101|26463716|P2|Overall Study|another study, enrolled in other study|1
7606110|NCT01895101|26463717|P1|Overall Study|another study, enrolled in other study|0
7606111|NCT01895101|26463715|P3|Overall Study|Withdrawal by Subject|2
7606112|NCT01895101|26463716|P2|Overall Study|Withdrawal by Subject|1
7606113|NCT01895101|26463717|P1|Overall Study|Withdrawal by Subject|0
7606114|NCT01895101|26463715|P3|Overall Study|OPCAB procedure|3
7606115|NCT01895101|26463716|P2|Overall Study|OPCAB procedure|1
7606116|NCT01895101|26463717|P1|Overall Study|OPCAB procedure|1
7606117|NCT01894984|26463752|P2|Overall Study|Other|175
7606118|NCT01894984|26463753|P1|Overall Study|Other|314
7606119|NCT01894919|26463782|P13|Overall Study|Lost to Follow-up|0
7606120|NCT01894919|26463783|P12|Overall Study|Lost to Follow-up|0
7606121|NCT01894919|26463784|P11|Overall Study|Lost to Follow-up|0
7606122|NCT01894919|26463785|P10|Overall Study|Lost to Follow-up|0
7606123|NCT01894919|26463786|P9|Overall Study|Lost to Follow-up|0
7606124|NCT01894919|26463787|P8|Overall Study|Lost to Follow-up|0
7606125|NCT01894919|26463788|P7|Overall Study|Lost to Follow-up|0
7606126|NCT01894919|26463789|P6|Overall Study|Lost to Follow-up|0
7606127|NCT01894919|26463790|P5|Overall Study|Lost to Follow-up|2
7606128|NCT01894919|26463791|P4|Overall Study|Lost to Follow-up|0
7606129|NCT01894919|26463792|P3|Overall Study|Lost to Follow-up|0
7606130|NCT01894919|26463793|P2|Overall Study|Lost to Follow-up|0
7606131|NCT01894919|26463794|P1|Overall Study|Lost to Follow-up|0
7606132|NCT01894919|26463782|P13|Overall Study|Other-Unspecified|0
7606133|NCT01894919|26463783|P12|Overall Study|Other-Unspecified|0
7606134|NCT01894919|26463784|P11|Overall Study|Other-Unspecified|0
7606135|NCT01894919|26463785|P10|Overall Study|Other-Unspecified|0
7606136|NCT01894919|26463786|P9|Overall Study|Other-Unspecified|0
7606137|NCT01894919|26463787|P8|Overall Study|Other-Unspecified|0
7606138|NCT01894919|26463788|P7|Overall Study|Other-Unspecified|0
7606139|NCT01894919|26463789|P6|Overall Study|Other-Unspecified|0
7606140|NCT01894919|26463790|P5|Overall Study|Other-Unspecified|0
7606141|NCT01894919|26463791|P4|Overall Study|Other-Unspecified|0
7606142|NCT01894919|26463792|P3|Overall Study|Other-Unspecified|0
7606143|NCT01894919|26463793|P2|Overall Study|Other-Unspecified|0
7606144|NCT01894919|26463794|P1|Overall Study|Other-Unspecified|1
7606145|NCT01894919|26463782|P13|Overall Study|Adverse Event|0
7606146|NCT01894919|26463783|P12|Overall Study|Adverse Event|0
7606147|NCT01894919|26463784|P11|Overall Study|Adverse Event|1
7606148|NCT01894919|26463785|P10|Overall Study|Adverse Event|0
7606149|NCT01894919|26463786|P9|Overall Study|Adverse Event|0
7606150|NCT01894919|26463787|P8|Overall Study|Adverse Event|0
7606151|NCT01894919|26463788|P7|Overall Study|Adverse Event|0
7606152|NCT01894919|26463789|P6|Overall Study|Adverse Event|0
7606153|NCT01894919|26463790|P5|Overall Study|Adverse Event|0
7606154|NCT01894919|26463791|P4|Overall Study|Adverse Event|0
7606155|NCT01894919|26463792|P3|Overall Study|Adverse Event|0
7606156|NCT01894919|26463793|P2|Overall Study|Adverse Event|0
7606157|NCT01894919|26463794|P1|Overall Study|Adverse Event|0
7606158|NCT01894919|26463782|P13|Overall Study|Withdrawal by Subject|0
7606159|NCT01894919|26463783|P12|Overall Study|Withdrawal by Subject|0
7606160|NCT01894919|26463784|P11|Overall Study|Withdrawal by Subject|1
7606161|NCT01894919|26463785|P10|Overall Study|Withdrawal by Subject|1
7606162|NCT01894919|26463786|P9|Overall Study|Withdrawal by Subject|0
7606163|NCT01894919|26463787|P8|Overall Study|Withdrawal by Subject|0
7606164|NCT01894919|26463788|P7|Overall Study|Withdrawal by Subject|0
7606165|NCT01894919|26463789|P6|Overall Study|Withdrawal by Subject|0
7606166|NCT01894919|26463790|P5|Overall Study|Withdrawal by Subject|1
7606167|NCT01894919|26463791|P4|Overall Study|Withdrawal by Subject|0
7606168|NCT01894919|26463792|P3|Overall Study|Withdrawal by Subject|0
7606169|NCT01894919|26463793|P2|Overall Study|Withdrawal by Subject|0
7606170|NCT01894919|26463794|P1|Overall Study|Withdrawal by Subject|1
7606171|NCT01894841|26463949|P2|Overall Study|Lost to Follow-up|3
7606172|NCT01894841|26463950|P1|Overall Study|Lost to Follow-up|7
7606173|NCT01894841|26463949|P2|Overall Study|Withdrawn by investigator|2
7606174|NCT01894841|26463950|P1|Overall Study|Withdrawn by investigator|2
7606175|NCT01894841|26463949|P2|Overall Study|Withdrawal by Subject|4
7606176|NCT01894841|26463950|P1|Overall Study|Withdrawal by Subject|9
7606177|NCT01894776|26463966|P1|Overall Study|Withdrawal by Subject|1
7606178|NCT01894620|26463980|P2|Overall Study|Withdrawal by Subject|1
7606179|NCT01894620|26463981|P1|Overall Study|Withdrawal by Subject|0
7606180|NCT01894607|26463989|P1|Overall Study|Ineligible|1
7606181|NCT01894581|26463996|P2|Overall Study|Screen Failure|4
7606182|NCT01894581|26463997|P1|Overall Study|Screen Failure|3
7606183|NCT01894581|26463996|P2|Overall Study|Withdrawal by Subject|3
7606184|NCT01894581|26463997|P1|Overall Study|Withdrawal by Subject|2
7606185|NCT01894568|26464005|P2|Overall Study|Lost to Follow-up|1
7606186|NCT01894568|26464006|P1|Overall Study|Lost to Follow-up|0
7606187|NCT01894568|26464005|P2|Overall Study|Physician Decision|0
7606188|NCT01894568|26464006|P1|Overall Study|Physician Decision|1
7606189|NCT01894568|26464005|P2|Overall Study|Withdrawal by Subject|5
7606190|NCT01894568|26464006|P1|Overall Study|Withdrawal by Subject|5
7606191|NCT01894568|26464005|P2|Overall Study|Protocol required discontinuation|1
7606192|NCT01894568|26464006|P1|Overall Study|Protocol required discontinuation|2
7606193|NCT01894568|26464005|P2|Overall Study|Adverse Event|3
7606194|NCT01894568|26464006|P1|Overall Study|Adverse Event|2
7606195|NCT01894516|26464054|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7606196|NCT01894516|26464055|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7606197|NCT01894516|26464056|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7606198|NCT01894516|26464057|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7606199|NCT01894516|26464054|P4|Period 2 (Week 13 to Week 24)|Adverse Event|1
7606200|NCT01894516|26464055|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
7606201|NCT01894516|26464056|P2|Period 2 (Week 13 to Week 24)|Adverse Event|2
7606202|NCT01894516|26464057|P1|Period 2 (Week 13 to Week 24)|Adverse Event|0
7606203|NCT01894516|26464054|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7606204|NCT01894516|26464055|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
7606205|NCT01894516|26464056|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7606206|NCT01894516|26464057|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7606207|NCT01894516|26464054|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
7606208|NCT01894516|26464055|P3|Period 1 (Baseline up to Week 12)|Adverse Event|0
7606209|NCT01894516|26464056|P2|Period 1 (Baseline up to Week 12)|Adverse Event|0
7606210|NCT01894516|26464057|P1|Period 1 (Baseline up to Week 12)|Adverse Event|2
7606211|NCT01894516|26464054|P4|Period 1 (Baseline up to Week 12)|Treatment failure|0
7606212|NCT01894516|26464055|P3|Period 1 (Baseline up to Week 12)|Treatment failure|1
7606213|NCT01894516|26464056|P2|Period 1 (Baseline up to Week 12)|Treatment failure|0
7606214|NCT01894516|26464057|P1|Period 1 (Baseline up to Week 12)|Treatment failure|0
7606215|NCT01894516|26464054|P4|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7606216|NCT01894516|26464055|P3|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7606217|NCT01894516|26464056|P2|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7606218|NCT01894516|26464057|P1|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7606219|NCT01894516|26464054|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606220|NCT01894516|26464055|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606221|NCT01894516|26464056|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606313|NCT01893411|26464441|P1|Overall Study|Physician Decision|1
7606222|NCT01894516|26464057|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
7606223|NCT01894516|26464054|P4|Period 1 (Baseline up to Week 12)|Other|0
7606224|NCT01894516|26464055|P3|Period 1 (Baseline up to Week 12)|Other|1
7606225|NCT01894516|26464056|P2|Period 1 (Baseline up to Week 12)|Other|1
7606226|NCT01894516|26464057|P1|Period 1 (Baseline up to Week 12)|Other|0
7606227|NCT01894477|26464113|P2|Overall Study|protocol changed due SC changed to cord|1
7606228|NCT01894477|26464114|P1|Overall Study|protocol changed due SC changed to cord|0
7606229|NCT01894477|26464113|P2|Overall Study|Protocol Violation|1
7606230|NCT01894477|26464114|P1|Overall Study|Protocol Violation|0
7606231|NCT01894256|26464125|P3|Part B|Lack of Efficacy|13
7606232|NCT01894256|26464126|P2|Part B|Lack of Efficacy|12
7606233|NCT01894256|26464127|P1|Part B|Lack of Efficacy|15
7606234|NCT01894256|26464125|P3|Part B|Withdrawal by Subject|0
7606235|NCT01894256|26464126|P2|Part B|Withdrawal by Subject|1
7606236|NCT01894256|26464127|P1|Part B|Withdrawal by Subject|0
7606237|NCT01894256|26464125|P3|Part B|Death|1
7606238|NCT01894256|26464126|P2|Part B|Death|1
7606239|NCT01894256|26464127|P1|Part B|Death|0
7606240|NCT01894256|26464125|P3|Part A|Adverse Event|0
7606241|NCT01894256|26464126|P2|Part A|Adverse Event|1
7606242|NCT01894256|26464127|P1|Part A|Adverse Event|0
7606243|NCT01894243|26464174|P3|Overall Study|Other|0
7606244|NCT01894243|26464175|P2|Overall Study|Other|0
7606245|NCT01894243|26464176|P1|Overall Study|Other|1
7606246|NCT01894243|26464174|P3|Overall Study|Subject decision|0
7606247|NCT01894243|26464175|P2|Overall Study|Subject decision|0
7606248|NCT01894243|26464176|P1|Overall Study|Subject decision|1
7606249|NCT01894243|26464174|P3|Overall Study|Condition under investigation worsened|2
7606250|NCT01894243|26464175|P2|Overall Study|Condition under investigation worsened|6
7606251|NCT01894243|26464176|P1|Overall Study|Condition under investigation worsened|8
7606252|NCT01894243|26464174|P3|Overall Study|Lack of Efficacy|1
7606253|NCT01894243|26464175|P2|Overall Study|Lack of Efficacy|3
7606254|NCT01894243|26464176|P1|Overall Study|Lack of Efficacy|3
7606255|NCT01894243|26464174|P3|Overall Study|Death|3
7606256|NCT01894243|26464175|P2|Overall Study|Death|0
7606257|NCT01894243|26464176|P1|Overall Study|Death|0
7606258|NCT01894243|26464174|P3|Overall Study|Adverse Event|2
7606259|NCT01894243|26464175|P2|Overall Study|Adverse Event|1
7606260|NCT01894243|26464176|P1|Overall Study|Adverse Event|0
7606261|NCT01894230|26464215|P2|Overall Study|Death|0
7606262|NCT01894230|26464216|P1|Overall Study|Death|1
7606263|NCT01894230|26464215|P2|Overall Study|Non-adherent|1
7606264|NCT01894230|26464216|P1|Overall Study|Non-adherent|0
7606265|NCT01894230|26464215|P2|Overall Study|Withdrawal by Subject|4
7606266|NCT01894230|26464216|P1|Overall Study|Withdrawal by Subject|4
7606267|NCT01894230|26464215|P2|Overall Study|Lost to Follow-up|2
7606268|NCT01894230|26464216|P1|Overall Study|Lost to Follow-up|2
7606269|NCT01894152|26464251|P1|Overall Study|No DMR and no Stent thrombosis|151
7606270|NCT01894100|26464294|P2|Overall Study|Withdrawal by Subject|0
7606271|NCT01894100|26464295|P1|Overall Study|Withdrawal by Subject|3
7606272|NCT01894100|26464294|P2|Overall Study|Lost to Follow-up|1
7606273|NCT01894100|26464295|P1|Overall Study|Lost to Follow-up|0
7606274|NCT01894022|26464320|P2|Overall Study|Study Closed/terminated|10
7606275|NCT01894022|26464321|P1|Overall Study|Study Closed/terminated|7
7606276|NCT01894022|26464320|P2|Overall Study|Adverse Event, non-fatal|0
7606277|NCT01894022|26464321|P1|Overall Study|Adverse Event, non-fatal|1
7606278|NCT01894022|26464320|P2|Overall Study|Death|0
7606279|NCT01894022|26464321|P1|Overall Study|Death|1
7606280|NCT01893905|26464390|P2|Overall Study|Other reason|3
7606281|NCT01893905|26464391|P1|Overall Study|Other reason|1
7606282|NCT01893905|26464390|P2|Overall Study|Lack of adherence to treatment|0
7606283|NCT01893905|26464391|P1|Overall Study|Lack of adherence to treatment|2
7606284|NCT01893905|26464390|P2|Overall Study|Protocol Violation|1
7606285|NCT01893905|26464391|P1|Overall Study|Protocol Violation|6
7606286|NCT01893905|26464390|P2|Overall Study|Lost to Follow-up|0
7606287|NCT01893905|26464391|P1|Overall Study|Lost to Follow-up|1
7606288|NCT01893905|26464390|P2|Overall Study|Lack of Efficacy|7
7606289|NCT01893905|26464391|P1|Overall Study|Lack of Efficacy|5
7606290|NCT01893905|26464390|P2|Overall Study|Adverse Event|3
7606291|NCT01893905|26464391|P1|Overall Study|Adverse Event|9
7606292|NCT01893905|26464390|P2|Overall Study|Withdrawal by Subject|0
7606293|NCT01893905|26464391|P1|Overall Study|Withdrawal by Subject|1
7606294|NCT01893827|26464408|P2|Overall Study|Lost to Follow-up|26
7606295|NCT01893827|26464409|P1|Overall Study|Lost to Follow-up|19
7606296|NCT01893411|26464439|P3|Overall Study|Lost to Follow-up|1
7606297|NCT01893411|26464440|P2|Overall Study|Lost to Follow-up|0
7606298|NCT01893411|26464441|P1|Overall Study|Lost to Follow-up|2
7606299|NCT01893411|26464439|P3|Overall Study|Withdrawal by Subject|3
7606300|NCT01893411|26464440|P2|Overall Study|Withdrawal by Subject|4
7606301|NCT01893411|26464441|P1|Overall Study|Withdrawal by Subject|7
7606302|NCT01893411|26464439|P3|Overall Study|Adverse Event|0
7606303|NCT01893411|26464440|P2|Overall Study|Adverse Event|0
7606304|NCT01893411|26464441|P1|Overall Study|Adverse Event|1
7606305|NCT01893411|26464439|P3|Overall Study|Other|3
7606306|NCT01893411|26464440|P2|Overall Study|Other|1
7606307|NCT01893411|26464441|P1|Overall Study|Other|3
7606308|NCT01893411|26464439|P3|Overall Study|Lack of Efficacy|0
7606309|NCT01893411|26464440|P2|Overall Study|Lack of Efficacy|1
7606310|NCT01893411|26464441|P1|Overall Study|Lack of Efficacy|2
7606311|NCT01893411|26464439|P3|Overall Study|Physician Decision|2
7606312|NCT01893411|26464440|P2|Overall Study|Physician Decision|1
7606314|NCT01893411|26464439|P3|Overall Study|Protocol Violation|0
7606315|NCT01893411|26464440|P2|Overall Study|Protocol Violation|0
7606316|NCT01893411|26464441|P1|Overall Study|Protocol Violation|1
7606317|NCT01893346|26464538|P4|Overall Study|Withdrawal by Subject|0
7606318|NCT01893346|26464539|P3|Overall Study|Withdrawal by Subject|0
7606319|NCT01893346|26464540|P2|Overall Study|Withdrawal by Subject|0
7606320|NCT01893346|26464541|P1|Overall Study|Withdrawal by Subject|2
7606321|NCT01893346|26464538|P4|Overall Study|Protocol Violation|0
7606322|NCT01893346|26464539|P3|Overall Study|Protocol Violation|0
7606323|NCT01893346|26464540|P2|Overall Study|Protocol Violation|0
7606324|NCT01893346|26464541|P1|Overall Study|Protocol Violation|1
7606325|NCT01893346|26464538|P4|Overall Study|Lost to Follow-up|0
7606326|NCT01893346|26464539|P3|Overall Study|Lost to Follow-up|0
7606327|NCT01893346|26464540|P2|Overall Study|Lost to Follow-up|1
7606328|NCT01893346|26464541|P1|Overall Study|Lost to Follow-up|0
7606329|NCT01893281|26464555|P1|Overall Study|Withdrawal by Subject|1
7606330|NCT01893281|26464555|P1|Overall Study|Protocol Violation|1
7606331|NCT01893281|26464555|P1|Overall Study|Adverse Event|1
7606332|NCT01893203|26464562|P1|Overall Study|Withdrawal by Subject|1
7606333|NCT01892722|26464586|P2|Overall Study|Withdrawal by Subject|5
7606334|NCT01892722|26464587|P1|Overall Study|Withdrawal by Subject|3
7606335|NCT01892722|26464586|P2|Overall Study|Lack of Efficacy|7
7606336|NCT01892722|26464587|P1|Overall Study|Lack of Efficacy|0
7606337|NCT01892722|26464586|P2|Overall Study|Adverse Event|2
7606338|NCT01892722|26464587|P1|Overall Study|Adverse Event|3
7606339|NCT01892722|26464586|P2|Overall Study|Physician Decision|2
7606340|NCT01892722|26464587|P1|Overall Study|Physician Decision|1
7606341|NCT01892722|26464586|P2|Overall Study|Patient/guardian decision|2
7606342|NCT01892722|26464587|P1|Overall Study|Patient/guardian decision|0
7606343|NCT01892722|26464586|P2|Overall Study|Administrative problems|1
7606344|NCT01892722|26464587|P1|Overall Study|Administrative problems|0
7606345|NCT01892722|26464586|P2|Overall Study|Protocol deviation|1
7606346|NCT01892722|26464587|P1|Overall Study|Protocol deviation|0
7606347|NCT01892657|26464603|P1|Overall Study|Protocol Violation|12
7606348|NCT01892657|26464603|P1|Overall Study|Withdrawal by Subject|6
7606349|NCT01892540|26464622|P3|Overall Study|Did not fit in scanner|1
7606350|NCT01892540|26464623|P2|Overall Study|Did not fit in scanner|0
7606351|NCT01892540|26464624|P1|Overall Study|Did not fit in scanner|0
7606352|NCT01892540|26464622|P3|Overall Study|Did not complete PET/MRI|2
7606353|NCT01892540|26464623|P2|Overall Study|Did not complete PET/MRI|0
7606354|NCT01892540|26464624|P1|Overall Study|Did not complete PET/MRI|0
7606355|NCT01892501|26464641|P1|Overall Study|Non-contributory histological result|12
7606356|NCT01892501|26464641|P1|Overall Study|Radiological monitoring not carried out|5
7606357|NCT01892501|26464641|P1|Overall Study|Puncture not carried out|9
7606358|NCT01892501|26464641|P1|Overall Study|Protocol Violation|2
7606359|NCT01892436|26464653|P4|Overall Study|Adverse Event|3
7606360|NCT01892436|26464654|P3|Overall Study|Adverse Event|2
7606361|NCT01892436|26464655|P2|Overall Study|Adverse Event|6
7606362|NCT01892436|26464656|P1|Overall Study|Adverse Event|7
7606363|NCT01892436|26464653|P4|Overall Study|non-compliance with treatment|0
7606364|NCT01892436|26464654|P3|Overall Study|non-compliance with treatment|0
7606365|NCT01892436|26464655|P2|Overall Study|non-compliance with treatment|0
7606366|NCT01892436|26464656|P1|Overall Study|non-compliance with treatment|1
7606367|NCT01892436|26464653|P4|Overall Study|Lost to Follow-up|3
7606368|NCT01892436|26464654|P3|Overall Study|Lost to Follow-up|1
7606369|NCT01892436|26464655|P2|Overall Study|Lost to Follow-up|1
7606370|NCT01892436|26464656|P1|Overall Study|Lost to Follow-up|1
7606371|NCT01892436|26464653|P4|Overall Study|Lack of Efficacy|2
7606372|NCT01892436|26464654|P3|Overall Study|Lack of Efficacy|2
7606373|NCT01892436|26464655|P2|Overall Study|Lack of Efficacy|2
7606374|NCT01892436|26464656|P1|Overall Study|Lack of Efficacy|1
7606375|NCT01892436|26464653|P4|Overall Study|Technical problems|1
7606376|NCT01892436|26464654|P3|Overall Study|Technical problems|1
7606377|NCT01892436|26464655|P2|Overall Study|Technical problems|1
7606378|NCT01892436|26464656|P1|Overall Study|Technical problems|2
7606379|NCT01892436|26464653|P4|Overall Study|Pregnancy|0
7606380|NCT01892436|26464654|P3|Overall Study|Pregnancy|1
7606381|NCT01892436|26464655|P2|Overall Study|Pregnancy|2
7606382|NCT01892436|26464656|P1|Overall Study|Pregnancy|0
7606383|NCT01892436|26464653|P4|Overall Study|Physician Decision|1
7606384|NCT01892436|26464654|P3|Overall Study|Physician Decision|0
7606385|NCT01892436|26464655|P2|Overall Study|Physician Decision|1
7606386|NCT01892436|26464656|P1|Overall Study|Physician Decision|2
7606387|NCT01892436|26464653|P4|Overall Study|Death|0
7606388|NCT01892436|26464654|P3|Overall Study|Death|0
7606389|NCT01892436|26464655|P2|Overall Study|Death|1
7606390|NCT01892436|26464656|P1|Overall Study|Death|1
7606391|NCT01892436|26464653|P4|Overall Study|Withdrawal by Subject|4
7606392|NCT01892436|26464654|P3|Overall Study|Withdrawal by Subject|4
7606393|NCT01892436|26464655|P2|Overall Study|Withdrawal by Subject|15
7606394|NCT01892436|26464656|P1|Overall Study|Withdrawal by Subject|8
7606395|NCT01892345|26464696|P2|Overall Study|Withdrawal by Subject|1
7606396|NCT01892345|26464697|P1|Overall Study|Withdrawal by Subject|12
7606397|NCT01892345|26464696|P2|Overall Study|Lost to Follow-up|0
7606398|NCT01892345|26464697|P1|Overall Study|Lost to Follow-up|3
7606399|NCT01892345|26464696|P2|Overall Study|Death|0
7606400|NCT01892345|26464697|P1|Overall Study|Death|1
7606401|NCT01892345|26464696|P2|Overall Study|Adverse Event|2
7606402|NCT01892345|26464697|P1|Overall Study|Adverse Event|0
7606403|NCT01892293|26464738|P1|Overall Study|Apheresed but not treated|4
7606404|NCT01892189|26464782|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606405|NCT01892189|26464783|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606406|NCT01892189|26464784|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606407|NCT01892189|26464785|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
7606408|NCT01892189|26464786|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606409|NCT01892189|26464787|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606410|NCT01892189|26464788|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606411|NCT01892189|26464789|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606412|NCT01892189|26464790|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7606413|NCT01892189|26464782|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7606414|NCT01892189|26464783|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7606415|NCT01892189|26464784|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7606416|NCT01892189|26464785|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7606417|NCT01892189|26464786|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7606418|NCT01892189|26464787|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7606419|NCT01892189|26464788|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
7606420|NCT01892189|26464789|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7606421|NCT01892189|26464790|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7606422|NCT01892189|26464782|P9|Washout Period 1 (7 Days)|Adverse Event|1
7606423|NCT01892189|26464783|P8|Washout Period 1 (7 Days)|Adverse Event|0
7606424|NCT01892189|26464784|P7|Washout Period 1 (7 Days)|Adverse Event|0
7606425|NCT01892189|26464785|P6|Washout Period 1 (7 Days)|Adverse Event|0
7606426|NCT01892189|26464786|P5|Washout Period 1 (7 Days)|Adverse Event|0
7606427|NCT01892189|26464787|P4|Washout Period 1 (7 Days)|Adverse Event|0
7606428|NCT01892189|26464788|P3|Washout Period 1 (7 Days)|Adverse Event|0
7606429|NCT01892189|26464789|P2|Washout Period 1 (7 Days)|Adverse Event|0
7606430|NCT01892189|26464790|P1|Washout Period 1 (7 Days)|Adverse Event|0
7606431|NCT01892163|26464832|P2|Overall Study|Lost to Follow-up|0
7606432|NCT01892163|26464833|P1|Overall Study|Lost to Follow-up|1
7606433|NCT01892163|26464832|P2|Overall Study|Death|1
7606434|NCT01892163|26464833|P1|Overall Study|Death|1
7606435|NCT01892020|26464845|P2|Period 2|Protocol Violation|0
7606436|NCT01892020|26464846|P1|Period 2|Protocol Violation|1
7606437|NCT01892020|26464845|P2|Period 1|Unclassified|1
7606438|NCT01892020|26464846|P1|Period 1|Unclassified|0
7606439|NCT01892020|26464845|P2|Period 1|Protocol Violation|4
7606440|NCT01892020|26464846|P1|Period 1|Protocol Violation|2
7606441|NCT01892020|26464845|P2|Period 1|Adverse Event|1
7606442|NCT01892020|26464846|P1|Period 1|Adverse Event|1
7606443|NCT01891890|26464904|P3|Overall Study|Study ended before endpoint reached|6
7606444|NCT01891890|26464905|P2|Overall Study|Study ended before endpoint reached|3
7606445|NCT01891890|26464906|P1|Overall Study|Study ended before endpoint reached|7
7606446|NCT01891890|26464904|P3|Overall Study|Lost to Follow-up|1
7606447|NCT01891890|26464905|P2|Overall Study|Lost to Follow-up|0
7606448|NCT01891890|26464906|P1|Overall Study|Lost to Follow-up|0
7606449|NCT01891864|26464949|P6|Extension Period|Lost to Follow-up|0
7606450|NCT01891864|26464950|P5|Extension Period|Lost to Follow-up|0
7606451|NCT01891864|26464951|P4|Extension Period|Lost to Follow-up|0
7606452|NCT01891864|26464952|P3|Extension Period|Lost to Follow-up|2
7606453|NCT01891864|26464953|P2|Extension Period|Lost to Follow-up|0
7606454|NCT01891864|26464954|P1|Extension Period|Lost to Follow-up|0
7606455|NCT01891864|26464949|P6|Extension Period|Withdrawal by Subject|0
7606456|NCT01891864|26464950|P5|Extension Period|Withdrawal by Subject|4
7606457|NCT01891864|26464951|P4|Extension Period|Withdrawal by Subject|2
7606458|NCT01891864|26464952|P3|Extension Period|Withdrawal by Subject|1
7606459|NCT01891864|26464953|P2|Extension Period|Withdrawal by Subject|0
7606460|NCT01891864|26464954|P1|Extension Period|Withdrawal by Subject|0
7606461|NCT01891864|26464949|P6|Extension Period|Adverse Event|0
7606462|NCT01891864|26464950|P5|Extension Period|Adverse Event|2
7606463|NCT01891864|26464951|P4|Extension Period|Adverse Event|2
7606464|NCT01891864|26464952|P3|Extension Period|Adverse Event|4
7606465|NCT01891864|26464953|P2|Extension Period|Adverse Event|0
7606466|NCT01891864|26464954|P1|Extension Period|Adverse Event|0
7606467|NCT01891864|26464949|P6|Extension Period|Pregnancy|0
7606468|NCT01891864|26464950|P5|Extension Period|Pregnancy|0
7606469|NCT01891864|26464951|P4|Extension Period|Pregnancy|0
7606470|NCT01891864|26464952|P3|Extension Period|Pregnancy|1
7606471|NCT01891864|26464953|P2|Extension Period|Pregnancy|0
7606472|NCT01891864|26464954|P1|Extension Period|Pregnancy|0
7606473|NCT01891864|26464949|P6|Extension Period|Lack of Efficacy|0
7606474|NCT01891864|26464950|P5|Extension Period|Lack of Efficacy|1
7606475|NCT01891864|26464951|P4|Extension Period|Lack of Efficacy|1
7606476|NCT01891864|26464952|P3|Extension Period|Lack of Efficacy|0
7606477|NCT01891864|26464953|P2|Extension Period|Lack of Efficacy|0
7606478|NCT01891864|26464954|P1|Extension Period|Lack of Efficacy|0
7606479|NCT01891864|26464949|P6|Treatment Period 2|Withdrawal by Subject|1
7606480|NCT01891864|26464950|P5|Treatment Period 2|Withdrawal by Subject|1
7606481|NCT01891864|26464951|P4|Treatment Period 2|Withdrawal by Subject|4
7606482|NCT01891864|26464952|P3|Treatment Period 2|Withdrawal by Subject|3
7606483|NCT01891864|26464953|P2|Treatment Period 2|Withdrawal by Subject|0
7606484|NCT01891864|26464954|P1|Treatment Period 2|Withdrawal by Subject|0
7606485|NCT01891864|26464949|P6|Treatment Period 2|Termination of Site|0
7606486|NCT01891864|26464950|P5|Treatment Period 2|Termination of Site|2
7606487|NCT01891864|26464951|P4|Treatment Period 2|Termination of Site|0
7606488|NCT01891864|26464952|P3|Treatment Period 2|Termination of Site|0
7606489|NCT01891864|26464953|P2|Treatment Period 2|Termination of Site|0
7606490|NCT01891864|26464954|P1|Treatment Period 2|Termination of Site|0
7606491|NCT01891864|26464949|P6|Treatment Period 2|Adverse Event|4
7606492|NCT01891864|26464950|P5|Treatment Period 2|Adverse Event|0
7606493|NCT01891864|26464951|P4|Treatment Period 2|Adverse Event|2
7606494|NCT01891864|26464952|P3|Treatment Period 2|Adverse Event|1
7606495|NCT01891864|26464953|P2|Treatment Period 2|Adverse Event|0
7606496|NCT01891864|26464954|P1|Treatment Period 2|Adverse Event|0
7606497|NCT01891864|26464949|P6|Treatment Period 2|Lack of Efficacy|0
7606498|NCT01891864|26464950|P5|Treatment Period 2|Lack of Efficacy|1
7606499|NCT01891864|26464951|P4|Treatment Period 2|Lack of Efficacy|0
7606500|NCT01891864|26464952|P3|Treatment Period 2|Lack of Efficacy|1
7606501|NCT01891864|26464953|P2|Treatment Period 2|Lack of Efficacy|0
7606502|NCT01891864|26464954|P1|Treatment Period 2|Lack of Efficacy|0
7606503|NCT01891864|26464949|P6|Treatment Period 2|Site Termination|0
7606504|NCT01891864|26464950|P5|Treatment Period 2|Site Termination|0
7606505|NCT01891864|26464951|P4|Treatment Period 2|Site Termination|2
7606506|NCT01891864|26464952|P3|Treatment Period 2|Site Termination|1
7606507|NCT01891864|26464953|P2|Treatment Period 2|Site Termination|0
7606508|NCT01891864|26464954|P1|Treatment Period 2|Site Termination|0
7606509|NCT01891864|26464949|P6|Treatment Period 2|Physician Decision|0
7606510|NCT01891864|26464950|P5|Treatment Period 2|Physician Decision|0
7606511|NCT01891864|26464951|P4|Treatment Period 2|Physician Decision|0
7606512|NCT01891864|26464952|P3|Treatment Period 2|Physician Decision|1
7606513|NCT01891864|26464953|P2|Treatment Period 2|Physician Decision|0
7606514|NCT01891864|26464954|P1|Treatment Period 2|Physician Decision|0
7606515|NCT01891864|26464949|P6|Treatment Period 2|Protocol Violation|0
7606516|NCT01891864|26464950|P5|Treatment Period 2|Protocol Violation|0
7606517|NCT01891864|26464951|P4|Treatment Period 2|Protocol Violation|1
7606518|NCT01891864|26464952|P3|Treatment Period 2|Protocol Violation|0
7606519|NCT01891864|26464953|P2|Treatment Period 2|Protocol Violation|0
7606520|NCT01891864|26464954|P1|Treatment Period 2|Protocol Violation|0
7606521|NCT01891864|26464949|P6|Treatment Period 1|Lost to Follow-up|0
7606522|NCT01891864|26464950|P5|Treatment Period 1|Lost to Follow-up|0
7606523|NCT01891864|26464951|P4|Treatment Period 1|Lost to Follow-up|0
7606524|NCT01891864|26464952|P3|Treatment Period 1|Lost to Follow-up|0
7606525|NCT01891864|26464953|P2|Treatment Period 1|Lost to Follow-up|0
7606526|NCT01891864|26464954|P1|Treatment Period 1|Lost to Follow-up|1
7606527|NCT01891864|26464949|P6|Treatment Period 1|Withdrawal by Subject|0
7606528|NCT01891864|26464950|P5|Treatment Period 1|Withdrawal by Subject|0
7606529|NCT01891864|26464951|P4|Treatment Period 1|Withdrawal by Subject|0
7606530|NCT01891864|26464952|P3|Treatment Period 1|Withdrawal by Subject|0
7606531|NCT01891864|26464953|P2|Treatment Period 1|Withdrawal by Subject|5
7606532|NCT01891864|26464954|P1|Treatment Period 1|Withdrawal by Subject|2
7606533|NCT01891864|26464949|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7606534|NCT01891864|26464950|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7606535|NCT01891864|26464951|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7606536|NCT01891864|26464952|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7606537|NCT01891864|26464953|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7606538|NCT01891864|26464954|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7606539|NCT01891864|26464949|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
7606540|NCT01891864|26464950|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
7606541|NCT01891864|26464951|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
7606542|NCT01891864|26464952|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
7606543|NCT01891864|26464953|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
7606544|NCT01891864|26464954|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
7606545|NCT01891864|26464949|P6|Treatment Period 1|Physician Decision|0
7606546|NCT01891864|26464950|P5|Treatment Period 1|Physician Decision|0
7606547|NCT01891864|26464951|P4|Treatment Period 1|Physician Decision|0
7606548|NCT01891864|26464952|P3|Treatment Period 1|Physician Decision|0
7606549|NCT01891864|26464953|P2|Treatment Period 1|Physician Decision|1
7606550|NCT01891864|26464954|P1|Treatment Period 1|Physician Decision|0
7606551|NCT01891864|26464949|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7606552|NCT01891864|26464950|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7606553|NCT01891864|26464951|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7606554|NCT01891864|26464952|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7606555|NCT01891864|26464953|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7606556|NCT01891864|26464954|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7606557|NCT01891721|26464990|P3|Overall Study|Lost to Follow-up|1
7606558|NCT01891721|26464991|P2|Overall Study|Lost to Follow-up|5
7606559|NCT01891721|26464992|P1|Overall Study|Lost to Follow-up|10
7606560|NCT01891669|26465016|P10|Overall Study|Other|0
7606561|NCT01891669|26465017|P9|Overall Study|Other|0
7606562|NCT01891669|26465018|P8|Overall Study|Other|1
7606563|NCT01891669|26465019|P7|Overall Study|Other|0
7606564|NCT01891669|26465020|P6|Overall Study|Other|0
7606565|NCT01891669|26465021|P5|Overall Study|Other|0
7606566|NCT01891669|26465022|P4|Overall Study|Other|0
7606567|NCT01891669|26465023|P3|Overall Study|Other|0
7606568|NCT01891669|26465024|P2|Overall Study|Other|0
7606569|NCT01891669|26465025|P1|Overall Study|Other|1
7606570|NCT01891669|26465016|P10|Overall Study|Withdrawal by Subject|1
7606571|NCT01891669|26465017|P9|Overall Study|Withdrawal by Subject|1
7606572|NCT01891669|26465018|P8|Overall Study|Withdrawal by Subject|2
7606573|NCT01891669|26465019|P7|Overall Study|Withdrawal by Subject|1
7606574|NCT01891669|26465020|P6|Overall Study|Withdrawal by Subject|0
7606575|NCT01891669|26465021|P5|Overall Study|Withdrawal by Subject|0
7606576|NCT01891669|26465022|P4|Overall Study|Withdrawal by Subject|0
7606577|NCT01891669|26465023|P3|Overall Study|Withdrawal by Subject|0
7606578|NCT01891669|26465024|P2|Overall Study|Withdrawal by Subject|1
7606579|NCT01891669|26465025|P1|Overall Study|Withdrawal by Subject|1
7606580|NCT01891669|26465016|P10|Overall Study|Death|1
7606581|NCT01891669|26465017|P9|Overall Study|Death|0
7606582|NCT01891669|26465018|P8|Overall Study|Death|1
7606583|NCT01891669|26465019|P7|Overall Study|Death|0
7606584|NCT01891669|26465020|P6|Overall Study|Death|0
7606585|NCT01891669|26465021|P5|Overall Study|Death|0
7606586|NCT01891669|26465022|P4|Overall Study|Death|0
7606587|NCT01891669|26465023|P3|Overall Study|Death|0
7606588|NCT01891669|26465024|P2|Overall Study|Death|0
7606589|NCT01891669|26465025|P1|Overall Study|Death|0
7606590|NCT01891643|26465178|P2|Overall Study|Participant request to discontinue|0
7606591|NCT01891643|26465179|P1|Overall Study|Participant request to discontinue|1
7606592|NCT01891643|26465178|P2|Overall Study|Poor/Non-compliance|1
7606593|NCT01891643|26465179|P1|Overall Study|Poor/Non-compliance|0
7606594|NCT01891643|26465178|P2|Overall Study|Maximum Clinical Benefit|1
7606595|NCT01891643|26465179|P1|Overall Study|Maximum Clinical Benefit|0
7606596|NCT01891643|26465178|P2|Overall Study|Study Drug Toxicity|0
7606597|NCT01891643|26465179|P1|Overall Study|Study Drug Toxicity|3
7606598|NCT01891643|26465178|P2|Overall Study|Disease Progression|3
7606599|NCT01891643|26465179|P1|Overall Study|Disease Progression|4
7606600|NCT01891643|26465178|P2|Overall Study|Adverse event unrelated to study drug|5
7606601|NCT01891643|26465179|P1|Overall Study|Adverse event unrelated to study drug|2
7606602|NCT01891357|26465197|P1|Overall Study|Protocol Violation|3
7606603|NCT01891344|26465208|P8|Overall Study|Ongoing|0
7606604|NCT01891344|26465209|P7|Overall Study|Ongoing|0
7606605|NCT01891344|26465210|P6|Overall Study|Ongoing|1
7606606|NCT01891344|26465211|P5|Overall Study|Ongoing|4
7606607|NCT01891344|26465212|P4|Overall Study|Ongoing|1
7606608|NCT01891344|26465213|P3|Overall Study|Ongoing|0
7606609|NCT01891344|26465214|P2|Overall Study|Ongoing|2
7606610|NCT01891344|26465215|P1|Overall Study|Ongoing|6
7606611|NCT01890967|26465297|P6|Overall Study|Withdrawal by Subject|1
7606612|NCT01890967|26465298|P5|Overall Study|Withdrawal by Subject|3
7606613|NCT01890967|26465299|P4|Overall Study|Withdrawal by Subject|3
7606614|NCT01890967|26465300|P3|Overall Study|Withdrawal by Subject|2
7606615|NCT01890967|26465301|P2|Overall Study|Withdrawal by Subject|4
7606616|NCT01890967|26465302|P1|Overall Study|Withdrawal by Subject|3
7606617|NCT01890967|26465297|P6|Overall Study|Sponsor Decision|3
7606618|NCT01890967|26465298|P5|Overall Study|Sponsor Decision|2
7606619|NCT01890967|26465299|P4|Overall Study|Sponsor Decision|3
7606620|NCT01890967|26465300|P3|Overall Study|Sponsor Decision|1
7606621|NCT01890967|26465301|P2|Overall Study|Sponsor Decision|0
7606622|NCT01890967|26465302|P1|Overall Study|Sponsor Decision|2
7606623|NCT01890967|26465297|P6|Overall Study|Protocol Violation|1
7606624|NCT01890967|26465298|P5|Overall Study|Protocol Violation|4
7606625|NCT01890967|26465299|P4|Overall Study|Protocol Violation|2
7606626|NCT01890967|26465300|P3|Overall Study|Protocol Violation|3
7606627|NCT01890967|26465301|P2|Overall Study|Protocol Violation|3
7606628|NCT01890967|26465302|P1|Overall Study|Protocol Violation|0
7606629|NCT01890967|26465297|P6|Overall Study|Lost to Follow-up|1
7606630|NCT01890967|26465298|P5|Overall Study|Lost to Follow-up|0
7606631|NCT01890967|26465299|P4|Overall Study|Lost to Follow-up|1
7606632|NCT01890967|26465300|P3|Overall Study|Lost to Follow-up|1
7606633|NCT01890967|26465301|P2|Overall Study|Lost to Follow-up|1
7606634|NCT01890967|26465302|P1|Overall Study|Lost to Follow-up|1
7606635|NCT01890967|26465297|P6|Overall Study|Death|0
7606636|NCT01890967|26465298|P5|Overall Study|Death|0
7606637|NCT01890967|26465299|P4|Overall Study|Death|0
7606638|NCT01890967|26465300|P3|Overall Study|Death|0
7606639|NCT01890967|26465301|P2|Overall Study|Death|0
7606640|NCT01890967|26465302|P1|Overall Study|Death|1
7606641|NCT01890967|26465297|P6|Overall Study|Adverse Event|7
7606642|NCT01890967|26465298|P5|Overall Study|Adverse Event|1
7606643|NCT01890967|26465299|P4|Overall Study|Adverse Event|2
7606644|NCT01890967|26465300|P3|Overall Study|Adverse Event|3
7606645|NCT01890967|26465301|P2|Overall Study|Adverse Event|3
7606646|NCT01890967|26465302|P1|Overall Study|Adverse Event|3
7606647|NCT01890915|26465380|P2|Overall Study|Equipment Malfunction|1
7606648|NCT01890915|26465381|P1|Overall Study|Equipment Malfunction|0
7606649|NCT01890915|26465380|P2|Overall Study|Protocol Violation|0
7606650|NCT01890915|26465381|P1|Overall Study|Protocol Violation|2
7606651|NCT01890915|26465380|P2|Overall Study|Adverse Event|0
7606652|NCT01890915|26465381|P1|Overall Study|Adverse Event|1
7606653|NCT01890785|26465397|P6|Third Intervention|Withdrawal by Subject|0
7606654|NCT01890785|26465398|P5|Third Intervention|Withdrawal by Subject|0
7606655|NCT01890785|26465399|P4|Third Intervention|Withdrawal by Subject|0
7606656|NCT01890785|26465400|P3|Third Intervention|Withdrawal by Subject|0
7606657|NCT01890785|26465401|P2|Third Intervention|Withdrawal by Subject|1
7606658|NCT01890785|26465402|P1|Third Intervention|Withdrawal by Subject|0
7606659|NCT01890759|26465421|P2|Overall Study|Withdrawal by Subject|8
7606660|NCT01890759|26465422|P1|Overall Study|Withdrawal by Subject|2
7606661|NCT01890759|26465421|P2|Overall Study|Lost to Follow-up|2
7606662|NCT01890759|26465422|P1|Overall Study|Lost to Follow-up|0
7606663|NCT01890759|26465421|P2|Overall Study|Protocol Violation|2
7606664|NCT01890759|26465422|P1|Overall Study|Protocol Violation|0
7606665|NCT01890746|26465456|P2|Overall Study|Withdrawal by Subject|8
7606666|NCT01890746|26465457|P1|Overall Study|Withdrawal by Subject|5
7606667|NCT01890746|26465456|P2|Overall Study|Physician Decision|2
7606668|NCT01890746|26465457|P1|Overall Study|Physician Decision|3
7606669|NCT01890746|26465456|P2|Overall Study|Lost to Follow-up|1
7606670|NCT01890746|26465457|P1|Overall Study|Lost to Follow-up|4
7606671|NCT01890746|26465456|P2|Overall Study|Adverse Event|0
7606672|NCT01890746|26465457|P1|Overall Study|Adverse Event|1
7606673|NCT01890746|26465456|P2|Overall Study|Death|30
7606674|NCT01890746|26465457|P1|Overall Study|Death|39
7606675|NCT01890707|26465543|P2|Overall Study|Lost to Follow-up|1
7606676|NCT01890707|26465544|P1|Overall Study|Lost to Follow-up|1
7606677|NCT01890512|26465623|P1|Overall Study|Protocol Violation|1
7606678|NCT01890512|26465623|P1|Overall Study|Withdrawal by Subject|1
7606679|NCT01890512|26465623|P1|Overall Study|Physician Decision|1
7606680|NCT01890473|26465629|P2|Overall Study|Poor/non-compliance|0
7606681|NCT01890473|26465630|P1|Overall Study|Poor/non-compliance|1
7606682|NCT01890473|26465629|P2|Overall Study|Lost to Follow-up|0
7606683|NCT01890473|26465630|P1|Overall Study|Lost to Follow-up|1
7606684|NCT01890434|26465656|P1|Overall Study|Withdrawal by PI for ICA not performed|2
7606685|NCT01890434|26465656|P1|Overall Study|Unable to contact|1
7606686|NCT01890434|26465656|P1|Overall Study|Moved out of position|1
7606687|NCT01890434|26465656|P1|Overall Study|Uncontactable by phone|1
7606688|NCT01890434|26465656|P1|Overall Study|Participant didn't complete MRI|1
7606689|NCT01890434|26465656|P1|Overall Study|GSPECT at rest was not done|1
7606690|NCT01890434|26465656|P1|Overall Study|Decline to return for GSPECT|1
7606691|NCT01890434|26465656|P1|Overall Study|Could not get whole set of images|1
7606692|NCT01890434|26465656|P1|Overall Study|CRC didn't contact participant for FU|1
7606693|NCT01890434|26465656|P1|Overall Study|Assessment discrepancy|1
7606694|NCT01890434|26465656|P1|Overall Study|PCI at external hospital|1
7606695|NCT01890434|26465656|P1|Overall Study|Adverse Event|8
7606696|NCT01890421|26465686|P1|Overall Study|Other reason|10
7606697|NCT01890421|26465686|P1|Overall Study|Adverse Event|1
7606698|NCT01890265|26465731|P6|Overall Study|Withdrawal by Subject|0
7606699|NCT01890265|26465732|P5|Overall Study|Withdrawal by Subject|2
7606700|NCT01890265|26465733|P4|Overall Study|Withdrawal by Subject|0
7606701|NCT01890265|26465734|P3|Overall Study|Withdrawal by Subject|3
7606702|NCT01890265|26465735|P2|Overall Study|Withdrawal by Subject|2
7606703|NCT01890265|26465736|P1|Overall Study|Withdrawal by Subject|0
7606704|NCT01890265|26465731|P6|Overall Study|Death|0
7606705|NCT01890265|26465732|P5|Overall Study|Death|0
7606706|NCT01890265|26465733|P4|Overall Study|Death|0
7606707|NCT01890265|26465734|P3|Overall Study|Death|1
7606708|NCT01890265|26465735|P2|Overall Study|Death|3
7606709|NCT01890265|26465736|P1|Overall Study|Death|2
7606710|NCT01890265|26465731|P6|Overall Study|Adverse Event|0
7606711|NCT01890265|26465732|P5|Overall Study|Adverse Event|0
7606712|NCT01890265|26465733|P4|Overall Study|Adverse Event|0
7606713|NCT01890265|26465734|P3|Overall Study|Adverse Event|0
7606714|NCT01890265|26465735|P2|Overall Study|Adverse Event|1
7606715|NCT01890265|26465736|P1|Overall Study|Adverse Event|2
7606716|NCT01890265|26465731|P6|Overall Study|Progressive disease|0
7606717|NCT01890265|26465732|P5|Overall Study|Progressive disease|0
7606718|NCT01890265|26465733|P4|Overall Study|Progressive disease|0
7606719|NCT01890265|26465734|P3|Overall Study|Progressive disease|0
7606720|NCT01890265|26465735|P2|Overall Study|Progressive disease|6
7606721|NCT01890265|26465736|P1|Overall Study|Progressive disease|6
7606722|NCT01890265|26465731|P6|Overall Study|Other (Unspecified reason)|0
7606723|NCT01890265|26465732|P5|Overall Study|Other (Unspecified reason)|0
7606724|NCT01890265|26465733|P4|Overall Study|Other (Unspecified reason)|0
7606725|NCT01890265|26465734|P3|Overall Study|Other (Unspecified reason)|0
7606726|NCT01890265|26465735|P2|Overall Study|Other (Unspecified reason)|1
7606727|NCT01890265|26465736|P1|Overall Study|Other (Unspecified reason)|0
7606728|NCT01890148|26465773|P1|Overall Study|Adverse Event|1
7606729|NCT01890122|26465793|P4|Overall Study|Randomized but not Treated|0
7606730|NCT01890122|26465794|P3|Overall Study|Randomized but not Treated|0
7606731|NCT01890122|26465795|P2|Overall Study|Randomized but not Treated|1
7606732|NCT01890122|26465796|P1|Overall Study|Randomized but not Treated|1
7606733|NCT01890122|26465793|P4|Overall Study|Reason not Specified|2
7606734|NCT01890122|26465794|P3|Overall Study|Reason not Specified|1
7606735|NCT01890122|26465795|P2|Overall Study|Reason not Specified|1
7606736|NCT01890122|26465796|P1|Overall Study|Reason not Specified|0
7606737|NCT01890122|26465793|P4|Overall Study|Lack of Efficacy|41
7606738|NCT01890122|26465794|P3|Overall Study|Lack of Efficacy|7
7606739|NCT01890122|26465795|P2|Overall Study|Lack of Efficacy|24
7606740|NCT01890122|26465796|P1|Overall Study|Lack of Efficacy|14
7606741|NCT01890122|26465793|P4|Overall Study|Voluntary Withdrawal|11
7606742|NCT01890122|26465794|P3|Overall Study|Voluntary Withdrawal|2
7606743|NCT01890122|26465795|P2|Overall Study|Voluntary Withdrawal|8
7606744|NCT01890122|26465796|P1|Overall Study|Voluntary Withdrawal|8
7606745|NCT01890122|26465793|P4|Overall Study|Lost to Follow-up|2
7606746|NCT01890122|26465794|P3|Overall Study|Lost to Follow-up|2
7606747|NCT01890122|26465795|P2|Overall Study|Lost to Follow-up|1
7606748|NCT01890122|26465796|P1|Overall Study|Lost to Follow-up|0
7606749|NCT01890122|26465793|P4|Overall Study|Major Protocol Deviation|1
7606750|NCT01890122|26465794|P3|Overall Study|Major Protocol Deviation|0
7606751|NCT01890122|26465795|P2|Overall Study|Major Protocol Deviation|1
7606752|NCT01890122|26465796|P1|Overall Study|Major Protocol Deviation|3
7606753|NCT01890122|26465793|P4|Overall Study|Adverse Event|2
7606754|NCT01890122|26465794|P3|Overall Study|Adverse Event|1
7606755|NCT01890122|26465795|P2|Overall Study|Adverse Event|1
7606756|NCT01890122|26465796|P1|Overall Study|Adverse Event|1
7606757|NCT01890109|26465860|P2|Overall Study|Lost to Follow-up|2
7606758|NCT01890109|26465861|P1|Overall Study|Lost to Follow-up|1
7606759|NCT01890109|26465860|P2|Overall Study|Withdrawal by Subject|3
7606760|NCT01890109|26465861|P1|Overall Study|Withdrawal by Subject|0
7606761|NCT01889862|26465906|P5|Part 4 (Up to 274 Weeks)|Protocol deviations|2
7606762|NCT01889862|26465907|P4|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7606763|NCT01889862|26465908|P3|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7606764|NCT01889862|26465909|P2|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7606765|NCT01889862|26465910|P1|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7606766|NCT01889862|26465906|P5|Part 4 (Up to 274 Weeks)|Physician Decision|5
7606767|NCT01889862|26465907|P4|Part 4 (Up to 274 Weeks)|Physician Decision|0
7606768|NCT01889862|26465908|P3|Part 4 (Up to 274 Weeks)|Physician Decision|0
7606769|NCT01889862|26465909|P2|Part 4 (Up to 274 Weeks)|Physician Decision|0
7606770|NCT01889862|26465910|P1|Part 4 (Up to 274 Weeks)|Physician Decision|0
7606771|NCT01889862|26465906|P5|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
7606772|NCT01889862|26465907|P4|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7606773|NCT01889862|26465908|P3|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7606774|NCT01889862|26465909|P2|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7606775|NCT01889862|26465910|P1|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7606776|NCT01889862|26465906|P5|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
7606777|NCT01889862|26465907|P4|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7606778|NCT01889862|26465908|P3|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7606779|NCT01889862|26465909|P2|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7606780|NCT01889862|26465910|P1|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7606781|NCT01889862|26465906|P5|Part 4 (Up to 274 Weeks)|Adverse Event|5
7606782|NCT01889862|26465907|P4|Part 4 (Up to 274 Weeks)|Adverse Event|0
7606783|NCT01889862|26465908|P3|Part 4 (Up to 274 Weeks)|Adverse Event|0
7606784|NCT01889862|26465909|P2|Part 4 (Up to 274 Weeks)|Adverse Event|0
7606785|NCT01889862|26465910|P1|Part 4 (Up to 274 Weeks)|Adverse Event|0
7606786|NCT01889862|26465906|P5|Part 2 (8 Weeks)|Withdrawal by Subject|0
7606787|NCT01889862|26465907|P4|Part 2 (8 Weeks)|Withdrawal by Subject|0
7606788|NCT01889862|26465908|P3|Part 2 (8 Weeks)|Withdrawal by Subject|1
7606789|NCT01889862|26465909|P2|Part 2 (8 Weeks)|Withdrawal by Subject|0
7606790|NCT01889862|26465910|P1|Part 2 (8 Weeks)|Withdrawal by Subject|0
7606791|NCT01889862|26465906|P5|Part 1 (Up to 13 Weeks)|Physician Decision|0
7606792|NCT01889862|26465907|P4|Part 1 (Up to 13 Weeks)|Physician Decision|0
7606793|NCT01889862|26465908|P3|Part 1 (Up to 13 Weeks)|Physician Decision|0
7606794|NCT01889862|26465909|P2|Part 1 (Up to 13 Weeks)|Physician Decision|0
7606795|NCT01889862|26465910|P1|Part 1 (Up to 13 Weeks)|Physician Decision|2
7606796|NCT01889862|26465906|P5|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7606797|NCT01889862|26465907|P4|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7606798|NCT01889862|26465908|P3|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7606799|NCT01889862|26465909|P2|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7606800|NCT01889862|26465910|P1|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
7606801|NCT01889862|26465906|P5|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7606802|NCT01889862|26465907|P4|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7606803|NCT01889862|26465908|P3|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7606804|NCT01889862|26465909|P2|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7606805|NCT01889862|26465910|P1|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
7606806|NCT01889862|26465906|P5|Part 1 (Up to 13 Weeks)|Adverse Event|0
7606807|NCT01889862|26465907|P4|Part 1 (Up to 13 Weeks)|Adverse Event|0
7606808|NCT01889862|26465908|P3|Part 1 (Up to 13 Weeks)|Adverse Event|0
7606809|NCT01889862|26465909|P2|Part 1 (Up to 13 Weeks)|Adverse Event|0
7606810|NCT01889862|26465910|P1|Part 1 (Up to 13 Weeks)|Adverse Event|4
7606811|NCT01889602|26465994|P3|Third Intervention|Withdrawal by Subject|0
7606812|NCT01889602|26465995|P2|Third Intervention|Withdrawal by Subject|2
7606813|NCT01889602|26465996|P1|Third Intervention|Withdrawal by Subject|2
7606814|NCT01889602|26465994|P3|Third Intervention|Protocol Violation|0
7606815|NCT01889602|26465995|P2|Third Intervention|Protocol Violation|0
7606816|NCT01889602|26465996|P1|Third Intervention|Protocol Violation|1
7606817|NCT01889602|26465994|P3|Second Intervention|Withdrawal by Subject|1
7606818|NCT01889602|26465995|P2|Second Intervention|Withdrawal by Subject|0
7606819|NCT01889602|26465996|P1|Second Intervention|Withdrawal by Subject|0
7606820|NCT01889602|26465994|P3|Second Intervention|Study ending|0
7606821|NCT01889602|26465995|P2|Second Intervention|Study ending|0
7606822|NCT01889602|26465996|P1|Second Intervention|Study ending|1
7606823|NCT01889602|26465994|P3|Second Intervention|Adverse Event|1
7606824|NCT01889602|26465995|P2|Second Intervention|Adverse Event|0
7606825|NCT01889602|26465996|P1|Second Intervention|Adverse Event|0
7606826|NCT01889602|26465994|P3|First Intervention|Study ending|0
7606827|NCT01889602|26465995|P2|First Intervention|Study ending|1
7606828|NCT01889602|26465996|P1|First Intervention|Study ending|0
7606829|NCT01889602|26465994|P3|First Intervention|Protocol Violation|1
7606830|NCT01889602|26465995|P2|First Intervention|Protocol Violation|1
7606831|NCT01889602|26465996|P1|First Intervention|Protocol Violation|0
7606832|NCT01889602|26465994|P3|First Intervention|Adverse Event|1
7606833|NCT01889602|26465995|P2|First Intervention|Adverse Event|1
7606834|NCT01889602|26465996|P1|First Intervention|Adverse Event|1
7606835|NCT01889251|26466044|P2|Overall Study|Adverse Event|0
7606836|NCT01889251|26466045|P1|Overall Study|Adverse Event|1
7606838|NCT01889069|26466070|P1|Overall Study|Consent Withdrawal|3
7606839|NCT01889069|26466070|P1|Overall Study|Other|4
7606840|NCT01889069|26466070|P1|Overall Study|Lost to Follow-up|6
7606841|NCT01889069|26466070|P1|Overall Study|Progression of Disease|14
7606842|NCT01889069|26466070|P1|Overall Study|Death|18
7606843|NCT01888965|26466115|P1|Overall Study|Lack of Efficacy|4
7606844|NCT01888965|26466115|P1|Overall Study|Adverse Event|5
7606845|NCT01888900|26466127|P2|Overall Study|failed treatment|2
7606846|NCT01888900|26466128|P1|Overall Study|failed treatment|0
7606847|NCT01888874|26466155|P7|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7606848|NCT01888874|26466156|P6|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7606849|NCT01888874|26466157|P5|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7606850|NCT01888874|26466158|P4|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7606851|NCT01888874|26466159|P3|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7606852|NCT01888874|26466160|P2|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7606853|NCT01888874|26466161|P1|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7606854|NCT01888874|26466155|P7|Period 2 (Week 13 to Week 24)|Adverse Event|3
7606855|NCT01888874|26466156|P6|Period 2 (Week 13 to Week 24)|Adverse Event|1
7606856|NCT01888874|26466157|P5|Period 2 (Week 13 to Week 24)|Adverse Event|1
7606857|NCT01888874|26466158|P4|Period 2 (Week 13 to Week 24)|Adverse Event|2
7606858|NCT01888874|26466159|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
7606859|NCT01888874|26466160|P2|Period 2 (Week 13 to Week 24)|Adverse Event|0
7606860|NCT01888874|26466161|P1|Period 2 (Week 13 to Week 24)|Adverse Event|2
7606861|NCT01888874|26466155|P7|Period 2 (Week 13 to Week 24)|Treatment failure|0
7606862|NCT01888874|26466156|P6|Period 2 (Week 13 to Week 24)|Treatment failure|0
7606863|NCT01888874|26466157|P5|Period 2 (Week 13 to Week 24)|Treatment failure|0
7606864|NCT01888874|26466158|P4|Period 2 (Week 13 to Week 24)|Treatment failure|0
7606865|NCT01888874|26466159|P3|Period 2 (Week 13 to Week 24)|Treatment failure|1
7606866|NCT01888874|26466160|P2|Period 2 (Week 13 to Week 24)|Treatment failure|0
7606867|NCT01888874|26466161|P1|Period 2 (Week 13 to Week 24)|Treatment failure|0
7606868|NCT01888874|26466155|P7|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7606869|NCT01888874|26466156|P6|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
7606870|NCT01888874|26466157|P5|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7606871|NCT01888874|26466158|P4|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7606872|NCT01888874|26466159|P3|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
7606873|NCT01888874|26466160|P2|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7606874|NCT01888874|26466161|P1|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7606875|NCT01888874|26466155|P7|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7606876|NCT01888874|26466156|P6|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7606877|NCT01888874|26466157|P5|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
7606878|NCT01888874|26466158|P4|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7606879|NCT01888874|26466159|P3|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7606880|NCT01888874|26466160|P2|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7606881|NCT01888874|26466161|P1|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7606882|NCT01888874|26466155|P7|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7606883|NCT01888874|26466156|P6|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7606884|NCT01888874|26466157|P5|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7606885|NCT01888874|26466158|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7606886|NCT01888874|26466159|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7606887|NCT01888874|26466160|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7606888|NCT01888874|26466161|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7606889|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7606890|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7606891|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7606892|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7606893|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7606894|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7606895|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7606896|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7606897|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7606898|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7606899|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7606900|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7606901|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
7606902|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7606903|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606904|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606905|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
7606906|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606907|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606908|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606909|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7606910|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Adverse Event|0
7606911|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Adverse Event|1
7606912|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Adverse Event|2
7606913|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
7606914|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Adverse Event|3
7606915|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Adverse Event|2
7606916|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Adverse Event|0
7606917|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Physician Decision|1
7606918|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Physician Decision|0
7606919|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Physician Decision|0
7606920|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Physician Decision|0
7606921|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Physician Decision|0
7606922|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Physician Decision|0
7606923|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Physician Decision|0
7606924|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Other|0
7606925|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Other|3
7606926|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Other|3
7606927|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Other|1
7606928|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Other|1
7606929|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Other|0
7606930|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Other|1
7606931|NCT01888874|26466155|P7|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7606932|NCT01888874|26466156|P6|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7606933|NCT01888874|26466157|P5|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7606934|NCT01888874|26466158|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
7606935|NCT01888874|26466159|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7606936|NCT01888874|26466160|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7606937|NCT01888874|26466161|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7606938|NCT01888640|26466250|P3|Overall Study|Researcher Termination of Participant|1
7606939|NCT01888640|26466251|P2|Overall Study|Researcher Termination of Participant|1
7606940|NCT01888640|26466252|P1|Overall Study|Researcher Termination of Participant|0
7606941|NCT01888640|26466250|P3|Overall Study|Excluded for prior TENS|0
7606942|NCT01888640|26466251|P2|Overall Study|Excluded for prior TENS|1
7606943|NCT01888640|26466252|P1|Overall Study|Excluded for prior TENS|0
7606944|NCT01888640|26466250|P3|Overall Study|Given wrong unit (placebo)|0
7606945|NCT01888640|26466251|P2|Overall Study|Given wrong unit (placebo)|0
7606946|NCT01888640|26466252|P1|Overall Study|Given wrong unit (placebo)|1
7606947|NCT01888640|26466250|P3|Overall Study|Minimum dose not met|0
7606948|NCT01888640|26466251|P2|Overall Study|Minimum dose not met|16
7606949|NCT01888640|26466252|P1|Overall Study|Minimum dose not met|10
7606950|NCT01888640|26466250|P3|Overall Study|Withdrawal by Subject|4
7606951|NCT01888640|26466251|P2|Overall Study|Withdrawal by Subject|11
7606952|NCT01888640|26466252|P1|Overall Study|Withdrawal by Subject|15
7606953|NCT01888640|26466250|P3|Overall Study|Lost to Follow-up|0
7606954|NCT01888640|26466251|P2|Overall Study|Lost to Follow-up|2
7606955|NCT01888640|26466252|P1|Overall Study|Lost to Follow-up|1
7606956|NCT01888497|26466306|P4|Washout Period 2|Withdrawal by Subject|1
7606957|NCT01888497|26466307|P3|Washout Period 2|Withdrawal by Subject|0
7606958|NCT01888497|26466308|P2|Washout Period 2|Withdrawal by Subject|0
7606959|NCT01888497|26466309|P1|Washout Period 2|Withdrawal by Subject|0
7606960|NCT01888497|26466306|P4|Washout Period 2|Adverse Event|1
7606961|NCT01888497|26466307|P3|Washout Period 2|Adverse Event|0
7606962|NCT01888497|26466308|P2|Washout Period 2|Adverse Event|0
7606963|NCT01888497|26466309|P1|Washout Period 2|Adverse Event|0
7606964|NCT01888497|26466306|P4|Washout Period 1|Withdrawal by Subject|1
7606965|NCT01888497|26466307|P3|Washout Period 1|Withdrawal by Subject|1
7606966|NCT01888497|26466308|P2|Washout Period 1|Withdrawal by Subject|0
7606967|NCT01888497|26466309|P1|Washout Period 1|Withdrawal by Subject|0
7606968|NCT01888432|26466344|P2|36-month Analysis (Extension)|Death|0
7606969|NCT01888432|26466345|P1|36-month Analysis (Extension)|Death|1
7606970|NCT01888432|26466344|P2|24-month Analysis (FAS)|Death|4
7606971|NCT01888432|26466345|P1|24-month Analysis (FAS)|Death|8
7606972|NCT01888432|26466344|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
7606973|NCT01888432|26466345|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
7606974|NCT01888432|26466344|P2|24-month Analysis (FAS)|Physician Decision|4
7606975|NCT01888432|26466345|P1|24-month Analysis (FAS)|Physician Decision|2
7606976|NCT01888432|26466344|P2|24-month Analysis (FAS)|Lost to Follow-up|2
7606977|NCT01888432|26466345|P1|24-month Analysis (FAS)|Lost to Follow-up|0
7606978|NCT01888432|26466344|P2|24-month Analysis (FAS)|Graft loss|1
7606979|NCT01888432|26466345|P1|24-month Analysis (FAS)|Graft loss|0
7606980|NCT01888432|26466344|P2|12-month Analysis (FAS)|Death|3
7606981|NCT01888432|26466345|P1|12-month Analysis (FAS)|Death|4
7606982|NCT01888432|26466344|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
7607071|NCT01887210|26466746|P2|Overall Study|Withdrawal by Subject|3
7606983|NCT01888432|26466345|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
7606984|NCT01888432|26466344|P2|12-month Analysis (FAS)|Physician Decision|1
7606985|NCT01888432|26466345|P1|12-month Analysis (FAS)|Physician Decision|1
7606986|NCT01888432|26466344|P2|12-month Analysis (FAS)|Lost to Follow-up|2
7606987|NCT01888432|26466345|P1|12-month Analysis (FAS)|Lost to Follow-up|0
7606988|NCT01888367|26466386|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7606989|NCT01888367|26466387|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7606990|NCT01888367|26466388|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
7606991|NCT01888367|26466386|P3|Overall Study|Protocol Violation|1
7606992|NCT01888367|26466387|P2|Overall Study|Protocol Violation|0
7606993|NCT01888367|26466388|P1|Overall Study|Protocol Violation|0
7606994|NCT01888367|26466386|P3|Overall Study|Lost to Follow-up|0
7606995|NCT01888367|26466387|P2|Overall Study|Lost to Follow-up|1
7606996|NCT01888367|26466388|P1|Overall Study|Lost to Follow-up|1
7606997|NCT01888367|26466386|P3|Overall Study|Withdrawal by Subject|1
7606998|NCT01888367|26466387|P2|Overall Study|Withdrawal by Subject|0
7606999|NCT01888367|26466388|P1|Overall Study|Withdrawal by Subject|1
7607000|NCT01888367|26466386|P3|Overall Study|Death|1
7607001|NCT01888367|26466387|P2|Overall Study|Death|0
7607002|NCT01888367|26466388|P1|Overall Study|Death|2
7607003|NCT01888367|26466386|P3|Overall Study|Physician Decision|2
7607004|NCT01888367|26466387|P2|Overall Study|Physician Decision|4
7607005|NCT01888367|26466388|P1|Overall Study|Physician Decision|3
7607006|NCT01888003|26466408|P3|Overall Study|Study Terminated|40
7607007|NCT01888003|26466409|P2|Overall Study|Study Terminated|6
7607008|NCT01888003|26466410|P1|Overall Study|Study Terminated|5
7607009|NCT01887912|26466450|P2|Overall Study|Other|58
7607010|NCT01887912|26466451|P1|Overall Study|Other|122
7607011|NCT01887912|26466450|P2|Overall Study|Withdrawal by Subject|349
7607012|NCT01887912|26466451|P1|Overall Study|Withdrawal by Subject|606
7607013|NCT01887912|26466450|P2|Overall Study|Lost to Follow-up|74
7607014|NCT01887912|26466451|P1|Overall Study|Lost to Follow-up|163
7607015|NCT01887912|26466450|P2|Overall Study|Protocol Violation|37
7607016|NCT01887912|26466451|P1|Overall Study|Protocol Violation|67
7607017|NCT01887912|26466450|P2|Overall Study|Other Adverse Event|15
7607018|NCT01887912|26466451|P1|Overall Study|Other Adverse Event|34
7607019|NCT01887912|26466450|P2|Overall Study|Serious adverse event|198
7607020|NCT01887912|26466451|P1|Overall Study|Serious adverse event|400
7607021|NCT01887717|26466479|P2|Overall Study|Administrative reasons|2
7607022|NCT01887717|26466480|P1|Overall Study|Administrative reasons|5
7607023|NCT01887717|26466479|P2|Overall Study|Physician Decision|2
7607024|NCT01887717|26466480|P1|Overall Study|Physician Decision|0
7607025|NCT01887717|26466479|P2|Overall Study|Withdrawal by Subject|7
7607026|NCT01887717|26466480|P1|Overall Study|Withdrawal by Subject|1
7607027|NCT01887678|26466502|P2|Overall Study|Specified|2
7607028|NCT01887678|26466503|P1|Overall Study|Specified|1
7607029|NCT01887678|26466502|P2|Overall Study|Non-compliance|3
7607030|NCT01887678|26466503|P1|Overall Study|Non-compliance|0
7607031|NCT01887678|26466502|P2|Overall Study|Lack of Efficacy|2
7607032|NCT01887678|26466503|P1|Overall Study|Lack of Efficacy|1
7607033|NCT01887678|26466502|P2|Overall Study|Deterioration of clinical condition|4
7607034|NCT01887678|26466503|P1|Overall Study|Deterioration of clinical condition|0
7607035|NCT01887678|26466502|P2|Overall Study|Lost to Follow-up|2
7607036|NCT01887678|26466503|P1|Overall Study|Lost to Follow-up|4
7607037|NCT01887678|26466502|P2|Overall Study|Withdrawal of consent|4
7607038|NCT01887678|26466503|P1|Overall Study|Withdrawal of consent|3
7607039|NCT01887678|26466502|P2|Overall Study|Exceeded rescue medication dosage|5
7607040|NCT01887678|26466503|P1|Overall Study|Exceeded rescue medication dosage|4
7607041|NCT01887678|26466502|P2|Overall Study|Adverse Event|6
7607042|NCT01887678|26466503|P1|Overall Study|Adverse Event|4
7607043|NCT01887600|26466547|P2|Overall Study|Progressive Disease|0
7607044|NCT01887600|26466548|P1|Overall Study|Progressive Disease|1
7607045|NCT01887600|26466547|P2|Overall Study|Miscellaneous|2
7607046|NCT01887600|26466548|P1|Overall Study|Miscellaneous|6
7607047|NCT01887600|26466547|P2|Overall Study|Non-compliance with study drug|0
7607048|NCT01887600|26466548|P1|Overall Study|Non-compliance with study drug|3
7607049|NCT01887600|26466547|P2|Overall Study|Adverse Event|9
7607050|NCT01887600|26466548|P1|Overall Study|Adverse Event|21
7607051|NCT01887600|26466547|P2|Overall Study|Withdrawal by Subject|52
7607052|NCT01887600|26466548|P1|Overall Study|Withdrawal by Subject|58
7607053|NCT01887600|26466547|P2|Overall Study|Protocol Deviation|0
7607054|NCT01887600|26466548|P1|Overall Study|Protocol Deviation|3
7607055|NCT01887600|26466547|P2|Overall Study|Physician Decision|8
7607056|NCT01887600|26466548|P1|Overall Study|Physician Decision|7
7607057|NCT01887600|26466547|P2|Overall Study|Lost to Follow-up|1
7607058|NCT01887600|26466548|P1|Overall Study|Lost to Follow-up|5
7607059|NCT01887600|26466547|P2|Overall Study|Lack of Efficacy|26
7607060|NCT01887600|26466548|P1|Overall Study|Lack of Efficacy|3
7607061|NCT01887600|26466547|P2|Overall Study|Death|16
7607062|NCT01887600|26466548|P1|Overall Study|Death|39
7607063|NCT01887418|26466689|P3|Overall Study|Travelling difficulties|1
7607064|NCT01887418|26466690|P2|Overall Study|Travelling difficulties|0
7607065|NCT01887418|26466691|P1|Overall Study|Travelling difficulties|0
7607066|NCT01887353|26466710|P2|Overall Study|Study stopped early|3
7607067|NCT01887353|26466711|P1|Overall Study|Study stopped early|4
7607068|NCT01887288|26466739|P1|Overall Study|The study was terminated and the PI has|16
7607069|NCT01887210|26466746|P2|Overall Study|Lost to Follow-up|1
7607070|NCT01887210|26466747|P1|Overall Study|Lost to Follow-up|0
7607072|NCT01887210|26466747|P1|Overall Study|Withdrawal by Subject|1
7607073|NCT01886872|26466794|P3|Overall Study|Ineligible|12
7607074|NCT01886872|26466795|P2|Overall Study|Ineligible|4
7607075|NCT01886872|26466796|P1|Overall Study|Ineligible|7
7607076|NCT01886833|26466829|P1|Overall Study|IgA not available from both periods|204
7607077|NCT01886781|26466861|P2|Overall Study|Worsening of symptoms|1
7607078|NCT01886781|26466862|P1|Overall Study|Worsening of symptoms|1
7607079|NCT01886781|26466861|P2|Overall Study|Withdrawal by Subject|1
7607080|NCT01886781|26466862|P1|Overall Study|Withdrawal by Subject|2
7607081|NCT01886781|26466861|P2|Overall Study|Lost to Follow-up|0
7607082|NCT01886781|26466862|P1|Overall Study|Lost to Follow-up|5
7607083|NCT01886781|26466861|P2|Overall Study|Adverse Event|0
7607084|NCT01886781|26466862|P1|Overall Study|Adverse Event|1
7607085|NCT01886781|26466861|P2|Overall Study|Protocol Violation|0
7607086|NCT01886781|26466862|P1|Overall Study|Protocol Violation|5
7607087|NCT01886716|26466872|P4|Week 3|Lost to Follow-up|1
7607088|NCT01886716|26466873|P3|Week 3|Lost to Follow-up|0
7607089|NCT01886716|26466874|P2|Week 3|Lost to Follow-up|1
7607090|NCT01886716|26466875|P1|Week 3|Lost to Follow-up|1
7607091|NCT01886716|26466872|P4|Week 2|Lost to Follow-up|3
7607092|NCT01886716|26466873|P3|Week 2|Lost to Follow-up|1
7607093|NCT01886716|26466874|P2|Week 2|Lost to Follow-up|2
7607094|NCT01886716|26466875|P1|Week 2|Lost to Follow-up|3
7607095|NCT01886716|26466872|P4|Week 1|Lost to Follow-up|2
7607096|NCT01886716|26466873|P3|Week 1|Lost to Follow-up|2
7607097|NCT01886716|26466874|P2|Week 1|Lost to Follow-up|0
7607098|NCT01886716|26466875|P1|Week 1|Lost to Follow-up|0
7607099|NCT01886690|26466891|P2|Overall Study|Personal Reasons|1
7607100|NCT01886690|26466892|P1|Overall Study|Personal Reasons|0
7607101|NCT01886690|26466891|P2|Overall Study|Protocol Violation|1
7607102|NCT01886690|26466892|P1|Overall Study|Protocol Violation|0
7607103|NCT01886378|26466906|P1|Overall Study|Withdrawal by Subject|4
7607104|NCT01886378|26466906|P1|Overall Study|Adverse Event|1
7607105|NCT01886313|26466929|P2|Overall Study|Adverse Event|1
7607106|NCT01886313|26466930|P1|Overall Study|Adverse Event|1
7607107|NCT01886300|26466936|P1|Overall Study|Trial terminated by sponsor|16
7607108|NCT01886287|26466947|P1|Overall Study|Clinical progression due to disease|1
7607109|NCT01886287|26466947|P1|Overall Study|Radiographic disease progression|1
7607110|NCT01886105|26466963|P1|Overall Study|Lack of Efficacy|3
7607111|NCT01885936|26466970|P2|Overall Study|Withdrawal by Subject|0
7607112|NCT01885936|26466971|P1|Overall Study|Withdrawal by Subject|1
7607113|NCT01885559|26467054|P2|Overall Study|Protocol Violation|1
7607114|NCT01885559|26467055|P1|Overall Study|Protocol Violation|0
7607115|NCT01885559|26467054|P2|Overall Study|Less than full participation|19
7607116|NCT01885559|26467055|P1|Overall Study|Less than full participation|9
7607117|NCT01885559|26467054|P2|Overall Study|Lost to Follow-up|16
7607118|NCT01885559|26467055|P1|Overall Study|Lost to Follow-up|15
7607119|NCT01885208|26467077|P2|Overall Study|Unclassified|38
7607120|NCT01885208|26467078|P1|Overall Study|Unclassified|32
7607121|NCT01885195|26467094|P1|Overall Study|Patient/guardian decision|8
7607122|NCT01885195|26467094|P1|Overall Study|Physician Decision|3
7607123|NCT01885195|26467094|P1|Overall Study|Protocol Deviation|2
7607124|NCT01885195|26467094|P1|Overall Study|Disease Progression|67
7607125|NCT01885195|26467094|P1|Overall Study|Death|1
7607126|NCT01885195|26467094|P1|Overall Study|Adverse Event|29
7607127|NCT01885182|26467114|P2|Overall Study|Lack of Efficacy|1
7607128|NCT01885182|26467115|P1|Overall Study|Lack of Efficacy|8
7607129|NCT01885182|26467114|P2|Overall Study|Lost to Follow-up|2
7607130|NCT01885182|26467115|P1|Overall Study|Lost to Follow-up|2
7607131|NCT01885182|26467114|P2|Overall Study|Withdrawal by Subject|6
7607132|NCT01885182|26467115|P1|Overall Study|Withdrawal by Subject|13
7607133|NCT01885182|26467114|P2|Overall Study|Adverse Event|13
7607134|NCT01885182|26467115|P1|Overall Study|Adverse Event|11
7607135|NCT01885104|26467162|P2|Overall Study|Physician Decision|0
7607136|NCT01885104|26467163|P1|Overall Study|Physician Decision|1
7607137|NCT01885104|26467162|P2|Overall Study|Lost to Follow-up|1
7607138|NCT01885104|26467163|P1|Overall Study|Lost to Follow-up|0
7607139|NCT01885104|26467162|P2|Overall Study|Withdrawal of Consent|0
7607140|NCT01885104|26467163|P1|Overall Study|Withdrawal of Consent|1
7607141|NCT01885000|26467173|P2|Overall Study|Protocol Violation|1
7607142|NCT01885000|26467174|P1|Overall Study|Protocol Violation|0
7607143|NCT01885000|26467173|P2|Overall Study|Withdrawal by Subject|1
7607144|NCT01885000|26467174|P1|Overall Study|Withdrawal by Subject|1
7607145|NCT01885000|26467173|P2|Overall Study|Adverse Event|0
7607146|NCT01885000|26467174|P1|Overall Study|Adverse Event|1
7607147|NCT01884688|26467205|P1|Overall Study|Screen Failure|2
7607148|NCT01884675|26467211|P2|Overall Study|Study closed/terminated|2
7607149|NCT01884675|26467212|P1|Overall Study|Study closed/terminated|3
7607150|NCT01884597|26467255|P3|Overall Study|Death|0
7607151|NCT01884597|26467256|P2|Overall Study|Death|1
7607152|NCT01884597|26467257|P1|Overall Study|Death|0
7607153|NCT01884597|26467255|P3|Overall Study|Lack of Efficacy|0
7607154|NCT01884597|26467256|P2|Overall Study|Lack of Efficacy|0
7607155|NCT01884597|26467257|P1|Overall Study|Lack of Efficacy|1
7607156|NCT01884597|26467255|P3|Overall Study|Adverse Event|1
7607157|NCT01884597|26467256|P2|Overall Study|Adverse Event|0
7607158|NCT01884597|26467257|P1|Overall Study|Adverse Event|0
7607159|NCT01884571|26467286|P1|Overall Study|Disease progression|3
7607160|NCT01884571|26467286|P1|Overall Study|Withdrawal by Subject|2
7607161|NCT01884571|26467286|P1|Overall Study|Death|2
7607162|NCT01884571|26467286|P1|Overall Study|Adverse Event|1
7607163|NCT01884545|26467301|P4|Overall Study|Non-adherence|0
7607164|NCT01884545|26467302|P3|Overall Study|Non-adherence|0
7607165|NCT01884545|26467303|P2|Overall Study|Non-adherence|2
7607166|NCT01884545|26467304|P1|Overall Study|Non-adherence|0
7607167|NCT01884545|26467301|P4|Overall Study|Patient withdrawn|5
7607168|NCT01884545|26467302|P3|Overall Study|Patient withdrawn|5
7607169|NCT01884545|26467303|P2|Overall Study|Patient withdrawn|12
7607170|NCT01884545|26467304|P1|Overall Study|Patient withdrawn|7
7607171|NCT01884545|26467301|P4|Overall Study|Lost to Follow-up|4
7607172|NCT01884545|26467302|P3|Overall Study|Lost to Follow-up|9
7607173|NCT01884545|26467303|P2|Overall Study|Lost to Follow-up|4
7607174|NCT01884545|26467304|P1|Overall Study|Lost to Follow-up|6
7607175|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7607176|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7607177|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
7607178|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7607179|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7607180|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
7607181|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
7607182|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
7607183|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
7607184|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7607185|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7607186|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
7607187|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7607188|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7607189|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
7607190|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
7607191|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
7607192|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
7607193|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
7607194|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
7607195|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
7607196|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
7607197|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
7607198|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
7607199|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7607200|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
7607201|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7607202|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7607203|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7607204|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
7607205|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
7607206|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
7607207|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
7607208|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
7607209|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7607210|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7607211|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
7607212|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7607213|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7607214|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
7607215|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7607216|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7607217|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7607218|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7607219|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
7607220|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
7607221|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
7607222|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
7607223|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7607224|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
7607225|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7607226|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
7607227|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
7607228|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
7607229|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
7607230|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
7607315|NCT01882803|26467792|P1|Overall Study|Protocol Violation|1
7607231|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
7607232|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7607233|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
7607234|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7607235|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
7607236|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
7607237|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
7607238|NCT01884350|26467457|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
7607239|NCT01884350|26467458|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
7607240|NCT01884350|26467459|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
7607241|NCT01884337|26467482|P2|Follow-up Period|Lost to Follow-up|1
7607242|NCT01884337|26467483|P1|Follow-up Period|Lost to Follow-up|1
7607243|NCT01884337|26467482|P2|Treatment|Subj. request to discont. treatment|0
7607244|NCT01884337|26467483|P1|Treatment|Subj. request to discont. treatment|2
7607245|NCT01884337|26467482|P2|Treatment|Adverse Event|2
7607246|NCT01884337|26467483|P1|Treatment|Adverse Event|2
7607247|NCT01884311|26467491|P1|Overall Study|Precautionary measure|1
7607248|NCT01884311|26467491|P1|Overall Study|withdrew consent due to AEs|1
7607249|NCT01884311|26467491|P1|Overall Study|Withdrawal by Subject|3
7607250|NCT01884077|26467501|P2|Overall Study|study closed|4
7607251|NCT01884077|26467502|P1|Overall Study|study closed|6
7607252|NCT01884077|26467501|P2|Overall Study|Lost to Follow-up|4
7607253|NCT01884077|26467502|P1|Overall Study|Lost to Follow-up|0
7607254|NCT01884077|26467501|P2|Overall Study|canceled surgery|0
7607255|NCT01884077|26467502|P1|Overall Study|canceled surgery|2
7607256|NCT01884077|26467501|P2|Overall Study|screen fail|2
7607257|NCT01884077|26467502|P1|Overall Study|screen fail|0
7607258|NCT01884025|26467523|P2|Overall Study|Lost to Follow-up|4
7607259|NCT01884025|26467524|P1|Overall Study|Lost to Follow-up|3
7607260|NCT01883895|26467584|P1|Overall Study|Lost to Follow-up|2
7607261|NCT01883635|26467611|P2|Overall Study|Withdrawal by Subject|0
7607262|NCT01883635|26467612|P1|Overall Study|Withdrawal by Subject|4
7607263|NCT01883492|26467626|P2|Overall Study|bone anatomy did not meet study criteria|1
7607264|NCT01883492|26467627|P1|Overall Study|bone anatomy did not meet study criteria|1
7607265|NCT01883492|26467626|P2|Overall Study|inappropriate implant used|1
7607266|NCT01883492|26467627|P1|Overall Study|inappropriate implant used|1
7607267|NCT01883492|26467626|P2|Overall Study|Withdrawal by Subject|0
7607268|NCT01883492|26467627|P1|Overall Study|Withdrawal by Subject|1
7607269|NCT01883492|26467626|P2|Overall Study|Poor X-ray quality|4
7607270|NCT01883492|26467627|P1|Overall Study|Poor X-ray quality|7
7607271|NCT01883492|26467626|P2|Overall Study|Surgery on contra-lateral hip|1
7607272|NCT01883492|26467627|P1|Overall Study|Surgery on contra-lateral hip|0
7607273|NCT01883492|26467626|P2|Overall Study|Lost to Follow-up|4
7607274|NCT01883492|26467627|P1|Overall Study|Lost to Follow-up|3
7607275|NCT01883453|26467659|P2|Overall Study|No episode of common cold|23
7607276|NCT01883453|26467660|P1|Overall Study|No episode of common cold|25
7607277|NCT01883362|26467688|P2|Post Treatment Follow-up|Relapse|2
7607278|NCT01883362|26467689|P1|Post Treatment Follow-up|Relapse|1
7607279|NCT01883362|26467688|P2|Post Treatment Follow-up|Death|4
7607280|NCT01883362|26467689|P1|Post Treatment Follow-up|Death|8
7607281|NCT01883362|26467688|P2|Post Treatment Follow-up|Administrative problems|0
7607282|NCT01883362|26467689|P1|Post Treatment Follow-up|Administrative problems|2
7607283|NCT01883362|26467688|P2|Post Treatment Follow-up|Lost to Follow-up|4
7607284|NCT01883362|26467689|P1|Post Treatment Follow-up|Lost to Follow-up|1
7607285|NCT01883362|26467688|P2|Post Treatment Follow-up|Withdrawal by Subject|3
7607286|NCT01883362|26467689|P1|Post Treatment Follow-up|Withdrawal by Subject|4
7607287|NCT01883362|26467688|P2|Post Treatment Follow-up|Protocol Violation|1
7607288|NCT01883362|26467689|P1|Post Treatment Follow-up|Protocol Violation|0
7607289|NCT01883362|26467688|P2|Treatment|Randomized, not treated|1
7607290|NCT01883362|26467689|P1|Treatment|Randomized, not treated|1
7607291|NCT01883362|26467688|P2|Treatment|Relapse|2
7607292|NCT01883362|26467689|P1|Treatment|Relapse|4
7607293|NCT01883362|26467688|P2|Treatment|Administrative problems|1
7607294|NCT01883362|26467689|P1|Treatment|Administrative problems|4
7607295|NCT01883362|26467688|P2|Treatment|Withdrawal by Subject|2
7607296|NCT01883362|26467689|P1|Treatment|Withdrawal by Subject|6
7607297|NCT01883362|26467688|P2|Treatment|Adverse Event|8
7607298|NCT01883362|26467689|P1|Treatment|Adverse Event|1
7607299|NCT01882985|26467722|P1|Overall Study|Withdrawal by Subject|1
7607300|NCT01882985|26467722|P1|Overall Study|Lost to Follow-up|1
7607301|NCT01882907|26467731|P2|Overall Study|Withdrawal by Subject|6
7607302|NCT01882907|26467732|P1|Overall Study|Withdrawal by Subject|0
7607303|NCT01882907|26467731|P2|Overall Study|Protocol Violation|14
7607304|NCT01882907|26467732|P1|Overall Study|Protocol Violation|10
7607305|NCT01882907|26467731|P2|Overall Study|Lost to Follow-up|4
7607306|NCT01882907|26467732|P1|Overall Study|Lost to Follow-up|1
7607307|NCT01882907|26467731|P2|Overall Study|Lack of Efficacy|3
7607308|NCT01882907|26467732|P1|Overall Study|Lack of Efficacy|0
7607309|NCT01882907|26467731|P2|Overall Study|Adverse Event|1
7607310|NCT01882907|26467732|P1|Overall Study|Adverse Event|3
7607311|NCT01882829|26467778|P1|Overall Study|Withdrawal by Subject|1
7607312|NCT01882829|26467778|P1|Overall Study|Protocol Violation|1
7607313|NCT01882829|26467778|P1|Overall Study|Adverse Event|4
7607314|NCT01882803|26467792|P1|Overall Study|Withdrawal by Subject|4
7607316|NCT01882803|26467792|P1|Overall Study|Physician Decision|7
7607317|NCT01882803|26467792|P1|Overall Study|Death|7
7607318|NCT01882803|26467792|P1|Overall Study|Adverse Event|22
7607319|NCT01882803|26467792|P1|Overall Study|Disease Progression|53
7607320|NCT01882647|26467819|P2|Overall Study|Withdrawal by Subject|4
7607321|NCT01882647|26467820|P1|Overall Study|Withdrawal by Subject|0
7607322|NCT01882647|26467819|P2|Overall Study|Lost to Follow-up|2
7607323|NCT01882647|26467820|P1|Overall Study|Lost to Follow-up|2
7607324|NCT01882465|26467860|P7|Period 2|Protocol Violation|0
7607325|NCT01882465|26467861|P6|Period 2|Protocol Violation|0
7607326|NCT01882465|26467862|P5|Period 2|Protocol Violation|1
7607327|NCT01882465|26467863|P4|Period 2|Protocol Violation|0
7607328|NCT01882465|26467864|P3|Period 2|Protocol Violation|0
7607329|NCT01882465|26467865|P2|Period 2|Protocol Violation|0
7607330|NCT01882465|26467866|P1|Period 2|Protocol Violation|0
7607331|NCT01882465|26467860|P7|Period 1|Withdrawal by Subject|1
7607332|NCT01882465|26467861|P6|Period 1|Withdrawal by Subject|0
7607333|NCT01882465|26467862|P5|Period 1|Withdrawal by Subject|0
7607334|NCT01882465|26467863|P4|Period 1|Withdrawal by Subject|0
7607335|NCT01882465|26467864|P3|Period 1|Withdrawal by Subject|0
7607336|NCT01882465|26467865|P2|Period 1|Withdrawal by Subject|0
7607337|NCT01882465|26467866|P1|Period 1|Withdrawal by Subject|0
7607338|NCT01882465|26467860|P7|Period 1|Lens Discomfort|0
7607339|NCT01882465|26467861|P6|Period 1|Lens Discomfort|0
7607340|NCT01882465|26467862|P5|Period 1|Lens Discomfort|0
7607341|NCT01882465|26467863|P4|Period 1|Lens Discomfort|1
7607342|NCT01882465|26467864|P3|Period 1|Lens Discomfort|0
7607343|NCT01882465|26467865|P2|Period 1|Lens Discomfort|0
7607344|NCT01882465|26467866|P1|Period 1|Lens Discomfort|0
7607345|NCT01882439|26467878|P4|Overall Study|Adverse event unrelated to study drug|1
7607346|NCT01882439|26467879|P3|Overall Study|Adverse event unrelated to study drug|1
7607347|NCT01882439|26467880|P2|Overall Study|Adverse event unrelated to study drug|2
7607348|NCT01882439|26467881|P1|Overall Study|Adverse event unrelated to study drug|2
7607349|NCT01882439|26467878|P4|Overall Study|Insufficient clinical response|2
7607350|NCT01882439|26467879|P3|Overall Study|Insufficient clinical response|4
7607351|NCT01882439|26467880|P2|Overall Study|Insufficient clinical response|4
7607352|NCT01882439|26467881|P1|Overall Study|Insufficient clinical response|1
7607353|NCT01882439|26467878|P4|Overall Study|Medication error with no associated AE|0
7607354|NCT01882439|26467879|P3|Overall Study|Medication error with no associated AE|2
7607355|NCT01882439|26467880|P2|Overall Study|Medication error with no associated AE|0
7607356|NCT01882439|26467881|P1|Overall Study|Medication error with no associated AE|0
7607357|NCT01882439|26467878|P4|Overall Study|No longer willing to participate|3
7607358|NCT01882439|26467879|P3|Overall Study|No longer willing to participate|2
7607359|NCT01882439|26467880|P2|Overall Study|No longer willing to participate|4
7607360|NCT01882439|26467881|P1|Overall Study|No longer willing to participate|1
7607361|NCT01882439|26467878|P4|Overall Study|Protocol Violation|1
7607362|NCT01882439|26467879|P3|Overall Study|Protocol Violation|0
7607363|NCT01882439|26467880|P2|Overall Study|Protocol Violation|2
7607364|NCT01882439|26467881|P1|Overall Study|Protocol Violation|2
7607365|NCT01882439|26467878|P4|Overall Study|Pregnancy|0
7607366|NCT01882439|26467879|P3|Overall Study|Pregnancy|0
7607367|NCT01882439|26467880|P2|Overall Study|Pregnancy|1
7607368|NCT01882439|26467881|P1|Overall Study|Pregnancy|0
7607369|NCT01882439|26467878|P4|Overall Study|Adverse event related to study drug|2
7607370|NCT01882439|26467879|P3|Overall Study|Adverse event related to study drug|1
7607371|NCT01882439|26467880|P2|Overall Study|Adverse event related to study drug|8
7607372|NCT01882439|26467881|P1|Overall Study|Adverse event related to study drug|3
7607373|NCT01882257|26468078|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
7607374|NCT01882257|26468079|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
7607375|NCT01882257|26468080|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
7607376|NCT01882257|26468078|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
7607377|NCT01882257|26468079|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
7607378|NCT01882257|26468080|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
7607379|NCT01882088|26468087|P1|Overall Study|inadequate pH-impedance tracings|2
7607380|NCT01882088|26468087|P1|Overall Study|Protocol Violation|1
7607381|NCT01882088|26468087|P1|Overall Study|no possibility to place the catheter|1
7607382|NCT01882088|26468087|P1|Overall Study|Intolerance of esophageal manometry|1
7607383|NCT01881789|26468172|P6|Overall Study|Other|1
7607384|NCT01881789|26468173|P5|Overall Study|Other|1
7607385|NCT01881789|26468174|P4|Overall Study|Other|3
7607386|NCT01881789|26468175|P3|Overall Study|Other|2
7607387|NCT01881789|26468176|P2|Overall Study|Other|5
7607388|NCT01881789|26468177|P1|Overall Study|Other|3
7607389|NCT01881789|26468172|P6|Overall Study|Study Terminated by Sponsor|1
7607390|NCT01881789|26468173|P5|Overall Study|Study Terminated by Sponsor|0
7607391|NCT01881789|26468174|P4|Overall Study|Study Terminated by Sponsor|0
7607392|NCT01881789|26468175|P3|Overall Study|Study Terminated by Sponsor|0
7607393|NCT01881789|26468176|P2|Overall Study|Study Terminated by Sponsor|0
7607394|NCT01881789|26468177|P1|Overall Study|Study Terminated by Sponsor|0
7607395|NCT01881789|26468172|P6|Overall Study|Withdrawal by Subject|1
7607396|NCT01881789|26468173|P5|Overall Study|Withdrawal by Subject|1
7607397|NCT01881789|26468174|P4|Overall Study|Withdrawal by Subject|0
7607398|NCT01881789|26468175|P3|Overall Study|Withdrawal by Subject|1
7607399|NCT01881789|26468176|P2|Overall Study|Withdrawal by Subject|2
7607400|NCT01881789|26468177|P1|Overall Study|Withdrawal by Subject|0
7607401|NCT01881776|26468221|P3|Overall Study|Protocol Violation|1
7607402|NCT01881776|26468222|P2|Overall Study|Protocol Violation|2
7607403|NCT01881776|26468223|P1|Overall Study|Protocol Violation|0
7607404|NCT01881776|26468221|P3|Overall Study|Lost to Follow-up|1
7607405|NCT01881776|26468222|P2|Overall Study|Lost to Follow-up|2
7607406|NCT01881776|26468223|P1|Overall Study|Lost to Follow-up|1
7607407|NCT01881750|26468251|P2|Overall Study|Lost to Follow-up|1
7607408|NCT01881750|26468252|P1|Overall Study|Lost to Follow-up|0
7607409|NCT01881750|26468251|P2|Overall Study|Changes in concomitant therapies|3
7607410|NCT01881750|26468252|P1|Overall Study|Changes in concomitant therapies|2
7607411|NCT01881737|26468270|P1|Overall Study|Worsening of baseline behavior|1
7607412|NCT01881737|26468270|P1|Overall Study|Withdrawal by Subject|1
7607413|NCT01881737|26468270|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7607414|NCT01881620|26468279|P1|Overall Study|Protocol Violation|4
7607415|NCT01881230|26468359|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
7607416|NCT01881230|26468360|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
7607417|NCT01881230|26468361|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
7607418|NCT01881230|26468359|P3|Overall Study|Untreated: Death|1
7607419|NCT01881230|26468360|P2|Overall Study|Untreated: Death|0
7607420|NCT01881230|26468361|P1|Overall Study|Untreated: Death|0
7607421|NCT01881230|26468359|P3|Overall Study|Untreated: Other|1
7607422|NCT01881230|26468360|P2|Overall Study|Untreated: Other|0
7607423|NCT01881230|26468361|P1|Overall Study|Untreated: Other|0
7607424|NCT01881230|26468359|P3|Overall Study|Miscellaneous|0
7607425|NCT01881230|26468360|P2|Overall Study|Miscellaneous|3
7607426|NCT01881230|26468361|P1|Overall Study|Miscellaneous|3
7607427|NCT01881230|26468359|P3|Overall Study|Protocol Violation|0
7607428|NCT01881230|26468360|P2|Overall Study|Protocol Violation|1
7607429|NCT01881230|26468361|P1|Overall Study|Protocol Violation|1
7607430|NCT01881230|26468359|P3|Overall Study|Given Commercially Available Drug|2
7607431|NCT01881230|26468360|P2|Overall Study|Given Commercially Available Drug|0
7607432|NCT01881230|26468361|P1|Overall Study|Given Commercially Available Drug|0
7607433|NCT01881230|26468359|P3|Overall Study|Non-Compliance with Study Drug|0
7607434|NCT01881230|26468360|P2|Overall Study|Non-Compliance with Study Drug|2
7607435|NCT01881230|26468361|P1|Overall Study|Non-Compliance with Study Drug|1
7607436|NCT01881230|26468359|P3|Overall Study|Physician Decision|6
7607437|NCT01881230|26468360|P2|Overall Study|Physician Decision|3
7607438|NCT01881230|26468361|P1|Overall Study|Physician Decision|4
7607439|NCT01881230|26468359|P3|Overall Study|Withdrawal by Subject|6
7607440|NCT01881230|26468360|P2|Overall Study|Withdrawal by Subject|4
7607441|NCT01881230|26468361|P1|Overall Study|Withdrawal by Subject|6
7607442|NCT01881230|26468359|P3|Overall Study|Symptomatic Deterioration|1
7607443|NCT01881230|26468360|P2|Overall Study|Symptomatic Deterioration|3
7607444|NCT01881230|26468361|P1|Overall Study|Symptomatic Deterioration|3
7607445|NCT01881230|26468359|P3|Overall Study|Progressive Disease|36
7607446|NCT01881230|26468360|P2|Overall Study|Progressive Disease|35
7607447|NCT01881230|26468361|P1|Overall Study|Progressive Disease|31
7607448|NCT01881230|26468359|P3|Overall Study|Adverse Event|12
7607449|NCT01881230|26468360|P2|Overall Study|Adverse Event|13
7607450|NCT01881230|26468361|P1|Overall Study|Adverse Event|9
7607451|NCT01881230|26468359|P3|Overall Study|Death|1
7607452|NCT01881230|26468360|P2|Overall Study|Death|0
7607453|NCT01881230|26468361|P1|Overall Study|Death|2
7607454|NCT01881126|26468389|P2|Overall Study|Adverse Event|1
7607455|NCT01881126|26468390|P1|Overall Study|Adverse Event|0
7607456|NCT01881126|26468389|P2|Overall Study|Non-compliance|1
7607457|NCT01881126|26468390|P1|Overall Study|Non-compliance|1
7607458|NCT01881009|26468471|P2|Summer Camp Session (6 Days)|Unable to wear device|1
7607459|NCT01881009|26468472|P1|Summer Camp Session (6 Days)|Unable to wear device|0
7607460|NCT01880736|26468494|P4|Overall Study|Withdrawal Criteria|5
7607461|NCT01880736|26468495|P3|Overall Study|Withdrawal Criteria|1
7607462|NCT01880736|26468496|P2|Overall Study|Withdrawal Criteria|2
7607463|NCT01880736|26468497|P1|Overall Study|Withdrawal Criteria|1
7607464|NCT01880736|26468494|P4|Overall Study|Adverse Event|1
7607465|NCT01880736|26468495|P3|Overall Study|Adverse Event|0
7607466|NCT01880736|26468496|P2|Overall Study|Adverse Event|0
7607467|NCT01880736|26468497|P1|Overall Study|Adverse Event|0
7607468|NCT01880593|26468581|P2|Overall Study|Withdrawal by Subject|1
7607469|NCT01880593|26468582|P1|Overall Study|Withdrawal by Subject|6
7607470|NCT01880593|26468581|P2|Overall Study|Lack of Efficacy|5
7607471|NCT01880593|26468582|P1|Overall Study|Lack of Efficacy|1
7607472|NCT01880593|26468581|P2|Overall Study|Adverse Event|0
7607473|NCT01880593|26468582|P1|Overall Study|Adverse Event|1
7607474|NCT01880554|26468600|P1|Overall Study|Simon's design requirements|2
7607475|NCT01880554|26468600|P1|Overall Study|Protocol Violation|14
7607476|NCT01880528|26468610|P2|Overall Study|Other|1
7607477|NCT01880528|26468611|P1|Overall Study|Other|1
7607478|NCT01880515|26468627|P2|Overall Study|Disease Progression|7
7607479|NCT01880515|26468628|P1|Overall Study|Disease Progression|5
7607480|NCT01880515|26468627|P2|Overall Study|Lost to Follow-up|2
7607481|NCT01880515|26468628|P1|Overall Study|Lost to Follow-up|3
7607482|NCT01880437|26468639|P3|Overall Study|Study terminated by Sponsor|2
7607483|NCT01880437|26468640|P2|Overall Study|Study terminated by Sponsor|0
7607484|NCT01880437|26468641|P1|Overall Study|Study terminated by Sponsor|3
7607485|NCT01880437|26468639|P3|Overall Study|Death|17
7607486|NCT01880437|26468640|P2|Overall Study|Death|4
7607487|NCT01880437|26468641|P1|Overall Study|Death|12
7607488|NCT01880424|26468667|P2|Overall Study|Other|0
7607489|NCT01880424|26468668|P1|Overall Study|Other|1
7607490|NCT01880424|26468667|P2|Overall Study|Withdrawal by Subject|30
7607491|NCT01880424|26468668|P1|Overall Study|Withdrawal by Subject|10
7607492|NCT01880424|26468667|P2|Overall Study|Protocol Violation|13
7607493|NCT01880424|26468668|P1|Overall Study|Protocol Violation|11
7607494|NCT01880424|26468667|P2|Overall Study|Lost to Follow-up|2
7607495|NCT01880424|26468668|P1|Overall Study|Lost to Follow-up|3
7607496|NCT01880424|26468667|P2|Overall Study|Lack of Efficacy|4
7607497|NCT01880424|26468668|P1|Overall Study|Lack of Efficacy|1
7607498|NCT01880424|26468667|P2|Overall Study|Adverse Event|6
7607499|NCT01880424|26468668|P1|Overall Study|Adverse Event|7
7607500|NCT01880086|26468724|P2|Overall Study|Lost to Follow-up|1
7607501|NCT01880086|26468725|P1|Overall Study|Lost to Follow-up|1
7607502|NCT01879852|26468780|P2|Overall Study|Withdrawal by Subject|0
7607503|NCT01879852|26468781|P1|Overall Study|Withdrawal by Subject|2
7607504|NCT01879722|26468836|P10|Overall Study|Voluntary Withdrawal|0
7607505|NCT01879722|26468837|P9|Overall Study|Voluntary Withdrawal|1
7607506|NCT01879722|26468838|P8|Overall Study|Voluntary Withdrawal|0
7607507|NCT01879722|26468839|P7|Overall Study|Voluntary Withdrawal|0
7607508|NCT01879722|26468840|P6|Overall Study|Voluntary Withdrawal|0
7607509|NCT01879722|26468841|P5|Overall Study|Voluntary Withdrawal|0
7607510|NCT01879722|26468842|P4|Overall Study|Voluntary Withdrawal|0
7607511|NCT01879722|26468843|P3|Overall Study|Voluntary Withdrawal|0
7607512|NCT01879722|26468844|P2|Overall Study|Voluntary Withdrawal|0
7607513|NCT01879722|26468845|P1|Overall Study|Voluntary Withdrawal|0
7607514|NCT01879722|26468836|P10|Overall Study|Pretreatment Event/Adverse Event|0
7607515|NCT01879722|26468837|P9|Overall Study|Pretreatment Event/Adverse Event|1
7607516|NCT01879722|26468838|P8|Overall Study|Pretreatment Event/Adverse Event|1
7607517|NCT01879722|26468839|P7|Overall Study|Pretreatment Event/Adverse Event|0
7607518|NCT01879722|26468840|P6|Overall Study|Pretreatment Event/Adverse Event|0
7607519|NCT01879722|26468841|P5|Overall Study|Pretreatment Event/Adverse Event|1
7607520|NCT01879722|26468842|P4|Overall Study|Pretreatment Event/Adverse Event|1
7607521|NCT01879722|26468843|P3|Overall Study|Pretreatment Event/Adverse Event|0
7607522|NCT01879722|26468844|P2|Overall Study|Pretreatment Event/Adverse Event|1
7607523|NCT01879722|26468845|P1|Overall Study|Pretreatment Event/Adverse Event|0
7607524|NCT01879683|26468993|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
7607525|NCT01879618|26469000|P1|Overall Study|Adverse Event|5
7607526|NCT01879618|26469000|P1|Overall Study|Protocol Violation|6
7607527|NCT01879618|26469000|P1|Overall Study|Surgery;changed schedule; not available|8
7607528|NCT01879618|26469000|P1|Overall Study|Withdrawal by Subject|1
7607529|NCT01879618|26469000|P1|Overall Study|Does not meet entrance criteria|1
7607530|NCT01879579|26469007|P2|Overall Study|Discontinued insulin - possible allergy|1
7607531|NCT01879579|26469008|P1|Overall Study|Discontinued insulin - possible allergy|0
7607532|NCT01879579|26469007|P2|Overall Study|Phenotypic type 1 diabetes|1
7607533|NCT01879579|26469008|P1|Overall Study|Phenotypic type 1 diabetes|0
7607534|NCT01879579|26469007|P2|Overall Study|Did not initiate insulin treatment|0
7607535|NCT01879579|26469008|P1|Overall Study|Did not initiate insulin treatment|1
7607536|NCT01879579|26469007|P2|Overall Study|Did not enroll in texting platform|0
7607537|NCT01879579|26469008|P1|Overall Study|Did not enroll in texting platform|1
7607538|NCT01879579|26469007|P2|Overall Study|Phone incompatible with texting platform|0
7607539|NCT01879579|26469008|P1|Overall Study|Phone incompatible with texting platform|3
7607540|NCT01879553|26469038|P2|Overall Study|Withdrawal by Subject|0
7607541|NCT01879553|26469039|P1|Overall Study|Withdrawal by Subject|1
7607542|NCT01879410|26469073|P2|Overall Study|Randomised in Error|2
7607543|NCT01879410|26469074|P1|Overall Study|Randomised in Error|1
7607544|NCT01879410|26469073|P2|Overall Study|Withdrawal by Subject|8
7607545|NCT01879410|26469074|P1|Overall Study|Withdrawal by Subject|7
7607546|NCT01879410|26469073|P2|Overall Study|Lost to Follow-up|1
7607547|NCT01879410|26469074|P1|Overall Study|Lost to Follow-up|2
7607548|NCT01879410|26469073|P2|Overall Study|Protocol Violation|7
7607549|NCT01879410|26469074|P1|Overall Study|Protocol Violation|1
7607550|NCT01879410|26469073|P2|Overall Study|Lack of Efficacy|6
7607551|NCT01879410|26469074|P1|Overall Study|Lack of Efficacy|4
7607552|NCT01879410|26469073|P2|Overall Study|Adverse Event|14
7607553|NCT01879410|26469074|P1|Overall Study|Adverse Event|9
7607554|NCT01879319|26469141|P2|Overall Study|Lost to Follow-up|5
7607555|NCT01879319|26469142|P1|Overall Study|Lost to Follow-up|1
7607556|NCT01879319|26469141|P2|Overall Study|Withdrawal by Subject|0
7607557|NCT01879319|26469142|P1|Overall Study|Withdrawal by Subject|1
7607558|NCT01879072|26469159|P1|Overall Study|Not Transplanted|30
7607559|NCT01879072|26469159|P1|Overall Study|Withdrawal by Subject|121
7607560|NCT01878890|26469171|P4|Overall Study|Protocol Violation|0
7607561|NCT01878890|26469172|P3|Overall Study|Protocol Violation|0
7607562|NCT01878890|26469173|P2|Overall Study|Protocol Violation|1
7607563|NCT01878890|26469174|P1|Overall Study|Protocol Violation|0
7607564|NCT01878383|26469323|P2|Overall Study|Lost to Follow-up|1499
7607565|NCT01878383|26469324|P1|Overall Study|Lost to Follow-up|0
7607566|NCT01878292|26469334|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
7607567|NCT01878292|26469335|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
7607568|NCT01878292|26469336|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
7607569|NCT01878292|26469334|P3|Double-blind Treatment Period|Adverse Event|8
7607570|NCT01878292|26469335|P2|Double-blind Treatment Period|Adverse Event|9
7607571|NCT01878292|26469336|P1|Double-blind Treatment Period|Adverse Event|4
7607572|NCT01878292|26469334|P3|Double-blind Treatment Period|Lack of Efficacy|0
7607573|NCT01878292|26469335|P2|Double-blind Treatment Period|Lack of Efficacy|3
7607574|NCT01878292|26469336|P1|Double-blind Treatment Period|Lack of Efficacy|5
7607575|NCT01878292|26469334|P3|Double-blind Treatment Period|Protocol Violation|2
7607576|NCT01878292|26469335|P2|Double-blind Treatment Period|Protocol Violation|4
7607577|NCT01878292|26469336|P1|Double-blind Treatment Period|Protocol Violation|3
7607578|NCT01878292|26469334|P3|Double-blind Treatment Period|Withdrawal by Subject|8
7607579|NCT01878292|26469335|P2|Double-blind Treatment Period|Withdrawal by Subject|7
7607580|NCT01878292|26469336|P1|Double-blind Treatment Period|Withdrawal by Subject|9
7607581|NCT01878292|26469334|P3|Double-blind Treatment Period|Lost to Follow-up|1
7607582|NCT01878292|26469335|P2|Double-blind Treatment Period|Lost to Follow-up|3
7607583|NCT01878292|26469336|P1|Double-blind Treatment Period|Lost to Follow-up|6
7607584|NCT01878292|26469334|P3|Double-blind Treatment Period|Other Reasons|0
7607585|NCT01878292|26469335|P2|Double-blind Treatment Period|Other Reasons|0
7607586|NCT01878292|26469336|P1|Double-blind Treatment Period|Other Reasons|2
7607587|NCT01878292|26469334|P3|Randomized|Adverse Event|0
7607588|NCT01878292|26469335|P2|Randomized|Adverse Event|0
7607589|NCT01878292|26469336|P1|Randomized|Adverse Event|1
7607590|NCT01878292|26469334|P3|Randomized|Lost to Follow-up|0
7607591|NCT01878292|26469335|P2|Randomized|Lost to Follow-up|0
7607592|NCT01878292|26469336|P1|Randomized|Lost to Follow-up|1
7607593|NCT01878292|26469334|P3|Randomized|Protocol Violation|0
7607594|NCT01878292|26469335|P2|Randomized|Protocol Violation|0
7607595|NCT01878292|26469336|P1|Randomized|Protocol Violation|1
7607596|NCT01878253|26469347|P1|Overall Study|Completed Study w/o Follow-up Data|2
7607597|NCT01878253|26469347|P1|Overall Study|Lost to Follow-up|2
7607598|NCT01878253|26469347|P1|Overall Study|Withdrawal by Subject|1
7607599|NCT01878253|26469347|P1|Overall Study|SIdus System Removal|3
7607600|NCT01878253|26469347|P1|Overall Study|Death|1
7607601|NCT01878214|26469358|P2|Overall Study|Lost to Follow-up|36
7607602|NCT01878214|26469359|P1|Overall Study|Lost to Follow-up|35
7607603|NCT01878214|26469358|P2|Overall Study|Death|1
7607604|NCT01878214|26469359|P1|Overall Study|Death|0
7607605|NCT01878214|26469358|P2|Overall Study|Withdrawal by Subject|7
7607606|NCT01878214|26469359|P1|Overall Study|Withdrawal by Subject|18
7607607|NCT01878175|26469373|P1|Overall Study|Developed contraindicated health problem|2
7607608|NCT01878149|26469392|P2|Overall Study|Did Not Meet Eligibility Criteria|2
7607609|NCT01878149|26469393|P1|Overall Study|Did Not Meet Eligibility Criteria|2
7607610|NCT01878097|26469401|P2|Implementation Year 4|Surveys not fully completed|3007
7607611|NCT01878097|26469402|P1|Implementation Year 4|Surveys not fully completed|3604
7607612|NCT01878097|26469401|P2|Implementation Year 3|Surveys not fully completed|2980
7607613|NCT01878097|26469402|P1|Implementation Year 3|Surveys not fully completed|3494
7607614|NCT01878097|26469401|P2|Implementation Year 2|Surveys not fully completed|2841
7607615|NCT01878097|26469402|P1|Implementation Year 2|Surveys not fully completed|3281
7607616|NCT01878097|26469401|P2|Implementation Year 1|Surveys not fully completed|2549
7607617|NCT01878097|26469402|P1|Implementation Year 1|Surveys not fully completed|3202
7607618|NCT01878097|26469401|P2|Baseline|Surveys not fully completed|1800
7607619|NCT01878097|26469402|P1|Baseline|Surveys not fully completed|2497
7607620|NCT01878084|26469410|P1|Overall Study|Physician Decision|2
7607621|NCT01877915|26469444|P2|Overall Study|Other|4
7607622|NCT01877915|26469445|P1|Overall Study|Other|2
7607623|NCT01877915|26469444|P2|Overall Study|Withdrawal by Subject|55
7607624|NCT01877915|26469445|P1|Overall Study|Withdrawal by Subject|42
7607625|NCT01877915|26469444|P2|Overall Study|Lost to Follow-up|9
7607626|NCT01877915|26469445|P1|Overall Study|Lost to Follow-up|10
7607627|NCT01877720|26469467|P2|Overall Study|Adverse Event|0
7607628|NCT01877720|26469468|P1|Overall Study|Adverse Event|1
7607629|NCT01877668|26469497|P5|Overall Study|Adverse event unrelated to study drug|1
7607630|NCT01877668|26469498|P4|Overall Study|Adverse event unrelated to study drug|0
7607631|NCT01877668|26469499|P3|Overall Study|Adverse event unrelated to study drug|2
7607632|NCT01877668|26469500|P2|Overall Study|Adverse event unrelated to study drug|1
7607633|NCT01877668|26469501|P1|Overall Study|Adverse event unrelated to study drug|4
7607634|NCT01877668|26469497|P5|Overall Study|Adverse event related to study drug|1
7607635|NCT01877668|26469498|P4|Overall Study|Adverse event related to study drug|2
7607636|NCT01877668|26469499|P3|Overall Study|Adverse event related to study drug|2
7607637|NCT01877668|26469500|P2|Overall Study|Adverse event related to study drug|2
7607638|NCT01877668|26469501|P1|Overall Study|Adverse event related to study drug|2
7607639|NCT01877668|26469497|P5|Overall Study|Protocol Violation|3
7607640|NCT01877668|26469498|P4|Overall Study|Protocol Violation|0
7607641|NCT01877668|26469499|P3|Overall Study|Protocol Violation|0
7607642|NCT01877668|26469500|P2|Overall Study|Protocol Violation|1
7607643|NCT01877668|26469501|P1|Overall Study|Protocol Violation|1
7607644|NCT01877668|26469497|P5|Overall Study|Other|3
7607645|NCT01877668|26469498|P4|Overall Study|Other|1
7607646|NCT01877668|26469499|P3|Overall Study|Other|1
7607647|NCT01877668|26469500|P2|Overall Study|Other|1
7607648|NCT01877668|26469501|P1|Overall Study|Other|1
7607649|NCT01877668|26469497|P5|Overall Study|Withdrawal by Subject|2
7607650|NCT01877668|26469498|P4|Overall Study|Withdrawal by Subject|2
7607651|NCT01877668|26469499|P3|Overall Study|Withdrawal by Subject|3
7607652|NCT01877668|26469500|P2|Overall Study|Withdrawal by Subject|0
7607653|NCT01877668|26469501|P1|Overall Study|Withdrawal by Subject|2
7607654|NCT01877668|26469497|P5|Overall Study|Lost to Follow-up|0
7607655|NCT01877668|26469498|P4|Overall Study|Lost to Follow-up|0
7607656|NCT01877668|26469499|P3|Overall Study|Lost to Follow-up|1
7607657|NCT01877668|26469500|P2|Overall Study|Lost to Follow-up|2
7607658|NCT01877668|26469501|P1|Overall Study|Lost to Follow-up|0
7607659|NCT01877668|26469497|P5|Overall Study|Insufficient clinical response|0
7607660|NCT01877668|26469498|P4|Overall Study|Insufficient clinical response|2
7607661|NCT01877668|26469499|P3|Overall Study|Insufficient clinical response|2
7607662|NCT01877668|26469500|P2|Overall Study|Insufficient clinical response|1
7607663|NCT01877668|26469501|P1|Overall Study|Insufficient clinical response|0
7607664|NCT01877668|26469497|P5|Overall Study|No longer met study criteria|0
7607665|NCT01877668|26469498|P4|Overall Study|No longer met study criteria|0
7607666|NCT01877668|26469499|P3|Overall Study|No longer met study criteria|1
7607667|NCT01877668|26469500|P2|Overall Study|No longer met study criteria|0
7607668|NCT01877668|26469501|P1|Overall Study|No longer met study criteria|1
7607669|NCT01877668|26469497|P5|Overall Study|Death|0
7607670|NCT01877668|26469498|P4|Overall Study|Death|1
7607671|NCT01877668|26469499|P3|Overall Study|Death|0
7607672|NCT01877668|26469500|P2|Overall Study|Death|0
7607673|NCT01877668|26469501|P1|Overall Study|Death|0
7607684|NCT01877551|26469789|P2|Overall Study|Physician Decision|1
7607685|NCT01877551|26469790|P1|Overall Study|Physician Decision|0
7607686|NCT01877421|26469839|P18|Phase 2|Protocol Violation|0
7607687|NCT01877421|26469840|P17|Phase 2|Protocol Violation|0
7607688|NCT01877421|26469841|P16|Phase 2|Protocol Violation|0
7607689|NCT01877421|26469842|P15|Phase 2|Protocol Violation|0
7607690|NCT01877421|26469843|P14|Phase 2|Protocol Violation|0
7607691|NCT01877421|26469844|P13|Phase 2|Protocol Violation|0
7607692|NCT01877421|26469845|P12|Phase 2|Protocol Violation|0
7607693|NCT01877421|26469846|P11|Phase 2|Protocol Violation|1
7607694|NCT01877421|26469847|P10|Phase 2|Protocol Violation|0
7607695|NCT01877421|26469848|P9|Phase 2|Protocol Violation|0
7607696|NCT01877421|26469849|P8|Phase 2|Protocol Violation|0
7607697|NCT01877421|26469850|P7|Phase 2|Protocol Violation|0
7607698|NCT01877421|26469851|P6|Phase 2|Protocol Violation|0
7607699|NCT01877421|26469852|P5|Phase 2|Protocol Violation|0
7607700|NCT01877421|26469853|P4|Phase 2|Protocol Violation|0
7607701|NCT01877421|26469854|P3|Phase 2|Protocol Violation|0
7607702|NCT01877421|26469855|P2|Phase 2|Protocol Violation|0
7607703|NCT01877421|26469856|P1|Phase 2|Protocol Violation|0
7607704|NCT01877421|26469839|P18|Phase 2|Withdrawal by Subject|0
7607705|NCT01877421|26469840|P17|Phase 2|Withdrawal by Subject|0
7607706|NCT01877421|26469841|P16|Phase 2|Withdrawal by Subject|1
7607707|NCT01877421|26469842|P15|Phase 2|Withdrawal by Subject|0
7607708|NCT01877421|26469843|P14|Phase 2|Withdrawal by Subject|0
7607709|NCT01877421|26469844|P13|Phase 2|Withdrawal by Subject|1
7607710|NCT01877421|26469845|P12|Phase 2|Withdrawal by Subject|0
7607711|NCT01877421|26469846|P11|Phase 2|Withdrawal by Subject|1
7607712|NCT01877421|26469847|P10|Phase 2|Withdrawal by Subject|0
7607713|NCT01877421|26469848|P9|Phase 2|Withdrawal by Subject|1
7607714|NCT01877421|26469849|P8|Phase 2|Withdrawal by Subject|0
7607715|NCT01877421|26469850|P7|Phase 2|Withdrawal by Subject|0
7607716|NCT01877421|26469851|P6|Phase 2|Withdrawal by Subject|0
7607717|NCT01877421|26469852|P5|Phase 2|Withdrawal by Subject|0
7607718|NCT01877421|26469853|P4|Phase 2|Withdrawal by Subject|0
7607719|NCT01877421|26469854|P3|Phase 2|Withdrawal by Subject|0
7607720|NCT01877421|26469855|P2|Phase 2|Withdrawal by Subject|0
7607721|NCT01877421|26469856|P1|Phase 2|Withdrawal by Subject|0
7607722|NCT01877421|26469839|P18|Phase 2|Lost to Follow-up|0
7607723|NCT01877421|26469840|P17|Phase 2|Lost to Follow-up|0
7607724|NCT01877421|26469841|P16|Phase 2|Lost to Follow-up|0
7607725|NCT01877421|26469842|P15|Phase 2|Lost to Follow-up|0
7607726|NCT01877421|26469843|P14|Phase 2|Lost to Follow-up|0
7607727|NCT01877421|26469844|P13|Phase 2|Lost to Follow-up|0
7607728|NCT01877421|26469845|P12|Phase 2|Lost to Follow-up|0
7607729|NCT01877421|26469846|P11|Phase 2|Lost to Follow-up|0
7607730|NCT01877421|26469847|P10|Phase 2|Lost to Follow-up|0
7607731|NCT01877421|26469848|P9|Phase 2|Lost to Follow-up|0
7607732|NCT01877421|26469849|P8|Phase 2|Lost to Follow-up|0
7607733|NCT01877421|26469850|P7|Phase 2|Lost to Follow-up|1
7607734|NCT01877421|26469851|P6|Phase 2|Lost to Follow-up|0
7607735|NCT01877421|26469852|P5|Phase 2|Lost to Follow-up|0
7607736|NCT01877421|26469853|P4|Phase 2|Lost to Follow-up|0
7607737|NCT01877421|26469854|P3|Phase 2|Lost to Follow-up|0
7607738|NCT01877421|26469855|P2|Phase 2|Lost to Follow-up|0
7607739|NCT01877421|26469856|P1|Phase 2|Lost to Follow-up|0
7607740|NCT01877408|26469966|P2|Overall Study|Lost to Follow-up|2
7607741|NCT01877408|26469967|P1|Overall Study|Lost to Follow-up|0
7607742|NCT01877278|26470000|P2|Overall Study|Lost to Follow-up|3
7607743|NCT01877278|26470001|P1|Overall Study|Lost to Follow-up|3
7607744|NCT01877265|26470009|P6|Treatment Period 3|Lost to Follow-up|0
7607745|NCT01877265|26470010|P5|Treatment Period 3|Lost to Follow-up|0
7607746|NCT01877265|26470011|P4|Treatment Period 3|Lost to Follow-up|0
7607747|NCT01877265|26470012|P3|Treatment Period 3|Lost to Follow-up|0
7607748|NCT01877265|26470013|P2|Treatment Period 3|Lost to Follow-up|0
7607749|NCT01877265|26470014|P1|Treatment Period 3|Lost to Follow-up|1
7607750|NCT01877265|26470009|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
7607751|NCT01877265|26470010|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7607752|NCT01877265|26470011|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7607753|NCT01877265|26470012|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7607754|NCT01877265|26470013|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7607755|NCT01877265|26470014|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7607756|NCT01877265|26470009|P6|Treatment Period 1|Sponsor Decision|0
7607757|NCT01877265|26470010|P5|Treatment Period 1|Sponsor Decision|0
7607758|NCT01877265|26470011|P4|Treatment Period 1|Sponsor Decision|0
7607759|NCT01877265|26470012|P3|Treatment Period 1|Sponsor Decision|1
7607760|NCT01877265|26470013|P2|Treatment Period 1|Sponsor Decision|0
7607761|NCT01877265|26470014|P1|Treatment Period 1|Sponsor Decision|0
7607762|NCT01877239|26470031|P1|Overall Study|Data not available|35
7607763|NCT01877239|26470031|P1|Overall Study|Lack of Efficacy|4
7607764|NCT01877239|26470031|P1|Overall Study|Other|2
7607765|NCT01877239|26470031|P1|Overall Study|Withdrawal by Subject|4
7607766|NCT01877239|26470031|P1|Overall Study|Disease Remission|1
7607767|NCT01877239|26470031|P1|Overall Study|Adverse Event|4
7607768|NCT01877187|26470037|P1|Overall Study|Liver transplant|2
7607769|NCT01877187|26470037|P1|Overall Study|Declining clinical status|11
7607770|NCT01877187|26470037|P1|Overall Study|Lost to Follow-up|3
7607771|NCT01877187|26470037|P1|Overall Study|Withdrawal by Subject|4
7607772|NCT01877187|26470037|P1|Overall Study|Death|2
7607773|NCT01877083|26470089|P1|Extension Phase|Adverse Event|2
7607774|NCT01877083|26470089|P1|Extension Phase|Disease Progression|3
7607775|NCT01877083|26470089|P1|Treatment Phase|Lost to Follow-up|1
7607776|NCT01877083|26470089|P1|Treatment Phase|Withdrawal by Subject|2
7607777|NCT01877083|26470089|P1|Treatment Phase|Adverse Event|6
7607778|NCT01877083|26470089|P1|Treatment Phase|Clinical Progression|1
7607779|NCT01877083|26470089|P1|Treatment Phase|Disease Progression|10
7607780|NCT01876979|26470113|P2|Overall Study|Physician Decision|3
7607781|NCT01876979|26470114|P1|Overall Study|Physician Decision|2
7607782|NCT01876901|26470136|P2|Overall Study|No or other surgical intervention|5
7607783|NCT01876901|26470137|P1|Overall Study|No or other surgical intervention|7
7607784|NCT01876901|26470136|P2|Overall Study|Protocol Violation|2
7607785|NCT01876901|26470137|P1|Overall Study|Protocol Violation|10
7607786|NCT01876823|26470157|P1|Overall Study|Patients moved|2
7607787|NCT01876823|26470157|P1|Overall Study|Physician Decision|2
7607788|NCT01876823|26470157|P1|Overall Study|Withdrawal by Subject|5
7607789|NCT01876810|26470170|P2|Overall Study|Physician Decision|1
7607790|NCT01876810|26470171|P1|Overall Study|Physician Decision|0
7607791|NCT01876784|26470183|P2|Overall Study|Ongoing|40
7607792|NCT01876784|26470184|P1|Overall Study|Ongoing|41
7607793|NCT01876784|26470183|P2|Overall Study|Other than specified above|6
7607794|NCT01876784|26470184|P1|Overall Study|Other than specified above|5
7607795|NCT01876784|26470183|P2|Overall Study|Randomized but not treated|1
7607796|NCT01876784|26470184|P1|Overall Study|Randomized but not treated|2
7607797|NCT01876784|26470183|P2|Overall Study|Death|0
7607798|NCT01876784|26470184|P1|Overall Study|Death|1
7607799|NCT01876784|26470183|P2|Overall Study|Lost to Follow-up|1
7607800|NCT01876784|26470184|P1|Overall Study|Lost to Follow-up|0
7607801|NCT01876784|26470183|P2|Overall Study|Disease progression|67
7607802|NCT01876784|26470184|P1|Overall Study|Disease progression|37
7607803|NCT01876784|26470183|P2|Overall Study|Protocol Violation|0
7607804|NCT01876784|26470184|P1|Overall Study|Protocol Violation|1
7607805|NCT01876784|26470183|P2|Overall Study|Adverse Event|2
7607806|NCT01876784|26470184|P1|Overall Study|Adverse Event|15
7607807|NCT01876784|26470183|P2|Overall Study|Withdrawal by Subject|2
7607808|NCT01876784|26470184|P1|Overall Study|Withdrawal by Subject|17
7607809|NCT01876732|26470190|P1|Overall Study|MMA was not over 800mg/dL|75
7607810|NCT01876706|26470195|P1|Overall Study|Death|3
7607811|NCT01876706|26470195|P1|Overall Study|Withdrawals|6
7607812|NCT01876706|26470195|P1|Overall Study|Lost to Follow-up|7
7607813|NCT01876706|26470195|P1|Overall Study|BPH Intervention|9
7607814|NCT01876511|26470215|P3|Overall Study|Physician Decision|1
7607815|NCT01876511|26470216|P2|Overall Study|Physician Decision|0
7607816|NCT01876511|26470217|P1|Overall Study|Physician Decision|1
7607817|NCT01876511|26470215|P3|Overall Study|Patient Decision|6
7607818|NCT01876511|26470216|P2|Overall Study|Patient Decision|0
7607819|NCT01876511|26470217|P1|Overall Study|Patient Decision|3
7607820|NCT01876511|26470215|P3|Overall Study|Drug-related Toxicity|6
7607821|NCT01876511|26470216|P2|Overall Study|Drug-related Toxicity|1
7607822|NCT01876511|26470217|P1|Overall Study|Drug-related Toxicity|5
7607823|NCT01876511|26470215|P3|Overall Study|Death (unrelated)|2
7607824|NCT01876511|26470216|P2|Overall Study|Death (unrelated)|0
7607825|NCT01876511|26470217|P1|Overall Study|Death (unrelated)|3
7607826|NCT01876511|26470215|P3|Overall Study|Disease Progression-clinical/radiologic|16
7607827|NCT01876511|26470216|P2|Overall Study|Disease Progression-clinical/radiologic|24
7607828|NCT01876511|26470217|P1|Overall Study|Disease Progression-clinical/radiologic|11
7607829|NCT01876446|26470265|P2|Overall Study|Physician Decision|3
7607830|NCT01876446|26470266|P1|Overall Study|Physician Decision|1
7607831|NCT01876446|26470265|P2|Overall Study|Withdrawal by Subject|2
7607832|NCT01876446|26470266|P1|Overall Study|Withdrawal by Subject|1
7607833|NCT01876446|26470265|P2|Overall Study|Death|1
7607834|NCT01876446|26470266|P1|Overall Study|Death|0
7607835|NCT01876420|26470282|P1|Overall Study|Missed 30 day visit|1
7607836|NCT01876381|26470294|P1|Overall Study|Withdrawal by Subject|1
7607837|NCT01876381|26470294|P1|Overall Study|Physician Decision|1
7607838|NCT01876381|26470294|P1|Overall Study|Lack of Efficacy|5
7607839|NCT01876368|26470301|P2|Overall Study|Subject/guardian decision|1
7607840|NCT01876368|26470302|P1|Overall Study|Subject/guardian decision|3
7607841|NCT01876368|26470301|P2|Overall Study|Protocol deviation|3
7607842|NCT01876368|26470302|P1|Overall Study|Protocol deviation|3
7607843|NCT01876368|26470301|P2|Overall Study|Physician Decision|2
7607844|NCT01876368|26470302|P1|Overall Study|Physician Decision|0
7607845|NCT01876368|26470301|P2|Overall Study|Non-compliance with study treatment|1
7607846|NCT01876368|26470302|P1|Overall Study|Non-compliance with study treatment|0
7607847|NCT01876368|26470301|P2|Overall Study|Lost to Follow-up|1
7607848|NCT01876368|26470302|P1|Overall Study|Lost to Follow-up|0
7607849|NCT01876368|26470301|P2|Overall Study|Lack of Efficacy|0
7607850|NCT01876368|26470302|P1|Overall Study|Lack of Efficacy|1
7607851|NCT01876368|26470301|P2|Overall Study|Adverse Event|5
7607852|NCT01876368|26470302|P1|Overall Study|Adverse Event|2
7607853|NCT01876251|26470347|P3|Overall Study|Objective progression or relapse|8
7607854|NCT01876251|26470348|P2|Overall Study|Objective progression or relapse|3
7607855|NCT01876251|26470349|P1|Overall Study|Objective progression or relapse|10
7607856|NCT01876251|26470347|P3|Overall Study|Study terminated|0
7607857|NCT01876251|26470348|P2|Overall Study|Study terminated|0
7607858|NCT01876251|26470349|P1|Overall Study|Study terminated|1
7607859|NCT01876251|26470347|P3|Overall Study|Participant refused further follow-up|1
7607860|NCT01876251|26470348|P2|Overall Study|Participant refused further follow-up|0
7607861|NCT01876251|26470349|P1|Overall Study|Participant refused further follow-up|0
7607862|NCT01876251|26470347|P3|Overall Study|Participant started new treatment|1
7607863|NCT01876251|26470348|P2|Overall Study|Participant started new treatment|0
7607864|NCT01876251|26470349|P1|Overall Study|Participant started new treatment|1
7607865|NCT01876251|26470347|P3|Overall Study|Death|1
7607866|NCT01876251|26470348|P2|Overall Study|Death|0
7607867|NCT01876251|26470349|P1|Overall Study|Death|2
7607868|NCT01876251|26470347|P3|Overall Study|Clinical progression|0
7607869|NCT01876251|26470348|P2|Overall Study|Clinical progression|0
7607870|NCT01876251|26470349|P1|Overall Study|Clinical progression|1
7607871|NCT01876082|26470455|P2|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
7607872|NCT01876082|26470456|P1|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
7607873|NCT01876082|26470455|P2|Overall Study|Adverse Event|1
7607874|NCT01876082|26470456|P1|Overall Study|Adverse Event|1
7607875|NCT01876082|26470455|P2|Overall Study|Protocol Violation|0
7607876|NCT01876082|26470456|P1|Overall Study|Protocol Violation|1
7607877|NCT01876082|26470455|P2|Overall Study|Withdrawal by Subject|2
7607878|NCT01876082|26470456|P1|Overall Study|Withdrawal by Subject|0
7607879|NCT01876043|26470468|P1|Overall Study|Withdrawal by Subject|1
7607880|NCT01876043|26470468|P1|Overall Study|Death|1
7607881|NCT01875991|26470480|P2|Overall Study|Sponsor Decision|0
7607882|NCT01875991|26470481|P1|Overall Study|Sponsor Decision|1
7607883|NCT01875991|26470480|P2|Overall Study|Withdrawal by Subject|6
7607884|NCT01875991|26470481|P1|Overall Study|Withdrawal by Subject|6
7607885|NCT01875874|26470517|P1|Overall Study|Death|3
7607886|NCT01875848|26470537|P2|Overall Study|Withdrawal by Subject|0
7607887|NCT01875848|26470538|P1|Overall Study|Withdrawal by Subject|2
7607888|NCT01875731|26470555|P2|Overall Study|Fail to obtain lab sample|0
7607889|NCT01875731|26470556|P1|Overall Study|Fail to obtain lab sample|1
7607890|NCT01875471|26470575|P2|Overall Study|Unsatisfactory Lens Fitting|0
7607891|NCT01875471|26470576|P1|Overall Study|Unsatisfactory Lens Fitting|1
7607892|NCT01875471|26470575|P2|Overall Study|Adverse Event|1
7607893|NCT01875471|26470576|P1|Overall Study|Adverse Event|0
7607894|NCT01875445|26470584|P2|Overall Study|Withdrawal by Subject|0
7607895|NCT01875445|26470585|P1|Overall Study|Withdrawal by Subject|2
7607896|NCT01875445|26470584|P2|Overall Study|Lost to Follow-up|0
7607897|NCT01875445|26470585|P1|Overall Study|Lost to Follow-up|5
7607898|NCT01875367|26470595|P2|Overall Study|Not receive study treatment|0
7607899|NCT01875367|26470596|P1|Overall Study|Not receive study treatment|1
7607900|NCT01875367|26470595|P2|Overall Study|Not complete at least 2 questionaries|2
7607901|NCT01875367|26470596|P1|Overall Study|Not complete at least 2 questionaries|4
7607902|NCT01875250|26470613|P2|Overall Study|Adverse Event|0
7607903|NCT01875250|26470614|P1|Overall Study|Adverse Event|2
7607904|NCT01875237|26470629|P2|Overall Study|DLI cells could not be produced|0
7607905|NCT01875237|26470630|P1|Overall Study|DLI cells could not be produced|1
7607906|NCT01875237|26470629|P2|Overall Study|GVDH before DLI|0
7607907|NCT01875237|26470630|P1|Overall Study|GVDH before DLI|1
7607908|NCT01875185|26470656|P2|Overall Study|study was terminated|48
7607909|NCT01875185|26470657|P1|Overall Study|study was terminated|52
7607910|NCT01874665|26470742|P2|Overall Study|Other|0
7607911|NCT01874665|26470743|P1|Overall Study|Other|2
7607912|NCT01874665|26470742|P2|Overall Study|Documented Progressive Disease|7
7607913|NCT01874665|26470743|P1|Overall Study|Documented Progressive Disease|11
7607914|NCT01874665|26470742|P2|Overall Study|Study Terminated by Sponsor|2
7607915|NCT01874665|26470743|P1|Overall Study|Study Terminated by Sponsor|0
7607916|NCT01874665|26470742|P2|Overall Study|Clinical Progressive Disease|3
7607917|NCT01874665|26470743|P1|Overall Study|Clinical Progressive Disease|4
7607918|NCT01874665|26470742|P2|Overall Study|Physician Decision|0
7607919|NCT01874665|26470743|P1|Overall Study|Physician Decision|3
7607920|NCT01874665|26470742|P2|Overall Study|Withdrawal by Subject|1
7607921|NCT01874665|26470743|P1|Overall Study|Withdrawal by Subject|4
7607922|NCT01874665|26470742|P2|Overall Study|Adverse Event|2
7607923|NCT01874665|26470743|P1|Overall Study|Adverse Event|6
7607924|NCT01874535|26470771|P2|Overall Study|incomplete symptom resolution|35
7607925|NCT01874535|26470772|P1|Overall Study|incomplete symptom resolution|45
7607926|NCT01874535|26470771|P2|Overall Study|Lost to Follow-up|9
7607927|NCT01874535|26470772|P1|Overall Study|Lost to Follow-up|10
7607928|NCT01874431|26470786|P8|Overall Study|Lost to Follow-up|0
7607929|NCT01874431|26470787|P7|Overall Study|Lost to Follow-up|0
7607930|NCT01874431|26470788|P6|Overall Study|Lost to Follow-up|0
7607931|NCT01874431|26470789|P5|Overall Study|Lost to Follow-up|0
7607932|NCT01874431|26470790|P4|Overall Study|Lost to Follow-up|0
7607933|NCT01874431|26470791|P3|Overall Study|Lost to Follow-up|1
7607934|NCT01874431|26470792|P2|Overall Study|Lost to Follow-up|0
7607935|NCT01874431|26470793|P1|Overall Study|Lost to Follow-up|0
7607936|NCT01874431|26470786|P8|Overall Study|Sponsor decision|0
7607937|NCT01874431|26470787|P7|Overall Study|Sponsor decision|0
7607938|NCT01874431|26470788|P6|Overall Study|Sponsor decision|0
7607939|NCT01874431|26470789|P5|Overall Study|Sponsor decision|1
7607940|NCT01874431|26470790|P4|Overall Study|Sponsor decision|0
7607941|NCT01874431|26470791|P3|Overall Study|Sponsor decision|0
7607942|NCT01874431|26470792|P2|Overall Study|Sponsor decision|0
7607943|NCT01874431|26470793|P1|Overall Study|Sponsor decision|0
7607944|NCT01874431|26470786|P8|Overall Study|Withdrawal by Subject|0
7607945|NCT01874431|26470787|P7|Overall Study|Withdrawal by Subject|3
7607946|NCT01874431|26470788|P6|Overall Study|Withdrawal by Subject|1
7607947|NCT01874431|26470789|P5|Overall Study|Withdrawal by Subject|1
7607948|NCT01874431|26470790|P4|Overall Study|Withdrawal by Subject|2
7607949|NCT01874431|26470791|P3|Overall Study|Withdrawal by Subject|1
7607950|NCT01874431|26470792|P2|Overall Study|Withdrawal by Subject|0
7607951|NCT01874431|26470793|P1|Overall Study|Withdrawal by Subject|0
7607952|NCT01874431|26470786|P8|Overall Study|Logistical difficulties|0
7607953|NCT01874431|26470787|P7|Overall Study|Logistical difficulties|1
7607954|NCT01874431|26470788|P6|Overall Study|Logistical difficulties|0
7607955|NCT01874431|26470789|P5|Overall Study|Logistical difficulties|0
7607956|NCT01874431|26470790|P4|Overall Study|Logistical difficulties|0
7607957|NCT01874431|26470791|P3|Overall Study|Logistical difficulties|0
7607958|NCT01874431|26470792|P2|Overall Study|Logistical difficulties|0
7607959|NCT01874431|26470793|P1|Overall Study|Logistical difficulties|0
7607960|NCT01874431|26470786|P8|Overall Study|Non-compliance|0
7607961|NCT01874431|26470787|P7|Overall Study|Non-compliance|1
7607962|NCT01874431|26470788|P6|Overall Study|Non-compliance|0
7607963|NCT01874431|26470789|P5|Overall Study|Non-compliance|1
7607964|NCT01874431|26470790|P4|Overall Study|Non-compliance|0
7607965|NCT01874431|26470791|P3|Overall Study|Non-compliance|0
7607966|NCT01874431|26470792|P2|Overall Study|Non-compliance|0
7607967|NCT01874431|26470793|P1|Overall Study|Non-compliance|0
7607968|NCT01874431|26470786|P8|Overall Study|Protocol Violation|1
7607969|NCT01874431|26470787|P7|Overall Study|Protocol Violation|1
7607970|NCT01874431|26470788|P6|Overall Study|Protocol Violation|2
7607971|NCT01874431|26470789|P5|Overall Study|Protocol Violation|3
7607972|NCT01874431|26470790|P4|Overall Study|Protocol Violation|0
7607973|NCT01874431|26470791|P3|Overall Study|Protocol Violation|1
7607974|NCT01874431|26470792|P2|Overall Study|Protocol Violation|1
7607975|NCT01874431|26470793|P1|Overall Study|Protocol Violation|1
7607976|NCT01874431|26470786|P8|Overall Study|Adverse Event|3
7607977|NCT01874431|26470787|P7|Overall Study|Adverse Event|2
7607978|NCT01874431|26470788|P6|Overall Study|Adverse Event|8
7607979|NCT01874431|26470789|P5|Overall Study|Adverse Event|2
7607980|NCT01874431|26470790|P4|Overall Study|Adverse Event|5
7607981|NCT01874431|26470791|P3|Overall Study|Adverse Event|6
7607982|NCT01874431|26470792|P2|Overall Study|Adverse Event|4
7607983|NCT01874431|26470793|P1|Overall Study|Adverse Event|5
7607984|NCT01874431|26470786|P8|Overall Study|Physician Decision|0
7607985|NCT01874431|26470787|P7|Overall Study|Physician Decision|0
7607986|NCT01874431|26470788|P6|Overall Study|Physician Decision|0
7607987|NCT01874431|26470789|P5|Overall Study|Physician Decision|0
7607988|NCT01874431|26470790|P4|Overall Study|Physician Decision|0
7607989|NCT01874431|26470791|P3|Overall Study|Physician Decision|1
7607990|NCT01874431|26470792|P2|Overall Study|Physician Decision|0
7607991|NCT01874431|26470793|P1|Overall Study|Physician Decision|0
7608008|NCT01874340|26470891|P4|Overall Study|Withdrawal by Subject|1
7608009|NCT01874340|26470892|P3|Overall Study|Withdrawal by Subject|0
7608010|NCT01874340|26470893|P2|Overall Study|Withdrawal by Subject|0
7608011|NCT01874340|26470894|P1|Overall Study|Withdrawal by Subject|0
7608012|NCT01874340|26470891|P4|Overall Study|Study terminated by Sponsor|4
7608013|NCT01874340|26470892|P3|Overall Study|Study terminated by Sponsor|8
7608014|NCT01874340|26470893|P2|Overall Study|Study terminated by Sponsor|8
7608015|NCT01874340|26470894|P1|Overall Study|Study terminated by Sponsor|6
7608016|NCT01874288|26470925|P5|Overall Study|Progressive disease|1
7608017|NCT01874288|26470926|P4|Overall Study|Progressive disease|5
7608018|NCT01874288|26470927|P3|Overall Study|Progressive disease|3
7608019|NCT01874288|26470928|P2|Overall Study|Progressive disease|0
7608020|NCT01874288|26470929|P1|Overall Study|Progressive disease|2
7608021|NCT01874288|26470925|P5|Overall Study|Physician Decision|0
7608022|NCT01874288|26470926|P4|Overall Study|Physician Decision|1
7608023|NCT01874288|26470927|P3|Overall Study|Physician Decision|0
7608024|NCT01874288|26470928|P2|Overall Study|Physician Decision|0
7608025|NCT01874288|26470929|P1|Overall Study|Physician Decision|0
7608026|NCT01874288|26470925|P5|Overall Study|Withdrawal by Subject|1
7608027|NCT01874288|26470926|P4|Overall Study|Withdrawal by Subject|1
7608028|NCT01874288|26470927|P3|Overall Study|Withdrawal by Subject|2
7608029|NCT01874288|26470928|P2|Overall Study|Withdrawal by Subject|0
7608030|NCT01874288|26470929|P1|Overall Study|Withdrawal by Subject|1
7608031|NCT01874275|26470964|P2|Overall Study|Lost to Follow-up|0
7608032|NCT01874275|26470965|P1|Overall Study|Lost to Follow-up|1
7608033|NCT01874145|26470988|P2|Extension Period|Lost to Follow-up|1
7608034|NCT01874145|26470989|P1|Extension Period|Lost to Follow-up|1
7608035|NCT01874145|26470988|P2|Extension Period|Withdrawal by Subject|1
7608036|NCT01874145|26470989|P1|Extension Period|Withdrawal by Subject|2
7608037|NCT01874145|26470988|P2|Extension Period|Adverse Event|2
7608038|NCT01874145|26470989|P1|Extension Period|Adverse Event|3
7608039|NCT01874145|26470988|P2|Core Period|Withdrawal by Subject|4
7608040|NCT01874145|26470989|P1|Core Period|Withdrawal by Subject|0
7608041|NCT01874145|26470988|P2|Core Period|Adverse Event|1
7608042|NCT01874145|26470989|P1|Core Period|Adverse Event|0
7608043|NCT01874145|26470988|P2|Core Period|Physician Decision|1
7608044|NCT01874145|26470989|P1|Core Period|Physician Decision|1
7608045|NCT01874145|26470988|P2|Core Period|Protocol Violation|1
7608046|NCT01874145|26470989|P1|Core Period|Protocol Violation|1
7608047|NCT01874145|26470988|P2|Core Period|Non-compliance|0
7608048|NCT01874145|26470989|P1|Core Period|Non-compliance|1
7608049|NCT01874054|26471048|P1|Overall Study|Death|5
7608050|NCT01874054|26471048|P1|Overall Study|Lost to Follow-up|5
7608051|NCT01874054|26471048|P1|Overall Study|Study Termination by Sponsor|42
7608052|NCT01874054|26471048|P1|Overall Study|Withdrawal by Subject|3
7608053|NCT01873950|26471070|P5|Period 5|Withdrawal by Subject|0
7608054|NCT01873950|26471071|P4|Period 5|Withdrawal by Subject|1
7608055|NCT01873950|26471072|P3|Period 5|Withdrawal by Subject|0
7608056|NCT01873950|26471073|P2|Period 5|Withdrawal by Subject|0
7608057|NCT01873950|26471074|P1|Period 5|Withdrawal by Subject|0
7608058|NCT01873859|26471111|P2|Overall Study|Withdrawal by Subject|4
7608059|NCT01873859|26471112|P1|Overall Study|Withdrawal by Subject|0
7608060|NCT01873742|26471130|P2|Overall Study|Lost to Follow-up|76
7608061|NCT01873742|26471131|P1|Overall Study|Lost to Follow-up|68
7608062|NCT01873729|26471137|P1|Overall Study|Withdrawal by Subject|1
7608063|NCT01873586|26471142|P1|Overall Study|Lost to Follow-up|3
7608064|NCT01873495|26471155|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
7608065|NCT01873495|26471155|P1|Overall Study|Removed for Transplantation|1
7608066|NCT01873495|26471155|P1|Overall Study|Adverse Event|1
7608067|NCT01873495|26471155|P1|Overall Study|Physician Decision|3
7608068|NCT01873495|26471155|P1|Overall Study|Withdrawal by Subject|1
7608069|NCT01873417|26471163|P1|Overall Study|Physician Decision|3
7608070|NCT01873417|26471163|P1|Overall Study|Withdrawal by Subject|2
7608071|NCT01873417|26471163|P1|Overall Study|Lost to Follow-up|2
7608072|NCT01873417|26471163|P1|Overall Study|Adverse Event|24
7608073|NCT01873417|26471163|P1|Overall Study|Did Not Receive Any Study Drug|4
7608074|NCT01872910|26471191|P6|Overall Study|Lost to Follow-up|0
7608075|NCT01872910|26471192|P5|Overall Study|Lost to Follow-up|0
7608076|NCT01872910|26471193|P4|Overall Study|Lost to Follow-up|0
7608077|NCT01872910|26471194|P3|Overall Study|Lost to Follow-up|2
7608078|NCT01872910|26471195|P2|Overall Study|Lost to Follow-up|0
7608079|NCT01872910|26471196|P1|Overall Study|Lost to Follow-up|2
7608080|NCT01872715|26471241|P1|Overall Study|Withdrawal by Subject|2
7608081|NCT01872715|26471241|P1|Overall Study|Protocol Violation|1
7608082|NCT01872715|26471241|P1|Overall Study|Adverse Event|1
7608083|NCT01872689|26471260|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7608084|NCT01872689|26471261|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7608085|NCT01872689|26471262|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
7608086|NCT01872689|26471263|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
7608087|NCT01872689|26471260|P4|Open-Label Period (Only For Monotherapy)|Death|0
7608088|NCT01872689|26471261|P3|Open-Label Period (Only For Monotherapy)|Death|0
7608089|NCT01872689|26471262|P2|Open-Label Period (Only For Monotherapy)|Death|3
7608090|NCT01872689|26471263|P1|Open-Label Period (Only For Monotherapy)|Death|5
7608091|NCT01872689|26471260|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7608092|NCT01872689|26471261|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7608093|NCT01872689|26471262|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
7608094|NCT01872689|26471263|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
7608095|NCT01872689|26471260|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7608096|NCT01872689|26471261|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7608097|NCT01872689|26471262|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
7608098|NCT01872689|26471263|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7608099|NCT01872689|26471260|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7608100|NCT01872689|26471261|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7608101|NCT01872689|26471262|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
7608102|NCT01872689|26471263|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
7608103|NCT01872689|26471260|P4|Open-Label Period (Only For Monotherapy)|Other|0
7608104|NCT01872689|26471261|P3|Open-Label Period (Only For Monotherapy)|Other|0
7608105|NCT01872689|26471262|P2|Open-Label Period (Only For Monotherapy)|Other|3
7608106|NCT01872689|26471263|P1|Open-Label Period (Only For Monotherapy)|Other|2
7608107|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
7608108|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
7608109|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
7608110|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
7608111|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Death|9
7608112|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Death|14
7608113|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Death|4
7608114|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Death|3
7608115|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7608116|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7608117|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7608118|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7608119|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
7608120|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7608121|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7608122|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
7608123|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7608124|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7608125|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7608126|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7608127|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
7608128|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
7608129|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
7608130|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
7608131|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Other|3
7608132|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Other|6
7608133|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Other|1
7608134|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Other|1
7608135|NCT01872689|26471260|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7608136|NCT01872689|26471261|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7608137|NCT01872689|26471262|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
7608138|NCT01872689|26471263|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7608139|NCT01872611|26471339|P2|Overall Study|Reason not provided|6
7608140|NCT01872611|26471340|P1|Overall Study|Reason not provided|6
7608141|NCT01872611|26471339|P2|Overall Study|Withdrawal by Subject|1
7608142|NCT01872611|26471340|P1|Overall Study|Withdrawal by Subject|6
7608143|NCT01872611|26471339|P2|Overall Study|Physician Decision|0
7608144|NCT01872611|26471340|P1|Overall Study|Physician Decision|1
7608145|NCT01872611|26471339|P2|Overall Study|Lost to Follow-up|1
7608146|NCT01872611|26471340|P1|Overall Study|Lost to Follow-up|8
7608147|NCT01872611|26471339|P2|Overall Study|Death, prior to treatment|1
7608148|NCT01872611|26471340|P1|Overall Study|Death, prior to treatment|0
7608149|NCT01872611|26471339|P2|Overall Study|Death|1
7608150|NCT01872611|26471340|P1|Overall Study|Death|0
7608151|NCT01872611|26471339|P2|Overall Study|Adverse Event, prior to treatment|1
7608152|NCT01872611|26471340|P1|Overall Study|Adverse Event, prior to treatment|0
7608153|NCT01872611|26471339|P2|Overall Study|Adverse Event|1
7608154|NCT01872611|26471340|P1|Overall Study|Adverse Event|3
7608155|NCT01872078|26471392|P4|Overall Study|Patient met exclusion criterion 16.|1
7608156|NCT01872078|26471393|P3|Overall Study|Patient met exclusion criterion 16.|0
7608157|NCT01872078|26471394|P2|Overall Study|Patient met exclusion criterion 16.|0
7608158|NCT01872078|26471395|P1|Overall Study|Patient met exclusion criterion 16.|0
7608159|NCT01872078|26471392|P4|Overall Study|Withdrawal by Subject|0
7608160|NCT01872078|26471393|P3|Overall Study|Withdrawal by Subject|1
7608161|NCT01872078|26471394|P2|Overall Study|Withdrawal by Subject|0
7608162|NCT01872078|26471395|P1|Overall Study|Withdrawal by Subject|0
7608163|NCT01872078|26471392|P4|Overall Study|Protocol Violation|0
7608164|NCT01872078|26471393|P3|Overall Study|Protocol Violation|1
7608165|NCT01872078|26471394|P2|Overall Study|Protocol Violation|0
7608166|NCT01872078|26471395|P1|Overall Study|Protocol Violation|0
7608167|NCT01872078|26471392|P4|Overall Study|Dose administration non-compliance|1
7608168|NCT01872078|26471393|P3|Overall Study|Dose administration non-compliance|0
7608169|NCT01872078|26471394|P2|Overall Study|Dose administration non-compliance|0
7608170|NCT01872078|26471395|P1|Overall Study|Dose administration non-compliance|0
7608171|NCT01872078|26471392|P4|Overall Study|Adverse Event|0
7608172|NCT01872078|26471393|P3|Overall Study|Adverse Event|1
7608173|NCT01872078|26471394|P2|Overall Study|Adverse Event|0
7608174|NCT01872078|26471395|P1|Overall Study|Adverse Event|0
7608175|NCT01871870|26471405|P1|Overall Study|hyperglycemia|2
7608176|NCT01871870|26471405|P1|Overall Study|Hardware issues|7
7608177|NCT01871805|26471416|P6|Phase II|Lost to Follow-up|13
7608178|NCT01871805|26471417|P5|Phase II|Lost to Follow-up|0
7608179|NCT01871805|26471418|P4|Phase II|Lost to Follow-up|0
7608180|NCT01871805|26471419|P3|Phase II|Lost to Follow-up|0
7608181|NCT01871805|26471420|P2|Phase II|Lost to Follow-up|0
7608182|NCT01871805|26471421|P1|Phase II|Lost to Follow-up|0
7608183|NCT01871805|26471416|P6|Phase II|Alive in Survival Follow-up|29
7608184|NCT01871805|26471417|P5|Phase II|Alive in Survival Follow-up|0
7608185|NCT01871805|26471418|P4|Phase II|Alive in Survival Follow-up|0
7608186|NCT01871805|26471419|P3|Phase II|Alive in Survival Follow-up|0
7608187|NCT01871805|26471420|P2|Phase II|Alive in Survival Follow-up|0
7608188|NCT01871805|26471421|P1|Phase II|Alive in Survival Follow-up|0
7608189|NCT01871805|26471416|P6|Phase II|Death|45
7608190|NCT01871805|26471417|P5|Phase II|Death|0
7608191|NCT01871805|26471418|P4|Phase II|Death|0
7608192|NCT01871805|26471419|P3|Phase II|Death|0
7608193|NCT01871805|26471420|P2|Phase II|Death|0
7608194|NCT01871805|26471421|P1|Phase II|Death|0
7608195|NCT01871805|26471416|P6|Phase I|Lost to Follow-up|0
7608196|NCT01871805|26471417|P5|Phase I|Lost to Follow-up|0
7608197|NCT01871805|26471418|P4|Phase I|Lost to Follow-up|0
7608198|NCT01871805|26471419|P3|Phase I|Lost to Follow-up|3
7608199|NCT01871805|26471420|P2|Phase I|Lost to Follow-up|1
7608200|NCT01871805|26471421|P1|Phase I|Lost to Follow-up|0
7608201|NCT01871805|26471416|P6|Phase I|Alive in Survival Follow-up|0
7608202|NCT01871805|26471417|P5|Phase I|Alive in Survival Follow-up|4
7608203|NCT01871805|26471418|P4|Phase I|Alive in Survival Follow-up|5
7608204|NCT01871805|26471419|P3|Phase I|Alive in Survival Follow-up|4
7608205|NCT01871805|26471420|P2|Phase I|Alive in Survival Follow-up|2
7608206|NCT01871805|26471421|P1|Phase I|Alive in Survival Follow-up|0
7608207|NCT01871805|26471416|P6|Phase I|Death|0
7608208|NCT01871805|26471417|P5|Phase I|Death|9
7608209|NCT01871805|26471418|P4|Phase I|Death|2
7608210|NCT01871805|26471419|P3|Phase I|Death|6
7608211|NCT01871805|26471420|P2|Phase I|Death|4
7608212|NCT01871805|26471421|P1|Phase I|Death|7
7608213|NCT01871558|26471493|P2|Overall Study|Withdrawal by Subject|0
7608214|NCT01871558|26471494|P1|Overall Study|Withdrawal by Subject|2
7608215|NCT01871558|26471493|P2|Overall Study|antidiabetic drug prematurely stopped|1
7608216|NCT01871558|26471494|P1|Overall Study|antidiabetic drug prematurely stopped|1
7608217|NCT01871558|26471493|P2|Overall Study|Other reason|1
7608218|NCT01871558|26471494|P1|Overall Study|Other reason|0
7608219|NCT01871545|26471514|P2|Overall Study|Withdrawal by Subject|1
7608220|NCT01871545|26471515|P1|Overall Study|Withdrawal by Subject|0
7608221|NCT01871545|26471514|P2|Overall Study|Physician Decision|0
7608222|NCT01871545|26471515|P1|Overall Study|Physician Decision|4
7608223|NCT01871545|26471514|P2|Overall Study|Lack of Efficacy|2
7608224|NCT01871545|26471515|P1|Overall Study|Lack of Efficacy|11
7608225|NCT01871545|26471514|P2|Overall Study|Death|0
7608226|NCT01871545|26471515|P1|Overall Study|Death|2
7608227|NCT01871532|26471556|P2|Overall Study|Withdrawal by Subject|2
7608228|NCT01871532|26471557|P1|Overall Study|Withdrawal by Subject|1
7608229|NCT01871519|26471591|P1|Overall Study|Withdrawal by Subject|49
7608230|NCT01871519|26471591|P1|Overall Study|Lost to Follow-up|15
7608231|NCT01871519|26471591|P1|Overall Study|Death|26
7608232|NCT01871402|26471648|P2|Overall Study|Non-compliance|1
7608233|NCT01871402|26471649|P1|Overall Study|Non-compliance|0
7608234|NCT01871402|26471648|P2|Overall Study|Withdrawal by Subject|2
7608235|NCT01871402|26471649|P1|Overall Study|Withdrawal by Subject|0
7608236|NCT01871402|26471648|P2|Overall Study|Lost to Follow-up|0
7608237|NCT01871402|26471649|P1|Overall Study|Lost to Follow-up|1
7608238|NCT01871285|26471667|P4|First Intervention (1 Day)|Lost to Follow-up|0
7608239|NCT01871285|26471668|P3|First Intervention (1 Day)|Lost to Follow-up|1
7608240|NCT01871285|26471669|P2|First Intervention (1 Day)|Lost to Follow-up|1
7608241|NCT01871285|26471670|P1|First Intervention (1 Day)|Lost to Follow-up|0
7608242|NCT01871285|26471667|P4|First Intervention (1 Day)|Adverse Event|0
7608243|NCT01871285|26471668|P3|First Intervention (1 Day)|Adverse Event|0
7608244|NCT01871285|26471669|P2|First Intervention (1 Day)|Adverse Event|0
7608245|NCT01871285|26471670|P1|First Intervention (1 Day)|Adverse Event|1
7608246|NCT01871142|26471696|P1|Overall Study|Adverse Event|1
7608247|NCT01871090|26471712|P2|Overall Study|Subject Non-Compliance|1
7608248|NCT01871090|26471713|P1|Overall Study|Subject Non-Compliance|0
7608249|NCT01871090|26471712|P2|Overall Study|Interrogation not completed correctly|0
7608250|NCT01871090|26471713|P1|Overall Study|Interrogation not completed correctly|1
7608251|NCT01871090|26471712|P2|Overall Study|Interrogation not done in Emergency Room|22
7608252|NCT01871090|26471713|P1|Overall Study|Interrogation not done in Emergency Room|1
7608253|NCT01870999|26471733|P3|Overall Study|Protocol Violation|1
7608254|NCT01870999|26471734|P2|Overall Study|Protocol Violation|0
7608255|NCT01870999|26471735|P1|Overall Study|Protocol Violation|0
7608256|NCT01870999|26471733|P3|Overall Study|Withdrawal by Subject|5
7608257|NCT01870999|26471734|P2|Overall Study|Withdrawal by Subject|2
7608258|NCT01870999|26471735|P1|Overall Study|Withdrawal by Subject|0
7608259|NCT01870999|26471733|P3|Overall Study|Subject withdrawn by Investigator|0
7608260|NCT01870999|26471734|P2|Overall Study|Subject withdrawn by Investigator|0
7608261|NCT01870999|26471735|P1|Overall Study|Subject withdrawn by Investigator|1
7608262|NCT01870999|26471733|P3|Overall Study|Subject met withdrawal criteria|0
7608263|NCT01870999|26471734|P2|Overall Study|Subject met withdrawal criteria|2
7608264|NCT01870999|26471735|P1|Overall Study|Subject met withdrawal criteria|3
7608265|NCT01870999|26471733|P3|Overall Study|Adverse Event|1
7608266|NCT01870999|26471734|P2|Overall Study|Adverse Event|4
7608267|NCT01870999|26471735|P1|Overall Study|Adverse Event|0
7608268|NCT01870973|26471793|P2|Overall Study|Lost to Follow-up|3
7608269|NCT01870973|26471794|P1|Overall Study|Lost to Follow-up|10
7608270|NCT01870921|26471800|P1|Overall Study|Other|1
7608271|NCT01870921|26471800|P1|Overall Study|Subject Lost to Follow up|2
7608272|NCT01870921|26471800|P1|Overall Study|Severe non-compliance to protocol|7
7608273|NCT01870921|26471800|P1|Overall Study|Subject decision|80
7608274|NCT01870869|26471810|P4|Overall Study|Not evaluable|10
7608275|NCT01870869|26471811|P3|Overall Study|Not evaluable|42
7608276|NCT01870869|26471812|P2|Overall Study|Not evaluable|5
7608277|NCT01870869|26471813|P1|Overall Study|Not evaluable|10
7608278|NCT01870869|26471810|P4|Overall Study|Reason not Specified|4
7608279|NCT01870869|26471811|P3|Overall Study|Reason not Specified|20
7608280|NCT01870869|26471812|P2|Overall Study|Reason not Specified|2
7608281|NCT01870869|26471813|P1|Overall Study|Reason not Specified|1
7608282|NCT01870869|26471810|P4|Overall Study|Lost to Follow-up|3
7608283|NCT01870869|26471811|P3|Overall Study|Lost to Follow-up|25
7608284|NCT01870869|26471812|P2|Overall Study|Lost to Follow-up|2
7608285|NCT01870869|26471813|P1|Overall Study|Lost to Follow-up|10
7608286|NCT01870869|26471810|P4|Overall Study|Subject choice|8
7608287|NCT01870869|26471811|P3|Overall Study|Subject choice|22
7608288|NCT01870869|26471812|P2|Overall Study|Subject choice|2
7608289|NCT01870869|26471813|P1|Overall Study|Subject choice|6
7608290|NCT01870869|26471810|P4|Overall Study|Death|1
7608291|NCT01870869|26471811|P3|Overall Study|Death|7
7608292|NCT01870869|26471812|P2|Overall Study|Death|0
7608293|NCT01870869|26471813|P1|Overall Study|Death|0
7608294|NCT01870869|26471810|P4|Overall Study|Implanted with nonstudy device|4
7608295|NCT01870869|26471811|P3|Overall Study|Implanted with nonstudy device|14
7608296|NCT01870869|26471812|P2|Overall Study|Implanted with nonstudy device|3
7608297|NCT01870869|26471813|P1|Overall Study|Implanted with nonstudy device|1
7608298|NCT01870843|26471852|P1|Overall Study|Withdrawal by Subject|18
7608299|NCT01870843|26471852|P1|Overall Study|Death|1
7608300|NCT01870843|26471852|P1|Overall Study|Lost to Follow-up|24
7608301|NCT01870843|26471852|P1|Overall Study|Adverse Event|10
7608302|NCT01870778|26471867|P2|Overall Study|Lost to Follow-up|2
7608303|NCT01870778|26471868|P1|Overall Study|Lost to Follow-up|0
7608304|NCT01870778|26471867|P2|Overall Study|Withdrawal by Subject|7
7608305|NCT01870778|26471868|P1|Overall Study|Withdrawal by Subject|8
7608306|NCT01870739|26471894|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
7608307|NCT01870739|26471895|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
7608308|NCT01870739|26471894|P2|Add-on Period (40 Weeks)|Protocol deviation|1
7608309|NCT01870739|26471895|P1|Add-on Period (40 Weeks)|Protocol deviation|1
7608310|NCT01870739|26471894|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
7608311|NCT01870739|26471895|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
7608312|NCT01870739|26471894|P2|Add-on Period (40 Weeks)|Adverse Event|1
7608313|NCT01870739|26471895|P1|Add-on Period (40 Weeks)|Adverse Event|0
7608314|NCT01870739|26471894|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
7608315|NCT01870739|26471895|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
7608316|NCT01870739|26471894|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
7608317|NCT01870739|26471895|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
7608318|NCT01870739|26471894|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
7608319|NCT01870739|26471895|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
7608320|NCT01870726|26471934|P7|Overall Study|Progressive disease|10
7608321|NCT01870726|26471935|P6|Overall Study|Progressive disease|4
7608322|NCT01870726|26471936|P5|Overall Study|Progressive disease|6
7608323|NCT01870726|26471937|P4|Overall Study|Progressive disease|5
7608324|NCT01870726|26471938|P3|Overall Study|Progressive disease|4
7608325|NCT01870726|26471939|P2|Overall Study|Progressive disease|5
7608326|NCT01870726|26471940|P1|Overall Study|Progressive disease|5
7608327|NCT01870726|26471934|P7|Overall Study|Adverse Event|0
7608328|NCT01870726|26471935|P6|Overall Study|Adverse Event|1
7608329|NCT01870726|26471936|P5|Overall Study|Adverse Event|1
7608330|NCT01870726|26471937|P4|Overall Study|Adverse Event|0
7608331|NCT01870726|26471938|P3|Overall Study|Adverse Event|0
7608332|NCT01870726|26471939|P2|Overall Study|Adverse Event|0
7608333|NCT01870726|26471940|P1|Overall Study|Adverse Event|0
7608334|NCT01870726|26471934|P7|Overall Study|Withdrawal by Subject|0
7608335|NCT01870726|26471935|P6|Overall Study|Withdrawal by Subject|0
7608336|NCT01870726|26471936|P5|Overall Study|Withdrawal by Subject|0
7608337|NCT01870726|26471937|P4|Overall Study|Withdrawal by Subject|0
7608338|NCT01870726|26471938|P3|Overall Study|Withdrawal by Subject|0
7608339|NCT01870726|26471939|P2|Overall Study|Withdrawal by Subject|1
7608340|NCT01870726|26471940|P1|Overall Study|Withdrawal by Subject|0
7608341|NCT01870726|26471934|P7|Overall Study|Withdrawal of informed consent|0
7608342|NCT01870726|26471935|P6|Overall Study|Withdrawal of informed consent|0
7608343|NCT01870726|26471936|P5|Overall Study|Withdrawal of informed consent|0
7608344|NCT01870726|26471937|P4|Overall Study|Withdrawal of informed consent|1
7608345|NCT01870726|26471938|P3|Overall Study|Withdrawal of informed consent|0
7608346|NCT01870726|26471939|P2|Overall Study|Withdrawal of informed consent|0
7608347|NCT01870726|26471940|P1|Overall Study|Withdrawal of informed consent|0
7608348|NCT01870583|26472035|P3|Overall Study|Lost to Follow-up|5
7608349|NCT01870583|26472036|P2|Overall Study|Lost to Follow-up|13
7608350|NCT01870583|26472037|P1|Overall Study|Lost to Follow-up|11
7608351|NCT01870583|26472035|P3|Overall Study|Protocol Violation|3
7608352|NCT01870583|26472036|P2|Overall Study|Protocol Violation|5
7608353|NCT01870583|26472037|P1|Overall Study|Protocol Violation|0
7608354|NCT01870401|26472047|P2|Overall Study|On-going in the Study|25
7608355|NCT01870401|26472048|P1|Overall Study|On-going in the Study|35
7608356|NCT01870401|26472047|P2|Overall Study|Other|7
7608357|NCT01870401|26472048|P1|Overall Study|Other|9
7608358|NCT01870401|26472047|P2|Overall Study|Lost to Follow-up|14
7608359|NCT01870401|26472048|P1|Overall Study|Lost to Follow-up|19
7608360|NCT01870401|26472047|P2|Overall Study|Withdrawal by Subject|26
7608361|NCT01870401|26472048|P1|Overall Study|Withdrawal by Subject|39
7608362|NCT01870401|26472047|P2|Overall Study|Death|24
7608363|NCT01870401|26472048|P1|Overall Study|Death|48
7608364|NCT01870297|26472124|P7|Overall Study|Sponsor Decision|1
7608365|NCT01870297|26472125|P6|Overall Study|Sponsor Decision|0
7608366|NCT01870297|26472126|P5|Overall Study|Sponsor Decision|0
7608367|NCT01870297|26472127|P4|Overall Study|Sponsor Decision|0
7608368|NCT01870297|26472128|P3|Overall Study|Sponsor Decision|0
7608369|NCT01870297|26472129|P2|Overall Study|Sponsor Decision|6
7608370|NCT01870297|26472130|P1|Overall Study|Sponsor Decision|0
7608371|NCT01870297|26472124|P7|Overall Study|Withdrawal by Subject|1
7608372|NCT01870297|26472125|P6|Overall Study|Withdrawal by Subject|1
7608373|NCT01870297|26472126|P5|Overall Study|Withdrawal by Subject|1
7608374|NCT01870297|26472127|P4|Overall Study|Withdrawal by Subject|0
7608375|NCT01870297|26472128|P3|Overall Study|Withdrawal by Subject|0
7608376|NCT01870297|26472129|P2|Overall Study|Withdrawal by Subject|0
7608377|NCT01870297|26472130|P1|Overall Study|Withdrawal by Subject|0
7608378|NCT01870297|26472124|P7|Overall Study|Lost to Follow-up|0
7608379|NCT01870297|26472125|P6|Overall Study|Lost to Follow-up|0
7608380|NCT01870297|26472126|P5|Overall Study|Lost to Follow-up|0
7608381|NCT01870297|26472127|P4|Overall Study|Lost to Follow-up|0
7608382|NCT01870297|26472128|P3|Overall Study|Lost to Follow-up|1
7608383|NCT01870297|26472129|P2|Overall Study|Lost to Follow-up|1
7608384|NCT01870297|26472130|P1|Overall Study|Lost to Follow-up|0
7608385|NCT01870297|26472124|P7|Overall Study|Adverse Event|0
7608386|NCT01870297|26472125|P6|Overall Study|Adverse Event|0
7608387|NCT01870297|26472126|P5|Overall Study|Adverse Event|2
7608388|NCT01870297|26472127|P4|Overall Study|Adverse Event|0
7608389|NCT01870297|26472128|P3|Overall Study|Adverse Event|0
7608390|NCT01870297|26472129|P2|Overall Study|Adverse Event|0
7608391|NCT01870297|26472130|P1|Overall Study|Adverse Event|0
7608392|NCT01870076|26472174|P4|Overall Study|Withdrawal by Subject|0
7608393|NCT01870076|26472175|P3|Overall Study|Withdrawal by Subject|1
7608394|NCT01870076|26472176|P2|Overall Study|Withdrawal by Subject|0
7608395|NCT01870076|26472177|P1|Overall Study|Withdrawal by Subject|1
7608396|NCT01869959|26472195|P5|Treatment Period|Withdrawal by Subject|0
7608397|NCT01869959|26472196|P4|Treatment Period|Withdrawal by Subject|0
7608398|NCT01869959|26472197|P3|Treatment Period|Withdrawal by Subject|0
7608399|NCT01869959|26472198|P2|Treatment Period|Withdrawal by Subject|1
7608400|NCT01869959|26472199|P1|Treatment Period|Withdrawal by Subject|0
7608401|NCT01869959|26472195|P5|Treatment Period|Sponsor decision|0
7608402|NCT01869959|26472196|P4|Treatment Period|Sponsor decision|1
7608403|NCT01869959|26472197|P3|Treatment Period|Sponsor decision|0
7608404|NCT01869959|26472198|P2|Treatment Period|Sponsor decision|1
7608405|NCT01869959|26472199|P1|Treatment Period|Sponsor decision|0
7608406|NCT01869959|26472195|P5|Treatment Period|Adverse Event|0
7608407|NCT01869959|26472196|P4|Treatment Period|Adverse Event|1
7608408|NCT01869959|26472197|P3|Treatment Period|Adverse Event|3
7608409|NCT01869959|26472198|P2|Treatment Period|Adverse Event|0
7608410|NCT01869959|26472199|P1|Treatment Period|Adverse Event|1
7608411|NCT01869959|26472195|P5|Randomization Period|Physician Decision|1
7608412|NCT01869959|26472196|P4|Randomization Period|Physician Decision|0
7608413|NCT01869959|26472197|P3|Randomization Period|Physician Decision|0
7608414|NCT01869959|26472198|P2|Randomization Period|Physician Decision|0
7608415|NCT01869959|26472199|P1|Randomization Period|Physician Decision|0
7608416|NCT01869777|26472267|P1|Overall Study|Excluded from the analysis, ineligible|1
7608417|NCT01869764|26472280|P2|Overall Study|Withdrawal by Subject|2
7608418|NCT01869764|26472281|P1|Overall Study|Withdrawal by Subject|0
7608419|NCT01869725|26472297|P1|Overall Study|Lost to Follow-up|2
7608420|NCT01869725|26472297|P1|Overall Study|Death|1
7608421|NCT01869725|26472297|P1|Overall Study|ineligible after registration|1
7608422|NCT01869699|26472305|P2|Overall Study|Withdrawal by Subject|0
7608423|NCT01869699|26472306|P1|Overall Study|Withdrawal by Subject|1
7608424|NCT01869348|26472391|P2|Overall Study|Withdrawal by Subject|1
7608425|NCT01869348|26472392|P1|Overall Study|Withdrawal by Subject|1
7608426|NCT01869192|26472400|P2|Postoperative Chemotherapy|Physician Decision|2
7608427|NCT01869192|26472401|P1|Postoperative Chemotherapy|Physician Decision|0
7608428|NCT01869192|26472400|P2|Preoperative Chemotherapy to Surgery|patient choice|1
7608429|NCT01869192|26472401|P1|Preoperative Chemotherapy to Surgery|patient choice|2
7608430|NCT01868997|26472436|P2|Overall Study|Other|1
7608431|NCT01868997|26472437|P1|Overall Study|Other|3
7608432|NCT01868997|26472436|P2|Overall Study|Lack of Efficacy|0
7608433|NCT01868997|26472437|P1|Overall Study|Lack of Efficacy|2
7608434|NCT01868997|26472436|P2|Overall Study|Adverse Event|5
7608435|NCT01868997|26472437|P1|Overall Study|Adverse Event|2
7608436|NCT01868893|26472453|P1|Overall Study|Neutropenia|1
7608437|NCT01868893|26472453|P1|Overall Study|Commercial availability of study drug|17
7608438|NCT01868893|26472453|P1|Overall Study|Adverse Event|2
7608439|NCT01868646|26472484|P2|Overall Study|Do not meet inclusion criteria|5
7608440|NCT01868646|26472485|P1|Overall Study|Do not meet inclusion criteria|3
7608441|NCT01868594|26472530|P2|Overall Study|Do not meet inclusion criteria|3
7608442|NCT01868594|26472531|P1|Overall Study|Do not meet inclusion criteria|4
7608443|NCT01868542|26472551|P2|Overall Study|Unclassified|1
7608444|NCT01868542|26472552|P1|Overall Study|Unclassified|0
7608445|NCT01868542|26472551|P2|Overall Study|Protocol Violation|1
7608446|NCT01868542|26472552|P1|Overall Study|Protocol Violation|0
7608447|NCT01868503|26472570|P1|Overall Study|Protocol Violation|1
7608448|NCT01868503|26472570|P1|Overall Study|Withdrawal by Subject|1
7608449|NCT01868477|26472580|P2|Overall Study|Withdrawal by Subject|0
7608450|NCT01868477|26472581|P1|Overall Study|Withdrawal by Subject|1
7608451|NCT01868477|26472580|P2|Overall Study|Disease progression|1
7608452|NCT01868477|26472581|P1|Overall Study|Disease progression|1
7608453|NCT01868477|26472580|P2|Overall Study|Adverse Event|4
7608454|NCT01868477|26472581|P1|Overall Study|Adverse Event|2
7608455|NCT01868243|26472685|P2|Overall Study|Death|1
7608456|NCT01868243|26472686|P1|Overall Study|Death|0
7608457|NCT01868165|26472694|P1|Overall Study|Death|4
7608458|NCT01868165|26472694|P1|Overall Study|Lost to Follow-up|3
7608459|NCT01868165|26472694|P1|Overall Study|Physician Decision|2
7608460|NCT01868165|26472694|P1|Overall Study|Withdrawal by Subject|36
7608461|NCT01868074|26472710|P2|Overall Study|Withdrawal by Subject|2
7608462|NCT01868074|26472711|P1|Overall Study|Withdrawal by Subject|4
7608463|NCT01868074|26472710|P2|Overall Study|Lost to Follow-up|2
7608464|NCT01868074|26472711|P1|Overall Study|Lost to Follow-up|3
7608465|NCT01868035|26472721|P1|Overall Study|Non-compliance|1
7608466|NCT01868035|26472721|P1|Overall Study|Progressive Disease|2
7608467|NCT01868035|26472721|P1|Overall Study|Withdrawal by Subject|1
7608468|NCT01868035|26472721|P1|Overall Study|Lost to Follow-up|3
7608469|NCT01868022|26472746|P9|Overall Study|Ongoing|0
7608470|NCT01868022|26472747|P8|Overall Study|Ongoing|3
7608471|NCT01868022|26472748|P7|Overall Study|Ongoing|0
7608472|NCT01868022|26472749|P6|Overall Study|Ongoing|0
7608473|NCT01868022|26472750|P5|Overall Study|Ongoing|0
7608474|NCT01868022|26472751|P4|Overall Study|Ongoing|0
7608475|NCT01868022|26472752|P3|Overall Study|Ongoing|0
7608476|NCT01868022|26472753|P2|Overall Study|Ongoing|0
7608477|NCT01868022|26472754|P1|Overall Study|Ongoing|0
7608478|NCT01868022|26472746|P9|Overall Study|Study closed/terminated|0
7608479|NCT01868022|26472747|P8|Overall Study|Study closed/terminated|1
7608480|NCT01868022|26472748|P7|Overall Study|Study closed/terminated|0
7608481|NCT01868022|26472749|P6|Overall Study|Study closed/terminated|0
7608482|NCT01868022|26472750|P5|Overall Study|Study closed/terminated|0
7608483|NCT01868022|26472751|P4|Overall Study|Study closed/terminated|0
7608484|NCT01868022|26472752|P3|Overall Study|Study closed/terminated|0
7608485|NCT01868022|26472753|P2|Overall Study|Study closed/terminated|0
7608486|NCT01868022|26472754|P1|Overall Study|Study closed/terminated|0
7608487|NCT01868022|26472746|P9|Overall Study|Physician Decision|0
7608488|NCT01868022|26472747|P8|Overall Study|Physician Decision|2
7608489|NCT01868022|26472748|P7|Overall Study|Physician Decision|0
7608490|NCT01868022|26472749|P6|Overall Study|Physician Decision|1
7608491|NCT01868022|26472750|P5|Overall Study|Physician Decision|0
7608492|NCT01868022|26472751|P4|Overall Study|Physician Decision|0
7608493|NCT01868022|26472752|P3|Overall Study|Physician Decision|0
7608494|NCT01868022|26472753|P2|Overall Study|Physician Decision|0
7608495|NCT01868022|26472754|P1|Overall Study|Physician Decision|0
7608496|NCT01868022|26472746|P9|Overall Study|Adverse Event|2
7608497|NCT01868022|26472747|P8|Overall Study|Adverse Event|2
7608498|NCT01868022|26472748|P7|Overall Study|Adverse Event|0
7608499|NCT01868022|26472749|P6|Overall Study|Adverse Event|0
7608500|NCT01868022|26472750|P5|Overall Study|Adverse Event|2
7608501|NCT01868022|26472751|P4|Overall Study|Adverse Event|0
7608502|NCT01868022|26472752|P3|Overall Study|Adverse Event|0
7608503|NCT01868022|26472753|P2|Overall Study|Adverse Event|0
7608504|NCT01868022|26472754|P1|Overall Study|Adverse Event|0
7608505|NCT01868022|26472746|P9|Overall Study|Withdrawal by Subject|0
7608506|NCT01868022|26472747|P8|Overall Study|Withdrawal by Subject|1
7608507|NCT01868022|26472748|P7|Overall Study|Withdrawal by Subject|0
7608508|NCT01868022|26472749|P6|Overall Study|Withdrawal by Subject|0
7608509|NCT01868022|26472750|P5|Overall Study|Withdrawal by Subject|0
7608510|NCT01868022|26472751|P4|Overall Study|Withdrawal by Subject|1
7608511|NCT01868022|26472752|P3|Overall Study|Withdrawal by Subject|1
7608512|NCT01868022|26472753|P2|Overall Study|Withdrawal by Subject|0
7608513|NCT01868022|26472754|P1|Overall Study|Withdrawal by Subject|0
7608514|NCT01868009|26472960|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
7608515|NCT01868009|26472961|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
7608516|NCT01868009|26472960|P2|Period 2 (5-9 Days)|Adverse Event|0
7608517|NCT01868009|26472961|P1|Period 2 (5-9 Days)|Adverse Event|1
7608518|NCT01868009|26472960|P2|Period 1 (5-9 Days)|Adverse Event|2
7608519|NCT01868009|26472961|P1|Period 1 (5-9 Days)|Adverse Event|0
7608520|NCT01867710|26472975|P4|Overall Study|Study medication no longer effective|0
7608521|NCT01867710|26472976|P3|Overall Study|Study medication no longer effective|0
7608522|NCT01867710|26472977|P2|Overall Study|Study medication no longer effective|1
7608523|NCT01867710|26472978|P1|Overall Study|Study medication no longer effective|0
7608524|NCT01867710|26472975|P4|Overall Study|PSA-progression|0
7608525|NCT01867710|26472976|P3|Overall Study|PSA-progression|0
7608526|NCT01867710|26472977|P2|Overall Study|PSA-progression|1
7608527|NCT01867710|26472978|P1|Overall Study|PSA-progression|0
7608528|NCT01867710|26472975|P4|Overall Study|Protocol Violation|1
7608529|NCT01867710|26472976|P3|Overall Study|Protocol Violation|0
7608530|NCT01867710|26472977|P2|Overall Study|Protocol Violation|0
7608531|NCT01867710|26472978|P1|Overall Study|Protocol Violation|0
7608532|NCT01867710|26472975|P4|Overall Study|Progressive disease|0
7608533|NCT01867710|26472976|P3|Overall Study|Progressive disease|0
7608534|NCT01867710|26472977|P2|Overall Study|Progressive disease|0
7608535|NCT01867710|26472978|P1|Overall Study|Progressive disease|1
7608536|NCT01867710|26472975|P4|Overall Study|Patient to follow subsequent treatment|0
7608537|NCT01867710|26472976|P3|Overall Study|Patient to follow subsequent treatment|0
7608538|NCT01867710|26472977|P2|Overall Study|Patient to follow subsequent treatment|1
7608539|NCT01867710|26472978|P1|Overall Study|Patient to follow subsequent treatment|0
7608540|NCT01867710|26472975|P4|Overall Study|Patient decision|1
7608541|NCT01867710|26472976|P3|Overall Study|Patient decision|0
7608542|NCT01867710|26472977|P2|Overall Study|Patient decision|0
7608543|NCT01867710|26472978|P1|Overall Study|Patient decision|0
7608544|NCT01867710|26472975|P4|Overall Study|Disease progression|0
7608545|NCT01867710|26472976|P3|Overall Study|Disease progression|0
7608546|NCT01867710|26472977|P2|Overall Study|Disease progression|0
7608547|NCT01867710|26472978|P1|Overall Study|Disease progression|1
7608548|NCT01867710|26472975|P4|Overall Study|Clinical progression|0
7608549|NCT01867710|26472976|P3|Overall Study|Clinical progression|1
7608550|NCT01867710|26472977|P2|Overall Study|Clinical progression|0
7608551|NCT01867710|26472978|P1|Overall Study|Clinical progression|0
7608552|NCT01867710|26472975|P4|Overall Study|Biochemical progression|0
7608553|NCT01867710|26472976|P3|Overall Study|Biochemical progression|0
7608554|NCT01867710|26472977|P2|Overall Study|Biochemical progression|1
7608555|NCT01867710|26472978|P1|Overall Study|Biochemical progression|0
7608556|NCT01867710|26472975|P4|Overall Study|Study Terminated by Sponsor|16
7608557|NCT01867710|26472976|P3|Overall Study|Study Terminated by Sponsor|8
7608558|NCT01867710|26472977|P2|Overall Study|Study Terminated by Sponsor|13
7608559|NCT01867710|26472978|P1|Overall Study|Study Terminated by Sponsor|9
7608560|NCT01867710|26472975|P4|Overall Study|Withdrawal of consent|2
7608561|NCT01867710|26472976|P3|Overall Study|Withdrawal of consent|1
7608562|NCT01867710|26472977|P2|Overall Study|Withdrawal of consent|5
7608563|NCT01867710|26472978|P1|Overall Study|Withdrawal of consent|2
7608564|NCT01867710|26472975|P4|Overall Study|Lost to Follow-up|2
7608565|NCT01867710|26472976|P3|Overall Study|Lost to Follow-up|3
7608566|NCT01867710|26472977|P2|Overall Study|Lost to Follow-up|4
7608567|NCT01867710|26472978|P1|Overall Study|Lost to Follow-up|3
7608568|NCT01867710|26472975|P4|Overall Study|Death|20
7608569|NCT01867710|26472976|P3|Overall Study|Death|27
7608570|NCT01867710|26472977|P2|Overall Study|Death|15
7608571|NCT01867710|26472978|P1|Overall Study|Death|25
7608572|NCT01867671|26473046|P2|Overall Study|Withdrawal by Subject|21
7608573|NCT01867671|26473047|P1|Overall Study|Withdrawal by Subject|21
7608574|NCT01867671|26473046|P2|Overall Study|Non-compliance with Study Drug|2
7608575|NCT01867671|26473047|P1|Overall Study|Non-compliance with Study Drug|1
7608576|NCT01867671|26473046|P2|Overall Study|Lost to Follow-up|1
7608577|NCT01867671|26473047|P1|Overall Study|Lost to Follow-up|0
7608578|NCT01867671|26473046|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
7608579|NCT01867671|26473047|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
7608580|NCT01867671|26473046|P2|Overall Study|Anaphylaxis|1
7608581|NCT01867671|26473047|P1|Overall Study|Anaphylaxis|0
7608582|NCT01867671|26473046|P2|Overall Study|Adverse Event|3
7608583|NCT01867671|26473047|P1|Overall Study|Adverse Event|5
7608584|NCT01867658|26473060|P1|Overall Study|Subject could not be contacted|1
7608585|NCT01867658|26473060|P1|Overall Study|Death|2
7608586|NCT01867658|26473060|P1|Overall Study|Withdrawal by Subject|6
7608587|NCT01867606|26473084|P2|Overall Study|Protocol Violation|1
7608588|NCT01867606|26473085|P1|Overall Study|Protocol Violation|0
7608589|NCT01867606|26473084|P2|Overall Study|Withdrawal by Subject|14
7608590|NCT01867606|26473085|P1|Overall Study|Withdrawal by Subject|10
7608591|NCT01867580|26473103|P2|Overall Study|Wound recurrence|1
7608592|NCT01867580|26473104|P1|Overall Study|Wound recurrence|0
7608593|NCT01867580|26473103|P2|Overall Study|Continuation of therapy|1
7608594|NCT01867580|26473104|P1|Overall Study|Continuation of therapy|0
7608595|NCT01867580|26473103|P2|Overall Study|Osteomyelitis|1
7608596|NCT01867580|26473104|P1|Overall Study|Osteomyelitis|0
7608597|NCT01867580|26473103|P2|Overall Study|Interruption to therapy|0
7608598|NCT01867580|26473104|P1|Overall Study|Interruption to therapy|3
7608599|NCT01867580|26473103|P2|Overall Study|Missed follow-up assessment|1
7608600|NCT01867580|26473104|P1|Overall Study|Missed follow-up assessment|2
7608601|NCT01867580|26473103|P2|Overall Study|Sponsor terminated study|0
7608602|NCT01867580|26473104|P1|Overall Study|Sponsor terminated study|1
7608603|NCT01867580|26473103|P2|Overall Study|Lost to Follow-up|5
7608604|NCT01867580|26473104|P1|Overall Study|Lost to Follow-up|3
7608605|NCT01867580|26473103|P2|Overall Study|Physician Decision|12
7608606|NCT01867580|26473104|P1|Overall Study|Physician Decision|17
7608607|NCT01867580|26473103|P2|Overall Study|Withdrawal by Subject|3
7608608|NCT01867580|26473104|P1|Overall Study|Withdrawal by Subject|2
7608609|NCT01867424|26473129|P2|Overall Study|Patient noncompliance|1
7608610|NCT01867424|26473130|P1|Overall Study|Patient noncompliance|2
7608611|NCT01867307|26473144|P2|Overall Study|Other Adverse Event|3
7608612|NCT01867307|26473145|P1|Overall Study|Other Adverse Event|1
7608613|NCT01867307|26473144|P2|Overall Study|Protocol Violation|0
7608614|NCT01867307|26473145|P1|Overall Study|Protocol Violation|2
7608615|NCT01867294|26473155|P4|Overall Study|Withdrawal by Subject|0
7608616|NCT01867294|26473156|P3|Overall Study|Withdrawal by Subject|0
7608617|NCT01867294|26473157|P2|Overall Study|Withdrawal by Subject|1
7608618|NCT01867294|26473158|P1|Overall Study|Withdrawal by Subject|1
7608619|NCT01867216|26473205|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
7608620|NCT01867216|26473206|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
7608621|NCT01867216|26473207|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
7608622|NCT01867216|26473208|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
7608623|NCT01867216|26473209|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
7608624|NCT01867216|26473210|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
7608625|NCT01867216|26473211|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
7608626|NCT01867216|26473205|P7|Overall Study|Physician Decision|0
7608627|NCT01867216|26473206|P6|Overall Study|Physician Decision|0
7608628|NCT01867216|26473207|P5|Overall Study|Physician Decision|0
7608629|NCT01867216|26473208|P4|Overall Study|Physician Decision|0
7608630|NCT01867216|26473209|P3|Overall Study|Physician Decision|0
7608631|NCT01867216|26473210|P2|Overall Study|Physician Decision|0
7608632|NCT01867216|26473211|P1|Overall Study|Physician Decision|1
7608633|NCT01867216|26473205|P7|Overall Study|Withdrawal by Subject|1
7608634|NCT01867216|26473206|P6|Overall Study|Withdrawal by Subject|0
7608635|NCT01867216|26473207|P5|Overall Study|Withdrawal by Subject|1
7608636|NCT01867216|26473208|P4|Overall Study|Withdrawal by Subject|0
7608637|NCT01867216|26473209|P3|Overall Study|Withdrawal by Subject|0
7608638|NCT01867216|26473210|P2|Overall Study|Withdrawal by Subject|0
7608639|NCT01867216|26473211|P1|Overall Study|Withdrawal by Subject|2
7608640|NCT01867086|26473283|P1|Overall Study|Disease Progression|1
7608641|NCT01867047|26473292|P2|Overall Study|surgery not indicated in protocol|2
7608642|NCT01867047|26473293|P1|Overall Study|surgery not indicated in protocol|1
7608643|NCT01867047|26473292|P2|Overall Study|Physician Decision|0
7608644|NCT01867047|26473293|P1|Overall Study|Physician Decision|2
7608645|NCT01867047|26473292|P2|Overall Study|Withdrawal by Subject|0
7608646|NCT01867047|26473293|P1|Overall Study|Withdrawal by Subject|2
7608647|NCT01867047|26473292|P2|Overall Study|Lost to Follow-up|3
7608648|NCT01867047|26473293|P1|Overall Study|Lost to Follow-up|3
7608649|NCT01867021|26473313|P2|Overall Study|Withdrawal by Subject|6
7608650|NCT01867021|26473314|P1|Overall Study|Withdrawal by Subject|1
7608651|NCT01867021|26473313|P2|Overall Study|Lost to Follow-up|2
7608652|NCT01867021|26473314|P1|Overall Study|Lost to Follow-up|0
7608653|NCT01867021|26473313|P2|Overall Study|Death|0
7608654|NCT01867021|26473314|P1|Overall Study|Death|1
7608655|NCT01867021|26473313|P2|Overall Study|Not Eligible|1
7608656|NCT01867021|26473314|P1|Overall Study|Not Eligible|0
7608657|NCT01867021|26473313|P2|Overall Study|Adverse Event|1
7608658|NCT01867021|26473314|P1|Overall Study|Adverse Event|0
7608659|NCT01867008|26473333|P1|Overall Study|Withdrawal by Subject|1
7608660|NCT01866917|26473349|P2|Overall Study|Pharmacist stopped dispensing treatment|6
7608661|NCT01866917|26473350|P1|Overall Study|Pharmacist stopped dispensing treatment|4
7608662|NCT01866826|26473374|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
7608663|NCT01866826|26473375|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
7608664|NCT01866826|26473374|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
7608665|NCT01866826|26473375|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
7608666|NCT01866826|26473374|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
7608667|NCT01866826|26473375|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
7608668|NCT01866709|26473391|P2|Overall Study|Adverse Event|0
7608669|NCT01866709|26473392|P1|Overall Study|Adverse Event|1
7608670|NCT01866423|26473433|P1|Overall Study|Sponsor Decision|1
7608671|NCT01866423|26473433|P1|Overall Study|Lack of Efficacy|3
7608672|NCT01866319|26473461|P3|Overall Study|Withdrawal by Subject|12
7608673|NCT01866319|26473462|P2|Overall Study|Withdrawal by Subject|14
7608674|NCT01866319|26473463|P1|Overall Study|Withdrawal by Subject|32
7608675|NCT01866319|26473461|P3|Overall Study|Protocol Violation|1
7608676|NCT01866319|26473462|P2|Overall Study|Protocol Violation|0
7608677|NCT01866319|26473463|P1|Overall Study|Protocol Violation|0
7608678|NCT01866319|26473461|P3|Overall Study|Physician Decision|1
7608679|NCT01866319|26473462|P2|Overall Study|Physician Decision|0
7608680|NCT01866319|26473463|P1|Overall Study|Physician Decision|1
7608681|NCT01866319|26473461|P3|Overall Study|Lost to Follow-up|8
7608682|NCT01866319|26473462|P2|Overall Study|Lost to Follow-up|3
7608683|NCT01866319|26473463|P1|Overall Study|Lost to Follow-up|6
7608684|NCT01866319|26473461|P3|Overall Study|Death|147
7608685|NCT01866319|26473462|P2|Overall Study|Death|154
7608686|NCT01866319|26473463|P1|Overall Study|Death|153
7608687|NCT01866319|26473461|P3|Overall Study|Clinical progression|2
7608688|NCT01866319|26473462|P2|Overall Study|Clinical progression|2
7608689|NCT01866319|26473463|P1|Overall Study|Clinical progression|3
7608690|NCT01866319|26473461|P3|Overall Study|Adverse Event|9
7608691|NCT01866319|26473462|P2|Overall Study|Adverse Event|5
7608692|NCT01866319|26473463|P1|Overall Study|Adverse Event|12
7608693|NCT01866293|26473562|P1|Overall Study|Adverse Event|2
7608694|NCT01866098|26473607|P3|Overall Study|Death|0
7608695|NCT01866098|26473608|P2|Overall Study|Death|1
7608696|NCT01866098|26473609|P1|Overall Study|Death|0
7608697|NCT01866098|26473607|P3|Overall Study|Pregnancy|0
7608698|NCT01866098|26473608|P2|Overall Study|Pregnancy|0
7608699|NCT01866098|26473609|P1|Overall Study|Pregnancy|2
7608700|NCT01866098|26473607|P3|Overall Study|Non-compliance|1
7608701|NCT01866098|26473608|P2|Overall Study|Non-compliance|0
7608702|NCT01866098|26473609|P1|Overall Study|Non-compliance|1
7608703|NCT01866098|26473607|P3|Overall Study|Unrelated Hospitalization|1
7608704|NCT01866098|26473608|P2|Overall Study|Unrelated Hospitalization|0
7608705|NCT01866098|26473609|P1|Overall Study|Unrelated Hospitalization|2
7608706|NCT01866098|26473607|P3|Overall Study|Withdrawal by Subject|0
7608707|NCT01866098|26473608|P2|Overall Study|Withdrawal by Subject|2
7608708|NCT01866098|26473609|P1|Overall Study|Withdrawal by Subject|1
7608709|NCT01866098|26473607|P3|Overall Study|Protocol Violation|0
7608710|NCT01866098|26473608|P2|Overall Study|Protocol Violation|0
7608711|NCT01866098|26473609|P1|Overall Study|Protocol Violation|1
7608712|NCT01866098|26473607|P3|Overall Study|Adverse Event|4
7608713|NCT01866098|26473608|P2|Overall Study|Adverse Event|5
7608714|NCT01866098|26473609|P1|Overall Study|Adverse Event|1
7608715|NCT01866098|26473607|P3|Overall Study|Physician Decision|2
7608716|NCT01866098|26473608|P2|Overall Study|Physician Decision|1
7608717|NCT01866098|26473609|P1|Overall Study|Physician Decision|0
7608718|NCT01866098|26473607|P3|Overall Study|Lost to Follow-up|13
7608719|NCT01866098|26473608|P2|Overall Study|Lost to Follow-up|18
7608720|NCT01866098|26473609|P1|Overall Study|Lost to Follow-up|11
7608721|NCT01865812|26473638|P1|Overall Study|Adverse Event|2
7608722|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Other|1
7608723|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Other|0
7608724|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
7608725|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
7608726|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
7608727|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
7608728|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Physician Decision|2
7608729|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Physician Decision|4
7608730|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
7608731|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
7608732|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
7608733|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
7608734|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
7608735|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
7608736|NCT01865747|26473646|P2|Primary Intent to Treat (PITT)|Adverse Event|20
7608737|NCT01865747|26473647|P1|Primary Intent to Treat (PITT)|Adverse Event|21
7608738|NCT01865747|26473646|P2|Overall Study (ITT)|Reason Not Provided|1
7608739|NCT01865747|26473647|P1|Overall Study (ITT)|Reason Not Provided|0
7608740|NCT01865747|26473646|P2|Overall Study (ITT)|Progressive Disease|158
7608741|NCT01865747|26473647|P1|Overall Study (ITT)|Progressive Disease|122
7608742|NCT01865747|26473646|P2|Overall Study (ITT)|Sponsor Decision|1
7608743|NCT01865747|26473647|P1|Overall Study (ITT)|Sponsor Decision|0
7608744|NCT01865747|26473646|P2|Overall Study (ITT)|Withdrawal by Subject|11
7608745|NCT01865747|26473647|P1|Overall Study (ITT)|Withdrawal by Subject|6
7608746|NCT01865747|26473646|P2|Overall Study (ITT)|Physician Decision|2
7608747|NCT01865747|26473647|P1|Overall Study (ITT)|Physician Decision|5
7608748|NCT01865747|26473646|P2|Overall Study (ITT)|Protocol Violation|1
7608749|NCT01865747|26473647|P1|Overall Study (ITT)|Protocol Violation|1
7608750|NCT01865747|26473646|P2|Overall Study (ITT)|Lack of Efficacy|0
7608751|NCT01865747|26473647|P1|Overall Study (ITT)|Lack of Efficacy|3
7608752|NCT01865747|26473646|P2|Overall Study (ITT)|Clinical Deterioration|50
7608753|NCT01865747|26473647|P1|Overall Study (ITT)|Clinical Deterioration|29
7608754|NCT01865747|26473646|P2|Overall Study (ITT)|Adverse Event|31
7608755|NCT01865747|26473647|P1|Overall Study (ITT)|Adverse Event|32
7608756|NCT01865552|26473668|P6|Period 1|Other|0
7608757|NCT01865552|26473669|P5|Period 1|Other|1
7608758|NCT01865552|26473670|P4|Period 1|Other|0
7608759|NCT01865552|26473671|P3|Period 1|Other|0
7608760|NCT01865552|26473672|P2|Period 1|Other|0
7608761|NCT01865552|26473673|P1|Period 1|Other|0
7608762|NCT01865552|26473668|P6|Period 1|Pathological lab|0
7608763|NCT01865552|26473669|P5|Period 1|Pathological lab|1
7608764|NCT01865552|26473670|P4|Period 1|Pathological lab|0
7608765|NCT01865552|26473671|P3|Period 1|Pathological lab|0
7608766|NCT01865552|26473672|P2|Period 1|Pathological lab|0
7608767|NCT01865552|26473673|P1|Period 1|Pathological lab|0
7608768|NCT01865552|26473668|P6|Period 1|Adverse Event|1
7608769|NCT01865552|26473669|P5|Period 1|Adverse Event|1
7608770|NCT01865552|26473670|P4|Period 1|Adverse Event|1
7608771|NCT01865552|26473671|P3|Period 1|Adverse Event|0
7608772|NCT01865552|26473672|P2|Period 1|Adverse Event|0
7608773|NCT01865552|26473673|P1|Period 1|Adverse Event|1
7608774|NCT01865487|26473711|P10|Overall Study|Withdrawal by Subject|0
7608775|NCT01865487|26473712|P9|Overall Study|Withdrawal by Subject|0
7608776|NCT01865487|26473713|P8|Overall Study|Withdrawal by Subject|0
7608777|NCT01865487|26473714|P7|Overall Study|Withdrawal by Subject|0
7608778|NCT01865487|26473715|P6|Overall Study|Withdrawal by Subject|0
7608779|NCT01865487|26473716|P5|Overall Study|Withdrawal by Subject|1
7608780|NCT01865487|26473717|P4|Overall Study|Withdrawal by Subject|0
7608781|NCT01865487|26473718|P3|Overall Study|Withdrawal by Subject|0
7608782|NCT01865487|26473719|P2|Overall Study|Withdrawal by Subject|0
7608783|NCT01865487|26473720|P1|Overall Study|Withdrawal by Subject|0
7608784|NCT01865487|26473711|P10|Overall Study|Lost to Follow-up|0
7608785|NCT01865487|26473712|P9|Overall Study|Lost to Follow-up|0
7608786|NCT01865487|26473713|P8|Overall Study|Lost to Follow-up|0
7608787|NCT01865487|26473714|P7|Overall Study|Lost to Follow-up|1
7608788|NCT01865487|26473715|P6|Overall Study|Lost to Follow-up|0
7608789|NCT01865487|26473716|P5|Overall Study|Lost to Follow-up|0
7608790|NCT01865487|26473717|P4|Overall Study|Lost to Follow-up|1
7608791|NCT01865487|26473718|P3|Overall Study|Lost to Follow-up|0
7608792|NCT01865487|26473719|P2|Overall Study|Lost to Follow-up|0
7608793|NCT01865487|26473720|P1|Overall Study|Lost to Follow-up|0
7608794|NCT01865448|26473759|P2|Overall Study|dropout unrelated to study|1
7608795|NCT01865448|26473760|P1|Overall Study|dropout unrelated to study|1
7608796|NCT01865448|26473759|P2|Overall Study|Pregnancy|1
7608797|NCT01865448|26473760|P1|Overall Study|Pregnancy|0
7608798|NCT01865448|26473759|P2|Overall Study|Adverse Event|1
7608799|NCT01865448|26473760|P1|Overall Study|Adverse Event|1
7608800|NCT01865084|26473871|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7608801|NCT01865084|26473872|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7608802|NCT01865084|26473873|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7608803|NCT01865084|26473871|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
7608804|NCT01865084|26473872|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
7608805|NCT01865084|26473873|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
7608806|NCT01865084|26473871|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
7608807|NCT01865084|26473872|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
7608808|NCT01865084|26473873|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
7608809|NCT01865084|26473871|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
7608810|NCT01865084|26473872|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
7608811|NCT01865084|26473873|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
7608812|NCT01865084|26473871|P3|Open Label Extension (OLE) Period|Adverse Event|1
7608813|NCT01865084|26473872|P2|Open Label Extension (OLE) Period|Adverse Event|0
7608814|NCT01865084|26473873|P1|Open Label Extension (OLE) Period|Adverse Event|0
7608815|NCT01865084|26473871|P3|Double Blind Period (DB)|Withdrawal by Subject|0
7608816|NCT01865084|26473872|P2|Double Blind Period (DB)|Withdrawal by Subject|0
7608817|NCT01865084|26473873|P1|Double Blind Period (DB)|Withdrawal by Subject|1
7608818|NCT01865084|26473871|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
7608819|NCT01865084|26473872|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7608820|NCT01865084|26473873|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7608821|NCT01865084|26473871|P3|Double Blind Period (DB)|Protocol Violation|1
7608822|NCT01865084|26473872|P2|Double Blind Period (DB)|Protocol Violation|0
7608823|NCT01865084|26473873|P1|Double Blind Period (DB)|Protocol Violation|0
7608824|NCT01865084|26473871|P3|Double Blind Period (DB)|Adverse Event|1
7608825|NCT01865084|26473872|P2|Double Blind Period (DB)|Adverse Event|2
7608826|NCT01865084|26473873|P1|Double Blind Period (DB)|Adverse Event|2
7608827|NCT01864564|26473901|P2|Overall Study|not reported|34
7608828|NCT01864564|26473902|P1|Overall Study|not reported|0
7608829|NCT01864564|26473901|P2|Overall Study|Protocol Violation|27
7608830|NCT01864564|26473902|P1|Overall Study|Protocol Violation|0
7608831|NCT01864564|26473901|P2|Overall Study|Withdrawal by Subject|11
7608832|NCT01864564|26473902|P1|Overall Study|Withdrawal by Subject|20
7608833|NCT01864564|26473901|P2|Overall Study|Lost to Follow-up|23
7608834|NCT01864564|26473902|P1|Overall Study|Lost to Follow-up|17
7608835|NCT01864525|26473934|P2|Overall Study|Adverse Event|0
7608836|NCT01864525|26473935|P1|Overall Study|Adverse Event|1
7608837|NCT01864291|26473956|P1|Overall Study|need for revision surgery|2
7608838|NCT01864200|26473964|P2|Overall Study|Protocol Violation|0
7608839|NCT01864200|26473965|P1|Overall Study|Protocol Violation|1
7608840|NCT01864200|26473964|P2|Overall Study|Lost to Follow-up|3
7608841|NCT01864200|26473965|P1|Overall Study|Lost to Follow-up|1
7608842|NCT01864174|26473973|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
7608843|NCT01864174|26473974|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
7608844|NCT01864174|26473973|P2|Off Treatment Follow-Up|Other|0
7608845|NCT01864174|26473974|P1|Off Treatment Follow-Up|Other|2
7608846|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Other|10
7608847|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Other|6
7608848|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
7608849|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
7608850|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
7608851|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
7608852|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Death|0
7608853|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Death|1
7608854|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
7608855|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
7608856|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
7608857|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
7608858|NCT01864174|26473973|P2|Double Blind - Compliant Randomized|Adverse Event|1
7608859|NCT01864174|26473974|P1|Double Blind - Compliant Randomized|Adverse Event|6
7608860|NCT01864174|26473973|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
7608861|NCT01864174|26473974|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
7608862|NCT01864148|26473993|P5|Overall Study|Not Dosed|0
7608863|NCT01864148|26473994|P4|Overall Study|Not Dosed|1
7608864|NCT01864148|26473995|P3|Overall Study|Not Dosed|0
7608865|NCT01864148|26473996|P2|Overall Study|Not Dosed|0
7608866|NCT01864148|26473997|P1|Overall Study|Not Dosed|0
7608867|NCT01864148|26473993|P5|Overall Study|Adverse Event|7
7608868|NCT01864148|26473994|P4|Overall Study|Adverse Event|7
7608869|NCT01864148|26473995|P3|Overall Study|Adverse Event|4
7608870|NCT01864148|26473996|P2|Overall Study|Adverse Event|2
7608871|NCT01864148|26473997|P1|Overall Study|Adverse Event|4
7608872|NCT01864148|26473993|P5|Overall Study|Lost to Follow-up|1
7608873|NCT01864148|26473994|P4|Overall Study|Lost to Follow-up|2
7608874|NCT01864148|26473995|P3|Overall Study|Lost to Follow-up|0
7608875|NCT01864148|26473996|P2|Overall Study|Lost to Follow-up|0
7608876|NCT01864148|26473997|P1|Overall Study|Lost to Follow-up|0
7608877|NCT01864148|26473993|P5|Overall Study|Withdrawal by Subject|8
7608878|NCT01864148|26473994|P4|Overall Study|Withdrawal by Subject|8
7608879|NCT01864148|26473995|P3|Overall Study|Withdrawal by Subject|6
7608880|NCT01864148|26473996|P2|Overall Study|Withdrawal by Subject|2
7608881|NCT01864148|26473997|P1|Overall Study|Withdrawal by Subject|9
7608882|NCT01864148|26473993|P5|Overall Study|Investigator Decision|6
7608883|NCT01864148|26473994|P4|Overall Study|Investigator Decision|4
7608884|NCT01864148|26473995|P3|Overall Study|Investigator Decision|0
7608885|NCT01864148|26473996|P2|Overall Study|Investigator Decision|0
7608886|NCT01864148|26473997|P1|Overall Study|Investigator Decision|5
7608887|NCT01864148|26473993|P5|Overall Study|Death|0
7608888|NCT01864148|26473994|P4|Overall Study|Death|1
7608889|NCT01864148|26473995|P3|Overall Study|Death|0
7608890|NCT01864148|26473996|P2|Overall Study|Death|0
7608891|NCT01864148|26473997|P1|Overall Study|Death|0
7608892|NCT01864148|26473993|P5|Overall Study|Other|1
7608893|NCT01864148|26473994|P4|Overall Study|Other|3
7608894|NCT01864148|26473995|P3|Overall Study|Other|1
7608895|NCT01864148|26473996|P2|Overall Study|Other|1
7608896|NCT01864148|26473997|P1|Overall Study|Other|2
7608897|NCT01864005|26474026|P2|Overall Study|Need GP IIb/IIIa|3
7608898|NCT01864005|26474027|P1|Overall Study|Need GP IIb/IIIa|1
7608899|NCT01864005|26474026|P2|Overall Study|Disease need|1
7608900|NCT01864005|26474027|P1|Overall Study|Disease need|1
7608901|NCT01864005|26474026|P2|Overall Study|Incorrect enrolment|0
7608902|NCT01864005|26474027|P1|Overall Study|Incorrect enrolment|1
7608903|NCT01864005|26474026|P2|Overall Study|Withdrawal by Subject|1
7608904|NCT01864005|26474027|P1|Overall Study|Withdrawal by Subject|0
7608905|NCT01864005|26474026|P2|Overall Study|Protocol Violation|1
7608906|NCT01864005|26474027|P1|Overall Study|Protocol Violation|0
7608907|NCT01863953|26474044|P3|Overall Study|Adverse Event|1
7608908|NCT01863953|26474045|P2|Overall Study|Adverse Event|0
7608909|NCT01863953|26474046|P1|Overall Study|Adverse Event|0
7608910|NCT01863849|26474062|P2|Overall Study|Lost to Follow-up|0
7608911|NCT01863849|26474063|P1|Overall Study|Lost to Follow-up|1
7608912|NCT01863771|26474085|P4|Maintenance Phase|Withdrawal by Subject|3
7608913|NCT01863771|26474086|P3|Maintenance Phase|Withdrawal by Subject|2
7608914|NCT01863771|26474087|P2|Maintenance Phase|Withdrawal by Subject|1
7608915|NCT01863771|26474088|P1|Maintenance Phase|Withdrawal by Subject|0
7608916|NCT01863771|26474085|P4|Maintenance Phase|Pregnancy|0
7608917|NCT01863771|26474086|P3|Maintenance Phase|Pregnancy|0
7608918|NCT01863771|26474087|P2|Maintenance Phase|Pregnancy|1
7608919|NCT01863771|26474088|P1|Maintenance Phase|Pregnancy|0
7608920|NCT01863771|26474085|P4|Maintenance Phase|Physician Decision|1
7608921|NCT01863771|26474086|P3|Maintenance Phase|Physician Decision|2
7608922|NCT01863771|26474087|P2|Maintenance Phase|Physician Decision|0
7608923|NCT01863771|26474088|P1|Maintenance Phase|Physician Decision|0
7608924|NCT01863771|26474085|P4|Maintenance Phase|Lack of Efficacy|38
7608925|NCT01863771|26474086|P3|Maintenance Phase|Lack of Efficacy|7
7608926|NCT01863771|26474087|P2|Maintenance Phase|Lack of Efficacy|3
7608927|NCT01863771|26474088|P1|Maintenance Phase|Lack of Efficacy|0
7608928|NCT01863771|26474085|P4|Maintenance Phase|Adverse Event|1
7608929|NCT01863771|26474086|P3|Maintenance Phase|Adverse Event|1
7608930|NCT01863771|26474087|P2|Maintenance Phase|Adverse Event|0
7608931|NCT01863771|26474088|P1|Maintenance Phase|Adverse Event|0
7608932|NCT01863771|26474085|P4|Induction Phase|Withdrawal by Subject|0
7608933|NCT01863771|26474086|P3|Induction Phase|Withdrawal by Subject|0
7608934|NCT01863771|26474087|P2|Induction Phase|Withdrawal by Subject|0
7608935|NCT01863771|26474088|P1|Induction Phase|Withdrawal by Subject|2
7608936|NCT01863771|26474085|P4|Induction Phase|Lack of Efficacy|0
7608937|NCT01863771|26474086|P3|Induction Phase|Lack of Efficacy|0
7608938|NCT01863771|26474087|P2|Induction Phase|Lack of Efficacy|0
7608939|NCT01863771|26474088|P1|Induction Phase|Lack of Efficacy|10
7608940|NCT01863771|26474085|P4|Induction Phase|Adverse Event|0
7608941|NCT01863771|26474086|P3|Induction Phase|Adverse Event|0
7608942|NCT01863771|26474087|P2|Induction Phase|Adverse Event|0
7608943|NCT01863771|26474088|P1|Induction Phase|Adverse Event|9
7608944|NCT01863758|26474100|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
7608945|NCT01863758|26474100|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
7608946|NCT01863732|26474112|P4|Overall Study|Death|1
7608947|NCT01863732|26474113|P3|Overall Study|Death|0
7608948|NCT01863732|26474114|P2|Overall Study|Death|0
7608949|NCT01863732|26474115|P1|Overall Study|Death|1
7608950|NCT01863732|26474112|P4|Overall Study|Subject/guardian decision|1
7608951|NCT01863732|26474113|P3|Overall Study|Subject/guardian decision|3
7608952|NCT01863732|26474114|P2|Overall Study|Subject/guardian decision|9
7608953|NCT01863732|26474115|P1|Overall Study|Subject/guardian decision|6
7608954|NCT01863732|26474112|P4|Overall Study|Technical problems|0
7608955|NCT01863732|26474113|P3|Overall Study|Technical problems|1
7608956|NCT01863732|26474114|P2|Overall Study|Technical problems|1
7608957|NCT01863732|26474115|P1|Overall Study|Technical problems|0
7608958|NCT01863732|26474112|P4|Overall Study|Pregnancy|1
7608959|NCT01863732|26474113|P3|Overall Study|Pregnancy|0
7608960|NCT01863732|26474114|P2|Overall Study|Pregnancy|0
7608961|NCT01863732|26474115|P1|Overall Study|Pregnancy|0
7608962|NCT01863732|26474112|P4|Overall Study|Physician Decision|0
7608963|NCT01863732|26474113|P3|Overall Study|Physician Decision|1
7608964|NCT01863732|26474114|P2|Overall Study|Physician Decision|0
7608965|NCT01863732|26474115|P1|Overall Study|Physician Decision|1
7608966|NCT01863732|26474112|P4|Overall Study|Lost to Follow-up|1
7608967|NCT01863732|26474113|P3|Overall Study|Lost to Follow-up|1
7608968|NCT01863732|26474114|P2|Overall Study|Lost to Follow-up|2
7608969|NCT01863732|26474115|P1|Overall Study|Lost to Follow-up|2
7608970|NCT01863732|26474112|P4|Overall Study|Lack of Efficacy|1
7608971|NCT01863732|26474113|P3|Overall Study|Lack of Efficacy|2
7608972|NCT01863732|26474114|P2|Overall Study|Lack of Efficacy|0
7608973|NCT01863732|26474115|P1|Overall Study|Lack of Efficacy|1
7608974|NCT01863732|26474112|P4|Overall Study|Adverse Event|3
7608975|NCT01863732|26474113|P3|Overall Study|Adverse Event|3
7608976|NCT01863732|26474114|P2|Overall Study|Adverse Event|0
7608977|NCT01863732|26474115|P1|Overall Study|Adverse Event|2
7608978|NCT01863680|26474128|P1|Overall Study|Other|6
7608979|NCT01863680|26474128|P1|Overall Study|Did not undergo IVF/ET|14
7608980|NCT01863680|26474128|P1|Overall Study|Withdrawal by Subject|1
7608981|NCT01863680|26474128|P1|Overall Study|Spontaneous pregnancy|2
7608982|NCT01863680|26474128|P1|Overall Study|Risk of OHSS|17
7608983|NCT01863680|26474128|P1|Overall Study|Adverse Event|17
7608984|NCT01863667|26474136|P2|Overall Study|Withdrawal by Subject|2
7608985|NCT01863667|26474137|P1|Overall Study|Withdrawal by Subject|2
7608986|NCT01863667|26474136|P2|Overall Study|Study terminated by Sponsor|30
7608987|NCT01863667|26474137|P1|Overall Study|Study terminated by Sponsor|30
7608988|NCT01863667|26474136|P2|Overall Study|Adverse Event|0
7608989|NCT01863667|26474137|P1|Overall Study|Adverse Event|1
7608990|NCT01863433|26474174|P1|Overall Study|Protocol Violation|1
7608991|NCT01863368|26474184|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
7608992|NCT01863368|26474185|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
7608993|NCT01863368|26474184|P2|Phase II, Day 35 to Day 90|Adverse Event|0
7608994|NCT01863368|26474185|P1|Phase II, Day 35 to Day 90|Adverse Event|1
7608995|NCT01863368|26474184|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
7608996|NCT01863368|26474185|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
7608997|NCT01863368|26474184|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
7608998|NCT01863368|26474185|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
7608999|NCT01863368|26474184|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
7609000|NCT01863368|26474185|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
7609001|NCT01863368|26474184|P2|Phase I, Day 0 to Day 35|Adverse Event|4
7609002|NCT01863368|26474185|P1|Phase I, Day 0 to Day 35|Adverse Event|2
7609003|NCT01862991|26474257|P3|Overall Study|Protocol Violation|0
7609004|NCT01862991|26474258|P2|Overall Study|Protocol Violation|0
7609005|NCT01862991|26474259|P1|Overall Study|Protocol Violation|1
7609006|NCT01862991|26474257|P3|Overall Study|Lost to Follow-up|1
7609007|NCT01862991|26474258|P2|Overall Study|Lost to Follow-up|1
7609008|NCT01862991|26474259|P1|Overall Study|Lost to Follow-up|2
7609009|NCT01862874|26474272|P2|Overall Study|Death|1
7609010|NCT01862874|26474273|P1|Overall Study|Death|0
7609011|NCT01862874|26474272|P2|Overall Study|Withdrawal by Subject|40
7609012|NCT01862874|26474273|P1|Overall Study|Withdrawal by Subject|46
7609013|NCT01862874|26474272|P2|Overall Study|Withdrawn by parent/guardian|1
7609014|NCT01862874|26474273|P1|Overall Study|Withdrawn by parent/guardian|1
7609015|NCT01862874|26474272|P2|Overall Study|Physician Decision|3
7609016|NCT01862874|26474273|P1|Overall Study|Physician Decision|5
7609017|NCT01862874|26474272|P2|Overall Study|Lost to Follow-up|29
7609018|NCT01862874|26474273|P1|Overall Study|Lost to Follow-up|26
7609019|NCT01862874|26474272|P2|Overall Study|Adverse Event|3
7609020|NCT01862874|26474273|P1|Overall Study|Adverse Event|0
7609021|NCT01862874|26474272|P2|Overall Study|Randomized not treated|0
7609022|NCT01862874|26474273|P1|Overall Study|Randomized not treated|1
7609023|NCT01862796|26474292|P3|Overall Study|Prohibited medications|1
7609024|NCT01862796|26474293|P2|Overall Study|Prohibited medications|0
7609025|NCT01862796|26474294|P1|Overall Study|Prohibited medications|0
7609026|NCT01862640|26474309|P4|Overall Study|Protocol Deviation|0
7609027|NCT01862640|26474310|P3|Overall Study|Protocol Deviation|1
7609028|NCT01862640|26474311|P2|Overall Study|Protocol Deviation|0
7609029|NCT01862640|26474312|P1|Overall Study|Protocol Deviation|0
7609030|NCT01862640|26474309|P4|Overall Study|Withdrawal by Subject|5
7609031|NCT01862640|26474310|P3|Overall Study|Withdrawal by Subject|8
7609032|NCT01862640|26474311|P2|Overall Study|Withdrawal by Subject|4
7609033|NCT01862640|26474312|P1|Overall Study|Withdrawal by Subject|2
7609034|NCT01862640|26474309|P4|Overall Study|Participant Withdrawn by Investigator|1
7609035|NCT01862640|26474310|P3|Overall Study|Participant Withdrawn by Investigator|1
7609036|NCT01862640|26474311|P2|Overall Study|Participant Withdrawn by Investigator|1
7609037|NCT01862640|26474312|P1|Overall Study|Participant Withdrawn by Investigator|0
7609038|NCT01862640|26474309|P4|Overall Study|Participant Met Withdrawal Criteria|1
7609039|NCT01862640|26474310|P3|Overall Study|Participant Met Withdrawal Criteria|2
7609040|NCT01862640|26474311|P2|Overall Study|Participant Met Withdrawal Criteria|1
7609041|NCT01862640|26474312|P1|Overall Study|Participant Met Withdrawal Criteria|1
7609042|NCT01862640|26474309|P4|Overall Study|Adverse Event|8
7609043|NCT01862640|26474310|P3|Overall Study|Adverse Event|6
7609044|NCT01862640|26474311|P2|Overall Study|Adverse Event|10
7609045|NCT01862640|26474312|P1|Overall Study|Adverse Event|4
7609046|NCT01862484|26474358|P2|Overall Study|Withdrawal by Subject|3
7609047|NCT01862484|26474359|P1|Overall Study|Withdrawal by Subject|0
7609048|NCT01862484|26474358|P2|Overall Study|Protocol Violation|2
7609049|NCT01862484|26474359|P1|Overall Study|Protocol Violation|0
7609050|NCT01862484|26474358|P2|Overall Study|Lost to Follow-up|2
7609051|NCT01862484|26474359|P1|Overall Study|Lost to Follow-up|1
7609052|NCT01862484|26474358|P2|Overall Study|Lack of Efficacy|1
7609053|NCT01862484|26474359|P1|Overall Study|Lack of Efficacy|1
7609054|NCT01862328|26474385|P7|Overall Study|Symptomatic Deterioration|1
7609055|NCT01862328|26474386|P6|Overall Study|Symptomatic Deterioration|0
7609056|NCT01862328|26474387|P5|Overall Study|Symptomatic Deterioration|0
7609057|NCT01862328|26474388|P4|Overall Study|Symptomatic Deterioration|0
7609058|NCT01862328|26474389|P3|Overall Study|Symptomatic Deterioration|0
7609059|NCT01862328|26474390|P2|Overall Study|Symptomatic Deterioration|0
7609060|NCT01862328|26474391|P1|Overall Study|Symptomatic Deterioration|0
7609061|NCT01862328|26474385|P7|Overall Study|Withdrawal by Subject|1
7609062|NCT01862328|26474386|P6|Overall Study|Withdrawal by Subject|1
7609063|NCT01862328|26474387|P5|Overall Study|Withdrawal by Subject|1
7609064|NCT01862328|26474388|P4|Overall Study|Withdrawal by Subject|0
7609065|NCT01862328|26474389|P3|Overall Study|Withdrawal by Subject|0
7609066|NCT01862328|26474390|P2|Overall Study|Withdrawal by Subject|1
7609067|NCT01862328|26474391|P1|Overall Study|Withdrawal by Subject|1
7609068|NCT01862328|26474385|P7|Overall Study|Other|1
7609069|NCT01862328|26474386|P6|Overall Study|Other|0
7609070|NCT01862328|26474387|P5|Overall Study|Other|4
7609071|NCT01862328|26474388|P4|Overall Study|Other|0
7609072|NCT01862328|26474389|P3|Overall Study|Other|1
7609073|NCT01862328|26474390|P2|Overall Study|Other|2
7609074|NCT01862328|26474391|P1|Overall Study|Other|0
7609075|NCT01862328|26474385|P7|Overall Study|Adverse Event|4
7609076|NCT01862328|26474386|P6|Overall Study|Adverse Event|2
7609077|NCT01862328|26474387|P5|Overall Study|Adverse Event|0
7609078|NCT01862328|26474388|P4|Overall Study|Adverse Event|1
7609079|NCT01862328|26474389|P3|Overall Study|Adverse Event|0
7609080|NCT01862328|26474390|P2|Overall Study|Adverse Event|4
7609081|NCT01862328|26474391|P1|Overall Study|Adverse Event|0
7609082|NCT01862328|26474385|P7|Overall Study|Progressive Disease|3
7609083|NCT01862328|26474386|P6|Overall Study|Progressive Disease|4
7609084|NCT01862328|26474387|P5|Overall Study|Progressive Disease|7
7609085|NCT01862328|26474388|P4|Overall Study|Progressive Disease|6
7609086|NCT01862328|26474389|P3|Overall Study|Progressive Disease|5
7609087|NCT01862328|26474390|P2|Overall Study|Progressive Disease|11
7609088|NCT01862328|26474391|P1|Overall Study|Progressive Disease|3
7609089|NCT01862250|26474443|P1|Overall Study|Adverse Event|4
7609090|NCT01862029|26474464|P1|Overall Study|Physician Decision|1
7609091|NCT01861717|26474504|P1|Overall Study|Withdrawal by Subject|1
7609092|NCT01861717|26474504|P1|Overall Study|Lost to Follow-up|1
7609093|NCT01861522|26474576|P2|Overall Study|Withdrawal by Subject|0
7609094|NCT01861522|26474577|P1|Overall Study|Withdrawal by Subject|2
7609095|NCT01861522|26474576|P2|Overall Study|Adverse Event|0
7609096|NCT01861522|26474577|P1|Overall Study|Adverse Event|1
7609097|NCT01860989|26474636|P1|Overall Study|Unsatisfactory therapeutic|5
7609098|NCT01860976|26474642|P2|Long Term Extension|Ongoing treatment at time of analysis|100
7609099|NCT01860976|26474643|P1|Long Term Extension|Ongoing treatment at time of analysis|106
7609100|NCT01860976|26474642|P2|Long Term Extension|Withdrawal by Subject|0
7609101|NCT01860976|26474643|P1|Long Term Extension|Withdrawal by Subject|1
7609102|NCT01860976|26474642|P2|Long Term Extension|Subject request to discontinue treatment|0
7609103|NCT01860976|26474643|P1|Long Term Extension|Subject request to discontinue treatment|2
7609104|NCT01860976|26474642|P2|Long Term Extension|Lack of Efficacy|7
7609105|NCT01860976|26474643|P1|Long Term Extension|Lack of Efficacy|3
7609106|NCT01860976|26474642|P2|Long Term Extension|Adverse Event|0
7609107|NCT01860976|26474643|P1|Long Term Extension|Adverse Event|1
7609108|NCT01860976|26474642|P2|Open-Label|Ongoing OL treatment at time of analysis|45
7609109|NCT01860976|26474643|P1|Open-Label|Ongoing OL treatment at time of analysis|46
7609110|NCT01860976|26474642|P2|Open-Label|Other Reasons|1
7609111|NCT01860976|26474643|P1|Open-Label|Other Reasons|1
7609112|NCT01860976|26474642|P2|Open-Label|Withdrawal by Subject|1
7609113|NCT01860976|26474643|P1|Open-Label|Withdrawal by Subject|4
7609114|NCT01860976|26474642|P2|Open-Label|Subject request discontinue treatment|3
7609115|NCT01860976|26474643|P1|Open-Label|Subject request discontinue treatment|4
7609116|NCT01860976|26474642|P2|Open-Label|Lost to Follow-up|2
7609117|NCT01860976|26474643|P1|Open-Label|Lost to Follow-up|1
7609118|NCT01860976|26474642|P2|Open-Label|Lack of Efficacy|8
7609119|NCT01860976|26474643|P1|Open-Label|Lack of Efficacy|16
7609120|NCT01860976|26474642|P2|Open-Label|Adverse Event|4
7609121|NCT01860976|26474643|P1|Open-Label|Adverse Event|2
7609122|NCT01860976|26474642|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
7609123|NCT01860976|26474643|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
7609124|NCT01860976|26474642|P2|Blinded Treatment|Entered Open-Label in error|1
7609125|NCT01860976|26474643|P1|Blinded Treatment|Entered Open-Label in error|0
7609126|NCT01860976|26474642|P2|Blinded Treatment|Subject no longer met criteria|0
7609127|NCT01860976|26474643|P1|Blinded Treatment|Subject no longer met criteria|1
7609128|NCT01860976|26474642|P2|Blinded Treatment|Withdrawal by Subject|5
7609129|NCT01860976|26474643|P1|Blinded Treatment|Withdrawal by Subject|3
7609130|NCT01860976|26474642|P2|Blinded Treatment|Subject request to discontinue treatment|3
7609131|NCT01860976|26474643|P1|Blinded Treatment|Subject request to discontinue treatment|2
7609132|NCT01860976|26474642|P2|Blinded Treatment|Lack of Efficacy|12
7609133|NCT01860976|26474643|P1|Blinded Treatment|Lack of Efficacy|5
7609134|NCT01860976|26474642|P2|Blinded Treatment|Adverse Event|3
7609135|NCT01860976|26474643|P1|Blinded Treatment|Adverse Event|1
7609136|NCT01860846|26474697|P1|Overall Study|Lost to Follow-up|33
7609137|NCT01860703|26474717|P4|Overall Study|Personal reason|0
7609138|NCT01860703|26474718|P3|Overall Study|Personal reason|1
7609139|NCT01860703|26474719|P2|Overall Study|Personal reason|0
7609140|NCT01860703|26474720|P1|Overall Study|Personal reason|1
7609141|NCT01860703|26474717|P4|Overall Study|Withdrawal by Subject|0
7609142|NCT01860703|26474718|P3|Overall Study|Withdrawal by Subject|0
7609143|NCT01860703|26474719|P2|Overall Study|Withdrawal by Subject|1
7609144|NCT01860703|26474720|P1|Overall Study|Withdrawal by Subject|0
7609145|NCT01860703|26474717|P4|Overall Study|Adverse Event|2
7609146|NCT01860703|26474718|P3|Overall Study|Adverse Event|0
7609147|NCT01860703|26474719|P2|Overall Study|Adverse Event|4
7609148|NCT01860703|26474720|P1|Overall Study|Adverse Event|1
7609149|NCT01860677|26474752|P2|Second Intervention (1 Day)|Lost to Follow-up|0
7609150|NCT01860677|26474753|P1|Second Intervention (1 Day)|Lost to Follow-up|7
7609151|NCT01860534|26474810|P2|ROP #2|discharged prior to ROP #2|0
7609152|NCT01860534|26474811|P1|ROP #2|discharged prior to ROP #2|1
7609153|NCT01860534|26474810|P2|ROP #1|Needed treatment for ROP|1
7609154|NCT01860534|26474811|P1|ROP #1|Needed treatment for ROP|0
7609155|NCT01860079|26474872|P2|Overall Study|Physician Decision|22
7609156|NCT01860079|26474873|P1|Overall Study|Physician Decision|14
7609157|NCT01860040|26474881|P2|Overall Study|Withdrawal by Subject|0
7609158|NCT01860040|26474882|P1|Overall Study|Withdrawal by Subject|1
7609159|NCT01859988|26474893|P6|Overall Study|Other than specified above|3
7609160|NCT01859988|26474894|P5|Overall Study|Other than specified above|5
7609161|NCT01859988|26474895|P4|Overall Study|Other than specified above|3
7609162|NCT01859988|26474896|P3|Overall Study|Other than specified above|11
7609163|NCT01859988|26474897|P2|Overall Study|Other than specified above|2
7609164|NCT01859988|26474898|P1|Overall Study|Other than specified above|0
7609165|NCT01859988|26474893|P6|Overall Study|Protocol Violation|0
7609166|NCT01859988|26474894|P5|Overall Study|Protocol Violation|0
7609167|NCT01859988|26474895|P4|Overall Study|Protocol Violation|0
7609168|NCT01859988|26474896|P3|Overall Study|Protocol Violation|1
7609169|NCT01859988|26474897|P2|Overall Study|Protocol Violation|0
7609170|NCT01859988|26474898|P1|Overall Study|Protocol Violation|0
7609171|NCT01859988|26474893|P6|Overall Study|Lost to Follow-up|2
7609172|NCT01859988|26474894|P5|Overall Study|Lost to Follow-up|3
7609173|NCT01859988|26474895|P4|Overall Study|Lost to Follow-up|0
7609174|NCT01859988|26474896|P3|Overall Study|Lost to Follow-up|3
7609175|NCT01859988|26474897|P2|Overall Study|Lost to Follow-up|2
7609176|NCT01859988|26474898|P1|Overall Study|Lost to Follow-up|1
7609177|NCT01859988|26474893|P6|Overall Study|Adverse Event|2
7609178|NCT01859988|26474894|P5|Overall Study|Adverse Event|2
7609179|NCT01859988|26474895|P4|Overall Study|Adverse Event|1
7609180|NCT01859988|26474896|P3|Overall Study|Adverse Event|3
7609181|NCT01859988|26474897|P2|Overall Study|Adverse Event|1
7609182|NCT01859988|26474898|P1|Overall Study|Adverse Event|2
7609183|NCT01859988|26474893|P6|Overall Study|Physician Decision|1
7609184|NCT01859988|26474894|P5|Overall Study|Physician Decision|4
7609185|NCT01859988|26474895|P4|Overall Study|Physician Decision|3
7609186|NCT01859988|26474896|P3|Overall Study|Physician Decision|1
7609187|NCT01859988|26474897|P2|Overall Study|Physician Decision|3
7609188|NCT01859988|26474898|P1|Overall Study|Physician Decision|1
7609189|NCT01859988|26474893|P6|Overall Study|Lack of Efficacy|9
7609190|NCT01859988|26474894|P5|Overall Study|Lack of Efficacy|7
7609191|NCT01859988|26474895|P4|Overall Study|Lack of Efficacy|0
7609192|NCT01859988|26474896|P3|Overall Study|Lack of Efficacy|5
7609193|NCT01859988|26474897|P2|Overall Study|Lack of Efficacy|1
7609194|NCT01859988|26474898|P1|Overall Study|Lack of Efficacy|1
7609195|NCT01859988|26474893|P6|Overall Study|Withdrawal by Subject|2
7609196|NCT01859988|26474894|P5|Overall Study|Withdrawal by Subject|2
7609197|NCT01859988|26474895|P4|Overall Study|Withdrawal by Subject|3
7609198|NCT01859988|26474896|P3|Overall Study|Withdrawal by Subject|4
7609199|NCT01859988|26474897|P2|Overall Study|Withdrawal by Subject|3
7609200|NCT01859988|26474898|P1|Overall Study|Withdrawal by Subject|6
7609201|NCT01859949|26474992|P2|Overall Study|Adverse Event|1
7609202|NCT01859949|26474993|P1|Overall Study|Adverse Event|0
7609203|NCT01859949|26474992|P2|Overall Study|Protocol Violation|1
7609204|NCT01859949|26474993|P1|Overall Study|Protocol Violation|1
7609205|NCT01859949|26474992|P2|Overall Study|Withdrawal by Subject|10
7609206|NCT01859949|26474993|P1|Overall Study|Withdrawal by Subject|11
7609207|NCT01859949|26474992|P2|Overall Study|Physician Decision|4
7609208|NCT01859949|26474993|P1|Overall Study|Physician Decision|2
7609209|NCT01859949|26474992|P2|Overall Study|Family Matters|1
7609210|NCT01859949|26474993|P1|Overall Study|Family Matters|0
7609211|NCT01859923|26475013|P4|Overall Study|Adverse Event|1
7609212|NCT01859923|26475014|P3|Overall Study|Adverse Event|1
7609213|NCT01859923|26475015|P2|Overall Study|Adverse Event|0
7609214|NCT01859923|26475016|P1|Overall Study|Adverse Event|0
7609215|NCT01859793|26475070|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
7609216|NCT01859793|26475071|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
7609217|NCT01859793|26475070|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
7609218|NCT01859793|26475071|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
7609219|NCT01859793|26475070|P2|First Intervention (8 Weeks)|Adverse Event|0
7609220|NCT01859793|26475071|P1|First Intervention (8 Weeks)|Adverse Event|1
7609221|NCT01859793|26475070|P2|First Intervention (8 Weeks)|Protocol Violation|0
7609222|NCT01859793|26475071|P1|First Intervention (8 Weeks)|Protocol Violation|2
7609223|NCT01859741|26475089|P8|Overall Study|Other|0
7609224|NCT01859741|26475090|P7|Overall Study|Other|2
7609225|NCT01859741|26475091|P6|Overall Study|Other|0
7609226|NCT01859741|26475092|P5|Overall Study|Other|0
7609227|NCT01859741|26475093|P4|Overall Study|Other|0
7609228|NCT01859741|26475094|P3|Overall Study|Other|0
7609229|NCT01859741|26475095|P2|Overall Study|Other|0
7609230|NCT01859741|26475096|P1|Overall Study|Other|0
7609231|NCT01859741|26475089|P8|Overall Study|Study Terminated by Sponsor|14
7609232|NCT01859741|26475090|P7|Overall Study|Study Terminated by Sponsor|16
7609233|NCT01859741|26475091|P6|Overall Study|Study Terminated by Sponsor|0
7609234|NCT01859741|26475092|P5|Overall Study|Study Terminated by Sponsor|1
7609235|NCT01859741|26475093|P4|Overall Study|Study Terminated by Sponsor|0
7609236|NCT01859741|26475094|P3|Overall Study|Study Terminated by Sponsor|0
7609237|NCT01859741|26475095|P2|Overall Study|Study Terminated by Sponsor|0
7609238|NCT01859741|26475096|P1|Overall Study|Study Terminated by Sponsor|0
7609239|NCT01859741|26475089|P8|Overall Study|Withdrawal by Subject|1
7609240|NCT01859741|26475090|P7|Overall Study|Withdrawal by Subject|1
7609241|NCT01859741|26475091|P6|Overall Study|Withdrawal by Subject|1
7609242|NCT01859741|26475092|P5|Overall Study|Withdrawal by Subject|0
7609243|NCT01859741|26475093|P4|Overall Study|Withdrawal by Subject|0
7609244|NCT01859741|26475094|P3|Overall Study|Withdrawal by Subject|2
7609245|NCT01859741|26475095|P2|Overall Study|Withdrawal by Subject|1
7609246|NCT01859741|26475096|P1|Overall Study|Withdrawal by Subject|0
7609247|NCT01859741|26475089|P8|Overall Study|Lost to Follow-up|4
7609248|NCT01859741|26475090|P7|Overall Study|Lost to Follow-up|0
7609249|NCT01859741|26475091|P6|Overall Study|Lost to Follow-up|1
7609250|NCT01859741|26475092|P5|Overall Study|Lost to Follow-up|0
7609251|NCT01859741|26475093|P4|Overall Study|Lost to Follow-up|0
7609252|NCT01859741|26475094|P3|Overall Study|Lost to Follow-up|0
7609253|NCT01859741|26475095|P2|Overall Study|Lost to Follow-up|0
7609254|NCT01859741|26475096|P1|Overall Study|Lost to Follow-up|0
7609255|NCT01859741|26475089|P8|Overall Study|Death|51
7609256|NCT01859741|26475090|P7|Overall Study|Death|51
7609257|NCT01859741|26475091|P6|Overall Study|Death|4
7609258|NCT01859741|26475092|P5|Overall Study|Death|5
7609259|NCT01859741|26475093|P4|Overall Study|Death|3
7609260|NCT01859741|26475094|P3|Overall Study|Death|4
7609261|NCT01859741|26475095|P2|Overall Study|Death|2
7609262|NCT01859741|26475096|P1|Overall Study|Death|3
7609263|NCT01859715|26475125|P3|Overall Study|No 2nd VAS|23
7609264|NCT01859715|26475126|P2|Overall Study|No 2nd VAS|8
7609265|NCT01859715|26475127|P1|Overall Study|No 2nd VAS|16
7609266|NCT01859702|26475138|P1|Overall Study|Adverse Event|2
7609267|NCT01859702|26475138|P1|Overall Study|Protocol deviation|3
7609268|NCT01859598|26475152|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
7609269|NCT01859507|26475160|P1|Overall Study|left the country|4
7609270|NCT01859494|26475165|P1|Overall Study|Adverse Event|1
7609271|NCT01859403|26475176|P2|Secondary Endpoint Measure|Withdrawal by Subject|8
7609272|NCT01859403|26475177|P1|Secondary Endpoint Measure|Withdrawal by Subject|6
7609273|NCT01859403|26475176|P2|Primary Endpoint Measure|Physician Decision|1
7609274|NCT01859403|26475177|P1|Primary Endpoint Measure|Physician Decision|0
7609275|NCT01859403|26475176|P2|Primary Endpoint Measure|Withdrawal by Subject|1
7609276|NCT01859403|26475177|P1|Primary Endpoint Measure|Withdrawal by Subject|1
7609277|NCT01859403|26475176|P2|Primary Endpoint Measure|Lost to Follow-up|2
7609278|NCT01859403|26475177|P1|Primary Endpoint Measure|Lost to Follow-up|0
7609279|NCT01859390|26475187|P2|Overall Study|Shipment Error|1
7609280|NCT01859390|26475188|P1|Overall Study|Shipment Error|0
7609281|NCT01859390|26475187|P2|Overall Study|Tube Cracked|2
7609282|NCT01859390|26475188|P1|Overall Study|Tube Cracked|0
7609283|NCT01859390|26475187|P2|Overall Study|Sample Missing Collection Date|1
7609284|NCT01859390|26475188|P1|Overall Study|Sample Missing Collection Date|0
7609285|NCT01859390|26475187|P2|Overall Study|Insufficient Sputum Collected|3
7609286|NCT01859390|26475188|P1|Overall Study|Insufficient Sputum Collected|1
7609287|NCT01859143|26475322|P2|Overall Study|Lost to Follow-up|0
7609288|NCT01859143|26475323|P1|Overall Study|Lost to Follow-up|2
7609289|NCT01858766|26475379|P19|Overall Study|Withdrew Consent|0
7609290|NCT01858766|26475380|P18|Overall Study|Withdrew Consent|0
7609291|NCT01858766|26475381|P17|Overall Study|Withdrew Consent|0
7609292|NCT01858766|26475382|P16|Overall Study|Withdrew Consent|0
7609293|NCT01858766|26475383|P15|Overall Study|Withdrew Consent|0
7609294|NCT01858766|26475384|P14|Overall Study|Withdrew Consent|0
7609295|NCT01858766|26475385|P13|Overall Study|Withdrew Consent|0
7609296|NCT01858766|26475386|P12|Overall Study|Withdrew Consent|1
7609297|NCT01858766|26475387|P11|Overall Study|Withdrew Consent|0
7609298|NCT01858766|26475388|P10|Overall Study|Withdrew Consent|0
7609299|NCT01858766|26475389|P9|Overall Study|Withdrew Consent|0
7609300|NCT01858766|26475390|P8|Overall Study|Withdrew Consent|0
7609301|NCT01858766|26475391|P7|Overall Study|Withdrew Consent|0
7609302|NCT01858766|26475392|P6|Overall Study|Withdrew Consent|0
7609303|NCT01858766|26475393|P5|Overall Study|Withdrew Consent|0
7609304|NCT01858766|26475394|P4|Overall Study|Withdrew Consent|0
7609305|NCT01858766|26475395|P3|Overall Study|Withdrew Consent|0
7609306|NCT01858766|26475396|P2|Overall Study|Withdrew Consent|0
7609307|NCT01858766|26475397|P1|Overall Study|Withdrew Consent|0
7609308|NCT01858766|26475379|P19|Overall Study|Lost to Follow-up|1
7609309|NCT01858766|26475380|P18|Overall Study|Lost to Follow-up|0
7609310|NCT01858766|26475381|P17|Overall Study|Lost to Follow-up|1
7609311|NCT01858766|26475382|P16|Overall Study|Lost to Follow-up|1
7609312|NCT01858766|26475383|P15|Overall Study|Lost to Follow-up|3
7609313|NCT01858766|26475384|P14|Overall Study|Lost to Follow-up|0
7609314|NCT01858766|26475385|P13|Overall Study|Lost to Follow-up|0
7609315|NCT01858766|26475386|P12|Overall Study|Lost to Follow-up|1
7609316|NCT01858766|26475387|P11|Overall Study|Lost to Follow-up|0
7609317|NCT01858766|26475388|P10|Overall Study|Lost to Follow-up|0
7609318|NCT01858766|26475389|P9|Overall Study|Lost to Follow-up|0
7609319|NCT01858766|26475390|P8|Overall Study|Lost to Follow-up|2
7609320|NCT01858766|26475391|P7|Overall Study|Lost to Follow-up|0
7609321|NCT01858766|26475392|P6|Overall Study|Lost to Follow-up|1
7609322|NCT01858766|26475393|P5|Overall Study|Lost to Follow-up|0
7609323|NCT01858766|26475394|P4|Overall Study|Lost to Follow-up|0
7609324|NCT01858766|26475395|P3|Overall Study|Lost to Follow-up|0
7609325|NCT01858766|26475396|P2|Overall Study|Lost to Follow-up|0
7609326|NCT01858766|26475397|P1|Overall Study|Lost to Follow-up|0
7609327|NCT01858766|26475379|P19|Overall Study|Lack of Efficacy|3
7609328|NCT01858766|26475380|P18|Overall Study|Lack of Efficacy|3
7609329|NCT01858766|26475381|P17|Overall Study|Lack of Efficacy|2
7609330|NCT01858766|26475382|P16|Overall Study|Lack of Efficacy|5
7609331|NCT01858766|26475383|P15|Overall Study|Lack of Efficacy|5
7609332|NCT01858766|26475384|P14|Overall Study|Lack of Efficacy|3
7609333|NCT01858766|26475385|P13|Overall Study|Lack of Efficacy|5
7609334|NCT01858766|26475386|P12|Overall Study|Lack of Efficacy|3
7609335|NCT01858766|26475387|P11|Overall Study|Lack of Efficacy|0
7609336|NCT01858766|26475388|P10|Overall Study|Lack of Efficacy|0
7609337|NCT01858766|26475389|P9|Overall Study|Lack of Efficacy|0
7609338|NCT01858766|26475390|P8|Overall Study|Lack of Efficacy|0
7609339|NCT01858766|26475391|P7|Overall Study|Lack of Efficacy|0
7609340|NCT01858766|26475392|P6|Overall Study|Lack of Efficacy|2
7609341|NCT01858766|26475393|P5|Overall Study|Lack of Efficacy|1
7609342|NCT01858766|26475394|P4|Overall Study|Lack of Efficacy|0
7609343|NCT01858766|26475395|P3|Overall Study|Lack of Efficacy|0
7609344|NCT01858766|26475396|P2|Overall Study|Lack of Efficacy|0
7609345|NCT01858766|26475397|P1|Overall Study|Lack of Efficacy|1
7609346|NCT01858766|26475379|P19|Overall Study|Death|0
7609347|NCT01858766|26475380|P18|Overall Study|Death|0
7609348|NCT01858766|26475381|P17|Overall Study|Death|0
7609349|NCT01858766|26475382|P16|Overall Study|Death|0
7609350|NCT01858766|26475383|P15|Overall Study|Death|0
7609351|NCT01858766|26475384|P14|Overall Study|Death|0
7609352|NCT01858766|26475385|P13|Overall Study|Death|0
7609353|NCT01858766|26475386|P12|Overall Study|Death|0
7609354|NCT01858766|26475387|P11|Overall Study|Death|0
7609355|NCT01858766|26475388|P10|Overall Study|Death|0
7609356|NCT01858766|26475389|P9|Overall Study|Death|0
7609357|NCT01858766|26475390|P8|Overall Study|Death|0
7609358|NCT01858766|26475391|P7|Overall Study|Death|0
7609359|NCT01858766|26475392|P6|Overall Study|Death|0
7609360|NCT01858766|26475393|P5|Overall Study|Death|0
7609361|NCT01858766|26475394|P4|Overall Study|Death|0
7609362|NCT01858766|26475395|P3|Overall Study|Death|1
7609363|NCT01858766|26475396|P2|Overall Study|Death|0
7609364|NCT01858766|26475397|P1|Overall Study|Death|0
7609365|NCT01858766|26475379|P19|Overall Study|Randomized but Never Treated|0
7609366|NCT01858766|26475380|P18|Overall Study|Randomized but Never Treated|1
7609367|NCT01858766|26475381|P17|Overall Study|Randomized but Never Treated|0
7609368|NCT01858766|26475382|P16|Overall Study|Randomized but Never Treated|0
7609369|NCT01858766|26475383|P15|Overall Study|Randomized but Never Treated|0
7609370|NCT01858766|26475384|P14|Overall Study|Randomized but Never Treated|0
7609371|NCT01858766|26475385|P13|Overall Study|Randomized but Never Treated|0
7609372|NCT01858766|26475386|P12|Overall Study|Randomized but Never Treated|0
7609373|NCT01858766|26475387|P11|Overall Study|Randomized but Never Treated|0
7609374|NCT01858766|26475388|P10|Overall Study|Randomized but Never Treated|0
7609375|NCT01858766|26475389|P9|Overall Study|Randomized but Never Treated|0
7609376|NCT01858766|26475390|P8|Overall Study|Randomized but Never Treated|0
7609377|NCT01858766|26475391|P7|Overall Study|Randomized but Never Treated|0
7609378|NCT01858766|26475392|P6|Overall Study|Randomized but Never Treated|1
7609379|NCT01858766|26475393|P5|Overall Study|Randomized but Never Treated|0
7609380|NCT01858766|26475394|P4|Overall Study|Randomized but Never Treated|0
7609381|NCT01858766|26475395|P3|Overall Study|Randomized but Never Treated|0
7609382|NCT01858766|26475396|P2|Overall Study|Randomized but Never Treated|0
7609383|NCT01858766|26475397|P1|Overall Study|Randomized but Never Treated|0
7609384|NCT01858701|26475485|P2|Period 2, Second 30 Days of Wear|Comfort|1
7609385|NCT01858701|26475486|P1|Period 2, Second 30 Days of Wear|Comfort|0
7609386|NCT01858701|26475485|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
7609387|NCT01858701|26475486|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
7609388|NCT01858701|26475485|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
7609389|NCT01858701|26475486|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
7609390|NCT01858701|26475485|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7609391|NCT01858701|26475486|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7609392|NCT01858636|26475492|P1|Overall Study|Withdrawal by Subject|1
7609393|NCT01858636|26475492|P1|Overall Study|Lost to Follow-up|1
7609394|NCT01858636|26475492|P1|Overall Study|Death|1
7609395|NCT01858636|26475492|P1|Overall Study|Physician Decision|1
7609396|NCT01858636|26475492|P1|Overall Study|No Device Deployment Attempted|24
7609397|NCT01858558|26475499|P2|Overall Study|Failed expansion of cell product|0
7609398|NCT01858558|26475500|P1|Overall Study|Failed expansion of cell product|2
7609399|NCT01858558|26475499|P2|Overall Study|Product contamination|0
7609400|NCT01858558|26475500|P1|Overall Study|Product contamination|2
7609401|NCT01858558|26475499|P2|Overall Study|Disease progression|1
7609402|NCT01858558|26475500|P1|Overall Study|Disease progression|3
7609403|NCT01858558|26475499|P2|Overall Study|Lost to Follow-up|0
7609404|NCT01858558|26475500|P1|Overall Study|Lost to Follow-up|1
7609405|NCT01858558|26475499|P2|Overall Study|Death|1
7609406|NCT01858558|26475500|P1|Overall Study|Death|1
7609407|NCT01858532|26475522|P4|Overall Study|Other, not specified|11
7609408|NCT01858532|26475523|P3|Overall Study|Other, not specified|13
7609409|NCT01858532|26475524|P2|Overall Study|Other, not specified|15
7609410|NCT01858532|26475525|P1|Overall Study|Other, not specified|29
7609411|NCT01858532|26475522|P4|Overall Study|Investigator request|6
7609412|NCT01858532|26475523|P3|Overall Study|Investigator request|2
7609413|NCT01858532|26475524|P2|Overall Study|Investigator request|4
7609414|NCT01858532|26475525|P1|Overall Study|Investigator request|3
7609415|NCT01858532|26475522|P4|Overall Study|Deterioration of medical status|7
7609416|NCT01858532|26475523|P3|Overall Study|Deterioration of medical status|3
7609417|NCT01858532|26475524|P2|Overall Study|Deterioration of medical status|4
7609418|NCT01858532|26475525|P1|Overall Study|Deterioration of medical status|3
7609419|NCT01858532|26475522|P4|Overall Study|Lost to Follow-up|14
7609420|NCT01858532|26475523|P3|Overall Study|Lost to Follow-up|11
7609421|NCT01858532|26475524|P2|Overall Study|Lost to Follow-up|26
7609422|NCT01858532|26475525|P1|Overall Study|Lost to Follow-up|17
7609423|NCT01858532|26475522|P4|Overall Study|Withdrew consent|27
7609424|NCT01858532|26475523|P3|Overall Study|Withdrew consent|46
7609425|NCT01858532|26475524|P2|Overall Study|Withdrew consent|93
7609426|NCT01858532|26475525|P1|Overall Study|Withdrew consent|71
7609427|NCT01858532|26475522|P4|Overall Study|Adverse Event|28
7609428|NCT01858532|26475523|P3|Overall Study|Adverse Event|23
7609429|NCT01858532|26475524|P2|Overall Study|Adverse Event|50
7609430|NCT01858532|26475525|P1|Overall Study|Adverse Event|58
7609431|NCT01858389|26475579|P2|Overall Study|Did not receive treatment|3
7609432|NCT01858389|26475580|P1|Overall Study|Did not receive treatment|0
7609433|NCT01858389|26475579|P2|Overall Study|Adverse Event|1
7609434|NCT01858389|26475580|P1|Overall Study|Adverse Event|3
7609435|NCT01858389|26475579|P2|Overall Study|Other|4
7609436|NCT01858389|26475580|P1|Overall Study|Other|2
7609437|NCT01858389|26475579|P2|Overall Study|Progressive disease|11
7609438|NCT01858389|26475580|P1|Overall Study|Progressive disease|10
7609439|NCT01858389|26475579|P2|Overall Study|Withdrawal by Subject|1
7609440|NCT01858389|26475580|P1|Overall Study|Withdrawal by Subject|0
7609441|NCT01858389|26475579|P2|Overall Study|Study terminated by sponsor|2
7609442|NCT01858389|26475580|P1|Overall Study|Study terminated by sponsor|0
7609443|NCT01858389|26475579|P2|Overall Study|Death|3
7609444|NCT01858389|26475580|P1|Overall Study|Death|1
7609445|NCT01858376|26475595|P1|Overall Study|Dropped d/t lab work not fitting criter|4
7609446|NCT01858363|26475604|P2|Overall Study|Lost to Follow-up|3
7609447|NCT01858363|26475605|P1|Overall Study|Lost to Follow-up|13
7609448|NCT01858363|26475604|P2|Overall Study|Withdrawal by Subject|14
7609449|NCT01858363|26475605|P1|Overall Study|Withdrawal by Subject|28
7609450|NCT01858363|26475604|P2|Overall Study|Death|9
7609451|NCT01858363|26475605|P1|Overall Study|Death|35
7609452|NCT01858194|26475615|P2|Overall Study|Lost to Follow-up|1
7609453|NCT01858194|26475616|P1|Overall Study|Lost to Follow-up|0
7609454|NCT01858194|26475615|P2|Overall Study|Total Artificial Heart Implant|1
7609455|NCT01858194|26475616|P1|Overall Study|Total Artificial Heart Implant|0
7609456|NCT01857973|26475669|P1|Overall Study|Physician Decision|1
7609457|NCT01857973|26475669|P1|Overall Study|drop out after 3 failed attempts|1
7609458|NCT01857973|26475669|P1|Overall Study|Subject did not meet required BG range|3
7609459|NCT01857869|26475699|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609460|NCT01857869|26475700|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609461|NCT01857869|26475701|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609462|NCT01857869|26475702|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609463|NCT01857869|26475703|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609464|NCT01857869|26475704|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609465|NCT01857869|26475705|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
7609466|NCT01857869|26475706|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609467|NCT01857869|26475707|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609468|NCT01857869|26475708|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7609469|NCT01857869|26475699|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609470|NCT01857869|26475700|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609471|NCT01857869|26475701|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609472|NCT01857869|26475702|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609473|NCT01857869|26475703|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609474|NCT01857869|26475704|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609475|NCT01857869|26475705|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
7609476|NCT01857869|26475706|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609477|NCT01857869|26475707|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609478|NCT01857869|26475708|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
7609479|NCT01857869|26475699|P10|Primary/Challenge Phase|Other|0
7609480|NCT01857869|26475700|P9|Primary/Challenge Phase|Other|0
7609481|NCT01857869|26475701|P8|Primary/Challenge Phase|Other|0
7609482|NCT01857869|26475702|P7|Primary/Challenge Phase|Other|0
7609483|NCT01857869|26475703|P6|Primary/Challenge Phase|Other|0
7609484|NCT01857869|26475704|P5|Primary/Challenge Phase|Other|0
7609485|NCT01857869|26475705|P4|Primary/Challenge Phase|Other|0
7609486|NCT01857869|26475706|P3|Primary/Challenge Phase|Other|0
7609487|NCT01857869|26475707|P2|Primary/Challenge Phase|Other|1
7609488|NCT01857869|26475708|P1|Primary/Challenge Phase|Other|1
7609489|NCT01857869|26475699|P10|Primary/Challenge Phase|Protocol Violation|0
7609490|NCT01857869|26475700|P9|Primary/Challenge Phase|Protocol Violation|0
7609491|NCT01857869|26475701|P8|Primary/Challenge Phase|Protocol Violation|0
7609492|NCT01857869|26475702|P7|Primary/Challenge Phase|Protocol Violation|0
7609493|NCT01857869|26475703|P6|Primary/Challenge Phase|Protocol Violation|0
7609494|NCT01857869|26475704|P5|Primary/Challenge Phase|Protocol Violation|0
7609495|NCT01857869|26475705|P4|Primary/Challenge Phase|Protocol Violation|0
7609496|NCT01857869|26475706|P3|Primary/Challenge Phase|Protocol Violation|0
7609497|NCT01857869|26475707|P2|Primary/Challenge Phase|Protocol Violation|0
7609498|NCT01857869|26475708|P1|Primary/Challenge Phase|Protocol Violation|1
7609499|NCT01857869|26475699|P10|Primary/Challenge Phase|Pregnancy|0
7609500|NCT01857869|26475700|P9|Primary/Challenge Phase|Pregnancy|0
7609501|NCT01857869|26475701|P8|Primary/Challenge Phase|Pregnancy|0
7609502|NCT01857869|26475702|P7|Primary/Challenge Phase|Pregnancy|0
7609503|NCT01857869|26475703|P6|Primary/Challenge Phase|Pregnancy|0
7609504|NCT01857869|26475704|P5|Primary/Challenge Phase|Pregnancy|0
7609505|NCT01857869|26475705|P4|Primary/Challenge Phase|Pregnancy|0
7609506|NCT01857869|26475706|P3|Primary/Challenge Phase|Pregnancy|0
7609507|NCT01857869|26475707|P2|Primary/Challenge Phase|Pregnancy|0
7609508|NCT01857869|26475708|P1|Primary/Challenge Phase|Pregnancy|1
7609509|NCT01857869|26475699|P10|Primary/Challenge Phase|Lost to Follow-up|0
7609510|NCT01857869|26475700|P9|Primary/Challenge Phase|Lost to Follow-up|0
7609511|NCT01857869|26475701|P8|Primary/Challenge Phase|Lost to Follow-up|0
7609512|NCT01857869|26475702|P7|Primary/Challenge Phase|Lost to Follow-up|0
7609513|NCT01857869|26475703|P6|Primary/Challenge Phase|Lost to Follow-up|0
7609514|NCT01857869|26475704|P5|Primary/Challenge Phase|Lost to Follow-up|0
7609515|NCT01857869|26475705|P4|Primary/Challenge Phase|Lost to Follow-up|0
7609516|NCT01857869|26475706|P3|Primary/Challenge Phase|Lost to Follow-up|0
7609517|NCT01857869|26475707|P2|Primary/Challenge Phase|Lost to Follow-up|0
7609518|NCT01857869|26475708|P1|Primary/Challenge Phase|Lost to Follow-up|2
7609519|NCT01857622|26475798|P3|Overall Study|Withdrawal by Subject|0
7609520|NCT01857622|26475799|P2|Overall Study|Withdrawal by Subject|0
7609521|NCT01857622|26475800|P1|Overall Study|Withdrawal by Subject|1
7609522|NCT01857622|26475798|P3|Overall Study|Protocol Violation|0
7609523|NCT01857622|26475799|P2|Overall Study|Protocol Violation|1
7609524|NCT01857622|26475800|P1|Overall Study|Protocol Violation|4
7609525|NCT01857622|26475798|P3|Overall Study|Physician Decision|0
7609526|NCT01857622|26475799|P2|Overall Study|Physician Decision|0
7609527|NCT01857622|26475800|P1|Overall Study|Physician Decision|1
7609528|NCT01857622|26475798|P3|Overall Study|Adverse Event|2
7609529|NCT01857622|26475799|P2|Overall Study|Adverse Event|0
7609530|NCT01857622|26475800|P1|Overall Study|Adverse Event|5
7609531|NCT01857583|26475812|P4|Overall Study|Withdrawal by Subject|2
7609532|NCT01857583|26475813|P3|Overall Study|Withdrawal by Subject|1
7609533|NCT01857583|26475814|P2|Overall Study|Withdrawal by Subject|0
7609534|NCT01857583|26475815|P1|Overall Study|Withdrawal by Subject|1
7609535|NCT01857583|26475812|P4|Overall Study|Physician Decision|1
7609536|NCT01857583|26475813|P3|Overall Study|Physician Decision|0
7609537|NCT01857583|26475814|P2|Overall Study|Physician Decision|0
7609538|NCT01857583|26475815|P1|Overall Study|Physician Decision|0
7609539|NCT01857583|26475812|P4|Overall Study|Death|0
7609540|NCT01857583|26475813|P3|Overall Study|Death|1
7609541|NCT01857583|26475814|P2|Overall Study|Death|1
7609542|NCT01857583|26475815|P1|Overall Study|Death|0
7609543|NCT01857583|26475812|P4|Overall Study|Adverse Event|1
7609544|NCT01857583|26475813|P3|Overall Study|Adverse Event|1
7609545|NCT01857583|26475814|P2|Overall Study|Adverse Event|0
7609546|NCT01857583|26475815|P1|Overall Study|Adverse Event|0
7609547|NCT01857531|26475825|P1|Overall Study|Withdrawal by Subject|4
7609548|NCT01857323|26475843|P1|Overall Study|Did not complete 180 doses|48
7609549|NCT01857323|26475843|P1|Overall Study|Other|4
7609550|NCT01857323|26475843|P1|Overall Study|Lost to Follow-up|1
7609551|NCT01857323|26475843|P1|Overall Study|Protocol Violation|6
7609552|NCT01857323|26475843|P1|Overall Study|Non-compliance|1
7609553|NCT01857323|26475843|P1|Overall Study|Withdrawal by Subject|3
7609554|NCT01857323|26475843|P1|Overall Study|Adverse Event|1
7609555|NCT01857310|26475854|P2|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
7609556|NCT01857310|26475855|P1|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
7609557|NCT01857271|26475950|P1|Overall Study|Lost to Follow-up|1
7609558|NCT01857206|26476003|P2|Overall Study|Withdrawal by Subject|0
7609559|NCT01857206|26476004|P1|Overall Study|Withdrawal by Subject|1
7609560|NCT01857206|26476003|P2|Overall Study|Unclassified|3
7609561|NCT01857206|26476004|P1|Overall Study|Unclassified|3
7609562|NCT01857206|26476003|P2|Overall Study|Lost to Follow-up|6
7609563|NCT01857206|26476004|P1|Overall Study|Lost to Follow-up|9
7609564|NCT01857206|26476003|P2|Overall Study|ADMINISTRATIVE REASON|1
7609565|NCT01857206|26476004|P1|Overall Study|ADMINISTRATIVE REASON|0
7609566|NCT01857102|26476022|P2|Period 2|Unsatisfactory Lens Fit|0
7609567|NCT01857102|26476023|P1|Period 2|Unsatisfactory Lens Fit|1
7609568|NCT01857102|26476022|P2|Period 2|Lens Discomfort|0
7609569|NCT01857102|26476023|P1|Period 2|Lens Discomfort|1
7609570|NCT01857102|26476022|P2|Period 1|Physician Decision|0
7609571|NCT01857102|26476023|P1|Period 1|Physician Decision|1
7609572|NCT01857102|26476022|P2|Period 1|Unsatisfactory Visual Response|0
7609573|NCT01857102|26476023|P1|Period 1|Unsatisfactory Visual Response|1
7609574|NCT01857102|26476022|P2|Period 1|Unsatisfactory Lens Fit|0
7609575|NCT01857102|26476023|P1|Period 1|Unsatisfactory Lens Fit|1
7609576|NCT01857102|26476022|P2|Period 1|Lost to Follow-up|3
7609577|NCT01857102|26476023|P1|Period 1|Lost to Follow-up|0
7609578|NCT01857102|26476022|P2|Period 1|No longer meets Eligibility Criteria|2
7609579|NCT01857102|26476023|P1|Period 1|No longer meets Eligibility Criteria|0
7609580|NCT01857063|26476033|P2|Period 2 (7 Days)|Withdrawal by Subject|0
7609581|NCT01857063|26476034|P1|Period 2 (7 Days)|Withdrawal by Subject|1
7609582|NCT01857063|26476033|P2|Period 2 (7 Days)|Physician Decision|1
7609583|NCT01857063|26476034|P1|Period 2 (7 Days)|Physician Decision|1
7609584|NCT01857063|26476033|P2|Period 2 (7 Days)|Adverse Event|1
7609585|NCT01857063|26476034|P1|Period 2 (7 Days)|Adverse Event|2
7609586|NCT01857063|26476033|P2|Period 1 (7 Days)|Withdrawal by Subject|3
7609587|NCT01857063|26476034|P1|Period 1 (7 Days)|Withdrawal by Subject|1
7609588|NCT01857063|26476033|P2|Period 1 (7 Days)|Physician Decision|0
7609589|NCT01857063|26476034|P1|Period 1 (7 Days)|Physician Decision|1
7609590|NCT01857063|26476033|P2|Period 1 (7 Days)|Adverse Event|1
7609591|NCT01857063|26476034|P1|Period 1 (7 Days)|Adverse Event|0
7609592|NCT01856907|26476068|P3|Overall Study|Withdrawal by Subject|0
7609593|NCT01856907|26476069|P2|Overall Study|Withdrawal by Subject|1
7609594|NCT01856907|26476070|P1|Overall Study|Withdrawal by Subject|0
7609595|NCT01856907|26476068|P3|Overall Study|Pregnancy|0
7609596|NCT01856907|26476069|P2|Overall Study|Pregnancy|1
7609597|NCT01856907|26476070|P1|Overall Study|Pregnancy|0
7609598|NCT01856907|26476068|P3|Overall Study|Pregnancy|0
7609599|NCT01856907|26476069|P2|Overall Study|Pregnancy|1
7609600|NCT01856907|26476070|P1|Overall Study|Pregnancy|0
7609601|NCT01856790|26476108|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
7609602|NCT01856790|26476108|P1|Closed Loop Control|Withdrawal by Subject|2
7609603|NCT01856686|26476162|P2|Overall Study|Lost to Follow-up|11
7609604|NCT01856686|26476163|P1|Overall Study|Lost to Follow-up|5
7609605|NCT01856673|26476206|P3|Overall Study|Protocol Violation|1
7609606|NCT01856673|26476207|P2|Overall Study|Protocol Violation|0
7609607|NCT01856673|26476208|P1|Overall Study|Protocol Violation|1
7609608|NCT01856673|26476206|P3|Overall Study|Death|0
7609609|NCT01856673|26476207|P2|Overall Study|Death|1
7609610|NCT01856673|26476208|P1|Overall Study|Death|1
7609611|NCT01856673|26476206|P3|Overall Study|Paperwork errors|0
7609612|NCT01856673|26476207|P2|Overall Study|Paperwork errors|0
7609613|NCT01856673|26476208|P1|Overall Study|Paperwork errors|8
7609614|NCT01856673|26476206|P3|Overall Study|Psychologist decision|0
7609615|NCT01856673|26476207|P2|Overall Study|Psychologist decision|0
7609616|NCT01856673|26476208|P1|Overall Study|Psychologist decision|1
7609617|NCT01856673|26476206|P3|Overall Study|Unknown reasons|0
7609618|NCT01856673|26476207|P2|Overall Study|Unknown reasons|0
7609619|NCT01856673|26476208|P1|Overall Study|Unknown reasons|9
7609620|NCT01856673|26476206|P3|Overall Study|Lost to Follow-up|0
7609621|NCT01856673|26476207|P2|Overall Study|Lost to Follow-up|34
7609622|NCT01856673|26476208|P1|Overall Study|Lost to Follow-up|31
7609623|NCT01856673|26476206|P3|Overall Study|Withdrawal by Subject|33
7609624|NCT01856673|26476207|P2|Overall Study|Withdrawal by Subject|50
7609625|NCT01856673|26476208|P1|Overall Study|Withdrawal by Subject|44
7609626|NCT01856595|26476228|P9|Overall Study|Withdrawal by Subject|0
7609627|NCT01856595|26476229|P8|Overall Study|Withdrawal by Subject|0
7609628|NCT01856595|26476230|P7|Overall Study|Withdrawal by Subject|1
7609629|NCT01856595|26476231|P6|Overall Study|Withdrawal by Subject|0
7609630|NCT01856595|26476232|P5|Overall Study|Withdrawal by Subject|0
7609631|NCT01856595|26476233|P4|Overall Study|Withdrawal by Subject|0
7609632|NCT01856595|26476234|P3|Overall Study|Withdrawal by Subject|0
7609633|NCT01856595|26476235|P2|Overall Study|Withdrawal by Subject|1
7609634|NCT01856595|26476236|P1|Overall Study|Withdrawal by Subject|0
7609635|NCT01856582|26476469|P1|Overall Study|Died prior to Boost infusion|1
7609636|NCT01856569|26476473|P1|Overall Study|Did not met inclusion criteria|8
7609637|NCT01856569|26476473|P1|Overall Study|Lost to Follow-up|3
7609638|NCT01856569|26476473|P1|Overall Study|Changed Site/Structure|1
7609639|NCT01856569|26476473|P1|Overall Study|Other|1
7609640|NCT01856543|26476484|P2|Overall Study|Withdrawn before start|3
7609641|NCT01856543|26476485|P1|Overall Study|Withdrawn before start|7
7609642|NCT01856543|26476484|P2|Overall Study|Treatment discontinued|3
7609643|NCT01856543|26476485|P1|Overall Study|Treatment discontinued|6
7609644|NCT01856322|26476543|P3|Overall Study|off study due to lack of accrual|3
7609645|NCT01856322|26476544|P2|Overall Study|off study due to lack of accrual|0
7609646|NCT01856322|26476545|P1|Overall Study|off study due to lack of accrual|0
7609647|NCT01856309|26476556|P4|Overall Study|Noncompliance With Study Drug|1
7609648|NCT01856309|26476557|P3|Overall Study|Noncompliance With Study Drug|4
7609649|NCT01856309|26476558|P2|Overall Study|Noncompliance With Study Drug|1
7609650|NCT01856309|26476559|P1|Overall Study|Noncompliance With Study Drug|0
7609651|NCT01856309|26476556|P4|Overall Study|Physician Decision|8
7609652|NCT01856309|26476557|P3|Overall Study|Physician Decision|6
7609653|NCT01856309|26476558|P2|Overall Study|Physician Decision|1
7609654|NCT01856309|26476559|P1|Overall Study|Physician Decision|6
7609655|NCT01856309|26476556|P4|Overall Study|Pregnancy|1
7609656|NCT01856309|26476557|P3|Overall Study|Pregnancy|0
7609657|NCT01856309|26476558|P2|Overall Study|Pregnancy|0
7609658|NCT01856309|26476559|P1|Overall Study|Pregnancy|0
7609659|NCT01856309|26476556|P4|Overall Study|Adverse Event|65
7609660|NCT01856309|26476557|P3|Overall Study|Adverse Event|55
7609661|NCT01856309|26476558|P2|Overall Study|Adverse Event|31
7609662|NCT01856309|26476559|P1|Overall Study|Adverse Event|31
7609663|NCT01856309|26476556|P4|Overall Study|Lack of Efficacy|25
7609664|NCT01856309|26476557|P3|Overall Study|Lack of Efficacy|40
7609665|NCT01856309|26476558|P2|Overall Study|Lack of Efficacy|9
7609666|NCT01856309|26476559|P1|Overall Study|Lack of Efficacy|14
7609667|NCT01856309|26476556|P4|Overall Study|Other|469
7609668|NCT01856309|26476557|P3|Overall Study|Other|447
7609669|NCT01856309|26476558|P2|Overall Study|Other|225
7609670|NCT01856309|26476559|P1|Overall Study|Other|227
7609671|NCT01856309|26476556|P4|Overall Study|Withdrawal by Subject|26
7609672|NCT01856309|26476557|P3|Overall Study|Withdrawal by Subject|28
7609673|NCT01856309|26476558|P2|Overall Study|Withdrawal by Subject|13
7609674|NCT01856309|26476559|P1|Overall Study|Withdrawal by Subject|11
7609675|NCT01856309|26476556|P4|Overall Study|Lost to Follow-up|8
7609676|NCT01856309|26476557|P3|Overall Study|Lost to Follow-up|4
7609677|NCT01856309|26476558|P2|Overall Study|Lost to Follow-up|2
7609678|NCT01856309|26476559|P1|Overall Study|Lost to Follow-up|6
7609679|NCT01856309|26476556|P4|Overall Study|Death|6
7609680|NCT01856309|26476557|P3|Overall Study|Death|11
7609681|NCT01856309|26476558|P2|Overall Study|Death|6
7609682|NCT01856309|26476559|P1|Overall Study|Death|4
7609683|NCT01856257|26476683|P4|Overall Study|Donor complication|1
7609684|NCT01856257|26476684|P3|Overall Study|Donor complication|0
7609685|NCT01856257|26476685|P2|Overall Study|Donor complication|0
7609686|NCT01856257|26476686|P1|Overall Study|Donor complication|0
7609687|NCT01856257|26476683|P4|Overall Study|Withdrawal by Subject|0
7609688|NCT01856257|26476684|P3|Overall Study|Withdrawal by Subject|0
7609689|NCT01856257|26476685|P2|Overall Study|Withdrawal by Subject|1
7609690|NCT01856257|26476686|P1|Overall Study|Withdrawal by Subject|1
7609691|NCT01856257|26476683|P4|Overall Study|Physician Decision|1
7609692|NCT01856257|26476684|P3|Overall Study|Physician Decision|0
7609693|NCT01856257|26476685|P2|Overall Study|Physician Decision|0
7609694|NCT01856257|26476686|P1|Overall Study|Physician Decision|0
7609695|NCT01856257|26476683|P4|Overall Study|Death|0
7609696|NCT01856257|26476684|P3|Overall Study|Death|0
7609697|NCT01856257|26476685|P2|Overall Study|Death|0
7609698|NCT01856257|26476686|P1|Overall Study|Death|2
7609699|NCT01856192|26476801|P2|Overall Study|Non-compliance|0
7609700|NCT01856192|26476802|P1|Overall Study|Non-compliance|1
7609701|NCT01856192|26476801|P2|Overall Study|Suspicion of progressive disease|0
7609702|NCT01856192|26476802|P1|Overall Study|Suspicion of progressive disease|1
7609703|NCT01856192|26476801|P2|Overall Study|Physician Decision|1
7609704|NCT01856192|26476802|P1|Overall Study|Physician Decision|1
7609705|NCT01856192|26476801|P2|Overall Study|Non-path ineligible|2
7609706|NCT01856192|26476802|P1|Overall Study|Non-path ineligible|2
7609707|NCT01856192|26476801|P2|Overall Study|Path ineligible|34
7609708|NCT01856192|26476802|P1|Overall Study|Path ineligible|20
7609709|NCT01856192|26476801|P2|Overall Study|Never started treatment|5
7609710|NCT01856192|26476802|P1|Overall Study|Never started treatment|7
7609711|NCT01856192|26476801|P2|Overall Study|Other diseases|0
7609712|NCT01856192|26476802|P1|Overall Study|Other diseases|1
7609713|NCT01856192|26476801|P2|Overall Study|Withdrawal by Subject|1
7609714|NCT01856192|26476802|P1|Overall Study|Withdrawal by Subject|1
7609715|NCT01856192|26476801|P2|Overall Study|Lack of Efficacy|5
7609716|NCT01856192|26476802|P1|Overall Study|Lack of Efficacy|0
7609717|NCT01856192|26476801|P2|Overall Study|Death|5
7609718|NCT01856192|26476802|P1|Overall Study|Death|3
7609719|NCT01856192|26476801|P2|Overall Study|Alternative therapy|3
7609720|NCT01856192|26476802|P1|Overall Study|Alternative therapy|0
7609721|NCT01856192|26476801|P2|Overall Study|Adverse Event|4
7609722|NCT01856192|26476802|P1|Overall Study|Adverse Event|12
7609723|NCT01856114|26476816|P2|Overall Study|Adverse Event|0
7609724|NCT01856114|26476817|P1|Overall Study|Adverse Event|1
7609725|NCT01856114|26476816|P2|Overall Study|Withdrawal by Subject|0
7609726|NCT01856114|26476817|P1|Overall Study|Withdrawal by Subject|1
7609727|NCT01855958|26476882|P2|Overall Study|Withdrawal by Subject|0
7609728|NCT01855958|26476883|P1|Overall Study|Withdrawal by Subject|1
7609729|NCT01855945|26476913|P12|Overall Study|Withdrawal by Subject|1
7609730|NCT01855945|26476914|P11|Overall Study|Withdrawal by Subject|4
7609731|NCT01855945|26476915|P10|Overall Study|Withdrawal by Subject|2
7609732|NCT01855945|26476916|P9|Overall Study|Withdrawal by Subject|0
7609733|NCT01855945|26476917|P8|Overall Study|Withdrawal by Subject|0
7609734|NCT01855945|26476918|P7|Overall Study|Withdrawal by Subject|1
7609735|NCT01855945|26476919|P6|Overall Study|Withdrawal by Subject|0
7609736|NCT01855945|26476920|P5|Overall Study|Withdrawal by Subject|1
7609737|NCT01855945|26476921|P4|Overall Study|Withdrawal by Subject|1
7609738|NCT01855945|26476922|P3|Overall Study|Withdrawal by Subject|4
7609739|NCT01855945|26476923|P2|Overall Study|Withdrawal by Subject|0
7609740|NCT01855945|26476924|P1|Overall Study|Withdrawal by Subject|4
7609741|NCT01855945|26476913|P12|Overall Study|Other - Unclassified|0
7609742|NCT01855945|26476914|P11|Overall Study|Other - Unclassified|1
7609743|NCT01855945|26476915|P10|Overall Study|Other - Unclassified|0
7609744|NCT01855945|26476916|P9|Overall Study|Other - Unclassified|0
7609745|NCT01855945|26476917|P8|Overall Study|Other - Unclassified|1
7609746|NCT01855945|26476918|P7|Overall Study|Other - Unclassified|2
7609747|NCT01855945|26476919|P6|Overall Study|Other - Unclassified|0
7609748|NCT01855945|26476920|P5|Overall Study|Other - Unclassified|0
7609749|NCT01855945|26476921|P4|Overall Study|Other - Unclassified|0
7609750|NCT01855945|26476922|P3|Overall Study|Other - Unclassified|1
7609751|NCT01855945|26476923|P2|Overall Study|Other - Unclassified|1
7609752|NCT01855945|26476924|P1|Overall Study|Other - Unclassified|1
7609753|NCT01855945|26476913|P12|Overall Study|Lost to Follow-up|2
7609754|NCT01855945|26476914|P11|Overall Study|Lost to Follow-up|0
7609755|NCT01855945|26476915|P10|Overall Study|Lost to Follow-up|0
7609756|NCT01855945|26476916|P9|Overall Study|Lost to Follow-up|2
7609757|NCT01855945|26476917|P8|Overall Study|Lost to Follow-up|7
7609758|NCT01855945|26476918|P7|Overall Study|Lost to Follow-up|4
7609759|NCT01855945|26476919|P6|Overall Study|Lost to Follow-up|3
7609760|NCT01855945|26476920|P5|Overall Study|Lost to Follow-up|0
7609761|NCT01855945|26476921|P4|Overall Study|Lost to Follow-up|3
7609762|NCT01855945|26476922|P3|Overall Study|Lost to Follow-up|7
7609763|NCT01855945|26476923|P2|Overall Study|Lost to Follow-up|10
7609764|NCT01855945|26476924|P1|Overall Study|Lost to Follow-up|11
7609765|NCT01855945|26476913|P12|Overall Study|Death|0
7609766|NCT01855945|26476914|P11|Overall Study|Death|0
7609767|NCT01855945|26476915|P10|Overall Study|Death|0
7609768|NCT01855945|26476916|P9|Overall Study|Death|0
7609769|NCT01855945|26476917|P8|Overall Study|Death|0
7609770|NCT01855945|26476918|P7|Overall Study|Death|2
7609771|NCT01855945|26476919|P6|Overall Study|Death|0
7609772|NCT01855945|26476920|P5|Overall Study|Death|0
7609773|NCT01855945|26476921|P4|Overall Study|Death|0
7609774|NCT01855945|26476922|P3|Overall Study|Death|0
7609775|NCT01855945|26476923|P2|Overall Study|Death|0
7609776|NCT01855945|26476924|P1|Overall Study|Death|0
7609777|NCT01855945|26476913|P12|Overall Study|Adverse Event|0
7609778|NCT01855945|26476914|P11|Overall Study|Adverse Event|0
7609779|NCT01855945|26476915|P10|Overall Study|Adverse Event|0
7609780|NCT01855945|26476916|P9|Overall Study|Adverse Event|0
7609781|NCT01855945|26476917|P8|Overall Study|Adverse Event|0
7609782|NCT01855945|26476918|P7|Overall Study|Adverse Event|1
7609783|NCT01855945|26476919|P6|Overall Study|Adverse Event|0
7609784|NCT01855945|26476920|P5|Overall Study|Adverse Event|0
7609785|NCT01855945|26476921|P4|Overall Study|Adverse Event|0
7609786|NCT01855945|26476922|P3|Overall Study|Adverse Event|0
7609787|NCT01855945|26476923|P2|Overall Study|Adverse Event|0
7609788|NCT01855945|26476924|P1|Overall Study|Adverse Event|0
7609789|NCT01855919|26477060|P2|Overall Study|Protocol Violation|4
7609790|NCT01855919|26477061|P1|Overall Study|Protocol Violation|1
7609791|NCT01855919|26477060|P2|Overall Study|Entry Criteria Not Met|1
7609792|NCT01855919|26477061|P1|Overall Study|Entry Criteria Not Met|1
7609793|NCT01855919|26477060|P2|Overall Study|Withdrawal by Subject|10
7609794|NCT01855919|26477061|P1|Overall Study|Withdrawal by Subject|4
7609795|NCT01855919|26477060|P2|Overall Study|Lack of Efficacy|3
7609796|NCT01855919|26477061|P1|Overall Study|Lack of Efficacy|1
7609797|NCT01855919|26477060|P2|Overall Study|Adverse Event|8
7609798|NCT01855919|26477061|P1|Overall Study|Adverse Event|16
7609799|NCT01855828|26477093|P1|Overall Study|Withdrawal by Subject|1
7609800|NCT01855828|26477093|P1|Overall Study|Adverse Event|1
7609801|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Other|1
7609802|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Other|0
7609803|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Other|0
7609804|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Other|0
7609805|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Sponsor Decision|1
7609806|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Sponsor Decision|0
7609807|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Sponsor Decision|0
7609808|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Sponsor Decision|0
7609809|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
7609810|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
7609811|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
7609812|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
7609813|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Physician Decision|4
7609814|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Physician Decision|2
7609815|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Physician Decision|0
7609816|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Physician Decision|0
7609817|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
7609818|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
7609819|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
7609820|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
7609821|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Protocol Violation|1
7609822|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Protocol Violation|0
7609823|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Protocol Violation|0
7609824|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Protocol Violation|0
7609825|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
7609826|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
7609827|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
7609828|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
7609829|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
7609830|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
7609831|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
7609832|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
7609833|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
7609834|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7609835|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7609836|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7609837|NCT01855789|26477103|P4|2) Week 24 up to End of Study|Adverse Event|21
7609838|NCT01855789|26477104|P3|2) Week 24 up to End of Study|Adverse Event|5
7609839|NCT01855789|26477105|P2|2) Week 24 up to End of Study|Adverse Event|4
7609840|NCT01855789|26477106|P1|2) Week 24 up to End of Study|Adverse Event|0
7609841|NCT01855789|26477103|P4|1) Baseline up to Week 24|Other|0
7609842|NCT01855789|26477104|P3|1) Baseline up to Week 24|Other|0
7609843|NCT01855789|26477105|P2|1) Baseline up to Week 24|Other|0
7609844|NCT01855789|26477106|P1|1) Baseline up to Week 24|Other|4
7609845|NCT01855789|26477103|P4|1) Baseline up to Week 24|Sponsor Decision|0
7609846|NCT01855789|26477104|P3|1) Baseline up to Week 24|Sponsor Decision|0
7609847|NCT01855789|26477105|P2|1) Baseline up to Week 24|Sponsor Decision|0
7609848|NCT01855789|26477106|P1|1) Baseline up to Week 24|Sponsor Decision|3
7609849|NCT01855789|26477103|P4|1) Baseline up to Week 24|Participant Non-compliance|0
7609850|NCT01855789|26477104|P3|1) Baseline up to Week 24|Participant Non-compliance|0
7609851|NCT01855789|26477105|P2|1) Baseline up to Week 24|Participant Non-compliance|0
7609852|NCT01855789|26477106|P1|1) Baseline up to Week 24|Participant Non-compliance|3
7609853|NCT01855789|26477103|P4|1) Baseline up to Week 24|Pregnancy|0
7609854|NCT01855789|26477104|P3|1) Baseline up to Week 24|Pregnancy|0
7609855|NCT01855789|26477105|P2|1) Baseline up to Week 24|Pregnancy|0
7609856|NCT01855789|26477106|P1|1) Baseline up to Week 24|Pregnancy|1
7609857|NCT01855789|26477103|P4|1) Baseline up to Week 24|Physician Decision|0
7609858|NCT01855789|26477104|P3|1) Baseline up to Week 24|Physician Decision|0
7609859|NCT01855789|26477105|P2|1) Baseline up to Week 24|Physician Decision|0
7609860|NCT01855789|26477106|P1|1) Baseline up to Week 24|Physician Decision|4
7609861|NCT01855789|26477103|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
7609862|NCT01855789|26477104|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
7609863|NCT01855789|26477105|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
7609864|NCT01855789|26477106|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
7609865|NCT01855789|26477103|P4|1) Baseline up to Week 24|Protocol Violation|0
7609866|NCT01855789|26477104|P3|1) Baseline up to Week 24|Protocol Violation|0
7609867|NCT01855789|26477105|P2|1) Baseline up to Week 24|Protocol Violation|0
7609868|NCT01855789|26477106|P1|1) Baseline up to Week 24|Protocol Violation|4
7609869|NCT01855789|26477103|P4|1) Baseline up to Week 24|Lost to Follow-up|0
7609870|NCT01855789|26477104|P3|1) Baseline up to Week 24|Lost to Follow-up|0
7609871|NCT01855789|26477105|P2|1) Baseline up to Week 24|Lost to Follow-up|0
7609872|NCT01855789|26477106|P1|1) Baseline up to Week 24|Lost to Follow-up|11
7609873|NCT01855789|26477103|P4|1) Baseline up to Week 24|Lack of Efficacy|0
7609874|NCT01855789|26477104|P3|1) Baseline up to Week 24|Lack of Efficacy|0
7609875|NCT01855789|26477105|P2|1) Baseline up to Week 24|Lack of Efficacy|0
7609876|NCT01855789|26477106|P1|1) Baseline up to Week 24|Lack of Efficacy|16
7609877|NCT01855789|26477103|P4|1) Baseline up to Week 24|Death|0
7609878|NCT01855789|26477104|P3|1) Baseline up to Week 24|Death|0
7609879|NCT01855789|26477105|P2|1) Baseline up to Week 24|Death|0
7609880|NCT01855789|26477106|P1|1) Baseline up to Week 24|Death|2
7609881|NCT01855789|26477103|P4|1) Baseline up to Week 24|Adverse Event|0
7609882|NCT01855789|26477104|P3|1) Baseline up to Week 24|Adverse Event|0
7609883|NCT01855789|26477105|P2|1) Baseline up to Week 24|Adverse Event|0
7609884|NCT01855789|26477106|P1|1) Baseline up to Week 24|Adverse Event|37
7609885|NCT01855750|26477130|P2|Overall Study|Sponsor ends the study|290
7609886|NCT01855750|26477131|P1|Overall Study|Sponsor ends the study|297
7609887|NCT01855750|26477130|P2|Overall Study|Withdrawal by Subject|28
7609888|NCT01855750|26477131|P1|Overall Study|Withdrawal by Subject|35
7609889|NCT01855750|26477130|P2|Overall Study|Lost to Follow-up|23
7609890|NCT01855750|26477131|P1|Overall Study|Lost to Follow-up|9
7609891|NCT01855750|26477130|P2|Overall Study|Death|78
7609892|NCT01855750|26477131|P1|Overall Study|Death|78
7609893|NCT01855425|26477147|P1|Overall Study|Physician Decision|20
7609894|NCT01855412|26477154|P3|Overall Study|Reason not Specified|3
7609895|NCT01855412|26477155|P2|Overall Study|Reason not Specified|2
7609896|NCT01855412|26477156|P1|Overall Study|Reason not Specified|1
7609897|NCT01855412|26477154|P3|Overall Study|Site Closure|1
7609898|NCT01855412|26477155|P2|Overall Study|Site Closure|18
7609899|NCT01855412|26477156|P1|Overall Study|Site Closure|4
7609900|NCT01855412|26477154|P3|Overall Study|Physician Decision|3
7609901|NCT01855412|26477155|P2|Overall Study|Physician Decision|31
7609902|NCT01855412|26477156|P1|Overall Study|Physician Decision|25
7609903|NCT01855412|26477154|P3|Overall Study|Withdrawal by Subject|24
7609904|NCT01855412|26477155|P2|Overall Study|Withdrawal by Subject|123
7609905|NCT01855412|26477156|P1|Overall Study|Withdrawal by Subject|77
7609906|NCT01855412|26477154|P3|Overall Study|Lost to Follow-up|15
7609907|NCT01855412|26477155|P2|Overall Study|Lost to Follow-up|46
7609908|NCT01855412|26477156|P1|Overall Study|Lost to Follow-up|28
7609909|NCT01855412|26477154|P3|Overall Study|Death|30
7609910|NCT01855412|26477155|P2|Overall Study|Death|123
7609911|NCT01855412|26477156|P1|Overall Study|Death|77
7609912|NCT01855399|26477178|P2|12 Month|Lost to Follow-up|11
7609913|NCT01855399|26477179|P1|12 Month|Lost to Follow-up|7
7609914|NCT01855399|26477178|P2|6 Month|Withdrawal by Subject|6
7609915|NCT01855399|26477179|P1|6 Month|Withdrawal by Subject|8
7609916|NCT01855399|26477178|P2|6 Month|Lost to Follow-up|9
7609917|NCT01855399|26477179|P1|6 Month|Lost to Follow-up|12
7609918|NCT01855243|26477193|P3|Overall Study|develpoed diabetic ketoacidosis|0
7609919|NCT01855243|26477194|P2|Overall Study|develpoed diabetic ketoacidosis|0
7609920|NCT01855243|26477195|P1|Overall Study|develpoed diabetic ketoacidosis|1
7609921|NCT01855126|26477217|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7609922|NCT01855126|26477218|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7609923|NCT01855126|26477217|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
7609924|NCT01855126|26477218|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
7609925|NCT01855074|26477230|P1|Overall Study|Started but not treated|1
7609926|NCT01855074|26477230|P1|Overall Study|Withdrawal by Subject|8
7609927|NCT01855074|26477230|P1|Overall Study|Lost to Follow-up|4
7609928|NCT01855074|26477230|P1|Overall Study|Adverse Event|1
7609929|NCT01854944|26477242|P3|Overall Study|Withdrawal by Subject|1
7609930|NCT01854944|26477243|P2|Overall Study|Withdrawal by Subject|0
7609931|NCT01854944|26477244|P1|Overall Study|Withdrawal by Subject|0
7609932|NCT01854918|26477296|P2|All-IP Period (Years 2 and 3)|Death|16
7609933|NCT01854918|26477297|P1|All-IP Period (Years 2 and 3)|Death|5
7609934|NCT01854918|26477296|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
7609935|NCT01854918|26477297|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
7609936|NCT01854918|26477296|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
7609937|NCT01854918|26477297|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
7609938|NCT01854918|26477296|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
7609939|NCT01854918|26477297|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
7609940|NCT01854918|26477296|P2|SOC-controlled Period (Year 1)|Death|5
7609941|NCT01854918|26477297|P1|SOC-controlled Period (Year 1)|Death|5
7609942|NCT01854918|26477296|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
7609943|NCT01854918|26477297|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
7609944|NCT01854918|26477296|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
7609945|NCT01854918|26477297|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
7609946|NCT01854918|26477296|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
7609947|NCT01854918|26477297|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
7609948|NCT01854879|26477316|P1|Overall Study|incomplete data set|1
7609949|NCT01854879|26477316|P1|Overall Study|screen fail|3
7609950|NCT01854879|26477316|P1|Overall Study|Could not complete testing within the scheduled time.|1
7609951|NCT01854827|26477320|P1|Overall Study|Death|1
7609952|NCT01854775|26477335|P3|Extension Phase|Still on Study|18
7609953|NCT01854775|26477336|P2|Extension Phase|Still on Study|47
7609954|NCT01854775|26477337|P1|Extension Phase|Still on Study|32
7609955|NCT01854775|26477335|P3|Extension Phase|Lost to Follow-up|0
7609956|NCT01854775|26477336|P2|Extension Phase|Lost to Follow-up|0
7609957|NCT01854775|26477337|P1|Extension Phase|Lost to Follow-up|2
7609958|NCT01854775|26477335|P3|Extension Phase|Non-Compliance with Study Drug|0
7609959|NCT01854775|26477336|P2|Extension Phase|Non-Compliance with Study Drug|0
7609960|NCT01854775|26477337|P1|Extension Phase|Non-Compliance with Study Drug|1
7609961|NCT01854775|26477335|P3|Extension Phase|Investigator's Discretion|0
7609962|NCT01854775|26477336|P2|Extension Phase|Investigator's Discretion|0
7609963|NCT01854775|26477337|P1|Extension Phase|Investigator's Discretion|1
7609964|NCT01854775|26477335|P3|Extension Phase|Pregnancy|0
7609965|NCT01854775|26477336|P2|Extension Phase|Pregnancy|0
7609966|NCT01854775|26477337|P1|Extension Phase|Pregnancy|3
7609967|NCT01854775|26477335|P3|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
7609968|NCT01854775|26477336|P2|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7609969|NCT01854775|26477337|P1|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7609970|NCT01854775|26477335|P3|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7609971|NCT01854775|26477336|P2|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7609972|NCT01854775|26477337|P1|Treatment Phase (48 Weeks)|Lost to Follow-up|1
7609973|NCT01854775|26477335|P3|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
7609974|NCT01854775|26477336|P2|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7609975|NCT01854775|26477337|P1|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7609976|NCT01854710|26477408|P6|Overall Study|CRI procedural error|2
7609977|NCT01854710|26477409|P5|Overall Study|CRI procedural error|2
7609978|NCT01854710|26477410|P4|Overall Study|CRI procedural error|2
7609979|NCT01854710|26477411|P3|Overall Study|CRI procedural error|2
7609980|NCT01854710|26477412|P2|Overall Study|CRI procedural error|2
7609981|NCT01854710|26477413|P1|Overall Study|CRI procedural error|2
7609982|NCT01854710|26477408|P6|Overall Study|Withdrawal by Subject|0
7609983|NCT01854710|26477409|P5|Overall Study|Withdrawal by Subject|0
7609984|NCT01854710|26477410|P4|Overall Study|Withdrawal by Subject|0
7609985|NCT01854710|26477411|P3|Overall Study|Withdrawal by Subject|0
7609986|NCT01854710|26477412|P2|Overall Study|Withdrawal by Subject|1
7609987|NCT01854710|26477413|P1|Overall Study|Withdrawal by Subject|2
7609988|NCT01854697|26477434|P5|Overall Study|Other|0
7609989|NCT01854697|26477435|P4|Overall Study|Other|0
7609990|NCT01854697|26477436|P3|Overall Study|Other|1
7609991|NCT01854697|26477437|P2|Overall Study|Other|1
7609992|NCT01854697|26477438|P1|Overall Study|Other|0
7609993|NCT01854697|26477434|P5|Overall Study|Withdrew Consent|0
7609994|NCT01854697|26477435|P4|Overall Study|Withdrew Consent|1
7609995|NCT01854697|26477436|P3|Overall Study|Withdrew Consent|0
7609996|NCT01854697|26477437|P2|Overall Study|Withdrew Consent|1
7609997|NCT01854697|26477438|P1|Overall Study|Withdrew Consent|0
7609998|NCT01854697|26477434|P5|Overall Study|To enter another AbbVie study|1
7609999|NCT01854697|26477435|P4|Overall Study|To enter another AbbVie study|0
7610000|NCT01854697|26477436|P3|Overall Study|To enter another AbbVie study|0
7610001|NCT01854697|26477437|P2|Overall Study|To enter another AbbVie study|0
7610002|NCT01854697|26477438|P1|Overall Study|To enter another AbbVie study|1
7610003|NCT01854697|26477434|P5|Overall Study|Lost to Follow-up|0
7610004|NCT01854697|26477435|P4|Overall Study|Lost to Follow-up|2
7610005|NCT01854697|26477436|P3|Overall Study|Lost to Follow-up|1
7610006|NCT01854697|26477437|P2|Overall Study|Lost to Follow-up|1
7610007|NCT01854697|26477438|P1|Overall Study|Lost to Follow-up|4
7610008|NCT01854697|26477434|P5|Overall Study|Adverse Event|1
7610009|NCT01854697|26477435|P4|Overall Study|Adverse Event|0
7610010|NCT01854697|26477436|P3|Overall Study|Adverse Event|0
7610011|NCT01854697|26477437|P2|Overall Study|Adverse Event|0
7610012|NCT01854697|26477438|P1|Overall Study|Adverse Event|1
7610013|NCT01854658|26477482|P4|Overall Study|Administrative reasons|2
7610014|NCT01854658|26477483|P3|Overall Study|Administrative reasons|2
7610015|NCT01854658|26477484|P2|Overall Study|Administrative reasons|1
7610016|NCT01854658|26477485|P1|Overall Study|Administrative reasons|5
7610017|NCT01854658|26477482|P4|Overall Study|Adverse Event|19
7610018|NCT01854658|26477483|P3|Overall Study|Adverse Event|23
7610019|NCT01854658|26477484|P2|Overall Study|Adverse Event|14
7610020|NCT01854658|26477485|P1|Overall Study|Adverse Event|21
7610021|NCT01854658|26477482|P4|Overall Study|Lack of Efficacy|7
7610022|NCT01854658|26477483|P3|Overall Study|Lack of Efficacy|4
7610023|NCT01854658|26477484|P2|Overall Study|Lack of Efficacy|8
7610024|NCT01854658|26477485|P1|Overall Study|Lack of Efficacy|3
7610025|NCT01854658|26477482|P4|Overall Study|Protocol-specified criteria|7
7610026|NCT01854658|26477483|P3|Overall Study|Protocol-specified criteria|10
7610027|NCT01854658|26477484|P2|Overall Study|Protocol-specified criteria|15
7610028|NCT01854658|26477485|P1|Overall Study|Protocol-specified criteria|15
7610029|NCT01854658|26477482|P4|Overall Study|Withdrawal by Subject|15
7610030|NCT01854658|26477483|P3|Overall Study|Withdrawal by Subject|29
7610031|NCT01854658|26477484|P2|Overall Study|Withdrawal by Subject|21
7610032|NCT01854658|26477485|P1|Overall Study|Withdrawal by Subject|28
7610033|NCT01854658|26477482|P4|Overall Study|Lost to Follow-up|4
7610034|NCT01854658|26477483|P3|Overall Study|Lost to Follow-up|8
7610035|NCT01854658|26477484|P2|Overall Study|Lost to Follow-up|9
7610036|NCT01854658|26477485|P1|Overall Study|Lost to Follow-up|8
7610037|NCT01854658|26477482|P4|Overall Study|Physician Decision|4
7610038|NCT01854658|26477483|P3|Overall Study|Physician Decision|2
7610039|NCT01854658|26477484|P2|Overall Study|Physician Decision|5
7610040|NCT01854658|26477485|P1|Overall Study|Physician Decision|7
7610041|NCT01854658|26477482|P4|Overall Study|Protocol Violation|1
7610042|NCT01854658|26477483|P3|Overall Study|Protocol Violation|2
7610043|NCT01854658|26477484|P2|Overall Study|Protocol Violation|2
7610044|NCT01854658|26477485|P1|Overall Study|Protocol Violation|6
7610045|NCT01854645|26477520|P5|Overall Study|Adverse Event|11
7610046|NCT01854645|26477521|P4|Overall Study|Adverse Event|20
7610047|NCT01854645|26477522|P3|Overall Study|Adverse Event|19
7610048|NCT01854645|26477523|P2|Overall Study|Adverse Event|31
7610049|NCT01854645|26477524|P1|Overall Study|Adverse Event|33
7610050|NCT01854645|26477520|P5|Overall Study|Lack of Efficacy|9
7610051|NCT01854645|26477521|P4|Overall Study|Lack of Efficacy|3
7610052|NCT01854645|26477522|P3|Overall Study|Lack of Efficacy|9
7610053|NCT01854645|26477523|P2|Overall Study|Lack of Efficacy|12
7610054|NCT01854645|26477524|P1|Overall Study|Lack of Efficacy|7
7610055|NCT01854645|26477520|P5|Overall Study|Withdrawal by Subject|24
7610056|NCT01854645|26477521|P4|Overall Study|Withdrawal by Subject|21
7610057|NCT01854645|26477522|P3|Overall Study|Withdrawal by Subject|30
7610058|NCT01854645|26477523|P2|Overall Study|Withdrawal by Subject|41
7610059|NCT01854645|26477524|P1|Overall Study|Withdrawal by Subject|31
7610060|NCT01854645|26477520|P5|Overall Study|Physician Decision|7
7610061|NCT01854645|26477521|P4|Overall Study|Physician Decision|3
7610062|NCT01854645|26477522|P3|Overall Study|Physician Decision|3
7610063|NCT01854645|26477523|P2|Overall Study|Physician Decision|5
7610064|NCT01854645|26477524|P1|Overall Study|Physician Decision|1
7610065|NCT01854645|26477520|P5|Overall Study|Lost to Follow-up|0
7610066|NCT01854645|26477521|P4|Overall Study|Lost to Follow-up|5
7610067|NCT01854645|26477522|P3|Overall Study|Lost to Follow-up|8
7610068|NCT01854645|26477523|P2|Overall Study|Lost to Follow-up|7
7610069|NCT01854645|26477524|P1|Overall Study|Lost to Follow-up|10
7610070|NCT01854645|26477520|P5|Overall Study|Protocol Violation|1
7610071|NCT01854645|26477521|P4|Overall Study|Protocol Violation|4
7610072|NCT01854645|26477522|P3|Overall Study|Protocol Violation|5
7610073|NCT01854645|26477523|P2|Overall Study|Protocol Violation|0
7610074|NCT01854645|26477524|P1|Overall Study|Protocol Violation|3
7610075|NCT01854645|26477520|P5|Overall Study|Administrative Reasons / Missing|1
7610076|NCT01854645|26477521|P4|Overall Study|Administrative Reasons / Missing|1
7610077|NCT01854645|26477522|P3|Overall Study|Administrative Reasons / Missing|0
7610078|NCT01854645|26477523|P2|Overall Study|Administrative Reasons / Missing|0
7610079|NCT01854645|26477524|P1|Overall Study|Administrative Reasons / Missing|0
7610080|NCT01854645|26477520|P5|Overall Study|Protocol-Specified Criteria|7
7610081|NCT01854645|26477521|P4|Overall Study|Protocol-Specified Criteria|5
7610082|NCT01854645|26477522|P3|Overall Study|Protocol-Specified Criteria|8
7610083|NCT01854645|26477523|P2|Overall Study|Protocol-Specified Criteria|10
7610084|NCT01854645|26477524|P1|Overall Study|Protocol-Specified Criteria|13
7610085|NCT01854528|26477605|P2|Overall Study|Virologic Failure|9
7610086|NCT01854528|26477606|P1|Overall Study|Virologic Failure|0
7610087|NCT01854528|26477605|P2|Overall Study|Withdrawal by Subject|2
7610088|NCT01854528|26477606|P1|Overall Study|Withdrawal by Subject|0
7610089|NCT01854528|26477605|P2|Overall Study|Adverse Event|4
7610090|NCT01854528|26477606|P1|Overall Study|Adverse Event|0
7610091|NCT01854047|26477706|P5|Overall Study|Other than specified above|8
7610092|NCT01854047|26477707|P4|Overall Study|Other than specified above|5
7610093|NCT01854047|26477708|P3|Overall Study|Other than specified above|3
7610094|NCT01854047|26477709|P2|Overall Study|Other than specified above|3
7610095|NCT01854047|26477710|P1|Overall Study|Other than specified above|3
7610096|NCT01854047|26477706|P5|Overall Study|Randomized but not treated|4
7610097|NCT01854047|26477707|P4|Overall Study|Randomized but not treated|0
7610098|NCT01854047|26477708|P3|Overall Study|Randomized but not treated|2
7610099|NCT01854047|26477709|P2|Overall Study|Randomized but not treated|1
7610100|NCT01854047|26477710|P1|Overall Study|Randomized but not treated|0
7610101|NCT01854047|26477706|P5|Overall Study|Adverse Event|7
7610102|NCT01854047|26477707|P4|Overall Study|Adverse Event|10
7610103|NCT01854047|26477708|P3|Overall Study|Adverse Event|6
7610104|NCT01854047|26477709|P2|Overall Study|Adverse Event|4
7610105|NCT01854047|26477710|P1|Overall Study|Adverse Event|5
7610106|NCT01854047|26477706|P5|Overall Study|Poor compliance to protocol|0
7610107|NCT01854047|26477707|P4|Overall Study|Poor compliance to protocol|0
7610108|NCT01854047|26477708|P3|Overall Study|Poor compliance to protocol|2
7610109|NCT01854047|26477709|P2|Overall Study|Poor compliance to protocol|0
7610110|NCT01854047|26477710|P1|Overall Study|Poor compliance to protocol|3
7610111|NCT01854047|26477706|P5|Overall Study|Lack of Efficacy|0
7610112|NCT01854047|26477707|P4|Overall Study|Lack of Efficacy|0
7610113|NCT01854047|26477708|P3|Overall Study|Lack of Efficacy|0
7610114|NCT01854047|26477709|P2|Overall Study|Lack of Efficacy|0
7610115|NCT01854047|26477710|P1|Overall Study|Lack of Efficacy|1
7610116|NCT01853982|26477841|P2|Overall Study|Lost to Follow-up|1
7610117|NCT01853982|26477842|P1|Overall Study|Lost to Follow-up|0
7610118|NCT01853982|26477841|P2|Overall Study|Death|0
7610119|NCT01853982|26477842|P1|Overall Study|Death|1
7610120|NCT01853982|26477841|P2|Overall Study|Withdrawal by Subject|0
7610121|NCT01853982|26477842|P1|Overall Study|Withdrawal by Subject|1
7610122|NCT01853878|26477859|P2|Overall Study|Other|43
7610123|NCT01853878|26477860|P1|Overall Study|Other|55
7610124|NCT01853878|26477859|P2|Overall Study|Migrated/moved from the study area|0
7610125|NCT01853878|26477860|P1|Overall Study|Migrated/moved from the study area|1
7610126|NCT01853878|26477859|P2|Overall Study|Withdrawal by Subject|1
7610127|NCT01853878|26477860|P1|Overall Study|Withdrawal by Subject|3
7610128|NCT01853878|26477859|P2|Overall Study|Adverse Event|0
7610129|NCT01853878|26477860|P1|Overall Study|Adverse Event|2
7610130|NCT01853878|26477859|P2|Overall Study|Recurrence|0
7610131|NCT01853878|26477860|P1|Overall Study|Recurrence|2
7610132|NCT01853839|26477884|P1|Overall Study|Lost to follow-up or no valid BP measure|336
7610133|NCT01853839|26477884|P1|Overall Study|End of treatment visit too early|33
7610134|NCT01853839|26477884|P1|Overall Study|Not meet ITT population definition|58
7610135|NCT01853839|26477884|P1|Overall Study|Violated inclusion criteria|2
7610136|NCT01853696|26477917|P2|Overall Study|Lost to Follow-up|4
7610137|NCT01853696|26477918|P1|Overall Study|Lost to Follow-up|5
7610138|NCT01853696|26477917|P2|Overall Study|Withdrawal by Subject|1
7610139|NCT01853696|26477918|P1|Overall Study|Withdrawal by Subject|1
7610140|NCT01853644|26477926|P1|Continued Treatment After First Response|Progressive Diseaes|10
7610141|NCT01853644|26477926|P1|Continued Treatment After First Response|Adverse Event|2
7610142|NCT01853644|26477926|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
7610143|NCT01853644|26477926|P1|Reached First Response/Complete 2 Cycles|Other|1
7610144|NCT01853644|26477926|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
7610145|NCT01853644|26477926|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
7610146|NCT01853644|26477926|P1|Registration and Treatment Start|Did not start treatment|1
7610147|NCT01853618|26477943|P5|Overall Study|Refused further treatment|1
7610148|NCT01853618|26477944|P4|Overall Study|Refused further treatment|0
7610149|NCT01853618|26477945|P3|Overall Study|Refused further treatment|0
7610150|NCT01853618|26477946|P2|Overall Study|Refused further treatment|0
7610151|NCT01853618|26477947|P1|Overall Study|Refused further treatment|0
7610152|NCT01853618|26477943|P5|Overall Study|Physician Decision|0
7610153|NCT01853618|26477944|P4|Overall Study|Physician Decision|0
7610154|NCT01853618|26477945|P3|Overall Study|Physician Decision|1
7610155|NCT01853618|26477946|P2|Overall Study|Physician Decision|1
7610156|NCT01853618|26477947|P1|Overall Study|Physician Decision|0
7610157|NCT01853618|26477943|P5|Overall Study|Progressive disease|2
7610158|NCT01853618|26477944|P4|Overall Study|Progressive disease|1
7610159|NCT01853618|26477945|P3|Overall Study|Progressive disease|1
7610160|NCT01853618|26477946|P2|Overall Study|Progressive disease|1
7610161|NCT01853618|26477947|P1|Overall Study|Progressive disease|1
7610162|NCT01853618|26477943|P5|Overall Study|Bile duct stent blockage/progressive dis|0
7610163|NCT01853618|26477944|P4|Overall Study|Bile duct stent blockage/progressive dis|0
7610164|NCT01853618|26477945|P3|Overall Study|Bile duct stent blockage/progressive dis|0
7610165|NCT01853618|26477946|P2|Overall Study|Bile duct stent blockage/progressive dis|0
7610166|NCT01853618|26477947|P1|Overall Study|Bile duct stent blockage/progressive dis|1
7610167|NCT01853475|26478013|P3|Overall Study|Withdrawal by Subject|0
7610168|NCT01853475|26478014|P2|Overall Study|Withdrawal by Subject|1
7610169|NCT01853475|26478015|P1|Overall Study|Withdrawal by Subject|0
7610170|NCT01853462|26478034|P2|Overall Study|Withdrawal by Subject|1
7610171|NCT01853462|26478035|P1|Overall Study|Withdrawal by Subject|1
7610172|NCT01853397|26478105|P4|Overall Study|Subject Noncompliance|1
7610173|NCT01853397|26478106|P3|Overall Study|Subject Noncompliance|0
7610174|NCT01853397|26478107|P2|Overall Study|Subject Noncompliance|0
7610175|NCT01853397|26478108|P1|Overall Study|Subject Noncompliance|0
7610176|NCT01853397|26478105|P4|Overall Study|Withdrawal by Subject|1
7610177|NCT01853397|26478106|P3|Overall Study|Withdrawal by Subject|0
7610178|NCT01853397|26478107|P2|Overall Study|Withdrawal by Subject|0
7610179|NCT01853397|26478108|P1|Overall Study|Withdrawal by Subject|0
7610180|NCT01853384|26478136|P2|Completed Follow up Visit 2|Lost to Follow-up|1
7610181|NCT01853384|26478137|P1|Completed Follow up Visit 2|Lost to Follow-up|0
7610182|NCT01853384|26478136|P2|Completed Follow up Visit 2|Death|0
7610183|NCT01853384|26478137|P1|Completed Follow up Visit 2|Death|1
7610184|NCT01853384|26478136|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
7610185|NCT01853384|26478137|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
7610186|NCT01853384|26478136|P2|Completed Follow up Visit 2|Adverse Event|0
7610187|NCT01853384|26478137|P1|Completed Follow up Visit 2|Adverse Event|1
7610188|NCT01853384|26478136|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
7610189|NCT01853384|26478137|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
7610190|NCT01853384|26478136|P2|Completed Follow up Visit 1|Early Termination|9
7610191|NCT01853384|26478137|P1|Completed Follow up Visit 1|Early Termination|13
7610192|NCT01853384|26478136|P2|Randomized|Other|3
7610193|NCT01853384|26478137|P1|Randomized|Other|3
7610194|NCT01853384|26478136|P2|Randomized|Sponsor Decision|34
7610195|NCT01853384|26478137|P1|Randomized|Sponsor Decision|47
7610196|NCT01853384|26478136|P2|Randomized|Withdrawal by Subject|3
7610197|NCT01853384|26478137|P1|Randomized|Withdrawal by Subject|5
7610198|NCT01853384|26478136|P2|Randomized|Lost to Follow-up|1
7610199|NCT01853384|26478137|P1|Randomized|Lost to Follow-up|1
7610200|NCT01853384|26478136|P2|Randomized|Death|2
7610201|NCT01853384|26478137|P1|Randomized|Death|1
7610202|NCT01853384|26478136|P2|Randomized|Adverse Event|3
7610203|NCT01853384|26478137|P1|Randomized|Adverse Event|5
7610204|NCT01853280|26478177|P2|Overall Study|Ineligible|1
7610205|NCT01853280|26478178|P1|Overall Study|Ineligible|0
7610206|NCT01853280|26478177|P2|Overall Study|Withdrawal by Subject|1
7610207|NCT01853280|26478178|P1|Overall Study|Withdrawal by Subject|0
7610208|NCT01853280|26478177|P2|Overall Study|Physician Decision|1
7610209|NCT01853280|26478178|P1|Overall Study|Physician Decision|0
7610210|NCT01853280|26478177|P2|Overall Study|Lost to Follow-up|1
7610211|NCT01853280|26478178|P1|Overall Study|Lost to Follow-up|0
7610212|NCT01853280|26478177|P2|Overall Study|Lack of Efficacy|2
7610213|NCT01853280|26478178|P1|Overall Study|Lack of Efficacy|2
7610214|NCT01853254|26478184|P1|Overall Study|Administrative/Other|16
7610215|NCT01853254|26478184|P1|Overall Study|Withdrawal of Consent|16
7610216|NCT01853254|26478184|P1|Overall Study|Other Protocol Violation|1
7610217|NCT01853254|26478184|P1|Overall Study|Refusal of Treatment|1
7610218|NCT01853254|26478184|P1|Overall Study|Insufficient Therapeutic Response|22
7610219|NCT01853254|26478184|P1|Overall Study|Failure to Return|43
7610220|NCT01853254|26478184|P1|Overall Study|Death|1
7610221|NCT01853254|26478184|P1|Overall Study|Adverse Event/Intercurrent Illness|3
7610222|NCT01853254|26478184|P1|Overall Study|Abnormal Laboratory Test|1
7610223|NCT01853228|26478188|P2|Phase 2|Lack of Efficacy|4
7610224|NCT01853228|26478189|P1|Phase 2|Lack of Efficacy|0
7610225|NCT01853228|26478188|P2|Phase 2|Proceed To Transplant|3
7610226|NCT01853228|26478189|P1|Phase 2|Proceed To Transplant|0
7610227|NCT01853228|26478188|P2|Phase 2|Physician Decision|1
7610228|NCT01853228|26478189|P1|Phase 2|Physician Decision|0
7610229|NCT01853228|26478188|P2|Phase 1|Other|0
7610230|NCT01853228|26478189|P1|Phase 1|Other|1
7610231|NCT01853228|26478188|P2|Phase 1|Lack of Efficacy|0
7610232|NCT01853228|26478189|P1|Phase 1|Lack of Efficacy|8
7610233|NCT01853176|26478219|P2|Overall Study|Study terminated|0
7610234|NCT01853176|26478220|P1|Overall Study|Study terminated|4
7610235|NCT01853137|26478228|P2|Overall Study|Lost to Follow-up|1
7610236|NCT01853137|26478229|P1|Overall Study|Lost to Follow-up|4
7610237|NCT01853072|26478250|P2|Overall Study|Reason not specified|6
7610238|NCT01853072|26478251|P1|Overall Study|Reason not specified|9
7610239|NCT01853072|26478250|P2|Overall Study|Withdrawal by Subject|2
7610240|NCT01853072|26478251|P1|Overall Study|Withdrawal by Subject|1
7610241|NCT01853072|26478250|P2|Overall Study|Physician Decision|1
7610242|NCT01853072|26478251|P1|Overall Study|Physician Decision|1
7610243|NCT01853072|26478250|P2|Overall Study|Non-compliance with study drug|1
7610244|NCT01853072|26478251|P1|Overall Study|Non-compliance with study drug|0
7610245|NCT01853072|26478250|P2|Overall Study|Lost to Follow-up|3
7610246|NCT01853072|26478251|P1|Overall Study|Lost to Follow-up|0
7610247|NCT01853072|26478250|P2|Overall Study|Death|4
7610248|NCT01853072|26478251|P1|Overall Study|Death|1
7610249|NCT01853072|26478250|P2|Overall Study|Adverse Event|3
7610250|NCT01853072|26478251|P1|Overall Study|Adverse Event|0
7610251|NCT01853072|26478250|P2|Overall Study|Adverse event prior to treatment|1
7610252|NCT01853072|26478251|P1|Overall Study|Adverse event prior to treatment|0
7610253|NCT01853046|26478271|P2|Overall Study|Disease progression|3
7610254|NCT01853046|26478272|P1|Overall Study|Disease progression|13
7610255|NCT01853046|26478271|P2|Overall Study|Adverse Event|2
7610256|NCT01853046|26478272|P1|Overall Study|Adverse Event|4
7610257|NCT01853046|26478271|P2|Overall Study|Withdrawal by Subject|1
7610258|NCT01853046|26478272|P1|Overall Study|Withdrawal by Subject|1
7610259|NCT01852942|26478339|P2|Overall Study|Lost to Follow-up|2
7610260|NCT01852942|26478340|P1|Overall Study|Lost to Follow-up|1
7610261|NCT01852942|26478339|P2|Overall Study|Withdrawal by Subject|3
7610262|NCT01852942|26478340|P1|Overall Study|Withdrawal by Subject|2
7610263|NCT01852942|26478339|P2|Overall Study|Death|1
7610264|NCT01852942|26478340|P1|Overall Study|Death|1
7610265|NCT01852942|26478339|P2|Overall Study|Physician Decision|0
7610266|NCT01852942|26478340|P1|Overall Study|Physician Decision|1
7610267|NCT01852825|26478435|P3|Overall Study|Withdrawal by Subject|0
7610268|NCT01852825|26478436|P2|Overall Study|Withdrawal by Subject|0
7610269|NCT01852825|26478437|P1|Overall Study|Withdrawal by Subject|2
7610270|NCT01852812|26478463|P3|Overall Study|Non-compliance With Study Drug|0
7610271|NCT01852812|26478464|P2|Overall Study|Non-compliance With Study Drug|1
7610272|NCT01852812|26478465|P1|Overall Study|Non-compliance With Study Drug|0
7610273|NCT01852812|26478463|P3|Overall Study|Adverse Event|1
7610274|NCT01852812|26478464|P2|Overall Study|Adverse Event|0
7610275|NCT01852812|26478465|P1|Overall Study|Adverse Event|0
7610276|NCT01852591|26478503|P1|Overall Study|Not Evaluable at Time of Analysis|1
7610277|NCT01852591|26478503|P1|Overall Study|Withdrawal by Subject|2
7610278|NCT01852292|26478557|P2|Overall Study|Progressive disease|52
7610279|NCT01852292|26478558|P1|Overall Study|Progressive disease|42
7610280|NCT01852292|26478557|P2|Overall Study|Study terminated by Sponsor|1
7610281|NCT01852292|26478558|P1|Overall Study|Study terminated by Sponsor|0
7610282|NCT01852292|26478557|P2|Overall Study|Non-compliance with study treatment|0
7610283|NCT01852292|26478558|P1|Overall Study|Non-compliance with study treatment|1
7610284|NCT01852292|26478557|P2|Overall Study|Protocol Violation|0
7610285|NCT01852292|26478558|P1|Overall Study|Protocol Violation|2
7610286|NCT01852292|26478557|P2|Overall Study|Physician Decision|2
7610287|NCT01852292|26478558|P1|Overall Study|Physician Decision|6
7610288|NCT01852292|26478557|P2|Overall Study|Adverse Event|11
7610289|NCT01852292|26478558|P1|Overall Study|Adverse Event|8
7610290|NCT01852292|26478557|P2|Overall Study|Patient/guardian decision|4
7610291|NCT01852292|26478558|P1|Overall Study|Patient/guardian decision|8
7610292|NCT01852292|26478557|P2|Overall Study|Death|8
7610293|NCT01852292|26478558|P1|Overall Study|Death|9
7610294|NCT01852292|26478557|P2|Overall Study|Untreated - did not receive study drug|1
7610295|NCT01852292|26478558|P1|Overall Study|Untreated - did not receive study drug|3
7610296|NCT01852214|26478582|P2|Washout Period|Withdrawal by Subject|1
7610297|NCT01852214|26478583|P1|Washout Period|Withdrawal by Subject|0
7610298|NCT01852214|26478582|P2|Period 1|Withdrawal by Subject|1
7610299|NCT01852214|26478583|P1|Period 1|Withdrawal by Subject|0
7610300|NCT01852214|26478582|P2|Period 1|Adverse Event|2
7610301|NCT01852214|26478583|P1|Period 1|Adverse Event|1
7610302|NCT01852162|26478635|P2|Overall Study|Withdrawal by Subject|1
7610303|NCT01852162|26478636|P1|Overall Study|Withdrawal by Subject|3
7610304|NCT01852162|26478635|P2|Overall Study|Adverse Event|0
7610305|NCT01852162|26478636|P1|Overall Study|Adverse Event|1
7610306|NCT01852110|26478652|P6|Overall Study|Withdrawal by Subject|0
7610307|NCT01852110|26478653|P5|Overall Study|Withdrawal by Subject|0
7610308|NCT01852110|26478654|P4|Overall Study|Withdrawal by Subject|0
7610309|NCT01852110|26478655|P3|Overall Study|Withdrawal by Subject|0
7610310|NCT01852110|26478656|P2|Overall Study|Withdrawal by Subject|4
7610311|NCT01852110|26478657|P1|Overall Study|Withdrawal by Subject|4
7610312|NCT01852110|26478652|P6|Overall Study|Study Terminated by Sponsor|0
7610313|NCT01852110|26478653|P5|Overall Study|Study Terminated by Sponsor|0
7610314|NCT01852110|26478654|P4|Overall Study|Study Terminated by Sponsor|0
7610315|NCT01852110|26478655|P3|Overall Study|Study Terminated by Sponsor|0
7610316|NCT01852110|26478656|P2|Overall Study|Study Terminated by Sponsor|32
7610317|NCT01852110|26478657|P1|Overall Study|Study Terminated by Sponsor|30
7610318|NCT01852110|26478652|P6|Overall Study|Protocol Violation|0
7610319|NCT01852110|26478653|P5|Overall Study|Protocol Violation|0
7610320|NCT01852110|26478654|P4|Overall Study|Protocol Violation|0
7610321|NCT01852110|26478655|P3|Overall Study|Protocol Violation|0
7610322|NCT01852110|26478656|P2|Overall Study|Protocol Violation|1
7610323|NCT01852110|26478657|P1|Overall Study|Protocol Violation|0
7610324|NCT01852110|26478652|P6|Overall Study|Physician Decision|0
7610325|NCT01852110|26478653|P5|Overall Study|Physician Decision|0
7610326|NCT01852110|26478654|P4|Overall Study|Physician Decision|0
7610327|NCT01852110|26478655|P3|Overall Study|Physician Decision|0
7610328|NCT01852110|26478656|P2|Overall Study|Physician Decision|0
7610329|NCT01852110|26478657|P1|Overall Study|Physician Decision|1
7610330|NCT01852110|26478652|P6|Overall Study|Non-compliance with Study Drug|0
7610331|NCT01852110|26478653|P5|Overall Study|Non-compliance with Study Drug|0
7610332|NCT01852110|26478654|P4|Overall Study|Non-compliance with Study Drug|0
7610333|NCT01852110|26478655|P3|Overall Study|Non-compliance with Study Drug|0
7610334|NCT01852110|26478656|P2|Overall Study|Non-compliance with Study Drug|1
7610335|NCT01852110|26478657|P1|Overall Study|Non-compliance with Study Drug|2
7610336|NCT01852110|26478652|P6|Overall Study|Lost to Follow-up|0
7610337|NCT01852110|26478653|P5|Overall Study|Lost to Follow-up|0
7610338|NCT01852110|26478654|P4|Overall Study|Lost to Follow-up|0
7610339|NCT01852110|26478655|P3|Overall Study|Lost to Follow-up|0
7610340|NCT01852110|26478656|P2|Overall Study|Lost to Follow-up|3
7610341|NCT01852110|26478657|P1|Overall Study|Lost to Follow-up|1
7610342|NCT01852110|26478652|P6|Overall Study|Adverse Event|0
7610343|NCT01852110|26478653|P5|Overall Study|Adverse Event|0
7610344|NCT01852110|26478654|P4|Overall Study|Adverse Event|0
7610345|NCT01852110|26478655|P3|Overall Study|Adverse Event|0
7610346|NCT01852110|26478656|P2|Overall Study|Adverse Event|5
7610347|NCT01852110|26478657|P1|Overall Study|Adverse Event|12
7610348|NCT01852058|26478761|P12|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610349|NCT01852058|26478762|P11|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610350|NCT01852058|26478763|P10|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610351|NCT01852058|26478764|P9|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
7610352|NCT01852058|26478765|P8|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610353|NCT01852058|26478766|P7|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610354|NCT01852058|26478767|P6|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610355|NCT01852058|26478768|P5|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610356|NCT01852058|26478769|P4|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610357|NCT01852058|26478770|P3|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610358|NCT01852058|26478771|P2|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610359|NCT01852058|26478772|P1|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7610360|NCT01852058|26478761|P12|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610361|NCT01852058|26478762|P11|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610362|NCT01852058|26478763|P10|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610363|NCT01852058|26478764|P9|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610364|NCT01852058|26478765|P8|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
7610365|NCT01852058|26478766|P7|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610366|NCT01852058|26478767|P6|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610367|NCT01852058|26478768|P5|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610368|NCT01852058|26478769|P4|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610369|NCT01852058|26478770|P3|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610370|NCT01852058|26478771|P2|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610371|NCT01852058|26478772|P1|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7610372|NCT01852058|26478761|P12|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610373|NCT01852058|26478762|P11|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610374|NCT01852058|26478763|P10|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610375|NCT01852058|26478764|P9|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610376|NCT01852058|26478765|P8|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610377|NCT01852058|26478766|P7|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610378|NCT01852058|26478767|P6|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
7610379|NCT01852058|26478768|P5|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
7610380|NCT01852058|26478769|P4|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610381|NCT01852058|26478770|P3|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610382|NCT01852058|26478771|P2|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610383|NCT01852058|26478772|P1|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7610384|NCT01852058|26478761|P12|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610385|NCT01852058|26478762|P11|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610386|NCT01852058|26478763|P10|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610387|NCT01852058|26478764|P9|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610388|NCT01852058|26478765|P8|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610389|NCT01852058|26478766|P7|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610390|NCT01852058|26478767|P6|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610391|NCT01852058|26478768|P5|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610392|NCT01852058|26478769|P4|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
7610393|NCT01852058|26478770|P3|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610394|NCT01852058|26478771|P2|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610395|NCT01852058|26478772|P1|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7610396|NCT01852058|26478761|P12|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610397|NCT01852058|26478762|P11|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610398|NCT01852058|26478763|P10|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610399|NCT01852058|26478764|P9|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610400|NCT01852058|26478765|P8|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610401|NCT01852058|26478766|P7|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610402|NCT01852058|26478767|P6|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
7610403|NCT01852058|26478768|P5|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
7610404|NCT01852058|26478769|P4|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610405|NCT01852058|26478770|P3|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610406|NCT01852058|26478771|P2|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610407|NCT01852058|26478772|P1|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7610408|NCT01852058|26478761|P12|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610409|NCT01852058|26478762|P11|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610410|NCT01852058|26478763|P10|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610411|NCT01852058|26478764|P9|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610412|NCT01852058|26478765|P8|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610413|NCT01852058|26478766|P7|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610414|NCT01852058|26478767|P6|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610415|NCT01852058|26478768|P5|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
7610416|NCT01852058|26478769|P4|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610417|NCT01852058|26478770|P3|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610418|NCT01852058|26478771|P2|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610419|NCT01852058|26478772|P1|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7610420|NCT01852058|26478761|P12|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610421|NCT01852058|26478762|P11|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610422|NCT01852058|26478763|P10|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610423|NCT01852058|26478764|P9|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610424|NCT01852058|26478765|P8|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610425|NCT01852058|26478766|P7|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610426|NCT01852058|26478767|P6|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7610427|NCT01852058|26478768|P5|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7610428|NCT01852058|26478769|P4|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610429|NCT01852058|26478770|P3|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610430|NCT01852058|26478771|P2|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610431|NCT01852058|26478772|P1|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7610432|NCT01852058|26478761|P12|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610433|NCT01852058|26478762|P11|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610434|NCT01852058|26478763|P10|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610435|NCT01852058|26478764|P9|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610436|NCT01852058|26478765|P8|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610437|NCT01852058|26478766|P7|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610438|NCT01852058|26478767|P6|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610439|NCT01852058|26478768|P5|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
7610440|NCT01852058|26478769|P4|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610441|NCT01852058|26478770|P3|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610442|NCT01852058|26478771|P2|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610443|NCT01852058|26478772|P1|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7610444|NCT01852058|26478761|P12|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610445|NCT01852058|26478762|P11|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610446|NCT01852058|26478763|P10|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610447|NCT01852058|26478764|P9|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610448|NCT01852058|26478765|P8|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610449|NCT01852058|26478766|P7|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610450|NCT01852058|26478767|P6|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610451|NCT01852058|26478768|P5|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610452|NCT01852058|26478769|P4|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610453|NCT01852058|26478770|P3|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610454|NCT01852058|26478771|P2|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7610455|NCT01852058|26478772|P1|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
7610456|NCT01852045|26478852|P3|Overall Study|Other Miscellaneous Reasons|2
7610457|NCT01852045|26478853|P2|Overall Study|Other Miscellaneous Reasons|3
7610458|NCT01852045|26478854|P1|Overall Study|Other Miscellaneous Reasons|1
7610459|NCT01852045|26478852|P3|Overall Study|Withdrawal by Subject|1
7610460|NCT01852045|26478853|P2|Overall Study|Withdrawal by Subject|0
7610461|NCT01852045|26478854|P1|Overall Study|Withdrawal by Subject|1
7610462|NCT01852045|26478852|P3|Overall Study|Lost to Follow-up|1
7610463|NCT01852045|26478853|P2|Overall Study|Lost to Follow-up|1
7610464|NCT01852045|26478854|P1|Overall Study|Lost to Follow-up|0
7610465|NCT01852045|26478852|P3|Overall Study|Lack of Efficacy|0
7610466|NCT01852045|26478853|P2|Overall Study|Lack of Efficacy|0
7610467|NCT01852045|26478854|P1|Overall Study|Lack of Efficacy|3
7610468|NCT01852045|26478852|P3|Overall Study|Adverse Event|0
7610469|NCT01852045|26478853|P2|Overall Study|Adverse Event|0
7610470|NCT01852045|26478854|P1|Overall Study|Adverse Event|1
7610471|NCT01851863|26478938|P4|Overall Study|Lost to Follow-up|3
7610472|NCT01851863|26478939|P3|Overall Study|Lost to Follow-up|2
7610473|NCT01851863|26478940|P2|Overall Study|Lost to Follow-up|4
7610474|NCT01851863|26478941|P1|Overall Study|Lost to Follow-up|3
7610475|NCT01851863|26478938|P4|Overall Study|Did not receive study medication|0
7610476|NCT01851863|26478939|P3|Overall Study|Did not receive study medication|3
7610477|NCT01851863|26478940|P2|Overall Study|Did not receive study medication|5
7610478|NCT01851863|26478941|P1|Overall Study|Did not receive study medication|2
7610479|NCT01851720|26478970|P2|Overall Study|Lost to Follow-up|1
7610480|NCT01851720|26478971|P1|Overall Study|Lost to Follow-up|0
7610481|NCT01851590|26479001|P3|Overall Study|Lack of Efficacy|0
7610482|NCT01851590|26479002|P2|Overall Study|Lack of Efficacy|1
7610483|NCT01851590|26479003|P1|Overall Study|Lack of Efficacy|0
7610484|NCT01851590|26479001|P3|Overall Study|Adverse Event|2
7610485|NCT01851590|26479002|P2|Overall Study|Adverse Event|0
7610486|NCT01851590|26479003|P1|Overall Study|Adverse Event|0
7610487|NCT01851590|26479001|P3|Overall Study|Withdrawal by Subject|1
7610488|NCT01851590|26479002|P2|Overall Study|Withdrawal by Subject|0
7610489|NCT01851590|26479003|P1|Overall Study|Withdrawal by Subject|0
7610490|NCT01851330|26479026|P3|Overall Study|Investigator's Discretion|1
7610491|NCT01851330|26479027|P2|Overall Study|Investigator's Discretion|0
7610492|NCT01851330|26479028|P1|Overall Study|Investigator's Discretion|0
7610493|NCT01851330|26479026|P3|Overall Study|Withdrew Consent|0
7610494|NCT01851330|26479027|P2|Overall Study|Withdrew Consent|1
7610495|NCT01851330|26479028|P1|Overall Study|Withdrew Consent|2
7610496|NCT01851330|26479026|P3|Overall Study|Lost to Follow-up|9
7610497|NCT01851330|26479027|P2|Overall Study|Lost to Follow-up|6
7610498|NCT01851330|26479028|P1|Overall Study|Lost to Follow-up|1
7610499|NCT01851330|26479026|P3|Overall Study|Lack of Efficacy|2
7610500|NCT01851330|26479027|P2|Overall Study|Lack of Efficacy|9
7610501|NCT01851330|26479028|P1|Overall Study|Lack of Efficacy|10
7610502|NCT01850823|26479071|P3|Overall Study|Withdrawal by Subject|1
7610503|NCT01850823|26479072|P2|Overall Study|Withdrawal by Subject|0
7610504|NCT01850823|26479073|P1|Overall Study|Withdrawal by Subject|2
7610505|NCT01850823|26479071|P3|Overall Study|Significant worstening of SAR|0
7610506|NCT01850823|26479072|P2|Overall Study|Significant worstening of SAR|1
7610507|NCT01850823|26479073|P1|Overall Study|Significant worstening of SAR|0
7610508|NCT01850823|26479071|P3|Overall Study|Restricted Medication|2
7610509|NCT01850823|26479072|P2|Overall Study|Restricted Medication|0
7610510|NCT01850823|26479073|P1|Overall Study|Restricted Medication|0
7610511|NCT01850823|26479071|P3|Overall Study|Lost to Follow-up|1
7610512|NCT01850823|26479072|P2|Overall Study|Lost to Follow-up|0
7610513|NCT01850823|26479073|P1|Overall Study|Lost to Follow-up|0
7610514|NCT01850823|26479071|P3|Overall Study|Lack of Efficacy|0
7610515|NCT01850823|26479072|P2|Overall Study|Lack of Efficacy|0
7610516|NCT01850823|26479073|P1|Overall Study|Lack of Efficacy|1
7610517|NCT01850823|26479071|P3|Overall Study|Enrolled in Error|2
7610518|NCT01850823|26479072|P2|Overall Study|Enrolled in Error|1
7610519|NCT01850823|26479073|P1|Overall Study|Enrolled in Error|0
7610520|NCT01850823|26479071|P3|Overall Study|Early Visit Window|4
7610521|NCT01850823|26479072|P2|Overall Study|Early Visit Window|1
7610522|NCT01850823|26479073|P1|Overall Study|Early Visit Window|0
7610523|NCT01850641|26479096|P1|Overall Study|Increase in serum ferritin|1
7610524|NCT01850641|26479096|P1|Overall Study|Decrease in serum calcium|2
7610525|NCT01850641|26479096|P1|Overall Study|Decrease in serum phosphorus|1
7610526|NCT01850641|26479096|P1|Overall Study|Physician Decision|1
7610527|NCT01850615|26479110|P2|Overall Study|Unclassified|1
7610528|NCT01850615|26479111|P1|Overall Study|Unclassified|0
7610529|NCT01850615|26479110|P2|Overall Study|Lost to Follow-up|1
7610530|NCT01850615|26479111|P1|Overall Study|Lost to Follow-up|0
7610531|NCT01850615|26479110|P2|Overall Study|Withdrawal by Subject|1
7610532|NCT01850615|26479111|P1|Overall Study|Withdrawal by Subject|3
7610533|NCT01850615|26479110|P2|Overall Study|Adverse Event|1
7610534|NCT01850615|26479111|P1|Overall Study|Adverse Event|2
7610535|NCT01850615|26479110|P2|Overall Study|Protocol Violation|1
7610536|NCT01850615|26479111|P1|Overall Study|Protocol Violation|4
7610537|NCT01850602|26479129|P2|Overall Study|Increase in serum ferritin|0
7610538|NCT01850602|26479130|P1|Overall Study|Increase in serum ferritin|1
7610539|NCT01850602|26479129|P2|Overall Study|Decrease in serum calcium|3
7610540|NCT01850602|26479130|P1|Overall Study|Decrease in serum calcium|2
7610541|NCT01850602|26479129|P2|Overall Study|Withdrawal by Subject|4
7610542|NCT01850602|26479130|P1|Overall Study|Withdrawal by Subject|2
7610543|NCT01850602|26479129|P2|Overall Study|Physician Decision|1
7610544|NCT01850602|26479130|P1|Overall Study|Physician Decision|2
7610545|NCT01850602|26479129|P2|Overall Study|Adverse Event|10
7610546|NCT01850602|26479130|P1|Overall Study|Adverse Event|7
7610547|NCT01850589|26479144|P2|Overall Study|Withdrawal by Subject|0
7610548|NCT01850589|26479145|P1|Overall Study|Withdrawal by Subject|8
7610549|NCT01850563|26479153|P2|Overall Study|Not eligible|0
7610550|NCT01850563|26479154|P1|Overall Study|Not eligible|3
7610551|NCT01850563|26479153|P2|Overall Study|Physician Decision|0
7610552|NCT01850563|26479154|P1|Overall Study|Physician Decision|4
7610553|NCT01850563|26479153|P2|Overall Study|Withdrawal by Subject|0
7610554|NCT01850563|26479154|P1|Overall Study|Withdrawal by Subject|3
7610555|NCT01850563|26479153|P2|Overall Study|Death|0
7610556|NCT01850563|26479154|P1|Overall Study|Death|8
7610557|NCT01850524|26479187|P2|Overall Study|Comorbidities|0
7610558|NCT01850524|26479188|P1|Overall Study|Comorbidities|1
7610559|NCT01850524|26479187|P2|Overall Study|Minimal Response|0
7610560|NCT01850524|26479188|P1|Overall Study|Minimal Response|1
7610561|NCT01850524|26479187|P2|Overall Study|Lack of Improvement|1
7610562|NCT01850524|26479188|P1|Overall Study|Lack of Improvement|0
7610563|NCT01850524|26479187|P2|Overall Study|Progressive Disease Per Local Lab|0
7610564|NCT01850524|26479188|P1|Overall Study|Progressive Disease Per Local Lab|1
7610565|NCT01850524|26479187|P2|Overall Study|Participants Decision|2
7610566|NCT01850524|26479188|P1|Overall Study|Participants Decision|2
7610567|NCT01850524|26479187|P2|Overall Study|Medical Monitor Decision|1
7610568|NCT01850524|26479188|P1|Overall Study|Medical Monitor Decision|0
7610569|NCT01850524|26479187|P2|Overall Study|Participants Removed From Study|1
7610570|NCT01850524|26479188|P1|Overall Study|Participants Removed From Study|0
7610571|NCT01850524|26479187|P2|Overall Study|Investigator Decision|4
7610572|NCT01850524|26479188|P1|Overall Study|Investigator Decision|4
7610573|NCT01850524|26479187|P2|Overall Study|Participant Wished to Discontinue Treatment|22
7610574|NCT01850524|26479188|P1|Overall Study|Participant Wished to Discontinue Treatment|15
7610575|NCT01850524|26479187|P2|Overall Study|Withdrawal by Subject|19
7610576|NCT01850524|26479188|P1|Overall Study|Withdrawal by Subject|8
7610577|NCT01850524|26479187|P2|Overall Study|Protocol Violation|2
7610578|NCT01850524|26479188|P1|Overall Study|Protocol Violation|1
7610579|NCT01850524|26479187|P2|Overall Study|Progressive Disease|123
7610580|NCT01850524|26479188|P1|Overall Study|Progressive Disease|166
7610581|NCT01850524|26479187|P2|Overall Study|Lost to Follow-up|0
7610582|NCT01850524|26479188|P1|Overall Study|Lost to Follow-up|2
7610583|NCT01850524|26479187|P2|Overall Study|Adverse Event|122
7610584|NCT01850524|26479188|P1|Overall Study|Adverse Event|96
7610585|NCT01850524|26479187|P2|Overall Study|Ongoing on Treatment|54
7610586|NCT01850524|26479188|P1|Overall Study|Ongoing on Treatment|57
7610587|NCT01850446|26479219|P2|Overall Study|Protocol Violation|2
7610588|NCT01850446|26479220|P1|Overall Study|Protocol Violation|0
7610589|NCT01850446|26479219|P2|Overall Study|Withdrawal by Subject|0
7610590|NCT01850446|26479220|P1|Overall Study|Withdrawal by Subject|4
7610591|NCT01850446|26479219|P2|Overall Study|Lack of Efficacy|0
7610592|NCT01850446|26479220|P1|Overall Study|Lack of Efficacy|1
7610593|NCT01850030|26479279|P2|Overall Study|pregnancy not confirmed at visit 4|249
7610594|NCT01850030|26479280|P1|Overall Study|pregnancy not confirmed at visit 4|248
7610595|NCT01850030|26479279|P2|Overall Study|Protocol Violation|28
7610596|NCT01850030|26479280|P1|Overall Study|Protocol Violation|24
7610597|NCT01850030|26479279|P2|Overall Study|Withdrawal by Subject|4
7610598|NCT01850030|26479280|P1|Overall Study|Withdrawal by Subject|3
7610599|NCT01850030|26479279|P2|Overall Study|Lost to Follow-up|5
7610600|NCT01850030|26479280|P1|Overall Study|Lost to Follow-up|5
7610601|NCT01850030|26479279|P2|Overall Study|Lack of Efficacy|1
7610602|NCT01850030|26479280|P1|Overall Study|Lack of Efficacy|3
7610603|NCT01850030|26479279|P2|Overall Study|Adverse Event|82
7610604|NCT01850030|26479280|P1|Overall Study|Adverse Event|64
7610605|NCT01850004|26479292|P1|Overall Study|AE Unrelated to Study Drug|1
7610606|NCT01850004|26479292|P1|Overall Study|Subject Request to Discontinue Treatment|1
7610607|NCT01850004|26479292|P1|Overall Study|Subject Withdrew Consent|4
7610608|NCT01850004|26479292|P1|Overall Study|Poor/Non-compliance|1
7610609|NCT01850004|26479292|P1|Overall Study|Subject Moved|1
7610610|NCT01849874|26479301|P2|Overall Study|Ongoing|69
7610611|NCT01849874|26479302|P1|Overall Study|Ongoing|162
7610612|NCT01849874|26479301|P2|Overall Study|Randomized but Never Treated|8
7610613|NCT01849874|26479302|P1|Overall Study|Randomized but Never Treated|1
7610614|NCT01849874|26479301|P2|Overall Study|Lost to Follow-up|1
7610615|NCT01849874|26479302|P1|Overall Study|Lost to Follow-up|0
7610616|NCT01849874|26479301|P2|Overall Study|Withdrawal by Subject|8
7610617|NCT01849874|26479302|P1|Overall Study|Withdrawal by Subject|4
7610618|NCT01849874|26479301|P2|Overall Study|Death|16
7610619|NCT01849874|26479302|P1|Overall Study|Death|34
7610620|NCT01849848|26479320|P1|Overall Study|Progression of the primary disease|3
7610621|NCT01849848|26479320|P1|Overall Study|Physician Decision|1
7610622|NCT01849588|26479423|P1|Overall Study|Lack of Efficacy|3
7610623|NCT01849562|26479448|P3|Overall Study|Non-compliance with Study Drug|0
7610624|NCT01849562|26479449|P2|Overall Study|Non-compliance with Study Drug|0
7610625|NCT01849562|26479450|P1|Overall Study|Non-compliance with Study Drug|1
7610626|NCT01849562|26479448|P3|Overall Study|Lost to Follow-up|0
7610627|NCT01849562|26479449|P2|Overall Study|Lost to Follow-up|0
7610628|NCT01849562|26479450|P1|Overall Study|Lost to Follow-up|1
7610629|NCT01849497|26479463|P2|Overall Study|Lost to Follow-up|1
7610630|NCT01849497|26479464|P1|Overall Study|Lost to Follow-up|0
7610631|NCT01849497|26479463|P2|Overall Study|Sponsor Decision|1
7610632|NCT01849497|26479464|P1|Overall Study|Sponsor Decision|0
7610633|NCT01849497|26479463|P2|Overall Study|Withdrawal by Subject|2
7610634|NCT01849497|26479464|P1|Overall Study|Withdrawal by Subject|1
7610635|NCT01849458|26479472|P1|Overall Study|Lost to Follow-up|4
7610636|NCT01849289|26479511|P2|Overall Study|Unclassified|18
7610637|NCT01849289|26479512|P1|Overall Study|Unclassified|25
7610638|NCT01849289|26479511|P2|Overall Study|Withdrawal criteria|0
7610639|NCT01849289|26479512|P1|Overall Study|Withdrawal criteria|1
7610640|NCT01849289|26479511|P2|Overall Study|Protocol Violation|3
7610641|NCT01849289|26479512|P1|Overall Study|Protocol Violation|3
7610642|NCT01849289|26479511|P2|Overall Study|Adverse Event|3
7610643|NCT01849289|26479512|P1|Overall Study|Adverse Event|3
7610644|NCT01849276|26479528|P1|Followed for Survival for 5 Years|Early termination of the study|1
7610645|NCT01849276|26479528|P1|Followed for Survival for 5 Years|Death|1
7610646|NCT01849055|26479610|P6|Overall Study|Withdrawal by Subject|0
7610647|NCT01849055|26479611|P5|Overall Study|Withdrawal by Subject|0
7610648|NCT01849055|26479612|P4|Overall Study|Withdrawal by Subject|0
7610649|NCT01849055|26479613|P3|Overall Study|Withdrawal by Subject|1
7610650|NCT01849055|26479614|P2|Overall Study|Withdrawal by Subject|0
7610651|NCT01849055|26479615|P1|Overall Study|Withdrawal by Subject|0
7610652|NCT01848990|26479650|P3|Overall Study|Other|2
7610653|NCT01848990|26479651|P2|Overall Study|Other|4
7610654|NCT01848990|26479652|P1|Overall Study|Other|1
7610655|NCT01848990|26479650|P3|Overall Study|Death|1
7610656|NCT01848990|26479651|P2|Overall Study|Death|0
7610657|NCT01848990|26479652|P1|Overall Study|Death|1
7610658|NCT01848990|26479650|P3|Overall Study|Non Compliance|0
7610659|NCT01848990|26479651|P2|Overall Study|Non Compliance|0
7610660|NCT01848990|26479652|P1|Overall Study|Non Compliance|1
7610661|NCT01848990|26479650|P3|Overall Study|Physician Decision|0
7610662|NCT01848990|26479651|P2|Overall Study|Physician Decision|1
7610663|NCT01848990|26479652|P1|Overall Study|Physician Decision|1
7610664|NCT01848990|26479650|P3|Overall Study|Withdrawal by Subject|11
7610665|NCT01848990|26479651|P2|Overall Study|Withdrawal by Subject|10
7610666|NCT01848990|26479652|P1|Overall Study|Withdrawal by Subject|29
7610667|NCT01848990|26479650|P3|Overall Study|Protocol Violation|0
7610668|NCT01848990|26479651|P2|Overall Study|Protocol Violation|1
7610669|NCT01848990|26479652|P1|Overall Study|Protocol Violation|1
7610670|NCT01848990|26479650|P3|Overall Study|Lost to Follow-up|2
7610671|NCT01848990|26479651|P2|Overall Study|Lost to Follow-up|2
7610672|NCT01848990|26479652|P1|Overall Study|Lost to Follow-up|6
7610673|NCT01848990|26479650|P3|Overall Study|Adverse Event|0
7610674|NCT01848990|26479651|P2|Overall Study|Adverse Event|2
7610675|NCT01848990|26479652|P1|Overall Study|Adverse Event|6
7610676|NCT01848938|26479722|P2|Overall Study|Lost to Follow-up|1
7610677|NCT01848938|26479723|P1|Overall Study|Lost to Follow-up|1
7610678|NCT01848834|26479772|P5|Overall Study|Withdrawal by Subject|36
7610679|NCT01848834|26479773|P4|Overall Study|Withdrawal by Subject|6
7610680|NCT01848834|26479774|P3|Overall Study|Withdrawal by Subject|10
7610681|NCT01848834|26479775|P2|Overall Study|Withdrawal by Subject|13
7610682|NCT01848834|26479776|P1|Overall Study|Withdrawal by Subject|2
7610683|NCT01848834|26479772|P5|Overall Study|Sponsor Decision|1
7610684|NCT01848834|26479773|P4|Overall Study|Sponsor Decision|1
7610685|NCT01848834|26479774|P3|Overall Study|Sponsor Decision|0
7610686|NCT01848834|26479775|P2|Overall Study|Sponsor Decision|1
7610687|NCT01848834|26479776|P1|Overall Study|Sponsor Decision|1
7610688|NCT01848834|26479772|P5|Overall Study|Protocol Violation|1
7610689|NCT01848834|26479773|P4|Overall Study|Protocol Violation|0
7610690|NCT01848834|26479774|P3|Overall Study|Protocol Violation|0
7610691|NCT01848834|26479775|P2|Overall Study|Protocol Violation|0
7610692|NCT01848834|26479776|P1|Overall Study|Protocol Violation|0
7610693|NCT01848834|26479772|P5|Overall Study|Physician Decision|11
7610694|NCT01848834|26479773|P4|Overall Study|Physician Decision|0
7610695|NCT01848834|26479774|P3|Overall Study|Physician Decision|4
7610696|NCT01848834|26479775|P2|Overall Study|Physician Decision|3
7610697|NCT01848834|26479776|P1|Overall Study|Physician Decision|1
7610698|NCT01848834|26479772|P5|Overall Study|Lost to Follow-up|3
7610699|NCT01848834|26479773|P4|Overall Study|Lost to Follow-up|0
7610700|NCT01848834|26479774|P3|Overall Study|Lost to Follow-up|3
7610701|NCT01848834|26479775|P2|Overall Study|Lost to Follow-up|5
7610702|NCT01848834|26479776|P1|Overall Study|Lost to Follow-up|5
7610703|NCT01848834|26479772|P5|Overall Study|Excluded Medication|6
7610704|NCT01848834|26479773|P4|Overall Study|Excluded Medication|6
7610705|NCT01848834|26479774|P3|Overall Study|Excluded Medication|3
7610706|NCT01848834|26479775|P2|Overall Study|Excluded Medication|4
7610707|NCT01848834|26479776|P1|Overall Study|Excluded Medication|5
7610708|NCT01848834|26479772|P5|Overall Study|Death|27
7610709|NCT01848834|26479773|P4|Overall Study|Death|8
7610710|NCT01848834|26479774|P3|Overall Study|Death|1
7610711|NCT01848834|26479775|P2|Overall Study|Death|11
7610712|NCT01848834|26479776|P1|Overall Study|Death|2
7610713|NCT01848834|26479772|P5|Overall Study|Adverse Event|9
7610714|NCT01848834|26479773|P4|Overall Study|Adverse Event|5
7610715|NCT01848834|26479774|P3|Overall Study|Adverse Event|3
7610716|NCT01848834|26479775|P2|Overall Study|Adverse Event|11
7610717|NCT01848834|26479776|P1|Overall Study|Adverse Event|3
7610718|NCT01848756|26479824|P1|Overall Study|Enrolled in Error|1
7610719|NCT01848756|26479824|P1|Overall Study|Withdrawal by Subject|1
7610720|NCT01848756|26479824|P1|Overall Study|Adverse Event|1
7610721|NCT01848483|26479836|P2|Overall Study|Incarceration|2
7610722|NCT01848483|26479837|P1|Overall Study|Incarceration|2
7610723|NCT01848483|26479836|P2|Overall Study|Withdrawal by Subject|0
7610724|NCT01848483|26479837|P1|Overall Study|Withdrawal by Subject|1
7610725|NCT01848483|26479836|P2|Overall Study|Lost to Follow-up|8
7610726|NCT01848483|26479837|P1|Overall Study|Lost to Follow-up|6
7610727|NCT01848483|26479836|P2|Overall Study|Death|1
7610728|NCT01848483|26479837|P1|Overall Study|Death|2
7610729|NCT01848457|26479855|P4|Overall Study|Death|0
7610730|NCT01848457|26479856|P3|Overall Study|Death|0
7610731|NCT01848457|26479857|P2|Overall Study|Death|0
7610732|NCT01848457|26479858|P1|Overall Study|Death|1
7610733|NCT01848353|26479890|P4|Phase 3|Withdrawal by Subject|0
7610734|NCT01848353|26479891|P3|Phase 3|Withdrawal by Subject|0
7610735|NCT01848353|26479892|P2|Phase 3|Withdrawal by Subject|1
7610736|NCT01848353|26479893|P1|Phase 3|Withdrawal by Subject|1
7610737|NCT01848353|26479890|P4|Phase 2|Withdrawal by Subject|0
7610738|NCT01848353|26479891|P3|Phase 2|Withdrawal by Subject|0
7610739|NCT01848353|26479892|P2|Phase 2|Withdrawal by Subject|2
7610740|NCT01848353|26479893|P1|Phase 2|Withdrawal by Subject|3
7610741|NCT01848353|26479890|P4|Phase 1|Withdrawal by Subject|0
7610742|NCT01848353|26479891|P3|Phase 1|Withdrawal by Subject|0
7610743|NCT01848353|26479892|P2|Phase 1|Withdrawal by Subject|1
7610744|NCT01848353|26479893|P1|Phase 1|Withdrawal by Subject|3
7610745|NCT01848288|26479949|P1|Overall Study|Withdrawal by Subject|1
7610746|NCT01848288|26479949|P1|Overall Study|Protocol Violation|1
7610747|NCT01848288|26479949|P1|Overall Study|Death|1
7610748|NCT01848210|26479960|P2|Overall Study|Administrative|0
7610749|NCT01848210|26479961|P1|Overall Study|Administrative|1
7610750|NCT01848210|26479960|P2|Overall Study|Chronic Venous Insufficiency Course|2
7610751|NCT01848210|26479961|P1|Overall Study|Chronic Venous Insufficiency Course|1
7610752|NCT01848210|26479960|P2|Overall Study|Hepatic Function Alteration|0
7610753|NCT01848210|26479961|P1|Overall Study|Hepatic Function Alteration|4
7610754|NCT01848210|26479960|P2|Overall Study|Hypesensitivity|0
7610755|NCT01848210|26479961|P1|Overall Study|Hypesensitivity|1
7610756|NCT01848210|26479960|P2|Overall Study|Discontinuation Criterion|7
7610757|NCT01848210|26479961|P1|Overall Study|Discontinuation Criterion|5
7610758|NCT01848210|26479960|P2|Overall Study|Adverse Event|9
7610759|NCT01848210|26479961|P1|Overall Study|Adverse Event|7
7610760|NCT01848210|26479960|P2|Overall Study|Impedition Condition|9
7610761|NCT01848210|26479961|P1|Overall Study|Impedition Condition|5
7610762|NCT01848210|26479960|P2|Overall Study|Use of Forbidden Drugs|10
7610763|NCT01848210|26479961|P1|Overall Study|Use of Forbidden Drugs|9
7610764|NCT01848210|26479960|P2|Overall Study|Protocol Violation|5
7610765|NCT01848210|26479961|P1|Overall Study|Protocol Violation|3
7610766|NCT01848210|26479960|P2|Overall Study|Lost to Follow-up|12
7610767|NCT01848210|26479961|P1|Overall Study|Lost to Follow-up|24
7610768|NCT01848210|26479960|P2|Overall Study|Informed Consent Form Withdrawal|24
7610769|NCT01848210|26479961|P1|Overall Study|Informed Consent Form Withdrawal|28
7610770|NCT01848145|26480010|P1|Subsequent Infusions: Weeks 3-8|Death|1
7610771|NCT01848145|26480010|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
7610772|NCT01848145|26480010|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
7610773|NCT01848145|26480010|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
7610774|NCT01848145|26480010|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
7610775|NCT01848145|26480010|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
7610776|NCT01848145|26480010|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
7610777|NCT01847885|26480072|P3|Randomization|Screen Failure|0
7610778|NCT01847885|26480073|P2|Randomization|Screen Failure|3
7610779|NCT01847885|26480074|P1|Randomization|Screen Failure|0
7610780|NCT01847885|26480072|P3|Randomization|Withdrawal by Subject|2
7610781|NCT01847885|26480073|P2|Randomization|Withdrawal by Subject|0
7610782|NCT01847885|26480074|P1|Randomization|Withdrawal by Subject|0
7610783|NCT01847885|26480072|P3|Randomization|Protocol Violation|0
7610784|NCT01847885|26480073|P2|Randomization|Protocol Violation|1
7610785|NCT01847885|26480074|P1|Randomization|Protocol Violation|0
7610786|NCT01847885|26480072|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7610787|NCT01847885|26480073|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7610788|NCT01847885|26480074|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
7610789|NCT01847885|26480072|P3|Initial Enrollment (Consented)|Screen failure|0
7610790|NCT01847885|26480073|P2|Initial Enrollment (Consented)|Screen failure|0
7610791|NCT01847885|26480074|P1|Initial Enrollment (Consented)|Screen failure|39
7610792|NCT01847885|26480072|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
7610793|NCT01847885|26480073|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
7610794|NCT01847885|26480074|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
7610795|NCT01847885|26480072|P3|Initial Enrollment (Consented)|Protocol Violation|0
7610796|NCT01847885|26480073|P2|Initial Enrollment (Consented)|Protocol Violation|0
7610797|NCT01847885|26480074|P1|Initial Enrollment (Consented)|Protocol Violation|1
7610798|NCT01847755|26480106|P1|Overall Study|Physician Decision|1
7610799|NCT01847755|26480106|P1|Overall Study|Withdrawal by Subject|2
7610800|NCT01847755|26480106|P1|Overall Study|Adverse Event|2
7610801|NCT01847443|26480242|P4|Washout Period Before Study Period 4|Positive alcohol test|0
7610802|NCT01847443|26480243|P3|Washout Period Before Study Period 4|Positive alcohol test|0
7610803|NCT01847443|26480244|P2|Washout Period Before Study Period 4|Positive alcohol test|0
7610804|NCT01847443|26480245|P1|Washout Period Before Study Period 4|Positive alcohol test|1
7610805|NCT01847443|26480242|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
7610806|NCT01847443|26480243|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
7610807|NCT01847443|26480244|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
7610808|NCT01847443|26480245|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
7610809|NCT01847443|26480242|P4|Washout Period Before Study Period 3|Other reason|0
7610810|NCT01847443|26480243|P3|Washout Period Before Study Period 3|Other reason|0
7610811|NCT01847443|26480244|P2|Washout Period Before Study Period 3|Other reason|0
7610812|NCT01847443|26480245|P1|Washout Period Before Study Period 3|Other reason|1
7610813|NCT01847443|26480242|P4|Washout Period Before Study Period 2|Other reason|0
7610814|NCT01847443|26480243|P3|Washout Period Before Study Period 2|Other reason|0
7610815|NCT01847443|26480244|P2|Washout Period Before Study Period 2|Other reason|0
7610816|NCT01847443|26480245|P1|Washout Period Before Study Period 2|Other reason|1
7610817|NCT01847443|26480242|P4|Washout Period Before Study Period 2|Adverse Event|0
7610818|NCT01847443|26480243|P3|Washout Period Before Study Period 2|Adverse Event|0
7610819|NCT01847443|26480244|P2|Washout Period Before Study Period 2|Adverse Event|1
7610820|NCT01847443|26480245|P1|Washout Period Before Study Period 2|Adverse Event|1
7610821|NCT01847443|26480242|P4|Study Period 1|Withdrawal by Subject|0
7610822|NCT01847443|26480243|P3|Study Period 1|Withdrawal by Subject|0
7610823|NCT01847443|26480244|P2|Study Period 1|Withdrawal by Subject|1
7610824|NCT01847443|26480245|P1|Study Period 1|Withdrawal by Subject|0
7610825|NCT01847313|26480288|P2|Overall Study|Withdrawal by Subject|1
7610826|NCT01847313|26480289|P1|Overall Study|Withdrawal by Subject|0
7610827|NCT01847313|26480288|P2|Overall Study|Death|1
7610828|NCT01847313|26480289|P1|Overall Study|Death|0
7610853|NCT01847209|26480362|P1|Overall Study|No lung nodule found on intraop CT scan|1
7610854|NCT01847209|26480362|P1|Overall Study|Withdrawal by Subject|1
7610855|NCT01847092|26480385|P2|Overall Study|Protocol Violation|2
7610856|NCT01847092|26480386|P1|Overall Study|Protocol Violation|0
7610857|NCT01847092|26480385|P2|Overall Study|Physician Decision|1
7610858|NCT01847092|26480386|P1|Overall Study|Physician Decision|1
7610859|NCT01847092|26480385|P2|Overall Study|Protocol Specified|0
7610860|NCT01847092|26480386|P1|Overall Study|Protocol Specified|8
7610861|NCT01847092|26480385|P2|Overall Study|Withdrawal by Subject|5
7610862|NCT01847092|26480386|P1|Overall Study|Withdrawal by Subject|5
7610863|NCT01847092|26480385|P2|Overall Study|Adverse Event|3
7610864|NCT01847092|26480386|P1|Overall Study|Adverse Event|12
7610865|NCT01846741|26480464|P1|Baseline Visit|Subject did not meet entry criteria|2
7610866|NCT01846624|26480620|P1|Overall Study|Died during induction, no midostaurin|1
7610867|NCT01846611|26480630|P2|Overall Study|Other|18
7610868|NCT01846611|26480631|P1|Overall Study|Other|19
7610869|NCT01846611|26480630|P2|Overall Study|Withdrawal by Subject|19
7610870|NCT01846611|26480631|P1|Overall Study|Withdrawal by Subject|15
7610871|NCT01846611|26480630|P2|Overall Study|Lost to Follow-up|6
7610872|NCT01846611|26480631|P1|Overall Study|Lost to Follow-up|4
7610873|NCT01846507|26480641|P1|Overall Study|Missing data|2
7610874|NCT01846507|26480641|P1|Overall Study|Protocol Violation|1
7610875|NCT01846507|26480641|P1|Overall Study|Lost to Follow-up|4
7610876|NCT01846442|26480739|P4|Overall Study|Left the city/Lost medication|1
7610877|NCT01846442|26480740|P3|Overall Study|Left the city/Lost medication|1
7610878|NCT01846442|26480741|P2|Overall Study|Left the city/Lost medication|0
7610879|NCT01846442|26480742|P1|Overall Study|Left the city/Lost medication|1
7610880|NCT01846442|26480739|P4|Overall Study|Withdrawal by Subject|1
7610881|NCT01846442|26480740|P3|Overall Study|Withdrawal by Subject|0
7610882|NCT01846442|26480741|P2|Overall Study|Withdrawal by Subject|2
7610883|NCT01846442|26480742|P1|Overall Study|Withdrawal by Subject|3
7610884|NCT01846442|26480739|P4|Overall Study|Lost to Follow-up|0
7610885|NCT01846442|26480740|P3|Overall Study|Lost to Follow-up|1
7610886|NCT01846442|26480741|P2|Overall Study|Lost to Follow-up|0
7610887|NCT01846442|26480742|P1|Overall Study|Lost to Follow-up|0
7610888|NCT01846442|26480739|P4|Overall Study|Adverse Event|1
7610889|NCT01846442|26480740|P3|Overall Study|Adverse Event|2
7610890|NCT01846442|26480741|P2|Overall Study|Adverse Event|4
7610891|NCT01846442|26480742|P1|Overall Study|Adverse Event|2
7610892|NCT01846416|26480783|P3|Survival Follow-up|Other|1
7610893|NCT01846416|26480784|P2|Survival Follow-up|Other|1
7610894|NCT01846416|26480785|P1|Survival Follow-up|Other|3
7610895|NCT01846416|26480783|P3|Survival Follow-up|Study Terminated by Sponsor|0
7610896|NCT01846416|26480784|P2|Survival Follow-up|Study Terminated by Sponsor|8
7610897|NCT01846416|26480785|P1|Survival Follow-up|Study Terminated by Sponsor|2
7610898|NCT01846416|26480783|P3|Survival Follow-up|Withdrawal by Subject|0
7610899|NCT01846416|26480784|P2|Survival Follow-up|Withdrawal by Subject|7
7610900|NCT01846416|26480785|P1|Survival Follow-up|Withdrawal by Subject|2
7610901|NCT01846416|26480783|P3|Survival Follow-up|Lost to Follow-up|2
7610902|NCT01846416|26480784|P2|Survival Follow-up|Lost to Follow-up|2
7610903|NCT01846416|26480785|P1|Survival Follow-up|Lost to Follow-up|0
7610904|NCT01846416|26480783|P3|Survival Follow-up|Death|9
7610905|NCT01846416|26480784|P2|Survival Follow-up|Death|62
7610906|NCT01846416|26480785|P1|Survival Follow-up|Death|21
7610907|NCT01846416|26480783|P3|Treatment Phase|Progressive Disease|9
7610908|NCT01846416|26480784|P2|Treatment Phase|Progressive Disease|63
7610909|NCT01846416|26480785|P1|Treatment Phase|Progressive Disease|21
7610910|NCT01846416|26480783|P3|Treatment Phase|Study Terminated by Sponsor|0
7610911|NCT01846416|26480784|P2|Treatment Phase|Study Terminated by Sponsor|4
7610912|NCT01846416|26480785|P1|Treatment Phase|Study Terminated by Sponsor|1
7610913|NCT01846416|26480783|P3|Treatment Phase|Non-compliance|0
7610914|NCT01846416|26480784|P2|Treatment Phase|Non-compliance|2
7610915|NCT01846416|26480785|P1|Treatment Phase|Non-compliance|0
7610916|NCT01846416|26480783|P3|Treatment Phase|Adverse Event|0
7610917|NCT01846416|26480784|P2|Treatment Phase|Adverse Event|4
7610918|NCT01846416|26480785|P1|Treatment Phase|Adverse Event|3
7610919|NCT01846416|26480783|P3|Treatment Phase|Physician Decision|0
7610920|NCT01846416|26480784|P2|Treatment Phase|Physician Decision|2
7610921|NCT01846416|26480785|P1|Treatment Phase|Physician Decision|1
7610922|NCT01846416|26480783|P3|Treatment Phase|Other|1
7610923|NCT01846416|26480784|P2|Treatment Phase|Other|5
7610924|NCT01846416|26480785|P1|Treatment Phase|Other|1
7610925|NCT01846416|26480783|P3|Treatment Phase|Withdrawal by Subject|2
7610926|NCT01846416|26480784|P2|Treatment Phase|Withdrawal by Subject|4
7610927|NCT01846416|26480785|P1|Treatment Phase|Withdrawal by Subject|2
7610928|NCT01846416|26480783|P3|Treatment Phase|Death|1
7610929|NCT01846416|26480784|P2|Treatment Phase|Death|9
7610930|NCT01846416|26480785|P1|Treatment Phase|Death|2
7610931|NCT01846299|26480830|P2|Overall Study|Adverse Event|0
7610932|NCT01846299|26480831|P1|Overall Study|Adverse Event|2
7610933|NCT01846299|26480830|P2|Overall Study|Withdrawal by Subject|6
7610934|NCT01846299|26480831|P1|Overall Study|Withdrawal by Subject|1
7610935|NCT01846299|26480830|P2|Overall Study|Lost to Follow-up|0
7610936|NCT01846299|26480831|P1|Overall Study|Lost to Follow-up|3
7610937|NCT01846299|26480830|P2|Overall Study|Death|2
7610938|NCT01846299|26480831|P1|Overall Study|Death|1
7610939|NCT01846299|26480830|P2|Overall Study|Protocol deviation|0
7610940|NCT01846299|26480831|P1|Overall Study|Protocol deviation|1
7610941|NCT01846299|26480830|P2|Overall Study|Physician Decision|2
7610942|NCT01846299|26480831|P1|Overall Study|Physician Decision|4
7610943|NCT01846273|26480870|P3|Overall Study|Physician Decision|0
7610944|NCT01846273|26480871|P2|Overall Study|Physician Decision|2
7610945|NCT01846273|26480872|P1|Overall Study|Physician Decision|1
7610946|NCT01846273|26480870|P3|Overall Study|Protocol Deviation|0
7610947|NCT01846273|26480871|P2|Overall Study|Protocol Deviation|3
7610948|NCT01846273|26480872|P1|Overall Study|Protocol Deviation|2
7610949|NCT01846273|26480870|P3|Overall Study|Disease Progression|0
7610950|NCT01846273|26480871|P2|Overall Study|Disease Progression|4
7610951|NCT01846273|26480872|P1|Overall Study|Disease Progression|0
7610952|NCT01846273|26480870|P3|Overall Study|Death|0
7610953|NCT01846273|26480871|P2|Overall Study|Death|1
7610954|NCT01846273|26480872|P1|Overall Study|Death|2
7610955|NCT01846273|26480870|P3|Overall Study|Administrative problems|0
7610956|NCT01846273|26480871|P2|Overall Study|Administrative problems|0
7610957|NCT01846273|26480872|P1|Overall Study|Administrative problems|1
7610958|NCT01846273|26480870|P3|Overall Study|Lost to Follow-up|0
7610959|NCT01846273|26480871|P2|Overall Study|Lost to Follow-up|1
7610960|NCT01846273|26480872|P1|Overall Study|Lost to Follow-up|2
7610961|NCT01846273|26480870|P3|Overall Study|Subject withdrew consent|0
7610962|NCT01846273|26480871|P2|Overall Study|Subject withdrew consent|8
7610963|NCT01846273|26480872|P1|Overall Study|Subject withdrew consent|5
7610964|NCT01846273|26480870|P3|Overall Study|Adverse Event|0
7610965|NCT01846273|26480871|P2|Overall Study|Adverse Event|7
7610966|NCT01846273|26480872|P1|Overall Study|Adverse Event|9
7610967|NCT01846221|26480928|P2|Overall Study|Age Exclusion|0
7610968|NCT01846221|26480929|P1|Overall Study|Age Exclusion|1
7610969|NCT01846221|26480928|P2|Overall Study|Catheter Failure|0
7610970|NCT01846221|26480929|P1|Overall Study|Catheter Failure|2
7610971|NCT01846208|26480946|P3|Overall Study|Refused SU OFC|1
7610972|NCT01846208|26480947|P2|Overall Study|Refused SU OFC|0
7610973|NCT01846208|26480948|P1|Overall Study|Refused SU OFC|0
7610974|NCT01846208|26480946|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7610975|NCT01846208|26480947|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7610976|NCT01846208|26480948|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
7610977|NCT01846208|26480946|P3|Overall Study|Non-compliance|0
7610978|NCT01846208|26480947|P2|Overall Study|Non-compliance|1
7610979|NCT01846208|26480948|P1|Overall Study|Non-compliance|1
7610980|NCT01846208|26480946|P3|Overall Study|Withdrawal by Subject|0
7610981|NCT01846208|26480947|P2|Overall Study|Withdrawal by Subject|0
7610982|NCT01846208|26480948|P1|Overall Study|Withdrawal by Subject|5
7610983|NCT01846208|26480946|P3|Overall Study|Dosing Symptoms|6
7610984|NCT01846208|26480947|P2|Overall Study|Dosing Symptoms|2
7610985|NCT01846208|26480948|P1|Overall Study|Dosing Symptoms|1
7610986|NCT01846208|26480946|P3|Overall Study|Withdrew prior to treatment|1
7610987|NCT01846208|26480947|P2|Overall Study|Withdrew prior to treatment|1
7610988|NCT01846208|26480948|P1|Overall Study|Withdrew prior to treatment|1
7610989|NCT01846104|26480987|P1|Overall Study|Withdrawal by Subject|1
7610990|NCT01846039|26480993|P1|Overall Study|Subject Withdrew Consent|1
7610991|NCT01846039|26480993|P1|Overall Study|Protocol Violation|1
7610992|NCT01845974|26481005|P2|Overall Study|screen failure|0
7610993|NCT01845974|26481006|P1|Overall Study|screen failure|1
7610994|NCT01845831|26481014|P5|Inpatient Phase|Withdrawal by Subject|0
7610995|NCT01845831|26481015|P4|Inpatient Phase|Withdrawal by Subject|0
7610996|NCT01845831|26481016|P3|Inpatient Phase|Withdrawal by Subject|0
7610997|NCT01845831|26481017|P2|Inpatient Phase|Withdrawal by Subject|1
7610998|NCT01845831|26481018|P1|Inpatient Phase|Withdrawal by Subject|1
7610999|NCT01845818|26481047|P2|Overall Study|No Follow-Up Data Available|1
7611000|NCT01845818|26481048|P1|Overall Study|No Follow-Up Data Available|4
7611001|NCT01845818|26481047|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
7611002|NCT01845818|26481048|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
7611003|NCT01845818|26481047|P2|Overall Study|Other|8
7611004|NCT01845818|26481048|P1|Overall Study|Other|25
7611005|NCT01845818|26481047|P2|Overall Study|Serious Adverse Event|1
7611006|NCT01845818|26481048|P1|Overall Study|Serious Adverse Event|1
7611007|NCT01845818|26481047|P2|Overall Study|Administrative Reasons|1
7611008|NCT01845818|26481048|P1|Overall Study|Administrative Reasons|3
7611009|NCT01845818|26481047|P2|Overall Study|Lost to Follow-up|5
7611010|NCT01845818|26481048|P1|Overall Study|Lost to Follow-up|7
7611011|NCT01845818|26481047|P2|Overall Study|Withdrawal by Subject|1
7611012|NCT01845818|26481048|P1|Overall Study|Withdrawal by Subject|0
7611013|NCT01845077|26481132|P6|Washout Period|Protocol Violation|0
7611014|NCT01845077|26481133|P5|Washout Period|Protocol Violation|1
7611015|NCT01845077|26481134|P4|Washout Period|Protocol Violation|1
7611016|NCT01845077|26481135|P3|Washout Period|Protocol Violation|0
7611017|NCT01845077|26481136|P2|Washout Period|Protocol Violation|0
7611018|NCT01845077|26481137|P1|Washout Period|Protocol Violation|0
7611019|NCT01845077|26481132|P6|Washout Period|elevated lab values (not clinic. sign.)|0
7611020|NCT01845077|26481133|P5|Washout Period|elevated lab values (not clinic. sign.)|0
7611021|NCT01845077|26481134|P4|Washout Period|elevated lab values (not clinic. sign.)|0
7611022|NCT01845077|26481135|P3|Washout Period|elevated lab values (not clinic. sign.)|1
7611023|NCT01845077|26481136|P2|Washout Period|elevated lab values (not clinic. sign.)|0
7611024|NCT01845077|26481137|P1|Washout Period|elevated lab values (not clinic. sign.)|0
7611025|NCT01845077|26481132|P6|Washout Period|Adverse Event|0
7611026|NCT01845077|26481133|P5|Washout Period|Adverse Event|0
7611027|NCT01845077|26481134|P4|Washout Period|Adverse Event|0
7611028|NCT01845077|26481135|P3|Washout Period|Adverse Event|0
7611029|NCT01845077|26481136|P2|Washout Period|Adverse Event|0
7611030|NCT01845077|26481137|P1|Washout Period|Adverse Event|1
7611031|NCT01845077|26481132|P6|Washout Period|Lost to Follow-up|1
7611032|NCT01845077|26481133|P5|Washout Period|Lost to Follow-up|0
7611033|NCT01845077|26481134|P4|Washout Period|Lost to Follow-up|1
7611034|NCT01845077|26481135|P3|Washout Period|Lost to Follow-up|0
7611035|NCT01845077|26481136|P2|Washout Period|Lost to Follow-up|1
7611036|NCT01845077|26481137|P1|Washout Period|Lost to Follow-up|0
7611037|NCT01845025|26481183|P2|Overall Study|Missing|1
7611038|NCT01845025|26481184|P1|Overall Study|Missing|1
7611039|NCT01845025|26481183|P2|Overall Study|Protocol deviation|6
7611040|NCT01845025|26481184|P1|Overall Study|Protocol deviation|3
7611041|NCT01845025|26481183|P2|Overall Study|Death|0
7611042|NCT01845025|26481184|P1|Overall Study|Death|2
7611043|NCT01845025|26481183|P2|Overall Study|Administrative problems|8
7611044|NCT01845025|26481184|P1|Overall Study|Administrative problems|8
7611045|NCT01845025|26481183|P2|Overall Study|Lost to Follow-up|13
7611046|NCT01845025|26481184|P1|Overall Study|Lost to Follow-up|13
7611047|NCT01845025|26481183|P2|Overall Study|Withdrawal by Subject|44
7611048|NCT01845025|26481184|P1|Overall Study|Withdrawal by Subject|48
7611049|NCT01845025|26481183|P2|Overall Study|Unsatisfactory therapeutic effect|2
7611050|NCT01845025|26481184|P1|Overall Study|Unsatisfactory therapeutic effect|4
7611051|NCT01845025|26481183|P2|Overall Study|Adverse Event|3
7611052|NCT01845025|26481184|P1|Overall Study|Adverse Event|6
7611053|NCT01844986|26481208|P2|Overall Study|Death|26
7611054|NCT01844986|26481209|P1|Overall Study|Death|55
7611055|NCT01844986|26481208|P2|Overall Study|Withdrawal by Subject|14
7611056|NCT01844986|26481209|P1|Overall Study|Withdrawal by Subject|21
7611057|NCT01844986|26481208|P2|Overall Study|Severe non-compliance to protocol|0
7611058|NCT01844986|26481209|P1|Overall Study|Severe non-compliance to protocol|1
7611059|NCT01844895|26481231|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
7611060|NCT01844895|26481231|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
7611061|NCT01844895|26481231|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
7611062|NCT01844895|26481231|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
7611063|NCT01844895|26481231|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
7611064|NCT01844895|26481231|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
7611065|NCT01844895|26481231|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
7611066|NCT01844856|26481249|P2|Overall Study|Randomized but was a Screen Failure|1
7611067|NCT01844856|26481250|P1|Overall Study|Randomized but was a Screen Failure|0
7611068|NCT01844856|26481249|P2|Overall Study|Inadvertently Not Scheduled|0
7611069|NCT01844856|26481250|P1|Overall Study|Inadvertently Not Scheduled|1
7611070|NCT01844856|26481249|P2|Overall Study|Enterococcus Resistant|1
7611071|NCT01844856|26481250|P1|Overall Study|Enterococcus Resistant|0
7611072|NCT01844856|26481249|P2|Overall Study|Noncompliance|3
7611073|NCT01844856|26481250|P1|Overall Study|Noncompliance|2
7611074|NCT01844856|26481249|P2|Overall Study|Withdrawal by Subject|2
7611075|NCT01844856|26481250|P1|Overall Study|Withdrawal by Subject|3
7611076|NCT01844856|26481249|P2|Overall Study|Adverse Event|6
7611077|NCT01844856|26481250|P1|Overall Study|Adverse Event|3
7611078|NCT01844856|26481249|P2|Overall Study|Lost to Follow-up|3
7611079|NCT01844856|26481250|P1|Overall Study|Lost to Follow-up|15
7611080|NCT01844830|26481262|P2|Overall Study|Withdrawal by Subject|0
7611081|NCT01844830|26481263|P1|Overall Study|Withdrawal by Subject|1
7611082|NCT01844817|26481293|P2|Treatment|Other|3
7611083|NCT01844817|26481294|P1|Treatment|Other|0
7611084|NCT01844817|26481293|P2|Treatment|Lost to Follow-up|1
7611085|NCT01844817|26481294|P1|Treatment|Lost to Follow-up|0
7611086|NCT01844817|26481293|P2|Treatment|Death|8
7611087|NCT01844817|26481294|P1|Treatment|Death|10
7611088|NCT01844817|26481293|P2|Treatment|Withdrawal by Subject|6
7611089|NCT01844817|26481294|P1|Treatment|Withdrawal by Subject|10
7611090|NCT01844817|26481293|P2|Treatment|Adverse Event|9
7611091|NCT01844817|26481294|P1|Treatment|Adverse Event|17
7611092|NCT01844817|26481293|P2|Treatment|Progressive Disease|36
7611093|NCT01844817|26481294|P1|Treatment|Progressive Disease|27
7611094|NCT01844817|26481293|P2|Enrolled and Randomized|Withdrawal by Subject|3
7611095|NCT01844817|26481294|P1|Enrolled and Randomized|Withdrawal by Subject|2
7611096|NCT01844778|26481307|P3|Overall Study|Adverse Event|2
7611097|NCT01844778|26481308|P2|Overall Study|Adverse Event|2
7611098|NCT01844778|26481309|P1|Overall Study|Adverse Event|0
7611099|NCT01844778|26481307|P3|Overall Study|Withdrawal by Subject|0
7611100|NCT01844778|26481308|P2|Overall Study|Withdrawal by Subject|0
7611101|NCT01844778|26481309|P1|Overall Study|Withdrawal by Subject|2
7611102|NCT01844778|26481307|P3|Overall Study|Protocol deviation|2
7611103|NCT01844778|26481308|P2|Overall Study|Protocol deviation|1
7611104|NCT01844778|26481309|P1|Overall Study|Protocol deviation|0
7611105|NCT01844765|26481335|P2|Overall Study|Untreated|0
7611106|NCT01844765|26481336|P1|Overall Study|Untreated|1
7611107|NCT01844765|26481335|P2|Overall Study|Protocol deviation|0
7611108|NCT01844765|26481336|P1|Overall Study|Protocol deviation|2
7611109|NCT01844765|26481335|P2|Overall Study|Administrative problems|4
7611110|NCT01844765|26481336|P1|Overall Study|Administrative problems|3
7611111|NCT01844765|26481335|P2|Overall Study|Disease progression|0
7611112|NCT01844765|26481336|P1|Overall Study|Disease progression|1
7611113|NCT01844765|26481335|P2|Overall Study|Withdrawal by Subject|3
7611114|NCT01844765|26481336|P1|Overall Study|Withdrawal by Subject|2
7611115|NCT01844765|26481335|P2|Overall Study|Adverse Event|8
7611116|NCT01844765|26481336|P1|Overall Study|Adverse Event|6
7611117|NCT01844700|26481383|P2|Overall Study|stopped taking meds|1
7611118|NCT01844700|26481384|P1|Overall Study|stopped taking meds|0
7611119|NCT01844700|26481383|P2|Overall Study|Withdrawal by Subject|0
7611120|NCT01844700|26481384|P1|Overall Study|Withdrawal by Subject|1
7611121|NCT01844700|26481383|P2|Overall Study|refused medication switch|0
7611122|NCT01844700|26481384|P1|Overall Study|refused medication switch|1
7611123|NCT01844700|26481383|P2|Overall Study|Lack of Efficacy|0
7611124|NCT01844700|26481384|P1|Overall Study|Lack of Efficacy|1
7611125|NCT01844687|26481396|P1|Visit 4|Withdrawal by Subject|2
7611126|NCT01844687|26481396|P1|Visit 4|Lost to Follow-up|1
7611127|NCT01844687|26481396|P1|Visit 4|Pregnancy|1
7611128|NCT01844687|26481396|P1|Visit 3|child care problems|1
7611129|NCT01844687|26481396|P1|Visit 3|Withdrawal by Subject|3
7611130|NCT01844687|26481396|P1|Visit 3|Lost to Follow-up|1
7611131|NCT01844687|26481396|P1|Visit 2|Protocol Violation|1
7611132|NCT01844687|26481396|P1|Visit 2|Withdrawal by Subject|1
7611133|NCT01844687|26481396|P1|Visit 1|Lost to Follow-up|5
7611134|NCT01844687|26481396|P1|Visit 1|Protocol Violation|3
7611135|NCT01844583|26481457|P2|Overall Study|Didn't complete dosing;PK/ECG assessment|10
7611136|NCT01844583|26481458|P1|Overall Study|Didn't complete dosing;PK/ECG assessment|8
7611137|NCT01844531|26481490|P4|Overall Study|Withdrawal by Subject|0
7611138|NCT01844531|26481491|P3|Overall Study|Withdrawal by Subject|0
7611139|NCT01844531|26481492|P2|Overall Study|Withdrawal by Subject|1
7611140|NCT01844531|26481493|P1|Overall Study|Withdrawal by Subject|0
7611141|NCT01844518|26481523|P1|Long-Term Extension|Still in On-Going Study|149
7611142|NCT01844518|26481523|P1|Long-Term Extension|No Longer Met Study Criteria|1
7611143|NCT01844518|26481523|P1|Long-Term Extension|Adverse Event|1
7611144|NCT01844518|26481523|P1|Long-Term Extension|Lack of Efficacy|6
7611145|NCT01844518|26481523|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
7611146|NCT01844518|26481523|P1|Short-Term (ST) Period|Withdrawal of Consent|2
7611147|NCT01844518|26481523|P1|Short-Term (ST) Period|Lack of Efficacy|3
7611148|NCT01844518|26481523|P1|Short-Term (ST) Period|Adverse Event|3
7611149|NCT01844505|26481540|P3|Overall Study|Not Reported|1
7611150|NCT01844505|26481541|P2|Overall Study|Not Reported|0
7611151|NCT01844505|26481542|P1|Overall Study|Not Reported|0
7611152|NCT01844505|26481540|P3|Overall Study|Other Reasons|2
7611153|NCT01844505|26481541|P2|Overall Study|Other Reasons|2
7611154|NCT01844505|26481542|P1|Overall Study|Other Reasons|4
7611155|NCT01844505|26481540|P3|Overall Study|Subject no longer meets criteria|0
7611156|NCT01844505|26481541|P2|Overall Study|Subject no longer meets criteria|1
7611157|NCT01844505|26481542|P1|Overall Study|Subject no longer meets criteria|0
7611158|NCT01844505|26481540|P3|Overall Study|Poor/non-compliance|1
7611159|NCT01844505|26481541|P2|Overall Study|Poor/non-compliance|1
7611160|NCT01844505|26481542|P1|Overall Study|Poor/non-compliance|1
7611161|NCT01844505|26481540|P3|Overall Study|Maximum clinical benefit|2
7611162|NCT01844505|26481541|P2|Overall Study|Maximum clinical benefit|11
7611163|NCT01844505|26481542|P1|Overall Study|Maximum clinical benefit|8
7611164|NCT01844505|26481540|P3|Overall Study|Lost to Follow-up|0
7611165|NCT01844505|26481541|P2|Overall Study|Lost to Follow-up|0
7611166|NCT01844505|26481542|P1|Overall Study|Lost to Follow-up|1
7611167|NCT01844505|26481540|P3|Overall Study|Withdrawal by Subject|0
7611168|NCT01844505|26481541|P2|Overall Study|Withdrawal by Subject|3
7611169|NCT01844505|26481542|P1|Overall Study|Withdrawal by Subject|0
7611170|NCT01844505|26481540|P3|Overall Study|Subject request discontinue treatment|8
7611171|NCT01844505|26481541|P2|Overall Study|Subject request discontinue treatment|14
7611172|NCT01844505|26481542|P1|Overall Study|Subject request discontinue treatment|17
7611173|NCT01844505|26481540|P3|Overall Study|Adverse event unrelated to study drug|6
7611174|NCT01844505|26481541|P2|Overall Study|Adverse event unrelated to study drug|15
7611175|NCT01844505|26481542|P1|Overall Study|Adverse event unrelated to study drug|7
7611176|NCT01844505|26481540|P3|Overall Study|Death|1
7611177|NCT01844505|26481541|P2|Overall Study|Death|3
7611178|NCT01844505|26481542|P1|Overall Study|Death|1
7611179|NCT01844505|26481540|P3|Overall Study|Study drug toxicity|50
7611180|NCT01844505|26481541|P2|Overall Study|Study drug toxicity|131
7611181|NCT01844505|26481542|P1|Overall Study|Study drug toxicity|40
7611182|NCT01844505|26481540|P3|Overall Study|Disease progression|224
7611183|NCT01844505|26481541|P2|Overall Study|Disease progression|88
7611184|NCT01844505|26481542|P1|Overall Study|Disease progression|170
7611185|NCT01844375|26481636|P2|Overall Study|Protocol Violation|1
7611186|NCT01844375|26481637|P1|Overall Study|Protocol Violation|1
7611187|NCT01844284|26481649|P2|Overall Study|Lost to Follow-up|7
7611188|NCT01844284|26481650|P1|Overall Study|Lost to Follow-up|12
7611189|NCT01844115|26481880|P2|Overall Study|Pregnancy|1
7611190|NCT01844115|26481881|P1|Overall Study|Pregnancy|0
7611191|NCT01844115|26481880|P2|Overall Study|Lost to Follow-up|10
7611192|NCT01844115|26481881|P1|Overall Study|Lost to Follow-up|11
7611193|NCT01844115|26481880|P2|Overall Study|Withdrawal by Subject|11
7611194|NCT01844115|26481881|P1|Overall Study|Withdrawal by Subject|11
7611195|NCT01844115|26481880|P2|Overall Study|Protocol Violation|10
7611196|NCT01844115|26481881|P1|Overall Study|Protocol Violation|12
7611197|NCT01844115|26481880|P2|Overall Study|Lack of Efficacy|4
7611198|NCT01844115|26481881|P1|Overall Study|Lack of Efficacy|1
7611199|NCT01844115|26481880|P2|Overall Study|Adverse Event|22
7611200|NCT01844115|26481881|P1|Overall Study|Adverse Event|4
7611201|NCT01844076|26481893|P4|Overall Study|Withdrawal by Subject|0
7611202|NCT01844076|26481894|P3|Overall Study|Withdrawal by Subject|0
7611203|NCT01844076|26481895|P2|Overall Study|Withdrawal by Subject|0
7611204|NCT01844076|26481896|P1|Overall Study|Withdrawal by Subject|1
7611205|NCT01844076|26481893|P4|Overall Study|Adverse Event|0
7611206|NCT01844076|26481894|P3|Overall Study|Adverse Event|0
7611207|NCT01844076|26481895|P2|Overall Study|Adverse Event|0
7611208|NCT01844076|26481896|P1|Overall Study|Adverse Event|1
7611209|NCT01843972|26481923|P10|Overall Study|Withdrawal by Subject|0
7611210|NCT01843972|26481924|P9|Overall Study|Withdrawal by Subject|0
7611211|NCT01843972|26481925|P8|Overall Study|Withdrawal by Subject|0
7611212|NCT01843972|26481926|P7|Overall Study|Withdrawal by Subject|0
7611213|NCT01843972|26481927|P6|Overall Study|Withdrawal by Subject|0
7611214|NCT01843972|26481928|P5|Overall Study|Withdrawal by Subject|1
7611215|NCT01843972|26481929|P4|Overall Study|Withdrawal by Subject|0
7611216|NCT01843972|26481930|P3|Overall Study|Withdrawal by Subject|0
7611217|NCT01843972|26481931|P2|Overall Study|Withdrawal by Subject|0
7611218|NCT01843972|26481932|P1|Overall Study|Withdrawal by Subject|0
7611219|NCT01843933|26482002|P2|Overall Study|Data lost|4
7611220|NCT01843933|26482003|P1|Overall Study|Data lost|6
7611221|NCT01843842|26482022|P2|Overall Study|Do not meet inclusion criteria|1
7611222|NCT01843842|26482023|P1|Overall Study|Do not meet inclusion criteria|1
7611223|NCT01843803|26482045|P2|Overall Study|not a Veteran, did not see provider|3
7611224|NCT01843803|26482046|P1|Overall Study|not a Veteran, did not see provider|1
7611225|NCT01843777|26482060|P2|Overall Study|Withdrawal by Subject|0
7611226|NCT01843777|26482061|P1|Overall Study|Withdrawal by Subject|1
7611227|NCT01843673|26482086|P1|Overall Study|Withdrawal by Subject|4
7611228|NCT01843673|26482086|P1|Overall Study|Lack of Efficacy|2
7611229|NCT01843660|26482098|P1|Overall Study|Other|30
7611236|NCT01843348|26482167|P3|Overall Study|Various reasons|6
7611237|NCT01843348|26482168|P2|Overall Study|Various reasons|9
7611238|NCT01843348|26482169|P1|Overall Study|Various reasons|4
7611239|NCT01843348|26482167|P3|Overall Study|Graft loss/retransplantation|11
7611240|NCT01843348|26482168|P2|Overall Study|Graft loss/retransplantation|8
7611241|NCT01843348|26482169|P1|Overall Study|Graft loss/retransplantation|5
7611242|NCT01843348|26482167|P3|Overall Study|Death|4
7611243|NCT01843348|26482168|P2|Overall Study|Death|3
7611244|NCT01843348|26482169|P1|Overall Study|Death|5
7611245|NCT01843348|26482167|P3|Overall Study|Lost to Follow-up|2
7611246|NCT01843348|26482168|P2|Overall Study|Lost to Follow-up|4
7611247|NCT01843348|26482169|P1|Overall Study|Lost to Follow-up|5
7611248|NCT01843348|26482167|P3|Overall Study|Withdrawal by Subject|18
7611249|NCT01843348|26482168|P2|Overall Study|Withdrawal by Subject|16
7611250|NCT01843348|26482169|P1|Overall Study|Withdrawal by Subject|4
7611251|NCT01843205|26482209|P2|First Treatment (11 Days)|Withdrawal by Subject|0
7611252|NCT01843205|26482210|P1|First Treatment (11 Days)|Withdrawal by Subject|1
7611253|NCT01843192|26482271|P3|Overall Study|Intra-operative exclusions per protocol|2
7611254|NCT01843192|26482272|P2|Overall Study|Intra-operative exclusions per protocol|6
7611255|NCT01843192|26482273|P1|Overall Study|Intra-operative exclusions per protocol|2
7611256|NCT01843062|26482304|P2|Overall Study|Lost to Follow-up|4
7611257|NCT01843062|26482305|P1|Overall Study|Lost to Follow-up|2
7611258|NCT01843062|26482304|P2|Overall Study|Death|2
7611259|NCT01843062|26482305|P1|Overall Study|Death|1
7611260|NCT01843062|26482304|P2|Overall Study|Withdrawal by Subject|3
7611261|NCT01843062|26482305|P1|Overall Study|Withdrawal by Subject|12
7611262|NCT01843062|26482304|P2|Overall Study|Incorrect randomisation|0
7611263|NCT01843062|26482305|P1|Overall Study|Incorrect randomisation|1
7611264|NCT01843062|26482304|P2|Overall Study|Adverse Event|0
7611265|NCT01843062|26482305|P1|Overall Study|Adverse Event|2
7611266|NCT01843062|26482304|P2|Overall Study|Pregnancy|0
7611267|NCT01843062|26482305|P1|Overall Study|Pregnancy|1
7611268|NCT01843062|26482304|P2|Overall Study|New treatment following progression|0
7611269|NCT01843062|26482305|P1|Overall Study|New treatment following progression|2
7611270|NCT01843062|26482304|P2|Overall Study|Protocol Violation|0
7611271|NCT01843062|26482305|P1|Overall Study|Protocol Violation|1
7611272|NCT01842958|26482319|P2|Overall Study|Lost to Follow-up|1
7611273|NCT01842958|26482320|P1|Overall Study|Lost to Follow-up|1
7611274|NCT01842633|26482404|P3|Overall Study|Technical issues|0
7611275|NCT01842633|26482405|P2|Overall Study|Technical issues|0
7611276|NCT01842633|26482406|P1|Overall Study|Technical issues|1
7611277|NCT01842633|26482404|P3|Overall Study|Withdrawal by Subject|0
7611278|NCT01842633|26482405|P2|Overall Study|Withdrawal by Subject|1
7611279|NCT01842633|26482406|P1|Overall Study|Withdrawal by Subject|0
7611280|NCT01842633|26482404|P3|Overall Study|Adverse Event|0
7611281|NCT01842633|26482405|P2|Overall Study|Adverse Event|1
7611282|NCT01842633|26482406|P1|Overall Study|Adverse Event|1
7611283|NCT01842633|26482404|P3|Overall Study|Screen Failure|0
7611284|NCT01842633|26482405|P2|Overall Study|Screen Failure|0
7611285|NCT01842633|26482406|P1|Overall Study|Screen Failure|1
7611286|NCT01842620|26482453|P2|Period 1|Withdrawal by Subject|0
7611287|NCT01842620|26482454|P1|Period 1|Withdrawal by Subject|1
7611288|NCT01842607|26482470|P1|Overall Study|Withdrawal by Subject|14
7611289|NCT01842607|26482470|P1|Overall Study|Physician Decision|9
7611290|NCT01842607|26482470|P1|Overall Study|Lost to Follow-up|3
7611291|NCT01842607|26482470|P1|Overall Study|Protocol defined stopping criteria|2
7611292|NCT01842607|26482470|P1|Overall Study|Protocol Violation|8
7611293|NCT01842607|26482470|P1|Overall Study|Lack of Efficacy|19
7611294|NCT01842607|26482470|P1|Overall Study|Adverse Event|11
7611295|NCT01842581|26482496|P2|Overall Study|Other than specified|1
7611296|NCT01842581|26482497|P1|Overall Study|Other than specified|3
7611297|NCT01842581|26482496|P2|Overall Study|Withdrawal by Subject|7
7611298|NCT01842581|26482497|P1|Overall Study|Withdrawal by Subject|5
7611299|NCT01842581|26482496|P2|Overall Study|Lost to Follow-up|5
7611300|NCT01842581|26482497|P1|Overall Study|Lost to Follow-up|2
7611301|NCT01842581|26482496|P2|Overall Study|Liver transplant|0
7611302|NCT01842581|26482497|P1|Overall Study|Liver transplant|2
7611303|NCT01842581|26482496|P2|Overall Study|HE breakthrough|13
7611304|NCT01842581|26482497|P1|Overall Study|HE breakthrough|26
7611305|NCT01842581|26482496|P2|Overall Study|Adverse Event|4
7611306|NCT01842581|26482497|P1|Overall Study|Adverse Event|6
7611307|NCT01842438|26482521|P2|T2: 6month Follow-up|Death|1
7611308|NCT01842438|26482522|P1|T2: 6month Follow-up|Death|0
7611309|NCT01842438|26482521|P2|T2: 6month Follow-up|Withdrawal by Subject|3
7611310|NCT01842438|26482522|P1|T2: 6month Follow-up|Withdrawal by Subject|4
7611311|NCT01842438|26482521|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
7611312|NCT01842438|26482522|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
7611313|NCT01842334|26482536|P2|Overall Study|Moved away mid-study|1
7611314|NCT01842334|26482537|P1|Overall Study|Moved away mid-study|0
7611315|NCT01842334|26482536|P2|Overall Study|Withdrawal by Subject|3
7611316|NCT01842334|26482537|P1|Overall Study|Withdrawal by Subject|3
7611317|NCT01842308|26482548|P5|Overall Study|Withdrawal by Subject|1
7611318|NCT01842308|26482549|P4|Overall Study|Withdrawal by Subject|0
7611319|NCT01842308|26482550|P3|Overall Study|Withdrawal by Subject|0
7611320|NCT01842308|26482551|P2|Overall Study|Withdrawal by Subject|0
7611321|NCT01842308|26482552|P1|Overall Study|Withdrawal by Subject|0
7611322|NCT01841970|26482588|P1|Overall Study|Lost to Follow-up|8
7611323|NCT01841970|26482588|P1|Overall Study|Physician Decision|2
7611324|NCT01841970|26482588|P1|Overall Study|Withdrawal by Subject|1
7611325|NCT01841762|26482612|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
7611326|NCT01841762|26482612|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
7611327|NCT01841762|26482612|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
7611328|NCT01841762|26482612|P1|Post-Treatment Safety Follow-Up Period|Death|1
7611329|NCT01841762|26482612|P1|Treatment Period|Other, including non-compliance|5
7611330|NCT01841762|26482612|P1|Treatment Period|Physician Decision|2
7611331|NCT01841762|26482612|P1|Treatment Period|Lost to Follow-up|1
7611332|NCT01841762|26482612|P1|Treatment Period|Withdrawal by Subject|7
7611333|NCT01841762|26482612|P1|Treatment Period|Death|1
7611334|NCT01841762|26482612|P1|Treatment Period|Adverse Event|16
7611335|NCT01841762|26482612|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
7611336|NCT01841697|26482636|P2|Overall Study|Withdrawal by Subject|16
7611337|NCT01841697|26482637|P1|Overall Study|Withdrawal by Subject|16
7611338|NCT01841697|26482636|P2|Overall Study|Lost to Follow-up|1
7611339|NCT01841697|26482637|P1|Overall Study|Lost to Follow-up|4
7611340|NCT01841697|26482636|P2|Overall Study|Death|1
7611341|NCT01841697|26482637|P1|Overall Study|Death|0
7611342|NCT01841593|26482677|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
7611343|NCT01841593|26482678|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
7611344|NCT01841593|26482677|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
7611345|NCT01841593|26482678|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
7611346|NCT01841567|26482694|P1|Overall Study|Adverse Event|3
7611347|NCT01841554|26482699|P1|Overall Study|Study exit due to secondary intervention|6
7611348|NCT01841554|26482699|P1|Overall Study|Discontinued Follow Up|5
7611349|NCT01841554|26482699|P1|Overall Study|No Implantation|1
7611350|NCT01841554|26482699|P1|Overall Study|Death|7
7611351|NCT01841073|26482748|P2|Overall Study|Lost to Follow-up|2
7611352|NCT01841073|26482749|P1|Overall Study|Lost to Follow-up|0
7611353|NCT01841073|26482748|P2|Overall Study|Physician Decision|0
7611354|NCT01841073|26482749|P1|Overall Study|Physician Decision|1
7611355|NCT01841073|26482748|P2|Overall Study|Adverse Event|1
7611356|NCT01841073|26482749|P1|Overall Study|Adverse Event|1
7611357|NCT01841060|26482759|P1|Overall Study|Protocol Violation|10
7611358|NCT01840943|26482788|P2|Overall Study|Lost to Follow-up|4
7611359|NCT01840943|26482789|P1|Overall Study|Lost to Follow-up|4
7611360|NCT01840943|26482788|P2|Overall Study|Physician Decision|2
7611361|NCT01840943|26482789|P1|Overall Study|Physician Decision|4
7611362|NCT01840943|26482788|P2|Overall Study|Withdrawal by Subject|6
7611363|NCT01840943|26482789|P1|Overall Study|Withdrawal by Subject|5
7611364|NCT01840605|26482838|P2|Overall Study|Physician Decision|1
7611365|NCT01840605|26482839|P1|Overall Study|Physician Decision|2
7611366|NCT01840605|26482838|P2|Overall Study|Adverse Event|1
7611367|NCT01840605|26482839|P1|Overall Study|Adverse Event|0
7611368|NCT01840579|26482861|P10|Overall Study|Follow-up ended by Sponsor|0
7611369|NCT01840579|26482862|P9|Overall Study|Follow-up ended by Sponsor|0
7611370|NCT01840579|26482863|P8|Overall Study|Follow-up ended by Sponsor|0
7611371|NCT01840579|26482864|P7|Overall Study|Follow-up ended by Sponsor|2
7611372|NCT01840579|26482865|P6|Overall Study|Follow-up ended by Sponsor|0
7611373|NCT01840579|26482866|P5|Overall Study|Follow-up ended by Sponsor|0
7611374|NCT01840579|26482867|P4|Overall Study|Follow-up ended by Sponsor|0
7611375|NCT01840579|26482868|P3|Overall Study|Follow-up ended by Sponsor|0
7611376|NCT01840579|26482869|P2|Overall Study|Follow-up ended by Sponsor|0
7611377|NCT01840579|26482870|P1|Overall Study|Follow-up ended by Sponsor|0
7611378|NCT01840579|26482861|P10|Overall Study|Adverse Event|0
7611379|NCT01840579|26482862|P9|Overall Study|Adverse Event|0
7611380|NCT01840579|26482863|P8|Overall Study|Adverse Event|0
7611381|NCT01840579|26482864|P7|Overall Study|Adverse Event|0
7611382|NCT01840579|26482865|P6|Overall Study|Adverse Event|0
7611383|NCT01840579|26482866|P5|Overall Study|Adverse Event|0
7611384|NCT01840579|26482867|P4|Overall Study|Adverse Event|0
7611385|NCT01840579|26482868|P3|Overall Study|Adverse Event|0
7611386|NCT01840579|26482869|P2|Overall Study|Adverse Event|1
7611387|NCT01840579|26482870|P1|Overall Study|Adverse Event|0
7611388|NCT01840579|26482861|P10|Overall Study|Death|0
7611389|NCT01840579|26482862|P9|Overall Study|Death|0
7611390|NCT01840579|26482863|P8|Overall Study|Death|0
7611391|NCT01840579|26482864|P7|Overall Study|Death|0
7611392|NCT01840579|26482865|P6|Overall Study|Death|1
7611393|NCT01840579|26482866|P5|Overall Study|Death|0
7611394|NCT01840579|26482867|P4|Overall Study|Death|0
7611395|NCT01840579|26482868|P3|Overall Study|Death|0
7611396|NCT01840579|26482869|P2|Overall Study|Death|0
7611397|NCT01840579|26482870|P1|Overall Study|Death|0
7611398|NCT01840579|26482861|P10|Overall Study|Ongoing in study|0
7611399|NCT01840579|26482862|P9|Overall Study|Ongoing in study|0
7611400|NCT01840579|26482863|P8|Overall Study|Ongoing in study|0
7611401|NCT01840579|26482864|P7|Overall Study|Ongoing in study|0
7611402|NCT01840579|26482865|P6|Overall Study|Ongoing in study|0
7611403|NCT01840579|26482866|P5|Overall Study|Ongoing in study|0
7611404|NCT01840579|26482867|P4|Overall Study|Ongoing in study|0
7611405|NCT01840579|26482868|P3|Overall Study|Ongoing in study|0
7611406|NCT01840579|26482869|P2|Overall Study|Ongoing in study|1
7611407|NCT01840579|26482870|P1|Overall Study|Ongoing in study|0
7611408|NCT01840579|26482861|P10|Overall Study|Progressive disease|0
7611409|NCT01840579|26482862|P9|Overall Study|Progressive disease|0
7611410|NCT01840579|26482863|P8|Overall Study|Progressive disease|0
7611411|NCT01840579|26482864|P7|Overall Study|Progressive disease|0
7611412|NCT01840579|26482865|P6|Overall Study|Progressive disease|0
7611413|NCT01840579|26482866|P5|Overall Study|Progressive disease|0
7611414|NCT01840579|26482867|P4|Overall Study|Progressive disease|0
7611415|NCT01840579|26482868|P3|Overall Study|Progressive disease|0
7611416|NCT01840579|26482869|P2|Overall Study|Progressive disease|5
7611417|NCT01840579|26482870|P1|Overall Study|Progressive disease|3
7611418|NCT01840579|26482861|P10|Overall Study|Status not recorded|3
7611419|NCT01840579|26482862|P9|Overall Study|Status not recorded|3
7611420|NCT01840579|26482863|P8|Overall Study|Status not recorded|3
7611421|NCT01840579|26482864|P7|Overall Study|Status not recorded|0
7611422|NCT01840579|26482865|P6|Overall Study|Status not recorded|3
7611423|NCT01840579|26482866|P5|Overall Study|Status not recorded|4
7611424|NCT01840579|26482867|P4|Overall Study|Status not recorded|3
7611425|NCT01840579|26482868|P3|Overall Study|Status not recorded|2
7611426|NCT01840579|26482869|P2|Overall Study|Status not recorded|0
7611427|NCT01840579|26482870|P1|Overall Study|Status not recorded|0
7611428|NCT01840410|26483069|P2|Overall Study|Adverse Event|1
7611429|NCT01840410|26483070|P1|Overall Study|Adverse Event|1
7611430|NCT01840410|26483069|P2|Overall Study|Withdrawal by Subject|1
7611431|NCT01840410|26483070|P1|Overall Study|Withdrawal by Subject|2
7611432|NCT01840410|26483069|P2|Overall Study|Lost to Follow-up|0
7611433|NCT01840410|26483070|P1|Overall Study|Lost to Follow-up|1
7611434|NCT01840410|26483069|P2|Overall Study|Protocol deviation|0
7611435|NCT01840410|26483070|P1|Overall Study|Protocol deviation|1
7611436|NCT01840410|26483069|P2|Overall Study|Pregnancy|0
7611437|NCT01840410|26483070|P1|Overall Study|Pregnancy|1
7611438|NCT01840410|26483069|P2|Overall Study|Physician Decision|2
7611439|NCT01840410|26483070|P1|Overall Study|Physician Decision|1
7611440|NCT01840228|26483119|P2|Overall Study|Lost to Follow-up|1
7611441|NCT01840228|26483120|P1|Overall Study|Lost to Follow-up|1
7611442|NCT01840163|26483148|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
7611443|NCT01840163|26483149|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
7611444|NCT01840163|26483148|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
7611445|NCT01840163|26483149|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
7611446|NCT01840163|26483148|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
7611447|NCT01840163|26483149|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
7611448|NCT01839916|26483194|P1|Overall Study|Graft Failure|1
7611449|NCT01839916|26483194|P1|Overall Study|GVHD|2
7611450|NCT01839916|26483194|P1|Overall Study|Relapse|12
7611451|NCT01839916|26483194|P1|Overall Study|Physician Decision|17
7611452|NCT01839916|26483194|P1|Overall Study|Death|9
7611453|NCT01839656|26483254|P2|Overall Study|Adverse Event|0
7611454|NCT01839656|26483255|P1|Overall Study|Adverse Event|1
7611455|NCT01839656|26483254|P2|Overall Study|Early study closure|11
7611456|NCT01839656|26483255|P1|Overall Study|Early study closure|0
7611457|NCT01839656|26483254|P2|Overall Study|Adverse event, serious fatal|4
7611458|NCT01839656|26483255|P1|Overall Study|Adverse event, serious fatal|1
7611459|NCT01839656|26483254|P2|Overall Study|Withdrawal by Subject|1
7611460|NCT01839656|26483255|P1|Overall Study|Withdrawal by Subject|1
7611461|NCT01839487|26483315|P6|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7611462|NCT01839487|26483316|P5|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
7611463|NCT01839487|26483317|P4|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
7611464|NCT01839487|26483318|P3|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7611465|NCT01839487|26483319|P2|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7611466|NCT01839487|26483320|P1|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7611467|NCT01839487|26483315|P6|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
7611468|NCT01839487|26483316|P5|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
7611469|NCT01839487|26483317|P4|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
7611470|NCT01839487|26483318|P3|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7611471|NCT01839487|26483319|P2|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7611472|NCT01839487|26483320|P1|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7611473|NCT01839487|26483315|P6|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7611474|NCT01839487|26483316|P5|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
7611475|NCT01839487|26483317|P4|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7611476|NCT01839487|26483318|P3|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
7611477|NCT01839487|26483319|P2|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7611478|NCT01839487|26483320|P1|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7611479|NCT01839487|26483315|P6|Phase 2 (Maximum Exposure:935 Days)|Death|32
7611480|NCT01839487|26483316|P5|Phase 2 (Maximum Exposure:935 Days)|Death|71
7611481|NCT01839487|26483317|P4|Phase 2 (Maximum Exposure:935 Days)|Death|49
7611482|NCT01839487|26483318|P3|Phase 2 (Maximum Exposure:935 Days)|Death|46
7611483|NCT01839487|26483319|P2|Phase 2 (Maximum Exposure:935 Days)|Death|0
7611484|NCT01839487|26483320|P1|Phase 2 (Maximum Exposure:935 Days)|Death|0
7611485|NCT01839487|26483315|P6|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
7611486|NCT01839487|26483316|P5|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
7611487|NCT01839487|26483317|P4|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
7611488|NCT01839487|26483318|P3|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
7611489|NCT01839487|26483319|P2|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7611490|NCT01839487|26483320|P1|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7611491|NCT01839487|26483315|P6|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7611492|NCT01839487|26483316|P5|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7611493|NCT01839487|26483317|P4|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7611494|NCT01839487|26483318|P3|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7611495|NCT01839487|26483319|P2|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7611496|NCT01839487|26483320|P1|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
7611497|NCT01839487|26483315|P6|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7611498|NCT01839487|26483316|P5|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7611499|NCT01839487|26483317|P4|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7611500|NCT01839487|26483318|P3|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7611501|NCT01839487|26483319|P2|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
7611502|NCT01839487|26483320|P1|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7611503|NCT01839487|26483315|P6|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7611504|NCT01839487|26483316|P5|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7611505|NCT01839487|26483317|P4|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7611506|NCT01839487|26483318|P3|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7611507|NCT01839487|26483319|P2|Run-in Phase (Maximum Exposure:295 Days)|Death|6
7611508|NCT01839487|26483320|P1|Run-in Phase (Maximum Exposure:295 Days)|Death|14
7611509|NCT01839487|26483315|P6|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7611510|NCT01839487|26483316|P5|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7611511|NCT01839487|26483317|P4|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7611512|NCT01839487|26483318|P3|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7611513|NCT01839487|26483319|P2|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7611514|NCT01839487|26483320|P1|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
7611515|NCT01839279|26483371|P3|Overall Study|Classified as 'Other'|0
7611516|NCT01839279|26483372|P2|Overall Study|Classified as 'Other'|0
7611517|NCT01839279|26483373|P1|Overall Study|Classified as 'Other'|5
7611518|NCT01839279|26483371|P3|Overall Study|Withdrawal by Subject|1
7611519|NCT01839279|26483372|P2|Overall Study|Withdrawal by Subject|1
7611520|NCT01839279|26483373|P1|Overall Study|Withdrawal by Subject|4
7611521|NCT01839279|26483371|P3|Overall Study|Adverse Event|1
7611522|NCT01839279|26483372|P2|Overall Study|Adverse Event|1
7611523|NCT01839279|26483373|P1|Overall Study|Adverse Event|4
7611524|NCT01839188|26483392|P1|Overall Study|Withdrawal by Subject|1
7611525|NCT01838941|26483464|P1|Overall Study|Withdrawal by Subject|1
7611526|NCT01838941|26483464|P1|Overall Study|Adverse Event|1
7611527|NCT01838876|26483469|P1|Overall Study|Did not meet eligibility criteria|78
7611528|NCT01838876|26483469|P1|Overall Study|Reason not Specified|7
7611529|NCT01838876|26483469|P1|Overall Study|Study or Site Terminated by Sponsor|1
7611530|NCT01838876|26483469|P1|Overall Study|Lost to Follow-up|21
7611531|NCT01838876|26483469|P1|Overall Study|Withdrawal of Consent|33
7611532|NCT01838876|26483469|P1|Overall Study|Protocol Violation|34
7611533|NCT01838876|26483469|P1|Overall Study|Insufficient Therapeutic Response|10
7611534|NCT01838876|26483469|P1|Overall Study|Adverse Event|49
7611535|NCT01838694|26483578|P2|Overall Study|Adverse Event|1
7611536|NCT01838694|26483579|P1|Overall Study|Adverse Event|0
7611537|NCT01838681|26483588|P4|Period B/A+|Administrative or other reasons|28
7611538|NCT01838681|26483589|P3|Period B/A+|Administrative or other reasons|10
7611539|NCT01838681|26483590|P2|Period B/A+|Administrative or other reasons|6
7611540|NCT01838681|26483591|P1|Period B/A+|Administrative or other reasons|0
7611541|NCT01838681|26483588|P4|Period B/A+|Withdrawal before treatment|0
7611542|NCT01838681|26483589|P3|Period B/A+|Withdrawal before treatment|0
7611543|NCT01838681|26483590|P2|Period B/A+|Withdrawal before treatment|1
7611544|NCT01838681|26483591|P1|Period B/A+|Withdrawal before treatment|0
7611545|NCT01838681|26483588|P4|Period B/A+|Lost to Follow-up|11
7611546|NCT01838681|26483589|P3|Period B/A+|Lost to Follow-up|5
7611547|NCT01838681|26483590|P2|Period B/A+|Lost to Follow-up|2
7611548|NCT01838681|26483591|P1|Period B/A+|Lost to Follow-up|0
7611549|NCT01838681|26483588|P4|Period B/A+|Non-compliance with IMP|3
7611550|NCT01838681|26483589|P3|Period B/A+|Non-compliance with IMP|3
7611551|NCT01838681|26483590|P2|Period B/A+|Non-compliance with IMP|2
7611552|NCT01838681|26483591|P1|Period B/A+|Non-compliance with IMP|0
7611553|NCT01838681|26483588|P4|Period B/A+|Protocol Violation|6
7611554|NCT01838681|26483589|P3|Period B/A+|Protocol Violation|4
7611555|NCT01838681|26483590|P2|Period B/A+|Protocol Violation|1
7611556|NCT01838681|26483591|P1|Period B/A+|Protocol Violation|0
7611557|NCT01838681|26483588|P4|Period B/A+|Withdrawal by Subject|47
7611558|NCT01838681|26483589|P3|Period B/A+|Withdrawal by Subject|35
7611559|NCT01838681|26483590|P2|Period B/A+|Withdrawal by Subject|28
7611560|NCT01838681|26483591|P1|Period B/A+|Withdrawal by Subject|0
7611561|NCT01838681|26483588|P4|Period B/A+|Lack of Efficacy|6
7611562|NCT01838681|26483589|P3|Period B/A+|Lack of Efficacy|11
7611563|NCT01838681|26483590|P2|Period B/A+|Lack of Efficacy|9
7611564|NCT01838681|26483591|P1|Period B/A+|Lack of Efficacy|0
7611565|NCT01838681|26483588|P4|Period B/A+|Adverse Event|16
7611566|NCT01838681|26483589|P3|Period B/A+|Adverse Event|27
7611567|NCT01838681|26483590|P2|Period B/A+|Adverse Event|13
7611568|NCT01838681|26483591|P1|Period B/A+|Adverse Event|0
7611569|NCT01838681|26483588|P4|Period A|Administrative or other reasons|0
7611570|NCT01838681|26483589|P3|Period A|Administrative or other reasons|0
7611571|NCT01838681|26483590|P2|Period A|Administrative or other reasons|0
7611572|NCT01838681|26483591|P1|Period A|Administrative or other reasons|17
7611573|NCT01838681|26483588|P4|Period A|Withdrawal before treatment|0
7611574|NCT01838681|26483589|P3|Period A|Withdrawal before treatment|0
7611575|NCT01838681|26483590|P2|Period A|Withdrawal before treatment|0
7611576|NCT01838681|26483591|P1|Period A|Withdrawal before treatment|4
7611577|NCT01838681|26483588|P4|Period A|Lost to Follow-up|0
7611578|NCT01838681|26483589|P3|Period A|Lost to Follow-up|0
7611579|NCT01838681|26483590|P2|Period A|Lost to Follow-up|0
7611580|NCT01838681|26483591|P1|Period A|Lost to Follow-up|4
7611581|NCT01838681|26483588|P4|Period A|Non-compliance with IMP|0
7611582|NCT01838681|26483589|P3|Period A|Non-compliance with IMP|0
7611583|NCT01838681|26483590|P2|Period A|Non-compliance with IMP|0
7611584|NCT01838681|26483591|P1|Period A|Non-compliance with IMP|6
7611585|NCT01838681|26483588|P4|Period A|Protocol Violation|0
7611586|NCT01838681|26483589|P3|Period A|Protocol Violation|0
7611587|NCT01838681|26483590|P2|Period A|Protocol Violation|0
7611588|NCT01838681|26483591|P1|Period A|Protocol Violation|16
7611589|NCT01838681|26483588|P4|Period A|Withdrawal by Subject|0
7611590|NCT01838681|26483589|P3|Period A|Withdrawal by Subject|0
7611591|NCT01838681|26483590|P2|Period A|Withdrawal by Subject|0
7611592|NCT01838681|26483591|P1|Period A|Withdrawal by Subject|70
7611593|NCT01838681|26483588|P4|Period A|Early response|0
7611594|NCT01838681|26483589|P3|Period A|Early response|0
7611595|NCT01838681|26483590|P2|Period A|Early response|0
7611596|NCT01838681|26483591|P1|Period A|Early response|148
7611597|NCT01838681|26483588|P4|Period A|Lack of Efficacy|0
7611598|NCT01838681|26483589|P3|Period A|Lack of Efficacy|0
7611599|NCT01838681|26483590|P2|Period A|Lack of Efficacy|0
7611600|NCT01838681|26483591|P1|Period A|Lack of Efficacy|21
7611601|NCT01838681|26483588|P4|Period A|Adverse Event|0
7611602|NCT01838681|26483589|P3|Period A|Adverse Event|0
7611603|NCT01838681|26483590|P2|Period A|Adverse Event|0
7611604|NCT01838681|26483591|P1|Period A|Adverse Event|39
7611605|NCT01838642|26483699|P1|Overall Study|Died on study|1
7611606|NCT01838616|26483712|P2|Pick-up Arm|Technical problems|0
7611607|NCT01838616|26483713|P1|Pick-up Arm|Technical problems|1
7611608|NCT01838616|26483712|P2|Pick-up Arm|Withdrawal by Subject|0
7611609|NCT01838616|26483713|P1|Pick-up Arm|Withdrawal by Subject|1
7611610|NCT01838616|26483712|P2|Pick-up Arm|Adverse Event|0
7611611|NCT01838616|26483713|P1|Pick-up Arm|Adverse Event|9
7611612|NCT01838616|26483712|P2|Pick-up Arm|Lack of Efficacy|0
7611613|NCT01838616|26483713|P1|Pick-up Arm|Lack of Efficacy|4
7611614|NCT01838616|26483712|P2|Continuation Period|Technical problems|1
7611615|NCT01838616|26483713|P1|Continuation Period|Technical problems|0
7611616|NCT01838616|26483712|P2|Continuation Period|Withdrawal by Subject|4
7611617|NCT01838616|26483713|P1|Continuation Period|Withdrawal by Subject|0
7611618|NCT01838616|26483712|P2|Continuation Period|Lost to Follow-up|0
7611619|NCT01838616|26483713|P1|Continuation Period|Lost to Follow-up|1
7611620|NCT01838616|26483712|P2|Continuation Period|Protocol Violation|0
7611621|NCT01838616|26483713|P1|Continuation Period|Protocol Violation|2
7611622|NCT01838616|26483712|P2|Continuation Period|Adverse Event|4
7611623|NCT01838616|26483713|P1|Continuation Period|Adverse Event|8
7611624|NCT01838616|26483712|P2|Continuation Period|Lack of Efficacy|5
7611625|NCT01838616|26483713|P1|Continuation Period|Lack of Efficacy|3
7611626|NCT01838616|26483712|P2|Titration Period|Protocol Violation|1
7611627|NCT01838616|26483713|P1|Titration Period|Protocol Violation|0
7611628|NCT01838616|26483712|P2|Titration Period|Other|0
7611629|NCT01838616|26483713|P1|Titration Period|Other|1
7611630|NCT01838616|26483712|P2|Titration Period|Technical problems|0
7611631|NCT01838616|26483713|P1|Titration Period|Technical problems|1
7611632|NCT01838616|26483712|P2|Titration Period|Withdrawal by Subject|5
7611633|NCT01838616|26483713|P1|Titration Period|Withdrawal by Subject|5
7611634|NCT01838616|26483712|P2|Titration Period|Lack of Efficacy|12
7611635|NCT01838616|26483713|P1|Titration Period|Lack of Efficacy|5
7611636|NCT01838616|26483712|P2|Titration Period|Adverse Event|48
7611637|NCT01838616|26483713|P1|Titration Period|Adverse Event|18
7611638|NCT01838590|26483784|P2|Overall Study|Lost to Follow-up|1
7611639|NCT01838590|26483785|P1|Overall Study|Lost to Follow-up|0
7611640|NCT01838590|26483784|P2|Overall Study|Lack of Efficacy|4
7611641|NCT01838590|26483785|P1|Overall Study|Lack of Efficacy|12
7611642|NCT01838551|26483807|P1|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
7611643|NCT01838551|26483807|P1|Overall Study|Withdrawal by Subject|10
7611644|NCT01838551|26483807|P1|Overall Study|Physician Decision|4
7611645|NCT01838551|26483807|P1|Overall Study|Lack of Efficacy|10
7611646|NCT01838551|26483807|P1|Overall Study|Death|1
7611647|NCT01838551|26483807|P1|Overall Study|Adverse Event|16
7611648|NCT01838499|26483813|P2|Overall Study|Withdrawal by Subject|9
7611649|NCT01838499|26483814|P1|Overall Study|Withdrawal by Subject|19
7611650|NCT01838499|26483813|P2|Overall Study|Adverse Event|1
7611651|NCT01838499|26483814|P1|Overall Study|Adverse Event|2
7611652|NCT01838499|26483813|P2|Overall Study|Lack of Efficacy|2
7611653|NCT01838499|26483814|P1|Overall Study|Lack of Efficacy|1
7611654|NCT01838499|26483813|P2|Overall Study|Lost to Follow-up|4
7611655|NCT01838499|26483814|P1|Overall Study|Lost to Follow-up|2
7611656|NCT01838499|26483813|P2|Overall Study|Protocol Violation|1
7611657|NCT01838499|26483814|P1|Overall Study|Protocol Violation|0
7611658|NCT01838447|26483826|P2|Overall Study|Withdrawal by Subject|1
7611659|NCT01838447|26483827|P1|Overall Study|Withdrawal by Subject|1
7611660|NCT01838447|26483826|P2|Overall Study|Change in surgical plan|2
7611661|NCT01838447|26483827|P1|Overall Study|Change in surgical plan|1
7611662|NCT01838213|26483902|P2|Overall Study|Ineligible|191
7611663|NCT01838213|26483903|P1|Overall Study|Ineligible|166
7611664|NCT01838200|26483911|P2|Overall Study|Progressive disease|0
7611665|NCT01838200|26483912|P1|Overall Study|Progressive disease|3
7611666|NCT01838200|26483911|P2|Overall Study|Adverse Event|2
7611667|NCT01838200|26483912|P1|Overall Study|Adverse Event|0
7611668|NCT01838044|26483924|P2|Overall Study|Lost to Follow-up|2
7611669|NCT01838044|26483925|P1|Overall Study|Lost to Follow-up|0
7611670|NCT01838044|26483924|P2|Overall Study|Medication error without associated AE|1
7611671|NCT01838044|26483925|P1|Overall Study|Medication error without associated AE|0
7611672|NCT01838044|26483924|P2|Overall Study|Insufficient clinical response|2
7611673|NCT01838044|26483925|P1|Overall Study|Insufficient clinical response|1
7611674|NCT01838044|26483924|P2|Overall Study|Withdrawal by Subject|2
7611675|NCT01838044|26483925|P1|Overall Study|Withdrawal by Subject|0
7611676|NCT01838044|26483924|P2|Overall Study|Protocol Violation|3
7611677|NCT01838044|26483925|P1|Overall Study|Protocol Violation|3
7611678|NCT01838044|26483924|P2|Overall Study|Adverse Event|6
7611679|NCT01838044|26483925|P1|Overall Study|Adverse Event|4
7611680|NCT01837966|26483958|P2|Overall Study|Withdrawal by Subject|1
7611681|NCT01837966|26483959|P1|Overall Study|Withdrawal by Subject|2
7611682|NCT01837823|26483981|P1|Overall Study|Lost to Follow-up|6
7611683|NCT01837797|26484012|P5|Period 3|Other|2
7611684|NCT01837797|26484013|P4|Period 3|Other|0
7611685|NCT01837797|26484014|P3|Period 3|Other|0
7611686|NCT01837797|26484015|P2|Period 3|Other|0
7611687|NCT01837797|26484016|P1|Period 3|Other|0
7611688|NCT01837797|26484012|P5|Period 3|Administrative reasons|20
7611689|NCT01837797|26484013|P4|Period 3|Administrative reasons|0
7611690|NCT01837797|26484014|P3|Period 3|Administrative reasons|0
7611691|NCT01837797|26484015|P2|Period 3|Administrative reasons|0
7611692|NCT01837797|26484016|P1|Period 3|Administrative reasons|0
7611693|NCT01837797|26484012|P5|Period 3|Adverse Event|1
7611694|NCT01837797|26484013|P4|Period 3|Adverse Event|0
7611695|NCT01837797|26484014|P3|Period 3|Adverse Event|0
7611696|NCT01837797|26484015|P2|Period 3|Adverse Event|0
7611697|NCT01837797|26484016|P1|Period 3|Adverse Event|0
7611698|NCT01837797|26484012|P5|Period 2|Adverse Event|0
7611699|NCT01837797|26484013|P4|Period 2|Adverse Event|1
7611700|NCT01837797|26484014|P3|Period 2|Adverse Event|0
7611701|NCT01837797|26484015|P2|Period 2|Adverse Event|0
7611702|NCT01837797|26484016|P1|Period 2|Adverse Event|0
7611703|NCT01837797|26484012|P5|Period 2|Administrative or other reasons|0
7611704|NCT01837797|26484013|P4|Period 2|Administrative or other reasons|4
7611705|NCT01837797|26484014|P3|Period 2|Administrative or other reasons|2
7611706|NCT01837797|26484015|P2|Period 2|Administrative or other reasons|5
7611707|NCT01837797|26484016|P1|Period 2|Administrative or other reasons|0
7611708|NCT01837797|26484012|P5|Period 1|Other|0
7611709|NCT01837797|26484013|P4|Period 1|Other|0
7611710|NCT01837797|26484014|P3|Period 1|Other|0
7611711|NCT01837797|26484015|P2|Period 1|Other|0
7611712|NCT01837797|26484016|P1|Period 1|Other|10
7611713|NCT01837797|26484012|P5|Period 1|Withdrawal of consent before treatment|0
7611714|NCT01837797|26484013|P4|Period 1|Withdrawal of consent before treatment|0
7611715|NCT01837797|26484014|P3|Period 1|Withdrawal of consent before treatment|0
7611716|NCT01837797|26484015|P2|Period 1|Withdrawal of consent before treatment|0
7611717|NCT01837797|26484016|P1|Period 1|Withdrawal of consent before treatment|1
7611718|NCT01837797|26484012|P5|Period 1|Administrative reasons|0
7611719|NCT01837797|26484013|P4|Period 1|Administrative reasons|0
7611720|NCT01837797|26484014|P3|Period 1|Administrative reasons|0
7611721|NCT01837797|26484015|P2|Period 1|Administrative reasons|0
7611722|NCT01837797|26484016|P1|Period 1|Administrative reasons|76
7611723|NCT01837797|26484012|P5|Period 1|Withdrawal by Subject|0
7611724|NCT01837797|26484013|P4|Period 1|Withdrawal by Subject|0
7611725|NCT01837797|26484014|P3|Period 1|Withdrawal by Subject|0
7611726|NCT01837797|26484015|P2|Period 1|Withdrawal by Subject|0
7611727|NCT01837797|26484016|P1|Period 1|Withdrawal by Subject|6
7611728|NCT01837797|26484012|P5|Period 1|Adverse Event|0
7611729|NCT01837797|26484013|P4|Period 1|Adverse Event|0
7611730|NCT01837797|26484014|P3|Period 1|Adverse Event|0
7611731|NCT01837797|26484015|P2|Period 1|Adverse Event|0
7611732|NCT01837797|26484016|P1|Period 1|Adverse Event|9
7611733|NCT01837719|26484051|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
7611734|NCT01837719|26484051|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
7611735|NCT01837680|26484120|P2|Overall Study|switched to oral hypoglycemic or diet|4
7611736|NCT01837680|26484121|P1|Overall Study|switched to oral hypoglycemic or diet|2
7611737|NCT01837680|26484120|P2|Overall Study|allergic reaction|0
7611738|NCT01837680|26484121|P1|Overall Study|allergic reaction|6
7611739|NCT01837680|26484120|P2|Overall Study|lack of insurance|2
7611740|NCT01837680|26484121|P1|Overall Study|lack of insurance|0
7611741|NCT01837680|26484120|P2|Overall Study|Lost to Follow-up|2
7611742|NCT01837680|26484121|P1|Overall Study|Lost to Follow-up|2
7611743|NCT01836549|26484255|P7|Overall Study|Patient inevaluable to start therapy|1
7611744|NCT01836549|26484256|P6|Overall Study|Patient inevaluable to start therapy|0
7611745|NCT01836549|26484257|P5|Overall Study|Patient inevaluable to start therapy|0
7611746|NCT01836549|26484258|P4|Overall Study|Patient inevaluable to start therapy|0
7611747|NCT01836549|26484259|P3|Overall Study|Patient inevaluable to start therapy|0
7611748|NCT01836549|26484260|P2|Overall Study|Patient inevaluable to start therapy|0
7611749|NCT01836549|26484261|P1|Overall Study|Patient inevaluable to start therapy|0
7611750|NCT01836549|26484255|P7|Overall Study|Patient declared ineligible|0
7611751|NCT01836549|26484256|P6|Overall Study|Patient declared ineligible|0
7611752|NCT01836549|26484257|P5|Overall Study|Patient declared ineligible|0
7611753|NCT01836549|26484258|P4|Overall Study|Patient declared ineligible|1
7611754|NCT01836549|26484259|P3|Overall Study|Patient declared ineligible|0
7611755|NCT01836549|26484260|P2|Overall Study|Patient declared ineligible|0
7611756|NCT01836549|26484261|P1|Overall Study|Patient declared ineligible|0
7611757|NCT01836549|26484255|P7|Overall Study|Did not receive study drug|0
7611758|NCT01836549|26484256|P6|Overall Study|Did not receive study drug|0
7611759|NCT01836549|26484257|P5|Overall Study|Did not receive study drug|0
7611760|NCT01836549|26484258|P4|Overall Study|Did not receive study drug|0
7611761|NCT01836549|26484259|P3|Overall Study|Did not receive study drug|1
7611762|NCT01836549|26484260|P2|Overall Study|Did not receive study drug|0
7611763|NCT01836549|26484261|P1|Overall Study|Did not receive study drug|0
7611764|NCT01836523|26484285|P4|Overall Study|Unclassified|29
7611765|NCT01836523|26484286|P3|Overall Study|Unclassified|19
7611766|NCT01836523|26484287|P2|Overall Study|Unclassified|28
7611767|NCT01836523|26484288|P1|Overall Study|Unclassified|17
7611768|NCT01836523|26484285|P4|Overall Study|Met Withdrawal Criteria|27
7611769|NCT01836523|26484286|P3|Overall Study|Met Withdrawal Criteria|21
7611770|NCT01836523|26484287|P2|Overall Study|Met Withdrawal Criteria|13
7611771|NCT01836523|26484288|P1|Overall Study|Met Withdrawal Criteria|13
7611772|NCT01836523|26484285|P4|Overall Study|Protocol Violation|4
7611773|NCT01836523|26484286|P3|Overall Study|Protocol Violation|2
7611774|NCT01836523|26484287|P2|Overall Study|Protocol Violation|3
7611775|NCT01836523|26484288|P1|Overall Study|Protocol Violation|6
7611776|NCT01836523|26484285|P4|Overall Study|Adverse Event|14
7611777|NCT01836523|26484286|P3|Overall Study|Adverse Event|49
7611778|NCT01836523|26484287|P2|Overall Study|Adverse Event|41
7611779|NCT01836523|26484288|P1|Overall Study|Adverse Event|15
7611780|NCT01836471|26484315|P5|Overall Study|Non compliance with tx|0
7611781|NCT01836471|26484316|P4|Overall Study|Non compliance with tx|0
7611782|NCT01836471|26484317|P3|Overall Study|Non compliance with tx|0
7611783|NCT01836471|26484318|P2|Overall Study|Non compliance with tx|1
7611784|NCT01836471|26484319|P1|Overall Study|Non compliance with tx|1
7611785|NCT01836471|26484315|P5|Overall Study|Adverse Event|2
7611786|NCT01836471|26484316|P4|Overall Study|Adverse Event|1
7611787|NCT01836471|26484317|P3|Overall Study|Adverse Event|1
7611788|NCT01836471|26484318|P2|Overall Study|Adverse Event|3
7611789|NCT01836471|26484319|P1|Overall Study|Adverse Event|6
7611790|NCT01836471|26484315|P5|Overall Study|Lost to Follow-up|1
7611791|NCT01836471|26484316|P4|Overall Study|Lost to Follow-up|1
7611792|NCT01836471|26484317|P3|Overall Study|Lost to Follow-up|0
7611793|NCT01836471|26484318|P2|Overall Study|Lost to Follow-up|0
7611794|NCT01836471|26484319|P1|Overall Study|Lost to Follow-up|0
7611795|NCT01836471|26484315|P5|Overall Study|Physician Decision|0
7611796|NCT01836471|26484316|P4|Overall Study|Physician Decision|0
7611797|NCT01836471|26484317|P3|Overall Study|Physician Decision|0
7611798|NCT01836471|26484318|P2|Overall Study|Physician Decision|1
7611799|NCT01836471|26484319|P1|Overall Study|Physician Decision|0
7611800|NCT01836471|26484315|P5|Overall Study|Withdrawal by Subject|2
7611801|NCT01836471|26484316|P4|Overall Study|Withdrawal by Subject|0
7611802|NCT01836471|26484317|P3|Overall Study|Withdrawal by Subject|1
7611803|NCT01836471|26484318|P2|Overall Study|Withdrawal by Subject|4
7611804|NCT01836471|26484319|P1|Overall Study|Withdrawal by Subject|3
7611805|NCT01836471|26484315|P5|Overall Study|Pregnancy|0
7611806|NCT01836471|26484316|P4|Overall Study|Pregnancy|0
7611807|NCT01836471|26484317|P3|Overall Study|Pregnancy|0
7611808|NCT01836471|26484318|P2|Overall Study|Pregnancy|0
7611809|NCT01836471|26484319|P1|Overall Study|Pregnancy|1
7611810|NCT01836458|26484348|P4|Overall Study|Unsatisfactory therapeutic effect|6
7611811|NCT01836458|26484349|P3|Overall Study|Unsatisfactory therapeutic effect|5
7611812|NCT01836458|26484350|P2|Overall Study|Unsatisfactory therapeutic effect|2
7611813|NCT01836458|26484351|P1|Overall Study|Unsatisfactory therapeutic effect|3
7611814|NCT01836276|26484436|P2|Overall Study|Lost to Follow-up|51
7611815|NCT01836276|26484437|P1|Overall Study|Lost to Follow-up|28
7611816|NCT01836198|26484445|P3|Part A, Period 2|Protocol Violation|0
7611817|NCT01836198|26484446|P2|Part A, Period 2|Protocol Violation|1
7611818|NCT01836198|26484447|P1|Part A, Period 2|Protocol Violation|0
7611819|NCT01835899|26484549|P3|Overall Study|Other than stated above|0
7611820|NCT01835899|26484550|P2|Overall Study|Other than stated above|1
7611821|NCT01835899|26484551|P1|Overall Study|Other than stated above|0
7611822|NCT01835899|26484549|P3|Overall Study|Adverse Event|1
7611823|NCT01835899|26484550|P2|Overall Study|Adverse Event|0
7611824|NCT01835899|26484551|P1|Overall Study|Adverse Event|0
7611825|NCT01835587|26484608|P4|Overall Study|Miscellaneous|0
7611826|NCT01835587|26484609|P3|Overall Study|Miscellaneous|0
7611827|NCT01835587|26484610|P2|Overall Study|Miscellaneous|1
7611828|NCT01835587|26484611|P1|Overall Study|Miscellaneous|0
7611829|NCT01835587|26484608|P4|Overall Study|Death|1
7611830|NCT01835587|26484609|P3|Overall Study|Death|0
7611831|NCT01835587|26484610|P2|Overall Study|Death|0
7611832|NCT01835587|26484611|P1|Overall Study|Death|0
7611833|NCT01835587|26484608|P4|Overall Study|Adverse Event|2
7611834|NCT01835587|26484609|P3|Overall Study|Adverse Event|2
7611835|NCT01835587|26484610|P2|Overall Study|Adverse Event|0
7611836|NCT01835587|26484611|P1|Overall Study|Adverse Event|0
7611837|NCT01835587|26484608|P4|Overall Study|Withdrawal by Subject|3
7611838|NCT01835587|26484609|P3|Overall Study|Withdrawal by Subject|0
7611839|NCT01835587|26484610|P2|Overall Study|Withdrawal by Subject|0
7611840|NCT01835587|26484611|P1|Overall Study|Withdrawal by Subject|2
7611841|NCT01835587|26484608|P4|Overall Study|Disease Recurrence or Relapse|3
7611842|NCT01835587|26484609|P3|Overall Study|Disease Recurrence or Relapse|0
7611843|NCT01835587|26484610|P2|Overall Study|Disease Recurrence or Relapse|3
7611844|NCT01835587|26484611|P1|Overall Study|Disease Recurrence or Relapse|0
7611845|NCT01835548|26484672|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
7611846|NCT01835548|26484673|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
7611847|NCT01835548|26484674|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7611848|NCT01835548|26484672|P3|Double-Blind Treatment Period|Adverse Event|0
7611849|NCT01835548|26484673|P2|Double-Blind Treatment Period|Adverse Event|1
7611850|NCT01835548|26484674|P1|Double-Blind Treatment Period|Adverse Event|0
7611851|NCT01835548|26484672|P3|Dose Optimization Period|Withdrawal by Subject|1
7611852|NCT01835548|26484673|P2|Dose Optimization Period|Withdrawal by Subject|0
7611853|NCT01835548|26484674|P1|Dose Optimization Period|Withdrawal by Subject|0
7611854|NCT01835548|26484672|P3|Dose Optimization Period|Adverse Event|1
7611855|NCT01835548|26484673|P2|Dose Optimization Period|Adverse Event|0
7611856|NCT01835548|26484674|P1|Dose Optimization Period|Adverse Event|0
7611857|NCT01835470|26484703|P1|Long Term Treatment Period|Lack of Efficacy|3
7611858|NCT01835470|26484703|P1|Long Term Treatment Period|Subject Request to Discontinue|1
7611859|NCT01835431|26484715|P2|Overall Study|Protocol Violation|0
7611860|NCT01835431|26484716|P1|Overall Study|Protocol Violation|1
7611861|NCT01835431|26484715|P2|Overall Study|Withdrawal by Subject|10
7611862|NCT01835431|26484716|P1|Overall Study|Withdrawal by Subject|6
7611863|NCT01835431|26484715|P2|Overall Study|other|2
7611864|NCT01835431|26484716|P1|Overall Study|other|0
7611865|NCT01835431|26484715|P2|Overall Study|Adverse Event|0
7611866|NCT01835431|26484716|P1|Overall Study|Adverse Event|1
7611867|NCT01835223|26484756|P2|Overall Study|Became Inelligible|0
7611868|NCT01835223|26484757|P1|Overall Study|Became Inelligible|4
7611869|NCT01835223|26484756|P2|Overall Study|Disease progression|1
7611870|NCT01835223|26484757|P1|Overall Study|Disease progression|2
7611871|NCT01835223|26484756|P2|Overall Study|Withdrawal by Subject|0
7611872|NCT01835223|26484757|P1|Overall Study|Withdrawal by Subject|2
7611873|NCT01835223|26484756|P2|Overall Study|Adverse Event|0
7611874|NCT01835223|26484757|P1|Overall Study|Adverse Event|1
7611875|NCT01835158|26484777|P2|Overall Study|Withdrawal by Subject|6
7611876|NCT01835158|26484778|P1|Overall Study|Withdrawal by Subject|1
7611877|NCT01835145|26484790|P2|Overall Study|Ineligible prior to treatment|0
7611878|NCT01835145|26484791|P1|Overall Study|Ineligible prior to treatment|1
7611879|NCT01835132|26484806|P1|Initial Phase|Insufficient Therapeutic Response|2
7611880|NCT01835015|26484851|P5|Overall Study|Adverse Event|0
7611881|NCT01835015|26484852|P4|Overall Study|Adverse Event|0
7611882|NCT01835015|26484853|P3|Overall Study|Adverse Event|1
7611883|NCT01835015|26484854|P2|Overall Study|Adverse Event|0
7611884|NCT01835015|26484855|P1|Overall Study|Adverse Event|0
7611885|NCT01834729|26484932|P4|Overall Study|Adverse Event|2
7611886|NCT01834729|26484933|P3|Overall Study|Adverse Event|0
7611887|NCT01834729|26484934|P2|Overall Study|Adverse Event|0
7611888|NCT01834729|26484935|P1|Overall Study|Adverse Event|0
7611889|NCT01834729|26484932|P4|Overall Study|Withdrawal by Subject|0
7611890|NCT01834729|26484933|P3|Overall Study|Withdrawal by Subject|0
7611891|NCT01834729|26484934|P2|Overall Study|Withdrawal by Subject|1
7611892|NCT01834729|26484935|P1|Overall Study|Withdrawal by Subject|1
7611893|NCT01834729|26484932|P4|Overall Study|Did not return bowel diaries|0
7611894|NCT01834729|26484933|P3|Overall Study|Did not return bowel diaries|3
7611895|NCT01834729|26484934|P2|Overall Study|Did not return bowel diaries|0
7611896|NCT01834729|26484935|P1|Overall Study|Did not return bowel diaries|0
7611897|NCT01834586|26484968|P1|Overall Study|Adverse Event|1
7611898|NCT01834274|26485023|P2|Overall Study|Other|1
7611899|NCT01834274|26485024|P1|Overall Study|Other|2
7611900|NCT01834274|26485023|P2|Overall Study|Lost to Follow-up|1
7611901|NCT01834274|26485024|P1|Overall Study|Lost to Follow-up|3
7611902|NCT01834274|26485023|P2|Overall Study|Withdrawal by Subject|1
7611903|NCT01834274|26485024|P1|Overall Study|Withdrawal by Subject|1
7611904|NCT01834274|26485023|P2|Overall Study|Study Termination|38
7611905|NCT01834274|26485024|P1|Overall Study|Study Termination|41
7611906|NCT01834222|26485047|P1|Overall Study|Not meet inclusion/exclusion criteria|1
7611907|NCT01833897|26485142|P1|Overall Study|Lack of Efficacy|1
7611908|NCT01833832|26485154|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
7611909|NCT01833533|26485309|P2|Overall Study|Other|7
7611910|NCT01833533|26485310|P1|Overall Study|Other|2
7611911|NCT01833533|26485309|P2|Overall Study|To Enter an Extension Study|4
7611912|NCT01833533|26485310|P1|Overall Study|To Enter an Extension Study|0
7611913|NCT01833533|26485309|P2|Overall Study|Lost to Follow-up|9
7611914|NCT01833533|26485310|P1|Overall Study|Lost to Follow-up|4
7611915|NCT01833533|26485309|P2|Overall Study|Adverse Event|1
7611916|NCT01833533|26485310|P1|Overall Study|Adverse Event|0
7611917|NCT01833520|26485326|P4|Overall Study|Lack of Efficacy|3
7611918|NCT01833520|26485327|P3|Overall Study|Lack of Efficacy|8
7611919|NCT01833520|26485328|P2|Overall Study|Lack of Efficacy|3
7611920|NCT01833520|26485329|P1|Overall Study|Lack of Efficacy|3
7611921|NCT01833494|26485341|P1|Overall Study|Increase in serum ferritin|1
7611922|NCT01833494|26485341|P1|Overall Study|Decrease in serum calcium|4
7611923|NCT01833494|26485341|P1|Overall Study|Decrease in serum phosphorus|4
7611924|NCT01833494|26485341|P1|Overall Study|Withdrawal by Subject|6
7611925|NCT01833494|26485341|P1|Overall Study|Physician Decision|6
7611926|NCT01833494|26485341|P1|Overall Study|Adverse Event|24
7611927|NCT01833455|26485369|P2|Overall Study|Withdrawal by Subject|0
7611928|NCT01833455|26485370|P1|Overall Study|Withdrawal by Subject|1
7611929|NCT01833169|26485399|P1|Overall Study|Physician Decision|2
7611930|NCT01833169|26485399|P1|Overall Study|Death|3
7611931|NCT01833169|26485399|P1|Overall Study|Withdrawal by Subject|9
7611932|NCT01833169|26485399|P1|Overall Study|Adverse Event|33
7611933|NCT01833169|26485399|P1|Overall Study|Disease Progression|99
7611934|NCT01833143|26485410|P1|Overall Study|Not Treated|1
7611935|NCT01833065|26485475|P5|Overall Study|Others|4
7611936|NCT01833065|26485476|P4|Overall Study|Others|1
7611937|NCT01833065|26485477|P3|Overall Study|Others|1
7611938|NCT01833065|26485478|P2|Overall Study|Others|1
7611939|NCT01833065|26485479|P1|Overall Study|Others|2
7611940|NCT01833065|26485475|P5|Overall Study|Trial terminated by sponsor|13
7611941|NCT01833065|26485476|P4|Overall Study|Trial terminated by sponsor|3
7611942|NCT01833065|26485477|P3|Overall Study|Trial terminated by sponsor|7
7611943|NCT01833065|26485478|P2|Overall Study|Trial terminated by sponsor|8
7611944|NCT01833065|26485479|P1|Overall Study|Trial terminated by sponsor|8
7611945|NCT01833065|26485475|P5|Overall Study|Subject's substantial non-compliance|0
7611946|NCT01833065|26485476|P4|Overall Study|Subject's substantial non-compliance|0
7611947|NCT01833065|26485477|P3|Overall Study|Subject's substantial non-compliance|0
7611948|NCT01833065|26485478|P2|Overall Study|Subject's substantial non-compliance|1
7611949|NCT01833065|26485479|P1|Overall Study|Subject's substantial non-compliance|0
7611950|NCT01833065|26485475|P5|Overall Study|Withdrawal by Subject|11
7611951|NCT01833065|26485476|P4|Overall Study|Withdrawal by Subject|3
7611952|NCT01833065|26485477|P3|Overall Study|Withdrawal by Subject|4
7611953|NCT01833065|26485478|P2|Overall Study|Withdrawal by Subject|2
7611954|NCT01833065|26485479|P1|Overall Study|Withdrawal by Subject|6
7611955|NCT01833065|26485475|P5|Overall Study|Lost to Follow-up|3
7611956|NCT01833065|26485476|P4|Overall Study|Lost to Follow-up|0
7611957|NCT01833065|26485477|P3|Overall Study|Lost to Follow-up|0
7611958|NCT01833065|26485478|P2|Overall Study|Lost to Follow-up|0
7611959|NCT01833065|26485479|P1|Overall Study|Lost to Follow-up|1
7611960|NCT01833065|26485475|P5|Overall Study|Protocol Violation|2
7611961|NCT01833065|26485476|P4|Overall Study|Protocol Violation|0
7611962|NCT01833065|26485477|P3|Overall Study|Protocol Violation|0
7611963|NCT01833065|26485478|P2|Overall Study|Protocol Violation|0
7611964|NCT01833065|26485479|P1|Overall Study|Protocol Violation|1
7611965|NCT01833065|26485475|P5|Overall Study|Adverse Event|3
7611966|NCT01833065|26485476|P4|Overall Study|Adverse Event|2
7611967|NCT01833065|26485477|P3|Overall Study|Adverse Event|0
7611968|NCT01833065|26485478|P2|Overall Study|Adverse Event|1
7611969|NCT01833065|26485479|P1|Overall Study|Adverse Event|6
7611970|NCT01832818|26485548|P1|Overall Study|Lost to Follow-up|6
7611971|NCT01832766|26485557|P2|Washout|Lost to Follow-up|1
7611972|NCT01832766|26485558|P1|Washout|Lost to Follow-up|0
7611973|NCT01832727|26485594|P9|Overall Study|Study terminated by sponsor|1
7611974|NCT01832727|26485595|P8|Overall Study|Study terminated by sponsor|1
7611975|NCT01832727|26485596|P7|Overall Study|Study terminated by sponsor|0
7611976|NCT01832727|26485597|P6|Overall Study|Study terminated by sponsor|0
7611977|NCT01832727|26485598|P5|Overall Study|Study terminated by sponsor|0
7611978|NCT01832727|26485599|P4|Overall Study|Study terminated by sponsor|0
7611979|NCT01832727|26485600|P3|Overall Study|Study terminated by sponsor|0
7611980|NCT01832727|26485601|P2|Overall Study|Study terminated by sponsor|0
7611981|NCT01832727|26485602|P1|Overall Study|Study terminated by sponsor|0
7611982|NCT01832727|26485594|P9|Overall Study|Withdrawal by Subject|1
7611983|NCT01832727|26485595|P8|Overall Study|Withdrawal by Subject|2
7611984|NCT01832727|26485596|P7|Overall Study|Withdrawal by Subject|0
7611985|NCT01832727|26485597|P6|Overall Study|Withdrawal by Subject|1
7611986|NCT01832727|26485598|P5|Overall Study|Withdrawal by Subject|0
7611987|NCT01832727|26485599|P4|Overall Study|Withdrawal by Subject|1
7611988|NCT01832727|26485600|P3|Overall Study|Withdrawal by Subject|0
7611989|NCT01832727|26485601|P2|Overall Study|Withdrawal by Subject|1
7611990|NCT01832727|26485602|P1|Overall Study|Withdrawal by Subject|1
7611991|NCT01832727|26485594|P9|Overall Study|Physician Decision|0
7611992|NCT01832727|26485595|P8|Overall Study|Physician Decision|0
7611993|NCT01832727|26485596|P7|Overall Study|Physician Decision|0
7611994|NCT01832727|26485597|P6|Overall Study|Physician Decision|1
7611995|NCT01832727|26485598|P5|Overall Study|Physician Decision|0
7611996|NCT01832727|26485599|P4|Overall Study|Physician Decision|1
7611997|NCT01832727|26485600|P3|Overall Study|Physician Decision|0
7611998|NCT01832727|26485601|P2|Overall Study|Physician Decision|0
7611999|NCT01832727|26485602|P1|Overall Study|Physician Decision|1
7612000|NCT01832727|26485594|P9|Overall Study|Lost to Follow-up|0
7612001|NCT01832727|26485595|P8|Overall Study|Lost to Follow-up|0
7612002|NCT01832727|26485596|P7|Overall Study|Lost to Follow-up|0
7612003|NCT01832727|26485597|P6|Overall Study|Lost to Follow-up|0
7612004|NCT01832727|26485598|P5|Overall Study|Lost to Follow-up|0
7612005|NCT01832727|26485599|P4|Overall Study|Lost to Follow-up|1
7612006|NCT01832727|26485600|P3|Overall Study|Lost to Follow-up|0
7612007|NCT01832727|26485601|P2|Overall Study|Lost to Follow-up|0
7612008|NCT01832727|26485602|P1|Overall Study|Lost to Follow-up|0
7612009|NCT01832727|26485594|P9|Overall Study|Disease progression|7
7612010|NCT01832727|26485595|P8|Overall Study|Disease progression|2
7612011|NCT01832727|26485596|P7|Overall Study|Disease progression|6
7612012|NCT01832727|26485597|P6|Overall Study|Disease progression|3
7612013|NCT01832727|26485598|P5|Overall Study|Disease progression|3
7612014|NCT01832727|26485599|P4|Overall Study|Disease progression|1
7612015|NCT01832727|26485600|P3|Overall Study|Disease progression|2
7612016|NCT01832727|26485601|P2|Overall Study|Disease progression|0
7612017|NCT01832727|26485602|P1|Overall Study|Disease progression|3
7612018|NCT01832727|26485594|P9|Overall Study|Adverse Event|9
7612019|NCT01832727|26485595|P8|Overall Study|Adverse Event|1
7612020|NCT01832727|26485596|P7|Overall Study|Adverse Event|2
7612021|NCT01832727|26485597|P6|Overall Study|Adverse Event|1
7612022|NCT01832727|26485598|P5|Overall Study|Adverse Event|1
7612023|NCT01832727|26485599|P4|Overall Study|Adverse Event|0
7612024|NCT01832727|26485600|P3|Overall Study|Adverse Event|1
7612025|NCT01832727|26485601|P2|Overall Study|Adverse Event|6
7612026|NCT01832727|26485602|P1|Overall Study|Adverse Event|4
7612027|NCT01832532|26485715|P2|Overall Study|Withdrawal by Subject|2
7612028|NCT01832532|26485716|P1|Overall Study|Withdrawal by Subject|5
7612029|NCT01832493|26485778|P1|Overall Study|Unable to place LV lead|2
7612030|NCT01832493|26485778|P1|Overall Study|Protocol Violation|4
7612031|NCT01832493|26485778|P1|Overall Study|Physician Decision|2
7612032|NCT01832480|26485787|P2|Overall Study|post randomization ineligible|10
7612033|NCT01832480|26485788|P1|Overall Study|post randomization ineligible|8
7612034|NCT01832480|26485787|P2|Overall Study|Withdrawal by Subject|2
7612035|NCT01832480|26485788|P1|Overall Study|Withdrawal by Subject|0
7612036|NCT01832480|26485787|P2|Overall Study|Lost to Follow-up|30
7612037|NCT01832480|26485788|P1|Overall Study|Lost to Follow-up|33
7612038|NCT01832402|26485796|P2|Overall Study|Declining Performance status|1
7612039|NCT01832402|26485797|P1|Overall Study|Declining Performance status|2
7612040|NCT01832402|26485796|P2|Overall Study|Withdrawal by Subject|3
7612041|NCT01832402|26485797|P1|Overall Study|Withdrawal by Subject|3
7612042|NCT01832402|26485796|P2|Overall Study|Lost to Follow-up|0
7612043|NCT01832402|26485797|P1|Overall Study|Lost to Follow-up|2
7612044|NCT01832155|26485824|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
7612045|NCT01832155|26485825|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
7612046|NCT01832155|26485824|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
7612047|NCT01832155|26485825|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
7612048|NCT01832038|26485892|P1|Overall Study|Subject considered the efficacy was poor|1
7612049|NCT01832038|26485892|P1|Overall Study|Pregnancy and abortion in EP0008 study|1
7612050|NCT01832038|26485892|P1|Overall Study|Prohibited concomitant medication|1
7612051|NCT01832038|26485892|P1|Overall Study|Bad mood and has suicidal thought|1
7612052|NCT01832038|26485892|P1|Overall Study|Plan to pregnancy|7
7612053|NCT01832038|26485892|P1|Overall Study|Changes of implementation system|3
7612054|NCT01832038|26485892|P1|Overall Study|Not possible to visit the hospital|1
7612055|NCT01832038|26485892|P1|Overall Study|Prohibit procedure|2
7612056|NCT01832038|26485892|P1|Overall Study|Low compliance|3
7612057|NCT01832038|26485892|P1|Overall Study|Pregnancy|1
7612058|NCT01832038|26485892|P1|Overall Study|Back home|1
7612059|NCT01832038|26485892|P1|Overall Study|Participant was asked to quit|5
7612060|NCT01832038|26485892|P1|Overall Study|Not convenient to come back to site|2
7612061|NCT01832038|26485892|P1|Overall Study|Subject refused to return visit|2
7612062|NCT01832038|26485892|P1|Overall Study|Visit non-compliance|2
7612063|NCT01832038|26485892|P1|Overall Study|Withdrawal by Subject|49
7612064|NCT01832038|26485892|P1|Overall Study|Lost to Follow-up|10
7612065|NCT01832038|26485892|P1|Overall Study|Protocol Violation|7
7612066|NCT01832038|26485892|P1|Overall Study|Lack of Efficacy|81
7612067|NCT01832038|26485892|P1|Overall Study|Adverse Event|50
7612068|NCT01832038|26485892|P1|Overall Study|Death|5
7612069|NCT01831856|26485950|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
7612070|NCT01831856|26485951|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
7612071|NCT01831856|26485950|P2|Overall Study|Lack of Efficacy|11
7612072|NCT01831856|26485951|P1|Overall Study|Lack of Efficacy|13
7612073|NCT01831856|26485950|P2|Overall Study|Adverse Event|8
7612074|NCT01831856|26485951|P1|Overall Study|Adverse Event|5
7612075|NCT01831817|26485961|P4|Overall Study|Withdrawl of Consent|0
7612076|NCT01831817|26485962|P3|Overall Study|Withdrawl of Consent|0
7612077|NCT01831817|26485963|P2|Overall Study|Withdrawl of Consent|0
7612078|NCT01831817|26485964|P1|Overall Study|Withdrawl of Consent|3
7612079|NCT01831817|26485961|P4|Overall Study|Lost to Follow-up|0
7612080|NCT01831817|26485962|P3|Overall Study|Lost to Follow-up|0
7612081|NCT01831817|26485963|P2|Overall Study|Lost to Follow-up|0
7612082|NCT01831817|26485964|P1|Overall Study|Lost to Follow-up|1
7612083|NCT01831804|26486011|P9|Overall Study|Withdrew Consent|0
7612084|NCT01831804|26486012|P8|Overall Study|Withdrew Consent|2
7612085|NCT01831804|26486013|P7|Overall Study|Withdrew Consent|0
7612086|NCT01831804|26486014|P6|Overall Study|Withdrew Consent|0
7612087|NCT01831804|26486015|P5|Overall Study|Withdrew Consent|0
7612088|NCT01831804|26486016|P4|Overall Study|Withdrew Consent|0
7612089|NCT01831804|26486017|P3|Overall Study|Withdrew Consent|0
7612090|NCT01831804|26486018|P2|Overall Study|Withdrew Consent|1
7612091|NCT01831804|26486019|P1|Overall Study|Withdrew Consent|0
7612092|NCT01831804|26486011|P9|Overall Study|Investigator discretion|0
7612093|NCT01831804|26486012|P8|Overall Study|Investigator discretion|1
7612094|NCT01831804|26486013|P7|Overall Study|Investigator discretion|0
7612095|NCT01831804|26486014|P6|Overall Study|Investigator discretion|0
7612096|NCT01831804|26486015|P5|Overall Study|Investigator discretion|1
7612097|NCT01831804|26486016|P4|Overall Study|Investigator discretion|0
7612098|NCT01831804|26486017|P3|Overall Study|Investigator discretion|0
7612099|NCT01831804|26486018|P2|Overall Study|Investigator discretion|0
7612100|NCT01831804|26486019|P1|Overall Study|Investigator discretion|0
7612101|NCT01831804|26486011|P9|Overall Study|Lost to Follow-up|1
7612102|NCT01831804|26486012|P8|Overall Study|Lost to Follow-up|0
7612103|NCT01831804|26486013|P7|Overall Study|Lost to Follow-up|0
7612104|NCT01831804|26486014|P6|Overall Study|Lost to Follow-up|0
7612105|NCT01831804|26486015|P5|Overall Study|Lost to Follow-up|0
7612106|NCT01831804|26486016|P4|Overall Study|Lost to Follow-up|0
7612107|NCT01831804|26486017|P3|Overall Study|Lost to Follow-up|1
7612108|NCT01831804|26486018|P2|Overall Study|Lost to Follow-up|0
7612109|NCT01831804|26486019|P1|Overall Study|Lost to Follow-up|0
7612110|NCT01831804|26486011|P9|Overall Study|Protocol defined stopping criteria|0
7612111|NCT01831804|26486012|P8|Overall Study|Protocol defined stopping criteria|0
7612112|NCT01831804|26486013|P7|Overall Study|Protocol defined stopping criteria|0
7612113|NCT01831804|26486014|P6|Overall Study|Protocol defined stopping criteria|0
7612114|NCT01831804|26486015|P5|Overall Study|Protocol defined stopping criteria|1
7612115|NCT01831804|26486016|P4|Overall Study|Protocol defined stopping criteria|0
7612116|NCT01831804|26486017|P3|Overall Study|Protocol defined stopping criteria|3
7612117|NCT01831804|26486018|P2|Overall Study|Protocol defined stopping criteria|1
7612118|NCT01831804|26486019|P1|Overall Study|Protocol defined stopping criteria|1
7612119|NCT01831804|26486011|P9|Overall Study|Protocol Violation|0
7612120|NCT01831804|26486012|P8|Overall Study|Protocol Violation|0
7612121|NCT01831804|26486013|P7|Overall Study|Protocol Violation|0
7612122|NCT01831804|26486014|P6|Overall Study|Protocol Violation|0
7612123|NCT01831804|26486015|P5|Overall Study|Protocol Violation|0
7612124|NCT01831804|26486016|P4|Overall Study|Protocol Violation|0
7612125|NCT01831804|26486017|P3|Overall Study|Protocol Violation|2
7612126|NCT01831804|26486018|P2|Overall Study|Protocol Violation|0
7612127|NCT01831804|26486019|P1|Overall Study|Protocol Violation|0
7612128|NCT01831804|26486011|P9|Overall Study|Adverse Event|1
7612129|NCT01831804|26486012|P8|Overall Study|Adverse Event|0
7612130|NCT01831804|26486013|P7|Overall Study|Adverse Event|1
7612131|NCT01831804|26486014|P6|Overall Study|Adverse Event|0
7612132|NCT01831804|26486015|P5|Overall Study|Adverse Event|0
7612133|NCT01831804|26486016|P4|Overall Study|Adverse Event|0
7612134|NCT01831804|26486017|P3|Overall Study|Adverse Event|0
7612135|NCT01831804|26486018|P2|Overall Study|Adverse Event|0
7612136|NCT01831804|26486019|P1|Overall Study|Adverse Event|0
7612137|NCT01831791|26486114|P1|Overall Study|Withdrawal by Subject|10
7612138|NCT01831765|26486143|P3|Overall Study|Lost to Follow-up|3
7612139|NCT01831765|26486144|P2|Overall Study|Lost to Follow-up|3
7612140|NCT01831765|26486145|P1|Overall Study|Lost to Follow-up|2
7612141|NCT01831765|26486143|P3|Overall Study|Withdrawal criteria|16
7612142|NCT01831765|26486144|P2|Overall Study|Withdrawal criteria|10
7612143|NCT01831765|26486145|P1|Overall Study|Withdrawal criteria|12
7612144|NCT01831765|26486143|P3|Overall Study|Withdrawal by Subject|17
7612145|NCT01831765|26486144|P2|Overall Study|Withdrawal by Subject|7
7612146|NCT01831765|26486145|P1|Overall Study|Withdrawal by Subject|22
7612147|NCT01831765|26486143|P3|Overall Study|Adverse Event|3
7612148|NCT01831765|26486144|P2|Overall Study|Adverse Event|3
7612149|NCT01831765|26486145|P1|Overall Study|Adverse Event|5
7612150|NCT01831765|26486143|P3|Overall Study|Other, site closed|0
7612151|NCT01831765|26486144|P2|Overall Study|Other, site closed|1
7612152|NCT01831765|26486145|P1|Overall Study|Other, site closed|1
7612153|NCT01831765|26486143|P3|Overall Study|Death|1
7612154|NCT01831765|26486144|P2|Overall Study|Death|1
7612155|NCT01831765|26486145|P1|Overall Study|Death|0
7612156|NCT01831765|26486143|P3|Overall Study|Pregnancy|2
7612157|NCT01831765|26486144|P2|Overall Study|Pregnancy|1
7612158|NCT01831765|26486145|P1|Overall Study|Pregnancy|1
7612159|NCT01831765|26486143|P3|Overall Study|Other, sponsor withdrew subject|0
7612160|NCT01831765|26486144|P2|Overall Study|Other, sponsor withdrew subject|1
7612161|NCT01831765|26486145|P1|Overall Study|Other, sponsor withdrew subject|0
7612162|NCT01831765|26486143|P3|Overall Study|Lack of Efficacy|0
7612163|NCT01831765|26486144|P2|Overall Study|Lack of Efficacy|0
7612164|NCT01831765|26486145|P1|Overall Study|Lack of Efficacy|1
7612165|NCT01831726|26486171|P1|Overall Study|Subject/guardian decision|7
7612166|NCT01831726|26486171|P1|Overall Study|Physician Decision|1
7612167|NCT01831726|26486171|P1|Overall Study|Disease Progression|49
7612168|NCT01831726|26486171|P1|Overall Study|Death|7
7612169|NCT01831726|26486171|P1|Overall Study|Adverse Event|16
7612170|NCT01831596|26486178|P1|Overall Study|Other|8
7612171|NCT01831544|26486182|P1|Overall Study|Still on original MVAD device|2
7612172|NCT01831544|26486182|P1|Overall Study|Death|1
7612173|NCT01831466|26486211|P12|Overall Study|Adverse Event|2
7612174|NCT01831466|26486212|P11|Overall Study|Adverse Event|0
7612175|NCT01831466|26486213|P10|Overall Study|Adverse Event|1
7612176|NCT01831466|26486214|P9|Overall Study|Adverse Event|1
7612177|NCT01831466|26486215|P8|Overall Study|Adverse Event|1
7612178|NCT01831466|26486216|P7|Overall Study|Adverse Event|0
7612179|NCT01831466|26486217|P6|Overall Study|Adverse Event|7
7612180|NCT01831466|26486218|P5|Overall Study|Adverse Event|3
7612181|NCT01831466|26486219|P4|Overall Study|Adverse Event|6
7612182|NCT01831466|26486220|P3|Overall Study|Adverse Event|4
7612183|NCT01831466|26486221|P2|Overall Study|Adverse Event|0
7612184|NCT01831466|26486222|P1|Overall Study|Adverse Event|0
7612185|NCT01831466|26486211|P12|Overall Study|Lack of Efficacy|0
7612186|NCT01831466|26486212|P11|Overall Study|Lack of Efficacy|2
7612187|NCT01831466|26486213|P10|Overall Study|Lack of Efficacy|2
7612188|NCT01831466|26486214|P9|Overall Study|Lack of Efficacy|2
7612189|NCT01831466|26486215|P8|Overall Study|Lack of Efficacy|1
7612190|NCT01831466|26486216|P7|Overall Study|Lack of Efficacy|1
7612191|NCT01831466|26486217|P6|Overall Study|Lack of Efficacy|8
7612192|NCT01831466|26486218|P5|Overall Study|Lack of Efficacy|9
7612193|NCT01831466|26486219|P4|Overall Study|Lack of Efficacy|6
7612194|NCT01831466|26486220|P3|Overall Study|Lack of Efficacy|7
7612195|NCT01831466|26486221|P2|Overall Study|Lack of Efficacy|8
7612196|NCT01831466|26486222|P1|Overall Study|Lack of Efficacy|5
7612197|NCT01831466|26486211|P12|Overall Study|Lost to Follow-up|1
7612198|NCT01831466|26486212|P11|Overall Study|Lost to Follow-up|0
7612199|NCT01831466|26486213|P10|Overall Study|Lost to Follow-up|1
7612200|NCT01831466|26486214|P9|Overall Study|Lost to Follow-up|0
7612201|NCT01831466|26486215|P8|Overall Study|Lost to Follow-up|0
7612202|NCT01831466|26486216|P7|Overall Study|Lost to Follow-up|0
7612203|NCT01831466|26486217|P6|Overall Study|Lost to Follow-up|3
7612204|NCT01831466|26486218|P5|Overall Study|Lost to Follow-up|0
7612205|NCT01831466|26486219|P4|Overall Study|Lost to Follow-up|2
7612206|NCT01831466|26486220|P3|Overall Study|Lost to Follow-up|4
7612207|NCT01831466|26486221|P2|Overall Study|Lost to Follow-up|1
7612208|NCT01831466|26486222|P1|Overall Study|Lost to Follow-up|0
7612209|NCT01831466|26486211|P12|Overall Study|Withdrawal by Subject|1
7612210|NCT01831466|26486212|P11|Overall Study|Withdrawal by Subject|0
7612211|NCT01831466|26486213|P10|Overall Study|Withdrawal by Subject|1
7612212|NCT01831466|26486214|P9|Overall Study|Withdrawal by Subject|0
7612213|NCT01831466|26486215|P8|Overall Study|Withdrawal by Subject|0
7612214|NCT01831466|26486216|P7|Overall Study|Withdrawal by Subject|0
7612215|NCT01831466|26486217|P6|Overall Study|Withdrawal by Subject|5
7612216|NCT01831466|26486218|P5|Overall Study|Withdrawal by Subject|3
7612217|NCT01831466|26486219|P4|Overall Study|Withdrawal by Subject|3
7612218|NCT01831466|26486220|P3|Overall Study|Withdrawal by Subject|3
7612219|NCT01831466|26486221|P2|Overall Study|Withdrawal by Subject|3
7612220|NCT01831466|26486222|P1|Overall Study|Withdrawal by Subject|6
7612221|NCT01831466|26486211|P12|Overall Study|Death|0
7612222|NCT01831466|26486212|P11|Overall Study|Death|0
7612223|NCT01831466|26486213|P10|Overall Study|Death|0
7612224|NCT01831466|26486214|P9|Overall Study|Death|0
7612225|NCT01831466|26486215|P8|Overall Study|Death|0
7612226|NCT01831466|26486216|P7|Overall Study|Death|0
7612227|NCT01831466|26486217|P6|Overall Study|Death|0
7612228|NCT01831466|26486218|P5|Overall Study|Death|0
7612229|NCT01831466|26486219|P4|Overall Study|Death|0
7612230|NCT01831466|26486220|P3|Overall Study|Death|0
7612231|NCT01831466|26486221|P2|Overall Study|Death|1
7612232|NCT01831466|26486222|P1|Overall Study|Death|0
7612233|NCT01831466|26486211|P12|Overall Study|Non-compliance with study treatment|0
7612234|NCT01831466|26486212|P11|Overall Study|Non-compliance with study treatment|0
7612235|NCT01831466|26486213|P10|Overall Study|Non-compliance with study treatment|0
7612236|NCT01831466|26486214|P9|Overall Study|Non-compliance with study treatment|0
7612237|NCT01831466|26486215|P8|Overall Study|Non-compliance with study treatment|0
7612238|NCT01831466|26486216|P7|Overall Study|Non-compliance with study treatment|0
7612239|NCT01831466|26486217|P6|Overall Study|Non-compliance with study treatment|1
7612240|NCT01831466|26486218|P5|Overall Study|Non-compliance with study treatment|0
7612241|NCT01831466|26486219|P4|Overall Study|Non-compliance with study treatment|0
7612242|NCT01831466|26486220|P3|Overall Study|Non-compliance with study treatment|1
7612243|NCT01831466|26486221|P2|Overall Study|Non-compliance with study treatment|1
7612244|NCT01831466|26486222|P1|Overall Study|Non-compliance with study treatment|2
7612245|NCT01831466|26486211|P12|Overall Study|Other|0
7612246|NCT01831466|26486212|P11|Overall Study|Other|0
7612247|NCT01831466|26486213|P10|Overall Study|Other|0
7612248|NCT01831466|26486214|P9|Overall Study|Other|0
7612249|NCT01831466|26486215|P8|Overall Study|Other|0
7612250|NCT01831466|26486216|P7|Overall Study|Other|0
7612251|NCT01831466|26486217|P6|Overall Study|Other|1
7612252|NCT01831466|26486218|P5|Overall Study|Other|2
7612253|NCT01831466|26486219|P4|Overall Study|Other|2
7612254|NCT01831466|26486220|P3|Overall Study|Other|2
7612255|NCT01831466|26486221|P2|Overall Study|Other|3
7612256|NCT01831466|26486222|P1|Overall Study|Other|2
7612257|NCT01831466|26486211|P12|Overall Study|Protocol Violation|0
7612258|NCT01831466|26486212|P11|Overall Study|Protocol Violation|0
7612259|NCT01831466|26486213|P10|Overall Study|Protocol Violation|0
7612260|NCT01831466|26486214|P9|Overall Study|Protocol Violation|0
7612261|NCT01831466|26486215|P8|Overall Study|Protocol Violation|0
7612262|NCT01831466|26486216|P7|Overall Study|Protocol Violation|0
7612263|NCT01831466|26486217|P6|Overall Study|Protocol Violation|1
7612264|NCT01831466|26486218|P5|Overall Study|Protocol Violation|0
7612265|NCT01831466|26486219|P4|Overall Study|Protocol Violation|0
7612266|NCT01831466|26486220|P3|Overall Study|Protocol Violation|2
7612267|NCT01831466|26486221|P2|Overall Study|Protocol Violation|1
7612268|NCT01831466|26486222|P1|Overall Study|Protocol Violation|1
7612269|NCT01831427|26486355|P11|Overall Study|Withdrew Consent|1
7612270|NCT01831427|26486356|P10|Overall Study|Withdrew Consent|1
7612271|NCT01831427|26486357|P9|Overall Study|Withdrew Consent|0
7612272|NCT01831427|26486358|P8|Overall Study|Withdrew Consent|0
7612273|NCT01831427|26486359|P7|Overall Study|Withdrew Consent|2
7612274|NCT01831427|26486360|P6|Overall Study|Withdrew Consent|0
7612275|NCT01831427|26486361|P5|Overall Study|Withdrew Consent|0
7612276|NCT01831427|26486362|P4|Overall Study|Withdrew Consent|0
7612277|NCT01831427|26486363|P3|Overall Study|Withdrew Consent|0
7612278|NCT01831427|26486364|P2|Overall Study|Withdrew Consent|0
7612279|NCT01831427|26486365|P1|Overall Study|Withdrew Consent|0
7612280|NCT01831427|26486355|P11|Overall Study|Investigator's Discretion|0
7612281|NCT01831427|26486356|P10|Overall Study|Investigator's Discretion|0
7612282|NCT01831427|26486357|P9|Overall Study|Investigator's Discretion|0
7612283|NCT01831427|26486358|P8|Overall Study|Investigator's Discretion|0
7612284|NCT01831427|26486359|P7|Overall Study|Investigator's Discretion|0
7612285|NCT01831427|26486360|P6|Overall Study|Investigator's Discretion|0
7612286|NCT01831427|26486361|P5|Overall Study|Investigator's Discretion|0
7612287|NCT01831427|26486362|P4|Overall Study|Investigator's Discretion|1
7612288|NCT01831427|26486363|P3|Overall Study|Investigator's Discretion|0
7612289|NCT01831427|26486364|P2|Overall Study|Investigator's Discretion|0
7612290|NCT01831427|26486365|P1|Overall Study|Investigator's Discretion|0
7612291|NCT01831427|26486355|P11|Overall Study|Adverse Event|2
7612292|NCT01831427|26486356|P10|Overall Study|Adverse Event|0
7612293|NCT01831427|26486357|P9|Overall Study|Adverse Event|0
7612294|NCT01831427|26486358|P8|Overall Study|Adverse Event|1
7612295|NCT01831427|26486359|P7|Overall Study|Adverse Event|0
7612296|NCT01831427|26486360|P6|Overall Study|Adverse Event|1
7612297|NCT01831427|26486361|P5|Overall Study|Adverse Event|0
7612298|NCT01831427|26486362|P4|Overall Study|Adverse Event|0
7612299|NCT01831427|26486363|P3|Overall Study|Adverse Event|0
7612300|NCT01831427|26486364|P2|Overall Study|Adverse Event|1
7612301|NCT01831427|26486365|P1|Overall Study|Adverse Event|0
7612302|NCT01831258|26486422|P2|Overall Study|Lost to Follow-up|2
7612303|NCT01831258|26486423|P1|Overall Study|Lost to Follow-up|3
7612304|NCT01831258|26486422|P2|Overall Study|Withdrawal by Subject|1
7612305|NCT01831258|26486423|P1|Overall Study|Withdrawal by Subject|2
7612306|NCT01831089|26486513|P6|Cohort B: Arm B|Global end of study|1
7612307|NCT01831089|26486514|P5|Cohort B: Arm B|Global end of study|0
7612308|NCT01831089|26486515|P4|Cohort B: Arm B|Global end of study|0
7612309|NCT01831089|26486516|P3|Cohort B: Arm B|Global end of study|0
7612310|NCT01831089|26486517|P2|Cohort B: Arm B|Global end of study|0
7612311|NCT01831089|26486518|P1|Cohort B: Arm B|Global end of study|0
7612312|NCT01831089|26486513|P6|Cohort B: Arm B|Adverse Event|1
7612313|NCT01831089|26486514|P5|Cohort B: Arm B|Adverse Event|0
7612314|NCT01831089|26486515|P4|Cohort B: Arm B|Adverse Event|0
7612315|NCT01831089|26486516|P3|Cohort B: Arm B|Adverse Event|0
7612316|NCT01831089|26486517|P2|Cohort B: Arm B|Adverse Event|0
7612317|NCT01831089|26486518|P1|Cohort B: Arm B|Adverse Event|0
7612318|NCT01831089|26486513|P6|Cohort B: Arm B|Never treated|2
7612319|NCT01831089|26486514|P5|Cohort B: Arm B|Never treated|0
7612320|NCT01831089|26486515|P4|Cohort B: Arm B|Never treated|0
7612321|NCT01831089|26486516|P3|Cohort B: Arm B|Never treated|0
7612322|NCT01831089|26486517|P2|Cohort B: Arm B|Never treated|0
7612323|NCT01831089|26486518|P1|Cohort B: Arm B|Never treated|0
7612324|NCT01831089|26486513|P6|Cohort B: Arm B|Physician Decision|2
7612325|NCT01831089|26486514|P5|Cohort B: Arm B|Physician Decision|0
7612326|NCT01831089|26486515|P4|Cohort B: Arm B|Physician Decision|0
7612327|NCT01831089|26486516|P3|Cohort B: Arm B|Physician Decision|0
7612328|NCT01831089|26486517|P2|Cohort B: Arm B|Physician Decision|0
7612329|NCT01831089|26486518|P1|Cohort B: Arm B|Physician Decision|0
7612330|NCT01831089|26486513|P6|Cohort B: Arm B|Progressive disease|8
7612331|NCT01831089|26486514|P5|Cohort B: Arm B|Progressive disease|0
7612332|NCT01831089|26486515|P4|Cohort B: Arm B|Progressive disease|0
7612333|NCT01831089|26486516|P3|Cohort B: Arm B|Progressive disease|0
7612334|NCT01831089|26486517|P2|Cohort B: Arm B|Progressive disease|0
7612335|NCT01831089|26486518|P1|Cohort B: Arm B|Progressive disease|0
7612336|NCT01831089|26486513|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
7612337|NCT01831089|26486514|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
7612338|NCT01831089|26486515|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
7612339|NCT01831089|26486516|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
7612340|NCT01831089|26486517|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
7612341|NCT01831089|26486518|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
7612342|NCT01831089|26486513|P6|Cohort V: Dose Level 5|Global end of study|0
7612343|NCT01831089|26486514|P5|Cohort V: Dose Level 5|Global end of study|2
7612344|NCT01831089|26486515|P4|Cohort V: Dose Level 5|Global end of study|0
7612345|NCT01831089|26486516|P3|Cohort V: Dose Level 5|Global end of study|0
7612346|NCT01831089|26486517|P2|Cohort V: Dose Level 5|Global end of study|0
7612347|NCT01831089|26486518|P1|Cohort V: Dose Level 5|Global end of study|0
7612348|NCT01831089|26486513|P6|Cohort V: Dose Level 5|Death|0
7612349|NCT01831089|26486514|P5|Cohort V: Dose Level 5|Death|1
7612350|NCT01831089|26486515|P4|Cohort V: Dose Level 5|Death|0
7612351|NCT01831089|26486516|P3|Cohort V: Dose Level 5|Death|0
7612352|NCT01831089|26486517|P2|Cohort V: Dose Level 5|Death|0
7612353|NCT01831089|26486518|P1|Cohort V: Dose Level 5|Death|0
7612354|NCT01831089|26486513|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
7612355|NCT01831089|26486514|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
7612356|NCT01831089|26486515|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
7612357|NCT01831089|26486516|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
7612358|NCT01831089|26486517|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
7612359|NCT01831089|26486518|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
7612360|NCT01831089|26486513|P6|Cohort V: Dose Level 5|Progressive disease|0
7612361|NCT01831089|26486514|P5|Cohort V: Dose Level 5|Progressive disease|30
7612362|NCT01831089|26486515|P4|Cohort V: Dose Level 5|Progressive disease|0
7612363|NCT01831089|26486516|P3|Cohort V: Dose Level 5|Progressive disease|0
7612364|NCT01831089|26486517|P2|Cohort V: Dose Level 5|Progressive disease|0
7612365|NCT01831089|26486518|P1|Cohort V: Dose Level 5|Progressive disease|0
7612366|NCT01831089|26486513|P6|Cohort IV: Dose Level 4|Progressive disease|0
7612367|NCT01831089|26486514|P5|Cohort IV: Dose Level 4|Progressive disease|0
7612368|NCT01831089|26486515|P4|Cohort IV: Dose Level 4|Progressive disease|6
7612369|NCT01831089|26486516|P3|Cohort IV: Dose Level 4|Progressive disease|0
7612370|NCT01831089|26486517|P2|Cohort IV: Dose Level 4|Progressive disease|0
7612371|NCT01831089|26486518|P1|Cohort IV: Dose Level 4|Progressive disease|0
7612372|NCT01831089|26486513|P6|Cohort III: Dose Level 3|Global end of study|0
7612373|NCT01831089|26486514|P5|Cohort III: Dose Level 3|Global end of study|0
7612374|NCT01831089|26486515|P4|Cohort III: Dose Level 3|Global end of study|0
7612375|NCT01831089|26486516|P3|Cohort III: Dose Level 3|Global end of study|1
7612376|NCT01831089|26486517|P2|Cohort III: Dose Level 3|Global end of study|0
7612377|NCT01831089|26486518|P1|Cohort III: Dose Level 3|Global end of study|0
7612378|NCT01831089|26486513|P6|Cohort III: Dose Level 3|Adverse Event|0
7612379|NCT01831089|26486514|P5|Cohort III: Dose Level 3|Adverse Event|0
7612380|NCT01831089|26486515|P4|Cohort III: Dose Level 3|Adverse Event|0
7612381|NCT01831089|26486516|P3|Cohort III: Dose Level 3|Adverse Event|1
7612382|NCT01831089|26486517|P2|Cohort III: Dose Level 3|Adverse Event|0
7612383|NCT01831089|26486518|P1|Cohort III: Dose Level 3|Adverse Event|0
7612384|NCT01831089|26486513|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
7612385|NCT01831089|26486514|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
7612386|NCT01831089|26486515|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
7612387|NCT01831089|26486516|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
7612388|NCT01831089|26486517|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
7612389|NCT01831089|26486518|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
7612390|NCT01831089|26486513|P6|Cohort III: Dose Level 3|Progressive disease|0
7612391|NCT01831089|26486514|P5|Cohort III: Dose Level 3|Progressive disease|0
7612392|NCT01831089|26486515|P4|Cohort III: Dose Level 3|Progressive disease|0
7612393|NCT01831089|26486516|P3|Cohort III: Dose Level 3|Progressive disease|3
7612394|NCT01831089|26486517|P2|Cohort III: Dose Level 3|Progressive disease|0
7612395|NCT01831089|26486518|P1|Cohort III: Dose Level 3|Progressive disease|0
7612396|NCT01831089|26486513|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
7612397|NCT01831089|26486514|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
7612398|NCT01831089|26486515|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
7612399|NCT01831089|26486516|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
7612400|NCT01831089|26486517|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
7612401|NCT01831089|26486518|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
7612402|NCT01831089|26486513|P6|Cohort II: Dose Level 2|Progressive disease|0
7612403|NCT01831089|26486514|P5|Cohort II: Dose Level 2|Progressive disease|0
7612404|NCT01831089|26486515|P4|Cohort II: Dose Level 2|Progressive disease|0
7612405|NCT01831089|26486516|P3|Cohort II: Dose Level 2|Progressive disease|0
7612406|NCT01831089|26486517|P2|Cohort II: Dose Level 2|Progressive disease|2
7612407|NCT01831089|26486518|P1|Cohort II: Dose Level 2|Progressive disease|0
7612408|NCT01831089|26486513|P6|Cohort I: Dose Level 1|Progressive disease|0
7612409|NCT01831089|26486514|P5|Cohort I: Dose Level 1|Progressive disease|0
7612410|NCT01831089|26486515|P4|Cohort I: Dose Level 1|Progressive disease|0
7612411|NCT01831089|26486516|P3|Cohort I: Dose Level 1|Progressive disease|0
7612412|NCT01831089|26486517|P2|Cohort I: Dose Level 1|Progressive disease|0
7612413|NCT01831089|26486518|P1|Cohort I: Dose Level 1|Progressive disease|3
7612414|NCT01830972|26486569|P2|Part IV|Non-Compliance|0
7612415|NCT01830972|26486570|P1|Part IV|Non-Compliance|1
7612416|NCT01830972|26486569|P2|Part IV|Withdrawal by Subject|1
7612417|NCT01830972|26486570|P1|Part IV|Withdrawal by Subject|2
7612418|NCT01830972|26486569|P2|Part III|Noncompliance|0
7612419|NCT01830972|26486570|P1|Part III|Noncompliance|1
7612420|NCT01830972|26486569|P2|Part III|Withdrawal by Subject|0
7612421|NCT01830972|26486570|P1|Part III|Withdrawal by Subject|1
7612422|NCT01830972|26486569|P2|Part II|Withdrawal by Subject|2
7612423|NCT01830972|26486570|P1|Part II|Withdrawal by Subject|2
7612424|NCT01830920|26486614|P5|Overall Study|Other|3
7612425|NCT01830920|26486615|P4|Overall Study|Other|5
7612426|NCT01830920|26486616|P3|Overall Study|Other|1
7612427|NCT01830920|26486617|P2|Overall Study|Other|1
7612428|NCT01830920|26486618|P1|Overall Study|Other|15
7612429|NCT01830920|26486614|P5|Overall Study|Death|4
7612430|NCT01830920|26486615|P4|Overall Study|Death|4
7612431|NCT01830920|26486616|P3|Overall Study|Death|5
7612432|NCT01830920|26486617|P2|Overall Study|Death|3
7612433|NCT01830920|26486618|P1|Overall Study|Death|3
7612434|NCT01830920|26486614|P5|Overall Study|Withdrawal by Subject|1
7612435|NCT01830920|26486615|P4|Overall Study|Withdrawal by Subject|7
7612436|NCT01830920|26486616|P3|Overall Study|Withdrawal by Subject|1
7612437|NCT01830920|26486617|P2|Overall Study|Withdrawal by Subject|2
7612438|NCT01830920|26486618|P1|Overall Study|Withdrawal by Subject|2
7612439|NCT01830920|26486614|P5|Overall Study|Adverse Event|0
7612440|NCT01830920|26486615|P4|Overall Study|Adverse Event|0
7612441|NCT01830920|26486616|P3|Overall Study|Adverse Event|1
7612442|NCT01830920|26486617|P2|Overall Study|Adverse Event|0
7612443|NCT01830920|26486618|P1|Overall Study|Adverse Event|1
7612444|NCT01830881|26486657|P2|Overall Study|Changed decision to have an abortion|1
7612445|NCT01830881|26486658|P1|Overall Study|Changed decision to have an abortion|0
7612446|NCT01830855|26486706|P4|Overall Study|Lost to Follow-up|33
7612447|NCT01830855|26486707|P3|Overall Study|Lost to Follow-up|23
7612448|NCT01830855|26486708|P2|Overall Study|Lost to Follow-up|20
7612449|NCT01830855|26486709|P1|Overall Study|Lost to Follow-up|47
7612450|NCT01830855|26486706|P4|Overall Study|No longer willing to participate|17
7612451|NCT01830855|26486707|P3|Overall Study|No longer willing to participate|12
7612452|NCT01830855|26486708|P2|Overall Study|No longer willing to participate|13
7612453|NCT01830855|26486709|P1|Overall Study|No longer willing to participate|32
7612454|NCT01830855|26486706|P4|Overall Study|Withdrawal by Subject|12
7612455|NCT01830855|26486707|P3|Overall Study|Withdrawal by Subject|10
7612456|NCT01830855|26486708|P2|Overall Study|Withdrawal by Subject|14
7612457|NCT01830855|26486709|P1|Overall Study|Withdrawal by Subject|33
7612458|NCT01830855|26486706|P4|Overall Study|Protocol deviation|6
7612459|NCT01830855|26486707|P3|Overall Study|Protocol deviation|6
7612460|NCT01830855|26486708|P2|Overall Study|Protocol deviation|5
7612461|NCT01830855|26486709|P1|Overall Study|Protocol deviation|10
7612462|NCT01830855|26486706|P4|Overall Study|Adverse Event|3
7612463|NCT01830855|26486707|P3|Overall Study|Adverse Event|6
7612464|NCT01830855|26486708|P2|Overall Study|Adverse Event|5
7612465|NCT01830855|26486709|P1|Overall Study|Adverse Event|11
7612466|NCT01830855|26486706|P4|Overall Study|No longer meets eligibility criteria|5
7612467|NCT01830855|26486707|P3|Overall Study|No longer meets eligibility criteria|3
7612468|NCT01830855|26486708|P2|Overall Study|No longer meets eligibility criteria|2
7612469|NCT01830855|26486709|P1|Overall Study|No longer meets eligibility criteria|11
7612470|NCT01830855|26486706|P4|Overall Study|Pregnancy|1
7612471|NCT01830855|26486707|P3|Overall Study|Pregnancy|2
7612472|NCT01830855|26486708|P2|Overall Study|Pregnancy|1
7612473|NCT01830855|26486709|P1|Overall Study|Pregnancy|3
7612474|NCT01830855|26486706|P4|Overall Study|Medication error without associated AE|1
7612475|NCT01830855|26486707|P3|Overall Study|Medication error without associated AE|0
7612476|NCT01830855|26486708|P2|Overall Study|Medication error without associated AE|0
7612477|NCT01830855|26486709|P1|Overall Study|Medication error without associated AE|1
7612478|NCT01830855|26486706|P4|Overall Study|Other|4
7612479|NCT01830855|26486707|P3|Overall Study|Other|4
7612480|NCT01830855|26486708|P2|Overall Study|Other|1
7612481|NCT01830855|26486709|P1|Overall Study|Other|7
7612482|NCT01830816|26486825|P3|Overall Study|Reason not Specified|0
7612483|NCT01830816|26486826|P2|Overall Study|Reason not Specified|0
7612484|NCT01830816|26486827|P1|Overall Study|Reason not Specified|2
7612485|NCT01830816|26486825|P3|Overall Study|Symptomatic Deterioration|0
7612486|NCT01830816|26486826|P2|Overall Study|Symptomatic Deterioration|0
7612487|NCT01830816|26486827|P1|Overall Study|Symptomatic Deterioration|1
7612488|NCT01830816|26486825|P3|Overall Study|Lost to Follow-up|0
7612489|NCT01830816|26486826|P2|Overall Study|Lost to Follow-up|1
7612490|NCT01830816|26486827|P1|Overall Study|Lost to Follow-up|0
7612491|NCT01830816|26486825|P3|Overall Study|Withdrawal by Subject|0
7612492|NCT01830816|26486826|P2|Overall Study|Withdrawal by Subject|1
7612493|NCT01830816|26486827|P1|Overall Study|Withdrawal by Subject|1
7612494|NCT01830816|26486825|P3|Overall Study|Study Terminated by Sponsor|0
7612495|NCT01830816|26486826|P2|Overall Study|Study Terminated by Sponsor|1
7612496|NCT01830816|26486827|P1|Overall Study|Study Terminated by Sponsor|1
7612497|NCT01830816|26486825|P3|Overall Study|Adverse Event|0
7612498|NCT01830816|26486826|P2|Overall Study|Adverse Event|4
7612499|NCT01830816|26486827|P1|Overall Study|Adverse Event|3
7612500|NCT01830816|26486825|P3|Overall Study|Progressive Disease|7
7612501|NCT01830816|26486826|P2|Overall Study|Progressive Disease|7
7612502|NCT01830816|26486827|P1|Overall Study|Progressive Disease|12
7612503|NCT01830595|26486891|P2|Washout|Withdrawal by Subject|2
7612504|NCT01830595|26486892|P1|Washout|Withdrawal by Subject|2
7612505|NCT01830595|26486891|P2|First Period|Withdrawal by Subject|3
7612506|NCT01830595|26486892|P1|First Period|Withdrawal by Subject|1
7612507|NCT01830543|26486909|P3|Overall Study|Other|37
7612508|NCT01830543|26486910|P2|Overall Study|Other|17
7612509|NCT01830543|26486911|P1|Overall Study|Other|12
7612510|NCT01830543|26486909|P3|Overall Study|Withdrawal by consent|3
7612511|NCT01830543|26486910|P2|Overall Study|Withdrawal by consent|3
7612512|NCT01830543|26486911|P1|Overall Study|Withdrawal by consent|3
7612513|NCT01830543|26486909|P3|Overall Study|Physician Decision|12
7612514|NCT01830543|26486910|P2|Overall Study|Physician Decision|5
7612515|NCT01830543|26486911|P1|Overall Study|Physician Decision|11
7612516|NCT01830543|26486909|P3|Overall Study|Protocol Violation|7
7612517|NCT01830543|26486910|P2|Overall Study|Protocol Violation|7
7612518|NCT01830543|26486911|P1|Overall Study|Protocol Violation|3
7612519|NCT01830543|26486909|P3|Overall Study|Death|22
7612520|NCT01830543|26486910|P2|Overall Study|Death|22
7612521|NCT01830543|26486911|P1|Overall Study|Death|20
7612522|NCT01830543|26486909|P3|Overall Study|Adverse Event|76
7612523|NCT01830543|26486910|P2|Overall Study|Adverse Event|77
7612524|NCT01830543|26486911|P1|Overall Study|Adverse Event|91
7612525|NCT01830543|26486909|P3|Overall Study|Subject Decision|57
7612526|NCT01830543|26486910|P2|Overall Study|Subject Decision|21
7612527|NCT01830543|26486911|P1|Overall Study|Subject Decision|19
7612528|NCT01830127|26487043|P2|Overall Study|Other reason not defined above|2
7612529|NCT01830127|26487044|P1|Overall Study|Other reason not defined above|0
7612530|NCT01830127|26487043|P2|Overall Study|Withdrawal by Subject|1
7612531|NCT01830127|26487044|P1|Overall Study|Withdrawal by Subject|1
7612532|NCT01830127|26487043|P2|Overall Study|Lack of Efficacy|0
7612533|NCT01830127|26487044|P1|Overall Study|Lack of Efficacy|3
7612534|NCT01830127|26487043|P2|Overall Study|Adverse Event|6
7612535|NCT01830127|26487044|P1|Overall Study|Adverse Event|1
7612536|NCT01829711|26487077|P1|Overall Study|Due to lack of response|1
7612537|NCT01829711|26487077|P1|Overall Study|Due to progression of disease|13
7612538|NCT01829711|26487077|P1|Overall Study|Adverse Event|3
7612539|NCT01829711|26487077|P1|Overall Study|Started new therapies|17
7612540|NCT01829711|26487077|P1|Overall Study|Death|4
7612541|NCT01829711|26487077|P1|Overall Study|Withdrawal by Subject|3
7612542|NCT01829711|26487077|P1|Overall Study|Lost to Follow-up|2
7612543|NCT01829477|26487134|P2|Overall Study|Withdrawal by Subject|0
7612544|NCT01829477|26487135|P1|Overall Study|Withdrawal by Subject|1
7612545|NCT01829477|26487134|P2|Overall Study|Study Terminated by Sponsor|15
7612546|NCT01829477|26487135|P1|Overall Study|Study Terminated by Sponsor|15
7612547|NCT01829464|26487148|P3|Overall Study|Lack of Efficacy|0
7612548|NCT01829464|26487149|P2|Overall Study|Lack of Efficacy|1
7612549|NCT01829464|26487150|P1|Overall Study|Lack of Efficacy|0
7612550|NCT01829464|26487148|P3|Overall Study|Study terminated by sponsor|25
7612551|NCT01829464|26487149|P2|Overall Study|Study terminated by sponsor|28
7612552|NCT01829464|26487150|P1|Overall Study|Study terminated by sponsor|25
7612553|NCT01829464|26487148|P3|Overall Study|Withdrawal by Subject|0
7612554|NCT01829464|26487149|P2|Overall Study|Withdrawal by Subject|0
7612555|NCT01829464|26487150|P1|Overall Study|Withdrawal by Subject|2
7612556|NCT01829464|26487148|P3|Overall Study|Lost to Follow-up|1
7612557|NCT01829464|26487149|P2|Overall Study|Lost to Follow-up|0
7612558|NCT01829464|26487150|P1|Overall Study|Lost to Follow-up|0
7612559|NCT01829464|26487148|P3|Overall Study|Adverse Event|0
7612560|NCT01829464|26487149|P2|Overall Study|Adverse Event|0
7612561|NCT01829464|26487150|P1|Overall Study|Adverse Event|1
7612562|NCT01829425|26487166|P2|Overall Study|Lost to Follow-up|1
7612563|NCT01829425|26487167|P1|Overall Study|Lost to Follow-up|2
7612564|NCT01829425|26487166|P2|Overall Study|Withdrawal by Subject|3
7612565|NCT01829425|26487167|P1|Overall Study|Withdrawal by Subject|4
7612566|NCT01829360|26487210|P4|Overall Study|Protocol Violation|0
7612567|NCT01829360|26487211|P3|Overall Study|Protocol Violation|1
7612568|NCT01829360|26487212|P2|Overall Study|Protocol Violation|0
7612569|NCT01829360|26487213|P1|Overall Study|Protocol Violation|0
7612570|NCT01829347|26487233|P2|VTI-210E|Study terminated prematurely|5
7612571|NCT01829347|26487234|P1|VTI-210E|Study terminated prematurely|1
7612572|NCT01829347|26487233|P2|VTI-210E|Death|1
7612573|NCT01829347|26487234|P1|VTI-210E|Death|2
7612574|NCT01829347|26487233|P2|VTI-210|Withdrawal by Subject|0
7612575|NCT01829347|26487234|P1|VTI-210|Withdrawal by Subject|1
7612576|NCT01829347|26487233|P2|VTI-210|Death|3
7612577|NCT01829347|26487234|P1|VTI-210|Death|5
7612578|NCT01829295|26487244|P4|6-12 Months|Withdrawal by Subject|0
7612579|NCT01829295|26487245|P3|6-12 Months|Withdrawal by Subject|0
7612580|NCT01829295|26487246|P2|6-12 Months|Withdrawal by Subject|2
7612581|NCT01829295|26487247|P1|6-12 Months|Withdrawal by Subject|2
7612582|NCT01829295|26487244|P4|6-12 Months|Lost to Follow-up|0
7612583|NCT01829295|26487245|P3|6-12 Months|Lost to Follow-up|0
7612584|NCT01829295|26487246|P2|6-12 Months|Lost to Follow-up|0
7612585|NCT01829295|26487247|P1|6-12 Months|Lost to Follow-up|2
7612586|NCT01829295|26487244|P4|6-12 Months|Adverse Event|2
7612587|NCT01829295|26487245|P3|6-12 Months|Adverse Event|3
7612588|NCT01829295|26487246|P2|6-12 Months|Adverse Event|0
7612589|NCT01829295|26487247|P1|6-12 Months|Adverse Event|0
7612590|NCT01829295|26487244|P4|6-12 Months|Did not want to switch antimetabolites|11
7612591|NCT01829295|26487245|P3|6-12 Months|Did not want to switch antimetabolites|9
7612592|NCT01829295|26487246|P2|6-12 Months|Did not want to switch antimetabolites|0
7612593|NCT01829295|26487247|P1|6-12 Months|Did not want to switch antimetabolites|0
7612594|NCT01829243|26487257|P2|First Intervention|Screen Failure|2
7612595|NCT01829243|26487258|P1|First Intervention|Screen Failure|4
7612596|NCT01829230|26487272|P2|Overall Study|Lost to Follow-up|1
7612597|NCT01829230|26487273|P1|Overall Study|Lost to Follow-up|1
7612598|NCT01829230|26487272|P2|Overall Study|Withdrawal by Subject|1
7612599|NCT01829230|26487273|P1|Overall Study|Withdrawal by Subject|0
7612600|NCT01829230|26487272|P2|Overall Study|Protocol Violation|2
7612601|NCT01829230|26487273|P1|Overall Study|Protocol Violation|0
7612602|NCT01829191|26487287|P2|Overall Study|Subject was fit for ortho - k|1
7612603|NCT01829191|26487288|P1|Overall Study|Subject was fit for ortho - k|0
7612604|NCT01829191|26487287|P2|Overall Study|Lost to Follow-up|1
7612605|NCT01829191|26487288|P1|Overall Study|Lost to Follow-up|0
7612606|NCT01829191|26487287|P2|Overall Study|Withdrawal by Subject|3
7612607|NCT01829191|26487288|P1|Overall Study|Withdrawal by Subject|2
7612608|NCT01829191|26487287|P2|Overall Study|Protocol Violation|1
7612609|NCT01829191|26487288|P1|Overall Study|Protocol Violation|4
7612610|NCT01829191|26487287|P2|Overall Study|Lens handling difficulty|4
7612611|NCT01829191|26487288|P1|Overall Study|Lens handling difficulty|1
7612612|NCT01829191|26487287|P2|Overall Study|Lens discomfort|3
7612613|NCT01829191|26487288|P1|Overall Study|Lens discomfort|0
7612614|NCT01829191|26487287|P2|Overall Study|Relocation|1
7612615|NCT01829191|26487288|P1|Overall Study|Relocation|0
7612616|NCT01829165|26487297|P2|Overall Study|Did not complete intervention|0
7612617|NCT01829165|26487298|P1|Overall Study|Did not complete intervention|2
7612618|NCT01829113|26487306|P2|Overall Study|Physician Decision|1
7612619|NCT01829113|26487307|P1|Overall Study|Physician Decision|1
7612620|NCT01829113|26487306|P2|Overall Study|No Study Treatment Received|2
7612621|NCT01829113|26487307|P1|Overall Study|No Study Treatment Received|3
7612622|NCT01829113|26487306|P2|Overall Study|Sponsor Decision|1
7612623|NCT01829113|26487307|P1|Overall Study|Sponsor Decision|1
7612624|NCT01829113|26487306|P2|Overall Study|Death|6
7612625|NCT01829113|26487307|P1|Overall Study|Death|4
7612626|NCT01829113|26487306|P2|Overall Study|Withdrawal by Subject|10
7612627|NCT01829113|26487307|P1|Overall Study|Withdrawal by Subject|17
7612628|NCT01829113|26487306|P2|Overall Study|Adverse Event|10
7612629|NCT01829113|26487307|P1|Overall Study|Adverse Event|14
7612630|NCT01829113|26487306|P2|Overall Study|Disease Progression|48
7612631|NCT01829113|26487307|P1|Overall Study|Disease Progression|37
7612632|NCT01829048|26487324|P5|Overall Study|Withdrawal by Subject|0
7612633|NCT01829048|26487325|P4|Overall Study|Withdrawal by Subject|2
7612634|NCT01829048|26487326|P3|Overall Study|Withdrawal by Subject|0
7612635|NCT01829048|26487327|P2|Overall Study|Withdrawal by Subject|0
7612636|NCT01829048|26487328|P1|Overall Study|Withdrawal by Subject|0
7612637|NCT01828567|26487441|P2|Overall Study|Excluded - did not meet criteria|1
7612638|NCT01828567|26487442|P1|Overall Study|Excluded - did not meet criteria|4
7612639|NCT01828567|26487441|P2|Overall Study|Lost to Follow-up|9
7612640|NCT01828567|26487442|P1|Overall Study|Lost to Follow-up|27
7612641|NCT01828281|26487497|P2|Overall Study|Withdrawal by Subject|0
7612642|NCT01828281|26487498|P1|Overall Study|Withdrawal by Subject|1
7612653|NCT01828099|26487557|P2|Overall Study|Subject/guardian decision|23
7612654|NCT01828099|26487558|P1|Overall Study|Subject/guardian decision|7
7612655|NCT01828099|26487557|P2|Overall Study|Protocol Violation|0
7612656|NCT01828099|26487558|P1|Overall Study|Protocol Violation|1
7612657|NCT01828099|26487557|P2|Overall Study|Progressive disease|94
7612658|NCT01828099|26487558|P1|Overall Study|Progressive disease|51
7612659|NCT01828099|26487557|P2|Overall Study|Physician Decision|11
7612660|NCT01828099|26487558|P1|Overall Study|Physician Decision|7
7612661|NCT01828099|26487557|P2|Overall Study|Non-compliance with study treatment|0
7612662|NCT01828099|26487558|P1|Overall Study|Non-compliance with study treatment|2
7612663|NCT01828099|26487557|P2|Overall Study|Lost to Follow-up|0
7612664|NCT01828099|26487558|P1|Overall Study|Lost to Follow-up|2
7612665|NCT01828099|26487557|P2|Overall Study|Death|11
7612666|NCT01828099|26487558|P1|Overall Study|Death|9
7612667|NCT01828099|26487557|P2|Overall Study|Adverse Event|18
7612668|NCT01828099|26487558|P1|Overall Study|Adverse Event|15
7612669|NCT01828073|26487566|P2|Overall Study|Lost to Follow-up|2
7612670|NCT01828073|26487567|P1|Overall Study|Lost to Follow-up|1
7612671|NCT01828034|26487591|P4|Overall Study|Withdrawal by Subject|1
7612672|NCT01828034|26487592|P3|Overall Study|Withdrawal by Subject|0
7612673|NCT01828034|26487593|P2|Overall Study|Withdrawal by Subject|0
7612674|NCT01828034|26487594|P1|Overall Study|Withdrawal by Subject|0
7612675|NCT01828021|26487606|P1|Overall Study|Ileal obstruction, unrelated|1
7612676|NCT01828021|26487606|P1|Overall Study|Withdrawal by Subject|2
7612677|NCT01828021|26487606|P1|Overall Study|Lack of Efficacy|17
7612678|NCT01828021|26487606|P1|Overall Study|Adverse Event|5
7612679|NCT01827943|26487611|P1|Overall Study|Never treated because of an rapid progression|1
7612680|NCT01827943|26487611|P1|Overall Study|Protocol Violation|8
7612681|NCT01827839|26487651|P1|Overall Study|Consent Withdrawal|2
7612682|NCT01827839|26487651|P1|Overall Study|Adverse Event|1
7612683|NCT01827670|26487696|P2|Overall Study|Lost to Follow-up|1
7612684|NCT01827670|26487697|P1|Overall Study|Lost to Follow-up|0
7612685|NCT01827670|26487696|P2|Overall Study|Withdrawal of Consent|2
7612686|NCT01827670|26487697|P1|Overall Study|Withdrawal of Consent|3
7612687|NCT01827592|26487716|P3|Overall Study|Others|3
7612688|NCT01827592|26487717|P2|Overall Study|Others|1
7612689|NCT01827592|26487718|P1|Overall Study|Others|0
7612690|NCT01827592|26487716|P3|Overall Study|Trial terminated by Sponsor|51
7612691|NCT01827592|26487717|P2|Overall Study|Trial terminated by Sponsor|53
7612692|NCT01827592|26487718|P1|Overall Study|Trial terminated by Sponsor|47
7612693|NCT01827592|26487716|P3|Overall Study|Patient's substantial non-compliance|6
7612694|NCT01827592|26487717|P2|Overall Study|Patient's substantial non-compliance|1
7612695|NCT01827592|26487718|P1|Overall Study|Patient's substantial non-compliance|1
7612696|NCT01827592|26487716|P3|Overall Study|Withdrawal by Subject|11
7612697|NCT01827592|26487717|P2|Overall Study|Withdrawal by Subject|11
7612698|NCT01827592|26487718|P1|Overall Study|Withdrawal by Subject|12
7612699|NCT01827592|26487716|P3|Overall Study|Lost to Follow-up|2
7612700|NCT01827592|26487717|P2|Overall Study|Lost to Follow-up|2
7612701|NCT01827592|26487718|P1|Overall Study|Lost to Follow-up|1
7612702|NCT01827592|26487716|P3|Overall Study|Protocol Violation|0
7612703|NCT01827592|26487717|P2|Overall Study|Protocol Violation|1
7612704|NCT01827592|26487718|P1|Overall Study|Protocol Violation|2
7612705|NCT01827592|26487716|P3|Overall Study|Physician Decision|1
7612706|NCT01827592|26487717|P2|Overall Study|Physician Decision|2
7612707|NCT01827592|26487718|P1|Overall Study|Physician Decision|0
7612708|NCT01827592|26487716|P3|Overall Study|Adverse Event|2
7612709|NCT01827592|26487717|P2|Overall Study|Adverse Event|9
7612710|NCT01827592|26487718|P1|Overall Study|Adverse Event|11
7612711|NCT01827371|26487783|P4|Overall Study|Temporary study halt to vaccinations|13
7612712|NCT01827371|26487784|P3|Overall Study|Temporary study halt to vaccinations|5
7612713|NCT01827371|26487785|P2|Overall Study|Temporary study halt to vaccinations|2
7612714|NCT01827371|26487786|P1|Overall Study|Temporary study halt to vaccinations|11
7612715|NCT01827371|26487783|P4|Overall Study|Physician Decision|1
7612716|NCT01827371|26487784|P3|Overall Study|Physician Decision|0
7612717|NCT01827371|26487785|P2|Overall Study|Physician Decision|1
7612718|NCT01827371|26487786|P1|Overall Study|Physician Decision|0
7612719|NCT01827371|26487783|P4|Overall Study|Withdrawal by Subject|3
7612720|NCT01827371|26487784|P3|Overall Study|Withdrawal by Subject|2
7612721|NCT01827371|26487785|P2|Overall Study|Withdrawal by Subject|2
7612722|NCT01827371|26487786|P1|Overall Study|Withdrawal by Subject|1
7612723|NCT01827371|26487783|P4|Overall Study|Protocol Violation|0
7612724|NCT01827371|26487784|P3|Overall Study|Protocol Violation|0
7612725|NCT01827371|26487785|P2|Overall Study|Protocol Violation|0
7612726|NCT01827371|26487786|P1|Overall Study|Protocol Violation|1
7612727|NCT01827371|26487783|P4|Overall Study|Lost to Follow-up|4
7612728|NCT01827371|26487784|P3|Overall Study|Lost to Follow-up|0
7612729|NCT01827371|26487785|P2|Overall Study|Lost to Follow-up|2
7612730|NCT01827371|26487786|P1|Overall Study|Lost to Follow-up|0
7612731|NCT01827371|26487783|P4|Overall Study|Adverse Event|2
7612732|NCT01827371|26487784|P3|Overall Study|Adverse Event|4
7612733|NCT01827371|26487785|P2|Overall Study|Adverse Event|0
7612734|NCT01827371|26487786|P1|Overall Study|Adverse Event|0
7612735|NCT01827332|26487845|P2|Overall Study|Lost to Follow-up|1
7612736|NCT01827332|26487846|P1|Overall Study|Lost to Follow-up|2
7612737|NCT01827319|26487854|P1|Overall Study|Lost to Follow-up|3
7612738|NCT01827267|26487877|P2|Overall Study|Still on study|2
7612739|NCT01827267|26487878|P1|Overall Study|Still on study|0
7612740|NCT01827267|26487877|P2|Overall Study|Sponsor Discontinued Study|8
7612741|NCT01827267|26487878|P1|Overall Study|Sponsor Discontinued Study|2
7612742|NCT01827267|26487877|P2|Overall Study|Disease Progression|1
7612743|NCT01827267|26487878|P1|Overall Study|Disease Progression|1
7612744|NCT01827267|26487877|P2|Overall Study|Physician Decision|0
7612745|NCT01827267|26487878|P1|Overall Study|Physician Decision|1
7612746|NCT01827267|26487877|P2|Overall Study|Did not receive study drug|1
7612747|NCT01827267|26487878|P1|Overall Study|Did not receive study drug|1
7612748|NCT01827254|26487893|P1|Overall Study|Intolerance to treatment|4
7612749|NCT01827254|26487893|P1|Overall Study|Disease progression|36
7612750|NCT01827254|26487893|P1|Overall Study|Did not complete re-challenge|1
7612751|NCT01827254|26487893|P1|Overall Study|Discontinued prior initiation: sunitinib|1
7612752|NCT01827254|26487893|P1|Overall Study|Invalidated centre|3
7612753|NCT01827254|26487893|P1|Overall Study|Case report form not completed|4
7612754|NCT01827254|26487893|P1|Overall Study|Death|10
7612755|NCT01827163|26487903|P1|Overall Study|Adverse Event|9
7612756|NCT01827163|26487903|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
7612757|NCT01827046|26487910|P2|Overall Study|Withdrawal by Subject|4
7612758|NCT01827046|26487911|P1|Overall Study|Withdrawal by Subject|0
7612759|NCT01827046|26487910|P2|Overall Study|Lost to Follow-up|5
7612760|NCT01827046|26487911|P1|Overall Study|Lost to Follow-up|1
7612761|NCT01826981|26487966|P15|Overall Study|Enrolled/Randomized but Not Treated|0
7612762|NCT01826981|26487967|P14|Overall Study|Enrolled/Randomized but Not Treated|0
7612763|NCT01826981|26487968|P13|Overall Study|Enrolled/Randomized but Not Treated|0
7612764|NCT01826981|26487969|P12|Overall Study|Enrolled/Randomized but Not Treated|0
7612765|NCT01826981|26487970|P11|Overall Study|Enrolled/Randomized but Not Treated|0
7612766|NCT01826981|26487971|P10|Overall Study|Enrolled/Randomized but Not Treated|0
7612767|NCT01826981|26487972|P9|Overall Study|Enrolled/Randomized but Not Treated|0
7612768|NCT01826981|26487973|P8|Overall Study|Enrolled/Randomized but Not Treated|1
7612769|NCT01826981|26487974|P7|Overall Study|Enrolled/Randomized but Not Treated|0
7612770|NCT01826981|26487975|P6|Overall Study|Enrolled/Randomized but Not Treated|0
7612771|NCT01826981|26487976|P5|Overall Study|Enrolled/Randomized but Not Treated|0
7612772|NCT01826981|26487977|P4|Overall Study|Enrolled/Randomized but Not Treated|0
7612773|NCT01826981|26487978|P3|Overall Study|Enrolled/Randomized but Not Treated|0
7612774|NCT01826981|26487979|P2|Overall Study|Enrolled/Randomized but Not Treated|0
7612775|NCT01826981|26487980|P1|Overall Study|Enrolled/Randomized but Not Treated|0
7612776|NCT01826981|26487966|P15|Overall Study|Upper G-I Haemorrhage|0
7612777|NCT01826981|26487967|P14|Overall Study|Upper G-I Haemorrhage|1
7612778|NCT01826981|26487968|P13|Overall Study|Upper G-I Haemorrhage|0
7612779|NCT01826981|26487969|P12|Overall Study|Upper G-I Haemorrhage|0
7612780|NCT01826981|26487970|P11|Overall Study|Upper G-I Haemorrhage|0
7612781|NCT01826981|26487971|P10|Overall Study|Upper G-I Haemorrhage|0
7612782|NCT01826981|26487972|P9|Overall Study|Upper G-I Haemorrhage|0
7612783|NCT01826981|26487973|P8|Overall Study|Upper G-I Haemorrhage|0
7612784|NCT01826981|26487974|P7|Overall Study|Upper G-I Haemorrhage|0
7612785|NCT01826981|26487975|P6|Overall Study|Upper G-I Haemorrhage|0
7612786|NCT01826981|26487976|P5|Overall Study|Upper G-I Haemorrhage|0
7612787|NCT01826981|26487977|P4|Overall Study|Upper G-I Haemorrhage|0
7612788|NCT01826981|26487978|P3|Overall Study|Upper G-I Haemorrhage|0
7612789|NCT01826981|26487979|P2|Overall Study|Upper G-I Haemorrhage|0
7612790|NCT01826981|26487980|P1|Overall Study|Upper G-I Haemorrhage|0
7612791|NCT01826981|26487966|P15|Overall Study|Adverse Event|0
7612792|NCT01826981|26487967|P14|Overall Study|Adverse Event|0
7612793|NCT01826981|26487968|P13|Overall Study|Adverse Event|0
7612794|NCT01826981|26487969|P12|Overall Study|Adverse Event|0
7612795|NCT01826981|26487970|P11|Overall Study|Adverse Event|0
7612796|NCT01826981|26487971|P10|Overall Study|Adverse Event|0
7612797|NCT01826981|26487972|P9|Overall Study|Adverse Event|0
7612798|NCT01826981|26487973|P8|Overall Study|Adverse Event|0
7612799|NCT01826981|26487974|P7|Overall Study|Adverse Event|0
7612800|NCT01826981|26487975|P6|Overall Study|Adverse Event|0
7612801|NCT01826981|26487976|P5|Overall Study|Adverse Event|1
7612802|NCT01826981|26487977|P4|Overall Study|Adverse Event|0
7612803|NCT01826981|26487978|P3|Overall Study|Adverse Event|0
7612804|NCT01826981|26487979|P2|Overall Study|Adverse Event|0
7612805|NCT01826981|26487980|P1|Overall Study|Adverse Event|0
7612806|NCT01826981|26487966|P15|Overall Study|Withdrew Consent|0
7612807|NCT01826981|26487967|P14|Overall Study|Withdrew Consent|1
7612808|NCT01826981|26487968|P13|Overall Study|Withdrew Consent|0
7612809|NCT01826981|26487969|P12|Overall Study|Withdrew Consent|1
7612810|NCT01826981|26487970|P11|Overall Study|Withdrew Consent|0
7612811|NCT01826981|26487971|P10|Overall Study|Withdrew Consent|0
7612812|NCT01826981|26487972|P9|Overall Study|Withdrew Consent|0
7612813|NCT01826981|26487973|P8|Overall Study|Withdrew Consent|1
7612814|NCT01826981|26487974|P7|Overall Study|Withdrew Consent|1
7612815|NCT01826981|26487975|P6|Overall Study|Withdrew Consent|0
7612816|NCT01826981|26487976|P5|Overall Study|Withdrew Consent|0
7612817|NCT01826981|26487977|P4|Overall Study|Withdrew Consent|0
7612818|NCT01826981|26487978|P3|Overall Study|Withdrew Consent|0
7612819|NCT01826981|26487979|P2|Overall Study|Withdrew Consent|0
7612820|NCT01826981|26487980|P1|Overall Study|Withdrew Consent|0
7612821|NCT01826981|26487966|P15|Overall Study|Lost to Follow-up|0
7612822|NCT01826981|26487967|P14|Overall Study|Lost to Follow-up|0
7612823|NCT01826981|26487968|P13|Overall Study|Lost to Follow-up|1
7612824|NCT01826981|26487969|P12|Overall Study|Lost to Follow-up|1
7612825|NCT01826981|26487970|P11|Overall Study|Lost to Follow-up|1
7612826|NCT01826981|26487971|P10|Overall Study|Lost to Follow-up|1
7612827|NCT01826981|26487972|P9|Overall Study|Lost to Follow-up|0
7612828|NCT01826981|26487973|P8|Overall Study|Lost to Follow-up|1
7612829|NCT01826981|26487974|P7|Overall Study|Lost to Follow-up|0
7612830|NCT01826981|26487975|P6|Overall Study|Lost to Follow-up|1
7612831|NCT01826981|26487976|P5|Overall Study|Lost to Follow-up|1
7612832|NCT01826981|26487977|P4|Overall Study|Lost to Follow-up|0
7612833|NCT01826981|26487978|P3|Overall Study|Lost to Follow-up|0
7612834|NCT01826981|26487979|P2|Overall Study|Lost to Follow-up|0
7612835|NCT01826981|26487980|P1|Overall Study|Lost to Follow-up|0
7612836|NCT01826981|26487966|P15|Overall Study|Lack of Efficacy|0
7612837|NCT01826981|26487967|P14|Overall Study|Lack of Efficacy|3
7612838|NCT01826981|26487968|P13|Overall Study|Lack of Efficacy|0
7612839|NCT01826981|26487969|P12|Overall Study|Lack of Efficacy|0
7612840|NCT01826981|26487970|P11|Overall Study|Lack of Efficacy|1
7612841|NCT01826981|26487971|P10|Overall Study|Lack of Efficacy|0
7612842|NCT01826981|26487972|P9|Overall Study|Lack of Efficacy|7
7612843|NCT01826981|26487973|P8|Overall Study|Lack of Efficacy|8
7612844|NCT01826981|26487974|P7|Overall Study|Lack of Efficacy|0
7612845|NCT01826981|26487975|P6|Overall Study|Lack of Efficacy|0
7612846|NCT01826981|26487976|P5|Overall Study|Lack of Efficacy|5
7612847|NCT01826981|26487977|P4|Overall Study|Lack of Efficacy|0
7612848|NCT01826981|26487978|P3|Overall Study|Lack of Efficacy|0
7612849|NCT01826981|26487979|P2|Overall Study|Lack of Efficacy|1
7612850|NCT01826981|26487980|P1|Overall Study|Lack of Efficacy|0
7612851|NCT01826825|26488149|P2|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
7612852|NCT01826825|26488150|P1|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
7612853|NCT01826604|26488179|P2|Overall Study|Lost to Follow-up|9
7612854|NCT01826604|26488180|P1|Overall Study|Lost to Follow-up|8
7612855|NCT01826487|26488224|P2|Overall Study|Protocol Violation|1
7612856|NCT01826487|26488225|P1|Overall Study|Protocol Violation|1
7612857|NCT01826487|26488224|P2|Overall Study|Withdrawal by Subject|3
7612858|NCT01826487|26488225|P1|Overall Study|Withdrawal by Subject|1
7612859|NCT01826487|26488224|P2|Overall Study|Lost to Follow-up|0
7612860|NCT01826487|26488225|P1|Overall Study|Lost to Follow-up|1
7612861|NCT01826487|26488224|P2|Overall Study|Adverse Event|1
7612862|NCT01826487|26488225|P1|Overall Study|Adverse Event|1
7612863|NCT01826448|26488252|P2|Overall Study|2 active cancers|1
7612864|NCT01826448|26488253|P1|Overall Study|2 active cancers|0
7612865|NCT01826448|26488252|P2|Overall Study|Physician Decision|1
7612866|NCT01826448|26488253|P1|Overall Study|Physician Decision|0
7612867|NCT01826448|26488252|P2|Overall Study|Withdrawal by Subject|0
7612868|NCT01826448|26488253|P1|Overall Study|Withdrawal by Subject|1
7612869|NCT01826448|26488252|P2|Overall Study|Disease progression|4
7612870|NCT01826448|26488253|P1|Overall Study|Disease progression|2
7612871|NCT01826448|26488252|P2|Overall Study|Adverse Event|3
7612872|NCT01826448|26488253|P1|Overall Study|Adverse Event|1
7612873|NCT01826422|26488261|P2|Overall Study|Withdrawal by Subject|3
7612874|NCT01826422|26488262|P1|Overall Study|Withdrawal by Subject|1
7612875|NCT01826370|26488306|P1|Overall Study|Other reason not defined above|2
7612876|NCT01826370|26488306|P1|Overall Study|Lost to Follow-up|12
7612877|NCT01826370|26488306|P1|Overall Study|Protocol Violation|6
7612878|NCT01826214|26488318|P2|Overall Study|Subject/guardian decision|3
7612879|NCT01826214|26488319|P1|Overall Study|Subject/guardian decision|2
7612880|NCT01826214|26488318|P2|Overall Study|Study terminated by Sponsor|1
7612881|NCT01826214|26488319|P1|Overall Study|Study terminated by Sponsor|0
7612882|NCT01826214|26488318|P2|Overall Study|Progressive disease|21
7612883|NCT01826214|26488319|P1|Overall Study|Progressive disease|22
7612884|NCT01826214|26488318|P2|Overall Study|Physician Decision|2
7612885|NCT01826214|26488319|P1|Overall Study|Physician Decision|0
7612886|NCT01826214|26488318|P2|Overall Study|Lost to Follow-up|0
7612887|NCT01826214|26488319|P1|Overall Study|Lost to Follow-up|1
7612888|NCT01826214|26488318|P2|Overall Study|Death|1
7612889|NCT01826214|26488319|P1|Overall Study|Death|3
7612890|NCT01826214|26488318|P2|Overall Study|Adverse Event|6
7612891|NCT01826214|26488319|P1|Overall Study|Adverse Event|7
7612892|NCT01826201|26488337|P1|Overall Study|Non compliance with protocol|4
7612893|NCT01825941|26488345|P2|Overall Study|Lost to Follow-up|1
7612894|NCT01825941|26488346|P1|Overall Study|Lost to Follow-up|4
7612895|NCT01825876|26488365|P2|Period 2|Withdrawal by Subject|1
7612896|NCT01825876|26488366|P1|Period 2|Withdrawal by Subject|0
7612897|NCT01825837|26488387|P4|PART II|reason unspecified|0
7612898|NCT01825837|26488388|P3|PART II|reason unspecified|2
7612899|NCT01825837|26488389|P2|PART II|reason unspecified|2
7612900|NCT01825837|26488390|P1|PART II|reason unspecified|2
7612901|NCT01825837|26488387|P4|PART II|Treatment failure|0
7612902|NCT01825837|26488388|P3|PART II|Treatment failure|5
7612903|NCT01825837|26488389|P2|PART II|Treatment failure|4
7612904|NCT01825837|26488390|P1|PART II|Treatment failure|6
7612905|NCT01825837|26488387|P4|PART II|Adverse Event|0
7612906|NCT01825837|26488388|P3|PART II|Adverse Event|1
7612907|NCT01825837|26488389|P2|PART II|Adverse Event|3
7612908|NCT01825837|26488390|P1|PART II|Adverse Event|3
7612909|NCT01825837|26488387|P4|PART II|Patient non-compliance|0
7612910|NCT01825837|26488388|P3|PART II|Patient non-compliance|4
7612911|NCT01825837|26488389|P2|PART II|Patient non-compliance|2
7612912|NCT01825837|26488390|P1|PART II|Patient non-compliance|5
7612913|NCT01825837|26488387|P4|PART II|Withdrawal by Subject|0
7612914|NCT01825837|26488388|P3|PART II|Withdrawal by Subject|7
7612915|NCT01825837|26488389|P2|PART II|Withdrawal by Subject|3
7612916|NCT01825837|26488390|P1|PART II|Withdrawal by Subject|3
7612917|NCT01825837|26488387|P4|PART I|reason unspecified|3
7612918|NCT01825837|26488388|P3|PART I|reason unspecified|0
7612919|NCT01825837|26488389|P2|PART I|reason unspecified|0
7612920|NCT01825837|26488390|P1|PART I|reason unspecified|0
7612921|NCT01825837|26488387|P4|PART I|Treatment failure|7
7612922|NCT01825837|26488388|P3|PART I|Treatment failure|0
7612923|NCT01825837|26488389|P2|PART I|Treatment failure|0
7612924|NCT01825837|26488390|P1|PART I|Treatment failure|0
7612925|NCT01825837|26488387|P4|PART I|Patient non-compliance|1
7612926|NCT01825837|26488388|P3|PART I|Patient non-compliance|0
7612927|NCT01825837|26488389|P2|PART I|Patient non-compliance|0
7612928|NCT01825837|26488390|P1|PART I|Patient non-compliance|0
7612929|NCT01825837|26488387|P4|PART I|Withdrawal by Subject|6
7612930|NCT01825837|26488388|P3|PART I|Withdrawal by Subject|0
7612931|NCT01825837|26488389|P2|PART I|Withdrawal by Subject|0
7612932|NCT01825837|26488390|P1|PART I|Withdrawal by Subject|0
7612933|NCT01825798|26488400|P2|Overall Study|Lost to Follow-up|0
7612934|NCT01825798|26488401|P1|Overall Study|Lost to Follow-up|1
7612935|NCT01825798|26488400|P2|Overall Study|Adverse Event|5
7612936|NCT01825798|26488401|P1|Overall Study|Adverse Event|1
7612937|NCT01825785|26488436|P7|Overall Study|Withdrawal by Subject|0
7612938|NCT01825785|26488437|P6|Overall Study|Withdrawal by Subject|1
7612939|NCT01825785|26488438|P5|Overall Study|Withdrawal by Subject|1
7612940|NCT01825785|26488439|P4|Overall Study|Withdrawal by Subject|0
7612941|NCT01825785|26488440|P3|Overall Study|Withdrawal by Subject|0
7612942|NCT01825785|26488441|P2|Overall Study|Withdrawal by Subject|0
7612943|NCT01825785|26488442|P1|Overall Study|Withdrawal by Subject|0
7612944|NCT01825785|26488436|P7|Overall Study|Adverse Event|0
7612945|NCT01825785|26488437|P6|Overall Study|Adverse Event|0
7612946|NCT01825785|26488438|P5|Overall Study|Adverse Event|1
7612947|NCT01825785|26488439|P4|Overall Study|Adverse Event|0
7612948|NCT01825785|26488440|P3|Overall Study|Adverse Event|0
7612949|NCT01825785|26488441|P2|Overall Study|Adverse Event|0
7612950|NCT01825785|26488442|P1|Overall Study|Adverse Event|0
7612951|NCT01825577|26488595|P1|Overall Study|Lack of Efficacy|3
7612952|NCT01825577|26488595|P1|Overall Study|Withdrawn by family members|2
7612953|NCT01825577|26488595|P1|Overall Study|Withdrawal by Subject|1
7612954|NCT01825577|26488595|P1|Overall Study|Physician Decision|2
7612955|NCT01825200|26488634|P2|Overall Study|Withdrawal by Subject|1
7612956|NCT01825200|26488635|P1|Overall Study|Withdrawal by Subject|0
7612957|NCT01825200|26488634|P2|Overall Study|Lost to Follow-up|6
7612958|NCT01825200|26488635|P1|Overall Study|Lost to Follow-up|5
7612959|NCT01824979|26488686|P2|Overall Study|Protocol Violation|13
7612960|NCT01824979|26488687|P1|Overall Study|Protocol Violation|6
7612961|NCT01824979|26488686|P2|Overall Study|Physician Decision|0
7612962|NCT01824979|26488687|P1|Overall Study|Physician Decision|2
7612963|NCT01824979|26488686|P2|Overall Study|Withdrawal by Subject|0
7612964|NCT01824979|26488687|P1|Overall Study|Withdrawal by Subject|5
7612965|NCT01824823|26488704|P2|Overall Study|Off-treatment reason not submitted|0
7612966|NCT01824823|26488705|P1|Overall Study|Off-treatment reason not submitted|1
7612967|NCT01824823|26488704|P2|Overall Study|Lack of Efficacy|1
7612968|NCT01824823|26488705|P1|Overall Study|Lack of Efficacy|1
7612969|NCT01824693|26488714|P3|Overall Study|No Transplant Planned|10
7612970|NCT01824693|26488715|P2|Overall Study|No Transplant Planned|0
7612971|NCT01824693|26488716|P1|Overall Study|No Transplant Planned|0
7612972|NCT01824693|26488714|P3|Overall Study|Ineligible|3
7612973|NCT01824693|26488715|P2|Overall Study|Ineligible|0
7612974|NCT01824693|26488716|P1|Overall Study|Ineligible|0
7612975|NCT01824693|26488714|P3|Overall Study|Progressive Disease|0
7612976|NCT01824693|26488715|P2|Overall Study|Progressive Disease|5
7612977|NCT01824693|26488716|P1|Overall Study|Progressive Disease|0
7612978|NCT01824693|26488714|P3|Overall Study|Withdrawal by Subject|1
7612979|NCT01824693|26488715|P2|Overall Study|Withdrawal by Subject|0
7612980|NCT01824693|26488716|P1|Overall Study|Withdrawal by Subject|0
7612981|NCT01824693|26488714|P3|Overall Study|Physician Decision|1
7612982|NCT01824693|26488715|P2|Overall Study|Physician Decision|1
7612983|NCT01824693|26488716|P1|Overall Study|Physician Decision|1
7612984|NCT01824693|26488714|P3|Overall Study|Death|0
7612985|NCT01824693|26488715|P2|Overall Study|Death|1
7612986|NCT01824693|26488716|P1|Overall Study|Death|0
7612987|NCT01824602|26488733|P4|Overall Study|Treatment failure|1
7612988|NCT01824602|26488734|P3|Overall Study|Treatment failure|0
7612989|NCT01824602|26488735|P2|Overall Study|Treatment failure|0
7612990|NCT01824602|26488736|P1|Overall Study|Treatment failure|0
7612991|NCT01824602|26488733|P4|Overall Study|Adverse Event|2
7612992|NCT01824602|26488734|P3|Overall Study|Adverse Event|2
7612993|NCT01824602|26488735|P2|Overall Study|Adverse Event|0
7612994|NCT01824602|26488736|P1|Overall Study|Adverse Event|1
7612995|NCT01824602|26488733|P4|Overall Study|Patient non-compliance|0
7612996|NCT01824602|26488734|P3|Overall Study|Patient non-compliance|1
7612997|NCT01824602|26488735|P2|Overall Study|Patient non-compliance|0
7612998|NCT01824602|26488736|P1|Overall Study|Patient non-compliance|0
7612999|NCT01824602|26488733|P4|Overall Study|Withdrawal by Subject|2
7613000|NCT01824602|26488734|P3|Overall Study|Withdrawal by Subject|1
7613001|NCT01824602|26488735|P2|Overall Study|Withdrawal by Subject|0
7613002|NCT01824602|26488736|P1|Overall Study|Withdrawal by Subject|0
7613003|NCT01824576|26488775|P1|Overall Study|Device deficiency|2
7613004|NCT01824498|26488793|P6|Washout (8 Weeks)|Withdrawal by Subject|0
7613005|NCT01824498|26488794|P5|Washout (8 Weeks)|Withdrawal by Subject|1
7613006|NCT01824498|26488795|P4|Washout (8 Weeks)|Withdrawal by Subject|1
7613007|NCT01824498|26488796|P3|Washout (8 Weeks)|Withdrawal by Subject|2
7613008|NCT01824498|26488797|P2|Washout (8 Weeks)|Withdrawal by Subject|0
7613009|NCT01824498|26488798|P1|Washout (8 Weeks)|Withdrawal by Subject|2
7613010|NCT01824472|26488809|P3|Overall Study|Ineligible post randomization&screening|0
7613011|NCT01824472|26488810|P2|Overall Study|Ineligible post randomization&screening|2
7613012|NCT01824472|26488811|P1|Overall Study|Ineligible post randomization&screening|0
7613013|NCT01824472|26488809|P3|Overall Study|Withdrawal by Subject|3
7613014|NCT01824472|26488810|P2|Overall Study|Withdrawal by Subject|5
7613015|NCT01824472|26488811|P1|Overall Study|Withdrawal by Subject|1
7613016|NCT01824472|26488809|P3|Overall Study|Lost to Follow-up|1
7613017|NCT01824472|26488810|P2|Overall Study|Lost to Follow-up|0
7613018|NCT01824472|26488811|P1|Overall Study|Lost to Follow-up|0
7613019|NCT01824394|26488845|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
7613020|NCT01824394|26488846|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
7613021|NCT01824394|26488847|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
7613022|NCT01824394|26488845|P3|Overall Study|Discontinued Subjects|2
7613023|NCT01824394|26488846|P2|Overall Study|Discontinued Subjects|1
7613024|NCT01824394|26488847|P1|Overall Study|Discontinued Subjects|1
7613025|NCT01824394|26488845|P3|Overall Study|Death|4
7613026|NCT01824394|26488846|P2|Overall Study|Death|2
7613027|NCT01824394|26488847|P1|Overall Study|Death|3
7613028|NCT01824394|26488845|P3|Overall Study|Lost to Follow-up|3
7613029|NCT01824394|26488846|P2|Overall Study|Lost to Follow-up|9
7613030|NCT01824394|26488847|P1|Overall Study|Lost to Follow-up|0
7613031|NCT01824394|26488845|P3|Overall Study|Withdrawn due to Study Termination|41
7613032|NCT01824394|26488846|P2|Overall Study|Withdrawn due to Study Termination|83
7613033|NCT01824394|26488847|P1|Overall Study|Withdrawn due to Study Termination|91
7613034|NCT01824394|26488845|P3|Overall Study|Early Termination|3
7613035|NCT01824394|26488846|P2|Overall Study|Early Termination|1
7613036|NCT01824394|26488847|P1|Overall Study|Early Termination|1
7613037|NCT01824355|26488857|P1|Overall Study|unevaluable reference method results per|1
7613038|NCT01824355|26488857|P1|Overall Study|Adverse Event|2
7613039|NCT01824342|26488868|P2|Overall Study|Death|0
7613040|NCT01824342|26488869|P1|Overall Study|Death|2
7613041|NCT01824342|26488868|P2|Overall Study|Physician Decision|0
7613042|NCT01824342|26488869|P1|Overall Study|Physician Decision|5
7613043|NCT01824342|26488868|P2|Overall Study|Disease Progression|1
7613044|NCT01824342|26488869|P1|Overall Study|Disease Progression|1
7613045|NCT01824342|26488868|P2|Overall Study|Adverse Event|1
7613046|NCT01824342|26488869|P1|Overall Study|Adverse Event|1
7613047|NCT01824342|26488868|P2|Overall Study|Withdrawal by Subject|3
7613048|NCT01824342|26488869|P1|Overall Study|Withdrawal by Subject|0
7613049|NCT01824303|26488883|P2|Randomized Study|Other Miscellaneous Reasons|0
7613050|NCT01824303|26488884|P1|Randomized Study|Other Miscellaneous Reasons|1
7613051|NCT01824303|26488883|P2|Randomized Study|Withdrawal by Subject|1
7613052|NCT01824303|26488884|P1|Randomized Study|Withdrawal by Subject|1
7613053|NCT01824290|26488910|P2|Overall Study|Investigator Reported Clinical Worsening|1
7613054|NCT01824290|26488911|P1|Overall Study|Investigator Reported Clinical Worsening|1
7613055|NCT01824290|26488910|P2|Overall Study|Parent/Caregiver Decision|1
7613056|NCT01824290|26488911|P1|Overall Study|Parent/Caregiver Decision|1
7613057|NCT01824290|26488910|P2|Overall Study|Entry Criteria Not Met|0
7613058|NCT01824290|26488911|P1|Overall Study|Entry Criteria Not Met|1
7613059|NCT01823991|26488990|P2|Overall Study|Withdrawal by Subject|5
7613060|NCT01823991|26488991|P1|Overall Study|Withdrawal by Subject|8
7613061|NCT01823835|26489047|P15|Overall Study|Withdrawal by Subject|0
7613062|NCT01823835|26489048|P14|Overall Study|Withdrawal by Subject|0
7613063|NCT01823835|26489049|P13|Overall Study|Withdrawal by Subject|1
7613064|NCT01823835|26489050|P12|Overall Study|Withdrawal by Subject|2
7613065|NCT01823835|26489051|P11|Overall Study|Withdrawal by Subject|1
7613066|NCT01823835|26489052|P10|Overall Study|Withdrawal by Subject|1
7613067|NCT01823835|26489053|P9|Overall Study|Withdrawal by Subject|0
7613068|NCT01823835|26489054|P8|Overall Study|Withdrawal by Subject|0
7613069|NCT01823835|26489055|P7|Overall Study|Withdrawal by Subject|0
7613070|NCT01823835|26489056|P6|Overall Study|Withdrawal by Subject|0
7613071|NCT01823835|26489057|P5|Overall Study|Withdrawal by Subject|0
7613072|NCT01823835|26489058|P4|Overall Study|Withdrawal by Subject|0
7613073|NCT01823835|26489059|P3|Overall Study|Withdrawal by Subject|1
7613074|NCT01823835|26489060|P2|Overall Study|Withdrawal by Subject|0
7613075|NCT01823835|26489061|P1|Overall Study|Withdrawal by Subject|0
7613076|NCT01823835|26489047|P15|Overall Study|Study Termination|0
7613077|NCT01823835|26489048|P14|Overall Study|Study Termination|0
7613078|NCT01823835|26489049|P13|Overall Study|Study Termination|0
7613079|NCT01823835|26489050|P12|Overall Study|Study Termination|1
7613080|NCT01823835|26489051|P11|Overall Study|Study Termination|0
7613081|NCT01823835|26489052|P10|Overall Study|Study Termination|0
7613082|NCT01823835|26489053|P9|Overall Study|Study Termination|0
7613083|NCT01823835|26489054|P8|Overall Study|Study Termination|0
7613084|NCT01823835|26489055|P7|Overall Study|Study Termination|0
7613085|NCT01823835|26489056|P6|Overall Study|Study Termination|0
7613086|NCT01823835|26489057|P5|Overall Study|Study Termination|1
7613087|NCT01823835|26489058|P4|Overall Study|Study Termination|0
7613088|NCT01823835|26489059|P3|Overall Study|Study Termination|0
7613089|NCT01823835|26489060|P2|Overall Study|Study Termination|0
7613090|NCT01823835|26489061|P1|Overall Study|Study Termination|0
7613091|NCT01823835|26489047|P15|Overall Study|Progressive Disease|6
7613092|NCT01823835|26489048|P14|Overall Study|Progressive Disease|4
7613093|NCT01823835|26489049|P13|Overall Study|Progressive Disease|18
7613094|NCT01823835|26489050|P12|Overall Study|Progressive Disease|46
7613095|NCT01823835|26489051|P11|Overall Study|Progressive Disease|8
7613096|NCT01823835|26489052|P10|Overall Study|Progressive Disease|18
7613097|NCT01823835|26489053|P9|Overall Study|Progressive Disease|3
7613098|NCT01823835|26489054|P8|Overall Study|Progressive Disease|3
7613099|NCT01823835|26489055|P7|Overall Study|Progressive Disease|5
7613100|NCT01823835|26489056|P6|Overall Study|Progressive Disease|6
7613101|NCT01823835|26489057|P5|Overall Study|Progressive Disease|4
7613102|NCT01823835|26489058|P4|Overall Study|Progressive Disease|6
7613103|NCT01823835|26489059|P3|Overall Study|Progressive Disease|3
7613104|NCT01823835|26489060|P2|Overall Study|Progressive Disease|4
7613105|NCT01823835|26489061|P1|Overall Study|Progressive Disease|3
7613106|NCT01823835|26489047|P15|Overall Study|Physician Decision|0
7613107|NCT01823835|26489048|P14|Overall Study|Physician Decision|0
7613108|NCT01823835|26489049|P13|Overall Study|Physician Decision|0
7613109|NCT01823835|26489050|P12|Overall Study|Physician Decision|2
7613110|NCT01823835|26489051|P11|Overall Study|Physician Decision|0
7613111|NCT01823835|26489052|P10|Overall Study|Physician Decision|0
7613112|NCT01823835|26489053|P9|Overall Study|Physician Decision|0
7613113|NCT01823835|26489054|P8|Overall Study|Physician Decision|0
7613114|NCT01823835|26489055|P7|Overall Study|Physician Decision|0
7613115|NCT01823835|26489056|P6|Overall Study|Physician Decision|0
7613116|NCT01823835|26489057|P5|Overall Study|Physician Decision|0
7613117|NCT01823835|26489058|P4|Overall Study|Physician Decision|0
7613118|NCT01823835|26489059|P3|Overall Study|Physician Decision|0
7613119|NCT01823835|26489060|P2|Overall Study|Physician Decision|0
7613120|NCT01823835|26489061|P1|Overall Study|Physician Decision|0
7613121|NCT01823835|26489047|P15|Overall Study|Adverse Event|0
7613122|NCT01823835|26489048|P14|Overall Study|Adverse Event|0
7613123|NCT01823835|26489049|P13|Overall Study|Adverse Event|0
7613124|NCT01823835|26489050|P12|Overall Study|Adverse Event|2
7613125|NCT01823835|26489051|P11|Overall Study|Adverse Event|1
7613126|NCT01823835|26489052|P10|Overall Study|Adverse Event|0
7613127|NCT01823835|26489053|P9|Overall Study|Adverse Event|0
7613128|NCT01823835|26489054|P8|Overall Study|Adverse Event|0
7613129|NCT01823835|26489055|P7|Overall Study|Adverse Event|1
7613130|NCT01823835|26489056|P6|Overall Study|Adverse Event|0
7613131|NCT01823835|26489057|P5|Overall Study|Adverse Event|1
7613132|NCT01823835|26489058|P4|Overall Study|Adverse Event|0
7613133|NCT01823835|26489059|P3|Overall Study|Adverse Event|0
7613134|NCT01823835|26489060|P2|Overall Study|Adverse Event|0
7613135|NCT01823835|26489061|P1|Overall Study|Adverse Event|0
7613136|NCT01823679|26489188|P1|Overall Study|Death|1
7613137|NCT01823536|26489241|P6|Overall Study|Subject moved out of the state|0
7613138|NCT01823536|26489242|P5|Overall Study|Subject moved out of the state|1
7613139|NCT01823536|26489243|P4|Overall Study|Subject moved out of the state|0
7613140|NCT01823536|26489244|P3|Overall Study|Subject moved out of the state|0
7613141|NCT01823536|26489245|P2|Overall Study|Subject moved out of the state|0
7613142|NCT01823536|26489246|P1|Overall Study|Subject moved out of the state|0
7613143|NCT01823536|26489241|P6|Overall Study|Met exclusion criterion No 6|0
7613144|NCT01823536|26489242|P5|Overall Study|Met exclusion criterion No 6|0
7613145|NCT01823536|26489243|P4|Overall Study|Met exclusion criterion No 6|1
7613146|NCT01823536|26489244|P3|Overall Study|Met exclusion criterion No 6|0
7613147|NCT01823536|26489245|P2|Overall Study|Met exclusion criterion No 6|0
7613148|NCT01823536|26489246|P1|Overall Study|Met exclusion criterion No 6|0
7613149|NCT01823536|26489241|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
7613150|NCT01823536|26489242|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
7613151|NCT01823536|26489243|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
7613152|NCT01823536|26489244|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
7613153|NCT01823536|26489245|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
7613154|NCT01823536|26489246|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
7613155|NCT01823536|26489241|P6|Overall Study|Withdrawal by Subject|0
7613156|NCT01823536|26489242|P5|Overall Study|Withdrawal by Subject|0
7613157|NCT01823536|26489243|P4|Overall Study|Withdrawal by Subject|0
7613158|NCT01823536|26489244|P3|Overall Study|Withdrawal by Subject|0
7613159|NCT01823536|26489245|P2|Overall Study|Withdrawal by Subject|1
7613160|NCT01823536|26489246|P1|Overall Study|Withdrawal by Subject|1
7613161|NCT01823536|26489241|P6|Overall Study|Protocol Violation|0
7613162|NCT01823536|26489242|P5|Overall Study|Protocol Violation|0
7613163|NCT01823536|26489243|P4|Overall Study|Protocol Violation|0
7613164|NCT01823536|26489244|P3|Overall Study|Protocol Violation|0
7613165|NCT01823536|26489245|P2|Overall Study|Protocol Violation|1
7613166|NCT01823536|26489246|P1|Overall Study|Protocol Violation|0
7613167|NCT01823536|26489241|P6|Overall Study|Lost to Follow-up|0
7613168|NCT01823536|26489242|P5|Overall Study|Lost to Follow-up|1
7613169|NCT01823536|26489243|P4|Overall Study|Lost to Follow-up|1
7613170|NCT01823536|26489244|P3|Overall Study|Lost to Follow-up|0
7613171|NCT01823536|26489245|P2|Overall Study|Lost to Follow-up|0
7613172|NCT01823536|26489246|P1|Overall Study|Lost to Follow-up|1
7613173|NCT01823341|26489308|P1|Overall Study|Adverse Event|1
7613174|NCT01823341|26489308|P1|Overall Study|Withdrawal by Subject|7
7613175|NCT01823341|26489308|P1|Overall Study|Failed run-in|7
7613176|NCT01823328|26489353|P2|Overall Study|Withdrawal by Subject|6
7613177|NCT01823328|26489354|P1|Overall Study|Withdrawal by Subject|8
7613178|NCT01823289|26489374|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
7613179|NCT01823289|26489374|P1|Overall Study|Drug affected efficacy and safety|1
7613180|NCT01823289|26489374|P1|Overall Study|Transaminase increased more than 3 times|1
7613181|NCT01823289|26489374|P1|Overall Study|Administered contraindicated medicine|1
7613182|NCT01823289|26489374|P1|Overall Study|Physician Decision|9
7613183|NCT01823289|26489374|P1|Overall Study|Lack of Efficacy|1
7613184|NCT01823289|26489374|P1|Overall Study|Adverse Event|5
7613185|NCT01823289|26489374|P1|Overall Study|Lost to Follow-up|5
7613186|NCT01823224|26489382|P2|Overall Study|Withdrawal by Subject|1
7613187|NCT01823224|26489383|P1|Overall Study|Withdrawal by Subject|0
7613188|NCT01823224|26489382|P2|Overall Study|missed med dose|1
7613189|NCT01823224|26489383|P1|Overall Study|missed med dose|0
7613190|NCT01823224|26489382|P2|Overall Study|pharmacy error|1
7613191|NCT01823224|26489383|P1|Overall Study|pharmacy error|0
7613192|NCT01823224|26489382|P2|Overall Study|didn't qualify|2
7613193|NCT01823224|26489383|P1|Overall Study|didn't qualify|1
7613194|NCT01823224|26489382|P2|Overall Study|Lost to Follow-up|6
7613195|NCT01823224|26489383|P1|Overall Study|Lost to Follow-up|5
7613196|NCT01823146|26489393|P2|Overall Study|Lost to Follow-up|1
7613197|NCT01823146|26489394|P1|Overall Study|Lost to Follow-up|2
7613198|NCT01823146|26489393|P2|Overall Study|Withdrawal by Subject|1
7613199|NCT01823146|26489394|P1|Overall Study|Withdrawal by Subject|0
7613200|NCT01823107|26489404|P1|Overall Study|Withdrawal by Subject|1
7613201|NCT01822925|26489414|P4|Overall Study|Taking prohibited medication|1
7613202|NCT01822925|26489415|P3|Overall Study|Taking prohibited medication|0
7613203|NCT01822925|26489416|P2|Overall Study|Taking prohibited medication|0
7613204|NCT01822925|26489417|P1|Overall Study|Taking prohibited medication|2
7613205|NCT01822925|26489414|P4|Overall Study|Withdrawal by Subject|2
7613206|NCT01822925|26489415|P3|Overall Study|Withdrawal by Subject|2
7613207|NCT01822925|26489416|P2|Overall Study|Withdrawal by Subject|0
7613208|NCT01822925|26489417|P1|Overall Study|Withdrawal by Subject|2
7613209|NCT01822925|26489414|P4|Overall Study|Protocol Violation|1
7613210|NCT01822925|26489415|P3|Overall Study|Protocol Violation|0
7613211|NCT01822925|26489416|P2|Overall Study|Protocol Violation|0
7613212|NCT01822925|26489417|P1|Overall Study|Protocol Violation|1
7613213|NCT01822925|26489414|P4|Overall Study|Lost to Follow-up|0
7613214|NCT01822925|26489415|P3|Overall Study|Lost to Follow-up|0
7613215|NCT01822925|26489416|P2|Overall Study|Lost to Follow-up|1
7613216|NCT01822925|26489417|P1|Overall Study|Lost to Follow-up|0
7613217|NCT01822925|26489414|P4|Overall Study|Adverse Event|1
7613218|NCT01822925|26489415|P3|Overall Study|Adverse Event|1
7613219|NCT01822925|26489416|P2|Overall Study|Adverse Event|1
7613220|NCT01822925|26489417|P1|Overall Study|Adverse Event|1
7613221|NCT01822899|26489469|P2|Overall Study|Withdrawal by Subject|7
7613222|NCT01822899|26489470|P1|Overall Study|Withdrawal by Subject|5
7613223|NCT01822899|26489469|P2|Overall Study|Lost to Follow-up|0
7613224|NCT01822899|26489470|P1|Overall Study|Lost to Follow-up|1
7613225|NCT01822899|26489469|P2|Overall Study|Protocol Violation|3
7613226|NCT01822899|26489470|P1|Overall Study|Protocol Violation|6
7613227|NCT01822899|26489469|P2|Overall Study|Lack of Efficacy|3
7613228|NCT01822899|26489470|P1|Overall Study|Lack of Efficacy|6
7613229|NCT01822899|26489469|P2|Overall Study|Adverse Event|5
7613230|NCT01822899|26489470|P1|Overall Study|Adverse Event|6
7613231|NCT01822821|26489488|P2|Overall Study|Other reasons|0
7613232|NCT01822821|26489489|P1|Overall Study|Other reasons|1
7613233|NCT01822821|26489488|P2|Overall Study|Eligible surgery cancelled|1
7613234|NCT01822821|26489489|P1|Overall Study|Eligible surgery cancelled|1
7613235|NCT01822756|26489518|P5|Overall Study|disease progression & patient preference|0
7613236|NCT01822756|26489519|P4|Overall Study|disease progression & patient preference|0
7613237|NCT01822756|26489520|P3|Overall Study|disease progression & patient preference|1
7613238|NCT01822756|26489521|P2|Overall Study|disease progression & patient preference|0
7613239|NCT01822756|26489522|P1|Overall Study|disease progression & patient preference|2
7613240|NCT01822756|26489518|P5|Overall Study|Physician Decision|0
7613241|NCT01822756|26489519|P4|Overall Study|Physician Decision|0
7613242|NCT01822756|26489520|P3|Overall Study|Physician Decision|0
7613243|NCT01822756|26489521|P2|Overall Study|Physician Decision|1
7613244|NCT01822756|26489522|P1|Overall Study|Physician Decision|0
7613245|NCT01822756|26489518|P5|Overall Study|Lost to Follow-up|1
7613246|NCT01822756|26489519|P4|Overall Study|Lost to Follow-up|0
7613247|NCT01822756|26489520|P3|Overall Study|Lost to Follow-up|1
7613248|NCT01822756|26489521|P2|Overall Study|Lost to Follow-up|0
7613249|NCT01822756|26489522|P1|Overall Study|Lost to Follow-up|1
7613250|NCT01822756|26489518|P5|Overall Study|Death|0
7613251|NCT01822756|26489519|P4|Overall Study|Death|0
7613252|NCT01822756|26489520|P3|Overall Study|Death|1
7613253|NCT01822756|26489521|P2|Overall Study|Death|2
7613254|NCT01822756|26489522|P1|Overall Study|Death|2
7613255|NCT01822756|26489518|P5|Overall Study|Disease progression|6
7613256|NCT01822756|26489519|P4|Overall Study|Disease progression|2
7613257|NCT01822756|26489520|P3|Overall Study|Disease progression|7
7613258|NCT01822756|26489521|P2|Overall Study|Disease progression|1
7613259|NCT01822756|26489522|P1|Overall Study|Disease progression|11
7613260|NCT01822756|26489518|P5|Overall Study|Adverse Event|0
7613261|NCT01822756|26489519|P4|Overall Study|Adverse Event|2
7613262|NCT01822756|26489520|P3|Overall Study|Adverse Event|0
7613263|NCT01822756|26489521|P2|Overall Study|Adverse Event|0
7613264|NCT01822756|26489522|P1|Overall Study|Adverse Event|0
7613265|NCT01822691|26489564|P1|Overall Study|Withdrawal by Subject|2
7613266|NCT01822678|26489575|P3|Overall Study|Lost to Follow-up|1
7613267|NCT01822678|26489576|P2|Overall Study|Lost to Follow-up|2
7613268|NCT01822678|26489577|P1|Overall Study|Lost to Follow-up|0
7613269|NCT01822678|26489575|P3|Overall Study|Lack of Efficacy|5
7613270|NCT01822678|26489576|P2|Overall Study|Lack of Efficacy|6
7613271|NCT01822678|26489577|P1|Overall Study|Lack of Efficacy|3
7613272|NCT01822678|26489575|P3|Overall Study|Adverse Event|1
7613273|NCT01822678|26489576|P2|Overall Study|Adverse Event|3
7613274|NCT01822678|26489577|P1|Overall Study|Adverse Event|4
7613275|NCT01822678|26489575|P3|Overall Study|Withdrawal by Subject|4
7613276|NCT01822678|26489576|P2|Overall Study|Withdrawal by Subject|4
7613277|NCT01822678|26489577|P1|Overall Study|Withdrawal by Subject|5
7613278|NCT01822665|26489585|P1|Overall Study|Other Reason|5
7613279|NCT01822665|26489585|P1|Overall Study|Adverse Event|3
7613280|NCT01822587|26489612|P3|Overall Study|Physician Decision|6
7613281|NCT01822587|26489613|P2|Overall Study|Physician Decision|6
7613282|NCT01822587|26489614|P1|Overall Study|Physician Decision|9
7613283|NCT01822587|26489612|P3|Overall Study|Lost to Follow-up|12
7613284|NCT01822587|26489613|P2|Overall Study|Lost to Follow-up|9
7613285|NCT01822587|26489614|P1|Overall Study|Lost to Follow-up|7
7613286|NCT01822561|26489653|P1|Overall Study|Withdrawal by Subject|2
7613287|NCT01822535|26489674|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
7613288|NCT01822535|26489675|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
7613289|NCT01822535|26489674|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
7613290|NCT01822535|26489675|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
7613291|NCT01822535|26489674|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
7613292|NCT01822535|26489675|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
7613293|NCT01822496|26489691|P4|Overall Study|Withdrawal by Subject|3
7613294|NCT01822496|26489692|P3|Overall Study|Withdrawal by Subject|0
7613295|NCT01822496|26489693|P2|Overall Study|Withdrawal by Subject|0
7613296|NCT01822496|26489694|P1|Overall Study|Withdrawal by Subject|0
7613297|NCT01822496|26489691|P4|Overall Study|Protocol Violation|1
7613298|NCT01822496|26489692|P3|Overall Study|Protocol Violation|0
7613299|NCT01822496|26489693|P2|Overall Study|Protocol Violation|2
7613300|NCT01822496|26489694|P1|Overall Study|Protocol Violation|2
7613301|NCT01822366|26489747|P4|Overall Study|Partial Intervention Completion|15
7613302|NCT01822366|26489748|P3|Overall Study|Partial Intervention Completion|0
7613303|NCT01822366|26489749|P2|Overall Study|Partial Intervention Completion|15
7613304|NCT01822366|26489750|P1|Overall Study|Partial Intervention Completion|0
7613305|NCT01822366|26489747|P4|Overall Study|Withdrawal by Subject|6
7613306|NCT01822366|26489748|P3|Overall Study|Withdrawal by Subject|0
7613307|NCT01822366|26489749|P2|Overall Study|Withdrawal by Subject|6
7613308|NCT01822366|26489750|P1|Overall Study|Withdrawal by Subject|0
7613309|NCT01822366|26489747|P4|Overall Study|Lost to Follow-up|1
7613310|NCT01822366|26489748|P3|Overall Study|Lost to Follow-up|5
7613311|NCT01822366|26489749|P2|Overall Study|Lost to Follow-up|1
7613312|NCT01822366|26489750|P1|Overall Study|Lost to Follow-up|5
7613313|NCT01822353|26489813|P3|Overall Study|Withdrawal by Subject|0
7613314|NCT01822353|26489814|P2|Overall Study|Withdrawal by Subject|1
7613315|NCT01822353|26489815|P1|Overall Study|Withdrawal by Subject|3
7613316|NCT01822353|26489813|P3|Overall Study|Pregnancy|0
7613317|NCT01822353|26489814|P2|Overall Study|Pregnancy|1
7613318|NCT01822353|26489815|P1|Overall Study|Pregnancy|0
7613319|NCT01822353|26489813|P3|Overall Study|Adverse Event|1
7613320|NCT01822353|26489814|P2|Overall Study|Adverse Event|3
7613321|NCT01822353|26489815|P1|Overall Study|Adverse Event|1
7613322|NCT01822223|26489850|P2|Overall Study|Death|1
7613323|NCT01822223|26489851|P1|Overall Study|Death|0
7613324|NCT01822132|26489875|P2|Overall Study|Lost to Follow-up|2
7613325|NCT01822132|26489876|P1|Overall Study|Lost to Follow-up|4
7613326|NCT01821963|26489913|P1|Overall Study|Adverse Event|1
7613327|NCT01821937|26489919|P2|Overall Study|Adverse Event|3
7613328|NCT01821937|26489920|P1|Overall Study|Adverse Event|0
7613329|NCT01821898|26489940|P2|Overall Study|Withdrawal by Subject|1
7613330|NCT01821898|26489941|P1|Overall Study|Withdrawal by Subject|2
7613331|NCT01821807|26489959|P2|Overall Study|Lost to Follow-up|1
7613332|NCT01821807|26489960|P1|Overall Study|Lost to Follow-up|3
7613333|NCT01821729|26489968|P1|Overall Study|Withdrawal by Subject|1
7613334|NCT01821625|26489973|P1|Overall Study|Medical contraindication|1
7613335|NCT01821625|26489973|P1|Overall Study|Adverse Event|1
7613336|NCT01821625|26489973|P1|Overall Study|Lack of Efficacy|2
7613337|NCT01821625|26489973|P1|Overall Study|Withdrawal by Subject|2
7613338|NCT01821560|26489979|P2|Overall Study|Protocol Violation|1
7613339|NCT01821560|26489980|P1|Overall Study|Protocol Violation|0
7613340|NCT01821560|26489979|P2|Overall Study|Withdrawal by Subject|1
7613341|NCT01821560|26489980|P1|Overall Study|Withdrawal by Subject|1
7613342|NCT01821560|26489979|P2|Overall Study|Lost to Follow-up|5
7613343|NCT01821560|26489980|P1|Overall Study|Lost to Follow-up|5
7613344|NCT01821391|26490008|P2|Overall Study|Adverse Event|0
7613345|NCT01821391|26490009|P1|Overall Study|Adverse Event|1
7613346|NCT01821118|26490112|P2|Overall Study|Death|1
7613347|NCT01821118|26490113|P1|Overall Study|Death|0
7613348|NCT01820637|26490160|P1|Overall Study|Withdrawal by Subject|1
7613349|NCT01820637|26490160|P1|Overall Study|Death|2
7613350|NCT01820585|26490169|P4|Overall Study|Pregnancy|0
7613351|NCT01820585|26490170|P3|Overall Study|Pregnancy|0
7613352|NCT01820585|26490171|P2|Overall Study|Pregnancy|1
7613353|NCT01820585|26490172|P1|Overall Study|Pregnancy|0
7613354|NCT01820585|26490169|P4|Overall Study|at sponsor request|0
7613355|NCT01820585|26490170|P3|Overall Study|at sponsor request|1
7613356|NCT01820585|26490171|P2|Overall Study|at sponsor request|0
7613357|NCT01820585|26490172|P1|Overall Study|at sponsor request|0
7613358|NCT01820585|26490169|P4|Overall Study|Subject non-compliance|2
7613359|NCT01820585|26490170|P3|Overall Study|Subject non-compliance|1
7613360|NCT01820585|26490171|P2|Overall Study|Subject non-compliance|0
7613361|NCT01820585|26490172|P1|Overall Study|Subject non-compliance|0
7613362|NCT01820585|26490169|P4|Overall Study|Protocol Violation|1
7613363|NCT01820585|26490170|P3|Overall Study|Protocol Violation|1
7613364|NCT01820585|26490171|P2|Overall Study|Protocol Violation|1
7613365|NCT01820585|26490172|P1|Overall Study|Protocol Violation|3
7613366|NCT01820585|26490169|P4|Overall Study|Lost to Follow-up|3
7613367|NCT01820585|26490170|P3|Overall Study|Lost to Follow-up|0
7613368|NCT01820585|26490171|P2|Overall Study|Lost to Follow-up|3
7613369|NCT01820585|26490172|P1|Overall Study|Lost to Follow-up|3
7613370|NCT01820585|26490169|P4|Overall Study|Withdrawal by Subject|8
7613371|NCT01820585|26490170|P3|Overall Study|Withdrawal by Subject|3
7613372|NCT01820585|26490171|P2|Overall Study|Withdrawal by Subject|7
7613373|NCT01820585|26490172|P1|Overall Study|Withdrawal by Subject|3
7613374|NCT01820585|26490169|P4|Overall Study|Lack of Efficacy|1
7613375|NCT01820585|26490170|P3|Overall Study|Lack of Efficacy|5
7613376|NCT01820585|26490171|P2|Overall Study|Lack of Efficacy|7
7613377|NCT01820585|26490172|P1|Overall Study|Lack of Efficacy|9
7613378|NCT01820585|26490169|P4|Overall Study|Adverse Event|34
7613379|NCT01820585|26490170|P3|Overall Study|Adverse Event|23
7613380|NCT01820585|26490171|P2|Overall Study|Adverse Event|13
7613381|NCT01820585|26490172|P1|Overall Study|Adverse Event|9
7613382|NCT01820572|26490184|P2|Treatment Period|withdrew consent|2
7613383|NCT01820572|26490185|P1|Treatment Period|withdrew consent|1
7613384|NCT01820572|26490184|P2|Treatment Period|No longer meets study criteria|10
7613385|NCT01820572|26490185|P1|Treatment Period|No longer meets study criteria|3
7613386|NCT01820572|26490184|P2|Treatment Period|request to discontinue|11
7613387|NCT01820572|26490185|P1|Treatment Period|request to discontinue|6
7613388|NCT01820572|26490184|P2|Treatment Period|poor/non compliance|3
7613389|NCT01820572|26490185|P1|Treatment Period|poor/non compliance|0
7613390|NCT01820572|26490184|P2|Treatment Period|Lack of Efficacy|0
7613391|NCT01820572|26490185|P1|Treatment Period|Lack of Efficacy|1
7613392|NCT01820572|26490184|P2|Treatment Period|Death|3
7613393|NCT01820572|26490185|P1|Treatment Period|Death|3
7613394|NCT01820572|26490184|P2|Treatment Period|Adverse Event|7
7613395|NCT01820572|26490185|P1|Treatment Period|Adverse Event|12
7613396|NCT01820572|26490184|P2|Randomization|Not Treated|1
7613397|NCT01820572|26490185|P1|Randomization|Not Treated|2
7613398|NCT01820559|26490228|P3|Overall Study|Lack of Efficacy|3
7613399|NCT01820559|26490229|P2|Overall Study|Lack of Efficacy|2
7613400|NCT01820559|26490230|P1|Overall Study|Lack of Efficacy|3
7613401|NCT01820559|26490228|P3|Overall Study|At sponsor request|1
7613402|NCT01820559|26490229|P2|Overall Study|At sponsor request|0
7613403|NCT01820559|26490230|P1|Overall Study|At sponsor request|0
7613404|NCT01820559|26490228|P3|Overall Study|Lost to Follow-up|2
7613405|NCT01820559|26490229|P2|Overall Study|Lost to Follow-up|2
7613406|NCT01820559|26490230|P1|Overall Study|Lost to Follow-up|3
7613407|NCT01820559|26490228|P3|Overall Study|Subject's non-compliance|2
7613408|NCT01820559|26490229|P2|Overall Study|Subject's non-compliance|0
7613409|NCT01820559|26490230|P1|Overall Study|Subject's non-compliance|1
7613410|NCT01820559|26490228|P3|Overall Study|Protocol Violation|3
7613411|NCT01820559|26490229|P2|Overall Study|Protocol Violation|1
7613412|NCT01820559|26490230|P1|Overall Study|Protocol Violation|2
7613413|NCT01820559|26490228|P3|Overall Study|Withdrawal by Subject|5
7613414|NCT01820559|26490229|P2|Overall Study|Withdrawal by Subject|2
7613415|NCT01820559|26490230|P1|Overall Study|Withdrawal by Subject|1
7613416|NCT01820559|26490228|P3|Overall Study|Adverse Event|13
7613417|NCT01820559|26490229|P2|Overall Study|Adverse Event|6
7613418|NCT01820559|26490230|P1|Overall Study|Adverse Event|4
7613419|NCT01820364|26490251|P2|Part II: LGX818 + MEK162|Study Termination|1
7613420|NCT01820364|26490252|P1|Part II: LGX818 + MEK162|Study Termination|0
7613421|NCT01820364|26490251|P2|Part I: LGX818|Disease Progression|0
7613422|NCT01820364|26490252|P1|Part I: LGX818|Disease Progression|4
7613423|NCT01820364|26490251|P2|Part I: LGX818|Adverse Event|0
7613424|NCT01820364|26490252|P1|Part I: LGX818|Adverse Event|6
7613425|NCT01820364|26490251|P2|Part I: LGX818|Administrative Problems|0
7613426|NCT01820364|26490252|P1|Part I: LGX818|Administrative Problems|3
7613427|NCT01820364|26490251|P2|Part I: LGX818|Death|0
7613428|NCT01820364|26490252|P1|Part I: LGX818|Death|1
7613429|NCT01820260|26490278|P14|Phase 2 (Part 2)|Withdrawal by Subject|0
7613430|NCT01820260|26490279|P13|Phase 2 (Part 2)|Withdrawal by Subject|0
7613431|NCT01820260|26490280|P12|Phase 2 (Part 2)|Withdrawal by Subject|0
7613432|NCT01820260|26490281|P11|Phase 2 (Part 2)|Withdrawal by Subject|0
7613433|NCT01820260|26490282|P10|Phase 2 (Part 2)|Withdrawal by Subject|1
7613434|NCT01820260|26490283|P9|Phase 2 (Part 2)|Withdrawal by Subject|0
7613435|NCT01820260|26490284|P8|Phase 2 (Part 2)|Withdrawal by Subject|0
7613436|NCT01820260|26490285|P7|Phase 2 (Part 2)|Withdrawal by Subject|0
7613437|NCT01820260|26490286|P6|Phase 2 (Part 2)|Withdrawal by Subject|0
7613438|NCT01820260|26490287|P5|Phase 2 (Part 2)|Withdrawal by Subject|0
7613439|NCT01820260|26490288|P4|Phase 2 (Part 2)|Withdrawal by Subject|0
7613440|NCT01820260|26490289|P3|Phase 2 (Part 2)|Withdrawal by Subject|0
7613441|NCT01820260|26490290|P2|Phase 2 (Part 2)|Withdrawal by Subject|0
7613442|NCT01820260|26490291|P1|Phase 2 (Part 2)|Withdrawal by Subject|0
7613443|NCT01820260|26490278|P14|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613444|NCT01820260|26490279|P13|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613445|NCT01820260|26490280|P12|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613446|NCT01820260|26490281|P11|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613447|NCT01820260|26490282|P10|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613448|NCT01820260|26490283|P9|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613449|NCT01820260|26490284|P8|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613450|NCT01820260|26490285|P7|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
7613451|NCT01820260|26490286|P6|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613452|NCT01820260|26490287|P5|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613453|NCT01820260|26490288|P4|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613454|NCT01820260|26490289|P3|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613455|NCT01820260|26490290|P2|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613456|NCT01820260|26490291|P1|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7613457|NCT01819727|26490465|P2|Overall Study|Quit due to lack of health benifits|1
7613458|NCT01819727|26490466|P1|Overall Study|Quit due to lack of health benifits|0
7613459|NCT01819727|26490465|P2|Overall Study|Unable to demostrate ability self-inject|1
7613460|NCT01819727|26490466|P1|Overall Study|Unable to demostrate ability self-inject|0
7613461|NCT01819727|26490465|P2|Overall Study|Withdrawal by Subject|11
7613462|NCT01819727|26490466|P1|Overall Study|Withdrawal by Subject|6
7613463|NCT01819727|26490465|P2|Overall Study|Study Terminated by Sponsor|1
7613464|NCT01819727|26490466|P1|Overall Study|Study Terminated by Sponsor|0
7613465|NCT01819727|26490465|P2|Overall Study|Protocol Violation|2
7613466|NCT01819727|26490466|P1|Overall Study|Protocol Violation|0
7613467|NCT01819727|26490465|P2|Overall Study|Pregnancy|0
7613468|NCT01819727|26490466|P1|Overall Study|Pregnancy|1
7613469|NCT01819727|26490465|P2|Overall Study|Physician Decision|2
7613470|NCT01819727|26490466|P1|Overall Study|Physician Decision|3
7613471|NCT01819727|26490465|P2|Overall Study|Lost to Follow-up|1
7613472|NCT01819727|26490466|P1|Overall Study|Lost to Follow-up|1
7613473|NCT01819727|26490465|P2|Overall Study|Death|0
7613474|NCT01819727|26490466|P1|Overall Study|Death|1
7613475|NCT01819727|26490465|P2|Overall Study|Adverse Event|9
7613476|NCT01819727|26490466|P1|Overall Study|Adverse Event|8
7613477|NCT01819506|26490488|P2|Overall Study|Withdrawal by Subject|3
7613478|NCT01819506|26490489|P1|Overall Study|Withdrawal by Subject|3
7613479|NCT01819506|26490488|P2|Overall Study|Physician Decision|2
7613480|NCT01819506|26490489|P1|Overall Study|Physician Decision|5
7613481|NCT01819272|26490541|P6|Overall Study|Loss of Glucose Control|0
7613482|NCT01819272|26490542|P5|Overall Study|Loss of Glucose Control|2
7613483|NCT01819272|26490543|P4|Overall Study|Loss of Glucose Control|1
7613484|NCT01819272|26490544|P3|Overall Study|Loss of Glucose Control|0
7613485|NCT01819272|26490545|P2|Overall Study|Loss of Glucose Control|1
7613486|NCT01819272|26490546|P1|Overall Study|Loss of Glucose Control|2
7613487|NCT01819272|26490541|P6|Overall Study|Withdrawal of Consent|1
7613488|NCT01819272|26490542|P5|Overall Study|Withdrawal of Consent|0
7613489|NCT01819272|26490543|P4|Overall Study|Withdrawal of Consent|1
7613490|NCT01819272|26490544|P3|Overall Study|Withdrawal of Consent|2
7613491|NCT01819272|26490545|P2|Overall Study|Withdrawal of Consent|1
7613492|NCT01819272|26490546|P1|Overall Study|Withdrawal of Consent|0
7613493|NCT01819272|26490541|P6|Overall Study|Physician Decision|0
7613494|NCT01819272|26490542|P5|Overall Study|Physician Decision|0
7613495|NCT01819272|26490543|P4|Overall Study|Physician Decision|0
7613496|NCT01819272|26490544|P3|Overall Study|Physician Decision|0
7613497|NCT01819272|26490545|P2|Overall Study|Physician Decision|1
7613498|NCT01819272|26490546|P1|Overall Study|Physician Decision|0
7613499|NCT01819272|26490541|P6|Overall Study|Protocol Violation|3
7613500|NCT01819272|26490542|P5|Overall Study|Protocol Violation|2
7613501|NCT01819272|26490543|P4|Overall Study|Protocol Violation|1
7613502|NCT01819272|26490544|P3|Overall Study|Protocol Violation|0
7613503|NCT01819272|26490545|P2|Overall Study|Protocol Violation|0
7613504|NCT01819272|26490546|P1|Overall Study|Protocol Violation|0
7613505|NCT01819272|26490541|P6|Overall Study|Lost to Follow-up|3
7613506|NCT01819272|26490542|P5|Overall Study|Lost to Follow-up|0
7613507|NCT01819272|26490543|P4|Overall Study|Lost to Follow-up|0
7613508|NCT01819272|26490544|P3|Overall Study|Lost to Follow-up|1
7613509|NCT01819272|26490545|P2|Overall Study|Lost to Follow-up|0
7613510|NCT01819272|26490546|P1|Overall Study|Lost to Follow-up|3
7613511|NCT01819272|26490541|P6|Overall Study|Adverse Event|0
7613512|NCT01819272|26490542|P5|Overall Study|Adverse Event|0
7613513|NCT01819272|26490543|P4|Overall Study|Adverse Event|2
7613514|NCT01819272|26490544|P3|Overall Study|Adverse Event|0
7613515|NCT01819272|26490545|P2|Overall Study|Adverse Event|0
7613516|NCT01819272|26490546|P1|Overall Study|Adverse Event|1
7613517|NCT01819194|26490584|P1|Overall Study|Loss of study articles|2
7613518|NCT01819129|26490591|P2|Overall Study|Withdrawal Criteria|15
7613519|NCT01819129|26490592|P1|Overall Study|Withdrawal Criteria|20
7613520|NCT01819129|26490591|P2|Overall Study|Death|1
7613521|NCT01819129|26490592|P1|Overall Study|Death|1
7613522|NCT01819129|26490591|P2|Overall Study|Adverse Event|4
7613523|NCT01819129|26490592|P1|Overall Study|Adverse Event|1
7613524|NCT01819129|26490591|P2|Overall Study|Lack of Efficacy|1
7613525|NCT01819129|26490592|P1|Overall Study|Lack of Efficacy|0
7613526|NCT01819129|26490591|P2|Overall Study|Lost to Follow-up|2
7613527|NCT01819129|26490592|P1|Overall Study|Lost to Follow-up|5
7613528|NCT01819129|26490591|P2|Overall Study|Withdrawal by Subject|15
7613529|NCT01819129|26490592|P1|Overall Study|Withdrawal by Subject|15
7613530|NCT01819129|26490591|P2|Overall Study|Other, Subject moved out of the country|1
7613531|NCT01819129|26490592|P1|Overall Study|Other, Subject moved out of the country|0
7613532|NCT01819129|26490591|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
7613533|NCT01819129|26490592|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
7613534|NCT01819129|26490591|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
7613535|NCT01819129|26490592|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
7613536|NCT01818765|26490617|P1|Overall Study|Death|2
7613537|NCT01818752|26490630|P2|Overall Study|Randomized but not Dosed|4
7613538|NCT01818752|26490631|P1|Overall Study|Randomized but not Dosed|7
7613539|NCT01818752|26490630|P2|Overall Study|Continuing Treatment|4
7613540|NCT01818752|26490631|P1|Overall Study|Continuing Treatment|1
7613541|NCT01818752|26490630|P2|Overall Study|Other|8
7613542|NCT01818752|26490631|P1|Overall Study|Other|7
7613543|NCT01818752|26490630|P2|Overall Study|Disease Progression|48
7613544|NCT01818752|26490631|P1|Overall Study|Disease Progression|54
7613545|NCT01818752|26490630|P2|Overall Study|Physician Decision|8
7613546|NCT01818752|26490631|P1|Overall Study|Physician Decision|9
7613547|NCT01818752|26490630|P2|Overall Study|Withdrawal by Subject|14
7613548|NCT01818752|26490631|P1|Overall Study|Withdrawal by Subject|15
7613549|NCT01818752|26490630|P2|Overall Study|Non-compliance|20
7613550|NCT01818752|26490631|P1|Overall Study|Non-compliance|16
7613551|NCT01818752|26490630|P2|Overall Study|Death|18
7613552|NCT01818752|26490631|P1|Overall Study|Death|14
7613553|NCT01818752|26490630|P2|Overall Study|Adverse Event|74
7613554|NCT01818752|26490631|P1|Overall Study|Adverse Event|64
7613555|NCT01818726|26490656|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
7613556|NCT01818726|26490657|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
7613557|NCT01818726|26490656|P2|Overall Study|Withdrawal by Subject|1
7613558|NCT01818726|26490657|P1|Overall Study|Withdrawal by Subject|0
7613559|NCT01818726|26490656|P2|Overall Study|Administrative reasons|1
7613560|NCT01818726|26490657|P1|Overall Study|Administrative reasons|5
7613561|NCT01818700|26490667|P1|Overall Study|Other|1
7613562|NCT01818700|26490667|P1|Overall Study|Protocol Violation|2
7613563|NCT01818700|26490667|P1|Overall Study|Withdrawal by Subject|27
7613564|NCT01818700|26490667|P1|Overall Study|Lost to Follow-up|5
7613565|NCT01818700|26490667|P1|Overall Study|Lack of Efficacy|2
7613566|NCT01818700|26490667|P1|Overall Study|Adverse Event|67
7613567|NCT01818596|26490678|P2|Overall Study|Lost to Follow-up|0
7613568|NCT01818596|26490679|P1|Overall Study|Lost to Follow-up|7
7613569|NCT01818596|26490678|P2|Overall Study|Withdrew Consent|0
7613570|NCT01818596|26490679|P1|Overall Study|Withdrew Consent|5
7613571|NCT01818596|26490678|P2|Overall Study|Protocol Violation|0
7613572|NCT01818596|26490679|P1|Overall Study|Protocol Violation|1
7613573|NCT01818596|26490678|P2|Overall Study|Investigator's Discretion|0
7613574|NCT01818596|26490679|P1|Overall Study|Investigator's Discretion|4
7613575|NCT01818596|26490678|P2|Overall Study|Death|0
7613576|NCT01818596|26490679|P1|Overall Study|Death|3
7613577|NCT01818596|26490678|P2|Overall Study|Adverse Event|0
7613578|NCT01818596|26490679|P1|Overall Study|Adverse Event|7
7613579|NCT01818596|26490678|P2|Overall Study|Enrolled but Not Treated|0
7613580|NCT01818596|26490679|P1|Overall Study|Enrolled but Not Treated|4
7613581|NCT01818531|26490718|P2|Overall Study|Withdrawn for failure to place block|1
7613582|NCT01818531|26490719|P1|Overall Study|Withdrawn for failure to place block|0
7613583|NCT01818531|26490718|P2|Overall Study|Withdrawn for long-acting opioid patch|1
7613584|NCT01818531|26490719|P1|Overall Study|Withdrawn for long-acting opioid patch|0
7613585|NCT01818531|26490718|P2|Overall Study|Withdrawn for case delay after block|0
7613586|NCT01818531|26490719|P1|Overall Study|Withdrawn for case delay after block|1
7613587|NCT01818492|26490758|P1|Overall Study|Additional therapy when not allowed PP|4
7613588|NCT01818492|26490758|P1|Overall Study|Withdrawal by Subject|1
7613589|NCT01818492|26490758|P1|Overall Study|Death|3
7613590|NCT01818492|26490758|P1|Overall Study|Adverse Event|2
7613591|NCT01818336|26490807|P2|Overall Study|Lost to Follow-up|1
7613592|NCT01818336|26490808|P1|Overall Study|Lost to Follow-up|0
7613593|NCT01818336|26490807|P2|Overall Study|Declined retest visit|11
7613594|NCT01818336|26490808|P1|Overall Study|Declined retest visit|0
7613595|NCT01818297|26490816|P2|Open Label Phase (3-12 Months)|Early study closure|10
7613596|NCT01818297|26490817|P1|Open Label Phase (3-12 Months)|Early study closure|17
7613597|NCT01818297|26490816|P2|Open Label Phase (3-12 Months)|Physician Decision|0
7613598|NCT01818297|26490817|P1|Open Label Phase (3-12 Months)|Physician Decision|1
7613599|NCT01818297|26490816|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
7613600|NCT01818297|26490817|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
7613601|NCT01818284|26490835|P2|Overall Study|Death|2
7613602|NCT01818284|26490836|P1|Overall Study|Death|0
7613603|NCT01818284|26490835|P2|Overall Study|Not eligible due to White Blood Counts|4
7613604|NCT01818284|26490836|P1|Overall Study|Not eligible due to White Blood Counts|4
7613605|NCT01818258|26490844|P2|Overall Study|Unable to Travel to Clinic|1
7613606|NCT01818258|26490845|P1|Overall Study|Unable to Travel to Clinic|0
7613607|NCT01818258|26490844|P2|Overall Study|Lost to Follow-up|1
7613608|NCT01818258|26490845|P1|Overall Study|Lost to Follow-up|0
7613609|NCT01818258|26490844|P2|Overall Study|Withdrawal by Subject|1
7613610|NCT01818258|26490845|P1|Overall Study|Withdrawal by Subject|0
7613611|NCT01818258|26490844|P2|Overall Study|Death|0
7613612|NCT01818258|26490845|P1|Overall Study|Death|3
7613613|NCT01818141|26490910|P2|Overall Study|Lost to Follow-up|2
7613614|NCT01818141|26490911|P1|Overall Study|Lost to Follow-up|0
7613615|NCT01818141|26490910|P2|Overall Study|No baseline C.diff colonies|1
7613616|NCT01818141|26490911|P1|Overall Study|No baseline C.diff colonies|1
7613617|NCT01818141|26490910|P2|Overall Study|Withdrawal by Subject|0
7613618|NCT01818141|26490911|P1|Overall Study|Withdrawal by Subject|2
7613619|NCT01817959|26490934|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7613620|NCT01817959|26490935|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7613621|NCT01817959|26490934|P2|Overall Study|Adverse Event|0
7613622|NCT01817959|26490935|P1|Overall Study|Adverse Event|1
7613623|NCT01817959|26490934|P2|Overall Study|forbidden medication|1
7613624|NCT01817959|26490935|P1|Overall Study|forbidden medication|1
7613625|NCT01817959|26490934|P2|Overall Study|Graft loss|1
7613626|NCT01817959|26490935|P1|Overall Study|Graft loss|1
7613627|NCT01817790|26491027|P2|Overall Study|Other: Could not attend appointment|1
7613628|NCT01817790|26491028|P1|Overall Study|Other: Could not attend appointment|1
7613629|NCT01817790|26491027|P2|Overall Study|Withdrawal by Subject|3
7613630|NCT01817790|26491028|P1|Overall Study|Withdrawal by Subject|1
7613631|NCT01817790|26491027|P2|Overall Study|Protocol Violation|1
7613632|NCT01817790|26491028|P1|Overall Study|Protocol Violation|2
7613633|NCT01817790|26491027|P2|Overall Study|Lost to Follow-up|1
7613634|NCT01817790|26491028|P1|Overall Study|Lost to Follow-up|0
7613635|NCT01817790|26491027|P2|Overall Study|Adverse Event|2
7613636|NCT01817790|26491028|P1|Overall Study|Adverse Event|0
7613637|NCT01817777|26491072|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
7613638|NCT01817777|26491073|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
7613639|NCT01817777|26491074|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
7613640|NCT01817777|26491072|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
7613641|NCT01817777|26491073|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
7613642|NCT01817777|26491074|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
7613643|NCT01817777|26491072|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7613644|NCT01817777|26491073|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
7613645|NCT01817777|26491074|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7613646|NCT01817777|26491072|P3|Observational Phase (8 Weeks)|Early Study Termination|0
7613647|NCT01817777|26491073|P2|Observational Phase (8 Weeks)|Early Study Termination|0
7613648|NCT01817777|26491074|P1|Observational Phase (8 Weeks)|Early Study Termination|2
7613649|NCT01817777|26491072|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
7613650|NCT01817777|26491073|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
7613651|NCT01817777|26491074|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
7613652|NCT01817764|26491098|P2|Overall Study|Withdrawal by Subject|12
7613653|NCT01817764|26491099|P1|Overall Study|Withdrawal by Subject|10
7613654|NCT01817764|26491098|P2|Overall Study|Lost to Follow-up|4
7613655|NCT01817764|26491099|P1|Overall Study|Lost to Follow-up|1
7613656|NCT01817764|26491098|P2|Overall Study|Protocol Violation|5
7613657|NCT01817764|26491099|P1|Overall Study|Protocol Violation|7
7613658|NCT01817764|26491098|P2|Overall Study|Lack of Efficacy|7
7613659|NCT01817764|26491099|P1|Overall Study|Lack of Efficacy|9
7613660|NCT01817764|26491098|P2|Overall Study|Adverse Event|10
7613661|NCT01817764|26491099|P1|Overall Study|Adverse Event|7
7613662|NCT01817725|26491107|P1|Overall Study|Withdrawal by Subject|1
7613663|NCT01817582|26491128|P3|Overall Study|Randomized but exclusion criteria met|0
7613664|NCT01817582|26491129|P2|Overall Study|Randomized but exclusion criteria met|0
7613665|NCT01817582|26491130|P1|Overall Study|Randomized but exclusion criteria met|1
7613666|NCT01817582|26491128|P3|Overall Study|Participant revealed masked treatment|0
7613667|NCT01817582|26491129|P2|Overall Study|Participant revealed masked treatment|0
7613668|NCT01817582|26491130|P1|Overall Study|Participant revealed masked treatment|1
7613669|NCT01817582|26491128|P3|Overall Study|Withdrawal by Subject|0
7613670|NCT01817582|26491129|P2|Overall Study|Withdrawal by Subject|1
7613671|NCT01817582|26491130|P1|Overall Study|Withdrawal by Subject|0
7613672|NCT01817530|26491200|P8|Overall Study|Lost to Follow-up|4
7613673|NCT01817530|26491201|P7|Overall Study|Lost to Follow-up|8
7613674|NCT01817530|26491202|P6|Overall Study|Lost to Follow-up|2
7613675|NCT01817530|26491203|P5|Overall Study|Lost to Follow-up|3
7613676|NCT01817530|26491204|P4|Overall Study|Lost to Follow-up|1
7613677|NCT01817530|26491205|P3|Overall Study|Lost to Follow-up|2
7613678|NCT01817530|26491206|P2|Overall Study|Lost to Follow-up|4
7613679|NCT01817530|26491207|P1|Overall Study|Lost to Follow-up|1
7613680|NCT01817530|26491200|P8|Overall Study|Consent Withdrawn by Subject|10
7613681|NCT01817530|26491201|P7|Overall Study|Consent Withdrawn by Subject|3
7613682|NCT01817530|26491202|P6|Overall Study|Consent Withdrawn by Subject|3
7613683|NCT01817530|26491203|P5|Overall Study|Consent Withdrawn by Subject|5
7613684|NCT01817530|26491204|P4|Overall Study|Consent Withdrawn by Subject|3
7613685|NCT01817530|26491205|P3|Overall Study|Consent Withdrawn by Subject|7
7613686|NCT01817530|26491206|P2|Overall Study|Consent Withdrawn by Subject|4
7613687|NCT01817530|26491207|P1|Overall Study|Consent Withdrawn by Subject|3
7613688|NCT01817530|26491200|P8|Overall Study|Surgery or Invasive Intervention|0
7613689|NCT01817530|26491201|P7|Overall Study|Surgery or Invasive Intervention|1
7613690|NCT01817530|26491202|P6|Overall Study|Surgery or Invasive Intervention|1
7613691|NCT01817530|26491203|P5|Overall Study|Surgery or Invasive Intervention|1
7613692|NCT01817530|26491204|P4|Overall Study|Surgery or Invasive Intervention|0
7613693|NCT01817530|26491205|P3|Overall Study|Surgery or Invasive Intervention|0
7613694|NCT01817530|26491206|P2|Overall Study|Surgery or Invasive Intervention|0
7613695|NCT01817530|26491207|P1|Overall Study|Surgery or Invasive Intervention|1
7613696|NCT01817530|26491200|P8|Overall Study|Other|0
7613697|NCT01817530|26491201|P7|Overall Study|Other|5
7613698|NCT01817530|26491202|P6|Overall Study|Other|0
7613699|NCT01817530|26491203|P5|Overall Study|Other|1
7613700|NCT01817530|26491204|P4|Overall Study|Other|0
7613701|NCT01817530|26491205|P3|Overall Study|Other|0
7613702|NCT01817530|26491206|P2|Overall Study|Other|1
7613703|NCT01817530|26491207|P1|Overall Study|Other|0
7613704|NCT01817530|26491200|P8|Overall Study|Pregnancy|0
7613705|NCT01817530|26491201|P7|Overall Study|Pregnancy|0
7613706|NCT01817530|26491202|P6|Overall Study|Pregnancy|1
7613707|NCT01817530|26491203|P5|Overall Study|Pregnancy|0
7613708|NCT01817530|26491204|P4|Overall Study|Pregnancy|0
7613709|NCT01817530|26491205|P3|Overall Study|Pregnancy|0
7613710|NCT01817530|26491206|P2|Overall Study|Pregnancy|0
7613711|NCT01817530|26491207|P1|Overall Study|Pregnancy|0
7613712|NCT01817530|26491200|P8|Overall Study|Lack of Efficacy|1
7613713|NCT01817530|26491201|P7|Overall Study|Lack of Efficacy|0
7613714|NCT01817530|26491202|P6|Overall Study|Lack of Efficacy|1
7613715|NCT01817530|26491203|P5|Overall Study|Lack of Efficacy|0
7613716|NCT01817530|26491204|P4|Overall Study|Lack of Efficacy|0
7613717|NCT01817530|26491205|P3|Overall Study|Lack of Efficacy|0
7613718|NCT01817530|26491206|P2|Overall Study|Lack of Efficacy|0
7613719|NCT01817530|26491207|P1|Overall Study|Lack of Efficacy|1
7613720|NCT01817530|26491200|P8|Overall Study|Subject Noncompliant|1
7613721|NCT01817530|26491201|P7|Overall Study|Subject Noncompliant|1
7613722|NCT01817530|26491202|P6|Overall Study|Subject Noncompliant|1
7613723|NCT01817530|26491203|P5|Overall Study|Subject Noncompliant|0
7613724|NCT01817530|26491204|P4|Overall Study|Subject Noncompliant|4
7613725|NCT01817530|26491205|P3|Overall Study|Subject Noncompliant|0
7613726|NCT01817530|26491206|P2|Overall Study|Subject Noncompliant|1
7613727|NCT01817530|26491207|P1|Overall Study|Subject Noncompliant|3
7613728|NCT01817530|26491200|P8|Overall Study|Adverse Event|8
7613729|NCT01817530|26491201|P7|Overall Study|Adverse Event|5
7613730|NCT01817530|26491202|P6|Overall Study|Adverse Event|10
7613731|NCT01817530|26491203|P5|Overall Study|Adverse Event|0
7613732|NCT01817530|26491204|P4|Overall Study|Adverse Event|5
7613733|NCT01817530|26491205|P3|Overall Study|Adverse Event|2
7613734|NCT01817530|26491206|P2|Overall Study|Adverse Event|3
7613735|NCT01817530|26491207|P1|Overall Study|Adverse Event|6
7613736|NCT01817530|26491200|P8|Overall Study|Exclusionary Medication Received|0
7613737|NCT01817530|26491201|P7|Overall Study|Exclusionary Medication Received|0
7613738|NCT01817530|26491202|P6|Overall Study|Exclusionary Medication Received|0
7613739|NCT01817530|26491203|P5|Overall Study|Exclusionary Medication Received|1
7613740|NCT01817530|26491204|P4|Overall Study|Exclusionary Medication Received|0
7613741|NCT01817530|26491205|P3|Overall Study|Exclusionary Medication Received|0
7613742|NCT01817530|26491206|P2|Overall Study|Exclusionary Medication Received|0
7613743|NCT01817530|26491207|P1|Overall Study|Exclusionary Medication Received|0
7613744|NCT01817075|26491432|P2|Overall Study|Ineligible|2
7613745|NCT01817075|26491433|P1|Overall Study|Ineligible|0
7613746|NCT01817075|26491432|P2|Overall Study|Received Sorafenib after enrollment|1
7613747|NCT01817075|26491433|P1|Overall Study|Received Sorafenib after enrollment|0
7613748|NCT01817075|26491432|P2|Overall Study|Withdrawal by Subject|15
7613749|NCT01817075|26491433|P1|Overall Study|Withdrawal by Subject|31
7613750|NCT01817075|26491432|P2|Overall Study|Physician Decision|12
7613751|NCT01817075|26491433|P1|Overall Study|Physician Decision|9
7613752|NCT01817075|26491432|P2|Overall Study|Adverse Event|5
7613753|NCT01817075|26491433|P1|Overall Study|Adverse Event|7
7613754|NCT01816984|26491445|P1|Overall Study|declining health status|1
7613755|NCT01816906|26491475|P2|12 Months|Lost to Follow-up|1
7613756|NCT01816906|26491476|P1|12 Months|Lost to Follow-up|2
7613757|NCT01816906|26491475|P2|12 Months|Death|2
7613758|NCT01816906|26491476|P1|12 Months|Death|0
7613759|NCT01816906|26491475|P2|12 Months|Adverse Event|2
7613760|NCT01816906|26491476|P1|12 Months|Adverse Event|2
7613761|NCT01816906|26491475|P2|Six Months|Lost to Follow-up|16
7613762|NCT01816906|26491476|P1|Six Months|Lost to Follow-up|14
7613763|NCT01816906|26491475|P2|Six Months|Did Not Show Up for Baseline Measurement|6
7613764|NCT01816906|26491476|P1|Six Months|Did Not Show Up for Baseline Measurement|7
7613765|NCT01816893|26491494|P2|Washout Period|Withdrawal by Subject|0
7613766|NCT01816893|26491495|P1|Washout Period|Withdrawal by Subject|2
7613767|NCT01816763|26491531|P3|Overall Study|The main reason for an incomplete survey|11
7613768|NCT01816763|26491532|P2|Overall Study|The main reason for an incomplete survey|15
7613769|NCT01816763|26491533|P1|Overall Study|The main reason for an incomplete survey|4
7613770|NCT01816685|26491558|P2|Overall Study|Surgery Cancelled|2
7613771|NCT01816685|26491559|P1|Overall Study|Surgery Cancelled|3
7613772|NCT01816685|26491558|P2|Overall Study|Lost to Follow-up|9
7613773|NCT01816685|26491559|P1|Overall Study|Lost to Follow-up|7
7613774|NCT01816594|26491569|P2|Overall Study|Physician Decision|0
7613775|NCT01816594|26491570|P1|Overall Study|Physician Decision|1
7613776|NCT01816594|26491569|P2|Overall Study|Withdrawal by Subject|0
7613777|NCT01816594|26491570|P1|Overall Study|Withdrawal by Subject|1
7613778|NCT01816594|26491569|P2|Overall Study|Adverse Event|0
7613779|NCT01816594|26491570|P1|Overall Study|Adverse Event|9
7613780|NCT01816594|26491569|P2|Overall Study|Local Progress|2
7613781|NCT01816594|26491570|P1|Overall Study|Local Progress|0
7613782|NCT01816477|26491608|P2|Overall Study|Unable to tolerate catheter placement|0
7613783|NCT01816477|26491609|P1|Overall Study|Unable to tolerate catheter placement|3
7613784|NCT01816477|26491608|P2|Overall Study|Withdrawal by Subject|1
7613785|NCT01816477|26491609|P1|Overall Study|Withdrawal by Subject|13
7613786|NCT01816295|26491663|P2|OLE Phase|Lack of Efficacy|7
7613787|NCT01816295|26491664|P1|OLE Phase|Lack of Efficacy|3
7613788|NCT01816295|26491663|P2|OLE Phase|Withdrawal by Subject|10
7613789|NCT01816295|26491664|P1|OLE Phase|Withdrawal by Subject|10
7613790|NCT01816295|26491663|P2|OLE Phase|Sponsor Decision|9
7613791|NCT01816295|26491664|P1|OLE Phase|Sponsor Decision|7
7613792|NCT01816295|26491663|P2|OLE Phase|Protocol Violation|4
7613793|NCT01816295|26491664|P1|OLE Phase|Protocol Violation|4
7613794|NCT01816295|26491663|P2|OLE Phase|Physician Decision|1
7613795|NCT01816295|26491664|P1|OLE Phase|Physician Decision|3
7613796|NCT01816295|26491663|P2|OLE Phase|Lost to Follow-up|5
7613797|NCT01816295|26491664|P1|OLE Phase|Lost to Follow-up|5
7613798|NCT01816295|26491663|P2|OLE Phase|Entry Criteria Not Met|5
7613799|NCT01816295|26491664|P1|OLE Phase|Entry Criteria Not Met|3
7613800|NCT01816295|26491663|P2|OLE Phase|Death|0
7613801|NCT01816295|26491664|P1|OLE Phase|Death|1
7613802|NCT01816295|26491663|P2|OLE Phase|Adverse Event|15
7613803|NCT01816295|26491664|P1|OLE Phase|Adverse Event|17
7613804|NCT01816295|26491663|P2|Double Blind Phase|Withdrawal by Subject|20
7613805|NCT01816295|26491664|P1|Double Blind Phase|Withdrawal by Subject|22
7613806|NCT01816295|26491663|P2|Double Blind Phase|Sponsor Decision|8
7613807|NCT01816295|26491664|P1|Double Blind Phase|Sponsor Decision|8
7613808|NCT01816295|26491663|P2|Double Blind Phase|Protocol Violation|11
7613809|NCT01816295|26491664|P1|Double Blind Phase|Protocol Violation|17
7613810|NCT01816295|26491663|P2|Double Blind Phase|Physician Decision|2
7613811|NCT01816295|26491664|P1|Double Blind Phase|Physician Decision|2
7613812|NCT01816295|26491663|P2|Double Blind Phase|Lost to Follow-up|5
7613813|NCT01816295|26491664|P1|Double Blind Phase|Lost to Follow-up|3
7613814|NCT01816295|26491663|P2|Double Blind Phase|Entry Criteria Not Met|2
7613815|NCT01816295|26491664|P1|Double Blind Phase|Entry Criteria Not Met|0
7613816|NCT01816295|26491663|P2|Double Blind Phase|Adverse Event|8
7613817|NCT01816295|26491664|P1|Double Blind Phase|Adverse Event|11
7613818|NCT01816243|26491679|P1|Overall Study|Amputation|3
7613819|NCT01816243|26491679|P1|Overall Study|Not eligible for the study|1
7613820|NCT01816243|26491679|P1|Overall Study|Lack of Efficacy|1
7613821|NCT01816243|26491679|P1|Overall Study|Lost to Follow-up|1
7613822|NCT01816243|26491679|P1|Overall Study|Adverse Event|6
7613823|NCT01816074|26491694|P4|Phase 2|Withdrawal by Subject|0
7613824|NCT01816074|26491695|P3|Phase 2|Withdrawal by Subject|0
7613825|NCT01816074|26491696|P2|Phase 2|Withdrawal by Subject|0
7613826|NCT01816074|26491697|P1|Phase 2|Withdrawal by Subject|1
7613827|NCT01816074|26491694|P4|Phase 2|Physician Decision|1
7613828|NCT01816074|26491695|P3|Phase 2|Physician Decision|0
7613829|NCT01816074|26491696|P2|Phase 2|Physician Decision|0
7613830|NCT01816074|26491697|P1|Phase 2|Physician Decision|0
7613831|NCT01816074|26491694|P4|Phase 2|Unsatisfied with Randomization assignmen|0
7613832|NCT01816074|26491695|P3|Phase 2|Unsatisfied with Randomization assignmen|0
7613833|NCT01816074|26491696|P2|Phase 2|Unsatisfied with Randomization assignmen|0
7613834|NCT01816074|26491697|P1|Phase 2|Unsatisfied with Randomization assignmen|1
7613835|NCT01816074|26491694|P4|Phase 2|Time commitment Issues|0
7613836|NCT01816074|26491695|P3|Phase 2|Time commitment Issues|0
7613837|NCT01816074|26491696|P2|Phase 2|Time commitment Issues|2
7613838|NCT01816074|26491697|P1|Phase 2|Time commitment Issues|0
7613839|NCT01816074|26491694|P4|Phase 1|Time commitment issues|0
7613840|NCT01816074|26491695|P3|Phase 1|Time commitment issues|1
7613841|NCT01816074|26491696|P2|Phase 1|Time commitment issues|0
7613842|NCT01816074|26491697|P1|Phase 1|Time commitment issues|0
7613843|NCT01816061|26491727|P2|Overall Study|Lost to Follow-up|24
7613844|NCT01816061|26491728|P1|Overall Study|Lost to Follow-up|13
7613845|NCT01816048|26491736|P1|Overall Study|Disease Progression|3
7613846|NCT01816048|26491736|P1|Overall Study|Withdrawal by Subject|1
7613847|NCT01816048|26491736|P1|Overall Study|Death|1
7613848|NCT01816048|26491736|P1|Overall Study|Adverse Event|1
7613849|NCT01815918|26491751|P2|Overall Study|Lack of Efficacy|15
7613850|NCT01815918|26491752|P1|Overall Study|Lack of Efficacy|15
7613851|NCT01815918|26491751|P2|Overall Study|Patient samples not analyzable|4
7613852|NCT01815918|26491752|P1|Overall Study|Patient samples not analyzable|3
7613853|NCT01815840|26491768|P2|Overall Study|Sponsor Termination Treatment|0
7613854|NCT01815840|26491769|P1|Overall Study|Sponsor Termination Treatment|1
7613855|NCT01815840|26491768|P2|Overall Study|Refused Treatment|1
7613856|NCT01815840|26491769|P1|Overall Study|Refused Treatment|5
7613857|NCT01815840|26491768|P2|Overall Study|Lost to Follow-up|6
7613858|NCT01815840|26491769|P1|Overall Study|Lost to Follow-up|3
7613859|NCT01815840|26491768|P2|Overall Study|Investigators Decision|3
7613860|NCT01815840|26491769|P1|Overall Study|Investigators Decision|2
7613861|NCT01815840|26491768|P2|Overall Study|Disease progression|2
7613862|NCT01815840|26491769|P1|Overall Study|Disease progression|3
7613863|NCT01815840|26491768|P2|Overall Study|Death|2
7613864|NCT01815840|26491769|P1|Overall Study|Death|2
7613865|NCT01815840|26491768|P2|Overall Study|Adverse Event|16
7613866|NCT01815840|26491769|P1|Overall Study|Adverse Event|10
7613867|NCT01815840|26491768|P2|Overall Study|Administrative/Other|3
7613868|NCT01815840|26491769|P1|Overall Study|Administrative/Other|1
7613869|NCT01815840|26491768|P2|Overall Study|Withdrew Consent|30
7613870|NCT01815840|26491769|P1|Overall Study|Withdrew Consent|31
7613871|NCT01815840|26491768|P2|Overall Study|Missing|0
7613872|NCT01815840|26491769|P1|Overall Study|Missing|1
7613873|NCT01815736|26491799|P2|Extension Treatment Phase- After Week 96|Death|0
7613874|NCT01815736|26491800|P1|Extension Treatment Phase- After Week 96|Death|1
7613875|NCT01815736|26491799|P2|Extension Treatment Phase- After Week 96|Adverse Event|1
7613876|NCT01815736|26491800|P1|Extension Treatment Phase- After Week 96|Adverse Event|1
7613877|NCT01815736|26491799|P2|Extension Treatment Phase- After Week 96|Withdrew Consent|1
7613878|NCT01815736|26491800|P1|Extension Treatment Phase- After Week 96|Withdrew Consent|5
7613879|NCT01815736|26491799|P2|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
7613880|NCT01815736|26491800|P1|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
7613881|NCT01815736|26491799|P2|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
7613882|NCT01815736|26491800|P1|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
7613883|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
7613884|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
7613885|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
7613886|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
7613887|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
7613888|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
7613889|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Death|0
7613890|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Death|4
7613891|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
7613892|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
7613893|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
7613894|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
7613895|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
7613896|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
7613897|NCT01815736|26491799|P2|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
7613898|NCT01815736|26491800|P1|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
7613899|NCT01815424|26491881|P5|Week 16 to 52|Withdrawal by Subject|0
7613900|NCT01815424|26491882|P4|Week 16 to 52|Withdrawal by Subject|0
7613901|NCT01815424|26491883|P3|Week 16 to 52|Withdrawal by Subject|0
7613902|NCT01815424|26491884|P2|Week 16 to 52|Withdrawal by Subject|2
7613903|NCT01815424|26491885|P1|Week 16 to 52|Withdrawal by Subject|1
7613904|NCT01815424|26491881|P5|Week 16 to 52|Lost to Follow-up|1
7613905|NCT01815424|26491882|P4|Week 16 to 52|Lost to Follow-up|2
7613906|NCT01815424|26491883|P3|Week 16 to 52|Lost to Follow-up|0
7613907|NCT01815424|26491884|P2|Week 16 to 52|Lost to Follow-up|2
7613908|NCT01815424|26491885|P1|Week 16 to 52|Lost to Follow-up|0
7613909|NCT01815424|26491881|P5|Week 16 to 52|Insufficient Clinical Response|1
7613910|NCT01815424|26491882|P4|Week 16 to 52|Insufficient Clinical Response|1
7613911|NCT01815424|26491883|P3|Week 16 to 52|Insufficient Clinical Response|0
7613912|NCT01815424|26491884|P2|Week 16 to 52|Insufficient Clinical Response|0
7613913|NCT01815424|26491885|P1|Week 16 to 52|Insufficient Clinical Response|1
7613914|NCT01815424|26491881|P5|Week 16 to 52|Adverse Event|1
7613915|NCT01815424|26491882|P4|Week 16 to 52|Adverse Event|0
7613916|NCT01815424|26491883|P3|Week 16 to 52|Adverse Event|0
7613917|NCT01815424|26491884|P2|Week 16 to 52|Adverse Event|0
7613918|NCT01815424|26491885|P1|Week 16 to 52|Adverse Event|0
7613919|NCT01815424|26491881|P5|Week 16 to 52|Other|0
7613920|NCT01815424|26491882|P4|Week 16 to 52|Other|0
7613921|NCT01815424|26491883|P3|Week 16 to 52|Other|0
7613922|NCT01815424|26491884|P2|Week 16 to 52|Other|1
7613923|NCT01815424|26491885|P1|Week 16 to 52|Other|0
7613924|NCT01815424|26491881|P5|Week 0 to 16|Insufficient Clinical Response|0
7613925|NCT01815424|26491882|P4|Week 0 to 16|Insufficient Clinical Response|0
7613926|NCT01815424|26491883|P3|Week 0 to 16|Insufficient Clinical Response|4
7613927|NCT01815424|26491884|P2|Week 0 to 16|Insufficient Clinical Response|0
7613928|NCT01815424|26491885|P1|Week 0 to 16|Insufficient Clinical Response|2
7613929|NCT01815424|26491881|P5|Week 0 to 16|Protocol Violation|0
7613930|NCT01815424|26491882|P4|Week 0 to 16|Protocol Violation|0
7613931|NCT01815424|26491883|P3|Week 0 to 16|Protocol Violation|0
7613932|NCT01815424|26491884|P2|Week 0 to 16|Protocol Violation|0
7613933|NCT01815424|26491885|P1|Week 0 to 16|Protocol Violation|1
7613934|NCT01815424|26491881|P5|Week 0 to 16|Other|0
7613935|NCT01815424|26491882|P4|Week 0 to 16|Other|0
7613936|NCT01815424|26491883|P3|Week 0 to 16|Other|3
7613937|NCT01815424|26491884|P2|Week 0 to 16|Other|0
7613938|NCT01815424|26491885|P1|Week 0 to 16|Other|1
7613939|NCT01815424|26491881|P5|Week 0 to 16|Withdrawal by Subject|0
7613940|NCT01815424|26491882|P4|Week 0 to 16|Withdrawal by Subject|0
7613941|NCT01815424|26491883|P3|Week 0 to 16|Withdrawal by Subject|1
7613942|NCT01815424|26491884|P2|Week 0 to 16|Withdrawal by Subject|0
7613943|NCT01815424|26491885|P1|Week 0 to 16|Withdrawal by Subject|0
7613944|NCT01815424|26491881|P5|Week 0 to 16|Lost to Follow-up|0
7613945|NCT01815424|26491882|P4|Week 0 to 16|Lost to Follow-up|0
7613946|NCT01815424|26491883|P3|Week 0 to 16|Lost to Follow-up|0
7613947|NCT01815424|26491884|P2|Week 0 to 16|Lost to Follow-up|1
7613948|NCT01815424|26491885|P1|Week 0 to 16|Lost to Follow-up|0
7613949|NCT01815424|26491881|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
7613950|NCT01815424|26491882|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
7613951|NCT01815424|26491883|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
7613952|NCT01815424|26491884|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
7613953|NCT01815424|26491885|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
7613954|NCT01815424|26491881|P5|Week 0 to 16|Adverse Event|0
7613955|NCT01815424|26491882|P4|Week 0 to 16|Adverse Event|0
7613956|NCT01815424|26491883|P3|Week 0 to 16|Adverse Event|3
7613957|NCT01815424|26491884|P2|Week 0 to 16|Adverse Event|3
7613958|NCT01815424|26491885|P1|Week 0 to 16|Adverse Event|1
7613959|NCT01815138|26492101|P2|Overall Study|Physician Decision|5
7613960|NCT01815138|26492102|P1|Overall Study|Physician Decision|8
7613961|NCT01815138|26492101|P2|Overall Study|Withdrawal by Subject|1
7613962|NCT01815138|26492102|P1|Overall Study|Withdrawal by Subject|0
7613963|NCT01815099|26492114|P1|Overall Study|unable to attend study visits|1
7613964|NCT01815099|26492114|P1|Overall Study|Lack of Efficacy|1
7613965|NCT01814878|26492128|P2|Overall Study|Other|0
7613966|NCT01814878|26492129|P1|Overall Study|Other|2
7613967|NCT01814878|26492128|P2|Overall Study|Screening failure (drop-out)|3
7613968|NCT01814878|26492129|P1|Overall Study|Screening failure (drop-out)|0
7613969|NCT01814878|26492128|P2|Overall Study|Physician Decision|1
7613970|NCT01814878|26492129|P1|Overall Study|Physician Decision|3
7613971|NCT01814878|26492128|P2|Overall Study|Protocol Violation|5
7613972|NCT01814878|26492129|P1|Overall Study|Protocol Violation|5
7613973|NCT01814878|26492128|P2|Overall Study|Withdrawal by Subject|16
7613974|NCT01814878|26492129|P1|Overall Study|Withdrawal by Subject|20
7613975|NCT01814878|26492128|P2|Overall Study|Adverse Event|5
7613976|NCT01814878|26492129|P1|Overall Study|Adverse Event|16
7613977|NCT01814826|26492152|P3|Overall Study|Death|3
7613978|NCT01814826|26492153|P2|Overall Study|Death|24
7613979|NCT01814826|26492154|P1|Overall Study|Death|29
7613980|NCT01814826|26492152|P3|Overall Study|Other|0
7613981|NCT01814826|26492153|P2|Overall Study|Other|5
7613982|NCT01814826|26492154|P1|Overall Study|Other|3
7613983|NCT01814800|26492246|P1|Overall Study|Subject relocation|1
7613984|NCT01814800|26492246|P1|Overall Study|Sponsor decision|1
7613985|NCT01814800|26492246|P1|Overall Study|Pregnancy|1
7613986|NCT01814800|26492246|P1|Overall Study|Adverse Event|2
7613987|NCT01814761|26492306|P2|Overall Study|Lost to Follow-up|5
7613988|NCT01814761|26492307|P1|Overall Study|Lost to Follow-up|1
7613989|NCT01814761|26492306|P2|Overall Study|Ocular Adverse Event|15
7613990|NCT01814761|26492307|P1|Overall Study|Ocular Adverse Event|6
7613991|NCT01814761|26492306|P2|Overall Study|Other Reasons|10
7613992|NCT01814761|26492307|P1|Overall Study|Other Reasons|1
7613993|NCT01814748|26492321|P2|Overall Study|Withdrawal by Subject|4
7613994|NCT01814748|26492322|P1|Overall Study|Withdrawal by Subject|6
7613995|NCT01814748|26492321|P2|Overall Study|Study site terminated by sponsor|1
7613996|NCT01814748|26492322|P1|Overall Study|Study site terminated by sponsor|1
7613997|NCT01814748|26492321|P2|Overall Study|Lost to Follow-up|2
7613998|NCT01814748|26492322|P1|Overall Study|Lost to Follow-up|1
7613999|NCT01814696|26492366|P2|Overall Study|Randomized to wrong group|0
7614000|NCT01814696|26492367|P1|Overall Study|Randomized to wrong group|1
7614001|NCT01814696|26492366|P2|Overall Study|Withdrawal by Subject|0
7614002|NCT01814696|26492367|P1|Overall Study|Withdrawal by Subject|1
7614003|NCT01814670|26492385|P1|Overall Study|Protocol Violation|12
7614004|NCT01814553|26492395|P2|Overall Study|Other than stated|8
7614005|NCT01814553|26492396|P1|Overall Study|Other than stated|7
7614006|NCT01814553|26492395|P2|Overall Study|Withdrawal by Subject|1
7614007|NCT01814553|26492396|P1|Overall Study|Withdrawal by Subject|1
7614008|NCT01814553|26492395|P2|Overall Study|Other Adverse Event|5
7614009|NCT01814553|26492396|P1|Overall Study|Other Adverse Event|4
7614010|NCT01814553|26492395|P2|Overall Study|PD per clinical progression|8
7614011|NCT01814553|26492396|P1|Overall Study|PD per clinical progression|6
7614012|NCT01814397|26492410|P1|Overall Study|Withdrawal by Subject|7
7614013|NCT01814397|26492410|P1|Overall Study|Adverse Event|7
7614014|NCT01814371|26492419|P2|Overall Study|Lost to Follow-up|27
7614015|NCT01814371|26492420|P1|Overall Study|Lost to Follow-up|30
7614016|NCT01814332|26492455|P2|Overall Study|Lost to Follow-up|1
7614017|NCT01814332|26492456|P1|Overall Study|Lost to Follow-up|5
7614018|NCT01814332|26492455|P2|Overall Study|Protocol Violation|4
7614019|NCT01814332|26492456|P1|Overall Study|Protocol Violation|0
7614020|NCT01814332|26492455|P2|Overall Study|Withdrawal by Subject|8
7614021|NCT01814332|26492456|P1|Overall Study|Withdrawal by Subject|3
7614022|NCT01814332|26492455|P2|Overall Study|Adverse Event|3
7614023|NCT01814332|26492456|P1|Overall Study|Adverse Event|8
7614024|NCT01814137|26492478|P2|Overall Study|Unclassified|1
7614025|NCT01814137|26492479|P1|Overall Study|Unclassified|2
7614026|NCT01814137|26492478|P2|Overall Study|Physician Decision|1
7614027|NCT01814137|26492479|P1|Overall Study|Physician Decision|1
7614028|NCT01814137|26492478|P2|Overall Study|Withdrawal by Subject|2
7614029|NCT01814137|26492479|P1|Overall Study|Withdrawal by Subject|2
7614030|NCT01814137|26492478|P2|Overall Study|Adverse Event|1
7614031|NCT01814137|26492479|P1|Overall Study|Adverse Event|0
7614032|NCT01814072|26492525|P32|Overall Study|Withdrawal by Subject|0
7614033|NCT01814072|26492526|P31|Overall Study|Withdrawal by Subject|0
7614034|NCT01814072|26492527|P30|Overall Study|Withdrawal by Subject|0
7614035|NCT01814072|26492528|P29|Overall Study|Withdrawal by Subject|1
7614036|NCT01814072|26492529|P28|Overall Study|Withdrawal by Subject|2
7614037|NCT01814072|26492530|P27|Overall Study|Withdrawal by Subject|1
7614038|NCT01814072|26492531|P26|Overall Study|Withdrawal by Subject|1
7614039|NCT01814072|26492532|P25|Overall Study|Withdrawal by Subject|2
7614040|NCT01814072|26492533|P24|Overall Study|Withdrawal by Subject|0
7614041|NCT01814072|26492534|P23|Overall Study|Withdrawal by Subject|1
7614042|NCT01814072|26492535|P22|Overall Study|Withdrawal by Subject|0
7614043|NCT01814072|26492536|P21|Overall Study|Withdrawal by Subject|0
7614044|NCT01814072|26492537|P20|Overall Study|Withdrawal by Subject|2
7614045|NCT01814072|26492538|P19|Overall Study|Withdrawal by Subject|0
7614046|NCT01814072|26492539|P18|Overall Study|Withdrawal by Subject|0
7614047|NCT01814072|26492540|P17|Overall Study|Withdrawal by Subject|0
7614048|NCT01814072|26492541|P16|Overall Study|Withdrawal by Subject|1
7614049|NCT01814072|26492542|P15|Overall Study|Withdrawal by Subject|1
7614050|NCT01814072|26492543|P14|Overall Study|Withdrawal by Subject|1
7614051|NCT01814072|26492544|P13|Overall Study|Withdrawal by Subject|1
7614052|NCT01814072|26492545|P12|Overall Study|Withdrawal by Subject|0
7614053|NCT01814072|26492546|P11|Overall Study|Withdrawal by Subject|0
7614054|NCT01814072|26492547|P10|Overall Study|Withdrawal by Subject|2
7614055|NCT01814072|26492548|P9|Overall Study|Withdrawal by Subject|1
7614056|NCT01814072|26492549|P8|Overall Study|Withdrawal by Subject|0
7614057|NCT01814072|26492550|P7|Overall Study|Withdrawal by Subject|1
7614058|NCT01814072|26492551|P6|Overall Study|Withdrawal by Subject|3
7614059|NCT01814072|26492552|P5|Overall Study|Withdrawal by Subject|2
7614060|NCT01814072|26492553|P4|Overall Study|Withdrawal by Subject|0
7614061|NCT01814072|26492554|P3|Overall Study|Withdrawal by Subject|1
7614062|NCT01814072|26492555|P2|Overall Study|Withdrawal by Subject|0
7614063|NCT01814072|26492556|P1|Overall Study|Withdrawal by Subject|2
7614064|NCT01814072|26492525|P32|Overall Study|Lost to Follow-up|0
7614065|NCT01814072|26492526|P31|Overall Study|Lost to Follow-up|2
7614066|NCT01814072|26492527|P30|Overall Study|Lost to Follow-up|3
7614067|NCT01814072|26492528|P29|Overall Study|Lost to Follow-up|3
7614068|NCT01814072|26492529|P28|Overall Study|Lost to Follow-up|2
7614069|NCT01814072|26492530|P27|Overall Study|Lost to Follow-up|1
7614070|NCT01814072|26492531|P26|Overall Study|Lost to Follow-up|1
7614071|NCT01814072|26492532|P25|Overall Study|Lost to Follow-up|4
7614072|NCT01814072|26492533|P24|Overall Study|Lost to Follow-up|1
7614073|NCT01814072|26492534|P23|Overall Study|Lost to Follow-up|3
7614074|NCT01814072|26492535|P22|Overall Study|Lost to Follow-up|1
7614075|NCT01814072|26492536|P21|Overall Study|Lost to Follow-up|2
7614076|NCT01814072|26492537|P20|Overall Study|Lost to Follow-up|3
7614077|NCT01814072|26492538|P19|Overall Study|Lost to Follow-up|3
7614078|NCT01814072|26492539|P18|Overall Study|Lost to Follow-up|1
7614079|NCT01814072|26492540|P17|Overall Study|Lost to Follow-up|3
7614080|NCT01814072|26492541|P16|Overall Study|Lost to Follow-up|1
7614081|NCT01814072|26492542|P15|Overall Study|Lost to Follow-up|2
7614082|NCT01814072|26492543|P14|Overall Study|Lost to Follow-up|1
7614083|NCT01814072|26492544|P13|Overall Study|Lost to Follow-up|2
7614084|NCT01814072|26492545|P12|Overall Study|Lost to Follow-up|2
7614085|NCT01814072|26492546|P11|Overall Study|Lost to Follow-up|1
7614086|NCT01814072|26492547|P10|Overall Study|Lost to Follow-up|3
7614087|NCT01814072|26492548|P9|Overall Study|Lost to Follow-up|2
7614088|NCT01814072|26492549|P8|Overall Study|Lost to Follow-up|1
7614089|NCT01814072|26492550|P7|Overall Study|Lost to Follow-up|3
7614090|NCT01814072|26492551|P6|Overall Study|Lost to Follow-up|3
7614091|NCT01814072|26492552|P5|Overall Study|Lost to Follow-up|2
7614092|NCT01814072|26492553|P4|Overall Study|Lost to Follow-up|0
7614093|NCT01814072|26492554|P3|Overall Study|Lost to Follow-up|2
7614094|NCT01814072|26492555|P2|Overall Study|Lost to Follow-up|2
7614095|NCT01814072|26492556|P1|Overall Study|Lost to Follow-up|2
7614096|NCT01814046|26492598|P3|Drug Administration|Death due to complications of RSV|0
7614097|NCT01814046|26492599|P2|Drug Administration|Death due to complications of RSV|0
7614098|NCT01814046|26492600|P1|Drug Administration|Death due to complications of RSV|1
7614099|NCT01814007|26492611|P1|Overall Study|Withdrawal by Subject|1
7614100|NCT01813890|26492624|P3|Overall Study|Lack of Efficacy|2
7614101|NCT01813890|26492625|P2|Overall Study|Lack of Efficacy|1
7614102|NCT01813890|26492626|P1|Overall Study|Lack of Efficacy|9
7614103|NCT01813890|26492624|P3|Overall Study|Adverse Event|4
7614104|NCT01813890|26492625|P2|Overall Study|Adverse Event|3
7614105|NCT01813890|26492626|P1|Overall Study|Adverse Event|0
7614106|NCT01813721|26492663|P1|Overall Study|Withdrawal by Subject|1
7614107|NCT01813721|26492663|P1|Overall Study|Ineligibility determined|63
7614108|NCT01813474|26492718|P3|Overall Study|Death|1
7614109|NCT01813474|26492719|P2|Overall Study|Death|0
7614110|NCT01813474|26492720|P1|Overall Study|Death|0
7614111|NCT01813474|26492718|P3|Overall Study|Lack of Efficacy|9
7614112|NCT01813474|26492719|P2|Overall Study|Lack of Efficacy|6
7614113|NCT01813474|26492720|P1|Overall Study|Lack of Efficacy|2
7614114|NCT01813474|26492718|P3|Overall Study|Adverse Event|0
7614115|NCT01813474|26492719|P2|Overall Study|Adverse Event|1
7614116|NCT01813474|26492720|P1|Overall Study|Adverse Event|1
7614117|NCT01813474|26492718|P3|Overall Study|Withdrawal by Subject|1
7614118|NCT01813474|26492719|P2|Overall Study|Withdrawal by Subject|0
7614119|NCT01813474|26492720|P1|Overall Study|Withdrawal by Subject|0
7614120|NCT01813435|26492744|P2|Overall Study|Lost to Follow-up|237
7614121|NCT01813435|26492745|P1|Overall Study|Lost to Follow-up|268
7614122|NCT01813435|26492744|P2|Overall Study|did not finish experimental regimen|770
7614123|NCT01813435|26492745|P1|Overall Study|did not finish experimental regimen|1902
7614124|NCT01813422|26492769|P2|Overall Study|Lost to Follow-up|4
7614125|NCT01813422|26492770|P1|Overall Study|Lost to Follow-up|2
7614126|NCT01813422|26492769|P2|Overall Study|Sponsor Decision|1
7614127|NCT01813422|26492770|P1|Overall Study|Sponsor Decision|2
7614128|NCT01813422|26492769|P2|Overall Study|Death|3
7614129|NCT01813422|26492770|P1|Overall Study|Death|2
7614130|NCT01813422|26492769|P2|Overall Study|Withdrawal by Subject|8
7614131|NCT01813422|26492770|P1|Overall Study|Withdrawal by Subject|14
7614132|NCT01813357|26492784|P2|Overall Study|Lost to Follow-up|6
7614133|NCT01813357|26492785|P1|Overall Study|Lost to Follow-up|5
7614134|NCT01813071|26492841|P9|Overall Study|Met inc/exc criteria|1
7614135|NCT01813071|26492842|P8|Overall Study|Met inc/exc criteria|1
7614136|NCT01813071|26492843|P7|Overall Study|Met inc/exc criteria|0
7614137|NCT01813071|26492844|P6|Overall Study|Met inc/exc criteria|1
7614138|NCT01813071|26492845|P5|Overall Study|Met inc/exc criteria|0
7614139|NCT01813071|26492846|P4|Overall Study|Met inc/exc criteria|0
7614140|NCT01813071|26492847|P3|Overall Study|Met inc/exc criteria|0
7614141|NCT01813071|26492848|P2|Overall Study|Met inc/exc criteria|0
7614142|NCT01813071|26492849|P1|Overall Study|Met inc/exc criteria|0
7614143|NCT01813071|26492841|P9|Overall Study|Physician Decision|0
7614144|NCT01813071|26492842|P8|Overall Study|Physician Decision|0
7614145|NCT01813071|26492843|P7|Overall Study|Physician Decision|1
7614146|NCT01813071|26492844|P6|Overall Study|Physician Decision|0
7614147|NCT01813071|26492845|P5|Overall Study|Physician Decision|0
7614148|NCT01813071|26492846|P4|Overall Study|Physician Decision|0
7614149|NCT01813071|26492847|P3|Overall Study|Physician Decision|0
7614150|NCT01813071|26492848|P2|Overall Study|Physician Decision|0
7614151|NCT01813071|26492849|P1|Overall Study|Physician Decision|0
7614152|NCT01813071|26492841|P9|Overall Study|Adverse Event|0
7614153|NCT01813071|26492842|P8|Overall Study|Adverse Event|0
7614154|NCT01813071|26492843|P7|Overall Study|Adverse Event|0
7614155|NCT01813071|26492844|P6|Overall Study|Adverse Event|1
7614156|NCT01813071|26492845|P5|Overall Study|Adverse Event|0
7614157|NCT01813071|26492846|P4|Overall Study|Adverse Event|0
7614158|NCT01813071|26492847|P3|Overall Study|Adverse Event|0
7614159|NCT01813071|26492848|P2|Overall Study|Adverse Event|0
7614160|NCT01813071|26492849|P1|Overall Study|Adverse Event|0
7614161|NCT01813071|26492841|P9|Overall Study|Withdrawal by Subject|0
7614162|NCT01813071|26492842|P8|Overall Study|Withdrawal by Subject|0
7614163|NCT01813071|26492843|P7|Overall Study|Withdrawal by Subject|0
7614164|NCT01813071|26492844|P6|Overall Study|Withdrawal by Subject|1
7614165|NCT01813071|26492845|P5|Overall Study|Withdrawal by Subject|0
7614166|NCT01813071|26492846|P4|Overall Study|Withdrawal by Subject|0
7614167|NCT01813071|26492847|P3|Overall Study|Withdrawal by Subject|0
7614168|NCT01813071|26492848|P2|Overall Study|Withdrawal by Subject|0
7614169|NCT01813071|26492849|P1|Overall Study|Withdrawal by Subject|0
7614170|NCT01813071|26492841|P9|Overall Study|Protocol Violation|2
7614171|NCT01813071|26492842|P8|Overall Study|Protocol Violation|4
7614172|NCT01813071|26492843|P7|Overall Study|Protocol Violation|2
7614173|NCT01813071|26492844|P6|Overall Study|Protocol Violation|4
7614174|NCT01813071|26492845|P5|Overall Study|Protocol Violation|1
7614175|NCT01813071|26492846|P4|Overall Study|Protocol Violation|0
7614176|NCT01813071|26492847|P3|Overall Study|Protocol Violation|0
7614177|NCT01813071|26492848|P2|Overall Study|Protocol Violation|0
7614178|NCT01813071|26492849|P1|Overall Study|Protocol Violation|0
7614179|NCT01813058|26493316|P2|Overall Study|Withdrawal by Subject|4
7614180|NCT01813058|26493317|P1|Overall Study|Withdrawal by Subject|5
7614181|NCT01813019|26493325|P2|Overall Study|Protocol Deviation|1
7614182|NCT01813019|26493326|P1|Overall Study|Protocol Deviation|2
7614183|NCT01813019|26493325|P2|Overall Study|administrative problems|0
7614184|NCT01813019|26493326|P1|Overall Study|administrative problems|2
7614185|NCT01813019|26493325|P2|Overall Study|Withdrawal by Subject|2
7614186|NCT01813019|26493326|P1|Overall Study|Withdrawal by Subject|3
7614187|NCT01813019|26493325|P2|Overall Study|Adverse Event|3
7614188|NCT01813019|26493326|P1|Overall Study|Adverse Event|0
7614189|NCT01812837|26493337|P3|Overall Study|Protocol Violation|0
7614190|NCT01812837|26493338|P2|Overall Study|Protocol Violation|0
7614191|NCT01812837|26493339|P1|Overall Study|Protocol Violation|1
7614192|NCT01812837|26493337|P3|Overall Study|Lost to Follow-up|0
7614193|NCT01812837|26493338|P2|Overall Study|Lost to Follow-up|1
7614194|NCT01812837|26493339|P1|Overall Study|Lost to Follow-up|1
7614195|NCT01812759|26493350|P3|Overall Study|Physician Decision|1
7614196|NCT01812759|26493351|P2|Overall Study|Physician Decision|0
7614197|NCT01812759|26493352|P1|Overall Study|Physician Decision|0
7614198|NCT01812707|26493364|P4|Overall Study|Consent withdrawn by participant|0
7614199|NCT01812707|26493365|P3|Overall Study|Consent withdrawn by participant|0
7614200|NCT01812707|26493366|P2|Overall Study|Consent withdrawn by participant|0
7614201|NCT01812707|26493367|P1|Overall Study|Consent withdrawn by participant|1
7614202|NCT01812707|26493364|P4|Overall Study|Poor compliance to protocol|0
7614203|NCT01812707|26493365|P3|Overall Study|Poor compliance to protocol|0
7614204|NCT01812707|26493366|P2|Overall Study|Poor compliance to protocol|0
7614205|NCT01812707|26493367|P1|Overall Study|Poor compliance to protocol|1
7614206|NCT01812707|26493364|P4|Overall Study|Adverse Event|2
7614207|NCT01812707|26493365|P3|Overall Study|Adverse Event|0
7614208|NCT01812707|26493366|P2|Overall Study|Adverse Event|0
7614209|NCT01812707|26493367|P1|Overall Study|Adverse Event|0
7614210|NCT01812655|26493424|P3|Overall Study|Protocol Violation|0
7614211|NCT01812655|26493425|P2|Overall Study|Protocol Violation|1
7614212|NCT01812655|26493426|P1|Overall Study|Protocol Violation|1
7614213|NCT01812109|26493449|P1|Overall Study|NIRS Unattainable|17
7614214|NCT01812109|26493449|P1|Overall Study|research personnel delay|16
7614215|NCT01812057|26493455|P2|Overall Study|Physician Decision|0
7614216|NCT01812057|26493456|P1|Overall Study|Physician Decision|1
7614217|NCT01812057|26493455|P2|Overall Study|Protocol Violation|0
7614218|NCT01812057|26493456|P1|Overall Study|Protocol Violation|1
7614219|NCT01811953|26493559|P6|Overall Study|Protocol Violation|0
7614220|NCT01811953|26493560|P5|Overall Study|Protocol Violation|1
7614221|NCT01811953|26493561|P4|Overall Study|Protocol Violation|0
7614222|NCT01811953|26493562|P3|Overall Study|Protocol Violation|0
7614223|NCT01811953|26493563|P2|Overall Study|Protocol Violation|0
7614224|NCT01811953|26493564|P1|Overall Study|Protocol Violation|0
7614225|NCT01811953|26493559|P6|Overall Study|Adverse Event|1
7614226|NCT01811953|26493560|P5|Overall Study|Adverse Event|0
7614227|NCT01811953|26493561|P4|Overall Study|Adverse Event|1
7614228|NCT01811953|26493562|P3|Overall Study|Adverse Event|0
7614229|NCT01811953|26493563|P2|Overall Study|Adverse Event|0
7614230|NCT01811953|26493564|P1|Overall Study|Adverse Event|0
7614231|NCT01811732|26493637|P2|Overall Study|Correct study drug not available on site|0
7614232|NCT01811732|26493638|P1|Overall Study|Correct study drug not available on site|1
7614233|NCT01811732|26493637|P2|Overall Study|Admitted to another facility|0
7614234|NCT01811732|26493638|P1|Overall Study|Admitted to another facility|1
7614235|NCT01811732|26493637|P2|Overall Study|Subject incarcerated|2
7614236|NCT01811732|26493638|P1|Overall Study|Subject incarcerated|1
7614237|NCT01811732|26493637|P2|Overall Study|Protocol Violation|1
7614238|NCT01811732|26493638|P1|Overall Study|Protocol Violation|0
7614239|NCT01811732|26493637|P2|Overall Study|Insufficient venous access|1
7614240|NCT01811732|26493638|P1|Overall Study|Insufficient venous access|0
7614241|NCT01811732|26493637|P2|Overall Study|Death|1
7614242|NCT01811732|26493638|P1|Overall Study|Death|1
7614243|NCT01811732|26493637|P2|Overall Study|Physician Decision|0
7614244|NCT01811732|26493638|P1|Overall Study|Physician Decision|2
7614245|NCT01811732|26493637|P2|Overall Study|Non-compliance with study drug/procedure|3
7614246|NCT01811732|26493638|P1|Overall Study|Non-compliance with study drug/procedure|3
7614247|NCT01811732|26493637|P2|Overall Study|Lack of Efficacy|1
7614248|NCT01811732|26493638|P1|Overall Study|Lack of Efficacy|3
7614249|NCT01811732|26493637|P2|Overall Study|Adverse Event|9
7614250|NCT01811732|26493638|P1|Overall Study|Adverse Event|3
7614251|NCT01811732|26493637|P2|Overall Study|Withdrawal by Subject|10
7614252|NCT01811732|26493638|P1|Overall Study|Withdrawal by Subject|16
7614253|NCT01811732|26493637|P2|Overall Study|Lost to Follow-up|30
7614254|NCT01811732|26493638|P1|Overall Study|Lost to Follow-up|24
7614255|NCT01811706|26493648|P2|First Intervention ( 4 Weeks)|Adverse Event|0
7614256|NCT01811706|26493649|P1|First Intervention ( 4 Weeks)|Adverse Event|1
7614257|NCT01811563|26493689|P2|Overall Study|Incorrect Randomization procedure|1
7614258|NCT01811563|26493690|P1|Overall Study|Incorrect Randomization procedure|0
7614259|NCT01811563|26493689|P2|Overall Study|Lost to Follow-up|2
7614260|NCT01811563|26493690|P1|Overall Study|Lost to Follow-up|5
7614261|NCT01811485|26493719|P3|Overall Study|Protocol Deviation|0
7614262|NCT01811485|26493720|P2|Overall Study|Protocol Deviation|1
7614263|NCT01811485|26493721|P1|Overall Study|Protocol Deviation|0
7614264|NCT01811485|26493719|P3|Overall Study|Administrative problems|0
7614265|NCT01811485|26493720|P2|Overall Study|Administrative problems|0
7614266|NCT01811485|26493721|P1|Overall Study|Administrative problems|1
7614267|NCT01811485|26493719|P3|Overall Study|Unsatisfactory therapeutic effect|3
7614268|NCT01811485|26493720|P2|Overall Study|Unsatisfactory therapeutic effect|0
7614269|NCT01811485|26493721|P1|Overall Study|Unsatisfactory therapeutic effect|0
7614270|NCT01811485|26493719|P3|Overall Study|Adverse Event|2
7614271|NCT01811485|26493720|P2|Overall Study|Adverse Event|3
7614272|NCT01811485|26493721|P1|Overall Study|Adverse Event|1
7614273|NCT01811472|26493741|P3|Overall Study|Subject/guardian decision|0
7614274|NCT01811472|26493742|P2|Overall Study|Subject/guardian decision|0
7614275|NCT01811472|26493743|P1|Overall Study|Subject/guardian decision|1
7614276|NCT01811472|26493741|P3|Overall Study|Lost to Follow-up|1
7614277|NCT01811472|26493742|P2|Overall Study|Lost to Follow-up|0
7614278|NCT01811472|26493743|P1|Overall Study|Lost to Follow-up|0
7614279|NCT01811472|26493741|P3|Overall Study|Adverse Event|4
7614280|NCT01811472|26493742|P2|Overall Study|Adverse Event|0
7614281|NCT01811472|26493743|P1|Overall Study|Adverse Event|1
7614282|NCT01811238|26493830|P1|Overall Study|subject refused study medication|6
7614283|NCT01811238|26493830|P1|Overall Study|Lack of Efficacy|4
7614284|NCT01811238|26493830|P1|Overall Study|Protocol Violation|4
7614285|NCT01811238|26493830|P1|Overall Study|Adverse Event|25
7614286|NCT01811238|26493830|P1|Overall Study|Withdrawal by Subject|42
7614287|NCT01811225|26493839|P2|Treatment Period 2|unable to remain smoke free overnight|4
7614288|NCT01811225|26493840|P1|Treatment Period 2|unable to remain smoke free overnight|3
7614289|NCT01811225|26493839|P2|Treatment Period 2|Lost to Follow-up|2
7614290|NCT01811225|26493840|P1|Treatment Period 2|Lost to Follow-up|1
7614291|NCT01811225|26493839|P2|Treatment Period 1|unable to remain smoke free overnight|6
7614292|NCT01811225|26493840|P1|Treatment Period 1|unable to remain smoke free overnight|10
7614293|NCT01811225|26493839|P2|Treatment Period 1|transporation|0
7614294|NCT01811225|26493840|P1|Treatment Period 1|transporation|1
7614295|NCT01811225|26493839|P2|Treatment Period 1|Lost to Follow-up|8
7614296|NCT01811225|26493840|P1|Treatment Period 1|Lost to Follow-up|12
7614297|NCT01811225|26493839|P2|Treatment Period 1|Adverse Event|3
7614298|NCT01811225|26493840|P1|Treatment Period 1|Adverse Event|2
7614299|NCT01811186|26493865|P2|Overall Study|Lost to Follow-up|2
7614300|NCT01811186|26493866|P1|Overall Study|Lost to Follow-up|4
7614301|NCT01811186|26493865|P2|Overall Study|Lack of Efficacy|6
7614302|NCT01811186|26493866|P1|Overall Study|Lack of Efficacy|3
7614303|NCT01811186|26493865|P2|Overall Study|Withdrawal by Subject|10
7614304|NCT01811186|26493866|P1|Overall Study|Withdrawal by Subject|5
7614305|NCT01811186|26493865|P2|Overall Study|Protocol Violation|6
7614306|NCT01811186|26493866|P1|Overall Study|Protocol Violation|5
7614307|NCT01811186|26493865|P2|Overall Study|Adverse Event|38
7614308|NCT01811186|26493866|P1|Overall Study|Adverse Event|54
7614309|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7614310|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
7614311|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7614312|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
7614313|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
7614314|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
7614315|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
7614316|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
7614317|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
7614318|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
7614319|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
7614320|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
7614321|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7614322|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7614323|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
7614324|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
7614325|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7614326|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7614327|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Death|1
7614328|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Death|0
7614329|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Death|0
7614330|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7614331|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7614332|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
7614333|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7614334|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
7614335|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7614336|NCT01810939|26493951|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7614337|NCT01810939|26493952|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7614338|NCT01810939|26493953|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
7614339|NCT01810939|26493951|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
7614340|NCT01810939|26493952|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
7614341|NCT01810939|26493953|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
7614342|NCT01810939|26493951|P3|Part A Treatment Period|Protocol-specified (High K+)|0
7614343|NCT01810939|26493952|P2|Part A Treatment Period|Protocol-specified (High K+)|0
7614344|NCT01810939|26493953|P1|Part A Treatment Period|Protocol-specified (High K+)|3
7614345|NCT01810939|26493951|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
7614346|NCT01810939|26493952|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
7614347|NCT01810939|26493953|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
7614348|NCT01810939|26493951|P3|Part A Treatment Period|Withdrawal by Subject|0
7614349|NCT01810939|26493952|P2|Part A Treatment Period|Withdrawal by Subject|0
7614350|NCT01810939|26493953|P1|Part A Treatment Period|Withdrawal by Subject|5
7614351|NCT01810939|26493951|P3|Part A Treatment Period|Adverse Event|0
7614352|NCT01810939|26493952|P2|Part A Treatment Period|Adverse Event|0
7614353|NCT01810939|26493953|P1|Part A Treatment Period|Adverse Event|10
7614354|NCT01810939|26493951|P3|Part A Treatment Period|Protocol Violation|0
7614355|NCT01810939|26493952|P2|Part A Treatment Period|Protocol Violation|0
7614356|NCT01810939|26493953|P1|Part A Treatment Period|Protocol Violation|2
7614357|NCT01810939|26493951|P3|Part A Treatment Period|Non-compliance with Study Drug|0
7614358|NCT01810939|26493952|P2|Part A Treatment Period|Non-compliance with Study Drug|0
7614359|NCT01810939|26493953|P1|Part A Treatment Period|Non-compliance with Study Drug|1
7614360|NCT01810783|26493966|P1|Overall Study|Enrolled, not treated|1
7614361|NCT01810783|26493966|P1|Overall Study|Adminstrative or other reason(s)|23
7614362|NCT01810783|26493966|P1|Overall Study|Non-compliance with IMP|4
7614363|NCT01810783|26493966|P1|Overall Study|Protocol Violation|5
7614364|NCT01810783|26493966|P1|Overall Study|Lost to Follow-up|10
7614365|NCT01810783|26493966|P1|Overall Study|Lack of Efficacy|12
7614366|NCT01810783|26493966|P1|Overall Study|Withdrawal by Subject|22
7614367|NCT01810783|26493966|P1|Overall Study|Adverse Event|32
7614368|NCT01810432|26493991|P2|Period 2|Lost to Follow-up|1
7614369|NCT01810432|26493992|P1|Period 2|Lost to Follow-up|1
7614370|NCT01810432|26493991|P2|Period 2|Physician Decision|0
7614371|NCT01810432|26493992|P1|Period 2|Physician Decision|1
7614372|NCT01810432|26493991|P2|Period 2|Withdrawal by Subject|1
7614373|NCT01810432|26493992|P1|Period 2|Withdrawal by Subject|2
7614374|NCT01810432|26493991|P2|Washout|Adverse Event|0
7614375|NCT01810432|26493992|P1|Washout|Adverse Event|1
7614376|NCT01810432|26493991|P2|Washout|Protocol Violation|1
7614377|NCT01810432|26493992|P1|Washout|Protocol Violation|0
7614378|NCT01810380|26494005|P3|Overall Study|Administrative or other reasons|9
7614379|NCT01810380|26494006|P2|Overall Study|Administrative or other reasons|13
7614380|NCT01810380|26494007|P1|Overall Study|Administrative or other reasons|11
7614381|NCT01810380|26494005|P3|Overall Study|Withdrawal by Subject|6
7614382|NCT01810380|26494006|P2|Overall Study|Withdrawal by Subject|0
7614383|NCT01810380|26494007|P1|Overall Study|Withdrawal by Subject|6
7614384|NCT01810380|26494005|P3|Overall Study|Protocol Violation|1
7614385|NCT01810380|26494006|P2|Overall Study|Protocol Violation|0
7614386|NCT01810380|26494007|P1|Overall Study|Protocol Violation|1
7614387|NCT01810380|26494005|P3|Overall Study|Lack of Efficacy|11
7614388|NCT01810380|26494006|P2|Overall Study|Lack of Efficacy|10
7614389|NCT01810380|26494007|P1|Overall Study|Lack of Efficacy|24
7614390|NCT01810380|26494005|P3|Overall Study|Adverse Event|4
7614391|NCT01810380|26494006|P2|Overall Study|Adverse Event|14
7614392|NCT01810380|26494007|P1|Overall Study|Adverse Event|11
7614393|NCT01810380|26494005|P3|Overall Study|Randomised not treated|1
7614394|NCT01810380|26494006|P2|Overall Study|Randomised not treated|1
7614395|NCT01810380|26494007|P1|Overall Study|Randomised not treated|2
7614396|NCT01810302|26494068|P2|Overall Study|Physician Decision|1
7614397|NCT01810302|26494069|P1|Overall Study|Physician Decision|0
7614398|NCT01810302|26494068|P2|Overall Study|Death|0
7614399|NCT01810302|26494069|P1|Overall Study|Death|1
7614400|NCT01810263|26494096|P2|Overall Study|Lost to Follow-up|7
7614401|NCT01810263|26494097|P1|Overall Study|Lost to Follow-up|8
7614402|NCT01810042|26494103|P1|Overall Study|Lost to Follow-up|10
7614403|NCT01810016|26494113|P3|Overall Study|Death|1
7614404|NCT01810016|26494114|P2|Overall Study|Death|0
7614405|NCT01810016|26494115|P1|Overall Study|Death|0
7614406|NCT01810016|26494113|P3|Overall Study|Progressive disease|0
7614407|NCT01810016|26494114|P2|Overall Study|Progressive disease|1
7614408|NCT01810016|26494115|P1|Overall Study|Progressive disease|1
7614409|NCT01809327|26494185|P5|Overall Study|Other|9
7614410|NCT01809327|26494186|P4|Overall Study|Other|4
7614411|NCT01809327|26494187|P3|Overall Study|Other|7
7614412|NCT01809327|26494188|P2|Overall Study|Other|15
7614413|NCT01809327|26494189|P1|Overall Study|Other|14
7614414|NCT01809327|26494185|P5|Overall Study|Pregnancy|0
7614415|NCT01809327|26494186|P4|Overall Study|Pregnancy|0
7614416|NCT01809327|26494187|P3|Overall Study|Pregnancy|0
7614417|NCT01809327|26494188|P2|Overall Study|Pregnancy|0
7614418|NCT01809327|26494189|P1|Overall Study|Pregnancy|1
7614419|NCT01809327|26494185|P5|Overall Study|Physician Decision|0
7614420|NCT01809327|26494186|P4|Overall Study|Physician Decision|0
7614421|NCT01809327|26494187|P3|Overall Study|Physician Decision|0
7614422|NCT01809327|26494188|P2|Overall Study|Physician Decision|1
7614423|NCT01809327|26494189|P1|Overall Study|Physician Decision|1
7614424|NCT01809327|26494185|P5|Overall Study|Protocol Violation|0
7614425|NCT01809327|26494186|P4|Overall Study|Protocol Violation|0
7614426|NCT01809327|26494187|P3|Overall Study|Protocol Violation|0
7614427|NCT01809327|26494188|P2|Overall Study|Protocol Violation|1
7614428|NCT01809327|26494189|P1|Overall Study|Protocol Violation|0
7614429|NCT01809327|26494185|P5|Overall Study|Death|0
7614430|NCT01809327|26494186|P4|Overall Study|Death|0
7614431|NCT01809327|26494187|P3|Overall Study|Death|0
7614432|NCT01809327|26494188|P2|Overall Study|Death|0
7614433|NCT01809327|26494189|P1|Overall Study|Death|1
7614434|NCT01809327|26494185|P5|Overall Study|Adverse Event|8
7614435|NCT01809327|26494186|P4|Overall Study|Adverse Event|4
7614436|NCT01809327|26494187|P3|Overall Study|Adverse Event|7
7614437|NCT01809327|26494188|P2|Overall Study|Adverse Event|3
7614438|NCT01809327|26494189|P1|Overall Study|Adverse Event|4
7614439|NCT01809327|26494185|P5|Overall Study|Withdrawal by Subject|5
7614440|NCT01809327|26494186|P4|Overall Study|Withdrawal by Subject|2
7614441|NCT01809327|26494187|P3|Overall Study|Withdrawal by Subject|4
7614442|NCT01809327|26494188|P2|Overall Study|Withdrawal by Subject|4
7614443|NCT01809327|26494189|P1|Overall Study|Withdrawal by Subject|6
7614444|NCT01809327|26494185|P5|Overall Study|Lost to Follow-up|3
7614445|NCT01809327|26494186|P4|Overall Study|Lost to Follow-up|2
7614446|NCT01809327|26494187|P3|Overall Study|Lost to Follow-up|4
7614447|NCT01809327|26494188|P2|Overall Study|Lost to Follow-up|2
7614448|NCT01809327|26494189|P1|Overall Study|Lost to Follow-up|5
7614449|NCT01809314|26494231|P1|Overall Study|Lost to Follow-up|724
7614450|NCT01809314|26494231|P1|Overall Study|Insufficient Therapeutic Response|14
7614451|NCT01809314|26494231|P1|Overall Study|Adverse Event|6
7614452|NCT01809314|26494231|P1|Overall Study|Withdrawal Prior to Treatment|1
7614453|NCT01809262|26494237|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
7614454|NCT01809262|26494238|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
7614455|NCT01809262|26494239|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
7614456|NCT01809262|26494240|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
7614457|NCT01809262|26494241|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
7614458|NCT01809262|26494242|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
7614459|NCT01809262|26494243|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
7614460|NCT01809262|26494244|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
7614461|NCT01809262|26494245|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
7614462|NCT01809262|26494246|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
7614463|NCT01809262|26494237|P10|Period 1 (First Dose + Washout)|Adverse Event|0
7614464|NCT01809262|26494238|P9|Period 1 (First Dose + Washout)|Adverse Event|0
7614465|NCT01809262|26494239|P8|Period 1 (First Dose + Washout)|Adverse Event|0
7614466|NCT01809262|26494240|P7|Period 1 (First Dose + Washout)|Adverse Event|0
7614467|NCT01809262|26494241|P6|Period 1 (First Dose + Washout)|Adverse Event|0
7614468|NCT01809262|26494242|P5|Period 1 (First Dose + Washout)|Adverse Event|1
7614469|NCT01809262|26494243|P4|Period 1 (First Dose + Washout)|Adverse Event|0
7614470|NCT01809262|26494244|P3|Period 1 (First Dose + Washout)|Adverse Event|0
7614471|NCT01809262|26494245|P2|Period 1 (First Dose + Washout)|Adverse Event|0
7614472|NCT01809262|26494246|P1|Period 1 (First Dose + Washout)|Adverse Event|0
7614473|NCT01809210|26494320|P7|Overall Study|Death|1
7614474|NCT01809210|26494321|P6|Overall Study|Death|3
7614475|NCT01809210|26494322|P5|Overall Study|Death|1
7614476|NCT01809210|26494323|P4|Overall Study|Death|0
7614477|NCT01809210|26494324|P3|Overall Study|Death|2
7614478|NCT01809210|26494325|P2|Overall Study|Death|1
7614479|NCT01809210|26494326|P1|Overall Study|Death|1
7614480|NCT01809210|26494320|P7|Overall Study|Withdrawal by Subject|4
7614481|NCT01809210|26494321|P6|Overall Study|Withdrawal by Subject|0
7614482|NCT01809210|26494322|P5|Overall Study|Withdrawal by Subject|1
7614483|NCT01809210|26494323|P4|Overall Study|Withdrawal by Subject|1
7614484|NCT01809210|26494324|P3|Overall Study|Withdrawal by Subject|1
7614485|NCT01809210|26494325|P2|Overall Study|Withdrawal by Subject|0
7614486|NCT01809210|26494326|P1|Overall Study|Withdrawal by Subject|0
7614487|NCT01809197|26494400|P2|Overall Study|Product not available|1
7614488|NCT01809197|26494401|P1|Overall Study|Product not available|0
7614489|NCT01809197|26494400|P2|Overall Study|Withdrawal by Subject|1
7614490|NCT01809197|26494401|P1|Overall Study|Withdrawal by Subject|1
7614491|NCT01809197|26494400|P2|Overall Study|Decision Unrelated to an Adverse Event|0
7614492|NCT01809197|26494401|P1|Overall Study|Decision Unrelated to an Adverse Event|1
7614493|NCT01809197|26494400|P2|Overall Study|Non-Compliance|1
7614494|NCT01809197|26494401|P1|Overall Study|Non-Compliance|1
7614495|NCT01809197|26494400|P2|Overall Study|Failed slit lamp exam|0
7614496|NCT01809197|26494401|P1|Overall Study|Failed slit lamp exam|1
7614497|NCT01809197|26494400|P2|Overall Study|Adverse Event|3
7614498|NCT01809197|26494401|P1|Overall Study|Adverse Event|2
7614499|NCT01809197|26494400|P2|Overall Study|Lost to Follow-up|2
7614500|NCT01809197|26494401|P1|Overall Study|Lost to Follow-up|4
7614504|NCT01808690|26494504|P2|Overall Study|Withdrawal by Subject|2
7614505|NCT01808690|26494505|P1|Overall Study|Withdrawal by Subject|1
7614506|NCT01808651|26494526|P3|Study Period 1|Participant Decision|3
7614507|NCT01808651|26494527|P2|Study Period 1|Participant Decision|7
7614508|NCT01808651|26494528|P1|Study Period 1|Participant Decision|9
7614509|NCT01808651|26494526|P3|Study Period 1|Adverse Event|1
7614510|NCT01808651|26494527|P2|Study Period 1|Adverse Event|4
7614511|NCT01808651|26494528|P1|Study Period 1|Adverse Event|10
7614512|NCT01808651|26494526|P3|Study Period 1|Lack of Efficacy|0
7614513|NCT01808651|26494527|P2|Study Period 1|Lack of Efficacy|1
7614514|NCT01808651|26494528|P1|Study Period 1|Lack of Efficacy|2
7614515|NCT01808651|26494526|P3|Study Period 1|Physician Decision|0
7614516|NCT01808651|26494527|P2|Study Period 1|Physician Decision|2
7614517|NCT01808651|26494528|P1|Study Period 1|Physician Decision|3
7614518|NCT01808651|26494526|P3|Study Period 1|Protocol Violation|1
7614519|NCT01808651|26494527|P2|Study Period 1|Protocol Violation|0
7614520|NCT01808651|26494528|P1|Study Period 1|Protocol Violation|1
7614521|NCT01808651|26494526|P3|Study Period 1|Lost to Follow-up|0
7614522|NCT01808651|26494527|P2|Study Period 1|Lost to Follow-up|3
7614523|NCT01808651|26494528|P1|Study Period 1|Lost to Follow-up|1
7614524|NCT01808612|26494563|P3|Discontinuation Period|Lost to Follow-up|0
7614525|NCT01808612|26494564|P2|Discontinuation Period|Lost to Follow-up|1
7614526|NCT01808612|26494565|P1|Discontinuation Period|Lost to Follow-up|0
7614527|NCT01808612|26494563|P3|Discontinuation Period|Physician Decision|0
7614528|NCT01808612|26494564|P2|Discontinuation Period|Physician Decision|0
7614529|NCT01808612|26494565|P1|Discontinuation Period|Physician Decision|1
7614530|NCT01808612|26494563|P3|Discontinuation Period|Adverse Event|0
7614531|NCT01808612|26494564|P2|Discontinuation Period|Adverse Event|0
7614532|NCT01808612|26494565|P1|Discontinuation Period|Adverse Event|1
7614533|NCT01808612|26494563|P3|Treatment Period|Lack of Efficacy|2
7614534|NCT01808612|26494564|P2|Treatment Period|Lack of Efficacy|1
7614535|NCT01808612|26494565|P1|Treatment Period|Lack of Efficacy|1
7614536|NCT01808612|26494563|P3|Treatment Period|Sponsor Decision|0
7614537|NCT01808612|26494564|P2|Treatment Period|Sponsor Decision|0
7614538|NCT01808612|26494565|P1|Treatment Period|Sponsor Decision|1
7614539|NCT01808612|26494563|P3|Treatment Period|Physician Decision|4
7614540|NCT01808612|26494564|P2|Treatment Period|Physician Decision|0
7614541|NCT01808612|26494565|P1|Treatment Period|Physician Decision|1
7614542|NCT01808612|26494563|P3|Treatment Period|Withdrawal by Subject|4
7614543|NCT01808612|26494564|P2|Treatment Period|Withdrawal by Subject|0
7614544|NCT01808612|26494565|P1|Treatment Period|Withdrawal by Subject|1
7614545|NCT01808612|26494563|P3|Treatment Period|Protocol Violation|0
7614546|NCT01808612|26494564|P2|Treatment Period|Protocol Violation|0
7614547|NCT01808612|26494565|P1|Treatment Period|Protocol Violation|1
7614548|NCT01808612|26494563|P3|Treatment Period|Lost to Follow-up|1
7614549|NCT01808612|26494564|P2|Treatment Period|Lost to Follow-up|2
7614550|NCT01808612|26494565|P1|Treatment Period|Lost to Follow-up|2
7614551|NCT01808612|26494563|P3|Treatment Period|Adverse Event|3
7614552|NCT01808612|26494564|P2|Treatment Period|Adverse Event|4
7614553|NCT01808612|26494565|P1|Treatment Period|Adverse Event|8
7614554|NCT01808573|26494596|P2|Overall Study|Randomized in Error|0
7614555|NCT01808573|26494597|P1|Overall Study|Randomized in Error|1
7614556|NCT01808573|26494596|P2|Overall Study|Discontinuation of study by sponsor|64
7614557|NCT01808573|26494597|P1|Overall Study|Discontinuation of study by sponsor|79
7614558|NCT01808573|26494596|P2|Overall Study|Lost to Follow-up|0
7614559|NCT01808573|26494597|P1|Overall Study|Lost to Follow-up|3
7614560|NCT01808573|26494596|P2|Overall Study|Withdrawal by Subject|10
7614561|NCT01808573|26494597|P1|Overall Study|Withdrawal by Subject|12
7614562|NCT01808573|26494596|P2|Overall Study|Death|240
7614563|NCT01808573|26494597|P1|Overall Study|Death|212
7614564|NCT01808534|26494652|P1|Overall Study|Physician Decision|1
7614565|NCT01808534|26494652|P1|Overall Study|Disease progression|3
7614566|NCT01808508|26494663|P3|Overall Study|Lost to Follow-up|0
7614567|NCT01808508|26494664|P2|Overall Study|Lost to Follow-up|0
7614568|NCT01808508|26494665|P1|Overall Study|Lost to Follow-up|1
7614569|NCT01808339|26494682|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614570|NCT01808339|26494683|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614571|NCT01808339|26494684|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614572|NCT01808339|26494685|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
7614573|NCT01808339|26494686|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614574|NCT01808339|26494687|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614575|NCT01808339|26494682|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7614576|NCT01808339|26494683|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7614577|NCT01808339|26494684|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7614578|NCT01808339|26494685|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7614579|NCT01808339|26494686|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7614580|NCT01808339|26494687|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7614581|NCT01808339|26494682|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7614582|NCT01808339|26494683|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
7614583|NCT01808339|26494684|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7614584|NCT01808339|26494685|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614585|NCT01808339|26494686|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614586|NCT01808339|26494687|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7614587|NCT01808313|26494731|P1|Overall Study|Physician Decision|1
7614588|NCT01808313|26494731|P1|Overall Study|Lost to Follow-up|1
7614589|NCT01808313|26494731|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
7614590|NCT01808313|26494731|P1|Overall Study|Protocol Violation|2
7614591|NCT01808313|26494731|P1|Overall Study|Adverse Event|5
7614592|NCT01808261|26494761|P2|Overall Study|Lost to Follow-up|1
7614593|NCT01808261|26494762|P1|Overall Study|Lost to Follow-up|3
7614594|NCT01808261|26494761|P2|Overall Study|Consent withdrawn by subject|7
7614595|NCT01808261|26494762|P1|Overall Study|Consent withdrawn by subject|6
7614596|NCT01808261|26494761|P2|Overall Study|Adverse event, non-fatal|0
7614597|NCT01808261|26494762|P1|Overall Study|Adverse event, non-fatal|2
7614598|NCT01808261|26494761|P2|Overall Study|Study Closed/Terminated|23
7614599|NCT01808261|26494762|P1|Overall Study|Study Closed/Terminated|25
7614600|NCT01808261|26494761|P2|Overall Study|Physician Decision|2
7614601|NCT01808261|26494762|P1|Overall Study|Physician Decision|0
7614602|NCT01808248|26494818|P1|Overall Study|Lost to Follow-up|1
7614603|NCT01808248|26494818|P1|Overall Study|Withdrawal by Subject|1
7614604|NCT01808248|26494818|P1|Overall Study|Lack of Efficacy|3
7614605|NCT01808222|26494830|P1|Overall Study|mpMR scan was not performed|1
7614606|NCT01808209|26494837|P2|Overall Study|Lost to Follow-up|1
7614607|NCT01808209|26494838|P1|Overall Study|Lost to Follow-up|0
7614608|NCT01808196|26494880|P1|Overall Study|Lost to Follow-up|1
7614609|NCT01808144|26494888|P2|Overall Study|Adverse Event|15
7614610|NCT01808144|26494889|P1|Overall Study|Adverse Event|11
7614611|NCT01808144|26494888|P2|Overall Study|Gout flare|1
7614612|NCT01808144|26494889|P1|Overall Study|Gout flare|0
7614613|NCT01808144|26494888|P2|Overall Study|Protocol Violation|6
7614614|NCT01808144|26494889|P1|Overall Study|Protocol Violation|6
7614615|NCT01808144|26494888|P2|Overall Study|Lost to Follow-up|3
7614616|NCT01808144|26494889|P1|Overall Study|Lost to Follow-up|6
7614617|NCT01808144|26494888|P2|Overall Study|Withdrawal by Subject|23
7614618|NCT01808144|26494889|P1|Overall Study|Withdrawal by Subject|16
7614619|NCT01808144|26494888|P2|Overall Study|Death|0
7614620|NCT01808144|26494889|P1|Overall Study|Death|1
7614621|NCT01808118|26494897|P3|Period 2|Switched to other therapy|0
7614622|NCT01808118|26494898|P2|Period 2|Switched to other therapy|1
7614623|NCT01808118|26494899|P1|Period 2|Switched to other therapy|0
7614624|NCT01808118|26494897|P3|Period 2|Investigator no longer conducting trials|0
7614625|NCT01808118|26494898|P2|Period 2|Investigator no longer conducting trials|1
7614626|NCT01808118|26494899|P1|Period 2|Investigator no longer conducting trials|0
7614627|NCT01808118|26494897|P3|Period 2|Lost to Follow-up|2
7614628|NCT01808118|26494898|P2|Period 2|Lost to Follow-up|0
7614629|NCT01808118|26494899|P1|Period 2|Lost to Follow-up|0
7614630|NCT01808118|26494897|P3|Period 2|Withdrew consent|6
7614631|NCT01808118|26494898|P2|Period 2|Withdrew consent|7
7614632|NCT01808118|26494899|P1|Period 2|Withdrew consent|0
7614633|NCT01808118|26494897|P3|Period 2|Adverse Event|0
7614634|NCT01808118|26494898|P2|Period 2|Adverse Event|4
7614635|NCT01808118|26494899|P1|Period 2|Adverse Event|0
7614636|NCT01808118|26494897|P3|Period 1|Lack of Efficacy|0
7614637|NCT01808118|26494898|P2|Period 1|Lack of Efficacy|0
7614638|NCT01808118|26494899|P1|Period 1|Lack of Efficacy|1
7614639|NCT01808118|26494897|P3|Period 1|Non-compliance per sponsor|0
7614640|NCT01808118|26494898|P2|Period 1|Non-compliance per sponsor|0
7614641|NCT01808118|26494899|P1|Period 1|Non-compliance per sponsor|1
7614642|NCT01808118|26494897|P3|Period 1|Investigator decision: site closure|0
7614643|NCT01808118|26494898|P2|Period 1|Investigator decision: site closure|0
7614644|NCT01808118|26494899|P1|Period 1|Investigator decision: site closure|2
7614645|NCT01808118|26494897|P3|Period 1|Non-conformance with inclusion criteria|0
7614646|NCT01808118|26494898|P2|Period 1|Non-conformance with inclusion criteria|0
7614647|NCT01808118|26494899|P1|Period 1|Non-conformance with inclusion criteria|3
7614648|NCT01808118|26494897|P3|Period 1|Did not meet inclusion criteria|0
7614649|NCT01808118|26494898|P2|Period 1|Did not meet inclusion criteria|0
7614650|NCT01808118|26494899|P1|Period 1|Did not meet inclusion criteria|3
7614651|NCT01808118|26494897|P3|Period 1|Enrolled in error|0
7614652|NCT01808118|26494898|P2|Period 1|Enrolled in error|0
7614653|NCT01808118|26494899|P1|Period 1|Enrolled in error|7
7614654|NCT01808118|26494897|P3|Period 1|Did not meet criteria for remission|0
7614655|NCT01808118|26494898|P2|Period 1|Did not meet criteria for remission|0
7614656|NCT01808118|26494899|P1|Period 1|Did not meet criteria for remission|303
7614657|NCT01808118|26494897|P3|Period 1|Lost to Follow-up|0
7614658|NCT01808118|26494898|P2|Period 1|Lost to Follow-up|0
7614659|NCT01808118|26494899|P1|Period 1|Lost to Follow-up|9
7614660|NCT01808118|26494897|P3|Period 1|Withdrew consent|0
7614661|NCT01808118|26494898|P2|Period 1|Withdrew consent|0
7614662|NCT01808118|26494899|P1|Period 1|Withdrew consent|24
7614663|NCT01808118|26494897|P3|Period 1|Adverse Event|0
7614664|NCT01808118|26494898|P2|Period 1|Adverse Event|0
7614665|NCT01808118|26494899|P1|Period 1|Adverse Event|15
7614666|NCT01808092|26494962|P2|Overall Study|Other Eligibility criteria|5
7614667|NCT01808092|26494963|P1|Overall Study|Other Eligibility criteria|3
7614668|NCT01808092|26494962|P2|Overall Study|Withdrawal by Subject|4
7614669|NCT01808092|26494963|P1|Overall Study|Withdrawal by Subject|9
7614670|NCT01808092|26494962|P2|Overall Study|Lost to Follow-up|7
7614671|NCT01808092|26494963|P1|Overall Study|Lost to Follow-up|3
7614672|NCT01808092|26494962|P2|Overall Study|Death|29
7614673|NCT01808092|26494963|P1|Overall Study|Death|39
7614674|NCT01808066|26495065|P1|Overall Study|Withdrawal by Subject|15
7614675|NCT01807949|26495076|P3|Overall Study|Randomized But Not Treated|2
7614676|NCT01807949|26495077|P2|Overall Study|Randomized But Not Treated|2
7614677|NCT01807949|26495078|P1|Overall Study|Randomized But Not Treated|0
7614678|NCT01807949|26495076|P3|Overall Study|Undefined|2
7614679|NCT01807949|26495077|P2|Overall Study|Undefined|1
7614680|NCT01807949|26495078|P1|Overall Study|Undefined|0
7614681|NCT01807949|26495076|P3|Overall Study|Non-Compliance|1
7614682|NCT01807949|26495077|P2|Overall Study|Non-Compliance|0
7614683|NCT01807949|26495078|P1|Overall Study|Non-Compliance|0
7614684|NCT01807949|26495076|P3|Overall Study|Withdrawal by Subject|2
7614685|NCT01807949|26495077|P2|Overall Study|Withdrawal by Subject|2
7614686|NCT01807949|26495078|P1|Overall Study|Withdrawal by Subject|1
7614687|NCT01807949|26495076|P3|Overall Study|Adverse Event|2
7614688|NCT01807949|26495077|P2|Overall Study|Adverse Event|2
7614689|NCT01807949|26495078|P1|Overall Study|Adverse Event|1
7614690|NCT01807923|26495130|P3|Overall Study|Randomized But Not Treated|5
7614691|NCT01807923|26495131|P2|Overall Study|Randomized But Not Treated|2
7614692|NCT01807923|26495132|P1|Overall Study|Randomized But Not Treated|3
7614693|NCT01807923|26495130|P3|Overall Study|Not Eligible (Genotype)|1
7614694|NCT01807923|26495131|P2|Overall Study|Not Eligible (Genotype)|0
7614695|NCT01807923|26495132|P1|Overall Study|Not Eligible (Genotype)|0
7614696|NCT01807923|26495130|P3|Overall Study|Physician Decision|1
7614697|NCT01807923|26495131|P2|Overall Study|Physician Decision|0
7614698|NCT01807923|26495132|P1|Overall Study|Physician Decision|0
7614699|NCT01807923|26495130|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
7614700|NCT01807923|26495131|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
7614701|NCT01807923|26495132|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
7614702|NCT01807923|26495130|P3|Overall Study|Adverse Event|2
7614703|NCT01807923|26495131|P2|Overall Study|Adverse Event|1
7614704|NCT01807923|26495132|P1|Overall Study|Adverse Event|2
7614705|NCT01807650|26495194|P1|Overall Study|Other|2
7614706|NCT01807650|26495194|P1|Overall Study|Adverse Event|5
7614707|NCT01807650|26495194|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
7614708|NCT01807598|26495280|P1|Overall Study|Other Physician Decision|1
7614709|NCT01807598|26495280|P1|Overall Study|Adverse Event|1
7614710|NCT01807598|26495280|P1|Overall Study|Withdrawal by Subject|4
7614711|NCT01807520|26495312|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
7614712|NCT01807520|26495313|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
7614713|NCT01807520|26495314|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7614714|NCT01807520|26495315|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7614715|NCT01807520|26495316|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7614716|NCT01807520|26495317|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7614717|NCT01807520|26495318|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7614718|NCT01807520|26495312|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
7614719|NCT01807520|26495313|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
7614720|NCT01807520|26495314|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
7614721|NCT01807520|26495315|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
7614722|NCT01807520|26495316|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
7614723|NCT01807520|26495317|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
7614724|NCT01807520|26495318|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
7614725|NCT01807520|26495312|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7614726|NCT01807520|26495313|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
7614727|NCT01807520|26495314|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7614728|NCT01807520|26495315|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7614729|NCT01807520|26495316|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7614730|NCT01807520|26495317|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7614731|NCT01807520|26495318|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7614732|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7614733|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7614734|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7614735|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7614736|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7614737|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
7614738|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
7614739|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7614740|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7614741|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7614742|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7614743|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7614744|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7614745|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7614746|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7614747|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7614748|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
7614749|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7614750|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7614751|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
7614752|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
7614753|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7614754|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7614755|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7614756|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
7614757|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7614758|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7614759|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
7614760|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7614761|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7614762|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7614763|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7614764|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7614765|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
7614766|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7614767|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7614768|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7614769|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7614770|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7614771|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7614772|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7614773|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
7614774|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7614775|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7614776|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7614777|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
7614778|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7614779|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7614780|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7614781|NCT01807520|26495312|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7614782|NCT01807520|26495313|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7614783|NCT01807520|26495314|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
7614784|NCT01807520|26495315|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7614785|NCT01807520|26495316|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7614786|NCT01807520|26495317|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
7614787|NCT01807520|26495318|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
7614788|NCT01807520|26495312|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7614789|NCT01807520|26495313|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7614790|NCT01807520|26495314|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7614791|NCT01807520|26495315|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7614792|NCT01807520|26495316|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7614793|NCT01807520|26495317|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7614794|NCT01807520|26495318|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
7614795|NCT01807520|26495312|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7614796|NCT01807520|26495313|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7614797|NCT01807520|26495314|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7614798|NCT01807520|26495315|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7614799|NCT01807520|26495316|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
7614800|NCT01807520|26495317|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7614801|NCT01807520|26495318|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7614802|NCT01807520|26495312|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7614803|NCT01807520|26495313|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7614804|NCT01807520|26495314|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7614805|NCT01807520|26495315|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7614806|NCT01807520|26495316|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7614807|NCT01807520|26495317|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7614808|NCT01807520|26495318|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
7614809|NCT01807520|26495312|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7614810|NCT01807520|26495313|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7614811|NCT01807520|26495314|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7614812|NCT01807520|26495315|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7614813|NCT01807520|26495316|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
7614814|NCT01807520|26495317|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7614815|NCT01807520|26495318|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7614816|NCT01807520|26495312|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7614817|NCT01807520|26495313|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7614818|NCT01807520|26495314|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7614819|NCT01807520|26495315|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7614820|NCT01807520|26495316|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7614821|NCT01807520|26495317|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7614822|NCT01807520|26495318|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7614823|NCT01807520|26495312|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7614824|NCT01807520|26495313|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7614825|NCT01807520|26495314|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7614826|NCT01807520|26495315|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7614827|NCT01807520|26495316|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
7614828|NCT01807520|26495317|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
7614829|NCT01807520|26495318|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7614830|NCT01807299|26495349|P4|Overall Study|Protocol Violation|2
7614831|NCT01807299|26495350|P3|Overall Study|Protocol Violation|0
7614832|NCT01807299|26495351|P2|Overall Study|Protocol Violation|1
7614833|NCT01807299|26495352|P1|Overall Study|Protocol Violation|3
7614834|NCT01807234|26495368|P6|Overall Study|Lack of Efficacy|1
7614835|NCT01807234|26495369|P5|Overall Study|Lack of Efficacy|1
7614836|NCT01807234|26495370|P4|Overall Study|Lack of Efficacy|0
7614837|NCT01807234|26495371|P3|Overall Study|Lack of Efficacy|0
7614838|NCT01807234|26495372|P2|Overall Study|Lack of Efficacy|0
7614839|NCT01807234|26495373|P1|Overall Study|Lack of Efficacy|0
7614840|NCT01807234|26495368|P6|Overall Study|Withdrawal by Subject|1
7614841|NCT01807234|26495369|P5|Overall Study|Withdrawal by Subject|2
7614842|NCT01807234|26495370|P4|Overall Study|Withdrawal by Subject|1
7614843|NCT01807234|26495371|P3|Overall Study|Withdrawal by Subject|1
7614844|NCT01807234|26495372|P2|Overall Study|Withdrawal by Subject|1
7614845|NCT01807234|26495373|P1|Overall Study|Withdrawal by Subject|3
7614846|NCT01807234|26495368|P6|Overall Study|Lost to Follow-up|2
7614847|NCT01807234|26495369|P5|Overall Study|Lost to Follow-up|1
7614848|NCT01807234|26495370|P4|Overall Study|Lost to Follow-up|1
7614849|NCT01807234|26495371|P3|Overall Study|Lost to Follow-up|1
7614850|NCT01807234|26495372|P2|Overall Study|Lost to Follow-up|5
7614851|NCT01807234|26495373|P1|Overall Study|Lost to Follow-up|2
7614852|NCT01807221|26495414|P6|Overall Study|Lost to Follow-up|0
7614853|NCT01807221|26495415|P5|Overall Study|Lost to Follow-up|0
7614854|NCT01807221|26495416|P4|Overall Study|Lost to Follow-up|1
7614855|NCT01807221|26495417|P3|Overall Study|Lost to Follow-up|2
7614856|NCT01807221|26495418|P2|Overall Study|Lost to Follow-up|0
7614857|NCT01807221|26495419|P1|Overall Study|Lost to Follow-up|1
7614858|NCT01807221|26495414|P6|Overall Study|Sponsor decision|0
7614859|NCT01807221|26495415|P5|Overall Study|Sponsor decision|0
7614860|NCT01807221|26495416|P4|Overall Study|Sponsor decision|1
7614861|NCT01807221|26495417|P3|Overall Study|Sponsor decision|1
7614862|NCT01807221|26495418|P2|Overall Study|Sponsor decision|0
7614863|NCT01807221|26495419|P1|Overall Study|Sponsor decision|2
7614864|NCT01807221|26495414|P6|Overall Study|Withdrawal by Subject|13
7614865|NCT01807221|26495415|P5|Overall Study|Withdrawal by Subject|16
7614866|NCT01807221|26495416|P4|Overall Study|Withdrawal by Subject|14
7614867|NCT01807221|26495417|P3|Overall Study|Withdrawal by Subject|8
7614868|NCT01807221|26495418|P2|Overall Study|Withdrawal by Subject|15
7614869|NCT01807221|26495419|P1|Overall Study|Withdrawal by Subject|33
7614870|NCT01807221|26495414|P6|Overall Study|Logistical difficulties|0
7614871|NCT01807221|26495415|P5|Overall Study|Logistical difficulties|1
7614872|NCT01807221|26495416|P4|Overall Study|Logistical difficulties|0
7614873|NCT01807221|26495417|P3|Overall Study|Logistical difficulties|0
7614874|NCT01807221|26495418|P2|Overall Study|Logistical difficulties|1
7614875|NCT01807221|26495419|P1|Overall Study|Logistical difficulties|0
7614876|NCT01807221|26495414|P6|Overall Study|Non-compliance|0
7614877|NCT01807221|26495415|P5|Overall Study|Non-compliance|0
7614878|NCT01807221|26495416|P4|Overall Study|Non-compliance|1
7614879|NCT01807221|26495417|P3|Overall Study|Non-compliance|0
7614880|NCT01807221|26495418|P2|Overall Study|Non-compliance|2
7614881|NCT01807221|26495419|P1|Overall Study|Non-compliance|1
7614882|NCT01807221|26495414|P6|Overall Study|Protocol Violation|1
7614883|NCT01807221|26495415|P5|Overall Study|Protocol Violation|0
7614884|NCT01807221|26495416|P4|Overall Study|Protocol Violation|2
7614885|NCT01807221|26495417|P3|Overall Study|Protocol Violation|1
7614886|NCT01807221|26495418|P2|Overall Study|Protocol Violation|2
7614887|NCT01807221|26495419|P1|Overall Study|Protocol Violation|0
7614888|NCT01807221|26495414|P6|Overall Study|Adverse Event|21
7614889|NCT01807221|26495415|P5|Overall Study|Adverse Event|18
7614890|NCT01807221|26495416|P4|Overall Study|Adverse Event|25
7614891|NCT01807221|26495417|P3|Overall Study|Adverse Event|26
7614892|NCT01807221|26495418|P2|Overall Study|Adverse Event|22
7614893|NCT01807221|26495419|P1|Overall Study|Adverse Event|33
7614894|NCT01807221|26495414|P6|Overall Study|Physician Decision|0
7614895|NCT01807221|26495415|P5|Overall Study|Physician Decision|0
7614896|NCT01807221|26495416|P4|Overall Study|Physician Decision|0
7614897|NCT01807221|26495417|P3|Overall Study|Physician Decision|0
7614898|NCT01807221|26495418|P2|Overall Study|Physician Decision|1
7614899|NCT01807221|26495419|P1|Overall Study|Physician Decision|2
7614900|NCT01807221|26495414|P6|Overall Study|Death|6
7614901|NCT01807221|26495415|P5|Overall Study|Death|1
7614902|NCT01807221|26495416|P4|Overall Study|Death|2
7614903|NCT01807221|26495417|P3|Overall Study|Death|4
7614904|NCT01807221|26495418|P2|Overall Study|Death|9
7614905|NCT01807221|26495419|P1|Overall Study|Death|7
7614906|NCT01807221|26495414|P6|Overall Study|Progressive disease|0
7614907|NCT01807221|26495415|P5|Overall Study|Progressive disease|0
7614908|NCT01807221|26495416|P4|Overall Study|Progressive disease|0
7614909|NCT01807221|26495417|P3|Overall Study|Progressive disease|1
7614910|NCT01807221|26495418|P2|Overall Study|Progressive disease|0
7614911|NCT01807221|26495419|P1|Overall Study|Progressive disease|1
7614912|NCT01807156|26495499|P1|Overall Study|Physician Decision|1
7614913|NCT01807117|26495504|P1|Overall Study|Disease diagnosis not a study disease|1
7614914|NCT01807117|26495504|P1|Overall Study|Physician Decision|2
7614915|NCT01807065|26495537|P2|Overall Study|Receive no sip-T due to IV access|1
7614916|NCT01807065|26495538|P1|Overall Study|Receive no sip-T due to IV access|1
7614917|NCT01806961|26495604|P1|Overall Study|sponsor decision|16
7614918|NCT01806896|26495610|P2|Overall Study|Other|0
7614919|NCT01806896|26495611|P1|Overall Study|Other|1
7614920|NCT01806896|26495610|P2|Overall Study|Adverse Event|0
7614921|NCT01806896|26495611|P1|Overall Study|Adverse Event|2
7614922|NCT01806779|26495678|P3|Overall Study|Withdrawal by Subject|22
7614923|NCT01806779|26495679|P2|Overall Study|Withdrawal by Subject|23
7614924|NCT01806779|26495680|P1|Overall Study|Withdrawal by Subject|20
7614925|NCT01806779|26495678|P3|Overall Study|Lost to Follow-up|0
7614926|NCT01806779|26495679|P2|Overall Study|Lost to Follow-up|20
7614927|NCT01806779|26495680|P1|Overall Study|Lost to Follow-up|19
7614928|NCT01806779|26495678|P3|Overall Study|Lack of Efficacy|0
7614929|NCT01806779|26495679|P2|Overall Study|Lack of Efficacy|1
7614930|NCT01806779|26495680|P1|Overall Study|Lack of Efficacy|1
7614931|NCT01806779|26495678|P3|Overall Study|Physician Decision|1
7614932|NCT01806779|26495679|P2|Overall Study|Physician Decision|0
7614933|NCT01806779|26495680|P1|Overall Study|Physician Decision|2
7614934|NCT01806740|26495693|P1|Overall Study|Patient's refusal of treatment|1
7614935|NCT01806740|26495693|P1|Overall Study|Physician Decision|1
7614936|NCT01806740|26495693|P1|Overall Study|Withdrawal by Subject|4
7614937|NCT01806714|26495704|P2|Overall Study|No functioning phone number|170
7614938|NCT01806714|26495705|P1|Overall Study|No functioning phone number|200
7614939|NCT01806662|26495753|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
7614940|NCT01806662|26495754|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
7614941|NCT01806662|26495753|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
7614942|NCT01806662|26495754|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
7614943|NCT01806662|26495753|P2|First Intervention (Weeks 0-16)|Adverse Event|1
7614944|NCT01806662|26495754|P1|First Intervention (Weeks 0-16)|Adverse Event|0
7614945|NCT01806662|26495753|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
7614946|NCT01806662|26495754|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
7614947|NCT01806623|26495760|P1|Overall Study|Did not meet the inclusion criteria|56
7614948|NCT01806623|26495760|P1|Overall Study|Adverse Event|1
7614949|NCT01806623|26495760|P1|Overall Study|Withdrawal by Subject|1
7614950|NCT01806597|26495780|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
7614951|NCT01806597|26495781|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7614952|NCT01806597|26495782|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7614953|NCT01806597|26495783|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7614954|NCT01806597|26495784|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7614955|NCT01806597|26495785|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7614956|NCT01806597|26495780|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
7614957|NCT01806597|26495781|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7614958|NCT01806597|26495782|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7614959|NCT01806597|26495783|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7614960|NCT01806597|26495784|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7614961|NCT01806597|26495785|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7614962|NCT01806597|26495780|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
7614963|NCT01806597|26495781|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7614964|NCT01806597|26495782|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7614965|NCT01806597|26495783|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7614966|NCT01806597|26495784|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7614967|NCT01806597|26495785|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7614968|NCT01806597|26495780|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
7614969|NCT01806597|26495781|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7614970|NCT01806597|26495782|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7614971|NCT01806597|26495783|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7614972|NCT01806597|26495784|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7614973|NCT01806597|26495785|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7614974|NCT01806597|26495780|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
7614975|NCT01806597|26495781|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7614976|NCT01806597|26495782|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7614977|NCT01806597|26495783|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7614978|NCT01806597|26495784|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7614979|NCT01806597|26495785|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7614980|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
7614981|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
7614982|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
7614983|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
7614984|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
7614985|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
7614986|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7614987|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7614988|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7614989|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7614990|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7614991|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7614992|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7614993|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7614994|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7614995|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
7614996|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7614997|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
7614998|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7614999|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7615000|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7615001|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7615002|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7615003|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7615004|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7615005|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7615006|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7615007|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7615008|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7615009|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
7615010|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7615011|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7615012|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7615013|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7615014|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7615015|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7615016|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7615017|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7615018|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7615019|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7615020|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7615021|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
7615022|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7615023|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7615024|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
7615025|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
7615026|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
7615027|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
7615028|NCT01806597|26495780|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
7615029|NCT01806597|26495781|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
7615030|NCT01806597|26495782|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
7615031|NCT01806597|26495783|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
7615032|NCT01806597|26495784|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
7615033|NCT01806597|26495785|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
7615034|NCT01806597|26495780|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
7615035|NCT01806597|26495781|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
7615036|NCT01806597|26495782|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
7615037|NCT01806597|26495783|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
7615038|NCT01806597|26495784|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
7615039|NCT01806597|26495785|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
7615040|NCT01806597|26495780|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7615041|NCT01806597|26495781|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7615042|NCT01806597|26495782|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7615043|NCT01806597|26495783|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7615044|NCT01806597|26495784|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7615045|NCT01806597|26495785|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
7615046|NCT01806597|26495780|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
7615047|NCT01806597|26495781|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
7615048|NCT01806597|26495782|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
7615049|NCT01806597|26495783|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
7615050|NCT01806597|26495784|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
7615051|NCT01806597|26495785|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
7615052|NCT01806597|26495780|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7615053|NCT01806597|26495781|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7615054|NCT01806597|26495782|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7615055|NCT01806597|26495783|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7615056|NCT01806597|26495784|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7615057|NCT01806597|26495785|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7615058|NCT01806597|26495780|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
7615059|NCT01806597|26495781|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
7615060|NCT01806597|26495782|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
7615061|NCT01806597|26495783|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
7615062|NCT01806597|26495784|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
7615063|NCT01806597|26495785|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
7615064|NCT01806584|26495821|P2|Overall Study|Other unspecified|0
7615065|NCT01806584|26495822|P1|Overall Study|Other unspecified|1
7615066|NCT01806584|26495821|P2|Overall Study|Withdrawal by Subject|1
7615067|NCT01806584|26495822|P1|Overall Study|Withdrawal by Subject|1
7615068|NCT01806584|26495821|P2|Overall Study|Study terminated by sponsor|14
7615069|NCT01806584|26495822|P1|Overall Study|Study terminated by sponsor|9
7615070|NCT01806584|26495821|P2|Overall Study|Lost to Follow-up|2
7615071|NCT01806584|26495822|P1|Overall Study|Lost to Follow-up|0
7615072|NCT01806584|26495821|P2|Overall Study|Death|0
7615073|NCT01806584|26495822|P1|Overall Study|Death|1
7615074|NCT01806584|26495821|P2|Overall Study|Adverse Event|1
7615075|NCT01806584|26495822|P1|Overall Study|Adverse Event|2
7615076|NCT01806545|26495844|P2|Overall Study|Withdrawal by Subject|2
7615077|NCT01806545|26495845|P1|Overall Study|Withdrawal by Subject|3
7615078|NCT01806545|26495844|P2|Overall Study|Lost to Follow-up|0
7615079|NCT01806545|26495845|P1|Overall Study|Lost to Follow-up|1
7615080|NCT01806545|26495844|P2|Overall Study|Adverse Event|3
7615081|NCT01806545|26495845|P1|Overall Study|Adverse Event|2
7615082|NCT01806506|26495869|P2|Overall Study|Lost to Follow-up|1
7615083|NCT01806506|26495870|P1|Overall Study|Lost to Follow-up|2
7615084|NCT01806389|26495876|P1|Overall Study|Withdrawal by Subject|4
7615085|NCT01806298|26495890|P1|Overall Study|Other|5
7615086|NCT01806298|26495890|P1|Overall Study|Withdrawal by Subject|1
7615087|NCT01806298|26495890|P1|Overall Study|Protocol Non-compliance|1
7615088|NCT01806298|26495890|P1|Overall Study|Adverse Event|3
7615089|NCT01806168|26495914|P3|Overall Study|Protocol Violation|1
7615090|NCT01806168|26495915|P2|Overall Study|Protocol Violation|0
7615091|NCT01806168|26495916|P1|Overall Study|Protocol Violation|0
7615092|NCT01806168|26495914|P3|Overall Study|Withdrawal by Subject|2
7615093|NCT01806168|26495915|P2|Overall Study|Withdrawal by Subject|1
7615094|NCT01806168|26495916|P1|Overall Study|Withdrawal by Subject|0
7615095|NCT01806168|26495914|P3|Overall Study|Adverse Event|0
7615096|NCT01806168|26495915|P2|Overall Study|Adverse Event|0
7615097|NCT01806168|26495916|P1|Overall Study|Adverse Event|1
7615098|NCT01806064|26495944|P5|Overall Study|Randomized Not Enrolled|2
7615099|NCT01806064|26495945|P4|Overall Study|Randomized Not Enrolled|1
7615100|NCT01806064|26495946|P3|Overall Study|Randomized Not Enrolled|0
7615101|NCT01806064|26495947|P2|Overall Study|Randomized Not Enrolled|0
7615102|NCT01806064|26495948|P1|Overall Study|Randomized Not Enrolled|0
7615103|NCT01806051|26495973|P1|Overall Study|Withdrawal by Subject|6
7615104|NCT01805180|26496090|P3|Lead-in Donor Phase|screen failure|0
7615105|NCT01805180|26496091|P2|Lead-in Donor Phase|screen failure|0
7615106|NCT01805180|26496092|P1|Lead-in Donor Phase|screen failure|1
7615107|NCT01805037|26496136|P2|Follow Up (up to 3 Years)|Lost to Follow-up|1
7615108|NCT01805037|26496137|P1|Follow Up (up to 3 Years)|Lost to Follow-up|0
7615109|NCT01805037|26496136|P2|Follow Up (up to 3 Years)|Withdrawal by Subject|3
7615110|NCT01805037|26496137|P1|Follow Up (up to 3 Years)|Withdrawal by Subject|0
7615111|NCT01805037|26496136|P2|Follow Up (up to 3 Years)|Death|2
7615112|NCT01805037|26496137|P1|Follow Up (up to 3 Years)|Death|0
7615113|NCT01805037|26496136|P2|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
7615114|NCT01805037|26496137|P1|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
7615115|NCT01805037|26496136|P2|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
7615116|NCT01805037|26496137|P1|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
7615117|NCT01805037|26496136|P2|2nd Cycle of Maintenance and Beyond|Adverse Event|10
7615118|NCT01805037|26496137|P1|2nd Cycle of Maintenance and Beyond|Adverse Event|0
7615119|NCT01805037|26496136|P2|1st Cycle of Maintenance (3 Weeks)|Death|1
7615120|NCT01805037|26496137|P1|1st Cycle of Maintenance (3 Weeks)|Death|0
7615121|NCT01805037|26496136|P2|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
7615122|NCT01805037|26496137|P1|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
7615123|NCT01805037|26496136|P2|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
7615124|NCT01805037|26496137|P1|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
7615125|NCT01805037|26496136|P2|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
7615126|NCT01805037|26496137|P1|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
7615127|NCT01804946|26496182|P2|Overall Study|Do not meet inclusion criteria|2
7615128|NCT01804946|26496183|P1|Overall Study|Do not meet inclusion criteria|1
7615129|NCT01804946|26496182|P2|Overall Study|Insufficient data available|1
7615130|NCT01804946|26496183|P1|Overall Study|Insufficient data available|0
7615131|NCT01804946|26496182|P2|Overall Study|Adverse Event|1
7615132|NCT01804946|26496183|P1|Overall Study|Adverse Event|0
7615133|NCT01804946|26496182|P2|Overall Study|Protocol Violation|0
7615134|NCT01804946|26496183|P1|Overall Study|Protocol Violation|1
7615135|NCT01804842|26496221|P3|Overall Study|Personal Reason|1
7615136|NCT01804842|26496222|P2|Overall Study|Personal Reason|0
7615137|NCT01804842|26496223|P1|Overall Study|Personal Reason|0
7615138|NCT01804842|26496221|P3|Overall Study|Non-Compliance|0
7615139|NCT01804842|26496222|P2|Overall Study|Non-Compliance|1
7615140|NCT01804842|26496223|P1|Overall Study|Non-Compliance|1
7615141|NCT01804842|26496221|P3|Overall Study|Lost to Follow-up|0
7615142|NCT01804842|26496222|P2|Overall Study|Lost to Follow-up|0
7615143|NCT01804842|26496223|P1|Overall Study|Lost to Follow-up|1
7615144|NCT01804842|26496221|P3|Overall Study|Adverse Event|0
7615145|NCT01804842|26496222|P2|Overall Study|Adverse Event|1
7615146|NCT01804842|26496223|P1|Overall Study|Adverse Event|1
7615147|NCT01804816|26496240|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
7615148|NCT01804816|26496240|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
7615149|NCT01804673|26496252|P1|Overall Study|Other|4
7615150|NCT01804673|26496252|P1|Overall Study|Use of Prohibited Medication|1
7615151|NCT01804673|26496252|P1|Overall Study|No Further Therapy Required|84
7615152|NCT01804673|26496252|P1|Overall Study|Change to Oral Therapy|37
7615153|NCT01804673|26496252|P1|Overall Study|Lack of Efficacy|9
7615154|NCT01804673|26496252|P1|Overall Study|Withdrawal by Subject|1
7615155|NCT01804673|26496252|P1|Overall Study|Adverse Event|4
7615156|NCT01804582|26496270|P2|Overall Study|Physician Decision|0
7615157|NCT01804582|26496271|P1|Overall Study|Physician Decision|2
7615158|NCT01804582|26496270|P2|Overall Study|Lost to Follow-up|56
7615159|NCT01804582|26496271|P1|Overall Study|Lost to Follow-up|47
7615160|NCT01804140|26496320|P1|Overall Study|No sampling or biopsy procedures done|114
7615161|NCT01804049|26496367|P2|Overall Study|Enrollment in dual studies|1
7615162|NCT01804049|26496368|P1|Overall Study|Enrollment in dual studies|0
7615163|NCT01804049|26496367|P2|Overall Study|other MD recommended|1
7615164|NCT01804049|26496368|P1|Overall Study|other MD recommended|1
7615165|NCT01804049|26496367|P2|Overall Study|Moved out of area|7
7615166|NCT01804049|26496368|P1|Overall Study|Moved out of area|0
7615167|NCT01804049|26496367|P2|Overall Study|Other health concerns|7
7615168|NCT01804049|26496368|P1|Overall Study|Other health concerns|2
7615169|NCT01804049|26496367|P2|Overall Study|Decreased interest/personal|5
7615170|NCT01804049|26496368|P1|Overall Study|Decreased interest/personal|4
7615171|NCT01804049|26496367|P2|Overall Study|Lost to Follow-up|1
7615172|NCT01804049|26496368|P1|Overall Study|Lost to Follow-up|2
7615173|NCT01804049|26496367|P2|Overall Study|Adverse Event|10
7615174|NCT01804049|26496368|P1|Overall Study|Adverse Event|2
7615175|NCT01803880|26496416|P3|Overall Study|Incomplete data entry by sites|0
7615176|NCT01803880|26496417|P2|Overall Study|Incomplete data entry by sites|0
7615177|NCT01803880|26496418|P1|Overall Study|Incomplete data entry by sites|2
7615178|NCT01803880|26496416|P3|Overall Study|Early study termination|5
7615179|NCT01803880|26496417|P2|Overall Study|Early study termination|6
7615180|NCT01803880|26496418|P1|Overall Study|Early study termination|0
7615181|NCT01803880|26496416|P3|Overall Study|Protocol Violation|0
7615182|NCT01803880|26496417|P2|Overall Study|Protocol Violation|0
7615183|NCT01803880|26496418|P1|Overall Study|Protocol Violation|1
7615184|NCT01803880|26496416|P3|Overall Study|Lost to Follow-up|3
7615185|NCT01803880|26496417|P2|Overall Study|Lost to Follow-up|2
7615186|NCT01803880|26496418|P1|Overall Study|Lost to Follow-up|1
7615187|NCT01803880|26496416|P3|Overall Study|Unable to return for follow-up visits|2
7615188|NCT01803880|26496417|P2|Overall Study|Unable to return for follow-up visits|1
7615189|NCT01803880|26496418|P1|Overall Study|Unable to return for follow-up visits|0
7615190|NCT01803880|26496416|P3|Overall Study|Physician Decision|1
7615191|NCT01803880|26496417|P2|Overall Study|Physician Decision|0
7615192|NCT01803880|26496418|P1|Overall Study|Physician Decision|0
7615193|NCT01803880|26496416|P3|Overall Study|Withdrawal by Subject|4
7615194|NCT01803880|26496417|P2|Overall Study|Withdrawal by Subject|1
7615195|NCT01803880|26496418|P1|Overall Study|Withdrawal by Subject|1
7615196|NCT01803880|26496416|P3|Overall Study|Adverse Event|0
7615197|NCT01803880|26496417|P2|Overall Study|Adverse Event|0
7615198|NCT01803880|26496418|P1|Overall Study|Adverse Event|1
7615199|NCT01803737|26496454|P2|Overall Study|Lost to Follow-up|2
7615200|NCT01803737|26496455|P1|Overall Study|Lost to Follow-up|0
7615201|NCT01803737|26496454|P2|Overall Study|Medical Reason|1
7615202|NCT01803737|26496455|P1|Overall Study|Medical Reason|0
7615203|NCT01803737|26496454|P2|Overall Study|Lack of Time|0
7615204|NCT01803737|26496455|P1|Overall Study|Lack of Time|1
7615205|NCT01803711|26496479|P2|Overall Study|Adverse Event|1
7615206|NCT01803711|26496480|P1|Overall Study|Adverse Event|1
7615207|NCT01803646|26496498|P2|Overall Study|Lost to Follow-up|1
7615208|NCT01803646|26496499|P1|Overall Study|Lost to Follow-up|5
7615209|NCT01803646|26496498|P2|Overall Study|Randomization error|2
7615210|NCT01803646|26496499|P1|Overall Study|Randomization error|1
7615211|NCT01803646|26496498|P2|Overall Study|Withdrawal by Subject|6
7615212|NCT01803646|26496499|P1|Overall Study|Withdrawal by Subject|9
7615213|NCT01803646|26496498|P2|Overall Study|Adverse Event|1
7615214|NCT01803646|26496499|P1|Overall Study|Adverse Event|1
7615215|NCT01803646|26496498|P2|Overall Study|Protocol Violation|0
7615216|NCT01803646|26496499|P1|Overall Study|Protocol Violation|1
7615217|NCT01803607|26496511|P2|Overall Study|Withdrawal by Subject|5
7615218|NCT01803607|26496512|P1|Overall Study|Withdrawal by Subject|6
7615219|NCT01803607|26496511|P2|Overall Study|Study terminated by sponsor|56
7615220|NCT01803607|26496512|P1|Overall Study|Study terminated by sponsor|54
7615221|NCT01803607|26496511|P2|Overall Study|Protocol Violation|2
7615222|NCT01803607|26496512|P1|Overall Study|Protocol Violation|3
7615223|NCT01803607|26496511|P2|Overall Study|Lack of Efficacy|1
7615224|NCT01803607|26496512|P1|Overall Study|Lack of Efficacy|0
7615225|NCT01803607|26496511|P2|Overall Study|Adverse Event|3
7615226|NCT01803607|26496512|P1|Overall Study|Adverse Event|5
7615227|NCT01803464|26496536|P4|Overall Study|Withdrawal by Subject|0
7615228|NCT01803464|26496537|P3|Overall Study|Withdrawal by Subject|0
7615229|NCT01803464|26496538|P2|Overall Study|Withdrawal by Subject|0
7615230|NCT01803464|26496539|P1|Overall Study|Withdrawal by Subject|1
7615231|NCT01803464|26496536|P4|Overall Study|Incomplete data|0
7615232|NCT01803464|26496537|P3|Overall Study|Incomplete data|4
7615233|NCT01803464|26496538|P2|Overall Study|Incomplete data|0
7615234|NCT01803464|26496539|P1|Overall Study|Incomplete data|0
7615235|NCT01803282|26496569|P12|Overall Study|Enrolled but Never Treated|0
7615236|NCT01803282|26496570|P11|Overall Study|Enrolled but Never Treated|0
7615237|NCT01803282|26496571|P10|Overall Study|Enrolled but Never Treated|1
7615238|NCT01803282|26496572|P9|Overall Study|Enrolled but Never Treated|0
7615239|NCT01803282|26496573|P8|Overall Study|Enrolled but Never Treated|1
7615240|NCT01803282|26496574|P7|Overall Study|Enrolled but Never Treated|1
7615241|NCT01803282|26496575|P6|Overall Study|Enrolled but Never Treated|0
7615242|NCT01803282|26496576|P5|Overall Study|Enrolled but Never Treated|1
7615243|NCT01803282|26496577|P4|Overall Study|Enrolled but Never Treated|0
7615244|NCT01803282|26496578|P3|Overall Study|Enrolled but Never Treated|0
7615245|NCT01803282|26496579|P2|Overall Study|Enrolled but Never Treated|0
7615246|NCT01803282|26496580|P1|Overall Study|Enrolled but Never Treated|0
7615247|NCT01803282|26496569|P12|Overall Study|Specified Criteria for Withdrawal|0
7615248|NCT01803282|26496570|P11|Overall Study|Specified Criteria for Withdrawal|1
7615249|NCT01803282|26496571|P10|Overall Study|Specified Criteria for Withdrawal|1
7615250|NCT01803282|26496572|P9|Overall Study|Specified Criteria for Withdrawal|0
7615251|NCT01803282|26496573|P8|Overall Study|Specified Criteria for Withdrawal|0
7615252|NCT01803282|26496574|P7|Overall Study|Specified Criteria for Withdrawal|0
7615253|NCT01803282|26496575|P6|Overall Study|Specified Criteria for Withdrawal|0
7615254|NCT01803282|26496576|P5|Overall Study|Specified Criteria for Withdrawal|0
7615255|NCT01803282|26496577|P4|Overall Study|Specified Criteria for Withdrawal|0
7615256|NCT01803282|26496578|P3|Overall Study|Specified Criteria for Withdrawal|0
7615257|NCT01803282|26496579|P2|Overall Study|Specified Criteria for Withdrawal|0
7615258|NCT01803282|26496580|P1|Overall Study|Specified Criteria for Withdrawal|0
7615259|NCT01803282|26496569|P12|Overall Study|Unknown Reason|0
7615260|NCT01803282|26496570|P11|Overall Study|Unknown Reason|0
7615261|NCT01803282|26496571|P10|Overall Study|Unknown Reason|0
7615262|NCT01803282|26496572|P9|Overall Study|Unknown Reason|0
7615263|NCT01803282|26496573|P8|Overall Study|Unknown Reason|1
7615264|NCT01803282|26496574|P7|Overall Study|Unknown Reason|0
7615265|NCT01803282|26496575|P6|Overall Study|Unknown Reason|0
7615266|NCT01803282|26496576|P5|Overall Study|Unknown Reason|0
7615267|NCT01803282|26496577|P4|Overall Study|Unknown Reason|0
7615268|NCT01803282|26496578|P3|Overall Study|Unknown Reason|0
7615269|NCT01803282|26496579|P2|Overall Study|Unknown Reason|0
7615270|NCT01803282|26496580|P1|Overall Study|Unknown Reason|0
7615271|NCT01803282|26496569|P12|Overall Study|Non-Compliance with Study Drug|0
7615272|NCT01803282|26496570|P11|Overall Study|Non-Compliance with Study Drug|0
7615273|NCT01803282|26496571|P10|Overall Study|Non-Compliance with Study Drug|0
7615274|NCT01803282|26496572|P9|Overall Study|Non-Compliance with Study Drug|0
7615275|NCT01803282|26496573|P8|Overall Study|Non-Compliance with Study Drug|0
7615276|NCT01803282|26496574|P7|Overall Study|Non-Compliance with Study Drug|0
7615277|NCT01803282|26496575|P6|Overall Study|Non-Compliance with Study Drug|0
7615278|NCT01803282|26496576|P5|Overall Study|Non-Compliance with Study Drug|0
7615279|NCT01803282|26496577|P4|Overall Study|Non-Compliance with Study Drug|1
7615280|NCT01803282|26496578|P3|Overall Study|Non-Compliance with Study Drug|0
7615281|NCT01803282|26496579|P2|Overall Study|Non-Compliance with Study Drug|0
7615282|NCT01803282|26496580|P1|Overall Study|Non-Compliance with Study Drug|0
7615283|NCT01803282|26496569|P12|Overall Study|Adverse Event|3
7615284|NCT01803282|26496570|P11|Overall Study|Adverse Event|0
7615285|NCT01803282|26496571|P10|Overall Study|Adverse Event|1
7615286|NCT01803282|26496572|P9|Overall Study|Adverse Event|0
7615287|NCT01803282|26496573|P8|Overall Study|Adverse Event|2
7615288|NCT01803282|26496574|P7|Overall Study|Adverse Event|1
7615289|NCT01803282|26496575|P6|Overall Study|Adverse Event|0
7615290|NCT01803282|26496576|P5|Overall Study|Adverse Event|0
7615291|NCT01803282|26496577|P4|Overall Study|Adverse Event|0
7615292|NCT01803282|26496578|P3|Overall Study|Adverse Event|0
7615293|NCT01803282|26496579|P2|Overall Study|Adverse Event|0
7615294|NCT01803282|26496580|P1|Overall Study|Adverse Event|0
7615295|NCT01803282|26496569|P12|Overall Study|Investigator's Discretion|0
7615296|NCT01803282|26496570|P11|Overall Study|Investigator's Discretion|1
7615297|NCT01803282|26496571|P10|Overall Study|Investigator's Discretion|7
7615298|NCT01803282|26496572|P9|Overall Study|Investigator's Discretion|6
7615299|NCT01803282|26496573|P8|Overall Study|Investigator's Discretion|10
7615300|NCT01803282|26496574|P7|Overall Study|Investigator's Discretion|7
7615301|NCT01803282|26496575|P6|Overall Study|Investigator's Discretion|1
7615302|NCT01803282|26496576|P5|Overall Study|Investigator's Discretion|2
7615303|NCT01803282|26496577|P4|Overall Study|Investigator's Discretion|7
7615304|NCT01803282|26496578|P3|Overall Study|Investigator's Discretion|0
7615305|NCT01803282|26496579|P2|Overall Study|Investigator's Discretion|0
7615306|NCT01803282|26496580|P1|Overall Study|Investigator's Discretion|0
7615307|NCT01803282|26496569|P12|Overall Study|Withdrew Consent|1
7615308|NCT01803282|26496570|P11|Overall Study|Withdrew Consent|0
7615309|NCT01803282|26496571|P10|Overall Study|Withdrew Consent|5
7615310|NCT01803282|26496572|P9|Overall Study|Withdrew Consent|1
7615311|NCT01803282|26496573|P8|Overall Study|Withdrew Consent|3
7615312|NCT01803282|26496574|P7|Overall Study|Withdrew Consent|8
7615313|NCT01803282|26496575|P6|Overall Study|Withdrew Consent|0
7615314|NCT01803282|26496576|P5|Overall Study|Withdrew Consent|1
7615315|NCT01803282|26496577|P4|Overall Study|Withdrew Consent|6
7615316|NCT01803282|26496578|P3|Overall Study|Withdrew Consent|0
7615317|NCT01803282|26496579|P2|Overall Study|Withdrew Consent|0
7615318|NCT01803282|26496580|P1|Overall Study|Withdrew Consent|0
7615319|NCT01803282|26496569|P12|Overall Study|Death|0
7615320|NCT01803282|26496570|P11|Overall Study|Death|0
7615321|NCT01803282|26496571|P10|Overall Study|Death|1
7615322|NCT01803282|26496572|P9|Overall Study|Death|1
7615323|NCT01803282|26496573|P8|Overall Study|Death|5
7615324|NCT01803282|26496574|P7|Overall Study|Death|1
7615325|NCT01803282|26496575|P6|Overall Study|Death|1
7615326|NCT01803282|26496576|P5|Overall Study|Death|2
7615327|NCT01803282|26496577|P4|Overall Study|Death|0
7615328|NCT01803282|26496578|P3|Overall Study|Death|0
7615329|NCT01803282|26496579|P2|Overall Study|Death|0
7615330|NCT01803282|26496580|P1|Overall Study|Death|0
7615331|NCT01803282|26496569|P12|Overall Study|Progressive Disease|11
7615332|NCT01803282|26496570|P11|Overall Study|Progressive Disease|6
7615333|NCT01803282|26496571|P10|Overall Study|Progressive Disease|29
7615334|NCT01803282|26496572|P9|Overall Study|Progressive Disease|3
7615335|NCT01803282|26496573|P8|Overall Study|Progressive Disease|24
7615336|NCT01803282|26496574|P7|Overall Study|Progressive Disease|23
7615337|NCT01803282|26496575|P6|Overall Study|Progressive Disease|8
7615338|NCT01803282|26496576|P5|Overall Study|Progressive Disease|5
7615339|NCT01803282|26496577|P4|Overall Study|Progressive Disease|22
7615340|NCT01803282|26496578|P3|Overall Study|Progressive Disease|6
7615341|NCT01803282|26496579|P2|Overall Study|Progressive Disease|3
7615342|NCT01803282|26496580|P1|Overall Study|Progressive Disease|4
7615343|NCT01803269|26496621|P3|Overall Study|Withdrawal by Subject|0
7615344|NCT01803269|26496622|P2|Overall Study|Withdrawal by Subject|0
7615345|NCT01803269|26496623|P1|Overall Study|Withdrawal by Subject|3
7615346|NCT01802879|26496937|P1|Overall Study|Disease progression|6
7615347|NCT01802879|26496937|P1|Overall Study|Administrative problems|2
7615348|NCT01802775|26496944|P2|Overall Study|Lost to Follow-up|2
7615349|NCT01802775|26496945|P1|Overall Study|Lost to Follow-up|1
7615350|NCT01802775|26496944|P2|Overall Study|Withdrawal by Subject|5
7615351|NCT01802775|26496945|P1|Overall Study|Withdrawal by Subject|3
7615352|NCT01802775|26496944|P2|Overall Study|Adverse Event|1
7615353|NCT01802775|26496945|P1|Overall Study|Adverse Event|1
7615354|NCT01802775|26496944|P2|Overall Study|Physician Decision|0
7615355|NCT01802775|26496945|P1|Overall Study|Physician Decision|1
7615356|NCT01802775|26496944|P2|Overall Study|Reason not provided|1
7615357|NCT01802775|26496945|P1|Overall Study|Reason not provided|0
7615358|NCT01802775|26496944|P2|Overall Study|Death|3
7615359|NCT01802775|26496945|P1|Overall Study|Death|0
7615360|NCT01802632|26496980|P6|Overall Study|Other (not specified)|1
7615361|NCT01802632|26496981|P5|Overall Study|Other (not specified)|0
7615362|NCT01802632|26496982|P4|Overall Study|Other (not specified)|1
7615363|NCT01802632|26496983|P3|Overall Study|Other (not specified)|7
7615364|NCT01802632|26496984|P2|Overall Study|Other (not specified)|0
7615365|NCT01802632|26496985|P1|Overall Study|Other (not specified)|0
7615366|NCT01802632|26496980|P6|Overall Study|Ongoing Study at Data Cut-off|22
7615367|NCT01802632|26496981|P5|Overall Study|Ongoing Study at Data Cut-off|6
7615368|NCT01802632|26496982|P4|Overall Study|Ongoing Study at Data Cut-off|50
7615369|NCT01802632|26496983|P3|Overall Study|Ongoing Study at Data Cut-off|115
7615370|NCT01802632|26496984|P2|Overall Study|Ongoing Study at Data Cut-off|16
7615371|NCT01802632|26496985|P1|Overall Study|Ongoing Study at Data Cut-off|168
7615372|NCT01802632|26496980|P6|Overall Study|Objective Disease Progression|4
7615373|NCT01802632|26496981|P5|Overall Study|Objective Disease Progression|4
7615374|NCT01802632|26496982|P4|Overall Study|Objective Disease Progression|6
7615375|NCT01802632|26496983|P3|Overall Study|Objective Disease Progression|104
7615376|NCT01802632|26496984|P2|Overall Study|Objective Disease Progression|12
7615377|NCT01802632|26496985|P1|Overall Study|Objective Disease Progression|1
7615378|NCT01802632|26496980|P6|Overall Study|Withdrawal by Subject|1
7615379|NCT01802632|26496981|P5|Overall Study|Withdrawal by Subject|0
7615380|NCT01802632|26496982|P4|Overall Study|Withdrawal by Subject|3
7615381|NCT01802632|26496983|P3|Overall Study|Withdrawal by Subject|7
7615382|NCT01802632|26496984|P2|Overall Study|Withdrawal by Subject|2
7615383|NCT01802632|26496985|P1|Overall Study|Withdrawal by Subject|4
7615384|NCT01802632|26496980|P6|Overall Study|Death|0
7615385|NCT01802632|26496981|P5|Overall Study|Death|2
7615386|NCT01802632|26496982|P4|Overall Study|Death|0
7615387|NCT01802632|26496983|P3|Overall Study|Death|38
7615388|NCT01802632|26496984|P2|Overall Study|Death|1
7615389|NCT01802632|26496985|P1|Overall Study|Death|28
7615390|NCT01802580|26497001|P2|Overall Study|Lack of Efficacy|2
7615391|NCT01802580|26497002|P1|Overall Study|Lack of Efficacy|0
7615392|NCT01802580|26497001|P2|Overall Study|Other|3
7615393|NCT01802580|26497002|P1|Overall Study|Other|1
7615394|NCT01802580|26497001|P2|Overall Study|Withdrawal by Subject|6
7615395|NCT01802580|26497002|P1|Overall Study|Withdrawal by Subject|5
7615396|NCT01802580|26497001|P2|Overall Study|Protocol Violation|0
7615397|NCT01802580|26497002|P1|Overall Study|Protocol Violation|2
7615398|NCT01802580|26497001|P2|Overall Study|Physician Decision|0
7615399|NCT01802580|26497002|P1|Overall Study|Physician Decision|1
7615400|NCT01802515|26497033|P3|Overall Study|Withdrawal by Subject|0
7615401|NCT01802515|26497034|P2|Overall Study|Withdrawal by Subject|0
7615402|NCT01802515|26497035|P1|Overall Study|Withdrawal by Subject|3
7615403|NCT01802437|26497048|P2|Overall Study|Withdrawal by Subject|4
7615404|NCT01802437|26497049|P1|Overall Study|Withdrawal by Subject|3
7615405|NCT01802437|26497048|P2|Overall Study|Lost to Follow-up|0
7615406|NCT01802437|26497049|P1|Overall Study|Lost to Follow-up|1
7615407|NCT01802411|26497061|P2|Overall Study|Proc changed to video-asst thorascopic|1
7615408|NCT01802411|26497062|P1|Overall Study|Proc changed to video-asst thorascopic|0
7615409|NCT01802411|26497061|P2|Overall Study|Surgery aborted after bronchoscopy|0
7615410|NCT01802411|26497062|P1|Overall Study|Surgery aborted after bronchoscopy|1
7615411|NCT01802411|26497061|P2|Overall Study|Planned pleurodesis as part of the proc|0
7615412|NCT01802411|26497062|P1|Overall Study|Planned pleurodesis as part of the proc|1
7615413|NCT01802411|26497061|P2|Overall Study|Withdrawal by Subject|2
7615414|NCT01802411|26497062|P1|Overall Study|Withdrawal by Subject|0
7615415|NCT01802411|26497061|P2|Overall Study|Lack of Efficacy|10
7615416|NCT01802411|26497062|P1|Overall Study|Lack of Efficacy|8
7615417|NCT01802411|26497061|P2|Overall Study|Adverse Event|7
7615418|NCT01802411|26497062|P1|Overall Study|Adverse Event|2
7615419|NCT01802411|26497061|P2|Overall Study|Death|1
7615420|NCT01802411|26497062|P1|Overall Study|Death|2
7615421|NCT01802385|26497074|P2|Overall Study|Death|120
7615422|NCT01802385|26497075|P1|Overall Study|Death|106
7615423|NCT01802333|26497098|P3|Overall Study|Did not start treatment|5
7615424|NCT01802333|26497099|P2|Overall Study|Did not start treatment|2
7615425|NCT01802333|26497100|P1|Overall Study|Did not start treatment|0
7615426|NCT01802333|26497098|P3|Overall Study|Other - not protocol specified|24
7615427|NCT01802333|26497099|P2|Overall Study|Other - not protocol specified|22
7615428|NCT01802333|26497100|P1|Overall Study|Other - not protocol specified|32
7615429|NCT01802333|26497098|P3|Overall Study|Death|13
7615430|NCT01802333|26497099|P2|Overall Study|Death|14
7615431|NCT01802333|26497100|P1|Overall Study|Death|7
7615432|NCT01802333|26497098|P3|Overall Study|Progression/relapse|0
7615433|NCT01802333|26497099|P2|Overall Study|Progression/relapse|3
7615434|NCT01802333|26497100|P1|Overall Study|Progression/relapse|1
7615435|NCT01802333|26497098|P3|Overall Study|Withdrawal by Subject|5
7615436|NCT01802333|26497099|P2|Overall Study|Withdrawal by Subject|6
7615437|NCT01802333|26497100|P1|Overall Study|Withdrawal by Subject|6
7615438|NCT01802333|26497098|P3|Overall Study|Adverse Event|8
7615439|NCT01802333|26497099|P2|Overall Study|Adverse Event|8
7615440|NCT01802333|26497100|P1|Overall Study|Adverse Event|1
7615441|NCT01802333|26497098|P3|Overall Study|Ineligible|8
7615442|NCT01802333|26497099|P2|Overall Study|Ineligible|6
7615443|NCT01802333|26497100|P1|Overall Study|Ineligible|2
7615444|NCT01802320|26497127|P1|Overall Study|Withdrawal by Subject|1
7615445|NCT01802320|26497127|P1|Overall Study|Death|1
7615446|NCT01802281|26497137|P2|Overall Study|Ineligible|3
7615447|NCT01802281|26497138|P1|Overall Study|Ineligible|5
7615448|NCT01802281|26497137|P2|Overall Study|Withdrawal by Subject|1
7615449|NCT01802281|26497138|P1|Overall Study|Withdrawal by Subject|2
7615450|NCT01802281|26497137|P2|Overall Study|Death|2
7615451|NCT01802281|26497138|P1|Overall Study|Death|1
7615452|NCT01802216|26497192|P2|12 Month Visit|Participant did not show to visit|4
7615453|NCT01802216|26497193|P1|12 Month Visit|Participant did not show to visit|3
7615454|NCT01802216|26497192|P2|8 Month Visit|Participant did not show to visit|5
7615455|NCT01802216|26497193|P1|8 Month Visit|Participant did not show to visit|3
7615456|NCT01802216|26497192|P2|4 Month Visit|Participant did not show to visit|4
7615457|NCT01802216|26497193|P1|4 Month Visit|Participant did not show to visit|3
7615458|NCT01802073|26497272|P2|Overall Study|Physician Decision|7
7615459|NCT01802073|26497273|P1|Overall Study|Physician Decision|0
7615460|NCT01802073|26497272|P2|Overall Study|Withdrawal by Subject|1
7615461|NCT01802073|26497273|P1|Overall Study|Withdrawal by Subject|1
7615462|NCT01802073|26497272|P2|Overall Study|Non-compliant|2
7615463|NCT01802073|26497273|P1|Overall Study|Non-compliant|4
7615464|NCT01802073|26497272|P2|Overall Study|Lost to Follow-up|1
7615465|NCT01802073|26497273|P1|Overall Study|Lost to Follow-up|0
7615466|NCT01801982|26497289|P1|Overall Study|Lost to Follow-up|1
7615467|NCT01801930|26497303|P4|Overall Study|DLT occurs|0
7615468|NCT01801930|26497304|P3|Overall Study|DLT occurs|0
7615469|NCT01801930|26497305|P2|Overall Study|DLT occurs|1
7615470|NCT01801930|26497306|P1|Overall Study|DLT occurs|0
7615471|NCT01801930|26497303|P4|Overall Study|Clear progression of the primary disease is observed|6
7615472|NCT01801930|26497304|P3|Overall Study|Clear progression of the primary disease is observed|6
7615473|NCT01801930|26497305|P2|Overall Study|Clear progression of the primary disease is observed|5
7615474|NCT01801930|26497306|P1|Overall Study|Clear progression of the primary disease is observed|6
7615475|NCT01801917|26497328|P4|Period 1 - Randomized|Adverse Event|0
7615476|NCT01801917|26497329|P3|Period 1 - Randomized|Adverse Event|1
7615477|NCT01801917|26497330|P2|Period 1 - Randomized|Adverse Event|0
7615478|NCT01801917|26497331|P1|Period 1 - Randomized|Adverse Event|1
7615479|NCT01801865|26497351|P1|Overall Study|Physician Decision|7
7615480|NCT01801865|26497351|P1|Overall Study|Patients scanned on another MRI scanner|35
7615481|NCT01801735|26497356|P1|Overall Study|Other, including site closure|19
7615482|NCT01801735|26497356|P1|Overall Study|Death|1
7615483|NCT01801735|26497356|P1|Overall Study|Physician Decision|3
7615484|NCT01801735|26497356|P1|Overall Study|Non-compliance with Trial Drug|13
7615485|NCT01801735|26497356|P1|Overall Study|Lost to Follow-up|15
7615486|NCT01801735|26497356|P1|Overall Study|Protocol Violation|25
7615487|NCT01801735|26497356|P1|Overall Study|Withdrawal by Subject|27
7615488|NCT01801735|26497356|P1|Overall Study|Lack of Efficacy|28
7615489|NCT01801735|26497356|P1|Overall Study|Adverse Event|79
7615490|NCT01801475|26497363|P5|Overall Study|Withdrawal by Subject|1
7615491|NCT01801475|26497364|P4|Overall Study|Withdrawal by Subject|0
7615492|NCT01801475|26497365|P3|Overall Study|Withdrawal by Subject|0
7615493|NCT01801475|26497366|P2|Overall Study|Withdrawal by Subject|0
7615494|NCT01801475|26497367|P1|Overall Study|Withdrawal by Subject|0
7615495|NCT01801436|26497392|P1|Overall Study|Progressive disease|4
7615496|NCT01801436|26497392|P1|Overall Study|Adverse Event|2
7615497|NCT01801436|26497392|P1|Overall Study|Withdrawal by Subject|3
7615498|NCT01801358|26497430|P6|Overall Study|Withdrawal by Subject|2
7615499|NCT01801358|26497431|P5|Overall Study|Withdrawal by Subject|0
7615500|NCT01801358|26497432|P4|Overall Study|Withdrawal by Subject|1
7615501|NCT01801358|26497433|P3|Overall Study|Withdrawal by Subject|0
7615502|NCT01801358|26497434|P2|Overall Study|Withdrawal by Subject|0
7615503|NCT01801358|26497435|P1|Overall Study|Withdrawal by Subject|0
7615504|NCT01801358|26497430|P6|Overall Study|Progressive Disease|5
7615505|NCT01801358|26497431|P5|Overall Study|Progressive Disease|6
7615506|NCT01801358|26497432|P4|Overall Study|Progressive Disease|5
7615507|NCT01801358|26497433|P3|Overall Study|Progressive Disease|4
7615508|NCT01801358|26497434|P2|Overall Study|Progressive Disease|4
7615509|NCT01801358|26497435|P1|Overall Study|Progressive Disease|6
7615510|NCT01801358|26497430|P6|Overall Study|Physician Decision|0
7615511|NCT01801358|26497431|P5|Overall Study|Physician Decision|0
7615512|NCT01801358|26497432|P4|Overall Study|Physician Decision|0
7615513|NCT01801358|26497433|P3|Overall Study|Physician Decision|1
7615514|NCT01801358|26497434|P2|Overall Study|Physician Decision|0
7615515|NCT01801358|26497435|P1|Overall Study|Physician Decision|0
7615516|NCT01801358|26497430|P6|Overall Study|Adverse Event|1
7615517|NCT01801358|26497431|P5|Overall Study|Adverse Event|0
7615518|NCT01801358|26497432|P4|Overall Study|Adverse Event|0
7615519|NCT01801358|26497433|P3|Overall Study|Adverse Event|1
7615520|NCT01801358|26497434|P2|Overall Study|Adverse Event|2
7615521|NCT01801358|26497435|P1|Overall Study|Adverse Event|0
7615522|NCT01801280|26497557|P4|Period 4|Protocol Violation|0
7615523|NCT01801280|26497558|P3|Period 4|Protocol Violation|1
7615524|NCT01801280|26497559|P2|Period 4|Protocol Violation|0
7615525|NCT01801280|26497560|P1|Period 4|Protocol Violation|0
7615526|NCT01801280|26497557|P4|Period 2|Withdrawal by Subject|0
7615527|NCT01801280|26497558|P3|Period 2|Withdrawal by Subject|0
7615528|NCT01801280|26497559|P2|Period 2|Withdrawal by Subject|0
7615529|NCT01801280|26497560|P1|Period 2|Withdrawal by Subject|1
7615530|NCT01801280|26497557|P4|Period 1|Withdrawal by Subject|0
7615531|NCT01801280|26497558|P3|Period 1|Withdrawal by Subject|0
7615532|NCT01801280|26497559|P2|Period 1|Withdrawal by Subject|1
7615533|NCT01801280|26497560|P1|Period 1|Withdrawal by Subject|0
7615534|NCT01801111|26497575|P1|Overall Study|Progressive Disease|81
7615535|NCT01801111|26497575|P1|Overall Study|Study Terminated by Sponsor|27
7615536|NCT01801111|26497575|P1|Overall Study|Withdrawal by Subject|4
7615537|NCT01801111|26497575|P1|Overall Study|Other|1
7615538|NCT01801111|26497575|P1|Overall Study|Physician Decision|5
7615539|NCT01801111|26497575|P1|Overall Study|Death|8
7615540|NCT01801111|26497575|P1|Overall Study|Adverse Event|12
7615541|NCT01801007|26497614|P1|Overall Study|Withdrawal by Subject|5
7615542|NCT01801007|26497614|P1|Overall Study|Lost to Follow-up|4
7615543|NCT01801007|26497614|P1|Overall Study|Adverse Event|2
7615544|NCT01800968|26497627|P2|Overall Study|Physician Decision|0
7615545|NCT01800968|26497628|P1|Overall Study|Physician Decision|1
7615546|NCT01800968|26497627|P2|Overall Study|Withdrawal by Subject|9
7615547|NCT01800968|26497628|P1|Overall Study|Withdrawal by Subject|7
7615548|NCT01800968|26497627|P2|Overall Study|Lost to Follow-up|7
7615549|NCT01800968|26497628|P1|Overall Study|Lost to Follow-up|5
7615550|NCT01800968|26497627|P2|Overall Study|Death|16
7615551|NCT01800968|26497628|P1|Overall Study|Death|23
7615552|NCT01800916|26497670|P9|Test Period 1 (1 Week)|Adverse Event|0
7615553|NCT01800916|26497671|P8|Test Period 1 (1 Week)|Adverse Event|0
7615554|NCT01800916|26497672|P7|Test Period 1 (1 Week)|Adverse Event|0
7615555|NCT01800916|26497673|P6|Test Period 1 (1 Week)|Adverse Event|0
7615556|NCT01800916|26497674|P5|Test Period 1 (1 Week)|Adverse Event|1
7615557|NCT01800916|26497675|P4|Test Period 1 (1 Week)|Adverse Event|0
7615558|NCT01800916|26497676|P3|Test Period 1 (1 Week)|Adverse Event|0
7615559|NCT01800916|26497677|P2|Test Period 1 (1 Week)|Adverse Event|0
7615560|NCT01800916|26497678|P1|Test Period 1 (1 Week)|Adverse Event|0
7615561|NCT01800916|26497670|P9|Test Period 1 (1 Week)|Convex product user|0
7615562|NCT01800916|26497671|P8|Test Period 1 (1 Week)|Convex product user|0
7615563|NCT01800916|26497672|P7|Test Period 1 (1 Week)|Convex product user|0
7615564|NCT01800916|26497673|P6|Test Period 1 (1 Week)|Convex product user|0
7615565|NCT01800916|26497674|P5|Test Period 1 (1 Week)|Convex product user|0
7615566|NCT01800916|26497675|P4|Test Period 1 (1 Week)|Convex product user|1
7615567|NCT01800916|26497676|P3|Test Period 1 (1 Week)|Convex product user|0
7615568|NCT01800916|26497677|P2|Test Period 1 (1 Week)|Convex product user|0
7615569|NCT01800916|26497678|P1|Test Period 1 (1 Week)|Convex product user|0
7615570|NCT01800903|26497688|P6|Second Test Period|unable to catheterise|0
7615571|NCT01800903|26497689|P5|Second Test Period|unable to catheterise|0
7615572|NCT01800903|26497690|P4|Second Test Period|unable to catheterise|0
7615573|NCT01800903|26497691|P3|Second Test Period|unable to catheterise|0
7615574|NCT01800903|26497692|P2|Second Test Period|unable to catheterise|0
7615575|NCT01800903|26497693|P1|Second Test Period|unable to catheterise|1
7615576|NCT01800201|26497782|P2|Overall Study|PI withdrawal, cognitive concerns|1
7615577|NCT01800201|26497783|P1|Overall Study|PI withdrawal, cognitive concerns|0
7615578|NCT01800201|26497782|P2|Overall Study|did not want to use device|1
7615579|NCT01800201|26497783|P1|Overall Study|did not want to use device|0
7615580|NCT01800201|26497782|P2|Overall Study|patient privacy concerns|1
7615581|NCT01800201|26497783|P1|Overall Study|patient privacy concerns|1
7615582|NCT01800201|26497782|P2|Overall Study|Withdrawal by Subject|0
7615583|NCT01800201|26497783|P1|Overall Study|Withdrawal by Subject|2
7615584|NCT01800058|26497824|P1|Overall Study|Lost to Follow-up|1
7615585|NCT01799993|26497837|P2|Overall Study|Subject didn't return for follow-up|1
7615586|NCT01799993|26497838|P1|Overall Study|Subject didn't return for follow-up|0
7615587|NCT01799993|26497837|P2|Overall Study|Other|0
7615588|NCT01799993|26497838|P1|Overall Study|Other|1
7615589|NCT01799993|26497837|P2|Overall Study|Withdrawal by parent/guardian|1
7615590|NCT01799993|26497838|P1|Overall Study|Withdrawal by parent/guardian|0
7615591|NCT01799993|26497837|P2|Overall Study|Non-compliance with medical device|0
7615592|NCT01799993|26497838|P1|Overall Study|Non-compliance with medical device|1
7615593|NCT01799993|26497837|P2|Overall Study|Protocol deviation|0
7615594|NCT01799993|26497838|P1|Overall Study|Protocol deviation|1
7615595|NCT01799993|26497837|P2|Overall Study|Logistical difficulties|0
7615596|NCT01799993|26497838|P1|Overall Study|Logistical difficulties|1
7615597|NCT01799993|26497837|P2|Overall Study|Recovery|1
7615598|NCT01799993|26497838|P1|Overall Study|Recovery|0
7615599|NCT01799993|26497837|P2|Overall Study|Lack of Efficacy|0
7615600|NCT01799993|26497838|P1|Overall Study|Lack of Efficacy|1
7615601|NCT01799993|26497837|P2|Overall Study|Adverse Event|0
7615602|NCT01799993|26497838|P1|Overall Study|Adverse Event|1
7615603|NCT01799993|26497837|P2|Overall Study|Screen failure|1
7615604|NCT01799993|26497838|P1|Overall Study|Screen failure|0
7615605|NCT01799993|26497837|P2|Overall Study|Deterioration of general conditions|0
7615606|NCT01799993|26497838|P1|Overall Study|Deterioration of general conditions|2
7615607|NCT01799993|26497837|P2|Overall Study|Protocol Violation|1
7615608|NCT01799993|26497838|P1|Overall Study|Protocol Violation|1
7615609|NCT01799993|26497837|P2|Overall Study|Protocol driven decision point|3
7615610|NCT01799993|26497838|P1|Overall Study|Protocol driven decision point|0
7615611|NCT01799993|26497837|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
7615612|NCT01799993|26497838|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
7615613|NCT01799993|26497837|P2|Overall Study|Lost to Follow-up|8
7615614|NCT01799993|26497838|P1|Overall Study|Lost to Follow-up|5
7615615|NCT01799993|26497837|P2|Overall Study|Withdrawal by Subject|24
7615616|NCT01799993|26497838|P1|Overall Study|Withdrawal by Subject|23
7615617|NCT01799993|26497837|P2|Overall Study|Death|45
7615618|NCT01799993|26497838|P1|Overall Study|Death|61
7615619|NCT01799993|26497837|P2|Overall Study|"Didn't complete CRF page End of FU"|40
7615620|NCT01799993|26497838|P1|Overall Study|"Didn't complete CRF page End of FU"|30
7615621|NCT01799941|26497870|P1|Overall Study|Other|15
7615622|NCT01799941|26497870|P1|Overall Study|Lost to Follow-up|17
7615623|NCT01799941|26497870|P1|Overall Study|Lack of Efficacy|3
7615624|NCT01799941|26497870|P1|Overall Study|Investigator Decision|4
7615625|NCT01799941|26497870|P1|Overall Study|Death|2
7615626|NCT01799941|26497870|P1|Overall Study|Withdrawal by Subject|21
7615627|NCT01799941|26497870|P1|Overall Study|Adverse Event|34
7615628|NCT01799889|26497936|P12|Overall Study|Non-Compliance With Study Drug|0
7615629|NCT01799889|26497937|P11|Overall Study|Non-Compliance With Study Drug|0
7615630|NCT01799889|26497938|P10|Overall Study|Non-Compliance With Study Drug|0
7615631|NCT01799889|26497939|P9|Overall Study|Non-Compliance With Study Drug|0
7615632|NCT01799889|26497940|P8|Overall Study|Non-Compliance With Study Drug|0
7615633|NCT01799889|26497941|P7|Overall Study|Non-Compliance With Study Drug|0
7615634|NCT01799889|26497942|P6|Overall Study|Non-Compliance With Study Drug|1
7615635|NCT01799889|26497943|P5|Overall Study|Non-Compliance With Study Drug|0
7615636|NCT01799889|26497944|P4|Overall Study|Non-Compliance With Study Drug|0
7615637|NCT01799889|26497945|P3|Overall Study|Non-Compliance With Study Drug|0
7615638|NCT01799889|26497946|P2|Overall Study|Non-Compliance With Study Drug|0
7615639|NCT01799889|26497947|P1|Overall Study|Non-Compliance With Study Drug|0
7615640|NCT01799889|26497936|P12|Overall Study|Withdrawal by Subject|1
7615641|NCT01799889|26497937|P11|Overall Study|Withdrawal by Subject|1
7615642|NCT01799889|26497938|P10|Overall Study|Withdrawal by Subject|1
7615643|NCT01799889|26497939|P9|Overall Study|Withdrawal by Subject|2
7615644|NCT01799889|26497940|P8|Overall Study|Withdrawal by Subject|1
7615645|NCT01799889|26497941|P7|Overall Study|Withdrawal by Subject|3
7615646|NCT01799889|26497942|P6|Overall Study|Withdrawal by Subject|1
7615647|NCT01799889|26497943|P5|Overall Study|Withdrawal by Subject|5
7615648|NCT01799889|26497944|P4|Overall Study|Withdrawal by Subject|0
7615649|NCT01799889|26497945|P3|Overall Study|Withdrawal by Subject|4
7615650|NCT01799889|26497946|P2|Overall Study|Withdrawal by Subject|6
7615651|NCT01799889|26497947|P1|Overall Study|Withdrawal by Subject|1
7615652|NCT01799889|26497936|P12|Overall Study|Study Terminated By Sponsor|0
7615653|NCT01799889|26497937|P11|Overall Study|Study Terminated By Sponsor|0
7615654|NCT01799889|26497938|P10|Overall Study|Study Terminated By Sponsor|1
7615655|NCT01799889|26497939|P9|Overall Study|Study Terminated By Sponsor|1
7615656|NCT01799889|26497940|P8|Overall Study|Study Terminated By Sponsor|2
7615657|NCT01799889|26497941|P7|Overall Study|Study Terminated By Sponsor|0
7615658|NCT01799889|26497942|P6|Overall Study|Study Terminated By Sponsor|1
7615659|NCT01799889|26497943|P5|Overall Study|Study Terminated By Sponsor|2
7615660|NCT01799889|26497944|P4|Overall Study|Study Terminated By Sponsor|0
7615661|NCT01799889|26497945|P3|Overall Study|Study Terminated By Sponsor|0
7615662|NCT01799889|26497946|P2|Overall Study|Study Terminated By Sponsor|0
7615663|NCT01799889|26497947|P1|Overall Study|Study Terminated By Sponsor|1
7615664|NCT01799889|26497936|P12|Overall Study|Specified Criteria for Withdrawal|0
7615665|NCT01799889|26497937|P11|Overall Study|Specified Criteria for Withdrawal|0
7615666|NCT01799889|26497938|P10|Overall Study|Specified Criteria for Withdrawal|0
7615667|NCT01799889|26497939|P9|Overall Study|Specified Criteria for Withdrawal|0
7615668|NCT01799889|26497940|P8|Overall Study|Specified Criteria for Withdrawal|0
7615669|NCT01799889|26497941|P7|Overall Study|Specified Criteria for Withdrawal|0
7615670|NCT01799889|26497942|P6|Overall Study|Specified Criteria for Withdrawal|0
7615671|NCT01799889|26497943|P5|Overall Study|Specified Criteria for Withdrawal|0
7615672|NCT01799889|26497944|P4|Overall Study|Specified Criteria for Withdrawal|0
7615673|NCT01799889|26497945|P3|Overall Study|Specified Criteria for Withdrawal|1
7615674|NCT01799889|26497946|P2|Overall Study|Specified Criteria for Withdrawal|1
7615675|NCT01799889|26497947|P1|Overall Study|Specified Criteria for Withdrawal|0
7615676|NCT01799889|26497936|P12|Overall Study|Progressive Disease|1
7615677|NCT01799889|26497937|P11|Overall Study|Progressive Disease|3
7615678|NCT01799889|26497938|P10|Overall Study|Progressive Disease|5
7615679|NCT01799889|26497939|P9|Overall Study|Progressive Disease|18
7615680|NCT01799889|26497940|P8|Overall Study|Progressive Disease|13
7615681|NCT01799889|26497941|P7|Overall Study|Progressive Disease|8
7615682|NCT01799889|26497942|P6|Overall Study|Progressive Disease|9
7615683|NCT01799889|26497943|P5|Overall Study|Progressive Disease|23
7615684|NCT01799889|26497944|P4|Overall Study|Progressive Disease|30
7615685|NCT01799889|26497945|P3|Overall Study|Progressive Disease|25
7615686|NCT01799889|26497946|P2|Overall Study|Progressive Disease|26
7615687|NCT01799889|26497947|P1|Overall Study|Progressive Disease|30
7615688|NCT01799889|26497936|P12|Overall Study|Physician Decision|1
7615689|NCT01799889|26497937|P11|Overall Study|Physician Decision|0
7615690|NCT01799889|26497938|P10|Overall Study|Physician Decision|0
7615691|NCT01799889|26497939|P9|Overall Study|Physician Decision|6
7615692|NCT01799889|26497940|P8|Overall Study|Physician Decision|2
7615693|NCT01799889|26497941|P7|Overall Study|Physician Decision|5
7615694|NCT01799889|26497942|P6|Overall Study|Physician Decision|5
7615695|NCT01799889|26497943|P5|Overall Study|Physician Decision|5
7615696|NCT01799889|26497944|P4|Overall Study|Physician Decision|4
7615697|NCT01799889|26497945|P3|Overall Study|Physician Decision|4
7615698|NCT01799889|26497946|P2|Overall Study|Physician Decision|2
7615699|NCT01799889|26497947|P1|Overall Study|Physician Decision|3
7615700|NCT01799889|26497936|P12|Overall Study|Lost to Follow-up|0
7615701|NCT01799889|26497937|P11|Overall Study|Lost to Follow-up|0
7615702|NCT01799889|26497938|P10|Overall Study|Lost to Follow-up|0
7615703|NCT01799889|26497939|P9|Overall Study|Lost to Follow-up|0
7615704|NCT01799889|26497940|P8|Overall Study|Lost to Follow-up|0
7615705|NCT01799889|26497941|P7|Overall Study|Lost to Follow-up|0
7615706|NCT01799889|26497942|P6|Overall Study|Lost to Follow-up|0
7615707|NCT01799889|26497943|P5|Overall Study|Lost to Follow-up|0
7615708|NCT01799889|26497944|P4|Overall Study|Lost to Follow-up|0
7615709|NCT01799889|26497945|P3|Overall Study|Lost to Follow-up|0
7615710|NCT01799889|26497946|P2|Overall Study|Lost to Follow-up|1
7615711|NCT01799889|26497947|P1|Overall Study|Lost to Follow-up|0
7615712|NCT01799889|26497936|P12|Overall Study|Lack of Efficacy|0
7615713|NCT01799889|26497937|P11|Overall Study|Lack of Efficacy|1
7615714|NCT01799889|26497938|P10|Overall Study|Lack of Efficacy|0
7615715|NCT01799889|26497939|P9|Overall Study|Lack of Efficacy|2
7615716|NCT01799889|26497940|P8|Overall Study|Lack of Efficacy|0
7615717|NCT01799889|26497941|P7|Overall Study|Lack of Efficacy|0
7615718|NCT01799889|26497942|P6|Overall Study|Lack of Efficacy|2
7615719|NCT01799889|26497943|P5|Overall Study|Lack of Efficacy|2
7615720|NCT01799889|26497944|P4|Overall Study|Lack of Efficacy|1
7615721|NCT01799889|26497945|P3|Overall Study|Lack of Efficacy|0
7615722|NCT01799889|26497946|P2|Overall Study|Lack of Efficacy|1
7615723|NCT01799889|26497947|P1|Overall Study|Lack of Efficacy|1
7615724|NCT01799889|26497936|P12|Overall Study|Death|0
7615725|NCT01799889|26497937|P11|Overall Study|Death|1
7615726|NCT01799889|26497938|P10|Overall Study|Death|0
7615727|NCT01799889|26497939|P9|Overall Study|Death|1
7615728|NCT01799889|26497940|P8|Overall Study|Death|0
7615729|NCT01799889|26497941|P7|Overall Study|Death|0
7615730|NCT01799889|26497942|P6|Overall Study|Death|0
7615731|NCT01799889|26497943|P5|Overall Study|Death|1
7615732|NCT01799889|26497944|P4|Overall Study|Death|3
7615733|NCT01799889|26497945|P3|Overall Study|Death|5
7615734|NCT01799889|26497946|P2|Overall Study|Death|0
7615735|NCT01799889|26497947|P1|Overall Study|Death|1
7615736|NCT01799889|26497936|P12|Overall Study|Adverse Event|0
7615737|NCT01799889|26497937|P11|Overall Study|Adverse Event|1
7615738|NCT01799889|26497938|P10|Overall Study|Adverse Event|1
7615739|NCT01799889|26497939|P9|Overall Study|Adverse Event|3
7615740|NCT01799889|26497940|P8|Overall Study|Adverse Event|2
7615741|NCT01799889|26497941|P7|Overall Study|Adverse Event|5
7615742|NCT01799889|26497942|P6|Overall Study|Adverse Event|1
7615743|NCT01799889|26497943|P5|Overall Study|Adverse Event|11
7615744|NCT01799889|26497944|P4|Overall Study|Adverse Event|1
7615745|NCT01799889|26497945|P3|Overall Study|Adverse Event|5
7615746|NCT01799889|26497946|P2|Overall Study|Adverse Event|4
7615747|NCT01799889|26497947|P1|Overall Study|Adverse Event|4
7615748|NCT01799720|26498048|P3|Overall Study|Pregnancy|1
7615749|NCT01799720|26498049|P2|Overall Study|Pregnancy|0
7615750|NCT01799720|26498050|P1|Overall Study|Pregnancy|0
7615751|NCT01799720|26498048|P3|Overall Study|Protocol Violation|0
7615752|NCT01799720|26498049|P2|Overall Study|Protocol Violation|1
7615753|NCT01799720|26498050|P1|Overall Study|Protocol Violation|0
7615754|NCT01799720|26498048|P3|Overall Study|Withdrawal by Subject|0
7615755|NCT01799720|26498049|P2|Overall Study|Withdrawal by Subject|0
7615756|NCT01799720|26498050|P1|Overall Study|Withdrawal by Subject|3
7615757|NCT01799590|26498088|P3|Overall Study|Other|1
7615758|NCT01799590|26498089|P2|Overall Study|Other|0
7615759|NCT01799590|26498090|P1|Overall Study|Other|3
7615760|NCT01799590|26498088|P3|Overall Study|Use of prohibited concomitant drugs|0
7615761|NCT01799590|26498089|P2|Overall Study|Use of prohibited concomitant drugs|0
7615762|NCT01799590|26498090|P1|Overall Study|Use of prohibited concomitant drugs|1
7615763|NCT01799590|26498088|P3|Overall Study|Using drugs with restricted days of use|2
7615764|NCT01799590|26498089|P2|Overall Study|Using drugs with restricted days of use|3
7615765|NCT01799590|26498090|P1|Overall Study|Using drugs with restricted days of use|0
7615766|NCT01799590|26498088|P3|Overall Study|Aggravation of complications|1
7615767|NCT01799590|26498089|P2|Overall Study|Aggravation of complications|1
7615768|NCT01799590|26498090|P1|Overall Study|Aggravation of complications|0
7615769|NCT01799590|26498088|P3|Overall Study|Participants convenience|2
7615770|NCT01799590|26498089|P2|Overall Study|Participants convenience|4
7615771|NCT01799590|26498090|P1|Overall Study|Participants convenience|4
7615772|NCT01799590|26498088|P3|Overall Study|Lack of Efficacy|3
7615773|NCT01799590|26498089|P2|Overall Study|Lack of Efficacy|1
7615774|NCT01799590|26498090|P1|Overall Study|Lack of Efficacy|3
7615775|NCT01799590|26498088|P3|Overall Study|Pregnancy|0
7615776|NCT01799590|26498089|P2|Overall Study|Pregnancy|0
7615777|NCT01799590|26498090|P1|Overall Study|Pregnancy|2
7615778|NCT01799590|26498088|P3|Overall Study|Adverse Event|5
7615779|NCT01799590|26498089|P2|Overall Study|Adverse Event|7
7615780|NCT01799590|26498090|P1|Overall Study|Adverse Event|13
7615781|NCT01799239|26498133|P2|Period 2 (7 Days)|Protocol Violation|0
7615782|NCT01799239|26498134|P1|Period 2 (7 Days)|Protocol Violation|1
7615783|NCT01799239|26498133|P2|Period 2 (7 Days)|Withdrawal by Subject|1
7615784|NCT01799239|26498134|P1|Period 2 (7 Days)|Withdrawal by Subject|1
7615785|NCT01799239|26498133|P2|Period 1 (7 Days)|Protocol Violation|1
7615786|NCT01799239|26498134|P1|Period 1 (7 Days)|Protocol Violation|0
7615787|NCT01799239|26498133|P2|Period 1 (7 Days)|Withdrawal by Subject|0
7615788|NCT01799239|26498134|P1|Period 1 (7 Days)|Withdrawal by Subject|2
7615789|NCT01799239|26498133|P2|Period 1 (7 Days)|Lack of Efficacy|0
7615790|NCT01799239|26498134|P1|Period 1 (7 Days)|Lack of Efficacy|1
7615791|NCT01799226|26498142|P2|Overall Study|Disqualified at Day 14|0
7615792|NCT01799226|26498143|P1|Overall Study|Disqualified at Day 14|1
7615793|NCT01799226|26498142|P2|Overall Study|Withdrawal by Subject|0
7615794|NCT01799226|26498143|P1|Overall Study|Withdrawal by Subject|1
7615795|NCT01798992|26498181|P4|Overall Study|Insufficient biopsy tissue|0
7615796|NCT01798992|26498182|P3|Overall Study|Insufficient biopsy tissue|1
7615797|NCT01798992|26498183|P2|Overall Study|Insufficient biopsy tissue|0
7615798|NCT01798992|26498184|P1|Overall Study|Insufficient biopsy tissue|0
7615799|NCT01798992|26498181|P4|Overall Study|Lost to Follow-up|0
7615800|NCT01798992|26498182|P3|Overall Study|Lost to Follow-up|1
7615801|NCT01798992|26498183|P2|Overall Study|Lost to Follow-up|1
7615802|NCT01798992|26498184|P1|Overall Study|Lost to Follow-up|0
7615803|NCT01798992|26498181|P4|Overall Study|Administrative withdrawal|1
7615804|NCT01798992|26498182|P3|Overall Study|Administrative withdrawal|0
7615805|NCT01798992|26498183|P2|Overall Study|Administrative withdrawal|1
7615806|NCT01798992|26498184|P1|Overall Study|Administrative withdrawal|0
7615807|NCT01798927|26498204|P1|Overall Study|Withdrawal by Subject|1
7615808|NCT01798849|26498213|P3|Overall Study|Physician Decision|1
7615809|NCT01798849|26498214|P2|Overall Study|Physician Decision|0
7615810|NCT01798849|26498215|P1|Overall Study|Physician Decision|0
7615811|NCT01798706|26498405|P2|Overall Study|Other than specified above|9
7615812|NCT01798706|26498406|P1|Overall Study|Other than specified above|5
7615813|NCT01798706|26498405|P2|Overall Study|Poor compliance to protocol|0
7615814|NCT01798706|26498406|P1|Overall Study|Poor compliance to protocol|1
7615815|NCT01798706|26498405|P2|Overall Study|Lack of Efficacy|2
7615816|NCT01798706|26498406|P1|Overall Study|Lack of Efficacy|0
7615817|NCT01798706|26498405|P2|Overall Study|Adverse Event|10
7615818|NCT01798706|26498406|P1|Overall Study|Adverse Event|15
7615819|NCT01798485|26498477|P2|Overall Study|Clinical Progression|24
7615820|NCT01798485|26498478|P1|Overall Study|Clinical Progression|35
7615821|NCT01798485|26498477|P2|Overall Study|Sponsor Decision|54
7615822|NCT01798485|26498478|P1|Overall Study|Sponsor Decision|61
7615823|NCT01798485|26498477|P2|Overall Study|Death|22
7615824|NCT01798485|26498478|P1|Overall Study|Death|25
7615825|NCT01798485|26498477|P2|Overall Study|Objective Disease Progression|106
7615826|NCT01798485|26498478|P1|Overall Study|Objective Disease Progression|152
7615827|NCT01798485|26498477|P2|Overall Study|Physician Decision|10
7615828|NCT01798485|26498478|P1|Overall Study|Physician Decision|14
7615829|NCT01798485|26498477|P2|Overall Study|Lost to Follow-up|3
7615830|NCT01798485|26498478|P1|Overall Study|Lost to Follow-up|0
7615831|NCT01798485|26498477|P2|Overall Study|Withdrawal by Subject|31
7615832|NCT01798485|26498478|P1|Overall Study|Withdrawal by Subject|27
7615833|NCT01798485|26498477|P2|Overall Study|Adverse Event|40
7615834|NCT01798485|26498478|P1|Overall Study|Adverse Event|32
7615835|NCT01798134|26498615|P1|Overall Study|Liver transplant/surgery|4
7615836|NCT01798134|26498615|P1|Overall Study|Physician Decision|3
7615837|NCT01798134|26498615|P1|Overall Study|Adverse Event|3
7615838|NCT01798134|26498615|P1|Overall Study|Death|2
7615839|NCT01798134|26498615|P1|Overall Study|Withdrawal by Subject|3
7615840|NCT01798134|26498615|P1|Overall Study|Lost to Follow-up|1
7615841|NCT01798056|26498624|P2|Overall Study|Other|2
7615842|NCT01798056|26498625|P1|Overall Study|Other|0
7615843|NCT01798056|26498624|P2|Overall Study|Lost to Follow-up|1
7615844|NCT01798056|26498625|P1|Overall Study|Lost to Follow-up|1
7615845|NCT01798056|26498624|P2|Overall Study|Migrated/moved from study area|1
7615846|NCT01798056|26498625|P1|Overall Study|Migrated/moved from study area|1
7615847|NCT01798056|26498624|P2|Overall Study|Withdrawal by Subject|9
7615848|NCT01798056|26498625|P1|Overall Study|Withdrawal by Subject|12
7615849|NCT01798056|26498624|P2|Overall Study|Serious Adverse Event|12
7615850|NCT01798056|26498625|P1|Overall Study|Serious Adverse Event|13
7615851|NCT01798004|26498659|P1|Overall Study|Enrollment another COG therapeutic trial|32
7615852|NCT01798004|26498659|P1|Overall Study|Initiation of other non-protocol therapy|5
7615853|NCT01798004|26498659|P1|Overall Study|Patient/parent refusal|7
7615854|NCT01798004|26498659|P1|Overall Study|Ineligible|4
7615855|NCT01798004|26498659|P1|Overall Study|Withdrawal by Subject|4
7615856|NCT01798004|26498659|P1|Overall Study|Physician Decision|25
7615857|NCT01798004|26498659|P1|Overall Study|Lack of Efficacy|8
7615858|NCT01798004|26498659|P1|Overall Study|Death|2
7615859|NCT01797965|26498667|P4|Overall Study|Reason Not Specified|15
7615860|NCT01797965|26498668|P3|Overall Study|Reason Not Specified|0
7615861|NCT01797965|26498669|P2|Overall Study|Reason Not Specified|295
7615862|NCT01797965|26498670|P1|Overall Study|Reason Not Specified|280
7615863|NCT01797965|26498667|P4|Overall Study|Disease progression, defined by protocol|0
7615864|NCT01797965|26498668|P3|Overall Study|Disease progression, defined by protocol|0
7615865|NCT01797965|26498669|P2|Overall Study|Disease progression, defined by protocol|1
7615866|NCT01797965|26498670|P1|Overall Study|Disease progression, defined by protocol|3
7615867|NCT01797965|26498667|P4|Overall Study|Death|0
7615868|NCT01797965|26498668|P3|Overall Study|Death|0
7615869|NCT01797965|26498669|P2|Overall Study|Death|4
7615870|NCT01797965|26498670|P1|Overall Study|Death|2
7615871|NCT01797965|26498667|P4|Overall Study|Investigator decision|0
7615872|NCT01797965|26498668|P3|Overall Study|Investigator decision|0
7615873|NCT01797965|26498669|P2|Overall Study|Investigator decision|15
7615874|NCT01797965|26498670|P1|Overall Study|Investigator decision|21
7615875|NCT01797965|26498667|P4|Overall Study|Consent withdrawn|35
7615876|NCT01797965|26498668|P3|Overall Study|Consent withdrawn|3
7615877|NCT01797965|26498669|P2|Overall Study|Consent withdrawn|117
7615878|NCT01797965|26498670|P1|Overall Study|Consent withdrawn|130
7615879|NCT01797965|26498667|P4|Overall Study|Lost to Follow-up|2
7615880|NCT01797965|26498668|P3|Overall Study|Lost to Follow-up|1
7615881|NCT01797965|26498669|P2|Overall Study|Lost to Follow-up|8
7615882|NCT01797965|26498670|P1|Overall Study|Lost to Follow-up|9
7615883|NCT01797965|26498667|P4|Overall Study|Adverse Event|21
7615884|NCT01797965|26498668|P3|Overall Study|Adverse Event|4
7615885|NCT01797965|26498669|P2|Overall Study|Adverse Event|129
7615886|NCT01797965|26498670|P1|Overall Study|Adverse Event|104
7615887|NCT01797835|26498804|P2|Overall Study|Lost to Follow-up|27
7615888|NCT01797835|26498805|P1|Overall Study|Lost to Follow-up|31
7615889|NCT01797783|26498821|P2|Overall Study|Withdrawal by Subject|0
7615890|NCT01797783|26498822|P1|Overall Study|Withdrawal by Subject|1
7615891|NCT01797783|26498821|P2|Overall Study|Adverse Event|1
7615892|NCT01797783|26498822|P1|Overall Study|Adverse Event|1
7615893|NCT01797731|26498846|P2|Overall Study|Didn't have proper radiographs required|3
7615894|NCT01797731|26498847|P1|Overall Study|Didn't have proper radiographs required|3
7615895|NCT01797705|26498855|P1|Overall Study|Withdrawal by Subject|1
7615896|NCT01797705|26498855|P1|Overall Study|Equipment anomalies during sleep studies|4
7615897|NCT01797562|26498916|P1|Overall Study|Protocol Violation|5
7615898|NCT01797536|26498925|P4|Overall Study|Adverse Event|0
7615899|NCT01797536|26498926|P3|Overall Study|Adverse Event|0
7615900|NCT01797536|26498927|P2|Overall Study|Adverse Event|1
7615901|NCT01797536|26498928|P1|Overall Study|Adverse Event|0
7615902|NCT01797445|26499000|P2|Open-Label Extension Phase|Investigator's Discretion|0
7615903|NCT01797445|26499001|P1|Open-Label Extension Phase|Investigator's Discretion|1
7615904|NCT01797445|26499000|P2|Double-Blind Phase|Lost to Follow-up|26
7615905|NCT01797445|26499001|P1|Double-Blind Phase|Lost to Follow-up|34
7615906|NCT01797445|26499000|P2|Double-Blind Phase|Withdrew Consent|35
7615907|NCT01797445|26499001|P1|Double-Blind Phase|Withdrew Consent|20
7615908|NCT01797445|26499000|P2|Double-Blind Phase|Protocol Violation|1
7615909|NCT01797445|26499001|P1|Double-Blind Phase|Protocol Violation|0
7615910|NCT01797445|26499000|P2|Double-Blind Phase|Noncompliance with Study Drug|1
7615911|NCT01797445|26499001|P1|Double-Blind Phase|Noncompliance with Study Drug|5
7615912|NCT01797445|26499000|P2|Double-Blind Phase|Investigator's Discretion|17
7615913|NCT01797445|26499001|P1|Double-Blind Phase|Investigator's Discretion|15
7615914|NCT01797445|26499000|P2|Double-Blind Phase|Lack of Efficacy|2
7615915|NCT01797445|26499001|P1|Double-Blind Phase|Lack of Efficacy|1
7615916|NCT01797445|26499000|P2|Double-Blind Phase|Pregnancy|1
7615917|NCT01797445|26499001|P1|Double-Blind Phase|Pregnancy|0
7615918|NCT01797445|26499000|P2|Double-Blind Phase|Death|4
7615919|NCT01797445|26499001|P1|Double-Blind Phase|Death|5
7615920|NCT01797445|26499000|P2|Double-Blind Phase|Adverse Event|0
7615921|NCT01797445|26499001|P1|Double-Blind Phase|Adverse Event|3
7615922|NCT01797445|26499000|P2|Double-Blind Phase|Randomized but Not Treated|2
7615923|NCT01797445|26499001|P1|Double-Blind Phase|Randomized but Not Treated|4
7615924|NCT01797432|26499041|P1|Overall Study|lived too far from study site|1
7615925|NCT01797432|26499041|P1|Overall Study|Withdrawal by Subject|1
7615926|NCT01797432|26499041|P1|Overall Study|Adverse Event|1
7615927|NCT01797432|26499041|P1|Overall Study|Lost to Follow-up|1
7615928|NCT01797302|26499067|P3|Overall Study|Withdrawal by Subject|4
7615929|NCT01797302|26499068|P2|Overall Study|Withdrawal by Subject|3
7615930|NCT01797302|26499069|P1|Overall Study|Withdrawal by Subject|1
7615931|NCT01797302|26499067|P3|Overall Study|Lost to Follow-up|22
7615932|NCT01797302|26499068|P2|Overall Study|Lost to Follow-up|23
7615933|NCT01797302|26499069|P1|Overall Study|Lost to Follow-up|16
7615934|NCT01797263|26499106|P2|Overall Study|Lost to Follow-up|15
7615935|NCT01797263|26499107|P1|Overall Study|Lost to Follow-up|15
7615936|NCT01797263|26499106|P2|Overall Study|Death|0
7615937|NCT01797263|26499107|P1|Overall Study|Death|1
7615938|NCT01797263|26499106|P2|Overall Study|Withdrawal by Subject|25
7615939|NCT01797263|26499107|P1|Overall Study|Withdrawal by Subject|21
7615940|NCT01797185|26499142|P3|Overall Study|Protocol Violation|0
7615941|NCT01797185|26499143|P2|Overall Study|Protocol Violation|1
7615942|NCT01797185|26499144|P1|Overall Study|Protocol Violation|1
7615943|NCT01797185|26499142|P3|Overall Study|Physician Decision|0
7615944|NCT01797185|26499143|P2|Overall Study|Physician Decision|3
7615945|NCT01797185|26499144|P1|Overall Study|Physician Decision|1
7615946|NCT01797185|26499142|P3|Overall Study|Withdrawn per sponsor|0
7615947|NCT01797185|26499143|P2|Overall Study|Withdrawn per sponsor|0
7615948|NCT01797185|26499144|P1|Overall Study|Withdrawn per sponsor|5
7615949|NCT01797185|26499142|P3|Overall Study|Lost to Follow-up|1
7615950|NCT01797185|26499143|P2|Overall Study|Lost to Follow-up|6
7615951|NCT01797185|26499144|P1|Overall Study|Lost to Follow-up|2
7615952|NCT01797185|26499142|P3|Overall Study|Site terminated|0
7615953|NCT01797185|26499143|P2|Overall Study|Site terminated|4
7615954|NCT01797185|26499144|P1|Overall Study|Site terminated|8
7615955|NCT01797185|26499142|P3|Overall Study|Withdrawal by Subject|5
7615956|NCT01797185|26499143|P2|Overall Study|Withdrawal by Subject|9
7615957|NCT01797185|26499144|P1|Overall Study|Withdrawal by Subject|6
7615958|NCT01797185|26499142|P3|Overall Study|Adverse Event|6
7615959|NCT01797185|26499143|P2|Overall Study|Adverse Event|15
7615960|NCT01797185|26499144|P1|Overall Study|Adverse Event|5
7615961|NCT01797120|26499168|P2|Overall Study|never start protocol therapy|0
7615962|NCT01797120|26499169|P1|Overall Study|never start protocol therapy|2
7615963|NCT01797120|26499168|P2|Overall Study|still on treatment|4
7615964|NCT01797120|26499169|P1|Overall Study|still on treatment|2
7615965|NCT01797120|26499168|P2|Overall Study|Physician Decision|0
7615966|NCT01797120|26499169|P1|Overall Study|Physician Decision|3
7615967|NCT01797120|26499168|P2|Overall Study|Non-compliance|0
7615968|NCT01797120|26499169|P1|Overall Study|Non-compliance|1
7615969|NCT01797120|26499168|P2|Overall Study|Symptomatic progression|1
7615970|NCT01797120|26499169|P1|Overall Study|Symptomatic progression|2
7615971|NCT01797120|26499168|P2|Overall Study|Withdrawal by Subject|6
7615972|NCT01797120|26499169|P1|Overall Study|Withdrawal by Subject|6
7615973|NCT01797120|26499168|P2|Overall Study|Adverse Event|5
7615974|NCT01797120|26499169|P1|Overall Study|Adverse Event|13
7615975|NCT01797120|26499168|P2|Overall Study|Disesae progression|49
7615976|NCT01797120|26499169|P1|Overall Study|Disesae progression|37
7615977|NCT01797094|26499183|P2|Overall Study|Other Miscellaneous Reasons|0
7615978|NCT01797094|26499184|P1|Overall Study|Other Miscellaneous Reasons|1
7615979|NCT01797094|26499183|P2|Overall Study|Protocol Violation|1
7615980|NCT01797094|26499184|P1|Overall Study|Protocol Violation|0
7615981|NCT01797094|26499183|P2|Overall Study|Personal Reasons|0
7615982|NCT01797094|26499184|P1|Overall Study|Personal Reasons|4
7615983|NCT01797094|26499183|P2|Overall Study|Adverse Event|1
7615984|NCT01797094|26499184|P1|Overall Study|Adverse Event|1
7615985|NCT01797081|26499206|P4|Overall Study|Protocol Violation|1
7615986|NCT01797081|26499207|P3|Overall Study|Protocol Violation|0
7615987|NCT01797081|26499208|P2|Overall Study|Protocol Violation|0
7615988|NCT01797081|26499209|P1|Overall Study|Protocol Violation|0
7615989|NCT01797081|26499206|P4|Overall Study|Personal Reasons|8
7615990|NCT01797081|26499207|P3|Overall Study|Personal Reasons|4
7615991|NCT01797081|26499208|P2|Overall Study|Personal Reasons|4
7615992|NCT01797081|26499209|P1|Overall Study|Personal Reasons|12
7615993|NCT01797081|26499206|P4|Overall Study|Pregnancy|0
7615994|NCT01797081|26499207|P3|Overall Study|Pregnancy|0
7615995|NCT01797081|26499208|P2|Overall Study|Pregnancy|0
7615996|NCT01797081|26499209|P1|Overall Study|Pregnancy|1
7615997|NCT01797081|26499206|P4|Overall Study|Adverse Event|0
7615998|NCT01797081|26499207|P3|Overall Study|Adverse Event|1
7615999|NCT01797081|26499208|P2|Overall Study|Adverse Event|0
7616000|NCT01797081|26499209|P1|Overall Study|Adverse Event|1
7616001|NCT01796964|26499250|P2|Overall Study|Withdrawal by Subject|1
7616002|NCT01796964|26499251|P1|Overall Study|Withdrawal by Subject|1
7616003|NCT01796964|26499250|P2|Overall Study|Protocol Violation|1
7616004|NCT01796964|26499251|P1|Overall Study|Protocol Violation|0
7616005|NCT01796964|26499250|P2|Overall Study|Death|0
7616006|NCT01796964|26499251|P1|Overall Study|Death|1
7616007|NCT01796964|26499250|P2|Overall Study|Adverse Event|1
7616008|NCT01796964|26499251|P1|Overall Study|Adverse Event|1
7616009|NCT01796860|26499292|P1|Overall Study|Withdrawal by Subject|3
7616010|NCT01796548|26499317|P1|Overall Study|Other|2
7616011|NCT01796548|26499317|P1|Overall Study|Lost to Follow-up|1
7616012|NCT01796470|26499334|P5|Overall Study|Withdrawal by Subject|1
7616013|NCT01796470|26499335|P4|Overall Study|Withdrawal by Subject|0
7616014|NCT01796470|26499336|P3|Overall Study|Withdrawal by Subject|0
7616015|NCT01796470|26499337|P2|Overall Study|Withdrawal by Subject|0
7616016|NCT01796470|26499338|P1|Overall Study|Withdrawal by Subject|7
7616017|NCT01796470|26499334|P5|Overall Study|Protocol Criteria for Withdrawal|0
7616018|NCT01796470|26499335|P4|Overall Study|Protocol Criteria for Withdrawal|0
7616019|NCT01796470|26499336|P3|Overall Study|Protocol Criteria for Withdrawal|0
7616020|NCT01796470|26499337|P2|Overall Study|Protocol Criteria for Withdrawal|0
7616021|NCT01796470|26499338|P1|Overall Study|Protocol Criteria for Withdrawal|1
7616022|NCT01796470|26499334|P5|Overall Study|Progressive Disease|0
7616023|NCT01796470|26499335|P4|Overall Study|Progressive Disease|2
7616024|NCT01796470|26499336|P3|Overall Study|Progressive Disease|3
7616025|NCT01796470|26499337|P2|Overall Study|Progressive Disease|7
7616026|NCT01796470|26499338|P1|Overall Study|Progressive Disease|7
7616027|NCT01796470|26499334|P5|Overall Study|Physician Decision|1
7616028|NCT01796470|26499335|P4|Overall Study|Physician Decision|0
7616029|NCT01796470|26499336|P3|Overall Study|Physician Decision|1
7616030|NCT01796470|26499337|P2|Overall Study|Physician Decision|4
7616031|NCT01796470|26499338|P1|Overall Study|Physician Decision|5
7616032|NCT01796470|26499334|P5|Overall Study|Lost to Follow-up|0
7616033|NCT01796470|26499335|P4|Overall Study|Lost to Follow-up|0
7616034|NCT01796470|26499336|P3|Overall Study|Lost to Follow-up|0
7616035|NCT01796470|26499337|P2|Overall Study|Lost to Follow-up|1
7616036|NCT01796470|26499338|P1|Overall Study|Lost to Follow-up|0
7616037|NCT01796470|26499334|P5|Overall Study|Initiated New Therapy|2
7616038|NCT01796470|26499335|P4|Overall Study|Initiated New Therapy|0
7616039|NCT01796470|26499336|P3|Overall Study|Initiated New Therapy|0
7616040|NCT01796470|26499337|P2|Overall Study|Initiated New Therapy|0
7616041|NCT01796470|26499338|P1|Overall Study|Initiated New Therapy|9
7616042|NCT01796470|26499334|P5|Overall Study|Death|1
7616043|NCT01796470|26499335|P4|Overall Study|Death|0
7616044|NCT01796470|26499336|P3|Overall Study|Death|0
7616045|NCT01796470|26499337|P2|Overall Study|Death|0
7616046|NCT01796470|26499338|P1|Overall Study|Death|2
7616047|NCT01796470|26499334|P5|Overall Study|Adverse Event|3
7616048|NCT01796470|26499335|P4|Overall Study|Adverse Event|1
7616049|NCT01796470|26499336|P3|Overall Study|Adverse Event|2
7616050|NCT01796470|26499337|P2|Overall Study|Adverse Event|2
7616051|NCT01796470|26499338|P1|Overall Study|Adverse Event|4
7616052|NCT01796392|26499382|P2|Overall Study|Lost to Follow-up|0
7616053|NCT01796392|26499383|P1|Overall Study|Lost to Follow-up|1
7616054|NCT01796392|26499382|P2|Overall Study|Excluded for medical reasons|2
7616055|NCT01796392|26499383|P1|Overall Study|Excluded for medical reasons|1
7616056|NCT01796392|26499382|P2|Overall Study|Death|1
7616057|NCT01796392|26499383|P1|Overall Study|Death|5
7616058|NCT01796392|26499382|P2|Overall Study|Withdrawal by Subject|0
7616059|NCT01796392|26499383|P1|Overall Study|Withdrawal by Subject|2
7616060|NCT01796301|26499397|P2|Overall Study|Decision by Sponsor|1
7616061|NCT01796301|26499398|P1|Overall Study|Decision by Sponsor|0
7616062|NCT01796301|26499397|P2|Overall Study|Death|1
7616063|NCT01796301|26499398|P1|Overall Study|Death|0
7616064|NCT01796301|26499397|P2|Overall Study|Lost to Follow-up|3
7616065|NCT01796301|26499398|P1|Overall Study|Lost to Follow-up|3
7616066|NCT01796301|26499397|P2|Overall Study|Withdrawal by Subject|15
7616067|NCT01796301|26499398|P1|Overall Study|Withdrawal by Subject|15
7616068|NCT01796197|26499481|P1|Overall Study|Lack of Efficacy|1
7616069|NCT01796197|26499481|P1|Overall Study|Lost to Follow-up|1
7616070|NCT01795937|26499497|P3|Overall Study|Physician Decision|0
7616071|NCT01795937|26499498|P2|Overall Study|Physician Decision|1
7616072|NCT01795937|26499499|P1|Overall Study|Physician Decision|0
7616073|NCT01795937|26499497|P3|Overall Study|Withdrawal by Subject|0
7616074|NCT01795937|26499498|P2|Overall Study|Withdrawal by Subject|0
7616075|NCT01795937|26499499|P1|Overall Study|Withdrawal by Subject|1
7616076|NCT01795898|26499528|P1|Overall Study|Physician Decision|1
7616077|NCT01795898|26499528|P1|Overall Study|Withdrew consent & had adverse events|3
7616078|NCT01795898|26499528|P1|Overall Study|Death|1
7616079|NCT01795898|26499528|P1|Overall Study|No pain|1
7616080|NCT01795898|26499528|P1|Overall Study|Diagnosed with metastasis|1
7616081|NCT01795898|26499528|P1|Overall Study|Withdrawal of consent|6
7616082|NCT01795898|26499528|P1|Overall Study|Lost to Follow-up|20
7616083|NCT01795898|26499528|P1|Overall Study|Adverse Event|27
7616084|NCT01795638|26499587|P2|Overall Study|Withdrawal by Subject|0
7616085|NCT01795638|26499588|P1|Overall Study|Withdrawal by Subject|1
7616086|NCT01795638|26499587|P2|Overall Study|discharged from hospital|5
7616087|NCT01795638|26499588|P1|Overall Study|discharged from hospital|7
7616088|NCT01795638|26499587|P2|Overall Study|Protocol Violation|0
7616089|NCT01795638|26499588|P1|Overall Study|Protocol Violation|3
7616090|NCT01795638|26499587|P2|Overall Study|transferred to quaternary hospital|3
7616091|NCT01795638|26499588|P1|Overall Study|transferred to quaternary hospital|2
7616092|NCT01795638|26499587|P2|Overall Study|Death|3
7616093|NCT01795638|26499588|P1|Overall Study|Death|0
7616094|NCT01795547|26499614|P2|Overall Study|Not stated|1
7616095|NCT01795547|26499615|P1|Overall Study|Not stated|0
7616096|NCT01795547|26499614|P2|Overall Study|Others|1
7616097|NCT01795547|26499615|P1|Overall Study|Others|4
7616098|NCT01795547|26499614|P2|Overall Study|Non-compliance with IMP|1
7616099|NCT01795547|26499615|P1|Overall Study|Non-compliance with IMP|1
7616100|NCT01795547|26499614|P2|Overall Study|Not Treated|10
7616101|NCT01795547|26499615|P1|Overall Study|Not Treated|4
7616102|NCT01795547|26499614|P2|Overall Study|Withdrawal of consent|12
7616103|NCT01795547|26499615|P1|Overall Study|Withdrawal of consent|7
7616104|NCT01795547|26499614|P2|Overall Study|Lost to Follow-up|5
7616105|NCT01795547|26499615|P1|Overall Study|Lost to Follow-up|2
7616106|NCT01795547|26499614|P2|Overall Study|Protocol Violation|4
7616107|NCT01795547|26499615|P1|Overall Study|Protocol Violation|6
7616108|NCT01795547|26499614|P2|Overall Study|Lack of Efficacy|3
7616109|NCT01795547|26499615|P1|Overall Study|Lack of Efficacy|8
7616110|NCT01795547|26499614|P2|Overall Study|Adverse Event|27
7616111|NCT01795547|26499615|P1|Overall Study|Adverse Event|16
7616112|NCT01795495|26499647|P3|Overall Study|Physician Decision|1
7616113|NCT01795495|26499648|P2|Overall Study|Physician Decision|0
7616114|NCT01795495|26499649|P1|Overall Study|Physician Decision|0
7616115|NCT01795495|26499647|P3|Overall Study|Protocol Violation|1
7616116|NCT01795495|26499648|P2|Overall Study|Protocol Violation|0
7616117|NCT01795495|26499649|P1|Overall Study|Protocol Violation|1
7616118|NCT01794949|26499686|P2|Overall Study|Lost to Follow-up|0
7616119|NCT01794949|26499687|P1|Overall Study|Lost to Follow-up|1
7616120|NCT01794923|26499701|P3|Overall Study|Adverse Event|1
7616121|NCT01794923|26499702|P2|Overall Study|Adverse Event|0
7616122|NCT01794923|26499703|P1|Overall Study|Adverse Event|0
7616123|NCT01794845|26499744|P1|Overall Study|Withdrawal by Subject|1
7616124|NCT01794780|26499772|P8|Overall Study|Other|1
7616125|NCT01794780|26499773|P7|Overall Study|Other|4
7616126|NCT01794780|26499774|P6|Overall Study|Other|24
7616127|NCT01794780|26499775|P5|Overall Study|Other|1
7616128|NCT01794780|26499776|P4|Overall Study|Other|20
7616129|NCT01794780|26499777|P3|Overall Study|Other|25
7616130|NCT01794780|26499778|P2|Overall Study|Other|12
7616131|NCT01794780|26499779|P1|Overall Study|Other|0
7616132|NCT01794780|26499772|P8|Overall Study|Withdrew informed consent|3
7616133|NCT01794780|26499773|P7|Overall Study|Withdrew informed consent|4
7616134|NCT01794780|26499774|P6|Overall Study|Withdrew informed consent|48
7616135|NCT01794780|26499775|P5|Overall Study|Withdrew informed consent|0
7616136|NCT01794780|26499776|P4|Overall Study|Withdrew informed consent|9
7616137|NCT01794780|26499777|P3|Overall Study|Withdrew informed consent|36
7616138|NCT01794780|26499778|P2|Overall Study|Withdrew informed consent|17
7616139|NCT01794780|26499779|P1|Overall Study|Withdrew informed consent|7
7616140|NCT01794780|26499772|P8|Overall Study|Lost to Follow-up|5
7616141|NCT01794780|26499773|P7|Overall Study|Lost to Follow-up|30
7616142|NCT01794780|26499774|P6|Overall Study|Lost to Follow-up|99
7616143|NCT01794780|26499775|P5|Overall Study|Lost to Follow-up|2
7616144|NCT01794780|26499776|P4|Overall Study|Lost to Follow-up|53
7616145|NCT01794780|26499777|P3|Overall Study|Lost to Follow-up|165
7616146|NCT01794780|26499778|P2|Overall Study|Lost to Follow-up|64
7616147|NCT01794780|26499779|P1|Overall Study|Lost to Follow-up|10
7616148|NCT01794780|26499772|P8|Overall Study|Death|0
7616149|NCT01794780|26499773|P7|Overall Study|Death|4
7616150|NCT01794780|26499774|P6|Overall Study|Death|9
7616151|NCT01794780|26499775|P5|Overall Study|Death|0
7616152|NCT01794780|26499776|P4|Overall Study|Death|1
7616153|NCT01794780|26499777|P3|Overall Study|Death|14
7616154|NCT01794780|26499778|P2|Overall Study|Death|2
7616155|NCT01794780|26499779|P1|Overall Study|Death|0
7616156|NCT01794780|26499772|P8|Overall Study|Adverse Event|0
7616157|NCT01794780|26499773|P7|Overall Study|Adverse Event|0
7616158|NCT01794780|26499774|P6|Overall Study|Adverse Event|0
7616159|NCT01794780|26499775|P5|Overall Study|Adverse Event|0
7616160|NCT01794780|26499776|P4|Overall Study|Adverse Event|0
7616161|NCT01794780|26499777|P3|Overall Study|Adverse Event|2
7616162|NCT01794780|26499778|P2|Overall Study|Adverse Event|1
7616163|NCT01794780|26499779|P1|Overall Study|Adverse Event|0
7616164|NCT01794689|26499855|P4|Intervention 1 (2 Nights)|Adverse Event|0
7616165|NCT01794689|26499856|P3|Intervention 1 (2 Nights)|Adverse Event|0
7616166|NCT01794689|26499857|P2|Intervention 1 (2 Nights)|Adverse Event|1
7616167|NCT01794689|26499858|P1|Intervention 1 (2 Nights)|Adverse Event|0
7616168|NCT01794689|26499855|P4|Intervention 1 (2 Nights)|Physician Decision|0
7616169|NCT01794689|26499856|P3|Intervention 1 (2 Nights)|Physician Decision|0
7616170|NCT01794689|26499857|P2|Intervention 1 (2 Nights)|Physician Decision|1
7616171|NCT01794689|26499858|P1|Intervention 1 (2 Nights)|Physician Decision|1
7616172|NCT01794689|26499855|P4|Intervention 1 (2 Nights)|Protocol Violation|0
7616173|NCT01794689|26499856|P3|Intervention 1 (2 Nights)|Protocol Violation|1
7616174|NCT01794689|26499857|P2|Intervention 1 (2 Nights)|Protocol Violation|0
7616175|NCT01794689|26499858|P1|Intervention 1 (2 Nights)|Protocol Violation|1
7616176|NCT01794689|26499855|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
7616177|NCT01794689|26499856|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
7616178|NCT01794689|26499857|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
7616179|NCT01794689|26499858|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
7616180|NCT01794299|26499912|P1|Overall Study|Relapse and rejection of ATIR batch|1
7616181|NCT01794299|26499912|P1|Overall Study|Discontinued from active follow-up|1
7616182|NCT01794299|26499912|P1|Overall Study|Relapse|2
7616183|NCT01794299|26499912|P1|Overall Study|ATIR batch rejected|2
7616184|NCT01794299|26499912|P1|Overall Study|Graft failure|1
7616185|NCT01794299|26499912|P1|Overall Study|Death|14
7616186|NCT01794299|26499912|P1|Overall Study|ATIR manufacturing not possible|1
7616187|NCT01794117|26499926|P4|Overall Study|Refused further treatment|0
7616188|NCT01794117|26499927|P3|Overall Study|Refused further treatment|0
7616189|NCT01794117|26499928|P2|Overall Study|Refused further treatment|2
7616190|NCT01794117|26499929|P1|Overall Study|Refused further treatment|0
7616191|NCT01794117|26499926|P4|Overall Study|Participant noncompliance|0
7616192|NCT01794117|26499927|P3|Overall Study|Participant noncompliance|0
7616193|NCT01794117|26499928|P2|Overall Study|Participant noncompliance|1
7616194|NCT01794117|26499929|P1|Overall Study|Participant noncompliance|0
7616195|NCT01794117|26499926|P4|Overall Study|Adverse Event|0
7616196|NCT01794117|26499927|P3|Overall Study|Adverse Event|0
7616197|NCT01794117|26499928|P2|Overall Study|Adverse Event|0
7616198|NCT01794117|26499929|P1|Overall Study|Adverse Event|1
7616199|NCT01794000|26499956|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7616200|NCT01794000|26499957|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
7616201|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
7616202|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
7616203|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
7616204|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
7616205|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Physician Decision|0
7616206|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Physician Decision|2
7616207|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
7616208|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
7616209|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
7616210|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
7616211|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Death|2
7616212|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Death|1
7616213|NCT01794000|26499956|P2|Double-Blind Phase (DBP)|Adverse Event|2
7616214|NCT01794000|26499957|P1|Double-Blind Phase (DBP)|Adverse Event|5
7616215|NCT01793935|26499990|P2|Overall Study|Lost to Follow-up|1
7616216|NCT01793935|26499991|P1|Overall Study|Lost to Follow-up|0
7616217|NCT01793935|26499990|P2|Overall Study|Patient did not take study medication|1
7616218|NCT01793935|26499991|P1|Overall Study|Patient did not take study medication|1
7616219|NCT01793935|26499990|P2|Overall Study|Adverse Event|0
7616220|NCT01793935|26499991|P1|Overall Study|Adverse Event|2
7616221|NCT01793935|26499990|P2|Overall Study|Protocol Violation|1
7616222|NCT01793935|26499991|P1|Overall Study|Protocol Violation|2
7616223|NCT01793935|26499990|P2|Overall Study|Pregnancy|0
7616224|NCT01793935|26499991|P1|Overall Study|Pregnancy|1
7616225|NCT01793883|26500037|P3|Overall Study|Respiratory distress during spirometry|1
7616226|NCT01793883|26500038|P2|Overall Study|Respiratory distress during spirometry|0
7616227|NCT01793883|26500039|P1|Overall Study|Respiratory distress during spirometry|0
7616228|NCT01793883|26500037|P3|Overall Study|Dosing error|0
7616229|NCT01793883|26500038|P2|Overall Study|Dosing error|1
7616230|NCT01793883|26500039|P1|Overall Study|Dosing error|0
7616231|NCT01793883|26500037|P3|Overall Study|Met exclusion criteria|0
7616232|NCT01793883|26500038|P2|Overall Study|Met exclusion criteria|0
7616233|NCT01793883|26500039|P1|Overall Study|Met exclusion criteria|1
7616234|NCT01793883|26500037|P3|Overall Study|Unable to complete measurements|0
7616235|NCT01793883|26500038|P2|Overall Study|Unable to complete measurements|0
7616236|NCT01793883|26500039|P1|Overall Study|Unable to complete measurements|1
7616237|NCT01793883|26500037|P3|Overall Study|Unable to complete spriometry|0
7616238|NCT01793883|26500038|P2|Overall Study|Unable to complete spriometry|0
7616239|NCT01793883|26500039|P1|Overall Study|Unable to complete spriometry|1
7616240|NCT01793883|26500037|P3|Overall Study|Randomized in error|0
7616241|NCT01793883|26500038|P2|Overall Study|Randomized in error|0
7616242|NCT01793883|26500039|P1|Overall Study|Randomized in error|1
7616243|NCT01793883|26500037|P3|Overall Study|Lost to Follow-up|3
7616244|NCT01793883|26500038|P2|Overall Study|Lost to Follow-up|1
7616245|NCT01793883|26500039|P1|Overall Study|Lost to Follow-up|5
7616246|NCT01793883|26500037|P3|Overall Study|Subject noncompliance|1
7616247|NCT01793883|26500038|P2|Overall Study|Subject noncompliance|1
7616248|NCT01793883|26500039|P1|Overall Study|Subject noncompliance|0
7616249|NCT01793883|26500037|P3|Overall Study|Withdrawal by Subject|3
7616250|NCT01793883|26500038|P2|Overall Study|Withdrawal by Subject|7
7616251|NCT01793883|26500039|P1|Overall Study|Withdrawal by Subject|3
7616252|NCT01793792|26500047|P1|Overall Study|Device Not Implanted|1
7616253|NCT01793792|26500047|P1|Overall Study|Withdrawal by Subject|1
7616254|NCT01793792|26500047|P1|Overall Study|Lost to Follow-up|5
7616255|NCT01793792|26500047|P1|Overall Study|Death|5
7616256|NCT01793688|26500052|P1|Overall Study|Protocol Violation|2
7616257|NCT01793610|26500062|P3|Overall Study|Withdrawal by Subject|1
7616258|NCT01793610|26500063|P2|Overall Study|Withdrawal by Subject|0
7616259|NCT01793610|26500064|P1|Overall Study|Withdrawal by Subject|1
7616260|NCT01793142|26500110|P1|Overall Study|Randomized not treated|7
7616261|NCT01792830|26500140|P11|Overall Study|Adverse Event|0
7616262|NCT01792830|26500141|P10|Overall Study|Adverse Event|0
7616263|NCT01792830|26500142|P9|Overall Study|Adverse Event|1
7616264|NCT01792830|26500143|P8|Overall Study|Adverse Event|0
7616265|NCT01792830|26500144|P7|Overall Study|Adverse Event|0
7616266|NCT01792830|26500145|P6|Overall Study|Adverse Event|0
7616267|NCT01792830|26500146|P5|Overall Study|Adverse Event|0
7616268|NCT01792830|26500147|P4|Overall Study|Adverse Event|0
7616269|NCT01792830|26500148|P3|Overall Study|Adverse Event|0
7616270|NCT01792830|26500149|P2|Overall Study|Adverse Event|0
7616271|NCT01792830|26500150|P1|Overall Study|Adverse Event|0
7616272|NCT01792830|26500140|P11|Overall Study|Death|1
7616273|NCT01792830|26500141|P10|Overall Study|Death|0
7616274|NCT01792830|26500142|P9|Overall Study|Death|1
7616275|NCT01792830|26500143|P8|Overall Study|Death|0
7616276|NCT01792830|26500144|P7|Overall Study|Death|1
7616277|NCT01792830|26500145|P6|Overall Study|Death|0
7616278|NCT01792830|26500146|P5|Overall Study|Death|0
7616279|NCT01792830|26500147|P4|Overall Study|Death|1
7616280|NCT01792830|26500148|P3|Overall Study|Death|0
7616281|NCT01792830|26500149|P2|Overall Study|Death|0
7616282|NCT01792830|26500150|P1|Overall Study|Death|3
7616283|NCT01792830|26500140|P11|Overall Study|Withdrawal by Subject|2
7616284|NCT01792830|26500141|P10|Overall Study|Withdrawal by Subject|0
7616285|NCT01792830|26500142|P9|Overall Study|Withdrawal by Subject|7
7616286|NCT01792830|26500143|P8|Overall Study|Withdrawal by Subject|1
7616287|NCT01792830|26500144|P7|Overall Study|Withdrawal by Subject|1
7616288|NCT01792830|26500145|P6|Overall Study|Withdrawal by Subject|1
7616289|NCT01792830|26500146|P5|Overall Study|Withdrawal by Subject|1
7616290|NCT01792830|26500147|P4|Overall Study|Withdrawal by Subject|2
7616291|NCT01792830|26500148|P3|Overall Study|Withdrawal by Subject|0
7616292|NCT01792830|26500149|P2|Overall Study|Withdrawal by Subject|0
7616293|NCT01792830|26500150|P1|Overall Study|Withdrawal by Subject|22
7616294|NCT01792635|26500237|P3|Part B|Study terminated|3
7616295|NCT01792635|26500238|P2|Part B|Study terminated|4
7616296|NCT01792635|26500239|P1|Part B|Study terminated|0
7616297|NCT01792635|26500237|P3|Part B|Adverse Event|1
7616298|NCT01792635|26500238|P2|Part B|Adverse Event|0
7616299|NCT01792635|26500239|P1|Part B|Adverse Event|0
7616300|NCT01792518|26500267|P2|Overall Study|Other Reason|1
7616301|NCT01792518|26500268|P1|Overall Study|Other Reason|0
7616302|NCT01792518|26500267|P2|Overall Study|Withdrawal by Subject|0
7616303|NCT01792518|26500268|P1|Overall Study|Withdrawal by Subject|2
7616304|NCT01792518|26500267|P2|Overall Study|Lost to Follow-up|1
7616305|NCT01792518|26500268|P1|Overall Study|Lost to Follow-up|3
7616306|NCT01792518|26500267|P2|Overall Study|Protocol Violation|1
7616307|NCT01792518|26500268|P1|Overall Study|Protocol Violation|0
7616308|NCT01792518|26500267|P2|Overall Study|Adverse Event|4
7616309|NCT01792518|26500268|P1|Overall Study|Adverse Event|3
7616310|NCT01792284|26500278|P3|Randomization Period 2|Withdrawal by Subject|0
7616311|NCT01792284|26500279|P2|Randomization Period 2|Withdrawal by Subject|2
7616312|NCT01792284|26500280|P1|Randomization Period 2|Withdrawal by Subject|0
7616313|NCT01792284|26500278|P3|Randomization Period 2|Protocol Violation|0
7616314|NCT01792284|26500279|P2|Randomization Period 2|Protocol Violation|1
7616315|NCT01792284|26500280|P1|Randomization Period 2|Protocol Violation|0
7616316|NCT01792284|26500278|P3|Randomization Period 1|Lost to Follow-up|1
7616317|NCT01792284|26500279|P2|Randomization Period 1|Lost to Follow-up|0
7616318|NCT01792284|26500280|P1|Randomization Period 1|Lost to Follow-up|0
7616319|NCT01792284|26500278|P3|Randomization Period 1|Adverse Event|2
7616320|NCT01792284|26500279|P2|Randomization Period 1|Adverse Event|0
7616321|NCT01792284|26500280|P1|Randomization Period 1|Adverse Event|0
7616322|NCT01792284|26500278|P3|Randomization Period 1|Physician Decision|1
7616323|NCT01792284|26500279|P2|Randomization Period 1|Physician Decision|1
7616324|NCT01792284|26500280|P1|Randomization Period 1|Physician Decision|0
7616325|NCT01792284|26500278|P3|Randomization Period 1|Withdrawal by Subject|1
7616326|NCT01792284|26500279|P2|Randomization Period 1|Withdrawal by Subject|1
7616327|NCT01792284|26500280|P1|Randomization Period 1|Withdrawal by Subject|0
7616328|NCT01792284|26500278|P3|Lead-in Period|Protocol Required Discontinuation|0
7616329|NCT01792284|26500279|P2|Lead-in Period|Protocol Required Discontinuation|0
7616330|NCT01792284|26500280|P1|Lead-in Period|Protocol Required Discontinuation|1
7616331|NCT01792284|26500278|P3|Lead-in Period|Physician Decision|0
7616332|NCT01792284|26500279|P2|Lead-in Period|Physician Decision|0
7616333|NCT01792284|26500280|P1|Lead-in Period|Physician Decision|1
7616334|NCT01792284|26500278|P3|Lead-in Period|Withdrawal by Subject|0
7616335|NCT01792284|26500279|P2|Lead-in Period|Withdrawal by Subject|0
7616336|NCT01792284|26500280|P1|Lead-in Period|Withdrawal by Subject|10
7616337|NCT01792284|26500278|P3|Lead-in Period|Protocol Violation|0
7616338|NCT01792284|26500279|P2|Lead-in Period|Protocol Violation|0
7616339|NCT01792284|26500280|P1|Lead-in Period|Protocol Violation|1
7616340|NCT01792284|26500278|P3|Lead-in Period|Lost to Follow-up|0
7616341|NCT01792284|26500279|P2|Lead-in Period|Lost to Follow-up|0
7616342|NCT01792284|26500280|P1|Lead-in Period|Lost to Follow-up|2
7616343|NCT01792284|26500278|P3|Lead-in Period|Adverse Event|0
7616344|NCT01792284|26500279|P2|Lead-in Period|Adverse Event|0
7616345|NCT01792284|26500280|P1|Lead-in Period|Adverse Event|15
7616346|NCT01792115|26500321|P3|Overall Study|Lost to Follow-up|0
7616347|NCT01792115|26500322|P2|Overall Study|Lost to Follow-up|1
7616348|NCT01792115|26500323|P1|Overall Study|Lost to Follow-up|0
7616349|NCT01791894|26500373|P1|Overall Study|Adverse Event|1
7616350|NCT01791803|26500384|P4|Overall Study|Death|2
7616351|NCT01791803|26500385|P3|Overall Study|Death|2
7616352|NCT01791803|26500386|P2|Overall Study|Death|0
7616353|NCT01791803|26500387|P1|Overall Study|Death|0
7616354|NCT01791803|26500384|P4|Overall Study|Physician Decision|1
7616355|NCT01791803|26500385|P3|Overall Study|Physician Decision|0
7616356|NCT01791803|26500386|P2|Overall Study|Physician Decision|2
7616357|NCT01791803|26500387|P1|Overall Study|Physician Decision|0
7616358|NCT01791803|26500384|P4|Overall Study|Withdrawal by Subject|2
7616359|NCT01791803|26500385|P3|Overall Study|Withdrawal by Subject|0
7616360|NCT01791803|26500386|P2|Overall Study|Withdrawal by Subject|0
7616361|NCT01791803|26500387|P1|Overall Study|Withdrawal by Subject|0
7616362|NCT01791725|26500405|P3|Overall Study|Withdrawal by Subject|0
7616363|NCT01791725|26500406|P2|Overall Study|Withdrawal by Subject|1
7616364|NCT01791725|26500407|P1|Overall Study|Withdrawal by Subject|0
7616365|NCT01791517|26500430|P12|Phase II|Pre-Existing Ocular Issue|1
7616366|NCT01791517|26500431|P11|Phase II|Pre-Existing Ocular Issue|0
7616367|NCT01791517|26500432|P10|Phase II|Pre-Existing Ocular Issue|0
7616368|NCT01791517|26500433|P9|Phase II|Pre-Existing Ocular Issue|0
7616369|NCT01791517|26500434|P8|Phase II|Pre-Existing Ocular Issue|0
7616370|NCT01791517|26500435|P7|Phase II|Pre-Existing Ocular Issue|0
7616371|NCT01791517|26500436|P6|Phase II|Pre-Existing Ocular Issue|0
7616372|NCT01791517|26500437|P5|Phase II|Pre-Existing Ocular Issue|0
7616373|NCT01791517|26500438|P4|Phase II|Pre-Existing Ocular Issue|0
7616374|NCT01791517|26500439|P3|Phase II|Pre-Existing Ocular Issue|0
7616375|NCT01791517|26500440|P2|Phase II|Pre-Existing Ocular Issue|0
7616376|NCT01791517|26500441|P1|Phase II|Pre-Existing Ocular Issue|0
7616377|NCT01791517|26500430|P12|Phase II|Unsatisfactory Lens Fitting|0
7616378|NCT01791517|26500431|P11|Phase II|Unsatisfactory Lens Fitting|0
7616379|NCT01791517|26500432|P10|Phase II|Unsatisfactory Lens Fitting|1
7616380|NCT01791517|26500433|P9|Phase II|Unsatisfactory Lens Fitting|0
7616381|NCT01791517|26500434|P8|Phase II|Unsatisfactory Lens Fitting|0
7616382|NCT01791517|26500435|P7|Phase II|Unsatisfactory Lens Fitting|0
7616383|NCT01791517|26500436|P6|Phase II|Unsatisfactory Lens Fitting|0
7616384|NCT01791517|26500437|P5|Phase II|Unsatisfactory Lens Fitting|0
7616385|NCT01791517|26500438|P4|Phase II|Unsatisfactory Lens Fitting|0
7616386|NCT01791517|26500439|P3|Phase II|Unsatisfactory Lens Fitting|0
7616387|NCT01791517|26500440|P2|Phase II|Unsatisfactory Lens Fitting|0
7616388|NCT01791517|26500441|P1|Phase II|Unsatisfactory Lens Fitting|0
7616389|NCT01791517|26500430|P12|Phase II|Lens Handling Difficulties|0
7616390|NCT01791517|26500431|P11|Phase II|Lens Handling Difficulties|0
7616391|NCT01791517|26500432|P10|Phase II|Lens Handling Difficulties|0
7616392|NCT01791517|26500433|P9|Phase II|Lens Handling Difficulties|1
7616393|NCT01791517|26500434|P8|Phase II|Lens Handling Difficulties|0
7616394|NCT01791517|26500435|P7|Phase II|Lens Handling Difficulties|0
7616395|NCT01791517|26500436|P6|Phase II|Lens Handling Difficulties|0
7616396|NCT01791517|26500437|P5|Phase II|Lens Handling Difficulties|0
7616397|NCT01791517|26500438|P4|Phase II|Lens Handling Difficulties|0
7616398|NCT01791517|26500439|P3|Phase II|Lens Handling Difficulties|0
7616399|NCT01791517|26500440|P2|Phase II|Lens Handling Difficulties|0
7616400|NCT01791517|26500441|P1|Phase II|Lens Handling Difficulties|0
7616401|NCT01791517|26500430|P12|Phase II|Adverse Event|0
7616402|NCT01791517|26500431|P11|Phase II|Adverse Event|0
7616403|NCT01791517|26500432|P10|Phase II|Adverse Event|1
7616404|NCT01791517|26500433|P9|Phase II|Adverse Event|0
7616405|NCT01791517|26500434|P8|Phase II|Adverse Event|1
7616406|NCT01791517|26500435|P7|Phase II|Adverse Event|2
7616407|NCT01791517|26500436|P6|Phase II|Adverse Event|0
7616408|NCT01791517|26500437|P5|Phase II|Adverse Event|0
7616409|NCT01791517|26500438|P4|Phase II|Adverse Event|0
7616410|NCT01791517|26500439|P3|Phase II|Adverse Event|0
7616411|NCT01791517|26500440|P2|Phase II|Adverse Event|0
7616412|NCT01791517|26500441|P1|Phase II|Adverse Event|0
7616413|NCT01791517|26500430|P12|Phase II|Lack of Efficacy|0
7616414|NCT01791517|26500431|P11|Phase II|Lack of Efficacy|0
7616415|NCT01791517|26500432|P10|Phase II|Lack of Efficacy|0
7616416|NCT01791517|26500433|P9|Phase II|Lack of Efficacy|0
7616417|NCT01791517|26500434|P8|Phase II|Lack of Efficacy|0
7616418|NCT01791517|26500435|P7|Phase II|Lack of Efficacy|0
7616419|NCT01791517|26500436|P6|Phase II|Lack of Efficacy|0
7616420|NCT01791517|26500437|P5|Phase II|Lack of Efficacy|1
7616421|NCT01791517|26500438|P4|Phase II|Lack of Efficacy|0
7616422|NCT01791517|26500439|P3|Phase II|Lack of Efficacy|0
7616423|NCT01791517|26500440|P2|Phase II|Lack of Efficacy|0
7616424|NCT01791517|26500441|P1|Phase II|Lack of Efficacy|0
7616425|NCT01791517|26500430|P12|Phase II|Withdrawal by Subject|0
7616426|NCT01791517|26500431|P11|Phase II|Withdrawal by Subject|1
7616427|NCT01791517|26500432|P10|Phase II|Withdrawal by Subject|0
7616428|NCT01791517|26500433|P9|Phase II|Withdrawal by Subject|0
7616429|NCT01791517|26500434|P8|Phase II|Withdrawal by Subject|1
7616430|NCT01791517|26500435|P7|Phase II|Withdrawal by Subject|0
7616431|NCT01791517|26500436|P6|Phase II|Withdrawal by Subject|2
7616432|NCT01791517|26500437|P5|Phase II|Withdrawal by Subject|0
7616433|NCT01791517|26500438|P4|Phase II|Withdrawal by Subject|0
7616434|NCT01791517|26500439|P3|Phase II|Withdrawal by Subject|0
7616435|NCT01791517|26500440|P2|Phase II|Withdrawal by Subject|0
7616436|NCT01791517|26500441|P1|Phase II|Withdrawal by Subject|1
7616437|NCT01791517|26500430|P12|Phase II|Lost to Follow-up|0
7616438|NCT01791517|26500431|P11|Phase II|Lost to Follow-up|0
7616439|NCT01791517|26500432|P10|Phase II|Lost to Follow-up|1
7616440|NCT01791517|26500433|P9|Phase II|Lost to Follow-up|1
7616441|NCT01791517|26500434|P8|Phase II|Lost to Follow-up|1
7616442|NCT01791517|26500435|P7|Phase II|Lost to Follow-up|0
7616443|NCT01791517|26500436|P6|Phase II|Lost to Follow-up|2
7616444|NCT01791517|26500437|P5|Phase II|Lost to Follow-up|1
7616445|NCT01791517|26500438|P4|Phase II|Lost to Follow-up|0
7616446|NCT01791517|26500439|P3|Phase II|Lost to Follow-up|1
7616447|NCT01791517|26500440|P2|Phase II|Lost to Follow-up|0
7616448|NCT01791517|26500441|P1|Phase II|Lost to Follow-up|1
7616449|NCT01791517|26500430|P12|Phase I: Period 3|Adverse Event|0
7616450|NCT01791517|26500431|P11|Phase I: Period 3|Adverse Event|0
7616451|NCT01791517|26500432|P10|Phase I: Period 3|Adverse Event|0
7616452|NCT01791517|26500433|P9|Phase I: Period 3|Adverse Event|0
7616453|NCT01791517|26500434|P8|Phase I: Period 3|Adverse Event|0
7616454|NCT01791517|26500435|P7|Phase I: Period 3|Adverse Event|0
7616455|NCT01791517|26500436|P6|Phase I: Period 3|Adverse Event|0
7616456|NCT01791517|26500437|P5|Phase I: Period 3|Adverse Event|0
7616457|NCT01791517|26500438|P4|Phase I: Period 3|Adverse Event|1
7616458|NCT01791517|26500439|P3|Phase I: Period 3|Adverse Event|0
7616459|NCT01791517|26500440|P2|Phase I: Period 3|Adverse Event|0
7616460|NCT01791517|26500441|P1|Phase I: Period 3|Adverse Event|0
7616461|NCT01791517|26500430|P12|Phase I: Period 3|Lost to Follow-up|0
7616462|NCT01791517|26500431|P11|Phase I: Period 3|Lost to Follow-up|0
7616463|NCT01791517|26500432|P10|Phase I: Period 3|Lost to Follow-up|0
7616464|NCT01791517|26500433|P9|Phase I: Period 3|Lost to Follow-up|0
7616465|NCT01791517|26500434|P8|Phase I: Period 3|Lost to Follow-up|0
7616466|NCT01791517|26500435|P7|Phase I: Period 3|Lost to Follow-up|0
7616467|NCT01791517|26500436|P6|Phase I: Period 3|Lost to Follow-up|0
7616468|NCT01791517|26500437|P5|Phase I: Period 3|Lost to Follow-up|1
7616469|NCT01791517|26500438|P4|Phase I: Period 3|Lost to Follow-up|0
7616470|NCT01791517|26500439|P3|Phase I: Period 3|Lost to Follow-up|0
7616471|NCT01791517|26500440|P2|Phase I: Period 3|Lost to Follow-up|1
7616472|NCT01791517|26500441|P1|Phase I: Period 3|Lost to Follow-up|0
7616473|NCT01791517|26500430|P12|Phase I: Period 3|Lens Discomfort|1
7616474|NCT01791517|26500431|P11|Phase I: Period 3|Lens Discomfort|0
7616475|NCT01791517|26500432|P10|Phase I: Period 3|Lens Discomfort|0
7616476|NCT01791517|26500433|P9|Phase I: Period 3|Lens Discomfort|0
7616477|NCT01791517|26500434|P8|Phase I: Period 3|Lens Discomfort|0
7616478|NCT01791517|26500435|P7|Phase I: Period 3|Lens Discomfort|0
7616479|NCT01791517|26500436|P6|Phase I: Period 3|Lens Discomfort|0
7616480|NCT01791517|26500437|P5|Phase I: Period 3|Lens Discomfort|0
7616481|NCT01791517|26500438|P4|Phase I: Period 3|Lens Discomfort|0
7616482|NCT01791517|26500439|P3|Phase I: Period 3|Lens Discomfort|0
7616483|NCT01791517|26500440|P2|Phase I: Period 3|Lens Discomfort|0
7616484|NCT01791517|26500441|P1|Phase I: Period 3|Lens Discomfort|0
7616485|NCT01791517|26500430|P12|Phase I: Period 2|Lost to Follow-up|0
7616486|NCT01791517|26500431|P11|Phase I: Period 2|Lost to Follow-up|0
7616487|NCT01791517|26500432|P10|Phase I: Period 2|Lost to Follow-up|0
7616488|NCT01791517|26500433|P9|Phase I: Period 2|Lost to Follow-up|0
7616489|NCT01791517|26500434|P8|Phase I: Period 2|Lost to Follow-up|0
7616490|NCT01791517|26500435|P7|Phase I: Period 2|Lost to Follow-up|0
7616491|NCT01791517|26500436|P6|Phase I: Period 2|Lost to Follow-up|0
7616492|NCT01791517|26500437|P5|Phase I: Period 2|Lost to Follow-up|0
7616493|NCT01791517|26500438|P4|Phase I: Period 2|Lost to Follow-up|0
7616494|NCT01791517|26500439|P3|Phase I: Period 2|Lost to Follow-up|2
7616495|NCT01791517|26500440|P2|Phase I: Period 2|Lost to Follow-up|3
7616496|NCT01791517|26500441|P1|Phase I: Period 2|Lost to Follow-up|0
7616497|NCT01791517|26500430|P12|Phase I: Period 2|Lens Discomfort|0
7616498|NCT01791517|26500431|P11|Phase I: Period 2|Lens Discomfort|0
7616499|NCT01791517|26500432|P10|Phase I: Period 2|Lens Discomfort|0
7616500|NCT01791517|26500433|P9|Phase I: Period 2|Lens Discomfort|0
7616501|NCT01791517|26500434|P8|Phase I: Period 2|Lens Discomfort|0
7616502|NCT01791517|26500435|P7|Phase I: Period 2|Lens Discomfort|0
7616503|NCT01791517|26500436|P6|Phase I: Period 2|Lens Discomfort|1
7616504|NCT01791517|26500437|P5|Phase I: Period 2|Lens Discomfort|0
7616505|NCT01791517|26500438|P4|Phase I: Period 2|Lens Discomfort|0
7616506|NCT01791517|26500439|P3|Phase I: Period 2|Lens Discomfort|0
7616507|NCT01791517|26500440|P2|Phase I: Period 2|Lens Discomfort|0
7616508|NCT01791517|26500441|P1|Phase I: Period 2|Lens Discomfort|0
7616509|NCT01791517|26500430|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
7616510|NCT01791517|26500431|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
7616511|NCT01791517|26500432|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
7616512|NCT01791517|26500433|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
7616513|NCT01791517|26500434|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
7616514|NCT01791517|26500435|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
7616515|NCT01791517|26500436|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
7616516|NCT01791517|26500437|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
7616517|NCT01791517|26500438|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
7616518|NCT01791517|26500439|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
7616519|NCT01791517|26500440|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
7616520|NCT01791517|26500441|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
7616521|NCT01791517|26500430|P12|Phase I: Period 2|Withdrawal by Subject|0
7616522|NCT01791517|26500431|P11|Phase I: Period 2|Withdrawal by Subject|1
7616523|NCT01791517|26500432|P10|Phase I: Period 2|Withdrawal by Subject|1
7616524|NCT01791517|26500433|P9|Phase I: Period 2|Withdrawal by Subject|0
7616525|NCT01791517|26500434|P8|Phase I: Period 2|Withdrawal by Subject|0
7616526|NCT01791517|26500435|P7|Phase I: Period 2|Withdrawal by Subject|0
7616527|NCT01791517|26500436|P6|Phase I: Period 2|Withdrawal by Subject|0
7616528|NCT01791517|26500437|P5|Phase I: Period 2|Withdrawal by Subject|0
7616529|NCT01791517|26500438|P4|Phase I: Period 2|Withdrawal by Subject|0
7616530|NCT01791517|26500439|P3|Phase I: Period 2|Withdrawal by Subject|0
7616531|NCT01791517|26500440|P2|Phase I: Period 2|Withdrawal by Subject|0
7616532|NCT01791517|26500441|P1|Phase I: Period 2|Withdrawal by Subject|0
7616533|NCT01791517|26500430|P12|Phase I: Period 2|Protocol Violation|0
7616534|NCT01791517|26500431|P11|Phase I: Period 2|Protocol Violation|0
7616535|NCT01791517|26500432|P10|Phase I: Period 2|Protocol Violation|0
7616536|NCT01791517|26500433|P9|Phase I: Period 2|Protocol Violation|0
7616537|NCT01791517|26500434|P8|Phase I: Period 2|Protocol Violation|0
7616538|NCT01791517|26500435|P7|Phase I: Period 2|Protocol Violation|0
7616539|NCT01791517|26500436|P6|Phase I: Period 2|Protocol Violation|0
7616540|NCT01791517|26500437|P5|Phase I: Period 2|Protocol Violation|0
7616541|NCT01791517|26500438|P4|Phase I: Period 2|Protocol Violation|1
7616542|NCT01791517|26500439|P3|Phase I: Period 2|Protocol Violation|0
7616543|NCT01791517|26500440|P2|Phase I: Period 2|Protocol Violation|0
7616544|NCT01791517|26500441|P1|Phase I: Period 2|Protocol Violation|0
7616545|NCT01791517|26500430|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616546|NCT01791517|26500431|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616547|NCT01791517|26500432|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616548|NCT01791517|26500433|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616549|NCT01791517|26500434|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616550|NCT01791517|26500435|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616551|NCT01791517|26500436|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616552|NCT01791517|26500437|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616553|NCT01791517|26500438|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616554|NCT01791517|26500439|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616555|NCT01791517|26500440|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
7616556|NCT01791517|26500441|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
7616557|NCT01791517|26500430|P12|Phase I: Period 1|Lens Handling DIfficulties|1
7616558|NCT01791517|26500431|P11|Phase I: Period 1|Lens Handling DIfficulties|0
7616559|NCT01791517|26500432|P10|Phase I: Period 1|Lens Handling DIfficulties|0
7616560|NCT01791517|26500433|P9|Phase I: Period 1|Lens Handling DIfficulties|0
7616561|NCT01791517|26500434|P8|Phase I: Period 1|Lens Handling DIfficulties|0
7616562|NCT01791517|26500435|P7|Phase I: Period 1|Lens Handling DIfficulties|0
7616563|NCT01791517|26500436|P6|Phase I: Period 1|Lens Handling DIfficulties|0
7616564|NCT01791517|26500437|P5|Phase I: Period 1|Lens Handling DIfficulties|0
7616565|NCT01791517|26500438|P4|Phase I: Period 1|Lens Handling DIfficulties|0
7616566|NCT01791517|26500439|P3|Phase I: Period 1|Lens Handling DIfficulties|0
7616567|NCT01791517|26500440|P2|Phase I: Period 1|Lens Handling DIfficulties|0
7616568|NCT01791517|26500441|P1|Phase I: Period 1|Lens Handling DIfficulties|0
7616569|NCT01791517|26500430|P12|Phase I: Period 1|Lost to Follow-up|0
7616570|NCT01791517|26500431|P11|Phase I: Period 1|Lost to Follow-up|0
7616571|NCT01791517|26500432|P10|Phase I: Period 1|Lost to Follow-up|1
7616572|NCT01791517|26500433|P9|Phase I: Period 1|Lost to Follow-up|1
7616573|NCT01791517|26500434|P8|Phase I: Period 1|Lost to Follow-up|0
7616574|NCT01791517|26500435|P7|Phase I: Period 1|Lost to Follow-up|1
7616575|NCT01791517|26500436|P6|Phase I: Period 1|Lost to Follow-up|0
7616576|NCT01791517|26500437|P5|Phase I: Period 1|Lost to Follow-up|0
7616577|NCT01791517|26500438|P4|Phase I: Period 1|Lost to Follow-up|1
7616578|NCT01791517|26500439|P3|Phase I: Period 1|Lost to Follow-up|0
7616579|NCT01791517|26500440|P2|Phase I: Period 1|Lost to Follow-up|0
7616580|NCT01791517|26500441|P1|Phase I: Period 1|Lost to Follow-up|0
7616581|NCT01791517|26500430|P12|Phase I: Period 1|Protocol Violation|0
7616582|NCT01791517|26500431|P11|Phase I: Period 1|Protocol Violation|0
7616583|NCT01791517|26500432|P10|Phase I: Period 1|Protocol Violation|0
7616584|NCT01791517|26500433|P9|Phase I: Period 1|Protocol Violation|0
7616585|NCT01791517|26500434|P8|Phase I: Period 1|Protocol Violation|0
7616586|NCT01791517|26500435|P7|Phase I: Period 1|Protocol Violation|0
7616587|NCT01791517|26500436|P6|Phase I: Period 1|Protocol Violation|0
7616588|NCT01791517|26500437|P5|Phase I: Period 1|Protocol Violation|0
7616589|NCT01791517|26500438|P4|Phase I: Period 1|Protocol Violation|0
7616590|NCT01791517|26500439|P3|Phase I: Period 1|Protocol Violation|0
7616591|NCT01791517|26500440|P2|Phase I: Period 1|Protocol Violation|1
7616592|NCT01791517|26500441|P1|Phase I: Period 1|Protocol Violation|0
7616593|NCT01791517|26500430|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616594|NCT01791517|26500431|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616595|NCT01791517|26500432|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616596|NCT01791517|26500433|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616597|NCT01791517|26500434|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616598|NCT01791517|26500435|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616599|NCT01791517|26500436|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616600|NCT01791517|26500437|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616601|NCT01791517|26500438|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616602|NCT01791517|26500439|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616603|NCT01791517|26500440|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7616604|NCT01791517|26500441|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
7616605|NCT01791517|26500430|P12|Phase I: Period 1|Adverse Event|0
7616606|NCT01791517|26500431|P11|Phase I: Period 1|Adverse Event|0
7616607|NCT01791517|26500432|P10|Phase I: Period 1|Adverse Event|0
7616608|NCT01791517|26500433|P9|Phase I: Period 1|Adverse Event|0
7616609|NCT01791517|26500434|P8|Phase I: Period 1|Adverse Event|0
7616610|NCT01791517|26500435|P7|Phase I: Period 1|Adverse Event|0
7616611|NCT01791517|26500436|P6|Phase I: Period 1|Adverse Event|0
7616612|NCT01791517|26500437|P5|Phase I: Period 1|Adverse Event|0
7616613|NCT01791517|26500438|P4|Phase I: Period 1|Adverse Event|1
7616614|NCT01791517|26500439|P3|Phase I: Period 1|Adverse Event|1
7616615|NCT01791517|26500440|P2|Phase I: Period 1|Adverse Event|0
7616616|NCT01791517|26500441|P1|Phase I: Period 1|Adverse Event|0
7616617|NCT01791517|26500430|P12|Phase I: Period 1|Withdrawal by Subject|0
7616618|NCT01791517|26500431|P11|Phase I: Period 1|Withdrawal by Subject|0
7616619|NCT01791517|26500432|P10|Phase I: Period 1|Withdrawal by Subject|0
7616620|NCT01791517|26500433|P9|Phase I: Period 1|Withdrawal by Subject|0
7616621|NCT01791517|26500434|P8|Phase I: Period 1|Withdrawal by Subject|0
7616622|NCT01791517|26500435|P7|Phase I: Period 1|Withdrawal by Subject|0
7616623|NCT01791517|26500436|P6|Phase I: Period 1|Withdrawal by Subject|1
7616624|NCT01791517|26500437|P5|Phase I: Period 1|Withdrawal by Subject|1
7616625|NCT01791517|26500438|P4|Phase I: Period 1|Withdrawal by Subject|0
7616626|NCT01791517|26500439|P3|Phase I: Period 1|Withdrawal by Subject|1
7616627|NCT01791517|26500440|P2|Phase I: Period 1|Withdrawal by Subject|1
7616628|NCT01791517|26500441|P1|Phase I: Period 1|Withdrawal by Subject|0
7616629|NCT01791413|26500505|P2|Overall Study|Lost to Follow-up|1
7616630|NCT01791413|26500506|P1|Overall Study|Lost to Follow-up|5
7616631|NCT01791244|26500515|P2|Overall Study|Laboratory Abnormality|1
7616632|NCT01791244|26500516|P1|Overall Study|Laboratory Abnormality|0
7616633|NCT01791244|26500515|P2|Overall Study|Insufficient clinical response|10
7616634|NCT01791244|26500516|P1|Overall Study|Insufficient clinical response|10
7616635|NCT01791244|26500515|P2|Overall Study|Adverse Event|7
7616636|NCT01791244|26500516|P1|Overall Study|Adverse Event|5
7616637|NCT01791205|26500552|P2|Phase II|Physician's decision|0
7616638|NCT01791205|26500553|P1|Phase II|Physician's decision|1
7616639|NCT01791205|26500552|P2|Phase II|Remission of disease|0
7616640|NCT01791205|26500553|P1|Phase II|Remission of disease|1
7616641|NCT01791205|26500552|P2|Phase II|Lost to Follow-up|0
7616642|NCT01791205|26500553|P1|Phase II|Lost to Follow-up|1
7616643|NCT01791205|26500552|P2|Phase II|Safety|0
7616644|NCT01791205|26500553|P1|Phase II|Safety|1
7616645|NCT01791205|26500552|P2|Phase II|Adverse Event|0
7616646|NCT01791205|26500553|P1|Phase II|Adverse Event|2
7616647|NCT01791205|26500552|P2|Phase II|Lack of Efficacy|0
7616648|NCT01791205|26500553|P1|Phase II|Lack of Efficacy|6
7616649|NCT01791153|26500637|P8|Part 2: Open-label Period|Physician Decision|0
7616650|NCT01791153|26500638|P7|Part 2: Open-label Period|Physician Decision|0
7616651|NCT01791153|26500639|P6|Part 2: Open-label Period|Physician Decision|1
7616652|NCT01791153|26500640|P5|Part 2: Open-label Period|Physician Decision|1
7616653|NCT01791153|26500641|P4|Part 2: Open-label Period|Physician Decision|0
7616654|NCT01791153|26500642|P3|Part 2: Open-label Period|Physician Decision|0
7616655|NCT01791153|26500643|P2|Part 2: Open-label Period|Physician Decision|0
7616656|NCT01791153|26500644|P1|Part 2: Open-label Period|Physician Decision|0
7616657|NCT01791153|26500637|P8|Part 2: Open-label Period|Withdrawal by Subject|2
7616658|NCT01791153|26500638|P7|Part 2: Open-label Period|Withdrawal by Subject|3
7616659|NCT01791153|26500639|P6|Part 2: Open-label Period|Withdrawal by Subject|1
7616660|NCT01791153|26500640|P5|Part 2: Open-label Period|Withdrawal by Subject|1
7616661|NCT01791153|26500641|P4|Part 2: Open-label Period|Withdrawal by Subject|0
7616662|NCT01791153|26500642|P3|Part 2: Open-label Period|Withdrawal by Subject|0
7616663|NCT01791153|26500643|P2|Part 2: Open-label Period|Withdrawal by Subject|0
7616664|NCT01791153|26500644|P1|Part 2: Open-label Period|Withdrawal by Subject|0
7616665|NCT01791153|26500637|P8|Part 2: Open-label Period|Lack of Efficacy|1
7616666|NCT01791153|26500638|P7|Part 2: Open-label Period|Lack of Efficacy|0
7616667|NCT01791153|26500639|P6|Part 2: Open-label Period|Lack of Efficacy|0
7616668|NCT01791153|26500640|P5|Part 2: Open-label Period|Lack of Efficacy|0
7616669|NCT01791153|26500641|P4|Part 2: Open-label Period|Lack of Efficacy|0
7616670|NCT01791153|26500642|P3|Part 2: Open-label Period|Lack of Efficacy|0
7616671|NCT01791153|26500643|P2|Part 2: Open-label Period|Lack of Efficacy|0
7616672|NCT01791153|26500644|P1|Part 2: Open-label Period|Lack of Efficacy|0
7616673|NCT01791153|26500637|P8|Part 2: Open-label Period|Lost to Follow-up|0
7616674|NCT01791153|26500638|P7|Part 2: Open-label Period|Lost to Follow-up|1
7616675|NCT01791153|26500639|P6|Part 2: Open-label Period|Lost to Follow-up|0
7616676|NCT01791153|26500640|P5|Part 2: Open-label Period|Lost to Follow-up|0
7616677|NCT01791153|26500641|P4|Part 2: Open-label Period|Lost to Follow-up|0
7616678|NCT01791153|26500642|P3|Part 2: Open-label Period|Lost to Follow-up|0
7616679|NCT01791153|26500643|P2|Part 2: Open-label Period|Lost to Follow-up|0
7616680|NCT01791153|26500644|P1|Part 2: Open-label Period|Lost to Follow-up|0
7616681|NCT01791153|26500637|P8|Part 2: Open-label Period|Death|1
7616682|NCT01791153|26500638|P7|Part 2: Open-label Period|Death|1
7616683|NCT01791153|26500639|P6|Part 2: Open-label Period|Death|1
7616684|NCT01791153|26500640|P5|Part 2: Open-label Period|Death|0
7616685|NCT01791153|26500641|P4|Part 2: Open-label Period|Death|0
7616686|NCT01791153|26500642|P3|Part 2: Open-label Period|Death|0
7616687|NCT01791153|26500643|P2|Part 2: Open-label Period|Death|0
7616688|NCT01791153|26500644|P1|Part 2: Open-label Period|Death|0
7616689|NCT01791153|26500637|P8|Part 2: Open-label Period|Adverse Event|2
7616690|NCT01791153|26500638|P7|Part 2: Open-label Period|Adverse Event|1
7616691|NCT01791153|26500639|P6|Part 2: Open-label Period|Adverse Event|1
7616692|NCT01791153|26500640|P5|Part 2: Open-label Period|Adverse Event|0
7616693|NCT01791153|26500641|P4|Part 2: Open-label Period|Adverse Event|0
7616694|NCT01791153|26500642|P3|Part 2: Open-label Period|Adverse Event|0
7616695|NCT01791153|26500643|P2|Part 2: Open-label Period|Adverse Event|0
7616696|NCT01791153|26500644|P1|Part 2: Open-label Period|Adverse Event|0
7616697|NCT01791153|26500637|P8|Part 1: Blinded Period|Withdrawal by Subject|0
7616698|NCT01791153|26500638|P7|Part 1: Blinded Period|Withdrawal by Subject|0
7616699|NCT01791153|26500639|P6|Part 1: Blinded Period|Withdrawal by Subject|0
7616700|NCT01791153|26500640|P5|Part 1: Blinded Period|Withdrawal by Subject|0
7616701|NCT01791153|26500641|P4|Part 1: Blinded Period|Withdrawal by Subject|1
7616702|NCT01791153|26500642|P3|Part 1: Blinded Period|Withdrawal by Subject|2
7616703|NCT01791153|26500643|P2|Part 1: Blinded Period|Withdrawal by Subject|2
7616704|NCT01791153|26500644|P1|Part 1: Blinded Period|Withdrawal by Subject|6
7616705|NCT01791153|26500637|P8|Part 1: Blinded Period|Protocol Violation|0
7616706|NCT01791153|26500638|P7|Part 1: Blinded Period|Protocol Violation|0
7616707|NCT01791153|26500639|P6|Part 1: Blinded Period|Protocol Violation|0
7616708|NCT01791153|26500640|P5|Part 1: Blinded Period|Protocol Violation|0
7616709|NCT01791153|26500641|P4|Part 1: Blinded Period|Protocol Violation|1
7616710|NCT01791153|26500642|P3|Part 1: Blinded Period|Protocol Violation|0
7616711|NCT01791153|26500643|P2|Part 1: Blinded Period|Protocol Violation|0
7616712|NCT01791153|26500644|P1|Part 1: Blinded Period|Protocol Violation|0
7616713|NCT01791153|26500637|P8|Part 1: Blinded Period|Physician Decision|0
7616714|NCT01791153|26500638|P7|Part 1: Blinded Period|Physician Decision|0
7616715|NCT01791153|26500639|P6|Part 1: Blinded Period|Physician Decision|0
7616716|NCT01791153|26500640|P5|Part 1: Blinded Period|Physician Decision|0
7616717|NCT01791153|26500641|P4|Part 1: Blinded Period|Physician Decision|1
7616718|NCT01791153|26500642|P3|Part 1: Blinded Period|Physician Decision|0
7616719|NCT01791153|26500643|P2|Part 1: Blinded Period|Physician Decision|0
7616720|NCT01791153|26500644|P1|Part 1: Blinded Period|Physician Decision|0
7616721|NCT01791153|26500637|P8|Part 1: Blinded Period|Non-Compliance|0
7616722|NCT01791153|26500638|P7|Part 1: Blinded Period|Non-Compliance|0
7616723|NCT01791153|26500639|P6|Part 1: Blinded Period|Non-Compliance|0
7616724|NCT01791153|26500640|P5|Part 1: Blinded Period|Non-Compliance|0
7616725|NCT01791153|26500641|P4|Part 1: Blinded Period|Non-Compliance|0
7616726|NCT01791153|26500642|P3|Part 1: Blinded Period|Non-Compliance|0
7616727|NCT01791153|26500643|P2|Part 1: Blinded Period|Non-Compliance|0
7616728|NCT01791153|26500644|P1|Part 1: Blinded Period|Non-Compliance|1
7616729|NCT01791153|26500637|P8|Part 1: Blinded Period|Lack of Efficacy|0
7616730|NCT01791153|26500638|P7|Part 1: Blinded Period|Lack of Efficacy|0
7616731|NCT01791153|26500639|P6|Part 1: Blinded Period|Lack of Efficacy|0
7616732|NCT01791153|26500640|P5|Part 1: Blinded Period|Lack of Efficacy|0
7616733|NCT01791153|26500641|P4|Part 1: Blinded Period|Lack of Efficacy|2
7616734|NCT01791153|26500642|P3|Part 1: Blinded Period|Lack of Efficacy|2
7616735|NCT01791153|26500643|P2|Part 1: Blinded Period|Lack of Efficacy|3
7616736|NCT01791153|26500644|P1|Part 1: Blinded Period|Lack of Efficacy|1
7616737|NCT01791153|26500637|P8|Part 1: Blinded Period|Adverse Event|0
7616738|NCT01791153|26500638|P7|Part 1: Blinded Period|Adverse Event|0
7616739|NCT01791153|26500639|P6|Part 1: Blinded Period|Adverse Event|0
7616740|NCT01791153|26500640|P5|Part 1: Blinded Period|Adverse Event|0
7616741|NCT01791153|26500641|P4|Part 1: Blinded Period|Adverse Event|0
7616742|NCT01791153|26500642|P3|Part 1: Blinded Period|Adverse Event|2
7616743|NCT01791153|26500643|P2|Part 1: Blinded Period|Adverse Event|3
7616744|NCT01791153|26500644|P1|Part 1: Blinded Period|Adverse Event|7
7616745|NCT01791127|26500704|P1|Overall Study|Study terminated for EP Passion|749
7616746|NCT01791127|26500704|P1|Overall Study|Completion of 30 day safety registry|1
7616747|NCT01791127|26500704|P1|Overall Study|All Siello leads are explanted|31
7616748|NCT01791127|26500704|P1|Overall Study|Lost to Follow-up|42
7616749|NCT01791127|26500704|P1|Overall Study|Patient has withdrawn from study|293
7616750|NCT01791127|26500704|P1|Overall Study|Death|356
7616751|NCT01790984|26500730|P4|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7616752|NCT01790984|26500731|P3|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7616753|NCT01790984|26500732|P2|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7616754|NCT01790984|26500733|P1|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7616755|NCT01790932|26500763|P1|Overall Study|Withdrawal by Subject|1
7616756|NCT01790932|26500763|P1|Overall Study|Physician Decision|1
7616757|NCT01790932|26500763|P1|Overall Study|Adverse Event|7
7616758|NCT01790932|26500763|P1|Overall Study|Disease Progression|41
7616759|NCT01790828|26500769|P1|Overall Study|Other|34
7616760|NCT01790633|26500827|P2|Overall Study|RT failure and no follow-up ELISA|3
7616761|NCT01790633|26500828|P1|Overall Study|RT failure and no follow-up ELISA|0
7616762|NCT01790633|26500827|P2|Overall Study|Did not have serology performed|0
7616763|NCT01790633|26500828|P1|Overall Study|Did not have serology performed|47
7616764|NCT01790633|26500827|P2|Overall Study|Protocol Violation|2
7616765|NCT01790633|26500828|P1|Overall Study|Protocol Violation|1
7616766|NCT01790594|26500841|P3|Overall Study|Terminated prior to week 76|0
7616767|NCT01790594|26500842|P2|Overall Study|Terminated prior to week 76|2
7616768|NCT01790594|26500843|P1|Overall Study|Terminated prior to week 76|0
7616769|NCT01790594|26500841|P3|Overall Study|Transplant was not done|3
7616770|NCT01790594|26500842|P2|Overall Study|Transplant was not done|0
7616771|NCT01790594|26500843|P1|Overall Study|Transplant was not done|0
7616772|NCT01790594|26500841|P3|Overall Study|Withdrawal by Subject|0
7616773|NCT01790594|26500842|P2|Overall Study|Withdrawal by Subject|0
7616774|NCT01790594|26500843|P1|Overall Study|Withdrawal by Subject|2
7616775|NCT01790594|26500841|P3|Overall Study|Physician Decision|0
7616776|NCT01790594|26500842|P2|Overall Study|Physician Decision|1
7616777|NCT01790594|26500843|P1|Overall Study|Physician Decision|2
7616778|NCT01790594|26500841|P3|Overall Study|Death|0
7616779|NCT01790594|26500842|P2|Overall Study|Death|0
7616780|NCT01790594|26500843|P1|Overall Study|Death|1
7616781|NCT01790568|26500920|P2|Overall Study|Progression prior to transplant|1
7616782|NCT01790568|26500921|P1|Overall Study|Progression prior to transplant|0
7616783|NCT01790516|26500929|P2|Overall Study|Physician Decision|0
7616784|NCT01790516|26500930|P1|Overall Study|Physician Decision|1
7616785|NCT01790503|26500947|P11|Overall Study|Other|0
7616786|NCT01790503|26500948|P10|Overall Study|Other|2
7616787|NCT01790503|26500949|P9|Overall Study|Other|1
7616788|NCT01790503|26500950|P8|Overall Study|Other|0
7616789|NCT01790503|26500951|P7|Overall Study|Other|0
7616790|NCT01790503|26500952|P6|Overall Study|Other|0
7616791|NCT01790503|26500953|P5|Overall Study|Other|1
7616792|NCT01790503|26500954|P4|Overall Study|Other|0
7616793|NCT01790503|26500955|P3|Overall Study|Other|0
7616794|NCT01790503|26500956|P2|Overall Study|Other|0
7616795|NCT01790503|26500957|P1|Overall Study|Other|0
7616796|NCT01790503|26500947|P11|Overall Study|Non Compliance|0
7616797|NCT01790503|26500948|P10|Overall Study|Non Compliance|0
7616798|NCT01790503|26500949|P9|Overall Study|Non Compliance|0
7616799|NCT01790503|26500950|P8|Overall Study|Non Compliance|0
7616800|NCT01790503|26500951|P7|Overall Study|Non Compliance|0
7616801|NCT01790503|26500952|P6|Overall Study|Non Compliance|0
7616802|NCT01790503|26500953|P5|Overall Study|Non Compliance|1
7616803|NCT01790503|26500954|P4|Overall Study|Non Compliance|0
7616804|NCT01790503|26500955|P3|Overall Study|Non Compliance|0
7616805|NCT01790503|26500956|P2|Overall Study|Non Compliance|0
7616806|NCT01790503|26500957|P1|Overall Study|Non Compliance|0
7616807|NCT01790503|26500947|P11|Overall Study|Death|0
7616808|NCT01790503|26500948|P10|Overall Study|Death|1
7616809|NCT01790503|26500949|P9|Overall Study|Death|0
7616810|NCT01790503|26500950|P8|Overall Study|Death|0
7616811|NCT01790503|26500951|P7|Overall Study|Death|0
7616812|NCT01790503|26500952|P6|Overall Study|Death|0
7616813|NCT01790503|26500953|P5|Overall Study|Death|0
7616814|NCT01790503|26500954|P4|Overall Study|Death|0
7616815|NCT01790503|26500955|P3|Overall Study|Death|0
7616816|NCT01790503|26500956|P2|Overall Study|Death|0
7616817|NCT01790503|26500957|P1|Overall Study|Death|0
7616818|NCT01790503|26500947|P11|Overall Study|Physician Decision|1
7616819|NCT01790503|26500948|P10|Overall Study|Physician Decision|1
7616820|NCT01790503|26500949|P9|Overall Study|Physician Decision|0
7616821|NCT01790503|26500950|P8|Overall Study|Physician Decision|0
7616822|NCT01790503|26500951|P7|Overall Study|Physician Decision|0
7616823|NCT01790503|26500952|P6|Overall Study|Physician Decision|0
7616824|NCT01790503|26500953|P5|Overall Study|Physician Decision|0
7616825|NCT01790503|26500954|P4|Overall Study|Physician Decision|0
7616826|NCT01790503|26500955|P3|Overall Study|Physician Decision|0
7616827|NCT01790503|26500956|P2|Overall Study|Physician Decision|0
7616828|NCT01790503|26500957|P1|Overall Study|Physician Decision|0
7616829|NCT01790503|26500947|P11|Overall Study|Protocol Violation|0
7616830|NCT01790503|26500948|P10|Overall Study|Protocol Violation|1
7616831|NCT01790503|26500949|P9|Overall Study|Protocol Violation|0
7616832|NCT01790503|26500950|P8|Overall Study|Protocol Violation|0
7616833|NCT01790503|26500951|P7|Overall Study|Protocol Violation|0
7616834|NCT01790503|26500952|P6|Overall Study|Protocol Violation|0
7616835|NCT01790503|26500953|P5|Overall Study|Protocol Violation|0
7616836|NCT01790503|26500954|P4|Overall Study|Protocol Violation|0
7616837|NCT01790503|26500955|P3|Overall Study|Protocol Violation|0
7616838|NCT01790503|26500956|P2|Overall Study|Protocol Violation|0
7616839|NCT01790503|26500957|P1|Overall Study|Protocol Violation|0
7616840|NCT01790503|26500947|P11|Overall Study|Disease progression|7
7616841|NCT01790503|26500948|P10|Overall Study|Disease progression|17
7616842|NCT01790503|26500949|P9|Overall Study|Disease progression|0
7616843|NCT01790503|26500950|P8|Overall Study|Disease progression|1
7616844|NCT01790503|26500951|P7|Overall Study|Disease progression|0
7616845|NCT01790503|26500952|P6|Overall Study|Disease progression|1
7616846|NCT01790503|26500953|P5|Overall Study|Disease progression|2
7616847|NCT01790503|26500954|P4|Overall Study|Disease progression|1
7616848|NCT01790503|26500955|P3|Overall Study|Disease progression|0
7616849|NCT01790503|26500956|P2|Overall Study|Disease progression|1
7616850|NCT01790503|26500957|P1|Overall Study|Disease progression|2
7616851|NCT01790503|26500947|P11|Overall Study|Withdrawal by Subject|1
7616852|NCT01790503|26500948|P10|Overall Study|Withdrawal by Subject|0
7616853|NCT01790503|26500949|P9|Overall Study|Withdrawal by Subject|0
7616854|NCT01790503|26500950|P8|Overall Study|Withdrawal by Subject|0
7616855|NCT01790503|26500951|P7|Overall Study|Withdrawal by Subject|1
7616856|NCT01790503|26500952|P6|Overall Study|Withdrawal by Subject|2
7616857|NCT01790503|26500953|P5|Overall Study|Withdrawal by Subject|1
7616858|NCT01790503|26500954|P4|Overall Study|Withdrawal by Subject|1
7616859|NCT01790503|26500955|P3|Overall Study|Withdrawal by Subject|1
7616860|NCT01790503|26500956|P2|Overall Study|Withdrawal by Subject|0
7616861|NCT01790503|26500957|P1|Overall Study|Withdrawal by Subject|0
7616862|NCT01790503|26500947|P11|Overall Study|Adverse Event|7
7616863|NCT01790503|26500948|P10|Overall Study|Adverse Event|4
7616864|NCT01790503|26500949|P9|Overall Study|Adverse Event|2
7616865|NCT01790503|26500950|P8|Overall Study|Adverse Event|0
7616866|NCT01790503|26500951|P7|Overall Study|Adverse Event|0
7616867|NCT01790503|26500952|P6|Overall Study|Adverse Event|2
7616868|NCT01790503|26500953|P5|Overall Study|Adverse Event|0
7616869|NCT01790503|26500954|P4|Overall Study|Adverse Event|0
7616870|NCT01790503|26500955|P3|Overall Study|Adverse Event|0
7616871|NCT01790503|26500956|P2|Overall Study|Adverse Event|0
7616872|NCT01790503|26500957|P1|Overall Study|Adverse Event|1
7616873|NCT01790438|26501027|P2|Overall Study|Protocol Required Discontinuation|1
7616874|NCT01790438|26501028|P1|Overall Study|Protocol Required Discontinuation|7
7616875|NCT01790438|26501027|P2|Overall Study|Sponsor Decision|3
7616876|NCT01790438|26501028|P1|Overall Study|Sponsor Decision|0
7616877|NCT01790438|26501027|P2|Overall Study|Physician Decision|1
7616878|NCT01790438|26501028|P1|Overall Study|Physician Decision|3
7616879|NCT01790438|26501027|P2|Overall Study|Withdrawal by Subject|2
7616880|NCT01790438|26501028|P1|Overall Study|Withdrawal by Subject|13
7616881|NCT01790438|26501027|P2|Overall Study|Lost to Follow-up|2
7616882|NCT01790438|26501028|P1|Overall Study|Lost to Follow-up|5
7616883|NCT01790438|26501027|P2|Overall Study|Death|0
7616884|NCT01790438|26501028|P1|Overall Study|Death|4
7616885|NCT01790438|26501027|P2|Overall Study|Adverse Event|2
7616886|NCT01790438|26501028|P1|Overall Study|Adverse Event|3
7616887|NCT01790295|26501078|P1|Overall Study|Study closure|4
7616888|NCT01790295|26501078|P1|Overall Study|Lack of Efficacy|2
7616889|NCT01790295|26501078|P1|Overall Study|Death|4
7616890|NCT01790295|26501078|P1|Overall Study|Adverse Event|1
7616891|NCT01790126|26501148|P3|Overall Study|Radiographic Progression|0
7616892|NCT01790126|26501149|P2|Overall Study|Radiographic Progression|1
7616893|NCT01790126|26501150|P1|Overall Study|Radiographic Progression|3
7616894|NCT01790126|26501148|P3|Overall Study|Death|0
7616895|NCT01790126|26501149|P2|Overall Study|Death|0
7616896|NCT01790126|26501150|P1|Overall Study|Death|2
7616897|NCT01790126|26501148|P3|Overall Study|Adverse Event|0
7616898|NCT01790126|26501149|P2|Overall Study|Adverse Event|2
7616899|NCT01790126|26501150|P1|Overall Study|Adverse Event|0
7616900|NCT01790126|26501148|P3|Overall Study|Lost to Follow-up|1
7616901|NCT01790126|26501149|P2|Overall Study|Lost to Follow-up|0
7616902|NCT01790126|26501150|P1|Overall Study|Lost to Follow-up|1
7616903|NCT01790126|26501148|P3|Overall Study|Withdrawal by Subject|2
7616904|NCT01790126|26501149|P2|Overall Study|Withdrawal by Subject|1
7616905|NCT01790126|26501150|P1|Overall Study|Withdrawal by Subject|3
7616906|NCT01790126|26501148|P3|Overall Study|Withdrawal by Physician|2
7616907|NCT01790126|26501149|P2|Overall Study|Withdrawal by Physician|1
7616908|NCT01790126|26501150|P1|Overall Study|Withdrawal by Physician|1
7616909|NCT01790126|26501148|P3|Overall Study|Initiation of Non-Protocol Therapy|2
7616910|NCT01790126|26501149|P2|Overall Study|Initiation of Non-Protocol Therapy|4
7616911|NCT01790126|26501150|P1|Overall Study|Initiation of Non-Protocol Therapy|3
7616912|NCT01790126|26501148|P3|Overall Study|Other|8
7616913|NCT01790126|26501149|P2|Overall Study|Other|4
7616914|NCT01790126|26501150|P1|Overall Study|Other|5
7616915|NCT01790126|26501148|P3|Overall Study|PSA Progression|16
7616916|NCT01790126|26501149|P2|Overall Study|PSA Progression|16
7616917|NCT01790126|26501150|P1|Overall Study|PSA Progression|12
7616918|NCT01790113|26501207|P2|Overall Study|Study ended due to FDA clearance|68
7616919|NCT01790113|26501208|P1|Overall Study|Study ended due to FDA clearance|1
7616920|NCT01790113|26501207|P2|Overall Study|Adverse Event|7
7616921|NCT01790113|26501208|P1|Overall Study|Adverse Event|2
7616922|NCT01790048|26501216|P2|Overall Study|Measurement error|0
7616923|NCT01790048|26501217|P1|Overall Study|Measurement error|1
7616924|NCT01790048|26501216|P2|Overall Study|SAM at Enrollment|0
7616925|NCT01790048|26501217|P1|Overall Study|SAM at Enrollment|2
7616926|NCT01790048|26501216|P2|Overall Study|Other|2
7616927|NCT01790048|26501217|P1|Overall Study|Other|0
7616928|NCT01790048|26501216|P2|Overall Study|data entry error|1
7616929|NCT01790048|26501217|P1|Overall Study|data entry error|0
7616930|NCT01790048|26501216|P2|Overall Study|Incorrect Age|14
7616931|NCT01790048|26501217|P1|Overall Study|Incorrect Age|9
7616932|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7616933|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
7616934|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7616935|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Other|3
7616936|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Other|1
7616937|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Other|0
7616938|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7616939|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
7616940|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7616941|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
7616942|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
7616943|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
7616944|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
7616945|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
7616946|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
7616947|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7616948|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7616949|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7616950|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
7616951|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7616952|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7616953|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
7616954|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
7616955|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7616956|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7616957|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7616958|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7616959|NCT01789970|26501235|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
7616960|NCT01789970|26501236|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
7616961|NCT01789970|26501237|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7616962|NCT01789970|26501235|P3|Open-label Titration Period|Dropped out prior to dosing|0
7616963|NCT01789970|26501236|P2|Open-label Titration Period|Dropped out prior to dosing|0
7616964|NCT01789970|26501237|P1|Open-label Titration Period|Dropped out prior to dosing|2
7616965|NCT01789970|26501235|P3|Open-label Titration Period|Other|0
7616966|NCT01789970|26501236|P2|Open-label Titration Period|Other|0
7616967|NCT01789970|26501237|P1|Open-label Titration Period|Other|76
7616968|NCT01789970|26501235|P3|Open-label Titration Period|Pregnancy|0
7616969|NCT01789970|26501236|P2|Open-label Titration Period|Pregnancy|0
7616970|NCT01789970|26501237|P1|Open-label Titration Period|Pregnancy|2
7616971|NCT01789970|26501235|P3|Open-label Titration Period|Noncompliance with study procedures|0
7616972|NCT01789970|26501236|P2|Open-label Titration Period|Noncompliance with study procedures|0
7616973|NCT01789970|26501237|P1|Open-label Titration Period|Noncompliance with study procedures|8
7616974|NCT01789970|26501235|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
7616975|NCT01789970|26501236|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
7616976|NCT01789970|26501237|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
7616977|NCT01789970|26501235|P3|Open-label Titration Period|Noncompliance to study drug admin|0
7616978|NCT01789970|26501236|P2|Open-label Titration Period|Noncompliance to study drug admin|0
7616979|NCT01789970|26501237|P1|Open-label Titration Period|Noncompliance to study drug admin|11
7616980|NCT01789970|26501235|P3|Open-label Titration Period|Lost to Follow-up|0
7616981|NCT01789970|26501236|P2|Open-label Titration Period|Lost to Follow-up|0
7616982|NCT01789970|26501237|P1|Open-label Titration Period|Lost to Follow-up|5
7616983|NCT01789970|26501235|P3|Open-label Titration Period|Protocol Violation|0
7616984|NCT01789970|26501236|P2|Open-label Titration Period|Protocol Violation|0
7616985|NCT01789970|26501237|P1|Open-label Titration Period|Protocol Violation|18
7616986|NCT01789970|26501235|P3|Open-label Titration Period|Withdrawal by Subject|0
7616987|NCT01789970|26501236|P2|Open-label Titration Period|Withdrawal by Subject|0
7616988|NCT01789970|26501237|P1|Open-label Titration Period|Withdrawal by Subject|31
7616989|NCT01789970|26501235|P3|Open-label Titration Period|Lack of Efficacy|0
7616990|NCT01789970|26501236|P2|Open-label Titration Period|Lack of Efficacy|0
7616991|NCT01789970|26501237|P1|Open-label Titration Period|Lack of Efficacy|31
7616992|NCT01789970|26501235|P3|Open-label Titration Period|Adverse Event|0
7616993|NCT01789970|26501236|P2|Open-label Titration Period|Adverse Event|0
7616994|NCT01789970|26501237|P1|Open-label Titration Period|Adverse Event|68
7616995|NCT01789606|26501295|P2|Overall Study|Ineligible or not Willing to Continue|348
7616996|NCT01789606|26501296|P1|Overall Study|Ineligible or not Willing to Continue|0
7616997|NCT01789606|26501295|P2|Overall Study|Lost to Follow-up|14
7616998|NCT01789606|26501296|P1|Overall Study|Lost to Follow-up|0
7616999|NCT01789606|26501295|P2|Overall Study|Adverse Event|3
7617000|NCT01789606|26501296|P1|Overall Study|Adverse Event|0
7617001|NCT01789606|26501295|P2|Overall Study|Protocol Violation|55
7617002|NCT01789606|26501296|P1|Overall Study|Protocol Violation|0
7617003|NCT01789606|26501295|P2|Overall Study|No Study Medication Taken|1
7617004|NCT01789606|26501296|P1|Overall Study|No Study Medication Taken|0
7617005|NCT01789606|26501295|P2|Overall Study|Administrative Reasons|6
7617006|NCT01789606|26501296|P1|Overall Study|Administrative Reasons|17
7617007|NCT01789606|26501295|P2|Overall Study|Ineligible|2
7617008|NCT01789606|26501296|P1|Overall Study|Ineligible|6
7617009|NCT01789606|26501295|P2|Overall Study|Withdrawal by Subject|1
7617010|NCT01789606|26501296|P1|Overall Study|Withdrawal by Subject|0
7617011|NCT01789606|26501295|P2|Overall Study|Participant not Purchased the Product|20
7617012|NCT01789606|26501296|P1|Overall Study|Participant not Purchased the Product|0
7617013|NCT01789567|26501314|P1|Overall Study|Death|6
7617014|NCT01789476|26501323|P2|Overall Study|Unable to get IV access|0
7617015|NCT01789476|26501324|P1|Overall Study|Unable to get IV access|1
7617016|NCT01789476|26501323|P2|Overall Study|Adverse Event|0
7617017|NCT01789476|26501324|P1|Overall Study|Adverse Event|1
7617018|NCT01789476|26501323|P2|Overall Study|Lack of Efficacy|2
7617019|NCT01789476|26501324|P1|Overall Study|Lack of Efficacy|6
7617020|NCT01789320|26501334|P1|Overall Study|Lost to Follow-up|1
7617021|NCT01789320|26501334|P1|Overall Study|Re-enrolled into study|1
7617022|NCT01789281|26501343|P2|Overall Study|Administrative problems|1
7617023|NCT01789281|26501344|P1|Overall Study|Administrative problems|0
7617024|NCT01789281|26501343|P2|Overall Study|Lost to Follow-up|0
7617025|NCT01789281|26501344|P1|Overall Study|Lost to Follow-up|1
7617026|NCT01789281|26501343|P2|Overall Study|Withdrawal by Subject|0
7617027|NCT01789281|26501344|P1|Overall Study|Withdrawal by Subject|1
7617028|NCT01789281|26501343|P2|Overall Study|Adverse Event|5
7617029|NCT01789281|26501344|P1|Overall Study|Adverse Event|5
7617030|NCT01789281|26501343|P2|Overall Study|Disease progression|4
7617031|NCT01789281|26501344|P1|Overall Study|Disease progression|15
7617032|NCT01789203|26501365|P2|Overall Study|patient non-adherent|0
7617033|NCT01789203|26501366|P1|Overall Study|patient non-adherent|2
7617034|NCT01789203|26501365|P2|Overall Study|Other|1
7617035|NCT01789203|26501366|P1|Overall Study|Other|1
7617036|NCT01789203|26501365|P2|Overall Study|Protocol Violation|1
7617037|NCT01789203|26501366|P1|Overall Study|Protocol Violation|2
7617038|NCT01789203|26501365|P2|Overall Study|Death|0
7617039|NCT01789203|26501366|P1|Overall Study|Death|1
7617040|NCT01789203|26501365|P2|Overall Study|Withdrawal by Subject|0
7617041|NCT01789203|26501366|P1|Overall Study|Withdrawal by Subject|1
7617042|NCT01789203|26501365|P2|Overall Study|Adverse Event|2
7617043|NCT01789203|26501366|P1|Overall Study|Adverse Event|2
7617044|NCT01789047|26501407|P2|Overall Study|Withdrawal by Subject|2
7617045|NCT01789047|26501408|P1|Overall Study|Withdrawal by Subject|1
7617046|NCT01789047|26501407|P2|Overall Study|Adverse Event|2
7617047|NCT01789047|26501408|P1|Overall Study|Adverse Event|3
7617048|NCT01788943|26501416|P2|Overall Study|Withdrawal by Subject|0
7617049|NCT01788943|26501417|P1|Overall Study|Withdrawal by Subject|1
7617050|NCT01788566|26501446|P1|Overall Study|Clinical Progressive Disease|3
7617051|NCT01788566|26501446|P1|Overall Study|Adverse Event|1
7617052|NCT01788566|26501446|P1|Overall Study|Death|4
7617053|NCT01788423|26501484|P3|Overall Study|See Comments in Completed (above)|5
7617054|NCT01788423|26501485|P2|Overall Study|See Comments in Completed (above)|4
7617055|NCT01788423|26501486|P1|Overall Study|See Comments in Completed (above)|0
7617056|NCT01788358|26501497|P1|Overall Study|Adverse Event|51
7617057|NCT01788358|26501497|P1|Overall Study|Lack of Efficacy|1
7617058|NCT01788358|26501497|P1|Overall Study|Withdrawal by Subject|26
7617059|NCT01788358|26501497|P1|Overall Study|Protocol Violation|3
7617060|NCT01788358|26501497|P1|Overall Study|Lost to Follow-up|5
7617061|NCT01788358|26501497|P1|Overall Study|Logistical difficulties|1
7617062|NCT01788358|26501497|P1|Overall Study|Other|11
7617063|NCT01788228|26501511|P2|Overall Study|Migrated/moved from study area|0
7617064|NCT01788228|26501512|P1|Overall Study|Migrated/moved from study area|1
7617065|NCT01788215|26501545|P2|Overall Study|Lost to Follow-up|0
7617066|NCT01788215|26501546|P1|Overall Study|Lost to Follow-up|2
7617067|NCT01788215|26501545|P2|Overall Study|Withdrawal by Subject|1
7617068|NCT01788215|26501546|P1|Overall Study|Withdrawal by Subject|0
7617069|NCT01788163|26501575|P9|Overall Study|Withdrawal by Subject|1
7617070|NCT01788163|26501576|P8|Overall Study|Withdrawal by Subject|0
7617071|NCT01788163|26501577|P7|Overall Study|Withdrawal by Subject|0
7617072|NCT01788163|26501578|P6|Overall Study|Withdrawal by Subject|0
7617073|NCT01788163|26501579|P5|Overall Study|Withdrawal by Subject|0
7617074|NCT01788163|26501580|P4|Overall Study|Withdrawal by Subject|0
7617075|NCT01788163|26501581|P3|Overall Study|Withdrawal by Subject|0
7617076|NCT01788163|26501582|P2|Overall Study|Withdrawal by Subject|0
7617077|NCT01788163|26501583|P1|Overall Study|Withdrawal by Subject|2
7617078|NCT01788163|26501575|P9|Overall Study|Other|15
7617079|NCT01788163|26501576|P8|Overall Study|Other|48
7617080|NCT01788163|26501577|P7|Overall Study|Other|1
7617081|NCT01788163|26501578|P6|Overall Study|Other|7
7617082|NCT01788163|26501579|P5|Overall Study|Other|0
7617083|NCT01788163|26501580|P4|Overall Study|Other|0
7617084|NCT01788163|26501581|P3|Overall Study|Other|0
7617085|NCT01788163|26501582|P2|Overall Study|Other|0
7617086|NCT01788163|26501583|P1|Overall Study|Other|53
7617087|NCT01788046|26501775|P2|Overall Study|Protocol Specified Criteria|1
7617088|NCT01788046|26501776|P1|Overall Study|Protocol Specified Criteria|25
7617089|NCT01788046|26501775|P2|Overall Study|Death|5
7617090|NCT01788046|26501776|P1|Overall Study|Death|7
7617091|NCT01788046|26501775|P2|Overall Study|Lost to Follow-up|19
7617092|NCT01788046|26501776|P1|Overall Study|Lost to Follow-up|12
7617093|NCT01788046|26501775|P2|Overall Study|Withdrawal by Subject|12
7617094|NCT01788046|26501776|P1|Overall Study|Withdrawal by Subject|12
7617095|NCT01787838|26501799|P1|Overall Study|refused|1413
7617096|NCT01787825|26501803|P2|Overall Study|Data Not Analyzable|1
7617097|NCT01787825|26501804|P1|Overall Study|Data Not Analyzable|5
7617098|NCT01787825|26501803|P2|Overall Study|Subject Did Not Ingest Capsules|0
7617099|NCT01787825|26501804|P1|Overall Study|Subject Did Not Ingest Capsules|1
7617100|NCT01787760|26501822|P3|Overall Study|Near vision blur|0
7617101|NCT01787760|26501823|P2|Overall Study|Near vision blur|0
7617102|NCT01787760|26501824|P1|Overall Study|Near vision blur|1
7617103|NCT01787760|26501822|P3|Overall Study|Unsatisfactory visual response|0
7617104|NCT01787760|26501823|P2|Overall Study|Unsatisfactory visual response|1
7617105|NCT01787760|26501824|P1|Overall Study|Unsatisfactory visual response|1
7617106|NCT01787760|26501822|P3|Overall Study|Unsatisfactory physiological response|0
7617107|NCT01787760|26501823|P2|Overall Study|Unsatisfactory physiological response|4
7617108|NCT01787760|26501824|P1|Overall Study|Unsatisfactory physiological response|2
7617109|NCT01787760|26501822|P3|Overall Study|Unsatisfactory lens fitting performance|0
7617110|NCT01787760|26501823|P2|Overall Study|Unsatisfactory lens fitting performance|6
7617111|NCT01787760|26501824|P1|Overall Study|Unsatisfactory lens fitting performance|3
7617112|NCT01787760|26501822|P3|Overall Study|Stroke|0
7617113|NCT01787760|26501823|P2|Overall Study|Stroke|0
7617114|NCT01787760|26501824|P1|Overall Study|Stroke|1
7617115|NCT01787760|26501822|P3|Overall Study|Lost to Follow-up|1
7617116|NCT01787760|26501823|P2|Overall Study|Lost to Follow-up|0
7617117|NCT01787760|26501824|P1|Overall Study|Lost to Follow-up|1
7617118|NCT01787760|26501822|P3|Overall Study|Withdrawal by Subject|2
7617119|NCT01787760|26501823|P2|Overall Study|Withdrawal by Subject|1
7617120|NCT01787760|26501824|P1|Overall Study|Withdrawal by Subject|5
7617121|NCT01787760|26501822|P3|Overall Study|Protocol Violation|1
7617122|NCT01787760|26501823|P2|Overall Study|Protocol Violation|0
7617123|NCT01787760|26501824|P1|Overall Study|Protocol Violation|6
7617124|NCT01787760|26501822|P3|Overall Study|Lens handling difficulty|0
7617125|NCT01787760|26501823|P2|Overall Study|Lens handling difficulty|2
7617126|NCT01787760|26501824|P1|Overall Study|Lens handling difficulty|1
7617127|NCT01787760|26501822|P3|Overall Study|Lens discomfort|0
7617128|NCT01787760|26501823|P2|Overall Study|Lens discomfort|0
7617129|NCT01787760|26501824|P1|Overall Study|Lens discomfort|3
7617130|NCT01787760|26501822|P3|Overall Study|Relocation|0
7617131|NCT01787760|26501823|P2|Overall Study|Relocation|1
7617132|NCT01787760|26501824|P1|Overall Study|Relocation|1
7617133|NCT01787760|26501822|P3|Overall Study|Dryness|0
7617134|NCT01787760|26501823|P2|Overall Study|Dryness|1
7617135|NCT01787760|26501824|P1|Overall Study|Dryness|0
7617136|NCT01787760|26501822|P3|Overall Study|Decompensated on left exotropia|1
7617137|NCT01787760|26501823|P2|Overall Study|Decompensated on left exotropia|0
7617138|NCT01787760|26501824|P1|Overall Study|Decompensated on left exotropia|0
7617139|NCT01787760|26501822|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
7617140|NCT01787760|26501823|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
7617141|NCT01787760|26501824|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
7617142|NCT01787591|26501849|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
7617143|NCT01787591|26501850|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7617144|NCT01787591|26501851|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7617145|NCT01787591|26501852|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7617146|NCT01787552|26501882|P4|Overall Study|Progressive Disease|1
7617147|NCT01787552|26501883|P3|Overall Study|Progressive Disease|1
7617148|NCT01787552|26501884|P2|Overall Study|Progressive Disease|2
7617149|NCT01787552|26501885|P1|Overall Study|Progressive Disease|2
7617150|NCT01787552|26501882|P4|Overall Study|Study terminated by Sponsor|3
7617151|NCT01787552|26501883|P3|Overall Study|Study terminated by Sponsor|1
7617152|NCT01787552|26501884|P2|Overall Study|Study terminated by Sponsor|0
7617153|NCT01787552|26501885|P1|Overall Study|Study terminated by Sponsor|0
7617154|NCT01787552|26501882|P4|Overall Study|Adverse Event|16
7617155|NCT01787552|26501883|P3|Overall Study|Adverse Event|2
7617156|NCT01787552|26501884|P2|Overall Study|Adverse Event|5
7617157|NCT01787552|26501885|P1|Overall Study|Adverse Event|2
7617158|NCT01787552|26501882|P4|Overall Study|Death|1
7617159|NCT01787552|26501883|P3|Overall Study|Death|0
7617160|NCT01787552|26501884|P2|Overall Study|Death|0
7617161|NCT01787552|26501885|P1|Overall Study|Death|0
7617162|NCT01787552|26501882|P4|Overall Study|Physician Decision|2
7617163|NCT01787552|26501883|P3|Overall Study|Physician Decision|1
7617164|NCT01787552|26501884|P2|Overall Study|Physician Decision|2
7617165|NCT01787552|26501885|P1|Overall Study|Physician Decision|2
7617166|NCT01787552|26501882|P4|Overall Study|Withdrawal by Subject|4
7617167|NCT01787552|26501883|P3|Overall Study|Withdrawal by Subject|0
7617168|NCT01787552|26501884|P2|Overall Study|Withdrawal by Subject|0
7617169|NCT01787552|26501885|P1|Overall Study|Withdrawal by Subject|2
7617170|NCT01787461|26501955|P2|Overall Study|Protocol Violation|0
7617171|NCT01787461|26501956|P1|Overall Study|Protocol Violation|3
7617172|NCT01787461|26501955|P2|Overall Study|Withdrawal by Subject|4
7617173|NCT01787461|26501956|P1|Overall Study|Withdrawal by Subject|3
7617174|NCT01787461|26501955|P2|Overall Study|No longer met eligibility criteria|0
7617175|NCT01787461|26501956|P1|Overall Study|No longer met eligibility criteria|1
7617176|NCT01787461|26501955|P2|Overall Study|Lost to Follow-up|2
7617177|NCT01787461|26501956|P1|Overall Study|Lost to Follow-up|3
7617178|NCT01787461|26501955|P2|Overall Study|Adverse Event|3
7617179|NCT01787461|26501956|P1|Overall Study|Adverse Event|4
7617180|NCT01787331|26502005|P1|Overall Study|Withdrawal by Subject|1
7617181|NCT01787331|26502005|P1|Overall Study|Physician Decision|1
7617182|NCT01787292|26502017|P2|Home Based Exercise Program|Withdrawal by Subject|1
7617183|NCT01787292|26502018|P1|Home Based Exercise Program|Withdrawal by Subject|3
7617184|NCT01787292|26502017|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
7617185|NCT01787292|26502018|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
7617186|NCT01787279|26502035|P1|Overall Study|Lack of Efficacy|1
7617187|NCT01787279|26502035|P1|Overall Study|Lost to Follow-up|2
7617188|NCT01787188|26502061|P3|Overall Study|Other, including patient moved|0
7617189|NCT01787188|26502062|P2|Overall Study|Other, including patient moved|3
7617190|NCT01787188|26502063|P1|Overall Study|Other, including patient moved|0
7617191|NCT01787188|26502061|P3|Overall Study|Lost to Follow-up|2
7617192|NCT01787188|26502062|P2|Overall Study|Lost to Follow-up|2
7617193|NCT01787188|26502063|P1|Overall Study|Lost to Follow-up|1
7617194|NCT01787188|26502061|P3|Overall Study|Protocol Violation|3
7617195|NCT01787188|26502062|P2|Overall Study|Protocol Violation|2
7617196|NCT01787188|26502063|P1|Overall Study|Protocol Violation|3
7617197|NCT01787188|26502061|P3|Overall Study|Withdrawal by Subject|2
7617198|NCT01787188|26502062|P2|Overall Study|Withdrawal by Subject|3
7617199|NCT01787188|26502063|P1|Overall Study|Withdrawal by Subject|4
7617200|NCT01787188|26502061|P3|Overall Study|Non-compliance with Study Drug|0
7617201|NCT01787188|26502062|P2|Overall Study|Non-compliance with Study Drug|1
7617202|NCT01787188|26502063|P1|Overall Study|Non-compliance with Study Drug|0
7617203|NCT01787188|26502061|P3|Overall Study|Lack of Efficacy|5
7617204|NCT01787188|26502062|P2|Overall Study|Lack of Efficacy|3
7617205|NCT01787188|26502063|P1|Overall Study|Lack of Efficacy|7
7617206|NCT01787188|26502061|P3|Overall Study|Adverse Event|6
7617207|NCT01787188|26502062|P2|Overall Study|Adverse Event|4
7617208|NCT01787188|26502063|P1|Overall Study|Adverse Event|2
7617209|NCT01787097|26502129|P4|Overall Study|Withdrawal by Subject|0
7617210|NCT01787097|26502130|P3|Overall Study|Withdrawal by Subject|0
7617211|NCT01787097|26502131|P2|Overall Study|Withdrawal by Subject|0
7617212|NCT01787097|26502132|P1|Overall Study|Withdrawal by Subject|1
7617213|NCT01787032|26502164|P6|Overall Study|Protocol Violation|1
7617214|NCT01787032|26502165|P5|Overall Study|Protocol Violation|1
7617215|NCT01787032|26502166|P4|Overall Study|Protocol Violation|0
7617216|NCT01787032|26502167|P3|Overall Study|Protocol Violation|0
7617217|NCT01787032|26502168|P2|Overall Study|Protocol Violation|0
7617218|NCT01787032|26502169|P1|Overall Study|Protocol Violation|0
7617219|NCT01786993|26502222|P2|Overall Study|Hospice Admission|0
7617220|NCT01786993|26502223|P1|Overall Study|Hospice Admission|1
7617221|NCT01786993|26502222|P2|Overall Study|System Explant|0
7617222|NCT01786993|26502223|P1|Overall Study|System Explant|1
7617223|NCT01786993|26502222|P2|Overall Study|Subject Non-Compliance|0
7617224|NCT01786993|26502223|P1|Overall Study|Subject Non-Compliance|1
7617225|NCT01786993|26502222|P2|Overall Study|Lost to Follow-up|1
7617226|NCT01786993|26502223|P1|Overall Study|Lost to Follow-up|0
7617227|NCT01786993|26502222|P2|Overall Study|Withdrawal by Subject|2
7617228|NCT01786993|26502223|P1|Overall Study|Withdrawal by Subject|3
7617229|NCT01786993|26502222|P2|Overall Study|Death|7
7617230|NCT01786993|26502223|P1|Overall Study|Death|6
7617231|NCT01786707|26502282|P2|Overall Study|Lost to Follow-up|1
7617232|NCT01786707|26502283|P1|Overall Study|Lost to Follow-up|1
7617233|NCT01786668|26502295|P4|Overall Study|Lost to Follow-up|0
7617234|NCT01786668|26502296|P3|Overall Study|Lost to Follow-up|1
7617235|NCT01786668|26502297|P2|Overall Study|Lost to Follow-up|0
7617236|NCT01786668|26502298|P1|Overall Study|Lost to Follow-up|1
7617237|NCT01786668|26502295|P4|Overall Study|Pregnancy|1
7617238|NCT01786668|26502296|P3|Overall Study|Pregnancy|0
7617239|NCT01786668|26502297|P2|Overall Study|Pregnancy|0
7617240|NCT01786668|26502298|P1|Overall Study|Pregnancy|0
7617241|NCT01786668|26502295|P4|Overall Study|Withdrawal by Subject|1
7617242|NCT01786668|26502296|P3|Overall Study|Withdrawal by Subject|3
7617243|NCT01786668|26502297|P2|Overall Study|Withdrawal by Subject|0
7617244|NCT01786668|26502298|P1|Overall Study|Withdrawal by Subject|0
7617245|NCT01786668|26502295|P4|Overall Study|Adverse Event|2
7617246|NCT01786668|26502296|P3|Overall Study|Adverse Event|1
7617247|NCT01786668|26502297|P2|Overall Study|Adverse Event|1
7617248|NCT01786668|26502298|P1|Overall Study|Adverse Event|0
7617249|NCT01786629|26502398|P2|Overall Study|Adverse Event|1
7617250|NCT01786629|26502399|P1|Overall Study|Adverse Event|0
7617251|NCT01786629|26502398|P2|Overall Study|Lack of Efficacy|4
7617252|NCT01786629|26502399|P1|Overall Study|Lack of Efficacy|0
7617253|NCT01786603|26502407|P2|Overall Study|Lost to Follow-up|2
7617254|NCT01786603|26502408|P1|Overall Study|Lost to Follow-up|1
7617255|NCT01786603|26502407|P2|Overall Study|Physician decision to withdraw|7
7617256|NCT01786603|26502408|P1|Overall Study|Physician decision to withdraw|6
7617257|NCT01786603|26502407|P2|Overall Study|Adverse Event|2
7617258|NCT01786603|26502408|P1|Overall Study|Adverse Event|6
7617259|NCT01786603|26502407|P2|Overall Study|Death|1
7617260|NCT01786603|26502408|P1|Overall Study|Death|5
7617261|NCT01786564|26502426|P1|Overall Study|Ineligible|17
7617262|NCT01786564|26502426|P1|Overall Study|Lost to Follow-up|47
7617263|NCT01786551|26502430|P1|Overall Study|Participant withdrew consent|2
7617264|NCT01786512|26502447|P11|Overall Study|Death|3
7617265|NCT01786512|26502448|P10|Overall Study|Death|1
7617266|NCT01786512|26502449|P9|Overall Study|Death|4
7617267|NCT01786512|26502450|P8|Overall Study|Death|0
7617268|NCT01786512|26502451|P7|Overall Study|Death|0
7617269|NCT01786512|26502452|P6|Overall Study|Death|0
7617270|NCT01786512|26502453|P5|Overall Study|Death|0
7617271|NCT01786512|26502454|P4|Overall Study|Death|0
7617272|NCT01786512|26502455|P3|Overall Study|Death|0
7617273|NCT01786512|26502456|P2|Overall Study|Death|0
7617274|NCT01786512|26502457|P1|Overall Study|Death|0
7617275|NCT01786512|26502447|P11|Overall Study|Withdrawal by Subject|7
7617276|NCT01786512|26502448|P10|Overall Study|Withdrawal by Subject|3
7617277|NCT01786512|26502449|P9|Overall Study|Withdrawal by Subject|0
7617278|NCT01786512|26502450|P8|Overall Study|Withdrawal by Subject|0
7617279|NCT01786512|26502451|P7|Overall Study|Withdrawal by Subject|1
7617280|NCT01786512|26502452|P6|Overall Study|Withdrawal by Subject|0
7617281|NCT01786512|26502453|P5|Overall Study|Withdrawal by Subject|0
7617282|NCT01786512|26502454|P4|Overall Study|Withdrawal by Subject|0
7617283|NCT01786512|26502455|P3|Overall Study|Withdrawal by Subject|0
7617284|NCT01786512|26502456|P2|Overall Study|Withdrawal by Subject|1
7617285|NCT01786512|26502457|P1|Overall Study|Withdrawal by Subject|0
7617286|NCT01786512|26502447|P11|Overall Study|Decision by sponsor|2
7617287|NCT01786512|26502448|P10|Overall Study|Decision by sponsor|0
7617288|NCT01786512|26502449|P9|Overall Study|Decision by sponsor|0
7617289|NCT01786512|26502450|P8|Overall Study|Decision by sponsor|0
7617290|NCT01786512|26502451|P7|Overall Study|Decision by sponsor|0
7617291|NCT01786512|26502452|P6|Overall Study|Decision by sponsor|0
7617292|NCT01786512|26502453|P5|Overall Study|Decision by sponsor|0
7617293|NCT01786512|26502454|P4|Overall Study|Decision by sponsor|0
7617294|NCT01786512|26502455|P3|Overall Study|Decision by sponsor|0
7617295|NCT01786512|26502456|P2|Overall Study|Decision by sponsor|0
7617296|NCT01786512|26502457|P1|Overall Study|Decision by sponsor|0
7617297|NCT01786512|26502447|P11|Overall Study|Lost to Follow-up|0
7617298|NCT01786512|26502448|P10|Overall Study|Lost to Follow-up|1
7617299|NCT01786512|26502449|P9|Overall Study|Lost to Follow-up|0
7617300|NCT01786512|26502450|P8|Overall Study|Lost to Follow-up|0
7617301|NCT01786512|26502451|P7|Overall Study|Lost to Follow-up|0
7617302|NCT01786512|26502452|P6|Overall Study|Lost to Follow-up|0
7617303|NCT01786512|26502453|P5|Overall Study|Lost to Follow-up|0
7617304|NCT01786512|26502454|P4|Overall Study|Lost to Follow-up|0
7617305|NCT01786512|26502455|P3|Overall Study|Lost to Follow-up|0
7617306|NCT01786512|26502456|P2|Overall Study|Lost to Follow-up|0
7617307|NCT01786512|26502457|P1|Overall Study|Lost to Follow-up|0
7617308|NCT01786330|26502542|P2|Overall Study|Protocol Violation|0
7617309|NCT01786330|26502543|P1|Overall Study|Protocol Violation|1
7617310|NCT01786330|26502542|P2|Overall Study|Excluded intraoperatively|1
7617311|NCT01786330|26502543|P1|Overall Study|Excluded intraoperatively|0
7617312|NCT01786330|26502542|P2|Overall Study|Lost to Follow-up|1
7617313|NCT01786330|26502543|P1|Overall Study|Lost to Follow-up|0
7617314|NCT01786330|26502542|P2|Overall Study|Withdrawal by Subject|1
7617315|NCT01786330|26502543|P1|Overall Study|Withdrawal by Subject|0
7617316|NCT01786174|26502595|P2|Overall Study|Discontinued Study Drug|0
7617317|NCT01786174|26502596|P1|Overall Study|Discontinued Study Drug|2
7617318|NCT01786148|26502625|P2|Overall Study|Incarceration|1
7617319|NCT01786148|26502626|P1|Overall Study|Incarceration|1
7617320|NCT01786148|26502625|P2|Overall Study|Withdrawal by Subject|7
7617321|NCT01786148|26502626|P1|Overall Study|Withdrawal by Subject|0
7617322|NCT01786148|26502625|P2|Overall Study|Death|1
7617323|NCT01786148|26502626|P1|Overall Study|Death|0
7617324|NCT01786148|26502625|P2|Overall Study|Lost to Follow-up|13
7617325|NCT01786148|26502626|P1|Overall Study|Lost to Follow-up|21
7617326|NCT01786109|26502641|P3|Overall Study|adverse effects colon preparation|1
7617327|NCT01786109|26502642|P2|Overall Study|adverse effects colon preparation|0
7617328|NCT01786109|26502643|P1|Overall Study|adverse effects colon preparation|0
7617329|NCT01786109|26502641|P3|Overall Study|unrelated illness|1
7617330|NCT01786109|26502642|P2|Overall Study|unrelated illness|0
7617331|NCT01786109|26502643|P1|Overall Study|unrelated illness|0
7617332|NCT01786109|26502641|P3|Overall Study|fail manometry barostat tube placement|0
7617333|NCT01786109|26502642|P2|Overall Study|fail manometry barostat tube placement|0
7617334|NCT01786109|26502643|P1|Overall Study|fail manometry barostat tube placement|1
7617335|NCT01785875|26502672|P3|Overall Study|Missing|3
7617336|NCT01785875|26502673|P2|Overall Study|Missing|1
7617337|NCT01785875|26502674|P1|Overall Study|Missing|0
7617338|NCT01785875|26502672|P3|Overall Study|Protocol Specified Criteria|55
7617339|NCT01785875|26502673|P2|Overall Study|Protocol Specified Criteria|214
7617340|NCT01785875|26502674|P1|Overall Study|Protocol Specified Criteria|207
7617341|NCT01785875|26502672|P3|Overall Study|Sponsor Decision|0
7617342|NCT01785875|26502673|P2|Overall Study|Sponsor Decision|2
7617343|NCT01785875|26502674|P1|Overall Study|Sponsor Decision|0
7617344|NCT01785875|26502672|P3|Overall Study|Death|7
7617345|NCT01785875|26502673|P2|Overall Study|Death|16
7617346|NCT01785875|26502674|P1|Overall Study|Death|27
7617347|NCT01785875|26502672|P3|Overall Study|Lost to Follow-up|6
7617348|NCT01785875|26502673|P2|Overall Study|Lost to Follow-up|22
7617349|NCT01785875|26502674|P1|Overall Study|Lost to Follow-up|19
7617350|NCT01785875|26502672|P3|Overall Study|Withdrawal by Subject|36
7617351|NCT01785875|26502673|P2|Overall Study|Withdrawal by Subject|34
7617352|NCT01785875|26502674|P1|Overall Study|Withdrawal by Subject|41
7617353|NCT01785849|26502743|P2|Overall Study|Lost to Follow-up|11
7617354|NCT01785849|26502744|P1|Overall Study|Lost to Follow-up|10
7617355|NCT01785849|26502743|P2|Overall Study|Sponsor Decision|1
7617356|NCT01785849|26502744|P1|Overall Study|Sponsor Decision|0
7617357|NCT01785849|26502743|P2|Overall Study|Withdrawal by Subject|12
7617358|NCT01785849|26502744|P1|Overall Study|Withdrawal by Subject|15
7617359|NCT01785849|26502743|P2|Overall Study|Protocol Specified Criteria|1
7617360|NCT01785849|26502744|P1|Overall Study|Protocol Specified Criteria|29
7617361|NCT01785849|26502743|P2|Overall Study|Death|9
7617362|NCT01785849|26502744|P1|Overall Study|Death|7
7617363|NCT01785628|26502781|P2|Overall Study|Lost to Follow-up|3
7617364|NCT01785628|26502782|P1|Overall Study|Lost to Follow-up|2
7617365|NCT01785615|26502805|P4|Dietary Phase|Lost to Follow-up|24
7617366|NCT01785615|26502806|P3|Dietary Phase|Lost to Follow-up|0
7617367|NCT01785615|26502807|P2|Dietary Phase|Lost to Follow-up|0
7617368|NCT01785615|26502808|P1|Dietary Phase|Lost to Follow-up|0
7617369|NCT01785602|26502880|P2|Overall Study|Administrative problems|3
7617370|NCT01785602|26502881|P1|Overall Study|Administrative problems|7
7617371|NCT01785602|26502880|P2|Overall Study|Adverse Event|5
7617372|NCT01785602|26502881|P1|Overall Study|Adverse Event|3
7617373|NCT01785602|26502880|P2|Overall Study|Lost to Follow-up|1
7617374|NCT01785602|26502881|P1|Overall Study|Lost to Follow-up|1
7617375|NCT01785602|26502880|P2|Overall Study|Withdrawal by Subject|0
7617376|NCT01785602|26502881|P1|Overall Study|Withdrawal by Subject|2
7617377|NCT01785524|26502891|P2|Overall Study|Withdrawal by Subject|2
7617378|NCT01785524|26502892|P1|Overall Study|Withdrawal by Subject|2
7617379|NCT01785472|26502911|P3|Overall Study|Technical problems|1
7617380|NCT01785472|26502912|P2|Overall Study|Technical problems|0
7617381|NCT01785472|26502913|P1|Overall Study|Technical problems|0
7617382|NCT01785472|26502911|P3|Overall Study|Subject/guardian decision|11
7617383|NCT01785472|26502912|P2|Overall Study|Subject/guardian decision|10
7617384|NCT01785472|26502913|P1|Overall Study|Subject/guardian decision|15
7617385|NCT01785472|26502911|P3|Overall Study|Protocol deviation|2
7617386|NCT01785472|26502912|P2|Overall Study|Protocol deviation|2
7617387|NCT01785472|26502913|P1|Overall Study|Protocol deviation|0
7617388|NCT01785472|26502911|P3|Overall Study|Physician Decision|1
7617389|NCT01785472|26502912|P2|Overall Study|Physician Decision|1
7617390|NCT01785472|26502913|P1|Overall Study|Physician Decision|1
7617391|NCT01785472|26502911|P3|Overall Study|Lost to Follow-up|0
7617392|NCT01785472|26502912|P2|Overall Study|Lost to Follow-up|2
7617393|NCT01785472|26502913|P1|Overall Study|Lost to Follow-up|1
7617394|NCT01785472|26502911|P3|Overall Study|Lack of Efficacy|1
7617395|NCT01785472|26502912|P2|Overall Study|Lack of Efficacy|0
7617396|NCT01785472|26502913|P1|Overall Study|Lack of Efficacy|2
7617397|NCT01785472|26502911|P3|Overall Study|Adverse Event|6
7617398|NCT01785472|26502912|P2|Overall Study|Adverse Event|4
7617399|NCT01785472|26502913|P1|Overall Study|Adverse Event|5
7617400|NCT01785160|26502999|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
7617401|NCT01785160|26502999|P1|Treatment Period 1: Raltegravir|Not treated|1
7617402|NCT01785069|26503036|P4|Overall Study|Not evaluable|8
7617403|NCT01785069|26503037|P3|Overall Study|Not evaluable|5
7617404|NCT01785069|26503038|P2|Overall Study|Not evaluable|4
7617405|NCT01785069|26503039|P1|Overall Study|Not evaluable|7
7617406|NCT01785069|26503036|P4|Overall Study|Reason not Specified|4
7617407|NCT01785069|26503037|P3|Overall Study|Reason not Specified|1
7617408|NCT01785069|26503038|P2|Overall Study|Reason not Specified|2
7617409|NCT01785069|26503039|P1|Overall Study|Reason not Specified|1
7617410|NCT01785069|26503036|P4|Overall Study|Lost to Follow-up|1
7617411|NCT01785069|26503037|P3|Overall Study|Lost to Follow-up|4
7617412|NCT01785069|26503038|P2|Overall Study|Lost to Follow-up|2
7617413|NCT01785069|26503039|P1|Overall Study|Lost to Follow-up|1
7617414|NCT01785069|26503036|P4|Overall Study|Subject choice|1
7617415|NCT01785069|26503037|P3|Overall Study|Subject choice|0
7617416|NCT01785069|26503038|P2|Overall Study|Subject choice|2
7617417|NCT01785069|26503039|P1|Overall Study|Subject choice|2
7617418|NCT01785069|26503036|P4|Overall Study|Death|0
7617419|NCT01785069|26503037|P3|Overall Study|Death|2
7617420|NCT01785069|26503038|P2|Overall Study|Death|0
7617421|NCT01785069|26503039|P1|Overall Study|Death|0
7617422|NCT01785069|26503036|P4|Overall Study|Implanted with nonstudy device|0
7617423|NCT01785069|26503037|P3|Overall Study|Implanted with nonstudy device|1
7617424|NCT01785069|26503038|P2|Overall Study|Implanted with nonstudy device|2
7617425|NCT01785069|26503039|P1|Overall Study|Implanted with nonstudy device|1
7617426|NCT01784965|26503088|P2|Overall Study|Adverse Event|8
7617427|NCT01784965|26503089|P1|Overall Study|Adverse Event|0
7617428|NCT01784965|26503088|P2|Overall Study|Withdrawal by Subject|3
7617429|NCT01784965|26503089|P1|Overall Study|Withdrawal by Subject|6
7617430|NCT01784861|26503124|P6|Overall Study|Physician Decision|1
7617431|NCT01784861|26503125|P5|Overall Study|Physician Decision|0
7617432|NCT01784861|26503126|P4|Overall Study|Physician Decision|2
7617433|NCT01784861|26503127|P3|Overall Study|Physician Decision|0
7617434|NCT01784861|26503128|P2|Overall Study|Physician Decision|0
7617435|NCT01784861|26503129|P1|Overall Study|Physician Decision|0
7617436|NCT01784861|26503124|P6|Overall Study|Withdrawal by Subject|0
7617437|NCT01784861|26503125|P5|Overall Study|Withdrawal by Subject|0
7617438|NCT01784861|26503126|P4|Overall Study|Withdrawal by Subject|1
7617439|NCT01784861|26503127|P3|Overall Study|Withdrawal by Subject|0
7617440|NCT01784861|26503128|P2|Overall Study|Withdrawal by Subject|0
7617441|NCT01784861|26503129|P1|Overall Study|Withdrawal by Subject|0
7617442|NCT01784861|26503124|P6|Overall Study|Adverse Event|0
7617443|NCT01784861|26503125|P5|Overall Study|Adverse Event|1
7617444|NCT01784861|26503126|P4|Overall Study|Adverse Event|2
7617445|NCT01784861|26503127|P3|Overall Study|Adverse Event|1
7617446|NCT01784861|26503128|P2|Overall Study|Adverse Event|0
7617447|NCT01784861|26503129|P1|Overall Study|Adverse Event|0
7617448|NCT01784523|26503275|P2|Overall Study|Study closed early|4
7617449|NCT01784523|26503276|P1|Overall Study|Study closed early|7
7617450|NCT01784419|26503282|P1|Overall Study|Adverse Event|3
7617451|NCT01784211|26503290|P6|Part A (Days 1-15)|Withdrawal by Subject|0
7617452|NCT01784211|26503291|P5|Part A (Days 1-15)|Withdrawal by Subject|0
7617453|NCT01784211|26503292|P4|Part A (Days 1-15)|Withdrawal by Subject|0
7617454|NCT01784211|26503293|P3|Part A (Days 1-15)|Withdrawal by Subject|0
7617455|NCT01784211|26503294|P2|Part A (Days 1-15)|Withdrawal by Subject|1
7617456|NCT01784211|26503295|P1|Part A (Days 1-15)|Withdrawal by Subject|2
7617457|NCT01784211|26503290|P6|Part A (Days 1-15)|Adverse Event|0
7617458|NCT01784211|26503291|P5|Part A (Days 1-15)|Adverse Event|0
7617459|NCT01784211|26503292|P4|Part A (Days 1-15)|Adverse Event|0
7617460|NCT01784211|26503293|P3|Part A (Days 1-15)|Adverse Event|0
7617461|NCT01784211|26503294|P2|Part A (Days 1-15)|Adverse Event|1
7617462|NCT01784211|26503295|P1|Part A (Days 1-15)|Adverse Event|1
7617463|NCT01784068|26503313|P2|TFR Phase|Lack of Efficacy|88
7617464|NCT01784068|26503314|P1|TFR Phase|Lack of Efficacy|0
7617465|NCT01784068|26503313|P2|TFR Phase|Death|1
7617466|NCT01784068|26503314|P1|TFR Phase|Death|0
7617467|NCT01784068|26503313|P2|TFR Phase|Patient/guardian decision|3
7617468|NCT01784068|26503314|P1|TFR Phase|Patient/guardian decision|0
7617469|NCT01784068|26503313|P2|TFR Phase|Physician Decision|1
7617470|NCT01784068|26503314|P1|TFR Phase|Physician Decision|0
7617471|NCT01784068|26503313|P2|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
7617472|NCT01784068|26503314|P1|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
7617473|NCT01784068|26503313|P2|NTCS Phase|Death|0
7617474|NCT01784068|26503314|P1|NTCS Phase|Death|2
7617475|NCT01784068|26503313|P2|NTCS Phase|Patient/guardian decision|0
7617476|NCT01784068|26503314|P1|NTCS Phase|Patient/guardian decision|3
7617477|NCT01784068|26503313|P2|NTCS Phase|Physician Decision|0
7617478|NCT01784068|26503314|P1|NTCS Phase|Physician Decision|2
7617479|NCT01784068|26503313|P2|NTCS Phase|Adverse Event|0
7617480|NCT01784068|26503314|P1|NTCS Phase|Adverse Event|5
7617481|NCT01784029|26503332|P3|Overall Study|Lost to Follow-up|22
7617482|NCT01784029|26503333|P2|Overall Study|Lost to Follow-up|20
7617483|NCT01784029|26503334|P1|Overall Study|Lost to Follow-up|19
7617484|NCT01783938|26503363|P2|Overall Study|Other Reasons|1
7617485|NCT01783938|26503364|P1|Overall Study|Other Reasons|3
7617486|NCT01783938|26503363|P2|Overall Study|Maximum Clinical Benefit|0
7617487|NCT01783938|26503364|P1|Overall Study|Maximum Clinical Benefit|1
7617488|NCT01783938|26503363|P2|Overall Study|Participant Withdrew Consent|0
7617489|NCT01783938|26503364|P1|Overall Study|Participant Withdrew Consent|2
7617490|NCT01783938|26503363|P2|Overall Study|Participant Request to Discontinue Study Treatment|3
7617491|NCT01783938|26503364|P1|Overall Study|Participant Request to Discontinue Study Treatment|2
7617492|NCT01783938|26503363|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
7617493|NCT01783938|26503364|P1|Overall Study|Adverse Event Unrelated to Study Drug|4
7617494|NCT01783938|26503363|P2|Overall Study|Study Drug Toxicity|14
7617495|NCT01783938|26503364|P1|Overall Study|Study Drug Toxicity|27
7617496|NCT01783938|26503363|P2|Overall Study|Disease Progression|41
7617497|NCT01783938|26503364|P1|Overall Study|Disease Progression|18
7617498|NCT01783886|26503392|P3|Overall Study|Adverse Event|4
7617499|NCT01783886|26503393|P2|Overall Study|Adverse Event|5
7617500|NCT01783886|26503394|P1|Overall Study|Adverse Event|4
7617501|NCT01783886|26503392|P3|Overall Study|Withdrawal of consent by participant|4
7617502|NCT01783886|26503393|P2|Overall Study|Withdrawal of consent by participant|3
7617503|NCT01783886|26503394|P1|Overall Study|Withdrawal of consent by participant|1
7617504|NCT01783886|26503392|P3|Overall Study|Protocol deviation|2
7617505|NCT01783886|26503393|P2|Overall Study|Protocol deviation|0
7617506|NCT01783886|26503394|P1|Overall Study|Protocol deviation|0
7617507|NCT01783886|26503392|P3|Overall Study|Lost to Follow-up|0
7617508|NCT01783886|26503393|P2|Overall Study|Lost to Follow-up|3
7617509|NCT01783886|26503394|P1|Overall Study|Lost to Follow-up|0
7617510|NCT01783821|26503457|P2|Overall Study|Screen Failure|1
7617511|NCT01783821|26503458|P1|Overall Study|Screen Failure|1
7617512|NCT01783743|26503476|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
7617513|NCT01783743|26503477|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
7617514|NCT01783743|26503476|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
7617515|NCT01783743|26503477|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
7617516|NCT01783743|26503476|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
7617517|NCT01783743|26503477|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
7617518|NCT01783730|26503491|P1|Overall Study|Failed to meet inclusion criteria|6
7617519|NCT01783678|26503516|P6|Overall Study|Withdrew Consent|0
7617520|NCT01783678|26503517|P5|Overall Study|Withdrew Consent|0
7617521|NCT01783678|26503518|P4|Overall Study|Withdrew Consent|2
7617522|NCT01783678|26503519|P3|Overall Study|Withdrew Consent|0
7617523|NCT01783678|26503520|P2|Overall Study|Withdrew Consent|1
7617524|NCT01783678|26503521|P1|Overall Study|Withdrew Consent|1
7617525|NCT01783678|26503516|P6|Overall Study|Lost to Follow-up|0
7617526|NCT01783678|26503517|P5|Overall Study|Lost to Follow-up|1
7617527|NCT01783678|26503518|P4|Overall Study|Lost to Follow-up|2
7617528|NCT01783678|26503519|P3|Overall Study|Lost to Follow-up|0
7617529|NCT01783678|26503520|P2|Overall Study|Lost to Follow-up|4
7617530|NCT01783678|26503521|P1|Overall Study|Lost to Follow-up|0
7617531|NCT01783678|26503516|P6|Overall Study|Lack of Efficacy|5
7617532|NCT01783678|26503517|P5|Overall Study|Lack of Efficacy|6
7617533|NCT01783678|26503518|P4|Overall Study|Lack of Efficacy|3
7617534|NCT01783678|26503519|P3|Overall Study|Lack of Efficacy|1
7617535|NCT01783678|26503520|P2|Overall Study|Lack of Efficacy|13
7617536|NCT01783678|26503521|P1|Overall Study|Lack of Efficacy|1
7617537|NCT01783678|26503516|P6|Overall Study|Randomized but Not Treated|0
7617538|NCT01783678|26503517|P5|Overall Study|Randomized but Not Treated|0
7617539|NCT01783678|26503518|P4|Overall Study|Randomized but Not Treated|1
7617540|NCT01783678|26503519|P3|Overall Study|Randomized but Not Treated|0
7617541|NCT01783678|26503520|P2|Overall Study|Randomized but Not Treated|0
7617542|NCT01783678|26503521|P1|Overall Study|Randomized but Not Treated|0
7617543|NCT01783548|26503625|P2|Overall Study|Lack of Efficacy|1
7617544|NCT01783548|26503626|P1|Overall Study|Lack of Efficacy|1
7617545|NCT01783548|26503625|P2|Overall Study|Lost to Follow-up|3
7617546|NCT01783548|26503626|P1|Overall Study|Lost to Follow-up|8
7617547|NCT01783548|26503625|P2|Overall Study|Protocol Violation|2
7617548|NCT01783548|26503626|P1|Overall Study|Protocol Violation|2
7617549|NCT01783548|26503625|P2|Overall Study|Non-compliance|0
7617550|NCT01783548|26503626|P1|Overall Study|Non-compliance|4
7617551|NCT01783548|26503625|P2|Overall Study|Withdrawal by Subject|8
7617552|NCT01783548|26503626|P1|Overall Study|Withdrawal by Subject|11
7617553|NCT01783548|26503625|P2|Overall Study|Adverse Event|4
7617554|NCT01783548|26503626|P1|Overall Study|Adverse Event|8
7617555|NCT01783496|26503659|P6|Overall Study|Withdrawal by Subject|0
7617556|NCT01783496|26503660|P5|Overall Study|Withdrawal by Subject|0
7617557|NCT01783496|26503661|P4|Overall Study|Withdrawal by Subject|0
7617558|NCT01783496|26503662|P3|Overall Study|Withdrawal by Subject|0
7617559|NCT01783496|26503663|P2|Overall Study|Withdrawal by Subject|0
7617560|NCT01783496|26503664|P1|Overall Study|Withdrawal by Subject|1
7617561|NCT01783496|26503659|P6|Overall Study|Lost to Follow-up|1
7617562|NCT01783496|26503660|P5|Overall Study|Lost to Follow-up|0
7617563|NCT01783496|26503661|P4|Overall Study|Lost to Follow-up|2
7617564|NCT01783496|26503662|P3|Overall Study|Lost to Follow-up|0
7617565|NCT01783496|26503663|P2|Overall Study|Lost to Follow-up|0
7617566|NCT01783496|26503664|P1|Overall Study|Lost to Follow-up|0
7617567|NCT01783483|26503692|P2|Overall Study|Physician Decision|1
7617568|NCT01783483|26503693|P1|Overall Study|Physician Decision|1
7617569|NCT01783483|26503692|P2|Overall Study|Withdrawal by Subject|1
7617570|NCT01783483|26503693|P1|Overall Study|Withdrawal by Subject|2
7617571|NCT01783483|26503692|P2|Overall Study|Lost to Follow-up|10
7617572|NCT01783483|26503693|P1|Overall Study|Lost to Follow-up|14
7617573|NCT01783483|26503692|P2|Overall Study|Death|3
7617574|NCT01783483|26503693|P1|Overall Study|Death|3
7617575|NCT01783444|26503732|P3|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
7617576|NCT01783444|26503733|P2|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
7617577|NCT01783444|26503734|P1|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
7617578|NCT01783444|26503732|P3|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
7617579|NCT01783444|26503733|P2|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
7617580|NCT01783444|26503734|P1|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
7617581|NCT01783444|26503732|P3|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7617582|NCT01783444|26503733|P2|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
7617583|NCT01783444|26503734|P1|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7617668|NCT01782664|26504072|P2|Overall Study|Protocol Violation|1
7617584|NCT01783444|26503732|P3|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7617585|NCT01783444|26503733|P2|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7617586|NCT01783444|26503734|P1|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
7617587|NCT01783444|26503732|P3|Post-Treatment Efficacy Follow-Up Phase|Death|5
7617588|NCT01783444|26503733|P2|Post-Treatment Efficacy Follow-Up Phase|Death|7
7617589|NCT01783444|26503734|P1|Post-Treatment Efficacy Follow-Up Phase|Death|9
7617590|NCT01783444|26503732|P3|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
7617591|NCT01783444|26503733|P2|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
7617592|NCT01783444|26503734|P1|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
7617593|NCT01783444|26503732|P3|Treatment Phase|Physician Decision|5
7617594|NCT01783444|26503733|P2|Treatment Phase|Physician Decision|6
7617595|NCT01783444|26503734|P1|Treatment Phase|Physician Decision|8
7617596|NCT01783444|26503732|P3|Treatment Phase|Administrative problems|1
7617597|NCT01783444|26503733|P2|Treatment Phase|Administrative problems|0
7617598|NCT01783444|26503734|P1|Treatment Phase|Administrative problems|2
7617599|NCT01783444|26503732|P3|Treatment Phase|Withdrawal by Subject|9
7617600|NCT01783444|26503733|P2|Treatment Phase|Withdrawal by Subject|8
7617601|NCT01783444|26503734|P1|Treatment Phase|Withdrawal by Subject|6
7617602|NCT01783444|26503732|P3|Treatment Phase|Protocol Violation|2
7617603|NCT01783444|26503733|P2|Treatment Phase|Protocol Violation|1
7617604|NCT01783444|26503734|P1|Treatment Phase|Protocol Violation|1
7617605|NCT01783444|26503732|P3|Treatment Phase|Death|2
7617606|NCT01783444|26503733|P2|Treatment Phase|Death|2
7617607|NCT01783444|26503734|P1|Treatment Phase|Death|2
7617608|NCT01783444|26503732|P3|Treatment Phase|Disease Progression|64
7617609|NCT01783444|26503733|P2|Treatment Phase|Disease Progression|66
7617610|NCT01783444|26503734|P1|Treatment Phase|Disease Progression|76
7617611|NCT01783444|26503732|P3|Treatment Phase|Adverse Event|19
7617612|NCT01783444|26503733|P2|Treatment Phase|Adverse Event|20
7617613|NCT01783444|26503734|P1|Treatment Phase|Adverse Event|9
7617614|NCT01783418|26503766|P2|Overall Study|Withdrawal by Subject|0
7617615|NCT01783418|26503767|P1|Overall Study|Withdrawal by Subject|1
7617616|NCT01783015|26503820|P3|Open Label Treatment|Study Terminated by Sponsor|6
7617617|NCT01783015|26503821|P2|Open Label Treatment|Study Terminated by Sponsor|0
7617618|NCT01783015|26503822|P1|Open Label Treatment|Study Terminated by Sponsor|0
7617619|NCT01783015|26503820|P3|Blinded Treatment|Study Terminated by Sponsor|0
7617620|NCT01783015|26503821|P2|Blinded Treatment|Study Terminated by Sponsor|0
7617621|NCT01783015|26503822|P1|Blinded Treatment|Study Terminated by Sponsor|2
7617622|NCT01783015|26503820|P3|Blinded Treatment|Withdrawal by Subject|0
7617623|NCT01783015|26503821|P2|Blinded Treatment|Withdrawal by Subject|1
7617624|NCT01783015|26503822|P1|Blinded Treatment|Withdrawal by Subject|0
7617625|NCT01783015|26503820|P3|Blinded Treatment|Protocol Violation|0
7617626|NCT01783015|26503821|P2|Blinded Treatment|Protocol Violation|1
7617627|NCT01783015|26503822|P1|Blinded Treatment|Protocol Violation|0
7617628|NCT01783015|26503820|P3|Blinded Treatment|Adverse Event|0
7617629|NCT01783015|26503821|P2|Blinded Treatment|Adverse Event|1
7617630|NCT01783015|26503822|P1|Blinded Treatment|Adverse Event|0
7617631|NCT01782885|26503935|P2|Overall Study|Lost to Follow-up|6
7617632|NCT01782885|26503936|P1|Overall Study|Lost to Follow-up|4
7617633|NCT01782872|26503962|P4|Overall Study|Withdrawal by Subject|0
7617634|NCT01782872|26503963|P3|Overall Study|Withdrawal by Subject|0
7617635|NCT01782872|26503964|P2|Overall Study|Withdrawal by Subject|1
7617636|NCT01782872|26503965|P1|Overall Study|Withdrawal by Subject|0
7617637|NCT01782872|26503962|P4|Overall Study|Protocol Violation|1
7617638|NCT01782872|26503963|P3|Overall Study|Protocol Violation|0
7617639|NCT01782872|26503964|P2|Overall Study|Protocol Violation|0
7617640|NCT01782872|26503965|P1|Overall Study|Protocol Violation|0
7617641|NCT01782859|26503989|P2|Overall Study|Withdrawal by Subject|1
7617642|NCT01782859|26503990|P1|Overall Study|Withdrawal by Subject|0
7617643|NCT01782859|26503989|P2|Overall Study|Protocol Violation|6
7617644|NCT01782859|26503990|P1|Overall Study|Protocol Violation|6
7617645|NCT01782742|26504012|P2|Double-blind Treatment Phase|Adverse Event|0
7617646|NCT01782742|26504013|P1|Double-blind Treatment Phase|Adverse Event|1
7617647|NCT01782690|26504046|P1|Overall Study|Study completion unknown|7
7617648|NCT01782690|26504046|P1|Overall Study|Death|133
7617649|NCT01782690|26504046|P1|Overall Study|Tumor progression|74
7617650|NCT01782690|26504046|P1|Overall Study|Patient's wish|21
7617651|NCT01782690|26504046|P1|Overall Study|Physician Decision|13
7617652|NCT01782690|26504046|P1|Overall Study|Absent rash|9
7617653|NCT01782690|26504046|P1|Overall Study|Withdrawal of informed consent|2
7617654|NCT01782690|26504046|P1|Overall Study|Lost to Follow-up|31
7617655|NCT01782690|26504046|P1|Overall Study|Toxicity of erlotinib|1
7617656|NCT01782690|26504046|P1|Overall Study|Toxicity of gemcitabine|1
7617657|NCT01782690|26504046|P1|Overall Study|Not reported|7
7617658|NCT01782664|26504068|P6|Overall Study|Withdrawal by Subject|0
7617659|NCT01782664|26504069|P5|Overall Study|Withdrawal by Subject|0
7617660|NCT01782664|26504070|P4|Overall Study|Withdrawal by Subject|0
7617661|NCT01782664|26504071|P3|Overall Study|Withdrawal by Subject|0
7617662|NCT01782664|26504072|P2|Overall Study|Withdrawal by Subject|2
7617663|NCT01782664|26504073|P1|Overall Study|Withdrawal by Subject|2
7617664|NCT01782664|26504068|P6|Overall Study|Protocol Violation|0
7617665|NCT01782664|26504069|P5|Overall Study|Protocol Violation|0
7617666|NCT01782664|26504070|P4|Overall Study|Protocol Violation|1
7617667|NCT01782664|26504071|P3|Overall Study|Protocol Violation|0
7617669|NCT01782664|26504073|P1|Overall Study|Protocol Violation|0
7617670|NCT01782664|26504068|P6|Overall Study|Lack of Efficacy|0
7617671|NCT01782664|26504069|P5|Overall Study|Lack of Efficacy|0
7617672|NCT01782664|26504070|P4|Overall Study|Lack of Efficacy|2
7617673|NCT01782664|26504071|P3|Overall Study|Lack of Efficacy|2
7617674|NCT01782664|26504072|P2|Overall Study|Lack of Efficacy|0
7617675|NCT01782664|26504073|P1|Overall Study|Lack of Efficacy|2
7617676|NCT01782664|26504068|P6|Overall Study|Adverse Event|0
7617677|NCT01782664|26504069|P5|Overall Study|Adverse Event|0
7617678|NCT01782664|26504070|P4|Overall Study|Adverse Event|2
7617679|NCT01782664|26504071|P3|Overall Study|Adverse Event|2
7617680|NCT01782664|26504072|P2|Overall Study|Adverse Event|2
7617681|NCT01782664|26504073|P1|Overall Study|Adverse Event|2
7617682|NCT01782495|26504230|P11|Overall Study|Withdrew Consent|0
7617683|NCT01782495|26504231|P10|Overall Study|Withdrew Consent|0
7617684|NCT01782495|26504232|P9|Overall Study|Withdrew Consent|0
7617685|NCT01782495|26504233|P8|Overall Study|Withdrew Consent|1
7617686|NCT01782495|26504234|P7|Overall Study|Withdrew Consent|0
7617687|NCT01782495|26504235|P6|Overall Study|Withdrew Consent|0
7617688|NCT01782495|26504236|P5|Overall Study|Withdrew Consent|0
7617689|NCT01782495|26504237|P4|Overall Study|Withdrew Consent|0
7617690|NCT01782495|26504238|P3|Overall Study|Withdrew Consent|0
7617691|NCT01782495|26504239|P2|Overall Study|Withdrew Consent|1
7617692|NCT01782495|26504240|P1|Overall Study|Withdrew Consent|0
7617693|NCT01782495|26504230|P11|Overall Study|Adverse Event|0
7617694|NCT01782495|26504231|P10|Overall Study|Adverse Event|0
7617695|NCT01782495|26504232|P9|Overall Study|Adverse Event|0
7617696|NCT01782495|26504233|P8|Overall Study|Adverse Event|2
7617697|NCT01782495|26504234|P7|Overall Study|Adverse Event|0
7617698|NCT01782495|26504235|P6|Overall Study|Adverse Event|0
7617699|NCT01782495|26504236|P5|Overall Study|Adverse Event|0
7617700|NCT01782495|26504237|P4|Overall Study|Adverse Event|0
7617701|NCT01782495|26504238|P3|Overall Study|Adverse Event|0
7617702|NCT01782495|26504239|P2|Overall Study|Adverse Event|0
7617703|NCT01782495|26504240|P1|Overall Study|Adverse Event|0
7617704|NCT01782482|26504299|P2|Overall Study|Habitually wearing toric lens OS|1
7617705|NCT01782482|26504300|P1|Overall Study|Habitually wearing toric lens OS|0
7617706|NCT01782482|26504299|P2|Overall Study|Randomized in Error|2
7617707|NCT01782482|26504300|P1|Overall Study|Randomized in Error|2
7617708|NCT01782482|26504299|P2|Overall Study|Withdrawal by Subject|3
7617709|NCT01782482|26504300|P1|Overall Study|Withdrawal by Subject|2
7617710|NCT01782482|26504299|P2|Overall Study|Protocol Violation|0
7617711|NCT01782482|26504300|P1|Overall Study|Protocol Violation|1
7617712|NCT01782482|26504299|P2|Overall Study|Physician Decision|0
7617713|NCT01782482|26504300|P1|Overall Study|Physician Decision|1
7617714|NCT01782482|26504299|P2|Overall Study|Lost to Follow-up|3
7617715|NCT01782482|26504300|P1|Overall Study|Lost to Follow-up|2
7617716|NCT01782482|26504299|P2|Overall Study|Adverse Event|1
7617717|NCT01782482|26504300|P1|Overall Study|Adverse Event|2
7617718|NCT01782469|26504308|P1|Overall Study|Lost to Follow-up|1
7617719|NCT01782378|26504318|P2|Second Series|Did not choose to complete S2 Optional|0
7617720|NCT01782378|26504319|P1|Second Series|Did not choose to complete S2 Optional|18
7617721|NCT01782378|26504318|P2|Second Series|Lost to Follow-up|7
7617722|NCT01782378|26504319|P1|Second Series|Lost to Follow-up|8
7617723|NCT01782378|26504318|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
7617724|NCT01782378|26504319|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
7617725|NCT01782378|26504318|P2|First Series|Lost to Follow-up|8
7617726|NCT01782378|26504319|P1|First Series|Lost to Follow-up|7
7617727|NCT01782326|26504385|P2|Double-blind Treatment|Technical problems|5
7617728|NCT01782326|26504386|P1|Double-blind Treatment|Technical problems|0
7617729|NCT01782326|26504385|P2|Double-blind Treatment|Protocol deviation|7
7617730|NCT01782326|26504386|P1|Double-blind Treatment|Protocol deviation|8
7617731|NCT01782326|26504385|P2|Double-blind Treatment|Physician Decision|16
7617732|NCT01782326|26504386|P1|Double-blind Treatment|Physician Decision|13
7617733|NCT01782326|26504385|P2|Double-blind Treatment|Lack of Efficacy|22
7617734|NCT01782326|26504386|P1|Double-blind Treatment|Lack of Efficacy|17
7617735|NCT01782326|26504385|P2|Double-blind Treatment|Subject/guardian decision|125
7617736|NCT01782326|26504386|P1|Double-blind Treatment|Subject/guardian decision|111
7617737|NCT01782326|26504385|P2|Double-blind Treatment|Adverse Event|145
7617738|NCT01782326|26504386|P1|Double-blind Treatment|Adverse Event|129
7617739|NCT01782326|26504385|P2|Planned Treatment Epoch|Technical problems|4
7617740|NCT01782326|26504386|P1|Planned Treatment Epoch|Technical problems|0
7617741|NCT01782326|26504385|P2|Planned Treatment Epoch|Lost to Follow-up|4
7617742|NCT01782326|26504386|P1|Planned Treatment Epoch|Lost to Follow-up|4
7617743|NCT01782326|26504385|P2|Planned Treatment Epoch|Protocol deviation|3
7617744|NCT01782326|26504386|P1|Planned Treatment Epoch|Protocol deviation|2
7617745|NCT01782326|26504385|P2|Planned Treatment Epoch|Physician Decision|16
7617746|NCT01782326|26504386|P1|Planned Treatment Epoch|Physician Decision|18
7617747|NCT01782326|26504385|P2|Planned Treatment Epoch|Death|30
7617748|NCT01782326|26504386|P1|Planned Treatment Epoch|Death|29
7617749|NCT01782326|26504385|P2|Planned Treatment Epoch|Subject/guardian decision|151
7617750|NCT01782326|26504386|P1|Planned Treatment Epoch|Subject/guardian decision|149
7617751|NCT01782313|26504446|P1|Survival Follow up|Lost to Follow-up|1
7617752|NCT01782313|26504446|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
7617753|NCT01782313|26504446|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
7617754|NCT01782313|26504446|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
7617755|NCT01782313|26504446|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
7617756|NCT01782313|26504446|P1|Treated Cycle 3|Progressive Disease|21
7617757|NCT01782313|26504446|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
7617758|NCT01782313|26504446|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
7617759|NCT01782222|26504460|P3|Overall Study|Moved to other state|0
7617760|NCT01782222|26504461|P2|Overall Study|Moved to other state|1
7617761|NCT01782222|26504462|P1|Overall Study|Moved to other state|0
7617762|NCT01782222|26504460|P3|Overall Study|Withdrawal by Subject|1
7617763|NCT01782222|26504461|P2|Overall Study|Withdrawal by Subject|4
7617764|NCT01782222|26504462|P1|Overall Study|Withdrawal by Subject|1
7617765|NCT01782222|26504460|P3|Overall Study|Protocol Violation|0
7617766|NCT01782222|26504461|P2|Overall Study|Protocol Violation|0
7617767|NCT01782222|26504462|P1|Overall Study|Protocol Violation|1
7617768|NCT01782222|26504460|P3|Overall Study|Lack of Efficacy|0
7617769|NCT01782222|26504461|P2|Overall Study|Lack of Efficacy|1
7617770|NCT01782222|26504462|P1|Overall Study|Lack of Efficacy|2
7617771|NCT01782222|26504460|P3|Overall Study|Adverse Event|3
7617772|NCT01782222|26504461|P2|Overall Study|Adverse Event|5
7617773|NCT01782222|26504462|P1|Overall Study|Adverse Event|4
7617774|NCT01782131|26504500|P2|Overall Study|Reason not provided|1
7617775|NCT01782131|26504501|P1|Overall Study|Reason not provided|0
7617776|NCT01782131|26504500|P2|Overall Study|Randomized but not treated|5
7617777|NCT01782131|26504501|P1|Overall Study|Randomized but not treated|5
7617778|NCT01782131|26504500|P2|Overall Study|Withdrawal by Subject|10
7617779|NCT01782131|26504501|P1|Overall Study|Withdrawal by Subject|10
7617780|NCT01782131|26504500|P2|Overall Study|Lost to Follow-up|3
7617781|NCT01782131|26504501|P1|Overall Study|Lost to Follow-up|1
7617782|NCT01782131|26504500|P2|Overall Study|Death|96
7617783|NCT01782131|26504501|P1|Overall Study|Death|93
7617784|NCT01781975|26504538|P2|Overall Study|Withdrawal by Subject|1
7617785|NCT01781975|26504539|P1|Overall Study|Withdrawal by Subject|1
7617786|NCT01781975|26504538|P2|Overall Study|Death|0
7617787|NCT01781975|26504539|P1|Overall Study|Death|1
7617788|NCT01781962|26504555|P1|Overall Study|Other Miscellaneous Reasons|5
7617789|NCT01781832|26504561|P1|Overall Study|Withdrawal by Subject|1
7617790|NCT01781637|26504581|P2|Overall Study|Withdrawal by Subject|0
7617791|NCT01781637|26504582|P1|Overall Study|Withdrawal by Subject|1
7617792|NCT01781637|26504581|P2|Overall Study|Lack of Efficacy|6
7617793|NCT01781637|26504582|P1|Overall Study|Lack of Efficacy|2
7617794|NCT01781637|26504581|P2|Overall Study|Adverse Event|0
7617795|NCT01781637|26504582|P1|Overall Study|Adverse Event|1
7617796|NCT01781611|26504592|P2|Overall Study|Adverse Event|0
7617797|NCT01781611|26504593|P1|Overall Study|Adverse Event|4
7617798|NCT01781572|26504614|P3|MEK162 45mg LEE011 600mg|Progressive Disease|0
7617799|NCT01781572|26504615|P2|MEK162 45mg LEE011 600mg|Progressive Disease|5
7617800|NCT01781572|26504616|P1|MEK162 45mg LEE011 600mg|Progressive Disease|0
7617801|NCT01781572|26504614|P3|MEK162 45mg LEE011 600mg|Adverse Event|0
7617802|NCT01781572|26504615|P2|MEK162 45mg LEE011 600mg|Adverse Event|1
7617803|NCT01781572|26504616|P1|MEK162 45mg LEE011 600mg|Adverse Event|0
7617804|NCT01781572|26504614|P3|MEK162 45mg LEE011 450mg|Progressive Disease|0
7617805|NCT01781572|26504615|P2|MEK162 45mg LEE011 450mg|Progressive Disease|6
7617806|NCT01781572|26504616|P1|MEK162 45mg LEE011 450mg|Progressive Disease|0
7617807|NCT01781572|26504614|P3|MEK162 45mg LEE011 450mg|Physician Decision|0
7617808|NCT01781572|26504615|P2|MEK162 45mg LEE011 450mg|Physician Decision|2
7617809|NCT01781572|26504616|P1|MEK162 45mg LEE011 450mg|Physician Decision|0
7617810|NCT01781572|26504614|P3|MEK162 45mg LEE011 450mg|Adverse Event|0
7617811|NCT01781572|26504615|P2|MEK162 45mg LEE011 450mg|Adverse Event|1
7617812|NCT01781572|26504616|P1|MEK162 45mg LEE011 450mg|Adverse Event|0
7617813|NCT01781572|26504614|P3|MEK162 30mg LEE011 200mg|Progressive Disease|0
7617814|NCT01781572|26504615|P2|MEK162 30mg LEE011 200mg|Progressive Disease|5
7617815|NCT01781572|26504616|P1|MEK162 30mg LEE011 200mg|Progressive Disease|0
7617816|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 300mg|Death|0
7617817|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 300mg|Death|0
7617818|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 300mg|Death|1
7617819|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
7617820|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
7617821|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
7617822|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
7617823|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7617824|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7617825|NCT01781572|26504614|P3|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
7617826|NCT01781572|26504615|P2|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
7617827|NCT01781572|26504616|P1|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
7617828|NCT01781572|26504614|P3|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7617829|NCT01781572|26504615|P2|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7617830|NCT01781572|26504616|P1|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
7617831|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7617832|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7617833|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
7617834|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7617835|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7617836|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
7617837|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 200mg|Death|1
7617838|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 200mg|Death|0
7617839|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 200mg|Death|0
7617840|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
7617841|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7617842|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7617843|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
7617844|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
7617845|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
7617846|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
7617847|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
7617848|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
7617849|NCT01781572|26504614|P3|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
7617850|NCT01781572|26504615|P2|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
7617851|NCT01781572|26504616|P1|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
7617852|NCT01781429|26504957|P16|Overall Study|Enrolled, but not treated|0
7617853|NCT01781429|26504958|P15|Overall Study|Enrolled, but not treated|0
7617854|NCT01781429|26504959|P14|Overall Study|Enrolled, but not treated|0
7617855|NCT01781429|26504960|P13|Overall Study|Enrolled, but not treated|0
7617856|NCT01781429|26504961|P12|Overall Study|Enrolled, but not treated|0
7617857|NCT01781429|26504962|P11|Overall Study|Enrolled, but not treated|1
7617858|NCT01781429|26504963|P10|Overall Study|Enrolled, but not treated|0
7617859|NCT01781429|26504964|P9|Overall Study|Enrolled, but not treated|0
7617860|NCT01781429|26504965|P8|Overall Study|Enrolled, but not treated|0
7617861|NCT01781429|26504966|P7|Overall Study|Enrolled, but not treated|0
7617862|NCT01781429|26504967|P6|Overall Study|Enrolled, but not treated|0
7617863|NCT01781429|26504968|P5|Overall Study|Enrolled, but not treated|0
7617864|NCT01781429|26504969|P4|Overall Study|Enrolled, but not treated|0
7617865|NCT01781429|26504970|P3|Overall Study|Enrolled, but not treated|0
7617866|NCT01781429|26504971|P2|Overall Study|Enrolled, but not treated|0
7617867|NCT01781429|26504972|P1|Overall Study|Enrolled, but not treated|0
7617868|NCT01781429|26504957|P16|Overall Study|Other - as entered by PI in eCRF|0
7617869|NCT01781429|26504958|P15|Overall Study|Other - as entered by PI in eCRF|1
7617870|NCT01781429|26504959|P14|Overall Study|Other - as entered by PI in eCRF|1
7617871|NCT01781429|26504960|P13|Overall Study|Other - as entered by PI in eCRF|1
7617872|NCT01781429|26504961|P12|Overall Study|Other - as entered by PI in eCRF|2
7617873|NCT01781429|26504962|P11|Overall Study|Other - as entered by PI in eCRF|1
7617874|NCT01781429|26504963|P10|Overall Study|Other - as entered by PI in eCRF|1
7617875|NCT01781429|26504964|P9|Overall Study|Other - as entered by PI in eCRF|0
7617876|NCT01781429|26504965|P8|Overall Study|Other - as entered by PI in eCRF|0
7617877|NCT01781429|26504966|P7|Overall Study|Other - as entered by PI in eCRF|0
7617878|NCT01781429|26504967|P6|Overall Study|Other - as entered by PI in eCRF|0
7617879|NCT01781429|26504968|P5|Overall Study|Other - as entered by PI in eCRF|0
7617880|NCT01781429|26504969|P4|Overall Study|Other - as entered by PI in eCRF|0
7617881|NCT01781429|26504970|P3|Overall Study|Other - as entered by PI in eCRF|0
7617882|NCT01781429|26504971|P2|Overall Study|Other - as entered by PI in eCRF|1
7617883|NCT01781429|26504972|P1|Overall Study|Other - as entered by PI in eCRF|0
7617884|NCT01781429|26504957|P16|Overall Study|Patient Condition Changed|0
7617885|NCT01781429|26504958|P15|Overall Study|Patient Condition Changed|0
7617886|NCT01781429|26504959|P14|Overall Study|Patient Condition Changed|1
7617887|NCT01781429|26504960|P13|Overall Study|Patient Condition Changed|0
7617888|NCT01781429|26504961|P12|Overall Study|Patient Condition Changed|1
7617889|NCT01781429|26504962|P11|Overall Study|Patient Condition Changed|0
7617890|NCT01781429|26504963|P10|Overall Study|Patient Condition Changed|4
7617891|NCT01781429|26504964|P9|Overall Study|Patient Condition Changed|0
7617892|NCT01781429|26504965|P8|Overall Study|Patient Condition Changed|0
7617893|NCT01781429|26504966|P7|Overall Study|Patient Condition Changed|0
7617894|NCT01781429|26504967|P6|Overall Study|Patient Condition Changed|0
7617895|NCT01781429|26504968|P5|Overall Study|Patient Condition Changed|0
7617896|NCT01781429|26504969|P4|Overall Study|Patient Condition Changed|0
7617897|NCT01781429|26504970|P3|Overall Study|Patient Condition Changed|0
7617898|NCT01781429|26504971|P2|Overall Study|Patient Condition Changed|0
7617899|NCT01781429|26504972|P1|Overall Study|Patient Condition Changed|0
7617900|NCT01781429|26504957|P16|Overall Study|Unacceptable Toxicity|0
7617901|NCT01781429|26504958|P15|Overall Study|Unacceptable Toxicity|0
7617902|NCT01781429|26504959|P14|Overall Study|Unacceptable Toxicity|0
7617903|NCT01781429|26504960|P13|Overall Study|Unacceptable Toxicity|0
7617904|NCT01781429|26504961|P12|Overall Study|Unacceptable Toxicity|2
7617905|NCT01781429|26504962|P11|Overall Study|Unacceptable Toxicity|0
7617906|NCT01781429|26504963|P10|Overall Study|Unacceptable Toxicity|0
7617907|NCT01781429|26504964|P9|Overall Study|Unacceptable Toxicity|0
7617908|NCT01781429|26504965|P8|Overall Study|Unacceptable Toxicity|0
7617909|NCT01781429|26504966|P7|Overall Study|Unacceptable Toxicity|0
7617910|NCT01781429|26504967|P6|Overall Study|Unacceptable Toxicity|0
7617911|NCT01781429|26504968|P5|Overall Study|Unacceptable Toxicity|0
7617912|NCT01781429|26504969|P4|Overall Study|Unacceptable Toxicity|0
7617913|NCT01781429|26504970|P3|Overall Study|Unacceptable Toxicity|0
7617914|NCT01781429|26504971|P2|Overall Study|Unacceptable Toxicity|0
7617915|NCT01781429|26504972|P1|Overall Study|Unacceptable Toxicity|0
7617916|NCT01781429|26504957|P16|Overall Study|Disease Progression|0
7617917|NCT01781429|26504958|P15|Overall Study|Disease Progression|11
7617918|NCT01781429|26504959|P14|Overall Study|Disease Progression|4
7617919|NCT01781429|26504960|P13|Overall Study|Disease Progression|15
7617920|NCT01781429|26504961|P12|Overall Study|Disease Progression|15
7617921|NCT01781429|26504962|P11|Overall Study|Disease Progression|15
7617922|NCT01781429|26504963|P10|Overall Study|Disease Progression|15
7617923|NCT01781429|26504964|P9|Overall Study|Disease Progression|6
7617924|NCT01781429|26504965|P8|Overall Study|Disease Progression|4
7617925|NCT01781429|26504966|P7|Overall Study|Disease Progression|7
7617926|NCT01781429|26504967|P6|Overall Study|Disease Progression|4
7617927|NCT01781429|26504968|P5|Overall Study|Disease Progression|1
7617928|NCT01781429|26504969|P4|Overall Study|Disease Progression|1
7617929|NCT01781429|26504970|P3|Overall Study|Disease Progression|1
7617930|NCT01781429|26504971|P2|Overall Study|Disease Progression|0
7617931|NCT01781429|26504972|P1|Overall Study|Disease Progression|1
7617932|NCT01781429|26504957|P16|Overall Study|Withdrawal by Subject|0
7617933|NCT01781429|26504958|P15|Overall Study|Withdrawal by Subject|3
7617934|NCT01781429|26504959|P14|Overall Study|Withdrawal by Subject|2
7617935|NCT01781429|26504960|P13|Overall Study|Withdrawal by Subject|5
7617936|NCT01781429|26504961|P12|Overall Study|Withdrawal by Subject|1
7617937|NCT01781429|26504962|P11|Overall Study|Withdrawal by Subject|1
7617938|NCT01781429|26504963|P10|Overall Study|Withdrawal by Subject|3
7617939|NCT01781429|26504964|P9|Overall Study|Withdrawal by Subject|1
7617940|NCT01781429|26504965|P8|Overall Study|Withdrawal by Subject|0
7617941|NCT01781429|26504966|P7|Overall Study|Withdrawal by Subject|0
7617942|NCT01781429|26504967|P6|Overall Study|Withdrawal by Subject|0
7617943|NCT01781429|26504968|P5|Overall Study|Withdrawal by Subject|0
7617944|NCT01781429|26504969|P4|Overall Study|Withdrawal by Subject|0
7617945|NCT01781429|26504970|P3|Overall Study|Withdrawal by Subject|0
7617946|NCT01781429|26504971|P2|Overall Study|Withdrawal by Subject|0
7617947|NCT01781429|26504972|P1|Overall Study|Withdrawal by Subject|0
7617948|NCT01781429|26504957|P16|Overall Study|Death|0
7617949|NCT01781429|26504958|P15|Overall Study|Death|1
7617950|NCT01781429|26504959|P14|Overall Study|Death|0
7617951|NCT01781429|26504960|P13|Overall Study|Death|1
7617952|NCT01781429|26504961|P12|Overall Study|Death|0
7617953|NCT01781429|26504962|P11|Overall Study|Death|0
7617954|NCT01781429|26504963|P10|Overall Study|Death|1
7617955|NCT01781429|26504964|P9|Overall Study|Death|0
7617956|NCT01781429|26504965|P8|Overall Study|Death|0
7617957|NCT01781429|26504966|P7|Overall Study|Death|0
7617958|NCT01781429|26504967|P6|Overall Study|Death|0
7617959|NCT01781429|26504968|P5|Overall Study|Death|0
7617960|NCT01781429|26504969|P4|Overall Study|Death|0
7617961|NCT01781429|26504970|P3|Overall Study|Death|0
7617962|NCT01781429|26504971|P2|Overall Study|Death|0
7617963|NCT01781429|26504972|P1|Overall Study|Death|0
7617964|NCT01781299|26505049|P2|Overall Study|Withdrawal by Subject|1
7617965|NCT01781299|26505050|P1|Overall Study|Withdrawal by Subject|0
7617966|NCT01781286|26505058|P6|Overall Study|Noncompliance|0
7617967|NCT01781286|26505059|P5|Overall Study|Noncompliance|0
7617968|NCT01781286|26505060|P4|Overall Study|Noncompliance|1
7617969|NCT01781286|26505061|P3|Overall Study|Noncompliance|0
7617970|NCT01781286|26505062|P2|Overall Study|Noncompliance|0
7617971|NCT01781286|26505063|P1|Overall Study|Noncompliance|0
7617972|NCT01781286|26505058|P6|Overall Study|Time Constraints|0
7617973|NCT01781286|26505059|P5|Overall Study|Time Constraints|0
7617974|NCT01781286|26505060|P4|Overall Study|Time Constraints|0
7617975|NCT01781286|26505061|P3|Overall Study|Time Constraints|2
7617976|NCT01781286|26505062|P2|Overall Study|Time Constraints|0
7617977|NCT01781286|26505063|P1|Overall Study|Time Constraints|2
7617978|NCT01781286|26505058|P6|Overall Study|Lost to Follow-up|1
7617979|NCT01781286|26505059|P5|Overall Study|Lost to Follow-up|0
7617980|NCT01781286|26505060|P4|Overall Study|Lost to Follow-up|0
7617981|NCT01781286|26505061|P3|Overall Study|Lost to Follow-up|0
7617982|NCT01781286|26505062|P2|Overall Study|Lost to Follow-up|0
7617983|NCT01781286|26505063|P1|Overall Study|Lost to Follow-up|0
7617984|NCT01781234|26505088|P2|Overall Study|Withdrawal by Subject|3
7617985|NCT01781234|26505089|P1|Overall Study|Withdrawal by Subject|4
7617986|NCT01781234|26505088|P2|Overall Study|Protocol Violation|0
7617987|NCT01781234|26505089|P1|Overall Study|Protocol Violation|3
7617988|NCT01781234|26505088|P2|Overall Study|Adverse Event|0
7617989|NCT01781234|26505089|P1|Overall Study|Adverse Event|2
7617990|NCT01781026|26505127|P1|Overall Study|Lack of Efficacy|2
7617991|NCT01780987|26505133|P2|Overall Study|Not Receiving any Study Medication|1
7617992|NCT01780987|26505134|P1|Overall Study|Not Receiving any Study Medication|0
7617993|NCT01780987|26505133|P2|Overall Study|Changing Residence|0
7617994|NCT01780987|26505134|P1|Overall Study|Changing Residence|1
7617995|NCT01780987|26505133|P2|Overall Study|Request of Changing Hospital|1
7617996|NCT01780987|26505134|P1|Overall Study|Request of Changing Hospital|0
7617997|NCT01780987|26505133|P2|Overall Study|Withdrawal by Subject|0
7617998|NCT01780987|26505134|P1|Overall Study|Withdrawal by Subject|2
7617999|NCT01780987|26505133|P2|Overall Study|Adverse Event|4
7618000|NCT01780987|26505134|P1|Overall Study|Adverse Event|0
7618001|NCT01780974|26505152|P2|Overall Study|Adverse Event|3
7618002|NCT01780974|26505153|P1|Overall Study|Adverse Event|1
7618003|NCT01780974|26505152|P2|Overall Study|Death|0
7618004|NCT01780974|26505153|P1|Overall Study|Death|1
7618005|NCT01780935|26505163|P2|Overall Study|Patient withdrew consent|9
7618006|NCT01780935|26505164|P1|Overall Study|Patient withdrew consent|8
7618007|NCT01780935|26505163|P2|Overall Study|Protocol deviation|1
7618008|NCT01780935|26505164|P1|Overall Study|Protocol deviation|0
7618009|NCT01780935|26505163|P2|Overall Study|Physician Decision|1
7618010|NCT01780935|26505164|P1|Overall Study|Physician Decision|1
7618011|NCT01780935|26505163|P2|Overall Study|Lost to Follow-up|6
7618012|NCT01780935|26505164|P1|Overall Study|Lost to Follow-up|2
7618013|NCT01780935|26505163|P2|Overall Study|Death|6
7618014|NCT01780935|26505164|P1|Overall Study|Death|1
7618015|NCT01780935|26505163|P2|Overall Study|Adverse Event|4
7618016|NCT01780935|26505164|P1|Overall Study|Adverse Event|2
7618017|NCT01780935|26505163|P2|Overall Study|Admin problems due to early termination|309
7618018|NCT01780935|26505164|P1|Overall Study|Admin problems due to early termination|321
7618019|NCT01780831|26505269|P4|Overall Study|Lost to Follow-up|1
7618020|NCT01780831|26505270|P3|Overall Study|Lost to Follow-up|0
7618021|NCT01780831|26505271|P2|Overall Study|Lost to Follow-up|0
7618022|NCT01780831|26505272|P1|Overall Study|Lost to Follow-up|0
7618023|NCT01780831|26505269|P4|Overall Study|Withdrawal by Subject|0
7618024|NCT01780831|26505270|P3|Overall Study|Withdrawal by Subject|4
7618025|NCT01780831|26505271|P2|Overall Study|Withdrawal by Subject|0
7618026|NCT01780831|26505272|P1|Overall Study|Withdrawal by Subject|0
7618039|NCT01780584|26505359|P3|Overall Study|Protocol Violation|1
7618040|NCT01780584|26505360|P2|Overall Study|Protocol Violation|0
7618041|NCT01780584|26505361|P1|Overall Study|Protocol Violation|0
7618042|NCT01780584|26505359|P3|Overall Study|Adverse Event|0
7618043|NCT01780584|26505360|P2|Overall Study|Adverse Event|1
7618044|NCT01780584|26505361|P1|Overall Study|Adverse Event|0
7618045|NCT01780584|26505359|P3|Overall Study|Death|1
7618046|NCT01780584|26505360|P2|Overall Study|Death|0
7618047|NCT01780584|26505361|P1|Overall Study|Death|1
7618048|NCT01780545|26505383|P2|Overall Study|Lost to Follow-up|1
7618049|NCT01780545|26505384|P1|Overall Study|Lost to Follow-up|1
7618050|NCT01780545|26505383|P2|Overall Study|Withdrawal by Subject|1
7618051|NCT01780545|26505384|P1|Overall Study|Withdrawal by Subject|3
7618052|NCT01780506|26505402|P2|Open-Label Extension Phase|Enrolled but not Treated|1
7618053|NCT01780506|26505403|P1|Open-Label Extension Phase|Enrolled but not Treated|0
7618054|NCT01780506|26505402|P2|Double-Blind Phase|Lost to Follow-up|26
7618055|NCT01780506|26505403|P1|Double-Blind Phase|Lost to Follow-up|23
7618056|NCT01780506|26505402|P2|Double-Blind Phase|Withdrew Consent|24
7618057|NCT01780506|26505403|P1|Double-Blind Phase|Withdrew Consent|23
7618058|NCT01780506|26505402|P2|Double-Blind Phase|Protocol Violation|3
7618059|NCT01780506|26505403|P1|Double-Blind Phase|Protocol Violation|4
7618060|NCT01780506|26505402|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
7618061|NCT01780506|26505403|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
7618062|NCT01780506|26505402|P2|Double-Blind Phase|Investigator's Discretion|2
7618063|NCT01780506|26505403|P1|Double-Blind Phase|Investigator's Discretion|5
7618064|NCT01780506|26505402|P2|Double-Blind Phase|Lack of Efficacy|1
7618065|NCT01780506|26505403|P1|Double-Blind Phase|Lack of Efficacy|1
7618066|NCT01780506|26505402|P2|Double-Blind Phase|Pregnancy|1
7618067|NCT01780506|26505403|P1|Double-Blind Phase|Pregnancy|2
7618068|NCT01780506|26505402|P2|Double-Blind Phase|Death|2
7618069|NCT01780506|26505403|P1|Double-Blind Phase|Death|1
7618070|NCT01780506|26505402|P2|Double-Blind Phase|Adverse Event|14
7618071|NCT01780506|26505403|P1|Double-Blind Phase|Adverse Event|4
7618072|NCT01780506|26505402|P2|Double-Blind Phase|Randomized but not Treated|2
7618073|NCT01780506|26505403|P1|Double-Blind Phase|Randomized but not Treated|3
7618074|NCT01780389|26505462|P1|Overall Study|Adverse Event|1
7618075|NCT01779869|26505500|P1|Overall Study|Physician Decision|2
7618076|NCT01779856|26505504|P1|Overall Study|Subject ineligible for Implant|2
7618077|NCT01779856|26505504|P1|Overall Study|Delays in scheduling implant|1
7618078|NCT01779856|26505504|P1|Overall Study|Inclusion/Exclusion Not Met|2
7618079|NCT01779856|26505504|P1|Overall Study|Physician Decision|1
7618080|NCT01779856|26505504|P1|Overall Study|Death|3
7618081|NCT01779856|26505504|P1|Overall Study|Withdrawal by Subject|15
7618082|NCT01779700|26505518|P2|Overall Study|Withdrawal by Subject|2
7618083|NCT01779700|26505519|P1|Overall Study|Withdrawal by Subject|0
7618084|NCT01779700|26505518|P2|Overall Study|Adverse Event|3
7618085|NCT01779700|26505519|P1|Overall Study|Adverse Event|4
7618086|NCT01779648|26505559|P2|Overall Study|Protocol Violation|0
7618087|NCT01779648|26505560|P1|Overall Study|Protocol Violation|1
7618088|NCT01779440|26505590|P2|Overall Study|Withdrawal by Subject|5
7618089|NCT01779440|26505591|P1|Overall Study|Withdrawal by Subject|3
7618090|NCT01778985|26505656|P2|Overall Study|Protocol Violation|1
7618091|NCT01778985|26505657|P1|Overall Study|Protocol Violation|4
7618092|NCT01778985|26505656|P2|Overall Study|Physician Decision|2
7618093|NCT01778985|26505657|P1|Overall Study|Physician Decision|2
7618094|NCT01778985|26505656|P2|Overall Study|Lost to Follow-up|0
7618095|NCT01778985|26505657|P1|Overall Study|Lost to Follow-up|1
7618096|NCT01778855|26505703|P2|Overall Study|Death|1
7618097|NCT01778855|26505704|P1|Overall Study|Death|0
7618098|NCT01778751|26505712|P2|Overall Study|Transfered care|0
7618099|NCT01778751|26505713|P1|Overall Study|Transfered care|1
7618100|NCT01778751|26505712|P2|Overall Study|Withdrawal by Subject|2
7618101|NCT01778751|26505713|P1|Overall Study|Withdrawal by Subject|0
7618102|NCT01778751|26505712|P2|Overall Study|Lost to Follow-up|0
7618103|NCT01778751|26505713|P1|Overall Study|Lost to Follow-up|1
7618104|NCT01778556|26505770|P2|Long-term Follow-up|noncompliance with metreleptin|0
7618105|NCT01778556|26505771|P1|Long-term Follow-up|noncompliance with metreleptin|1
7618106|NCT01778556|26505770|P2|Intervention 2 (14 Days)|Protocol Violation|0
7618107|NCT01778556|26505771|P1|Intervention 2 (14 Days)|Protocol Violation|1
7618108|NCT01778556|26505770|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
7618109|NCT01778556|26505771|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
7618110|NCT01778556|26505770|P2|Intervention 1 (5 Days)|Protocol Violation|1
7618111|NCT01778556|26505771|P1|Intervention 1 (5 Days)|Protocol Violation|0
7618112|NCT01778530|26505784|P1|Overall Study|Adverse event/side effect|1
7618113|NCT01778530|26505784|P1|Overall Study|Progression on study|1
7618114|NCT01778127|26505841|P3|Overall Study|Withdrawal by Subject|4
7618115|NCT01778127|26505842|P2|Overall Study|Withdrawal by Subject|1
7618116|NCT01778127|26505843|P1|Overall Study|Withdrawal by Subject|3
7618117|NCT01778127|26505841|P3|Overall Study|Lost to Follow-up|2
7618118|NCT01778127|26505842|P2|Overall Study|Lost to Follow-up|1
7618119|NCT01778127|26505843|P1|Overall Study|Lost to Follow-up|5
7618120|NCT01778062|26505886|P2|Overall Study|major protocol deviation|3
7618121|NCT01778062|26505887|P1|Overall Study|major protocol deviation|4
7618122|NCT01778062|26505886|P2|Overall Study|Consent Withdrawal|5
7618123|NCT01778062|26505887|P1|Overall Study|Consent Withdrawal|1
7618124|NCT01778062|26505886|P2|Overall Study|Adverse Event|3
7618125|NCT01778062|26505887|P1|Overall Study|Adverse Event|1
7618126|NCT01778049|26505901|P6|Double Blind Treatment Period|Other reason not defined above|1
7618127|NCT01778049|26505902|P5|Double Blind Treatment Period|Other reason not defined above|2
7618128|NCT01778049|26505903|P4|Double Blind Treatment Period|Other reason not defined above|2
7618129|NCT01778049|26505904|P3|Double Blind Treatment Period|Other reason not defined above|4
7618130|NCT01778049|26505905|P2|Double Blind Treatment Period|Other reason not defined above|0
7618131|NCT01778049|26505906|P1|Double Blind Treatment Period|Other reason not defined above|0
7618132|NCT01778049|26505901|P6|Double Blind Treatment Period|Not treated|0
7618133|NCT01778049|26505902|P5|Double Blind Treatment Period|Not treated|2
7618134|NCT01778049|26505903|P4|Double Blind Treatment Period|Not treated|2
7618135|NCT01778049|26505904|P3|Double Blind Treatment Period|Not treated|0
7618136|NCT01778049|26505905|P2|Double Blind Treatment Period|Not treated|0
7618137|NCT01778049|26505906|P1|Double Blind Treatment Period|Not treated|0
7618138|NCT01778049|26505901|P6|Double Blind Treatment Period|Withdrawal by Subject|1
7618139|NCT01778049|26505902|P5|Double Blind Treatment Period|Withdrawal by Subject|0
7618140|NCT01778049|26505903|P4|Double Blind Treatment Period|Withdrawal by Subject|2
7618141|NCT01778049|26505904|P3|Double Blind Treatment Period|Withdrawal by Subject|1
7618142|NCT01778049|26505905|P2|Double Blind Treatment Period|Withdrawal by Subject|0
7618143|NCT01778049|26505906|P1|Double Blind Treatment Period|Withdrawal by Subject|0
7618144|NCT01778049|26505901|P6|Double Blind Treatment Period|Lost to Follow-up|2
7618145|NCT01778049|26505902|P5|Double Blind Treatment Period|Lost to Follow-up|5
7618146|NCT01778049|26505903|P4|Double Blind Treatment Period|Lost to Follow-up|1
7618147|NCT01778049|26505904|P3|Double Blind Treatment Period|Lost to Follow-up|4
7618148|NCT01778049|26505905|P2|Double Blind Treatment Period|Lost to Follow-up|0
7618149|NCT01778049|26505906|P1|Double Blind Treatment Period|Lost to Follow-up|0
7618150|NCT01778049|26505901|P6|Double Blind Treatment Period|Protocol Violation|0
7618151|NCT01778049|26505902|P5|Double Blind Treatment Period|Protocol Violation|0
7618152|NCT01778049|26505903|P4|Double Blind Treatment Period|Protocol Violation|0
7618153|NCT01778049|26505904|P3|Double Blind Treatment Period|Protocol Violation|2
7618154|NCT01778049|26505905|P2|Double Blind Treatment Period|Protocol Violation|0
7618155|NCT01778049|26505906|P1|Double Blind Treatment Period|Protocol Violation|0
7618156|NCT01778049|26505901|P6|Double Blind Treatment Period|Lack of Efficacy|1
7618157|NCT01778049|26505902|P5|Double Blind Treatment Period|Lack of Efficacy|0
7618158|NCT01778049|26505903|P4|Double Blind Treatment Period|Lack of Efficacy|0
7618159|NCT01778049|26505904|P3|Double Blind Treatment Period|Lack of Efficacy|0
7618160|NCT01778049|26505905|P2|Double Blind Treatment Period|Lack of Efficacy|0
7618161|NCT01778049|26505906|P1|Double Blind Treatment Period|Lack of Efficacy|0
7618162|NCT01778049|26505901|P6|Double Blind Treatment Period|Adverse Event|2
7618163|NCT01778049|26505902|P5|Double Blind Treatment Period|Adverse Event|3
7618164|NCT01778049|26505903|P4|Double Blind Treatment Period|Adverse Event|5
7618165|NCT01778049|26505904|P3|Double Blind Treatment Period|Adverse Event|4
7618166|NCT01778049|26505905|P2|Double Blind Treatment Period|Adverse Event|0
7618167|NCT01778049|26505906|P1|Double Blind Treatment Period|Adverse Event|0
7618168|NCT01778049|26505901|P6|Open Label Treatment Period|Other reason not defined above|0
7618169|NCT01778049|26505902|P5|Open Label Treatment Period|Other reason not defined above|0
7618170|NCT01778049|26505903|P4|Open Label Treatment Period|Other reason not defined above|0
7618171|NCT01778049|26505904|P3|Open Label Treatment Period|Other reason not defined above|0
7618172|NCT01778049|26505905|P2|Open Label Treatment Period|Other reason not defined above|94
7618173|NCT01778049|26505906|P1|Open Label Treatment Period|Other reason not defined above|77
7618174|NCT01778049|26505901|P6|Open Label Treatment Period|Not treated|0
7618175|NCT01778049|26505902|P5|Open Label Treatment Period|Not treated|0
7618176|NCT01778049|26505903|P4|Open Label Treatment Period|Not treated|0
7618177|NCT01778049|26505904|P3|Open Label Treatment Period|Not treated|0
7618178|NCT01778049|26505905|P2|Open Label Treatment Period|Not treated|1
7618179|NCT01778049|26505906|P1|Open Label Treatment Period|Not treated|2
7618180|NCT01778049|26505901|P6|Open Label Treatment Period|Withdrawal by Subject|0
7618181|NCT01778049|26505902|P5|Open Label Treatment Period|Withdrawal by Subject|0
7618182|NCT01778049|26505903|P4|Open Label Treatment Period|Withdrawal by Subject|0
7618183|NCT01778049|26505904|P3|Open Label Treatment Period|Withdrawal by Subject|0
7618184|NCT01778049|26505905|P2|Open Label Treatment Period|Withdrawal by Subject|10
7618185|NCT01778049|26505906|P1|Open Label Treatment Period|Withdrawal by Subject|4
7618186|NCT01778049|26505901|P6|Open Label Treatment Period|Lost to Follow-up|0
7618187|NCT01778049|26505902|P5|Open Label Treatment Period|Lost to Follow-up|0
7618188|NCT01778049|26505903|P4|Open Label Treatment Period|Lost to Follow-up|0
7618189|NCT01778049|26505904|P3|Open Label Treatment Period|Lost to Follow-up|0
7618190|NCT01778049|26505905|P2|Open Label Treatment Period|Lost to Follow-up|3
7618191|NCT01778049|26505906|P1|Open Label Treatment Period|Lost to Follow-up|4
7618192|NCT01778049|26505901|P6|Open Label Treatment Period|Protocol Violation|0
7618193|NCT01778049|26505902|P5|Open Label Treatment Period|Protocol Violation|0
7618194|NCT01778049|26505903|P4|Open Label Treatment Period|Protocol Violation|0
7618195|NCT01778049|26505904|P3|Open Label Treatment Period|Protocol Violation|0
7618196|NCT01778049|26505905|P2|Open Label Treatment Period|Protocol Violation|5
7618197|NCT01778049|26505906|P1|Open Label Treatment Period|Protocol Violation|5
7618198|NCT01778049|26505901|P6|Open Label Treatment Period|Lack of Efficacy|0
7618199|NCT01778049|26505902|P5|Open Label Treatment Period|Lack of Efficacy|0
7618200|NCT01778049|26505903|P4|Open Label Treatment Period|Lack of Efficacy|0
7618201|NCT01778049|26505904|P3|Open Label Treatment Period|Lack of Efficacy|0
7618202|NCT01778049|26505905|P2|Open Label Treatment Period|Lack of Efficacy|1
7618203|NCT01778049|26505906|P1|Open Label Treatment Period|Lack of Efficacy|1
7618204|NCT01778049|26505901|P6|Open Label Treatment Period|Adverse Event|0
7618205|NCT01778049|26505902|P5|Open Label Treatment Period|Adverse Event|0
7618206|NCT01778049|26505903|P4|Open Label Treatment Period|Adverse Event|0
7618207|NCT01778049|26505904|P3|Open Label Treatment Period|Adverse Event|0
7618208|NCT01778049|26505905|P2|Open Label Treatment Period|Adverse Event|15
7618209|NCT01778049|26505906|P1|Open Label Treatment Period|Adverse Event|5
7618210|NCT01778023|26505924|P2|Overall Study|Withdrawal by Subject|3
7618211|NCT01778023|26505925|P1|Overall Study|Withdrawal by Subject|0
7618212|NCT01778010|26505942|P1|Overall Study|rash while on placebo|1
7618213|NCT01778010|26505942|P1|Overall Study|Arrested|1
7618214|NCT01778010|26505942|P1|Overall Study|abnormal ECG before meds|1
7618215|NCT01778010|26505942|P1|Overall Study|Withdrawal by Subject|2
7618216|NCT01777997|26505983|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
7618217|NCT01777997|26505983|P1|Weeks 48 to 72/96 on ART|Death|1
7618218|NCT01777997|26505983|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
7618219|NCT01777997|26505983|P1|12 Week lead-in of no ART|Severe debilitation|2
7618220|NCT01777932|26506005|P1|Overall Study|Patient refused further treatment|10
7618221|NCT01777932|26506005|P1|Overall Study|Reimbursement limit|9
7618222|NCT01777932|26506005|P1|Overall Study|Investigator decision|10
7618223|NCT01777932|26506005|P1|Overall Study|Lost to Follow-up|3
7618224|NCT01777932|26506005|P1|Overall Study|Adverse Event|34
7618225|NCT01777932|26506005|P1|Overall Study|Death|3
7618226|NCT01777932|26506005|P1|Overall Study|Disease progression|136
7618227|NCT01777854|26506019|P2|Overall Study|Physician Decision|3
7618228|NCT01777854|26506020|P1|Overall Study|Physician Decision|3
7618229|NCT01777776|26506028|P4|Overall Study|Withdrawal by Subject|1
7618230|NCT01777776|26506029|P3|Overall Study|Withdrawal by Subject|0
7618231|NCT01777776|26506030|P2|Overall Study|Withdrawal by Subject|0
7618232|NCT01777776|26506031|P1|Overall Study|Withdrawal by Subject|0
7618233|NCT01777776|26506028|P4|Overall Study|Disease Progression|3
7618234|NCT01777776|26506029|P3|Overall Study|Disease Progression|6
7618235|NCT01777776|26506030|P2|Overall Study|Disease Progression|8
7618236|NCT01777776|26506031|P1|Overall Study|Disease Progression|4
7618237|NCT01777776|26506028|P4|Overall Study|Adverse Event|0
7618238|NCT01777776|26506029|P3|Overall Study|Adverse Event|0
7618239|NCT01777776|26506030|P2|Overall Study|Adverse Event|4
7618240|NCT01777776|26506031|P1|Overall Study|Adverse Event|2
7618241|NCT01777763|26506090|P2|Overall Study|Treatment Failure|6
7618242|NCT01777763|26506091|P1|Overall Study|Treatment Failure|1
7618243|NCT01777763|26506090|P2|Overall Study|Withdrawal by Subject|2
7618244|NCT01777763|26506091|P1|Overall Study|Withdrawal by Subject|0
7618245|NCT01777763|26506090|P2|Overall Study|Protocol Violation|7
7618246|NCT01777763|26506091|P1|Overall Study|Protocol Violation|1
7618247|NCT01777763|26506090|P2|Overall Study|Adverse Event|32
7618248|NCT01777763|26506091|P1|Overall Study|Adverse Event|2
7618249|NCT01777620|26506115|P2|Overall Study|Subject Withdrawal|0
7618250|NCT01777620|26506116|P1|Overall Study|Subject Withdrawal|1
7618251|NCT01777581|26506142|P2|Overall Study|Lack of Efficacy|1
7618252|NCT01777581|26506143|P1|Overall Study|Lack of Efficacy|0
7618253|NCT01777581|26506142|P2|Overall Study|Adverse Event|0
7618254|NCT01777581|26506143|P1|Overall Study|Adverse Event|2
7618255|NCT01777581|26506142|P2|Overall Study|Lost to Follow-up|1
7618256|NCT01777581|26506143|P1|Overall Study|Lost to Follow-up|1
7618257|NCT01777542|26506172|P2|Second Intervention (20 Weeks)|Adverse Event|1
7618258|NCT01777542|26506173|P1|Second Intervention (20 Weeks)|Adverse Event|0
7618259|NCT01777490|26506216|P4|Overall Study|Dyad withdrew with data use prohibition|1
7618260|NCT01777490|26506217|P3|Overall Study|Dyad withdrew with data use prohibition|1
7618261|NCT01777490|26506218|P2|Overall Study|Dyad withdrew with data use prohibition|0
7618262|NCT01777490|26506219|P1|Overall Study|Dyad withdrew with data use prohibition|0
7618263|NCT01777334|26506264|P2|Overall Study|Withdrawal by Subject|11
7618264|NCT01777334|26506265|P1|Overall Study|Withdrawal by Subject|14
7618265|NCT01777334|26506264|P2|Overall Study|Lost to Follow-up|2
7618266|NCT01777334|26506265|P1|Overall Study|Lost to Follow-up|3
7618267|NCT01777334|26506264|P2|Overall Study|Protocol Violation|7
7618268|NCT01777334|26506265|P1|Overall Study|Protocol Violation|3
7618269|NCT01777334|26506264|P2|Overall Study|Lack of Efficacy|29
7618270|NCT01777334|26506265|P1|Overall Study|Lack of Efficacy|15
7618271|NCT01777334|26506264|P2|Overall Study|Adverse Event|14
7618272|NCT01777334|26506265|P1|Overall Study|Adverse Event|18
7618273|NCT01777321|26506275|P2|Overall Study|Withdrawal by Subject|1
7618274|NCT01777321|26506276|P1|Overall Study|Withdrawal by Subject|0
7618275|NCT01777308|26506314|P2|Overall Study|Blood draw refusal at Visit 3|0
7618276|NCT01777308|26506315|P1|Overall Study|Blood draw refusal at Visit 3|1
7618277|NCT01777308|26506314|P2|Overall Study|Lost to Follow-up|2
7618278|NCT01777308|26506315|P1|Overall Study|Lost to Follow-up|7
7618279|NCT01777308|26506314|P2|Overall Study|Migrated/moved from study area|0
7618280|NCT01777308|26506315|P1|Overall Study|Migrated/moved from study area|1
7618281|NCT01777308|26506314|P2|Overall Study|Withdrawal by Subject|1
7618282|NCT01777308|26506315|P1|Overall Study|Withdrawal by Subject|5
7618283|NCT01777295|26506347|P2|Overall Study|Investigator call for AEs check|0
7618284|NCT01777295|26506348|P1|Overall Study|Investigator call for AEs check|1
7618285|NCT01777295|26506347|P2|Overall Study|Personal problem|0
7618286|NCT01777295|26506348|P1|Overall Study|Personal problem|1
7618287|NCT01777295|26506347|P2|Overall Study|Pregnancy|1
7618288|NCT01777295|26506348|P1|Overall Study|Pregnancy|0
7618289|NCT01777295|26506347|P2|Overall Study|Withdrawal by Subject|2
7618290|NCT01777295|26506348|P1|Overall Study|Withdrawal by Subject|2
7618291|NCT01777282|26506555|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
7618292|NCT01777282|26506556|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
7618293|NCT01777282|26506557|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
7618294|NCT01777282|26506558|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
7618295|NCT01777282|26506559|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
7618296|NCT01777282|26506555|P5|Overall Study|Protocol Violation|2
7618297|NCT01777282|26506556|P4|Overall Study|Protocol Violation|0
7618298|NCT01777282|26506557|P3|Overall Study|Protocol Violation|1
7618299|NCT01777282|26506558|P2|Overall Study|Protocol Violation|0
7618300|NCT01777282|26506559|P1|Overall Study|Protocol Violation|2
7618301|NCT01777282|26506555|P5|Overall Study|Withdrawal by Subject|2
7618302|NCT01777282|26506556|P4|Overall Study|Withdrawal by Subject|1
7618303|NCT01777282|26506557|P3|Overall Study|Withdrawal by Subject|0
7618304|NCT01777282|26506558|P2|Overall Study|Withdrawal by Subject|0
7618305|NCT01777282|26506559|P1|Overall Study|Withdrawal by Subject|4
7618306|NCT01777282|26506555|P5|Overall Study|Adverse Event|3
7618307|NCT01777282|26506556|P4|Overall Study|Adverse Event|1
7618308|NCT01777282|26506557|P3|Overall Study|Adverse Event|2
7618309|NCT01777282|26506558|P2|Overall Study|Adverse Event|4
7618310|NCT01777282|26506559|P1|Overall Study|Adverse Event|4
7618311|NCT01777282|26506555|P5|Overall Study|New Antidiabetic Medication|0
7618312|NCT01777282|26506556|P4|Overall Study|New Antidiabetic Medication|0
7618313|NCT01777282|26506557|P3|Overall Study|New Antidiabetic Medication|1
7618314|NCT01777282|26506558|P2|Overall Study|New Antidiabetic Medication|0
7618315|NCT01777282|26506559|P1|Overall Study|New Antidiabetic Medication|0
7618316|NCT01777282|26506555|P5|Overall Study|Persistent Hyperglycemia|0
7618317|NCT01777282|26506556|P4|Overall Study|Persistent Hyperglycemia|0
7618318|NCT01777282|26506557|P3|Overall Study|Persistent Hyperglycemia|1
7618319|NCT01777282|26506558|P2|Overall Study|Persistent Hyperglycemia|0
7618320|NCT01777282|26506559|P1|Overall Study|Persistent Hyperglycemia|0
7618321|NCT01777269|26506603|P2|Overall Study|Withdrawal by Subject|9
7618322|NCT01777269|26506604|P1|Overall Study|Withdrawal by Subject|9
7618323|NCT01777269|26506603|P2|Overall Study|Physician Decision|2
7618324|NCT01777269|26506604|P1|Overall Study|Physician Decision|5
7618325|NCT01777269|26506603|P2|Overall Study|Lost to Follow-up|0
7618326|NCT01777269|26506604|P1|Overall Study|Lost to Follow-up|4
7618327|NCT01777269|26506603|P2|Overall Study|Participants reached stopping criteria|1
7618328|NCT01777269|26506604|P1|Overall Study|Participants reached stopping criteria|1
7618329|NCT01777269|26506603|P2|Overall Study|Protocol Violation|4
7618330|NCT01777269|26506604|P1|Overall Study|Protocol Violation|4
7618331|NCT01777269|26506603|P2|Overall Study|Lack of Efficacy|10
7618332|NCT01777269|26506604|P1|Overall Study|Lack of Efficacy|8
7618333|NCT01777269|26506603|P2|Overall Study|Adverse Event|33
7618334|NCT01777269|26506604|P1|Overall Study|Adverse Event|24
7618335|NCT01777191|26506641|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
7618336|NCT01777191|26506642|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
7618337|NCT01777191|26506641|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
7618338|NCT01777191|26506642|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
7618339|NCT01777191|26506641|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7618340|NCT01777191|26506642|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7618341|NCT01777191|26506641|P2|Safety Extension Per (Week 12-Week 48)|Death|1
7618342|NCT01777191|26506642|P1|Safety Extension Per (Week 12-Week 48)|Death|0
7618343|NCT01777191|26506641|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7618344|NCT01777191|26506642|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7618425|NCT01775787|26507110|P1|Second 7-10 Days|concerns with using IV|0
7618345|NCT01777191|26506641|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
7618346|NCT01777191|26506642|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
7618347|NCT01777191|26506641|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7618348|NCT01777191|26506642|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7618349|NCT01777191|26506641|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
7618350|NCT01777191|26506642|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
7618351|NCT01777191|26506641|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
7618352|NCT01777191|26506642|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
7618353|NCT01777191|26506641|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7618354|NCT01777191|26506642|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7618355|NCT01777191|26506641|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
7618356|NCT01777191|26506642|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
7618357|NCT01777152|26506672|P2|Overall Study|Change of diagnosis|0
7618358|NCT01777152|26506673|P1|Overall Study|Change of diagnosis|1
7618359|NCT01777152|26506672|P2|Overall Study|Not eligible, no study drug received|0
7618360|NCT01777152|26506673|P1|Overall Study|Not eligible, no study drug received|1
7618361|NCT01777152|26506672|P2|Overall Study|Death|73
7618362|NCT01777152|26506673|P1|Overall Study|Death|51
7618363|NCT01777152|26506672|P2|Overall Study|Lost to Follow-up|4
7618364|NCT01777152|26506673|P1|Overall Study|Lost to Follow-up|0
7618365|NCT01777152|26506672|P2|Overall Study|Withdrawal by Subject|10
7618366|NCT01777152|26506673|P1|Overall Study|Withdrawal by Subject|16
7618367|NCT01777152|26506672|P2|Overall Study|In Follow Up|139
7618368|NCT01777152|26506673|P1|Overall Study|In Follow Up|157
7618369|NCT01777139|26506690|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
7618370|NCT01777139|26506691|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
7618371|NCT01777139|26506690|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
7618372|NCT01777139|26506691|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
7618373|NCT01777139|26506690|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
7618374|NCT01777139|26506691|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
7618375|NCT01777139|26506690|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
7618376|NCT01777139|26506691|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
7618377|NCT01777139|26506690|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
7618378|NCT01777139|26506691|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
7618379|NCT01777139|26506690|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
7618380|NCT01777139|26506691|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
7618381|NCT01777139|26506690|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
7618382|NCT01777139|26506691|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
7618383|NCT01777139|26506690|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
7618384|NCT01777139|26506691|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
7618385|NCT01776554|26506805|P2|Overall Study|Unclassified|1
7618386|NCT01776554|26506806|P1|Overall Study|Unclassified|4
7618387|NCT01776554|26506805|P2|Overall Study|Protocol Violation|0
7618388|NCT01776554|26506806|P1|Overall Study|Protocol Violation|1
7618389|NCT01776554|26506805|P2|Overall Study|Administrative Reason|5
7618390|NCT01776554|26506806|P1|Overall Study|Administrative Reason|2
7618391|NCT01776554|26506805|P2|Overall Study|Lost to Follow-up|9
7618392|NCT01776554|26506806|P1|Overall Study|Lost to Follow-up|6
7618393|NCT01776554|26506805|P2|Overall Study|Withdrawal by Subject|8
7618394|NCT01776554|26506806|P1|Overall Study|Withdrawal by Subject|3
7618395|NCT01776554|26506805|P2|Overall Study|Adverse Event|0
7618396|NCT01776554|26506806|P1|Overall Study|Adverse Event|1
7618397|NCT01776541|26506849|P2|Overall Study|Withdrawal by Subject|20
7618398|NCT01776541|26506850|P1|Overall Study|Withdrawal by Subject|12
7618399|NCT01776541|26506849|P2|Overall Study|Protocol Violation|1
7618400|NCT01776541|26506850|P1|Overall Study|Protocol Violation|2
7618401|NCT01776541|26506849|P2|Overall Study|Unclassified|4
7618402|NCT01776541|26506850|P1|Overall Study|Unclassified|5
7618403|NCT01776541|26506849|P2|Overall Study|Lost to Follow-up|48
7618404|NCT01776541|26506850|P1|Overall Study|Lost to Follow-up|27
7618405|NCT01776541|26506849|P2|Overall Study|Death|0
7618406|NCT01776541|26506850|P1|Overall Study|Death|4
7618407|NCT01776541|26506849|P2|Overall Study|Administrative Reason|2
7618408|NCT01776541|26506850|P1|Overall Study|Administrative Reason|6
7618409|NCT01776424|26506872|P3|Overall Study|Withdrawal by Subject|15
7618410|NCT01776424|26506873|P2|Overall Study|Withdrawal by Subject|11
7618411|NCT01776424|26506874|P1|Overall Study|Withdrawal by Subject|10
7618412|NCT01776424|26506872|P3|Overall Study|Lost to Follow-up|9
7618413|NCT01776424|26506873|P2|Overall Study|Lost to Follow-up|8
7618414|NCT01776424|26506874|P1|Overall Study|Lost to Follow-up|10
7618415|NCT01776307|26506897|P3|Overall Study|Not dosed|1
7618416|NCT01776307|26506898|P2|Overall Study|Not dosed|0
7618417|NCT01776307|26506899|P1|Overall Study|Not dosed|0
7618418|NCT01776008|26506960|P1|Overall Study|ineligible|2
7618419|NCT01775995|26506974|P2|Overall Study|Lost to Follow-up|1
7618420|NCT01775995|26506975|P1|Overall Study|Lost to Follow-up|1
7618421|NCT01775930|26507035|P1|Overall Study|Futility stopping boundary met|1
7618422|NCT01775904|26507043|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
7618423|NCT01775904|26507043|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
7618424|NCT01775787|26507109|P2|Second 7-10 Days|concerns with using IV|1
7618426|NCT01775787|26507109|P2|Second 7-10 Days|time commitment|1
7618427|NCT01775787|26507110|P1|Second 7-10 Days|time commitment|0
7618428|NCT01775787|26507109|P2|First 7-10 Days|concerns with using IV|2
7618429|NCT01775787|26507110|P1|First 7-10 Days|concerns with using IV|1
7618430|NCT01775787|26507109|P2|First 7-10 Days|time commitment|2
7618431|NCT01775787|26507110|P1|First 7-10 Days|time commitment|0
7618432|NCT01775787|26507109|P2|First 7-10 Days|family emergency|1
7618433|NCT01775787|26507110|P1|First 7-10 Days|family emergency|0
7618434|NCT01775787|26507109|P2|First 7-10 Days|Adverse Event|1
7618435|NCT01775787|26507110|P1|First 7-10 Days|Adverse Event|0
7618436|NCT01775670|26507166|P2|Overall Study|Lost to Follow-up|1
7618437|NCT01775670|26507167|P1|Overall Study|Lost to Follow-up|1
7618438|NCT01775553|26507193|P1|Overall Study|Disease Progression|12
7618439|NCT01775553|26507193|P1|Overall Study|Adverse Event|1
7618440|NCT01775501|26507201|P1|Overall Study|Discontinued prior to treatment|1
7618441|NCT01775189|26507234|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
7618442|NCT01775189|26507235|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
7618443|NCT01775189|26507236|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
7618444|NCT01775189|26507237|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
7618445|NCT01775189|26507238|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
7618446|NCT01775189|26507239|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
7618447|NCT01775189|26507240|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
7618448|NCT01775189|26507234|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
7618449|NCT01775189|26507235|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
7618450|NCT01775189|26507236|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
7618451|NCT01775189|26507237|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
7618452|NCT01775189|26507238|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
7618453|NCT01775189|26507239|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
7618454|NCT01775189|26507240|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
7618455|NCT01775189|26507234|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
7618456|NCT01775189|26507235|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
7618457|NCT01775189|26507236|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
7618458|NCT01775189|26507237|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
7618459|NCT01775189|26507238|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
7618460|NCT01775189|26507239|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
7618461|NCT01775189|26507240|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
7618462|NCT01775189|26507234|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7618463|NCT01775189|26507235|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7618464|NCT01775189|26507236|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7618465|NCT01775189|26507237|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7618466|NCT01775189|26507238|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
7618467|NCT01775189|26507239|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
7618468|NCT01775189|26507240|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7618469|NCT01775189|26507234|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
7618470|NCT01775189|26507235|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
7618471|NCT01775189|26507236|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
7618472|NCT01775189|26507237|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
7618473|NCT01775189|26507238|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
7618474|NCT01775189|26507239|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
7618475|NCT01775189|26507240|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
7618476|NCT01775189|26507234|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
7618477|NCT01775189|26507235|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
7618478|NCT01775189|26507236|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
7618479|NCT01775189|26507237|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
7618480|NCT01775189|26507238|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
7618481|NCT01775189|26507239|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
7618482|NCT01775189|26507240|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
7618483|NCT01775137|26507459|P1|Overall Study|Withdrawal by participants|5
7618484|NCT01775137|26507459|P1|Overall Study|Adverse Event|1
7618485|NCT01775137|26507459|P1|Overall Study|Unsatisfactory therapeutic effect|2
7618486|NCT01775137|26507459|P1|Overall Study|Protocol deviation|2
7618487|NCT01775137|26507459|P1|Overall Study|Death|1
7618488|NCT01775124|26507486|P2|Extension Period|Withdrawal by Subject|12
7618489|NCT01775124|26507487|P1|Extension Period|Withdrawal by Subject|9
7618490|NCT01775124|26507486|P2|Extension Period|Lost to Follow-up|1
7618491|NCT01775124|26507487|P1|Extension Period|Lost to Follow-up|0
7618492|NCT01775124|26507486|P2|Extension Period|Administrative problems|1
7618493|NCT01775124|26507487|P1|Extension Period|Administrative problems|0
7618494|NCT01775124|26507486|P2|Extension Period|Physician Decision|2
7618495|NCT01775124|26507487|P1|Extension Period|Physician Decision|0
7618496|NCT01775124|26507486|P2|Extension Period|Adverse Event|2
7618497|NCT01775124|26507487|P1|Extension Period|Adverse Event|3
7618498|NCT01775124|26507486|P2|Core Period|Adverse Event|5
7618499|NCT01775124|26507487|P1|Core Period|Adverse Event|5
7618500|NCT01775124|26507486|P2|Core Period|Withdrawal by Subject|2
7618501|NCT01775124|26507487|P1|Core Period|Withdrawal by Subject|4
7618502|NCT01775124|26507486|P2|Core Period|Administrative problems|0
7618503|NCT01775124|26507487|P1|Core Period|Administrative problems|1
7618504|NCT01775124|26507486|P2|Core Period|Death|1
7618505|NCT01775124|26507487|P1|Core Period|Death|0
7618506|NCT01775124|26507486|P2|Core Period|Physician Decision|1
7618507|NCT01775124|26507487|P1|Core Period|Physician Decision|1
7618508|NCT01775124|26507486|P2|Core Period|Disease Progression|1
7618509|NCT01775124|26507487|P1|Core Period|Disease Progression|0
7618510|NCT01774981|26507522|P8|Overall Study|Death|0
7618511|NCT01774981|26507523|P7|Overall Study|Death|0
7618512|NCT01774981|26507524|P6|Overall Study|Death|0
7618513|NCT01774981|26507525|P5|Overall Study|Death|1
7618514|NCT01774981|26507526|P4|Overall Study|Death|0
7618515|NCT01774981|26507527|P3|Overall Study|Death|0
7618516|NCT01774981|26507528|P2|Overall Study|Death|0
7618517|NCT01774981|26507529|P1|Overall Study|Death|0
7618518|NCT01774981|26507522|P8|Overall Study|Withdrawal by Subject|1
7618519|NCT01774981|26507523|P7|Overall Study|Withdrawal by Subject|0
7618520|NCT01774981|26507524|P6|Overall Study|Withdrawal by Subject|0
7618521|NCT01774981|26507525|P5|Overall Study|Withdrawal by Subject|0
7618522|NCT01774981|26507526|P4|Overall Study|Withdrawal by Subject|0
7618523|NCT01774981|26507527|P3|Overall Study|Withdrawal by Subject|0
7618524|NCT01774981|26507528|P2|Overall Study|Withdrawal by Subject|0
7618525|NCT01774981|26507529|P1|Overall Study|Withdrawal by Subject|0
7618526|NCT01774981|26507522|P8|Overall Study|Adverse Event|0
7618527|NCT01774981|26507523|P7|Overall Study|Adverse Event|0
7618528|NCT01774981|26507524|P6|Overall Study|Adverse Event|1
7618529|NCT01774981|26507525|P5|Overall Study|Adverse Event|0
7618530|NCT01774981|26507526|P4|Overall Study|Adverse Event|0
7618531|NCT01774981|26507527|P3|Overall Study|Adverse Event|0
7618532|NCT01774981|26507528|P2|Overall Study|Adverse Event|0
7618533|NCT01774981|26507529|P1|Overall Study|Adverse Event|0
7618534|NCT01774968|26507561|P2|Overall Study|Withdrawal by Subject|11
7618535|NCT01774968|26507562|P1|Overall Study|Withdrawal by Subject|6
7618536|NCT01774968|26507561|P2|Overall Study|Sponsor Decision|2
7618537|NCT01774968|26507562|P1|Overall Study|Sponsor Decision|0
7618538|NCT01774968|26507561|P2|Overall Study|Protocol Violation|13
7618539|NCT01774968|26507562|P1|Overall Study|Protocol Violation|14
7618540|NCT01774968|26507561|P2|Overall Study|Physician Decision|1
7618541|NCT01774968|26507562|P1|Overall Study|Physician Decision|5
7618542|NCT01774968|26507561|P2|Overall Study|Lost to Follow-up|3
7618543|NCT01774968|26507562|P1|Overall Study|Lost to Follow-up|1
7618544|NCT01774968|26507561|P2|Overall Study|Death|1
7618545|NCT01774968|26507562|P1|Overall Study|Death|0
7618546|NCT01774968|26507561|P2|Overall Study|Adverse Event|4
7618547|NCT01774968|26507562|P1|Overall Study|Adverse Event|4
7618548|NCT01774929|26507596|P1|Overall Study|Adverse Event|3
7618549|NCT01774903|26507602|P1|Overall Study|Ineligible to continue the trial|1
7618550|NCT01774903|26507602|P1|Overall Study|Lack of Efficacy|1
7618551|NCT01774903|26507602|P1|Overall Study|Withdrawal by Subject|2
7618552|NCT01774903|26507602|P1|Overall Study|Adverse Event|7
7618553|NCT01774799|26507622|P4|Overall Study|Lost to Follow-up|0
7618554|NCT01774799|26507623|P3|Overall Study|Lost to Follow-up|0
7618555|NCT01774799|26507624|P2|Overall Study|Lost to Follow-up|1
7618556|NCT01774799|26507625|P1|Overall Study|Lost to Follow-up|1
7618557|NCT01774786|26507641|P2|Overall Study|Reason Not Specified|5
7618558|NCT01774786|26507642|P1|Overall Study|Reason Not Specified|2
7618559|NCT01774786|26507641|P2|Overall Study|Non-compliance|1
7618560|NCT01774786|26507642|P1|Overall Study|Non-compliance|0
7618561|NCT01774786|26507641|P2|Overall Study|Physician Decision|0
7618562|NCT01774786|26507642|P1|Overall Study|Physician Decision|2
7618563|NCT01774786|26507641|P2|Overall Study|Withdrawal by Subject|14
7618564|NCT01774786|26507642|P1|Overall Study|Withdrawal by Subject|18
7618565|NCT01774786|26507641|P2|Overall Study|Lost to Follow-up|7
7618566|NCT01774786|26507642|P1|Overall Study|Lost to Follow-up|6
7618567|NCT01774786|26507641|P2|Overall Study|Death|319
7618568|NCT01774786|26507642|P1|Overall Study|Death|300
7618569|NCT01774721|26507678|P2|Overall Study|Ongoing in study|120
7618570|NCT01774721|26507679|P1|Overall Study|Ongoing in study|136
7618571|NCT01774721|26507678|P2|Overall Study|Did not meet eligibility criteria|3
7618572|NCT01774721|26507679|P1|Overall Study|Did not meet eligibility criteria|0
7618573|NCT01774721|26507678|P2|Overall Study|Lost to Follow-up|1
7618574|NCT01774721|26507679|P1|Overall Study|Lost to Follow-up|1
7618575|NCT01774721|26507678|P2|Overall Study|Withdrawal by Subject|10
7618576|NCT01774721|26507679|P1|Overall Study|Withdrawal by Subject|14
7618577|NCT01774721|26507678|P2|Overall Study|Death|91
7618578|NCT01774721|26507679|P1|Overall Study|Death|76
7618579|NCT01774591|26507744|P2|Overall Study|Adverse Event|2
7618580|NCT01774591|26507745|P1|Overall Study|Adverse Event|0
7618581|NCT01774591|26507744|P2|Overall Study|Withdrawal by Subject|1
7618582|NCT01774591|26507745|P1|Overall Study|Withdrawal by Subject|0
7618583|NCT01774591|26507744|P2|Overall Study|Physician Decision|1
7618584|NCT01774591|26507745|P1|Overall Study|Physician Decision|1
7618585|NCT01774370|26507755|P1|Overall Study|Follow-up failure|34
7618586|NCT01774370|26507755|P1|Overall Study|Violated inclusion/exclusion criteria|53
7618587|NCT01774370|26507755|P1|Overall Study|Subjects of contraindications|34
7618588|NCT01774370|26507755|P1|Overall Study|Administered prior to the contract date|4
7618589|NCT01774370|26507755|P1|Overall Study|Never taken the PRADAXA during the study|4
7618590|NCT01774344|26507763|P2|Overall Study|Did not enter Survival Follow up|83
7618591|NCT01774344|26507764|P1|Overall Study|Did not enter Survival Follow up|49
7618592|NCT01774344|26507763|P2|Overall Study|Other|1
7618593|NCT01774344|26507764|P1|Overall Study|Other|0
7618594|NCT01774344|26507763|P2|Overall Study|Data collection finished|14
7618595|NCT01774344|26507764|P1|Overall Study|Data collection finished|4
7618684|NCT01773109|26508036|P1|Overall Study|Symptomatic Progression|2
7618596|NCT01774344|26507763|P2|Overall Study|End of survival follow-up not available|2
7618597|NCT01774344|26507764|P1|Overall Study|End of survival follow-up not available|2
7618598|NCT01774344|26507763|P2|Overall Study|Lost to Follow-up|10
7618599|NCT01774344|26507764|P1|Overall Study|Lost to Follow-up|4
7618600|NCT01774344|26507763|P2|Overall Study|Protocol Violation|1
7618601|NCT01774344|26507764|P1|Overall Study|Protocol Violation|0
7618602|NCT01774344|26507763|P2|Overall Study|Withdrawal by Subject|10
7618603|NCT01774344|26507764|P1|Overall Study|Withdrawal by Subject|3
7618604|NCT01774305|26507782|P2|Overall Study|Physician Decision|0
7618605|NCT01774305|26507783|P1|Overall Study|Physician Decision|1
7618606|NCT01774253|26507791|P1|Overall Study|Death|1
7618607|NCT01774253|26507791|P1|Overall Study|Withdrawal by Subject|2
7618608|NCT01774253|26507791|P1|Overall Study|Physician Decision|2
7618609|NCT01774253|26507791|P1|Overall Study|Lack of Efficacy|4
7618610|NCT01774110|26507810|P1|Overall Study|Lost to Follow-up|7
7618611|NCT01774097|26507818|P2|Overall Study|Adverse Event|1
7618612|NCT01774097|26507819|P1|Overall Study|Adverse Event|1
7618613|NCT01774097|26507818|P2|Overall Study|Withdrawal by Subject|1
7618614|NCT01774097|26507819|P1|Overall Study|Withdrawal by Subject|1
7618615|NCT01774084|26507849|P2|Overall Study|Personal reasons|0
7618616|NCT01774084|26507850|P1|Overall Study|Personal reasons|1
7618617|NCT01773993|26507875|P1|Overall Study|No Visit After Treatment|35
7618618|NCT01773967|26507894|P2|Overall Study|Lost to Follow-up|13
7618619|NCT01773967|26507895|P1|Overall Study|Lost to Follow-up|15
7618620|NCT01773889|26507910|P1|Overall Study|lack of funding|2
7618621|NCT01773473|26507916|P2|Overall Study|Lost to Follow-up|0
7618622|NCT01773473|26507917|P1|Overall Study|Lost to Follow-up|2
7618623|NCT01773473|26507916|P2|Overall Study|Withdrawal by Subject|3
7618624|NCT01773473|26507917|P1|Overall Study|Withdrawal by Subject|5
7618625|NCT01773473|26507916|P2|Overall Study|Non-Compliance with study drug|4
7618626|NCT01773473|26507917|P1|Overall Study|Non-Compliance with study drug|1
7618627|NCT01773473|26507916|P2|Overall Study|Lack of Efficacy|1
7618628|NCT01773473|26507917|P1|Overall Study|Lack of Efficacy|0
7618629|NCT01773473|26507916|P2|Overall Study|Sponsor Decision|0
7618630|NCT01773473|26507917|P1|Overall Study|Sponsor Decision|2
7618631|NCT01773473|26507916|P2|Overall Study|Physician Decision|5
7618632|NCT01773473|26507917|P1|Overall Study|Physician Decision|3
7618633|NCT01773473|26507916|P2|Overall Study|Protocol Violation|4
7618634|NCT01773473|26507917|P1|Overall Study|Protocol Violation|0
7618635|NCT01773473|26507916|P2|Overall Study|Adverse Event|2
7618636|NCT01773473|26507917|P1|Overall Study|Adverse Event|3
7618637|NCT01773421|26507939|P7|Extension Phase|Adverse Event|0
7618638|NCT01773421|26507940|P6|Extension Phase|Adverse Event|0
7618639|NCT01773421|26507941|P5|Extension Phase|Adverse Event|2
7618640|NCT01773421|26507942|P4|Extension Phase|Adverse Event|0
7618641|NCT01773421|26507943|P3|Extension Phase|Adverse Event|0
7618642|NCT01773421|26507944|P2|Extension Phase|Adverse Event|0
7618643|NCT01773421|26507945|P1|Extension Phase|Adverse Event|0
7618644|NCT01773421|26507939|P7|Extension Phase|Other|0
7618645|NCT01773421|26507940|P6|Extension Phase|Other|2
7618646|NCT01773421|26507941|P5|Extension Phase|Other|1
7618647|NCT01773421|26507942|P4|Extension Phase|Other|0
7618648|NCT01773421|26507943|P3|Extension Phase|Other|0
7618649|NCT01773421|26507944|P2|Extension Phase|Other|0
7618650|NCT01773421|26507945|P1|Extension Phase|Other|0
7618651|NCT01773421|26507939|P7|Treatment Phase|Withdrawal by Subject|0
7618652|NCT01773421|26507940|P6|Treatment Phase|Withdrawal by Subject|0
7618653|NCT01773421|26507941|P5|Treatment Phase|Withdrawal by Subject|0
7618654|NCT01773421|26507942|P4|Treatment Phase|Withdrawal by Subject|1
7618655|NCT01773421|26507943|P3|Treatment Phase|Withdrawal by Subject|1
7618656|NCT01773421|26507944|P2|Treatment Phase|Withdrawal by Subject|0
7618657|NCT01773421|26507945|P1|Treatment Phase|Withdrawal by Subject|0
7618658|NCT01773421|26507939|P7|Treatment Phase|Adverse Event|0
7618659|NCT01773421|26507940|P6|Treatment Phase|Adverse Event|0
7618660|NCT01773421|26507941|P5|Treatment Phase|Adverse Event|0
7618661|NCT01773421|26507942|P4|Treatment Phase|Adverse Event|1
7618662|NCT01773421|26507943|P3|Treatment Phase|Adverse Event|3
7618663|NCT01773421|26507944|P2|Treatment Phase|Adverse Event|0
7618664|NCT01773421|26507945|P1|Treatment Phase|Adverse Event|0
7618665|NCT01773421|26507939|P7|Treatment Phase|Other|0
7618666|NCT01773421|26507940|P6|Treatment Phase|Other|0
7618667|NCT01773421|26507941|P5|Treatment Phase|Other|0
7618668|NCT01773421|26507942|P4|Treatment Phase|Other|0
7618669|NCT01773421|26507943|P3|Treatment Phase|Other|2
7618670|NCT01773421|26507944|P2|Treatment Phase|Other|0
7618671|NCT01773421|26507945|P1|Treatment Phase|Other|0
7618672|NCT01773291|26507976|P3|Overall Study|Withdrawal by Subject|1
7618673|NCT01773291|26507977|P2|Overall Study|Withdrawal by Subject|0
7618674|NCT01773291|26507978|P1|Overall Study|Withdrawal by Subject|0
7618675|NCT01773291|26507976|P3|Overall Study|Protocol Violation|0
7618676|NCT01773291|26507977|P2|Overall Study|Protocol Violation|0
7618677|NCT01773291|26507978|P1|Overall Study|Protocol Violation|1
7618678|NCT01773226|26507989|P1|Overall Study|Withdrawal by Subject|1
7618679|NCT01773122|26508019|P4|Overall Study|Due to amended age eligibility criteria|1
7618680|NCT01773122|26508020|P3|Overall Study|Due to amended age eligibility criteria|0
7618681|NCT01773122|26508021|P2|Overall Study|Due to amended age eligibility criteria|1
7618682|NCT01773122|26508022|P1|Overall Study|Due to amended age eligibility criteria|3
7618683|NCT01773109|26508036|P1|Overall Study|Death|1
7618685|NCT01773070|26508040|P1|Overall Study|Death (unrelated to study procedures)|3
7618686|NCT01773070|26508040|P1|Overall Study|Other|15
7618687|NCT01773070|26508040|P1|Overall Study|Lost to Follow-up|39
7618688|NCT01773070|26508040|P1|Overall Study|Withdrawal by Subject|24
7618689|NCT01772823|26508050|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
7618690|NCT01772823|26508051|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
7618691|NCT01772823|26508050|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7618692|NCT01772823|26508051|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7618693|NCT01772823|26508050|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
7618694|NCT01772823|26508051|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
7618695|NCT01772823|26508050|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
7618696|NCT01772823|26508051|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
7618697|NCT01772823|26508050|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7618698|NCT01772823|26508051|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7618699|NCT01772823|26508050|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
7618700|NCT01772823|26508051|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
7618701|NCT01772823|26508050|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
7618702|NCT01772823|26508051|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
7618703|NCT01772823|26508050|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
7618704|NCT01772823|26508051|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
7618705|NCT01772823|26508050|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
7618706|NCT01772823|26508051|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
7618707|NCT01772823|26508050|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
7618708|NCT01772823|26508051|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
7618709|NCT01772823|26508050|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
7618710|NCT01772823|26508051|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
7618711|NCT01772823|26508050|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
7618712|NCT01772823|26508051|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
7618713|NCT01772823|26508050|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
7618714|NCT01772823|26508051|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
7618715|NCT01772823|26508050|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
7618716|NCT01772823|26508051|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
7618717|NCT01772823|26508050|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7618718|NCT01772823|26508051|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7618719|NCT01772823|26508050|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
7618720|NCT01772823|26508051|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
7618721|NCT01772719|26508164|P1|Overall Study|Lost to Follow-up|1
7618722|NCT01772719|26508164|P1|Overall Study|Protocol Violation|1
7618723|NCT01772719|26508164|P1|Overall Study|Adverse Event|2
7618724|NCT01772719|26508164|P1|Overall Study|Withdrawal by Subject|3
7618725|NCT01772693|26508177|P2|Overall Study|Alternative Treatment|0
7618726|NCT01772693|26508178|P1|Overall Study|Alternative Treatment|2
7618727|NCT01772693|26508177|P2|Overall Study|Withdrawal by Subject|0
7618728|NCT01772693|26508178|P1|Overall Study|Withdrawal by Subject|2
7618729|NCT01772693|26508177|P2|Overall Study|Health Concerns Unrelated to Study|1
7618730|NCT01772693|26508178|P1|Overall Study|Health Concerns Unrelated to Study|2
7618731|NCT01772576|26508199|P1|Overall Study|Withdrawal by Subject|6
7618732|NCT01772576|26508199|P1|Overall Study|Adverse Event|6
7618733|NCT01772576|26508199|P1|Overall Study|Study device not used|3
7618734|NCT01772576|26508199|P1|Overall Study|Lost to Follow-up|3
7618735|NCT01772576|26508199|P1|Overall Study|Protocol Violation|1
7618736|NCT01772576|26508199|P1|Overall Study|Death|15
7618737|NCT01772550|26508211|P3|Overall Study|Adverse Event|1
7618738|NCT01772550|26508212|P2|Overall Study|Adverse Event|0
7618739|NCT01772550|26508213|P1|Overall Study|Adverse Event|0
7618740|NCT01772550|26508211|P3|Overall Study|Unable to insert IV in antecubital vein|5
7618741|NCT01772550|26508212|P2|Overall Study|Unable to insert IV in antecubital vein|1
7618742|NCT01772550|26508213|P1|Overall Study|Unable to insert IV in antecubital vein|1
7618743|NCT01772537|26508254|P3|Overall Study|unsuccessful lumbar drain placement|0
7618744|NCT01772537|26508255|P2|Overall Study|unsuccessful lumbar drain placement|0
7618745|NCT01772537|26508256|P1|Overall Study|unsuccessful lumbar drain placement|1
7618746|NCT01772472|26508272|P2|Overall Study|Ongoing|635
7618747|NCT01772472|26508273|P1|Overall Study|Ongoing|597
7618748|NCT01772472|26508272|P2|Overall Study|Withdrawal by Subject|50
7618749|NCT01772472|26508273|P1|Overall Study|Withdrawal by Subject|72
7618750|NCT01772472|26508272|P2|Overall Study|Lost to Follow-up|8
7618751|NCT01772472|26508273|P1|Overall Study|Lost to Follow-up|12
7618752|NCT01772472|26508272|P2|Overall Study|Other|5
7618753|NCT01772472|26508273|P1|Overall Study|Other|5
7618754|NCT01772472|26508272|P2|Overall Study|Physician Decision|3
7618755|NCT01772472|26508273|P1|Overall Study|Physician Decision|1
7618756|NCT01772472|26508272|P2|Overall Study|Death|42
7618757|NCT01772472|26508273|P1|Overall Study|Death|56
7618758|NCT01772368|26508285|P1|Overall Study|Other|1
7618759|NCT01772368|26508285|P1|Overall Study|Protocol Violation|2
7618760|NCT01772368|26508285|P1|Overall Study|Withdrawal by Subject|3
7618761|NCT01772368|26508285|P1|Overall Study|Adverse Event|1
7618762|NCT01772316|26508331|P1|Overall Study|Withdrawn by sponsor decision|5
7618763|NCT01772316|26508331|P1|Overall Study|Inform consent withdrawn|1
7618764|NCT01772316|26508331|P1|Overall Study|Serious adverse event|1
7618765|NCT01772160|26508349|P1|Overall Study|Other|5
7618766|NCT01772160|26508349|P1|Overall Study|Lost to Follow-up|30
7618767|NCT01772160|26508349|P1|Overall Study|Migrated / moved from the study area|4
7618768|NCT01772160|26508349|P1|Overall Study|Consent withdrawal|3
7618769|NCT01772160|26508349|P1|Overall Study|Eligibility criteria not fulfilled|3
7618770|NCT01772160|26508349|P1|Overall Study|Death|3
7618771|NCT01772147|26508372|P3|Overall Study|Lack of Efficacy|6
7618772|NCT01772147|26508373|P2|Overall Study|Lack of Efficacy|6
7618773|NCT01772147|26508374|P1|Overall Study|Lack of Efficacy|8
7618774|NCT01772147|26508372|P3|Overall Study|Protocol Deviation|1
7618775|NCT01772147|26508373|P2|Overall Study|Protocol Deviation|1
7618776|NCT01772147|26508374|P1|Overall Study|Protocol Deviation|2
7618777|NCT01772147|26508372|P3|Overall Study|Lost to Follow-up|1
7618778|NCT01772147|26508373|P2|Overall Study|Lost to Follow-up|0
7618779|NCT01772147|26508374|P1|Overall Study|Lost to Follow-up|1
7618780|NCT01772147|26508372|P3|Overall Study|Withdrew Consent|4
7618781|NCT01772147|26508373|P2|Overall Study|Withdrew Consent|8
7618782|NCT01772147|26508374|P1|Overall Study|Withdrew Consent|7
7618783|NCT01772147|26508372|P3|Overall Study|Adverse Event|6
7618784|NCT01772147|26508373|P2|Overall Study|Adverse Event|10
7618785|NCT01772147|26508374|P1|Overall Study|Adverse Event|13
7618786|NCT01772134|26508394|P3|Overall Study|Randomized Study Medication Not Received|1
7618787|NCT01772134|26508395|P2|Overall Study|Randomized Study Medication Not Received|0
7618788|NCT01772134|26508396|P1|Overall Study|Randomized Study Medication Not Received|2
7618789|NCT01772134|26508394|P3|Overall Study|Protocol-defined Stopping Criteria|0
7618790|NCT01772134|26508395|P2|Overall Study|Protocol-defined Stopping Criteria|0
7618791|NCT01772134|26508396|P1|Overall Study|Protocol-defined Stopping Criteria|1
7618792|NCT01772134|26508394|P3|Overall Study|Lack of Efficacy|3
7618793|NCT01772134|26508395|P2|Overall Study|Lack of Efficacy|5
7618794|NCT01772134|26508396|P1|Overall Study|Lack of Efficacy|11
7618795|NCT01772134|26508394|P3|Overall Study|Protocol Deviation|3
7618796|NCT01772134|26508395|P2|Overall Study|Protocol Deviation|3
7618797|NCT01772134|26508396|P1|Overall Study|Protocol Deviation|4
7618798|NCT01772134|26508394|P3|Overall Study|Lost to Follow-up|0
7618799|NCT01772134|26508395|P2|Overall Study|Lost to Follow-up|0
7618800|NCT01772134|26508396|P1|Overall Study|Lost to Follow-up|2
7618801|NCT01772134|26508394|P3|Overall Study|Withdrew Consent|5
7618802|NCT01772134|26508395|P2|Overall Study|Withdrew Consent|1
7618803|NCT01772134|26508396|P1|Overall Study|Withdrew Consent|3
7618804|NCT01772134|26508394|P3|Overall Study|Adverse Event|10
7618805|NCT01772134|26508395|P2|Overall Study|Adverse Event|5
7618806|NCT01772134|26508396|P1|Overall Study|Adverse Event|6
7618807|NCT01771913|26508452|P2|Overall Study|Withdrawal by Subject|0
7618808|NCT01771913|26508453|P1|Overall Study|Withdrawal by Subject|1
7618809|NCT01771809|26508465|P2|Overall Study|Other (other)|5
7618810|NCT01771809|26508466|P1|Overall Study|Other (other)|9
7618811|NCT01771809|26508465|P2|Overall Study|Death|0
7618812|NCT01771809|26508466|P1|Overall Study|Death|1
7618813|NCT01771809|26508465|P2|Overall Study|Other (Insufficient clinical response)|20
7618814|NCT01771809|26508466|P1|Overall Study|Other (Insufficient clinical response)|22
7618815|NCT01771809|26508465|P2|Overall Study|Lost to Follow-up|3
7618816|NCT01771809|26508466|P1|Overall Study|Lost to Follow-up|1
7618817|NCT01771809|26508465|P2|Overall Study|Withdrawal by Subject|42
7618818|NCT01771809|26508466|P1|Overall Study|Withdrawal by Subject|34
7618819|NCT01771809|26508465|P2|Overall Study|Protocol Violation|1
7618820|NCT01771809|26508466|P1|Overall Study|Protocol Violation|0
7618821|NCT01771809|26508465|P2|Overall Study|Adverse Event|12
7618822|NCT01771809|26508466|P1|Overall Study|Adverse Event|4
7618823|NCT01771731|26508482|P2|Overall Study|Adverse event: Pain Crisis|1
7618824|NCT01771731|26508483|P1|Overall Study|Adverse event: Pain Crisis|1
7618825|NCT01771731|26508482|P2|Overall Study|Protocol Violation|1
7618826|NCT01771731|26508483|P1|Overall Study|Protocol Violation|0
7618827|NCT01771731|26508482|P2|Overall Study|Physician Decision|0
7618828|NCT01771731|26508483|P1|Overall Study|Physician Decision|1
7618829|NCT01771250|26508503|P2|Period 1|Met exclusion criteria|0
7618830|NCT01771250|26508504|P1|Period 1|Met exclusion criteria|1
7618831|NCT01770912|26508531|P2|Overall Study|Lost to Follow-up|0
7618832|NCT01770912|26508532|P1|Overall Study|Lost to Follow-up|2
7618833|NCT01770860|26508566|P1|Overall Study|Administrative decision made by the PI|1
7618834|NCT01770860|26508566|P1|Overall Study|Lost to Follow-up|1
7618835|NCT01770860|26508566|P1|Overall Study|Withdrawal by Subject|4
7618836|NCT01770743|26508614|P5|Overall Study|Moving Out of State|0
7618837|NCT01770743|26508615|P4|Overall Study|Moving Out of State|0
7618838|NCT01770743|26508616|P3|Overall Study|Moving Out of State|0
7618839|NCT01770743|26508617|P2|Overall Study|Moving Out of State|1
7618840|NCT01770743|26508618|P1|Overall Study|Moving Out of State|0
7618841|NCT01770743|26508614|P5|Overall Study|Sponsor Terminated Subject|0
7618842|NCT01770743|26508615|P4|Overall Study|Sponsor Terminated Subject|1
7618843|NCT01770743|26508616|P3|Overall Study|Sponsor Terminated Subject|0
7618844|NCT01770743|26508617|P2|Overall Study|Sponsor Terminated Subject|0
7618845|NCT01770743|26508618|P1|Overall Study|Sponsor Terminated Subject|1
7618846|NCT01770743|26508614|P5|Overall Study|Lost to Follow-up|1
7618847|NCT01770743|26508615|P4|Overall Study|Lost to Follow-up|0
7618848|NCT01770743|26508616|P3|Overall Study|Lost to Follow-up|0
7618849|NCT01770743|26508617|P2|Overall Study|Lost to Follow-up|2
7618850|NCT01770743|26508618|P1|Overall Study|Lost to Follow-up|0
7618851|NCT01770743|26508614|P5|Overall Study|Withdrawal by Subject|1
7618852|NCT01770743|26508615|P4|Overall Study|Withdrawal by Subject|1
7618853|NCT01770743|26508616|P3|Overall Study|Withdrawal by Subject|1
7618854|NCT01770743|26508617|P2|Overall Study|Withdrawal by Subject|0
7618855|NCT01770743|26508618|P1|Overall Study|Withdrawal by Subject|0
7618856|NCT01770743|26508614|P5|Overall Study|Adverse Event|0
7618857|NCT01770743|26508615|P4|Overall Study|Adverse Event|0
7618858|NCT01770743|26508616|P3|Overall Study|Adverse Event|0
7618859|NCT01770743|26508617|P2|Overall Study|Adverse Event|0
7618860|NCT01770743|26508618|P1|Overall Study|Adverse Event|1
7618861|NCT01770509|26508720|P2|Overall Study|Lost to Follow-up|2
7618862|NCT01770509|26508721|P1|Overall Study|Lost to Follow-up|1
7618863|NCT01770509|26508720|P2|Overall Study|Injury|1
7618864|NCT01770509|26508721|P1|Overall Study|Injury|0
7618865|NCT01770392|26508757|P1|Washout Period of at Least 14 Days|Adverse Event|1
7618866|NCT01770379|26508772|P3|Overall Study|Adverse Event|2
7618867|NCT01770379|26508773|P2|Overall Study|Adverse Event|3
7618868|NCT01770379|26508774|P1|Overall Study|Adverse Event|1
7618869|NCT01770379|26508772|P3|Overall Study|Lack of Efficacy|6
7618870|NCT01770379|26508773|P2|Overall Study|Lack of Efficacy|6
7618871|NCT01770379|26508774|P1|Overall Study|Lack of Efficacy|8
7618872|NCT01770379|26508772|P3|Overall Study|Lost to Follow-up|2
7618873|NCT01770379|26508773|P2|Overall Study|Lost to Follow-up|0
7618874|NCT01770379|26508774|P1|Overall Study|Lost to Follow-up|0
7618875|NCT01770379|26508772|P3|Overall Study|Physician Decision|2
7618876|NCT01770379|26508773|P2|Overall Study|Physician Decision|1
7618877|NCT01770379|26508774|P1|Overall Study|Physician Decision|0
7618878|NCT01770379|26508772|P3|Overall Study|Protocol Violation|1
7618879|NCT01770379|26508773|P2|Overall Study|Protocol Violation|1
7618880|NCT01770379|26508774|P1|Overall Study|Protocol Violation|0
7618881|NCT01770379|26508772|P3|Overall Study|study terminated by sponsor|22
7618882|NCT01770379|26508773|P2|Overall Study|study terminated by sponsor|23
7618883|NCT01770379|26508774|P1|Overall Study|study terminated by sponsor|22
7618884|NCT01770379|26508772|P3|Overall Study|Withdrawal by Subject|7
7618885|NCT01770379|26508773|P2|Overall Study|Withdrawal by Subject|10
7618886|NCT01770379|26508774|P1|Overall Study|Withdrawal by Subject|7
7618887|NCT01770379|26508772|P3|Overall Study|Technical issues|0
7618888|NCT01770379|26508773|P2|Overall Study|Technical issues|0
7618889|NCT01770379|26508774|P1|Overall Study|Technical issues|1
7618890|NCT01770353|26508802|P2|Overall Study|Toxicity related diarrhoea + progression|1
7618891|NCT01770353|26508803|P1|Overall Study|Toxicity related diarrhoea + progression|0
7618892|NCT01770353|26508802|P2|Overall Study|Clinical deterioration|6
7618893|NCT01770353|26508803|P1|Overall Study|Clinical deterioration|3
7618894|NCT01770353|26508802|P2|Overall Study|Physician Decision|3
7618895|NCT01770353|26508803|P1|Overall Study|Physician Decision|0
7618896|NCT01770353|26508802|P2|Overall Study|Protocol Violation|0
7618897|NCT01770353|26508803|P1|Overall Study|Protocol Violation|1
7618898|NCT01770353|26508802|P2|Overall Study|Adverse Event|1
7618899|NCT01770353|26508803|P1|Overall Study|Adverse Event|0
7618900|NCT01770353|26508802|P2|Overall Study|Progressive disease|1
7618901|NCT01770353|26508803|P1|Overall Study|Progressive disease|2
7618902|NCT01770145|26508862|P1|Treatment|Withdrawal by Subject|1
7618903|NCT01770145|26508862|P1|Treatment|Adverse Event|3
7618904|NCT01770145|26508862|P1|Baseline|Unable to define optimal dose|4
7618905|NCT01770145|26508862|P1|Baseline|Lost to Follow-up|1
7618906|NCT01770145|26508862|P1|Baseline|Withdrawal by Subject|1
7618907|NCT01770145|26508862|P1|Baseline|Adverse Event|20
7618908|NCT01769508|26508918|P1|Overall Study|Lost to Follow-up|1
7618909|NCT01769508|26508918|P1|Overall Study|Adverse Event|1
7618910|NCT01769508|26508918|P1|Overall Study|Withdrawal by Subject|1
7618911|NCT01769508|26508918|P1|Overall Study|Death|3
7618912|NCT01769469|26508927|P1|Overall Study|Subject Confirmed HIV Positive|3
7618913|NCT01769469|26508927|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
7618914|NCT01769469|26508927|P1|Overall Study|Lost to Follow-up|17
7618915|NCT01769469|26508927|P1|Overall Study|Moved Out Of Area|3
7618916|NCT01769469|26508927|P1|Overall Study|Consent Withdrawn|5
7618917|NCT01769456|26509087|P1|Overall Study|Parental request to youth to withdraw|1
7618918|NCT01769456|26509087|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
7618919|NCT01769456|26509087|P1|Overall Study|Moved out of the area|3
7618920|NCT01769456|26509087|P1|Overall Study|Did not receive PCC intervention|6
7618921|NCT01769456|26509087|P1|Overall Study|Withdrawal by Subject|3
7618922|NCT01769456|26509087|P1|Overall Study|Lost to Follow-up|19
7618923|NCT01769443|26509108|P2|Overall Study|Study closure|0
7618924|NCT01769443|26509109|P1|Overall Study|Study closure|1
7618925|NCT01769404|26509151|P2|Treatment Period 2|Sponsor decision|0
7618926|NCT01769404|26509152|P1|Treatment Period 2|Sponsor decision|7
7618927|NCT01769404|26509151|P2|Treatment Period 1|Sponsor decision|0
7618928|NCT01769404|26509152|P1|Treatment Period 1|Sponsor decision|1
7618929|NCT01769404|26509151|P2|Treatment Period 1|Withdrawal by Subject|0
7618930|NCT01769404|26509152|P1|Treatment Period 1|Withdrawal by Subject|3
7618931|NCT01769404|26509151|P2|Treatment Period 1|Did not meet eligibility criteria|0
7618932|NCT01769404|26509152|P1|Treatment Period 1|Did not meet eligibility criteria|1
7618933|NCT01769391|26509174|P2|Overall Study|Investigator Decision|0
7618934|NCT01769391|26509175|P1|Overall Study|Investigator Decision|2
7618935|NCT01769391|26509174|P2|Overall Study|Withdrawal by Subject|3
7618936|NCT01769391|26509175|P1|Overall Study|Withdrawal by Subject|4
7618937|NCT01769391|26509174|P2|Overall Study|Progressive Disease|2
7618938|NCT01769391|26509175|P1|Overall Study|Progressive Disease|1
7618939|NCT01769391|26509174|P2|Overall Study|Adverse Event|3
7618940|NCT01769391|26509175|P1|Overall Study|Adverse Event|0
7618941|NCT01769391|26509174|P2|Overall Study|Death|1
7618942|NCT01769391|26509175|P1|Overall Study|Death|10
7618943|NCT01769378|26509194|P2|Overall Study|Lost to Follow-up|0
7618944|NCT01769378|26509195|P1|Overall Study|Lost to Follow-up|2
7618945|NCT01769378|26509194|P2|Overall Study|Sponsor Decision|0
7618946|NCT01769378|26509195|P1|Overall Study|Sponsor Decision|1
7618947|NCT01769378|26509194|P2|Overall Study|Withdrawal by Subject|3
7618948|NCT01769378|26509195|P1|Overall Study|Withdrawal by Subject|10
7618949|NCT01769378|26509194|P2|Overall Study|Protocol Violation|1
7618950|NCT01769378|26509195|P1|Overall Study|Protocol Violation|1
7618951|NCT01769378|26509194|P2|Overall Study|Entry criteria not met|0
7618952|NCT01769378|26509195|P1|Overall Study|Entry criteria not met|1
7618953|NCT01769378|26509194|P2|Overall Study|Adverse Event|0
7618954|NCT01769378|26509195|P1|Overall Study|Adverse Event|10
7618955|NCT01769339|26509275|P1|Overall Study|Adverse Event|1
7618956|NCT01769339|26509275|P1|Overall Study|Lost to Follow-up|42
7618957|NCT01769326|26509286|P4|Overall Study|Got sick and could not complete study|0
7618958|NCT01769326|26509287|P3|Overall Study|Got sick and could not complete study|1
7618959|NCT01769326|26509288|P2|Overall Study|Got sick and could not complete study|0
7618960|NCT01769326|26509289|P1|Overall Study|Got sick and could not complete study|0
7618961|NCT01769326|26509286|P4|Overall Study|got a job|0
7618962|NCT01769326|26509287|P3|Overall Study|got a job|0
7618963|NCT01769326|26509288|P2|Overall Study|got a job|1
7618964|NCT01769326|26509289|P1|Overall Study|got a job|0
7618965|NCT01769326|26509286|P4|Overall Study|unrelated injry|0
7618966|NCT01769326|26509287|P3|Overall Study|unrelated injry|0
7618967|NCT01769326|26509288|P2|Overall Study|unrelated injry|1
7618968|NCT01769326|26509289|P1|Overall Study|unrelated injry|1
7618969|NCT01769326|26509286|P4|Overall Study|Lost to Follow-up|0
7618970|NCT01769326|26509287|P3|Overall Study|Lost to Follow-up|0
7618971|NCT01769326|26509288|P2|Overall Study|Lost to Follow-up|2
7618972|NCT01769326|26509289|P1|Overall Study|Lost to Follow-up|1
7618973|NCT01769196|26509434|P2|Overall Study|Withdrew consent|40
7618974|NCT01769196|26509435|P1|Overall Study|Withdrew consent|36
7618975|NCT01769196|26509434|P2|Overall Study|Participant never dosed with study drug|0
7618976|NCT01769196|26509435|P1|Overall Study|Participant never dosed with study drug|1
7618977|NCT01769196|26509434|P2|Overall Study|Study terminated by sponsor|161
7618978|NCT01769196|26509435|P1|Overall Study|Study terminated by sponsor|160
7618979|NCT01769196|26509434|P2|Overall Study|Protocol Violation|3
7618980|NCT01769196|26509435|P1|Overall Study|Protocol Violation|0
7618981|NCT01769196|26509434|P2|Overall Study|Protocol defined criteria for withdrawal|11
7618982|NCT01769196|26509435|P1|Overall Study|Protocol defined criteria for withdrawal|9
7618983|NCT01769196|26509434|P2|Overall Study|Progressive disease|6
7618984|NCT01769196|26509435|P1|Overall Study|Progressive disease|11
7618985|NCT01769196|26509434|P2|Overall Study|Lack of Efficacy|2
7618986|NCT01769196|26509435|P1|Overall Study|Lack of Efficacy|3
7618987|NCT01769196|26509434|P2|Overall Study|Investigator Discretion|3
7618988|NCT01769196|26509435|P1|Overall Study|Investigator Discretion|7
7618989|NCT01769196|26509434|P2|Overall Study|Death|26
7618990|NCT01769196|26509435|P1|Overall Study|Death|21
7618991|NCT01769196|26509434|P2|Overall Study|Adverse Event|20
7618992|NCT01769196|26509435|P1|Overall Study|Adverse Event|24
7618993|NCT01769105|26509476|P2|Cross-over|Lost to Follow-up|0
7618994|NCT01769105|26509477|P1|Cross-over|Lost to Follow-up|5
7618995|NCT01769105|26509476|P2|First Intervention|Protocol Violation|2
7618996|NCT01769105|26509477|P1|First Intervention|Protocol Violation|2
7618997|NCT01768858|26509496|P1|Overall Study|Withdrawal by Subject|1
7618998|NCT01768858|26509496|P1|Overall Study|Exanthema|1
7618999|NCT01768858|26509496|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
7619000|NCT01768858|26509496|P1|Overall Study|Participant moved to Germany|1
7619001|NCT01768858|26509496|P1|Overall Study|Serious Adverse Event|1
7619002|NCT01768858|26509496|P1|Overall Study|Lack of Efficacy|8
7619003|NCT01768858|26509496|P1|Overall Study|Lost to Follow-up|9
7619004|NCT01768676|26509552|P2|Overall Study|Withdrawal by Subject|10
7619005|NCT01768676|26509553|P1|Overall Study|Withdrawal by Subject|3
7619006|NCT01768676|26509552|P2|Overall Study|Physician Decision|1
7619007|NCT01768676|26509553|P1|Overall Study|Physician Decision|4
7619008|NCT01768676|26509552|P2|Overall Study|Protocol Violation|1
7619009|NCT01768676|26509553|P1|Overall Study|Protocol Violation|1
7619010|NCT01768676|26509552|P2|Overall Study|Lost to Follow-up|16
7619011|NCT01768676|26509553|P1|Overall Study|Lost to Follow-up|13
7619012|NCT01768676|26509552|P2|Overall Study|Adverse Event|3
7619013|NCT01768676|26509553|P1|Overall Study|Adverse Event|3
7619014|NCT01768637|26509569|P2|Overall Study|Difficult blood draw|0
7619015|NCT01768637|26509570|P1|Overall Study|Difficult blood draw|1
7619016|NCT01768637|26509569|P2|Overall Study|Lost to Follow-up|7
7619017|NCT01768637|26509570|P1|Overall Study|Lost to Follow-up|2
7619018|NCT01768572|26509583|P3|Overall Study|Other, Not due to an adverse event|1
7619019|NCT01768572|26509584|P2|Overall Study|Other, Not due to an adverse event|1
7619020|NCT01768572|26509585|P1|Overall Study|Other, Not due to an adverse event|1
7619021|NCT01768572|26509583|P3|Overall Study|Lack of Efficacy|1
7619022|NCT01768572|26509584|P2|Overall Study|Lack of Efficacy|3
7619023|NCT01768572|26509585|P1|Overall Study|Lack of Efficacy|1
7619024|NCT01768572|26509583|P3|Overall Study|Adverse Event|4
7619025|NCT01768572|26509584|P2|Overall Study|Adverse Event|8
7619026|NCT01768572|26509585|P1|Overall Study|Adverse Event|7
7619027|NCT01768559|26509596|P3|Overall Study|Other than specified|5
7619028|NCT01768559|26509597|P2|Overall Study|Other than specified|8
7619029|NCT01768559|26509598|P1|Overall Study|Other than specified|9
7619030|NCT01768559|26509596|P3|Overall Study|Poor compliance to protocol|2
7619031|NCT01768559|26509597|P2|Overall Study|Poor compliance to protocol|3
7619032|NCT01768559|26509598|P1|Overall Study|Poor compliance to protocol|0
7619033|NCT01768559|26509596|P3|Overall Study|Lack of Efficacy|0
7619034|NCT01768559|26509597|P2|Overall Study|Lack of Efficacy|4
7619035|NCT01768559|26509598|P1|Overall Study|Lack of Efficacy|6
7619036|NCT01768559|26509596|P3|Overall Study|Adverse Event|5
7619037|NCT01768559|26509597|P2|Overall Study|Adverse Event|2
7619038|NCT01768559|26509598|P1|Overall Study|Adverse Event|15
7619039|NCT01768559|26509596|P3|Overall Study|Randomized but not treated|1
7619040|NCT01768559|26509597|P2|Overall Study|Randomized but not treated|0
7619041|NCT01768559|26509598|P1|Overall Study|Randomized but not treated|0
7619042|NCT01768286|26509679|P4|Overall Study|Withdrew Consent|0
7619043|NCT01768286|26509680|P3|Overall Study|Withdrew Consent|1
7619044|NCT01768286|26509681|P2|Overall Study|Withdrew Consent|0
7619045|NCT01768286|26509682|P1|Overall Study|Withdrew Consent|0
7619046|NCT01768286|26509679|P4|Overall Study|Lack of Efficacy|1
7619047|NCT01768286|26509680|P3|Overall Study|Lack of Efficacy|0
7619048|NCT01768286|26509681|P2|Overall Study|Lack of Efficacy|4
7619049|NCT01768286|26509682|P1|Overall Study|Lack of Efficacy|7
7619050|NCT01768286|26509679|P4|Overall Study|Randomized But Not Treated|0
7619051|NCT01768286|26509680|P3|Overall Study|Randomized But Not Treated|1
7619052|NCT01768286|26509681|P2|Overall Study|Randomized But Not Treated|0
7619053|NCT01768286|26509682|P1|Overall Study|Randomized But Not Treated|0
7619054|NCT01768117|26509744|P1|Overall Study|Protocol Violation|3
7619055|NCT01768117|26509744|P1|Overall Study|Withdrawal by Subject|2
7619056|NCT01768117|26509744|P1|Overall Study|Lost to Follow-up|1
7619057|NCT01767987|26509808|P2|Overall Study|Physician Decision|1
7619058|NCT01767987|26509809|P1|Overall Study|Physician Decision|4
7619059|NCT01767909|26509841|P2|Overall Study|LP uncessessful|1
7619060|NCT01767909|26509842|P1|Overall Study|LP uncessessful|0
7619061|NCT01767909|26509841|P2|Overall Study|Lost to Follow-up|1
7619062|NCT01767909|26509842|P1|Overall Study|Lost to Follow-up|0
7619063|NCT01767909|26509841|P2|Overall Study|Investigator Recommendation|1
7619064|NCT01767909|26509842|P1|Overall Study|Investigator Recommendation|0
7619065|NCT01767909|26509841|P2|Overall Study|Perceived Lack of Efficacy|0
7619066|NCT01767909|26509842|P1|Overall Study|Perceived Lack of Efficacy|1
7619067|NCT01767909|26509841|P2|Overall Study|Non-Compliance|0
7619068|NCT01767909|26509842|P1|Overall Study|Non-Compliance|2
7619069|NCT01767909|26509841|P2|Overall Study|Withdrawal by Study Partner|1
7619070|NCT01767909|26509842|P1|Overall Study|Withdrawal by Study Partner|3
7619071|NCT01767909|26509841|P2|Overall Study|Adverse Event|1
7619072|NCT01767909|26509842|P1|Overall Study|Adverse Event|3
7619073|NCT01767909|26509841|P2|Overall Study|Withdrawal by Subject|7
7619074|NCT01767909|26509842|P1|Overall Study|Withdrawal by Subject|4
7619075|NCT01767857|26509860|P2|Overall Study|Randomized But Never Treated|13
7619076|NCT01767857|26509861|P1|Overall Study|Randomized But Never Treated|19
7619077|NCT01767857|26509860|P2|Overall Study|Protocol Terminated|0
7619078|NCT01767857|26509861|P1|Overall Study|Protocol Terminated|1
7619079|NCT01767857|26509860|P2|Overall Study|Physician Decision|10
7619080|NCT01767857|26509861|P1|Overall Study|Physician Decision|17
7619081|NCT01767857|26509860|P2|Overall Study|Withdrawal by Subject|18
7619082|NCT01767857|26509861|P1|Overall Study|Withdrawal by Subject|38
7619083|NCT01767857|26509860|P2|Overall Study|Lost to Follow-up|1
7619084|NCT01767857|26509861|P1|Overall Study|Lost to Follow-up|1
7619085|NCT01767857|26509860|P2|Overall Study|Lack of Efficacy|151
7619086|NCT01767857|26509861|P1|Overall Study|Lack of Efficacy|299
7619087|NCT01767857|26509860|P2|Overall Study|Death|13
7619088|NCT01767857|26509861|P1|Overall Study|Death|28
7619089|NCT01767857|26509860|P2|Overall Study|Adverse Event|7
7619090|NCT01767857|26509861|P1|Overall Study|Adverse Event|27
7619091|NCT01767597|26509933|P2|Overall Study|Withdrawal by Subject|0
7619092|NCT01767597|26509934|P1|Overall Study|Withdrawal by Subject|1
7619093|NCT01767597|26509933|P2|Overall Study|Incomplete intervention|1
7619094|NCT01767597|26509934|P1|Overall Study|Incomplete intervention|3
7619095|NCT01767519|26509943|P3|Overall Study|Adverse Event|1
7619096|NCT01767519|26509944|P2|Overall Study|Adverse Event|5
7619097|NCT01767519|26509945|P1|Overall Study|Adverse Event|5
7619098|NCT01767519|26509943|P3|Overall Study|Lack of Efficacy|0
7619099|NCT01767519|26509944|P2|Overall Study|Lack of Efficacy|0
7619100|NCT01767519|26509945|P1|Overall Study|Lack of Efficacy|1
7619101|NCT01767519|26509943|P3|Overall Study|Lost to Follow-up|2
7619102|NCT01767519|26509944|P2|Overall Study|Lost to Follow-up|1
7619103|NCT01767519|26509945|P1|Overall Study|Lost to Follow-up|3
7619104|NCT01767519|26509943|P3|Overall Study|Personal Reasons|0
7619105|NCT01767519|26509944|P2|Overall Study|Personal Reasons|0
7619106|NCT01767519|26509945|P1|Overall Study|Personal Reasons|1
7619107|NCT01767519|26509943|P3|Overall Study|Protocol Violation|0
7619108|NCT01767519|26509944|P2|Overall Study|Protocol Violation|3
7619109|NCT01767519|26509945|P1|Overall Study|Protocol Violation|0
7619110|NCT01767519|26509943|P3|Overall Study|Other Reasons|2
7619111|NCT01767519|26509944|P2|Overall Study|Other Reasons|4
7619112|NCT01767519|26509945|P1|Overall Study|Other Reasons|4
7619113|NCT01767493|26509984|P1|Overall Study|screen failures|3
7619114|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
7619115|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
7619116|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Physician Decision|0
7619117|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Physician Decision|1
7619118|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
7619119|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
7619120|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
7619121|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
7619122|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
7619123|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
7619124|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
7619125|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
7619126|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
7619127|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
7619128|NCT01767467|26509990|P2|End of Study Phase (up to Month 13)|Adverse Event|39
7619129|NCT01767467|26509991|P1|End of Study Phase (up to Month 13)|Adverse Event|29
7619130|NCT01767467|26509990|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
7619131|NCT01767467|26509991|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
7619132|NCT01767467|26509990|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
7619133|NCT01767467|26509991|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
7619134|NCT01767467|26509990|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
7619135|NCT01767467|26509991|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
7619136|NCT01767467|26509990|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
7619137|NCT01767467|26509991|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
7619138|NCT01767467|26509990|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
7619139|NCT01767467|26509991|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
7619140|NCT01767467|26509990|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
7619141|NCT01767467|26509991|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
7619142|NCT01767376|26510047|P3|Overall Study|Withdrawal by Subject|0
7619143|NCT01767376|26510048|P2|Overall Study|Withdrawal by Subject|1
7619144|NCT01767376|26510049|P1|Overall Study|Withdrawal by Subject|1
7619145|NCT01767376|26510047|P3|Overall Study|Lost to Follow-up|0
7619146|NCT01767376|26510048|P2|Overall Study|Lost to Follow-up|2
7619147|NCT01767376|26510049|P1|Overall Study|Lost to Follow-up|3
7619148|NCT01767194|26510115|P2|Overall Study|Criteria not met on time for next cycle|1
7619149|NCT01767194|26510116|P1|Overall Study|Criteria not met on time for next cycle|0
7619150|NCT01767194|26510115|P2|Overall Study|Refusal by patient/parent|4
7619151|NCT01767194|26510116|P1|Overall Study|Refusal by patient/parent|2
7619152|NCT01767194|26510115|P2|Overall Study|Ineligible|1
7619153|NCT01767194|26510116|P1|Overall Study|Ineligible|1
7619154|NCT01767194|26510115|P2|Overall Study|Withdrawal by Subject|1
7619155|NCT01767194|26510116|P1|Overall Study|Withdrawal by Subject|0
7619156|NCT01767194|26510115|P2|Overall Study|Physician Decision|23
7619157|NCT01767194|26510116|P1|Overall Study|Physician Decision|2
7619158|NCT01767194|26510115|P2|Overall Study|Lack of Efficacy|11
7619159|NCT01767194|26510116|P1|Overall Study|Lack of Efficacy|12
7619160|NCT01767194|26510115|P2|Overall Study|Death|1
7619161|NCT01767194|26510116|P1|Overall Study|Death|0
7619162|NCT01767194|26510115|P2|Overall Study|Adverse Event|1
7619163|NCT01767194|26510116|P1|Overall Study|Adverse Event|1
7619164|NCT01767142|26510138|P1|Overall Study|Lost to Follow-up|3
7619165|NCT01767116|26510147|P2|Overall Study|Lost to Follow-up|2
7619166|NCT01767116|26510148|P1|Overall Study|Lost to Follow-up|2
7619167|NCT01766921|26510219|P2|Overall Study|Withdrawal by Subject|5
7619168|NCT01766921|26510220|P1|Overall Study|Withdrawal by Subject|14
7619169|NCT01766921|26510219|P2|Overall Study|Protocol Violation|1
7619170|NCT01766921|26510220|P1|Overall Study|Protocol Violation|1
7619171|NCT01766921|26510219|P2|Overall Study|Unclassified|2
7619172|NCT01766921|26510220|P1|Overall Study|Unclassified|2
7619173|NCT01766921|26510219|P2|Overall Study|Lost to Follow-up|3
7619174|NCT01766921|26510220|P1|Overall Study|Lost to Follow-up|1
7619175|NCT01766921|26510219|P2|Overall Study|Death|1
7619176|NCT01766921|26510220|P1|Overall Study|Death|1
7619177|NCT01766921|26510219|P2|Overall Study|Administrative Reason|5
7619178|NCT01766921|26510220|P1|Overall Study|Administrative Reason|5
7619179|NCT01766817|26510242|P3|Overall Study|Other|0
7619180|NCT01766817|26510243|P2|Overall Study|Other|0
7619181|NCT01766817|26510244|P1|Overall Study|Other|1
7619182|NCT01766817|26510242|P3|Overall Study|Physician Decision|4
7619183|NCT01766817|26510243|P2|Overall Study|Physician Decision|3
7619184|NCT01766817|26510244|P1|Overall Study|Physician Decision|3
7619185|NCT01766817|26510242|P3|Overall Study|Subject non-compliance|2
7619186|NCT01766817|26510243|P2|Overall Study|Subject non-compliance|1
7619187|NCT01766817|26510244|P1|Overall Study|Subject non-compliance|0
7619188|NCT01766817|26510242|P3|Overall Study|Withdrawal by Subject|3
7619189|NCT01766817|26510243|P2|Overall Study|Withdrawal by Subject|0
7619190|NCT01766817|26510244|P1|Overall Study|Withdrawal by Subject|2
7619191|NCT01766817|26510242|P3|Overall Study|Unable to take study drug|0
7619192|NCT01766817|26510243|P2|Overall Study|Unable to take study drug|1
7619193|NCT01766817|26510244|P1|Overall Study|Unable to take study drug|0
7619194|NCT01766817|26510242|P3|Overall Study|Death|0
7619195|NCT01766817|26510243|P2|Overall Study|Death|1
7619196|NCT01766817|26510244|P1|Overall Study|Death|1
7619197|NCT01766817|26510242|P3|Overall Study|Drug-unrelated adverse event|3
7619198|NCT01766817|26510243|P2|Overall Study|Drug-unrelated adverse event|3
7619199|NCT01766817|26510244|P1|Overall Study|Drug-unrelated adverse event|3
7619200|NCT01766817|26510242|P3|Overall Study|Drug-related adverse event|1
7619201|NCT01766817|26510243|P2|Overall Study|Drug-related adverse event|2
7619202|NCT01766817|26510244|P1|Overall Study|Drug-related adverse event|1
7619203|NCT01766778|26510295|P2|Overall Study|Withdrawal by Subject|0
7619204|NCT01766778|26510296|P1|Overall Study|Withdrawal by Subject|1
7619205|NCT01766778|26510295|P2|Overall Study|Adverse Event|4
7619206|NCT01766778|26510296|P1|Overall Study|Adverse Event|4
7619207|NCT01766401|26510350|P2|Overall Study|Pregnancy|1
7619208|NCT01766401|26510351|P1|Overall Study|Pregnancy|1
7619209|NCT01766401|26510350|P2|Overall Study|Lost to Follow-up|11
7619210|NCT01766401|26510351|P1|Overall Study|Lost to Follow-up|10
7619211|NCT01766401|26510350|P2|Overall Study|Withdrawal by Subject|12
7619212|NCT01766401|26510351|P1|Overall Study|Withdrawal by Subject|15
7619213|NCT01766401|26510350|P2|Overall Study|Protocol Violation|8
7619214|NCT01766401|26510351|P1|Overall Study|Protocol Violation|3
7619215|NCT01766401|26510350|P2|Overall Study|Lack of Efficacy|2
7619216|NCT01766401|26510351|P1|Overall Study|Lack of Efficacy|1
7619217|NCT01766401|26510350|P2|Overall Study|Adverse Event|22
7619218|NCT01766401|26510351|P1|Overall Study|Adverse Event|7
7619219|NCT01766336|26510361|P2|Overall Study|Withdrawal by Subject|15
7619220|NCT01766336|26510362|P1|Overall Study|Withdrawal by Subject|18
7619221|NCT01766336|26510361|P2|Overall Study|Sponsor Decision|43
7619222|NCT01766336|26510362|P1|Overall Study|Sponsor Decision|52
7619223|NCT01766336|26510361|P2|Overall Study|Protocol Violation|1
7619224|NCT01766336|26510362|P1|Overall Study|Protocol Violation|0
7619225|NCT01766336|26510361|P2|Overall Study|Physician Decision|2
7619226|NCT01766336|26510362|P1|Overall Study|Physician Decision|4
7619227|NCT01766336|26510361|P2|Overall Study|Lost to Follow-up|3
7619228|NCT01766336|26510362|P1|Overall Study|Lost to Follow-up|1
7619229|NCT01766336|26510361|P2|Overall Study|Death|3
7619230|NCT01766336|26510362|P1|Overall Study|Death|4
7619231|NCT01766336|26510361|P2|Overall Study|Adverse Event|8
7619232|NCT01766336|26510362|P1|Overall Study|Adverse Event|11
7619233|NCT01766310|26510370|P2|Overall Study|Lost to Follow-up|3
7619234|NCT01766310|26510371|P1|Overall Study|Lost to Follow-up|1
7619235|NCT01766206|26510401|P1|Overall Study|Withdrawal and inappropriate enrollment|1
7619236|NCT01766206|26510401|P1|Overall Study|Inappropriate enrollment|18
7619237|NCT01766206|26510401|P1|Overall Study|Lost to Follow-up|10
7619238|NCT01766206|26510401|P1|Overall Study|Withdrawal by Subject|22
7619239|NCT01766050|26510428|P1|Overall Study|Withdrawal by Subject|2
7619240|NCT01766050|26510428|P1|Overall Study|Lost to Follow-up|1
7619241|NCT01766050|26510428|P1|Overall Study|Adverse Event|1
7619242|NCT01766037|26510563|P2|Overall Study|nausea / discomfort|0
7619243|NCT01766037|26510564|P1|Overall Study|nausea / discomfort|3
7619244|NCT01766037|26510563|P2|Overall Study|medical - unrelated|2
7619245|NCT01766037|26510564|P1|Overall Study|medical - unrelated|1
7619246|NCT01766037|26510563|P2|Overall Study|Moved from area|0
7619247|NCT01766037|26510564|P1|Overall Study|Moved from area|5
7619248|NCT01766037|26510563|P2|Overall Study|Withdrawal by Subject|16
7619249|NCT01766037|26510564|P1|Overall Study|Withdrawal by Subject|18
7619250|NCT01766037|26510563|P2|Overall Study|Physician Decision|1
7619251|NCT01766037|26510564|P1|Overall Study|Physician Decision|0
7619252|NCT01766037|26510563|P2|Overall Study|Lost to Follow-up|10
7619253|NCT01766037|26510564|P1|Overall Study|Lost to Follow-up|0
7619254|NCT01766037|26510563|P2|Overall Study|Lack of Efficacy|0
7619255|NCT01766037|26510564|P1|Overall Study|Lack of Efficacy|1
7619256|NCT01766037|26510563|P2|Overall Study|Adverse Event|0
7619257|NCT01766037|26510564|P1|Overall Study|Adverse Event|1
7619258|NCT01765920|26510627|P2|Overall Study|Patient code disclosure|1
7619259|NCT01765920|26510628|P1|Overall Study|Patient code disclosure|0
7619260|NCT01765920|26510627|P2|Overall Study|Incorrect inclusion ineligible patient|5
7619261|NCT01765920|26510628|P1|Overall Study|Incorrect inclusion ineligible patient|2
7619262|NCT01765764|26510650|P3|Treatment Period|Other Miscellaneous Reasons|2
7619263|NCT01765764|26510651|P2|Treatment Period|Other Miscellaneous Reasons|2
7619264|NCT01765764|26510652|P1|Treatment Period|Other Miscellaneous Reasons|1
7619265|NCT01765764|26510650|P3|Treatment Period|Personal Reasons|1
7619266|NCT01765764|26510651|P2|Treatment Period|Personal Reasons|2
7619267|NCT01765764|26510652|P1|Treatment Period|Personal Reasons|1
7619268|NCT01765764|26510650|P3|Treatment Period|Lost to Follow-up|2
7619269|NCT01765764|26510651|P2|Treatment Period|Lost to Follow-up|3
7619270|NCT01765764|26510652|P1|Treatment Period|Lost to Follow-up|0
7619271|NCT01765764|26510650|P3|Treatment Period|Adverse Event|1
7619272|NCT01765764|26510651|P2|Treatment Period|Adverse Event|2
7619273|NCT01765764|26510652|P1|Treatment Period|Adverse Event|1
7619274|NCT01765751|26510672|P3|Overall Study|Lost to Follow-up|1
7619275|NCT01765751|26510673|P2|Overall Study|Lost to Follow-up|2
7619276|NCT01765751|26510674|P1|Overall Study|Lost to Follow-up|0
7619277|NCT01765673|26510723|P1|Overall Study|No transportation for 2nd/3rd visits|1
7619278|NCT01765582|26510756|P3|Overall Study|Withdrawal of Consent|10
7619279|NCT01765582|26510757|P2|Overall Study|Withdrawal of Consent|6
7619280|NCT01765582|26510758|P1|Overall Study|Withdrawal of Consent|11
7619281|NCT01765582|26510756|P3|Overall Study|Sponsor Decision|42
7619282|NCT01765582|26510757|P2|Overall Study|Sponsor Decision|42
7619283|NCT01765582|26510758|P1|Overall Study|Sponsor Decision|46
7619284|NCT01765582|26510756|P3|Overall Study|Death|33
7619285|NCT01765582|26510757|P2|Overall Study|Death|36
7619286|NCT01765582|26510758|P1|Overall Study|Death|31
7619287|NCT01765582|26510756|P3|Overall Study|Lost to Follow-up|1
7619288|NCT01765582|26510757|P2|Overall Study|Lost to Follow-up|2
7619289|NCT01765582|26510758|P1|Overall Study|Lost to Follow-up|2
7619290|NCT01765582|26510756|P3|Overall Study|Other|9
7619291|NCT01765582|26510757|P2|Overall Study|Other|6
7619292|NCT01765582|26510758|P1|Overall Study|Other|3
7619293|NCT01765569|26510791|P1|Period C|Death|1
7619294|NCT01765569|26510791|P1|Period B|Withdrawal by Subject|1
7619295|NCT01765543|26510812|P1|Overall Study|Withdrawal by Subject|2
7619296|NCT01765543|26510812|P1|Overall Study|Death|1
7619297|NCT01765426|26510864|P4|Overall Study|Lost to Follow-up|0
7619298|NCT01765426|26510865|P3|Overall Study|Lost to Follow-up|0
7619299|NCT01765426|26510866|P2|Overall Study|Lost to Follow-up|1
7619300|NCT01765426|26510867|P1|Overall Study|Lost to Follow-up|0
7619301|NCT01765270|26510923|P2|Overall Study|Withdrawal by Subject|1
7619302|NCT01765270|26510924|P1|Overall Study|Withdrawal by Subject|0
7619303|NCT01765270|26510923|P2|Overall Study|Physician Decision|0
7619304|NCT01765270|26510924|P1|Overall Study|Physician Decision|1
7619305|NCT01765192|26510946|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
7619306|NCT01765192|26510947|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
7619307|NCT01765192|26510946|P2|Treatment Period 2|Reason not specified|2
7619308|NCT01765192|26510947|P1|Treatment Period 2|Reason not specified|0
7619309|NCT01765192|26510946|P2|Washout Period|Reason not specified|0
7619310|NCT01765192|26510947|P1|Washout Period|Reason not specified|1
7619311|NCT01765192|26510946|P2|Washout Period|Voluntary Withdrawal|1
7619312|NCT01765192|26510947|P1|Washout Period|Voluntary Withdrawal|1
7619313|NCT01765192|26510946|P2|Treatment Period 1|Adverse Event|1
7619314|NCT01765192|26510947|P1|Treatment Period 1|Adverse Event|0
7619315|NCT01765179|26510965|P1|Overall Study|Ca elevated 10.6|1
7619316|NCT01765179|26510965|P1|Overall Study|work conflict|1
7619317|NCT01765179|26510965|P1|Overall Study|lack of venous access|1
7619318|NCT01765179|26510965|P1|Overall Study|Out of country unable to finish study|1
7619319|NCT01765179|26510965|P1|Overall Study|prohibited med|1
7619320|NCT01765179|26510965|P1|Overall Study|Hematocrit >54%|3
7619321|NCT01765179|26510965|P1|Overall Study|Withdrawal by Subject|8
7619322|NCT01765179|26510965|P1|Overall Study|Protocol Violation|1
7619323|NCT01765179|26510965|P1|Overall Study|Non-compliance with study drug|2
7619324|NCT01765179|26510965|P1|Overall Study|Lost to Follow-up|5
7619325|NCT01765179|26510965|P1|Overall Study|Adverse Event|3
7619326|NCT01765153|26510972|P2|Rest Phase 2|Lost to Follow-up|1
7619327|NCT01765153|26510973|P1|Rest Phase 2|Lost to Follow-up|2
7619328|NCT01765153|26510972|P2|Training Phase 2|Withdrawal by Subject|1
7619329|NCT01765153|26510973|P1|Training Phase 2|Withdrawal by Subject|0
7619330|NCT01765153|26510972|P2|Rest Phase 1|Withdrawal by Subject|1
7619331|NCT01765153|26510973|P1|Rest Phase 1|Withdrawal by Subject|0
7619332|NCT01765153|26510972|P2|Training Phase 1|Poor participation in intervention|1
7619333|NCT01765153|26510973|P1|Training Phase 1|Poor participation in intervention|0
7619334|NCT01765153|26510972|P2|Training Phase 1|Format of intervention differed|0
7619335|NCT01765153|26510973|P1|Training Phase 1|Format of intervention differed|1
7619336|NCT01764997|26511080|P5|Study Drug Treatment Period|Other than specified above|10
7619337|NCT01764997|26511081|P4|Study Drug Treatment Period|Other than specified above|0
7619338|NCT01764997|26511082|P3|Study Drug Treatment Period|Other than specified above|0
7619339|NCT01764997|26511083|P2|Study Drug Treatment Period|Other than specified above|0
7619340|NCT01764997|26511084|P1|Study Drug Treatment Period|Other than specified above|0
7619341|NCT01764997|26511080|P5|Study Drug Treatment Period|Lack of Efficacy|2
7619342|NCT01764997|26511081|P4|Study Drug Treatment Period|Lack of Efficacy|0
7619343|NCT01764997|26511082|P3|Study Drug Treatment Period|Lack of Efficacy|0
7619344|NCT01764997|26511083|P2|Study Drug Treatment Period|Lack of Efficacy|0
7619345|NCT01764997|26511084|P1|Study Drug Treatment Period|Lack of Efficacy|0
7619346|NCT01764997|26511080|P5|Study Drug Treatment Period|Adverse Event|24
7619347|NCT01764997|26511081|P4|Study Drug Treatment Period|Adverse Event|0
7619348|NCT01764997|26511082|P3|Study Drug Treatment Period|Adverse Event|0
7619349|NCT01764997|26511083|P2|Study Drug Treatment Period|Adverse Event|1
7619350|NCT01764997|26511084|P1|Study Drug Treatment Period|Adverse Event|0
7619351|NCT01764997|26511080|P5|Run-in Period|Other than specified above|0
7619352|NCT01764997|26511081|P4|Run-in Period|Other than specified above|0
7619353|NCT01764997|26511082|P3|Run-in Period|Other than specified above|0
7619354|NCT01764997|26511083|P2|Run-in Period|Other than specified above|0
7619355|NCT01764997|26511084|P1|Run-in Period|Other than specified above|17
7619356|NCT01764997|26511080|P5|Run-in Period|Poor compliance to protocol|0
7619357|NCT01764997|26511081|P4|Run-in Period|Poor compliance to protocol|0
7619358|NCT01764997|26511082|P3|Run-in Period|Poor compliance to protocol|0
7619359|NCT01764997|26511083|P2|Run-in Period|Poor compliance to protocol|0
7619360|NCT01764997|26511084|P1|Run-in Period|Poor compliance to protocol|1
7619361|NCT01764997|26511080|P5|Run-in Period|Lack of Efficacy|0
7619362|NCT01764997|26511081|P4|Run-in Period|Lack of Efficacy|0
7619363|NCT01764997|26511082|P3|Run-in Period|Lack of Efficacy|0
7619364|NCT01764997|26511083|P2|Run-in Period|Lack of Efficacy|0
7619365|NCT01764997|26511084|P1|Run-in Period|Lack of Efficacy|5
7619366|NCT01764997|26511080|P5|Run-in Period|Adverse Event|0
7619367|NCT01764997|26511081|P4|Run-in Period|Adverse Event|0
7619368|NCT01764997|26511082|P3|Run-in Period|Adverse Event|0
7619369|NCT01764997|26511083|P2|Run-in Period|Adverse Event|0
7619370|NCT01764997|26511084|P1|Run-in Period|Adverse Event|15
7619371|NCT01764945|26511111|P8|Overall Study|Adverse Event|0
7619372|NCT01764945|26511112|P7|Overall Study|Adverse Event|1
7619373|NCT01764945|26511113|P6|Overall Study|Adverse Event|0
7619374|NCT01764945|26511114|P5|Overall Study|Adverse Event|0
7619375|NCT01764945|26511115|P4|Overall Study|Adverse Event|0
7619376|NCT01764945|26511116|P3|Overall Study|Adverse Event|0
7619377|NCT01764945|26511117|P2|Overall Study|Adverse Event|1
7619378|NCT01764945|26511118|P1|Overall Study|Adverse Event|0
7619379|NCT01764854|26511164|P4|Overall Study|Protocol Violation|2
7619380|NCT01764854|26511165|P3|Overall Study|Protocol Violation|1
7619381|NCT01764854|26511166|P2|Overall Study|Protocol Violation|0
7619382|NCT01764854|26511167|P1|Overall Study|Protocol Violation|0
7619383|NCT01764854|26511164|P4|Overall Study|relocation|0
7619384|NCT01764854|26511165|P3|Overall Study|relocation|2
7619385|NCT01764854|26511166|P2|Overall Study|relocation|0
7619386|NCT01764854|26511167|P1|Overall Study|relocation|0
7619387|NCT01764854|26511164|P4|Overall Study|Withdrawal by Subject|0
7619388|NCT01764854|26511165|P3|Overall Study|Withdrawal by Subject|1
7619389|NCT01764854|26511166|P2|Overall Study|Withdrawal by Subject|0
7619390|NCT01764854|26511167|P1|Overall Study|Withdrawal by Subject|0
7619391|NCT01764854|26511164|P4|Overall Study|Adverse Event|0
7619392|NCT01764854|26511165|P3|Overall Study|Adverse Event|2
7619393|NCT01764854|26511166|P2|Overall Study|Adverse Event|0
7619394|NCT01764854|26511167|P1|Overall Study|Adverse Event|0
7619395|NCT01764841|26511181|P4|Overall Study|Lost to Follow-up|0
7619396|NCT01764841|26511182|P3|Overall Study|Lost to Follow-up|1
7619397|NCT01764841|26511183|P2|Overall Study|Lost to Follow-up|0
7619398|NCT01764841|26511184|P1|Overall Study|Lost to Follow-up|3
7619399|NCT01764841|26511181|P4|Overall Study|Withdrawal by Subject|15
7619400|NCT01764841|26511182|P3|Overall Study|Withdrawal by Subject|11
7619401|NCT01764841|26511183|P2|Overall Study|Withdrawal by Subject|24
7619402|NCT01764841|26511184|P1|Overall Study|Withdrawal by Subject|16
7619403|NCT01764841|26511181|P4|Overall Study|Protocol Violation|0
7619404|NCT01764841|26511182|P3|Overall Study|Protocol Violation|0
7619405|NCT01764841|26511183|P2|Overall Study|Protocol Violation|1
7619406|NCT01764841|26511184|P1|Overall Study|Protocol Violation|0
7619407|NCT01764841|26511181|P4|Overall Study|No Follow Up|0
7619408|NCT01764841|26511182|P3|Overall Study|No Follow Up|1
7619409|NCT01764841|26511183|P2|Overall Study|No Follow Up|0
7619410|NCT01764841|26511184|P1|Overall Study|No Follow Up|1
7619411|NCT01764841|26511181|P4|Overall Study|Death|4
7619412|NCT01764841|26511182|P3|Overall Study|Death|1
7619413|NCT01764841|26511183|P2|Overall Study|Death|0
7619414|NCT01764841|26511184|P1|Overall Study|Death|3
7619415|NCT01764841|26511181|P4|Overall Study|Logistical Difficulties|0
7619416|NCT01764841|26511182|P3|Overall Study|Logistical Difficulties|0
7619417|NCT01764841|26511183|P2|Overall Study|Logistical Difficulties|1
7619418|NCT01764841|26511184|P1|Overall Study|Logistical Difficulties|0
7619419|NCT01764659|26511225|P1|Overall Study|Physician Decision|1
7619420|NCT01764659|26511225|P1|Overall Study|Death|1
7619421|NCT01764633|26511239|P2|Overall Study|Lost to Follow-up|5
7619422|NCT01764633|26511240|P1|Overall Study|Lost to Follow-up|13
7619423|NCT01764633|26511239|P2|Overall Study|Withdrawal by Subject|88
7619424|NCT01764633|26511240|P1|Overall Study|Withdrawal by Subject|105
7619425|NCT01764464|26511269|P2|Second Intervention (Cross-over)|Adverse Event|0
7619426|NCT01764464|26511270|P1|Second Intervention (Cross-over)|Adverse Event|2
7619427|NCT01764464|26511269|P2|First Intervention|did not receive study drug|1
7619428|NCT01764464|26511270|P1|First Intervention|did not receive study drug|0
7619429|NCT01764464|26511269|P2|First Intervention|Adverse Event|2
7619430|NCT01764464|26511270|P1|First Intervention|Adverse Event|0
7619431|NCT01764464|26511269|P2|First Intervention|Lost to Follow-up|0
7619432|NCT01764464|26511270|P1|First Intervention|Lost to Follow-up|1
7619433|NCT01764464|26511269|P2|First Intervention|Withdrawal by Subject|0
7619434|NCT01764464|26511270|P1|First Intervention|Withdrawal by Subject|1
7619435|NCT01764386|26511288|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7619436|NCT01764386|26511289|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7619437|NCT01764386|26511288|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7619438|NCT01764386|26511289|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7619439|NCT01764386|26511288|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
7619440|NCT01764386|26511289|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
7619441|NCT01764386|26511288|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
7619442|NCT01764386|26511289|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
7619443|NCT01764386|26511288|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
7619444|NCT01764386|26511289|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
7619445|NCT01764386|26511288|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
7619446|NCT01764386|26511289|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
7619447|NCT01764386|26511288|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
7619448|NCT01764386|26511289|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
7619449|NCT01764386|26511288|P2|Controlled Treatment Period (CTP)|Adverse Event|0
7619450|NCT01764386|26511289|P1|Controlled Treatment Period (CTP)|Adverse Event|35
7619451|NCT01764256|26511334|P4|Completed Study|Lost to Follow-up|1
7619452|NCT01764256|26511335|P3|Completed Study|Lost to Follow-up|0
7619453|NCT01764256|26511336|P2|Completed Study|Lost to Follow-up|0
7619454|NCT01764256|26511337|P1|Completed Study|Lost to Follow-up|0
7619455|NCT01764256|26511334|P4|Received All Vaccinations|Lost to Follow-up|0
7619456|NCT01764256|26511335|P3|Received All Vaccinations|Lost to Follow-up|0
7619457|NCT01764256|26511336|P2|Received All Vaccinations|Lost to Follow-up|0
7619458|NCT01764256|26511337|P1|Received All Vaccinations|Lost to Follow-up|1
7619459|NCT01764256|26511334|P4|Received All Vaccinations|Did not meet inclusion criteria|0
7619460|NCT01764256|26511335|P3|Received All Vaccinations|Did not meet inclusion criteria|1
7619461|NCT01764256|26511336|P2|Received All Vaccinations|Did not meet inclusion criteria|0
7619462|NCT01764256|26511337|P1|Received All Vaccinations|Did not meet inclusion criteria|0
7619463|NCT01764256|26511334|P4|Received All Vaccinations|Adverse Event|0
7619464|NCT01764256|26511335|P3|Received All Vaccinations|Adverse Event|0
7619465|NCT01764256|26511336|P2|Received All Vaccinations|Adverse Event|1
7619466|NCT01764256|26511337|P1|Received All Vaccinations|Adverse Event|1
7619467|NCT01764022|26511380|P2|Overall Study|Protocol Violation|0
7619468|NCT01764022|26511381|P1|Overall Study|Protocol Violation|1
7619469|NCT01764022|26511380|P2|Overall Study|Lost to Follow-up|0
7619470|NCT01764022|26511381|P1|Overall Study|Lost to Follow-up|2
7619471|NCT01764022|26511380|P2|Overall Study|Physician Decision|2
7619472|NCT01764022|26511381|P1|Overall Study|Physician Decision|0
7619473|NCT01764022|26511380|P2|Overall Study|Lack of Efficacy|1
7619474|NCT01764022|26511381|P1|Overall Study|Lack of Efficacy|0
7619475|NCT01764022|26511380|P2|Overall Study|Withdrawal by Subject|6
7619476|NCT01764022|26511381|P1|Overall Study|Withdrawal by Subject|2
7619477|NCT01764022|26511380|P2|Overall Study|Death|5
7619478|NCT01764022|26511381|P1|Overall Study|Death|3
7619479|NCT01763996|26511413|P2|Treatment Period 2|Adverse Event|1
7619480|NCT01763996|26511414|P1|Treatment Period 2|Adverse Event|0
7619481|NCT01763918|26511468|P4|Overall Study|Sponsor Decision|0
7619482|NCT01763918|26511469|P3|Overall Study|Sponsor Decision|9
7619483|NCT01763918|26511470|P2|Overall Study|Sponsor Decision|0
7619484|NCT01763918|26511471|P1|Overall Study|Sponsor Decision|4
7619485|NCT01763918|26511468|P4|Overall Study|Withdrawal by Subject|2
7619486|NCT01763918|26511469|P3|Overall Study|Withdrawal by Subject|1
7619487|NCT01763918|26511470|P2|Overall Study|Withdrawal by Subject|1
7619488|NCT01763918|26511471|P1|Overall Study|Withdrawal by Subject|2
7619489|NCT01763905|26511569|P4|Overall Study|Lost to Follow-up|0
7619490|NCT01763905|26511570|P3|Overall Study|Lost to Follow-up|1
7619491|NCT01763905|26511571|P2|Overall Study|Lost to Follow-up|0
7619492|NCT01763905|26511572|P1|Overall Study|Lost to Follow-up|0
7619493|NCT01763905|26511569|P4|Overall Study|Decision by sponsor|0
7619494|NCT01763905|26511570|P3|Overall Study|Decision by sponsor|8
7619495|NCT01763905|26511571|P2|Overall Study|Decision by sponsor|0
7619496|NCT01763905|26511572|P1|Overall Study|Decision by sponsor|5
7619497|NCT01763905|26511569|P4|Overall Study|Withdrawal by Subject|1
7619498|NCT01763905|26511570|P3|Overall Study|Withdrawal by Subject|0
7619499|NCT01763905|26511571|P2|Overall Study|Withdrawal by Subject|1
7619500|NCT01763905|26511572|P1|Overall Study|Withdrawal by Subject|1
7619501|NCT01763866|26511690|P24|Overall Study|Death|0
7619502|NCT01763866|26511691|P23|Overall Study|Death|0
7619503|NCT01763866|26511692|P22|Overall Study|Death|0
7619504|NCT01763866|26511693|P21|Overall Study|Death|0
7619505|NCT01763866|26511694|P20|Overall Study|Death|0
7619506|NCT01763866|26511695|P19|Overall Study|Death|0
7619507|NCT01763866|26511696|P18|Overall Study|Death|0
7619508|NCT01763866|26511697|P17|Overall Study|Death|1
7619509|NCT01763866|26511698|P16|Overall Study|Death|0
7619510|NCT01763866|26511699|P15|Overall Study|Death|0
7619511|NCT01763866|26511700|P14|Overall Study|Death|0
7619512|NCT01763866|26511701|P13|Overall Study|Death|0
7619513|NCT01763866|26511702|P12|Overall Study|Death|0
7619514|NCT01763866|26511703|P11|Overall Study|Death|0
7619515|NCT01763866|26511704|P10|Overall Study|Death|0
7619516|NCT01763866|26511705|P9|Overall Study|Death|0
7619517|NCT01763866|26511706|P8|Overall Study|Death|0
7619518|NCT01763866|26511707|P7|Overall Study|Death|0
7619519|NCT01763866|26511708|P6|Overall Study|Death|0
7619520|NCT01763866|26511709|P5|Overall Study|Death|0
7619521|NCT01763866|26511710|P4|Overall Study|Death|0
7619522|NCT01763866|26511711|P3|Overall Study|Death|0
7619523|NCT01763866|26511712|P2|Overall Study|Death|0
7619524|NCT01763866|26511713|P1|Overall Study|Death|0
7619525|NCT01763866|26511690|P24|Overall Study|Lost to Follow-up|1
7619526|NCT01763866|26511691|P23|Overall Study|Lost to Follow-up|0
7619527|NCT01763866|26511692|P22|Overall Study|Lost to Follow-up|0
7619528|NCT01763866|26511693|P21|Overall Study|Lost to Follow-up|0
7619529|NCT01763866|26511694|P20|Overall Study|Lost to Follow-up|1
7619530|NCT01763866|26511695|P19|Overall Study|Lost to Follow-up|1
7619531|NCT01763866|26511696|P18|Overall Study|Lost to Follow-up|0
7619532|NCT01763866|26511697|P17|Overall Study|Lost to Follow-up|0
7619533|NCT01763866|26511698|P16|Overall Study|Lost to Follow-up|0
7619534|NCT01763866|26511699|P15|Overall Study|Lost to Follow-up|1
7619535|NCT01763866|26511700|P14|Overall Study|Lost to Follow-up|0
7619536|NCT01763866|26511701|P13|Overall Study|Lost to Follow-up|1
7619537|NCT01763866|26511702|P12|Overall Study|Lost to Follow-up|0
7619538|NCT01763866|26511703|P11|Overall Study|Lost to Follow-up|0
7619539|NCT01763866|26511704|P10|Overall Study|Lost to Follow-up|0
7619540|NCT01763866|26511705|P9|Overall Study|Lost to Follow-up|0
7619541|NCT01763866|26511706|P8|Overall Study|Lost to Follow-up|0
7619542|NCT01763866|26511707|P7|Overall Study|Lost to Follow-up|1
7619543|NCT01763866|26511708|P6|Overall Study|Lost to Follow-up|0
7619544|NCT01763866|26511709|P5|Overall Study|Lost to Follow-up|0
7619545|NCT01763866|26511710|P4|Overall Study|Lost to Follow-up|0
7619546|NCT01763866|26511711|P3|Overall Study|Lost to Follow-up|0
7619547|NCT01763866|26511712|P2|Overall Study|Lost to Follow-up|0
7619548|NCT01763866|26511713|P1|Overall Study|Lost to Follow-up|0
7619549|NCT01763866|26511690|P24|Overall Study|Decision by sponsor|0
7619550|NCT01763866|26511691|P23|Overall Study|Decision by sponsor|1
7619551|NCT01763866|26511692|P22|Overall Study|Decision by sponsor|0
7619552|NCT01763866|26511693|P21|Overall Study|Decision by sponsor|2
7619553|NCT01763866|26511694|P20|Overall Study|Decision by sponsor|0
7619554|NCT01763866|26511695|P19|Overall Study|Decision by sponsor|4
7619555|NCT01763866|26511696|P18|Overall Study|Decision by sponsor|0
7619556|NCT01763866|26511697|P17|Overall Study|Decision by sponsor|0
7619557|NCT01763866|26511698|P16|Overall Study|Decision by sponsor|0
7619558|NCT01763866|26511699|P15|Overall Study|Decision by sponsor|5
7619559|NCT01763866|26511700|P14|Overall Study|Decision by sponsor|0
7619560|NCT01763866|26511701|P13|Overall Study|Decision by sponsor|1
7619561|NCT01763866|26511702|P12|Overall Study|Decision by sponsor|0
7619562|NCT01763866|26511703|P11|Overall Study|Decision by sponsor|6
7619563|NCT01763866|26511704|P10|Overall Study|Decision by sponsor|0
7619564|NCT01763866|26511705|P9|Overall Study|Decision by sponsor|2
7619565|NCT01763866|26511706|P8|Overall Study|Decision by sponsor|0
7619566|NCT01763866|26511707|P7|Overall Study|Decision by sponsor|2
7619567|NCT01763866|26511708|P6|Overall Study|Decision by sponsor|0
7619568|NCT01763866|26511709|P5|Overall Study|Decision by sponsor|2
7619569|NCT01763866|26511710|P4|Overall Study|Decision by sponsor|0
7619570|NCT01763866|26511711|P3|Overall Study|Decision by sponsor|1
7619571|NCT01763866|26511712|P2|Overall Study|Decision by sponsor|0
7619572|NCT01763866|26511713|P1|Overall Study|Decision by sponsor|0
7619573|NCT01763866|26511690|P24|Overall Study|Withdrawal by Subject|1
7619574|NCT01763866|26511691|P23|Overall Study|Withdrawal by Subject|2
7619575|NCT01763866|26511692|P22|Overall Study|Withdrawal by Subject|1
7619576|NCT01763866|26511693|P21|Overall Study|Withdrawal by Subject|2
7619577|NCT01763866|26511694|P20|Overall Study|Withdrawal by Subject|1
7619578|NCT01763866|26511695|P19|Overall Study|Withdrawal by Subject|1
7619579|NCT01763866|26511696|P18|Overall Study|Withdrawal by Subject|1
7619580|NCT01763866|26511697|P17|Overall Study|Withdrawal by Subject|0
7619581|NCT01763866|26511698|P16|Overall Study|Withdrawal by Subject|3
7619582|NCT01763866|26511699|P15|Overall Study|Withdrawal by Subject|6
7619583|NCT01763866|26511700|P14|Overall Study|Withdrawal by Subject|0
7619584|NCT01763866|26511701|P13|Overall Study|Withdrawal by Subject|2
7619585|NCT01763866|26511702|P12|Overall Study|Withdrawal by Subject|2
7619586|NCT01763866|26511703|P11|Overall Study|Withdrawal by Subject|2
7619587|NCT01763866|26511704|P10|Overall Study|Withdrawal by Subject|1
7619588|NCT01763866|26511705|P9|Overall Study|Withdrawal by Subject|1
7619589|NCT01763866|26511706|P8|Overall Study|Withdrawal by Subject|0
7619590|NCT01763866|26511707|P7|Overall Study|Withdrawal by Subject|4
7619591|NCT01763866|26511708|P6|Overall Study|Withdrawal by Subject|3
7619592|NCT01763866|26511709|P5|Overall Study|Withdrawal by Subject|0
7619593|NCT01763866|26511710|P4|Overall Study|Withdrawal by Subject|0
7619594|NCT01763866|26511711|P3|Overall Study|Withdrawal by Subject|4
7619595|NCT01763866|26511712|P2|Overall Study|Withdrawal by Subject|1
7619596|NCT01763866|26511713|P1|Overall Study|Withdrawal by Subject|2
7619597|NCT01763827|26512273|P6|Overall Study|Lost to Follow-up|1
7619598|NCT01763827|26512274|P5|Overall Study|Lost to Follow-up|2
7619599|NCT01763827|26512275|P4|Overall Study|Lost to Follow-up|1
7619600|NCT01763827|26512276|P3|Overall Study|Lost to Follow-up|1
7619601|NCT01763827|26512277|P2|Overall Study|Lost to Follow-up|1
7619602|NCT01763827|26512278|P1|Overall Study|Lost to Follow-up|0
7619603|NCT01763827|26512273|P6|Overall Study|Decision by sponsor|1
7619604|NCT01763827|26512274|P5|Overall Study|Decision by sponsor|2
7619605|NCT01763827|26512275|P4|Overall Study|Decision by sponsor|0
7619606|NCT01763827|26512276|P3|Overall Study|Decision by sponsor|3
7619607|NCT01763827|26512277|P2|Overall Study|Decision by sponsor|0
7619608|NCT01763827|26512278|P1|Overall Study|Decision by sponsor|2
7619609|NCT01763827|26512273|P6|Overall Study|Withdrawal by Subject|0
7619610|NCT01763827|26512274|P5|Overall Study|Withdrawal by Subject|2
7619611|NCT01763827|26512275|P4|Overall Study|Withdrawal by Subject|0
7619612|NCT01763827|26512276|P3|Overall Study|Withdrawal by Subject|0
7619613|NCT01763827|26512277|P2|Overall Study|Withdrawal by Subject|0
7619614|NCT01763827|26512278|P1|Overall Study|Withdrawal by Subject|1
7619615|NCT01763788|26512422|P4|Overall Study|Lost to Follow-up|0
7619616|NCT01763788|26512423|P3|Overall Study|Lost to Follow-up|1
7619617|NCT01763788|26512424|P2|Overall Study|Lost to Follow-up|0
7619618|NCT01763788|26512425|P1|Overall Study|Lost to Follow-up|0
7619619|NCT01763684|26512461|P2|Overall Study|Study surgery not performed|6
7619620|NCT01763684|26512462|P1|Overall Study|Study surgery not performed|7
7619621|NCT01763684|26512461|P2|Overall Study|Study terminated early due to low enrollment|127
7619622|NCT01763684|26512462|P1|Overall Study|Study terminated early due to low enrollment|126
7619623|NCT01763203|26512675|P2|Overall Study|Physician Decision|1
7619624|NCT01763203|26512676|P1|Overall Study|Physician Decision|2
7619625|NCT01763203|26512675|P2|Overall Study|Moved out of study region|10
7619626|NCT01763203|26512676|P1|Overall Study|Moved out of study region|7
7619627|NCT01763203|26512675|P2|Overall Study|Withdrawal by Subject|12
7619628|NCT01763203|26512676|P1|Overall Study|Withdrawal by Subject|8
7619629|NCT01763203|26512675|P2|Overall Study|Lost to Follow-up|12
7619630|NCT01763203|26512676|P1|Overall Study|Lost to Follow-up|12
7619631|NCT01763203|26512675|P2|Overall Study|Death|7
7619632|NCT01763203|26512676|P1|Overall Study|Death|4
7619633|NCT01763164|26512722|P2|Follow up Phase|Adverse Event|1
7619634|NCT01763164|26512723|P1|Follow up Phase|Adverse Event|17
7619635|NCT01763164|26512722|P2|Follow up Phase|Lost to Follow-up|0
7619636|NCT01763164|26512723|P1|Follow up Phase|Lost to Follow-up|1
7619637|NCT01763164|26512722|P2|Follow up Phase|Physician Decision|3
7619638|NCT01763164|26512723|P1|Follow up Phase|Physician Decision|10
7619639|NCT01763164|26512722|P2|Follow up Phase|Progressive disease|62
7619640|NCT01763164|26512723|P1|Follow up Phase|Progressive disease|127
7619641|NCT01763164|26512722|P2|Follow up Phase|Subject/guardian decision|2
7619642|NCT01763164|26512723|P1|Follow up Phase|Subject/guardian decision|9
7619643|NCT01763164|26512722|P2|Follow up Phase|Death|4
7619644|NCT01763164|26512723|P1|Follow up Phase|Death|21
7619645|NCT01763164|26512722|P2|Follow up Phase|New therapy for study indication|3
7619646|NCT01763164|26512723|P1|Follow up Phase|New therapy for study indication|12
7619647|NCT01763164|26512722|P2|Treatment Phase|Other|1
7619648|NCT01763164|26512723|P1|Treatment Phase|Other|0
7619649|NCT01763164|26512722|P2|Treatment Phase|Randomized but not Treated|19
7619650|NCT01763164|26512723|P1|Treatment Phase|Randomized but not Treated|0
7619651|NCT01763164|26512722|P2|Treatment Phase|Adverse Event|8
7619652|NCT01763164|26512723|P1|Treatment Phase|Adverse Event|66
7619653|NCT01763164|26512722|P2|Treatment Phase|Death|1
7619654|NCT01763164|26512723|P1|Treatment Phase|Death|10
7619655|NCT01763164|26512722|P2|Treatment Phase|Physician Decision|13
7619656|NCT01763164|26512723|P1|Treatment Phase|Physician Decision|24
7619657|NCT01763164|26512722|P2|Treatment Phase|Progressive Disease|76
7619658|NCT01763164|26512723|P1|Treatment Phase|Progressive Disease|142
7619659|NCT01763164|26512722|P2|Treatment Phase|Protocol Violation|1
7619660|NCT01763164|26512723|P1|Treatment Phase|Protocol Violation|1
7619661|NCT01763164|26512722|P2|Treatment Phase|Participant/Guardian decision|14
7619662|NCT01763164|26512723|P1|Treatment Phase|Participant/Guardian decision|26
7619663|NCT01763047|26512770|P2|Period 2|Unsatisfactory lens Fitting|1
7619664|NCT01763047|26512771|P1|Period 2|Unsatisfactory lens Fitting|0
7619665|NCT01763047|26512770|P2|Period 2|Protocol Violation|2
7619666|NCT01763047|26512771|P1|Period 2|Protocol Violation|0
7619667|NCT01763047|26512770|P2|Period 2|Unsatisfactory Visual Response|1
7619668|NCT01763047|26512771|P1|Period 2|Unsatisfactory Visual Response|1
7619669|NCT01763047|26512770|P2|Period 2|Study Site office Closed|1
7619670|NCT01763047|26512771|P1|Period 2|Study Site office Closed|1
7619671|NCT01763047|26512770|P2|Period 2|No longer meets Eligibility Criteria|0
7619672|NCT01763047|26512771|P1|Period 2|No longer meets Eligibility Criteria|1
7619673|NCT01763047|26512770|P2|Period 2|Lens Discomfort|0
7619674|NCT01763047|26512771|P1|Period 2|Lens Discomfort|1
7619675|NCT01763047|26512770|P2|Period 1|Study Site office Closed|1
7619676|NCT01763047|26512771|P1|Period 1|Study Site office Closed|0
7619677|NCT01763047|26512770|P2|Period 1|Lens Power Not Available|1
7619678|NCT01763047|26512771|P1|Period 1|Lens Power Not Available|0
7619679|NCT01763047|26512770|P2|Period 1|Unsatisfactory Visual Response|3
7619680|NCT01763047|26512771|P1|Period 1|Unsatisfactory Visual Response|0
7619681|NCT01763047|26512770|P2|Period 1|Adverse Event|1
7619682|NCT01763047|26512771|P1|Period 1|Adverse Event|0
7619683|NCT01763047|26512770|P2|Period 1|No Longer Meets Eligibility criteria|0
7619684|NCT01763047|26512771|P1|Period 1|No Longer Meets Eligibility criteria|1
7619685|NCT01763047|26512770|P2|Period 1|Protocol Violation|4
7619686|NCT01763047|26512771|P1|Period 1|Protocol Violation|4
7619687|NCT01763047|26512770|P2|Period 1|Test Article Not Available|1
7619688|NCT01763047|26512771|P1|Period 1|Test Article Not Available|4
7619689|NCT01762943|26512810|P2|Overall Study|Withdrawal by Subject|1
7619690|NCT01762943|26512811|P1|Overall Study|Withdrawal by Subject|2
7619691|NCT01762943|26512810|P2|Overall Study|Protocol Violation|0
7619692|NCT01762943|26512811|P1|Overall Study|Protocol Violation|1
7619693|NCT01762943|26512810|P2|Overall Study|Physician Decision|1
7619694|NCT01762943|26512811|P1|Overall Study|Physician Decision|1
7619695|NCT01762800|26512828|P2|Overall Study|Withdrawal by Subject|4
7619696|NCT01762800|26512829|P1|Overall Study|Withdrawal by Subject|7
7619697|NCT01762800|26512828|P2|Overall Study|Physician Decision|1
7619698|NCT01762800|26512829|P1|Overall Study|Physician Decision|1
7619699|NCT01762800|26512828|P2|Overall Study|Study Closed/Terminated|1
7619700|NCT01762800|26512829|P1|Overall Study|Study Closed/Terminated|0
7619701|NCT01762800|26512828|P2|Overall Study|Lack of Efficacy|2
7619702|NCT01762800|26512829|P1|Overall Study|Lack of Efficacy|3
7619703|NCT01762800|26512828|P2|Overall Study|Adverse Event|13
7619704|NCT01762800|26512829|P1|Overall Study|Adverse Event|8
7619705|NCT01762761|26512903|P2|Overall Study|Withdrawal by Subject|8
7619706|NCT01762761|26512904|P1|Overall Study|Withdrawal by Subject|7
7619707|NCT01762761|26512903|P2|Overall Study|Physician Decision|6
7619708|NCT01762761|26512904|P1|Overall Study|Physician Decision|4
7619709|NCT01762761|26512903|P2|Overall Study|Lost to Follow-up|6
7619710|NCT01762761|26512904|P1|Overall Study|Lost to Follow-up|3
7619711|NCT01762761|26512903|P2|Overall Study|Study closed/terminated|2
7619712|NCT01762761|26512904|P1|Overall Study|Study closed/terminated|0
7619713|NCT01762761|26512903|P2|Overall Study|Protocol Violation|1
7619714|NCT01762761|26512904|P1|Overall Study|Protocol Violation|1
7619715|NCT01762761|26512903|P2|Overall Study|Lack of Efficacy|25
7619716|NCT01762761|26512904|P1|Overall Study|Lack of Efficacy|9
7619717|NCT01762761|26512903|P2|Overall Study|Adverse Event|17
7619718|NCT01762761|26512904|P1|Overall Study|Adverse Event|15
7619719|NCT01762345|26513003|P1|Overall Study|Protocol Violation|2
7619720|NCT01762345|26513003|P1|Overall Study|Adverse Event|5
7619721|NCT01761565|26513064|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
7619722|NCT01761292|26513076|P1|Extension 1|Withdrawal by Subject|1
7619723|NCT01761292|26513076|P1|Part 1|not receiving treatment in Part 1|1
7619724|NCT01761292|26513076|P1|Part 1|Adverse Event|1
7619725|NCT01761266|26513110|P2|Overall Study|Ongoing as of data-cut off|107
7619726|NCT01761266|26513111|P1|Overall Study|Ongoing as of data-cut off|109
7619727|NCT01761266|26513110|P2|Overall Study|Withdrawal by Subject|8
7619728|NCT01761266|26513111|P1|Overall Study|Withdrawal by Subject|13
7619729|NCT01761266|26513110|P2|Overall Study|Lost to Follow-up|11
7619730|NCT01761266|26513111|P1|Overall Study|Lost to Follow-up|5
7619731|NCT01761266|26513110|P2|Overall Study|Death|350
7619732|NCT01761266|26513111|P1|Overall Study|Death|351
7619733|NCT01761162|26513168|P1|Overall Study|Withdrawal by Subject|3
7619734|NCT01760954|26513257|P4|Post-treatment Follow-up (12 Months)|Other|6
7619735|NCT01760954|26513258|P3|Post-treatment Follow-up (12 Months)|Other|9
7619736|NCT01760954|26513259|P2|Post-treatment Follow-up (12 Months)|Other|8
7619737|NCT01760954|26513260|P1|Post-treatment Follow-up (12 Months)|Other|13
7619738|NCT01760954|26513257|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7619739|NCT01760954|26513258|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
7619740|NCT01760954|26513259|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7619741|NCT01760954|26513260|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7619742|NCT01760954|26513257|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7619743|NCT01760954|26513258|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7619744|NCT01760954|26513259|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
7619745|NCT01760954|26513260|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
7619746|NCT01760954|26513257|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7619747|NCT01760954|26513258|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7619748|NCT01760954|26513259|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
7619749|NCT01760954|26513260|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
7619750|NCT01760954|26513257|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
7619751|NCT01760954|26513258|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
7619752|NCT01760954|26513259|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
7619753|NCT01760954|26513260|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
7619754|NCT01760954|26513257|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
7619755|NCT01760954|26513258|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7619756|NCT01760954|26513259|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7619757|NCT01760954|26513260|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7619758|NCT01760954|26513257|P4|Treatment Period (6 Months)|Exclusionary Medication|0
7619759|NCT01760954|26513258|P3|Treatment Period (6 Months)|Exclusionary Medication|0
7619760|NCT01760954|26513259|P2|Treatment Period (6 Months)|Exclusionary Medication|0
7619761|NCT01760954|26513260|P1|Treatment Period (6 Months)|Exclusionary Medication|1
7619762|NCT01760954|26513257|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7619763|NCT01760954|26513258|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7619764|NCT01760954|26513259|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
7619765|NCT01760954|26513260|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
7619766|NCT01760954|26513257|P4|Treatment Period (6 Months)|Other|1
7619767|NCT01760954|26513258|P3|Treatment Period (6 Months)|Other|3
7619768|NCT01760954|26513259|P2|Treatment Period (6 Months)|Other|3
7619769|NCT01760954|26513260|P1|Treatment Period (6 Months)|Other|0
7619770|NCT01760954|26513257|P4|Treatment Period (6 Months)|Non-compliance|3
7619771|NCT01760954|26513258|P3|Treatment Period (6 Months)|Non-compliance|0
7619772|NCT01760954|26513259|P2|Treatment Period (6 Months)|Non-compliance|4
7619773|NCT01760954|26513260|P1|Treatment Period (6 Months)|Non-compliance|1
7619774|NCT01760954|26513257|P4|Treatment Period (6 Months)|Pregnancy|2
7619775|NCT01760954|26513258|P3|Treatment Period (6 Months)|Pregnancy|3
7619776|NCT01760954|26513259|P2|Treatment Period (6 Months)|Pregnancy|0
7619777|NCT01760954|26513260|P1|Treatment Period (6 Months)|Pregnancy|5
7619778|NCT01760954|26513257|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
7619779|NCT01760954|26513258|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7619780|NCT01760954|26513259|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7619781|NCT01760954|26513260|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7619782|NCT01760954|26513257|P4|Treatment Period (6 Months)|Lost to Follow-up|3
7619783|NCT01760954|26513258|P3|Treatment Period (6 Months)|Lost to Follow-up|4
7619784|NCT01760954|26513259|P2|Treatment Period (6 Months)|Lost to Follow-up|1
7619785|NCT01760954|26513260|P1|Treatment Period (6 Months)|Lost to Follow-up|9
7619786|NCT01760954|26513257|P4|Treatment Period (6 Months)|Adverse Event|10
7619787|NCT01760954|26513258|P3|Treatment Period (6 Months)|Adverse Event|4
7619788|NCT01760954|26513259|P2|Treatment Period (6 Months)|Adverse Event|3
7619789|NCT01760954|26513260|P1|Treatment Period (6 Months)|Adverse Event|5
7619790|NCT01760954|26513257|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
7619791|NCT01760954|26513258|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
7619792|NCT01760954|26513259|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
7619793|NCT01760954|26513260|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
7619794|NCT01760876|26513397|P1|Overall Study|Very poor baseline OCT quality|2
7619795|NCT01760876|26513397|P1|Overall Study|Major depression|1
7619796|NCT01760876|26513397|P1|Overall Study|Impaired renal function|1
7619797|NCT01760876|26513397|P1|Overall Study|Carcinoma of prostate|1
7619798|NCT01760876|26513397|P1|Overall Study|Non-cardiac death (head injury)|1
7619799|NCT01760733|26513412|P1|Transplanted|Graft loss|7
7619800|NCT01760733|26513412|P1|Transplanted|Death|26
7619801|NCT01760733|26513412|P1|Transplanted|Not reached 10 years post transplant|184
7619802|NCT01760733|26513412|P1|Waiting List|Not received a transplant yet|13
7619803|NCT01760733|26513412|P1|Waiting List|Removed from waiting list|41
7619804|NCT01760733|26513412|P1|Waiting List|Death|18
7619805|NCT01760447|26513442|P4|Weeks 20-54|Lost to Follow-up|2
7619806|NCT01760447|26513443|P3|Weeks 20-54|Lost to Follow-up|1
7619807|NCT01760447|26513444|P2|Weeks 20-54|Lost to Follow-up|0
7619808|NCT01760447|26513445|P1|Weeks 20-54|Lost to Follow-up|0
7619809|NCT01760447|26513442|P4|Weeks 20-54|Withdrawal by Subject|2
7619810|NCT01760447|26513443|P3|Weeks 20-54|Withdrawal by Subject|1
7619811|NCT01760447|26513444|P2|Weeks 20-54|Withdrawal by Subject|1
7619812|NCT01760447|26513445|P1|Weeks 20-54|Withdrawal by Subject|2
7619813|NCT01760447|26513442|P4|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
7619814|NCT01760447|26513443|P3|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7619815|NCT01760447|26513444|P2|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7619816|NCT01760447|26513445|P1|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7619817|NCT01760447|26513442|P4|Weeks 0-20|Randomized but not treated|0
7619818|NCT01760447|26513443|P3|Weeks 0-20|Randomized but not treated|2
7619819|NCT01760447|26513444|P2|Weeks 0-20|Randomized but not treated|0
7619820|NCT01760447|26513445|P1|Weeks 0-20|Randomized but not treated|0
7619821|NCT01760447|26513442|P4|Weeks 0-20|Lost to Follow-up|1
7619822|NCT01760447|26513443|P3|Weeks 0-20|Lost to Follow-up|1
7619823|NCT01760447|26513444|P2|Weeks 0-20|Lost to Follow-up|0
7619824|NCT01760447|26513445|P1|Weeks 0-20|Lost to Follow-up|1
7619825|NCT01760447|26513442|P4|Weeks 0-20|Withdrawal by Subject|0
7619826|NCT01760447|26513443|P3|Weeks 0-20|Withdrawal by Subject|1
7619827|NCT01760447|26513444|P2|Weeks 0-20|Withdrawal by Subject|0
7619828|NCT01760447|26513445|P1|Weeks 0-20|Withdrawal by Subject|2
7619829|NCT01760447|26513442|P4|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
7619830|NCT01760447|26513443|P3|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
7619831|NCT01760447|26513444|P2|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7619832|NCT01760447|26513445|P1|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7619833|NCT01759862|26513773|P2|Overall Study|Adverse Event|1
7619834|NCT01759862|26513774|P1|Overall Study|Adverse Event|0
7619835|NCT01759862|26513773|P2|Overall Study|Physician Decision|1
7619836|NCT01759862|26513774|P1|Overall Study|Physician Decision|3
7619837|NCT01759511|26513792|P1|Overall Study|Withdrawal by Subject|3
7619838|NCT01759511|26513792|P1|Overall Study|Study Terminated by Sponsor|13
7619839|NCT01759511|26513792|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
7619840|NCT01759511|26513792|P1|Overall Study|Progressive Disease|5
7619841|NCT01759511|26513792|P1|Overall Study|Physician Decision|1
7619842|NCT01759511|26513792|P1|Overall Study|Lack of Efficacy|2
7619843|NCT01759511|26513792|P1|Overall Study|Death|2
7619844|NCT01759511|26513792|P1|Overall Study|Adverse Event|4
7619845|NCT01759446|26513805|P5|Overall Study|Withdrawal by Subject|0
7619846|NCT01759446|26513806|P4|Overall Study|Withdrawal by Subject|1
7619847|NCT01759446|26513807|P3|Overall Study|Withdrawal by Subject|0
7619848|NCT01759446|26513808|P2|Overall Study|Withdrawal by Subject|1
7619849|NCT01759446|26513809|P1|Overall Study|Withdrawal by Subject|0
7619850|NCT01759446|26513805|P5|Overall Study|Protocol Violation|0
7619851|NCT01759446|26513806|P4|Overall Study|Protocol Violation|0
7619852|NCT01759446|26513807|P3|Overall Study|Protocol Violation|1
7619853|NCT01759446|26513808|P2|Overall Study|Protocol Violation|0
7619854|NCT01759446|26513809|P1|Overall Study|Protocol Violation|1
7619855|NCT01759420|26513821|P1|Overall Study|Inaccurate EKG machine readings|1
7619856|NCT01759420|26513821|P1|Overall Study|Screen failure|5
7619857|NCT01759407|26513828|P2|Overall Study|Protocol Violation|2
7619858|NCT01759407|26513829|P1|Overall Study|Protocol Violation|0
7619859|NCT01759381|26513841|P2|Overall Study|Death|0
7619860|NCT01759381|26513842|P1|Overall Study|Death|1
7619861|NCT01759368|26513850|P2|Overall Study|Lost to Follow-up|0
7619862|NCT01759368|26513851|P1|Overall Study|Lost to Follow-up|1
7619863|NCT01759290|26513869|P1|Overall Study|Unknown reason|4
7619864|NCT01759290|26513869|P1|Overall Study|Lost to Follow-up|53
7619865|NCT01759290|26513869|P1|Overall Study|Death|17
7619866|NCT01759290|26513869|P1|Overall Study|Physician Decision|2
7619867|NCT01759290|26513869|P1|Overall Study|Subjects withdrawn consent|5
7619868|NCT01759264|26513950|P1|Overall Study|Discontinued Humira Due to Business Trip|1
7619869|NCT01759264|26513950|P1|Overall Study|Withdrawal by Subject|3
7619870|NCT01759264|26513950|P1|Overall Study|Lost to Follow-up|2
7619871|NCT01759264|26513950|P1|Overall Study|Other|2
7619872|NCT01759264|26513950|P1|Overall Study|Adverse Event|1
7619873|NCT01759264|26513950|P1|Overall Study|Serious Adverse Events (SAEs)|1
7619874|NCT01758900|26513978|P2|Overall Study|difficulty for further intubation|8
7619875|NCT01758900|26513979|P1|Overall Study|difficulty for further intubation|7
7619876|NCT01758731|26513997|P1|Overall Study|Physician Decision|1
7619877|NCT01758523|26514016|P2|Overall Study|Withdrawal by Subject|7
7619878|NCT01758523|26514017|P1|Overall Study|Withdrawal by Subject|12
7619879|NCT01758523|26514016|P2|Overall Study|Lost to Follow-up|4
7619880|NCT01758523|26514017|P1|Overall Study|Lost to Follow-up|3
7619881|NCT01758523|26514016|P2|Overall Study|Lack of Efficacy|2
7619882|NCT01758523|26514017|P1|Overall Study|Lack of Efficacy|4
7619883|NCT01758523|26514016|P2|Overall Study|Adverse Event|1
7619884|NCT01758523|26514017|P1|Overall Study|Adverse Event|2
7619885|NCT01758289|26514120|P1|Overall Study|Adverse Event|9
7619886|NCT01758289|26514120|P1|Overall Study|Premature Study Termination|44
7619887|NCT01757847|26514146|P2|Overall Study|Withdrawal by Subject|4
7619888|NCT01757847|26514147|P1|Overall Study|Withdrawal by Subject|3
7619889|NCT01757821|26514155|P1|Overall Study|Adverse Event|1
7619890|NCT01757704|26514170|P2|Overall Study|Protocol Violation|3
7619891|NCT01757704|26514171|P1|Overall Study|Protocol Violation|1
7619892|NCT01757691|26514189|P2|Overall Study|Administrative problems|0
7619893|NCT01757691|26514190|P1|Overall Study|Administrative problems|2
7619894|NCT01757665|26514217|P2|Overall Study|Not Implanted with Device|1
7619895|NCT01757665|26514218|P1|Overall Study|Not Implanted with Device|5
7619896|NCT01757665|26514217|P2|Overall Study|Lost to Follow-up|1
7619897|NCT01757665|26514218|P1|Overall Study|Lost to Follow-up|1
7619898|NCT01757665|26514217|P2|Overall Study|Withdrawal by Subject|0
7619899|NCT01757665|26514218|P1|Overall Study|Withdrawal by Subject|10
7619900|NCT01757665|26514217|P2|Overall Study|Explant|2
7619901|NCT01757665|26514218|P1|Overall Study|Explant|1
7619902|NCT01757665|26514217|P2|Overall Study|Death|8
7619903|NCT01757665|26514218|P1|Overall Study|Death|25
7619904|NCT01757665|26514217|P2|Overall Study|Still on Study - Missed Visit|1
7619905|NCT01757665|26514218|P1|Overall Study|Still on Study - Missed Visit|14
7619906|NCT01757665|26514217|P2|Overall Study|Still on Study - Visit Pending|40
7619907|NCT01757665|26514218|P1|Overall Study|Still on Study - Visit Pending|398
7619908|NCT01757665|26514217|P2|Overall Study|Still on Study - Visit Completed|30
7619909|NCT01757665|26514218|P1|Overall Study|Still on Study - Visit Completed|240
7619910|NCT01757535|26514390|P2|Overall Study|Death|2
7619911|NCT01757535|26514391|P1|Overall Study|Death|1
7619912|NCT01757535|26514390|P2|Overall Study|Physician Decision|0
7619913|NCT01757535|26514391|P1|Overall Study|Physician Decision|6
7619914|NCT01757535|26514390|P2|Overall Study|Miscellaneous|2
7619915|NCT01757535|26514391|P1|Overall Study|Miscellaneous|5
7619916|NCT01757535|26514390|P2|Overall Study|Withdrawal by Subject|13
7619917|NCT01757535|26514391|P1|Overall Study|Withdrawal by Subject|9
7619918|NCT01757535|26514390|P2|Overall Study|Adverse Event|11
7619919|NCT01757535|26514391|P1|Overall Study|Adverse Event|29
7619920|NCT01757535|26514390|P2|Overall Study|Disease Relapse|180
7619921|NCT01757535|26514391|P1|Overall Study|Disease Relapse|143
7619922|NCT01757405|26514423|P2|Overall Study|Withdrawal by Subject|1
7619923|NCT01757405|26514424|P1|Overall Study|Withdrawal by Subject|0
7619924|NCT01757405|26514423|P2|Overall Study|Lost to Follow-up|1
7619925|NCT01757405|26514424|P1|Overall Study|Lost to Follow-up|1
7619926|NCT01757392|26514440|P1|Overall Study|Screen Fail|3
7619927|NCT01757392|26514440|P1|Overall Study|Withdrawal by Subject|1
7619955|NCT01757275|26514510|P2|Overall Study|Not treated|4
7619956|NCT01757275|26514511|P1|Overall Study|Not treated|3
7619957|NCT01757275|26514510|P2|Overall Study|Withdrawal by Subject|4
7619958|NCT01757275|26514511|P1|Overall Study|Withdrawal by Subject|2
7619959|NCT01757275|26514510|P2|Overall Study|Adverse Event|3
7619960|NCT01757275|26514511|P1|Overall Study|Adverse Event|3
7619961|NCT01757275|26514510|P2|Overall Study|Lost to Follow-up|2
7619962|NCT01757275|26514511|P1|Overall Study|Lost to Follow-up|1
7619963|NCT01757197|26514533|P1|Overall Study|Death|2
7619964|NCT01757184|26514542|P4|Open-label Period|Discontinued by Sponsor|2
7619965|NCT01757184|26514543|P3|Open-label Period|Discontinued by Sponsor|1
7619966|NCT01757184|26514544|P2|Open-label Period|Discontinued by Sponsor|0
7619967|NCT01757184|26514545|P1|Open-label Period|Discontinued by Sponsor|0
7619968|NCT01757184|26514542|P4|Open-label Period|Withdrawal by Subject|1
7619969|NCT01757184|26514543|P3|Open-label Period|Withdrawal by Subject|1
7619970|NCT01757184|26514544|P2|Open-label Period|Withdrawal by Subject|0
7619971|NCT01757184|26514545|P1|Open-label Period|Withdrawal by Subject|0
7619972|NCT01757184|26514542|P4|Open-label Period|Lost to Follow-up|0
7619973|NCT01757184|26514543|P3|Open-label Period|Lost to Follow-up|2
7619974|NCT01757184|26514544|P2|Open-label Period|Lost to Follow-up|0
7619975|NCT01757184|26514545|P1|Open-label Period|Lost to Follow-up|0
7619976|NCT01757184|26514542|P4|Double-blind Period|Adverse Event|0
7619977|NCT01757184|26514543|P3|Double-blind Period|Adverse Event|0
7619978|NCT01757184|26514544|P2|Double-blind Period|Adverse Event|0
7619979|NCT01757184|26514545|P1|Double-blind Period|Adverse Event|1
7619980|NCT01757171|26514589|P2|Overall Study|ECOG decline|0
7619981|NCT01757171|26514590|P1|Overall Study|ECOG decline|1
7619982|NCT01757171|26514589|P2|Overall Study|Hospitalization|0
7619983|NCT01757171|26514590|P1|Overall Study|Hospitalization|1
7619984|NCT01757171|26514589|P2|Overall Study|Disease Progression|0
7619985|NCT01757171|26514590|P1|Overall Study|Disease Progression|1
7619986|NCT01757171|26514589|P2|Overall Study|Adverse Event|1
7619987|NCT01757171|26514590|P1|Overall Study|Adverse Event|5
7619988|NCT01756898|26514624|P4|Overall Study|Other|0
7619989|NCT01756898|26514625|P3|Overall Study|Other|2
7619990|NCT01756898|26514626|P2|Overall Study|Other|2
7619991|NCT01756898|26514627|P1|Overall Study|Other|0
7619992|NCT01756898|26514624|P4|Overall Study|Withdrew Consent|6
7619993|NCT01756898|26514625|P3|Overall Study|Withdrew Consent|5
7619994|NCT01756898|26514626|P2|Overall Study|Withdrew Consent|3
7619995|NCT01756898|26514627|P1|Overall Study|Withdrew Consent|5
7619996|NCT01756898|26514624|P4|Overall Study|Protocol Violation|1
7619997|NCT01756898|26514625|P3|Overall Study|Protocol Violation|2
7619998|NCT01756898|26514626|P2|Overall Study|Protocol Violation|2
7619999|NCT01756898|26514627|P1|Overall Study|Protocol Violation|1
7620000|NCT01756898|26514624|P4|Overall Study|Lost to Follow-up|3
7620001|NCT01756898|26514625|P3|Overall Study|Lost to Follow-up|2
7620002|NCT01756898|26514626|P2|Overall Study|Lost to Follow-up|4
7620003|NCT01756898|26514627|P1|Overall Study|Lost to Follow-up|2
7620004|NCT01756898|26514624|P4|Overall Study|Lack of Efficacy|6
7620005|NCT01756898|26514625|P3|Overall Study|Lack of Efficacy|6
7620006|NCT01756898|26514626|P2|Overall Study|Lack of Efficacy|7
7620007|NCT01756898|26514627|P1|Overall Study|Lack of Efficacy|4
7620008|NCT01756898|26514624|P4|Overall Study|Adverse Event|0
7620009|NCT01756898|26514625|P3|Overall Study|Adverse Event|0
7620010|NCT01756898|26514626|P2|Overall Study|Adverse Event|1
7620011|NCT01756898|26514627|P1|Overall Study|Adverse Event|7
7620012|NCT01756846|26514688|P2|Overall Study|Withdrawal by Subject|2
7620013|NCT01756846|26514689|P1|Overall Study|Withdrawal by Subject|1
7620014|NCT01756846|26514688|P2|Overall Study|Lost to Follow-up|10
7620015|NCT01756846|26514689|P1|Overall Study|Lost to Follow-up|5
7620016|NCT01756456|26514734|P6|Follow Up Period Phase I/II|Other causes|5
7620017|NCT01756456|26514735|P5|Follow Up Period Phase I/II|Other causes|3
7620018|NCT01756456|26514736|P4|Follow Up Period Phase I/II|Other causes|1
7620019|NCT01756456|26514737|P3|Follow Up Period Phase I/II|Other causes|0
7620020|NCT01756456|26514738|P2|Follow Up Period Phase I/II|Other causes|0
7620021|NCT01756456|26514739|P1|Follow Up Period Phase I/II|Other causes|0
7620022|NCT01756456|26514734|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
7620023|NCT01756456|26514735|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
7620024|NCT01756456|26514736|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
7620025|NCT01756456|26514737|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
7620026|NCT01756456|26514738|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
7620027|NCT01756456|26514739|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
7620028|NCT01756456|26514734|P6|Follow Up Period Phase I/II|Adverse Event|1
7620029|NCT01756456|26514735|P5|Follow Up Period Phase I/II|Adverse Event|0
7620030|NCT01756456|26514736|P4|Follow Up Period Phase I/II|Adverse Event|5
7620031|NCT01756456|26514737|P3|Follow Up Period Phase I/II|Adverse Event|0
7620032|NCT01756456|26514738|P2|Follow Up Period Phase I/II|Adverse Event|0
7620033|NCT01756456|26514739|P1|Follow Up Period Phase I/II|Adverse Event|1
7620034|NCT01756456|26514734|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
7620035|NCT01756456|26514735|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
7620036|NCT01756456|26514736|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
7620037|NCT01756456|26514737|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
7620038|NCT01756456|26514738|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
7620039|NCT01756456|26514739|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
7620040|NCT01756456|26514734|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7620041|NCT01756456|26514735|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7620042|NCT01756456|26514736|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7620043|NCT01756456|26514737|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7620044|NCT01756456|26514738|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
7620045|NCT01756456|26514739|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7620046|NCT01756456|26514734|P6|Follow Up Period Phase I/II|still in study after week 20|25
7620047|NCT01756456|26514735|P5|Follow Up Period Phase I/II|still in study after week 20|23
7620048|NCT01756456|26514736|P4|Follow Up Period Phase I/II|still in study after week 20|25
7620049|NCT01756456|26514737|P3|Follow Up Period Phase I/II|still in study after week 20|0
7620050|NCT01756456|26514738|P2|Follow Up Period Phase I/II|still in study after week 20|0
7620051|NCT01756456|26514739|P1|Follow Up Period Phase I/II|still in study after week 20|0
7620052|NCT01756456|26514734|P6|Treatment Period: Phase I/II|Other causes|2
7620053|NCT01756456|26514735|P5|Treatment Period: Phase I/II|Other causes|2
7620054|NCT01756456|26514736|P4|Treatment Period: Phase I/II|Other causes|1
7620055|NCT01756456|26514737|P3|Treatment Period: Phase I/II|Other causes|0
7620056|NCT01756456|26514738|P2|Treatment Period: Phase I/II|Other causes|0
7620057|NCT01756456|26514739|P1|Treatment Period: Phase I/II|Other causes|0
7620058|NCT01756456|26514734|P6|Treatment Period: Phase I/II|Adverse Event|1
7620059|NCT01756456|26514735|P5|Treatment Period: Phase I/II|Adverse Event|9
7620060|NCT01756456|26514736|P4|Treatment Period: Phase I/II|Adverse Event|3
7620061|NCT01756456|26514737|P3|Treatment Period: Phase I/II|Adverse Event|2
7620062|NCT01756456|26514738|P2|Treatment Period: Phase I/II|Adverse Event|0
7620063|NCT01756456|26514739|P1|Treatment Period: Phase I/II|Adverse Event|1
7620064|NCT01756456|26514734|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
7620065|NCT01756456|26514735|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
7620066|NCT01756456|26514736|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
7620067|NCT01756456|26514737|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
7620068|NCT01756456|26514738|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
7620069|NCT01756456|26514739|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
7620070|NCT01756456|26514734|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
7620071|NCT01756456|26514735|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
7620072|NCT01756456|26514736|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
7620073|NCT01756456|26514737|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
7620074|NCT01756456|26514738|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
7620075|NCT01756456|26514739|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
7620076|NCT01756456|26514734|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7620077|NCT01756456|26514735|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7620078|NCT01756456|26514736|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7620079|NCT01756456|26514737|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7620080|NCT01756456|26514738|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7620081|NCT01756456|26514739|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7620082|NCT01756352|26514841|P1|Overall Study|moved away and lost to followup|1
7620083|NCT01756300|26514846|P1|Overall Study|Withdrawal by Subject|1
7620084|NCT01756300|26514846|P1|Overall Study|Death|1
7620085|NCT01756274|26514868|P1|Overall Study|Laboratory error|1
7620086|NCT01756274|26514868|P1|Overall Study|Protocol Violation|2
7620087|NCT01756235|26514875|P1|Overall Study|Adalimumab Treatment was not Documented|2
7620088|NCT01756157|26514913|P2|First Intervention Period|Lost to Follow-up|2
7620089|NCT01756157|26514914|P1|First Intervention Period|Lost to Follow-up|0
7620090|NCT01756157|26514913|P2|First Intervention Period|Withdrawal by Subject|0
7620091|NCT01756157|26514914|P1|First Intervention Period|Withdrawal by Subject|1
7620092|NCT01756079|26514928|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
7620093|NCT01756079|26514928|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
7620094|NCT01756079|26514928|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
7620095|NCT01756079|26514928|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
7620096|NCT01756079|26514928|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
7620097|NCT01756053|26514934|P2|Period 2 (10 Days)|Protocol Violation|2
7620098|NCT01756053|26514935|P1|Period 2 (10 Days)|Protocol Violation|0
7620099|NCT01756053|26514934|P2|Period 1 (10 Days)|Protocol Violation|1
7620100|NCT01756053|26514935|P1|Period 1 (10 Days)|Protocol Violation|1
7620101|NCT01755858|26514994|P2|Overall Study|Adverse Event|1
7620102|NCT01755858|26514995|P1|Overall Study|Adverse Event|1
7620103|NCT01755767|26515021|P4|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
7620104|NCT01755767|26515022|P3|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
7620105|NCT01755767|26515023|P2|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7620106|NCT01755767|26515024|P1|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7620107|NCT01755767|26515021|P4|Overall Study|Other|3
7620108|NCT01755767|26515022|P3|Overall Study|Other|2
7620109|NCT01755767|26515023|P2|Overall Study|Other|0
7620110|NCT01755767|26515024|P1|Overall Study|Other|0
7620111|NCT01755767|26515021|P4|Overall Study|Withdrawal by Subject|1
7620112|NCT01755767|26515022|P3|Overall Study|Withdrawal by Subject|2
7620113|NCT01755767|26515023|P2|Overall Study|Withdrawal by Subject|0
7620114|NCT01755767|26515024|P1|Overall Study|Withdrawal by Subject|0
7620115|NCT01755767|26515021|P4|Overall Study|Subject Decision|3
7620116|NCT01755767|26515022|P3|Overall Study|Subject Decision|10
7620117|NCT01755767|26515023|P2|Overall Study|Subject Decision|0
7620118|NCT01755767|26515024|P1|Overall Study|Subject Decision|0
7620119|NCT01755767|26515021|P4|Overall Study|Death|4
7620120|NCT01755767|26515022|P3|Overall Study|Death|15
7620121|NCT01755767|26515023|P2|Overall Study|Death|2
7620122|NCT01755767|26515024|P1|Overall Study|Death|1
7620123|NCT01755767|26515021|P4|Overall Study|Adverse Event|11
7620124|NCT01755767|26515022|P3|Overall Study|Adverse Event|28
7620125|NCT01755767|26515023|P2|Overall Study|Adverse Event|0
7620126|NCT01755767|26515024|P1|Overall Study|Adverse Event|6
7620127|NCT01755767|26515021|P4|Overall Study|Radiographic Disease Progression|27
7620128|NCT01755767|26515022|P3|Overall Study|Radiographic Disease Progression|44
7620129|NCT01755767|26515023|P2|Overall Study|Radiographic Disease Progression|4
7620130|NCT01755767|26515024|P1|Overall Study|Radiographic Disease Progression|9
7620131|NCT01755767|26515021|P4|Overall Study|Clinical Disease Progression|20
7620132|NCT01755767|26515022|P3|Overall Study|Clinical Disease Progression|29
7620133|NCT01755767|26515023|P2|Overall Study|Clinical Disease Progression|2
7620134|NCT01755767|26515024|P1|Overall Study|Clinical Disease Progression|4
7620135|NCT01755767|26515021|P4|Overall Study|Progressive Disease|43
7620136|NCT01755767|26515022|P3|Overall Study|Progressive Disease|91
7620137|NCT01755767|26515023|P2|Overall Study|Progressive Disease|7
7620138|NCT01755767|26515024|P1|Overall Study|Progressive Disease|8
7620139|NCT01755702|26515040|P1|Washout Period II|Other Reason|5
7620140|NCT01755702|26515040|P1|Wash Out Period I|Other Reason|3
7620141|NCT01755689|26515087|P5|Overall Study|Pregnancy|2
7620142|NCT01755689|26515088|P4|Overall Study|Pregnancy|4
7620143|NCT01755689|26515089|P3|Overall Study|Pregnancy|2
7620144|NCT01755689|26515090|P2|Overall Study|Pregnancy|1
7620145|NCT01755689|26515091|P1|Overall Study|Pregnancy|1
7620146|NCT01755689|26515087|P5|Overall Study|Lost to Follow-up|2
7620147|NCT01755689|26515088|P4|Overall Study|Lost to Follow-up|0
7620148|NCT01755689|26515089|P3|Overall Study|Lost to Follow-up|1
7620149|NCT01755689|26515090|P2|Overall Study|Lost to Follow-up|0
7620150|NCT01755689|26515091|P1|Overall Study|Lost to Follow-up|1
7620151|NCT01755689|26515087|P5|Overall Study|Migrated/moved from study area|1
7620152|NCT01755689|26515088|P4|Overall Study|Migrated/moved from study area|1
7620153|NCT01755689|26515089|P3|Overall Study|Migrated/moved from study area|1
7620154|NCT01755689|26515090|P2|Overall Study|Migrated/moved from study area|1
7620155|NCT01755689|26515091|P1|Overall Study|Migrated/moved from study area|0
7620156|NCT01755689|26515087|P5|Overall Study|Withdrawal by Subject|1
7620157|NCT01755689|26515088|P4|Overall Study|Withdrawal by Subject|1
7620158|NCT01755689|26515089|P3|Overall Study|Withdrawal by Subject|2
7620159|NCT01755689|26515090|P2|Overall Study|Withdrawal by Subject|3
7620160|NCT01755689|26515091|P1|Overall Study|Withdrawal by Subject|1
7620161|NCT01755637|26515166|P2|Period 1|Adverse Event|1
7620162|NCT01755637|26515167|P1|Period 1|Adverse Event|0
7620163|NCT01755598|26515187|P2|Overall Study|Adverse Event|28
7620164|NCT01755598|26515188|P1|Overall Study|Adverse Event|19
7620165|NCT01755598|26515187|P2|Overall Study|Protocol Violation|7
7620166|NCT01755598|26515188|P1|Overall Study|Protocol Violation|7
7620167|NCT01755598|26515187|P2|Overall Study|Withdrawal by Subject|31
7620168|NCT01755598|26515188|P1|Overall Study|Withdrawal by Subject|22
7620169|NCT01755598|26515187|P2|Overall Study|Migrated/moved from study area|65
7620170|NCT01755598|26515188|P1|Overall Study|Migrated/moved from study area|76
7620171|NCT01755598|26515187|P2|Overall Study|Lost to Follow-up|43
7620172|NCT01755598|26515188|P1|Overall Study|Lost to Follow-up|32
7620173|NCT01755598|26515187|P2|Overall Study|Other|109
7620174|NCT01755598|26515188|P1|Overall Study|Other|109
7620175|NCT01755546|26515222|P1|Long Term Treatment|other and ongoing|41
7620176|NCT01755546|26515222|P1|Long Term Treatment|Lost to Follow-up|17
7620177|NCT01755546|26515222|P1|Long Term Treatment|Withdrawal by Subject|35
7620178|NCT01755546|26515222|P1|Long Term Treatment|Protocol Violation|10
7620179|NCT01755546|26515222|P1|Long Term Treatment|Lack of Efficacy|6
7620180|NCT01755546|26515222|P1|Long Term Treatment|Adverse Event|12
7620181|NCT01755546|26515222|P1|Titration Phase|Withdrawal by Subject|8
7620182|NCT01755546|26515222|P1|Titration Phase|Other and Continuing|22
7620183|NCT01755546|26515222|P1|Titration Phase|Lost to Follow-up|2
7620184|NCT01755546|26515222|P1|Titration Phase|Protocol Violation|9
7620185|NCT01755546|26515222|P1|Titration Phase|Lack of Efficacy|18
7620186|NCT01755546|26515222|P1|Titration Phase|Adverse Event|11
7620187|NCT01755546|26515222|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
7620188|NCT01755546|26515222|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
7620189|NCT01755546|26515222|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
7620190|NCT01755546|26515222|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
7620191|NCT01755416|26515239|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
7620192|NCT01755416|26515240|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
7620193|NCT01755234|26515248|P2|Overall Study|unblinded|0
7620194|NCT01755234|26515249|P1|Overall Study|unblinded|1
7620195|NCT01755234|26515248|P2|Overall Study|Withdrawal by Subject|1
7620196|NCT01755234|26515249|P1|Overall Study|Withdrawal by Subject|0
7620197|NCT01755234|26515248|P2|Overall Study|case cancelled|0
7620198|NCT01755234|26515249|P1|Overall Study|case cancelled|1
7620199|NCT01755234|26515248|P2|Overall Study|Change in surgical case|1
7620200|NCT01755234|26515249|P1|Overall Study|Change in surgical case|2
7620201|NCT01755234|26515248|P2|Overall Study|Lost to Follow-up|6
7620202|NCT01755234|26515249|P1|Overall Study|Lost to Follow-up|11
7620203|NCT01755195|26515261|P1|Overall Study|Complicating disease/intercurrent illness|1
7620204|NCT01755195|26515261|P1|Overall Study|Refused further treatment|3
7620205|NCT01755195|26515261|P1|Overall Study|Participant has been consented for another trial|1
7620206|NCT01755195|26515261|P1|Overall Study|Participant refused to start treatment|1
7620207|NCT01755195|26515261|P1|Overall Study|Withdrawal by Subject|1
7620208|NCT01755195|26515261|P1|Overall Study|Switched to alternative treatment|4
7620209|NCT01755195|26515261|P1|Overall Study|Participant noncompliance|2
7620210|NCT01755156|26515290|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
7620211|NCT01755156|26515291|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
7620212|NCT01755156|26515290|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
7620213|NCT01755156|26515291|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
7620214|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7620215|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7620216|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
7620217|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
7620218|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
7620219|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
7620220|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Protocol Violation|1
7620221|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Protocol Violation|1
7620222|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Physician Decision|1
7620223|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Physician Decision|0
7620224|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
7620225|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
7620226|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
7620227|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
7620228|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
7620229|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
7620230|NCT01755156|26515290|P2|Phase A (Weeks 0-24)|Adverse Event|3
7620231|NCT01755156|26515291|P1|Phase A (Weeks 0-24)|Adverse Event|2
7620232|NCT01755091|26515355|P3|Overall Study|Physician Decision|2
7620233|NCT01755091|26515356|P2|Overall Study|Physician Decision|1
7620234|NCT01755091|26515357|P1|Overall Study|Physician Decision|1
7620235|NCT01755091|26515355|P3|Overall Study|Lost to Follow-up|1
7620236|NCT01755091|26515356|P2|Overall Study|Lost to Follow-up|0
7620237|NCT01755091|26515357|P1|Overall Study|Lost to Follow-up|1
7620238|NCT01755091|26515355|P3|Overall Study|Adverse Event|1
7620239|NCT01755091|26515356|P2|Overall Study|Adverse Event|1
7620240|NCT01755091|26515357|P1|Overall Study|Adverse Event|1
7620241|NCT01755091|26515355|P3|Overall Study|Withdrawal by Subject|3
7620242|NCT01755091|26515356|P2|Overall Study|Withdrawal by Subject|1
7620243|NCT01755091|26515357|P1|Overall Study|Withdrawal by Subject|6
7620244|NCT01755026|26515382|P2|Overall Study|Withdrawal by Subject|1
7620245|NCT01755026|26515383|P1|Overall Study|Withdrawal by Subject|1
7620246|NCT01755026|26515382|P2|Overall Study|Adverse Event|0
7620247|NCT01755026|26515383|P1|Overall Study|Adverse Event|1
7620248|NCT01754922|26515406|P2|Overall Study|Adverse Event|1
7620249|NCT01754922|26515407|P1|Overall Study|Adverse Event|0
7620250|NCT01754766|26515433|P3|Overall Study|Personal reasons|0
7620251|NCT01754766|26515434|P2|Overall Study|Personal reasons|1
7620252|NCT01754766|26515435|P1|Overall Study|Personal reasons|1
7620253|NCT01754753|26515451|P2|Overall Study|Lost to Follow-up|5
7620254|NCT01754753|26515452|P1|Overall Study|Lost to Follow-up|9
7620255|NCT01754753|26515451|P2|Overall Study|Study close|44
7620256|NCT01754753|26515452|P1|Overall Study|Study close|43
7620257|NCT01754727|26515470|P1|Overall Study|Adalimumab Treatment was not Documented|2
7620258|NCT01754493|26515602|P1|Overall Study|Scheduling conflict|1
7620259|NCT01754493|26515602|P1|Overall Study|Moved out of town|1
7620260|NCT01754493|26515602|P1|Overall Study|Withdrawal by Subject|1
7620261|NCT01754493|26515602|P1|Overall Study|Lost to Follow-up|3
7620262|NCT01754493|26515602|P1|Overall Study|Adverse Event|1
7620263|NCT01754467|26515627|P1|Overall Study|Lost to Follow-up|1
7620264|NCT01754402|26515637|P3|Overall Study|Lack of Efficacy|1
7620265|NCT01754402|26515638|P2|Overall Study|Lack of Efficacy|0
7620266|NCT01754402|26515639|P1|Overall Study|Lack of Efficacy|0
7620267|NCT01754402|26515637|P3|Overall Study|Withdrawal by Subject|1
7620268|NCT01754402|26515638|P2|Overall Study|Withdrawal by Subject|0
7620269|NCT01754402|26515639|P1|Overall Study|Withdrawal by Subject|0
7620270|NCT01754402|26515637|P3|Overall Study|Adverse Event|1
7620271|NCT01754402|26515638|P2|Overall Study|Adverse Event|2
7620272|NCT01754402|26515639|P1|Overall Study|Adverse Event|2
7620273|NCT01754402|26515637|P3|Overall Study|Death|1
7620274|NCT01754402|26515638|P2|Overall Study|Death|0
7620275|NCT01754402|26515639|P1|Overall Study|Death|0
7620276|NCT01754376|26515673|P1|Overall Study|Lack of Efficacy|2
7620277|NCT01754376|26515673|P1|Overall Study|Adverse Event|1
7620278|NCT01754259|26515693|P2|Overall Study|Lost to Follow-up|1
7620279|NCT01754259|26515694|P1|Overall Study|Lost to Follow-up|0
7620280|NCT01754259|26515693|P2|Overall Study|Adverse Event|1
7620281|NCT01754259|26515694|P1|Overall Study|Adverse Event|3
7620282|NCT01754259|26515693|P2|Overall Study|Withdrawal by Subject|4
7620283|NCT01754259|26515694|P1|Overall Study|Withdrawal by Subject|2
7620284|NCT01754194|26515708|P2|Overall Study|Other|8
7620285|NCT01754194|26515709|P1|Overall Study|Other|9
7620286|NCT01754194|26515708|P2|Overall Study|Withdrawal by Subject|5
7620287|NCT01754194|26515709|P1|Overall Study|Withdrawal by Subject|4
7620288|NCT01754194|26515708|P2|Overall Study|Lost to Follow-up|14
7620289|NCT01754194|26515709|P1|Overall Study|Lost to Follow-up|39
7620290|NCT01754129|26515729|P1|Overall Study|Inclusion/exclusion criteria violation|3
7620291|NCT01754129|26515729|P1|Overall Study|Withdrew consent|1
7620292|NCT01754129|26515729|P1|Overall Study|Lost to Follow-up|7
7620293|NCT01754129|26515729|P1|Overall Study|Duodopa discontinuation|9
7620294|NCT01754129|26515729|P1|Overall Study|Death|13
7620295|NCT01753999|26515752|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
7620296|NCT01753999|26515753|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
7620297|NCT01753999|26515752|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
7620298|NCT01753999|26515753|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
7620299|NCT01753999|26515752|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
7620300|NCT01753999|26515753|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
7620301|NCT01753999|26515752|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
7620302|NCT01753999|26515753|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
7620303|NCT01753999|26515752|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
7620304|NCT01753999|26515753|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
7620305|NCT01753999|26515752|P2|Period 1 - Initial Assignment|Physician Decision|3
7620306|NCT01753999|26515753|P1|Period 1 - Initial Assignment|Physician Decision|2
7620307|NCT01753856|26515771|P2|Overall Study|Sponsor Decision|0
7620308|NCT01753856|26515772|P1|Overall Study|Sponsor Decision|2
7620309|NCT01753856|26515771|P2|Overall Study|Withdrawal by Subject|2
7620310|NCT01753856|26515772|P1|Overall Study|Withdrawal by Subject|0
7620311|NCT01753856|26515771|P2|Overall Study|Adverse Event|0
7620312|NCT01753856|26515772|P1|Overall Study|Adverse Event|1
7620313|NCT01753570|26515884|P3|Overall Study|Withdrawal by Subject|0
7620314|NCT01753570|26515885|P2|Overall Study|Withdrawal by Subject|4
7620315|NCT01753570|26515886|P1|Overall Study|Withdrawal by Subject|1
7620316|NCT01753570|26515884|P3|Overall Study|Physician Decision|0
7620317|NCT01753570|26515885|P2|Overall Study|Physician Decision|1
7620318|NCT01753570|26515886|P1|Overall Study|Physician Decision|0
7620319|NCT01753570|26515884|P3|Overall Study|Adverse Event|1
7620320|NCT01753570|26515885|P2|Overall Study|Adverse Event|0
7620321|NCT01753570|26515886|P1|Overall Study|Adverse Event|1
7620322|NCT01753518|26515929|P2|Postpartum Follow-up|Lost to Follow-up|15
7620323|NCT01753518|26515930|P1|Postpartum Follow-up|Lost to Follow-up|22
7620324|NCT01753518|26515929|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
7620325|NCT01753518|26515930|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
7620326|NCT01753518|26515929|P2|Intention-to-Treat Analysis|Multifetal gestation|3
7620327|NCT01753518|26515930|P1|Intention-to-Treat Analysis|Multifetal gestation|2
7620328|NCT01753518|26515929|P2|Intention-to-Treat Analysis|Missing consent form|3
7620329|NCT01753518|26515930|P1|Intention-to-Treat Analysis|Missing consent form|5
7620330|NCT01753401|26515954|P4|Open Label Period (44 Weeks)|Reason not provided|2
7620331|NCT01753401|26515955|P3|Open Label Period (44 Weeks)|Reason not provided|0
7620332|NCT01753401|26515956|P2|Open Label Period (44 Weeks)|Reason not provided|0
7620333|NCT01753401|26515957|P1|Open Label Period (44 Weeks)|Reason not provided|0
7620334|NCT01753401|26515954|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
7620335|NCT01753401|26515955|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
7620336|NCT01753401|26515956|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
7620337|NCT01753401|26515957|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
7620338|NCT01753401|26515954|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
7620339|NCT01753401|26515955|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7620340|NCT01753401|26515956|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7620341|NCT01753401|26515957|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7620342|NCT01753401|26515954|P4|Open Label Period (44 Weeks)|Adverse Event|4
7620343|NCT01753401|26515955|P3|Open Label Period (44 Weeks)|Adverse Event|3
7620344|NCT01753401|26515956|P2|Open Label Period (44 Weeks)|Adverse Event|0
7620345|NCT01753401|26515957|P1|Open Label Period (44 Weeks)|Adverse Event|0
7620346|NCT01753401|26515954|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
7620347|NCT01753401|26515955|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
7620348|NCT01753401|26515956|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
7620349|NCT01753401|26515957|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
7620350|NCT01753401|26515954|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7620351|NCT01753401|26515955|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7620352|NCT01753401|26515956|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7620353|NCT01753401|26515957|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7620354|NCT01753401|26515954|P4|Double-blind Period (8 Weeks)|Adverse Event|0
7620355|NCT01753401|26515955|P3|Double-blind Period (8 Weeks)|Adverse Event|0
7620356|NCT01753401|26515956|P2|Double-blind Period (8 Weeks)|Adverse Event|2
7620357|NCT01753401|26515957|P1|Double-blind Period (8 Weeks)|Adverse Event|0
7620358|NCT01753336|26516016|P1|Overall Study|Withdrawal by Subject|1
7620359|NCT01753336|26516016|P1|Overall Study|Sponsor's decision|2
7620360|NCT01753336|26516016|P1|Overall Study|Physician Decision|2
7620361|NCT01753336|26516016|P1|Overall Study|Lost to Follow-up|3
7620362|NCT01753336|26516016|P1|Overall Study|Patient decision|12
7620363|NCT01753323|26516028|P3|Overall Study|Adverse Event|1
7620364|NCT01753323|26516029|P2|Overall Study|Adverse Event|0
7620365|NCT01753323|26516030|P1|Overall Study|Adverse Event|0
7620366|NCT01753323|26516028|P3|Overall Study|Protocol deviation|0
7620367|NCT01753323|26516029|P2|Overall Study|Protocol deviation|0
7620368|NCT01753323|26516030|P1|Overall Study|Protocol deviation|1
7620369|NCT01753323|26516028|P3|Overall Study|Lack of Efficacy|8
7620370|NCT01753323|26516029|P2|Overall Study|Lack of Efficacy|0
7620371|NCT01753323|26516030|P1|Overall Study|Lack of Efficacy|0
7620372|NCT01753310|26516068|P2|Overall Study|Withdrawal by Subject|0
7620373|NCT01753310|26516069|P1|Overall Study|Withdrawal by Subject|1
7620374|NCT01753310|26516068|P2|Overall Study|Sponsor decision|0
7620375|NCT01753310|26516069|P1|Overall Study|Sponsor decision|1
7620376|NCT01753310|26516068|P2|Overall Study|Subject decision|2
7620377|NCT01753310|26516069|P1|Overall Study|Subject decision|2
7620378|NCT01753310|26516068|P2|Overall Study|Lost to Follow-up|0
7620379|NCT01753310|26516069|P1|Overall Study|Lost to Follow-up|2
7620380|NCT01753310|26516068|P2|Overall Study|Adverse Event|0
7620381|NCT01753310|26516069|P1|Overall Study|Adverse Event|1
7620382|NCT01753310|26516068|P2|Overall Study|Entered into open label extension study|22
7620383|NCT01753310|26516069|P1|Overall Study|Entered into open label extension study|25
7620384|NCT01753297|26516091|P2|Overall Study|Did not attend end of study visit|8
7620385|NCT01753297|26516092|P1|Overall Study|Did not attend end of study visit|7
7620386|NCT01753297|26516091|P2|Overall Study|Death|2
7620387|NCT01753297|26516092|P1|Overall Study|Death|0
7620388|NCT01753297|26516091|P2|Overall Study|Adverse Event (up to Month 36)|1
7620389|NCT01753297|26516092|P1|Overall Study|Adverse Event (up to Month 36)|1
7620390|NCT01753297|26516091|P2|Overall Study|Withdrawal by Subject|23
7620391|NCT01753297|26516092|P1|Overall Study|Withdrawal by Subject|26
7620392|NCT01753297|26516091|P2|Overall Study|Lost to Follow-up|2
7620393|NCT01753297|26516092|P1|Overall Study|Lost to Follow-up|7
7620394|NCT01753193|26516124|P1|Overall Study|Other|16
7620395|NCT01753193|26516124|P1|Overall Study|Death|1
7620396|NCT01753193|26516124|P1|Overall Study|Lost to Follow-up|6
7620397|NCT01753193|26516124|P1|Overall Study|Withdrawal by Subject|23
7620398|NCT01753115|26516139|P3|Overall Study|Used excluded drug|0
7620399|NCT01753115|26516140|P2|Overall Study|Used excluded drug|1
7620400|NCT01753115|26516141|P1|Overall Study|Used excluded drug|0
7620401|NCT01753115|26516139|P3|Overall Study|Subject non-compliant|0
7620402|NCT01753115|26516140|P2|Overall Study|Subject non-compliant|3
7620403|NCT01753115|26516141|P1|Overall Study|Subject non-compliant|3
7620404|NCT01753115|26516139|P3|Overall Study|Withdrawal by Subject|6
7620405|NCT01753115|26516140|P2|Overall Study|Withdrawal by Subject|5
7620406|NCT01753115|26516141|P1|Overall Study|Withdrawal by Subject|6
7620407|NCT01753115|26516139|P3|Overall Study|Lost to Follow-up|8
7620408|NCT01753115|26516140|P2|Overall Study|Lost to Follow-up|6
7620409|NCT01753115|26516141|P1|Overall Study|Lost to Follow-up|3
7620410|NCT01753076|26516151|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
7620411|NCT01753076|26516152|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
7620412|NCT01753076|26516151|P2|Overall Study|Withdrawal by Subject|24
7620413|NCT01753076|26516152|P1|Overall Study|Withdrawal by Subject|14
7620414|NCT01753076|26516151|P2|Overall Study|Physician Decision|2
7620415|NCT01753076|26516152|P1|Overall Study|Physician Decision|4
7620416|NCT01753076|26516151|P2|Overall Study|Lost to Follow-up|1
7620417|NCT01753076|26516152|P1|Overall Study|Lost to Follow-up|2
7620418|NCT01753076|26516151|P2|Overall Study|Lack of Efficacy|1
7620419|NCT01753076|26516152|P1|Overall Study|Lack of Efficacy|3
7620420|NCT01753076|26516151|P2|Overall Study|Adverse Event|18
7620421|NCT01753076|26516152|P1|Overall Study|Adverse Event|17
7620422|NCT01752985|26516179|P3|Treatment Period|Lost to Follow-up|1
7620423|NCT01752985|26516180|P2|Treatment Period|Lost to Follow-up|0
7620424|NCT01752985|26516181|P1|Treatment Period|Lost to Follow-up|0
7620425|NCT01752985|26516179|P3|Treatment Period|Withdrawal by Subject|0
7620426|NCT01752985|26516180|P2|Treatment Period|Withdrawal by Subject|1
7620427|NCT01752985|26516181|P1|Treatment Period|Withdrawal by Subject|1
7620428|NCT01752985|26516179|P3|Treatment Period|Adverse Event|2
7620429|NCT01752985|26516180|P2|Treatment Period|Adverse Event|1
7620430|NCT01752985|26516181|P1|Treatment Period|Adverse Event|2
7620431|NCT01752985|26516179|P3|Treatment Period|Subject no longer meets study criteria|1
7620432|NCT01752985|26516180|P2|Treatment Period|Subject no longer meets study criteria|1
7620433|NCT01752985|26516181|P1|Treatment Period|Subject no longer meets study criteria|0
7620434|NCT01752985|26516179|P3|Treatment Period|Subject request to discontinue treatment|1
7620435|NCT01752985|26516180|P2|Treatment Period|Subject request to discontinue treatment|0
7620436|NCT01752985|26516181|P1|Treatment Period|Subject request to discontinue treatment|1
7620437|NCT01752933|26516209|P2|Overall Study and Follow-up|Lost to Follow-up|2
7620438|NCT01752933|26516210|P1|Overall Study and Follow-up|Lost to Follow-up|0
7620439|NCT01752933|26516209|P2|Overall Study and Follow-up|Withdrawal by Subject|3
7620440|NCT01752933|26516210|P1|Overall Study and Follow-up|Withdrawal by Subject|0
7620441|NCT01752933|26516209|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
7620442|NCT01752933|26516210|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
7620443|NCT01752933|26516209|P2|Overall Study and Follow-up|Death|34
7620444|NCT01752933|26516210|P1|Overall Study and Follow-up|Death|4
7620445|NCT01752933|26516209|P2|Treatment|Patient unable to travel to appointments|1
7620446|NCT01752933|26516210|P1|Treatment|Patient unable to travel to appointments|0
7620447|NCT01752933|26516209|P2|Treatment|Patient noncompliant|1
7620448|NCT01752933|26516210|P1|Treatment|Patient noncompliant|0
7620449|NCT01752933|26516209|P2|Treatment|Hepatocellular carcinoma not confirmed|1
7620450|NCT01752933|26516210|P1|Treatment|Hepatocellular carcinoma not confirmed|0
7620451|NCT01752933|26516209|P2|Treatment|Death|2
7620452|NCT01752933|26516210|P1|Treatment|Death|0
7620453|NCT01752933|26516209|P2|Treatment|Physician Decision|3
7620454|NCT01752933|26516210|P1|Treatment|Physician Decision|0
7620455|NCT01752933|26516209|P2|Treatment|Adverse Event|4
7620456|NCT01752933|26516210|P1|Treatment|Adverse Event|1
7620457|NCT01752933|26516209|P2|Treatment|Withdrawal by Subject|5
7620458|NCT01752933|26516210|P1|Treatment|Withdrawal by Subject|0
7620459|NCT01752933|26516209|P2|Treatment|Disease Progression|29
7620460|NCT01752933|26516210|P1|Treatment|Disease Progression|3
7620461|NCT01752907|26516228|P2|Overall Study|Decision by Sponsor|9
7620462|NCT01752907|26516229|P1|Overall Study|Decision by Sponsor|6
7620463|NCT01752907|26516228|P2|Overall Study|Lost to Follow-up|1
7620464|NCT01752907|26516229|P1|Overall Study|Lost to Follow-up|2
7620465|NCT01752907|26516228|P2|Overall Study|Withdrawal by Subject|10
7620466|NCT01752907|26516229|P1|Overall Study|Withdrawal by Subject|4
7620467|NCT01752855|26516249|P2|Overall Study|Lack of Efficacy|2
7620468|NCT01752855|26516250|P1|Overall Study|Lack of Efficacy|0
7620469|NCT01752855|26516249|P2|Overall Study|Withdrew Consent|2
7620470|NCT01752855|26516250|P1|Overall Study|Withdrew Consent|0
7620471|NCT01752855|26516249|P2|Overall Study|Adverse Event|0
7620472|NCT01752855|26516250|P1|Overall Study|Adverse Event|1
7620473|NCT01752842|26516266|P2|Overall Study|Withdrawal by Subject|2
7620474|NCT01752842|26516267|P1|Overall Study|Withdrawal by Subject|0
7620475|NCT01752842|26516266|P2|Overall Study|Adverse Event|0
7620476|NCT01752842|26516267|P1|Overall Study|Adverse Event|3
7620477|NCT01752634|26516302|P6|Week 24 to Week 260|Adverse Event|0
7620478|NCT01752634|26516303|P5|Week 24 to Week 260|Adverse Event|2
7620479|NCT01752634|26516304|P4|Week 24 to Week 260|Adverse Event|4
7620480|NCT01752634|26516305|P3|Week 24 to Week 260|Adverse Event|8
7620481|NCT01752634|26516306|P2|Week 24 to Week 260|Adverse Event|8
7620482|NCT01752634|26516307|P1|Week 24 to Week 260|Adverse Event|4
7620483|NCT01752634|26516302|P6|Week 24 to Week 260|Lost to Follow-up|0
7620484|NCT01752634|26516303|P5|Week 24 to Week 260|Lost to Follow-up|2
7620485|NCT01752634|26516304|P4|Week 24 to Week 260|Lost to Follow-up|0
7620486|NCT01752634|26516305|P3|Week 24 to Week 260|Lost to Follow-up|3
7620487|NCT01752634|26516306|P2|Week 24 to Week 260|Lost to Follow-up|2
7620488|NCT01752634|26516307|P1|Week 24 to Week 260|Lost to Follow-up|2
7620489|NCT01752634|26516302|P6|Week 24 to Week 260|Noncompliance with study treatment|0
7620490|NCT01752634|26516303|P5|Week 24 to Week 260|Noncompliance with study treatment|0
7620491|NCT01752634|26516304|P4|Week 24 to Week 260|Noncompliance with study treatment|0
7620492|NCT01752634|26516305|P3|Week 24 to Week 260|Noncompliance with study treatment|1
7620493|NCT01752634|26516306|P2|Week 24 to Week 260|Noncompliance with study treatment|0
7620494|NCT01752634|26516307|P1|Week 24 to Week 260|Noncompliance with study treatment|0
7620495|NCT01752634|26516302|P6|Week 24 to Week 260|Pregnancy|0
7620496|NCT01752634|26516303|P5|Week 24 to Week 260|Pregnancy|0
7620497|NCT01752634|26516304|P4|Week 24 to Week 260|Pregnancy|0
7620498|NCT01752634|26516305|P3|Week 24 to Week 260|Pregnancy|1
7620499|NCT01752634|26516306|P2|Week 24 to Week 260|Pregnancy|0
7620500|NCT01752634|26516307|P1|Week 24 to Week 260|Pregnancy|0
7620501|NCT01752634|26516302|P6|Week 24 to Week 260|Death|0
7620502|NCT01752634|26516303|P5|Week 24 to Week 260|Death|0
7620503|NCT01752634|26516304|P4|Week 24 to Week 260|Death|0
7620504|NCT01752634|26516305|P3|Week 24 to Week 260|Death|0
7620505|NCT01752634|26516306|P2|Week 24 to Week 260|Death|1
7620506|NCT01752634|26516307|P1|Week 24 to Week 260|Death|0
7620507|NCT01752634|26516302|P6|Week 24 to Week 260|Physician Decision|0
7620508|NCT01752634|26516303|P5|Week 24 to Week 260|Physician Decision|1
7620509|NCT01752634|26516304|P4|Week 24 to Week 260|Physician Decision|2
7620510|NCT01752634|26516305|P3|Week 24 to Week 260|Physician Decision|4
7620511|NCT01752634|26516306|P2|Week 24 to Week 260|Physician Decision|2
7620512|NCT01752634|26516307|P1|Week 24 to Week 260|Physician Decision|1
7620513|NCT01752634|26516302|P6|Week 24 to Week 260|Subject/guardian decision|0
7620514|NCT01752634|26516303|P5|Week 24 to Week 260|Subject/guardian decision|5
7620515|NCT01752634|26516304|P4|Week 24 to Week 260|Subject/guardian decision|5
7620516|NCT01752634|26516305|P3|Week 24 to Week 260|Subject/guardian decision|9
7620517|NCT01752634|26516306|P2|Week 24 to Week 260|Subject/guardian decision|10
7620518|NCT01752634|26516307|P1|Week 24 to Week 260|Subject/guardian decision|12
7620519|NCT01752634|26516302|P6|Week 24 to Week 260|Lack of Efficacy|0
7620520|NCT01752634|26516303|P5|Week 24 to Week 260|Lack of Efficacy|4
7620521|NCT01752634|26516304|P4|Week 24 to Week 260|Lack of Efficacy|3
7620522|NCT01752634|26516305|P3|Week 24 to Week 260|Lack of Efficacy|7
7620523|NCT01752634|26516306|P2|Week 24 to Week 260|Lack of Efficacy|7
7620524|NCT01752634|26516307|P1|Week 24 to Week 260|Lack of Efficacy|15
7620525|NCT01752634|26516302|P6|Up to Week 24 (Primary Analysis)|Adverse Event|4
7620526|NCT01752634|26516303|P5|Up to Week 24 (Primary Analysis)|Adverse Event|0
7620527|NCT01752634|26516304|P4|Up to Week 24 (Primary Analysis)|Adverse Event|0
7620528|NCT01752634|26516305|P3|Up to Week 24 (Primary Analysis)|Adverse Event|2
7620529|NCT01752634|26516306|P2|Up to Week 24 (Primary Analysis)|Adverse Event|0
7620530|NCT01752634|26516307|P1|Up to Week 24 (Primary Analysis)|Adverse Event|3
7620531|NCT01752634|26516302|P6|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7620532|NCT01752634|26516303|P5|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7620533|NCT01752634|26516304|P4|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7620534|NCT01752634|26516305|P3|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7620535|NCT01752634|26516306|P2|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7620536|NCT01752634|26516307|P1|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
7620537|NCT01752634|26516302|P6|Up to Week 24 (Primary Analysis)|Physician Decision|0
7620538|NCT01752634|26516303|P5|Up to Week 24 (Primary Analysis)|Physician Decision|0
7620539|NCT01752634|26516304|P4|Up to Week 24 (Primary Analysis)|Physician Decision|0
7620540|NCT01752634|26516305|P3|Up to Week 24 (Primary Analysis)|Physician Decision|0
7620541|NCT01752634|26516306|P2|Up to Week 24 (Primary Analysis)|Physician Decision|1
7620542|NCT01752634|26516307|P1|Up to Week 24 (Primary Analysis)|Physician Decision|0
7620543|NCT01752634|26516302|P6|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
7620544|NCT01752634|26516303|P5|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7620545|NCT01752634|26516304|P4|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7620546|NCT01752634|26516305|P3|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7620547|NCT01752634|26516306|P2|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7620548|NCT01752634|26516307|P1|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7620549|NCT01752036|26516376|P1|Overall Study|Death|2
7620550|NCT01752023|26516389|P2|Overall Study|Physician Decision|1
7620551|NCT01752023|26516390|P1|Overall Study|Physician Decision|2
7620552|NCT01751906|26516426|P2|Overall Study|Denied on premises for follow-up by law|0
7620553|NCT01751906|26516427|P1|Overall Study|Denied on premises for follow-up by law|1
7620554|NCT01751906|26516426|P2|Overall Study|Death|43
7620555|NCT01751906|26516427|P1|Overall Study|Death|84
7620556|NCT01751906|26516426|P2|Overall Study|Physician Decision|2
7620557|NCT01751906|26516427|P1|Overall Study|Physician Decision|5
7620558|NCT01751906|26516426|P2|Overall Study|Withdrawal by Subject|18
7620559|NCT01751906|26516427|P1|Overall Study|Withdrawal by Subject|22
7620560|NCT01751906|26516426|P2|Overall Study|Lost to Follow-up|68
7620561|NCT01751906|26516427|P1|Overall Study|Lost to Follow-up|151
7620562|NCT01751867|26516537|P2|Overall Study|Randomized but not treated.|1
7620563|NCT01751867|26516538|P1|Overall Study|Randomized but not treated.|2
7620564|NCT01751867|26516537|P2|Overall Study|Other|37
7620565|NCT01751867|26516538|P1|Overall Study|Other|11
7620566|NCT01751867|26516537|P2|Overall Study|Death|5
7620567|NCT01751867|26516538|P1|Overall Study|Death|0
7620568|NCT01751867|26516537|P2|Overall Study|Protocol Violation|2
7620569|NCT01751867|26516538|P1|Overall Study|Protocol Violation|0
7620570|NCT01751867|26516537|P2|Overall Study|Physician Decision|7
7620571|NCT01751867|26516538|P1|Overall Study|Physician Decision|4
7620572|NCT01751867|26516537|P2|Overall Study|Withdrawal by Subject|1
7620573|NCT01751867|26516538|P1|Overall Study|Withdrawal by Subject|3
7620574|NCT01751867|26516537|P2|Overall Study|Poor Compliance|5
7620575|NCT01751867|26516538|P1|Overall Study|Poor Compliance|0
7620576|NCT01751867|26516537|P2|Overall Study|Adverse Event|15
7620577|NCT01751867|26516538|P1|Overall Study|Adverse Event|8
7620578|NCT01751867|26516537|P2|Overall Study|Diease Progression|18
7620579|NCT01751867|26516538|P1|Overall Study|Diease Progression|4
7620580|NCT01751867|26516537|P2|Overall Study|Completed treatment,dropped in follow-up|8
7620581|NCT01751867|26516538|P1|Overall Study|Completed treatment,dropped in follow-up|4
7620582|NCT01751802|26516558|P2|Overall Study|Adverse Event|2
7620583|NCT01751802|26516559|P1|Overall Study|Adverse Event|4
7620584|NCT01751724|26516573|P2|Overall Study|withdrawn by parent|2
7620585|NCT01751724|26516574|P1|Overall Study|withdrawn by parent|0
7620586|NCT01751724|26516573|P2|Overall Study|extubated bef.start assigned treatment|0
7620587|NCT01751724|26516574|P1|Overall Study|extubated bef.start assigned treatment|1
7620588|NCT01751646|26516602|P2|Overall Study|Childcare issues|1
7620589|NCT01751646|26516603|P1|Overall Study|Childcare issues|1
7620590|NCT01751646|26516602|P2|Overall Study|Fails to comply with study requirements|1
7620591|NCT01751646|26516603|P1|Overall Study|Fails to comply with study requirements|0
7620592|NCT01751646|26516602|P2|Overall Study|Off study due to multiple obligations|1
7620593|NCT01751646|26516603|P1|Overall Study|Off study due to multiple obligations|0
7620594|NCT01751646|26516602|P2|Overall Study|Inability to attend required visits|1
7620595|NCT01751646|26516603|P1|Overall Study|Inability to attend required visits|0
7620596|NCT01751646|26516602|P2|Overall Study|Moved out of the area|5
7620597|NCT01751646|26516603|P1|Overall Study|Moved out of the area|1
7620598|NCT01751646|26516602|P2|Overall Study|Inadvertent enrollment|1
7620599|NCT01751646|26516603|P1|Overall Study|Inadvertent enrollment|1
7620600|NCT01751646|26516602|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
7620601|NCT01751646|26516603|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
7620602|NCT01751646|26516602|P2|Overall Study|Starting hormone therapy|0
7620603|NCT01751646|26516603|P1|Overall Study|Starting hormone therapy|1
7620604|NCT01751646|26516602|P2|Overall Study|Withdrawal by Subject|4
7620605|NCT01751646|26516603|P1|Overall Study|Withdrawal by Subject|0
7620606|NCT01751646|26516602|P2|Overall Study|Lost to Follow-up|1
7620607|NCT01751646|26516603|P1|Overall Study|Lost to Follow-up|5
7620608|NCT01751568|26516754|P3|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7620609|NCT01751568|26516755|P2|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7620610|NCT01751568|26516756|P1|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
7620611|NCT01751412|26516785|P1|Overall Study|Disease Progression Before Treatment|1
7620612|NCT01751178|26516895|P3|Overall Study|Other Reason (unknown)|2
7620613|NCT01751178|26516896|P2|Overall Study|Other Reason (unknown)|0
7620614|NCT01751178|26516897|P1|Overall Study|Other Reason (unknown)|1
7620615|NCT01751178|26516895|P3|Overall Study|Adverse Event|0
7620616|NCT01751178|26516896|P2|Overall Study|Adverse Event|0
7620617|NCT01751178|26516897|P1|Overall Study|Adverse Event|2
7620618|NCT01751165|26516917|P3|Overall Study|Lost to Follow-up|1
7620619|NCT01751165|26516918|P2|Overall Study|Lost to Follow-up|1
7620620|NCT01751165|26516919|P1|Overall Study|Lost to Follow-up|1
7620621|NCT01751165|26516917|P3|Overall Study|Serious adverse event|0
7620622|NCT01751165|26516918|P2|Overall Study|Serious adverse event|2
7620623|NCT01751165|26516919|P1|Overall Study|Serious adverse event|0
7620624|NCT01751165|26516917|P3|Overall Study|Withdrawal by Subject|1
7620625|NCT01751165|26516918|P2|Overall Study|Withdrawal by Subject|0
7620626|NCT01751165|26516919|P1|Overall Study|Withdrawal by Subject|0
7620627|NCT01751165|26516917|P3|Overall Study|Adverse event, serious fatal|1
7620628|NCT01751165|26516918|P2|Overall Study|Adverse event, serious fatal|0
7620629|NCT01751165|26516919|P1|Overall Study|Adverse event, serious fatal|1
7620630|NCT01751139|26516959|P1|Overall Study|Death|31
7620631|NCT01751139|26516959|P1|Overall Study|Adverse Event|1
7620632|NCT01751139|26516959|P1|Overall Study|Withdrawal by Subject|251
7620633|NCT01751139|26516959|P1|Overall Study|Lost to Follow-up|240
7620634|NCT01751139|26516959|P1|Overall Study|Sponsor study termination|1609
7620635|NCT01751139|26516959|P1|Overall Study|Other|135
7620636|NCT01751113|26516977|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
7620637|NCT01751113|26516978|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
7620638|NCT01751113|26516979|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
7620639|NCT01751113|26516980|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
7620640|NCT01751113|26516981|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
7620641|NCT01751113|26516982|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
7620642|NCT01751113|26516977|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
7620643|NCT01751113|26516978|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
7620644|NCT01751113|26516979|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
7620645|NCT01751113|26516980|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
7620646|NCT01751113|26516981|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
7620647|NCT01751113|26516982|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
7620648|NCT01751087|26517023|P3|Overall Study|Physician Decision|1
7620649|NCT01751087|26517024|P2|Overall Study|Physician Decision|0
7620650|NCT01751087|26517025|P1|Overall Study|Physician Decision|0
7620651|NCT01751087|26517023|P3|Overall Study|Withdrawal by Subject|0
7620652|NCT01751087|26517024|P2|Overall Study|Withdrawal by Subject|0
7620653|NCT01751087|26517025|P1|Overall Study|Withdrawal by Subject|1
7620654|NCT01751061|26517059|P2|Overall Study|Physician Decision|0
7620655|NCT01751061|26517060|P1|Overall Study|Physician Decision|2
7620656|NCT01751061|26517059|P2|Overall Study|Withdrawal by Subject|1
7620657|NCT01751061|26517060|P1|Overall Study|Withdrawal by Subject|4
7620658|NCT01751061|26517059|P2|Overall Study|patient regained decisional capacity|8
7620659|NCT01751061|26517060|P1|Overall Study|patient regained decisional capacity|4
7620660|NCT01751061|26517059|P2|Overall Study|Lost to Follow-up|25
7620661|NCT01751061|26517060|P1|Overall Study|Lost to Follow-up|40
7620662|NCT01751061|26517059|P2|Overall Study|patient death|0
7620663|NCT01751061|26517060|P1|Overall Study|patient death|5
7620664|NCT01751061|26517059|P2|Overall Study|Death|0
7620665|NCT01751061|26517060|P1|Overall Study|Death|1
7620666|NCT01750879|26517136|P2|Overall Study|Did not complete per protocol|3
7620667|NCT01750879|26517137|P1|Overall Study|Did not complete per protocol|0
7620668|NCT01750879|26517136|P2|Overall Study|Withdrawal by Subject|0
7620669|NCT01750879|26517137|P1|Overall Study|Withdrawal by Subject|1
7620670|NCT01750879|26517136|P2|Overall Study|Lack of Efficacy|0
7620671|NCT01750879|26517137|P1|Overall Study|Lack of Efficacy|1
7620672|NCT01750879|26517136|P2|Overall Study|Adverse Event|0
7620673|NCT01750879|26517137|P1|Overall Study|Adverse Event|8
7620674|NCT01750840|26517163|P1|Overall Study|Lost to Follow-up|4
7620675|NCT01750697|26517168|P1|Overall Study|Withdrawal by Subject|1
7620676|NCT01750697|26517168|P1|Overall Study|Physician Decision|1
7620677|NCT01750697|26517168|P1|Overall Study|Transferred to Adult Services|5
7620678|NCT01750697|26517168|P1|Overall Study|Physician and Family Decision|1
7620679|NCT01750697|26517168|P1|Overall Study|Transferred Back to Local Hospital|1
7620680|NCT01750684|26517180|P2|Overall Study|Protocol Violation|0
7620681|NCT01750684|26517181|P1|Overall Study|Protocol Violation|1
7620682|NCT01750684|26517180|P2|Overall Study|Withdrawn by Sponsor|1
7620683|NCT01750684|26517181|P1|Overall Study|Withdrawn by Sponsor|0
7620684|NCT01750684|26517180|P2|Overall Study|Non-compliance with Study Drug|1
7620685|NCT01750684|26517181|P1|Overall Study|Non-compliance with Study Drug|0
7620686|NCT01750684|26517180|P2|Overall Study|Death|0
7620687|NCT01750684|26517181|P1|Overall Study|Death|1
7620688|NCT01750346|26517218|P3|Overall Study|Adverse Event|0
7620689|NCT01750346|26517219|P2|Overall Study|Adverse Event|0
7620690|NCT01750346|26517220|P1|Overall Study|Adverse Event|1
7620691|NCT01750294|26517246|P1|Overall Study|Safety Endpoint|1
7620692|NCT01750294|26517246|P1|Overall Study|Withdrawal by Subject|1
7620693|NCT01750281|26517253|P3|Overall Study|Did not receive treatment|0
7620694|NCT01750281|26517254|P2|Overall Study|Did not receive treatment|1
7620695|NCT01750281|26517255|P1|Overall Study|Did not receive treatment|0
7620696|NCT01750281|26517253|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
7620697|NCT01750281|26517254|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
7620698|NCT01750281|26517255|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
7620699|NCT01750281|26517253|P3|Overall Study|Discontinued Selumetinib/Placebo|75
7620700|NCT01750281|26517254|P2|Overall Study|Discontinued Selumetinib/Placebo|77
7620701|NCT01750281|26517255|P1|Overall Study|Discontinued Selumetinib/Placebo|37
7620702|NCT01750268|26517268|P2|Overall Study|Withdrawal by Subject|0
7620703|NCT01750268|26517269|P1|Overall Study|Withdrawal by Subject|2
7620704|NCT01750268|26517268|P2|Overall Study|Physician Decision|3
7620705|NCT01750268|26517269|P1|Overall Study|Physician Decision|0
7620706|NCT01750268|26517268|P2|Overall Study|Lost to Follow-up|2
7620707|NCT01750268|26517269|P1|Overall Study|Lost to Follow-up|0
7620708|NCT01750242|26517296|P1|Overall Study|Unreadable Images|3
7620709|NCT01750229|26517301|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
7620710|NCT01750229|26517301|P1|Long-term Follow-up Phase|Adverse Event|2
7620711|NCT01750229|26517301|P1|Randomized Crossover Phase|Withdrawal by Subject|1
7620712|NCT01750229|26517301|P1|Randomized Crossover Phase|Adverse Event|1
7620713|NCT01750190|26517313|P2|Overall Study|Other than Specified|4
7620714|NCT01750190|26517314|P1|Overall Study|Other than Specified|13
7620715|NCT01750190|26517313|P2|Overall Study|Dialysis|8
7620716|NCT01750190|26517314|P1|Overall Study|Dialysis|22
7620717|NCT01750190|26517313|P2|Overall Study|Kidney Transplant|4
7620718|NCT01750190|26517314|P1|Overall Study|Kidney Transplant|8
7620719|NCT01750190|26517313|P2|Overall Study|Withdrawal by Subject|89
7620720|NCT01750190|26517314|P1|Overall Study|Withdrawal by Subject|83
7620721|NCT01750190|26517313|P2|Overall Study|Study/Site Terminated by Sponsor|1
7620722|NCT01750190|26517314|P1|Overall Study|Study/Site Terminated by Sponsor|4
7620723|NCT01750190|26517313|P2|Overall Study|Protocol Violation|5
7620724|NCT01750190|26517314|P1|Overall Study|Protocol Violation|6
7620725|NCT01750190|26517313|P2|Overall Study|Physician Decision|17
7620726|NCT01750190|26517314|P1|Overall Study|Physician Decision|16
7620727|NCT01750190|26517313|P2|Overall Study|Lost to Follow-up|7
7620728|NCT01750190|26517314|P1|Overall Study|Lost to Follow-up|28
7620729|NCT01750190|26517313|P2|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
7620730|NCT01750190|26517314|P1|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
7620731|NCT01750190|26517313|P2|Overall Study|Death|11
7620732|NCT01750190|26517314|P1|Overall Study|Death|38
7620733|NCT01750190|26517313|P2|Overall Study|Adverse Event|19
7620734|NCT01750190|26517314|P1|Overall Study|Adverse Event|47
7620735|NCT01749982|26517359|P4|Overall Study|Withdrawal by Subject|1
7620736|NCT01749982|26517360|P3|Overall Study|Withdrawal by Subject|0
7620737|NCT01749982|26517361|P2|Overall Study|Withdrawal by Subject|0
7620738|NCT01749982|26517362|P1|Overall Study|Withdrawal by Subject|0
7620739|NCT01749982|26517359|P4|Overall Study|Lost to Follow-up|1
7620740|NCT01749982|26517360|P3|Overall Study|Lost to Follow-up|0
7620741|NCT01749982|26517361|P2|Overall Study|Lost to Follow-up|0
7620742|NCT01749982|26517362|P1|Overall Study|Lost to Follow-up|0
7620743|NCT01749982|26517359|P4|Overall Study|Physician Decision|1
7620744|NCT01749982|26517360|P3|Overall Study|Physician Decision|0
7620745|NCT01749982|26517361|P2|Overall Study|Physician Decision|0
7620746|NCT01749982|26517362|P1|Overall Study|Physician Decision|0
7620747|NCT01749826|26517426|P2|Overall Study|Study Terminated|0
7620748|NCT01749826|26517427|P1|Overall Study|Study Terminated|20
7620749|NCT01749800|26517442|P3|Overall Study|Withdrawal by Subject|0
7620750|NCT01749800|26517443|P2|Overall Study|Withdrawal by Subject|1
7620751|NCT01749800|26517444|P1|Overall Study|Withdrawal by Subject|0
7620752|NCT01749800|26517442|P3|Overall Study|not meeting inclusion criteria|0
7620753|NCT01749800|26517443|P2|Overall Study|not meeting inclusion criteria|0
7620754|NCT01749800|26517444|P1|Overall Study|not meeting inclusion criteria|3
7620755|NCT01749735|26517454|P2|Overall Study|Withdrawal by Subject|0
7620756|NCT01749735|26517455|P1|Overall Study|Withdrawal by Subject|1
7620757|NCT01749033|26517523|P3|Overall Study|Lost to Follow-up|1
7620758|NCT01749033|26517524|P2|Overall Study|Lost to Follow-up|2
7620759|NCT01749033|26517525|P1|Overall Study|Lost to Follow-up|0
7620760|NCT01749033|26517523|P3|Overall Study|Did not receive allocated intervention|0
7620761|NCT01749033|26517524|P2|Overall Study|Did not receive allocated intervention|3
7620762|NCT01749033|26517525|P1|Overall Study|Did not receive allocated intervention|3
7620763|NCT01748994|26517550|P2|Overall Study|Lost to Follow-up|6
7620764|NCT01748994|26517551|P1|Overall Study|Lost to Follow-up|8
7620765|NCT01748890|26517610|P1|Overall Study|Insufficient recruitment for analysis|4
7620766|NCT01748825|26517624|P10|Dose Expansion|Physician Decision|0
7620767|NCT01748825|26517625|P9|Dose Expansion|Physician Decision|1
7620768|NCT01748825|26517626|P8|Dose Expansion|Physician Decision|0
7620769|NCT01748825|26517627|P7|Dose Expansion|Physician Decision|0
7620770|NCT01748825|26517628|P6|Dose Expansion|Physician Decision|0
7620771|NCT01748825|26517629|P5|Dose Expansion|Physician Decision|0
7620772|NCT01748825|26517630|P4|Dose Expansion|Physician Decision|0
7620773|NCT01748825|26517631|P3|Dose Expansion|Physician Decision|0
7620774|NCT01748825|26517632|P2|Dose Expansion|Physician Decision|0
7620775|NCT01748825|26517633|P1|Dose Expansion|Physician Decision|0
7620776|NCT01748825|26517624|P10|Dose Expansion|Adverse Event|3
7620777|NCT01748825|26517625|P9|Dose Expansion|Adverse Event|0
7620778|NCT01748825|26517626|P8|Dose Expansion|Adverse Event|0
7620779|NCT01748825|26517627|P7|Dose Expansion|Adverse Event|0
7620780|NCT01748825|26517628|P6|Dose Expansion|Adverse Event|0
7620781|NCT01748825|26517629|P5|Dose Expansion|Adverse Event|0
7620782|NCT01748825|26517630|P4|Dose Expansion|Adverse Event|0
7620783|NCT01748825|26517631|P3|Dose Expansion|Adverse Event|0
7620784|NCT01748825|26517632|P2|Dose Expansion|Adverse Event|0
7620785|NCT01748825|26517633|P1|Dose Expansion|Adverse Event|0
7620786|NCT01748825|26517624|P10|Dose Expansion|Switched to alternative treatment|1
7620787|NCT01748825|26517625|P9|Dose Expansion|Switched to alternative treatment|0
7620788|NCT01748825|26517626|P8|Dose Expansion|Switched to alternative treatment|0
7620789|NCT01748825|26517627|P7|Dose Expansion|Switched to alternative treatment|0
7620790|NCT01748825|26517628|P6|Dose Expansion|Switched to alternative treatment|0
7620791|NCT01748825|26517629|P5|Dose Expansion|Switched to alternative treatment|0
7620792|NCT01748825|26517630|P4|Dose Expansion|Switched to alternative treatment|0
7620793|NCT01748825|26517631|P3|Dose Expansion|Switched to alternative treatment|0
7620794|NCT01748825|26517632|P2|Dose Expansion|Switched to alternative treatment|0
7620795|NCT01748825|26517633|P1|Dose Expansion|Switched to alternative treatment|0
7620796|NCT01748825|26517624|P10|Dose Expansion|Refused further treatment|1
7620797|NCT01748825|26517625|P9|Dose Expansion|Refused further treatment|1
7620798|NCT01748825|26517626|P8|Dose Expansion|Refused further treatment|0
7620799|NCT01748825|26517627|P7|Dose Expansion|Refused further treatment|0
7620800|NCT01748825|26517628|P6|Dose Expansion|Refused further treatment|0
7620801|NCT01748825|26517629|P5|Dose Expansion|Refused further treatment|0
7620802|NCT01748825|26517630|P4|Dose Expansion|Refused further treatment|0
7620803|NCT01748825|26517631|P3|Dose Expansion|Refused further treatment|0
7620804|NCT01748825|26517632|P2|Dose Expansion|Refused further treatment|0
7620805|NCT01748825|26517633|P1|Dose Expansion|Refused further treatment|0
7620806|NCT01748825|26517624|P10|Dose Escalation|Adverse Event|0
7620807|NCT01748825|26517625|P9|Dose Escalation|Adverse Event|0
7620808|NCT01748825|26517626|P8|Dose Escalation|Adverse Event|0
7620809|NCT01748825|26517627|P7|Dose Escalation|Adverse Event|1
7620810|NCT01748825|26517628|P6|Dose Escalation|Adverse Event|0
7620811|NCT01748825|26517629|P5|Dose Escalation|Adverse Event|0
7620812|NCT01748825|26517630|P4|Dose Escalation|Adverse Event|0
7620813|NCT01748825|26517631|P3|Dose Escalation|Adverse Event|0
7620814|NCT01748825|26517632|P2|Dose Escalation|Adverse Event|0
7620815|NCT01748825|26517633|P1|Dose Escalation|Adverse Event|0
7620816|NCT01748825|26517624|P10|Dose Escalation|Switched to alternative treatment|0
7620817|NCT01748825|26517625|P9|Dose Escalation|Switched to alternative treatment|0
7620818|NCT01748825|26517626|P8|Dose Escalation|Switched to alternative treatment|0
7620819|NCT01748825|26517627|P7|Dose Escalation|Switched to alternative treatment|0
7620820|NCT01748825|26517628|P6|Dose Escalation|Switched to alternative treatment|0
7620821|NCT01748825|26517629|P5|Dose Escalation|Switched to alternative treatment|0
7620822|NCT01748825|26517630|P4|Dose Escalation|Switched to alternative treatment|1
7620823|NCT01748825|26517631|P3|Dose Escalation|Switched to alternative treatment|0
7620824|NCT01748825|26517632|P2|Dose Escalation|Switched to alternative treatment|0
7620825|NCT01748825|26517633|P1|Dose Escalation|Switched to alternative treatment|0
7620826|NCT01748825|26517624|P10|Dose Escalation|Refused further treatment|0
7620827|NCT01748825|26517625|P9|Dose Escalation|Refused further treatment|0
7620828|NCT01748825|26517626|P8|Dose Escalation|Refused further treatment|0
7620829|NCT01748825|26517627|P7|Dose Escalation|Refused further treatment|0
7620830|NCT01748825|26517628|P6|Dose Escalation|Refused further treatment|2
7620831|NCT01748825|26517629|P5|Dose Escalation|Refused further treatment|1
7620832|NCT01748825|26517630|P4|Dose Escalation|Refused further treatment|0
7620833|NCT01748825|26517631|P3|Dose Escalation|Refused further treatment|0
7620834|NCT01748825|26517632|P2|Dose Escalation|Refused further treatment|2
7620835|NCT01748825|26517633|P1|Dose Escalation|Refused further treatment|2
7620836|NCT01748760|26517741|P2|Overall Study|Lost to Follow-up|1
7620837|NCT01748760|26517742|P1|Overall Study|Lost to Follow-up|5
7620838|NCT01748760|26517741|P2|Overall Study|Withdrawal by Subject|1
7620839|NCT01748760|26517742|P1|Overall Study|Withdrawal by Subject|1
7620840|NCT01748552|26517788|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
7620841|NCT01748552|26517789|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
7620842|NCT01748552|26517790|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
7620843|NCT01748552|26517791|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
7620844|NCT01748552|26517792|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
7620845|NCT01748552|26517793|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
7620846|NCT01748552|26517794|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
7620847|NCT01748552|26517795|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
7620848|NCT01748552|26517796|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
7620849|NCT01748552|26517797|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
7620850|NCT01748552|26517798|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
7620851|NCT01748552|26517799|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
7620852|NCT01748552|26517788|P12|Intervention Period 2 and Washout|Physician Decision|0
7620853|NCT01748552|26517789|P11|Intervention Period 2 and Washout|Physician Decision|0
7620854|NCT01748552|26517790|P10|Intervention Period 2 and Washout|Physician Decision|0
7620855|NCT01748552|26517791|P9|Intervention Period 2 and Washout|Physician Decision|0
7620856|NCT01748552|26517792|P8|Intervention Period 2 and Washout|Physician Decision|0
7620857|NCT01748552|26517793|P7|Intervention Period 2 and Washout|Physician Decision|0
7620858|NCT01748552|26517794|P6|Intervention Period 2 and Washout|Physician Decision|0
7620859|NCT01748552|26517795|P5|Intervention Period 2 and Washout|Physician Decision|0
7620860|NCT01748552|26517796|P4|Intervention Period 2 and Washout|Physician Decision|0
7620861|NCT01748552|26517797|P3|Intervention Period 2 and Washout|Physician Decision|1
7620862|NCT01748552|26517798|P2|Intervention Period 2 and Washout|Physician Decision|0
7620863|NCT01748552|26517799|P1|Intervention Period 2 and Washout|Physician Decision|0
7620864|NCT01748292|26517869|P2|Overall Study|Withdrawal by Subject|2
7620865|NCT01748292|26517870|P1|Overall Study|Withdrawal by Subject|0
7620866|NCT01748292|26517869|P2|Overall Study|Death|3
7620867|NCT01748292|26517870|P1|Overall Study|Death|0
7620868|NCT01748292|26517869|P2|Overall Study|Lost to Follow-up|3
7620869|NCT01748292|26517870|P1|Overall Study|Lost to Follow-up|0
7620870|NCT01748292|26517869|P2|Overall Study|Adverse Event|4
7620871|NCT01748292|26517870|P1|Overall Study|Adverse Event|2
7620872|NCT01748162|26517904|P2|Overall Study|reasons not available|2
7620873|NCT01748162|26517905|P1|Overall Study|reasons not available|3
7620874|NCT01748162|26517904|P2|Overall Study|participant consented but did not begin|1
7620875|NCT01748162|26517905|P1|Overall Study|participant consented but did not begin|0
7620876|NCT01748162|26517904|P2|Overall Study|no additional croup episodes to evaluate|2
7620877|NCT01748162|26517905|P1|Overall Study|no additional croup episodes to evaluate|2
7620878|NCT01748071|26517916|P3|Overall Study|Adverse Event|0
7620879|NCT01748071|26517917|P2|Overall Study|Adverse Event|2
7620880|NCT01748071|26517918|P1|Overall Study|Adverse Event|2
7620881|NCT01747915|26518181|P3|Overall Study|Pregnancy|1
7620882|NCT01747915|26518182|P2|Overall Study|Pregnancy|0
7620883|NCT01747915|26518183|P1|Overall Study|Pregnancy|0
7620884|NCT01747915|26518181|P3|Overall Study|Protocol Violation|0
7620885|NCT01747915|26518182|P2|Overall Study|Protocol Violation|0
7620886|NCT01747915|26518183|P1|Overall Study|Protocol Violation|1
7620887|NCT01747915|26518181|P3|Overall Study|Withdrawal by Subject|1
7620888|NCT01747915|26518182|P2|Overall Study|Withdrawal by Subject|4
7620889|NCT01747915|26518183|P1|Overall Study|Withdrawal by Subject|4
7620890|NCT01747915|26518181|P3|Overall Study|Lost to Follow-up|0
7620891|NCT01747915|26518182|P2|Overall Study|Lost to Follow-up|0
7620892|NCT01747915|26518183|P1|Overall Study|Lost to Follow-up|1
7620893|NCT01747915|26518181|P3|Overall Study|Lack of Efficacy|0
7620894|NCT01747915|26518182|P2|Overall Study|Lack of Efficacy|1
7620895|NCT01747915|26518183|P1|Overall Study|Lack of Efficacy|0
7620896|NCT01747915|26518181|P3|Overall Study|Death|1
7620897|NCT01747915|26518182|P2|Overall Study|Death|0
7620898|NCT01747915|26518183|P1|Overall Study|Death|0
7620899|NCT01747915|26518181|P3|Overall Study|Adverse Event|2
7620900|NCT01747915|26518182|P2|Overall Study|Adverse Event|5
7620901|NCT01747915|26518183|P1|Overall Study|Adverse Event|8
7620902|NCT01747915|26518181|P3|Overall Study|Other|1
7620903|NCT01747915|26518182|P2|Overall Study|Other|1
7620904|NCT01747915|26518183|P1|Overall Study|Other|1
7620905|NCT01747876|26518197|P3|Overall Study|Trtment duration compl. as per protocol|1
7620906|NCT01747876|26518198|P2|Overall Study|Trtment duration compl. as per protocol|1
7620907|NCT01747876|26518199|P1|Overall Study|Trtment duration compl. as per protocol|0
7620908|NCT01747876|26518197|P3|Overall Study|Disease progression|8
7620909|NCT01747876|26518198|P2|Overall Study|Disease progression|13
7620910|NCT01747876|26518199|P1|Overall Study|Disease progression|4
7620911|NCT01747876|26518197|P3|Overall Study|Withdrawal by Subject|1
7620912|NCT01747876|26518198|P2|Overall Study|Withdrawal by Subject|1
7620913|NCT01747876|26518199|P1|Overall Study|Withdrawal by Subject|0
7620914|NCT01747876|26518197|P3|Overall Study|Adverse Event|2
7620915|NCT01747876|26518198|P2|Overall Study|Adverse Event|0
7620916|NCT01747876|26518199|P1|Overall Study|Adverse Event|1
7620917|NCT01747837|26518252|P2|Overall Study|Death|4
7620918|NCT01747837|26518253|P1|Overall Study|Death|4
7620919|NCT01747837|26518252|P2|Overall Study|Lost to Follow-up|2
7620920|NCT01747837|26518253|P1|Overall Study|Lost to Follow-up|5
7620921|NCT01747811|26518283|P2|Overall Study|Lack of Efficacy|4
7620922|NCT01747811|26518284|P1|Overall Study|Lack of Efficacy|2
7620923|NCT01747772|26518300|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
7620924|NCT01747655|26518308|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
7620925|NCT01747655|26518309|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
7620926|NCT01747655|26518308|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
7620927|NCT01747655|26518309|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
7620928|NCT01747655|26518308|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
7620929|NCT01747655|26518309|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
7620930|NCT01747629|26518339|P2|Overall Study|Other|1
7620931|NCT01747629|26518340|P1|Overall Study|Other|2
7620932|NCT01747629|26518339|P2|Overall Study|Not treated|0
7620933|NCT01747629|26518340|P1|Overall Study|Not treated|1
7620934|NCT01747629|26518339|P2|Overall Study|Inclusion criteria not met|0
7620935|NCT01747629|26518340|P1|Overall Study|Inclusion criteria not met|1
7620936|NCT01747629|26518339|P2|Overall Study|Noncompliance|1
7620937|NCT01747629|26518340|P1|Overall Study|Noncompliance|1
7620938|NCT01747629|26518339|P2|Overall Study|Withdrawal by Subject|2
7620939|NCT01747629|26518340|P1|Overall Study|Withdrawal by Subject|2
7620940|NCT01747629|26518339|P2|Overall Study|Adverse Event|2
7620941|NCT01747629|26518340|P1|Overall Study|Adverse Event|1
7620942|NCT01747551|26518374|P2|Overall Study|Other|0
7620943|NCT01747551|26518375|P1|Overall Study|Other|2
7620944|NCT01747551|26518374|P2|Overall Study|Physician Decision|1
7620945|NCT01747551|26518375|P1|Overall Study|Physician Decision|2
7620946|NCT01747551|26518374|P2|Overall Study|Withdrawal by Subject|1
7620947|NCT01747551|26518375|P1|Overall Study|Withdrawal by Subject|3
7620948|NCT01747551|26518374|P2|Overall Study|Prolonged Treatment Delay|0
7620949|NCT01747551|26518375|P1|Overall Study|Prolonged Treatment Delay|2
7620950|NCT01747551|26518374|P2|Overall Study|Adverse Event|1
7620951|NCT01747551|26518375|P1|Overall Study|Adverse Event|7
7620952|NCT01747551|26518374|P2|Overall Study|Death|1
7620953|NCT01747551|26518375|P1|Overall Study|Death|3
7620954|NCT01747551|26518374|P2|Overall Study|Progressive Disease|17
7620955|NCT01747551|26518375|P1|Overall Study|Progressive Disease|24
7620956|NCT01747499|26518392|P5|Overall Study|Determined not to be eligible|1
7620957|NCT01747499|26518393|P4|Overall Study|Determined not to be eligible|0
7620958|NCT01747499|26518394|P3|Overall Study|Determined not to be eligible|0
7620959|NCT01747499|26518395|P2|Overall Study|Determined not to be eligible|0
7620960|NCT01747499|26518396|P1|Overall Study|Determined not to be eligible|0
7620961|NCT01747499|26518392|P5|Overall Study|Developed AML and death|1
7620962|NCT01747499|26518393|P4|Overall Study|Developed AML and death|0
7620963|NCT01747499|26518394|P3|Overall Study|Developed AML and death|0
7620964|NCT01747499|26518395|P2|Overall Study|Developed AML and death|0
7620965|NCT01747499|26518396|P1|Overall Study|Developed AML and death|0
7620966|NCT01747499|26518392|P5|Overall Study|Withdrawal by Subject|6
7620967|NCT01747499|26518393|P4|Overall Study|Withdrawal by Subject|0
7620968|NCT01747499|26518394|P3|Overall Study|Withdrawal by Subject|0
7620969|NCT01747499|26518395|P2|Overall Study|Withdrawal by Subject|0
7620970|NCT01747499|26518396|P1|Overall Study|Withdrawal by Subject|0
7620971|NCT01747499|26518392|P5|Overall Study|Death|1
7620972|NCT01747499|26518393|P4|Overall Study|Death|1
7620973|NCT01747499|26518394|P3|Overall Study|Death|0
7620974|NCT01747499|26518395|P2|Overall Study|Death|0
7620975|NCT01747499|26518396|P1|Overall Study|Death|0
7620976|NCT01747499|26518392|P5|Overall Study|Physician Decision|2
7620977|NCT01747499|26518393|P4|Overall Study|Physician Decision|0
7620978|NCT01747499|26518394|P3|Overall Study|Physician Decision|0
7620979|NCT01747499|26518395|P2|Overall Study|Physician Decision|1
7620980|NCT01747499|26518396|P1|Overall Study|Physician Decision|0
7620981|NCT01747499|26518392|P5|Overall Study|Steroid refractory aGvHD|4
7620982|NCT01747499|26518393|P4|Overall Study|Steroid refractory aGvHD|1
7620983|NCT01747499|26518394|P3|Overall Study|Steroid refractory aGvHD|0
7620984|NCT01747499|26518395|P2|Overall Study|Steroid refractory aGvHD|0
7620985|NCT01747499|26518396|P1|Overall Study|Steroid refractory aGvHD|1
7620986|NCT01747486|26518432|P2|Stage 2|Disease Progression|0
7620987|NCT01747486|26518433|P1|Stage 2|Disease Progression|3
7620988|NCT01747486|26518432|P2|Stage 2|New Cancer Therapy|0
7620989|NCT01747486|26518433|P1|Stage 2|New Cancer Therapy|3
7620990|NCT01747486|26518432|P2|Stage 2|Withdrawal by Subject|0
7620991|NCT01747486|26518433|P1|Stage 2|Withdrawal by Subject|1
7620992|NCT01747486|26518432|P2|Stage 2|Physician Decision|0
7620993|NCT01747486|26518433|P1|Stage 2|Physician Decision|2
7620994|NCT01747486|26518432|P2|Stage 1|Death|1
7620995|NCT01747486|26518433|P1|Stage 1|Death|1
7620996|NCT01747486|26518432|P2|Stage 1|Disease progression|9
7620997|NCT01747486|26518433|P1|Stage 1|Disease progression|4
7620998|NCT01747486|26518432|P2|Stage 1|Withdrawal by Subject|3
7620999|NCT01747486|26518433|P1|Stage 1|Withdrawal by Subject|4
7621000|NCT01747486|26518432|P2|Stage 1|Physician Decision|0
7621001|NCT01747486|26518433|P1|Stage 1|Physician Decision|3
7621002|NCT01746901|26518496|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
7621003|NCT01746901|26518497|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621004|NCT01746901|26518498|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
7621005|NCT01746901|26518499|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621006|NCT01746901|26518500|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621007|NCT01746901|26518501|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621008|NCT01746901|26518502|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621009|NCT01746901|26518503|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621010|NCT01746901|26518504|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
7621011|NCT01746901|26518496|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
7621012|NCT01746901|26518497|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
7621013|NCT01746901|26518498|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
7621014|NCT01746901|26518499|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
7621015|NCT01746901|26518500|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
7621016|NCT01746901|26518501|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
7621017|NCT01746901|26518502|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
7621018|NCT01746901|26518503|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
7621019|NCT01746901|26518504|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
7621020|NCT01746901|26518496|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621021|NCT01746901|26518497|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621022|NCT01746901|26518498|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621023|NCT01746901|26518499|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621024|NCT01746901|26518500|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621025|NCT01746901|26518501|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
7621026|NCT01746901|26518502|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621027|NCT01746901|26518503|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621028|NCT01746901|26518504|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7621029|NCT01746901|26518496|P9|Treatment Phase: Third Intervention|Protocol Violation|0
7621030|NCT01746901|26518497|P8|Treatment Phase: Third Intervention|Protocol Violation|0
7621031|NCT01746901|26518498|P7|Treatment Phase: Third Intervention|Protocol Violation|1
7621032|NCT01746901|26518499|P6|Treatment Phase: Third Intervention|Protocol Violation|1
7621033|NCT01746901|26518500|P5|Treatment Phase: Third Intervention|Protocol Violation|0
7621034|NCT01746901|26518501|P4|Treatment Phase: Third Intervention|Protocol Violation|0
7621035|NCT01746901|26518502|P3|Treatment Phase: Third Intervention|Protocol Violation|0
7621036|NCT01746901|26518503|P2|Treatment Phase: Third Intervention|Protocol Violation|0
7621037|NCT01746901|26518504|P1|Treatment Phase: Third Intervention|Protocol Violation|0
7621038|NCT01746901|26518496|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621039|NCT01746901|26518497|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
7621040|NCT01746901|26518498|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621041|NCT01746901|26518499|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621042|NCT01746901|26518500|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621043|NCT01746901|26518501|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621044|NCT01746901|26518502|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621045|NCT01746901|26518503|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621046|NCT01746901|26518504|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7621047|NCT01746901|26518496|P9|Treatment Phase: First Intervention|Protocol Violation|0
7621048|NCT01746901|26518497|P8|Treatment Phase: First Intervention|Protocol Violation|0
7621049|NCT01746901|26518498|P7|Treatment Phase: First Intervention|Protocol Violation|1
7621050|NCT01746901|26518499|P6|Treatment Phase: First Intervention|Protocol Violation|0
7621051|NCT01746901|26518500|P5|Treatment Phase: First Intervention|Protocol Violation|0
7621052|NCT01746901|26518501|P4|Treatment Phase: First Intervention|Protocol Violation|0
7621053|NCT01746901|26518502|P3|Treatment Phase: First Intervention|Protocol Violation|0
7621054|NCT01746901|26518503|P2|Treatment Phase: First Intervention|Protocol Violation|0
7621055|NCT01746901|26518504|P1|Treatment Phase: First Intervention|Protocol Violation|0
7621056|NCT01746901|26518496|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621057|NCT01746901|26518497|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621058|NCT01746901|26518498|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621059|NCT01746901|26518499|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621060|NCT01746901|26518500|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621061|NCT01746901|26518501|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621062|NCT01746901|26518502|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
7621063|NCT01746901|26518503|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
7621064|NCT01746901|26518504|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
7621065|NCT01746901|26518496|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621066|NCT01746901|26518497|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621067|NCT01746901|26518498|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621068|NCT01746901|26518499|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621069|NCT01746901|26518500|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621070|NCT01746901|26518501|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621071|NCT01746901|26518502|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
7621072|NCT01746901|26518503|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
7621073|NCT01746901|26518504|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7621074|NCT01746901|26518496|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
7621075|NCT01746901|26518497|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
7621076|NCT01746901|26518498|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
7621077|NCT01746901|26518499|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
7621078|NCT01746901|26518500|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
7621079|NCT01746901|26518501|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
7621080|NCT01746901|26518502|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
7621081|NCT01746901|26518503|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
7621082|NCT01746901|26518504|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
7621083|NCT01746901|26518496|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
7621084|NCT01746901|26518497|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
7621085|NCT01746901|26518498|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
7621086|NCT01746901|26518499|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
7621087|NCT01746901|26518500|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
7621088|NCT01746901|26518501|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
7621089|NCT01746901|26518502|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
7621090|NCT01746901|26518503|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
7621091|NCT01746901|26518504|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
7621092|NCT01746901|26518496|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621093|NCT01746901|26518497|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621094|NCT01746901|26518498|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621095|NCT01746901|26518499|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621096|NCT01746901|26518500|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621097|NCT01746901|26518501|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621098|NCT01746901|26518502|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621099|NCT01746901|26518503|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
7621100|NCT01746901|26518504|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
7621101|NCT01746901|26518496|P9|Naloxone Challenge Phase|Adverse Event|0
7621102|NCT01746901|26518497|P8|Naloxone Challenge Phase|Adverse Event|0
7621103|NCT01746901|26518498|P7|Naloxone Challenge Phase|Adverse Event|0
7621104|NCT01746901|26518499|P6|Naloxone Challenge Phase|Adverse Event|0
7621105|NCT01746901|26518500|P5|Naloxone Challenge Phase|Adverse Event|0
7621106|NCT01746901|26518501|P4|Naloxone Challenge Phase|Adverse Event|0
7621107|NCT01746901|26518502|P3|Naloxone Challenge Phase|Adverse Event|0
7621108|NCT01746901|26518503|P2|Naloxone Challenge Phase|Adverse Event|0
7621109|NCT01746901|26518504|P1|Naloxone Challenge Phase|Adverse Event|2
7621110|NCT01746862|26518827|P2|Overall Study|Entered puberty during the study|0
7621111|NCT01746862|26518828|P1|Overall Study|Entered puberty during the study|1
7621112|NCT01746862|26518827|P2|Overall Study|Consent withdrawal by parent's guardian|2
7621113|NCT01746862|26518828|P1|Overall Study|Consent withdrawal by parent's guardian|5
7621114|NCT01746862|26518827|P2|Overall Study|Protocol Violation|0
7621115|NCT01746862|26518828|P1|Overall Study|Protocol Violation|1
7621116|NCT01746862|26518827|P2|Overall Study|Withdrawal by Subject|1
7621117|NCT01746862|26518828|P1|Overall Study|Withdrawal by Subject|1
7621118|NCT01746732|26518892|P3|Period 2|Lost to Follow-up|1
7621119|NCT01746732|26518893|P2|Period 2|Lost to Follow-up|0
7621120|NCT01746732|26518894|P1|Period 2|Lost to Follow-up|0
7621121|NCT01746732|26518892|P3|Period 2|Adverse Event|1
7621122|NCT01746732|26518893|P2|Period 2|Adverse Event|0
7621123|NCT01746732|26518894|P1|Period 2|Adverse Event|0
7621124|NCT01746732|26518892|P3|Period 2|Withdrawal by Subject|2
7621125|NCT01746732|26518893|P2|Period 2|Withdrawal by Subject|0
7621126|NCT01746732|26518894|P1|Period 2|Withdrawal by Subject|0
7621127|NCT01746732|26518892|P3|Period 1|Physician Decision|0
7621128|NCT01746732|26518893|P2|Period 1|Physician Decision|1
7621129|NCT01746732|26518894|P1|Period 1|Physician Decision|0
7621130|NCT01746732|26518892|P3|Lead-In Period|Withdrawal by Subject|0
7621131|NCT01746732|26518893|P2|Lead-In Period|Withdrawal by Subject|0
7621132|NCT01746732|26518894|P1|Lead-In Period|Withdrawal by Subject|1
7621133|NCT01746368|26518975|P2|Overall Study|Withdrawal by Subject|1
7621134|NCT01746368|26518976|P1|Overall Study|Withdrawal by Subject|0
7621135|NCT01746368|26518975|P2|Overall Study|Lost to Follow-up|0
7621136|NCT01746368|26518976|P1|Overall Study|Lost to Follow-up|2
7621137|NCT01746225|26519006|P3|Overall Study|Continuing Treatment|3
7621138|NCT01746225|26519007|P2|Overall Study|Continuing Treatment|8
7621139|NCT01746225|26519008|P1|Overall Study|Continuing Treatment|5
7621140|NCT01746225|26519006|P3|Overall Study|Adverse Event|17
7621141|NCT01746225|26519007|P2|Overall Study|Adverse Event|12
7621142|NCT01746225|26519008|P1|Overall Study|Adverse Event|15
7621143|NCT01746225|26519006|P3|Overall Study|Physician Decision|3
7621144|NCT01746225|26519007|P2|Overall Study|Physician Decision|11
7621145|NCT01746225|26519008|P1|Overall Study|Physician Decision|14
7621146|NCT01746225|26519006|P3|Overall Study|Withdrawal by Subject|19
7621147|NCT01746225|26519007|P2|Overall Study|Withdrawal by Subject|15
7621148|NCT01746225|26519008|P1|Overall Study|Withdrawal by Subject|5
7621149|NCT01746225|26519006|P3|Overall Study|Death|1
7621150|NCT01746225|26519007|P2|Overall Study|Death|0
7621151|NCT01746225|26519008|P1|Overall Study|Death|1
7621152|NCT01746173|26519031|P1|Overall Study|Disease Progression|2
7621153|NCT01746108|26519039|P3|Overall Study|Lost to Follow-up|0
7621154|NCT01746108|26519040|P2|Overall Study|Lost to Follow-up|1
7621155|NCT01746108|26519041|P1|Overall Study|Lost to Follow-up|0
7621156|NCT01746108|26519039|P3|Overall Study|Withdrawal by Subject|0
7621157|NCT01746108|26519040|P2|Overall Study|Withdrawal by Subject|1
7621158|NCT01746108|26519041|P1|Overall Study|Withdrawal by Subject|0
7621159|NCT01746108|26519039|P3|Overall Study|Adverse event, non-fatal|0
7621160|NCT01746108|26519040|P2|Overall Study|Adverse event, non-fatal|1
7621161|NCT01746108|26519041|P1|Overall Study|Adverse event, non-fatal|0
7621162|NCT01746108|26519039|P3|Overall Study|Migrated /moved from study area|0
7621163|NCT01746108|26519040|P2|Overall Study|Migrated /moved from study area|1
7621164|NCT01746108|26519041|P1|Overall Study|Migrated /moved from study area|0
7621165|NCT01746017|26519158|P11|Period 3|Withdrawal by Subject|0
7621166|NCT01746017|26519159|P10|Period 3|Withdrawal by Subject|0
7621167|NCT01746017|26519160|P9|Period 3|Withdrawal by Subject|0
7621168|NCT01746017|26519161|P8|Period 3|Withdrawal by Subject|0
7621169|NCT01746017|26519162|P7|Period 3|Withdrawal by Subject|0
7621170|NCT01746017|26519163|P6|Period 3|Withdrawal by Subject|1
7621171|NCT01746017|26519164|P5|Period 3|Withdrawal by Subject|0
7621172|NCT01746017|26519165|P4|Period 3|Withdrawal by Subject|0
7621173|NCT01746017|26519166|P3|Period 3|Withdrawal by Subject|0
7621174|NCT01746017|26519167|P2|Period 3|Withdrawal by Subject|0
7621175|NCT01746017|26519168|P1|Period 3|Withdrawal by Subject|0
7621176|NCT01746017|26519158|P11|Period 1|Withdrawal by Subject|0
7621177|NCT01746017|26519159|P10|Period 1|Withdrawal by Subject|0
7621178|NCT01746017|26519160|P9|Period 1|Withdrawal by Subject|0
7621179|NCT01746017|26519161|P8|Period 1|Withdrawal by Subject|0
7621180|NCT01746017|26519162|P7|Period 1|Withdrawal by Subject|1
7621181|NCT01746017|26519163|P6|Period 1|Withdrawal by Subject|0
7621182|NCT01746017|26519164|P5|Period 1|Withdrawal by Subject|0
7621183|NCT01746017|26519165|P4|Period 1|Withdrawal by Subject|0
7621184|NCT01746017|26519166|P3|Period 1|Withdrawal by Subject|0
7621185|NCT01746017|26519167|P2|Period 1|Withdrawal by Subject|0
7621186|NCT01746017|26519168|P1|Period 1|Withdrawal by Subject|0
7621187|NCT01745848|26519289|P1|Overall Study|Adverse Event|6
7621188|NCT01745393|26519318|P2|12-month Follow-up|Lost to Follow-up|5
7621189|NCT01745393|26519319|P1|12-month Follow-up|Lost to Follow-up|6
7621190|NCT01745393|26519318|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
7621191|NCT01745393|26519319|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
7621192|NCT01745393|26519318|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
7621193|NCT01745393|26519319|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
7621194|NCT01745380|26519331|P2|Overall Study|Lack of Efficacy|1
7621195|NCT01745380|26519332|P1|Overall Study|Lack of Efficacy|0
7621196|NCT01745380|26519331|P2|Overall Study|Lost to Follow-up|0
7621197|NCT01745380|26519332|P1|Overall Study|Lost to Follow-up|1
7621198|NCT01745367|26519370|P2|Overall Study|Other Reasons Unspecified|2
7621199|NCT01745367|26519371|P1|Overall Study|Other Reasons Unspecified|0
7621200|NCT01745367|26519370|P2|Overall Study|Termination of The Study by The Sponsor|18
7621201|NCT01745367|26519371|P1|Overall Study|Termination of The Study by The Sponsor|6
7621202|NCT01745367|26519370|P2|Overall Study|Withdrawal by Subject|2
7621203|NCT01745367|26519371|P1|Overall Study|Withdrawal by Subject|1
7621204|NCT01745367|26519370|P2|Overall Study|Death|0
7621205|NCT01745367|26519371|P1|Overall Study|Death|1
7621206|NCT01745146|26519395|P2|Overall Study|Lost to Follow-up|0
7621207|NCT01745146|26519396|P1|Overall Study|Lost to Follow-up|2
7621208|NCT01745146|26519395|P2|Overall Study|Withdrawal by Subject|3
7621209|NCT01745146|26519396|P1|Overall Study|Withdrawal by Subject|1
7621210|NCT01745120|26519418|P2|Overall Study|Investigator decision|0
7621211|NCT01745120|26519419|P1|Overall Study|Investigator decision|1
7621212|NCT01745094|26519477|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
7621213|NCT01745094|26519478|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
7621214|NCT01745094|26519479|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
7621215|NCT01745094|26519480|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
7621216|NCT01745094|26519477|P4|Overall Study|Show no Stable Solifenacin Intake|0
7621217|NCT01745094|26519478|P3|Overall Study|Show no Stable Solifenacin Intake|1
7621218|NCT01745094|26519479|P2|Overall Study|Show no Stable Solifenacin Intake|0
7621219|NCT01745094|26519480|P1|Overall Study|Show no Stable Solifenacin Intake|0
7621220|NCT01745094|26519477|P4|Overall Study|Need Further Examinations Due to Biopsy|0
7621221|NCT01745094|26519478|P3|Overall Study|Need Further Examinations Due to Biopsy|1
7621222|NCT01745094|26519479|P2|Overall Study|Need Further Examinations Due to Biopsy|0
7621223|NCT01745094|26519480|P1|Overall Study|Need Further Examinations Due to Biopsy|0
7621224|NCT01745094|26519477|P4|Overall Study|Protocol Violation|1
7621225|NCT01745094|26519478|P3|Overall Study|Protocol Violation|3
7621226|NCT01745094|26519479|P2|Overall Study|Protocol Violation|0
7621227|NCT01745094|26519480|P1|Overall Study|Protocol Violation|1
7621228|NCT01745094|26519477|P4|Overall Study|Withdrawal by Subject|2
7621229|NCT01745094|26519478|P3|Overall Study|Withdrawal by Subject|1
7621230|NCT01745094|26519479|P2|Overall Study|Withdrawal by Subject|0
7621231|NCT01745094|26519480|P1|Overall Study|Withdrawal by Subject|2
7621232|NCT01745094|26519477|P4|Overall Study|Adverse Event|0
7621233|NCT01745094|26519478|P3|Overall Study|Adverse Event|3
7621234|NCT01745094|26519479|P2|Overall Study|Adverse Event|0
7621235|NCT01745094|26519480|P1|Overall Study|Adverse Event|0
7621236|NCT01745094|26519477|P4|Overall Study|Not Meeting the Eligibility Criteria|0
7621237|NCT01745094|26519478|P3|Overall Study|Not Meeting the Eligibility Criteria|3
7621238|NCT01745094|26519479|P2|Overall Study|Not Meeting the Eligibility Criteria|0
7621239|NCT01745094|26519480|P1|Overall Study|Not Meeting the Eligibility Criteria|1
7621240|NCT01744977|26519581|P2|Overall Study|No longer meets inclusion|0
7621241|NCT01744977|26519582|P1|Overall Study|No longer meets inclusion|6
7621242|NCT01744977|26519581|P2|Overall Study|Lost to Follow-up|0
7621243|NCT01744977|26519582|P1|Overall Study|Lost to Follow-up|2
7621244|NCT01744977|26519581|P2|Overall Study|Death|3
7621245|NCT01744977|26519582|P1|Overall Study|Death|2
7621246|NCT01744977|26519581|P2|Overall Study|Withdrawal by Subject|2
7621247|NCT01744977|26519582|P1|Overall Study|Withdrawal by Subject|1
7621248|NCT01744782|26519653|P1|Overall Study|Death|1
7621249|NCT01744691|26519814|P1|Overall Study|Physician Decision|4
7621250|NCT01744691|26519814|P1|Overall Study|Withdrawal of consent for treatment|3
7621251|NCT01744691|26519814|P1|Overall Study|Unacceptable toxicity, AE or death|18
7621252|NCT01744691|26519814|P1|Overall Study|Progressive Disease|18
7621253|NCT01744665|26519819|P1|Re-initiation Phase|Withdrawal by Subject|1
7621254|NCT01744665|26519819|P1|Re-initiation Phase|No longer required treatment|1
7621255|NCT01744665|26519819|P1|Re-initiation Phase|Adverse Event|1
7621256|NCT01744665|26519819|P1|Re-initiation Phase|Administrative problems|10
7621257|NCT01744665|26519819|P1|Consolidation Phase|Administrative problems|9
7621258|NCT01744665|26519819|P1|Consolidation Phase|Withdrawal by Subject|4
7621259|NCT01744665|26519819|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
7621260|NCT01744665|26519819|P1|Consolidation Phase|Adverse Event|2
7621261|NCT01744665|26519819|P1|Monitoring Phase|Did not achieve MR4.5|1
7621262|NCT01744665|26519819|P1|Monitoring Phase|Withdrawal by Subject|5
7621263|NCT01744665|26519819|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
7621264|NCT01744665|26519819|P1|Monitoring Phase|Abnormal laboratory value(s)|1
7621265|NCT01744665|26519819|P1|Monitoring Phase|Adverse Event|4
7621266|NCT01744496|26519889|P2|Maintenance Period|Subject left town|0
7621267|NCT01744496|26519890|P1|Maintenance Period|Subject left town|1
7621268|NCT01744496|26519889|P2|Maintenance Period|Withdrawal by Subject|1
7621269|NCT01744496|26519890|P1|Maintenance Period|Withdrawal by Subject|1
7621270|NCT01744496|26519889|P2|Maintenance Period|Protocol Violation|0
7621271|NCT01744496|26519890|P1|Maintenance Period|Protocol Violation|1
7621272|NCT01744496|26519889|P2|Maintenance Period|Adverse Event|3
7621273|NCT01744496|26519890|P1|Maintenance Period|Adverse Event|1
7621274|NCT01744496|26519889|P2|Titration Period|Personal reasons|1
7621275|NCT01744496|26519890|P1|Titration Period|Personal reasons|0
7621276|NCT01744496|26519889|P2|Titration Period|Adverse Event|1
7621277|NCT01744496|26519890|P1|Titration Period|Adverse Event|2
7621278|NCT01744483|26519911|P3|Overall Study|Routed to OSH|1
7621279|NCT01744483|26519912|P2|Overall Study|Routed to OSH|0
7621280|NCT01744483|26519913|P1|Overall Study|Routed to OSH|2
7621281|NCT01744483|26519911|P3|Overall Study|No ICU Admit|2
7621282|NCT01744483|26519912|P2|Overall Study|No ICU Admit|1
7621283|NCT01744483|26519913|P1|Overall Study|No ICU Admit|5
7621284|NCT01744483|26519911|P3|Overall Study|Withdrawal by Subject|2
7621285|NCT01744483|26519912|P2|Overall Study|Withdrawal by Subject|6
7621286|NCT01744483|26519913|P1|Overall Study|Withdrawal by Subject|4
7621287|NCT01744483|26519911|P3|Overall Study|Protocol Violation|1
7621288|NCT01744483|26519912|P2|Overall Study|Protocol Violation|2
7621289|NCT01744483|26519913|P1|Overall Study|Protocol Violation|1
7621290|NCT01744483|26519911|P3|Overall Study|Lost to Follow-up|11
7621291|NCT01744483|26519912|P2|Overall Study|Lost to Follow-up|9
7621292|NCT01744483|26519913|P1|Overall Study|Lost to Follow-up|8
7621293|NCT01744483|26519911|P3|Overall Study|Death|11
7621294|NCT01744483|26519912|P2|Overall Study|Death|4
7621295|NCT01744483|26519913|P1|Overall Study|Death|9
7621296|NCT01744392|26519921|P1|Overall Study|Physician Decision|1
7621297|NCT01744197|26519961|P2|Overall Study|No patch received|2
7621298|NCT01744197|26519962|P1|Overall Study|No patch received|2
7621299|NCT01744197|26519961|P2|Overall Study|Received 1 patch|1
7621300|NCT01744197|26519962|P1|Overall Study|Received 1 patch|2
7621301|NCT01743989|26519986|P3|Re-treatment Phase|Lost to Follow-up|0
7621302|NCT01743989|26519987|P2|Re-treatment Phase|Lost to Follow-up|1
7621303|NCT01743989|26519988|P1|Re-treatment Phase|Lost to Follow-up|0
7621304|NCT01743989|26519986|P3|Re-treatment Phase|Physician Decision|0
7621305|NCT01743989|26519987|P2|Re-treatment Phase|Physician Decision|1
7621306|NCT01743989|26519988|P1|Re-treatment Phase|Physician Decision|0
7621307|NCT01743989|26519986|P3|Re-treatment Phase|Unstable MR|0
7621308|NCT01743989|26519987|P2|Re-treatment Phase|Unstable MR|0
7621309|NCT01743989|26519988|P1|Re-treatment Phase|Unstable MR|1
7621310|NCT01743989|26519986|P3|Re-treatment Phase|Withdrawal by Subject|0
7621311|NCT01743989|26519987|P2|Re-treatment Phase|Withdrawal by Subject|1
7621312|NCT01743989|26519988|P1|Re-treatment Phase|Withdrawal by Subject|5
7621313|NCT01743989|26519986|P3|Re-treatment Phase|Administrative problems|0
7621314|NCT01743989|26519987|P2|Re-treatment Phase|Administrative problems|1
7621315|NCT01743989|26519988|P1|Re-treatment Phase|Administrative problems|1
7621316|NCT01743989|26519986|P3|Re-treatment Phase|Death|0
7621317|NCT01743989|26519987|P2|Re-treatment Phase|Death|1
7621318|NCT01743989|26519988|P1|Re-treatment Phase|Death|1
7621319|NCT01743989|26519986|P3|Re-treatment Phase|Adverse Event|0
7621320|NCT01743989|26519987|P2|Re-treatment Phase|Adverse Event|4
7621321|NCT01743989|26519988|P1|Re-treatment Phase|Adverse Event|8
7621322|NCT01743989|26519986|P3|TFR Phase|Withdrawal by Subject|0
7621323|NCT01743989|26519987|P2|TFR Phase|Withdrawal by Subject|2
7621324|NCT01743989|26519988|P1|TFR Phase|Withdrawal by Subject|0
7621325|NCT01743989|26519986|P3|TFR Phase|Protocol deviation|0
7621326|NCT01743989|26519987|P2|TFR Phase|Protocol deviation|1
7621327|NCT01743989|26519988|P1|TFR Phase|Protocol deviation|0
7621328|NCT01743989|26519986|P3|TFR Phase|Logistical problems|0
7621329|NCT01743989|26519987|P2|TFR Phase|Logistical problems|2
7621330|NCT01743989|26519988|P1|TFR Phase|Logistical problems|0
7621331|NCT01743989|26519986|P3|TFR Phase|Physician Decision|0
7621332|NCT01743989|26519987|P2|TFR Phase|Physician Decision|1
7621333|NCT01743989|26519988|P1|TFR Phase|Physician Decision|0
7621334|NCT01743989|26519986|P3|TFR Phase|Lost to Follow-up|0
7621335|NCT01743989|26519987|P2|TFR Phase|Lost to Follow-up|2
7621336|NCT01743989|26519988|P1|TFR Phase|Lost to Follow-up|0
7621337|NCT01743989|26519986|P3|TFR Phase|Adverse Event|0
7621338|NCT01743989|26519987|P2|TFR Phase|Adverse Event|1
7621339|NCT01743989|26519988|P1|TFR Phase|Adverse Event|0
7621340|NCT01743989|26519986|P3|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
7621341|NCT01743989|26519987|P2|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
7621342|NCT01743989|26519988|P1|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
7621343|NCT01743989|26519986|P3|Treatment Phase|Included by mistake|1
7621344|NCT01743989|26519987|P2|Treatment Phase|Included by mistake|0
7621345|NCT01743989|26519988|P1|Treatment Phase|Included by mistake|0
7621346|NCT01743989|26519986|P3|Treatment Phase|Not randomized by mistake|1
7621347|NCT01743989|26519987|P2|Treatment Phase|Not randomized by mistake|0
7621348|NCT01743989|26519988|P1|Treatment Phase|Not randomized by mistake|0
7621349|NCT01743989|26519986|P3|Treatment Phase|Patient non-compliance to treatment|3
7621350|NCT01743989|26519987|P2|Treatment Phase|Patient non-compliance to treatment|0
7621351|NCT01743989|26519988|P1|Treatment Phase|Patient non-compliance to treatment|0
7621352|NCT01743989|26519986|P3|Treatment Phase|Physician Decision|3
7621353|NCT01743989|26519987|P2|Treatment Phase|Physician Decision|0
7621354|NCT01743989|26519988|P1|Treatment Phase|Physician Decision|0
7621355|NCT01743989|26519986|P3|Treatment Phase|New cancer (CML) therapy|0
7621356|NCT01743989|26519987|P2|Treatment Phase|New cancer (CML) therapy|1
7621357|NCT01743989|26519988|P1|Treatment Phase|New cancer (CML) therapy|0
7621358|NCT01743989|26519986|P3|Treatment Phase|Administrative problems|1
7621359|NCT01743989|26519987|P2|Treatment Phase|Administrative problems|0
7621360|NCT01743989|26519988|P1|Treatment Phase|Administrative problems|0
7621361|NCT01743989|26519986|P3|Treatment Phase|Abnormal test procedure result(s)|1
7621362|NCT01743989|26519987|P2|Treatment Phase|Abnormal test procedure result(s)|0
7621363|NCT01743989|26519988|P1|Treatment Phase|Abnormal test procedure result(s)|0
7621364|NCT01743989|26519986|P3|Treatment Phase|Lost to Follow-up|2
7621365|NCT01743989|26519987|P2|Treatment Phase|Lost to Follow-up|0
7621366|NCT01743989|26519988|P1|Treatment Phase|Lost to Follow-up|0
7621367|NCT01743989|26519986|P3|Treatment Phase|Pregnancy|2
7621368|NCT01743989|26519987|P2|Treatment Phase|Pregnancy|0
7621369|NCT01743989|26519988|P1|Treatment Phase|Pregnancy|0
7621370|NCT01743989|26519986|P3|Treatment Phase|Protocol deviation|3
7621371|NCT01743989|26519987|P2|Treatment Phase|Protocol deviation|0
7621372|NCT01743989|26519988|P1|Treatment Phase|Protocol deviation|0
7621373|NCT01743989|26519986|P3|Treatment Phase|Abnormal laboratory value(s)|3
7621374|NCT01743989|26519987|P2|Treatment Phase|Abnormal laboratory value(s)|0
7621375|NCT01743989|26519988|P1|Treatment Phase|Abnormal laboratory value(s)|0
7621376|NCT01743989|26519986|P3|Treatment Phase|Death|3
7621377|NCT01743989|26519987|P2|Treatment Phase|Death|1
7621378|NCT01743989|26519988|P1|Treatment Phase|Death|0
7621379|NCT01743989|26519986|P3|Treatment Phase|Withdrawal by Subject|28
7621380|NCT01743989|26519987|P2|Treatment Phase|Withdrawal by Subject|3
7621381|NCT01743989|26519988|P1|Treatment Phase|Withdrawal by Subject|1
7621382|NCT01743989|26519986|P3|Treatment Phase|Adverse Event|67
7621383|NCT01743989|26519987|P2|Treatment Phase|Adverse Event|4
7621384|NCT01743989|26519988|P1|Treatment Phase|Adverse Event|0
7621385|NCT01743989|26519986|P3|Treatment Phase|Unstable MR4.0|263
7621386|NCT01743989|26519987|P2|Treatment Phase|Unstable MR4.0|6
7621387|NCT01743989|26519988|P1|Treatment Phase|Unstable MR4.0|0
7621388|NCT01743560|26520131|P1|Overall Study|>1 dose of study drug|3
7621389|NCT01743560|26520131|P1|Overall Study|Protocol Violation|1
7621390|NCT01743560|26520131|P1|Overall Study|Withdrawal by Subject|2
7621391|NCT01743560|26520131|P1|Overall Study|Death|3
7621392|NCT01743560|26520131|P1|Overall Study|Adverse Event|8
7621393|NCT01743560|26520131|P1|Overall Study|Disease progression|26
7621394|NCT01743469|26520215|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7621395|NCT01743469|26520216|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7621396|NCT01743469|26520217|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7621397|NCT01743469|26520218|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7621398|NCT01743469|26520215|P4|Follow-up Period - Post-Treatment|Death|16
7621399|NCT01743469|26520216|P3|Follow-up Period - Post-Treatment|Death|22
7621400|NCT01743469|26520217|P2|Follow-up Period - Post-Treatment|Death|47
7621401|NCT01743469|26520218|P1|Follow-up Period - Post-Treatment|Death|43
7621402|NCT01743469|26520215|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7621403|NCT01743469|26520216|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7621404|NCT01743469|26520217|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7621405|NCT01743469|26520218|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7621406|NCT01743469|26520215|P4|Active Treatment Phase|Missing|0
7621407|NCT01743469|26520216|P3|Active Treatment Phase|Missing|0
7621408|NCT01743469|26520217|P2|Active Treatment Phase|Missing|0
7621409|NCT01743469|26520218|P1|Active Treatment Phase|Missing|1
7621410|NCT01743469|26520215|P4|Active Treatment Phase|Withdrawal by Subject|0
7621411|NCT01743469|26520216|P3|Active Treatment Phase|Withdrawal by Subject|0
7621412|NCT01743469|26520217|P2|Active Treatment Phase|Withdrawal by Subject|3
7621413|NCT01743469|26520218|P1|Active Treatment Phase|Withdrawal by Subject|2
7621414|NCT01743469|26520215|P4|Active Treatment Phase|Disease Progression|20
7621415|NCT01743469|26520216|P3|Active Treatment Phase|Disease Progression|30
7621416|NCT01743469|26520217|P2|Active Treatment Phase|Disease Progression|47
7621417|NCT01743469|26520218|P1|Active Treatment Phase|Disease Progression|40
7621418|NCT01743469|26520215|P4|Active Treatment Phase|Adverse Event|1
7621419|NCT01743469|26520216|P3|Active Treatment Phase|Adverse Event|8
7621420|NCT01743469|26520217|P2|Active Treatment Phase|Adverse Event|5
7621421|NCT01743469|26520218|P1|Active Treatment Phase|Adverse Event|10
7621422|NCT01743092|26520283|P2|Overall Study|Lost to Follow-up|15
7621423|NCT01743092|26520284|P1|Overall Study|Lost to Follow-up|14
7621424|NCT01743040|26520292|P1|Overall Study|Withdrawal by Subject|121
7621425|NCT01743040|26520292|P1|Overall Study|Protocol Violation|1
7621426|NCT01743040|26520292|P1|Overall Study|Physician Decision|40
7621427|NCT01743040|26520292|P1|Overall Study|Lost to Follow-up|66
7621428|NCT01743040|26520292|P1|Overall Study|Death|1
7621429|NCT01743027|26520300|P4|Overall Study|Withdrawal by Subject|1
7621430|NCT01743027|26520301|P3|Overall Study|Withdrawal by Subject|3
7621431|NCT01743027|26520302|P2|Overall Study|Withdrawal by Subject|0
7621432|NCT01743027|26520303|P1|Overall Study|Withdrawal by Subject|1
7621433|NCT01743027|26520300|P4|Overall Study|Protocol Violation|0
7621434|NCT01743027|26520301|P3|Overall Study|Protocol Violation|1
7621435|NCT01743027|26520302|P2|Overall Study|Protocol Violation|1
7621436|NCT01743027|26520303|P1|Overall Study|Protocol Violation|1
7621437|NCT01743027|26520300|P4|Overall Study|Progressive Disease|0
7621438|NCT01743027|26520301|P3|Overall Study|Progressive Disease|3
7621439|NCT01743027|26520302|P2|Overall Study|Progressive Disease|4
7621440|NCT01743027|26520303|P1|Overall Study|Progressive Disease|1
7621441|NCT01743027|26520300|P4|Overall Study|Lost to Follow-up|0
7621442|NCT01743027|26520301|P3|Overall Study|Lost to Follow-up|2
7621443|NCT01743027|26520302|P2|Overall Study|Lost to Follow-up|0
7621444|NCT01743027|26520303|P1|Overall Study|Lost to Follow-up|0
7621445|NCT01743027|26520300|P4|Overall Study|Adverse Event|0
7621446|NCT01743027|26520301|P3|Overall Study|Adverse Event|0
7621447|NCT01743027|26520302|P2|Overall Study|Adverse Event|0
7621448|NCT01743027|26520303|P1|Overall Study|Adverse Event|2
7621449|NCT01743001|26520343|P2|Overall Study|Death|0
7621450|NCT01743001|26520344|P1|Overall Study|Death|1
7621451|NCT01743001|26520343|P2|Overall Study|Pregnancy|0
7621452|NCT01743001|26520344|P1|Overall Study|Pregnancy|1
7621453|NCT01743001|26520343|P2|Overall Study|Physician Decision|0
7621454|NCT01743001|26520344|P1|Overall Study|Physician Decision|1
7621455|NCT01742897|26520387|P1|Overall Study|Other|1
7621456|NCT01742897|26520387|P1|Overall Study|Withdrawal by Subject|1
7621457|NCT01742897|26520387|P1|Overall Study|Adverse Event|3
7621458|NCT01742286|26520440|P7|Expansion Phase|Withdrawal by Subject|1
7621459|NCT01742286|26520441|P6|Expansion Phase|Withdrawal by Subject|0
7621460|NCT01742286|26520442|P5|Expansion Phase|Withdrawal by Subject|0
7621461|NCT01742286|26520443|P4|Expansion Phase|Withdrawal by Subject|0
7621462|NCT01742286|26520444|P3|Expansion Phase|Withdrawal by Subject|0
7621463|NCT01742286|26520445|P2|Expansion Phase|Withdrawal by Subject|0
7621464|NCT01742286|26520446|P1|Expansion Phase|Withdrawal by Subject|0
7621465|NCT01742286|26520440|P7|Expansion Phase|Disease progression|15
7621466|NCT01742286|26520441|P6|Expansion Phase|Disease progression|0
7621467|NCT01742286|26520442|P5|Expansion Phase|Disease progression|0
7621468|NCT01742286|26520443|P4|Expansion Phase|Disease progression|0
7621469|NCT01742286|26520444|P3|Expansion Phase|Disease progression|3
7621470|NCT01742286|26520445|P2|Expansion Phase|Disease progression|0
7621471|NCT01742286|26520446|P1|Expansion Phase|Disease progression|0
7621472|NCT01742286|26520440|P7|Expansion Phase|Adverse Event|6
7621473|NCT01742286|26520441|P6|Expansion Phase|Adverse Event|0
7621474|NCT01742286|26520442|P5|Expansion Phase|Adverse Event|0
7621475|NCT01742286|26520443|P4|Expansion Phase|Adverse Event|0
7621476|NCT01742286|26520444|P3|Expansion Phase|Adverse Event|0
7621477|NCT01742286|26520445|P2|Expansion Phase|Adverse Event|0
7621478|NCT01742286|26520446|P1|Expansion Phase|Adverse Event|0
7621479|NCT01742286|26520440|P7|Expansion Phase|Physician Decision|9
7621480|NCT01742286|26520441|P6|Expansion Phase|Physician Decision|0
7621481|NCT01742286|26520442|P5|Expansion Phase|Physician Decision|0
7621482|NCT01742286|26520443|P4|Expansion Phase|Physician Decision|0
7621483|NCT01742286|26520444|P3|Expansion Phase|Physician Decision|4
7621484|NCT01742286|26520445|P2|Expansion Phase|Physician Decision|0
7621485|NCT01742286|26520446|P1|Expansion Phase|Physician Decision|0
7621486|NCT01742286|26520440|P7|Expansion Phase|Administrative problems|5
7621487|NCT01742286|26520441|P6|Expansion Phase|Administrative problems|0
7621488|NCT01742286|26520442|P5|Expansion Phase|Administrative problems|0
7621489|NCT01742286|26520443|P4|Expansion Phase|Administrative problems|0
7621490|NCT01742286|26520444|P3|Expansion Phase|Administrative problems|0
7621491|NCT01742286|26520445|P2|Expansion Phase|Administrative problems|0
7621492|NCT01742286|26520446|P1|Expansion Phase|Administrative problems|0
7621493|NCT01742286|26520440|P7|Escalation Phase|Subject/guardian decision|0
7621494|NCT01742286|26520441|P6|Escalation Phase|Subject/guardian decision|0
7621495|NCT01742286|26520442|P5|Escalation Phase|Subject/guardian decision|0
7621496|NCT01742286|26520443|P4|Escalation Phase|Subject/guardian decision|0
7621497|NCT01742286|26520444|P3|Escalation Phase|Subject/guardian decision|0
7621498|NCT01742286|26520445|P2|Escalation Phase|Subject/guardian decision|0
7621499|NCT01742286|26520446|P1|Escalation Phase|Subject/guardian decision|1
7621500|NCT01742286|26520440|P7|Escalation Phase|Physician Decision|2
7621501|NCT01742286|26520441|P6|Escalation Phase|Physician Decision|0
7621502|NCT01742286|26520442|P5|Escalation Phase|Physician Decision|0
7621503|NCT01742286|26520443|P4|Escalation Phase|Physician Decision|1
7621504|NCT01742286|26520444|P3|Escalation Phase|Physician Decision|0
7621505|NCT01742286|26520445|P2|Escalation Phase|Physician Decision|3
7621506|NCT01742286|26520446|P1|Escalation Phase|Physician Decision|0
7621507|NCT01742286|26520440|P7|Escalation Phase|Death|0
7621508|NCT01742286|26520441|P6|Escalation Phase|Death|1
7621509|NCT01742286|26520442|P5|Escalation Phase|Death|0
7621510|NCT01742286|26520443|P4|Escalation Phase|Death|0
7621511|NCT01742286|26520444|P3|Escalation Phase|Death|0
7621512|NCT01742286|26520445|P2|Escalation Phase|Death|0
7621513|NCT01742286|26520446|P1|Escalation Phase|Death|0
7621514|NCT01742286|26520440|P7|Escalation Phase|Disease progression|2
7621515|NCT01742286|26520441|P6|Escalation Phase|Disease progression|3
7621516|NCT01742286|26520442|P5|Escalation Phase|Disease progression|4
7621517|NCT01742286|26520443|P4|Escalation Phase|Disease progression|1
7621518|NCT01742286|26520444|P3|Escalation Phase|Disease progression|4
7621519|NCT01742286|26520445|P2|Escalation Phase|Disease progression|7
7621520|NCT01742286|26520446|P1|Escalation Phase|Disease progression|3
7621521|NCT01742286|26520440|P7|Escalation Phase|Adverse Event|0
7621522|NCT01742286|26520441|P6|Escalation Phase|Adverse Event|1
7621523|NCT01742286|26520442|P5|Escalation Phase|Adverse Event|0
7621524|NCT01742286|26520443|P4|Escalation Phase|Adverse Event|0
7621525|NCT01742286|26520444|P3|Escalation Phase|Adverse Event|2
7621526|NCT01742286|26520445|P2|Escalation Phase|Adverse Event|1
7621527|NCT01742286|26520446|P1|Escalation Phase|Adverse Event|0
7621528|NCT01742286|26520440|P7|Escalation Phase|Administrative problems|2
7621529|NCT01742286|26520441|P6|Escalation Phase|Administrative problems|0
7621530|NCT01742286|26520442|P5|Escalation Phase|Administrative problems|0
7621531|NCT01742286|26520443|P4|Escalation Phase|Administrative problems|0
7621532|NCT01742286|26520444|P3|Escalation Phase|Administrative problems|0
7621533|NCT01742286|26520445|P2|Escalation Phase|Administrative problems|1
7621534|NCT01742286|26520446|P1|Escalation Phase|Administrative problems|1
7621535|NCT01742091|26520579|P6|Overall Study|Lost to Follow-up|1
7621536|NCT01742091|26520580|P5|Overall Study|Lost to Follow-up|0
7621537|NCT01742091|26520581|P4|Overall Study|Lost to Follow-up|0
7621538|NCT01742091|26520582|P3|Overall Study|Lost to Follow-up|0
7621539|NCT01742091|26520583|P2|Overall Study|Lost to Follow-up|0
7621540|NCT01742091|26520584|P1|Overall Study|Lost to Follow-up|0
7621541|NCT01742091|26520579|P6|Overall Study|Withdrawal by Subject|0
7621542|NCT01742091|26520580|P5|Overall Study|Withdrawal by Subject|0
7621543|NCT01742091|26520581|P4|Overall Study|Withdrawal by Subject|1
7621544|NCT01742091|26520582|P3|Overall Study|Withdrawal by Subject|0
7621545|NCT01742091|26520583|P2|Overall Study|Withdrawal by Subject|0
7621546|NCT01742091|26520584|P1|Overall Study|Withdrawal by Subject|0
7621547|NCT01742091|26520579|P6|Overall Study|Physician Decision|1
7621548|NCT01742091|26520580|P5|Overall Study|Physician Decision|0
7621549|NCT01742091|26520581|P4|Overall Study|Physician Decision|0
7621550|NCT01742091|26520582|P3|Overall Study|Physician Decision|0
7621551|NCT01742091|26520583|P2|Overall Study|Physician Decision|0
7621552|NCT01742091|26520584|P1|Overall Study|Physician Decision|0
7621553|NCT01742091|26520579|P6|Overall Study|Adverse Event|0
7621554|NCT01742091|26520580|P5|Overall Study|Adverse Event|1
7621555|NCT01742091|26520581|P4|Overall Study|Adverse Event|0
7621556|NCT01742091|26520582|P3|Overall Study|Adverse Event|0
7621557|NCT01742091|26520583|P2|Overall Study|Adverse Event|0
7621558|NCT01742091|26520584|P1|Overall Study|Adverse Event|0
7621559|NCT01742078|26520630|P9|Overall Study|Withdrawal by Subject|0
7621560|NCT01742078|26520631|P8|Overall Study|Withdrawal by Subject|0
7621561|NCT01742078|26520632|P7|Overall Study|Withdrawal by Subject|0
7621562|NCT01742078|26520633|P6|Overall Study|Withdrawal by Subject|0
7621563|NCT01742078|26520634|P5|Overall Study|Withdrawal by Subject|0
7621564|NCT01742078|26520635|P4|Overall Study|Withdrawal by Subject|1
7621565|NCT01742078|26520636|P3|Overall Study|Withdrawal by Subject|0
7621566|NCT01742078|26520637|P2|Overall Study|Withdrawal by Subject|0
7621567|NCT01742078|26520638|P1|Overall Study|Withdrawal by Subject|0
7621568|NCT01741792|26520707|P3|Overall Study|Death|12
7621569|NCT01741792|26520708|P2|Overall Study|Death|1
7621570|NCT01741792|26520709|P1|Overall Study|Death|6
7621571|NCT01741701|26520776|P2|Overall Study|Withdrawal by Subject|1
7621572|NCT01741701|26520777|P1|Overall Study|Withdrawal by Subject|0
7621573|NCT01741701|26520776|P2|Overall Study|Adverse Event|1
7621574|NCT01741701|26520777|P1|Overall Study|Adverse Event|5
7621575|NCT01741688|26520793|P1|Overall Study|Withdrawal by Subject|1
7621576|NCT01741688|26520793|P1|Overall Study|Lack of insurance coverage|2
7621577|NCT01741545|26520812|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7621578|NCT01741545|26520813|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7621579|NCT01741545|26520812|P2|Follow-up Period (24 Weeks)|Other than specified|1
7621580|NCT01741545|26520813|P1|Follow-up Period (24 Weeks)|Other than specified|0
7621581|NCT01741545|26520812|P2|Treatment Period|Adverse event, non-fatal|3
7621582|NCT01741545|26520813|P1|Treatment Period|Adverse event, non-fatal|1
7621583|NCT01741545|26520812|P2|Treatment Period|Lack of Efficacy|1
7621584|NCT01741545|26520813|P1|Treatment Period|Lack of Efficacy|0
7621585|NCT01741532|26520837|P2|Overall Study|Medical event|0
7621586|NCT01741532|26520838|P1|Overall Study|Medical event|1
7621587|NCT01741532|26520837|P2|Overall Study|Sponsor decision|0
7621588|NCT01741532|26520838|P1|Overall Study|Sponsor decision|1
7621589|NCT01741532|26520837|P2|Overall Study|Worsening of the disease|1
7621590|NCT01741532|26520838|P1|Overall Study|Worsening of the disease|3
7621591|NCT01741532|26520837|P2|Overall Study|Protocol Violation|1
7621592|NCT01741532|26520838|P1|Overall Study|Protocol Violation|0
7621593|NCT01741532|26520837|P2|Overall Study|Withdrawal by Subject|1
7621594|NCT01741532|26520838|P1|Overall Study|Withdrawal by Subject|1
7621595|NCT01741532|26520837|P2|Overall Study|Adverse Event|0
7621596|NCT01741532|26520838|P1|Overall Study|Adverse Event|4
7621597|NCT01741259|26521052|P2|Overall Study|Withdrawal by Subject|2
7621598|NCT01741259|26521053|P1|Overall Study|Withdrawal by Subject|0
7621599|NCT01741259|26521052|P2|Overall Study|Protocol Violation|4
7621600|NCT01741259|26521053|P1|Overall Study|Protocol Violation|6
7621601|NCT01741012|26521107|P1|Overall Study|Withdrawal by Subject|2
7621602|NCT01741012|26521107|P1|Overall Study|Lost to Follow-up|1
7621603|NCT01740791|26521131|P6|Overall Study|Adverse Event|1
7621604|NCT01740791|26521132|P5|Overall Study|Adverse Event|0
7621605|NCT01740791|26521133|P4|Overall Study|Adverse Event|0
7621606|NCT01740791|26521134|P3|Overall Study|Adverse Event|0
7621607|NCT01740791|26521135|P2|Overall Study|Adverse Event|0
7621608|NCT01740791|26521136|P1|Overall Study|Adverse Event|0
7621609|NCT01740791|26521131|P6|Overall Study|Investigator's discretion|1
7621610|NCT01740791|26521132|P5|Overall Study|Investigator's discretion|0
7621611|NCT01740791|26521133|P4|Overall Study|Investigator's discretion|0
7621612|NCT01740791|26521134|P3|Overall Study|Investigator's discretion|1
7621613|NCT01740791|26521135|P2|Overall Study|Investigator's discretion|0
7621614|NCT01740791|26521136|P1|Overall Study|Investigator's discretion|1
7621615|NCT01740791|26521131|P6|Overall Study|Withdrew Consent|3
7621616|NCT01740791|26521132|P5|Overall Study|Withdrew Consent|0
7621617|NCT01740791|26521133|P4|Overall Study|Withdrew Consent|2
7621618|NCT01740791|26521134|P3|Overall Study|Withdrew Consent|1
7621619|NCT01740791|26521135|P2|Overall Study|Withdrew Consent|0
7621620|NCT01740791|26521136|P1|Overall Study|Withdrew Consent|4
7621621|NCT01740791|26521131|P6|Overall Study|Lost to Follow-up|3
7621622|NCT01740791|26521132|P5|Overall Study|Lost to Follow-up|2
7621623|NCT01740791|26521133|P4|Overall Study|Lost to Follow-up|3
7621624|NCT01740791|26521134|P3|Overall Study|Lost to Follow-up|2
7621625|NCT01740791|26521135|P2|Overall Study|Lost to Follow-up|0
7621626|NCT01740791|26521136|P1|Overall Study|Lost to Follow-up|2
7621627|NCT01740791|26521131|P6|Overall Study|Randomized but never treated|3
7621628|NCT01740791|26521132|P5|Overall Study|Randomized but never treated|1
7621629|NCT01740791|26521133|P4|Overall Study|Randomized but never treated|2
7621630|NCT01740791|26521134|P3|Overall Study|Randomized but never treated|2
7621631|NCT01740791|26521135|P2|Overall Study|Randomized but never treated|3
7621632|NCT01740791|26521136|P1|Overall Study|Randomized but never treated|5
7621633|NCT01740440|26521319|P1|Overall Study|Lost to Follow-up|3
7621634|NCT01740427|26521327|P2|Overall Study|Study terminated by Sponsor|0
7621635|NCT01740427|26521328|P1|Overall Study|Study terminated by Sponsor|1
7621636|NCT01740427|26521327|P2|Overall Study|Lost to Follow-up|0
7621637|NCT01740427|26521328|P1|Overall Study|Lost to Follow-up|1
7621638|NCT01740427|26521327|P2|Overall Study|Protocol Violation|3
7621639|NCT01740427|26521328|P1|Overall Study|Protocol Violation|5
7621640|NCT01740427|26521327|P2|Overall Study|Death|2
7621641|NCT01740427|26521328|P1|Overall Study|Death|6
7621642|NCT01740427|26521327|P2|Overall Study|Unspecified reasons|4
7621643|NCT01740427|26521328|P1|Overall Study|Unspecified reasons|6
7621644|NCT01740427|26521327|P2|Overall Study|Subject refused continued treatment|9
7621645|NCT01740427|26521328|P1|Overall Study|Subject refused continued treatment|12
7621646|NCT01740427|26521327|P2|Overall Study|Global deterioration of health status|9
7621647|NCT01740427|26521328|P1|Overall Study|Global deterioration of health status|16
7621648|NCT01740427|26521327|P2|Overall Study|Adverse Event|9
7621649|NCT01740427|26521328|P1|Overall Study|Adverse Event|20
7621650|NCT01740427|26521327|P2|Overall Study|Objective progression or relapse|125
7621651|NCT01740427|26521328|P1|Overall Study|Objective progression or relapse|172
7621652|NCT01740427|26521327|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
7621653|NCT01740427|26521328|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
7621654|NCT01740401|26521380|P1|Overall Study|Did not reach primary endpoint|2
7621655|NCT01740401|26521380|P1|Overall Study|Adverse Event|2
7621656|NCT01740401|26521380|P1|Overall Study|Progression of disease|6
7621657|NCT01740388|26521389|P2|Overall Study|Subjects missing data, completed|36
7621658|NCT01740388|26521390|P1|Overall Study|Subjects missing data, completed|41
7621659|NCT01740388|26521389|P2|Overall Study|Physician Decision|6
7621660|NCT01740388|26521390|P1|Overall Study|Physician Decision|2
7621661|NCT01740388|26521389|P2|Overall Study|Lost to Follow-up|0
7621662|NCT01740388|26521390|P1|Overall Study|Lost to Follow-up|2
7621663|NCT01740388|26521389|P2|Overall Study|Withdrawal by Subject|2
7621664|NCT01740388|26521390|P1|Overall Study|Withdrawal by Subject|1
7621665|NCT01740323|26521441|P2|Overall Study|Randomized but did not take study drug|0
7621666|NCT01740323|26521442|P1|Overall Study|Randomized but did not take study drug|1
7621667|NCT01740323|26521441|P2|Overall Study|Adverse Event|0
7621668|NCT01740323|26521442|P1|Overall Study|Adverse Event|1
7621669|NCT01740297|26521463|P3|Overall Study|Sponsor Decision|0
7621670|NCT01740297|26521464|P2|Overall Study|Sponsor Decision|1
7621671|NCT01740297|26521465|P1|Overall Study|Sponsor Decision|0
7621672|NCT01740297|26521463|P3|Overall Study|Death|19
7621673|NCT01740297|26521464|P2|Overall Study|Death|23
7621674|NCT01740297|26521465|P1|Overall Study|Death|8
7621675|NCT01740297|26521463|P3|Overall Study|Withdrawal by Subject|11
7621676|NCT01740297|26521464|P2|Overall Study|Withdrawal by Subject|9
7621677|NCT01740297|26521465|P1|Overall Study|Withdrawal by Subject|1
7621678|NCT01740297|26521463|P3|Overall Study|Continuing Study|68
7621679|NCT01740297|26521464|P2|Overall Study|Continuing Study|67
7621680|NCT01740297|26521465|P1|Overall Study|Continuing Study|10
7621681|NCT01740154|26521520|P1|Overall Study|Adverse Event|1
7621682|NCT01740128|26521528|P2|Overall Study|Insufficient protocol compliance|2
7621683|NCT01740128|26521529|P1|Overall Study|Insufficient protocol compliance|2
7621684|NCT01740128|26521528|P2|Overall Study|Withdrawal by Subject|0
7621685|NCT01740128|26521529|P1|Overall Study|Withdrawal by Subject|1
7621686|NCT01740128|26521528|P2|Overall Study|Lost to Follow-up|2
7621687|NCT01740128|26521529|P1|Overall Study|Lost to Follow-up|2
7621688|NCT01740128|26521528|P2|Overall Study|Protocol Violation|2
7621689|NCT01740128|26521529|P1|Overall Study|Protocol Violation|1
7621690|NCT01740128|26521528|P2|Overall Study|Pregnancy|1
7621691|NCT01740128|26521529|P1|Overall Study|Pregnancy|0
7621692|NCT01740089|26521558|P3|After 12 Weeks|Withdrawal by Subject|1
7621693|NCT01740089|26521559|P2|After 12 Weeks|Withdrawal by Subject|1
7621694|NCT01740089|26521560|P1|After 12 Weeks|Withdrawal by Subject|1
7621695|NCT01740089|26521558|P3|After 12 Weeks|Protocol Violation|1
7621696|NCT01740089|26521559|P2|After 12 Weeks|Protocol Violation|1
7621697|NCT01740089|26521560|P1|After 12 Weeks|Protocol Violation|1
7621698|NCT01740089|26521558|P3|After 12 Weeks|Adverse Event|5
7621699|NCT01740089|26521559|P2|After 12 Weeks|Adverse Event|0
7621700|NCT01740089|26521560|P1|After 12 Weeks|Adverse Event|2
7621701|NCT01740089|26521558|P3|After 12 Weeks|Lack of Efficacy|4
7621702|NCT01740089|26521559|P2|After 12 Weeks|Lack of Efficacy|1
7621703|NCT01740089|26521560|P1|After 12 Weeks|Lack of Efficacy|3
7621704|NCT01740089|26521558|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
7621705|NCT01740089|26521559|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
7621706|NCT01740089|26521560|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
7621707|NCT01740089|26521558|P3|First 12 Weeks of Treatment|Adverse Event|2
7621708|NCT01740089|26521559|P2|First 12 Weeks of Treatment|Adverse Event|1
7621709|NCT01740089|26521560|P1|First 12 Weeks of Treatment|Adverse Event|0
7621710|NCT01739933|26521578|P2|Overall Study|Did not speak English required for neurospychological testing|3
7621711|NCT01739933|26521579|P1|Overall Study|Did not speak English required for neurospychological testing|4
7621712|NCT01739933|26521578|P2|Overall Study|Lost to Follow-up|10
7621713|NCT01739933|26521579|P1|Overall Study|Lost to Follow-up|3
7621714|NCT01739933|26521578|P2|Overall Study|Withdrawal by Subject|8
7621715|NCT01739933|26521579|P1|Overall Study|Withdrawal by Subject|10
7621716|NCT01739933|26521578|P2|Overall Study|Death|86
7621717|NCT01739933|26521579|P1|Overall Study|Death|89
7621718|NCT01739803|26521593|P2|Overall Study|Lost to Follow-up|6
7621719|NCT01739803|26521594|P1|Overall Study|Lost to Follow-up|9
7621720|NCT01739790|26521606|P2|Overall Study|Early Trial Termination|4
7621721|NCT01739790|26521607|P1|Overall Study|Early Trial Termination|2
7621722|NCT01739764|26521616|P3|Overall Study|Withdrawal by Subject|27
7621723|NCT01739764|26521617|P2|Overall Study|Withdrawal by Subject|5
7621724|NCT01739764|26521618|P1|Overall Study|Withdrawal by Subject|6
7621725|NCT01739764|26521616|P3|Overall Study|Study Terminated by Sponsor|26
7621726|NCT01739764|26521617|P2|Overall Study|Study Terminated by Sponsor|13
7621727|NCT01739764|26521618|P1|Overall Study|Study Terminated by Sponsor|8
7621728|NCT01739764|26521616|P3|Overall Study|Protocol Violation|2
7621729|NCT01739764|26521617|P2|Overall Study|Protocol Violation|0
7621730|NCT01739764|26521618|P1|Overall Study|Protocol Violation|0
7621731|NCT01739764|26521616|P3|Overall Study|Progressive Disease|16
7621732|NCT01739764|26521617|P2|Overall Study|Progressive Disease|5
7621733|NCT01739764|26521618|P1|Overall Study|Progressive Disease|3
7621734|NCT01739764|26521616|P3|Overall Study|Physician Decision|4
7621735|NCT01739764|26521617|P2|Overall Study|Physician Decision|2
7621736|NCT01739764|26521618|P1|Overall Study|Physician Decision|2
7621737|NCT01739764|26521616|P3|Overall Study|Multiple Reasons|3
7621738|NCT01739764|26521617|P2|Overall Study|Multiple Reasons|2
7621739|NCT01739764|26521618|P1|Overall Study|Multiple Reasons|3
7621740|NCT01739764|26521616|P3|Overall Study|Non-Compliance|1
7621741|NCT01739764|26521617|P2|Overall Study|Non-Compliance|0
7621742|NCT01739764|26521618|P1|Overall Study|Non-Compliance|0
7621743|NCT01739764|26521616|P3|Overall Study|Lost to Follow-up|5
7621744|NCT01739764|26521617|P2|Overall Study|Lost to Follow-up|0
7621745|NCT01739764|26521618|P1|Overall Study|Lost to Follow-up|0
7621746|NCT01739764|26521616|P3|Overall Study|Death|38
7621747|NCT01739764|26521617|P2|Overall Study|Death|6
7621748|NCT01739764|26521618|P1|Overall Study|Death|4
7621749|NCT01739764|26521616|P3|Overall Study|Adverse Event|4
7621750|NCT01739764|26521617|P2|Overall Study|Adverse Event|3
7621751|NCT01739764|26521618|P1|Overall Study|Adverse Event|0
7621752|NCT01739595|26521632|P3|Overall Study|Drug discrepancy|0
7621753|NCT01739595|26521633|P2|Overall Study|Drug discrepancy|0
7621754|NCT01739595|26521634|P1|Overall Study|Drug discrepancy|1
7621755|NCT01739595|26521632|P3|Overall Study|Lab assessment|0
7621756|NCT01739595|26521633|P2|Overall Study|Lab assessment|0
7621757|NCT01739595|26521634|P1|Overall Study|Lab assessment|1
7621758|NCT01739595|26521632|P3|Overall Study|Protocol Violation|0
7621759|NCT01739595|26521633|P2|Overall Study|Protocol Violation|0
7621760|NCT01739595|26521634|P1|Overall Study|Protocol Violation|1
7621761|NCT01739595|26521632|P3|Overall Study|Eligibility issue|0
7621762|NCT01739595|26521633|P2|Overall Study|Eligibility issue|0
7621763|NCT01739595|26521634|P1|Overall Study|Eligibility issue|3
7621764|NCT01739595|26521632|P3|Overall Study|Withdrawal by Subject|2
7621765|NCT01739595|26521633|P2|Overall Study|Withdrawal by Subject|1
7621766|NCT01739595|26521634|P1|Overall Study|Withdrawal by Subject|2
7621767|NCT01739595|26521632|P3|Overall Study|Lost to Follow-up|0
7621768|NCT01739595|26521633|P2|Overall Study|Lost to Follow-up|0
7621769|NCT01739595|26521634|P1|Overall Study|Lost to Follow-up|2
7621770|NCT01739595|26521632|P3|Overall Study|Adverse Event|0
7621771|NCT01739595|26521633|P2|Overall Study|Adverse Event|0
7621772|NCT01739595|26521634|P1|Overall Study|Adverse Event|3
7621773|NCT01739400|26521644|P2|Overall Study|Withdrawal by Subject|7
7621774|NCT01739400|26521645|P1|Overall Study|Withdrawal by Subject|7
7621775|NCT01739400|26521644|P2|Overall Study|Death|2
7621776|NCT01739400|26521645|P1|Overall Study|Death|5
7621777|NCT01739400|26521644|P2|Overall Study|Lost to Follow-up|0
7621778|NCT01739400|26521645|P1|Overall Study|Lost to Follow-up|2
7621779|NCT01739400|26521644|P2|Overall Study|Physician Decision|0
7621780|NCT01739400|26521645|P1|Overall Study|Physician Decision|3
7621781|NCT01739348|26521673|P4|Part II (Extension Study)|Withdrawal by Subject|7
7621782|NCT01739348|26521674|P3|Part II (Extension Study)|Withdrawal by Subject|4
7621783|NCT01739348|26521675|P2|Part II (Extension Study)|Withdrawal by Subject|2
7621784|NCT01739348|26521676|P1|Part II (Extension Study)|Withdrawal by Subject|5
7621785|NCT01739348|26521673|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
7621786|NCT01739348|26521674|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
7621787|NCT01739348|26521675|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
7621788|NCT01739348|26521676|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
7621789|NCT01739348|26521673|P4|Part II (Extension Study)|Participant Moved|3
7621790|NCT01739348|26521674|P3|Part II (Extension Study)|Participant Moved|0
7621791|NCT01739348|26521675|P2|Part II (Extension Study)|Participant Moved|3
7621792|NCT01739348|26521676|P1|Part II (Extension Study)|Participant Moved|3
7621793|NCT01739348|26521673|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
7621794|NCT01739348|26521674|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
7621795|NCT01739348|26521675|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
7621796|NCT01739348|26521676|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
7621797|NCT01739348|26521673|P4|Part II (Extension Study)|Physician Decision|12
7621798|NCT01739348|26521674|P3|Part II (Extension Study)|Physician Decision|6
7621799|NCT01739348|26521675|P2|Part II (Extension Study)|Physician Decision|11
7621800|NCT01739348|26521676|P1|Part II (Extension Study)|Physician Decision|7
7621801|NCT01739348|26521673|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
7621802|NCT01739348|26521674|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
7621803|NCT01739348|26521675|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
7621804|NCT01739348|26521676|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
7621805|NCT01739348|26521673|P4|Part II (Extension Study)|Lost to Follow-up|1
7621806|NCT01739348|26521674|P3|Part II (Extension Study)|Lost to Follow-up|0
7621807|NCT01739348|26521675|P2|Part II (Extension Study)|Lost to Follow-up|4
7621808|NCT01739348|26521676|P1|Part II (Extension Study)|Lost to Follow-up|3
7621809|NCT01739348|26521673|P4|Part II (Extension Study)|Lack of Efficacy|1
7621810|NCT01739348|26521674|P3|Part II (Extension Study)|Lack of Efficacy|0
7621811|NCT01739348|26521675|P2|Part II (Extension Study)|Lack of Efficacy|5
7621812|NCT01739348|26521676|P1|Part II (Extension Study)|Lack of Efficacy|1
7621813|NCT01739348|26521673|P4|Part II (Extension Study)|Death|6
7621814|NCT01739348|26521674|P3|Part II (Extension Study)|Death|2
7621815|NCT01739348|26521675|P2|Part II (Extension Study)|Death|3
7621816|NCT01739348|26521676|P1|Part II (Extension Study)|Death|3
7621817|NCT01739348|26521673|P4|Part II (Extension Study)|Adverse Event|26
7621818|NCT01739348|26521674|P3|Part II (Extension Study)|Adverse Event|7
7621819|NCT01739348|26521675|P2|Part II (Extension Study)|Adverse Event|11
7621820|NCT01739348|26521676|P1|Part II (Extension Study)|Adverse Event|10
7621821|NCT01739348|26521673|P4|Part I (Base Study)|Withdrawal by Subject|20
7621822|NCT01739348|26521674|P3|Part I (Base Study)|Withdrawal by Subject|7
7621823|NCT01739348|26521675|P2|Part I (Base Study)|Withdrawal by Subject|21
7621824|NCT01739348|26521676|P1|Part I (Base Study)|Withdrawal by Subject|23
7621825|NCT01739348|26521673|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
7621826|NCT01739348|26521674|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
7621827|NCT01739348|26521675|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
7621828|NCT01739348|26521676|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
7621829|NCT01739348|26521673|P4|Part I (Base Study)|Participant Moved|7
7621830|NCT01739348|26521674|P3|Part I (Base Study)|Participant Moved|1
7621831|NCT01739348|26521675|P2|Part I (Base Study)|Participant Moved|3
7621832|NCT01739348|26521676|P1|Part I (Base Study)|Participant Moved|4
7621833|NCT01739348|26521673|P4|Part I (Base Study)|Study Terminated by Sponsor|86
7621834|NCT01739348|26521674|P3|Part I (Base Study)|Study Terminated by Sponsor|0
7621835|NCT01739348|26521675|P2|Part I (Base Study)|Study Terminated by Sponsor|73
7621836|NCT01739348|26521676|P1|Part I (Base Study)|Study Terminated by Sponsor|72
7621837|NCT01739348|26521673|P4|Part I (Base Study)|Site Discontinued Study Participation|0
7621838|NCT01739348|26521674|P3|Part I (Base Study)|Site Discontinued Study Participation|0
7621839|NCT01739348|26521675|P2|Part I (Base Study)|Site Discontinued Study Participation|3
7621840|NCT01739348|26521676|P1|Part I (Base Study)|Site Discontinued Study Participation|1
7621841|NCT01739348|26521673|P4|Part I (Base Study)|Screen Failure|0
7621842|NCT01739348|26521674|P3|Part I (Base Study)|Screen Failure|0
7621843|NCT01739348|26521675|P2|Part I (Base Study)|Screen Failure|0
7621844|NCT01739348|26521676|P1|Part I (Base Study)|Screen Failure|2
7621845|NCT01739348|26521673|P4|Part I (Base Study)|Protocol Violation|2
7621846|NCT01739348|26521674|P3|Part I (Base Study)|Protocol Violation|1
7621847|NCT01739348|26521675|P2|Part I (Base Study)|Protocol Violation|0
7621848|NCT01739348|26521676|P1|Part I (Base Study)|Protocol Violation|2
7621849|NCT01739348|26521673|P4|Part I (Base Study)|Physician Decision|4
7621850|NCT01739348|26521674|P3|Part I (Base Study)|Physician Decision|1
7621851|NCT01739348|26521675|P2|Part I (Base Study)|Physician Decision|7
7621852|NCT01739348|26521676|P1|Part I (Base Study)|Physician Decision|10
7621853|NCT01739348|26521673|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
7621854|NCT01739348|26521674|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
7621855|NCT01739348|26521675|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
7621856|NCT01739348|26521676|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
7621857|NCT01739348|26521673|P4|Part I (Base Study)|Lost to Follow-up|4
7621858|NCT01739348|26521674|P3|Part I (Base Study)|Lost to Follow-up|4
7621859|NCT01739348|26521675|P2|Part I (Base Study)|Lost to Follow-up|2
7621860|NCT01739348|26521676|P1|Part I (Base Study)|Lost to Follow-up|4
7621861|NCT01739348|26521673|P4|Part I (Base Study)|Lack of Efficacy|7
7621862|NCT01739348|26521674|P3|Part I (Base Study)|Lack of Efficacy|0
7621863|NCT01739348|26521675|P2|Part I (Base Study)|Lack of Efficacy|8
7621864|NCT01739348|26521676|P1|Part I (Base Study)|Lack of Efficacy|3
7621865|NCT01739348|26521673|P4|Part I (Base Study)|Death|8
7621866|NCT01739348|26521674|P3|Part I (Base Study)|Death|2
7621867|NCT01739348|26521675|P2|Part I (Base Study)|Death|7
7621868|NCT01739348|26521676|P1|Part I (Base Study)|Death|10
7621869|NCT01739348|26521673|P4|Part I (Base Study)|Adverse Event|33
7621870|NCT01739348|26521674|P3|Part I (Base Study)|Adverse Event|8
7621871|NCT01739348|26521675|P2|Part I (Base Study)|Adverse Event|52
7621872|NCT01739348|26521676|P1|Part I (Base Study)|Adverse Event|41
7621873|NCT01739335|26521748|P2|Overall Study|Ineligible patient randomized|1
7621874|NCT01739335|26521749|P1|Overall Study|Ineligible patient randomized|0
7621875|NCT01739335|26521748|P2|Overall Study|Lost to Follow-up|4
7621876|NCT01739335|26521749|P1|Overall Study|Lost to Follow-up|7
7621877|NCT01739309|26521781|P1|Overall Study|On study treatment|3
7621878|NCT01738984|26521976|P2|Overall Study|Lost to Follow-up|39
7621879|NCT01738984|26521977|P1|Overall Study|Lost to Follow-up|59
7621880|NCT01738984|26521976|P2|Overall Study|Withdrawal by Subject|0
7621881|NCT01738984|26521977|P1|Overall Study|Withdrawal by Subject|1
7621882|NCT01738984|26521976|P2|Overall Study|Pregnancy|0
7621883|NCT01738984|26521977|P1|Overall Study|Pregnancy|4
7621884|NCT01738971|26521990|P3|Overall Study|Lost to Follow-up|17
7621885|NCT01738971|26521991|P2|Overall Study|Lost to Follow-up|30
7621886|NCT01738971|26521992|P1|Overall Study|Lost to Follow-up|19
7621887|NCT01738919|26522008|P2|Overall Study|Not treated in accordance to guidelines|1
7621888|NCT01738919|26522009|P1|Overall Study|Not treated in accordance to guidelines|0
7621889|NCT01738919|26522008|P2|Overall Study|Withdrawal by Subject|1
7621890|NCT01738919|26522009|P1|Overall Study|Withdrawal by Subject|0
7621891|NCT01738919|26522008|P2|Overall Study|Immigrated|1
7621892|NCT01738919|26522009|P1|Overall Study|Immigrated|0
7621893|NCT01738919|26522008|P2|Overall Study|Lost to Follow-up|0
7621894|NCT01738919|26522009|P1|Overall Study|Lost to Follow-up|1
7621895|NCT01738646|26522159|P1|Overall Study|Still Receiving Treatment|2
7621896|NCT01738594|26522170|P8|Follow up for 1 Year|Other|0
7621897|NCT01738594|26522171|P7|Follow up for 1 Year|Other|0
7621898|NCT01738594|26522172|P6|Follow up for 1 Year|Other|2
7621899|NCT01738594|26522173|P5|Follow up for 1 Year|Other|0
7621900|NCT01738594|26522174|P4|Follow up for 1 Year|Other|0
7621901|NCT01738594|26522175|P3|Follow up for 1 Year|Other|0
7621902|NCT01738594|26522176|P2|Follow up for 1 Year|Other|0
7621903|NCT01738594|26522177|P1|Follow up for 1 Year|Other|0
7621904|NCT01738594|26522170|P8|Follow up for 1 Year|Death|0
7621905|NCT01738594|26522171|P7|Follow up for 1 Year|Death|0
7621906|NCT01738594|26522172|P6|Follow up for 1 Year|Death|1
7621907|NCT01738594|26522173|P5|Follow up for 1 Year|Death|0
7621908|NCT01738594|26522174|P4|Follow up for 1 Year|Death|0
7621909|NCT01738594|26522175|P3|Follow up for 1 Year|Death|0
7621910|NCT01738594|26522176|P2|Follow up for 1 Year|Death|0
7621911|NCT01738594|26522177|P1|Follow up for 1 Year|Death|0
7621912|NCT01738594|26522170|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621913|NCT01738594|26522171|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621914|NCT01738594|26522172|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621915|NCT01738594|26522173|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
7621916|NCT01738594|26522174|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621917|NCT01738594|26522175|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621918|NCT01738594|26522176|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621919|NCT01738594|26522177|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7621920|NCT01738594|26522170|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621921|NCT01738594|26522171|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621922|NCT01738594|26522172|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
7621923|NCT01738594|26522173|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621924|NCT01738594|26522174|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621925|NCT01738594|26522175|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621926|NCT01738594|26522176|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621927|NCT01738594|26522177|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7621928|NCT01738594|26522170|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621929|NCT01738594|26522171|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621930|NCT01738594|26522172|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
7621931|NCT01738594|26522173|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621932|NCT01738594|26522174|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621933|NCT01738594|26522175|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621934|NCT01738594|26522176|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621935|NCT01738594|26522177|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
7621936|NCT01738594|26522170|P8|Completed 4 Cycles of Treatment|Progressive disease|0
7621937|NCT01738594|26522171|P7|Completed 4 Cycles of Treatment|Progressive disease|0
7621938|NCT01738594|26522172|P6|Completed 4 Cycles of Treatment|Progressive disease|0
7621939|NCT01738594|26522173|P5|Completed 4 Cycles of Treatment|Progressive disease|0
7621940|NCT01738594|26522174|P4|Completed 4 Cycles of Treatment|Progressive disease|0
7621941|NCT01738594|26522175|P3|Completed 4 Cycles of Treatment|Progressive disease|0
7621942|NCT01738594|26522176|P2|Completed 4 Cycles of Treatment|Progressive disease|2
7621943|NCT01738594|26522177|P1|Completed 4 Cycles of Treatment|Progressive disease|0
7621944|NCT01738594|26522170|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621945|NCT01738594|26522171|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621946|NCT01738594|26522172|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
7621947|NCT01738594|26522173|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621948|NCT01738594|26522174|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621949|NCT01738594|26522175|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621950|NCT01738594|26522176|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621951|NCT01738594|26522177|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7621952|NCT01738594|26522170|P8|Registration and Treatment Start|Adverse Event|0
7621953|NCT01738594|26522171|P7|Registration and Treatment Start|Adverse Event|0
7621954|NCT01738594|26522172|P6|Registration and Treatment Start|Adverse Event|0
7621955|NCT01738594|26522173|P5|Registration and Treatment Start|Adverse Event|0
7621956|NCT01738594|26522174|P4|Registration and Treatment Start|Adverse Event|0
7621957|NCT01738594|26522175|P3|Registration and Treatment Start|Adverse Event|0
7621958|NCT01738594|26522176|P2|Registration and Treatment Start|Adverse Event|1
7621959|NCT01738594|26522177|P1|Registration and Treatment Start|Adverse Event|0
7621960|NCT01738581|26522195|P2|Overall Study|Lost to Follow-up|0
7621961|NCT01738581|26522196|P1|Overall Study|Lost to Follow-up|1
7621962|NCT01738503|26522220|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7621963|NCT01738503|26522221|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7621964|NCT01738503|26522222|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7621965|NCT01738503|26522223|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7621966|NCT01738503|26522224|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7621967|NCT01738503|26522225|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7621968|NCT01738503|26522226|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7621969|NCT01738503|26522220|P7|PET Imaging Sub-study|Adverse Event|0
7621970|NCT01738503|26522221|P6|PET Imaging Sub-study|Adverse Event|1
7621971|NCT01738503|26522222|P5|PET Imaging Sub-study|Adverse Event|0
7621972|NCT01738503|26522223|P4|PET Imaging Sub-study|Adverse Event|0
7621973|NCT01738503|26522224|P3|PET Imaging Sub-study|Adverse Event|0
7621974|NCT01738503|26522225|P2|PET Imaging Sub-study|Adverse Event|0
7621975|NCT01738503|26522226|P1|PET Imaging Sub-study|Adverse Event|0
7621976|NCT01738503|26522220|P7|Treatment Period|Other|0
7621977|NCT01738503|26522221|P6|Treatment Period|Other|0
7621978|NCT01738503|26522222|P5|Treatment Period|Other|0
7621979|NCT01738503|26522223|P4|Treatment Period|Other|0
7621980|NCT01738503|26522224|P3|Treatment Period|Other|1
7621981|NCT01738503|26522225|P2|Treatment Period|Other|0
7621982|NCT01738503|26522226|P1|Treatment Period|Other|0
7621983|NCT01738503|26522220|P7|Treatment Period|Protocol Violation|0
7621984|NCT01738503|26522221|P6|Treatment Period|Protocol Violation|2
7621985|NCT01738503|26522222|P5|Treatment Period|Protocol Violation|4
7621986|NCT01738503|26522223|P4|Treatment Period|Protocol Violation|0
7621987|NCT01738503|26522224|P3|Treatment Period|Protocol Violation|1
7621988|NCT01738503|26522225|P2|Treatment Period|Protocol Violation|3
7621989|NCT01738503|26522226|P1|Treatment Period|Protocol Violation|0
7621990|NCT01738503|26522220|P7|Treatment Period|Withdrawal by Subject|1
7621991|NCT01738503|26522221|P6|Treatment Period|Withdrawal by Subject|1
7621992|NCT01738503|26522222|P5|Treatment Period|Withdrawal by Subject|1
7621993|NCT01738503|26522223|P4|Treatment Period|Withdrawal by Subject|1
7621994|NCT01738503|26522224|P3|Treatment Period|Withdrawal by Subject|0
7621995|NCT01738503|26522225|P2|Treatment Period|Withdrawal by Subject|1
7621996|NCT01738503|26522226|P1|Treatment Period|Withdrawal by Subject|0
7621997|NCT01738503|26522220|P7|Treatment Period|Lost to Follow-up|5
7621998|NCT01738503|26522221|P6|Treatment Period|Lost to Follow-up|1
7621999|NCT01738503|26522222|P5|Treatment Period|Lost to Follow-up|1
7622000|NCT01738503|26522223|P4|Treatment Period|Lost to Follow-up|4
7622001|NCT01738503|26522224|P3|Treatment Period|Lost to Follow-up|3
7622002|NCT01738503|26522225|P2|Treatment Period|Lost to Follow-up|0
7622003|NCT01738503|26522226|P1|Treatment Period|Lost to Follow-up|0
7622004|NCT01738503|26522220|P7|Treatment Period|Adverse Event|2
7622005|NCT01738503|26522221|P6|Treatment Period|Adverse Event|2
7622006|NCT01738503|26522222|P5|Treatment Period|Adverse Event|2
7622007|NCT01738503|26522223|P4|Treatment Period|Adverse Event|1
7622008|NCT01738503|26522224|P3|Treatment Period|Adverse Event|0
7622009|NCT01738503|26522225|P2|Treatment Period|Adverse Event|1
7622010|NCT01738503|26522226|P1|Treatment Period|Adverse Event|0
7622011|NCT01738503|26522220|P7|Induction/Stabilization (Days -14 to -1)|Other|0
7622012|NCT01738503|26522221|P6|Induction/Stabilization (Days -14 to -1)|Other|0
7622013|NCT01738503|26522222|P5|Induction/Stabilization (Days -14 to -1)|Other|0
7622014|NCT01738503|26522223|P4|Induction/Stabilization (Days -14 to -1)|Other|0
7622015|NCT01738503|26522224|P3|Induction/Stabilization (Days -14 to -1)|Other|0
7622016|NCT01738503|26522225|P2|Induction/Stabilization (Days -14 to -1)|Other|0
7622017|NCT01738503|26522226|P1|Induction/Stabilization (Days -14 to -1)|Other|35
7622018|NCT01738477|26522424|P2|Overall Study|Lost to Follow-up|4
7622019|NCT01738477|26522425|P1|Overall Study|Lost to Follow-up|1
7622020|NCT01738438|26522453|P1|Overall Study|Adverse Event|3
7622021|NCT01738438|26522453|P1|Overall Study|Disease Progression|32
7622022|NCT01738191|26522470|P2|Overall Study|Withdrawal by Subject|1
7622023|NCT01738191|26522471|P1|Overall Study|Withdrawal by Subject|4
7622024|NCT01737996|26522494|P3|Overall Study|Withdrawal by Subject|1
7622025|NCT01737996|26522495|P2|Overall Study|Withdrawal by Subject|0
7622026|NCT01737996|26522496|P1|Overall Study|Withdrawal by Subject|0
7622027|NCT01737996|26522494|P3|Overall Study|Adverse Event|1
7622028|NCT01737996|26522495|P2|Overall Study|Adverse Event|1
7622029|NCT01737996|26522496|P1|Overall Study|Adverse Event|0
7622030|NCT01737931|26522558|P3|Overall Study|Physician Decision|0
7622031|NCT01737931|26522559|P2|Overall Study|Physician Decision|1
7622032|NCT01737931|26522560|P1|Overall Study|Physician Decision|0
7622033|NCT01737931|26522558|P3|Overall Study|Withdrawal by Subject|1
7622034|NCT01737931|26522559|P2|Overall Study|Withdrawal by Subject|1
7622035|NCT01737931|26522560|P1|Overall Study|Withdrawal by Subject|0
7622036|NCT01737879|26522575|P1|Overall Study|Sponsor decision|40
7622037|NCT01737879|26522575|P1|Overall Study|Death|1
7622038|NCT01737840|26522584|P2|Overall Study|Diagnosed with an other pathology|2
7622039|NCT01737840|26522585|P1|Overall Study|Diagnosed with an other pathology|2
7622040|NCT01737762|26522595|P2|Overall Study|Trial termination|9
7622041|NCT01737762|26522596|P1|Overall Study|Trial termination|11
7622042|NCT01737762|26522595|P2|Overall Study|Moved from area|1
7622043|NCT01737762|26522596|P1|Overall Study|Moved from area|2
7622044|NCT01737762|26522595|P2|Overall Study|Physician Decision|1
7622045|NCT01737762|26522596|P1|Overall Study|Physician Decision|1
7622046|NCT01737762|26522595|P2|Overall Study|Progressive disease|2
7622047|NCT01737762|26522596|P1|Overall Study|Progressive disease|1
7622048|NCT01737762|26522595|P2|Overall Study|Withdrawal by Subject|2
7622049|NCT01737762|26522596|P1|Overall Study|Withdrawal by Subject|2
7622050|NCT01737762|26522595|P2|Overall Study|Lost to Follow-up|0
7622051|NCT01737762|26522596|P1|Overall Study|Lost to Follow-up|1
7622052|NCT01737762|26522595|P2|Overall Study|Adverse Event|2
7622053|NCT01737762|26522596|P1|Overall Study|Adverse Event|2
7622054|NCT01737710|26522609|P5|Overall Study|Vaccinated in Error/Ineligible|0
7622055|NCT01737710|26522610|P4|Overall Study|Vaccinated in Error/Ineligible|0
7622056|NCT01737710|26522611|P3|Overall Study|Vaccinated in Error/Ineligible|0
7622057|NCT01737710|26522612|P2|Overall Study|Vaccinated in Error/Ineligible|1
7622058|NCT01737710|26522613|P1|Overall Study|Vaccinated in Error/Ineligible|1
7622059|NCT01737710|26522609|P5|Overall Study|Withdrawal by Subject|0
7622060|NCT01737710|26522610|P4|Overall Study|Withdrawal by Subject|0
7622061|NCT01737710|26522611|P3|Overall Study|Withdrawal by Subject|1
7622062|NCT01737710|26522612|P2|Overall Study|Withdrawal by Subject|1
7622063|NCT01737710|26522613|P1|Overall Study|Withdrawal by Subject|1
7622064|NCT01737710|26522609|P5|Overall Study|Lost to Follow-up|0
7622065|NCT01737710|26522610|P4|Overall Study|Lost to Follow-up|0
7622066|NCT01737710|26522611|P3|Overall Study|Lost to Follow-up|2
7622067|NCT01737710|26522612|P2|Overall Study|Lost to Follow-up|2
7622068|NCT01737710|26522613|P1|Overall Study|Lost to Follow-up|0
7622069|NCT01737697|26522655|P15|Subacute Phase|Death|0
7622070|NCT01737697|26522656|P14|Subacute Phase|Death|0
7622071|NCT01737697|26522657|P13|Subacute Phase|Death|0
7622072|NCT01737697|26522658|P12|Subacute Phase|Death|0
7622073|NCT01737697|26522659|P11|Subacute Phase|Death|1
7622074|NCT01737697|26522660|P10|Subacute Phase|Death|0
7622075|NCT01737697|26522661|P9|Subacute Phase|Death|0
7622076|NCT01737697|26522662|P8|Subacute Phase|Death|0
7622077|NCT01737697|26522663|P7|Subacute Phase|Death|0
7622078|NCT01737697|26522664|P6|Subacute Phase|Death|0
7622079|NCT01737697|26522665|P5|Subacute Phase|Death|0
7622080|NCT01737697|26522666|P4|Subacute Phase|Death|0
7622081|NCT01737697|26522667|P3|Subacute Phase|Death|0
7622082|NCT01737697|26522668|P2|Subacute Phase|Death|0
7622083|NCT01737697|26522669|P1|Subacute Phase|Death|0
7622084|NCT01737697|26522655|P15|Subacute Phase|Physician Decision|0
7622085|NCT01737697|26522656|P14|Subacute Phase|Physician Decision|0
7622086|NCT01737697|26522657|P13|Subacute Phase|Physician Decision|0
7622087|NCT01737697|26522658|P12|Subacute Phase|Physician Decision|0
7622088|NCT01737697|26522659|P11|Subacute Phase|Physician Decision|0
7622089|NCT01737697|26522660|P10|Subacute Phase|Physician Decision|0
7622090|NCT01737697|26522661|P9|Subacute Phase|Physician Decision|1
7622091|NCT01737697|26522662|P8|Subacute Phase|Physician Decision|0
7622092|NCT01737697|26522663|P7|Subacute Phase|Physician Decision|0
7622093|NCT01737697|26522664|P6|Subacute Phase|Physician Decision|0
7622094|NCT01737697|26522665|P5|Subacute Phase|Physician Decision|0
7622095|NCT01737697|26522666|P4|Subacute Phase|Physician Decision|0
7622096|NCT01737697|26522667|P3|Subacute Phase|Physician Decision|0
7622097|NCT01737697|26522668|P2|Subacute Phase|Physician Decision|0
7622098|NCT01737697|26522669|P1|Subacute Phase|Physician Decision|0
7622099|NCT01737697|26522655|P15|Subacute Phase|Protocol Violation|0
7622100|NCT01737697|26522656|P14|Subacute Phase|Protocol Violation|0
7622101|NCT01737697|26522657|P13|Subacute Phase|Protocol Violation|0
7622102|NCT01737697|26522658|P12|Subacute Phase|Protocol Violation|0
7622103|NCT01737697|26522659|P11|Subacute Phase|Protocol Violation|1
7622104|NCT01737697|26522660|P10|Subacute Phase|Protocol Violation|0
7622105|NCT01737697|26522661|P9|Subacute Phase|Protocol Violation|0
7622106|NCT01737697|26522662|P8|Subacute Phase|Protocol Violation|0
7622107|NCT01737697|26522663|P7|Subacute Phase|Protocol Violation|0
7622108|NCT01737697|26522664|P6|Subacute Phase|Protocol Violation|1
7622109|NCT01737697|26522665|P5|Subacute Phase|Protocol Violation|0
7622110|NCT01737697|26522666|P4|Subacute Phase|Protocol Violation|0
7622111|NCT01737697|26522667|P3|Subacute Phase|Protocol Violation|0
7622112|NCT01737697|26522668|P2|Subacute Phase|Protocol Violation|0
7622113|NCT01737697|26522669|P1|Subacute Phase|Protocol Violation|0
7622114|NCT01737697|26522655|P15|Subacute Phase|Hypo-or hyperkalemia|0
7622115|NCT01737697|26522656|P14|Subacute Phase|Hypo-or hyperkalemia|1
7622116|NCT01737697|26522657|P13|Subacute Phase|Hypo-or hyperkalemia|0
7622117|NCT01737697|26522658|P12|Subacute Phase|Hypo-or hyperkalemia|1
7622118|NCT01737697|26522659|P11|Subacute Phase|Hypo-or hyperkalemia|0
7622119|NCT01737697|26522660|P10|Subacute Phase|Hypo-or hyperkalemia|0
7622120|NCT01737697|26522661|P9|Subacute Phase|Hypo-or hyperkalemia|0
7622121|NCT01737697|26522662|P8|Subacute Phase|Hypo-or hyperkalemia|0
7622122|NCT01737697|26522663|P7|Subacute Phase|Hypo-or hyperkalemia|0
7622123|NCT01737697|26522664|P6|Subacute Phase|Hypo-or hyperkalemia|0
7622124|NCT01737697|26522665|P5|Subacute Phase|Hypo-or hyperkalemia|0
7622125|NCT01737697|26522666|P4|Subacute Phase|Hypo-or hyperkalemia|0
7622126|NCT01737697|26522667|P3|Subacute Phase|Hypo-or hyperkalemia|0
7622127|NCT01737697|26522668|P2|Subacute Phase|Hypo-or hyperkalemia|0
7622128|NCT01737697|26522669|P1|Subacute Phase|Hypo-or hyperkalemia|0
7622129|NCT01737697|26522655|P15|Subacute Phase|Lost to Follow-up|1
7622130|NCT01737697|26522656|P14|Subacute Phase|Lost to Follow-up|0
7622131|NCT01737697|26522657|P13|Subacute Phase|Lost to Follow-up|0
7622132|NCT01737697|26522658|P12|Subacute Phase|Lost to Follow-up|0
7622133|NCT01737697|26522659|P11|Subacute Phase|Lost to Follow-up|0
7622134|NCT01737697|26522660|P10|Subacute Phase|Lost to Follow-up|0
7622135|NCT01737697|26522661|P9|Subacute Phase|Lost to Follow-up|0
7622136|NCT01737697|26522662|P8|Subacute Phase|Lost to Follow-up|0
7622137|NCT01737697|26522663|P7|Subacute Phase|Lost to Follow-up|0
7622138|NCT01737697|26522664|P6|Subacute Phase|Lost to Follow-up|0
7622139|NCT01737697|26522665|P5|Subacute Phase|Lost to Follow-up|0
7622140|NCT01737697|26522666|P4|Subacute Phase|Lost to Follow-up|0
7622141|NCT01737697|26522667|P3|Subacute Phase|Lost to Follow-up|0
7622142|NCT01737697|26522668|P2|Subacute Phase|Lost to Follow-up|0
7622143|NCT01737697|26522669|P1|Subacute Phase|Lost to Follow-up|0
7622144|NCT01737697|26522655|P15|Subacute Phase|Withdrawal by Subject|0
7622145|NCT01737697|26522656|P14|Subacute Phase|Withdrawal by Subject|1
7622146|NCT01737697|26522657|P13|Subacute Phase|Withdrawal by Subject|1
7622147|NCT01737697|26522658|P12|Subacute Phase|Withdrawal by Subject|1
7622148|NCT01737697|26522659|P11|Subacute Phase|Withdrawal by Subject|0
7622149|NCT01737697|26522660|P10|Subacute Phase|Withdrawal by Subject|1
7622150|NCT01737697|26522661|P9|Subacute Phase|Withdrawal by Subject|0
7622151|NCT01737697|26522662|P8|Subacute Phase|Withdrawal by Subject|2
7622152|NCT01737697|26522663|P7|Subacute Phase|Withdrawal by Subject|0
7622153|NCT01737697|26522664|P6|Subacute Phase|Withdrawal by Subject|1
7622154|NCT01737697|26522665|P5|Subacute Phase|Withdrawal by Subject|0
7622155|NCT01737697|26522666|P4|Subacute Phase|Withdrawal by Subject|0
7622156|NCT01737697|26522667|P3|Subacute Phase|Withdrawal by Subject|0
7622157|NCT01737697|26522668|P2|Subacute Phase|Withdrawal by Subject|0
7622158|NCT01737697|26522669|P1|Subacute Phase|Withdrawal by Subject|0
7622159|NCT01737697|26522655|P15|Subacute Phase|Adverse Event|0
7622160|NCT01737697|26522656|P14|Subacute Phase|Adverse Event|0
7622161|NCT01737697|26522657|P13|Subacute Phase|Adverse Event|1
7622162|NCT01737697|26522658|P12|Subacute Phase|Adverse Event|1
7622163|NCT01737697|26522659|P11|Subacute Phase|Adverse Event|4
7622164|NCT01737697|26522660|P10|Subacute Phase|Adverse Event|1
7622165|NCT01737697|26522661|P9|Subacute Phase|Adverse Event|1
7622166|NCT01737697|26522662|P8|Subacute Phase|Adverse Event|1
7622167|NCT01737697|26522663|P7|Subacute Phase|Adverse Event|1
7622168|NCT01737697|26522664|P6|Subacute Phase|Adverse Event|1
7622169|NCT01737697|26522665|P5|Subacute Phase|Adverse Event|0
7622170|NCT01737697|26522666|P4|Subacute Phase|Adverse Event|0
7622171|NCT01737697|26522667|P3|Subacute Phase|Adverse Event|0
7622172|NCT01737697|26522668|P2|Subacute Phase|Adverse Event|0
7622173|NCT01737697|26522669|P1|Subacute Phase|Adverse Event|0
7622174|NCT01737697|26522655|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622175|NCT01737697|26522656|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622176|NCT01737697|26522657|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622177|NCT01737697|26522658|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622178|NCT01737697|26522659|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622179|NCT01737697|26522660|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622180|NCT01737697|26522661|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622181|NCT01737697|26522662|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622182|NCT01737697|26522663|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622183|NCT01737697|26522664|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622184|NCT01737697|26522665|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7622185|NCT01737697|26522666|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
7622186|NCT01737697|26522667|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7622187|NCT01737697|26522668|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7622188|NCT01737697|26522669|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7622189|NCT01737697|26522655|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622190|NCT01737697|26522656|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622191|NCT01737697|26522657|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622192|NCT01737697|26522658|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622193|NCT01737697|26522659|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622194|NCT01737697|26522660|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622195|NCT01737697|26522661|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622196|NCT01737697|26522662|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622197|NCT01737697|26522663|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622198|NCT01737697|26522664|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622199|NCT01737697|26522665|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
7622200|NCT01737697|26522666|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622201|NCT01737697|26522667|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622202|NCT01737697|26522668|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622203|NCT01737697|26522669|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7622204|NCT01737697|26522655|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622205|NCT01737697|26522656|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622206|NCT01737697|26522657|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622207|NCT01737697|26522658|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622208|NCT01737697|26522659|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622209|NCT01737697|26522660|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622210|NCT01737697|26522661|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622211|NCT01737697|26522662|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622212|NCT01737697|26522663|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622213|NCT01737697|26522664|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622214|NCT01737697|26522665|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622215|NCT01737697|26522666|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622216|NCT01737697|26522667|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622217|NCT01737697|26522668|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
7622218|NCT01737697|26522669|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7622219|NCT01737697|26522655|P15|Acute Phase-Initial 48 Hours|Family emergency|0
7622220|NCT01737697|26522656|P14|Acute Phase-Initial 48 Hours|Family emergency|0
7622221|NCT01737697|26522657|P13|Acute Phase-Initial 48 Hours|Family emergency|0
7622222|NCT01737697|26522658|P12|Acute Phase-Initial 48 Hours|Family emergency|0
7622223|NCT01737697|26522659|P11|Acute Phase-Initial 48 Hours|Family emergency|0
7622224|NCT01737697|26522660|P10|Acute Phase-Initial 48 Hours|Family emergency|0
7622225|NCT01737697|26522661|P9|Acute Phase-Initial 48 Hours|Family emergency|0
7622226|NCT01737697|26522662|P8|Acute Phase-Initial 48 Hours|Family emergency|0
7622227|NCT01737697|26522663|P7|Acute Phase-Initial 48 Hours|Family emergency|0
7622228|NCT01737697|26522664|P6|Acute Phase-Initial 48 Hours|Family emergency|0
7622229|NCT01737697|26522665|P5|Acute Phase-Initial 48 Hours|Family emergency|0
7622230|NCT01737697|26522666|P4|Acute Phase-Initial 48 Hours|Family emergency|1
7622231|NCT01737697|26522667|P3|Acute Phase-Initial 48 Hours|Family emergency|0
7622232|NCT01737697|26522668|P2|Acute Phase-Initial 48 Hours|Family emergency|0
7622233|NCT01737697|26522669|P1|Acute Phase-Initial 48 Hours|Family emergency|0
7622234|NCT01737697|26522655|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622235|NCT01737697|26522656|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622236|NCT01737697|26522657|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622237|NCT01737697|26522658|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622238|NCT01737697|26522659|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622239|NCT01737697|26522660|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622240|NCT01737697|26522661|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622241|NCT01737697|26522662|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622242|NCT01737697|26522663|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622243|NCT01737697|26522664|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622244|NCT01737697|26522665|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622245|NCT01737697|26522666|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7622246|NCT01737697|26522667|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
7622247|NCT01737697|26522668|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7622248|NCT01737697|26522669|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7622249|NCT01737697|26522655|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
7622250|NCT01737697|26522656|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
7622251|NCT01737697|26522657|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
7622252|NCT01737697|26522658|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
7622253|NCT01737697|26522659|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
7622254|NCT01737697|26522660|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
7622255|NCT01737697|26522661|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
7622256|NCT01737697|26522662|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
7622257|NCT01737697|26522663|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
7622258|NCT01737697|26522664|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
7622259|NCT01737697|26522665|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
7622260|NCT01737697|26522666|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
7622261|NCT01737697|26522667|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
7622262|NCT01737697|26522668|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
7622263|NCT01737697|26522669|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
7622264|NCT01737398|26522812|P2|Overall Study|Sponsor's decision|0
7622265|NCT01737398|26522813|P1|Overall Study|Sponsor's decision|2
7622266|NCT01737398|26522812|P2|Overall Study|Disease progression|3
7622267|NCT01737398|26522813|P1|Overall Study|Disease progression|2
7622268|NCT01737398|26522812|P2|Overall Study|Liver transplant|0
7622269|NCT01737398|26522813|P1|Overall Study|Liver transplant|1
7622270|NCT01737398|26522812|P2|Overall Study|Ineligibility|0
7622271|NCT01737398|26522813|P1|Overall Study|Ineligibility|1
7622272|NCT01737398|26522812|P2|Overall Study|Voluntary withdrawal|3
7622273|NCT01737398|26522813|P1|Overall Study|Voluntary withdrawal|2
7622274|NCT01737398|26522812|P2|Overall Study|Stopping rule met|1
7622275|NCT01737398|26522813|P1|Overall Study|Stopping rule met|2
7622276|NCT01737398|26522812|P2|Overall Study|Adverse event or SAE|1
7622277|NCT01737398|26522813|P1|Overall Study|Adverse event or SAE|16
7622278|NCT01737268|26522866|P1|Overall Study|In consideration of the patient's safety|1
7622279|NCT01737268|26522866|P1|Overall Study|Worsening of Target Disease|2
7622280|NCT01737268|26522866|P1|Overall Study|Adverse Event|6
7622281|NCT01737021|26522880|P2|Overall Study|Lost to Follow-up|3
7622282|NCT01737021|26522881|P1|Overall Study|Lost to Follow-up|5
7622283|NCT01736917|26522933|P1|Overall Study|Protocol Violation|10
7622284|NCT01736917|26522933|P1|Overall Study|Adverse Event|1
7622285|NCT01736696|26522973|P7|Overall Study|Withdrawal by Subject|0
7622286|NCT01736696|26522974|P6|Overall Study|Withdrawal by Subject|0
7622287|NCT01736696|26522975|P5|Overall Study|Withdrawal by Subject|0
7622288|NCT01736696|26522976|P4|Overall Study|Withdrawal by Subject|0
7622289|NCT01736696|26522977|P3|Overall Study|Withdrawal by Subject|1
7622290|NCT01736696|26522978|P2|Overall Study|Withdrawal by Subject|0
7622291|NCT01736696|26522979|P1|Overall Study|Withdrawal by Subject|0
7622292|NCT01736683|26523301|P5|Overall Study|Other|1
7622293|NCT01736683|26523302|P4|Overall Study|Other|9
7622294|NCT01736683|26523303|P3|Overall Study|Other|1
7622295|NCT01736683|26523304|P2|Overall Study|Other|0
7622296|NCT01736683|26523305|P1|Overall Study|Other|0
7622297|NCT01736683|26523301|P5|Overall Study|Progressive Disease|0
7622298|NCT01736683|26523302|P4|Overall Study|Progressive Disease|1
7622299|NCT01736683|26523303|P3|Overall Study|Progressive Disease|0
7622300|NCT01736683|26523304|P2|Overall Study|Progressive Disease|0
7622301|NCT01736683|26523305|P1|Overall Study|Progressive Disease|0
7622302|NCT01736683|26523301|P5|Overall Study|Lack of Therapeutic Effect|1
7622303|NCT01736683|26523302|P4|Overall Study|Lack of Therapeutic Effect|20
7622304|NCT01736683|26523303|P3|Overall Study|Lack of Therapeutic Effect|13
7622305|NCT01736683|26523304|P2|Overall Study|Lack of Therapeutic Effect|4
7622306|NCT01736683|26523305|P1|Overall Study|Lack of Therapeutic Effect|7
7622307|NCT01736683|26523301|P5|Overall Study|Withdrawal by Subject|1
7622308|NCT01736683|26523302|P4|Overall Study|Withdrawal by Subject|1
7622309|NCT01736683|26523303|P3|Overall Study|Withdrawal by Subject|3
7622310|NCT01736683|26523304|P2|Overall Study|Withdrawal by Subject|0
7622311|NCT01736683|26523305|P1|Overall Study|Withdrawal by Subject|0
7622312|NCT01736683|26523301|P5|Overall Study|Adverse Event|2
7622313|NCT01736683|26523302|P4|Overall Study|Adverse Event|3
7622314|NCT01736683|26523303|P3|Overall Study|Adverse Event|2
7622315|NCT01736683|26523304|P2|Overall Study|Adverse Event|2
7622316|NCT01736683|26523305|P1|Overall Study|Adverse Event|0
7622317|NCT01736683|26523301|P5|Overall Study|Disease Relapse|0
7622318|NCT01736683|26523302|P4|Overall Study|Disease Relapse|1
7622319|NCT01736683|26523303|P3|Overall Study|Disease Relapse|2
7622320|NCT01736683|26523304|P2|Overall Study|Disease Relapse|0
7622321|NCT01736683|26523305|P1|Overall Study|Disease Relapse|0
7622322|NCT01736657|26523367|P1|Overall Study|insufficient vascular access|1
7622323|NCT01736579|26523376|P2|Overall Study|Termination of Study by Sponsor|2
7622324|NCT01736579|26523377|P1|Overall Study|Termination of Study by Sponsor|2
7622325|NCT01736566|26523416|P5|Long Term Follow-up|Still collecting data|1
7622326|NCT01736566|26523417|P4|Long Term Follow-up|Still collecting data|0
7622327|NCT01736566|26523418|P3|Long Term Follow-up|Still collecting data|49
7622328|NCT01736566|26523419|P2|Long Term Follow-up|Still collecting data|0
7622329|NCT01736566|26523420|P1|Long Term Follow-up|Still collecting data|42
7622330|NCT01736553|26523505|P2|Overall Study|Lost to Follow-up|2
7622331|NCT01736553|26523506|P1|Overall Study|Lost to Follow-up|2
7622332|NCT01736553|26523505|P2|Overall Study|Withdrawal by Subject|2
7622333|NCT01736553|26523506|P1|Overall Study|Withdrawal by Subject|5
7622334|NCT01736553|26523505|P2|Overall Study|Death|0
7622335|NCT01736553|26523506|P1|Overall Study|Death|12
7622336|NCT01736540|26523557|P1|Overall Study|Unable to make MRI appointment|3
7622337|NCT01736540|26523557|P1|Overall Study|No show for MRI appointment|1
7622338|NCT01736540|26523557|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
7622339|NCT01736540|26523557|P1|Overall Study|Protocol Violation|1
7622340|NCT01736540|26523557|P1|Overall Study|Withdrawal by Subject|5
7622341|NCT01736540|26523557|P1|Overall Study|Abnormal test procedure|1
7622342|NCT01736540|26523557|P1|Overall Study|Death|1
7622343|NCT01736540|26523557|P1|Overall Study|Did not complete scan within 45 days|2
7622344|NCT01736475|26523623|P2|Overall Study|Other - Surgical procedure|0
7622345|NCT01736475|26523624|P1|Overall Study|Other - Surgical procedure|1
7622346|NCT01736475|26523623|P2|Overall Study|Other - Screen failure|0
7622347|NCT01736475|26523624|P1|Overall Study|Other - Screen failure|1
7622348|NCT01736475|26523623|P2|Overall Study|Protocol Violation|0
7622349|NCT01736475|26523624|P1|Overall Study|Protocol Violation|4
7622350|NCT01736475|26523623|P2|Overall Study|Withdrawal by Subject|0
7622351|NCT01736475|26523624|P1|Overall Study|Withdrawal by Subject|2
7622352|NCT01736475|26523623|P2|Overall Study|Adverse Event|0
7622353|NCT01736475|26523624|P1|Overall Study|Adverse Event|4
7622354|NCT01736397|26523679|P2|Overall Study|Not stated|4
7622355|NCT01736397|26523680|P1|Overall Study|Not stated|1
7622356|NCT01736397|26523679|P2|Overall Study|Adverse Event|3
7622357|NCT01736397|26523680|P1|Overall Study|Adverse Event|6
7622358|NCT01736397|26523679|P2|Overall Study|Lost to Follow-up|1
7622359|NCT01736397|26523680|P1|Overall Study|Lost to Follow-up|0
7622360|NCT01736397|26523679|P2|Overall Study|Withdrawal by Subject|5
7622361|NCT01736397|26523680|P1|Overall Study|Withdrawal by Subject|6
7622362|NCT01736397|26523679|P2|Overall Study|Lack of Efficacy|11
7622363|NCT01736397|26523680|P1|Overall Study|Lack of Efficacy|1
7622364|NCT01736254|26523713|P1|Period 3 (Days 13 to 23)|Adverse Event|1
7622365|NCT01736254|26523713|P1|Period 2 (Days 2 to 12)|Adverse Event|3
7622366|NCT01736215|26523778|P1|Overall Study|Insufficient data to perform analysis|8
7622367|NCT01736215|26523778|P1|Overall Study|Progressive disease stop chemotherapy|1
7622368|NCT01736215|26523778|P1|Overall Study|Adverse Event|4
7622369|NCT01736215|26523778|P1|Overall Study|Early termination of erythropoietin use|1
7622370|NCT01736189|26523790|P1|Overall Study|Criteria and protocol violations|1
7622371|NCT01736189|26523790|P1|Overall Study|Protocol Violation|4
7622372|NCT01736189|26523790|P1|Overall Study|Violation of registration criteria|41
7622373|NCT01736176|26523799|P1|Overall Study|Unable to Complete PEG Placement|1
7622374|NCT01736176|26523799|P1|Overall Study|Lack of Efficacy|3
7622375|NCT01736176|26523799|P1|Overall Study|Withdrawal by Subject|4
7622376|NCT01736176|26523799|P1|Overall Study|Adverse Event|3
7622377|NCT01736124|26523845|P2|12 Mo. Post-Intervention Assessment|End of study|10
7622378|NCT01736124|26523846|P1|12 Mo. Post-Intervention Assessment|End of study|10
7622379|NCT01736124|26523845|P2|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
7622380|NCT01736124|26523846|P1|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
7622381|NCT01736124|26523845|P2|12 Mo. Post-Intervention Assessment|Moved away|0
7622382|NCT01736124|26523846|P1|12 Mo. Post-Intervention Assessment|Moved away|1
7622383|NCT01736124|26523845|P2|12 Mo. Post-Intervention Assessment|Death|0
7622384|NCT01736124|26523846|P1|12 Mo. Post-Intervention Assessment|Death|1
7622385|NCT01736124|26523845|P2|6 Mo. Post-Intervention Assessment|Temporarily away|4
7622386|NCT01736124|26523846|P1|6 Mo. Post-Intervention Assessment|Temporarily away|1
7622387|NCT01736124|26523845|P2|6 Mo. Post-Intervention Assessment|Illness|2
7622388|NCT01736124|26523846|P1|6 Mo. Post-Intervention Assessment|Illness|1
7622389|NCT01736124|26523845|P2|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7622390|NCT01736124|26523846|P1|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7622391|NCT01736124|26523845|P2|6 Mo. Post-Intervention Assessment|Moved away|2
7622392|NCT01736124|26523846|P1|6 Mo. Post-Intervention Assessment|Moved away|0
7622393|NCT01736124|26523845|P2|6 Mo. Post-Intervention Assessment|Death|1
7622394|NCT01736124|26523846|P1|6 Mo. Post-Intervention Assessment|Death|0
7622395|NCT01736124|26523845|P2|Post-intervention Assessment|Temporarily away|1
7622396|NCT01736124|26523846|P1|Post-intervention Assessment|Temporarily away|3
7622397|NCT01736124|26523845|P2|Post-intervention Assessment|Lost to Follow-up|5
7622398|NCT01736124|26523846|P1|Post-intervention Assessment|Lost to Follow-up|8
7622399|NCT01736124|26523845|P2|Post-intervention Assessment|Illness|2
7622400|NCT01736124|26523846|P1|Post-intervention Assessment|Illness|3
7622401|NCT01736124|26523845|P2|Post-intervention Assessment|Withdrawal by Subject|9
7622402|NCT01736124|26523846|P1|Post-intervention Assessment|Withdrawal by Subject|11
7622403|NCT01736124|26523845|P2|Post-intervention Assessment|Moved away|1
7622404|NCT01736124|26523846|P1|Post-intervention Assessment|Moved away|3
7622405|NCT01736124|26523845|P2|Post-intervention Assessment|lost computer access|1
7622406|NCT01736124|26523846|P1|Post-intervention Assessment|lost computer access|1
7622407|NCT01736124|26523845|P2|Post-intervention Assessment|Death|2
7622408|NCT01736124|26523846|P1|Post-intervention Assessment|Death|2
7622409|NCT01735994|26523893|P2|Overall Study|Lost to Follow-up|62
7622410|NCT01735994|26523894|P1|Overall Study|Lost to Follow-up|50
7622411|NCT01735994|26523893|P2|Overall Study|Kicked off team|0
7622412|NCT01735994|26523894|P1|Overall Study|Kicked off team|5
7622413|NCT01735994|26523893|P2|Overall Study|Injury|0
7622414|NCT01735994|26523894|P1|Overall Study|Injury|2
7622415|NCT01735994|26523893|P2|Overall Study|Withdrawal by Subject|4
7622416|NCT01735994|26523894|P1|Overall Study|Withdrawal by Subject|6
7622417|NCT01735916|26523946|P3|Overall Study|Withdrawal by Subject|0
7622418|NCT01735916|26523947|P2|Overall Study|Withdrawal by Subject|0
7622419|NCT01735916|26523948|P1|Overall Study|Withdrawal by Subject|3
7622420|NCT01735916|26523946|P3|Overall Study|Early termination of study by sponsor|7
7622421|NCT01735916|26523947|P2|Overall Study|Early termination of study by sponsor|19
7622422|NCT01735916|26523948|P1|Overall Study|Early termination of study by sponsor|4
7622423|NCT01735916|26523946|P3|Overall Study|Subject not eligible to be randomized|0
7622424|NCT01735916|26523947|P2|Overall Study|Subject not eligible to be randomized|0
7622425|NCT01735916|26523948|P1|Overall Study|Subject not eligible to be randomized|11
7622426|NCT01735630|26523986|P2|Overall Study|Withdrawal by Subject|9
7622427|NCT01735630|26523987|P1|Overall Study|Withdrawal by Subject|7
7622428|NCT01735630|26523986|P2|Overall Study|Sponsor Decision|1
7622429|NCT01735630|26523987|P1|Overall Study|Sponsor Decision|2
7622430|NCT01735630|26523986|P2|Overall Study|Physician Decision|1
7622431|NCT01735630|26523987|P1|Overall Study|Physician Decision|0
7622432|NCT01735630|26523986|P2|Overall Study|Lost to Follow-up|0
7622433|NCT01735630|26523987|P1|Overall Study|Lost to Follow-up|1
7622434|NCT01735630|26523986|P2|Overall Study|Adverse Event|7
7622435|NCT01735630|26523987|P1|Overall Study|Adverse Event|8
7622436|NCT01735396|26524014|P1|Overall Study|not evaluable|1
7622437|NCT01735279|26524025|P2|Overall Study|Lost to Follow-up|8
7622438|NCT01735279|26524026|P1|Overall Study|Lost to Follow-up|11
7622439|NCT01735201|26524058|P8|Overall Study|Other Miscellaneous Reasons|1
7622440|NCT01735201|26524059|P7|Overall Study|Other Miscellaneous Reasons|1
7622441|NCT01735201|26524060|P6|Overall Study|Other Miscellaneous Reasons|2
7622442|NCT01735201|26524061|P5|Overall Study|Other Miscellaneous Reasons|0
7622443|NCT01735201|26524062|P4|Overall Study|Other Miscellaneous Reasons|1
7622444|NCT01735201|26524063|P3|Overall Study|Other Miscellaneous Reasons|0
7622445|NCT01735201|26524064|P2|Overall Study|Other Miscellaneous Reasons|0
7622446|NCT01735201|26524065|P1|Overall Study|Other Miscellaneous Reasons|0
7622447|NCT01735201|26524058|P8|Overall Study|Protocol Violation|0
7622448|NCT01735201|26524059|P7|Overall Study|Protocol Violation|0
7622449|NCT01735201|26524060|P6|Overall Study|Protocol Violation|0
7622450|NCT01735201|26524061|P5|Overall Study|Protocol Violation|0
7622451|NCT01735201|26524062|P4|Overall Study|Protocol Violation|0
7622452|NCT01735201|26524063|P3|Overall Study|Protocol Violation|0
7622453|NCT01735201|26524064|P2|Overall Study|Protocol Violation|0
7622454|NCT01735201|26524065|P1|Overall Study|Protocol Violation|1
7622455|NCT01735201|26524058|P8|Overall Study|Personal Reasons|0
7622456|NCT01735201|26524059|P7|Overall Study|Personal Reasons|0
7622457|NCT01735201|26524060|P6|Overall Study|Personal Reasons|0
7622458|NCT01735201|26524061|P5|Overall Study|Personal Reasons|0
7622459|NCT01735201|26524062|P4|Overall Study|Personal Reasons|0
7622460|NCT01735201|26524063|P3|Overall Study|Personal Reasons|0
7622461|NCT01735201|26524064|P2|Overall Study|Personal Reasons|0
7622462|NCT01735201|26524065|P1|Overall Study|Personal Reasons|1
7622463|NCT01735201|26524058|P8|Overall Study|Adverse Event|1
7622464|NCT01735201|26524059|P7|Overall Study|Adverse Event|2
7622465|NCT01735201|26524060|P6|Overall Study|Adverse Event|3
7622466|NCT01735201|26524061|P5|Overall Study|Adverse Event|1
7622467|NCT01735201|26524062|P4|Overall Study|Adverse Event|1
7622468|NCT01735201|26524063|P3|Overall Study|Adverse Event|0
7622469|NCT01735201|26524064|P2|Overall Study|Adverse Event|1
7622470|NCT01735201|26524065|P1|Overall Study|Adverse Event|1
7622471|NCT01735175|26524101|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
7622472|NCT01735175|26524102|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
7622473|NCT01735175|26524101|P2|Overall Study|Death|2
7622474|NCT01735175|26524102|P1|Overall Study|Death|3
7622475|NCT01735175|26524101|P2|Overall Study|Lost to Follow-up|2
7622476|NCT01735175|26524102|P1|Overall Study|Lost to Follow-up|4
7622477|NCT01735175|26524101|P2|Overall Study|Withdrawal by Subject|2
7622478|NCT01735175|26524102|P1|Overall Study|Withdrawal by Subject|9
7622479|NCT01734993|26524122|P1|Overall Study|Lack of Efficacy|1
7622480|NCT01734993|26524122|P1|Overall Study|Adverse Event|1
7622481|NCT01734902|26524150|P2|Overall Study|Other than listed|2
7622482|NCT01734902|26524151|P1|Overall Study|Other than listed|0
7622566|NCT01734434|26524340|P3|Overall Study|Withdrawal by Subject|8
7622483|NCT01734850|26524172|P3|Overall Study|Not infused due to manufacturing failure|1
7622484|NCT01734850|26524173|P2|Overall Study|Not infused due to manufacturing failure|0
7622485|NCT01734850|26524174|P1|Overall Study|Not infused due to manufacturing failure|0
7622486|NCT01734850|26524172|P3|Overall Study|Continued to Week 48 but recommenced ART|3
7622487|NCT01734850|26524173|P2|Overall Study|Continued to Week 48 but recommenced ART|2
7622488|NCT01734850|26524174|P1|Overall Study|Continued to Week 48 but recommenced ART|3
7622489|NCT01734811|26524231|P2|Overall Study|Withdrawal by Subject|0
7622490|NCT01734811|26524232|P1|Overall Study|Withdrawal by Subject|2
7622491|NCT01734811|26524231|P2|Overall Study|Lost to Follow-up|3
7622492|NCT01734811|26524232|P1|Overall Study|Lost to Follow-up|2
7622493|NCT01734785|26524259|P4|Double-Blind Period|Not treated|0
7622494|NCT01734785|26524260|P3|Double-Blind Period|Not treated|0
7622495|NCT01734785|26524261|P2|Double-Blind Period|Not treated|0
7622496|NCT01734785|26524262|P1|Double-Blind Period|Not treated|1
7622497|NCT01734785|26524259|P4|Double-Blind Period|Withdrawal by Subject|0
7622498|NCT01734785|26524260|P3|Double-Blind Period|Withdrawal by Subject|0
7622499|NCT01734785|26524261|P2|Double-Blind Period|Withdrawal by Subject|0
7622500|NCT01734785|26524262|P1|Double-Blind Period|Withdrawal by Subject|2
7622501|NCT01734785|26524259|P4|Double-Blind Period|Lost to Follow-up|0
7622502|NCT01734785|26524260|P3|Double-Blind Period|Lost to Follow-up|2
7622503|NCT01734785|26524261|P2|Double-Blind Period|Lost to Follow-up|4
7622504|NCT01734785|26524262|P1|Double-Blind Period|Lost to Follow-up|2
7622505|NCT01734785|26524259|P4|Double-Blind Period|Protocol Violation|0
7622506|NCT01734785|26524260|P3|Double-Blind Period|Protocol Violation|1
7622507|NCT01734785|26524261|P2|Double-Blind Period|Protocol Violation|1
7622508|NCT01734785|26524262|P1|Double-Blind Period|Protocol Violation|0
7622509|NCT01734785|26524259|P4|Double-Blind Period|Lack of Efficacy|0
7622510|NCT01734785|26524260|P3|Double-Blind Period|Lack of Efficacy|0
7622511|NCT01734785|26524261|P2|Double-Blind Period|Lack of Efficacy|1
7622512|NCT01734785|26524262|P1|Double-Blind Period|Lack of Efficacy|0
7622513|NCT01734785|26524259|P4|Double-Blind Period|Adverse Event|0
7622514|NCT01734785|26524260|P3|Double-Blind Period|Adverse Event|2
7622515|NCT01734785|26524261|P2|Double-Blind Period|Adverse Event|3
7622516|NCT01734785|26524262|P1|Double-Blind Period|Adverse Event|0
7622517|NCT01734785|26524259|P4|Open-Label Period|Other Reasons|224
7622518|NCT01734785|26524260|P3|Open-Label Period|Other Reasons|0
7622519|NCT01734785|26524261|P2|Open-Label Period|Other Reasons|0
7622520|NCT01734785|26524262|P1|Open-Label Period|Other Reasons|0
7622521|NCT01734785|26524259|P4|Open-Label Period|Withdrawal by Subject|12
7622522|NCT01734785|26524260|P3|Open-Label Period|Withdrawal by Subject|0
7622523|NCT01734785|26524261|P2|Open-Label Period|Withdrawal by Subject|0
7622524|NCT01734785|26524262|P1|Open-Label Period|Withdrawal by Subject|0
7622525|NCT01734785|26524259|P4|Open-Label Period|Lost to Follow-up|14
7622526|NCT01734785|26524260|P3|Open-Label Period|Lost to Follow-up|0
7622527|NCT01734785|26524261|P2|Open-Label Period|Lost to Follow-up|0
7622528|NCT01734785|26524262|P1|Open-Label Period|Lost to Follow-up|0
7622529|NCT01734785|26524259|P4|Open-Label Period|Protocol Violation|13
7622530|NCT01734785|26524260|P3|Open-Label Period|Protocol Violation|0
7622531|NCT01734785|26524261|P2|Open-Label Period|Protocol Violation|0
7622532|NCT01734785|26524262|P1|Open-Label Period|Protocol Violation|0
7622533|NCT01734785|26524259|P4|Open-Label Period|Lack of Efficacy|1
7622534|NCT01734785|26524260|P3|Open-Label Period|Lack of Efficacy|0
7622535|NCT01734785|26524261|P2|Open-Label Period|Lack of Efficacy|0
7622536|NCT01734785|26524262|P1|Open-Label Period|Lack of Efficacy|0
7622537|NCT01734785|26524259|P4|Open-Label Period|Adverse Event|9
7622538|NCT01734785|26524260|P3|Open-Label Period|Adverse Event|0
7622539|NCT01734785|26524261|P2|Open-Label Period|Adverse Event|0
7622540|NCT01734785|26524262|P1|Open-Label Period|Adverse Event|0
7622541|NCT01734772|26524279|P2|Overall Study|Withdrawal by Subject|1
7622542|NCT01734772|26524280|P1|Overall Study|Withdrawal by Subject|0
7622543|NCT01734772|26524279|P2|Overall Study|Adverse Event|2
7622544|NCT01734772|26524280|P1|Overall Study|Adverse Event|1
7622545|NCT01734434|26524339|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
7622546|NCT01734434|26524340|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
7622547|NCT01734434|26524341|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
7622548|NCT01734434|26524342|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
7622549|NCT01734434|26524339|P4|Overall Study|Wrong Version of Consent Form Signed|0
7622550|NCT01734434|26524340|P3|Overall Study|Wrong Version of Consent Form Signed|1
7622551|NCT01734434|26524341|P2|Overall Study|Wrong Version of Consent Form Signed|0
7622552|NCT01734434|26524342|P1|Overall Study|Wrong Version of Consent Form Signed|0
7622553|NCT01734434|26524339|P4|Overall Study|Treatment Defaulter|0
7622554|NCT01734434|26524340|P3|Overall Study|Treatment Defaulter|1
7622555|NCT01734434|26524341|P2|Overall Study|Treatment Defaulter|0
7622556|NCT01734434|26524342|P1|Overall Study|Treatment Defaulter|0
7622557|NCT01734434|26524339|P4|Overall Study|Subject Not Reachable|0
7622558|NCT01734434|26524340|P3|Overall Study|Subject Not Reachable|1
7622559|NCT01734434|26524341|P2|Overall Study|Subject Not Reachable|0
7622560|NCT01734434|26524342|P1|Overall Study|Subject Not Reachable|0
7622561|NCT01734434|26524339|P4|Overall Study|Signed Adult Version of Consent Form|0
7622562|NCT01734434|26524340|P3|Overall Study|Signed Adult Version of Consent Form|1
7622563|NCT01734434|26524341|P2|Overall Study|Signed Adult Version of Consent Form|0
7622564|NCT01734434|26524342|P1|Overall Study|Signed Adult Version of Consent Form|0
7622565|NCT01734434|26524339|P4|Overall Study|Withdrawal by Subject|1
7623104|NCT01729754|26526377|P3|Part 3|Death|0
7622567|NCT01734434|26524341|P2|Overall Study|Withdrawal by Subject|0
7622568|NCT01734434|26524342|P1|Overall Study|Withdrawal by Subject|4
7622569|NCT01734434|26524339|P4|Overall Study|No Live Birth|6
7622570|NCT01734434|26524340|P3|Overall Study|No Live Birth|32
7622571|NCT01734434|26524341|P2|Overall Study|No Live Birth|2
7622572|NCT01734434|26524342|P1|Overall Study|No Live Birth|1
7622573|NCT01734434|26524339|P4|Overall Study|Lost to Follow-up|11
7622574|NCT01734434|26524340|P3|Overall Study|Lost to Follow-up|67
7622575|NCT01734434|26524341|P2|Overall Study|Lost to Follow-up|9
7622576|NCT01734434|26524342|P1|Overall Study|Lost to Follow-up|2
7622577|NCT01734434|26524339|P4|Overall Study|Death Infant|5
7622578|NCT01734434|26524340|P3|Overall Study|Death Infant|17
7622579|NCT01734434|26524341|P2|Overall Study|Death Infant|1
7622580|NCT01734434|26524342|P1|Overall Study|Death Infant|3
7622581|NCT01734395|26524364|P1|Overall Study|Missing the reasons for not completed|3
7622582|NCT01734395|26524364|P1|Overall Study|Withdrawal by Subject|10
7622583|NCT01734395|26524364|P1|Overall Study|Adverse Event|40
7622584|NCT01734395|26524364|P1|Overall Study|Lack of Efficacy|5
7622585|NCT01734395|26524364|P1|Overall Study|Lost to Follow-up|287
7622586|NCT01734395|26524364|P1|Overall Study|Other|65
7622587|NCT01734382|26524373|P3|Part 2|Withdrawal by Subject|1
7622588|NCT01734382|26524374|P2|Part 2|Withdrawal by Subject|0
7622589|NCT01734382|26524375|P1|Part 2|Withdrawal by Subject|0
7622590|NCT01734382|26524373|P3|Part 2|Protocol Violation|0
7622591|NCT01734382|26524374|P2|Part 2|Protocol Violation|1
7622592|NCT01734382|26524375|P1|Part 2|Protocol Violation|0
7622593|NCT01734382|26524373|P3|Part 2|Physician Decision|3
7622594|NCT01734382|26524374|P2|Part 2|Physician Decision|0
7622595|NCT01734382|26524375|P1|Part 2|Physician Decision|0
7622596|NCT01734382|26524373|P3|Part 2|Other|1
7622597|NCT01734382|26524374|P2|Part 2|Other|0
7622598|NCT01734382|26524375|P1|Part 2|Other|0
7622599|NCT01734382|26524373|P3|Part 2|Lack of Efficacy|1
7622600|NCT01734382|26524374|P2|Part 2|Lack of Efficacy|1
7622601|NCT01734382|26524375|P1|Part 2|Lack of Efficacy|0
7622602|NCT01734382|26524373|P3|Part 2|Adverse Event|1
7622603|NCT01734382|26524374|P2|Part 2|Adverse Event|0
7622604|NCT01734382|26524375|P1|Part 2|Adverse Event|0
7622605|NCT01734382|26524373|P3|Part 1|Adverse Event|0
7622606|NCT01734382|26524374|P2|Part 1|Adverse Event|0
7622607|NCT01734382|26524375|P1|Part 1|Adverse Event|2
7622608|NCT01733758|26524488|P4|Overall Study|Inv Decision, HbA1c not controlled|1
7622609|NCT01733758|26524489|P3|Overall Study|Inv Decision, HbA1c not controlled|0
7622610|NCT01733758|26524490|P2|Overall Study|Inv Decision, HbA1c not controlled|1
7622611|NCT01733758|26524491|P1|Overall Study|Inv Decision, HbA1c not controlled|1
7622612|NCT01733758|26524488|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
7622613|NCT01733758|26524489|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
7622614|NCT01733758|26524490|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
7622615|NCT01733758|26524491|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
7622616|NCT01733758|26524488|P4|Overall Study|Non-compliance|0
7622617|NCT01733758|26524489|P3|Overall Study|Non-compliance|0
7622618|NCT01733758|26524490|P2|Overall Study|Non-compliance|0
7622619|NCT01733758|26524491|P1|Overall Study|Non-compliance|1
7622620|NCT01733758|26524488|P4|Overall Study|Protocol Violation|2
7622621|NCT01733758|26524489|P3|Overall Study|Protocol Violation|2
7622622|NCT01733758|26524490|P2|Overall Study|Protocol Violation|1
7622623|NCT01733758|26524491|P1|Overall Study|Protocol Violation|0
7622624|NCT01733758|26524488|P4|Overall Study|Persistent Hyperglycemia|0
7622625|NCT01733758|26524489|P3|Overall Study|Persistent Hyperglycemia|0
7622626|NCT01733758|26524490|P2|Overall Study|Persistent Hyperglycemia|2
7622627|NCT01733758|26524491|P1|Overall Study|Persistent Hyperglycemia|3
7622628|NCT01733758|26524488|P4|Overall Study|Withdrawal by Subject|3
7622629|NCT01733758|26524489|P3|Overall Study|Withdrawal by Subject|5
7622630|NCT01733758|26524490|P2|Overall Study|Withdrawal by Subject|1
7622631|NCT01733758|26524491|P1|Overall Study|Withdrawal by Subject|1
7622632|NCT01733758|26524488|P4|Overall Study|Adverse Event|1
7622633|NCT01733758|26524489|P3|Overall Study|Adverse Event|8
7622634|NCT01733758|26524490|P2|Overall Study|Adverse Event|7
7622635|NCT01733758|26524491|P1|Overall Study|Adverse Event|5
7622636|NCT01733732|26524557|P2|Overall Study|Did not attend all study visits|0
7622637|NCT01733732|26524558|P1|Overall Study|Did not attend all study visits|1
7622638|NCT01733732|26524557|P2|Overall Study|Adverse Event|0
7622639|NCT01733732|26524558|P1|Overall Study|Adverse Event|1
7622640|NCT01733680|26524594|P2|Overall Study|Withdrawal by Subject|1
7622641|NCT01733680|26524595|P1|Overall Study|Withdrawal by Subject|0
7622642|NCT01733329|26524654|P2|Overall Study|Uterine artery injury|0
7622643|NCT01733329|26524655|P1|Overall Study|Uterine artery injury|1
7622644|NCT01733329|26524654|P2|Overall Study|Protocol Violation|1
7622645|NCT01733329|26524655|P1|Overall Study|Protocol Violation|1
7622646|NCT01733316|26524667|P1|Long Term Extension Phase|Sponsor Decision|2
7622647|NCT01733316|26524667|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
7622648|NCT01733316|26524667|P1|Long Term Extension Phase|Adverse Event|1
7622649|NCT01733316|26524667|P1|RP103 Phase|Non-compliance|1
7622650|NCT01733121|26524727|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7622651|NCT01733121|26524728|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7622652|NCT01733121|26524727|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
7622653|NCT01733121|26524728|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7622654|NCT01733121|26524727|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7622655|NCT01733121|26524728|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7622656|NCT01733121|26524727|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7622657|NCT01733121|26524728|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
7622658|NCT01732926|26524770|P2|Overall Study|Blind Broken by Subject or Study Site|1
7622659|NCT01732926|26524771|P1|Overall Study|Blind Broken by Subject or Study Site|1
7622660|NCT01732926|26524770|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
7622661|NCT01732926|26524771|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
7622662|NCT01732926|26524770|P2|Overall Study|Other Reason|4
7622663|NCT01732926|26524771|P1|Overall Study|Other Reason|21
7622664|NCT01732926|26524770|P2|Overall Study|Physician Decision|11
7622665|NCT01732926|26524771|P1|Overall Study|Physician Decision|24
7622666|NCT01732926|26524770|P2|Overall Study|Withdrawal by Subject|8
7622667|NCT01732926|26524771|P1|Overall Study|Withdrawal by Subject|46
7622668|NCT01732926|26524770|P2|Overall Study|Study Terminated by Sponsor|80
7622669|NCT01732926|26524771|P1|Overall Study|Study Terminated by Sponsor|168
7622670|NCT01732913|26524787|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
7622671|NCT01732913|26524788|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
7622672|NCT01732913|26524787|P2|Overall Study|Other|1
7622673|NCT01732913|26524788|P1|Overall Study|Other|7
7622674|NCT01732913|26524787|P2|Overall Study|Physician Decision|7
7622675|NCT01732913|26524788|P1|Overall Study|Physician Decision|14
7622676|NCT01732913|26524787|P2|Overall Study|Withdrawal by Subject|4
7622677|NCT01732913|26524788|P1|Overall Study|Withdrawal by Subject|27
7622678|NCT01732913|26524787|P2|Overall Study|Study Terminated by Sponsor|55
7622679|NCT01732913|26524788|P1|Overall Study|Study Terminated by Sponsor|105
7622680|NCT01732874|26524804|P2|Overall Study|Death of Infant|2
7622681|NCT01732874|26524805|P1|Overall Study|Death of Infant|3
7622682|NCT01732874|26524804|P2|Overall Study|Withdrawal by Subject|1
7622683|NCT01732874|26524805|P1|Overall Study|Withdrawal by Subject|5
7622684|NCT01732835|26524811|P1|2-year Extended Follow-up|Death|1
7622685|NCT01732835|26524811|P1|2-year Extended Follow-up|Adverse Event|3
7622686|NCT01732835|26524811|P1|2-year Extended Follow-up|Withdrawal by Subject|1
7622687|NCT01732835|26524811|P1|6-month Primary Endpoint|Adverse Event|3
7622688|NCT01732835|26524811|P1|6-month Primary Endpoint|Withdrawal by Subject|2
7622689|NCT01732835|26524811|P1|6-month Primary Endpoint|Did not receive device|19
7622690|NCT01732822|26524844|P2|Overall Study|Withdrawal by Subject|113
7622691|NCT01732822|26524845|P1|Overall Study|Withdrawal by Subject|123
7622692|NCT01732796|26524937|P3|Overall Study|Other reason not defined above|2
7622693|NCT01732796|26524938|P2|Overall Study|Other reason not defined above|0
7622694|NCT01732796|26524939|P1|Overall Study|Other reason not defined above|1
7622695|NCT01732796|26524937|P3|Overall Study|Withdrawal by Subject|2
7622696|NCT01732796|26524938|P2|Overall Study|Withdrawal by Subject|8
7622697|NCT01732796|26524939|P1|Overall Study|Withdrawal by Subject|6
7622698|NCT01732796|26524937|P3|Overall Study|Lost to Follow-up|0
7622699|NCT01732796|26524938|P2|Overall Study|Lost to Follow-up|0
7622700|NCT01732796|26524939|P1|Overall Study|Lost to Follow-up|2
7622701|NCT01732796|26524937|P3|Overall Study|Lack of Efficacy|5
7622702|NCT01732796|26524938|P2|Overall Study|Lack of Efficacy|18
7622703|NCT01732796|26524939|P1|Overall Study|Lack of Efficacy|21
7622704|NCT01732796|26524937|P3|Overall Study|Adverse Event|4
7622705|NCT01732796|26524938|P2|Overall Study|Adverse Event|16
7622706|NCT01732796|26524939|P1|Overall Study|Adverse Event|16
7622707|NCT01732783|26524958|P3|Overall Study|Withdrawal by Subject|0
7622708|NCT01732783|26524959|P2|Overall Study|Withdrawal by Subject|0
7622709|NCT01732783|26524960|P1|Overall Study|Withdrawal by Subject|1
7622710|NCT01732783|26524958|P3|Overall Study|Administrative Decision|1
7622711|NCT01732783|26524959|P2|Overall Study|Administrative Decision|2
7622712|NCT01732783|26524960|P1|Overall Study|Administrative Decision|8
7622713|NCT01732783|26524958|P3|Overall Study|Lost to Follow-up|1
7622714|NCT01732783|26524959|P2|Overall Study|Lost to Follow-up|1
7622715|NCT01732783|26524960|P1|Overall Study|Lost to Follow-up|7
7622716|NCT01732783|26524958|P3|Overall Study|Death|1
7622717|NCT01732783|26524959|P2|Overall Study|Death|4
7622718|NCT01732783|26524960|P1|Overall Study|Death|13
7622719|NCT01732783|26524958|P3|Overall Study|Discontinued Panitumumab Treatment|7
7622720|NCT01732783|26524959|P2|Overall Study|Discontinued Panitumumab Treatment|25
7622721|NCT01732783|26524960|P1|Overall Study|Discontinued Panitumumab Treatment|106
7622722|NCT01732770|26525024|P2|Overall Study|Death|0
7622723|NCT01732770|26525025|P1|Overall Study|Death|1
7622724|NCT01732770|26525024|P2|Overall Study|Decision by Sponsor|2
7622725|NCT01732770|26525025|P1|Overall Study|Decision by Sponsor|2
7622726|NCT01732770|26525024|P2|Overall Study|Withdrawal by Subject|3
7622727|NCT01732770|26525025|P1|Overall Study|Withdrawal by Subject|5
7622728|NCT01732770|26525024|P2|Overall Study|Lost to Follow-up|3
7622729|NCT01732770|26525025|P1|Overall Study|Lost to Follow-up|2
7622730|NCT01732757|26525040|P3|Overall Study|Lost to Follow-up|0
7622731|NCT01732757|26525041|P2|Overall Study|Lost to Follow-up|0
7622732|NCT01732757|26525042|P1|Overall Study|Lost to Follow-up|1
7622733|NCT01732692|26525119|P2|Overall Study|Adverse Event|1
7622734|NCT01732692|26525120|P1|Overall Study|Adverse Event|0
7622735|NCT01732640|26525134|P2|Overall Study|Death|1
7622736|NCT01732640|26525135|P1|Overall Study|Death|0
7622737|NCT01732640|26525134|P2|Overall Study|Adverse Event|1
7622738|NCT01732640|26525135|P1|Overall Study|Adverse Event|0
7622739|NCT01732627|26525152|P2|Overall Study|Withdrawal by Subject|0
7622740|NCT01732627|26525153|P1|Overall Study|Withdrawal by Subject|1
7622741|NCT01732588|26525186|P3|First Intervention (7 Days)|Adverse Event|0
7622742|NCT01732588|26525187|P2|First Intervention (7 Days)|Adverse Event|1
7622743|NCT01732588|26525188|P1|First Intervention (7 Days)|Adverse Event|0
7622744|NCT01732549|26525204|P2|Overall Study|Other|14
7622745|NCT01732549|26525205|P1|Overall Study|Other|8
7622746|NCT01732549|26525204|P2|Overall Study|Disease progression|50
7622747|NCT01732549|26525205|P1|Overall Study|Disease progression|37
7622748|NCT01732549|26525204|P2|Overall Study|Consent withdrawn|6
7622749|NCT01732549|26525205|P1|Overall Study|Consent withdrawn|13
7622750|NCT01732549|26525204|P2|Overall Study|Adverse Event|3
7622751|NCT01732549|26525205|P1|Overall Study|Adverse Event|13
7622752|NCT01732536|26525227|P2|Overall Study|Withdrawal by Subject|1
7622753|NCT01732536|26525228|P1|Overall Study|Withdrawal by Subject|1
7622754|NCT01732510|26525251|P7|Overall Study|Study Terminated By Sponsor|6
7622755|NCT01732510|26525252|P6|Overall Study|Study Terminated By Sponsor|12
7622756|NCT01732510|26525253|P5|Overall Study|Study Terminated By Sponsor|0
7622757|NCT01732510|26525254|P4|Overall Study|Study Terminated By Sponsor|1
7622758|NCT01732510|26525255|P3|Overall Study|Study Terminated By Sponsor|0
7622759|NCT01732510|26525256|P2|Overall Study|Study Terminated By Sponsor|0
7622760|NCT01732510|26525257|P1|Overall Study|Study Terminated By Sponsor|0
7622761|NCT01732510|26525251|P7|Overall Study|Pregnancy|0
7622762|NCT01732510|26525252|P6|Overall Study|Pregnancy|0
7622763|NCT01732510|26525253|P5|Overall Study|Pregnancy|0
7622764|NCT01732510|26525254|P4|Overall Study|Pregnancy|1
7622765|NCT01732510|26525255|P3|Overall Study|Pregnancy|0
7622766|NCT01732510|26525256|P2|Overall Study|Pregnancy|0
7622767|NCT01732510|26525257|P1|Overall Study|Pregnancy|0
7622768|NCT01732510|26525251|P7|Overall Study|Physician Decision|0
7622769|NCT01732510|26525252|P6|Overall Study|Physician Decision|0
7622770|NCT01732510|26525253|P5|Overall Study|Physician Decision|0
7622771|NCT01732510|26525254|P4|Overall Study|Physician Decision|0
7622772|NCT01732510|26525255|P3|Overall Study|Physician Decision|0
7622773|NCT01732510|26525256|P2|Overall Study|Physician Decision|1
7622774|NCT01732510|26525257|P1|Overall Study|Physician Decision|0
7622775|NCT01732510|26525251|P7|Overall Study|Lost to Follow-up|0
7622776|NCT01732510|26525252|P6|Overall Study|Lost to Follow-up|1
7622777|NCT01732510|26525253|P5|Overall Study|Lost to Follow-up|0
7622778|NCT01732510|26525254|P4|Overall Study|Lost to Follow-up|1
7622779|NCT01732510|26525255|P3|Overall Study|Lost to Follow-up|1
7622780|NCT01732510|26525256|P2|Overall Study|Lost to Follow-up|0
7622781|NCT01732510|26525257|P1|Overall Study|Lost to Follow-up|0
7622782|NCT01732510|26525251|P7|Overall Study|Withdrawal by Subject|1
7622783|NCT01732510|26525252|P6|Overall Study|Withdrawal by Subject|0
7622784|NCT01732510|26525253|P5|Overall Study|Withdrawal by Subject|5
7622785|NCT01732510|26525254|P4|Overall Study|Withdrawal by Subject|1
7622786|NCT01732510|26525255|P3|Overall Study|Withdrawal by Subject|2
7622787|NCT01732510|26525256|P2|Overall Study|Withdrawal by Subject|3
7622788|NCT01732510|26525257|P1|Overall Study|Withdrawal by Subject|1
7622789|NCT01732510|26525251|P7|Overall Study|Protocol Violation|0
7622790|NCT01732510|26525252|P6|Overall Study|Protocol Violation|0
7622791|NCT01732510|26525253|P5|Overall Study|Protocol Violation|0
7622792|NCT01732510|26525254|P4|Overall Study|Protocol Violation|1
7622793|NCT01732510|26525255|P3|Overall Study|Protocol Violation|0
7622794|NCT01732510|26525256|P2|Overall Study|Protocol Violation|0
7622795|NCT01732510|26525257|P1|Overall Study|Protocol Violation|0
7622796|NCT01732510|26525251|P7|Overall Study|Adverse Event|1
7622797|NCT01732510|26525252|P6|Overall Study|Adverse Event|0
7622798|NCT01732510|26525253|P5|Overall Study|Adverse Event|0
7622799|NCT01732510|26525254|P4|Overall Study|Adverse Event|0
7622800|NCT01732510|26525255|P3|Overall Study|Adverse Event|1
7622801|NCT01732510|26525256|P2|Overall Study|Adverse Event|1
7622802|NCT01732510|26525257|P1|Overall Study|Adverse Event|0
7622803|NCT01732484|26525336|P1|Overall Study|chronical illness|5
7622804|NCT01732484|26525336|P1|Overall Study|Lost to Follow-up|14
7622805|NCT01732484|26525336|P1|Overall Study|Death|7
7622806|NCT01732471|26525344|P1|Overall Study|Withdrawal by Subject|1
7622807|NCT01732458|26525355|P4|Overall Study|Screen Failure|0
7622808|NCT01732458|26525356|P3|Overall Study|Screen Failure|0
7622809|NCT01732458|26525357|P2|Overall Study|Screen Failure|1
7622810|NCT01732458|26525358|P1|Overall Study|Screen Failure|0
7622811|NCT01732458|26525355|P4|Overall Study|Protocol Violation|2
7622812|NCT01732458|26525356|P3|Overall Study|Protocol Violation|0
7622813|NCT01732458|26525357|P2|Overall Study|Protocol Violation|0
7622814|NCT01732458|26525358|P1|Overall Study|Protocol Violation|2
7622815|NCT01732458|26525355|P4|Overall Study|Physician Decision|0
7622816|NCT01732458|26525356|P3|Overall Study|Physician Decision|2
7622817|NCT01732458|26525357|P2|Overall Study|Physician Decision|2
7622818|NCT01732458|26525358|P1|Overall Study|Physician Decision|1
7622819|NCT01732458|26525355|P4|Overall Study|Non-Compliance With Study Drug|0
7622820|NCT01732458|26525356|P3|Overall Study|Non-Compliance With Study Drug|1
7622821|NCT01732458|26525357|P2|Overall Study|Non-Compliance With Study Drug|0
7622822|NCT01732458|26525358|P1|Overall Study|Non-Compliance With Study Drug|0
7622823|NCT01732458|26525355|P4|Overall Study|Lost to Follow-up|0
7622824|NCT01732458|26525356|P3|Overall Study|Lost to Follow-up|0
7622825|NCT01732458|26525357|P2|Overall Study|Lost to Follow-up|2
7622826|NCT01732458|26525358|P1|Overall Study|Lost to Follow-up|0
7622827|NCT01732107|26525520|P1|Overall Study|Withdrawal by Subject|2
7622828|NCT01732107|26525520|P1|Overall Study|Physician Decision|1
7622829|NCT01732107|26525520|P1|Overall Study|Disease Progression|8
7622830|NCT01732107|26525520|P1|Overall Study|Adverse Event|2
7622831|NCT01731990|26525537|P2|Overall Study|Death|0
7622832|NCT01731990|26525538|P1|Overall Study|Death|1
7622833|NCT01731990|26525537|P2|Overall Study|Protocol deviation|2
7622834|NCT01731990|26525538|P1|Overall Study|Protocol deviation|1
7622835|NCT01731990|26525537|P2|Overall Study|Withdrawal by Subject|1
7622836|NCT01731990|26525538|P1|Overall Study|Withdrawal by Subject|1
7622837|NCT01731990|26525537|P2|Overall Study|Adverse Event|5
7622838|NCT01731990|26525538|P1|Overall Study|Adverse Event|1
7622839|NCT01731951|26525556|P6|Overall Study|Death|6
7622840|NCT01731951|26525557|P5|Overall Study|Death|9
7622841|NCT01731951|26525558|P4|Overall Study|Death|8
7622842|NCT01731951|26525559|P3|Overall Study|Death|9
7622843|NCT01731951|26525560|P2|Overall Study|Death|15
7622844|NCT01731951|26525561|P1|Overall Study|Death|13
7622845|NCT01731951|26525556|P6|Overall Study|Withdrawal of Consent|2
7622846|NCT01731951|26525557|P5|Overall Study|Withdrawal of Consent|0
7622847|NCT01731951|26525558|P4|Overall Study|Withdrawal of Consent|0
7622848|NCT01731951|26525559|P3|Overall Study|Withdrawal of Consent|0
7622849|NCT01731951|26525560|P2|Overall Study|Withdrawal of Consent|0
7622850|NCT01731951|26525561|P1|Overall Study|Withdrawal of Consent|1
7622851|NCT01731951|26525556|P6|Overall Study|Lost to Follow-up|1
7622852|NCT01731951|26525557|P5|Overall Study|Lost to Follow-up|3
7622853|NCT01731951|26525558|P4|Overall Study|Lost to Follow-up|1
7622854|NCT01731951|26525559|P3|Overall Study|Lost to Follow-up|0
7622855|NCT01731951|26525560|P2|Overall Study|Lost to Follow-up|0
7622856|NCT01731951|26525561|P1|Overall Study|Lost to Follow-up|2
7622857|NCT01731951|26525556|P6|Overall Study|Documented Disease Progression|0
7622858|NCT01731951|26525557|P5|Overall Study|Documented Disease Progression|0
7622859|NCT01731951|26525558|P4|Overall Study|Documented Disease Progression|0
7622860|NCT01731951|26525559|P3|Overall Study|Documented Disease Progression|0
7622861|NCT01731951|26525560|P2|Overall Study|Documented Disease Progression|0
7622862|NCT01731951|26525561|P1|Overall Study|Documented Disease Progression|1
7622863|NCT01731938|26525614|P2|Primary Part II|Missed Week 6 visit|3
7622864|NCT01731938|26525615|P1|Primary Part II|Missed Week 6 visit|2
7622865|NCT01731938|26525614|P2|Primary Part II|Death|1
7622866|NCT01731938|26525615|P1|Primary Part II|Death|2
7622867|NCT01731938|26525614|P2|Primary Part II|Lost to Follow-up|5
7622868|NCT01731938|26525615|P1|Primary Part II|Lost to Follow-up|4
7622869|NCT01731938|26525614|P2|Primary Part II|Withdrawal by Subject|4
7622870|NCT01731938|26525615|P1|Primary Part II|Withdrawal by Subject|5
7622871|NCT01731938|26525614|P2|Preliminary Part I|Missed Week 6 visit|3
7622872|NCT01731938|26525615|P1|Preliminary Part I|Missed Week 6 visit|0
7622873|NCT01731938|26525614|P2|Preliminary Part I|Lost to Follow-up|3
7622874|NCT01731938|26525615|P1|Preliminary Part I|Lost to Follow-up|0
7622875|NCT01731938|26525614|P2|Preliminary Part I|Physician Decision|0
7622876|NCT01731938|26525615|P1|Preliminary Part I|Physician Decision|1
7622877|NCT01731938|26525614|P2|Preliminary Part I|Withdrawal by Subject|2
7622878|NCT01731938|26525615|P1|Preliminary Part I|Withdrawal by Subject|2
7622879|NCT01731912|26525627|P1|Overall Study|noncompliance|2
7622880|NCT01731886|26525634|P2|Overall Study|Non-compliant|0
7622881|NCT01731886|26525635|P1|Overall Study|Non-compliant|1
7622882|NCT01731886|26525634|P2|Overall Study|Never started treatment|1
7622883|NCT01731886|26525635|P1|Overall Study|Never started treatment|0
7622884|NCT01731886|26525634|P2|Overall Study|Death|0
7622885|NCT01731886|26525635|P1|Overall Study|Death|1
7622886|NCT01731678|26525680|P1|Overall Study|RMT too high, making TMS difficult|3
7622887|NCT01731678|26525680|P1|Overall Study|Did not meet inclusion criteria|1
7622888|NCT01731678|26525680|P1|Overall Study|Withdrawal by Subject|3
7622889|NCT01731600|26525686|P2|Overall Study|Other reasons|0
7622890|NCT01731600|26525687|P1|Overall Study|Other reasons|3
7622891|NCT01731600|26525686|P2|Overall Study|Withdrawal criteria|0
7622892|NCT01731600|26525687|P1|Overall Study|Withdrawal criteria|1
7622893|NCT01731600|26525686|P2|Overall Study|Adverse Event|0
7622894|NCT01731600|26525687|P1|Overall Study|Adverse Event|2
7622895|NCT01731470|26525741|P1|Overall Study|Did not meet study criteria|1
7622896|NCT01731470|26525741|P1|Overall Study|Withdrawal by Subject|1
7622897|NCT01731171|26525748|P2|Overall Study|Terminated for Safety Reasons|1
7622898|NCT01731171|26525749|P1|Overall Study|Terminated for Safety Reasons|0
7622899|NCT01731171|26525748|P2|Overall Study|Terminated for Lack of Adherence|1
7622900|NCT01731171|26525749|P1|Overall Study|Terminated for Lack of Adherence|0
7622901|NCT01731171|26525748|P2|Overall Study|Moved out of Area|2
7622902|NCT01731171|26525749|P1|Overall Study|Moved out of Area|0
7622903|NCT01731171|26525748|P2|Overall Study|Lost to Follow-up|2
7622904|NCT01731171|26525749|P1|Overall Study|Lost to Follow-up|3
7622905|NCT01731171|26525748|P2|Overall Study|Withdrawal by Subject|1
7622906|NCT01731171|26525749|P1|Overall Study|Withdrawal by Subject|4
7622907|NCT01731002|26525783|P3|Overall Study|Inappropriate use of study medications|1
7622908|NCT01731002|26525784|P2|Overall Study|Inappropriate use of study medications|0
7622909|NCT01731002|26525785|P1|Overall Study|Inappropriate use of study medications|0
7622910|NCT01731002|26525783|P3|Overall Study|Elevated IOP|0
7622911|NCT01731002|26525784|P2|Overall Study|Elevated IOP|0
7622912|NCT01731002|26525785|P1|Overall Study|Elevated IOP|1
7622913|NCT01731002|26525783|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7622914|NCT01731002|26525784|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7622915|NCT01731002|26525785|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
7622916|NCT01731002|26525783|P3|Overall Study|Test Agent Discontinuation|0
7622917|NCT01731002|26525784|P2|Overall Study|Test Agent Discontinuation|1
7622918|NCT01731002|26525785|P1|Overall Study|Test Agent Discontinuation|0
7622919|NCT01731002|26525783|P3|Overall Study|Lost to Follow-up|0
7622920|NCT01731002|26525784|P2|Overall Study|Lost to Follow-up|0
7622921|NCT01731002|26525785|P1|Overall Study|Lost to Follow-up|1
7622922|NCT01731002|26525783|P3|Overall Study|Non-Compliant|0
7622923|NCT01731002|26525784|P2|Overall Study|Non-Compliant|1
7622924|NCT01731002|26525785|P1|Overall Study|Non-Compliant|0
7622925|NCT01731002|26525783|P3|Overall Study|Adverse Event|2
7622926|NCT01731002|26525784|P2|Overall Study|Adverse Event|2
7622927|NCT01731002|26525785|P1|Overall Study|Adverse Event|0
7622928|NCT01730950|26525798|P2|Overall Study|Protocol Violation|6
7622929|NCT01730950|26525799|P1|Overall Study|Protocol Violation|6
7622930|NCT01730729|26525845|P1|Overall Study|Progressive Disease|12
7622931|NCT01730729|26525845|P1|Overall Study|Death|1
7622932|NCT01730729|26525845|P1|Overall Study|Adverse Event|1
7622933|NCT01730586|26525859|P1|Overall Study|Hospice|1
7622934|NCT01730586|26525859|P1|Overall Study|Adverse Event|2
7622935|NCT01730586|26525859|P1|Overall Study|Inadequate Trial|8
7622936|NCT01730586|26525859|P1|Overall Study|Progressive Disease|2
7622937|NCT01730534|26525868|P2|Overall Study|Lost to Follow-up|18
7622938|NCT01730534|26525869|P1|Overall Study|Lost to Follow-up|12
7622939|NCT01730534|26525868|P2|Overall Study|Withdrawal by Subject|127
7622940|NCT01730534|26525869|P1|Overall Study|Withdrawal by Subject|97
7622941|NCT01730378|26525883|P2|Overall Study|Lost to Follow-up|0
7622942|NCT01730378|26525884|P1|Overall Study|Lost to Follow-up|1
7622943|NCT01730339|26525915|P2|Overall Study|Un-specified|0
7622944|NCT01730339|26525916|P1|Overall Study|Un-specified|1
7622945|NCT01730339|26525915|P2|Overall Study|Lost to Follow-up|1
7622946|NCT01730339|26525916|P1|Overall Study|Lost to Follow-up|1
7622947|NCT01730339|26525915|P2|Overall Study|Withdrawal by Subject|2
7622948|NCT01730339|26525916|P1|Overall Study|Withdrawal by Subject|3
7622949|NCT01730053|26525956|P6|Overall Study|Other than specified|9
7622950|NCT01730053|26525957|P5|Overall Study|Other than specified|7
7622951|NCT01730053|26525958|P4|Overall Study|Other than specified|4
7622952|NCT01730053|26525959|P3|Overall Study|Other than specified|5
7622953|NCT01730053|26525960|P2|Overall Study|Other than specified|6
7622954|NCT01730053|26525961|P1|Overall Study|Other than specified|2
7622955|NCT01730053|26525956|P6|Overall Study|Poor compliance to protocol|2
7622956|NCT01730053|26525957|P5|Overall Study|Poor compliance to protocol|0
7622957|NCT01730053|26525958|P4|Overall Study|Poor compliance to protocol|0
7622958|NCT01730053|26525959|P3|Overall Study|Poor compliance to protocol|2
7622959|NCT01730053|26525960|P2|Overall Study|Poor compliance to protocol|2
7622960|NCT01730053|26525961|P1|Overall Study|Poor compliance to protocol|1
7622961|NCT01730053|26525956|P6|Overall Study|Adverse Event|2
7622962|NCT01730053|26525957|P5|Overall Study|Adverse Event|2
7622963|NCT01730053|26525958|P4|Overall Study|Adverse Event|3
7622964|NCT01730053|26525959|P3|Overall Study|Adverse Event|3
7622965|NCT01730053|26525960|P2|Overall Study|Adverse Event|6
7622966|NCT01730053|26525961|P1|Overall Study|Adverse Event|2
7622967|NCT01730053|26525956|P6|Overall Study|Physician Decision|0
7622968|NCT01730053|26525957|P5|Overall Study|Physician Decision|0
7622969|NCT01730053|26525958|P4|Overall Study|Physician Decision|1
7622970|NCT01730053|26525959|P3|Overall Study|Physician Decision|0
7622971|NCT01730053|26525960|P2|Overall Study|Physician Decision|0
7622972|NCT01730053|26525961|P1|Overall Study|Physician Decision|0
7622973|NCT01730053|26525956|P6|Overall Study|Participant moved|0
7622974|NCT01730053|26525957|P5|Overall Study|Participant moved|0
7622975|NCT01730053|26525958|P4|Overall Study|Participant moved|0
7622976|NCT01730053|26525959|P3|Overall Study|Participant moved|1
7622977|NCT01730053|26525960|P2|Overall Study|Participant moved|0
7622978|NCT01730053|26525961|P1|Overall Study|Participant moved|0
7622979|NCT01730040|26526120|P7|Overall Study|Poor compliance to protocol|1
7622980|NCT01730040|26526121|P6|Overall Study|Poor compliance to protocol|0
7622981|NCT01730040|26526122|P5|Overall Study|Poor compliance to protocol|0
7622982|NCT01730040|26526123|P4|Overall Study|Poor compliance to protocol|0
7622983|NCT01730040|26526124|P3|Overall Study|Poor compliance to protocol|0
7622984|NCT01730040|26526125|P2|Overall Study|Poor compliance to protocol|4
7622985|NCT01730040|26526126|P1|Overall Study|Poor compliance to protocol|2
7622986|NCT01730040|26526120|P7|Overall Study|Adverse Event|2
7622987|NCT01730040|26526121|P6|Overall Study|Adverse Event|1
7622988|NCT01730040|26526122|P5|Overall Study|Adverse Event|1
7622989|NCT01730040|26526123|P4|Overall Study|Adverse Event|3
7622990|NCT01730040|26526124|P3|Overall Study|Adverse Event|5
7622991|NCT01730040|26526125|P2|Overall Study|Adverse Event|3
7622992|NCT01730040|26526126|P1|Overall Study|Adverse Event|4
7622993|NCT01730040|26526120|P7|Overall Study|Other than specified|4
7622994|NCT01730040|26526121|P6|Overall Study|Other than specified|4
7622995|NCT01730040|26526122|P5|Overall Study|Other than specified|5
7622996|NCT01730040|26526123|P4|Overall Study|Other than specified|5
7622997|NCT01730040|26526124|P3|Overall Study|Other than specified|5
7622998|NCT01730040|26526125|P2|Overall Study|Other than specified|8
7622999|NCT01730040|26526126|P1|Overall Study|Other than specified|7
7623000|NCT01730040|26526120|P7|Overall Study|Physician Decision|1
7623001|NCT01730040|26526121|P6|Overall Study|Physician Decision|1
7623002|NCT01730040|26526122|P5|Overall Study|Physician Decision|0
7623003|NCT01730040|26526123|P4|Overall Study|Physician Decision|0
7623004|NCT01730040|26526124|P3|Overall Study|Physician Decision|0
7623005|NCT01730040|26526125|P2|Overall Study|Physician Decision|0
7623006|NCT01730040|26526126|P1|Overall Study|Physician Decision|0
7623007|NCT01730040|26526120|P7|Overall Study|Subject moved|1
7623008|NCT01730040|26526121|P6|Overall Study|Subject moved|0
7623009|NCT01730040|26526122|P5|Overall Study|Subject moved|0
7623010|NCT01730040|26526123|P4|Overall Study|Subject moved|0
7623011|NCT01730040|26526124|P3|Overall Study|Subject moved|1
7623012|NCT01730040|26526125|P2|Overall Study|Subject moved|0
7623013|NCT01730040|26526126|P1|Overall Study|Subject moved|0
7623014|NCT01730040|26526120|P7|Overall Study|Randomized but not treated|0
7623015|NCT01730040|26526121|P6|Overall Study|Randomized but not treated|1
7623016|NCT01730040|26526122|P5|Overall Study|Randomized but not treated|0
7623017|NCT01730040|26526123|P4|Overall Study|Randomized but not treated|0
7623018|NCT01730040|26526124|P3|Overall Study|Randomized but not treated|0
7623019|NCT01730040|26526125|P2|Overall Study|Randomized but not treated|0
7623020|NCT01730040|26526126|P1|Overall Study|Randomized but not treated|0
7623021|NCT01729871|26526315|P2|Overall Study|Other|9
7623022|NCT01729871|26526316|P1|Overall Study|Other|4
7623023|NCT01729871|26526315|P2|Overall Study|Withdrawal by Subject|3
7623024|NCT01729871|26526316|P1|Overall Study|Withdrawal by Subject|0
7623025|NCT01729871|26526315|P2|Overall Study|Protocol Violation|0
7623026|NCT01729871|26526316|P1|Overall Study|Protocol Violation|1
7623027|NCT01729871|26526315|P2|Overall Study|Physician Decision|2
7623028|NCT01729871|26526316|P1|Overall Study|Physician Decision|0
7623029|NCT01729871|26526315|P2|Overall Study|Lack of Efficacy|1
7623030|NCT01729871|26526316|P1|Overall Study|Lack of Efficacy|0
7623031|NCT01729871|26526315|P2|Overall Study|Death|1
7623032|NCT01729871|26526316|P1|Overall Study|Death|0
7623033|NCT01729871|26526315|P2|Overall Study|Adverse Event|7
7623034|NCT01729871|26526316|P1|Overall Study|Adverse Event|7
7623035|NCT01729819|26526350|P2|Overall Study|Withdrawal by Subject|2
7623036|NCT01729819|26526351|P1|Overall Study|Withdrawal by Subject|0
7623037|NCT01729819|26526350|P2|Overall Study|Protocol Violation|1
7623038|NCT01729819|26526351|P1|Overall Study|Protocol Violation|0
7623039|NCT01729819|26526350|P2|Overall Study|Other reason|0
7623040|NCT01729819|26526351|P1|Overall Study|Other reason|1
7623041|NCT01729819|26526350|P2|Overall Study|Lost to Follow-up|0
7623042|NCT01729819|26526351|P1|Overall Study|Lost to Follow-up|2
7623043|NCT01729819|26526350|P2|Overall Study|Lack of Efficacy|0
7623044|NCT01729819|26526351|P1|Overall Study|Lack of Efficacy|1
7623045|NCT01729819|26526350|P2|Overall Study|Adverse Event|4
7623046|NCT01729819|26526351|P1|Overall Study|Adverse Event|2
7623047|NCT01729754|26526370|P10|Part 3|Other Protocol Specified Criteria|0
7623048|NCT01729754|26526371|P9|Part 3|Other Protocol Specified Criteria|0
7623049|NCT01729754|26526372|P8|Part 3|Other Protocol Specified Criteria|1
7623050|NCT01729754|26526373|P7|Part 3|Other Protocol Specified Criteria|0
7623051|NCT01729754|26526374|P6|Part 3|Other Protocol Specified Criteria|2
7623052|NCT01729754|26526375|P5|Part 3|Other Protocol Specified Criteria|0
7623053|NCT01729754|26526376|P4|Part 3|Other Protocol Specified Criteria|0
7623054|NCT01729754|26526377|P3|Part 3|Other Protocol Specified Criteria|0
7623055|NCT01729754|26526378|P2|Part 3|Other Protocol Specified Criteria|0
7623056|NCT01729754|26526379|P1|Part 3|Other Protocol Specified Criteria|0
7623057|NCT01729754|26526370|P10|Part 3|Withdrawal by Subject|0
7623058|NCT01729754|26526371|P9|Part 3|Withdrawal by Subject|0
7623059|NCT01729754|26526372|P8|Part 3|Withdrawal by Subject|2
7623060|NCT01729754|26526373|P7|Part 3|Withdrawal by Subject|0
7623061|NCT01729754|26526374|P6|Part 3|Withdrawal by Subject|1
7623062|NCT01729754|26526375|P5|Part 3|Withdrawal by Subject|2
7623063|NCT01729754|26526376|P4|Part 3|Withdrawal by Subject|0
7623064|NCT01729754|26526377|P3|Part 3|Withdrawal by Subject|1
7623065|NCT01729754|26526378|P2|Part 3|Withdrawal by Subject|4
7623066|NCT01729754|26526379|P1|Part 3|Withdrawal by Subject|0
7623067|NCT01729754|26526370|P10|Part 3|Physician Decision|0
7623068|NCT01729754|26526371|P9|Part 3|Physician Decision|0
7623069|NCT01729754|26526372|P8|Part 3|Physician Decision|0
7623070|NCT01729754|26526373|P7|Part 3|Physician Decision|0
7623071|NCT01729754|26526374|P6|Part 3|Physician Decision|0
7623072|NCT01729754|26526375|P5|Part 3|Physician Decision|0
7623073|NCT01729754|26526376|P4|Part 3|Physician Decision|0
7623074|NCT01729754|26526377|P3|Part 3|Physician Decision|1
7623075|NCT01729754|26526378|P2|Part 3|Physician Decision|0
7623076|NCT01729754|26526379|P1|Part 3|Physician Decision|0
7623077|NCT01729754|26526370|P10|Part 3|Lost to Follow-up|0
7623078|NCT01729754|26526371|P9|Part 3|Lost to Follow-up|1
7623079|NCT01729754|26526372|P8|Part 3|Lost to Follow-up|0
7623080|NCT01729754|26526373|P7|Part 3|Lost to Follow-up|0
7623081|NCT01729754|26526374|P6|Part 3|Lost to Follow-up|3
7623082|NCT01729754|26526375|P5|Part 3|Lost to Follow-up|0
7623083|NCT01729754|26526376|P4|Part 3|Lost to Follow-up|0
7623084|NCT01729754|26526377|P3|Part 3|Lost to Follow-up|2
7623085|NCT01729754|26526378|P2|Part 3|Lost to Follow-up|1
7623086|NCT01729754|26526379|P1|Part 3|Lost to Follow-up|0
7623087|NCT01729754|26526370|P10|Part 3|Lack of Efficacy|4
7623088|NCT01729754|26526371|P9|Part 3|Lack of Efficacy|0
7623089|NCT01729754|26526372|P8|Part 3|Lack of Efficacy|0
7623090|NCT01729754|26526373|P7|Part 3|Lack of Efficacy|0
7623091|NCT01729754|26526374|P6|Part 3|Lack of Efficacy|0
7623092|NCT01729754|26526375|P5|Part 3|Lack of Efficacy|2
7623093|NCT01729754|26526376|P4|Part 3|Lack of Efficacy|0
7623094|NCT01729754|26526377|P3|Part 3|Lack of Efficacy|0
7623095|NCT01729754|26526378|P2|Part 3|Lack of Efficacy|0
7623096|NCT01729754|26526379|P1|Part 3|Lack of Efficacy|0
7623097|NCT01729754|26526370|P10|Part 3|Death|0
7623098|NCT01729754|26526371|P9|Part 3|Death|0
7623099|NCT01729754|26526372|P8|Part 3|Death|0
7623100|NCT01729754|26526373|P7|Part 3|Death|0
7623101|NCT01729754|26526374|P6|Part 3|Death|2
7623102|NCT01729754|26526375|P5|Part 3|Death|0
7623103|NCT01729754|26526376|P4|Part 3|Death|0
7623107|NCT01729754|26526370|P10|Part 3|Adverse Event|3
7623108|NCT01729754|26526371|P9|Part 3|Adverse Event|0
7623109|NCT01729754|26526372|P8|Part 3|Adverse Event|0
7623110|NCT01729754|26526373|P7|Part 3|Adverse Event|0
7623111|NCT01729754|26526374|P6|Part 3|Adverse Event|5
7623112|NCT01729754|26526375|P5|Part 3|Adverse Event|0
7623113|NCT01729754|26526376|P4|Part 3|Adverse Event|0
7623114|NCT01729754|26526377|P3|Part 3|Adverse Event|1
7623115|NCT01729754|26526378|P2|Part 3|Adverse Event|0
7623116|NCT01729754|26526379|P1|Part 3|Adverse Event|0
7623117|NCT01729754|26526370|P10|Part 2|Other Protocol Specified Criteria|0
7623118|NCT01729754|26526371|P9|Part 2|Other Protocol Specified Criteria|0
7623119|NCT01729754|26526372|P8|Part 2|Other Protocol Specified Criteria|1
7623120|NCT01729754|26526373|P7|Part 2|Other Protocol Specified Criteria|0
7623121|NCT01729754|26526374|P6|Part 2|Other Protocol Specified Criteria|0
7623122|NCT01729754|26526375|P5|Part 2|Other Protocol Specified Criteria|0
7623123|NCT01729754|26526376|P4|Part 2|Other Protocol Specified Criteria|0
7623124|NCT01729754|26526377|P3|Part 2|Other Protocol Specified Criteria|0
7623125|NCT01729754|26526378|P2|Part 2|Other Protocol Specified Criteria|0
7623126|NCT01729754|26526379|P1|Part 2|Other Protocol Specified Criteria|1
7623127|NCT01729754|26526370|P10|Part 2|Withdrawal by Subject|4
7623128|NCT01729754|26526371|P9|Part 2|Withdrawal by Subject|1
7623129|NCT01729754|26526372|P8|Part 2|Withdrawal by Subject|1
7623130|NCT01729754|26526373|P7|Part 2|Withdrawal by Subject|0
7623131|NCT01729754|26526374|P6|Part 2|Withdrawal by Subject|0
7623132|NCT01729754|26526375|P5|Part 2|Withdrawal by Subject|0
7623133|NCT01729754|26526376|P4|Part 2|Withdrawal by Subject|2
7623134|NCT01729754|26526377|P3|Part 2|Withdrawal by Subject|0
7623135|NCT01729754|26526378|P2|Part 2|Withdrawal by Subject|0
7623136|NCT01729754|26526379|P1|Part 2|Withdrawal by Subject|3
7623137|NCT01729754|26526370|P10|Part 2|Pregnancy|1
7623138|NCT01729754|26526371|P9|Part 2|Pregnancy|0
7623139|NCT01729754|26526372|P8|Part 2|Pregnancy|0
7623140|NCT01729754|26526373|P7|Part 2|Pregnancy|0
7623141|NCT01729754|26526374|P6|Part 2|Pregnancy|0
7623142|NCT01729754|26526375|P5|Part 2|Pregnancy|0
7623143|NCT01729754|26526376|P4|Part 2|Pregnancy|1
7623144|NCT01729754|26526377|P3|Part 2|Pregnancy|0
7623145|NCT01729754|26526378|P2|Part 2|Pregnancy|0
7623146|NCT01729754|26526379|P1|Part 2|Pregnancy|0
7623147|NCT01729754|26526370|P10|Part 2|Non-Compliance with Study Drug|1
7623148|NCT01729754|26526371|P9|Part 2|Non-Compliance with Study Drug|0
7623149|NCT01729754|26526372|P8|Part 2|Non-Compliance with Study Drug|0
7623150|NCT01729754|26526373|P7|Part 2|Non-Compliance with Study Drug|0
7623151|NCT01729754|26526374|P6|Part 2|Non-Compliance with Study Drug|0
7623152|NCT01729754|26526375|P5|Part 2|Non-Compliance with Study Drug|0
7623153|NCT01729754|26526376|P4|Part 2|Non-Compliance with Study Drug|0
7623154|NCT01729754|26526377|P3|Part 2|Non-Compliance with Study Drug|0
7623155|NCT01729754|26526378|P2|Part 2|Non-Compliance with Study Drug|0
7623156|NCT01729754|26526379|P1|Part 2|Non-Compliance with Study Drug|0
7623157|NCT01729754|26526370|P10|Part 2|Lost to Follow-up|2
7623158|NCT01729754|26526371|P9|Part 2|Lost to Follow-up|0
7623159|NCT01729754|26526372|P8|Part 2|Lost to Follow-up|1
7623160|NCT01729754|26526373|P7|Part 2|Lost to Follow-up|0
7623161|NCT01729754|26526374|P6|Part 2|Lost to Follow-up|0
7623162|NCT01729754|26526375|P5|Part 2|Lost to Follow-up|0
7623163|NCT01729754|26526376|P4|Part 2|Lost to Follow-up|2
7623164|NCT01729754|26526377|P3|Part 2|Lost to Follow-up|0
7623165|NCT01729754|26526378|P2|Part 2|Lost to Follow-up|0
7623166|NCT01729754|26526379|P1|Part 2|Lost to Follow-up|0
7623167|NCT01729754|26526370|P10|Part 2|Lack of Efficacy|2
7623168|NCT01729754|26526371|P9|Part 2|Lack of Efficacy|2
7623169|NCT01729754|26526372|P8|Part 2|Lack of Efficacy|0
7623170|NCT01729754|26526373|P7|Part 2|Lack of Efficacy|0
7623171|NCT01729754|26526374|P6|Part 2|Lack of Efficacy|0
7623172|NCT01729754|26526375|P5|Part 2|Lack of Efficacy|0
7623173|NCT01729754|26526376|P4|Part 2|Lack of Efficacy|0
7623174|NCT01729754|26526377|P3|Part 2|Lack of Efficacy|0
7623175|NCT01729754|26526378|P2|Part 2|Lack of Efficacy|0
7623176|NCT01729754|26526379|P1|Part 2|Lack of Efficacy|0
7623177|NCT01729754|26526370|P10|Part 2|Adverse Event|2
7623178|NCT01729754|26526371|P9|Part 2|Adverse Event|1
7623179|NCT01729754|26526372|P8|Part 2|Adverse Event|0
7623180|NCT01729754|26526373|P7|Part 2|Adverse Event|0
7623181|NCT01729754|26526374|P6|Part 2|Adverse Event|0
7623182|NCT01729754|26526375|P5|Part 2|Adverse Event|0
7623183|NCT01729754|26526376|P4|Part 2|Adverse Event|0
7623184|NCT01729754|26526377|P3|Part 2|Adverse Event|0
7623185|NCT01729754|26526378|P2|Part 2|Adverse Event|0
7623186|NCT01729754|26526379|P1|Part 2|Adverse Event|2
7623187|NCT01729754|26526370|P10|Part 1|Other Protocol Specified Criteria|4
7623188|NCT01729754|26526371|P9|Part 1|Other Protocol Specified Criteria|0
7623189|NCT01729754|26526372|P8|Part 1|Other Protocol Specified Criteria|0
7623190|NCT01729754|26526373|P7|Part 1|Other Protocol Specified Criteria|1
7623191|NCT01729754|26526374|P6|Part 1|Other Protocol Specified Criteria|0
7623192|NCT01729754|26526375|P5|Part 1|Other Protocol Specified Criteria|0
7623193|NCT01729754|26526376|P4|Part 1|Other Protocol Specified Criteria|0
7623194|NCT01729754|26526377|P3|Part 1|Other Protocol Specified Criteria|0
7623195|NCT01729754|26526378|P2|Part 1|Other Protocol Specified Criteria|0
7623196|NCT01729754|26526379|P1|Part 1|Other Protocol Specified Criteria|2
7623197|NCT01729754|26526370|P10|Part 1|Withdrawal by Subject|6
7623198|NCT01729754|26526371|P9|Part 1|Withdrawal by Subject|0
7623199|NCT01729754|26526372|P8|Part 1|Withdrawal by Subject|0
7623200|NCT01729754|26526373|P7|Part 1|Withdrawal by Subject|5
7623201|NCT01729754|26526374|P6|Part 1|Withdrawal by Subject|0
7623202|NCT01729754|26526375|P5|Part 1|Withdrawal by Subject|0
7623203|NCT01729754|26526376|P4|Part 1|Withdrawal by Subject|7
7623204|NCT01729754|26526377|P3|Part 1|Withdrawal by Subject|0
7623205|NCT01729754|26526378|P2|Part 1|Withdrawal by Subject|0
7623206|NCT01729754|26526379|P1|Part 1|Withdrawal by Subject|5
7623207|NCT01729754|26526370|P10|Part 1|Protocol Violation|0
7623208|NCT01729754|26526371|P9|Part 1|Protocol Violation|0
7623209|NCT01729754|26526372|P8|Part 1|Protocol Violation|0
7623210|NCT01729754|26526373|P7|Part 1|Protocol Violation|1
7623211|NCT01729754|26526374|P6|Part 1|Protocol Violation|0
7623212|NCT01729754|26526375|P5|Part 1|Protocol Violation|0
7623213|NCT01729754|26526376|P4|Part 1|Protocol Violation|1
7623214|NCT01729754|26526377|P3|Part 1|Protocol Violation|0
7623215|NCT01729754|26526378|P2|Part 1|Protocol Violation|0
7623216|NCT01729754|26526379|P1|Part 1|Protocol Violation|2
7623217|NCT01729754|26526370|P10|Part 1|Progressive Disease|1
7623218|NCT01729754|26526371|P9|Part 1|Progressive Disease|0
7623219|NCT01729754|26526372|P8|Part 1|Progressive Disease|0
7623220|NCT01729754|26526373|P7|Part 1|Progressive Disease|0
7623221|NCT01729754|26526374|P6|Part 1|Progressive Disease|0
7623222|NCT01729754|26526375|P5|Part 1|Progressive Disease|0
7623223|NCT01729754|26526376|P4|Part 1|Progressive Disease|0
7623224|NCT01729754|26526377|P3|Part 1|Progressive Disease|0
7623225|NCT01729754|26526378|P2|Part 1|Progressive Disease|0
7623226|NCT01729754|26526379|P1|Part 1|Progressive Disease|0
7623227|NCT01729754|26526370|P10|Part 1|Pregnancy|1
7623228|NCT01729754|26526371|P9|Part 1|Pregnancy|0
7623229|NCT01729754|26526372|P8|Part 1|Pregnancy|0
7623230|NCT01729754|26526373|P7|Part 1|Pregnancy|0
7623231|NCT01729754|26526374|P6|Part 1|Pregnancy|0
7623232|NCT01729754|26526375|P5|Part 1|Pregnancy|0
7623233|NCT01729754|26526376|P4|Part 1|Pregnancy|1
7623234|NCT01729754|26526377|P3|Part 1|Pregnancy|0
7623235|NCT01729754|26526378|P2|Part 1|Pregnancy|0
7623236|NCT01729754|26526379|P1|Part 1|Pregnancy|0
7623237|NCT01729754|26526370|P10|Part 1|Physician Decision|4
7623238|NCT01729754|26526371|P9|Part 1|Physician Decision|0
7623239|NCT01729754|26526372|P8|Part 1|Physician Decision|0
7623240|NCT01729754|26526373|P7|Part 1|Physician Decision|0
7623241|NCT01729754|26526374|P6|Part 1|Physician Decision|0
7623242|NCT01729754|26526375|P5|Part 1|Physician Decision|0
7623243|NCT01729754|26526376|P4|Part 1|Physician Decision|0
7623244|NCT01729754|26526377|P3|Part 1|Physician Decision|0
7623245|NCT01729754|26526378|P2|Part 1|Physician Decision|0
7623246|NCT01729754|26526379|P1|Part 1|Physician Decision|0
7623247|NCT01729754|26526370|P10|Part 1|Non-compliance with Study Drug|0
7623248|NCT01729754|26526371|P9|Part 1|Non-compliance with Study Drug|0
7623249|NCT01729754|26526372|P8|Part 1|Non-compliance with Study Drug|0
7623250|NCT01729754|26526373|P7|Part 1|Non-compliance with Study Drug|0
7623251|NCT01729754|26526374|P6|Part 1|Non-compliance with Study Drug|0
7623252|NCT01729754|26526375|P5|Part 1|Non-compliance with Study Drug|0
7623253|NCT01729754|26526376|P4|Part 1|Non-compliance with Study Drug|0
7623254|NCT01729754|26526377|P3|Part 1|Non-compliance with Study Drug|0
7623255|NCT01729754|26526378|P2|Part 1|Non-compliance with Study Drug|0
7623256|NCT01729754|26526379|P1|Part 1|Non-compliance with Study Drug|1
7623257|NCT01729754|26526370|P10|Part 1|Lost to Follow-up|3
7623258|NCT01729754|26526371|P9|Part 1|Lost to Follow-up|0
7623259|NCT01729754|26526372|P8|Part 1|Lost to Follow-up|0
7623260|NCT01729754|26526373|P7|Part 1|Lost to Follow-up|3
7623261|NCT01729754|26526374|P6|Part 1|Lost to Follow-up|0
7623262|NCT01729754|26526375|P5|Part 1|Lost to Follow-up|0
7623263|NCT01729754|26526376|P4|Part 1|Lost to Follow-up|2
7623264|NCT01729754|26526377|P3|Part 1|Lost to Follow-up|0
7623265|NCT01729754|26526378|P2|Part 1|Lost to Follow-up|0
7623266|NCT01729754|26526379|P1|Part 1|Lost to Follow-up|1
7623267|NCT01729754|26526370|P10|Part 1|Lack of Efficacy|0
7623268|NCT01729754|26526371|P9|Part 1|Lack of Efficacy|0
7623269|NCT01729754|26526372|P8|Part 1|Lack of Efficacy|0
7623270|NCT01729754|26526373|P7|Part 1|Lack of Efficacy|2
7623271|NCT01729754|26526374|P6|Part 1|Lack of Efficacy|0
7623272|NCT01729754|26526375|P5|Part 1|Lack of Efficacy|0
7623273|NCT01729754|26526376|P4|Part 1|Lack of Efficacy|0
7623274|NCT01729754|26526377|P3|Part 1|Lack of Efficacy|0
7623275|NCT01729754|26526378|P2|Part 1|Lack of Efficacy|0
7623276|NCT01729754|26526379|P1|Part 1|Lack of Efficacy|1
7623277|NCT01729754|26526370|P10|Part 1|Adverse Event|5
7623278|NCT01729754|26526371|P9|Part 1|Adverse Event|0
7623279|NCT01729754|26526372|P8|Part 1|Adverse Event|0
7623280|NCT01729754|26526373|P7|Part 1|Adverse Event|2
7623281|NCT01729754|26526374|P6|Part 1|Adverse Event|0
7623282|NCT01729754|26526375|P5|Part 1|Adverse Event|0
7623283|NCT01729754|26526376|P4|Part 1|Adverse Event|1
7623284|NCT01729754|26526377|P3|Part 1|Adverse Event|0
7623285|NCT01729754|26526378|P2|Part 1|Adverse Event|0
7623286|NCT01729754|26526379|P1|Part 1|Adverse Event|2
7623287|NCT01729728|26526586|P3|Overall Study|Protocol Violation|1
7623288|NCT01729728|26526587|P2|Overall Study|Protocol Violation|0
7623289|NCT01729728|26526588|P1|Overall Study|Protocol Violation|1
7623290|NCT01729728|26526586|P3|Overall Study|Adverse Event|0
7623291|NCT01729728|26526587|P2|Overall Study|Adverse Event|6
7623292|NCT01729728|26526588|P1|Overall Study|Adverse Event|0
7623293|NCT01729559|26526738|P2|Overall Study|Protocol Violation|28
7623294|NCT01729559|26526739|P1|Overall Study|Protocol Violation|31
7623295|NCT01729208|26526855|P2|36 Months Follow-up|Withdrawal by Subject|4
7623296|NCT01729208|26526856|P1|36 Months Follow-up|Withdrawal by Subject|2
7623297|NCT01729208|26526855|P2|36 Months Follow-up|Physician Decision|0
7623298|NCT01729208|26526856|P1|36 Months Follow-up|Physician Decision|1
7623299|NCT01729208|26526855|P2|24 Months Follow-up|Lost to Follow-up|0
7623300|NCT01729208|26526856|P1|24 Months Follow-up|Lost to Follow-up|3
7623301|NCT01729208|26526855|P2|12 Months Follow-up|Lost to Follow-up|3
7623302|NCT01729208|26526856|P1|12 Months Follow-up|Lost to Follow-up|3
7623303|NCT01729208|26526855|P2|12 Months Follow-up|Withdrawal by Subject|7
7623304|NCT01729208|26526856|P1|12 Months Follow-up|Withdrawal by Subject|4
7623305|NCT01729208|26526855|P2|Baseline|Physician Decision|4
7623306|NCT01729208|26526856|P1|Baseline|Physician Decision|5
7623307|NCT01729156|26526889|P3|Overall Study|Withdrawal by Subject|0
7623308|NCT01729156|26526890|P2|Overall Study|Withdrawal by Subject|0
7623309|NCT01729156|26526891|P1|Overall Study|Withdrawal by Subject|1
7623310|NCT01729039|26526919|P2|Overall Study|Withdrawal by Subject|7
7623311|NCT01729039|26526920|P1|Overall Study|Withdrawal by Subject|8
7623312|NCT01729039|26526919|P2|Overall Study|disqualified|5
7623313|NCT01729039|26526920|P1|Overall Study|disqualified|2
7623314|NCT01729026|26526936|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
7623315|NCT01729026|26526937|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
7623316|NCT01729026|26526936|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
7623317|NCT01729026|26526937|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
7623318|NCT01728792|26527040|P5|Overall Study|Lost to Follow-up|0
7623319|NCT01728792|26527041|P4|Overall Study|Lost to Follow-up|2
7623320|NCT01728792|26527042|P3|Overall Study|Lost to Follow-up|4
7623321|NCT01728792|26527043|P2|Overall Study|Lost to Follow-up|1
7623322|NCT01728792|26527044|P1|Overall Study|Lost to Follow-up|2
7623323|NCT01728792|26527040|P5|Overall Study|Withdrawal of Consent|0
7623324|NCT01728792|26527041|P4|Overall Study|Withdrawal of Consent|1
7623325|NCT01728792|26527042|P3|Overall Study|Withdrawal of Consent|0
7623326|NCT01728792|26527043|P2|Overall Study|Withdrawal of Consent|1
7623327|NCT01728792|26527044|P1|Overall Study|Withdrawal of Consent|1
7623328|NCT01728779|26527091|P1|Overall Study|Withdrawal by Subject|1
7623329|NCT01728623|26527122|P1|Overall Study|Withdrawal by Subject|1
7623330|NCT01728623|26527122|P1|Overall Study|Adverse Event|1
7623331|NCT01728623|26527122|P1|Overall Study|Disease progression|26
7623332|NCT01728584|26527148|P4|Overall Study|Other reason (not specified)|1
7623333|NCT01728584|26527149|P3|Overall Study|Other reason (not specified)|0
7623334|NCT01728584|26527150|P2|Overall Study|Other reason (not specified)|0
7623335|NCT01728584|26527151|P1|Overall Study|Other reason (not specified)|1
7623336|NCT01728584|26527148|P4|Overall Study|Screen failure|0
7623337|NCT01728584|26527149|P3|Overall Study|Screen failure|0
7623338|NCT01728584|26527150|P2|Overall Study|Screen failure|0
7623339|NCT01728584|26527151|P1|Overall Study|Screen failure|1
7623340|NCT01728584|26527148|P4|Overall Study|Withdrawal by Subject|0
7623341|NCT01728584|26527149|P3|Overall Study|Withdrawal by Subject|0
7623342|NCT01728584|26527150|P2|Overall Study|Withdrawal by Subject|0
7623343|NCT01728584|26527151|P1|Overall Study|Withdrawal by Subject|1
7623344|NCT01728584|26527148|P4|Overall Study|Physician Decision|0
7623345|NCT01728584|26527149|P3|Overall Study|Physician Decision|1
7623346|NCT01728584|26527150|P2|Overall Study|Physician Decision|0
7623347|NCT01728584|26527151|P1|Overall Study|Physician Decision|4
7623348|NCT01728584|26527148|P4|Overall Study|Adverse Event|0
7623349|NCT01728584|26527149|P3|Overall Study|Adverse Event|0
7623350|NCT01728584|26527150|P2|Overall Study|Adverse Event|0
7623351|NCT01728584|26527151|P1|Overall Study|Adverse Event|1
7623352|NCT01728454|26527206|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7623353|NCT01728454|26527207|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7623354|NCT01728454|26527208|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
7623355|NCT01728454|26527206|P3|Stage 3|Lost to Follow-up|1
7623356|NCT01728454|26527207|P2|Stage 3|Lost to Follow-up|3
7623357|NCT01728454|26527208|P1|Stage 3|Lost to Follow-up|0
7623358|NCT01728454|26527206|P3|Stage 3|Non-compliance with Protocol|1
7623359|NCT01728454|26527207|P2|Stage 3|Non-compliance with Protocol|0
7623360|NCT01728454|26527208|P1|Stage 3|Non-compliance with Protocol|0
7623361|NCT01728454|26527206|P3|Stage 3|Withdrew Consent|1
7623362|NCT01728454|26527207|P2|Stage 3|Withdrew Consent|0
7623363|NCT01728454|26527208|P1|Stage 3|Withdrew Consent|1
7623364|NCT01728454|26527206|P3|Stage 3|Pregnancy|0
7623365|NCT01728454|26527207|P2|Stage 3|Pregnancy|0
7623366|NCT01728454|26527208|P1|Stage 3|Pregnancy|1
7623367|NCT01728454|26527206|P3|Stage 3|Subject Required Other Treatment|0
7623368|NCT01728454|26527207|P2|Stage 3|Subject Required Other Treatment|1
7623369|NCT01728454|26527208|P1|Stage 3|Subject Required Other Treatment|0
7623370|NCT01728454|26527206|P3|Stage 3|Reason Missing|1
7623371|NCT01728454|26527207|P2|Stage 3|Reason Missing|0
7623372|NCT01728454|26527208|P1|Stage 3|Reason Missing|0
7623373|NCT01728454|26527206|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7623374|NCT01728454|26527207|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7623375|NCT01728454|26527208|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
7623376|NCT01728454|26527206|P3|Stage 1 and 2|Lost to Follow-up|0
7623377|NCT01728454|26527207|P2|Stage 1 and 2|Lost to Follow-up|1
7623378|NCT01728454|26527208|P1|Stage 1 and 2|Lost to Follow-up|1
7623379|NCT01728454|26527206|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7623380|NCT01728454|26527207|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7623381|NCT01728454|26527208|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
7623382|NCT01728454|26527206|P3|Stage 1 and 2|Non-compliance with Protocol|1
7623383|NCT01728454|26527207|P2|Stage 1 and 2|Non-compliance with Protocol|0
7623384|NCT01728454|26527208|P1|Stage 1 and 2|Non-compliance with Protocol|0
7623385|NCT01728454|26527206|P3|Stage 1 and 2|Pregnancy|0
7623386|NCT01728454|26527207|P2|Stage 1 and 2|Pregnancy|0
7623387|NCT01728454|26527208|P1|Stage 1 and 2|Pregnancy|1
7623388|NCT01728376|26527258|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
7623389|NCT01728376|26527259|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
7623390|NCT01728376|26527260|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
7623391|NCT01728376|26527261|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
7623392|NCT01728376|26527262|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
7623393|NCT01728376|26527263|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
7623394|NCT01728376|26527258|P6|Overall Study|Did not receive treatment|0
7623395|NCT01728376|26527259|P5|Overall Study|Did not receive treatment|0
7623396|NCT01728376|26527260|P4|Overall Study|Did not receive treatment|0
7623397|NCT01728376|26527261|P3|Overall Study|Did not receive treatment|0
7623398|NCT01728376|26527262|P2|Overall Study|Did not receive treatment|1
7623399|NCT01728376|26527263|P1|Overall Study|Did not receive treatment|0
7623400|NCT01728376|26527258|P6|Overall Study|No relevant bacteria|1
7623401|NCT01728376|26527259|P5|Overall Study|No relevant bacteria|1
7623402|NCT01728376|26527260|P4|Overall Study|No relevant bacteria|0
7623403|NCT01728376|26527261|P3|Overall Study|No relevant bacteria|0
7623404|NCT01728376|26527262|P2|Overall Study|No relevant bacteria|0
7623405|NCT01728376|26527263|P1|Overall Study|No relevant bacteria|2
7623406|NCT01728376|26527258|P6|Overall Study|Persistent Positive Blood Cultures|0
7623407|NCT01728376|26527259|P5|Overall Study|Persistent Positive Blood Cultures|0
7623408|NCT01728376|26527260|P4|Overall Study|Persistent Positive Blood Cultures|0
7623409|NCT01728376|26527261|P3|Overall Study|Persistent Positive Blood Cultures|1
7623410|NCT01728376|26527262|P2|Overall Study|Persistent Positive Blood Cultures|0
7623411|NCT01728376|26527263|P1|Overall Study|Persistent Positive Blood Cultures|1
7623412|NCT01728376|26527258|P6|Overall Study|Adverse Event|0
7623413|NCT01728376|26527259|P5|Overall Study|Adverse Event|1
7623414|NCT01728376|26527260|P4|Overall Study|Adverse Event|1
7623415|NCT01728376|26527261|P3|Overall Study|Adverse Event|1
7623416|NCT01728376|26527262|P2|Overall Study|Adverse Event|1
7623417|NCT01728376|26527263|P1|Overall Study|Adverse Event|1
7623418|NCT01728324|26527336|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
7623419|NCT01728324|26527337|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
7623420|NCT01728324|26527338|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
7623421|NCT01728324|26527336|P3|Termination of RBV|Adverse Event (Placebo Period)|0
7623422|NCT01728324|26527337|P2|Termination of RBV|Adverse Event (Placebo Period)|1
7623423|NCT01728324|26527338|P1|Termination of RBV|Adverse Event (Placebo Period)|0
7623424|NCT01728324|26527336|P3|Termination of RBV|Other than stated|1
7623425|NCT01728324|26527337|P2|Termination of RBV|Other than stated|3
7623426|NCT01728324|26527338|P1|Termination of RBV|Other than stated|1
7623427|NCT01728324|26527336|P3|Termination of RBV|Withdrawal by Subject|2
7623428|NCT01728324|26527337|P2|Termination of RBV|Withdrawal by Subject|5
7623429|NCT01728324|26527338|P1|Termination of RBV|Withdrawal by Subject|9
7623430|NCT01728324|26527336|P3|Termination of RBV|Lack of Efficacy|7
7623431|NCT01728324|26527337|P2|Termination of RBV|Lack of Efficacy|11
7623432|NCT01728324|26527338|P1|Termination of RBV|Lack of Efficacy|14
7623433|NCT01728324|26527336|P3|Termination of RBV|Adverse Event|5
7623434|NCT01728324|26527337|P2|Termination of RBV|Adverse Event|16
7623435|NCT01728324|26527338|P1|Termination of RBV|Adverse Event|15
7623436|NCT01728324|26527336|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
7623437|NCT01728324|26527337|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
7623438|NCT01728324|26527338|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
7623439|NCT01728324|26527336|P3|Termination of FDV|Adverse Event (Placebo Period)|0
7623440|NCT01728324|26527337|P2|Termination of FDV|Adverse Event (Placebo Period)|1
7623441|NCT01728324|26527338|P1|Termination of FDV|Adverse Event (Placebo Period)|0
7623442|NCT01728324|26527336|P3|Termination of FDV|Other than stated|0
7623443|NCT01728324|26527337|P2|Termination of FDV|Other than stated|3
7623444|NCT01728324|26527338|P1|Termination of FDV|Other than stated|1
7623445|NCT01728324|26527336|P3|Termination of FDV|Withdrawal by Subject|2
7623446|NCT01728324|26527337|P2|Termination of FDV|Withdrawal by Subject|6
7623447|NCT01728324|26527338|P1|Termination of FDV|Withdrawal by Subject|9
7623448|NCT01728324|26527336|P3|Termination of FDV|Lack of Efficacy|8
7623449|NCT01728324|26527337|P2|Termination of FDV|Lack of Efficacy|12
7623450|NCT01728324|26527338|P1|Termination of FDV|Lack of Efficacy|14
7623451|NCT01728324|26527336|P3|Termination of FDV|Adverse Event|4
7623452|NCT01728324|26527337|P2|Termination of FDV|Adverse Event|13
7623453|NCT01728324|26527338|P1|Termination of FDV|Adverse Event|14
7623454|NCT01728324|26527336|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
7623455|NCT01728324|26527337|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
7623456|NCT01728324|26527338|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
7623457|NCT01728324|26527336|P3|Termination of DBV|Adverse Event (Placebo Period)|0
7623458|NCT01728324|26527337|P2|Termination of DBV|Adverse Event (Placebo Period)|1
7623459|NCT01728324|26527338|P1|Termination of DBV|Adverse Event (Placebo Period)|0
7623460|NCT01728324|26527336|P3|Termination of DBV|Other than stated|0
7623461|NCT01728324|26527337|P2|Termination of DBV|Other than stated|3
7623462|NCT01728324|26527338|P1|Termination of DBV|Other than stated|1
7623463|NCT01728324|26527336|P3|Termination of DBV|Withdrawal by Subject|2
7623464|NCT01728324|26527337|P2|Termination of DBV|Withdrawal by Subject|6
7623465|NCT01728324|26527338|P1|Termination of DBV|Withdrawal by Subject|9
7623466|NCT01728324|26527336|P3|Termination of DBV|Lack of Efficacy|8
7623467|NCT01728324|26527337|P2|Termination of DBV|Lack of Efficacy|12
7623468|NCT01728324|26527338|P1|Termination of DBV|Lack of Efficacy|14
7623469|NCT01728324|26527336|P3|Termination of DBV|Adverse Event|4
7623470|NCT01728324|26527337|P2|Termination of DBV|Adverse Event|13
7623471|NCT01728324|26527338|P1|Termination of DBV|Adverse Event|14
7623472|NCT01728246|26527359|P2|Overall Study|Adverse Event|5
7623473|NCT01728246|26527360|P1|Overall Study|Adverse Event|8
7623474|NCT01728246|26527359|P2|Overall Study|Lack of Efficacy|1
7623475|NCT01728246|26527360|P1|Overall Study|Lack of Efficacy|1
7623476|NCT01728246|26527359|P2|Overall Study|Lost to Follow-up|22
7623477|NCT01728246|26527360|P1|Overall Study|Lost to Follow-up|23
7623478|NCT01728246|26527359|P2|Overall Study|Withdrawal by Subject|3
7623479|NCT01728246|26527360|P1|Overall Study|Withdrawal by Subject|2
7623480|NCT01728246|26527359|P2|Overall Study|Protocol Violation|0
7623481|NCT01728246|26527360|P1|Overall Study|Protocol Violation|1
7623482|NCT01728246|26527359|P2|Overall Study|Participant needed rescue medication|5
7623483|NCT01728246|26527360|P1|Overall Study|Participant needed rescue medication|1
7623484|NCT01728194|26527378|P2|Overall Study|Family Member Request|0
7623485|NCT01728194|26527379|P1|Overall Study|Family Member Request|1
7623486|NCT01728194|26527378|P2|Overall Study|Perceived Medication Side Effects|0
7623487|NCT01728194|26527379|P1|Overall Study|Perceived Medication Side Effects|4
7623488|NCT01728194|26527378|P2|Overall Study|Withdrawal by Subject|3
7623489|NCT01728194|26527379|P1|Overall Study|Withdrawal by Subject|7
7623490|NCT01728194|26527378|P2|Overall Study|Physician Decision|0
7623491|NCT01728194|26527379|P1|Overall Study|Physician Decision|4
7623492|NCT01728194|26527378|P2|Overall Study|Lost to Follow-up|3
7623493|NCT01728194|26527379|P1|Overall Study|Lost to Follow-up|4
7623494|NCT01728116|26527389|P2|Overall Study|various not noted previously|0
7623495|NCT01728116|26527390|P1|Overall Study|various not noted previously|5
7623496|NCT01728116|26527389|P2|Overall Study|Incorrectly enrolled in Study|1
7623497|NCT01728116|26527390|P1|Overall Study|Incorrectly enrolled in Study|0
7623498|NCT01728116|26527389|P2|Overall Study|Inter-current finding at procedure|0
7623499|NCT01728116|26527390|P1|Overall Study|Inter-current finding at procedure|1
7623500|NCT01728116|26527389|P2|Overall Study|Subject Non-Compliance|0
7623501|NCT01728116|26527390|P1|Overall Study|Subject Non-Compliance|2
7623502|NCT01728116|26527389|P2|Overall Study|Physician Decision|0
7623503|NCT01728116|26527390|P1|Overall Study|Physician Decision|2
7623504|NCT01728116|26527389|P2|Overall Study|Lost to Follow-up|2
7623505|NCT01728116|26527390|P1|Overall Study|Lost to Follow-up|9
7623506|NCT01728116|26527389|P2|Overall Study|Procedure/device failure|0
7623507|NCT01728116|26527390|P1|Overall Study|Procedure/device failure|7
7623508|NCT01728116|26527389|P2|Overall Study|Adverse Event|0
7623509|NCT01728116|26527390|P1|Overall Study|Adverse Event|13
7623510|NCT01728116|26527389|P2|Overall Study|Withdrawal by Subject|9
7623511|NCT01728116|26527390|P1|Overall Study|Withdrawal by Subject|16
7623512|NCT01728116|26527389|P2|Overall Study|Sponsor Terminated Study|35
7623513|NCT01728116|26527390|P1|Overall Study|Sponsor Terminated Study|106
7623514|NCT01728077|26527415|P2|Overall Study|Non compliance|0
7623515|NCT01728077|26527416|P1|Overall Study|Non compliance|1
7623516|NCT01728077|26527415|P2|Overall Study|Patient moving|0
7623517|NCT01728077|26527416|P1|Overall Study|Patient moving|1
7623518|NCT01728077|26527415|P2|Overall Study|Death|1
7623519|NCT01728077|26527416|P1|Overall Study|Death|0
7623520|NCT01728077|26527415|P2|Overall Study|Subject choice|3
7623521|NCT01728077|26527416|P1|Overall Study|Subject choice|2
7623522|NCT01728077|26527415|P2|Overall Study|Lost to Follow-up|0
7623523|NCT01728077|26527416|P1|Overall Study|Lost to Follow-up|1
7623524|NCT01728077|26527415|P2|Overall Study|Lack of Efficacy|1
7623525|NCT01728077|26527416|P1|Overall Study|Lack of Efficacy|3
7623526|NCT01727713|26527514|P1|Overall Study|Protocol Deviation|2
7623527|NCT01727713|26527514|P1|Overall Study|Withdrawal by Subject|13
7623528|NCT01727713|26527514|P1|Overall Study|Participant Met Withdrawal Criteria|5
7623529|NCT01727713|26527514|P1|Overall Study|Adverse Event|10
7623530|NCT01727713|26527514|P1|Overall Study|Lost to Follow-up|5
7623531|NCT01727700|26527541|P3|Overall Study|Protocol Violation|0
7623532|NCT01727700|26527542|P2|Overall Study|Protocol Violation|0
7623533|NCT01727700|26527543|P1|Overall Study|Protocol Violation|2
7623534|NCT01727700|26527541|P3|Overall Study|Particpant withdrew consent|1
7623535|NCT01727700|26527542|P2|Overall Study|Particpant withdrew consent|3
7623536|NCT01727700|26527543|P1|Overall Study|Particpant withdrew consent|0
7623537|NCT01727700|26527541|P3|Overall Study|Adverse Event|1
7623538|NCT01727700|26527542|P2|Overall Study|Adverse Event|7
7623539|NCT01727700|26527543|P1|Overall Study|Adverse Event|0
7623540|NCT01727505|26527566|P2|Second 24 Hours|Missing data|1
7623541|NCT01727505|26527567|P1|Second 24 Hours|Missing data|0
7623542|NCT01727505|26527566|P2|First 24 Hours|Adverse Event|1
7623543|NCT01727505|26527567|P1|First 24 Hours|Adverse Event|0
7623544|NCT01727336|26527598|P6|Part 2 Blinded|use of prohibited medications|3
7623545|NCT01727336|26527599|P5|Part 2 Blinded|use of prohibited medications|1
7623546|NCT01727336|26527600|P4|Part 2 Blinded|use of prohibited medications|0
7623547|NCT01727336|26527601|P3|Part 2 Blinded|use of prohibited medications|0
7623548|NCT01727336|26527602|P2|Part 2 Blinded|use of prohibited medications|0
7623549|NCT01727336|26527603|P1|Part 2 Blinded|use of prohibited medications|0
7623550|NCT01727336|26527598|P6|Part 2 Blinded|Withdrawal by Subject|4
7623551|NCT01727336|26527599|P5|Part 2 Blinded|Withdrawal by Subject|0
7623552|NCT01727336|26527600|P4|Part 2 Blinded|Withdrawal by Subject|0
7623553|NCT01727336|26527601|P3|Part 2 Blinded|Withdrawal by Subject|0
7623554|NCT01727336|26527602|P2|Part 2 Blinded|Withdrawal by Subject|0
7623555|NCT01727336|26527603|P1|Part 2 Blinded|Withdrawal by Subject|0
7623556|NCT01727336|26527598|P6|Part 2 Blinded|Lost to Follow-up|1
7623557|NCT01727336|26527599|P5|Part 2 Blinded|Lost to Follow-up|0
7623558|NCT01727336|26527600|P4|Part 2 Blinded|Lost to Follow-up|0
7623559|NCT01727336|26527601|P3|Part 2 Blinded|Lost to Follow-up|0
7623560|NCT01727336|26527602|P2|Part 2 Blinded|Lost to Follow-up|0
7623561|NCT01727336|26527603|P1|Part 2 Blinded|Lost to Follow-up|0
7623562|NCT01727336|26527598|P6|Part 2 Blinded|Lack of Efficacy|44
7623563|NCT01727336|26527599|P5|Part 2 Blinded|Lack of Efficacy|42
7623564|NCT01727336|26527600|P4|Part 2 Blinded|Lack of Efficacy|0
7623565|NCT01727336|26527601|P3|Part 2 Blinded|Lack of Efficacy|0
7623566|NCT01727336|26527602|P2|Part 2 Blinded|Lack of Efficacy|0
7623567|NCT01727336|26527603|P1|Part 2 Blinded|Lack of Efficacy|0
7623568|NCT01727336|26527598|P6|Part 2 Blinded|Death|16
7623569|NCT01727336|26527599|P5|Part 2 Blinded|Death|20
7623570|NCT01727336|26527600|P4|Part 2 Blinded|Death|0
7623571|NCT01727336|26527601|P3|Part 2 Blinded|Death|0
7623572|NCT01727336|26527602|P2|Part 2 Blinded|Death|0
7623573|NCT01727336|26527603|P1|Part 2 Blinded|Death|0
7623574|NCT01727336|26527598|P6|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7623575|NCT01727336|26527599|P5|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7623576|NCT01727336|26527600|P4|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7623577|NCT01727336|26527601|P3|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7623578|NCT01727336|26527602|P2|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
7623579|NCT01727336|26527603|P1|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7623580|NCT01727336|26527598|P6|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7623581|NCT01727336|26527599|P5|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7623582|NCT01727336|26527600|P4|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7623583|NCT01727336|26527601|P3|Part 1 Dalantercept Dose Escalation|Adverse Event|5
7623584|NCT01727336|26527602|P2|Part 1 Dalantercept Dose Escalation|Adverse Event|1
7623585|NCT01727336|26527603|P1|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7623586|NCT01727297|26527645|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
7623587|NCT01727297|26527646|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
7623588|NCT01727297|26527645|P2|Overall Study|Physician Decision|5
7623589|NCT01727297|26527646|P1|Overall Study|Physician Decision|19
7623590|NCT01727297|26527645|P2|Overall Study|Withdrawal by Subject|27
7623591|NCT01727297|26527646|P1|Overall Study|Withdrawal by Subject|26
7623592|NCT01727297|26527645|P2|Overall Study|Lost to Follow-up|0
7623593|NCT01727297|26527646|P1|Overall Study|Lost to Follow-up|11
7623594|NCT01727297|26527645|P2|Overall Study|Adverse Event|1
7623595|NCT01727297|26527646|P1|Overall Study|Adverse Event|3
7623596|NCT01727297|26527645|P2|Overall Study|Protocol Violation|10
7623597|NCT01727297|26527646|P1|Overall Study|Protocol Violation|1
7623598|NCT01727297|26527645|P2|Overall Study|Death|0
7623599|NCT01727297|26527646|P1|Overall Study|Death|13
7623600|NCT01727258|26527662|P3|Overall Study|Lost to Follow-up|0
7623601|NCT01727258|26527663|P2|Overall Study|Lost to Follow-up|0
7623602|NCT01727258|26527664|P1|Overall Study|Lost to Follow-up|1
7623603|NCT01727258|26527662|P3|Overall Study|Withdrawal by Subject|0
7623604|NCT01727258|26527663|P2|Overall Study|Withdrawal by Subject|1
7623605|NCT01727258|26527664|P1|Overall Study|Withdrawal by Subject|1
7623606|NCT01727258|26527662|P3|Overall Study|Noncompliance with Study Drug|1
7623607|NCT01727258|26527663|P2|Overall Study|Noncompliance with Study Drug|0
7623608|NCT01727258|26527664|P1|Overall Study|Noncompliance with Study Drug|0
7623609|NCT01727258|26527662|P3|Overall Study|Adverse Event|0
7623610|NCT01727258|26527663|P2|Overall Study|Adverse Event|2
7623611|NCT01727258|26527664|P1|Overall Study|Adverse Event|0
7623612|NCT01727154|26527702|P1|Overall Study|No Discontinuation Documentation|4
7623613|NCT01727154|26527702|P1|Overall Study|Study Terminated|6
7623614|NCT01727154|26527702|P1|Overall Study|Subject Withdrew Consent|18
7623615|NCT01727154|26527702|P1|Overall Study|Withdrawal by Subject|14
7623616|NCT01727154|26527702|P1|Overall Study|Death|17
7623617|NCT01727141|26527710|P4|Overall Study|Withdrawal by Subject|11
7623618|NCT01727141|26527711|P3|Overall Study|Withdrawal by Subject|2
7623619|NCT01727141|26527712|P2|Overall Study|Withdrawal by Subject|4
7623620|NCT01727141|26527713|P1|Overall Study|Withdrawal by Subject|4
7623621|NCT01727141|26527710|P4|Overall Study|Protocol deviation|1
7623622|NCT01727141|26527711|P3|Overall Study|Protocol deviation|0
7623623|NCT01727141|26527712|P2|Overall Study|Protocol deviation|1
7623624|NCT01727141|26527713|P1|Overall Study|Protocol deviation|1
7623625|NCT01727141|26527710|P4|Overall Study|Death|1
7623626|NCT01727141|26527711|P3|Overall Study|Death|1
7623627|NCT01727141|26527712|P2|Overall Study|Death|1
7623628|NCT01727141|26527713|P1|Overall Study|Death|0
7623629|NCT01727141|26527710|P4|Overall Study|Lost to Follow-up|0
7623630|NCT01727141|26527711|P3|Overall Study|Lost to Follow-up|0
7623631|NCT01727141|26527712|P2|Overall Study|Lost to Follow-up|2
7623632|NCT01727141|26527713|P1|Overall Study|Lost to Follow-up|0
7623633|NCT01727141|26527710|P4|Overall Study|Physician Decision|2
7623634|NCT01727141|26527711|P3|Overall Study|Physician Decision|0
7623635|NCT01727141|26527712|P2|Overall Study|Physician Decision|1
7623636|NCT01727141|26527713|P1|Overall Study|Physician Decision|0
7623637|NCT01727024|26527778|P2|Period 1|Withdrawal by Subject|3
7623638|NCT01727024|26527779|P1|Period 1|Withdrawal by Subject|2
7623639|NCT01727024|26527778|P2|Period 1|Lost to Follow-up|1
7623640|NCT01727024|26527779|P1|Period 1|Lost to Follow-up|1
7623641|NCT01726803|26527794|P2|Overall Study|Withdrawal by Subject|0
7623642|NCT01726803|26527795|P1|Overall Study|Withdrawal by Subject|1
7623643|NCT01726803|26527794|P2|Overall Study|Lost to Follow-up|1
7623644|NCT01726803|26527795|P1|Overall Study|Lost to Follow-up|6
7623645|NCT01726517|26527847|P5|Overall Study|Withdrawal by Subject|0
7623646|NCT01726517|26527848|P4|Overall Study|Withdrawal by Subject|0
7623647|NCT01726517|26527849|P3|Overall Study|Withdrawal by Subject|1
7623648|NCT01726517|26527850|P2|Overall Study|Withdrawal by Subject|0
7623649|NCT01726517|26527851|P1|Overall Study|Withdrawal by Subject|0
7623650|NCT01726335|26527907|P1|Overall Study|Exacerbation of psychotic symptoms|1
7623651|NCT01726335|26527907|P1|Overall Study|Lost to Follow-up|2
7623652|NCT01726335|26527907|P1|Overall Study|Adverse Event|4
7623653|NCT01726335|26527907|P1|Overall Study|Withdrawal by Subject|15
7623654|NCT01726335|26527907|P1|Overall Study|Lost to Follow-up|2
7623655|NCT01726270|26527923|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
7623656|NCT01726270|26527923|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
7623657|NCT01726270|26527923|P1|Part 2, Actual-Use Phase|Adverse Event|6
7623658|NCT01726270|26527923|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
7623659|NCT01726270|26527923|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
7623660|NCT01726270|26527923|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
7623661|NCT01726049|26527936|P2|Overall Study|refused second HC|2
7623662|NCT01726049|26527937|P1|Overall Study|refused second HC|0
7623663|NCT01726049|26527936|P2|Overall Study|Adverse Event|1
7623664|NCT01726049|26527937|P1|Overall Study|Adverse Event|4
7623665|NCT01726049|26527936|P2|Overall Study|Death|1
7623666|NCT01726049|26527937|P1|Overall Study|Death|1
7623667|NCT01726023|26527962|P2|Overall Study|Withdrawal by Subject|8
7623668|NCT01726023|26527963|P1|Overall Study|Withdrawal by Subject|16
7623669|NCT01726023|26527962|P2|Overall Study|Other Eligibility criteria|7
7623670|NCT01726023|26527963|P1|Overall Study|Other Eligibility criteria|7
7623671|NCT01726023|26527962|P2|Overall Study|Lost to Follow-up|10
7623672|NCT01726023|26527963|P1|Overall Study|Lost to Follow-up|5
7623673|NCT01726023|26527962|P2|Overall Study|Death|1
7623674|NCT01726023|26527963|P1|Overall Study|Death|1
7623675|NCT01725750|26528097|P2|Overall Study|Withdrawal by Subject|9
7623676|NCT01725750|26528098|P1|Overall Study|Withdrawal by Subject|0
7623677|NCT01725750|26528097|P2|Overall Study|Lost to Follow-up|1
7623678|NCT01725750|26528098|P1|Overall Study|Lost to Follow-up|1
7623679|NCT01725750|26528097|P2|Overall Study|Adverse Event|0
7623680|NCT01725750|26528098|P1|Overall Study|Adverse Event|1
7623681|NCT01725529|26528131|P3|Overall Study|Withdrawal by Subject|8
7623682|NCT01725529|26528132|P2|Overall Study|Withdrawal by Subject|14
7623683|NCT01725529|26528133|P1|Overall Study|Withdrawal by Subject|12
7623684|NCT01725529|26528131|P3|Overall Study|Protocol Violation|1
7623685|NCT01725529|26528132|P2|Overall Study|Protocol Violation|1
7623686|NCT01725529|26528133|P1|Overall Study|Protocol Violation|0
7623687|NCT01725529|26528131|P3|Overall Study|Lost to Follow-up|1
7623688|NCT01725529|26528132|P2|Overall Study|Lost to Follow-up|1
7623689|NCT01725529|26528133|P1|Overall Study|Lost to Follow-up|2
7623690|NCT01725529|26528131|P3|Overall Study|Adverse Event|0
7623691|NCT01725529|26528132|P2|Overall Study|Adverse Event|0
7623692|NCT01725529|26528133|P1|Overall Study|Adverse Event|1
7623693|NCT01725451|26528159|P4|Period 4|Adverse Event|0
7623694|NCT01725451|26528160|P3|Period 4|Adverse Event|1
7623695|NCT01725451|26528161|P2|Period 4|Adverse Event|0
7623696|NCT01725451|26528162|P1|Period 4|Adverse Event|0
7623697|NCT01725451|26528159|P4|Washout From Period 3|Adverse Event|0
7623698|NCT01725451|26528160|P3|Washout From Period 3|Adverse Event|0
7623699|NCT01725451|26528161|P2|Washout From Period 3|Adverse Event|1
7623700|NCT01725451|26528162|P1|Washout From Period 3|Adverse Event|0
7623701|NCT01725451|26528159|P4|Washout From Period 3|Protocol Violation|0
7623702|NCT01725451|26528160|P3|Washout From Period 3|Protocol Violation|1
7623703|NCT01725451|26528161|P2|Washout From Period 3|Protocol Violation|0
7623704|NCT01725451|26528162|P1|Washout From Period 3|Protocol Violation|0
7623705|NCT01725451|26528159|P4|Period 1|Withdrawal by Subject|0
7623706|NCT01725451|26528160|P3|Period 1|Withdrawal by Subject|0
7623707|NCT01725451|26528161|P2|Period 1|Withdrawal by Subject|0
7623708|NCT01725451|26528162|P1|Period 1|Withdrawal by Subject|1
7623709|NCT01725386|26528184|P2|Overall Study|Withdrawal by Subject|0
7623710|NCT01725386|26528185|P1|Overall Study|Withdrawal by Subject|10
7623711|NCT01725386|26528184|P2|Overall Study|Lost to Follow-up|6
7623712|NCT01725386|26528185|P1|Overall Study|Lost to Follow-up|81
7623713|NCT01725386|26528184|P2|Overall Study|Death|40
7623714|NCT01725386|26528185|P1|Overall Study|Death|84
7623715|NCT01725308|26528204|P3|Treatment Period II|Miscellaneous|7
7623716|NCT01725308|26528205|P2|Treatment Period II|Miscellaneous|3
7623717|NCT01725308|26528206|P1|Treatment Period II|Miscellaneous|5
7623718|NCT01725308|26528204|P3|Treatment Period II|Protocol Deviations|1
7623719|NCT01725308|26528205|P2|Treatment Period II|Protocol Deviations|0
7623720|NCT01725308|26528206|P1|Treatment Period II|Protocol Deviations|0
7623721|NCT01725308|26528204|P3|Treatment Period II|Lost to Follow-up|3
7623722|NCT01725308|26528205|P2|Treatment Period II|Lost to Follow-up|5
7623723|NCT01725308|26528206|P1|Treatment Period II|Lost to Follow-up|1
7623724|NCT01725308|26528204|P3|Treatment Period II|Withdrawal of Consent|16
7623725|NCT01725308|26528205|P2|Treatment Period II|Withdrawal of Consent|2
7623726|NCT01725308|26528206|P1|Treatment Period II|Withdrawal of Consent|28
7623727|NCT01725308|26528204|P3|Treatment Period II|Changes in the Episodes|5
7623728|NCT01725308|26528205|P2|Treatment Period II|Changes in the Episodes|0
7623729|NCT01725308|26528206|P1|Treatment Period II|Changes in the Episodes|1
7623730|NCT01725308|26528204|P3|Treatment Period II|Worsening of the Target Disease|2
7623731|NCT01725308|26528205|P2|Treatment Period II|Worsening of the Target Disease|4
7623732|NCT01725308|26528206|P1|Treatment Period II|Worsening of the Target Disease|1
7623733|NCT01725308|26528204|P3|Treatment Period II|Insufficient Response|6
7623734|NCT01725308|26528205|P2|Treatment Period II|Insufficient Response|4
7623735|NCT01725308|26528206|P1|Treatment Period II|Insufficient Response|2
7623736|NCT01725308|26528204|P3|Treatment Period II|Adverse Event|20
7623737|NCT01725308|26528205|P2|Treatment Period II|Adverse Event|8
7623738|NCT01725308|26528206|P1|Treatment Period II|Adverse Event|13
7623739|NCT01725308|26528204|P3|Treatment Period II|Did Not Receive Drug|0
7623740|NCT01725308|26528205|P2|Treatment Period II|Did Not Receive Drug|0
7623741|NCT01725308|26528206|P1|Treatment Period II|Did Not Receive Drug|4
7623742|NCT01725308|26528204|P3|Treatment Period II|Did Not Meet Transition Criteria|4
7623743|NCT01725308|26528205|P2|Treatment Period II|Did Not Meet Transition Criteria|3
7623744|NCT01725308|26528206|P1|Treatment Period II|Did Not Meet Transition Criteria|0
7623745|NCT01725308|26528204|P3|Treatment Period I|Miscellaneous|3
7623746|NCT01725308|26528205|P2|Treatment Period I|Miscellaneous|0
7623747|NCT01725308|26528206|P1|Treatment Period I|Miscellaneous|2
7623748|NCT01725308|26528204|P3|Treatment Period I|Protocol Deviations|1
7623749|NCT01725308|26528205|P2|Treatment Period I|Protocol Deviations|1
7623750|NCT01725308|26528206|P1|Treatment Period I|Protocol Deviations|3
7623751|NCT01725308|26528204|P3|Treatment Period I|Lost to Follow-up|2
7623752|NCT01725308|26528205|P2|Treatment Period I|Lost to Follow-up|2
7623753|NCT01725308|26528206|P1|Treatment Period I|Lost to Follow-up|3
7623754|NCT01725308|26528204|P3|Treatment Period I|Withdrawal of Consent|5
7623755|NCT01725308|26528205|P2|Treatment Period I|Withdrawal of Consent|7
7623756|NCT01725308|26528206|P1|Treatment Period I|Withdrawal of Consent|12
7623757|NCT01725308|26528204|P3|Treatment Period I|Changes in the Episodes|2
7623758|NCT01725308|26528205|P2|Treatment Period I|Changes in the Episodes|0
7623759|NCT01725308|26528206|P1|Treatment Period I|Changes in the Episodes|3
7623760|NCT01725308|26528204|P3|Treatment Period I|Worsening of the Target Disease|2
7623761|NCT01725308|26528205|P2|Treatment Period I|Worsening of the Target Disease|0
7623762|NCT01725308|26528206|P1|Treatment Period I|Worsening of the Target Disease|8
7623763|NCT01725308|26528204|P3|Treatment Period I|Insufficient Response|5
7623764|NCT01725308|26528205|P2|Treatment Period I|Insufficient Response|0
7623765|NCT01725308|26528206|P1|Treatment Period I|Insufficient Response|7
7623766|NCT01725308|26528204|P3|Treatment Period I|Adverse Event|21
7623767|NCT01725308|26528205|P2|Treatment Period I|Adverse Event|4
7623768|NCT01725308|26528206|P1|Treatment Period I|Adverse Event|5
7623769|NCT01725308|26528204|P3|Treatment Period I|Did Not Receive Drug|0
7623770|NCT01725308|26528205|P2|Treatment Period I|Did Not Receive Drug|0
7623771|NCT01725308|26528206|P1|Treatment Period I|Did Not Receive Drug|1
7623772|NCT01725282|26528353|P4|Overall Study|Lack of Efficacy|1
7623773|NCT01725282|26528354|P3|Overall Study|Lack of Efficacy|0
7623774|NCT01725282|26528355|P2|Overall Study|Lack of Efficacy|1
7623775|NCT01725282|26528356|P1|Overall Study|Lack of Efficacy|0
7623776|NCT01725282|26528353|P4|Overall Study|Withdrawal by Subject|1
7623777|NCT01725282|26528354|P3|Overall Study|Withdrawal by Subject|1
7623778|NCT01725282|26528355|P2|Overall Study|Withdrawal by Subject|0
7623779|NCT01725282|26528356|P1|Overall Study|Withdrawal by Subject|0
7623780|NCT01725282|26528353|P4|Overall Study|Study Site Withdrawal|0
7623781|NCT01725282|26528354|P3|Overall Study|Study Site Withdrawal|0
7623782|NCT01725282|26528355|P2|Overall Study|Study Site Withdrawal|1
7623783|NCT01725282|26528356|P1|Overall Study|Study Site Withdrawal|0
7623784|NCT01725282|26528353|P4|Overall Study|Met Exclusion Criteria|0
7623785|NCT01725282|26528354|P3|Overall Study|Met Exclusion Criteria|1
7623786|NCT01725282|26528355|P2|Overall Study|Met Exclusion Criteria|0
7623787|NCT01725282|26528356|P1|Overall Study|Met Exclusion Criteria|0
7623788|NCT01725282|26528353|P4|Overall Study|Exacerbation of Target Disease|1
7623789|NCT01725282|26528354|P3|Overall Study|Exacerbation of Target Disease|0
7623790|NCT01725282|26528355|P2|Overall Study|Exacerbation of Target Disease|0
7623791|NCT01725282|26528356|P1|Overall Study|Exacerbation of Target Disease|1
7623792|NCT01725282|26528353|P4|Overall Study|Adverse Event|4
7623793|NCT01725282|26528354|P3|Overall Study|Adverse Event|6
7623794|NCT01725282|26528355|P2|Overall Study|Adverse Event|3
7623795|NCT01725282|26528356|P1|Overall Study|Adverse Event|1
7623796|NCT01725217|26528389|P3|Overall Study|Withdrawal by Subject|0
7623797|NCT01725217|26528390|P2|Overall Study|Withdrawal by Subject|0
7623798|NCT01725217|26528391|P1|Overall Study|Withdrawal by Subject|1
7623799|NCT01725126|26528425|P6|Overall Study|Withdrawal by Subject|0
7623800|NCT01725126|26528426|P5|Overall Study|Withdrawal by Subject|0
7623801|NCT01725126|26528427|P4|Overall Study|Withdrawal by Subject|1
7623802|NCT01725126|26528428|P3|Overall Study|Withdrawal by Subject|0
7623803|NCT01725126|26528429|P2|Overall Study|Withdrawal by Subject|0
7623804|NCT01725126|26528430|P1|Overall Study|Withdrawal by Subject|0
7623805|NCT01725126|26528425|P6|Overall Study|Protocol Violation|0
7623806|NCT01725126|26528426|P5|Overall Study|Protocol Violation|0
7623807|NCT01725126|26528427|P4|Overall Study|Protocol Violation|0
7623808|NCT01725126|26528428|P3|Overall Study|Protocol Violation|0
7623809|NCT01725126|26528429|P2|Overall Study|Protocol Violation|1
7623810|NCT01725126|26528430|P1|Overall Study|Protocol Violation|0
7623811|NCT01724528|26528628|P2|Overall Study|Patient refused to attend last visit|0
7623812|NCT01724528|26528629|P1|Overall Study|Patient refused to attend last visit|1
7623813|NCT01724528|26528628|P2|Overall Study|Protocol Violation|1
7623814|NCT01724528|26528629|P1|Overall Study|Protocol Violation|0
7623815|NCT01724528|26528628|P2|Overall Study|Withdrawal by Subject|2
7623816|NCT01724528|26528629|P1|Overall Study|Withdrawal by Subject|0
7623817|NCT01724528|26528628|P2|Overall Study|Death|0
7623818|NCT01724528|26528629|P1|Overall Study|Death|3
7623819|NCT01724489|26528645|P2|Overall Study|Withdrawal by Subject|6
7623820|NCT01724489|26528646|P1|Overall Study|Withdrawal by Subject|6
7623821|NCT01724489|26528645|P2|Overall Study|Lost to Follow-up|2
7623822|NCT01724489|26528646|P1|Overall Study|Lost to Follow-up|1
7623823|NCT01724489|26528645|P2|Overall Study|Surgery, medication|1
7623824|NCT01724489|26528646|P1|Overall Study|Surgery, medication|1
7623825|NCT01724489|26528645|P2|Overall Study|Adverse Event|3
7623826|NCT01724489|26528646|P1|Overall Study|Adverse Event|8
7623827|NCT01724359|26528652|P1|Overall Study|Other|20
7623828|NCT01724359|26528652|P1|Overall Study|Death|1
7623829|NCT01724359|26528652|P1|Overall Study|Adverse Event|10
7623830|NCT01724216|26528665|P1|Overall Study|Scan was not completed|1
7623831|NCT01724177|26528669|P1|Overall Study|Serious Adverse Event Related|1
7623832|NCT01724177|26528669|P1|Overall Study|Nervous participant|1
7623833|NCT01724177|26528669|P1|Overall Study|Progressive disease or Relapsed Disease|16
7623834|NCT01724177|26528669|P1|Overall Study|Adverse Event|8
7623835|NCT01724021|26528715|P2|Overall Study|Missing|1
7623836|NCT01724021|26528716|P1|Overall Study|Missing|1
7623837|NCT01724021|26528715|P2|Overall Study|Reason Not Specified|39
7623838|NCT01724021|26528716|P1|Overall Study|Reason Not Specified|36
7623839|NCT01724021|26528715|P2|Overall Study|Lost to Follow-up|15
7623840|NCT01724021|26528716|P1|Overall Study|Lost to Follow-up|15
7623841|NCT01724021|26528715|P2|Overall Study|Participant request/ Withdrew consent|14
7623842|NCT01724021|26528716|P1|Overall Study|Participant request/ Withdrew consent|18
7623843|NCT01724021|26528715|P2|Overall Study|Death|58
7623844|NCT01724021|26528716|P1|Overall Study|Death|46
7623845|NCT01724021|26528715|P2|Overall Study|Adverse Event|6
7623846|NCT01724021|26528716|P1|Overall Study|Adverse Event|11
7623847|NCT01723904|26528748|P1|Overall Study|Unable to follow protocol/ judged by inv|3
7623848|NCT01723904|26528748|P1|Overall Study|Adverse Event|5
7623849|NCT01723904|26528748|P1|Overall Study|Noncompliant|3
7623850|NCT01723826|26528762|P4|Overall Study|Withdrawal by Subject|48
7623851|NCT01723826|26528763|P3|Overall Study|Withdrawal by Subject|27
7623852|NCT01723826|26528764|P2|Overall Study|Withdrawal by Subject|17
7623853|NCT01723826|26528765|P1|Overall Study|Withdrawal by Subject|10
7623854|NCT01723826|26528762|P4|Overall Study|Protocol Violation|1
7623855|NCT01723826|26528763|P3|Overall Study|Protocol Violation|3
7623856|NCT01723826|26528764|P2|Overall Study|Protocol Violation|1
7623857|NCT01723826|26528765|P1|Overall Study|Protocol Violation|1
7623858|NCT01723826|26528762|P4|Overall Study|Physician Decision|11
7623859|NCT01723826|26528763|P3|Overall Study|Physician Decision|4
7623860|NCT01723826|26528764|P2|Overall Study|Physician Decision|3
7623861|NCT01723826|26528765|P1|Overall Study|Physician Decision|1
7623862|NCT01723826|26528762|P4|Overall Study|Other Reason|14
7623863|NCT01723826|26528763|P3|Overall Study|Other Reason|12
7623864|NCT01723826|26528764|P2|Overall Study|Other Reason|6
7623865|NCT01723826|26528765|P1|Overall Study|Other Reason|8
7623866|NCT01723826|26528762|P4|Overall Study|Non-compliance With Study Drug|0
7623867|NCT01723826|26528763|P3|Overall Study|Non-compliance With Study Drug|0
7623868|NCT01723826|26528764|P2|Overall Study|Non-compliance With Study Drug|1
7623869|NCT01723826|26528765|P1|Overall Study|Non-compliance With Study Drug|0
7623870|NCT01723826|26528762|P4|Overall Study|Non-compliance|3
7623871|NCT01723826|26528763|P3|Overall Study|Non-compliance|3
7623872|NCT01723826|26528764|P2|Overall Study|Non-compliance|1
7623873|NCT01723826|26528765|P1|Overall Study|Non-compliance|0
7623874|NCT01723826|26528762|P4|Overall Study|Lost to Follow-up|1
7623875|NCT01723826|26528763|P3|Overall Study|Lost to Follow-up|1
7623876|NCT01723826|26528764|P2|Overall Study|Lost to Follow-up|3
7623877|NCT01723826|26528765|P1|Overall Study|Lost to Follow-up|1
7623878|NCT01723826|26528762|P4|Overall Study|Death according to AE eCRF|7
7623879|NCT01723826|26528763|P3|Overall Study|Death according to AE eCRF|3
7623880|NCT01723826|26528764|P2|Overall Study|Death according to AE eCRF|3
7623881|NCT01723826|26528765|P1|Overall Study|Death according to AE eCRF|2
7623882|NCT01723826|26528762|P4|Overall Study|Adverse Event|5
7623883|NCT01723826|26528763|P3|Overall Study|Adverse Event|4
7623884|NCT01723826|26528764|P2|Overall Study|Adverse Event|1
7623885|NCT01723826|26528765|P1|Overall Study|Adverse Event|4
7623886|NCT01723397|26528910|P2|Study Period 2|Protocol Violation|1
7623887|NCT01723397|26528911|P1|Study Period 2|Protocol Violation|0
7623888|NCT01723397|26528910|P2|Study Period 1|Protocol Violation|1
7623889|NCT01723397|26528911|P1|Study Period 1|Protocol Violation|0
7623890|NCT01723254|26528938|P8|Overall Study|Withdrawal by Subject|2
7623891|NCT01723254|26528939|P7|Overall Study|Withdrawal by Subject|1
7623892|NCT01723254|26528940|P6|Overall Study|Withdrawal by Subject|1
7623893|NCT01723254|26528941|P5|Overall Study|Withdrawal by Subject|1
7623894|NCT01723254|26528942|P4|Overall Study|Withdrawal by Subject|0
7623895|NCT01723254|26528943|P3|Overall Study|Withdrawal by Subject|1
7623896|NCT01723254|26528944|P2|Overall Study|Withdrawal by Subject|2
7623897|NCT01723254|26528945|P1|Overall Study|Withdrawal by Subject|1
7623898|NCT01723254|26528938|P8|Overall Study|Protocol Violation|0
7623899|NCT01723254|26528939|P7|Overall Study|Protocol Violation|0
7623900|NCT01723254|26528940|P6|Overall Study|Protocol Violation|0
7623901|NCT01723254|26528941|P5|Overall Study|Protocol Violation|0
7623902|NCT01723254|26528942|P4|Overall Study|Protocol Violation|0
7623903|NCT01723254|26528943|P3|Overall Study|Protocol Violation|0
7623904|NCT01723254|26528944|P2|Overall Study|Protocol Violation|1
7623905|NCT01723254|26528945|P1|Overall Study|Protocol Violation|0
7623906|NCT01723254|26528938|P8|Overall Study|Move/Left to another country/city|0
7623907|NCT01723254|26528939|P7|Overall Study|Move/Left to another country/city|0
7623908|NCT01723254|26528940|P6|Overall Study|Move/Left to another country/city|0
7623909|NCT01723254|26528941|P5|Overall Study|Move/Left to another country/city|1
7623910|NCT01723254|26528942|P4|Overall Study|Move/Left to another country/city|1
7623911|NCT01723254|26528943|P3|Overall Study|Move/Left to another country/city|2
7623912|NCT01723254|26528944|P2|Overall Study|Move/Left to another country/city|0
7623913|NCT01723254|26528945|P1|Overall Study|Move/Left to another country/city|0
7623914|NCT01723254|26528938|P8|Overall Study|No longer have time to participate|0
7623915|NCT01723254|26528939|P7|Overall Study|No longer have time to participate|0
7623916|NCT01723254|26528940|P6|Overall Study|No longer have time to participate|0
7623917|NCT01723254|26528941|P5|Overall Study|No longer have time to participate|0
7623918|NCT01723254|26528942|P4|Overall Study|No longer have time to participate|1
7623919|NCT01723254|26528943|P3|Overall Study|No longer have time to participate|0
7623920|NCT01723254|26528944|P2|Overall Study|No longer have time to participate|0
7623921|NCT01723254|26528945|P1|Overall Study|No longer have time to participate|0
7623922|NCT01723254|26528938|P8|Overall Study|Personal issues|0
7623923|NCT01723254|26528939|P7|Overall Study|Personal issues|0
7623924|NCT01723254|26528940|P6|Overall Study|Personal issues|1
7623925|NCT01723254|26528941|P5|Overall Study|Personal issues|0
7623926|NCT01723254|26528942|P4|Overall Study|Personal issues|0
7623927|NCT01723254|26528943|P3|Overall Study|Personal issues|0
7623928|NCT01723254|26528944|P2|Overall Study|Personal issues|0
7623929|NCT01723254|26528945|P1|Overall Study|Personal issues|0
7623930|NCT01723254|26528938|P8|Overall Study|Conflict with work schedule|1
7623931|NCT01723254|26528939|P7|Overall Study|Conflict with work schedule|0
7623932|NCT01723254|26528940|P6|Overall Study|Conflict with work schedule|0
7623933|NCT01723254|26528941|P5|Overall Study|Conflict with work schedule|0
7623934|NCT01723254|26528942|P4|Overall Study|Conflict with work schedule|0
7623935|NCT01723254|26528943|P3|Overall Study|Conflict with work schedule|0
7623936|NCT01723254|26528944|P2|Overall Study|Conflict with work schedule|0
7623937|NCT01723254|26528945|P1|Overall Study|Conflict with work schedule|0
7623938|NCT01723228|26528997|P2|Overall Study|Other|1
7623939|NCT01723228|26528998|P1|Overall Study|Other|2
7623940|NCT01723228|26528997|P2|Overall Study|Lost to Follow-up|1
7623941|NCT01723228|26528998|P1|Overall Study|Lost to Follow-up|2
7623942|NCT01723228|26528997|P2|Overall Study|Protocol Violation|2
7623943|NCT01723228|26528998|P1|Overall Study|Protocol Violation|0
7623944|NCT01723228|26528997|P2|Overall Study|Withdrawal by Subject|1
7623945|NCT01723228|26528998|P1|Overall Study|Withdrawal by Subject|2
7623946|NCT01723228|26528997|P2|Overall Study|Adverse Event|6
7623947|NCT01723228|26528998|P1|Overall Study|Adverse Event|2
7623948|NCT01723163|26529016|P2|12-Month Follow-up|Unable to Contact|28
7623949|NCT01723163|26529017|P1|12-Month Follow-up|Unable to Contact|23
7623950|NCT01723163|26529016|P2|12-Month Follow-up|Death|0
7623951|NCT01723163|26529017|P1|12-Month Follow-up|Death|1
7623952|NCT01723163|26529016|P2|6-Month Follow-up|Unable to Contact|15
7623953|NCT01723163|26529017|P1|6-Month Follow-up|Unable to Contact|17
7623954|NCT01723163|26529016|P2|6-Month Follow-up|Death|0
7623955|NCT01723163|26529017|P1|6-Month Follow-up|Death|1
7623956|NCT01723163|26529016|P2|3-Month Follow-up|Unable to Contact|19
7623957|NCT01723163|26529017|P1|3-Month Follow-up|Unable to Contact|12
7623958|NCT01723163|26529016|P2|3-Month Follow-up|Withdrawal by Subject|0
7623959|NCT01723163|26529017|P1|3-Month Follow-up|Withdrawal by Subject|1
7623960|NCT01723163|26529016|P2|Treatment Phase|Withdrawal by PI|1
7623961|NCT01723163|26529017|P1|Treatment Phase|Withdrawal by PI|5
7623962|NCT01723163|26529016|P2|Treatment Phase|Withdrawal by Subject|6
7623963|NCT01723163|26529017|P1|Treatment Phase|Withdrawal by Subject|14
7623964|NCT01723072|26529025|P2|Overall Study|Other|3
7623965|NCT01723072|26529026|P1|Overall Study|Other|4
7623966|NCT01723072|26529025|P2|Overall Study|Discon for rescue medication after wk 24|5
7623967|NCT01723072|26529026|P1|Overall Study|Discon for rescue medication after wk 24|0
7623968|NCT01723072|26529025|P2|Overall Study|Withdrawal by Subject|13
7623969|NCT01723072|26529026|P1|Overall Study|Withdrawal by Subject|7
7623970|NCT01722994|26529064|P2|Overall Study|Missing data|17
7623971|NCT01722994|26529065|P1|Overall Study|Missing data|25
7623972|NCT01722877|26529084|P1|Overall Study|Lost to Follow-up|1
7623973|NCT01722877|26529084|P1|Overall Study|Death|1
7623974|NCT01722669|26529110|P6|Overall Study|Withdrawal by Subject|2
7623975|NCT01722669|26529111|P5|Overall Study|Withdrawal by Subject|0
7623976|NCT01722669|26529112|P4|Overall Study|Withdrawal by Subject|0
7623977|NCT01722669|26529113|P3|Overall Study|Withdrawal by Subject|0
7623978|NCT01722669|26529114|P2|Overall Study|Withdrawal by Subject|0
7623979|NCT01722669|26529115|P1|Overall Study|Withdrawal by Subject|0
7623980|NCT01722331|26529197|P7|Part 3|Other Protocol Specified Criteria|0
7623981|NCT01722331|26529198|P6|Part 3|Other Protocol Specified Criteria|0
7623982|NCT01722331|26529199|P5|Part 3|Other Protocol Specified Criteria|0
7623983|NCT01722331|26529200|P4|Part 3|Other Protocol Specified Criteria|0
7623984|NCT01722331|26529201|P3|Part 3|Other Protocol Specified Criteria|0
7623985|NCT01722331|26529202|P2|Part 3|Other Protocol Specified Criteria|1
7623986|NCT01722331|26529203|P1|Part 3|Other Protocol Specified Criteria|1
7623987|NCT01722331|26529197|P7|Part 3|Withdrawal by Subject|1
7623988|NCT01722331|26529198|P6|Part 3|Withdrawal by Subject|2
7623989|NCT01722331|26529199|P5|Part 3|Withdrawal by Subject|0
7623990|NCT01722331|26529200|P4|Part 3|Withdrawal by Subject|0
7623991|NCT01722331|26529201|P3|Part 3|Withdrawal by Subject|0
7623992|NCT01722331|26529202|P2|Part 3|Withdrawal by Subject|7
7623993|NCT01722331|26529203|P1|Part 3|Withdrawal by Subject|4
7623994|NCT01722331|26529197|P7|Part 3|Protocol Violation|0
7623995|NCT01722331|26529198|P6|Part 3|Protocol Violation|0
7623996|NCT01722331|26529199|P5|Part 3|Protocol Violation|0
7623997|NCT01722331|26529200|P4|Part 3|Protocol Violation|0
7623998|NCT01722331|26529201|P3|Part 3|Protocol Violation|0
7623999|NCT01722331|26529202|P2|Part 3|Protocol Violation|1
7624000|NCT01722331|26529203|P1|Part 3|Protocol Violation|2
7624001|NCT01722331|26529197|P7|Part 3|Physician Decision|1
7624002|NCT01722331|26529198|P6|Part 3|Physician Decision|0
7624003|NCT01722331|26529199|P5|Part 3|Physician Decision|0
7624004|NCT01722331|26529200|P4|Part 3|Physician Decision|0
7624005|NCT01722331|26529201|P3|Part 3|Physician Decision|0
7624006|NCT01722331|26529202|P2|Part 3|Physician Decision|1
7624007|NCT01722331|26529203|P1|Part 3|Physician Decision|1
7624008|NCT01722331|26529197|P7|Part 3|Non-Compliance with Study Drug|0
7624009|NCT01722331|26529198|P6|Part 3|Non-Compliance with Study Drug|0
7624010|NCT01722331|26529199|P5|Part 3|Non-Compliance with Study Drug|0
7624011|NCT01722331|26529200|P4|Part 3|Non-Compliance with Study Drug|0
7624012|NCT01722331|26529201|P3|Part 3|Non-Compliance with Study Drug|0
7624013|NCT01722331|26529202|P2|Part 3|Non-Compliance with Study Drug|1
7624014|NCT01722331|26529203|P1|Part 3|Non-Compliance with Study Drug|0
7624015|NCT01722331|26529197|P7|Part 3|Lost to Follow-up|0
7624016|NCT01722331|26529198|P6|Part 3|Lost to Follow-up|1
7624017|NCT01722331|26529199|P5|Part 3|Lost to Follow-up|0
7624018|NCT01722331|26529200|P4|Part 3|Lost to Follow-up|0
7624019|NCT01722331|26529201|P3|Part 3|Lost to Follow-up|0
7624020|NCT01722331|26529202|P2|Part 3|Lost to Follow-up|4
7624021|NCT01722331|26529203|P1|Part 3|Lost to Follow-up|3
7624022|NCT01722331|26529197|P7|Part 3|Lack of Efficacy|0
7624023|NCT01722331|26529198|P6|Part 3|Lack of Efficacy|0
7624024|NCT01722331|26529199|P5|Part 3|Lack of Efficacy|0
7624025|NCT01722331|26529200|P4|Part 3|Lack of Efficacy|0
7624026|NCT01722331|26529201|P3|Part 3|Lack of Efficacy|0
7624027|NCT01722331|26529202|P2|Part 3|Lack of Efficacy|0
7624028|NCT01722331|26529203|P1|Part 3|Lack of Efficacy|1
7624029|NCT01722331|26529197|P7|Part 3|Death|0
7624030|NCT01722331|26529198|P6|Part 3|Death|0
7624031|NCT01722331|26529199|P5|Part 3|Death|0
7624032|NCT01722331|26529200|P4|Part 3|Death|0
7624033|NCT01722331|26529201|P3|Part 3|Death|0
7624034|NCT01722331|26529202|P2|Part 3|Death|0
7624035|NCT01722331|26529203|P1|Part 3|Death|1
7624036|NCT01722331|26529197|P7|Part 3|Adverse Event|0
7624037|NCT01722331|26529198|P6|Part 3|Adverse Event|0
7624038|NCT01722331|26529199|P5|Part 3|Adverse Event|0
7624039|NCT01722331|26529200|P4|Part 3|Adverse Event|1
7624040|NCT01722331|26529201|P3|Part 3|Adverse Event|0
7624041|NCT01722331|26529202|P2|Part 3|Adverse Event|2
7624042|NCT01722331|26529203|P1|Part 3|Adverse Event|2
7624043|NCT01722331|26529197|P7|Part 2|Other Protocol Specified Criteria|1
7624044|NCT01722331|26529198|P6|Part 2|Other Protocol Specified Criteria|2
7624045|NCT01722331|26529199|P5|Part 2|Other Protocol Specified Criteria|0
7624046|NCT01722331|26529200|P4|Part 2|Other Protocol Specified Criteria|0
7624047|NCT01722331|26529201|P3|Part 2|Other Protocol Specified Criteria|10
7624048|NCT01722331|26529202|P2|Part 2|Other Protocol Specified Criteria|0
7624049|NCT01722331|26529203|P1|Part 2|Other Protocol Specified Criteria|6
7624050|NCT01722331|26529197|P7|Part 2|Withdrawal by Subject|2
7624051|NCT01722331|26529198|P6|Part 2|Withdrawal by Subject|2
7624052|NCT01722331|26529199|P5|Part 2|Withdrawal by Subject|0
7624053|NCT01722331|26529200|P4|Part 2|Withdrawal by Subject|0
7624054|NCT01722331|26529201|P3|Part 2|Withdrawal by Subject|3
7624055|NCT01722331|26529202|P2|Part 2|Withdrawal by Subject|0
7624056|NCT01722331|26529203|P1|Part 2|Withdrawal by Subject|5
7624057|NCT01722331|26529197|P7|Part 2|Protocol Violation|0
7624058|NCT01722331|26529198|P6|Part 2|Protocol Violation|0
7624059|NCT01722331|26529199|P5|Part 2|Protocol Violation|0
7624060|NCT01722331|26529200|P4|Part 2|Protocol Violation|0
7624061|NCT01722331|26529201|P3|Part 2|Protocol Violation|0
7624062|NCT01722331|26529202|P2|Part 2|Protocol Violation|0
7624063|NCT01722331|26529203|P1|Part 2|Protocol Violation|1
7624064|NCT01722331|26529197|P7|Part 2|Progressive Disease|0
7624065|NCT01722331|26529198|P6|Part 2|Progressive Disease|0
7624066|NCT01722331|26529199|P5|Part 2|Progressive Disease|0
7624067|NCT01722331|26529200|P4|Part 2|Progressive Disease|0
7624068|NCT01722331|26529201|P3|Part 2|Progressive Disease|1
7624069|NCT01722331|26529202|P2|Part 2|Progressive Disease|0
7624070|NCT01722331|26529203|P1|Part 2|Progressive Disease|0
7624071|NCT01722331|26529197|P7|Part 2|Pregnancy|0
7624072|NCT01722331|26529198|P6|Part 2|Pregnancy|1
7624073|NCT01722331|26529199|P5|Part 2|Pregnancy|0
7624074|NCT01722331|26529200|P4|Part 2|Pregnancy|0
7624075|NCT01722331|26529201|P3|Part 2|Pregnancy|0
7624076|NCT01722331|26529202|P2|Part 2|Pregnancy|0
7624077|NCT01722331|26529203|P1|Part 2|Pregnancy|0
7624078|NCT01722331|26529197|P7|Part 2|Physician Decision|0
7624079|NCT01722331|26529198|P6|Part 2|Physician Decision|0
7624080|NCT01722331|26529199|P5|Part 2|Physician Decision|0
7624081|NCT01722331|26529200|P4|Part 2|Physician Decision|0
7624082|NCT01722331|26529201|P3|Part 2|Physician Decision|2
7624083|NCT01722331|26529202|P2|Part 2|Physician Decision|0
7624084|NCT01722331|26529203|P1|Part 2|Physician Decision|0
7624085|NCT01722331|26529197|P7|Part 2|Non-Compliance with Study Drug|0
7624086|NCT01722331|26529198|P6|Part 2|Non-Compliance with Study Drug|0
7624087|NCT01722331|26529199|P5|Part 2|Non-Compliance with Study Drug|0
7624088|NCT01722331|26529200|P4|Part 2|Non-Compliance with Study Drug|0
7624089|NCT01722331|26529201|P3|Part 2|Non-Compliance with Study Drug|1
7624090|NCT01722331|26529202|P2|Part 2|Non-Compliance with Study Drug|0
7624091|NCT01722331|26529203|P1|Part 2|Non-Compliance with Study Drug|1
7624092|NCT01722331|26529197|P7|Part 2|Lost to Follow-up|1
7624093|NCT01722331|26529198|P6|Part 2|Lost to Follow-up|1
7624094|NCT01722331|26529199|P5|Part 2|Lost to Follow-up|0
7624095|NCT01722331|26529200|P4|Part 2|Lost to Follow-up|0
7624096|NCT01722331|26529201|P3|Part 2|Lost to Follow-up|3
7624097|NCT01722331|26529202|P2|Part 2|Lost to Follow-up|0
7624098|NCT01722331|26529203|P1|Part 2|Lost to Follow-up|0
7624099|NCT01722331|26529197|P7|Part 2|Lack of Efficacy|3
7624100|NCT01722331|26529198|P6|Part 2|Lack of Efficacy|3
7624101|NCT01722331|26529199|P5|Part 2|Lack of Efficacy|0
7624102|NCT01722331|26529200|P4|Part 2|Lack of Efficacy|0
7624103|NCT01722331|26529201|P3|Part 2|Lack of Efficacy|11
7624104|NCT01722331|26529202|P2|Part 2|Lack of Efficacy|0
7624105|NCT01722331|26529203|P1|Part 2|Lack of Efficacy|3
7624106|NCT01722331|26529197|P7|Part 2|Adverse Event|0
7624107|NCT01722331|26529198|P6|Part 2|Adverse Event|1
7624108|NCT01722331|26529199|P5|Part 2|Adverse Event|0
7624109|NCT01722331|26529200|P4|Part 2|Adverse Event|0
7624110|NCT01722331|26529201|P3|Part 2|Adverse Event|0
7624111|NCT01722331|26529202|P2|Part 2|Adverse Event|0
7624112|NCT01722331|26529203|P1|Part 2|Adverse Event|3
7624113|NCT01722331|26529197|P7|Part 1|Withdrawal by Subject|0
7624114|NCT01722331|26529198|P6|Part 1|Withdrawal by Subject|0
7624115|NCT01722331|26529199|P5|Part 1|Withdrawal by Subject|3
7624116|NCT01722331|26529200|P4|Part 1|Withdrawal by Subject|0
7624117|NCT01722331|26529201|P3|Part 1|Withdrawal by Subject|3
7624118|NCT01722331|26529202|P2|Part 1|Withdrawal by Subject|0
7624119|NCT01722331|26529203|P1|Part 1|Withdrawal by Subject|2
7624120|NCT01722331|26529197|P7|Part 1|Protocol Violation|0
7624121|NCT01722331|26529198|P6|Part 1|Protocol Violation|0
7624122|NCT01722331|26529199|P5|Part 1|Protocol Violation|1
7624123|NCT01722331|26529200|P4|Part 1|Protocol Violation|0
7624124|NCT01722331|26529201|P3|Part 1|Protocol Violation|0
7624125|NCT01722331|26529202|P2|Part 1|Protocol Violation|0
7624126|NCT01722331|26529203|P1|Part 1|Protocol Violation|1
7624127|NCT01722331|26529197|P7|Part 1|Progressive Disease|0
7624128|NCT01722331|26529198|P6|Part 1|Progressive Disease|0
7624129|NCT01722331|26529199|P5|Part 1|Progressive Disease|1
7624130|NCT01722331|26529200|P4|Part 1|Progressive Disease|0
7624131|NCT01722331|26529201|P3|Part 1|Progressive Disease|0
7624132|NCT01722331|26529202|P2|Part 1|Progressive Disease|0
7624133|NCT01722331|26529203|P1|Part 1|Progressive Disease|0
7624134|NCT01722331|26529197|P7|Part 1|Pregnancy|0
7624135|NCT01722331|26529198|P6|Part 1|Pregnancy|0
7624136|NCT01722331|26529199|P5|Part 1|Pregnancy|0
7624137|NCT01722331|26529200|P4|Part 1|Pregnancy|0
7624138|NCT01722331|26529201|P3|Part 1|Pregnancy|0
7624139|NCT01722331|26529202|P2|Part 1|Pregnancy|0
7624140|NCT01722331|26529203|P1|Part 1|Pregnancy|1
7624141|NCT01722331|26529197|P7|Part 1|Physician Decision|0
7624142|NCT01722331|26529198|P6|Part 1|Physician Decision|0
7624143|NCT01722331|26529199|P5|Part 1|Physician Decision|1
7624144|NCT01722331|26529200|P4|Part 1|Physician Decision|0
7624145|NCT01722331|26529201|P3|Part 1|Physician Decision|3
7624146|NCT01722331|26529202|P2|Part 1|Physician Decision|0
7624147|NCT01722331|26529203|P1|Part 1|Physician Decision|0
7624148|NCT01722331|26529197|P7|Part 1|Lost to Follow-up|0
7624149|NCT01722331|26529198|P6|Part 1|Lost to Follow-up|0
7624150|NCT01722331|26529199|P5|Part 1|Lost to Follow-up|1
7624151|NCT01722331|26529200|P4|Part 1|Lost to Follow-up|0
7624152|NCT01722331|26529201|P3|Part 1|Lost to Follow-up|2
7624153|NCT01722331|26529202|P2|Part 1|Lost to Follow-up|0
7624154|NCT01722331|26529203|P1|Part 1|Lost to Follow-up|1
7624155|NCT01722331|26529197|P7|Part 1|Lack of Efficacy|0
7624156|NCT01722331|26529198|P6|Part 1|Lack of Efficacy|0
7624157|NCT01722331|26529199|P5|Part 1|Lack of Efficacy|2
7624158|NCT01722331|26529200|P4|Part 1|Lack of Efficacy|0
7624159|NCT01722331|26529201|P3|Part 1|Lack of Efficacy|1
7624160|NCT01722331|26529202|P2|Part 1|Lack of Efficacy|0
7624161|NCT01722331|26529203|P1|Part 1|Lack of Efficacy|0
7624162|NCT01722331|26529197|P7|Part 1|Adverse Event|0
7624163|NCT01722331|26529198|P6|Part 1|Adverse Event|0
7624164|NCT01722331|26529199|P5|Part 1|Adverse Event|0
7624165|NCT01722331|26529200|P4|Part 1|Adverse Event|0
7624166|NCT01722331|26529201|P3|Part 1|Adverse Event|0
7624167|NCT01722331|26529202|P2|Part 1|Adverse Event|0
7624168|NCT01722331|26529203|P1|Part 1|Adverse Event|5
7624169|NCT01722266|26529319|P4|Overall Study|Dropped out due to Nausea|0
7624170|NCT01722266|26529320|P3|Overall Study|Dropped out due to Nausea|2
7624171|NCT01722266|26529321|P2|Overall Study|Dropped out due to Nausea|0
7624172|NCT01722266|26529322|P1|Overall Study|Dropped out due to Nausea|0
7624173|NCT01722266|26529319|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
7624174|NCT01722266|26529320|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
7624175|NCT01722266|26529321|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
7624176|NCT01722266|26529322|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
7624177|NCT01722266|26529319|P4|Overall Study|Withdrawal by Subject|0
7624178|NCT01722266|26529320|P3|Overall Study|Withdrawal by Subject|0
7624179|NCT01722266|26529321|P2|Overall Study|Withdrawal by Subject|2
7624180|NCT01722266|26529322|P1|Overall Study|Withdrawal by Subject|1
7624181|NCT01722162|26529350|P2|Overall Study|Noncompliance|1
7624182|NCT01722162|26529351|P1|Overall Study|Noncompliance|0
7624183|NCT01722162|26529350|P2|Overall Study|Insurance denial post enrollment|1
7624184|NCT01722162|26529351|P1|Overall Study|Insurance denial post enrollment|0
7624185|NCT01722162|26529350|P2|Overall Study|Adverse Event|1
7624186|NCT01722162|26529351|P1|Overall Study|Adverse Event|1
7624187|NCT01722162|26529350|P2|Overall Study|Unrelated to study adverse event|2
7624188|NCT01722162|26529351|P1|Overall Study|Unrelated to study adverse event|2
7624189|NCT01722162|26529350|P2|Overall Study|Found ineligible|0
7624190|NCT01722162|26529351|P1|Overall Study|Found ineligible|1
7624191|NCT01722162|26529350|P2|Overall Study|Withdrawal by Subject|1
7624192|NCT01722162|26529351|P1|Overall Study|Withdrawal by Subject|1
7624193|NCT01722097|26529361|P2|Overall Study|Patient sheets not returned|5
7624194|NCT01722097|26529362|P1|Overall Study|Patient sheets not returned|6
7624195|NCT01722071|26529370|P2|Overall Study|Protocol Violation|0
7624196|NCT01722071|26529371|P1|Overall Study|Protocol Violation|1
7624197|NCT01722045|26529377|P1|Overall Study|Relocation (did not wish to transfer)|1
7624198|NCT01722045|26529377|P1|Overall Study|Physician Decision|3
7624199|NCT01722045|26529377|P1|Overall Study|Protocol Deviation|1
7624200|NCT01722045|26529377|P1|Overall Study|Lost to Follow-up|4
7624201|NCT01722045|26529377|P1|Overall Study|Withdrawal by Subject|8
7624202|NCT01722045|26529377|P1|Overall Study|Death|3
7624203|NCT01722045|26529377|P1|Overall Study|Adverse Event|8
7624204|NCT01721954|26529398|P2|Overall Study|Lost to Follow-up|1
7624205|NCT01721954|26529399|P1|Overall Study|Lost to Follow-up|2
7624206|NCT01721954|26529398|P2|Overall Study|Adverse Event|0
7624207|NCT01721954|26529399|P1|Overall Study|Adverse Event|2
7624208|NCT01721954|26529398|P2|Overall Study|Withdrawal by Subject|4
7624209|NCT01721954|26529399|P1|Overall Study|Withdrawal by Subject|8
7624210|NCT01721954|26529398|P2|Overall Study|Death|64
7624211|NCT01721954|26529399|P1|Overall Study|Death|58
7624212|NCT01721772|26529413|P2|Overall Study|Other|1
7624213|NCT01721772|26529414|P1|Overall Study|Other|0
7624214|NCT01721772|26529413|P2|Overall Study|Maximum clinical benefit|1
7624215|NCT01721772|26529414|P1|Overall Study|Maximum clinical benefit|1
7624216|NCT01721772|26529413|P2|Overall Study|Withdrawal by Subject|5
7624217|NCT01721772|26529414|P1|Overall Study|Withdrawal by Subject|7
7624218|NCT01721772|26529413|P2|Overall Study|Unrelated adverse event|3
7624219|NCT01721772|26529414|P1|Overall Study|Unrelated adverse event|2
7624220|NCT01721772|26529413|P2|Overall Study|Study drug toxicity|7
7624221|NCT01721772|26529414|P1|Overall Study|Study drug toxicity|5
7624222|NCT01721772|26529413|P2|Overall Study|Disease progression|175
7624223|NCT01721772|26529414|P1|Overall Study|Disease progression|96
7624224|NCT01721759|26529434|P1|Overall Study|Withdrawal by Subject|1
7624225|NCT01721759|26529434|P1|Overall Study|Adverse event unrelated to study drug|9
7624226|NCT01721759|26529434|P1|Overall Study|Study drug toxicity|14
7624227|NCT01721759|26529434|P1|Overall Study|Disease progression|78
7624228|NCT01721746|26529442|P3|Treatment Period|Other|1
7624229|NCT01721746|26529443|P2|Treatment Period|Other|1
7624230|NCT01721746|26529444|P1|Treatment Period|Other|2
7624231|NCT01721746|26529442|P3|Treatment Period|Subject No Longer Met Study Criteria|0
7624232|NCT01721746|26529443|P2|Treatment Period|Subject No Longer Met Study Criteria|0
7624233|NCT01721746|26529444|P1|Treatment Period|Subject No Longer Met Study Criteria|4
7624234|NCT01721746|26529442|P3|Treatment Period|Poor/Non-compliance|0
7624235|NCT01721746|26529443|P2|Treatment Period|Poor/Non-compliance|0
7624236|NCT01721746|26529444|P1|Treatment Period|Poor/Non-compliance|1
7624237|NCT01721746|26529442|P3|Treatment Period|Maximum Clinical Benefit|3
7624238|NCT01721746|26529443|P2|Treatment Period|Maximum Clinical Benefit|0
7624239|NCT01721746|26529444|P1|Treatment Period|Maximum Clinical Benefit|1
7624240|NCT01721746|26529442|P3|Treatment Period|Subject Withdrew Consent|2
7624241|NCT01721746|26529443|P2|Treatment Period|Subject Withdrew Consent|0
7624242|NCT01721746|26529444|P1|Treatment Period|Subject Withdrew Consent|3
7624243|NCT01721746|26529442|P3|Treatment Period|Subject Request to Discontinue Treatment|6
7624244|NCT01721746|26529443|P2|Treatment Period|Subject Request to Discontinue Treatment|1
7624245|NCT01721746|26529444|P1|Treatment Period|Subject Request to Discontinue Treatment|19
7624246|NCT01721746|26529442|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
7624247|NCT01721746|26529443|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
7624248|NCT01721746|26529444|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
7624249|NCT01721746|26529442|P3|Treatment Period|Study Drug Toxicity|9
7624250|NCT01721746|26529443|P2|Treatment Period|Study Drug Toxicity|2
7624251|NCT01721746|26529444|P1|Treatment Period|Study Drug Toxicity|15
7624252|NCT01721746|26529442|P3|Treatment Period|Disease Progression|34
7624253|NCT01721746|26529443|P2|Treatment Period|Disease Progression|40
7624254|NCT01721746|26529444|P1|Treatment Period|Disease Progression|182
7624255|NCT01721486|26529484|P2|Overall Study|Physician Decision|1
7624256|NCT01721486|26529485|P1|Overall Study|Physician Decision|0
7624257|NCT01721486|26529484|P2|Overall Study|Protocol Violation|0
7624258|NCT01721486|26529485|P1|Overall Study|Protocol Violation|1
7624259|NCT01721408|26529533|P2|Overall Study|Does not meet entrance criteria|0
7624260|NCT01721408|26529534|P1|Overall Study|Does not meet entrance criteria|1
7624261|NCT01721408|26529533|P2|Overall Study|Lost to Follow-up|2
7624262|NCT01721408|26529534|P1|Overall Study|Lost to Follow-up|1
7624263|NCT01721408|26529533|P2|Overall Study|Other|3
7624264|NCT01721408|26529534|P1|Overall Study|Other|3
7624265|NCT01721408|26529533|P2|Overall Study|Protocol Violation|2
7624266|NCT01721408|26529534|P1|Overall Study|Protocol Violation|0
7624267|NCT01721408|26529533|P2|Overall Study|No longer willing to participate study|10
7624268|NCT01721408|26529534|P1|Overall Study|No longer willing to participate study|9
7624269|NCT01721408|26529533|P2|Overall Study|Insufficient clinical response|6
7624270|NCT01721408|26529534|P1|Overall Study|Insufficient clinical response|15
7624271|NCT01721408|26529533|P2|Overall Study|Death|0
7624272|NCT01721408|26529534|P1|Overall Study|Death|1
7624273|NCT01721408|26529533|P2|Overall Study|Adverse Event|1
7624274|NCT01721408|26529534|P1|Overall Study|Adverse Event|6
7624275|NCT01721369|26529548|P1|Overall Study|Not initial etiological diagnosis|12
7624276|NCT01721330|26529554|P2|Overall Study|Withdrawal by Subject|1
7624277|NCT01721330|26529555|P1|Overall Study|Withdrawal by Subject|0
7624278|NCT01721317|26529563|P2|Overall Study|Withdrawal by Subject|1
7624279|NCT01721317|26529564|P1|Overall Study|Withdrawal by Subject|0
7624280|NCT01721317|26529563|P2|Overall Study|Physician Decision|1
7624281|NCT01721317|26529564|P1|Overall Study|Physician Decision|0
7624282|NCT01721317|26529563|P2|Overall Study|Study Closed / Terminated|2
7624283|NCT01721317|26529564|P1|Overall Study|Study Closed / Terminated|2
7624284|NCT01721200|26529643|P2|Overall Study|Lost to Follow-up|5
7624285|NCT01721200|26529644|P1|Overall Study|Lost to Follow-up|3
7624286|NCT01721161|26529669|P2|Overall Study|Other|1
7624287|NCT01721161|26529670|P1|Overall Study|Other|0
7624288|NCT01721161|26529669|P2|Overall Study|Withdrawal by Subject|1
7624289|NCT01721161|26529670|P1|Overall Study|Withdrawal by Subject|1
7624290|NCT01721161|26529669|P2|Overall Study|Lost to Follow-up|2
7624291|NCT01721161|26529670|P1|Overall Study|Lost to Follow-up|1
7624292|NCT01721161|26529669|P2|Overall Study|Adverse Event|3
7624293|NCT01721161|26529670|P1|Overall Study|Adverse Event|2
7624294|NCT01721109|26529693|P1|Overall Study|Lost to Follow-up|2
7624295|NCT01721109|26529693|P1|Overall Study|Withdrew Consent|1
7624296|NCT01721109|26529693|P1|Overall Study|Non- Compliance with Study Drug|3
7624297|NCT01721109|26529693|P1|Overall Study|Lack of Efficacy|1
7624298|NCT01721070|26529888|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
7624299|NCT01721057|26529899|P7|Rescue Period|Lack of Efficacy|0
7624300|NCT01721057|26529900|P6|Rescue Period|Lack of Efficacy|0
7624301|NCT01721057|26529901|P5|Rescue Period|Lack of Efficacy|0
7624302|NCT01721057|26529902|P4|Rescue Period|Lack of Efficacy|2
7624303|NCT01721057|26529903|P3|Rescue Period|Lack of Efficacy|0
7624304|NCT01721057|26529904|P2|Rescue Period|Lack of Efficacy|0
7624305|NCT01721057|26529905|P1|Rescue Period|Lack of Efficacy|0
7624306|NCT01721057|26529899|P7|Rescue Period|Adverse Event|0
7624307|NCT01721057|26529900|P6|Rescue Period|Adverse Event|0
7624308|NCT01721057|26529901|P5|Rescue Period|Adverse Event|0
7624309|NCT01721057|26529902|P4|Rescue Period|Adverse Event|1
7624310|NCT01721057|26529903|P3|Rescue Period|Adverse Event|0
7624311|NCT01721057|26529904|P2|Rescue Period|Adverse Event|0
7624312|NCT01721057|26529905|P1|Rescue Period|Adverse Event|0
7624313|NCT01721057|26529899|P7|Treatment Period|Death|0
7624314|NCT01721057|26529900|P6|Treatment Period|Death|0
7624315|NCT01721057|26529901|P5|Treatment Period|Death|0
7624316|NCT01721057|26529902|P4|Treatment Period|Death|0
7624317|NCT01721057|26529903|P3|Treatment Period|Death|0
7624318|NCT01721057|26529904|P2|Treatment Period|Death|0
7624319|NCT01721057|26529905|P1|Treatment Period|Death|2
7624320|NCT01721057|26529899|P7|Treatment Period|Physician Decision|0
7624321|NCT01721057|26529900|P6|Treatment Period|Physician Decision|0
7624322|NCT01721057|26529901|P5|Treatment Period|Physician Decision|0
7624323|NCT01721057|26529902|P4|Treatment Period|Physician Decision|0
7624324|NCT01721057|26529903|P3|Treatment Period|Physician Decision|3
7624325|NCT01721057|26529904|P2|Treatment Period|Physician Decision|1
7624326|NCT01721057|26529905|P1|Treatment Period|Physician Decision|0
7624327|NCT01721057|26529899|P7|Treatment Period|Lost to Follow-up|0
7624328|NCT01721057|26529900|P6|Treatment Period|Lost to Follow-up|0
7624329|NCT01721057|26529901|P5|Treatment Period|Lost to Follow-up|0
7624330|NCT01721057|26529902|P4|Treatment Period|Lost to Follow-up|0
7624331|NCT01721057|26529903|P3|Treatment Period|Lost to Follow-up|0
7624332|NCT01721057|26529904|P2|Treatment Period|Lost to Follow-up|0
7624333|NCT01721057|26529905|P1|Treatment Period|Lost to Follow-up|1
7624334|NCT01721057|26529899|P7|Treatment Period|Lack of Efficacy|0
7624335|NCT01721057|26529900|P6|Treatment Period|Lack of Efficacy|0
7624336|NCT01721057|26529901|P5|Treatment Period|Lack of Efficacy|0
7624337|NCT01721057|26529902|P4|Treatment Period|Lack of Efficacy|0
7624338|NCT01721057|26529903|P3|Treatment Period|Lack of Efficacy|0
7624339|NCT01721057|26529904|P2|Treatment Period|Lack of Efficacy|3
7624340|NCT01721057|26529905|P1|Treatment Period|Lack of Efficacy|7
7624341|NCT01721057|26529899|P7|Treatment Period|Adverse Event|0
7624342|NCT01721057|26529900|P6|Treatment Period|Adverse Event|0
7624343|NCT01721057|26529901|P5|Treatment Period|Adverse Event|0
7624344|NCT01721057|26529902|P4|Treatment Period|Adverse Event|0
7624345|NCT01721057|26529903|P3|Treatment Period|Adverse Event|12
7624346|NCT01721057|26529904|P2|Treatment Period|Adverse Event|10
7624347|NCT01721057|26529905|P1|Treatment Period|Adverse Event|7
7624348|NCT01721057|26529899|P7|Treatment Period|Withdrawal by Subject|0
7624349|NCT01721057|26529900|P6|Treatment Period|Withdrawal by Subject|0
7624350|NCT01721057|26529901|P5|Treatment Period|Withdrawal by Subject|0
7624351|NCT01721057|26529902|P4|Treatment Period|Withdrawal by Subject|0
7624352|NCT01721057|26529903|P3|Treatment Period|Withdrawal by Subject|8
7624353|NCT01721057|26529904|P2|Treatment Period|Withdrawal by Subject|5
7624354|NCT01721057|26529905|P1|Treatment Period|Withdrawal by Subject|11
7624355|NCT01721044|26529978|P3|Treatment Period|Withdrawal by Subject|1
7624356|NCT01721044|26529979|P2|Treatment Period|Withdrawal by Subject|6
7624357|NCT01721044|26529980|P1|Treatment Period|Withdrawal by Subject|7
7624358|NCT01721044|26529978|P3|Treatment Period|Protocol Violation|0
7624359|NCT01721044|26529979|P2|Treatment Period|Protocol Violation|0
7624360|NCT01721044|26529980|P1|Treatment Period|Protocol Violation|1
7624361|NCT01721044|26529978|P3|Treatment Period|Physician Decision|2
7624362|NCT01721044|26529979|P2|Treatment Period|Physician Decision|0
7624363|NCT01721044|26529980|P1|Treatment Period|Physician Decision|1
7624364|NCT01721044|26529978|P3|Treatment Period|Lost to Follow-up|1
7624365|NCT01721044|26529979|P2|Treatment Period|Lost to Follow-up|0
7624366|NCT01721044|26529980|P1|Treatment Period|Lost to Follow-up|0
7624367|NCT01721044|26529978|P3|Treatment Period|Lack of Efficacy|4
7624368|NCT01721044|26529979|P2|Treatment Period|Lack of Efficacy|4
7624369|NCT01721044|26529980|P1|Treatment Period|Lack of Efficacy|16
7624370|NCT01721044|26529978|P3|Treatment Period|Death|1
7624371|NCT01721044|26529979|P2|Treatment Period|Death|0
7624372|NCT01721044|26529980|P1|Treatment Period|Death|0
7624373|NCT01721044|26529978|P3|Treatment Period|Adverse Event|10
7624374|NCT01721044|26529979|P2|Treatment Period|Adverse Event|7
7624375|NCT01721044|26529980|P1|Treatment Period|Adverse Event|7
7624376|NCT01720797|26530053|P2|Overall Study|Withdrawal by Subject|0
7624377|NCT01720797|26530054|P1|Overall Study|Withdrawal by Subject|3
7624378|NCT01720667|26530062|P2|Overall Study|Withdrawal by Subject|0
7624379|NCT01720667|26530063|P1|Overall Study|Withdrawal by Subject|3
7624380|NCT01720667|26530062|P2|Overall Study|Adverse Event|1
7624381|NCT01720667|26530063|P1|Overall Study|Adverse Event|1
7624382|NCT01720602|26530077|P1|Overall Study|Progressive disease on therapy|2
7624383|NCT01720602|26530077|P1|Overall Study|Adverse Event|3
7624384|NCT01720524|26530087|P2|Part B|Death|2
7624385|NCT01720524|26530088|P1|Part B|Death|0
7624386|NCT01720524|26530087|P2|Part B|Lost to Follow-up|3
7624387|NCT01720524|26530088|P1|Part B|Lost to Follow-up|2
7624388|NCT01720524|26530087|P2|Part B|Other|0
7624389|NCT01720524|26530088|P1|Part B|Other|2
7624390|NCT01720524|26530087|P2|Part B|No longer willing to participate in study|4
7624391|NCT01720524|26530088|P1|Part B|No longer willing to participate in study|1
7624392|NCT01720524|26530087|P2|Part A|Lost to Follow-up|1
7624393|NCT01720524|26530088|P1|Part A|Lost to Follow-up|0
7624394|NCT01720524|26530087|P2|Part A|Other|1
7624395|NCT01720524|26530088|P1|Part A|Other|0
7624396|NCT01720524|26530087|P2|Part A|Withdrawal by Subject|1
7624397|NCT01720524|26530088|P1|Part A|Withdrawal by Subject|0
7624398|NCT01720524|26530087|P2|Part A|Missed 28 day follow-up visit|1
7624399|NCT01720524|26530088|P1|Part A|Missed 28 day follow-up visit|1
7624400|NCT01720524|26530087|P2|Part A|Lost to Follow-up|1
7624401|NCT01720524|26530088|P1|Part A|Lost to Follow-up|0
7624402|NCT01720524|26530087|P2|Part A|Death|1
7624403|NCT01720524|26530088|P1|Part A|Death|2
7624404|NCT01720524|26530087|P2|Part A|Adverse Event|2
7624405|NCT01720524|26530088|P1|Part A|Adverse Event|2
7624406|NCT01720524|26530087|P2|Part A|Insufficient Clinical Response|4
7624407|NCT01720524|26530088|P1|Part A|Insufficient Clinical Response|2
7624408|NCT01720446|26530159|P4|Overall Study|Withdrawal by Subject|4
7624409|NCT01720446|26530160|P3|Overall Study|Withdrawal by Subject|4
7624410|NCT01720446|26530161|P2|Overall Study|Withdrawal by Subject|5
7624411|NCT01720446|26530162|P1|Overall Study|Withdrawal by Subject|2
7624412|NCT01720446|26530159|P4|Overall Study|Lost to Follow-up|16
7624413|NCT01720446|26530160|P3|Overall Study|Lost to Follow-up|16
7624414|NCT01720446|26530161|P2|Overall Study|Lost to Follow-up|6
7624415|NCT01720446|26530162|P1|Overall Study|Lost to Follow-up|12
7624416|NCT01720264|26530283|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
7624417|NCT01720264|26530283|P1|Post-transplant (Day 16) to 1 Year|Death|8
7624418|NCT01720264|26530283|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
7624419|NCT01720225|26530305|P2|Overall Study|Did not complete 2 cycles of therapy|0
7624420|NCT01720225|26530306|P1|Overall Study|Did not complete 2 cycles of therapy|3
7624421|NCT01720225|26530305|P2|Overall Study|Withdrawal by Subject|1
7624422|NCT01720225|26530306|P1|Overall Study|Withdrawal by Subject|0
7624423|NCT01720069|26530325|P3|Overall Study|Lost to Follow-up|1
7624424|NCT01720069|26530326|P2|Overall Study|Lost to Follow-up|0
7624425|NCT01720069|26530327|P1|Overall Study|Lost to Follow-up|0
7624426|NCT01720069|26530325|P3|Overall Study|Non-compliance on using e-diary|1
7624427|NCT01720069|26530326|P2|Overall Study|Non-compliance on using e-diary|0
7624428|NCT01720069|26530327|P1|Overall Study|Non-compliance on using e-diary|0
7624429|NCT01720069|26530325|P3|Overall Study|OCS bursts occured, discontinued in line|0
7624430|NCT01720069|26530326|P2|Overall Study|OCS bursts occured, discontinued in line|0
7624431|NCT01720069|26530327|P1|Overall Study|OCS bursts occured, discontinued in line|1
7624432|NCT01720069|26530325|P3|Overall Study|Withdrawal by Subject|1
7624433|NCT01720069|26530326|P2|Overall Study|Withdrawal by Subject|2
7624434|NCT01720069|26530327|P1|Overall Study|Withdrawal by Subject|0
7624435|NCT01720069|26530325|P3|Overall Study|Treatment period withdrawal criteria met|9
7624436|NCT01720069|26530326|P2|Overall Study|Treatment period withdrawal criteria met|8
7624437|NCT01720069|26530327|P1|Overall Study|Treatment period withdrawal criteria met|4
7624438|NCT01720069|26530325|P3|Overall Study|Lack of Efficacy|0
7624439|NCT01720069|26530326|P2|Overall Study|Lack of Efficacy|4
7624440|NCT01720069|26530327|P1|Overall Study|Lack of Efficacy|0
7624441|NCT01720069|26530325|P3|Overall Study|Adverse Event|1
7624442|NCT01720069|26530326|P2|Overall Study|Adverse Event|0
7624443|NCT01720069|26530327|P1|Overall Study|Adverse Event|0
7624444|NCT01720069|26530325|P3|Overall Study|Randomised without baseline values|1
7624445|NCT01720069|26530326|P2|Overall Study|Randomised without baseline values|0
7624446|NCT01720069|26530327|P1|Overall Study|Randomised without baseline values|0
7624447|NCT01720069|26530325|P3|Overall Study|Could not use e-diary correctly|1
7624448|NCT01720069|26530326|P2|Overall Study|Could not use e-diary correctly|1
7624449|NCT01720069|26530327|P1|Overall Study|Could not use e-diary correctly|0
7624450|NCT01720043|26530353|P1|Overall Study|Withdrawal by Subject|1
7624451|NCT01719861|26530382|P1|Cycle 2|Death|1
7624452|NCT01719861|26530382|P1|Cycle 1|Death|4
7624453|NCT01719783|26530392|P2|Dose 2|Physician Decision|0
7624454|NCT01719783|26530393|P1|Dose 2|Physician Decision|1
7624455|NCT01719757|26530479|P1|Overall Study|well controlled pain|27
7624456|NCT01719757|26530479|P1|Overall Study|Protocol Violation|1
7624457|NCT01719757|26530479|P1|Overall Study|Lost to Follow-up|20
7624458|NCT01719757|26530479|P1|Overall Study|Withdrawal by Subject|15
7624459|NCT01719757|26530479|P1|Overall Study|Adverse Event|38
7624460|NCT01719380|26530534|P10|Overall Study|Progressive Disease|0
7624461|NCT01719380|26530535|P9|Overall Study|Progressive Disease|1
7624462|NCT01719380|26530536|P8|Overall Study|Progressive Disease|0
7624463|NCT01719380|26530537|P7|Overall Study|Progressive Disease|0
7624464|NCT01719380|26530538|P6|Overall Study|Progressive Disease|0
7624465|NCT01719380|26530539|P5|Overall Study|Progressive Disease|0
7624466|NCT01719380|26530540|P4|Overall Study|Progressive Disease|0
7624467|NCT01719380|26530541|P3|Overall Study|Progressive Disease|0
7624468|NCT01719380|26530542|P2|Overall Study|Progressive Disease|0
7624469|NCT01719380|26530543|P1|Overall Study|Progressive Disease|0
7624470|NCT01719380|26530534|P10|Overall Study|Lack of Efficacy|42
7624471|NCT01719380|26530535|P9|Overall Study|Lack of Efficacy|39
7624472|NCT01719380|26530536|P8|Overall Study|Lack of Efficacy|6
7624473|NCT01719380|26530537|P7|Overall Study|Lack of Efficacy|10
7624474|NCT01719380|26530538|P6|Overall Study|Lack of Efficacy|7
7624475|NCT01719380|26530539|P5|Overall Study|Lack of Efficacy|3
7624476|NCT01719380|26530540|P4|Overall Study|Lack of Efficacy|6
7624477|NCT01719380|26530541|P3|Overall Study|Lack of Efficacy|5
7624478|NCT01719380|26530542|P2|Overall Study|Lack of Efficacy|6
7624479|NCT01719380|26530543|P1|Overall Study|Lack of Efficacy|2
7624480|NCT01719380|26530534|P10|Overall Study|Physician Decision|1
7624481|NCT01719380|26530535|P9|Overall Study|Physician Decision|1
7624482|NCT01719380|26530536|P8|Overall Study|Physician Decision|0
7624483|NCT01719380|26530537|P7|Overall Study|Physician Decision|0
7624484|NCT01719380|26530538|P6|Overall Study|Physician Decision|0
7624485|NCT01719380|26530539|P5|Overall Study|Physician Decision|0
7624486|NCT01719380|26530540|P4|Overall Study|Physician Decision|0
7624487|NCT01719380|26530541|P3|Overall Study|Physician Decision|2
7624488|NCT01719380|26530542|P2|Overall Study|Physician Decision|0
7624489|NCT01719380|26530543|P1|Overall Study|Physician Decision|0
7624490|NCT01719380|26530534|P10|Overall Study|Participant/Guardian Decision|2
7624491|NCT01719380|26530535|P9|Overall Study|Participant/Guardian Decision|2
7624492|NCT01719380|26530536|P8|Overall Study|Participant/Guardian Decision|0
7624493|NCT01719380|26530537|P7|Overall Study|Participant/Guardian Decision|0
7624494|NCT01719380|26530538|P6|Overall Study|Participant/Guardian Decision|0
7624495|NCT01719380|26530539|P5|Overall Study|Participant/Guardian Decision|0
7624496|NCT01719380|26530540|P4|Overall Study|Participant/Guardian Decision|0
7624497|NCT01719380|26530541|P3|Overall Study|Participant/Guardian Decision|1
7624498|NCT01719380|26530542|P2|Overall Study|Participant/Guardian Decision|0
7624499|NCT01719380|26530543|P1|Overall Study|Participant/Guardian Decision|0
7624500|NCT01719380|26530534|P10|Overall Study|Death|3
7624501|NCT01719380|26530535|P9|Overall Study|Death|3
7624502|NCT01719380|26530536|P8|Overall Study|Death|0
7624503|NCT01719380|26530537|P7|Overall Study|Death|0
7624504|NCT01719380|26530538|P6|Overall Study|Death|0
7624505|NCT01719380|26530539|P5|Overall Study|Death|0
7624506|NCT01719380|26530540|P4|Overall Study|Death|0
7624507|NCT01719380|26530541|P3|Overall Study|Death|0
7624508|NCT01719380|26530542|P2|Overall Study|Death|1
7624509|NCT01719380|26530543|P1|Overall Study|Death|0
7624510|NCT01719380|26530534|P10|Overall Study|Adverse Event|3
7624511|NCT01719380|26530535|P9|Overall Study|Adverse Event|4
7624512|NCT01719380|26530536|P8|Overall Study|Adverse Event|1
7624513|NCT01719380|26530537|P7|Overall Study|Adverse Event|0
7624514|NCT01719380|26530538|P6|Overall Study|Adverse Event|1
7624515|NCT01719380|26530539|P5|Overall Study|Adverse Event|0
7624516|NCT01719380|26530540|P4|Overall Study|Adverse Event|2
7624517|NCT01719380|26530541|P3|Overall Study|Adverse Event|1
7624518|NCT01719380|26530542|P2|Overall Study|Adverse Event|0
7624519|NCT01719380|26530543|P1|Overall Study|Adverse Event|0
7624520|NCT01719224|26530769|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
7624521|NCT01719224|26530770|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
7624522|NCT01719172|26530779|P1|Overall Study|Death|1
7624523|NCT01719172|26530779|P1|Overall Study|Lost to Follow-up|1
7624524|NCT01719003|26530793|P9|Overall Study|Lack of Efficacy|0
7624525|NCT01719003|26530794|P8|Overall Study|Lack of Efficacy|0
7624526|NCT01719003|26530795|P7|Overall Study|Lack of Efficacy|1
7624527|NCT01719003|26530796|P6|Overall Study|Lack of Efficacy|0
7624528|NCT01719003|26530797|P5|Overall Study|Lack of Efficacy|0
7624529|NCT01719003|26530798|P4|Overall Study|Lack of Efficacy|0
7624530|NCT01719003|26530799|P3|Overall Study|Lack of Efficacy|0
7624531|NCT01719003|26530800|P2|Overall Study|Lack of Efficacy|0
7624532|NCT01719003|26530801|P1|Overall Study|Lack of Efficacy|0
7624533|NCT01719003|26530793|P9|Overall Study|Reason other than those specified|1
7624534|NCT01719003|26530794|P8|Overall Study|Reason other than those specified|3
7624535|NCT01719003|26530795|P7|Overall Study|Reason other than those specified|0
7624536|NCT01719003|26530796|P6|Overall Study|Reason other than those specified|1
7624537|NCT01719003|26530797|P5|Overall Study|Reason other than those specified|4
7624538|NCT01719003|26530798|P4|Overall Study|Reason other than those specified|3
7624539|NCT01719003|26530799|P3|Overall Study|Reason other than those specified|2
7624540|NCT01719003|26530800|P2|Overall Study|Reason other than those specified|0
7624541|NCT01719003|26530801|P1|Overall Study|Reason other than those specified|0
7624542|NCT01719003|26530793|P9|Overall Study|Refusal to continue, not due to AE|1
7624543|NCT01719003|26530794|P8|Overall Study|Refusal to continue, not due to AE|7
7624544|NCT01719003|26530795|P7|Overall Study|Refusal to continue, not due to AE|8
7624545|NCT01719003|26530796|P6|Overall Study|Refusal to continue, not due to AE|3
7624546|NCT01719003|26530797|P5|Overall Study|Refusal to continue, not due to AE|4
7624547|NCT01719003|26530798|P4|Overall Study|Refusal to continue, not due to AE|4
7624548|NCT01719003|26530799|P3|Overall Study|Refusal to continue, not due to AE|4
7624549|NCT01719003|26530800|P2|Overall Study|Refusal to continue, not due to AE|5
7624550|NCT01719003|26530801|P1|Overall Study|Refusal to continue, not due to AE|2
7624551|NCT01719003|26530793|P9|Overall Study|Lost to Follow-up|2
7624552|NCT01719003|26530794|P8|Overall Study|Lost to Follow-up|2
7624553|NCT01719003|26530795|P7|Overall Study|Lost to Follow-up|3
7624554|NCT01719003|26530796|P6|Overall Study|Lost to Follow-up|4
7624555|NCT01719003|26530797|P5|Overall Study|Lost to Follow-up|3
7624556|NCT01719003|26530798|P4|Overall Study|Lost to Follow-up|2
7624557|NCT01719003|26530799|P3|Overall Study|Lost to Follow-up|7
7624558|NCT01719003|26530800|P2|Overall Study|Lost to Follow-up|6
7624559|NCT01719003|26530801|P1|Overall Study|Lost to Follow-up|0
7624560|NCT01719003|26530793|P9|Overall Study|Adverse Event|0
7624561|NCT01719003|26530794|P8|Overall Study|Adverse Event|5
7624562|NCT01719003|26530795|P7|Overall Study|Adverse Event|6
7624563|NCT01719003|26530796|P6|Overall Study|Adverse Event|3
7624564|NCT01719003|26530797|P5|Overall Study|Adverse Event|4
7624565|NCT01719003|26530798|P4|Overall Study|Adverse Event|3
7624566|NCT01719003|26530799|P3|Overall Study|Adverse Event|4
7624567|NCT01719003|26530800|P2|Overall Study|Adverse Event|5
7624568|NCT01719003|26530801|P1|Overall Study|Adverse Event|6
7624569|NCT01719003|26530793|P9|Overall Study|Non compliant with protocol|0
7624570|NCT01719003|26530794|P8|Overall Study|Non compliant with protocol|3
7624571|NCT01719003|26530795|P7|Overall Study|Non compliant with protocol|2
7624572|NCT01719003|26530796|P6|Overall Study|Non compliant with protocol|1
7624573|NCT01719003|26530797|P5|Overall Study|Non compliant with protocol|2
7624574|NCT01719003|26530798|P4|Overall Study|Non compliant with protocol|1
7624575|NCT01719003|26530799|P3|Overall Study|Non compliant with protocol|0
7624576|NCT01719003|26530800|P2|Overall Study|Non compliant with protocol|1
7624577|NCT01719003|26530801|P1|Overall Study|Non compliant with protocol|1
7624578|NCT01718535|26530882|P10|Overall Study|Bidirectional Sequencing not possible|0
7624579|NCT01718535|26530883|P9|Overall Study|Bidirectional Sequencing not possible|0
7624580|NCT01718535|26530884|P8|Overall Study|Bidirectional Sequencing not possible|0
7624581|NCT01718535|26530885|P7|Overall Study|Bidirectional Sequencing not possible|0
7624582|NCT01718535|26530886|P6|Overall Study|Bidirectional Sequencing not possible|0
7624583|NCT01718535|26530887|P5|Overall Study|Bidirectional Sequencing not possible|0
7624584|NCT01718535|26530888|P4|Overall Study|Bidirectional Sequencing not possible|1
7624585|NCT01718535|26530889|P3|Overall Study|Bidirectional Sequencing not possible|0
7624586|NCT01718535|26530890|P2|Overall Study|Bidirectional Sequencing not possible|0
7624587|NCT01718535|26530891|P1|Overall Study|Bidirectional Sequencing not possible|1
7624588|NCT01718509|26530929|P2|Overall Study|Lack of Efficacy|0
7624589|NCT01718509|26530930|P1|Overall Study|Lack of Efficacy|1
7624590|NCT01718509|26530929|P2|Overall Study|Protocol Violation|2
7624591|NCT01718509|26530930|P1|Overall Study|Protocol Violation|4
7624592|NCT01718509|26530929|P2|Overall Study|Other|11
7624593|NCT01718509|26530930|P1|Overall Study|Other|13
7624594|NCT01718509|26530929|P2|Overall Study|Adverse Event|7
7624595|NCT01718509|26530930|P1|Overall Study|Adverse Event|5
7624596|NCT01718509|26530929|P2|Overall Study|Withdrawal by Subject|13
7624597|NCT01718509|26530930|P1|Overall Study|Withdrawal by Subject|7
7624598|NCT01718509|26530929|P2|Overall Study|Lost to Follow-up|15
7624599|NCT01718509|26530930|P1|Overall Study|Lost to Follow-up|18
7624600|NCT01718483|26530976|P2|Overall Study|Lack of Efficacy|0
7624601|NCT01718483|26530977|P1|Overall Study|Lack of Efficacy|1
7624602|NCT01718483|26530976|P2|Overall Study|Pregnancy|1
7624603|NCT01718483|26530977|P1|Overall Study|Pregnancy|1
7624604|NCT01718483|26530976|P2|Overall Study|Other|4
7624605|NCT01718483|26530977|P1|Overall Study|Other|1
7624606|NCT01718483|26530976|P2|Overall Study|Protocol Violation|2
7624607|NCT01718483|26530977|P1|Overall Study|Protocol Violation|4
7624608|NCT01718483|26530976|P2|Overall Study|Lost to Follow-up|3
7624609|NCT01718483|26530977|P1|Overall Study|Lost to Follow-up|8
7624610|NCT01718483|26530976|P2|Overall Study|Adverse Event|12
7624611|NCT01718483|26530977|P1|Overall Study|Adverse Event|5
7624612|NCT01718483|26530976|P2|Overall Study|Withdrawal by Subject|12
7624613|NCT01718483|26530977|P1|Overall Study|Withdrawal by Subject|14
7624614|NCT01718353|26531032|P2|Overall Study|Randomized but not treated|0
7624615|NCT01718353|26531033|P1|Overall Study|Randomized but not treated|2
7624616|NCT01718353|26531032|P2|Overall Study|Principal Investigator's Decision|4
7624617|NCT01718353|26531033|P1|Overall Study|Principal Investigator's Decision|10
7624618|NCT01718353|26531032|P2|Overall Study|Lost to Follow-up|1
7624619|NCT01718353|26531033|P1|Overall Study|Lost to Follow-up|0
7624620|NCT01717989|26531064|P1|Overall Study|Other|40
7624621|NCT01717989|26531064|P1|Overall Study|Protocol-specified criteria|551
7624622|NCT01717989|26531064|P1|Overall Study|Death|439
7624623|NCT01717989|26531064|P1|Overall Study|Lost to Follow-up|11
7624624|NCT01717989|26531064|P1|Overall Study|Physician Decision|2
7624625|NCT01717989|26531064|P1|Overall Study|Withdrawal by Subject|11
7624626|NCT01717989|26531064|P1|Overall Study|Protocol deviation|6
7624627|NCT01717989|26531064|P1|Overall Study|Ineligibility determined|6
7624628|NCT01717976|26531132|P2|Overall Study|Protocol Violation|1
7624629|NCT01717976|26531133|P1|Overall Study|Protocol Violation|0
7624630|NCT01717859|26531188|P1|Overall Study|Withdrawal by Subject|2
7624631|NCT01717859|26531188|P1|Overall Study|Lost to Follow-up|1
7624632|NCT01717859|26531188|P1|Overall Study|Patient concerned about mental health|1
7624633|NCT01717859|26531188|P1|Overall Study|Moved out of state|1
7624634|NCT01717859|26531188|P1|Overall Study|Adverse Event|5
7624635|NCT01717768|26531209|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624636|NCT01717768|26531210|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624637|NCT01717768|26531211|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
7624638|NCT01717768|26531212|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624639|NCT01717768|26531213|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624640|NCT01717768|26531214|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624641|NCT01717768|26531215|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624642|NCT01717768|26531216|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624643|NCT01717768|26531217|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624644|NCT01717768|26531218|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624645|NCT01717768|26531219|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624646|NCT01717768|26531220|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7624647|NCT01717768|26531209|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624648|NCT01717768|26531210|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624649|NCT01717768|26531211|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624650|NCT01717768|26531212|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624651|NCT01717768|26531213|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
7624652|NCT01717768|26531214|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624653|NCT01717768|26531215|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624654|NCT01717768|26531216|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624655|NCT01717768|26531217|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624656|NCT01717768|26531218|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624657|NCT01717768|26531219|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624658|NCT01717768|26531220|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7624659|NCT01717768|26531209|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
7624660|NCT01717768|26531210|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624661|NCT01717768|26531211|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624662|NCT01717768|26531212|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624663|NCT01717768|26531213|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624664|NCT01717768|26531214|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624665|NCT01717768|26531215|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624666|NCT01717768|26531216|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624667|NCT01717768|26531217|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624668|NCT01717768|26531218|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624669|NCT01717768|26531219|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624670|NCT01717768|26531220|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7624671|NCT01717768|26531209|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624672|NCT01717768|26531210|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624673|NCT01717768|26531211|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624674|NCT01717768|26531212|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624675|NCT01717768|26531213|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624676|NCT01717768|26531214|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624677|NCT01717768|26531215|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624678|NCT01717768|26531216|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624679|NCT01717768|26531217|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624680|NCT01717768|26531218|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624681|NCT01717768|26531219|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
7624682|NCT01717768|26531220|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7624683|NCT01717638|26531300|P13|Overall Study|Withdrawal by Subject|18
7624684|NCT01717638|26531301|P12|Overall Study|Withdrawal by Subject|0
7624685|NCT01717638|26531302|P11|Overall Study|Withdrawal by Subject|0
7624686|NCT01717638|26531303|P10|Overall Study|Withdrawal by Subject|1
7624687|NCT01717638|26531304|P9|Overall Study|Withdrawal by Subject|2
7624688|NCT01717638|26531305|P8|Overall Study|Withdrawal by Subject|1
7624689|NCT01717638|26531306|P7|Overall Study|Withdrawal by Subject|2
7624690|NCT01717638|26531307|P6|Overall Study|Withdrawal by Subject|0
7624691|NCT01717638|26531308|P5|Overall Study|Withdrawal by Subject|1
7624692|NCT01717638|26531309|P4|Overall Study|Withdrawal by Subject|0
7624693|NCT01717638|26531310|P3|Overall Study|Withdrawal by Subject|1
7624694|NCT01717638|26531311|P2|Overall Study|Withdrawal by Subject|1
7624695|NCT01717638|26531312|P1|Overall Study|Withdrawal by Subject|0
7624696|NCT01717638|26531300|P13|Overall Study|Father in hospital|1
7624697|NCT01717638|26531301|P12|Overall Study|Father in hospital|0
7624698|NCT01717638|26531302|P11|Overall Study|Father in hospital|0
7624699|NCT01717638|26531303|P10|Overall Study|Father in hospital|0
7624700|NCT01717638|26531304|P9|Overall Study|Father in hospital|0
7624701|NCT01717638|26531305|P8|Overall Study|Father in hospital|0
7624702|NCT01717638|26531306|P7|Overall Study|Father in hospital|0
7624703|NCT01717638|26531307|P6|Overall Study|Father in hospital|0
7624704|NCT01717638|26531308|P5|Overall Study|Father in hospital|0
7624705|NCT01717638|26531309|P4|Overall Study|Father in hospital|0
7624706|NCT01717638|26531310|P3|Overall Study|Father in hospital|0
7624707|NCT01717638|26531311|P2|Overall Study|Father in hospital|0
7624708|NCT01717638|26531312|P1|Overall Study|Father in hospital|0
7624709|NCT01717638|26531300|P13|Overall Study|Lost to Follow-up|0
7624710|NCT01717638|26531301|P12|Overall Study|Lost to Follow-up|0
7624711|NCT01717638|26531302|P11|Overall Study|Lost to Follow-up|0
7624712|NCT01717638|26531303|P10|Overall Study|Lost to Follow-up|0
7624713|NCT01717638|26531304|P9|Overall Study|Lost to Follow-up|0
7624714|NCT01717638|26531305|P8|Overall Study|Lost to Follow-up|0
7624715|NCT01717638|26531306|P7|Overall Study|Lost to Follow-up|0
7624716|NCT01717638|26531307|P6|Overall Study|Lost to Follow-up|1
7624717|NCT01717638|26531308|P5|Overall Study|Lost to Follow-up|0
7624718|NCT01717638|26531309|P4|Overall Study|Lost to Follow-up|0
7624719|NCT01717638|26531310|P3|Overall Study|Lost to Follow-up|0
7624720|NCT01717638|26531311|P2|Overall Study|Lost to Follow-up|0
7624721|NCT01717638|26531312|P1|Overall Study|Lost to Follow-up|0
7624722|NCT01717456|26531488|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7624723|NCT01717456|26531489|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7624724|NCT01717456|26531488|P2|End of Treatment|Lost to Follow-up|1
7624725|NCT01717456|26531489|P1|End of Treatment|Lost to Follow-up|0
7624726|NCT01717456|26531488|P2|End of Treatment|Physician Decision|1
7624727|NCT01717456|26531489|P1|End of Treatment|Physician Decision|0
7624728|NCT01717391|26531557|P1|Overall Study|FLT technical failure|3
7624729|NCT01717391|26531557|P1|Overall Study|Physician Decision|1
7624730|NCT01717391|26531557|P1|Overall Study|Withdrawal by Subject|5
7624731|NCT01717326|26531586|P20|Overall Study|Withdrawal by Subject|3
7624732|NCT01717326|26531587|P19|Overall Study|Withdrawal by Subject|2
7624733|NCT01717326|26531588|P18|Overall Study|Withdrawal by Subject|0
7624734|NCT01717326|26531589|P17|Overall Study|Withdrawal by Subject|0
7624735|NCT01717326|26531590|P16|Overall Study|Withdrawal by Subject|1
7624736|NCT01717326|26531591|P15|Overall Study|Withdrawal by Subject|0
7624737|NCT01717326|26531592|P14|Overall Study|Withdrawal by Subject|0
7624738|NCT01717326|26531593|P13|Overall Study|Withdrawal by Subject|1
7624739|NCT01717326|26531594|P12|Overall Study|Withdrawal by Subject|0
7624740|NCT01717326|26531595|P11|Overall Study|Withdrawal by Subject|0
7624741|NCT01717326|26531596|P10|Overall Study|Withdrawal by Subject|1
7624742|NCT01717326|26531597|P9|Overall Study|Withdrawal by Subject|0
7624743|NCT01717326|26531598|P8|Overall Study|Withdrawal by Subject|0
7624744|NCT01717326|26531599|P7|Overall Study|Withdrawal by Subject|0
7624745|NCT01717326|26531600|P6|Overall Study|Withdrawal by Subject|0
7624746|NCT01717326|26531601|P5|Overall Study|Withdrawal by Subject|0
7624747|NCT01717326|26531602|P4|Overall Study|Withdrawal by Subject|0
7624748|NCT01717326|26531603|P3|Overall Study|Withdrawal by Subject|0
7624749|NCT01717326|26531604|P2|Overall Study|Withdrawal by Subject|1
7624750|NCT01717326|26531605|P1|Overall Study|Withdrawal by Subject|0
7624751|NCT01717326|26531586|P20|Overall Study|Protocol Violation|0
7624752|NCT01717326|26531587|P19|Overall Study|Protocol Violation|0
7624753|NCT01717326|26531588|P18|Overall Study|Protocol Violation|0
7624754|NCT01717326|26531589|P17|Overall Study|Protocol Violation|0
7624755|NCT01717326|26531590|P16|Overall Study|Protocol Violation|0
7624756|NCT01717326|26531591|P15|Overall Study|Protocol Violation|0
7624757|NCT01717326|26531592|P14|Overall Study|Protocol Violation|0
7624758|NCT01717326|26531593|P13|Overall Study|Protocol Violation|0
7624759|NCT01717326|26531594|P12|Overall Study|Protocol Violation|0
7624760|NCT01717326|26531595|P11|Overall Study|Protocol Violation|0
7624761|NCT01717326|26531596|P10|Overall Study|Protocol Violation|0
7624762|NCT01717326|26531597|P9|Overall Study|Protocol Violation|0
7624763|NCT01717326|26531598|P8|Overall Study|Protocol Violation|0
7624764|NCT01717326|26531599|P7|Overall Study|Protocol Violation|0
7624765|NCT01717326|26531600|P6|Overall Study|Protocol Violation|0
7624766|NCT01717326|26531601|P5|Overall Study|Protocol Violation|1
7624767|NCT01717326|26531602|P4|Overall Study|Protocol Violation|0
7624768|NCT01717326|26531603|P3|Overall Study|Protocol Violation|0
7624769|NCT01717326|26531604|P2|Overall Study|Protocol Violation|0
7624770|NCT01717326|26531605|P1|Overall Study|Protocol Violation|0
7624771|NCT01717326|26531586|P20|Overall Study|Physician Decision|0
7624772|NCT01717326|26531587|P19|Overall Study|Physician Decision|0
7624773|NCT01717326|26531588|P18|Overall Study|Physician Decision|0
7624774|NCT01717326|26531589|P17|Overall Study|Physician Decision|0
7624775|NCT01717326|26531590|P16|Overall Study|Physician Decision|0
7624776|NCT01717326|26531591|P15|Overall Study|Physician Decision|0
7624777|NCT01717326|26531592|P14|Overall Study|Physician Decision|0
7624778|NCT01717326|26531593|P13|Overall Study|Physician Decision|0
7624779|NCT01717326|26531594|P12|Overall Study|Physician Decision|0
7624780|NCT01717326|26531595|P11|Overall Study|Physician Decision|0
7624781|NCT01717326|26531596|P10|Overall Study|Physician Decision|1
7624782|NCT01717326|26531597|P9|Overall Study|Physician Decision|0
7624783|NCT01717326|26531598|P8|Overall Study|Physician Decision|0
7624784|NCT01717326|26531599|P7|Overall Study|Physician Decision|0
7624785|NCT01717326|26531600|P6|Overall Study|Physician Decision|0
7624786|NCT01717326|26531601|P5|Overall Study|Physician Decision|0
7624787|NCT01717326|26531602|P4|Overall Study|Physician Decision|0
7624788|NCT01717326|26531603|P3|Overall Study|Physician Decision|0
7624789|NCT01717326|26531604|P2|Overall Study|Physician Decision|0
7624790|NCT01717326|26531605|P1|Overall Study|Physician Decision|0
7624791|NCT01717326|26531586|P20|Overall Study|Lost to Follow-up|3
7624792|NCT01717326|26531587|P19|Overall Study|Lost to Follow-up|2
7624793|NCT01717326|26531588|P18|Overall Study|Lost to Follow-up|0
7624794|NCT01717326|26531589|P17|Overall Study|Lost to Follow-up|1
7624795|NCT01717326|26531590|P16|Overall Study|Lost to Follow-up|2
7624796|NCT01717326|26531591|P15|Overall Study|Lost to Follow-up|0
7624797|NCT01717326|26531592|P14|Overall Study|Lost to Follow-up|0
7624798|NCT01717326|26531593|P13|Overall Study|Lost to Follow-up|0
7624799|NCT01717326|26531594|P12|Overall Study|Lost to Follow-up|0
7624800|NCT01717326|26531595|P11|Overall Study|Lost to Follow-up|1
7624801|NCT01717326|26531596|P10|Overall Study|Lost to Follow-up|0
7624802|NCT01717326|26531597|P9|Overall Study|Lost to Follow-up|0
7624803|NCT01717326|26531598|P8|Overall Study|Lost to Follow-up|0
7624804|NCT01717326|26531599|P7|Overall Study|Lost to Follow-up|1
7624805|NCT01717326|26531600|P6|Overall Study|Lost to Follow-up|0
7624806|NCT01717326|26531601|P5|Overall Study|Lost to Follow-up|1
7624807|NCT01717326|26531602|P4|Overall Study|Lost to Follow-up|2
7624808|NCT01717326|26531603|P3|Overall Study|Lost to Follow-up|0
7624809|NCT01717326|26531604|P2|Overall Study|Lost to Follow-up|0
7624810|NCT01717326|26531605|P1|Overall Study|Lost to Follow-up|3
7624811|NCT01717326|26531586|P20|Overall Study|Death|0
7624812|NCT01717326|26531587|P19|Overall Study|Death|0
7624813|NCT01717326|26531588|P18|Overall Study|Death|0
7624814|NCT01717326|26531589|P17|Overall Study|Death|0
7624815|NCT01717326|26531590|P16|Overall Study|Death|0
7624816|NCT01717326|26531591|P15|Overall Study|Death|0
7624817|NCT01717326|26531592|P14|Overall Study|Death|0
7624818|NCT01717326|26531593|P13|Overall Study|Death|0
7624819|NCT01717326|26531594|P12|Overall Study|Death|0
7624820|NCT01717326|26531595|P11|Overall Study|Death|1
7624821|NCT01717326|26531596|P10|Overall Study|Death|0
7624822|NCT01717326|26531597|P9|Overall Study|Death|0
7624823|NCT01717326|26531598|P8|Overall Study|Death|0
7624824|NCT01717326|26531599|P7|Overall Study|Death|0
7624825|NCT01717326|26531600|P6|Overall Study|Death|0
7624826|NCT01717326|26531601|P5|Overall Study|Death|0
7624827|NCT01717326|26531602|P4|Overall Study|Death|0
7624828|NCT01717326|26531603|P3|Overall Study|Death|0
7624829|NCT01717326|26531604|P2|Overall Study|Death|0
7624830|NCT01717326|26531605|P1|Overall Study|Death|0
7624831|NCT01717313|26531869|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
7624832|NCT01717313|26531870|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
7624833|NCT01717313|26531869|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
7624834|NCT01717313|26531870|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
7624835|NCT01717313|26531869|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7624836|NCT01717313|26531870|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7624837|NCT01717313|26531869|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
7624838|NCT01717313|26531870|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
7624839|NCT01717313|26531869|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7624840|NCT01717313|26531870|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7624841|NCT01717313|26531869|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
7624842|NCT01717313|26531870|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
7624843|NCT01717313|26531869|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
7624844|NCT01717313|26531870|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
7624845|NCT01717313|26531869|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
7624846|NCT01717313|26531870|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
7624847|NCT01717313|26531869|P2|Phase A (Weeks 0 to 24)|Death|1
7624848|NCT01717313|26531870|P1|Phase A (Weeks 0 to 24)|Death|0
7624849|NCT01717287|26531908|P2|Overall Study|Protocol Violation|1
7624850|NCT01717287|26531909|P1|Overall Study|Protocol Violation|0
7624851|NCT01717287|26531908|P2|Overall Study|Lost to Follow-up|2
7624852|NCT01717287|26531909|P1|Overall Study|Lost to Follow-up|0
7624853|NCT01717040|26531949|P2|Overall Study|New Substance Use Disorder|0
7624854|NCT01717040|26531950|P1|Overall Study|New Substance Use Disorder|1
7624855|NCT01717040|26531949|P2|Overall Study|Required Medication Change|1
7624856|NCT01717040|26531950|P1|Overall Study|Required Medication Change|0
7624857|NCT01717040|26531949|P2|Overall Study|Adverse Event|0
7624858|NCT01717040|26531950|P1|Overall Study|Adverse Event|1
7624859|NCT01717040|26531949|P2|Overall Study|Lack of Efficacy|1
7624860|NCT01717040|26531950|P1|Overall Study|Lack of Efficacy|1
7624861|NCT01717040|26531949|P2|Overall Study|Lost to Follow-up|3
7624862|NCT01717040|26531950|P1|Overall Study|Lost to Follow-up|2
7624863|NCT01716754|26531977|P4|Overall Study|Withdrawal by Subject|3
7624864|NCT01716754|26531978|P3|Overall Study|Withdrawal by Subject|4
7624865|NCT01716754|26531979|P2|Overall Study|Withdrawal by Subject|0
7624866|NCT01716754|26531980|P1|Overall Study|Withdrawal by Subject|5
7624867|NCT01716754|26531977|P4|Overall Study|Adverse Event|1
7624868|NCT01716754|26531978|P3|Overall Study|Adverse Event|2
7624869|NCT01716754|26531979|P2|Overall Study|Adverse Event|2
7624870|NCT01716754|26531980|P1|Overall Study|Adverse Event|4
7624871|NCT01716754|26531977|P4|Overall Study|Lost to Follow-up|1
7624872|NCT01716754|26531978|P3|Overall Study|Lost to Follow-up|0
7624873|NCT01716754|26531979|P2|Overall Study|Lost to Follow-up|0
7624874|NCT01716754|26531980|P1|Overall Study|Lost to Follow-up|1
7624875|NCT01716754|26531977|P4|Overall Study|Physician Decision|0
7624876|NCT01716754|26531978|P3|Overall Study|Physician Decision|0
7624877|NCT01716754|26531979|P2|Overall Study|Physician Decision|0
7624878|NCT01716754|26531980|P1|Overall Study|Physician Decision|1
7624879|NCT01716754|26531977|P4|Overall Study|Non-compliance with study treatment|0
7624880|NCT01716754|26531978|P3|Overall Study|Non-compliance with study treatment|1
7624881|NCT01716754|26531979|P2|Overall Study|Non-compliance with study treatment|0
7624882|NCT01716754|26531980|P1|Overall Study|Non-compliance with study treatment|0
7624883|NCT01716754|26531977|P4|Overall Study|Protocol deviation|2
7624884|NCT01716754|26531978|P3|Overall Study|Protocol deviation|7
7624885|NCT01716754|26531979|P2|Overall Study|Protocol deviation|2
7624886|NCT01716754|26531980|P1|Overall Study|Protocol deviation|0
7624887|NCT01716754|26531977|P4|Overall Study|Death|1
7624888|NCT01716754|26531978|P3|Overall Study|Death|0
7624889|NCT01716754|26531979|P2|Overall Study|Death|0
7624890|NCT01716754|26531980|P1|Overall Study|Death|0
7624891|NCT01716715|26532003|P2|Overall Study|Never Treated|4
7624892|NCT01716715|26532004|P1|Overall Study|Never Treated|2
7624893|NCT01716663|26532020|P1|Overall Study|Treated with non-study catheter|2
7624894|NCT01716663|26532020|P1|Overall Study|Withdrawn prior to procedure|4
7624895|NCT01716585|26532030|P2|Open-label Treatment|Withdrawal by Subject|3
7624896|NCT01716585|26532031|P1|Open-label Treatment|Withdrawal by Subject|0
7624897|NCT01716585|26532030|P2|Open-label Treatment|Virologic Failure|2
7624898|NCT01716585|26532031|P1|Open-label Treatment|Virologic Failure|0
7624899|NCT01716585|26532030|P2|Open-label Treatment|Adverse Event|2
7624900|NCT01716585|26532031|P1|Open-label Treatment|Adverse Event|0
7624901|NCT01716585|26532030|P2|Double-blind Treatment|Other|0
7624902|NCT01716585|26532031|P1|Double-blind Treatment|Other|1
7624903|NCT01716585|26532030|P2|Double-blind Treatment|Subject Noncompliant|0
7624904|NCT01716585|26532031|P1|Double-blind Treatment|Subject Noncompliant|1
7624905|NCT01716585|26532030|P2|Double-blind Treatment|Lost to Follow-up|0
7624906|NCT01716585|26532031|P1|Double-blind Treatment|Lost to Follow-up|2
7624907|NCT01716585|26532030|P2|Double-blind Treatment|Withdrawal by Subject|0
7624908|NCT01716585|26532031|P1|Double-blind Treatment|Withdrawal by Subject|3
7624909|NCT01716585|26532030|P2|Double-blind Treatment|Adverse Event|1
7624910|NCT01716585|26532031|P1|Double-blind Treatment|Adverse Event|2
7624911|NCT01716585|26532030|P2|Double-blind Treatment|Did Not Receive Study Drug|1
7624912|NCT01716585|26532031|P1|Double-blind Treatment|Did Not Receive Study Drug|4
7624913|NCT01716559|26532043|P1|Overall Study|Other withdrawal reason|75
7624914|NCT01716559|26532043|P1|Overall Study|Withdrawal by Subject|4
7624915|NCT01716559|26532043|P1|Overall Study|Death|21
7624916|NCT01716559|26532043|P1|Overall Study|Adverse Event|11
7624917|NCT01716533|26532055|P4|Overall Study|Immunosuppressants>14days past 6months|1
7624918|NCT01716533|26532056|P3|Overall Study|Immunosuppressants>14days past 6months|0
7624919|NCT01716533|26532057|P2|Overall Study|Immunosuppressants>14days past 6months|0
7624920|NCT01716533|26532058|P1|Overall Study|Immunosuppressants>14days past 6months|0
7624921|NCT01716533|26532055|P4|Overall Study|Death|2
7624922|NCT01716533|26532056|P3|Overall Study|Death|0
7624923|NCT01716533|26532057|P2|Overall Study|Death|0
7624924|NCT01716533|26532058|P1|Overall Study|Death|0
7624925|NCT01716533|26532055|P4|Overall Study|Withdrawal by Subject|5
7624926|NCT01716533|26532056|P3|Overall Study|Withdrawal by Subject|0
7624927|NCT01716533|26532057|P2|Overall Study|Withdrawal by Subject|0
7624928|NCT01716533|26532058|P1|Overall Study|Withdrawal by Subject|0
7624929|NCT01716533|26532055|P4|Overall Study|Failure of antibiotic treatment to treat|0
7624930|NCT01716533|26532056|P3|Overall Study|Failure of antibiotic treatment to treat|5
7624931|NCT01716533|26532057|P2|Overall Study|Failure of antibiotic treatment to treat|0
7624932|NCT01716533|26532058|P1|Overall Study|Failure of antibiotic treatment to treat|0
7624933|NCT01716520|26532112|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7624934|NCT01716520|26532113|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7624935|NCT01716520|26532114|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7624936|NCT01716520|26532115|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7624937|NCT01716520|26532116|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7624938|NCT01716520|26532117|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7624939|NCT01716520|26532112|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
7624940|NCT01716520|26532113|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7624941|NCT01716520|26532114|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7624942|NCT01716520|26532115|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7624943|NCT01716520|26532116|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7624944|NCT01716520|26532117|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7624945|NCT01716520|26532112|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7624946|NCT01716520|26532113|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7624947|NCT01716520|26532114|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7624948|NCT01716520|26532115|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7624949|NCT01716520|26532116|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
7624950|NCT01716520|26532117|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7624951|NCT01716520|26532112|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
7624952|NCT01716520|26532113|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7624953|NCT01716520|26532114|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7624954|NCT01716520|26532115|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7624955|NCT01716520|26532116|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7624956|NCT01716520|26532117|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7624957|NCT01716520|26532112|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7624958|NCT01716520|26532113|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7624959|NCT01716520|26532114|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7624960|NCT01716520|26532115|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7624961|NCT01716520|26532116|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7624962|NCT01716520|26532117|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
7624963|NCT01716520|26532112|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7624964|NCT01716520|26532113|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7624965|NCT01716520|26532114|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7624966|NCT01716520|26532115|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7624967|NCT01716520|26532116|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7624968|NCT01716520|26532117|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7624969|NCT01716520|26532112|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7624970|NCT01716520|26532113|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7624971|NCT01716520|26532114|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
7624972|NCT01716520|26532115|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7624973|NCT01716520|26532116|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7624974|NCT01716520|26532117|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7624975|NCT01716520|26532112|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
7624976|NCT01716520|26532113|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
7624977|NCT01716520|26532114|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
7624978|NCT01716520|26532115|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
7624979|NCT01716520|26532116|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
7624980|NCT01716520|26532117|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
7624981|NCT01716520|26532112|P6|Treatment Period 2 (14 Days)|Adverse Event|0
7624982|NCT01716520|26532113|P5|Treatment Period 2 (14 Days)|Adverse Event|1
7624983|NCT01716520|26532114|P4|Treatment Period 2 (14 Days)|Adverse Event|0
7624984|NCT01716520|26532115|P3|Treatment Period 2 (14 Days)|Adverse Event|0
7624985|NCT01716520|26532116|P2|Treatment Period 2 (14 Days)|Adverse Event|0
7624986|NCT01716520|26532117|P1|Treatment Period 2 (14 Days)|Adverse Event|0
7624987|NCT01716520|26532112|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7624988|NCT01716520|26532113|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7624989|NCT01716520|26532114|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7624990|NCT01716520|26532115|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7624991|NCT01716520|26532116|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7624992|NCT01716520|26532117|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7624993|NCT01716520|26532112|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7624994|NCT01716520|26532113|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7624995|NCT01716520|26532114|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7624996|NCT01716520|26532115|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7624997|NCT01716520|26532116|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7624998|NCT01716520|26532117|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7624999|NCT01716520|26532112|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7625000|NCT01716520|26532113|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7625001|NCT01716520|26532114|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7625002|NCT01716520|26532115|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7625003|NCT01716520|26532116|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
7625004|NCT01716520|26532117|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7625005|NCT01716520|26532112|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7625006|NCT01716520|26532113|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7625007|NCT01716520|26532114|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7625008|NCT01716520|26532115|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7625009|NCT01716520|26532116|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7625010|NCT01716520|26532117|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7625011|NCT01716520|26532112|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7625012|NCT01716520|26532113|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7625013|NCT01716520|26532114|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7625014|NCT01716520|26532115|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
7625015|NCT01716520|26532116|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7625016|NCT01716520|26532117|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7625017|NCT01716520|26532112|P6|Treatment Period 1 (14 Days)|Adverse Event|0
7625018|NCT01716520|26532113|P5|Treatment Period 1 (14 Days)|Adverse Event|0
7625019|NCT01716520|26532114|P4|Treatment Period 1 (14 Days)|Adverse Event|0
7625020|NCT01716520|26532115|P3|Treatment Period 1 (14 Days)|Adverse Event|0
7625021|NCT01716520|26532116|P2|Treatment Period 1 (14 Days)|Adverse Event|0
7625022|NCT01716520|26532117|P1|Treatment Period 1 (14 Days)|Adverse Event|1
7625023|NCT01716234|26532172|P7|Overall Study|Withdrawal by Subject|0
7625024|NCT01716234|26532173|P6|Overall Study|Withdrawal by Subject|3
7625025|NCT01716234|26532174|P5|Overall Study|Withdrawal by Subject|1
7625026|NCT01716234|26532175|P4|Overall Study|Withdrawal by Subject|2
7625027|NCT01716234|26532176|P3|Overall Study|Withdrawal by Subject|2
7625028|NCT01716234|26532177|P2|Overall Study|Withdrawal by Subject|0
7625029|NCT01716234|26532178|P1|Overall Study|Withdrawal by Subject|3
7625030|NCT01716234|26532172|P7|Overall Study|Adverse Event|0
7625031|NCT01716234|26532173|P6|Overall Study|Adverse Event|6
7625032|NCT01716234|26532174|P5|Overall Study|Adverse Event|3
7625033|NCT01716234|26532175|P4|Overall Study|Adverse Event|8
7625034|NCT01716234|26532176|P3|Overall Study|Adverse Event|2
7625035|NCT01716234|26532177|P2|Overall Study|Adverse Event|10
7625036|NCT01716234|26532178|P1|Overall Study|Adverse Event|7
7625037|NCT01716234|26532172|P7|Overall Study|Did not meet protocol eligibility|0
7625038|NCT01716234|26532173|P6|Overall Study|Did not meet protocol eligibility|4
7625039|NCT01716234|26532174|P5|Overall Study|Did not meet protocol eligibility|0
7625040|NCT01716234|26532175|P4|Overall Study|Did not meet protocol eligibility|0
7625041|NCT01716234|26532176|P3|Overall Study|Did not meet protocol eligibility|1
7625042|NCT01716234|26532177|P2|Overall Study|Did not meet protocol eligibility|0
7625043|NCT01716234|26532178|P1|Overall Study|Did not meet protocol eligibility|0
7625044|NCT01716234|26532172|P7|Overall Study|Lack of Efficacy|0
7625045|NCT01716234|26532173|P6|Overall Study|Lack of Efficacy|0
7625046|NCT01716234|26532174|P5|Overall Study|Lack of Efficacy|0
7625047|NCT01716234|26532175|P4|Overall Study|Lack of Efficacy|1
7625048|NCT01716234|26532176|P3|Overall Study|Lack of Efficacy|0
7625049|NCT01716234|26532177|P2|Overall Study|Lack of Efficacy|0
7625050|NCT01716234|26532178|P1|Overall Study|Lack of Efficacy|0
7625051|NCT01716234|26532172|P7|Overall Study|Protocol Violation|0
7625052|NCT01716234|26532173|P6|Overall Study|Protocol Violation|1
7625053|NCT01716234|26532174|P5|Overall Study|Protocol Violation|1
7625054|NCT01716234|26532175|P4|Overall Study|Protocol Violation|1
7625055|NCT01716234|26532176|P3|Overall Study|Protocol Violation|0
7625056|NCT01716234|26532177|P2|Overall Study|Protocol Violation|0
7625057|NCT01716234|26532178|P1|Overall Study|Protocol Violation|0
7625058|NCT01716169|26532254|P1|Overall Study|inconsistent dressing application|1
7625059|NCT01716169|26532254|P1|Overall Study|Withdrawal by Subject|1
7625060|NCT01716169|26532254|P1|Overall Study|Lost to Follow-up|1
7625061|NCT01716169|26532254|P1|Overall Study|Adverse Event|1
7625062|NCT01716156|26532263|P3|Overall Study|Lost to Follow-up|0
7625063|NCT01716156|26532264|P2|Overall Study|Lost to Follow-up|0
7625064|NCT01716156|26532265|P1|Overall Study|Lost to Follow-up|1
7625065|NCT01716156|26532263|P3|Overall Study|Withdrawal by Subject|2
7625066|NCT01716156|26532264|P2|Overall Study|Withdrawal by Subject|1
7625067|NCT01716156|26532265|P1|Overall Study|Withdrawal by Subject|0
7625068|NCT01716156|26532263|P3|Overall Study|Protocol Violation|0
7625069|NCT01716156|26532264|P2|Overall Study|Protocol Violation|0
7625070|NCT01716156|26532265|P1|Overall Study|Protocol Violation|1
7625071|NCT01716117|26532291|P2|Overall Study|Withdrawal by Subject|0
7625072|NCT01716117|26532292|P1|Overall Study|Withdrawal by Subject|2
7625073|NCT01716117|26532291|P2|Overall Study|Death|2
7625074|NCT01716117|26532292|P1|Overall Study|Death|5
7625075|NCT01716104|26532311|P2|Overall Study|Do not meet inclusion criteria|7
7625076|NCT01716104|26532312|P1|Overall Study|Do not meet inclusion criteria|6
7625077|NCT01716052|26532338|P2|Overall Study|Withdrawal of funding|1
7625078|NCT01716052|26532339|P1|Overall Study|Withdrawal of funding|1
7625079|NCT01715896|26532397|P2|Overall Study|Other|5
7625080|NCT01715896|26532398|P1|Overall Study|Other|2
7625081|NCT01715896|26532397|P2|Overall Study|Withdrawal by Subject|4
7625082|NCT01715896|26532398|P1|Overall Study|Withdrawal by Subject|1
7625083|NCT01715896|26532397|P2|Overall Study|Lost to Follow-up|2
7625084|NCT01715896|26532398|P1|Overall Study|Lost to Follow-up|0
7625085|NCT01715857|26532471|P1|Overall Study|Did Not Meet Eligibility Criteria|96
7625086|NCT01715831|26532481|P1|Overall Study|Adverse Event|1
7625087|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7625088|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7625089|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
7625090|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7625091|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
7625092|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7625093|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
7625094|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7625095|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
7625096|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
7625097|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
7625098|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
7625099|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
7625100|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
7625101|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
7625102|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
7625103|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Protocol Violation|19
7625104|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Protocol Violation|12
7625105|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Protocol Violation|14
7625106|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Protocol Violation|0
7625107|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Adverse Event|2
7625187|NCT01715285|26532579|P3|Treatment Period|Lost to Follow-up|0
7625108|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Adverse Event|23
7625109|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Adverse Event|3
7625110|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Adverse Event|0
7625111|NCT01715805|26532497|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
7625112|NCT01715805|26532498|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7625113|NCT01715805|26532499|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7625114|NCT01715805|26532500|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7625115|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7625116|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7625117|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7625118|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
7625119|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7625120|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7625121|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7625122|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
7625123|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7625124|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7625125|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7625126|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
7625127|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7625128|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7625129|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7625130|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
7625131|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
7625132|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
7625133|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
7625134|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
7625135|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7625136|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7625137|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7625138|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
7625139|NCT01715805|26532497|P4|Placebo + ADT Lead-in Period|Adverse Event|0
7625140|NCT01715805|26532498|P3|Placebo + ADT Lead-in Period|Adverse Event|0
7625141|NCT01715805|26532499|P2|Placebo + ADT Lead-in Period|Adverse Event|0
7625142|NCT01715805|26532500|P1|Placebo + ADT Lead-in Period|Adverse Event|41
7625143|NCT01715571|26532512|P1|Overall Study|Lost to Follow-up|8
7625144|NCT01715415|26532525|P2|Open-label Treatment|Subject Noncompliant|1
7625145|NCT01715415|26532526|P1|Open-label Treatment|Subject Noncompliant|0
7625146|NCT01715415|26532525|P2|Open-label Treatment|Adverse Event|1
7625147|NCT01715415|26532526|P1|Open-label Treatment|Adverse Event|0
7625148|NCT01715415|26532525|P2|Double-blind Treatment|Other|0
7625149|NCT01715415|26532526|P1|Double-blind Treatment|Other|1
7625150|NCT01715415|26532525|P2|Double-blind Treatment|Withdrawal by Subject|1
7625151|NCT01715415|26532526|P1|Double-blind Treatment|Withdrawal by Subject|1
7625152|NCT01715415|26532525|P2|Double-blind Treatment|Adverse Event|0
7625153|NCT01715415|26532526|P1|Double-blind Treatment|Adverse Event|3
7625154|NCT01715415|26532525|P2|Double-blind Treatment|Did Not Receive Study Drug|1
7625155|NCT01715415|26532526|P1|Double-blind Treatment|Did Not Receive Study Drug|0
7625156|NCT01715298|26532540|P2|Overall Study|Patient/guardian decision|9
7625157|NCT01715298|26532541|P1|Overall Study|Patient/guardian decision|7
7625158|NCT01715298|26532540|P2|Overall Study|Lost to Follow-up|2
7625159|NCT01715298|26532541|P1|Overall Study|Lost to Follow-up|0
7625160|NCT01715285|26532579|P3|Open-label (OL) Extension Phase|Ongoing|72
7625161|NCT01715285|26532580|P2|Open-label (OL) Extension Phase|Ongoing|0
7625162|NCT01715285|26532581|P1|Open-label (OL) Extension Phase|Ongoing|157
7625163|NCT01715285|26532579|P3|Treatment Period|Placebo Cross-over|0
7625164|NCT01715285|26532580|P2|Treatment Period|Placebo Cross-over|72
7625165|NCT01715285|26532581|P1|Treatment Period|Placebo Cross-over|0
7625166|NCT01715285|26532579|P3|Treatment Period|Other|0
7625167|NCT01715285|26532580|P2|Treatment Period|Other|12
7625168|NCT01715285|26532581|P1|Treatment Period|Other|10
7625169|NCT01715285|26532579|P3|Treatment Period|Ongoing|0
7625170|NCT01715285|26532580|P2|Treatment Period|Ongoing|0
7625171|NCT01715285|26532581|P1|Treatment Period|Ongoing|157
7625172|NCT01715285|26532579|P3|Treatment Period|Physician Decision|0
7625173|NCT01715285|26532580|P2|Treatment Period|Physician Decision|23
7625174|NCT01715285|26532581|P1|Treatment Period|Physician Decision|21
7625175|NCT01715285|26532579|P3|Treatment Period|Withdrawal Of Consent|0
7625176|NCT01715285|26532580|P2|Treatment Period|Withdrawal Of Consent|47
7625177|NCT01715285|26532581|P1|Treatment Period|Withdrawal Of Consent|52
7625178|NCT01715285|26532579|P3|Treatment Period|Progressive Disease|0
7625179|NCT01715285|26532580|P2|Treatment Period|Progressive Disease|388
7625180|NCT01715285|26532581|P1|Treatment Period|Progressive Disease|254
7625181|NCT01715285|26532579|P3|Treatment Period|Noncompliance With Study Drug|0
7625182|NCT01715285|26532580|P2|Treatment Period|Noncompliance With Study Drug|2
7625183|NCT01715285|26532581|P1|Treatment Period|Noncompliance With Study Drug|4
7625184|NCT01715285|26532579|P3|Treatment Period|Death|0
7625185|NCT01715285|26532580|P2|Treatment Period|Death|23
7625186|NCT01715285|26532581|P1|Treatment Period|Death|36
7625188|NCT01715285|26532580|P2|Treatment Period|Lost to Follow-up|2
7625189|NCT01715285|26532581|P1|Treatment Period|Lost to Follow-up|3
7625190|NCT01715285|26532579|P3|Treatment Period|Adverse Event|0
7625191|NCT01715285|26532580|P2|Treatment Period|Adverse Event|33
7625192|NCT01715285|26532581|P1|Treatment Period|Adverse Event|60
7625193|NCT01715129|26532617|P1|Overall Study|Other|1
7625194|NCT01715129|26532617|P1|Overall Study|Lost to Follow-up|1
7625195|NCT01715129|26532617|P1|Overall Study|Consent Withdrawn|2
7625196|NCT01715129|26532617|P1|Overall Study|Protocol Violation|1
7625197|NCT01715129|26532617|P1|Overall Study|Lack of Efficacy|3
7625198|NCT01715129|26532617|P1|Overall Study|Adverse Event, fatal|1
7625199|NCT01714947|26532643|P1|Part B|Progressive Disease|3
7625200|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Study was terminated|1
7625201|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Study was terminated|0
7625202|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
7625203|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
7625204|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Absence of renal response|1
7625205|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Absence of renal response|0
7625206|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
7625207|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
7625208|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
7625209|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
7625210|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Study drug toxicity|0
7625211|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Study drug toxicity|1
7625212|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Pregnancy|0
7625213|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Pregnancy|1
7625214|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Lost to Follow-up|1
7625215|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Lost to Follow-up|0
7625216|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
7625217|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
7625218|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7625219|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7625220|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7625221|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7625222|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Not effective|1
7625223|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Not effective|0
7625224|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Disease progression|4
7625225|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Disease progression|1
7625226|NCT01714817|26532684|P2|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
7625227|NCT01714817|26532685|P1|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
7625228|NCT01714817|26532684|P2|Year 2 Period|Given cyclophosphamide, corticosteroids|1
7625229|NCT01714817|26532685|P1|Year 2 Period|Given cyclophosphamide, corticosteroids|0
7625230|NCT01714817|26532684|P2|Year 2 Period|Completed Year 1, did not enter Year 2|1
7625231|NCT01714817|26532685|P1|Year 2 Period|Completed Year 1, did not enter Year 2|2
7625232|NCT01714817|26532684|P2|Year 2 Period|Pregnancy|1
7625233|NCT01714817|26532685|P1|Year 2 Period|Pregnancy|1
7625234|NCT01714817|26532684|P2|Year 2 Period|Participant went to US stopped treatment|1
7625235|NCT01714817|26532685|P1|Year 2 Period|Participant went to US stopped treatment|0
7625236|NCT01714817|26532684|P2|Year 2 Period|Lost to Follow-up|0
7625237|NCT01714817|26532685|P1|Year 2 Period|Lost to Follow-up|2
7625238|NCT01714817|26532684|P2|Year 2 Period|Participant no longer meets criteria|4
7625239|NCT01714817|26532685|P1|Year 2 Period|Participant no longer meets criteria|1
7625240|NCT01714817|26532684|P2|Year 2 Period|Participant withdrew consent|5
7625241|NCT01714817|26532685|P1|Year 2 Period|Participant withdrew consent|1
7625242|NCT01714817|26532684|P2|Year 2 Period|Administrative reason by Sponsor|3
7625243|NCT01714817|26532685|P1|Year 2 Period|Administrative reason by Sponsor|4
7625244|NCT01714817|26532684|P2|Year 2 Period|Participant request to stop treatment|4
7625245|NCT01714817|26532685|P1|Year 2 Period|Participant request to stop treatment|4
7625246|NCT01714817|26532684|P2|Year 2 Period|Adverse Event|6
7625247|NCT01714817|26532685|P1|Year 2 Period|Adverse Event|7
7625248|NCT01714817|26532684|P2|Year 2 Period|Lack of Efficacy|12
7625249|NCT01714817|26532685|P1|Year 2 Period|Lack of Efficacy|4
7625250|NCT01714817|26532684|P2|Year 1 Period|Hypersensitivity to the medication|1
7625251|NCT01714817|26532685|P1|Year 1 Period|Hypersensitivity to the medication|0
7625252|NCT01714817|26532684|P2|Year 1 Period|Antiproteinuric changed/dose increased|1
7625253|NCT01714817|26532685|P1|Year 1 Period|Antiproteinuric changed/dose increased|0
7625254|NCT01714817|26532684|P2|Year 1 Period|Need of use of Prohibited Medications|0
7625255|NCT01714817|26532685|P1|Year 1 Period|Need of use of Prohibited Medications|1
7625256|NCT01714817|26532684|P2|Year 1 Period|Change in Concomitant Medication|1
7625257|NCT01714817|26532685|P1|Year 1 Period|Change in Concomitant Medication|0
7625258|NCT01714817|26532684|P2|Year 1 Period|Not treated- received ACE inhibition|0
7625259|NCT01714817|26532685|P1|Year 1 Period|Not treated- received ACE inhibition|1
7625260|NCT01714817|26532684|P2|Year 1 Period|Participant no longer meets criteria|2
7625261|NCT01714817|26532685|P1|Year 1 Period|Participant no longer meets criteria|6
7625262|NCT01714817|26532684|P2|Year 1 Period|Pregnancy|0
7625263|NCT01714817|26532685|P1|Year 1 Period|Pregnancy|2
7625264|NCT01714817|26532684|P2|Year 1 Period|Poor / non-compliance|1
7625265|NCT01714817|26532685|P1|Year 1 Period|Poor / non-compliance|0
7625266|NCT01714817|26532684|P2|Year 1 Period|Lost to Follow-up|2
7625267|NCT01714817|26532685|P1|Year 1 Period|Lost to Follow-up|0
7625268|NCT01714817|26532684|P2|Year 1 Period|Death|1
7625269|NCT01714817|26532685|P1|Year 1 Period|Death|1
7625270|NCT01714817|26532684|P2|Year 1 Period|Withdrawal by Subject|7
7625271|NCT01714817|26532685|P1|Year 1 Period|Withdrawal by Subject|6
7625272|NCT01714817|26532684|P2|Year 1 Period|Adverse Event|17
7625273|NCT01714817|26532685|P1|Year 1 Period|Adverse Event|20
7625274|NCT01714817|26532684|P2|Year 1 Period|Lack of Efficacy|9
7625275|NCT01714817|26532685|P1|Year 1 Period|Lack of Efficacy|11
7625276|NCT01714726|26532792|P4|Open-Label Period|Lost to Follow-up|4
7625277|NCT01714726|26532793|P3|Open-Label Period|Lost to Follow-up|3
7625278|NCT01714726|26532794|P2|Open-Label Period|Lost to Follow-up|0
7625279|NCT01714726|26532795|P1|Open-Label Period|Lost to Follow-up|0
7625280|NCT01714726|26532792|P4|Open-Label Period|Developed specific withdrawal criteria|2
7625281|NCT01714726|26532793|P3|Open-Label Period|Developed specific withdrawal criteria|5
7625282|NCT01714726|26532794|P2|Open-Label Period|Developed specific withdrawal criteria|0
7625283|NCT01714726|26532795|P1|Open-Label Period|Developed specific withdrawal criteria|0
7625284|NCT01714726|26532792|P4|Open-Label Period|Withdrawal by Subject|19
7625285|NCT01714726|26532793|P3|Open-Label Period|Withdrawal by Subject|9
7625286|NCT01714726|26532794|P2|Open-Label Period|Withdrawal by Subject|0
7625287|NCT01714726|26532795|P1|Open-Label Period|Withdrawal by Subject|0
7625288|NCT01714726|26532792|P4|Open-Label Period|Adverse Event|0
7625289|NCT01714726|26532793|P3|Open-Label Period|Adverse Event|1
7625290|NCT01714726|26532794|P2|Open-Label Period|Adverse Event|0
7625291|NCT01714726|26532795|P1|Open-Label Period|Adverse Event|0
7625292|NCT01714726|26532792|P4|Open-Label Period|Other|3
7625293|NCT01714726|26532793|P3|Open-Label Period|Other|1
7625294|NCT01714726|26532794|P2|Open-Label Period|Other|0
7625295|NCT01714726|26532795|P1|Open-Label Period|Other|0
7625296|NCT01714726|26532792|P4|Double-Blinded Induction Period|Lost to Follow-up|0
7625297|NCT01714726|26532793|P3|Double-Blinded Induction Period|Lost to Follow-up|0
7625298|NCT01714726|26532794|P2|Double-Blinded Induction Period|Lost to Follow-up|2
7625299|NCT01714726|26532795|P1|Double-Blinded Induction Period|Lost to Follow-up|0
7625300|NCT01714726|26532792|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
7625301|NCT01714726|26532793|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
7625302|NCT01714726|26532794|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
7625303|NCT01714726|26532795|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
7625304|NCT01714726|26532792|P4|Double-Blinded Induction Period|Adverse Event|0
7625305|NCT01714726|26532793|P3|Double-Blinded Induction Period|Adverse Event|0
7625306|NCT01714726|26532794|P2|Double-Blinded Induction Period|Adverse Event|1
7625307|NCT01714726|26532795|P1|Double-Blinded Induction Period|Adverse Event|0
7625308|NCT01714726|26532792|P4|Double-Blinded Induction Period|Subject not in open label period|0
7625309|NCT01714726|26532793|P3|Double-Blinded Induction Period|Subject not in open label period|0
7625310|NCT01714726|26532794|P2|Double-Blinded Induction Period|Subject not in open label period|1
7625311|NCT01714726|26532795|P1|Double-Blinded Induction Period|Subject not in open label period|3
7625312|NCT01714687|26532875|P2|Overall Study|Lost to Follow-up|4
7625313|NCT01714687|26532876|P1|Overall Study|Lost to Follow-up|2
7625314|NCT01714687|26532875|P2|Overall Study|Withdrawal by Subject|0
7625315|NCT01714687|26532876|P1|Overall Study|Withdrawal by Subject|1
7625316|NCT01714635|26532900|P3|Overall Study|Missed 6-month exam|0
7625317|NCT01714635|26532901|P2|Overall Study|Missed 6-month exam|0
7625318|NCT01714635|26532902|P1|Overall Study|Missed 6-month exam|1
7625319|NCT01714635|26532900|P3|Overall Study|Discontinued|2
7625320|NCT01714635|26532901|P2|Overall Study|Discontinued|0
7625321|NCT01714635|26532902|P1|Overall Study|Discontinued|1
7625322|NCT01714609|26532918|P2|Overall Study|Protocol Violation|0
7625323|NCT01714609|26532919|P1|Overall Study|Protocol Violation|1
7625324|NCT01714544|26532925|P1|Overall Study|Withdrawal by Subject|1
7625325|NCT01714544|26532925|P1|Overall Study|Physician Decision|1
7625326|NCT01714544|26532925|P1|Overall Study|Lost to Follow-up|1
7625327|NCT01714310|26532996|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
7625328|NCT01714310|26532997|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
7625329|NCT01714310|26532998|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
7625330|NCT01714310|26532996|P3|Double Blind Adjunctive Treatment|Adverse Event|0
7625331|NCT01714310|26532997|P2|Double Blind Adjunctive Treatment|Adverse Event|1
7625332|NCT01714310|26532998|P1|Double Blind Adjunctive Treatment|Adverse Event|1
7625333|NCT01714310|26532996|P3|Open Lisdexamfetamine Titration|Adverse Event|3
7625334|NCT01714310|26532997|P2|Open Lisdexamfetamine Titration|Adverse Event|0
7625335|NCT01714310|26532998|P1|Open Lisdexamfetamine Titration|Adverse Event|0
7625336|NCT01714310|26532996|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
7625337|NCT01714310|26532997|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
7625338|NCT01714310|26532998|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
7625339|NCT01714063|26533051|P1|Overall Study|Equipment malfunction|2
7625340|NCT01713998|26533088|P3|Overall Study|Withdrawal by Subject|0
7625341|NCT01713998|26533089|P2|Overall Study|Withdrawal by Subject|0
7625342|NCT01713998|26533090|P1|Overall Study|Withdrawal by Subject|1
7625343|NCT01713998|26533088|P3|Overall Study|Lost to Follow-up|2
7625344|NCT01713998|26533089|P2|Overall Study|Lost to Follow-up|0
7625345|NCT01713998|26533090|P1|Overall Study|Lost to Follow-up|2
7625346|NCT01713946|26533111|P3|Overall Study|Patients never switched to everolimus|5
7625347|NCT01713946|26533112|P2|Overall Study|Patients never switched to everolimus|0
7625348|NCT01713946|26533113|P1|Overall Study|Patients never switched to everolimus|0
7625349|NCT01713946|26533111|P3|Overall Study|Did not continue in Post-Ext. Phase|0
7625350|NCT01713946|26533112|P2|Overall Study|Did not continue in Post-Ext. Phase|2
7625351|NCT01713946|26533113|P1|Overall Study|Did not continue in Post-Ext. Phase|1
7625352|NCT01713946|26533111|P3|Overall Study|Did not continue in Ext|0
7625353|NCT01713946|26533112|P2|Overall Study|Did not continue in Ext|3
7625354|NCT01713946|26533113|P1|Overall Study|Did not continue in Ext|0
7625355|NCT01713946|26533111|P3|Overall Study|Administrative problems|0
7625356|NCT01713946|26533112|P2|Overall Study|Administrative problems|0
7625357|NCT01713946|26533113|P1|Overall Study|Administrative problems|1
7625358|NCT01713946|26533111|P3|Overall Study|Lost to Follow-up|1
7625359|NCT01713946|26533112|P2|Overall Study|Lost to Follow-up|0
7625360|NCT01713946|26533113|P1|Overall Study|Lost to Follow-up|0
7625361|NCT01713946|26533111|P3|Overall Study|Protocol Violation|1
7625362|NCT01713946|26533112|P2|Overall Study|Protocol Violation|4
7625363|NCT01713946|26533113|P1|Overall Study|Protocol Violation|2
7625364|NCT01713946|26533111|P3|Overall Study|Lack of Efficacy|14
7625365|NCT01713946|26533112|P2|Overall Study|Lack of Efficacy|8
7625366|NCT01713946|26533113|P1|Overall Study|Lack of Efficacy|8
7625367|NCT01713946|26533111|P3|Overall Study|Withdrawal by Subject|8
7625368|NCT01713946|26533112|P2|Overall Study|Withdrawal by Subject|12
7625369|NCT01713946|26533113|P1|Overall Study|Withdrawal by Subject|12
7625370|NCT01713946|26533111|P3|Overall Study|Adverse Event|13
7625371|NCT01713946|26533112|P2|Overall Study|Adverse Event|14
7625372|NCT01713946|26533113|P1|Overall Study|Adverse Event|19
7625373|NCT01713946|26533111|P3|Overall Study|Death|2
7625374|NCT01713946|26533112|P2|Overall Study|Death|2
7625375|NCT01713946|26533113|P1|Overall Study|Death|0
7625376|NCT01713933|26533204|P1|Overall Study|Excluded from analysis as a BMI outlier|1
7625377|NCT01713933|26533204|P1|Overall Study|Withdrawal by Subject|3
7625378|NCT01713933|26533204|P1|Overall Study|Lost to Follow-up|2
7625379|NCT01713686|26533253|P1|Overall Study|Withdrawal by Subject|6
7625380|NCT01713686|26533253|P1|Overall Study|Lost to Follow-up|9
7625381|NCT01713582|26533323|P21|Overall Study|Disease progression and adverse event|0
7625382|NCT01713582|26533324|P20|Overall Study|Disease progression and adverse event|0
7625383|NCT01713582|26533325|P19|Overall Study|Disease progression and adverse event|0
7625384|NCT01713582|26533326|P18|Overall Study|Disease progression and adverse event|0
7625385|NCT01713582|26533327|P17|Overall Study|Disease progression and adverse event|1
7625386|NCT01713582|26533328|P16|Overall Study|Disease progression and adverse event|0
7625387|NCT01713582|26533329|P15|Overall Study|Disease progression and adverse event|0
7625388|NCT01713582|26533330|P14|Overall Study|Disease progression and adverse event|0
7625389|NCT01713582|26533331|P13|Overall Study|Disease progression and adverse event|0
7625390|NCT01713582|26533332|P12|Overall Study|Disease progression and adverse event|0
7625391|NCT01713582|26533333|P11|Overall Study|Disease progression and adverse event|0
7625392|NCT01713582|26533334|P10|Overall Study|Disease progression and adverse event|0
7625393|NCT01713582|26533335|P9|Overall Study|Disease progression and adverse event|0
7625394|NCT01713582|26533336|P8|Overall Study|Disease progression and adverse event|0
7625395|NCT01713582|26533337|P7|Overall Study|Disease progression and adverse event|0
7625396|NCT01713582|26533338|P6|Overall Study|Disease progression and adverse event|0
7625397|NCT01713582|26533339|P5|Overall Study|Disease progression and adverse event|0
7625398|NCT01713582|26533340|P4|Overall Study|Disease progression and adverse event|0
7625399|NCT01713582|26533341|P3|Overall Study|Disease progression and adverse event|0
7625400|NCT01713582|26533342|P2|Overall Study|Disease progression and adverse event|0
7625401|NCT01713582|26533343|P1|Overall Study|Disease progression and adverse event|0
7625402|NCT01713582|26533323|P21|Overall Study|Stopped to receive bone marrow graft|0
7625403|NCT01713582|26533324|P20|Overall Study|Stopped to receive bone marrow graft|0
7625404|NCT01713582|26533325|P19|Overall Study|Stopped to receive bone marrow graft|0
7625405|NCT01713582|26533326|P18|Overall Study|Stopped to receive bone marrow graft|0
7625406|NCT01713582|26533327|P17|Overall Study|Stopped to receive bone marrow graft|1
7625407|NCT01713582|26533328|P16|Overall Study|Stopped to receive bone marrow graft|0
7625408|NCT01713582|26533329|P15|Overall Study|Stopped to receive bone marrow graft|0
7625409|NCT01713582|26533330|P14|Overall Study|Stopped to receive bone marrow graft|0
7625410|NCT01713582|26533331|P13|Overall Study|Stopped to receive bone marrow graft|0
7625411|NCT01713582|26533332|P12|Overall Study|Stopped to receive bone marrow graft|0
7625412|NCT01713582|26533333|P11|Overall Study|Stopped to receive bone marrow graft|0
7625413|NCT01713582|26533334|P10|Overall Study|Stopped to receive bone marrow graft|0
7625414|NCT01713582|26533335|P9|Overall Study|Stopped to receive bone marrow graft|0
7625415|NCT01713582|26533336|P8|Overall Study|Stopped to receive bone marrow graft|0
7625416|NCT01713582|26533337|P7|Overall Study|Stopped to receive bone marrow graft|0
7625417|NCT01713582|26533338|P6|Overall Study|Stopped to receive bone marrow graft|0
7625418|NCT01713582|26533339|P5|Overall Study|Stopped to receive bone marrow graft|0
7625419|NCT01713582|26533340|P4|Overall Study|Stopped to receive bone marrow graft|0
7625420|NCT01713582|26533341|P3|Overall Study|Stopped to receive bone marrow graft|0
7625421|NCT01713582|26533342|P2|Overall Study|Stopped to receive bone marrow graft|0
7625422|NCT01713582|26533343|P1|Overall Study|Stopped to receive bone marrow graft|0
7625423|NCT01713582|26533323|P21|Overall Study|Withdrawal by Subject|0
7625424|NCT01713582|26533324|P20|Overall Study|Withdrawal by Subject|0
7625425|NCT01713582|26533325|P19|Overall Study|Withdrawal by Subject|0
7625426|NCT01713582|26533326|P18|Overall Study|Withdrawal by Subject|1
7625427|NCT01713582|26533327|P17|Overall Study|Withdrawal by Subject|0
7625428|NCT01713582|26533328|P16|Overall Study|Withdrawal by Subject|0
7625429|NCT01713582|26533329|P15|Overall Study|Withdrawal by Subject|0
7625430|NCT01713582|26533330|P14|Overall Study|Withdrawal by Subject|0
7625431|NCT01713582|26533331|P13|Overall Study|Withdrawal by Subject|0
7625432|NCT01713582|26533332|P12|Overall Study|Withdrawal by Subject|0
7625433|NCT01713582|26533333|P11|Overall Study|Withdrawal by Subject|0
7625434|NCT01713582|26533334|P10|Overall Study|Withdrawal by Subject|0
7625435|NCT01713582|26533335|P9|Overall Study|Withdrawal by Subject|0
7625436|NCT01713582|26533336|P8|Overall Study|Withdrawal by Subject|0
7625437|NCT01713582|26533337|P7|Overall Study|Withdrawal by Subject|0
7625438|NCT01713582|26533338|P6|Overall Study|Withdrawal by Subject|0
7625439|NCT01713582|26533339|P5|Overall Study|Withdrawal by Subject|0
7625440|NCT01713582|26533340|P4|Overall Study|Withdrawal by Subject|0
7625441|NCT01713582|26533341|P3|Overall Study|Withdrawal by Subject|0
7625442|NCT01713582|26533342|P2|Overall Study|Withdrawal by Subject|0
7625443|NCT01713582|26533343|P1|Overall Study|Withdrawal by Subject|0
7625444|NCT01713582|26533323|P21|Overall Study|Lack of Efficacy|0
7625445|NCT01713582|26533324|P20|Overall Study|Lack of Efficacy|0
7625446|NCT01713582|26533325|P19|Overall Study|Lack of Efficacy|0
7625447|NCT01713582|26533326|P18|Overall Study|Lack of Efficacy|0
7625448|NCT01713582|26533327|P17|Overall Study|Lack of Efficacy|0
7625449|NCT01713582|26533328|P16|Overall Study|Lack of Efficacy|0
7625450|NCT01713582|26533329|P15|Overall Study|Lack of Efficacy|0
7625451|NCT01713582|26533330|P14|Overall Study|Lack of Efficacy|0
7625452|NCT01713582|26533331|P13|Overall Study|Lack of Efficacy|0
7625453|NCT01713582|26533332|P12|Overall Study|Lack of Efficacy|0
7625454|NCT01713582|26533333|P11|Overall Study|Lack of Efficacy|2
7625455|NCT01713582|26533334|P10|Overall Study|Lack of Efficacy|1
7625456|NCT01713582|26533335|P9|Overall Study|Lack of Efficacy|0
7625457|NCT01713582|26533336|P8|Overall Study|Lack of Efficacy|0
7625458|NCT01713582|26533337|P7|Overall Study|Lack of Efficacy|0
7625459|NCT01713582|26533338|P6|Overall Study|Lack of Efficacy|0
7625460|NCT01713582|26533339|P5|Overall Study|Lack of Efficacy|0
7625461|NCT01713582|26533340|P4|Overall Study|Lack of Efficacy|0
7625462|NCT01713582|26533341|P3|Overall Study|Lack of Efficacy|0
7625463|NCT01713582|26533342|P2|Overall Study|Lack of Efficacy|0
7625464|NCT01713582|26533343|P1|Overall Study|Lack of Efficacy|0
7625465|NCT01713582|26533323|P21|Overall Study|Withdrawal of consent|0
7625466|NCT01713582|26533324|P20|Overall Study|Withdrawal of consent|0
7625467|NCT01713582|26533325|P19|Overall Study|Withdrawal of consent|1
7625468|NCT01713582|26533326|P18|Overall Study|Withdrawal of consent|0
7625469|NCT01713582|26533327|P17|Overall Study|Withdrawal of consent|0
7625470|NCT01713582|26533328|P16|Overall Study|Withdrawal of consent|0
7625471|NCT01713582|26533329|P15|Overall Study|Withdrawal of consent|0
7625472|NCT01713582|26533330|P14|Overall Study|Withdrawal of consent|0
7625473|NCT01713582|26533331|P13|Overall Study|Withdrawal of consent|0
7625474|NCT01713582|26533332|P12|Overall Study|Withdrawal of consent|0
7625475|NCT01713582|26533333|P11|Overall Study|Withdrawal of consent|0
7625476|NCT01713582|26533334|P10|Overall Study|Withdrawal of consent|1
7625477|NCT01713582|26533335|P9|Overall Study|Withdrawal of consent|0
7625478|NCT01713582|26533336|P8|Overall Study|Withdrawal of consent|0
7625479|NCT01713582|26533337|P7|Overall Study|Withdrawal of consent|0
7625480|NCT01713582|26533338|P6|Overall Study|Withdrawal of consent|1
7625481|NCT01713582|26533339|P5|Overall Study|Withdrawal of consent|0
7625482|NCT01713582|26533340|P4|Overall Study|Withdrawal of consent|0
7625483|NCT01713582|26533341|P3|Overall Study|Withdrawal of consent|1
7625484|NCT01713582|26533342|P2|Overall Study|Withdrawal of consent|0
7625485|NCT01713582|26533343|P1|Overall Study|Withdrawal of consent|0
7625486|NCT01713582|26533323|P21|Overall Study|Adverse event-unrelated|0
7625487|NCT01713582|26533324|P20|Overall Study|Adverse event-unrelated|0
7625488|NCT01713582|26533325|P19|Overall Study|Adverse event-unrelated|0
7625489|NCT01713582|26533326|P18|Overall Study|Adverse event-unrelated|0
7625490|NCT01713582|26533327|P17|Overall Study|Adverse event-unrelated|0
7625491|NCT01713582|26533328|P16|Overall Study|Adverse event-unrelated|0
7625492|NCT01713582|26533329|P15|Overall Study|Adverse event-unrelated|1
7625493|NCT01713582|26533330|P14|Overall Study|Adverse event-unrelated|1
7625494|NCT01713582|26533331|P13|Overall Study|Adverse event-unrelated|0
7625495|NCT01713582|26533332|P12|Overall Study|Adverse event-unrelated|0
7625496|NCT01713582|26533333|P11|Overall Study|Adverse event-unrelated|0
7625497|NCT01713582|26533334|P10|Overall Study|Adverse event-unrelated|0
7625498|NCT01713582|26533335|P9|Overall Study|Adverse event-unrelated|0
7625499|NCT01713582|26533336|P8|Overall Study|Adverse event-unrelated|1
7625500|NCT01713582|26533337|P7|Overall Study|Adverse event-unrelated|1
7625501|NCT01713582|26533338|P6|Overall Study|Adverse event-unrelated|1
7625502|NCT01713582|26533339|P5|Overall Study|Adverse event-unrelated|0
7625503|NCT01713582|26533340|P4|Overall Study|Adverse event-unrelated|0
7625504|NCT01713582|26533341|P3|Overall Study|Adverse event-unrelated|0
7625505|NCT01713582|26533342|P2|Overall Study|Adverse event-unrelated|0
7625506|NCT01713582|26533343|P1|Overall Study|Adverse event-unrelated|0
7625507|NCT01713582|26533323|P21|Overall Study|Adverse event-related|0
7625508|NCT01713582|26533324|P20|Overall Study|Adverse event-related|0
7625509|NCT01713582|26533325|P19|Overall Study|Adverse event-related|1
7625510|NCT01713582|26533326|P18|Overall Study|Adverse event-related|0
7625511|NCT01713582|26533327|P17|Overall Study|Adverse event-related|0
7625512|NCT01713582|26533328|P16|Overall Study|Adverse event-related|0
7625513|NCT01713582|26533329|P15|Overall Study|Adverse event-related|0
7625514|NCT01713582|26533330|P14|Overall Study|Adverse event-related|0
7625515|NCT01713582|26533331|P13|Overall Study|Adverse event-related|0
7625516|NCT01713582|26533332|P12|Overall Study|Adverse event-related|0
7625517|NCT01713582|26533333|P11|Overall Study|Adverse event-related|1
7625518|NCT01713582|26533334|P10|Overall Study|Adverse event-related|1
7625519|NCT01713582|26533335|P9|Overall Study|Adverse event-related|0
7625520|NCT01713582|26533336|P8|Overall Study|Adverse event-related|0
7625521|NCT01713582|26533337|P7|Overall Study|Adverse event-related|0
7625522|NCT01713582|26533338|P6|Overall Study|Adverse event-related|0
7625523|NCT01713582|26533339|P5|Overall Study|Adverse event-related|0
7625524|NCT01713582|26533340|P4|Overall Study|Adverse event-related|0
7625525|NCT01713582|26533341|P3|Overall Study|Adverse event-related|0
7625526|NCT01713582|26533342|P2|Overall Study|Adverse event-related|0
7625527|NCT01713582|26533343|P1|Overall Study|Adverse event-related|0
7625528|NCT01713582|26533323|P21|Overall Study|Death|0
7625529|NCT01713582|26533324|P20|Overall Study|Death|0
7625530|NCT01713582|26533325|P19|Overall Study|Death|0
7625531|NCT01713582|26533326|P18|Overall Study|Death|0
7625532|NCT01713582|26533327|P17|Overall Study|Death|0
7625533|NCT01713582|26533328|P16|Overall Study|Death|0
7625534|NCT01713582|26533329|P15|Overall Study|Death|0
7625535|NCT01713582|26533330|P14|Overall Study|Death|0
7625536|NCT01713582|26533331|P13|Overall Study|Death|0
7625537|NCT01713582|26533332|P12|Overall Study|Death|0
7625538|NCT01713582|26533333|P11|Overall Study|Death|3
7625539|NCT01713582|26533334|P10|Overall Study|Death|4
7625540|NCT01713582|26533335|P9|Overall Study|Death|3
7625541|NCT01713582|26533336|P8|Overall Study|Death|2
7625542|NCT01713582|26533337|P7|Overall Study|Death|3
7625543|NCT01713582|26533338|P6|Overall Study|Death|3
7625544|NCT01713582|26533339|P5|Overall Study|Death|1
7625545|NCT01713582|26533340|P4|Overall Study|Death|1
7625546|NCT01713582|26533341|P3|Overall Study|Death|0
7625547|NCT01713582|26533342|P2|Overall Study|Death|0
7625548|NCT01713582|26533343|P1|Overall Study|Death|0
7625549|NCT01713582|26533323|P21|Overall Study|Disease progression|15
7625550|NCT01713582|26533324|P20|Overall Study|Disease progression|5
7625551|NCT01713582|26533325|P19|Overall Study|Disease progression|3
7625552|NCT01713582|26533326|P18|Overall Study|Disease progression|2
7625553|NCT01713582|26533327|P17|Overall Study|Disease progression|5
7625554|NCT01713582|26533328|P16|Overall Study|Disease progression|6
7625555|NCT01713582|26533329|P15|Overall Study|Disease progression|6
7625556|NCT01713582|26533330|P14|Overall Study|Disease progression|3
7625557|NCT01713582|26533331|P13|Overall Study|Disease progression|3
7625558|NCT01713582|26533332|P12|Overall Study|Disease progression|5
7625559|NCT01713582|26533333|P11|Overall Study|Disease progression|10
7625560|NCT01713582|26533334|P10|Overall Study|Disease progression|11
7625561|NCT01713582|26533335|P9|Overall Study|Disease progression|3
7625562|NCT01713582|26533336|P8|Overall Study|Disease progression|3
7625563|NCT01713582|26533337|P7|Overall Study|Disease progression|3
7625564|NCT01713582|26533338|P6|Overall Study|Disease progression|3
7625565|NCT01713582|26533339|P5|Overall Study|Disease progression|3
7625566|NCT01713582|26533340|P4|Overall Study|Disease progression|2
7625567|NCT01713582|26533341|P3|Overall Study|Disease progression|3
7625568|NCT01713582|26533342|P2|Overall Study|Disease progression|3
7625569|NCT01713582|26533343|P1|Overall Study|Disease progression|3
7625570|NCT01713530|26533506|P2|Overall Study|Unclassified|2
7625571|NCT01713530|26533507|P1|Overall Study|Unclassified|4
7625572|NCT01713530|26533506|P2|Overall Study|Withdrawal criteria|12
7625573|NCT01713530|26533507|P1|Overall Study|Withdrawal criteria|21
7625574|NCT01713530|26533506|P2|Overall Study|Adverse Event|5
7625575|NCT01713530|26533507|P1|Overall Study|Adverse Event|0
7625576|NCT01713348|26533538|P4|Overall Study|Lost to Follow-up|0
7625577|NCT01713348|26533539|P3|Overall Study|Lost to Follow-up|0
7625578|NCT01713348|26533540|P2|Overall Study|Lost to Follow-up|0
7625579|NCT01713348|26533541|P1|Overall Study|Lost to Follow-up|1
7625580|NCT01713348|26533538|P4|Overall Study|Withdrawal by Subject|0
7625581|NCT01713348|26533539|P3|Overall Study|Withdrawal by Subject|2
7625582|NCT01713348|26533540|P2|Overall Study|Withdrawal by Subject|2
7625583|NCT01713348|26533541|P1|Overall Study|Withdrawal by Subject|3
7625584|NCT01713283|26533571|P2|Overall Study|Lost to Follow-up|1
7625585|NCT01713283|26533572|P1|Overall Study|Lost to Follow-up|1
7625586|NCT01713283|26533571|P2|Overall Study|Lack of Efficacy|2
7625587|NCT01713283|26533572|P1|Overall Study|Lack of Efficacy|10
7625588|NCT01713036|26533594|P1|Overall Study|Death|1
7625589|NCT01712984|26533634|P3|Overall Study|Withdrawal by Subject|7
7625590|NCT01712984|26533635|P2|Overall Study|Withdrawal by Subject|6
7625591|NCT01712984|26533636|P1|Overall Study|Withdrawal by Subject|6
7625592|NCT01712984|26533634|P3|Overall Study|Lost to Follow-up|1
7625593|NCT01712984|26533635|P2|Overall Study|Lost to Follow-up|10
7625594|NCT01712984|26533636|P1|Overall Study|Lost to Follow-up|8
7625595|NCT01712984|26533634|P3|Overall Study|Protocol Violation|1
7625596|NCT01712984|26533635|P2|Overall Study|Protocol Violation|0
7625597|NCT01712984|26533636|P1|Overall Study|Protocol Violation|2
7625598|NCT01712984|26533634|P3|Overall Study|Adverse Event|1
7625599|NCT01712984|26533635|P2|Overall Study|Adverse Event|0
7625600|NCT01712984|26533636|P1|Overall Study|Adverse Event|0
7625601|NCT01712854|26533656|P1|Overall Study|Physician Decision|1
7625602|NCT01712685|26533679|P1|Overall Study|pt declined to participate before trmt|1
7625603|NCT01712516|26533695|P4|Overall Study|Withdrawal by Subject|9
7625604|NCT01712516|26533696|P3|Overall Study|Withdrawal by Subject|3
7625605|NCT01712516|26533697|P2|Overall Study|Withdrawal by Subject|9
7625606|NCT01712516|26533698|P1|Overall Study|Withdrawal by Subject|3
7625607|NCT01712516|26533695|P4|Overall Study|Physician Decision|1
7625608|NCT01712516|26533696|P3|Overall Study|Physician Decision|0
7625609|NCT01712516|26533697|P2|Overall Study|Physician Decision|0
7625610|NCT01712516|26533698|P1|Overall Study|Physician Decision|2
7625611|NCT01712516|26533695|P4|Overall Study|Protocol deviation|0
7625612|NCT01712516|26533696|P3|Overall Study|Protocol deviation|1
7625613|NCT01712516|26533697|P2|Overall Study|Protocol deviation|0
7625614|NCT01712516|26533698|P1|Overall Study|Protocol deviation|1
7625615|NCT01712516|26533695|P4|Overall Study|Death|0
7625616|NCT01712516|26533696|P3|Overall Study|Death|0
7625617|NCT01712516|26533697|P2|Overall Study|Death|1
7625618|NCT01712516|26533698|P1|Overall Study|Death|0
7625619|NCT01712516|26533695|P4|Overall Study|Lost to Follow-up|1
7625620|NCT01712516|26533696|P3|Overall Study|Lost to Follow-up|2
7625621|NCT01712516|26533697|P2|Overall Study|Lost to Follow-up|0
7625622|NCT01712516|26533698|P1|Overall Study|Lost to Follow-up|0
7625623|NCT01712516|26533695|P4|Overall Study|Technical problems|2
7625624|NCT01712516|26533696|P3|Overall Study|Technical problems|0
7625625|NCT01712516|26533697|P2|Overall Study|Technical problems|0
7625626|NCT01712516|26533698|P1|Overall Study|Technical problems|0
7625627|NCT01712490|26533750|P2|Overall Study|Lost to Follow-up|29
7625628|NCT01712490|26533751|P1|Overall Study|Lost to Follow-up|16
7625629|NCT01712490|26533750|P2|Overall Study|Withdrawal by Subject|44
7625630|NCT01712490|26533751|P1|Overall Study|Withdrawal by Subject|36
7625631|NCT01712490|26533750|P2|Overall Study|Other|11
7625632|NCT01712490|26533751|P1|Overall Study|Other|11
7625633|NCT01712490|26533750|P2|Overall Study|Ongoing|586
7625634|NCT01712490|26533751|P1|Overall Study|Ongoing|601
7625635|NCT01712438|26533788|P1|Overall Study|Prematurely Discontinued|25
7625636|NCT01712438|26533788|P1|Overall Study|Violated inclusion & exclusion criteria|4
7625637|NCT01712438|26533788|P1|Overall Study|Ongoing ITI treatment|6
7625638|NCT01712438|26533788|P1|Overall Study|Not treated with Human-cl rhFVIII|2
7625639|NCT01712399|26533798|P1|Overall Study|Study closure|345
7625640|NCT01712399|26533798|P1|Overall Study|Adverse Event|11
7625641|NCT01712399|26533798|P1|Overall Study|Death|1
7625642|NCT01712399|26533798|P1|Overall Study|Withdrawal by Subject|39
7625643|NCT01712399|26533798|P1|Overall Study|Lost to Follow-up|1
7625644|NCT01712334|26533844|P2|Treatment Period 1|Randomized in Error|2
7625645|NCT01712334|26533845|P1|Treatment Period 1|Randomized in Error|0
7625646|NCT01712256|26533853|P1|Overall Study|Lost to Follow-up|1
7625647|NCT01712204|26533883|P2|Overall Study|Protocol Violation|1
7625648|NCT01712204|26533884|P1|Overall Study|Protocol Violation|1
7625649|NCT01712204|26533883|P2|Overall Study|Lost to Follow-up|0
7625650|NCT01712204|26533884|P1|Overall Study|Lost to Follow-up|1
7625651|NCT01712204|26533883|P2|Overall Study|Withdrawal by Subject|3
7625652|NCT01712204|26533884|P1|Overall Study|Withdrawal by Subject|3
7625653|NCT01712204|26533883|P2|Overall Study|Adverse Event|1
7625654|NCT01712204|26533884|P1|Overall Study|Adverse Event|3
7625655|NCT01712178|26533892|P2|Overall Study|Lost to Follow-up|1
7625656|NCT01712178|26533893|P1|Overall Study|Lost to Follow-up|0
7625657|NCT01712178|26533892|P2|Overall Study|Serious adverse event/withdrew consent|1
7625658|NCT01712178|26533893|P1|Overall Study|Serious adverse event/withdrew consent|0
7625659|NCT01712178|26533892|P2|Overall Study|Withdrew consent due to an adverse event|1
7625660|NCT01712178|26533893|P1|Overall Study|Withdrew consent due to an adverse event|1
7625661|NCT01712074|26533918|P3|Double Blind Period|No longer met eligibility criteria|0
7625662|NCT01712074|26533919|P2|Double Blind Period|No longer met eligibility criteria|3
7625663|NCT01712074|26533920|P1|Double Blind Period|No longer met eligibility criteria|0
7625664|NCT01712074|26533918|P3|Double Blind Period|Protocol Violation|1
7625665|NCT01712074|26533919|P2|Double Blind Period|Protocol Violation|0
7625666|NCT01712074|26533920|P1|Double Blind Period|Protocol Violation|0
7625667|NCT01712074|26533918|P3|Double Blind Period|Other|1
7625668|NCT01712074|26533919|P2|Double Blind Period|Other|4
7625669|NCT01712074|26533920|P1|Double Blind Period|Other|0
7625670|NCT01712074|26533918|P3|Double Blind Period|Lost to Follow-up|1
7625671|NCT01712074|26533919|P2|Double Blind Period|Lost to Follow-up|2
7625672|NCT01712074|26533920|P1|Double Blind Period|Lost to Follow-up|0
7625673|NCT01712074|26533918|P3|Double Blind Period|Death|0
7625674|NCT01712074|26533919|P2|Double Blind Period|Death|1
7625675|NCT01712074|26533920|P1|Double Blind Period|Death|0
7625676|NCT01712074|26533918|P3|Double Blind Period|No longer willing to participate|4
7625677|NCT01712074|26533919|P2|Double Blind Period|No longer willing to participate|2
7625678|NCT01712074|26533920|P1|Double Blind Period|No longer willing to participate|0
7625679|NCT01712074|26533918|P3|Double Blind Period|Adverse Event|1
7625680|NCT01712074|26533919|P2|Double Blind Period|Adverse Event|2
7625681|NCT01712074|26533920|P1|Double Blind Period|Adverse Event|0
7625682|NCT01712074|26533918|P3|Placebo Run-in Period|No longer willing to participate|0
7625683|NCT01712074|26533919|P2|Placebo Run-in Period|No longer willing to participate|0
7625684|NCT01712074|26533920|P1|Placebo Run-in Period|No longer willing to participate|1
7625685|NCT01712074|26533918|P3|Placebo Run-in Period|Other|0
7625686|NCT01712074|26533919|P2|Placebo Run-in Period|Other|0
7625687|NCT01712074|26533920|P1|Placebo Run-in Period|Other|1
7625688|NCT01712074|26533918|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
7625689|NCT01712074|26533919|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
7625690|NCT01712074|26533920|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
7625691|NCT01712074|26533918|P3|Placebo Run-in Period|Lost to Follow-up|0
7625692|NCT01712074|26533919|P2|Placebo Run-in Period|Lost to Follow-up|0
7625693|NCT01712074|26533920|P1|Placebo Run-in Period|Lost to Follow-up|1
7625694|NCT01712074|26533918|P3|Placebo Run-in Period|Adverse Event|0
7625695|NCT01712074|26533919|P2|Placebo Run-in Period|Adverse Event|0
7625696|NCT01712074|26533920|P1|Placebo Run-in Period|Adverse Event|2
7625697|NCT01712061|26533976|P3|Overall Study|Other|0
7625698|NCT01712061|26533977|P2|Overall Study|Other|3
7625699|NCT01712061|26533978|P1|Overall Study|Other|0
7625700|NCT01712061|26533976|P3|Overall Study|Withdrawal by Subject|1
7625701|NCT01712061|26533977|P2|Overall Study|Withdrawal by Subject|7
7625702|NCT01712061|26533978|P1|Overall Study|Withdrawal by Subject|1
7625703|NCT01712061|26533976|P3|Overall Study|Medication Error Without Associated AE|0
7625704|NCT01712061|26533977|P2|Overall Study|Medication Error Without Associated AE|1
7625705|NCT01712061|26533978|P1|Overall Study|Medication Error Without Associated AE|0
7625706|NCT01712061|26533976|P3|Overall Study|Did Not Meet Entrance Criteria|3
7625707|NCT01712061|26533977|P2|Overall Study|Did Not Meet Entrance Criteria|6
7625708|NCT01712061|26533978|P1|Overall Study|Did Not Meet Entrance Criteria|4
7625709|NCT01712061|26533976|P3|Overall Study|Lost to Follow-up|1
7625710|NCT01712061|26533977|P2|Overall Study|Lost to Follow-up|0
7625711|NCT01712061|26533978|P1|Overall Study|Lost to Follow-up|1
7625712|NCT01712061|26533976|P3|Overall Study|Death|1
7625713|NCT01712061|26533977|P2|Overall Study|Death|0
7625714|NCT01712061|26533978|P1|Overall Study|Death|0
7625715|NCT01712061|26533976|P3|Overall Study|Adverse Event|5
7625716|NCT01712061|26533977|P2|Overall Study|Adverse Event|9
7625717|NCT01712061|26533978|P1|Overall Study|Adverse Event|4
7625718|NCT01712009|26534018|P3|Overall Study|Decision by Sponsor|12
7625719|NCT01712009|26534019|P2|Overall Study|Decision by Sponsor|14
7625720|NCT01712009|26534020|P1|Overall Study|Decision by Sponsor|12
7625721|NCT01712009|26534018|P3|Overall Study|Lost to Follow-up|1
7625722|NCT01712009|26534019|P2|Overall Study|Lost to Follow-up|0
7625723|NCT01712009|26534020|P1|Overall Study|Lost to Follow-up|2
7625724|NCT01712009|26534018|P3|Overall Study|Withdrawal by Subject|8
7625725|NCT01712009|26534019|P2|Overall Study|Withdrawal by Subject|15
7625726|NCT01712009|26534020|P1|Overall Study|Withdrawal by Subject|24
7625727|NCT01711983|26534046|P1|36-Month Closure Evaluation|Missed Echocardiograph|62
7625728|NCT01711983|26534046|P1|36-Month Closure Evaluation|Test Device Removal|2
7625729|NCT01711983|26534046|P1|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
7625730|NCT01711983|26534046|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
7625731|NCT01711879|26534066|P2|Overall Study|Death|0
7625732|NCT01711879|26534067|P1|Overall Study|Death|1
7625733|NCT01711866|26534101|P1|Overall Study|Adverse Event|2
7625734|NCT01711866|26534101|P1|Overall Study|Withdrawal by Subject|3
7625735|NCT01711866|26534101|P1|Overall Study|Noncompliant|3
7625736|NCT01711853|26534106|P1|Overall Study|Not treated|3
7625737|NCT01711736|26534113|P2|Overall Study|Migrated/moved from study area|1
7625738|NCT01711736|26534114|P1|Overall Study|Migrated/moved from study area|2
7625739|NCT01711736|26534113|P2|Overall Study|Withdrawal by Subject|6
7625740|NCT01711736|26534114|P1|Overall Study|Withdrawal by Subject|6
7625741|NCT01711736|26534113|P2|Overall Study|Lost to Follow-up|1
7625742|NCT01711736|26534114|P1|Overall Study|Lost to Follow-up|4
7625743|NCT01711645|26534142|P1|Overall Study|Physician Decision|5
7625744|NCT01711645|26534142|P1|Overall Study|Lost to Follow-up|6
7625745|NCT01711645|26534142|P1|Overall Study|Withdrawal by Subject|8
7625746|NCT01711619|26534179|P2|Overall Study|Lost to Follow-up|0
7625747|NCT01711619|26534180|P1|Overall Study|Lost to Follow-up|1
7625748|NCT01711619|26534179|P2|Overall Study|Adverse Event|0
7625749|NCT01711619|26534180|P1|Overall Study|Adverse Event|2
7625750|NCT01711619|26534179|P2|Overall Study|Protocol Violation|3
7625751|NCT01711619|26534180|P1|Overall Study|Protocol Violation|2
7625752|NCT01711619|26534179|P2|Overall Study|Withdrawal by Subject|7
7625753|NCT01711619|26534180|P1|Overall Study|Withdrawal by Subject|3
7625754|NCT01711619|26534179|P2|Overall Study|Early study termination|14
7625755|NCT01711619|26534180|P1|Overall Study|Early study termination|10
7625756|NCT01711541|26534197|P5|Overall Study|Ineligible|0
7625757|NCT01711541|26534198|P4|Overall Study|Ineligible|0
7625758|NCT01711541|26534199|P3|Overall Study|Ineligible|0
7625759|NCT01711541|26534200|P2|Overall Study|Ineligible|1
7625760|NCT01711541|26534201|P1|Overall Study|Ineligible|0
7625761|NCT01711541|26534197|P5|Overall Study|Cancel prior to treatment|0
7625762|NCT01711541|26534198|P4|Overall Study|Cancel prior to treatment|1
7625763|NCT01711541|26534199|P3|Overall Study|Cancel prior to treatment|0
7625764|NCT01711541|26534200|P2|Overall Study|Cancel prior to treatment|0
7625765|NCT01711541|26534201|P1|Overall Study|Cancel prior to treatment|0
7625766|NCT01711359|26534250|P3|Treatment Period|Randomized, Not Treated|0
7625767|NCT01711359|26534251|P2|Treatment Period|Randomized, Not Treated|1
7625768|NCT01711359|26534252|P1|Treatment Period|Randomized, Not Treated|3
7625769|NCT01711359|26534250|P3|Treatment Period|Lost to Follow-up|1
7625770|NCT01711359|26534251|P2|Treatment Period|Lost to Follow-up|1
7625771|NCT01711359|26534252|P1|Treatment Period|Lost to Follow-up|1
7625772|NCT01711359|26534250|P3|Treatment Period|Sponsor Decision|0
7625773|NCT01711359|26534251|P2|Treatment Period|Sponsor Decision|0
7625774|NCT01711359|26534252|P1|Treatment Period|Sponsor Decision|1
7625775|NCT01711359|26534250|P3|Treatment Period|Entry Criteria Not Met|0
7625776|NCT01711359|26534251|P2|Treatment Period|Entry Criteria Not Met|0
7625777|NCT01711359|26534252|P1|Treatment Period|Entry Criteria Not Met|1
7625778|NCT01711359|26534250|P3|Treatment Period|Death|0
7625779|NCT01711359|26534251|P2|Treatment Period|Death|0
7625780|NCT01711359|26534252|P1|Treatment Period|Death|3
7625781|NCT01711359|26534250|P3|Treatment Period|Physician Decision|2
7625782|NCT01711359|26534251|P2|Treatment Period|Physician Decision|3
7625783|NCT01711359|26534252|P1|Treatment Period|Physician Decision|4
7625784|NCT01711359|26534250|P3|Treatment Period|Adverse Event|24
7625785|NCT01711359|26534251|P2|Treatment Period|Adverse Event|10
7625786|NCT01711359|26534252|P1|Treatment Period|Adverse Event|8
7625787|NCT01711359|26534250|P3|Treatment Period|Lack of Efficacy|2
7625788|NCT01711359|26534251|P2|Treatment Period|Lack of Efficacy|2
7625789|NCT01711359|26534252|P1|Treatment Period|Lack of Efficacy|13
7625790|NCT01711359|26534250|P3|Treatment Period|Withdrawal by Subject|13
7625791|NCT01711359|26534251|P2|Treatment Period|Withdrawal by Subject|7
7625792|NCT01711359|26534252|P1|Treatment Period|Withdrawal by Subject|18
7625793|NCT01711216|26534381|P1|Overall Study|no reason specified|22
7625794|NCT01711216|26534381|P1|Overall Study|variety of other minor reasons|83
7625795|NCT01711216|26534381|P1|Overall Study|Lost to Follow-up|46
7625796|NCT01711216|26534381|P1|Overall Study|Withdrawal by Subject|6
7625797|NCT01711216|26534381|P1|Overall Study|Pregnancy|56
7625798|NCT01711216|26534381|P1|Overall Study|Adverse Event|4
7625799|NCT01710800|26534459|P1|Overall Study|Protocol Violation|1
7625800|NCT01710800|26534459|P1|Overall Study|Withdrawal by Subject|21
7625801|NCT01710709|26534523|P1|Overall Study|Lack of Efficacy|3
7625802|NCT01710709|26534523|P1|Overall Study|Protocol Violation|5
7625803|NCT01710709|26534523|P1|Overall Study|Withdrawal by Subject|53
7625804|NCT01710709|26534523|P1|Overall Study|Participant withdrawn by investigator|2
7625805|NCT01710709|26534523|P1|Overall Study|Participant met withdrawal criteria|33
7625806|NCT01710709|26534523|P1|Overall Study|Adverse Event|48
7625807|NCT01710709|26534523|P1|Overall Study|Lost to Follow-up|29
7625808|NCT01710657|26534538|P3|Overall Study|Lack of Efficacy|1
7625809|NCT01710657|26534539|P2|Overall Study|Lack of Efficacy|1
7625810|NCT01710657|26534540|P1|Overall Study|Lack of Efficacy|0
7625811|NCT01710657|26534538|P3|Overall Study|Withdrawal by Subject|2
7625812|NCT01710657|26534539|P2|Overall Study|Withdrawal by Subject|1
7625813|NCT01710657|26534540|P1|Overall Study|Withdrawal by Subject|0
7625814|NCT01710657|26534538|P3|Overall Study|Adverse Event|28
7625815|NCT01710657|26534539|P2|Overall Study|Adverse Event|8
7625816|NCT01710657|26534540|P1|Overall Study|Adverse Event|14
7625817|NCT01710657|26534538|P3|Overall Study|Protocol Violation|0
7625818|NCT01710657|26534539|P2|Overall Study|Protocol Violation|2
7625819|NCT01710657|26534540|P1|Overall Study|Protocol Violation|2
7625820|NCT01710657|26534538|P3|Overall Study|Lost to Follow-up|1
7625821|NCT01710657|26534539|P2|Overall Study|Lost to Follow-up|0
7625822|NCT01710657|26534540|P1|Overall Study|Lost to Follow-up|2
7625823|NCT01710527|26534557|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
7625824|NCT01710527|26534558|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
7625825|NCT01710514|26534584|P2|Overall Study|Withdrawal by Subject|0
7625826|NCT01710514|26534585|P1|Overall Study|Withdrawal by Subject|1
7625827|NCT01710514|26534584|P2|Overall Study|Adverse Event|7
7625828|NCT01710514|26534585|P1|Overall Study|Adverse Event|6
7625829|NCT01710501|26534606|P3|Overall Study|Lost to Follow-up|0
7625830|NCT01710501|26534607|P2|Overall Study|Lost to Follow-up|0
7625831|NCT01710501|26534608|P1|Overall Study|Lost to Follow-up|2
7625832|NCT01710358|26534640|P3|Rescue Period|Withdrawal by Subject|0
7625833|NCT01710358|26534641|P2|Rescue Period|Withdrawal by Subject|8
7625834|NCT01710358|26534642|P1|Rescue Period|Withdrawal by Subject|0
7625835|NCT01710358|26534640|P3|Rescue Period|Lack of Efficacy|0
7625836|NCT01710358|26534641|P2|Rescue Period|Lack of Efficacy|7
7625837|NCT01710358|26534642|P1|Rescue Period|Lack of Efficacy|0
7625838|NCT01710358|26534640|P3|Rescue Period|Death|0
7625839|NCT01710358|26534641|P2|Rescue Period|Death|1
7625840|NCT01710358|26534642|P1|Rescue Period|Death|0
7625841|NCT01710358|26534640|P3|Rescue Period|Adverse Event|0
7625842|NCT01710358|26534641|P2|Rescue Period|Adverse Event|15
7625843|NCT01710358|26534642|P1|Rescue Period|Adverse Event|0
7625844|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
7625845|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
7625846|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
7625847|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
7625848|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
7625849|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
7625850|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7625851|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
7625852|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7625853|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
7625854|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7625855|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7625856|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
7625857|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7625858|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7625859|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
7625860|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
7625861|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
7625862|NCT01710358|26534640|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
7625863|NCT01710358|26534641|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
7625864|NCT01710358|26534642|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
7625865|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
7625866|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7625867|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7625868|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
7625869|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
7625870|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
7625871|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7625872|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7625873|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
7625874|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7625875|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7625876|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
7625877|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7625878|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
7625879|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7625880|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
7625881|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
7625882|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
7625883|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7625884|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7625885|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
7625886|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
7625887|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
7625888|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
7625889|NCT01710358|26534640|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
7625890|NCT01710358|26534641|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
7625891|NCT01710358|26534642|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
7625892|NCT01710345|26534713|P3|Overall Study|Drug Dosing Error|0
7625893|NCT01710345|26534714|P2|Overall Study|Drug Dosing Error|0
7625894|NCT01710345|26534715|P1|Overall Study|Drug Dosing Error|1
7625895|NCT01710345|26534713|P3|Overall Study|Lack of Efficacy|1
7625896|NCT01710345|26534714|P2|Overall Study|Lack of Efficacy|3
7625897|NCT01710345|26534715|P1|Overall Study|Lack of Efficacy|2
7625898|NCT01710345|26534713|P3|Overall Study|Adverse Event|0
7625899|NCT01710345|26534714|P2|Overall Study|Adverse Event|2
7625900|NCT01710345|26534715|P1|Overall Study|Adverse Event|0
7625901|NCT01710046|26534774|P2|Overall Study|Lost to Follow-up|0
7625902|NCT01710046|26534775|P1|Overall Study|Lost to Follow-up|1
7625903|NCT01710033|26534815|P5|Stage 2|Adverse Event|1
7625904|NCT01710033|26534816|P4|Stage 2|Adverse Event|0
7625905|NCT01710033|26534817|P3|Stage 2|Adverse Event|0
7625906|NCT01710033|26534818|P2|Stage 2|Adverse Event|0
7625907|NCT01710033|26534819|P1|Stage 2|Adverse Event|0
7625908|NCT01710020|26534900|P1|Period 1|Protocol Violation|1
7625909|NCT01709903|26534936|P2|Overall Study|Adverse Event|18
7625910|NCT01709903|26534937|P1|Overall Study|Adverse Event|11
7625911|NCT01709903|26534936|P2|Overall Study|Withdrawal by Subject|6
7625912|NCT01709903|26534937|P1|Overall Study|Withdrawal by Subject|6
7625913|NCT01709903|26534936|P2|Overall Study|Lack of Efficacy|3
7625914|NCT01709903|26534937|P1|Overall Study|Lack of Efficacy|3
7625915|NCT01709903|26534936|P2|Overall Study|Protocol Violation|2
7625916|NCT01709903|26534937|P1|Overall Study|Protocol Violation|3
7625917|NCT01709903|26534936|P2|Overall Study|Death|0
7625918|NCT01709903|26534937|P1|Overall Study|Death|2
7625919|NCT01709903|26534936|P2|Overall Study|Lost to Follow-up|2
7625920|NCT01709903|26534937|P1|Overall Study|Lost to Follow-up|0
7625921|NCT01709903|26534936|P2|Overall Study|no longer needed study drug|1
7625922|NCT01709903|26534937|P1|Overall Study|no longer needed study drug|0
7625923|NCT01709903|26534936|P2|Overall Study|In ability to use device|1
7625924|NCT01709903|26534937|P1|Overall Study|In ability to use device|1
7625925|NCT01709903|26534936|P2|Overall Study|Abnormal test procedure results|0
7625926|NCT01709903|26534937|P1|Overall Study|Abnormal test procedure results|1
7625927|NCT01709903|26534936|P2|Overall Study|administrative problems|6
7625928|NCT01709903|26534937|P1|Overall Study|administrative problems|2
7625929|NCT01709864|26534961|P2|Overall Study|Death|1
7625930|NCT01709864|26534962|P1|Overall Study|Death|0
7625931|NCT01709864|26534961|P2|Overall Study|Adverse Event|2
7625932|NCT01709864|26534962|P1|Overall Study|Adverse Event|0
7625933|NCT01709864|26534961|P2|Overall Study|non-compliance with study treatment|1
7625934|NCT01709864|26534962|P1|Overall Study|non-compliance with study treatment|1
7625935|NCT01709864|26534961|P2|Overall Study|Lost to Follow-up|0
7625936|NCT01709864|26534962|P1|Overall Study|Lost to Follow-up|1
7625937|NCT01709864|26534961|P2|Overall Study|subject/guardian decision|6
7625938|NCT01709864|26534962|P1|Overall Study|subject/guardian decision|5
7625939|NCT01709864|26534961|P2|Overall Study|Physician Decision|1
7625940|NCT01709864|26534962|P1|Overall Study|Physician Decision|0
7625941|NCT01709838|26534996|P1|Overall Study|Protocol Violation|1
7625942|NCT01709838|26534996|P1|Overall Study|Death|3
7625943|NCT01709838|26534996|P1|Overall Study|Physician Decision|4
7625944|NCT01709838|26534996|P1|Overall Study|Adverse Event|4
7625945|NCT01709838|26534996|P1|Overall Study|Subject/guardian decision|8
7625946|NCT01709838|26534996|P1|Overall Study|Pregnancy|10
7625947|NCT01709838|26534996|P1|Overall Study|Lost to Follow-up|16
7625948|NCT01709838|26534996|P1|Overall Study|Withdrawal by Subject|21
7625949|NCT01709721|26535061|P3|Randomized Phase|Other, Specify text field in database|0
7625950|NCT01709721|26535062|P2|Randomized Phase|Other, Specify text field in database|3
7625951|NCT01709721|26535063|P1|Randomized Phase|Other, Specify text field in database|1
7625952|NCT01709721|26535061|P3|Randomized Phase|Inadequate Pain Control|0
7625953|NCT01709721|26535062|P2|Randomized Phase|Inadequate Pain Control|2
7625954|NCT01709721|26535063|P1|Randomized Phase|Inadequate Pain Control|1
7625955|NCT01709721|26535061|P3|Randomized Phase|Lost to Follow-up|0
7625956|NCT01709721|26535062|P2|Randomized Phase|Lost to Follow-up|0
7625957|NCT01709721|26535063|P1|Randomized Phase|Lost to Follow-up|1
7625958|NCT01709721|26535061|P3|Randomized Phase|Adverse Event|0
7625959|NCT01709721|26535062|P2|Randomized Phase|Adverse Event|1
7625960|NCT01709721|26535063|P1|Randomized Phase|Adverse Event|0
7625961|NCT01709721|26535061|P3|Open Label Phase|Other, Specify in text field in database|14
7625962|NCT01709721|26535062|P2|Open Label Phase|Other, Specify in text field in database|0
7625963|NCT01709721|26535063|P1|Open Label Phase|Other, Specify in text field in database|0
7625964|NCT01709721|26535061|P3|Open Label Phase|Inadequate Pain Control|37
7625965|NCT01709721|26535062|P2|Open Label Phase|Inadequate Pain Control|0
7625966|NCT01709721|26535063|P1|Open Label Phase|Inadequate Pain Control|0
7625967|NCT01709721|26535061|P3|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
7625968|NCT01709721|26535062|P2|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7625969|NCT01709721|26535063|P1|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7625970|NCT01709721|26535061|P3|Open Label Phase|Protocol Violation|1
7625971|NCT01709721|26535062|P2|Open Label Phase|Protocol Violation|0
7625972|NCT01709721|26535063|P1|Open Label Phase|Protocol Violation|0
7625973|NCT01709721|26535061|P3|Open Label Phase|Sponsor Decision|2
7625974|NCT01709721|26535062|P2|Open Label Phase|Sponsor Decision|0
7625975|NCT01709721|26535063|P1|Open Label Phase|Sponsor Decision|0
7625976|NCT01709721|26535061|P3|Open Label Phase|Investigator Decision|1
7625977|NCT01709721|26535062|P2|Open Label Phase|Investigator Decision|0
7625978|NCT01709721|26535063|P1|Open Label Phase|Investigator Decision|0
7625979|NCT01709721|26535061|P3|Open Label Phase|Non-compliance With Study Drug|3
7625980|NCT01709721|26535062|P2|Open Label Phase|Non-compliance With Study Drug|0
7625981|NCT01709721|26535063|P1|Open Label Phase|Non-compliance With Study Drug|0
7625982|NCT01709721|26535061|P3|Open Label Phase|Adverse Event|8
7625983|NCT01709721|26535062|P2|Open Label Phase|Adverse Event|0
7625984|NCT01709721|26535063|P1|Open Label Phase|Adverse Event|0
7625985|NCT01709721|26535061|P3|Open Label Phase|Withdrawal by Subject|5
7625986|NCT01709721|26535062|P2|Open Label Phase|Withdrawal by Subject|0
7625987|NCT01709721|26535063|P1|Open Label Phase|Withdrawal by Subject|0
7625988|NCT01709708|26535091|P2|Overall Study|Protocol Violation|2
7625989|NCT01709708|26535092|P1|Overall Study|Protocol Violation|1
7625990|NCT01709695|26535116|P2|Overall Study|Withdrawal by Subject|1
7625991|NCT01709695|26535117|P1|Overall Study|Withdrawal by Subject|1
7625992|NCT01709578|26535142|P3|Overall Study|Other, not related to safety or efficacy|5
7625993|NCT01709578|26535143|P2|Overall Study|Other, not related to safety or efficacy|7
7625994|NCT01709578|26535144|P1|Overall Study|Other, not related to safety or efficacy|2
7625995|NCT01709578|26535142|P3|Overall Study|Poor compliance to protocol|1
7625996|NCT01709578|26535143|P2|Overall Study|Poor compliance to protocol|2
7625997|NCT01709578|26535144|P1|Overall Study|Poor compliance to protocol|1
7625998|NCT01709578|26535142|P3|Overall Study|Lack of Efficacy|2
7625999|NCT01709578|26535143|P2|Overall Study|Lack of Efficacy|4
7626000|NCT01709578|26535144|P1|Overall Study|Lack of Efficacy|5
7626001|NCT01709578|26535142|P3|Overall Study|Adverse Event|17
7626002|NCT01709578|26535143|P2|Overall Study|Adverse Event|18
7626003|NCT01709578|26535144|P1|Overall Study|Adverse Event|9
7626004|NCT01709578|26535142|P3|Overall Study|Rescued and entered in long term safety|26
7626005|NCT01709578|26535143|P2|Overall Study|Rescued and entered in long term safety|25
7626006|NCT01709578|26535144|P1|Overall Study|Rescued and entered in long term safety|63
7626007|NCT01709513|26535275|P3|Overall Study|Other|7
7626008|NCT01709513|26535276|P2|Overall Study|Other|11
7626009|NCT01709513|26535277|P1|Overall Study|Other|3
7626010|NCT01709513|26535275|P3|Overall Study|Poor compliance to protocol|0
7626011|NCT01709513|26535276|P2|Overall Study|Poor compliance to protocol|0
7626012|NCT01709513|26535277|P1|Overall Study|Poor compliance to protocol|2
7626013|NCT01709513|26535275|P3|Overall Study|Adverse Event|23
7626014|NCT01709513|26535276|P2|Overall Study|Adverse Event|31
7626015|NCT01709513|26535277|P1|Overall Study|Adverse Event|16
7626016|NCT01709513|26535275|P3|Overall Study|Randomized but not treated|0
7626017|NCT01709513|26535276|P2|Overall Study|Randomized but not treated|1
7626018|NCT01709513|26535277|P1|Overall Study|Randomized but not treated|0
7626019|NCT01709500|26535338|P2|Overall Study|Treatment ongoing|78
7626020|NCT01709500|26535339|P1|Overall Study|Treatment ongoing|156
7626021|NCT01709500|26535338|P2|Overall Study|Related to IMP administration|0
7626022|NCT01709500|26535339|P1|Overall Study|Related to IMP administration|1
7626023|NCT01709500|26535338|P2|Overall Study|Other|1
7626024|NCT01709500|26535339|P1|Overall Study|Other|3
7626025|NCT01709500|26535338|P2|Overall Study|Poor compliance to protocol|1
7626026|NCT01709500|26535339|P1|Overall Study|Poor compliance to protocol|2
7626027|NCT01709500|26535338|P2|Overall Study|Adverse Event|1
7626028|NCT01709500|26535339|P1|Overall Study|Adverse Event|5
7626029|NCT01709500|26535338|P2|Overall Study|Randomized but not treated|1
7626030|NCT01709500|26535339|P1|Overall Study|Randomized but not treated|0
7626031|NCT01709409|26535417|P2|Overall Study|Protocol Violation|0
7626032|NCT01709409|26535418|P1|Overall Study|Protocol Violation|1
7626033|NCT01709383|26535426|P2|Overall Study|Lost to Follow-up|0
7626034|NCT01709383|26535427|P1|Overall Study|Lost to Follow-up|1
7626035|NCT01709331|26535445|P1|Overall Study|Adverse Event|1
7626036|NCT01709318|26535458|P7|Overall Study|Other Protocol Specified Criteria|0
7626037|NCT01709318|26535459|P6|Overall Study|Other Protocol Specified Criteria|0
7626038|NCT01709318|26535460|P5|Overall Study|Other Protocol Specified Criteria|0
7626039|NCT01709318|26535461|P4|Overall Study|Other Protocol Specified Criteria|0
7626040|NCT01709318|26535462|P3|Overall Study|Other Protocol Specified Criteria|0
7626041|NCT01709318|26535463|P2|Overall Study|Other Protocol Specified Criteria|1
7626042|NCT01709318|26535464|P1|Overall Study|Other Protocol Specified Criteria|0
7626043|NCT01709318|26535458|P7|Overall Study|Withdrawal by Subject|4
7626044|NCT01709318|26535459|P6|Overall Study|Withdrawal by Subject|2
7626045|NCT01709318|26535460|P5|Overall Study|Withdrawal by Subject|0
7626046|NCT01709318|26535461|P4|Overall Study|Withdrawal by Subject|3
7626047|NCT01709318|26535462|P3|Overall Study|Withdrawal by Subject|3
7626048|NCT01709318|26535463|P2|Overall Study|Withdrawal by Subject|0
7626049|NCT01709318|26535464|P1|Overall Study|Withdrawal by Subject|3
7626050|NCT01709318|26535458|P7|Overall Study|Technical Problems|0
7626051|NCT01709318|26535459|P6|Overall Study|Technical Problems|0
7626052|NCT01709318|26535460|P5|Overall Study|Technical Problems|0
7626053|NCT01709318|26535461|P4|Overall Study|Technical Problems|0
7626054|NCT01709318|26535462|P3|Overall Study|Technical Problems|0
7626055|NCT01709318|26535463|P2|Overall Study|Technical Problems|0
7626056|NCT01709318|26535464|P1|Overall Study|Technical Problems|1
7626057|NCT01709318|26535458|P7|Overall Study|Protocol Violation|1
7626058|NCT01709318|26535459|P6|Overall Study|Protocol Violation|0
7626059|NCT01709318|26535460|P5|Overall Study|Protocol Violation|2
7626060|NCT01709318|26535461|P4|Overall Study|Protocol Violation|0
7626061|NCT01709318|26535462|P3|Overall Study|Protocol Violation|0
7626062|NCT01709318|26535463|P2|Overall Study|Protocol Violation|0
7626063|NCT01709318|26535464|P1|Overall Study|Protocol Violation|0
7626064|NCT01709318|26535458|P7|Overall Study|Pregnancy|0
7626065|NCT01709318|26535459|P6|Overall Study|Pregnancy|0
7626066|NCT01709318|26535460|P5|Overall Study|Pregnancy|1
7626067|NCT01709318|26535461|P4|Overall Study|Pregnancy|0
7626068|NCT01709318|26535462|P3|Overall Study|Pregnancy|0
7626069|NCT01709318|26535463|P2|Overall Study|Pregnancy|0
7626070|NCT01709318|26535464|P1|Overall Study|Pregnancy|0
7626071|NCT01709318|26535458|P7|Overall Study|Physician Decision|1
7626072|NCT01709318|26535459|P6|Overall Study|Physician Decision|0
7626073|NCT01709318|26535460|P5|Overall Study|Physician Decision|0
7626074|NCT01709318|26535461|P4|Overall Study|Physician Decision|0
7626075|NCT01709318|26535462|P3|Overall Study|Physician Decision|0
7626076|NCT01709318|26535463|P2|Overall Study|Physician Decision|0
7626077|NCT01709318|26535464|P1|Overall Study|Physician Decision|0
7626078|NCT01709318|26535458|P7|Overall Study|Non-compliance with Study Drug|2
7626079|NCT01709318|26535459|P6|Overall Study|Non-compliance with Study Drug|0
7626080|NCT01709318|26535460|P5|Overall Study|Non-compliance with Study Drug|0
7626081|NCT01709318|26535461|P4|Overall Study|Non-compliance with Study Drug|1
7626082|NCT01709318|26535462|P3|Overall Study|Non-compliance with Study Drug|1
7626083|NCT01709318|26535463|P2|Overall Study|Non-compliance with Study Drug|2
7626084|NCT01709318|26535464|P1|Overall Study|Non-compliance with Study Drug|0
7626085|NCT01709318|26535458|P7|Overall Study|Lost to Follow-up|1
7626086|NCT01709318|26535459|P6|Overall Study|Lost to Follow-up|1
7626087|NCT01709318|26535460|P5|Overall Study|Lost to Follow-up|1
7626088|NCT01709318|26535461|P4|Overall Study|Lost to Follow-up|0
7626089|NCT01709318|26535462|P3|Overall Study|Lost to Follow-up|0
7626090|NCT01709318|26535463|P2|Overall Study|Lost to Follow-up|0
7626091|NCT01709318|26535464|P1|Overall Study|Lost to Follow-up|2
7626092|NCT01709318|26535458|P7|Overall Study|Adverse Event|2
7626093|NCT01709318|26535459|P6|Overall Study|Adverse Event|1
7626094|NCT01709318|26535460|P5|Overall Study|Adverse Event|0
7626095|NCT01709318|26535461|P4|Overall Study|Adverse Event|2
7626096|NCT01709318|26535462|P3|Overall Study|Adverse Event|2
7626097|NCT01709318|26535463|P2|Overall Study|Adverse Event|4
7626098|NCT01709318|26535464|P1|Overall Study|Adverse Event|3
7626099|NCT01709305|26535557|P5|Phase 2|Withdrawal by Subject|12
7626100|NCT01709305|26535558|P4|Phase 2|Withdrawal by Subject|15
7626101|NCT01709305|26535559|P3|Phase 2|Withdrawal by Subject|6
7626102|NCT01709305|26535560|P2|Phase 2|Withdrawal by Subject|8
7626103|NCT01709305|26535561|P1|Phase 2|Withdrawal by Subject|0
7626104|NCT01709305|26535557|P5|Phase 2|Protocol Violation|9
7626105|NCT01709305|26535558|P4|Phase 2|Protocol Violation|13
7626106|NCT01709305|26535559|P3|Phase 2|Protocol Violation|19
7626107|NCT01709305|26535560|P2|Phase 2|Protocol Violation|19
7626108|NCT01709305|26535561|P1|Phase 2|Protocol Violation|0
7626109|NCT01709305|26535557|P5|Phase 2|Physician Decision|2
7626110|NCT01709305|26535558|P4|Phase 2|Physician Decision|1
7626111|NCT01709305|26535559|P3|Phase 2|Physician Decision|0
7626112|NCT01709305|26535560|P2|Phase 2|Physician Decision|2
7626113|NCT01709305|26535561|P1|Phase 2|Physician Decision|0
7626114|NCT01709305|26535557|P5|Phase 2|Travel, moving, etc.|5
7626115|NCT01709305|26535558|P4|Phase 2|Travel, moving, etc.|3
7626116|NCT01709305|26535559|P3|Phase 2|Travel, moving, etc.|3
7626117|NCT01709305|26535560|P2|Phase 2|Travel, moving, etc.|2
7626118|NCT01709305|26535561|P1|Phase 2|Travel, moving, etc.|0
7626119|NCT01709305|26535557|P5|Phase 2|Lost to Follow-up|5
7626120|NCT01709305|26535558|P4|Phase 2|Lost to Follow-up|9
7626121|NCT01709305|26535559|P3|Phase 2|Lost to Follow-up|6
7626122|NCT01709305|26535560|P2|Phase 2|Lost to Follow-up|10
7626123|NCT01709305|26535561|P1|Phase 2|Lost to Follow-up|0
7626124|NCT01709305|26535557|P5|Phase 2|Laboratory Adverse Event|1
7626125|NCT01709305|26535558|P4|Phase 2|Laboratory Adverse Event|1
7626126|NCT01709305|26535559|P3|Phase 2|Laboratory Adverse Event|0
7626127|NCT01709305|26535560|P2|Phase 2|Laboratory Adverse Event|1
7626128|NCT01709305|26535561|P1|Phase 2|Laboratory Adverse Event|0
7626129|NCT01709305|26535557|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
7626130|NCT01709305|26535558|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
7626131|NCT01709305|26535559|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
7626132|NCT01709305|26535560|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
7626133|NCT01709305|26535561|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
7626134|NCT01709305|26535557|P5|Phase 2|Death|0
7626135|NCT01709305|26535558|P4|Phase 2|Death|0
7626136|NCT01709305|26535559|P3|Phase 2|Death|1
7626137|NCT01709305|26535560|P2|Phase 2|Death|0
7626138|NCT01709305|26535561|P1|Phase 2|Death|0
7626139|NCT01709305|26535557|P5|Phase 2|Clinical Adverse Event|11
7626140|NCT01709305|26535558|P4|Phase 2|Clinical Adverse Event|6
7626141|NCT01709305|26535559|P3|Phase 2|Clinical Adverse Event|10
7626142|NCT01709305|26535560|P2|Phase 2|Clinical Adverse Event|10
7626143|NCT01709305|26535561|P1|Phase 2|Clinical Adverse Event|0
7626144|NCT01709305|26535557|P5|Phase 1|Withdrawal by Subject|0
7626145|NCT01709305|26535558|P4|Phase 1|Withdrawal by Subject|0
7626146|NCT01709305|26535559|P3|Phase 1|Withdrawal by Subject|0
7626147|NCT01709305|26535560|P2|Phase 1|Withdrawal by Subject|0
7626148|NCT01709305|26535561|P1|Phase 1|Withdrawal by Subject|218
7626149|NCT01709305|26535557|P5|Phase 1|Protocol Violation|0
7626150|NCT01709305|26535558|P4|Phase 1|Protocol Violation|0
7626151|NCT01709305|26535559|P3|Phase 1|Protocol Violation|0
7626152|NCT01709305|26535560|P2|Phase 1|Protocol Violation|0
7626153|NCT01709305|26535561|P1|Phase 1|Protocol Violation|118
7626154|NCT01709305|26535557|P5|Phase 1|Physician Decision|0
7626155|NCT01709305|26535558|P4|Phase 1|Physician Decision|0
7626156|NCT01709305|26535559|P3|Phase 1|Physician Decision|0
7626157|NCT01709305|26535560|P2|Phase 1|Physician Decision|0
7626158|NCT01709305|26535561|P1|Phase 1|Physician Decision|13
7626159|NCT01709305|26535557|P5|Phase 1|Travel, moving, etc.|0
7626160|NCT01709305|26535558|P4|Phase 1|Travel, moving, etc.|0
7626161|NCT01709305|26535559|P3|Phase 1|Travel, moving, etc.|0
7626162|NCT01709305|26535560|P2|Phase 1|Travel, moving, etc.|0
7626163|NCT01709305|26535561|P1|Phase 1|Travel, moving, etc.|30
7626164|NCT01709305|26535557|P5|Phase 1|Lost to Follow-up|0
7626165|NCT01709305|26535558|P4|Phase 1|Lost to Follow-up|0
7626166|NCT01709305|26535559|P3|Phase 1|Lost to Follow-up|0
7626167|NCT01709305|26535560|P2|Phase 1|Lost to Follow-up|0
7626168|NCT01709305|26535561|P1|Phase 1|Lost to Follow-up|147
7626169|NCT01709305|26535557|P5|Phase 1|Laboratory Adverse Event|0
7626170|NCT01709305|26535558|P4|Phase 1|Laboratory Adverse Event|0
7626171|NCT01709305|26535559|P3|Phase 1|Laboratory Adverse Event|0
7626172|NCT01709305|26535560|P2|Phase 1|Laboratory Adverse Event|0
7626173|NCT01709305|26535561|P1|Phase 1|Laboratory Adverse Event|16
7626174|NCT01709305|26535557|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
7626175|NCT01709305|26535558|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
7626176|NCT01709305|26535559|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
7626177|NCT01709305|26535560|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
7626178|NCT01709305|26535561|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
7626179|NCT01709305|26535557|P5|Phase 1|Death|0
7626180|NCT01709305|26535558|P4|Phase 1|Death|0
7626181|NCT01709305|26535559|P3|Phase 1|Death|0
7626182|NCT01709305|26535560|P2|Phase 1|Death|0
7626183|NCT01709305|26535561|P1|Phase 1|Death|2
7626184|NCT01709305|26535557|P5|Phase 1|Clinical Adverse Event|0
7626185|NCT01709305|26535558|P4|Phase 1|Clinical Adverse Event|0
7626186|NCT01709305|26535559|P3|Phase 1|Clinical Adverse Event|0
7626187|NCT01709305|26535560|P2|Phase 1|Clinical Adverse Event|0
7626188|NCT01709305|26535561|P1|Phase 1|Clinical Adverse Event|80
7626189|NCT01709227|26535598|P2|Overall Study|Pleural Peritoneal communication|9
7626190|NCT01709227|26535599|P1|Overall Study|Pleural Peritoneal communication|0
7626191|NCT01709227|26535598|P2|Overall Study|Physician Decision|0
7626192|NCT01709227|26535599|P1|Overall Study|Physician Decision|1
7626193|NCT01709162|26535625|P2|Overall Study|Withdrawal by Subject|1
7626194|NCT01709162|26535626|P1|Overall Study|Withdrawal by Subject|0
7626195|NCT01709162|26535625|P2|Overall Study|Other|0
7626196|NCT01709162|26535626|P1|Overall Study|Other|1
7626197|NCT01709162|26535625|P2|Overall Study|Administrative reason by sponsor|1
7626198|NCT01709162|26535626|P1|Overall Study|Administrative reason by sponsor|0
7626199|NCT01709162|26535625|P2|Overall Study|Study drug toxicity|0
7626200|NCT01709162|26535626|P1|Overall Study|Study drug toxicity|2
7626201|NCT01709162|26535625|P2|Overall Study|Disease progression|3
7626202|NCT01709162|26535626|P1|Overall Study|Disease progression|3
7626203|NCT01709149|26535641|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7626204|NCT01709149|26535642|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7626205|NCT01709149|26535643|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7626206|NCT01709149|26535641|P3|Double-blind, Placebo-controlled Phase|not defined|2
7626207|NCT01709149|26535642|P2|Double-blind, Placebo-controlled Phase|not defined|1
7626208|NCT01709149|26535643|P1|Double-blind, Placebo-controlled Phase|not defined|0
7626209|NCT01709149|26535641|P3|Double-blind, Placebo-controlled Phase|Death|0
7626210|NCT01709149|26535642|P2|Double-blind, Placebo-controlled Phase|Death|2
7626211|NCT01709149|26535643|P1|Double-blind, Placebo-controlled Phase|Death|0
7626212|NCT01709149|26535641|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
7626213|NCT01709149|26535642|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
7626214|NCT01709149|26535643|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
7626215|NCT01709149|26535641|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
7626216|NCT01709149|26535642|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
7626217|NCT01709149|26535643|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7626218|NCT01709149|26535641|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
7626219|NCT01709149|26535642|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
7626220|NCT01709149|26535643|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
7626221|NCT01709149|26535641|P3|Open-label Lead-in Phase|Protocol Violation|0
7626222|NCT01709149|26535642|P2|Open-label Lead-in Phase|Protocol Violation|0
7626223|NCT01709149|26535643|P1|Open-label Lead-in Phase|Protocol Violation|3
7626224|NCT01709149|26535641|P3|Open-label Lead-in Phase|Death|0
7626225|NCT01709149|26535642|P2|Open-label Lead-in Phase|Death|0
7626226|NCT01709149|26535643|P1|Open-label Lead-in Phase|Death|1
7626227|NCT01709149|26535641|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
7626228|NCT01709149|26535642|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
7626229|NCT01709149|26535643|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
7626230|NCT01709149|26535641|P3|Open-label Lead-in Phase|Adverse Event|0
7626231|NCT01709149|26535642|P2|Open-label Lead-in Phase|Adverse Event|0
7626232|NCT01709149|26535643|P1|Open-label Lead-in Phase|Adverse Event|109
7626233|NCT01709110|26535671|P2|Overall Study|Caregiver Decision|1
7626234|NCT01709110|26535672|P1|Overall Study|Caregiver Decision|1
7626235|NCT01709110|26535671|P2|Overall Study|Lack of Efficacy|1
7626236|NCT01709110|26535672|P1|Overall Study|Lack of Efficacy|1
7626237|NCT01709110|26535671|P2|Overall Study|Sponsor Decision|2
7626238|NCT01709110|26535672|P1|Overall Study|Sponsor Decision|2
7626239|NCT01709110|26535671|P2|Overall Study|Physician Decision|10
7626240|NCT01709110|26535672|P1|Overall Study|Physician Decision|4
7626241|NCT01709110|26535671|P2|Overall Study|Withdrawal by Subject|89
7626242|NCT01709110|26535672|P1|Overall Study|Withdrawal by Subject|96
7626243|NCT01709110|26535671|P2|Overall Study|Protocol Violation|6
7626244|NCT01709110|26535672|P1|Overall Study|Protocol Violation|4
7626245|NCT01709110|26535671|P2|Overall Study|Lost to Follow-up|5
7626246|NCT01709110|26535672|P1|Overall Study|Lost to Follow-up|7
7626247|NCT01709110|26535671|P2|Overall Study|Death|6
7626248|NCT01709110|26535672|P1|Overall Study|Death|14
7626249|NCT01709110|26535671|P2|Overall Study|Adverse Event|48
7626250|NCT01709110|26535672|P1|Overall Study|Adverse Event|56
7626251|NCT01709084|26535702|P2|Overall Study|Not Treated|2
7626252|NCT01709084|26535703|P1|Overall Study|Not Treated|0
7626253|NCT01709084|26535702|P2|Overall Study|Participant Reached a Virologic Endpoint|1
7626254|NCT01709084|26535703|P1|Overall Study|Participant Reached a Virologic Endpoint|0
7626255|NCT01709084|26535702|P2|Overall Study|Other|3
7626256|NCT01709084|26535703|P1|Overall Study|Other|5
7626257|NCT01709084|26535702|P2|Overall Study|Adverse Event|0
7626258|NCT01709084|26535703|P1|Overall Study|Adverse Event|5
7626259|NCT01709084|26535702|P2|Overall Study|Withdrawal by Subject|2
7626260|NCT01709084|26535703|P1|Overall Study|Withdrawal by Subject|2
7626261|NCT01709084|26535702|P2|Overall Study|Lost to Follow-up|7
7626262|NCT01709084|26535703|P1|Overall Study|Lost to Follow-up|4
7626299|NCT01708941|26535763|P4|Overall Study|Ineligible|0
7626300|NCT01708941|26535764|P3|Overall Study|Ineligible|2
7626301|NCT01708941|26535765|P2|Overall Study|Ineligible|0
7626302|NCT01708941|26535766|P1|Overall Study|Ineligible|0
7626303|NCT01708941|26535763|P4|Overall Study|Never started treatment|0
7626304|NCT01708941|26535764|P3|Overall Study|Never started treatment|0
7626305|NCT01708941|26535765|P2|Overall Study|Never started treatment|1
7626306|NCT01708941|26535766|P1|Overall Study|Never started treatment|2
7626307|NCT01708941|26535763|P4|Overall Study|Ineligible and never started treatment|0
7626308|NCT01708941|26535764|P3|Overall Study|Ineligible and never started treatment|1
7626309|NCT01708941|26535765|P2|Overall Study|Ineligible and never started treatment|0
7626310|NCT01708941|26535766|P1|Overall Study|Ineligible and never started treatment|1
7626311|NCT01708941|26535763|P4|Overall Study|Alternative therapy|0
7626312|NCT01708941|26535764|P3|Overall Study|Alternative therapy|2
7626313|NCT01708941|26535765|P2|Overall Study|Alternative therapy|0
7626314|NCT01708941|26535766|P1|Overall Study|Alternative therapy|0
7626315|NCT01708941|26535763|P4|Overall Study|Disease progression|0
7626316|NCT01708941|26535764|P3|Overall Study|Disease progression|8
7626317|NCT01708941|26535765|P2|Overall Study|Disease progression|10
7626318|NCT01708941|26535766|P1|Overall Study|Disease progression|9
7626319|NCT01708941|26535763|P4|Overall Study|Withdrawal by Subject|4
7626320|NCT01708941|26535764|P3|Overall Study|Withdrawal by Subject|3
7626321|NCT01708941|26535765|P2|Overall Study|Withdrawal by Subject|0
7626322|NCT01708941|26535766|P1|Overall Study|Withdrawal by Subject|1
7626323|NCT01708941|26535763|P4|Overall Study|Death|14
7626324|NCT01708941|26535764|P3|Overall Study|Death|2
7626325|NCT01708941|26535765|P2|Overall Study|Death|1
7626326|NCT01708941|26535766|P1|Overall Study|Death|1
7626327|NCT01708941|26535763|P4|Overall Study|Adverse Event|0
7626328|NCT01708941|26535764|P3|Overall Study|Adverse Event|1
7626329|NCT01708941|26535765|P2|Overall Study|Adverse Event|6
7626330|NCT01708941|26535766|P1|Overall Study|Adverse Event|4
7626331|NCT01708915|26535784|P4|Overall Study|Other reasons than stated above|2
7626332|NCT01708915|26535785|P3|Overall Study|Other reasons than stated above|0
7626333|NCT01708915|26535786|P2|Overall Study|Other reasons than stated above|1
7626334|NCT01708915|26535787|P1|Overall Study|Other reasons than stated above|1
7626335|NCT01708915|26535784|P4|Overall Study|Withdrawal by Subject|2
7626336|NCT01708915|26535785|P3|Overall Study|Withdrawal by Subject|2
7626337|NCT01708915|26535786|P2|Overall Study|Withdrawal by Subject|1
7626338|NCT01708915|26535787|P1|Overall Study|Withdrawal by Subject|0
7626339|NCT01708915|26535784|P4|Overall Study|Protocol Violation|1
7626340|NCT01708915|26535785|P3|Overall Study|Protocol Violation|0
7626341|NCT01708915|26535786|P2|Overall Study|Protocol Violation|0
7626342|NCT01708915|26535787|P1|Overall Study|Protocol Violation|0
7626343|NCT01708915|26535784|P4|Overall Study|Lack of Efficacy|15
7626344|NCT01708915|26535785|P3|Overall Study|Lack of Efficacy|35
7626345|NCT01708915|26535786|P2|Overall Study|Lack of Efficacy|60
7626346|NCT01708915|26535787|P1|Overall Study|Lack of Efficacy|84
7626347|NCT01708915|26535784|P4|Overall Study|Adverse Event|13
7626348|NCT01708915|26535785|P3|Overall Study|Adverse Event|9
7626349|NCT01708915|26535786|P2|Overall Study|Adverse Event|0
7626350|NCT01708915|26535787|P1|Overall Study|Adverse Event|1
7626351|NCT01708902|26535816|P7|Overall Study|Other Reason|0
7626352|NCT01708902|26535817|P6|Overall Study|Other Reason|2
7626353|NCT01708902|26535818|P5|Overall Study|Other Reason|1
7626354|NCT01708902|26535819|P4|Overall Study|Other Reason|1
7626355|NCT01708902|26535820|P3|Overall Study|Other Reason|1
7626356|NCT01708902|26535821|P2|Overall Study|Other Reason|0
7626357|NCT01708902|26535822|P1|Overall Study|Other Reason|1
7626358|NCT01708902|26535816|P7|Overall Study|Refused to continue trial medication|1
7626359|NCT01708902|26535817|P6|Overall Study|Refused to continue trial medication|1
7626360|NCT01708902|26535818|P5|Overall Study|Refused to continue trial medication|8
7626361|NCT01708902|26535819|P4|Overall Study|Refused to continue trial medication|2
7626362|NCT01708902|26535820|P3|Overall Study|Refused to continue trial medication|4
7626363|NCT01708902|26535821|P2|Overall Study|Refused to continue trial medication|0
7626364|NCT01708902|26535822|P1|Overall Study|Refused to continue trial medication|8
7626365|NCT01708902|26535816|P7|Overall Study|Lost to Follow-up|1
7626366|NCT01708902|26535817|P6|Overall Study|Lost to Follow-up|0
7626367|NCT01708902|26535818|P5|Overall Study|Lost to Follow-up|0
7626368|NCT01708902|26535819|P4|Overall Study|Lost to Follow-up|2
7626369|NCT01708902|26535820|P3|Overall Study|Lost to Follow-up|2
7626370|NCT01708902|26535821|P2|Overall Study|Lost to Follow-up|1
7626371|NCT01708902|26535822|P1|Overall Study|Lost to Follow-up|2
7626372|NCT01708902|26535816|P7|Overall Study|Non compliance with protocol|0
7626373|NCT01708902|26535817|P6|Overall Study|Non compliance with protocol|0
7626374|NCT01708902|26535818|P5|Overall Study|Non compliance with protocol|0
7626375|NCT01708902|26535819|P4|Overall Study|Non compliance with protocol|3
7626376|NCT01708902|26535820|P3|Overall Study|Non compliance with protocol|1
7626377|NCT01708902|26535821|P2|Overall Study|Non compliance with protocol|2
7626378|NCT01708902|26535822|P1|Overall Study|Non compliance with protocol|0
7626379|NCT01708902|26535816|P7|Overall Study|Lack of Efficacy|0
7626380|NCT01708902|26535817|P6|Overall Study|Lack of Efficacy|1
7626381|NCT01708902|26535818|P5|Overall Study|Lack of Efficacy|0
7626382|NCT01708902|26535819|P4|Overall Study|Lack of Efficacy|0
7626383|NCT01708902|26535820|P3|Overall Study|Lack of Efficacy|0
7626384|NCT01708902|26535821|P2|Overall Study|Lack of Efficacy|1
7626385|NCT01708902|26535822|P1|Overall Study|Lack of Efficacy|3
7626386|NCT01708902|26535816|P7|Overall Study|Adverse Event|5
7626387|NCT01708902|26535817|P6|Overall Study|Adverse Event|3
7626388|NCT01708902|26535818|P5|Overall Study|Adverse Event|7
7626389|NCT01708902|26535819|P4|Overall Study|Adverse Event|2
7626390|NCT01708902|26535820|P3|Overall Study|Adverse Event|9
7626391|NCT01708902|26535821|P2|Overall Study|Adverse Event|4
7626392|NCT01708902|26535822|P1|Overall Study|Adverse Event|3
7626393|NCT01708291|26535964|P2|Overall Study|fighting|1
7626394|NCT01708291|26535965|P1|Overall Study|fighting|2
7626395|NCT01708187|26536004|P2|Overall Study|Lost to Follow-up|1
7626396|NCT01708187|26536005|P1|Overall Study|Lost to Follow-up|0
7626397|NCT01708174|26536014|P3|Treatment Period|Adverse Event|0
7626398|NCT01708174|26536015|P2|Treatment Period|Adverse Event|1
7626399|NCT01708174|26536016|P1|Treatment Period|Adverse Event|0
7626400|NCT01708174|26536014|P3|Treatment Period|Death|1
7626401|NCT01708174|26536015|P2|Treatment Period|Death|0
7626402|NCT01708174|26536016|P1|Treatment Period|Death|0
7626403|NCT01708174|26536014|P3|Treatment Period|Progressive disease|0
7626404|NCT01708174|26536015|P2|Treatment Period|Progressive disease|1
7626405|NCT01708174|26536016|P1|Treatment Period|Progressive disease|0
7626406|NCT01708174|26536014|P3|Treatment Period|Withdrawal by Subject|0
7626407|NCT01708174|26536015|P2|Treatment Period|Withdrawal by Subject|0
7626408|NCT01708174|26536016|P1|Treatment Period|Withdrawal by Subject|1
7626409|NCT01708161|26536048|P6|Overall Study|Disease progression|0
7626410|NCT01708161|26536049|P5|Overall Study|Disease progression|3
7626411|NCT01708161|26536050|P4|Overall Study|Disease progression|13
7626412|NCT01708161|26536051|P3|Overall Study|Disease progression|5
7626413|NCT01708161|26536052|P2|Overall Study|Disease progression|5
7626414|NCT01708161|26536053|P1|Overall Study|Disease progression|3
7626415|NCT01708161|26536048|P6|Overall Study|Administrative problems|0
7626416|NCT01708161|26536049|P5|Overall Study|Administrative problems|0
7626417|NCT01708161|26536050|P4|Overall Study|Administrative problems|0
7626418|NCT01708161|26536051|P3|Overall Study|Administrative problems|0
7626419|NCT01708161|26536052|P2|Overall Study|Administrative problems|1
7626420|NCT01708161|26536053|P1|Overall Study|Administrative problems|0
7626421|NCT01708161|26536048|P6|Overall Study|Withdrawal by Subject|0
7626422|NCT01708161|26536049|P5|Overall Study|Withdrawal by Subject|0
7626423|NCT01708161|26536050|P4|Overall Study|Withdrawal by Subject|0
7626424|NCT01708161|26536051|P3|Overall Study|Withdrawal by Subject|1
7626425|NCT01708161|26536052|P2|Overall Study|Withdrawal by Subject|1
7626426|NCT01708161|26536053|P1|Overall Study|Withdrawal by Subject|0
7626427|NCT01708161|26536048|P6|Overall Study|Death|1
7626428|NCT01708161|26536049|P5|Overall Study|Death|0
7626429|NCT01708161|26536050|P4|Overall Study|Death|1
7626430|NCT01708161|26536051|P3|Overall Study|Death|0
7626431|NCT01708161|26536052|P2|Overall Study|Death|0
7626432|NCT01708161|26536053|P1|Overall Study|Death|0
7626433|NCT01708161|26536048|P6|Overall Study|Adverse Event|0
7626434|NCT01708161|26536049|P5|Overall Study|Adverse Event|3
7626435|NCT01708161|26536050|P4|Overall Study|Adverse Event|2
7626436|NCT01708161|26536051|P3|Overall Study|Adverse Event|4
7626437|NCT01708161|26536052|P2|Overall Study|Adverse Event|3
7626438|NCT01708161|26536053|P1|Overall Study|Adverse Event|1
7626439|NCT01708057|26536104|P3|Overall Study|Withdrawal due to study termination.|1
7626440|NCT01708057|26536105|P2|Overall Study|Withdrawal due to study termination.|1
7626441|NCT01708057|26536106|P1|Overall Study|Withdrawal due to study termination.|1
7626442|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7626443|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
7626444|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7626445|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7626446|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7626447|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7626448|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
7626449|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
7626450|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
7626451|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7626452|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7626453|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7626454|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Noncompliance|2
7626455|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Noncompliance|4
7626456|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Noncompliance|0
7626457|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Noncompliance|0
7626458|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Noncompliance|0
7626459|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Noncompliance|0
7626460|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Other than specified|2
7626461|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Other than specified|5
7626462|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Other than specified|1
7626463|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Other than specified|0
7626464|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Other than specified|0
7626465|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Other than specified|0
7626466|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Death|0
7626467|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Death|0
7626468|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Death|2
7626469|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Death|0
7626470|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Death|0
7626471|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Death|0
7626472|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
7626473|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
7626474|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
7626475|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7626476|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7626477|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7626478|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Pregnancy|2
7626479|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Pregnancy|5
7626480|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Pregnancy|2
7626481|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Pregnancy|0
7626482|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Pregnancy|0
7626483|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Pregnancy|0
7626484|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
7626485|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
7626486|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
7626487|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7626488|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7626489|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7626490|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
7626491|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
7626492|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
7626493|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7626494|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7626495|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7626496|NCT01707992|26536165|P6|Active Treatment Phase (24 Months)|Adverse Event|0
7626497|NCT01707992|26536166|P5|Active Treatment Phase (24 Months)|Adverse Event|1
7626498|NCT01707992|26536167|P4|Active Treatment Phase (24 Months)|Adverse Event|4
7626499|NCT01707992|26536168|P3|Active Treatment Phase (24 Months)|Adverse Event|0
7626500|NCT01707992|26536169|P2|Active Treatment Phase (24 Months)|Adverse Event|0
7626501|NCT01707992|26536170|P1|Active Treatment Phase (24 Months)|Adverse Event|0
7626502|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
7626503|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
7626504|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
7626505|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
7626506|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
7626507|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
7626508|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7626509|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7626510|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7626511|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
7626512|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
7626513|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
7626514|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Death|0
7626515|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Death|0
7626516|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Death|0
7626517|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Death|1
7626518|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Death|1
7626519|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Death|2
7626520|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7626521|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7626522|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7626523|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
7626524|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
7626525|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
7626526|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7626527|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7626528|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7626529|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
7626530|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
7626531|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
7626532|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7626533|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7626534|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7626535|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7626536|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7626537|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
7626538|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7626539|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7626540|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7626541|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
7626542|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
7626543|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
7626544|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7626545|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7626546|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7626547|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
7626548|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
7626549|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
7626550|NCT01707992|26536165|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7626551|NCT01707992|26536166|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7626552|NCT01707992|26536167|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7626553|NCT01707992|26536168|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
7626554|NCT01707992|26536169|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
7626555|NCT01707992|26536170|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
7626556|NCT01707693|26536222|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
7626557|NCT01707693|26536223|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
7626558|NCT01707693|26536222|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
7626559|NCT01707693|26536223|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
7626560|NCT01707693|26536222|P2|Overall Study Allocation|Protocol Violation|3
7626561|NCT01707693|26536223|P1|Overall Study Allocation|Protocol Violation|4
7626562|NCT01707693|26536222|P2|Overall Study Allocation|Withdrawal by Subject|5
7626563|NCT01707693|26536223|P1|Overall Study Allocation|Withdrawal by Subject|9
7626564|NCT01707667|26536237|P2|Period 1|expulsion of colonic sensor catheter|0
7626565|NCT01707667|26536238|P1|Period 1|expulsion of colonic sensor catheter|1
7626566|NCT01707290|26536321|P2|Overall Study|Other unspecified|0
7626567|NCT01707290|26536322|P1|Overall Study|Other unspecified|17
7626568|NCT01707290|26536321|P2|Overall Study|Commercial drug available|1
7626569|NCT01707290|26536322|P1|Overall Study|Commercial drug available|60
7626570|NCT01707290|26536321|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
7626571|NCT01707290|26536322|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
7626572|NCT01707290|26536321|P2|Overall Study|Lost to Follow-up|0
7626573|NCT01707290|26536322|P1|Overall Study|Lost to Follow-up|3
7626574|NCT01707290|26536321|P2|Overall Study|Physician Decision|0
7626575|NCT01707290|26536322|P1|Overall Study|Physician Decision|1
7626576|NCT01707290|26536321|P2|Overall Study|Adverse event (AE)|0
7626577|NCT01707290|26536322|P1|Overall Study|Adverse event (AE)|1
7626578|NCT01707147|26536367|P1|Overall Study|Violated inclusion/exclusion criteria|77
7626579|NCT01707147|26536367|P1|Overall Study|Follow-up failure|17
7626580|NCT01707147|26536367|P1|Overall Study|Patients who have not taken Trajenta|1
7626581|NCT01707147|26536367|P1|Overall Study|Administered Trajenta prior to contract|5
7626582|NCT01707030|26536404|P2|Overall Study|Lost to Follow-up|13
7626583|NCT01707030|26536405|P1|Overall Study|Lost to Follow-up|8
7626584|NCT01707030|26536404|P2|Overall Study|Withdrawal by Subject|3
7626585|NCT01707030|26536405|P1|Overall Study|Withdrawal by Subject|2
7626586|NCT01707030|26536404|P2|Overall Study|Death|1
7626587|NCT01707030|26536405|P1|Overall Study|Death|1
7626588|NCT01707004|26536423|P1|Overall Study|Physician Decision|3
7626589|NCT01706926|26536477|P4|Overall Study|Other|3
7626590|NCT01706926|26536478|P3|Overall Study|Other|4
7626591|NCT01706926|26536479|P2|Overall Study|Other|4
7626592|NCT01706926|26536480|P1|Overall Study|Other|4
7626593|NCT01706926|26536477|P4|Overall Study|Withdrawal by Subject|2
7626594|NCT01706926|26536478|P3|Overall Study|Withdrawal by Subject|1
7626595|NCT01706926|26536479|P2|Overall Study|Withdrawal by Subject|0
7626596|NCT01706926|26536480|P1|Overall Study|Withdrawal by Subject|2
7626597|NCT01706926|26536477|P4|Overall Study|Lost to Follow-up|0
7626598|NCT01706926|26536478|P3|Overall Study|Lost to Follow-up|1
7626599|NCT01706926|26536479|P2|Overall Study|Lost to Follow-up|0
7626600|NCT01706926|26536480|P1|Overall Study|Lost to Follow-up|0
7626601|NCT01706770|26536599|P2|Overall Study|Physician Decision|0
7626602|NCT01706770|26536600|P1|Overall Study|Physician Decision|1
7626603|NCT01706770|26536599|P2|Overall Study|Lost to Follow-up|0
7626604|NCT01706770|26536600|P1|Overall Study|Lost to Follow-up|1
7626605|NCT01706575|26536648|P1|Overall Study|Started but not Treated|6
7626606|NCT01706575|26536648|P1|Overall Study|Lost to Follow-up|2
7626607|NCT01706575|26536648|P1|Overall Study|Participant Withdrew Consent|4
7626608|NCT01706536|26536669|P5|Overall Study|non compliance|0
7626609|NCT01706536|26536670|P4|Overall Study|non compliance|0
7626610|NCT01706536|26536671|P3|Overall Study|non compliance|0
7626611|NCT01706536|26536672|P2|Overall Study|non compliance|1
7626612|NCT01706536|26536673|P1|Overall Study|non compliance|0
7626613|NCT01706536|26536669|P5|Overall Study|Lack of Efficacy|0
7626614|NCT01706536|26536670|P4|Overall Study|Lack of Efficacy|1
7626615|NCT01706536|26536671|P3|Overall Study|Lack of Efficacy|0
7626616|NCT01706536|26536672|P2|Overall Study|Lack of Efficacy|0
7626617|NCT01706536|26536673|P1|Overall Study|Lack of Efficacy|1
7626618|NCT01706536|26536669|P5|Overall Study|Adverse Event|2
7626619|NCT01706536|26536670|P4|Overall Study|Adverse Event|3
7626620|NCT01706536|26536671|P3|Overall Study|Adverse Event|4
7626621|NCT01706536|26536672|P2|Overall Study|Adverse Event|3
7626622|NCT01706536|26536673|P1|Overall Study|Adverse Event|2
7626623|NCT01706536|26536669|P5|Overall Study|Withdrawal by Subject|0
7626624|NCT01706536|26536670|P4|Overall Study|Withdrawal by Subject|0
7626625|NCT01706536|26536671|P3|Overall Study|Withdrawal by Subject|1
7626626|NCT01706536|26536672|P2|Overall Study|Withdrawal by Subject|0
7626627|NCT01706536|26536673|P1|Overall Study|Withdrawal by Subject|1
7626628|NCT01706458|26536740|P2|Overall Study|Physician Decision|4
7626629|NCT01706458|26536741|P1|Overall Study|Physician Decision|3
7626630|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
7626631|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
7626632|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
7626633|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Physician Decision|2
7626634|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Physician Decision|2
7626635|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Physician Decision|0
7626636|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
7626637|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
7626638|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
7626639|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
7626640|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
7626641|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
7626642|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Protocol Violation|2
7626643|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Protocol Violation|4
7626644|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Protocol Violation|0
7626645|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
7626646|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
7626647|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
7626648|NCT01706328|26536767|P3|12-week Double-blind Treatment Period|Adverse Event|16
7626649|NCT01706328|26536768|P2|12-week Double-blind Treatment Period|Adverse Event|14
7626650|NCT01706328|26536769|P1|12-week Double-blind Treatment Period|Adverse Event|0
7626651|NCT01706328|26536767|P3|2-week Run-in Period|Lost to Follow-up|0
7626652|NCT01706328|26536768|P2|2-week Run-in Period|Lost to Follow-up|0
7626653|NCT01706328|26536769|P1|2-week Run-in Period|Lost to Follow-up|2
7626654|NCT01706328|26536767|P3|2-week Run-in Period|Adverse Event|0
7626655|NCT01706328|26536768|P2|2-week Run-in Period|Adverse Event|0
7626656|NCT01706328|26536769|P1|2-week Run-in Period|Adverse Event|4
7626657|NCT01706328|26536767|P3|2-week Run-in Period|Physician Decision|0
7626658|NCT01706328|26536768|P2|2-week Run-in Period|Physician Decision|0
7626659|NCT01706328|26536769|P1|2-week Run-in Period|Physician Decision|4
7626660|NCT01706328|26536767|P3|2-week Run-in Period|Withdrawal by Subject|0
7626661|NCT01706328|26536768|P2|2-week Run-in Period|Withdrawal by Subject|0
7626662|NCT01706328|26536769|P1|2-week Run-in Period|Withdrawal by Subject|15
7626663|NCT01706328|26536767|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7626664|NCT01706328|26536768|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7626665|NCT01706328|26536769|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
7626666|NCT01706250|26536788|P1|Overall Study|Lost to Follow-up|2
7626667|NCT01706198|26536819|P2|Overall Study|Withdrawal by Subject|31
7626668|NCT01706198|26536820|P1|Overall Study|Withdrawal by Subject|23
7626669|NCT01706198|26536819|P2|Overall Study|Physician Decision|37
7626670|NCT01706198|26536820|P1|Overall Study|Physician Decision|23
7626671|NCT01706198|26536819|P2|Overall Study|Lost to Follow-up|93
7626672|NCT01706198|26536820|P1|Overall Study|Lost to Follow-up|97
7626673|NCT01706198|26536819|P2|Overall Study|Other: Subject reached stopping criteria|13
7626674|NCT01706198|26536820|P1|Overall Study|Other: Subject reached stopping criteria|11
7626675|NCT01706198|26536819|P2|Overall Study|Protocol Violation|5
7626676|NCT01706198|26536820|P1|Overall Study|Protocol Violation|7
7626677|NCT01706198|26536819|P2|Overall Study|Adverse Event|15
7626678|NCT01706198|26536820|P1|Overall Study|Adverse Event|12
7626679|NCT01706159|26536872|P2|Overall Study|Unclassified|1
7626680|NCT01706159|26536873|P1|Overall Study|Unclassified|6
7626681|NCT01706159|26536872|P2|Overall Study|Withdrawal Criteria|1
7626682|NCT01706159|26536873|P1|Overall Study|Withdrawal Criteria|2
7626683|NCT01706146|26536887|P1|Overall Study|Developed AF and need for antiplatelets|2
7626684|NCT01706146|26536887|P1|Overall Study|Adverse Event|3
7626685|NCT01706146|26536887|P1|Overall Study|Withdrawal by Subject|1
7626686|NCT01706003|26536907|P2|Overall Study|Lost to Follow-up|4
7626687|NCT01706003|26536908|P1|Overall Study|Lost to Follow-up|6
7626688|NCT01706003|26536907|P2|Overall Study|Not scheduled|0
7626689|NCT01706003|26536908|P1|Overall Study|Not scheduled|3
7626690|NCT01706003|26536907|P2|Overall Study|Withdrawal by Subject|0
7626691|NCT01706003|26536908|P1|Overall Study|Withdrawal by Subject|2
7626692|NCT01705977|26536916|P2|Overall Study|Missing study conclusion form|2
7626693|NCT01705977|26536917|P1|Overall Study|Missing study conclusion form|2
7626694|NCT01705977|26536916|P2|Overall Study|Physician Decision|38
7626695|NCT01705977|26536917|P1|Overall Study|Physician Decision|48
7626696|NCT01705977|26536916|P2|Overall Study|Lost to Follow-up|37
7626697|NCT01705977|26536917|P1|Overall Study|Lost to Follow-up|33
7626698|NCT01705977|26536916|P2|Overall Study|Site closure|2
7626699|NCT01705977|26536917|P1|Overall Study|Site closure|3
7626700|NCT01705977|26536916|P2|Overall Study|Protocol Violation|4
7626701|NCT01705977|26536917|P1|Overall Study|Protocol Violation|2
7626702|NCT01705977|26536916|P2|Overall Study|Adverse Event|49
7626703|NCT01705977|26536917|P1|Overall Study|Adverse Event|57
7626704|NCT01705977|26536916|P2|Overall Study|Withdrawal by Subject|128
7626705|NCT01705977|26536917|P1|Overall Study|Withdrawal by Subject|128
7626706|NCT01705730|26536952|P1|Overall Study|Reason not Specified|4
7626707|NCT01705730|26536952|P1|Overall Study|Lost to Follow-up|1
7626708|NCT01705730|26536952|P1|Overall Study|Adverse Event|3
7626709|NCT01705730|26536952|P1|Overall Study|Lack of Efficacy|1
7626710|NCT01705717|26536992|P2|Overall Study|Other|2
7626711|NCT01705717|26536993|P1|Overall Study|Other|0
7626712|NCT01705717|26536992|P2|Overall Study|Lack of Efficacy|1
7626713|NCT01705717|26536993|P1|Overall Study|Lack of Efficacy|0
7626714|NCT01705717|26536992|P2|Overall Study|Adverse Event|2
7626715|NCT01705717|26536993|P1|Overall Study|Adverse Event|2
7626716|NCT01705691|26537010|P2|Overall Study|Other|1
7626717|NCT01705691|26537011|P1|Overall Study|Other|0
7626718|NCT01705691|26537010|P2|Overall Study|Lost to Follow-up|1
7626719|NCT01705691|26537011|P1|Overall Study|Lost to Follow-up|1
7626720|NCT01705691|26537010|P2|Overall Study|Withdrawal by Subject|2
7626721|NCT01705691|26537011|P1|Overall Study|Withdrawal by Subject|1
7626722|NCT01705691|26537010|P2|Overall Study|Death|2
7626723|NCT01705691|26537011|P1|Overall Study|Death|1
7626724|NCT01705652|26537031|P2|Overall Study|non-compliance|1
7626725|NCT01705652|26537032|P1|Overall Study|non-compliance|1
7626726|NCT01705652|26537031|P2|Overall Study|Withdrawal by Subject|2
7626727|NCT01705652|26537032|P1|Overall Study|Withdrawal by Subject|1
7626728|NCT01705652|26537031|P2|Overall Study|Adverse Event|0
7626729|NCT01705652|26537032|P1|Overall Study|Adverse Event|1
7626730|NCT01705587|26537040|P2|Overall Study|Withdrawal by Subject|1
7626731|NCT01705587|26537041|P1|Overall Study|Withdrawal by Subject|0
7626732|NCT01705574|26537059|P4|Open-Label Extension Phase|Pregnancy|1
7626733|NCT01705574|26537060|P3|Open-Label Extension Phase|Pregnancy|1
7626734|NCT01705574|26537061|P2|Open-Label Extension Phase|Pregnancy|0
7626735|NCT01705574|26537062|P1|Open-Label Extension Phase|Pregnancy|0
7626736|NCT01705574|26537059|P4|Open-Label Extension Phase|Physician Decision|0
7626737|NCT01705574|26537060|P3|Open-Label Extension Phase|Physician Decision|2
7626738|NCT01705574|26537061|P2|Open-Label Extension Phase|Physician Decision|0
7626739|NCT01705574|26537062|P1|Open-Label Extension Phase|Physician Decision|0
7626740|NCT01705574|26537059|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7626741|NCT01705574|26537060|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
7626742|NCT01705574|26537061|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7626743|NCT01705574|26537062|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7626744|NCT01705574|26537059|P4|Open-Label Extension Phase|Death|0
7626745|NCT01705574|26537060|P3|Open-Label Extension Phase|Death|1
7626746|NCT01705574|26537061|P2|Open-Label Extension Phase|Death|0
7626747|NCT01705574|26537062|P1|Open-Label Extension Phase|Death|2
7626748|NCT01705574|26537059|P4|Open-Label Extension Phase|Adverse Event|1
7626749|NCT01705574|26537060|P3|Open-Label Extension Phase|Adverse Event|0
7626750|NCT01705574|26537061|P2|Open-Label Extension Phase|Adverse Event|0
7626751|NCT01705574|26537062|P1|Open-Label Extension Phase|Adverse Event|3
7626752|NCT01705574|26537059|P4|Open-Label Extension Phase|Withdrew Consent|1
7626753|NCT01705574|26537060|P3|Open-Label Extension Phase|Withdrew Consent|4
7626754|NCT01705574|26537061|P2|Open-Label Extension Phase|Withdrew Consent|0
7626755|NCT01705574|26537062|P1|Open-Label Extension Phase|Withdrew Consent|4
7626756|NCT01705574|26537059|P4|Open-Label Extension Phase|Lost to Follow-up|2
7626757|NCT01705574|26537060|P3|Open-Label Extension Phase|Lost to Follow-up|2
7626758|NCT01705574|26537061|P2|Open-Label Extension Phase|Lost to Follow-up|0
7626759|NCT01705574|26537062|P1|Open-Label Extension Phase|Lost to Follow-up|6
7626760|NCT01705574|26537059|P4|Double-Blind Phase|Randomized but Not Treated|0
7626761|NCT01705574|26537060|P3|Double-Blind Phase|Randomized but Not Treated|0
7626762|NCT01705574|26537061|P2|Double-Blind Phase|Randomized but Not Treated|4
7626763|NCT01705574|26537062|P1|Double-Blind Phase|Randomized but Not Treated|4
7626764|NCT01705574|26537059|P4|Double-Blind Phase|Protocol Violation|0
7626765|NCT01705574|26537060|P3|Double-Blind Phase|Protocol Violation|0
7626766|NCT01705574|26537061|P2|Double-Blind Phase|Protocol Violation|0
7626767|NCT01705574|26537062|P1|Double-Blind Phase|Protocol Violation|1
7626768|NCT01705574|26537059|P4|Double-Blind Phase|Pregnancy|0
7626769|NCT01705574|26537060|P3|Double-Blind Phase|Pregnancy|0
7626770|NCT01705574|26537061|P2|Double-Blind Phase|Pregnancy|1
7626771|NCT01705574|26537062|P1|Double-Blind Phase|Pregnancy|1
7626772|NCT01705574|26537059|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
7626773|NCT01705574|26537060|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
7626774|NCT01705574|26537061|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
7626775|NCT01705574|26537062|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
7626776|NCT01705574|26537059|P4|Double-Blind Phase|Withdrew Consent|0
7626777|NCT01705574|26537060|P3|Double-Blind Phase|Withdrew Consent|0
7626778|NCT01705574|26537061|P2|Double-Blind Phase|Withdrew Consent|5
7626779|NCT01705574|26537062|P1|Double-Blind Phase|Withdrew Consent|8
7626780|NCT01705574|26537059|P4|Double-Blind Phase|Adverse Event|0
7626781|NCT01705574|26537060|P3|Double-Blind Phase|Adverse Event|0
7626782|NCT01705574|26537061|P2|Double-Blind Phase|Adverse Event|10
7626783|NCT01705574|26537062|P1|Double-Blind Phase|Adverse Event|3
7626784|NCT01705574|26537059|P4|Double-Blind Phase|Lost to Follow-up|0
7626785|NCT01705574|26537060|P3|Double-Blind Phase|Lost to Follow-up|0
7626786|NCT01705574|26537061|P2|Double-Blind Phase|Lost to Follow-up|16
7626787|NCT01705574|26537062|P1|Double-Blind Phase|Lost to Follow-up|12
7626788|NCT01705509|26537079|P1|CPET w/ Ranexa|Screen Failure|2
7626789|NCT01705509|26537079|P1|Inclusion CPET|Withdrawal by Subject|2
7626790|NCT01705509|26537079|P1|Inclusion CPET|Screen Failure|5
7626791|NCT01705236|26537106|P1|Overall Study|Adverse Event|5
7626792|NCT01705236|26537106|P1|Overall Study|Withdrawal by Subject|5
7626793|NCT01705236|26537106|P1|Overall Study|Abnormal laboratory value(s)|4
7626794|NCT01705236|26537106|P1|Overall Study|Abnormal test procedure result(s)|4
7626795|NCT01705236|26537106|P1|Overall Study|Protocol Violation|3
7626796|NCT01705236|26537106|P1|Overall Study|Unsatisfactory therapeutic effect|3
7626797|NCT01705236|26537106|P1|Overall Study|Administrative problems|2
7626798|NCT01705236|26537106|P1|Overall Study|Lost to Follow-up|1
7626799|NCT01705145|26537115|P1|Part B|Adverse Event|1
7626800|NCT01705080|26537154|P3|Overall Study|Withdrawal by Subject|9
7626801|NCT01705080|26537155|P2|Overall Study|Withdrawal by Subject|44
7626802|NCT01705080|26537156|P1|Overall Study|Withdrawal by Subject|61
7626803|NCT01705080|26537154|P3|Overall Study|Death|6
7626804|NCT01705080|26537155|P2|Overall Study|Death|4
7626805|NCT01705080|26537156|P1|Overall Study|Death|4
7626806|NCT01705080|26537154|P3|Overall Study|Missed visit|1
7626807|NCT01705080|26537155|P2|Overall Study|Missed visit|4
7626808|NCT01705080|26537156|P1|Overall Study|Missed visit|10
7626809|NCT01704846|26537276|P2|Treatment Period 2|Withdrawal by Subject|1
7626810|NCT01704846|26537277|P1|Treatment Period 2|Withdrawal by Subject|0
7626811|NCT01704755|26537332|P2|Overall Study|Withdrew consent and personal issues|0
7626812|NCT01704755|26537333|P1|Overall Study|Withdrew consent and personal issues|1
7626813|NCT01704755|26537332|P2|Overall Study|Other (not specified)|1
7626814|NCT01704755|26537333|P1|Overall Study|Other (not specified)|3
7626815|NCT01704755|26537332|P2|Overall Study|Withdrew consent|1
7626816|NCT01704755|26537333|P1|Overall Study|Withdrew consent|1
7626817|NCT01704755|26537332|P2|Overall Study|Lost to Follow-up|4
7626818|NCT01704755|26537333|P1|Overall Study|Lost to Follow-up|3
7626819|NCT01704755|26537332|P2|Overall Study|Adverse Event|1
7626820|NCT01704755|26537333|P1|Overall Study|Adverse Event|4
7626821|NCT01704651|26537347|P2|Overall Study|Post-op did not have laparotomy|1
7626822|NCT01704651|26537348|P1|Overall Study|Post-op did not have laparotomy|2
7626823|NCT01704651|26537347|P2|Overall Study|Nasogastric tube placement in surgery|1
7626824|NCT01704651|26537348|P1|Overall Study|Nasogastric tube placement in surgery|1
7626825|NCT01704651|26537347|P2|Overall Study|Pre-op change in treatment plan|4
7626826|NCT01704651|26537348|P1|Overall Study|Pre-op change in treatment plan|1
7626827|NCT01704651|26537347|P2|Overall Study|Pre-op withdrawal by subject|1
7626828|NCT01704651|26537348|P1|Overall Study|Pre-op withdrawal by subject|1
7626829|NCT01704599|26537356|P1|Overall Study|Adverse Event|1
7626830|NCT01704495|26537396|P4|Optional Safety Extension|Withdrawal by Subject|2
7626831|NCT01704495|26537397|P3|Optional Safety Extension|Withdrawal by Subject|1
7626832|NCT01704495|26537398|P2|Optional Safety Extension|Withdrawal by Subject|0
7626833|NCT01704495|26537399|P1|Optional Safety Extension|Withdrawal by Subject|2
7626834|NCT01704495|26537396|P4|Optional Safety Extension|Other reason|28
7626835|NCT01704495|26537397|P3|Optional Safety Extension|Other reason|30
7626836|NCT01704495|26537398|P2|Optional Safety Extension|Other reason|29
7626837|NCT01704495|26537399|P1|Optional Safety Extension|Other reason|27
7626838|NCT01704495|26537396|P4|Optional Safety Extension|Adverse Event|1
7626839|NCT01704495|26537397|P3|Optional Safety Extension|Adverse Event|0
7626840|NCT01704495|26537398|P2|Optional Safety Extension|Adverse Event|4
7626841|NCT01704495|26537399|P1|Optional Safety Extension|Adverse Event|0
7626842|NCT01704495|26537396|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
7626843|NCT01704495|26537397|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
7626844|NCT01704495|26537398|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
7626845|NCT01704495|26537399|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
7626846|NCT01704495|26537396|P4|Subjects Randomized|Protocol Violation|0
7626847|NCT01704495|26537397|P3|Subjects Randomized|Protocol Violation|2
7626848|NCT01704495|26537398|P2|Subjects Randomized|Protocol Violation|1
7626849|NCT01704495|26537399|P1|Subjects Randomized|Protocol Violation|1
7626850|NCT01704495|26537396|P4|Subjects Randomized|Withdrawal by Subject|5
7626851|NCT01704495|26537397|P3|Subjects Randomized|Withdrawal by Subject|5
7626852|NCT01704495|26537398|P2|Subjects Randomized|Withdrawal by Subject|5
7626853|NCT01704495|26537399|P1|Subjects Randomized|Withdrawal by Subject|5
7626854|NCT01704495|26537396|P4|Subjects Randomized|Adverse Event|7
7626855|NCT01704495|26537397|P3|Subjects Randomized|Adverse Event|0
7626856|NCT01704495|26537398|P2|Subjects Randomized|Adverse Event|2
7626857|NCT01704495|26537399|P1|Subjects Randomized|Adverse Event|8
7626858|NCT01704495|26537396|P4|Subjects Randomized|Discontinuation criteria met|0
7626859|NCT01704495|26537397|P3|Subjects Randomized|Discontinuation criteria met|2
7626860|NCT01704495|26537398|P2|Subjects Randomized|Discontinuation criteria met|2
7626861|NCT01704495|26537399|P1|Subjects Randomized|Discontinuation criteria met|4
7626862|NCT01704495|26537396|P4|Subjects Randomized|Other Reason|2
7626863|NCT01704495|26537397|P3|Subjects Randomized|Other Reason|3
7626864|NCT01704495|26537398|P2|Subjects Randomized|Other Reason|2
7626865|NCT01704495|26537399|P1|Subjects Randomized|Other Reason|3
7626866|NCT01704456|26537575|P2|Overall Study|Lost to Follow-up|14
7626867|NCT01704456|26537576|P1|Overall Study|Lost to Follow-up|8
7626868|NCT01704287|26537638|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7626869|NCT01704287|26537639|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
7626870|NCT01704287|26537640|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7626871|NCT01704287|26537641|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7626872|NCT01704287|26537642|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7626873|NCT01704287|26537638|P5|Switch to Pembrolizumab Treatment Period|Death|37
7626874|NCT01704287|26537639|P4|Switch to Pembrolizumab Treatment Period|Death|35
7626875|NCT01704287|26537640|P3|Switch to Pembrolizumab Treatment Period|Death|0
7626876|NCT01704287|26537641|P2|Switch to Pembrolizumab Treatment Period|Death|0
7626877|NCT01704287|26537642|P1|Switch to Pembrolizumab Treatment Period|Death|0
7626878|NCT01704287|26537638|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
7626879|NCT01704287|26537639|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
7626880|NCT01704287|26537640|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7626881|NCT01704287|26537641|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7626882|NCT01704287|26537642|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7626883|NCT01704287|26537638|P5|Initial Treatment Period|Switched to Pembrolizumab|0
7626884|NCT01704287|26537639|P4|Initial Treatment Period|Switched to Pembrolizumab|0
7626885|NCT01704287|26537640|P3|Initial Treatment Period|Switched to Pembrolizumab|98
7626886|NCT01704287|26537641|P2|Initial Treatment Period|Switched to Pembrolizumab|0
7626887|NCT01704287|26537642|P1|Initial Treatment Period|Switched to Pembrolizumab|0
7626888|NCT01704287|26537638|P5|Initial Treatment Period|Lost to Follow-up|0
7626889|NCT01704287|26537639|P4|Initial Treatment Period|Lost to Follow-up|0
7626890|NCT01704287|26537640|P3|Initial Treatment Period|Lost to Follow-up|0
7626891|NCT01704287|26537641|P2|Initial Treatment Period|Lost to Follow-up|3
7626892|NCT01704287|26537642|P1|Initial Treatment Period|Lost to Follow-up|5
7626893|NCT01704287|26537638|P5|Initial Treatment Period|Withdrawal by Subject|0
7626894|NCT01704287|26537639|P4|Initial Treatment Period|Withdrawal by Subject|0
7626895|NCT01704287|26537640|P3|Initial Treatment Period|Withdrawal by Subject|4
7626896|NCT01704287|26537641|P2|Initial Treatment Period|Withdrawal by Subject|2
7626897|NCT01704287|26537642|P1|Initial Treatment Period|Withdrawal by Subject|3
7626898|NCT01704287|26537638|P5|Initial Treatment Period|Death|0
7626899|NCT01704287|26537639|P4|Initial Treatment Period|Death|0
7626900|NCT01704287|26537640|P3|Initial Treatment Period|Death|71
7626901|NCT01704287|26537641|P2|Initial Treatment Period|Death|129
7626902|NCT01704287|26537642|P1|Initial Treatment Period|Death|139
7626903|NCT01704261|26537690|P2|Overall Study|Lost to Follow-up|0
7626904|NCT01704261|26537691|P1|Overall Study|Lost to Follow-up|1
7626905|NCT01704261|26537690|P2|Overall Study|Withdrawal by Subject|15
7626906|NCT01704261|26537691|P1|Overall Study|Withdrawal by Subject|12
7626907|NCT01704079|26537718|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
7626908|NCT01704079|26537719|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
7626909|NCT01704079|26537718|P2|Overall Study|Subject noncompliance|3
7626910|NCT01704079|26537719|P1|Overall Study|Subject noncompliance|2
7626911|NCT01704079|26537718|P2|Overall Study|Protocol Violation|0
7626912|NCT01704079|26537719|P1|Overall Study|Protocol Violation|1
7626913|NCT01704079|26537718|P2|Overall Study|Adverse Event|7
7626914|NCT01704079|26537719|P1|Overall Study|Adverse Event|4
7626915|NCT01704079|26537718|P2|Overall Study|Lost to Follow-up|5
7626916|NCT01704079|26537719|P1|Overall Study|Lost to Follow-up|2
7626917|NCT01704079|26537718|P2|Overall Study|Withdrawal by Subject|7
7626918|NCT01704079|26537719|P1|Overall Study|Withdrawal by Subject|5
7626919|NCT01703988|26537735|P4|Overall Study|Investigator Judgment|1
7626920|NCT01703988|26537736|P3|Overall Study|Investigator Judgment|0
7626921|NCT01703988|26537737|P2|Overall Study|Investigator Judgment|0
7626922|NCT01703988|26537738|P1|Overall Study|Investigator Judgment|0
7626923|NCT01703858|26537768|P3|Overall Study|Withdrawal by Subject|0
7626924|NCT01703858|26537769|P2|Overall Study|Withdrawal by Subject|1
7626925|NCT01703858|26537770|P1|Overall Study|Withdrawal by Subject|0
7626926|NCT01703845|26537795|P2|Overall Study|other than stated above|0
7626927|NCT01703845|26537796|P1|Overall Study|other than stated above|1
7626928|NCT01703845|26537795|P2|Overall Study|Protocol Violation|0
7626929|NCT01703845|26537796|P1|Overall Study|Protocol Violation|1
7626930|NCT01703845|26537795|P2|Overall Study|Adverse Event|0
7626931|NCT01703845|26537796|P1|Overall Study|Adverse Event|1
7626932|NCT01703832|26537833|P2|Overall Study|Withdrawal by Subject|0
7626933|NCT01703832|26537834|P1|Overall Study|Withdrawal by Subject|1
7626934|NCT01703819|26537866|P2|Overall Study|Withdrawal by Subject|1
7626935|NCT01703819|26537867|P1|Overall Study|Withdrawal by Subject|0
7626936|NCT01703819|26537866|P2|Overall Study|Adverse Event|1
7626937|NCT01703819|26537867|P1|Overall Study|Adverse Event|0
7626938|NCT01703741|26537897|P1|Overall Study|Subject started testosterone injections|1
7626939|NCT01703741|26537897|P1|Overall Study|Subject cannot comply with study visits|1
7626940|NCT01703741|26537897|P1|Overall Study|Subject did not want to continue|2
7626941|NCT01703741|26537897|P1|Overall Study|Lost to Follow-up|3
7626942|NCT01703741|26537897|P1|Overall Study|Protocol Violation|1
7626943|NCT01703741|26537897|P1|Overall Study|Physician Decision|2
7626944|NCT01703741|26537897|P1|Overall Study|Adverse Event|2
7626945|NCT01703741|26537897|P1|Overall Study|Withdrawal by Subject|6
7626946|NCT01703286|26537963|P6|Period 2 Including Washout|Adverse Event|0
7626947|NCT01703286|26537964|P5|Period 2 Including Washout|Adverse Event|0
7626948|NCT01703286|26537965|P4|Period 2 Including Washout|Adverse Event|1
7626949|NCT01703286|26537966|P3|Period 2 Including Washout|Adverse Event|0
7626950|NCT01703286|26537967|P2|Period 2 Including Washout|Adverse Event|0
7626951|NCT01703286|26537968|P1|Period 2 Including Washout|Adverse Event|0
7626952|NCT01703286|26537963|P6|Period 1 Including Washout|Withdrawal by Subject|1
7626953|NCT01703286|26537964|P5|Period 1 Including Washout|Withdrawal by Subject|0
7626954|NCT01703286|26537965|P4|Period 1 Including Washout|Withdrawal by Subject|1
7626955|NCT01703286|26537966|P3|Period 1 Including Washout|Withdrawal by Subject|0
7626956|NCT01703286|26537967|P2|Period 1 Including Washout|Withdrawal by Subject|0
7626957|NCT01703286|26537968|P1|Period 1 Including Washout|Withdrawal by Subject|0
7626958|NCT01703260|26537991|P3|Overall Study|Study Termination|0
7626959|NCT01703260|26537992|P2|Overall Study|Study Termination|2
7626960|NCT01703260|26537993|P1|Overall Study|Study Termination|1
7626961|NCT01703260|26537991|P3|Overall Study|Withdrawal by Subject|1
7626962|NCT01703260|26537992|P2|Overall Study|Withdrawal by Subject|0
7626963|NCT01703260|26537993|P1|Overall Study|Withdrawal by Subject|0
7626964|NCT01703260|26537991|P3|Overall Study|Lost to Follow-up|0
7626965|NCT01703260|26537992|P2|Overall Study|Lost to Follow-up|0
7626966|NCT01703260|26537993|P1|Overall Study|Lost to Follow-up|1
7626967|NCT01703260|26537991|P3|Overall Study|Adverse Event|2
7626968|NCT01703260|26537992|P2|Overall Study|Adverse Event|2
7626969|NCT01703260|26537993|P1|Overall Study|Adverse Event|1
7626970|NCT01703221|26538019|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
7626971|NCT01703221|26538020|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
7626972|NCT01703221|26538021|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
7626973|NCT01703221|26538019|P3|Phase B - (Week 25 to 52)|Adverse Event|2
7626974|NCT01703221|26538020|P2|Phase B - (Week 25 to 52)|Adverse Event|3
7626975|NCT01703221|26538021|P1|Phase B - (Week 25 to 52)|Adverse Event|2
7626976|NCT01703221|26538019|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
7626977|NCT01703221|26538020|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
7626978|NCT01703221|26538021|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
7626979|NCT01703221|26538019|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
7626980|NCT01703221|26538020|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
7626981|NCT01703221|26538021|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
7626982|NCT01703221|26538019|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7626983|NCT01703221|26538020|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7626984|NCT01703221|26538021|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
7626985|NCT01703221|26538019|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
7626986|NCT01703221|26538020|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
7626987|NCT01703221|26538021|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
7626988|NCT01703221|26538019|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
7626989|NCT01703221|26538020|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
7626990|NCT01703221|26538021|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
7626991|NCT01703221|26538019|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
7626992|NCT01703221|26538020|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
7626993|NCT01703221|26538021|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
7626994|NCT01703208|26538052|P2|Overall Study|Protocol Deviation|0
7626995|NCT01703208|26538053|P1|Overall Study|Protocol Deviation|2
7626996|NCT01703208|26538052|P2|Overall Study|Technical Problems|1
7626997|NCT01703208|26538053|P1|Overall Study|Technical Problems|0
7626998|NCT01703208|26538052|P2|Overall Study|Adverse Event|19
7626999|NCT01703208|26538053|P1|Overall Study|Adverse Event|14
7627000|NCT01703208|26538052|P2|Overall Study|Withdrawal by Subject|209
7627001|NCT01703208|26538053|P1|Overall Study|Withdrawal by Subject|205
7627002|NCT01703208|26538052|P2|Overall Study|Study Terminated by Sponsor|1716
7627003|NCT01703208|26538053|P1|Overall Study|Study Terminated by Sponsor|1710
7627004|NCT01703208|26538052|P2|Overall Study|Protocol Violation|1
7627005|NCT01703208|26538053|P1|Overall Study|Protocol Violation|1
7627006|NCT01703208|26538052|P2|Overall Study|Progressive disease|2
7627007|NCT01703208|26538053|P1|Overall Study|Progressive disease|2
7627008|NCT01703208|26538052|P2|Overall Study|Physician Decision|13
7627009|NCT01703208|26538053|P1|Overall Study|Physician Decision|11
7627010|NCT01703208|26538052|P2|Overall Study|Site Discontinued Study Participation|27
7627011|NCT01703208|26538053|P1|Overall Study|Site Discontinued Study Participation|23
7627012|NCT01703208|26538052|P2|Overall Study|Excluded Medication|2
7627013|NCT01703208|26538053|P1|Overall Study|Excluded Medication|1
7627014|NCT01703208|26538052|P2|Overall Study|Non-Compliance with Study Drug|0
7627015|NCT01703208|26538053|P1|Overall Study|Non-Compliance with Study Drug|1
7627016|NCT01703208|26538052|P2|Overall Study|Lost to Follow-up|62
7627017|NCT01703208|26538053|P1|Overall Study|Lost to Follow-up|68
7627018|NCT01703208|26538052|P2|Overall Study|Lack of Efficacy|2
7627019|NCT01703208|26538053|P1|Overall Study|Lack of Efficacy|1
7627020|NCT01703208|26538052|P2|Overall Study|Death|48
7627021|NCT01703208|26538053|P1|Overall Study|Death|61
7627022|NCT01703117|26538117|P2|Overall Study|Withdrawal by Subject|1
7627023|NCT01703117|26538118|P1|Overall Study|Withdrawal by Subject|0
7627024|NCT01703117|26538117|P2|Overall Study|Adverse Event|3
7627025|NCT01703117|26538118|P1|Overall Study|Adverse Event|4
7627026|NCT01703091|26538136|P2|Overall Study|Sponsor Decision|0
7627027|NCT01703091|26538137|P1|Overall Study|Sponsor Decision|1
7627028|NCT01703091|26538136|P2|Overall Study|Withdrawal by Subject|0
7627029|NCT01703091|26538137|P1|Overall Study|Withdrawal by Subject|1
7627030|NCT01703091|26538136|P2|Overall Study|Physician Decision|1
7627031|NCT01703091|26538137|P1|Overall Study|Physician Decision|2
7627032|NCT01703091|26538136|P2|Overall Study|Adverse Event|3
7627033|NCT01703091|26538137|P1|Overall Study|Adverse Event|5
7627034|NCT01703065|26538155|P2|Overall Study|Lack of Efficacy|0
7627035|NCT01703065|26538156|P1|Overall Study|Lack of Efficacy|1
7627036|NCT01703000|26538186|P1|Overall Study|Death|1
7627037|NCT01702987|26538219|P2|Overall Study|Withdrawal by Subject|0
7627038|NCT01702987|26538220|P1|Overall Study|Withdrawal by Subject|1
7627039|NCT01702961|26538226|P1|Overall Study|Ongoing|11
7627040|NCT01702961|26538226|P1|Overall Study|Lost to Follow-up|2
7627041|NCT01702961|26538226|P1|Overall Study|Death|6
7627042|NCT01702961|26538226|P1|Overall Study|Relapse|20
7627043|NCT01702961|26538226|P1|Overall Study|Progressive disease|5
7627044|NCT01702961|26538226|P1|Overall Study|Additional treatment|3
7627045|NCT01702844|26538244|P1|Overall Study|Physician Decision|6
7627046|NCT01702844|26538244|P1|Overall Study|Withdrawal by Subject|3
7627047|NCT01702844|26538244|P1|Overall Study|Death|1
7627048|NCT01702844|26538244|P1|Overall Study|Adverse Event|9
7627049|NCT01702571|26538253|P2|Overall Study|Withdrawal by Subject|29
7627050|NCT01702571|26538254|P1|Overall Study|Withdrawal by Subject|177
7627051|NCT01702571|26538253|P2|Overall Study|Termination By Sponsor|0
7627052|NCT01702571|26538254|P1|Overall Study|Termination By Sponsor|4
7627053|NCT01702571|26538253|P2|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
7627054|NCT01702571|26538254|P1|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
7627055|NCT01702571|26538253|P2|Overall Study|Protocol Violation|0
7627056|NCT01702571|26538254|P1|Overall Study|Protocol Violation|2
7627057|NCT01702571|26538253|P2|Overall Study|Progressive Disease|0
7627058|NCT01702571|26538254|P1|Overall Study|Progressive Disease|3
7627059|NCT01702571|26538253|P2|Overall Study|On Study Treatment At Lplv/Cohort 2|1
7627060|NCT01702571|26538254|P1|Overall Study|On Study Treatment At Lplv/Cohort 2|0
7627061|NCT01702571|26538253|P2|Overall Study|On Study Treatment At Lplv/Cohort 1|0
7627062|NCT01702571|26538254|P1|Overall Study|On Study Treatment At Lplv/Cohort 1|93
7627063|NCT01702571|26538253|P2|Overall Study|Not Classifiable|0
7627064|NCT01702571|26538254|P1|Overall Study|Not Classifiable|1
7627065|NCT01702571|26538253|P2|Overall Study|Investigator Decision|0
7627066|NCT01702571|26538254|P1|Overall Study|Investigator Decision|5
7627067|NCT01702571|26538253|P2|Overall Study|Adverse Event/Unacceptable Toxicity|0
7627068|NCT01702571|26538254|P1|Overall Study|Adverse Event/Unacceptable Toxicity|4
7627069|NCT01702571|26538253|P2|Overall Study|Lost to Follow-up|10
7627070|NCT01702571|26538254|P1|Overall Study|Lost to Follow-up|144
7627071|NCT01702571|26538253|P2|Overall Study|Death|76
7627072|NCT01702571|26538254|P1|Overall Study|Death|1067
7627073|NCT01702558|26538285|P5|Overall Study|Other|17
7627074|NCT01702558|26538286|P4|Overall Study|Other|16
7627075|NCT01702558|26538287|P3|Overall Study|Other|0
7627076|NCT01702558|26538288|P2|Overall Study|Other|0
7627077|NCT01702558|26538289|P1|Overall Study|Other|0
7627078|NCT01702558|26538285|P5|Overall Study|Study Terminated by Sponsor|1
7627079|NCT01702558|26538286|P4|Overall Study|Study Terminated by Sponsor|0
7627080|NCT01702558|26538287|P3|Overall Study|Study Terminated by Sponsor|0
7627081|NCT01702558|26538288|P2|Overall Study|Study Terminated by Sponsor|1
7627082|NCT01702558|26538289|P1|Overall Study|Study Terminated by Sponsor|0
7627083|NCT01702558|26538285|P5|Overall Study|Safety Follow-Up less than 3 Months|0
7627084|NCT01702558|26538286|P4|Overall Study|Safety Follow-Up less than 3 Months|0
7627085|NCT01702558|26538287|P3|Overall Study|Safety Follow-Up less than 3 Months|2
7627086|NCT01702558|26538288|P2|Overall Study|Safety Follow-Up less than 3 Months|0
7627087|NCT01702558|26538289|P1|Overall Study|Safety Follow-Up less than 3 Months|0
7627088|NCT01702558|26538285|P5|Overall Study|Death|20
7627089|NCT01702558|26538286|P4|Overall Study|Death|16
7627090|NCT01702558|26538287|P3|Overall Study|Death|3
7627091|NCT01702558|26538288|P2|Overall Study|Death|3
7627092|NCT01702558|26538289|P1|Overall Study|Death|4
7627093|NCT01702558|26538285|P5|Overall Study|Lost to Follow-up|0
7627094|NCT01702558|26538286|P4|Overall Study|Lost to Follow-up|3
7627095|NCT01702558|26538287|P3|Overall Study|Lost to Follow-up|0
7627096|NCT01702558|26538288|P2|Overall Study|Lost to Follow-up|0
7627097|NCT01702558|26538289|P1|Overall Study|Lost to Follow-up|0
7627098|NCT01702558|26538285|P5|Overall Study|Withdrawal by Subject|4
7627099|NCT01702558|26538286|P4|Overall Study|Withdrawal by Subject|12
7627100|NCT01702558|26538287|P3|Overall Study|Withdrawal by Subject|0
7627101|NCT01702558|26538288|P2|Overall Study|Withdrawal by Subject|0
7627102|NCT01702558|26538289|P1|Overall Study|Withdrawal by Subject|0
7627103|NCT01702532|26538354|P2|Overall Study|Adverse Event|1
7627104|NCT01702532|26538355|P1|Overall Study|Adverse Event|0
7627105|NCT01702519|26538365|P2|Washout Period|Withdrawal by Subject|2
7627106|NCT01702519|26538366|P1|Washout Period|Withdrawal by Subject|0
7627107|NCT01702519|26538365|P2|Washout Period|Lost to Follow-up|0
7627108|NCT01702519|26538366|P1|Washout Period|Lost to Follow-up|1
7627109|NCT01702454|26538384|P2|Overall Study|Lost to Follow-up|6
7627110|NCT01702454|26538385|P1|Overall Study|Lost to Follow-up|3
7627111|NCT01702454|26538384|P2|Overall Study|Migrated/moved from study area|1
7627112|NCT01702454|26538385|P1|Overall Study|Migrated/moved from study area|0
7627113|NCT01702454|26538384|P2|Overall Study|Consent withdrawal|1
7627114|NCT01702454|26538385|P1|Overall Study|Consent withdrawal|0
7627115|NCT01702428|26538467|P4|Overall Study|Withdrawal by Subject|10
7627116|NCT01702428|26538468|P3|Overall Study|Withdrawal by Subject|14
7627117|NCT01702428|26538469|P2|Overall Study|Withdrawal by Subject|23
7627118|NCT01702428|26538470|P1|Overall Study|Withdrawal by Subject|21
7627119|NCT01702428|26538467|P4|Overall Study|Protocol Violation|0
7627120|NCT01702428|26538468|P3|Overall Study|Protocol Violation|1
7627121|NCT01702428|26538469|P2|Overall Study|Protocol Violation|0
7627122|NCT01702428|26538470|P1|Overall Study|Protocol Violation|3
7627123|NCT01702428|26538467|P4|Overall Study|Parents too busy|0
7627124|NCT01702428|26538468|P3|Overall Study|Parents too busy|0
7627125|NCT01702428|26538469|P2|Overall Study|Parents too busy|0
7627126|NCT01702428|26538470|P1|Overall Study|Parents too busy|1
7627127|NCT01702428|26538467|P4|Overall Study|Mother transferred care|0
7627128|NCT01702428|26538468|P3|Overall Study|Mother transferred care|0
7627129|NCT01702428|26538469|P2|Overall Study|Mother transferred care|1
7627130|NCT01702428|26538470|P1|Overall Study|Mother transferred care|0
7627131|NCT01702428|26538467|P4|Overall Study|Lost Health Plan|2
7627132|NCT01702428|26538468|P3|Overall Study|Lost Health Plan|0
7627133|NCT01702428|26538469|P2|Overall Study|Lost Health Plan|5
7627134|NCT01702428|26538470|P1|Overall Study|Lost Health Plan|3
7627135|NCT01702428|26538467|P4|Overall Study|Lost Coverage|1
7627136|NCT01702428|26538468|P3|Overall Study|Lost Coverage|0
7627137|NCT01702428|26538469|P2|Overall Study|Lost Coverage|0
7627138|NCT01702428|26538470|P1|Overall Study|Lost Coverage|0
7627139|NCT01702428|26538467|P4|Overall Study|Parents cannot assist to site|0
7627140|NCT01702428|26538468|P3|Overall Study|Parents cannot assist to site|1
7627141|NCT01702428|26538469|P2|Overall Study|Parents cannot assist to site|0
7627142|NCT01702428|26538470|P1|Overall Study|Parents cannot assist to site|1
7627143|NCT01702428|26538467|P4|Overall Study|Lost to Follow-up|44
7627144|NCT01702428|26538468|P3|Overall Study|Lost to Follow-up|37
7627145|NCT01702428|26538469|P2|Overall Study|Lost to Follow-up|41
7627146|NCT01702428|26538470|P1|Overall Study|Lost to Follow-up|33
7627147|NCT01702428|26538467|P4|Overall Study|Adverse Event|0
7627148|NCT01702428|26538468|P3|Overall Study|Adverse Event|0
7627149|NCT01702428|26538469|P2|Overall Study|Adverse Event|0
7627150|NCT01702428|26538470|P1|Overall Study|Adverse Event|2
7627151|NCT01702363|26538557|P1|Overall Study|Withdrawal by Subject|2
7627152|NCT01702363|26538557|P1|Overall Study|Lack of Efficacy|4
7627153|NCT01702363|26538557|P1|Overall Study|Adverse Event|14
7627154|NCT01702311|26538574|P2|Overall Study|Physician Decision|4
7627155|NCT01702311|26538575|P1|Overall Study|Physician Decision|3
7627156|NCT01702311|26538574|P2|Overall Study|Discharge less than 24 hours|7
7627157|NCT01702311|26538575|P1|Overall Study|Discharge less than 24 hours|10
7627158|NCT01702311|26538574|P2|Overall Study|Withdrawal by Subject|2
7627159|NCT01702311|26538575|P1|Overall Study|Withdrawal by Subject|3
7627160|NCT01702298|26538605|P1|Overall Study|Withdrawal by Subject|1
7627161|NCT01702246|26538633|P1|Overall Study|Physician Decision|1
7627162|NCT01702246|26538633|P1|Overall Study|Withdrawal by Subject|2
7627163|NCT01702246|26538633|P1|Overall Study|Lost to Follow-up|2
7627164|NCT01702025|26538687|P4|Overall Study|Adverse Event|0
7627165|NCT01702025|26538688|P3|Overall Study|Adverse Event|1
7627166|NCT01702025|26538689|P2|Overall Study|Adverse Event|1
7627167|NCT01702025|26538690|P1|Overall Study|Adverse Event|1
7627168|NCT01702025|26538687|P4|Overall Study|Equipment failure|0
7627169|NCT01702025|26538688|P3|Overall Study|Equipment failure|0
7627170|NCT01702025|26538689|P2|Overall Study|Equipment failure|0
7627171|NCT01702025|26538690|P1|Overall Study|Equipment failure|1
7627172|NCT01701973|26538719|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627173|NCT01701973|26538720|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627174|NCT01701973|26538721|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627175|NCT01701973|26538722|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627176|NCT01701973|26538723|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627177|NCT01701973|26538724|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627178|NCT01701973|26538725|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
7627179|NCT01701973|26538726|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
7627180|NCT01701674|26538773|P1|Overall Study|Unable to safely complete treatment|1
7627181|NCT01701583|26538787|P2|Overall Study|Withdrawal by Subject|0
7627182|NCT01701583|26538788|P1|Overall Study|Withdrawal by Subject|2
7627183|NCT01701401|26538871|P4|Overall Study|Protocol Violation|0
7627184|NCT01701401|26538872|P3|Overall Study|Protocol Violation|1
7627185|NCT01701401|26538873|P2|Overall Study|Protocol Violation|0
7627186|NCT01701401|26538874|P1|Overall Study|Protocol Violation|0
7627187|NCT01701401|26538871|P4|Overall Study|Adverse Event|0
7627188|NCT01701401|26538872|P3|Overall Study|Adverse Event|0
7627189|NCT01701401|26538873|P2|Overall Study|Adverse Event|0
7627190|NCT01701401|26538874|P1|Overall Study|Adverse Event|1
7627191|NCT01701401|26538871|P4|Overall Study|Lack of Efficacy|0
7627192|NCT01701401|26538872|P3|Overall Study|Lack of Efficacy|2
7627193|NCT01701401|26538873|P2|Overall Study|Lack of Efficacy|0
7627194|NCT01701401|26538874|P1|Overall Study|Lack of Efficacy|1
7627195|NCT01701401|26538871|P4|Overall Study|Withdrew Consent|2
7627196|NCT01701401|26538872|P3|Overall Study|Withdrew Consent|1
7627197|NCT01701401|26538873|P2|Overall Study|Withdrew Consent|3
7627198|NCT01701401|26538874|P1|Overall Study|Withdrew Consent|0
7627199|NCT01701401|26538871|P4|Overall Study|Lost to Follow-up|3
7627200|NCT01701401|26538872|P3|Overall Study|Lost to Follow-up|1
7627201|NCT01701401|26538873|P2|Overall Study|Lost to Follow-up|5
7627202|NCT01701401|26538874|P1|Overall Study|Lost to Follow-up|5
7627203|NCT01701401|26538871|P4|Overall Study|Randomized But Not Treated|1
7627204|NCT01701401|26538872|P3|Overall Study|Randomized But Not Treated|0
7627205|NCT01701401|26538873|P2|Overall Study|Randomized But Not Treated|1
7627206|NCT01701401|26538874|P1|Overall Study|Randomized But Not Treated|3
7627207|NCT01701362|26538926|P2|Overall Study|Reasons other than those mentioned above|5
7627208|NCT01701362|26538927|P1|Overall Study|Reasons other than those mentioned above|3
7627209|NCT01701362|26538926|P2|Overall Study|Randomized but not treated|2
7627210|NCT01701362|26538927|P1|Overall Study|Randomized but not treated|1
7627211|NCT01701362|26538926|P2|Overall Study|Death|1
7627212|NCT01701362|26538927|P1|Overall Study|Death|0
7627213|NCT01701362|26538926|P2|Overall Study|Insufficient clinical response|6
7627214|NCT01701362|26538927|P1|Overall Study|Insufficient clinical response|6
7627215|NCT01701362|26538926|P2|Overall Study|Lost to Follow-up|9
7627216|NCT01701362|26538927|P1|Overall Study|Lost to Follow-up|6
7627217|NCT01701362|26538926|P2|Overall Study|No longer willing to participate|14
7627218|NCT01701362|26538927|P1|Overall Study|No longer willing to participate|8
7627219|NCT01701362|26538926|P2|Overall Study|Protocol Violation|3
7627220|NCT01701362|26538927|P1|Overall Study|Protocol Violation|5
7627221|NCT01701362|26538926|P2|Overall Study|Adverse events related to study drug|10
7627222|NCT01701362|26538927|P1|Overall Study|Adverse events related to study drug|12
7627223|NCT01701362|26538926|P2|Overall Study|Adverse events not related to study drug|6
7627224|NCT01701362|26538927|P1|Overall Study|Adverse events not related to study drug|1
7627225|NCT01701258|26538965|P13|Assessment and Scheduling|Investigator Terminated|0
7627226|NCT01701258|26538966|P12|Assessment and Scheduling|Investigator Terminated|0
7627227|NCT01701258|26538967|P11|Assessment and Scheduling|Investigator Terminated|0
7627228|NCT01701258|26538968|P10|Assessment and Scheduling|Investigator Terminated|0
7627229|NCT01701258|26538969|P9|Assessment and Scheduling|Investigator Terminated|0
7627230|NCT01701258|26538970|P8|Assessment and Scheduling|Investigator Terminated|0
7627231|NCT01701258|26538971|P7|Assessment and Scheduling|Investigator Terminated|0
7627232|NCT01701258|26538972|P6|Assessment and Scheduling|Investigator Terminated|0
7627233|NCT01701258|26538973|P5|Assessment and Scheduling|Investigator Terminated|0
7627234|NCT01701258|26538974|P4|Assessment and Scheduling|Investigator Terminated|0
7627235|NCT01701258|26538975|P3|Assessment and Scheduling|Investigator Terminated|0
7627236|NCT01701258|26538976|P2|Assessment and Scheduling|Investigator Terminated|0
7627237|NCT01701258|26538977|P1|Assessment and Scheduling|Investigator Terminated|2
7627238|NCT01701258|26538965|P13|Assessment and Scheduling|Withdrawal by Subject|0
7627239|NCT01701258|26538966|P12|Assessment and Scheduling|Withdrawal by Subject|0
7627240|NCT01701258|26538967|P11|Assessment and Scheduling|Withdrawal by Subject|0
7627241|NCT01701258|26538968|P10|Assessment and Scheduling|Withdrawal by Subject|0
7627242|NCT01701258|26538969|P9|Assessment and Scheduling|Withdrawal by Subject|0
7627243|NCT01701258|26538970|P8|Assessment and Scheduling|Withdrawal by Subject|0
7627244|NCT01701258|26538971|P7|Assessment and Scheduling|Withdrawal by Subject|0
7627245|NCT01701258|26538972|P6|Assessment and Scheduling|Withdrawal by Subject|0
7627246|NCT01701258|26538973|P5|Assessment and Scheduling|Withdrawal by Subject|0
7627247|NCT01701258|26538974|P4|Assessment and Scheduling|Withdrawal by Subject|0
7627248|NCT01701258|26538975|P3|Assessment and Scheduling|Withdrawal by Subject|0
7627249|NCT01701258|26538976|P2|Assessment and Scheduling|Withdrawal by Subject|0
7627250|NCT01701258|26538977|P1|Assessment and Scheduling|Withdrawal by Subject|14
7627251|NCT01701258|26538965|P13|Assessment and Scheduling|Lost to Follow-up|0
7627252|NCT01701258|26538966|P12|Assessment and Scheduling|Lost to Follow-up|0
7627253|NCT01701258|26538967|P11|Assessment and Scheduling|Lost to Follow-up|0
7627254|NCT01701258|26538968|P10|Assessment and Scheduling|Lost to Follow-up|0
7627255|NCT01701258|26538969|P9|Assessment and Scheduling|Lost to Follow-up|0
7627256|NCT01701258|26538970|P8|Assessment and Scheduling|Lost to Follow-up|0
7627257|NCT01701258|26538971|P7|Assessment and Scheduling|Lost to Follow-up|0
7627258|NCT01701258|26538972|P6|Assessment and Scheduling|Lost to Follow-up|0
7627259|NCT01701258|26538973|P5|Assessment and Scheduling|Lost to Follow-up|0
7627260|NCT01701258|26538974|P4|Assessment and Scheduling|Lost to Follow-up|0
7627261|NCT01701258|26538975|P3|Assessment and Scheduling|Lost to Follow-up|0
7627262|NCT01701258|26538976|P2|Assessment and Scheduling|Lost to Follow-up|0
7627263|NCT01701258|26538977|P1|Assessment and Scheduling|Lost to Follow-up|10
7627264|NCT01701258|26538965|P13|Assessment and Scheduling|Found to be Ineligible|0
7627265|NCT01701258|26538966|P12|Assessment and Scheduling|Found to be Ineligible|0
7627266|NCT01701258|26538967|P11|Assessment and Scheduling|Found to be Ineligible|0
7627267|NCT01701258|26538968|P10|Assessment and Scheduling|Found to be Ineligible|0
7627268|NCT01701258|26538969|P9|Assessment and Scheduling|Found to be Ineligible|0
7627269|NCT01701258|26538970|P8|Assessment and Scheduling|Found to be Ineligible|0
7627270|NCT01701258|26538971|P7|Assessment and Scheduling|Found to be Ineligible|0
7627271|NCT01701258|26538972|P6|Assessment and Scheduling|Found to be Ineligible|0
7627272|NCT01701258|26538973|P5|Assessment and Scheduling|Found to be Ineligible|0
7627273|NCT01701258|26538974|P4|Assessment and Scheduling|Found to be Ineligible|0
7627274|NCT01701258|26538975|P3|Assessment and Scheduling|Found to be Ineligible|0
7627275|NCT01701258|26538976|P2|Assessment and Scheduling|Found to be Ineligible|0
7627276|NCT01701258|26538977|P1|Assessment and Scheduling|Found to be Ineligible|57
7627277|NCT01701245|26539031|P2|Overall Study|Did not complete the open label period|12
7627278|NCT01701245|26539032|P1|Overall Study|Did not complete the open label period|11
7627279|NCT01701245|26539031|P2|Overall Study|Protocol Violation|3
7627280|NCT01701245|26539032|P1|Overall Study|Protocol Violation|1
7627281|NCT01701193|26539048|P4|Overall Study|Adverse Event|0
7627282|NCT01701193|26539049|P3|Overall Study|Adverse Event|0
7627283|NCT01701193|26539050|P2|Overall Study|Adverse Event|0
7627284|NCT01701193|26539051|P1|Overall Study|Adverse Event|1
7627285|NCT01701193|26539048|P4|Overall Study|Withdrawal by Subject|2
7627286|NCT01701193|26539049|P3|Overall Study|Withdrawal by Subject|1
7627287|NCT01701193|26539050|P2|Overall Study|Withdrawal by Subject|2
7627288|NCT01701193|26539051|P1|Overall Study|Withdrawal by Subject|2
7627289|NCT01701063|26539100|P3|Overall Study|Other|1
7627290|NCT01701063|26539101|P2|Overall Study|Other|0
7627291|NCT01701063|26539102|P1|Overall Study|Other|0
7627292|NCT01701063|26539100|P3|Overall Study|Withdrawal by Subject|1
7627293|NCT01701063|26539101|P2|Overall Study|Withdrawal by Subject|0
7627294|NCT01701063|26539102|P1|Overall Study|Withdrawal by Subject|0
7627295|NCT01701063|26539100|P3|Overall Study|Lost to Follow-up|0
7627296|NCT01701063|26539101|P2|Overall Study|Lost to Follow-up|1
7627297|NCT01701063|26539102|P1|Overall Study|Lost to Follow-up|0
7627298|NCT01700985|26539186|P2|Overall Study|Incarcerated|1
7627299|NCT01700985|26539187|P1|Overall Study|Incarcerated|0
7627300|NCT01700959|26539209|P6|Overall Study|Side effects|1
7627301|NCT01700959|26539210|P5|Overall Study|Side effects|4
7627302|NCT01700959|26539211|P4|Overall Study|Side effects|4
7627303|NCT01700959|26539212|P3|Overall Study|Side effects|8
7627304|NCT01700959|26539213|P2|Overall Study|Side effects|4
7627305|NCT01700959|26539214|P1|Overall Study|Side effects|1
7627306|NCT01700959|26539209|P6|Overall Study|Noncompliant|9
7627307|NCT01700959|26539210|P5|Overall Study|Noncompliant|15
7627308|NCT01700959|26539211|P4|Overall Study|Noncompliant|18
7627309|NCT01700959|26539212|P3|Overall Study|Noncompliant|17
7627310|NCT01700959|26539213|P2|Overall Study|Noncompliant|9
7627311|NCT01700959|26539214|P1|Overall Study|Noncompliant|9
7627312|NCT01700959|26539209|P6|Overall Study|Ineligible|1
7627313|NCT01700959|26539210|P5|Overall Study|Ineligible|0
7627314|NCT01700959|26539211|P4|Overall Study|Ineligible|0
7627315|NCT01700959|26539212|P3|Overall Study|Ineligible|2
7627316|NCT01700959|26539213|P2|Overall Study|Ineligible|1
7627317|NCT01700959|26539214|P1|Overall Study|Ineligible|2
7627318|NCT01700959|26539209|P6|Overall Study|Withdrawal by Subject|12
7627319|NCT01700959|26539210|P5|Overall Study|Withdrawal by Subject|8
7627320|NCT01700959|26539211|P4|Overall Study|Withdrawal by Subject|11
7627321|NCT01700959|26539212|P3|Overall Study|Withdrawal by Subject|12
7627322|NCT01700959|26539213|P2|Overall Study|Withdrawal by Subject|9
7627323|NCT01700959|26539214|P1|Overall Study|Withdrawal by Subject|15
7627324|NCT01700959|26539209|P6|Overall Study|Adverse Event|2
7627325|NCT01700959|26539210|P5|Overall Study|Adverse Event|0
7627326|NCT01700959|26539211|P4|Overall Study|Adverse Event|2
7627327|NCT01700959|26539212|P3|Overall Study|Adverse Event|1
7627328|NCT01700959|26539213|P2|Overall Study|Adverse Event|1
7627329|NCT01700959|26539214|P1|Overall Study|Adverse Event|0
7627330|NCT01700829|26539255|P2|Overall Study|Withdrawal by Subject|1
7627331|NCT01700829|26539256|P1|Overall Study|Withdrawal by Subject|1
7627332|NCT01700621|26539338|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
7627333|NCT01700621|26539339|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
7627334|NCT01700621|26539338|P2|Analyzed for Immunogenicity|Protocol Violation|1
7627335|NCT01700621|26539339|P1|Analyzed for Immunogenicity|Protocol Violation|5
7627336|NCT01700621|26539338|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
7627337|NCT01700621|26539339|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
7627338|NCT01700530|26539377|P3|Overall Study|Withdrawal by Subject|1
7627339|NCT01700530|26539378|P2|Overall Study|Withdrawal by Subject|3
7627340|NCT01700530|26539379|P1|Overall Study|Withdrawal by Subject|0
7627341|NCT01700387|26539428|P2|Overall Study|Lost to Follow-up|1
7627342|NCT01700387|26539429|P1|Overall Study|Lost to Follow-up|2
7627343|NCT01700387|26539428|P2|Overall Study|Adverse Event|1
7627344|NCT01700387|26539429|P1|Overall Study|Adverse Event|1
7627345|NCT01700387|26539428|P2|Overall Study|Withdrawal by Subject|2
7627346|NCT01700387|26539429|P1|Overall Study|Withdrawal by Subject|1
7627347|NCT01700348|26539459|P1|Overall Study|Lost to Follow-up|1
7627348|NCT01700348|26539459|P1|Overall Study|Withdrawal by Subject|22
7627349|NCT01700205|26539482|P2|Overall Study|Protocol Violation|2
7627350|NCT01700205|26539483|P1|Overall Study|Protocol Violation|2
7627351|NCT01700205|26539482|P2|Overall Study|Withdrawal by Subject|13
7627352|NCT01700205|26539483|P1|Overall Study|Withdrawal by Subject|13
7627353|NCT01700192|26539505|P2|Overall Study|Never received study drug|0
7627354|NCT01700192|26539506|P1|Overall Study|Never received study drug|1
7627355|NCT01700192|26539505|P2|Overall Study|Withdrawal by Subject|64
7627356|NCT01700192|26539506|P1|Overall Study|Withdrawal by Subject|56
7627357|NCT01700192|26539505|P2|Overall Study|Technical problems|1
7627358|NCT01700192|26539506|P1|Overall Study|Technical problems|0
7627359|NCT01700192|26539505|P2|Overall Study|Protocol Violation|4
7627360|NCT01700192|26539506|P1|Overall Study|Protocol Violation|3
7627361|NCT01700192|26539505|P2|Overall Study|Progressive disease|0
7627362|NCT01700192|26539506|P1|Overall Study|Progressive disease|1
7627363|NCT01700192|26539505|P2|Overall Study|Pregnancy|4
7627364|NCT01700192|26539506|P1|Overall Study|Pregnancy|1
7627365|NCT01700192|26539505|P2|Overall Study|Physician Decision|3
7627366|NCT01700192|26539506|P1|Overall Study|Physician Decision|2
7627367|NCT01700192|26539505|P2|Overall Study|Noncompliance with study drug|5
7627368|NCT01700192|26539506|P1|Overall Study|Noncompliance with study drug|0
7627369|NCT01700192|26539505|P2|Overall Study|Lost to Follow-up|29
7627370|NCT01700192|26539506|P1|Overall Study|Lost to Follow-up|42
7627371|NCT01700192|26539505|P2|Overall Study|Lack of Efficacy|0
7627372|NCT01700192|26539506|P1|Overall Study|Lack of Efficacy|1
7627373|NCT01700192|26539505|P2|Overall Study|Adverse Event|18
7627374|NCT01700192|26539506|P1|Overall Study|Adverse Event|73
7627375|NCT01700179|26539524|P1|Overall Study|Physician Decision|2
7627376|NCT01700140|26539531|P3|Overall Study|Inclusion/exclusion criteria deviation|0
7627377|NCT01700140|26539532|P2|Overall Study|Inclusion/exclusion criteria deviation|4
7627378|NCT01700140|26539533|P1|Overall Study|Inclusion/exclusion criteria deviation|1
7627379|NCT01700140|26539531|P3|Overall Study|Adverse Event|0
7627380|NCT01700140|26539532|P2|Overall Study|Adverse Event|1
7627381|NCT01700140|26539533|P1|Overall Study|Adverse Event|0
7627382|NCT01700140|26539531|P3|Overall Study|Aggravation of symptoms|0
7627383|NCT01700140|26539532|P2|Overall Study|Aggravation of symptoms|0
7627384|NCT01700140|26539533|P1|Overall Study|Aggravation of symptoms|1
7627385|NCT01700140|26539531|P3|Overall Study|Use of chemotherapy or surgical therapy|0
7627386|NCT01700140|26539532|P2|Overall Study|Use of chemotherapy or surgical therapy|1
7627387|NCT01700140|26539533|P1|Overall Study|Use of chemotherapy or surgical therapy|0
7627388|NCT01700140|26539531|P3|Overall Study|Discontinuation of radiotherapy|0
7627389|NCT01700140|26539532|P2|Overall Study|Discontinuation of radiotherapy|0
7627390|NCT01700140|26539533|P1|Overall Study|Discontinuation of radiotherapy|1
7627391|NCT01700140|26539531|P3|Overall Study|Use of rescue drugs|1
7627392|NCT01700140|26539532|P2|Overall Study|Use of rescue drugs|3
7627393|NCT01700140|26539533|P1|Overall Study|Use of rescue drugs|3
7627394|NCT01700049|26539565|P1|Overall Study|Withdrawal by Subject|1
7627395|NCT01699867|26539580|P1|Overall Study|Screening Failure|3
7627396|NCT01699815|26539587|P2|Overall Study|Adverse Event|1
7627397|NCT01699815|26539588|P1|Overall Study|Adverse Event|0
7627398|NCT01699815|26539587|P2|Overall Study|record could not be located|0
7627399|NCT01699815|26539588|P1|Overall Study|record could not be located|1
7627400|NCT01699815|26539587|P2|Overall Study|Protocol Violation|7
7627401|NCT01699815|26539588|P1|Overall Study|Protocol Violation|4
7627402|NCT01699789|26539600|P2|Overall Study|Lost to Follow-up|101
7627403|NCT01699789|26539601|P1|Overall Study|Lost to Follow-up|83
7627404|NCT01699789|26539600|P2|Overall Study|Death|2
7627405|NCT01699789|26539601|P1|Overall Study|Death|1
7627406|NCT01699789|26539600|P2|Overall Study|Withdrawal by Subject|23
7627407|NCT01699789|26539601|P1|Overall Study|Withdrawal by Subject|18
7627408|NCT01699750|26539717|P2|Overall Study|Other|2
7627409|NCT01699750|26539718|P1|Overall Study|Other|0
7627410|NCT01699750|26539717|P2|Overall Study|Withdrew Consent|1
7627411|NCT01699750|26539718|P1|Overall Study|Withdrew Consent|0
7627412|NCT01699685|26539753|P2|Period 2|Lost to Follow-up|0
7627413|NCT01699685|26539754|P1|Period 2|Lost to Follow-up|1
7627414|NCT01699685|26539753|P2|Period 1|Patient request|1
7627415|NCT01699685|26539754|P1|Period 1|Patient request|0
7627416|NCT01699685|26539753|P2|Period 1|Other|1
7627417|NCT01699685|26539754|P1|Period 1|Other|0
7627418|NCT01699685|26539753|P2|Period 1|Medical or ethical, noncompliance|0
7627419|NCT01699685|26539754|P1|Period 1|Medical or ethical, noncompliance|2
7627420|NCT01699685|26539753|P2|Period 1|Adverse Event|1
7627421|NCT01699685|26539754|P1|Period 1|Adverse Event|1
7627422|NCT01699503|26539807|P2|Overall Study|Excluded due to quality|791
7627423|NCT01699503|26539808|P1|Overall Study|Excluded due to quality|783
7627424|NCT01699503|26539807|P2|Overall Study|Lost to Follow-up|117
7627425|NCT01699503|26539808|P1|Overall Study|Lost to Follow-up|121
7627426|NCT01699503|26539807|P2|Overall Study|Withdrawal by Subject|57
7627427|NCT01699503|26539808|P1|Overall Study|Withdrawal by Subject|65
7627428|NCT01699503|26539807|P2|Overall Study|Death|40
7627429|NCT01699503|26539808|P1|Overall Study|Death|31
7627430|NCT01699178|26539833|P2|Overall Study|ineligible/noncompliant/ subject reason|4
7627431|NCT01699178|26539834|P1|Overall Study|ineligible/noncompliant/ subject reason|4
7627432|NCT01699178|26539833|P2|Overall Study|PSA increase of >1.4 ng/mL|3
7627433|NCT01699178|26539834|P1|Overall Study|PSA increase of >1.4 ng/mL|4
7627434|NCT01699178|26539833|P2|Overall Study|Hematocrit >54%|1
7627435|NCT01699178|26539834|P1|Overall Study|Hematocrit >54%|1
7627436|NCT01699178|26539833|P2|Overall Study|Withdrawal by Subject|12
7627437|NCT01699178|26539834|P1|Overall Study|Withdrawal by Subject|4
7627438|NCT01699178|26539833|P2|Overall Study|Physician Decision|0
7627439|NCT01699178|26539834|P1|Overall Study|Physician Decision|1
7627440|NCT01699178|26539833|P2|Overall Study|Non-compliance with Study Drug|1
7627441|NCT01699178|26539834|P1|Overall Study|Non-compliance with Study Drug|3
7627442|NCT01699178|26539833|P2|Overall Study|Lost to Follow-up|6
7627443|NCT01699178|26539834|P1|Overall Study|Lost to Follow-up|1
7627444|NCT01699178|26539833|P2|Overall Study|Adverse Event|5
7627445|NCT01699178|26539834|P1|Overall Study|Adverse Event|1
7627446|NCT01699087|26539850|P1|Overall Study|Unable to make future visits|2
7627447|NCT01699087|26539850|P1|Overall Study|Screen failure (prior to treatment)|15
7627448|NCT01699087|26539850|P1|Overall Study|Lost to Follow-up|7
7627449|NCT01699022|26539864|P1|Overall Study|Early discontinuation from the study|3
7627450|NCT01698905|26539877|P1|Overall Study|Death|1
7627451|NCT01698905|26539877|P1|Overall Study|Subject/guardian decision|2
7627452|NCT01698905|26539877|P1|Overall Study|Protocol Violation|1
7627453|NCT01698905|26539877|P1|Overall Study|Pregnancy|1
7627454|NCT01698905|26539877|P1|Overall Study|Physician Decision|2
7627455|NCT01698905|26539877|P1|Overall Study|Adverse Event|4
7627456|NCT01698879|26539891|P3|Overall Study|Withdrawal by Subject|0
7627457|NCT01698879|26539892|P2|Overall Study|Withdrawal by Subject|0
7627458|NCT01698879|26539893|P1|Overall Study|Withdrawal by Subject|1
7627459|NCT01698814|26539916|P2|Overall Study|Randomized in error|0
7627460|NCT01698814|26539917|P1|Overall Study|Randomized in error|1
7627461|NCT01698814|26539916|P2|Overall Study|Pregnancy|0
7627462|NCT01698814|26539917|P1|Overall Study|Pregnancy|1
7627463|NCT01698814|26539916|P2|Overall Study|Lost to Follow-up|1
7627464|NCT01698814|26539917|P1|Overall Study|Lost to Follow-up|0
7627465|NCT01698814|26539916|P2|Overall Study|Adverse Event|2
7627466|NCT01698814|26539917|P1|Overall Study|Adverse Event|0
7627467|NCT01698801|26539923|P1|Follow Up Phase|Death|4
7627468|NCT01698801|26539923|P1|Follow Up Phase|Withdrawal by Subject|1
7627469|NCT01698801|26539923|P1|Treatment Phase|Disease progression|1
7627470|NCT01698801|26539923|P1|Treatment Phase|Withdrawal by Subject|1
7627471|NCT01698801|26539923|P1|Treatment Phase|Other|4
7627472|NCT01698801|26539923|P1|Treatment Phase|Protocol Violation|1
7627473|NCT01698801|26539923|P1|Treatment Phase|Adverse Event|4
7627474|NCT01698775|26539934|P2|Phase B|Withdrawal by Subject|2
7627475|NCT01698775|26539935|P1|Phase B|Withdrawal by Subject|6
7627476|NCT01698775|26539934|P2|Phase B|Protocol Violation|1
7627477|NCT01698775|26539935|P1|Phase B|Protocol Violation|1
7627478|NCT01698775|26539934|P2|Phase B|Physician Decision|1
7627479|NCT01698775|26539935|P1|Phase B|Physician Decision|1
7627480|NCT01698775|26539934|P2|Phase B|Lost to Follow-up|1
7627481|NCT01698775|26539935|P1|Phase B|Lost to Follow-up|0
7627482|NCT01698775|26539934|P2|Phase B|Lack of Efficacy|1
7627483|NCT01698775|26539935|P1|Phase B|Lack of Efficacy|0
7627484|NCT01698775|26539934|P2|Phase B|Death|1
7627485|NCT01698775|26539935|P1|Phase B|Death|0
7627486|NCT01698775|26539934|P2|Phase B|Adverse Event|3
7627487|NCT01698775|26539935|P1|Phase B|Adverse Event|6
7627488|NCT01698775|26539934|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
7627489|NCT01698775|26539935|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
7627490|NCT01698775|26539934|P2|Phase A|Kidney [transplant]|1
7627491|NCT01698775|26539935|P1|Phase A|Kidney [transplant]|0
7627492|NCT01698775|26539934|P2|Phase A|Withdrawal by Subject|4
7627493|NCT01698775|26539935|P1|Phase A|Withdrawal by Subject|3
7627494|NCT01698775|26539934|P2|Phase A|Protocol Violation|0
7627495|NCT01698775|26539935|P1|Phase A|Protocol Violation|1
7627496|NCT01698775|26539934|P2|Phase A|Lost to Follow-up|2
7627497|NCT01698775|26539935|P1|Phase A|Lost to Follow-up|1
7627498|NCT01698775|26539934|P2|Phase A|Lack of Efficacy|0
7627499|NCT01698775|26539935|P1|Phase A|Lack of Efficacy|1
7627500|NCT01698775|26539934|P2|Phase A|Death|1
7627501|NCT01698775|26539935|P1|Phase A|Death|1
7627502|NCT01698775|26539934|P2|Phase A|Adverse Event|1
7627503|NCT01698775|26539935|P1|Phase A|Adverse Event|2
7627504|NCT01698554|26539984|P4|Overall Study|Other Miscellaneous Reasons|0
7627505|NCT01698554|26539985|P3|Overall Study|Other Miscellaneous Reasons|0
7627506|NCT01698554|26539986|P2|Overall Study|Other Miscellaneous Reasons|0
7627507|NCT01698554|26539987|P1|Overall Study|Other Miscellaneous Reasons|1
7627508|NCT01698554|26539984|P4|Overall Study|Protocol Violation|0
7627509|NCT01698554|26539985|P3|Overall Study|Protocol Violation|1
7627510|NCT01698554|26539986|P2|Overall Study|Protocol Violation|0
7627511|NCT01698554|26539987|P1|Overall Study|Protocol Violation|2
7627512|NCT01698554|26539984|P4|Overall Study|Personal Reasons|1
7627513|NCT01698554|26539985|P3|Overall Study|Personal Reasons|1
7627514|NCT01698554|26539986|P2|Overall Study|Personal Reasons|5
7627515|NCT01698554|26539987|P1|Overall Study|Personal Reasons|0
7627516|NCT01698554|26539984|P4|Overall Study|Lost to Follow-up|0
7627517|NCT01698554|26539985|P3|Overall Study|Lost to Follow-up|0
7627518|NCT01698554|26539986|P2|Overall Study|Lost to Follow-up|0
7627519|NCT01698554|26539987|P1|Overall Study|Lost to Follow-up|1
7627520|NCT01698554|26539984|P4|Overall Study|Adverse Event|1
7627521|NCT01698554|26539985|P3|Overall Study|Adverse Event|0
7627522|NCT01698554|26539986|P2|Overall Study|Adverse Event|5
7627523|NCT01698554|26539987|P1|Overall Study|Adverse Event|2
7627524|NCT01698320|26540057|P3|40-Week Open-Label Period|Lost to Follow-up|0
7627525|NCT01698320|26540058|P2|40-Week Open-Label Period|Lost to Follow-up|2
7627526|NCT01698320|26540059|P1|40-Week Open-Label Period|Lost to Follow-up|0
7627527|NCT01698320|26540057|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7627528|NCT01698320|26540058|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
7627529|NCT01698320|26540059|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7627530|NCT01698320|26540057|P3|40-Week Open-Label Period|Pregnancy|1
7627531|NCT01698320|26540058|P2|40-Week Open-Label Period|Pregnancy|2
7627532|NCT01698320|26540059|P1|40-Week Open-Label Period|Pregnancy|0
7627533|NCT01698320|26540057|P3|40-Week Open-Label Period|Withdrawal by Subject|7
7627534|NCT01698320|26540058|P2|40-Week Open-Label Period|Withdrawal by Subject|11
7627535|NCT01698320|26540059|P1|40-Week Open-Label Period|Withdrawal by Subject|0
7627536|NCT01698320|26540057|P3|40-Week Open-Label Period|Adverse Event|2
7627537|NCT01698320|26540058|P2|40-Week Open-Label Period|Adverse Event|3
7627538|NCT01698320|26540059|P1|40-Week Open-Label Period|Adverse Event|0
7627539|NCT01698320|26540057|P3|12-Week Double-Blind Period|Lost to Follow-up|4
7627540|NCT01698320|26540058|P2|12-Week Double-Blind Period|Lost to Follow-up|0
7627541|NCT01698320|26540059|P1|12-Week Double-Blind Period|Lost to Follow-up|0
7627542|NCT01698320|26540057|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
7627543|NCT01698320|26540058|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7627544|NCT01698320|26540059|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7627545|NCT01698320|26540057|P3|12-Week Double-Blind Period|Pregnancy|1
7627546|NCT01698320|26540058|P2|12-Week Double-Blind Period|Pregnancy|1
7627547|NCT01698320|26540059|P1|12-Week Double-Blind Period|Pregnancy|0
7627548|NCT01698320|26540057|P3|12-Week Double-Blind Period|Protocol Violation|2
7627549|NCT01698320|26540058|P2|12-Week Double-Blind Period|Protocol Violation|0
7627550|NCT01698320|26540059|P1|12-Week Double-Blind Period|Protocol Violation|0
7627551|NCT01698320|26540057|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
7627552|NCT01698320|26540058|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
7627553|NCT01698320|26540059|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
7627554|NCT01698320|26540057|P3|12-Week Double-Blind Period|Adverse Event|1
7627555|NCT01698320|26540058|P2|12-Week Double-Blind Period|Adverse Event|1
7627556|NCT01698320|26540059|P1|12-Week Double-Blind Period|Adverse Event|0
7627557|NCT01698320|26540057|P3|Run-In Period (Week -1 to Day 0)|Other|0
7627558|NCT01698320|26540058|P2|Run-In Period (Week -1 to Day 0)|Other|0
7627559|NCT01698320|26540059|P1|Run-In Period (Week -1 to Day 0)|Other|1
7627560|NCT01698320|26540057|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7627561|NCT01698320|26540058|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7627562|NCT01698320|26540059|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
7627563|NCT01698320|26540057|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7627564|NCT01698320|26540058|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7627565|NCT01698320|26540059|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
7627566|NCT01698320|26540057|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7627567|NCT01698320|26540058|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7627568|NCT01698320|26540059|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
7627569|NCT01698268|26540079|P2|Overall Study|Physician Decision|1
7627570|NCT01698268|26540080|P1|Overall Study|Physician Decision|2
7627571|NCT01698008|26540088|P2|Overall Study|Withdrawal by Subject|2
7627572|NCT01698008|26540089|P1|Overall Study|Withdrawal by Subject|1
7627573|NCT01697969|26540095|P1|Overall Study|Did not meet inc/exc criteria|3
7627574|NCT01697956|26540102|P2|Overall Study|Protocol Violation|1
7627575|NCT01697956|26540103|P1|Overall Study|Protocol Violation|1
7627576|NCT01697800|26540133|P2|Overall Study|Death|1
7627577|NCT01697800|26540134|P1|Overall Study|Death|0
7627578|NCT01697748|26540142|P2|Overall Study|Lost to Follow-up|65
7627579|NCT01697748|26540143|P1|Overall Study|Lost to Follow-up|53
7627580|NCT01697748|26540142|P2|Overall Study|ineligible uterine incision|1
7627581|NCT01697748|26540143|P1|Overall Study|ineligible uterine incision|4
7627582|NCT01697748|26540142|P2|Overall Study|ineligible skin incision|2
7627583|NCT01697748|26540143|P1|Overall Study|ineligible skin incision|1
7627584|NCT01697696|26540172|P2|Overall Study|Subject/guardian decision|35
7627585|NCT01697696|26540173|P1|Overall Study|Subject/guardian decision|31
7627586|NCT01697696|26540172|P2|Overall Study|Lost to Follow-up|7
7627587|NCT01697696|26540173|P1|Overall Study|Lost to Follow-up|10
7627588|NCT01697696|26540172|P2|Overall Study|Death|2
7627589|NCT01697696|26540173|P1|Overall Study|Death|4
7627590|NCT01697696|26540172|P2|Overall Study|Physician Decision|0
7627591|NCT01697696|26540173|P1|Overall Study|Physician Decision|1
7627592|NCT01697696|26540172|P2|Overall Study|Protocol deviation|0
7627593|NCT01697696|26540173|P1|Overall Study|Protocol deviation|1
7627594|NCT01697696|26540172|P2|Overall Study|Study terminated by sponsor|3
7627595|NCT01697696|26540173|P1|Overall Study|Study terminated by sponsor|0
7627596|NCT01697592|26540205|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
7627597|NCT01697592|26540206|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
7627598|NCT01697592|26540207|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
7627599|NCT01697592|26540208|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
7627600|NCT01697592|26540209|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
7627601|NCT01697592|26540210|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
7627602|NCT01697592|26540211|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
7627603|NCT01697592|26540212|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
7627604|NCT01697592|26540213|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
7627605|NCT01697592|26540214|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
7627606|NCT01697592|26540205|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627607|NCT01697592|26540206|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627608|NCT01697592|26540207|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7627609|NCT01697592|26540208|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627610|NCT01697592|26540209|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7627611|NCT01697592|26540210|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627612|NCT01697592|26540211|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627613|NCT01697592|26540212|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627614|NCT01697592|26540213|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7627615|NCT01697592|26540214|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
7627616|NCT01697592|26540205|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
7627617|NCT01697592|26540206|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
7627618|NCT01697592|26540207|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
7627619|NCT01697592|26540208|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
7627620|NCT01697592|26540209|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
7627621|NCT01697592|26540210|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
7627622|NCT01697592|26540211|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
7627623|NCT01697592|26540212|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
7627624|NCT01697592|26540213|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
7627625|NCT01697592|26540214|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
7627626|NCT01697592|26540205|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
7627627|NCT01697592|26540206|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
7627628|NCT01697592|26540207|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
7627629|NCT01697592|26540208|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
7627630|NCT01697592|26540209|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
7627631|NCT01697592|26540210|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
7627632|NCT01697592|26540211|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
7627633|NCT01697592|26540212|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
7627634|NCT01697592|26540213|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
7627635|NCT01697592|26540214|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
7627636|NCT01697592|26540205|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7627637|NCT01697592|26540206|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7627638|NCT01697592|26540207|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7627639|NCT01697592|26540208|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7627640|NCT01697592|26540209|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7627641|NCT01697592|26540210|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7627642|NCT01697592|26540211|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7627643|NCT01697592|26540212|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7627644|NCT01697592|26540213|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7627645|NCT01697592|26540214|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7627646|NCT01697592|26540205|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627647|NCT01697592|26540206|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627648|NCT01697592|26540207|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627649|NCT01697592|26540208|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627650|NCT01697592|26540209|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627651|NCT01697592|26540210|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627652|NCT01697592|26540211|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627653|NCT01697592|26540212|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627654|NCT01697592|26540213|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
7627655|NCT01697592|26540214|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
7627656|NCT01697592|26540205|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
7627657|NCT01697592|26540206|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
7627658|NCT01697592|26540207|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
7627659|NCT01697592|26540208|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
7627660|NCT01697592|26540209|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
7627661|NCT01697592|26540210|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
7627662|NCT01697592|26540211|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
7627663|NCT01697592|26540212|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
7627664|NCT01697592|26540213|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
7627665|NCT01697592|26540214|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
7627666|NCT01697592|26540205|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627667|NCT01697592|26540206|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627668|NCT01697592|26540207|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627669|NCT01697592|26540208|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627670|NCT01697592|26540209|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627671|NCT01697592|26540210|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627672|NCT01697592|26540211|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627673|NCT01697592|26540212|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627674|NCT01697592|26540213|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7627675|NCT01697592|26540214|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
7627676|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
7627677|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7627678|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7627679|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7627680|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7627681|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7627682|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7627683|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
7627684|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
7627685|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7627686|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7627687|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7627688|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7627689|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7627690|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Participant Moved|2
7627691|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Participant Moved|0
7627692|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Participant Moved|0
7627693|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Participant Moved|0
7627694|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Participant Moved|0
7627695|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Participant Moved|0
7627696|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Participant Moved|0
7627697|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Technical Problems|1
7627698|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Technical Problems|0
7627699|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Technical Problems|0
7627700|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Technical Problems|0
7627701|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Technical Problems|0
7627702|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Technical Problems|0
7627703|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Technical Problems|0
7627704|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
7627705|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7627706|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7627707|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7627708|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7627709|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7627710|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7627711|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
7627712|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
7627713|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7627714|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7627715|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7627716|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7627717|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7627718|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
7627719|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
7627720|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7627721|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7627722|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7627723|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7627724|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7627725|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7627726|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
7627727|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7627728|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7627729|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7627730|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7627731|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7627732|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
7627733|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
7627734|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
7627735|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
7627736|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
7627737|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
7627738|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
7627739|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
7627740|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
7627741|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
7627742|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
7627743|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
7627744|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
7627745|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
7627746|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Physician Decision|11
7627747|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Physician Decision|7
7627748|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Physician Decision|0
7627749|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Physician Decision|0
7627750|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Physician Decision|0
7627751|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Physician Decision|0
7627752|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Physician Decision|0
7627753|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
7627754|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
7627755|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7627756|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7627757|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7627758|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7627759|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7627760|NCT01697579|26540283|P7|Optional Extension-Cycles 2-6|Death|2
7627761|NCT01697579|26540284|P6|Optional Extension-Cycles 2-6|Death|0
7627762|NCT01697579|26540285|P5|Optional Extension-Cycles 2-6|Death|0
7627763|NCT01697579|26540286|P4|Optional Extension-Cycles 2-6|Death|0
7627764|NCT01697579|26540287|P3|Optional Extension-Cycles 2-6|Death|0
7627765|NCT01697579|26540288|P2|Optional Extension-Cycles 2-6|Death|0
7627766|NCT01697579|26540289|P1|Optional Extension-Cycles 2-6|Death|0
7627767|NCT01697579|26540283|P7|Base Study-Cycle 1|Technical Problems|0
7627768|NCT01697579|26540284|P6|Base Study-Cycle 1|Technical Problems|0
7627769|NCT01697579|26540285|P5|Base Study-Cycle 1|Technical Problems|0
7627770|NCT01697579|26540286|P4|Base Study-Cycle 1|Technical Problems|1
7627771|NCT01697579|26540287|P3|Base Study-Cycle 1|Technical Problems|1
7627772|NCT01697579|26540288|P2|Base Study-Cycle 1|Technical Problems|0
7627773|NCT01697579|26540289|P1|Base Study-Cycle 1|Technical Problems|0
7627774|NCT01697579|26540283|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7627775|NCT01697579|26540284|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7627776|NCT01697579|26540285|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7627777|NCT01697579|26540286|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7627778|NCT01697579|26540287|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7627779|NCT01697579|26540288|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
7627780|NCT01697579|26540289|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7627781|NCT01697579|26540283|P7|Base Study-Cycle 1|Protocol Violation|0
7627782|NCT01697579|26540284|P6|Base Study-Cycle 1|Protocol Violation|0
7627783|NCT01697579|26540285|P5|Base Study-Cycle 1|Protocol Violation|3
7627784|NCT01697579|26540286|P4|Base Study-Cycle 1|Protocol Violation|0
7627785|NCT01697579|26540287|P3|Base Study-Cycle 1|Protocol Violation|0
7627786|NCT01697579|26540288|P2|Base Study-Cycle 1|Protocol Violation|0
7627787|NCT01697579|26540289|P1|Base Study-Cycle 1|Protocol Violation|0
7627788|NCT01697579|26540283|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7627789|NCT01697579|26540284|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7627790|NCT01697579|26540285|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7627791|NCT01697579|26540286|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7627792|NCT01697579|26540287|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7627793|NCT01697579|26540288|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7627794|NCT01697579|26540289|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
7627795|NCT01697579|26540283|P7|Base Study-Cycle 1|Adverse Event|0
7627796|NCT01697579|26540284|P6|Base Study-Cycle 1|Adverse Event|0
7627797|NCT01697579|26540285|P5|Base Study-Cycle 1|Adverse Event|0
7627798|NCT01697579|26540286|P4|Base Study-Cycle 1|Adverse Event|0
7627799|NCT01697579|26540287|P3|Base Study-Cycle 1|Adverse Event|0
7627800|NCT01697579|26540288|P2|Base Study-Cycle 1|Adverse Event|0
7627801|NCT01697579|26540289|P1|Base Study-Cycle 1|Adverse Event|1
7627802|NCT01697501|26540401|P1|Overall Study|Protocol Violation|2
7627803|NCT01697462|26540444|P1|Overall Study|Missing|5
7627804|NCT01697462|26540444|P1|Overall Study|Other|10
7627805|NCT01697462|26540444|P1|Overall Study|Death|1
7627806|NCT01697462|26540444|P1|Overall Study|Investigator Decision|21
7627807|NCT01697462|26540444|P1|Overall Study|Withdrawal by Subject|12
7627808|NCT01697462|26540444|P1|Overall Study|Lost to Follow-up|21
7627809|NCT01697462|26540444|P1|Overall Study|Adverse Event|6
7627810|NCT01697462|26540444|P1|Overall Study|Disease Progression|1
7627811|NCT01697449|26540451|P1|Overall Study|Missing|25
7627812|NCT01697449|26540451|P1|Overall Study|Other|1
7627813|NCT01697449|26540451|P1|Overall Study|Death|2
7627814|NCT01697449|26540451|P1|Overall Study|Physician Decision|1
7627815|NCT01697449|26540451|P1|Overall Study|Withdrawal by Subject|2
7627816|NCT01697449|26540451|P1|Overall Study|Lost to Follow-up|5
7627817|NCT01697449|26540451|P1|Overall Study|Adverse Event|7
7627818|NCT01697449|26540451|P1|Overall Study|Disease progression|47
7627819|NCT01697358|26540462|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
7627820|NCT01697358|26540463|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
7627821|NCT01697358|26540462|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
7627822|NCT01697358|26540463|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
7627823|NCT01697358|26540462|P2|Period II: 6-24M Long-term Follow-up|Death|1
7627824|NCT01697358|26540463|P1|Period II: 6-24M Long-term Follow-up|Death|1
7627825|NCT01697358|26540462|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7627826|NCT01697358|26540463|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7627827|NCT01697358|26540462|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
7627828|NCT01697358|26540463|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
7627829|NCT01697358|26540462|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
7627830|NCT01697358|26540463|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
7627831|NCT01697358|26540462|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
7627832|NCT01697358|26540463|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
7627833|NCT01697358|26540462|P2|Period I: Randomization to 6 Months|Adverse Event|1
7627834|NCT01697358|26540463|P1|Period I: Randomization to 6 Months|Adverse Event|1
7627835|NCT01697358|26540462|P2|Period I: Randomization to 6 Months|Physician Decision|0
7627836|NCT01697358|26540463|P1|Period I: Randomization to 6 Months|Physician Decision|4
7627837|NCT01697358|26540462|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
7627838|NCT01697358|26540463|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
7627839|NCT01697345|26540479|P1|Overall Study|Withdrawal by Subject|1
7627840|NCT01697319|26540504|P1|Extension Phase|Terminated by Sponsor|15
7627841|NCT01697319|26540504|P1|Primary Phase|Withdrawal by Subject|1
7627842|NCT01696994|26540513|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
7627843|NCT01696994|26540514|P1|Overall Study|Refused Screen (Ovarian Screening)|0
7627844|NCT01696994|26540513|P2|Overall Study|Refused ASU (Control)|0
7627845|NCT01696994|26540514|P1|Overall Study|Refused ASU (Control)|311
7627846|NCT01696994|26540513|P2|Overall Study|No Ovaries at Baseline|4851
7627847|NCT01696994|26540514|P1|Overall Study|No Ovaries at Baseline|4807
7627848|NCT01696994|26540513|P2|Overall Study|Died Before ASU (Control)|0
7627849|NCT01696994|26540514|P1|Overall Study|Died Before ASU (Control)|73
7627850|NCT01696994|26540513|P2|Overall Study|Died Before Randomization|2
7627851|NCT01696994|26540514|P1|Overall Study|Died Before Randomization|1
7627852|NCT01696994|26540513|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
7627853|NCT01696994|26540514|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
7627854|NCT01696981|26540542|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
7627855|NCT01696981|26540543|P1|Overall Study|Refused Screen (Colorectal Screening)|0
7627856|NCT01696981|26540542|P2|Overall Study|Refused ASU (Control)|0
7627857|NCT01696981|26540543|P1|Overall Study|Refused ASU (Control)|920
7627858|NCT01696981|26540542|P2|Overall Study|Died Before ASU (Control)|0
7627859|NCT01696981|26540543|P1|Overall Study|Died Before ASU (Control)|278
7627860|NCT01696981|26540542|P2|Overall Study|Died Before Randomization|8
7627861|NCT01696981|26540543|P1|Overall Study|Died Before Randomization|3
7627862|NCT01696981|26540542|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
7627863|NCT01696981|26540543|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
7627864|NCT01696968|26540563|P2|Overall Study|Refused Screen (Lung Screening)|6796
7627865|NCT01696968|26540564|P1|Overall Study|Refused Screen (Lung Screening)|0
7627866|NCT01696968|26540563|P2|Overall Study|Refused ASU (Control)|0
7627867|NCT01696968|26540564|P1|Overall Study|Refused ASU (Control)|920
7627868|NCT01696968|26540563|P2|Overall Study|Died Before ASU (Control)|0
7627869|NCT01696968|26540564|P1|Overall Study|Died Before ASU (Control)|278
7627870|NCT01696968|26540563|P2|Overall Study|Died Before Randomization|8
7627871|NCT01696968|26540564|P1|Overall Study|Died Before Randomization|3
7627872|NCT01696968|26540563|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
7627873|NCT01696968|26540564|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
7627874|NCT01696955|26540586|P2|Main Study|Withdrawal by Subject|1
7627875|NCT01696955|26540587|P1|Main Study|Withdrawal by Subject|1
7627876|NCT01696955|26540586|P2|Main Study|Protocol Violation|0
7627877|NCT01696955|26540587|P1|Main Study|Protocol Violation|1
7627878|NCT01696942|26540612|P2|Overall Study|screen failure|1
7627879|NCT01696942|26540613|P1|Overall Study|screen failure|0
7627880|NCT01696942|26540612|P2|Overall Study|Protocol Violation|2
7627881|NCT01696942|26540613|P1|Overall Study|Protocol Violation|1
7627882|NCT01696942|26540612|P2|Overall Study|Withdrawal by Subject|0
7627883|NCT01696942|26540613|P1|Overall Study|Withdrawal by Subject|1
7627884|NCT01696929|26540621|P1|Overall Study|Physician Decision|1
7627885|NCT01696877|26540628|P2|Overall Study|Adverse Event|1
7627886|NCT01696877|26540629|P1|Overall Study|Adverse Event|0
7627887|NCT01696773|26540651|P2|Days 15-27, Washout|Adverse Event|0
7627888|NCT01696773|26540652|P1|Days 15-27, Washout|Adverse Event|1
7627889|NCT01696695|26540679|P1|Overall Study|Major Protocol Violation|192
7627890|NCT01696695|26540679|P1|Overall Study|Other|74
7627891|NCT01696695|26540679|P1|Overall Study|Lost to Follow-up|48
7627892|NCT01696695|26540679|P1|Overall Study|Withdrawal by Subject|92
7627893|NCT01696695|26540679|P1|Overall Study|Adverse Event|74
7627894|NCT01696695|26540679|P1|Overall Study|Death|29
7627895|NCT01696695|26540679|P1|Overall Study|Disease progression|373
7627896|NCT01696643|26540691|P2|Overall Study|Participant Did Not Receive Study Drug|2
7627897|NCT01696643|26540692|P1|Overall Study|Participant Did Not Receive Study Drug|2
7627898|NCT01696643|26540691|P2|Overall Study|Medical Monitor Decision|2
7627899|NCT01696643|26540692|P1|Overall Study|Medical Monitor Decision|0
7627900|NCT01696643|26540691|P2|Overall Study|Participant Incarcerated|1
7627901|NCT01696643|26540692|P1|Overall Study|Participant Incarcerated|0
7627902|NCT01696643|26540691|P2|Overall Study|Site Error|1
7627903|NCT01696643|26540692|P1|Overall Study|Site Error|2
7627904|NCT01696643|26540691|P2|Overall Study|Participant on Restricted Bed Rest|0
7627905|NCT01696643|26540692|P1|Overall Study|Participant on Restricted Bed Rest|1
7627906|NCT01696643|26540691|P2|Overall Study|Withdrawal by Subject|149
7627907|NCT01696643|26540692|P1|Overall Study|Withdrawal by Subject|142
7627908|NCT01696643|26540691|P2|Overall Study|Study Terminated by Sponsor|294
7627909|NCT01696643|26540692|P1|Overall Study|Study Terminated by Sponsor|286
7627910|NCT01696643|26540691|P2|Overall Study|Protocol Violation|7
7627911|NCT01696643|26540692|P1|Overall Study|Protocol Violation|7
7627912|NCT01696643|26540691|P2|Overall Study|Pregnancy|1
7627913|NCT01696643|26540692|P1|Overall Study|Pregnancy|0
7627914|NCT01696643|26540691|P2|Overall Study|Physician Decision|2
7627915|NCT01696643|26540692|P1|Overall Study|Physician Decision|3
7627916|NCT01696643|26540691|P2|Overall Study|Lost to Follow-up|67
7627917|NCT01696643|26540692|P1|Overall Study|Lost to Follow-up|67
7627918|NCT01696643|26540691|P2|Overall Study|Lack of Efficacy|0
7627919|NCT01696643|26540692|P1|Overall Study|Lack of Efficacy|3
7627920|NCT01696643|26540691|P2|Overall Study|Death|2
7627921|NCT01696643|26540692|P1|Overall Study|Death|1
7627922|NCT01696643|26540691|P2|Overall Study|Adverse Event|7
7627923|NCT01696643|26540692|P1|Overall Study|Adverse Event|15
7627924|NCT01696396|26540711|P4|Overall Study|Death|0
7627925|NCT01696396|26540712|P3|Overall Study|Death|1
7627926|NCT01696396|26540713|P2|Overall Study|Death|0
7627927|NCT01696396|26540714|P1|Overall Study|Death|0
7627928|NCT01696396|26540711|P4|Overall Study|Lost to Follow-up|1
7627929|NCT01696396|26540712|P3|Overall Study|Lost to Follow-up|4
7627930|NCT01696396|26540713|P2|Overall Study|Lost to Follow-up|1
7627931|NCT01696396|26540714|P1|Overall Study|Lost to Follow-up|9
7627932|NCT01696396|26540711|P4|Overall Study|Decision by Sponsor|2
7627933|NCT01696396|26540712|P3|Overall Study|Decision by Sponsor|2
7627934|NCT01696396|26540713|P2|Overall Study|Decision by Sponsor|1
7627935|NCT01696396|26540714|P1|Overall Study|Decision by Sponsor|3
7627936|NCT01696396|26540711|P4|Overall Study|Withdrawal by Subject|11
7627937|NCT01696396|26540712|P3|Overall Study|Withdrawal by Subject|19
7627938|NCT01696396|26540713|P2|Overall Study|Withdrawal by Subject|5
7627939|NCT01696396|26540714|P1|Overall Study|Withdrawal by Subject|19
7627940|NCT01696279|26540765|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
7627941|NCT01696279|26540766|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7627942|NCT01696279|26540767|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7627943|NCT01696279|26540768|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7627944|NCT01696279|26540765|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
7627945|NCT01696279|26540766|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7627946|NCT01696279|26540767|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7627947|NCT01696279|26540768|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7627948|NCT01696279|26540765|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
7627949|NCT01696279|26540766|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7627950|NCT01696279|26540767|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7627951|NCT01696279|26540768|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7627952|NCT01696279|26540765|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7627953|NCT01696279|26540766|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
7627954|NCT01696279|26540767|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7627955|NCT01696279|26540768|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7627956|NCT01696279|26540765|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7627957|NCT01696279|26540766|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7627958|NCT01696279|26540767|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
7627959|NCT01696279|26540768|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7627960|NCT01696279|26540765|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7627961|NCT01696279|26540766|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7627962|NCT01696279|26540767|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
7627963|NCT01696279|26540768|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7627964|NCT01696279|26540765|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7627965|NCT01696279|26540766|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7627966|NCT01696279|26540767|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
7627967|NCT01696279|26540768|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7627968|NCT01696279|26540765|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7627969|NCT01696279|26540766|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7627970|NCT01696279|26540767|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
7627971|NCT01696279|26540768|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7627972|NCT01696279|26540765|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7627973|NCT01696279|26540766|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7627974|NCT01696279|26540767|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
7627975|NCT01696279|26540768|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7627976|NCT01696279|26540765|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7627977|NCT01696279|26540766|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7627978|NCT01696279|26540767|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
7627979|NCT01696279|26540768|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7627980|NCT01696279|26540765|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7627981|NCT01696279|26540766|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7627982|NCT01696279|26540767|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7627983|NCT01696279|26540768|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
7627984|NCT01696214|26540806|P4|Overall Study|Lost to Follow-up|0
7627985|NCT01696214|26540807|P3|Overall Study|Lost to Follow-up|0
7627986|NCT01696214|26540808|P2|Overall Study|Lost to Follow-up|0
7627987|NCT01696214|26540809|P1|Overall Study|Lost to Follow-up|1
7627988|NCT01696188|26540829|P2|Overall Study|Protocol Violation|1
7627989|NCT01696188|26540830|P1|Overall Study|Protocol Violation|1
7627990|NCT01696071|26540861|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
7627991|NCT01696071|26540862|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
7627992|NCT01696058|26540890|P2|Overall Study|Other reason prematurely discontinued|3
7627993|NCT01696058|26540891|P1|Overall Study|Other reason prematurely discontinued|5
7627994|NCT01696058|26540890|P2|Overall Study|Withdrawal by Subject|6
7627995|NCT01696058|26540891|P1|Overall Study|Withdrawal by Subject|4
7627996|NCT01696058|26540890|P2|Overall Study|Lost to Follow-up|5
7627997|NCT01696058|26540891|P1|Overall Study|Lost to Follow-up|2
7627998|NCT01696058|26540890|P2|Overall Study|Protocol Violation|3
7627999|NCT01696058|26540891|P1|Overall Study|Protocol Violation|9
7628000|NCT01696058|26540890|P2|Overall Study|Lack of Efficacy|3
7628001|NCT01696058|26540891|P1|Overall Study|Lack of Efficacy|2
7628002|NCT01696058|26540890|P2|Overall Study|Adverse Event|11
7628003|NCT01696058|26540891|P1|Overall Study|Adverse Event|21
7628004|NCT01696045|26540919|P2|Overall Study|Disease progression|2
7628005|NCT01696045|26540920|P1|Overall Study|Disease progression|2
7628006|NCT01696045|26540919|P2|Overall Study|Study drug toxicity|5
7628007|NCT01696045|26540920|P1|Overall Study|Study drug toxicity|1
7628008|NCT01696032|26540940|P4|Overall Study|Database lock|2
7628009|NCT01696032|26540941|P3|Overall Study|Database lock|7
7628010|NCT01696032|26540942|P2|Overall Study|Database lock|1
7628011|NCT01696032|26540943|P1|Overall Study|Database lock|0
7628012|NCT01696032|26540940|P4|Overall Study|Lost to Follow-up|0
7628013|NCT01696032|26540941|P3|Overall Study|Lost to Follow-up|0
7628014|NCT01696032|26540942|P2|Overall Study|Lost to Follow-up|1
7628015|NCT01696032|26540943|P1|Overall Study|Lost to Follow-up|0
7628016|NCT01696032|26540940|P4|Overall Study|Death|18
7628017|NCT01696032|26540941|P3|Overall Study|Death|43
7628018|NCT01696032|26540942|P2|Overall Study|Death|4
7628019|NCT01696032|26540943|P1|Overall Study|Death|14
7628020|NCT01696032|26540940|P4|Overall Study|Withdrawal by Subject|2
7628021|NCT01696032|26540941|P3|Overall Study|Withdrawal by Subject|1
7628022|NCT01696032|26540942|P2|Overall Study|Withdrawal by Subject|0
7628023|NCT01696032|26540943|P1|Overall Study|Withdrawal by Subject|0
7628024|NCT01695993|26540993|P3|Overall Study|Changed Medical Facility|1
7628025|NCT01695993|26540994|P2|Overall Study|Changed Medical Facility|0
7628026|NCT01695993|26540995|P1|Overall Study|Changed Medical Facility|0
7628027|NCT01695993|26540993|P3|Overall Study|To ill to continue|0
7628028|NCT01695993|26540994|P2|Overall Study|To ill to continue|2
7628029|NCT01695993|26540995|P1|Overall Study|To ill to continue|1
7628030|NCT01695993|26540993|P3|Overall Study|Withdrawal by Subject|2
7628031|NCT01695993|26540994|P2|Overall Study|Withdrawal by Subject|2
7628032|NCT01695993|26540995|P1|Overall Study|Withdrawal by Subject|2
7628033|NCT01695993|26540993|P3|Overall Study|Lost to Follow-up|3
7628034|NCT01695993|26540994|P2|Overall Study|Lost to Follow-up|1
7628035|NCT01695993|26540995|P1|Overall Study|Lost to Follow-up|2
7628036|NCT01695954|26541005|P2|Overall Study|Adverse Event|2
7628037|NCT01695954|26541006|P1|Overall Study|Adverse Event|0
7628038|NCT01695954|26541005|P2|Overall Study|Withdrawal by Subject|0
7628039|NCT01695954|26541006|P1|Overall Study|Withdrawal by Subject|4
7628040|NCT01695772|26541016|P1|Overall Study|Unspecified Reason|1
7628041|NCT01695772|26541016|P1|Overall Study|Protocol Violation|2
7628042|NCT01695772|26541016|P1|Overall Study|Lost to Follow-up|4
7628043|NCT01695772|26541016|P1|Overall Study|Investigator Decision|5
7628044|NCT01695772|26541016|P1|Overall Study|Progressive Disease|8
7628045|NCT01695772|26541016|P1|Overall Study|Withdrawal by Subject|18
7628046|NCT01695746|26541028|P1|Overall Study|Participant not willing to participate|3
7628047|NCT01695746|26541028|P1|Overall Study|Protocol Violation|5
7628048|NCT01695746|26541028|P1|Overall Study|Non-compliance by the participant|3
7628049|NCT01695746|26541028|P1|Overall Study|Adverse Event|1
7628050|NCT01695239|26541095|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
7628051|NCT01695239|26541096|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
7628052|NCT01695239|26541097|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
7628053|NCT01695239|26541098|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
7628054|NCT01695239|26541099|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
7628055|NCT01695239|26541100|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
7628056|NCT01695239|26541101|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
7628057|NCT01695239|26541102|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
7628058|NCT01695239|26541103|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
7628059|NCT01695239|26541104|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
7628060|NCT01695239|26541105|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
7628061|NCT01695239|26541106|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
7628062|NCT01695239|26541107|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
7628063|NCT01695239|26541108|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
7628064|NCT01695239|26541095|P14|Post-Treatment Follow-Up Period|Physician Decision|0
7628065|NCT01695239|26541096|P13|Post-Treatment Follow-Up Period|Physician Decision|2
7628066|NCT01695239|26541097|P12|Post-Treatment Follow-Up Period|Physician Decision|0
7628067|NCT01695239|26541098|P11|Post-Treatment Follow-Up Period|Physician Decision|0
7628068|NCT01695239|26541099|P10|Post-Treatment Follow-Up Period|Physician Decision|0
7628069|NCT01695239|26541100|P9|Post-Treatment Follow-Up Period|Physician Decision|0
7628070|NCT01695239|26541101|P8|Post-Treatment Follow-Up Period|Physician Decision|0
7628071|NCT01695239|26541102|P7|Post-Treatment Follow-Up Period|Physician Decision|0
7628072|NCT01695239|26541103|P6|Post-Treatment Follow-Up Period|Physician Decision|0
7628073|NCT01695239|26541104|P5|Post-Treatment Follow-Up Period|Physician Decision|0
7628074|NCT01695239|26541105|P4|Post-Treatment Follow-Up Period|Physician Decision|0
7628075|NCT01695239|26541106|P3|Post-Treatment Follow-Up Period|Physician Decision|0
7628076|NCT01695239|26541107|P2|Post-Treatment Follow-Up Period|Physician Decision|0
7628077|NCT01695239|26541108|P1|Post-Treatment Follow-Up Period|Physician Decision|0
7628078|NCT01695239|26541095|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7628079|NCT01695239|26541096|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7628080|NCT01695239|26541097|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628081|NCT01695239|26541098|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628082|NCT01695239|26541099|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628083|NCT01695239|26541100|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628084|NCT01695239|26541101|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628085|NCT01695239|26541102|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628086|NCT01695239|26541103|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628087|NCT01695239|26541104|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628088|NCT01695239|26541105|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628089|NCT01695239|26541106|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628090|NCT01695239|26541107|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628091|NCT01695239|26541108|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7628092|NCT01695239|26541095|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7628093|NCT01695239|26541096|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7628094|NCT01695239|26541097|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7628095|NCT01695239|26541098|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628096|NCT01695239|26541099|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628097|NCT01695239|26541100|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628098|NCT01695239|26541101|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628099|NCT01695239|26541102|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628100|NCT01695239|26541103|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628101|NCT01695239|26541104|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628102|NCT01695239|26541105|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628103|NCT01695239|26541106|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628104|NCT01695239|26541107|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628105|NCT01695239|26541108|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7628106|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Death|0
7628107|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Death|0
7628108|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Death|0
7628109|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Death|0
7628110|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Death|0
7628111|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Death|1
7628112|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Death|0
7628113|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Death|0
7628114|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Death|0
7628115|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Death|0
7628116|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Death|0
7628117|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Death|0
7628118|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Death|0
7628119|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Death|0
7628120|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
7628121|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
7628122|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
7628123|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
7628124|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
7628125|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
7628126|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
7628127|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
7628128|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
7628129|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
7628130|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
7628131|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
7628132|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
7628133|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
7628134|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628135|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628136|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628137|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628138|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
7628139|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
7628140|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628141|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628142|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628143|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628144|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628145|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628146|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628147|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
7628148|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Physician Decision|0
7628149|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Physician Decision|0
7628150|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Physician Decision|0
7628151|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Physician Decision|0
7628152|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Physician Decision|0
7628153|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Physician Decision|3
7628154|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Physician Decision|0
7628155|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Physician Decision|0
7628156|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Physician Decision|0
7628157|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Physician Decision|0
7628158|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Physician Decision|0
7628159|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Physician Decision|0
7628160|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Physician Decision|0
7628161|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Physician Decision|0
7628162|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628163|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628164|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628165|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628166|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
7628167|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
7628168|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628169|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628170|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628171|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628172|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628173|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628174|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628175|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7628176|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Adverse Event|0
7628177|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Adverse Event|0
7628178|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Adverse Event|0
7628179|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Adverse Event|0
7628180|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Adverse Event|21
7628181|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Adverse Event|15
7628182|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Adverse Event|0
7628183|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Adverse Event|0
7628184|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Adverse Event|0
7628185|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Adverse Event|0
7628186|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Adverse Event|0
7628187|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Adverse Event|0
7628188|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Adverse Event|0
7628189|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Adverse Event|0
7628190|NCT01695239|26541095|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628191|NCT01695239|26541096|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628192|NCT01695239|26541097|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628193|NCT01695239|26541098|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628194|NCT01695239|26541099|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
7628195|NCT01695239|26541100|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
7628196|NCT01695239|26541101|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628197|NCT01695239|26541102|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628198|NCT01695239|26541103|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628199|NCT01695239|26541104|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628200|NCT01695239|26541105|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628201|NCT01695239|26541106|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628202|NCT01695239|26541107|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628203|NCT01695239|26541108|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
7628204|NCT01695239|26541095|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628205|NCT01695239|26541096|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628206|NCT01695239|26541097|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628207|NCT01695239|26541098|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628208|NCT01695239|26541099|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628209|NCT01695239|26541100|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628210|NCT01695239|26541101|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
7628211|NCT01695239|26541102|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628212|NCT01695239|26541103|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628213|NCT01695239|26541104|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628214|NCT01695239|26541105|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628215|NCT01695239|26541106|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628216|NCT01695239|26541107|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628217|NCT01695239|26541108|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7628218|NCT01695239|26541095|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628219|NCT01695239|26541096|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628220|NCT01695239|26541097|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628221|NCT01695239|26541098|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628222|NCT01695239|26541099|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628223|NCT01695239|26541100|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628224|NCT01695239|26541101|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
7628225|NCT01695239|26541102|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628226|NCT01695239|26541103|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628227|NCT01695239|26541104|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628228|NCT01695239|26541105|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628229|NCT01695239|26541106|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628230|NCT01695239|26541107|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628231|NCT01695239|26541108|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7628232|NCT01695239|26541095|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628233|NCT01695239|26541096|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628234|NCT01695239|26541097|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628235|NCT01695239|26541098|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628236|NCT01695239|26541099|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628237|NCT01695239|26541100|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628238|NCT01695239|26541101|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
7628239|NCT01695239|26541102|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628240|NCT01695239|26541103|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628241|NCT01695239|26541104|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628242|NCT01695239|26541105|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628243|NCT01695239|26541106|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628244|NCT01695239|26541107|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628245|NCT01695239|26541108|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7628246|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628247|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628248|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628249|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628250|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628251|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628252|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628253|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628254|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628255|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628256|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628257|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628258|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
7628259|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
7628260|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628261|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628262|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628263|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628264|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628265|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628266|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628267|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628268|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628269|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628270|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628271|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7628272|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7628273|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7628274|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628275|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628276|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628277|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628278|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628279|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628280|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628281|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628282|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628283|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628284|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628285|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
7628286|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7628287|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
7628288|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628289|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628290|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628291|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628292|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628293|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628294|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628295|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628296|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628297|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628298|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7628299|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7628300|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7628301|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
7628302|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628303|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628304|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628305|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628306|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628307|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628308|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628309|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628310|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628311|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628312|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628313|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7628314|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7628315|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
7628316|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
7628317|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
7628318|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
7628319|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
7628320|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
7628321|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
7628322|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
7628323|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
7628324|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
7628325|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
7628326|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
7628327|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
7628328|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
7628329|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
7628330|NCT01695239|26541095|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628331|NCT01695239|26541096|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628332|NCT01695239|26541097|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628333|NCT01695239|26541098|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628334|NCT01695239|26541099|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628335|NCT01695239|26541100|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628336|NCT01695239|26541101|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628337|NCT01695239|26541102|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628338|NCT01695239|26541103|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628339|NCT01695239|26541104|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7628340|NCT01695239|26541105|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
7628341|NCT01695239|26541106|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
7628342|NCT01695239|26541107|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7628343|NCT01695239|26541108|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7628344|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
7628345|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7628346|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7628347|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7628348|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Death|7
7628349|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Death|2
7628350|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Death|0
7628351|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Death|0
7628352|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Physician Decision|1
7628353|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Physician Decision|4
7628354|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Physician Decision|0
7628355|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Physician Decision|0
7628356|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Other|7
7628357|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Other|4
7628358|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Other|0
7628359|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Other|0
7628360|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Adverse Event|16
7628361|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Adverse Event|11
7628362|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Adverse Event|0
7628363|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Adverse Event|0
7628364|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
7628365|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
7628366|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7628367|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7628368|NCT01695135|26541249|P4|Open Label Extension Treatment Phase|Progressive disease|22
7628369|NCT01695135|26541250|P3|Open Label Extension Treatment Phase|Progressive disease|13
7628370|NCT01695135|26541251|P2|Open Label Extension Treatment Phase|Progressive disease|0
7628371|NCT01695135|26541252|P1|Open Label Extension Treatment Phase|Progressive disease|0
7628372|NCT01695135|26541249|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
7628373|NCT01695135|26541250|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
7628374|NCT01695135|26541251|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
7628375|NCT01695135|26541252|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
7628376|NCT01695135|26541249|P4|Double-blind Treatment Phase|Death|0
7628377|NCT01695135|26541250|P3|Double-blind Treatment Phase|Death|0
7628378|NCT01695135|26541251|P2|Double-blind Treatment Phase|Death|1
7628379|NCT01695135|26541252|P1|Double-blind Treatment Phase|Death|1
7628380|NCT01695135|26541249|P4|Double-blind Treatment Phase|Physician Decision|0
7628381|NCT01695135|26541250|P3|Double-blind Treatment Phase|Physician Decision|0
7628382|NCT01695135|26541251|P2|Double-blind Treatment Phase|Physician Decision|3
7628383|NCT01695135|26541252|P1|Double-blind Treatment Phase|Physician Decision|6
7628384|NCT01695135|26541249|P4|Double-blind Treatment Phase|Other|0
7628385|NCT01695135|26541250|P3|Double-blind Treatment Phase|Other|0
7628386|NCT01695135|26541251|P2|Double-blind Treatment Phase|Other|3
7628387|NCT01695135|26541252|P1|Double-blind Treatment Phase|Other|1
7628388|NCT01695135|26541249|P4|Double-blind Treatment Phase|Adverse Event|0
7628389|NCT01695135|26541250|P3|Double-blind Treatment Phase|Adverse Event|0
7628390|NCT01695135|26541251|P2|Double-blind Treatment Phase|Adverse Event|7
7628391|NCT01695135|26541252|P1|Double-blind Treatment Phase|Adverse Event|7
7628392|NCT01695135|26541249|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
7628393|NCT01695135|26541250|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
7628394|NCT01695135|26541251|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
7628395|NCT01695135|26541252|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
7628396|NCT01695135|26541249|P4|Double-blind Treatment Phase|Progressive disease|0
7628397|NCT01695135|26541250|P3|Double-blind Treatment Phase|Progressive disease|0
7628398|NCT01695135|26541251|P2|Double-blind Treatment Phase|Progressive disease|110
7628399|NCT01695135|26541252|P1|Double-blind Treatment Phase|Progressive disease|50
7628400|NCT01694771|26541301|P2|Overall Study|Other reasons|6
7628401|NCT01694771|26541302|P1|Overall Study|Other reasons|5
7628402|NCT01694771|26541301|P2|Overall Study|Consent withdrawn|9
7628403|NCT01694771|26541302|P1|Overall Study|Consent withdrawn|7
7628404|NCT01694771|26541301|P2|Overall Study|Lost to Follow-up|3
7628405|NCT01694771|26541302|P1|Overall Study|Lost to Follow-up|2
7628406|NCT01694771|26541301|P2|Overall Study|Non compliance protocol|6
7628407|NCT01694771|26541302|P1|Overall Study|Non compliance protocol|7
7628408|NCT01694771|26541301|P2|Overall Study|Lack of Efficacy|0
7628409|NCT01694771|26541302|P1|Overall Study|Lack of Efficacy|1
7628410|NCT01694771|26541301|P2|Overall Study|Adverse Event|16
7628411|NCT01694771|26541302|P1|Overall Study|Adverse Event|18
7628412|NCT01694706|26541326|P3|Overall Study|other reason not defined above|0
7628413|NCT01694706|26541327|P2|Overall Study|other reason not defined above|0
7628414|NCT01694706|26541328|P1|Overall Study|other reason not defined above|1
7628415|NCT01694706|26541326|P3|Overall Study|Adverse Event|0
7628416|NCT01694706|26541327|P2|Overall Study|Adverse Event|1
7628417|NCT01694706|26541328|P1|Overall Study|Adverse Event|0
7628418|NCT01694485|26541387|P5|Overall Study|Death|0
7628419|NCT01694485|26541388|P4|Overall Study|Death|1
7628420|NCT01694485|26541389|P3|Overall Study|Death|0
7628421|NCT01694485|26541390|P2|Overall Study|Death|0
7628422|NCT01694485|26541391|P1|Overall Study|Death|1
7628423|NCT01694485|26541387|P5|Overall Study|Lost to Follow-up|7
7628424|NCT01694485|26541388|P4|Overall Study|Lost to Follow-up|10
7628425|NCT01694485|26541389|P3|Overall Study|Lost to Follow-up|6
7628426|NCT01694485|26541390|P2|Overall Study|Lost to Follow-up|1
7628427|NCT01694485|26541391|P1|Overall Study|Lost to Follow-up|9
7628428|NCT01694485|26541387|P5|Overall Study|Sponsor Decision|0
7628429|NCT01694485|26541388|P4|Overall Study|Sponsor Decision|2
7628430|NCT01694485|26541389|P3|Overall Study|Sponsor Decision|0
7628431|NCT01694485|26541390|P2|Overall Study|Sponsor Decision|0
7628432|NCT01694485|26541391|P1|Overall Study|Sponsor Decision|3
7628433|NCT01694485|26541387|P5|Overall Study|Withdrawal by Subject|18
7628434|NCT01694485|26541388|P4|Overall Study|Withdrawal by Subject|25
7628435|NCT01694485|26541389|P3|Overall Study|Withdrawal by Subject|7
7628436|NCT01694485|26541390|P2|Overall Study|Withdrawal by Subject|6
7628437|NCT01694485|26541391|P1|Overall Study|Withdrawal by Subject|20
7628438|NCT01694433|26541425|P2|Overall Study|Withdrawal by Subject|4
7628439|NCT01694433|26541426|P1|Overall Study|Withdrawal by Subject|3
7628440|NCT01694433|26541425|P2|Overall Study|Physician Decision|0
7628441|NCT01694433|26541426|P1|Overall Study|Physician Decision|1
7628442|NCT01694433|26541425|P2|Overall Study|Adverse Event|0
7628443|NCT01694433|26541426|P1|Overall Study|Adverse Event|7
7628444|NCT01694420|26541434|P1|Overall Study|Lost to Follow-up|3
7628445|NCT01694121|26541471|P2|Overall Study|Participant used false ID, was withdrawn|0
7628446|NCT01694121|26541472|P1|Overall Study|Participant used false ID, was withdrawn|1
7628447|NCT01693614|26541586|P3|Overall Study|Withdrawal by Subject|5
7628448|NCT01693614|26541587|P2|Overall Study|Withdrawal by Subject|0
7628449|NCT01693614|26541588|P1|Overall Study|Withdrawal by Subject|1
7628450|NCT01693614|26541586|P3|Overall Study|Withdrawal by subject/guardian|2
7628451|NCT01693614|26541587|P2|Overall Study|Withdrawal by subject/guardian|0
7628452|NCT01693614|26541588|P1|Overall Study|Withdrawal by subject/guardian|0
7628453|NCT01693614|26541586|P3|Overall Study|Physician Decision|4
7628454|NCT01693614|26541587|P2|Overall Study|Physician Decision|1
7628455|NCT01693614|26541588|P1|Overall Study|Physician Decision|1
7628456|NCT01693614|26541586|P3|Overall Study|Death|0
7628457|NCT01693614|26541587|P2|Overall Study|Death|0
7628458|NCT01693614|26541588|P1|Overall Study|Death|1
7628459|NCT01693614|26541586|P3|Overall Study|Protocol Violation|1
7628460|NCT01693614|26541587|P2|Overall Study|Protocol Violation|2
7628461|NCT01693614|26541588|P1|Overall Study|Protocol Violation|5
7628462|NCT01693614|26541586|P3|Overall Study|Disease progression|7
7628463|NCT01693614|26541587|P2|Overall Study|Disease progression|8
7628464|NCT01693614|26541588|P1|Overall Study|Disease progression|11
7628465|NCT01693614|26541586|P3|Overall Study|Adverse Event|5
7628466|NCT01693614|26541587|P2|Overall Study|Adverse Event|11
7628467|NCT01693614|26541588|P1|Overall Study|Adverse Event|7
7628468|NCT01693562|26541633|P23|Expansion Phase|Other|1
7628469|NCT01693562|26541634|P22|Expansion Phase|Other|17
7628470|NCT01693562|26541635|P21|Expansion Phase|Other|1
7628471|NCT01693562|26541636|P20|Expansion Phase|Other|0
7628472|NCT01693562|26541637|P19|Expansion Phase|Other|1
7628473|NCT01693562|26541638|P18|Expansion Phase|Other|0
7628474|NCT01693562|26541639|P17|Expansion Phase|Other|28
7628475|NCT01693562|26541640|P16|Expansion Phase|Other|0
7628476|NCT01693562|26541641|P15|Expansion Phase|Other|1
7628477|NCT01693562|26541642|P14|Expansion Phase|Other|1
7628478|NCT01693562|26541643|P13|Expansion Phase|Other|0
7628479|NCT01693562|26541644|P12|Expansion Phase|Other|7
7628480|NCT01693562|26541645|P11|Expansion Phase|Other|4
7628481|NCT01693562|26541646|P10|Expansion Phase|Other|28
7628482|NCT01693562|26541647|P9|Expansion Phase|Other|1
7628483|NCT01693562|26541648|P8|Expansion Phase|Other|3
7628484|NCT01693562|26541649|P7|Expansion Phase|Other|0
7628485|NCT01693562|26541650|P6|Expansion Phase|Other|0
7628486|NCT01693562|26541651|P5|Expansion Phase|Other|0
7628487|NCT01693562|26541652|P4|Expansion Phase|Other|0
7628488|NCT01693562|26541653|P3|Expansion Phase|Other|0
7628489|NCT01693562|26541654|P2|Expansion Phase|Other|0
7628490|NCT01693562|26541655|P1|Expansion Phase|Other|0
7628491|NCT01693562|26541633|P23|Expansion Phase|Lost to Follow-up|1
7628492|NCT01693562|26541634|P22|Expansion Phase|Lost to Follow-up|2
7628493|NCT01693562|26541635|P21|Expansion Phase|Lost to Follow-up|2
7628494|NCT01693562|26541636|P20|Expansion Phase|Lost to Follow-up|1
7628495|NCT01693562|26541637|P19|Expansion Phase|Lost to Follow-up|2
7628496|NCT01693562|26541638|P18|Expansion Phase|Lost to Follow-up|0
7628497|NCT01693562|26541639|P17|Expansion Phase|Lost to Follow-up|1
7628498|NCT01693562|26541640|P16|Expansion Phase|Lost to Follow-up|1
7628499|NCT01693562|26541641|P15|Expansion Phase|Lost to Follow-up|0
7628500|NCT01693562|26541642|P14|Expansion Phase|Lost to Follow-up|3
7628501|NCT01693562|26541643|P13|Expansion Phase|Lost to Follow-up|1
7628502|NCT01693562|26541644|P12|Expansion Phase|Lost to Follow-up|4
7628503|NCT01693562|26541645|P11|Expansion Phase|Lost to Follow-up|4
7628504|NCT01693562|26541646|P10|Expansion Phase|Lost to Follow-up|10
7628505|NCT01693562|26541647|P9|Expansion Phase|Lost to Follow-up|2
7628506|NCT01693562|26541648|P8|Expansion Phase|Lost to Follow-up|1
7628507|NCT01693562|26541649|P7|Expansion Phase|Lost to Follow-up|0
7628508|NCT01693562|26541650|P6|Expansion Phase|Lost to Follow-up|0
7628509|NCT01693562|26541651|P5|Expansion Phase|Lost to Follow-up|0
7628510|NCT01693562|26541652|P4|Expansion Phase|Lost to Follow-up|0
7628511|NCT01693562|26541653|P3|Expansion Phase|Lost to Follow-up|0
7628512|NCT01693562|26541654|P2|Expansion Phase|Lost to Follow-up|0
7628513|NCT01693562|26541655|P1|Expansion Phase|Lost to Follow-up|0
7628514|NCT01693562|26541633|P23|Expansion Phase|Death|7
7628515|NCT01693562|26541634|P22|Expansion Phase|Death|35
7628516|NCT01693562|26541635|P21|Expansion Phase|Death|17
7628517|NCT01693562|26541636|P20|Expansion Phase|Death|16
7628518|NCT01693562|26541637|P19|Expansion Phase|Death|36
7628519|NCT01693562|26541638|P18|Expansion Phase|Death|16
7628520|NCT01693562|26541639|P17|Expansion Phase|Death|128
7628521|NCT01693562|26541640|P16|Expansion Phase|Death|23
7628522|NCT01693562|26541641|P15|Expansion Phase|Death|23
7628523|NCT01693562|26541642|P14|Expansion Phase|Death|42
7628524|NCT01693562|26541643|P13|Expansion Phase|Death|19
7628525|NCT01693562|26541644|P12|Expansion Phase|Death|8
7628526|NCT01693562|26541645|P11|Expansion Phase|Death|30
7628527|NCT01693562|26541646|P10|Expansion Phase|Death|208
7628528|NCT01693562|26541647|P9|Expansion Phase|Death|17
7628529|NCT01693562|26541648|P8|Expansion Phase|Death|42
7628530|NCT01693562|26541649|P7|Expansion Phase|Death|0
7628531|NCT01693562|26541650|P6|Expansion Phase|Death|0
7628532|NCT01693562|26541651|P5|Expansion Phase|Death|0
7628533|NCT01693562|26541652|P4|Expansion Phase|Death|0
7628534|NCT01693562|26541653|P3|Expansion Phase|Death|0
7628535|NCT01693562|26541654|P2|Expansion Phase|Death|0
7628536|NCT01693562|26541655|P1|Expansion Phase|Death|0
7628537|NCT01693562|26541633|P23|Expansion Phase|Withdrawal by Subject|1
7628538|NCT01693562|26541634|P22|Expansion Phase|Withdrawal by Subject|8
7628539|NCT01693562|26541635|P21|Expansion Phase|Withdrawal by Subject|1
7628540|NCT01693562|26541636|P20|Expansion Phase|Withdrawal by Subject|3
7628541|NCT01693562|26541637|P19|Expansion Phase|Withdrawal by Subject|8
7628542|NCT01693562|26541638|P18|Expansion Phase|Withdrawal by Subject|4
7628543|NCT01693562|26541639|P17|Expansion Phase|Withdrawal by Subject|40
7628544|NCT01693562|26541640|P16|Expansion Phase|Withdrawal by Subject|7
7628545|NCT01693562|26541641|P15|Expansion Phase|Withdrawal by Subject|16
7628546|NCT01693562|26541642|P14|Expansion Phase|Withdrawal by Subject|5
7628547|NCT01693562|26541643|P13|Expansion Phase|Withdrawal by Subject|3
7628548|NCT01693562|26541644|P12|Expansion Phase|Withdrawal by Subject|2
7628549|NCT01693562|26541645|P11|Expansion Phase|Withdrawal by Subject|2
7628550|NCT01693562|26541646|P10|Expansion Phase|Withdrawal by Subject|54
7628551|NCT01693562|26541647|P9|Expansion Phase|Withdrawal by Subject|2
7628552|NCT01693562|26541648|P8|Expansion Phase|Withdrawal by Subject|16
7628553|NCT01693562|26541649|P7|Expansion Phase|Withdrawal by Subject|0
7628554|NCT01693562|26541650|P6|Expansion Phase|Withdrawal by Subject|0
7628555|NCT01693562|26541651|P5|Expansion Phase|Withdrawal by Subject|0
7628556|NCT01693562|26541652|P4|Expansion Phase|Withdrawal by Subject|0
7628557|NCT01693562|26541653|P3|Expansion Phase|Withdrawal by Subject|0
7628558|NCT01693562|26541654|P2|Expansion Phase|Withdrawal by Subject|0
7628559|NCT01693562|26541655|P1|Expansion Phase|Withdrawal by Subject|0
7628560|NCT01693562|26541633|P23|Exploration Phase|Other|0
7628561|NCT01693562|26541634|P22|Exploration Phase|Other|0
7628562|NCT01693562|26541635|P21|Exploration Phase|Other|0
7628563|NCT01693562|26541636|P20|Exploration Phase|Other|0
7628564|NCT01693562|26541637|P19|Exploration Phase|Other|0
7628565|NCT01693562|26541638|P18|Exploration Phase|Other|0
7628566|NCT01693562|26541639|P17|Exploration Phase|Other|0
7628567|NCT01693562|26541640|P16|Exploration Phase|Other|0
7628568|NCT01693562|26541641|P15|Exploration Phase|Other|0
7628569|NCT01693562|26541642|P14|Exploration Phase|Other|0
7628570|NCT01693562|26541643|P13|Exploration Phase|Other|0
7628571|NCT01693562|26541644|P12|Exploration Phase|Other|0
7628572|NCT01693562|26541645|P11|Exploration Phase|Other|0
7628573|NCT01693562|26541646|P10|Exploration Phase|Other|0
7628574|NCT01693562|26541647|P9|Exploration Phase|Other|0
7628575|NCT01693562|26541648|P8|Exploration Phase|Other|0
7628576|NCT01693562|26541649|P7|Exploration Phase|Other|2
7628577|NCT01693562|26541650|P6|Exploration Phase|Other|0
7628578|NCT01693562|26541651|P5|Exploration Phase|Other|0
7628579|NCT01693562|26541652|P4|Exploration Phase|Other|0
7628580|NCT01693562|26541653|P3|Exploration Phase|Other|0
7628581|NCT01693562|26541654|P2|Exploration Phase|Other|0
7628582|NCT01693562|26541655|P1|Exploration Phase|Other|0
7628583|NCT01693562|26541633|P23|Exploration Phase|Death|0
7628584|NCT01693562|26541634|P22|Exploration Phase|Death|0
7628585|NCT01693562|26541635|P21|Exploration Phase|Death|0
7628586|NCT01693562|26541636|P20|Exploration Phase|Death|0
7628587|NCT01693562|26541637|P19|Exploration Phase|Death|0
7628588|NCT01693562|26541638|P18|Exploration Phase|Death|0
7628589|NCT01693562|26541639|P17|Exploration Phase|Death|0
7628590|NCT01693562|26541640|P16|Exploration Phase|Death|0
7628591|NCT01693562|26541641|P15|Exploration Phase|Death|0
7628592|NCT01693562|26541642|P14|Exploration Phase|Death|0
7628593|NCT01693562|26541643|P13|Exploration Phase|Death|0
7628594|NCT01693562|26541644|P12|Exploration Phase|Death|0
7628595|NCT01693562|26541645|P11|Exploration Phase|Death|0
7628596|NCT01693562|26541646|P10|Exploration Phase|Death|0
7628597|NCT01693562|26541647|P9|Exploration Phase|Death|0
7628598|NCT01693562|26541648|P8|Exploration Phase|Death|0
7628599|NCT01693562|26541649|P7|Exploration Phase|Death|17
7628600|NCT01693562|26541650|P6|Exploration Phase|Death|0
7628601|NCT01693562|26541651|P5|Exploration Phase|Death|0
7628602|NCT01693562|26541652|P4|Exploration Phase|Death|0
7628603|NCT01693562|26541653|P3|Exploration Phase|Death|0
7628604|NCT01693562|26541654|P2|Exploration Phase|Death|0
7628605|NCT01693562|26541655|P1|Exploration Phase|Death|0
7628606|NCT01693562|26541633|P23|Exploration Phase|Withdrawal by Subject|0
7628607|NCT01693562|26541634|P22|Exploration Phase|Withdrawal by Subject|0
7628608|NCT01693562|26541635|P21|Exploration Phase|Withdrawal by Subject|0
7628609|NCT01693562|26541636|P20|Exploration Phase|Withdrawal by Subject|0
7628610|NCT01693562|26541637|P19|Exploration Phase|Withdrawal by Subject|0
7628611|NCT01693562|26541638|P18|Exploration Phase|Withdrawal by Subject|0
7628612|NCT01693562|26541639|P17|Exploration Phase|Withdrawal by Subject|0
7628613|NCT01693562|26541640|P16|Exploration Phase|Withdrawal by Subject|0
7628614|NCT01693562|26541641|P15|Exploration Phase|Withdrawal by Subject|0
7628615|NCT01693562|26541642|P14|Exploration Phase|Withdrawal by Subject|0
7628616|NCT01693562|26541643|P13|Exploration Phase|Withdrawal by Subject|0
7628617|NCT01693562|26541644|P12|Exploration Phase|Withdrawal by Subject|0
7628618|NCT01693562|26541645|P11|Exploration Phase|Withdrawal by Subject|0
7628619|NCT01693562|26541646|P10|Exploration Phase|Withdrawal by Subject|0
7628620|NCT01693562|26541647|P9|Exploration Phase|Withdrawal by Subject|0
7628621|NCT01693562|26541648|P8|Exploration Phase|Withdrawal by Subject|0
7628622|NCT01693562|26541649|P7|Exploration Phase|Withdrawal by Subject|2
7628623|NCT01693562|26541650|P6|Exploration Phase|Withdrawal by Subject|0
7628624|NCT01693562|26541651|P5|Exploration Phase|Withdrawal by Subject|0
7628625|NCT01693562|26541652|P4|Exploration Phase|Withdrawal by Subject|0
7628626|NCT01693562|26541653|P3|Exploration Phase|Withdrawal by Subject|0
7628627|NCT01693562|26541654|P2|Exploration Phase|Withdrawal by Subject|0
7628628|NCT01693562|26541655|P1|Exploration Phase|Withdrawal by Subject|0
7628629|NCT01693562|26541633|P23|Escalation Phase|Other|0
7628630|NCT01693562|26541634|P22|Escalation Phase|Other|0
7628631|NCT01693562|26541635|P21|Escalation Phase|Other|0
7628632|NCT01693562|26541636|P20|Escalation Phase|Other|0
7628633|NCT01693562|26541637|P19|Escalation Phase|Other|0
7628634|NCT01693562|26541638|P18|Escalation Phase|Other|0
7628635|NCT01693562|26541639|P17|Escalation Phase|Other|0
7628636|NCT01693562|26541640|P16|Escalation Phase|Other|0
7628637|NCT01693562|26541641|P15|Escalation Phase|Other|0
7628638|NCT01693562|26541642|P14|Escalation Phase|Other|0
7628639|NCT01693562|26541643|P13|Escalation Phase|Other|0
7628640|NCT01693562|26541644|P12|Escalation Phase|Other|0
7628641|NCT01693562|26541645|P11|Escalation Phase|Other|0
7628642|NCT01693562|26541646|P10|Escalation Phase|Other|0
7628643|NCT01693562|26541647|P9|Escalation Phase|Other|0
7628644|NCT01693562|26541648|P8|Escalation Phase|Other|0
7628645|NCT01693562|26541649|P7|Escalation Phase|Other|0
7628646|NCT01693562|26541650|P6|Escalation Phase|Other|1
7628647|NCT01693562|26541651|P5|Escalation Phase|Other|0
7628648|NCT01693562|26541652|P4|Escalation Phase|Other|0
7628649|NCT01693562|26541653|P3|Escalation Phase|Other|2
7628650|NCT01693562|26541654|P2|Escalation Phase|Other|0
7628651|NCT01693562|26541655|P1|Escalation Phase|Other|0
7628652|NCT01693562|26541633|P23|Escalation Phase|Lost to Follow-up|0
7628653|NCT01693562|26541634|P22|Escalation Phase|Lost to Follow-up|0
7628654|NCT01693562|26541635|P21|Escalation Phase|Lost to Follow-up|0
7628655|NCT01693562|26541636|P20|Escalation Phase|Lost to Follow-up|0
7628656|NCT01693562|26541637|P19|Escalation Phase|Lost to Follow-up|0
7628657|NCT01693562|26541638|P18|Escalation Phase|Lost to Follow-up|0
7628658|NCT01693562|26541639|P17|Escalation Phase|Lost to Follow-up|0
7628659|NCT01693562|26541640|P16|Escalation Phase|Lost to Follow-up|0
7628660|NCT01693562|26541641|P15|Escalation Phase|Lost to Follow-up|0
7628661|NCT01693562|26541642|P14|Escalation Phase|Lost to Follow-up|0
7628662|NCT01693562|26541643|P13|Escalation Phase|Lost to Follow-up|0
7628663|NCT01693562|26541644|P12|Escalation Phase|Lost to Follow-up|0
7628664|NCT01693562|26541645|P11|Escalation Phase|Lost to Follow-up|0
7628665|NCT01693562|26541646|P10|Escalation Phase|Lost to Follow-up|0
7628666|NCT01693562|26541647|P9|Escalation Phase|Lost to Follow-up|0
7628667|NCT01693562|26541648|P8|Escalation Phase|Lost to Follow-up|0
7628668|NCT01693562|26541649|P7|Escalation Phase|Lost to Follow-up|0
7628669|NCT01693562|26541650|P6|Escalation Phase|Lost to Follow-up|0
7628670|NCT01693562|26541651|P5|Escalation Phase|Lost to Follow-up|0
7628671|NCT01693562|26541652|P4|Escalation Phase|Lost to Follow-up|0
7628672|NCT01693562|26541653|P3|Escalation Phase|Lost to Follow-up|1
7628673|NCT01693562|26541654|P2|Escalation Phase|Lost to Follow-up|1
7628674|NCT01693562|26541655|P1|Escalation Phase|Lost to Follow-up|0
7628675|NCT01693562|26541633|P23|Escalation Phase|Death|0
7628676|NCT01693562|26541634|P22|Escalation Phase|Death|0
7628677|NCT01693562|26541635|P21|Escalation Phase|Death|0
7628678|NCT01693562|26541636|P20|Escalation Phase|Death|0
7628679|NCT01693562|26541637|P19|Escalation Phase|Death|0
7628680|NCT01693562|26541638|P18|Escalation Phase|Death|0
7628681|NCT01693562|26541639|P17|Escalation Phase|Death|0
7628682|NCT01693562|26541640|P16|Escalation Phase|Death|0
7628683|NCT01693562|26541641|P15|Escalation Phase|Death|0
7628684|NCT01693562|26541642|P14|Escalation Phase|Death|0
7628685|NCT01693562|26541643|P13|Escalation Phase|Death|0
7628686|NCT01693562|26541644|P12|Escalation Phase|Death|0
7628687|NCT01693562|26541645|P11|Escalation Phase|Death|0
7628688|NCT01693562|26541646|P10|Escalation Phase|Death|0
7628689|NCT01693562|26541647|P9|Escalation Phase|Death|0
7628690|NCT01693562|26541648|P8|Escalation Phase|Death|0
7628691|NCT01693562|26541649|P7|Escalation Phase|Death|0
7628692|NCT01693562|26541650|P6|Escalation Phase|Death|4
7628693|NCT01693562|26541651|P5|Escalation Phase|Death|6
7628694|NCT01693562|26541652|P4|Escalation Phase|Death|3
7628695|NCT01693562|26541653|P3|Escalation Phase|Death|0
7628696|NCT01693562|26541654|P2|Escalation Phase|Death|2
7628697|NCT01693562|26541655|P1|Escalation Phase|Death|4
7628698|NCT01693562|26541633|P23|Escalation Phase|Withdrawal by Subject|0
7628699|NCT01693562|26541634|P22|Escalation Phase|Withdrawal by Subject|0
7628700|NCT01693562|26541635|P21|Escalation Phase|Withdrawal by Subject|0
7628701|NCT01693562|26541636|P20|Escalation Phase|Withdrawal by Subject|0
7628702|NCT01693562|26541637|P19|Escalation Phase|Withdrawal by Subject|0
7628703|NCT01693562|26541638|P18|Escalation Phase|Withdrawal by Subject|0
7628704|NCT01693562|26541639|P17|Escalation Phase|Withdrawal by Subject|0
7628705|NCT01693562|26541640|P16|Escalation Phase|Withdrawal by Subject|0
7628706|NCT01693562|26541641|P15|Escalation Phase|Withdrawal by Subject|0
7628707|NCT01693562|26541642|P14|Escalation Phase|Withdrawal by Subject|0
7628708|NCT01693562|26541643|P13|Escalation Phase|Withdrawal by Subject|0
7628709|NCT01693562|26541644|P12|Escalation Phase|Withdrawal by Subject|0
7628710|NCT01693562|26541645|P11|Escalation Phase|Withdrawal by Subject|0
7628711|NCT01693562|26541646|P10|Escalation Phase|Withdrawal by Subject|0
7628712|NCT01693562|26541647|P9|Escalation Phase|Withdrawal by Subject|0
7628713|NCT01693562|26541648|P8|Escalation Phase|Withdrawal by Subject|0
7628714|NCT01693562|26541649|P7|Escalation Phase|Withdrawal by Subject|0
7628715|NCT01693562|26541650|P6|Escalation Phase|Withdrawal by Subject|2
7628716|NCT01693562|26541651|P5|Escalation Phase|Withdrawal by Subject|0
7628717|NCT01693562|26541652|P4|Escalation Phase|Withdrawal by Subject|0
7628718|NCT01693562|26541653|P3|Escalation Phase|Withdrawal by Subject|0
7628719|NCT01693562|26541654|P2|Escalation Phase|Withdrawal by Subject|1
7628720|NCT01693562|26541655|P1|Escalation Phase|Withdrawal by Subject|0
7628721|NCT01693523|26541872|P3|Overall Study|Chemotherapy was held|0
7628722|NCT01693523|26541873|P2|Overall Study|Chemotherapy was held|2
7628723|NCT01693523|26541874|P1|Overall Study|Chemotherapy was held|1
7628724|NCT01693523|26541872|P3|Overall Study|Lack of compliance study medication|0
7628725|NCT01693523|26541873|P2|Overall Study|Lack of compliance study medication|2
7628726|NCT01693523|26541874|P1|Overall Study|Lack of compliance study medication|1
7628727|NCT01693523|26541872|P3|Overall Study|Withdrawal by Subject|2
7628728|NCT01693523|26541873|P2|Overall Study|Withdrawal by Subject|2
7628729|NCT01693523|26541874|P1|Overall Study|Withdrawal by Subject|1
7628730|NCT01693523|26541872|P3|Overall Study|Physician Decision|1
7628731|NCT01693523|26541873|P2|Overall Study|Physician Decision|0
7628732|NCT01693523|26541874|P1|Overall Study|Physician Decision|0
7628733|NCT01693523|26541872|P3|Overall Study|Lost to Follow-up|4
7628734|NCT01693523|26541873|P2|Overall Study|Lost to Follow-up|0
7628735|NCT01693523|26541874|P1|Overall Study|Lost to Follow-up|0
7628736|NCT01693523|26541872|P3|Overall Study|Death|1
7628737|NCT01693523|26541873|P2|Overall Study|Death|1
7628738|NCT01693523|26541874|P1|Overall Study|Death|0
7628739|NCT01693523|26541872|P3|Overall Study|Adverse Event|0
7628740|NCT01693523|26541873|P2|Overall Study|Adverse Event|1
7628741|NCT01693523|26541874|P1|Overall Study|Adverse Event|2
7628742|NCT01693367|26541890|P2|Overall Study|Physician Decision|1
7628743|NCT01693367|26541891|P1|Overall Study|Physician Decision|0
7628744|NCT01693367|26541890|P2|Overall Study|Withdrawal by Subject|1
7628745|NCT01693367|26541891|P1|Overall Study|Withdrawal by Subject|1
7628746|NCT01693250|26541909|P2|Overall Study|Lost to Follow-up|2
7628747|NCT01693250|26541910|P1|Overall Study|Lost to Follow-up|2
7628748|NCT01693185|26541920|P2|Overall Study|diagnostic procedure after colonoscopy|6
7628749|NCT01693185|26541921|P1|Overall Study|diagnostic procedure after colonoscopy|0
7628750|NCT01693120|26541937|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
7628751|NCT01693120|26541937|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
7628926|NCT01691794|26542570|P1|Overall Study|Lack of Efficacy|0
7628752|NCT01693120|26541937|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
7628753|NCT01693120|26541937|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
7628754|NCT01693120|26541937|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
7628755|NCT01693120|26541937|P1|Enrollment|Other|1
7628756|NCT01693120|26541937|P1|Enrollment|Study closed|8
7628757|NCT01693120|26541937|P1|Enrollment|Adverse Event|1
7628758|NCT01693120|26541937|P1|Enrollment|Physician Decision|3
7628759|NCT01693120|26541937|P1|Enrollment|Protocol Violation|46
7628760|NCT01693120|26541937|P1|Enrollment|Withdrawal by Subject|10
7628761|NCT01693120|26541937|P1|Enrollment|Lost to Follow-up|1
7628762|NCT01693068|26541946|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
7628763|NCT01693068|26541947|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7628764|NCT01693068|26541948|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7628765|NCT01693068|26541946|P3|Randomization Period|On-study|0
7628766|NCT01693068|26541947|P2|Randomization Period|On-study|5
7628767|NCT01693068|26541948|P1|Randomization Period|On-study|2
7628768|NCT01693029|26541980|P2|Overall Study|Non-compliance|1
7628769|NCT01693029|26541981|P1|Overall Study|Non-compliance|2
7628770|NCT01693029|26541980|P2|Overall Study|Death|8
7628771|NCT01693029|26541981|P1|Overall Study|Death|5
7628772|NCT01693029|26541980|P2|Overall Study|Adverse Event|6
7628773|NCT01693029|26541981|P1|Overall Study|Adverse Event|1
7628774|NCT01693029|26541980|P2|Overall Study|Lost to Follow-up|1
7628775|NCT01693029|26541981|P1|Overall Study|Lost to Follow-up|0
7628776|NCT01693029|26541980|P2|Overall Study|Physician Decision|2
7628777|NCT01693029|26541981|P1|Overall Study|Physician Decision|0
7628778|NCT01693029|26541980|P2|Overall Study|Change in dialysis modality|1
7628779|NCT01693029|26541981|P1|Overall Study|Change in dialysis modality|2
7628780|NCT01693029|26541980|P2|Overall Study|Protocol Violation|7
7628781|NCT01693029|26541981|P1|Overall Study|Protocol Violation|6
7628782|NCT01693029|26541980|P2|Overall Study|Bindinging anti-EPO antibodies|2
7628783|NCT01693029|26541981|P1|Overall Study|Bindinging anti-EPO antibodies|6
7628784|NCT01693029|26541980|P2|Overall Study|Kidney transplantation|7
7628785|NCT01693029|26541981|P1|Overall Study|Kidney transplantation|7
7628786|NCT01693029|26541980|P2|Overall Study|Withdrawal by Subject|22
7628787|NCT01693029|26541981|P1|Overall Study|Withdrawal by Subject|15
7628788|NCT01692938|26542017|P2|Overall Study|Study completed prior to site completion|3
7628789|NCT01692938|26542018|P1|Overall Study|Study completed prior to site completion|3
7628790|NCT01692938|26542017|P2|Overall Study|Protocol Deviation|1
7628791|NCT01692938|26542018|P1|Overall Study|Protocol Deviation|1
7628792|NCT01692782|26542029|P3|Overall Study|Withdrawal by Subject|3
7628793|NCT01692782|26542030|P2|Overall Study|Withdrawal by Subject|10
7628794|NCT01692782|26542031|P1|Overall Study|Withdrawal by Subject|3
7628795|NCT01692782|26542029|P3|Overall Study|SAE not related to study drug|0
7628796|NCT01692782|26542030|P2|Overall Study|SAE not related to study drug|1
7628797|NCT01692782|26542031|P1|Overall Study|SAE not related to study drug|0
7628798|NCT01692782|26542029|P3|Overall Study|Non-compliant with study visits|1
7628799|NCT01692782|26542030|P2|Overall Study|Non-compliant with study visits|0
7628800|NCT01692782|26542031|P1|Overall Study|Non-compliant with study visits|0
7628801|NCT01692782|26542029|P3|Overall Study|Non-complance with study drug|1
7628802|NCT01692782|26542030|P2|Overall Study|Non-complance with study drug|4
7628803|NCT01692782|26542031|P1|Overall Study|Non-complance with study drug|0
7628804|NCT01692782|26542029|P3|Overall Study|Protocol Violation|2
7628805|NCT01692782|26542030|P2|Overall Study|Protocol Violation|0
7628806|NCT01692782|26542031|P1|Overall Study|Protocol Violation|1
7628807|NCT01692782|26542029|P3|Overall Study|Pregnancy|0
7628808|NCT01692782|26542030|P2|Overall Study|Pregnancy|0
7628809|NCT01692782|26542031|P1|Overall Study|Pregnancy|1
7628810|NCT01692782|26542029|P3|Overall Study|Lost to Follow-up|1
7628811|NCT01692782|26542030|P2|Overall Study|Lost to Follow-up|7
7628812|NCT01692782|26542031|P1|Overall Study|Lost to Follow-up|2
7628813|NCT01692782|26542029|P3|Overall Study|Lack of Efficacy|0
7628814|NCT01692782|26542030|P2|Overall Study|Lack of Efficacy|2
7628815|NCT01692782|26542031|P1|Overall Study|Lack of Efficacy|1
7628816|NCT01692782|26542029|P3|Overall Study|Adverse Event|2
7628817|NCT01692782|26542030|P2|Overall Study|Adverse Event|32
7628818|NCT01692782|26542031|P1|Overall Study|Adverse Event|12
7628819|NCT01692730|26542140|P2|Overall Study|Lost to Follow-up|227
7628820|NCT01692730|26542141|P1|Overall Study|Lost to Follow-up|225
7628821|NCT01692626|26542155|P2|Overall Study|Withdrawal by Subject|0
7628822|NCT01692626|26542156|P1|Overall Study|Withdrawal by Subject|1
7628823|NCT01692626|26542155|P2|Overall Study|Protocol Violation|2
7628824|NCT01692626|26542156|P1|Overall Study|Protocol Violation|1
7628825|NCT01692626|26542155|P2|Overall Study|Adverse Event|3
7628826|NCT01692626|26542156|P1|Overall Study|Adverse Event|2
7628827|NCT01692626|26542155|P2|Overall Study|Death|1
7628828|NCT01692626|26542156|P1|Overall Study|Death|0
7628829|NCT01692301|26542191|P2|Overall Study|Lost to Follow-up|1
7628830|NCT01692301|26542192|P1|Overall Study|Lost to Follow-up|1
7628831|NCT01692301|26542191|P2|Overall Study|Physician Decision|2
7628832|NCT01692301|26542192|P1|Overall Study|Physician Decision|2
7628833|NCT01692301|26542191|P2|Overall Study|Technical problems|1
7628834|NCT01692301|26542192|P1|Overall Study|Technical problems|0
7628835|NCT01692301|26542191|P2|Overall Study|Patient/guardian decision|15
7628836|NCT01692301|26542192|P1|Overall Study|Patient/guardian decision|16
7628837|NCT01692301|26542191|P2|Overall Study|Protocol deviation|2
7628838|NCT01692301|26542192|P1|Overall Study|Protocol deviation|9
7628839|NCT01692301|26542191|P2|Overall Study|Non-compliance with study treatment|2
7628840|NCT01692301|26542192|P1|Overall Study|Non-compliance with study treatment|1
7628841|NCT01692301|26542191|P2|Overall Study|Lack of Efficacy|5
7628842|NCT01692301|26542192|P1|Overall Study|Lack of Efficacy|0
7628843|NCT01692301|26542191|P2|Overall Study|Death|2
7628844|NCT01692301|26542192|P1|Overall Study|Death|1
7628845|NCT01692301|26542191|P2|Overall Study|Adverse Event|12
7628846|NCT01692301|26542192|P1|Overall Study|Adverse Event|15
7628847|NCT01692275|26542224|P2|Overall Study|Withdrawal by Subject|11
7628848|NCT01692275|26542225|P1|Overall Study|Withdrawal by Subject|9
7628849|NCT01692275|26542224|P2|Overall Study|Lost to Follow-up|48
7628850|NCT01692275|26542225|P1|Overall Study|Lost to Follow-up|57
7628851|NCT01692197|26542285|P1|Overall Study|Failed Screening|3
7628852|NCT01692119|26542294|P2|Overall Study|Intervention: pts. did not present to participating pharmacy|0
7628853|NCT01692119|26542295|P1|Overall Study|Intervention: pts. did not present to participating pharmacy|17
7628854|NCT01692119|26542294|P2|Overall Study|Protocol Violation|1
7628855|NCT01692119|26542295|P1|Overall Study|Protocol Violation|3
7628856|NCT01691898|26542318|P6|Overall Study|Non-Compliance|0
7628857|NCT01691898|26542319|P5|Overall Study|Non-Compliance|1
7628858|NCT01691898|26542320|P4|Overall Study|Non-Compliance|0
7628859|NCT01691898|26542321|P3|Overall Study|Non-Compliance|0
7628860|NCT01691898|26542322|P2|Overall Study|Non-Compliance|0
7628861|NCT01691898|26542323|P1|Overall Study|Non-Compliance|0
7628862|NCT01691898|26542318|P6|Overall Study|Withdrawal by Subject|3
7628863|NCT01691898|26542319|P5|Overall Study|Withdrawal by Subject|3
7628864|NCT01691898|26542320|P4|Overall Study|Withdrawal by Subject|1
7628865|NCT01691898|26542321|P3|Overall Study|Withdrawal by Subject|2
7628866|NCT01691898|26542322|P2|Overall Study|Withdrawal by Subject|8
7628867|NCT01691898|26542323|P1|Overall Study|Withdrawal by Subject|9
7628868|NCT01691898|26542318|P6|Overall Study|Lost to Follow-up|0
7628869|NCT01691898|26542319|P5|Overall Study|Lost to Follow-up|1
7628870|NCT01691898|26542320|P4|Overall Study|Lost to Follow-up|0
7628871|NCT01691898|26542321|P3|Overall Study|Lost to Follow-up|0
7628872|NCT01691898|26542322|P2|Overall Study|Lost to Follow-up|1
7628873|NCT01691898|26542323|P1|Overall Study|Lost to Follow-up|3
7628874|NCT01691898|26542318|P6|Overall Study|Progression of Disease|1
7628875|NCT01691898|26542319|P5|Overall Study|Progression of Disease|0
7628876|NCT01691898|26542320|P4|Overall Study|Progression of Disease|0
7628877|NCT01691898|26542321|P3|Overall Study|Progression of Disease|1
7628878|NCT01691898|26542322|P2|Overall Study|Progression of Disease|2
7628879|NCT01691898|26542323|P1|Overall Study|Progression of Disease|1
7628880|NCT01691898|26542318|P6|Overall Study|Adverse Event|0
7628881|NCT01691898|26542319|P5|Overall Study|Adverse Event|1
7628882|NCT01691898|26542320|P4|Overall Study|Adverse Event|1
7628883|NCT01691898|26542321|P3|Overall Study|Adverse Event|0
7628884|NCT01691898|26542322|P2|Overall Study|Adverse Event|1
7628885|NCT01691898|26542323|P1|Overall Study|Adverse Event|0
7628886|NCT01691898|26542318|P6|Overall Study|Death|31
7628887|NCT01691898|26542319|P5|Overall Study|Death|8
7628888|NCT01691898|26542320|P4|Overall Study|Death|3
7628889|NCT01691898|26542321|P3|Overall Study|Death|6
7628890|NCT01691898|26542322|P2|Overall Study|Death|32
7628891|NCT01691898|26542323|P1|Overall Study|Death|34
7628892|NCT01691885|26542477|P2|Washout Period (7-9 Days)|Adverse Event|1
7628893|NCT01691885|26542478|P1|Washout Period (7-9 Days)|Adverse Event|0
7628894|NCT01691885|26542477|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
7628895|NCT01691885|26542478|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
7628896|NCT01691859|26542484|P1|Overall Study|Withdrawal by Subject|31
7628897|NCT01691859|26542484|P1|Overall Study|Physician Decision|6
7628898|NCT01691859|26542484|P1|Overall Study|Lost to Follow-up|5
7628899|NCT01691859|26542484|P1|Overall Study|Study closed/terminated|50
7628900|NCT01691859|26542484|P1|Overall Study|Product commercially available|221
7628901|NCT01691859|26542484|P1|Overall Study|Protocol Violation|4
7628902|NCT01691859|26542484|P1|Overall Study|Lack of Efficacy|11
7628903|NCT01691859|26542484|P1|Overall Study|Adverse Event|19
7628904|NCT01691820|26542530|P2|Overall Study|Other (unspecified)|1
7628905|NCT01691820|26542531|P1|Overall Study|Other (unspecified)|4
7628906|NCT01691820|26542530|P2|Overall Study|Lost to Follow-up|17
7628907|NCT01691820|26542531|P1|Overall Study|Lost to Follow-up|6
7628908|NCT01691820|26542530|P2|Overall Study|Migrated/moved from study area|4
7628909|NCT01691820|26542531|P1|Overall Study|Migrated/moved from study area|7
7628910|NCT01691820|26542530|P2|Overall Study|Consent withdrawal (not due to an AE)|15
7628911|NCT01691820|26542531|P1|Overall Study|Consent withdrawal (not due to an AE)|9
7628912|NCT01691794|26542568|P3|Overall Study|Did not complete first 24 weeks of study|3
7628913|NCT01691794|26542569|P2|Overall Study|Did not complete first 24 weeks of study|3
7628914|NCT01691794|26542570|P1|Overall Study|Did not complete first 24 weeks of study|0
7628915|NCT01691794|26542568|P3|Overall Study|Completed Only first 24 weeks of study|3
7628916|NCT01691794|26542569|P2|Overall Study|Completed Only first 24 weeks of study|2
7628917|NCT01691794|26542570|P1|Overall Study|Completed Only first 24 weeks of study|0
7628918|NCT01691794|26542568|P3|Overall Study|Adverse Event|1
7628919|NCT01691794|26542569|P2|Overall Study|Adverse Event|1
7628920|NCT01691794|26542570|P1|Overall Study|Adverse Event|0
7628921|NCT01691794|26542568|P3|Overall Study|Participant request to discontinue|0
7628922|NCT01691794|26542569|P2|Overall Study|Participant request to discontinue|1
7628923|NCT01691794|26542570|P1|Overall Study|Participant request to discontinue|0
7628924|NCT01691794|26542568|P3|Overall Study|Lack of Efficacy|1
7628925|NCT01691794|26542569|P2|Overall Study|Lack of Efficacy|7
7628927|NCT01691794|26542568|P3|Overall Study|Death|1
7628928|NCT01691794|26542569|P2|Overall Study|Death|0
7628929|NCT01691794|26542570|P1|Overall Study|Death|0
7628930|NCT01691794|26542568|P3|Overall Study|Poor/Non-Compliance|1
7628931|NCT01691794|26542569|P2|Overall Study|Poor/Non-Compliance|4
7628932|NCT01691794|26542570|P1|Overall Study|Poor/Non-Compliance|1
7628933|NCT01691781|26542586|P2|Overall Study|Adverse Event|1
7628934|NCT01691781|26542587|P1|Overall Study|Adverse Event|0
7628935|NCT01691781|26542586|P2|Overall Study|Protocol Violation|2
7628936|NCT01691781|26542587|P1|Overall Study|Protocol Violation|2
7628937|NCT01691781|26542586|P2|Overall Study|Physician Decision|1
7628938|NCT01691781|26542587|P1|Overall Study|Physician Decision|1
7628939|NCT01691781|26542586|P2|Overall Study|Withdrawal by Subject|3
7628940|NCT01691781|26542587|P1|Overall Study|Withdrawal by Subject|4
7628941|NCT01691768|26542599|P2|Overall Study|Investigator decision|1
7628942|NCT01691768|26542600|P1|Overall Study|Investigator decision|1
7628943|NCT01691768|26542599|P2|Overall Study|Relocated|1
7628944|NCT01691768|26542600|P1|Overall Study|Relocated|0
7628945|NCT01691768|26542599|P2|Overall Study|Withdrawal by Subject|9
7628946|NCT01691768|26542600|P1|Overall Study|Withdrawal by Subject|10
7628947|NCT01691768|26542599|P2|Overall Study|Lost to Follow-up|3
7628948|NCT01691768|26542600|P1|Overall Study|Lost to Follow-up|4
7628949|NCT01691768|26542599|P2|Overall Study|Death|2
7628950|NCT01691768|26542600|P1|Overall Study|Death|0
7628951|NCT01691612|26542635|P1|Overall Study|Adverse Event|1
7628952|NCT01691612|26542635|P1|Overall Study|deemed ineligible after 1st visit|6
7628953|NCT01691521|26542746|P3|Overall Study|Withdrawal by Subject|4
7628954|NCT01691521|26542747|P2|Overall Study|Withdrawal by Subject|9
7628955|NCT01691521|26542748|P1|Overall Study|Withdrawal by Subject|5
7628956|NCT01691521|26542746|P3|Overall Study|Physician Decision|0
7628957|NCT01691521|26542747|P2|Overall Study|Physician Decision|1
7628958|NCT01691521|26542748|P1|Overall Study|Physician Decision|2
7628959|NCT01691521|26542746|P3|Overall Study|Lost to Follow-up|2
7628960|NCT01691521|26542747|P2|Overall Study|Lost to Follow-up|2
7628961|NCT01691521|26542748|P1|Overall Study|Lost to Follow-up|0
7628962|NCT01691521|26542746|P3|Overall Study|Protocol Violation|0
7628963|NCT01691521|26542747|P2|Overall Study|Protocol Violation|3
7628964|NCT01691521|26542748|P1|Overall Study|Protocol Violation|0
7628965|NCT01691521|26542746|P3|Overall Study|Lack of Efficacy|2
7628966|NCT01691521|26542747|P2|Overall Study|Lack of Efficacy|1
7628967|NCT01691521|26542748|P1|Overall Study|Lack of Efficacy|1
7628968|NCT01691521|26542746|P3|Overall Study|Adverse Event|1
7628969|NCT01691521|26542747|P2|Overall Study|Adverse Event|0
7628970|NCT01691521|26542748|P1|Overall Study|Adverse Event|4
7628971|NCT01691508|26542770|P2|Overall Study|Withdrawal by Subject|0
7628972|NCT01691508|26542771|P1|Overall Study|Withdrawal by Subject|1
7628973|NCT01691508|26542770|P2|Overall Study|Adverse Event|3
7628974|NCT01691508|26542771|P1|Overall Study|Adverse Event|3
7628975|NCT01691482|26542785|P2|Treatment Period 2|Protocol Violation|1
7628976|NCT01691482|26542786|P1|Treatment Period 2|Protocol Violation|1
7628977|NCT01691482|26542785|P2|Treatment Period 2|Adverse Event|1
7628978|NCT01691482|26542786|P1|Treatment Period 2|Adverse Event|0
7628979|NCT01691430|26542804|P2|Overall Study|Lost to Follow-up|3
7628980|NCT01691430|26542805|P1|Overall Study|Lost to Follow-up|0
7628981|NCT01691430|26542804|P2|Overall Study|Withdrawal by Subject|1
7628982|NCT01691430|26542805|P1|Overall Study|Withdrawal by Subject|5
7628983|NCT01691430|26542804|P2|Overall Study|Death|16
7628984|NCT01691430|26542805|P1|Overall Study|Death|17
7628985|NCT01691378|26542831|P2|Overall Study|Lost to Follow-up|2
7628986|NCT01691378|26542832|P1|Overall Study|Lost to Follow-up|5
7628987|NCT01691378|26542831|P2|Overall Study|Withdrawal by Subject|0
7628988|NCT01691378|26542832|P1|Overall Study|Withdrawal by Subject|2
7628989|NCT01691248|26542915|P2|Overall Study|Not Treated|7
7628990|NCT01691248|26542916|P1|Overall Study|Not Treated|4
7628991|NCT01691248|26542915|P2|Overall Study|Reason not provided|4
7628992|NCT01691248|26542916|P1|Overall Study|Reason not provided|4
7628993|NCT01691248|26542915|P2|Overall Study|Lost to Follow-up|5
7628994|NCT01691248|26542916|P1|Overall Study|Lost to Follow-up|2
7628995|NCT01691248|26542915|P2|Overall Study|Confirmed CDAD|31
7628996|NCT01691248|26542916|P1|Overall Study|Confirmed CDAD|14
7628997|NCT01691248|26542915|P2|Overall Study|Withdrawal by Subject|18
7628998|NCT01691248|26542916|P1|Overall Study|Withdrawal by Subject|20
7628999|NCT01691248|26542915|P2|Overall Study|Adverse Event|22
7629000|NCT01691248|26542916|P1|Overall Study|Adverse Event|24
7629001|NCT01691248|26542915|P2|Overall Study|Protocol Violation|27
7629002|NCT01691248|26542916|P1|Overall Study|Protocol Violation|43
7629003|NCT01691105|26542928|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
7629004|NCT01691105|26542929|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
7629005|NCT01691105|26542928|P2|12 Month Biochemical Verification|Lost to Follow-up|71
7629006|NCT01691105|26542929|P1|12 Month Biochemical Verification|Lost to Follow-up|50
7629007|NCT01691105|26542928|P2|12 Month Biochemical Verification|Death|30
7629008|NCT01691105|26542929|P1|12 Month Biochemical Verification|Death|22
7629009|NCT01691105|26542928|P2|12 Month Follow-up|Death|30
7629010|NCT01691105|26542929|P1|12 Month Follow-up|Death|22
7629011|NCT01691105|26542928|P2|12 Month Follow-up|Lost to Follow-up|71
7629012|NCT01691105|26542929|P1|12 Month Follow-up|Lost to Follow-up|50
7629013|NCT01691105|26542928|P2|6 Month Follow-up|Death|13
7629014|NCT01691105|26542929|P1|6 Month Follow-up|Death|13
7629015|NCT01691105|26542928|P2|6 Month Follow-up|Lost to Follow-up|58
7629016|NCT01691105|26542929|P1|6 Month Follow-up|Lost to Follow-up|39
7629017|NCT01691105|26542928|P2|1 Month Follow-up|Death|3
7629018|NCT01691105|26542929|P1|1 Month Follow-up|Death|2
7629019|NCT01691105|26542928|P2|1 Month Follow-up|Lost to Follow-up|38
7629020|NCT01691105|26542929|P1|1 Month Follow-up|Lost to Follow-up|41
7629021|NCT01691092|26542949|P1|Overall Study|screen fail|19
7629022|NCT01691092|26542949|P1|Overall Study|used for different study|2
7629023|NCT01691092|26542949|P1|Overall Study|non-compliance|3
7629024|NCT01691092|26542949|P1|Overall Study|Withdrawal by Subject|3
7629025|NCT01691092|26542949|P1|Overall Study|Physician Decision|4
7629026|NCT01691092|26542949|P1|Overall Study|Lost to Follow-up|10
7629027|NCT01691014|26542973|P4|Overall Study|Lack of Efficacy|0
7629028|NCT01691014|26542974|P3|Overall Study|Lack of Efficacy|7
7629029|NCT01691014|26542975|P2|Overall Study|Lack of Efficacy|3
7629030|NCT01691014|26542976|P1|Overall Study|Lack of Efficacy|2
7629031|NCT01691014|26542973|P4|Overall Study|Adverse Event|1
7629032|NCT01691014|26542974|P3|Overall Study|Adverse Event|1
7629033|NCT01691014|26542975|P2|Overall Study|Adverse Event|5
7629034|NCT01691014|26542976|P1|Overall Study|Adverse Event|0
7629035|NCT01691014|26542973|P4|Overall Study|Withdrawal by Subject|1
7629036|NCT01691014|26542974|P3|Overall Study|Withdrawal by Subject|1
7629037|NCT01691014|26542975|P2|Overall Study|Withdrawal by Subject|1
7629038|NCT01691014|26542976|P1|Overall Study|Withdrawal by Subject|0
7629039|NCT01691014|26542973|P4|Overall Study|Other|0
7629040|NCT01691014|26542974|P3|Overall Study|Other|2
7629041|NCT01691014|26542975|P2|Overall Study|Other|0
7629042|NCT01691014|26542976|P1|Overall Study|Other|0
7629043|NCT01691014|26542973|P4|Overall Study|Premature Termination|3
7629044|NCT01691014|26542974|P3|Overall Study|Premature Termination|0
7629045|NCT01691014|26542975|P2|Overall Study|Premature Termination|6
7629046|NCT01691014|26542976|P1|Overall Study|Premature Termination|1
7629047|NCT01690988|26543021|P3|Overall Study|Sedated|2
7629048|NCT01690988|26543022|P2|Overall Study|Sedated|1
7629049|NCT01690988|26543023|P1|Overall Study|Sedated|1
7629050|NCT01690988|26543021|P3|Overall Study|Death|1
7629051|NCT01690988|26543022|P2|Overall Study|Death|1
7629052|NCT01690988|26543023|P1|Overall Study|Death|1
7629053|NCT01690988|26543021|P3|Overall Study|Determined ineligible|0
7629054|NCT01690988|26543022|P2|Overall Study|Determined ineligible|0
7629055|NCT01690988|26543023|P1|Overall Study|Determined ineligible|1
7629056|NCT01690988|26543021|P3|Overall Study|Operation Cancelled|0
7629057|NCT01690988|26543022|P2|Overall Study|Operation Cancelled|1
7629058|NCT01690988|26543023|P1|Overall Study|Operation Cancelled|1
7629059|NCT01690988|26543021|P3|Overall Study|Physician Decision|1
7629060|NCT01690988|26543022|P2|Overall Study|Physician Decision|0
7629061|NCT01690988|26543023|P1|Overall Study|Physician Decision|0
7629062|NCT01690988|26543021|P3|Overall Study|Withdrawal by Subject|3
7629063|NCT01690988|26543022|P2|Overall Study|Withdrawal by Subject|2
7629064|NCT01690988|26543023|P1|Overall Study|Withdrawal by Subject|2
7629065|NCT01690520|26543101|P2|Overall Study|Ongoing Follow-Up at time of Analysis|21
7629066|NCT01690520|26543102|P1|Overall Study|Ongoing Follow-Up at time of Analysis|22
7629067|NCT01690520|26543101|P2|Overall Study|Other|1
7629068|NCT01690520|26543102|P1|Overall Study|Other|0
7629069|NCT01690520|26543101|P2|Overall Study|Relapse|1
7629070|NCT01690520|26543102|P1|Overall Study|Relapse|0
7629071|NCT01690520|26543101|P2|Overall Study|Withdrawal by Subject|0
7629072|NCT01690520|26543102|P1|Overall Study|Withdrawal by Subject|2
7629073|NCT01690520|26543101|P2|Overall Study|Lost to Follow-up|3
7629074|NCT01690520|26543102|P1|Overall Study|Lost to Follow-up|2
7629075|NCT01690520|26543101|P2|Overall Study|Death|21
7629076|NCT01690520|26543102|P1|Overall Study|Death|25
7629077|NCT01690299|26543121|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
7629078|NCT01690299|26543122|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7629079|NCT01690299|26543123|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7629080|NCT01690299|26543124|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7629081|NCT01690299|26543125|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7629082|NCT01690299|26543126|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7629083|NCT01690299|26543121|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
7629084|NCT01690299|26543122|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
7629085|NCT01690299|26543123|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
7629086|NCT01690299|26543124|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7629087|NCT01690299|26543125|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7629088|NCT01690299|26543126|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7629089|NCT01690299|26543121|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
7629090|NCT01690299|26543122|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
7629091|NCT01690299|26543123|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
7629092|NCT01690299|26543124|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7629093|NCT01690299|26543125|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7629094|NCT01690299|26543126|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7629095|NCT01690299|26543121|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
7629096|NCT01690299|26543122|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
7629097|NCT01690299|26543123|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7629098|NCT01690299|26543124|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7629099|NCT01690299|26543125|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7629100|NCT01690299|26543126|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7629101|NCT01690299|26543121|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
7629102|NCT01690299|26543122|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
7629103|NCT01690299|26543123|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
7629104|NCT01690299|26543124|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7629105|NCT01690299|26543125|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7629106|NCT01690299|26543126|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7629107|NCT01690299|26543121|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
7629108|NCT01690299|26543122|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
7629109|NCT01690299|26543123|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
7629110|NCT01690299|26543124|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7629111|NCT01690299|26543125|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7629112|NCT01690299|26543126|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7629113|NCT01690299|26543121|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
7629114|NCT01690299|26543122|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
7629115|NCT01690299|26543123|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
7629116|NCT01690299|26543124|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
7629117|NCT01690299|26543125|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
7629118|NCT01690299|26543126|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
7629119|NCT01690299|26543121|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7629120|NCT01690299|26543122|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7629121|NCT01690299|26543123|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7629122|NCT01690299|26543124|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7629123|NCT01690299|26543125|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
7629124|NCT01690299|26543126|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
7629125|NCT01690299|26543121|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7629126|NCT01690299|26543122|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7629127|NCT01690299|26543123|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7629128|NCT01690299|26543124|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7629129|NCT01690299|26543125|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7629130|NCT01690299|26543126|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
7629131|NCT01690299|26543121|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7629132|NCT01690299|26543122|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7629133|NCT01690299|26543123|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7629134|NCT01690299|26543124|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
7629135|NCT01690299|26543125|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
7629136|NCT01690299|26543126|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
7629137|NCT01690143|26543223|P1|Overall Study|Withdrawal by Subject|1
7629138|NCT01690130|26543233|P2|Overall Study|Subject have cancelled visit.|0
7629139|NCT01690130|26543234|P1|Overall Study|Subject have cancelled visit.|1
7629140|NCT01690052|26543281|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
7629141|NCT01690052|26543282|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
7629142|NCT01689974|26543299|P2|Overall Study|Termination of Study|5
7629143|NCT01689974|26543300|P1|Overall Study|Termination of Study|5
7629144|NCT01689857|26543331|P2|Overall Study|Lost to Follow-up|2
7629145|NCT01689857|26543332|P1|Overall Study|Lost to Follow-up|5
7629146|NCT01689649|26543425|P1|Overall Study|Lost to Follow-up|5
7629147|NCT01689649|26543425|P1|Overall Study|Protocol Violation|3
7629148|NCT01689649|26543425|P1|Overall Study|Non-compliance|11
7629149|NCT01689649|26543425|P1|Overall Study|Lack of Efficacy|3
7629150|NCT01689532|26543437|P2|Overall Study|Physician Decision|0
7629151|NCT01689532|26543438|P1|Overall Study|Physician Decision|2
7629152|NCT01689532|26543437|P2|Overall Study|Withdrawal by Subject|2
7629153|NCT01689532|26543438|P1|Overall Study|Withdrawal by Subject|1
7629154|NCT01689532|26543437|P2|Overall Study|Lack of Efficacy|2
7629155|NCT01689532|26543438|P1|Overall Study|Lack of Efficacy|2
7629156|NCT01689532|26543437|P2|Overall Study|Adverse Event|5
7629157|NCT01689532|26543438|P1|Overall Study|Adverse Event|9
7629158|NCT01689519|26543502|P2|Safety Population|Withdrawal by Subject|20
7629159|NCT01689519|26543503|P1|Safety Population|Withdrawal by Subject|20
7629160|NCT01689519|26543502|P2|Safety Population|Study Terminated By Sponsor|47
7629161|NCT01689519|26543503|P1|Safety Population|Study Terminated By Sponsor|60
7629162|NCT01689519|26543502|P2|Safety Population|Physician Decision|1
7629163|NCT01689519|26543503|P1|Safety Population|Physician Decision|4
7629164|NCT01689519|26543502|P2|Safety Population|Other|4
7629165|NCT01689519|26543503|P1|Safety Population|Other|2
7629166|NCT01689519|26543502|P2|Safety Population|Lost to Follow-up|8
7629167|NCT01689519|26543503|P1|Safety Population|Lost to Follow-up|4
7629168|NCT01689519|26543502|P2|Safety Population|Death|165
7629169|NCT01689519|26543503|P1|Safety Population|Death|158
7629170|NCT01689519|26543502|P2|Intent to Treat|Withdrawal by Subject|20
7629171|NCT01689519|26543503|P1|Intent to Treat|Withdrawal by Subject|21
7629172|NCT01689519|26543502|P2|Intent to Treat|Study terminated by Spon6sor|48
7629173|NCT01689519|26543503|P1|Intent to Treat|Study terminated by Spon6sor|59
7629174|NCT01689519|26543502|P2|Intent to Treat|Physician Decision|1
7629175|NCT01689519|26543503|P1|Intent to Treat|Physician Decision|4
7629176|NCT01689519|26543502|P2|Intent to Treat|Other|4
7629177|NCT01689519|26543503|P1|Intent to Treat|Other|2
7629178|NCT01689519|26543502|P2|Intent to Treat|Lost to Follow-up|8
7629179|NCT01689519|26543503|P1|Intent to Treat|Lost to Follow-up|4
7629180|NCT01689519|26543502|P2|Intent to Treat|Death|167
7629181|NCT01689519|26543503|P1|Intent to Treat|Death|157
7629182|NCT01689363|26543528|P8|Overall Study|Protocol Violation|0
7629183|NCT01689363|26543529|P7|Overall Study|Protocol Violation|0
7629184|NCT01689363|26543530|P6|Overall Study|Protocol Violation|0
7629185|NCT01689363|26543531|P5|Overall Study|Protocol Violation|0
7629186|NCT01689363|26543532|P4|Overall Study|Protocol Violation|0
7629187|NCT01689363|26543533|P3|Overall Study|Protocol Violation|0
7629188|NCT01689363|26543534|P2|Overall Study|Protocol Violation|1
7629189|NCT01689363|26543535|P1|Overall Study|Protocol Violation|0
7629190|NCT01689337|26543590|P1|Overall Study|Study Discontinuation|1
7629191|NCT01689207|26543629|P11|Overall Study|Adverse Event|0
7629192|NCT01689207|26543630|P10|Overall Study|Adverse Event|0
7629193|NCT01689207|26543631|P9|Overall Study|Adverse Event|1
7629194|NCT01689207|26543632|P8|Overall Study|Adverse Event|0
7629195|NCT01689207|26543633|P7|Overall Study|Adverse Event|0
7629196|NCT01689207|26543634|P6|Overall Study|Adverse Event|1
7629197|NCT01689207|26543635|P5|Overall Study|Adverse Event|2
7629198|NCT01689207|26543636|P4|Overall Study|Adverse Event|0
7629199|NCT01689207|26543637|P3|Overall Study|Adverse Event|0
7629200|NCT01689207|26543638|P2|Overall Study|Adverse Event|1
7629201|NCT01689207|26543639|P1|Overall Study|Adverse Event|0
7629202|NCT01688999|26543747|P3|Overall Study|Ineligible/Not treated|0
7629203|NCT01688999|26543748|P2|Overall Study|Ineligible/Not treated|0
7629204|NCT01688999|26543749|P1|Overall Study|Ineligible/Not treated|1
7629205|NCT01688999|26543747|P3|Overall Study|Adverse Event|2
7629206|NCT01688999|26543748|P2|Overall Study|Adverse Event|0
7629207|NCT01688999|26543749|P1|Overall Study|Adverse Event|2
7629208|NCT01688999|26543747|P3|Overall Study|Withdrawal by Subject|1
7629209|NCT01688999|26543748|P2|Overall Study|Withdrawal by Subject|1
7629210|NCT01688999|26543749|P1|Overall Study|Withdrawal by Subject|5
7629211|NCT01688973|26543765|P2|Overall Study|Ineligible|3
7629212|NCT01688973|26543766|P1|Overall Study|Ineligible|2
7629213|NCT01688921|26543780|P2|Overall Study|informed consent|0
7629214|NCT01688921|26543781|P1|Overall Study|informed consent|3
7629215|NCT01688921|26543780|P2|Overall Study|Protocol Violation|1
7629216|NCT01688921|26543781|P1|Overall Study|Protocol Violation|0
7629217|NCT01688921|26543780|P2|Overall Study|Physician Decision|1
7629218|NCT01688921|26543781|P1|Overall Study|Physician Decision|6
7629219|NCT01688921|26543780|P2|Overall Study|Lost to Follow-up|13
7629220|NCT01688921|26543781|P1|Overall Study|Lost to Follow-up|7
7629221|NCT01688882|26543813|P2|Overall Study|Administrative problems|0
7629222|NCT01688882|26543814|P1|Overall Study|Administrative problems|1
7629223|NCT01688882|26543813|P2|Overall Study|Unsatisfactory therapeutic effect|1
7629224|NCT01688882|26543814|P1|Overall Study|Unsatisfactory therapeutic effect|1
7629225|NCT01688882|26543813|P2|Overall Study|Adverse Event|0
7629226|NCT01688882|26543814|P1|Overall Study|Adverse Event|1
7629227|NCT01688830|26543885|P21|Overall Study|Lost to Follow-up|0
7629228|NCT01688830|26543886|P20|Overall Study|Lost to Follow-up|0
7629229|NCT01688830|26543887|P19|Overall Study|Lost to Follow-up|0
7629230|NCT01688830|26543888|P18|Overall Study|Lost to Follow-up|0
7629231|NCT01688830|26543889|P17|Overall Study|Lost to Follow-up|0
7629232|NCT01688830|26543890|P16|Overall Study|Lost to Follow-up|0
7629233|NCT01688830|26543891|P15|Overall Study|Lost to Follow-up|0
7629234|NCT01688830|26543892|P14|Overall Study|Lost to Follow-up|0
7629235|NCT01688830|26543893|P13|Overall Study|Lost to Follow-up|0
7629236|NCT01688830|26543894|P12|Overall Study|Lost to Follow-up|0
7629237|NCT01688830|26543895|P11|Overall Study|Lost to Follow-up|1
7629238|NCT01688830|26543896|P10|Overall Study|Lost to Follow-up|0
7629239|NCT01688830|26543897|P9|Overall Study|Lost to Follow-up|0
7629240|NCT01688830|26543898|P8|Overall Study|Lost to Follow-up|0
7629241|NCT01688830|26543899|P7|Overall Study|Lost to Follow-up|0
7629242|NCT01688830|26543900|P6|Overall Study|Lost to Follow-up|0
7629243|NCT01688830|26543901|P5|Overall Study|Lost to Follow-up|0
7629244|NCT01688830|26543902|P4|Overall Study|Lost to Follow-up|0
7629245|NCT01688830|26543903|P3|Overall Study|Lost to Follow-up|0
7629246|NCT01688830|26543904|P2|Overall Study|Lost to Follow-up|0
7629247|NCT01688830|26543905|P1|Overall Study|Lost to Follow-up|0
7629248|NCT01688739|26544059|P10|Overall Study|Administrative Decision|0
7629249|NCT01688739|26544060|P9|Overall Study|Administrative Decision|0
7629250|NCT01688739|26544061|P8|Overall Study|Administrative Decision|0
7629251|NCT01688739|26544062|P7|Overall Study|Administrative Decision|0
7629252|NCT01688739|26544063|P6|Overall Study|Administrative Decision|0
7629253|NCT01688739|26544064|P5|Overall Study|Administrative Decision|0
7629254|NCT01688739|26544065|P4|Overall Study|Administrative Decision|0
7629255|NCT01688739|26544066|P3|Overall Study|Administrative Decision|0
7629256|NCT01688739|26544067|P2|Overall Study|Administrative Decision|0
7629257|NCT01688739|26544068|P1|Overall Study|Administrative Decision|1
7629258|NCT01688726|26544144|P2|Overall Study|Relocated abroad|1
7629259|NCT01688726|26544145|P1|Overall Study|Relocated abroad|0
7629260|NCT01688726|26544144|P2|Overall Study|Adverse Event|0
7629261|NCT01688726|26544145|P1|Overall Study|Adverse Event|1
7629262|NCT01688635|26544157|P2|Washout 3|Withdrawal by Subject|0
7629263|NCT01688635|26544158|P1|Washout 3|Withdrawal by Subject|1
7629264|NCT01688635|26544157|P2|Washout 2|Sponsor Decision|2
7629265|NCT01688635|26544158|P1|Washout 2|Sponsor Decision|1
7629266|NCT01688635|26544157|P2|Washout 2|Withdrawal by Subject|0
7629267|NCT01688635|26544158|P1|Washout 2|Withdrawal by Subject|1
7629268|NCT01688635|26544157|P2|Washout 2|Physician Decision|0
7629269|NCT01688635|26544158|P1|Washout 2|Physician Decision|1
7629270|NCT01688635|26544157|P2|Washout 1|Physician Decision|1
7629271|NCT01688635|26544158|P1|Washout 1|Physician Decision|0
7629272|NCT01688635|26544157|P2|Washout 1|Adverse Event|1
7629273|NCT01688635|26544158|P1|Washout 1|Adverse Event|0
7629274|NCT01688635|26544157|P2|Washout 1|Withdrawal by Subject|0
7629275|NCT01688635|26544158|P1|Washout 1|Withdrawal by Subject|1
7629276|NCT01688466|26544205|P2|Overall Study|Not evaluable|1
7629277|NCT01688466|26544206|P1|Overall Study|Not evaluable|0
7629278|NCT01688466|26544205|P2|Overall Study|Adverse Event|4
7629279|NCT01688466|26544206|P1|Overall Study|Adverse Event|0
7629280|NCT01688466|26544205|P2|Overall Study|Death|1
7629281|NCT01688466|26544206|P1|Overall Study|Death|0
7629282|NCT01688466|26544205|P2|Overall Study|Withdrawal by Subject|1
7629283|NCT01688466|26544206|P1|Overall Study|Withdrawal by Subject|2
7629284|NCT01688050|26544297|P1|Overall Study|Withdrawal by Subject|10
7629285|NCT01688050|26544297|P1|Overall Study|Lost to Follow-up|13
7629286|NCT01688050|26544297|P1|Overall Study|Conversion to open repair|1
7629287|NCT01688050|26544297|P1|Overall Study|Death|7
7629288|NCT01688037|26544306|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7629289|NCT01688037|26544307|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
7629290|NCT01688037|26544308|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7629291|NCT01688037|26544306|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
7629292|NCT01688037|26544307|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7629293|NCT01688037|26544308|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7629294|NCT01688037|26544306|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
7629295|NCT01688037|26544307|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
7629296|NCT01688037|26544308|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
7629297|NCT01688037|26544306|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
7629298|NCT01688037|26544307|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
7629299|NCT01688037|26544308|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
7629300|NCT01688037|26544306|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
7629301|NCT01688037|26544307|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
7629302|NCT01688037|26544308|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
7629303|NCT01688037|26544306|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7629304|NCT01688037|26544307|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
7629305|NCT01688037|26544308|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7629306|NCT01688037|26544306|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7629307|NCT01688037|26544307|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7629308|NCT01688037|26544308|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7629309|NCT01688037|26544306|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7629310|NCT01688037|26544307|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
7629311|NCT01688037|26544308|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
7629312|NCT01688037|26544306|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7629313|NCT01688037|26544307|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7629314|NCT01688037|26544308|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
7629315|NCT01688037|26544306|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7629316|NCT01688037|26544307|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7629317|NCT01688037|26544308|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7629318|NCT01687998|26544324|P2|Overall Study|Lost to Follow-up|7
7629319|NCT01687998|26544325|P1|Overall Study|Lost to Follow-up|9
7629320|NCT01687998|26544324|P2|Overall Study|Known to be Alive at Study End|62
7629321|NCT01687998|26544325|P1|Overall Study|Known to be Alive at Study End|54
7629322|NCT01687998|26544324|P2|Overall Study|Withdrawal by Subject|51
7629323|NCT01687998|26544325|P1|Overall Study|Withdrawal by Subject|49
7629324|NCT01687712|26544361|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
7629325|NCT01687712|26544362|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
7629326|NCT01687712|26544361|P2|Cycle 3|Ectopic Pregnancy|0
7629327|NCT01687712|26544362|P1|Cycle 3|Ectopic Pregnancy|1
7629328|NCT01687712|26544361|P2|Cycle 3|Early Pregnancy Loss|2
7629329|NCT01687712|26544362|P1|Cycle 3|Early Pregnancy Loss|1
7629330|NCT01687712|26544361|P2|Cycle 3|Not Biochemically Pregnant|22
7629331|NCT01687712|26544362|P1|Cycle 3|Not Biochemically Pregnant|21
7629332|NCT01687712|26544361|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
7629333|NCT01687712|26544362|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
7629334|NCT01687712|26544361|P2|Cycle 2|Still Birth|0
7629335|NCT01687712|26544362|P1|Cycle 2|Still Birth|1
7629336|NCT01687712|26544361|P2|Cycle 2|Ectopic Pregnancy|1
7629337|NCT01687712|26544362|P1|Cycle 2|Ectopic Pregnancy|0
7629338|NCT01687712|26544361|P2|Cycle 2|Early Pregnancy Loss|16
7629339|NCT01687712|26544362|P1|Cycle 2|Early Pregnancy Loss|18
7629340|NCT01687712|26544361|P2|Cycle 2|Not Biochemically Pregnant|77
7629341|NCT01687712|26544362|P1|Cycle 2|Not Biochemically Pregnant|74
7629342|NCT01687712|26544361|P2|Cycle 1|Lost to Follow-up|1
7629343|NCT01687712|26544362|P1|Cycle 1|Lost to Follow-up|1
7629344|NCT01687712|26544361|P2|Cycle 1|Intrauterine Fetal Death|1
7629345|NCT01687712|26544362|P1|Cycle 1|Intrauterine Fetal Death|0
7629346|NCT01687712|26544361|P2|Cycle 1|Abortion|0
7629347|NCT01687712|26544362|P1|Cycle 1|Abortion|3
7629348|NCT01687712|26544361|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
7629349|NCT01687712|26544362|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
7629350|NCT01687712|26544361|P2|Cycle 1|Heterotropic Pregnancy|0
7629351|NCT01687712|26544362|P1|Cycle 1|Heterotropic Pregnancy|1
7629352|NCT01687712|26544361|P2|Cycle 1|Ectopic Pregnancy|5
7629353|NCT01687712|26544362|P1|Cycle 1|Ectopic Pregnancy|5
7629354|NCT01687712|26544361|P2|Cycle 1|Early Pregnancy Loss|60
7629355|NCT01687712|26544362|P1|Cycle 1|Early Pregnancy Loss|43
7629356|NCT01687712|26544361|P2|Cycle 1|Not Biochemically Pregnant|348
7629357|NCT01687712|26544362|P1|Cycle 1|Not Biochemically Pregnant|386
7629358|NCT01687673|26544400|P1|Overall Study|Physician Decision|1
7629359|NCT01687595|26544414|P2|Overall Study|Other than specified|7
7629360|NCT01687595|26544415|P1|Overall Study|Other than specified|56
7629361|NCT01687595|26544414|P2|Overall Study|Noncompliance|2
7629362|NCT01687595|26544415|P1|Overall Study|Noncompliance|1
7629363|NCT01687595|26544414|P2|Overall Study|Sponsor's decision|0
7629364|NCT01687595|26544415|P1|Overall Study|Sponsor's decision|1
7629365|NCT01687595|26544414|P2|Overall Study|Investigator's decision|0
7629366|NCT01687595|26544415|P1|Overall Study|Investigator's decision|1
7629367|NCT01687595|26544414|P2|Overall Study|Lost to Follow-up|1
7629368|NCT01687595|26544415|P1|Overall Study|Lost to Follow-up|3
7629369|NCT01687595|26544414|P2|Overall Study|Withdrawal by Subject|0
7629370|NCT01687595|26544415|P1|Overall Study|Withdrawal by Subject|8
7629371|NCT01687478|26544427|P2|Overall Study|Entry Criteria Not Met|2
7629372|NCT01687478|26544428|P1|Overall Study|Entry Criteria Not Met|6
7629373|NCT01687478|26544427|P2|Overall Study|Physician Decision|3
7629374|NCT01687478|26544428|P1|Overall Study|Physician Decision|1
7629375|NCT01687478|26544427|P2|Overall Study|Withdrawal by Subject|19
7629376|NCT01687478|26544428|P1|Overall Study|Withdrawal by Subject|21
7629377|NCT01687478|26544427|P2|Overall Study|Protocol Violation|2
7629378|NCT01687478|26544428|P1|Overall Study|Protocol Violation|0
7629379|NCT01687478|26544427|P2|Overall Study|Lost to Follow-up|3
7629380|NCT01687478|26544428|P1|Overall Study|Lost to Follow-up|1
7629381|NCT01687478|26544427|P2|Overall Study|Adverse Event|10
7629382|NCT01687478|26544428|P1|Overall Study|Adverse Event|3
7629383|NCT01687413|26544452|P2|Overall Study|Patient withdrew before completing all radiotherapy|0
7629384|NCT01687413|26544453|P1|Overall Study|Patient withdrew before completing all radiotherapy|1
7629385|NCT01687413|26544452|P2|Overall Study|Not eligible|2
7629386|NCT01687413|26544453|P1|Overall Study|Not eligible|0
7629387|NCT01687413|26544452|P2|Overall Study|Withdrawal by Subject|2
7629388|NCT01687413|26544453|P1|Overall Study|Withdrawal by Subject|0
7629389|NCT01687296|26544558|P2|Overall Study|Withdrawal by Subject|3
7629390|NCT01687296|26544559|P1|Overall Study|Withdrawal by Subject|6
7629391|NCT01687296|26544558|P2|Overall Study|Protocol Violation|1
7629392|NCT01687296|26544559|P1|Overall Study|Protocol Violation|0
7629393|NCT01687296|26544558|P2|Overall Study|Lack of Efficacy|1
7629394|NCT01687296|26544559|P1|Overall Study|Lack of Efficacy|1
7629395|NCT01687283|26544581|P2|Overall Study|Withdrawal by Subject|8
7629396|NCT01687283|26544582|P1|Overall Study|Withdrawal by Subject|9
7629397|NCT01687283|26544581|P2|Overall Study|Investigator discretion|0
7629398|NCT01687283|26544582|P1|Overall Study|Investigator discretion|2
7629399|NCT01687283|26544581|P2|Overall Study|Lost to Follow-up|1
7629400|NCT01687283|26544582|P1|Overall Study|Lost to Follow-up|1
7629401|NCT01687283|26544581|P2|Overall Study|protocol defined stopping criteria|10
7629402|NCT01687283|26544582|P1|Overall Study|protocol defined stopping criteria|8
7629403|NCT01687283|26544581|P2|Overall Study|Protocol Violation|3
7629404|NCT01687283|26544582|P1|Overall Study|Protocol Violation|1
7629405|NCT01687283|26544581|P2|Overall Study|Lack of Efficacy|1
7629406|NCT01687283|26544582|P1|Overall Study|Lack of Efficacy|3
7629407|NCT01687283|26544581|P2|Overall Study|Adverse Event|4
7629408|NCT01687283|26544582|P1|Overall Study|Adverse Event|11
7629409|NCT01687270|26544605|P1|Overall Study|Lost to Follow-up|1
7629410|NCT01687270|26544605|P1|Overall Study|Lack of Efficacy|11
7629411|NCT01687257|26544616|P3|Overall Study|Investigator's Discretion|0
7629412|NCT01687257|26544617|P2|Overall Study|Investigator's Discretion|3
7629413|NCT01687257|26544618|P1|Overall Study|Investigator's Discretion|0
7629414|NCT01687257|26544616|P3|Overall Study|Adverse Event|0
7629415|NCT01687257|26544617|P2|Overall Study|Adverse Event|0
7629416|NCT01687257|26544618|P1|Overall Study|Adverse Event|1
7629417|NCT01687257|26544616|P3|Overall Study|Subject Withdrew Consent|1
7629418|NCT01687257|26544617|P2|Overall Study|Subject Withdrew Consent|1
7629419|NCT01687257|26544618|P1|Overall Study|Subject Withdrew Consent|1
7629420|NCT01687257|26544616|P3|Overall Study|Efficacy Failure|5
7629421|NCT01687257|26544617|P2|Overall Study|Efficacy Failure|0
7629422|NCT01687257|26544618|P1|Overall Study|Efficacy Failure|6
7629423|NCT01687218|26544683|P6|Overall Study|Relocated, no follow-up planned|0
7629424|NCT01687218|26544684|P5|Overall Study|Relocated, no follow-up planned|0
7629425|NCT01687218|26544685|P4|Overall Study|Relocated, no follow-up planned|1
7629426|NCT01687218|26544686|P3|Overall Study|Relocated, no follow-up planned|1
7629427|NCT01687218|26544687|P2|Overall Study|Relocated, no follow-up planned|0
7629428|NCT01687218|26544688|P1|Overall Study|Relocated, no follow-up planned|1
7629429|NCT01687218|26544683|P6|Overall Study|Withdrawal by Subject|0
7629430|NCT01687218|26544684|P5|Overall Study|Withdrawal by Subject|1
7629431|NCT01687218|26544685|P4|Overall Study|Withdrawal by Subject|1
7629432|NCT01687218|26544686|P3|Overall Study|Withdrawal by Subject|0
7629433|NCT01687218|26544687|P2|Overall Study|Withdrawal by Subject|3
7629434|NCT01687218|26544688|P1|Overall Study|Withdrawal by Subject|2
7629435|NCT01687166|26544740|P4|Overall Study|Insurance|1
7629436|NCT01687166|26544741|P3|Overall Study|Insurance|1
7629437|NCT01687166|26544742|P2|Overall Study|Insurance|0
7629438|NCT01687166|26544743|P1|Overall Study|Insurance|0
7629439|NCT01687166|26544740|P4|Overall Study|Physician choice to use different device|0
7629440|NCT01687166|26544741|P3|Overall Study|Physician choice to use different device|4
7629441|NCT01687166|26544742|P2|Overall Study|Physician choice to use different device|2
7629442|NCT01687166|26544743|P1|Overall Study|Physician choice to use different device|1
7629443|NCT01687166|26544740|P4|Overall Study|Patient unable to be compliant|0
7629444|NCT01687166|26544741|P3|Overall Study|Patient unable to be compliant|0
7629445|NCT01687166|26544742|P2|Overall Study|Patient unable to be compliant|0
7629446|NCT01687166|26544743|P1|Overall Study|Patient unable to be compliant|1
7629447|NCT01687166|26544740|P4|Overall Study|Subject moved out of state|0
7629448|NCT01687166|26544741|P3|Overall Study|Subject moved out of state|0
7629449|NCT01687166|26544742|P2|Overall Study|Subject moved out of state|1
7629450|NCT01687166|26544743|P1|Overall Study|Subject moved out of state|0
7629451|NCT01687166|26544740|P4|Overall Study|Protocol Violation|0
7629452|NCT01687166|26544741|P3|Overall Study|Protocol Violation|1
7629453|NCT01687166|26544742|P2|Overall Study|Protocol Violation|1
7629454|NCT01687166|26544743|P1|Overall Study|Protocol Violation|1
7629455|NCT01687166|26544740|P4|Overall Study|Death|0
7629456|NCT01687166|26544741|P3|Overall Study|Death|0
7629457|NCT01687166|26544742|P2|Overall Study|Death|1
7629458|NCT01687166|26544743|P1|Overall Study|Death|1
7629459|NCT01687166|26544740|P4|Overall Study|Equipment/Device Availability|0
7629460|NCT01687166|26544741|P3|Overall Study|Equipment/Device Availability|0
7629461|NCT01687166|26544742|P2|Overall Study|Equipment/Device Availability|1
7629462|NCT01687166|26544743|P1|Overall Study|Equipment/Device Availability|0
7629463|NCT01687166|26544740|P4|Overall Study|Lost to Follow-up|0
7629464|NCT01687166|26544741|P3|Overall Study|Lost to Follow-up|1
7629465|NCT01687166|26544742|P2|Overall Study|Lost to Follow-up|5
7629466|NCT01687166|26544743|P1|Overall Study|Lost to Follow-up|2
7629467|NCT01687166|26544740|P4|Overall Study|Withdrawal by Subject|0
7629468|NCT01687166|26544741|P3|Overall Study|Withdrawal by Subject|3
7629469|NCT01687166|26544742|P2|Overall Study|Withdrawal by Subject|4
7629470|NCT01687166|26544743|P1|Overall Study|Withdrawal by Subject|11
7629471|NCT01687166|26544740|P4|Overall Study|Physician Decision|0
7629472|NCT01687166|26544741|P3|Overall Study|Physician Decision|1
7629473|NCT01687166|26544742|P2|Overall Study|Physician Decision|2
7629474|NCT01687166|26544743|P1|Overall Study|Physician Decision|3
7629475|NCT01687166|26544740|P4|Overall Study|Adverse Event|0
7629476|NCT01687166|26544741|P3|Overall Study|Adverse Event|0
7629477|NCT01687166|26544742|P2|Overall Study|Adverse Event|1
7629478|NCT01687166|26544743|P1|Overall Study|Adverse Event|2
7629479|NCT01687166|26544740|P4|Overall Study|Did not meet eligibility criteria|1
7629480|NCT01687166|26544741|P3|Overall Study|Did not meet eligibility criteria|1
7629481|NCT01687166|26544742|P2|Overall Study|Did not meet eligibility criteria|6
7629482|NCT01687166|26544743|P1|Overall Study|Did not meet eligibility criteria|4
7629483|NCT01687166|26544740|P4|Overall Study|Attempt subject|0
7629484|NCT01687166|26544741|P3|Overall Study|Attempt subject|2
7629485|NCT01687166|26544742|P2|Overall Study|Attempt subject|3
7629486|NCT01687166|26544743|P1|Overall Study|Attempt subject|2
7629487|NCT01687101|26544759|P1|Overall Study|Lost to Follow-up|7
7629488|NCT01686958|26544784|P1|Overall Study|Withdrawal by Subject|1
7629489|NCT01686932|26544797|P2|Period 1|Adverse Event|1
7629490|NCT01686932|26544798|P1|Period 1|Adverse Event|1
7629491|NCT01686828|26544828|P4|Overall Study|Weight Loss|0
7629492|NCT01686828|26544829|P3|Overall Study|Weight Loss|1
7629493|NCT01686828|26544830|P2|Overall Study|Weight Loss|0
7629494|NCT01686828|26544831|P1|Overall Study|Weight Loss|0
7629495|NCT01686828|26544828|P4|Overall Study|New Job|0
7629496|NCT01686828|26544829|P3|Overall Study|New Job|0
7629497|NCT01686828|26544830|P2|Overall Study|New Job|1
7629498|NCT01686828|26544831|P1|Overall Study|New Job|0
7629499|NCT01686828|26544828|P4|Overall Study|Physician Decision|0
7629500|NCT01686828|26544829|P3|Overall Study|Physician Decision|0
7629501|NCT01686828|26544830|P2|Overall Study|Physician Decision|0
7629502|NCT01686828|26544831|P1|Overall Study|Physician Decision|1
7629503|NCT01686633|26544944|P3|Overall Study|Lost to Follow-up|1
7629504|NCT01686633|26544945|P2|Overall Study|Lost to Follow-up|1
7629505|NCT01686633|26544946|P1|Overall Study|Lost to Follow-up|0
7629506|NCT01686633|26544944|P3|Overall Study|Protocol-defined Stopping Criteria|1
7629507|NCT01686633|26544945|P2|Overall Study|Protocol-defined Stopping Criteria|0
7629508|NCT01686633|26544946|P1|Overall Study|Protocol-defined Stopping Criteria|1
7629509|NCT01686633|26544944|P3|Overall Study|Protocol Violation|0
7629510|NCT01686633|26544945|P2|Overall Study|Protocol Violation|3
7629511|NCT01686633|26544946|P1|Overall Study|Protocol Violation|2
7629512|NCT01686633|26544944|P3|Overall Study|Adverse Event|3
7629513|NCT01686633|26544945|P2|Overall Study|Adverse Event|3
7629514|NCT01686633|26544946|P1|Overall Study|Adverse Event|4
7629515|NCT01686633|26544944|P3|Overall Study|Physician Decision|4
7629516|NCT01686633|26544945|P2|Overall Study|Physician Decision|4
7629517|NCT01686633|26544946|P1|Overall Study|Physician Decision|3
7629518|NCT01686633|26544944|P3|Overall Study|Withdrawal by Subject|5
7629519|NCT01686633|26544945|P2|Overall Study|Withdrawal by Subject|8
7629520|NCT01686633|26544946|P1|Overall Study|Withdrawal by Subject|8
7629521|NCT01686633|26544944|P3|Overall Study|Lack of Efficacy|11
7629522|NCT01686633|26544945|P2|Overall Study|Lack of Efficacy|13
7629523|NCT01686633|26544946|P1|Overall Study|Lack of Efficacy|33
7629524|NCT01686581|26544969|P1|Overall Study|Reason Missing|1
7629525|NCT01686581|26544969|P1|Overall Study|Other Miscellaneous Reasons|36
7629526|NCT01686581|26544969|P1|Overall Study|Thinks it is Inconvenient|17
7629527|NCT01686581|26544969|P1|Overall Study|Trying to get Pregnant or Nursing|2
7629528|NCT01686581|26544969|P1|Overall Study|Thinks Injections Take Too Much Time|2
7629529|NCT01686581|26544969|P1|Overall Study|Thinks Injections Too Painful|8
7629530|NCT01686581|26544969|P1|Overall Study|Participant Concerned about Risks|6
7629531|NCT01686581|26544969|P1|Overall Study|Lack of Efficacy|90
7629532|NCT01686581|26544969|P1|Overall Study|Side-effects or Health Problems|15
7629533|NCT01686568|26544982|P2|Sub-Study|Not consented for sub-study|2
7629534|NCT01686568|26544983|P1|Sub-Study|Not consented for sub-study|2
7629535|NCT01686568|26544982|P2|Main Study|Liver enzymes above range of exclusion|0
7629536|NCT01686568|26544983|P1|Main Study|Liver enzymes above range of exclusion|1
7629537|NCT01686568|26544982|P2|Main Study|Noncompliance with protocol|1
7629538|NCT01686568|26544983|P1|Main Study|Noncompliance with protocol|0
7629539|NCT01686568|26544982|P2|Main Study|Withdrawal by Subject|3
7629540|NCT01686568|26544983|P1|Main Study|Withdrawal by Subject|1
7629541|NCT01686438|26545060|P3|Overall Study|Withdrawal by Subject|1
7629542|NCT01686438|26545061|P2|Overall Study|Withdrawal by Subject|0
7629543|NCT01686438|26545062|P1|Overall Study|Withdrawal by Subject|0
7629544|NCT01686438|26545060|P3|Overall Study|Protocol Violation|1
7629545|NCT01686438|26545061|P2|Overall Study|Protocol Violation|0
7629546|NCT01686438|26545062|P1|Overall Study|Protocol Violation|0
7629547|NCT01686438|26545060|P3|Overall Study|Adverse Event|1
7629548|NCT01686438|26545061|P2|Overall Study|Adverse Event|0
7629549|NCT01686438|26545062|P1|Overall Study|Adverse Event|0
7629550|NCT01686438|26545060|P3|Overall Study|Lost to Follow-up|10
7629551|NCT01686438|26545061|P2|Overall Study|Lost to Follow-up|9
7629552|NCT01686438|26545062|P1|Overall Study|Lost to Follow-up|8
7629553|NCT01686373|26545110|P2|Overall Study|Adverse Event|1
7629554|NCT01686373|26545111|P1|Overall Study|Adverse Event|0
7629555|NCT01686373|26545110|P2|Overall Study|Withdrawal by Subject|1
7629556|NCT01686373|26545111|P1|Overall Study|Withdrawal by Subject|0
7629557|NCT01686373|26545110|P2|Overall Study|Lost to Follow-up|0
7629558|NCT01686373|26545111|P1|Overall Study|Lost to Follow-up|3
7629559|NCT01686152|26545127|P3|Overall Study|Lost to Follow-up|5
7629560|NCT01686152|26545128|P2|Overall Study|Lost to Follow-up|6
7629561|NCT01686152|26545129|P1|Overall Study|Lost to Follow-up|7
7629562|NCT01686152|26545127|P3|Overall Study|IP Non-compliance|0
7629563|NCT01686152|26545128|P2|Overall Study|IP Non-compliance|5
7629564|NCT01686152|26545129|P1|Overall Study|IP Non-compliance|5
7629565|NCT01686152|26545127|P3|Overall Study|Lack of Efficacy|1
7629566|NCT01686152|26545128|P2|Overall Study|Lack of Efficacy|0
7629567|NCT01686152|26545129|P1|Overall Study|Lack of Efficacy|0
7629568|NCT01686152|26545127|P3|Overall Study|Adverse Event|0
7629569|NCT01686152|26545128|P2|Overall Study|Adverse Event|11
7629570|NCT01686152|26545129|P1|Overall Study|Adverse Event|12
7629571|NCT01686152|26545127|P3|Overall Study|Protocol Violation|0
7629572|NCT01686152|26545128|P2|Overall Study|Protocol Violation|1
7629573|NCT01686152|26545129|P1|Overall Study|Protocol Violation|6
7629574|NCT01686152|26545127|P3|Overall Study|Drug Code Unblinded|0
7629575|NCT01686152|26545128|P2|Overall Study|Drug Code Unblinded|1
7629576|NCT01686152|26545129|P1|Overall Study|Drug Code Unblinded|0
7629577|NCT01686152|26545127|P3|Overall Study|Withdrawal by Subject|3
7629578|NCT01686152|26545128|P2|Overall Study|Withdrawal by Subject|11
7629579|NCT01686152|26545129|P1|Overall Study|Withdrawal by Subject|11
7629580|NCT01685983|26545148|P1|Overall Study|Noncompliance with Study Drug|1
7629581|NCT01685983|26545148|P1|Overall Study|Progressive Disease|32
7629582|NCT01685983|26545148|P1|Overall Study|Other|7
7629583|NCT01685983|26545148|P1|Overall Study|Physician Decision|13
7629584|NCT01685983|26545148|P1|Overall Study|Protocol Violation|2
7629585|NCT01685983|26545148|P1|Overall Study|Withdrawal by Subject|19
7629586|NCT01685983|26545148|P1|Overall Study|Death|1
7629587|NCT01685983|26545148|P1|Overall Study|Adverse Event|7
7629588|NCT01685840|26545160|P2|Overall Study|Had VAD, Dialysis or Transplant|17
7629589|NCT01685840|26545161|P1|Overall Study|Had VAD, Dialysis or Transplant|11
7629590|NCT01685840|26545160|P2|Overall Study|Futility|200
7629591|NCT01685840|26545161|P1|Overall Study|Futility|197
7629592|NCT01685840|26545160|P2|Overall Study|Withdrawal by Subject|17
7629593|NCT01685840|26545161|P1|Overall Study|Withdrawal by Subject|14
7629594|NCT01685840|26545160|P2|Overall Study|Physician Decision|7
7629595|NCT01685840|26545161|P1|Overall Study|Physician Decision|3
7629596|NCT01685840|26545160|P2|Overall Study|Lost to Follow-up|25
7629597|NCT01685840|26545161|P1|Overall Study|Lost to Follow-up|27
7629598|NCT01685840|26545160|P2|Overall Study|Death|66
7629599|NCT01685840|26545161|P1|Overall Study|Death|77
7629600|NCT01685801|26545205|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7629601|NCT01685801|26545206|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7629602|NCT01685801|26545207|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7629603|NCT01685801|26545208|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7629604|NCT01685801|26545205|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
7629605|NCT01685801|26545206|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7629606|NCT01685801|26545207|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7629607|NCT01685801|26545208|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7629608|NCT01685697|26545230|P2|Overall Study|Protocol Violation|3
7629609|NCT01685697|26545231|P1|Overall Study|Protocol Violation|3
7629610|NCT01685606|26545265|P1|Overall Study|Withdrawal by Subject|1
7629611|NCT01685437|26545293|P1|Overall Study|Unable to make visits due to work|1
7629612|NCT01685437|26545293|P1|Overall Study|Protocol Violation|4
7629613|NCT01685437|26545293|P1|Overall Study|Adverse Event|1
7629614|NCT01685437|26545293|P1|Overall Study|Lost to Follow-up|3
7629615|NCT01685437|26545293|P1|Overall Study|Withdrawal by Subject|22
7629616|NCT01685372|26545325|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
7629617|NCT01685372|26545326|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
7629618|NCT01685229|26545416|P2|Overall Study|Death|0
7629619|NCT01685229|26545417|P1|Overall Study|Death|1
7629620|NCT01685229|26545416|P2|Overall Study|Withdrawal by Subject|5
7629621|NCT01685229|26545417|P1|Overall Study|Withdrawal by Subject|6
7629622|NCT01685229|26545416|P2|Overall Study|Lost to Follow-up|10
7629623|NCT01685229|26545417|P1|Overall Study|Lost to Follow-up|16
7629624|NCT01685229|26545416|P2|Overall Study|Subjects missing Study Exit form|1
7629625|NCT01685229|26545417|P1|Overall Study|Subjects missing Study Exit form|3
7629626|NCT01685216|26545443|P1|Overall Study|Did not receive study drug|1
7629627|NCT01685203|26545460|P7|Overall Study|Patient's decision|0
7629628|NCT01685203|26545461|P6|Overall Study|Patient's decision|1
7629629|NCT01685203|26545462|P5|Overall Study|Patient's decision|0
7629630|NCT01685203|26545463|P4|Overall Study|Patient's decision|0
7629631|NCT01685203|26545464|P3|Overall Study|Patient's decision|0
7629632|NCT01685203|26545465|P2|Overall Study|Patient's decision|0
7629633|NCT01685203|26545466|P1|Overall Study|Patient's decision|0
7629634|NCT01685203|26545460|P7|Overall Study|Adverse event and withdrew consent|0
7629635|NCT01685203|26545461|P6|Overall Study|Adverse event and withdrew consent|0
7629636|NCT01685203|26545462|P5|Overall Study|Adverse event and withdrew consent|0
7629637|NCT01685203|26545463|P4|Overall Study|Adverse event and withdrew consent|0
7629638|NCT01685203|26545464|P3|Overall Study|Adverse event and withdrew consent|0
7629639|NCT01685203|26545465|P2|Overall Study|Adverse event and withdrew consent|0
7629640|NCT01685203|26545466|P1|Overall Study|Adverse event and withdrew consent|1
7629641|NCT01685203|26545460|P7|Overall Study|Adverse Event|0
7629642|NCT01685203|26545461|P6|Overall Study|Adverse Event|2
7629643|NCT01685203|26545462|P5|Overall Study|Adverse Event|0
7629644|NCT01685203|26545463|P4|Overall Study|Adverse Event|0
7629645|NCT01685203|26545464|P3|Overall Study|Adverse Event|0
7629646|NCT01685203|26545465|P2|Overall Study|Adverse Event|0
7629647|NCT01685203|26545466|P1|Overall Study|Adverse Event|0
7629648|NCT01685203|26545460|P7|Overall Study|Lost to Follow-up|0
7629649|NCT01685203|26545461|P6|Overall Study|Lost to Follow-up|0
7629650|NCT01685203|26545462|P5|Overall Study|Lost to Follow-up|0
7629651|NCT01685203|26545463|P4|Overall Study|Lost to Follow-up|1
7629652|NCT01685203|26545464|P3|Overall Study|Lost to Follow-up|0
7629653|NCT01685203|26545465|P2|Overall Study|Lost to Follow-up|3
7629654|NCT01685203|26545466|P1|Overall Study|Lost to Follow-up|3
7629655|NCT01685138|26545510|P1|Overall Study|Progressive disease|53
7629656|NCT01685138|26545510|P1|Overall Study|Adverse Event|18
7629657|NCT01685138|26545510|P1|Overall Study|Death|10
7629658|NCT01685138|26545510|P1|Overall Study|Physician Decision|6
7629659|NCT01685138|26545510|P1|Overall Study|Subject/guardian decision|2
7629660|NCT01685138|26545510|P1|Overall Study|No longer requires treatment|1
7629661|NCT01685138|26545510|P1|Overall Study|Protocol Violation|1
7629662|NCT01685138|26545510|P1|Overall Study|Lost to Follow-up|1
7629663|NCT01685073|26545526|P2|Overall Study|Withdrawal by Subject|24
7629664|NCT01685073|26545527|P1|Overall Study|Withdrawal by Subject|24
7629665|NCT01685073|26545526|P2|Overall Study|Lost to Follow-up|8
7629666|NCT01685073|26545527|P1|Overall Study|Lost to Follow-up|6
7629667|NCT01685060|26545535|P1|Overall Study|Death|8
7629668|NCT01685060|26545535|P1|Overall Study|Lost to Follow-up|1
7629669|NCT01685060|26545535|P1|Overall Study|Subject/guardian decision|20
7629670|NCT01685060|26545535|P1|Overall Study|Physician Decision|14
7629671|NCT01685060|26545535|P1|Overall Study|Progressive disease|69
7629672|NCT01685060|26545535|P1|Overall Study|Adverse Event|12
7629673|NCT01685060|26545535|P1|Overall Study|Rollover patients|16
7629674|NCT01685047|26545550|P1|Overall Study|patient withdrawn by sponsor|1
7629675|NCT01685047|26545550|P1|Overall Study|Adverse Event|5
7629676|NCT01685047|26545550|P1|Overall Study|Physician Decision|25
7629677|NCT01685047|26545550|P1|Overall Study|Lost to Follow-up|8
7629678|NCT01685047|26545550|P1|Overall Study|Death|26
7629679|NCT01685047|26545550|P1|Overall Study|Withdrawal by Subject|20
7629680|NCT01684943|26545566|P3|Overall Study|Planning Pregnancy|0
7629681|NCT01684943|26545567|P2|Overall Study|Planning Pregnancy|0
7629682|NCT01684943|26545568|P1|Overall Study|Planning Pregnancy|1
7629683|NCT01684943|26545566|P3|Overall Study|Lost to Follow-up|0
7629684|NCT01684943|26545567|P2|Overall Study|Lost to Follow-up|0
7629685|NCT01684943|26545568|P1|Overall Study|Lost to Follow-up|3
7629686|NCT01684943|26545566|P3|Overall Study|Excluded from Analysis|1
7629687|NCT01684943|26545567|P2|Overall Study|Excluded from Analysis|1
7629688|NCT01684943|26545568|P1|Overall Study|Excluded from Analysis|1
7629689|NCT01684943|26545566|P3|Overall Study|Principal Investigator Determination|0
7629690|NCT01684943|26545567|P2|Overall Study|Principal Investigator Determination|0
7629691|NCT01684943|26545568|P1|Overall Study|Principal Investigator Determination|1
7629692|NCT01684943|26545566|P3|Overall Study|Inadequate Venous Access|0
7629693|NCT01684943|26545567|P2|Overall Study|Inadequate Venous Access|0
7629694|NCT01684943|26545568|P1|Overall Study|Inadequate Venous Access|3
7629695|NCT01684930|26545587|P2|Overall Study|Withdrawal by Subject|1
7629696|NCT01684930|26545588|P1|Overall Study|Withdrawal by Subject|3
7629697|NCT01684878|26545645|P4|Part 2: Randomized Phase|Participant noncompliance|1
7629698|NCT01684878|26545646|P3|Part 2: Randomized Phase|Participant noncompliance|0
7629699|NCT01684878|26545647|P2|Part 2: Randomized Phase|Participant noncompliance|0
7629700|NCT01684878|26545648|P1|Part 2: Randomized Phase|Participant noncompliance|0
7629701|NCT01684878|26545645|P4|Part 2: Randomized Phase|Alive at data-cut|7
7629702|NCT01684878|26545646|P3|Part 2: Randomized Phase|Alive at data-cut|13
7629703|NCT01684878|26545647|P2|Part 2: Randomized Phase|Alive at data-cut|0
7629704|NCT01684878|26545648|P1|Part 2: Randomized Phase|Alive at data-cut|0
7629705|NCT01684878|26545645|P4|Part 2: Randomized Phase|Death|68
7629706|NCT01684878|26545646|P3|Part 2: Randomized Phase|Death|62
7629707|NCT01684878|26545647|P2|Part 2: Randomized Phase|Death|0
7629708|NCT01684878|26545648|P1|Part 2: Randomized Phase|Death|0
7629709|NCT01684878|26545645|P4|Part 2: Randomized Phase|Lost to Follow-up|0
7629710|NCT01684878|26545646|P3|Part 2: Randomized Phase|Lost to Follow-up|2
7629711|NCT01684878|26545647|P2|Part 2: Randomized Phase|Lost to Follow-up|0
7629712|NCT01684878|26545648|P1|Part 2: Randomized Phase|Lost to Follow-up|0
7629713|NCT01684878|26545645|P4|Part 2: Randomized Phase|Participant withdrew consent|2
7629714|NCT01684878|26545646|P3|Part 2: Randomized Phase|Participant withdrew consent|1
7629715|NCT01684878|26545647|P2|Part 2: Randomized Phase|Participant withdrew consent|0
7629716|NCT01684878|26545648|P1|Part 2: Randomized Phase|Participant withdrew consent|0
7629717|NCT01684878|26545645|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
7629718|NCT01684878|26545646|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
7629719|NCT01684878|26545647|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
7629720|NCT01684878|26545648|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
7629721|NCT01684878|26545645|P4|Part 1: Safety Run in Phase|Death|0
7629722|NCT01684878|26545646|P3|Part 1: Safety Run in Phase|Death|0
7629723|NCT01684878|26545647|P2|Part 1: Safety Run in Phase|Death|20
7629724|NCT01684878|26545648|P1|Part 1: Safety Run in Phase|Death|15
7629725|NCT01684878|26545645|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7629726|NCT01684878|26545646|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7629727|NCT01684878|26545647|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7629728|NCT01684878|26545648|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7629729|NCT01684722|26545696|P4|Overall Study|Death|21
7629730|NCT01684722|26545697|P3|Overall Study|Death|19
7629731|NCT01684722|26545698|P2|Overall Study|Death|21
7629732|NCT01684722|26545699|P1|Overall Study|Death|19
7629733|NCT01684722|26545696|P4|Overall Study|Lost to Follow-up|89
7629734|NCT01684722|26545697|P3|Overall Study|Lost to Follow-up|75
7629735|NCT01684722|26545698|P2|Overall Study|Lost to Follow-up|56
7629736|NCT01684722|26545699|P1|Overall Study|Lost to Follow-up|78
7629737|NCT01684423|26545785|P5|Overall Study|Withdrawal by Subject|0
7629738|NCT01684423|26545786|P4|Overall Study|Withdrawal by Subject|0
7629739|NCT01684423|26545787|P3|Overall Study|Withdrawal by Subject|1
7629740|NCT01684423|26545788|P2|Overall Study|Withdrawal by Subject|0
7629741|NCT01684423|26545789|P1|Overall Study|Withdrawal by Subject|0
7629742|NCT01684215|26545846|P4|Phase 2|Lost to Follow-up|4
7629743|NCT01684215|26545847|P3|Phase 2|Lost to Follow-up|0
7629744|NCT01684215|26545848|P2|Phase 2|Lost to Follow-up|0
7629745|NCT01684215|26545849|P1|Phase 2|Lost to Follow-up|0
7629746|NCT01684215|26545846|P4|Phase 2|Enrolled but not treated|1
7629747|NCT01684215|26545847|P3|Phase 2|Enrolled but not treated|0
7629748|NCT01684215|26545848|P2|Phase 2|Enrolled but not treated|0
7629749|NCT01684215|26545849|P1|Phase 2|Enrolled but not treated|0
7629750|NCT01684215|26545846|P4|Phase 2|Study terminated by sponsor|30
7629751|NCT01684215|26545847|P3|Phase 2|Study terminated by sponsor|0
7629752|NCT01684215|26545848|P2|Phase 2|Study terminated by sponsor|0
7629753|NCT01684215|26545849|P1|Phase 2|Study terminated by sponsor|0
7629754|NCT01684215|26545846|P4|Phase 2|Death|8
7629755|NCT01684215|26545847|P3|Phase 2|Death|0
7629756|NCT01684215|26545848|P2|Phase 2|Death|0
7629757|NCT01684215|26545849|P1|Phase 2|Death|0
7629758|NCT01684215|26545846|P4|Phase 1, Part 2|Withdrawal by Subject|0
7629759|NCT01684215|26545847|P3|Phase 1, Part 2|Withdrawal by Subject|1
7629760|NCT01684215|26545848|P2|Phase 1, Part 2|Withdrawal by Subject|0
7629761|NCT01684215|26545849|P1|Phase 1, Part 2|Withdrawal by Subject|0
7629762|NCT01684215|26545846|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7629763|NCT01684215|26545847|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
7629764|NCT01684215|26545848|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7629765|NCT01684215|26545849|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7629766|NCT01684215|26545846|P4|Phase 1, Part 2|Adverse Event|0
7629767|NCT01684215|26545847|P3|Phase 1, Part 2|Adverse Event|1
7629768|NCT01684215|26545848|P2|Phase 1, Part 2|Adverse Event|0
7629769|NCT01684215|26545849|P1|Phase 1, Part 2|Adverse Event|0
7629770|NCT01684215|26545846|P4|Phase 1, Part 1|Objective progression or relapse|0
7629771|NCT01684215|26545847|P3|Phase 1, Part 1|Objective progression or relapse|0
7629772|NCT01684215|26545848|P2|Phase 1, Part 1|Objective progression or relapse|6
7629773|NCT01684215|26545849|P1|Phase 1, Part 1|Objective progression or relapse|5
7629774|NCT01684215|26545846|P4|Phase 1, Part 1|Adverse Event|0
7629775|NCT01684215|26545847|P3|Phase 1, Part 1|Adverse Event|0
7629776|NCT01684215|26545848|P2|Phase 1, Part 1|Adverse Event|0
7629777|NCT01684215|26545849|P1|Phase 1, Part 1|Adverse Event|1
7629778|NCT01684202|26545927|P4|Maintenance Period|Withdrawal by Subject|0
7629779|NCT01684202|26545928|P3|Maintenance Period|Withdrawal by Subject|0
7629780|NCT01684202|26545929|P2|Maintenance Period|Withdrawal by Subject|1
7629781|NCT01684202|26545930|P1|Maintenance Period|Withdrawal by Subject|0
7629782|NCT01684202|26545927|P4|Maintenance Period|Physician Decision|0
7629783|NCT01684202|26545928|P3|Maintenance Period|Physician Decision|0
7629784|NCT01684202|26545929|P2|Maintenance Period|Physician Decision|1
7629785|NCT01684202|26545930|P1|Maintenance Period|Physician Decision|0
7629786|NCT01684202|26545927|P4|Maintenance Period|Adverse Event|1
7629787|NCT01684202|26545928|P3|Maintenance Period|Adverse Event|1
7629788|NCT01684202|26545929|P2|Maintenance Period|Adverse Event|1
7629789|NCT01684202|26545930|P1|Maintenance Period|Adverse Event|1
7629790|NCT01684202|26545927|P4|Dose-escalation Period|Withdrawal by Subject|0
7629791|NCT01684202|26545928|P3|Dose-escalation Period|Withdrawal by Subject|0
7629792|NCT01684202|26545929|P2|Dose-escalation Period|Withdrawal by Subject|0
7629793|NCT01684202|26545930|P1|Dose-escalation Period|Withdrawal by Subject|1
7629794|NCT01684202|26545927|P4|Dose-escalation Period|Adverse Event|0
7629795|NCT01684202|26545928|P3|Dose-escalation Period|Adverse Event|0
7629796|NCT01684202|26545929|P2|Dose-escalation Period|Adverse Event|1
7629797|NCT01684202|26545930|P1|Dose-escalation Period|Adverse Event|0
7629798|NCT01684046|26545944|P2|Period 1, First 30 Days|Adverse Event|2
7629799|NCT01684046|26545945|P1|Period 1, First 30 Days|Adverse Event|0
7629800|NCT01684033|26545951|P2|Period 2, Second 30 Days|Adverse Event|0
7629801|NCT01684033|26545952|P1|Period 2, Second 30 Days|Adverse Event|1
7629802|NCT01684033|26545951|P2|Period 1, First 30 Days|Lost to Follow-up|0
7629803|NCT01684033|26545952|P1|Period 1, First 30 Days|Lost to Follow-up|1
7629804|NCT01684033|26545951|P2|Period 1, First 30 Days|Withdrawal by Subject|0
7629805|NCT01684033|26545952|P1|Period 1, First 30 Days|Withdrawal by Subject|1
7629806|NCT01684033|26545951|P2|Period 1, First 30 Days|Noncompliance|0
7629807|NCT01684033|26545952|P1|Period 1, First 30 Days|Noncompliance|1
7629808|NCT01684033|26545951|P2|Period 1, First 30 Days|Adverse Event|1
7629809|NCT01684033|26545952|P1|Period 1, First 30 Days|Adverse Event|1
7629810|NCT01683994|26546001|P5|Overall Study|Intercurrent illness|1
7629811|NCT01683994|26546002|P4|Overall Study|Intercurrent illness|2
7629812|NCT01683994|26546003|P3|Overall Study|Intercurrent illness|0
7629813|NCT01683994|26546004|P2|Overall Study|Intercurrent illness|0
7629814|NCT01683994|26546005|P1|Overall Study|Intercurrent illness|0
7629815|NCT01683994|26546001|P5|Overall Study|Withdrawal by Subject|0
7629816|NCT01683994|26546002|P4|Overall Study|Withdrawal by Subject|1
7629817|NCT01683994|26546003|P3|Overall Study|Withdrawal by Subject|0
7629818|NCT01683994|26546004|P2|Overall Study|Withdrawal by Subject|0
7629819|NCT01683994|26546005|P1|Overall Study|Withdrawal by Subject|1
7629820|NCT01683838|26546046|P2|Overall Study|Other|3
7629821|NCT01683838|26546047|P1|Overall Study|Other|4
7629822|NCT01683838|26546046|P2|Overall Study|Lost to Follow-up|1
7629823|NCT01683838|26546047|P1|Overall Study|Lost to Follow-up|1
7629824|NCT01683838|26546046|P2|Overall Study|Withdrawal by Subject|5
7629825|NCT01683838|26546047|P1|Overall Study|Withdrawal by Subject|6
7629826|NCT01683838|26546046|P2|Overall Study|Protocol Violation|1
7629827|NCT01683838|26546047|P1|Overall Study|Protocol Violation|3
7629828|NCT01683838|26546046|P2|Overall Study|Adverse Event|2
7629829|NCT01683838|26546047|P1|Overall Study|Adverse Event|12
7629830|NCT01683604|26546087|P1|Overall Study|Other|2
7629831|NCT01683604|26546087|P1|Overall Study|Lack of Efficacy|1
7629832|NCT01683604|26546087|P1|Overall Study|Adverse Event|2
7629833|NCT01683565|26546252|P2|Overall Study|Discontinued Intervention|1
7629834|NCT01683565|26546253|P1|Overall Study|Discontinued Intervention|1
7629835|NCT01683565|26546252|P2|Overall Study|Lost to Follow-up|0
7629836|NCT01683565|26546253|P1|Overall Study|Lost to Follow-up|2
7629837|NCT01683409|26546291|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7629838|NCT01683409|26546292|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7629839|NCT01683409|26546293|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
7629840|NCT01683409|26546294|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7629841|NCT01683409|26546295|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7629842|NCT01683409|26546291|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
7629843|NCT01683409|26546292|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7629844|NCT01683409|26546293|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7629845|NCT01683409|26546294|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7629846|NCT01683409|26546295|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7629847|NCT01683409|26546291|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
7629848|NCT01683409|26546292|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
7629849|NCT01683409|26546293|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7629850|NCT01683409|26546294|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
7629851|NCT01683409|26546295|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7629852|NCT01683409|26546291|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7629853|NCT01683409|26546292|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7629854|NCT01683409|26546293|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7629855|NCT01683409|26546294|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7629856|NCT01683409|26546295|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
7629857|NCT01683409|26546291|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7629858|NCT01683409|26546292|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7629859|NCT01683409|26546293|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7629860|NCT01683409|26546294|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7629861|NCT01683409|26546295|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7629862|NCT01683409|26546291|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7629863|NCT01683409|26546292|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7629864|NCT01683409|26546293|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7629865|NCT01683409|26546294|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7629866|NCT01683409|26546295|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7629867|NCT01683409|26546291|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7629868|NCT01683409|26546292|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7629869|NCT01683409|26546293|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
7629870|NCT01683409|26546294|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7629871|NCT01683409|26546295|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7629872|NCT01683409|26546291|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7629873|NCT01683409|26546292|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7629874|NCT01683409|26546293|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7629875|NCT01683409|26546294|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7629876|NCT01683409|26546295|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7629877|NCT01683409|26546291|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7629878|NCT01683409|26546292|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7629879|NCT01683409|26546293|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7629880|NCT01683409|26546294|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
7629881|NCT01683409|26546295|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7629882|NCT01683409|26546291|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
7629883|NCT01683409|26546292|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
7629884|NCT01683409|26546293|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
7629885|NCT01683409|26546294|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
7629886|NCT01683409|26546295|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
7629887|NCT01683409|26546291|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7629888|NCT01683409|26546292|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7629889|NCT01683409|26546293|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
7629890|NCT01683409|26546294|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7629891|NCT01683409|26546295|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7629892|NCT01683383|26546338|P2|Overall Study|Infant was not transported|0
7629893|NCT01683383|26546339|P1|Overall Study|Infant was not transported|1
7629894|NCT01683266|26546366|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
7629895|NCT01683266|26546367|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
7629896|NCT01683266|26546366|P2|Overall Study|Possibly Hypoglycemia|0
7629897|NCT01683266|26546367|P1|Overall Study|Possibly Hypoglycemia|1
7629898|NCT01683266|26546366|P2|Overall Study|Perceived Lack of Efficacy|1
7629899|NCT01683266|26546367|P1|Overall Study|Perceived Lack of Efficacy|1
7629900|NCT01683266|26546366|P2|Overall Study|Nonserious Hypoglycemia|3
7629901|NCT01683266|26546367|P1|Overall Study|Nonserious Hypoglycemia|0
7629902|NCT01683266|26546366|P2|Overall Study|Site Closure / Site Withdrawal|3
7629903|NCT01683266|26546367|P1|Overall Study|Site Closure / Site Withdrawal|1
7629904|NCT01683266|26546366|P2|Overall Study|Lost to Follow-up|0
7629905|NCT01683266|26546367|P1|Overall Study|Lost to Follow-up|5
7629906|NCT01683266|26546366|P2|Overall Study|Selection Criterion / Protocol Violation|5
7629907|NCT01683266|26546367|P1|Overall Study|Selection Criterion / Protocol Violation|7
7629908|NCT01683266|26546366|P2|Overall Study|Personal Reason|25
7629909|NCT01683266|26546367|P1|Overall Study|Personal Reason|17
7629910|NCT01683266|26546366|P2|Overall Study|Protocol Violation|6
7629911|NCT01683266|26546367|P1|Overall Study|Protocol Violation|13
7629912|NCT01683266|26546366|P2|Overall Study|Lack of Efficacy|2
7629913|NCT01683266|26546367|P1|Overall Study|Lack of Efficacy|5
7629914|NCT01683266|26546366|P2|Overall Study|Adverse Event|4
7629915|NCT01683266|26546367|P1|Overall Study|Adverse Event|5
7629916|NCT01683071|26546401|P6|Part 2|Withdrawal by investigator decision|2
7629917|NCT01683071|26546402|P5|Part 2|Withdrawal by investigator decision|1
7629918|NCT01683071|26546403|P4|Part 2|Withdrawal by investigator decision|0
7629919|NCT01683071|26546404|P3|Part 2|Withdrawal by investigator decision|0
7629920|NCT01683071|26546405|P2|Part 2|Withdrawal by investigator decision|0
7629921|NCT01683071|26546406|P1|Part 2|Withdrawal by investigator decision|0
7629922|NCT01683071|26546401|P6|Part 2|Protocol deviation|2
7629923|NCT01683071|26546402|P5|Part 2|Protocol deviation|1
7629924|NCT01683071|26546403|P4|Part 2|Protocol deviation|0
7629925|NCT01683071|26546404|P3|Part 2|Protocol deviation|0
7629926|NCT01683071|26546405|P2|Part 2|Protocol deviation|0
7629927|NCT01683071|26546406|P1|Part 2|Protocol deviation|0
7629928|NCT01683071|26546401|P6|Part 2|Met exclusion criterion|1
7629929|NCT01683071|26546402|P5|Part 2|Met exclusion criterion|1
7629930|NCT01683071|26546403|P4|Part 2|Met exclusion criterion|0
7629931|NCT01683071|26546404|P3|Part 2|Met exclusion criterion|0
7629932|NCT01683071|26546405|P2|Part 2|Met exclusion criterion|0
7629933|NCT01683071|26546406|P1|Part 2|Met exclusion criterion|0
7629934|NCT01683071|26546401|P6|Part 2|Did not receive study drug|1
7629935|NCT01683071|26546402|P5|Part 2|Did not receive study drug|2
7629936|NCT01683071|26546403|P4|Part 2|Did not receive study drug|0
7629937|NCT01683071|26546404|P3|Part 2|Did not receive study drug|0
7629938|NCT01683071|26546405|P2|Part 2|Did not receive study drug|0
7629939|NCT01683071|26546406|P1|Part 2|Did not receive study drug|0
7629940|NCT01683071|26546401|P6|Part 2|Surgery cancelled|2
7629941|NCT01683071|26546402|P5|Part 2|Surgery cancelled|4
7629942|NCT01683071|26546403|P4|Part 2|Surgery cancelled|0
7629943|NCT01683071|26546404|P3|Part 2|Surgery cancelled|0
7629944|NCT01683071|26546405|P2|Part 2|Surgery cancelled|0
7629945|NCT01683071|26546406|P1|Part 2|Surgery cancelled|0
7629946|NCT01683071|26546401|P6|Part 2|Withdrawal by Subject|3
7629947|NCT01683071|26546402|P5|Part 2|Withdrawal by Subject|3
7629948|NCT01683071|26546403|P4|Part 2|Withdrawal by Subject|0
7629949|NCT01683071|26546404|P3|Part 2|Withdrawal by Subject|0
7629950|NCT01683071|26546405|P2|Part 2|Withdrawal by Subject|0
7629951|NCT01683071|26546406|P1|Part 2|Withdrawal by Subject|0
7629952|NCT01683071|26546401|P6|Part 2|Lost to Follow-up|0
7629953|NCT01683071|26546402|P5|Part 2|Lost to Follow-up|2
7629954|NCT01683071|26546403|P4|Part 2|Lost to Follow-up|0
7629955|NCT01683071|26546404|P3|Part 2|Lost to Follow-up|0
7629956|NCT01683071|26546405|P2|Part 2|Lost to Follow-up|0
7629957|NCT01683071|26546406|P1|Part 2|Lost to Follow-up|0
7629958|NCT01683071|26546401|P6|Part 2|Lack of Efficacy|4
7629959|NCT01683071|26546402|P5|Part 2|Lack of Efficacy|3
7629960|NCT01683071|26546403|P4|Part 2|Lack of Efficacy|0
7629961|NCT01683071|26546404|P3|Part 2|Lack of Efficacy|0
7629962|NCT01683071|26546405|P2|Part 2|Lack of Efficacy|0
7629963|NCT01683071|26546406|P1|Part 2|Lack of Efficacy|0
7629964|NCT01683071|26546401|P6|Part 1|Early termination; met exclusion criteria|0
7629965|NCT01683071|26546402|P5|Part 1|Early termination; met exclusion criteria|0
7629966|NCT01683071|26546403|P4|Part 1|Early termination; met exclusion criteria|0
7629967|NCT01683071|26546404|P3|Part 1|Early termination; met exclusion criteria|1
7629968|NCT01683071|26546405|P2|Part 1|Early termination; met exclusion criteria|2
7629969|NCT01683071|26546406|P1|Part 1|Early termination; met exclusion criteria|0
7629970|NCT01683071|26546401|P6|Part 1|Did not receive study drug|0
7629971|NCT01683071|26546402|P5|Part 1|Did not receive study drug|0
7629972|NCT01683071|26546403|P4|Part 1|Did not receive study drug|1
7629973|NCT01683071|26546404|P3|Part 1|Did not receive study drug|0
7629974|NCT01683071|26546405|P2|Part 1|Did not receive study drug|0
7629975|NCT01683071|26546406|P1|Part 1|Did not receive study drug|1
7629976|NCT01683071|26546401|P6|Part 1|Surgery Cancelled|0
7629977|NCT01683071|26546402|P5|Part 1|Surgery Cancelled|0
7629978|NCT01683071|26546403|P4|Part 1|Surgery Cancelled|0
7629979|NCT01683071|26546404|P3|Part 1|Surgery Cancelled|0
7629980|NCT01683071|26546405|P2|Part 1|Surgery Cancelled|0
7629981|NCT01683071|26546406|P1|Part 1|Surgery Cancelled|1
7629982|NCT01683071|26546401|P6|Part 1|Withdrawal by Subject|0
7629983|NCT01683071|26546402|P5|Part 1|Withdrawal by Subject|0
7629984|NCT01683071|26546403|P4|Part 1|Withdrawal by Subject|1
7629985|NCT01683071|26546404|P3|Part 1|Withdrawal by Subject|2
7629986|NCT01683071|26546405|P2|Part 1|Withdrawal by Subject|2
7629987|NCT01683071|26546406|P1|Part 1|Withdrawal by Subject|1
7629988|NCT01683071|26546401|P6|Part 1|Lack of Efficacy|0
7629989|NCT01683071|26546402|P5|Part 1|Lack of Efficacy|0
7629990|NCT01683071|26546403|P4|Part 1|Lack of Efficacy|3
7629991|NCT01683071|26546404|P3|Part 1|Lack of Efficacy|0
7629992|NCT01683071|26546405|P2|Part 1|Lack of Efficacy|0
7629993|NCT01683071|26546406|P1|Part 1|Lack of Efficacy|1
7629994|NCT01683058|26546432|P1|Overall Study|Lack of Efficacy|2
7629995|NCT01683058|26546432|P1|Overall Study|Withdrawal by Subject|7
7629996|NCT01683058|26546432|P1|Overall Study|Subject Met Withdrawal Criteria|5
7629997|NCT01683058|26546432|P1|Overall Study|Adverse Event|6
7629998|NCT01683058|26546432|P1|Overall Study|Lost to Follow-up|9
7629999|NCT01683019|26546463|P3|Overall Study|Withdrawal by Subject|4
7630000|NCT01683019|26546464|P2|Overall Study|Withdrawal by Subject|1
7630001|NCT01683019|26546465|P1|Overall Study|Withdrawal by Subject|2
7630002|NCT01682876|26546499|P4|Overall Study|Other|1
7630003|NCT01682876|26546500|P3|Overall Study|Other|1
7630004|NCT01682876|26546501|P2|Overall Study|Other|0
7630005|NCT01682876|26546502|P1|Overall Study|Other|1
7630006|NCT01682876|26546499|P4|Overall Study|Withdrawal by Subject|2
7630007|NCT01682876|26546500|P3|Overall Study|Withdrawal by Subject|0
7630008|NCT01682876|26546501|P2|Overall Study|Withdrawal by Subject|0
7630009|NCT01682876|26546502|P1|Overall Study|Withdrawal by Subject|4
7630010|NCT01682876|26546499|P4|Overall Study|Protocol Violation|1
7630011|NCT01682876|26546500|P3|Overall Study|Protocol Violation|1
7630012|NCT01682876|26546501|P2|Overall Study|Protocol Violation|1
7630013|NCT01682876|26546502|P1|Overall Study|Protocol Violation|1
7630014|NCT01682876|26546499|P4|Overall Study|Lost to Follow-up|11
7630015|NCT01682876|26546500|P3|Overall Study|Lost to Follow-up|9
7630016|NCT01682876|26546501|P2|Overall Study|Lost to Follow-up|15
7630017|NCT01682876|26546502|P1|Overall Study|Lost to Follow-up|11
7630018|NCT01682876|26546499|P4|Overall Study|Adverse Event|1
7630019|NCT01682876|26546500|P3|Overall Study|Adverse Event|0
7630020|NCT01682876|26546501|P2|Overall Study|Adverse Event|0
7630021|NCT01682876|26546502|P1|Overall Study|Adverse Event|0
7630022|NCT01682876|26546499|P4|Overall Study|Administrative reason|3
7630023|NCT01682876|26546500|P3|Overall Study|Administrative reason|0
7630024|NCT01682876|26546501|P2|Overall Study|Administrative reason|4
7630025|NCT01682876|26546502|P1|Overall Study|Administrative reason|4
7630026|NCT01682863|26546548|P3|Overall Study|Physician Decision|1
7630027|NCT01682863|26546549|P2|Overall Study|Physician Decision|0
7630028|NCT01682863|26546550|P1|Overall Study|Physician Decision|0
7630029|NCT01682863|26546548|P3|Overall Study|Adverse Event|2
7630030|NCT01682863|26546549|P2|Overall Study|Adverse Event|1
7630031|NCT01682863|26546550|P1|Overall Study|Adverse Event|0
7630032|NCT01682863|26546548|P3|Overall Study|Technical problems|0
7630033|NCT01682863|26546549|P2|Overall Study|Technical problems|0
7630034|NCT01682863|26546550|P1|Overall Study|Technical problems|1
7630035|NCT01682863|26546548|P3|Overall Study|Protocol deviation|1
7630036|NCT01682863|26546549|P2|Overall Study|Protocol deviation|0
7630037|NCT01682863|26546550|P1|Overall Study|Protocol deviation|1
7630038|NCT01682863|26546548|P3|Overall Study|Death|4
7630039|NCT01682863|26546549|P2|Overall Study|Death|3
7630040|NCT01682863|26546550|P1|Overall Study|Death|1
7630041|NCT01682863|26546548|P3|Overall Study|Lost to Follow-up|6
7630042|NCT01682863|26546549|P2|Overall Study|Lost to Follow-up|1
7630043|NCT01682863|26546550|P1|Overall Study|Lost to Follow-up|5
7630044|NCT01682863|26546548|P3|Overall Study|Subject/guardian decision|10
7630045|NCT01682863|26546549|P2|Overall Study|Subject/guardian decision|12
7630046|NCT01682863|26546550|P1|Overall Study|Subject/guardian decision|19
7630047|NCT01682837|26546579|P1|Baseline|Withdrawal by Subject|5
7630048|NCT01682811|26546628|P7|Part 2 Dose Level 2|Lost to Follow-up|0
7630049|NCT01682811|26546629|P6|Part 2 Dose Level 2|Lost to Follow-up|3
7630050|NCT01682811|26546630|P5|Part 2 Dose Level 2|Lost to Follow-up|0
7630051|NCT01682811|26546631|P4|Part 2 Dose Level 2|Lost to Follow-up|0
7630052|NCT01682811|26546632|P3|Part 2 Dose Level 2|Lost to Follow-up|0
7630053|NCT01682811|26546633|P2|Part 2 Dose Level 2|Lost to Follow-up|0
7630054|NCT01682811|26546634|P1|Part 2 Dose Level 2|Lost to Follow-up|0
7630055|NCT01682811|26546628|P7|Part 2 Dose Level 1|Lost to Follow-up|0
7630056|NCT01682811|26546629|P6|Part 2 Dose Level 1|Lost to Follow-up|0
7630057|NCT01682811|26546630|P5|Part 2 Dose Level 1|Lost to Follow-up|6
7630058|NCT01682811|26546631|P4|Part 2 Dose Level 1|Lost to Follow-up|0
7630059|NCT01682811|26546632|P3|Part 2 Dose Level 1|Lost to Follow-up|0
7630060|NCT01682811|26546633|P2|Part 2 Dose Level 1|Lost to Follow-up|0
7630061|NCT01682811|26546634|P1|Part 2 Dose Level 1|Lost to Follow-up|0
7630062|NCT01682811|26546628|P7|Part 2 Dose Level 1|Protocol Violation|0
7630063|NCT01682811|26546629|P6|Part 2 Dose Level 1|Protocol Violation|0
7630064|NCT01682811|26546630|P5|Part 2 Dose Level 1|Protocol Violation|4
7630065|NCT01682811|26546631|P4|Part 2 Dose Level 1|Protocol Violation|0
7630066|NCT01682811|26546632|P3|Part 2 Dose Level 1|Protocol Violation|0
7630067|NCT01682811|26546633|P2|Part 2 Dose Level 1|Protocol Violation|0
7630068|NCT01682811|26546634|P1|Part 2 Dose Level 1|Protocol Violation|0
7630069|NCT01682811|26546628|P7|Part 2 Dose Level 1|Withdrawal by Subject|0
7630070|NCT01682811|26546629|P6|Part 2 Dose Level 1|Withdrawal by Subject|0
7630071|NCT01682811|26546630|P5|Part 2 Dose Level 1|Withdrawal by Subject|1
7630072|NCT01682811|26546631|P4|Part 2 Dose Level 1|Withdrawal by Subject|0
7630073|NCT01682811|26546632|P3|Part 2 Dose Level 1|Withdrawal by Subject|0
7630074|NCT01682811|26546633|P2|Part 2 Dose Level 1|Withdrawal by Subject|0
7630075|NCT01682811|26546634|P1|Part 2 Dose Level 1|Withdrawal by Subject|0
7630076|NCT01682759|26546664|P2|Overall Study|Withdrawal by Subject|55
7630077|NCT01682759|26546665|P1|Overall Study|Withdrawal by Subject|56
7630078|NCT01682759|26546664|P2|Overall Study|Physician Decision|1
7630079|NCT01682759|26546665|P1|Overall Study|Physician Decision|1
7630080|NCT01682759|26546664|P2|Overall Study|Lost to Follow-up|13
7630081|NCT01682759|26546665|P1|Overall Study|Lost to Follow-up|10
7630082|NCT01682759|26546664|P2|Overall Study|Death|1
7630083|NCT01682759|26546665|P1|Overall Study|Death|2
7630084|NCT01682720|26546689|P4|Overall Study|Adverse Event|1
7630085|NCT01682720|26546690|P3|Overall Study|Adverse Event|1
7630086|NCT01682720|26546691|P2|Overall Study|Adverse Event|0
7630087|NCT01682720|26546692|P1|Overall Study|Adverse Event|1
7630088|NCT01682720|26546689|P4|Overall Study|Subject Withdrew Consent|2
7630089|NCT01682720|26546690|P3|Overall Study|Subject Withdrew Consent|2
7630090|NCT01682720|26546691|P2|Overall Study|Subject Withdrew Consent|0
7630091|NCT01682720|26546692|P1|Overall Study|Subject Withdrew Consent|0
7630092|NCT01682720|26546689|P4|Overall Study|Lost to Follow-up|6
7630093|NCT01682720|26546690|P3|Overall Study|Lost to Follow-up|0
7630094|NCT01682720|26546691|P2|Overall Study|Lost to Follow-up|1
7630095|NCT01682720|26546692|P1|Overall Study|Lost to Follow-up|1
7630096|NCT01682720|26546689|P4|Overall Study|Efficacy Failure|30
7630097|NCT01682720|26546690|P3|Overall Study|Efficacy Failure|3
7630098|NCT01682720|26546691|P2|Overall Study|Efficacy Failure|3
7630099|NCT01682720|26546692|P1|Overall Study|Efficacy Failure|0
7630100|NCT01682720|26546689|P4|Overall Study|Terminated by Sponsor|0
7630101|NCT01682720|26546690|P3|Overall Study|Terminated by Sponsor|0
7630102|NCT01682720|26546691|P2|Overall Study|Terminated by Sponsor|0
7630103|NCT01682720|26546692|P1|Overall Study|Terminated by Sponsor|83
7630104|NCT01682720|26546689|P4|Overall Study|Randomized but Not Treated|0
7630105|NCT01682720|26546690|P3|Overall Study|Randomized but Not Treated|1
7630106|NCT01682720|26546691|P2|Overall Study|Randomized but Not Treated|1
7630107|NCT01682720|26546692|P1|Overall Study|Randomized but Not Treated|0
7630108|NCT01682681|26546709|P1|Overall Study|Low compliance|13
7630109|NCT01682681|26546709|P1|Overall Study|Other|21
7630110|NCT01682681|26546709|P1|Overall Study|tapering of topiramate|5
7630111|NCT01682681|26546709|P1|Overall Study|Adverse Event|46
7630112|NCT01682681|26546709|P1|Overall Study|Lost to Follow-up|174
7630113|NCT01682681|26546709|P1|Overall Study|Moved to other hospital|10
7630114|NCT01682681|26546709|P1|Overall Study|Withdrawal by Subject|1
7630115|NCT01682681|26546709|P1|Overall Study|Lack of Efficacy|62
7630116|NCT01682603|26546738|P1|Overall Study|Lost to Follow-up|3
7630117|NCT01682512|26546783|P3|Overall Study|Other than stated above|2
7630118|NCT01682512|26546784|P2|Overall Study|Other than stated above|4
7630119|NCT01682512|26546785|P1|Overall Study|Other than stated above|2
7630120|NCT01682512|26546783|P3|Overall Study|Secondary lack of efficacy|0
7630121|NCT01682512|26546784|P2|Overall Study|Secondary lack of efficacy|1
7630122|NCT01682512|26546785|P1|Overall Study|Secondary lack of efficacy|1
7630123|NCT01682512|26546783|P3|Overall Study|Primary lack of efficacy|7
7630124|NCT01682512|26546784|P2|Overall Study|Primary lack of efficacy|7
7630125|NCT01682512|26546785|P1|Overall Study|Primary lack of efficacy|10
7630126|NCT01682512|26546783|P3|Overall Study|Protocol Violation|2
7630127|NCT01682512|26546784|P2|Overall Study|Protocol Violation|3
7630128|NCT01682512|26546785|P1|Overall Study|Protocol Violation|2
7630129|NCT01682512|26546783|P3|Overall Study|Lost to Follow-up|2
7630130|NCT01682512|26546784|P2|Overall Study|Lost to Follow-up|0
7630131|NCT01682512|26546785|P1|Overall Study|Lost to Follow-up|3
7630132|NCT01682512|26546783|P3|Overall Study|Study terminated by sponsor|0
7630133|NCT01682512|26546784|P2|Overall Study|Study terminated by sponsor|43
7630134|NCT01682512|26546785|P1|Overall Study|Study terminated by sponsor|46
7630135|NCT01682512|26546783|P3|Overall Study|Physician Decision|0
7630136|NCT01682512|26546784|P2|Overall Study|Physician Decision|2
7630137|NCT01682512|26546785|P1|Overall Study|Physician Decision|0
7630138|NCT01682512|26546783|P3|Overall Study|Withdrawal by Subject|3
7630139|NCT01682512|26546784|P2|Overall Study|Withdrawal by Subject|6
7630140|NCT01682512|26546785|P1|Overall Study|Withdrawal by Subject|2
7630141|NCT01682512|26546783|P3|Overall Study|Adverse Event|2
7630142|NCT01682512|26546784|P2|Overall Study|Adverse Event|5
7630143|NCT01682512|26546785|P1|Overall Study|Adverse Event|6
7630144|NCT01682460|26546810|P1|Overall Study|Did not meet inclusion criteria|2
7630145|NCT01682460|26546810|P1|Overall Study|Withdrawal by Subject|2
7630146|NCT01682213|26546825|P1|Overall Study|Withdrawal by Subject|2
7630147|NCT01682148|26546833|P2|Overall Study|Protocol Violation|1
7630148|NCT01682148|26546834|P1|Overall Study|Protocol Violation|1
7630149|NCT01682148|26546833|P2|Overall Study|Lost to Follow-up|2
7630150|NCT01682148|26546834|P1|Overall Study|Lost to Follow-up|1
7630151|NCT01682148|26546833|P2|Overall Study|Withdrawal by Subject|0
7630152|NCT01682148|26546834|P1|Overall Study|Withdrawal by Subject|2
7630153|NCT01682083|26546894|P2|Overall Study|Physician Decision|4
7630154|NCT01682083|26546895|P1|Overall Study|Physician Decision|5
7630155|NCT01682083|26546894|P2|Overall Study|Death|93
7630156|NCT01682083|26546895|P1|Overall Study|Death|60
7630157|NCT01682083|26546894|P2|Overall Study|Withdrawal by Subject|40
7630158|NCT01682083|26546895|P1|Overall Study|Withdrawal by Subject|31
7630159|NCT01682083|26546894|P2|Overall Study|Lost to Follow-up|18
7630160|NCT01682083|26546895|P1|Overall Study|Lost to Follow-up|11
7630161|NCT01682044|26546907|P1|Overall Study|Progression|3
7630162|NCT01682044|26546907|P1|Overall Study|Death|1
7630163|NCT01682031|26546919|P2|Overall Study|Patient stopped selenium on his own|1
7630164|NCT01682031|26546920|P1|Overall Study|Patient stopped selenium on his own|0
7630165|NCT01682031|26546919|P2|Overall Study|Patient could not swallow tablets|0
7630166|NCT01682031|26546920|P1|Overall Study|Patient could not swallow tablets|1
7630167|NCT01682031|26546919|P2|Overall Study|MRI results indicate increased nodul|1
7630168|NCT01682031|26546920|P1|Overall Study|MRI results indicate increased nodul|0
7630169|NCT01682031|26546919|P2|Overall Study|Adverse Event|2
7630170|NCT01682031|26546920|P1|Overall Study|Adverse Event|0
7630171|NCT01682031|26546919|P2|Overall Study|Withdrawal by Subject|1
7630172|NCT01682031|26546920|P1|Overall Study|Withdrawal by Subject|0
7630173|NCT01681992|26546943|P3|Overall Study|Withdrawal by Subject|25
7630174|NCT01681992|26546944|P2|Overall Study|Withdrawal by Subject|30
7630175|NCT01681992|26546945|P1|Overall Study|Withdrawal by Subject|27
7630176|NCT01681992|26546943|P3|Overall Study|Protocol Violation|1
7630177|NCT01681992|26546944|P2|Overall Study|Protocol Violation|0
7630178|NCT01681992|26546945|P1|Overall Study|Protocol Violation|0
7630179|NCT01681992|26546943|P3|Overall Study|As Per Sponsor Decision|1
7630180|NCT01681992|26546944|P2|Overall Study|As Per Sponsor Decision|0
7630181|NCT01681992|26546945|P1|Overall Study|As Per Sponsor Decision|0
7630182|NCT01681992|26546943|P3|Overall Study|Lost to Follow-up|53
7630183|NCT01681992|26546944|P2|Overall Study|Lost to Follow-up|38
7630184|NCT01681992|26546945|P1|Overall Study|Lost to Follow-up|36
7630185|NCT01681992|26546943|P3|Overall Study|Adverse Event|3
7630186|NCT01681992|26546944|P2|Overall Study|Adverse Event|2
7630187|NCT01681992|26546945|P1|Overall Study|Adverse Event|3
7630188|NCT01681849|26547034|P3|Overall Study|Lost to Follow-up|6
7630189|NCT01681849|26547035|P2|Overall Study|Lost to Follow-up|2
7630190|NCT01681849|26547036|P1|Overall Study|Lost to Follow-up|3
7630191|NCT01681849|26547034|P3|Overall Study|Withdrawal by Subject|33
7630192|NCT01681849|26547035|P2|Overall Study|Withdrawal by Subject|5
7630193|NCT01681849|26547036|P1|Overall Study|Withdrawal by Subject|3
7630194|NCT01681849|26547034|P3|Overall Study|Protocol Violation|0
7630195|NCT01681849|26547035|P2|Overall Study|Protocol Violation|0
7630196|NCT01681849|26547036|P1|Overall Study|Protocol Violation|2
7630197|NCT01681836|26547045|P2|Second Intervention|Withdrawal by Subject|1
7630198|NCT01681836|26547046|P1|Second Intervention|Withdrawal by Subject|0
7630199|NCT01681771|26547080|P2|Overall Study|Lost to Follow-up|2
7630200|NCT01681771|26547081|P1|Overall Study|Lost to Follow-up|4
7630201|NCT01681628|26547094|P2|19 Months Follow-up|Lost to Follow-up|43
7630202|NCT01681628|26547095|P1|19 Months Follow-up|Lost to Follow-up|61
7630203|NCT01681628|26547094|P2|19 Months Follow-up|Death|0
7630204|NCT01681628|26547095|P1|19 Months Follow-up|Death|1
7630205|NCT01681628|26547094|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
7630206|NCT01681628|26547095|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
7630207|NCT01681628|26547094|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
7630208|NCT01681628|26547095|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
7630209|NCT01681576|26547124|P2|Period 2|Non-compliance with study treatment|0
7630210|NCT01681576|26547125|P1|Period 2|Non-compliance with study treatment|1
7630211|NCT01681576|26547124|P2|Period 2|subject/guardian decision|1
7630212|NCT01681576|26547125|P1|Period 2|subject/guardian decision|3
7630213|NCT01681576|26547124|P2|Period 1|Protocol Deviation|0
7630214|NCT01681576|26547125|P1|Period 1|Protocol Deviation|1
7630215|NCT01681576|26547124|P2|Period 1|Adverse Event|0
7630216|NCT01681576|26547125|P1|Period 1|Adverse Event|1
7630217|NCT01681511|26547141|P2|Overall Study|No post-catheter sample collected|4
7630218|NCT01681511|26547142|P1|Overall Study|No post-catheter sample collected|11
7630219|NCT01681511|26547141|P2|Overall Study|No Daily Urine Sample Collected|1
7630220|NCT01681511|26547142|P1|Overall Study|No Daily Urine Sample Collected|0
7630221|NCT01681511|26547141|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
7630222|NCT01681511|26547142|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
7630223|NCT01681511|26547141|P2|Overall Study|Failed Inclusion/Exclusion|0
7630224|NCT01681511|26547142|P1|Overall Study|Failed Inclusion/Exclusion|3
7630225|NCT01681511|26547141|P2|Overall Study|No Treatment Received|3
7630226|NCT01681511|26547142|P1|Overall Study|No Treatment Received|1
7630227|NCT01681472|26547160|P4|Overall Study|Adverse Event|0
7630228|NCT01681472|26547161|P3|Overall Study|Adverse Event|0
7630229|NCT01681472|26547162|P2|Overall Study|Adverse Event|1
7630230|NCT01681472|26547163|P1|Overall Study|Adverse Event|0
7630231|NCT01681433|26547343|P2|Overall Study|Lost to Follow-up|1
7630232|NCT01681433|26547344|P1|Overall Study|Lost to Follow-up|0
7630233|NCT01681433|26547343|P2|Overall Study|Adverse Event|4
7630234|NCT01681433|26547344|P1|Overall Study|Adverse Event|2
7630235|NCT01681433|26547343|P2|Overall Study|Protocol Violation|0
7630236|NCT01681433|26547344|P1|Overall Study|Protocol Violation|2
7630237|NCT01681433|26547343|P2|Overall Study|Withdrawal by Subject|5
7630238|NCT01681433|26547344|P1|Overall Study|Withdrawal by Subject|5
7630239|NCT01681433|26547343|P2|Overall Study|Lack of Efficacy|23
7630240|NCT01681433|26547344|P1|Overall Study|Lack of Efficacy|23
7630241|NCT01681368|26547362|P1|Overall Study|Refused further follow up|1
7630242|NCT01681368|26547362|P1|Overall Study|Refused further treatment|1
7630243|NCT01681277|26547379|P5|Overall Study|Adverse Event|0
7630244|NCT01681277|26547380|P4|Overall Study|Adverse Event|0
7630245|NCT01681277|26547381|P3|Overall Study|Adverse Event|0
7630246|NCT01681277|26547382|P2|Overall Study|Adverse Event|0
7630247|NCT01681277|26547383|P1|Overall Study|Adverse Event|1
7630248|NCT01681212|26547424|P1|Overall Study|Administrative reason by sponsor|1
7630249|NCT01681212|26547424|P1|Overall Study|No longer met study criteria|5
7630250|NCT01681186|26547438|P8|Fourth Intervention|Protocol Violation|1
7630251|NCT01681186|26547439|P7|Fourth Intervention|Protocol Violation|0
7630252|NCT01681186|26547440|P6|Fourth Intervention|Protocol Violation|0
7630253|NCT01681186|26547441|P5|Fourth Intervention|Protocol Violation|0
7630254|NCT01681186|26547442|P4|Fourth Intervention|Protocol Violation|0
7630255|NCT01681186|26547443|P3|Fourth Intervention|Protocol Violation|0
7630256|NCT01681186|26547444|P2|Fourth Intervention|Protocol Violation|0
7630257|NCT01681186|26547445|P1|Fourth Intervention|Protocol Violation|0
7630258|NCT01681186|26547438|P8|Washout Period From Third Intervention|Lost to Follow-up|0
7630259|NCT01681186|26547439|P7|Washout Period From Third Intervention|Lost to Follow-up|1
7630260|NCT01681186|26547440|P6|Washout Period From Third Intervention|Lost to Follow-up|0
7630261|NCT01681186|26547441|P5|Washout Period From Third Intervention|Lost to Follow-up|0
7630262|NCT01681186|26547442|P4|Washout Period From Third Intervention|Lost to Follow-up|0
7630263|NCT01681186|26547443|P3|Washout Period From Third Intervention|Lost to Follow-up|0
7630264|NCT01681186|26547444|P2|Washout Period From Third Intervention|Lost to Follow-up|0
7630265|NCT01681186|26547445|P1|Washout Period From Third Intervention|Lost to Follow-up|0
7630266|NCT01681186|26547438|P8|Washout Period From Second Intervention|Protocol Violation|1
7630267|NCT01681186|26547439|P7|Washout Period From Second Intervention|Protocol Violation|0
7630268|NCT01681186|26547440|P6|Washout Period From Second Intervention|Protocol Violation|0
7630269|NCT01681186|26547441|P5|Washout Period From Second Intervention|Protocol Violation|0
7630270|NCT01681186|26547442|P4|Washout Period From Second Intervention|Protocol Violation|0
7630271|NCT01681186|26547443|P3|Washout Period From Second Intervention|Protocol Violation|0
7630272|NCT01681186|26547444|P2|Washout Period From Second Intervention|Protocol Violation|0
7630273|NCT01681186|26547445|P1|Washout Period From Second Intervention|Protocol Violation|0
7630274|NCT01681186|26547438|P8|Washout Period From Second Intervention|Adverse Event|0
7630275|NCT01681186|26547439|P7|Washout Period From Second Intervention|Adverse Event|1
7630276|NCT01681186|26547440|P6|Washout Period From Second Intervention|Adverse Event|0
7630277|NCT01681186|26547441|P5|Washout Period From Second Intervention|Adverse Event|0
7630278|NCT01681186|26547442|P4|Washout Period From Second Intervention|Adverse Event|0
7630279|NCT01681186|26547443|P3|Washout Period From Second Intervention|Adverse Event|0
7630280|NCT01681186|26547444|P2|Washout Period From Second Intervention|Adverse Event|0
7630281|NCT01681186|26547445|P1|Washout Period From Second Intervention|Adverse Event|0
7630282|NCT01681069|26547566|P2|Overall Study|Adverse Event|1
7630283|NCT01681069|26547567|P1|Overall Study|Adverse Event|0
7630284|NCT01681069|26547566|P2|Overall Study|Protocol Violation|1
7630285|NCT01681069|26547567|P1|Overall Study|Protocol Violation|1
7630286|NCT01681069|26547566|P2|Overall Study|Withdrawal by Subject|5
7630287|NCT01681069|26547567|P1|Overall Study|Withdrawal by Subject|4
7630288|NCT01681004|26547604|P2|Study Completion|Death|1
7630289|NCT01681004|26547605|P1|Study Completion|Death|1
7630290|NCT01681004|26547604|P2|Study Completion|Site Termination|1
7630291|NCT01681004|26547605|P1|Study Completion|Site Termination|2
7630292|NCT01681004|26547604|P2|Study Completion|Physician Decision|3
7630293|NCT01681004|26547605|P1|Study Completion|Physician Decision|1
7630294|NCT01681004|26547604|P2|Study Completion|Lost to Follow-up|3
7630295|NCT01681004|26547605|P1|Study Completion|Lost to Follow-up|8
7630296|NCT01681004|26547604|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
7630297|NCT01681004|26547605|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
7630298|NCT01680991|26547662|P3|Overall Study|PD confirmed in other hospital|0
7630299|NCT01680991|26547663|P2|Overall Study|PD confirmed in other hospital|0
7630300|NCT01680991|26547664|P1|Overall Study|PD confirmed in other hospital|1
7630301|NCT01680991|26547662|P3|Overall Study|Bad physical condition|1
7630302|NCT01680991|26547663|P2|Overall Study|Bad physical condition|0
7630303|NCT01680991|26547664|P1|Overall Study|Bad physical condition|0
7630304|NCT01680991|26547662|P3|Overall Study|Physician Decision|2
7630305|NCT01680991|26547663|P2|Overall Study|Physician Decision|7
7630306|NCT01680991|26547664|P1|Overall Study|Physician Decision|0
7630307|NCT01680991|26547662|P3|Overall Study|Progressive disease (PD)|0
7630308|NCT01680991|26547663|P2|Overall Study|Progressive disease (PD)|10
7630309|NCT01680991|26547664|P1|Overall Study|Progressive disease (PD)|0
7630310|NCT01680991|26547662|P3|Overall Study|Withdrawal by Subject|0
7630311|NCT01680991|26547663|P2|Overall Study|Withdrawal by Subject|1
7630312|NCT01680991|26547664|P1|Overall Study|Withdrawal by Subject|5
7630313|NCT01680991|26547662|P3|Overall Study|Protocol Violation|0
7630314|NCT01680991|26547663|P2|Overall Study|Protocol Violation|1
7630315|NCT01680991|26547664|P1|Overall Study|Protocol Violation|0
7630316|NCT01680991|26547662|P3|Overall Study|Death|1
7630317|NCT01680991|26547663|P2|Overall Study|Death|0
7630318|NCT01680991|26547664|P1|Overall Study|Death|1
7630319|NCT01680991|26547662|P3|Overall Study|Adverse Event|0
7630320|NCT01680991|26547663|P2|Overall Study|Adverse Event|0
7630321|NCT01680991|26547664|P1|Overall Study|Adverse Event|1
7630322|NCT01680965|26547727|P4|Overall Study|Death|6
7630323|NCT01680965|26547728|P3|Overall Study|Death|0
7630324|NCT01680965|26547729|P2|Overall Study|Death|0
7630325|NCT01680965|26547730|P1|Overall Study|Death|0
7630326|NCT01680861|26547771|P2|Early Post-transplant Period|Protocol Violation|1
7630327|NCT01680861|26547772|P1|Early Post-transplant Period|Protocol Violation|1
7630328|NCT01680497|26547884|P1|Overall Study|Lost to Follow-up|2
7630329|NCT01680458|26547894|P1|Overall Study|Protocol Violation|3
7630330|NCT01680341|26547905|P2|Overall Study|Unclassified|15
7630331|NCT01680341|26547906|P1|Overall Study|Unclassified|18
7630332|NCT01680341|26547905|P2|Overall Study|Adverse Event|2
7630333|NCT01680341|26547906|P1|Overall Study|Adverse Event|3
7630334|NCT01680159|26547977|P1|Increased Dose Period|Withdrawal by Subject|2
7630335|NCT01680159|26547977|P1|Increased Dose Period|Adverse Event|6
7630336|NCT01680159|26547977|P1|Screening Period|Not meet criteria for dose-up period|7
7630337|NCT01680016|26548004|P4|Overall Study|Withdrawal by Subject|1
7630338|NCT01680016|26548005|P3|Overall Study|Withdrawal by Subject|1
7630339|NCT01680016|26548006|P2|Overall Study|Withdrawal by Subject|7
7630340|NCT01680016|26548007|P1|Overall Study|Withdrawal by Subject|5
7630341|NCT01680016|26548004|P4|Overall Study|Protocol Violation|0
7630342|NCT01680016|26548005|P3|Overall Study|Protocol Violation|0
7630343|NCT01680016|26548006|P2|Overall Study|Protocol Violation|1
7630344|NCT01680016|26548007|P1|Overall Study|Protocol Violation|0
7630345|NCT01680016|26548004|P4|Overall Study|The Subject went out of The Trial|0
7630346|NCT01680016|26548005|P3|Overall Study|The Subject went out of The Trial|3
7630347|NCT01680016|26548006|P2|Overall Study|The Subject went out of The Trial|0
7630348|NCT01680016|26548007|P1|Overall Study|The Subject went out of The Trial|1
7630349|NCT01680016|26548004|P4|Overall Study|Adverse Event|4
7630350|NCT01680016|26548005|P3|Overall Study|Adverse Event|1
7630351|NCT01680016|26548006|P2|Overall Study|Adverse Event|0
7630352|NCT01680016|26548007|P1|Overall Study|Adverse Event|0
7630353|NCT01679613|26548069|P4|Overall Study|other than stated above|2
7630354|NCT01679613|26548070|P3|Overall Study|other than stated above|2
7630355|NCT01679613|26548071|P2|Overall Study|other than stated above|1
7630356|NCT01679613|26548072|P1|Overall Study|other than stated above|0
7630357|NCT01679405|26548094|P2|Overall Study|Death|5
7630358|NCT01679405|26548095|P1|Overall Study|Death|2
7630359|NCT01679301|26548130|P3|Screening Period|screen failure|0
7630360|NCT01679301|26548131|P2|Screening Period|screen failure|0
7630361|NCT01679301|26548132|P1|Screening Period|screen failure|3
7630362|NCT01679236|26548140|P2|Overall Study|Lost to Follow-up|15
7630363|NCT01679236|26548141|P1|Overall Study|Lost to Follow-up|15
7630364|NCT01679002|26548188|P3|Overall Study|Adverse Event|0
7630365|NCT01679002|26548189|P2|Overall Study|Adverse Event|1
7630366|NCT01679002|26548190|P1|Overall Study|Adverse Event|1
7630367|NCT01678924|26548221|P4|Overall Study|Unable to attend scheduled visits|1
7630368|NCT01678924|26548222|P3|Overall Study|Unable to attend scheduled visits|0
7630369|NCT01678924|26548223|P2|Overall Study|Unable to attend scheduled visits|0
7630370|NCT01678924|26548224|P1|Overall Study|Unable to attend scheduled visits|0
7630371|NCT01678924|26548221|P4|Overall Study|Withdrawal by Subject|2
7630372|NCT01678924|26548222|P3|Overall Study|Withdrawal by Subject|0
7630373|NCT01678924|26548223|P2|Overall Study|Withdrawal by Subject|3
7630374|NCT01678924|26548224|P1|Overall Study|Withdrawal by Subject|0
7630375|NCT01678924|26548221|P4|Overall Study|Personal Reasons|7
7630376|NCT01678924|26548222|P3|Overall Study|Personal Reasons|2
7630377|NCT01678924|26548223|P2|Overall Study|Personal Reasons|2
7630378|NCT01678924|26548224|P1|Overall Study|Personal Reasons|2
7630379|NCT01678924|26548221|P4|Overall Study|Lost to Follow-up|2
7630380|NCT01678924|26548222|P3|Overall Study|Lost to Follow-up|0
7630381|NCT01678924|26548223|P2|Overall Study|Lost to Follow-up|4
7630382|NCT01678924|26548224|P1|Overall Study|Lost to Follow-up|0
7630383|NCT01678924|26548221|P4|Overall Study|Lack of Efficacy|5
7630384|NCT01678924|26548222|P3|Overall Study|Lack of Efficacy|0
7630385|NCT01678924|26548223|P2|Overall Study|Lack of Efficacy|2
7630386|NCT01678924|26548224|P1|Overall Study|Lack of Efficacy|7
7630387|NCT01678924|26548221|P4|Overall Study|Adverse Event|1
7630388|NCT01678924|26548222|P3|Overall Study|Adverse Event|0
7630389|NCT01678924|26548223|P2|Overall Study|Adverse Event|1
7630390|NCT01678924|26548224|P1|Overall Study|Adverse Event|1
7630391|NCT01678911|26548355|P2|Second Intervention|Lost to Follow-up|0
7630392|NCT01678911|26548356|P1|Second Intervention|Lost to Follow-up|2
7630393|NCT01678898|26548373|P3|PB-102-F01|Physician Decision|0
7630394|NCT01678898|26548374|P2|PB-102-F01|Physician Decision|1
7630395|NCT01678898|26548375|P1|PB-102-F01|Physician Decision|0
7630396|NCT01678898|26548373|P3|PB-102-F01|Adverse Event|0
7630397|NCT01678898|26548374|P2|PB-102-F01|Adverse Event|1
7630398|NCT01678898|26548375|P1|PB-102-F01|Adverse Event|0
7630399|NCT01678820|26548485|P3|Overall Study|Not treated with double-blind study drug|2
7630400|NCT01678820|26548486|P2|Overall Study|Not treated with double-blind study drug|2
7630401|NCT01678820|26548487|P1|Overall Study|Not treated with double-blind study drug|0
7630402|NCT01678820|26548485|P3|Overall Study|Protocol Violation|4
7630403|NCT01678820|26548486|P2|Overall Study|Protocol Violation|5
7630404|NCT01678820|26548487|P1|Overall Study|Protocol Violation|4
7630405|NCT01678820|26548485|P3|Overall Study|Physician Decision|1
7630406|NCT01678820|26548486|P2|Overall Study|Physician Decision|0
7630407|NCT01678820|26548487|P1|Overall Study|Physician Decision|0
7630408|NCT01678820|26548485|P3|Overall Study|Non-compliance with study drug|0
7630409|NCT01678820|26548486|P2|Overall Study|Non-compliance with study drug|1
7630410|NCT01678820|26548487|P1|Overall Study|Non-compliance with study drug|0
7630411|NCT01678820|26548485|P3|Overall Study|Lost to Follow-up|2
7630412|NCT01678820|26548486|P2|Overall Study|Lost to Follow-up|2
7630413|NCT01678820|26548487|P1|Overall Study|Lost to Follow-up|7
7630414|NCT01678820|26548485|P3|Overall Study|Adverse Event|2
7630415|NCT01678820|26548486|P2|Overall Study|Adverse Event|2
7630416|NCT01678820|26548487|P1|Overall Study|Adverse Event|2
7630417|NCT01678820|26548485|P3|Overall Study|Protocol Specified Criteria|1
7630418|NCT01678820|26548486|P2|Overall Study|Protocol Specified Criteria|3
7630419|NCT01678820|26548487|P1|Overall Study|Protocol Specified Criteria|2
7630420|NCT01678820|26548485|P3|Overall Study|Withdrawal by Subject|2
7630421|NCT01678820|26548486|P2|Overall Study|Withdrawal by Subject|5
7630422|NCT01678820|26548487|P1|Overall Study|Withdrawal by Subject|2
7630423|NCT01678820|26548485|P3|Overall Study|Study Terminated by Sponsor|43
7630424|NCT01678820|26548486|P2|Overall Study|Study Terminated by Sponsor|43
7630425|NCT01678820|26548487|P1|Overall Study|Study Terminated by Sponsor|45
7630426|NCT01678807|26548532|P3|Overall Study|Withdrawn by Parent/Guardian|0
7630427|NCT01678807|26548533|P2|Overall Study|Withdrawn by Parent/Guardian|1
7630428|NCT01678807|26548534|P1|Overall Study|Withdrawn by Parent/Guardian|0
7630429|NCT01678807|26548532|P3|Overall Study|Adverse Event|0
7630430|NCT01678807|26548533|P2|Overall Study|Adverse Event|4
7630431|NCT01678807|26548534|P1|Overall Study|Adverse Event|4
7630432|NCT01678560|26548547|P2|Overall Study|Withdrawal by Subject|1
7630433|NCT01678560|26548548|P1|Overall Study|Withdrawal by Subject|0
7630434|NCT01678560|26548547|P2|Overall Study|Death|1
7630435|NCT01678560|26548548|P1|Overall Study|Death|0
7630436|NCT01678560|26548547|P2|Overall Study|Physician Decision|4
7630437|NCT01678560|26548548|P1|Overall Study|Physician Decision|4
7630438|NCT01678313|26548572|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
7630439|NCT01678313|26548573|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
7630440|NCT01678313|26548572|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
7630441|NCT01678313|26548573|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
7630442|NCT01678313|26548572|P2|Completed the 3-month Therapy|Physician Decision|4
7630443|NCT01678313|26548573|P1|Completed the 3-month Therapy|Physician Decision|3
7630444|NCT01678313|26548572|P2|Completed the 3-month Therapy|Lost to Follow-up|8
7630445|NCT01678313|26548573|P1|Completed the 3-month Therapy|Lost to Follow-up|3
7630446|NCT01678209|26548592|P3|Overall Study|screen fail|16
7630447|NCT01678209|26548593|P2|Overall Study|screen fail|17
7630448|NCT01678209|26548594|P1|Overall Study|screen fail|16
7630449|NCT01678209|26548592|P3|Overall Study|scheduling conflicts|1
7630450|NCT01678209|26548593|P2|Overall Study|scheduling conflicts|0
7630451|NCT01678209|26548594|P1|Overall Study|scheduling conflicts|0
7630452|NCT01678209|26548592|P3|Overall Study|could not scan twice|1
7630453|NCT01678209|26548593|P2|Overall Study|could not scan twice|1
7630454|NCT01678209|26548594|P1|Overall Study|could not scan twice|1
7630455|NCT01678144|26548635|P1|Stage 1: MAR Classic|Adverse Event|1
7630456|NCT01678131|26548654|P3|Overall Study|Withdrawal by Subject|2
7630457|NCT01678131|26548655|P2|Overall Study|Withdrawal by Subject|0
7630458|NCT01678131|26548656|P1|Overall Study|Withdrawal by Subject|0
7630459|NCT01678131|26548654|P3|Overall Study|Adverse Event|0
7630460|NCT01678131|26548655|P2|Overall Study|Adverse Event|1
7630461|NCT01678131|26548656|P1|Overall Study|Adverse Event|0
7630462|NCT01677988|26548664|P1|Overall Study|Lack of Efficacy|2
7630463|NCT01677936|26548677|P2|Overall Study|Protocol Violation|4
7630464|NCT01677936|26548678|P1|Overall Study|Protocol Violation|0
7630465|NCT01677936|26548677|P2|Overall Study|Lost to Follow-up|0
7630466|NCT01677936|26548678|P1|Overall Study|Lost to Follow-up|1
7630467|NCT01677936|26548677|P2|Overall Study|Adverse Event|0
7630468|NCT01677936|26548678|P1|Overall Study|Adverse Event|1
7630469|NCT01677936|26548677|P2|Overall Study|Protocol Violation|0
7630470|NCT01677936|26548678|P1|Overall Study|Protocol Violation|3
7630471|NCT01677936|26548677|P2|Overall Study|Lost to Follow-up|1
7630472|NCT01677936|26548678|P1|Overall Study|Lost to Follow-up|4
7630473|NCT01677910|26548689|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
7630474|NCT01677910|26548690|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7630475|NCT01677910|26548691|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7630476|NCT01677910|26548692|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7630477|NCT01677910|26548689|P4|Open-Label Extension Period (OLE)|Adverse Event|15
7630478|NCT01677910|26548690|P3|Open-Label Extension Period (OLE)|Adverse Event|0
7630479|NCT01677910|26548691|P2|Open-Label Extension Period (OLE)|Adverse Event|0
7630480|NCT01677910|26548692|P1|Open-Label Extension Period (OLE)|Adverse Event|0
7630481|NCT01677910|26548689|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
7630482|NCT01677910|26548690|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7630483|NCT01677910|26548691|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7630484|NCT01677910|26548692|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7630485|NCT01677910|26548689|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7630486|NCT01677910|26548690|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7630487|NCT01677910|26548691|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7630488|NCT01677910|26548692|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7630489|NCT01677910|26548689|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
7630490|NCT01677910|26548690|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
7630491|NCT01677910|26548691|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
7630492|NCT01677910|26548692|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
7630493|NCT01677910|26548689|P4|Open-Label Extension Period (OLE)|Physician Decision|4
7630494|NCT01677910|26548690|P3|Open-Label Extension Period (OLE)|Physician Decision|0
7630495|NCT01677910|26548691|P2|Open-Label Extension Period (OLE)|Physician Decision|0
7630496|NCT01677910|26548692|P1|Open-Label Extension Period (OLE)|Physician Decision|0
7630497|NCT01677910|26548689|P4|Double-Blind Treatment Period|Reason Not Specified|0
7630498|NCT01677910|26548690|P3|Double-Blind Treatment Period|Reason Not Specified|0
7630499|NCT01677910|26548691|P2|Double-Blind Treatment Period|Reason Not Specified|1
7630500|NCT01677910|26548692|P1|Double-Blind Treatment Period|Reason Not Specified|0
7630501|NCT01677910|26548689|P4|Double-Blind Treatment Period|Withdrawal of consent|0
7630502|NCT01677910|26548690|P3|Double-Blind Treatment Period|Withdrawal of consent|3
7630503|NCT01677910|26548691|P2|Double-Blind Treatment Period|Withdrawal of consent|0
7630504|NCT01677910|26548692|P1|Double-Blind Treatment Period|Withdrawal of consent|1
7630505|NCT01677910|26548689|P4|Double-Blind Treatment Period|Physician Decision|0
7630506|NCT01677910|26548690|P3|Double-Blind Treatment Period|Physician Decision|1
7630507|NCT01677910|26548691|P2|Double-Blind Treatment Period|Physician Decision|0
7630508|NCT01677910|26548692|P1|Double-Blind Treatment Period|Physician Decision|0
7630509|NCT01677910|26548689|P4|Double-Blind Treatment Period|Adverse Event|0
7630510|NCT01677910|26548690|P3|Double-Blind Treatment Period|Adverse Event|3
7630511|NCT01677910|26548691|P2|Double-Blind Treatment Period|Adverse Event|2
7630512|NCT01677910|26548692|P1|Double-Blind Treatment Period|Adverse Event|6
7630513|NCT01677858|26548719|P5|Overall Study|Lost to Follow-up|1
7630514|NCT01677858|26548720|P4|Overall Study|Lost to Follow-up|0
7630515|NCT01677858|26548721|P3|Overall Study|Lost to Follow-up|0
7630516|NCT01677858|26548722|P2|Overall Study|Lost to Follow-up|0
7630517|NCT01677858|26548723|P1|Overall Study|Lost to Follow-up|0
7630518|NCT01677858|26548719|P5|Overall Study|Withdrawal by Subject|15
7630519|NCT01677858|26548720|P4|Overall Study|Withdrawal by Subject|0
7630520|NCT01677858|26548721|P3|Overall Study|Withdrawal by Subject|1
7630521|NCT01677858|26548722|P2|Overall Study|Withdrawal by Subject|1
7630522|NCT01677858|26548723|P1|Overall Study|Withdrawal by Subject|0
7630523|NCT01677858|26548719|P5|Overall Study|Progressive Disease|43
7630524|NCT01677858|26548720|P4|Overall Study|Progressive Disease|3
7630525|NCT01677858|26548721|P3|Overall Study|Progressive Disease|9
7630526|NCT01677858|26548722|P2|Overall Study|Progressive Disease|1
7630527|NCT01677858|26548723|P1|Overall Study|Progressive Disease|2
7630528|NCT01677858|26548719|P5|Overall Study|Physician Decision|12
7630529|NCT01677858|26548720|P4|Overall Study|Physician Decision|0
7630530|NCT01677858|26548721|P3|Overall Study|Physician Decision|2
7630531|NCT01677858|26548722|P2|Overall Study|Physician Decision|0
7630532|NCT01677858|26548723|P1|Overall Study|Physician Decision|1
7630533|NCT01677858|26548719|P5|Overall Study|Death|1
7630534|NCT01677858|26548720|P4|Overall Study|Death|0
7630535|NCT01677858|26548721|P3|Overall Study|Death|0
7630536|NCT01677858|26548722|P2|Overall Study|Death|0
7630537|NCT01677858|26548723|P1|Overall Study|Death|0
7630538|NCT01677858|26548719|P5|Overall Study|Adverse Event|13
7630539|NCT01677858|26548720|P4|Overall Study|Adverse Event|3
7630540|NCT01677858|26548721|P3|Overall Study|Adverse Event|2
7630541|NCT01677858|26548722|P2|Overall Study|Adverse Event|0
7630542|NCT01677858|26548723|P1|Overall Study|Adverse Event|0
7630543|NCT01677767|26548796|P1|Overall Study|Non-compliance by the participants|3
7630544|NCT01677767|26548796|P1|Overall Study|Withdrawal by Subject|10
7630545|NCT01677767|26548796|P1|Overall Study|Protocol Violation|4
7630546|NCT01677767|26548796|P1|Overall Study|Death|4
7630547|NCT01677767|26548796|P1|Overall Study|Adverse Event|1
7630548|NCT01677624|26548810|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
7630549|NCT01677507|26548815|P2|Second Assigment|Adverse Event|3
7630550|NCT01677507|26548816|P1|Second Assigment|Adverse Event|1
7630551|NCT01677507|26548815|P2|Second Assigment|Withdrawal by Subject|2
7630552|NCT01677507|26548816|P1|Second Assigment|Withdrawal by Subject|2
7630553|NCT01677507|26548815|P2|Initial Assignment|Protocol Violation|1
7630554|NCT01677507|26548816|P1|Initial Assignment|Protocol Violation|0
7630555|NCT01677507|26548815|P2|Initial Assignment|Adverse Event|1
7630556|NCT01677507|26548816|P1|Initial Assignment|Adverse Event|0
7630557|NCT01677377|26548829|P3|Overall Study|Pregnancy|1
7630558|NCT01677377|26548830|P2|Overall Study|Pregnancy|0
7630559|NCT01677377|26548831|P1|Overall Study|Pregnancy|0
7630560|NCT01677377|26548829|P3|Overall Study|Lack of Efficacy|1
7630561|NCT01677377|26548830|P2|Overall Study|Lack of Efficacy|0
7630562|NCT01677377|26548831|P1|Overall Study|Lack of Efficacy|0
7630563|NCT01677377|26548829|P3|Overall Study|Withdrawal by Subject|3
7630564|NCT01677377|26548830|P2|Overall Study|Withdrawal by Subject|0
7630565|NCT01677377|26548831|P1|Overall Study|Withdrawal by Subject|0
7630566|NCT01677377|26548829|P3|Overall Study|Lost to Follow-up|1
7630567|NCT01677377|26548830|P2|Overall Study|Lost to Follow-up|1
7630568|NCT01677377|26548831|P1|Overall Study|Lost to Follow-up|0
7630569|NCT01677377|26548829|P3|Overall Study|Protocol Violation|0
7630570|NCT01677377|26548830|P2|Overall Study|Protocol Violation|0
7630571|NCT01677377|26548831|P1|Overall Study|Protocol Violation|1
7630572|NCT01677299|26549047|P4|Overall Study|Withdrawal by Subject|1
7630573|NCT01677299|26549048|P3|Overall Study|Withdrawal by Subject|0
7630574|NCT01677299|26549049|P2|Overall Study|Withdrawal by Subject|1
7630575|NCT01677299|26549050|P1|Overall Study|Withdrawal by Subject|0
7630576|NCT01677299|26549047|P4|Overall Study|Adverse Event|0
7630577|NCT01677299|26549048|P3|Overall Study|Adverse Event|1
7630578|NCT01677299|26549049|P2|Overall Study|Adverse Event|2
7630579|NCT01677299|26549050|P1|Overall Study|Adverse Event|0
7630580|NCT01677195|26549082|P3|Overall Study|Protocol Violation|4
7630581|NCT01677195|26549083|P2|Overall Study|Protocol Violation|3
7630582|NCT01677195|26549084|P1|Overall Study|Protocol Violation|7
7630583|NCT01677195|26549082|P3|Overall Study|Pregnancy|0
7630584|NCT01677195|26549083|P2|Overall Study|Pregnancy|1
7630585|NCT01677195|26549084|P1|Overall Study|Pregnancy|0
7630586|NCT01677195|26549082|P3|Overall Study|Physician Decision|2
7630587|NCT01677195|26549083|P2|Overall Study|Physician Decision|2
7630588|NCT01677195|26549084|P1|Overall Study|Physician Decision|1
7630589|NCT01677195|26549082|P3|Overall Study|Adverse Event|1
7630590|NCT01677195|26549083|P2|Overall Study|Adverse Event|4
7630591|NCT01677195|26549084|P1|Overall Study|Adverse Event|6
7630592|NCT01677195|26549082|P3|Overall Study|Withdrawal by Subject|1
7630593|NCT01677195|26549083|P2|Overall Study|Withdrawal by Subject|0
7630594|NCT01677195|26549084|P1|Overall Study|Withdrawal by Subject|1
7630595|NCT01677195|26549082|P3|Overall Study|Lost to Follow-up|22
7630596|NCT01677195|26549083|P2|Overall Study|Lost to Follow-up|22
7630597|NCT01677195|26549084|P1|Overall Study|Lost to Follow-up|14
7630598|NCT01677182|26549095|P3|Overall Study|Other reasons|2
7630599|NCT01677182|26549096|P2|Overall Study|Other reasons|5
7630600|NCT01677182|26549097|P1|Overall Study|Other reasons|1
7630601|NCT01677182|26549095|P3|Overall Study|Lack of Efficacy|1
7630602|NCT01677182|26549096|P2|Overall Study|Lack of Efficacy|0
7630603|NCT01677182|26549097|P1|Overall Study|Lack of Efficacy|3
7630604|NCT01677182|26549095|P3|Overall Study|Study termination|11
7630605|NCT01677182|26549096|P2|Overall Study|Study termination|9
7630606|NCT01677182|26549097|P1|Overall Study|Study termination|12
7630607|NCT01677182|26549095|P3|Overall Study|Withdrawal by Subject|10
7630608|NCT01677182|26549096|P2|Overall Study|Withdrawal by Subject|12
7630609|NCT01677182|26549097|P1|Overall Study|Withdrawal by Subject|7
7630610|NCT01677182|26549095|P3|Overall Study|Lost to Follow-up|3
7630611|NCT01677182|26549096|P2|Overall Study|Lost to Follow-up|0
7630612|NCT01677182|26549097|P1|Overall Study|Lost to Follow-up|4
7630613|NCT01677182|26549095|P3|Overall Study|Protocol Violation|4
7630614|NCT01677182|26549096|P2|Overall Study|Protocol Violation|1
7630615|NCT01677182|26549097|P1|Overall Study|Protocol Violation|5
7630616|NCT01677182|26549095|P3|Overall Study|Adverse Event|8
7630617|NCT01677182|26549096|P2|Overall Study|Adverse Event|1
7630618|NCT01677182|26549097|P1|Overall Study|Adverse Event|2
7630619|NCT01676961|26549129|P1|Overall Study|Withdrawal by Subject|1
7630620|NCT01676961|26549129|P1|Overall Study|Lost to Follow-up|1
7630621|NCT01676961|26549129|P1|Overall Study|Death|3
7630622|NCT01676909|26549136|P2|Overall Study|Lost to Follow-up|9
7630623|NCT01676909|26549137|P1|Overall Study|Lost to Follow-up|15
7630624|NCT01676909|26549136|P2|Overall Study|Withdrawal by Subject|5
7630625|NCT01676909|26549137|P1|Overall Study|Withdrawal by Subject|3
7630626|NCT01676896|26549202|P3|Overall Study|Withdrawal by Subject|19
7630627|NCT01676896|26549203|P2|Overall Study|Withdrawal by Subject|7
7630628|NCT01676896|26549204|P1|Overall Study|Withdrawal by Subject|12
7630629|NCT01676727|26549312|P1|Overall Study|Valve explanted|1
7630630|NCT01676727|26549312|P1|Overall Study|Not willing to attend 1-year visit|2
7630631|NCT01676727|26549312|P1|Overall Study|Screening failure|5
7630632|NCT01676727|26549312|P1|Overall Study|Withdrawal by Subject|6
7630633|NCT01676727|26549312|P1|Overall Study|Death|18
7630634|NCT01676701|26549326|P2|Overall Study|Sponsor Decision|4
7630635|NCT01676701|26549327|P1|Overall Study|Sponsor Decision|3
7630636|NCT01676701|26549326|P2|Overall Study|Protocol Violation|0
7630637|NCT01676701|26549327|P1|Overall Study|Protocol Violation|1
7630638|NCT01676220|26549429|P2|Overall Study|No More Need of Insulin|0
7630639|NCT01676220|26549430|P1|Overall Study|No More Need of Insulin|1
7630640|NCT01676220|26549429|P2|Overall Study|Non Serious Hypoglycemia|0
7630641|NCT01676220|26549430|P1|Overall Study|Non Serious Hypoglycemia|2
7630642|NCT01676220|26549429|P2|Overall Study|Perceived Lack of Efficacy|1
7630643|NCT01676220|26549430|P1|Overall Study|Perceived Lack of Efficacy|3
7630644|NCT01676220|26549429|P2|Overall Study|Site Closure/Site Withdrawal|4
7630645|NCT01676220|26549430|P1|Overall Study|Site Closure/Site Withdrawal|1
7630646|NCT01676220|26549429|P2|Overall Study|Selection Criterion/Protocol Violation|9
7630647|NCT01676220|26549430|P1|Overall Study|Selection Criterion/Protocol Violation|9
7630648|NCT01676220|26549429|P2|Overall Study|Lost to Follow-up|18
7630649|NCT01676220|26549430|P1|Overall Study|Lost to Follow-up|11
7630650|NCT01676220|26549429|P2|Overall Study|Personal Reason|45
7630651|NCT01676220|26549430|P1|Overall Study|Personal Reason|34
7630652|NCT01676220|26549429|P2|Overall Study|Received Rescue Therapy|22
7630653|NCT01676220|26549430|P1|Overall Study|Received Rescue Therapy|14
7630654|NCT01676220|26549429|P2|Overall Study|Protocol Violation|12
7630655|NCT01676220|26549430|P1|Overall Study|Protocol Violation|11
7630656|NCT01676220|26549429|P2|Overall Study|Lack of Efficacy|5
7630657|NCT01676220|26549430|P1|Overall Study|Lack of Efficacy|2
7630658|NCT01676220|26549429|P2|Overall Study|Adverse Event|8
7630659|NCT01676220|26549430|P1|Overall Study|Adverse Event|10
7630660|NCT01676220|26549429|P2|Overall Study|Randomized But Not Treated|1
7630661|NCT01676220|26549430|P1|Overall Study|Randomized But Not Treated|4
7630662|NCT01676116|26549462|P2|Overall Study|Protocol Violation|3
7630663|NCT01676116|26549463|P1|Overall Study|Protocol Violation|9
7630664|NCT01676116|26549462|P2|Overall Study|Unclassified|10
7630665|NCT01676116|26549463|P1|Overall Study|Unclassified|4
7630666|NCT01676116|26549462|P2|Overall Study|Adverse Event|2
7630667|NCT01676116|26549463|P1|Overall Study|Adverse Event|1
7630668|NCT01676116|26549462|P2|Overall Study|Withdrawal criteria|14
7630669|NCT01676116|26549463|P1|Overall Study|Withdrawal criteria|2
7630670|NCT01676012|26549485|P1|Overall Study|incomplete set of videos|1
7630671|NCT01676012|26549485|P1|Overall Study|Adverse Event|2
7630672|NCT01675765|26549529|P2|Overall Study|Clinical progression|2
7630673|NCT01675765|26549530|P1|Overall Study|Clinical progression|3
7630674|NCT01675765|26549529|P2|Overall Study|Death|0
7630675|NCT01675765|26549530|P1|Overall Study|Death|1
7630676|NCT01675765|26549529|P2|Overall Study|Withdrawal by Subject|0
7630677|NCT01675765|26549530|P1|Overall Study|Withdrawal by Subject|2
7630678|NCT01675765|26549529|P2|Overall Study|Adverse Event|2
7630679|NCT01675765|26549530|P1|Overall Study|Adverse Event|1
7630680|NCT01675765|26549529|P2|Overall Study|Progressive disease|4
7630681|NCT01675765|26549530|P1|Overall Study|Progressive disease|4
7630682|NCT01675661|26549546|P2|Overall Study|Other reason|2
7630683|NCT01675661|26549547|P1|Overall Study|Other reason|1
7630684|NCT01675661|26549546|P2|Overall Study|Death|1
7630685|NCT01675661|26549547|P1|Overall Study|Death|0
7630686|NCT01675661|26549546|P2|Overall Study|Physician Decision|2
7630687|NCT01675661|26549547|P1|Overall Study|Physician Decision|0
7630688|NCT01675661|26549546|P2|Overall Study|Withdrawal by Subject|7
7630689|NCT01675661|26549547|P1|Overall Study|Withdrawal by Subject|3
7630690|NCT01675661|26549546|P2|Overall Study|Moved away|6
7630691|NCT01675661|26549547|P1|Overall Study|Moved away|5
7630692|NCT01675661|26549546|P2|Overall Study|Practical problems|5
7630693|NCT01675661|26549547|P1|Overall Study|Practical problems|9
7630694|NCT01675661|26549546|P2|Overall Study|Lost to Follow-up|23
7630695|NCT01675661|26549547|P1|Overall Study|Lost to Follow-up|22
7630696|NCT01675622|26549576|P2|Overall Study|Other|4
7630697|NCT01675622|26549577|P1|Overall Study|Other|5
7630698|NCT01675622|26549576|P2|Overall Study|Lost to Follow-up|3
7630699|NCT01675622|26549577|P1|Overall Study|Lost to Follow-up|1
7630700|NCT01675622|26549576|P2|Overall Study|Lack of Efficacy|4
7630701|NCT01675622|26549577|P1|Overall Study|Lack of Efficacy|2
7630702|NCT01675622|26549576|P2|Overall Study|Protocol Violation|1
7630703|NCT01675622|26549577|P1|Overall Study|Protocol Violation|4
7630704|NCT01675622|26549576|P2|Overall Study|Adverse Event|10
7630705|NCT01675622|26549577|P1|Overall Study|Adverse Event|12
7630706|NCT01675622|26549576|P2|Overall Study|Withdrawal by Subject|2
7630707|NCT01675622|26549577|P1|Overall Study|Withdrawal by Subject|2
7630708|NCT01675596|26549601|P1|Overall Study|Missed Visit|1
7630709|NCT01675596|26549601|P1|Overall Study|Exit with other reason|1
7630710|NCT01675596|26549601|P1|Overall Study|Death|6
7630711|NCT01675544|26549607|P1|Overall Study|Withdrawal by Subject|2
7630712|NCT01675531|26549612|P1|Overall Study|Protocol Violation|8
7630713|NCT01675531|26549612|P1|Overall Study|Lack of Efficacy|1
7630714|NCT01675531|26549612|P1|Overall Study|Withdrawal by Subject|7
7630715|NCT01675531|26549612|P1|Overall Study|Adverse Event|9
7630716|NCT01675492|26549619|P1|Overall Study|study completed early - product approval|42
7630717|NCT01675479|26549624|P1|Overall Study|Lost to Follow-up|11
7630718|NCT01675427|26549638|P1|Overall Study|Other|2
7630719|NCT01675427|26549638|P1|Overall Study|Lost to Follow-up|5
7630720|NCT01675427|26549638|P1|Overall Study|Sample not Collected by Mistake|2
7630721|NCT01675427|26549638|P1|Overall Study|Participant Refused Sample Collection|18
7630722|NCT01675427|26549638|P1|Overall Study|Withdrawal by Subject|7
7630723|NCT01675167|26549938|P3|Double-blind Treatment Phase|Other|5
7630724|NCT01675167|26549939|P2|Double-blind Treatment Phase|Other|7
7630725|NCT01675167|26549940|P1|Double-blind Treatment Phase|Other|0
7630726|NCT01675167|26549938|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
7630727|NCT01675167|26549939|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7630728|NCT01675167|26549940|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7630729|NCT01675167|26549938|P3|Double-blind Treatment Phase|Lost to Follow-up|5
7630730|NCT01675167|26549939|P2|Double-blind Treatment Phase|Lost to Follow-up|1
7630731|NCT01675167|26549940|P1|Double-blind Treatment Phase|Lost to Follow-up|0
7630732|NCT01675167|26549938|P3|Double-blind Treatment Phase|Protocol Violation|11
7630733|NCT01675167|26549939|P2|Double-blind Treatment Phase|Protocol Violation|4
7630734|NCT01675167|26549940|P1|Double-blind Treatment Phase|Protocol Violation|0
7630735|NCT01675167|26549938|P3|Double-blind Treatment Phase|Adverse Event|13
7630736|NCT01675167|26549939|P2|Double-blind Treatment Phase|Adverse Event|5
7630737|NCT01675167|26549940|P1|Double-blind Treatment Phase|Adverse Event|0
7630738|NCT01675167|26549938|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
7630739|NCT01675167|26549939|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
7630740|NCT01675167|26549940|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
7630741|NCT01675167|26549938|P3|Double-blind Treatment Phase|Lack of Efficacy|61
7630742|NCT01675167|26549939|P2|Double-blind Treatment Phase|Lack of Efficacy|19
7630743|NCT01675167|26549940|P1|Double-blind Treatment Phase|Lack of Efficacy|0
7630744|NCT01675167|26549938|P3|Open-label Titration Phase|Other|0
7630745|NCT01675167|26549939|P2|Open-label Titration Phase|Other|0
7630746|NCT01675167|26549940|P1|Open-label Titration Phase|Other|55
7630747|NCT01675167|26549938|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7630748|NCT01675167|26549939|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7630749|NCT01675167|26549940|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
7630750|NCT01675167|26549938|P3|Open-label Titration Phase|Lost to Follow-up|0
7630751|NCT01675167|26549939|P2|Open-label Titration Phase|Lost to Follow-up|0
7630752|NCT01675167|26549940|P1|Open-label Titration Phase|Lost to Follow-up|15
7630753|NCT01675167|26549938|P3|Open-label Titration Phase|Protocol Violation|0
7630754|NCT01675167|26549939|P2|Open-label Titration Phase|Protocol Violation|0
7630755|NCT01675167|26549940|P1|Open-label Titration Phase|Protocol Violation|43
7630756|NCT01675167|26549938|P3|Open-label Titration Phase|Withdrawal by Subject|0
7630757|NCT01675167|26549939|P2|Open-label Titration Phase|Withdrawal by Subject|0
7630758|NCT01675167|26549940|P1|Open-label Titration Phase|Withdrawal by Subject|46
7630759|NCT01675167|26549938|P3|Open-label Titration Phase|Lack of Efficacy|0
7630760|NCT01675167|26549939|P2|Open-label Titration Phase|Lack of Efficacy|0
7630761|NCT01675167|26549940|P1|Open-label Titration Phase|Lack of Efficacy|63
7630762|NCT01675167|26549938|P3|Open-label Titration Phase|Adverse Event|0
7630763|NCT01675167|26549939|P2|Open-label Titration Phase|Adverse Event|0
7630764|NCT01675167|26549940|P1|Open-label Titration Phase|Adverse Event|81
7630765|NCT01675154|26549966|P4|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7630766|NCT01675154|26549967|P3|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7630767|NCT01675154|26549968|P2|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
7630768|NCT01675154|26549969|P1|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7630769|NCT01675141|26550003|P1|Overall Study|No treatment, per protocol|1
7630770|NCT01675141|26550003|P1|Overall Study|Physician Decision|4
7630771|NCT01675141|26550003|P1|Overall Study|Withdrawal by Subject|3
7630772|NCT01675141|26550003|P1|Overall Study|Lenalidomide outside NIH|3
7630773|NCT01675128|26550016|P3|Overall Study|Pulmonary complication; off study|0
7630774|NCT01675128|26550017|P2|Overall Study|Pulmonary complication; off study|1
7630775|NCT01675128|26550018|P1|Overall Study|Pulmonary complication; off study|0
7630776|NCT01675128|26550016|P3|Overall Study|Refused further treatment|0
7630777|NCT01675128|26550017|P2|Overall Study|Refused further treatment|0
7630778|NCT01675128|26550018|P1|Overall Study|Refused further treatment|1
7630779|NCT01675128|26550016|P3|Overall Study|Disease progression on study|1
7630780|NCT01675128|26550017|P2|Overall Study|Disease progression on study|1
7630781|NCT01675128|26550018|P1|Overall Study|Disease progression on study|1
7630782|NCT01675050|26550046|P2|Period One Treatment|Withdrawal by Subject|0
7630783|NCT01675050|26550047|P1|Period One Treatment|Withdrawal by Subject|1
7630784|NCT01675011|26550057|P2|Overall Study|Trial terminated by Sponsor|1
7630785|NCT01675011|26550058|P1|Overall Study|Trial terminated by Sponsor|3
7630786|NCT01674725|26550066|P2|Overall Study|Lost to Follow-up|1
7630787|NCT01674725|26550067|P1|Overall Study|Lost to Follow-up|0
7630788|NCT01674725|26550066|P2|Overall Study|Withdrawal by Subject|0
7630789|NCT01674725|26550067|P1|Overall Study|Withdrawal by Subject|1
7630790|NCT01674725|26550066|P2|Overall Study|Did not receive study drug|0
7630791|NCT01674725|26550067|P1|Overall Study|Did not receive study drug|1
7630792|NCT01674725|26550066|P2|Overall Study|Adverse Event|0
7630793|NCT01674725|26550067|P1|Overall Study|Adverse Event|1
7630794|NCT01674712|26550086|P5|Overall Study|Lack of Efficacy|1
7630795|NCT01674712|26550087|P4|Overall Study|Lack of Efficacy|0
7630796|NCT01674712|26550088|P3|Overall Study|Lack of Efficacy|1
7630797|NCT01674712|26550089|P2|Overall Study|Lack of Efficacy|0
7630798|NCT01674712|26550090|P1|Overall Study|Lack of Efficacy|0
7630799|NCT01674712|26550086|P5|Overall Study|Administrative|1
7630800|NCT01674712|26550087|P4|Overall Study|Administrative|0
7630801|NCT01674712|26550088|P3|Overall Study|Administrative|0
7630802|NCT01674712|26550089|P2|Overall Study|Administrative|1
7630803|NCT01674712|26550090|P1|Overall Study|Administrative|0
7630804|NCT01674712|26550086|P5|Overall Study|Withdrawal by Subject|3
7630805|NCT01674712|26550087|P4|Overall Study|Withdrawal by Subject|4
7630806|NCT01674712|26550088|P3|Overall Study|Withdrawal by Subject|5
7630807|NCT01674712|26550089|P2|Overall Study|Withdrawal by Subject|2
7630808|NCT01674712|26550090|P1|Overall Study|Withdrawal by Subject|2
7630809|NCT01674712|26550086|P5|Overall Study|Protocol Violation|0
7630810|NCT01674712|26550087|P4|Overall Study|Protocol Violation|0
7630811|NCT01674712|26550088|P3|Overall Study|Protocol Violation|0
7630812|NCT01674712|26550089|P2|Overall Study|Protocol Violation|0
7630813|NCT01674712|26550090|P1|Overall Study|Protocol Violation|2
7630814|NCT01674712|26550086|P5|Overall Study|Lost to Follow-up|0
7630815|NCT01674712|26550087|P4|Overall Study|Lost to Follow-up|0
7630816|NCT01674712|26550088|P3|Overall Study|Lost to Follow-up|0
7630817|NCT01674712|26550089|P2|Overall Study|Lost to Follow-up|0
7630818|NCT01674712|26550090|P1|Overall Study|Lost to Follow-up|1
7630819|NCT01674712|26550086|P5|Overall Study|Adverse Event|6
7630820|NCT01674712|26550087|P4|Overall Study|Adverse Event|4
7630821|NCT01674712|26550088|P3|Overall Study|Adverse Event|3
7630822|NCT01674712|26550089|P2|Overall Study|Adverse Event|6
7630823|NCT01674712|26550090|P1|Overall Study|Adverse Event|5
7630824|NCT01674647|26550114|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
7630825|NCT01674647|26550115|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
7630826|NCT01674647|26550114|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
7630827|NCT01674647|26550115|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
7630828|NCT01674647|26550114|P2|30-day Safety Follow-up Period|Logistical difficulties|3
7630829|NCT01674647|26550115|P1|30-day Safety Follow-up Period|Logistical difficulties|1
7630830|NCT01674647|26550114|P2|30-day Safety Follow-up Period|Protocol Violation|22
7630831|NCT01674647|26550115|P1|30-day Safety Follow-up Period|Protocol Violation|39
7630832|NCT01674647|26550114|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
7630833|NCT01674647|26550115|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
7630834|NCT01674647|26550114|P2|30-day Safety Follow-up Period|Death|2
7630835|NCT01674647|26550115|P1|30-day Safety Follow-up Period|Death|3
7630836|NCT01674647|26550114|P2|Treatment Period|Protocol Violation|36
7630837|NCT01674647|26550115|P1|Treatment Period|Protocol Violation|56
7630838|NCT01674647|26550114|P2|Treatment Period|Treatment failure|14
7630839|NCT01674647|26550115|P1|Treatment Period|Treatment failure|0
7630840|NCT01674647|26550114|P2|Treatment Period|Logistical difficulties|8
7630841|NCT01674647|26550115|P1|Treatment Period|Logistical difficulties|5
7630842|NCT01674647|26550114|P2|Treatment Period|Switching to other therapy|2
7630843|NCT01674647|26550115|P1|Treatment Period|Switching to other therapy|5
7630844|NCT01674647|26550114|P2|Treatment Period|Withdrawal by Subject|16
7630845|NCT01674647|26550115|P1|Treatment Period|Withdrawal by Subject|19
7630846|NCT01674647|26550114|P2|Treatment Period|Lost to Follow-up|1
7630847|NCT01674647|26550115|P1|Treatment Period|Lost to Follow-up|1
7630848|NCT01674647|26550114|P2|Treatment Period|Non-compliance with study drug|0
7630849|NCT01674647|26550115|P1|Treatment Period|Non-compliance with study drug|3
7630850|NCT01674647|26550114|P2|Treatment Period|Adverse Event|22
7630851|NCT01674647|26550115|P1|Treatment Period|Adverse Event|60
7630852|NCT01674647|26550114|P2|Treatment Period|Physician Decision|1
7630853|NCT01674647|26550115|P1|Treatment Period|Physician Decision|3
7630854|NCT01674647|26550114|P2|Treatment Period|Efficacy outcome reached|1
7630855|NCT01674647|26550115|P1|Treatment Period|Efficacy outcome reached|0
7630856|NCT01674647|26550114|P2|Treatment Period|Death|1
7630857|NCT01674647|26550115|P1|Treatment Period|Death|4
7630858|NCT01674634|26550141|P1|Overall Study|Lost to Follow-up|3
7630859|NCT01674634|26550141|P1|Overall Study|Withdrawal by Subject|3
7630860|NCT01674621|26550161|P5|Overall Study|Other than specified|2
7630861|NCT01674621|26550162|P4|Overall Study|Other than specified|0
7630862|NCT01674621|26550163|P3|Overall Study|Other than specified|0
7630863|NCT01674621|26550164|P2|Overall Study|Other than specified|1
7630864|NCT01674621|26550165|P1|Overall Study|Other than specified|0
7630865|NCT01674621|26550161|P5|Overall Study|Withdrawal by Subject|1
7630866|NCT01674621|26550162|P4|Overall Study|Withdrawal by Subject|0
7630867|NCT01674621|26550163|P3|Overall Study|Withdrawal by Subject|2
7630868|NCT01674621|26550164|P2|Overall Study|Withdrawal by Subject|5
7630869|NCT01674621|26550165|P1|Overall Study|Withdrawal by Subject|2
7630870|NCT01674621|26550161|P5|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7630871|NCT01674621|26550162|P4|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
7630872|NCT01674621|26550163|P3|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7630873|NCT01674621|26550164|P2|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7630874|NCT01674621|26550165|P1|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7630875|NCT01674621|26550161|P5|Overall Study|Inability to Complete Study Procedures|2
7630876|NCT01674621|26550162|P4|Overall Study|Inability to Complete Study Procedures|0
7630877|NCT01674621|26550163|P3|Overall Study|Inability to Complete Study Procedures|0
7630878|NCT01674621|26550164|P2|Overall Study|Inability to Complete Study Procedures|0
7630879|NCT01674621|26550165|P1|Overall Study|Inability to Complete Study Procedures|0
7630880|NCT01674621|26550161|P5|Overall Study|Adverse Event|1
7630881|NCT01674621|26550162|P4|Overall Study|Adverse Event|5
7630882|NCT01674621|26550163|P3|Overall Study|Adverse Event|5
7630883|NCT01674621|26550164|P2|Overall Study|Adverse Event|2
7630884|NCT01674621|26550165|P1|Overall Study|Adverse Event|3
7630885|NCT01674569|26550242|P6|Overall Study|Withdrawal by Subject|0
7630886|NCT01674569|26550243|P5|Overall Study|Withdrawal by Subject|0
7630887|NCT01674569|26550244|P4|Overall Study|Withdrawal by Subject|0
7630888|NCT01674569|26550245|P3|Overall Study|Withdrawal by Subject|1
7630889|NCT01674569|26550246|P2|Overall Study|Withdrawal by Subject|0
7630890|NCT01674569|26550247|P1|Overall Study|Withdrawal by Subject|0
7630891|NCT01674569|26550242|P6|Overall Study|Protocol Violation|0
7630892|NCT01674569|26550243|P5|Overall Study|Protocol Violation|0
7630893|NCT01674569|26550244|P4|Overall Study|Protocol Violation|0
7630894|NCT01674569|26550245|P3|Overall Study|Protocol Violation|1
7630895|NCT01674569|26550246|P2|Overall Study|Protocol Violation|1
7630896|NCT01674569|26550247|P1|Overall Study|Protocol Violation|0
7630897|NCT01674569|26550242|P6|Overall Study|Adverse Event|2
7630898|NCT01674569|26550243|P5|Overall Study|Adverse Event|2
7630899|NCT01674569|26550244|P4|Overall Study|Adverse Event|1
7630900|NCT01674569|26550245|P3|Overall Study|Adverse Event|0
7630901|NCT01674569|26550246|P2|Overall Study|Adverse Event|2
7630902|NCT01674569|26550247|P1|Overall Study|Adverse Event|0
7630903|NCT01674062|26550268|P2|Overall Study|Programming Error|0
7630904|NCT01674062|26550269|P1|Overall Study|Programming Error|1
7630905|NCT01674062|26550268|P2|Overall Study|Death|1
7630906|NCT01674062|26550269|P1|Overall Study|Death|0
7630907|NCT01674062|26550268|P2|Overall Study|Adverse Event|1
7630908|NCT01674062|26550269|P1|Overall Study|Adverse Event|1
7630909|NCT01674062|26550268|P2|Overall Study|Other|1
7630910|NCT01674062|26550269|P1|Overall Study|Other|8
7630911|NCT01674062|26550268|P2|Overall Study|Insufficient Therapeutic Response|26
7630912|NCT01674062|26550269|P1|Overall Study|Insufficient Therapeutic Response|56
7630913|NCT01674010|26550284|P3|Randomization Phase 2|Withdrawal by Subject|7
7630914|NCT01674010|26550285|P2|Randomization Phase 2|Withdrawal by Subject|8
7630915|NCT01674010|26550286|P1|Randomization Phase 2|Withdrawal by Subject|0
7630916|NCT01674010|26550284|P3|Randomization Phase 2|Sponsor Decision|45
7630917|NCT01674010|26550285|P2|Randomization Phase 2|Sponsor Decision|42
7630918|NCT01674010|26550286|P1|Randomization Phase 2|Sponsor Decision|0
7630919|NCT01674010|26550284|P3|Randomization Phase 2|Protocol Violation|1
7630920|NCT01674010|26550285|P2|Randomization Phase 2|Protocol Violation|1
7630921|NCT01674010|26550286|P1|Randomization Phase 2|Protocol Violation|0
7630922|NCT01674010|26550284|P3|Randomization Phase 2|Pregnancy|1
7630923|NCT01674010|26550285|P2|Randomization Phase 2|Pregnancy|1
7630924|NCT01674010|26550286|P1|Randomization Phase 2|Pregnancy|0
7630925|NCT01674010|26550284|P3|Randomization Phase 2|Physician Decision|2
7630926|NCT01674010|26550285|P2|Randomization Phase 2|Physician Decision|0
7630927|NCT01674010|26550286|P1|Randomization Phase 2|Physician Decision|0
7630928|NCT01674010|26550284|P3|Randomization Phase 2|Mood episode recurrence|2
7630929|NCT01674010|26550285|P2|Randomization Phase 2|Mood episode recurrence|8
7630930|NCT01674010|26550286|P1|Randomization Phase 2|Mood episode recurrence|0
7630931|NCT01674010|26550284|P3|Randomization Phase 2|Lost to Follow-up|2
7630932|NCT01674010|26550285|P2|Randomization Phase 2|Lost to Follow-up|1
7630933|NCT01674010|26550286|P1|Randomization Phase 2|Lost to Follow-up|0
7630934|NCT01674010|26550284|P3|Randomization Phase 2|Adverse Event|1
7630935|NCT01674010|26550285|P2|Randomization Phase 2|Adverse Event|1
7630936|NCT01674010|26550286|P1|Randomization Phase 2|Adverse Event|0
7630937|NCT01674010|26550284|P3|Open Treatment Phase 1|Withdrawal by Subject|0
7630938|NCT01674010|26550285|P2|Open Treatment Phase 1|Withdrawal by Subject|0
7630939|NCT01674010|26550286|P1|Open Treatment Phase 1|Withdrawal by Subject|25
7630940|NCT01674010|26550284|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
7630941|NCT01674010|26550285|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
7630942|NCT01674010|26550286|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
7630943|NCT01674010|26550284|P3|Open Treatment Phase 1|Sponsor Decision|0
7630944|NCT01674010|26550285|P2|Open Treatment Phase 1|Sponsor Decision|0
7630945|NCT01674010|26550286|P1|Open Treatment Phase 1|Sponsor Decision|79
7630946|NCT01674010|26550284|P3|Open Treatment Phase 1|Protocol Violation|0
7630947|NCT01674010|26550285|P2|Open Treatment Phase 1|Protocol Violation|0
7630948|NCT01674010|26550286|P1|Open Treatment Phase 1|Protocol Violation|7
7630949|NCT01674010|26550284|P3|Open Treatment Phase 1|Physician Decision|0
7630950|NCT01674010|26550285|P2|Open Treatment Phase 1|Physician Decision|0
7630951|NCT01674010|26550286|P1|Open Treatment Phase 1|Physician Decision|9
7630952|NCT01674010|26550284|P3|Open Treatment Phase 1|Lost to Follow-up|0
7630953|NCT01674010|26550285|P2|Open Treatment Phase 1|Lost to Follow-up|0
7630954|NCT01674010|26550286|P1|Open Treatment Phase 1|Lost to Follow-up|19
7630955|NCT01674010|26550284|P3|Open Treatment Phase 1|Death|0
7630956|NCT01674010|26550285|P2|Open Treatment Phase 1|Death|0
7630957|NCT01674010|26550286|P1|Open Treatment Phase 1|Death|1
7630958|NCT01674010|26550284|P3|Open Treatment Phase 1|Adverse Event|0
7630959|NCT01674010|26550285|P2|Open Treatment Phase 1|Adverse Event|0
7630960|NCT01674010|26550286|P1|Open Treatment Phase 1|Adverse Event|10
7630961|NCT01673984|26550305|P2|Overall Study|Study termination|6
7630962|NCT01673984|26550306|P1|Overall Study|Study termination|9
7630963|NCT01673984|26550305|P2|Overall Study|Adverse Event|0
7630964|NCT01673984|26550306|P1|Overall Study|Adverse Event|1
7630965|NCT01673867|26550356|P2|Treatment|Physician Decision|1
7630966|NCT01673867|26550357|P1|Treatment|Physician Decision|0
7630967|NCT01673867|26550356|P2|Treatment|Symptomatic deterioration|1
7630968|NCT01673867|26550357|P1|Treatment|Symptomatic deterioration|0
7630969|NCT01673867|26550356|P2|Treatment|Required prolonged hospitalization|1
7630970|NCT01673867|26550357|P1|Treatment|Required prolonged hospitalization|0
7630971|NCT01673867|26550356|P2|Treatment|Health status not improved|0
7630972|NCT01673867|26550357|P1|Treatment|Health status not improved|1
7630973|NCT01673867|26550356|P2|Treatment|Required steroid therapy|0
7630974|NCT01673867|26550357|P1|Treatment|Required steroid therapy|1
7630975|NCT01673867|26550356|P2|Treatment|No longer meets criteria|0
7630976|NCT01673867|26550357|P1|Treatment|No longer meets criteria|2
7630977|NCT01673867|26550356|P2|Treatment|Maximum clinical benefit|10
7630978|NCT01673867|26550357|P1|Treatment|Maximum clinical benefit|0
7630979|NCT01673867|26550356|P2|Treatment|Withdrawal by Subject|6
7630980|NCT01673867|26550357|P1|Treatment|Withdrawal by Subject|4
7630981|NCT01673867|26550356|P2|Treatment|Requested treatment discontinuation|16
7630982|NCT01673867|26550357|P1|Treatment|Requested treatment discontinuation|5
7630983|NCT01673867|26550356|P2|Treatment|AE unrelated to study drug|11
7630984|NCT01673867|26550357|P1|Treatment|AE unrelated to study drug|19
7630985|NCT01673867|26550356|P2|Treatment|Death|1
7630986|NCT01673867|26550357|P1|Treatment|Death|1
7630987|NCT01673867|26550356|P2|Treatment|Study Drug Toxicity|42
7630988|NCT01673867|26550357|P1|Treatment|Study Drug Toxicity|17
7630989|NCT01673867|26550356|P2|Treatment|Disease Progression|179
7630990|NCT01673867|26550357|P1|Treatment|Disease Progression|194
7630991|NCT01673867|26550356|P2|Randomization|No longer meets criteria|5
7630992|NCT01673867|26550357|P1|Randomization|No longer meets criteria|4
7630993|NCT01673867|26550356|P2|Randomization|Lost to Follow-up|1
7630994|NCT01673867|26550357|P1|Randomization|Lost to Follow-up|0
7630995|NCT01673867|26550356|P2|Randomization|Withdrawal by Subject|12
7630996|NCT01673867|26550357|P1|Randomization|Withdrawal by Subject|0
7630997|NCT01673867|26550356|P2|Randomization|Requested treatment discontinuation|4
7630998|NCT01673867|26550357|P1|Randomization|Requested treatment discontinuation|0
7630999|NCT01673867|26550356|P2|Randomization|AE unrelated to study drug|0
7631000|NCT01673867|26550357|P1|Randomization|AE unrelated to study drug|1
7631001|NCT01673854|26550383|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
7631002|NCT01673854|26550383|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
7631003|NCT01673854|26550383|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
7631004|NCT01673854|26550383|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
7631005|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
7631006|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
7631007|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
7631008|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
7631009|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
7631010|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
7631011|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
7631012|NCT01673854|26550383|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
7631013|NCT01673698|26550406|P2|Overall Study|Lost to Follow-up|13
7631014|NCT01673698|26550407|P1|Overall Study|Lost to Follow-up|51
7631015|NCT01673646|26550418|P3|Overall Study|Completed Core/did not enter Ext.|1
7631016|NCT01673646|26550419|P2|Overall Study|Completed Core/did not enter Ext.|1
7631017|NCT01673646|26550420|P1|Overall Study|Completed Core/did not enter Ext.|2
7631018|NCT01673646|26550418|P3|Overall Study|Withdrawal by Subject|2
7631019|NCT01673646|26550419|P2|Overall Study|Withdrawal by Subject|2
7631020|NCT01673646|26550420|P1|Overall Study|Withdrawal by Subject|0
7631021|NCT01673646|26550418|P3|Overall Study|Condition no longer requires study drug|0
7631022|NCT01673646|26550419|P2|Overall Study|Condition no longer requires study drug|1
7631023|NCT01673646|26550420|P1|Overall Study|Condition no longer requires study drug|0
7631024|NCT01673646|26550418|P3|Overall Study|Unsatisfactory therapeutic effect|0
7631025|NCT01673646|26550419|P2|Overall Study|Unsatisfactory therapeutic effect|2
7631026|NCT01673646|26550420|P1|Overall Study|Unsatisfactory therapeutic effect|0
7631027|NCT01673646|26550418|P3|Overall Study|Adverse Event|1
7631028|NCT01673646|26550419|P2|Overall Study|Adverse Event|1
7631029|NCT01673646|26550420|P1|Overall Study|Adverse Event|2
7631030|NCT01673620|26550459|P2|Overall Study|Adverse Event|0
7631031|NCT01673620|26550460|P1|Overall Study|Adverse Event|1
7631032|NCT01673594|26550470|P2|Overall Study|Withdrawal by Subject|1
7631033|NCT01673594|26550471|P1|Overall Study|Withdrawal by Subject|0
7631034|NCT01673594|26550470|P2|Overall Study|Physician Decision|4
7631035|NCT01673594|26550471|P1|Overall Study|Physician Decision|2
7631036|NCT01673594|26550470|P2|Overall Study|Lost to Follow-up|0
7631037|NCT01673594|26550471|P1|Overall Study|Lost to Follow-up|1
7631038|NCT01673594|26550470|P2|Overall Study|Adverse Event|1
7631039|NCT01673594|26550471|P1|Overall Study|Adverse Event|3
7631040|NCT01673490|26550490|P1|Overall Study|Withdrawal by Subject|3
7631041|NCT01673490|26550490|P1|Overall Study|Adverse Event|3
7631042|NCT01673490|26550490|P1|Overall Study|Lost to Follow-up|1
7631043|NCT01673386|26550507|P2|Overall Study|Withdrawal by Subject|2
7631044|NCT01673386|26550508|P1|Overall Study|Withdrawal by Subject|0
7631045|NCT01673386|26550507|P2|Overall Study|Progressive disease|1
7631046|NCT01673386|26550508|P1|Overall Study|Progressive disease|4
7631047|NCT01673386|26550507|P2|Overall Study|Adverse Event|2
7631048|NCT01673386|26550508|P1|Overall Study|Adverse Event|5
7631049|NCT01673386|26550507|P2|Overall Study|Study terminated by sponsor|22
7631050|NCT01673386|26550508|P1|Overall Study|Study terminated by sponsor|16
7631051|NCT01673373|26550538|P1|Overall Study|Death|2
7631052|NCT01673347|26550554|P1|Overall Study|failure of allograft|7
7631053|NCT01673282|26550563|P2|Overall Study|Other|6
7631054|NCT01673282|26550564|P1|Overall Study|Other|1
7631055|NCT01673282|26550563|P2|Overall Study|Withdrawal by Subject|3
7631056|NCT01673282|26550564|P1|Overall Study|Withdrawal by Subject|3
7631057|NCT01673282|26550563|P2|Overall Study|Lost to Follow-up|10
7631058|NCT01673282|26550564|P1|Overall Study|Lost to Follow-up|11
7631059|NCT01673282|26550563|P2|Overall Study|Lack of Efficacy|2
7631060|NCT01673282|26550564|P1|Overall Study|Lack of Efficacy|9
7631061|NCT01673282|26550563|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
7631062|NCT01673282|26550564|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
7631063|NCT01673178|26550600|P5|Overall Study|Other|0
7631064|NCT01673178|26550601|P4|Overall Study|Other|1
7631065|NCT01673178|26550602|P3|Overall Study|Other|2
7631066|NCT01673178|26550603|P2|Overall Study|Other|0
7631067|NCT01673178|26550604|P1|Overall Study|Other|1
7631068|NCT01673178|26550600|P5|Overall Study|Adverse Event|0
7631069|NCT01673178|26550601|P4|Overall Study|Adverse Event|2
7631070|NCT01673178|26550602|P3|Overall Study|Adverse Event|0
7631071|NCT01673178|26550603|P2|Overall Study|Adverse Event|0
7631072|NCT01673178|26550604|P1|Overall Study|Adverse Event|1
7631073|NCT01673178|26550600|P5|Overall Study|Protocol Violation|0
7631074|NCT01673178|26550601|P4|Overall Study|Protocol Violation|1
7631075|NCT01673178|26550602|P3|Overall Study|Protocol Violation|0
7631076|NCT01673178|26550603|P2|Overall Study|Protocol Violation|1
7631077|NCT01673178|26550604|P1|Overall Study|Protocol Violation|1
7631078|NCT01673178|26550600|P5|Overall Study|Withdrawal by Subject|2
7631079|NCT01673178|26550601|P4|Overall Study|Withdrawal by Subject|4
7631080|NCT01673178|26550602|P3|Overall Study|Withdrawal by Subject|1
7631081|NCT01673178|26550603|P2|Overall Study|Withdrawal by Subject|0
7631082|NCT01673178|26550604|P1|Overall Study|Withdrawal by Subject|0
7631083|NCT01673178|26550600|P5|Overall Study|Lost to Follow-up|0
7631084|NCT01673178|26550601|P4|Overall Study|Lost to Follow-up|0
7631085|NCT01673178|26550602|P3|Overall Study|Lost to Follow-up|0
7631086|NCT01673178|26550603|P2|Overall Study|Lost to Follow-up|1
7631087|NCT01673178|26550604|P1|Overall Study|Lost to Follow-up|0
7631088|NCT01673126|26550843|P2|Overall Study|change of diagnosis|3
7631089|NCT01673126|26550844|P1|Overall Study|change of diagnosis|4
7631090|NCT01673009|26550883|P1|Overall Study|Withdrawal by Subject|8
7631091|NCT01673009|26550883|P1|Overall Study|Physician Decision|5
7631092|NCT01672970|26550968|P1|Overall Study|Enrolled but not treated|1
7631093|NCT01672970|26550968|P1|Overall Study|Other|9
7631094|NCT01672970|26550968|P1|Overall Study|Lost to Follow-up|5
7631095|NCT01672970|26550968|P1|Overall Study|Withdrawal by Subject|2
7631096|NCT01672970|26550968|P1|Overall Study|Adverse Event|18
7631097|NCT01672970|26550968|P1|Overall Study|Lack of Efficacy|12
7631098|NCT01672957|26551004|P1|Overall Study|ICF Signed After Transplantation|5
7631099|NCT01672957|26551004|P1|Overall Study|Death|2
7631100|NCT01672957|26551004|P1|Overall Study|Protocol Violation|48
7631101|NCT01672892|26551019|P2|Overall Study|Protocol Violation|3
7631102|NCT01672892|26551020|P1|Overall Study|Protocol Violation|7
7631103|NCT01672879|26551049|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7631104|NCT01672879|26551050|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7631105|NCT01672879|26551051|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
7631106|NCT01672879|26551049|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7631107|NCT01672879|26551050|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
7631108|NCT01672879|26551051|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7631109|NCT01672879|26551049|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7631110|NCT01672879|26551050|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7631111|NCT01672879|26551051|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
7631112|NCT01672879|26551049|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
7631113|NCT01672879|26551050|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
7631114|NCT01672879|26551051|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
7631115|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
7631116|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
7631117|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
7631118|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
7631119|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7631120|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7631121|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
7631122|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
7631123|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
7631124|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Death|0
7631125|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Death|2
7631126|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Death|0
7631127|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
7631128|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
7631129|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
7631130|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
7631131|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
7631132|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
7631133|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
7631134|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
7631135|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
7631136|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
7631137|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
7631138|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
7631139|NCT01672879|26551049|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
7631140|NCT01672879|26551050|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
7631141|NCT01672879|26551051|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
7631142|NCT01672866|26551066|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7631143|NCT01672866|26551067|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7631144|NCT01672866|26551068|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
7631145|NCT01672866|26551066|P3|Open-Label Phase (up to 240 Weeks)|Death|0
7631146|NCT01672866|26551067|P2|Open-Label Phase (up to 240 Weeks)|Death|0
7631147|NCT01672866|26551068|P1|Open-Label Phase (up to 240 Weeks)|Death|1
7631148|NCT01672866|26551066|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7631149|NCT01672866|26551067|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
7631150|NCT01672866|26551068|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7631151|NCT01672866|26551066|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7631152|NCT01672866|26551067|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7631153|NCT01672866|26551068|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
7631154|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
7631155|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
7631156|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
7631157|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7631158|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7631159|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
7631160|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Death|1
7631161|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Death|0
7631162|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Death|0
7631163|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7631164|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7631165|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
7631166|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
7631167|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7631168|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7631169|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7631170|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7631171|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7631172|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
7631173|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7631174|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7631175|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
7631176|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
7631177|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
7631178|NCT01672866|26551066|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
7631179|NCT01672866|26551067|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
7631180|NCT01672866|26551068|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
7631181|NCT01672853|26551083|P3|Overall Study|Randomized but Never Treated|1
7631182|NCT01672853|26551084|P2|Overall Study|Randomized but Never Treated|0
7631183|NCT01672853|26551085|P1|Overall Study|Randomized but Never Treated|0
7631184|NCT01672853|26551083|P3|Overall Study|Lost to Follow-up|0
7631185|NCT01672853|26551084|P2|Overall Study|Lost to Follow-up|1
7631186|NCT01672853|26551085|P1|Overall Study|Lost to Follow-up|0
7631187|NCT01672853|26551083|P3|Overall Study|Adverse Event|8
7631188|NCT01672853|26551084|P2|Overall Study|Adverse Event|6
7631189|NCT01672853|26551085|P1|Overall Study|Adverse Event|4
7631190|NCT01672853|26551083|P3|Overall Study|Withdrew Consent|5
7631191|NCT01672853|26551084|P2|Overall Study|Withdrew Consent|5
7631192|NCT01672853|26551085|P1|Overall Study|Withdrew Consent|5
7631193|NCT01672853|26551083|P3|Overall Study|Investigator's Discretion|0
7631194|NCT01672853|26551084|P2|Overall Study|Investigator's Discretion|0
7631195|NCT01672853|26551085|P1|Overall Study|Investigator's Discretion|1
7631196|NCT01672853|26551083|P3|Overall Study|Pregnancy|0
7631197|NCT01672853|26551084|P2|Overall Study|Pregnancy|1
7631198|NCT01672853|26551085|P1|Overall Study|Pregnancy|0
7631199|NCT01672853|26551083|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
7631200|NCT01672853|26551084|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
7631201|NCT01672853|26551085|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
7631202|NCT01672801|26551110|P2|Overall Study|Screen Failure|1
7631203|NCT01672801|26551111|P1|Overall Study|Screen Failure|0
7631204|NCT01672788|26551119|P4|Washout Period 2 (7 Days)|Adverse Event|1
7631205|NCT01672788|26551120|P3|Washout Period 2 (7 Days)|Adverse Event|0
7631206|NCT01672788|26551121|P2|Washout Period 2 (7 Days)|Adverse Event|0
7631207|NCT01672788|26551122|P1|Washout Period 2 (7 Days)|Adverse Event|0
7631208|NCT01672736|26551152|P1|Overall Study|Available drug expired on 31 May 16|3
7631209|NCT01672723|26551156|P2|First Intervention|Adverse Event|0
7631210|NCT01672723|26551157|P1|First Intervention|Adverse Event|3
7631211|NCT01672710|26551169|P2|3 Month Follow up|follow up due after termination date|1
7631212|NCT01672710|26551170|P1|3 Month Follow up|follow up due after termination date|4
7631213|NCT01672710|26551169|P2|3 Month Follow up|Lost to Follow-up|3
7631214|NCT01672710|26551170|P1|3 Month Follow up|Lost to Follow-up|2
7631215|NCT01672710|26551169|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
7631216|NCT01672710|26551170|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
7631217|NCT01672294|26551205|P4|Overall Study|Lost to Follow-up|9
7631218|NCT01672294|26551206|P3|Overall Study|Lost to Follow-up|7
7631219|NCT01672294|26551207|P2|Overall Study|Lost to Follow-up|16
7631220|NCT01672294|26551208|P1|Overall Study|Lost to Follow-up|1
7631221|NCT01672294|26551205|P4|Overall Study|Excluded by study|0
7631222|NCT01672294|26551206|P3|Overall Study|Excluded by study|0
7631223|NCT01672294|26551207|P2|Overall Study|Excluded by study|1
7631224|NCT01672294|26551208|P1|Overall Study|Excluded by study|1
7631225|NCT01672294|26551205|P4|Overall Study|Withdrawal by Subject|4
7631226|NCT01672294|26551206|P3|Overall Study|Withdrawal by Subject|4
7631227|NCT01672294|26551207|P2|Overall Study|Withdrawal by Subject|4
7631228|NCT01672294|26551208|P1|Overall Study|Withdrawal by Subject|4
7631229|NCT01671748|26551253|P2|4 Week run-in Phase|Not eligible|0
7631230|NCT01671748|26551254|P1|4 Week run-in Phase|Not eligible|9
7631231|NCT01671748|26551253|P2|4 Week run-in Phase|Adverse Event|0
7631232|NCT01671748|26551254|P1|4 Week run-in Phase|Adverse Event|1
7631233|NCT01671748|26551253|P2|4 Week run-in Phase|Withdrawal by Subject|0
7631234|NCT01671748|26551254|P1|4 Week run-in Phase|Withdrawal by Subject|1
7631235|NCT01671488|26551281|P1|Overall Study|Withdrawal by Subject|1
7631236|NCT01671345|26551312|P2|Overall Study|visit with non-participating physician|3
7631237|NCT01671345|26551313|P1|Overall Study|visit with non-participating physician|3
7631238|NCT01671345|26551312|P2|Overall Study|Lost to Follow-up|6
7631239|NCT01671345|26551313|P1|Overall Study|Lost to Follow-up|10
7631240|NCT01671332|26551327|P2|Overall Study|Withdrawal by Subject|1
7631241|NCT01671332|26551328|P1|Overall Study|Withdrawal by Subject|1
7631242|NCT01671319|26551342|P1|Overall Study|Withdrawal by Subject|1
7631243|NCT01671280|26551357|P1|Overall Study|Withdrawal by Subject|2
7631244|NCT01671111|26551368|P1|Overall Study|Other|24
7631245|NCT01671111|26551368|P1|Overall Study|Physician Decision|1
7631246|NCT01671111|26551368|P1|Overall Study|Withdrawal by Subject|2
7631247|NCT01671111|26551368|P1|Overall Study|Lack of Efficacy|1
7631248|NCT01671111|26551368|P1|Overall Study|Adverse Event|2
7631249|NCT01671085|26551380|P2|Overall Study|Withdrawal by Subject|0
7631250|NCT01671085|26551381|P1|Overall Study|Withdrawal by Subject|1
7631251|NCT01671059|26551392|P1|Overall Study|Lack of Efficacy|1
7631252|NCT01671059|26551392|P1|Overall Study|Adverse Event|4
7631253|NCT01671007|26551424|P9|Overall Study|Not eligible|0
7631254|NCT01671007|26551425|P8|Overall Study|Not eligible|19
7631255|NCT01671007|26551426|P7|Overall Study|Not eligible|1
7631256|NCT01671007|26551427|P6|Overall Study|Not eligible|6
7631257|NCT01671007|26551428|P5|Overall Study|Not eligible|0
7631258|NCT01671007|26551429|P4|Overall Study|Not eligible|17
7631259|NCT01671007|26551430|P3|Overall Study|Not eligible|25
7631260|NCT01671007|26551431|P2|Overall Study|Not eligible|76
7631261|NCT01671007|26551432|P1|Overall Study|Not eligible|23
7631262|NCT01671007|26551424|P9|Overall Study|No end of study case report form|0
7631263|NCT01671007|26551425|P8|Overall Study|No end of study case report form|0
7631264|NCT01671007|26551426|P7|Overall Study|No end of study case report form|0
7631265|NCT01671007|26551427|P6|Overall Study|No end of study case report form|0
7631266|NCT01671007|26551428|P5|Overall Study|No end of study case report form|0
7631267|NCT01671007|26551429|P4|Overall Study|No end of study case report form|2
7631268|NCT01671007|26551430|P3|Overall Study|No end of study case report form|0
7631269|NCT01671007|26551431|P2|Overall Study|No end of study case report form|1
7631270|NCT01671007|26551432|P1|Overall Study|No end of study case report form|3
7631271|NCT01671007|26551424|P9|Overall Study|Lost to Follow-up|0
7631272|NCT01671007|26551425|P8|Overall Study|Lost to Follow-up|28
7631273|NCT01671007|26551426|P7|Overall Study|Lost to Follow-up|2
7631274|NCT01671007|26551427|P6|Overall Study|Lost to Follow-up|20
7631275|NCT01671007|26551428|P5|Overall Study|Lost to Follow-up|7
7631276|NCT01671007|26551429|P4|Overall Study|Lost to Follow-up|63
7631277|NCT01671007|26551430|P3|Overall Study|Lost to Follow-up|91
7631278|NCT01671007|26551431|P2|Overall Study|Lost to Follow-up|142
7631279|NCT01671007|26551432|P1|Overall Study|Lost to Follow-up|93
7631280|NCT01671007|26551424|P9|Overall Study|Withdrawal by Subject|0
7631281|NCT01671007|26551425|P8|Overall Study|Withdrawal by Subject|19
7631282|NCT01671007|26551426|P7|Overall Study|Withdrawal by Subject|1
7631283|NCT01671007|26551427|P6|Overall Study|Withdrawal by Subject|15
7631284|NCT01671007|26551428|P5|Overall Study|Withdrawal by Subject|4
7631285|NCT01671007|26551429|P4|Overall Study|Withdrawal by Subject|58
7631286|NCT01671007|26551430|P3|Overall Study|Withdrawal by Subject|53
7631287|NCT01671007|26551431|P2|Overall Study|Withdrawal by Subject|59
7631288|NCT01671007|26551432|P1|Overall Study|Withdrawal by Subject|36
7631289|NCT01671007|26551424|P9|Overall Study|Other reasons than listed|0
7631290|NCT01671007|26551425|P8|Overall Study|Other reasons than listed|66
7631291|NCT01671007|26551426|P7|Overall Study|Other reasons than listed|17
7631292|NCT01671007|26551427|P6|Overall Study|Other reasons than listed|71
7631293|NCT01671007|26551428|P5|Overall Study|Other reasons than listed|14
7631294|NCT01671007|26551429|P4|Overall Study|Other reasons than listed|228
7631295|NCT01671007|26551430|P3|Overall Study|Other reasons than listed|197
7631296|NCT01671007|26551431|P2|Overall Study|Other reasons than listed|373
7631297|NCT01671007|26551432|P1|Overall Study|Other reasons than listed|166
7631298|NCT01670721|26551538|P1|Overall Study|Other than specified above|38
7631299|NCT01670721|26551538|P1|Overall Study|Participant's decision|15
7631300|NCT01670656|26551550|P5|Overall Study|Subject moved|0
7631301|NCT01670656|26551551|P4|Overall Study|Subject moved|1
7631302|NCT01670656|26551552|P3|Overall Study|Subject moved|0
7631303|NCT01670656|26551553|P2|Overall Study|Subject moved|0
7631304|NCT01670656|26551554|P1|Overall Study|Subject moved|0
7631305|NCT01670656|26551550|P5|Overall Study|Lost to Follow-up|3
7631306|NCT01670656|26551551|P4|Overall Study|Lost to Follow-up|0
7631307|NCT01670656|26551552|P3|Overall Study|Lost to Follow-up|0
7631308|NCT01670656|26551553|P2|Overall Study|Lost to Follow-up|0
7631309|NCT01670656|26551554|P1|Overall Study|Lost to Follow-up|0
7631310|NCT01670656|26551550|P5|Overall Study|Subject withdrew consent|1
7631311|NCT01670656|26551551|P4|Overall Study|Subject withdrew consent|1
7631312|NCT01670656|26551552|P3|Overall Study|Subject withdrew consent|2
7631313|NCT01670656|26551553|P2|Overall Study|Subject withdrew consent|1
7631314|NCT01670656|26551554|P1|Overall Study|Subject withdrew consent|0
7631315|NCT01670656|26551550|P5|Overall Study|Adverse Event|3
7631316|NCT01670656|26551551|P4|Overall Study|Adverse Event|3
7631317|NCT01670656|26551552|P3|Overall Study|Adverse Event|2
7631318|NCT01670656|26551553|P2|Overall Study|Adverse Event|2
7631319|NCT01670656|26551554|P1|Overall Study|Adverse Event|2
7631320|NCT01670656|26551550|P5|Overall Study|Non-compliance with protocol|2
7631321|NCT01670656|26551551|P4|Overall Study|Non-compliance with protocol|1
7631322|NCT01670656|26551552|P3|Overall Study|Non-compliance with protocol|1
7631323|NCT01670656|26551553|P2|Overall Study|Non-compliance with protocol|3
7631324|NCT01670656|26551554|P1|Overall Study|Non-compliance with protocol|0
7631325|NCT01670656|26551550|P5|Overall Study|Withdrawal by Subject|0
7631326|NCT01670656|26551551|P4|Overall Study|Withdrawal by Subject|0
7631327|NCT01670656|26551552|P3|Overall Study|Withdrawal by Subject|0
7631328|NCT01670656|26551553|P2|Overall Study|Withdrawal by Subject|1
7631329|NCT01670656|26551554|P1|Overall Study|Withdrawal by Subject|1
7631330|NCT01670656|26551550|P5|Overall Study|Pregnancy|1
7631331|NCT01670656|26551551|P4|Overall Study|Pregnancy|0
7631332|NCT01670656|26551552|P3|Overall Study|Pregnancy|0
7631333|NCT01670656|26551553|P2|Overall Study|Pregnancy|0
7631334|NCT01670656|26551554|P1|Overall Study|Pregnancy|0
7631335|NCT01670656|26551550|P5|Overall Study|Non-compliance with study drug|1
7631336|NCT01670656|26551551|P4|Overall Study|Non-compliance with study drug|0
7631337|NCT01670656|26551552|P3|Overall Study|Non-compliance with study drug|3
7631338|NCT01670656|26551553|P2|Overall Study|Non-compliance with study drug|0
7631339|NCT01670656|26551554|P1|Overall Study|Non-compliance with study drug|0
7631340|NCT01670526|26551583|P2|Overall Study|Lost to Follow-up|5
7631341|NCT01670526|26551584|P1|Overall Study|Lost to Follow-up|9
7631342|NCT01670526|26551583|P2|Overall Study|Withdrawal by Subject|1
7631343|NCT01670526|26551584|P1|Overall Study|Withdrawal by Subject|3
7631344|NCT01670500|26551598|P2|Overall Study|Withdrawal by Subject|0
7631345|NCT01670500|26551599|P1|Overall Study|Withdrawal by Subject|1
7631346|NCT01670292|26551622|P1|Overall Study|Lost to Follow-up|14
7631347|NCT01670279|26551663|P4|Overall Study|Participant met withdrawal criteria|1
7631348|NCT01670279|26551664|P3|Overall Study|Participant met withdrawal criteria|0
7631349|NCT01670279|26551665|P2|Overall Study|Participant met withdrawal criteria|0
7631350|NCT01670279|26551666|P1|Overall Study|Participant met withdrawal criteria|0
7631351|NCT01670279|26551663|P4|Overall Study|Physician Decision|0
7631352|NCT01670279|26551664|P3|Overall Study|Physician Decision|0
7631353|NCT01670279|26551665|P2|Overall Study|Physician Decision|1
7631354|NCT01670279|26551666|P1|Overall Study|Physician Decision|0
7631355|NCT01670279|26551663|P4|Overall Study|Adverse Event|0
7631356|NCT01670279|26551664|P3|Overall Study|Adverse Event|0
7631357|NCT01670279|26551665|P2|Overall Study|Adverse Event|1
7631358|NCT01670279|26551666|P1|Overall Study|Adverse Event|0
7631359|NCT01670188|26551708|P2|Overall Study|Death|1
7631360|NCT01670188|26551709|P1|Overall Study|Death|0
7631361|NCT01670097|26551740|P2|Overall Study|Disease progression|1
7631362|NCT01670097|26551741|P1|Overall Study|Disease progression|0
7631363|NCT01670097|26551740|P2|Overall Study|Clinical deterioration|1
7631364|NCT01670097|26551741|P1|Overall Study|Clinical deterioration|0
7631365|NCT01670097|26551740|P2|Overall Study|Neutropenia|1
7631366|NCT01670097|26551741|P1|Overall Study|Neutropenia|0
7631367|NCT01670097|26551740|P2|Overall Study|COPD exacerbation|1
7631368|NCT01670097|26551741|P1|Overall Study|COPD exacerbation|0
7631369|NCT01670097|26551740|P2|Overall Study|Study burden|0
7631370|NCT01670097|26551741|P1|Overall Study|Study burden|1
7631371|NCT01670097|26551740|P2|Overall Study|Started Phase 1 cancer treatment|0
7631372|NCT01670097|26551741|P1|Overall Study|Started Phase 1 cancer treatment|1
7631373|NCT01670045|26551753|P1|Overall Study|Lost to Follow-up|11
7631374|NCT01670045|26551753|P1|Overall Study|Death|1
7631375|NCT01670045|26551753|P1|Overall Study|Adverse Event|1
7631376|NCT01670045|26551753|P1|Overall Study|Withdrawal by Subject|3
7631377|NCT01670019|26551771|P2|Overall Study|Withdrawal by Subject|0
7631378|NCT01670019|26551772|P1|Overall Study|Withdrawal by Subject|6
7631379|NCT01670019|26551771|P2|Overall Study|Adverse Event|0
7631380|NCT01670019|26551772|P1|Overall Study|Adverse Event|3
7631381|NCT01669928|26551788|P2|First Intervention|Withdrawal by Subject|5
7631382|NCT01669928|26551789|P1|First Intervention|Withdrawal by Subject|3
7631383|NCT01669902|26551811|P1|Overall Study|Other|8
7631384|NCT01669902|26551811|P1|Overall Study|Lack of Efficacy|10
7631385|NCT01669902|26551811|P1|Overall Study|Adverse Event|11
7631386|NCT01669811|26551846|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
7631387|NCT01669811|26551847|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
7631388|NCT01669811|26551846|P2|Overall Study|Adverse Event|6
7631389|NCT01669811|26551847|P1|Overall Study|Adverse Event|2
7631390|NCT01669811|26551846|P2|Overall Study|Withdrawal by Subject|2
7631391|NCT01669811|26551847|P1|Overall Study|Withdrawal by Subject|1
7631392|NCT01669811|26551846|P2|Overall Study|Investigator decision|1
7631393|NCT01669811|26551847|P1|Overall Study|Investigator decision|0
7631394|NCT01669798|26551865|P1|Overall Study|Physician Decision|5
7631395|NCT01669629|26551971|P2|Period 1|protocol deviation|2
7631396|NCT01669629|26551972|P1|Period 1|protocol deviation|1
7631397|NCT01669577|26551995|P1|Overall Study|Physician Decision|34
7631398|NCT01669577|26551995|P1|Overall Study|Lost to Follow-up|78
7631399|NCT01669577|26551995|P1|Overall Study|Death|22
7631400|NCT01669421|26552033|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
7631401|NCT01669421|26552033|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
7631402|NCT01669343|26552050|P1|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
7631403|NCT01669343|26552050|P1|Part B: Patients With BMI>=25|Recruited during interim analysis|3
7631404|NCT01669343|26552050|P1|Part B: Patients With BMI>=25|Withdrawal by Subject|13
7631405|NCT01669343|26552050|P1|Part A: All Patients|Ineligibility discovered after enrollment|2
7631406|NCT01669343|26552050|P1|Part A: All Patients|Withdrawal by Subject|7
7631407|NCT01669174|26552063|P2|Overall Study|Administrative problems|2
7631408|NCT01669174|26552064|P1|Overall Study|Administrative problems|1
7631409|NCT01669174|26552063|P2|Overall Study|Adverse Event|2
7631410|NCT01669174|26552064|P1|Overall Study|Adverse Event|2
7631411|NCT01669174|26552063|P2|Overall Study|Lost to Follow-up|0
7631412|NCT01669174|26552064|P1|Overall Study|Lost to Follow-up|1
7631413|NCT01669174|26552063|P2|Overall Study|Subject withdrew consent|2
7631414|NCT01669174|26552064|P1|Overall Study|Subject withdrew consent|2
7631415|NCT01669122|26552080|P1|Washout Period II|Protocol Violation|2
7631416|NCT01669122|26552080|P1|Period I|Lost to Follow-up|1
7631417|NCT01668966|26552147|P1|Overall Study|Not treated|2
7631418|NCT01668966|26552147|P1|Overall Study|Death|1
7631419|NCT01668966|26552147|P1|Overall Study|Withdrawal by Subject|1
7631420|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
7631421|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
7631422|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7631423|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7631424|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
7631425|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
7631426|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7631427|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7631428|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
7631429|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
7631430|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7631431|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7631432|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
7631433|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
7631434|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7631435|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7631436|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7631437|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
7631438|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7631439|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7631440|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
7631441|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
7631442|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7631443|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7631444|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
7631445|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
7631446|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7631447|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7631448|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7631449|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7631450|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7631451|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7631452|NCT01668797|26552243|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
7631453|NCT01668797|26552244|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
7631454|NCT01668797|26552245|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7631455|NCT01668797|26552246|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7631456|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7631457|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7631458|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
7631459|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7631460|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7631461|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7631462|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
7631463|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7631464|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
7631465|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
7631466|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
7631467|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
7631468|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Protocol Violation|0
7631469|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Protocol Violation|0
7631470|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Protocol Violation|3
7631471|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Protocol Violation|0
7631472|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7631473|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7631474|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
7631475|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7631476|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Physician Decision|0
7631477|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Physician Decision|0
7631478|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Physician Decision|11
7631479|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Physician Decision|0
7631480|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7631481|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7631482|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
7631483|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7631484|NCT01668797|26552243|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
7631485|NCT01668797|26552244|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
7631486|NCT01668797|26552245|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
7631487|NCT01668797|26552246|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
7631488|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7631489|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7631490|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7631491|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
7631492|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7631493|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7631494|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7631495|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
7631496|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
7631497|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
7631498|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
7631499|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
7631500|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Protocol Violation|0
7631501|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Protocol Violation|0
7631502|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Protocol Violation|0
7631503|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Protocol Violation|2
7631504|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
7631505|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
7631506|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
7631507|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
7631508|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Physician Decision|0
7631509|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Physician Decision|0
7631510|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Physician Decision|0
7631511|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Physician Decision|2
7631512|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7631513|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7631514|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7631515|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
7631516|NCT01668797|26552243|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
7631517|NCT01668797|26552244|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
7631518|NCT01668797|26552245|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
7631519|NCT01668797|26552246|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
7631520|NCT01668784|26552311|P2|Treated (Overall)|Other|4
7631521|NCT01668784|26552312|P1|Treated (Overall)|Other|0
7631522|NCT01668784|26552311|P2|Treated (Overall)|Maximal Clinical Benefit|3
7631523|NCT01668784|26552312|P1|Treated (Overall)|Maximal Clinical Benefit|2
7631524|NCT01668784|26552311|P2|Treated (Overall)|Withdrawal by Subject|3
7631525|NCT01668784|26552312|P1|Treated (Overall)|Withdrawal by Subject|2
7631526|NCT01668784|26552311|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
7631527|NCT01668784|26552312|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
7631528|NCT01668784|26552311|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
7631529|NCT01668784|26552312|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
7631530|NCT01668784|26552311|P2|Treated (Overall)|Death|1
7631531|NCT01668784|26552312|P1|Treated (Overall)|Death|1
7631532|NCT01668784|26552311|P2|Treated (Overall)|Study Drug Toxicity|53
7631533|NCT01668784|26552312|P1|Treated (Overall)|Study Drug Toxicity|35
7631534|NCT01668784|26552311|P2|Treated (Overall)|Disease Progression|273
7631535|NCT01668784|26552312|P1|Treated (Overall)|Disease Progression|285
7631536|NCT01668784|26552311|P2|Randomized (Pre-treatment)|Other|1
7631537|NCT01668784|26552312|P1|Randomized (Pre-treatment)|Other|0
7631538|NCT01668784|26552311|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
7631539|NCT01668784|26552312|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
7631540|NCT01668784|26552311|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
7631541|NCT01668784|26552312|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
7631542|NCT01668784|26552311|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
7631543|NCT01668784|26552312|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
7631544|NCT01668784|26552311|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
7631545|NCT01668784|26552312|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
7631546|NCT01668784|26552311|P2|Randomized (Pre-treatment)|Disease Progression|1
7631547|NCT01668784|26552312|P1|Randomized (Pre-treatment)|Disease Progression|0
7631548|NCT01668667|26552340|P4|Overall Study|Withdrawal by Subject|5
7631549|NCT01668667|26552341|P3|Overall Study|Withdrawal by Subject|5
7631550|NCT01668667|26552342|P2|Overall Study|Withdrawal by Subject|4
7631551|NCT01668667|26552343|P1|Overall Study|Withdrawal by Subject|7
7631552|NCT01668667|26552340|P4|Overall Study|Physician Decision|0
7631553|NCT01668667|26552341|P3|Overall Study|Physician Decision|1
7631554|NCT01668667|26552342|P2|Overall Study|Physician Decision|0
7631555|NCT01668667|26552343|P1|Overall Study|Physician Decision|3
7631556|NCT01668667|26552340|P4|Overall Study|Lost to Follow-up|6
7631557|NCT01668667|26552341|P3|Overall Study|Lost to Follow-up|7
7631558|NCT01668667|26552342|P2|Overall Study|Lost to Follow-up|4
7631559|NCT01668667|26552343|P1|Overall Study|Lost to Follow-up|9
7631560|NCT01668667|26552340|P4|Overall Study|Protocol Violation|5
7631561|NCT01668667|26552341|P3|Overall Study|Protocol Violation|12
7631562|NCT01668667|26552342|P2|Overall Study|Protocol Violation|10
7631563|NCT01668667|26552343|P1|Overall Study|Protocol Violation|6
7631564|NCT01668667|26552340|P4|Overall Study|Lack of Efficacy|3
7631565|NCT01668667|26552341|P3|Overall Study|Lack of Efficacy|2
7631566|NCT01668667|26552342|P2|Overall Study|Lack of Efficacy|2
7631567|NCT01668667|26552343|P1|Overall Study|Lack of Efficacy|3
7631568|NCT01668667|26552340|P4|Overall Study|Adverse Event|4
7631569|NCT01668667|26552341|P3|Overall Study|Adverse Event|4
7631570|NCT01668667|26552342|P2|Overall Study|Adverse Event|6
7631571|NCT01668667|26552343|P1|Overall Study|Adverse Event|3
7631572|NCT01668654|26552365|P1|Overall Study|Withdrawal by Subject|1
7631573|NCT01668654|26552365|P1|Overall Study|Study Closed/Terminated|3
7631574|NCT01668589|26552443|P4|Overall Study|Other|15
7631575|NCT01668589|26552444|P3|Overall Study|Other|7
7631576|NCT01668589|26552445|P2|Overall Study|Other|10
7631577|NCT01668589|26552446|P1|Overall Study|Other|44
7631578|NCT01668589|26552443|P4|Overall Study|Death|11
7631579|NCT01668589|26552444|P3|Overall Study|Death|2
7631580|NCT01668589|26552445|P2|Overall Study|Death|3
7631581|NCT01668589|26552446|P1|Overall Study|Death|12
7631582|NCT01668589|26552443|P4|Overall Study|Full Consent/Agreement Withdrawn|4
7631583|NCT01668589|26552444|P3|Overall Study|Full Consent/Agreement Withdrawn|11
7631584|NCT01668589|26552445|P2|Overall Study|Full Consent/Agreement Withdrawn|8
7631585|NCT01668589|26552446|P1|Overall Study|Full Consent/Agreement Withdrawn|54
7631586|NCT01668589|26552443|P4|Overall Study|Lost to Follow-up|5
7631587|NCT01668589|26552444|P3|Overall Study|Lost to Follow-up|15
7631588|NCT01668589|26552445|P2|Overall Study|Lost to Follow-up|37
7631589|NCT01668589|26552446|P1|Overall Study|Lost to Follow-up|29
7631590|NCT01668537|26552486|P2|Overall Study|Other|3
7631591|NCT01668537|26552487|P1|Overall Study|Other|2
7631592|NCT01668537|26552486|P2|Overall Study|Lost to Follow-up|6
7631593|NCT01668537|26552487|P1|Overall Study|Lost to Follow-up|13
7631594|NCT01668537|26552486|P2|Overall Study|Reason Precludes Participation|0
7631595|NCT01668537|26552487|P1|Overall Study|Reason Precludes Participation|1
7631596|NCT01668537|26552486|P2|Overall Study|Subject unwilling/unable to comply|0
7631597|NCT01668537|26552487|P1|Overall Study|Subject unwilling/unable to comply|5
7631598|NCT01668537|26552486|P2|Overall Study|Request to Discontinue Prematurely|1
7631599|NCT01668537|26552487|P1|Overall Study|Request to Discontinue Prematurely|1
7631600|NCT01668355|26552529|P2|Overall Study|Withdrawal by Subject|1
7631601|NCT01668355|26552530|P1|Overall Study|Withdrawal by Subject|6
7631602|NCT01668355|26552529|P2|Overall Study|Death|1
7631603|NCT01668355|26552530|P1|Overall Study|Death|3
7631604|NCT01668173|26552550|P1|Overall Study|Trial suspension|4
7631605|NCT01668173|26552550|P1|Overall Study|Adverse Event|3
7631606|NCT01668147|26552554|P1|Overall Study|Withdrawal by Subject|6
7631607|NCT01668004|26552684|P1|Overall Study|Non-compliance with treatment|2
7631608|NCT01668004|26552684|P1|Overall Study|Lack of Efficacy|9
7631609|NCT01668004|26552684|P1|Overall Study|Lost to Follow-up|5
7631610|NCT01668004|26552684|P1|Overall Study|Withdrawal by Subject|2
7631611|NCT01668004|26552684|P1|Overall Study|Adverse Event|7
7631612|NCT01667926|26552706|P3|Overall Study|Side effects|0
7631613|NCT01667926|26552707|P2|Overall Study|Side effects|0
7631614|NCT01667926|26552708|P1|Overall Study|Side effects|3
7631615|NCT01667926|26552706|P3|Overall Study|Lost to Follow-up|1
7631616|NCT01667926|26552707|P2|Overall Study|Lost to Follow-up|2
7631617|NCT01667926|26552708|P1|Overall Study|Lost to Follow-up|1
7631618|NCT01667926|26552706|P3|Overall Study|Inclusion/Exclusion Criteria|5
7631619|NCT01667926|26552707|P2|Overall Study|Inclusion/Exclusion Criteria|0
7631620|NCT01667926|26552708|P1|Overall Study|Inclusion/Exclusion Criteria|0
7631621|NCT01667926|26552706|P3|Overall Study|Time committment|2
7631622|NCT01667926|26552707|P2|Overall Study|Time committment|0
7631623|NCT01667926|26552708|P1|Overall Study|Time committment|0
7631624|NCT01667926|26552706|P3|Overall Study|Physician Decision|1
7631625|NCT01667926|26552707|P2|Overall Study|Physician Decision|0
7631626|NCT01667926|26552708|P1|Overall Study|Physician Decision|0
7631627|NCT01667926|26552706|P3|Overall Study|Withdrawal by Subject|2
7631628|NCT01667926|26552707|P2|Overall Study|Withdrawal by Subject|2
7631629|NCT01667926|26552708|P1|Overall Study|Withdrawal by Subject|1
7631630|NCT01667900|26552721|P20|Part B|Death|0
7631631|NCT01667900|26552722|P19|Part B|Death|0
7631632|NCT01667900|26552723|P18|Part B|Death|0
7631633|NCT01667900|26552724|P17|Part B|Death|1
7631634|NCT01667900|26552725|P16|Part B|Death|0
7631635|NCT01667900|26552726|P15|Part B|Death|0
7631636|NCT01667900|26552727|P14|Part B|Death|0
7631637|NCT01667900|26552728|P13|Part B|Death|0
7631638|NCT01667900|26552729|P12|Part B|Death|0
7631639|NCT01667900|26552730|P11|Part B|Death|0
7631640|NCT01667900|26552731|P10|Part B|Death|0
7631641|NCT01667900|26552732|P9|Part B|Death|0
7631642|NCT01667900|26552733|P8|Part B|Death|0
7631643|NCT01667900|26552734|P7|Part B|Death|0
7631644|NCT01667900|26552735|P6|Part B|Death|0
7631645|NCT01667900|26552736|P5|Part B|Death|0
7631646|NCT01667900|26552737|P4|Part B|Death|0
7631647|NCT01667900|26552738|P3|Part B|Death|0
7631648|NCT01667900|26552739|P2|Part B|Death|0
7631649|NCT01667900|26552740|P1|Part B|Death|0
7631650|NCT01667731|26552810|P5|Overall Study|Death|0
7631651|NCT01667731|26552811|P4|Overall Study|Death|0
7631652|NCT01667731|26552812|P3|Overall Study|Death|0
7631653|NCT01667731|26552813|P2|Overall Study|Death|1
7631654|NCT01667731|26552814|P1|Overall Study|Death|0
7631655|NCT01667731|26552810|P5|Overall Study|Subject Withdrew Consent|1
7631656|NCT01667731|26552811|P4|Overall Study|Subject Withdrew Consent|0
7631657|NCT01667731|26552812|P3|Overall Study|Subject Withdrew Consent|1
7631658|NCT01667731|26552813|P2|Overall Study|Subject Withdrew Consent|0
7631659|NCT01667731|26552814|P1|Overall Study|Subject Withdrew Consent|2
7631660|NCT01667731|26552810|P5|Overall Study|Lost to Follow-up|2
7631661|NCT01667731|26552811|P4|Overall Study|Lost to Follow-up|1
7631662|NCT01667731|26552812|P3|Overall Study|Lost to Follow-up|1
7631663|NCT01667731|26552813|P2|Overall Study|Lost to Follow-up|3
7631664|NCT01667731|26552814|P1|Overall Study|Lost to Follow-up|2
7631665|NCT01667731|26552810|P5|Overall Study|Efficacy Failure|24
7631666|NCT01667731|26552811|P4|Overall Study|Efficacy Failure|1
7631667|NCT01667731|26552812|P3|Overall Study|Efficacy Failure|0
7631668|NCT01667731|26552813|P2|Overall Study|Efficacy Failure|12
7631669|NCT01667731|26552814|P1|Overall Study|Efficacy Failure|1
7631670|NCT01667731|26552810|P5|Overall Study|Enrolled but not treated|1
7631671|NCT01667731|26552811|P4|Overall Study|Enrolled but not treated|0
7631672|NCT01667731|26552812|P3|Overall Study|Enrolled but not treated|0
7631673|NCT01667731|26552813|P2|Overall Study|Enrolled but not treated|0
7631674|NCT01667731|26552814|P1|Overall Study|Enrolled but not treated|0
7631675|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
7631676|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
7631677|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
7631678|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
7631679|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
7631680|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
7631681|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
7631682|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
7631683|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
7631684|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
7631685|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
7631686|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
7631687|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
7631688|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
7631689|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
7631690|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
7631691|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
7631692|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
7631693|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
7631694|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
7631695|NCT01667679|26552869|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
7631696|NCT01667679|26552870|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
7631697|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
7631698|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
7631699|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
7631700|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
7631701|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
7631702|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
7631703|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
7631704|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
7631705|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7631706|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7631707|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
7631708|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
7631709|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
7631710|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
7631711|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
7631712|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
7631713|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
7631714|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
7631715|NCT01667679|26552869|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
7631716|NCT01667679|26552870|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
7631717|NCT01667562|26552928|P2|Erlotinib Phase|Switch to Commercial Drug|1
7631718|NCT01667562|26552929|P1|Erlotinib Phase|Switch to Commercial Drug|0
7631719|NCT01667562|26552928|P2|Erlotinib Phase|Adverse Event|1
7631720|NCT01667562|26552929|P1|Erlotinib Phase|Adverse Event|0
7631721|NCT01667562|26552928|P2|Erlotinib Phase|Lost to Follow-up|1
7631722|NCT01667562|26552929|P1|Erlotinib Phase|Lost to Follow-up|0
7631723|NCT01667562|26552928|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
7631724|NCT01667562|26552929|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
7631725|NCT01667549|26552943|P5|Overall Study|Withdrawal by Subject|1
7631726|NCT01667549|26552944|P4|Overall Study|Withdrawal by Subject|6
7631727|NCT01667549|26552945|P3|Overall Study|Withdrawal by Subject|7
7631728|NCT01667549|26552946|P2|Overall Study|Withdrawal by Subject|5
7631729|NCT01667549|26552947|P1|Overall Study|Withdrawal by Subject|3
7631730|NCT01667432|26553006|P1|Overall Study|Missing Information|4
7631731|NCT01667432|26553006|P1|Overall Study|Reason Not Specified|2
7631732|NCT01667432|26553006|P1|Overall Study|Principal Investigator Decision|1
7631733|NCT01667432|26553006|P1|Overall Study|Protocol Deviation|2
7631734|NCT01667432|26553006|P1|Overall Study|Adverse Event|1
7631735|NCT01667432|26553006|P1|Overall Study|Insufficient Therapeutic Response|4
7631736|NCT01667432|26553006|P1|Overall Study|Refused Treatment/Withdrew Consent|1
7631737|NCT01667432|26553006|P1|Overall Study|Lost to Follow-up|3
7631738|NCT01667432|26553006|P1|Overall Study|Moved to Another Center|3
7631739|NCT01667432|26553006|P1|Overall Study|Failure to Return|10
7631740|NCT01667432|26553006|P1|Overall Study|Premature Study Termination|26
7631741|NCT01667419|26553015|P4|Overall Study|Death|26
7631742|NCT01667419|26553016|P3|Overall Study|Death|25
7631743|NCT01667419|26553017|P2|Overall Study|Death|33
7631744|NCT01667419|26553018|P1|Overall Study|Death|18
7631745|NCT01667419|26553015|P4|Overall Study|Lost to Follow-up|4
7631746|NCT01667419|26553016|P3|Overall Study|Lost to Follow-up|2
7631747|NCT01667419|26553017|P2|Overall Study|Lost to Follow-up|6
7631748|NCT01667419|26553018|P1|Overall Study|Lost to Follow-up|7
7631749|NCT01667419|26553015|P4|Overall Study|Protocol Violation|0
7631750|NCT01667419|26553016|P3|Overall Study|Protocol Violation|0
7631751|NCT01667419|26553017|P2|Overall Study|Protocol Violation|0
7631752|NCT01667419|26553018|P1|Overall Study|Protocol Violation|1
7631753|NCT01667419|26553015|P4|Overall Study|Non-compliance|1
7631754|NCT01667419|26553016|P3|Overall Study|Non-compliance|0
7631755|NCT01667419|26553017|P2|Overall Study|Non-compliance|0
7631756|NCT01667419|26553018|P1|Overall Study|Non-compliance|0
7631757|NCT01667419|26553015|P4|Overall Study|Withdrawal by Subject|8
7631758|NCT01667419|26553016|P3|Overall Study|Withdrawal by Subject|9
7631759|NCT01667419|26553017|P2|Overall Study|Withdrawal by Subject|8
7631760|NCT01667419|26553018|P1|Overall Study|Withdrawal by Subject|16
7631761|NCT01667419|26553015|P4|Overall Study|Reason Not Specified|0
7631762|NCT01667419|26553016|P3|Overall Study|Reason Not Specified|0
7631763|NCT01667419|26553017|P2|Overall Study|Reason Not Specified|0
7631764|NCT01667419|26553018|P1|Overall Study|Reason Not Specified|1
7631765|NCT01667224|26553157|P2|Overall Study|Protocol Violation|1
7631766|NCT01667224|26553158|P1|Overall Study|Protocol Violation|1
7631767|NCT01667224|26553157|P2|Overall Study|Withdrawal by Subject|1
7631768|NCT01667224|26553158|P1|Overall Study|Withdrawal by Subject|3
7631769|NCT01667107|26553172|P2|Overall Study|Lack of Efficacy|1
7631770|NCT01667107|26553173|P1|Overall Study|Lack of Efficacy|0
7631771|NCT01667107|26553172|P2|Overall Study|Protocol Violation|1
7631772|NCT01667107|26553173|P1|Overall Study|Protocol Violation|0
7631773|NCT01667107|26553172|P2|Overall Study|Tolerability issues|2
7631774|NCT01667107|26553173|P1|Overall Study|Tolerability issues|0
7631775|NCT01667107|26553172|P2|Overall Study|Adverse Event|3
7631776|NCT01667107|26553173|P1|Overall Study|Adverse Event|4
7631777|NCT01666951|26553232|P2|Overall Study|Not dosed|1
7631778|NCT01666951|26553233|P1|Overall Study|Not dosed|1
7631779|NCT01666782|26553284|P2|Overall Study|Enrolled both years; year 1 data used|0
7631780|NCT01666782|26553285|P1|Overall Study|Enrolled both years; year 1 data used|4
7631781|NCT01666782|26553284|P2|Overall Study|Received 2 doses of vaccine|1
7631782|NCT01666782|26553285|P1|Overall Study|Received 2 doses of vaccine|0
7631783|NCT01666730|26553301|P1|Overall Study|Disease progression/relapse|18
7631784|NCT01666730|26553301|P1|Overall Study|Withdrawal by Subject|9
7631785|NCT01666730|26553301|P1|Overall Study|Physician Decision|5
7631786|NCT01666730|26553301|P1|Overall Study|Death|2
7631787|NCT01666730|26553301|P1|Overall Study|Adverse Event|16
7631788|NCT01666652|26553314|P5|Overall Study|Lost to Follow-up|0
7631789|NCT01666652|26553315|P4|Overall Study|Lost to Follow-up|1
7631790|NCT01666652|26553316|P3|Overall Study|Lost to Follow-up|1
7631791|NCT01666652|26553317|P2|Overall Study|Lost to Follow-up|1
7631792|NCT01666652|26553318|P1|Overall Study|Lost to Follow-up|1
7631793|NCT01666652|26553314|P5|Overall Study|Moved from study area|0
7631794|NCT01666652|26553315|P4|Overall Study|Moved from study area|2
7631795|NCT01666652|26553316|P3|Overall Study|Moved from study area|0
7631796|NCT01666652|26553317|P2|Overall Study|Moved from study area|0
7631797|NCT01666652|26553318|P1|Overall Study|Moved from study area|1
7631798|NCT01666652|26553314|P5|Overall Study|Withdrawal by Subject|1
7631799|NCT01666652|26553315|P4|Overall Study|Withdrawal by Subject|0
7631800|NCT01666652|26553316|P3|Overall Study|Withdrawal by Subject|0
7631801|NCT01666652|26553317|P2|Overall Study|Withdrawal by Subject|0
7631802|NCT01666652|26553318|P1|Overall Study|Withdrawal by Subject|0
7631803|NCT01666652|26553314|P5|Overall Study|Serious Adverse Event|0
7631804|NCT01666652|26553315|P4|Overall Study|Serious Adverse Event|1
7631805|NCT01666652|26553316|P3|Overall Study|Serious Adverse Event|0
7631806|NCT01666652|26553317|P2|Overall Study|Serious Adverse Event|0
7631807|NCT01666652|26553318|P1|Overall Study|Serious Adverse Event|0
7631808|NCT01666444|26553367|P2|Overall Study|Did not initiate treatment|1
7631809|NCT01666444|26553368|P1|Overall Study|Did not initiate treatment|2
7631810|NCT01666314|26553386|P4|Overall Study|Reason not Specified|5
7631811|NCT01666314|26553387|P3|Overall Study|Reason not Specified|5
7631812|NCT01666314|26553388|P2|Overall Study|Reason not Specified|7
7631813|NCT01666314|26553389|P1|Overall Study|Reason not Specified|10
7631814|NCT01666314|26553386|P4|Overall Study|Withdrawal by Subject|3
7631815|NCT01666314|26553387|P3|Overall Study|Withdrawal by Subject|2
7631816|NCT01666314|26553388|P2|Overall Study|Withdrawal by Subject|1
7631817|NCT01666314|26553389|P1|Overall Study|Withdrawal by Subject|1
7631818|NCT01666314|26553386|P4|Overall Study|Unsatisfactory Therapeutic Response|1
7631819|NCT01666314|26553387|P3|Overall Study|Unsatisfactory Therapeutic Response|1
7631820|NCT01666314|26553388|P2|Overall Study|Unsatisfactory Therapeutic Response|2
7631821|NCT01666314|26553389|P1|Overall Study|Unsatisfactory Therapeutic Response|7
7631822|NCT01666314|26553386|P4|Overall Study|Symptomatic Deterioration|0
7631823|NCT01666314|26553387|P3|Overall Study|Symptomatic Deterioration|2
7631824|NCT01666314|26553388|P2|Overall Study|Symptomatic Deterioration|0
7631825|NCT01666314|26553389|P1|Overall Study|Symptomatic Deterioration|1
7631826|NCT01666314|26553386|P4|Overall Study|Progressive Disease|20
7631827|NCT01666314|26553387|P3|Overall Study|Progressive Disease|19
7631828|NCT01666314|26553388|P2|Overall Study|Progressive Disease|9
7631829|NCT01666314|26553389|P1|Overall Study|Progressive Disease|11
7631830|NCT01666314|26553386|P4|Overall Study|Adverse Event|7
7631831|NCT01666314|26553387|P3|Overall Study|Adverse Event|7
7631832|NCT01666314|26553388|P2|Overall Study|Adverse Event|13
7631833|NCT01666314|26553389|P1|Overall Study|Adverse Event|3
7631834|NCT01666119|26553525|P1|Overall Study|Subject experiencing withdrawal symptoms|5
7631835|NCT01666119|26553525|P1|Overall Study|non compliance with study medication, pa|18
7631836|NCT01666119|26553525|P1|Overall Study|Lost to Follow-up|7
7631837|NCT01666119|26553525|P1|Overall Study|Withdrawal by Subject|16
7631838|NCT01666119|26553525|P1|Overall Study|Adverse Event|6
7631839|NCT01666002|26553532|P2|Overall Study|Lost to Follow-up|0
7631840|NCT01666002|26553533|P1|Overall Study|Lost to Follow-up|5
7631841|NCT01665911|26553554|P1|Overall Study|Adverse Event|1
7631842|NCT01665911|26553554|P1|Overall Study|Withdrawal by Subject|1
7631843|NCT01665911|26553554|P1|Overall Study|Protocol Violation|4
7631844|NCT01665807|26553580|P3|Overall Study|Withdrawal by Subject|1
7631845|NCT01665807|26553581|P2|Overall Study|Withdrawal by Subject|0
7631846|NCT01665807|26553582|P1|Overall Study|Withdrawal by Subject|2
7631850|NCT01665599|26553598|P1|Overall Study|Could Not Continue Due to Time Constrain|1
7631851|NCT01665599|26553598|P1|Overall Study|Participant Left for More Than 3 Months|1
7631852|NCT01665599|26553598|P1|Overall Study|Lost to Follow-up|2
7631853|NCT01665599|26553598|P1|Overall Study|Death|1
7631854|NCT01665599|26553598|P1|Overall Study|Investigator/Sponsor decision|1
7631855|NCT01665599|26553598|P1|Overall Study|Consent Withdrawn|1
7631856|NCT01665599|26553598|P1|Overall Study|Adverse Event|1
7631857|NCT01665430|26553634|P1|Overall Study|Other Unspecified|2
7631858|NCT01665430|26553634|P1|Overall Study|Withdrawal by Subject|6
7631859|NCT01665430|26553634|P1|Overall Study|Adverse Event|1
7631882|NCT01664949|26553813|P2|Overall Study|Other Miscellaneous Reasons|1
7631883|NCT01664949|26553814|P1|Overall Study|Other Miscellaneous Reasons|3
7631884|NCT01664949|26553813|P2|Overall Study|Protocol Violation|5
7631885|NCT01664949|26553814|P1|Overall Study|Protocol Violation|5
7631886|NCT01664949|26553813|P2|Overall Study|Personal Reasons|4
7631887|NCT01664949|26553814|P1|Overall Study|Personal Reasons|3
7631888|NCT01664949|26553813|P2|Overall Study|Lost to Follow-up|2
7631889|NCT01664949|26553814|P1|Overall Study|Lost to Follow-up|1
7631890|NCT01664949|26553813|P2|Overall Study|Lack of Efficacy|1
7631891|NCT01664949|26553814|P1|Overall Study|Lack of Efficacy|1
7631892|NCT01664949|26553813|P2|Overall Study|Adverse Event|12
7631893|NCT01664949|26553814|P1|Overall Study|Adverse Event|11
7631894|NCT01664923|26553830|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
7631895|NCT01664923|26553831|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
7631896|NCT01664923|26553830|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
7631897|NCT01664923|26553831|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
7631898|NCT01664923|26553830|P2|Period 2: Open-label Phase-36 Months|Other|1
7631899|NCT01664923|26553831|P1|Period 2: Open-label Phase-36 Months|Other|3
7631900|NCT01664923|26553830|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
7631901|NCT01664923|26553831|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
7631902|NCT01664923|26553830|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
7631903|NCT01664923|26553831|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
7631904|NCT01664923|26553830|P2|Period 2: Open-label Phase-36 Months|Death|1
7631905|NCT01664923|26553831|P1|Period 2: Open-label Phase-36 Months|Death|3
7631906|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
7631907|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
7631908|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Other|4
7631909|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Other|3
7631910|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
7631911|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
7631912|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
7631913|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
7631914|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
7631915|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
7631916|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
7631917|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
7631918|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
7631919|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
7631920|NCT01664923|26553830|P2|Period1:Double Blind Phase-29 Months|Death|6
7631921|NCT01664923|26553831|P1|Period1:Double Blind Phase-29 Months|Death|8
7631922|NCT01664624|26553922|P4|Overall Study|Adverse Event|0
7631923|NCT01664624|26553923|P3|Overall Study|Adverse Event|0
7631924|NCT01664624|26553924|P2|Overall Study|Adverse Event|1
7631925|NCT01664624|26553925|P1|Overall Study|Adverse Event|0
7631926|NCT01664533|26553972|P1|Overall Study|Protocol Violation|3
7631927|NCT01664533|26553972|P1|Overall Study|Study termination|9
7631928|NCT01664533|26553972|P1|Overall Study|Lost to Follow-up|3
7631929|NCT01664533|26553972|P1|Overall Study|Death|42
7631930|NCT01664494|26553980|P1|Overall Study|Lost to Follow-up|99
7631931|NCT01664494|26553980|P1|Overall Study|Other|49
7631932|NCT01664494|26553980|P1|Overall Study|Death|18
7631933|NCT01664494|26553980|P1|Overall Study|Withdrawal by Subject|27
7631934|NCT01664247|26553987|P2|Overall Study|Unclassified|29
7631935|NCT01664247|26553988|P1|Overall Study|Unclassified|5
7631936|NCT01664247|26553987|P2|Overall Study|Withdrawal Criteria|4
7631937|NCT01664247|26553988|P1|Overall Study|Withdrawal Criteria|1
7631938|NCT01664247|26553987|P2|Overall Study|Protocol Violation|5
7631939|NCT01664247|26553988|P1|Overall Study|Protocol Violation|3
7631940|NCT01664247|26553987|P2|Overall Study|Adverse Event|3
7631941|NCT01664247|26553988|P1|Overall Study|Adverse Event|5
7631942|NCT01664130|26554010|P1|Overall Study|competing secondary disease|2
7631943|NCT01664104|26554088|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
7631944|NCT01664104|26554088|P1|Overall Study|Other|1
7631945|NCT01664104|26554088|P1|Overall Study|Lost to Follow-up|4
7631946|NCT01664104|26554088|P1|Overall Study|Withdrawal by Subject|1
7631947|NCT01664104|26554088|P1|Overall Study|Lack of Efficacy|2
7631948|NCT01664104|26554088|P1|Overall Study|Adverse Event|6
7631949|NCT01664091|26554155|P1|Overall Study|Withdrawal by Subject|1
7631950|NCT01664091|26554155|P1|Overall Study|Lost to Follow-up|2
7631951|NCT01664091|26554155|P1|Overall Study|Disease Progression|2
7631952|NCT01664091|26554155|P1|Overall Study|Death|1
7631953|NCT01664078|26554163|P1|Overall Study|Other|53
7631954|NCT01664078|26554163|P1|Overall Study|missed 5 year visit|1
7631955|NCT01664078|26554163|P1|Overall Study|Lost to Follow-up|2
7631956|NCT01664078|26554163|P1|Overall Study|Withdrawal by Subject|4
7631957|NCT01664078|26554163|P1|Overall Study|Death|9
7631958|NCT01664052|26554216|P2|Phase 2|No device placement|4
7631959|NCT01664052|26554217|P1|Phase 2|No device placement|0
7631960|NCT01664052|26554216|P2|Phase 1|No HSG 1 hr post placement|0
7631961|NCT01664052|26554217|P1|Phase 1|No HSG 1 hr post placement|1
7631962|NCT01664052|26554216|P2|Phase 1|No device placement|0
7631963|NCT01664052|26554217|P1|Phase 1|No device placement|6
7631964|NCT01664039|26554235|P2|Overall Study|Noncompliance|1
7631965|NCT01664039|26554236|P1|Overall Study|Noncompliance|1
7631966|NCT01664039|26554235|P2|Overall Study|Withdrawal by Subject|3
7631967|NCT01664039|26554236|P1|Overall Study|Withdrawal by Subject|1
7631968|NCT01664039|26554235|P2|Overall Study|Lost to Follow-up|1
7631969|NCT01664039|26554236|P1|Overall Study|Lost to Follow-up|1
7631970|NCT01664039|26554235|P2|Overall Study|Adverse Event|4
7631971|NCT01664039|26554236|P1|Overall Study|Adverse Event|3
7631972|NCT01663987|26554258|P2|Overall Study|Other reason not defined above|0
7631973|NCT01663987|26554259|P1|Overall Study|Other reason not defined above|3
7631974|NCT01663987|26554258|P2|Overall Study|Withdrawal by Subject|3
7631975|NCT01663987|26554259|P1|Overall Study|Withdrawal by Subject|2
7631976|NCT01663987|26554258|P2|Overall Study|Lost to Follow-up|1
7631977|NCT01663987|26554259|P1|Overall Study|Lost to Follow-up|1
7631978|NCT01663987|26554258|P2|Overall Study|Adverse Event|2
7631979|NCT01663987|26554259|P1|Overall Study|Adverse Event|7
7631980|NCT01663896|26554298|P1|Overall Study|Various reasons|43
7631981|NCT01663857|26554309|P4|Overall Study|Lost to Follow-up|1
7631982|NCT01663857|26554310|P3|Overall Study|Lost to Follow-up|3
7631983|NCT01663857|26554311|P2|Overall Study|Lost to Follow-up|0
7631984|NCT01663857|26554312|P1|Overall Study|Lost to Follow-up|0
7631985|NCT01663857|26554309|P4|Overall Study|Withdrew Consent to Study Participation|3
7631986|NCT01663857|26554310|P3|Overall Study|Withdrew Consent to Study Participation|7
7631987|NCT01663857|26554311|P2|Overall Study|Withdrew Consent to Study Participation|1
7631988|NCT01663857|26554312|P1|Overall Study|Withdrew Consent to Study Participation|0
7631989|NCT01663740|26554340|P2|Overall Study|No end of study status|0
7631990|NCT01663740|26554341|P1|Overall Study|No end of study status|3
7631991|NCT01663740|26554340|P2|Overall Study|Withdrawal by Subject|1
7631992|NCT01663740|26554341|P1|Overall Study|Withdrawal by Subject|2
7631993|NCT01663740|26554340|P2|Overall Study|Death|1
7631994|NCT01663740|26554341|P1|Overall Study|Death|0
7631995|NCT01663740|26554340|P2|Overall Study|Inclusion/Exclusion not met|0
7631996|NCT01663740|26554341|P1|Overall Study|Inclusion/Exclusion not met|1
7631997|NCT01663740|26554340|P2|Overall Study|Other|2
7631998|NCT01663740|26554341|P1|Overall Study|Other|9
7631999|NCT01663740|26554340|P2|Overall Study|Lost to Follow-up|4
7632000|NCT01663740|26554341|P1|Overall Study|Lost to Follow-up|1
7632001|NCT01663727|26554401|P2|Overall Study|Withdrawal prior to dosing.|0
7632002|NCT01663727|26554402|P1|Overall Study|Withdrawal prior to dosing.|1
7632003|NCT01663727|26554401|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
7632004|NCT01663727|26554402|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
7632005|NCT01663727|26554401|P2|Overall Study|Study Terminated|50
7632006|NCT01663727|26554402|P1|Overall Study|Study Terminated|51
7632007|NCT01663727|26554401|P2|Overall Study|Withdrawal by Subject|25
7632008|NCT01663727|26554402|P1|Overall Study|Withdrawal by Subject|18
7632009|NCT01663727|26554401|P2|Overall Study|Lost to Follow-up|8
7632010|NCT01663727|26554402|P1|Overall Study|Lost to Follow-up|10
7632011|NCT01663727|26554401|P2|Overall Study|Death|155
7632012|NCT01663727|26554402|P1|Overall Study|Death|161
7632013|NCT01663714|26554434|P1|Long-Term Follow-Up|Non-compliance|1
7632014|NCT01663714|26554434|P1|Long-Term Follow-Up|Death|4
7632015|NCT01663714|26554434|P1|Long-Term Follow-Up|Lost to Follow-up|1
7632016|NCT01663714|26554434|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
7632017|NCT01663714|26554434|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
7632018|NCT01663714|26554434|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7632019|NCT01663636|26554463|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
7632020|NCT01663636|26554464|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
7632021|NCT01663623|26554472|P2|Overall Study|Withdrawal by Subject|1
7632022|NCT01663623|26554473|P1|Overall Study|Withdrawal by Subject|2
7632023|NCT01663623|26554472|P2|Overall Study|Physician Decision|4
7632024|NCT01663623|26554473|P1|Overall Study|Physician Decision|1
7632025|NCT01663623|26554472|P2|Overall Study|Other-Study closed/terminated|1
7632026|NCT01663623|26554473|P1|Overall Study|Other-Study closed/terminated|1
7632027|NCT01663623|26554472|P2|Overall Study|Protocol Violation|1
7632028|NCT01663623|26554473|P1|Overall Study|Protocol Violation|0
7632029|NCT01663623|26554472|P2|Overall Study|Lack of Efficacy|6
7632030|NCT01663623|26554473|P1|Overall Study|Lack of Efficacy|5
7632031|NCT01663623|26554472|P2|Overall Study|Adverse Event|7
7632032|NCT01663623|26554473|P1|Overall Study|Adverse Event|3
7632033|NCT01663532|26554483|P2|Overall Study|Lack of Efficacy|60
7632034|NCT01663532|26554484|P1|Overall Study|Lack of Efficacy|15
7632035|NCT01663532|26554483|P2|Overall Study|Withdrawal by Subject|17
7632036|NCT01663532|26554484|P1|Overall Study|Withdrawal by Subject|35
7632037|NCT01663532|26554483|P2|Overall Study|Physician Decision|1
7632038|NCT01663532|26554484|P1|Overall Study|Physician Decision|1
7632039|NCT01663532|26554483|P2|Overall Study|Met Withdrawal Criteria|6
7632040|NCT01663532|26554484|P1|Overall Study|Met Withdrawal Criteria|7
7632041|NCT01663532|26554483|P2|Overall Study|Adverse Event|13
7632042|NCT01663532|26554484|P1|Overall Study|Adverse Event|7
7632043|NCT01663532|26554483|P2|Overall Study|Lost to Follow-up|10
7632044|NCT01663532|26554484|P1|Overall Study|Lost to Follow-up|9
7632045|NCT01663506|26554502|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
7632046|NCT01663506|26554502|P1|Overall Study|Adverse Event|1
7632047|NCT01663506|26554502|P1|Overall Study|Lost to Follow-up|1
7632048|NCT01663506|26554502|P1|Overall Study|Consent Withdrawal by Subject|1
7632049|NCT01663506|26554502|P1|Overall Study|Lack of Efficacy|3
7632050|NCT01663402|26554533|P2|Overall Study|Other than specified above|147
7632051|NCT01663402|26554534|P1|Overall Study|Other than specified above|172
7632052|NCT01663402|26554533|P2|Overall Study|Lost to Follow-up|15
7632053|NCT01663402|26554534|P1|Overall Study|Lost to Follow-up|17
7632054|NCT01663402|26554533|P2|Overall Study|Related to study drug administration|105
7632055|NCT01663402|26554534|P1|Overall Study|Related to study drug administration|96
7632056|NCT01663402|26554533|P2|Overall Study|Withdrawal by Subject|91
7632057|NCT01663402|26554534|P1|Overall Study|Withdrawal by Subject|118
7632058|NCT01663402|26554533|P2|Overall Study|Participant moved|104
7632059|NCT01663402|26554534|P1|Overall Study|Participant moved|139
7632060|NCT01663402|26554533|P2|Overall Study|Site terminated by sponsor|3
7632061|NCT01663402|26554534|P1|Overall Study|Site terminated by sponsor|1
7632062|NCT01663402|26554533|P2|Overall Study|Physician Decision|62
7632063|NCT01663402|26554534|P1|Overall Study|Physician Decision|77
7632064|NCT01663402|26554533|P2|Overall Study|Poor compliance to protocol|454
7632065|NCT01663402|26554534|P1|Overall Study|Poor compliance to protocol|529
7632066|NCT01663402|26554533|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
7632067|NCT01663402|26554534|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
7632068|NCT01663402|26554533|P2|Overall Study|Adverse Event|362
7632069|NCT01663402|26554534|P1|Overall Study|Adverse Event|347
7632070|NCT01663402|26554533|P2|Overall Study|Randomized but not treated|11
7632071|NCT01663402|26554534|P1|Overall Study|Randomized but not treated|19
7632072|NCT01663233|26554600|P2|Overall Study|Lost to Follow-up|1
7632073|NCT01663233|26554601|P1|Overall Study|Lost to Follow-up|0
7632074|NCT01663233|26554600|P2|Overall Study|Protocol Deviation|4
7632075|NCT01663233|26554601|P1|Overall Study|Protocol Deviation|1
7632076|NCT01663233|26554600|P2|Overall Study|Withdrawal by Subject|2
7632077|NCT01663233|26554601|P1|Overall Study|Withdrawal by Subject|3
7632078|NCT01663103|26554625|P2|Overall Study|dog bite|0
7632079|NCT01663103|26554626|P1|Overall Study|dog bite|1
7632080|NCT01663103|26554625|P2|Overall Study|Adverse Event|0
7632081|NCT01663103|26554626|P1|Overall Study|Adverse Event|1
7632082|NCT01663103|26554625|P2|Overall Study|Withdrawal by Subject|2
7632083|NCT01663103|26554626|P1|Overall Study|Withdrawal by Subject|1
7632084|NCT01662999|26554654|P6|Period 3|Withdrawal by Subject|0
7632085|NCT01662999|26554655|P5|Period 3|Withdrawal by Subject|0
7632086|NCT01662999|26554656|P4|Period 3|Withdrawal by Subject|0
7632087|NCT01662999|26554657|P3|Period 3|Withdrawal by Subject|0
7632088|NCT01662999|26554658|P2|Period 3|Withdrawal by Subject|1
7632089|NCT01662999|26554659|P1|Period 3|Withdrawal by Subject|0
7632090|NCT01662986|26554730|P2|Overall Study|Other than stated above|0
7632091|NCT01662986|26554731|P1|Overall Study|Other than stated above|3
7632092|NCT01662986|26554730|P2|Overall Study|Not Treated|0
7632093|NCT01662986|26554731|P1|Overall Study|Not Treated|1
7632094|NCT01662986|26554730|P2|Overall Study|Withdrawal by Subject|2
7632095|NCT01662986|26554731|P1|Overall Study|Withdrawal by Subject|2
7632096|NCT01662986|26554730|P2|Overall Study|Lost to Follow-up|4
7632097|NCT01662986|26554731|P1|Overall Study|Lost to Follow-up|5
7632098|NCT01662986|26554730|P2|Overall Study|Protocol Violation|3
7632099|NCT01662986|26554731|P1|Overall Study|Protocol Violation|2
7632100|NCT01662986|26554730|P2|Overall Study|Adverse Event|4
7632101|NCT01662986|26554731|P1|Overall Study|Adverse Event|5
7632102|NCT01662895|26554819|P2|Overall Study|Lost to Follow-up|1
7632103|NCT01662895|26554820|P1|Overall Study|Lost to Follow-up|0
7632104|NCT01662648|26554944|P2|Overall Study|LOE and Participant non-compliant|1
7632105|NCT01662648|26554945|P1|Overall Study|LOE and Participant non-compliant|0
7632106|NCT01662648|26554944|P2|Overall Study|LOE and other reason unspecified|0
7632107|NCT01662648|26554945|P1|Overall Study|LOE and other reason unspecified|1
7632108|NCT01662648|26554944|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
7632109|NCT01662648|26554945|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
7632110|NCT01662648|26554944|P2|Overall Study|Other|11
7632111|NCT01662648|26554945|P1|Overall Study|Other|8
7632112|NCT01662648|26554944|P2|Overall Study|Participant non-compliant|20
7632113|NCT01662648|26554945|P1|Overall Study|Participant non-compliant|16
7632114|NCT01662648|26554944|P2|Overall Study|Withdrawal by Subject|53
7632115|NCT01662648|26554945|P1|Overall Study|Withdrawal by Subject|36
7632116|NCT01662648|26554944|P2|Overall Study|Lost to Follow-up|36
7632117|NCT01662648|26554945|P1|Overall Study|Lost to Follow-up|24
7632118|NCT01662648|26554944|P2|Overall Study|Participant ineligible to continue trial|1
7632119|NCT01662648|26554945|P1|Overall Study|Participant ineligible to continue trial|1
7632120|NCT01662648|26554944|P2|Overall Study|Lack of Efficacy|16
7632121|NCT01662648|26554945|P1|Overall Study|Lack of Efficacy|17
7632122|NCT01662648|26554944|P2|Overall Study|Adverse Event|37
7632123|NCT01662648|26554945|P1|Overall Study|Adverse Event|40
7632124|NCT01662648|26554944|P2|Overall Study|Death|3
7632125|NCT01662648|26554945|P1|Overall Study|Death|1
7632126|NCT01662635|26554967|P1|Overall Study|scarce samples for evaluation|30
7632127|NCT01662505|26555018|P3|Overall Study|Not specified above|2
7632128|NCT01662505|26555019|P2|Overall Study|Not specified above|3
7632129|NCT01662505|26555020|P1|Overall Study|Not specified above|1
7632130|NCT01662505|26555018|P3|Overall Study|Refused cont. medication|1
7632131|NCT01662505|26555019|P2|Overall Study|Refused cont. medication|0
7632132|NCT01662505|26555020|P1|Overall Study|Refused cont. medication|0
7632133|NCT01662505|26555018|P3|Overall Study|Progressive disease|5
7632134|NCT01662505|26555019|P2|Overall Study|Progressive disease|1
7632135|NCT01662505|26555020|P1|Overall Study|Progressive disease|6
7632136|NCT01662492|26555044|P3|Overall Study|Lack of Efficacy|2
7632137|NCT01662492|26555045|P2|Overall Study|Lack of Efficacy|1
7632138|NCT01662492|26555046|P1|Overall Study|Lack of Efficacy|1
7632139|NCT01662492|26555044|P3|Overall Study|Lost to Follow-up|2
7632140|NCT01662492|26555045|P2|Overall Study|Lost to Follow-up|0
7632141|NCT01662492|26555046|P1|Overall Study|Lost to Follow-up|0
7632142|NCT01662492|26555044|P3|Overall Study|Protocol Violation|0
7632143|NCT01662492|26555045|P2|Overall Study|Protocol Violation|0
7632144|NCT01662492|26555046|P1|Overall Study|Protocol Violation|1
7632145|NCT01662492|26555044|P3|Overall Study|Withdrawal by Subject|1
7632146|NCT01662492|26555045|P2|Overall Study|Withdrawal by Subject|0
7632147|NCT01662492|26555046|P1|Overall Study|Withdrawal by Subject|0
7632148|NCT01662492|26555044|P3|Overall Study|Other miscellaneous reasons.|1
7632149|NCT01662492|26555045|P2|Overall Study|Other miscellaneous reasons.|0
7632150|NCT01662492|26555046|P1|Overall Study|Other miscellaneous reasons.|1
7632151|NCT01662440|26555070|P4|Overall Study|Withdrawal by Subject|2
7632152|NCT01662440|26555071|P3|Overall Study|Withdrawal by Subject|2
7632153|NCT01662440|26555072|P2|Overall Study|Withdrawal by Subject|2
7632154|NCT01662440|26555073|P1|Overall Study|Withdrawal by Subject|5
7632155|NCT01662440|26555070|P4|Overall Study|Protocol Violation|0
7632156|NCT01662440|26555071|P3|Overall Study|Protocol Violation|0
7632157|NCT01662440|26555072|P2|Overall Study|Protocol Violation|0
7632158|NCT01662440|26555073|P1|Overall Study|Protocol Violation|1
7632159|NCT01662440|26555070|P4|Overall Study|Subject moved to another country.|0
7632160|NCT01662440|26555071|P3|Overall Study|Subject moved to another country.|0
7632161|NCT01662440|26555072|P2|Overall Study|Subject moved to another country.|1
7632162|NCT01662440|26555073|P1|Overall Study|Subject moved to another country.|0
7632163|NCT01662440|26555070|P4|Overall Study|Lost to Follow-up|1
7632164|NCT01662440|26555071|P3|Overall Study|Lost to Follow-up|4
7632165|NCT01662440|26555072|P2|Overall Study|Lost to Follow-up|2
7632166|NCT01662440|26555073|P1|Overall Study|Lost to Follow-up|2
7632167|NCT01662440|26555070|P4|Overall Study|Death|0
7632168|NCT01662440|26555071|P3|Overall Study|Death|0
7632169|NCT01662440|26555072|P2|Overall Study|Death|1
7632170|NCT01662440|26555073|P1|Overall Study|Death|0
7632171|NCT01662440|26555070|P4|Overall Study|Adverse Event|1
7632172|NCT01662440|26555071|P3|Overall Study|Adverse Event|0
7632173|NCT01662440|26555072|P2|Overall Study|Adverse Event|0
7632174|NCT01662440|26555073|P1|Overall Study|Adverse Event|1
7632175|NCT01662362|26555121|P1|Overall Study|Lost to Follow-up|38
7632176|NCT01662336|26555126|P1|Overall Study|Withdrawal by Subject|6
7632177|NCT01662336|26555126|P1|Overall Study|Other|29
7632178|NCT01662336|26555126|P1|Overall Study|No longer on LPV/r|30
7632179|NCT01662336|26555126|P1|Overall Study|Adverse Event|1
7632180|NCT01662310|26555152|P5|Open-Label Extension Phase|Withdrawal by Subject|7
7632181|NCT01662310|26555153|P4|Open-Label Extension Phase|Withdrawal by Subject|2
7632182|NCT01662310|26555154|P3|Open-Label Extension Phase|Withdrawal by Subject|0
7632183|NCT01662310|26555155|P2|Open-Label Extension Phase|Withdrawal by Subject|0
7632184|NCT01662310|26555156|P1|Open-Label Extension Phase|Withdrawal by Subject|0
7632185|NCT01662310|26555152|P5|Open-Label Extension Phase|Pregnancy|0
7632186|NCT01662310|26555153|P4|Open-Label Extension Phase|Pregnancy|1
7632187|NCT01662310|26555154|P3|Open-Label Extension Phase|Pregnancy|0
7632188|NCT01662310|26555155|P2|Open-Label Extension Phase|Pregnancy|0
7632189|NCT01662310|26555156|P1|Open-Label Extension Phase|Pregnancy|0
7632190|NCT01662310|26555152|P5|Open-Label Extension Phase|Lost to Follow-up|1
7632191|NCT01662310|26555153|P4|Open-Label Extension Phase|Lost to Follow-up|2
7632192|NCT01662310|26555154|P3|Open-Label Extension Phase|Lost to Follow-up|0
7632193|NCT01662310|26555155|P2|Open-Label Extension Phase|Lost to Follow-up|0
7632194|NCT01662310|26555156|P1|Open-Label Extension Phase|Lost to Follow-up|0
7632195|NCT01662310|26555152|P5|Open-Label Extension Phase|Lack of Efficacy|2
7632196|NCT01662310|26555153|P4|Open-Label Extension Phase|Lack of Efficacy|2
7632197|NCT01662310|26555154|P3|Open-Label Extension Phase|Lack of Efficacy|0
7632198|NCT01662310|26555155|P2|Open-Label Extension Phase|Lack of Efficacy|0
7632199|NCT01662310|26555156|P1|Open-Label Extension Phase|Lack of Efficacy|0
7632200|NCT01662310|26555152|P5|Open-Label Extension Phase|Death|0
7632201|NCT01662310|26555153|P4|Open-Label Extension Phase|Death|1
7632202|NCT01662310|26555154|P3|Open-Label Extension Phase|Death|0
7632203|NCT01662310|26555155|P2|Open-Label Extension Phase|Death|0
7632204|NCT01662310|26555156|P1|Open-Label Extension Phase|Death|0
7632205|NCT01662310|26555152|P5|Open-Label Extension Phase|Adverse Event|0
7632206|NCT01662310|26555153|P4|Open-Label Extension Phase|Adverse Event|3
7632207|NCT01662310|26555154|P3|Open-Label Extension Phase|Adverse Event|0
7632208|NCT01662310|26555155|P2|Open-Label Extension Phase|Adverse Event|0
7632209|NCT01662310|26555156|P1|Open-Label Extension Phase|Adverse Event|0
7632210|NCT01662310|26555152|P5|Double-Blind Phase|Randomized but not treated|0
7632211|NCT01662310|26555153|P4|Double-Blind Phase|Randomized but not treated|0
7632212|NCT01662310|26555154|P3|Double-Blind Phase|Randomized but not treated|0
7632213|NCT01662310|26555155|P2|Double-Blind Phase|Randomized but not treated|1
7632214|NCT01662310|26555156|P1|Double-Blind Phase|Randomized but not treated|0
7632215|NCT01662310|26555152|P5|Double-Blind Phase|Other|0
7632216|NCT01662310|26555153|P4|Double-Blind Phase|Other|0
7632217|NCT01662310|26555154|P3|Double-Blind Phase|Other|1
7632218|NCT01662310|26555155|P2|Double-Blind Phase|Other|0
7632219|NCT01662310|26555156|P1|Double-Blind Phase|Other|0
7632220|NCT01662310|26555152|P5|Double-Blind Phase|Withdrawal by Subject|0
7632221|NCT01662310|26555153|P4|Double-Blind Phase|Withdrawal by Subject|0
7632222|NCT01662310|26555154|P3|Double-Blind Phase|Withdrawal by Subject|3
7632223|NCT01662310|26555155|P2|Double-Blind Phase|Withdrawal by Subject|9
7632224|NCT01662310|26555156|P1|Double-Blind Phase|Withdrawal by Subject|0
7632225|NCT01662310|26555152|P5|Double-Blind Phase|Pregnancy|0
7632226|NCT01662310|26555153|P4|Double-Blind Phase|Pregnancy|0
7632227|NCT01662310|26555154|P3|Double-Blind Phase|Pregnancy|0
7632228|NCT01662310|26555155|P2|Double-Blind Phase|Pregnancy|2
7632229|NCT01662310|26555156|P1|Double-Blind Phase|Pregnancy|0
7632230|NCT01662310|26555152|P5|Double-Blind Phase|Lost to Follow-up|0
7632231|NCT01662310|26555153|P4|Double-Blind Phase|Lost to Follow-up|0
7632232|NCT01662310|26555154|P3|Double-Blind Phase|Lost to Follow-up|0
7632233|NCT01662310|26555155|P2|Double-Blind Phase|Lost to Follow-up|3
7632234|NCT01662310|26555156|P1|Double-Blind Phase|Lost to Follow-up|0
7632235|NCT01662310|26555152|P5|Double-Blind Phase|Adverse Event|0
7632236|NCT01662310|26555153|P4|Double-Blind Phase|Adverse Event|0
7632237|NCT01662310|26555154|P3|Double-Blind Phase|Adverse Event|1
7632238|NCT01662310|26555155|P2|Double-Blind Phase|Adverse Event|0
7632239|NCT01662310|26555156|P1|Double-Blind Phase|Adverse Event|0
7632240|NCT01662310|26555152|P5|Run-In or Stabilization Phase|Other|0
7632241|NCT01662310|26555153|P4|Run-In or Stabilization Phase|Other|0
7632242|NCT01662310|26555154|P3|Run-In or Stabilization Phase|Other|0
7632243|NCT01662310|26555155|P2|Run-In or Stabilization Phase|Other|0
7632244|NCT01662310|26555156|P1|Run-In or Stabilization Phase|Other|1
7632245|NCT01662310|26555152|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
7632246|NCT01662310|26555153|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
7632247|NCT01662310|26555154|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
7632248|NCT01662310|26555155|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
7632249|NCT01662310|26555156|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
7632250|NCT01662310|26555152|P5|Run-In or Stabilization Phase|Protocol Violation|0
7632251|NCT01662310|26555153|P4|Run-In or Stabilization Phase|Protocol Violation|0
7632252|NCT01662310|26555154|P3|Run-In or Stabilization Phase|Protocol Violation|0
7632253|NCT01662310|26555155|P2|Run-In or Stabilization Phase|Protocol Violation|0
7632254|NCT01662310|26555156|P1|Run-In or Stabilization Phase|Protocol Violation|15
7632255|NCT01662310|26555152|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
7632256|NCT01662310|26555153|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
7632257|NCT01662310|26555154|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
7632258|NCT01662310|26555155|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
7632259|NCT01662310|26555156|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
7632260|NCT01662310|26555152|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
7632261|NCT01662310|26555153|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
7632262|NCT01662310|26555154|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
7632263|NCT01662310|26555155|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
7632264|NCT01662310|26555156|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
7632265|NCT01662310|26555152|P5|Run-In or Stabilization Phase|Adverse Event|0
7632266|NCT01662310|26555153|P4|Run-In or Stabilization Phase|Adverse Event|0
7632267|NCT01662310|26555154|P3|Run-In or Stabilization Phase|Adverse Event|0
7632268|NCT01662310|26555155|P2|Run-In or Stabilization Phase|Adverse Event|0
7632269|NCT01662310|26555156|P1|Run-In or Stabilization Phase|Adverse Event|11
7632270|NCT01662102|26555237|P2|Overall Study|Sponsor's decision|0
7632271|NCT01662102|26555238|P1|Overall Study|Sponsor's decision|1
7632272|NCT01662063|26555272|P3|Overall Study|Other|0
7632273|NCT01662063|26555273|P2|Overall Study|Other|1
7632274|NCT01662063|26555274|P1|Overall Study|Other|0
7632275|NCT01662063|26555272|P3|Overall Study|Physician Decision|0
7632276|NCT01662063|26555273|P2|Overall Study|Physician Decision|2
7632277|NCT01662063|26555274|P1|Overall Study|Physician Decision|0
7632278|NCT01662063|26555272|P3|Overall Study|Withdrawal by Subject|1
7632279|NCT01662063|26555273|P2|Overall Study|Withdrawal by Subject|4
7632280|NCT01662063|26555274|P1|Overall Study|Withdrawal by Subject|2
7632281|NCT01662063|26555272|P3|Overall Study|Protocol Violation|0
7632282|NCT01662063|26555273|P2|Overall Study|Protocol Violation|0
7632283|NCT01662063|26555274|P1|Overall Study|Protocol Violation|1
7632284|NCT01662063|26555272|P3|Overall Study|Lost to Follow-up|0
7632285|NCT01662063|26555273|P2|Overall Study|Lost to Follow-up|4
7632286|NCT01662063|26555274|P1|Overall Study|Lost to Follow-up|0
7632287|NCT01662063|26555272|P3|Overall Study|Lack of Efficacy|0
7632288|NCT01662063|26555273|P2|Overall Study|Lack of Efficacy|6
7632289|NCT01662063|26555274|P1|Overall Study|Lack of Efficacy|1
7632290|NCT01662063|26555272|P3|Overall Study|Adverse Event or Intercurrent Illness|0
7632291|NCT01662063|26555273|P2|Overall Study|Adverse Event or Intercurrent Illness|12
7632292|NCT01662063|26555274|P1|Overall Study|Adverse Event or Intercurrent Illness|1
7632293|NCT01662024|26555353|P1|Overall Study|Withdrawal by Subject|3
7632294|NCT01662024|26555353|P1|Overall Study|Pregnancy|2
7632295|NCT01661972|26555365|P2|Overall Study|Withdrawal by Subject|1
7632296|NCT01661972|26555366|P1|Overall Study|Withdrawal by Subject|0
7632297|NCT01661972|26555365|P2|Overall Study|Death during Treatment period|1
7632298|NCT01661972|26555366|P1|Overall Study|Death during Treatment period|1
7632299|NCT01661972|26555365|P2|Overall Study|Adverse Event|2
7632300|NCT01661972|26555366|P1|Overall Study|Adverse Event|1
7632301|NCT01661933|26555385|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
7632302|NCT01661933|26555385|P1|Low-dose Gluten Challenge|Physician Decision|2
7632303|NCT01661881|26555392|P1|Overall Study|Disease Progression|1
7632304|NCT01661790|26555400|P2|Overall Study|Lost to Follow-up|2
7632305|NCT01661790|26555401|P1|Overall Study|Lost to Follow-up|0
7632306|NCT01661686|26555501|P2|Overall Study|did not receive allocated intervention|1
7632307|NCT01661686|26555502|P1|Overall Study|did not receive allocated intervention|0
7632308|NCT01661686|26555501|P2|Overall Study|Lost to Follow-up|1
7632309|NCT01661686|26555502|P1|Overall Study|Lost to Follow-up|2
7632310|NCT01661595|26555543|P4|Phase 2: Week 5-8.|Protocol Violation|0
7632311|NCT01661595|26555544|P3|Phase 2: Week 5-8.|Protocol Violation|1
7632312|NCT01661595|26555545|P2|Phase 2: Week 5-8.|Protocol Violation|0
7632313|NCT01661595|26555546|P1|Phase 2: Week 5-8.|Protocol Violation|0
7632314|NCT01661595|26555543|P4|Phase 1: Week 0-4|Adverse Event|0
7632315|NCT01661595|26555544|P3|Phase 1: Week 0-4|Adverse Event|0
7632316|NCT01661595|26555545|P2|Phase 1: Week 0-4|Adverse Event|0
7632317|NCT01661595|26555546|P1|Phase 1: Week 0-4|Adverse Event|1
7632318|NCT01661205|26555674|P1|Overall Study|Physician Decision|2
7632319|NCT01661179|26555685|P1|Overall Study|Other Eligibility criteria|4
7632320|NCT01661179|26555685|P1|Overall Study|Withdrawal by Subject|1
7632321|NCT01661179|26555685|P1|Overall Study|Death|1
7632322|NCT01661140|26555689|P3|Double-Blind Period|Administrative/Other|6
7632323|NCT01661140|26555690|P2|Double-Blind Period|Administrative/Other|7
7632324|NCT01661140|26555691|P1|Double-Blind Period|Administrative/Other|0
7632325|NCT01661140|26555689|P3|Double-Blind Period|Sponsor Termination|17
7632326|NCT01661140|26555690|P2|Double-Blind Period|Sponsor Termination|14
7632327|NCT01661140|26555691|P1|Double-Blind Period|Sponsor Termination|0
7632328|NCT01661140|26555689|P3|Double-Blind Period|Investigator's Decision|2
7632329|NCT01661140|26555690|P2|Double-Blind Period|Investigator's Decision|1
7632330|NCT01661140|26555691|P1|Double-Blind Period|Investigator's Decision|0
7632331|NCT01661140|26555689|P3|Double-Blind Period|Withdrawal by Subject|3
7632332|NCT01661140|26555690|P2|Double-Blind Period|Withdrawal by Subject|1
7632333|NCT01661140|26555691|P1|Double-Blind Period|Withdrawal by Subject|0
7632334|NCT01661140|26555689|P3|Double-Blind Period|Protocol Violation|3
7632335|NCT01661140|26555690|P2|Double-Blind Period|Protocol Violation|2
7632336|NCT01661140|26555691|P1|Double-Blind Period|Protocol Violation|0
7632337|NCT01661140|26555689|P3|Double-Blind Period|Adverse Event|18
7632338|NCT01661140|26555690|P2|Double-Blind Period|Adverse Event|16
7632339|NCT01661140|26555691|P1|Double-Blind Period|Adverse Event|0
7632340|NCT01661140|26555689|P3|Double-Blind Period|Refused Treatment|1
7632341|NCT01661140|26555690|P2|Double-Blind Period|Refused Treatment|0
7632342|NCT01661140|26555691|P1|Double-Blind Period|Refused Treatment|0
7632343|NCT01661140|26555689|P3|Open-Label Period|Lost to Follow-up|0
7632344|NCT01661140|26555690|P2|Open-Label Period|Lost to Follow-up|0
7632345|NCT01661140|26555691|P1|Open-Label Period|Lost to Follow-up|2
7632346|NCT01661140|26555689|P3|Open-Label Period|Did not meet EULAR criteria|0
7632347|NCT01661140|26555690|P2|Open-Label Period|Did not meet EULAR criteria|0
7632348|NCT01661140|26555691|P1|Open-Label Period|Did not meet EULAR criteria|1
7632349|NCT01661140|26555689|P3|Open-Label Period|Sponsor termination|0
7632350|NCT01661140|26555690|P2|Open-Label Period|Sponsor termination|0
7632351|NCT01661140|26555691|P1|Open-Label Period|Sponsor termination|16
7632352|NCT01661140|26555689|P3|Open-Label Period|Administrative/Other|0
7632353|NCT01661140|26555690|P2|Open-Label Period|Administrative/Other|0
7632354|NCT01661140|26555691|P1|Open-Label Period|Administrative/Other|1
7632355|NCT01661140|26555689|P3|Open-Label Period|Death|0
7632356|NCT01661140|26555690|P2|Open-Label Period|Death|0
7632357|NCT01661140|26555691|P1|Open-Label Period|Death|1
7632358|NCT01661140|26555689|P3|Open-Label Period|Investigator Decision|0
7632359|NCT01661140|26555690|P2|Open-Label Period|Investigator Decision|0
7632360|NCT01661140|26555691|P1|Open-Label Period|Investigator Decision|3
7632361|NCT01661140|26555689|P3|Open-Label Period|Withdrawal by Subject|0
7632362|NCT01661140|26555690|P2|Open-Label Period|Withdrawal by Subject|0
7632363|NCT01661140|26555691|P1|Open-Label Period|Withdrawal by Subject|5
7632364|NCT01661140|26555689|P3|Open-Label Period|Protocol Violation|0
7632365|NCT01661140|26555690|P2|Open-Label Period|Protocol Violation|0
7632366|NCT01661140|26555691|P1|Open-Label Period|Protocol Violation|3
7632367|NCT01661140|26555689|P3|Open-Label Period|Adverse Event|0
7632368|NCT01661140|26555690|P2|Open-Label Period|Adverse Event|0
7632369|NCT01661140|26555691|P1|Open-Label Period|Adverse Event|44
7632370|NCT01661062|26555743|P1|Overall Study|Withdrawal by Subject|2
7632371|NCT01661062|26555743|P1|Overall Study|Completed Treatment Off Study|3
7632372|NCT01660906|26555748|P1|Overall Study|Discontinued due to study drug toxicity|3
7632373|NCT01660763|26555831|P2|Overall Study|Patient ready for early discharge|4
7632374|NCT01660763|26555832|P1|Overall Study|Patient ready for early discharge|28
7632375|NCT01660763|26555831|P2|Overall Study|Withdrawal by Subject|0
7632376|NCT01660763|26555832|P1|Overall Study|Withdrawal by Subject|4
7632377|NCT01660763|26555831|P2|Overall Study|Protocol Violation|0
7632378|NCT01660763|26555832|P1|Overall Study|Protocol Violation|1
7632379|NCT01660763|26555831|P2|Overall Study|Adverse Event|7
7632380|NCT01660763|26555832|P1|Overall Study|Adverse Event|22
7632381|NCT01660763|26555831|P2|Overall Study|Lack of Efficacy|50
7632382|NCT01660763|26555832|P1|Overall Study|Lack of Efficacy|45
7632569|NCT01659255|26556385|P1|Overall Study|Progressive Disease|2
7632407|NCT01660412|26555910|P2|Overall Study|Protocol Violation|3
7632408|NCT01660412|26555911|P1|Overall Study|Protocol Violation|0
7632409|NCT01660334|26555917|P1|Overall Study|Lost to Follow-up|1
7632410|NCT01660256|26555937|P3|Overall Study|Withdrawal by Subject|2
7632411|NCT01660256|26555938|P2|Overall Study|Withdrawal by Subject|0
7632412|NCT01660256|26555939|P1|Overall Study|Withdrawal by Subject|1
7632413|NCT01660256|26555937|P3|Overall Study|Adverse Event|2
7632414|NCT01660256|26555938|P2|Overall Study|Adverse Event|0
7632415|NCT01660256|26555939|P1|Overall Study|Adverse Event|4
7632416|NCT01660022|26556176|P6|First Sequence (7 Days)|Protocol Violation|1
7632417|NCT01660022|26556177|P5|First Sequence (7 Days)|Protocol Violation|0
7632418|NCT01660022|26556178|P4|First Sequence (7 Days)|Protocol Violation|0
7632419|NCT01660022|26556179|P3|First Sequence (7 Days)|Protocol Violation|0
7632420|NCT01660022|26556180|P2|First Sequence (7 Days)|Protocol Violation|0
7632421|NCT01660022|26556181|P1|First Sequence (7 Days)|Protocol Violation|0
7632422|NCT01660022|26556176|P6|First Sequence (7 Days)|Adverse Event|3
7632423|NCT01660022|26556177|P5|First Sequence (7 Days)|Adverse Event|1
7632424|NCT01660022|26556178|P4|First Sequence (7 Days)|Adverse Event|0
7632425|NCT01660022|26556179|P3|First Sequence (7 Days)|Adverse Event|0
7632426|NCT01660022|26556180|P2|First Sequence (7 Days)|Adverse Event|0
7632427|NCT01660022|26556181|P1|First Sequence (7 Days)|Adverse Event|0
7632428|NCT01660022|26556176|P6|First Sequence (7 Days)|Withdrawal by Subject|0
7632429|NCT01660022|26556177|P5|First Sequence (7 Days)|Withdrawal by Subject|0
7632430|NCT01660022|26556178|P4|First Sequence (7 Days)|Withdrawal by Subject|1
7632431|NCT01660022|26556179|P3|First Sequence (7 Days)|Withdrawal by Subject|0
7632432|NCT01660022|26556180|P2|First Sequence (7 Days)|Withdrawal by Subject|1
7632433|NCT01660022|26556181|P1|First Sequence (7 Days)|Withdrawal by Subject|0
7632434|NCT01659996|26556240|P3|Overall Study|Withdrawal by Subject|5
7632435|NCT01659996|26556241|P2|Overall Study|Withdrawal by Subject|1
7632436|NCT01659996|26556242|P1|Overall Study|Withdrawal by Subject|4
7632437|NCT01659996|26556240|P3|Overall Study|Adverse Event|1
7632438|NCT01659996|26556241|P2|Overall Study|Adverse Event|0
7632439|NCT01659996|26556242|P1|Overall Study|Adverse Event|0
7632440|NCT01659996|26556240|P3|Overall Study|Lost to Follow-up|2
7632441|NCT01659996|26556241|P2|Overall Study|Lost to Follow-up|3
7632442|NCT01659996|26556242|P1|Overall Study|Lost to Follow-up|1
7632443|NCT01659996|26556240|P3|Overall Study|Protocol Violation|3
7632444|NCT01659996|26556241|P2|Overall Study|Protocol Violation|3
7632445|NCT01659996|26556242|P1|Overall Study|Protocol Violation|3
7632446|NCT01659853|26556283|P2|Washout , 3 to 7 Days|Protocol Violation|0
7632447|NCT01659853|26556284|P1|Washout , 3 to 7 Days|Protocol Violation|1
7632448|NCT01659853|26556283|P2|Washout , 3 to 7 Days|Adverse Event|0
7632449|NCT01659853|26556284|P1|Washout , 3 to 7 Days|Adverse Event|1
7632450|NCT01659736|26556294|P2|3-month Follow-up|Lost to Follow-up|1
7632451|NCT01659736|26556295|P1|3-month Follow-up|Lost to Follow-up|0
7632452|NCT01659736|26556294|P2|Treatment Period|Withdrawal by Subject|0
7632453|NCT01659736|26556295|P1|Treatment Period|Withdrawal by Subject|1
7632454|NCT01659736|26556294|P2|Treatment Period|Protocol Violation|1
7632455|NCT01659736|26556295|P1|Treatment Period|Protocol Violation|3
7632456|NCT01659736|26556294|P2|Treatment Period|Adverse Event|1
7632457|NCT01659736|26556295|P1|Treatment Period|Adverse Event|1
7632458|NCT01659567|26556309|P1|Overall Study|Other|13
7632459|NCT01659567|26556309|P1|Overall Study|Progression of the main disease|1
7632460|NCT01659567|26556309|P1|Overall Study|Withdrawal by Subject|64
7632461|NCT01659567|26556309|P1|Overall Study|Good result at early stage of treatment|5
7632462|NCT01659567|26556309|P1|Overall Study|Adverse Event|12
7632463|NCT01659567|26556309|P1|Overall Study|Switched to Pegferon|6
7632464|NCT01659567|26556309|P1|Overall Study|Lack of Efficacy|22
7632465|NCT01659554|26556326|P1|Overall Study|Study Termination|4
7632466|NCT01659320|26556333|P1|Overall Study|Physician Decision|1
7632467|NCT01659320|26556333|P1|Overall Study|Withdrawal by Subject|2
7632468|NCT01659255|26556369|P17|Overall Study|Participant Went on to Have an Allograft|0
7632469|NCT01659255|26556370|P16|Overall Study|Participant Went on to Have an Allograft|0
7632470|NCT01659255|26556371|P15|Overall Study|Participant Went on to Have an Allograft|0
7632471|NCT01659255|26556372|P14|Overall Study|Participant Went on to Have an Allograft|0
7632472|NCT01659255|26556373|P13|Overall Study|Participant Went on to Have an Allograft|1
7632473|NCT01659255|26556374|P12|Overall Study|Participant Went on to Have an Allograft|0
7632474|NCT01659255|26556375|P11|Overall Study|Participant Went on to Have an Allograft|0
7632475|NCT01659255|26556376|P10|Overall Study|Participant Went on to Have an Allograft|0
7632476|NCT01659255|26556377|P9|Overall Study|Participant Went on to Have an Allograft|0
7632477|NCT01659255|26556378|P8|Overall Study|Participant Went on to Have an Allograft|0
7632478|NCT01659255|26556379|P7|Overall Study|Participant Went on to Have an Allograft|0
7632479|NCT01659255|26556380|P6|Overall Study|Participant Went on to Have an Allograft|0
7632480|NCT01659255|26556381|P5|Overall Study|Participant Went on to Have an Allograft|0
7632481|NCT01659255|26556382|P4|Overall Study|Participant Went on to Have an Allograft|0
7632482|NCT01659255|26556383|P3|Overall Study|Participant Went on to Have an Allograft|0
7632483|NCT01659255|26556384|P2|Overall Study|Participant Went on to Have an Allograft|0
7632484|NCT01659255|26556385|P1|Overall Study|Participant Went on to Have an Allograft|0
7632485|NCT01659255|26556369|P17|Overall Study|Completed Treatment Per Protocol at the Time|0
7632486|NCT01659255|26556370|P16|Overall Study|Completed Treatment Per Protocol at the Time|1
7632487|NCT01659255|26556371|P15|Overall Study|Completed Treatment Per Protocol at the Time|0
7632488|NCT01659255|26556372|P14|Overall Study|Completed Treatment Per Protocol at the Time|0
7632489|NCT01659255|26556373|P13|Overall Study|Completed Treatment Per Protocol at the Time|0
7632490|NCT01659255|26556374|P12|Overall Study|Completed Treatment Per Protocol at the Time|0
7632491|NCT01659255|26556375|P11|Overall Study|Completed Treatment Per Protocol at the Time|0
7632492|NCT01659255|26556376|P10|Overall Study|Completed Treatment Per Protocol at the Time|0
7632493|NCT01659255|26556377|P9|Overall Study|Completed Treatment Per Protocol at the Time|0
7632494|NCT01659255|26556378|P8|Overall Study|Completed Treatment Per Protocol at the Time|0
7632495|NCT01659255|26556379|P7|Overall Study|Completed Treatment Per Protocol at the Time|0
7632496|NCT01659255|26556380|P6|Overall Study|Completed Treatment Per Protocol at the Time|0
7632497|NCT01659255|26556381|P5|Overall Study|Completed Treatment Per Protocol at the Time|0
7632498|NCT01659255|26556382|P4|Overall Study|Completed Treatment Per Protocol at the Time|0
7632499|NCT01659255|26556383|P3|Overall Study|Completed Treatment Per Protocol at the Time|0
7632500|NCT01659255|26556384|P2|Overall Study|Completed Treatment Per Protocol at the Time|0
7632501|NCT01659255|26556385|P1|Overall Study|Completed Treatment Per Protocol at the Time|0
7632502|NCT01659255|26556369|P17|Overall Study|Sponsor's Decision|0
7632503|NCT01659255|26556370|P16|Overall Study|Sponsor's Decision|0
7632504|NCT01659255|26556371|P15|Overall Study|Sponsor's Decision|0
7632505|NCT01659255|26556372|P14|Overall Study|Sponsor's Decision|0
7632506|NCT01659255|26556373|P13|Overall Study|Sponsor's Decision|0
7632507|NCT01659255|26556374|P12|Overall Study|Sponsor's Decision|0
7632508|NCT01659255|26556375|P11|Overall Study|Sponsor's Decision|0
7632509|NCT01659255|26556376|P10|Overall Study|Sponsor's Decision|0
7632510|NCT01659255|26556377|P9|Overall Study|Sponsor's Decision|0
7632511|NCT01659255|26556378|P8|Overall Study|Sponsor's Decision|0
7632512|NCT01659255|26556379|P7|Overall Study|Sponsor's Decision|1
7632513|NCT01659255|26556380|P6|Overall Study|Sponsor's Decision|0
7632514|NCT01659255|26556381|P5|Overall Study|Sponsor's Decision|0
7632515|NCT01659255|26556382|P4|Overall Study|Sponsor's Decision|0
7632516|NCT01659255|26556383|P3|Overall Study|Sponsor's Decision|0
7632517|NCT01659255|26556384|P2|Overall Study|Sponsor's Decision|0
7632518|NCT01659255|26556385|P1|Overall Study|Sponsor's Decision|0
7632519|NCT01659255|26556369|P17|Overall Study|Investigator Decision|0
7632520|NCT01659255|26556370|P16|Overall Study|Investigator Decision|0
7632521|NCT01659255|26556371|P15|Overall Study|Investigator Decision|0
7632522|NCT01659255|26556372|P14|Overall Study|Investigator Decision|1
7632523|NCT01659255|26556373|P13|Overall Study|Investigator Decision|1
7632524|NCT01659255|26556374|P12|Overall Study|Investigator Decision|0
7632525|NCT01659255|26556375|P11|Overall Study|Investigator Decision|0
7632526|NCT01659255|26556376|P10|Overall Study|Investigator Decision|0
7632527|NCT01659255|26556377|P9|Overall Study|Investigator Decision|0
7632528|NCT01659255|26556378|P8|Overall Study|Investigator Decision|0
7632529|NCT01659255|26556379|P7|Overall Study|Investigator Decision|0
7632530|NCT01659255|26556380|P6|Overall Study|Investigator Decision|0
7632531|NCT01659255|26556381|P5|Overall Study|Investigator Decision|0
7632532|NCT01659255|26556382|P4|Overall Study|Investigator Decision|0
7632533|NCT01659255|26556383|P3|Overall Study|Investigator Decision|0
7632534|NCT01659255|26556384|P2|Overall Study|Investigator Decision|0
7632535|NCT01659255|26556385|P1|Overall Study|Investigator Decision|0
7632536|NCT01659255|26556369|P17|Overall Study|Withdrew Consent|0
7632537|NCT01659255|26556370|P16|Overall Study|Withdrew Consent|0
7632538|NCT01659255|26556371|P15|Overall Study|Withdrew Consent|0
7632539|NCT01659255|26556372|P14|Overall Study|Withdrew Consent|1
7632540|NCT01659255|26556373|P13|Overall Study|Withdrew Consent|0
7632541|NCT01659255|26556374|P12|Overall Study|Withdrew Consent|0
7632542|NCT01659255|26556375|P11|Overall Study|Withdrew Consent|1
7632543|NCT01659255|26556376|P10|Overall Study|Withdrew Consent|0
7632544|NCT01659255|26556377|P9|Overall Study|Withdrew Consent|0
7632545|NCT01659255|26556378|P8|Overall Study|Withdrew Consent|0
7632546|NCT01659255|26556379|P7|Overall Study|Withdrew Consent|0
7632547|NCT01659255|26556380|P6|Overall Study|Withdrew Consent|0
7632548|NCT01659255|26556381|P5|Overall Study|Withdrew Consent|0
7632549|NCT01659255|26556382|P4|Overall Study|Withdrew Consent|0
7632550|NCT01659255|26556383|P3|Overall Study|Withdrew Consent|0
7632551|NCT01659255|26556384|P2|Overall Study|Withdrew Consent|0
7632552|NCT01659255|26556385|P1|Overall Study|Withdrew Consent|0
7632553|NCT01659255|26556369|P17|Overall Study|Progressive Disease|3
7632554|NCT01659255|26556370|P16|Overall Study|Progressive Disease|2
7632555|NCT01659255|26556371|P15|Overall Study|Progressive Disease|6
7632556|NCT01659255|26556372|P14|Overall Study|Progressive Disease|13
7632557|NCT01659255|26556373|P13|Overall Study|Progressive Disease|5
7632558|NCT01659255|26556374|P12|Overall Study|Progressive Disease|3
7632559|NCT01659255|26556375|P11|Overall Study|Progressive Disease|2
7632560|NCT01659255|26556376|P10|Overall Study|Progressive Disease|2
7632561|NCT01659255|26556377|P9|Overall Study|Progressive Disease|0
7632562|NCT01659255|26556378|P8|Overall Study|Progressive Disease|1
7632563|NCT01659255|26556379|P7|Overall Study|Progressive Disease|0
7632564|NCT01659255|26556380|P6|Overall Study|Progressive Disease|0
7632565|NCT01659255|26556381|P5|Overall Study|Progressive Disease|0
7632566|NCT01659255|26556382|P4|Overall Study|Progressive Disease|0
7632567|NCT01659255|26556383|P3|Overall Study|Progressive Disease|0
7632568|NCT01659255|26556384|P2|Overall Study|Progressive Disease|0
7632570|NCT01659255|26556369|P17|Overall Study|Death|0
7632571|NCT01659255|26556370|P16|Overall Study|Death|1
7632572|NCT01659255|26556371|P15|Overall Study|Death|2
7632573|NCT01659255|26556372|P14|Overall Study|Death|1
7632574|NCT01659255|26556373|P13|Overall Study|Death|1
7632575|NCT01659255|26556374|P12|Overall Study|Death|0
7632576|NCT01659255|26556375|P11|Overall Study|Death|0
7632577|NCT01659255|26556376|P10|Overall Study|Death|0
7632578|NCT01659255|26556377|P9|Overall Study|Death|1
7632579|NCT01659255|26556378|P8|Overall Study|Death|1
7632580|NCT01659255|26556379|P7|Overall Study|Death|0
7632581|NCT01659255|26556380|P6|Overall Study|Death|0
7632582|NCT01659255|26556381|P5|Overall Study|Death|0
7632583|NCT01659255|26556382|P4|Overall Study|Death|0
7632584|NCT01659255|26556383|P3|Overall Study|Death|0
7632585|NCT01659255|26556384|P2|Overall Study|Death|1
7632586|NCT01659255|26556385|P1|Overall Study|Death|0
7632587|NCT01659255|26556369|P17|Overall Study|Adverse Event|0
7632588|NCT01659255|26556370|P16|Overall Study|Adverse Event|1
7632589|NCT01659255|26556371|P15|Overall Study|Adverse Event|0
7632590|NCT01659255|26556372|P14|Overall Study|Adverse Event|2
7632591|NCT01659255|26556373|P13|Overall Study|Adverse Event|0
7632592|NCT01659255|26556374|P12|Overall Study|Adverse Event|1
7632593|NCT01659255|26556375|P11|Overall Study|Adverse Event|0
7632594|NCT01659255|26556376|P10|Overall Study|Adverse Event|1
7632595|NCT01659255|26556377|P9|Overall Study|Adverse Event|0
7632596|NCT01659255|26556378|P8|Overall Study|Adverse Event|0
7632597|NCT01659255|26556379|P7|Overall Study|Adverse Event|1
7632598|NCT01659255|26556380|P6|Overall Study|Adverse Event|1
7632599|NCT01659255|26556381|P5|Overall Study|Adverse Event|0
7632600|NCT01659255|26556382|P4|Overall Study|Adverse Event|0
7632601|NCT01659255|26556383|P3|Overall Study|Adverse Event|0
7632602|NCT01659255|26556384|P2|Overall Study|Adverse Event|0
7632603|NCT01659255|26556385|P1|Overall Study|Adverse Event|0
7632604|NCT01659125|26556435|P1|Overall Study|Failed to Start Treatment|2
7632605|NCT01659125|26556435|P1|Overall Study|Time Constraints|2
7632606|NCT01659125|26556435|P1|Overall Study|Technical Problem|1
7632607|NCT01659125|26556435|P1|Overall Study|Lost to Follow-up|7
7632608|NCT01659125|26556435|P1|Overall Study|Withdrawal by Subject|2
7632609|NCT01659021|26556442|P2|Long-Term Follow Up|Withdrawal by Subject|1
7632610|NCT01659021|26556443|P1|Long-Term Follow Up|Withdrawal by Subject|2
7632611|NCT01659021|26556442|P2|Long-Term Follow Up|Lost to Follow-up|3
7632612|NCT01659021|26556443|P1|Long-Term Follow Up|Lost to Follow-up|3
7632613|NCT01659021|26556442|P2|Main Study|Study Terminated by Sponsor|1
7632614|NCT01659021|26556443|P1|Main Study|Study Terminated by Sponsor|16
7632615|NCT01659021|26556442|P2|Main Study|Withdrawal by Subject|16
7632616|NCT01659021|26556443|P1|Main Study|Withdrawal by Subject|19
7632617|NCT01659021|26556442|P2|Main Study|Physician Decision|16
7632618|NCT01659021|26556443|P1|Main Study|Physician Decision|34
7632619|NCT01659021|26556442|P2|Main Study|Unknown Reasons|1
7632620|NCT01659021|26556443|P1|Main Study|Unknown Reasons|2
7632621|NCT01659021|26556442|P2|Main Study|Lost to Follow-up|0
7632622|NCT01659021|26556443|P1|Main Study|Lost to Follow-up|1
7632623|NCT01659021|26556442|P2|Main Study|Adverse Event|3
7632624|NCT01659021|26556443|P1|Main Study|Adverse Event|2
7632625|NCT01658943|26556474|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
7632626|NCT01658943|26556475|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
7632627|NCT01658943|26556474|P2|Overall Study|Not eligible|9
7632628|NCT01658943|26556475|P1|Overall Study|Not eligible|7
7632629|NCT01658943|26556474|P2|Overall Study|not protocol specified|1
7632630|NCT01658943|26556475|P1|Overall Study|not protocol specified|4
7632631|NCT01658943|26556474|P2|Overall Study|Death|2
7632632|NCT01658943|26556475|P1|Overall Study|Death|4
7632633|NCT01658943|26556474|P2|Overall Study|Progression/Relapse|40
7632634|NCT01658943|26556475|P1|Overall Study|Progression/Relapse|39
7632635|NCT01658943|26556474|P2|Overall Study|Withdrawal by Subject|2
7632636|NCT01658943|26556475|P1|Overall Study|Withdrawal by Subject|9
7632637|NCT01658943|26556474|P2|Overall Study|Adverse Event|13
7632638|NCT01658943|26556475|P1|Overall Study|Adverse Event|6
7632639|NCT01658904|26556490|P3|Overall Study|Principal Investigator discretion|0
7632640|NCT01658904|26556491|P2|Overall Study|Principal Investigator discretion|0
7632641|NCT01658904|26556492|P1|Overall Study|Principal Investigator discretion|2
7632642|NCT01658813|26556518|P1|Overall Study|Disease progression|3
7632643|NCT01658735|26556529|P3|Overall Study|Withdrawal by Subject|3
7632644|NCT01658735|26556530|P2|Overall Study|Withdrawal by Subject|5
7632645|NCT01658735|26556531|P1|Overall Study|Withdrawal by Subject|3
7632646|NCT01658735|26556529|P3|Overall Study|Protocol Violation|0
7632647|NCT01658735|26556530|P2|Overall Study|Protocol Violation|1
7632648|NCT01658735|26556531|P1|Overall Study|Protocol Violation|0
7632649|NCT01658735|26556529|P3|Overall Study|Lost to Follow-up|0
7632650|NCT01658735|26556530|P2|Overall Study|Lost to Follow-up|1
7632651|NCT01658735|26556531|P1|Overall Study|Lost to Follow-up|1
7632652|NCT01658735|26556529|P3|Overall Study|Lack of Efficacy|1
7632653|NCT01658735|26556530|P2|Overall Study|Lack of Efficacy|0
7632654|NCT01658735|26556531|P1|Overall Study|Lack of Efficacy|1
7632655|NCT01658579|26556573|P4|Treatment Period B|Other|1
7632656|NCT01658579|26556574|P3|Treatment Period B|Other|0
7632657|NCT01658579|26556575|P2|Treatment Period B|Other|0
7632658|NCT01658579|26556576|P1|Treatment Period B|Other|0
7632659|NCT01658579|26556573|P4|Treatment Period A|Adverse Event|0
7632660|NCT01658579|26556574|P3|Treatment Period A|Adverse Event|0
7632661|NCT01658579|26556575|P2|Treatment Period A|Adverse Event|0
7632662|NCT01658579|26556576|P1|Treatment Period A|Adverse Event|1
7632663|NCT01658579|26556573|P4|Treatment Period A|Other|1
7632664|NCT01658579|26556574|P3|Treatment Period A|Other|1
7632665|NCT01658579|26556575|P2|Treatment Period A|Other|0
7632666|NCT01658579|26556576|P1|Treatment Period A|Other|0
7632667|NCT01658514|26556604|P3|Overall Study|Protocol Violation|2
7632668|NCT01658514|26556605|P2|Overall Study|Protocol Violation|0
7632669|NCT01658514|26556606|P1|Overall Study|Protocol Violation|1
7632670|NCT01658436|26556617|P2|Overall Study|Death|0
7632671|NCT01658436|26556618|P1|Overall Study|Death|1
7632672|NCT01658436|26556617|P2|Overall Study|Subject/guardian decision|1
7632673|NCT01658436|26556618|P1|Overall Study|Subject/guardian decision|0
7632674|NCT01658436|26556617|P2|Overall Study|Study terminated by sponsor|1
7632675|NCT01658436|26556618|P1|Overall Study|Study terminated by sponsor|0
7632676|NCT01658436|26556617|P2|Overall Study|Progressive disease|4
7632677|NCT01658436|26556618|P1|Overall Study|Progressive disease|12
7632678|NCT01658436|26556617|P2|Overall Study|Physician Decision|0
7632679|NCT01658436|26556618|P1|Overall Study|Physician Decision|1
7632680|NCT01658436|26556617|P2|Overall Study|Adverse Event|5
7632681|NCT01658436|26556618|P1|Overall Study|Adverse Event|6
7632682|NCT01658150|26556638|P1|Overall Study|Withdrawal by Subject|1
7632683|NCT01658072|26556660|P2|Overall Study|Protocol Violation|2
7632684|NCT01658072|26556661|P1|Overall Study|Protocol Violation|4
7632685|NCT01658020|26556676|P2|Overall Study|Protocol Violation|1
7632686|NCT01658020|26556677|P1|Overall Study|Protocol Violation|0
7632687|NCT01658020|26556676|P2|Overall Study|Withdrawal by Subject|5
7632688|NCT01658020|26556677|P1|Overall Study|Withdrawal by Subject|4
7632689|NCT01658020|26556676|P2|Overall Study|Lost to Follow-up|0
7632690|NCT01658020|26556677|P1|Overall Study|Lost to Follow-up|1
7632691|NCT01658020|26556676|P2|Overall Study|Adverse Event|3
7632692|NCT01658020|26556677|P1|Overall Study|Adverse Event|3
7632693|NCT01657903|26556693|P1|Overall Study|Withdrawal by Subject|1
7632694|NCT01657903|26556693|P1|Overall Study|Lost to Follow-up|1
7632695|NCT01657877|26556715|P1|Overall Study|Other Reason|2
7632696|NCT01657877|26556715|P1|Overall Study|Adverse Event|2
7632697|NCT01657877|26556715|P1|Overall Study|Protocol Violation|6
7632698|NCT01657877|26556715|P1|Overall Study|Withdrawal by Subject|4
7632699|NCT01657799|26556735|P3|Overall Study|Other|49
7632700|NCT01657799|26556736|P2|Overall Study|Other|62
7632701|NCT01657799|26556737|P1|Overall Study|Other|52
7632702|NCT01657799|26556735|P3|Overall Study|Radiographic & Clinical Progression|15
7632703|NCT01657799|26556736|P2|Overall Study|Radiographic & Clinical Progression|11
7632704|NCT01657799|26556737|P1|Overall Study|Radiographic & Clinical Progression|16
7632705|NCT01657799|26556735|P3|Overall Study|Progressive Disease Clinical|7
7632706|NCT01657799|26556736|P2|Overall Study|Progressive Disease Clinical|4
7632707|NCT01657799|26556737|P1|Overall Study|Progressive Disease Clinical|7
7632708|NCT01657799|26556735|P3|Overall Study|Disease Progression|4
7632709|NCT01657799|26556736|P2|Overall Study|Disease Progression|4
7632710|NCT01657799|26556737|P1|Overall Study|Disease Progression|2
7632711|NCT01657799|26556735|P3|Overall Study|Lost to Follow-up|1
7632712|NCT01657799|26556736|P2|Overall Study|Lost to Follow-up|0
7632713|NCT01657799|26556737|P1|Overall Study|Lost to Follow-up|1
7632714|NCT01657799|26556735|P3|Overall Study|Withdrawal by Subject|10
7632715|NCT01657799|26556736|P2|Overall Study|Withdrawal by Subject|10
7632716|NCT01657799|26556737|P1|Overall Study|Withdrawal by Subject|13
7632717|NCT01657799|26556735|P3|Overall Study|Adverse Event Not Related to Progression|4
7632718|NCT01657799|26556736|P2|Overall Study|Adverse Event Not Related to Progression|4
7632719|NCT01657799|26556737|P1|Overall Study|Adverse Event Not Related to Progression|5
7632720|NCT01657799|26556735|P3|Overall Study|Adverse Event Related to progression|12
7632721|NCT01657799|26556736|P2|Overall Study|Adverse Event Related to progression|8
7632722|NCT01657799|26556737|P1|Overall Study|Adverse Event Related to progression|6
7632723|NCT01657760|26556756|P4|Overall Study|Physician Decision|2
7632724|NCT01657760|26556757|P3|Overall Study|Physician Decision|1
7632725|NCT01657760|26556758|P2|Overall Study|Physician Decision|1
7632726|NCT01657760|26556759|P1|Overall Study|Physician Decision|1
7632727|NCT01657760|26556756|P4|Overall Study|Withdrawal by Subject|1
7632728|NCT01657760|26556757|P3|Overall Study|Withdrawal by Subject|0
7632729|NCT01657760|26556758|P2|Overall Study|Withdrawal by Subject|0
7632730|NCT01657760|26556759|P1|Overall Study|Withdrawal by Subject|0
7632731|NCT01657461|26556778|P2|Overall Study|Withdrawal by Subject|3
7632732|NCT01657461|26556779|P1|Overall Study|Withdrawal by Subject|1
7632733|NCT01657461|26556778|P2|Overall Study|Physician Decision|2
7632734|NCT01657461|26556779|P1|Overall Study|Physician Decision|0
7632735|NCT01657461|26556778|P2|Overall Study|Lost to Follow-up|3
7632736|NCT01657461|26556779|P1|Overall Study|Lost to Follow-up|0
7632737|NCT01657461|26556778|P2|Overall Study|Death|12
7632738|NCT01657461|26556779|P1|Overall Study|Death|9
7632739|NCT01657370|26556809|P6|Overall Study|Lost to Follow-up|1
7632740|NCT01657370|26556810|P5|Overall Study|Lost to Follow-up|0
7632741|NCT01657370|26556811|P4|Overall Study|Lost to Follow-up|0
7632742|NCT01657370|26556812|P3|Overall Study|Lost to Follow-up|1
7632743|NCT01657370|26556813|P2|Overall Study|Lost to Follow-up|0
7632744|NCT01657370|26556814|P1|Overall Study|Lost to Follow-up|2
7632745|NCT01657370|26556809|P6|Overall Study|Protocol Violation|0
7632746|NCT01657370|26556810|P5|Overall Study|Protocol Violation|0
7632747|NCT01657370|26556811|P4|Overall Study|Protocol Violation|1
7632748|NCT01657370|26556812|P3|Overall Study|Protocol Violation|1
7632749|NCT01657370|26556813|P2|Overall Study|Protocol Violation|1
7632750|NCT01657370|26556814|P1|Overall Study|Protocol Violation|1
7632751|NCT01657370|26556809|P6|Overall Study|Adverse Event|0
7632752|NCT01657370|26556810|P5|Overall Study|Adverse Event|1
7632753|NCT01657370|26556811|P4|Overall Study|Adverse Event|0
7632754|NCT01657370|26556812|P3|Overall Study|Adverse Event|0
7632755|NCT01657370|26556813|P2|Overall Study|Adverse Event|0
7632756|NCT01657370|26556814|P1|Overall Study|Adverse Event|0
7632757|NCT01657370|26556809|P6|Overall Study|Lack of Qualifying Event|2
7632758|NCT01657370|26556810|P5|Overall Study|Lack of Qualifying Event|1
7632759|NCT01657370|26556811|P4|Overall Study|Lack of Qualifying Event|2
7632760|NCT01657370|26556812|P3|Overall Study|Lack of Qualifying Event|3
7632761|NCT01657370|26556813|P2|Overall Study|Lack of Qualifying Event|0
7632762|NCT01657370|26556814|P1|Overall Study|Lack of Qualifying Event|1
7632763|NCT01657370|26556809|P6|Overall Study|Physician Decision|0
7632764|NCT01657370|26556810|P5|Overall Study|Physician Decision|5
7632765|NCT01657370|26556811|P4|Overall Study|Physician Decision|2
7632766|NCT01657370|26556812|P3|Overall Study|Physician Decision|1
7632767|NCT01657370|26556813|P2|Overall Study|Physician Decision|3
7632768|NCT01657370|26556814|P1|Overall Study|Physician Decision|2
7632769|NCT01657370|26556809|P6|Overall Study|Withdrawal by Subject|1
7632770|NCT01657370|26556810|P5|Overall Study|Withdrawal by Subject|0
7632771|NCT01657370|26556811|P4|Overall Study|Withdrawal by Subject|0
7632772|NCT01657370|26556812|P3|Overall Study|Withdrawal by Subject|1
7632773|NCT01657370|26556813|P2|Overall Study|Withdrawal by Subject|0
7632774|NCT01657370|26556814|P1|Overall Study|Withdrawal by Subject|0
7632775|NCT01657305|26556912|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
7632776|NCT01657305|26556912|P1|Overall Study|Lost to Follow-up|1
7632777|NCT01657305|26556912|P1|Overall Study|Adverse Event|1
7632778|NCT01657305|26556912|P1|Overall Study|Withdrawal by Subject|4
7632779|NCT01657305|26556912|P1|Overall Study|Lack of Wound Closure at Day 28|15
7632780|NCT01657292|26556962|P1|Overall Study|Change of therapy|1
7632781|NCT01657292|26556962|P1|Overall Study|Violation of eligibility criteria|1
7632782|NCT01657292|26556962|P1|Overall Study|Withdrawal by Subject|2
7632783|NCT01657292|26556962|P1|Overall Study|Adverse Event|6
7632784|NCT01657266|26556971|P2|Overall Study|Adverse Event|3
7632785|NCT01657266|26556972|P1|Overall Study|Adverse Event|2
7632786|NCT01657266|26556971|P2|Overall Study|Lost to Follow-up|2
7632787|NCT01657266|26556972|P1|Overall Study|Lost to Follow-up|2
7632788|NCT01657253|26556994|P2|Overall Study|Adverse Event|1
7632789|NCT01657253|26556995|P1|Overall Study|Adverse Event|0
7632790|NCT01657253|26556994|P2|Overall Study|Withdrawal by Subject|12
7632791|NCT01657253|26556995|P1|Overall Study|Withdrawal by Subject|11
7632792|NCT01657253|26556994|P2|Overall Study|Lost to Follow-up|5
7632793|NCT01657253|26556995|P1|Overall Study|Lost to Follow-up|6
7632794|NCT01657162|26557007|P2|Overall Study|Other than Specified|2
7632795|NCT01657162|26557008|P1|Overall Study|Other than Specified|0
7632796|NCT01657162|26557007|P2|Overall Study|Hypersensitivity to Alendronate|1
7632797|NCT01657162|26557008|P1|Overall Study|Hypersensitivity to Alendronate|0
7632798|NCT01657162|26557007|P2|Overall Study|Protocol Violation|0
7632799|NCT01657162|26557008|P1|Overall Study|Protocol Violation|1
7632800|NCT01657162|26557007|P2|Overall Study|Inability to Complete Study Procedures|7
7632801|NCT01657162|26557008|P1|Overall Study|Inability to Complete Study Procedures|1
7632802|NCT01657162|26557007|P2|Overall Study|Death|3
7632803|NCT01657162|26557008|P1|Overall Study|Death|2
7632804|NCT01657162|26557007|P2|Overall Study|Lost to Follow-up|4
7632805|NCT01657162|26557008|P1|Overall Study|Lost to Follow-up|3
7632806|NCT01657162|26557007|P2|Overall Study|Refusal of Treatment|6
7632807|NCT01657162|26557008|P1|Overall Study|Refusal of Treatment|4
7632808|NCT01657162|26557007|P2|Overall Study|Continuing Significant Deterioration|3
7632809|NCT01657162|26557008|P1|Overall Study|Continuing Significant Deterioration|9
7632810|NCT01657162|26557007|P2|Overall Study|Withdrawal by Subject|13
7632811|NCT01657162|26557008|P1|Overall Study|Withdrawal by Subject|13
7632812|NCT01657162|26557007|P2|Overall Study|Adverse Event|36
7632813|NCT01657162|26557008|P1|Overall Study|Adverse Event|26
7632814|NCT01657032|26557036|P2|Overall Study|Lost to Follow-up|7
7632815|NCT01657032|26557037|P1|Overall Study|Lost to Follow-up|0
7632816|NCT01657019|26557063|P1|Overall Study|Other|58
7632817|NCT01657019|26557063|P1|Overall Study|Lack of Efficacy|3
7632818|NCT01657019|26557063|P1|Overall Study|Protocol Violation|6
7632819|NCT01657019|26557063|P1|Overall Study|Lost to Follow-up|48
7632820|NCT01657019|26557063|P1|Overall Study|Adverse Event|55
7632821|NCT01657019|26557063|P1|Overall Study|Withdrawal by Subject|65
7632822|NCT01656967|26557077|P2|Overall Study|unsuccessful ETT insertion|2
7632823|NCT01656967|26557078|P1|Overall Study|unsuccessful ETT insertion|3
7632824|NCT01656967|26557077|P2|Overall Study|faulty monitor|0
7632825|NCT01656967|26557078|P1|Overall Study|faulty monitor|1
7632826|NCT01656889|26557104|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
7632827|NCT01656889|26557105|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
7632828|NCT01656889|26557104|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
7632829|NCT01656889|26557105|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
7632830|NCT01656889|26557104|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
7632831|NCT01656889|26557105|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
7632832|NCT01656889|26557104|P2|Post Treatment Follow-Up, 3 Months|Death|5
7632833|NCT01656889|26557105|P1|Post Treatment Follow-Up, 3 Months|Death|1
7632834|NCT01656889|26557104|P2|Treatment Period, 12 Weeks|Moved out of the area|2
7632835|NCT01656889|26557105|P1|Treatment Period, 12 Weeks|Moved out of the area|0
7632836|NCT01656889|26557104|P2|Treatment Period, 12 Weeks|Protocol Violation|1
7632837|NCT01656889|26557105|P1|Treatment Period, 12 Weeks|Protocol Violation|0
7632838|NCT01656889|26557104|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
7632839|NCT01656889|26557105|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
7632840|NCT01656889|26557104|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
7632841|NCT01656889|26557105|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
7632842|NCT01656889|26557104|P2|Treatment Period, 12 Weeks|Death|1
7632843|NCT01656889|26557105|P1|Treatment Period, 12 Weeks|Death|0
7632844|NCT01656889|26557104|P2|Treatment Period, 12 Weeks|Adverse Event|4
7632845|NCT01656889|26557105|P1|Treatment Period, 12 Weeks|Adverse Event|10
7632846|NCT01656850|26557125|P2|First Intervention (3 Months)|Withdrawal by Subject|4
7632847|NCT01656850|26557126|P1|First Intervention (3 Months)|Withdrawal by Subject|3
7632848|NCT01656759|26557217|P2|Overall Study|Protocol Violation|3
7632849|NCT01656759|26557218|P1|Overall Study|Protocol Violation|2
7632850|NCT01656733|26557232|P2|Overall Study|Spontaneous abortion|1
7632851|NCT01656733|26557233|P1|Overall Study|Spontaneous abortion|0
7632852|NCT01656733|26557232|P2|Overall Study|Delivery at another hospital|2
7632853|NCT01656733|26557233|P1|Overall Study|Delivery at another hospital|0
7632854|NCT01656733|26557232|P2|Overall Study|No permission to collect birth outcomes|1
7632855|NCT01656733|26557233|P1|Overall Study|No permission to collect birth outcomes|0
7632856|NCT01656434|26557283|P2|Overall Study|Withdrawal by Subject|7
7632857|NCT01656434|26557284|P1|Overall Study|Withdrawal by Subject|64
7632858|NCT01656434|26557283|P2|Overall Study|Participant withdrew consent|9
7632859|NCT01656434|26557284|P1|Overall Study|Participant withdrew consent|28
7632860|NCT01656434|26557283|P2|Overall Study|Participant moved|12
7632861|NCT01656434|26557284|P1|Overall Study|Participant moved|40
7632862|NCT01656434|26557283|P2|Overall Study|Non-compliance with protocol|15
7632863|NCT01656434|26557284|P1|Overall Study|Non-compliance with protocol|39
7632864|NCT01656434|26557283|P2|Overall Study|Part. discontinued; unrelated to drug|10
7632865|NCT01656434|26557284|P1|Overall Study|Part. discontinued; unrelated to drug|55
7632866|NCT01656434|26557283|P2|Overall Study|Participant discontinued; drug related|4
7632867|NCT01656434|26557284|P1|Overall Study|Participant discontinued; drug related|13
7632868|NCT01656434|26557283|P2|Overall Study|Study terminated by sponsor|348
7632869|NCT01656434|26557284|P1|Overall Study|Study terminated by sponsor|1501
7632870|NCT01656434|26557283|P2|Overall Study|Non-compliance with study drug|9
7632871|NCT01656434|26557284|P1|Overall Study|Non-compliance with study drug|48
7632872|NCT01656434|26557283|P2|Overall Study|Physician Decision|2
7632873|NCT01656434|26557284|P1|Overall Study|Physician Decision|7
7632874|NCT01656434|26557283|P2|Overall Study|Pregnancy|10
7632875|NCT01656434|26557284|P1|Overall Study|Pregnancy|45
7632876|NCT01656434|26557283|P2|Overall Study|Pregnancy wish|6
7632877|NCT01656434|26557284|P1|Overall Study|Pregnancy wish|18
7632878|NCT01656434|26557283|P2|Overall Study|Protocol Violation|0
7632879|NCT01656434|26557284|P1|Overall Study|Protocol Violation|7
7632880|NCT01656434|26557283|P2|Overall Study|Screen failure|0
7632881|NCT01656434|26557284|P1|Overall Study|Screen failure|2
7632882|NCT01656434|26557283|P2|Overall Study|Site discontinued study participation|9
7632883|NCT01656434|26557284|P1|Overall Study|Site discontinued study participation|24
7632884|NCT01656434|26557283|P2|Overall Study|Lost to Follow-up|76
7632885|NCT01656434|26557284|P1|Overall Study|Lost to Follow-up|309
7632886|NCT01656434|26557283|P2|Overall Study|Enrollment terminated at trial site|0
7632887|NCT01656434|26557284|P1|Overall Study|Enrollment terminated at trial site|2
7632888|NCT01656434|26557283|P2|Overall Study|Adverse Event|63
7632889|NCT01656434|26557284|P1|Overall Study|Adverse Event|199
7632890|NCT01656408|26557310|P10|Overall Study|Physician Decision|3
7632891|NCT01656408|26557311|P9|Overall Study|Physician Decision|1
7632892|NCT01656408|26557312|P8|Overall Study|Physician Decision|1
7632893|NCT01656408|26557313|P7|Overall Study|Physician Decision|0
7632894|NCT01656408|26557314|P6|Overall Study|Physician Decision|1
7632895|NCT01656408|26557315|P5|Overall Study|Physician Decision|1
7632896|NCT01656408|26557316|P4|Overall Study|Physician Decision|0
7632897|NCT01656408|26557317|P3|Overall Study|Physician Decision|1
7632898|NCT01656408|26557318|P2|Overall Study|Physician Decision|0
7632899|NCT01656408|26557319|P1|Overall Study|Physician Decision|1
7632900|NCT01656408|26557310|P10|Overall Study|Adverse Event|0
7632901|NCT01656408|26557311|P9|Overall Study|Adverse Event|1
7632902|NCT01656408|26557312|P8|Overall Study|Adverse Event|0
7632903|NCT01656408|26557313|P7|Overall Study|Adverse Event|1
7632904|NCT01656408|26557314|P6|Overall Study|Adverse Event|1
7632905|NCT01656408|26557315|P5|Overall Study|Adverse Event|0
7632906|NCT01656408|26557316|P4|Overall Study|Adverse Event|0
7632907|NCT01656408|26557317|P3|Overall Study|Adverse Event|1
7632908|NCT01656408|26557318|P2|Overall Study|Adverse Event|0
7632909|NCT01656408|26557319|P1|Overall Study|Adverse Event|0
7632910|NCT01656395|26557514|P8|Overall Study|Withdrawal by Subject|0
7632911|NCT01656395|26557515|P7|Overall Study|Withdrawal by Subject|0
7632912|NCT01656395|26557516|P6|Overall Study|Withdrawal by Subject|3
7632913|NCT01656395|26557517|P5|Overall Study|Withdrawal by Subject|0
7632914|NCT01656395|26557518|P4|Overall Study|Withdrawal by Subject|2
7632915|NCT01656395|26557519|P3|Overall Study|Withdrawal by Subject|4
7632916|NCT01656395|26557520|P2|Overall Study|Withdrawal by Subject|1
7632917|NCT01656395|26557521|P1|Overall Study|Withdrawal by Subject|3
7632918|NCT01656395|26557514|P8|Overall Study|Screen Failure|0
7632919|NCT01656395|26557515|P7|Overall Study|Screen Failure|0
7632920|NCT01656395|26557516|P6|Overall Study|Screen Failure|8
7632921|NCT01656395|26557517|P5|Overall Study|Screen Failure|0
7632922|NCT01656395|26557518|P4|Overall Study|Screen Failure|1
7632923|NCT01656395|26557519|P3|Overall Study|Screen Failure|7
7632924|NCT01656395|26557520|P2|Overall Study|Screen Failure|1
7632925|NCT01656395|26557521|P1|Overall Study|Screen Failure|2
7632926|NCT01656395|26557514|P8|Overall Study|Protocol Violation|0
7632927|NCT01656395|26557515|P7|Overall Study|Protocol Violation|0
7632928|NCT01656395|26557516|P6|Overall Study|Protocol Violation|10
7632929|NCT01656395|26557517|P5|Overall Study|Protocol Violation|4
7632930|NCT01656395|26557518|P4|Overall Study|Protocol Violation|2
7632931|NCT01656395|26557519|P3|Overall Study|Protocol Violation|9
7632932|NCT01656395|26557520|P2|Overall Study|Protocol Violation|6
7632933|NCT01656395|26557521|P1|Overall Study|Protocol Violation|6
7632934|NCT01656395|26557514|P8|Overall Study|Progressive Disease|0
7632935|NCT01656395|26557515|P7|Overall Study|Progressive Disease|0
7632936|NCT01656395|26557516|P6|Overall Study|Progressive Disease|1
7632937|NCT01656395|26557517|P5|Overall Study|Progressive Disease|0
7632938|NCT01656395|26557518|P4|Overall Study|Progressive Disease|0
7632939|NCT01656395|26557519|P3|Overall Study|Progressive Disease|0
7632940|NCT01656395|26557520|P2|Overall Study|Progressive Disease|0
7632941|NCT01656395|26557521|P1|Overall Study|Progressive Disease|0
7632942|NCT01656395|26557514|P8|Overall Study|Pregnancy|0
7632943|NCT01656395|26557515|P7|Overall Study|Pregnancy|0
7632944|NCT01656395|26557516|P6|Overall Study|Pregnancy|0
7632945|NCT01656395|26557517|P5|Overall Study|Pregnancy|0
7632946|NCT01656395|26557518|P4|Overall Study|Pregnancy|0
7632947|NCT01656395|26557519|P3|Overall Study|Pregnancy|1
7632948|NCT01656395|26557520|P2|Overall Study|Pregnancy|0
7632949|NCT01656395|26557521|P1|Overall Study|Pregnancy|0
7632950|NCT01656395|26557514|P8|Overall Study|Physician Decision|0
7632951|NCT01656395|26557515|P7|Overall Study|Physician Decision|0
7632952|NCT01656395|26557516|P6|Overall Study|Physician Decision|3
7632953|NCT01656395|26557517|P5|Overall Study|Physician Decision|3
7632954|NCT01656395|26557518|P4|Overall Study|Physician Decision|2
7632955|NCT01656395|26557519|P3|Overall Study|Physician Decision|3
7632956|NCT01656395|26557520|P2|Overall Study|Physician Decision|3
7632957|NCT01656395|26557521|P1|Overall Study|Physician Decision|2
7632958|NCT01656395|26557514|P8|Overall Study|Other|0
7632959|NCT01656395|26557515|P7|Overall Study|Other|0
7632960|NCT01656395|26557516|P6|Overall Study|Other|1
7632961|NCT01656395|26557517|P5|Overall Study|Other|0
7632962|NCT01656395|26557518|P4|Overall Study|Other|0
7632963|NCT01656395|26557519|P3|Overall Study|Other|1
7632964|NCT01656395|26557520|P2|Overall Study|Other|0
7632965|NCT01656395|26557521|P1|Overall Study|Other|0
7632966|NCT01656395|26557514|P8|Overall Study|Non-Compliance with Study Drug|0
7632967|NCT01656395|26557515|P7|Overall Study|Non-Compliance with Study Drug|0
7632968|NCT01656395|26557516|P6|Overall Study|Non-Compliance with Study Drug|1
7632969|NCT01656395|26557517|P5|Overall Study|Non-Compliance with Study Drug|1
7632970|NCT01656395|26557518|P4|Overall Study|Non-Compliance with Study Drug|0
7632971|NCT01656395|26557519|P3|Overall Study|Non-Compliance with Study Drug|0
7632972|NCT01656395|26557520|P2|Overall Study|Non-Compliance with Study Drug|1
7632973|NCT01656395|26557521|P1|Overall Study|Non-Compliance with Study Drug|1
7632974|NCT01656395|26557514|P8|Overall Study|Lost to Follow-up|0
7632975|NCT01656395|26557515|P7|Overall Study|Lost to Follow-up|0
7632976|NCT01656395|26557516|P6|Overall Study|Lost to Follow-up|0
7632977|NCT01656395|26557517|P5|Overall Study|Lost to Follow-up|0
7632978|NCT01656395|26557518|P4|Overall Study|Lost to Follow-up|0
7632979|NCT01656395|26557519|P3|Overall Study|Lost to Follow-up|0
7632980|NCT01656395|26557520|P2|Overall Study|Lost to Follow-up|0
7632981|NCT01656395|26557521|P1|Overall Study|Lost to Follow-up|1
7632982|NCT01656395|26557514|P8|Overall Study|Lack of Efficacy|0
7632983|NCT01656395|26557515|P7|Overall Study|Lack of Efficacy|0
7632984|NCT01656395|26557516|P6|Overall Study|Lack of Efficacy|6
7632985|NCT01656395|26557517|P5|Overall Study|Lack of Efficacy|1
7632986|NCT01656395|26557518|P4|Overall Study|Lack of Efficacy|1
7632987|NCT01656395|26557519|P3|Overall Study|Lack of Efficacy|6
7632988|NCT01656395|26557520|P2|Overall Study|Lack of Efficacy|8
7632989|NCT01656395|26557521|P1|Overall Study|Lack of Efficacy|1
7632990|NCT01656395|26557514|P8|Overall Study|Adverse Event|0
7632991|NCT01656395|26557515|P7|Overall Study|Adverse Event|0
7632992|NCT01656395|26557516|P6|Overall Study|Adverse Event|7
7632993|NCT01656395|26557517|P5|Overall Study|Adverse Event|5
7632994|NCT01656395|26557518|P4|Overall Study|Adverse Event|4
7632995|NCT01656395|26557519|P3|Overall Study|Adverse Event|5
7632996|NCT01656395|26557520|P2|Overall Study|Adverse Event|14
7632997|NCT01656395|26557521|P1|Overall Study|Adverse Event|1
7632998|NCT01656304|26557607|P1|Overall Study|Ineligible, uncontrolled hypertension|1
7632999|NCT01656200|26557648|P1|Overall Study|Withdrawal by Subject|1
7633000|NCT01656161|26557663|P1|Overall Study|Withdrawal by Subject|1
7633001|NCT01656161|26557663|P1|Overall Study|Protocol Violation|1
7633002|NCT01656161|26557663|P1|Overall Study|Adverse Event|2
7633003|NCT01656161|26557663|P1|Overall Study|Death|3
7633004|NCT01655901|26557681|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
7633005|NCT01655901|26557682|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
7633006|NCT01655901|26557683|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
7633007|NCT01655901|26557684|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
7633008|NCT01655901|26557685|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
7633009|NCT01655901|26557686|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
7633010|NCT01655823|26557700|P5|Overall Study|Withdrawal by Subject|0
7633011|NCT01655823|26557701|P4|Overall Study|Withdrawal by Subject|1
7633012|NCT01655823|26557702|P3|Overall Study|Withdrawal by Subject|0
7633013|NCT01655823|26557703|P2|Overall Study|Withdrawal by Subject|1
7633014|NCT01655823|26557704|P1|Overall Study|Withdrawal by Subject|0
7633015|NCT01655823|26557700|P5|Overall Study|Lost to Follow-up|1
7633016|NCT01655823|26557701|P4|Overall Study|Lost to Follow-up|0
7633017|NCT01655823|26557702|P3|Overall Study|Lost to Follow-up|0
7633018|NCT01655823|26557703|P2|Overall Study|Lost to Follow-up|1
7633019|NCT01655823|26557704|P1|Overall Study|Lost to Follow-up|0
7633020|NCT01655693|26557725|P3|Overall Study|Other|15
7633021|NCT01655693|26557726|P2|Overall Study|Other|6
7633022|NCT01655693|26557727|P1|Overall Study|Other|8
7633023|NCT01655693|26557725|P3|Overall Study|Screening Failure|0
7633024|NCT01655693|26557726|P2|Overall Study|Screening Failure|0
7633025|NCT01655693|26557727|P1|Overall Study|Screening Failure|1
7633026|NCT01655693|26557725|P3|Overall Study|Lost to Follow-up|1
7633027|NCT01655693|26557726|P2|Overall Study|Lost to Follow-up|0
7633028|NCT01655693|26557727|P1|Overall Study|Lost to Follow-up|1
7633029|NCT01655693|26557725|P3|Overall Study|Protocol Violation|3
7633030|NCT01655693|26557726|P2|Overall Study|Protocol Violation|0
7633031|NCT01655693|26557727|P1|Overall Study|Protocol Violation|1
7633032|NCT01655693|26557725|P3|Overall Study|No Respect of Criteria for Continuing Treatment|0
7633033|NCT01655693|26557726|P2|Overall Study|No Respect of Criteria for Continuing Treatment|3
7633034|NCT01655693|26557727|P1|Overall Study|No Respect of Criteria for Continuing Treatment|1
7633035|NCT01655693|26557725|P3|Overall Study|Non-Compliance|7
7633036|NCT01655693|26557726|P2|Overall Study|Non-Compliance|0
7633037|NCT01655693|26557727|P1|Overall Study|Non-Compliance|0
7633038|NCT01655693|26557725|P3|Overall Study|Aggravation of Liver Dysfunction|0
7633039|NCT01655693|26557726|P2|Overall Study|Aggravation of Liver Dysfunction|4
7633040|NCT01655693|26557727|P1|Overall Study|Aggravation of Liver Dysfunction|5
7633041|NCT01655693|26557725|P3|Overall Study|Adverse Event|3
7633042|NCT01655693|26557726|P2|Overall Study|Adverse Event|11
7633043|NCT01655693|26557727|P1|Overall Study|Adverse Event|3
7633044|NCT01655693|26557725|P3|Overall Study|Withdrawal by Subject|20
7633045|NCT01655693|26557726|P2|Overall Study|Withdrawal by Subject|2
7633046|NCT01655693|26557727|P1|Overall Study|Withdrawal by Subject|3
7633047|NCT01655693|26557725|P3|Overall Study|Serious Adverse Event|11
7633048|NCT01655693|26557726|P2|Overall Study|Serious Adverse Event|15
7633049|NCT01655693|26557727|P1|Overall Study|Serious Adverse Event|3
7633050|NCT01655693|26557725|P3|Overall Study|Death|12
7633051|NCT01655693|26557726|P2|Overall Study|Death|9
7633052|NCT01655693|26557727|P1|Overall Study|Death|8
7633053|NCT01655693|26557725|P3|Overall Study|Progression of Disease|58
7633054|NCT01655693|26557726|P2|Overall Study|Progression of Disease|76
7633055|NCT01655693|26557727|P1|Overall Study|Progression of Disease|92
7633056|NCT01655498|26557774|P1|Overall Study|Withdrawal by Subject|1
7633057|NCT01655498|26557774|P1|Overall Study|Protocol Violation|2
7633058|NCT01655498|26557774|P1|Overall Study|Unrelated health issue|2
7633059|NCT01655381|26557781|P1|Overall Study|Insufficient Treatment Response|1
7633060|NCT01655381|26557781|P1|Overall Study|Moved to Another City|1
7633061|NCT01655381|26557781|P1|Overall Study|Investigator Decision|1
7633062|NCT01655069|26557821|P4|Overall Study|Withdrawal by Subject|0
7633063|NCT01655069|26557822|P3|Overall Study|Withdrawal by Subject|0
7633064|NCT01655069|26557823|P2|Overall Study|Withdrawal by Subject|3
7633065|NCT01655069|26557824|P1|Overall Study|Withdrawal by Subject|2
7633066|NCT01655069|26557821|P4|Overall Study|No Treatment Needed|0
7633067|NCT01655069|26557822|P3|Overall Study|No Treatment Needed|0
7633068|NCT01655069|26557823|P2|Overall Study|No Treatment Needed|1
7633069|NCT01655069|26557824|P1|Overall Study|No Treatment Needed|0
7633070|NCT01655069|26557821|P4|Overall Study|Lack of Efficacy|0
7633071|NCT01655069|26557822|P3|Overall Study|Lack of Efficacy|0
7633072|NCT01655069|26557823|P2|Overall Study|Lack of Efficacy|1
7633073|NCT01655069|26557824|P1|Overall Study|Lack of Efficacy|0
7633074|NCT01655069|26557821|P4|Overall Study|Adverse Event|3
7633075|NCT01655069|26557822|P3|Overall Study|Adverse Event|2
7633076|NCT01655069|26557823|P2|Overall Study|Adverse Event|7
7633077|NCT01655069|26557824|P1|Overall Study|Adverse Event|6
7633078|NCT01655069|26557821|P4|Overall Study|Physician Decision|1
7633079|NCT01655069|26557822|P3|Overall Study|Physician Decision|0
7633080|NCT01655069|26557823|P2|Overall Study|Physician Decision|0
7633081|NCT01655069|26557824|P1|Overall Study|Physician Decision|0
7633082|NCT01654666|26557884|P3|Overall Study|Withdrawal by Subject|1
7633083|NCT01654666|26557885|P2|Overall Study|Withdrawal by Subject|4
7633084|NCT01654666|26557886|P1|Overall Study|Withdrawal by Subject|4
7633085|NCT01654666|26557884|P3|Overall Study|Lost to Follow-up|5
7633086|NCT01654666|26557885|P2|Overall Study|Lost to Follow-up|5
7633087|NCT01654666|26557886|P1|Overall Study|Lost to Follow-up|4
7633088|NCT01654666|26557884|P3|Overall Study|Protocol Violation|8
7633089|NCT01654666|26557885|P2|Overall Study|Protocol Violation|4
7633090|NCT01654666|26557886|P1|Overall Study|Protocol Violation|7
7633091|NCT01654601|26557911|P2|2nd Administration|Protocol Violation|1
7633092|NCT01654601|26557912|P1|2nd Administration|Protocol Violation|0
7633093|NCT01654601|26557911|P2|2nd Administration|Adverse Event|0
7633094|NCT01654601|26557912|P1|2nd Administration|Adverse Event|1
7633095|NCT01654601|26557911|P2|1st Administration|Protocol Violation|2
7633096|NCT01654601|26557912|P1|1st Administration|Protocol Violation|0
7633097|NCT01654601|26557911|P2|1st Administration|Withdrawal by Subject|0
7633098|NCT01654601|26557912|P1|1st Administration|Withdrawal by Subject|2
7633099|NCT01654549|26557926|P2|Overall Study|H.pylori eradication not successful|1
7633100|NCT01654549|26557927|P1|Overall Study|H.pylori eradication not successful|0
7633101|NCT01654536|26557939|P2|Overall Study|Withdrawal by Subject|25
7633102|NCT01654536|26557940|P1|Overall Study|Withdrawal by Subject|27
7633103|NCT01654536|26557939|P2|Overall Study|Physician Decision|8
7633104|NCT01654536|26557940|P1|Overall Study|Physician Decision|12
7633105|NCT01654536|26557939|P2|Overall Study|Lost to Follow-up|5
7633106|NCT01654536|26557940|P1|Overall Study|Lost to Follow-up|5
7633107|NCT01654523|26557976|P1|Overall Study|Withdrawal by Subject|1
7633108|NCT01654380|26557995|P4|Part B, Period 1|Physician Decision|0
7633109|NCT01654380|26557996|P3|Part B, Period 1|Physician Decision|1
7633110|NCT01654380|26557997|P2|Part B, Period 1|Physician Decision|0
7633111|NCT01654380|26557998|P1|Part B, Period 1|Physician Decision|0
7633112|NCT01654302|26558041|P2|Second Intervention (Day 7)|Lost to Follow-up|1
7633113|NCT01654302|26558042|P1|Second Intervention (Day 7)|Lost to Follow-up|1
7633114|NCT01654289|26558051|P3|Overall Study|Withdrew from intervention only|0
7633115|NCT01654289|26558052|P2|Overall Study|Withdrew from intervention only|20
7633116|NCT01654289|26558053|P1|Overall Study|Withdrew from intervention only|17
7633117|NCT01654289|26558051|P3|Overall Study|Withdrawal by Subject|5
7633118|NCT01654289|26558052|P2|Overall Study|Withdrawal by Subject|8
7633119|NCT01654289|26558053|P1|Overall Study|Withdrawal by Subject|10
7633120|NCT01654276|26558091|P1|Overall Study|Withdrawal by Subject|1
7633121|NCT01654276|26558091|P1|Overall Study|Lost to Follow-up|4
7633122|NCT01654276|26558091|P1|Overall Study|Lack of Efficacy|1
7633123|NCT01654250|26558145|P2|Overall Study|Lost to Follow-up|0
7633124|NCT01654250|26558146|P1|Overall Study|Lost to Follow-up|1
7633125|NCT01654224|26558163|P2|Overall Study|Insufficient blood sample|2
7633126|NCT01654224|26558164|P1|Overall Study|Insufficient blood sample|3
7633127|NCT01654224|26558163|P2|Overall Study|Did not receive allocation|8
7633128|NCT01654224|26558164|P1|Overall Study|Did not receive allocation|1
7633129|NCT01654224|26558163|P2|Overall Study|Lost to Follow-up|2
7633130|NCT01654224|26558164|P1|Overall Study|Lost to Follow-up|2
7633131|NCT01653912|26558195|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
7633132|NCT01653912|26558196|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7633133|NCT01653912|26558197|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7633134|NCT01653912|26558198|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7633135|NCT01653912|26558199|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7633136|NCT01653912|26558200|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7633137|NCT01653912|26558195|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
7633138|NCT01653912|26558196|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7633139|NCT01653912|26558197|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7633140|NCT01653912|26558198|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7633141|NCT01653912|26558199|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7633142|NCT01653912|26558200|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7633143|NCT01653912|26558195|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
7633144|NCT01653912|26558196|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
7633145|NCT01653912|26558197|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
7633146|NCT01653912|26558198|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
7633147|NCT01653912|26558199|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
7633148|NCT01653912|26558200|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
7633149|NCT01653912|26558195|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7633150|NCT01653912|26558196|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7633151|NCT01653912|26558197|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
7633152|NCT01653912|26558198|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7633153|NCT01653912|26558199|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7633154|NCT01653912|26558200|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7633155|NCT01653912|26558195|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7633156|NCT01653912|26558196|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7633157|NCT01653912|26558197|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
7633158|NCT01653912|26558198|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7633159|NCT01653912|26558199|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7633160|NCT01653912|26558200|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7633161|NCT01653912|26558195|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7633162|NCT01653912|26558196|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7633163|NCT01653912|26558197|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7633164|NCT01653912|26558198|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
7633165|NCT01653912|26558199|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7633166|NCT01653912|26558200|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7633167|NCT01653912|26558195|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7633168|NCT01653912|26558196|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7633169|NCT01653912|26558197|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7633170|NCT01653912|26558198|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7633171|NCT01653912|26558199|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
7633172|NCT01653912|26558200|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7633173|NCT01653847|26558217|P2|Overall Study|Withdrawal by Subject|0
7633174|NCT01653847|26558218|P1|Overall Study|Withdrawal by Subject|1
7633175|NCT01653782|26558235|P3|Overall Study|Lost to Follow-up|2
7633176|NCT01653782|26558236|P2|Overall Study|Lost to Follow-up|3
7633177|NCT01653782|26558237|P1|Overall Study|Lost to Follow-up|7
7633178|NCT01653782|26558235|P3|Overall Study|Withdrawal by Subject|4
7633179|NCT01653782|26558236|P2|Overall Study|Withdrawal by Subject|15
7633180|NCT01653782|26558237|P1|Overall Study|Withdrawal by Subject|9
7633181|NCT01653743|26558247|P2|Overall Study|Investigator discretion|0
7633182|NCT01653743|26558248|P1|Overall Study|Investigator discretion|3
7633183|NCT01653743|26558247|P2|Overall Study|Withdrawal by Subject|0
7633184|NCT01653743|26558248|P1|Overall Study|Withdrawal by Subject|1
7633185|NCT01653704|26558264|P2|Overall Study|Performance not reflective of training|0
7633186|NCT01653704|26558265|P1|Overall Study|Performance not reflective of training|1
7633187|NCT01653704|26558264|P2|Overall Study|Technical failure during recording|1
7633188|NCT01653704|26558265|P1|Overall Study|Technical failure during recording|1
7633189|NCT01653327|26558334|P1|Overall Study|Withdrawal by Subject|1
7633190|NCT01653262|26558359|P1|Overall Study|AE, non-serious non-fatal|1
7633191|NCT01653262|26558359|P1|Overall Study|SAE, non-fatal|1
7633192|NCT01653262|26558359|P1|Overall Study|Lack of Efficacy|1
7633193|NCT01653158|26558377|P8|Overall Study|Withdrawal by Subject|0
7633194|NCT01653158|26558378|P7|Overall Study|Withdrawal by Subject|0
7633195|NCT01653158|26558379|P6|Overall Study|Withdrawal by Subject|0
7633196|NCT01653158|26558380|P5|Overall Study|Withdrawal by Subject|0
7633197|NCT01653158|26558381|P4|Overall Study|Withdrawal by Subject|0
7633198|NCT01653158|26558382|P3|Overall Study|Withdrawal by Subject|0
7633199|NCT01653158|26558383|P2|Overall Study|Withdrawal by Subject|0
7633200|NCT01653158|26558384|P1|Overall Study|Withdrawal by Subject|1
7633201|NCT01653158|26558377|P8|Overall Study|Progressive disease|9
7633202|NCT01653158|26558378|P7|Overall Study|Progressive disease|2
7633203|NCT01653158|26558379|P6|Overall Study|Progressive disease|1
7633204|NCT01653158|26558380|P5|Overall Study|Progressive disease|1
7633205|NCT01653158|26558381|P4|Overall Study|Progressive disease|0
7633206|NCT01653158|26558382|P3|Overall Study|Progressive disease|0
7633207|NCT01653158|26558383|P2|Overall Study|Progressive disease|0
7633208|NCT01653158|26558384|P1|Overall Study|Progressive disease|0
7633209|NCT01653158|26558377|P8|Overall Study|Other|1
7633210|NCT01653158|26558378|P7|Overall Study|Other|0
7633211|NCT01653158|26558379|P6|Overall Study|Other|0
7633212|NCT01653158|26558380|P5|Overall Study|Other|0
7633213|NCT01653158|26558381|P4|Overall Study|Other|0
7633214|NCT01653158|26558382|P3|Overall Study|Other|0
7633215|NCT01653158|26558383|P2|Overall Study|Other|0
7633216|NCT01653158|26558384|P1|Overall Study|Other|0
7633217|NCT01653158|26558377|P8|Overall Study|Adverse Event|3
7633218|NCT01653158|26558378|P7|Overall Study|Adverse Event|0
7633219|NCT01653158|26558379|P6|Overall Study|Adverse Event|0
7633220|NCT01653158|26558380|P5|Overall Study|Adverse Event|0
7633221|NCT01653158|26558381|P4|Overall Study|Adverse Event|1
7633222|NCT01653158|26558382|P3|Overall Study|Adverse Event|0
7633223|NCT01653158|26558383|P2|Overall Study|Adverse Event|0
7633224|NCT01653158|26558384|P1|Overall Study|Adverse Event|0
7633225|NCT01653158|26558377|P8|Overall Study|Death|2
7633226|NCT01653158|26558378|P7|Overall Study|Death|0
7633227|NCT01653158|26558379|P6|Overall Study|Death|0
7633228|NCT01653158|26558380|P5|Overall Study|Death|0
7633229|NCT01653158|26558381|P4|Overall Study|Death|1
7633230|NCT01653158|26558382|P3|Overall Study|Death|0
7633231|NCT01653158|26558383|P2|Overall Study|Death|0
7633232|NCT01653158|26558384|P1|Overall Study|Death|0
7633233|NCT01653132|26558656|P2|First Intervention|Protocol Violation|0
7633234|NCT01653132|26558657|P1|First Intervention|Protocol Violation|1
7633235|NCT01652885|26558721|P1|Overall Study|Adverse Event|1
7633236|NCT01652872|26558748|P2|Overall Study|Withdrawal by Subject|84
7633237|NCT01652872|26558749|P1|Overall Study|Withdrawal by Subject|76
7633238|NCT01652872|26558748|P2|Overall Study|Decision by sponsor|7
7633239|NCT01652872|26558749|P1|Overall Study|Decision by sponsor|5
7633240|NCT01652872|26558748|P2|Overall Study|Lost to Follow-up|23
7633241|NCT01652872|26558749|P1|Overall Study|Lost to Follow-up|28
7633242|NCT01652872|26558748|P2|Overall Study|Death|39
7633243|NCT01652872|26558749|P1|Overall Study|Death|36
7633244|NCT01652729|26558766|P3|Overall Study|Administrative|0
7633245|NCT01652729|26558767|P2|Overall Study|Administrative|0
7633246|NCT01652729|26558768|P1|Overall Study|Administrative|1
7633247|NCT01652729|26558766|P3|Overall Study|Lost to Follow-up|3
7633248|NCT01652729|26558767|P2|Overall Study|Lost to Follow-up|6
7633249|NCT01652729|26558768|P1|Overall Study|Lost to Follow-up|6
7633250|NCT01652729|26558766|P3|Overall Study|Protocol Violation|0
7633251|NCT01652729|26558767|P2|Overall Study|Protocol Violation|0
7633252|NCT01652729|26558768|P1|Overall Study|Protocol Violation|1
7633253|NCT01652729|26558766|P3|Overall Study|Physician Decision|1
7633254|NCT01652729|26558767|P2|Overall Study|Physician Decision|0
7633255|NCT01652729|26558768|P1|Overall Study|Physician Decision|1
7633256|NCT01652729|26558766|P3|Overall Study|Adverse Event|3
7633257|NCT01652729|26558767|P2|Overall Study|Adverse Event|0
7633258|NCT01652729|26558768|P1|Overall Study|Adverse Event|4
7633259|NCT01652729|26558766|P3|Overall Study|Withdrawal by Subject|7
7633260|NCT01652729|26558767|P2|Overall Study|Withdrawal by Subject|7
7633261|NCT01652729|26558768|P1|Overall Study|Withdrawal by Subject|14
7633262|NCT01652716|26558790|P2|Overall Study|Withdrawal by Subject|18
7633263|NCT01652716|26558791|P1|Overall Study|Withdrawal by Subject|33
7633264|NCT01652716|26558790|P2|Overall Study|Adverse Event|10
7633265|NCT01652716|26558791|P1|Overall Study|Adverse Event|7
7633266|NCT01652716|26558790|P2|Overall Study|Protocol Violation|1
7633267|NCT01652716|26558791|P1|Overall Study|Protocol Violation|2
7633268|NCT01652716|26558790|P2|Overall Study|Lost to Follow-up|11
7633269|NCT01652716|26558791|P1|Overall Study|Lost to Follow-up|12
7633270|NCT01652716|26558790|P2|Overall Study|Investigator decision|4
7633271|NCT01652716|26558791|P1|Overall Study|Investigator decision|1
7633272|NCT01652716|26558790|P2|Overall Study|Administrative|2
7633273|NCT01652716|26558791|P1|Overall Study|Administrative|0
7633274|NCT01652716|26558790|P2|Overall Study|Loss of glucose control|0
7633275|NCT01652716|26558791|P1|Overall Study|Loss of glucose control|1
7633276|NCT01652703|26558811|P6|Overall Study|Other|1
7633277|NCT01652703|26558812|P5|Overall Study|Other|1
7633278|NCT01652703|26558813|P4|Overall Study|Other|1
7633279|NCT01652703|26558814|P3|Overall Study|Other|0
7633280|NCT01652703|26558815|P2|Overall Study|Other|0
7633281|NCT01652703|26558816|P1|Overall Study|Other|0
7633282|NCT01652703|26558811|P6|Overall Study|Withdrawal by Subject|1
7633283|NCT01652703|26558812|P5|Overall Study|Withdrawal by Subject|0
7633284|NCT01652703|26558813|P4|Overall Study|Withdrawal by Subject|1
7633285|NCT01652703|26558814|P3|Overall Study|Withdrawal by Subject|3
7633286|NCT01652703|26558815|P2|Overall Study|Withdrawal by Subject|1
7633287|NCT01652703|26558816|P1|Overall Study|Withdrawal by Subject|0
7633288|NCT01652690|26558874|P2|Overall Study|Death|2
7633289|NCT01652690|26558875|P1|Overall Study|Death|5
7633290|NCT01652690|26558874|P2|Overall Study|Lost to Follow-up|6
7633291|NCT01652690|26558875|P1|Overall Study|Lost to Follow-up|6
7633292|NCT01652690|26558874|P2|Overall Study|Other|9
7633293|NCT01652690|26558875|P1|Overall Study|Other|8
7633294|NCT01652690|26558874|P2|Overall Study|Withdrawal by Subject|4
7633295|NCT01652690|26558875|P1|Overall Study|Withdrawal by Subject|16
7633296|NCT01652664|26558909|P2|Overall Study|Inadequate IOP control|0
7633297|NCT01652664|26558910|P1|Overall Study|Inadequate IOP control|1
7633298|NCT01652664|26558909|P2|Overall Study|Treatment Failure|1
7633299|NCT01652664|26558910|P1|Overall Study|Treatment Failure|5
7633300|NCT01652573|26558919|P2|Overall Study|Adverse Event|1
7633301|NCT01652573|26558920|P1|Overall Study|Adverse Event|0
7633302|NCT01652534|26558962|P2|Overall Study|Lack of Efficacy|0
7633303|NCT01652534|26558963|P1|Overall Study|Lack of Efficacy|1
7633304|NCT01652469|26559004|P2|Overall Study|Lost to Follow-up|2
7633305|NCT01652469|26559005|P1|Overall Study|Lost to Follow-up|0
7633306|NCT01652469|26559004|P2|Overall Study|Withdrawal by Subject|4
7633307|NCT01652469|26559005|P1|Overall Study|Withdrawal by Subject|1
7633308|NCT01652287|26559021|P2|Overall Study|Withdrawal by Subject|0
7633309|NCT01652287|26559022|P1|Overall Study|Withdrawal by Subject|2
7633310|NCT01651949|26559053|P3|Overall Study|Withdrawal by Subject|9
7633311|NCT01651949|26559054|P2|Overall Study|Withdrawal by Subject|18
7633312|NCT01651949|26559055|P1|Overall Study|Withdrawal by Subject|17
7633313|NCT01651949|26559053|P3|Overall Study|Screen failure|0
7633314|NCT01651949|26559054|P2|Overall Study|Screen failure|2
7633315|NCT01651949|26559055|P1|Overall Study|Screen failure|2
7633316|NCT01651949|26559053|P3|Overall Study|Adverse Event|1
7633317|NCT01651949|26559054|P2|Overall Study|Adverse Event|2
7633318|NCT01651949|26559055|P1|Overall Study|Adverse Event|0
7633319|NCT01651949|26559053|P3|Overall Study|Physician Decision|0
7633320|NCT01651949|26559054|P2|Overall Study|Physician Decision|2
7633321|NCT01651949|26559055|P1|Overall Study|Physician Decision|0
7633322|NCT01651949|26559053|P3|Overall Study|Protocol Violation|1
7633323|NCT01651949|26559054|P2|Overall Study|Protocol Violation|2
7633324|NCT01651949|26559055|P1|Overall Study|Protocol Violation|0
7633325|NCT01651949|26559053|P3|Overall Study|Lost to Follow-up|20
7633326|NCT01651949|26559054|P2|Overall Study|Lost to Follow-up|56
7633327|NCT01651949|26559055|P1|Overall Study|Lost to Follow-up|30
7633328|NCT01651949|26559053|P3|Overall Study|Unknown status|0
7633329|NCT01651949|26559054|P2|Overall Study|Unknown status|4
7633330|NCT01651949|26559055|P1|Overall Study|Unknown status|4
7633331|NCT01651936|26559075|P3|Extension Study|Study terminated by sponsor|13
7633332|NCT01651936|26559076|P2|Extension Study|Study terminated by sponsor|0
7633333|NCT01651936|26559077|P1|Extension Study|Study terminated by sponsor|0
7633334|NCT01651936|26559075|P3|Extension Study|Lack of Efficacy|1
7633335|NCT01651936|26559076|P2|Extension Study|Lack of Efficacy|0
7633336|NCT01651936|26559077|P1|Extension Study|Lack of Efficacy|0
7633337|NCT01651936|26559075|P3|Base Study|Study terminated by sponsor|0
7633338|NCT01651936|26559076|P2|Base Study|Study terminated by sponsor|16
7633339|NCT01651936|26559077|P1|Base Study|Study terminated by sponsor|21
7633340|NCT01651936|26559075|P3|Base Study|Early Escape|0
7633341|NCT01651936|26559076|P2|Base Study|Early Escape|8
7633342|NCT01651936|26559077|P1|Base Study|Early Escape|2
7633343|NCT01651936|26559075|P3|Base Study|Withdrawal by Subject|0
7633344|NCT01651936|26559076|P2|Base Study|Withdrawal by Subject|1
7633345|NCT01651936|26559077|P1|Base Study|Withdrawal by Subject|1
7633346|NCT01651936|26559075|P3|Base Study|Adverse Event|0
7633347|NCT01651936|26559076|P2|Base Study|Adverse Event|0
7633348|NCT01651936|26559077|P1|Base Study|Adverse Event|3
7633349|NCT01651780|26559147|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
7633350|NCT01651780|26559148|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
7633351|NCT01651780|26559147|P2|Overall Study|Lost to Follow-up|2
7633352|NCT01651780|26559148|P1|Overall Study|Lost to Follow-up|1
7633353|NCT01651780|26559147|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7633354|NCT01651780|26559148|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7633355|NCT01651780|26559147|P2|Overall Study|Withdrawal by Subject|0
7633356|NCT01651780|26559148|P1|Overall Study|Withdrawal by Subject|2
7633357|NCT01651780|26559147|P2|Overall Study|Reason Not Specified: No 30-day visit|2
7633358|NCT01651780|26559148|P1|Overall Study|Reason Not Specified: No 30-day visit|2
7633359|NCT01651780|26559147|P2|Overall Study|Physician decision: No 30-day visit|1
7633360|NCT01651780|26559148|P1|Overall Study|Physician decision: No 30-day visit|2
7633361|NCT01651403|26559199|P2|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
7633362|NCT01651403|26559200|P1|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
7633363|NCT01651403|26559199|P2|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
7633364|NCT01651403|26559200|P1|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
7633365|NCT01651403|26559199|P2|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
7633366|NCT01651403|26559200|P1|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
7633367|NCT01651403|26559199|P2|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
7633368|NCT01651403|26559200|P1|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
7633369|NCT01651403|26559199|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
7633370|NCT01651403|26559200|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
7633371|NCT01651403|26559199|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
7633372|NCT01651403|26559200|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
7633373|NCT01651260|26559284|P1|Overall Study|unable to apply product|3
7633374|NCT01651208|26559291|P2|Overall Study|Lost to Follow-up|16
7633375|NCT01651208|26559292|P1|Overall Study|Lost to Follow-up|14
7633376|NCT01651117|26559333|P4|Overall Study|Death|2
7633377|NCT01651117|26559334|P3|Overall Study|Death|2
7633378|NCT01651117|26559335|P2|Overall Study|Death|3
7633379|NCT01651117|26559336|P1|Overall Study|Death|2
7633380|NCT01651052|26559416|P1|Overall Study|Lost to Follow-up|3
7633381|NCT01651052|26559416|P1|Overall Study|Withdrawal by Subject|1
7633382|NCT01651052|26559416|P1|Overall Study|Explant|1
7633383|NCT01651052|26559416|P1|Overall Study|Death|21
7633384|NCT01651039|26559436|P1|Overall Study|Progressive Disease|22
7633385|NCT01651039|26559436|P1|Overall Study|Withdrawal by Subject|1
7633386|NCT01651039|26559436|P1|Overall Study|Physician Decision|2
7633387|NCT01651039|26559436|P1|Overall Study|Non-evaluables|5
7633388|NCT01651000|26559449|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
7633389|NCT01651000|26559450|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
7633390|NCT01651000|26559449|P2|Overall Study|Administrative reason|0
7633391|NCT01651000|26559450|P1|Overall Study|Administrative reason|1
7633392|NCT01651000|26559449|P2|Overall Study|Physician Decision|0
7633393|NCT01651000|26559450|P1|Overall Study|Physician Decision|1
7633394|NCT01651000|26559449|P2|Overall Study|Lack of Efficacy|1
7633395|NCT01651000|26559450|P1|Overall Study|Lack of Efficacy|1
7633396|NCT01651000|26559449|P2|Overall Study|Subject noncompliance|3
7633397|NCT01651000|26559450|P1|Overall Study|Subject noncompliance|0
7633398|NCT01651000|26559449|P2|Overall Study|Withdrawal by Subject|10
7633399|NCT01651000|26559450|P1|Overall Study|Withdrawal by Subject|2
7633400|NCT01651000|26559449|P2|Overall Study|Protocol Violation|3
7633401|NCT01651000|26559450|P1|Overall Study|Protocol Violation|0
7633402|NCT01651000|26559449|P2|Overall Study|Lost to Follow-up|2
7633403|NCT01651000|26559450|P1|Overall Study|Lost to Follow-up|3
7633404|NCT01651000|26559449|P2|Overall Study|Adverse Event|8
7633405|NCT01651000|26559450|P1|Overall Study|Adverse Event|2
7633406|NCT01650831|26559471|P1|Overall Study|Screen failure|1
7633407|NCT01650805|26559481|P2|Overall Study|Withdrawal by Subject|0
7633408|NCT01650805|26559482|P1|Overall Study|Withdrawal by Subject|1
7633409|NCT01650779|26559492|P1|Overall Study|Withdrawal by Subject|1
7633410|NCT01650636|26559501|P2|Washout up to 9 Months|Lost to Follow-up|1
7633411|NCT01650636|26559502|P1|Washout up to 9 Months|Lost to Follow-up|2
7633412|NCT01650636|26559501|P2|Washout up to 9 Months|Withdrawal by Subject|2
7633413|NCT01650636|26559502|P1|Washout up to 9 Months|Withdrawal by Subject|4
7633414|NCT01650636|26559501|P2|Washout up to 5 Months|Lost to Follow-up|8
7633415|NCT01650636|26559502|P1|Washout up to 5 Months|Lost to Follow-up|2
7633416|NCT01650636|26559501|P2|Washout up to 5 Months|Death|0
7633417|NCT01650636|26559502|P1|Washout up to 5 Months|Death|1
7633418|NCT01650636|26559501|P2|Washout up to 5 Months|Physician Decision|2
7633419|NCT01650636|26559502|P1|Washout up to 5 Months|Physician Decision|2
7633420|NCT01650636|26559501|P2|Washout up to 5 Months|Withdrawal by Subject|8
7633421|NCT01650636|26559502|P1|Washout up to 5 Months|Withdrawal by Subject|4
7633422|NCT01650558|26559530|P3|Overall Study|Physician Decision|0
7633423|NCT01650558|26559531|P2|Overall Study|Physician Decision|1
7633424|NCT01650558|26559532|P1|Overall Study|Physician Decision|0
7633425|NCT01650558|26559530|P3|Overall Study|Non-compliant participant|2
7633426|NCT01650558|26559531|P2|Overall Study|Non-compliant participant|0
7633427|NCT01650558|26559532|P1|Overall Study|Non-compliant participant|1
7633428|NCT01650558|26559530|P3|Overall Study|Withdrawal by Subject|3
7633429|NCT01650558|26559531|P2|Overall Study|Withdrawal by Subject|1
7633430|NCT01650558|26559532|P1|Overall Study|Withdrawal by Subject|1
7633431|NCT01650558|26559530|P3|Overall Study|Death|8
7633432|NCT01650558|26559531|P2|Overall Study|Death|6
7633433|NCT01650558|26559532|P1|Overall Study|Death|10
7633434|NCT01650558|26559530|P3|Overall Study|Lost to Follow-up|6
7633435|NCT01650558|26559531|P2|Overall Study|Lost to Follow-up|13
7633436|NCT01650558|26559532|P1|Overall Study|Lost to Follow-up|10
7633437|NCT01650558|26559530|P3|Overall Study|Migration out of study area|56
7633438|NCT01650558|26559531|P2|Overall Study|Migration out of study area|71
7633439|NCT01650558|26559532|P1|Overall Study|Migration out of study area|61
7633440|NCT01650519|26559570|P2|Overall Study|Withdrawal by Subject|0
7633441|NCT01650519|26559571|P1|Overall Study|Withdrawal by Subject|1
7633442|NCT01650285|26559653|P1|Overall Study|Adverse Event|1
7633443|NCT01650259|26559660|P2|Overall Study|Other than listed|146
7633444|NCT01650259|26559661|P1|Overall Study|Other than listed|64
7633445|NCT01650259|26559660|P2|Overall Study|Not treated|7
7633446|NCT01650259|26559661|P1|Overall Study|Not treated|1
7633447|NCT01650259|26559660|P2|Overall Study|CRF not collected|82
7633448|NCT01650259|26559661|P1|Overall Study|CRF not collected|98
7633449|NCT01650259|26559660|P2|Overall Study|Patients had no visit after entry|0
7633450|NCT01650259|26559661|P1|Overall Study|Patients had no visit after entry|70
7633451|NCT01650259|26559660|P2|Overall Study|Lost to Follow-up|0
7633452|NCT01650259|26559661|P1|Overall Study|Lost to Follow-up|435
7633453|NCT01650259|26559660|P2|Overall Study|Lack of Efficacy|0
7633454|NCT01650259|26559661|P1|Overall Study|Lack of Efficacy|143
7633455|NCT01650259|26559660|P2|Overall Study|Adverse Event|0
7633456|NCT01650259|26559661|P1|Overall Study|Adverse Event|127
7633457|NCT01650259|26559660|P2|Overall Study|Improvement|0
7633458|NCT01650259|26559661|P1|Overall Study|Improvement|105
7633459|NCT01650246|26559666|P1|Overall Study|Lack of Efficacy|30
7633460|NCT01650246|26559666|P1|Overall Study|Death|1
7633461|NCT01650246|26559666|P1|Overall Study|Withdrawal by Subject|26
7633462|NCT01650246|26559666|P1|Overall Study|Lost to Follow-up|5
7633463|NCT01650246|26559666|P1|Overall Study|Sponsor terminated study|53
7633464|NCT01650246|26559666|P1|Overall Study|Protocol Violation|5
7633465|NCT01650246|26559666|P1|Overall Study|Adverse Event|23
7633466|NCT01650194|26559671|P1|Overall Study|Miscellaneous|10
7633467|NCT01650194|26559671|P1|Overall Study|Withdrawal by Subject|2
7633468|NCT01650194|26559671|P1|Overall Study|Progressive Disease (PD)|35
7633469|NCT01649869|26559707|P2|Overall Study|Severe hearing loss borderline eligible|1
7633470|NCT01649869|26559708|P1|Overall Study|Severe hearing loss borderline eligible|0
7633471|NCT01649869|26559707|P2|Overall Study|Required treatment outside protocol|0
7633472|NCT01649869|26559708|P1|Overall Study|Required treatment outside protocol|1
7633473|NCT01649869|26559707|P2|Overall Study|Family member illness|0
7633474|NCT01649869|26559708|P1|Overall Study|Family member illness|1
7633475|NCT01649856|26559756|P2|Overall Study|Other|5
7633476|NCT01649856|26559757|P1|Overall Study|Other|20
7633477|NCT01649856|26559756|P2|Overall Study|Lack of Compliance|1
7633478|NCT01649856|26559757|P1|Overall Study|Lack of Compliance|6
7633479|NCT01649856|26559756|P2|Overall Study|Lost to Follow-up|16
7633480|NCT01649856|26559757|P1|Overall Study|Lost to Follow-up|20
7633481|NCT01649856|26559756|P2|Overall Study|Stable or Progressed Disease|3
7633482|NCT01649856|26559757|P1|Overall Study|Stable or Progressed Disease|5
7633483|NCT01649856|26559756|P2|Overall Study|Death|34
7633484|NCT01649856|26559757|P1|Overall Study|Death|69
7633485|NCT01649856|26559756|P2|Overall Study|Treatment Failure|1
7633486|NCT01649856|26559757|P1|Overall Study|Treatment Failure|1
7633487|NCT01649856|26559756|P2|Overall Study|Protocol Violation|4
7633488|NCT01649856|26559757|P1|Overall Study|Protocol Violation|4
7633489|NCT01649856|26559756|P2|Overall Study|Withdrawal by Subject|14
7633490|NCT01649856|26559757|P1|Overall Study|Withdrawal by Subject|14
7633491|NCT01649804|26559789|P1|Overall Study|Administrative/Other|8
7633492|NCT01649791|26559801|P1|Overall Study|Adverse Event|1
7633493|NCT01649791|26559801|P1|Overall Study|Disease Progression|2
7633494|NCT01649765|26559810|P2|Overall Study|Withdrawal by Subject|1
7633495|NCT01649765|26559811|P1|Overall Study|Withdrawal by Subject|2
7633496|NCT01649765|26559810|P2|Overall Study|Protocol Violation|0
7633497|NCT01649765|26559811|P1|Overall Study|Protocol Violation|1
7633498|NCT01649765|26559810|P2|Overall Study|Physician Decision|3
7633499|NCT01649765|26559811|P1|Overall Study|Physician Decision|0
7633500|NCT01649765|26559810|P2|Overall Study|Lack of Efficacy|1
7633501|NCT01649765|26559811|P1|Overall Study|Lack of Efficacy|1
7633502|NCT01649765|26559810|P2|Overall Study|Adverse Event|3
7633503|NCT01649765|26559811|P1|Overall Study|Adverse Event|5
7633504|NCT01649557|26559862|P3|Overall Study|Lack of Efficacy|0
7633505|NCT01649557|26559863|P2|Overall Study|Lack of Efficacy|0
7633506|NCT01649557|26559864|P1|Overall Study|Lack of Efficacy|5
7633507|NCT01649557|26559862|P3|Overall Study|Protocol deviation|0
7633508|NCT01649557|26559863|P2|Overall Study|Protocol deviation|2
7633509|NCT01649557|26559864|P1|Overall Study|Protocol deviation|0
7633510|NCT01649557|26559862|P3|Overall Study|Withdrawal by Subject|4
7633511|NCT01649557|26559863|P2|Overall Study|Withdrawal by Subject|5
7633512|NCT01649557|26559864|P1|Overall Study|Withdrawal by Subject|15
7633513|NCT01649557|26559862|P3|Overall Study|Physician Decision|1
7633514|NCT01649557|26559863|P2|Overall Study|Physician Decision|2
7633515|NCT01649557|26559864|P1|Overall Study|Physician Decision|8
7633516|NCT01649557|26559862|P3|Overall Study|Met withdrawal criteria|0
7633517|NCT01649557|26559863|P2|Overall Study|Met withdrawal criteria|0
7633518|NCT01649557|26559864|P1|Overall Study|Met withdrawal criteria|4
7633519|NCT01649557|26559862|P3|Overall Study|Adverse Event|1
7633520|NCT01649557|26559863|P2|Overall Study|Adverse Event|5
7633521|NCT01649557|26559864|P1|Overall Study|Adverse Event|7
7633522|NCT01649557|26559862|P3|Overall Study|Lost to Follow-up|3
7633523|NCT01649557|26559863|P2|Overall Study|Lost to Follow-up|0
7633524|NCT01649557|26559864|P1|Overall Study|Lost to Follow-up|5
7633525|NCT01649427|26559910|P2|Overall Study|Surgical problems during nephrectomy|2
7633526|NCT01649427|26559911|P1|Overall Study|Surgical problems during nephrectomy|2
7633527|NCT01649427|26559910|P2|Overall Study|Graft loss|1
7633528|NCT01649427|26559911|P1|Overall Study|Graft loss|0
7633529|NCT01649427|26559910|P2|Overall Study|Lost to Follow-up|1
7633530|NCT01649427|26559911|P1|Overall Study|Lost to Follow-up|0
7633531|NCT01649427|26559910|P2|Overall Study|Withdrawal by Subject|7
7633532|NCT01649427|26559911|P1|Overall Study|Withdrawal by Subject|8
7633533|NCT01649427|26559910|P2|Overall Study|Adverse Event|1
7633534|NCT01649427|26559911|P1|Overall Study|Adverse Event|1
7633535|NCT01649375|26559930|P5|Week 16 up to Week 260|Adverse Event|2
7633536|NCT01649375|26559931|P4|Week 16 up to Week 260|Adverse Event|3
7633537|NCT01649375|26559932|P3|Week 16 up to Week 260|Adverse Event|0
7633538|NCT01649375|26559933|P2|Week 16 up to Week 260|Adverse Event|2
7633539|NCT01649375|26559934|P1|Week 16 up to Week 260|Adverse Event|5
7633540|NCT01649375|26559930|P5|Week 16 up to Week 260|Death|0
7633541|NCT01649375|26559931|P4|Week 16 up to Week 260|Death|0
7633542|NCT01649375|26559932|P3|Week 16 up to Week 260|Death|0
7633543|NCT01649375|26559933|P2|Week 16 up to Week 260|Death|1
7633544|NCT01649375|26559934|P1|Week 16 up to Week 260|Death|1
7633545|NCT01649375|26559930|P5|Week 16 up to Week 260|Withdrawal by Subject|1
7633546|NCT01649375|26559931|P4|Week 16 up to Week 260|Withdrawal by Subject|3
7633547|NCT01649375|26559932|P3|Week 16 up to Week 260|Withdrawal by Subject|0
7633548|NCT01649375|26559933|P2|Week 16 up to Week 260|Withdrawal by Subject|2
7633549|NCT01649375|26559934|P1|Week 16 up to Week 260|Withdrawal by Subject|7
7633550|NCT01649375|26559930|P5|Week 16 up to Week 260|Technical issues|0
7633551|NCT01649375|26559931|P4|Week 16 up to Week 260|Technical issues|1
7633552|NCT01649375|26559932|P3|Week 16 up to Week 260|Technical issues|0
7633553|NCT01649375|26559933|P2|Week 16 up to Week 260|Technical issues|1
7633554|NCT01649375|26559934|P1|Week 16 up to Week 260|Technical issues|0
7633555|NCT01649375|26559930|P5|Week 16 up to Week 260|Physician Decision|0
7633556|NCT01649375|26559931|P4|Week 16 up to Week 260|Physician Decision|0
7633557|NCT01649375|26559932|P3|Week 16 up to Week 260|Physician Decision|0
7633558|NCT01649375|26559933|P2|Week 16 up to Week 260|Physician Decision|2
7633559|NCT01649375|26559934|P1|Week 16 up to Week 260|Physician Decision|0
7633560|NCT01649375|26559930|P5|Week 16 up to Week 260|Non-compliance|0
7633561|NCT01649375|26559931|P4|Week 16 up to Week 260|Non-compliance|1
7633562|NCT01649375|26559932|P3|Week 16 up to Week 260|Non-compliance|0
7633563|NCT01649375|26559933|P2|Week 16 up to Week 260|Non-compliance|1
7633564|NCT01649375|26559934|P1|Week 16 up to Week 260|Non-compliance|0
7633565|NCT01649375|26559930|P5|Week 16 up to Week 260|Lack of Efficacy|2
7633566|NCT01649375|26559931|P4|Week 16 up to Week 260|Lack of Efficacy|4
7633567|NCT01649375|26559932|P3|Week 16 up to Week 260|Lack of Efficacy|0
7633568|NCT01649375|26559933|P2|Week 16 up to Week 260|Lack of Efficacy|4
7633569|NCT01649375|26559934|P1|Week 16 up to Week 260|Lack of Efficacy|7
7633570|NCT01649375|26559930|P5|Up to Week 16|Death|0
7633571|NCT01649375|26559931|P4|Up to Week 16|Death|0
7633572|NCT01649375|26559932|P3|Up to Week 16|Death|0
7633573|NCT01649375|26559933|P2|Up to Week 16|Death|0
7633574|NCT01649375|26559934|P1|Up to Week 16|Death|1
7633575|NCT01649375|26559930|P5|Up to Week 16|Withdrawal by Subject|0
7633576|NCT01649375|26559931|P4|Up to Week 16|Withdrawal by Subject|0
7633577|NCT01649375|26559932|P3|Up to Week 16|Withdrawal by Subject|2
7633578|NCT01649375|26559933|P2|Up to Week 16|Withdrawal by Subject|1
7633579|NCT01649375|26559934|P1|Up to Week 16|Withdrawal by Subject|2
7633580|NCT01649375|26559930|P5|Up to Week 16|Physician Decision|0
7633581|NCT01649375|26559931|P4|Up to Week 16|Physician Decision|0
7633582|NCT01649375|26559932|P3|Up to Week 16|Physician Decision|1
7633583|NCT01649375|26559933|P2|Up to Week 16|Physician Decision|0
7633584|NCT01649375|26559934|P1|Up to Week 16|Physician Decision|0
7633585|NCT01649375|26559930|P5|Up to Week 16|Lack of Efficacy|0
7633586|NCT01649375|26559931|P4|Up to Week 16|Lack of Efficacy|0
7633587|NCT01649375|26559932|P3|Up to Week 16|Lack of Efficacy|1
7633588|NCT01649375|26559933|P2|Up to Week 16|Lack of Efficacy|0
7633589|NCT01649375|26559934|P1|Up to Week 16|Lack of Efficacy|0
7633590|NCT01649375|26559930|P5|Up to Week 16|Adverse Event|0
7633591|NCT01649375|26559931|P4|Up to Week 16|Adverse Event|0
7633592|NCT01649375|26559932|P3|Up to Week 16|Adverse Event|4
7633593|NCT01649375|26559933|P2|Up to Week 16|Adverse Event|5
7633594|NCT01649375|26559934|P1|Up to Week 16|Adverse Event|2
7633595|NCT01649297|26559981|P5|Overall Study|For other reason|0
7633596|NCT01649297|26559982|P4|Overall Study|For other reason|0
7633597|NCT01649297|26559983|P3|Overall Study|For other reason|2
7633598|NCT01649297|26559984|P2|Overall Study|For other reason|1
7633599|NCT01649297|26559985|P1|Overall Study|For other reason|4
7633600|NCT01649297|26559981|P5|Overall Study|Patient withdrawal (not due to AE)|1
7633601|NCT01649297|26559982|P4|Overall Study|Patient withdrawal (not due to AE)|1
7633602|NCT01649297|26559983|P3|Overall Study|Patient withdrawal (not due to AE)|4
7633603|NCT01649297|26559984|P2|Overall Study|Patient withdrawal (not due to AE)|6
7633604|NCT01649297|26559985|P1|Overall Study|Patient withdrawal (not due to AE)|3
7633605|NCT01649297|26559981|P5|Overall Study|Lost to Follow-up|0
7633606|NCT01649297|26559982|P4|Overall Study|Lost to Follow-up|3
7633607|NCT01649297|26559983|P3|Overall Study|Lost to Follow-up|4
7633608|NCT01649297|26559984|P2|Overall Study|Lost to Follow-up|1
7633609|NCT01649297|26559985|P1|Overall Study|Lost to Follow-up|1
7633610|NCT01649297|26559981|P5|Overall Study|Non compliant with Protocol|1
7633611|NCT01649297|26559982|P4|Overall Study|Non compliant with Protocol|2
7633612|NCT01649297|26559983|P3|Overall Study|Non compliant with Protocol|3
7633613|NCT01649297|26559984|P2|Overall Study|Non compliant with Protocol|0
7633614|NCT01649297|26559985|P1|Overall Study|Non compliant with Protocol|1
7633615|NCT01649297|26559981|P5|Overall Study|Lack of Efficacy|1
7633616|NCT01649297|26559982|P4|Overall Study|Lack of Efficacy|0
7633617|NCT01649297|26559983|P3|Overall Study|Lack of Efficacy|0
7633618|NCT01649297|26559984|P2|Overall Study|Lack of Efficacy|0
7633619|NCT01649297|26559985|P1|Overall Study|Lack of Efficacy|0
7633620|NCT01649297|26559981|P5|Overall Study|Adverse Event|1
7633621|NCT01649297|26559982|P4|Overall Study|Adverse Event|13
7633622|NCT01649297|26559983|P3|Overall Study|Adverse Event|4
7633623|NCT01649297|26559984|P2|Overall Study|Adverse Event|5
7633624|NCT01649297|26559985|P1|Overall Study|Adverse Event|5
7633625|NCT01649271|26560004|P2|Overall Study|Other than stated above|0
7633626|NCT01649271|26560005|P1|Overall Study|Other than stated above|1
7633627|NCT01649271|26560004|P2|Overall Study|Withdrawal by Subject|0
7633628|NCT01649271|26560005|P1|Overall Study|Withdrawal by Subject|1
7633629|NCT01649271|26560004|P2|Overall Study|Other Adverse Event|2
7633630|NCT01649271|26560005|P1|Overall Study|Other Adverse Event|0
7633631|NCT01649271|26560004|P2|Overall Study|Progressive disease|5
7633632|NCT01649271|26560005|P1|Overall Study|Progressive disease|4
7633633|NCT01649232|26560020|P2|Overall Study|Physician Decision|0
7633634|NCT01649232|26560021|P1|Overall Study|Physician Decision|2
7633635|NCT01648790|26560077|P5|Treatment 3|Withdrawal by Subject|0
7633636|NCT01648790|26560078|P4|Treatment 3|Withdrawal by Subject|1
7633637|NCT01648790|26560079|P3|Treatment 3|Withdrawal by Subject|0
7633638|NCT01648790|26560080|P2|Treatment 3|Withdrawal by Subject|0
7633639|NCT01648790|26560081|P1|Treatment 3|Withdrawal by Subject|0
7633640|NCT01648764|26560116|P14|Overall Study|Investigator Decision|0
7633641|NCT01648764|26560117|P13|Overall Study|Investigator Decision|0
7633642|NCT01648764|26560118|P12|Overall Study|Investigator Decision|1
7633643|NCT01648764|26560119|P11|Overall Study|Investigator Decision|0
7633644|NCT01648764|26560120|P10|Overall Study|Investigator Decision|0
7633645|NCT01648764|26560121|P9|Overall Study|Investigator Decision|0
7633646|NCT01648764|26560122|P8|Overall Study|Investigator Decision|0
7633647|NCT01648764|26560123|P7|Overall Study|Investigator Decision|1
7633648|NCT01648764|26560124|P6|Overall Study|Investigator Decision|0
7633649|NCT01648764|26560125|P5|Overall Study|Investigator Decision|0
7633650|NCT01648764|26560126|P4|Overall Study|Investigator Decision|0
7633651|NCT01648764|26560127|P3|Overall Study|Investigator Decision|0
7633652|NCT01648764|26560128|P2|Overall Study|Investigator Decision|0
7633653|NCT01648764|26560129|P1|Overall Study|Investigator Decision|0
7633654|NCT01648764|26560116|P14|Overall Study|Withdrawal by Subject|0
7633655|NCT01648764|26560117|P13|Overall Study|Withdrawal by Subject|1
7633656|NCT01648764|26560118|P12|Overall Study|Withdrawal by Subject|0
7633657|NCT01648764|26560119|P11|Overall Study|Withdrawal by Subject|0
7633658|NCT01648764|26560120|P10|Overall Study|Withdrawal by Subject|0
7633659|NCT01648764|26560121|P9|Overall Study|Withdrawal by Subject|0
7633660|NCT01648764|26560122|P8|Overall Study|Withdrawal by Subject|0
7633661|NCT01648764|26560123|P7|Overall Study|Withdrawal by Subject|2
7633662|NCT01648764|26560124|P6|Overall Study|Withdrawal by Subject|0
7633663|NCT01648764|26560125|P5|Overall Study|Withdrawal by Subject|0
7633664|NCT01648764|26560126|P4|Overall Study|Withdrawal by Subject|0
7633665|NCT01648764|26560127|P3|Overall Study|Withdrawal by Subject|0
7633666|NCT01648764|26560128|P2|Overall Study|Withdrawal by Subject|0
7633667|NCT01648764|26560129|P1|Overall Study|Withdrawal by Subject|0
7633668|NCT01648764|26560116|P14|Overall Study|Death|1
7633669|NCT01648764|26560117|P13|Overall Study|Death|0
7633670|NCT01648764|26560118|P12|Overall Study|Death|0
7633671|NCT01648764|26560119|P11|Overall Study|Death|0
7633672|NCT01648764|26560120|P10|Overall Study|Death|0
7633673|NCT01648764|26560121|P9|Overall Study|Death|0
7633674|NCT01648764|26560122|P8|Overall Study|Death|0
7633675|NCT01648764|26560123|P7|Overall Study|Death|1
7633676|NCT01648764|26560124|P6|Overall Study|Death|0
7633677|NCT01648764|26560125|P5|Overall Study|Death|0
7633678|NCT01648764|26560126|P4|Overall Study|Death|0
7633679|NCT01648764|26560127|P3|Overall Study|Death|0
7633680|NCT01648764|26560128|P2|Overall Study|Death|0
7633681|NCT01648764|26560129|P1|Overall Study|Death|0
7633682|NCT01648764|26560116|P14|Overall Study|Adverse Event|1
7633683|NCT01648764|26560117|P13|Overall Study|Adverse Event|1
7633684|NCT01648764|26560118|P12|Overall Study|Adverse Event|3
7633685|NCT01648764|26560119|P11|Overall Study|Adverse Event|0
7633686|NCT01648764|26560120|P10|Overall Study|Adverse Event|1
7633687|NCT01648764|26560121|P9|Overall Study|Adverse Event|0
7633688|NCT01648764|26560122|P8|Overall Study|Adverse Event|0
7633689|NCT01648764|26560123|P7|Overall Study|Adverse Event|0
7633690|NCT01648764|26560124|P6|Overall Study|Adverse Event|1
7633691|NCT01648764|26560125|P5|Overall Study|Adverse Event|0
7633692|NCT01648764|26560126|P4|Overall Study|Adverse Event|0
7633693|NCT01648764|26560127|P3|Overall Study|Adverse Event|0
7633694|NCT01648764|26560128|P2|Overall Study|Adverse Event|0
7633695|NCT01648764|26560129|P1|Overall Study|Adverse Event|0
7633696|NCT01648764|26560116|P14|Overall Study|Progressive Disease|1
7633697|NCT01648764|26560117|P13|Overall Study|Progressive Disease|2
7633698|NCT01648764|26560118|P12|Overall Study|Progressive Disease|1
7633699|NCT01648764|26560119|P11|Overall Study|Progressive Disease|0
7633700|NCT01648764|26560120|P10|Overall Study|Progressive Disease|2
7633701|NCT01648764|26560121|P9|Overall Study|Progressive Disease|0
7633702|NCT01648764|26560122|P8|Overall Study|Progressive Disease|0
7633703|NCT01648764|26560123|P7|Overall Study|Progressive Disease|1
7633704|NCT01648764|26560124|P6|Overall Study|Progressive Disease|1
7633705|NCT01648764|26560125|P5|Overall Study|Progressive Disease|0
7633706|NCT01648764|26560126|P4|Overall Study|Progressive Disease|0
7633707|NCT01648764|26560127|P3|Overall Study|Progressive Disease|0
7633708|NCT01648764|26560128|P2|Overall Study|Progressive Disease|1
7633709|NCT01648764|26560129|P1|Overall Study|Progressive Disease|0
7633710|NCT01648699|26560281|P1|Overall Study|Unspecified/unable to complete 4 visits|2
7633711|NCT01648699|26560281|P1|Overall Study|Lost to Follow-up|2
7633712|NCT01648699|26560281|P1|Overall Study|Death|1
7633713|NCT01648582|26560310|P3|Overall Study|Sponsor Decision|1
7633714|NCT01648582|26560311|P2|Overall Study|Sponsor Decision|1
7633715|NCT01648582|26560312|P1|Overall Study|Sponsor Decision|0
7633716|NCT01648582|26560310|P3|Overall Study|Death|0
7633717|NCT01648582|26560311|P2|Overall Study|Death|0
7633718|NCT01648582|26560312|P1|Overall Study|Death|1
7633719|NCT01648582|26560310|P3|Overall Study|Physician Decision|3
7633720|NCT01648582|26560311|P2|Overall Study|Physician Decision|1
7633721|NCT01648582|26560312|P1|Overall Study|Physician Decision|0
7633722|NCT01648582|26560310|P3|Overall Study|Withdrawal by Subject|17
7633723|NCT01648582|26560311|P2|Overall Study|Withdrawal by Subject|17
7633724|NCT01648582|26560312|P1|Overall Study|Withdrawal by Subject|15
7633725|NCT01648582|26560310|P3|Overall Study|Protocol Violation|1
7633726|NCT01648582|26560311|P2|Overall Study|Protocol Violation|2
7633727|NCT01648582|26560312|P1|Overall Study|Protocol Violation|1
7633728|NCT01648582|26560310|P3|Overall Study|Lost to Follow-up|8
7633729|NCT01648582|26560311|P2|Overall Study|Lost to Follow-up|6
7633730|NCT01648582|26560312|P1|Overall Study|Lost to Follow-up|9
7633731|NCT01648582|26560310|P3|Overall Study|Adverse Event|2
7633732|NCT01648582|26560311|P2|Overall Study|Adverse Event|11
7633733|NCT01648582|26560312|P1|Overall Study|Adverse Event|6
7633734|NCT01648348|26560415|P6|Overall Study|Replaced for MTD analysis|0
7633735|NCT01648348|26560416|P5|Overall Study|Replaced for MTD analysis|0
7633736|NCT01648348|26560417|P4|Overall Study|Replaced for MTD analysis|0
7633737|NCT01648348|26560418|P3|Overall Study|Replaced for MTD analysis|1
7633738|NCT01648348|26560419|P2|Overall Study|Replaced for MTD analysis|0
7633739|NCT01648348|26560420|P1|Overall Study|Replaced for MTD analysis|1
7633740|NCT01648348|26560415|P6|Overall Study|Cancel|6
7633741|NCT01648348|26560416|P5|Overall Study|Cancel|3
7633742|NCT01648348|26560417|P4|Overall Study|Cancel|0
7633743|NCT01648348|26560418|P3|Overall Study|Cancel|0
7633744|NCT01648348|26560419|P2|Overall Study|Cancel|0
7633745|NCT01648348|26560420|P1|Overall Study|Cancel|1
7633746|NCT01648283|26560507|P1|Overall Study|Withdrawal by Subject|14
7633747|NCT01648270|26560513|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
7633748|NCT01648166|26560525|P2|Overall Study|inadequate toenail samples|100
7633749|NCT01648166|26560526|P1|Overall Study|inadequate toenail samples|53
7633750|NCT01648140|26560536|P4|Overall Study|Lost to Follow-up|0
7633751|NCT01648140|26560537|P3|Overall Study|Lost to Follow-up|2
7633752|NCT01648140|26560538|P2|Overall Study|Lost to Follow-up|1
7633753|NCT01648140|26560539|P1|Overall Study|Lost to Follow-up|2
7633754|NCT01648140|26560536|P4|Overall Study|Withdrawal by Subject|2
7633755|NCT01648140|26560537|P3|Overall Study|Withdrawal by Subject|3
7633756|NCT01648140|26560538|P2|Overall Study|Withdrawal by Subject|3
7633757|NCT01648140|26560539|P1|Overall Study|Withdrawal by Subject|2
7633758|NCT01648140|26560536|P4|Overall Study|Adverse Event|0
7633759|NCT01648140|26560537|P3|Overall Study|Adverse Event|2
7633760|NCT01648140|26560538|P2|Overall Study|Adverse Event|1
7633761|NCT01648140|26560539|P1|Overall Study|Adverse Event|3
7633762|NCT01648140|26560536|P4|Overall Study|Lack of Efficacy|0
7633763|NCT01648140|26560537|P3|Overall Study|Lack of Efficacy|1
7633764|NCT01648140|26560538|P2|Overall Study|Lack of Efficacy|7
7633765|NCT01648140|26560539|P1|Overall Study|Lack of Efficacy|4
7633766|NCT01648140|26560536|P4|Overall Study|Physician Decision|0
7633767|NCT01648140|26560537|P3|Overall Study|Physician Decision|0
7633768|NCT01648140|26560538|P2|Overall Study|Physician Decision|0
7633769|NCT01648140|26560539|P1|Overall Study|Physician Decision|1
7633770|NCT01648101|26560704|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7633771|NCT01648101|26560705|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
7633772|NCT01648101|26560706|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7633773|NCT01648101|26560704|P3|Transition Phase (4 Weeks)|Study Terminated|0
7633774|NCT01648101|26560705|P2|Transition Phase (4 Weeks)|Study Terminated|0
7633775|NCT01648101|26560706|P1|Transition Phase (4 Weeks)|Study Terminated|1
7633776|NCT01648101|26560704|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
7633777|NCT01648101|26560705|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7633778|NCT01648101|26560706|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7633779|NCT01648101|26560704|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
7633780|NCT01648101|26560705|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
7633781|NCT01648101|26560706|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
7633782|NCT01648101|26560704|P3|Transition Phase (4 Weeks)|Adverse Event|2
7633783|NCT01648101|26560705|P2|Transition Phase (4 Weeks)|Adverse Event|3
7633784|NCT01648101|26560706|P1|Transition Phase (4 Weeks)|Adverse Event|4
7633785|NCT01648101|26560704|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
7633786|NCT01648101|26560705|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
7633787|NCT01648101|26560706|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
7633788|NCT01648101|26560704|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7633789|NCT01648101|26560705|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
7633790|NCT01648101|26560706|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7633791|NCT01648101|26560704|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7633792|NCT01648101|26560705|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
7633793|NCT01648101|26560706|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7633794|NCT01648101|26560704|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
7633795|NCT01648101|26560705|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7633796|NCT01648101|26560706|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7633797|NCT01648101|26560704|P3|Titration Phase (4 Weeks)|Adverse Event|3
7633798|NCT01648101|26560705|P2|Titration Phase (4 Weeks)|Adverse Event|2
7633799|NCT01648101|26560706|P1|Titration Phase (4 Weeks)|Adverse Event|0
7633800|NCT01648101|26560704|P3|Titration Phase (4 Weeks)|Protocol Violation|2
7633801|NCT01648101|26560705|P2|Titration Phase (4 Weeks)|Protocol Violation|1
7633802|NCT01648101|26560706|P1|Titration Phase (4 Weeks)|Protocol Violation|2
7633803|NCT01647958|26560756|P2|Extended Follow-up Phase|Lost to Follow-up|0
7633804|NCT01647958|26560757|P1|Extended Follow-up Phase|Lost to Follow-up|8
7633805|NCT01647958|26560756|P2|Continuation Phase|treatment received during Overall Study|0
7633806|NCT01647958|26560757|P1|Continuation Phase|treatment received during Overall Study|39
7633807|NCT01647958|26560756|P2|Initial Study|Lost to Follow-up|3
7633808|NCT01647958|26560757|P1|Initial Study|Lost to Follow-up|2
7633809|NCT01647711|26560844|P5|Overall Study|Other reason not defined|0
7633810|NCT01647711|26560845|P4|Overall Study|Other reason not defined|1
7633811|NCT01647711|26560846|P3|Overall Study|Other reason not defined|1
7633812|NCT01647711|26560847|P2|Overall Study|Other reason not defined|1
7633813|NCT01647711|26560848|P1|Overall Study|Other reason not defined|0
7633814|NCT01647711|26560844|P5|Overall Study|Refused to continue taking medication|1
7633815|NCT01647711|26560845|P4|Overall Study|Refused to continue taking medication|2
7633816|NCT01647711|26560846|P3|Overall Study|Refused to continue taking medication|0
7633817|NCT01647711|26560847|P2|Overall Study|Refused to continue taking medication|0
7633818|NCT01647711|26560848|P1|Overall Study|Refused to continue taking medication|0
7633819|NCT01647711|26560844|P5|Overall Study|Protocol Violation|1
7633820|NCT01647711|26560845|P4|Overall Study|Protocol Violation|0
7633821|NCT01647711|26560846|P3|Overall Study|Protocol Violation|0
7633822|NCT01647711|26560847|P2|Overall Study|Protocol Violation|0
7633823|NCT01647711|26560848|P1|Overall Study|Protocol Violation|0
7633824|NCT01647711|26560844|P5|Overall Study|Other adverse event|2
7633825|NCT01647711|26560845|P4|Overall Study|Other adverse event|0
7633826|NCT01647711|26560846|P3|Overall Study|Other adverse event|2
7633827|NCT01647711|26560847|P2|Overall Study|Other adverse event|0
7633828|NCT01647711|26560848|P1|Overall Study|Other adverse event|0
7633829|NCT01647711|26560844|P5|Overall Study|Progressive disease|2
7633830|NCT01647711|26560845|P4|Overall Study|Progressive disease|8
7633831|NCT01647711|26560846|P3|Overall Study|Progressive disease|6
7633832|NCT01647711|26560847|P2|Overall Study|Progressive disease|2
7633833|NCT01647711|26560848|P1|Overall Study|Progressive disease|6
7633834|NCT01647542|26560885|P3|Overall Study|Death|1
7633835|NCT01647542|26560886|P2|Overall Study|Death|0
7633836|NCT01647542|26560887|P1|Overall Study|Death|0
7633837|NCT01647542|26560885|P3|Overall Study|Lack of Efficacy|0
7633838|NCT01647542|26560886|P2|Overall Study|Lack of Efficacy|1
7633839|NCT01647542|26560887|P1|Overall Study|Lack of Efficacy|1
7633840|NCT01647542|26560885|P3|Overall Study|Study Termination|65
7633841|NCT01647542|26560886|P2|Overall Study|Study Termination|61
7633842|NCT01647542|26560887|P1|Overall Study|Study Termination|64
7633843|NCT01647542|26560885|P3|Overall Study|Withdrawal by Subject|0
7633844|NCT01647542|26560886|P2|Overall Study|Withdrawal by Subject|4
7633845|NCT01647542|26560887|P1|Overall Study|Withdrawal by Subject|6
7633846|NCT01647542|26560885|P3|Overall Study|Lost to Follow-up|2
7633847|NCT01647542|26560886|P2|Overall Study|Lost to Follow-up|2
7633848|NCT01647542|26560887|P1|Overall Study|Lost to Follow-up|0
7633849|NCT01647542|26560885|P3|Overall Study|Adverse Event|4
7633850|NCT01647542|26560886|P2|Overall Study|Adverse Event|5
7633851|NCT01647542|26560887|P1|Overall Study|Adverse Event|4
7633852|NCT01647542|26560885|P3|Overall Study|Major Protocol Deviation|0
7633853|NCT01647542|26560886|P2|Overall Study|Major Protocol Deviation|0
7633854|NCT01647542|26560887|P1|Overall Study|Major Protocol Deviation|1
7633855|NCT01647516|26560907|P6|Open-Label Period|No completion / discontinuation visit|1
7633856|NCT01647516|26560908|P5|Open-Label Period|No completion / discontinuation visit|2
7633857|NCT01647516|26560909|P4|Open-Label Period|No completion / discontinuation visit|0
7633858|NCT01647516|26560910|P3|Open-Label Period|No completion / discontinuation visit|0
7633859|NCT01647516|26560911|P2|Open-Label Period|No completion / discontinuation visit|0
7633860|NCT01647516|26560912|P1|Open-Label Period|No completion / discontinuation visit|0
7633861|NCT01647516|26560907|P6|Open-Label Period|Participant Choice to Stop Study Drug|10
7633862|NCT01647516|26560908|P5|Open-Label Period|Participant Choice to Stop Study Drug|9
7633863|NCT01647516|26560909|P4|Open-Label Period|Participant Choice to Stop Study Drug|7
7633864|NCT01647516|26560910|P3|Open-Label Period|Participant Choice to Stop Study Drug|0
7633865|NCT01647516|26560911|P2|Open-Label Period|Participant Choice to Stop Study Drug|0
7633866|NCT01647516|26560912|P1|Open-Label Period|Participant Choice to Stop Study Drug|0
7633867|NCT01647516|26560907|P6|Open-Label Period|Lack of Efficacy|10
7633868|NCT01647516|26560908|P5|Open-Label Period|Lack of Efficacy|9
7633869|NCT01647516|26560909|P4|Open-Label Period|Lack of Efficacy|7
7633870|NCT01647516|26560910|P3|Open-Label Period|Lack of Efficacy|0
7633871|NCT01647516|26560911|P2|Open-Label Period|Lack of Efficacy|0
7633872|NCT01647516|26560912|P1|Open-Label Period|Lack of Efficacy|0
7633873|NCT01647516|26560907|P6|Open-Label Period|Sponsor Termination; moved to 3102 study|23
7633874|NCT01647516|26560908|P5|Open-Label Period|Sponsor Termination; moved to 3102 study|13
7633875|NCT01647516|26560909|P4|Open-Label Period|Sponsor Termination; moved to 3102 study|18
7633876|NCT01647516|26560910|P3|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7633877|NCT01647516|26560911|P2|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7633878|NCT01647516|26560912|P1|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7633879|NCT01647516|26560907|P6|Open-Label Period|Lost to Follow-up|1
7633880|NCT01647516|26560908|P5|Open-Label Period|Lost to Follow-up|0
7633881|NCT01647516|26560909|P4|Open-Label Period|Lost to Follow-up|1
7633882|NCT01647516|26560910|P3|Open-Label Period|Lost to Follow-up|0
7633883|NCT01647516|26560911|P2|Open-Label Period|Lost to Follow-up|0
7633884|NCT01647516|26560912|P1|Open-Label Period|Lost to Follow-up|0
7633885|NCT01647516|26560907|P6|Open-Label Period|Withdrawal by Subject|6
7633886|NCT01647516|26560908|P5|Open-Label Period|Withdrawal by Subject|11
7633887|NCT01647516|26560909|P4|Open-Label Period|Withdrawal by Subject|9
7633888|NCT01647516|26560910|P3|Open-Label Period|Withdrawal by Subject|0
7633889|NCT01647516|26560911|P2|Open-Label Period|Withdrawal by Subject|0
7633890|NCT01647516|26560912|P1|Open-Label Period|Withdrawal by Subject|0
7633891|NCT01647516|26560907|P6|Open-Label Period|Physician Decision|0
7633892|NCT01647516|26560908|P5|Open-Label Period|Physician Decision|1
7633893|NCT01647516|26560909|P4|Open-Label Period|Physician Decision|1
7633894|NCT01647516|26560910|P3|Open-Label Period|Physician Decision|0
7633895|NCT01647516|26560911|P2|Open-Label Period|Physician Decision|0
7633896|NCT01647516|26560912|P1|Open-Label Period|Physician Decision|0
7633897|NCT01647516|26560907|P6|Open-Label Period|Non-compliance|1
7633898|NCT01647516|26560908|P5|Open-Label Period|Non-compliance|0
7633899|NCT01647516|26560909|P4|Open-Label Period|Non-compliance|1
7633900|NCT01647516|26560910|P3|Open-Label Period|Non-compliance|0
7633901|NCT01647516|26560911|P2|Open-Label Period|Non-compliance|0
7633902|NCT01647516|26560912|P1|Open-Label Period|Non-compliance|0
7633903|NCT01647516|26560907|P6|Open-Label Period|Pregnancy|1
7633904|NCT01647516|26560908|P5|Open-Label Period|Pregnancy|0
7633905|NCT01647516|26560909|P4|Open-Label Period|Pregnancy|0
7633906|NCT01647516|26560910|P3|Open-Label Period|Pregnancy|0
7633907|NCT01647516|26560911|P2|Open-Label Period|Pregnancy|0
7633908|NCT01647516|26560912|P1|Open-Label Period|Pregnancy|0
7633909|NCT01647516|26560907|P6|Open-Label Period|Adverse Event|3
7633910|NCT01647516|26560908|P5|Open-Label Period|Adverse Event|6
7633911|NCT01647516|26560909|P4|Open-Label Period|Adverse Event|5
7633912|NCT01647516|26560910|P3|Open-Label Period|Adverse Event|0
7633913|NCT01647516|26560911|P2|Open-Label Period|Adverse Event|0
7633914|NCT01647516|26560912|P1|Open-Label Period|Adverse Event|0
7633915|NCT01647516|26560907|P6|Maintenance Period (MP)|Lack of Efficacy|0
7633916|NCT01647516|26560908|P5|Maintenance Period (MP)|Lack of Efficacy|0
7633917|NCT01647516|26560909|P4|Maintenance Period (MP)|Lack of Efficacy|0
7633918|NCT01647516|26560910|P3|Maintenance Period (MP)|Lack of Efficacy|1
7633919|NCT01647516|26560911|P2|Maintenance Period (MP)|Lack of Efficacy|4
7633920|NCT01647516|26560912|P1|Maintenance Period (MP)|Lack of Efficacy|1
7633921|NCT01647516|26560907|P6|Maintenance Period (MP)|Withdrawal by Subject|0
7633922|NCT01647516|26560908|P5|Maintenance Period (MP)|Withdrawal by Subject|0
7633923|NCT01647516|26560909|P4|Maintenance Period (MP)|Withdrawal by Subject|0
7633924|NCT01647516|26560910|P3|Maintenance Period (MP)|Withdrawal by Subject|1
7633925|NCT01647516|26560911|P2|Maintenance Period (MP)|Withdrawal by Subject|1
7633926|NCT01647516|26560912|P1|Maintenance Period (MP)|Withdrawal by Subject|0
7633927|NCT01647516|26560907|P6|Maintenance Period (MP)|Non-compliance|0
7633928|NCT01647516|26560908|P5|Maintenance Period (MP)|Non-compliance|0
7633929|NCT01647516|26560909|P4|Maintenance Period (MP)|Non-compliance|0
7633930|NCT01647516|26560910|P3|Maintenance Period (MP)|Non-compliance|0
7633931|NCT01647516|26560911|P2|Maintenance Period (MP)|Non-compliance|0
7633932|NCT01647516|26560912|P1|Maintenance Period (MP)|Non-compliance|1
7633933|NCT01647516|26560907|P6|Maintenance Period (MP)|Adverse Event|0
7633934|NCT01647516|26560908|P5|Maintenance Period (MP)|Adverse Event|0
7633935|NCT01647516|26560909|P4|Maintenance Period (MP)|Adverse Event|0
7633936|NCT01647516|26560910|P3|Maintenance Period (MP)|Adverse Event|0
7633937|NCT01647516|26560911|P2|Maintenance Period (MP)|Adverse Event|1
7633938|NCT01647516|26560912|P1|Maintenance Period (MP)|Adverse Event|2
7633939|NCT01647516|26560907|P6|Induction Period (IP)|No study drug received|0
7633940|NCT01647516|26560908|P5|Induction Period (IP)|No study drug received|0
7633941|NCT01647516|26560909|P4|Induction Period (IP)|No study drug received|0
7633942|NCT01647516|26560910|P3|Induction Period (IP)|No study drug received|0
7633943|NCT01647516|26560911|P2|Induction Period (IP)|No study drug received|1
7633944|NCT01647516|26560912|P1|Induction Period (IP)|No study drug received|1
7633945|NCT01647516|26560907|P6|Induction Period (IP)|Lack of Efficacy|0
7633946|NCT01647516|26560908|P5|Induction Period (IP)|Lack of Efficacy|0
7633947|NCT01647516|26560909|P4|Induction Period (IP)|Lack of Efficacy|0
7633948|NCT01647516|26560910|P3|Induction Period (IP)|Lack of Efficacy|0
7633949|NCT01647516|26560911|P2|Induction Period (IP)|Lack of Efficacy|0
7633950|NCT01647516|26560912|P1|Induction Period (IP)|Lack of Efficacy|1
7633951|NCT01647516|26560907|P6|Induction Period (IP)|Participant Choice|0
7633952|NCT01647516|26560908|P5|Induction Period (IP)|Participant Choice|0
7633953|NCT01647516|26560909|P4|Induction Period (IP)|Participant Choice|0
7633954|NCT01647516|26560910|P3|Induction Period (IP)|Participant Choice|1
7633955|NCT01647516|26560911|P2|Induction Period (IP)|Participant Choice|0
7633956|NCT01647516|26560912|P1|Induction Period (IP)|Participant Choice|0
7633957|NCT01647516|26560907|P6|Induction Period (IP)|Withdrawal by Subject|0
7633958|NCT01647516|26560908|P5|Induction Period (IP)|Withdrawal by Subject|0
7633959|NCT01647516|26560909|P4|Induction Period (IP)|Withdrawal by Subject|0
7633960|NCT01647516|26560910|P3|Induction Period (IP)|Withdrawal by Subject|3
7633961|NCT01647516|26560911|P2|Induction Period (IP)|Withdrawal by Subject|0
7633962|NCT01647516|26560912|P1|Induction Period (IP)|Withdrawal by Subject|1
7633963|NCT01647516|26560907|P6|Induction Period (IP)|Adverse Event|0
7633964|NCT01647516|26560908|P5|Induction Period (IP)|Adverse Event|0
7633965|NCT01647516|26560909|P4|Induction Period (IP)|Adverse Event|0
7633966|NCT01647516|26560910|P3|Induction Period (IP)|Adverse Event|0
7633967|NCT01647516|26560911|P2|Induction Period (IP)|Adverse Event|2
7633968|NCT01647516|26560912|P1|Induction Period (IP)|Adverse Event|1
7633969|NCT01647516|26560907|P6|Induction Period (IP)|Physician Decision|0
7633970|NCT01647516|26560908|P5|Induction Period (IP)|Physician Decision|0
7633971|NCT01647516|26560909|P4|Induction Period (IP)|Physician Decision|0
7633972|NCT01647516|26560910|P3|Induction Period (IP)|Physician Decision|0
7633973|NCT01647516|26560911|P2|Induction Period (IP)|Physician Decision|0
7633974|NCT01647516|26560912|P1|Induction Period (IP)|Physician Decision|2
7633975|NCT01647282|26560968|P2|Overall Study|Physician Decision|5
7633976|NCT01647282|26560969|P1|Overall Study|Physician Decision|7
7633977|NCT01646827|26560990|P2|Overall Study|Withdrawal by Subject|0
7633978|NCT01646827|26560991|P1|Overall Study|Withdrawal by Subject|1
7633979|NCT01646827|26560990|P2|Overall Study|Physician Decision|2
7633980|NCT01646827|26560991|P1|Overall Study|Physician Decision|1
7633981|NCT01646827|26560990|P2|Overall Study|Lost to Follow-up|3
7633982|NCT01646827|26560991|P1|Overall Study|Lost to Follow-up|0
7633983|NCT01646645|26561076|P1|Overall Study|Inevaluable Donor|29
7633984|NCT01646645|26561076|P1|Overall Study|No Treated|1
7633985|NCT01646398|26561083|P2|Overall Study|Withdrawal by Subject|0
7633986|NCT01646398|26561084|P1|Overall Study|Withdrawal by Subject|1
7633987|NCT01646385|26561100|P2|Overall Study|Switched to alternate biologic|649
7633988|NCT01646385|26561101|P1|Overall Study|Switched to alternate biologic|636
7633989|NCT01646385|26561100|P2|Overall Study|Death|222
7633990|NCT01646385|26561101|P1|Overall Study|Death|202
7633991|NCT01646320|26561144|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
7633992|NCT01646320|26561145|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
7633993|NCT01646320|26561144|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
7633994|NCT01646320|26561145|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
7633995|NCT01646320|26561144|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
7633996|NCT01646320|26561145|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
7633997|NCT01646320|26561144|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
7633998|NCT01646320|26561145|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
7633999|NCT01646320|26561144|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
7634000|NCT01646320|26561145|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
7634001|NCT01646320|26561144|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
7634002|NCT01646320|26561145|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
7634003|NCT01646320|26561144|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7634004|NCT01646320|26561145|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7634005|NCT01646320|26561144|P2|Short-term Period (Day 1 to Week 24)|Other|0
7634006|NCT01646320|26561145|P1|Short-term Period (Day 1 to Week 24)|Other|1
7634007|NCT01646320|26561144|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
7634008|NCT01646320|26561145|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
7634009|NCT01646320|26561144|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
7634010|NCT01646320|26561145|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7634011|NCT01646320|26561144|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
7634012|NCT01646320|26561145|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
7634013|NCT01646268|26561161|P2|Overall Study|Other|0
7634014|NCT01646268|26561162|P1|Overall Study|Other|2
7634015|NCT01646268|26561161|P2|Overall Study|Withdrawal by Subject|5
7634016|NCT01646268|26561162|P1|Overall Study|Withdrawal by Subject|2
7634017|NCT01646268|26561161|P2|Overall Study|Protocol Violation|1
7634018|NCT01646268|26561162|P1|Overall Study|Protocol Violation|0
7634019|NCT01646268|26561161|P2|Overall Study|Lack of Efficacy|3
7634020|NCT01646268|26561162|P1|Overall Study|Lack of Efficacy|1
7634021|NCT01646268|26561161|P2|Overall Study|Adverse Event|7
7634022|NCT01646268|26561162|P1|Overall Study|Adverse Event|6
7634023|NCT01646255|26561176|P2|Overall Study|Inclusion Criteria Deviation|0
7634024|NCT01646255|26561177|P1|Overall Study|Inclusion Criteria Deviation|1
7634025|NCT01646255|26561176|P2|Overall Study|Compliance is not well|0
7634026|NCT01646255|26561177|P1|Overall Study|Compliance is not well|1
7634027|NCT01646255|26561176|P2|Overall Study|Withdrawal by Subject|6
7634028|NCT01646255|26561177|P1|Overall Study|Withdrawal by Subject|10
7634029|NCT01646255|26561176|P2|Overall Study|Lack of Efficacy|0
7634030|NCT01646255|26561177|P1|Overall Study|Lack of Efficacy|2
7634031|NCT01646255|26561176|P2|Overall Study|Adverse Event|8
7634032|NCT01646255|26561177|P1|Overall Study|Adverse Event|7
7634033|NCT01646216|26561209|P2|Overall Study|Investigator decision|1
7634034|NCT01646216|26561210|P1|Overall Study|Investigator decision|1
7634035|NCT01646216|26561209|P2|Overall Study|Did not complete training|2
7634036|NCT01646216|26561210|P1|Overall Study|Did not complete training|0
7634037|NCT01646216|26561209|P2|Overall Study|Baseline step length difference (<5cm)|10
7634038|NCT01646216|26561210|P1|Overall Study|Baseline step length difference (<5cm)|10
7634039|NCT01646203|26561232|P3|Overall Study|Physician's Decision|0
7634040|NCT01646203|26561233|P2|Overall Study|Physician's Decision|1
7634041|NCT01646203|26561234|P1|Overall Study|Physician's Decision|0
7634042|NCT01646203|26561232|P3|Overall Study|Withdrawal by Subject|0
7634043|NCT01646203|26561233|P2|Overall Study|Withdrawal by Subject|1
7634044|NCT01646203|26561234|P1|Overall Study|Withdrawal by Subject|0
7634045|NCT01646203|26561232|P3|Overall Study|Adverse Event|1
7634046|NCT01646203|26561233|P2|Overall Study|Adverse Event|0
7634047|NCT01646203|26561234|P1|Overall Study|Adverse Event|2
7634048|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7634049|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7634050|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634051|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634052|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634053|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634054|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634055|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634056|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634057|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634058|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634059|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7634060|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7634061|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7634062|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634063|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7634064|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634065|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634066|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634067|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634068|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634069|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634070|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634071|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7634072|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7634073|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7634074|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7634075|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634076|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634077|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634078|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634079|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634080|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634081|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634082|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634083|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7634084|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
7634085|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7634086|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7634087|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634088|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634089|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634090|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634091|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634092|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634093|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634094|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634095|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7634096|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
7634097|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7634098|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7634099|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
7634100|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634101|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634102|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634103|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634104|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634105|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634106|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634107|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7634108|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
7634109|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
7634110|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
7634111|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
7634112|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634113|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634114|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634115|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634116|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634117|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634118|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634119|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7634120|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7634121|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
7634122|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7634123|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
7634124|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634125|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634126|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634127|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634128|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634129|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634130|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634131|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7634132|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7634133|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7634134|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
7634135|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
7634136|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634137|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634138|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634139|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634140|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634141|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634142|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634143|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7634144|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7634145|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7634146|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
7634147|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
7634148|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634149|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634150|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634151|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634152|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634153|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634154|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634155|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7634156|NCT01646177|26561263|P12|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
7634157|NCT01646177|26561264|P11|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
7634158|NCT01646177|26561265|P10|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
7634159|NCT01646177|26561266|P9|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
7634160|NCT01646177|26561267|P8|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634161|NCT01646177|26561268|P7|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634162|NCT01646177|26561269|P6|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634163|NCT01646177|26561270|P5|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634164|NCT01646177|26561271|P4|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634165|NCT01646177|26561272|P3|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634166|NCT01646177|26561273|P2|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634167|NCT01646177|26561274|P1|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7634168|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634169|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634170|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634171|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634172|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
7634173|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
7634174|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
7634175|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634176|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634177|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634178|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634179|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7634180|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634181|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634182|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634183|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634184|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
7634185|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634186|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634187|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634188|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634189|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634190|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634191|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7634192|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634193|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634194|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634195|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634196|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
7634197|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7634198|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7634199|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7634200|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634201|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634202|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634203|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7634204|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Death|0
7634205|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Death|0
7634206|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Death|0
7634207|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Death|0
7634208|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Death|3
7634209|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Death|1
7634210|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Death|3
7634211|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Death|1
7634212|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Death|0
7634213|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Death|0
7634214|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Death|0
7634215|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Death|0
7634216|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634217|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634218|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634219|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634220|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7634221|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7634222|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7634223|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
7634224|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634225|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634226|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634227|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7634228|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634229|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634230|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634231|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634232|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
7634233|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634234|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
7634235|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
7634236|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634237|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634238|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634239|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7634240|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634241|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634242|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634243|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634244|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7634245|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7634246|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7634247|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Physician Decision|3
7634248|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634249|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634250|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634251|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7634252|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634253|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634254|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634255|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634256|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
7634257|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
7634404|NCT01646073|26561421|P1|Period A (12 Weeks)|Withdrawal by Subject|1
7634258|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
7634259|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
7634260|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634261|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634262|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634263|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7634264|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634265|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634266|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634267|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634268|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
7634269|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
7634270|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
7634271|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
7634272|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634273|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634274|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634275|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7634276|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634277|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634278|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634279|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634280|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
7634281|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
7634282|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
7634283|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
7634284|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634285|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634286|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634287|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7634288|NCT01646177|26561263|P12|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634289|NCT01646177|26561264|P11|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634290|NCT01646177|26561265|P10|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634291|NCT01646177|26561266|P9|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634292|NCT01646177|26561267|P8|Long-Term Extension Period (Week 12-264)|Adverse Event|30
7634293|NCT01646177|26561268|P7|Long-Term Extension Period (Week 12-264)|Adverse Event|43
7634294|NCT01646177|26561269|P6|Long-Term Extension Period (Week 12-264)|Adverse Event|34
7634295|NCT01646177|26561270|P5|Long-Term Extension Period (Week 12-264)|Adverse Event|16
7634296|NCT01646177|26561271|P4|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634297|NCT01646177|26561272|P3|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634298|NCT01646177|26561273|P2|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634299|NCT01646177|26561274|P1|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7634300|NCT01646177|26561263|P12|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634301|NCT01646177|26561264|P11|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634302|NCT01646177|26561265|P10|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634303|NCT01646177|26561266|P9|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634304|NCT01646177|26561267|P8|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634305|NCT01646177|26561268|P7|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634306|NCT01646177|26561269|P6|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634307|NCT01646177|26561270|P5|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634308|NCT01646177|26561271|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7634309|NCT01646177|26561272|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7634310|NCT01646177|26561273|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7634311|NCT01646177|26561274|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
7634312|NCT01646177|26561263|P12|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634313|NCT01646177|26561264|P11|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634314|NCT01646177|26561265|P10|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634315|NCT01646177|26561266|P9|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634316|NCT01646177|26561267|P8|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634317|NCT01646177|26561268|P7|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634318|NCT01646177|26561269|P6|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634319|NCT01646177|26561270|P5|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634320|NCT01646177|26561271|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
7634321|NCT01646177|26561272|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
7634322|NCT01646177|26561273|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634323|NCT01646177|26561274|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7634324|NCT01646177|26561263|P12|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634325|NCT01646177|26561264|P11|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634326|NCT01646177|26561265|P10|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634327|NCT01646177|26561266|P9|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634328|NCT01646177|26561267|P8|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634329|NCT01646177|26561268|P7|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634330|NCT01646177|26561269|P6|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634331|NCT01646177|26561270|P5|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7634332|NCT01646177|26561271|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7634333|NCT01646177|26561272|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7634334|NCT01646177|26561273|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7634335|NCT01646177|26561274|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7634336|NCT01646177|26561263|P12|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634337|NCT01646177|26561264|P11|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634338|NCT01646177|26561265|P10|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634339|NCT01646177|26561266|P9|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634340|NCT01646177|26561267|P8|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634341|NCT01646177|26561268|P7|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634342|NCT01646177|26561269|P6|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634343|NCT01646177|26561270|P5|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7634344|NCT01646177|26561271|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7634345|NCT01646177|26561272|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7634346|NCT01646177|26561273|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
7634347|NCT01646177|26561274|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
7634348|NCT01646177|26561263|P12|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634349|NCT01646177|26561264|P11|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634350|NCT01646177|26561265|P10|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634351|NCT01646177|26561266|P9|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634352|NCT01646177|26561267|P8|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634353|NCT01646177|26561268|P7|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634354|NCT01646177|26561269|P6|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634355|NCT01646177|26561270|P5|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7634356|NCT01646177|26561271|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
7634357|NCT01646177|26561272|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
7634358|NCT01646177|26561273|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
7634359|NCT01646177|26561274|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
7634360|NCT01646177|26561263|P12|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634361|NCT01646177|26561264|P11|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634362|NCT01646177|26561265|P10|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634363|NCT01646177|26561266|P9|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634364|NCT01646177|26561267|P8|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634365|NCT01646177|26561268|P7|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634366|NCT01646177|26561269|P6|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634367|NCT01646177|26561270|P5|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7634368|NCT01646177|26561271|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
7634369|NCT01646177|26561272|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
7634370|NCT01646177|26561273|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
7634371|NCT01646177|26561274|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
7634372|NCT01646138|26561376|P5|Overall Study|Lost to Follow-up|2
7634373|NCT01646138|26561377|P4|Overall Study|Lost to Follow-up|0
7634374|NCT01646138|26561378|P3|Overall Study|Lost to Follow-up|0
7634375|NCT01646138|26561379|P2|Overall Study|Lost to Follow-up|0
7634376|NCT01646138|26561380|P1|Overall Study|Lost to Follow-up|0
7634377|NCT01646125|26561394|P2|Overall Study|Subject/Guardian decision|1
7634378|NCT01646125|26561395|P1|Overall Study|Subject/Guardian decision|1
7634379|NCT01646125|26561394|P2|Overall Study|Study terminated by sponsor|1
7634380|NCT01646125|26561395|P1|Overall Study|Study terminated by sponsor|2
7634381|NCT01646125|26561394|P2|Overall Study|Progressive disease|16
7634382|NCT01646125|26561395|P1|Overall Study|Progressive disease|22
7634383|NCT01646125|26561394|P2|Overall Study|Physician Decision|3
7634384|NCT01646125|26561395|P1|Overall Study|Physician Decision|1
7634385|NCT01646125|26561394|P2|Overall Study|Death|1
7634386|NCT01646125|26561395|P1|Overall Study|Death|1
7634387|NCT01646125|26561394|P2|Overall Study|Adverse Event|1
7634388|NCT01646125|26561395|P1|Overall Study|Adverse Event|2
7634389|NCT01646125|26561394|P2|Overall Study|Untreated|5
7634390|NCT01646125|26561395|P1|Overall Study|Untreated|2
7634391|NCT01646073|26561420|P2|Period B (12 Weeks)|Lost to Follow-up|1
7634392|NCT01646073|26561421|P1|Period B (12 Weeks)|Lost to Follow-up|0
7634393|NCT01646073|26561420|P2|Period B (12 Weeks)|Withdrawal by Subject|5
7634394|NCT01646073|26561421|P1|Period B (12 Weeks)|Withdrawal by Subject|1
7634395|NCT01646073|26561420|P2|Period B (12 Weeks)|Adverse Event|7
7634396|NCT01646073|26561421|P1|Period B (12 Weeks)|Adverse Event|0
7634397|NCT01646073|26561420|P2|Period A (12 Weeks)|Other|1
7634398|NCT01646073|26561421|P1|Period A (12 Weeks)|Other|0
7634399|NCT01646073|26561420|P2|Period A (12 Weeks)|Protocol Violation|1
7634400|NCT01646073|26561421|P1|Period A (12 Weeks)|Protocol Violation|0
7634401|NCT01646073|26561420|P2|Period A (12 Weeks)|Lack of Efficacy|0
7634402|NCT01646073|26561421|P1|Period A (12 Weeks)|Lack of Efficacy|1
7634403|NCT01646073|26561420|P2|Period A (12 Weeks)|Withdrawal by Subject|1
7634405|NCT01646073|26561420|P2|Period A (12 Weeks)|Adverse Event|2
7634406|NCT01646073|26561421|P1|Period A (12 Weeks)|Adverse Event|0
7634407|NCT01646021|26561462|P2|Overall Study|Withdrawal by Subject|15
7634408|NCT01646021|26561463|P1|Overall Study|Withdrawal by Subject|10
7634409|NCT01646021|26561462|P2|Overall Study|Lost to Follow-up|2
7634410|NCT01646021|26561463|P1|Overall Study|Lost to Follow-up|2
7634411|NCT01646021|26561462|P2|Overall Study|Study Terminated by Sponsor|41
7634412|NCT01646021|26561463|P1|Overall Study|Study Terminated by Sponsor|50
7634413|NCT01646021|26561462|P2|Overall Study|Death|83
7634414|NCT01646021|26561463|P1|Overall Study|Death|77
7634415|NCT01645930|26561500|P1|Overall Study|Reason not Defined|1
7634416|NCT01645930|26561500|P1|Overall Study|Withdrawal by Participant|2
7634417|NCT01645930|26561500|P1|Overall Study|Unsatisfactory Therapeutic Response|2
7634418|NCT01645930|26561500|P1|Overall Study|Adverse Event|4
7634419|NCT01645930|26561500|P1|Overall Study|Progressive Disease|12
7634420|NCT01645930|26561500|P1|Overall Study|Participants Ongoing on Study Treatment|22
7634421|NCT01645735|26561517|P2|Overall Study|Adverse Event|1
7634422|NCT01645735|26561518|P1|Overall Study|Adverse Event|0
7634423|NCT01645735|26561517|P2|Overall Study|Protocol Violation|0
7634424|NCT01645735|26561518|P1|Overall Study|Protocol Violation|1
7634425|NCT01645735|26561517|P2|Overall Study|Withdrawal by Subject|0
7634426|NCT01645735|26561518|P1|Overall Study|Withdrawal by Subject|1
7634427|NCT01645735|26561517|P2|Overall Study|Physician Decision|0
7634428|NCT01645735|26561518|P1|Overall Study|Physician Decision|2
7634429|NCT01645280|26561588|P5|Overall Study|Treatment not completed/Completed f/u|2
7634430|NCT01645280|26561589|P4|Overall Study|Treatment not completed/Completed f/u|0
7634431|NCT01645280|26561590|P3|Overall Study|Treatment not completed/Completed f/u|2
7634432|NCT01645280|26561591|P2|Overall Study|Treatment not completed/Completed f/u|1
7634433|NCT01645280|26561592|P1|Overall Study|Treatment not completed/Completed f/u|1
7634434|NCT01645280|26561588|P5|Overall Study|Other|0
7634435|NCT01645280|26561589|P4|Overall Study|Other|0
7634436|NCT01645280|26561590|P3|Overall Study|Other|2
7634437|NCT01645280|26561591|P2|Overall Study|Other|1
7634438|NCT01645280|26561592|P1|Overall Study|Other|1
7634439|NCT01645280|26561588|P5|Overall Study|Lost to Follow-up|1
7634440|NCT01645280|26561589|P4|Overall Study|Lost to Follow-up|2
7634441|NCT01645280|26561590|P3|Overall Study|Lost to Follow-up|0
7634442|NCT01645280|26561591|P2|Overall Study|Lost to Follow-up|0
7634443|NCT01645280|26561592|P1|Overall Study|Lost to Follow-up|0
7634444|NCT01645280|26561588|P5|Overall Study|Withdrawal by Subject|5
7634445|NCT01645280|26561589|P4|Overall Study|Withdrawal by Subject|4
7634446|NCT01645280|26561590|P3|Overall Study|Withdrawal by Subject|2
7634447|NCT01645280|26561591|P2|Overall Study|Withdrawal by Subject|0
7634448|NCT01645280|26561592|P1|Overall Study|Withdrawal by Subject|4
7634449|NCT01645280|26561588|P5|Overall Study|Death|0
7634450|NCT01645280|26561589|P4|Overall Study|Death|0
7634451|NCT01645280|26561590|P3|Overall Study|Death|0
7634452|NCT01645280|26561591|P2|Overall Study|Death|1
7634453|NCT01645280|26561592|P1|Overall Study|Death|0
7634454|NCT01645176|26561620|P1|Overall Study|did not complete final MRI|1
7634455|NCT01645176|26561620|P1|Overall Study|Lack of Efficacy|4
7634456|NCT01645111|26561624|P1|Overall Study|Did not require Clevidipine|15
7634457|NCT01644890|26561665|P2|Overall Study|Other|9
7634458|NCT01644890|26561666|P1|Overall Study|Other|8
7634459|NCT01644890|26561665|P2|Overall Study|> 28 days since last dose of study drug|3
7634460|NCT01644890|26561666|P1|Overall Study|> 28 days since last dose of study drug|6
7634461|NCT01644890|26561665|P2|Overall Study|Clinical Progression|6
7634462|NCT01644890|26561666|P1|Overall Study|Clinical Progression|6
7634463|NCT01644890|26561665|P2|Overall Study|Progression Disease|131
7634464|NCT01644890|26561666|P1|Overall Study|Progression Disease|160
7634465|NCT01644890|26561665|P2|Overall Study|Withdrawal by Subject|27
7634466|NCT01644890|26561666|P1|Overall Study|Withdrawal by Subject|19
7634467|NCT01644890|26561665|P2|Overall Study|Protocol Violation|7
7634468|NCT01644890|26561666|P1|Overall Study|Protocol Violation|6
7634469|NCT01644890|26561665|P2|Overall Study|Physician Decision|9
7634470|NCT01644890|26561666|P1|Overall Study|Physician Decision|3
7634471|NCT01644890|26561665|P2|Overall Study|Death|3
7634472|NCT01644890|26561666|P1|Overall Study|Death|1
7634473|NCT01644890|26561665|P2|Overall Study|Adverse Event|20
7634474|NCT01644890|26561666|P1|Overall Study|Adverse Event|7
7634475|NCT01644734|26561676|P1|Overall Study|Missing documentation|238
7634476|NCT01644734|26561676|P1|Overall Study|Reasons other than stated above|7
7634477|NCT01644734|26561676|P1|Overall Study|Lost to Follow-up|17
7634478|NCT01644734|26561676|P1|Overall Study|Adverse Event|4
7634479|NCT01644643|26561690|P4|Overall Study|Other Eligibility criteria|2
7634480|NCT01644643|26561691|P3|Overall Study|Other Eligibility criteria|0
7634481|NCT01644643|26561692|P2|Overall Study|Other Eligibility criteria|0
7634482|NCT01644643|26561693|P1|Overall Study|Other Eligibility criteria|0
7634483|NCT01644643|26561690|P4|Overall Study|Withdrawal by Subject|1
7634484|NCT01644643|26561691|P3|Overall Study|Withdrawal by Subject|2
7634485|NCT01644643|26561692|P2|Overall Study|Withdrawal by Subject|0
7634486|NCT01644643|26561693|P1|Overall Study|Withdrawal by Subject|1
7634487|NCT01644643|26561690|P4|Overall Study|Lost to Follow-up|4
7634488|NCT01644643|26561691|P3|Overall Study|Lost to Follow-up|0
7634489|NCT01644643|26561692|P2|Overall Study|Lost to Follow-up|0
7634490|NCT01644643|26561693|P1|Overall Study|Lost to Follow-up|0
7634491|NCT01644643|26561690|P4|Overall Study|Death|3
7634492|NCT01644643|26561691|P3|Overall Study|Death|3
7634493|NCT01644643|26561692|P2|Overall Study|Death|0
7634494|NCT01644643|26561693|P1|Overall Study|Death|1
7634495|NCT01644617|26561858|P3|Overall Study|Adverse Event|6
7634496|NCT01644617|26561859|P2|Overall Study|Adverse Event|0
7634497|NCT01644617|26561860|P1|Overall Study|Adverse Event|3
7634498|NCT01644617|26561858|P3|Overall Study|Lost to Follow-up|0
7634499|NCT01644617|26561859|P2|Overall Study|Lost to Follow-up|1
7634500|NCT01644617|26561860|P1|Overall Study|Lost to Follow-up|0
7634501|NCT01644617|26561858|P3|Overall Study|Withdrawal by Subject|1
7634502|NCT01644617|26561859|P2|Overall Study|Withdrawal by Subject|4
7634503|NCT01644617|26561860|P1|Overall Study|Withdrawal by Subject|3
7634504|NCT01644565|26561910|P9|Overall Study|Relocation|1
7634505|NCT01644565|26561911|P8|Overall Study|Relocation|0
7634506|NCT01644565|26561912|P7|Overall Study|Relocation|0
7634507|NCT01644565|26561913|P6|Overall Study|Relocation|0
7634508|NCT01644565|26561914|P5|Overall Study|Relocation|0
7634509|NCT01644565|26561915|P4|Overall Study|Relocation|0
7634510|NCT01644565|26561916|P3|Overall Study|Relocation|0
7634511|NCT01644565|26561917|P2|Overall Study|Relocation|0
7634512|NCT01644565|26561918|P1|Overall Study|Relocation|0
7634513|NCT01644565|26561910|P9|Overall Study|Family emergency|0
7634514|NCT01644565|26561911|P8|Overall Study|Family emergency|0
7634515|NCT01644565|26561912|P7|Overall Study|Family emergency|0
7634516|NCT01644565|26561913|P6|Overall Study|Family emergency|0
7634517|NCT01644565|26561914|P5|Overall Study|Family emergency|1
7634518|NCT01644565|26561915|P4|Overall Study|Family emergency|0
7634519|NCT01644565|26561916|P3|Overall Study|Family emergency|0
7634520|NCT01644565|26561917|P2|Overall Study|Family emergency|0
7634521|NCT01644565|26561918|P1|Overall Study|Family emergency|0
7634522|NCT01644565|26561910|P9|Overall Study|Lost to Follow-up|0
7634523|NCT01644565|26561911|P8|Overall Study|Lost to Follow-up|2
7634524|NCT01644565|26561912|P7|Overall Study|Lost to Follow-up|0
7634525|NCT01644565|26561913|P6|Overall Study|Lost to Follow-up|0
7634526|NCT01644565|26561914|P5|Overall Study|Lost to Follow-up|0
7634527|NCT01644565|26561915|P4|Overall Study|Lost to Follow-up|1
7634528|NCT01644565|26561916|P3|Overall Study|Lost to Follow-up|0
7634529|NCT01644565|26561917|P2|Overall Study|Lost to Follow-up|0
7634530|NCT01644565|26561918|P1|Overall Study|Lost to Follow-up|0
7634531|NCT01644565|26561910|P9|Overall Study|Undisclosed Medical History|0
7634532|NCT01644565|26561911|P8|Overall Study|Undisclosed Medical History|0
7634533|NCT01644565|26561912|P7|Overall Study|Undisclosed Medical History|0
7634534|NCT01644565|26561913|P6|Overall Study|Undisclosed Medical History|0
7634535|NCT01644565|26561914|P5|Overall Study|Undisclosed Medical History|0
7634536|NCT01644565|26561915|P4|Overall Study|Undisclosed Medical History|0
7634537|NCT01644565|26561916|P3|Overall Study|Undisclosed Medical History|0
7634538|NCT01644565|26561917|P2|Overall Study|Undisclosed Medical History|0
7634539|NCT01644565|26561918|P1|Overall Study|Undisclosed Medical History|1
7634540|NCT01644500|26561959|P3|Overall Study|Physician Decision|1
7634541|NCT01644500|26561960|P2|Overall Study|Physician Decision|1
7634542|NCT01644500|26561961|P1|Overall Study|Physician Decision|1
7634543|NCT01644500|26561959|P3|Overall Study|Withdrawal by Subject|12
7634544|NCT01644500|26561960|P2|Overall Study|Withdrawal by Subject|12
7634545|NCT01644500|26561961|P1|Overall Study|Withdrawal by Subject|11
7634546|NCT01644500|26561959|P3|Overall Study|Protocol Violation|0
7634547|NCT01644500|26561960|P2|Overall Study|Protocol Violation|1
7634548|NCT01644500|26561961|P1|Overall Study|Protocol Violation|1
7634549|NCT01644500|26561959|P3|Overall Study|Lost to Follow-up|0
7634550|NCT01644500|26561960|P2|Overall Study|Lost to Follow-up|8
7634551|NCT01644500|26561961|P1|Overall Study|Lost to Follow-up|3
7634552|NCT01644500|26561959|P3|Overall Study|Death|0
7634553|NCT01644500|26561960|P2|Overall Study|Death|1
7634554|NCT01644500|26561961|P1|Overall Study|Death|0
7634555|NCT01644500|26561959|P3|Overall Study|Adverse Event|2
7634556|NCT01644500|26561960|P2|Overall Study|Adverse Event|1
7634557|NCT01644500|26561961|P1|Overall Study|Adverse Event|6
7634558|NCT01644474|26562031|P2|Overall Study|Protocol Violation|0
7634559|NCT01644474|26562032|P1|Overall Study|Protocol Violation|1
7634560|NCT01644474|26562031|P2|Overall Study|Site scheduling error|1
7634561|NCT01644474|26562032|P1|Overall Study|Site scheduling error|1
7634562|NCT01644474|26562031|P2|Overall Study|Adverse Event|5
7634563|NCT01644474|26562032|P1|Overall Study|Adverse Event|4
7634564|NCT01644474|26562031|P2|Overall Study|Participant moved|1
7634565|NCT01644474|26562032|P1|Overall Study|Participant moved|0
7634566|NCT01644474|26562031|P2|Overall Study|Consent withdrawn by participant|1
7634567|NCT01644474|26562032|P1|Overall Study|Consent withdrawn by participant|0
7634568|NCT01644474|26562031|P2|Overall Study|Poor compliance to protocol|0
7634569|NCT01644474|26562032|P1|Overall Study|Poor compliance to protocol|1
7634570|NCT01644188|26562216|P2|Overall Study|Other than specified above|7
7634571|NCT01644188|26562217|P1|Overall Study|Other than specified above|6
7634572|NCT01644188|26562216|P2|Overall Study|Site closure|1
7634573|NCT01644188|26562217|P1|Overall Study|Site closure|1
7634574|NCT01644188|26562216|P2|Overall Study|Last visit outside protocol visit window|16
7634575|NCT01644188|26562217|P1|Overall Study|Last visit outside protocol visit window|14
7634576|NCT01644188|26562216|P2|Overall Study|Death|3
7634577|NCT01644188|26562217|P1|Overall Study|Death|4
7634578|NCT01644188|26562216|P2|Overall Study|Lost to Follow-up|0
7634579|NCT01644188|26562217|P1|Overall Study|Lost to Follow-up|1
7634580|NCT01644188|26562216|P2|Overall Study|Selection criteria finally not met|0
7634581|NCT01644188|26562217|P1|Overall Study|Selection criteria finally not met|2
7634582|NCT01644188|26562216|P2|Overall Study|Consent withdrawn by participant|7
7634583|NCT01644188|26562217|P1|Overall Study|Consent withdrawn by participant|14
7634584|NCT01644188|26562216|P2|Overall Study|Related to auto-injector administration|2
7634585|NCT01644188|26562217|P1|Overall Study|Related to auto-injector administration|2
7634586|NCT01644188|26562216|P2|Overall Study|Participant moved|2
7634587|NCT01644188|26562217|P1|Overall Study|Participant moved|7
7634588|NCT01644188|26562216|P2|Overall Study|Physician Decision|3
7634589|NCT01644188|26562217|P1|Overall Study|Physician Decision|1
7634590|NCT01644188|26562216|P2|Overall Study|Poor compliance to protocol|14
7634591|NCT01644188|26562217|P1|Overall Study|Poor compliance to protocol|26
7634592|NCT01644188|26562216|P2|Overall Study|Adverse Event|20
7634593|NCT01644188|26562217|P1|Overall Study|Adverse Event|44
7634594|NCT01644175|26562275|P2|Overall Study|Other than specified above|3
7634595|NCT01644175|26562276|P1|Overall Study|Other than specified above|0
7634596|NCT01644175|26562275|P2|Overall Study|Lost to Follow-up|0
7634597|NCT01644175|26562276|P1|Overall Study|Lost to Follow-up|1
7634598|NCT01644175|26562275|P2|Overall Study|Site closure|2
7634599|NCT01644175|26562276|P1|Overall Study|Site closure|2
7634600|NCT01644175|26562275|P2|Overall Study|Selection criteria finally not met|1
7634601|NCT01644175|26562276|P1|Overall Study|Selection criteria finally not met|0
7634602|NCT01644175|26562275|P2|Overall Study|Last visit outside protocol visit window|11
7634603|NCT01644175|26562276|P1|Overall Study|Last visit outside protocol visit window|4
7634604|NCT01644175|26562275|P2|Overall Study|Related to Autoinjector Administration|1
7634605|NCT01644175|26562276|P1|Overall Study|Related to Autoinjector Administration|2
7634606|NCT01644175|26562275|P2|Overall Study|Consent withdrawn by participant|4
7634607|NCT01644175|26562276|P1|Overall Study|Consent withdrawn by participant|3
7634608|NCT01644175|26562275|P2|Overall Study|Participant Moved|2
7634609|NCT01644175|26562276|P1|Overall Study|Participant Moved|1
7634610|NCT01644175|26562275|P2|Overall Study|Physician Decision|2
7634611|NCT01644175|26562276|P1|Overall Study|Physician Decision|1
7634612|NCT01644175|26562275|P2|Overall Study|Poor compliance to protocol|10
7634613|NCT01644175|26562276|P1|Overall Study|Poor compliance to protocol|9
7634614|NCT01644175|26562275|P2|Overall Study|Death|2
7634615|NCT01644175|26562276|P1|Overall Study|Death|1
7634616|NCT01644175|26562275|P2|Overall Study|Adverse Event|13
7634617|NCT01644175|26562276|P1|Overall Study|Adverse Event|8
7634618|NCT01644175|26562275|P2|Overall Study|Randomized But Not Treated|2
7634619|NCT01644175|26562276|P1|Overall Study|Randomized But Not Treated|0
7634620|NCT01644149|26562328|P2|Overall Study|Lost to Follow-up|1
7634621|NCT01644149|26562329|P1|Overall Study|Lost to Follow-up|3
7634622|NCT01644149|26562328|P2|Overall Study|Withdrawal by Subject|0
7634623|NCT01644149|26562329|P1|Overall Study|Withdrawal by Subject|1
7634624|NCT01643928|26562349|P5|Overall Study|Adverse Event|2
7634625|NCT01643928|26562350|P4|Overall Study|Adverse Event|1
7634626|NCT01643928|26562351|P3|Overall Study|Adverse Event|0
7634627|NCT01643928|26562352|P2|Overall Study|Adverse Event|1
7634628|NCT01643928|26562353|P1|Overall Study|Adverse Event|2
7634629|NCT01643928|26562349|P5|Overall Study|Other|0
7634630|NCT01643928|26562350|P4|Overall Study|Other|0
7634631|NCT01643928|26562351|P3|Overall Study|Other|1
7634632|NCT01643928|26562352|P2|Overall Study|Other|1
7634633|NCT01643928|26562353|P1|Overall Study|Other|5
7634634|NCT01643928|26562349|P5|Overall Study|Pregnancy|0
7634635|NCT01643928|26562350|P4|Overall Study|Pregnancy|1
7634636|NCT01643928|26562351|P3|Overall Study|Pregnancy|0
7634637|NCT01643928|26562352|P2|Overall Study|Pregnancy|0
7634638|NCT01643928|26562353|P1|Overall Study|Pregnancy|0
7634639|NCT01643928|26562349|P5|Overall Study|Withdrawal by Subject|0
7634640|NCT01643928|26562350|P4|Overall Study|Withdrawal by Subject|1
7634641|NCT01643928|26562351|P3|Overall Study|Withdrawal by Subject|0
7634642|NCT01643928|26562352|P2|Overall Study|Withdrawal by Subject|0
7634643|NCT01643928|26562353|P1|Overall Study|Withdrawal by Subject|2
7634644|NCT01643928|26562349|P5|Overall Study|Lost to Follow-up|0
7634645|NCT01643928|26562350|P4|Overall Study|Lost to Follow-up|0
7634646|NCT01643928|26562351|P3|Overall Study|Lost to Follow-up|2
7634647|NCT01643928|26562352|P2|Overall Study|Lost to Follow-up|0
7634648|NCT01643928|26562353|P1|Overall Study|Lost to Follow-up|1
7634649|NCT01643850|26562657|P9|Overall Study|Administrative Problems|0
7634650|NCT01643850|26562658|P8|Overall Study|Administrative Problems|0
7634651|NCT01643850|26562659|P7|Overall Study|Administrative Problems|0
7634652|NCT01643850|26562660|P6|Overall Study|Administrative Problems|0
7634653|NCT01643850|26562661|P5|Overall Study|Administrative Problems|1
7634654|NCT01643850|26562662|P4|Overall Study|Administrative Problems|0
7634655|NCT01643850|26562663|P3|Overall Study|Administrative Problems|1
7634656|NCT01643850|26562664|P2|Overall Study|Administrative Problems|0
7634657|NCT01643850|26562665|P1|Overall Study|Administrative Problems|0
7634658|NCT01643850|26562657|P9|Overall Study|Adverse Event|0
7634659|NCT01643850|26562658|P8|Overall Study|Adverse Event|0
7634660|NCT01643850|26562659|P7|Overall Study|Adverse Event|0
7634661|NCT01643850|26562660|P6|Overall Study|Adverse Event|0
7634662|NCT01643850|26562661|P5|Overall Study|Adverse Event|1
7634663|NCT01643850|26562662|P4|Overall Study|Adverse Event|0
7634664|NCT01643850|26562663|P3|Overall Study|Adverse Event|0
7634665|NCT01643850|26562664|P2|Overall Study|Adverse Event|0
7634666|NCT01643850|26562665|P1|Overall Study|Adverse Event|0
7634667|NCT01643850|26562657|P9|Overall Study|Lost to Follow-up|1
7634668|NCT01643850|26562658|P8|Overall Study|Lost to Follow-up|0
7634669|NCT01643850|26562659|P7|Overall Study|Lost to Follow-up|1
7634670|NCT01643850|26562660|P6|Overall Study|Lost to Follow-up|0
7634671|NCT01643850|26562661|P5|Overall Study|Lost to Follow-up|0
7634672|NCT01643850|26562662|P4|Overall Study|Lost to Follow-up|0
7634673|NCT01643850|26562663|P3|Overall Study|Lost to Follow-up|0
7634674|NCT01643850|26562664|P2|Overall Study|Lost to Follow-up|0
7634675|NCT01643850|26562665|P1|Overall Study|Lost to Follow-up|0
7634676|NCT01643850|26562657|P9|Overall Study|Withdrawal by Subject|0
7634677|NCT01643850|26562658|P8|Overall Study|Withdrawal by Subject|0
7634678|NCT01643850|26562659|P7|Overall Study|Withdrawal by Subject|0
7634679|NCT01643850|26562660|P6|Overall Study|Withdrawal by Subject|0
7634680|NCT01643850|26562661|P5|Overall Study|Withdrawal by Subject|1
7634681|NCT01643850|26562662|P4|Overall Study|Withdrawal by Subject|0
7634682|NCT01643850|26562663|P3|Overall Study|Withdrawal by Subject|0
7634683|NCT01643850|26562664|P2|Overall Study|Withdrawal by Subject|0
7634684|NCT01643850|26562665|P1|Overall Study|Withdrawal by Subject|0
7634685|NCT01643798|26562804|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
7634686|NCT01643798|26562805|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
7634687|NCT01643772|26562820|P4|Overall Study|Adverse Event|1
7634688|NCT01643772|26562821|P3|Overall Study|Adverse Event|0
7634689|NCT01643772|26562822|P2|Overall Study|Adverse Event|0
7634690|NCT01643772|26562823|P1|Overall Study|Adverse Event|0
7634691|NCT01643772|26562820|P4|Overall Study|Protocol Violation|1
7634692|NCT01643772|26562821|P3|Overall Study|Protocol Violation|0
7634693|NCT01643772|26562822|P2|Overall Study|Protocol Violation|0
7634694|NCT01643772|26562823|P1|Overall Study|Protocol Violation|0
7634695|NCT01643668|26562882|P1|Overall Study|Death|1
7634696|NCT01643473|26562913|P2|Overall Study|Lost to Follow-up|0
7634697|NCT01643473|26562914|P1|Overall Study|Lost to Follow-up|1
7634698|NCT01643408|26562926|P1|Overall Study|Other|2
7634699|NCT01643408|26562926|P1|Overall Study|Adverse Event|12
7634700|NCT01643044|26562954|P2|Overall Study|Delivered outside of hospital|2
7634701|NCT01643044|26562955|P1|Overall Study|Delivered outside of hospital|1
7634702|NCT01643044|26562954|P2|Overall Study|Miscarried baby|2
7634703|NCT01643044|26562955|P1|Overall Study|Miscarried baby|2
7634704|NCT01643044|26562954|P2|Overall Study|Lost to Follow-up|1
7634705|NCT01643044|26562955|P1|Overall Study|Lost to Follow-up|1
7634706|NCT01642914|26562964|P3|Overall Study|Other Reason|0
7634707|NCT01642914|26562965|P2|Overall Study|Other Reason|0
7634708|NCT01642914|26562966|P1|Overall Study|Other Reason|1
7634709|NCT01642914|26562964|P3|Overall Study|Lost to Follow-up|7
7634710|NCT01642914|26562965|P2|Overall Study|Lost to Follow-up|3
7634711|NCT01642914|26562966|P1|Overall Study|Lost to Follow-up|5
7634712|NCT01642914|26562964|P3|Overall Study|Withdrawal by Subject|10
7634713|NCT01642914|26562965|P2|Overall Study|Withdrawal by Subject|5
7634714|NCT01642914|26562966|P1|Overall Study|Withdrawal by Subject|5
7634715|NCT01642914|26562964|P3|Overall Study|Protocol Violation|6
7634716|NCT01642914|26562965|P2|Overall Study|Protocol Violation|13
7634717|NCT01642914|26562966|P1|Overall Study|Protocol Violation|15
7634718|NCT01642914|26562964|P3|Overall Study|Lack of Efficacy|2
7634719|NCT01642914|26562965|P2|Overall Study|Lack of Efficacy|4
7634720|NCT01642914|26562966|P1|Overall Study|Lack of Efficacy|9
7634721|NCT01642914|26562964|P3|Overall Study|Adverse Event|15
7634722|NCT01642914|26562965|P2|Overall Study|Adverse Event|7
7634723|NCT01642914|26562966|P1|Overall Study|Adverse Event|11
7634724|NCT01642732|26563041|P1|Overall Study|Withdrawal by Subject|1
7634725|NCT01642615|26563046|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
7634726|NCT01642615|26563047|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7634727|NCT01642615|26563048|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7634728|NCT01642615|26563046|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7634729|NCT01642615|26563047|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
7634730|NCT01642615|26563048|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7634731|NCT01642615|26563046|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
7634732|NCT01642615|26563047|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
7634733|NCT01642615|26563048|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
7634734|NCT01642615|26563046|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
7634735|NCT01642615|26563047|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
7634736|NCT01642615|26563048|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
7634737|NCT01642615|26563046|P3|Open Label Maintenance Phase|Did not receive treatment|0
7634738|NCT01642615|26563047|P2|Open Label Maintenance Phase|Did not receive treatment|0
7634739|NCT01642615|26563048|P1|Open Label Maintenance Phase|Did not receive treatment|1
7634740|NCT01642615|26563046|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
7634741|NCT01642615|26563047|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
7634742|NCT01642615|26563048|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
7634743|NCT01642615|26563046|P3|Open Label Maintenance Phase|Lost to Follow-up|0
7634744|NCT01642615|26563047|P2|Open Label Maintenance Phase|Lost to Follow-up|0
7634745|NCT01642615|26563048|P1|Open Label Maintenance Phase|Lost to Follow-up|1
7634746|NCT01642615|26563046|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
7634747|NCT01642615|26563047|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
7634748|NCT01642615|26563048|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
7634749|NCT01642615|26563046|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7634750|NCT01642615|26563047|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7634751|NCT01642615|26563048|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
7634752|NCT01642602|26563062|P1|Overall Study|Adverse Event|2
7634753|NCT01642589|26563069|P2|Overall Study|Withdrawal by Subject|1
7634754|NCT01642589|26563070|P1|Overall Study|Withdrawal by Subject|1
7634755|NCT01642407|26563109|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
7634756|NCT01642407|26563109|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
7634757|NCT01642407|26563109|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
7634758|NCT01642277|26563156|P2|Overall Study|Withdrawal by Subject|0
7634759|NCT01642277|26563157|P1|Overall Study|Withdrawal by Subject|11
7634760|NCT01642277|26563156|P2|Overall Study|Protocol Violation|0
7634761|NCT01642277|26563157|P1|Overall Study|Protocol Violation|1
7634762|NCT01642277|26563156|P2|Overall Study|Physician Decision|0
7634763|NCT01642277|26563157|P1|Overall Study|Physician Decision|2
7634764|NCT01642277|26563156|P2|Overall Study|Adverse Event|0
7634765|NCT01642277|26563157|P1|Overall Study|Adverse Event|10
7634766|NCT01642251|26563169|P4|Overall Study|Ineligible/never start protocol therapy|8
7634767|NCT01642251|26563170|P3|Overall Study|Ineligible/never start protocol therapy|11
7634768|NCT01642251|26563171|P2|Overall Study|Ineligible/never start protocol therapy|0
7634769|NCT01642251|26563172|P1|Overall Study|Ineligible/never start protocol therapy|0
7634770|NCT01642251|26563169|P4|Overall Study|Other complicating disease|0
7634771|NCT01642251|26563170|P3|Overall Study|Other complicating disease|1
7634772|NCT01642251|26563171|P2|Overall Study|Other complicating disease|0
7634773|NCT01642251|26563172|P1|Overall Study|Other complicating disease|0
7634774|NCT01642251|26563169|P4|Overall Study|Alternative therapy|2
7634775|NCT01642251|26563170|P3|Overall Study|Alternative therapy|0
7634776|NCT01642251|26563171|P2|Overall Study|Alternative therapy|0
7634777|NCT01642251|26563172|P1|Overall Study|Alternative therapy|0
7634778|NCT01642251|26563169|P4|Overall Study|Withdrawal by Subject|3
7634779|NCT01642251|26563170|P3|Overall Study|Withdrawal by Subject|1
7634780|NCT01642251|26563171|P2|Overall Study|Withdrawal by Subject|0
7634781|NCT01642251|26563172|P1|Overall Study|Withdrawal by Subject|0
7634782|NCT01642251|26563169|P4|Overall Study|Death|3
7634783|NCT01642251|26563170|P3|Overall Study|Death|1
7634784|NCT01642251|26563171|P2|Overall Study|Death|0
7634785|NCT01642251|26563172|P1|Overall Study|Death|0
7634786|NCT01642251|26563169|P4|Overall Study|Adverse Event|4
7634787|NCT01642251|26563170|P3|Overall Study|Adverse Event|5
7634788|NCT01642251|26563171|P2|Overall Study|Adverse Event|0
7634789|NCT01642251|26563172|P1|Overall Study|Adverse Event|0
7634790|NCT01642251|26563169|P4|Overall Study|Progressive disease|3
7634791|NCT01642251|26563170|P3|Overall Study|Progressive disease|3
7634792|NCT01642251|26563171|P2|Overall Study|Progressive disease|0
7634793|NCT01642251|26563172|P1|Overall Study|Progressive disease|0
7634794|NCT01642212|26563210|P5|Open-label Extension|Other|1
7634795|NCT01642212|26563211|P4|Open-label Extension|Other|0
7634796|NCT01642212|26563212|P3|Open-label Extension|Other|0
7634797|NCT01642212|26563213|P2|Open-label Extension|Other|0
7634798|NCT01642212|26563214|P1|Open-label Extension|Other|0
7634799|NCT01642212|26563210|P5|Open-label Extension|Lost to Follow-up|1
7634800|NCT01642212|26563211|P4|Open-label Extension|Lost to Follow-up|0
7634801|NCT01642212|26563212|P3|Open-label Extension|Lost to Follow-up|0
7634802|NCT01642212|26563213|P2|Open-label Extension|Lost to Follow-up|0
7634803|NCT01642212|26563214|P1|Open-label Extension|Lost to Follow-up|0
7634804|NCT01642212|26563210|P5|Open-label Extension|Consent Withdrawn|2
7634805|NCT01642212|26563211|P4|Open-label Extension|Consent Withdrawn|0
7634806|NCT01642212|26563212|P3|Open-label Extension|Consent Withdrawn|0
7634807|NCT01642212|26563213|P2|Open-label Extension|Consent Withdrawn|0
7634808|NCT01642212|26563214|P1|Open-label Extension|Consent Withdrawn|0
7634809|NCT01642212|26563210|P5|Open-label Extension|Sponsor Decision|4
7634810|NCT01642212|26563211|P4|Open-label Extension|Sponsor Decision|7
7634811|NCT01642212|26563212|P3|Open-label Extension|Sponsor Decision|0
7634812|NCT01642212|26563213|P2|Open-label Extension|Sponsor Decision|0
7634813|NCT01642212|26563214|P1|Open-label Extension|Sponsor Decision|0
7634814|NCT01642212|26563210|P5|Open-label Extension|Adverse Event|0
7634815|NCT01642212|26563211|P4|Open-label Extension|Adverse Event|3
7634816|NCT01642212|26563212|P3|Open-label Extension|Adverse Event|0
7634817|NCT01642212|26563213|P2|Open-label Extension|Adverse Event|0
7634818|NCT01642212|26563214|P1|Open-label Extension|Adverse Event|0
7634819|NCT01642212|26563210|P5|Double-blind Treatment|Adverse Event|0
7634820|NCT01642212|26563211|P4|Double-blind Treatment|Adverse Event|0
7634821|NCT01642212|26563212|P3|Double-blind Treatment|Adverse Event|1
7634822|NCT01642212|26563213|P2|Double-blind Treatment|Adverse Event|0
7634823|NCT01642212|26563214|P1|Double-blind Treatment|Adverse Event|0
7634824|NCT01642212|26563210|P5|Double-blind Treatment|Non-compliance|0
7634825|NCT01642212|26563211|P4|Double-blind Treatment|Non-compliance|0
7634826|NCT01642212|26563212|P3|Double-blind Treatment|Non-compliance|0
7634827|NCT01642212|26563213|P2|Double-blind Treatment|Non-compliance|1
7634828|NCT01642212|26563214|P1|Double-blind Treatment|Non-compliance|0
7634829|NCT01642212|26563210|P5|Double-blind Treatment|Other|0
7634830|NCT01642212|26563211|P4|Double-blind Treatment|Other|0
7634831|NCT01642212|26563212|P3|Double-blind Treatment|Other|1
7634832|NCT01642212|26563213|P2|Double-blind Treatment|Other|2
7634833|NCT01642212|26563214|P1|Double-blind Treatment|Other|0
7634834|NCT01642212|26563210|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7634835|NCT01642212|26563211|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7634836|NCT01642212|26563212|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7634837|NCT01642212|26563213|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7634838|NCT01642212|26563214|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
7634839|NCT01642004|26563324|P2|Treatment|Missing from data|1
7634840|NCT01642004|26563325|P1|Treatment|Missing from data|0
7634841|NCT01642004|26563324|P2|Treatment|Other|2
7634842|NCT01642004|26563325|P1|Treatment|Other|1
7634843|NCT01642004|26563324|P2|Treatment|No longer meets study criteria|2
7634844|NCT01642004|26563325|P1|Treatment|No longer meets study criteria|1
7634845|NCT01642004|26563324|P2|Treatment|Poor/non-compliance|0
7634846|NCT01642004|26563325|P1|Treatment|Poor/non-compliance|1
7634847|NCT01642004|26563324|P2|Treatment|Maximum clinical benefit|7
7634848|NCT01642004|26563325|P1|Treatment|Maximum clinical benefit|2
7634849|NCT01642004|26563324|P2|Treatment|Withdrawal by Subject|9
7634850|NCT01642004|26563325|P1|Treatment|Withdrawal by Subject|5
7634851|NCT01642004|26563324|P2|Treatment|Adverse event unrelated to study drug|13
7634852|NCT01642004|26563325|P1|Treatment|Adverse event unrelated to study drug|6
7634853|NCT01642004|26563324|P2|Treatment|Death|0
7634854|NCT01642004|26563325|P1|Treatment|Death|1
7634855|NCT01642004|26563324|P2|Treatment|Study drug toxicity|13
7634856|NCT01642004|26563325|P1|Treatment|Study drug toxicity|5
7634857|NCT01642004|26563324|P2|Treatment|Disease progression|80
7634858|NCT01642004|26563325|P1|Treatment|Disease progression|88
7634859|NCT01642004|26563324|P2|Randomization|No longer meets study criteria|2
7634860|NCT01642004|26563325|P1|Randomization|No longer meets study criteria|2
7634861|NCT01642004|26563324|P2|Randomization|Withdrawal by Subject|6
7634862|NCT01642004|26563325|P1|Randomization|Withdrawal by Subject|1
7634863|NCT01642004|26563324|P2|Randomization|Adverse Event unrelated to study drug|0
7634864|NCT01642004|26563325|P1|Randomization|Adverse Event unrelated to study drug|1
7634865|NCT01641991|26563359|P4|Overall Study|no longer eligible|4
7634866|NCT01641991|26563360|P3|Overall Study|no longer eligible|0
7634867|NCT01641991|26563361|P2|Overall Study|no longer eligible|1
7634868|NCT01641991|26563362|P1|Overall Study|no longer eligible|2
7634869|NCT01641991|26563359|P4|Overall Study|Pregnancy|0
7634870|NCT01641991|26563360|P3|Overall Study|Pregnancy|1
7634871|NCT01641991|26563361|P2|Overall Study|Pregnancy|0
7634872|NCT01641991|26563362|P1|Overall Study|Pregnancy|0
7634873|NCT01641991|26563359|P4|Overall Study|Protocol Violation|0
7634874|NCT01641991|26563360|P3|Overall Study|Protocol Violation|3
7634875|NCT01641991|26563361|P2|Overall Study|Protocol Violation|1
7634876|NCT01641991|26563362|P1|Overall Study|Protocol Violation|1
7634877|NCT01641991|26563359|P4|Overall Study|Lost to Follow-up|1
7634878|NCT01641991|26563360|P3|Overall Study|Lost to Follow-up|3
7634879|NCT01641991|26563361|P2|Overall Study|Lost to Follow-up|2
7634880|NCT01641991|26563362|P1|Overall Study|Lost to Follow-up|0
7634881|NCT01641991|26563359|P4|Overall Study|Adverse Event|1
7634882|NCT01641991|26563360|P3|Overall Study|Adverse Event|2
7634883|NCT01641991|26563361|P2|Overall Study|Adverse Event|1
7634884|NCT01641991|26563362|P1|Overall Study|Adverse Event|2
7634885|NCT01641991|26563359|P4|Overall Study|Withdrawal by Subject|5
7634886|NCT01641991|26563360|P3|Overall Study|Withdrawal by Subject|1
7634887|NCT01641991|26563361|P2|Overall Study|Withdrawal by Subject|2
7634888|NCT01641991|26563362|P1|Overall Study|Withdrawal by Subject|4
7634889|NCT01641991|26563359|P4|Overall Study|Physician Decision|5
7634890|NCT01641991|26563360|P3|Overall Study|Physician Decision|7
7634891|NCT01641991|26563361|P2|Overall Study|Physician Decision|1
7634892|NCT01641991|26563362|P1|Overall Study|Physician Decision|0
7634893|NCT01641952|26563446|P1|Overall Study|Adverse Event|6
7634894|NCT01641952|26563446|P1|Overall Study|Lost to Follow-up|28
7634895|NCT01641939|26563462|P3|Overall Study|Study Terminated by Sponsor|3
7634896|NCT01641939|26563463|P2|Overall Study|Study Terminated by Sponsor|28
7634897|NCT01641939|26563464|P1|Overall Study|Study Terminated by Sponsor|10
7634898|NCT01641939|26563462|P3|Overall Study|Withdrawal by Subject|5
7634899|NCT01641939|26563463|P2|Overall Study|Withdrawal by Subject|11
7634900|NCT01641939|26563464|P1|Overall Study|Withdrawal by Subject|14
7634901|NCT01641939|26563462|P3|Overall Study|Lost to Follow-up|1
7634902|NCT01641939|26563463|P2|Overall Study|Lost to Follow-up|2
7634903|NCT01641939|26563464|P1|Overall Study|Lost to Follow-up|3
7634904|NCT01641939|26563462|P3|Overall Study|Death|61
7634905|NCT01641939|26563463|P2|Overall Study|Death|187
7634906|NCT01641939|26563464|P1|Overall Study|Death|90
7634907|NCT01641926|26563507|P4|Overall Study|Not Treated|0
7634908|NCT01641926|26563508|P3|Overall Study|Not Treated|1
7634909|NCT01641926|26563509|P2|Overall Study|Not Treated|1
7634910|NCT01641926|26563510|P1|Overall Study|Not Treated|1
7634911|NCT01641926|26563507|P4|Overall Study|Withdrawal by Subject|1
7634912|NCT01641926|26563508|P3|Overall Study|Withdrawal by Subject|6
7634913|NCT01641926|26563509|P2|Overall Study|Withdrawal by Subject|5
7634914|NCT01641926|26563510|P1|Overall Study|Withdrawal by Subject|13
7634915|NCT01641926|26563507|P4|Overall Study|Protocol Violation|1
7634916|NCT01641926|26563508|P3|Overall Study|Protocol Violation|0
7634917|NCT01641926|26563509|P2|Overall Study|Protocol Violation|0
7634918|NCT01641926|26563510|P1|Overall Study|Protocol Violation|1
7634919|NCT01641926|26563507|P4|Overall Study|Physician Decision|1
7634920|NCT01641926|26563508|P3|Overall Study|Physician Decision|0
7634921|NCT01641926|26563509|P2|Overall Study|Physician Decision|5
7634922|NCT01641926|26563510|P1|Overall Study|Physician Decision|6
7634923|NCT01641926|26563507|P4|Overall Study|Lost to Follow-up|0
7634924|NCT01641926|26563508|P3|Overall Study|Lost to Follow-up|1
7634925|NCT01641926|26563509|P2|Overall Study|Lost to Follow-up|2
7634926|NCT01641926|26563510|P1|Overall Study|Lost to Follow-up|2
7634927|NCT01641926|26563507|P4|Overall Study|Adverse Event|1
7634928|NCT01641926|26563508|P3|Overall Study|Adverse Event|3
7634929|NCT01641926|26563509|P2|Overall Study|Adverse Event|2
7634930|NCT01641926|26563510|P1|Overall Study|Adverse Event|5
7634931|NCT01641900|26563538|P2|Overall Study|Withdrawal by Subject|2
7634932|NCT01641900|26563539|P1|Overall Study|Withdrawal by Subject|2
7634933|NCT01641861|26563551|P2|Overall Study|Died due to drowning|1
7634934|NCT01641861|26563552|P1|Overall Study|Died due to drowning|0
7634935|NCT01641861|26563551|P2|Overall Study|Lost the tooth due to normal exfoliation|8
7634936|NCT01641861|26563552|P1|Overall Study|Lost the tooth due to normal exfoliation|14
7634937|NCT01641861|26563551|P2|Overall Study|Lost to Follow-up|16
7634938|NCT01641861|26563552|P1|Overall Study|Lost to Follow-up|21
7634939|NCT01641822|26563573|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
7634940|NCT01641822|26563574|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
7634941|NCT01641822|26563575|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
7634942|NCT01641822|26563573|P3|Comparative Phase|Withdrew consent|7
7634943|NCT01641822|26563574|P2|Comparative Phase|Withdrew consent|3
7634944|NCT01641822|26563575|P1|Comparative Phase|Withdrew consent|0
7634945|NCT01641822|26563573|P3|Comparative Phase|Adverse event, serious fatal|0
7634946|NCT01641822|26563574|P2|Comparative Phase|Adverse event, serious fatal|1
7634947|NCT01641822|26563575|P1|Comparative Phase|Adverse event, serious fatal|0
7634948|NCT01641822|26563573|P3|Comparative Phase|Pregnancy|1
7634949|NCT01641822|26563574|P2|Comparative Phase|Pregnancy|0
7634950|NCT01641822|26563575|P1|Comparative Phase|Pregnancy|0
7634951|NCT01641822|26563573|P3|Comparative Phase|Investigator's discretion|1
7634952|NCT01641822|26563574|P2|Comparative Phase|Investigator's discretion|0
7634953|NCT01641822|26563575|P1|Comparative Phase|Investigator's discretion|0
7634954|NCT01641822|26563573|P3|Comparative Phase|Noncompliance with study drug|0
7634955|NCT01641822|26563574|P2|Comparative Phase|Noncompliance with study drug|1
7634956|NCT01641822|26563575|P1|Comparative Phase|Noncompliance with study drug|0
7634957|NCT01641822|26563573|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
7634958|NCT01641822|26563574|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
7634959|NCT01641822|26563575|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
7634960|NCT01641822|26563573|P3|Run-in Phase|Withdrew consent|0
7634961|NCT01641822|26563574|P2|Run-in Phase|Withdrew consent|0
7634962|NCT01641822|26563575|P1|Run-in Phase|Withdrew consent|1
7634963|NCT01641822|26563573|P3|Run-in Phase|Adverse Event|0
7634964|NCT01641822|26563574|P2|Run-in Phase|Adverse Event|0
7634965|NCT01641822|26563575|P1|Run-in Phase|Adverse Event|3
7634966|NCT01641822|26563573|P3|Run-in Phase|Noncompliance with study drug|0
7634967|NCT01641822|26563574|P2|Run-in Phase|Noncompliance with study drug|0
7634968|NCT01641822|26563575|P1|Run-in Phase|Noncompliance with study drug|1
7634969|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
7634970|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
7634971|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
7634972|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
7634973|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7634974|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7634975|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
7634976|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
7634977|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
7634978|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
7634979|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
7634980|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
7634981|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Site closed|0
7634982|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Site closed|0
7634983|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Site closed|0
7634984|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Site closed|1
7634985|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
7634986|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7634987|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
7634988|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7634989|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
7634990|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
7634991|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
7634992|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
7634993|NCT01641809|26563596|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
7634994|NCT01641809|26563597|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
7634995|NCT01641809|26563598|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
7634996|NCT01641809|26563599|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
7634997|NCT01641809|26563596|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
7634998|NCT01641809|26563597|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7634999|NCT01641809|26563598|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
7635000|NCT01641809|26563599|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7635001|NCT01641809|26563596|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
7635002|NCT01641809|26563597|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
7635003|NCT01641809|26563598|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7635004|NCT01641809|26563599|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7635005|NCT01641809|26563596|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7635006|NCT01641809|26563597|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
7635007|NCT01641809|26563598|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
7635008|NCT01641809|26563599|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7635009|NCT01641809|26563596|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7635010|NCT01641809|26563597|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7635011|NCT01641809|26563598|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
7635012|NCT01641809|26563599|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7635013|NCT01641809|26563596|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
7635014|NCT01641809|26563597|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
7635015|NCT01641809|26563598|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
7635016|NCT01641809|26563599|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
7635017|NCT01641809|26563596|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
7635018|NCT01641809|26563597|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
7635019|NCT01641809|26563598|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
7635020|NCT01641809|26563599|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
7635021|NCT01641809|26563596|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
7635022|NCT01641809|26563597|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
7635023|NCT01641809|26563598|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
7635024|NCT01641809|26563599|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
7635025|NCT01641809|26563596|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
7635026|NCT01641809|26563597|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7635027|NCT01641809|26563598|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7635028|NCT01641809|26563599|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
7635029|NCT01641809|26563596|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
7635030|NCT01641809|26563597|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
7635031|NCT01641809|26563598|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
7635032|NCT01641809|26563599|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
7635033|NCT01641809|26563596|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7635034|NCT01641809|26563597|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7635035|NCT01641809|26563598|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7635036|NCT01641809|26563599|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7635037|NCT01641809|26563596|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7635038|NCT01641809|26563597|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
7635039|NCT01641809|26563598|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7635040|NCT01641809|26563599|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7635041|NCT01641692|26563783|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7635042|NCT01641692|26563784|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7635043|NCT01641692|26563785|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7635044|NCT01641692|26563786|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7635045|NCT01641692|26563787|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7635046|NCT01641692|26563788|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7635047|NCT01641692|26563789|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7635048|NCT01641692|26563790|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7635049|NCT01641692|26563783|P8|Washout Period 3 or Follow-up|Protocol Violation|0
7635050|NCT01641692|26563784|P7|Washout Period 3 or Follow-up|Protocol Violation|0
7635051|NCT01641692|26563785|P6|Washout Period 3 or Follow-up|Protocol Violation|1
7635052|NCT01641692|26563786|P5|Washout Period 3 or Follow-up|Protocol Violation|0
7635053|NCT01641692|26563787|P4|Washout Period 3 or Follow-up|Protocol Violation|0
7635054|NCT01641692|26563788|P3|Washout Period 3 or Follow-up|Protocol Violation|0
7635055|NCT01641692|26563789|P2|Washout Period 3 or Follow-up|Protocol Violation|0
7635056|NCT01641692|26563790|P1|Washout Period 3 or Follow-up|Protocol Violation|0
7635057|NCT01641692|26563783|P8|Treatment Period 3|Lost to Follow-up|0
7635058|NCT01641692|26563784|P7|Treatment Period 3|Lost to Follow-up|0
7635059|NCT01641692|26563785|P6|Treatment Period 3|Lost to Follow-up|0
7635060|NCT01641692|26563786|P5|Treatment Period 3|Lost to Follow-up|0
7635061|NCT01641692|26563787|P4|Treatment Period 3|Lost to Follow-up|0
7635062|NCT01641692|26563788|P3|Treatment Period 3|Lost to Follow-up|0
7635063|NCT01641692|26563789|P2|Treatment Period 3|Lost to Follow-up|1
7635064|NCT01641692|26563790|P1|Treatment Period 3|Lost to Follow-up|0
7635065|NCT01641692|26563783|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635066|NCT01641692|26563784|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
7635067|NCT01641692|26563785|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635068|NCT01641692|26563786|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635069|NCT01641692|26563787|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635070|NCT01641692|26563788|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635071|NCT01641692|26563789|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635072|NCT01641692|26563790|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
7635073|NCT01641692|26563783|P8|Treatment Period 3|Protocol Violation|0
7635074|NCT01641692|26563784|P7|Treatment Period 3|Protocol Violation|0
7635075|NCT01641692|26563785|P6|Treatment Period 3|Protocol Violation|0
7635076|NCT01641692|26563786|P5|Treatment Period 3|Protocol Violation|0
7635077|NCT01641692|26563787|P4|Treatment Period 3|Protocol Violation|0
7635078|NCT01641692|26563788|P3|Treatment Period 3|Protocol Violation|1
7635079|NCT01641692|26563789|P2|Treatment Period 3|Protocol Violation|0
7635080|NCT01641692|26563790|P1|Treatment Period 3|Protocol Violation|0
7635081|NCT01641692|26563783|P8|Treatment Period 3|Adverse Event|0
7635082|NCT01641692|26563784|P7|Treatment Period 3|Adverse Event|1
7635083|NCT01641692|26563785|P6|Treatment Period 3|Adverse Event|0
7635084|NCT01641692|26563786|P5|Treatment Period 3|Adverse Event|0
7635085|NCT01641692|26563787|P4|Treatment Period 3|Adverse Event|0
7635086|NCT01641692|26563788|P3|Treatment Period 3|Adverse Event|0
7635087|NCT01641692|26563789|P2|Treatment Period 3|Adverse Event|0
7635088|NCT01641692|26563790|P1|Treatment Period 3|Adverse Event|0
7635089|NCT01641692|26563783|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7635090|NCT01641692|26563784|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7635091|NCT01641692|26563785|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7635092|NCT01641692|26563786|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7635093|NCT01641692|26563787|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7635094|NCT01641692|26563788|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7635095|NCT01641692|26563789|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7635096|NCT01641692|26563790|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7635097|NCT01641692|26563783|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635098|NCT01641692|26563784|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
7635099|NCT01641692|26563785|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635100|NCT01641692|26563786|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
7635101|NCT01641692|26563787|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635102|NCT01641692|26563788|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635103|NCT01641692|26563789|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635104|NCT01641692|26563790|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635105|NCT01641692|26563783|P8|Treatment Period 2|Withdrawal by Subject|1
7635106|NCT01641692|26563784|P7|Treatment Period 2|Withdrawal by Subject|0
7635107|NCT01641692|26563785|P6|Treatment Period 2|Withdrawal by Subject|1
7635108|NCT01641692|26563786|P5|Treatment Period 2|Withdrawal by Subject|0
7635109|NCT01641692|26563787|P4|Treatment Period 2|Withdrawal by Subject|0
7635110|NCT01641692|26563788|P3|Treatment Period 2|Withdrawal by Subject|0
7635111|NCT01641692|26563789|P2|Treatment Period 2|Withdrawal by Subject|0
7635112|NCT01641692|26563790|P1|Treatment Period 2|Withdrawal by Subject|1
7635113|NCT01641692|26563783|P8|Treatment Period 2|Lost to Follow-up|0
7635114|NCT01641692|26563784|P7|Treatment Period 2|Lost to Follow-up|0
7635115|NCT01641692|26563785|P6|Treatment Period 2|Lost to Follow-up|1
7635116|NCT01641692|26563786|P5|Treatment Period 2|Lost to Follow-up|0
7635117|NCT01641692|26563787|P4|Treatment Period 2|Lost to Follow-up|0
7635118|NCT01641692|26563788|P3|Treatment Period 2|Lost to Follow-up|0
7635119|NCT01641692|26563789|P2|Treatment Period 2|Lost to Follow-up|0
7635120|NCT01641692|26563790|P1|Treatment Period 2|Lost to Follow-up|0
7635121|NCT01641692|26563783|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635122|NCT01641692|26563784|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635123|NCT01641692|26563785|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635124|NCT01641692|26563786|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635125|NCT01641692|26563787|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635126|NCT01641692|26563788|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635127|NCT01641692|26563789|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
7635128|NCT01641692|26563790|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
7635129|NCT01641692|26563783|P8|Treatment Period 2|Lack of Efficacy|0
7635130|NCT01641692|26563784|P7|Treatment Period 2|Lack of Efficacy|0
7635131|NCT01641692|26563785|P6|Treatment Period 2|Lack of Efficacy|0
7635132|NCT01641692|26563786|P5|Treatment Period 2|Lack of Efficacy|0
7635133|NCT01641692|26563787|P4|Treatment Period 2|Lack of Efficacy|0
7635134|NCT01641692|26563788|P3|Treatment Period 2|Lack of Efficacy|0
7635135|NCT01641692|26563789|P2|Treatment Period 2|Lack of Efficacy|0
7635136|NCT01641692|26563790|P1|Treatment Period 2|Lack of Efficacy|1
7635137|NCT01641692|26563783|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7635138|NCT01641692|26563784|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7635139|NCT01641692|26563785|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7635140|NCT01641692|26563786|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7635141|NCT01641692|26563787|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7635142|NCT01641692|26563788|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7635143|NCT01641692|26563789|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7635144|NCT01641692|26563790|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7635145|NCT01641692|26563783|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7635146|NCT01641692|26563784|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635147|NCT01641692|26563785|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635148|NCT01641692|26563786|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7635149|NCT01641692|26563787|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7635150|NCT01641692|26563788|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7635151|NCT01641692|26563789|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7635152|NCT01641692|26563790|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7635153|NCT01641692|26563783|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635154|NCT01641692|26563784|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
7635237|NCT01641471|26564013|P1|Overall Study|Withdrawal by Subject|19
7635155|NCT01641692|26563785|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635156|NCT01641692|26563786|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635157|NCT01641692|26563787|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635158|NCT01641692|26563788|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635159|NCT01641692|26563789|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635160|NCT01641692|26563790|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
7635161|NCT01641692|26563783|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
7635162|NCT01641692|26563784|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
7635163|NCT01641692|26563785|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
7635164|NCT01641692|26563786|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
7635165|NCT01641692|26563787|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
7635166|NCT01641692|26563788|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
7635167|NCT01641692|26563789|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
7635168|NCT01641692|26563790|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
7635169|NCT01641692|26563783|P8|Treatment Period 1|Withdrawal by Subject|1
7635170|NCT01641692|26563784|P7|Treatment Period 1|Withdrawal by Subject|0
7635171|NCT01641692|26563785|P6|Treatment Period 1|Withdrawal by Subject|2
7635172|NCT01641692|26563786|P5|Treatment Period 1|Withdrawal by Subject|0
7635173|NCT01641692|26563787|P4|Treatment Period 1|Withdrawal by Subject|0
7635174|NCT01641692|26563788|P3|Treatment Period 1|Withdrawal by Subject|0
7635175|NCT01641692|26563789|P2|Treatment Period 1|Withdrawal by Subject|0
7635176|NCT01641692|26563790|P1|Treatment Period 1|Withdrawal by Subject|0
7635177|NCT01641692|26563783|P8|Treatment Period 1|Physician Decision|0
7635178|NCT01641692|26563784|P7|Treatment Period 1|Physician Decision|0
7635179|NCT01641692|26563785|P6|Treatment Period 1|Physician Decision|0
7635180|NCT01641692|26563786|P5|Treatment Period 1|Physician Decision|1
7635181|NCT01641692|26563787|P4|Treatment Period 1|Physician Decision|0
7635182|NCT01641692|26563788|P3|Treatment Period 1|Physician Decision|0
7635183|NCT01641692|26563789|P2|Treatment Period 1|Physician Decision|0
7635184|NCT01641692|26563790|P1|Treatment Period 1|Physician Decision|0
7635185|NCT01641692|26563783|P8|Treatment Period 1|Lost to Follow-up|0
7635186|NCT01641692|26563784|P7|Treatment Period 1|Lost to Follow-up|0
7635187|NCT01641692|26563785|P6|Treatment Period 1|Lost to Follow-up|0
7635188|NCT01641692|26563786|P5|Treatment Period 1|Lost to Follow-up|0
7635189|NCT01641692|26563787|P4|Treatment Period 1|Lost to Follow-up|0
7635190|NCT01641692|26563788|P3|Treatment Period 1|Lost to Follow-up|1
7635191|NCT01641692|26563789|P2|Treatment Period 1|Lost to Follow-up|0
7635192|NCT01641692|26563790|P1|Treatment Period 1|Lost to Follow-up|0
7635193|NCT01641692|26563783|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
7635194|NCT01641692|26563784|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
7635195|NCT01641692|26563785|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
7635196|NCT01641692|26563786|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
7635197|NCT01641692|26563787|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
7635198|NCT01641692|26563788|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
7635199|NCT01641692|26563789|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
7635200|NCT01641692|26563790|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
7635201|NCT01641692|26563783|P8|Treatment Period 1|Protocol Violation|0
7635202|NCT01641692|26563784|P7|Treatment Period 1|Protocol Violation|0
7635203|NCT01641692|26563785|P6|Treatment Period 1|Protocol Violation|0
7635204|NCT01641692|26563786|P5|Treatment Period 1|Protocol Violation|2
7635205|NCT01641692|26563787|P4|Treatment Period 1|Protocol Violation|0
7635206|NCT01641692|26563788|P3|Treatment Period 1|Protocol Violation|0
7635207|NCT01641692|26563789|P2|Treatment Period 1|Protocol Violation|0
7635208|NCT01641692|26563790|P1|Treatment Period 1|Protocol Violation|1
7635209|NCT01641692|26563783|P8|Treatment Period 1|Lack of Efficacy|1
7635210|NCT01641692|26563784|P7|Treatment Period 1|Lack of Efficacy|0
7635211|NCT01641692|26563785|P6|Treatment Period 1|Lack of Efficacy|0
7635212|NCT01641692|26563786|P5|Treatment Period 1|Lack of Efficacy|0
7635213|NCT01641692|26563787|P4|Treatment Period 1|Lack of Efficacy|0
7635214|NCT01641692|26563788|P3|Treatment Period 1|Lack of Efficacy|0
7635215|NCT01641692|26563789|P2|Treatment Period 1|Lack of Efficacy|0
7635216|NCT01641692|26563790|P1|Treatment Period 1|Lack of Efficacy|0
7635217|NCT01641692|26563783|P8|Treatment Period 1|Adverse Event|0
7635218|NCT01641692|26563784|P7|Treatment Period 1|Adverse Event|0
7635219|NCT01641692|26563785|P6|Treatment Period 1|Adverse Event|0
7635220|NCT01641692|26563786|P5|Treatment Period 1|Adverse Event|0
7635221|NCT01641692|26563787|P4|Treatment Period 1|Adverse Event|0
7635222|NCT01641692|26563788|P3|Treatment Period 1|Adverse Event|0
7635223|NCT01641692|26563789|P2|Treatment Period 1|Adverse Event|0
7635224|NCT01641692|26563790|P1|Treatment Period 1|Adverse Event|1
7635225|NCT01641640|26563990|P1|Overall Study|Adverse Event|1
7635226|NCT01641640|26563990|P1|Overall Study|Withdrawal by Subject|2
7635227|NCT01641640|26563990|P1|Overall Study|Lost to Follow-up|3
7635228|NCT01641640|26563990|P1|Overall Study|Efficacy failure|29
7635229|NCT01641640|26563990|P1|Overall Study|Enrolled but not treated|1
7635230|NCT01641601|26564001|P2|Overall Study|Study discontinued.|5
7635231|NCT01641601|26564002|P1|Overall Study|Study discontinued.|3
7635232|NCT01641471|26564012|P2|Overall Study|Protocol Violation|4
7635233|NCT01641471|26564013|P1|Overall Study|Protocol Violation|2
7635234|NCT01641471|26564012|P2|Overall Study|Lost to Follow-up|4
7635235|NCT01641471|26564013|P1|Overall Study|Lost to Follow-up|2
7635236|NCT01641471|26564012|P2|Overall Study|Withdrawal by Subject|19
7635238|NCT01641367|26564060|P8|Randomized Adherence Intervention|Lost to Follow-up|12
7635239|NCT01641367|26564061|P7|Randomized Adherence Intervention|Lost to Follow-up|8
7635240|NCT01641367|26564062|P6|Randomized Adherence Intervention|Lost to Follow-up|0
7635241|NCT01641367|26564063|P5|Randomized Adherence Intervention|Lost to Follow-up|0
7635242|NCT01641367|26564064|P4|Randomized Adherence Intervention|Lost to Follow-up|0
7635243|NCT01641367|26564065|P3|Randomized Adherence Intervention|Lost to Follow-up|0
7635244|NCT01641367|26564066|P2|Randomized Adherence Intervention|Lost to Follow-up|0
7635245|NCT01641367|26564067|P1|Randomized Adherence Intervention|Lost to Follow-up|0
7635246|NCT01641367|26564060|P8|Randomized Adherence Intervention|Death|12
7635247|NCT01641367|26564061|P7|Randomized Adherence Intervention|Death|11
7635248|NCT01641367|26564062|P6|Randomized Adherence Intervention|Death|0
7635249|NCT01641367|26564063|P5|Randomized Adherence Intervention|Death|0
7635250|NCT01641367|26564064|P4|Randomized Adherence Intervention|Death|0
7635251|NCT01641367|26564065|P3|Randomized Adherence Intervention|Death|0
7635252|NCT01641367|26564066|P2|Randomized Adherence Intervention|Death|0
7635253|NCT01641367|26564067|P1|Randomized Adherence Intervention|Death|0
7635254|NCT01641367|26564060|P8|Cohorts|Lost to Follow-up|0
7635255|NCT01641367|26564061|P7|Cohorts|Lost to Follow-up|0
7635256|NCT01641367|26564062|P6|Cohorts|Lost to Follow-up|0
7635257|NCT01641367|26564063|P5|Cohorts|Lost to Follow-up|2
7635258|NCT01641367|26564064|P4|Cohorts|Lost to Follow-up|0
7635259|NCT01641367|26564065|P3|Cohorts|Lost to Follow-up|2
7635260|NCT01641367|26564066|P2|Cohorts|Lost to Follow-up|0
7635261|NCT01641367|26564067|P1|Cohorts|Lost to Follow-up|16
7635262|NCT01641367|26564060|P8|Cohorts|Death|0
7635263|NCT01641367|26564061|P7|Cohorts|Death|0
7635264|NCT01641367|26564062|P6|Cohorts|Death|1
7635265|NCT01641367|26564063|P5|Cohorts|Death|1
7635266|NCT01641367|26564064|P4|Cohorts|Death|0
7635267|NCT01641367|26564065|P3|Cohorts|Death|2
7635268|NCT01641367|26564066|P2|Cohorts|Death|1
7635269|NCT01641367|26564067|P1|Cohorts|Death|18
7635270|NCT01641237|26564318|P4|Period III|Lost to Follow-up|0
7635271|NCT01641237|26564319|P3|Period III|Lost to Follow-up|0
7635272|NCT01641237|26564320|P2|Period III|Lost to Follow-up|0
7635273|NCT01641237|26564321|P1|Period III|Lost to Follow-up|1
7635274|NCT01641237|26564318|P4|Period II|Withdrawal by Subject|0
7635275|NCT01641237|26564319|P3|Period II|Withdrawal by Subject|0
7635276|NCT01641237|26564320|P2|Period II|Withdrawal by Subject|0
7635277|NCT01641237|26564321|P1|Period II|Withdrawal by Subject|1
7635278|NCT01641198|26564346|P3|At 15-20 Years of Function|Death|1
7635279|NCT01641198|26564347|P2|At 15-20 Years of Function|Death|0
7635280|NCT01641198|26564348|P1|At 15-20 Years of Function|Death|1
7635281|NCT01641198|26564346|P3|At 15-20 Years of Function|Lost to Follow-up|1
7635282|NCT01641198|26564347|P2|At 15-20 Years of Function|Lost to Follow-up|1
7635283|NCT01641198|26564348|P1|At 15-20 Years of Function|Lost to Follow-up|5
7635284|NCT01641198|26564346|P3|After 24 Months of Function|Lost to Follow-up|6
7635285|NCT01641198|26564347|P2|After 24 Months of Function|Lost to Follow-up|9
7635286|NCT01641198|26564348|P1|After 24 Months of Function|Lost to Follow-up|4
7635287|NCT01641198|26564346|P3|After 12 Months of Function|Adverse Event|0
7635288|NCT01641198|26564347|P2|After 12 Months of Function|Adverse Event|1
7635289|NCT01641198|26564348|P1|After 12 Months of Function|Adverse Event|0
7635290|NCT01641198|26564346|P3|After 12 Months of Function|Protocol Violation|0
7635291|NCT01641198|26564347|P2|After 12 Months of Function|Protocol Violation|0
7635292|NCT01641198|26564348|P1|After 12 Months of Function|Protocol Violation|1
7635293|NCT01641198|26564346|P3|After 12 Months of Function|Lost to Follow-up|2
7635294|NCT01641198|26564347|P2|After 12 Months of Function|Lost to Follow-up|2
7635295|NCT01641198|26564348|P1|After 12 Months of Function|Lost to Follow-up|3
7635296|NCT01641159|26564364|P2|Overall Study|Withdrawal by Subject|1
7635297|NCT01641159|26564365|P1|Overall Study|Withdrawal by Subject|0
7635298|NCT01641159|26564364|P2|Overall Study|Lost to Follow-up|1
7635299|NCT01641159|26564365|P1|Overall Study|Lost to Follow-up|2
7635300|NCT01641133|26564376|P3|Overall Study|Lost to Follow-up|2
7635301|NCT01641133|26564377|P2|Overall Study|Lost to Follow-up|2
7635302|NCT01641133|26564378|P1|Overall Study|Lost to Follow-up|0
7635303|NCT01641133|26564376|P3|Overall Study|Withdrawal by Subject|3
7635304|NCT01641133|26564377|P2|Overall Study|Withdrawal by Subject|3
7635305|NCT01641133|26564378|P1|Overall Study|Withdrawal by Subject|5
7635306|NCT01641133|26564376|P3|Overall Study|Adverse Event|1
7635307|NCT01641133|26564377|P2|Overall Study|Adverse Event|0
7635308|NCT01641133|26564378|P1|Overall Study|Adverse Event|0
7635309|NCT01641133|26564376|P3|Overall Study|Migrated/moved from study area|1
7635310|NCT01641133|26564377|P2|Overall Study|Migrated/moved from study area|3
7635311|NCT01641133|26564378|P1|Overall Study|Migrated/moved from study area|5
7635312|NCT01641133|26564376|P3|Overall Study|Protocol Violation|1
7635313|NCT01641133|26564377|P2|Overall Study|Protocol Violation|1
7635314|NCT01641133|26564378|P1|Overall Study|Protocol Violation|0
7635315|NCT01641081|26564431|P10|Period 5|Adverse Event|0
7635316|NCT01641081|26564432|P9|Period 5|Adverse Event|0
7635317|NCT01641081|26564433|P8|Period 5|Adverse Event|0
7635318|NCT01641081|26564434|P7|Period 5|Adverse Event|0
7635319|NCT01641081|26564435|P6|Period 5|Adverse Event|0
7635320|NCT01641081|26564436|P5|Period 5|Adverse Event|0
7635321|NCT01641081|26564437|P4|Period 5|Adverse Event|0
7635322|NCT01641081|26564438|P3|Period 5|Adverse Event|2
7635323|NCT01641081|26564439|P2|Period 5|Adverse Event|0
7635324|NCT01641081|26564440|P1|Period 5|Adverse Event|0
7635325|NCT01641081|26564431|P10|Period 4|Adverse Event|0
7635326|NCT01641081|26564432|P9|Period 4|Adverse Event|0
7635327|NCT01641081|26564433|P8|Period 4|Adverse Event|0
7635328|NCT01641081|26564434|P7|Period 4|Adverse Event|0
7635329|NCT01641081|26564435|P6|Period 4|Adverse Event|0
7635330|NCT01641081|26564436|P5|Period 4|Adverse Event|0
7635331|NCT01641081|26564437|P4|Period 4|Adverse Event|1
7635332|NCT01641081|26564438|P3|Period 4|Adverse Event|0
7635333|NCT01641081|26564439|P2|Period 4|Adverse Event|1
7635334|NCT01641081|26564440|P1|Period 4|Adverse Event|0
7635335|NCT01641081|26564431|P10|Period 3|Withdrawal by Subject|0
7635336|NCT01641081|26564432|P9|Period 3|Withdrawal by Subject|1
7635337|NCT01641081|26564433|P8|Period 3|Withdrawal by Subject|0
7635338|NCT01641081|26564434|P7|Period 3|Withdrawal by Subject|0
7635339|NCT01641081|26564435|P6|Period 3|Withdrawal by Subject|0
7635340|NCT01641081|26564436|P5|Period 3|Withdrawal by Subject|0
7635341|NCT01641081|26564437|P4|Period 3|Withdrawal by Subject|0
7635342|NCT01641081|26564438|P3|Period 3|Withdrawal by Subject|0
7635343|NCT01641081|26564439|P2|Period 3|Withdrawal by Subject|0
7635344|NCT01641081|26564440|P1|Period 3|Withdrawal by Subject|0
7635345|NCT01641081|26564431|P10|Period 3|Adverse Event|0
7635346|NCT01641081|26564432|P9|Period 3|Adverse Event|0
7635347|NCT01641081|26564433|P8|Period 3|Adverse Event|0
7635348|NCT01641081|26564434|P7|Period 3|Adverse Event|0
7635349|NCT01641081|26564435|P6|Period 3|Adverse Event|0
7635350|NCT01641081|26564436|P5|Period 3|Adverse Event|0
7635351|NCT01641081|26564437|P4|Period 3|Adverse Event|0
7635352|NCT01641081|26564438|P3|Period 3|Adverse Event|1
7635353|NCT01641081|26564439|P2|Period 3|Adverse Event|0
7635354|NCT01641081|26564440|P1|Period 3|Adverse Event|0
7635355|NCT01641081|26564431|P10|Period 2|Protocol Violation|0
7635356|NCT01641081|26564432|P9|Period 2|Protocol Violation|0
7635357|NCT01641081|26564433|P8|Period 2|Protocol Violation|0
7635358|NCT01641081|26564434|P7|Period 2|Protocol Violation|0
7635359|NCT01641081|26564435|P6|Period 2|Protocol Violation|0
7635360|NCT01641081|26564436|P5|Period 2|Protocol Violation|0
7635361|NCT01641081|26564437|P4|Period 2|Protocol Violation|0
7635362|NCT01641081|26564438|P3|Period 2|Protocol Violation|0
7635363|NCT01641081|26564439|P2|Period 2|Protocol Violation|0
7635364|NCT01641081|26564440|P1|Period 2|Protocol Violation|1
7635365|NCT01641081|26564431|P10|Period 2|Withdrawal by Subject|0
7635366|NCT01641081|26564432|P9|Period 2|Withdrawal by Subject|0
7635367|NCT01641081|26564433|P8|Period 2|Withdrawal by Subject|0
7635368|NCT01641081|26564434|P7|Period 2|Withdrawal by Subject|2
7635369|NCT01641081|26564435|P6|Period 2|Withdrawal by Subject|0
7635370|NCT01641081|26564436|P5|Period 2|Withdrawal by Subject|0
7635371|NCT01641081|26564437|P4|Period 2|Withdrawal by Subject|1
7635372|NCT01641081|26564438|P3|Period 2|Withdrawal by Subject|0
7635373|NCT01641081|26564439|P2|Period 2|Withdrawal by Subject|0
7635374|NCT01641081|26564440|P1|Period 2|Withdrawal by Subject|0
7635375|NCT01641081|26564431|P10|Period 2|Adverse Event|0
7635376|NCT01641081|26564432|P9|Period 2|Adverse Event|0
7635377|NCT01641081|26564433|P8|Period 2|Adverse Event|0
7635378|NCT01641081|26564434|P7|Period 2|Adverse Event|0
7635379|NCT01641081|26564435|P6|Period 2|Adverse Event|1
7635380|NCT01641081|26564436|P5|Period 2|Adverse Event|0
7635381|NCT01641081|26564437|P4|Period 2|Adverse Event|0
7635382|NCT01641081|26564438|P3|Period 2|Adverse Event|0
7635383|NCT01641081|26564439|P2|Period 2|Adverse Event|0
7635384|NCT01641081|26564440|P1|Period 2|Adverse Event|0
7635385|NCT01641081|26564431|P10|Period 1|Adverse Event|0
7635386|NCT01641081|26564432|P9|Period 1|Adverse Event|0
7635387|NCT01641081|26564433|P8|Period 1|Adverse Event|2
7635388|NCT01641081|26564434|P7|Period 1|Adverse Event|0
7635389|NCT01641081|26564435|P6|Period 1|Adverse Event|0
7635390|NCT01641081|26564436|P5|Period 1|Adverse Event|0
7635391|NCT01641081|26564437|P4|Period 1|Adverse Event|0
7635392|NCT01641081|26564438|P3|Period 1|Adverse Event|0
7635393|NCT01641081|26564439|P2|Period 1|Adverse Event|0
7635394|NCT01641081|26564440|P1|Period 1|Adverse Event|1
7635395|NCT01641081|26564431|P10|Period 1|Protocol Violation|0
7635396|NCT01641081|26564432|P9|Period 1|Protocol Violation|0
7635397|NCT01641081|26564433|P8|Period 1|Protocol Violation|1
7635398|NCT01641081|26564434|P7|Period 1|Protocol Violation|0
7635399|NCT01641081|26564435|P6|Period 1|Protocol Violation|0
7635400|NCT01641081|26564436|P5|Period 1|Protocol Violation|1
7635401|NCT01641081|26564437|P4|Period 1|Protocol Violation|0
7635402|NCT01641081|26564438|P3|Period 1|Protocol Violation|0
7635403|NCT01641081|26564439|P2|Period 1|Protocol Violation|0
7635404|NCT01641081|26564440|P1|Period 1|Protocol Violation|0
7635405|NCT01641081|26564431|P10|Period 1|Sponsor request (potential unblinding)|0
7635406|NCT01641081|26564432|P9|Period 1|Sponsor request (potential unblinding)|0
7635407|NCT01641081|26564433|P8|Period 1|Sponsor request (potential unblinding)|0
7635408|NCT01641081|26564434|P7|Period 1|Sponsor request (potential unblinding)|1
7635409|NCT01641081|26564435|P6|Period 1|Sponsor request (potential unblinding)|0
7635410|NCT01641081|26564436|P5|Period 1|Sponsor request (potential unblinding)|0
7635411|NCT01641081|26564437|P4|Period 1|Sponsor request (potential unblinding)|0
7635412|NCT01641081|26564438|P3|Period 1|Sponsor request (potential unblinding)|0
7635413|NCT01641081|26564439|P2|Period 1|Sponsor request (potential unblinding)|0
7635414|NCT01641081|26564440|P1|Period 1|Sponsor request (potential unblinding)|0
7635415|NCT01640964|26564509|P3|Overall Study|Protocol Deviation|2
7635416|NCT01640964|26564510|P2|Overall Study|Protocol Deviation|1
7635417|NCT01640964|26564511|P1|Overall Study|Protocol Deviation|1
7635418|NCT01640964|26564509|P3|Overall Study|Lost to Follow-up|1
7635419|NCT01640964|26564510|P2|Overall Study|Lost to Follow-up|0
7635420|NCT01640964|26564511|P1|Overall Study|Lost to Follow-up|0
7635421|NCT01640951|26564534|P8|Overall Study|Death|2
7635422|NCT01640951|26564535|P7|Overall Study|Death|0
7635423|NCT01640951|26564536|P6|Overall Study|Death|0
7635424|NCT01640951|26564537|P5|Overall Study|Death|0
7635425|NCT01640951|26564538|P4|Overall Study|Death|0
7635426|NCT01640951|26564539|P3|Overall Study|Death|1
7635427|NCT01640951|26564540|P2|Overall Study|Death|1
7635428|NCT01640951|26564541|P1|Overall Study|Death|0
7635429|NCT01640951|26564534|P8|Overall Study|Subject/Guardian decision|4
7635430|NCT01640951|26564535|P7|Overall Study|Subject/Guardian decision|5
7635431|NCT01640951|26564536|P6|Overall Study|Subject/Guardian decision|19
7635432|NCT01640951|26564537|P5|Overall Study|Subject/Guardian decision|7
7635433|NCT01640951|26564538|P4|Overall Study|Subject/Guardian decision|15
7635434|NCT01640951|26564539|P3|Overall Study|Subject/Guardian decision|13
7635435|NCT01640951|26564540|P2|Overall Study|Subject/Guardian decision|4
7635436|NCT01640951|26564541|P1|Overall Study|Subject/Guardian decision|12
7635437|NCT01640951|26564534|P8|Overall Study|Protocol Deviation|0
7635438|NCT01640951|26564535|P7|Overall Study|Protocol Deviation|0
7635439|NCT01640951|26564536|P6|Overall Study|Protocol Deviation|1
7635440|NCT01640951|26564537|P5|Overall Study|Protocol Deviation|0
7635441|NCT01640951|26564538|P4|Overall Study|Protocol Deviation|1
7635442|NCT01640951|26564539|P3|Overall Study|Protocol Deviation|2
7635443|NCT01640951|26564540|P2|Overall Study|Protocol Deviation|1
7635444|NCT01640951|26564541|P1|Overall Study|Protocol Deviation|0
7635445|NCT01640951|26564534|P8|Overall Study|Pregnancy|0
7635446|NCT01640951|26564535|P7|Overall Study|Pregnancy|2
7635447|NCT01640951|26564536|P6|Overall Study|Pregnancy|0
7635448|NCT01640951|26564537|P5|Overall Study|Pregnancy|0
7635449|NCT01640951|26564538|P4|Overall Study|Pregnancy|4
7635450|NCT01640951|26564539|P3|Overall Study|Pregnancy|0
7635451|NCT01640951|26564540|P2|Overall Study|Pregnancy|0
7635452|NCT01640951|26564541|P1|Overall Study|Pregnancy|3
7635453|NCT01640951|26564534|P8|Overall Study|Physician Decision|0
7635454|NCT01640951|26564535|P7|Overall Study|Physician Decision|3
7635455|NCT01640951|26564536|P6|Overall Study|Physician Decision|3
7635456|NCT01640951|26564537|P5|Overall Study|Physician Decision|2
7635457|NCT01640951|26564538|P4|Overall Study|Physician Decision|2
7635458|NCT01640951|26564539|P3|Overall Study|Physician Decision|2
7635459|NCT01640951|26564540|P2|Overall Study|Physician Decision|5
7635460|NCT01640951|26564541|P1|Overall Study|Physician Decision|2
7635461|NCT01640951|26564534|P8|Overall Study|Non-compliance with study treatment|0
7635462|NCT01640951|26564535|P7|Overall Study|Non-compliance with study treatment|1
7635463|NCT01640951|26564536|P6|Overall Study|Non-compliance with study treatment|4
7635464|NCT01640951|26564537|P5|Overall Study|Non-compliance with study treatment|1
7635465|NCT01640951|26564538|P4|Overall Study|Non-compliance with study treatment|1
7635466|NCT01640951|26564539|P3|Overall Study|Non-compliance with study treatment|1
7635467|NCT01640951|26564540|P2|Overall Study|Non-compliance with study treatment|0
7635468|NCT01640951|26564541|P1|Overall Study|Non-compliance with study treatment|0
7635469|NCT01640951|26564534|P8|Overall Study|Lost to Follow-up|1
7635470|NCT01640951|26564535|P7|Overall Study|Lost to Follow-up|1
7635471|NCT01640951|26564536|P6|Overall Study|Lost to Follow-up|3
7635472|NCT01640951|26564537|P5|Overall Study|Lost to Follow-up|2
7635473|NCT01640951|26564538|P4|Overall Study|Lost to Follow-up|2
7635474|NCT01640951|26564539|P3|Overall Study|Lost to Follow-up|6
7635475|NCT01640951|26564540|P2|Overall Study|Lost to Follow-up|0
7635476|NCT01640951|26564541|P1|Overall Study|Lost to Follow-up|1
7635477|NCT01640951|26564534|P8|Overall Study|Lack of Efficacy|6
7635478|NCT01640951|26564535|P7|Overall Study|Lack of Efficacy|5
7635479|NCT01640951|26564536|P6|Overall Study|Lack of Efficacy|6
7635480|NCT01640951|26564537|P5|Overall Study|Lack of Efficacy|0
7635481|NCT01640951|26564538|P4|Overall Study|Lack of Efficacy|14
7635482|NCT01640951|26564539|P3|Overall Study|Lack of Efficacy|7
7635483|NCT01640951|26564540|P2|Overall Study|Lack of Efficacy|1
7635484|NCT01640951|26564541|P1|Overall Study|Lack of Efficacy|20
7635485|NCT01640951|26564534|P8|Overall Study|Adverse Event|3
7635486|NCT01640951|26564535|P7|Overall Study|Adverse Event|1
7635487|NCT01640951|26564536|P6|Overall Study|Adverse Event|11
7635488|NCT01640951|26564537|P5|Overall Study|Adverse Event|1
7635489|NCT01640951|26564538|P4|Overall Study|Adverse Event|6
7635490|NCT01640951|26564539|P3|Overall Study|Adverse Event|10
7635491|NCT01640951|26564540|P2|Overall Study|Adverse Event|3
7635492|NCT01640951|26564541|P1|Overall Study|Adverse Event|8
7635493|NCT01640925|26564643|P2|Overall Study|Previously enrolled in this trial|11
7635494|NCT01640925|26564644|P1|Overall Study|Previously enrolled in this trial|13
7635495|NCT01640925|26564643|P2|Overall Study|Withdrawal by Subject|0
7635496|NCT01640925|26564644|P1|Overall Study|Withdrawal by Subject|1
7635497|NCT01640873|26564658|P2|Overall Study|Protocol Violation|1
7635498|NCT01640873|26564659|P1|Overall Study|Protocol Violation|2
7635499|NCT01640808|26564709|P2|Overall Study|Randomized but not treated|2
7635500|NCT01640808|26564710|P1|Overall Study|Randomized but not treated|4
7635501|NCT01640808|26564709|P2|Overall Study|Physician Decision|5
7635502|NCT01640808|26564710|P1|Overall Study|Physician Decision|19
7635503|NCT01640808|26564709|P2|Overall Study|Administration of anticancer drugs|1
7635504|NCT01640808|26564710|P1|Overall Study|Administration of anticancer drugs|2
7635505|NCT01640808|26564709|P2|Overall Study|Start an antiviral therapy using IFN|0
7635506|NCT01640808|26564710|P1|Overall Study|Start an antiviral therapy using IFN|3
7635507|NCT01640808|26564709|P2|Overall Study|Lost to Follow-up|0
7635508|NCT01640808|26564710|P1|Overall Study|Lost to Follow-up|4
7635509|NCT01640808|26564709|P2|Overall Study|Withdrawal by Subject|4
7635510|NCT01640808|26564710|P1|Overall Study|Withdrawal by Subject|12
7635511|NCT01640808|26564709|P2|Overall Study|Unable to continue dynamic CT|4
7635512|NCT01640808|26564710|P1|Overall Study|Unable to continue dynamic CT|14
7635513|NCT01640366|26564745|P1|Overall Study|Lost to Follow-up|5
7635514|NCT01640366|26564745|P1|Overall Study|Protocol Violation|16
7635515|NCT01640366|26564745|P1|Overall Study|Withdrawal by Subject|1
7635516|NCT01640353|26564758|P1|Overall Study|Physician Decision|1
7635517|NCT01640353|26564758|P1|Overall Study|Lost to Follow-up|12
7635518|NCT01640353|26564758|P1|Overall Study|Early site termination|3
7635519|NCT01640353|26564758|P1|Overall Study|Death|2
7635520|NCT01640353|26564758|P1|Overall Study|Withdrawal by Subject|5
7635521|NCT01640353|26564758|P1|Overall Study|Withdrawn from analysis at term site|12
7635522|NCT01640353|26564758|P1|Overall Study|Withdrew prior to treatment|10
7635523|NCT01640314|26564806|P2|Overall Study|Protocol Violation|1
7635524|NCT01640314|26564807|P1|Overall Study|Protocol Violation|0
7635525|NCT01640288|26564823|P2|Overall Study|Withdrawal by Subject|0
7635526|NCT01640288|26564824|P1|Overall Study|Withdrawal by Subject|1
7635527|NCT01640288|26564823|P2|Overall Study|Withdrawn by PI|0
7635528|NCT01640288|26564824|P1|Overall Study|Withdrawn by PI|5
7635529|NCT01640288|26564823|P2|Overall Study|Screen Failure|18
7635530|NCT01640288|26564824|P1|Overall Study|Screen Failure|20
7635531|NCT01640288|26564823|P2|Overall Study|Equipment Failure or Poor Image Quality|5
7635532|NCT01640288|26564824|P1|Overall Study|Equipment Failure or Poor Image Quality|4
7635533|NCT01640249|26564841|P7|Period 1|Withdrawal by Subject|0
7635534|NCT01640249|26564842|P6|Period 1|Withdrawal by Subject|1
7635535|NCT01640249|26564843|P5|Period 1|Withdrawal by Subject|0
7635536|NCT01640249|26564844|P4|Period 1|Withdrawal by Subject|0
7635537|NCT01640249|26564845|P3|Period 1|Withdrawal by Subject|0
7635538|NCT01640249|26564846|P2|Period 1|Withdrawal by Subject|0
7635539|NCT01640249|26564847|P1|Period 1|Withdrawal by Subject|1
7635540|NCT01640184|26564895|P3|Overall Study|Protocol Violation|1
7635541|NCT01640184|26564896|P2|Overall Study|Protocol Violation|0
7635542|NCT01640184|26564897|P1|Overall Study|Protocol Violation|0
7635543|NCT01640184|26564895|P3|Overall Study|Withdrawal by Subject|1
7635544|NCT01640184|26564896|P2|Overall Study|Withdrawal by Subject|1
7635545|NCT01640184|26564897|P1|Overall Study|Withdrawal by Subject|0
7635546|NCT01640184|26564895|P3|Overall Study|Physician Decision|0
7635547|NCT01640184|26564896|P2|Overall Study|Physician Decision|0
7635548|NCT01640184|26564897|P1|Overall Study|Physician Decision|3
7635549|NCT01640184|26564895|P3|Overall Study|Lost to Follow-up|0
7635550|NCT01640184|26564896|P2|Overall Study|Lost to Follow-up|1
7635551|NCT01640184|26564897|P1|Overall Study|Lost to Follow-up|4
7635552|NCT01640184|26564895|P3|Overall Study|Death|0
7635553|NCT01640184|26564896|P2|Overall Study|Death|0
7635554|NCT01640184|26564897|P1|Overall Study|Death|1
7635555|NCT01640054|26564926|P1|Overall Study|Adverse Event|2
7635556|NCT01640054|26564926|P1|Overall Study|Lack of Efficacy|3
7635557|NCT01640054|26564926|P1|Overall Study|Study-specific disc criteria|1
7635558|NCT01639833|26564947|P2|Overall Study|Withdrawal by Subject|2
7635559|NCT01639833|26564948|P1|Overall Study|Withdrawal by Subject|2
7635560|NCT01639833|26564947|P2|Overall Study|Death|2
7635561|NCT01639833|26564948|P1|Overall Study|Death|4
7635562|NCT01639755|26564956|P1|Overall Study|Patient had device explantation|4
7635563|NCT01639755|26564956|P1|Overall Study|Study Ongoing|15
7635564|NCT01639742|26564964|P1|Overall Study|Lost to Follow-up|1
7635565|NCT01639742|26564964|P1|Overall Study|Study Ongoing|17
7635566|NCT01639729|26564972|P6|Overall Study|Withdrawal by Subject|0
7635567|NCT01639729|26564973|P5|Overall Study|Withdrawal by Subject|0
7635568|NCT01639729|26564974|P4|Overall Study|Withdrawal by Subject|1
7635569|NCT01639729|26564975|P3|Overall Study|Withdrawal by Subject|1
7635570|NCT01639729|26564976|P2|Overall Study|Withdrawal by Subject|0
7635571|NCT01639729|26564977|P1|Overall Study|Withdrawal by Subject|1
7635572|NCT01639703|26564999|P1|Overall Study|Other reason|7
7635573|NCT01639703|26564999|P1|Overall Study|Withdrawal by Subject|5
7635574|NCT01639560|26565077|P2|Overall Study|Adverse Event|2
7635575|NCT01639560|26565078|P1|Overall Study|Adverse Event|0
7635576|NCT01639560|26565077|P2|Overall Study|Lost to Follow-up|11
7635577|NCT01639560|26565078|P1|Overall Study|Lost to Follow-up|9
7635578|NCT01639560|26565077|P2|Overall Study|Lack of Efficacy|2
7635579|NCT01639560|26565078|P1|Overall Study|Lack of Efficacy|1
7635580|NCT01639560|26565077|P2|Overall Study|Withdrawal by Subject|14
7635581|NCT01639560|26565078|P1|Overall Study|Withdrawal by Subject|9
7635582|NCT01639495|26565090|P1|Overall Study|No radiofrequency energy applied|2
7635583|NCT01639495|26565090|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
7635584|NCT01639495|26565090|P1|Overall Study|Consented but didn't have study catheter|4
7635585|NCT01639495|26565090|P1|Overall Study|Lost to Follow-up|6
7635586|NCT01639469|26565100|P2|Overall Study|Lost to Follow-up|1
7635587|NCT01639469|26565101|P1|Overall Study|Lost to Follow-up|1
7635588|NCT01639469|26565100|P2|Overall Study|Death|2
7635589|NCT01639469|26565101|P1|Overall Study|Death|4
7635590|NCT01639339|26565137|P2|Open-label Period (Up to Week 28)|Adverse Event|4
7635591|NCT01639339|26565138|P1|Open-label Period (Up to Week 28)|Adverse Event|1
7635592|NCT01639339|26565137|P2|Open-label Period (Up to Week 28)|Protocol Violation|1
7635593|NCT01639339|26565138|P1|Open-label Period (Up to Week 28)|Protocol Violation|0
7635594|NCT01639339|26565137|P2|Open-label Period (Up to Week 28)|Lost to Follow-up|1
7635595|NCT01639339|26565138|P1|Open-label Period (Up to Week 28)|Lost to Follow-up|0
7635596|NCT01639339|26565137|P2|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
7635597|NCT01639339|26565138|P1|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
7635598|NCT01639339|26565137|P2|Double-blind Period (Up to Week 104)|Adverse Event|7
7635599|NCT01639339|26565138|P1|Double-blind Period (Up to Week 104)|Adverse Event|10
7635600|NCT01639339|26565137|P2|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
7635601|NCT01639339|26565138|P1|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
7635602|NCT01639339|26565137|P2|Double-blind Period (Up to Week 104)|Protocol Violation|2
7635603|NCT01639339|26565138|P1|Double-blind Period (Up to Week 104)|Protocol Violation|0
7635604|NCT01639339|26565137|P2|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
7635605|NCT01639339|26565138|P1|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
7635606|NCT01639339|26565137|P2|Double-blind Period (Up to Week 104)|Physician Decision|5
7635607|NCT01639339|26565138|P1|Double-blind Period (Up to Week 104)|Physician Decision|11
7635608|NCT01639339|26565137|P2|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
7635609|NCT01639339|26565138|P1|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
7635610|NCT01639144|26565233|P2|Overall Study|Met postoperative exclusion criteria|3
7635611|NCT01639144|26565234|P1|Overall Study|Met postoperative exclusion criteria|4
7635612|NCT01639144|26565233|P2|Overall Study|Physician Decision|0
7635613|NCT01639144|26565234|P1|Overall Study|Physician Decision|2
7635614|NCT01639144|26565233|P2|Overall Study|Withdrawal by Subject|2
7635615|NCT01639144|26565234|P1|Overall Study|Withdrawal by Subject|4
7635616|NCT01639040|26565242|P2|Overall Study|Adverse Event|0
7635617|NCT01639040|26565243|P1|Overall Study|Adverse Event|1
7635618|NCT01639001|26565261|P2|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
7635619|NCT01639001|26565262|P1|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
7635620|NCT01639001|26565261|P2|Overall Study|Randomized but not treated|2
7635621|NCT01639001|26565262|P1|Overall Study|Randomized but not treated|0
7635622|NCT01639001|26565261|P2|Overall Study|Death|61
7635623|NCT01639001|26565262|P1|Overall Study|Death|62
7635624|NCT01639001|26565261|P2|Overall Study|Lost to Follow-up|0
7635625|NCT01639001|26565262|P1|Overall Study|Lost to Follow-up|3
7635626|NCT01639001|26565261|P2|Overall Study|Refused further follow-up|12
7635627|NCT01639001|26565262|P1|Overall Study|Refused further follow-up|9
7635628|NCT01638819|26565308|P2|Overall Study|Lost to Follow-up|0
7635629|NCT01638819|26565309|P1|Overall Study|Lost to Follow-up|1
7635630|NCT01638559|26565318|P1|Overall Study|Subject declined to travel for biopsy|1
7635631|NCT01638559|26565318|P1|Overall Study|Withdrawal by Subject|1
7635632|NCT01638559|26565318|P1|Overall Study|Lost to Follow-up|1
7635633|NCT01638546|26565336|P2|Overall Study|Adverse Event|3
7635634|NCT01638546|26565337|P1|Overall Study|Adverse Event|1
7635635|NCT01638429|26565376|P1|Overall Study|Withdrawal by Subject|1
7635636|NCT01638390|26565427|P1|Overall Study|screening failures|21
7635637|NCT01638013|26565464|P3|Overall Study|Not met inclusion or exclusion criteria|1
7635638|NCT01638013|26565465|P2|Overall Study|Not met inclusion or exclusion criteria|0
7635639|NCT01638013|26565466|P1|Overall Study|Not met inclusion or exclusion criteria|0
7635640|NCT01638013|26565464|P3|Overall Study|Withdrawal of Consent|16
7635641|NCT01638013|26565465|P2|Overall Study|Withdrawal of Consent|12
7635642|NCT01638013|26565466|P1|Overall Study|Withdrawal of Consent|16
7635643|NCT01638013|26565464|P3|Overall Study|Miscellaneous|23
7635644|NCT01638013|26565465|P2|Overall Study|Miscellaneous|19
7635645|NCT01638013|26565466|P1|Overall Study|Miscellaneous|25
7635646|NCT01638013|26565464|P3|Overall Study|Subject Lost to Follow up|1
7635647|NCT01638013|26565465|P2|Overall Study|Subject Lost to Follow up|0
7635648|NCT01638013|26565466|P1|Overall Study|Subject Lost to Follow up|1
7635649|NCT01638013|26565464|P3|Overall Study|Met discontinuation criteria|7
7635650|NCT01638013|26565465|P2|Overall Study|Met discontinuation criteria|0
7635651|NCT01638013|26565466|P1|Overall Study|Met discontinuation criteria|4
7635652|NCT01638013|26565464|P3|Overall Study|Protocol Violation|11
7635653|NCT01638013|26565465|P2|Overall Study|Protocol Violation|7
7635654|NCT01638013|26565466|P1|Overall Study|Protocol Violation|10
7635655|NCT01638013|26565464|P3|Overall Study|Lack of Efficacy|14
7635656|NCT01638013|26565465|P2|Overall Study|Lack of Efficacy|11
7635657|NCT01638013|26565466|P1|Overall Study|Lack of Efficacy|39
7635658|NCT01638013|26565464|P3|Overall Study|Adverse Event|48
7635659|NCT01638013|26565465|P2|Overall Study|Adverse Event|29
7635660|NCT01638013|26565466|P1|Overall Study|Adverse Event|36
7635661|NCT01638000|26565599|P2|Overall Study|Miscellaneous|2
7635662|NCT01638000|26565600|P1|Overall Study|Miscellaneous|2
7635663|NCT01638000|26565599|P2|Overall Study|Withdrawal by Subject|24
7635664|NCT01638000|26565600|P1|Overall Study|Withdrawal by Subject|21
7635665|NCT01638000|26565599|P2|Overall Study|Protocol Violation|13
7635666|NCT01638000|26565600|P1|Overall Study|Protocol Violation|11
7635667|NCT01638000|26565599|P2|Overall Study|Lack of Efficacy|6
7635668|NCT01638000|26565600|P1|Overall Study|Lack of Efficacy|5
7635669|NCT01638000|26565599|P2|Overall Study|Adverse Event|16
7635670|NCT01638000|26565600|P1|Overall Study|Adverse Event|14
7635671|NCT01638000|26565599|P2|Overall Study|Randomized but Never Received Drug|10
7635672|NCT01638000|26565600|P1|Overall Study|Randomized but Never Received Drug|7
7635673|NCT01637961|26565698|P1|Overall Study|Ineligible: inadequate pathology|1
7635674|NCT01637961|26565698|P1|Overall Study|Ineligible: wrong primary|1
7635675|NCT01637922|26565730|P2|Overall Study|Lost to Follow-up|0
7635676|NCT01637922|26565731|P1|Overall Study|Lost to Follow-up|2
7635677|NCT01637922|26565730|P2|Overall Study|Withdrawal by Subject|3
7635678|NCT01637922|26565731|P1|Overall Study|Withdrawal by Subject|0
7635679|NCT01637922|26565730|P2|Overall Study|Protocol Violation|1
7635680|NCT01637922|26565731|P1|Overall Study|Protocol Violation|0
7635681|NCT01637922|26565730|P2|Overall Study|Adverse Event|1
7635682|NCT01637922|26565731|P1|Overall Study|Adverse Event|0
7635683|NCT01637623|26565761|P3|Overall Study|Physician Decision|1
7635684|NCT01637623|26565762|P2|Overall Study|Physician Decision|0
7635685|NCT01637623|26565763|P1|Overall Study|Physician Decision|1
7635686|NCT01637623|26565761|P3|Overall Study|Lost to Follow-up|2
7635687|NCT01637623|26565762|P2|Overall Study|Lost to Follow-up|0
7635688|NCT01637623|26565763|P1|Overall Study|Lost to Follow-up|0
7635689|NCT01637584|26565803|P2|Overall Study|Withdrawal by Subject|3
7635690|NCT01637584|26565804|P1|Overall Study|Withdrawal by Subject|1
7635691|NCT01637402|26565811|P2|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
7635692|NCT01637402|26565812|P1|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
7635693|NCT01637402|26565811|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7635694|NCT01637402|26565812|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|4
7635695|NCT01637402|26565811|P2|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
7635696|NCT01637402|26565812|P1|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
7635697|NCT01637402|26565811|P2|Week 12 Evaluation|Lack of Efficacy|0
7635698|NCT01637402|26565812|P1|Week 12 Evaluation|Lack of Efficacy|6
7635699|NCT01637402|26565811|P2|Standard Dose Regimen|Adverse Event|0
7635700|NCT01637402|26565812|P1|Standard Dose Regimen|Adverse Event|1
7635701|NCT01637402|26565811|P2|Standard Dose Regimen|Lack of Efficacy|0
7635702|NCT01637402|26565812|P1|Standard Dose Regimen|Lack of Efficacy|2
7635703|NCT01637272|26565843|P1|Overall Study|Protocol Violation|2
7635704|NCT01637272|26565843|P1|Overall Study|Administrative problems|1
7635705|NCT01637272|26565843|P1|Overall Study|completed core, did not enter ext. phase|4
7635706|NCT01637272|26565843|P1|Overall Study|Lost to Follow-up|2
7635707|NCT01637272|26565843|P1|Overall Study|Withdrawal by Subject|3
7635708|NCT01637272|26565843|P1|Overall Study|Unsatisfactory therapeutic effect|2
7635709|NCT01637272|26565843|P1|Overall Study|Adverse Event|6
7635710|NCT01637142|26565913|P1|Washout Period (at Least 3 Days)|Physician Decision|1
7635711|NCT01637077|26565929|P2|Overall Study|No cycle 1 questionnaire data|0
7635712|NCT01637077|26565930|P1|Overall Study|No cycle 1 questionnaire data|2
7635713|NCT01637077|26565929|P2|Overall Study|Withdrawal by Subject|0
7635714|NCT01637077|26565930|P1|Overall Study|Withdrawal by Subject|1
7635715|NCT01637077|26565929|P2|Overall Study|Cancel|1
7635716|NCT01637077|26565930|P1|Overall Study|Cancel|1
7635717|NCT01636986|26565958|P2|Overall Study|Corneal Staining|1
7635718|NCT01636986|26565959|P1|Overall Study|Corneal Staining|0
7635719|NCT01636986|26565958|P2|Overall Study|Withdrawal by Subject|1
7635720|NCT01636986|26565959|P1|Overall Study|Withdrawal by Subject|0
7635721|NCT01636960|26565965|P1|Maintenance Phase|Progressive disease|1
7635722|NCT01636960|26565965|P1|Maintenance Phase|Adverse Event|3
7635723|NCT01636960|26565965|P1|Maintenance Phase|Continued drug after regulatory approval|3
7635724|NCT01636960|26565965|P1|Induction Phase|Adverse Event|2
7635725|NCT01636947|26565973|P2|Overall Study|Did Not Meet Eligibility Criteria|4
7635726|NCT01636947|26565974|P1|Overall Study|Did Not Meet Eligibility Criteria|1
7635727|NCT01636947|26565973|P2|Overall Study|Adverse Event|1
7635728|NCT01636947|26565974|P1|Overall Study|Adverse Event|1
7635729|NCT01636947|26565973|P2|Overall Study|Withdrawal by Subject|3
7635730|NCT01636947|26565974|P1|Overall Study|Withdrawal by Subject|3
7635731|NCT01636947|26565973|P2|Overall Study|Protocol Violation|1
7635732|NCT01636947|26565974|P1|Overall Study|Protocol Violation|1
7635733|NCT01636947|26565973|P2|Overall Study|Lost to Follow-up|0
7635734|NCT01636947|26565974|P1|Overall Study|Lost to Follow-up|4
7635735|NCT01636947|26565973|P2|Overall Study|Not Treated|2
7635736|NCT01636947|26565974|P1|Overall Study|Not Treated|2
7635737|NCT01636934|26565996|P2|Overall Study|Never started study medication|1
7635738|NCT01636934|26565997|P1|Overall Study|Never started study medication|1
7635739|NCT01636934|26565996|P2|Overall Study|Too ill to continue|0
7635740|NCT01636934|26565997|P1|Overall Study|Too ill to continue|1
7635741|NCT01636934|26565996|P2|Overall Study|Chemo cancel|0
7635742|NCT01636934|26565997|P1|Overall Study|Chemo cancel|1
7635743|NCT01636934|26565996|P2|Overall Study|Withdrawal by Subject|2
7635744|NCT01636934|26565997|P1|Overall Study|Withdrawal by Subject|3
7635745|NCT01636778|26566009|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
7635746|NCT01636778|26566010|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
7635747|NCT01636778|26566011|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
7635748|NCT01636778|26566009|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
7635749|NCT01636778|26566010|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7635750|NCT01636778|26566011|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7635751|NCT01636778|26566009|P3|Follow-up Period After Part 2|Other|1
7635752|NCT01636778|26566010|P2|Follow-up Period After Part 2|Other|0
7635753|NCT01636778|26566011|P1|Follow-up Period After Part 2|Other|0
7635754|NCT01636778|26566009|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
7635755|NCT01636778|26566010|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
7635756|NCT01636778|26566011|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
7635757|NCT01636778|26566009|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7635841|NCT01636687|26566105|P1|Maintenance Period|Lack of Efficacy|4
7635758|NCT01636778|26566010|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
7635759|NCT01636778|26566011|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7635760|NCT01636778|26566009|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
7635761|NCT01636778|26566010|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
7635762|NCT01636778|26566011|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
7635763|NCT01636778|26566009|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7635764|NCT01636778|26566010|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7635765|NCT01636778|26566011|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
7635766|NCT01636778|26566009|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7635767|NCT01636778|26566010|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7635768|NCT01636778|26566011|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
7635769|NCT01636713|26566082|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
7635770|NCT01636713|26566083|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
7635771|NCT01636713|26566084|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
7635772|NCT01636713|26566082|P3|Overall Study|Withdrawal by Subject|8
7635773|NCT01636713|26566083|P2|Overall Study|Withdrawal by Subject|4
7635774|NCT01636713|26566084|P1|Overall Study|Withdrawal by Subject|5
7635775|NCT01636713|26566082|P3|Overall Study|Lost to Follow-up|1
7635776|NCT01636713|26566083|P2|Overall Study|Lost to Follow-up|0
7635777|NCT01636713|26566084|P1|Overall Study|Lost to Follow-up|0
7635778|NCT01636713|26566082|P3|Overall Study|Protocol Violation|1
7635779|NCT01636713|26566083|P2|Overall Study|Protocol Violation|0
7635780|NCT01636713|26566084|P1|Overall Study|Protocol Violation|3
7635781|NCT01636713|26566082|P3|Overall Study|Lack of Efficacy|2
7635782|NCT01636713|26566083|P2|Overall Study|Lack of Efficacy|6
7635783|NCT01636713|26566084|P1|Overall Study|Lack of Efficacy|6
7635784|NCT01636713|26566082|P3|Overall Study|Adverse Event|7
7635785|NCT01636713|26566083|P2|Overall Study|Adverse Event|16
7635786|NCT01636713|26566084|P1|Overall Study|Adverse Event|16
7635787|NCT01636687|26566101|P5|Follow-up Period|Withdrawal by Subject|1
7635788|NCT01636687|26566102|P4|Follow-up Period|Withdrawal by Subject|0
7635789|NCT01636687|26566103|P3|Follow-up Period|Withdrawal by Subject|0
7635790|NCT01636687|26566104|P2|Follow-up Period|Withdrawal by Subject|0
7635791|NCT01636687|26566105|P1|Follow-up Period|Withdrawal by Subject|1
7635792|NCT01636687|26566101|P5|Extension Period|Withdrawal by Subject|0
7635793|NCT01636687|26566102|P4|Extension Period|Withdrawal by Subject|1
7635794|NCT01636687|26566103|P3|Extension Period|Withdrawal by Subject|1
7635795|NCT01636687|26566104|P2|Extension Period|Withdrawal by Subject|0
7635796|NCT01636687|26566105|P1|Extension Period|Withdrawal by Subject|1
7635797|NCT01636687|26566101|P5|Extension Period|study terminated by sponsor|0
7635798|NCT01636687|26566102|P4|Extension Period|study terminated by sponsor|23
7635799|NCT01636687|26566103|P3|Extension Period|study terminated by sponsor|17
7635800|NCT01636687|26566104|P2|Extension Period|study terminated by sponsor|50
7635801|NCT01636687|26566105|P1|Extension Period|study terminated by sponsor|33
7635802|NCT01636687|26566101|P5|Extension Period|Physician Decision|0
7635803|NCT01636687|26566102|P4|Extension Period|Physician Decision|1
7635804|NCT01636687|26566103|P3|Extension Period|Physician Decision|0
7635805|NCT01636687|26566104|P2|Extension Period|Physician Decision|0
7635806|NCT01636687|26566105|P1|Extension Period|Physician Decision|1
7635807|NCT01636687|26566101|P5|Extension Period|Lost to Follow-up|0
7635808|NCT01636687|26566102|P4|Extension Period|Lost to Follow-up|0
7635809|NCT01636687|26566103|P3|Extension Period|Lost to Follow-up|1
7635810|NCT01636687|26566104|P2|Extension Period|Lost to Follow-up|0
7635811|NCT01636687|26566105|P1|Extension Period|Lost to Follow-up|1
7635812|NCT01636687|26566101|P5|Extension Period|Lack of Efficacy|0
7635813|NCT01636687|26566102|P4|Extension Period|Lack of Efficacy|1
7635814|NCT01636687|26566103|P3|Extension Period|Lack of Efficacy|2
7635815|NCT01636687|26566104|P2|Extension Period|Lack of Efficacy|0
7635816|NCT01636687|26566105|P1|Extension Period|Lack of Efficacy|7
7635817|NCT01636687|26566101|P5|Extension Period|Adverse Event|0
7635818|NCT01636687|26566102|P4|Extension Period|Adverse Event|1
7635819|NCT01636687|26566103|P3|Extension Period|Adverse Event|2
7635820|NCT01636687|26566104|P2|Extension Period|Adverse Event|3
7635821|NCT01636687|26566105|P1|Extension Period|Adverse Event|4
7635822|NCT01636687|26566101|P5|Extension Period|technical problems|0
7635823|NCT01636687|26566102|P4|Extension Period|technical problems|1
7635824|NCT01636687|26566103|P3|Extension Period|technical problems|2
7635825|NCT01636687|26566104|P2|Extension Period|technical problems|1
7635826|NCT01636687|26566105|P1|Extension Period|technical problems|0
7635827|NCT01636687|26566101|P5|Maintenance Period|Physician Decision|1
7635828|NCT01636687|26566102|P4|Maintenance Period|Physician Decision|0
7635829|NCT01636687|26566103|P3|Maintenance Period|Physician Decision|0
7635830|NCT01636687|26566104|P2|Maintenance Period|Physician Decision|0
7635831|NCT01636687|26566105|P1|Maintenance Period|Physician Decision|0
7635832|NCT01636687|26566101|P5|Maintenance Period|Lost to Follow-up|1
7635833|NCT01636687|26566102|P4|Maintenance Period|Lost to Follow-up|0
7635834|NCT01636687|26566103|P3|Maintenance Period|Lost to Follow-up|0
7635835|NCT01636687|26566104|P2|Maintenance Period|Lost to Follow-up|1
7635836|NCT01636687|26566105|P1|Maintenance Period|Lost to Follow-up|1
7635837|NCT01636687|26566101|P5|Maintenance Period|Lack of Efficacy|0
7635838|NCT01636687|26566102|P4|Maintenance Period|Lack of Efficacy|0
7635839|NCT01636687|26566103|P3|Maintenance Period|Lack of Efficacy|0
7635840|NCT01636687|26566104|P2|Maintenance Period|Lack of Efficacy|1
7635842|NCT01636687|26566101|P5|Maintenance Period|Adverse Event|0
7635843|NCT01636687|26566102|P4|Maintenance Period|Adverse Event|0
7635844|NCT01636687|26566103|P3|Maintenance Period|Adverse Event|0
7635845|NCT01636687|26566104|P2|Maintenance Period|Adverse Event|0
7635846|NCT01636687|26566105|P1|Maintenance Period|Adverse Event|1
7635847|NCT01636687|26566101|P5|Maintenance Period|Withdrawal by Subject|0
7635848|NCT01636687|26566102|P4|Maintenance Period|Withdrawal by Subject|0
7635849|NCT01636687|26566103|P3|Maintenance Period|Withdrawal by Subject|2
7635850|NCT01636687|26566104|P2|Maintenance Period|Withdrawal by Subject|0
7635851|NCT01636687|26566105|P1|Maintenance Period|Withdrawal by Subject|2
7635852|NCT01636687|26566101|P5|Induction Period|Physician Decision|0
7635853|NCT01636687|26566102|P4|Induction Period|Physician Decision|0
7635854|NCT01636687|26566103|P3|Induction Period|Physician Decision|0
7635855|NCT01636687|26566104|P2|Induction Period|Physician Decision|0
7635856|NCT01636687|26566105|P1|Induction Period|Physician Decision|1
7635857|NCT01636687|26566101|P5|Induction Period|Lack of Efficacy|1
7635858|NCT01636687|26566102|P4|Induction Period|Lack of Efficacy|0
7635859|NCT01636687|26566103|P3|Induction Period|Lack of Efficacy|0
7635860|NCT01636687|26566104|P2|Induction Period|Lack of Efficacy|0
7635861|NCT01636687|26566105|P1|Induction Period|Lack of Efficacy|0
7635862|NCT01636687|26566101|P5|Induction Period|Adverse Event|1
7635863|NCT01636687|26566102|P4|Induction Period|Adverse Event|0
7635864|NCT01636687|26566103|P3|Induction Period|Adverse Event|0
7635865|NCT01636687|26566104|P2|Induction Period|Adverse Event|0
7635866|NCT01636687|26566105|P1|Induction Period|Adverse Event|1
7635867|NCT01636687|26566101|P5|Induction Period|Withdrawal by Subject|0
7635868|NCT01636687|26566102|P4|Induction Period|Withdrawal by Subject|0
7635869|NCT01636687|26566103|P3|Induction Period|Withdrawal by Subject|0
7635870|NCT01636687|26566104|P2|Induction Period|Withdrawal by Subject|0
7635871|NCT01636687|26566105|P1|Induction Period|Withdrawal by Subject|1
7635872|NCT01636362|26566246|P1|Overall Study|Withdrawal by Subject|1
7635873|NCT01636362|26566246|P1|Overall Study|Subject healed, not returning|1
7635874|NCT01636362|26566246|P1|Overall Study|Physician Decision|6
7635875|NCT01636258|26566279|P2|Overall Study|Lost to Follow-up|0
7635876|NCT01636258|26566280|P1|Overall Study|Lost to Follow-up|1
7635877|NCT01636076|26566320|P2|Overall Study|Withdrawal by Subject|10
7635878|NCT01636076|26566321|P1|Overall Study|Withdrawal by Subject|7
7635879|NCT01636076|26566320|P2|Overall Study|Adverse Event|11
7635880|NCT01636076|26566321|P1|Overall Study|Adverse Event|6
7635881|NCT01636076|26566320|P2|Overall Study|Non-compliance with study treatment|1
7635882|NCT01636076|26566321|P1|Overall Study|Non-compliance with study treatment|1
7635883|NCT01636076|26566320|P2|Overall Study|Physician Decision|1
7635884|NCT01636076|26566321|P1|Overall Study|Physician Decision|1
7635885|NCT01636076|26566320|P2|Overall Study|Lost to Follow-up|0
7635886|NCT01636076|26566321|P1|Overall Study|Lost to Follow-up|1
7635887|NCT01636076|26566320|P2|Overall Study|Lack of Efficacy|1
7635888|NCT01636076|26566321|P1|Overall Study|Lack of Efficacy|0
7635889|NCT01636076|26566320|P2|Overall Study|Terminated by sponsor|1
7635890|NCT01636076|26566321|P1|Overall Study|Terminated by sponsor|1
7635891|NCT01635998|26566392|P2|Overall Study|Withdrawal by Subject|5
7635892|NCT01635998|26566393|P1|Overall Study|Withdrawal by Subject|1
7635893|NCT01635998|26566392|P2|Overall Study|Lost to Follow-up|1
7635894|NCT01635998|26566393|P1|Overall Study|Lost to Follow-up|2
7635895|NCT01635998|26566392|P2|Overall Study|Death|1
7635896|NCT01635998|26566393|P1|Overall Study|Death|1
7635897|NCT01635933|26566421|P2|Overall Study|No longer had transportation|1
7635898|NCT01635933|26566422|P1|Overall Study|No longer had transportation|0
7635899|NCT01635933|26566421|P2|Overall Study|Noncompliance|1
7635900|NCT01635933|26566422|P1|Overall Study|Noncompliance|0
7635901|NCT01635933|26566421|P2|Overall Study|Subject decision|1
7635902|NCT01635933|26566422|P1|Overall Study|Subject decision|1
7635903|NCT01635933|26566421|P2|Overall Study|Lost to Follow-up|5
7635904|NCT01635933|26566422|P1|Overall Study|Lost to Follow-up|0
7635905|NCT01635933|26566421|P2|Overall Study|Adverse Event|0
7635906|NCT01635933|26566422|P1|Overall Study|Adverse Event|1
7635907|NCT01635920|26566434|P2|Overall Study|Subject decision|0
7635908|NCT01635920|26566435|P1|Overall Study|Subject decision|2
7635909|NCT01635920|26566434|P2|Overall Study|Lost to Follow-up|1
7635910|NCT01635920|26566435|P1|Overall Study|Lost to Follow-up|0
7635911|NCT01635920|26566434|P2|Overall Study|Adverse Event|0
7635912|NCT01635920|26566435|P1|Overall Study|Adverse Event|1
7635913|NCT01635855|26566448|P1|Overall Study|Withdrawal by Subject|4
7635914|NCT01635764|26566457|P1|Overall Study|Other|28
7635915|NCT01635764|26566457|P1|Overall Study|Lost to Follow-up|53
7635916|NCT01635764|26566457|P1|Overall Study|Withdrew Consent|67
7635917|NCT01635764|26566457|P1|Overall Study|Protocol Deviation|1
7635918|NCT01635764|26566457|P1|Overall Study|Exceed Protocol-specified Interventions|2
7635919|NCT01635764|26566457|P1|Overall Study|Lack of Efficacy|76
7635920|NCT01635764|26566457|P1|Overall Study|Adverse Event|46
7635921|NCT01635283|26566507|P1|Overall Study|Lost to Follow-up|1
7635922|NCT01635283|26566507|P1|Overall Study|Tumor Progression|3
7635923|NCT01635218|26566531|P3|Overall Study|Lost to Follow-up|6
7635924|NCT01635218|26566532|P2|Overall Study|Lost to Follow-up|7
7635925|NCT01635218|26566533|P1|Overall Study|Lost to Follow-up|3
7635926|NCT01635153|26566555|P2|Overall Study|Lost to Follow-up|43
7635927|NCT01635153|26566556|P1|Overall Study|Lost to Follow-up|40
7635928|NCT01634854|26566609|P2|Overall Study|Cesarean delivery|7
7635929|NCT01634854|26566610|P1|Overall Study|Cesarean delivery|2
7635930|NCT01634659|26566630|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
7635931|NCT01634659|26566631|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
7635932|NCT01634659|26566630|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
7635933|NCT01634659|26566631|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
7635934|NCT01634555|26566661|P1|Overall Study|Physician Decision|1
7635935|NCT01634555|26566661|P1|Overall Study|Adverse Event|3
7635936|NCT01634360|26566672|P2|Overall Study|Study termination by sponsor|44
7635937|NCT01634360|26566673|P1|Overall Study|Study termination by sponsor|18
7635938|NCT01634360|26566672|P2|Overall Study|Other|20
7635939|NCT01634360|26566673|P1|Overall Study|Other|3
7635940|NCT01634360|26566672|P2|Overall Study|Lack of Efficacy|14
7635941|NCT01634360|26566673|P1|Overall Study|Lack of Efficacy|4
7635942|NCT01634360|26566672|P2|Overall Study|Protocol Violation|1
7635943|NCT01634360|26566673|P1|Overall Study|Protocol Violation|1
7635944|NCT01634360|26566672|P2|Overall Study|subject withdrew consent|23
7635945|NCT01634360|26566673|P1|Overall Study|subject withdrew consent|13
7635946|NCT01634360|26566672|P2|Overall Study|Adverse Event|34
7635947|NCT01634360|26566673|P1|Overall Study|Adverse Event|10
7635948|NCT01634243|26566747|P2|Overall Study|Lack of Efficacy|0
7635949|NCT01634243|26566748|P1|Overall Study|Lack of Efficacy|1
7635950|NCT01634243|26566747|P2|Overall Study|Adverse Event|5
7635951|NCT01634243|26566748|P1|Overall Study|Adverse Event|5
7635952|NCT01634178|26566820|P2|Treatment Period 2|Adverse Event|0
7635953|NCT01634178|26566821|P1|Treatment Period 2|Adverse Event|1
7635954|NCT01634178|26566820|P2|Treatment Period 1|Adverse Event|1
7635955|NCT01634178|26566821|P1|Treatment Period 1|Adverse Event|0
7635956|NCT01634165|26566842|P4|Period 2|Adverse Event|0
7635957|NCT01634165|26566843|P3|Period 2|Adverse Event|0
7635958|NCT01634165|26566844|P2|Period 2|Adverse Event|1
7635959|NCT01634165|26566845|P1|Period 2|Adverse Event|0
7635960|NCT01634152|26566878|P3|Overall Study|Other reason not defined above|1
7635961|NCT01634152|26566879|P2|Overall Study|Other reason not defined above|0
7635962|NCT01634152|26566880|P1|Overall Study|Other reason not defined above|1
7635963|NCT01634152|26566878|P3|Overall Study|Not treated|0
7635964|NCT01634152|26566879|P2|Overall Study|Not treated|1
7635965|NCT01634152|26566880|P1|Overall Study|Not treated|0
7635966|NCT01634152|26566878|P3|Overall Study|Consent withdrawn not due to AE|1
7635967|NCT01634152|26566879|P2|Overall Study|Consent withdrawn not due to AE|0
7635968|NCT01634152|26566880|P1|Overall Study|Consent withdrawn not due to AE|1
7635969|NCT01634152|26566878|P3|Overall Study|Adverse Event|2
7635970|NCT01634152|26566879|P2|Overall Study|Adverse Event|0
7635971|NCT01634152|26566880|P1|Overall Study|Adverse Event|2
7635972|NCT01634139|26566963|P3|Overall Study|Not treated|0
7635973|NCT01634139|26566964|P2|Overall Study|Not treated|1
7635974|NCT01634139|26566965|P1|Overall Study|Not treated|1
7635975|NCT01634139|26566963|P3|Overall Study|Lost to Follow-up|0
7635976|NCT01634139|26566964|P2|Overall Study|Lost to Follow-up|2
7635977|NCT01634139|26566965|P1|Overall Study|Lost to Follow-up|0
7635978|NCT01634139|26566963|P3|Overall Study|Other|3
7635979|NCT01634139|26566964|P2|Overall Study|Other|0
7635980|NCT01634139|26566965|P1|Overall Study|Other|4
7635981|NCT01634139|26566963|P3|Overall Study|Consent withdrawn not due to AE|2
7635982|NCT01634139|26566964|P2|Overall Study|Consent withdrawn not due to AE|3
7635983|NCT01634139|26566965|P1|Overall Study|Consent withdrawn not due to AE|4
7635984|NCT01634139|26566963|P3|Overall Study|Non compliant with protocol|0
7635985|NCT01634139|26566964|P2|Overall Study|Non compliant with protocol|0
7635986|NCT01634139|26566965|P1|Overall Study|Non compliant with protocol|1
7635987|NCT01634113|26567066|P3|Overall Study|Not treated|1
7635988|NCT01634113|26567067|P2|Overall Study|Not treated|0
7635989|NCT01634113|26567068|P1|Overall Study|Not treated|0
7635990|NCT01634100|26567112|P6|Overall Study|Withdrawal by Subject|0
7635991|NCT01634100|26567113|P5|Overall Study|Withdrawal by Subject|0
7635992|NCT01634100|26567114|P4|Overall Study|Withdrawal by Subject|0
7635993|NCT01634100|26567115|P3|Overall Study|Withdrawal by Subject|1
7635994|NCT01634100|26567116|P2|Overall Study|Withdrawal by Subject|0
7635995|NCT01634100|26567117|P1|Overall Study|Withdrawal by Subject|1
7635996|NCT01633944|26567146|P3|Double-blind Treatment Phase|Other|0
7635997|NCT01633944|26567147|P2|Double-blind Treatment Phase|Other|7
7635998|NCT01633944|26567148|P1|Double-blind Treatment Phase|Other|0
7635999|NCT01633944|26567146|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
7636000|NCT01633944|26567147|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
7636001|NCT01633944|26567148|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
7636002|NCT01633944|26567146|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7636003|NCT01633944|26567147|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
7636004|NCT01633944|26567148|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7636005|NCT01633944|26567146|P3|Double-blind Treatment Phase|Lost to Follow-up|9
7636006|NCT01633944|26567147|P2|Double-blind Treatment Phase|Lost to Follow-up|4
7636007|NCT01633944|26567148|P1|Double-blind Treatment Phase|Lost to Follow-up|0
7636008|NCT01633944|26567146|P3|Double-blind Treatment Phase|Protocol Violation|10
7636009|NCT01633944|26567147|P2|Double-blind Treatment Phase|Protocol Violation|7
7636010|NCT01633944|26567148|P1|Double-blind Treatment Phase|Protocol Violation|0
7636011|NCT01633944|26567146|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
7636012|NCT01633944|26567147|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
7636013|NCT01633944|26567148|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
7636014|NCT01633944|26567146|P3|Double-blind Treatment Phase|Lack of Efficacy|23
7636015|NCT01633944|26567147|P2|Double-blind Treatment Phase|Lack of Efficacy|8
7636016|NCT01633944|26567148|P1|Double-blind Treatment Phase|Lack of Efficacy|0
7636017|NCT01633944|26567146|P3|Double-blind Treatment Phase|Adverse Event|7
7636018|NCT01633944|26567147|P2|Double-blind Treatment Phase|Adverse Event|13
7636019|NCT01633944|26567148|P1|Double-blind Treatment Phase|Adverse Event|0
7636020|NCT01633944|26567146|P3|Open-label Titration Phase|Other|0
7636021|NCT01633944|26567147|P2|Open-label Titration Phase|Other|0
7636022|NCT01633944|26567148|P1|Open-label Titration Phase|Other|68
7636023|NCT01633944|26567146|P3|Open-label Titration Phase|Lost to Follow-up|0
7636024|NCT01633944|26567147|P2|Open-label Titration Phase|Lost to Follow-up|0
7636025|NCT01633944|26567148|P1|Open-label Titration Phase|Lost to Follow-up|22
7636026|NCT01633944|26567146|P3|Open-label Titration Phase|Protocol Violation|0
7636027|NCT01633944|26567147|P2|Open-label Titration Phase|Protocol Violation|0
7636028|NCT01633944|26567148|P1|Open-label Titration Phase|Protocol Violation|24
7636029|NCT01633944|26567146|P3|Open-label Titration Phase|Withdrawal by Subject|0
7636030|NCT01633944|26567147|P2|Open-label Titration Phase|Withdrawal by Subject|0
7636031|NCT01633944|26567148|P1|Open-label Titration Phase|Withdrawal by Subject|34
7636032|NCT01633944|26567146|P3|Open-label Titration Phase|Lack of Efficacy|0
7636033|NCT01633944|26567147|P2|Open-label Titration Phase|Lack of Efficacy|0
7636034|NCT01633944|26567148|P1|Open-label Titration Phase|Lack of Efficacy|33
7636035|NCT01633944|26567146|P3|Open-label Titration Phase|Adverse Event|0
7636036|NCT01633944|26567147|P2|Open-label Titration Phase|Adverse Event|0
7636037|NCT01633944|26567148|P1|Open-label Titration Phase|Adverse Event|109
7636038|NCT01633788|26567216|P4|Overall Study|Other Reasons|7
7636039|NCT01633788|26567217|P3|Overall Study|Other Reasons|3
7636040|NCT01633788|26567218|P2|Overall Study|Other Reasons|2
7636041|NCT01633788|26567219|P1|Overall Study|Other Reasons|0
7636042|NCT01633788|26567216|P4|Overall Study|Protocol Violation|0
7636043|NCT01633788|26567217|P3|Overall Study|Protocol Violation|1
7636044|NCT01633788|26567218|P2|Overall Study|Protocol Violation|0
7636045|NCT01633788|26567219|P1|Overall Study|Protocol Violation|1
7636046|NCT01633788|26567216|P4|Overall Study|Personal Reasons|3
7636047|NCT01633788|26567217|P3|Overall Study|Personal Reasons|1
7636048|NCT01633788|26567218|P2|Overall Study|Personal Reasons|1
7636049|NCT01633788|26567219|P1|Overall Study|Personal Reasons|3
7636050|NCT01633788|26567216|P4|Overall Study|Lost to Follow-up|0
7636051|NCT01633788|26567217|P3|Overall Study|Lost to Follow-up|2
7636052|NCT01633788|26567218|P2|Overall Study|Lost to Follow-up|2
7636053|NCT01633788|26567219|P1|Overall Study|Lost to Follow-up|2
7636054|NCT01633788|26567216|P4|Overall Study|Adverse Event|3
7636055|NCT01633788|26567217|P3|Overall Study|Adverse Event|3
7636056|NCT01633788|26567218|P2|Overall Study|Adverse Event|3
7636057|NCT01633788|26567219|P1|Overall Study|Adverse Event|1
7636058|NCT01633112|26567262|P3|Overall Study|missing Study Completion CRF|4
7636059|NCT01633112|26567263|P2|Overall Study|missing Study Completion CRF|1
7636060|NCT01633112|26567264|P1|Overall Study|missing Study Completion CRF|1
7636061|NCT01633112|26567262|P3|Overall Study|Withdrawal by Subject|41
7636062|NCT01633112|26567263|P2|Overall Study|Withdrawal by Subject|12
7636063|NCT01633112|26567264|P1|Overall Study|Withdrawal by Subject|20
7636064|NCT01633112|26567262|P3|Overall Study|Subject no longer requires study drug|1
7636065|NCT01633112|26567263|P2|Overall Study|Subject no longer requires study drug|0
7636066|NCT01633112|26567264|P1|Overall Study|Subject no longer requires study drug|0
7636067|NCT01633112|26567262|P3|Overall Study|Protocol Violation|2
7636068|NCT01633112|26567263|P2|Overall Study|Protocol Violation|0
7636069|NCT01633112|26567264|P1|Overall Study|Protocol Violation|4
7636070|NCT01633112|26567262|P3|Overall Study|Lost to Follow-up|6
7636071|NCT01633112|26567263|P2|Overall Study|Lost to Follow-up|19
7636072|NCT01633112|26567264|P1|Overall Study|Lost to Follow-up|7
7636073|NCT01633112|26567262|P3|Overall Study|Adverse Event|20
7636074|NCT01633112|26567263|P2|Overall Study|Adverse Event|18
7636075|NCT01633112|26567264|P1|Overall Study|Adverse Event|16
7636076|NCT01633112|26567262|P3|Overall Study|Administrative problems|5
7636077|NCT01633112|26567263|P2|Overall Study|Administrative problems|2
7636078|NCT01633112|26567264|P1|Overall Study|Administrative problems|1
7636079|NCT01633112|26567262|P3|Overall Study|Abnormal test procedure result(s)|0
7636080|NCT01633112|26567263|P2|Overall Study|Abnormal test procedure result(s)|1
7636081|NCT01633112|26567264|P1|Overall Study|Abnormal test procedure result(s)|0
7636082|NCT01633112|26567262|P3|Overall Study|Abnormal laboratory value(s)|0
7636083|NCT01633112|26567263|P2|Overall Study|Abnormal laboratory value(s)|1
7636084|NCT01633112|26567264|P1|Overall Study|Abnormal laboratory value(s)|3
7636085|NCT01633112|26567262|P3|Overall Study|Lack of Efficacy|13
7636086|NCT01633112|26567263|P2|Overall Study|Lack of Efficacy|6
7636087|NCT01633112|26567264|P1|Overall Study|Lack of Efficacy|1
7636088|NCT01633060|26567299|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
7636089|NCT01633060|26567300|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
7636090|NCT01633060|26567299|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7636091|NCT01633060|26567300|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7636092|NCT01633060|26567299|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
7636093|NCT01633060|26567300|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
7636094|NCT01633060|26567299|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
7636095|NCT01633060|26567300|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
7636096|NCT01633060|26567299|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
7636097|NCT01633060|26567300|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
7636098|NCT01633060|26567299|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7636099|NCT01633060|26567300|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7636100|NCT01633060|26567299|P2|Treatment Phase|Death|3
7636101|NCT01633060|26567300|P1|Treatment Phase|Death|4
7636102|NCT01633060|26567299|P2|Treatment Phase|Subject/guardian decision|4
7636103|NCT01633060|26567300|P1|Treatment Phase|Subject/guardian decision|25
7636104|NCT01633060|26567299|P2|Treatment Phase|Study Terminated by sponsor|3
7636105|NCT01633060|26567300|P1|Treatment Phase|Study Terminated by sponsor|7
7636106|NCT01633060|26567299|P2|Treatment Phase|Protocol Deviation|0
7636107|NCT01633060|26567300|P1|Treatment Phase|Protocol Deviation|1
7636108|NCT01633060|26567299|P2|Treatment Phase|Progressive Disease|120
7636109|NCT01633060|26567300|P1|Treatment Phase|Progressive Disease|210
7636110|NCT01633060|26567299|P2|Treatment Phase|Physician Decision|7
7636111|NCT01633060|26567300|P1|Treatment Phase|Physician Decision|16
7636112|NCT01633060|26567299|P2|Treatment Phase|Lost to Follow-up|0
7636113|NCT01633060|26567300|P1|Treatment Phase|Lost to Follow-up|1
7636114|NCT01633060|26567299|P2|Treatment Phase|Adverse Event|3
7636115|NCT01633060|26567300|P1|Treatment Phase|Adverse Event|24
7636116|NCT01633060|26567299|P2|Randomization Phase|Technical problem|1
7636117|NCT01633060|26567300|P1|Randomization Phase|Technical problem|0
7636118|NCT01633060|26567299|P2|Randomization Phase|Protocol deviation|2
7636119|NCT01633060|26567300|P1|Randomization Phase|Protocol deviation|1
7636120|NCT01632904|26567340|P2|Overall Study|Reason for discontinuation not available|1
7636121|NCT01632904|26567341|P1|Overall Study|Reason for discontinuation not available|0
7636122|NCT01632904|26567340|P2|Overall Study|Disease Progression|1
7636123|NCT01632904|26567341|P1|Overall Study|Disease Progression|0
7636124|NCT01632904|26567340|P2|Overall Study|Subject decision|2
7636125|NCT01632904|26567341|P1|Overall Study|Subject decision|3
7636126|NCT01632904|26567340|P2|Overall Study|Physician Decision|1
7636127|NCT01632904|26567341|P1|Overall Study|Physician Decision|0
7636128|NCT01632904|26567340|P2|Overall Study|Adverse Event|1
7636129|NCT01632904|26567341|P1|Overall Study|Adverse Event|4
7636130|NCT01632891|26567352|P2|Overall Study|Withdrawal by Subject|0
7636131|NCT01632891|26567353|P1|Overall Study|Withdrawal by Subject|1
7636132|NCT01632891|26567352|P2|Overall Study|Lost to Follow-up|1
7636133|NCT01632891|26567353|P1|Overall Study|Lost to Follow-up|0
7636134|NCT01632878|26567377|P1|Treatment|no information on study completion|43
7636135|NCT01632878|26567377|P1|Treatment|missing information|4
7636136|NCT01632878|26567377|P1|Treatment|Physician Decision|34
7636137|NCT01632878|26567377|P1|Treatment|Withdrawal by Subject|36
7636138|NCT01632878|26567377|P1|Treatment|Lost to Follow-up|41
7636139|NCT01632878|26567377|P1|Screening|Physician Decision|268
7636140|NCT01632800|26567381|P1|Overall Study|Subject did not fit in apparatus|1
7636141|NCT01632579|26567448|P9|Period 2 (Second Intervention)|Adverse Event|0
7636142|NCT01632579|26567449|P8|Period 2 (Second Intervention)|Adverse Event|0
7636143|NCT01632579|26567450|P7|Period 2 (Second Intervention)|Adverse Event|0
7636144|NCT01632579|26567451|P6|Period 2 (Second Intervention)|Adverse Event|0
7636145|NCT01632579|26567452|P5|Period 2 (Second Intervention)|Adverse Event|0
7636146|NCT01632579|26567453|P4|Period 2 (Second Intervention)|Adverse Event|0
7636147|NCT01632579|26567454|P3|Period 2 (Second Intervention)|Adverse Event|0
7636148|NCT01632579|26567455|P2|Period 2 (Second Intervention)|Adverse Event|0
7636149|NCT01632579|26567456|P1|Period 2 (Second Intervention)|Adverse Event|1
7636150|NCT01632579|26567448|P9|Washout Period|Adverse Event|0
7636151|NCT01632579|26567449|P8|Washout Period|Adverse Event|0
7636152|NCT01632579|26567450|P7|Washout Period|Adverse Event|0
7636153|NCT01632579|26567451|P6|Washout Period|Adverse Event|0
7636154|NCT01632579|26567452|P5|Washout Period|Adverse Event|0
7636155|NCT01632579|26567453|P4|Washout Period|Adverse Event|0
7636156|NCT01632579|26567454|P3|Washout Period|Adverse Event|0
7636157|NCT01632579|26567455|P2|Washout Period|Adverse Event|0
7636158|NCT01632579|26567456|P1|Washout Period|Adverse Event|1
7636159|NCT01632566|26567523|P5|Overall Study|Sponsor Decision|2
7636160|NCT01632566|26567524|P4|Overall Study|Sponsor Decision|2
7636161|NCT01632566|26567525|P3|Overall Study|Sponsor Decision|9
7636162|NCT01632566|26567526|P2|Overall Study|Sponsor Decision|2
7636163|NCT01632566|26567527|P1|Overall Study|Sponsor Decision|0
7636164|NCT01632566|26567523|P5|Overall Study|Withdrawal by Subject|0
7636165|NCT01632566|26567524|P4|Overall Study|Withdrawal by Subject|0
7636166|NCT01632566|26567525|P3|Overall Study|Withdrawal by Subject|0
7636167|NCT01632566|26567526|P2|Overall Study|Withdrawal by Subject|1
7636168|NCT01632566|26567527|P1|Overall Study|Withdrawal by Subject|0
7636169|NCT01632345|26567578|P7|Treatment: Part II|Withdrawal by Subject|2
7636170|NCT01632345|26567579|P6|Treatment: Part II|Withdrawal by Subject|2
7636171|NCT01632345|26567580|P5|Treatment: Part II|Withdrawal by Subject|0
7636172|NCT01632345|26567581|P4|Treatment: Part II|Withdrawal by Subject|0
7636173|NCT01632345|26567582|P3|Treatment: Part II|Withdrawal by Subject|0
7636174|NCT01632345|26567583|P2|Treatment: Part II|Withdrawal by Subject|0
7636175|NCT01632345|26567584|P1|Treatment: Part II|Withdrawal by Subject|0
7636176|NCT01632345|26567578|P7|Treatment: Part II|Non-Compliance with Study Drug|0
7636177|NCT01632345|26567579|P6|Treatment: Part II|Non-Compliance with Study Drug|3
7636178|NCT01632345|26567580|P5|Treatment: Part II|Non-Compliance with Study Drug|0
7636179|NCT01632345|26567581|P4|Treatment: Part II|Non-Compliance with Study Drug|0
7636180|NCT01632345|26567582|P3|Treatment: Part II|Non-Compliance with Study Drug|0
7636181|NCT01632345|26567583|P2|Treatment: Part II|Non-Compliance with Study Drug|0
7636182|NCT01632345|26567584|P1|Treatment: Part II|Non-Compliance with Study Drug|0
7636183|NCT01632345|26567578|P7|Treatment: Part II|Lost to Follow-up|1
7636184|NCT01632345|26567579|P6|Treatment: Part II|Lost to Follow-up|3
7636185|NCT01632345|26567580|P5|Treatment: Part II|Lost to Follow-up|0
7636186|NCT01632345|26567581|P4|Treatment: Part II|Lost to Follow-up|0
7636187|NCT01632345|26567582|P3|Treatment: Part II|Lost to Follow-up|0
7636188|NCT01632345|26567583|P2|Treatment: Part II|Lost to Follow-up|0
7636189|NCT01632345|26567584|P1|Treatment: Part II|Lost to Follow-up|0
7636190|NCT01632345|26567578|P7|Treatment: Part II|Adverse Event|8
7636191|NCT01632345|26567579|P6|Treatment: Part II|Adverse Event|3
7636192|NCT01632345|26567580|P5|Treatment: Part II|Adverse Event|0
7636193|NCT01632345|26567581|P4|Treatment: Part II|Adverse Event|0
7636194|NCT01632345|26567582|P3|Treatment: Part II|Adverse Event|0
7636195|NCT01632345|26567583|P2|Treatment: Part II|Adverse Event|0
7636196|NCT01632345|26567584|P1|Treatment: Part II|Adverse Event|0
7636197|NCT01632345|26567578|P7|Treatment: Part I|Withdrawal by Subject|0
7636198|NCT01632345|26567579|P6|Treatment: Part I|Withdrawal by Subject|0
7636199|NCT01632345|26567580|P5|Treatment: Part I|Withdrawal by Subject|4
7636200|NCT01632345|26567581|P4|Treatment: Part I|Withdrawal by Subject|1
7636201|NCT01632345|26567582|P3|Treatment: Part I|Withdrawal by Subject|4
7636202|NCT01632345|26567583|P2|Treatment: Part I|Withdrawal by Subject|4
7636203|NCT01632345|26567584|P1|Treatment: Part I|Withdrawal by Subject|3
7636204|NCT01632345|26567578|P7|Treatment: Part I|Protocol Deviation|0
7636205|NCT01632345|26567579|P6|Treatment: Part I|Protocol Deviation|0
7636206|NCT01632345|26567580|P5|Treatment: Part I|Protocol Deviation|0
7636207|NCT01632345|26567581|P4|Treatment: Part I|Protocol Deviation|1
7636208|NCT01632345|26567582|P3|Treatment: Part I|Protocol Deviation|1
7636209|NCT01632345|26567583|P2|Treatment: Part I|Protocol Deviation|0
7636210|NCT01632345|26567584|P1|Treatment: Part I|Protocol Deviation|0
7636211|NCT01632345|26567578|P7|Treatment: Part I|Pregnancy|0
7636212|NCT01632345|26567579|P6|Treatment: Part I|Pregnancy|0
7636213|NCT01632345|26567580|P5|Treatment: Part I|Pregnancy|0
7636214|NCT01632345|26567581|P4|Treatment: Part I|Pregnancy|0
7636215|NCT01632345|26567582|P3|Treatment: Part I|Pregnancy|0
7636216|NCT01632345|26567583|P2|Treatment: Part I|Pregnancy|1
7636217|NCT01632345|26567584|P1|Treatment: Part I|Pregnancy|0
7636218|NCT01632345|26567578|P7|Treatment: Part I|Physician Decision|0
7636219|NCT01632345|26567579|P6|Treatment: Part I|Physician Decision|0
7636220|NCT01632345|26567580|P5|Treatment: Part I|Physician Decision|1
7636221|NCT01632345|26567581|P4|Treatment: Part I|Physician Decision|0
7636222|NCT01632345|26567582|P3|Treatment: Part I|Physician Decision|0
7636223|NCT01632345|26567583|P2|Treatment: Part I|Physician Decision|1
7636224|NCT01632345|26567584|P1|Treatment: Part I|Physician Decision|2
7636225|NCT01632345|26567578|P7|Treatment: Part I|Non-Compliance with Study Drug|0
7636226|NCT01632345|26567579|P6|Treatment: Part I|Non-Compliance with Study Drug|0
7636227|NCT01632345|26567580|P5|Treatment: Part I|Non-Compliance with Study Drug|0
7636228|NCT01632345|26567581|P4|Treatment: Part I|Non-Compliance with Study Drug|1
7636229|NCT01632345|26567582|P3|Treatment: Part I|Non-Compliance with Study Drug|2
7636230|NCT01632345|26567583|P2|Treatment: Part I|Non-Compliance with Study Drug|2
7636231|NCT01632345|26567584|P1|Treatment: Part I|Non-Compliance with Study Drug|3
7636232|NCT01632345|26567578|P7|Treatment: Part I|Lost to Follow-up|0
7636233|NCT01632345|26567579|P6|Treatment: Part I|Lost to Follow-up|0
7636234|NCT01632345|26567580|P5|Treatment: Part I|Lost to Follow-up|4
7636235|NCT01632345|26567581|P4|Treatment: Part I|Lost to Follow-up|3
7636236|NCT01632345|26567582|P3|Treatment: Part I|Lost to Follow-up|1
7636237|NCT01632345|26567583|P2|Treatment: Part I|Lost to Follow-up|2
7636238|NCT01632345|26567584|P1|Treatment: Part I|Lost to Follow-up|3
7636239|NCT01632345|26567578|P7|Treatment: Part I|Lack of Efficacy|0
7636240|NCT01632345|26567579|P6|Treatment: Part I|Lack of Efficacy|0
7636241|NCT01632345|26567580|P5|Treatment: Part I|Lack of Efficacy|1
7636242|NCT01632345|26567581|P4|Treatment: Part I|Lack of Efficacy|1
7636243|NCT01632345|26567582|P3|Treatment: Part I|Lack of Efficacy|0
7636244|NCT01632345|26567583|P2|Treatment: Part I|Lack of Efficacy|1
7636245|NCT01632345|26567584|P1|Treatment: Part I|Lack of Efficacy|0
7636246|NCT01632345|26567578|P7|Treatment: Part I|Adverse Event|0
7636247|NCT01632345|26567579|P6|Treatment: Part I|Adverse Event|0
7636248|NCT01632345|26567580|P5|Treatment: Part I|Adverse Event|3
7636249|NCT01632345|26567581|P4|Treatment: Part I|Adverse Event|1
7636250|NCT01632345|26567582|P3|Treatment: Part I|Adverse Event|2
7636251|NCT01632345|26567583|P2|Treatment: Part I|Adverse Event|4
7636252|NCT01632345|26567584|P1|Treatment: Part I|Adverse Event|1
7636253|NCT01632306|26567646|P3|Overall Study|Protocol Violation|0
7636254|NCT01632306|26567647|P2|Overall Study|Protocol Violation|0
7636255|NCT01632306|26567648|P1|Overall Study|Protocol Violation|1
7636256|NCT01632280|26567664|P2|Overall Study|Withdrawal by Subject|0
7636257|NCT01632280|26567665|P1|Overall Study|Withdrawal by Subject|1
7636258|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
7636259|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
7636260|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
7636261|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
7636262|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
7636263|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
7636264|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Site Closed|8
7636265|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Site Closed|2
7636266|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
7636267|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
7636268|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
7636269|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
7636270|NCT01632241|26567681|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
7636271|NCT01632241|26567682|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
7636272|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Adverse Event|19
7636273|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Adverse Event|10
7636274|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
7636275|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
7636276|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
7636277|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
7636278|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Physician Decision|12
7636279|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Physician Decision|9
7636280|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
7636281|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
7636282|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
7636283|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
7636284|NCT01632241|26567681|P2|Double-blinded (Up to Week 52)|Site Closed|5
7636285|NCT01632241|26567682|P1|Double-blinded (Up to Week 52)|Site Closed|3
7636286|NCT01632150|26567752|P1|Overall Study|Moved to compassionate program|2
7636287|NCT01632150|26567752|P1|Overall Study|Patient underwent autologous transplant|1
7636288|NCT01632150|26567752|P1|Overall Study|Withdrawal by Subject|2
7636289|NCT01632150|26567752|P1|Overall Study|Unrelated adverse event|7
7636290|NCT01632150|26567752|P1|Overall Study|Study drug toxicity|1
7636291|NCT01632150|26567752|P1|Overall Study|Disease progression|27
7636292|NCT01632020|26567761|P2|Overall Study|Adverse Event|0
7636293|NCT01632020|26567762|P1|Overall Study|Adverse Event|1
7636294|NCT01632020|26567761|P2|Overall Study|Withdrawal by Subject|0
7636295|NCT01632020|26567762|P1|Overall Study|Withdrawal by Subject|1
7636296|NCT01631864|26567781|P2|Overall Study|Adverse Event|3
7636297|NCT01631864|26567782|P1|Overall Study|Adverse Event|2
7636298|NCT01631864|26567781|P2|Overall Study|Withdrawal by Subject|1
7636299|NCT01631864|26567782|P1|Overall Study|Withdrawal by Subject|0
7636300|NCT01631825|26567794|P1|Overall Study|Physician Decision|2
7636301|NCT01631825|26567794|P1|Overall Study|Discontinuation criteria|1
7636302|NCT01631825|26567794|P1|Overall Study|Protocol Violation|4
7636303|NCT01631825|26567794|P1|Overall Study|Withdrawal by Subject|9
7636304|NCT01631825|26567794|P1|Overall Study|Lack of Efficacy|7
7636305|NCT01631825|26567794|P1|Overall Study|Adverse Event|42
7636306|NCT01631812|26567814|P1|Overall Study|Physician Decision|3
7636307|NCT01631812|26567814|P1|Overall Study|Withdrawal by Subject|4
7636308|NCT01631812|26567814|P1|Overall Study|Lack of Efficacy|5
7636309|NCT01631812|26567814|P1|Overall Study|Adverse Event|25
7636310|NCT01631747|26567824|P2|One Year Infant Outcomes|Patient Refused|9
7636311|NCT01631747|26567825|P1|One Year Infant Outcomes|Patient Refused|13
7636312|NCT01631747|26567824|P2|Live Birth|Stillbirth|1
7636313|NCT01631747|26567825|P1|Live Birth|Stillbirth|1
7636314|NCT01631747|26567824|P2|Live Birth|MIscarriage|0
7636315|NCT01631747|26567825|P1|Live Birth|MIscarriage|2
7636316|NCT01631747|26567824|P2|Live Birth|Pregnancy Termination|0
7636317|NCT01631747|26567825|P1|Live Birth|Pregnancy Termination|1
7636318|NCT01631747|26567824|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
7636319|NCT01631747|26567825|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
7636320|NCT01631474|26568055|P5|Overall Study|Adverse Event|0
7636321|NCT01631474|26568056|P4|Overall Study|Adverse Event|0
7636322|NCT01631474|26568057|P3|Overall Study|Adverse Event|0
7636323|NCT01631474|26568058|P2|Overall Study|Adverse Event|1
7636324|NCT01631474|26568059|P1|Overall Study|Adverse Event|0
7636325|NCT01631474|26568055|P5|Overall Study|Noncompliance with Study Drug|1
7636326|NCT01631474|26568056|P4|Overall Study|Noncompliance with Study Drug|0
7636327|NCT01631474|26568057|P3|Overall Study|Noncompliance with Study Drug|0
7636328|NCT01631474|26568058|P2|Overall Study|Noncompliance with Study Drug|0
7636329|NCT01631474|26568059|P1|Overall Study|Noncompliance with Study Drug|0
7636330|NCT01631474|26568055|P5|Overall Study|Lack of Efficacy|2
7636331|NCT01631474|26568056|P4|Overall Study|Lack of Efficacy|0
7636332|NCT01631474|26568057|P3|Overall Study|Lack of Efficacy|0
7636333|NCT01631474|26568058|P2|Overall Study|Lack of Efficacy|2
7636334|NCT01631474|26568059|P1|Overall Study|Lack of Efficacy|2
7636335|NCT01631474|26568055|P5|Overall Study|Withdrawal by Subject|5
7636336|NCT01631474|26568056|P4|Overall Study|Withdrawal by Subject|6
7636337|NCT01631474|26568057|P3|Overall Study|Withdrawal by Subject|2
7636338|NCT01631474|26568058|P2|Overall Study|Withdrawal by Subject|4
7636339|NCT01631474|26568059|P1|Overall Study|Withdrawal by Subject|4
7636340|NCT01631474|26568055|P5|Overall Study|Lost to Follow-up|5
7636341|NCT01631474|26568056|P4|Overall Study|Lost to Follow-up|5
7636342|NCT01631474|26568057|P3|Overall Study|Lost to Follow-up|7
7636343|NCT01631474|26568058|P2|Overall Study|Lost to Follow-up|5
7636344|NCT01631474|26568059|P1|Overall Study|Lost to Follow-up|8
7636345|NCT01631435|26568096|P1|Overall Study|incomplete study procedure|5
7636346|NCT01631435|26568096|P1|Overall Study|Withdrawal by Subject|2
7636347|NCT01631435|26568096|P1|Overall Study|Adverse Event|2
7636348|NCT01631227|26568110|P2|Overall Study|administrative|1
7636349|NCT01631227|26568111|P1|Overall Study|administrative|2
7636350|NCT01631227|26568110|P2|Overall Study|Adverse Event|0
7636351|NCT01631227|26568111|P1|Overall Study|Adverse Event|1
7636352|NCT01631227|26568110|P2|Overall Study|withdrawn consent|21
7636353|NCT01631227|26568111|P1|Overall Study|withdrawn consent|27
7636354|NCT01631214|26568119|P2|Overall Study|Administrative Decision|0
7636355|NCT01631214|26568120|P1|Overall Study|Administrative Decision|1
7636356|NCT01631214|26568119|P2|Overall Study|Ineligibility determined|2
7636357|NCT01631214|26568120|P1|Overall Study|Ineligibility determined|5
7636358|NCT01631214|26568119|P2|Overall Study|Protocol Deviation|3
7636359|NCT01631214|26568120|P1|Overall Study|Protocol Deviation|4
7636360|NCT01631214|26568119|P2|Overall Study|Requirement for Alternative Therapy|3
7636361|NCT01631214|26568120|P1|Overall Study|Requirement for Alternative Therapy|8
7636362|NCT01631214|26568119|P2|Overall Study|Noncompliance|15
7636363|NCT01631214|26568120|P1|Overall Study|Noncompliance|16
7636364|NCT01631214|26568119|P2|Overall Study|Other|19
7636365|NCT01631214|26568120|P1|Overall Study|Other|22
7636366|NCT01631214|26568119|P2|Overall Study|Adverse Event|45
7636367|NCT01631214|26568120|P1|Overall Study|Adverse Event|45
7636368|NCT01631214|26568119|P2|Overall Study|Lost to Follow-up|40
7636369|NCT01631214|26568120|P1|Overall Study|Lost to Follow-up|54
7636370|NCT01631214|26568119|P2|Overall Study|Death|106
7636371|NCT01631214|26568120|P1|Overall Study|Death|113
7636372|NCT01631214|26568119|P2|Overall Study|Withdrawal by Subject|290
7636373|NCT01631214|26568120|P1|Overall Study|Withdrawal by Subject|276
7636374|NCT01630889|26568229|P1|Overall Study|Other|1
7636375|NCT01630889|26568229|P1|Overall Study|Lost to Follow-up|4
7636376|NCT01630889|26568229|P1|Overall Study|Other than Specified|2
7636377|NCT01630889|26568229|P1|Overall Study|Withdrawal by Subject|1
7636378|NCT01630889|26568229|P1|Overall Study|Death|2
7636379|NCT01630811|26568238|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7636380|NCT01630811|26568239|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7636381|NCT01630616|26568266|P6|Overall Study|Withdrawal by Subject|0
7636382|NCT01630616|26568267|P5|Overall Study|Withdrawal by Subject|0
7636383|NCT01630616|26568268|P4|Overall Study|Withdrawal by Subject|2
7636384|NCT01630616|26568269|P3|Overall Study|Withdrawal by Subject|0
7636385|NCT01630616|26568270|P2|Overall Study|Withdrawal by Subject|0
7636386|NCT01630616|26568271|P1|Overall Study|Withdrawal by Subject|0
7636387|NCT01630616|26568266|P6|Overall Study|Adverse Event|0
7636388|NCT01630616|26568267|P5|Overall Study|Adverse Event|0
7636389|NCT01630616|26568268|P4|Overall Study|Adverse Event|1
7636390|NCT01630616|26568269|P3|Overall Study|Adverse Event|0
7636391|NCT01630616|26568270|P2|Overall Study|Adverse Event|0
7636392|NCT01630616|26568271|P1|Overall Study|Adverse Event|0
7636393|NCT01630135|26568371|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
7636394|NCT01630135|26568372|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
7636395|NCT01629966|26568436|P3|Overall Study|Adverse Event|30
7636396|NCT01629966|26568437|P2|Overall Study|Adverse Event|18
7636397|NCT01629966|26568438|P1|Overall Study|Adverse Event|11
7636398|NCT01629966|26568436|P3|Overall Study|Lack of Efficacy|4
7636399|NCT01629966|26568437|P2|Overall Study|Lack of Efficacy|2
7636400|NCT01629966|26568438|P1|Overall Study|Lack of Efficacy|5
7636401|NCT01629966|26568436|P3|Overall Study|Protocol Violation|7
7636402|NCT01629966|26568437|P2|Overall Study|Protocol Violation|9
7636403|NCT01629966|26568438|P1|Overall Study|Protocol Violation|7
7636404|NCT01629966|26568436|P3|Overall Study|Withdrawal by Subject|16
7636405|NCT01629966|26568437|P2|Overall Study|Withdrawal by Subject|9
7636406|NCT01629966|26568438|P1|Overall Study|Withdrawal by Subject|8
7636407|NCT01629966|26568436|P3|Overall Study|Lost to Follow-up|9
7636408|NCT01629966|26568437|P2|Overall Study|Lost to Follow-up|13
7636409|NCT01629966|26568438|P1|Overall Study|Lost to Follow-up|10
7636410|NCT01629966|26568436|P3|Overall Study|Pregnancy|0
7636411|NCT01629966|26568437|P2|Overall Study|Pregnancy|1
7636412|NCT01629966|26568438|P1|Overall Study|Pregnancy|0
7636413|NCT01629953|26568451|P2|Overall Study|Lost to Follow-up|14
7636414|NCT01629953|26568452|P1|Overall Study|Lost to Follow-up|10
7636415|NCT01629953|26568451|P2|Overall Study|Death|1
7636416|NCT01629953|26568452|P1|Overall Study|Death|3
7636417|NCT01629823|26568472|P3|Washout Period|Protocol Violation|0
7636418|NCT01629823|26568473|P2|Washout Period|Protocol Violation|1
7636419|NCT01629823|26568474|P1|Washout Period|Protocol Violation|0
7636420|NCT01629823|26568472|P3|Washout Period|Pregnancy|0
7636421|NCT01629823|26568473|P2|Washout Period|Pregnancy|0
7636422|NCT01629823|26568474|P1|Washout Period|Pregnancy|1
7636423|NCT01629823|26568472|P3|Washout Period|Safety|0
7636424|NCT01629823|26568473|P2|Washout Period|Safety|5
7636425|NCT01629823|26568474|P1|Washout Period|Safety|2
7636426|NCT01629823|26568472|P3|Trial Period|Failed to hold medication|1
7636427|NCT01629823|26568473|P2|Trial Period|Failed to hold medication|0
7636428|NCT01629823|26568474|P1|Trial Period|Failed to hold medication|0
7636429|NCT01629823|26568472|P3|Trial Period|Out-of-window visit|0
7636430|NCT01629823|26568473|P2|Trial Period|Out-of-window visit|2
7636431|NCT01629823|26568474|P1|Trial Period|Out-of-window visit|0
7636432|NCT01629823|26568472|P3|Trial Period|Adverse Event|0
7636433|NCT01629823|26568473|P2|Trial Period|Adverse Event|1
7636434|NCT01629823|26568474|P1|Trial Period|Adverse Event|0
7636435|NCT01629823|26568472|P3|Trial Period|Pregnancy|0
7636436|NCT01629823|26568473|P2|Trial Period|Pregnancy|0
7636437|NCT01629823|26568474|P1|Trial Period|Pregnancy|1
7636438|NCT01629823|26568472|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7636439|NCT01629823|26568473|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7636440|NCT01629823|26568474|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7636441|NCT01629823|26568472|P3|Trial Period|Missed visit|8
7636442|NCT01629823|26568473|P2|Trial Period|Missed visit|9
7636443|NCT01629823|26568474|P1|Trial Period|Missed visit|11
7636444|NCT01629706|26568509|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
7636445|NCT01629706|26568509|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
7636446|NCT01629706|26568509|P1|Phase 2 Habitual|Relocation prior to Dispense|1
7636447|NCT01629706|26568509|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
7636448|NCT01629706|26568509|P1|Phase 2 Habitual|Screen Failure|6
7636449|NCT01629706|26568509|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
7636450|NCT01629706|26568509|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
7636451|NCT01629706|26568509|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
7636452|NCT01629706|26568509|P1|Phase 1 PureVision|Screen Failure|4
7636453|NCT01629693|26568537|P2|Overall Study|Subject decision unrelated to AE|1
7636454|NCT01629693|26568538|P1|Overall Study|Subject decision unrelated to AE|0
7636455|NCT01629693|26568537|P2|Overall Study|Poor comfort of study lenses|2
7636456|NCT01629693|26568538|P1|Overall Study|Poor comfort of study lenses|0
7636457|NCT01629693|26568537|P2|Overall Study|Investigator decision|1
7636458|NCT01629693|26568538|P1|Overall Study|Investigator decision|0
7636459|NCT01629693|26568537|P2|Overall Study|Adverse Event|0
7636460|NCT01629693|26568538|P1|Overall Study|Adverse Event|1
7636461|NCT01629693|26568537|P2|Overall Study|Withdrawal by Subject|2
7636462|NCT01629693|26568538|P1|Overall Study|Withdrawal by Subject|2
7636463|NCT01629693|26568537|P2|Overall Study|Lost to Follow-up|4
7636464|NCT01629693|26568538|P1|Overall Study|Lost to Follow-up|2
7636465|NCT01629667|26568547|P3|Overall Study|Code break|0
7636466|NCT01629667|26568548|P2|Overall Study|Code break|0
7636467|NCT01629667|26568549|P1|Overall Study|Code break|1
7636468|NCT01629667|26568547|P3|Overall Study|Enrolled in another clinical study|0
7636469|NCT01629667|26568548|P2|Overall Study|Enrolled in another clinical study|1
7636470|NCT01629667|26568549|P1|Overall Study|Enrolled in another clinical study|0
7636471|NCT01629667|26568547|P3|Overall Study|Site error in safety follow-up|1
7636472|NCT01629667|26568548|P2|Overall Study|Site error in safety follow-up|0
7636473|NCT01629667|26568549|P1|Overall Study|Site error in safety follow-up|0
7636474|NCT01629667|26568547|P3|Overall Study|Started other medicine|1
7636475|NCT01629667|26568548|P2|Overall Study|Started other medicine|0
7636476|NCT01629667|26568549|P1|Overall Study|Started other medicine|1
7636477|NCT01629667|26568547|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
7636478|NCT01629667|26568548|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
7636479|NCT01629667|26568549|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
7636480|NCT01629667|26568547|P3|Overall Study|Requiring lung transplant|3
7636481|NCT01629667|26568548|P2|Overall Study|Requiring lung transplant|1
7636482|NCT01629667|26568549|P1|Overall Study|Requiring lung transplant|2
7636483|NCT01629667|26568547|P3|Overall Study|Ongoing AE worsening right heart failure|0
7636484|NCT01629667|26568548|P2|Overall Study|Ongoing AE worsening right heart failure|1
7636485|NCT01629667|26568549|P1|Overall Study|Ongoing AE worsening right heart failure|0
7636486|NCT01629667|26568547|P3|Overall Study|Randomized, not treated|0
7636487|NCT01629667|26568548|P2|Overall Study|Randomized, not treated|1
7636488|NCT01629667|26568549|P1|Overall Study|Randomized, not treated|2
7636489|NCT01629667|26568547|P3|Overall Study|Death|3
7636490|NCT01629667|26568548|P2|Overall Study|Death|5
7636491|NCT01629667|26568549|P1|Overall Study|Death|1
7636492|NCT01629667|26568547|P3|Overall Study|Withdrawal by Subject|28
7636493|NCT01629667|26568548|P2|Overall Study|Withdrawal by Subject|20
7636494|NCT01629667|26568549|P1|Overall Study|Withdrawal by Subject|31
7636495|NCT01629667|26568547|P3|Overall Study|Lost to Follow-up|1
7636496|NCT01629667|26568548|P2|Overall Study|Lost to Follow-up|1
7636497|NCT01629667|26568549|P1|Overall Study|Lost to Follow-up|0
7636498|NCT01629589|26568640|P2|Overall Study|Did not receive study vaccine|1
7636499|NCT01629589|26568641|P1|Overall Study|Did not receive study vaccine|0
7636500|NCT01629589|26568640|P2|Overall Study|Withdrawal by Subject|3
7636501|NCT01629589|26568641|P1|Overall Study|Withdrawal by Subject|2
7636502|NCT01629589|26568640|P2|Overall Study|Lost to Follow-up|1
7636503|NCT01629589|26568641|P1|Overall Study|Lost to Follow-up|2
7636504|NCT01629589|26568640|P2|Overall Study|Protocol Violation|2
7636505|NCT01629589|26568641|P1|Overall Study|Protocol Violation|4
7636506|NCT01629563|26568659|P2|Overall Study|Protocol Violation|1
7636507|NCT01629563|26568660|P1|Overall Study|Protocol Violation|0
7636508|NCT01629563|26568659|P2|Overall Study|Lack of return of menses|7
7636509|NCT01629563|26568660|P1|Overall Study|Lack of return of menses|12
7636510|NCT01629563|26568659|P2|Overall Study|surgery|3
7636511|NCT01629563|26568660|P1|Overall Study|surgery|0
7636512|NCT01629563|26568659|P2|Overall Study|Withdrawal by Subject|20
7636513|NCT01629563|26568660|P1|Overall Study|Withdrawal by Subject|27
7636514|NCT01629563|26568659|P2|Overall Study|Protocol Violation|1
7636515|NCT01629563|26568660|P1|Overall Study|Protocol Violation|0
7636516|NCT01629563|26568659|P2|Overall Study|Pregnancy|2
7636517|NCT01629563|26568660|P1|Overall Study|Pregnancy|1
7636518|NCT01629563|26568659|P2|Overall Study|Lost to Follow-up|0
7636519|NCT01629563|26568660|P1|Overall Study|Lost to Follow-up|1
7636520|NCT01629563|26568659|P2|Overall Study|Lack of Efficacy|3
7636521|NCT01629563|26568660|P1|Overall Study|Lack of Efficacy|2
7636522|NCT01629563|26568659|P2|Overall Study|Death|0
7636523|NCT01629563|26568660|P1|Overall Study|Death|2
7636524|NCT01629563|26568659|P2|Overall Study|Adverse Event|16
7636525|NCT01629563|26568660|P1|Overall Study|Adverse Event|16
7636526|NCT01629381|26568717|P2|Overall Study|Withdrawal by Subject|5
7636527|NCT01629381|26568718|P1|Overall Study|Withdrawal by Subject|2
7636528|NCT01628965|26568764|P1|Overall Study|Discontinuation criteria|8
7636529|NCT01628965|26568764|P1|Overall Study|Lost to Follow-up|1
7636530|NCT01628965|26568764|P1|Overall Study|Withdrawal by Subject|3
7636531|NCT01628965|26568764|P1|Overall Study|Lack of Efficacy|7
7636532|NCT01628965|26568764|P1|Overall Study|Adverse Event|30
7636533|NCT01628926|26568773|P3|Overall Study|Physician Decision|1
7636534|NCT01628926|26568774|P2|Overall Study|Physician Decision|2
7636535|NCT01628926|26568775|P1|Overall Study|Physician Decision|2
7636536|NCT01628926|26568773|P3|Overall Study|Discontinuation criteria|0
7636537|NCT01628926|26568774|P2|Overall Study|Discontinuation criteria|4
7636538|NCT01628926|26568775|P1|Overall Study|Discontinuation criteria|3
7636539|NCT01628926|26568773|P3|Overall Study|Protocol Violation|0
7636540|NCT01628926|26568774|P2|Overall Study|Protocol Violation|1
7636541|NCT01628926|26568775|P1|Overall Study|Protocol Violation|0
7636542|NCT01628926|26568773|P3|Overall Study|Withdrawal by Subject|2
7636543|NCT01628926|26568774|P2|Overall Study|Withdrawal by Subject|4
7636544|NCT01628926|26568775|P1|Overall Study|Withdrawal by Subject|6
7636545|NCT01628926|26568773|P3|Overall Study|Lack of Efficacy|5
7636546|NCT01628926|26568774|P2|Overall Study|Lack of Efficacy|1
7636547|NCT01628926|26568775|P1|Overall Study|Lack of Efficacy|2
7636548|NCT01628926|26568773|P3|Overall Study|Adverse Event|9
7636549|NCT01628926|26568774|P2|Overall Study|Adverse Event|11
7636550|NCT01628926|26568775|P1|Overall Study|Adverse Event|13
7636551|NCT01628913|26568824|P2|Overall Study|Physician Decision|3
7636552|NCT01628913|26568825|P1|Overall Study|Physician Decision|1
7636553|NCT01628913|26568824|P2|Overall Study|Withdrawal by Subject|0
7636554|NCT01628913|26568825|P1|Overall Study|Withdrawal by Subject|1
7636555|NCT01628913|26568824|P2|Overall Study|study terminated by Sponsor|9
7636556|NCT01628913|26568825|P1|Overall Study|study terminated by Sponsor|4
7636557|NCT01628913|26568824|P2|Overall Study|Death|0
7636558|NCT01628913|26568825|P1|Overall Study|Death|1
7636559|NCT01628913|26568824|P2|Overall Study|Protocol Violation|0
7636560|NCT01628913|26568825|P1|Overall Study|Protocol Violation|1
7636561|NCT01628913|26568824|P2|Overall Study|Disease Progression|14
7636562|NCT01628913|26568825|P1|Overall Study|Disease Progression|11
7636563|NCT01628913|26568824|P2|Overall Study|Adverse Event|5
7636564|NCT01628913|26568825|P1|Overall Study|Adverse Event|12
7636565|NCT01628874|26568839|P2|Overall Study|Age >4 months|2
7636566|NCT01628874|26568840|P1|Overall Study|Age >4 months|4
7636567|NCT01628874|26568839|P2|Overall Study|Physician Decision|1
7636568|NCT01628874|26568840|P1|Overall Study|Physician Decision|1
7636569|NCT01628848|26568856|P2|Overall Study|Physician Decision|1
7636570|NCT01628848|26568857|P1|Overall Study|Physician Decision|3
7636571|NCT01628848|26568856|P2|Overall Study|Withdrawal by Subject|2
7636572|NCT01628848|26568857|P1|Overall Study|Withdrawal by Subject|0
7636573|NCT01628848|26568856|P2|Overall Study|Lack of Efficacy|4
7636574|NCT01628848|26568857|P1|Overall Study|Lack of Efficacy|0
7636575|NCT01628848|26568856|P2|Overall Study|Adverse Event|7
7636576|NCT01628848|26568857|P1|Overall Study|Adverse Event|9
7636577|NCT01628692|26568900|P6|Overall Study|Completed 12 Week only|1
7636578|NCT01628692|26568901|P5|Overall Study|Completed 12 Week only|0
7636579|NCT01628692|26568902|P4|Overall Study|Completed 12 Week only|0
7636580|NCT01628692|26568903|P3|Overall Study|Completed 12 Week only|0
7636581|NCT01628692|26568904|P2|Overall Study|Completed 12 Week only|0
7636582|NCT01628692|26568905|P1|Overall Study|Completed 12 Week only|0
7636583|NCT01628692|26568900|P6|Overall Study|Administrative reason by sponsor|1
7636584|NCT01628692|26568901|P5|Overall Study|Administrative reason by sponsor|0
7636585|NCT01628692|26568902|P4|Overall Study|Administrative reason by sponsor|0
7636586|NCT01628692|26568903|P3|Overall Study|Administrative reason by sponsor|0
7636587|NCT01628692|26568904|P2|Overall Study|Administrative reason by sponsor|0
7636588|NCT01628692|26568905|P1|Overall Study|Administrative reason by sponsor|0
7636589|NCT01628692|26568900|P6|Overall Study|Poor compliance/noncompliance|0
7636590|NCT01628692|26568901|P5|Overall Study|Poor compliance/noncompliance|0
7636591|NCT01628692|26568902|P4|Overall Study|Poor compliance/noncompliance|0
7636592|NCT01628692|26568903|P3|Overall Study|Poor compliance/noncompliance|0
7636593|NCT01628692|26568904|P2|Overall Study|Poor compliance/noncompliance|0
7636594|NCT01628692|26568905|P1|Overall Study|Poor compliance/noncompliance|1
7636595|NCT01628692|26568900|P6|Overall Study|Death|0
7636596|NCT01628692|26568901|P5|Overall Study|Death|0
7636597|NCT01628692|26568902|P4|Overall Study|Death|0
7636598|NCT01628692|26568903|P3|Overall Study|Death|0
7636599|NCT01628692|26568904|P2|Overall Study|Death|1
7636600|NCT01628692|26568905|P1|Overall Study|Death|0
7636601|NCT01628692|26568900|P6|Overall Study|Withdrawal by Subject|0
7636602|NCT01628692|26568901|P5|Overall Study|Withdrawal by Subject|0
7636603|NCT01628692|26568902|P4|Overall Study|Withdrawal by Subject|0
7636604|NCT01628692|26568903|P3|Overall Study|Withdrawal by Subject|1
7636605|NCT01628692|26568904|P2|Overall Study|Withdrawal by Subject|1
7636606|NCT01628692|26568905|P1|Overall Study|Withdrawal by Subject|0
7636607|NCT01628692|26568900|P6|Overall Study|Adverse Event|0
7636608|NCT01628692|26568901|P5|Overall Study|Adverse Event|0
7636609|NCT01628692|26568902|P4|Overall Study|Adverse Event|0
7636610|NCT01628692|26568903|P3|Overall Study|Adverse Event|2
7636611|NCT01628692|26568904|P2|Overall Study|Adverse Event|0
7636612|NCT01628692|26568905|P1|Overall Study|Adverse Event|2
7636613|NCT01628692|26568900|P6|Overall Study|Lack of Efficacy|7
7636614|NCT01628692|26568901|P5|Overall Study|Lack of Efficacy|4
7636615|NCT01628692|26568902|P4|Overall Study|Lack of Efficacy|1
7636616|NCT01628692|26568903|P3|Overall Study|Lack of Efficacy|5
7636617|NCT01628692|26568904|P2|Overall Study|Lack of Efficacy|4
7636618|NCT01628692|26568905|P1|Overall Study|Lack of Efficacy|4
7636619|NCT01628549|26568975|P4|Overall Study|positive pregnancy test|1
7636620|NCT01628549|26568976|P3|Overall Study|positive pregnancy test|0
7636621|NCT01628549|26568977|P2|Overall Study|positive pregnancy test|0
7636622|NCT01628549|26568978|P1|Overall Study|positive pregnancy test|0
7636623|NCT01628549|26568975|P4|Overall Study|abnormal laboratory test results|0
7636624|NCT01628549|26568976|P3|Overall Study|abnormal laboratory test results|1
7636625|NCT01628549|26568977|P2|Overall Study|abnormal laboratory test results|0
7636626|NCT01628549|26568978|P1|Overall Study|abnormal laboratory test results|0
7636627|NCT01628549|26568975|P4|Overall Study|withdrawn for noncompliance|0
7636628|NCT01628549|26568976|P3|Overall Study|withdrawn for noncompliance|1
7636629|NCT01628549|26568977|P2|Overall Study|withdrawn for noncompliance|2
7636630|NCT01628549|26568978|P1|Overall Study|withdrawn for noncompliance|0
7636631|NCT01628549|26568975|P4|Overall Study|Protocol Violation|0
7636632|NCT01628549|26568976|P3|Overall Study|Protocol Violation|1
7636633|NCT01628549|26568977|P2|Overall Study|Protocol Violation|1
7636634|NCT01628549|26568978|P1|Overall Study|Protocol Violation|2
7636635|NCT01628549|26568975|P4|Overall Study|Withdrawal by Subject|1
7636636|NCT01628549|26568976|P3|Overall Study|Withdrawal by Subject|4
7636637|NCT01628549|26568977|P2|Overall Study|Withdrawal by Subject|4
7636638|NCT01628549|26568978|P1|Overall Study|Withdrawal by Subject|3
7636639|NCT01628549|26568975|P4|Overall Study|Lost to Follow-up|3
7636640|NCT01628549|26568976|P3|Overall Study|Lost to Follow-up|3
7636641|NCT01628549|26568977|P2|Overall Study|Lost to Follow-up|4
7636642|NCT01628549|26568978|P1|Overall Study|Lost to Follow-up|3
7636643|NCT01628549|26568975|P4|Overall Study|Adverse Event|4
7636644|NCT01628549|26568976|P3|Overall Study|Adverse Event|0
7636645|NCT01628549|26568977|P2|Overall Study|Adverse Event|1
7636646|NCT01628549|26568978|P1|Overall Study|Adverse Event|1
7636647|NCT01628510|26569019|P2|Overall Study|Death|1
7636648|NCT01628510|26569020|P1|Overall Study|Death|3
7636649|NCT01628510|26569019|P2|Overall Study|Withdrawal by Subject|4
7636650|NCT01628510|26569020|P1|Overall Study|Withdrawal by Subject|0
7636651|NCT01628393|26569031|P5|Blinded Active Extension Period|Withdrawal by Subject|2
7636652|NCT01628393|26569032|P4|Blinded Active Extension Period|Withdrawal by Subject|0
7636653|NCT01628393|26569033|P3|Blinded Active Extension Period|Withdrawal by Subject|2
7636654|NCT01628393|26569034|P2|Blinded Active Extension Period|Withdrawal by Subject|6
7636655|NCT01628393|26569035|P1|Blinded Active Extension Period|Withdrawal by Subject|0
7636656|NCT01628393|26569031|P5|Blinded Active Extension Period|Protocol Violation|0
7636657|NCT01628393|26569032|P4|Blinded Active Extension Period|Protocol Violation|1
7636658|NCT01628393|26569033|P3|Blinded Active Extension Period|Protocol Violation|2
7636659|NCT01628393|26569034|P2|Blinded Active Extension Period|Protocol Violation|0
7636660|NCT01628393|26569035|P1|Blinded Active Extension Period|Protocol Violation|0
7636661|NCT01628393|26569031|P5|Blinded Active Extension Period|Physician Decision|0
7636662|NCT01628393|26569032|P4|Blinded Active Extension Period|Physician Decision|1
7636663|NCT01628393|26569033|P3|Blinded Active Extension Period|Physician Decision|0
7636664|NCT01628393|26569034|P2|Blinded Active Extension Period|Physician Decision|3
7636665|NCT01628393|26569035|P1|Blinded Active Extension Period|Physician Decision|0
7636666|NCT01628393|26569031|P5|Blinded Active Extension Period|Lack of Efficacy|2
7636667|NCT01628393|26569032|P4|Blinded Active Extension Period|Lack of Efficacy|0
7636668|NCT01628393|26569033|P3|Blinded Active Extension Period|Lack of Efficacy|2
7636669|NCT01628393|26569034|P2|Blinded Active Extension Period|Lack of Efficacy|0
7636670|NCT01628393|26569035|P1|Blinded Active Extension Period|Lack of Efficacy|0
7636671|NCT01628393|26569031|P5|Blinded Active Extension Period|Adverse Event|2
7636672|NCT01628393|26569032|P4|Blinded Active Extension Period|Adverse Event|2
7636673|NCT01628393|26569033|P3|Blinded Active Extension Period|Adverse Event|0
7636674|NCT01628393|26569034|P2|Blinded Active Extension Period|Adverse Event|1
7636675|NCT01628393|26569035|P1|Blinded Active Extension Period|Adverse Event|0
7636676|NCT01628393|26569031|P5|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7636677|NCT01628393|26569032|P4|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7636678|NCT01628393|26569033|P3|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7636679|NCT01628393|26569034|P2|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7636680|NCT01628393|26569035|P1|Placebo-controlled Treatment Period|Withdrawal by Subject|2
7636681|NCT01628393|26569031|P5|Placebo-controlled Treatment Period|Protocol Violation|0
7636682|NCT01628393|26569032|P4|Placebo-controlled Treatment Period|Protocol Violation|0
7636683|NCT01628393|26569033|P3|Placebo-controlled Treatment Period|Protocol Violation|0
7636684|NCT01628393|26569034|P2|Placebo-controlled Treatment Period|Protocol Violation|1
7636685|NCT01628393|26569035|P1|Placebo-controlled Treatment Period|Protocol Violation|0
7636686|NCT01628393|26569031|P5|Placebo-controlled Treatment Period|Lost to Follow-up|0
7636687|NCT01628393|26569032|P4|Placebo-controlled Treatment Period|Lost to Follow-up|0
7636688|NCT01628393|26569033|P3|Placebo-controlled Treatment Period|Lost to Follow-up|0
7636689|NCT01628393|26569034|P2|Placebo-controlled Treatment Period|Lost to Follow-up|0
7636690|NCT01628393|26569035|P1|Placebo-controlled Treatment Period|Lost to Follow-up|1
7636691|NCT01628367|26569071|P2|Overall Study|Adverse Event|0
7636692|NCT01628367|26569072|P1|Overall Study|Adverse Event|1
7636693|NCT01628198|26569091|P1|Overall Study|Screen failure|1
7636694|NCT01628198|26569091|P1|Overall Study|Withdrawal by Subject|10
7636695|NCT01628198|26569091|P1|Overall Study|Lost to Follow-up|7
7636696|NCT01628120|26569118|P1|Overall Study|Use of Standard of Care|1
7636697|NCT01628120|26569118|P1|Overall Study|Kidney Transplant|2
7636698|NCT01628120|26569118|P1|Overall Study|Moved or Relocated|5
7636699|NCT01628120|26569118|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
7636700|NCT01628120|26569118|P1|Overall Study|Switched Dialysis Method|2
7636701|NCT01628120|26569118|P1|Overall Study|Sponsor Decision|5
7636702|NCT01628120|26569118|P1|Overall Study|Not Treated|3
7636703|NCT01628120|26569118|P1|Overall Study|Non-compliant with Study Procedures|1
7636704|NCT01628120|26569118|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
7636705|NCT01628120|26569118|P1|Overall Study|Lost to Follow-up|1
7636706|NCT01628120|26569118|P1|Overall Study|Adverse Event|12
7636707|NCT01628120|26569118|P1|Overall Study|Withdrawal by Subject|7
7636708|NCT01628107|26569143|P1|Overall Study|Use of Standard of Care|9
7636709|NCT01628107|26569143|P1|Overall Study|Kidney Transplant|9
7636710|NCT01628107|26569143|P1|Overall Study|Relocated|8
7636711|NCT01628107|26569143|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
7636712|NCT01628107|26569143|P1|Overall Study|Sponsor Decision|11
7636713|NCT01628107|26569143|P1|Overall Study|Not Treated|8
7636714|NCT01628107|26569143|P1|Overall Study|Non-compliant with Study Procedures|10
7636715|NCT01628107|26569143|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
7636716|NCT01628107|26569143|P1|Overall Study|Physician Decision|2
7636717|NCT01628107|26569143|P1|Overall Study|Adverse Event|33
7636718|NCT01628107|26569143|P1|Overall Study|Lost to Follow-up|4
7636719|NCT01628107|26569143|P1|Overall Study|Withdrawal by Subject|17
7636720|NCT01627899|26569209|P1|Overall Study|Study terminated early by sponsor.|5
7636721|NCT01627860|26569219|P2|Overall Study|Protocol Violation|0
7636722|NCT01627860|26569220|P1|Overall Study|Protocol Violation|1
7636723|NCT01627860|26569219|P2|Overall Study|Seizure frequency doubled|1
7636724|NCT01627860|26569220|P1|Overall Study|Seizure frequency doubled|0
7636725|NCT01627860|26569219|P2|Overall Study|Withdrawal by Subject|1
7636726|NCT01627860|26569220|P1|Overall Study|Withdrawal by Subject|2
7636727|NCT01627860|26569219|P2|Overall Study|Adverse Event|4
7636728|NCT01627860|26569220|P1|Overall Study|Adverse Event|9
7636729|NCT01627782|26569234|P4|Overall Study|Randomized But Not Treated|0
7636730|NCT01627782|26569235|P3|Overall Study|Randomized But Not Treated|0
7636731|NCT01627782|26569236|P2|Overall Study|Randomized But Not Treated|0
7636732|NCT01627782|26569237|P1|Overall Study|Randomized But Not Treated|1
7636733|NCT01627782|26569234|P4|Overall Study|Other|3
7636734|NCT01627782|26569235|P3|Overall Study|Other|0
7636735|NCT01627782|26569236|P2|Overall Study|Other|2
7636736|NCT01627782|26569237|P1|Overall Study|Other|0
7636737|NCT01627782|26569234|P4|Overall Study|Withdrawal by Subject|0
7636738|NCT01627782|26569235|P3|Overall Study|Withdrawal by Subject|0
7636739|NCT01627782|26569236|P2|Overall Study|Withdrawal by Subject|1
7636740|NCT01627782|26569237|P1|Overall Study|Withdrawal by Subject|2
7636741|NCT01627782|26569234|P4|Overall Study|Protocol Violation|0
7636742|NCT01627782|26569235|P3|Overall Study|Protocol Violation|0
7636743|NCT01627782|26569236|P2|Overall Study|Protocol Violation|0
7636744|NCT01627782|26569237|P1|Overall Study|Protocol Violation|1
7636745|NCT01627782|26569234|P4|Overall Study|Lack of Efficacy|2
7636746|NCT01627782|26569235|P3|Overall Study|Lack of Efficacy|15
7636747|NCT01627782|26569236|P2|Overall Study|Lack of Efficacy|1
7636748|NCT01627782|26569237|P1|Overall Study|Lack of Efficacy|11
7636749|NCT01627782|26569234|P4|Overall Study|Adverse Event|1
7636750|NCT01627782|26569235|P3|Overall Study|Adverse Event|0
7636751|NCT01627782|26569236|P2|Overall Study|Adverse Event|2
7636752|NCT01627782|26569237|P1|Overall Study|Adverse Event|1
7636753|NCT01627691|26569293|P1|Overall Study|Missed the visit|3
7636754|NCT01627691|26569293|P1|Overall Study|Withdrawal by Subject|1
7636755|NCT01627691|26569293|P1|Overall Study|Lost to Follow-up|3
7636756|NCT01627691|26569293|P1|Overall Study|Death|11
7636757|NCT01627574|26569306|P2|Overall Study|Lost to Follow-up|13
7636758|NCT01627574|26569307|P1|Overall Study|Lost to Follow-up|13
7636759|NCT01627574|26569306|P2|Overall Study|Withdrawal by Subject|5
7636760|NCT01627574|26569307|P1|Overall Study|Withdrawal by Subject|8
7636761|NCT01627561|26569321|P2|Overall Study|Migrated/moved from study area|2
7636762|NCT01627561|26569322|P1|Overall Study|Migrated/moved from study area|0
7636763|NCT01627561|26569321|P2|Overall Study|Withdrawal by Subject|1
7636764|NCT01627561|26569322|P1|Overall Study|Withdrawal by Subject|0
7636765|NCT01627561|26569321|P2|Overall Study|Lost to Follow-up|0
7636766|NCT01627561|26569322|P1|Overall Study|Lost to Follow-up|1
7636767|NCT01627340|26569388|P2|Overall Study|Withdrawal by Subject|0
7636768|NCT01627340|26569389|P1|Overall Study|Withdrawal by Subject|2
7636769|NCT01627340|26569388|P2|Overall Study|Pregnancy|0
7636770|NCT01627340|26569389|P1|Overall Study|Pregnancy|1
7636771|NCT01627340|26569388|P2|Overall Study|Lost to Follow-up|4
7636772|NCT01627340|26569389|P1|Overall Study|Lost to Follow-up|8
7636773|NCT01627340|26569388|P2|Overall Study|Adverse Event|0
7636774|NCT01627340|26569389|P1|Overall Study|Adverse Event|1
7636775|NCT01627327|26569407|P2|Overall Study|Withdrawal by Subject|3
7636776|NCT01627327|26569408|P1|Overall Study|Withdrawal by Subject|3
7636777|NCT01627327|26569407|P2|Overall Study|Physician Decision|0
7636778|NCT01627327|26569408|P1|Overall Study|Physician Decision|1
7636779|NCT01627327|26569407|P2|Overall Study|Lost to Follow-up|3
7636780|NCT01627327|26569408|P1|Overall Study|Lost to Follow-up|1
7636781|NCT01627327|26569407|P2|Overall Study|Protocol Violation|10
7636782|NCT01627327|26569408|P1|Overall Study|Protocol Violation|4
7636783|NCT01627327|26569407|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
7636784|NCT01627327|26569408|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
7636785|NCT01627327|26569407|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
7636786|NCT01627327|26569408|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
7636787|NCT01627327|26569407|P2|Overall Study|Adverse Event|12
7636788|NCT01627327|26569408|P1|Overall Study|Adverse Event|6
7636789|NCT01627249|26569458|P3|Overall Study|Missed Visit|0
7636790|NCT01627249|26569459|P2|Overall Study|Missed Visit|1
7636791|NCT01627249|26569460|P1|Overall Study|Missed Visit|1
7636792|NCT01627249|26569458|P3|Overall Study|Withdrawal by Subject|9
7636793|NCT01627249|26569459|P2|Overall Study|Withdrawal by Subject|6
7636794|NCT01627249|26569460|P1|Overall Study|Withdrawal by Subject|12
7636795|NCT01627249|26569458|P3|Overall Study|Death|3
7636796|NCT01627249|26569459|P2|Overall Study|Death|5
7636797|NCT01627249|26569460|P1|Overall Study|Death|3
7636798|NCT01627067|26569495|P1|Overall Study|Screen Failure|1
7636799|NCT01626989|26569564|P3|Screening Period|Withdrawal by Subject|0
7636800|NCT01626989|26569565|P2|Screening Period|Withdrawal by Subject|0
7636801|NCT01626989|26569566|P1|Screening Period|Withdrawal by Subject|2
7636802|NCT01626989|26569564|P3|Screening Period|Screen Failure|0
7636803|NCT01626989|26569565|P2|Screening Period|Screen Failure|0
7636804|NCT01626989|26569566|P1|Screening Period|Screen Failure|15
7636805|NCT01626885|26569613|P1|Overall Study|Withdrawal by Subject|4
7636806|NCT01626885|26569613|P1|Overall Study|Adverse Event|8
7636807|NCT01626872|26569620|P3|Overall Study|Protocol Violation (including Pregnancy)|2
7636808|NCT01626872|26569621|P2|Overall Study|Protocol Violation (including Pregnancy)|2
7636809|NCT01626872|26569622|P1|Overall Study|Protocol Violation (including Pregnancy)|0
7636810|NCT01626872|26569620|P3|Overall Study|Adverse Event (including Death)|8
7636811|NCT01626872|26569621|P2|Overall Study|Adverse Event (including Death)|28
7636812|NCT01626872|26569622|P1|Overall Study|Adverse Event (including Death)|20
7636813|NCT01626872|26569620|P3|Overall Study|Withdrawal by Subject|8
7636814|NCT01626872|26569621|P2|Overall Study|Withdrawal by Subject|27
7636815|NCT01626872|26569622|P1|Overall Study|Withdrawal by Subject|19
7636816|NCT01626872|26569620|P3|Overall Study|Physician Decision|6
7636817|NCT01626872|26569621|P2|Overall Study|Physician Decision|9
7636818|NCT01626872|26569622|P1|Overall Study|Physician Decision|13
7636819|NCT01626859|26569633|P3|Overall Study|Withdrawal by Subject|2
7636820|NCT01626859|26569634|P2|Overall Study|Withdrawal by Subject|4
7636821|NCT01626859|26569635|P1|Overall Study|Withdrawal by Subject|1
7636822|NCT01626859|26569633|P3|Overall Study|Physician Decision|0
7636823|NCT01626859|26569634|P2|Overall Study|Physician Decision|1
7636824|NCT01626859|26569635|P1|Overall Study|Physician Decision|0
7636825|NCT01626859|26569633|P3|Overall Study|Adverse Event|2
7636826|NCT01626859|26569634|P2|Overall Study|Adverse Event|3
7636827|NCT01626859|26569635|P1|Overall Study|Adverse Event|1
7636828|NCT01626690|26569677|P2|Overall Study|Adverse Event|0
7636829|NCT01626690|26569678|P1|Overall Study|Adverse Event|1
7636830|NCT01626690|26569677|P2|Overall Study|Protocol Violation|0
7636831|NCT01626690|26569678|P1|Overall Study|Protocol Violation|1
7636832|NCT01626495|26569715|P1|Overall Study|Manufacturing failure|1
7636833|NCT01626495|26569715|P1|Overall Study|New cancer therapy|16
7636834|NCT01626495|26569715|P1|Overall Study|Physician Decision|1
7636835|NCT01626495|26569715|P1|Overall Study|Death|2
7636836|NCT01626495|26569715|P1|Overall Study|Administrative problem|1
7636837|NCT01626495|26569715|P1|Overall Study|Withdrawal by Subject|1
7636838|NCT01626495|26569715|P1|Overall Study|Disease progression|27
7636839|NCT01626495|26569715|P1|Overall Study|Adverse Event|3
7636840|NCT01626456|26569724|P2|Overall Study|Incarceration|2
7636841|NCT01626456|26569725|P1|Overall Study|Incarceration|0
7636842|NCT01626456|26569724|P2|Overall Study|Site Closure|3
7636843|NCT01626456|26569725|P1|Overall Study|Site Closure|2
7636844|NCT01626456|26569724|P2|Overall Study|Protocol Violation|1
7636845|NCT01626456|26569725|P1|Overall Study|Protocol Violation|1
7636846|NCT01626456|26569724|P2|Overall Study|Physician Decision|4
7636847|NCT01626456|26569725|P1|Overall Study|Physician Decision|1
7636848|NCT01626456|26569724|P2|Overall Study|Lack of Efficacy|7
7636849|NCT01626456|26569725|P1|Overall Study|Lack of Efficacy|6
7636850|NCT01626456|26569724|P2|Overall Study|Lost to Follow-up|27
7636851|NCT01626456|26569725|P1|Overall Study|Lost to Follow-up|2
7636852|NCT01626456|26569724|P2|Overall Study|Adverse Event|27
7636853|NCT01626456|26569725|P1|Overall Study|Adverse Event|2
7636854|NCT01626456|26569724|P2|Overall Study|Withdrawal by Subject|46
7636855|NCT01626456|26569725|P1|Overall Study|Withdrawal by Subject|21
7636856|NCT01626391|26569755|P2|Overall Study|Withdrawal by Subject|0
7636857|NCT01626391|26569756|P1|Overall Study|Withdrawal by Subject|1
7636858|NCT01626391|26569755|P2|Overall Study|Physician Decision|0
7636859|NCT01626391|26569756|P1|Overall Study|Physician Decision|1
7636860|NCT01626352|26569762|P1|Overall Study|Never Treated|1
7636861|NCT01626352|26569762|P1|Overall Study|Non-Compliance|1
7636862|NCT01626352|26569762|P1|Overall Study|Withdrawal by Subject|1
7636863|NCT01626352|26569762|P1|Overall Study|Death|2
7636864|NCT01626352|26569762|P1|Overall Study|Intercurrent Illness|2
7636865|NCT01626352|26569762|P1|Overall Study|Disease Progression|3
7636866|NCT01626118|26569776|P4|Overall Study|Investigator Decision|0
7636867|NCT01626118|26569777|P3|Overall Study|Investigator Decision|0
7636868|NCT01626118|26569778|P2|Overall Study|Investigator Decision|1
7636869|NCT01626118|26569779|P1|Overall Study|Investigator Decision|0
7636870|NCT01626118|26569776|P4|Overall Study|Adverse Event|0
7636871|NCT01626118|26569777|P3|Overall Study|Adverse Event|1
7636872|NCT01626118|26569778|P2|Overall Study|Adverse Event|1
7636873|NCT01626118|26569779|P1|Overall Study|Adverse Event|0
7636874|NCT01626118|26569776|P4|Overall Study|Lost to Follow-up|0
7636875|NCT01626118|26569777|P3|Overall Study|Lost to Follow-up|0
7636876|NCT01626118|26569778|P2|Overall Study|Lost to Follow-up|0
7636877|NCT01626118|26569779|P1|Overall Study|Lost to Follow-up|1
7636878|NCT01626118|26569776|P4|Overall Study|Lack of Efficacy|3
7636879|NCT01626118|26569777|P3|Overall Study|Lack of Efficacy|1
7636880|NCT01626118|26569778|P2|Overall Study|Lack of Efficacy|0
7636881|NCT01626118|26569779|P1|Overall Study|Lack of Efficacy|1
7636882|NCT01626079|26569825|P2|Overall Study|Visits Expected or Not Due|69
7636883|NCT01626079|26569826|P1|Overall Study|Visits Expected or Not Due|74
7636884|NCT01626079|26569825|P2|Overall Study|Lost to Follow-up|3
7636885|NCT01626079|26569826|P1|Overall Study|Lost to Follow-up|3
7636886|NCT01626079|26569825|P2|Overall Study|Withdrawal by Subject|29
7636887|NCT01626079|26569826|P1|Overall Study|Withdrawal by Subject|12
7636888|NCT01626079|26569825|P2|Overall Study|Death|115
7636889|NCT01626079|26569826|P1|Overall Study|Death|78
7636890|NCT01625988|26570199|P2|Overall Study|Protocol Violation|2
7636891|NCT01625988|26570200|P1|Overall Study|Protocol Violation|0
7636892|NCT01625988|26570199|P2|Overall Study|Randomized Inappropriately|0
7636893|NCT01625988|26570200|P1|Overall Study|Randomized Inappropriately|1
7636894|NCT01625988|26570199|P2|Overall Study|Lack of Efficacy|1
7636895|NCT01625988|26570200|P1|Overall Study|Lack of Efficacy|0
7636896|NCT01625988|26570199|P2|Overall Study|Adverse Event|1
7636897|NCT01625988|26570200|P1|Overall Study|Adverse Event|0
7636898|NCT01625988|26570199|P2|Overall Study|Withdrawal by Subject|3
7636899|NCT01625988|26570200|P1|Overall Study|Withdrawal by Subject|8
7636900|NCT01625988|26570199|P2|Overall Study|Lost to Follow-up|6
7636901|NCT01625988|26570200|P1|Overall Study|Lost to Follow-up|5
7636902|NCT01625910|26570224|P2|Overall Study|Lost to Follow-up|4
7636903|NCT01625910|26570225|P1|Overall Study|Lost to Follow-up|3
7636904|NCT01625897|26570235|P2|Overall Study|Withdrawal by Subject|3
7636905|NCT01625897|26570236|P1|Overall Study|Withdrawal by Subject|25
7636906|NCT01625897|26570235|P2|Overall Study|Physician Decision|1
7636907|NCT01625897|26570236|P1|Overall Study|Physician Decision|0
7636908|NCT01625897|26570235|P2|Overall Study|Adverse Event|10
7636909|NCT01625897|26570236|P1|Overall Study|Adverse Event|27
7636910|NCT01625845|26570244|P2|Overall Study|Withdrawal by Subject|0
7636911|NCT01625845|26570245|P1|Overall Study|Withdrawal by Subject|2
7636912|NCT01625845|26570244|P2|Overall Study|Lost to Follow-up|1
7636913|NCT01625845|26570245|P1|Overall Study|Lost to Follow-up|2
7636914|NCT01625845|26570244|P2|Overall Study|Adverse Event|2
7636915|NCT01625845|26570245|P1|Overall Study|Adverse Event|1
7636916|NCT01625689|26570265|P2|Overall Study|Migration|1
7636917|NCT01625689|26570266|P1|Overall Study|Migration|2
7636918|NCT01625377|26570321|P2|Overall Study|Abnormal laboratory values|0
7636919|NCT01625377|26570322|P1|Overall Study|Abnormal laboratory values|1
7636920|NCT01625377|26570321|P2|Overall Study|Unsatisfactory therapeutic effect|1
7636921|NCT01625377|26570322|P1|Overall Study|Unsatisfactory therapeutic effect|0
7636922|NCT01625377|26570321|P2|Overall Study|Graft loss|0
7636923|NCT01625377|26570322|P1|Overall Study|Graft loss|1
7636924|NCT01625377|26570321|P2|Overall Study|Adverse Event|16
7636925|NCT01625377|26570322|P1|Overall Study|Adverse Event|3
7636926|NCT01625377|26570321|P2|Overall Study|Protocol Violation|3
7636927|NCT01625377|26570322|P1|Overall Study|Protocol Violation|0
7636928|NCT01625377|26570321|P2|Overall Study|Administrative Problem|1
7636929|NCT01625377|26570322|P1|Overall Study|Administrative Problem|1
7636930|NCT01625377|26570321|P2|Overall Study|Death|1
7636931|NCT01625377|26570322|P1|Overall Study|Death|1
7636932|NCT01625338|26570355|P3|Overall Study|Study Discontinued by Sponsor|1
7636933|NCT01625338|26570356|P2|Overall Study|Study Discontinued by Sponsor|0
7636934|NCT01625338|26570357|P1|Overall Study|Study Discontinued by Sponsor|0
7636935|NCT01625338|26570355|P3|Overall Study|Adverse Event|1
7636936|NCT01625338|26570356|P2|Overall Study|Adverse Event|0
7636937|NCT01625338|26570357|P1|Overall Study|Adverse Event|1
7636938|NCT01625338|26570355|P3|Overall Study|Subject Withdrew Consent|2
7636939|NCT01625338|26570356|P2|Overall Study|Subject Withdrew Consent|0
7636940|NCT01625338|26570357|P1|Overall Study|Subject Withdrew Consent|1
7636941|NCT01625338|26570355|P3|Overall Study|Investigator Decision|1
7636942|NCT01625338|26570356|P2|Overall Study|Investigator Decision|2
7636943|NCT01625338|26570357|P1|Overall Study|Investigator Decision|0
7636944|NCT01625338|26570355|P3|Overall Study|Lost to Follow-up|2
7636945|NCT01625338|26570356|P2|Overall Study|Lost to Follow-up|3
7636946|NCT01625338|26570357|P1|Overall Study|Lost to Follow-up|3
7636947|NCT01625338|26570355|P3|Overall Study|Efficacy Failure|31
7636948|NCT01625338|26570356|P2|Overall Study|Efficacy Failure|39
7636949|NCT01625338|26570357|P1|Overall Study|Efficacy Failure|27
7636950|NCT01625338|26570355|P3|Overall Study|Enrolled but not Treated|1
7636951|NCT01625338|26570356|P2|Overall Study|Enrolled but not Treated|0
7636952|NCT01625338|26570357|P1|Overall Study|Enrolled but not Treated|0
7636953|NCT01625286|26570384|P7|Overall Study|Ongoing on-treatment at DCO|6
7636954|NCT01625286|26570385|P6|Overall Study|Ongoing on-treatment at DCO|8
7636955|NCT01625286|26570386|P5|Overall Study|Ongoing on-treatment at DCO|0
7636956|NCT01625286|26570387|P4|Overall Study|Ongoing on-treatment at DCO|0
7636957|NCT01625286|26570388|P3|Overall Study|Ongoing on-treatment at DCO|0
7636958|NCT01625286|26570389|P2|Overall Study|Ongoing on-treatment at DCO|4
7636959|NCT01625286|26570390|P1|Overall Study|Ongoing on-treatment at DCO|6
7636960|NCT01625286|26570384|P7|Overall Study|Ongoing off-treatment at DCO|31
7636961|NCT01625286|26570385|P6|Overall Study|Ongoing off-treatment at DCO|32
7636962|NCT01625286|26570386|P5|Overall Study|Ongoing off-treatment at DCO|0
7636963|NCT01625286|26570387|P4|Overall Study|Ongoing off-treatment at DCO|0
7636964|NCT01625286|26570388|P3|Overall Study|Ongoing off-treatment at DCO|0
7636965|NCT01625286|26570389|P2|Overall Study|Ongoing off-treatment at DCO|0
7636966|NCT01625286|26570390|P1|Overall Study|Ongoing off-treatment at DCO|0
7636967|NCT01625286|26570384|P7|Overall Study|Lost to Follow-up|1
7636968|NCT01625286|26570385|P6|Overall Study|Lost to Follow-up|0
7636969|NCT01625286|26570386|P5|Overall Study|Lost to Follow-up|0
7636970|NCT01625286|26570387|P4|Overall Study|Lost to Follow-up|0
7636971|NCT01625286|26570388|P3|Overall Study|Lost to Follow-up|0
7636972|NCT01625286|26570389|P2|Overall Study|Lost to Follow-up|0
7636973|NCT01625286|26570390|P1|Overall Study|Lost to Follow-up|0
7636974|NCT01625286|26570384|P7|Overall Study|Progressive disease|0
7636975|NCT01625286|26570385|P6|Overall Study|Progressive disease|0
7636976|NCT01625286|26570386|P5|Overall Study|Progressive disease|5
7636977|NCT01625286|26570387|P4|Overall Study|Progressive disease|5
7636978|NCT01625286|26570388|P3|Overall Study|Progressive disease|4
7636979|NCT01625286|26570389|P2|Overall Study|Progressive disease|3
7636980|NCT01625286|26570390|P1|Overall Study|Progressive disease|6
7636981|NCT01625286|26570384|P7|Overall Study|Any reason not specifically recorded|0
7636982|NCT01625286|26570385|P6|Overall Study|Any reason not specifically recorded|1
7636983|NCT01625286|26570386|P5|Overall Study|Any reason not specifically recorded|0
7636984|NCT01625286|26570387|P4|Overall Study|Any reason not specifically recorded|0
7636985|NCT01625286|26570388|P3|Overall Study|Any reason not specifically recorded|0
7636986|NCT01625286|26570389|P2|Overall Study|Any reason not specifically recorded|0
7636987|NCT01625286|26570390|P1|Overall Study|Any reason not specifically recorded|0
7636988|NCT01625286|26570384|P7|Overall Study|Withdrawal by Subject|1
7636989|NCT01625286|26570385|P6|Overall Study|Withdrawal by Subject|0
7636990|NCT01625286|26570386|P5|Overall Study|Withdrawal by Subject|0
7636991|NCT01625286|26570387|P4|Overall Study|Withdrawal by Subject|1
7636992|NCT01625286|26570388|P3|Overall Study|Withdrawal by Subject|0
7636993|NCT01625286|26570389|P2|Overall Study|Withdrawal by Subject|1
7636994|NCT01625286|26570390|P1|Overall Study|Withdrawal by Subject|0
7636995|NCT01625286|26570384|P7|Overall Study|Death|16
7636996|NCT01625286|26570385|P6|Overall Study|Death|11
7636997|NCT01625286|26570386|P5|Overall Study|Death|0
7636998|NCT01625286|26570387|P4|Overall Study|Death|1
7636999|NCT01625286|26570388|P3|Overall Study|Death|1
7637000|NCT01625286|26570389|P2|Overall Study|Death|0
7637001|NCT01625286|26570390|P1|Overall Study|Death|0
7637002|NCT01625286|26570384|P7|Overall Study|Adverse Event|1
7637003|NCT01625286|26570385|P6|Overall Study|Adverse Event|2
7637004|NCT01625286|26570386|P5|Overall Study|Adverse Event|1
7637005|NCT01625286|26570387|P4|Overall Study|Adverse Event|0
7637006|NCT01625286|26570388|P3|Overall Study|Adverse Event|0
7637007|NCT01625286|26570389|P2|Overall Study|Adverse Event|0
7637008|NCT01625286|26570390|P1|Overall Study|Adverse Event|0
7637009|NCT01625182|26570476|P2|Overall Study|Lack of Efficacy|8
7637010|NCT01625182|26570477|P1|Overall Study|Lack of Efficacy|12
7637011|NCT01625182|26570476|P2|Overall Study|Withdrawal by Subject|1
7637012|NCT01625182|26570477|P1|Overall Study|Withdrawal by Subject|5
7637013|NCT01625182|26570476|P2|Overall Study|Adverse Event|0
7637014|NCT01625182|26570477|P1|Overall Study|Adverse Event|2
7637015|NCT01625182|26570476|P2|Overall Study|Protocol deviation|2
7637016|NCT01625182|26570477|P1|Overall Study|Protocol deviation|0
7637017|NCT01625182|26570476|P2|Overall Study|Administrative problems|0
7637018|NCT01625182|26570477|P1|Overall Study|Administrative problems|1
7637019|NCT01625091|26570514|P2|Post-intervention|Study termination|1
7637020|NCT01625091|26570515|P1|Post-intervention|Study termination|2
7637021|NCT01625091|26570514|P2|Post-intervention|Lost to Follow-up|0
7637022|NCT01625091|26570515|P1|Post-intervention|Lost to Follow-up|2
7637023|NCT01625091|26570514|P2|Post-intervention|Death|1
7637024|NCT01625091|26570515|P1|Post-intervention|Death|0
7637025|NCT01625091|26570514|P2|Intervention|Study termination|3
7637026|NCT01625091|26570515|P1|Intervention|Study termination|2
7637027|NCT01625091|26570514|P2|Intervention|Lost to Follow-up|4
7637028|NCT01625091|26570515|P1|Intervention|Lost to Follow-up|4
7637029|NCT01625091|26570514|P2|Intervention|Adverse Event|2
7637030|NCT01625091|26570515|P1|Intervention|Adverse Event|0
7637031|NCT01625091|26570514|P2|Intervention|Withdrawal by Subject|1
7637032|NCT01625091|26570515|P1|Intervention|Withdrawal by Subject|4
7637033|NCT01625091|26570514|P2|Intervention|Death|1
7637034|NCT01625091|26570515|P1|Intervention|Death|1
7637035|NCT01625000|26570539|P5|Overall Study|Adverse Event (including Death)|21
7637036|NCT01625000|26570540|P4|Overall Study|Adverse Event (including Death)|7
7637037|NCT01625000|26570541|P3|Overall Study|Adverse Event (including Death)|11
7637038|NCT01625000|26570542|P2|Overall Study|Adverse Event (including Death)|19
7637039|NCT01625000|26570543|P1|Overall Study|Adverse Event (including Death)|15
7637040|NCT01625000|26570539|P5|Overall Study|Withdrawal by Subject|17
7637041|NCT01625000|26570540|P4|Overall Study|Withdrawal by Subject|9
7637042|NCT01625000|26570541|P3|Overall Study|Withdrawal by Subject|11
7637043|NCT01625000|26570542|P2|Overall Study|Withdrawal by Subject|16
7637044|NCT01625000|26570543|P1|Overall Study|Withdrawal by Subject|19
7637045|NCT01625000|26570539|P5|Overall Study|Protocol Violation|2
7637046|NCT01625000|26570540|P4|Overall Study|Protocol Violation|1
7637047|NCT01625000|26570541|P3|Overall Study|Protocol Violation|4
7637048|NCT01625000|26570542|P2|Overall Study|Protocol Violation|10
7637049|NCT01625000|26570543|P1|Overall Study|Protocol Violation|3
7637050|NCT01625000|26570539|P5|Overall Study|Physician Decision|15
7637051|NCT01625000|26570540|P4|Overall Study|Physician Decision|2
7637052|NCT01625000|26570541|P3|Overall Study|Physician Decision|7
7637053|NCT01625000|26570542|P2|Overall Study|Physician Decision|7
7637054|NCT01625000|26570543|P1|Overall Study|Physician Decision|15
7637055|NCT01624974|26570562|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
7637056|NCT01624974|26570563|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
7637057|NCT01624974|26570562|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
7637058|NCT01624974|26570563|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
7637059|NCT01624974|26570562|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
7637060|NCT01624974|26570563|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
7637061|NCT01624974|26570562|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
7637062|NCT01624974|26570563|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
7637063|NCT01624974|26570562|P2|Period IV Washout (4 Weeks)|Adverse Event|0
7637064|NCT01624974|26570563|P1|Period IV Washout (4 Weeks)|Adverse Event|2
7637065|NCT01624974|26570562|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
7637066|NCT01624974|26570563|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
7637067|NCT01624974|26570562|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7637068|NCT01624974|26570563|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7637069|NCT01624974|26570562|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
7637070|NCT01624974|26570563|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
7637071|NCT01624974|26570562|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
7637072|NCT01624974|26570563|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
7637073|NCT01624974|26570562|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
7637074|NCT01624974|26570563|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
7637075|NCT01624974|26570562|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
7637076|NCT01624974|26570563|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
7637077|NCT01624974|26570562|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
7637078|NCT01624974|26570563|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
7637079|NCT01624870|26570604|P1|Overall Study|Lost to follow up|1
7637080|NCT01624870|26570604|P1|Overall Study|CoreValve not implanted|6
7637081|NCT01624870|26570604|P1|Overall Study|Withdrawal by Subject|1
7637082|NCT01624870|26570604|P1|Overall Study|Death|19
7637083|NCT01624662|26570624|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7637084|NCT01624662|26570625|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7637085|NCT01624662|26570626|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7637086|NCT01624662|26570627|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7637087|NCT01624662|26570624|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7637088|NCT01624662|26570625|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7637089|NCT01624662|26570626|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7637090|NCT01624662|26570627|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7637091|NCT01624662|26570624|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7637092|NCT01624662|26570625|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7637093|NCT01624662|26570626|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7637094|NCT01624662|26570627|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7637095|NCT01624662|26570624|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7637096|NCT01624662|26570625|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7637097|NCT01624662|26570626|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7637098|NCT01624662|26570627|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7637099|NCT01624662|26570624|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7637100|NCT01624662|26570625|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7637101|NCT01624662|26570626|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7637102|NCT01624662|26570627|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7637103|NCT01624662|26570624|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7637104|NCT01624662|26570625|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7637105|NCT01624662|26570626|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
7637106|NCT01624662|26570627|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
7637107|NCT01624662|26570624|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
7637108|NCT01624662|26570625|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7637109|NCT01624662|26570626|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7637110|NCT01624662|26570627|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7637111|NCT01624506|26570700|P2|Overall Study|Adverse Event|0
7637112|NCT01624506|26570701|P1|Overall Study|Adverse Event|3
7637113|NCT01624506|26570700|P2|Overall Study|LINX explants|0
7637114|NCT01624506|26570701|P1|Overall Study|LINX explants|23
7637115|NCT01624506|26570700|P2|Overall Study|Death|0
7637116|NCT01624506|26570701|P1|Overall Study|Death|1
7637117|NCT01624506|26570700|P2|Overall Study|Withdrawal by Subject|2
7637118|NCT01624506|26570701|P1|Overall Study|Withdrawal by Subject|9
7637119|NCT01624506|26570700|P2|Overall Study|Lost to Follow-up|15
7637120|NCT01624506|26570701|P1|Overall Study|Lost to Follow-up|29
7637121|NCT01624467|26570707|P1|Overall Study|Subject Withdrew from Treatment|1
7637122|NCT01624467|26570707|P1|Overall Study|Per Sponsor Requirement|1
7637123|NCT01624467|26570707|P1|Overall Study|Progressive Disease|19
7637124|NCT01624467|26570707|P1|Overall Study|Adverse Event|7
7637125|NCT01624467|26570707|P1|Overall Study|Lost to Follow-up|1
7637126|NCT01624467|26570707|P1|Overall Study|Withdrawal by Subject|2
7637127|NCT01624259|26570746|P2|Overall Study|Abnormal laboratory measure|0
7637128|NCT01624259|26570747|P1|Overall Study|Abnormal laboratory measure|3
7637129|NCT01624259|26570746|P2|Overall Study|Lost to Follow-up|3
7637130|NCT01624259|26570747|P1|Overall Study|Lost to Follow-up|2
7637131|NCT01624259|26570746|P2|Overall Study|Physician Decision|1
7637132|NCT01624259|26570747|P1|Overall Study|Physician Decision|1
7637133|NCT01624259|26570746|P2|Overall Study|Withdrawal by Subject|7
7637134|NCT01624259|26570747|P1|Overall Study|Withdrawal by Subject|5
7637135|NCT01624259|26570746|P2|Overall Study|Protocol Violation|2
7637136|NCT01624259|26570747|P1|Overall Study|Protocol Violation|1
7637137|NCT01624259|26570746|P2|Overall Study|Adverse Event|18
7637138|NCT01624259|26570747|P1|Overall Study|Adverse Event|18
7637139|NCT01624233|26570796|P1|Period 6: Follow-up|Withdrawal by Subject|3
7637140|NCT01624233|26570796|P1|Period 6: Follow-up|Physician Decision|1
7637141|NCT01624233|26570796|P1|Period 6: Follow-up|Lack of Efficacy|2
7637142|NCT01624233|26570796|P1|Period 6: Follow-up|Adverse Event|3
7637143|NCT01624233|26570796|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
7637144|NCT01624233|26570796|P1|Period 5 - Retreatment Period|Physician Decision|1
7637145|NCT01624233|26570796|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
7637146|NCT01624233|26570796|P1|Period 5 - Retreatment Period|Adverse Event|5
7637147|NCT01624233|26570796|P1|Period 4 - Drug Free Period|Relapsed|61
7637148|NCT01624233|26570796|P1|Period 3 - Maintenance|Withdrawal by Subject|2
7637149|NCT01624233|26570796|P1|Period 3 - Maintenance|Physician Decision|2
7637150|NCT01624233|26570796|P1|Period 3 - Maintenance|Lack of Efficacy|1
7637151|NCT01624233|26570796|P1|Period 3 - Maintenance|Adverse Event|2
7637152|NCT01624233|26570796|P1|Period 2 - Induction|Adverse Event|1
7637153|NCT01624194|26570828|P2|Overall Study|Withdrawal by Subject|0
7637154|NCT01624194|26570829|P1|Overall Study|Withdrawal by Subject|1
7637155|NCT01624194|26570828|P2|Overall Study|Lost to Follow-up|0
7637156|NCT01624194|26570829|P1|Overall Study|Lost to Follow-up|1
7637157|NCT01624142|26570897|P2|Overall Study|Other|0
7637158|NCT01624142|26570898|P1|Overall Study|Other|1
7637159|NCT01624142|26570897|P2|Overall Study|Lost to Follow-up|0
7637160|NCT01624142|26570898|P1|Overall Study|Lost to Follow-up|2
7637161|NCT01624142|26570897|P2|Overall Study|Study Closure|6
7637162|NCT01624142|26570898|P1|Overall Study|Study Closure|12
7637163|NCT01624142|26570897|P2|Overall Study|Death|6
7637164|NCT01624142|26570898|P1|Overall Study|Death|3
7637165|NCT01624142|26570897|P2|Overall Study|Withdrawal by Subject|4
7637166|NCT01624142|26570898|P1|Overall Study|Withdrawal by Subject|14
7637167|NCT01624090|26570923|P4|Overall Study|Dose escalated|0
7637168|NCT01624090|26570924|P3|Overall Study|Dose escalated|3
7637169|NCT01624090|26570925|P2|Overall Study|Dose escalated|0
7637170|NCT01624090|26570926|P1|Overall Study|Dose escalated|0
7637171|NCT01624090|26570923|P4|Overall Study|Did not complete 1 crse of therapy|0
7637172|NCT01624090|26570924|P3|Overall Study|Did not complete 1 crse of therapy|2
7637173|NCT01624090|26570925|P2|Overall Study|Did not complete 1 crse of therapy|0
7637174|NCT01624090|26570926|P1|Overall Study|Did not complete 1 crse of therapy|0
7637175|NCT01624090|26570923|P4|Overall Study|Died on study|0
7637176|NCT01624090|26570924|P3|Overall Study|Died on study|2
7637177|NCT01624090|26570925|P2|Overall Study|Died on study|0
7637178|NCT01624090|26570926|P1|Overall Study|Died on study|0
7637179|NCT01624090|26570923|P4|Overall Study|Withdrew prior to treatment|0
7637180|NCT01624090|26570924|P3|Overall Study|Withdrew prior to treatment|0
7637181|NCT01624090|26570925|P2|Overall Study|Withdrew prior to treatment|1
7637182|NCT01624090|26570926|P1|Overall Study|Withdrew prior to treatment|0
7637183|NCT01624090|26570923|P4|Overall Study|DLT, taken off therapy|0
7637184|NCT01624090|26570924|P3|Overall Study|DLT, taken off therapy|0
7637185|NCT01624090|26570925|P2|Overall Study|DLT, taken off therapy|1
7637186|NCT01624090|26570926|P1|Overall Study|DLT, taken off therapy|0
7637187|NCT01623830|26570948|P2|Overall Study|Exclusion from Study|2
7637188|NCT01623830|26570949|P1|Overall Study|Exclusion from Study|1
7637189|NCT01623830|26570948|P2|Overall Study|Withdrawal by Subject|7
7637190|NCT01623830|26570949|P1|Overall Study|Withdrawal by Subject|6
7637191|NCT01623752|26570966|P3|Phase 2 (78 Weeks)|Adverse Event|0
7637192|NCT01623752|26570967|P2|Phase 2 (78 Weeks)|Adverse Event|4
7637193|NCT01623752|26570968|P1|Phase 2 (78 Weeks)|Adverse Event|4
7637194|NCT01623752|26570966|P3|Phase 2 (78 Weeks)|No Data|0
7637195|NCT01623752|26570967|P2|Phase 2 (78 Weeks)|No Data|11
7637196|NCT01623752|26570968|P1|Phase 2 (78 Weeks)|No Data|43
7637197|NCT01623752|26570966|P3|Phase 2 (78 Weeks)|Other|0
7637198|NCT01623752|26570967|P2|Phase 2 (78 Weeks)|Other|1
7637199|NCT01623752|26570968|P1|Phase 2 (78 Weeks)|Other|5
7637200|NCT01623752|26570966|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
7637201|NCT01623752|26570967|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
7637202|NCT01623752|26570968|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
7637203|NCT01623752|26570966|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
7637204|NCT01623752|26570967|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
7637205|NCT01623752|26570968|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
7637206|NCT01623752|26570966|P3|Phase 1 (78 Weeks)|Adverse Event|0
7637207|NCT01623752|26570967|P2|Phase 1 (78 Weeks)|Adverse Event|39
7637208|NCT01623752|26570968|P1|Phase 1 (78 Weeks)|Adverse Event|122
7637209|NCT01623752|26570966|P3|Phase 1 (78 Weeks)|Other|0
7637210|NCT01623752|26570967|P2|Phase 1 (78 Weeks)|Other|20
7637211|NCT01623752|26570968|P1|Phase 1 (78 Weeks)|Other|33
7637212|NCT01623752|26570966|P3|Phase 1 (78 Weeks)|No Data|2
7637213|NCT01623752|26570967|P2|Phase 1 (78 Weeks)|No Data|66
7637214|NCT01623752|26570968|P1|Phase 1 (78 Weeks)|No Data|249
7637215|NCT01623596|26571071|P2|Overall Study|Lack of Efficacy|3
7637216|NCT01623596|26571072|P1|Overall Study|Lack of Efficacy|5
7637217|NCT01623596|26571071|P2|Overall Study|Protocol Violation|6
7637218|NCT01623596|26571072|P1|Overall Study|Protocol Violation|0
7637219|NCT01623596|26571071|P2|Overall Study|Patient no longer requires study drug|0
7637220|NCT01623596|26571072|P1|Overall Study|Patient no longer requires study drug|1
7637221|NCT01623596|26571071|P2|Overall Study|Withdrawal by Subject|31
7637222|NCT01623596|26571072|P1|Overall Study|Withdrawal by Subject|13
7637223|NCT01623596|26571071|P2|Overall Study|Lost to Follow-up|16
7637224|NCT01623596|26571072|P1|Overall Study|Lost to Follow-up|12
7637225|NCT01623596|26571071|P2|Overall Study|Death|2
7637226|NCT01623596|26571072|P1|Overall Study|Death|0
7637227|NCT01623596|26571071|P2|Overall Study|Adverse Event|29
7637228|NCT01623596|26571072|P1|Overall Study|Adverse Event|20
7637229|NCT01623596|26571071|P2|Overall Study|Administrative problems|13
7637230|NCT01623596|26571072|P1|Overall Study|Administrative problems|9
7637231|NCT01623596|26571071|P2|Overall Study|Abnormal laboratory values|0
7637232|NCT01623596|26571072|P1|Overall Study|Abnormal laboratory values|2
7637233|NCT01623531|26571090|P2|Overall Study|Missing data at primary outcome time poi|1
7637234|NCT01623531|26571091|P1|Overall Study|Missing data at primary outcome time poi|1
7637235|NCT01623531|26571090|P2|Overall Study|Protocol Violation|1
7637236|NCT01623531|26571091|P1|Overall Study|Protocol Violation|2
7637237|NCT01623531|26571090|P2|Overall Study|Death|0
7637238|NCT01623531|26571091|P1|Overall Study|Death|1
7637239|NCT01623310|26571158|P1|Overall Study|Investigators Discretion-Noncompliant|1
7637240|NCT01623310|26571158|P1|Overall Study|Diagnoses of bilateral cateracts|1
7637241|NCT01623310|26571158|P1|Overall Study|Became potentially child-bearing|1
7637242|NCT01623310|26571158|P1|Overall Study|Withdrawal by Subject|25
7637243|NCT01623310|26571158|P1|Overall Study|Protocol Violation|6
7637244|NCT01623310|26571158|P1|Overall Study|Lack of Efficacy|6
7637245|NCT01623310|26571158|P1|Overall Study|Lost to Follow-up|18
7637246|NCT01623310|26571158|P1|Overall Study|Adverse Event|21
7637247|NCT01623271|26571167|P1|Overall Study|Withdrawal by Subject|2
7637248|NCT01623154|26571184|P1|Overall Study|Did not drink Pranactin Citric|4
7637249|NCT01623115|26571192|P2|Overall Study|Other than specified above|3
7637250|NCT01623115|26571193|P1|Overall Study|Other than specified above|0
7637251|NCT01623115|26571192|P2|Overall Study|Death|4
7637252|NCT01623115|26571193|P1|Overall Study|Death|0
7637253|NCT01623115|26571192|P2|Overall Study|Site closure|7
7637254|NCT01623115|26571193|P1|Overall Study|Site closure|1
7637255|NCT01623115|26571192|P2|Overall Study|Last visit outside protocol visit window|26
7637256|NCT01623115|26571193|P1|Overall Study|Last visit outside protocol visit window|14
7637257|NCT01623115|26571192|P2|Overall Study|Related to study drug administration|2
7637258|NCT01623115|26571193|P1|Overall Study|Related to study drug administration|0
7637259|NCT01623115|26571192|P2|Overall Study|Consent withdrawn by participant|6
7637260|NCT01623115|26571193|P1|Overall Study|Consent withdrawn by participant|2
7637261|NCT01623115|26571192|P2|Overall Study|Poor compliance to protocol|10
7637262|NCT01623115|26571193|P1|Overall Study|Poor compliance to protocol|4
7637263|NCT01623115|26571192|P2|Overall Study|Adverse Event|13
7637264|NCT01623115|26571193|P1|Overall Study|Adverse Event|10
7637265|NCT01623115|26571192|P2|Overall Study|Participants moved|5
7637266|NCT01623115|26571193|P1|Overall Study|Participants moved|1
7637267|NCT01623115|26571192|P2|Overall Study|Physician Decision|0
7637268|NCT01623115|26571193|P1|Overall Study|Physician Decision|1
7637269|NCT01623115|26571192|P2|Overall Study|Randomized but not treated|1
7637270|NCT01623115|26571193|P1|Overall Study|Randomized but not treated|0
7637271|NCT01623050|26571253|P1|Overall Study|Lost to Follow-up|9
7637272|NCT01622868|26571272|P2|Overall Study|Protocol Violation|0
7637273|NCT01622868|26571273|P1|Overall Study|Protocol Violation|7
7637274|NCT01622673|26571320|P6|Treatment Period 3|Protocol Violation|0
7637275|NCT01622673|26571321|P5|Treatment Period 3|Protocol Violation|0
7637276|NCT01622673|26571322|P4|Treatment Period 3|Protocol Violation|0
7637277|NCT01622673|26571323|P3|Treatment Period 3|Protocol Violation|0
7637278|NCT01622673|26571324|P2|Treatment Period 3|Protocol Violation|1
7637279|NCT01622673|26571325|P1|Treatment Period 3|Protocol Violation|0
7637280|NCT01622673|26571320|P6|Treatment Period 2|Withdrawal by Subject|0
7637281|NCT01622673|26571321|P5|Treatment Period 2|Withdrawal by Subject|0
7637282|NCT01622673|26571322|P4|Treatment Period 2|Withdrawal by Subject|1
7637283|NCT01622673|26571323|P3|Treatment Period 2|Withdrawal by Subject|0
7637284|NCT01622673|26571324|P2|Treatment Period 2|Withdrawal by Subject|0
7637285|NCT01622673|26571325|P1|Treatment Period 2|Withdrawal by Subject|0
7637286|NCT01622673|26571320|P6|Treatment Period 1|Protocol Violation|0
7637287|NCT01622673|26571321|P5|Treatment Period 1|Protocol Violation|0
7637288|NCT01622673|26571322|P4|Treatment Period 1|Protocol Violation|0
7637289|NCT01622673|26571323|P3|Treatment Period 1|Protocol Violation|0
7637290|NCT01622673|26571324|P2|Treatment Period 1|Protocol Violation|1
7637291|NCT01622673|26571325|P1|Treatment Period 1|Protocol Violation|0
7637292|NCT01622673|26571320|P6|Treatment Period 1|Withdrawal by Subject|0
7637293|NCT01622673|26571321|P5|Treatment Period 1|Withdrawal by Subject|0
7637294|NCT01622673|26571322|P4|Treatment Period 1|Withdrawal by Subject|1
7637295|NCT01622673|26571323|P3|Treatment Period 1|Withdrawal by Subject|0
7637296|NCT01622673|26571324|P2|Treatment Period 1|Withdrawal by Subject|0
7637297|NCT01622673|26571325|P1|Treatment Period 1|Withdrawal by Subject|0
7637298|NCT01622660|26571360|P1|Overall Study|Adverse Event|1
7637299|NCT01622569|26571368|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7637300|NCT01622569|26571369|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7637301|NCT01622569|26571370|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7637302|NCT01622569|26571371|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7637303|NCT01622569|26571368|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7637304|NCT01622569|26571369|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
7637305|NCT01622569|26571370|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7637306|NCT01622569|26571371|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7637307|NCT01622569|26571368|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7637308|NCT01622569|26571369|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7637309|NCT01622569|26571370|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
7637310|NCT01622569|26571371|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7637311|NCT01622569|26571368|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7637312|NCT01622569|26571369|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7637313|NCT01622569|26571370|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7637314|NCT01622569|26571371|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7637315|NCT01622569|26571368|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7637316|NCT01622569|26571369|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7637317|NCT01622569|26571370|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
7637318|NCT01622569|26571371|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7637319|NCT01622569|26571368|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
7637320|NCT01622569|26571369|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
7637321|NCT01622569|26571370|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7637322|NCT01622569|26571371|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
7637323|NCT01622569|26571368|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7637324|NCT01622569|26571369|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
7637325|NCT01622569|26571370|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7637326|NCT01622569|26571371|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7637327|NCT01622569|26571368|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7637328|NCT01622569|26571369|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
7637329|NCT01622569|26571370|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7637330|NCT01622569|26571371|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
7637331|NCT01622348|26571456|P3|Overall Study|Withdrawal by Subject|1
7637332|NCT01622348|26571457|P2|Overall Study|Withdrawal by Subject|0
7637333|NCT01622348|26571458|P1|Overall Study|Withdrawal by Subject|1
7637334|NCT01622231|26571497|P1|Overall Study|Withdrawal by Subject|1
7637335|NCT01622231|26571497|P1|Overall Study|Physician Decision|1
7637336|NCT01621880|26571542|P2|Overall Study|Withdrawal by Subject|4
7637337|NCT01621880|26571543|P1|Overall Study|Withdrawal by Subject|5
7637338|NCT01621880|26571542|P2|Overall Study|Adverse Event|1
7637339|NCT01621880|26571543|P1|Overall Study|Adverse Event|5
7637340|NCT01621802|26571557|P6|Overall Study|Lost to Follow-up|11
7637341|NCT01621802|26571558|P5|Overall Study|Lost to Follow-up|31
7637342|NCT01621802|26571559|P4|Overall Study|Lost to Follow-up|7
7637343|NCT01621802|26571560|P3|Overall Study|Lost to Follow-up|24
7637344|NCT01621802|26571561|P2|Overall Study|Lost to Follow-up|16
7637345|NCT01621802|26571562|P1|Overall Study|Lost to Follow-up|36
7637346|NCT01621802|26571557|P6|Overall Study|Others|0
7637347|NCT01621802|26571558|P5|Overall Study|Others|1
7637348|NCT01621802|26571559|P4|Overall Study|Others|2
7637349|NCT01621802|26571560|P3|Overall Study|Others|3
7637350|NCT01621802|26571561|P2|Overall Study|Others|3
7637351|NCT01621802|26571562|P1|Overall Study|Others|3
7637352|NCT01621802|26571557|P6|Overall Study|Migrated/moved from study area|0
7637353|NCT01621802|26571558|P5|Overall Study|Migrated/moved from study area|1
7637354|NCT01621802|26571559|P4|Overall Study|Migrated/moved from study area|0
7637355|NCT01621802|26571560|P3|Overall Study|Migrated/moved from study area|2
7637356|NCT01621802|26571561|P2|Overall Study|Migrated/moved from study area|0
7637357|NCT01621802|26571562|P1|Overall Study|Migrated/moved from study area|0
7637358|NCT01621802|26571557|P6|Overall Study|Withdrawal by Subject|0
7637359|NCT01621802|26571558|P5|Overall Study|Withdrawal by Subject|2
7637360|NCT01621802|26571559|P4|Overall Study|Withdrawal by Subject|2
7637361|NCT01621802|26571560|P3|Overall Study|Withdrawal by Subject|4
7637362|NCT01621802|26571561|P2|Overall Study|Withdrawal by Subject|4
7637363|NCT01621802|26571562|P1|Overall Study|Withdrawal by Subject|8
7637364|NCT01621802|26571557|P6|Overall Study|Protocol Violation|1
7637365|NCT01621802|26571558|P5|Overall Study|Protocol Violation|0
7637366|NCT01621802|26571559|P4|Overall Study|Protocol Violation|0
7637367|NCT01621802|26571560|P3|Overall Study|Protocol Violation|0
7637368|NCT01621802|26571561|P2|Overall Study|Protocol Violation|0
7637369|NCT01621802|26571562|P1|Overall Study|Protocol Violation|0
7637370|NCT01621542|26571747|P6|Overall Study|study stopped by sponsor|0
7637371|NCT01621542|26571748|P5|Overall Study|study stopped by sponsor|0
7637372|NCT01621542|26571749|P4|Overall Study|study stopped by sponsor|1
7637373|NCT01621542|26571750|P3|Overall Study|study stopped by sponsor|0
7637374|NCT01621542|26571751|P2|Overall Study|study stopped by sponsor|0
7637375|NCT01621542|26571752|P1|Overall Study|study stopped by sponsor|0
7637376|NCT01621542|26571747|P6|Overall Study|Protocol Violation|0
7637377|NCT01621542|26571748|P5|Overall Study|Protocol Violation|0
7637378|NCT01621542|26571749|P4|Overall Study|Protocol Violation|1
7637379|NCT01621542|26571750|P3|Overall Study|Protocol Violation|0
7637380|NCT01621542|26571751|P2|Overall Study|Protocol Violation|0
7637381|NCT01621542|26571752|P1|Overall Study|Protocol Violation|0
7637382|NCT01621542|26571747|P6|Overall Study|progression/treatment failure|5
7637383|NCT01621542|26571748|P5|Overall Study|progression/treatment failure|3
7637384|NCT01621542|26571749|P4|Overall Study|progression/treatment failure|7
7637385|NCT01621542|26571750|P3|Overall Study|progression/treatment failure|3
7637386|NCT01621542|26571751|P2|Overall Study|progression/treatment failure|4
7637387|NCT01621542|26571752|P1|Overall Study|progression/treatment failure|2
7637388|NCT01621542|26571747|P6|Overall Study|Withdrawal by Subject|3
7637389|NCT01621542|26571748|P5|Overall Study|Withdrawal by Subject|3
7637390|NCT01621542|26571749|P4|Overall Study|Withdrawal by Subject|3
7637391|NCT01621542|26571750|P3|Overall Study|Withdrawal by Subject|1
7637392|NCT01621542|26571751|P2|Overall Study|Withdrawal by Subject|0
7637393|NCT01621542|26571752|P1|Overall Study|Withdrawal by Subject|2
7637394|NCT01621542|26571747|P6|Overall Study|Physician Decision|1
7637395|NCT01621542|26571748|P5|Overall Study|Physician Decision|3
7637396|NCT01621542|26571749|P4|Overall Study|Physician Decision|13
7637397|NCT01621542|26571750|P3|Overall Study|Physician Decision|1
7637398|NCT01621542|26571751|P2|Overall Study|Physician Decision|0
7637399|NCT01621542|26571752|P1|Overall Study|Physician Decision|1
7637400|NCT01621542|26571747|P6|Overall Study|Death|0
7637401|NCT01621542|26571748|P5|Overall Study|Death|0
7637402|NCT01621542|26571749|P4|Overall Study|Death|0
7637403|NCT01621542|26571750|P3|Overall Study|Death|0
7637404|NCT01621542|26571751|P2|Overall Study|Death|1
7637405|NCT01621542|26571752|P1|Overall Study|Death|0
7637406|NCT01621542|26571747|P6|Overall Study|Adverse Event|0
7637407|NCT01621542|26571748|P5|Overall Study|Adverse Event|0
7637408|NCT01621542|26571749|P4|Overall Study|Adverse Event|3
7637409|NCT01621542|26571750|P3|Overall Study|Adverse Event|1
7637410|NCT01621542|26571751|P2|Overall Study|Adverse Event|0
7637411|NCT01621542|26571752|P1|Overall Study|Adverse Event|0
7637412|NCT01621490|26571793|P9|Overall Study|Patient delayed due to toxicity|0
7637413|NCT01621490|26571794|P8|Overall Study|Patient delayed due to toxicity|0
7637414|NCT01621490|26571795|P7|Overall Study|Patient delayed due to toxicity|0
7637415|NCT01621490|26571796|P6|Overall Study|Patient delayed due to toxicity|1
7637416|NCT01621490|26571797|P5|Overall Study|Patient delayed due to toxicity|0
7637417|NCT01621490|26571798|P4|Overall Study|Patient delayed due to toxicity|0
7637418|NCT01621490|26571799|P3|Overall Study|Patient delayed due to toxicity|0
7637419|NCT01621490|26571800|P2|Overall Study|Patient delayed due to toxicity|0
7637420|NCT01621490|26571801|P1|Overall Study|Patient delayed due to toxicity|0
7637421|NCT01621490|26571793|P9|Overall Study|Complete response|1
7637422|NCT01621490|26571794|P8|Overall Study|Complete response|0
7637423|NCT01621490|26571795|P7|Overall Study|Complete response|0
7637424|NCT01621490|26571796|P6|Overall Study|Complete response|0
7637425|NCT01621490|26571797|P5|Overall Study|Complete response|0
7637426|NCT01621490|26571798|P4|Overall Study|Complete response|0
7637427|NCT01621490|26571799|P3|Overall Study|Complete response|0
7637428|NCT01621490|26571800|P2|Overall Study|Complete response|0
7637429|NCT01621490|26571801|P1|Overall Study|Complete response|0
7637430|NCT01621490|26571793|P9|Overall Study|Clinical deterioration|0
7637431|NCT01621490|26571794|P8|Overall Study|Clinical deterioration|0
7637432|NCT01621490|26571795|P7|Overall Study|Clinical deterioration|0
7637433|NCT01621490|26571796|P6|Overall Study|Clinical deterioration|0
7637434|NCT01621490|26571797|P5|Overall Study|Clinical deterioration|0
7637435|NCT01621490|26571798|P4|Overall Study|Clinical deterioration|0
7637436|NCT01621490|26571799|P3|Overall Study|Clinical deterioration|0
7637437|NCT01621490|26571800|P2|Overall Study|Clinical deterioration|1
7637438|NCT01621490|26571801|P1|Overall Study|Clinical deterioration|0
7637439|NCT01621490|26571793|P9|Overall Study|Patient reached treatment 2 yr limit|0
7637440|NCT01621490|26571794|P8|Overall Study|Patient reached treatment 2 yr limit|0
7637441|NCT01621490|26571795|P7|Overall Study|Patient reached treatment 2 yr limit|0
7637442|NCT01621490|26571796|P6|Overall Study|Patient reached treatment 2 yr limit|0
7637443|NCT01621490|26571797|P5|Overall Study|Patient reached treatment 2 yr limit|0
7637444|NCT01621490|26571798|P4|Overall Study|Patient reached treatment 2 yr limit|0
7637445|NCT01621490|26571799|P3|Overall Study|Patient reached treatment 2 yr limit|0
7637446|NCT01621490|26571800|P2|Overall Study|Patient reached treatment 2 yr limit|1
7637447|NCT01621490|26571801|P1|Overall Study|Patient reached treatment 2 yr limit|0
7637448|NCT01621490|26571793|P9|Overall Study|Documented disease progression|0
7637449|NCT01621490|26571794|P8|Overall Study|Documented disease progression|0
7637450|NCT01621490|26571795|P7|Overall Study|Documented disease progression|0
7637451|NCT01621490|26571796|P6|Overall Study|Documented disease progression|0
7637452|NCT01621490|26571797|P5|Overall Study|Documented disease progression|0
7637453|NCT01621490|26571798|P4|Overall Study|Documented disease progression|0
7637454|NCT01621490|26571799|P3|Overall Study|Documented disease progression|1
7637455|NCT01621490|26571800|P2|Overall Study|Documented disease progression|0
7637456|NCT01621490|26571801|P1|Overall Study|Documented disease progression|0
7637457|NCT01621490|26571793|P9|Overall Study|Investigator decision|0
7637458|NCT01621490|26571794|P8|Overall Study|Investigator decision|0
7637459|NCT01621490|26571795|P7|Overall Study|Investigator decision|1
7637460|NCT01621490|26571796|P6|Overall Study|Investigator decision|0
7637461|NCT01621490|26571797|P5|Overall Study|Investigator decision|1
7637462|NCT01621490|26571798|P4|Overall Study|Investigator decision|0
7637463|NCT01621490|26571799|P3|Overall Study|Investigator decision|1
7637464|NCT01621490|26571800|P2|Overall Study|Investigator decision|0
7637465|NCT01621490|26571801|P1|Overall Study|Investigator decision|0
7637466|NCT01621490|26571793|P9|Overall Study|BMS informed of patient status|0
7637467|NCT01621490|26571794|P8|Overall Study|BMS informed of patient status|0
7637468|NCT01621490|26571795|P7|Overall Study|BMS informed of patient status|0
7637469|NCT01621490|26571796|P6|Overall Study|BMS informed of patient status|0
7637470|NCT01621490|26571797|P5|Overall Study|BMS informed of patient status|0
7637471|NCT01621490|26571798|P4|Overall Study|BMS informed of patient status|0
7637472|NCT01621490|26571799|P3|Overall Study|BMS informed of patient status|1
7637473|NCT01621490|26571800|P2|Overall Study|BMS informed of patient status|0
7637474|NCT01621490|26571801|P1|Overall Study|BMS informed of patient status|0
7637475|NCT01621490|26571793|P9|Overall Study|Grade 4 Lipase elevation|0
7637476|NCT01621490|26571794|P8|Overall Study|Grade 4 Lipase elevation|0
7637477|NCT01621490|26571795|P7|Overall Study|Grade 4 Lipase elevation|0
7637478|NCT01621490|26571796|P6|Overall Study|Grade 4 Lipase elevation|0
7637479|NCT01621490|26571797|P5|Overall Study|Grade 4 Lipase elevation|0
7637480|NCT01621490|26571798|P4|Overall Study|Grade 4 Lipase elevation|0
7637481|NCT01621490|26571799|P3|Overall Study|Grade 4 Lipase elevation|0
7637482|NCT01621490|26571800|P2|Overall Study|Grade 4 Lipase elevation|0
7637483|NCT01621490|26571801|P1|Overall Study|Grade 4 Lipase elevation|1
7637484|NCT01621490|26571793|P9|Overall Study|Death|0
7637485|NCT01621490|26571794|P8|Overall Study|Death|1
7637486|NCT01621490|26571795|P7|Overall Study|Death|0
7637487|NCT01621490|26571796|P6|Overall Study|Death|0
7637488|NCT01621490|26571797|P5|Overall Study|Death|0
7637489|NCT01621490|26571798|P4|Overall Study|Death|0
7637490|NCT01621490|26571799|P3|Overall Study|Death|0
7637491|NCT01621490|26571800|P2|Overall Study|Death|0
7637492|NCT01621490|26571801|P1|Overall Study|Death|0
7637493|NCT01621490|26571793|P9|Overall Study|Study drug toxicity|1
7637494|NCT01621490|26571794|P8|Overall Study|Study drug toxicity|4
7637495|NCT01621490|26571795|P7|Overall Study|Study drug toxicity|1
7637496|NCT01621490|26571796|P6|Overall Study|Study drug toxicity|10
7637497|NCT01621490|26571797|P5|Overall Study|Study drug toxicity|1
7637498|NCT01621490|26571798|P4|Overall Study|Study drug toxicity|3
7637499|NCT01621490|26571799|P3|Overall Study|Study drug toxicity|5
7637500|NCT01621490|26571800|P2|Overall Study|Study drug toxicity|4
7637501|NCT01621490|26571801|P1|Overall Study|Study drug toxicity|1
7637502|NCT01621490|26571793|P9|Overall Study|Disease progression|4
7637503|NCT01621490|26571794|P8|Overall Study|Disease progression|0
7637504|NCT01621490|26571795|P7|Overall Study|Disease progression|7
7637505|NCT01621490|26571796|P6|Overall Study|Disease progression|8
7637506|NCT01621490|26571797|P5|Overall Study|Disease progression|3
7637507|NCT01621490|26571798|P4|Overall Study|Disease progression|5
7637508|NCT01621490|26571799|P3|Overall Study|Disease progression|1
7637509|NCT01621490|26571800|P2|Overall Study|Disease progression|28
7637510|NCT01621490|26571801|P1|Overall Study|Disease progression|27
7637511|NCT01621490|26571793|P9|Overall Study|Adverse event unrelated to study drug|1
7637512|NCT01621490|26571794|P8|Overall Study|Adverse event unrelated to study drug|2
7637513|NCT01621490|26571795|P7|Overall Study|Adverse event unrelated to study drug|0
7637514|NCT01621490|26571796|P6|Overall Study|Adverse event unrelated to study drug|0
7637515|NCT01621490|26571797|P5|Overall Study|Adverse event unrelated to study drug|0
7637516|NCT01621490|26571798|P4|Overall Study|Adverse event unrelated to study drug|0
7637517|NCT01621490|26571799|P3|Overall Study|Adverse event unrelated to study drug|0
7637518|NCT01621490|26571800|P2|Overall Study|Adverse event unrelated to study drug|1
7637519|NCT01621490|26571801|P1|Overall Study|Adverse event unrelated to study drug|2
7637520|NCT01621490|26571793|P9|Overall Study|Subject request to discontinue study|1
7637521|NCT01621490|26571794|P8|Overall Study|Subject request to discontinue study|0
7637522|NCT01621490|26571795|P7|Overall Study|Subject request to discontinue study|1
7637523|NCT01621490|26571796|P6|Overall Study|Subject request to discontinue study|2
7637524|NCT01621490|26571797|P5|Overall Study|Subject request to discontinue study|0
7637525|NCT01621490|26571798|P4|Overall Study|Subject request to discontinue study|1
7637526|NCT01621490|26571799|P3|Overall Study|Subject request to discontinue study|1
7637527|NCT01621490|26571800|P2|Overall Study|Subject request to discontinue study|3
7637528|NCT01621490|26571801|P1|Overall Study|Subject request to discontinue study|1
7637529|NCT01621490|26571793|P9|Overall Study|Withdrawal by Subject|0
7637530|NCT01621490|26571794|P8|Overall Study|Withdrawal by Subject|0
7637531|NCT01621490|26571795|P7|Overall Study|Withdrawal by Subject|0
7637532|NCT01621490|26571796|P6|Overall Study|Withdrawal by Subject|3
7637533|NCT01621490|26571797|P5|Overall Study|Withdrawal by Subject|0
7637534|NCT01621490|26571798|P4|Overall Study|Withdrawal by Subject|0
7637535|NCT01621490|26571799|P3|Overall Study|Withdrawal by Subject|0
7637536|NCT01621490|26571800|P2|Overall Study|Withdrawal by Subject|0
7637537|NCT01621490|26571801|P1|Overall Study|Withdrawal by Subject|1
7637538|NCT01621490|26571793|P9|Overall Study|Maximum clinical benefit|0
7637539|NCT01621490|26571794|P8|Overall Study|Maximum clinical benefit|2
7637540|NCT01621490|26571795|P7|Overall Study|Maximum clinical benefit|1
7637541|NCT01621490|26571796|P6|Overall Study|Maximum clinical benefit|0
7637542|NCT01621490|26571797|P5|Overall Study|Maximum clinical benefit|0
7637543|NCT01621490|26571798|P4|Overall Study|Maximum clinical benefit|0
7637544|NCT01621490|26571799|P3|Overall Study|Maximum clinical benefit|0
7637545|NCT01621490|26571800|P2|Overall Study|Maximum clinical benefit|2
7637546|NCT01621490|26571801|P1|Overall Study|Maximum clinical benefit|3
7637547|NCT01621490|26571793|P9|Overall Study|Subject no longer meets study criteria|0
7637548|NCT01621490|26571794|P8|Overall Study|Subject no longer meets study criteria|0
7637549|NCT01621490|26571795|P7|Overall Study|Subject no longer meets study criteria|0
7637550|NCT01621490|26571796|P6|Overall Study|Subject no longer meets study criteria|0
7637551|NCT01621490|26571797|P5|Overall Study|Subject no longer meets study criteria|1
7637552|NCT01621490|26571798|P4|Overall Study|Subject no longer meets study criteria|0
7637553|NCT01621490|26571799|P3|Overall Study|Subject no longer meets study criteria|0
7637554|NCT01621490|26571800|P2|Overall Study|Subject no longer meets study criteria|0
7637555|NCT01621490|26571801|P1|Overall Study|Subject no longer meets study criteria|0
7637556|NCT01621490|26571793|P9|Overall Study|Patient could not travel|0
7637557|NCT01621490|26571794|P8|Overall Study|Patient could not travel|0
7637558|NCT01621490|26571795|P7|Overall Study|Patient could not travel|0
7637559|NCT01621490|26571796|P6|Overall Study|Patient could not travel|0
7637560|NCT01621490|26571797|P5|Overall Study|Patient could not travel|0
7637561|NCT01621490|26571798|P4|Overall Study|Patient could not travel|0
7637562|NCT01621490|26571799|P3|Overall Study|Patient could not travel|0
7637563|NCT01621490|26571800|P2|Overall Study|Patient could not travel|0
7637564|NCT01621490|26571801|P1|Overall Study|Patient could not travel|1
7637565|NCT01621490|26571793|P9|Overall Study|Participant completed treatment|0
7637566|NCT01621490|26571794|P8|Overall Study|Participant completed treatment|1
7637567|NCT01621490|26571795|P7|Overall Study|Participant completed treatment|0
7637568|NCT01621490|26571796|P6|Overall Study|Participant completed treatment|0
7637569|NCT01621490|26571797|P5|Overall Study|Participant completed treatment|0
7637570|NCT01621490|26571798|P4|Overall Study|Participant completed treatment|0
7637571|NCT01621490|26571799|P3|Overall Study|Participant completed treatment|1
7637572|NCT01621490|26571800|P2|Overall Study|Participant completed treatment|4
7637573|NCT01621490|26571801|P1|Overall Study|Participant completed treatment|4
7637574|NCT01621191|26572053|P1|Overall Study|Site Removed From Study|1
7637575|NCT01621191|26572053|P1|Overall Study|Lost to Follow-up|1
7637576|NCT01621191|26572053|P1|Overall Study|Lack of Efficacy|6
7637577|NCT01621191|26572053|P1|Overall Study|Withdrawal by Subject|8
7637578|NCT01621191|26572053|P1|Overall Study|Adverse Event|9
7637579|NCT01621178|26572067|P3|Overall Study|Physician Decision|7
7637580|NCT01621178|26572068|P2|Overall Study|Physician Decision|2
7637581|NCT01621178|26572069|P1|Overall Study|Physician Decision|5
7637582|NCT01621178|26572067|P3|Overall Study|Withdrawal by Subject|18
7637583|NCT01621178|26572068|P2|Overall Study|Withdrawal by Subject|17
7637584|NCT01621178|26572069|P1|Overall Study|Withdrawal by Subject|14
7637585|NCT01621178|26572067|P3|Overall Study|Lost to Follow-up|1
7637586|NCT01621178|26572068|P2|Overall Study|Lost to Follow-up|2
7637587|NCT01621178|26572069|P1|Overall Study|Lost to Follow-up|1
7637588|NCT01621178|26572067|P3|Overall Study|Death|2
7637589|NCT01621178|26572068|P2|Overall Study|Death|7
7637590|NCT01621178|26572069|P1|Overall Study|Death|6
7637591|NCT01621178|26572067|P3|Overall Study|Adverse Event|8
7637592|NCT01621178|26572068|P2|Overall Study|Adverse Event|2
7637593|NCT01621178|26572069|P1|Overall Study|Adverse Event|5
7637594|NCT01621126|26572161|P1|Overall Study|Physician Decision|6
7637595|NCT01620983|26572183|P3|Overall Study|Physician Decision|5
7637596|NCT01620983|26572184|P2|Overall Study|Physician Decision|10
7637597|NCT01620983|26572185|P1|Overall Study|Physician Decision|3
7637598|NCT01620983|26572183|P3|Overall Study|Death|0
7637599|NCT01620983|26572184|P2|Overall Study|Death|0
7637600|NCT01620983|26572185|P1|Overall Study|Death|2
7637601|NCT01620983|26572183|P3|Overall Study|Withdrawal by Subject|1
7637602|NCT01620983|26572184|P2|Overall Study|Withdrawal by Subject|8
7637603|NCT01620983|26572185|P1|Overall Study|Withdrawal by Subject|6
7637604|NCT01620983|26572183|P3|Overall Study|Lost to Follow-up|9
7637605|NCT01620983|26572184|P2|Overall Study|Lost to Follow-up|4
7637606|NCT01620983|26572185|P1|Overall Study|Lost to Follow-up|8
7637607|NCT01620944|26572213|P2|Overall Study|Early termination of Study|1
7637608|NCT01620944|26572214|P1|Overall Study|Early termination of Study|2
7637609|NCT01620762|26572233|P3|Overall Study|Use of prohibted therapies|1
7637610|NCT01620762|26572234|P2|Overall Study|Use of prohibted therapies|1
7637611|NCT01620762|26572235|P1|Overall Study|Use of prohibted therapies|0
7637612|NCT01620762|26572233|P3|Overall Study|Non-specified|5
7637613|NCT01620762|26572234|P2|Overall Study|Non-specified|6
7637614|NCT01620762|26572235|P1|Overall Study|Non-specified|3
7637615|NCT01620762|26572233|P3|Overall Study|Subject deterioration|1
7637616|NCT01620762|26572234|P2|Overall Study|Subject deterioration|1
7637617|NCT01620762|26572235|P1|Overall Study|Subject deterioration|0
7637618|NCT01620762|26572233|P3|Overall Study|Protocol deviation|6
7637619|NCT01620762|26572234|P2|Overall Study|Protocol deviation|1
7637620|NCT01620762|26572235|P1|Overall Study|Protocol deviation|1
7637621|NCT01620762|26572233|P3|Overall Study|Lost to Follow-up|10
7637622|NCT01620762|26572234|P2|Overall Study|Lost to Follow-up|17
7637623|NCT01620762|26572235|P1|Overall Study|Lost to Follow-up|11
7637624|NCT01620762|26572233|P3|Overall Study|Withdrawal by Subject|27
7637625|NCT01620762|26572234|P2|Overall Study|Withdrawal by Subject|26
7637626|NCT01620762|26572235|P1|Overall Study|Withdrawal by Subject|23
7637627|NCT01620762|26572233|P3|Overall Study|Adverse Event|2
7637628|NCT01620762|26572234|P2|Overall Study|Adverse Event|5
7637629|NCT01620762|26572235|P1|Overall Study|Adverse Event|9
7637630|NCT01620762|26572233|P3|Overall Study|Protocol Violation|1
7637631|NCT01620762|26572234|P2|Overall Study|Protocol Violation|1
7637632|NCT01620762|26572235|P1|Overall Study|Protocol Violation|1
7637633|NCT01620528|26572296|P3|Post-Treatment Follow-Up Period|Other|2
7637634|NCT01620528|26572297|P2|Post-Treatment Follow-Up Period|Other|4
7637635|NCT01620528|26572298|P1|Post-Treatment Follow-Up Period|Other|6
7637636|NCT01620528|26572296|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
7637637|NCT01620528|26572297|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
7637638|NCT01620528|26572298|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
7637639|NCT01620528|26572296|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7637640|NCT01620528|26572297|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7637641|NCT01620528|26572298|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
7637642|NCT01620528|26572296|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7637643|NCT01620528|26572297|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7637644|NCT01620528|26572298|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7637645|NCT01620528|26572296|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7637646|NCT01620528|26572297|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7637647|NCT01620528|26572298|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7637648|NCT01620528|26572296|P3|Treatment Period|Exclusionary Medication Received|0
7637649|NCT01620528|26572297|P2|Treatment Period|Exclusionary Medication Received|1
7637650|NCT01620528|26572298|P1|Treatment Period|Exclusionary Medication Received|0
7637651|NCT01620528|26572296|P3|Treatment Period|Surgery/Invasive Intervention|3
7637652|NCT01620528|26572297|P2|Treatment Period|Surgery/Invasive Intervention|1
7637653|NCT01620528|26572298|P1|Treatment Period|Surgery/Invasive Intervention|5
7637654|NCT01620528|26572296|P3|Treatment Period|Pregnancy|2
7637655|NCT01620528|26572297|P2|Treatment Period|Pregnancy|2
7637656|NCT01620528|26572298|P1|Treatment Period|Pregnancy|7
7637657|NCT01620528|26572296|P3|Treatment Period|Subject Noncompliant|2
7637658|NCT01620528|26572297|P2|Treatment Period|Subject Noncompliant|2
7637659|NCT01620528|26572298|P1|Treatment Period|Subject Noncompliant|11
7637660|NCT01620528|26572296|P3|Treatment Period|Other|7
7637661|NCT01620528|26572297|P2|Treatment Period|Other|5
7637662|NCT01620528|26572298|P1|Treatment Period|Other|9
7637663|NCT01620528|26572296|P3|Treatment Period|Lost to Follow-up|14
7637664|NCT01620528|26572297|P2|Treatment Period|Lost to Follow-up|8
7637665|NCT01620528|26572298|P1|Treatment Period|Lost to Follow-up|16
7637666|NCT01620528|26572296|P3|Treatment Period|Adverse Event|21
7637667|NCT01620528|26572297|P2|Treatment Period|Adverse Event|13
7637668|NCT01620528|26572298|P1|Treatment Period|Adverse Event|17
7637669|NCT01620528|26572296|P3|Treatment Period|Withdrawal by Subject|16
7637670|NCT01620528|26572297|P2|Treatment Period|Withdrawal by Subject|21
7637671|NCT01620528|26572298|P1|Treatment Period|Withdrawal by Subject|35
7637672|NCT01620528|26572296|P3|Treatment Period|Did Not Receive Study Drug|1
7637673|NCT01620528|26572297|P2|Treatment Period|Did Not Receive Study Drug|0
7637674|NCT01620528|26572298|P1|Treatment Period|Did Not Receive Study Drug|0
7637675|NCT01620489|26572638|P2|Overall Study|Unclassified|2
7637676|NCT01620489|26572639|P1|Overall Study|Unclassified|1
7637677|NCT01620489|26572638|P2|Overall Study|Withdrawal Criteria|25
7637678|NCT01620489|26572639|P1|Overall Study|Withdrawal Criteria|17
7637679|NCT01620489|26572638|P2|Overall Study|Protocol Violation|3
7637680|NCT01620489|26572639|P1|Overall Study|Protocol Violation|0
7637681|NCT01620489|26572638|P2|Overall Study|Adverse Event|4
7637682|NCT01620489|26572639|P1|Overall Study|Adverse Event|17
7637683|NCT01620255|26572660|P5|Overall Study|Withdrawn at discretion of investigator|1
7637684|NCT01620255|26572661|P4|Overall Study|Withdrawn at discretion of investigator|0
7637685|NCT01620255|26572662|P3|Overall Study|Withdrawn at discretion of investigator|0
7637686|NCT01620255|26572663|P2|Overall Study|Withdrawn at discretion of investigator|0
7637687|NCT01620255|26572664|P1|Overall Study|Withdrawn at discretion of investigator|0
7637688|NCT01620255|26572660|P5|Overall Study|Adverse Event|1
7637689|NCT01620255|26572661|P4|Overall Study|Adverse Event|1
7637690|NCT01620255|26572662|P3|Overall Study|Adverse Event|0
7637691|NCT01620255|26572663|P2|Overall Study|Adverse Event|4
7637692|NCT01620255|26572664|P1|Overall Study|Adverse Event|0
7637693|NCT01620255|26572660|P5|Overall Study|Non-compliance|0
7637694|NCT01620255|26572661|P4|Overall Study|Non-compliance|0
7637695|NCT01620255|26572662|P3|Overall Study|Non-compliance|0
7637696|NCT01620255|26572663|P2|Overall Study|Non-compliance|1
7637697|NCT01620255|26572664|P1|Overall Study|Non-compliance|0
7637698|NCT01620255|26572660|P5|Overall Study|Participant underwent fecal transplant|0
7637699|NCT01620255|26572661|P4|Overall Study|Participant underwent fecal transplant|0
7637700|NCT01620255|26572662|P3|Overall Study|Participant underwent fecal transplant|1
7637701|NCT01620255|26572663|P2|Overall Study|Participant underwent fecal transplant|0
7637702|NCT01620255|26572664|P1|Overall Study|Participant underwent fecal transplant|0
7637703|NCT01620255|26572660|P5|Overall Study|Withdrawal by Subject|4
7637704|NCT01620255|26572661|P4|Overall Study|Withdrawal by Subject|2
7637705|NCT01620255|26572662|P3|Overall Study|Withdrawal by Subject|1
7637706|NCT01620255|26572663|P2|Overall Study|Withdrawal by Subject|1
7637707|NCT01620255|26572664|P1|Overall Study|Withdrawal by Subject|4
7637708|NCT01620177|26572813|P1|Overall Study|Randomized, Not Active due to Scheduling|1
7637709|NCT01620177|26572813|P1|Overall Study|Physician Decision|2
7637710|NCT01620177|26572813|P1|Overall Study|Lost to Follow-up|7
7637711|NCT01620177|26572813|P1|Overall Study|Withdrawal by Subject|26
7637712|NCT01620177|26572813|P1|Overall Study|Failure at Screening Visit|43
7637713|NCT01620138|26572838|P2|Overall Study|Adverse Event|0
7637714|NCT01620138|26572839|P1|Overall Study|Adverse Event|2
7637715|NCT01620138|26572838|P2|Overall Study|Lack of Efficacy|0
7637716|NCT01620138|26572839|P1|Overall Study|Lack of Efficacy|1
7637717|NCT01620138|26572838|P2|Overall Study|Withdrawal by Subject|0
7637718|NCT01620138|26572839|P1|Overall Study|Withdrawal by Subject|3
7637719|NCT01620086|26572847|P3|Overall Study|Physician Decision|0
7637720|NCT01620086|26572848|P2|Overall Study|Physician Decision|0
7637721|NCT01620086|26572849|P1|Overall Study|Physician Decision|1
7637722|NCT01620086|26572847|P3|Overall Study|failed study criteria|0
7637723|NCT01620086|26572848|P2|Overall Study|failed study criteria|4
7637724|NCT01620086|26572849|P1|Overall Study|failed study criteria|1
7637725|NCT01620086|26572847|P3|Overall Study|Withdrawal by Subject|0
7637726|NCT01620086|26572848|P2|Overall Study|Withdrawal by Subject|3
7637727|NCT01620086|26572849|P1|Overall Study|Withdrawal by Subject|3
7637728|NCT01620060|26572868|P1|Overall Study|Per Sponsor Decision|2
7637729|NCT01620060|26572868|P1|Overall Study|Family emergency|1
7637730|NCT01620060|26572868|P1|Overall Study|Did not comply with Study Produre|1
7637731|NCT01620060|26572868|P1|Overall Study|Withdrawal by Subject|1
7637732|NCT01620060|26572868|P1|Overall Study|Protocol Violation|1
7637733|NCT01620060|26572868|P1|Overall Study|Adverse Event|9
7637734|NCT01619878|26572906|P1|Follow-up at 12 Months of Age|Death|2
7637735|NCT01619878|26572906|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
7637736|NCT01619878|26572906|P1|6 Week Follow-up Phase|Adverse Event|1
7637737|NCT01619865|26572918|P1|Overall Study|subject not able to comply|1
7637738|NCT01619865|26572918|P1|Overall Study|Death|2
7637739|NCT01619865|26572918|P1|Overall Study|Adverse Event|1
7637740|NCT01619852|26572925|P2|3 Month Follow up|Lost to Follow-up|34
7637741|NCT01619852|26572926|P1|3 Month Follow up|Lost to Follow-up|31
7637742|NCT01619852|26572925|P2|24 Hour Assessment|Withdrawal by Subject|1
7637743|NCT01619852|26572926|P1|24 Hour Assessment|Withdrawal by Subject|1
7637744|NCT01619800|26572962|P2|Overall Study|study terminated|0
7637745|NCT01619800|26572963|P1|Overall Study|study terminated|2
7637746|NCT01619787|26572971|P1|Overall Study|Lost to Follow-up|5
7637747|NCT01619579|26572988|P2|Overall Study|Withdrawal by Subject|3
7637748|NCT01619579|26572989|P1|Overall Study|Withdrawal by Subject|0
7637749|NCT01619423|26573003|P4|Part 1 (Dose Escalation)|High basal Mn|0
7637750|NCT01619423|26573004|P3|Part 1 (Dose Escalation)|High basal Mn|0
7637751|NCT01619423|26573005|P2|Part 1 (Dose Escalation)|High basal Mn|2
7637752|NCT01619423|26573006|P1|Part 1 (Dose Escalation)|High basal Mn|0
7637753|NCT01619410|26573019|P2|Overall Study|Lost to Follow-up|4
7637754|NCT01619410|26573020|P1|Overall Study|Lost to Follow-up|7
7637755|NCT01619085|26573032|P1|Overall Study|Ongoing on trial|27
7637756|NCT01619085|26573032|P1|Overall Study|Not treated|1
7637757|NCT01619085|26573032|P1|Overall Study|Other than specified|94
7637758|NCT01619085|26573032|P1|Overall Study|Withdrawal by Subject|15
7637759|NCT01619085|26573032|P1|Overall Study|Lost to Follow-up|10
7637760|NCT01619085|26573032|P1|Overall Study|Protocol Violation|10
7637761|NCT01619085|26573032|P1|Overall Study|Adverse Event|212
7637762|NCT01619059|26573038|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
7637763|NCT01619059|26573039|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
7637764|NCT01619059|26573038|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7637765|NCT01619059|26573039|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7637766|NCT01619059|26573038|P2|Long-Term (LT) Treatment Period|Death|0
7637767|NCT01619059|26573039|P1|Long-Term (LT) Treatment Period|Death|1
7637768|NCT01619059|26573038|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
7637769|NCT01619059|26573039|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
7637770|NCT01619059|26573038|P2|Long-Term (LT) Treatment Period|Adverse Event|3
7637771|NCT01619059|26573039|P1|Long-Term (LT) Treatment Period|Adverse Event|2
7637772|NCT01619059|26573038|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
7637773|NCT01619059|26573039|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
7637774|NCT01619059|26573038|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
7637775|NCT01619059|26573039|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
7637776|NCT01619059|26573038|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
7637777|NCT01619059|26573039|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
7637778|NCT01619059|26573038|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
7637779|NCT01619059|26573039|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
7637780|NCT01619059|26573038|P2|Short-Term (ST) Treatment Period|Adverse Event|0
7637781|NCT01619059|26573039|P1|Short-Term (ST) Treatment Period|Adverse Event|1
7637782|NCT01618968|26573055|P4|Overall Study|Death|1
7637783|NCT01618968|26573056|P3|Overall Study|Death|0
7637784|NCT01618968|26573057|P2|Overall Study|Death|0
7637785|NCT01618968|26573058|P1|Overall Study|Death|0
7637786|NCT01618968|26573055|P4|Overall Study|Adverse Event|0
7637787|NCT01618968|26573056|P3|Overall Study|Adverse Event|0
7637788|NCT01618968|26573057|P2|Overall Study|Adverse Event|0
7637789|NCT01618968|26573058|P1|Overall Study|Adverse Event|1
7637790|NCT01618916|26573131|P6|Overall Study|Lost to Follow-up|0
7637791|NCT01618916|26573132|P5|Overall Study|Lost to Follow-up|0
7637792|NCT01618916|26573133|P4|Overall Study|Lost to Follow-up|2
7637793|NCT01618916|26573134|P3|Overall Study|Lost to Follow-up|0
7637794|NCT01618916|26573135|P2|Overall Study|Lost to Follow-up|0
7637795|NCT01618916|26573136|P1|Overall Study|Lost to Follow-up|1
7637796|NCT01618916|26573131|P6|Overall Study|Withdrawal by Subject|0
7637797|NCT01618916|26573132|P5|Overall Study|Withdrawal by Subject|1
7637798|NCT01618916|26573133|P4|Overall Study|Withdrawal by Subject|0
7637799|NCT01618916|26573134|P3|Overall Study|Withdrawal by Subject|1
7637800|NCT01618916|26573135|P2|Overall Study|Withdrawal by Subject|1
7637801|NCT01618916|26573136|P1|Overall Study|Withdrawal by Subject|0
7637802|NCT01618916|26573131|P6|Overall Study|Adverse Event|0
7637803|NCT01618916|26573132|P5|Overall Study|Adverse Event|0
7637804|NCT01618916|26573133|P4|Overall Study|Adverse Event|0
7637805|NCT01618916|26573134|P3|Overall Study|Adverse Event|0
7637806|NCT01618916|26573135|P2|Overall Study|Adverse Event|0
7637807|NCT01618916|26573136|P1|Overall Study|Adverse Event|1
7637808|NCT01618864|26573166|P1|Overall Study|Lost to Follow-up|2
7637809|NCT01618864|26573166|P1|Overall Study|Withdrawal by Subject|2
7637810|NCT01618838|26573175|P1|Overall Study|slow accrual, trial closed prematurely.|4
7637811|NCT01618708|26573183|P2|Overall Study|Randomized but not treated|2
7637812|NCT01618708|26573184|P1|Overall Study|Randomized but not treated|3
7637813|NCT01618708|26573183|P2|Overall Study|Other than specified above|1
7637814|NCT01618708|26573184|P1|Overall Study|Other than specified above|1
7637815|NCT01618708|26573183|P2|Overall Study|Technical problems|0
7637816|NCT01618708|26573184|P1|Overall Study|Technical problems|2
7637817|NCT01618708|26573183|P2|Overall Study|Lack of Efficacy|8
7637818|NCT01618708|26573184|P1|Overall Study|Lack of Efficacy|8
7637819|NCT01618708|26573183|P2|Overall Study|Withdrawal by Subject|22
7637820|NCT01618708|26573184|P1|Overall Study|Withdrawal by Subject|17
7637821|NCT01618708|26573183|P2|Overall Study|Lost to Follow-up|3
7637822|NCT01618708|26573184|P1|Overall Study|Lost to Follow-up|3
7637823|NCT01618708|26573183|P2|Overall Study|Adverse Event|10
7637824|NCT01618708|26573184|P1|Overall Study|Adverse Event|10
7637825|NCT01618695|26573200|P4|Extension Phase|Other than specified|18
7637826|NCT01618695|26573201|P3|Extension Phase|Other than specified|13
7637827|NCT01618695|26573202|P2|Extension Phase|Other than specified|18
7637828|NCT01618695|26573203|P1|Extension Phase|Other than specified|13
7637829|NCT01618695|26573200|P4|Extension Phase|Lost to Follow-up|1
7637830|NCT01618695|26573201|P3|Extension Phase|Lost to Follow-up|1
7637831|NCT01618695|26573202|P2|Extension Phase|Lost to Follow-up|1
7637832|NCT01618695|26573203|P1|Extension Phase|Lost to Follow-up|2
7637833|NCT01618695|26573200|P4|Extension Phase|Adverse Event|20
7637834|NCT01618695|26573201|P3|Extension Phase|Adverse Event|9
7637835|NCT01618695|26573202|P2|Extension Phase|Adverse Event|16
7637836|NCT01618695|26573203|P1|Extension Phase|Adverse Event|18
7637837|NCT01618695|26573200|P4|Extension Phase|Withdrawal by Subject|33
7637838|NCT01618695|26573201|P3|Extension Phase|Withdrawal by Subject|42
7637839|NCT01618695|26573202|P2|Extension Phase|Withdrawal by Subject|48
7637840|NCT01618695|26573203|P1|Extension Phase|Withdrawal by Subject|43
7637841|NCT01618695|26573200|P4|Extension Phase|Pregnancy|1
7637842|NCT01618695|26573201|P3|Extension Phase|Pregnancy|1
7637843|NCT01618695|26573202|P2|Extension Phase|Pregnancy|0
7637844|NCT01618695|26573203|P1|Extension Phase|Pregnancy|2
7637845|NCT01618695|26573200|P4|Extension Phase|Lack of Efficacy|24
7637846|NCT01618695|26573201|P3|Extension Phase|Lack of Efficacy|26
7637847|NCT01618695|26573202|P2|Extension Phase|Lack of Efficacy|33
7637848|NCT01618695|26573203|P1|Extension Phase|Lack of Efficacy|17
7637849|NCT01618695|26573200|P4|Core Phase|Not treated|0
7637850|NCT01618695|26573201|P3|Core Phase|Not treated|2
7637851|NCT01618695|26573202|P2|Core Phase|Not treated|0
7637852|NCT01618695|26573203|P1|Core Phase|Not treated|1
7637853|NCT01618695|26573200|P4|Core Phase|Other than specified|2
7637854|NCT01618695|26573201|P3|Core Phase|Other than specified|2
7637855|NCT01618695|26573202|P2|Core Phase|Other than specified|2
7637856|NCT01618695|26573203|P1|Core Phase|Other than specified|1
7637857|NCT01618695|26573200|P4|Core Phase|Lack of Efficacy|1
7637858|NCT01618695|26573201|P3|Core Phase|Lack of Efficacy|1
7637859|NCT01618695|26573202|P2|Core Phase|Lack of Efficacy|2
7637860|NCT01618695|26573203|P1|Core Phase|Lack of Efficacy|1
7637861|NCT01618695|26573200|P4|Core Phase|Pregnancy|0
7637862|NCT01618695|26573201|P3|Core Phase|Pregnancy|0
7637863|NCT01618695|26573202|P2|Core Phase|Pregnancy|0
7637864|NCT01618695|26573203|P1|Core Phase|Pregnancy|2
7637865|NCT01618695|26573200|P4|Core Phase|Withdrawal by Subject|13
7637866|NCT01618695|26573201|P3|Core Phase|Withdrawal by Subject|9
7637867|NCT01618695|26573202|P2|Core Phase|Withdrawal by Subject|11
7637868|NCT01618695|26573203|P1|Core Phase|Withdrawal by Subject|16
7637869|NCT01618695|26573200|P4|Core Phase|Lost to Follow-up|0
7637870|NCT01618695|26573201|P3|Core Phase|Lost to Follow-up|1
7637871|NCT01618695|26573202|P2|Core Phase|Lost to Follow-up|0
7637872|NCT01618695|26573203|P1|Core Phase|Lost to Follow-up|0
7637873|NCT01618695|26573200|P4|Core Phase|Adverse Event|20
7637874|NCT01618695|26573201|P3|Core Phase|Adverse Event|15
7637875|NCT01618695|26573202|P2|Core Phase|Adverse Event|5
7637876|NCT01618695|26573203|P1|Core Phase|Adverse Event|4
7637877|NCT01618669|26573228|P2|Overall Study|Miscellaneous Reason|1
7637878|NCT01618669|26573229|P1|Overall Study|Miscellaneous Reason|0
7637879|NCT01618669|26573228|P2|Overall Study|Withdrawal by Subject|9
7637880|NCT01618669|26573229|P1|Overall Study|Withdrawal by Subject|9
7637881|NCT01618669|26573228|P2|Overall Study|Protocol Violation|3
7637882|NCT01618669|26573229|P1|Overall Study|Protocol Violation|5
7637883|NCT01618669|26573228|P2|Overall Study|Adverse Event|7
7637884|NCT01618669|26573229|P1|Overall Study|Adverse Event|16
7637885|NCT01618669|26573228|P2|Overall Study|Randomized but Never Received Study Drug|2
7637886|NCT01618669|26573229|P1|Overall Study|Randomized but Never Received Study Drug|3
7637887|NCT01618669|26573228|P2|Overall Study|Lost to Follow-up|1
7637888|NCT01618669|26573229|P1|Overall Study|Lost to Follow-up|1
7637889|NCT01618305|26573288|P2|Overall Study|Withdrawal by Subject|2
7637890|NCT01618305|26573289|P1|Overall Study|Withdrawal by Subject|3
7637891|NCT01618305|26573288|P2|Overall Study|Protocol Violation|0
7637892|NCT01618305|26573289|P1|Overall Study|Protocol Violation|1
7637893|NCT01618305|26573288|P2|Overall Study|Lost to Follow-up|7
7637894|NCT01618305|26573289|P1|Overall Study|Lost to Follow-up|11
7637895|NCT01618305|26573288|P2|Overall Study|Death|1
7637896|NCT01618305|26573289|P1|Overall Study|Death|0
7637897|NCT01618266|26573331|P1|Overall Study|Protocol Violation|43
7637898|NCT01618266|26573331|P1|Overall Study|Lack of Efficacy|23
7637899|NCT01618266|26573331|P1|Overall Study|Other reasons|11
7637900|NCT01618266|26573331|P1|Overall Study|Treatment satisfaction|10
7637901|NCT01618266|26573331|P1|Overall Study|Lost to Follow-up|9
7637902|NCT01618214|26573368|P2|Overall Study|Unclassified|5
7637903|NCT01618214|26573369|P1|Overall Study|Unclassified|4
7637904|NCT01618214|26573368|P2|Overall Study|Withdrawal Criteria|2
7637905|NCT01618214|26573369|P1|Overall Study|Withdrawal Criteria|1
7637906|NCT01618214|26573368|P2|Overall Study|Protocol Violation|4
7637907|NCT01618214|26573369|P1|Overall Study|Protocol Violation|1
7637908|NCT01618214|26573368|P2|Overall Study|Lack of Efficacy|1
7637909|NCT01618214|26573369|P1|Overall Study|Lack of Efficacy|1
7637910|NCT01618214|26573368|P2|Overall Study|Adverse Event|1
7637911|NCT01618214|26573369|P1|Overall Study|Adverse Event|3
7637912|NCT01618162|26573385|P2|Overall Study|Unclassified|13
7637913|NCT01618162|26573386|P1|Overall Study|Unclassified|14
7637914|NCT01618162|26573385|P2|Overall Study|Withdrawal Criteria|10
7637915|NCT01618162|26573386|P1|Overall Study|Withdrawal Criteria|2
7637916|NCT01618162|26573385|P2|Overall Study|Adverse Event|2
7637917|NCT01618162|26573386|P1|Overall Study|Adverse Event|9
7637918|NCT01618162|26573385|P2|Overall Study|Protocol Violation|10
7637919|NCT01618162|26573386|P1|Overall Study|Protocol Violation|13
7637920|NCT01618019|26573406|P2|Overall Study|Withdrawal by Subject|14
7637921|NCT01618019|26573407|P1|Overall Study|Withdrawal by Subject|14
7637922|NCT01617967|26573433|P6|Overall Study|Dosing Suspended by Sponsor|0
7637923|NCT01617967|26573434|P5|Overall Study|Dosing Suspended by Sponsor|0
7637924|NCT01617967|26573435|P4|Overall Study|Dosing Suspended by Sponsor|0
7637925|NCT01617967|26573436|P3|Overall Study|Dosing Suspended by Sponsor|0
7637926|NCT01617967|26573437|P2|Overall Study|Dosing Suspended by Sponsor|0
7637927|NCT01617967|26573438|P1|Overall Study|Dosing Suspended by Sponsor|1
7637928|NCT01617967|26573433|P6|Overall Study|Withdrawal by Subject|1
7637929|NCT01617967|26573434|P5|Overall Study|Withdrawal by Subject|0
7637930|NCT01617967|26573435|P4|Overall Study|Withdrawal by Subject|0
7637931|NCT01617967|26573436|P3|Overall Study|Withdrawal by Subject|0
7637932|NCT01617967|26573437|P2|Overall Study|Withdrawal by Subject|0
7637933|NCT01617967|26573438|P1|Overall Study|Withdrawal by Subject|0
7637934|NCT01617967|26573433|P6|Overall Study|Protocol Violation|0
7637935|NCT01617967|26573434|P5|Overall Study|Protocol Violation|0
7637936|NCT01617967|26573435|P4|Overall Study|Protocol Violation|1
7637937|NCT01617967|26573436|P3|Overall Study|Protocol Violation|0
7637938|NCT01617967|26573437|P2|Overall Study|Protocol Violation|0
7637939|NCT01617967|26573438|P1|Overall Study|Protocol Violation|0
7637940|NCT01617681|26573492|P5|Period 2 Open Label|Withdrawal by Subject|3
7637941|NCT01617681|26573493|P4|Period 2 Open Label|Withdrawal by Subject|0
7637942|NCT01617681|26573494|P3|Period 2 Open Label|Withdrawal by Subject|0
7637943|NCT01617681|26573495|P2|Period 2 Open Label|Withdrawal by Subject|0
7637944|NCT01617681|26573496|P1|Period 2 Open Label|Withdrawal by Subject|0
7637945|NCT01617681|26573492|P5|Period 2 Open Label|Adverse Event|3
7637946|NCT01617681|26573493|P4|Period 2 Open Label|Adverse Event|0
7637947|NCT01617681|26573494|P3|Period 2 Open Label|Adverse Event|0
7637948|NCT01617681|26573495|P2|Period 2 Open Label|Adverse Event|0
7637949|NCT01617681|26573496|P1|Period 2 Open Label|Adverse Event|0
7637950|NCT01617681|26573492|P5|Period 1 Double Blind|Withdrawal by Subject|0
7637951|NCT01617681|26573493|P4|Period 1 Double Blind|Withdrawal by Subject|0
7637952|NCT01617681|26573494|P3|Period 1 Double Blind|Withdrawal by Subject|1
7637953|NCT01617681|26573495|P2|Period 1 Double Blind|Withdrawal by Subject|1
7637954|NCT01617681|26573496|P1|Period 1 Double Blind|Withdrawal by Subject|1
7637955|NCT01617681|26573492|P5|Period 1 Double Blind|Adverse Event|0
7637956|NCT01617681|26573493|P4|Period 1 Double Blind|Adverse Event|2
7637957|NCT01617681|26573494|P3|Period 1 Double Blind|Adverse Event|0
7637958|NCT01617681|26573495|P2|Period 1 Double Blind|Adverse Event|0
7637959|NCT01617681|26573496|P1|Period 1 Double Blind|Adverse Event|2
7637960|NCT01617668|26573517|P4|Overall Study|Subject/guardian decision|1
7637961|NCT01617668|26573518|P3|Overall Study|Subject/guardian decision|2
7637962|NCT01617668|26573519|P2|Overall Study|Subject/guardian decision|3
7637963|NCT01617668|26573520|P1|Overall Study|Subject/guardian decision|1
7637964|NCT01617668|26573517|P4|Overall Study|Progressive Disease|9
7637965|NCT01617668|26573518|P3|Overall Study|Progressive Disease|6
7637966|NCT01617668|26573519|P2|Overall Study|Progressive Disease|4
7637967|NCT01617668|26573520|P1|Overall Study|Progressive Disease|4
7637968|NCT01617668|26573517|P4|Overall Study|Physician Decision|0
7637969|NCT01617668|26573518|P3|Overall Study|Physician Decision|3
7637970|NCT01617668|26573519|P2|Overall Study|Physician Decision|2
7637971|NCT01617668|26573520|P1|Overall Study|Physician Decision|1
7637972|NCT01617668|26573517|P4|Overall Study|Adverse Event|5
7637973|NCT01617668|26573518|P3|Overall Study|Adverse Event|12
7637974|NCT01617668|26573519|P2|Overall Study|Adverse Event|0
7637975|NCT01617668|26573520|P1|Overall Study|Adverse Event|7
7637976|NCT01617655|26573561|P2|Overall Study|Other than specified above|2
7637977|NCT01617655|26573562|P1|Overall Study|Other than specified above|1
7637978|NCT01617655|26573561|P2|Overall Study|Site closure|5
7637979|NCT01617655|26573562|P1|Overall Study|Site closure|3
7637980|NCT01617655|26573561|P2|Overall Study|Last visit outside protocol visit window|10
7637981|NCT01617655|26573562|P1|Overall Study|Last visit outside protocol visit window|1
7637982|NCT01617655|26573561|P2|Overall Study|Consent withdrawn by participant|1
7637983|NCT01617655|26573562|P1|Overall Study|Consent withdrawn by participant|1
7637984|NCT01617655|26573561|P2|Overall Study|Participants moved|4
7637985|NCT01617655|26573562|P1|Overall Study|Participants moved|0
7637986|NCT01617655|26573561|P2|Overall Study|Poor compliance to protocol|4
7637987|NCT01617655|26573562|P1|Overall Study|Poor compliance to protocol|1
7637988|NCT01617655|26573561|P2|Overall Study|Adverse Event|3
7637989|NCT01617655|26573562|P1|Overall Study|Adverse Event|2
7637990|NCT01617629|26573622|P1|Overall Study|Participant Withdrew Consent|2
7637991|NCT01617629|26573622|P1|Overall Study|Reason Not Specified|1
7637992|NCT01617629|26573622|P1|Overall Study|Investigator's Clinical Judgement|1
7637993|NCT01617629|26573622|P1|Overall Study|Death|2
7637994|NCT01617460|26573650|P1|Overall Study|Withdrawal by Subject|9
7637995|NCT01617460|26573650|P1|Overall Study|Protocol Violation|5
7637996|NCT01617460|26573650|P1|Overall Study|Physician Decision|16
7637997|NCT01617460|26573650|P1|Overall Study|Adverse Event|10
7637998|NCT01617447|26573656|P2|Overall Study|Physician Decision|2
7637999|NCT01617447|26573657|P1|Overall Study|Physician Decision|0
7638000|NCT01617447|26573656|P2|Overall Study|Adverse Event|1
7638001|NCT01617447|26573657|P1|Overall Study|Adverse Event|0
7638002|NCT01617434|26573665|P2|Overall Study|Unclassified|4
7638003|NCT01617434|26573666|P1|Overall Study|Unclassified|3
7638004|NCT01617434|26573665|P2|Overall Study|Withdrawal Criteria|37
7638005|NCT01617434|26573666|P1|Overall Study|Withdrawal Criteria|12
7638006|NCT01617434|26573665|P2|Overall Study|Protocol Violation|7
7638007|NCT01617434|26573666|P1|Overall Study|Protocol Violation|8
7638008|NCT01617434|26573665|P2|Overall Study|Adverse Event|3
7638009|NCT01617434|26573666|P1|Overall Study|Adverse Event|12
7638010|NCT01617187|26573705|P4|Treatment Through Study Completion|Protocol Violation|1
7638011|NCT01617187|26573706|P3|Treatment Through Study Completion|Protocol Violation|0
7638012|NCT01617187|26573707|P2|Treatment Through Study Completion|Protocol Violation|0
7638013|NCT01617187|26573708|P1|Treatment Through Study Completion|Protocol Violation|1
7638014|NCT01617187|26573705|P4|Treatment Through Study Completion|Withdrawal by Subject|6
7638015|NCT01617187|26573706|P3|Treatment Through Study Completion|Withdrawal by Subject|3
7638016|NCT01617187|26573707|P2|Treatment Through Study Completion|Withdrawal by Subject|8
7638017|NCT01617187|26573708|P1|Treatment Through Study Completion|Withdrawal by Subject|5
7638018|NCT01617187|26573705|P4|Treatment Through Study Completion|Lost to Follow-up|2
7638019|NCT01617187|26573706|P3|Treatment Through Study Completion|Lost to Follow-up|2
7638020|NCT01617187|26573707|P2|Treatment Through Study Completion|Lost to Follow-up|2
7638021|NCT01617187|26573708|P1|Treatment Through Study Completion|Lost to Follow-up|4
7638022|NCT01617187|26573705|P4|Treatment Through Study Completion|Adverse Event|1
7638023|NCT01617187|26573706|P3|Treatment Through Study Completion|Adverse Event|0
7638024|NCT01617187|26573707|P2|Treatment Through Study Completion|Adverse Event|1
7638025|NCT01617187|26573708|P1|Treatment Through Study Completion|Adverse Event|1
7638026|NCT01617187|26573705|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7638027|NCT01617187|26573706|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7638028|NCT01617187|26573707|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7638029|NCT01617187|26573708|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
7638030|NCT01617187|26573705|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
7638031|NCT01617187|26573706|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7638032|NCT01617187|26573707|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7638033|NCT01617187|26573708|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7638034|NCT01617187|26573705|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
7638035|NCT01617187|26573706|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7638036|NCT01617187|26573707|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7638037|NCT01617187|26573708|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7638038|NCT01617070|26573805|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
7638039|NCT01617005|26573823|P1|Overall Study|Lack of motivation for treatment|1
7638040|NCT01617005|26573823|P1|Overall Study|Pregnancy|1
7638041|NCT01616953|26573832|P2|Overall Study|lack of bone and soft tissue|0
7638042|NCT01616953|26573833|P1|Overall Study|lack of bone and soft tissue|1
7638043|NCT01616953|26573832|P2|Overall Study|Lost to Follow-up|0
7638044|NCT01616953|26573833|P1|Overall Study|Lost to Follow-up|1
7638045|NCT01616771|26573841|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
7638046|NCT01616693|26573854|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
7638047|NCT01616693|26573855|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
7638048|NCT01616693|26573856|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
7638049|NCT01616693|26573857|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
7638050|NCT01616693|26573854|P4|Received Both Vaccines|Lost to Follow-up|4
7638051|NCT01616693|26573855|P3|Received Both Vaccines|Lost to Follow-up|4
7638052|NCT01616693|26573856|P2|Received Both Vaccines|Lost to Follow-up|3
7638053|NCT01616693|26573857|P1|Received Both Vaccines|Lost to Follow-up|4
7638054|NCT01616693|26573854|P4|Received Both Vaccines|Withdrawal by Subject|15
7638055|NCT01616693|26573855|P3|Received Both Vaccines|Withdrawal by Subject|8
7638056|NCT01616693|26573856|P2|Received Both Vaccines|Withdrawal by Subject|7
7638057|NCT01616693|26573857|P1|Received Both Vaccines|Withdrawal by Subject|7
7638058|NCT01616693|26573854|P4|Received Both Vaccines|Adverse Event|0
7638059|NCT01616693|26573855|P3|Received Both Vaccines|Adverse Event|0
7638060|NCT01616693|26573856|P2|Received Both Vaccines|Adverse Event|0
7638061|NCT01616693|26573857|P1|Received Both Vaccines|Adverse Event|2
7638062|NCT01616693|26573854|P4|Evaluated for Safety|Physician Decision|0
7638063|NCT01616693|26573855|P3|Evaluated for Safety|Physician Decision|1
7638064|NCT01616693|26573856|P2|Evaluated for Safety|Physician Decision|0
7638065|NCT01616693|26573857|P1|Evaluated for Safety|Physician Decision|1
7638066|NCT01616654|26573912|P5|Overall Study|Pregnancy|1
7638067|NCT01616654|26573913|P4|Overall Study|Pregnancy|0
7638068|NCT01616654|26573914|P3|Overall Study|Pregnancy|0
7638069|NCT01616654|26573915|P2|Overall Study|Pregnancy|0
7638070|NCT01616654|26573916|P1|Overall Study|Pregnancy|1
7638071|NCT01616654|26573912|P5|Overall Study|Lost to Follow-up|1
7638072|NCT01616654|26573913|P4|Overall Study|Lost to Follow-up|2
7638073|NCT01616654|26573914|P3|Overall Study|Lost to Follow-up|3
7638074|NCT01616654|26573915|P2|Overall Study|Lost to Follow-up|0
7638075|NCT01616654|26573916|P1|Overall Study|Lost to Follow-up|1
7638076|NCT01616654|26573912|P5|Overall Study|Protocol Violation|4
7638077|NCT01616654|26573913|P4|Overall Study|Protocol Violation|4
7638078|NCT01616654|26573914|P3|Overall Study|Protocol Violation|2
7638079|NCT01616654|26573915|P2|Overall Study|Protocol Violation|5
7638080|NCT01616654|26573916|P1|Overall Study|Protocol Violation|0
7638081|NCT01616654|26573912|P5|Overall Study|Withdrawal by Subject|5
7638082|NCT01616654|26573913|P4|Overall Study|Withdrawal by Subject|1
7638083|NCT01616654|26573914|P3|Overall Study|Withdrawal by Subject|3
7638084|NCT01616654|26573915|P2|Overall Study|Withdrawal by Subject|2
7638085|NCT01616654|26573916|P1|Overall Study|Withdrawal by Subject|2
7638086|NCT01616654|26573912|P5|Overall Study|Adverse Event|0
7638087|NCT01616654|26573913|P4|Overall Study|Adverse Event|1
7638088|NCT01616654|26573914|P3|Overall Study|Adverse Event|2
7638089|NCT01616654|26573915|P2|Overall Study|Adverse Event|1
7638090|NCT01616654|26573916|P1|Overall Study|Adverse Event|0
7638091|NCT01616654|26573912|P5|Overall Study|Lack of Efficacy|1
7638092|NCT01616654|26573913|P4|Overall Study|Lack of Efficacy|0
7638093|NCT01616654|26573914|P3|Overall Study|Lack of Efficacy|0
7638094|NCT01616654|26573915|P2|Overall Study|Lack of Efficacy|0
7638095|NCT01616654|26573916|P1|Overall Study|Lack of Efficacy|1
7638096|NCT01616563|26573965|P1|Overall Study|Lost to Follow-up|40
7638097|NCT01616459|26573981|P4|Overall Study|Other reason|0
7638098|NCT01616459|26573982|P3|Overall Study|Other reason|1
7638099|NCT01616459|26573983|P2|Overall Study|Other reason|1
7638100|NCT01616459|26573984|P1|Overall Study|Other reason|0
7638101|NCT01616459|26573981|P4|Overall Study|Withdrawal by Subject|4
7638102|NCT01616459|26573982|P3|Overall Study|Withdrawal by Subject|4
7638103|NCT01616459|26573983|P2|Overall Study|Withdrawal by Subject|4
7638104|NCT01616459|26573984|P1|Overall Study|Withdrawal by Subject|2
7638105|NCT01616459|26573981|P4|Overall Study|Protocol Violation|2
7638106|NCT01616459|26573982|P3|Overall Study|Protocol Violation|0
7638107|NCT01616459|26573983|P2|Overall Study|Protocol Violation|0
7638108|NCT01616459|26573984|P1|Overall Study|Protocol Violation|0
7638109|NCT01616459|26573981|P4|Overall Study|Lost to Follow-up|2
7638110|NCT01616459|26573982|P3|Overall Study|Lost to Follow-up|3
7638111|NCT01616459|26573983|P2|Overall Study|Lost to Follow-up|11
7638112|NCT01616459|26573984|P1|Overall Study|Lost to Follow-up|1
7638113|NCT01616459|26573981|P4|Overall Study|Adverse Event|0
7638114|NCT01616459|26573982|P3|Overall Study|Adverse Event|2
7638115|NCT01616459|26573983|P2|Overall Study|Adverse Event|1
7638116|NCT01616459|26573984|P1|Overall Study|Adverse Event|1
7638117|NCT01616173|26574085|P3|Overall Study|Lost to Follow-up|0
7638118|NCT01616173|26574086|P2|Overall Study|Lost to Follow-up|2
7638119|NCT01616173|26574087|P1|Overall Study|Lost to Follow-up|0
7638120|NCT01615939|26574133|P2|Overall Study|Lost to Follow-up|0
7638121|NCT01615939|26574134|P1|Overall Study|Lost to Follow-up|5
7638122|NCT01615822|26574147|P3|Period 2|Lost to Follow-up|2
7638123|NCT01615822|26574148|P2|Period 2|Lost to Follow-up|1
7638124|NCT01615822|26574149|P1|Period 2|Lost to Follow-up|0
7638125|NCT01615822|26574147|P3|Period 1|Adverse Event|0
7638126|NCT01615822|26574148|P2|Period 1|Adverse Event|1
7638127|NCT01615822|26574149|P1|Period 1|Adverse Event|1
7638128|NCT01615822|26574147|P3|Period 1|Withdrawal by Subject|0
7638129|NCT01615822|26574148|P2|Period 1|Withdrawal by Subject|1
7638130|NCT01615822|26574149|P1|Period 1|Withdrawal by Subject|0
7638131|NCT01615328|26574237|P2|Overall Study|Lost to Follow-up|5
7638132|NCT01615328|26574238|P1|Overall Study|Lost to Follow-up|3
7638133|NCT01615263|26574250|P2|Overall Study|Post-randomization exclusion|2
7638134|NCT01615263|26574251|P1|Overall Study|Post-randomization exclusion|0
7638135|NCT01615198|26574265|P2|Overall Study|Adverse Event|5
7638136|NCT01615198|26574266|P1|Overall Study|Adverse Event|11
7638137|NCT01615198|26574265|P2|Overall Study|Lack of Efficacy|6
7638138|NCT01615198|26574266|P1|Overall Study|Lack of Efficacy|1
7638139|NCT01615198|26574265|P2|Overall Study|Lost to Follow-up|1
7638140|NCT01615198|26574266|P1|Overall Study|Lost to Follow-up|1
7638141|NCT01615198|26574265|P2|Overall Study|Physician Decision|1
7638142|NCT01615198|26574266|P1|Overall Study|Physician Decision|5
7638143|NCT01615198|26574265|P2|Overall Study|Protocol deviation|1
7638144|NCT01615198|26574266|P1|Overall Study|Protocol deviation|1
7638145|NCT01615198|26574265|P2|Overall Study|Withdrawal by Subject|5
7638146|NCT01615198|26574266|P1|Overall Study|Withdrawal by Subject|5
7638177|NCT01614925|26574335|P2|Overall Study|Protocol Violation|2
7638178|NCT01614925|26574336|P1|Overall Study|Protocol Violation|3
7638179|NCT01614925|26574335|P2|Overall Study|Withdrawal by Subject|0
7638180|NCT01614925|26574336|P1|Overall Study|Withdrawal by Subject|1
7638181|NCT01614886|26574403|P2|Overall Study|Protocol deviation|2
7638182|NCT01614886|26574404|P1|Overall Study|Protocol deviation|0
7638183|NCT01614886|26574403|P2|Overall Study|Death|0
7638184|NCT01614886|26574404|P1|Overall Study|Death|1
7638185|NCT01614886|26574403|P2|Overall Study|Withdrawal by Subject|4
7638186|NCT01614886|26574404|P1|Overall Study|Withdrawal by Subject|4
7638187|NCT01614886|26574403|P2|Overall Study|Adverse Event|20
7638188|NCT01614886|26574404|P1|Overall Study|Adverse Event|15
7638189|NCT01614795|26574445|P4|Overall Study|Ineligible|0
7638190|NCT01614795|26574446|P3|Overall Study|Ineligible|0
7638191|NCT01614795|26574447|P2|Overall Study|Ineligible|1
7638192|NCT01614795|26574448|P1|Overall Study|Ineligible|0
7638193|NCT01614795|26574445|P4|Overall Study|Withdrawal by Subject|2
7638194|NCT01614795|26574446|P3|Overall Study|Withdrawal by Subject|0
7638195|NCT01614795|26574447|P2|Overall Study|Withdrawal by Subject|1
7638196|NCT01614795|26574448|P1|Overall Study|Withdrawal by Subject|0
7638197|NCT01614795|26574445|P4|Overall Study|Physician Decision|1
7638198|NCT01614795|26574446|P3|Overall Study|Physician Decision|1
7638199|NCT01614795|26574447|P2|Overall Study|Physician Decision|0
7638200|NCT01614795|26574448|P1|Overall Study|Physician Decision|1
7638201|NCT01614795|26574445|P4|Overall Study|Lack of Efficacy|8
7638202|NCT01614795|26574446|P3|Overall Study|Lack of Efficacy|9
7638203|NCT01614795|26574447|P2|Overall Study|Lack of Efficacy|10
7638204|NCT01614795|26574448|P1|Overall Study|Lack of Efficacy|10
7638205|NCT01614795|26574445|P4|Overall Study|Adverse Event|1
7638206|NCT01614795|26574446|P3|Overall Study|Adverse Event|1
7638207|NCT01614795|26574447|P2|Overall Study|Adverse Event|0
7638208|NCT01614795|26574448|P1|Overall Study|Adverse Event|0
7638209|NCT01614769|26574468|P6|Period 3|Withdrawal by Subject|0
7638210|NCT01614769|26574469|P5|Period 3|Withdrawal by Subject|0
7638211|NCT01614769|26574470|P4|Period 3|Withdrawal by Subject|0
7638212|NCT01614769|26574471|P3|Period 3|Withdrawal by Subject|1
7638213|NCT01614769|26574472|P2|Period 3|Withdrawal by Subject|0
7638214|NCT01614769|26574473|P1|Period 3|Withdrawal by Subject|0
7638215|NCT01614769|26574468|P6|Period 1|Withdrawal by Subject|0
7638216|NCT01614769|26574469|P5|Period 1|Withdrawal by Subject|0
7638217|NCT01614769|26574470|P4|Period 1|Withdrawal by Subject|0
7638218|NCT01614769|26574471|P3|Period 1|Withdrawal by Subject|0
7638219|NCT01614769|26574472|P2|Period 1|Withdrawal by Subject|0
7638220|NCT01614769|26574473|P1|Period 1|Withdrawal by Subject|1
7638221|NCT01614769|26574468|P6|Period 1|Protocol Violation|0
7638222|NCT01614769|26574469|P5|Period 1|Protocol Violation|0
7638223|NCT01614769|26574470|P4|Period 1|Protocol Violation|1
7638224|NCT01614769|26574471|P3|Period 1|Protocol Violation|0
7638225|NCT01614769|26574472|P2|Period 1|Protocol Violation|0
7638226|NCT01614769|26574473|P1|Period 1|Protocol Violation|0
7638227|NCT01614769|26574468|P6|Period 1|Discontinued due to Hypoglycemia|1
7638228|NCT01614769|26574469|P5|Period 1|Discontinued due to Hypoglycemia|0
7638229|NCT01614769|26574470|P4|Period 1|Discontinued due to Hypoglycemia|1
7638230|NCT01614769|26574471|P3|Period 1|Discontinued due to Hypoglycemia|0
7638231|NCT01614769|26574472|P2|Period 1|Discontinued due to Hypoglycemia|0
7638232|NCT01614769|26574473|P1|Period 1|Discontinued due to Hypoglycemia|0
7638233|NCT01614600|26574510|P1|Overall Study|Protocol deviation|1
7638234|NCT01614600|26574510|P1|Overall Study|Unable to remove lens at the end of day|1
7638235|NCT01614600|26574510|P1|Overall Study|Discomfort|1
7638236|NCT01614600|26574510|P1|Overall Study|Unacceptable fit|1
7638237|NCT01614470|26574541|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
7638238|NCT01614470|26574542|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7638239|NCT01614470|26574543|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7638240|NCT01614470|26574541|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7638241|NCT01614470|26574542|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7638242|NCT01614470|26574543|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7638243|NCT01614457|26574565|P2|Overall Study|Pregnancy (Self or Partner)|0
7638244|NCT01614457|26574566|P1|Overall Study|Pregnancy (Self or Partner)|1
7638245|NCT01614457|26574565|P2|Overall Study|Non-Compliance|0
7638246|NCT01614457|26574566|P1|Overall Study|Non-Compliance|1
7638247|NCT01614249|26574593|P2|Overall Study|Lost to Follow-up|23
7638248|NCT01614249|26574594|P1|Overall Study|Lost to Follow-up|11
7638249|NCT01614093|26574608|P1|Overall Study|Withdrawal by Subject|1
7638250|NCT01614067|26574615|P2|Overall Study|Study terminated early by sponsor and was unable to collect data|9
7638251|NCT01614067|26574616|P1|Overall Study|Study terminated early by sponsor and was unable to collect data|8
7638252|NCT01614067|26574615|P2|Overall Study|Withdrawal by Subject|1
7638253|NCT01614067|26574616|P1|Overall Study|Withdrawal by Subject|0
7638254|NCT01614067|26574615|P2|Overall Study|Physician Decision|5
7638255|NCT01614067|26574616|P1|Overall Study|Physician Decision|6
7638256|NCT01614067|26574615|P2|Overall Study|Pregnancy|0
7638257|NCT01614067|26574616|P1|Overall Study|Pregnancy|1
7638258|NCT01613716|26574642|P1|Overall Study|Lost to Follow-up|4
7638259|NCT01613716|26574642|P1|Overall Study|screen failures|3
7638260|NCT01613599|26574647|P1|Overall Study|Reason not specified|3
7638261|NCT01613599|26574647|P1|Overall Study|Withdrawal by Subject|8
7638262|NCT01613599|26574647|P1|Overall Study|Lost to Follow-up|5
7638263|NCT01613599|26574647|P1|Overall Study|Death|9
7638264|NCT01613417|26574662|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
7638265|NCT01613417|26574663|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
7638266|NCT01613378|26574700|P1|Overall Study|Other Reason|4
7638267|NCT01613378|26574700|P1|Overall Study|Lost to Follow-up|1
7638268|NCT01613378|26574700|P1|Overall Study|Death|2
7638269|NCT01613378|26574700|P1|Overall Study|Withdrawal by Subject|8
7638270|NCT01613378|26574700|P1|Overall Study|Adverse Event|11
7638271|NCT01613378|26574700|P1|Overall Study|Lack of Efficacy|13
7638272|NCT01613326|26574730|P2|Overall Study|Protocol Violation|1
7638273|NCT01613326|26574731|P1|Overall Study|Protocol Violation|0
7638274|NCT01613326|26574730|P2|Overall Study|Administrative|2
7638275|NCT01613326|26574731|P1|Overall Study|Administrative|0
7638276|NCT01613326|26574730|P2|Overall Study|Lost to Follow-up|1
7638277|NCT01613326|26574731|P1|Overall Study|Lost to Follow-up|0
7638278|NCT01613326|26574730|P2|Overall Study|Lack of Efficacy|1
7638279|NCT01613326|26574731|P1|Overall Study|Lack of Efficacy|0
7638280|NCT01613326|26574730|P2|Overall Study|inability to use device|0
7638281|NCT01613326|26574731|P1|Overall Study|inability to use device|1
7638282|NCT01613326|26574730|P2|Overall Study|Abnormal test procedure result(s)|0
7638283|NCT01613326|26574731|P1|Overall Study|Abnormal test procedure result(s)|2
7638284|NCT01613326|26574730|P2|Overall Study|Withdrawal by Subject|4
7638285|NCT01613326|26574731|P1|Overall Study|Withdrawal by Subject|3
7638286|NCT01613326|26574730|P2|Overall Study|Adverse Event|5
7638287|NCT01613326|26574731|P1|Overall Study|Adverse Event|7
7638288|NCT01613248|26574788|P6|Overall Study|Pregnancy|0
7638289|NCT01613248|26574789|P5|Overall Study|Pregnancy|0
7638290|NCT01613248|26574790|P4|Overall Study|Pregnancy|1
7638291|NCT01613248|26574791|P3|Overall Study|Pregnancy|0
7638292|NCT01613248|26574792|P2|Overall Study|Pregnancy|0
7638293|NCT01613248|26574793|P1|Overall Study|Pregnancy|0
7638294|NCT01613248|26574788|P6|Overall Study|Lack of Qualifying Event|18
7638295|NCT01613248|26574789|P5|Overall Study|Lack of Qualifying Event|15
7638296|NCT01613248|26574790|P4|Overall Study|Lack of Qualifying Event|11
7638297|NCT01613248|26574791|P3|Overall Study|Lack of Qualifying Event|10
7638298|NCT01613248|26574792|P2|Overall Study|Lack of Qualifying Event|11
7638299|NCT01613248|26574793|P1|Overall Study|Lack of Qualifying Event|9
7638300|NCT01613248|26574788|P6|Overall Study|Physician Decision|6
7638301|NCT01613248|26574789|P5|Overall Study|Physician Decision|7
7638302|NCT01613248|26574790|P4|Overall Study|Physician Decision|4
7638303|NCT01613248|26574791|P3|Overall Study|Physician Decision|9
7638304|NCT01613248|26574792|P2|Overall Study|Physician Decision|8
7638305|NCT01613248|26574793|P1|Overall Study|Physician Decision|8
7638306|NCT01613248|26574788|P6|Overall Study|Study Terminated by Sponsor|11
7638307|NCT01613248|26574789|P5|Overall Study|Study Terminated by Sponsor|9
7638308|NCT01613248|26574790|P4|Overall Study|Study Terminated by Sponsor|8
7638309|NCT01613248|26574791|P3|Overall Study|Study Terminated by Sponsor|8
7638310|NCT01613248|26574792|P2|Overall Study|Study Terminated by Sponsor|6
7638311|NCT01613248|26574793|P1|Overall Study|Study Terminated by Sponsor|4
7638312|NCT01613248|26574788|P6|Overall Study|Lost to Follow-up|2
7638313|NCT01613248|26574789|P5|Overall Study|Lost to Follow-up|4
7638314|NCT01613248|26574790|P4|Overall Study|Lost to Follow-up|8
7638315|NCT01613248|26574791|P3|Overall Study|Lost to Follow-up|4
7638316|NCT01613248|26574792|P2|Overall Study|Lost to Follow-up|7
7638317|NCT01613248|26574793|P1|Overall Study|Lost to Follow-up|5
7638318|NCT01613248|26574788|P6|Overall Study|Withdrawal by Subject|1
7638319|NCT01613248|26574789|P5|Overall Study|Withdrawal by Subject|0
7638320|NCT01613248|26574790|P4|Overall Study|Withdrawal by Subject|5
7638321|NCT01613248|26574791|P3|Overall Study|Withdrawal by Subject|2
7638322|NCT01613248|26574792|P2|Overall Study|Withdrawal by Subject|2
7638323|NCT01613248|26574793|P1|Overall Study|Withdrawal by Subject|3
7638324|NCT01613248|26574788|P6|Overall Study|Adverse Event|0
7638325|NCT01613248|26574789|P5|Overall Study|Adverse Event|0
7638326|NCT01613248|26574790|P4|Overall Study|Adverse Event|1
7638327|NCT01613248|26574791|P3|Overall Study|Adverse Event|0
7638328|NCT01613248|26574792|P2|Overall Study|Adverse Event|0
7638329|NCT01613248|26574793|P1|Overall Study|Adverse Event|0
7638330|NCT01613222|26574891|P1|Overall Study|Reused disposable sensors|10
7638331|NCT01613222|26574891|P1|Overall Study|Unable to place arterial line|1
7638332|NCT01613222|26574891|P1|Overall Study|Physician Decision|1
7638333|NCT01613131|26574906|P2|Overall Study|Withdrawal by Subject|5
7638334|NCT01613131|26574907|P1|Overall Study|Withdrawal by Subject|3
7638335|NCT01613027|26574953|P1|Overall Study|Patient's Decision Due to Adverse Event|1
7638336|NCT01613027|26574953|P1|Overall Study|Lack of Efficacy|1
7638337|NCT01613027|26574953|P1|Overall Study|Switched Physician|1
7638338|NCT01613027|26574953|P1|Overall Study|Lost to Follow-up|5
7638339|NCT01612858|26574996|P2|Overall Study|Withdrawal by Subject|1
7638340|NCT01612858|26574997|P1|Overall Study|Withdrawal by Subject|5
7638341|NCT01612780|26575014|P1|Overall Study|Withdrawal by Subject|5
7638342|NCT01612780|26575014|P1|Overall Study|Treatment not completed|1
7638343|NCT01612702|26575076|P2|Overall Study|Protocol Violation|11
7638344|NCT01612702|26575077|P1|Overall Study|Protocol Violation|11
7638345|NCT01612676|26575091|P4|Overall Study|Protocol Violation|0
7638346|NCT01612676|26575092|P3|Overall Study|Protocol Violation|0
7638347|NCT01612676|26575093|P2|Overall Study|Protocol Violation|1
7638348|NCT01612676|26575094|P1|Overall Study|Protocol Violation|0
7638349|NCT01612676|26575091|P4|Overall Study|Adverse Event|3
7638350|NCT01612676|26575092|P3|Overall Study|Adverse Event|1
7638351|NCT01612676|26575093|P2|Overall Study|Adverse Event|3
7638352|NCT01612676|26575094|P1|Overall Study|Adverse Event|2
7638353|NCT01612156|26575192|P2|Overall Study|Protocol Violation|0
7638354|NCT01612156|26575193|P1|Overall Study|Protocol Violation|2
7638355|NCT01612000|26575205|P4|Overall Study|Withdrawal by Subject|2
7638356|NCT01612000|26575206|P3|Overall Study|Withdrawal by Subject|2
7638357|NCT01612000|26575207|P2|Overall Study|Withdrawal by Subject|1
7638358|NCT01612000|26575208|P1|Overall Study|Withdrawal by Subject|3
7638359|NCT01612000|26575205|P4|Overall Study|Physician Decision|0
7638360|NCT01612000|26575206|P3|Overall Study|Physician Decision|1
7638361|NCT01612000|26575207|P2|Overall Study|Physician Decision|0
7638362|NCT01612000|26575208|P1|Overall Study|Physician Decision|0
7638363|NCT01612000|26575205|P4|Overall Study|Lost to Follow-up|8
7638364|NCT01612000|26575206|P3|Overall Study|Lost to Follow-up|4
7638365|NCT01612000|26575207|P2|Overall Study|Lost to Follow-up|4
7638366|NCT01612000|26575208|P1|Overall Study|Lost to Follow-up|6
7638367|NCT01611974|26575233|P3|Overall Study|Withdrawal by Subject|4
7638368|NCT01611974|26575234|P2|Overall Study|Withdrawal by Subject|1
7638369|NCT01611974|26575235|P1|Overall Study|Withdrawal by Subject|0
7638370|NCT01611974|26575233|P3|Overall Study|Physician Decision|2
7638371|NCT01611974|26575234|P2|Overall Study|Physician Decision|1
7638372|NCT01611974|26575235|P1|Overall Study|Physician Decision|5
7638373|NCT01611974|26575233|P3|Overall Study|Lost to Follow-up|0
7638374|NCT01611974|26575234|P2|Overall Study|Lost to Follow-up|1
7638375|NCT01611974|26575235|P1|Overall Study|Lost to Follow-up|0
7638376|NCT01611974|26575233|P3|Overall Study|Death|10
7638377|NCT01611974|26575234|P2|Overall Study|Death|12
7638378|NCT01611974|26575235|P1|Overall Study|Death|10
7638379|NCT01611935|26575281|P2|Overall Study|Family Declined Participation|0
7638380|NCT01611935|26575282|P1|Overall Study|Family Declined Participation|1
7638381|NCT01611883|26575294|P2|Overall Study|Adverse Event|1
7638382|NCT01611883|26575295|P1|Overall Study|Adverse Event|1
7638383|NCT01611857|26575321|P2|Overall Study|Withdrawal by Subject|2
7638384|NCT01611857|26575322|P1|Overall Study|Withdrawal by Subject|0
7638385|NCT01611792|26575334|P2|Followup: at 6 Months|Lost to Follow-up|13
7638386|NCT01611792|26575335|P1|Followup: at 6 Months|Lost to Follow-up|6
7638387|NCT01611792|26575334|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
7638388|NCT01611792|26575335|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
7638389|NCT01611558|26575389|P1|Maintenance Phase|Elevated Uric acid|1
7638390|NCT01611558|26575389|P1|Maintenance Phase|Withdrawal by Subject|1
7638391|NCT01611558|26575389|P1|Induction Phase|Death|1
7638392|NCT01611558|26575389|P1|Induction Phase|Adverse event unrelated to study drug|3
7638393|NCT01611558|26575389|P1|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
7638394|NCT01611558|26575389|P1|Induction Phase|Disease progression|18
7638395|NCT01611558|26575389|P1|Induction Phase|Study drug toxicity|15
7638396|NCT01611298|26575395|P1|Overall Study|Relapsed|2
7638397|NCT01611259|26575400|P1|Overall Study|Withdrawal by Subject|7
7638398|NCT01611259|26575400|P1|Overall Study|Adverse Event|4
7638399|NCT01611259|26575400|P1|Overall Study|Lack of Efficacy|2
7638400|NCT01611259|26575400|P1|Overall Study|Physician Decision|1
7638401|NCT01611194|26575406|P2|Overall Study|drug use|1
7638402|NCT01611194|26575407|P1|Overall Study|drug use|0
7638403|NCT01611194|26575406|P2|Overall Study|Withdrawal by Subject|1
7638404|NCT01611194|26575407|P1|Overall Study|Withdrawal by Subject|0
7638405|NCT01611194|26575406|P2|Overall Study|Lost to Follow-up|1
7638406|NCT01611194|26575407|P1|Overall Study|Lost to Follow-up|0
7638407|NCT01611155|26575445|P2|Overall Study|Ineligible patient|1
7638408|NCT01611155|26575446|P1|Overall Study|Ineligible patient|0
7638409|NCT01611155|26575445|P2|Overall Study|Alternative treatment|1
7638410|NCT01611155|26575446|P1|Overall Study|Alternative treatment|0
7638411|NCT01611155|26575445|P2|Overall Study|Withdrawal by Subject|0
7638412|NCT01611155|26575446|P1|Overall Study|Withdrawal by Subject|1
7638413|NCT01611155|26575445|P2|Overall Study|Disease progression|0
7638414|NCT01611155|26575446|P1|Overall Study|Disease progression|1
7638415|NCT01611155|26575445|P2|Overall Study|Refused further treatment|4
7638416|NCT01611155|26575446|P1|Overall Study|Refused further treatment|6
7638417|NCT01611155|26575445|P2|Overall Study|Adverse Event|1
7638418|NCT01611155|26575446|P1|Overall Study|Adverse Event|1
7638419|NCT01611090|26575456|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
7638420|NCT01611090|26575457|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7638421|NCT01611090|26575458|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7638422|NCT01611090|26575456|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
7638423|NCT01611090|26575457|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7638424|NCT01611090|26575458|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7638425|NCT01611090|26575456|P3|Randomized Period|Withdrawal by Subject|0
7638426|NCT01611090|26575457|P2|Randomized Period|Withdrawal by Subject|26
7638427|NCT01611090|26575458|P1|Randomized Period|Withdrawal by Subject|22
7638428|NCT01611090|26575456|P3|Randomized Period|Lost to Follow-up|0
7638429|NCT01611090|26575457|P2|Randomized Period|Lost to Follow-up|3
7638430|NCT01611090|26575458|P1|Randomized Period|Lost to Follow-up|8
7638431|NCT01610791|26575491|P1|Overall Study|Not determined|5
7638432|NCT01610791|26575491|P1|Overall Study|Death|1
7638433|NCT01610791|26575491|P1|Overall Study|Adverse event and Investigator decision|1
7638434|NCT01610791|26575491|P1|Overall Study|Physician Decision|1
7638435|NCT01610791|26575491|P1|Overall Study|Adverse Event|6
7638436|NCT01610791|26575491|P1|Overall Study|Lost to Follow-up|7
7638437|NCT01610752|26575515|P3|Overall Study|Miscarriage/Pregnancy loss|4
7638438|NCT01610752|26575516|P2|Overall Study|Miscarriage/Pregnancy loss|0
7638439|NCT01610752|26575517|P1|Overall Study|Miscarriage/Pregnancy loss|0
7638440|NCT01610713|26575539|P2|Overall Study|Lost to Follow-up|1
7638441|NCT01610713|26575540|P1|Overall Study|Lost to Follow-up|0
7638442|NCT01610713|26575539|P2|Overall Study|adv. to use original dose/amitriptyline|0
7638443|NCT01610713|26575540|P1|Overall Study|adv. to use original dose/amitriptyline|1
7638444|NCT01610713|26575539|P2|Overall Study|low mood and poor motivation|0
7638445|NCT01610713|26575540|P1|Overall Study|low mood and poor motivation|1
7638446|NCT01610713|26575539|P2|Overall Study|Lack of Efficacy|0
7638447|NCT01610713|26575540|P1|Overall Study|Lack of Efficacy|1
7638448|NCT01610713|26575539|P2|Overall Study|Adverse Event|0
7638449|NCT01610713|26575540|P1|Overall Study|Adverse Event|3
7638450|NCT01610700|26575598|P2|Overall Study|subject took one dose of street cannabis|1
7638451|NCT01610700|26575599|P1|Overall Study|subject took one dose of street cannabis|0
7638452|NCT01610700|26575598|P2|Overall Study|Withdrawal by Subject|1
7638453|NCT01610700|26575599|P1|Overall Study|Withdrawal by Subject|0
7638454|NCT01610700|26575598|P2|Overall Study|Adverse Event|1
7638455|NCT01610700|26575599|P1|Overall Study|Adverse Event|3
7638456|NCT01610687|26575653|P1|Overall Study|Felt more alter without study medication|1
7638457|NCT01610687|26575653|P1|Overall Study|Cannabis affecting job|1
7638458|NCT01610687|26575653|P1|Overall Study|Death|1
7638459|NCT01610687|26575653|P1|Overall Study|Unable to make journey|1
7638460|NCT01610687|26575653|P1|Overall Study|Symptom control without study medication|2
7638461|NCT01610687|26575653|P1|Overall Study|Lost to Follow-up|4
7638462|NCT01610687|26575653|P1|Overall Study|Withdrawal by Subject|7
7638463|NCT01610687|26575653|P1|Overall Study|Moved out of area|6
7638464|NCT01610687|26575653|P1|Overall Study|Adverse Event|18
7638465|NCT01610687|26575653|P1|Overall Study|Lack of Efficacy|26
7638466|NCT01610596|26575666|P2|Overall Study|Lost to Follow-up|1
7638467|NCT01610596|26575667|P1|Overall Study|Lost to Follow-up|0
7638468|NCT01610557|26575725|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
7638469|NCT01610557|26575726|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
7638470|NCT01610557|26575727|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
7638471|NCT01610557|26575728|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
7638472|NCT01610557|26575729|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
7638473|NCT01610557|26575725|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7638474|NCT01610557|26575726|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7638475|NCT01610557|26575727|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7638476|NCT01610557|26575728|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
7638477|NCT01610557|26575729|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7638478|NCT01610492|26575742|P1|Overall Study|Other:Treatment stopped due to remission|1
7638479|NCT01610492|26575742|P1|Overall Study|Other: Reached stopping criteria|1
7638480|NCT01610492|26575742|P1|Overall Study|Lack of Efficacy|3
7638481|NCT01610492|26575742|P1|Overall Study|Adverse Event|1
7638482|NCT01610414|26575808|P2|After Month 25|Study end not reached|53
7638483|NCT01610414|26575809|P1|After Month 25|Study end not reached|48
7638484|NCT01610414|26575808|P2|Month 13 - Month 25|Other reasons for withdrawal|7
7638485|NCT01610414|26575809|P1|Month 13 - Month 25|Other reasons for withdrawal|6
7638486|NCT01610414|26575808|P2|Month 13 - Month 25|Lost to Follow-up|9
7638487|NCT01610414|26575809|P1|Month 13 - Month 25|Lost to Follow-up|5
7638488|NCT01610414|26575808|P2|Month 13 - Month 25|Protocol Violation|2
7638489|NCT01610414|26575809|P1|Month 13 - Month 25|Protocol Violation|0
7638490|NCT01610414|26575808|P2|Month 13 - Month 25|Migrated/moved from study area|2
7638491|NCT01610414|26575809|P1|Month 13 - Month 25|Migrated/moved from study area|4
7638492|NCT01610414|26575808|P2|Month 13 - Month 25|Withdrawal by Subject|8
7638493|NCT01610414|26575809|P1|Month 13 - Month 25|Withdrawal by Subject|7
7638494|NCT01610414|26575808|P2|Month 13 - Month 25|Adverse Event|4
7638495|NCT01610414|26575809|P1|Month 13 - Month 25|Adverse Event|8
7638496|NCT01610414|26575808|P2|Month 13 - Month 25|Serious Adverse Event|38
7638497|NCT01610414|26575809|P1|Month 13 - Month 25|Serious Adverse Event|35
7638498|NCT01610414|26575808|P2|Study Start - Month 13|Other reasons for withdrawal|4
7638499|NCT01610414|26575809|P1|Study Start - Month 13|Other reasons for withdrawal|3
7638500|NCT01610414|26575808|P2|Study Start - Month 13|Suspected HZ episode|3
7638501|NCT01610414|26575809|P1|Study Start - Month 13|Suspected HZ episode|1
7638502|NCT01610414|26575808|P2|Study Start - Month 13|Lost to Follow-up|6
7638503|NCT01610414|26575809|P1|Study Start - Month 13|Lost to Follow-up|4
7638504|NCT01610414|26575808|P2|Study Start - Month 13|Migrated/moved from study area|4
7638505|NCT01610414|26575809|P1|Study Start - Month 13|Migrated/moved from study area|2
7638506|NCT01610414|26575808|P2|Study Start - Month 13|Withdrawal by Subject|30
7638507|NCT01610414|26575809|P1|Study Start - Month 13|Withdrawal by Subject|23
7638508|NCT01610414|26575808|P2|Study Start - Month 13|Protocol Violation|1
7638509|NCT01610414|26575809|P1|Study Start - Month 13|Protocol Violation|3
7638510|NCT01610414|26575808|P2|Study Start - Month 13|Adverse Event|14
7638511|NCT01610414|26575809|P1|Study Start - Month 13|Adverse Event|14
7638512|NCT01610414|26575808|P2|Study Start - Month 13|Serious Adverse Event|67
7638513|NCT01610414|26575809|P1|Study Start - Month 13|Serious Adverse Event|65
7638514|NCT01610336|26575849|P11|Overall Study|Transfer to another trial|1
7638515|NCT01610336|26575850|P10|Overall Study|Transfer to another trial|0
7638516|NCT01610336|26575851|P9|Overall Study|Transfer to another trial|0
7638517|NCT01610336|26575852|P8|Overall Study|Transfer to another trial|0
7638518|NCT01610336|26575853|P7|Overall Study|Transfer to another trial|0
7638519|NCT01610336|26575854|P6|Overall Study|Transfer to another trial|0
7638520|NCT01610336|26575855|P5|Overall Study|Transfer to another trial|0
7638521|NCT01610336|26575856|P4|Overall Study|Transfer to another trial|0
7638522|NCT01610336|26575857|P3|Overall Study|Transfer to another trial|0
7638523|NCT01610336|26575858|P2|Overall Study|Transfer to another trial|0
7638524|NCT01610336|26575859|P1|Overall Study|Transfer to another trial|0
7638525|NCT01610336|26575849|P11|Overall Study|Protocol Deviation|0
7638526|NCT01610336|26575850|P10|Overall Study|Protocol Deviation|1
7638527|NCT01610336|26575851|P9|Overall Study|Protocol Deviation|0
7638528|NCT01610336|26575852|P8|Overall Study|Protocol Deviation|0
7638529|NCT01610336|26575853|P7|Overall Study|Protocol Deviation|0
7638530|NCT01610336|26575854|P6|Overall Study|Protocol Deviation|0
7638531|NCT01610336|26575855|P5|Overall Study|Protocol Deviation|0
7638532|NCT01610336|26575856|P4|Overall Study|Protocol Deviation|0
7638533|NCT01610336|26575857|P3|Overall Study|Protocol Deviation|0
7638534|NCT01610336|26575858|P2|Overall Study|Protocol Deviation|0
7638535|NCT01610336|26575859|P1|Overall Study|Protocol Deviation|0
7638536|NCT01610336|26575849|P11|Overall Study|Physician Decision|0
7638537|NCT01610336|26575850|P10|Overall Study|Physician Decision|0
7638538|NCT01610336|26575851|P9|Overall Study|Physician Decision|0
7638539|NCT01610336|26575852|P8|Overall Study|Physician Decision|0
7638540|NCT01610336|26575853|P7|Overall Study|Physician Decision|1
7638541|NCT01610336|26575854|P6|Overall Study|Physician Decision|0
7638542|NCT01610336|26575855|P5|Overall Study|Physician Decision|0
7638543|NCT01610336|26575856|P4|Overall Study|Physician Decision|0
7638544|NCT01610336|26575857|P3|Overall Study|Physician Decision|0
7638545|NCT01610336|26575858|P2|Overall Study|Physician Decision|0
7638546|NCT01610336|26575859|P1|Overall Study|Physician Decision|0
7638547|NCT01610336|26575849|P11|Overall Study|Non-Compliance with study treatment|0
7638548|NCT01610336|26575850|P10|Overall Study|Non-Compliance with study treatment|1
7638549|NCT01610336|26575851|P9|Overall Study|Non-Compliance with study treatment|0
7638550|NCT01610336|26575852|P8|Overall Study|Non-Compliance with study treatment|0
7638551|NCT01610336|26575853|P7|Overall Study|Non-Compliance with study treatment|0
7638552|NCT01610336|26575854|P6|Overall Study|Non-Compliance with study treatment|0
7638553|NCT01610336|26575855|P5|Overall Study|Non-Compliance with study treatment|0
7638554|NCT01610336|26575856|P4|Overall Study|Non-Compliance with study treatment|0
7638555|NCT01610336|26575857|P3|Overall Study|Non-Compliance with study treatment|0
7638556|NCT01610336|26575858|P2|Overall Study|Non-Compliance with study treatment|0
7638557|NCT01610336|26575859|P1|Overall Study|Non-Compliance with study treatment|0
7638558|NCT01610336|26575849|P11|Overall Study|Death|2
7638559|NCT01610336|26575850|P10|Overall Study|Death|1
7638560|NCT01610336|26575851|P9|Overall Study|Death|0
7638561|NCT01610336|26575852|P8|Overall Study|Death|0
7638562|NCT01610336|26575853|P7|Overall Study|Death|3
7638563|NCT01610336|26575854|P6|Overall Study|Death|1
7638564|NCT01610336|26575855|P5|Overall Study|Death|0
7638565|NCT01610336|26575856|P4|Overall Study|Death|0
7638566|NCT01610336|26575857|P3|Overall Study|Death|0
7638567|NCT01610336|26575858|P2|Overall Study|Death|0
7638568|NCT01610336|26575859|P1|Overall Study|Death|0
7638569|NCT01610336|26575849|P11|Overall Study|Subject/Guardian decision|2
7638570|NCT01610336|26575850|P10|Overall Study|Subject/Guardian decision|2
7638571|NCT01610336|26575851|P9|Overall Study|Subject/Guardian decision|0
7638572|NCT01610336|26575852|P8|Overall Study|Subject/Guardian decision|1
7638573|NCT01610336|26575853|P7|Overall Study|Subject/Guardian decision|0
7638574|NCT01610336|26575854|P6|Overall Study|Subject/Guardian decision|0
7638575|NCT01610336|26575855|P5|Overall Study|Subject/Guardian decision|0
7638576|NCT01610336|26575856|P4|Overall Study|Subject/Guardian decision|1
7638577|NCT01610336|26575857|P3|Overall Study|Subject/Guardian decision|0
7638578|NCT01610336|26575858|P2|Overall Study|Subject/Guardian decision|1
7638579|NCT01610336|26575859|P1|Overall Study|Subject/Guardian decision|1
7638580|NCT01610336|26575849|P11|Overall Study|Adverse Event|6
7638581|NCT01610336|26575850|P10|Overall Study|Adverse Event|8
7638582|NCT01610336|26575851|P9|Overall Study|Adverse Event|2
7638583|NCT01610336|26575852|P8|Overall Study|Adverse Event|0
7638584|NCT01610336|26575853|P7|Overall Study|Adverse Event|0
7638585|NCT01610336|26575854|P6|Overall Study|Adverse Event|1
7638586|NCT01610336|26575855|P5|Overall Study|Adverse Event|1
7638587|NCT01610336|26575856|P4|Overall Study|Adverse Event|1
7638588|NCT01610336|26575857|P3|Overall Study|Adverse Event|0
7638589|NCT01610336|26575858|P2|Overall Study|Adverse Event|0
7638590|NCT01610336|26575859|P1|Overall Study|Adverse Event|0
7638591|NCT01610336|26575849|P11|Overall Study|Progressive Disease|36
7638592|NCT01610336|26575850|P10|Overall Study|Progressive Disease|40
7638593|NCT01610336|26575851|P9|Overall Study|Progressive Disease|6
7638594|NCT01610336|26575852|P8|Overall Study|Progressive Disease|6
7638595|NCT01610336|26575853|P7|Overall Study|Progressive Disease|1
7638596|NCT01610336|26575854|P6|Overall Study|Progressive Disease|10
7638597|NCT01610336|26575855|P5|Overall Study|Progressive Disease|3
7638598|NCT01610336|26575856|P4|Overall Study|Progressive Disease|5
7638599|NCT01610336|26575857|P3|Overall Study|Progressive Disease|6
7638600|NCT01610336|26575858|P2|Overall Study|Progressive Disease|6
7638601|NCT01610336|26575859|P1|Overall Study|Progressive Disease|4
7638602|NCT01610297|26575989|P1|Overall Study|Lost to Follow-up|1
7638603|NCT01610284|26575999|P2|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
7638604|NCT01610284|26576000|P1|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
7638605|NCT01610284|26575999|P2|Post-Treatment Efficacy Follow-Up Phase|Death|4
7638606|NCT01610284|26576000|P1|Post-Treatment Efficacy Follow-Up Phase|Death|4
7638607|NCT01610284|26575999|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7638608|NCT01610284|26576000|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
7638609|NCT01610284|26575999|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
7638610|NCT01610284|26576000|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
7638611|NCT01610284|26575999|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
7638612|NCT01610284|26576000|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
7638613|NCT01610284|26575999|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7638614|NCT01610284|26576000|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7638615|NCT01610284|26575999|P2|Treatment Phase|Death|5
7638616|NCT01610284|26576000|P1|Treatment Phase|Death|6
7638617|NCT01610284|26575999|P2|Treatment Phase|Subject/Guardian Decision|23
7638618|NCT01610284|26576000|P1|Treatment Phase|Subject/Guardian Decision|55
7638619|NCT01610284|26575999|P2|Treatment Phase|Study terminated by Sponsor|15
7638620|NCT01610284|26576000|P1|Treatment Phase|Study terminated by Sponsor|18
7638621|NCT01610284|26575999|P2|Treatment Phase|Protocol Deviation|3
7638622|NCT01610284|26576000|P1|Treatment Phase|Protocol Deviation|2
7638623|NCT01610284|26575999|P2|Treatment Phase|Progressive Disease|486
7638624|NCT01610284|26576000|P1|Treatment Phase|Progressive Disease|377
7638625|NCT01610284|26575999|P2|Treatment Phase|Physician Decision|24
7638626|NCT01610284|26576000|P1|Treatment Phase|Physician Decision|27
7638627|NCT01610284|26575999|P2|Treatment Phase|Non-compliance with Study Treatment|1
7638628|NCT01610284|26576000|P1|Treatment Phase|Non-compliance with Study Treatment|8
7638629|NCT01610284|26575999|P2|Treatment Phase|Lost to Follow-up|0
7638630|NCT01610284|26576000|P1|Treatment Phase|Lost to Follow-up|1
7638631|NCT01610284|26575999|P2|Treatment Phase|Adverse Event|12
7638632|NCT01610284|26576000|P1|Treatment Phase|Adverse Event|80
7638633|NCT01610284|26575999|P2|Randomization Phase|Death|1
7638634|NCT01610284|26576000|P1|Randomization Phase|Death|0
7638635|NCT01610284|26575999|P2|Randomization Phase|Physician Decision|1
7638636|NCT01610284|26576000|P1|Randomization Phase|Physician Decision|1
7638637|NCT01610284|26575999|P2|Randomization Phase|Adverse Event|0
7638638|NCT01610284|26576000|P1|Randomization Phase|Adverse Event|1
7638639|NCT01610271|26576022|P2|Overall Study|Prosthesis not implanted|3
7638640|NCT01610271|26576023|P1|Overall Study|Prosthesis not implanted|2
7638641|NCT01610271|26576022|P2|Overall Study|Surgery not complete|1
7638642|NCT01610271|26576023|P1|Overall Study|Surgery not complete|0
7638643|NCT01610206|26576037|P2|Overall Study|Adverse Event|30
7638644|NCT01610206|26576038|P1|Overall Study|Adverse Event|10
7638645|NCT01610167|26576049|P3|Overall Study|Scheduling conflict.|2
7638646|NCT01610167|26576050|P2|Overall Study|Scheduling conflict.|0
7638647|NCT01610167|26576051|P1|Overall Study|Scheduling conflict.|0
7638648|NCT01610076|26576088|P2|Overall Study|Lost to Follow-up|4
7638649|NCT01610076|26576089|P1|Overall Study|Lost to Follow-up|3
7638650|NCT01610076|26576088|P2|Overall Study|Technical issue with video|1
7638651|NCT01610076|26576089|P1|Overall Study|Technical issue with video|0
7638652|NCT01610063|26576100|P2|Overall Study|Lost to Follow-up|20
7638653|NCT01610063|26576101|P1|Overall Study|Lost to Follow-up|42
7638654|NCT01610037|26576124|P3|Treatment and Follow up Period|Lost to Follow-up|4
7638655|NCT01610037|26576125|P2|Treatment and Follow up Period|Lost to Follow-up|6
7638656|NCT01610037|26576126|P1|Treatment and Follow up Period|Lost to Follow-up|1
7638657|NCT01610037|26576124|P3|Treatment and Follow up Period|Administrative problems|2
7638658|NCT01610037|26576125|P2|Treatment and Follow up Period|Administrative problems|3
7638659|NCT01610037|26576126|P1|Treatment and Follow up Period|Administrative problems|1
7638660|NCT01610037|26576124|P3|Treatment and Follow up Period|Death|4
7638661|NCT01610037|26576125|P2|Treatment and Follow up Period|Death|5
7638662|NCT01610037|26576126|P1|Treatment and Follow up Period|Death|10
7638663|NCT01610037|26576124|P3|Treatment and Follow up Period|Subject withdrew consent|16
7638664|NCT01610037|26576125|P2|Treatment and Follow up Period|Subject withdrew consent|14
7638665|NCT01610037|26576126|P1|Treatment and Follow up Period|Subject withdrew consent|13
7638666|NCT01610037|26576124|P3|All Patients|Abnormal test procedure result(s)|3
7638667|NCT01610037|26576125|P2|All Patients|Abnormal test procedure result(s)|1
7638668|NCT01610037|26576126|P1|All Patients|Abnormal test procedure result(s)|0
7638669|NCT01610037|26576124|P3|All Patients|Lost to Follow-up|0
7638670|NCT01610037|26576125|P2|All Patients|Lost to Follow-up|0
7638671|NCT01610037|26576126|P1|All Patients|Lost to Follow-up|1
7638672|NCT01610037|26576124|P3|All Patients|Administrative problems|4
7638673|NCT01610037|26576125|P2|All Patients|Administrative problems|4
7638674|NCT01610037|26576126|P1|All Patients|Administrative problems|1
7638675|NCT01610037|26576124|P3|All Patients|Abnormal laboratory value|0
7638676|NCT01610037|26576125|P2|All Patients|Abnormal laboratory value|1
7638677|NCT01610037|26576126|P1|All Patients|Abnormal laboratory value|1
7638678|NCT01610037|26576124|P3|All Patients|Protocol deviation|3
7638679|NCT01610037|26576125|P2|All Patients|Protocol deviation|3
7638680|NCT01610037|26576126|P1|All Patients|Protocol deviation|4
7638681|NCT01610037|26576124|P3|All Patients|Death|1
7638682|NCT01610037|26576125|P2|All Patients|Death|2
7638683|NCT01610037|26576126|P1|All Patients|Death|4
7638684|NCT01610037|26576124|P3|All Patients|Unsatisfactory therapeutic effect|27
7638685|NCT01610037|26576125|P2|All Patients|Unsatisfactory therapeutic effect|8
7638686|NCT01610037|26576126|P1|All Patients|Unsatisfactory therapeutic effect|9
7638687|NCT01610037|26576124|P3|All Patients|Withdrawal by Subject|20
7638688|NCT01610037|26576125|P2|All Patients|Withdrawal by Subject|10
7638689|NCT01610037|26576126|P1|All Patients|Withdrawal by Subject|12
7638690|NCT01610037|26576124|P3|All Patients|Adverse Event|26
7638691|NCT01610037|26576125|P2|All Patients|Adverse Event|22
7638692|NCT01610037|26576126|P1|All Patients|Adverse Event|27
7638693|NCT01609933|26576176|P1|Overall Study|Withdrawal by Subject|3
7638694|NCT01609933|26576176|P1|Overall Study|Adverse Event|1
7638695|NCT01609842|26576187|P2|Concurrent Intervention Control|pharmacy data not available|0
7638696|NCT01609842|26576188|P1|Concurrent Intervention Control|pharmacy data not available|2
7638697|NCT01609790|26576215|P3|Overall Study|Protocol Violation|8
7638698|NCT01609790|26576216|P2|Overall Study|Protocol Violation|7
7638699|NCT01609790|26576217|P1|Overall Study|Protocol Violation|1
7638700|NCT01609582|26576236|P2|Overall Study|Randomized, but not treated|3
7638701|NCT01609582|26576237|P1|Overall Study|Randomized, but not treated|0
7638702|NCT01609582|26576236|P2|Overall Study|Other|10
7638703|NCT01609582|26576237|P1|Overall Study|Other|9
7638704|NCT01609582|26576236|P2|Overall Study|Study Terminated by Sponsor|1548
7638705|NCT01609582|26576237|P1|Overall Study|Study Terminated by Sponsor|1543
7638706|NCT01609582|26576236|P2|Overall Study|Withdrawal by Subject|15
7638707|NCT01609582|26576237|P1|Overall Study|Withdrawal by Subject|21
7638708|NCT01609582|26576236|P2|Overall Study|Lost to Follow-up|10
7638709|NCT01609582|26576237|P1|Overall Study|Lost to Follow-up|10
7638710|NCT01609582|26576236|P2|Overall Study|Adverse Event|18
7638711|NCT01609582|26576237|P1|Overall Study|Adverse Event|20
7638712|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638713|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638714|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638715|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
7638716|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638717|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638718|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638719|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638720|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638721|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638722|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638723|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638724|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638725|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638726|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638727|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7638728|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Death|3
7638729|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Death|0
7638730|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Death|2
7638731|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Death|4
7638732|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Death|0
7638733|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Death|0
7638734|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Death|0
7638735|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Death|0
7638736|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Death|0
7638737|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Death|0
7638738|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Death|0
7638739|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Death|0
7638740|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Death|0
7638741|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Death|0
7638742|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Death|0
7638743|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Death|0
7638744|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
7638745|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638746|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638747|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638748|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638749|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638750|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638751|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638752|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638753|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638754|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638755|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638756|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638757|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638758|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638759|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7638760|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
7638761|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
7638762|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
7638763|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
7638764|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638765|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638766|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638767|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638768|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638769|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638770|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638771|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638772|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638773|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638774|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638775|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7638776|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638777|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638778|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638779|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
7638780|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638781|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638782|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638783|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638784|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638785|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638786|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638787|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638788|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638789|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638790|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638791|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7638792|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
7638793|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7638794|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7638795|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7638796|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638797|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638798|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638799|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638800|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638801|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638802|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638803|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638804|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638805|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638806|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638807|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7638808|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
7638809|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
7638810|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
7638811|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
7638812|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638813|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638814|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638815|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638816|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638817|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638818|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638819|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638820|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638821|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638822|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638823|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7638824|NCT01609556|26576261|P16|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7638825|NCT01609556|26576262|P15|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7638826|NCT01609556|26576263|P14|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7638827|NCT01609556|26576264|P13|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
7638828|NCT01609556|26576265|P12|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638829|NCT01609556|26576266|P11|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638830|NCT01609556|26576267|P10|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638831|NCT01609556|26576268|P9|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638832|NCT01609556|26576269|P8|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638833|NCT01609556|26576270|P7|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638834|NCT01609556|26576271|P6|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638835|NCT01609556|26576272|P5|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638836|NCT01609556|26576273|P4|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638837|NCT01609556|26576274|P3|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638838|NCT01609556|26576275|P2|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638839|NCT01609556|26576276|P1|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7638840|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638841|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638842|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638843|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638844|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638845|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Death|1
7638846|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638847|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638848|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638849|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638850|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Death|1
7638851|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638852|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638853|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638854|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Death|0
7638855|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Death|2
7638856|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638857|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638858|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638859|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638860|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638861|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638862|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638863|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
7638864|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638865|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638866|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638867|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638868|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638869|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638870|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638871|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7638872|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638873|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638874|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638875|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638876|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638877|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638878|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638879|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638880|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638881|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638882|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
7638883|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638884|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638885|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638886|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638887|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7638888|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638889|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638890|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638891|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638892|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7638893|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638894|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638895|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638896|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638897|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638898|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7638899|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638900|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638901|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638902|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638903|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7638904|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638905|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638906|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638907|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638908|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7638909|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7638910|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7638911|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638912|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638913|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7638914|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7638915|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638916|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638917|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638918|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638919|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7638920|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7638921|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7638922|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7638923|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7638924|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7638925|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
7638926|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7638927|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7638928|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
7638929|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
7638930|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
7638931|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
7638932|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7638933|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7638934|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7638935|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7638936|NCT01609556|26576261|P16|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638937|NCT01609556|26576262|P15|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638938|NCT01609556|26576263|P14|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638939|NCT01609556|26576264|P13|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638940|NCT01609556|26576265|P12|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7638941|NCT01609556|26576266|P11|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7638942|NCT01609556|26576267|P10|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638943|NCT01609556|26576268|P9|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7638944|NCT01609556|26576269|P8|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7638945|NCT01609556|26576270|P7|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638946|NCT01609556|26576271|P6|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638947|NCT01609556|26576272|P5|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7638948|NCT01609556|26576273|P4|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638949|NCT01609556|26576274|P3|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638950|NCT01609556|26576275|P2|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638951|NCT01609556|26576276|P1|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7638952|NCT01609543|26576436|P1|Overall Study|Death|7
7638953|NCT01609543|26576436|P1|Overall Study|Protocol Violation|1
7638954|NCT01609543|26576436|P1|Overall Study|Withdrawal by Subject|1
7638955|NCT01609543|26576436|P1|Overall Study|Adverse Event|5
7638956|NCT01609543|26576436|P1|Overall Study|Disease Progression|28
7638957|NCT01609478|26576445|P3|Overall Study|Withdrawal by Subject|2
7638958|NCT01609478|26576446|P2|Overall Study|Withdrawal by Subject|0
7638959|NCT01609478|26576447|P1|Overall Study|Withdrawal by Subject|2
7638960|NCT01609478|26576445|P3|Overall Study|Physician Decision|1
7638961|NCT01609478|26576446|P2|Overall Study|Physician Decision|0
7638962|NCT01609478|26576447|P1|Overall Study|Physician Decision|1
7638963|NCT01609478|26576445|P3|Overall Study|Non-Compliance with study treatment|0
7638964|NCT01609478|26576446|P2|Overall Study|Non-Compliance with study treatment|0
7638965|NCT01609478|26576447|P1|Overall Study|Non-Compliance with study treatment|1
7638966|NCT01609478|26576445|P3|Overall Study|Protocol Deviation|1
7638967|NCT01609478|26576446|P2|Overall Study|Protocol Deviation|1
7638968|NCT01609478|26576447|P1|Overall Study|Protocol Deviation|0
7638969|NCT01609478|26576445|P3|Overall Study|Adverse Event|5
7638970|NCT01609478|26576446|P2|Overall Study|Adverse Event|1
7638971|NCT01609478|26576447|P1|Overall Study|Adverse Event|3
7638972|NCT01609296|26576520|P1|Overall Study|missed visit but known to be alive|28
7638973|NCT01609296|26576520|P1|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
7638974|NCT01609296|26576520|P1|Overall Study|Lost to Follow-up|21
7638975|NCT01609296|26576520|P1|Overall Study|Withdrawal by Subject|151
7638976|NCT01609296|26576520|P1|Overall Study|Death|253
7638977|NCT01609257|26576676|P2|Overall Study|Non-compliance/Protocol deviation|6
7638978|NCT01609257|26576677|P1|Overall Study|Non-compliance/Protocol deviation|4
7638979|NCT01609257|26576676|P2|Overall Study|Voluntary Withdrawal by Subject|1
7638980|NCT01609257|26576677|P1|Overall Study|Voluntary Withdrawal by Subject|0
7638981|NCT01609257|26576676|P2|Overall Study|Lost to Follow-up|1
7638982|NCT01609257|26576677|P1|Overall Study|Lost to Follow-up|2
7638983|NCT01609231|26576749|P2|Overall Study|Withdrawal by Subject|0
7638984|NCT01609231|26576750|P1|Overall Study|Withdrawal by Subject|1
7638985|NCT01609231|26576749|P2|Overall Study|Physician Decision|0
7638986|NCT01609231|26576750|P1|Overall Study|Physician Decision|1
7638987|NCT01609231|26576749|P2|Overall Study|Adverse Event|3
7638988|NCT01609231|26576750|P1|Overall Study|Adverse Event|1
7638989|NCT01609218|26576758|P2|Period 2|Adverse Event|0
7638990|NCT01609218|26576759|P1|Period 2|Adverse Event|1
7638991|NCT01609218|26576758|P2|Period 1|Sponsor Decision|1
7638992|NCT01609218|26576759|P1|Period 1|Sponsor Decision|0
7638993|NCT01609218|26576758|P2|Period 1|Adverse Event|5
7638994|NCT01609218|26576759|P1|Period 1|Adverse Event|3
7638995|NCT01609062|26576773|P2|Extension Phase|Anticipated surgery & transition to EAP|1
7638996|NCT01609062|26576774|P1|Extension Phase|Anticipated surgery & transition to EAP|0
7638997|NCT01609062|26576773|P2|Extension Phase|Discontinued drug and then was pregnant|0
7638998|NCT01609062|26576774|P1|Extension Phase|Discontinued drug and then was pregnant|1
7638999|NCT01609062|26576773|P2|Extension Phase|Terminated by Sponsor|9
7639000|NCT01609062|26576774|P1|Extension Phase|Terminated by Sponsor|14
7639001|NCT01609023|26576817|P1|Overall Study|Personal reasons|1
7639002|NCT01609023|26576817|P1|Overall Study|Death|2
7639003|NCT01609023|26576817|P1|Overall Study|Physician Decision|2
7639004|NCT01609023|26576817|P1|Overall Study|Disease progression|10
7639005|NCT01609023|26576817|P1|Overall Study|Toxicity|3
7639006|NCT01609023|26576817|P1|Overall Study|Lost to Follow-up|8
7639007|NCT01609023|26576817|P1|Overall Study|Withdrawal by Subject|4
7639008|NCT01609023|26576817|P1|Overall Study|Lack of Efficacy|3
7639009|NCT01609010|26576829|P2|Overall Study|Lost to Follow-up|1
7639010|NCT01609010|26576830|P1|Overall Study|Lost to Follow-up|1
7639011|NCT01609010|26576829|P2|Overall Study|New cancer|0
7639012|NCT01609010|26576830|P1|Overall Study|New cancer|1
7639013|NCT01609010|26576829|P2|Overall Study|Protocol Violation|1
7639014|NCT01609010|26576830|P1|Overall Study|Protocol Violation|1
7639015|NCT01609010|26576829|P2|Overall Study|Pathology review|1
7639016|NCT01609010|26576830|P1|Overall Study|Pathology review|2
7639017|NCT01609010|26576829|P2|Overall Study|Other malignancy|0
7639018|NCT01609010|26576830|P1|Overall Study|Other malignancy|1
7639019|NCT01609010|26576829|P2|Overall Study|Other|0
7639020|NCT01609010|26576830|P1|Overall Study|Other|2
7639021|NCT01609010|26576829|P2|Overall Study|Withdrawal by Subject|2
7639022|NCT01609010|26576830|P1|Overall Study|Withdrawal by Subject|2
7639023|NCT01609010|26576829|P2|Overall Study|Adverse Event|6
7639024|NCT01609010|26576830|P1|Overall Study|Adverse Event|3
7639025|NCT01609010|26576829|P2|Overall Study|Progressive disease (PD)|10
7639026|NCT01609010|26576830|P1|Overall Study|Progressive disease (PD)|8
7639027|NCT01609010|26576829|P2|Overall Study|Stable disease (SD)|16
7639028|NCT01609010|26576830|P1|Overall Study|Stable disease (SD)|22
7639029|NCT01608724|26576898|P1|Overall Study|Safety reasons|1
7639030|NCT01608724|26576898|P1|Overall Study|bood sugar too high, etc.|3
7639031|NCT01608724|26576898|P1|Overall Study|Protocol Violation|6
7639032|NCT01608724|26576898|P1|Overall Study|Adverse Event|29
7639033|NCT01608724|26576898|P1|Overall Study|Study-specific discontinuation criteria|32
7639034|NCT01608724|26576898|P1|Overall Study|Lost to Follow-up|41
7639035|NCT01608724|26576898|P1|Overall Study|Withdrawal by Subject|131
7639036|NCT01608321|26576940|P2|Overall Study|Withdrawal by Subject|0
7639037|NCT01608321|26576941|P1|Overall Study|Withdrawal by Subject|1
7639038|NCT01608308|26576949|P2|Overall Study|pretreatment medical and billing reasons|2
7639039|NCT01608308|26576950|P1|Overall Study|pretreatment medical and billing reasons|0
7639040|NCT01608087|26577013|P3|Overall Study|Other Reason|0
7639041|NCT01608087|26577014|P2|Overall Study|Other Reason|1
7639042|NCT01608087|26577015|P1|Overall Study|Other Reason|0
7639043|NCT01608087|26577013|P3|Overall Study|Lost to Follow-up|0
7639044|NCT01608087|26577014|P2|Overall Study|Lost to Follow-up|1
7639045|NCT01608087|26577015|P1|Overall Study|Lost to Follow-up|0
7639046|NCT01607957|26577045|P2|Overall Study|Participant refusal|0
7639047|NCT01607957|26577046|P1|Overall Study|Participant refusal|1
7639048|NCT01607957|26577045|P2|Overall Study|Lost to Follow-up|3
7639049|NCT01607957|26577046|P1|Overall Study|Lost to Follow-up|3
7639050|NCT01607957|26577045|P2|Overall Study|Death|211
7639051|NCT01607957|26577046|P1|Overall Study|Death|367
7639052|NCT01607957|26577045|P2|Overall Study|Not treated|1
7639053|NCT01607957|26577046|P1|Overall Study|Not treated|1
7639054|NCT01607905|26577063|P7|Overall Study|Randomized but not treated|0
7639055|NCT01607905|26577064|P6|Overall Study|Randomized but not treated|1
7639056|NCT01607905|26577065|P5|Overall Study|Randomized but not treated|1
7639057|NCT01607905|26577066|P4|Overall Study|Randomized but not treated|0
7639058|NCT01607905|26577067|P3|Overall Study|Randomized but not treated|0
7639059|NCT01607905|26577068|P2|Overall Study|Randomized but not treated|0
7639060|NCT01607905|26577069|P1|Overall Study|Randomized but not treated|1
7639061|NCT01607905|26577063|P7|Overall Study|Other|1
7639062|NCT01607905|26577064|P6|Overall Study|Other|0
7639063|NCT01607905|26577065|P5|Overall Study|Other|0
7639064|NCT01607905|26577066|P4|Overall Study|Other|0
7639065|NCT01607905|26577067|P3|Overall Study|Other|0
7639066|NCT01607905|26577068|P2|Overall Study|Other|0
7639067|NCT01607905|26577069|P1|Overall Study|Other|1
7639068|NCT01607905|26577063|P7|Overall Study|Investigator discretion|0
7639069|NCT01607905|26577064|P6|Overall Study|Investigator discretion|1
7639070|NCT01607905|26577065|P5|Overall Study|Investigator discretion|0
7639071|NCT01607905|26577066|P4|Overall Study|Investigator discretion|0
7639072|NCT01607905|26577067|P3|Overall Study|Investigator discretion|0
7639073|NCT01607905|26577068|P2|Overall Study|Investigator discretion|0
7639074|NCT01607905|26577069|P1|Overall Study|Investigator discretion|0
7639075|NCT01607905|26577063|P7|Overall Study|Other treatments become available|1
7639076|NCT01607905|26577064|P6|Overall Study|Other treatments become available|0
7639077|NCT01607905|26577065|P5|Overall Study|Other treatments become available|0
7639078|NCT01607905|26577066|P4|Overall Study|Other treatments become available|0
7639079|NCT01607905|26577067|P3|Overall Study|Other treatments become available|0
7639080|NCT01607905|26577068|P2|Overall Study|Other treatments become available|0
7639081|NCT01607905|26577069|P1|Overall Study|Other treatments become available|1
7639082|NCT01607905|26577063|P7|Overall Study|Death|3
7639083|NCT01607905|26577064|P6|Overall Study|Death|0
7639084|NCT01607905|26577065|P5|Overall Study|Death|0
7639085|NCT01607905|26577066|P4|Overall Study|Death|1
7639086|NCT01607905|26577067|P3|Overall Study|Death|1
7639087|NCT01607905|26577068|P2|Overall Study|Death|1
7639088|NCT01607905|26577069|P1|Overall Study|Death|1
7639089|NCT01607905|26577063|P7|Overall Study|Non-compliance with study procedures|1
7639090|NCT01607905|26577064|P6|Overall Study|Non-compliance with study procedures|0
7639091|NCT01607905|26577065|P5|Overall Study|Non-compliance with study procedures|0
7639092|NCT01607905|26577066|P4|Overall Study|Non-compliance with study procedures|0
7639093|NCT01607905|26577067|P3|Overall Study|Non-compliance with study procedures|0
7639094|NCT01607905|26577068|P2|Overall Study|Non-compliance with study procedures|0
7639095|NCT01607905|26577069|P1|Overall Study|Non-compliance with study procedures|0
7639096|NCT01607905|26577063|P7|Overall Study|Disease progression|21
7639097|NCT01607905|26577064|P6|Overall Study|Disease progression|7
7639098|NCT01607905|26577065|P5|Overall Study|Disease progression|6
7639099|NCT01607905|26577066|P4|Overall Study|Disease progression|11
7639100|NCT01607905|26577067|P3|Overall Study|Disease progression|15
7639101|NCT01607905|26577068|P2|Overall Study|Disease progression|16
7639102|NCT01607905|26577069|P1|Overall Study|Disease progression|44
7639103|NCT01607905|26577063|P7|Overall Study|Incidence or severity of AEs|8
7639104|NCT01607905|26577064|P6|Overall Study|Incidence or severity of AEs|2
7639105|NCT01607905|26577065|P5|Overall Study|Incidence or severity of AEs|0
7639106|NCT01607905|26577066|P4|Overall Study|Incidence or severity of AEs|3
7639107|NCT01607905|26577067|P3|Overall Study|Incidence or severity of AEs|1
7639108|NCT01607905|26577068|P2|Overall Study|Incidence or severity of AEs|1
7639109|NCT01607905|26577069|P1|Overall Study|Incidence or severity of AEs|5
7639110|NCT01607905|26577063|P7|Overall Study|Withdrawal by participant|12
7639111|NCT01607905|26577064|P6|Overall Study|Withdrawal by participant|4
7639112|NCT01607905|26577065|P5|Overall Study|Withdrawal by participant|0
7639113|NCT01607905|26577066|P4|Overall Study|Withdrawal by participant|6
7639114|NCT01607905|26577067|P3|Overall Study|Withdrawal by participant|4
7639115|NCT01607905|26577068|P2|Overall Study|Withdrawal by participant|2
7639116|NCT01607905|26577069|P1|Overall Study|Withdrawal by participant|7
7639117|NCT01607892|26577280|P5|Overall Study|Incidence or severity of Adverse events|6
7639118|NCT01607892|26577281|P4|Overall Study|Incidence or severity of Adverse events|2
7639119|NCT01607892|26577282|P3|Overall Study|Incidence or severity of Adverse events|7
7639120|NCT01607892|26577283|P2|Overall Study|Incidence or severity of Adverse events|3
7639121|NCT01607892|26577284|P1|Overall Study|Incidence or severity of Adverse events|3
7639122|NCT01607892|26577280|P5|Overall Study|Disease progression|9
7639123|NCT01607892|26577281|P4|Overall Study|Disease progression|57
7639124|NCT01607892|26577282|P3|Overall Study|Disease progression|37
7639125|NCT01607892|26577283|P2|Overall Study|Disease progression|13
7639126|NCT01607892|26577284|P1|Overall Study|Disease progression|38
7639127|NCT01607892|26577280|P5|Overall Study|Consent withdrawn by participant|4
7639128|NCT01607892|26577281|P4|Overall Study|Consent withdrawn by participant|14
7639129|NCT01607892|26577282|P3|Overall Study|Consent withdrawn by participant|24
7639130|NCT01607892|26577283|P2|Overall Study|Consent withdrawn by participant|4
7639131|NCT01607892|26577284|P1|Overall Study|Consent withdrawn by participant|9
7639132|NCT01607892|26577280|P5|Overall Study|Non-Compliance with study procedures|0
7639133|NCT01607892|26577281|P4|Overall Study|Non-Compliance with study procedures|0
7639134|NCT01607892|26577282|P3|Overall Study|Non-Compliance with study procedures|1
7639135|NCT01607892|26577283|P2|Overall Study|Non-Compliance with study procedures|0
7639136|NCT01607892|26577284|P1|Overall Study|Non-Compliance with study procedures|0
7639137|NCT01607892|26577280|P5|Overall Study|Intercurrent illness|0
7639138|NCT01607892|26577281|P4|Overall Study|Intercurrent illness|3
7639139|NCT01607892|26577282|P3|Overall Study|Intercurrent illness|0
7639140|NCT01607892|26577283|P2|Overall Study|Intercurrent illness|0
7639141|NCT01607892|26577284|P1|Overall Study|Intercurrent illness|1
7639142|NCT01607892|26577280|P5|Overall Study|Other treatments became available|2
7639143|NCT01607892|26577281|P4|Overall Study|Other treatments became available|0
7639144|NCT01607892|26577282|P3|Overall Study|Other treatments became available|0
7639145|NCT01607892|26577283|P2|Overall Study|Other treatments became available|1
7639146|NCT01607892|26577284|P1|Overall Study|Other treatments became available|1
7639147|NCT01607892|26577280|P5|Overall Study|Investigator discretion|0
7639148|NCT01607892|26577281|P4|Overall Study|Investigator discretion|8
7639149|NCT01607892|26577282|P3|Overall Study|Investigator discretion|4
7639150|NCT01607892|26577283|P2|Overall Study|Investigator discretion|4
7639151|NCT01607892|26577284|P1|Overall Study|Investigator discretion|2
7639152|NCT01607892|26577280|P5|Overall Study|Death|3
7639153|NCT01607892|26577281|P4|Overall Study|Death|10
7639154|NCT01607892|26577282|P3|Overall Study|Death|8
7639155|NCT01607892|26577283|P2|Overall Study|Death|2
7639156|NCT01607892|26577284|P1|Overall Study|Death|4
7639157|NCT01607892|26577280|P5|Overall Study|Need of treatment not allowed per protocol|0
7639158|NCT01607892|26577281|P4|Overall Study|Need of treatment not allowed per protocol|1
7639159|NCT01607892|26577282|P3|Overall Study|Need of treatment not allowed per protocol|0
7639160|NCT01607892|26577283|P2|Overall Study|Need of treatment not allowed per protocol|0
7639161|NCT01607892|26577284|P1|Overall Study|Need of treatment not allowed per protocol|0
7639162|NCT01607593|26577595|P1|Overall Study|Other|4
7639163|NCT01607593|26577595|P1|Overall Study|Continuation|33
7639164|NCT01607593|26577595|P1|Overall Study|Lost to Follow-up|25
7639165|NCT01607593|26577595|P1|Overall Study|Lack of Efficacy|16
7639166|NCT01607593|26577595|P1|Overall Study|Adverse Event|15
7639167|NCT01607554|26577601|P1|Overall Study|Disease progression|2
7639168|NCT01607476|26577614|P3|Overall Study|Lost to Follow-up|2
7639169|NCT01607476|26577615|P2|Overall Study|Lost to Follow-up|0
7639170|NCT01607476|26577616|P1|Overall Study|Lost to Follow-up|0
7639171|NCT01607476|26577614|P3|Overall Study|Withdrawal by Subject|1
7639172|NCT01607476|26577615|P2|Overall Study|Withdrawal by Subject|0
7639173|NCT01607476|26577616|P1|Overall Study|Withdrawal by Subject|1
7639174|NCT01607398|26577710|P2|Overall Study|Severe COPD|0
7639175|NCT01607398|26577711|P1|Overall Study|Severe COPD|2
7639176|NCT01607398|26577710|P2|Overall Study|Adverse Event|2
7639177|NCT01607398|26577711|P1|Overall Study|Adverse Event|0
7639178|NCT01607346|26577755|P1|Overall Study|Adverse Event|3
7639179|NCT01607073|26577840|P1|Overall Study|Adverse Event|1
7639180|NCT01606800|26577862|P2|Overall Study|Missing completion status|0
7639181|NCT01606800|26577863|P1|Overall Study|Missing completion status|2
7639182|NCT01606800|26577862|P2|Overall Study|Participant withdrew consent|1
7639183|NCT01606800|26577863|P1|Overall Study|Participant withdrew consent|0
7639184|NCT01606800|26577862|P2|Overall Study|Adverse Event|1
7639185|NCT01606800|26577863|P1|Overall Study|Adverse Event|3
7639186|NCT01606787|26577871|P2|Overall Study|Surgery canceled|2
7639187|NCT01606787|26577872|P1|Overall Study|Surgery canceled|0
7639188|NCT01606787|26577871|P2|Overall Study|Withdrawal by Subject|5
7639189|NCT01606787|26577872|P1|Overall Study|Withdrawal by Subject|4
7639190|NCT01606761|26577883|P5|Safety Follow-up Period (Week 52-68)|Other|3
7639191|NCT01606761|26577884|P4|Safety Follow-up Period (Week 52-68)|Other|1
7639192|NCT01606761|26577885|P3|Safety Follow-up Period (Week 52-68)|Other|9
7639193|NCT01606761|26577886|P2|Safety Follow-up Period (Week 52-68)|Other|3
7639194|NCT01606761|26577887|P1|Safety Follow-up Period (Week 52-68)|Other|0
7639195|NCT01606761|26577883|P5|Safety Follow-up Period (Week 52-68)|Death|1
7639196|NCT01606761|26577884|P4|Safety Follow-up Period (Week 52-68)|Death|0
7639197|NCT01606761|26577885|P3|Safety Follow-up Period (Week 52-68)|Death|0
7639198|NCT01606761|26577886|P2|Safety Follow-up Period (Week 52-68)|Death|0
7639199|NCT01606761|26577887|P1|Safety Follow-up Period (Week 52-68)|Death|0
7639200|NCT01606761|26577883|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
7639201|NCT01606761|26577884|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
7639202|NCT01606761|26577885|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7639203|NCT01606761|26577886|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7639204|NCT01606761|26577887|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
7639205|NCT01606761|26577883|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7639206|NCT01606761|26577884|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7639207|NCT01606761|26577885|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
7639208|NCT01606761|26577886|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7639209|NCT01606761|26577887|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7639210|NCT01606761|26577883|P5|Week 24 to Week 52|Other|2
7639211|NCT01606761|26577884|P4|Week 24 to Week 52|Other|2
7639212|NCT01606761|26577885|P3|Week 24 to Week 52|Other|5
7639213|NCT01606761|26577886|P2|Week 24 to Week 52|Other|1
7639214|NCT01606761|26577887|P1|Week 24 to Week 52|Other|0
7639215|NCT01606761|26577883|P5|Week 24 to Week 52|Physician Decision|0
7639216|NCT01606761|26577884|P4|Week 24 to Week 52|Physician Decision|0
7639217|NCT01606761|26577885|P3|Week 24 to Week 52|Physician Decision|1
7639218|NCT01606761|26577886|P2|Week 24 to Week 52|Physician Decision|1
7639219|NCT01606761|26577887|P1|Week 24 to Week 52|Physician Decision|0
7639220|NCT01606761|26577883|P5|Week 24 to Week 52|Lack of Efficacy|3
7639221|NCT01606761|26577884|P4|Week 24 to Week 52|Lack of Efficacy|10
7639222|NCT01606761|26577885|P3|Week 24 to Week 52|Lack of Efficacy|7
7639223|NCT01606761|26577886|P2|Week 24 to Week 52|Lack of Efficacy|13
7639224|NCT01606761|26577887|P1|Week 24 to Week 52|Lack of Efficacy|0
7639225|NCT01606761|26577883|P5|Week 24 to Week 52|Death|0
7639226|NCT01606761|26577884|P4|Week 24 to Week 52|Death|1
7639227|NCT01606761|26577885|P3|Week 24 to Week 52|Death|2
7639228|NCT01606761|26577886|P2|Week 24 to Week 52|Death|0
7639229|NCT01606761|26577887|P1|Week 24 to Week 52|Death|0
7639230|NCT01606761|26577883|P5|Week 24 to Week 52|Adverse Event|15
7639231|NCT01606761|26577884|P4|Week 24 to Week 52|Adverse Event|3
7639232|NCT01606761|26577885|P3|Week 24 to Week 52|Adverse Event|14
7639233|NCT01606761|26577886|P2|Week 24 to Week 52|Adverse Event|11
7639234|NCT01606761|26577887|P1|Week 24 to Week 52|Adverse Event|0
7639235|NCT01606761|26577883|P5|Week 24 to Week 52|Withdrawal by Subject|0
7639236|NCT01606761|26577884|P4|Week 24 to Week 52|Withdrawal by Subject|0
7639237|NCT01606761|26577885|P3|Week 24 to Week 52|Withdrawal by Subject|3
7639238|NCT01606761|26577886|P2|Week 24 to Week 52|Withdrawal by Subject|6
7639239|NCT01606761|26577887|P1|Week 24 to Week 52|Withdrawal by Subject|0
7639240|NCT01606761|26577883|P5|Week 24 to Week 52|Lost to Follow-up|0
7639241|NCT01606761|26577884|P4|Week 24 to Week 52|Lost to Follow-up|1
7639242|NCT01606761|26577885|P3|Week 24 to Week 52|Lost to Follow-up|1
7639243|NCT01606761|26577886|P2|Week 24 to Week 52|Lost to Follow-up|1
7639244|NCT01606761|26577887|P1|Week 24 to Week 52|Lost to Follow-up|0
7639245|NCT01606761|26577883|P5|Prior to Week 24|Other|0
7639246|NCT01606761|26577884|P4|Prior to Week 24|Other|0
7639247|NCT01606761|26577885|P3|Prior to Week 24|Other|5
7639248|NCT01606761|26577886|P2|Prior to Week 24|Other|7
7639249|NCT01606761|26577887|P1|Prior to Week 24|Other|4
7639250|NCT01606761|26577883|P5|Prior to Week 24|Physician Decision|0
7639251|NCT01606761|26577884|P4|Prior to Week 24|Physician Decision|0
7639252|NCT01606761|26577885|P3|Prior to Week 24|Physician Decision|1
7639253|NCT01606761|26577886|P2|Prior to Week 24|Physician Decision|3
7639254|NCT01606761|26577887|P1|Prior to Week 24|Physician Decision|0
7639255|NCT01606761|26577883|P5|Prior to Week 24|Lack of Efficacy|0
7639256|NCT01606761|26577884|P4|Prior to Week 24|Lack of Efficacy|0
7639257|NCT01606761|26577885|P3|Prior to Week 24|Lack of Efficacy|8
7639258|NCT01606761|26577886|P2|Prior to Week 24|Lack of Efficacy|14
7639259|NCT01606761|26577887|P1|Prior to Week 24|Lack of Efficacy|15
7639260|NCT01606761|26577883|P5|Prior to Week 24|Adverse Event|0
7639261|NCT01606761|26577884|P4|Prior to Week 24|Adverse Event|0
7639262|NCT01606761|26577885|P3|Prior to Week 24|Adverse Event|22
7639263|NCT01606761|26577886|P2|Prior to Week 24|Adverse Event|18
7639264|NCT01606761|26577887|P1|Prior to Week 24|Adverse Event|11
7639265|NCT01606761|26577883|P5|Prior to Week 24|Withdrawal by Subject|0
7639266|NCT01606761|26577884|P4|Prior to Week 24|Withdrawal by Subject|0
7639267|NCT01606761|26577885|P3|Prior to Week 24|Withdrawal by Subject|9
7639268|NCT01606761|26577886|P2|Prior to Week 24|Withdrawal by Subject|10
7639269|NCT01606761|26577887|P1|Prior to Week 24|Withdrawal by Subject|12
7639270|NCT01606761|26577883|P5|Prior to Week 24|Lost to Follow-up|0
7639271|NCT01606761|26577884|P4|Prior to Week 24|Lost to Follow-up|0
7639272|NCT01606761|26577885|P3|Prior to Week 24|Lost to Follow-up|2
7639273|NCT01606761|26577886|P2|Prior to Week 24|Lost to Follow-up|3
7639274|NCT01606761|26577887|P1|Prior to Week 24|Lost to Follow-up|0
7639275|NCT01606748|26577913|P2|Overall Study|Withdrawal by Subject|0
7639276|NCT01606748|26577914|P1|Overall Study|Withdrawal by Subject|1
7639277|NCT01606748|26577913|P2|Overall Study|Progressive Disease|0
7639278|NCT01606748|26577914|P1|Overall Study|Progressive Disease|1
7639279|NCT01606748|26577913|P2|Overall Study|Adverse Event|0
7639280|NCT01606748|26577914|P1|Overall Study|Adverse Event|1
7639281|NCT01606670|26577966|P1|Overall Study|Other Reason|2
7639282|NCT01606670|26577966|P1|Overall Study|Withdrawal by Subject|3
7639283|NCT01606670|26577966|P1|Overall Study|Lost to Follow-up|3
7639284|NCT01606670|26577966|P1|Overall Study|Lack of Efficacy|2
7639285|NCT01606670|26577966|P1|Overall Study|Adverse Event|6
7639286|NCT01606319|26577976|P2|Overall Study|Adverse Event|4
7639287|NCT01606319|26577977|P1|Overall Study|Adverse Event|1
7639288|NCT01606319|26577976|P2|Overall Study|Lack of Efficacy|8
7639289|NCT01606319|26577977|P1|Overall Study|Lack of Efficacy|6
7639290|NCT01606319|26577976|P2|Overall Study|Physician Decision|2
7639291|NCT01606319|26577977|P1|Overall Study|Physician Decision|1
7639292|NCT01606319|26577976|P2|Overall Study|Withdrawal by Subject|12
7639293|NCT01606319|26577977|P1|Overall Study|Withdrawal by Subject|9
7639294|NCT01606319|26577976|P2|Overall Study|Lost to Follow-up|14
7639295|NCT01606319|26577977|P1|Overall Study|Lost to Follow-up|17
7639296|NCT01606306|26577995|P6|Overall Study|Physician Decision|0
7639297|NCT01606306|26577996|P5|Overall Study|Physician Decision|0
7639298|NCT01606306|26577997|P4|Overall Study|Physician Decision|0
7639299|NCT01606306|26577998|P3|Overall Study|Physician Decision|0
7639300|NCT01606306|26577999|P2|Overall Study|Physician Decision|2
7639301|NCT01606306|26578000|P1|Overall Study|Physician Decision|1
7639302|NCT01606306|26577995|P6|Overall Study|Withdrawal by Subject|4
7639303|NCT01606306|26577996|P5|Overall Study|Withdrawal by Subject|5
7639304|NCT01606306|26577997|P4|Overall Study|Withdrawal by Subject|4
7639305|NCT01606306|26577998|P3|Overall Study|Withdrawal by Subject|4
7639306|NCT01606306|26577999|P2|Overall Study|Withdrawal by Subject|3
7639307|NCT01606306|26578000|P1|Overall Study|Withdrawal by Subject|4
7639308|NCT01606306|26577995|P6|Overall Study|Lost to Follow-up|5
7639309|NCT01606306|26577996|P5|Overall Study|Lost to Follow-up|3
7639310|NCT01606306|26577997|P4|Overall Study|Lost to Follow-up|4
7639311|NCT01606306|26577998|P3|Overall Study|Lost to Follow-up|5
7639312|NCT01606306|26577999|P2|Overall Study|Lost to Follow-up|4
7639313|NCT01606306|26578000|P1|Overall Study|Lost to Follow-up|7
7639314|NCT01606306|26577995|P6|Overall Study|Adverse Event|0
7639315|NCT01606306|26577996|P5|Overall Study|Adverse Event|2
7639316|NCT01606306|26577997|P4|Overall Study|Adverse Event|1
7639317|NCT01606306|26577998|P3|Overall Study|Adverse Event|1
7639318|NCT01606306|26577999|P2|Overall Study|Adverse Event|0
7639319|NCT01606306|26578000|P1|Overall Study|Adverse Event|1
7639320|NCT01606306|26577995|P6|Overall Study|Lack of Efficacy|2
7639321|NCT01606306|26577996|P5|Overall Study|Lack of Efficacy|1
7639322|NCT01606306|26577997|P4|Overall Study|Lack of Efficacy|4
7639323|NCT01606306|26577998|P3|Overall Study|Lack of Efficacy|4
7639324|NCT01606306|26577999|P2|Overall Study|Lack of Efficacy|1
7639325|NCT01606306|26578000|P1|Overall Study|Lack of Efficacy|2
7639326|NCT01606254|26578010|P4|Overall Study|Adverse Event|1
7639327|NCT01606254|26578011|P3|Overall Study|Adverse Event|0
7639328|NCT01606254|26578012|P2|Overall Study|Adverse Event|1
7639329|NCT01606254|26578013|P1|Overall Study|Adverse Event|1
7639330|NCT01606254|26578010|P4|Overall Study|Withdrawal by Subject|2
7639331|NCT01606254|26578011|P3|Overall Study|Withdrawal by Subject|0
7639332|NCT01606254|26578012|P2|Overall Study|Withdrawal by Subject|3
7639333|NCT01606254|26578013|P1|Overall Study|Withdrawal by Subject|1
7639334|NCT01606228|26578095|P1|Overall Study|Adverse Event|1
7639335|NCT01606228|26578095|P1|Overall Study|Lack of Efficacy|2
7639336|NCT01606228|26578095|P1|Overall Study|Non-compliant|3
7639337|NCT01606228|26578095|P1|Overall Study|Withdrawal by Subject|3
7639338|NCT01606228|26578095|P1|Overall Study|Lost to Follow-up|20
7639339|NCT01606202|26578112|P2|Overall Study|Problems with administration|1
7639340|NCT01606202|26578113|P1|Overall Study|Problems with administration|0
7639341|NCT01606202|26578112|P2|Overall Study|Personal problems|1
7639342|NCT01606202|26578113|P1|Overall Study|Personal problems|0
7639343|NCT01606202|26578112|P2|Overall Study|Withdrawal by Subject|1
7639344|NCT01606202|26578113|P1|Overall Study|Withdrawal by Subject|2
7639345|NCT01606202|26578112|P2|Overall Study|Adverse Event|0
7639346|NCT01606202|26578113|P1|Overall Study|Adverse Event|5
7639347|NCT01606189|26578145|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
7639348|NCT01606189|26578146|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7639349|NCT01606189|26578147|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7639350|NCT01606189|26578148|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7639351|NCT01606189|26578149|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7639352|NCT01606189|26578150|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7639353|NCT01606189|26578145|P6|Second Intenvention (14-20 Days)|Adverse Event|1
7639354|NCT01606189|26578146|P5|Second Intenvention (14-20 Days)|Adverse Event|0
7639355|NCT01606189|26578147|P4|Second Intenvention (14-20 Days)|Adverse Event|0
7639356|NCT01606189|26578148|P3|Second Intenvention (14-20 Days)|Adverse Event|0
7639357|NCT01606189|26578149|P2|Second Intenvention (14-20 Days)|Adverse Event|0
7639358|NCT01606189|26578150|P1|Second Intenvention (14-20 Days)|Adverse Event|0
7639359|NCT01606176|26578184|P2|Overall Study|Withdrawal by Subject|0
7639360|NCT01606176|26578185|P1|Overall Study|Withdrawal by Subject|1
7639361|NCT01606176|26578184|P2|Overall Study|Disease progression|0
7639362|NCT01606176|26578185|P1|Overall Study|Disease progression|1
7639363|NCT01606176|26578184|P2|Overall Study|Adverse Event|3
7639364|NCT01606176|26578185|P1|Overall Study|Adverse Event|2
7639365|NCT01606137|26578230|P1|Overall Study|Unable to collect consistent data|1
7639366|NCT01606137|26578230|P1|Overall Study|Patient moving|1
7639367|NCT01606137|26578230|P1|Overall Study|Unable to tolerate study med. taste|1
7639368|NCT01606137|26578230|P1|Overall Study|Personal reasons|1
7639369|NCT01606137|26578230|P1|Overall Study|Patient leaving country|1
7639370|NCT01606137|26578230|P1|Overall Study|Wanted to try another treatment|1
7639371|NCT01606137|26578230|P1|Overall Study|Not enough improvement|4
7639372|NCT01606137|26578230|P1|Overall Study|Spray causes nausea|1
7639373|NCT01606137|26578230|P1|Overall Study|Increased bilirubin|1
7639374|NCT01606137|26578230|P1|Overall Study|multiple sclerosis less stable|1
7639375|NCT01606137|26578230|P1|Overall Study|Issues with driving|4
7639376|NCT01606137|26578230|P1|Overall Study|Decreased/no pain|4
7639377|NCT01606137|26578230|P1|Overall Study|Death|1
7639378|NCT01606137|26578230|P1|Overall Study|Patient non-compliance|9
7639379|NCT01606137|26578230|P1|Overall Study|Protocol Violation|1
7639380|NCT01606137|26578230|P1|Overall Study|Lost to Follow-up|15
7639381|NCT01606137|26578230|P1|Overall Study|Lack of Efficacy|56
7639382|NCT01606137|26578230|P1|Overall Study|Withdrawal by Subject|74
7639383|NCT01606137|26578230|P1|Overall Study|Adverse Event|85
7639384|NCT01606007|26578264|P3|Overall Study|Poor/Non-compliance|0
7639385|NCT01606007|26578265|P2|Overall Study|Poor/Non-compliance|0
7639386|NCT01606007|26578266|P1|Overall Study|Poor/Non-compliance|1
7639387|NCT01606007|26578264|P3|Overall Study|Lost to Follow-up|5
7639388|NCT01606007|26578265|P2|Overall Study|Lost to Follow-up|8
7639389|NCT01606007|26578266|P1|Overall Study|Lost to Follow-up|6
7639390|NCT01606007|26578264|P3|Overall Study|discontinue study treatment|1
7639391|NCT01606007|26578265|P2|Overall Study|discontinue study treatment|2
7639392|NCT01606007|26578266|P1|Overall Study|discontinue study treatment|0
7639393|NCT01606007|26578264|P3|Overall Study|Adverse Event|1
7639394|NCT01606007|26578265|P2|Overall Study|Adverse Event|1
7639395|NCT01606007|26578266|P1|Overall Study|Adverse Event|0
7639396|NCT01606007|26578264|P3|Overall Study|Withdrawal by Subject|1
7639397|NCT01606007|26578265|P2|Overall Study|Withdrawal by Subject|6
7639398|NCT01606007|26578266|P1|Overall Study|Withdrawal by Subject|8
7639399|NCT01606007|26578264|P3|Overall Study|Pregnancy|1
7639400|NCT01606007|26578265|P2|Overall Study|Pregnancy|1
7639401|NCT01606007|26578266|P1|Overall Study|Pregnancy|0
7639402|NCT01606007|26578264|P3|Overall Study|Reason 'Other' in the protocol|1
7639403|NCT01606007|26578265|P2|Overall Study|Reason 'Other' in the protocol|1
7639404|NCT01606007|26578266|P1|Overall Study|Reason 'Other' in the protocol|0
7639405|NCT01605916|26578301|P5|Overall Study|Withdrawal by Subject|2
7639406|NCT01605916|26578302|P4|Overall Study|Withdrawal by Subject|0
7639407|NCT01605916|26578303|P3|Overall Study|Withdrawal by Subject|0
7639408|NCT01605916|26578304|P2|Overall Study|Withdrawal by Subject|1
7639409|NCT01605916|26578305|P1|Overall Study|Withdrawal by Subject|1
7639410|NCT01605916|26578301|P5|Overall Study|Lack of Efficacy|4
7639411|NCT01605916|26578302|P4|Overall Study|Lack of Efficacy|5
7639412|NCT01605916|26578303|P3|Overall Study|Lack of Efficacy|3
7639413|NCT01605916|26578304|P2|Overall Study|Lack of Efficacy|3
7639414|NCT01605916|26578305|P1|Overall Study|Lack of Efficacy|2
7639415|NCT01605916|26578301|P5|Overall Study|Adverse Event|0
7639416|NCT01605916|26578302|P4|Overall Study|Adverse Event|1
7639417|NCT01605916|26578303|P3|Overall Study|Adverse Event|0
7639418|NCT01605916|26578304|P2|Overall Study|Adverse Event|0
7639419|NCT01605916|26578305|P1|Overall Study|Adverse Event|1
7639420|NCT01605877|26578402|P1|Overall Study|Withdrawal by Subject|1
7639421|NCT01605825|26578466|P2|Overall Study|Non-Compliance with Protocol|0
7639422|NCT01605825|26578467|P1|Overall Study|Non-Compliance with Protocol|3
7639423|NCT01605825|26578466|P2|Overall Study|Non-Compliance -Investigational Drug|0
7639424|NCT01605825|26578467|P1|Overall Study|Non-Compliance -Investigational Drug|3
7639425|NCT01605825|26578466|P2|Overall Study|Withdrawal by Subject|1
7639426|NCT01605825|26578467|P1|Overall Study|Withdrawal by Subject|0
7639427|NCT01605825|26578466|P2|Overall Study|Adverse Event|2
7639428|NCT01605825|26578467|P1|Overall Study|Adverse Event|4
7639429|NCT01605799|26578475|P2|Overall Study|Withdrawal by Subject|1
7639430|NCT01605799|26578476|P1|Overall Study|Withdrawal by Subject|2
7639431|NCT01605617|26578491|P2|Washout Period of 4 Weeks|Study Terminated|1
7639432|NCT01605617|26578492|P1|Washout Period of 4 Weeks|Study Terminated|2
7639433|NCT01605617|26578491|P2|First Intervention|Adverse Event|1
7639434|NCT01605617|26578492|P1|First Intervention|Adverse Event|0
7639435|NCT01605461|26578551|P1|Overall Study|Withdrawal by Subject|1
7639436|NCT01605461|26578551|P1|Overall Study|Lost to Follow-up|3
7639437|NCT01605396|26578610|P2|Overall Study|Transfer Off Study|5
7639438|NCT01605396|26578611|P1|Overall Study|Transfer Off Study|4
7639439|NCT01605396|26578610|P2|Overall Study|Withdrawal by Subject|2
7639440|NCT01605396|26578611|P1|Overall Study|Withdrawal by Subject|4
7639441|NCT01605396|26578610|P2|Overall Study|Progressive Disease|27
7639442|NCT01605396|26578611|P1|Overall Study|Progressive Disease|23
7639443|NCT01605396|26578610|P2|Overall Study|Physician Decision|2
7639444|NCT01605396|26578611|P1|Overall Study|Physician Decision|2
7639445|NCT01605396|26578610|P2|Overall Study|Non-Compliance With Study Drug|1
7639446|NCT01605396|26578611|P1|Overall Study|Non-Compliance With Study Drug|1
7639447|NCT01605396|26578610|P2|Overall Study|Lost to Follow-up|0
7639448|NCT01605396|26578611|P1|Overall Study|Lost to Follow-up|1
7639449|NCT01605396|26578610|P2|Overall Study|Adverse Event|3
7639450|NCT01605396|26578611|P1|Overall Study|Adverse Event|5
7639451|NCT01605370|26578625|P2|Overall Study|Adverse Event|0
7639452|NCT01605370|26578626|P1|Overall Study|Adverse Event|1
7639453|NCT01605227|26578661|P2|Overall Study|Dose Held >6 weeks|1
7639454|NCT01605227|26578662|P1|Overall Study|Dose Held >6 weeks|0
7639455|NCT01605227|26578661|P2|Overall Study|Subject Decision|1
7639456|NCT01605227|26578662|P1|Overall Study|Subject Decision|0
7639457|NCT01605227|26578661|P2|Overall Study|Started New Therapy|0
7639458|NCT01605227|26578662|P1|Overall Study|Started New Therapy|1
7639459|NCT01605227|26578661|P2|Overall Study|Sponsor Decision|0
7639460|NCT01605227|26578662|P1|Overall Study|Sponsor Decision|2
7639461|NCT01605227|26578661|P2|Overall Study|Withdrawal by Subject|14
7639462|NCT01605227|26578662|P1|Overall Study|Withdrawal by Subject|18
7639463|NCT01605227|26578661|P2|Overall Study|Physician Decision|7
7639464|NCT01605227|26578662|P1|Overall Study|Physician Decision|9
7639465|NCT01605227|26578661|P2|Overall Study|Protocol Violation|0
7639466|NCT01605227|26578662|P1|Overall Study|Protocol Violation|1
7639467|NCT01605227|26578661|P2|Overall Study|Lost to Follow-up|0
7639468|NCT01605227|26578662|P1|Overall Study|Lost to Follow-up|1
7639469|NCT01605227|26578661|P2|Overall Study|Clinical Deterioration|133
7639470|NCT01605227|26578662|P1|Overall Study|Clinical Deterioration|227
7639471|NCT01605227|26578661|P2|Overall Study|Progressive Disease|128
7639472|NCT01605227|26578662|P1|Overall Study|Progressive Disease|132
7639473|NCT01605227|26578661|P2|Overall Study|Adverse Event|42
7639474|NCT01605227|26578662|P1|Overall Study|Adverse Event|228
7639475|NCT01605227|26578661|P2|Overall Study|Did not receive study treatment|3
7639476|NCT01605227|26578662|P1|Overall Study|Did not receive study treatment|2
7639477|NCT01605136|26578674|P2|Safety Follow-Up Period|Withdrawal by Subject|2
7639478|NCT01605136|26578675|P1|Safety Follow-Up Period|Withdrawal by Subject|1
7639479|NCT01605136|26578674|P2|Study Period|Lost to Follow-up|2
7639480|NCT01605136|26578675|P1|Study Period|Lost to Follow-up|0
7639481|NCT01605136|26578674|P2|Study Period|Physician Decision|1
7639482|NCT01605136|26578675|P1|Study Period|Physician Decision|1
7639483|NCT01605136|26578674|P2|Study Period|Withdrawal by Subject|0
7639484|NCT01605136|26578675|P1|Study Period|Withdrawal by Subject|2
7639485|NCT01605097|26578693|P1|Overall Study|Protocol Violation|1
7639486|NCT01605071|26578701|P2|Overall Study|Withdrawal by Subject|2
7639487|NCT01605071|26578702|P1|Overall Study|Withdrawal by Subject|3
7639488|NCT01605019|26578727|P2|Overall Study|pt did not meet transplant endpoint|0
7639489|NCT01605019|26578728|P1|Overall Study|pt did not meet transplant endpoint|3
7639490|NCT01604941|26578738|P6|Overall Study|Early Study Termination|0
7639491|NCT01604941|26578739|P5|Overall Study|Early Study Termination|0
7639492|NCT01604941|26578740|P4|Overall Study|Early Study Termination|3
7639493|NCT01604941|26578741|P3|Overall Study|Early Study Termination|3
7639494|NCT01604941|26578742|P2|Overall Study|Early Study Termination|2
7639495|NCT01604941|26578743|P1|Overall Study|Early Study Termination|9
7639496|NCT01604941|26578738|P6|Overall Study|Participant Decision|2
7639497|NCT01604941|26578739|P5|Overall Study|Participant Decision|0
7639498|NCT01604941|26578740|P4|Overall Study|Participant Decision|0
7639499|NCT01604941|26578741|P3|Overall Study|Participant Decision|0
7639500|NCT01604941|26578742|P2|Overall Study|Participant Decision|0
7639501|NCT01604941|26578743|P1|Overall Study|Participant Decision|0
7639502|NCT01604941|26578738|P6|Overall Study|Non-compliance|0
7639503|NCT01604941|26578739|P5|Overall Study|Non-compliance|0
7639504|NCT01604941|26578740|P4|Overall Study|Non-compliance|0
7639505|NCT01604941|26578741|P3|Overall Study|Non-compliance|0
7639506|NCT01604941|26578742|P2|Overall Study|Non-compliance|0
7639507|NCT01604941|26578743|P1|Overall Study|Non-compliance|1
7639508|NCT01604941|26578738|P6|Overall Study|Adverse Event|5
7639509|NCT01604941|26578739|P5|Overall Study|Adverse Event|1
7639510|NCT01604941|26578740|P4|Overall Study|Adverse Event|0
7639511|NCT01604941|26578741|P3|Overall Study|Adverse Event|0
7639512|NCT01604941|26578742|P2|Overall Study|Adverse Event|2
7639513|NCT01604941|26578743|P1|Overall Study|Adverse Event|1
7639514|NCT01604850|26578771|P2|Overall Study|Subject withdrew consent|0
7639515|NCT01604850|26578772|P1|Overall Study|Subject withdrew consent|1
7639516|NCT01604850|26578771|P2|Overall Study|Lost to Follow-up|0
7639517|NCT01604850|26578772|P1|Overall Study|Lost to Follow-up|1
7639518|NCT01604850|26578771|P2|Overall Study|Efficacy Failure|29
7639519|NCT01604850|26578772|P1|Overall Study|Efficacy Failure|50
7639520|NCT01604850|26578771|P2|Overall Study|Enrolled but never treated|1
7639521|NCT01604850|26578772|P1|Overall Study|Enrolled but never treated|0
7639522|NCT01604824|26578792|P6|Open-label Extension (OLE) Period|Refused to come into office|0
7639523|NCT01604824|26578793|P5|Open-label Extension (OLE) Period|Refused to come into office|1
7639524|NCT01604824|26578794|P4|Open-label Extension (OLE) Period|Refused to come into office|0
7639525|NCT01604824|26578795|P3|Open-label Extension (OLE) Period|Refused to come into office|0
7639526|NCT01604824|26578796|P2|Open-label Extension (OLE) Period|Refused to come into office|0
7639527|NCT01604824|26578797|P1|Open-label Extension (OLE) Period|Refused to come into office|0
7639528|NCT01604824|26578792|P6|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7639529|NCT01604824|26578793|P5|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
7639530|NCT01604824|26578794|P4|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7639531|NCT01604824|26578795|P3|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7639532|NCT01604824|26578796|P2|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7639533|NCT01604824|26578797|P1|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7639534|NCT01604785|26578827|P2|Overall Study|Repeat Visits Not Included in Analysis|1
7639535|NCT01604785|26578828|P1|Overall Study|Repeat Visits Not Included in Analysis|7
7639536|NCT01604408|26578847|P2|Observation Period|Withdrawal by Subject|2
7639537|NCT01604408|26578848|P1|Observation Period|Withdrawal by Subject|0
7639538|NCT01604408|26578847|P2|Observation Period|Adverse Event|1
7639539|NCT01604408|26578848|P1|Observation Period|Adverse Event|1
7639540|NCT01604408|26578847|P2|Treatment Period 6|Sponsor decision|1
7639541|NCT01604408|26578848|P1|Treatment Period 6|Sponsor decision|0
7639542|NCT01604408|26578847|P2|Treatment Period 6|Adverse Event|0
7639543|NCT01604408|26578848|P1|Treatment Period 6|Adverse Event|2
7639544|NCT01604408|26578847|P2|Treatment Period 6|Lost to Follow-up|1
7639545|NCT01604408|26578848|P1|Treatment Period 6|Lost to Follow-up|0
7639546|NCT01604408|26578847|P2|Treatment Period 5|Adverse Event|0
7639547|NCT01604408|26578848|P1|Treatment Period 5|Adverse Event|4
7639548|NCT01604408|26578847|P2|Treatment Period 4|Adverse Event|1
7639549|NCT01604408|26578848|P1|Treatment Period 4|Adverse Event|0
7639550|NCT01604408|26578847|P2|Treatment Period 4|Withdrawal by Subject|1
7639551|NCT01604408|26578848|P1|Treatment Period 4|Withdrawal by Subject|2
7639552|NCT01604408|26578847|P2|Treatment Period 4|Death|0
7639553|NCT01604408|26578848|P1|Treatment Period 4|Death|1
7639554|NCT01604408|26578847|P2|Treatment Period 3|Sponsor Decision|0
7639555|NCT01604408|26578848|P1|Treatment Period 3|Sponsor Decision|1
7639556|NCT01604408|26578847|P2|Treatment Period 3|Withdrawal by Subject|1
7639557|NCT01604408|26578848|P1|Treatment Period 3|Withdrawal by Subject|3
7639558|NCT01604408|26578847|P2|Treatment Period 3|Adverse Event|3
7639559|NCT01604408|26578848|P1|Treatment Period 3|Adverse Event|0
7639560|NCT01604408|26578847|P2|Treatment Period 3|Protocol Violation|1
7639561|NCT01604408|26578848|P1|Treatment Period 3|Protocol Violation|1
7639562|NCT01604408|26578847|P2|Treatment Period 2|Adverse Event|1
7639563|NCT01604408|26578848|P1|Treatment Period 2|Adverse Event|0
7639564|NCT01604408|26578847|P2|Treatment Period 2|Protocol Violation|0
7639565|NCT01604408|26578848|P1|Treatment Period 2|Protocol Violation|1
7639566|NCT01604408|26578847|P2|Treatment Period 2|Withdrawal by Subject|1
7639567|NCT01604408|26578848|P1|Treatment Period 2|Withdrawal by Subject|1
7639568|NCT01604408|26578847|P2|Treatment Period 1|Protocol Violation|1
7639569|NCT01604408|26578848|P1|Treatment Period 1|Protocol Violation|0
7639570|NCT01604343|26578863|P5|Safety Follow-up Period (Week 104-120)|Other|14
7639571|NCT01604343|26578864|P4|Safety Follow-up Period (Week 104-120)|Other|6
7639572|NCT01604343|26578865|P3|Safety Follow-up Period (Week 104-120)|Other|20
7639573|NCT01604343|26578866|P2|Safety Follow-up Period (Week 104-120)|Other|2
7639574|NCT01604343|26578867|P1|Safety Follow-up Period (Week 104-120)|Other|15
7639575|NCT01604343|26578863|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
7639576|NCT01604343|26578864|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
7639577|NCT01604343|26578865|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
7639578|NCT01604343|26578866|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
7639579|NCT01604343|26578867|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
7639580|NCT01604343|26578863|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7639581|NCT01604343|26578864|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7639582|NCT01604343|26578865|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
7639583|NCT01604343|26578866|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7639584|NCT01604343|26578867|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
7639585|NCT01604343|26578863|P5|Week 52 to Week 104|Other|3
7639586|NCT01604343|26578864|P4|Week 52 to Week 104|Other|6
7639587|NCT01604343|26578865|P3|Week 52 to Week 104|Other|11
7639588|NCT01604343|26578866|P2|Week 52 to Week 104|Other|11
7639589|NCT01604343|26578867|P1|Week 52 to Week 104|Other|0
7639590|NCT01604343|26578863|P5|Week 52 to Week 104|Pregnancy|1
7639591|NCT01604343|26578864|P4|Week 52 to Week 104|Pregnancy|2
7639592|NCT01604343|26578865|P3|Week 52 to Week 104|Pregnancy|1
7639593|NCT01604343|26578866|P2|Week 52 to Week 104|Pregnancy|0
7639594|NCT01604343|26578867|P1|Week 52 to Week 104|Pregnancy|0
7639595|NCT01604343|26578863|P5|Week 52 to Week 104|Physician Decision|2
7639596|NCT01604343|26578864|P4|Week 52 to Week 104|Physician Decision|0
7639597|NCT01604343|26578865|P3|Week 52 to Week 104|Physician Decision|0
7639598|NCT01604343|26578866|P2|Week 52 to Week 104|Physician Decision|1
7639599|NCT01604343|26578867|P1|Week 52 to Week 104|Physician Decision|0
7639600|NCT01604343|26578863|P5|Week 52 to Week 104|Lack of Efficacy|3
7639601|NCT01604343|26578864|P4|Week 52 to Week 104|Lack of Efficacy|2
7639602|NCT01604343|26578865|P3|Week 52 to Week 104|Lack of Efficacy|11
7639603|NCT01604343|26578866|P2|Week 52 to Week 104|Lack of Efficacy|6
7639604|NCT01604343|26578867|P1|Week 52 to Week 104|Lack of Efficacy|0
7639605|NCT01604343|26578863|P5|Week 52 to Week 104|Death|0
7639606|NCT01604343|26578864|P4|Week 52 to Week 104|Death|5
7639607|NCT01604343|26578865|P3|Week 52 to Week 104|Death|2
7639608|NCT01604343|26578866|P2|Week 52 to Week 104|Death|4
7639609|NCT01604343|26578867|P1|Week 52 to Week 104|Death|0
7639610|NCT01604343|26578863|P5|Week 52 to Week 104|Adverse Event|27
7639611|NCT01604343|26578864|P4|Week 52 to Week 104|Adverse Event|21
7639612|NCT01604343|26578865|P3|Week 52 to Week 104|Adverse Event|26
7639613|NCT01604343|26578866|P2|Week 52 to Week 104|Adverse Event|12
7639614|NCT01604343|26578867|P1|Week 52 to Week 104|Adverse Event|0
7639615|NCT01604343|26578863|P5|Week 52 to Week 104|Withdrawal by Subject|4
7639616|NCT01604343|26578864|P4|Week 52 to Week 104|Withdrawal by Subject|8
7639617|NCT01604343|26578865|P3|Week 52 to Week 104|Withdrawal by Subject|12
7639618|NCT01604343|26578866|P2|Week 52 to Week 104|Withdrawal by Subject|7
7639619|NCT01604343|26578867|P1|Week 52 to Week 104|Withdrawal by Subject|0
7639620|NCT01604343|26578863|P5|Week 52 to Week 104|Lost to Follow-up|1
7639621|NCT01604343|26578864|P4|Week 52 to Week 104|Lost to Follow-up|2
7639622|NCT01604343|26578865|P3|Week 52 to Week 104|Lost to Follow-up|4
7639623|NCT01604343|26578866|P2|Week 52 to Week 104|Lost to Follow-up|2
7639624|NCT01604343|26578867|P1|Week 52 to Week 104|Lost to Follow-up|0
7639625|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Other|6
7639626|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Other|0
7639627|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Other|10
7639628|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Other|0
7639629|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Other|15
7639630|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
7639631|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
7639632|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
7639633|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
7639634|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
7639635|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
7639636|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
7639718|NCT01603459|26579248|P1|Overall Study|Administrative reason|1
7639637|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
7639638|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
7639639|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
7639640|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
7639641|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7639642|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
7639643|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7639644|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
7639645|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Death|4
7639646|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Death|0
7639647|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Death|2
7639648|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Death|0
7639649|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Death|5
7639650|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
7639651|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
7639652|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
7639653|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
7639654|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
7639655|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
7639656|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7639657|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
7639658|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7639659|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
7639660|NCT01604343|26578863|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
7639661|NCT01604343|26578864|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7639662|NCT01604343|26578865|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
7639663|NCT01604343|26578866|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7639664|NCT01604343|26578867|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
7639665|NCT01604278|26579032|P2|Overall Study|Protocol Deviation|3
7639666|NCT01604278|26579033|P1|Overall Study|Protocol Deviation|5
7639667|NCT01604278|26579032|P2|Overall Study|Adverse Event|5
7639668|NCT01604278|26579033|P1|Overall Study|Adverse Event|3
7639669|NCT01604278|26579032|P2|Overall Study|Withdrawal by Subject|3
7639670|NCT01604278|26579033|P1|Overall Study|Withdrawal by Subject|3
7639671|NCT01604278|26579032|P2|Overall Study|Administrative problems|1
7639672|NCT01604278|26579033|P1|Overall Study|Administrative problems|2
7639673|NCT01604278|26579032|P2|Overall Study|Lost to Follow-up|0
7639674|NCT01604278|26579033|P1|Overall Study|Lost to Follow-up|1
7639675|NCT01604278|26579032|P2|Overall Study|Lack of Efficacy|1
7639676|NCT01604278|26579033|P1|Overall Study|Lack of Efficacy|0
7639677|NCT01604265|26579059|P2|Overall Study|Withdrawal by Subject|0
7639678|NCT01604265|26579060|P1|Overall Study|Withdrawal by Subject|1
7639679|NCT01604265|26579059|P2|Overall Study|Adverse Event|0
7639680|NCT01604265|26579060|P1|Overall Study|Adverse Event|1
7639681|NCT01603875|26579171|P3|Overall Study|Protocol Violation|0
7639682|NCT01603875|26579172|P2|Overall Study|Protocol Violation|1
7639683|NCT01603875|26579173|P1|Overall Study|Protocol Violation|0
7639684|NCT01603875|26579171|P3|Overall Study|Lost to Follow-up|6
7639685|NCT01603875|26579172|P2|Overall Study|Lost to Follow-up|3
7639686|NCT01603875|26579173|P1|Overall Study|Lost to Follow-up|4
7639687|NCT01603875|26579171|P3|Overall Study|Preexisting rabies antibody|3
7639688|NCT01603875|26579172|P2|Overall Study|Preexisting rabies antibody|4
7639689|NCT01603875|26579173|P1|Overall Study|Preexisting rabies antibody|3
7639690|NCT01603641|26579193|P1|Overall Study|Other Miscellaneous Reasons|6
7639691|NCT01603641|26579193|P1|Overall Study|Personal Reasons|18
7639692|NCT01603641|26579193|P1|Overall Study|Lost to Follow-up|6
7639693|NCT01603641|26579193|P1|Overall Study|Lack of Efficacy|1
7639694|NCT01603641|26579193|P1|Overall Study|Adverse Event|1
7639695|NCT01603641|26579193|P1|Overall Study|Did not Receive Treatment|3
7639696|NCT01603628|26579200|P3|Overall Study|Other Miscellaneous Reason|0
7639697|NCT01603628|26579201|P2|Overall Study|Other Miscellaneous Reason|0
7639698|NCT01603628|26579202|P1|Overall Study|Other Miscellaneous Reason|1
7639699|NCT01603628|26579200|P3|Overall Study|Lost to Follow-up|0
7639700|NCT01603628|26579201|P2|Overall Study|Lost to Follow-up|1
7639701|NCT01603628|26579202|P1|Overall Study|Lost to Follow-up|0
7639702|NCT01603628|26579200|P3|Overall Study|Protocol Violation|0
7639703|NCT01603628|26579201|P2|Overall Study|Protocol Violation|1
7639704|NCT01603628|26579202|P1|Overall Study|Protocol Violation|1
7639705|NCT01603628|26579200|P3|Overall Study|Personal Reasons|2
7639706|NCT01603628|26579201|P2|Overall Study|Personal Reasons|1
7639707|NCT01603628|26579202|P1|Overall Study|Personal Reasons|1
7639708|NCT01603615|26579219|P1|Overall Study|Other Miscellaneous|1
7639709|NCT01603615|26579219|P1|Overall Study|Personal Reasons|17
7639710|NCT01603615|26579219|P1|Overall Study|Lost to Follow-up|9
7639711|NCT01603615|26579219|P1|Overall Study|Did not Receive Treatment|7
7639712|NCT01603602|26579226|P3|Overall Study|Personal Reasons|1
7639713|NCT01603602|26579227|P2|Overall Study|Personal Reasons|0
7639714|NCT01603602|26579228|P1|Overall Study|Personal Reasons|1
7639715|NCT01603602|26579226|P3|Overall Study|Adverse Event|0
7639716|NCT01603602|26579227|P2|Overall Study|Adverse Event|0
7639717|NCT01603602|26579228|P1|Overall Study|Adverse Event|1
7639719|NCT01603459|26579248|P1|Overall Study|Non-compliance|1
7639720|NCT01603459|26579248|P1|Overall Study|Predefined discontinuation criteria|3
7639721|NCT01603459|26579248|P1|Overall Study|Lost to Follow-up|3
7639722|NCT01603459|26579248|P1|Overall Study|Withdrawal by Subject|5
7639723|NCT01603459|26579248|P1|Overall Study|Adverse Event|5
7639724|NCT01603394|26579399|P1|Overall Study|Adverse Event|1
7639725|NCT01603355|26579453|P1|Overall Study|Lack of Efficacy|2
7639726|NCT01603277|26579459|P2|Overall Study|Non-Compliance|1
7639727|NCT01603277|26579460|P1|Overall Study|Non-Compliance|2
7639728|NCT01603277|26579459|P2|Overall Study|Withdrawal by Subject|4
7639729|NCT01603277|26579460|P1|Overall Study|Withdrawal by Subject|5
7639730|NCT01603277|26579459|P2|Overall Study|Protocol Violation|10
7639731|NCT01603277|26579460|P1|Overall Study|Protocol Violation|6
7639732|NCT01603277|26579459|P2|Overall Study|Physician Decision|1
7639733|NCT01603277|26579460|P1|Overall Study|Physician Decision|0
7639734|NCT01603277|26579459|P2|Overall Study|Adverse Event|2
7639735|NCT01603277|26579460|P1|Overall Study|Adverse Event|1
7639736|NCT01603121|26579466|P2|Second Intervention, 10 Hours|Adverse Event|0
7639737|NCT01603121|26579467|P1|Second Intervention, 10 Hours|Adverse Event|1
7639738|NCT01603082|26579479|P2|Overall Study|Failed inclusion criterion after dosed|0
7639739|NCT01603082|26579480|P1|Overall Study|Failed inclusion criterion after dosed|1
7639740|NCT01603082|26579479|P2|Overall Study|Withdrawal by Subject|0
7639741|NCT01603082|26579480|P1|Overall Study|Withdrawal by Subject|1
7639742|NCT01603082|26579479|P2|Overall Study|Adverse Event|1
7639743|NCT01603082|26579480|P1|Overall Study|Adverse Event|0
7639744|NCT01603043|26579521|P2|Overall Study|Study Futility|3
7639745|NCT01603043|26579522|P1|Overall Study|Study Futility|7
7639746|NCT01602965|26579534|P2|Overall Study|Lost to Follow-up|2
7639747|NCT01602965|26579535|P1|Overall Study|Lost to Follow-up|4
7639748|NCT01602744|26579543|P2|Overall Study|Lost to Follow-up|8
7639749|NCT01602744|26579544|P1|Overall Study|Lost to Follow-up|13
7639750|NCT01602744|26579543|P2|Overall Study|Death|15
7639751|NCT01602744|26579544|P1|Overall Study|Death|17
7639752|NCT01602666|26579602|P2|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
7639753|NCT01602666|26579603|P1|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
7639754|NCT01602666|26579602|P2|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
7639755|NCT01602666|26579603|P1|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
7639756|NCT01602666|26579602|P2|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
7639757|NCT01602666|26579603|P1|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
7639758|NCT01602666|26579602|P2|Radiation Therapy on Protocol|Withdrawal by Subject|3
7639759|NCT01602666|26579603|P1|Radiation Therapy on Protocol|Withdrawal by Subject|2
7639760|NCT01602666|26579602|P2|Radiation Therapy on Protocol|Lost to Follow-up|5
7639761|NCT01602666|26579603|P1|Radiation Therapy on Protocol|Lost to Follow-up|4
7639762|NCT01602666|26579602|P2|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
7639763|NCT01602666|26579603|P1|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
7639764|NCT01602666|26579602|P2|Induction Chemotherapy|Refusal of further protocol therapy|6
7639765|NCT01602666|26579603|P1|Induction Chemotherapy|Refusal of further protocol therapy|5
7639766|NCT01602666|26579602|P2|Induction Chemotherapy|Withdrawal by Subject|2
7639767|NCT01602666|26579603|P1|Induction Chemotherapy|Withdrawal by Subject|0
7639768|NCT01602666|26579602|P2|Induction Chemotherapy|Physician Decision|5
7639769|NCT01602666|26579603|P1|Induction Chemotherapy|Physician Decision|12
7639770|NCT01602666|26579602|P2|Induction Chemotherapy|Lack of Efficacy|7
7639771|NCT01602666|26579603|P1|Induction Chemotherapy|Lack of Efficacy|16
7639772|NCT01602666|26579602|P2|Induction Chemotherapy|Death|1
7639773|NCT01602666|26579603|P1|Induction Chemotherapy|Death|2
7639774|NCT01602562|26579690|P2|Overall Study|Withdrawal by Subject|1
7639775|NCT01602562|26579691|P1|Overall Study|Withdrawal by Subject|1
7639776|NCT01602562|26579690|P2|Overall Study|Physician Decision|1
7639777|NCT01602562|26579691|P1|Overall Study|Physician Decision|1
7639778|NCT01602562|26579690|P2|Overall Study|Adverse Event|1
7639779|NCT01602562|26579691|P1|Overall Study|Adverse Event|3
7639780|NCT01602549|26579727|P2|Overall Study|Withdrawal by Subject|0
7639781|NCT01602549|26579728|P1|Overall Study|Withdrawal by Subject|1
7639782|NCT01602549|26579727|P2|Overall Study|Protocol Violation|1
7639783|NCT01602549|26579728|P1|Overall Study|Protocol Violation|0
7639784|NCT01602510|26579807|P3|Randomized Phase|Withdrawal by Subject|7
7639785|NCT01602510|26579808|P2|Randomized Phase|Withdrawal by Subject|6
7639786|NCT01602510|26579809|P1|Randomized Phase|Withdrawal by Subject|0
7639787|NCT01602510|26579807|P3|Randomized Phase|Physician Decision|2
7639788|NCT01602510|26579808|P2|Randomized Phase|Physician Decision|0
7639789|NCT01602510|26579809|P1|Randomized Phase|Physician Decision|0
7639790|NCT01602510|26579807|P3|Randomized Phase|Lost to Follow-up|3
7639791|NCT01602510|26579808|P2|Randomized Phase|Lost to Follow-up|1
7639792|NCT01602510|26579809|P1|Randomized Phase|Lost to Follow-up|0
7639793|NCT01602510|26579807|P3|Randomized Phase|Met protocol-defined stopping criteria|48
7639794|NCT01602510|26579808|P2|Randomized Phase|Met protocol-defined stopping criteria|58
7639795|NCT01602510|26579809|P1|Randomized Phase|Met protocol-defined stopping criteria|0
7639796|NCT01602510|26579807|P3|Randomized Phase|Protocol Violation|3
7639797|NCT01602510|26579808|P2|Randomized Phase|Protocol Violation|3
7639798|NCT01602510|26579809|P1|Randomized Phase|Protocol Violation|0
7639799|NCT01602510|26579807|P3|Randomized Phase|Lack of Efficacy|4
7639800|NCT01602510|26579808|P2|Randomized Phase|Lack of Efficacy|4
7639801|NCT01602510|26579809|P1|Randomized Phase|Lack of Efficacy|0
7639802|NCT01602510|26579807|P3|Randomized Phase|Adverse Event|6
7639803|NCT01602510|26579808|P2|Randomized Phase|Adverse Event|2
7639804|NCT01602510|26579809|P1|Randomized Phase|Adverse Event|0
7639805|NCT01602510|26579807|P3|Open Label Phase|Withdrawal by Subject|0
7639806|NCT01602510|26579808|P2|Open Label Phase|Withdrawal by Subject|0
7639807|NCT01602510|26579809|P1|Open Label Phase|Withdrawal by Subject|57
7639808|NCT01602510|26579807|P3|Open Label Phase|Physician Decision|0
7639809|NCT01602510|26579808|P2|Open Label Phase|Physician Decision|0
7639810|NCT01602510|26579809|P1|Open Label Phase|Physician Decision|19
7639811|NCT01602510|26579807|P3|Open Label Phase|Lost to Follow-up|0
7639812|NCT01602510|26579808|P2|Open Label Phase|Lost to Follow-up|0
7639813|NCT01602510|26579809|P1|Open Label Phase|Lost to Follow-up|22
7639814|NCT01602510|26579807|P3|Open Label Phase|Met protocol-defined stopping criteria|0
7639815|NCT01602510|26579808|P2|Open Label Phase|Met protocol-defined stopping criteria|0
7639816|NCT01602510|26579809|P1|Open Label Phase|Met protocol-defined stopping criteria|122
7639817|NCT01602510|26579807|P3|Open Label Phase|Protocol Violation|0
7639818|NCT01602510|26579808|P2|Open Label Phase|Protocol Violation|0
7639819|NCT01602510|26579809|P1|Open Label Phase|Protocol Violation|15
7639820|NCT01602510|26579807|P3|Open Label Phase|Lack of Efficacy|0
7639821|NCT01602510|26579808|P2|Open Label Phase|Lack of Efficacy|0
7639822|NCT01602510|26579809|P1|Open Label Phase|Lack of Efficacy|22
7639823|NCT01602510|26579807|P3|Open Label Phase|Adverse Event|0
7639824|NCT01602510|26579808|P2|Open Label Phase|Adverse Event|0
7639825|NCT01602510|26579809|P1|Open Label Phase|Adverse Event|46
7639826|NCT01602484|26579835|P2|Overall Study|Airway issues unrelated to study|1
7639827|NCT01602484|26579836|P1|Overall Study|Airway issues unrelated to study|0
7639828|NCT01602419|26579852|P1|Overall Study|Lost to Follow-up|6
7639829|NCT01602419|26579852|P1|Overall Study|Withdrawal by Subject|5
7639830|NCT01602419|26579852|P1|Overall Study|Treatment centre closed|1
7639831|NCT01602419|26579852|P1|Overall Study|Changed treatment centre|1
7639832|NCT01602419|26579852|P1|Overall Study|Insurance issues|3
7639833|NCT01602419|26579852|P1|Overall Study|Adverse Drug Reaction|4
7639834|NCT01602419|26579852|P1|Overall Study|Not treated with Wilate|9
7639835|NCT01602380|26579907|P2|Overall Study|Eligibility criteria not fulfilled|3
7639836|NCT01602380|26579908|P1|Overall Study|Eligibility criteria not fulfilled|2
7639837|NCT01602380|26579907|P2|Overall Study|Lost to Follow-up|1
7639838|NCT01602380|26579908|P1|Overall Study|Lost to Follow-up|6
7639839|NCT01602380|26579907|P2|Overall Study|Withdrawal by Subject|29
7639840|NCT01602380|26579908|P1|Overall Study|Withdrawal by Subject|22
7639841|NCT01602380|26579907|P2|Overall Study|Death|68
7639842|NCT01602380|26579908|P1|Overall Study|Death|63
7639843|NCT01602341|26579932|P2|Overall Study|Adverse Event|1
7639844|NCT01602341|26579933|P1|Overall Study|Adverse Event|0
7639845|NCT01602315|26579974|P7|Overall Study|Cross-over patients to combo treatment|0
7639846|NCT01602315|26579975|P6|Overall Study|Cross-over patients to combo treatment|16
7639847|NCT01602315|26579976|P5|Overall Study|Cross-over patients to combo treatment|0
7639848|NCT01602315|26579977|P4|Overall Study|Cross-over patients to combo treatment|0
7639849|NCT01602315|26579978|P3|Overall Study|Cross-over patients to combo treatment|0
7639850|NCT01602315|26579979|P2|Overall Study|Cross-over patients to combo treatment|0
7639851|NCT01602315|26579980|P1|Overall Study|Cross-over patients to combo treatment|0
7639852|NCT01602315|26579974|P7|Overall Study|Subject/guardian decision|1
7639853|NCT01602315|26579975|P6|Overall Study|Subject/guardian decision|0
7639854|NCT01602315|26579976|P5|Overall Study|Subject/guardian decision|0
7639855|NCT01602315|26579977|P4|Overall Study|Subject/guardian decision|0
7639856|NCT01602315|26579978|P3|Overall Study|Subject/guardian decision|0
7639857|NCT01602315|26579979|P2|Overall Study|Subject/guardian decision|0
7639858|NCT01602315|26579980|P1|Overall Study|Subject/guardian decision|0
7639859|NCT01602315|26579974|P7|Overall Study|Adverse Event|9
7639860|NCT01602315|26579975|P6|Overall Study|Adverse Event|3
7639861|NCT01602315|26579976|P5|Overall Study|Adverse Event|15
7639862|NCT01602315|26579977|P4|Overall Study|Adverse Event|4
7639863|NCT01602315|26579978|P3|Overall Study|Adverse Event|5
7639864|NCT01602315|26579979|P2|Overall Study|Adverse Event|1
7639865|NCT01602315|26579980|P1|Overall Study|Adverse Event|5
7639866|NCT01602315|26579974|P7|Overall Study|Withdrawal by Subject|1
7639867|NCT01602315|26579975|P6|Overall Study|Withdrawal by Subject|0
7639868|NCT01602315|26579976|P5|Overall Study|Withdrawal by Subject|6
7639869|NCT01602315|26579977|P4|Overall Study|Withdrawal by Subject|0
7639870|NCT01602315|26579978|P3|Overall Study|Withdrawal by Subject|2
7639871|NCT01602315|26579979|P2|Overall Study|Withdrawal by Subject|0
7639872|NCT01602315|26579980|P1|Overall Study|Withdrawal by Subject|2
7639873|NCT01602315|26579974|P7|Overall Study|Death|2
7639874|NCT01602315|26579975|P6|Overall Study|Death|2
7639875|NCT01602315|26579976|P5|Overall Study|Death|7
7639876|NCT01602315|26579977|P4|Overall Study|Death|1
7639877|NCT01602315|26579978|P3|Overall Study|Death|1
7639878|NCT01602315|26579979|P2|Overall Study|Death|1
7639879|NCT01602315|26579980|P1|Overall Study|Death|1
7639880|NCT01602315|26579974|P7|Overall Study|Disease progression|15
7639881|NCT01602315|26579975|P6|Overall Study|Disease progression|12
7639882|NCT01602315|26579976|P5|Overall Study|Disease progression|41
7639883|NCT01602315|26579977|P4|Overall Study|Disease progression|1
7639884|NCT01602315|26579978|P3|Overall Study|Disease progression|10
7639885|NCT01602315|26579979|P2|Overall Study|Disease progression|3
7639886|NCT01602315|26579980|P1|Overall Study|Disease progression|6
7639887|NCT01602315|26579974|P7|Overall Study|Physician Decision|1
7639888|NCT01602315|26579975|P6|Overall Study|Physician Decision|1
7639889|NCT01602315|26579976|P5|Overall Study|Physician Decision|2
7639890|NCT01602315|26579977|P4|Overall Study|Physician Decision|0
7639891|NCT01602315|26579978|P3|Overall Study|Physician Decision|0
7639892|NCT01602315|26579979|P2|Overall Study|Physician Decision|0
7639893|NCT01602315|26579980|P1|Overall Study|Physician Decision|2
7639894|NCT01602315|26579974|P7|Overall Study|Protocol Violation|0
7639895|NCT01602315|26579975|P6|Overall Study|Protocol Violation|1
7639896|NCT01602315|26579976|P5|Overall Study|Protocol Violation|0
7639897|NCT01602315|26579977|P4|Overall Study|Protocol Violation|0
7639898|NCT01602315|26579978|P3|Overall Study|Protocol Violation|0
7639899|NCT01602315|26579979|P2|Overall Study|Protocol Violation|0
7639900|NCT01602315|26579980|P1|Overall Study|Protocol Violation|0
7639901|NCT01602224|26580069|P3|Overall Study|Withdrawal by Subject|3
7639902|NCT01602224|26580070|P2|Overall Study|Withdrawal by Subject|3
7639903|NCT01602224|26580071|P1|Overall Study|Withdrawal by Subject|5
7639904|NCT01602224|26580069|P3|Overall Study|Sponsor Decision|2
7639905|NCT01602224|26580070|P2|Overall Study|Sponsor Decision|3
7639906|NCT01602224|26580071|P1|Overall Study|Sponsor Decision|2
7639907|NCT01602224|26580069|P3|Overall Study|Protocol Violation|0
7639908|NCT01602224|26580070|P2|Overall Study|Protocol Violation|1
7639909|NCT01602224|26580071|P1|Overall Study|Protocol Violation|0
7639910|NCT01602224|26580069|P3|Overall Study|Lost to Follow-up|1
7639911|NCT01602224|26580070|P2|Overall Study|Lost to Follow-up|0
7639912|NCT01602224|26580071|P1|Overall Study|Lost to Follow-up|0
7639913|NCT01602224|26580069|P3|Overall Study|Investigator Decison|0
7639914|NCT01602224|26580070|P2|Overall Study|Investigator Decison|0
7639915|NCT01602224|26580071|P1|Overall Study|Investigator Decison|1
7639916|NCT01602224|26580069|P3|Overall Study|Adverse Event|0
7639917|NCT01602224|26580070|P2|Overall Study|Adverse Event|1
7639918|NCT01602224|26580071|P1|Overall Study|Adverse Event|0
7639919|NCT01602120|26580156|P4|Overall Study|Unspecified Reason|2
7639920|NCT01602120|26580157|P3|Overall Study|Unspecified Reason|0
7639921|NCT01602120|26580158|P2|Overall Study|Unspecified Reason|1
7639922|NCT01602120|26580159|P1|Overall Study|Unspecified Reason|3
7639923|NCT01602120|26580156|P4|Overall Study|Physician Decision|0
7639924|NCT01602120|26580157|P3|Overall Study|Physician Decision|0
7639925|NCT01602120|26580158|P2|Overall Study|Physician Decision|3
7639926|NCT01602120|26580159|P1|Overall Study|Physician Decision|2
7639927|NCT01602120|26580156|P4|Overall Study|Study Terminated by Sponsor|44
7639928|NCT01602120|26580157|P3|Overall Study|Study Terminated by Sponsor|17
7639929|NCT01602120|26580158|P2|Overall Study|Study Terminated by Sponsor|24
7639930|NCT01602120|26580159|P1|Overall Study|Study Terminated by Sponsor|12
7639931|NCT01602120|26580156|P4|Overall Study|Withdrawal by Subject|3
7639932|NCT01602120|26580157|P3|Overall Study|Withdrawal by Subject|0
7639933|NCT01602120|26580158|P2|Overall Study|Withdrawal by Subject|17
7639934|NCT01602120|26580159|P1|Overall Study|Withdrawal by Subject|8
7639935|NCT01602120|26580156|P4|Overall Study|Non-compliance|1
7639936|NCT01602120|26580157|P3|Overall Study|Non-compliance|0
7639937|NCT01602120|26580158|P2|Overall Study|Non-compliance|3
7639938|NCT01602120|26580159|P1|Overall Study|Non-compliance|0
7639939|NCT01602120|26580156|P4|Overall Study|Protocol Violation|0
7639940|NCT01602120|26580157|P3|Overall Study|Protocol Violation|0
7639941|NCT01602120|26580158|P2|Overall Study|Protocol Violation|1
7639942|NCT01602120|26580159|P1|Overall Study|Protocol Violation|1
7639943|NCT01602120|26580156|P4|Overall Study|Lost to Follow-up|1
7639944|NCT01602120|26580157|P3|Overall Study|Lost to Follow-up|0
7639945|NCT01602120|26580158|P2|Overall Study|Lost to Follow-up|1
7639946|NCT01602120|26580159|P1|Overall Study|Lost to Follow-up|0
7639947|NCT01602120|26580156|P4|Overall Study|Death|0
7639948|NCT01602120|26580157|P3|Overall Study|Death|0
7639949|NCT01602120|26580158|P2|Overall Study|Death|4
7639950|NCT01602120|26580159|P1|Overall Study|Death|0
7639951|NCT01602120|26580156|P4|Overall Study|Adverse Event|2
7639952|NCT01602120|26580157|P3|Overall Study|Adverse Event|0
7639953|NCT01602120|26580158|P2|Overall Study|Adverse Event|6
7639954|NCT01602120|26580159|P1|Overall Study|Adverse Event|3
7639955|NCT01601873|26580207|P2|Overall Study|Lost to Follow-up|3
7639956|NCT01601873|26580208|P1|Overall Study|Lost to Follow-up|2
7639957|NCT01601847|26580263|P2|Overall Study|Lost to Follow-up|3
7639958|NCT01601847|26580264|P1|Overall Study|Lost to Follow-up|1
7639959|NCT01601847|26580263|P2|Overall Study|Withdrawal by Subject|7
7639960|NCT01601847|26580264|P1|Overall Study|Withdrawal by Subject|11
7639961|NCT01601847|26580263|P2|Overall Study|Death|0
7639962|NCT01601847|26580264|P1|Overall Study|Death|1
7639963|NCT01601821|26580276|P2|Overall Study|Other|1
7639964|NCT01601821|26580277|P1|Overall Study|Other|5
7639965|NCT01601821|26580276|P2|Overall Study|Study Events|1
7639966|NCT01601821|26580277|P1|Overall Study|Study Events|7
7639967|NCT01601821|26580276|P2|Overall Study|Graft Loss|6
7639968|NCT01601821|26580277|P1|Overall Study|Graft Loss|6
7639969|NCT01601821|26580276|P2|Overall Study|Withdrawal by Subject|0
7639970|NCT01601821|26580277|P1|Overall Study|Withdrawal by Subject|1
7639971|NCT01601821|26580276|P2|Overall Study|Lost to Follow-up|14
7639972|NCT01601821|26580277|P1|Overall Study|Lost to Follow-up|6
7639973|NCT01601821|26580276|P2|Overall Study|Protocol Violation|2
7639974|NCT01601821|26580277|P1|Overall Study|Protocol Violation|2
7639975|NCT01601821|26580276|P2|Overall Study|Death|5
7639976|NCT01601821|26580277|P1|Overall Study|Death|2
7639977|NCT01601704|26580313|P2|Overall Study|Randomized but not dispensed study med|4
7639978|NCT01601704|26580314|P1|Overall Study|Randomized but not dispensed study med|1
7639979|NCT01601652|26580332|P1|Overall Study|Death|1
7639980|NCT01601626|26580340|P3|Overall Study|Not Willing to Adhere to Requirements|0
7639981|NCT01601626|26580341|P2|Overall Study|Not Willing to Adhere to Requirements|0
7639982|NCT01601626|26580342|P1|Overall Study|Not Willing to Adhere to Requirements|1
7639983|NCT01601626|26580340|P3|Overall Study|Withdrawal by Subject|1
7639984|NCT01601626|26580341|P2|Overall Study|Withdrawal by Subject|1
7639985|NCT01601626|26580342|P1|Overall Study|Withdrawal by Subject|0
7639986|NCT01601626|26580340|P3|Overall Study|Unable to Get to Clinic|0
7639987|NCT01601626|26580341|P2|Overall Study|Unable to Get to Clinic|1
7639988|NCT01601626|26580342|P1|Overall Study|Unable to Get to Clinic|0
7639989|NCT01601626|26580340|P3|Overall Study|Lost to Follow-up|0
7639990|NCT01601626|26580341|P2|Overall Study|Lost to Follow-up|2
7639991|NCT01601626|26580342|P1|Overall Study|Lost to Follow-up|1
7639992|NCT01601626|26580340|P3|Overall Study|Death|1
7639993|NCT01601626|26580341|P2|Overall Study|Death|1
7639994|NCT01601626|26580342|P1|Overall Study|Death|1
7639995|NCT01601535|26580431|P6|Phase 2|Started Another Treatment|2
7639996|NCT01601535|26580432|P5|Phase 2|Started Another Treatment|1
7639997|NCT01601535|26580433|P4|Phase 2|Started Another Treatment|0
7639998|NCT01601535|26580434|P3|Phase 2|Started Another Treatment|0
7639999|NCT01601535|26580435|P2|Phase 2|Started Another Treatment|0
7640000|NCT01601535|26580436|P1|Phase 2|Started Another Treatment|0
7640001|NCT01601535|26580431|P6|Phase 2|Progressive Disease|7
7640002|NCT01601535|26580432|P5|Phase 2|Progressive Disease|5
7640003|NCT01601535|26580433|P4|Phase 2|Progressive Disease|0
7640004|NCT01601535|26580434|P3|Phase 2|Progressive Disease|0
7640005|NCT01601535|26580435|P2|Phase 2|Progressive Disease|0
7640006|NCT01601535|26580436|P1|Phase 2|Progressive Disease|0
7640007|NCT01601535|26580431|P6|Phase 2|Withdrawal by Subject|2
7640008|NCT01601535|26580432|P5|Phase 2|Withdrawal by Subject|8
7640009|NCT01601535|26580433|P4|Phase 2|Withdrawal by Subject|0
7640010|NCT01601535|26580434|P3|Phase 2|Withdrawal by Subject|0
7640011|NCT01601535|26580435|P2|Phase 2|Withdrawal by Subject|0
7640012|NCT01601535|26580436|P1|Phase 2|Withdrawal by Subject|0
7640013|NCT01601535|26580431|P6|Phase 2|Adverse Event|1
7640014|NCT01601535|26580432|P5|Phase 2|Adverse Event|5
7640015|NCT01601535|26580433|P4|Phase 2|Adverse Event|0
7640016|NCT01601535|26580434|P3|Phase 2|Adverse Event|0
7640017|NCT01601535|26580435|P2|Phase 2|Adverse Event|0
7640018|NCT01601535|26580436|P1|Phase 2|Adverse Event|0
7640019|NCT01601535|26580431|P6|Phase 1|Started Another Treatment|0
7640020|NCT01601535|26580432|P5|Phase 1|Started Another Treatment|0
7640021|NCT01601535|26580433|P4|Phase 1|Started Another Treatment|0
7640022|NCT01601535|26580434|P3|Phase 1|Started Another Treatment|0
7640023|NCT01601535|26580435|P2|Phase 1|Started Another Treatment|2
7640024|NCT01601535|26580436|P1|Phase 1|Started Another Treatment|1
7640025|NCT01601535|26580431|P6|Phase 1|Progressive Disease|0
7640026|NCT01601535|26580432|P5|Phase 1|Progressive Disease|0
7640027|NCT01601535|26580433|P4|Phase 1|Progressive Disease|1
7640028|NCT01601535|26580434|P3|Phase 1|Progressive Disease|2
7640029|NCT01601535|26580435|P2|Phase 1|Progressive Disease|3
7640030|NCT01601535|26580436|P1|Phase 1|Progressive Disease|2
7640031|NCT01601535|26580431|P6|Phase 1|Withdrawal by Subject|0
7640032|NCT01601535|26580432|P5|Phase 1|Withdrawal by Subject|0
7640033|NCT01601535|26580433|P4|Phase 1|Withdrawal by Subject|2
7640034|NCT01601535|26580434|P3|Phase 1|Withdrawal by Subject|1
7640035|NCT01601535|26580435|P2|Phase 1|Withdrawal by Subject|1
7640036|NCT01601535|26580436|P1|Phase 1|Withdrawal by Subject|2
7640037|NCT01601535|26580431|P6|Phase 1|Adverse Event|0
7640038|NCT01601535|26580432|P5|Phase 1|Adverse Event|0
7640039|NCT01601535|26580433|P4|Phase 1|Adverse Event|1
7640040|NCT01601535|26580434|P3|Phase 1|Adverse Event|2
7640041|NCT01601535|26580435|P2|Phase 1|Adverse Event|0
7640042|NCT01601535|26580436|P1|Phase 1|Adverse Event|1
7640043|NCT01601496|26580492|P1|Overall Study|Other: patient refusal to continue|3
7640044|NCT01601496|26580492|P1|Overall Study|Death|4
7640045|NCT01601496|26580492|P1|Overall Study|Lost to Follow-up|6
7640046|NCT01601496|26580492|P1|Overall Study|Withdrawal by Subject|1
7640047|NCT01601496|26580492|P1|Overall Study|Physician Decision|1
7640048|NCT01601470|26580500|P1|Period 2 - LCZ696|Physician Decision|1
7640049|NCT01601132|26580571|P1|Overall Study|Protocol deviation|1
7640050|NCT01601132|26580571|P1|Overall Study|Patient withdrew consent|1
7640051|NCT01600885|26580616|P2|First Period|moved out of area|0
7640052|NCT01600885|26580617|P1|First Period|moved out of area|1
7640053|NCT01600885|26580616|P2|First Period|Adverse Event|1
7640054|NCT01600885|26580617|P1|First Period|Adverse Event|1
7640055|NCT01600716|26580634|P2|Overall Study|Adverse Event|1
7640056|NCT01600716|26580635|P1|Overall Study|Adverse Event|1
7640057|NCT01600716|26580634|P2|Overall Study|Lack of Efficacy|1
7640058|NCT01600716|26580635|P1|Overall Study|Lack of Efficacy|2
7640059|NCT01600716|26580634|P2|Overall Study|Pregnancy|0
7640060|NCT01600716|26580635|P1|Overall Study|Pregnancy|1
7640061|NCT01600716|26580634|P2|Overall Study|Lost to Follow-up|2
7640062|NCT01600716|26580635|P1|Overall Study|Lost to Follow-up|0
7640063|NCT01600716|26580634|P2|Overall Study|Personal Reasons|2
7640064|NCT01600716|26580635|P1|Overall Study|Personal Reasons|0
7640065|NCT01600716|26580634|P2|Overall Study|Other Reasons|1
7640066|NCT01600716|26580635|P1|Overall Study|Other Reasons|3
7640067|NCT01600586|26580683|P2|Overall Study|Physician Decision|3
7640068|NCT01600586|26580684|P1|Overall Study|Physician Decision|3
7640069|NCT01600326|26580736|P2|Overall Study|Lost to Follow-up|1
7640070|NCT01600326|26580737|P1|Overall Study|Lost to Follow-up|1
7640071|NCT01600105|26580838|P2|Sub Study V|Poor Image Quality|0
7640072|NCT01600105|26580839|P1|Sub Study V|Poor Image Quality|2
7640073|NCT01600105|26580838|P2|Sub Study III|Insufficient image quality|0
7640074|NCT01600105|26580839|P1|Sub Study III|Insufficient image quality|5
7640075|NCT01600105|26580838|P2|Sub Study II|Insufficient image quality|0
7640076|NCT01600105|26580839|P1|Sub Study II|Insufficient image quality|3
7640077|NCT01600105|26580838|P2|Sub Study II|No images in PACS|0
7640078|NCT01600105|26580839|P1|Sub Study II|No images in PACS|1
7640079|NCT01600105|26580838|P2|Sub Study II|Withdrawal by Subject|0
7640080|NCT01600105|26580839|P1|Sub Study II|Withdrawal by Subject|1
7640081|NCT01600105|26580838|P2|Sub Study I|Insufficient image quality|10
7640082|NCT01600105|26580839|P1|Sub Study I|Insufficient image quality|0
7640083|NCT01600105|26580838|P2|Total Participants|Insufficient image quality|10
7640084|NCT01600105|26580839|P1|Total Participants|Insufficient image quality|30
7640085|NCT01600105|26580838|P2|Total Participants|No images in PACS|0
7640086|NCT01600105|26580839|P1|Total Participants|No images in PACS|10
7640087|NCT01600105|26580838|P2|Total Participants|Withdrawal by Subject|0
7640088|NCT01600105|26580839|P1|Total Participants|Withdrawal by Subject|1
7640089|NCT01600092|26580867|P2|Overall Study|Randomized but not vaccinated|3
7640090|NCT01600092|26580868|P1|Overall Study|Randomized but not vaccinated|3
7640091|NCT01600092|26580867|P2|Overall Study|Physician Decision|1
7640092|NCT01600092|26580868|P1|Overall Study|Physician Decision|1
7640093|NCT01600092|26580867|P2|Overall Study|Withdrawal by parent/guardian|6
7640094|NCT01600092|26580868|P1|Overall Study|Withdrawal by parent/guardian|8
7640095|NCT01600092|26580867|P2|Overall Study|Lost to Follow-up|6
7640096|NCT01600092|26580868|P1|Overall Study|Lost to Follow-up|4
7640097|NCT01600092|26580867|P2|Overall Study|Adverse Event|0
7640098|NCT01600092|26580868|P1|Overall Study|Adverse Event|2
7640099|NCT01600053|26580882|P1|Overall Study|trial will not meet the interim endpoint|9
7640100|NCT01600053|26580882|P1|Overall Study|Adverse Event|2
7640101|NCT01600014|26580887|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
7640102|NCT01600014|26580888|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
7640103|NCT01600014|26580887|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
7640104|NCT01600014|26580888|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
7640105|NCT01600014|26580887|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
7640106|NCT01600014|26580888|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
7640107|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
7640108|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
7640109|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7640110|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7640111|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
7640112|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
7640113|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
7640114|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
7640115|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
7640116|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
7640117|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
7640118|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
7640119|NCT01600014|26580887|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
7640120|NCT01600014|26580888|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
7640121|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
7640122|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
7640123|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
7640124|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
7640125|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
7640126|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
7640127|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Other|0
7640128|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Other|27
7640129|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
7640130|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
7640131|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
7640132|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
7640133|NCT01600014|26580887|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
7640134|NCT01600014|26580888|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
7640135|NCT01599806|26580916|P2|Overall Study|Other Eligibility criteria|9
7640136|NCT01599806|26580917|P1|Overall Study|Other Eligibility criteria|11
7640137|NCT01599806|26580916|P2|Overall Study|Withdrawal by Subject|12
7640138|NCT01599806|26580917|P1|Overall Study|Withdrawal by Subject|12
7640139|NCT01599806|26580916|P2|Overall Study|Lost to Follow-up|20
7640140|NCT01599806|26580917|P1|Overall Study|Lost to Follow-up|20
7640141|NCT01599793|26581041|P1|Overall Study|Adverse Event|2
7640142|NCT01599754|26581053|P2|Overall Study|Study terminated by sponsor|285
7640143|NCT01599754|26581054|P1|Overall Study|Study terminated by sponsor|282
7640144|NCT01599754|26581053|P2|Overall Study|Withdrawal by Subject|25
7640145|NCT01599754|26581054|P1|Overall Study|Withdrawal by Subject|24
7640146|NCT01599754|26581053|P2|Overall Study|Investigator decision|3
7640147|NCT01599754|26581054|P1|Overall Study|Investigator decision|1
7640148|NCT01599754|26581053|P2|Overall Study|Adverse Event|2
7640149|NCT01599754|26581054|P1|Overall Study|Adverse Event|3
7640150|NCT01599754|26581053|P2|Overall Study|Death|33
7640151|NCT01599754|26581054|P1|Overall Study|Death|31
7640152|NCT01599754|26581053|P2|Overall Study|Lost to Follow-up|6
7640153|NCT01599754|26581054|P1|Overall Study|Lost to Follow-up|13
7640154|NCT01599754|26581053|P2|Overall Study|Participant noncompliance|4
7640155|NCT01599754|26581054|P1|Overall Study|Participant noncompliance|4
7640156|NCT01599754|26581053|P2|Overall Study|Anticancer therapy need not in protocol|2
7640157|NCT01599754|26581054|P1|Overall Study|Anticancer therapy need not in protocol|5
7640158|NCT01599650|26581085|P3|Overall Study|Adverse Event|4
7640159|NCT01599650|26581086|P2|Overall Study|Adverse Event|8
7640160|NCT01599650|26581087|P1|Overall Study|Adverse Event|3
7640161|NCT01599650|26581085|P3|Overall Study|Withdrawal by Subject|10
7640162|NCT01599650|26581086|P2|Overall Study|Withdrawal by Subject|11
7640163|NCT01599650|26581087|P1|Overall Study|Withdrawal by Subject|11
7640164|NCT01599650|26581085|P3|Overall Study|Lost to Follow-up|3
7640165|NCT01599650|26581086|P2|Overall Study|Lost to Follow-up|3
7640166|NCT01599650|26581087|P1|Overall Study|Lost to Follow-up|3
7640167|NCT01599650|26581085|P3|Overall Study|Death|2
7640168|NCT01599650|26581086|P2|Overall Study|Death|1
7640169|NCT01599650|26581087|P1|Overall Study|Death|2
7640170|NCT01599650|26581085|P3|Overall Study|Protocol Violation|0
7640171|NCT01599650|26581086|P2|Overall Study|Protocol Violation|3
7640172|NCT01599650|26581087|P1|Overall Study|Protocol Violation|0
7640173|NCT01599650|26581085|P3|Overall Study|Physician Decision|7
7640174|NCT01599650|26581086|P2|Overall Study|Physician Decision|0
7640175|NCT01599650|26581087|P1|Overall Study|Physician Decision|2
7640176|NCT01599650|26581085|P3|Overall Study|Administrative issue|1
7640177|NCT01599650|26581086|P2|Overall Study|Administrative issue|0
7640178|NCT01599650|26581087|P1|Overall Study|Administrative issue|1
7640179|NCT01599637|26581126|P3|Overall Study|Adverse Event|0
7640180|NCT01599637|26581127|P2|Overall Study|Adverse Event|0
7640181|NCT01599637|26581128|P1|Overall Study|Adverse Event|1
7640182|NCT01599637|26581126|P3|Overall Study|administrative problems|0
7640183|NCT01599637|26581127|P2|Overall Study|administrative problems|2
7640184|NCT01599637|26581128|P1|Overall Study|administrative problems|0
7640185|NCT01599585|26581175|P2|Overall Study|randomized did not start treatment|3
7640186|NCT01599585|26581176|P1|Overall Study|randomized did not start treatment|3
7640187|NCT01599585|26581175|P2|Overall Study|Lost to Follow-up|5
7640188|NCT01599585|26581176|P1|Overall Study|Lost to Follow-up|3
7640189|NCT01599585|26581175|P2|Overall Study|Withdrawal by Subject|9
7640190|NCT01599585|26581176|P1|Overall Study|Withdrawal by Subject|16
7640191|NCT01599325|26581214|P1|Extension Phase|Withdrawal by Subject|8
7640192|NCT01599325|26581214|P1|Extension Phase|Disease Progression|1
7640193|NCT01599325|26581214|P1|Extension Phase|Lack of Therapeutic Effect|4
7640194|NCT01599325|26581214|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
7640195|NCT01599325|26581214|P1|Extension Phase|Study Closure|1
7640196|NCT01599325|26581214|P1|Primary Parent Phase|Other|2
7640197|NCT01599325|26581214|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
7640198|NCT01599325|26581214|P1|Primary Parent Phase|Protocol Violation|1
7640199|NCT01599325|26581214|P1|Primary Parent Phase|Death|13
7640200|NCT01599325|26581214|P1|Primary Parent Phase|Withdrawal by Subject|20
7640201|NCT01599325|26581214|P1|Primary Parent Phase|Disease Progression|7
7640202|NCT01599325|26581214|P1|Primary Parent Phase|Adverse Event|5
7640203|NCT01599234|26581247|P2|Overall Study|Pregnancy|1
7640204|NCT01599234|26581248|P1|Overall Study|Pregnancy|0
7640205|NCT01599234|26581247|P2|Overall Study|Contra-indication discovered|1
7640206|NCT01599234|26581248|P1|Overall Study|Contra-indication discovered|0
7640207|NCT01599234|26581247|P2|Overall Study|Patient would not stop driving|0
7640208|NCT01599234|26581248|P1|Overall Study|Patient would not stop driving|1
7640209|NCT01599234|26581247|P2|Overall Study|Death|0
7640210|NCT01599234|26581248|P1|Overall Study|Death|1
7640211|NCT01599234|26581247|P2|Overall Study|Sponsor request as creatinine levels <50|1
7640212|NCT01599234|26581248|P1|Overall Study|Sponsor request as creatinine levels <50|0
7640213|NCT01599234|26581247|P2|Overall Study|Unable to operate spray|0
7640214|NCT01599234|26581248|P1|Overall Study|Unable to operate spray|1
7640215|NCT01599234|26581247|P2|Overall Study|Lack of Efficacy|4
7640216|NCT01599234|26581248|P1|Overall Study|Lack of Efficacy|2
7640217|NCT01599234|26581247|P2|Overall Study|Lost to Follow-up|2
7640218|NCT01599234|26581248|P1|Overall Study|Lost to Follow-up|1
7640219|NCT01599234|26581247|P2|Overall Study|Withdrawal by Subject|1
7640220|NCT01599234|26581248|P1|Overall Study|Withdrawal by Subject|2
7640221|NCT01599234|26581247|P2|Overall Study|Adverse Event|5
7640222|NCT01599234|26581248|P1|Overall Study|Adverse Event|9
7640223|NCT01599104|26581273|P3|Overall Study|Adverse Event|12
7640224|NCT01599104|26581274|P2|Overall Study|Adverse Event|6
7640225|NCT01599104|26581275|P1|Overall Study|Adverse Event|7
7640226|NCT01599104|26581273|P3|Overall Study|Lack of Efficacy|10
7640227|NCT01599104|26581274|P2|Overall Study|Lack of Efficacy|4
7640228|NCT01599104|26581275|P1|Overall Study|Lack of Efficacy|4
7640229|NCT01599104|26581273|P3|Overall Study|Non-compliance with study treatment|0
7640230|NCT01599104|26581274|P2|Overall Study|Non-compliance with study treatment|1
7640231|NCT01599104|26581275|P1|Overall Study|Non-compliance with study treatment|0
7640232|NCT01599104|26581273|P3|Overall Study|Physician Decision|2
7640233|NCT01599104|26581274|P2|Overall Study|Physician Decision|2
7640234|NCT01599104|26581275|P1|Overall Study|Physician Decision|3
7640235|NCT01599104|26581273|P3|Overall Study|Technical Problems|0
7640236|NCT01599104|26581274|P2|Overall Study|Technical Problems|0
7640237|NCT01599104|26581275|P1|Overall Study|Technical Problems|1
7640238|NCT01599104|26581273|P3|Overall Study|Withdrawal by Subject|2
7640239|NCT01599104|26581274|P2|Overall Study|Withdrawal by Subject|1
7640240|NCT01599104|26581275|P1|Overall Study|Withdrawal by Subject|1
7640241|NCT01598987|26581313|P1|Baseline to 24 Month|Lost to Follow-up|1
7640242|NCT01598987|26581313|P1|Baseline to 24 Month|Administrative problems|2
7640243|NCT01598987|26581313|P1|Baseline to 24 Month|Withdrawal by Subject|5
7640244|NCT01598987|26581313|P1|Baseline to Month 12|Withdrawal by Subject|4
7640245|NCT01598987|26581313|P1|Baseline to Month 12|Administrative problems|2
7640246|NCT01598896|26581372|P2|Overall Study|Lack of Efficacy|1
7640247|NCT01598896|26581373|P1|Overall Study|Lack of Efficacy|0
7640248|NCT01598896|26581372|P2|Overall Study|Withdrawal by Subject|1
7640249|NCT01598896|26581373|P1|Overall Study|Withdrawal by Subject|0
7640250|NCT01598753|26581412|P4|Overall Study|Withdrawal by Subject|1
7640251|NCT01598753|26581413|P3|Overall Study|Withdrawal by Subject|0
7640252|NCT01598753|26581414|P2|Overall Study|Withdrawal by Subject|2
7640253|NCT01598753|26581415|P1|Overall Study|Withdrawal by Subject|7
7640254|NCT01598753|26581412|P4|Overall Study|Physician Decision|2
7640255|NCT01598753|26581413|P3|Overall Study|Physician Decision|0
7640256|NCT01598753|26581414|P2|Overall Study|Physician Decision|1
7640257|NCT01598753|26581415|P1|Overall Study|Physician Decision|0
7640258|NCT01598753|26581412|P4|Overall Study|Lost to Follow-up|5
7640259|NCT01598753|26581413|P3|Overall Study|Lost to Follow-up|7
7640260|NCT01598753|26581414|P2|Overall Study|Lost to Follow-up|3
7640261|NCT01598753|26581415|P1|Overall Study|Lost to Follow-up|4
7640262|NCT01598753|26581412|P4|Overall Study|Adverse Event|7
7640263|NCT01598753|26581413|P3|Overall Study|Adverse Event|1
7640264|NCT01598753|26581414|P2|Overall Study|Adverse Event|9
7640265|NCT01598753|26581415|P1|Overall Study|Adverse Event|1
7640266|NCT01598662|26581455|P2|Overall Study|IUD expelled before month 6|2
7640267|NCT01598662|26581456|P1|Overall Study|IUD expelled before month 6|0
7640268|NCT01598662|26581455|P2|Overall Study|Physician Decision|2
7640269|NCT01598662|26581456|P1|Overall Study|Physician Decision|1
7640270|NCT01598662|26581455|P2|Overall Study|Lost to Follow-up|17
7640271|NCT01598662|26581456|P1|Overall Study|Lost to Follow-up|10
7640272|NCT01598610|26581462|P1|Overall Study|Adverse Event|1
7640273|NCT01598532|26581479|P1|Overall Study|Did not meet inclusion criteria|8
7640274|NCT01598532|26581479|P1|Overall Study|Lost to Follow-up|3
7640275|NCT01598506|26581488|P1|Overall Study|Withdrawal by Subject|2
7640276|NCT01598311|26581508|P2|Overall Study|Assigned to CB but received vancomycin|0
7640277|NCT01598311|26581509|P1|Overall Study|Assigned to CB but received vancomycin|1
7640278|NCT01598311|26581508|P2|Overall Study|Treated but no confirmed CDAD|8
7640279|NCT01598311|26581509|P1|Overall Study|Treated but no confirmed CDAD|9
7640280|NCT01598311|26581508|P2|Overall Study|Randomized but never treated|5
7640281|NCT01598311|26581509|P1|Overall Study|Randomized but never treated|8
7640282|NCT01598311|26581508|P2|Overall Study|No reason provided.|5
7640283|NCT01598311|26581509|P1|Overall Study|No reason provided.|0
7640284|NCT01598311|26581508|P2|Overall Study|Withdrawal by Subject|13
7640285|NCT01598311|26581509|P1|Overall Study|Withdrawal by Subject|9
7640286|NCT01598311|26581508|P2|Overall Study|Lost to Follow-up|12
7640287|NCT01598311|26581509|P1|Overall Study|Lost to Follow-up|7
7640288|NCT01598311|26581508|P2|Overall Study|Adverse Event|13
7640289|NCT01598311|26581509|P1|Overall Study|Adverse Event|9
7640290|NCT01598311|26581508|P2|Overall Study|Physician Decision|5
7640291|NCT01598311|26581509|P1|Overall Study|Physician Decision|4
7640292|NCT01598298|26581525|P2|Overall Study|Other reason (not protocol specified)|0
7640293|NCT01598298|26581526|P1|Overall Study|Other reason (not protocol specified)|4
7640294|NCT01598298|26581525|P2|Overall Study|Withdrawal by Subject|15
7640295|NCT01598298|26581526|P1|Overall Study|Withdrawal by Subject|10
7640296|NCT01598298|26581525|P2|Overall Study|Progression/relapse|2
7640297|NCT01598298|26581526|P1|Overall Study|Progression/relapse|0
7640298|NCT01598298|26581525|P2|Overall Study|Adverse Event|19
7640299|NCT01598298|26581526|P1|Overall Study|Adverse Event|21
7640300|NCT01598298|26581525|P2|Overall Study|Not eligible|5
7640301|NCT01598298|26581526|P1|Overall Study|Not eligible|5
7640302|NCT01598129|26581570|P1|Overall Study|Withdrawal by Subject|1
7640303|NCT01598129|26581570|P1|Overall Study|Deterioration of WHO status to WHO 4|2
7640304|NCT01598129|26581570|P1|Overall Study|Disease progression|6
7640305|NCT01598090|26581582|P3|Follow-up Period|Lost to Follow-up|12
7640306|NCT01598090|26581583|P2|Follow-up Period|Lost to Follow-up|10
7640307|NCT01598090|26581584|P1|Follow-up Period|Lost to Follow-up|2
7640308|NCT01598090|26581582|P3|Follow-up Period|Other reasons|8
7640309|NCT01598090|26581583|P2|Follow-up Period|Other reasons|8
7640310|NCT01598090|26581584|P1|Follow-up Period|Other reasons|2
7640311|NCT01598090|26581582|P3|Follow-up Period|Withdrawal by Subject|2
7640312|NCT01598090|26581583|P2|Follow-up Period|Withdrawal by Subject|3
7640313|NCT01598090|26581584|P1|Follow-up Period|Withdrawal by Subject|0
7640314|NCT01598090|26581582|P3|Follow-up Period|Not reported|4
7640315|NCT01598090|26581583|P2|Follow-up Period|Not reported|10
7640316|NCT01598090|26581584|P1|Follow-up Period|Not reported|0
7640317|NCT01598090|26581582|P3|Follow-up Period|No longer required per protocol|2
7640318|NCT01598090|26581583|P2|Follow-up Period|No longer required per protocol|3
7640319|NCT01598090|26581584|P1|Follow-up Period|No longer required per protocol|1
7640320|NCT01598090|26581582|P3|Follow-up Period|Death|0
7640321|NCT01598090|26581583|P2|Follow-up Period|Death|1
7640322|NCT01598090|26581584|P1|Follow-up Period|Death|0
7640323|NCT01598090|26581582|P3|Treatment Period|Lost to Follow-up|1
7640324|NCT01598090|26581583|P2|Treatment Period|Lost to Follow-up|5
7640325|NCT01598090|26581584|P1|Treatment Period|Lost to Follow-up|1
7640326|NCT01598090|26581582|P3|Treatment Period|Withdrawal by Subject|10
7640327|NCT01598090|26581583|P2|Treatment Period|Withdrawal by Subject|13
7640328|NCT01598090|26581584|P1|Treatment Period|Withdrawal by Subject|3
7640329|NCT01598090|26581582|P3|Treatment Period|Other reasons|1
7640330|NCT01598090|26581583|P2|Treatment Period|Other reasons|4
7640331|NCT01598090|26581584|P1|Treatment Period|Other reasons|0
7640332|NCT01598090|26581582|P3|Treatment Period|Adverse Event|17
7640333|NCT01598090|26581583|P2|Treatment Period|Adverse Event|33
7640334|NCT01598090|26581584|P1|Treatment Period|Adverse Event|2
7640335|NCT01598090|26581582|P3|Treatment Period|Lack of Efficacy|6
7640336|NCT01598090|26581583|P2|Treatment Period|Lack of Efficacy|14
7640337|NCT01598090|26581584|P1|Treatment Period|Lack of Efficacy|5
7640338|NCT01598090|26581582|P3|Treatment Period|No longer meet study criteria|0
7640339|NCT01598090|26581583|P2|Treatment Period|No longer meet study criteria|1
7640340|NCT01598090|26581584|P1|Treatment Period|No longer meet study criteria|0
7640341|NCT01598090|26581582|P3|Treatment Period|Poor/non-compliance|0
7640342|NCT01598090|26581583|P2|Treatment Period|Poor/non-compliance|2
7640343|NCT01598090|26581584|P1|Treatment Period|Poor/non-compliance|0
7640344|NCT01597908|26581631|P3|Crossover Phase|Sponsor Decision|20
7640345|NCT01597908|26581632|P2|Crossover Phase|Sponsor Decision|0
7640346|NCT01597908|26581633|P1|Crossover Phase|Sponsor Decision|0
7640347|NCT01597908|26581631|P3|Crossover Phase|Withdrawal by Subject|3
7640348|NCT01597908|26581632|P2|Crossover Phase|Withdrawal by Subject|0
7640349|NCT01597908|26581633|P1|Crossover Phase|Withdrawal by Subject|0
7640350|NCT01597908|26581631|P3|Crossover Phase|Death|11
7640351|NCT01597908|26581632|P2|Crossover Phase|Death|0
7640352|NCT01597908|26581633|P1|Crossover Phase|Death|0
7640353|NCT01597908|26581631|P3|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7640354|NCT01597908|26581632|P2|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
7640355|NCT01597908|26581633|P1|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7640356|NCT01597908|26581631|P3|Randomized Phase|Withdrawal by Subject|0
7640357|NCT01597908|26581632|P2|Randomized Phase|Withdrawal by Subject|22
7640358|NCT01597908|26581633|P1|Randomized Phase|Withdrawal by Subject|26
7640359|NCT01597908|26581631|P3|Randomized Phase|Physician Decision|0
7640360|NCT01597908|26581632|P2|Randomized Phase|Physician Decision|3
7640361|NCT01597908|26581633|P1|Randomized Phase|Physician Decision|6
7640362|NCT01597908|26581631|P3|Randomized Phase|Lost to Follow-up|0
7640363|NCT01597908|26581632|P2|Randomized Phase|Lost to Follow-up|16
7640364|NCT01597908|26581633|P1|Randomized Phase|Lost to Follow-up|9
7640365|NCT01597908|26581631|P3|Randomized Phase|Sponsor Decision|0
7640366|NCT01597908|26581632|P2|Randomized Phase|Sponsor Decision|39
7640367|NCT01597908|26581633|P1|Randomized Phase|Sponsor Decision|93
7640368|NCT01597908|26581631|P3|Randomized Phase|Death|0
7640369|NCT01597908|26581632|P2|Randomized Phase|Death|238
7640370|NCT01597908|26581633|P1|Randomized Phase|Death|217
7640371|NCT01597791|26581684|P2|Overall Study|Protocol Violation|1
7640372|NCT01597791|26581685|P1|Overall Study|Protocol Violation|0
7640373|NCT01597791|26581684|P2|Overall Study|Subject withdrawal|1
7640374|NCT01597791|26581685|P1|Overall Study|Subject withdrawal|0
7640375|NCT01597791|26581684|P2|Overall Study|Cesarean Section|7
7640376|NCT01597791|26581685|P1|Overall Study|Cesarean Section|6
7640377|NCT01597791|26581684|P2|Overall Study|Physician Decision|1
7640378|NCT01597791|26581685|P1|Overall Study|Physician Decision|2
7640379|NCT01597635|26581772|P3|Part B|Withdrawal by Subject|0
7640380|NCT01597635|26581773|P2|Part B|Withdrawal by Subject|1
7640381|NCT01597635|26581774|P1|Part B|Withdrawal by Subject|0
7640382|NCT01597635|26581772|P3|Part B|Protocol-defined stopping criteria|3
7640383|NCT01597635|26581773|P2|Part B|Protocol-defined stopping criteria|4
7640384|NCT01597635|26581774|P1|Part B|Protocol-defined stopping criteria|0
7640385|NCT01597635|26581772|P3|Part B|Protocol Violation|0
7640386|NCT01597635|26581773|P2|Part B|Protocol Violation|1
7640387|NCT01597635|26581774|P1|Part B|Protocol Violation|0
7640388|NCT01597635|26581772|P3|Part B|Adverse Event|1
7640389|NCT01597635|26581773|P2|Part B|Adverse Event|0
7640390|NCT01597635|26581774|P1|Part B|Adverse Event|0
7640391|NCT01597635|26581772|P3|Part A|Adverse Event|0
7640392|NCT01597635|26581773|P2|Part A|Adverse Event|0
7640393|NCT01597635|26581774|P1|Part A|Adverse Event|3
7640394|NCT01597622|26581837|P1|Overall Study|Death|1
7640395|NCT01597622|26581837|P1|Overall Study|Withdrawal by Subject|20
7640396|NCT01597622|26581837|P1|Overall Study|Investigator Discretion|5
7640397|NCT01597622|26581837|P1|Overall Study|Lost to Follow-up|1
7640398|NCT01597622|26581837|P1|Overall Study|Protocol Violation|1
7640399|NCT01597622|26581837|P1|Overall Study|Lack of Efficacy|3
7640400|NCT01597622|26581837|P1|Overall Study|Adverse Event|7
7640401|NCT01597596|26581844|P2|Overall Study|Physician Decision|1
7640402|NCT01597596|26581845|P1|Overall Study|Physician Decision|0
7640403|NCT01597596|26581844|P2|Overall Study|Study terminated by sponsor|0
7640404|NCT01597596|26581845|P1|Overall Study|Study terminated by sponsor|1
7640405|NCT01597557|26581859|P2|Overall Study|Did not undergo cardioversion procedure|3
7640406|NCT01597557|26581860|P1|Overall Study|Did not undergo cardioversion procedure|4
7640407|NCT01597505|26581872|P2|Overall Study|Missing|0
7640408|NCT01597505|26581873|P1|Overall Study|Missing|1
7640409|NCT01597505|26581872|P2|Overall Study|Other|6
7640410|NCT01597505|26581873|P1|Overall Study|Other|5
7640411|NCT01597505|26581872|P2|Overall Study|Withdrawal by Subject|18
7640412|NCT01597505|26581873|P1|Overall Study|Withdrawal by Subject|10
7640413|NCT01597505|26581872|P2|Overall Study|Lost to Follow-up|2
7640414|NCT01597505|26581873|P1|Overall Study|Lost to Follow-up|4
7640415|NCT01597505|26581872|P2|Overall Study|Adverse Event|7
7640416|NCT01597505|26581873|P1|Overall Study|Adverse Event|19
7640417|NCT01597505|26581872|P2|Overall Study|Physician Decision|0
7640418|NCT01597505|26581873|P1|Overall Study|Physician Decision|5
7640419|NCT01597492|26581907|P2|Overall Study|Other Reason|0
7640420|NCT01597492|26581908|P1|Overall Study|Other Reason|2
7640421|NCT01597492|26581907|P2|Overall Study|Lost to Follow-up|2
7640422|NCT01597492|26581908|P1|Overall Study|Lost to Follow-up|0
7640423|NCT01597492|26581907|P2|Overall Study|Adverse Event|0
7640424|NCT01597492|26581908|P1|Overall Study|Adverse Event|3
7640425|NCT01597492|26581907|P2|Overall Study|Withdrawal by Subject|2
7640426|NCT01597492|26581908|P1|Overall Study|Withdrawal by Subject|1
7640427|NCT01597479|26581916|P2|Overall Study|Lost to Follow-up|0
7640428|NCT01597479|26581917|P1|Overall Study|Lost to Follow-up|1
7640429|NCT01597479|26581916|P2|Overall Study|Protocol Violation|0
7640430|NCT01597479|26581917|P1|Overall Study|Protocol Violation|1
7640431|NCT01597375|26582203|P2|Second Intervention|Failed to react at both Aspirin|1
7640432|NCT01597375|26582204|P1|Second Intervention|Failed to react at both Aspirin|1
7640433|NCT01597375|26582203|P2|Washout (2 Weeks)|Adverse Event|0
7640434|NCT01597375|26582204|P1|Washout (2 Weeks)|Adverse Event|1
7640435|NCT01597375|26582203|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
7640436|NCT01597375|26582204|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
7640437|NCT01597375|26582203|P2|First Intervention (4 Weeks)|Needed surgery|0
7640438|NCT01597375|26582204|P1|First Intervention (4 Weeks)|Needed surgery|1
7640439|NCT01597375|26582203|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
7640440|NCT01597375|26582204|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
7640441|NCT01597258|26582221|P1|Overall Study|No Drug Administration|1
7640442|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640443|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
7640444|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640445|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640446|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640447|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640448|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640449|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640450|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640451|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640452|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640453|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640454|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640455|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640456|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640457|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640458|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640459|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640460|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640461|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640462|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7640463|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640464|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7640465|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640466|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640467|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7640468|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640469|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640470|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640471|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640472|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640473|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640474|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640475|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640476|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640477|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640478|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640479|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640480|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640481|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640482|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640483|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7640484|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640485|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
7640486|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640487|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640488|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
7640489|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640490|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640491|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640492|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640493|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640494|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640495|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640496|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640497|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640498|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640499|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640500|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640501|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640502|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640503|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640504|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7640505|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
7640506|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
7640507|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640508|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640509|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
7640510|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640511|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640512|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640513|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640514|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640515|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640516|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640517|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640518|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640519|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640520|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640521|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640522|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640523|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640524|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640525|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7640526|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7640527|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
7640528|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640529|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640530|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7640531|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640532|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640533|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640534|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640535|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640536|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640537|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640538|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640539|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640540|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640541|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640542|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640543|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640544|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640545|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640546|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7640547|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
7640548|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
7640549|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
7640550|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640551|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640552|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640553|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640554|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640555|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640556|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640557|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640558|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640559|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640560|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640561|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640562|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640563|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640564|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640565|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640566|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640567|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7640568|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
7640569|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
7640570|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640571|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640572|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
7640573|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640574|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640575|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640576|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640577|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640578|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640579|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640580|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640581|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640582|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640583|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640584|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640585|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640586|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640587|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640588|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7640589|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
7640590|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
7640591|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7640592|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7640593|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640594|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640595|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640596|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640597|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640598|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640599|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640600|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640601|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640602|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640603|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640604|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640605|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640606|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640607|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640608|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640609|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7640610|NCT01597245|26582230|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
7640611|NCT01597245|26582231|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
7640612|NCT01597245|26582232|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
7640613|NCT01597245|26582233|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
7640614|NCT01597245|26582234|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
7640615|NCT01597245|26582235|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640616|NCT01597245|26582236|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640617|NCT01597245|26582237|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640618|NCT01597245|26582238|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640619|NCT01597245|26582239|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640620|NCT01597245|26582240|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640621|NCT01597245|26582241|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640622|NCT01597245|26582242|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640623|NCT01597245|26582243|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7641270|NCT01595009|26583019|P4|Core|Lost to Follow-up|0
7640624|NCT01597245|26582244|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640625|NCT01597245|26582245|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640626|NCT01597245|26582246|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640627|NCT01597245|26582247|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640628|NCT01597245|26582248|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640629|NCT01597245|26582249|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640630|NCT01597245|26582250|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7640631|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640632|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640633|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640634|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640635|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640636|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640637|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640638|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
7640639|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640640|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640641|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640642|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640643|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640644|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640645|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640646|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640647|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640648|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640649|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640650|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640651|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7640652|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640653|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640654|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640655|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640656|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640657|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7640658|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7640659|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640660|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640661|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640662|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640663|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640664|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640665|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640666|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640667|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640668|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640669|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640670|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640671|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640672|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7640673|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640674|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640675|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640676|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640677|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640678|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7640679|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7640680|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640681|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640682|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640683|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640684|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640685|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640686|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640687|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640688|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640689|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640690|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640691|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7641271|NCT01595009|26583020|P3|Core|Lost to Follow-up|0
7640692|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640693|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7640694|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640695|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640696|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640697|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640698|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640699|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7640700|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7640701|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640702|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640703|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640704|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640705|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640706|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640707|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640708|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640709|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640710|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640711|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640712|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640713|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640714|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7640715|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Death|0
7640716|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Death|0
7640717|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Death|0
7640718|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Death|0
7640719|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Death|0
7640720|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Death|8
7640721|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Death|8
7640722|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Death|0
7640723|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Death|0
7640724|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Death|0
7640725|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Death|0
7640726|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Death|0
7640727|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Death|0
7640728|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Death|0
7640729|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Death|0
7640730|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Death|0
7640731|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Death|0
7640732|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Death|0
7640733|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Death|0
7640734|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Death|0
7640735|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Death|0
7640736|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640737|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640738|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640739|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640740|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640741|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
7640742|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
7640743|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
7640744|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640745|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640746|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640747|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640748|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640749|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640750|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640751|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640752|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640753|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640754|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640755|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640756|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7640757|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640758|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640759|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640760|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640761|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640762|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7641272|NCT01595009|26583021|P2|Core|Lost to Follow-up|2
7640763|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7640764|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640765|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640766|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640767|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640768|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640769|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640770|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640771|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640772|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640773|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640774|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640775|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640776|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640777|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7640778|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640779|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640780|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640781|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640782|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640783|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7640784|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7640785|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640786|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640787|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640788|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640789|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640790|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640791|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640792|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640793|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640794|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640795|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640796|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640797|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640798|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7640799|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640800|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640801|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640802|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640803|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640804|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
7640805|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
7640806|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
7640807|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640808|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640809|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640810|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640811|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640812|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640813|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640814|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640815|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640816|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640817|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640818|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640819|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7640820|NCT01597245|26582230|P21|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640821|NCT01597245|26582231|P20|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640822|NCT01597245|26582232|P19|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640823|NCT01597245|26582233|P18|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640824|NCT01597245|26582234|P17|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640825|NCT01597245|26582235|P16|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
7640826|NCT01597245|26582236|P15|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
7640827|NCT01597245|26582237|P14|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
7640828|NCT01597245|26582238|P13|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640829|NCT01597245|26582239|P12|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640830|NCT01597245|26582240|P11|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7641273|NCT01595009|26583022|P1|Core|Lost to Follow-up|1
7640831|NCT01597245|26582241|P10|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640832|NCT01597245|26582242|P9|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640833|NCT01597245|26582243|P8|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640834|NCT01597245|26582244|P7|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640835|NCT01597245|26582245|P6|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640836|NCT01597245|26582246|P5|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640837|NCT01597245|26582247|P4|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640838|NCT01597245|26582248|P3|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640839|NCT01597245|26582249|P2|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640840|NCT01597245|26582250|P1|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7640841|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640842|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640843|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640844|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640845|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640846|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640847|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640848|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640849|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640850|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640851|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
7640852|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640853|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640854|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640855|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640856|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640857|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640858|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640859|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640860|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640861|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7640862|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640863|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640864|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640865|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640866|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640867|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640868|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640869|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640870|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640871|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7640872|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7640873|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7640874|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7640875|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640876|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640877|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7640878|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640879|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640880|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640881|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640882|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7640883|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640884|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640885|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640886|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640887|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640888|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640889|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640890|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640891|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7640892|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7640893|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7640894|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7640895|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7640896|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640897|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7640898|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
7640899|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
7640900|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640901|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640902|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640903|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7640904|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640905|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640906|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640907|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640908|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640909|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640910|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640911|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640912|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7640913|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640914|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
7640915|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7640916|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
7640917|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640918|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640919|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640920|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7640921|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640922|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640923|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640924|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7640925|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640926|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640927|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640928|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640929|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640930|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640931|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640932|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640933|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7640934|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
7640935|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
7640936|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7640937|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7640938|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640939|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7640940|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7640941|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7640942|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640943|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640944|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640945|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7640946|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640947|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640948|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640949|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640950|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640951|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640952|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640953|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640954|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7640955|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7640956|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7640957|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7640958|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7640959|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7640960|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7640961|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7640962|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
7640963|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640964|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640965|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640966|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7640967|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640968|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7641274|NCT01595009|26583019|P4|Core|Death|0
7640969|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640970|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640971|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640972|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640973|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640974|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640975|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
7640976|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
7640977|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
7640978|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640979|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
7640980|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640981|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640982|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
7640983|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640984|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640985|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640986|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640987|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7640988|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640989|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640990|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640991|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640992|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640993|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640994|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640995|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640996|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640997|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640998|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7640999|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|114
7641000|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7641001|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
7641002|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|80
7641003|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|22
7641004|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|150
7641005|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7641006|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7641007|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7641008|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7641009|NCT01597245|26582230|P21|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641010|NCT01597245|26582231|P20|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641011|NCT01597245|26582232|P19|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641012|NCT01597245|26582233|P18|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641013|NCT01597245|26582234|P17|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641014|NCT01597245|26582235|P16|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641015|NCT01597245|26582236|P15|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641016|NCT01597245|26582237|P14|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641017|NCT01597245|26582238|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641018|NCT01597245|26582239|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641019|NCT01597245|26582240|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641020|NCT01597245|26582241|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641021|NCT01597245|26582242|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641022|NCT01597245|26582243|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641023|NCT01597245|26582244|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7641024|NCT01597245|26582245|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7641025|NCT01597245|26582246|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641026|NCT01597245|26582247|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641027|NCT01597245|26582248|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641028|NCT01597245|26582249|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641029|NCT01597245|26582250|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7641030|NCT01597245|26582230|P21|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641031|NCT01597245|26582231|P20|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641032|NCT01597245|26582232|P19|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641033|NCT01597245|26582233|P18|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641034|NCT01597245|26582234|P17|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641035|NCT01597245|26582235|P16|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641036|NCT01597245|26582236|P15|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641037|NCT01597245|26582237|P14|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641038|NCT01597245|26582238|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641039|NCT01597245|26582239|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641275|NCT01595009|26583020|P3|Core|Death|0
7641040|NCT01597245|26582240|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641041|NCT01597245|26582241|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641042|NCT01597245|26582242|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641043|NCT01597245|26582243|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641044|NCT01597245|26582244|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641045|NCT01597245|26582245|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641046|NCT01597245|26582246|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641047|NCT01597245|26582247|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7641048|NCT01597245|26582248|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
7641049|NCT01597245|26582249|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7641050|NCT01597245|26582250|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7641051|NCT01597245|26582230|P21|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641052|NCT01597245|26582231|P20|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641053|NCT01597245|26582232|P19|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641054|NCT01597245|26582233|P18|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641055|NCT01597245|26582234|P17|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641056|NCT01597245|26582235|P16|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641057|NCT01597245|26582236|P15|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641058|NCT01597245|26582237|P14|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641059|NCT01597245|26582238|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641060|NCT01597245|26582239|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641061|NCT01597245|26582240|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641062|NCT01597245|26582241|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641063|NCT01597245|26582242|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641064|NCT01597245|26582243|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641065|NCT01597245|26582244|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641066|NCT01597245|26582245|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641067|NCT01597245|26582246|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641068|NCT01597245|26582247|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
7641069|NCT01597245|26582248|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641070|NCT01597245|26582249|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
7641071|NCT01597245|26582250|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
7641072|NCT01597245|26582230|P21|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641073|NCT01597245|26582231|P20|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641074|NCT01597245|26582232|P19|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641075|NCT01597245|26582233|P18|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641076|NCT01597245|26582234|P17|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641077|NCT01597245|26582235|P16|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641078|NCT01597245|26582236|P15|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641079|NCT01597245|26582237|P14|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641080|NCT01597245|26582238|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641081|NCT01597245|26582239|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641082|NCT01597245|26582240|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641083|NCT01597245|26582241|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641084|NCT01597245|26582242|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641085|NCT01597245|26582243|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641086|NCT01597245|26582244|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641087|NCT01597245|26582245|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641088|NCT01597245|26582246|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641089|NCT01597245|26582247|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7641090|NCT01597245|26582248|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
7641091|NCT01597245|26582249|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
7641092|NCT01597245|26582250|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
7641093|NCT01597245|26582230|P21|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641094|NCT01597245|26582231|P20|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641095|NCT01597245|26582232|P19|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641096|NCT01597245|26582233|P18|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641097|NCT01597245|26582234|P17|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641098|NCT01597245|26582235|P16|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641099|NCT01597245|26582236|P15|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641100|NCT01597245|26582237|P14|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641101|NCT01597245|26582238|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641102|NCT01597245|26582239|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641103|NCT01597245|26582240|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641104|NCT01597245|26582241|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641105|NCT01597245|26582242|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641106|NCT01597245|26582243|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641107|NCT01597245|26582244|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641108|NCT01597245|26582245|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641109|NCT01597245|26582246|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7641110|NCT01597245|26582247|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7641111|NCT01597245|26582248|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
7641112|NCT01597245|26582249|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
7641113|NCT01597245|26582250|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7641114|NCT01597245|26582230|P21|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641115|NCT01597245|26582231|P20|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641116|NCT01597245|26582232|P19|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641117|NCT01597245|26582233|P18|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641118|NCT01597245|26582234|P17|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641119|NCT01597245|26582235|P16|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641120|NCT01597245|26582236|P15|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641121|NCT01597245|26582237|P14|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641122|NCT01597245|26582238|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641123|NCT01597245|26582239|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641124|NCT01597245|26582240|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641125|NCT01597245|26582241|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641126|NCT01597245|26582242|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641127|NCT01597245|26582243|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641128|NCT01597245|26582244|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641129|NCT01597245|26582245|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641130|NCT01597245|26582246|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7641131|NCT01597245|26582247|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7641132|NCT01597245|26582248|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
7641133|NCT01597245|26582249|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
7641134|NCT01597245|26582250|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7641135|NCT01597245|26582230|P21|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641136|NCT01597245|26582231|P20|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641137|NCT01597245|26582232|P19|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641138|NCT01597245|26582233|P18|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641139|NCT01597245|26582234|P17|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641140|NCT01597245|26582235|P16|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641141|NCT01597245|26582236|P15|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641142|NCT01597245|26582237|P14|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641143|NCT01597245|26582238|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641144|NCT01597245|26582239|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641145|NCT01597245|26582240|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641146|NCT01597245|26582241|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641147|NCT01597245|26582242|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641148|NCT01597245|26582243|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641149|NCT01597245|26582244|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641150|NCT01597245|26582245|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641151|NCT01597245|26582246|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
7641152|NCT01597245|26582247|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
7641153|NCT01597245|26582248|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
7641154|NCT01597245|26582249|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
7641155|NCT01597245|26582250|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
7641156|NCT01597193|26582348|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7641157|NCT01597193|26582349|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7641158|NCT01597193|26582350|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7641159|NCT01597193|26582351|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7641160|NCT01597193|26582352|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7641161|NCT01597193|26582353|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7641162|NCT01597193|26582354|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7641163|NCT01597193|26582348|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
7641164|NCT01597193|26582349|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
7641165|NCT01597193|26582350|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
7641166|NCT01597193|26582351|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
7641167|NCT01597193|26582352|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
7641168|NCT01597193|26582353|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
7641169|NCT01597193|26582354|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
7641170|NCT01597193|26582348|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
7641171|NCT01597193|26582349|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7641172|NCT01597193|26582350|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7641173|NCT01597193|26582351|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7641174|NCT01597193|26582352|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7641175|NCT01597193|26582353|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7641176|NCT01597193|26582354|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7641177|NCT01597193|26582348|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7641178|NCT01597193|26582349|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
7641179|NCT01597193|26582350|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
7641180|NCT01597193|26582351|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
7641181|NCT01597193|26582352|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7641182|NCT01597193|26582353|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7641183|NCT01597193|26582354|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7641184|NCT01597193|26582348|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7641185|NCT01597193|26582349|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7641186|NCT01597193|26582350|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7641187|NCT01597193|26582351|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7641188|NCT01597193|26582352|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7641189|NCT01597193|26582353|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
7641190|NCT01597193|26582354|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
7641191|NCT01597050|26582473|P2|Overall Study|Withdrawal by Subject|0
7641192|NCT01597050|26582474|P1|Overall Study|Withdrawal by Subject|1
7641193|NCT01596972|26582482|P2|Overall Study|Withdrawal by Subject|1
7641194|NCT01596972|26582483|P1|Overall Study|Withdrawal by Subject|0
7641195|NCT01596972|26582482|P2|Overall Study|Lost to Follow-up|4
7641196|NCT01596972|26582483|P1|Overall Study|Lost to Follow-up|0
7641197|NCT01596972|26582482|P2|Overall Study|Physician Decision|9
7641198|NCT01596972|26582483|P1|Overall Study|Physician Decision|1
7641199|NCT01596582|26582559|P2|Overall Study|Missing all outcome data|1
7641200|NCT01596582|26582560|P1|Overall Study|Missing all outcome data|1
7641201|NCT01596582|26582559|P2|Overall Study|Deemed ineligible after study visit|6
7641202|NCT01596582|26582560|P1|Overall Study|Deemed ineligible after study visit|3
7641203|NCT01596504|26582587|P3|Overall Study|Withdrawal by Subject|0
7641204|NCT01596504|26582588|P2|Overall Study|Withdrawal by Subject|0
7641205|NCT01596504|26582589|P1|Overall Study|Withdrawal by Subject|1
7641206|NCT01596504|26582587|P3|Overall Study|Adverse Event|1
7641207|NCT01596504|26582588|P2|Overall Study|Adverse Event|2
7641208|NCT01596504|26582589|P1|Overall Study|Adverse Event|1
7641209|NCT01596504|26582587|P3|Overall Study|Participant's Private Reason|0
7641210|NCT01596504|26582588|P2|Overall Study|Participant's Private Reason|1
7641211|NCT01596504|26582589|P1|Overall Study|Participant's Private Reason|0
7641212|NCT01596335|26582647|P2|Overall Study|exacerbation of primary disease|9
7641213|NCT01596335|26582648|P1|Overall Study|exacerbation of primary disease|5
7641214|NCT01596127|26582684|P1|Overall Study|Patient Ineligible|1
7641215|NCT01596062|26582696|P3|Overall Study|Lack of Efficacy|1
7641216|NCT01596062|26582697|P2|Overall Study|Lack of Efficacy|0
7641217|NCT01596062|26582698|P1|Overall Study|Lack of Efficacy|0
7641218|NCT01596062|26582696|P3|Overall Study|Adverse Event|2
7641219|NCT01596062|26582697|P2|Overall Study|Adverse Event|0
7641220|NCT01596062|26582698|P1|Overall Study|Adverse Event|1
7641221|NCT01595646|26582762|P3|Overall Study|Withdrawal by Subject|0
7641222|NCT01595646|26582763|P2|Overall Study|Withdrawal by Subject|0
7641223|NCT01595646|26582764|P1|Overall Study|Withdrawal by Subject|1
7641224|NCT01595529|26582786|P2|Overall Study|Entry Failure/Screening Failure|1
7641225|NCT01595529|26582787|P1|Overall Study|Entry Failure/Screening Failure|6
7641226|NCT01595529|26582786|P2|Overall Study|Administrative Decision|0
7641227|NCT01595529|26582787|P1|Overall Study|Administrative Decision|1
7641228|NCT01595529|26582786|P2|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7641229|NCT01595529|26582787|P1|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7641230|NCT01595529|26582786|P2|Overall Study|Physician Decision|0
7641231|NCT01595529|26582787|P1|Overall Study|Physician Decision|1
7641232|NCT01595529|26582786|P2|Overall Study|Protocol Violation|2
7641233|NCT01595529|26582787|P1|Overall Study|Protocol Violation|1
7641234|NCT01595529|26582786|P2|Overall Study|Lost to Follow-up|14
7641235|NCT01595529|26582787|P1|Overall Study|Lost to Follow-up|8
7641236|NCT01595529|26582786|P2|Overall Study|Subject Non-Compliant|0
7641237|NCT01595529|26582787|P1|Overall Study|Subject Non-Compliant|2
7641238|NCT01595529|26582786|P2|Overall Study|Adverse Event|0
7641239|NCT01595529|26582787|P1|Overall Study|Adverse Event|2
7641240|NCT01595438|26582850|P2|Overall Study|Other Eligibility criteria|9
7641241|NCT01595438|26582851|P1|Overall Study|Other Eligibility criteria|11
7641242|NCT01595438|26582850|P2|Overall Study|Withdrawal by Subject|12
7641243|NCT01595438|26582851|P1|Overall Study|Withdrawal by Subject|12
7641244|NCT01595438|26582850|P2|Overall Study|Lost to Follow-up|20
7641245|NCT01595438|26582851|P1|Overall Study|Lost to Follow-up|20
7641246|NCT01595009|26583019|P4|Extension|Adverse Event|1
7641247|NCT01595009|26583020|P3|Extension|Adverse Event|0
7641248|NCT01595009|26583021|P2|Extension|Adverse Event|0
7641249|NCT01595009|26583022|P1|Extension|Adverse Event|0
7641250|NCT01595009|26583019|P4|Extension|Disease progression|7
7641251|NCT01595009|26583020|P3|Extension|Disease progression|4
7641252|NCT01595009|26583021|P2|Extension|Disease progression|0
7641253|NCT01595009|26583022|P1|Extension|Disease progression|0
7641254|NCT01595009|26583019|P4|Extension|Patients completed per protocol|2
7641255|NCT01595009|26583020|P3|Extension|Patients completed per protocol|0
7641256|NCT01595009|26583021|P2|Extension|Patients completed per protocol|0
7641257|NCT01595009|26583022|P1|Extension|Patients completed per protocol|0
7641258|NCT01595009|26583019|P4|Extension|Administrative problems|1
7641259|NCT01595009|26583020|P3|Extension|Administrative problems|0
7641260|NCT01595009|26583021|P2|Extension|Administrative problems|0
7641261|NCT01595009|26583022|P1|Extension|Administrative problems|0
7641262|NCT01595009|26583019|P4|Core|Administrative problems|0
7641263|NCT01595009|26583020|P3|Core|Administrative problems|0
7641264|NCT01595009|26583021|P2|Core|Administrative problems|1
7641265|NCT01595009|26583022|P1|Core|Administrative problems|0
7641266|NCT01595009|26583019|P4|Core|Protocol deviation|0
7641267|NCT01595009|26583020|P3|Core|Protocol deviation|0
7641268|NCT01595009|26583021|P2|Core|Protocol deviation|1
7641269|NCT01595009|26583022|P1|Core|Protocol deviation|0
7641278|NCT01595009|26583019|P4|Core|Withdrawal by Subject|0
7641279|NCT01595009|26583020|P3|Core|Withdrawal by Subject|0
7641280|NCT01595009|26583021|P2|Core|Withdrawal by Subject|17
7641281|NCT01595009|26583022|P1|Core|Withdrawal by Subject|4
7641282|NCT01595009|26583019|P4|Core|Disease progression|0
7641283|NCT01595009|26583020|P3|Core|Disease progression|0
7641284|NCT01595009|26583021|P2|Core|Disease progression|26
7641285|NCT01595009|26583022|P1|Core|Disease progression|14
7641286|NCT01595009|26583019|P4|Core|Adverse Event|0
7641287|NCT01595009|26583020|P3|Core|Adverse Event|0
7641288|NCT01595009|26583021|P2|Core|Adverse Event|23
7641289|NCT01595009|26583022|P1|Core|Adverse Event|19
7641290|NCT01595009|26583019|P4|Core|Patients completed per protocol|0
7641291|NCT01595009|26583020|P3|Core|Patients completed per protocol|0
7641292|NCT01595009|26583021|P2|Core|Patients completed per protocol|44
7641293|NCT01595009|26583022|P1|Core|Patients completed per protocol|85
7641294|NCT01594970|26583057|P3|Overall Study|Lost to Follow-up|37
7641295|NCT01594970|26583058|P2|Overall Study|Lost to Follow-up|54
7641296|NCT01594970|26583059|P1|Overall Study|Lost to Follow-up|54
7641297|NCT01594970|26583057|P3|Overall Study|Adverse Event|23
7641298|NCT01594970|26583058|P2|Overall Study|Adverse Event|23
7641299|NCT01594970|26583059|P1|Overall Study|Adverse Event|17
7641300|NCT01594970|26583057|P3|Overall Study|Non-Adverse Event Related|6
7641301|NCT01594970|26583058|P2|Overall Study|Non-Adverse Event Related|5
7641302|NCT01594970|26583059|P1|Overall Study|Non-Adverse Event Related|4
7641303|NCT01594931|26583079|P3|Overall Study|No defiined|7
7641304|NCT01594931|26583080|P2|Overall Study|No defiined|4
7641305|NCT01594931|26583081|P1|Overall Study|No defiined|11
7641306|NCT01594931|26583079|P3|Overall Study|Protocol Violation|0
7641307|NCT01594931|26583080|P2|Overall Study|Protocol Violation|1
7641308|NCT01594931|26583081|P1|Overall Study|Protocol Violation|2
7641309|NCT01594931|26583079|P3|Overall Study|Lost to Follow-up|3
7641310|NCT01594931|26583080|P2|Overall Study|Lost to Follow-up|3
7641311|NCT01594931|26583081|P1|Overall Study|Lost to Follow-up|4
7641312|NCT01594931|26583079|P3|Overall Study|Lack of Efficacy|2
7641313|NCT01594931|26583080|P2|Overall Study|Lack of Efficacy|2
7641314|NCT01594931|26583081|P1|Overall Study|Lack of Efficacy|7
7641315|NCT01594931|26583079|P3|Overall Study|Withdrawal by Subject|1
7641316|NCT01594931|26583080|P2|Overall Study|Withdrawal by Subject|1
7641317|NCT01594931|26583081|P1|Overall Study|Withdrawal by Subject|2
7641318|NCT01594931|26583079|P3|Overall Study|Adverse Event|1
7641319|NCT01594931|26583080|P2|Overall Study|Adverse Event|1
7641320|NCT01594931|26583081|P1|Overall Study|Adverse Event|3
7641321|NCT01594853|26583109|P2|Overall Study|noncompliance with exercise|1
7641322|NCT01594853|26583110|P1|Overall Study|noncompliance with exercise|0
7641323|NCT01594853|26583109|P2|Overall Study|Lost to Follow-up|1
7641324|NCT01594853|26583110|P1|Overall Study|Lost to Follow-up|1
7641325|NCT01594853|26583109|P2|Overall Study|Withdrawal by Subject|1
7641326|NCT01594853|26583110|P1|Overall Study|Withdrawal by Subject|1
7641327|NCT01594827|26583118|P2|Overall Study|Physician Decision|0
7641328|NCT01594827|26583119|P1|Overall Study|Physician Decision|3
7641329|NCT01594827|26583118|P2|Overall Study|Adverse Event|0
7641330|NCT01594827|26583119|P1|Overall Study|Adverse Event|1
7641331|NCT01594762|26583143|P2|Overall Study|Lost to Follow-up|10
7641332|NCT01594762|26583144|P1|Overall Study|Lost to Follow-up|10
7641333|NCT01594762|26583143|P2|Overall Study|Withdrawal by Subject|0
7641334|NCT01594762|26583144|P1|Overall Study|Withdrawal by Subject|1
7641335|NCT01594749|26583156|P2|Overall Study|Lost Source Documentation|0
7641336|NCT01594749|26583157|P1|Overall Study|Lost Source Documentation|1
7641337|NCT01594749|26583156|P2|Overall Study|Not Treated|10
7641338|NCT01594749|26583157|P1|Overall Study|Not Treated|4
7641339|NCT01594749|26583156|P2|Overall Study|Death|3
7641340|NCT01594749|26583157|P1|Overall Study|Death|9
7641341|NCT01594749|26583156|P2|Overall Study|Lost to Follow-up|0
7641342|NCT01594749|26583157|P1|Overall Study|Lost to Follow-up|1
7641343|NCT01594749|26583156|P2|Overall Study|Non-compliance with Protocol|1
7641344|NCT01594749|26583157|P1|Overall Study|Non-compliance with Protocol|0
7641345|NCT01594749|26583156|P2|Overall Study|Physician Decision|1
7641346|NCT01594749|26583157|P1|Overall Study|Physician Decision|1
7641347|NCT01594749|26583156|P2|Overall Study|Protocol Violation|0
7641348|NCT01594749|26583157|P1|Overall Study|Protocol Violation|2
7641349|NCT01594749|26583156|P2|Overall Study|Withdrawal by Subject|2
7641350|NCT01594749|26583157|P1|Overall Study|Withdrawal by Subject|2
7641351|NCT01594749|26583156|P2|Overall Study|Adverse Event|1
7641352|NCT01594749|26583157|P1|Overall Study|Adverse Event|2
7641353|NCT01594476|26583295|P2|Overall Study|Protocol Violation|3
7641354|NCT01594476|26583296|P1|Overall Study|Protocol Violation|1
7641355|NCT01594411|26583318|P1|Overall Study|Lost to Follow-up|2
7641356|NCT01594333|26583352|P2|Overall Study|Withdrawal by Subject|63
7641357|NCT01594333|26583353|P1|Overall Study|Withdrawal by Subject|60
7641358|NCT01594333|26583352|P2|Overall Study|Lost to Follow-up|5
7641359|NCT01594333|26583353|P1|Overall Study|Lost to Follow-up|5
7641360|NCT01594333|26583352|P2|Overall Study|Death|83
7641361|NCT01594333|26583353|P1|Overall Study|Death|96
7641362|NCT01594281|26583399|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7641363|NCT01594281|26583400|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
7641364|NCT01594281|26583401|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7641365|NCT01594281|26583399|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
7641366|NCT01594281|26583400|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
7641541|NCT01592240|26584021|P3|Overall Study|Did Not Meet Entrance Criteria|1
7641367|NCT01594281|26583401|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
7641368|NCT01594281|26583399|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
7641369|NCT01594281|26583400|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7641370|NCT01594281|26583401|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7641371|NCT01594281|26583399|P3|Interventional Core Phase|Adverse Event|4
7641372|NCT01594281|26583400|P2|Interventional Core Phase|Adverse Event|4
7641373|NCT01594281|26583401|P1|Interventional Core Phase|Adverse Event|4
7641374|NCT01594281|26583399|P3|Interventional Core Phase|Lost to Follow-up|1
7641375|NCT01594281|26583400|P2|Interventional Core Phase|Lost to Follow-up|4
7641376|NCT01594281|26583401|P1|Interventional Core Phase|Lost to Follow-up|1
7641377|NCT01594281|26583399|P3|Interventional Core Phase|Death|2
7641378|NCT01594281|26583400|P2|Interventional Core Phase|Death|1
7641379|NCT01594281|26583401|P1|Interventional Core Phase|Death|1
7641380|NCT01594281|26583399|P3|Interventional Core Phase|Subject Withdrew Consent|1
7641381|NCT01594281|26583400|P2|Interventional Core Phase|Subject Withdrew Consent|1
7641382|NCT01594281|26583401|P1|Interventional Core Phase|Subject Withdrew Consent|0
7641383|NCT01594281|26583399|P3|Interventional Core Phase|Protocol Deviation|0
7641384|NCT01594281|26583400|P2|Interventional Core Phase|Protocol Deviation|0
7641385|NCT01594281|26583401|P1|Interventional Core Phase|Protocol Deviation|1
7641386|NCT01594125|26583441|P5|Overall Study|Progressive Disease|7
7641387|NCT01594125|26583442|P4|Overall Study|Progressive Disease|3
7641388|NCT01594125|26583443|P3|Overall Study|Progressive Disease|3
7641389|NCT01594125|26583444|P2|Overall Study|Progressive Disease|12
7641390|NCT01594125|26583445|P1|Overall Study|Progressive Disease|3
7641391|NCT01594125|26583441|P5|Overall Study|Withdrawal by Subject|0
7641392|NCT01594125|26583442|P4|Overall Study|Withdrawal by Subject|1
7641393|NCT01594125|26583443|P3|Overall Study|Withdrawal by Subject|0
7641394|NCT01594125|26583444|P2|Overall Study|Withdrawal by Subject|0
7641395|NCT01594125|26583445|P1|Overall Study|Withdrawal by Subject|1
7641396|NCT01593917|26583477|P1|Overall Study|Physician Decision|3
7641397|NCT01593917|26583477|P1|Overall Study|Protocol Violation|5
7641398|NCT01593917|26583477|P1|Overall Study|Lost to Follow-up|12
7641399|NCT01593917|26583477|P1|Overall Study|Withdrawal by Subject|23
7641400|NCT01593917|26583477|P1|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
7641401|NCT01593917|26583477|P1|Overall Study|Death|67
7641402|NCT01593787|26583517|P3|Overall Study|Adverse Event|0
7641403|NCT01593787|26583518|P2|Overall Study|Adverse Event|0
7641404|NCT01593787|26583519|P1|Overall Study|Adverse Event|1
7641405|NCT01593696|26583595|P4|Dose Expansion|Fungal infection|0
7641406|NCT01593696|26583596|P3|Dose Expansion|Fungal infection|1
7641407|NCT01593696|26583597|P2|Dose Expansion|Fungal infection|0
7641408|NCT01593696|26583598|P1|Dose Expansion|Fungal infection|0
7641409|NCT01593696|26583595|P4|Dose Escalation|Progressive Disease|0
7641410|NCT01593696|26583596|P3|Dose Escalation|Progressive Disease|0
7641411|NCT01593696|26583597|P2|Dose Escalation|Progressive Disease|0
7641412|NCT01593696|26583598|P1|Dose Escalation|Progressive Disease|2
7641413|NCT01593254|26583655|P2|Follow-Up Period|Study Drug Side Effects|1
7641414|NCT01593254|26583656|P1|Follow-Up Period|Study Drug Side Effects|0
7641415|NCT01593254|26583655|P2|Follow-Up Period|Disease Progression|1
7641416|NCT01593254|26583656|P1|Follow-Up Period|Disease Progression|0
7641417|NCT01593254|26583655|P2|Follow-Up Period|Fundus Hemorrhage|1
7641418|NCT01593254|26583656|P1|Follow-Up Period|Fundus Hemorrhage|0
7641419|NCT01593254|26583655|P2|Follow-Up Period|Patient refused to return|1
7641420|NCT01593254|26583656|P1|Follow-Up Period|Patient refused to return|0
7641421|NCT01593254|26583655|P2|Follow-Up Period|Study Drug Toxicity|1
7641422|NCT01593254|26583656|P1|Follow-Up Period|Study Drug Toxicity|0
7641423|NCT01593254|26583655|P2|Follow-Up Period|Pregnancy|1
7641424|NCT01593254|26583656|P1|Follow-Up Period|Pregnancy|0
7641425|NCT01593254|26583655|P2|Follow-Up Period|Subject request to Discontinue|1
7641426|NCT01593254|26583656|P1|Follow-Up Period|Subject request to Discontinue|0
7641427|NCT01593254|26583655|P2|Follow-Up Period|Death|2
7641428|NCT01593254|26583656|P1|Follow-Up Period|Death|2
7641429|NCT01593254|26583655|P2|Follow-Up Period|Non-Compliance|0
7641430|NCT01593254|26583656|P1|Follow-Up Period|Non-Compliance|1
7641431|NCT01593254|26583655|P2|Follow-Up Period|Withdrawal by Subject|2
7641432|NCT01593254|26583656|P1|Follow-Up Period|Withdrawal by Subject|0
7641433|NCT01593254|26583655|P2|Treatment Period|Investigator Decision|1
7641434|NCT01593254|26583656|P1|Treatment Period|Investigator Decision|2
7641435|NCT01593254|26583655|P2|Treatment Period|T315I MUTATION|1
7641436|NCT01593254|26583656|P1|Treatment Period|T315I MUTATION|0
7641437|NCT01593254|26583655|P2|Treatment Period|No Response|0
7641438|NCT01593254|26583656|P1|Treatment Period|No Response|1
7641439|NCT01593254|26583655|P2|Treatment Period|Patient Refused to Return|1
7641440|NCT01593254|26583656|P1|Treatment Period|Patient Refused to Return|0
7641441|NCT01593254|26583655|P2|Treatment Period|Did Not Achieve RCC|1
7641442|NCT01593254|26583656|P1|Treatment Period|Did Not Achieve RCC|0
7641443|NCT01593254|26583655|P2|Treatment Period|Disease Progression|6
7641444|NCT01593254|26583656|P1|Treatment Period|Disease Progression|1
7641445|NCT01593254|26583655|P2|Treatment Period|Study Drug Toxicity|9
7641446|NCT01593254|26583656|P1|Treatment Period|Study Drug Toxicity|3
7641447|NCT01593254|26583655|P2|Treatment Period|Death|1
7641448|NCT01593254|26583656|P1|Treatment Period|Death|2
7641449|NCT01593254|26583655|P2|Treatment Period|AE unrelated to Study Drug|1
7641450|NCT01593254|26583656|P1|Treatment Period|AE unrelated to Study Drug|0
7641451|NCT01593254|26583655|P2|Treatment Period|Subject Request to Discontinue|1
7641452|NCT01593254|26583656|P1|Treatment Period|Subject Request to Discontinue|1
7641453|NCT01593254|26583655|P2|Treatment Period|Subject withdrew consent|5
7641454|NCT01593254|26583656|P1|Treatment Period|Subject withdrew consent|0
7641455|NCT01593254|26583655|P2|Treatment Period|Maximum clinical benefit|0
7641456|NCT01593254|26583656|P1|Treatment Period|Maximum clinical benefit|1
7641457|NCT01593254|26583655|P2|Treatment Period|Poor/Non-Compliance|1
7641458|NCT01593254|26583656|P1|Treatment Period|Poor/Non-Compliance|2
7641459|NCT01593254|26583655|P2|Treatment Period|Pregnancy|1
7641460|NCT01593254|26583656|P1|Treatment Period|Pregnancy|0
7641461|NCT01593254|26583655|P2|Treatment Period|Treatment Failure|2
7641462|NCT01593254|26583656|P1|Treatment Period|Treatment Failure|1
7641463|NCT01593020|26583674|P2|Overall Study|Ineligible|0
7641464|NCT01593020|26583675|P1|Overall Study|Ineligible|1
7641465|NCT01593020|26583674|P2|Overall Study|Death|1
7641466|NCT01593020|26583675|P1|Overall Study|Death|0
7641467|NCT01593020|26583674|P2|Overall Study|Adverse Event|1
7641468|NCT01593020|26583675|P1|Overall Study|Adverse Event|1
7641469|NCT01592864|26583687|P2|Overall Study|Withdrawal by Subject|1
7641470|NCT01592864|26583688|P1|Overall Study|Withdrawal by Subject|0
7641471|NCT01592786|26583749|P1|Overall Study|Other|3
7641472|NCT01592786|26583749|P1|Overall Study|Lost to Follow-up|19
7641473|NCT01592786|26583749|P1|Overall Study|Withdrawal by Subject|23
7641474|NCT01592786|26583749|P1|Overall Study|Protocol Violation|14
7641475|NCT01592786|26583749|P1|Overall Study|Lack of Efficacy|19
7641476|NCT01592786|26583749|P1|Overall Study|Adverse Event|60
7641477|NCT01592773|26583753|P1|Overall Study|Other Reason|1
7641478|NCT01592773|26583753|P1|Overall Study|Inclusion/exclusion not meet|1
7641479|NCT01592773|26583753|P1|Overall Study|Protocol Violation|2
7641480|NCT01592773|26583753|P1|Overall Study|Lack of Efficacy|9
7641481|NCT01592773|26583753|P1|Overall Study|Adverse Event|17
7641482|NCT01592773|26583753|P1|Overall Study|Lost to Follow-up|19
7641483|NCT01592773|26583753|P1|Overall Study|Withdrawal by Subject|35
7641484|NCT01592773|26583753|P1|Overall Study|Study Terminated by Sponsor|582
7641485|NCT01592760|26583760|P3|24-hour Follow-Up|Lost to Follow-up|2
7641486|NCT01592760|26583761|P2|24-hour Follow-Up|Lost to Follow-up|3
7641487|NCT01592760|26583762|P1|24-hour Follow-Up|Lost to Follow-up|4
7641488|NCT01592747|26583806|P3|Overall Study|Other Reasons|0
7641489|NCT01592747|26583807|P2|Overall Study|Other Reasons|1
7641490|NCT01592747|26583808|P1|Overall Study|Other Reasons|1
7641491|NCT01592747|26583806|P3|Overall Study|Lost to Follow-up|1
7641492|NCT01592747|26583807|P2|Overall Study|Lost to Follow-up|0
7641493|NCT01592747|26583808|P1|Overall Study|Lost to Follow-up|1
7641494|NCT01592747|26583806|P3|Overall Study|Withdrawal by Subject|2
7641495|NCT01592747|26583807|P2|Overall Study|Withdrawal by Subject|0
7641496|NCT01592747|26583808|P1|Overall Study|Withdrawal by Subject|2
7641497|NCT01592747|26583806|P3|Overall Study|Lack of Efficacy|0
7641498|NCT01592747|26583807|P2|Overall Study|Lack of Efficacy|1
7641499|NCT01592747|26583808|P1|Overall Study|Lack of Efficacy|0
7641500|NCT01592747|26583806|P3|Overall Study|Protocol Violation|4
7641501|NCT01592747|26583807|P2|Overall Study|Protocol Violation|0
7641502|NCT01592747|26583808|P1|Overall Study|Protocol Violation|4
7641503|NCT01592747|26583806|P3|Overall Study|Adverse Event|0
7641504|NCT01592747|26583807|P2|Overall Study|Adverse Event|0
7641505|NCT01592747|26583808|P1|Overall Study|Adverse Event|1
7641506|NCT01592747|26583806|P3|Overall Study|Inclusion/Exclusion criteria not met|1
7641507|NCT01592747|26583807|P2|Overall Study|Inclusion/Exclusion criteria not met|1
7641508|NCT01592747|26583808|P1|Overall Study|Inclusion/Exclusion criteria not met|0
7641509|NCT01592747|26583806|P3|Overall Study|Loss of Therapeutic Response|100
7641510|NCT01592747|26583807|P2|Overall Study|Loss of Therapeutic Response|108
7641511|NCT01592747|26583808|P1|Overall Study|Loss of Therapeutic Response|107
7641512|NCT01592708|26583851|P2|Overall Study|Protocol Violation|0
7641513|NCT01592708|26583852|P1|Overall Study|Protocol Violation|3
7641514|NCT01592695|26583868|P2|Overall Study|Lost to Follow-up|4
7641515|NCT01592695|26583869|P1|Overall Study|Lost to Follow-up|8
7641516|NCT01592409|26583924|P2|Overall Study|Withdrawal by Subject|1
7641517|NCT01592409|26583925|P1|Overall Study|Withdrawal by Subject|0
7641518|NCT01592383|26583949|P1|Overall Study|Adverse Event|1
7641519|NCT01592344|26583960|P2|Overall Study|not available at primary outcome visit|4
7641520|NCT01592344|26583961|P1|Overall Study|not available at primary outcome visit|2
7641521|NCT01592344|26583960|P2|Overall Study|Lack of Efficacy|0
7641522|NCT01592344|26583961|P1|Overall Study|Lack of Efficacy|1
7641523|NCT01592344|26583960|P2|Overall Study|Adverse Event|1
7641524|NCT01592344|26583961|P1|Overall Study|Adverse Event|1
7641525|NCT01592292|26583975|P4|Overall Study|Other|1
7641526|NCT01592292|26583976|P3|Overall Study|Other|2
7641527|NCT01592292|26583977|P2|Overall Study|Other|1
7641528|NCT01592292|26583978|P1|Overall Study|Other|1
7641529|NCT01592292|26583975|P4|Overall Study|Withdrew consent|0
7641530|NCT01592292|26583976|P3|Overall Study|Withdrew consent|0
7641531|NCT01592292|26583977|P2|Overall Study|Withdrew consent|1
7641532|NCT01592292|26583978|P1|Overall Study|Withdrew consent|2
7641533|NCT01592292|26583975|P4|Overall Study|Follow-up loss|0
7641534|NCT01592292|26583976|P3|Overall Study|Follow-up loss|1
7641535|NCT01592292|26583977|P2|Overall Study|Follow-up loss|3
7641536|NCT01592292|26583978|P1|Overall Study|Follow-up loss|3
7641537|NCT01592240|26584017|P7|Overall Study|Did Not Meet Entrance Criteria|0
7641538|NCT01592240|26584018|P6|Overall Study|Did Not Meet Entrance Criteria|0
7641539|NCT01592240|26584019|P5|Overall Study|Did Not Meet Entrance Criteria|0
7641540|NCT01592240|26584020|P4|Overall Study|Did Not Meet Entrance Criteria|0
7641542|NCT01592240|26584022|P2|Overall Study|Did Not Meet Entrance Criteria|0
7641543|NCT01592240|26584023|P1|Overall Study|Did Not Meet Entrance Criteria|1
7641544|NCT01592240|26584017|P7|Overall Study|Other|1
7641545|NCT01592240|26584018|P6|Overall Study|Other|0
7641546|NCT01592240|26584019|P5|Overall Study|Other|0
7641547|NCT01592240|26584020|P4|Overall Study|Other|1
7641548|NCT01592240|26584021|P3|Overall Study|Other|1
7641549|NCT01592240|26584022|P2|Overall Study|Other|3
7641550|NCT01592240|26584023|P1|Overall Study|Other|0
7641551|NCT01592240|26584017|P7|Overall Study|Withdrawal by Subject|2
7641552|NCT01592240|26584018|P6|Overall Study|Withdrawal by Subject|0
7641553|NCT01592240|26584019|P5|Overall Study|Withdrawal by Subject|3
7641554|NCT01592240|26584020|P4|Overall Study|Withdrawal by Subject|1
7641555|NCT01592240|26584021|P3|Overall Study|Withdrawal by Subject|4
7641556|NCT01592240|26584022|P2|Overall Study|Withdrawal by Subject|4
7641557|NCT01592240|26584023|P1|Overall Study|Withdrawal by Subject|0
7641558|NCT01592240|26584017|P7|Overall Study|Protocol Violation|0
7641559|NCT01592240|26584018|P6|Overall Study|Protocol Violation|1
7641560|NCT01592240|26584019|P5|Overall Study|Protocol Violation|0
7641561|NCT01592240|26584020|P4|Overall Study|Protocol Violation|0
7641562|NCT01592240|26584021|P3|Overall Study|Protocol Violation|0
7641563|NCT01592240|26584022|P2|Overall Study|Protocol Violation|0
7641564|NCT01592240|26584023|P1|Overall Study|Protocol Violation|0
7641565|NCT01592240|26584017|P7|Overall Study|Lost to Follow-up|0
7641566|NCT01592240|26584018|P6|Overall Study|Lost to Follow-up|2
7641567|NCT01592240|26584019|P5|Overall Study|Lost to Follow-up|3
7641568|NCT01592240|26584020|P4|Overall Study|Lost to Follow-up|0
7641569|NCT01592240|26584021|P3|Overall Study|Lost to Follow-up|1
7641570|NCT01592240|26584022|P2|Overall Study|Lost to Follow-up|3
7641571|NCT01592240|26584023|P1|Overall Study|Lost to Follow-up|1
7641572|NCT01592240|26584017|P7|Overall Study|Death|0
7641573|NCT01592240|26584018|P6|Overall Study|Death|0
7641574|NCT01592240|26584019|P5|Overall Study|Death|0
7641575|NCT01592240|26584020|P4|Overall Study|Death|0
7641576|NCT01592240|26584021|P3|Overall Study|Death|0
7641577|NCT01592240|26584022|P2|Overall Study|Death|1
7641578|NCT01592240|26584023|P1|Overall Study|Death|0
7641579|NCT01592240|26584017|P7|Overall Study|Adverse Event|0
7641580|NCT01592240|26584018|P6|Overall Study|Adverse Event|0
7641581|NCT01592240|26584019|P5|Overall Study|Adverse Event|1
7641582|NCT01592240|26584020|P4|Overall Study|Adverse Event|1
7641583|NCT01592240|26584021|P3|Overall Study|Adverse Event|0
7641584|NCT01592240|26584022|P2|Overall Study|Adverse Event|0
7641585|NCT01592240|26584023|P1|Overall Study|Adverse Event|1
7641586|NCT01592045|26584216|P2|Overall Study|Moved out of country|0
7641587|NCT01592045|26584217|P1|Overall Study|Moved out of country|2
7641588|NCT01592045|26584216|P2|Overall Study|Withdrawal by Subject|0
7641589|NCT01592045|26584217|P1|Overall Study|Withdrawal by Subject|1
7641590|NCT01592045|26584216|P2|Overall Study|Adverse Event|1
7641591|NCT01592045|26584217|P1|Overall Study|Adverse Event|1
7641592|NCT01592045|26584216|P2|Overall Study|Disease Progression|1
7641593|NCT01592045|26584217|P1|Overall Study|Disease Progression|1
7641594|NCT01591863|26584235|P1|Overall Study|Lack of Efficacy|1
7641595|NCT01591863|26584235|P1|Overall Study|recurrence|9
7641596|NCT01591863|26584235|P1|Overall Study|Withdrawal by Subject|1
7641597|NCT01591863|26584235|P1|Overall Study|Adverse Event|3
7641598|NCT01591785|26584264|P2|Overall Study|Lost to Follow-up|0
7641599|NCT01591785|26584265|P1|Overall Study|Lost to Follow-up|1
7641600|NCT01591785|26584264|P2|Overall Study|Protocol Violation|0
7641601|NCT01591785|26584265|P1|Overall Study|Protocol Violation|2
7641602|NCT01591785|26584264|P2|Overall Study|worsening condition|2
7641603|NCT01591785|26584265|P1|Overall Study|worsening condition|1
7641604|NCT01591681|26584307|P1|Overall Study|Failed to use system during run-in|1
7641605|NCT01591681|26584307|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
7641606|NCT01591616|26584354|P1|Overall Study|Withdrawal by Subject|1
7641607|NCT01591499|26584495|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7641608|NCT01591499|26584496|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
7641609|NCT01591499|26584497|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7641610|NCT01591499|26584498|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
7641611|NCT01591499|26584495|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7641612|NCT01591499|26584496|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7641613|NCT01591499|26584497|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7641614|NCT01591499|26584498|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7641615|NCT01591499|26584495|P4|Baseline Visit|Withdrawal by Subject|2
7641616|NCT01591499|26584496|P3|Baseline Visit|Withdrawal by Subject|0
7641617|NCT01591499|26584497|P2|Baseline Visit|Withdrawal by Subject|2
7641618|NCT01591499|26584498|P1|Baseline Visit|Withdrawal by Subject|0
7641619|NCT01591460|26584564|P1|Overall Study|Protocol Violation|1
7641620|NCT01591460|26584564|P1|Overall Study|Withdrawal by Subject|1
7641621|NCT01591460|26584564|P1|Overall Study|Participant Refusal|3
7641622|NCT01591460|26584564|P1|Overall Study|Noncompliance|1
7641623|NCT01591460|26584564|P1|Overall Study|Lost to Follow-up|1
7641624|NCT01591460|26584564|P1|Overall Study|Treatment Discontinued by Error|1
7641625|NCT01591460|26584564|P1|Overall Study|Rebound or Breakthrough|3
7641626|NCT01591460|26584564|P1|Overall Study|Futility Rule (Week 24)|3
7641627|NCT01591460|26584564|P1|Overall Study|Futility Rule (Week 12)|7
7641628|NCT01591460|26584564|P1|Overall Study|Adverse Event or Intercurrent Illness|5
7641629|NCT01591382|26584655|P2|Overall Study|Participant Opted for Morphine PCA|1
7641630|NCT01591382|26584656|P1|Overall Study|Participant Opted for Morphine PCA|1
7641631|NCT01591382|26584655|P2|Overall Study|Discharged Prior to Study Completion|1
7641632|NCT01591382|26584656|P1|Overall Study|Discharged Prior to Study Completion|2
7641633|NCT01591330|26584670|P4|Period 2|Adverse Event|0
7641634|NCT01591330|26584671|P3|Period 2|Adverse Event|0
7641635|NCT01591330|26584672|P2|Period 2|Adverse Event|0
7641636|NCT01591330|26584673|P1|Period 2|Adverse Event|1
7641637|NCT01591330|26584670|P4|Washout of at Least 3 Days|Withdrawal by Subject|0
7641638|NCT01591330|26584671|P3|Washout of at Least 3 Days|Withdrawal by Subject|0
7641639|NCT01591330|26584672|P2|Washout of at Least 3 Days|Withdrawal by Subject|0
7641640|NCT01591330|26584673|P1|Washout of at Least 3 Days|Withdrawal by Subject|1
7641641|NCT01591330|26584670|P4|Period 1|Adverse Event|0
7641642|NCT01591330|26584671|P3|Period 1|Adverse Event|0
7641643|NCT01591330|26584672|P2|Period 1|Adverse Event|0
7641644|NCT01591330|26584673|P1|Period 1|Adverse Event|1
7641645|NCT01591096|26584781|P1|Overall Study|Adverse Event|1
7641646|NCT01590888|26584866|P3|Overall Study|Lost to Follow-up|0
7641647|NCT01590888|26584867|P2|Overall Study|Lost to Follow-up|0
7641648|NCT01590888|26584868|P1|Overall Study|Lost to Follow-up|1
7641649|NCT01590888|26584866|P3|Overall Study|Adverse Event|1
7641650|NCT01590888|26584867|P2|Overall Study|Adverse Event|0
7641651|NCT01590888|26584868|P1|Overall Study|Adverse Event|3
7641652|NCT01590810|26584928|P5|Overall Study|Physician Decision|0
7641653|NCT01590810|26584929|P4|Overall Study|Physician Decision|0
7641654|NCT01590810|26584930|P3|Overall Study|Physician Decision|1
7641655|NCT01590810|26584931|P2|Overall Study|Physician Decision|1
7641656|NCT01590810|26584932|P1|Overall Study|Physician Decision|0
7641657|NCT01590797|26585077|P2|Overall Study|Other Protocol Specified Criteria|4
7641658|NCT01590797|26585078|P1|Overall Study|Other Protocol Specified Criteria|2
7641659|NCT01590797|26585077|P2|Overall Study|Withdrawal by Subject|5
7641660|NCT01590797|26585078|P1|Overall Study|Withdrawal by Subject|7
7641661|NCT01590797|26585077|P2|Overall Study|Protocol Violation|1
7641662|NCT01590797|26585078|P1|Overall Study|Protocol Violation|4
7641663|NCT01590797|26585077|P2|Overall Study|Lost to Follow-up|1
7641664|NCT01590797|26585078|P1|Overall Study|Lost to Follow-up|0
7641665|NCT01590797|26585077|P2|Overall Study|Lack of Efficacy|2
7641666|NCT01590797|26585078|P1|Overall Study|Lack of Efficacy|0
7641667|NCT01590797|26585077|P2|Overall Study|Adverse Event|3
7641668|NCT01590797|26585078|P1|Overall Study|Adverse Event|4
7641669|NCT01590771|26585094|P2|Overall Study|Adverse Event|7
7641670|NCT01590771|26585095|P1|Overall Study|Adverse Event|3
7641671|NCT01590771|26585094|P2|Overall Study|Lack of Efficacy|0
7641672|NCT01590771|26585095|P1|Overall Study|Lack of Efficacy|1
7641673|NCT01590771|26585094|P2|Overall Study|Lost to Follow-up|1
7641674|NCT01590771|26585095|P1|Overall Study|Lost to Follow-up|1
7641675|NCT01590771|26585094|P2|Overall Study|Protocol Violation|2
7641676|NCT01590771|26585095|P1|Overall Study|Protocol Violation|1
7641677|NCT01590771|26585094|P2|Overall Study|Withdrawal by Subject|15
7641678|NCT01590771|26585095|P1|Overall Study|Withdrawal by Subject|8
7641679|NCT01590771|26585094|P2|Overall Study|Other Protocol Specified Criteria|14
7641680|NCT01590771|26585095|P1|Overall Study|Other Protocol Specified Criteria|5
7641681|NCT01590758|26585123|P2|Overall Study|Lost to Follow-up|2
7641682|NCT01590758|26585124|P1|Overall Study|Lost to Follow-up|4
7641683|NCT01590758|26585123|P2|Overall Study|Physician Decision|2
7641684|NCT01590758|26585124|P1|Overall Study|Physician Decision|1
7641685|NCT01590758|26585123|P2|Overall Study|Withdrawal by Subject|3
7641686|NCT01590758|26585124|P1|Overall Study|Withdrawal by Subject|0
7641687|NCT01590563|26585134|P1|Overall Study|simple uterine hyperplasia - not related|1
7641688|NCT01590433|26585148|P2|Overall Study|Adverse Event|3
7641689|NCT01590433|26585149|P1|Overall Study|Adverse Event|11
7641690|NCT01590433|26585148|P2|Overall Study|Withdrawal by Subject|11
7641691|NCT01590433|26585149|P1|Overall Study|Withdrawal by Subject|21
7641692|NCT01590433|26585148|P2|Overall Study|Lost to Follow-up|8
7641693|NCT01590433|26585149|P1|Overall Study|Lost to Follow-up|20
7641694|NCT01590212|26585171|P3|Overall Study|Lost to Follow-up|3
7641695|NCT01590212|26585172|P2|Overall Study|Lost to Follow-up|2
7641696|NCT01590212|26585173|P1|Overall Study|Lost to Follow-up|1
7641697|NCT01590212|26585171|P3|Overall Study|Withdrawal by Subject|2
7641698|NCT01590212|26585172|P2|Overall Study|Withdrawal by Subject|2
7641699|NCT01590212|26585173|P1|Overall Study|Withdrawal by Subject|2
7641700|NCT01590082|26585192|P2|Overall Study|Ineligible|0
7641701|NCT01590082|26585193|P1|Overall Study|Ineligible|1
7641702|NCT01590082|26585192|P2|Overall Study|Withdrawal by Subject|0
7641703|NCT01590082|26585193|P1|Overall Study|Withdrawal by Subject|1
7641704|NCT01590017|26585199|P1|Overall Study|Physician Decision|1
7641705|NCT01590017|26585199|P1|Overall Study|Lack of Efficacy|1
7641706|NCT01590017|26585199|P1|Overall Study|Withdrawal by Subject|1
7641707|NCT01590017|26585199|P1|Overall Study|Adverse Event|1
7641708|NCT01589822|26585252|P3|Overall Study|Missed 90 day visit|1
7641709|NCT01589822|26585253|P2|Overall Study|Missed 90 day visit|1
7641710|NCT01589822|26585254|P1|Overall Study|Missed 90 day visit|2
7641711|NCT01589822|26585252|P3|Overall Study|Death|0
7641712|NCT01589822|26585253|P2|Overall Study|Death|0
7641713|NCT01589822|26585254|P1|Overall Study|Death|1
7641714|NCT01589822|26585252|P3|Overall Study|Withdrawal by Subject|0
7641715|NCT01589822|26585253|P2|Overall Study|Withdrawal by Subject|2
7641716|NCT01589822|26585254|P1|Overall Study|Withdrawal by Subject|1
7641717|NCT01589770|26585273|P2|Overall Study|claustrophobic when entering cardiac MRI|1
7641718|NCT01589770|26585274|P1|Overall Study|claustrophobic when entering cardiac MRI|2
7641719|NCT01589770|26585273|P2|Overall Study|EGFR <60ml/min|4
7641720|NCT01589770|26585274|P1|Overall Study|EGFR <60ml/min|6
7641721|NCT01589653|26585284|P2|Overall Study|Unclassified|3
7641722|NCT01589653|26585285|P1|Overall Study|Unclassified|0
7641723|NCT01589653|26585284|P2|Overall Study|Withdrawal criteria|7
7641724|NCT01589653|26585285|P1|Overall Study|Withdrawal criteria|4
7641725|NCT01589653|26585284|P2|Overall Study|Protocol Violation|1
7641726|NCT01589653|26585285|P1|Overall Study|Protocol Violation|3
7641727|NCT01589497|26585335|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
7641728|NCT01589497|26585336|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
7641729|NCT01589497|26585337|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
7641730|NCT01589497|26585338|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
7641731|NCT01589497|26585335|P4|Overall Study|Death|0
7641732|NCT01589497|26585336|P3|Overall Study|Death|0
7641733|NCT01589497|26585337|P2|Overall Study|Death|0
7641734|NCT01589497|26585338|P1|Overall Study|Death|1
7641735|NCT01589497|26585335|P4|Overall Study|Withdrawal by Subject|1
7641736|NCT01589497|26585336|P3|Overall Study|Withdrawal by Subject|0
7641737|NCT01589497|26585337|P2|Overall Study|Withdrawal by Subject|1
7641738|NCT01589497|26585338|P1|Overall Study|Withdrawal by Subject|0
7641739|NCT01589445|26585444|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
7641740|NCT01589445|26585444|P1|002 (Metformin)-3 Months|Adverse Event|2
7641741|NCT01589445|26585444|P1|002 (Metformin)-3 Months|Protocol Violation|2
7641742|NCT01589445|26585444|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
7641743|NCT01589445|26585444|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
7641744|NCT01589445|26585444|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
7641745|NCT01589445|26585444|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
7641746|NCT01589445|26585444|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
7641747|NCT01589445|26585444|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
7641748|NCT01589445|26585444|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
7641749|NCT01589237|26585496|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
7641750|NCT01589237|26585497|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7641751|NCT01589237|26585498|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7641752|NCT01589237|26585499|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7641753|NCT01589237|26585496|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
7641754|NCT01589237|26585497|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
7641755|NCT01589237|26585498|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7641756|NCT01589237|26585499|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7641757|NCT01589237|26585496|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7641758|NCT01589237|26585497|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7641759|NCT01589237|26585498|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
7641760|NCT01589237|26585499|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7641761|NCT01589237|26585496|P4|Part A (52 Weeks)|Subject/guardian decision|0
7641762|NCT01589237|26585497|P3|Part A (52 Weeks)|Subject/guardian decision|2
7641763|NCT01589237|26585498|P2|Part A (52 Weeks)|Subject/guardian decision|3
7641764|NCT01589237|26585499|P1|Part A (52 Weeks)|Subject/guardian decision|2
7641765|NCT01589185|26585550|P5|Overall Study|Lost to Follow-up|0
7641766|NCT01589185|26585551|P4|Overall Study|Lost to Follow-up|3
7641767|NCT01589185|26585552|P3|Overall Study|Lost to Follow-up|2
7641768|NCT01589185|26585553|P2|Overall Study|Lost to Follow-up|0
7641769|NCT01589185|26585554|P1|Overall Study|Lost to Follow-up|1
7641770|NCT01589185|26585550|P5|Overall Study|Death|1
7641771|NCT01589185|26585551|P4|Overall Study|Death|0
7641772|NCT01589185|26585552|P3|Overall Study|Death|2
7641773|NCT01589185|26585553|P2|Overall Study|Death|2
7641774|NCT01589185|26585554|P1|Overall Study|Death|1
7641775|NCT01589094|26585587|P1|Overall Study|Did not receive treatment|2
7641776|NCT01588990|26585594|P1|Phase B|Other|2
7641777|NCT01588990|26585594|P1|Phase B|Physician Decision|4
7641778|NCT01588990|26585594|P1|Phase B|Withdrawal by Subject|3
7641779|NCT01588990|26585594|P1|Phase B|Still on therapy at end of study|5
7641780|NCT01588990|26585594|P1|Phase B|Adverse Event|2
7641781|NCT01588990|26585594|P1|Phase A|Still on therapy at end of study|6
7641782|NCT01588990|26585594|P1|Phase A|Adverse Event|28
7641783|NCT01588990|26585594|P1|Phase A|Death|5
7641784|NCT01588990|26585594|P1|Phase A|Lost to Follow-up|1
7641785|NCT01588990|26585594|P1|Phase A|Other|14
7641786|NCT01588990|26585594|P1|Phase A|Physician Decision|11
7641787|NCT01588990|26585594|P1|Phase A|Withdrawal by Subject|5
7641788|NCT01588951|26585622|P3|Overall Study|Ineligible in retrospect|1
7641789|NCT01588951|26585623|P2|Overall Study|Ineligible in retrospect|0
7641790|NCT01588951|26585624|P1|Overall Study|Ineligible in retrospect|0
7641791|NCT01588548|26585660|P6|Overall Study|Condition Under Investigation Worsened|3
7641792|NCT01588548|26585661|P5|Overall Study|Condition Under Investigation Worsened|3
7641793|NCT01588548|26585662|P4|Overall Study|Condition Under Investigation Worsened|4
7641794|NCT01588548|26585663|P3|Overall Study|Condition Under Investigation Worsened|4
7641795|NCT01588548|26585664|P2|Overall Study|Condition Under Investigation Worsened|6
7641796|NCT01588548|26585665|P1|Overall Study|Condition Under Investigation Worsened|3
7641797|NCT01588548|26585660|P6|Overall Study|Adverse Event|0
7641798|NCT01588548|26585661|P5|Overall Study|Adverse Event|1
7641799|NCT01588548|26585662|P4|Overall Study|Adverse Event|2
7641800|NCT01588548|26585663|P3|Overall Study|Adverse Event|1
7641801|NCT01588548|26585664|P2|Overall Study|Adverse Event|0
7641802|NCT01588548|26585665|P1|Overall Study|Adverse Event|0
7641803|NCT01588548|26585660|P6|Overall Study|Withdrawal by Subject|3
7641804|NCT01588548|26585661|P5|Overall Study|Withdrawal by Subject|2
7641805|NCT01588548|26585662|P4|Overall Study|Withdrawal by Subject|1
7641806|NCT01588548|26585663|P3|Overall Study|Withdrawal by Subject|1
7641807|NCT01588548|26585664|P2|Overall Study|Withdrawal by Subject|1
7641808|NCT01588548|26585665|P1|Overall Study|Withdrawal by Subject|0
7641809|NCT01588509|26585681|P2|Overall Study|Lost to Follow-up|0
7641810|NCT01588509|26585682|P1|Overall Study|Lost to Follow-up|1
7641811|NCT01588496|26585705|P3|Overall Study|Withdrawal by Subject|0
7641812|NCT01588496|26585706|P2|Overall Study|Withdrawal by Subject|1
7641813|NCT01588496|26585707|P1|Overall Study|Withdrawal by Subject|0
7641814|NCT01588405|26585782|P1|Overall Study|Clinical Worsening|1
7641815|NCT01588405|26585782|P1|Overall Study|Adverse Event|1
7641816|NCT01588366|26585811|P6|Overall Study|Adverse Event|2
7641817|NCT01588366|26585812|P5|Overall Study|Adverse Event|0
7641818|NCT01588366|26585813|P4|Overall Study|Adverse Event|1
7641819|NCT01588366|26585814|P3|Overall Study|Adverse Event|0
7641820|NCT01588366|26585815|P2|Overall Study|Adverse Event|1
7641821|NCT01588366|26585816|P1|Overall Study|Adverse Event|0
7641822|NCT01588353|26585844|P3|Step3|Adverse Event|2
7641823|NCT01588353|26585845|P2|Step3|Adverse Event|0
7641824|NCT01588353|26585846|P1|Step3|Adverse Event|0
7641825|NCT01588353|26585844|P3|Step2|Withdrawal by Subject|0
7641826|NCT01588353|26585845|P2|Step2|Withdrawal by Subject|1
7641827|NCT01588353|26585846|P1|Step2|Withdrawal by Subject|0
7641828|NCT01588197|26585895|P2|Overall Study|No MRI|0
7641829|NCT01588197|26585896|P1|Overall Study|No MRI|1
7641830|NCT01588197|26585895|P2|Overall Study|Lack of Efficacy|1
7641831|NCT01588197|26585896|P1|Overall Study|Lack of Efficacy|0
7641832|NCT01588184|26585912|P6|Overall Study|multiple reasons|0
7641833|NCT01588184|26585913|P5|Overall Study|multiple reasons|0
7641834|NCT01588184|26585914|P4|Overall Study|multiple reasons|1
7641835|NCT01588184|26585915|P3|Overall Study|multiple reasons|0
7641836|NCT01588184|26585916|P2|Overall Study|multiple reasons|3
7641837|NCT01588184|26585917|P1|Overall Study|multiple reasons|0
7641838|NCT01588184|26585912|P6|Overall Study|Bevacizumab treatment provision changed|3
7641839|NCT01588184|26585913|P5|Overall Study|Bevacizumab treatment provision changed|1
7641840|NCT01588184|26585914|P4|Overall Study|Bevacizumab treatment provision changed|0
7641841|NCT01588184|26585915|P3|Overall Study|Bevacizumab treatment provision changed|2
7641842|NCT01588184|26585916|P2|Overall Study|Bevacizumab treatment provision changed|6
7641843|NCT01588184|26585917|P1|Overall Study|Bevacizumab treatment provision changed|0
7641844|NCT01588184|26585912|P6|Overall Study|Withdrawal by Subject|0
7641845|NCT01588184|26585913|P5|Overall Study|Withdrawal by Subject|0
7641846|NCT01588184|26585914|P4|Overall Study|Withdrawal by Subject|1
7641847|NCT01588184|26585915|P3|Overall Study|Withdrawal by Subject|0
7641848|NCT01588184|26585916|P2|Overall Study|Withdrawal by Subject|4
7641849|NCT01588184|26585917|P1|Overall Study|Withdrawal by Subject|2
7641850|NCT01588184|26585912|P6|Overall Study|Death|1
7641851|NCT01588184|26585913|P5|Overall Study|Death|1
7641852|NCT01588184|26585914|P4|Overall Study|Death|1
7641853|NCT01588184|26585915|P3|Overall Study|Death|0
7641854|NCT01588184|26585916|P2|Overall Study|Death|0
7641855|NCT01588184|26585917|P1|Overall Study|Death|1
7641856|NCT01588106|26585970|P2|Overall Study|Withdrawal by Subject|4
7641857|NCT01588106|26585971|P1|Overall Study|Withdrawal by Subject|5
7641858|NCT01587989|26585979|P3|Randomized Study Treatment|Physician Decision|1
7641859|NCT01587989|26585980|P2|Randomized Study Treatment|Physician Decision|0
7641860|NCT01587989|26585981|P1|Randomized Study Treatment|Physician Decision|0
7641861|NCT01587989|26585979|P3|Randomized Study Treatment|Screening failure|0
7641862|NCT01587989|26585980|P2|Randomized Study Treatment|Screening failure|1
7641863|NCT01587989|26585981|P1|Randomized Study Treatment|Screening failure|0
7641864|NCT01587989|26585979|P3|Randomized Study Treatment|Withdrawal by Subject|0
7641865|NCT01587989|26585980|P2|Randomized Study Treatment|Withdrawal by Subject|1
7641866|NCT01587989|26585981|P1|Randomized Study Treatment|Withdrawal by Subject|0
7641867|NCT01587989|26585979|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
7641868|NCT01587989|26585980|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
7641869|NCT01587989|26585981|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
7641870|NCT01587989|26585979|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7641871|NCT01587989|26585980|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7641872|NCT01587989|26585981|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
7641873|NCT01587989|26585979|P3|12-Week Open-Label Run-In Period|Physician Decision|0
7641874|NCT01587989|26585980|P2|12-Week Open-Label Run-In Period|Physician Decision|0
7641875|NCT01587989|26585981|P1|12-Week Open-Label Run-In Period|Physician Decision|7
7641876|NCT01587924|26586046|P4|Overall Study|Withdrawal by Subject|0
7641877|NCT01587924|26586047|P3|Overall Study|Withdrawal by Subject|1
7641878|NCT01587924|26586048|P2|Overall Study|Withdrawal by Subject|1
7641879|NCT01587924|26586049|P1|Overall Study|Withdrawal by Subject|0
7641880|NCT01587924|26586046|P4|Overall Study|Met Hemoglobin stopping criteria|0
7641881|NCT01587924|26586047|P3|Overall Study|Met Hemoglobin stopping criteria|1
7641882|NCT01587924|26586048|P2|Overall Study|Met Hemoglobin stopping criteria|0
7641883|NCT01587924|26586049|P1|Overall Study|Met Hemoglobin stopping criteria|2
7641884|NCT01587924|26586046|P4|Overall Study|Protocol Violation|1
7641885|NCT01587924|26586047|P3|Overall Study|Protocol Violation|2
7641886|NCT01587924|26586048|P2|Overall Study|Protocol Violation|1
7641887|NCT01587924|26586049|P1|Overall Study|Protocol Violation|2
7641888|NCT01587924|26586046|P4|Overall Study|Adverse Event|0
7641889|NCT01587924|26586047|P3|Overall Study|Adverse Event|0
7641890|NCT01587924|26586048|P2|Overall Study|Adverse Event|2
7641891|NCT01587924|26586049|P1|Overall Study|Adverse Event|0
7641892|NCT01587898|26586150|P4|Overall Study|Met haemoglobin stopping criteria|0
7641893|NCT01587898|26586151|P3|Overall Study|Met haemoglobin stopping criteria|1
7641894|NCT01587898|26586152|P2|Overall Study|Met haemoglobin stopping criteria|1
7641895|NCT01587898|26586153|P1|Overall Study|Met haemoglobin stopping criteria|1
7641896|NCT01587898|26586150|P4|Overall Study|Withdrawal by Subject|0
7641897|NCT01587898|26586151|P3|Overall Study|Withdrawal by Subject|0
7641898|NCT01587898|26586152|P2|Overall Study|Withdrawal by Subject|1
7641899|NCT01587898|26586153|P1|Overall Study|Withdrawal by Subject|2
7641900|NCT01587898|26586150|P4|Overall Study|Lost to Follow-up|1
7641901|NCT01587898|26586151|P3|Overall Study|Lost to Follow-up|0
7641902|NCT01587898|26586152|P2|Overall Study|Lost to Follow-up|0
7641903|NCT01587898|26586153|P1|Overall Study|Lost to Follow-up|0
7641904|NCT01587898|26586150|P4|Overall Study|Protocol Violation|1
7641905|NCT01587898|26586151|P3|Overall Study|Protocol Violation|1
7641906|NCT01587898|26586152|P2|Overall Study|Protocol Violation|2
7641907|NCT01587898|26586153|P1|Overall Study|Protocol Violation|0
7641908|NCT01587898|26586150|P4|Overall Study|Adverse Event|0
7641909|NCT01587898|26586151|P3|Overall Study|Adverse Event|0
7641910|NCT01587898|26586152|P2|Overall Study|Adverse Event|1
7641911|NCT01587898|26586153|P1|Overall Study|Adverse Event|1
7641912|NCT01587885|26586329|P2|Treatment Period 1|Protocol Violation|2
7641913|NCT01587885|26586330|P1|Treatment Period 1|Protocol Violation|0
7641914|NCT01587885|26586329|P2|Treatment Period 1|Failure to Return|1
7641915|NCT01587885|26586330|P1|Treatment Period 1|Failure to Return|0
7641916|NCT01587703|26586361|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641917|NCT01587703|26586362|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641918|NCT01587703|26586363|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641919|NCT01587703|26586364|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641920|NCT01587703|26586365|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641921|NCT01587703|26586366|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641922|NCT01587703|26586367|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641923|NCT01587703|26586368|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
7641924|NCT01587703|26586369|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641925|NCT01587703|26586370|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641926|NCT01587703|26586371|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641927|NCT01587703|26586372|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641928|NCT01587703|26586373|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641929|NCT01587703|26586374|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641930|NCT01587703|26586375|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641931|NCT01587703|26586376|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641932|NCT01587703|26586377|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641933|NCT01587703|26586378|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641934|NCT01587703|26586379|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7641935|NCT01587703|26586361|P19|Part2(Median Exposure of 1.41 Months)|Death|0
7641936|NCT01587703|26586362|P18|Part2(Median Exposure of 1.41 Months)|Death|0
7641937|NCT01587703|26586363|P17|Part2(Median Exposure of 1.41 Months)|Death|5
7641938|NCT01587703|26586364|P16|Part2(Median Exposure of 1.41 Months)|Death|17
7641939|NCT01587703|26586365|P15|Part2(Median Exposure of 1.41 Months)|Death|16
7641940|NCT01587703|26586366|P14|Part2(Median Exposure of 1.41 Months)|Death|21
7641941|NCT01587703|26586367|P13|Part2(Median Exposure of 1.41 Months)|Death|12
7641942|NCT01587703|26586368|P12|Part2(Median Exposure of 1.41 Months)|Death|8
7641943|NCT01587703|26586369|P11|Part2(Median Exposure of 1.41 Months)|Death|0
7641944|NCT01587703|26586370|P10|Part2(Median Exposure of 1.41 Months)|Death|0
7641945|NCT01587703|26586371|P9|Part2(Median Exposure of 1.41 Months)|Death|0
7641946|NCT01587703|26586372|P8|Part2(Median Exposure of 1.41 Months)|Death|0
7641947|NCT01587703|26586373|P7|Part2(Median Exposure of 1.41 Months)|Death|0
7641948|NCT01587703|26586374|P6|Part2(Median Exposure of 1.41 Months)|Death|0
7641949|NCT01587703|26586375|P5|Part2(Median Exposure of 1.41 Months)|Death|0
7641950|NCT01587703|26586376|P4|Part2(Median Exposure of 1.41 Months)|Death|0
7641951|NCT01587703|26586377|P3|Part2(Median Exposure of 1.41 Months)|Death|0
7641952|NCT01587703|26586378|P2|Part2(Median Exposure of 1.41 Months)|Death|0
7641953|NCT01587703|26586379|P1|Part2(Median Exposure of 1.41 Months)|Death|0
7641954|NCT01587703|26586361|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641955|NCT01587703|26586362|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641956|NCT01587703|26586363|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
7641957|NCT01587703|26586364|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
7641958|NCT01587703|26586365|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
7641959|NCT01587703|26586366|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
7641960|NCT01587703|26586367|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
7641961|NCT01587703|26586368|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
7641962|NCT01587703|26586369|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641963|NCT01587703|26586370|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641964|NCT01587703|26586371|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641965|NCT01587703|26586372|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641966|NCT01587703|26586373|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641967|NCT01587703|26586374|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641968|NCT01587703|26586375|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641969|NCT01587703|26586376|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641970|NCT01587703|26586377|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641971|NCT01587703|26586378|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641972|NCT01587703|26586379|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
7641973|NCT01587703|26586361|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641974|NCT01587703|26586362|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641975|NCT01587703|26586363|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641976|NCT01587703|26586364|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641977|NCT01587703|26586365|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
7641978|NCT01587703|26586366|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641979|NCT01587703|26586367|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641980|NCT01587703|26586368|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
7641981|NCT01587703|26586369|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641982|NCT01587703|26586370|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641983|NCT01587703|26586371|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641984|NCT01587703|26586372|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641985|NCT01587703|26586373|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641986|NCT01587703|26586374|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641987|NCT01587703|26586375|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641988|NCT01587703|26586376|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641989|NCT01587703|26586377|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641990|NCT01587703|26586378|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641991|NCT01587703|26586379|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7641992|NCT01587703|26586361|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7641993|NCT01587703|26586362|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7641994|NCT01587703|26586363|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7641995|NCT01587703|26586364|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
7641996|NCT01587703|26586365|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7641997|NCT01587703|26586366|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7641998|NCT01587703|26586367|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7641999|NCT01587703|26586368|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642000|NCT01587703|26586369|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642001|NCT01587703|26586370|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642002|NCT01587703|26586371|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642003|NCT01587703|26586372|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642004|NCT01587703|26586373|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642005|NCT01587703|26586374|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642006|NCT01587703|26586375|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642007|NCT01587703|26586376|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642008|NCT01587703|26586377|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642009|NCT01587703|26586378|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642010|NCT01587703|26586379|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7642011|NCT01587703|26586361|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
7642012|NCT01587703|26586362|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
7642013|NCT01587703|26586363|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642014|NCT01587703|26586364|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642015|NCT01587703|26586365|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642016|NCT01587703|26586366|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642017|NCT01587703|26586367|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642018|NCT01587703|26586368|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642019|NCT01587703|26586369|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642020|NCT01587703|26586370|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642021|NCT01587703|26586371|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642022|NCT01587703|26586372|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642023|NCT01587703|26586373|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642024|NCT01587703|26586374|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642025|NCT01587703|26586375|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642026|NCT01587703|26586376|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642027|NCT01587703|26586377|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642028|NCT01587703|26586378|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642029|NCT01587703|26586379|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7642030|NCT01587703|26586361|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
7642031|NCT01587703|26586362|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642032|NCT01587703|26586363|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642033|NCT01587703|26586364|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642034|NCT01587703|26586365|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642035|NCT01587703|26586366|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642036|NCT01587703|26586367|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642037|NCT01587703|26586368|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642038|NCT01587703|26586369|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642039|NCT01587703|26586370|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642040|NCT01587703|26586371|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642041|NCT01587703|26586372|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642042|NCT01587703|26586373|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642043|NCT01587703|26586374|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642044|NCT01587703|26586375|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642045|NCT01587703|26586376|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642046|NCT01587703|26586377|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642047|NCT01587703|26586378|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642048|NCT01587703|26586379|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7642049|NCT01587703|26586361|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642050|NCT01587703|26586362|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642051|NCT01587703|26586363|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642052|NCT01587703|26586364|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642053|NCT01587703|26586365|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642054|NCT01587703|26586366|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642055|NCT01587703|26586367|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642056|NCT01587703|26586368|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642057|NCT01587703|26586369|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642058|NCT01587703|26586370|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642059|NCT01587703|26586371|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
7642060|NCT01587703|26586372|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642061|NCT01587703|26586373|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642062|NCT01587703|26586374|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642063|NCT01587703|26586375|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642064|NCT01587703|26586376|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642065|NCT01587703|26586377|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642066|NCT01587703|26586378|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642067|NCT01587703|26586379|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7642068|NCT01587703|26586361|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642069|NCT01587703|26586362|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642070|NCT01587703|26586363|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642071|NCT01587703|26586364|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642072|NCT01587703|26586365|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642073|NCT01587703|26586366|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642074|NCT01587703|26586367|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642075|NCT01587703|26586368|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642076|NCT01587703|26586369|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7642077|NCT01587703|26586370|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7642078|NCT01587703|26586371|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642079|NCT01587703|26586372|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642080|NCT01587703|26586373|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642081|NCT01587703|26586374|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642082|NCT01587703|26586375|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642083|NCT01587703|26586376|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642084|NCT01587703|26586377|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642085|NCT01587703|26586378|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642086|NCT01587703|26586379|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7642087|NCT01587703|26586361|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642088|NCT01587703|26586362|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642089|NCT01587703|26586363|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642090|NCT01587703|26586364|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642091|NCT01587703|26586365|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642092|NCT01587703|26586366|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642093|NCT01587703|26586367|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642094|NCT01587703|26586368|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642095|NCT01587703|26586369|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7642096|NCT01587703|26586370|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642097|NCT01587703|26586371|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7642098|NCT01587703|26586372|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642099|NCT01587703|26586373|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642100|NCT01587703|26586374|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642101|NCT01587703|26586375|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642102|NCT01587703|26586376|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642103|NCT01587703|26586377|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642104|NCT01587703|26586378|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642832|NCT01581684|26589016|P6|Overall Study|Other reason not defined|0
7642105|NCT01587703|26586379|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7642106|NCT01587703|26586361|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
7642107|NCT01587703|26586362|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
7642108|NCT01587703|26586363|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
7642109|NCT01587703|26586364|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
7642110|NCT01587703|26586365|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
7642111|NCT01587703|26586366|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
7642112|NCT01587703|26586367|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
7642113|NCT01587703|26586368|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
7642114|NCT01587703|26586369|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
7642115|NCT01587703|26586370|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
7642116|NCT01587703|26586371|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
7642117|NCT01587703|26586372|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
7642118|NCT01587703|26586373|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
7642119|NCT01587703|26586374|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
7642120|NCT01587703|26586375|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
7642121|NCT01587703|26586376|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
7642122|NCT01587703|26586377|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
7642123|NCT01587703|26586378|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
7642124|NCT01587703|26586379|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
7642125|NCT01587703|26586361|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
7642126|NCT01587703|26586362|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
7642127|NCT01587703|26586363|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
7642128|NCT01587703|26586364|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
7642129|NCT01587703|26586365|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
7642130|NCT01587703|26586366|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
7642131|NCT01587703|26586367|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
7642132|NCT01587703|26586368|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
7642133|NCT01587703|26586369|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
7642134|NCT01587703|26586370|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
7642135|NCT01587703|26586371|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
7642136|NCT01587703|26586372|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
7642137|NCT01587703|26586373|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
7642138|NCT01587703|26586374|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
7642139|NCT01587703|26586375|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
7642140|NCT01587703|26586376|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
7642141|NCT01587703|26586377|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
7642142|NCT01587703|26586378|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
7642143|NCT01587703|26586379|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
7642144|NCT01587703|26586361|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642145|NCT01587703|26586362|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642146|NCT01587703|26586363|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642147|NCT01587703|26586364|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642148|NCT01587703|26586365|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642149|NCT01587703|26586366|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642150|NCT01587703|26586367|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642151|NCT01587703|26586368|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642152|NCT01587703|26586369|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642153|NCT01587703|26586370|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642154|NCT01587703|26586371|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642155|NCT01587703|26586372|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642156|NCT01587703|26586373|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
7642157|NCT01587703|26586374|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642158|NCT01587703|26586375|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642159|NCT01587703|26586376|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642160|NCT01587703|26586377|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642161|NCT01587703|26586378|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642162|NCT01587703|26586379|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7642163|NCT01587703|26586361|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642164|NCT01587703|26586362|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642165|NCT01587703|26586363|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642166|NCT01587703|26586364|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642167|NCT01587703|26586365|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642168|NCT01587703|26586366|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642169|NCT01587703|26586367|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642170|NCT01587703|26586368|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642171|NCT01587703|26586369|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642172|NCT01587703|26586370|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642173|NCT01587703|26586371|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642174|NCT01587703|26586372|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
7642175|NCT01587703|26586373|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642176|NCT01587703|26586374|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
7642177|NCT01587703|26586375|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642178|NCT01587703|26586376|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642179|NCT01587703|26586377|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642180|NCT01587703|26586378|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642181|NCT01587703|26586379|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7642182|NCT01587703|26586361|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642183|NCT01587703|26586362|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642184|NCT01587703|26586363|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642185|NCT01587703|26586364|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642186|NCT01587703|26586365|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642187|NCT01587703|26586366|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642188|NCT01587703|26586367|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642189|NCT01587703|26586368|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642190|NCT01587703|26586369|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642191|NCT01587703|26586370|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642192|NCT01587703|26586371|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642193|NCT01587703|26586372|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642194|NCT01587703|26586373|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642195|NCT01587703|26586374|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642196|NCT01587703|26586375|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642197|NCT01587703|26586376|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642198|NCT01587703|26586377|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642199|NCT01587703|26586378|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7642200|NCT01587703|26586379|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
7642201|NCT01587651|26586786|P3|Overall Study|Withdrawal by Subject|0
7642202|NCT01587651|26586787|P2|Overall Study|Withdrawal by Subject|1
7642203|NCT01587651|26586788|P1|Overall Study|Withdrawal by Subject|0
7642204|NCT01587651|26586786|P3|Overall Study|Protocol Violation|1
7642205|NCT01587651|26586787|P2|Overall Study|Protocol Violation|1
7642206|NCT01587651|26586788|P1|Overall Study|Protocol Violation|0
7642207|NCT01587651|26586786|P3|Overall Study|Adverse Event|0
7642208|NCT01587651|26586787|P2|Overall Study|Adverse Event|1
7642209|NCT01587651|26586788|P1|Overall Study|Adverse Event|0
7642210|NCT01587274|26586818|P3|Overall Study|Lost to Follow-up|3
7642211|NCT01587274|26586819|P2|Overall Study|Lost to Follow-up|5
7642212|NCT01587274|26586820|P1|Overall Study|Lost to Follow-up|4
7642213|NCT01587118|26586828|P1|Overall Study|nonresponse|1
7642214|NCT01587118|26586828|P1|Overall Study|Relocation|1
7642215|NCT01587118|26586828|P1|Overall Study|Lost to Follow-up|2
7642216|NCT01587118|26586828|P1|Overall Study|Adverse Event|3
7642217|NCT01587079|26586852|P1|Overall Study|Adverse Event|14
7642218|NCT01587079|26586852|P1|Overall Study|Withdrawal by Subject|7
7642219|NCT01587079|26586852|P1|Overall Study|Physician Decision|2
7642220|NCT01587079|26586852|P1|Overall Study|Lost to Follow-up|2
7642221|NCT01587079|26586852|P1|Overall Study|Protocol Violation|5
7642222|NCT01587079|26586852|P1|Overall Study|Protocol-specified criteria|9
7642223|NCT01587040|26586978|P4|Overall Study|Other than specified|1
7642224|NCT01587040|26586979|P3|Overall Study|Other than specified|11
7642225|NCT01587040|26586980|P2|Overall Study|Other than specified|1
7642226|NCT01587040|26586981|P1|Overall Study|Other than specified|5
7642227|NCT01587040|26586978|P4|Overall Study|Disease progression|3
7642228|NCT01587040|26586979|P3|Overall Study|Disease progression|15
7642229|NCT01587040|26586980|P2|Overall Study|Disease progression|1
7642230|NCT01587040|26586981|P1|Overall Study|Disease progression|12
7642231|NCT01587040|26586978|P4|Overall Study|Adverse Event|0
7642232|NCT01587040|26586979|P3|Overall Study|Adverse Event|10
7642233|NCT01587040|26586980|P2|Overall Study|Adverse Event|1
7642234|NCT01587040|26586981|P1|Overall Study|Adverse Event|0
7642235|NCT01587040|26586978|P4|Overall Study|Protocol Violation|0
7642236|NCT01587040|26586979|P3|Overall Study|Protocol Violation|1
7642237|NCT01587040|26586980|P2|Overall Study|Protocol Violation|0
7642238|NCT01587040|26586981|P1|Overall Study|Protocol Violation|0
7642239|NCT01587014|26587008|P1|Overall Study|Death|2
7642240|NCT01587001|26587015|P2|Overall Study|Insufficient samples to complete testing|1
7642241|NCT01587001|26587016|P1|Overall Study|Insufficient samples to complete testing|4
7642242|NCT01587001|26587015|P2|Overall Study|Lost to Follow-up|0
7642243|NCT01587001|26587016|P1|Overall Study|Lost to Follow-up|2
7642244|NCT01586910|26587045|P2|Overall Study|Physician withdrew Subject|24
7642245|NCT01586910|26587046|P1|Overall Study|Physician withdrew Subject|5
7642246|NCT01586910|26587045|P2|Overall Study|Withdrawal by Subject|43
7642247|NCT01586910|26587046|P1|Overall Study|Withdrawal by Subject|6
7642248|NCT01586910|26587045|P2|Overall Study|Death|4
7642249|NCT01586910|26587046|P1|Overall Study|Death|4
7642250|NCT01586819|26587142|P2|Overall Study|Withdrawal by Subject|0
7642251|NCT01586819|26587143|P1|Overall Study|Withdrawal by Subject|1
7642252|NCT01586806|26587154|P3|Overall Study|Lost to Follow-up|2
7642253|NCT01586806|26587155|P2|Overall Study|Lost to Follow-up|3
7642254|NCT01586806|26587156|P1|Overall Study|Lost to Follow-up|2
7642255|NCT01586806|26587154|P3|Overall Study|Withdrawal by Subject|0
7642256|NCT01586806|26587155|P2|Overall Study|Withdrawal by Subject|0
7642257|NCT01586806|26587156|P1|Overall Study|Withdrawal by Subject|1
7642258|NCT01586806|26587154|P3|Overall Study|Protocol Violation|0
7642259|NCT01586806|26587155|P2|Overall Study|Protocol Violation|1
7642260|NCT01586806|26587156|P1|Overall Study|Protocol Violation|0
7642261|NCT01586624|26587197|P8|Overall Study|Screen failure (no treatment received)|0
7642262|NCT01586624|26587198|P7|Overall Study|Screen failure (no treatment received)|1
7642263|NCT01586624|26587199|P6|Overall Study|Screen failure (no treatment received)|0
7642264|NCT01586624|26587200|P5|Overall Study|Screen failure (no treatment received)|0
7642265|NCT01586624|26587201|P4|Overall Study|Screen failure (no treatment received)|0
7642266|NCT01586624|26587202|P3|Overall Study|Screen failure (no treatment received)|0
7642267|NCT01586624|26587203|P2|Overall Study|Screen failure (no treatment received)|0
7642268|NCT01586624|26587204|P1|Overall Study|Screen failure (no treatment received)|0
7642269|NCT01586624|26587197|P8|Overall Study|Evidence of disease progression|6
7642270|NCT01586624|26587198|P7|Overall Study|Evidence of disease progression|4
7642271|NCT01586624|26587199|P6|Overall Study|Evidence of disease progression|5
7642272|NCT01586624|26587200|P5|Overall Study|Evidence of disease progression|3
7642273|NCT01586624|26587201|P4|Overall Study|Evidence of disease progression|5
7642274|NCT01586624|26587202|P3|Overall Study|Evidence of disease progression|2
7642275|NCT01586624|26587203|P2|Overall Study|Evidence of disease progression|3
7642276|NCT01586624|26587204|P1|Overall Study|Evidence of disease progression|1
7642277|NCT01586624|26587197|P8|Overall Study|Withdrawal by Subject|0
7642278|NCT01586624|26587198|P7|Overall Study|Withdrawal by Subject|0
7642279|NCT01586624|26587199|P6|Overall Study|Withdrawal by Subject|0
7642280|NCT01586624|26587200|P5|Overall Study|Withdrawal by Subject|0
7642281|NCT01586624|26587201|P4|Overall Study|Withdrawal by Subject|1
7642282|NCT01586624|26587202|P3|Overall Study|Withdrawal by Subject|0
7642283|NCT01586624|26587203|P2|Overall Study|Withdrawal by Subject|0
7642284|NCT01586624|26587204|P1|Overall Study|Withdrawal by Subject|0
7642285|NCT01586624|26587197|P8|Overall Study|Physician Decision|1
7642286|NCT01586624|26587198|P7|Overall Study|Physician Decision|1
7642287|NCT01586624|26587199|P6|Overall Study|Physician Decision|0
7642288|NCT01586624|26587200|P5|Overall Study|Physician Decision|2
7642289|NCT01586624|26587201|P4|Overall Study|Physician Decision|0
7642290|NCT01586624|26587202|P3|Overall Study|Physician Decision|1
7642291|NCT01586624|26587203|P2|Overall Study|Physician Decision|1
7642292|NCT01586624|26587204|P1|Overall Study|Physician Decision|0
7642293|NCT01586624|26587197|P8|Overall Study|Adverse Event|3
7642294|NCT01586624|26587198|P7|Overall Study|Adverse Event|2
7642295|NCT01586624|26587199|P6|Overall Study|Adverse Event|3
7642296|NCT01586624|26587200|P5|Overall Study|Adverse Event|3
7642297|NCT01586624|26587201|P4|Overall Study|Adverse Event|1
7642298|NCT01586624|26587202|P3|Overall Study|Adverse Event|2
7642299|NCT01586624|26587203|P2|Overall Study|Adverse Event|0
7642300|NCT01586624|26587204|P1|Overall Study|Adverse Event|3
7642301|NCT01586364|26587268|P1|Overall Study|Other-Not specified|1
7642302|NCT01586364|26587268|P1|Overall Study|Other-PI discretion, site closing|2
7642303|NCT01586364|26587268|P1|Overall Study|Other-Site closure due to PI illness|1
7642304|NCT01586364|26587268|P1|Overall Study|Other-Subject wasn't getting much relief|1
7642305|NCT01586364|26587268|P1|Overall Study|Other-Did not feel better post-treatment|1
7642306|NCT01586364|26587268|P1|Overall Study|Lack of Efficacy|1
7642307|NCT01586364|26587268|P1|Overall Study|Protocol Violation|16
7642308|NCT01586364|26587268|P1|Overall Study|Lost to Follow-up|17
7642309|NCT01586364|26587268|P1|Overall Study|Adverse Event|37
7642310|NCT01586364|26587268|P1|Overall Study|Withdrawal by Subject|40
7642311|NCT01586338|26587321|P1|Overall Study|Other|1
7642312|NCT01586338|26587321|P1|Overall Study|Withdrawal by participant|3
7642313|NCT01586338|26587321|P1|Overall Study|Lost to Follow-up|1
7642314|NCT01586338|26587321|P1|Overall Study|Adverse Event|3
7642315|NCT01586195|26587344|P1|Overall Study|Reason not specified|9
7642316|NCT01586195|26587344|P1|Overall Study|Started new anti-melanoma therapy|1
7642317|NCT01586195|26587344|P1|Overall Study|Withdrawal of Consent|5
7642318|NCT01586195|26587344|P1|Overall Study|Death|11
7642319|NCT01586156|26587358|P3|Overall Study|Pregnancy|0
7642320|NCT01586156|26587359|P2|Overall Study|Pregnancy|1
7642321|NCT01586156|26587360|P1|Overall Study|Pregnancy|0
7642322|NCT01585987|26587450|P2|Treated|Poor/Non-Compliance|1
7642323|NCT01585987|26587451|P1|Treated|Poor/Non-Compliance|0
7642324|NCT01585987|26587450|P2|Treated|Subject Request|1
7642325|NCT01585987|26587451|P1|Treated|Subject Request|0
7642326|NCT01585987|26587450|P2|Treated|Non-Specified|2
7642327|NCT01585987|26587451|P1|Treated|Non-Specified|1
7642328|NCT01585987|26587450|P2|Treated|Maximum Clinical Benefit|1
7642329|NCT01585987|26587451|P1|Treated|Maximum Clinical Benefit|0
7642330|NCT01585987|26587450|P2|Treated|Lost to Follow-up|1
7642331|NCT01585987|26587451|P1|Treated|Lost to Follow-up|0
7642332|NCT01585987|26587450|P2|Treated|Death|0
7642333|NCT01585987|26587451|P1|Treated|Death|1
7642334|NCT01585987|26587450|P2|Treated|Withdrawal by Subject|2
7642335|NCT01585987|26587451|P1|Treated|Withdrawal by Subject|1
7642336|NCT01585987|26587450|P2|Treated|Adverse Event|0
7642337|NCT01585987|26587451|P1|Treated|Adverse Event|3
7642338|NCT01585987|26587450|P2|Treated|Study Drug Toxicity|5
7642339|NCT01585987|26587451|P1|Treated|Study Drug Toxicity|9
7642340|NCT01585987|26587450|P2|Treated|Disease Progression|36
7642341|NCT01585987|26587451|P1|Treated|Disease Progression|39
7642342|NCT01585987|26587450|P2|Randomized|No longer met criteria|2
7642343|NCT01585987|26587451|P1|Randomized|No longer met criteria|0
7642344|NCT01585987|26587450|P2|Randomized|Withdrawal by Subject|4
7642345|NCT01585987|26587451|P1|Randomized|Withdrawal by Subject|0
7642346|NCT01585961|26587466|P1|Overall Study|Ablation cancelled for slow-heal wound|1
7642347|NCT01585961|26587466|P1|Overall Study|Lost to Follow-up|23
7642348|NCT01585961|26587466|P1|Overall Study|Withdrawal by Subject|1
7642349|NCT01585961|26587466|P1|Overall Study|Decision to use non-study catheter|1
7642350|NCT01585961|26587466|P1|Overall Study|Physician Decision|1
7642351|NCT01585961|26587466|P1|Overall Study|Death|6
7642352|NCT01585831|26587483|P2|Overall Study|Withdrawal by Subject|1
7642353|NCT01585831|26587484|P1|Overall Study|Withdrawal by Subject|2
7642354|NCT01585831|26587483|P2|Overall Study|Physician Decision|1
7642355|NCT01585831|26587484|P1|Overall Study|Physician Decision|0
7642356|NCT01585766|26587571|P6|Overall Study|Physician Decision|0
7642357|NCT01585766|26587572|P5|Overall Study|Physician Decision|0
7642358|NCT01585766|26587573|P4|Overall Study|Physician Decision|0
7642359|NCT01585766|26587574|P3|Overall Study|Physician Decision|1
7642360|NCT01585766|26587575|P2|Overall Study|Physician Decision|0
7642361|NCT01585766|26587576|P1|Overall Study|Physician Decision|0
7642362|NCT01585766|26587571|P6|Overall Study|Death|0
7642363|NCT01585766|26587572|P5|Overall Study|Death|0
7642364|NCT01585766|26587573|P4|Overall Study|Death|0
7642365|NCT01585766|26587574|P3|Overall Study|Death|0
7642366|NCT01585766|26587575|P2|Overall Study|Death|1
7642367|NCT01585766|26587576|P1|Overall Study|Death|0
7642368|NCT01585766|26587571|P6|Overall Study|Withdrawal by Subject|0
7642369|NCT01585766|26587572|P5|Overall Study|Withdrawal by Subject|0
7642370|NCT01585766|26587573|P4|Overall Study|Withdrawal by Subject|0
7642371|NCT01585766|26587574|P3|Overall Study|Withdrawal by Subject|1
7642372|NCT01585766|26587575|P2|Overall Study|Withdrawal by Subject|1
7642373|NCT01585766|26587576|P1|Overall Study|Withdrawal by Subject|0
7642374|NCT01585584|26587680|P1|Overall Study|Physician Decision|2
7642375|NCT01585584|26587680|P1|Overall Study|Withdrawal by Subject|1
7642376|NCT01585584|26587680|P1|Overall Study|Lack of Efficacy|1
7642377|NCT01585558|26587687|P3|Overall Study|Lack of Efficacy|1
7642378|NCT01585558|26587688|P2|Overall Study|Lack of Efficacy|0
7642379|NCT01585558|26587689|P1|Overall Study|Lack of Efficacy|0
7642380|NCT01585558|26587687|P3|Overall Study|Protocol Violation|2
7642381|NCT01585558|26587688|P2|Overall Study|Protocol Violation|3
7642382|NCT01585558|26587689|P1|Overall Study|Protocol Violation|4
7642383|NCT01585558|26587687|P3|Overall Study|Adverse Event|1
7642384|NCT01585558|26587688|P2|Overall Study|Adverse Event|4
7642385|NCT01585558|26587689|P1|Overall Study|Adverse Event|3
7642386|NCT01585558|26587687|P3|Overall Study|Lost to Follow-up|3
7642387|NCT01585558|26587688|P2|Overall Study|Lost to Follow-up|0
7642388|NCT01585558|26587689|P1|Overall Study|Lost to Follow-up|2
7642389|NCT01585558|26587687|P3|Overall Study|Withdrawal by Subject|8
7642390|NCT01585558|26587688|P2|Overall Study|Withdrawal by Subject|5
7642391|NCT01585558|26587689|P1|Overall Study|Withdrawal by Subject|4
7642392|NCT01585428|26587923|P2|Overall Study|Death during treatment|0
7642393|NCT01585428|26587924|P1|Overall Study|Death during treatment|1
7642394|NCT01585298|26587948|P1|Overall Study|Adverse Event|24
7642395|NCT01585298|26587948|P1|Overall Study|Abnormal test procedure results|1
7642396|NCT01585298|26587948|P1|Overall Study|Withdrawal by Subject|4
7642397|NCT01585298|26587948|P1|Overall Study|Lost to Follow-up|2
7642398|NCT01585298|26587948|P1|Overall Study|Administrative problems|4
7642399|NCT01585298|26587948|P1|Overall Study|Protocol deviation|1
7642400|NCT01585298|26587948|P1|Overall Study|Study completion was not documented.|1
7642401|NCT01585272|26587956|P1|Overall Study|Withdrawal by Subject|10
7642402|NCT01585272|26587956|P1|Overall Study|Protocol Violation|7
7642403|NCT01585272|26587956|P1|Overall Study|Adverse Event|22
7642404|NCT01585246|26587969|P5|Overall Study|Other|0
7642405|NCT01585246|26587970|P4|Overall Study|Other|1
7642406|NCT01585246|26587971|P3|Overall Study|Other|1
7642407|NCT01585246|26587972|P2|Overall Study|Other|1
7642408|NCT01585246|26587973|P1|Overall Study|Other|0
7642409|NCT01585246|26587969|P5|Overall Study|Withdrawal by Subject|1
7642410|NCT01585246|26587970|P4|Overall Study|Withdrawal by Subject|2
7642411|NCT01585246|26587971|P3|Overall Study|Withdrawal by Subject|1
7642412|NCT01585246|26587972|P2|Overall Study|Withdrawal by Subject|0
7642413|NCT01585246|26587973|P1|Overall Study|Withdrawal by Subject|0
7642414|NCT01585246|26587969|P5|Overall Study|Protocol Violation|1
7642415|NCT01585246|26587970|P4|Overall Study|Protocol Violation|0
7642416|NCT01585246|26587971|P3|Overall Study|Protocol Violation|0
7642417|NCT01585246|26587972|P2|Overall Study|Protocol Violation|0
7642418|NCT01585246|26587973|P1|Overall Study|Protocol Violation|0
7642419|NCT01585246|26587969|P5|Overall Study|Lost to Follow-up|0
7642420|NCT01585246|26587970|P4|Overall Study|Lost to Follow-up|1
7642421|NCT01585246|26587971|P3|Overall Study|Lost to Follow-up|2
7642422|NCT01585246|26587972|P2|Overall Study|Lost to Follow-up|0
7642423|NCT01585246|26587973|P1|Overall Study|Lost to Follow-up|0
7642424|NCT01585194|26587992|P1|Overall Study|Lack of insurance|1
7642425|NCT01585194|26587992|P1|Overall Study|Physician Decision|2
7642426|NCT01585194|26587992|P1|Overall Study|Withdrawal by Subject|1
7642427|NCT01585168|26588001|P4|Overall Study|Lost to Follow-up|1
7642428|NCT01585168|26588002|P3|Overall Study|Lost to Follow-up|1
7642429|NCT01585168|26588003|P2|Overall Study|Lost to Follow-up|1
7642430|NCT01585168|26588004|P1|Overall Study|Lost to Follow-up|3
7642431|NCT01585155|26588024|P1|Overall Study|Worsening ulcerative colitis|2
7642432|NCT01585155|26588024|P1|Overall Study|Lack of Efficacy|2
7642433|NCT01585155|26588024|P1|Overall Study|Adverse Event|1
7642434|NCT01585038|26588046|P2|Overall Study|Adverse Event|2
7642435|NCT01585038|26588047|P1|Overall Study|Adverse Event|2
7642436|NCT01585025|26588062|P3|Overall Study|Withdrawal by Subject|4
7642437|NCT01585025|26588063|P2|Overall Study|Withdrawal by Subject|3
7642438|NCT01585025|26588064|P1|Overall Study|Withdrawal by Subject|0
7642439|NCT01584843|26588094|P6|Second Treatment Period|Withdrawal by Subject|1
7642440|NCT01584843|26588095|P5|Second Treatment Period|Withdrawal by Subject|0
7642441|NCT01584843|26588096|P4|Second Treatment Period|Withdrawal by Subject|0
7642442|NCT01584843|26588097|P3|Second Treatment Period|Withdrawal by Subject|0
7642443|NCT01584843|26588098|P2|Second Treatment Period|Withdrawal by Subject|0
7642444|NCT01584843|26588099|P1|Second Treatment Period|Withdrawal by Subject|0
7642445|NCT01584843|26588094|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
7642446|NCT01584843|26588095|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7642447|NCT01584843|26588096|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7642448|NCT01584843|26588097|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7642449|NCT01584843|26588098|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7642450|NCT01584843|26588099|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7642451|NCT01584843|26588094|P6|First Treatment Period|Protocol Violation|1
7642452|NCT01584843|26588095|P5|First Treatment Period|Protocol Violation|0
7642453|NCT01584843|26588096|P4|First Treatment Period|Protocol Violation|0
7642454|NCT01584843|26588097|P3|First Treatment Period|Protocol Violation|0
7642455|NCT01584843|26588098|P2|First Treatment Period|Protocol Violation|0
7642456|NCT01584843|26588099|P1|First Treatment Period|Protocol Violation|0
7642457|NCT01584843|26588094|P6|First Treatment Period|Adverse Event|0
7642458|NCT01584843|26588095|P5|First Treatment Period|Adverse Event|0
7642459|NCT01584843|26588096|P4|First Treatment Period|Adverse Event|0
7642460|NCT01584843|26588097|P3|First Treatment Period|Adverse Event|1
7642461|NCT01584843|26588098|P2|First Treatment Period|Adverse Event|0
7642462|NCT01584843|26588099|P1|First Treatment Period|Adverse Event|0
7642463|NCT01584648|26588210|P2|Overall Study|Crossover to Dabrafenib + Trametinib|28
7642464|NCT01584648|26588211|P1|Overall Study|Crossover to Dabrafenib + Trametinib|0
7642465|NCT01584648|26588210|P2|Overall Study|Study closed/terminated|23
7642466|NCT01584648|26588211|P1|Overall Study|Study closed/terminated|50
7642467|NCT01584648|26588210|P2|Overall Study|Withdrew consent|4
7642468|NCT01584648|26588211|P1|Overall Study|Withdrew consent|13
7642469|NCT01584648|26588210|P2|Overall Study|Investigator discretion|2
7642470|NCT01584648|26588211|P1|Overall Study|Investigator discretion|3
7642471|NCT01584648|26588210|P2|Overall Study|Lost to Follow-up|9
7642472|NCT01584648|26588211|P1|Overall Study|Lost to Follow-up|9
7642473|NCT01584648|26588210|P2|Overall Study|Death|146
7642474|NCT01584648|26588211|P1|Overall Study|Death|136
7642475|NCT01584232|26588325|P2|Overall Study|Lost to Follow-up|0
7642476|NCT01584232|26588326|P1|Overall Study|Lost to Follow-up|1
7642477|NCT01584232|26588325|P2|Overall Study|Physician Decision|1
7642478|NCT01584232|26588326|P1|Overall Study|Physician Decision|2
7642479|NCT01584232|26588325|P2|Overall Study|Withdrawal by Subject|1
7642480|NCT01584232|26588326|P1|Overall Study|Withdrawal by Subject|2
7642481|NCT01584232|26588325|P2|Overall Study|Adverse Event|1
7642482|NCT01584232|26588326|P1|Overall Study|Adverse Event|3
7642483|NCT01584024|26588342|P1|Overall Study|Withdrawal by Subject|3
7642484|NCT01584024|26588342|P1|Overall Study|Lost to Follow-up|10
7642485|NCT01583530|26588439|P6|Overall Study|Lack of compliance|0
7642486|NCT01583530|26588440|P5|Overall Study|Lack of compliance|1
7642487|NCT01583530|26588441|P4|Overall Study|Lack of compliance|0
7642488|NCT01583530|26588442|P3|Overall Study|Lack of compliance|0
7642489|NCT01583530|26588443|P2|Overall Study|Lack of compliance|0
7642490|NCT01583530|26588444|P1|Overall Study|Lack of compliance|0
7642491|NCT01583530|26588439|P6|Overall Study|Lost to Follow-up|0
7642492|NCT01583530|26588440|P5|Overall Study|Lost to Follow-up|3
7642493|NCT01583530|26588441|P4|Overall Study|Lost to Follow-up|0
7642494|NCT01583530|26588442|P3|Overall Study|Lost to Follow-up|0
7642495|NCT01583530|26588443|P2|Overall Study|Lost to Follow-up|0
7642496|NCT01583530|26588444|P1|Overall Study|Lost to Follow-up|0
7642497|NCT01583530|26588439|P6|Overall Study|Withdrawal by Subject|2
7642498|NCT01583530|26588440|P5|Overall Study|Withdrawal by Subject|1
7642499|NCT01583530|26588441|P4|Overall Study|Withdrawal by Subject|1
7642500|NCT01583530|26588442|P3|Overall Study|Withdrawal by Subject|0
7642501|NCT01583530|26588443|P2|Overall Study|Withdrawal by Subject|3
7642502|NCT01583530|26588444|P1|Overall Study|Withdrawal by Subject|0
7642503|NCT01583530|26588439|P6|Overall Study|Adverse Event|1
7642504|NCT01583530|26588440|P5|Overall Study|Adverse Event|0
7642505|NCT01583530|26588441|P4|Overall Study|Adverse Event|0
7642506|NCT01583530|26588442|P3|Overall Study|Adverse Event|0
7642507|NCT01583530|26588443|P2|Overall Study|Adverse Event|0
7642508|NCT01583530|26588444|P1|Overall Study|Adverse Event|0
7642509|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7642510|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7642511|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7642512|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7642513|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7642514|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
7642515|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7642516|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7642517|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7642518|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7642519|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7642520|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7642833|NCT01581684|26589017|P5|Overall Study|Other reason not defined|0
7642521|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7642522|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7642523|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7642524|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7642525|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7642526|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7642527|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Death|0
7642528|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Death|0
7642529|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Death|1
7642530|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Death|0
7642531|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Death|1
7642532|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Death|0
7642533|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Death|0
7642534|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Death|0
7642535|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Death|0
7642536|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7642537|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7642538|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
7642539|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
7642540|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
7642541|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
7642542|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7642543|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7642544|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
7642545|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7642546|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7642547|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7642548|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7642549|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7642550|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7642551|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7642552|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7642553|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7642554|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7642555|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
7642556|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7642557|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7642558|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
7642559|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7642560|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
7642561|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7642562|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
7642563|NCT01583374|26588506|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
7642564|NCT01583374|26588507|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
7642565|NCT01583374|26588508|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7642566|NCT01583374|26588509|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7642567|NCT01583374|26588510|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
7642568|NCT01583374|26588511|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7642569|NCT01583374|26588512|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7642570|NCT01583374|26588513|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
7642571|NCT01583374|26588514|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
7642572|NCT01583374|26588506|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7642573|NCT01583374|26588507|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7642574|NCT01583374|26588508|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7642575|NCT01583374|26588509|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
7642576|NCT01583374|26588510|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7642577|NCT01583374|26588511|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7642578|NCT01583374|26588512|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7642579|NCT01583374|26588513|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7642580|NCT01583374|26588514|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7642581|NCT01583374|26588506|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7642582|NCT01583374|26588507|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7642583|NCT01583374|26588508|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7642584|NCT01583374|26588509|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7642585|NCT01583374|26588510|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7642586|NCT01583374|26588511|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7642587|NCT01583374|26588512|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7642588|NCT01583374|26588513|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
7642589|NCT01583374|26588514|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7642590|NCT01583374|26588506|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7642591|NCT01583374|26588507|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7642592|NCT01583374|26588508|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
7642593|NCT01583374|26588509|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7642594|NCT01583374|26588510|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
7642595|NCT01583374|26588511|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
7642596|NCT01583374|26588512|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7642597|NCT01583374|26588513|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7642598|NCT01583374|26588514|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7642599|NCT01583374|26588506|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7642600|NCT01583374|26588507|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7642601|NCT01583374|26588508|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7642602|NCT01583374|26588509|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7642603|NCT01583374|26588510|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7642604|NCT01583374|26588511|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7642605|NCT01583374|26588512|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
7642606|NCT01583374|26588513|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7642607|NCT01583374|26588514|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7642608|NCT01583374|26588506|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642609|NCT01583374|26588507|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7642610|NCT01583374|26588508|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642611|NCT01583374|26588509|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642612|NCT01583374|26588510|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642613|NCT01583374|26588511|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642614|NCT01583374|26588512|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642615|NCT01583374|26588513|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642616|NCT01583374|26588514|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7642617|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Other|0
7642618|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Other|0
7642619|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Other|0
7642620|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Other|0
7642621|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Other|0
7642622|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Other|0
7642623|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Other|0
7642624|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Other|1
7642625|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Other|0
7642626|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642627|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642628|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642629|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642630|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642631|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642632|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
7642633|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642634|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7642635|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642636|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642637|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642638|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642639|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642640|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642641|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7642642|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
7642643|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
7642644|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7642645|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7642646|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7642647|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7642648|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7642649|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7642650|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7642651|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7642652|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
7642653|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642654|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642655|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642656|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642657|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642658|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642659|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7642660|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7642661|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7642662|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7642663|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7642664|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7642665|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7642666|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7642667|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7642668|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7642669|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
7642670|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
7642671|NCT01583374|26588506|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7642672|NCT01583374|26588507|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7642673|NCT01583374|26588508|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7642674|NCT01583374|26588509|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7642675|NCT01583374|26588510|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7642676|NCT01583374|26588511|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7642677|NCT01583374|26588512|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
7642678|NCT01583374|26588513|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
7642679|NCT01583374|26588514|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
7642680|NCT01583218|26588556|P2|Overall Study|Withdraw of consent on day of random|0
7642681|NCT01583218|26588557|P1|Overall Study|Withdraw of consent on day of random|1
7642682|NCT01583218|26588556|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
7642683|NCT01583218|26588557|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
7642684|NCT01583218|26588556|P2|Overall Study|Patient was randomized due to mistake|0
7642685|NCT01583218|26588557|P1|Overall Study|Patient was randomized due to mistake|1
7642686|NCT01583218|26588556|P2|Overall Study|Patient was early terminated from study|1
7642687|NCT01583218|26588557|P1|Overall Study|Patient was early terminated from study|0
7642688|NCT01583218|26588556|P2|Overall Study|Patient deemed ineligible after random|0
7642689|NCT01583218|26588557|P1|Overall Study|Patient deemed ineligible after random|2
7642690|NCT01583218|26588556|P2|Overall Study|Patient was assessed via phone in person|0
7642691|NCT01583218|26588557|P1|Overall Study|Patient was assessed via phone in person|1
7642692|NCT01583218|26588556|P2|Overall Study|Patient randomized but not dosed|16
7642693|NCT01583218|26588557|P1|Overall Study|Patient randomized but not dosed|17
7642694|NCT01583218|26588556|P2|Overall Study|Patient did not wish to attend visits|1
7642695|NCT01583218|26588557|P1|Overall Study|Patient did not wish to attend visits|0
7642696|NCT01583218|26588556|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
7642697|NCT01583218|26588557|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
7642698|NCT01583218|26588556|P2|Overall Study|Cannot contact patient directly|2
7642699|NCT01583218|26588557|P1|Overall Study|Cannot contact patient directly|1
7642700|NCT01583218|26588556|P2|Overall Study|Patient /Family decision|0
7642701|NCT01583218|26588557|P1|Overall Study|Patient /Family decision|3
7642702|NCT01583218|26588556|P2|Overall Study|Adverse event or serious adverse event|3
7642703|NCT01583218|26588557|P1|Overall Study|Adverse event or serious adverse event|3
7642704|NCT01583218|26588556|P2|Overall Study|Lost to Follow-up|17
7642705|NCT01583218|26588557|P1|Overall Study|Lost to Follow-up|11
7642706|NCT01583218|26588556|P2|Overall Study|Death|211
7642707|NCT01583218|26588557|P1|Overall Study|Death|206
7642708|NCT01583218|26588556|P2|Overall Study|Withdrawal by Subject|29
7642709|NCT01583218|26588557|P1|Overall Study|Withdrawal by Subject|43
7642710|NCT01583179|26588577|P2|Overall Study|Screen failure|2
7642711|NCT01583179|26588578|P1|Overall Study|Screen failure|1
7642712|NCT01583166|26588588|P2|Overall Study|Withdrawal by Subject|6
7642713|NCT01583166|26588589|P1|Overall Study|Withdrawal by Subject|4
7642714|NCT01582971|26588612|P2|Overall Study|Other|13
7642715|NCT01582971|26588613|P1|Overall Study|Other|15
7642716|NCT01582971|26588612|P2|Overall Study|Withdrawal by Subject|2
7642717|NCT01582971|26588613|P1|Overall Study|Withdrawal by Subject|4
7642718|NCT01582971|26588612|P2|Overall Study|Lost to Follow-up|21
7642719|NCT01582971|26588613|P1|Overall Study|Lost to Follow-up|18
7642720|NCT01582971|26588612|P2|Overall Study|Death|1
7642721|NCT01582971|26588613|P1|Overall Study|Death|2
7642722|NCT01582945|26588631|P1|Overall Study|Scheduling conflicts|1
7642723|NCT01582945|26588631|P1|Overall Study|Intolerable side-effects|1
7642724|NCT01582854|26588645|P2|Overall Study|Other Miscellaneous Reason|0
7642725|NCT01582854|26588646|P1|Overall Study|Other Miscellaneous Reason|1
7642726|NCT01582854|26588645|P2|Overall Study|General Anaesthesia|1
7642727|NCT01582854|26588646|P1|Overall Study|General Anaesthesia|0
7642728|NCT01582854|26588645|P2|Overall Study|Carotid or Neurosurgery|1
7642729|NCT01582854|26588646|P1|Overall Study|Carotid or Neurosurgery|0
7642730|NCT01582854|26588645|P2|Overall Study|Disallowed Concomitant Medication|2
7642731|NCT01582854|26588646|P1|Overall Study|Disallowed Concomitant Medication|3
7642732|NCT01582854|26588645|P2|Overall Study|Recurrent Stroke|8
7642733|NCT01582854|26588646|P1|Overall Study|Recurrent Stroke|13
7642734|NCT01582854|26588645|P2|Overall Study|Physician Decision|1
7642735|NCT01582854|26588646|P1|Overall Study|Physician Decision|0
7642736|NCT01582854|26588645|P2|Overall Study|Lost to Follow-up|2
7642737|NCT01582854|26588646|P1|Overall Study|Lost to Follow-up|1
7642738|NCT01582854|26588645|P2|Overall Study|Withdrawal by Participant|11
7642739|NCT01582854|26588646|P1|Overall Study|Withdrawal by Participant|8
7642740|NCT01582854|26588645|P2|Overall Study|Adverse Event|3
7642741|NCT01582854|26588646|P1|Overall Study|Adverse Event|2
7642742|NCT01582854|26588645|P2|Overall Study|Death|5
7642743|NCT01582854|26588646|P1|Overall Study|Death|8
7642744|NCT01582789|26588674|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
7642745|NCT01582789|26588675|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
7642746|NCT01582451|26588735|P2|Overall Study|Sponsor Decision|0
7642747|NCT01582451|26588736|P1|Overall Study|Sponsor Decision|1
7642748|NCT01582451|26588735|P2|Overall Study|Physician Decision|0
7642749|NCT01582451|26588736|P1|Overall Study|Physician Decision|3
7642750|NCT01582451|26588735|P2|Overall Study|Withdrawal by Subject|9
7642751|NCT01582451|26588736|P1|Overall Study|Withdrawal by Subject|13
7642752|NCT01582451|26588735|P2|Overall Study|Protocol Violation|3
7642753|NCT01582451|26588736|P1|Overall Study|Protocol Violation|11
7642754|NCT01582451|26588735|P2|Overall Study|Lost to Follow-up|2
7642755|NCT01582451|26588736|P1|Overall Study|Lost to Follow-up|0
7642756|NCT01582451|26588735|P2|Overall Study|Death|3
7642757|NCT01582451|26588736|P1|Overall Study|Death|3
7642758|NCT01582451|26588735|P2|Overall Study|Adverse Event|3
7642759|NCT01582451|26588736|P1|Overall Study|Adverse Event|1
7642760|NCT01582308|26588778|P10|Period 4|Physician Decision|1
7642761|NCT01582308|26588779|P9|Period 4|Physician Decision|0
7642762|NCT01582308|26588780|P8|Period 4|Physician Decision|0
7642763|NCT01582308|26588781|P7|Period 4|Physician Decision|0
7642764|NCT01582308|26588782|P6|Period 4|Physician Decision|1
7642765|NCT01582308|26588783|P5|Period 4|Physician Decision|0
7642766|NCT01582308|26588784|P4|Period 4|Physician Decision|0
7642767|NCT01582308|26588785|P3|Period 4|Physician Decision|0
7642768|NCT01582308|26588786|P2|Period 4|Physician Decision|0
7642769|NCT01582308|26588787|P1|Period 4|Physician Decision|1
7642770|NCT01582308|26588778|P10|10-day Washout Following Period 1|Physician Decision|0
7642771|NCT01582308|26588779|P9|10-day Washout Following Period 1|Physician Decision|0
7642772|NCT01582308|26588780|P8|10-day Washout Following Period 1|Physician Decision|0
7642773|NCT01582308|26588781|P7|10-day Washout Following Period 1|Physician Decision|0
7642774|NCT01582308|26588782|P6|10-day Washout Following Period 1|Physician Decision|0
7642775|NCT01582308|26588783|P5|10-day Washout Following Period 1|Physician Decision|1
7642776|NCT01582308|26588784|P4|10-day Washout Following Period 1|Physician Decision|0
7642777|NCT01582308|26588785|P3|10-day Washout Following Period 1|Physician Decision|0
7642778|NCT01582308|26588786|P2|10-day Washout Following Period 1|Physician Decision|0
7642779|NCT01582308|26588787|P1|10-day Washout Following Period 1|Physician Decision|0
7642780|NCT01582308|26588778|P10|Period 1|Withdrawal by Subject|0
7642781|NCT01582308|26588779|P9|Period 1|Withdrawal by Subject|0
7642782|NCT01582308|26588780|P8|Period 1|Withdrawal by Subject|0
7642783|NCT01582308|26588781|P7|Period 1|Withdrawal by Subject|1
7642784|NCT01582308|26588782|P6|Period 1|Withdrawal by Subject|0
7642785|NCT01582308|26588783|P5|Period 1|Withdrawal by Subject|0
7642786|NCT01582308|26588784|P4|Period 1|Withdrawal by Subject|0
7642787|NCT01582308|26588785|P3|Period 1|Withdrawal by Subject|0
7642788|NCT01582308|26588786|P2|Period 1|Withdrawal by Subject|0
7642789|NCT01582308|26588787|P1|Period 1|Withdrawal by Subject|0
7642790|NCT01582282|26588815|P3|Overall Study|fasting blood glucose outside Protocol|0
7642791|NCT01582282|26588816|P2|Overall Study|fasting blood glucose outside Protocol|1
7642792|NCT01582282|26588817|P1|Overall Study|fasting blood glucose outside Protocol|0
7642793|NCT01582282|26588815|P3|Overall Study|Lost to Follow-up|0
7642794|NCT01582282|26588816|P2|Overall Study|Lost to Follow-up|0
7642795|NCT01582282|26588817|P1|Overall Study|Lost to Follow-up|1
7642796|NCT01582282|26588815|P3|Overall Study|Adverse Event|0
7642797|NCT01582282|26588816|P2|Overall Study|Adverse Event|1
7642798|NCT01582282|26588817|P1|Overall Study|Adverse Event|1
7642799|NCT01582243|26588840|P1|Overall Study|Lost to Follow-up|1
7642800|NCT01582243|26588840|P1|Overall Study|Adverse Event|1
7642801|NCT01582243|26588840|P1|Overall Study|Withdrawal by Subject|1
7642802|NCT01582178|26588851|P2|Overall Study|Physician Decision|5
7642803|NCT01582178|26588852|P1|Overall Study|Physician Decision|6
7642804|NCT01582152|26588860|P2|Overall Study|Adverse Event|1
7642805|NCT01582152|26588861|P1|Overall Study|Adverse Event|2
7642806|NCT01582152|26588860|P2|Overall Study|Disease Progression|5
7642807|NCT01582152|26588861|P1|Overall Study|Disease Progression|4
7642808|NCT01582100|26588884|P1|Overall Study|Withdrawal by Subject|1
7642809|NCT01582100|26588884|P1|Overall Study|Adverse Event|1
7642810|NCT01582061|26588890|P2|Overall Study|Lost to Follow-up|0
7642811|NCT01582061|26588891|P1|Overall Study|Lost to Follow-up|1
7642812|NCT01582061|26588890|P2|Overall Study|condition no longer requires study drug|0
7642813|NCT01582061|26588891|P1|Overall Study|condition no longer requires study drug|1
7642814|NCT01582061|26588890|P2|Overall Study|Death|1
7642815|NCT01582061|26588891|P1|Overall Study|Death|0
7642816|NCT01582061|26588890|P2|Overall Study|Abnormal laboratory value(s)|0
7642817|NCT01582061|26588891|P1|Overall Study|Abnormal laboratory value(s)|1
7642818|NCT01582061|26588890|P2|Overall Study|Withdrawal by Subject|4
7642819|NCT01582061|26588891|P1|Overall Study|Withdrawal by Subject|10
7642820|NCT01582061|26588890|P2|Overall Study|Adverse Event|8
7642821|NCT01582061|26588891|P1|Overall Study|Adverse Event|12
7642822|NCT01582061|26588890|P2|Overall Study|Lack of Efficacy|23
7642823|NCT01582061|26588891|P1|Overall Study|Lack of Efficacy|3
7642824|NCT01582009|26588941|P1|Overall Study|Physician Decision|1
7642825|NCT01582009|26588941|P1|Overall Study|Withdrawal by Subject|1
7642826|NCT01581931|26588958|P2|Washout|Adverse Event|1
7642827|NCT01581931|26588959|P1|Washout|Adverse Event|0
7642828|NCT01581684|26589012|P10|Overall Study|Other reason not defined|0
7642829|NCT01581684|26589013|P9|Overall Study|Other reason not defined|1
7642830|NCT01581684|26589014|P8|Overall Study|Other reason not defined|0
7642831|NCT01581684|26589015|P7|Overall Study|Other reason not defined|0
7642834|NCT01581684|26589018|P4|Overall Study|Other reason not defined|0
7642835|NCT01581684|26589019|P3|Overall Study|Other reason not defined|0
7642836|NCT01581684|26589020|P2|Overall Study|Other reason not defined|0
7642837|NCT01581684|26589021|P1|Overall Study|Other reason not defined|0
7642838|NCT01581619|26589117|P1|Overall Study|Lost to Follow-up|1
7642839|NCT01581619|26589117|P1|Overall Study|Withdrawal by Subject|1
7642840|NCT01581593|26589125|P1|Overall Study|Withdrawal by Subject|1
7642841|NCT01581307|26589288|P1|Overall Study|Withdrawal by Subject|1
7642842|NCT01581281|26589297|P3|Overall Study|Early Study Closure|12
7642843|NCT01581281|26589298|P2|Overall Study|Early Study Closure|6
7642844|NCT01581281|26589299|P1|Overall Study|Early Study Closure|15
7642845|NCT01581021|26589321|P2|Overall Study|Lack of Efficacy|1
7642846|NCT01581021|26589322|P1|Overall Study|Lack of Efficacy|0
7642847|NCT01581021|26589321|P2|Overall Study|Lenke 6 Classification|1
7642848|NCT01581021|26589322|P1|Overall Study|Lenke 6 Classification|0
7642849|NCT01581021|26589321|P2|Overall Study|Not Randomized|2
7642850|NCT01581021|26589322|P1|Overall Study|Not Randomized|1
7642851|NCT01581021|26589321|P2|Overall Study|Neuromuscular|1
7642852|NCT01581021|26589322|P1|Overall Study|Neuromuscular|2
7642853|NCT01581021|26589321|P2|Overall Study|More than 2 hooks in thoracic|0
7642854|NCT01581021|26589322|P1|Overall Study|More than 2 hooks in thoracic|3
7642855|NCT01581021|26589321|P2|Overall Study|Lost to Follow-up|6
7642856|NCT01581021|26589322|P1|Overall Study|Lost to Follow-up|4
7642857|NCT01580995|26589349|P2|Overall Study|Lost to Follow-up|2
7642858|NCT01580995|26589350|P1|Overall Study|Lost to Follow-up|2
7642859|NCT01580969|26589359|P3|Overall Study|Physician Decision|0
7642860|NCT01580969|26589360|P2|Overall Study|Physician Decision|0
7642861|NCT01580969|26589361|P1|Overall Study|Physician Decision|3
7642862|NCT01580670|26589408|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
7642863|NCT01580670|26589408|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
7642864|NCT01580488|26589449|P1|Overall Study|Withdrawal by Subject|1
7642865|NCT01580293|26589555|P3|Part B|Other reason|1
7642866|NCT01580293|26589556|P2|Part B|Other reason|0
7642867|NCT01580293|26589557|P1|Part B|Other reason|0
7642868|NCT01580293|26589555|P3|Part B|Withdrawal by Subject|1
7642869|NCT01580293|26589556|P2|Part B|Withdrawal by Subject|0
7642870|NCT01580293|26589557|P1|Part B|Withdrawal by Subject|0
7642871|NCT01580293|26589555|P3|Part A_Extension|Completed Japan only|0
7642872|NCT01580293|26589556|P2|Part A_Extension|Completed Japan only|5
7642873|NCT01580293|26589557|P1|Part A_Extension|Completed Japan only|0
7642874|NCT01580293|26589555|P3|Part A_Extension|Other Reason|0
7642875|NCT01580293|26589556|P2|Part A_Extension|Other Reason|1
7642876|NCT01580293|26589557|P1|Part A_Extension|Other Reason|0
7642877|NCT01580293|26589555|P3|Part A_Extension|Lost to Follow-up|0
7642878|NCT01580293|26589556|P2|Part A_Extension|Lost to Follow-up|1
7642879|NCT01580293|26589557|P1|Part A_Extension|Lost to Follow-up|0
7642880|NCT01580293|26589555|P3|Part A_Extension|Withdrawal by Subject|0
7642881|NCT01580293|26589556|P2|Part A_Extension|Withdrawal by Subject|3
7642882|NCT01580293|26589557|P1|Part A_Extension|Withdrawal by Subject|0
7642883|NCT01580293|26589555|P3|Part A_Extension|Adverse Event|0
7642884|NCT01580293|26589556|P2|Part A_Extension|Adverse Event|2
7642885|NCT01580293|26589557|P1|Part A_Extension|Adverse Event|0
7642886|NCT01580293|26589555|P3|Part A_Main Trial|Non-adherence to the protocol|0
7642887|NCT01580293|26589556|P2|Part A_Main Trial|Non-adherence to the protocol|0
7642888|NCT01580293|26589557|P1|Part A_Main Trial|Non-adherence to the protocol|1
7642889|NCT01580293|26589555|P3|Part A_Main Trial|Withdrawal by Subject|0
7642890|NCT01580293|26589556|P2|Part A_Main Trial|Withdrawal by Subject|4
7642891|NCT01580293|26589557|P1|Part A_Main Trial|Withdrawal by Subject|1
7642892|NCT01580293|26589555|P3|Part A_Main Trial|Adverse Event|0
7642893|NCT01580293|26589556|P2|Part A_Main Trial|Adverse Event|2
7642894|NCT01580293|26589557|P1|Part A_Main Trial|Adverse Event|0
7642895|NCT01580020|26589697|P4|Overall Study|Lost to Follow-up|0
7642896|NCT01580020|26589698|P3|Overall Study|Lost to Follow-up|1
7642897|NCT01580020|26589699|P2|Overall Study|Lost to Follow-up|0
7642898|NCT01580020|26589700|P1|Overall Study|Lost to Follow-up|0
7642899|NCT01580020|26589697|P4|Overall Study|Administrative Problems|0
7642900|NCT01580020|26589698|P3|Overall Study|Administrative Problems|1
7642901|NCT01580020|26589699|P2|Overall Study|Administrative Problems|0
7642902|NCT01580020|26589700|P1|Overall Study|Administrative Problems|0
7642903|NCT01580020|26589697|P4|Overall Study|Adverse Event|1
7642904|NCT01580020|26589698|P3|Overall Study|Adverse Event|1
7642905|NCT01580020|26589699|P2|Overall Study|Adverse Event|1
7642906|NCT01580020|26589700|P1|Overall Study|Adverse Event|1
7642907|NCT01580020|26589697|P4|Overall Study|Withdrawal by Subject|0
7642908|NCT01580020|26589698|P3|Overall Study|Withdrawal by Subject|1
7642909|NCT01580020|26589699|P2|Overall Study|Withdrawal by Subject|1
7642910|NCT01580020|26589700|P1|Overall Study|Withdrawal by Subject|0
7642911|NCT01580020|26589697|P4|Overall Study|Lack of Efficacy|1
7642912|NCT01580020|26589698|P3|Overall Study|Lack of Efficacy|0
7642913|NCT01580020|26589699|P2|Overall Study|Lack of Efficacy|5
7642914|NCT01580020|26589700|P1|Overall Study|Lack of Efficacy|0
7642915|NCT01579916|26589744|P2|Overall Study|Death|0
7642916|NCT01579916|26589745|P1|Overall Study|Death|1
7642917|NCT01579916|26589744|P2|Overall Study|Withdrawal by Subject|1
7642918|NCT01579916|26589745|P1|Overall Study|Withdrawal by Subject|1
7642919|NCT01579916|26589744|P2|Overall Study|Lost to Follow-up|1
7642920|NCT01579916|26589745|P1|Overall Study|Lost to Follow-up|6
7642921|NCT01579812|26589771|P1|Overall Study|Withdrawal by Subject|6
7642922|NCT01579812|26589771|P1|Overall Study|Noncompliance|3
7642923|NCT01579812|26589771|P1|Overall Study|Patient choice|3
7642924|NCT01579812|26589771|P1|Overall Study|Ineligible after treatment start|40
7642925|NCT01579578|26589805|P2|Overall Study|Ongoing|0
7642926|NCT01579578|26589806|P1|Overall Study|Ongoing|3
7642927|NCT01579578|26589805|P2|Overall Study|Eligibility criteria|9
7642928|NCT01579578|26589806|P1|Overall Study|Eligibility criteria|3
7642929|NCT01579578|26589805|P2|Overall Study|Withdrawal by Subject|1
7642930|NCT01579578|26589806|P1|Overall Study|Withdrawal by Subject|2
7642931|NCT01579578|26589805|P2|Overall Study|Lost to Follow-up|1
7642932|NCT01579578|26589806|P1|Overall Study|Lost to Follow-up|1
7642933|NCT01579578|26589805|P2|Overall Study|Death|1
7642934|NCT01579578|26589806|P1|Overall Study|Death|4
7642935|NCT01579565|26589818|P2|Treated|declined to return for final visit|1
7642936|NCT01579565|26589819|P1|Treated|declined to return for final visit|0
7642937|NCT01579565|26589818|P2|Treated|Lost to Follow-up|1
7642938|NCT01579565|26589819|P1|Treated|Lost to Follow-up|2
7642939|NCT01579565|26589818|P2|Treated|Physician Decision|1
7642940|NCT01579565|26589819|P1|Treated|Physician Decision|0
7642941|NCT01579565|26589818|P2|Randomized|prohibited preoperative medication|1
7642942|NCT01579565|26589819|P1|Randomized|prohibited preoperative medication|0
7642943|NCT01579565|26589818|P2|Randomized|prohibited preoperative eating|0
7642944|NCT01579565|26589819|P1|Randomized|prohibited preoperative eating|1
7642945|NCT01579565|26589818|P2|Randomized|inadequate preoperative pupil dilation|1
7642946|NCT01579565|26589819|P1|Randomized|inadequate preoperative pupil dilation|0
7642947|NCT01579565|26589818|P2|Randomized|Withdrawal by Subject|0
7642948|NCT01579565|26589819|P1|Randomized|Withdrawal by Subject|3
7642949|NCT01579565|26589818|P2|Randomized|Adverse Event|3
7642950|NCT01579565|26589819|P1|Randomized|Adverse Event|1
7642951|NCT01579474|26589870|P6|Overall Study|Withdrawal by Subject|0
7642952|NCT01579474|26589871|P5|Overall Study|Withdrawal by Subject|0
7642953|NCT01579474|26589872|P4|Overall Study|Withdrawal by Subject|0
7642954|NCT01579474|26589873|P3|Overall Study|Withdrawal by Subject|0
7642955|NCT01579474|26589874|P2|Overall Study|Withdrawal by Subject|0
7642956|NCT01579474|26589875|P1|Overall Study|Withdrawal by Subject|1
7642957|NCT01579474|26589870|P6|Overall Study|Lack of Efficacy|0
7642958|NCT01579474|26589871|P5|Overall Study|Lack of Efficacy|1
7642959|NCT01579474|26589872|P4|Overall Study|Lack of Efficacy|0
7642960|NCT01579474|26589873|P3|Overall Study|Lack of Efficacy|0
7642961|NCT01579474|26589874|P2|Overall Study|Lack of Efficacy|0
7642962|NCT01579474|26589875|P1|Overall Study|Lack of Efficacy|1
7642963|NCT01579474|26589870|P6|Overall Study|Adverse Event|1
7642964|NCT01579474|26589871|P5|Overall Study|Adverse Event|0
7642965|NCT01579474|26589872|P4|Overall Study|Adverse Event|0
7642966|NCT01579474|26589873|P3|Overall Study|Adverse Event|2
7642967|NCT01579474|26589874|P2|Overall Study|Adverse Event|13
7642968|NCT01579474|26589875|P1|Overall Study|Adverse Event|1
7642969|NCT01579318|26589949|P1|Overall Study|Disease Progression|1
7642970|NCT01579006|26590066|P1|Overall Study|Scheduled surgery|1
7642971|NCT01579006|26590066|P1|Overall Study|Due to participant's health fund|1
7642972|NCT01579006|26590066|P1|Overall Study|Non-compliance|3
7642973|NCT01579006|26590066|P1|Overall Study|Withdrawal by Subject|5
7642974|NCT01579006|26590066|P1|Overall Study|Adverse Event|13
7642975|NCT01579006|26590066|P1|Overall Study|Lack of Efficacy|10
7642976|NCT01578850|26590134|P3|Period 2|Unspecified Reasons|0
7642977|NCT01578850|26590135|P2|Period 2|Unspecified Reasons|1
7642978|NCT01578850|26590136|P1|Period 2|Unspecified Reasons|0
7642979|NCT01578850|26590134|P3|Period 2|Study Terminated by Sponsor|4
7642980|NCT01578850|26590135|P2|Period 2|Study Terminated by Sponsor|5
7642981|NCT01578850|26590136|P1|Period 2|Study Terminated by Sponsor|0
7642982|NCT01578850|26590134|P3|Period 2|Withdrawal by Subject|2
7642983|NCT01578850|26590135|P2|Period 2|Withdrawal by Subject|2
7642984|NCT01578850|26590136|P1|Period 2|Withdrawal by Subject|0
7642985|NCT01578850|26590134|P3|Period 2|Lost to Follow-up|2
7642986|NCT01578850|26590135|P2|Period 2|Lost to Follow-up|1
7642987|NCT01578850|26590136|P1|Period 2|Lost to Follow-up|0
7642988|NCT01578850|26590134|P3|Period 2|Adverse Event|6
7642989|NCT01578850|26590135|P2|Period 2|Adverse Event|3
7642990|NCT01578850|26590136|P1|Period 2|Adverse Event|0
7642991|NCT01578850|26590134|P3|Period 2|Insufficient Clinical Response|0
7642992|NCT01578850|26590135|P2|Period 2|Insufficient Clinical Response|1
7642993|NCT01578850|26590136|P1|Period 2|Insufficient Clinical Response|0
7642994|NCT01578850|26590134|P3|Period 1|Study Terminated by Sponsor|0
7642995|NCT01578850|26590135|P2|Period 1|Study Terminated by Sponsor|0
7642996|NCT01578850|26590136|P1|Period 1|Study Terminated by Sponsor|3
7642997|NCT01578850|26590134|P3|Period 1|Withdrawal by Subject|0
7642998|NCT01578850|26590135|P2|Period 1|Withdrawal by Subject|0
7642999|NCT01578850|26590136|P1|Period 1|Withdrawal by Subject|9
7643000|NCT01578850|26590134|P3|Period 1|Does Not Meet Entrance Criteria|0
7643001|NCT01578850|26590135|P2|Period 1|Does Not Meet Entrance Criteria|0
7643002|NCT01578850|26590136|P1|Period 1|Does Not Meet Entrance Criteria|12
7643003|NCT01578850|26590134|P3|Period 1|Death|0
7643004|NCT01578850|26590135|P2|Period 1|Death|0
7643005|NCT01578850|26590136|P1|Period 1|Death|1
7643006|NCT01578850|26590134|P3|Period 1|Adverse Event|0
7643007|NCT01578850|26590135|P2|Period 1|Adverse Event|0
7643008|NCT01578850|26590136|P1|Period 1|Adverse Event|11
7643009|NCT01578850|26590134|P3|Period 1|Insufficient Clinical Response|0
7643010|NCT01578850|26590135|P2|Period 1|Insufficient Clinical Response|0
7643011|NCT01578850|26590136|P1|Period 1|Insufficient Clinical Response|1
7643012|NCT01578785|26590188|P2|Overall Study|Study terminated by sponsor|118
7643013|NCT01578785|26590189|P1|Overall Study|Study terminated by sponsor|59
7643014|NCT01578785|26590188|P2|Overall Study|Withdrawal by Subject|1
7643015|NCT01578785|26590189|P1|Overall Study|Withdrawal by Subject|0
7643016|NCT01578551|26590254|P2|Overall Study|Adverse Event|0
7643017|NCT01578551|26590255|P1|Overall Study|Adverse Event|1
7643018|NCT01578499|26590267|P2|Overall Study|Died and End of Study Page not Completed|0
7643019|NCT01578499|26590268|P1|Overall Study|Died and End of Study Page not Completed|2
7643020|NCT01578499|26590267|P2|Overall Study|Death|25
7643021|NCT01578499|26590268|P1|Overall Study|Death|20
7643022|NCT01578499|26590267|P2|Overall Study|Withdrawal by Subject|16
7643023|NCT01578499|26590268|P1|Overall Study|Withdrawal by Subject|10
7643024|NCT01578499|26590267|P2|Overall Study|Lost to Follow-up|1
7643025|NCT01578499|26590268|P1|Overall Study|Lost to Follow-up|2
7643026|NCT01578499|26590267|P2|Overall Study|Reason not Specified|1
7643027|NCT01578499|26590268|P1|Overall Study|Reason not Specified|0
7643028|NCT01578486|26590302|P1|Overall Study|Withdrawal by Subject|2
7643029|NCT01578486|26590302|P1|Overall Study|Physician Decision|3
7643030|NCT01578330|26590313|P1|Overall Study|Protocol Violation|5
7643031|NCT01578330|26590313|P1|Overall Study|Adverse Event|2
7643032|NCT01578239|26590348|P2|Long-term Follow-Up Period|Other|2
7643033|NCT01578239|26590349|P1|Long-term Follow-Up Period|Other|2
7643034|NCT01578239|26590348|P2|Long-term Follow-Up Period|Lost to Follow-up|4
7643035|NCT01578239|26590349|P1|Long-term Follow-Up Period|Lost to Follow-up|2
7643036|NCT01578239|26590348|P2|Long-term Follow-Up Period|Consent withdrawal|10
7643037|NCT01578239|26590349|P1|Long-term Follow-Up Period|Consent withdrawal|4
7643038|NCT01578239|26590348|P2|Long-term Follow-Up Period|Death|64
7643039|NCT01578239|26590349|P1|Long-term Follow-Up Period|Death|69
7643040|NCT01578239|26590348|P2|Treatment Period|Other|1
7643041|NCT01578239|26590349|P1|Treatment Period|Other|6
7643042|NCT01578239|26590348|P2|Treatment Period|Withdrawal by Subject|9
7643043|NCT01578239|26590349|P1|Treatment Period|Withdrawal by Subject|10
7643044|NCT01578239|26590348|P2|Treatment Period|Non-compliance|0
7643045|NCT01578239|26590349|P1|Treatment Period|Non-compliance|2
7643046|NCT01578239|26590348|P2|Treatment Period|Adverse Event|10
7643047|NCT01578239|26590349|P1|Treatment Period|Adverse Event|13
7643048|NCT01578239|26590348|P2|Treatment Period|Physician Decision|17
7643049|NCT01578239|26590349|P1|Treatment Period|Physician Decision|17
7643050|NCT01578239|26590348|P2|Treatment Period|Progressive Disease|64
7643051|NCT01578239|26590349|P1|Treatment Period|Progressive Disease|19
7643052|NCT01578187|26590371|P1|Usability Phase|Withdrawal by Subject|1
7643053|NCT01577758|26590413|P8|mCRC Expansion Phase|Progression Disease|19
7643054|NCT01577758|26590414|P7|mCRC Expansion Phase|Progression Disease|0
7643055|NCT01577758|26590415|P6|mCRC Expansion Phase|Progression Disease|0
7643056|NCT01577758|26590416|P5|mCRC Expansion Phase|Progression Disease|0
7643057|NCT01577758|26590417|P4|mCRC Expansion Phase|Progression Disease|0
7643058|NCT01577758|26590418|P3|mCRC Expansion Phase|Progression Disease|0
7643059|NCT01577758|26590419|P2|mCRC Expansion Phase|Progression Disease|0
7643060|NCT01577758|26590420|P1|mCRC Expansion Phase|Progression Disease|0
7643061|NCT01577758|26590413|P8|mCRC Expansion Phase|Withdrawal by Subject|2
7643062|NCT01577758|26590414|P7|mCRC Expansion Phase|Withdrawal by Subject|0
7643063|NCT01577758|26590415|P6|mCRC Expansion Phase|Withdrawal by Subject|0
7643064|NCT01577758|26590416|P5|mCRC Expansion Phase|Withdrawal by Subject|0
7643065|NCT01577758|26590417|P4|mCRC Expansion Phase|Withdrawal by Subject|0
7643066|NCT01577758|26590418|P3|mCRC Expansion Phase|Withdrawal by Subject|0
7643067|NCT01577758|26590419|P2|mCRC Expansion Phase|Withdrawal by Subject|0
7643068|NCT01577758|26590420|P1|mCRC Expansion Phase|Withdrawal by Subject|0
7643069|NCT01577758|26590413|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
7643070|NCT01577758|26590414|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
7643071|NCT01577758|26590415|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
7643072|NCT01577758|26590416|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
7643073|NCT01577758|26590417|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
7643074|NCT01577758|26590418|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
7643075|NCT01577758|26590419|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
7643076|NCT01577758|26590420|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
7643077|NCT01577758|26590413|P8|Dose Escalation Phase|Progression Disease|0
7643078|NCT01577758|26590414|P7|Dose Escalation Phase|Progression Disease|0
7643079|NCT01577758|26590415|P6|Dose Escalation Phase|Progression Disease|0
7643080|NCT01577758|26590416|P5|Dose Escalation Phase|Progression Disease|5
7643081|NCT01577758|26590417|P4|Dose Escalation Phase|Progression Disease|2
7643082|NCT01577758|26590418|P3|Dose Escalation Phase|Progression Disease|1
7643083|NCT01577758|26590419|P2|Dose Escalation Phase|Progression Disease|2
7643084|NCT01577758|26590420|P1|Dose Escalation Phase|Progression Disease|2
7643085|NCT01577758|26590413|P8|Dose Escalation Phase|Withdrawal by Subject|0
7643086|NCT01577758|26590414|P7|Dose Escalation Phase|Withdrawal by Subject|0
7643087|NCT01577758|26590415|P6|Dose Escalation Phase|Withdrawal by Subject|1
7643088|NCT01577758|26590416|P5|Dose Escalation Phase|Withdrawal by Subject|0
7643089|NCT01577758|26590417|P4|Dose Escalation Phase|Withdrawal by Subject|0
7643090|NCT01577758|26590418|P3|Dose Escalation Phase|Withdrawal by Subject|0
7643091|NCT01577758|26590419|P2|Dose Escalation Phase|Withdrawal by Subject|0
7643092|NCT01577758|26590420|P1|Dose Escalation Phase|Withdrawal by Subject|0
7643093|NCT01577758|26590413|P8|Dose Escalation Phase|Symptomatic Deterioration|0
7643094|NCT01577758|26590414|P7|Dose Escalation Phase|Symptomatic Deterioration|0
7643095|NCT01577758|26590415|P6|Dose Escalation Phase|Symptomatic Deterioration|1
7643096|NCT01577758|26590416|P5|Dose Escalation Phase|Symptomatic Deterioration|1
7643097|NCT01577758|26590417|P4|Dose Escalation Phase|Symptomatic Deterioration|0
7643098|NCT01577758|26590418|P3|Dose Escalation Phase|Symptomatic Deterioration|1
7643099|NCT01577758|26590419|P2|Dose Escalation Phase|Symptomatic Deterioration|0
7643100|NCT01577758|26590420|P1|Dose Escalation Phase|Symptomatic Deterioration|0
7643101|NCT01577758|26590413|P8|Dose Escalation Phase|Adverse Event|0
7643102|NCT01577758|26590414|P7|Dose Escalation Phase|Adverse Event|1
7643103|NCT01577758|26590415|P6|Dose Escalation Phase|Adverse Event|2
7643104|NCT01577758|26590416|P5|Dose Escalation Phase|Adverse Event|0
7643105|NCT01577758|26590417|P4|Dose Escalation Phase|Adverse Event|0
7643106|NCT01577758|26590418|P3|Dose Escalation Phase|Adverse Event|0
7643107|NCT01577758|26590419|P2|Dose Escalation Phase|Adverse Event|0
7643108|NCT01577758|26590420|P1|Dose Escalation Phase|Adverse Event|0
7643109|NCT01577745|26590459|P6|Overall Study|Alternative Therapy|0
7643110|NCT01577745|26590460|P5|Overall Study|Alternative Therapy|1
7643111|NCT01577745|26590461|P4|Overall Study|Alternative Therapy|1
7643112|NCT01577745|26590462|P3|Overall Study|Alternative Therapy|0
7643113|NCT01577745|26590463|P2|Overall Study|Alternative Therapy|0
7643114|NCT01577745|26590464|P1|Overall Study|Alternative Therapy|0
7643115|NCT01577745|26590459|P6|Overall Study|Lost to Follow-up|1
7643116|NCT01577745|26590460|P5|Overall Study|Lost to Follow-up|0
7643117|NCT01577745|26590461|P4|Overall Study|Lost to Follow-up|0
7643118|NCT01577745|26590462|P3|Overall Study|Lost to Follow-up|0
7643119|NCT01577745|26590463|P2|Overall Study|Lost to Follow-up|0
7643120|NCT01577745|26590464|P1|Overall Study|Lost to Follow-up|0
7643121|NCT01577745|26590459|P6|Overall Study|Physician Decision|0
7643122|NCT01577745|26590460|P5|Overall Study|Physician Decision|1
7643123|NCT01577745|26590461|P4|Overall Study|Physician Decision|1
7643124|NCT01577745|26590462|P3|Overall Study|Physician Decision|0
7643125|NCT01577745|26590463|P2|Overall Study|Physician Decision|0
7643126|NCT01577745|26590464|P1|Overall Study|Physician Decision|0
7643127|NCT01577745|26590459|P6|Overall Study|Death|3
7643128|NCT01577745|26590460|P5|Overall Study|Death|1
7643129|NCT01577745|26590461|P4|Overall Study|Death|1
7643130|NCT01577745|26590462|P3|Overall Study|Death|2
7643131|NCT01577745|26590463|P2|Overall Study|Death|2
7643132|NCT01577745|26590464|P1|Overall Study|Death|3
7643133|NCT01577745|26590459|P6|Overall Study|Withdrawal by Subject|0
7643134|NCT01577745|26590460|P5|Overall Study|Withdrawal by Subject|2
7643135|NCT01577745|26590461|P4|Overall Study|Withdrawal by Subject|3
7643136|NCT01577745|26590462|P3|Overall Study|Withdrawal by Subject|0
7643137|NCT01577745|26590463|P2|Overall Study|Withdrawal by Subject|1
7643138|NCT01577745|26590464|P1|Overall Study|Withdrawal by Subject|0
7643139|NCT01577381|26590665|P4|Overall Study|Ongoing at Date of Cut-Off|0
7643140|NCT01577381|26590666|P3|Overall Study|Ongoing at Date of Cut-Off|1
7643141|NCT01577381|26590667|P2|Overall Study|Ongoing at Date of Cut-Off|2
7643142|NCT01577381|26590668|P1|Overall Study|Ongoing at Date of Cut-Off|0
7643143|NCT01577381|26590665|P4|Overall Study|Discontinued|2
7643144|NCT01577381|26590666|P3|Overall Study|Discontinued|2
7643145|NCT01577381|26590667|P2|Overall Study|Discontinued|1
7643146|NCT01577381|26590668|P1|Overall Study|Discontinued|2
7643147|NCT01577186|26590823|P1|Overall Study|Other|2
7643148|NCT01577186|26590823|P1|Overall Study|Non-Compliant|8
7643149|NCT01577186|26590823|P1|Overall Study|Ineligible to Continue|15
7643150|NCT01577186|26590823|P1|Overall Study|Insufficient Response|18
7643151|NCT01577186|26590823|P1|Overall Study|Withdrawal by Subject|35
7643152|NCT01577186|26590823|P1|Overall Study|Lost to Follow-up|28
7643153|NCT01577186|26590823|P1|Overall Study|Death|1
7643154|NCT01577186|26590823|P1|Overall Study|Adverse Event|23
7643155|NCT01577160|26590831|P1|Overall Study|Other|9
7643156|NCT01577160|26590831|P1|Overall Study|Subject Uncooperative|7
7643157|NCT01577160|26590831|P1|Overall Study|Withdrawal by Subject|18
7643158|NCT01577160|26590831|P1|Overall Study|Lost to Follow-up|40
7643159|NCT01577160|26590831|P1|Overall Study|Lack of Efficacy|15
7643160|NCT01577160|26590831|P1|Overall Study|Adverse Event|9
7643161|NCT01576783|26590886|P2|Overall Study|Withdrawal by Subject|1
7643162|NCT01576783|26590887|P1|Overall Study|Withdrawal by Subject|5
7643163|NCT01576783|26590886|P2|Overall Study|Lost to Follow-up|16
7643164|NCT01576783|26590887|P1|Overall Study|Lost to Follow-up|14
7643165|NCT01576783|26590886|P2|Overall Study|Change in Medical Care|0
7643166|NCT01576783|26590887|P1|Overall Study|Change in Medical Care|1
7643167|NCT01576718|26590935|P7|Treatment Period|Noncompliance to study medication|1
7643168|NCT01576718|26590936|P6|Treatment Period|Noncompliance to study medication|1
7643169|NCT01576718|26590937|P5|Treatment Period|Noncompliance to study medication|0
7643170|NCT01576718|26590938|P4|Treatment Period|Noncompliance to study medication|0
7643171|NCT01576718|26590939|P3|Treatment Period|Noncompliance to study medication|0
7643172|NCT01576718|26590940|P2|Treatment Period|Noncompliance to study medication|0
7643173|NCT01576718|26590941|P1|Treatment Period|Noncompliance to study medication|0
7643174|NCT01576718|26590935|P7|Treatment Period|Lost to Follow-up|0
7643175|NCT01576718|26590936|P6|Treatment Period|Lost to Follow-up|0
7643176|NCT01576718|26590937|P5|Treatment Period|Lost to Follow-up|1
7643177|NCT01576718|26590938|P4|Treatment Period|Lost to Follow-up|0
7643178|NCT01576718|26590939|P3|Treatment Period|Lost to Follow-up|0
7643179|NCT01576718|26590940|P2|Treatment Period|Lost to Follow-up|0
7643180|NCT01576718|26590941|P1|Treatment Period|Lost to Follow-up|0
7643181|NCT01576718|26590935|P7|Treatment Period|Met stopping criteria|15
7643182|NCT01576718|26590936|P6|Treatment Period|Met stopping criteria|33
7643183|NCT01576718|26590937|P5|Treatment Period|Met stopping criteria|16
7643184|NCT01576718|26590938|P4|Treatment Period|Met stopping criteria|19
7643185|NCT01576718|26590939|P3|Treatment Period|Met stopping criteria|13
7643186|NCT01576718|26590940|P2|Treatment Period|Met stopping criteria|16
7643187|NCT01576718|26590941|P1|Treatment Period|Met stopping criteria|0
7643188|NCT01576718|26590935|P7|Treatment Period|Sponsor request|0
7643189|NCT01576718|26590936|P6|Treatment Period|Sponsor request|1
7643190|NCT01576718|26590937|P5|Treatment Period|Sponsor request|0
7643191|NCT01576718|26590938|P4|Treatment Period|Sponsor request|0
7643192|NCT01576718|26590939|P3|Treatment Period|Sponsor request|0
7643193|NCT01576718|26590940|P2|Treatment Period|Sponsor request|1
7643194|NCT01576718|26590941|P1|Treatment Period|Sponsor request|0
7643195|NCT01576718|26590935|P7|Treatment Period|Protocol Violation|12
7643196|NCT01576718|26590936|P6|Treatment Period|Protocol Violation|8
7643197|NCT01576718|26590937|P5|Treatment Period|Protocol Violation|6
7643198|NCT01576718|26590938|P4|Treatment Period|Protocol Violation|10
7643199|NCT01576718|26590939|P3|Treatment Period|Protocol Violation|4
7643200|NCT01576718|26590940|P2|Treatment Period|Protocol Violation|5
7643201|NCT01576718|26590941|P1|Treatment Period|Protocol Violation|0
7643202|NCT01576718|26590935|P7|Treatment Period|Physician Decision|0
7643203|NCT01576718|26590936|P6|Treatment Period|Physician Decision|0
7643204|NCT01576718|26590937|P5|Treatment Period|Physician Decision|1
7643205|NCT01576718|26590938|P4|Treatment Period|Physician Decision|1
7643206|NCT01576718|26590939|P3|Treatment Period|Physician Decision|1
7643207|NCT01576718|26590940|P2|Treatment Period|Physician Decision|1
7643208|NCT01576718|26590941|P1|Treatment Period|Physician Decision|0
7643209|NCT01576718|26590935|P7|Treatment Period|Withdrawal by Subject|2
7643210|NCT01576718|26590936|P6|Treatment Period|Withdrawal by Subject|4
7643211|NCT01576718|26590937|P5|Treatment Period|Withdrawal by Subject|2
7643212|NCT01576718|26590938|P4|Treatment Period|Withdrawal by Subject|0
7643213|NCT01576718|26590939|P3|Treatment Period|Withdrawal by Subject|1
7643214|NCT01576718|26590940|P2|Treatment Period|Withdrawal by Subject|1
7643215|NCT01576718|26590941|P1|Treatment Period|Withdrawal by Subject|0
7643216|NCT01576718|26590935|P7|Treatment Period|Adverse Event|0
7643217|NCT01576718|26590936|P6|Treatment Period|Adverse Event|1
7643218|NCT01576718|26590937|P5|Treatment Period|Adverse Event|1
7643219|NCT01576718|26590938|P4|Treatment Period|Adverse Event|1
7643220|NCT01576718|26590939|P3|Treatment Period|Adverse Event|1
7643221|NCT01576718|26590940|P2|Treatment Period|Adverse Event|1
7643222|NCT01576718|26590941|P1|Treatment Period|Adverse Event|0
7643223|NCT01576718|26590935|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
7643224|NCT01576718|26590936|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
7643225|NCT01576718|26590937|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
7643226|NCT01576718|26590938|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
7643227|NCT01576718|26590939|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
7643228|NCT01576718|26590940|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
7643229|NCT01576718|26590941|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
7643230|NCT01576718|26590935|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7643231|NCT01576718|26590936|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7643232|NCT01576718|26590937|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7643233|NCT01576718|26590938|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7643234|NCT01576718|26590939|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7643235|NCT01576718|26590940|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7643236|NCT01576718|26590941|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
7643237|NCT01576718|26590935|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7643238|NCT01576718|26590936|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7643239|NCT01576718|26590937|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7643240|NCT01576718|26590938|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7643241|NCT01576718|26590939|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7643242|NCT01576718|26590940|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7643243|NCT01576718|26590941|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
7643244|NCT01576718|26590935|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7643245|NCT01576718|26590936|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7643246|NCT01576718|26590937|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7643247|NCT01576718|26590938|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7643248|NCT01576718|26590939|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7643249|NCT01576718|26590940|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7643250|NCT01576718|26590941|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
7643251|NCT01576718|26590935|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7643252|NCT01576718|26590936|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7643253|NCT01576718|26590937|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7643254|NCT01576718|26590938|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7643255|NCT01576718|26590939|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7643256|NCT01576718|26590940|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7643257|NCT01576718|26590941|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
7643258|NCT01576705|26591037|P4|Overall Study|invalid ICF|0
7643259|NCT01576705|26591038|P3|Overall Study|invalid ICF|0
7643260|NCT01576705|26591039|P2|Overall Study|invalid ICF|1
7643261|NCT01576705|26591040|P1|Overall Study|invalid ICF|0
7643262|NCT01576705|26591037|P4|Overall Study|TSH > 7 mIU/L at baseline|3
7643263|NCT01576705|26591038|P3|Overall Study|TSH > 7 mIU/L at baseline|5
7643264|NCT01576705|26591039|P2|Overall Study|TSH > 7 mIU/L at baseline|7
7643265|NCT01576705|26591040|P1|Overall Study|TSH > 7 mIU/L at baseline|3
7643266|NCT01576575|26591061|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
7643267|NCT01576575|26591061|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
7643268|NCT01576575|26591061|P1|Buprenorphine Control|Withdrawal by Subject|3
7643269|NCT01576549|26591071|P1|Overall Study|Sponsor Decision|2
7643270|NCT01576484|26591125|P2|Overall Study|Other|5
7643271|NCT01576484|26591126|P1|Overall Study|Other|2
7643272|NCT01576484|26591125|P2|Overall Study|Withdrawal by Subject|3
7643273|NCT01576484|26591126|P1|Overall Study|Withdrawal by Subject|0
7643274|NCT01576484|26591125|P2|Overall Study|Sponsor Decision|8
7643275|NCT01576484|26591126|P1|Overall Study|Sponsor Decision|2
7643276|NCT01576484|26591125|P2|Overall Study|Protocol Violation|2
7643277|NCT01576484|26591126|P1|Overall Study|Protocol Violation|0
7643278|NCT01576484|26591125|P2|Overall Study|Adverse Event|1
7643279|NCT01576484|26591126|P1|Overall Study|Adverse Event|1
7643280|NCT01576406|26591205|P6|Overall Study|Other|0
7643281|NCT01576406|26591206|P5|Overall Study|Other|0
7643282|NCT01576406|26591207|P4|Overall Study|Other|2
7643283|NCT01576406|26591208|P3|Overall Study|Other|2
7643284|NCT01576406|26591209|P2|Overall Study|Other|0
7643285|NCT01576406|26591210|P1|Overall Study|Other|0
7643286|NCT01576406|26591205|P6|Overall Study|Withdrawal the consent|3
7643287|NCT01576406|26591206|P5|Overall Study|Withdrawal the consent|1
7643288|NCT01576406|26591207|P4|Overall Study|Withdrawal the consent|1
7643289|NCT01576406|26591208|P3|Overall Study|Withdrawal the consent|5
7643290|NCT01576406|26591209|P2|Overall Study|Withdrawal the consent|2
7643291|NCT01576406|26591210|P1|Overall Study|Withdrawal the consent|2
7643292|NCT01576406|26591205|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
7643293|NCT01576406|26591206|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
7643294|NCT01576406|26591207|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
7643295|NCT01576406|26591208|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
7643296|NCT01576406|26591209|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
7643297|NCT01576406|26591210|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
7643298|NCT01576406|26591205|P6|Overall Study|Death|9
7643299|NCT01576406|26591206|P5|Overall Study|Death|7
7643300|NCT01576406|26591207|P4|Overall Study|Death|5
7643301|NCT01576406|26591208|P3|Overall Study|Death|8
7643302|NCT01576406|26591209|P2|Overall Study|Death|4
7643303|NCT01576406|26591210|P1|Overall Study|Death|3
7643304|NCT01576406|26591205|P6|Overall Study|Lost to Follow-up|0
7643305|NCT01576406|26591206|P5|Overall Study|Lost to Follow-up|0
7643306|NCT01576406|26591207|P4|Overall Study|Lost to Follow-up|0
7643307|NCT01576406|26591208|P3|Overall Study|Lost to Follow-up|0
7643308|NCT01576406|26591209|P2|Overall Study|Lost to Follow-up|2
7643309|NCT01576406|26591210|P1|Overall Study|Lost to Follow-up|1
7643310|NCT01576367|26591458|P1|Overall Study|Moved to commercial use after 6 months|1
7643311|NCT01576367|26591458|P1|Overall Study|Unsatisfactory therapeutic effect|2
7643312|NCT01576341|26591466|P1|Overall Study|Other|12
7643313|NCT01576341|26591466|P1|Overall Study|Protocol Violation|12
7643314|NCT01576341|26591466|P1|Overall Study|Kidney transplantation|10
7643315|NCT01576341|26591466|P1|Overall Study|Lost to Follow-up|2
7643316|NCT01576341|26591466|P1|Overall Study|Physician Decision|2
7643317|NCT01576341|26591466|P1|Overall Study|Death|21
7643318|NCT01576341|26591466|P1|Overall Study|Adverse Event|10
7643319|NCT01576341|26591466|P1|Overall Study|Withdrawal by Subject|24
7643320|NCT01576172|26591485|P2|Overall Study|Insurance issue|0
7643321|NCT01576172|26591486|P1|Overall Study|Insurance issue|1
7643322|NCT01576172|26591485|P2|Overall Study|Withdrawal by Subject|0
7643323|NCT01576172|26591486|P1|Overall Study|Withdrawal by Subject|2
7643324|NCT01576172|26591485|P2|Overall Study|Ineligible|1
7643325|NCT01576172|26591486|P1|Overall Study|Ineligible|2
7643326|NCT01576159|26591504|P4|Overall Study|Protocol Violation|0
7643327|NCT01576159|26591505|P3|Overall Study|Protocol Violation|0
7643328|NCT01576159|26591506|P2|Overall Study|Protocol Violation|0
7643329|NCT01576159|26591507|P1|Overall Study|Protocol Violation|1
7643330|NCT01576159|26591504|P4|Overall Study|Lost to Follow-up|1
7643331|NCT01576159|26591505|P3|Overall Study|Lost to Follow-up|0
7643332|NCT01576159|26591506|P2|Overall Study|Lost to Follow-up|0
7643333|NCT01576159|26591507|P1|Overall Study|Lost to Follow-up|0
7643334|NCT01576159|26591504|P4|Overall Study|Physician Decision|0
7643335|NCT01576159|26591505|P3|Overall Study|Physician Decision|1
7643336|NCT01576159|26591506|P2|Overall Study|Physician Decision|0
7643337|NCT01576159|26591507|P1|Overall Study|Physician Decision|0
7643338|NCT01576159|26591504|P4|Overall Study|Withdrawal by Subject|0
7643339|NCT01576159|26591505|P3|Overall Study|Withdrawal by Subject|0
7643340|NCT01576159|26591506|P2|Overall Study|Withdrawal by Subject|1
7643341|NCT01576159|26591507|P1|Overall Study|Withdrawal by Subject|0
7643342|NCT01576146|26591525|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
7643343|NCT01576146|26591525|P1|Extension Period 2|Renal Transplant|1
7643344|NCT01576146|26591525|P1|Extension Period 2|Adverse Event|1
7643345|NCT01576146|26591525|P1|Extension Period 2|Death|1
7643346|NCT01576146|26591525|P1|Extension Period 2|Sponsor Decision|13
7643347|NCT01576146|26591525|P1|Extension Period 1|Renal Transplant|1
7643348|NCT01576146|26591525|P1|Extension Period 1|Parathyroidectomy|1
7643349|NCT01576146|26591525|P1|Extension Period 1|Lost to Follow-up|1
7643350|NCT01576146|26591525|P1|Extension Period 1|Withdrawal by Subject|1
7643351|NCT01576146|26591525|P1|Extension Period 1|Physician Decision|2
7643352|NCT01576146|26591525|P1|Extension Period 1|Death|2
7643353|NCT01576146|26591525|P1|Extension Period 1|Adverse Event|2
7643354|NCT01576042|26591558|P2|Overall Study|Physician Decision|0
7643355|NCT01576042|26591559|P1|Overall Study|Physician Decision|2
7643356|NCT01576016|26591581|P2|MRI Safety|MRI scan not performed at MRI visit|3
7643357|NCT01576016|26591582|P1|MRI Safety|MRI scan not performed at MRI visit|0
7643358|NCT01576016|26591581|P2|MRI Safety|Has not yet completed MRI scan|56
7643359|NCT01576016|26591582|P1|MRI Safety|Has not yet completed MRI scan|0
7643360|NCT01576016|26591581|P2|MRI Safety|Non-MRI Compatible Device or Material|5
7643361|NCT01576016|26591582|P1|MRI Safety|Non-MRI Compatible Device or Material|0
7643362|NCT01576016|26591581|P2|MRI Safety|Withdrawal by Subject|10
7643363|NCT01576016|26591582|P1|MRI Safety|Withdrawal by Subject|0
7643364|NCT01576016|26591581|P2|Lead Safety|Patient no longer followed by study PI|0
7643365|NCT01576016|26591582|P1|Lead Safety|Patient no longer followed by study PI|1
7643366|NCT01576016|26591581|P2|Lead Safety|System deactivated|0
7643367|NCT01576016|26591582|P1|Lead Safety|System deactivated|1
7643368|NCT01576016|26591581|P2|Lead Safety|Too far from study site|0
7643369|NCT01576016|26591582|P1|Lead Safety|Too far from study site|1
7643370|NCT01576016|26591581|P2|Lead Safety|Patient noncompliance|0
7643371|NCT01576016|26591582|P1|Lead Safety|Patient noncompliance|1
7643372|NCT01576016|26591581|P2|Lead Safety|Patient on Palliative Care|0
7643373|NCT01576016|26591582|P1|Lead Safety|Patient on Palliative Care|1
7643374|NCT01576016|26591581|P2|Lead Safety|Device replaced with CRT-D|0
7643375|NCT01576016|26591582|P1|Lead Safety|Device replaced with CRT-D|1
7643376|NCT01576016|26591581|P2|Lead Safety|Sponsor request|0
7643377|NCT01576016|26591582|P1|Lead Safety|Sponsor request|1
7643378|NCT01576016|26591581|P2|Lead Safety|Unsuccessful implant|0
7643379|NCT01576016|26591582|P1|Lead Safety|Unsuccessful implant|2
7643380|NCT01576016|26591581|P2|Lead Safety|Lost to Follow-up|0
7643381|NCT01576016|26591582|P1|Lead Safety|Lost to Follow-up|13
7643382|NCT01576016|26591581|P2|Lead Safety|Physician Decision|0
7643383|NCT01576016|26591582|P1|Lead Safety|Physician Decision|14
7643384|NCT01576016|26591581|P2|Lead Safety|System Explanted without Replacement|0
7643385|NCT01576016|26591582|P1|Lead Safety|System Explanted without Replacement|24
7643386|NCT01576016|26591581|P2|Lead Safety|Withdrawal by Subject|0
7643387|NCT01576016|26591582|P1|Lead Safety|Withdrawal by Subject|81
7643388|NCT01576016|26591581|P2|Lead Safety|Death|0
7643389|NCT01576016|26591582|P1|Lead Safety|Death|132
7643390|NCT01575899|26591634|P3|Overall Study|Protocol Violation|0
7643391|NCT01575899|26591635|P2|Overall Study|Protocol Violation|1
7643392|NCT01575899|26591636|P1|Overall Study|Protocol Violation|2
7643393|NCT01575899|26591634|P3|Overall Study|Lost to Follow-up|2
7643394|NCT01575899|26591635|P2|Overall Study|Lost to Follow-up|4
7643395|NCT01575899|26591636|P1|Overall Study|Lost to Follow-up|3
7643396|NCT01575873|26591650|P4|Overall Study|Other|2
7643397|NCT01575873|26591651|P3|Overall Study|Other|4
7643398|NCT01575873|26591652|P2|Overall Study|Other|0
7643399|NCT01575873|26591653|P1|Overall Study|Other|0
7643400|NCT01575873|26591650|P4|Overall Study|Requirement for Alternative Therapy|1
7643401|NCT01575873|26591651|P3|Overall Study|Requirement for Alternative Therapy|1
7643402|NCT01575873|26591652|P2|Overall Study|Requirement for Alternative Therapy|0
7643403|NCT01575873|26591653|P1|Overall Study|Requirement for Alternative Therapy|0
7643404|NCT01575873|26591650|P4|Overall Study|Protocol deviation|1
7643405|NCT01575873|26591651|P3|Overall Study|Protocol deviation|0
7643406|NCT01575873|26591652|P2|Overall Study|Protocol deviation|1
7643407|NCT01575873|26591653|P1|Overall Study|Protocol deviation|0
7643408|NCT01575873|26591650|P4|Overall Study|Administrative decision|0
7643409|NCT01575873|26591651|P3|Overall Study|Administrative decision|1
7643410|NCT01575873|26591652|P2|Overall Study|Administrative decision|1
7643411|NCT01575873|26591653|P1|Overall Study|Administrative decision|1
7643412|NCT01575873|26591650|P4|Overall Study|Noncompliance|3
7643413|NCT01575873|26591651|P3|Overall Study|Noncompliance|4
7643414|NCT01575873|26591652|P2|Overall Study|Noncompliance|2
7643415|NCT01575873|26591653|P1|Overall Study|Noncompliance|1
7643416|NCT01575873|26591650|P4|Overall Study|Death|9
7643417|NCT01575873|26591651|P3|Overall Study|Death|8
7643418|NCT01575873|26591652|P2|Overall Study|Death|2
7643419|NCT01575873|26591653|P1|Overall Study|Death|3
7643420|NCT01575873|26591650|P4|Overall Study|Lost to Follow-up|5
7643421|NCT01575873|26591651|P3|Overall Study|Lost to Follow-up|13
7643422|NCT01575873|26591652|P2|Overall Study|Lost to Follow-up|3
7643423|NCT01575873|26591653|P1|Overall Study|Lost to Follow-up|1
7643424|NCT01575873|26591650|P4|Overall Study|Adverse Event|12
7643425|NCT01575873|26591651|P3|Overall Study|Adverse Event|9
7643426|NCT01575873|26591652|P2|Overall Study|Adverse Event|7
7643427|NCT01575873|26591653|P1|Overall Study|Adverse Event|7
7643428|NCT01575873|26591650|P4|Overall Study|Withdrawal by Subject|34
7643429|NCT01575873|26591651|P3|Overall Study|Withdrawal by Subject|34
7643430|NCT01575873|26591652|P2|Overall Study|Withdrawal by Subject|20
7643431|NCT01575873|26591653|P1|Overall Study|Withdrawal by Subject|15
7643432|NCT01575860|26591677|P1|Overall Study|Progression Prior to Lenalidomide Maint.|1
7643433|NCT01575860|26591677|P1|Overall Study|Withdrawal by Subject|1
7643434|NCT01575834|26591685|P2|Overall Study|Requirement for Alternative Therapy|4
7643435|NCT01575834|26591686|P1|Overall Study|Requirement for Alternative Therapy|2
7643436|NCT01575834|26591685|P2|Overall Study|Protocol Deviation|3
7643437|NCT01575834|26591686|P1|Overall Study|Protocol Deviation|4
7643438|NCT01575834|26591685|P2|Overall Study|Ineligibility Determined|8
7643439|NCT01575834|26591686|P1|Overall Study|Ineligibility Determined|5
7643440|NCT01575834|26591685|P2|Overall Study|Administrative decision|33
7643441|NCT01575834|26591686|P1|Overall Study|Administrative decision|15
7643442|NCT01575834|26591685|P2|Overall Study|Noncompliance|27
7643443|NCT01575834|26591686|P1|Overall Study|Noncompliance|52
7643444|NCT01575834|26591685|P2|Overall Study|Lost to Follow-up|68
7643445|NCT01575834|26591686|P1|Overall Study|Lost to Follow-up|55
7643446|NCT01575834|26591685|P2|Overall Study|Adverse Event|61
7643447|NCT01575834|26591686|P1|Overall Study|Adverse Event|63
7643448|NCT01575834|26591685|P2|Overall Study|Other|70
7643449|NCT01575834|26591686|P1|Overall Study|Other|70
7643450|NCT01575834|26591685|P2|Overall Study|Death|74
7643451|NCT01575834|26591686|P1|Overall Study|Death|81
7643452|NCT01575834|26591685|P2|Overall Study|Withdrawal by Subject|390
7643453|NCT01575834|26591686|P1|Overall Study|Withdrawal by Subject|352
7643454|NCT01575808|26591738|P2|Overall Study|Withdrawal by Subject|0
7643455|NCT01575808|26591739|P1|Overall Study|Withdrawal by Subject|1
7643456|NCT01575808|26591738|P2|Overall Study|Death|0
7643457|NCT01575808|26591739|P1|Overall Study|Death|2
7643458|NCT01575769|26591786|P1|Overall Study|Study terminated by sponsor|40
7643459|NCT01575769|26591786|P1|Overall Study|Adverse Event|1
7643460|NCT01575561|26591844|P1|Overall Study|administration|1
7643461|NCT01575561|26591844|P1|Overall Study|Withdrawal by Subject|11
7643462|NCT01575561|26591844|P1|Overall Study|Protocol Violation|4
7643463|NCT01575561|26591844|P1|Overall Study|Lost to Follow-up|6
7643464|NCT01575561|26591844|P1|Overall Study|Lack of Efficacy|8
7643465|NCT01575561|26591844|P1|Overall Study|Adverse Event|9
7643466|NCT01575197|26591874|P3|Overall Study|Protocol Violation|1
7643467|NCT01575197|26591875|P2|Overall Study|Protocol Violation|1
7643468|NCT01575197|26591876|P1|Overall Study|Protocol Violation|2
7643469|NCT01575197|26591874|P3|Overall Study|Withdrawal by Subject|1
7643470|NCT01575197|26591875|P2|Overall Study|Withdrawal by Subject|1
7643471|NCT01575197|26591876|P1|Overall Study|Withdrawal by Subject|0
7643472|NCT01575197|26591874|P3|Overall Study|Lost to Follow-up|0
7643473|NCT01575197|26591875|P2|Overall Study|Lost to Follow-up|1
7643474|NCT01575197|26591876|P1|Overall Study|Lost to Follow-up|0
7643475|NCT01575197|26591874|P3|Overall Study|SAE|0
7643476|NCT01575197|26591875|P2|Overall Study|SAE|1
7643477|NCT01575197|26591876|P1|Overall Study|SAE|0
7643478|NCT01575197|26591874|P3|Overall Study|Migration out of study area|4
7643479|NCT01575197|26591875|P2|Overall Study|Migration out of study area|5
7643480|NCT01575197|26591876|P1|Overall Study|Migration out of study area|1
7643481|NCT01575054|26591904|P2|Overall Study|Adverse Event|8
7643482|NCT01575054|26591905|P1|Overall Study|Adverse Event|9
7643483|NCT01575054|26591904|P2|Overall Study|Lost to Follow-up|3
7643484|NCT01575054|26591905|P1|Overall Study|Lost to Follow-up|3
7643485|NCT01575054|26591904|P2|Overall Study|Personal Reasons|11
7643486|NCT01575054|26591905|P1|Overall Study|Personal Reasons|10
7643487|NCT01575054|26591904|P2|Overall Study|Protocol Violation|1
7643488|NCT01575054|26591905|P1|Overall Study|Protocol Violation|2
7643489|NCT01575054|26591904|P2|Overall Study|Other Reasons|3
7643490|NCT01575054|26591905|P1|Overall Study|Other Reasons|5
7643491|NCT01575028|26591921|P2|Overall Study|Physician Decision|1
7643492|NCT01575028|26591922|P1|Overall Study|Physician Decision|0
7643493|NCT01574716|26591939|P5|Part 2|Lost to Follow-up|0
7643494|NCT01574716|26591940|P4|Part 2|Lost to Follow-up|3
7643495|NCT01574716|26591941|P3|Part 2|Lost to Follow-up|0
7643496|NCT01574716|26591942|P2|Part 2|Lost to Follow-up|0
7643497|NCT01574716|26591943|P1|Part 2|Lost to Follow-up|0
7643498|NCT01574716|26591939|P5|Part 2|Brain metastases|0
7643499|NCT01574716|26591940|P4|Part 2|Brain metastases|1
7643500|NCT01574716|26591941|P3|Part 2|Brain metastases|0
7643501|NCT01574716|26591942|P2|Part 2|Brain metastases|0
7643502|NCT01574716|26591943|P1|Part 2|Brain metastases|0
7643503|NCT01574716|26591939|P5|Part 2|Withdrawal by Subject|4
7643504|NCT01574716|26591940|P4|Part 2|Withdrawal by Subject|5
7643505|NCT01574716|26591941|P3|Part 2|Withdrawal by Subject|0
7643506|NCT01574716|26591942|P2|Part 2|Withdrawal by Subject|0
7643507|NCT01574716|26591943|P1|Part 2|Withdrawal by Subject|0
7643508|NCT01574716|26591939|P5|Part 2|Discontinuation of study by sponsor|31
7643509|NCT01574716|26591940|P4|Part 2|Discontinuation of study by sponsor|51
7643510|NCT01574716|26591941|P3|Part 2|Discontinuation of study by sponsor|0
7643511|NCT01574716|26591942|P2|Part 2|Discontinuation of study by sponsor|0
7643512|NCT01574716|26591943|P1|Part 2|Discontinuation of study by sponsor|0
7643513|NCT01574716|26591939|P5|Part 2|Death|35
7643514|NCT01574716|26591940|P4|Part 2|Death|76
7643515|NCT01574716|26591941|P3|Part 2|Death|0
7643516|NCT01574716|26591942|P2|Part 2|Death|0
7643517|NCT01574716|26591943|P1|Part 2|Death|0
7643518|NCT01574716|26591939|P5|Part 2|Progressive disease|0
7643519|NCT01574716|26591940|P4|Part 2|Progressive disease|1
7643520|NCT01574716|26591941|P3|Part 2|Progressive disease|0
7643521|NCT01574716|26591942|P2|Part 2|Progressive disease|0
7643522|NCT01574716|26591943|P1|Part 2|Progressive disease|0
7643523|NCT01574716|26591939|P5|Part 1|Lost to Follow-up|0
7643524|NCT01574716|26591940|P4|Part 1|Lost to Follow-up|0
7643525|NCT01574716|26591941|P3|Part 1|Lost to Follow-up|0
7643526|NCT01574716|26591942|P2|Part 1|Lost to Follow-up|1
7643527|NCT01574716|26591943|P1|Part 1|Lost to Follow-up|0
7643528|NCT01574716|26591939|P5|Part 1|Withdrawal by Subject|0
7643529|NCT01574716|26591940|P4|Part 1|Withdrawal by Subject|0
7643530|NCT01574716|26591941|P3|Part 1|Withdrawal by Subject|0
7643531|NCT01574716|26591942|P2|Part 1|Withdrawal by Subject|2
7643532|NCT01574716|26591943|P1|Part 1|Withdrawal by Subject|0
7643533|NCT01574716|26591939|P5|Part 1|Discontinuation of study by sponsor|0
7643534|NCT01574716|26591940|P4|Part 1|Discontinuation of study by sponsor|0
7643535|NCT01574716|26591941|P3|Part 1|Discontinuation of study by sponsor|1
7643536|NCT01574716|26591942|P2|Part 1|Discontinuation of study by sponsor|0
7643537|NCT01574716|26591943|P1|Part 1|Discontinuation of study by sponsor|0
7643538|NCT01574716|26591939|P5|Part 1|Death|0
7643539|NCT01574716|26591940|P4|Part 1|Death|0
7643540|NCT01574716|26591941|P3|Part 1|Death|8
7643541|NCT01574716|26591942|P2|Part 1|Death|1
7643542|NCT01574716|26591943|P1|Part 1|Death|3
7643543|NCT01574703|26591966|P4|Overall Study|Death|0
7643544|NCT01574703|26591967|P3|Overall Study|Death|1
7643545|NCT01574703|26591968|P2|Overall Study|Death|1
7643546|NCT01574703|26591969|P1|Overall Study|Death|2
7643547|NCT01574703|26591966|P4|Overall Study|Lost to Follow-up|35
7643548|NCT01574703|26591967|P3|Overall Study|Lost to Follow-up|46
7643549|NCT01574703|26591968|P2|Overall Study|Lost to Follow-up|41
7643550|NCT01574703|26591969|P1|Overall Study|Lost to Follow-up|43
7643551|NCT01574703|26591966|P4|Overall Study|Met Withdrawal Criteria|0
7643552|NCT01574703|26591967|P3|Overall Study|Met Withdrawal Criteria|1
7643553|NCT01574703|26591968|P2|Overall Study|Met Withdrawal Criteria|1
7643554|NCT01574703|26591969|P1|Overall Study|Met Withdrawal Criteria|0
7643555|NCT01574703|26591966|P4|Overall Study|Withdrawal by Subject|61
7643556|NCT01574703|26591967|P3|Overall Study|Withdrawal by Subject|36
7643557|NCT01574703|26591968|P2|Overall Study|Withdrawal by Subject|52
7643558|NCT01574703|26591969|P1|Overall Study|Withdrawal by Subject|53
7643559|NCT01574703|26591966|P4|Overall Study|Unspecified Reason|16
7643560|NCT01574703|26591967|P3|Overall Study|Unspecified Reason|20
7643561|NCT01574703|26591968|P2|Overall Study|Unspecified Reason|15
7643562|NCT01574703|26591969|P1|Overall Study|Unspecified Reason|27
7643563|NCT01574703|26591966|P4|Overall Study|Protocol Violation|1
7643564|NCT01574703|26591967|P3|Overall Study|Protocol Violation|0
7643565|NCT01574703|26591968|P2|Overall Study|Protocol Violation|0
7643566|NCT01574703|26591969|P1|Overall Study|Protocol Violation|0
7643567|NCT01574703|26591966|P4|Overall Study|Adverse Event|1
7643568|NCT01574703|26591967|P3|Overall Study|Adverse Event|1
7643569|NCT01574703|26591968|P2|Overall Study|Adverse Event|2
7643570|NCT01574703|26591969|P1|Overall Study|Adverse Event|0
7643571|NCT01574651|26592013|P2|Overall Study|Withdrawal by Subject|10
7643572|NCT01574651|26592014|P1|Overall Study|Withdrawal by Subject|9
7643573|NCT01574651|26592013|P2|Overall Study|Protocol Violation|5
7643574|NCT01574651|26592014|P1|Overall Study|Protocol Violation|3
7643575|NCT01574651|26592013|P2|Overall Study|Unsatisfactory therapeutic effect|0
7643576|NCT01574651|26592014|P1|Overall Study|Unsatisfactory therapeutic effect|6
7643577|NCT01574651|26592013|P2|Overall Study|Abnormal test procedure result(s)|1
7643578|NCT01574651|26592014|P1|Overall Study|Abnormal test procedure result(s)|1
7643579|NCT01574651|26592013|P2|Overall Study|Abnormal laboratory value(s)|0
7643580|NCT01574651|26592014|P1|Overall Study|Abnormal laboratory value(s)|1
7643581|NCT01574651|26592013|P2|Overall Study|Adverse Event|27
7643582|NCT01574651|26592014|P1|Overall Study|Adverse Event|36
7643583|NCT01574651|26592013|P2|Overall Study|Patient's inability to use the device|1
7643584|NCT01574651|26592014|P1|Overall Study|Patient's inability to use the device|0
7643585|NCT01574651|26592013|P2|Overall Study|Death|3
7643586|NCT01574651|26592014|P1|Overall Study|Death|3
7643587|NCT01574651|26592013|P2|Overall Study|Administrative problems|1
7643588|NCT01574651|26592014|P1|Overall Study|Administrative problems|0
7643589|NCT01574651|26592013|P2|Overall Study|Lost to Follow-up|4
7643590|NCT01574651|26592014|P1|Overall Study|Lost to Follow-up|2
7643591|NCT01574612|26592036|P1|Overall Study|Lost to Follow-up|2
7643592|NCT01574612|26592036|P1|Overall Study|Withdrawal by Subject|1
7643593|NCT01574612|26592036|P1|Overall Study|non compliant with drug|2
7643594|NCT01574612|26592036|P1|Overall Study|Adverse Event|3
7643595|NCT01574352|26592042|P2|Overall Study|Injury in non-camp related sport|0
7643596|NCT01574352|26592043|P1|Overall Study|Injury in non-camp related sport|1
7643597|NCT01574352|26592042|P2|Overall Study|Withdrawal by Subject|13
7643598|NCT01574352|26592043|P1|Overall Study|Withdrawal by Subject|6
7643599|NCT01574326|26592055|P2|Overall Study|Other: Mainly kidney transplant|8
7643600|NCT01574326|26592056|P1|Overall Study|Other: Mainly kidney transplant|8
7643601|NCT01574326|26592055|P2|Overall Study|Adverse Event|3
7643602|NCT01574326|26592056|P1|Overall Study|Adverse Event|1
7643603|NCT01574326|26592055|P2|Overall Study|Physician Decision|3
7643604|NCT01574326|26592056|P1|Overall Study|Physician Decision|5
7643605|NCT01574326|26592055|P2|Overall Study|Withdrawal by Participant|4
7643606|NCT01574326|26592056|P1|Overall Study|Withdrawal by Participant|2
7643607|NCT01574326|26592055|P2|Overall Study|Randomized but not treated|1
7643608|NCT01574326|26592056|P1|Overall Study|Randomized but not treated|0
7643609|NCT01574248|26592074|P2|Overall Study|Missing primary endpoint data|0
7643610|NCT01574248|26592075|P1|Overall Study|Missing primary endpoint data|1
7643611|NCT01574248|26592074|P2|Overall Study|Withdrawal by Subject|0
7643612|NCT01574248|26592075|P1|Overall Study|Withdrawal by Subject|2
7643613|NCT01574157|26592108|P2|Overall Study|Lost to Follow-up|3
7643614|NCT01574157|26592109|P1|Overall Study|Lost to Follow-up|0
7643615|NCT01574157|26592108|P2|Overall Study|Withdrawal by Subject|5
7643616|NCT01574157|26592109|P1|Overall Study|Withdrawal by Subject|4
7643617|NCT01574079|26592143|P2|Overall Study|Lost to Follow-up|0
7643618|NCT01574079|26592144|P1|Overall Study|Lost to Follow-up|1
7643619|NCT01574079|26592143|P2|Overall Study|Physician Decision|2
7643620|NCT01574079|26592144|P1|Overall Study|Physician Decision|0
7643621|NCT01573910|26592163|P2|Overall Study|Patient decision unrelated to Advs Event|11
7643622|NCT01573910|26592164|P1|Overall Study|Patient decision unrelated to Advs Event|11
7643623|NCT01573910|26592163|P2|Overall Study|Protocol Violation|0
7643624|NCT01573910|26592164|P1|Overall Study|Protocol Violation|3
7643625|NCT01573910|26592163|P2|Overall Study|Withdrawal by Subject|1
7643626|NCT01573910|26592164|P1|Overall Study|Withdrawal by Subject|0
7643627|NCT01573910|26592163|P2|Overall Study|Lost to Follow-up|1
7643628|NCT01573910|26592164|P1|Overall Study|Lost to Follow-up|2
7643629|NCT01573910|26592163|P2|Overall Study|Adverse Event|4
7643630|NCT01573910|26592164|P1|Overall Study|Adverse Event|4
7643631|NCT01573767|26592176|P4|Overall Study|Withdrawal by Subject|0
7643632|NCT01573767|26592177|P3|Overall Study|Withdrawal by Subject|0
7643633|NCT01573767|26592178|P2|Overall Study|Withdrawal by Subject|1
7643634|NCT01573767|26592179|P1|Overall Study|Withdrawal by Subject|0
7643635|NCT01573767|26592176|P4|Overall Study|Physician Decision|2
7643636|NCT01573767|26592177|P3|Overall Study|Physician Decision|0
7643637|NCT01573767|26592178|P2|Overall Study|Physician Decision|2
7643638|NCT01573767|26592179|P1|Overall Study|Physician Decision|1
7643639|NCT01573767|26592176|P4|Overall Study|Lost to Follow-up|1
7643640|NCT01573767|26592177|P3|Overall Study|Lost to Follow-up|1
7643641|NCT01573767|26592178|P2|Overall Study|Lost to Follow-up|1
7643642|NCT01573767|26592179|P1|Overall Study|Lost to Follow-up|0
7643643|NCT01573767|26592176|P4|Overall Study|Protocol Violation|3
7643644|NCT01573767|26592177|P3|Overall Study|Protocol Violation|1
7643645|NCT01573767|26592178|P2|Overall Study|Protocol Violation|1
7643646|NCT01573767|26592179|P1|Overall Study|Protocol Violation|3
7643647|NCT01573767|26592176|P4|Overall Study|Lack of Efficacy|17
7643648|NCT01573767|26592177|P3|Overall Study|Lack of Efficacy|12
7643649|NCT01573767|26592178|P2|Overall Study|Lack of Efficacy|15
7643650|NCT01573767|26592179|P1|Overall Study|Lack of Efficacy|18
7643651|NCT01573767|26592176|P4|Overall Study|Adverse Event|1
7643652|NCT01573767|26592177|P3|Overall Study|Adverse Event|0
7643653|NCT01573767|26592178|P2|Overall Study|Adverse Event|1
7643654|NCT01573767|26592179|P1|Overall Study|Adverse Event|0
7643655|NCT01573624|26592221|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7643656|NCT01573624|26592222|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7643657|NCT01573624|26592223|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7643658|NCT01573624|26592224|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7643659|NCT01573624|26592225|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7643660|NCT01573624|26592226|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7643661|NCT01573624|26592227|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
7643662|NCT01573624|26592221|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7643663|NCT01573624|26592222|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
7643664|NCT01573624|26592223|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
7643665|NCT01573624|26592224|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7643666|NCT01573624|26592225|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7643667|NCT01573624|26592226|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7643668|NCT01573624|26592227|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7643669|NCT01573624|26592221|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7643670|NCT01573624|26592222|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7643671|NCT01573624|26592223|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7643672|NCT01573624|26592224|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7643673|NCT01573624|26592225|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7643674|NCT01573624|26592226|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7643675|NCT01573624|26592227|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
7643676|NCT01573624|26592221|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7643677|NCT01573624|26592222|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7643678|NCT01573624|26592223|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7643679|NCT01573624|26592224|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7643680|NCT01573624|26592225|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7643681|NCT01573624|26592226|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7643682|NCT01573624|26592227|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7643683|NCT01573624|26592221|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
7643684|NCT01573624|26592222|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7643685|NCT01573624|26592223|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7643686|NCT01573624|26592224|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7643687|NCT01573624|26592225|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7643688|NCT01573624|26592226|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7643689|NCT01573624|26592227|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
7643690|NCT01573624|26592221|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7643691|NCT01573624|26592222|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7643692|NCT01573624|26592223|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7643693|NCT01573624|26592224|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7643694|NCT01573624|26592225|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7643911|NCT01572792|26592639|P3|Extension Study|Withdrawal by Subject|11
7643695|NCT01573624|26592226|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7643696|NCT01573624|26592227|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7643697|NCT01573624|26592221|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7643698|NCT01573624|26592222|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7643699|NCT01573624|26592223|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7643700|NCT01573624|26592224|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7643701|NCT01573624|26592225|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7643702|NCT01573624|26592226|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7643703|NCT01573624|26592227|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7643704|NCT01573624|26592221|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7643705|NCT01573624|26592222|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7643706|NCT01573624|26592223|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7643707|NCT01573624|26592224|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7643708|NCT01573624|26592225|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7643709|NCT01573624|26592226|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
7643710|NCT01573624|26592227|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7643711|NCT01573624|26592221|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7643712|NCT01573624|26592222|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7643713|NCT01573624|26592223|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7643714|NCT01573624|26592224|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7643715|NCT01573624|26592225|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7643716|NCT01573624|26592226|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
7643717|NCT01573624|26592227|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7643718|NCT01573624|26592221|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7643719|NCT01573624|26592222|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7643720|NCT01573624|26592223|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7643721|NCT01573624|26592224|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7643722|NCT01573624|26592225|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7643723|NCT01573624|26592226|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7643724|NCT01573624|26592227|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7643725|NCT01573624|26592221|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7643726|NCT01573624|26592222|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7643727|NCT01573624|26592223|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7643728|NCT01573624|26592224|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7643729|NCT01573624|26592225|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7643730|NCT01573624|26592226|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7643731|NCT01573624|26592227|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7643732|NCT01573624|26592221|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7643733|NCT01573624|26592222|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7643734|NCT01573624|26592223|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7643735|NCT01573624|26592224|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7643736|NCT01573624|26592225|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7643737|NCT01573624|26592226|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7643738|NCT01573624|26592227|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
7643739|NCT01573624|26592221|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7643740|NCT01573624|26592222|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7643741|NCT01573624|26592223|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7643742|NCT01573624|26592224|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7643743|NCT01573624|26592225|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7643744|NCT01573624|26592226|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7643745|NCT01573624|26592227|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7643746|NCT01573624|26592221|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7643747|NCT01573624|26592222|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7643748|NCT01573624|26592223|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7643749|NCT01573624|26592224|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7643750|NCT01573624|26592225|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7643751|NCT01573624|26592226|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7643752|NCT01573624|26592227|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
7643753|NCT01573624|26592221|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7643754|NCT01573624|26592222|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
7643755|NCT01573624|26592223|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7643756|NCT01573624|26592224|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7643757|NCT01573624|26592225|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7643758|NCT01573624|26592226|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
7643759|NCT01573624|26592227|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7643760|NCT01573624|26592221|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
7643761|NCT01573624|26592222|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7643762|NCT01573624|26592223|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
7643763|NCT01573624|26592224|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
7643764|NCT01573624|26592225|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7643765|NCT01573624|26592226|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
7643766|NCT01573624|26592227|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
7643767|NCT01573624|26592221|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7643768|NCT01573624|26592222|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7643769|NCT01573624|26592223|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7643770|NCT01573624|26592224|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7643771|NCT01573624|26592225|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7643772|NCT01573624|26592226|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7643773|NCT01573624|26592227|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7643774|NCT01573624|26592221|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7643775|NCT01573624|26592222|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7643776|NCT01573624|26592223|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7643777|NCT01573624|26592224|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
7643778|NCT01573624|26592225|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7643779|NCT01573624|26592226|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7643780|NCT01573624|26592227|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7643781|NCT01573624|26592221|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7643782|NCT01573624|26592222|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
7643783|NCT01573624|26592223|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7643784|NCT01573624|26592224|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7643785|NCT01573624|26592225|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7643786|NCT01573624|26592226|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7643787|NCT01573624|26592227|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7643788|NCT01573624|26592221|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7643789|NCT01573624|26592222|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7643790|NCT01573624|26592223|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7643791|NCT01573624|26592224|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7643792|NCT01573624|26592225|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
7643793|NCT01573624|26592226|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7643794|NCT01573624|26592227|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7643795|NCT01573624|26592221|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7643796|NCT01573624|26592222|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7643797|NCT01573624|26592223|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7643798|NCT01573624|26592224|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7643799|NCT01573624|26592225|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7643800|NCT01573624|26592226|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7643801|NCT01573624|26592227|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7643802|NCT01573624|26592221|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7643803|NCT01573624|26592222|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
7643804|NCT01573624|26592223|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7643805|NCT01573624|26592224|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7643806|NCT01573624|26592225|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7643807|NCT01573624|26592226|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7643808|NCT01573624|26592227|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7643809|NCT01573624|26592221|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7643810|NCT01573624|26592222|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7643811|NCT01573624|26592223|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7643812|NCT01573624|26592224|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7643813|NCT01573624|26592225|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7643814|NCT01573624|26592226|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7643815|NCT01573624|26592227|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7643816|NCT01573624|26592221|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7643817|NCT01573624|26592222|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7643818|NCT01573624|26592223|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7643819|NCT01573624|26592224|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7643820|NCT01573624|26592225|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7643821|NCT01573624|26592226|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7643822|NCT01573624|26592227|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7643823|NCT01573624|26592221|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7643824|NCT01573624|26592222|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7643825|NCT01573624|26592223|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7643826|NCT01573624|26592224|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7643827|NCT01573624|26592225|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7643828|NCT01573624|26592226|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7643829|NCT01573624|26592227|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
7643830|NCT01573624|26592221|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7643831|NCT01573624|26592222|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
7643832|NCT01573624|26592223|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
7643833|NCT01573624|26592224|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7643834|NCT01573624|26592225|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
7643835|NCT01573624|26592226|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
7643836|NCT01573624|26592227|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
7643837|NCT01573624|26592221|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7643838|NCT01573624|26592222|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7643839|NCT01573624|26592223|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7643840|NCT01573624|26592224|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7643841|NCT01573624|26592225|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7643842|NCT01573624|26592226|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7643843|NCT01573624|26592227|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7643844|NCT01573442|26592287|P2|Overall Study|Cancels|10
7643845|NCT01573442|26592288|P1|Overall Study|Cancels|9
7643846|NCT01573000|26592447|P2|Long-Term Follow-Up|Lost to Follow-up|1
7643847|NCT01573000|26592448|P1|Long-Term Follow-Up|Lost to Follow-up|0
7643848|NCT01573000|26592447|P2|Long-Term Follow-Up|Death|0
7643849|NCT01573000|26592448|P1|Long-Term Follow-Up|Death|3
7643850|NCT01573000|26592447|P2|Crossover Phase|Death|3
7643851|NCT01573000|26592448|P1|Crossover Phase|Death|0
7643852|NCT01573000|26592447|P2|Crossover Phase|Lost to Follow-up|2
7643853|NCT01573000|26592448|P1|Crossover Phase|Lost to Follow-up|0
7643854|NCT01573000|26592447|P2|Crossover Phase|Lack of Efficacy|13
7643855|NCT01573000|26592448|P1|Crossover Phase|Lack of Efficacy|0
7643856|NCT01573000|26592447|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
7643857|NCT01573000|26592448|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
7643858|NCT01573000|26592447|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
7643859|NCT01573000|26592448|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
7643860|NCT01573000|26592447|P2|Dosimetric and Therapeutic Treatment|Death|1
7643861|NCT01573000|26592448|P1|Dosimetric and Therapeutic Treatment|Death|0
7643862|NCT01573000|26592447|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7643863|NCT01573000|26592448|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
7643864|NCT01573000|26592447|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
7643865|NCT01573000|26592448|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
7643866|NCT01572948|26592544|P2|Overall Study|unable to contact|1
7643867|NCT01572948|26592545|P1|Overall Study|unable to contact|0
7643868|NCT01572948|26592544|P2|Overall Study|Lost to Follow-up|0
7643869|NCT01572948|26592545|P1|Overall Study|Lost to Follow-up|1
7643870|NCT01572922|26592561|P1|Overall Study|Death|1
7643871|NCT01572922|26592561|P1|Overall Study|Protocol Violation|1
7643872|NCT01572922|26592561|P1|Overall Study|Adverse Event|1
7643873|NCT01572909|26592573|P2|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
7643874|NCT01572909|26592574|P1|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
7643875|NCT01572909|26592573|P2|Overall Study|Withdrawal by Subject|11
7643876|NCT01572909|26592574|P1|Overall Study|Withdrawal by Subject|12
7643877|NCT01572909|26592573|P2|Overall Study|Technical Issues|0
7643878|NCT01572909|26592574|P1|Overall Study|Technical Issues|1
7643879|NCT01572909|26592573|P2|Overall Study|Physician Decision|1
7643880|NCT01572909|26592574|P1|Overall Study|Physician Decision|1
7643881|NCT01572909|26592573|P2|Overall Study|Lost to Follow-up|7
7643882|NCT01572909|26592574|P1|Overall Study|Lost to Follow-up|8
7643883|NCT01572909|26592573|P2|Overall Study|Death|1
7643884|NCT01572909|26592574|P1|Overall Study|Death|3
7643885|NCT01572909|26592573|P2|Overall Study|Adverse Event|2
7643886|NCT01572909|26592574|P1|Overall Study|Adverse Event|7
7643887|NCT01572844|26592618|P2|Overall Study|Physician Decision|1
7643888|NCT01572844|26592619|P1|Overall Study|Physician Decision|1
7643889|NCT01572792|26592637|P5|Extension Study|Site termination/COPD exacerbation/other|6
7643890|NCT01572792|26592638|P4|Extension Study|Site termination/COPD exacerbation/other|6
7643891|NCT01572792|26592639|P3|Extension Study|Site termination/COPD exacerbation/other|4
7643892|NCT01572792|26592640|P2|Extension Study|Site termination/COPD exacerbation/other|8
7643893|NCT01572792|26592641|P1|Extension Study|Site termination/COPD exacerbation/other|3
7643894|NCT01572792|26592637|P5|Extension Study|Adverse Event|4
7643895|NCT01572792|26592638|P4|Extension Study|Adverse Event|6
7643896|NCT01572792|26592639|P3|Extension Study|Adverse Event|5
7643897|NCT01572792|26592640|P2|Extension Study|Adverse Event|6
7643898|NCT01572792|26592641|P1|Extension Study|Adverse Event|7
7643899|NCT01572792|26592637|P5|Extension Study|Lack of Efficacy|2
7643900|NCT01572792|26592638|P4|Extension Study|Lack of Efficacy|2
7643901|NCT01572792|26592639|P3|Extension Study|Lack of Efficacy|3
7643902|NCT01572792|26592640|P2|Extension Study|Lack of Efficacy|3
7643903|NCT01572792|26592641|P1|Extension Study|Lack of Efficacy|2
7643904|NCT01572792|26592637|P5|Extension Study|Protocol Violation|3
7643905|NCT01572792|26592638|P4|Extension Study|Protocol Violation|4
7643906|NCT01572792|26592639|P3|Extension Study|Protocol Violation|3
7643907|NCT01572792|26592640|P2|Extension Study|Protocol Violation|4
7643908|NCT01572792|26592641|P1|Extension Study|Protocol Violation|0
7643909|NCT01572792|26592637|P5|Extension Study|Withdrawal by Subject|14
7643910|NCT01572792|26592638|P4|Extension Study|Withdrawal by Subject|8
7643912|NCT01572792|26592640|P2|Extension Study|Withdrawal by Subject|6
7643913|NCT01572792|26592641|P1|Extension Study|Withdrawal by Subject|7
7643914|NCT01572792|26592637|P5|Extension Study|Lost to Follow-up|3
7643915|NCT01572792|26592638|P4|Extension Study|Lost to Follow-up|3
7643916|NCT01572792|26592639|P3|Extension Study|Lost to Follow-up|0
7643917|NCT01572792|26592640|P2|Extension Study|Lost to Follow-up|2
7643918|NCT01572792|26592641|P1|Extension Study|Lost to Follow-up|6
7643919|NCT01572792|26592637|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
7643920|NCT01572792|26592638|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
7643921|NCT01572792|26592639|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
7643922|NCT01572792|26592640|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
7643923|NCT01572792|26592641|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
7643924|NCT01572792|26592637|P5|Lead-in Study|Adverse Event|14
7643925|NCT01572792|26592638|P4|Lead-in Study|Adverse Event|16
7643926|NCT01572792|26592639|P3|Lead-in Study|Adverse Event|22
7643927|NCT01572792|26592640|P2|Lead-in Study|Adverse Event|21
7643928|NCT01572792|26592641|P1|Lead-in Study|Adverse Event|21
7643929|NCT01572792|26592637|P5|Lead-in Study|Lack of Efficacy|10
7643930|NCT01572792|26592638|P4|Lead-in Study|Lack of Efficacy|8
7643931|NCT01572792|26592639|P3|Lead-in Study|Lack of Efficacy|4
7643932|NCT01572792|26592640|P2|Lead-in Study|Lack of Efficacy|5
7643933|NCT01572792|26592641|P1|Lead-in Study|Lack of Efficacy|20
7643934|NCT01572792|26592637|P5|Lead-in Study|Protocol Violation|21
7643935|NCT01572792|26592638|P4|Lead-in Study|Protocol Violation|13
7643936|NCT01572792|26592639|P3|Lead-in Study|Protocol Violation|12
7643937|NCT01572792|26592640|P2|Lead-in Study|Protocol Violation|10
7643938|NCT01572792|26592641|P1|Lead-in Study|Protocol Violation|19
7643939|NCT01572792|26592637|P5|Lead-in Study|Withdrawal by Subject|11
7643940|NCT01572792|26592638|P4|Lead-in Study|Withdrawal by Subject|24
7643941|NCT01572792|26592639|P3|Lead-in Study|Withdrawal by Subject|12
7643942|NCT01572792|26592640|P2|Lead-in Study|Withdrawal by Subject|11
7643943|NCT01572792|26592641|P1|Lead-in Study|Withdrawal by Subject|22
7643944|NCT01572792|26592637|P5|Lead-in Study|Lost to Follow-up|4
7643945|NCT01572792|26592638|P4|Lead-in Study|Lost to Follow-up|2
7643946|NCT01572792|26592639|P3|Lead-in Study|Lost to Follow-up|4
7643947|NCT01572792|26592640|P2|Lead-in Study|Lost to Follow-up|9
7643948|NCT01572792|26592641|P1|Lead-in Study|Lost to Follow-up|5
7643949|NCT01572740|26592690|P2|Overall Study|unclassified|3
7643950|NCT01572740|26592691|P1|Overall Study|unclassified|4
7643951|NCT01572740|26592690|P2|Overall Study|Withdrawal by Subject|1
7643952|NCT01572740|26592691|P1|Overall Study|Withdrawal by Subject|1
7643953|NCT01572740|26592690|P2|Overall Study|Adverse Event|1
7643954|NCT01572740|26592691|P1|Overall Study|Adverse Event|1
7643955|NCT01572727|26592721|P2|Overall Study|Untreated|7
7643956|NCT01572727|26592722|P1|Overall Study|Untreated|4
7643957|NCT01572727|26592721|P2|Overall Study|Death|2
7643958|NCT01572727|26592722|P1|Overall Study|Death|2
7643959|NCT01572727|26592721|P2|Overall Study|Parent/guardian decision|9
7643960|NCT01572727|26592722|P1|Overall Study|Parent/guardian decision|14
7643961|NCT01572727|26592721|P2|Overall Study|Study terminated by sponsor|83
7643962|NCT01572727|26592722|P1|Overall Study|Study terminated by sponsor|61
7643963|NCT01572727|26592721|P2|Overall Study|Protocol Violation|1
7643964|NCT01572727|26592722|P1|Overall Study|Protocol Violation|0
7643965|NCT01572727|26592721|P2|Overall Study|Progressive disease|82
7643966|NCT01572727|26592722|P1|Overall Study|Progressive disease|59
7643967|NCT01572727|26592721|P2|Overall Study|Physician Decision|9
7643968|NCT01572727|26592722|P1|Overall Study|Physician Decision|23
7643969|NCT01572727|26592721|P2|Overall Study|Lost to Follow-up|1
7643970|NCT01572727|26592722|P1|Overall Study|Lost to Follow-up|1
7643971|NCT01572727|26592721|P2|Overall Study|Adverse Event|15
7643972|NCT01572727|26592722|P1|Overall Study|Adverse Event|43
7643973|NCT01572675|26592744|P2|Overall Study|Lost to Follow-up|27
7643974|NCT01572675|26592745|P1|Overall Study|Lost to Follow-up|22
7643975|NCT01572675|26592744|P2|Overall Study|Missing data|4
7643976|NCT01572675|26592745|P1|Overall Study|Missing data|1
7643977|NCT01572675|26592744|P2|Overall Study|Rheumatologist new evaluation|1
7643978|NCT01572675|26592745|P1|Overall Study|Rheumatologist new evaluation|0
7643979|NCT01572675|26592744|P2|Overall Study|Unknown reason|1
7643980|NCT01572675|26592745|P1|Overall Study|Unknown reason|1
7643981|NCT01572675|26592744|P2|Overall Study|Other disease detected|1
7643982|NCT01572675|26592745|P1|Overall Study|Other disease detected|1
7643983|NCT01572675|26592744|P2|Overall Study|Death unrelated to coxibs|1
7643984|NCT01572675|26592745|P1|Overall Study|Death unrelated to coxibs|1
7643985|NCT01572675|26592744|P2|Overall Study|Physician Decision|2
7643986|NCT01572675|26592745|P1|Overall Study|Physician Decision|2
7643987|NCT01572675|26592744|P2|Overall Study|Withdrawal by Subject|1
7643988|NCT01572675|26592745|P1|Overall Study|Withdrawal by Subject|5
7643989|NCT01572675|26592744|P2|Overall Study|Surgical intervention|6
7643990|NCT01572675|26592745|P1|Overall Study|Surgical intervention|3
7643991|NCT01572675|26592744|P2|Overall Study|Improved symptoms|2
7643992|NCT01572675|26592745|P1|Overall Study|Improved symptoms|8
7643993|NCT01572675|26592744|P2|Overall Study|Intolerance|5
7643994|NCT01572675|26592745|P1|Overall Study|Intolerance|6
7643995|NCT01572675|26592744|P2|Overall Study|Lack of Efficacy|31
7643996|NCT01572675|26592745|P1|Overall Study|Lack of Efficacy|31
7643997|NCT01572675|26592744|P2|Overall Study|Recovery|23
7643998|NCT01572675|26592745|P1|Overall Study|Recovery|16
7643999|NCT01572675|26592744|P2|Overall Study|End of prescribed treatment|118
7644000|NCT01572675|26592745|P1|Overall Study|End of prescribed treatment|140
7644001|NCT01572389|26592863|P2|Overall Study|Only A1C or Assessment was Collected|2
7644002|NCT01572389|26592864|P1|Overall Study|Only A1C or Assessment was Collected|6
7644003|NCT01572389|26592863|P2|Overall Study|Lost to Follow-up|14
7644004|NCT01572389|26592864|P1|Overall Study|Lost to Follow-up|25
7644005|NCT01572389|26592863|P2|Overall Study|Withdrawal by Subject|2
7644006|NCT01572389|26592864|P1|Overall Study|Withdrawal by Subject|14
7644007|NCT01572389|26592863|P2|Overall Study|Death|3
7644008|NCT01572389|26592864|P1|Overall Study|Death|1
7644009|NCT01572038|26592896|P1|Overall Study|Sponsor Decision|1
7644010|NCT01572038|26592896|P1|Overall Study|Patient Deterioration|1
7644011|NCT01572038|26592896|P1|Overall Study|Termination by Sponsor|2
7644012|NCT01572038|26592896|P1|Overall Study|Participated in Another Trial|3
7644013|NCT01572038|26592896|P1|Overall Study|Enrolled into Another Trial|3
7644014|NCT01572038|26592896|P1|Overall Study|Site Closed Before Completing Form|6
7644015|NCT01572038|26592896|P1|Overall Study|Progressive Disease|8
7644016|NCT01572038|26592896|P1|Overall Study|Patient Decision|14
7644017|NCT01572038|26592896|P1|Overall Study|Physician Decision|20
7644018|NCT01572038|26592896|P1|Overall Study|Lost to Follow-up|81
7644019|NCT01572038|26592896|P1|Overall Study|Withdrawal by Subject|204
7644020|NCT01572038|26592896|P1|Overall Study|Death|648
7644021|NCT01571596|26593005|P3|Overall Study|Study Terminated by the Sponsor|1
7644022|NCT01571596|26593006|P2|Overall Study|Study Terminated by the Sponsor|1
7644023|NCT01571596|26593007|P1|Overall Study|Study Terminated by the Sponsor|0
7644024|NCT01571596|26593005|P3|Overall Study|Adverse Event|0
7644025|NCT01571596|26593006|P2|Overall Study|Adverse Event|0
7644026|NCT01571596|26593007|P1|Overall Study|Adverse Event|2
7644027|NCT01571453|26593027|P2|Overall Study|Administrative or other reason(s)|3
7644028|NCT01571453|26593028|P1|Overall Study|Administrative or other reason(s)|4
7644029|NCT01571453|26593027|P2|Overall Study|Lost to Follow-up|2
7644030|NCT01571453|26593028|P1|Overall Study|Lost to Follow-up|4
7644031|NCT01571453|26593027|P2|Overall Study|Withdrawal of consent|13
7644032|NCT01571453|26593028|P1|Overall Study|Withdrawal of consent|5
7644033|NCT01571453|26593027|P2|Overall Study|Protocol Violation|5
7644034|NCT01571453|26593028|P1|Overall Study|Protocol Violation|1
7644035|NCT01571453|26593027|P2|Overall Study|Non-compliance|4
7644036|NCT01571453|26593028|P1|Overall Study|Non-compliance|2
7644037|NCT01571453|26593027|P2|Overall Study|Lack of Efficacy|3
7644038|NCT01571453|26593028|P1|Overall Study|Lack of Efficacy|8
7644039|NCT01571453|26593027|P2|Overall Study|Adverse Event|32
7644040|NCT01571453|26593028|P1|Overall Study|Adverse Event|14
7644041|NCT01571362|26593075|P3|Double-Blind Treatment Period|Other - unspecified|1
7644042|NCT01571362|26593076|P2|Double-Blind Treatment Period|Other - unspecified|6
7644043|NCT01571362|26593077|P1|Double-Blind Treatment Period|Other - unspecified|0
7644044|NCT01571362|26593075|P3|Double-Blind Treatment Period|Insufficient clinical response|4
7644045|NCT01571362|26593076|P2|Double-Blind Treatment Period|Insufficient clinical response|16
7644046|NCT01571362|26593077|P1|Double-Blind Treatment Period|Insufficient clinical response|0
7644047|NCT01571362|26593075|P3|Double-Blind Treatment Period|Lost to Follow-up|6
7644048|NCT01571362|26593076|P2|Double-Blind Treatment Period|Lost to Follow-up|3
7644049|NCT01571362|26593077|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7644050|NCT01571362|26593075|P3|Double-Blind Treatment Period|Adverse Event|14
7644051|NCT01571362|26593076|P2|Double-Blind Treatment Period|Adverse Event|9
7644052|NCT01571362|26593077|P1|Double-Blind Treatment Period|Adverse Event|0
7644053|NCT01571362|26593075|P3|Double-Blind Treatment Period|Protocol Violation|9
7644054|NCT01571362|26593076|P2|Double-Blind Treatment Period|Protocol Violation|8
7644055|NCT01571362|26593077|P1|Double-Blind Treatment Period|Protocol Violation|0
7644056|NCT01571362|26593075|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
7644057|NCT01571362|26593076|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
7644058|NCT01571362|26593077|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7644059|NCT01571362|26593075|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
7644060|NCT01571362|26593076|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
7644061|NCT01571362|26593077|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
7644062|NCT01571362|26593075|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7644063|NCT01571362|26593076|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7644064|NCT01571362|26593077|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
7644065|NCT01571362|26593075|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7644066|NCT01571362|26593076|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7644067|NCT01571362|26593077|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
7644068|NCT01571362|26593075|P3|Open-Label Conversion + Titration Period|Adverse Event|0
7644069|NCT01571362|26593076|P2|Open-Label Conversion + Titration Period|Adverse Event|0
7644070|NCT01571362|26593077|P1|Open-Label Conversion + Titration Period|Adverse Event|57
7644071|NCT01571362|26593075|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
7644072|NCT01571362|26593076|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
7644073|NCT01571362|26593077|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
7644074|NCT01571362|26593075|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7644075|NCT01571362|26593076|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7644076|NCT01571362|26593077|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
7644077|NCT01571284|26593247|P1|Overall Study|Other than specified above|80
7644078|NCT01571284|26593247|P1|Overall Study|Enrolled but not treated|2
7644079|NCT01571284|26593247|P1|Overall Study|Lost to Follow-up|3
7644080|NCT01571284|26593247|P1|Overall Study|Participant's decision|84
7644081|NCT01571232|26593270|P2|Overall Study|Withdrawal by Subject|0
7644082|NCT01571232|26593271|P1|Overall Study|Withdrawal by Subject|1
7644083|NCT01571232|26593270|P2|Overall Study|Lost to Follow-up|1
7644084|NCT01571232|26593271|P1|Overall Study|Lost to Follow-up|0
7644085|NCT01570868|26593287|P2|Overall Study|Withdrawal by Subject|0
7644086|NCT01570868|26593288|P1|Overall Study|Withdrawal by Subject|1
7644087|NCT01570868|26593287|P2|Overall Study|Lost to Follow-up|0
7644088|NCT01570868|26593288|P1|Overall Study|Lost to Follow-up|1
7644089|NCT01570868|26593287|P2|Overall Study|Physician Decision|4
7644090|NCT01570868|26593288|P1|Overall Study|Physician Decision|10
7644091|NCT01570868|26593287|P2|Overall Study|FDA Recommendation|3
7644092|NCT01570868|26593288|P1|Overall Study|FDA Recommendation|23
7644093|NCT01570868|26593287|P2|Overall Study|Adverse Event|1
7644094|NCT01570868|26593288|P1|Overall Study|Adverse Event|8
7644095|NCT01570751|26593323|P2|Period B (16 Weeks)|Protocol Violation|1
7644096|NCT01570751|26593324|P1|Period B (16 Weeks)|Protocol Violation|0
7644097|NCT01570751|26593323|P2|Period B (16 Weeks)|Adverse Event|0
7644098|NCT01570751|26593324|P1|Period B (16 Weeks)|Adverse Event|1
7644099|NCT01570751|26593323|P2|Period A (16 Weeks)|Unclassified|3
7644100|NCT01570751|26593324|P1|Period A (16 Weeks)|Unclassified|2
7644101|NCT01570751|26593323|P2|Period A (16 Weeks)|Withdrawal criteria|1
7644102|NCT01570751|26593324|P1|Period A (16 Weeks)|Withdrawal criteria|0
7644103|NCT01570751|26593323|P2|Period A (16 Weeks)|Protocol Violation|1
7644104|NCT01570751|26593324|P1|Period A (16 Weeks)|Protocol Violation|1
7644105|NCT01570686|26593342|P2|Overall Study|Unsatisfactory therapeutic effect|1
7644106|NCT01570686|26593343|P1|Overall Study|Unsatisfactory therapeutic effect|2
7644107|NCT01570686|26593342|P2|Overall Study|Withdrawal by Subject|4
7644108|NCT01570686|26593343|P1|Overall Study|Withdrawal by Subject|4
7644109|NCT01570686|26593342|P2|Overall Study|Protocol Deviation|0
7644110|NCT01570686|26593343|P1|Overall Study|Protocol Deviation|3
7644111|NCT01570686|26593342|P2|Overall Study|Lost to Follow-up|3
7644112|NCT01570686|26593343|P1|Overall Study|Lost to Follow-up|4
7644113|NCT01570686|26593342|P2|Overall Study|Adverse Event|6
7644114|NCT01570686|26593343|P1|Overall Study|Adverse Event|8
7644115|NCT01570686|26593342|P2|Overall Study|Administrative problems|1
7644116|NCT01570686|26593343|P1|Overall Study|Administrative problems|0
7644117|NCT01570686|26593342|P2|Overall Study|Abnormal test procedure result(s)|1
7644118|NCT01570686|26593343|P1|Overall Study|Abnormal test procedure result(s)|1
7644119|NCT01570491|26593379|P2|Overall Study|treatment: not given or discontinued|0
7644120|NCT01570491|26593380|P1|Overall Study|treatment: not given or discontinued|2
7644121|NCT01570491|26593379|P2|Overall Study|Lost to Follow-up|1
7644122|NCT01570491|26593380|P1|Overall Study|Lost to Follow-up|3
7644123|NCT01570387|26593396|P4|Overall Study|Withdrawal by Subject|1
7644124|NCT01570387|26593397|P3|Overall Study|Withdrawal by Subject|0
7644125|NCT01570387|26593398|P2|Overall Study|Withdrawal by Subject|0
7644126|NCT01570387|26593399|P1|Overall Study|Withdrawal by Subject|0
7644127|NCT01570387|26593396|P4|Overall Study|Death|1
7644128|NCT01570387|26593397|P3|Overall Study|Death|0
7644129|NCT01570387|26593398|P2|Overall Study|Death|0
7644130|NCT01570387|26593399|P1|Overall Study|Death|0
7644131|NCT01570387|26593396|P4|Overall Study|Adverse Event|0
7644132|NCT01570387|26593397|P3|Overall Study|Adverse Event|0
7644133|NCT01570387|26593398|P2|Overall Study|Adverse Event|0
7644134|NCT01570387|26593399|P1|Overall Study|Adverse Event|1
7644135|NCT01570361|26593411|P2|Overall Study|Other|2
7644136|NCT01570361|26593412|P1|Overall Study|Other|0
7644137|NCT01570361|26593411|P2|Overall Study|Death|4
7644138|NCT01570361|26593412|P1|Overall Study|Death|5
7644139|NCT01570361|26593411|P2|Overall Study|Lost to Follow-up|4
7644140|NCT01570361|26593412|P1|Overall Study|Lost to Follow-up|4
7644141|NCT01570361|26593411|P2|Overall Study|Adverse Event|1
7644142|NCT01570361|26593412|P1|Overall Study|Adverse Event|2
7644143|NCT01570361|26593411|P2|Overall Study|Subject withdrew consent|9
7644144|NCT01570361|26593412|P1|Overall Study|Subject withdrew consent|14
7644145|NCT01570361|26593411|P2|Overall Study|Subject excluded|3
7644146|NCT01570361|26593412|P1|Overall Study|Subject excluded|5
7644147|NCT01570361|26593411|P2|Overall Study|Sponsor closing the study|50
7644148|NCT01570361|26593412|P1|Overall Study|Sponsor closing the study|51
7644149|NCT01570361|26593411|P2|Overall Study|Subject discontinued|2
7644150|NCT01570361|26593412|P1|Overall Study|Subject discontinued|1
7644151|NCT01570309|26593455|P2|Overall Study|Withdrawal by Subject|3
7644152|NCT01570309|26593456|P1|Overall Study|Withdrawal by Subject|3
7644153|NCT01570283|26593473|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
7644154|NCT01570283|26593474|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7644155|NCT01570283|26593475|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7644156|NCT01570283|26593476|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7644157|NCT01570283|26593477|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7644158|NCT01570283|26593478|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7644159|NCT01570283|26593473|P6|Cohort 3: Dose Level 3|Death|1
7644160|NCT01570283|26593474|P5|Cohort 3: Dose Level 3|Death|0
7644161|NCT01570283|26593475|P4|Cohort 3: Dose Level 3|Death|0
7644162|NCT01570283|26593476|P3|Cohort 3: Dose Level 3|Death|0
7644163|NCT01570283|26593477|P2|Cohort 3: Dose Level 3|Death|0
7644164|NCT01570283|26593478|P1|Cohort 3: Dose Level 3|Death|0
7644165|NCT01570283|26593473|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7644166|NCT01570283|26593474|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7644167|NCT01570283|26593475|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
7644168|NCT01570283|26593476|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7644169|NCT01570283|26593477|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7644170|NCT01570283|26593478|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7644171|NCT01570283|26593473|P6|Cohort 2: Dose Level 2|Death|0
7644172|NCT01570283|26593474|P5|Cohort 2: Dose Level 2|Death|0
7644173|NCT01570283|26593475|P4|Cohort 2: Dose Level 2|Death|0
7644174|NCT01570283|26593476|P3|Cohort 2: Dose Level 2|Death|1
7644175|NCT01570283|26593477|P2|Cohort 2: Dose Level 2|Death|0
7644176|NCT01570283|26593478|P1|Cohort 2: Dose Level 2|Death|0
7644177|NCT01570283|26593473|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7644178|NCT01570283|26593474|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7644179|NCT01570283|26593475|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7644180|NCT01570283|26593476|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7644181|NCT01570283|26593477|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
7644182|NCT01570283|26593478|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7644183|NCT01570283|26593473|P6|Cohort 1: Dose Level 1|Death|0
7644184|NCT01570283|26593474|P5|Cohort 1: Dose Level 1|Death|0
7644185|NCT01570283|26593475|P4|Cohort 1: Dose Level 1|Death|0
7644186|NCT01570283|26593476|P3|Cohort 1: Dose Level 1|Death|0
7644187|NCT01570283|26593477|P2|Cohort 1: Dose Level 1|Death|1
7644188|NCT01570283|26593478|P1|Cohort 1: Dose Level 1|Death|0
7644189|NCT01570244|26593495|P1|Microgynon+Faldaprevir|Adverse Event|1
7644190|NCT01570192|26593517|P2|Overall Study|Physician Decision|1
7644191|NCT01570192|26593518|P1|Overall Study|Physician Decision|0
7644192|NCT01570192|26593517|P2|Overall Study|changed to palliative care|0
7644193|NCT01570192|26593518|P1|Overall Study|changed to palliative care|1
7644194|NCT01570192|26593517|P2|Overall Study|no qualifying organism|12
7644195|NCT01570192|26593518|P1|Overall Study|no qualifying organism|6
7644196|NCT01569841|26593571|P2|Period A (6 Weeks)|Withdrawal by Subject|1
7644197|NCT01569841|26593572|P1|Period A (6 Weeks)|Withdrawal by Subject|0
7644198|NCT01569763|26593661|P2|Overall Study|Adverse Event|0
7644199|NCT01569763|26593662|P1|Overall Study|Adverse Event|1
7644200|NCT01569763|26593661|P2|Overall Study|Lack of Efficacy|7
7644201|NCT01569763|26593662|P1|Overall Study|Lack of Efficacy|2
7644202|NCT01569594|26593701|P1|Overall Study|No ECM used|9
7644203|NCT01569594|26593701|P1|Overall Study|Other|4
7644204|NCT01569594|26593701|P1|Overall Study|Withdrawal by Subject|13
7644205|NCT01569594|26593701|P1|Overall Study|Adverse Event|2
7644206|NCT01569594|26593701|P1|Overall Study|Lost to Follow-up|22
7644207|NCT01569594|26593701|P1|Overall Study|Death|13
7644208|NCT01569594|26593701|P1|Overall Study|Physician Decision|4
7644209|NCT01569568|26593707|P2|Overall Study|Physician Decision|2
7644210|NCT01569568|26593708|P1|Overall Study|Physician Decision|0
7644211|NCT01569464|26593731|P2|Overall Study|Other|1
7644212|NCT01569464|26593732|P1|Overall Study|Other|1
7644213|NCT01569464|26593731|P2|Overall Study|Withdrawal by Subject|1
7644214|NCT01569464|26593732|P1|Overall Study|Withdrawal by Subject|1
7644215|NCT01569464|26593731|P2|Overall Study|Lost to Follow-up|3
7644216|NCT01569464|26593732|P1|Overall Study|Lost to Follow-up|2
7644217|NCT01569464|26593731|P2|Overall Study|Protocol Violation|0
7644218|NCT01569464|26593732|P1|Overall Study|Protocol Violation|1
7644219|NCT01569464|26593731|P2|Overall Study|Lack of Efficacy|0
7644220|NCT01569464|26593732|P1|Overall Study|Lack of Efficacy|1
7644221|NCT01569464|26593731|P2|Overall Study|Adverse Event|0
7644222|NCT01569464|26593732|P1|Overall Study|Adverse Event|4
7644223|NCT01569438|26593799|P2|Overall Study|Unable to adhere to study schedule|1
7644224|NCT01569438|26593800|P1|Overall Study|Unable to adhere to study schedule|0
7644225|NCT01569438|26593799|P2|Overall Study|Sponsor/Physician decision|1
7644226|NCT01569438|26593800|P1|Overall Study|Sponsor/Physician decision|1
7644227|NCT01569438|26593799|P2|Overall Study|Decrease of GFR greater than 30 ml/min|0
7644228|NCT01569438|26593800|P1|Overall Study|Decrease of GFR greater than 30 ml/min|1
7644229|NCT01569438|26593799|P2|Overall Study|Protocol Violation|0
7644230|NCT01569438|26593800|P1|Overall Study|Protocol Violation|2
7644231|NCT01569438|26593799|P2|Overall Study|Adverse Event|15
7644232|NCT01569438|26593800|P1|Overall Study|Adverse Event|2
7644233|NCT01569438|26593799|P2|Overall Study|Withdrawal by Subject|3
7644234|NCT01569438|26593800|P1|Overall Study|Withdrawal by Subject|0
7644235|NCT01569438|26593799|P2|Overall Study|Lack of Efficacy|2
7644236|NCT01569438|26593800|P1|Overall Study|Lack of Efficacy|1
7644237|NCT01569295|26593814|P2|Overall Study|Lost to Follow-up|1
7644238|NCT01569295|26593815|P1|Overall Study|Lost to Follow-up|1
7644239|NCT01569295|26593814|P2|Overall Study|Other Anticancer/Experimental Therapy|2
7644240|NCT01569295|26593815|P1|Overall Study|Other Anticancer/Experimental Therapy|2
7644241|NCT01569295|26593814|P2|Overall Study|Non-Compliance with Study Drug|1
7644242|NCT01569295|26593815|P1|Overall Study|Non-Compliance with Study Drug|6
7644243|NCT01569295|26593814|P2|Overall Study|Other Reason not Specified|5
7644244|NCT01569295|26593815|P1|Overall Study|Other Reason not Specified|3
7644245|NCT01569295|26593814|P2|Overall Study|Study Terminated by Sponsor|2
7644246|NCT01569295|26593815|P1|Overall Study|Study Terminated by Sponsor|24
7644247|NCT01569295|26593814|P2|Overall Study|Physician Decision|18
7644248|NCT01569295|26593815|P1|Overall Study|Physician Decision|13
7644249|NCT01569295|26593814|P2|Overall Study|Death|15
7644250|NCT01569295|26593815|P1|Overall Study|Death|19
7644251|NCT01569295|26593814|P2|Overall Study|Withdrawal by Subject|12
7644252|NCT01569295|26593815|P1|Overall Study|Withdrawal by Subject|25
7644253|NCT01569295|26593814|P2|Overall Study|Adverse Event|14
7644254|NCT01569295|26593815|P1|Overall Study|Adverse Event|39
7644255|NCT01569295|26593814|P2|Overall Study|Progressive Disease|139
7644256|NCT01569295|26593815|P1|Overall Study|Progressive Disease|75
7644257|NCT01569152|26593852|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
7644258|NCT01569152|26593853|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
7644259|NCT01569152|26593854|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
7644260|NCT01569152|26593852|P3|Safety Extension, Period 3|Physician Decision|2
7644261|NCT01569152|26593853|P2|Safety Extension, Period 3|Physician Decision|0
7644262|NCT01569152|26593854|P1|Safety Extension, Period 3|Physician Decision|0
7644263|NCT01569152|26593852|P3|Safety Extension, Period 3|Withdrawal by Subject|2
7644264|NCT01569152|26593853|P2|Safety Extension, Period 3|Withdrawal by Subject|0
7644265|NCT01569152|26593854|P1|Safety Extension, Period 3|Withdrawal by Subject|0
7644266|NCT01569152|26593852|P3|Safety Extension, Period 3|Adverse Event|4
7644267|NCT01569152|26593853|P2|Safety Extension, Period 3|Adverse Event|0
7644268|NCT01569152|26593854|P1|Safety Extension, Period 3|Adverse Event|0
7644269|NCT01569152|26593852|P3|Phase IIa, Period 1|Withdrawal by Subject|0
7644270|NCT01569152|26593853|P2|Phase IIa, Period 1|Withdrawal by Subject|1
7644271|NCT01569152|26593854|P1|Phase IIa, Period 1|Withdrawal by Subject|2
7644272|NCT01569152|26593852|P3|Phase IIa, Period 1|Protocol Violation|0
7644273|NCT01569152|26593853|P2|Phase IIa, Period 1|Protocol Violation|1
7644274|NCT01569152|26593854|P1|Phase IIa, Period 1|Protocol Violation|0
7644275|NCT01569152|26593852|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
7644276|NCT01569152|26593853|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
7644277|NCT01569152|26593854|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
7644278|NCT01569152|26593852|P3|Phase IIa, Period 1|Lost to Follow-up|0
7644279|NCT01569152|26593853|P2|Phase IIa, Period 1|Lost to Follow-up|0
7644280|NCT01569152|26593854|P1|Phase IIa, Period 1|Lost to Follow-up|1
7644281|NCT01569152|26593852|P3|Phase IIa, Period 1|Adverse Event|0
7644282|NCT01569152|26593853|P2|Phase IIa, Period 1|Adverse Event|0
7644283|NCT01569152|26593854|P1|Phase IIa, Period 1|Adverse Event|4
7644284|NCT01569152|26593852|P3|Phase IIa, Period 1|Early Escape|0
7644285|NCT01569152|26593853|P2|Phase IIa, Period 1|Early Escape|22
7644286|NCT01569152|26593854|P1|Phase IIa, Period 1|Early Escape|5
7644287|NCT01569074|26593990|P5|Overall Study|Adverse Event|0
7644288|NCT01569074|26593991|P4|Overall Study|Adverse Event|0
7644289|NCT01569074|26593992|P3|Overall Study|Adverse Event|3
7644290|NCT01569074|26593993|P2|Overall Study|Adverse Event|0
7644291|NCT01569074|26593994|P1|Overall Study|Adverse Event|1
7644292|NCT01569074|26593990|P5|Overall Study|eg change in circumstances|1
7644293|NCT01569074|26593991|P4|Overall Study|eg change in circumstances|1
7644294|NCT01569074|26593992|P3|Overall Study|eg change in circumstances|0
7644295|NCT01569074|26593993|P2|Overall Study|eg change in circumstances|2
7644296|NCT01569074|26593994|P1|Overall Study|eg change in circumstances|0
7644297|NCT01569074|26593990|P5|Overall Study|Severe non-compliance to protocol|0
7644298|NCT01569074|26593991|P4|Overall Study|Severe non-compliance to protocol|0
7644299|NCT01569074|26593992|P3|Overall Study|Severe non-compliance to protocol|1
7644300|NCT01569074|26593993|P2|Overall Study|Severe non-compliance to protocol|0
7644301|NCT01569074|26593994|P1|Overall Study|Severe non-compliance to protocol|0
7644302|NCT01569074|26593990|P5|Overall Study|Study-specific discontinuation criteria|0
7644303|NCT01569074|26593991|P4|Overall Study|Study-specific discontinuation criteria|0
7644304|NCT01569074|26593992|P3|Overall Study|Study-specific discontinuation criteria|0
7644305|NCT01569074|26593993|P2|Overall Study|Study-specific discontinuation criteria|1
7644306|NCT01569074|26593994|P1|Overall Study|Study-specific discontinuation criteria|0
7644307|NCT01569074|26593990|P5|Overall Study|Study stopped|7
7644308|NCT01569074|26593991|P4|Overall Study|Study stopped|7
7644309|NCT01569074|26593992|P3|Overall Study|Study stopped|8
7644310|NCT01569074|26593993|P2|Overall Study|Study stopped|6
7644311|NCT01569074|26593994|P1|Overall Study|Study stopped|6
7644312|NCT01569022|26594050|P2|Second Intervention|Lost to Follow-up|2
7644313|NCT01569022|26594051|P1|Second Intervention|Lost to Follow-up|2
7644314|NCT01569022|26594050|P2|First Intervention|Lost to Follow-up|1
7644315|NCT01569022|26594051|P1|First Intervention|Lost to Follow-up|2
7644316|NCT01568892|26594106|P2|Open-label Phase|Lost to Follow-up|1
7644317|NCT01568892|26594107|P1|Open-label Phase|Lost to Follow-up|0
7644318|NCT01568892|26594106|P2|Open-label Phase|Lack of Efficacy|2
7644319|NCT01568892|26594107|P1|Open-label Phase|Lack of Efficacy|4
7644320|NCT01568892|26594106|P2|Open-label Phase|Adverse Event|0
7644321|NCT01568892|26594107|P1|Open-label Phase|Adverse Event|2
7644322|NCT01568866|26594177|P2|Overall Study|Randomized but Not Dosed|1
7644323|NCT01568866|26594178|P1|Overall Study|Randomized but Not Dosed|9
7644324|NCT01568866|26594177|P2|Overall Study|Lost to Follow-up|0
7644325|NCT01568866|26594178|P1|Overall Study|Lost to Follow-up|1
7644326|NCT01568866|26594177|P2|Overall Study|Protocol Non-compliance|4
7644327|NCT01568866|26594178|P1|Overall Study|Protocol Non-compliance|2
7644328|NCT01568866|26594177|P2|Overall Study|Death|18
7644329|NCT01568866|26594178|P1|Overall Study|Death|10
7644330|NCT01568866|26594177|P2|Overall Study|Withdrawal by Subject|11
7644331|NCT01568866|26594178|P1|Overall Study|Withdrawal by Subject|19
7644332|NCT01568866|26594177|P2|Overall Study|Physician Decision|32
7644333|NCT01568866|26594178|P1|Overall Study|Physician Decision|40
7644334|NCT01568866|26594177|P2|Overall Study|Patient Request|71
7644335|NCT01568866|26594178|P1|Overall Study|Patient Request|55
7644336|NCT01568866|26594177|P2|Overall Study|Adverse Event|96
7644337|NCT01568866|26594178|P1|Overall Study|Adverse Event|94
7644338|NCT01568866|26594177|P2|Overall Study|Disease Progression|183
7644339|NCT01568866|26594178|P1|Overall Study|Disease Progression|208
7644340|NCT01568593|26594213|P2|Overall Study|Adverse Event|2
7644341|NCT01568593|26594214|P1|Overall Study|Adverse Event|3
7644342|NCT01568593|26594213|P2|Overall Study|Lack of Efficacy|1
7644343|NCT01568593|26594214|P1|Overall Study|Lack of Efficacy|4
7644344|NCT01568320|26594255|P1|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
7644345|NCT01568320|26594255|P1|Overall Study|Conversion to open repair|1
7644346|NCT01568320|26594255|P1|Overall Study|Withdrawal by Subject|10
7644347|NCT01568320|26594255|P1|Overall Study|Lost to Follow-up|9
7644348|NCT01568320|26594255|P1|Overall Study|Death|20
7644349|NCT01568112|26594287|P4|Overall Study|Withdrawal by Physician|1
7644350|NCT01568112|26594288|P3|Overall Study|Withdrawal by Physician|1
7644351|NCT01568112|26594289|P2|Overall Study|Withdrawal by Physician|0
7644352|NCT01568112|26594290|P1|Overall Study|Withdrawal by Physician|1
7644353|NCT01568112|26594287|P4|Overall Study|Withdrawal by Subject|7
7644354|NCT01568112|26594288|P3|Overall Study|Withdrawal by Subject|0
7644355|NCT01568112|26594289|P2|Overall Study|Withdrawal by Subject|3
7644356|NCT01568112|26594290|P1|Overall Study|Withdrawal by Subject|2
7644357|NCT01568112|26594287|P4|Overall Study|Lost to Follow-up|1
7644358|NCT01568112|26594288|P3|Overall Study|Lost to Follow-up|0
7644359|NCT01568112|26594289|P2|Overall Study|Lost to Follow-up|0
7644360|NCT01568112|26594290|P1|Overall Study|Lost to Follow-up|0
7644361|NCT01568112|26594287|P4|Overall Study|Withdrew due to Adverse Event|3
7644362|NCT01568112|26594288|P3|Overall Study|Withdrew due to Adverse Event|6
7644363|NCT01568112|26594289|P2|Overall Study|Withdrew due to Adverse Event|4
7644364|NCT01568112|26594290|P1|Overall Study|Withdrew due to Adverse Event|2
7644365|NCT01568112|26594287|P4|Overall Study|Randomized But Not Treated|0
7644366|NCT01568112|26594288|P3|Overall Study|Randomized But Not Treated|0
7644367|NCT01568112|26594289|P2|Overall Study|Randomized But Not Treated|1
7644368|NCT01568112|26594290|P1|Overall Study|Randomized But Not Treated|0
7644369|NCT01568047|26594448|P4|Overall Study|Adverse Event|1
7644370|NCT01568047|26594449|P3|Overall Study|Adverse Event|1
7644371|NCT01568047|26594450|P2|Overall Study|Adverse Event|0
7644372|NCT01568047|26594451|P1|Overall Study|Adverse Event|0
7644373|NCT01568047|26594448|P4|Overall Study|Withdrawal by Subject|0
7644374|NCT01568047|26594449|P3|Overall Study|Withdrawal by Subject|0
7644375|NCT01568047|26594450|P2|Overall Study|Withdrawal by Subject|1
7644376|NCT01568047|26594451|P1|Overall Study|Withdrawal by Subject|0
7644377|NCT01568047|26594448|P4|Overall Study|Ineligibility|0
7644378|NCT01568047|26594449|P3|Overall Study|Ineligibility|0
7644379|NCT01568047|26594450|P2|Overall Study|Ineligibility|0
7644380|NCT01568047|26594451|P1|Overall Study|Ineligibility|1
7644381|NCT01568034|26594469|P4|Overall Study|Withdrawal by Subject|0
7644382|NCT01568034|26594470|P3|Overall Study|Withdrawal by Subject|0
7644383|NCT01568034|26594471|P2|Overall Study|Withdrawal by Subject|0
7644384|NCT01568034|26594472|P1|Overall Study|Withdrawal by Subject|1
7644385|NCT01567865|26594535|P4|Evaluated for Immunogenicity|Missing blood sample|28
7644386|NCT01567865|26594536|P3|Evaluated for Immunogenicity|Missing blood sample|16
7644387|NCT01567865|26594537|P2|Evaluated for Immunogenicity|Missing blood sample|24
7644388|NCT01567865|26594538|P1|Evaluated for Immunogenicity|Missing blood sample|17
7644389|NCT01567865|26594535|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
7644390|NCT01567865|26594536|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
7644391|NCT01567865|26594537|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
7644392|NCT01567865|26594538|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
7644393|NCT01567852|26594568|P2|Overall Study|ECT discontinued|1
7644394|NCT01567852|26594569|P1|Overall Study|ECT discontinued|1
7644395|NCT01567852|26594568|P2|Overall Study|Withdrawal by Subject|6
7644396|NCT01567852|26594569|P1|Overall Study|Withdrawal by Subject|3
7644397|NCT01567826|26594587|P2|Overall Study|Lost to Follow-up|2
7644398|NCT01567826|26594588|P1|Overall Study|Lost to Follow-up|3
7644399|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
7644400|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
7644401|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7644402|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7644403|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7644404|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
7644405|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
7644406|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7644407|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7644408|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7644409|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
7644410|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
7644411|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7644412|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7644413|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7644414|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
7644415|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
7644416|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7644417|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7644418|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7644419|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
7644420|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
7644421|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7644422|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7644423|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7644424|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
7644425|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
7644426|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7644427|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7644428|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7644429|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
7644430|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
7644431|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7644432|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7644433|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7644434|NCT01567527|26594614|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7644435|NCT01567527|26594615|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7644436|NCT01567527|26594616|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7644437|NCT01567527|26594617|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7644438|NCT01567527|26594618|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7644439|NCT01567527|26594614|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
7644440|NCT01567527|26594615|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
7644441|NCT01567527|26594616|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
7644442|NCT01567527|26594617|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
7644443|NCT01567527|26594618|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
7644444|NCT01567527|26594614|P5|IM Depot Stabilization.|Adverse Event|0
7644445|NCT01567527|26594615|P4|IM Depot Stabilization.|Adverse Event|0
7644446|NCT01567527|26594616|P3|IM Depot Stabilization.|Adverse Event|37
7644447|NCT01567527|26594617|P2|IM Depot Stabilization.|Adverse Event|0
7644448|NCT01567527|26594618|P1|IM Depot Stabilization.|Adverse Event|0
7644449|NCT01567527|26594614|P5|IM Depot Stabilization.|Lack of Efficacy|0
7644450|NCT01567527|26594615|P4|IM Depot Stabilization.|Lack of Efficacy|0
7644451|NCT01567527|26594616|P3|IM Depot Stabilization.|Lack of Efficacy|7
7644452|NCT01567527|26594617|P2|IM Depot Stabilization.|Lack of Efficacy|0
7644453|NCT01567527|26594618|P1|IM Depot Stabilization.|Lack of Efficacy|0
7644454|NCT01567527|26594614|P5|IM Depot Stabilization.|Lost to Follow-up|0
7644455|NCT01567527|26594615|P4|IM Depot Stabilization.|Lost to Follow-up|0
7644456|NCT01567527|26594616|P3|IM Depot Stabilization.|Lost to Follow-up|21
7644457|NCT01567527|26594617|P2|IM Depot Stabilization.|Lost to Follow-up|0
7644458|NCT01567527|26594618|P1|IM Depot Stabilization.|Lost to Follow-up|0
7644459|NCT01567527|26594614|P5|IM Depot Stabilization.|Sponsor discontinued study|0
7644460|NCT01567527|26594615|P4|IM Depot Stabilization.|Sponsor discontinued study|0
7644461|NCT01567527|26594616|P3|IM Depot Stabilization.|Sponsor discontinued study|1
7644462|NCT01567527|26594617|P2|IM Depot Stabilization.|Sponsor discontinued study|0
7644463|NCT01567527|26594618|P1|IM Depot Stabilization.|Sponsor discontinued study|0
7644464|NCT01567527|26594614|P5|IM Depot Stabilization.|Withdrawal by Subject|0
7644465|NCT01567527|26594615|P4|IM Depot Stabilization.|Withdrawal by Subject|0
7644466|NCT01567527|26594616|P3|IM Depot Stabilization.|Withdrawal by Subject|56
7644467|NCT01567527|26594617|P2|IM Depot Stabilization.|Withdrawal by Subject|0
7644468|NCT01567527|26594618|P1|IM Depot Stabilization.|Withdrawal by Subject|0
7644469|NCT01567527|26594614|P5|IM Depot Stabilization.|Met withdrawal criteria|0
7644470|NCT01567527|26594615|P4|IM Depot Stabilization.|Met withdrawal criteria|0
7644471|NCT01567527|26594616|P3|IM Depot Stabilization.|Met withdrawal criteria|26
7644472|NCT01567527|26594617|P2|IM Depot Stabilization.|Met withdrawal criteria|0
7644473|NCT01567527|26594618|P1|IM Depot Stabilization.|Met withdrawal criteria|0
7644474|NCT01567527|26594614|P5|IM Depot Stabilization.|Protocol deviation|0
7644475|NCT01567527|26594615|P4|IM Depot Stabilization.|Protocol deviation|0
7644476|NCT01567527|26594616|P3|IM Depot Stabilization.|Protocol deviation|5
7644477|NCT01567527|26594617|P2|IM Depot Stabilization.|Protocol deviation|0
7644478|NCT01567527|26594618|P1|IM Depot Stabilization.|Protocol deviation|0
7644479|NCT01567527|26594614|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7644480|NCT01567527|26594615|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7644481|NCT01567527|26594616|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7644482|NCT01567527|26594617|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
7644483|NCT01567527|26594618|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7644484|NCT01567527|26594614|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7644485|NCT01567527|26594615|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7644486|NCT01567527|26594616|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7644487|NCT01567527|26594617|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
7644488|NCT01567527|26594618|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7644489|NCT01567527|26594614|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7644490|NCT01567527|26594615|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7644491|NCT01567527|26594616|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7644492|NCT01567527|26594617|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
7644493|NCT01567527|26594618|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7644494|NCT01567527|26594614|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7644495|NCT01567527|26594615|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7644496|NCT01567527|26594616|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7644497|NCT01567527|26594617|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
7644498|NCT01567527|26594618|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7644499|NCT01567527|26594614|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7644500|NCT01567527|26594615|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7644501|NCT01567527|26594616|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7644502|NCT01567527|26594617|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
7644503|NCT01567527|26594618|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7644504|NCT01567527|26594614|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7644505|NCT01567527|26594615|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7644506|NCT01567527|26594616|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7644507|NCT01567527|26594617|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
7644508|NCT01567527|26594618|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7644509|NCT01567527|26594614|P5|Conversion Phase.|Withdrawn by the investigator|0
7644510|NCT01567527|26594615|P4|Conversion Phase.|Withdrawn by the investigator|0
7644511|NCT01567527|26594616|P3|Conversion Phase.|Withdrawn by the investigator|0
7644512|NCT01567527|26594617|P2|Conversion Phase.|Withdrawn by the investigator|0
7644513|NCT01567527|26594618|P1|Conversion Phase.|Withdrawn by the investigator|3
7644514|NCT01567527|26594614|P5|Conversion Phase.|Adverse Event|0
7644515|NCT01567527|26594615|P4|Conversion Phase.|Adverse Event|0
7644516|NCT01567527|26594616|P3|Conversion Phase.|Adverse Event|0
7644517|NCT01567527|26594617|P2|Conversion Phase.|Adverse Event|0
7644518|NCT01567527|26594618|P1|Conversion Phase.|Adverse Event|33
7644519|NCT01567527|26594614|P5|Conversion Phase.|Lack of Efficacy|0
7644520|NCT01567527|26594615|P4|Conversion Phase.|Lack of Efficacy|0
7644521|NCT01567527|26594616|P3|Conversion Phase.|Lack of Efficacy|0
7644522|NCT01567527|26594617|P2|Conversion Phase.|Lack of Efficacy|0
7644523|NCT01567527|26594618|P1|Conversion Phase.|Lack of Efficacy|2
7644524|NCT01567527|26594614|P5|Conversion Phase.|Lost to Follow-up|0
7644525|NCT01567527|26594615|P4|Conversion Phase.|Lost to Follow-up|0
7644526|NCT01567527|26594616|P3|Conversion Phase.|Lost to Follow-up|0
7644527|NCT01567527|26594617|P2|Conversion Phase.|Lost to Follow-up|0
7644528|NCT01567527|26594618|P1|Conversion Phase.|Lost to Follow-up|16
7644529|NCT01567527|26594614|P5|Conversion Phase.|Withdrawal by Subject|0
7644530|NCT01567527|26594615|P4|Conversion Phase.|Withdrawal by Subject|0
7644531|NCT01567527|26594616|P3|Conversion Phase.|Withdrawal by Subject|0
7644532|NCT01567527|26594617|P2|Conversion Phase.|Withdrawal by Subject|0
7644533|NCT01567527|26594618|P1|Conversion Phase.|Withdrawal by Subject|32
7644534|NCT01567527|26594614|P5|Conversion Phase.|Met withdrawal criteria|0
7644535|NCT01567527|26594615|P4|Conversion Phase.|Met withdrawal criteria|0
7644536|NCT01567527|26594616|P3|Conversion Phase.|Met withdrawal criteria|0
7644537|NCT01567527|26594617|P2|Conversion Phase.|Met withdrawal criteria|0
7644538|NCT01567527|26594618|P1|Conversion Phase.|Met withdrawal criteria|10
7644539|NCT01567527|26594614|P5|Conversion Phase.|Protocol deviation|0
7644540|NCT01567527|26594615|P4|Conversion Phase.|Protocol deviation|0
7644541|NCT01567527|26594616|P3|Conversion Phase.|Protocol deviation|0
7644542|NCT01567527|26594617|P2|Conversion Phase.|Protocol deviation|0
7644543|NCT01567527|26594618|P1|Conversion Phase.|Protocol deviation|3
7644544|NCT01567462|26594635|P2|Overall Study|Withdrawal by Subject|7
7644545|NCT01567462|26594636|P1|Overall Study|Withdrawal by Subject|4
7644546|NCT01567306|26594659|P6|Overall Study|Withdrawal by Subject|1
7644547|NCT01567306|26594660|P5|Overall Study|Withdrawal by Subject|0
7644548|NCT01567306|26594661|P4|Overall Study|Withdrawal by Subject|0
7644549|NCT01567306|26594662|P3|Overall Study|Withdrawal by Subject|0
7644550|NCT01567306|26594663|P2|Overall Study|Withdrawal by Subject|0
7644551|NCT01567306|26594664|P1|Overall Study|Withdrawal by Subject|0
7644552|NCT01567306|26594659|P6|Overall Study|Lost to Follow-up|0
7644553|NCT01567306|26594660|P5|Overall Study|Lost to Follow-up|2
7644554|NCT01567306|26594661|P4|Overall Study|Lost to Follow-up|0
7644555|NCT01567306|26594662|P3|Overall Study|Lost to Follow-up|0
7644556|NCT01567306|26594663|P2|Overall Study|Lost to Follow-up|0
7644557|NCT01567306|26594664|P1|Overall Study|Lost to Follow-up|0
7644558|NCT01567306|26594659|P6|Overall Study|Adverse Event|1
7644559|NCT01567306|26594660|P5|Overall Study|Adverse Event|4
7644560|NCT01567306|26594661|P4|Overall Study|Adverse Event|2
7644561|NCT01567306|26594662|P3|Overall Study|Adverse Event|0
7644562|NCT01567306|26594663|P2|Overall Study|Adverse Event|0
7644563|NCT01567306|26594664|P1|Overall Study|Adverse Event|0
7644564|NCT01567306|26594659|P6|Overall Study|Change site living|0
7644565|NCT01567306|26594660|P5|Overall Study|Change site living|0
7644566|NCT01567306|26594661|P4|Overall Study|Change site living|0
7644567|NCT01567306|26594662|P3|Overall Study|Change site living|0
7644568|NCT01567306|26594663|P2|Overall Study|Change site living|0
7644569|NCT01567306|26594664|P1|Overall Study|Change site living|1
7644570|NCT01567306|26594659|P6|Overall Study|Protocol Violation|1
7644571|NCT01567306|26594660|P5|Overall Study|Protocol Violation|1
7644572|NCT01567306|26594661|P4|Overall Study|Protocol Violation|3
7644573|NCT01567306|26594662|P3|Overall Study|Protocol Violation|0
7644574|NCT01567306|26594663|P2|Overall Study|Protocol Violation|2
7644575|NCT01567306|26594664|P1|Overall Study|Protocol Violation|2
7644576|NCT01567163|26594678|P1|Overall Study|Lost to Follow-up|2
7644577|NCT01567163|26594678|P1|Overall Study|Progressive Disease|2
7644578|NCT01567085|26594699|P1|Overall Study|Terminal chronic kidney dysfunction|1
7644579|NCT01567085|26594699|P1|Overall Study|Returned to chronic dialysis|1
7644580|NCT01567085|26594699|P1|Overall Study|Renal transplantectomy|1
7644581|NCT01567085|26594699|P1|Overall Study|Graft loss|2
7644582|NCT01567085|26594699|P1|Overall Study|Lost to Follow-up|3
7644583|NCT01567085|26594699|P1|Overall Study|Adverse Event|6
7644584|NCT01567085|26594699|P1|Overall Study|Death|6
7644585|NCT01566981|26594736|P2|Overall Study|Lost to Follow-up|8
7644586|NCT01566981|26594737|P1|Overall Study|Lost to Follow-up|5
7644587|NCT01566773|26594766|P1|Overall Study|Physician Decision|2
7644588|NCT01566773|26594766|P1|Overall Study|Adverse Event|10
7644589|NCT01566773|26594766|P1|Overall Study|Administrative reason|1
7644590|NCT01566773|26594766|P1|Overall Study|Withdrawal by Subject|9
7644591|NCT01566773|26594766|P1|Overall Study|Protocol Violation|4
7644592|NCT01566773|26594766|P1|Overall Study|Protocol specified criteria|4
7644593|NCT01566721|26594975|P2|Safety Follow-up|Adverse Event|4
7644594|NCT01566721|26594976|P1|Safety Follow-up|Adverse Event|8
7644595|NCT01566721|26594975|P2|Safety Follow-up|Sponsor decision|0
7644596|NCT01566721|26594976|P1|Safety Follow-up|Sponsor decision|1
7644597|NCT01566721|26594975|P2|Safety Follow-up|Disease progression /disease recurrence|90
7644598|NCT01566721|26594976|P1|Safety Follow-up|Disease progression /disease recurrence|223
7644599|NCT01566721|26594975|P2|Safety Follow-up|Missing|2
7644600|NCT01566721|26594976|P1|Safety Follow-up|Missing|7
7644601|NCT01566721|26594975|P2|Safety Follow-up|Erroneous reporting or late reporting|0
7644602|NCT01566721|26594976|P1|Safety Follow-up|Erroneous reporting or late reporting|2
7644603|NCT01566721|26594975|P2|Safety Follow-up|Site closure|3
7644604|NCT01566721|26594976|P1|Safety Follow-up|Site closure|2
7644605|NCT01566721|26594975|P2|Safety Follow-up|Protocol Violation|0
7644606|NCT01566721|26594976|P1|Safety Follow-up|Protocol Violation|7
7644607|NCT01566721|26594975|P2|Safety Follow-up|Non-compliance|3
7644608|NCT01566721|26594976|P1|Safety Follow-up|Non-compliance|7
7644609|NCT01566721|26594975|P2|Safety Follow-up|Death|4
7644610|NCT01566721|26594976|P1|Safety Follow-up|Death|28
7644611|NCT01566721|26594975|P2|Safety Follow-up|Withdrawal by Subject|49
7644612|NCT01566721|26594976|P1|Safety Follow-up|Withdrawal by Subject|155
7644613|NCT01566721|26594975|P2|Safety Follow-up|Lost to Follow-up|48
7644614|NCT01566721|26594976|P1|Safety Follow-up|Lost to Follow-up|101
7644615|NCT01566721|26594975|P2|Safety Follow-up|Physician Decision|4
7644616|NCT01566721|26594976|P1|Safety Follow-up|Physician Decision|6
7644617|NCT01566721|26594975|P2|Treatment Period|Pregnancy|0
7644618|NCT01566721|26594976|P1|Treatment Period|Pregnancy|1
7644619|NCT01566721|26594975|P2|Treatment Period|Adverse Event|30
7644620|NCT01566721|26594976|P1|Treatment Period|Adverse Event|100
7644621|NCT01566721|26594975|P2|Treatment Period|Lack of Compliance|1
7644622|NCT01566721|26594976|P1|Treatment Period|Lack of Compliance|5
7644623|NCT01566721|26594975|P2|Treatment Period|Other|2
7644624|NCT01566721|26594976|P1|Treatment Period|Other|13
7644625|NCT01566721|26594975|P2|Treatment Period|Investigator/Sponsor Decision|3
7644626|NCT01566721|26594976|P1|Treatment Period|Investigator/Sponsor Decision|6
7644627|NCT01566721|26594975|P2|Treatment Period|Disease Progression/Recurrence|13
7644628|NCT01566721|26594976|P1|Treatment Period|Disease Progression/Recurrence|37
7644629|NCT01566721|26594975|P2|Treatment Period|Withdrawal by Subject|9
7644630|NCT01566721|26594976|P1|Treatment Period|Withdrawal by Subject|35
7644631|NCT01566695|26595009|P2|Overall Study|Miscellaneous|6
7644632|NCT01566695|26595010|P1|Overall Study|Miscellaneous|4
7644633|NCT01566695|26595009|P2|Overall Study|Progressive Disease|6
7644634|NCT01566695|26595010|P1|Overall Study|Progressive Disease|11
7644635|NCT01566695|26595009|P2|Overall Study|Withdrawal by Subject|7
7644636|NCT01566695|26595010|P1|Overall Study|Withdrawal by Subject|14
7644637|NCT01566695|26595009|P2|Overall Study|Death|8
7644638|NCT01566695|26595010|P1|Overall Study|Death|20
7644639|NCT01566695|26595009|P2|Overall Study|Adverse Event|27
7644640|NCT01566695|26595010|P1|Overall Study|Adverse Event|28
7644641|NCT01566695|26595009|P2|Overall Study|Lack of Efficacy|45
7644642|NCT01566695|26595010|P1|Overall Study|Lack of Efficacy|18
7644643|NCT01566604|26595175|P2|Overall Study|Withdrawal by Subject|6
7644644|NCT01566604|26595176|P1|Overall Study|Withdrawal by Subject|9
7644645|NCT01566604|26595175|P2|Overall Study|Adverse Event|2
7644646|NCT01566604|26595176|P1|Overall Study|Adverse Event|4
7644647|NCT01566604|26595175|P2|Overall Study|Death|1
7644648|NCT01566604|26595176|P1|Overall Study|Death|4
7644649|NCT01566604|26595175|P2|Overall Study|Abnormal laboratory value|0
7644650|NCT01566604|26595176|P1|Overall Study|Abnormal laboratory value|2
7644651|NCT01566604|26595175|P2|Overall Study|Protocol deviation|0
7644652|NCT01566604|26595176|P1|Overall Study|Protocol deviation|2
7644653|NCT01566604|26595175|P2|Overall Study|Lack of Efficacy|2
7644654|NCT01566604|26595176|P1|Overall Study|Lack of Efficacy|1
7644655|NCT01566604|26595175|P2|Overall Study|Administrative problems|0
7644656|NCT01566604|26595176|P1|Overall Study|Administrative problems|1
7644657|NCT01566604|26595175|P2|Overall Study|Patient's inability to use the device|0
7644658|NCT01566604|26595176|P1|Overall Study|Patient's inability to use the device|1
7644659|NCT01566435|26595341|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
7644660|NCT01566214|26595407|P2|Overall Study|Lost to Follow-up|0
7644661|NCT01566214|26595408|P1|Overall Study|Lost to Follow-up|3
7644662|NCT01566149|26595452|P2|Overall Study|Withdrawal by Subject|0
7644663|NCT01566149|26595453|P1|Overall Study|Withdrawal by Subject|1
7644664|NCT01566149|26595452|P2|Overall Study|Protocol Violation|1
7644665|NCT01566149|26595453|P1|Overall Study|Protocol Violation|0
7644666|NCT01566149|26595452|P2|Overall Study|Non-compliance with study medication|0
7644667|NCT01566149|26595453|P1|Overall Study|Non-compliance with study medication|2
7644668|NCT01566149|26595452|P2|Overall Study|Adverse Event|1
7644669|NCT01566149|26595453|P1|Overall Study|Adverse Event|0
7644670|NCT01565993|26595486|P2|Overall Study|Physician Decision|3
7644671|NCT01565993|26595487|P1|Overall Study|Physician Decision|0
7644672|NCT01565980|26595495|P2|Overall Study|Withdrawal by Subject|3
7644673|NCT01565980|26595496|P1|Overall Study|Withdrawal by Subject|0
7644674|NCT01565980|26595495|P2|Overall Study|stopped medical treatment|0
7644675|NCT01565980|26595496|P1|Overall Study|stopped medical treatment|1
7644676|NCT01565980|26595495|P2|Overall Study|health complications|1
7644677|NCT01565980|26595496|P1|Overall Study|health complications|1
7644678|NCT01565980|26595495|P2|Overall Study|Lost to Follow-up|0
7644679|NCT01565980|26595496|P1|Overall Study|Lost to Follow-up|1
7644680|NCT01565980|26595495|P2|Overall Study|Death|0
7644681|NCT01565980|26595496|P1|Overall Study|Death|1
7644682|NCT01565941|26595516|P2|Overall Study|Randomized; did not receive intevention|2
7644683|NCT01565941|26595517|P1|Overall Study|Randomized; did not receive intevention|8
7644684|NCT01565941|26595516|P2|Overall Study|Withdrawn by parent/guardian|2
7644685|NCT01565941|26595517|P1|Overall Study|Withdrawn by parent/guardian|3
7644686|NCT01565928|26595563|P1|Overall Study|Death|2
7644687|NCT01565928|26595563|P1|Overall Study|Withdrawal by Subject|1
7644688|NCT01565928|26595563|P1|Overall Study|Progressive Disease|13
7644689|NCT01565928|26595563|P1|Overall Study|Other|3
7644690|NCT01565928|26595563|P1|Overall Study|Adverse Event|3
7644691|NCT01565889|26595617|P6|Part B|Lost to Follow-up|1
7644692|NCT01565889|26595618|P5|Part B|Lost to Follow-up|0
7644693|NCT01565889|26595619|P4|Part B|Lost to Follow-up|0
7644694|NCT01565889|26595620|P3|Part B|Lost to Follow-up|0
7644695|NCT01565889|26595621|P2|Part B|Lost to Follow-up|0
7644696|NCT01565889|26595622|P1|Part B|Lost to Follow-up|0
7644697|NCT01565889|26595617|P6|Part B|Lack of Efficacy|2
7644698|NCT01565889|26595618|P5|Part B|Lack of Efficacy|0
7644699|NCT01565889|26595619|P4|Part B|Lack of Efficacy|0
7644700|NCT01565889|26595620|P3|Part B|Lack of Efficacy|0
7644701|NCT01565889|26595621|P2|Part B|Lack of Efficacy|0
7644702|NCT01565889|26595622|P1|Part B|Lack of Efficacy|0
7644703|NCT01565889|26595617|P6|Part B|Withdrawal by Subject|1
7644704|NCT01565889|26595618|P5|Part B|Withdrawal by Subject|0
7644705|NCT01565889|26595619|P4|Part B|Withdrawal by Subject|0
7644706|NCT01565889|26595620|P3|Part B|Withdrawal by Subject|0
7644707|NCT01565889|26595621|P2|Part B|Withdrawal by Subject|0
7644708|NCT01565889|26595622|P1|Part B|Withdrawal by Subject|0
7644709|NCT01565889|26595617|P6|Part A|Withdrawal by Subject|0
7644710|NCT01565889|26595618|P5|Part A|Withdrawal by Subject|0
7644711|NCT01565889|26595619|P4|Part A|Withdrawal by Subject|0
7644712|NCT01565889|26595620|P3|Part A|Withdrawal by Subject|0
7644713|NCT01565889|26595621|P2|Part A|Withdrawal by Subject|0
7644714|NCT01565889|26595622|P1|Part A|Withdrawal by Subject|1
7644715|NCT01565850|26595653|P2|Overall Study|Withdrew Consent|2
7644716|NCT01565850|26595654|P1|Overall Study|Withdrew Consent|4
7644717|NCT01565850|26595653|P2|Overall Study|Participant noncompliance|0
7644718|NCT01565850|26595654|P1|Overall Study|Participant noncompliance|2
7644719|NCT01565850|26595653|P2|Overall Study|Investigator's Discretion|1
7644720|NCT01565850|26595654|P1|Overall Study|Investigator's Discretion|2
7644721|NCT01565850|26595653|P2|Overall Study|Lost to Follow-up|4
7644722|NCT01565850|26595654|P1|Overall Study|Lost to Follow-up|12
7644723|NCT01565850|26595653|P2|Overall Study|Adverse Event|1
7644724|NCT01565850|26595654|P1|Overall Study|Adverse Event|0
7644725|NCT01565707|26595674|P4|Overall Study|Miscellaneous|2
7644726|NCT01565707|26595675|P3|Overall Study|Miscellaneous|0
7644727|NCT01565707|26595676|P2|Overall Study|Miscellaneous|1
7644728|NCT01565707|26595677|P1|Overall Study|Miscellaneous|1
7644729|NCT01565707|26595674|P4|Overall Study|Randomized but not evaluable|0
7644730|NCT01565707|26595675|P3|Overall Study|Randomized but not evaluable|0
7644731|NCT01565707|26595676|P2|Overall Study|Randomized but not evaluable|0
7644732|NCT01565707|26595677|P1|Overall Study|Randomized but not evaluable|2
7644733|NCT01565707|26595674|P4|Overall Study|Withdrawal by Subject|1
7644734|NCT01565707|26595675|P3|Overall Study|Withdrawal by Subject|1
7644735|NCT01565707|26595676|P2|Overall Study|Withdrawal by Subject|1
7644736|NCT01565707|26595677|P1|Overall Study|Withdrawal by Subject|3
7644737|NCT01565707|26595674|P4|Overall Study|Protocol Violation|1
7644738|NCT01565707|26595675|P3|Overall Study|Protocol Violation|0
7644739|NCT01565707|26595676|P2|Overall Study|Protocol Violation|0
7644740|NCT01565707|26595677|P1|Overall Study|Protocol Violation|1
7644741|NCT01565707|26595674|P4|Overall Study|Lost to Follow-up|0
7644742|NCT01565707|26595675|P3|Overall Study|Lost to Follow-up|0
7644743|NCT01565707|26595676|P2|Overall Study|Lost to Follow-up|0
7644744|NCT01565707|26595677|P1|Overall Study|Lost to Follow-up|1
7644745|NCT01565707|26595674|P4|Overall Study|Adverse Event|1
7644746|NCT01565707|26595675|P3|Overall Study|Adverse Event|2
7644747|NCT01565707|26595676|P2|Overall Study|Adverse Event|6
7644748|NCT01565707|26595677|P1|Overall Study|Adverse Event|1
7644749|NCT01565694|26595768|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
7644750|NCT01565694|26595768|P1|Dose-Titration Period|Protocol Violation|10
7644751|NCT01565694|26595768|P1|Dose-Titration Period|Adverse Event|4
7644752|NCT01565668|26595789|P2|Overall Study|HSCT Transplant|15
7644753|NCT01565668|26595790|P1|Overall Study|HSCT Transplant|11
7644754|NCT01565668|26595789|P2|Overall Study|Withdrawal by Subject|3
7644755|NCT01565668|26595790|P1|Overall Study|Withdrawal by Subject|1
7644756|NCT01565668|26595789|P2|Overall Study|Progressive disease|14
7644757|NCT01565668|26595790|P1|Overall Study|Progressive disease|13
7644758|NCT01565668|26595789|P2|Overall Study|Randomized, but never received drug|2
7644759|NCT01565668|26595790|P1|Overall Study|Randomized, but never received drug|0
7644760|NCT01565668|26595789|P2|Overall Study|Adverse Event|1
7644761|NCT01565668|26595790|P1|Overall Study|Adverse Event|6
7644762|NCT01565668|26595789|P2|Overall Study|Participant went on Hospice Care|0
7644763|NCT01565668|26595790|P1|Overall Study|Participant went on Hospice Care|1
7644764|NCT01565668|26595789|P2|Overall Study|Lack of Efficacy|2
7644765|NCT01565668|26595790|P1|Overall Study|Lack of Efficacy|4
7644766|NCT01565668|26595789|P2|Overall Study|Death|1
7644767|NCT01565668|26595790|P1|Overall Study|Death|2
7644768|NCT01565642|26595814|P2|Overall Study|Withdrawal by Subject|1
7644769|NCT01565642|26595815|P1|Overall Study|Withdrawal by Subject|2
7644770|NCT01565564|26595850|P2|Overall Study|Lost to Follow-up|1
7644771|NCT01565564|26595851|P1|Overall Study|Lost to Follow-up|5
7644772|NCT01565499|26595881|P1|Overall Study|Withdrawal by Subject|2
7644773|NCT01565499|26595881|P1|Overall Study|Adverse Event|5
7644774|NCT01565499|26595881|P1|Overall Study|Physician Decision|1
7644775|NCT01565343|26595915|P3|Overall Study|Administrative decision/technical issues|0
7644776|NCT01565343|26595916|P2|Overall Study|Administrative decision/technical issues|0
7644777|NCT01565343|26595917|P1|Overall Study|Administrative decision/technical issues|1
7644778|NCT01565291|26595947|P2|Overall Study|Withdrawal by Subject|0
7644779|NCT01565291|26595948|P1|Overall Study|Withdrawal by Subject|1
7644780|NCT01565148|26595960|P4|Overall Study|Physician Decision|0
7644781|NCT01565148|26595961|P3|Overall Study|Physician Decision|0
7644782|NCT01565148|26595962|P2|Overall Study|Physician Decision|5
7644783|NCT01565148|26595963|P1|Overall Study|Physician Decision|2
7644784|NCT01565148|26595960|P4|Overall Study|Death|0
7644785|NCT01565148|26595961|P3|Overall Study|Death|1
7644786|NCT01565148|26595962|P2|Overall Study|Death|0
7644787|NCT01565148|26595963|P1|Overall Study|Death|0
7644788|NCT01565148|26595960|P4|Overall Study|Rescue Therapy|8
7644789|NCT01565148|26595961|P3|Overall Study|Rescue Therapy|5
7644790|NCT01565148|26595962|P2|Overall Study|Rescue Therapy|5
7644791|NCT01565148|26595963|P1|Overall Study|Rescue Therapy|8
7644792|NCT01565148|26595960|P4|Overall Study|Lost to Follow-up|3
7644793|NCT01565148|26595961|P3|Overall Study|Lost to Follow-up|0
7644794|NCT01565148|26595962|P2|Overall Study|Lost to Follow-up|4
7644795|NCT01565148|26595963|P1|Overall Study|Lost to Follow-up|4
7644796|NCT01565148|26595960|P4|Overall Study|Withdrawal by Subject|2
7644797|NCT01565148|26595961|P3|Overall Study|Withdrawal by Subject|1
7644798|NCT01565148|26595962|P2|Overall Study|Withdrawal by Subject|1
7644799|NCT01565148|26595963|P1|Overall Study|Withdrawal by Subject|1
7644800|NCT01565083|26595999|P2|Overall Study|Other|5
7644801|NCT01565083|26596000|P1|Overall Study|Other|3
7644802|NCT01565083|26595999|P2|Overall Study|Death|23
7644803|NCT01565083|26596000|P1|Overall Study|Death|22
7644804|NCT01565083|26595999|P2|Overall Study|Lost to Follow-up|7
7644805|NCT01565083|26596000|P1|Overall Study|Lost to Follow-up|2
7644806|NCT01565083|26595999|P2|Overall Study|Withdrawal by Subject|4
7644807|NCT01565083|26596000|P1|Overall Study|Withdrawal by Subject|6
7644808|NCT01564862|26596051|P3|Overall Study|Other reason(s)|0
7644809|NCT01564862|26596052|P2|Overall Study|Other reason(s)|0
7644810|NCT01564862|26596053|P1|Overall Study|Other reason(s)|1
7644811|NCT01564862|26596051|P3|Overall Study|Lack of Efficacy|6
7644812|NCT01564862|26596052|P2|Overall Study|Lack of Efficacy|5
7644813|NCT01564862|26596053|P1|Overall Study|Lack of Efficacy|1
7644814|NCT01564862|26596051|P3|Overall Study|Voluntary Withdrawal|8
7644815|NCT01564862|26596052|P2|Overall Study|Voluntary Withdrawal|6
7644816|NCT01564862|26596053|P1|Overall Study|Voluntary Withdrawal|9
7644817|NCT01564862|26596051|P3|Overall Study|Lost to Follow-up|6
7644818|NCT01564862|26596052|P2|Overall Study|Lost to Follow-up|8
7644819|NCT01564862|26596053|P1|Overall Study|Lost to Follow-up|10
7644820|NCT01564862|26596051|P3|Overall Study|Major Protocol Deviation|4
7644821|NCT01564862|26596052|P2|Overall Study|Major Protocol Deviation|3
7644822|NCT01564862|26596053|P1|Overall Study|Major Protocol Deviation|3
7644823|NCT01564862|26596051|P3|Overall Study|Pretreatment Event or Adverse Event|6
7644824|NCT01564862|26596052|P2|Overall Study|Pretreatment Event or Adverse Event|12
7644825|NCT01564862|26596053|P1|Overall Study|Pretreatment Event or Adverse Event|6
7644826|NCT01564784|26596104|P2|Overall Study|Death|126
7644827|NCT01564784|26596105|P1|Overall Study|Death|131
7644828|NCT01564784|26596104|P2|Overall Study|Lost to Follow-up|1
7644829|NCT01564784|26596105|P1|Overall Study|Lost to Follow-up|1
7644830|NCT01564784|26596104|P2|Overall Study|Subject refused further follow-up|6
7644831|NCT01564784|26596105|P1|Overall Study|Subject refused further follow-up|1
7644832|NCT01564784|26596104|P2|Overall Study|Other|0
7644833|NCT01564784|26596105|P1|Overall Study|Other|1
7644834|NCT01564758|26596132|P1|Overall Study|Other|3
7644835|NCT01564758|26596132|P1|Overall Study|Adverse Event|3
7644836|NCT01564758|26596132|P1|Overall Study|Death|8
7644837|NCT01564732|26596139|P2|Overall Study|Early termination by the study sponsor|5
7644838|NCT01564732|26596140|P1|Overall Study|Early termination by the study sponsor|6
7644839|NCT01564537|26596188|P2|Overall Study|Other Miscellaneous Reasons|2
7644840|NCT01564537|26596189|P1|Overall Study|Other Miscellaneous Reasons|1
7644841|NCT01564537|26596188|P2|Overall Study|Lost to Follow-up|0
7644842|NCT01564537|26596189|P1|Overall Study|Lost to Follow-up|1
7644843|NCT01564537|26596188|P2|Overall Study|Withdrawal by Participant|4
7644844|NCT01564537|26596189|P1|Overall Study|Withdrawal by Participant|4
7644845|NCT01564459|26596221|P3|Double-blind Treatment|Adverse Event|1
7644846|NCT01564459|26596222|P2|Double-blind Treatment|Adverse Event|0
7644847|NCT01564459|26596223|P1|Double-blind Treatment|Adverse Event|0
7644848|NCT01564459|26596221|P3|Run-In|Withdrawal by Subject|0
7644849|NCT01564459|26596222|P2|Run-In|Withdrawal by Subject|0
7644850|NCT01564459|26596223|P1|Run-In|Withdrawal by Subject|1
7644851|NCT01564459|26596221|P3|Run-In|Protocol Violation|0
7644852|NCT01564459|26596222|P2|Run-In|Protocol Violation|0
7644853|NCT01564459|26596223|P1|Run-In|Protocol Violation|1
7644854|NCT01564459|26596221|P3|Run-In|Non-compliance with study drug|0
7644855|NCT01564459|26596222|P2|Run-In|Non-compliance with study drug|0
7644856|NCT01564459|26596223|P1|Run-In|Non-compliance with study drug|2
7644857|NCT01564459|26596221|P3|Run-In|Lost to Follow-up|0
7644858|NCT01564459|26596222|P2|Run-In|Lost to Follow-up|0
7644859|NCT01564459|26596223|P1|Run-In|Lost to Follow-up|1
7644860|NCT01564459|26596221|P3|Run-In|Adverse Event|0
7644861|NCT01564459|26596222|P2|Run-In|Adverse Event|0
7644862|NCT01564459|26596223|P1|Run-In|Adverse Event|7
7644863|NCT01564407|26596247|P5|Overall Study|funding lost, study ended|0
7644864|NCT01564407|26596248|P4|Overall Study|funding lost, study ended|1
7644865|NCT01564407|26596249|P3|Overall Study|funding lost, study ended|0
7644866|NCT01564407|26596250|P2|Overall Study|funding lost, study ended|0
7644867|NCT01564407|26596251|P1|Overall Study|funding lost, study ended|0
7644868|NCT01564407|26596247|P5|Overall Study|Withdrawal by Subject|0
7644869|NCT01564407|26596248|P4|Overall Study|Withdrawal by Subject|0
7644870|NCT01564407|26596249|P3|Overall Study|Withdrawal by Subject|0
7644871|NCT01564407|26596250|P2|Overall Study|Withdrawal by Subject|1
7644872|NCT01564407|26596251|P1|Overall Study|Withdrawal by Subject|0
7644873|NCT01564407|26596247|P5|Overall Study|Lost to Follow-up|0
7644874|NCT01564407|26596248|P4|Overall Study|Lost to Follow-up|0
7644875|NCT01564407|26596249|P3|Overall Study|Lost to Follow-up|0
7644876|NCT01564407|26596250|P2|Overall Study|Lost to Follow-up|1
7644877|NCT01564407|26596251|P1|Overall Study|Lost to Follow-up|0
7644878|NCT01564394|26596292|P2|Overall Study|Withdrawal by Subject|10
7644879|NCT01564394|26596293|P1|Overall Study|Withdrawal by Subject|6
7644880|NCT01564277|26596307|P2|Overall Study|Physician Decision|0
7644881|NCT01564277|26596308|P1|Overall Study|Physician Decision|1
7644882|NCT01564277|26596307|P2|Overall Study|Protocol Violation|1
7644883|NCT01564277|26596308|P1|Overall Study|Protocol Violation|0
7644884|NCT01563978|26596326|P2|Overall Study|Adverse Event|2
7644885|NCT01563978|26596327|P1|Overall Study|Adverse Event|1
7644886|NCT01563978|26596326|P2|Overall Study|Dev. of study specific discont. criteria|0
7644887|NCT01563978|26596327|P1|Overall Study|Dev. of study specific discont. criteria|1
7644888|NCT01563978|26596326|P2|Overall Study|Lost to Follow-up|0
7644889|NCT01563978|26596327|P1|Overall Study|Lost to Follow-up|1
7644890|NCT01563978|26596326|P2|Overall Study|Physician Decision|0
7644891|NCT01563978|26596327|P1|Overall Study|Physician Decision|1
7644892|NCT01563913|26596353|P2|Overall Study|Spouse Passed Away|0
7644893|NCT01563913|26596354|P1|Overall Study|Spouse Passed Away|1
7644894|NCT01563913|26596353|P2|Overall Study|Physician Decision|0
7644895|NCT01563913|26596354|P1|Overall Study|Physician Decision|1
7644896|NCT01563536|26596366|P2|Overall Study|Lost to Follow-up|0
7644897|NCT01563536|26596367|P1|Overall Study|Lost to Follow-up|1
7644898|NCT01563536|26596366|P2|Overall Study|Withdrawal by Subject|2
7644899|NCT01563536|26596367|P1|Overall Study|Withdrawal by Subject|0
7644900|NCT01563354|26596423|P3|Extension Phase|Disease progression|10
7644901|NCT01563354|26596424|P2|Extension Phase|Disease progression|8
7644902|NCT01563354|26596425|P1|Extension Phase|Disease progression|9
7644903|NCT01563354|26596423|P3|Extension Phase|Administration problems|3
7644904|NCT01563354|26596424|P2|Extension Phase|Administration problems|2
7644905|NCT01563354|26596425|P1|Extension Phase|Administration problems|3
7644906|NCT01563354|26596423|P3|Extension Phase|Withdrawal by Subject|0
7644907|NCT01563354|26596424|P2|Extension Phase|Withdrawal by Subject|1
7644908|NCT01563354|26596425|P1|Extension Phase|Withdrawal by Subject|0
7644909|NCT01563354|26596423|P3|Extension Phase|Adverse Event|2
7644910|NCT01563354|26596424|P2|Extension Phase|Adverse Event|3
7644911|NCT01563354|26596425|P1|Extension Phase|Adverse Event|0
7644912|NCT01563354|26596423|P3|Core Phase|Worsening of clinical condition - did not enter extension|0
7644913|NCT01563354|26596424|P2|Core Phase|Worsening of clinical condition - did not enter extension|0
7644914|NCT01563354|26596425|P1|Core Phase|Worsening of clinical condition - did not enter extension|1
7644915|NCT01563354|26596423|P3|Core Phase|PI decision - did not enter extension|0
7644916|NCT01563354|26596424|P2|Core Phase|PI decision - did not enter extension|1
7644917|NCT01563354|26596425|P1|Core Phase|PI decision - did not enter extension|0
7644918|NCT01563354|26596423|P3|Core Phase|Protocol deviation|0
7644919|NCT01563354|26596424|P2|Core Phase|Protocol deviation|0
7644920|NCT01563354|26596425|P1|Core Phase|Protocol deviation|2
7644921|NCT01563354|26596423|P3|Core Phase|Diseasse progression|8
7644922|NCT01563354|26596424|P2|Core Phase|Diseasse progression|7
7644923|NCT01563354|26596425|P1|Core Phase|Diseasse progression|18
7644924|NCT01563354|26596423|P3|Core Phase|Death|2
7644925|NCT01563354|26596424|P2|Core Phase|Death|5
7644926|NCT01563354|26596425|P1|Core Phase|Death|1
7644927|NCT01563354|26596423|P3|Core Phase|Lost to Follow-up|0
7644928|NCT01563354|26596424|P2|Core Phase|Lost to Follow-up|0
7644929|NCT01563354|26596425|P1|Core Phase|Lost to Follow-up|1
7644930|NCT01563354|26596423|P3|Core Phase|Withdrawal by Subject|3
7644931|NCT01563354|26596424|P2|Core Phase|Withdrawal by Subject|0
7644932|NCT01563354|26596425|P1|Core Phase|Withdrawal by Subject|1
7644933|NCT01563354|26596423|P3|Core Phase|Adverse Event|13
7644934|NCT01563354|26596424|P2|Core Phase|Adverse Event|15
7644935|NCT01563354|26596425|P1|Core Phase|Adverse Event|5
7644936|NCT01563237|26596466|P2|Overall Study|Death|0
7644937|NCT01563237|26596467|P1|Overall Study|Death|1
7644938|NCT01563237|26596466|P2|Overall Study|Medical Reasons|0
7644939|NCT01563237|26596467|P1|Overall Study|Medical Reasons|1
7644940|NCT01563237|26596466|P2|Overall Study|Adverse Event|0
7644941|NCT01563237|26596467|P1|Overall Study|Adverse Event|1
7644942|NCT01563237|26596466|P2|Overall Study|Withdrawal by Subject|0
7644943|NCT01563237|26596467|P1|Overall Study|Withdrawal by Subject|1
7644944|NCT01563237|26596466|P2|Overall Study|Lost to Follow-up|0
7644945|NCT01563237|26596467|P1|Overall Study|Lost to Follow-up|6
7644946|NCT01563185|26596478|P1|Overall Study|Non-Compliance with study drug|1
7644947|NCT01563185|26596478|P1|Overall Study|Withdrawal by Subject|1
7644948|NCT01563172|26596492|P1|Overall Study|Other (Not specified)|1
7644949|NCT01563172|26596492|P1|Overall Study|Other (Protocol deviation)|5
7644950|NCT01563172|26596492|P1|Overall Study|Lost to Follow-up|2
7644951|NCT01563172|26596492|P1|Overall Study|Adverse Event|5
7644952|NCT01563029|26596598|P5|Overall Study|Withdrawal by Subject|3
7644953|NCT01563029|26596599|P4|Overall Study|Withdrawal by Subject|4
7644954|NCT01563029|26596600|P3|Overall Study|Withdrawal by Subject|3
7644955|NCT01563029|26596601|P2|Overall Study|Withdrawal by Subject|1
7644956|NCT01563029|26596602|P1|Overall Study|Withdrawal by Subject|4
7644957|NCT01563029|26596598|P5|Overall Study|Physician Decision|2
7644958|NCT01563029|26596599|P4|Overall Study|Physician Decision|4
7644959|NCT01563029|26596600|P3|Overall Study|Physician Decision|2
7644960|NCT01563029|26596601|P2|Overall Study|Physician Decision|5
7644961|NCT01563029|26596602|P1|Overall Study|Physician Decision|3
7644962|NCT01563029|26596598|P5|Overall Study|Lost to Follow-up|1
7644963|NCT01563029|26596599|P4|Overall Study|Lost to Follow-up|1
7644964|NCT01563029|26596600|P3|Overall Study|Lost to Follow-up|1
7644965|NCT01563029|26596601|P2|Overall Study|Lost to Follow-up|0
7644966|NCT01563029|26596602|P1|Overall Study|Lost to Follow-up|1
7644967|NCT01563029|26596598|P5|Overall Study|Protocol defined stopping criteria|0
7644968|NCT01563029|26596599|P4|Overall Study|Protocol defined stopping criteria|0
7644969|NCT01563029|26596600|P3|Overall Study|Protocol defined stopping criteria|0
7644970|NCT01563029|26596601|P2|Overall Study|Protocol defined stopping criteria|0
7644971|NCT01563029|26596602|P1|Overall Study|Protocol defined stopping criteria|1
7644972|NCT01563029|26596598|P5|Overall Study|Protocol Violation|3
7644973|NCT01563029|26596599|P4|Overall Study|Protocol Violation|1
7644974|NCT01563029|26596600|P3|Overall Study|Protocol Violation|3
7644975|NCT01563029|26596601|P2|Overall Study|Protocol Violation|2
7644976|NCT01563029|26596602|P1|Overall Study|Protocol Violation|1
7644977|NCT01563029|26596598|P5|Overall Study|Lack of Efficacy|19
7644978|NCT01563029|26596599|P4|Overall Study|Lack of Efficacy|21
7644979|NCT01563029|26596600|P3|Overall Study|Lack of Efficacy|23
7644980|NCT01563029|26596601|P2|Overall Study|Lack of Efficacy|16
7644981|NCT01563029|26596602|P1|Overall Study|Lack of Efficacy|42
7644982|NCT01563029|26596598|P5|Overall Study|Adverse Event|1
7644983|NCT01563029|26596599|P4|Overall Study|Adverse Event|2
7644984|NCT01563029|26596600|P3|Overall Study|Adverse Event|1
7644985|NCT01563029|26596601|P2|Overall Study|Adverse Event|0
7644986|NCT01563029|26596602|P1|Overall Study|Adverse Event|1
7644987|NCT01562873|26596668|P2|Overall Study|Clinical PD and adverse event|0
7644988|NCT01562873|26596669|P1|Overall Study|Clinical PD and adverse event|1
7644989|NCT01562873|26596668|P2|Overall Study|Clinical Disease Progression|0
7644990|NCT01562873|26596669|P1|Overall Study|Clinical Disease Progression|9
7644991|NCT01562873|26596668|P2|Overall Study|Adverse Event|0
7644992|NCT01562873|26596669|P1|Overall Study|Adverse Event|1
7644993|NCT01562873|26596668|P2|Overall Study|Disease Progression per RECIST|0
7644994|NCT01562873|26596669|P1|Overall Study|Disease Progression per RECIST|10
7644995|NCT01562782|26596678|P2|Overall Study|screen failure|2
7644996|NCT01562782|26596679|P1|Overall Study|screen failure|1
7644997|NCT01562782|26596678|P2|Overall Study|Withdrawal by Subject|3
7644998|NCT01562782|26596679|P1|Overall Study|Withdrawal by Subject|3
7644999|NCT01562743|26596708|P1|Overall Study|Physician Decision|2
7645000|NCT01562743|26596708|P1|Overall Study|Lost to Follow-up|2
7645001|NCT01562743|26596708|P1|Overall Study|Discontinuation criteria|2
7645002|NCT01562743|26596708|P1|Overall Study|Protocol Violation|1
7645003|NCT01562743|26596708|P1|Overall Study|Withdrawal by Subject|13
7645004|NCT01562743|26596708|P1|Overall Study|Lack of Efficacy|3
7645005|NCT01562743|26596708|P1|Overall Study|Adverse Event|29
7645006|NCT01562613|26596727|P1|Overall Study|Withdrawal by Subject|2
7645007|NCT01562613|26596727|P1|Overall Study|Lost to Follow-up|2
7645008|NCT01562548|26596737|P4|Overall Study|Lost to Follow-up|0
7645009|NCT01562548|26596738|P3|Overall Study|Lost to Follow-up|1
7645010|NCT01562548|26596739|P2|Overall Study|Lost to Follow-up|0
7645011|NCT01562548|26596740|P1|Overall Study|Lost to Follow-up|0
7645012|NCT01562444|26596793|P3|Overall Study|Protocol forbidden medication|0
7645013|NCT01562444|26596794|P2|Overall Study|Protocol forbidden medication|0
7645014|NCT01562444|26596795|P1|Overall Study|Protocol forbidden medication|1
7645015|NCT01562444|26596793|P3|Overall Study|Protocol forbidden concomitant vaccine|1
7645016|NCT01562444|26596794|P2|Overall Study|Protocol forbidden concomitant vaccine|0
7645017|NCT01562444|26596795|P1|Overall Study|Protocol forbidden concomitant vaccine|1
7645018|NCT01562444|26596793|P3|Overall Study|Unavailable serological results|2
7645019|NCT01562444|26596794|P2|Overall Study|Unavailable serological results|2
7645020|NCT01562444|26596795|P1|Overall Study|Unavailable serological results|0
7645021|NCT01562444|26596793|P3|Overall Study|Did not comply with blood draw schedule|1
7645022|NCT01562444|26596794|P2|Overall Study|Did not comply with blood draw schedule|0
7645023|NCT01562444|26596795|P1|Overall Study|Did not comply with blood draw schedule|1
7645024|NCT01562444|26596793|P3|Overall Study|Did not meet entry criteria|3
7645025|NCT01562444|26596794|P2|Overall Study|Did not meet entry criteria|0
7645026|NCT01562444|26596795|P1|Overall Study|Did not meet entry criteria|2
7645027|NCT01562327|26597061|P1|Overall Study|Infusion not received at 6 month window|4
7645028|NCT01562327|26597061|P1|Overall Study|Participant drop-out|1
7645029|NCT01562327|26597061|P1|Overall Study|Lack of Efficacy|1
7645030|NCT01562327|26597061|P1|Overall Study|Adverse Event|2
7645031|NCT01562314|26597091|P2|Overall Study|Withdrawal by Subject|1
7645032|NCT01562314|26597092|P1|Overall Study|Withdrawal by Subject|0
7645033|NCT01562314|26597091|P2|Overall Study|Met Withdrawal Criteria|2
7645034|NCT01562314|26597092|P1|Overall Study|Met Withdrawal Criteria|3
7645035|NCT01562314|26597091|P2|Overall Study|Adverse Event|5
7645036|NCT01562314|26597092|P1|Overall Study|Adverse Event|10
7645037|NCT01562275|26597149|P13|Stage 2|Progression of Disease|4
7645038|NCT01562275|26597150|P12|Stage 2|Progression of Disease|12
7645039|NCT01562275|26597151|P11|Stage 2|Progression of Disease|0
7645040|NCT01562275|26597152|P10|Stage 2|Progression of Disease|0
7645041|NCT01562275|26597153|P9|Stage 2|Progression of Disease|0
7645042|NCT01562275|26597154|P8|Stage 2|Progression of Disease|0
7645043|NCT01562275|26597155|P7|Stage 2|Progression of Disease|0
7645044|NCT01562275|26597156|P6|Stage 2|Progression of Disease|0
7645045|NCT01562275|26597157|P5|Stage 2|Progression of Disease|0
7645046|NCT01562275|26597158|P4|Stage 2|Progression of Disease|0
7645047|NCT01562275|26597159|P3|Stage 2|Progression of Disease|0
7645048|NCT01562275|26597160|P2|Stage 2|Progression of Disease|0
7645049|NCT01562275|26597161|P1|Stage 2|Progression of Disease|0
7645050|NCT01562275|26597149|P13|Stage 2|Death|1
7645051|NCT01562275|26597150|P12|Stage 2|Death|2
7645052|NCT01562275|26597151|P11|Stage 2|Death|0
7645053|NCT01562275|26597152|P10|Stage 2|Death|0
7645054|NCT01562275|26597153|P9|Stage 2|Death|0
7645055|NCT01562275|26597154|P8|Stage 2|Death|0
7645056|NCT01562275|26597155|P7|Stage 2|Death|0
7645057|NCT01562275|26597156|P6|Stage 2|Death|0
7645058|NCT01562275|26597157|P5|Stage 2|Death|0
7645059|NCT01562275|26597158|P4|Stage 2|Death|0
7645060|NCT01562275|26597159|P3|Stage 2|Death|0
7645061|NCT01562275|26597160|P2|Stage 2|Death|0
7645062|NCT01562275|26597161|P1|Stage 2|Death|0
7645063|NCT01562275|26597149|P13|Stage 1|Withdrawal by Subject|0
7645064|NCT01562275|26597150|P12|Stage 1|Withdrawal by Subject|0
7645065|NCT01562275|26597151|P11|Stage 1|Withdrawal by Subject|0
7645066|NCT01562275|26597152|P10|Stage 1|Withdrawal by Subject|1
7645067|NCT01562275|26597153|P9|Stage 1|Withdrawal by Subject|0
7645068|NCT01562275|26597154|P8|Stage 1|Withdrawal by Subject|0
7645069|NCT01562275|26597155|P7|Stage 1|Withdrawal by Subject|1
7645070|NCT01562275|26597156|P6|Stage 1|Withdrawal by Subject|0
7645071|NCT01562275|26597157|P5|Stage 1|Withdrawal by Subject|0
7645072|NCT01562275|26597158|P4|Stage 1|Withdrawal by Subject|2
7645073|NCT01562275|26597159|P3|Stage 1|Withdrawal by Subject|0
7645074|NCT01562275|26597160|P2|Stage 1|Withdrawal by Subject|1
7645075|NCT01562275|26597161|P1|Stage 1|Withdrawal by Subject|0
7645076|NCT01562275|26597149|P13|Stage 1|Progression of Disease|0
7645077|NCT01562275|26597150|P12|Stage 1|Progression of Disease|0
7645078|NCT01562275|26597151|P11|Stage 1|Progression of Disease|3
7645079|NCT01562275|26597152|P10|Stage 1|Progression of Disease|5
7645080|NCT01562275|26597153|P9|Stage 1|Progression of Disease|2
7645081|NCT01562275|26597154|P8|Stage 1|Progression of Disease|7
7645082|NCT01562275|26597155|P7|Stage 1|Progression of Disease|1
7645083|NCT01562275|26597156|P6|Stage 1|Progression of Disease|4
7645084|NCT01562275|26597157|P5|Stage 1|Progression of Disease|2
7645085|NCT01562275|26597158|P4|Stage 1|Progression of Disease|1
7645086|NCT01562275|26597159|P3|Stage 1|Progression of Disease|2
7645087|NCT01562275|26597160|P2|Stage 1|Progression of Disease|6
7645088|NCT01562275|26597161|P1|Stage 1|Progression of Disease|2
7645089|NCT01562275|26597149|P13|Stage 1|Physician Decision|0
7645090|NCT01562275|26597150|P12|Stage 1|Physician Decision|0
7645091|NCT01562275|26597151|P11|Stage 1|Physician Decision|0
7645092|NCT01562275|26597152|P10|Stage 1|Physician Decision|0
7645093|NCT01562275|26597153|P9|Stage 1|Physician Decision|1
7645094|NCT01562275|26597154|P8|Stage 1|Physician Decision|0
7645095|NCT01562275|26597155|P7|Stage 1|Physician Decision|1
7645096|NCT01562275|26597156|P6|Stage 1|Physician Decision|0
7645097|NCT01562275|26597157|P5|Stage 1|Physician Decision|1
7645098|NCT01562275|26597158|P4|Stage 1|Physician Decision|0
7645099|NCT01562275|26597159|P3|Stage 1|Physician Decision|0
7645100|NCT01562275|26597160|P2|Stage 1|Physician Decision|0
7645101|NCT01562275|26597161|P1|Stage 1|Physician Decision|0
7645102|NCT01562275|26597149|P13|Stage 1|Non Compliance|0
7645103|NCT01562275|26597150|P12|Stage 1|Non Compliance|0
7645104|NCT01562275|26597151|P11|Stage 1|Non Compliance|0
7645105|NCT01562275|26597152|P10|Stage 1|Non Compliance|0
7645106|NCT01562275|26597153|P9|Stage 1|Non Compliance|0
7645107|NCT01562275|26597154|P8|Stage 1|Non Compliance|0
7645108|NCT01562275|26597155|P7|Stage 1|Non Compliance|0
7645109|NCT01562275|26597156|P6|Stage 1|Non Compliance|0
7645110|NCT01562275|26597157|P5|Stage 1|Non Compliance|0
7645111|NCT01562275|26597158|P4|Stage 1|Non Compliance|0
7645112|NCT01562275|26597159|P3|Stage 1|Non Compliance|1
7645113|NCT01562275|26597160|P2|Stage 1|Non Compliance|0
7645114|NCT01562275|26597161|P1|Stage 1|Non Compliance|0
7645115|NCT01562275|26597149|P13|Stage 1|Death|0
7645116|NCT01562275|26597150|P12|Stage 1|Death|0
7645117|NCT01562275|26597151|P11|Stage 1|Death|0
7645118|NCT01562275|26597152|P10|Stage 1|Death|0
7645119|NCT01562275|26597153|P9|Stage 1|Death|0
7645120|NCT01562275|26597154|P8|Stage 1|Death|0
7645121|NCT01562275|26597155|P7|Stage 1|Death|0
7645122|NCT01562275|26597156|P6|Stage 1|Death|0
7645123|NCT01562275|26597157|P5|Stage 1|Death|0
7645124|NCT01562275|26597158|P4|Stage 1|Death|0
7645125|NCT01562275|26597159|P3|Stage 1|Death|0
7645126|NCT01562275|26597160|P2|Stage 1|Death|0
7645127|NCT01562275|26597161|P1|Stage 1|Death|1
7645128|NCT01562275|26597149|P13|Stage 1|Adverse Event|0
7645129|NCT01562275|26597150|P12|Stage 1|Adverse Event|0
7645130|NCT01562275|26597151|P11|Stage 1|Adverse Event|0
7645131|NCT01562275|26597152|P10|Stage 1|Adverse Event|1
7645132|NCT01562275|26597153|P9|Stage 1|Adverse Event|0
7645133|NCT01562275|26597154|P8|Stage 1|Adverse Event|0
7645134|NCT01562275|26597155|P7|Stage 1|Adverse Event|0
7645135|NCT01562275|26597156|P6|Stage 1|Adverse Event|0
7645136|NCT01562275|26597157|P5|Stage 1|Adverse Event|1
7645137|NCT01562275|26597158|P4|Stage 1|Adverse Event|1
7645138|NCT01562275|26597159|P3|Stage 1|Adverse Event|0
7645139|NCT01562275|26597160|P2|Stage 1|Adverse Event|0
7645140|NCT01562275|26597161|P1|Stage 1|Adverse Event|0
7645141|NCT01562028|26597311|P2|Overall Study|Lost to Follow-up|1
7645142|NCT01562028|26597312|P1|Overall Study|Lost to Follow-up|2
7645143|NCT01562028|26597311|P2|Overall Study|Withdrawal by Subject|1
7645144|NCT01562028|26597312|P1|Overall Study|Withdrawal by Subject|1
7645145|NCT01561989|26597332|P2|Overall Study|accural target not met.|6
7645146|NCT01561989|26597333|P1|Overall Study|accural target not met.|5
7645147|NCT01561976|26597355|P6|Washout Period 2 (7 Days)|Non-compliance|0
7645148|NCT01561976|26597356|P5|Washout Period 2 (7 Days)|Non-compliance|0
7645149|NCT01561976|26597357|P4|Washout Period 2 (7 Days)|Non-compliance|0
7645150|NCT01561976|26597358|P3|Washout Period 2 (7 Days)|Non-compliance|1
7645151|NCT01561976|26597359|P2|Washout Period 2 (7 Days)|Non-compliance|0
7645152|NCT01561976|26597360|P1|Washout Period 2 (7 Days)|Non-compliance|1
7645153|NCT01561976|26597355|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7645154|NCT01561976|26597356|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7645155|NCT01561976|26597357|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7645156|NCT01561976|26597358|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7645157|NCT01561976|26597359|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7645158|NCT01561976|26597360|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7645159|NCT01561976|26597355|P6|Washout Period 1 (7 Days)|Adverse Event|0
7645160|NCT01561976|26597356|P5|Washout Period 1 (7 Days)|Adverse Event|0
7645161|NCT01561976|26597357|P4|Washout Period 1 (7 Days)|Adverse Event|1
7645162|NCT01561976|26597358|P3|Washout Period 1 (7 Days)|Adverse Event|0
7645163|NCT01561976|26597359|P2|Washout Period 1 (7 Days)|Adverse Event|0
7645164|NCT01561976|26597360|P1|Washout Period 1 (7 Days)|Adverse Event|0
7645165|NCT01561976|26597355|P6|Period 1|Adverse Event|0
7645166|NCT01561976|26597356|P5|Period 1|Adverse Event|0
7645167|NCT01561976|26597357|P4|Period 1|Adverse Event|0
7645168|NCT01561976|26597358|P3|Period 1|Adverse Event|1
7645169|NCT01561976|26597359|P2|Period 1|Adverse Event|0
7645170|NCT01561976|26597360|P1|Period 1|Adverse Event|0
7645171|NCT01561963|26597389|P1|Overall Study|Adverse Event|1
7645172|NCT01561898|26597420|P4|Overall Study|Physician Decision|1
7645173|NCT01561898|26597421|P3|Overall Study|Physician Decision|7
7645174|NCT01561898|26597422|P2|Overall Study|Physician Decision|5
7645175|NCT01561898|26597423|P1|Overall Study|Physician Decision|1
7645176|NCT01561898|26597420|P4|Overall Study|Adverse Event|9
7645177|NCT01561898|26597421|P3|Overall Study|Adverse Event|14
7645178|NCT01561898|26597422|P2|Overall Study|Adverse Event|19
7645179|NCT01561898|26597423|P1|Overall Study|Adverse Event|1
7645180|NCT01561898|26597420|P4|Overall Study|Lost to Follow-up|0
7645181|NCT01561898|26597421|P3|Overall Study|Lost to Follow-up|1
7645182|NCT01561898|26597422|P2|Overall Study|Lost to Follow-up|0
7645183|NCT01561898|26597423|P1|Overall Study|Lost to Follow-up|0
7645184|NCT01561898|26597420|P4|Overall Study|Worsening of complications|0
7645185|NCT01561898|26597421|P3|Overall Study|Worsening of complications|0
7645186|NCT01561898|26597422|P2|Overall Study|Worsening of complications|1
7645187|NCT01561898|26597423|P1|Overall Study|Worsening of complications|0
7645188|NCT01561898|26597420|P4|Overall Study|Lack of Efficacy|5
7645189|NCT01561898|26597421|P3|Overall Study|Lack of Efficacy|10
7645190|NCT01561898|26597422|P2|Overall Study|Lack of Efficacy|8
7645191|NCT01561898|26597423|P1|Overall Study|Lack of Efficacy|0
7645192|NCT01561898|26597420|P4|Overall Study|Withdrawal by Subject|5
7645193|NCT01561898|26597421|P3|Overall Study|Withdrawal by Subject|12
7645194|NCT01561898|26597422|P2|Overall Study|Withdrawal by Subject|8
7645195|NCT01561898|26597423|P1|Overall Study|Withdrawal by Subject|0
7645196|NCT01561755|26597441|P2|Overall Study|Lost to Follow-up|1
7645197|NCT01561755|26597442|P1|Overall Study|Lost to Follow-up|0
7645198|NCT01561560|26597494|P2|Second Two Weeks of Wear|Adverse Event|1
7645199|NCT01561560|26597495|P1|Second Two Weeks of Wear|Adverse Event|0
7645200|NCT01561560|26597494|P2|First Two Weeks of Wear|Adverse Event|1
7645201|NCT01561560|26597495|P1|First Two Weeks of Wear|Adverse Event|0
7645202|NCT01561560|26597494|P2|First Two Weeks of Wear|Time/job conflict|1
7645203|NCT01561560|26597495|P1|First Two Weeks of Wear|Time/job conflict|0
7645204|NCT01561430|26597530|P4|Overall Study|Sponsor Decision|12
7645205|NCT01561430|26597531|P3|Overall Study|Sponsor Decision|13
7645206|NCT01561430|26597532|P2|Overall Study|Sponsor Decision|14
7645207|NCT01561430|26597533|P1|Overall Study|Sponsor Decision|1
7645208|NCT01561430|26597530|P4|Overall Study|Physician Decision|0
7645209|NCT01561430|26597531|P3|Overall Study|Physician Decision|0
7645210|NCT01561430|26597532|P2|Overall Study|Physician Decision|1
7645211|NCT01561430|26597533|P1|Overall Study|Physician Decision|0
7645212|NCT01561430|26597530|P4|Overall Study|Withdrawal by Subject|0
7645213|NCT01561430|26597531|P3|Overall Study|Withdrawal by Subject|1
7645214|NCT01561430|26597532|P2|Overall Study|Withdrawal by Subject|0
7645215|NCT01561430|26597533|P1|Overall Study|Withdrawal by Subject|0
7645216|NCT01561430|26597530|P4|Overall Study|Adverse Event|1
7645217|NCT01561430|26597531|P3|Overall Study|Adverse Event|3
7645218|NCT01561430|26597532|P2|Overall Study|Adverse Event|0
7645219|NCT01561430|26597533|P1|Overall Study|Adverse Event|0
7645220|NCT01561313|26597596|P2|Overall Study|Adverse event and withdrawal by subject|0
7645221|NCT01561313|26597597|P1|Overall Study|Adverse event and withdrawal by subject|1
7645222|NCT01561313|26597596|P2|Overall Study|Withdrawal by Subject|0
7645223|NCT01561313|26597597|P1|Overall Study|Withdrawal by Subject|1
7645224|NCT01561300|26597615|P2|Run in on Placebo|Adverse Event|0
7645225|NCT01561300|26597616|P1|Run in on Placebo|Adverse Event|1
7645226|NCT01561079|26597627|P1|Overall Study|Protocol Violation|2
7645227|NCT01561079|26597627|P1|Overall Study|Withdrawal by Subject|59
7645228|NCT01561079|26597627|P1|Overall Study|Physician Decision|17
7645229|NCT01560988|26597713|P2|Washout (Six Weeks)|Lost to Follow-up|2
7645230|NCT01560988|26597714|P1|Washout (Six Weeks)|Lost to Follow-up|2
7645231|NCT01560988|26597713|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
7645232|NCT01560988|26597714|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
7645233|NCT01560988|26597713|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
7645234|NCT01560988|26597714|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
7645235|NCT01560949|26597750|P1|Surgery Phase|Physician Decision|3
7645236|NCT01560949|26597750|P1|Systemic Phase: mFOLFIRINOX|Adverse Event|6
7645237|NCT01560871|26597784|P2|Overall Study|Lost to Follow-up|0
7645238|NCT01560871|26597785|P1|Overall Study|Lost to Follow-up|1
7645239|NCT01560871|26597784|P2|Overall Study|readmission to a hospital|1
7645240|NCT01560871|26597785|P1|Overall Study|readmission to a hospital|2
7645241|NCT01560871|26597784|P2|Overall Study|relocation|0
7645242|NCT01560871|26597785|P1|Overall Study|relocation|1
7645243|NCT01560871|26597784|P2|Overall Study|transportation issues|1
7645244|NCT01560871|26597785|P1|Overall Study|transportation issues|2
7645245|NCT01560819|26597801|P2|Overall Study|Physician Decision|0
7645246|NCT01560819|26597802|P1|Overall Study|Physician Decision|1
7645247|NCT01560780|26597808|P2|Overall Study|Patient Preference|11
7645248|NCT01560780|26597809|P1|Overall Study|Patient Preference|11
7645249|NCT01560780|26597808|P2|Overall Study|Death|1
7645250|NCT01560780|26597809|P1|Overall Study|Death|2
7645251|NCT01560507|26597845|P3|Overall Study|Withdrawal by Subject|0
7645252|NCT01560507|26597846|P2|Overall Study|Withdrawal by Subject|1
7645253|NCT01560507|26597847|P1|Overall Study|Withdrawal by Subject|1
7645254|NCT01560507|26597845|P3|Overall Study|Lost to Follow-up|2
7645255|NCT01560507|26597846|P2|Overall Study|Lost to Follow-up|1
7645256|NCT01560507|26597847|P1|Overall Study|Lost to Follow-up|3
7645257|NCT01560429|26597860|P2|Overall Study|Protocol Violation|6
7645258|NCT01560429|26597861|P1|Overall Study|Protocol Violation|3
7645259|NCT01560416|26597871|P2|Randomized Phase|Crossover Participants|0
7645260|NCT01560416|26597872|P1|Randomized Phase|Crossover Participants|7
7645261|NCT01560403|26597890|P2|Overall Study|Lost to Follow-up|1
7645262|NCT01560403|26597891|P1|Overall Study|Lost to Follow-up|0
7645263|NCT01560234|26597939|P8|Overall Study|Lost to Follow-up|2
7645264|NCT01560234|26597940|P7|Overall Study|Lost to Follow-up|0
7645265|NCT01560234|26597941|P6|Overall Study|Lost to Follow-up|2
7645266|NCT01560234|26597942|P5|Overall Study|Lost to Follow-up|0
7645267|NCT01560234|26597943|P4|Overall Study|Lost to Follow-up|0
7645268|NCT01560234|26597944|P3|Overall Study|Lost to Follow-up|1
7645269|NCT01560234|26597945|P2|Overall Study|Lost to Follow-up|0
7645270|NCT01560234|26597946|P1|Overall Study|Lost to Follow-up|3
7645271|NCT01559935|26598041|P1|Maintenance Phase|Non-compliance|2
7645272|NCT01559935|26598041|P1|Maintenance Phase|Withdrawal by Subject|5
7645273|NCT01559935|26598041|P1|Maintenance Phase|Lack of Efficacy|18
7645274|NCT01559935|26598041|P1|Maintenance Phase|Toxicity|1
7645275|NCT01559935|26598041|P1|Maintenance Phase|Remains on study|28
7645276|NCT01559935|26598041|P1|BiRD Phase|Withdrawal by Subject|2
7645277|NCT01559935|26598041|P1|BiRD Phase|Lack of Efficacy|1
7645278|NCT01559935|26598041|P1|BiRD Phase|Toxicity|1
7645279|NCT01559935|26598041|P1|Car Phase|non-compliance|1
7645280|NCT01559935|26598041|P1|Car Phase|Insurance|1
7645281|NCT01559935|26598041|P1|Car Phase|Per protocol|1
7645282|NCT01559935|26598041|P1|Car Phase|Withdrawal by Subject|2
7645283|NCT01559935|26598041|P1|Car Phase|Physician Decision|1
7645284|NCT01559935|26598041|P1|Car Phase|Lost to Follow-up|1
7645285|NCT01559935|26598041|P1|Car Phase|Lack of Efficacy|2
7645286|NCT01559935|26598041|P1|Car Phase|Death|1
7645287|NCT01559935|26598041|P1|Car Phase|Toxicity|4
7645288|NCT01559844|26598077|P1|Overall Study|No Longer A Transplant Candidate|3
7645289|NCT01559844|26598077|P1|Overall Study|Efficacy Failure|10
7645290|NCT01559844|26598077|P1|Overall Study|Death|5
7645291|NCT01559844|26598077|P1|Overall Study|Consent Withdrawn|7
7645292|NCT01559675|26598090|P2|Overall Study|2nd operation on same patient excluded|12
7645293|NCT01559675|26598091|P1|Overall Study|2nd operation on same patient excluded|14
7645294|NCT01559675|26598090|P2|Overall Study|Protocol Violation|2
7645295|NCT01559675|26598091|P1|Overall Study|Protocol Violation|1
7645296|NCT01559454|26598122|P2|Overall Study|Lack of Efficacy|1
7645297|NCT01559454|26598123|P1|Overall Study|Lack of Efficacy|0
7645298|NCT01559454|26598122|P2|Overall Study|Protocol Violation|1
7645299|NCT01559454|26598123|P1|Overall Study|Protocol Violation|0
7645300|NCT01559454|26598122|P2|Overall Study|Physician Decision|1
7645301|NCT01559454|26598123|P1|Overall Study|Physician Decision|0
7645302|NCT01559454|26598122|P2|Overall Study|Withdrawal by Subject|1
7645303|NCT01559454|26598123|P1|Overall Study|Withdrawal by Subject|0
7645304|NCT01559454|26598122|P2|Overall Study|Lost to Follow-up|2
7645305|NCT01559454|26598123|P1|Overall Study|Lost to Follow-up|3
7645306|NCT01559389|26598141|P2|Overall Study|Withdrawal by Subject|20
7645307|NCT01559389|26598142|P1|Overall Study|Withdrawal by Subject|20
7645308|NCT01559311|26598155|P3|Overall Study|Adverse Event|1
7645309|NCT01559311|26598156|P2|Overall Study|Adverse Event|0
7645310|NCT01559311|26598157|P1|Overall Study|Adverse Event|0
7645311|NCT01559311|26598155|P3|Overall Study|Lost to Follow-up|2
7645312|NCT01559311|26598156|P2|Overall Study|Lost to Follow-up|3
7645313|NCT01559311|26598157|P1|Overall Study|Lost to Follow-up|0
7645314|NCT01559311|26598155|P3|Overall Study|Death|3
7645315|NCT01559311|26598156|P2|Overall Study|Death|2
7645316|NCT01559311|26598157|P1|Overall Study|Death|0
7645317|NCT01559311|26598155|P3|Overall Study|Withdrawal by Subject|0
7645318|NCT01559311|26598156|P2|Overall Study|Withdrawal by Subject|1
7645319|NCT01559311|26598157|P1|Overall Study|Withdrawal by Subject|2
7645320|NCT01559311|26598155|P3|Overall Study|Difficulty in cannulating the lateral ve|0
7645321|NCT01559311|26598156|P2|Overall Study|Difficulty in cannulating the lateral ve|0
7645322|NCT01559311|26598157|P1|Overall Study|Difficulty in cannulating the lateral ve|1
7645323|NCT01559311|26598155|P3|Overall Study|Protocol Violation|2
7645324|NCT01559311|26598156|P2|Overall Study|Protocol Violation|0
7645325|NCT01559311|26598157|P1|Overall Study|Protocol Violation|0
7645326|NCT01559259|26598173|P5|Overall Study|Adverse Event|0
7645327|NCT01559259|26598174|P4|Overall Study|Adverse Event|0
7645328|NCT01559259|26598175|P3|Overall Study|Adverse Event|1
7645329|NCT01559259|26598176|P2|Overall Study|Adverse Event|1
7645330|NCT01559259|26598177|P1|Overall Study|Adverse Event|0
7645331|NCT01559259|26598173|P5|Overall Study|Withdrawal by Subject|0
7645332|NCT01559259|26598174|P4|Overall Study|Withdrawal by Subject|1
7645333|NCT01559259|26598175|P3|Overall Study|Withdrawal by Subject|0
7645334|NCT01559259|26598176|P2|Overall Study|Withdrawal by Subject|0
7645335|NCT01559259|26598177|P1|Overall Study|Withdrawal by Subject|0
7645336|NCT01559129|26598266|P2|Open-label Extension Period|Study Terminated by Sponsor|2
7645337|NCT01559129|26598267|P1|Open-label Extension Period|Study Terminated by Sponsor|5
7645338|NCT01559129|26598266|P2|Open-label Extension Period|Adverse Event|0
7645339|NCT01559129|26598267|P1|Open-label Extension Period|Adverse Event|1
7645340|NCT01559129|26598266|P2|Treatment Phase|Did Not Receive Study Drug|1
7645341|NCT01559129|26598267|P1|Treatment Phase|Did Not Receive Study Drug|0
7645342|NCT01559129|26598266|P2|Treatment Phase|Protocol Exclusion Criteria|0
7645343|NCT01559129|26598267|P1|Treatment Phase|Protocol Exclusion Criteria|1
7645344|NCT01559129|26598266|P2|Treatment Phase|Study Terminated by Sponsor|2
7645345|NCT01559129|26598267|P1|Treatment Phase|Study Terminated by Sponsor|3
7645346|NCT01559129|26598266|P2|Treatment Phase|Lack of Efficacy|1
7645347|NCT01559129|26598267|P1|Treatment Phase|Lack of Efficacy|0
7645348|NCT01559129|26598266|P2|Treatment Phase|Progressive Disease|1
7645349|NCT01559129|26598267|P1|Treatment Phase|Progressive Disease|1
7645350|NCT01559129|26598266|P2|Treatment Phase|Adverse Event|2
7645351|NCT01559129|26598267|P1|Treatment Phase|Adverse Event|0
7645352|NCT01559116|26598343|P1|Overall Study|other than stated above|9
7645353|NCT01559116|26598343|P1|Overall Study|Withdrawal by Subject|4
7645354|NCT01559116|26598343|P1|Overall Study|Protocol Violation|1
7645355|NCT01559116|26598343|P1|Overall Study|Lost to Follow-up|1
7645356|NCT01559116|26598343|P1|Overall Study|Lack of Efficacy|1
7645357|NCT01559116|26598343|P1|Overall Study|Adverse Event|10
7645358|NCT01559090|26598414|P3|Stage II|Withdrawal by Subject|0
7645359|NCT01559090|26598415|P2|Stage II|Withdrawal by Subject|0
7645360|NCT01559090|26598416|P1|Stage II|Withdrawal by Subject|1
7645361|NCT01559090|26598414|P3|Stage I|Withdrawal by Subject|3
7645362|NCT01559090|26598415|P2|Stage I|Withdrawal by Subject|2
7645363|NCT01559090|26598416|P1|Stage I|Withdrawal by Subject|2
7645364|NCT01559012|26598448|P2|Overall Study|Withdrawal by Subject|1
7645365|NCT01559012|26598449|P1|Overall Study|Withdrawal by Subject|0
7645366|NCT01558752|26598489|P2|Overall Study|Physician Decision|0
7645367|NCT01558752|26598490|P1|Overall Study|Physician Decision|2
7645368|NCT01558739|26598496|P1|Overall Study|Protocol Violation|1
7645369|NCT01558739|26598496|P1|Overall Study|Disease Progression|4
7645370|NCT01558739|26598496|P1|Overall Study|Death|3
7645371|NCT01558739|26598496|P1|Overall Study|Withdrawal by Subject|2
7645372|NCT01558739|26598496|P1|Overall Study|Adverse Event|7
7645373|NCT01558674|26598521|P2|Part 1|Withdrawal by Subject|0
7645374|NCT01558674|26598522|P1|Part 1|Withdrawal by Subject|1
7645375|NCT01558674|26598521|P2|Part 1|Study Terminated by Sponsor|0
7645376|NCT01558674|26598522|P1|Part 1|Study Terminated by Sponsor|10
7645377|NCT01558635|26598573|P1|Overall Study|Reveal XT was explanted|1
7645378|NCT01558635|26598573|P1|Overall Study|Subject received other treatment|1
7645379|NCT01558635|26598573|P1|Overall Study|Physician Decision|1
7645380|NCT01558635|26598573|P1|Overall Study|Withdrawal by Subject|2
7645381|NCT01558635|26598573|P1|Overall Study|Death|1
7645382|NCT01558596|26598590|P2|Overall Study|Protocol Violation|0
7645383|NCT01558596|26598591|P1|Overall Study|Protocol Violation|1
7645384|NCT01558596|26598590|P2|Overall Study|surgery elsewhere or cancelled|1
7645385|NCT01558596|26598591|P1|Overall Study|surgery elsewhere or cancelled|1
7645386|NCT01558596|26598590|P2|Overall Study|Withdrawal by Subject|0
7645387|NCT01558596|26598591|P1|Overall Study|Withdrawal by Subject|1
7645388|NCT01558297|26598606|P3|Overall Study|Withdrawal by Subject|1
7645389|NCT01558297|26598607|P2|Overall Study|Withdrawal by Subject|2
7645390|NCT01558297|26598608|P1|Overall Study|Withdrawal by Subject|2
7645391|NCT01558271|26598625|P3|Overall Study|Physician Decision|1
7645392|NCT01558271|26598626|P2|Overall Study|Physician Decision|2
7645393|NCT01558271|26598627|P1|Overall Study|Physician Decision|0
7645394|NCT01558271|26598625|P3|Overall Study|Withdrawal by Subject|12
7645395|NCT01558271|26598626|P2|Overall Study|Withdrawal by Subject|6
7645396|NCT01558271|26598627|P1|Overall Study|Withdrawal by Subject|10
7645397|NCT01558271|26598625|P3|Overall Study|Protocol Violation|0
7645398|NCT01558271|26598626|P2|Overall Study|Protocol Violation|0
7645399|NCT01558271|26598627|P1|Overall Study|Protocol Violation|1
7645400|NCT01558271|26598625|P3|Overall Study|Lost to Follow-up|0
7645401|NCT01558271|26598626|P2|Overall Study|Lost to Follow-up|0
7645402|NCT01558271|26598627|P1|Overall Study|Lost to Follow-up|1
7645403|NCT01558271|26598625|P3|Overall Study|Adverse Event|4
7645404|NCT01558271|26598626|P2|Overall Study|Adverse Event|3
7645405|NCT01558271|26598627|P1|Overall Study|Adverse Event|6
7645406|NCT01558089|26598693|P1|Overall Study|Withdrawal by Subject|6
7645407|NCT01558089|26598693|P1|Overall Study|Lost to Follow-up|5
7645408|NCT01558089|26598693|P1|Overall Study|Lack of Efficacy|1
7645409|NCT01558089|26598693|P1|Overall Study|Adverse Event|1
7645410|NCT01557946|26598746|P2|Overall Study|Adverse Event|0
7645411|NCT01557946|26598747|P1|Overall Study|Adverse Event|3
7645412|NCT01557920|26598753|P2|Overall Study|Lack of Efficacy|0
7645413|NCT01557920|26598754|P1|Overall Study|Lack of Efficacy|1
7645414|NCT01557920|26598753|P2|Overall Study|Withdrawal by Subject|3
7645415|NCT01557920|26598754|P1|Overall Study|Withdrawal by Subject|2
7645416|NCT01557842|26598823|P2|Overall Study|Not Ablated|0
7645417|NCT01557842|26598824|P1|Overall Study|Not Ablated|2
7645418|NCT01557842|26598823|P2|Overall Study|Study Terminated by Sponsor|4
7645419|NCT01557842|26598824|P1|Overall Study|Study Terminated by Sponsor|3
7645420|NCT01557842|26598823|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
7645421|NCT01557842|26598824|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
7645422|NCT01557842|26598823|P2|Overall Study|Lack of Efficacy|1
7645423|NCT01557842|26598824|P1|Overall Study|Lack of Efficacy|0
7645424|NCT01557842|26598823|P2|Overall Study|Death|0
7645425|NCT01557842|26598824|P1|Overall Study|Death|1
7645426|NCT01557842|26598823|P2|Overall Study|Lost to Follow-up|1
7645427|NCT01557842|26598824|P1|Overall Study|Lost to Follow-up|0
7645428|NCT01557751|26598836|P1|Overall Study|Physician Decision|3
7645429|NCT01557582|26598881|P1|Overall Study|Operator error|2
7645430|NCT01557582|26598881|P1|Overall Study|Protocol Violation|4
7645431|NCT01557569|26598889|P2|Overall Study|noncompliance with rules of residential|1
7645432|NCT01557569|26598890|P1|Overall Study|noncompliance with rules of residential|0
7645433|NCT01557569|26598889|P2|Overall Study|Withdrawal by Subject|5
7645434|NCT01557569|26598890|P1|Overall Study|Withdrawal by Subject|3
7645435|NCT01557569|26598889|P2|Overall Study|high blood pressure|1
7645436|NCT01557569|26598890|P1|Overall Study|high blood pressure|0
7645437|NCT01557569|26598889|P2|Overall Study|Adverse Event|0
7645438|NCT01557569|26598890|P1|Overall Study|Adverse Event|2
7645439|NCT01557517|26598898|P2|Overall Study|Pt declined before treatment started|0
7645440|NCT01557517|26598899|P1|Overall Study|Pt declined before treatment started|1
7645441|NCT01557517|26598898|P2|Overall Study|Adverse Event|2
7645442|NCT01557517|26598899|P1|Overall Study|Adverse Event|0
7645443|NCT01557517|26598898|P2|Overall Study|Refused further treatment|2
7645444|NCT01557517|26598899|P1|Overall Study|Refused further treatment|0
7645445|NCT01557517|26598898|P2|Overall Study|Death|0
7645446|NCT01557517|26598899|P1|Overall Study|Death|1
7645447|NCT01557504|26598925|P2|Overall Study|Physician Decision|0
7645448|NCT01557504|26598926|P1|Overall Study|Physician Decision|1
7645449|NCT01557400|26598955|P1|Overall Study|Withdrawal by Subject|9
7645450|NCT01557400|26598955|P1|Overall Study|Lost to Follow-up|5
7645451|NCT01557400|26598955|P1|Overall Study|Adverse Event|3
7645452|NCT01557400|26598955|P1|Overall Study|Transitioned to Commercial Drug Product|40
7645453|NCT01557348|26598967|P2|Overall Study|Administrative|11
7645454|NCT01557348|26598968|P1|Overall Study|Administrative|18
7645455|NCT01557348|26598967|P2|Overall Study|Lost to Follow-up|22
7645456|NCT01557348|26598968|P1|Overall Study|Lost to Follow-up|26
7645457|NCT01557348|26598967|P2|Overall Study|Withdrawal by Subject|4
7645458|NCT01557348|26598968|P1|Overall Study|Withdrawal by Subject|5
7645459|NCT01557348|26598967|P2|Overall Study|Insufficient Therapeutic Response|28
7645460|NCT01557348|26598968|P1|Overall Study|Insufficient Therapeutic Response|13
7645461|NCT01557348|26598967|P2|Overall Study|Death|4
7645462|NCT01557348|26598968|P1|Overall Study|Death|7
7645463|NCT01557348|26598967|P2|Overall Study|Infusion reaction event|5
7645464|NCT01557348|26598968|P1|Overall Study|Infusion reaction event|5
7645465|NCT01557348|26598967|P2|Overall Study|Adverse Event|16
7645466|NCT01557348|26598968|P1|Overall Study|Adverse Event|6
7645467|NCT01557283|26599085|P1|Overall Study|Other|6
7645468|NCT01557283|26599085|P1|Overall Study|Worsening of psoriasis|1
7645469|NCT01557283|26599085|P1|Overall Study|Participant's weight too high for dose|1
7645470|NCT01557283|26599085|P1|Overall Study|Withdrawal by Subject|1
7645471|NCT01557283|26599085|P1|Overall Study|Non-compliance|1
7645472|NCT01557283|26599085|P1|Overall Study|Lack of Efficacy|1
7645473|NCT01557283|26599085|P1|Overall Study|Adverse Event|7
7645474|NCT01557283|26599085|P1|Overall Study|Non-responder|19
7645475|NCT01557283|26599085|P1|Overall Study|Lost to Follow-up|7
7645476|NCT01557244|26599100|P7|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7645477|NCT01557244|26599101|P6|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7645478|NCT01557244|26599102|P5|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7645479|NCT01557244|26599103|P4|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7645480|NCT01557244|26599104|P3|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7645481|NCT01557244|26599105|P2|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
7645482|NCT01557244|26599106|P1|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
7645483|NCT01557244|26599100|P7|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7645484|NCT01557244|26599101|P6|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7645485|NCT01557244|26599102|P5|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7645486|NCT01557244|26599103|P4|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
7645487|NCT01557244|26599104|P3|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7645488|NCT01557244|26599105|P2|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7645489|NCT01557244|26599106|P1|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7645490|NCT01557244|26599100|P7|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7645491|NCT01557244|26599101|P6|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7645492|NCT01557244|26599102|P5|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7645493|NCT01557244|26599103|P4|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7645494|NCT01557244|26599104|P3|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7645495|NCT01557244|26599105|P2|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7645496|NCT01557244|26599106|P1|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7645497|NCT01557244|26599100|P7|Safety Extension Phase: 12 Weeks|Adverse Event|0
7645498|NCT01557244|26599101|P6|Safety Extension Phase: 12 Weeks|Adverse Event|1
7645499|NCT01557244|26599102|P5|Safety Extension Phase: 12 Weeks|Adverse Event|0
7645500|NCT01557244|26599103|P4|Safety Extension Phase: 12 Weeks|Adverse Event|0
7645501|NCT01557244|26599104|P3|Safety Extension Phase: 12 Weeks|Adverse Event|0
7645502|NCT01557244|26599105|P2|Safety Extension Phase: 12 Weeks|Adverse Event|1
7645503|NCT01557244|26599106|P1|Safety Extension Phase: 12 Weeks|Adverse Event|1
7645504|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Other|0
7645505|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Other|0
7645506|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Other|0
7645507|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Other|0
7645508|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Other|2
7645509|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Other|0
7645510|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Other|2
7645511|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7645512|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7645513|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7645514|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7645515|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7645516|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7645517|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7645518|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7645519|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7645520|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7645521|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7645522|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7645523|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7645524|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7645525|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7645526|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7645527|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7645528|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7645529|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7645530|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
7645531|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7645532|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7645533|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
7645534|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7645535|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7645536|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7645537|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7645538|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
7645539|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7645540|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7645541|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7645542|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7645543|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7645544|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7645545|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
7645546|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7645547|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7645548|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7645549|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7645550|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
7645551|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7645552|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
7645553|NCT01557244|26599100|P7|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7645554|NCT01557244|26599101|P6|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7645555|NCT01557244|26599102|P5|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7645556|NCT01557244|26599103|P4|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7645557|NCT01557244|26599104|P3|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7645558|NCT01557244|26599105|P2|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7645559|NCT01557244|26599106|P1|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7645560|NCT01557166|26599365|P2|Overall Study|Unclassified|5
7645561|NCT01557166|26599366|P1|Overall Study|Unclassified|2
7645562|NCT01557166|26599365|P2|Overall Study|Psychiatric disorder|0
7645563|NCT01557166|26599366|P1|Overall Study|Psychiatric disorder|1
7645564|NCT01557166|26599365|P2|Overall Study|Target dose not tolerated|0
7645565|NCT01557166|26599366|P1|Overall Study|Target dose not tolerated|1
7645566|NCT01557166|26599365|P2|Overall Study|Withdrawn consent|20
7645567|NCT01557166|26599366|P1|Overall Study|Withdrawn consent|12
7645568|NCT01557166|26599365|P2|Overall Study|Protocol Violation|5
7645569|NCT01557166|26599366|P1|Overall Study|Protocol Violation|8
7645570|NCT01557166|26599365|P2|Overall Study|Lack of Efficacy|1
7645571|NCT01557166|26599366|P1|Overall Study|Lack of Efficacy|2
7645572|NCT01557166|26599365|P2|Overall Study|Adverse Event|6
7645573|NCT01557166|26599366|P1|Overall Study|Adverse Event|20
7645574|NCT01556997|26599381|P3|Overall Study|Other|7
7645575|NCT01556997|26599382|P2|Overall Study|Other|3
7645576|NCT01556997|26599383|P1|Overall Study|Other|2
7645577|NCT01556997|26599381|P3|Overall Study|Withdrawal by Subject|8
7645578|NCT01556997|26599382|P2|Overall Study|Withdrawal by Subject|6
7645579|NCT01556997|26599383|P1|Overall Study|Withdrawal by Subject|7
7645580|NCT01556997|26599381|P3|Overall Study|Physician Decision|1
7645581|NCT01556997|26599382|P2|Overall Study|Physician Decision|1
7645582|NCT01556997|26599383|P1|Overall Study|Physician Decision|1
7645583|NCT01556997|26599381|P3|Overall Study|Lost to Follow-up|4
7645584|NCT01556997|26599382|P2|Overall Study|Lost to Follow-up|6
7645585|NCT01556997|26599383|P1|Overall Study|Lost to Follow-up|6
7645586|NCT01556997|26599381|P3|Overall Study|Adverse Event|12
7645587|NCT01556997|26599382|P2|Overall Study|Adverse Event|12
7645588|NCT01556997|26599383|P1|Overall Study|Adverse Event|10
7645589|NCT01556932|26599394|P2|Time Point 60 Minutes|Withdrawal by Subject|1
7645590|NCT01556932|26599395|P1|Time Point 60 Minutes|Withdrawal by Subject|1
7645591|NCT01556763|26599421|P3|Overall Study|Withdrawal by Subject|0
7645592|NCT01556763|26599422|P2|Overall Study|Withdrawal by Subject|1
7645593|NCT01556763|26599423|P1|Overall Study|Withdrawal by Subject|0
7645594|NCT01556438|26599562|P2|Overall Study|Death|1
7645595|NCT01556438|26599563|P1|Overall Study|Death|0
7645596|NCT01556438|26599562|P2|Overall Study|Progressive Disease|6
7645597|NCT01556438|26599563|P1|Overall Study|Progressive Disease|0
7645598|NCT01556438|26599562|P2|Overall Study|Sponsor Decision|2
7645599|NCT01556438|26599563|P1|Overall Study|Sponsor Decision|0
7645600|NCT01556438|26599562|P2|Overall Study|Adverse Event|2
7645601|NCT01556438|26599563|P1|Overall Study|Adverse Event|4
7645602|NCT01556165|26599650|P2|Overall Study|Withdrawal of Consent|1
7645603|NCT01556165|26599651|P1|Overall Study|Withdrawal of Consent|7
7645604|NCT01556165|26599650|P2|Overall Study|Protocol Violation|3
7645605|NCT01556165|26599651|P1|Overall Study|Protocol Violation|0
7645606|NCT01556165|26599650|P2|Overall Study|Adverse Event|3
7645607|NCT01556165|26599651|P1|Overall Study|Adverse Event|5
7645608|NCT01555983|26599692|P6|Overall Study|Withdrawal by Subject|1
7645609|NCT01555983|26599693|P5|Overall Study|Withdrawal by Subject|1
7645610|NCT01555983|26599694|P4|Overall Study|Withdrawal by Subject|0
7645611|NCT01555983|26599695|P3|Overall Study|Withdrawal by Subject|0
7645612|NCT01555983|26599696|P2|Overall Study|Withdrawal by Subject|0
7645613|NCT01555983|26599697|P1|Overall Study|Withdrawal by Subject|1
7645614|NCT01555931|26599718|P2|Overall Study|Lost to Follow-up|5
7645615|NCT01555931|26599719|P1|Overall Study|Lost to Follow-up|2
7645616|NCT01555762|26599727|P1|Overall Study|Death linked to an adverse event|14
7645617|NCT01555762|26599727|P1|Overall Study|Missing data|1
7645618|NCT01555762|26599727|P1|Overall Study|Participant not wishing to continue|5
7645619|NCT01555762|26599727|P1|Overall Study|Investigator's decision|10
7645620|NCT01555762|26599727|P1|Overall Study|Lost follow-up/moved house/changed team|35
7645621|NCT01555762|26599727|P1|Overall Study|Death linked to progression of disease|165
7645622|NCT01555762|26599727|P1|Overall Study|Treatment with Bevacizumab ticked No|24
7645623|NCT01555762|26599727|P1|Overall Study|75 years old or more ticked No|1
7645624|NCT01555762|26599727|P1|Overall Study|Missing start date of infusion|8
7645625|NCT01555762|26599727|P1|Overall Study|No information on Bevacizumab intake|11
7645626|NCT01555671|26599774|P2|Overall Study|Physician Decision|25
7645627|NCT01555671|26599775|P1|Overall Study|Physician Decision|20
7645628|NCT01555463|26599820|P2|Follow up|Other reason|3
7645629|NCT01555463|26599821|P1|Follow up|Other reason|3
7645630|NCT01555463|26599820|P2|Follow up|Protocol Violation|4
7645631|NCT01555463|26599821|P1|Follow up|Protocol Violation|2
7645632|NCT01555463|26599820|P2|Follow up|Lost to Follow-up|10
7645633|NCT01555463|26599821|P1|Follow up|Lost to Follow-up|9
7645634|NCT01555463|26599820|P2|Follow up|Withdrawal by Subject|22
7645635|NCT01555463|26599821|P1|Follow up|Withdrawal by Subject|22
7645636|NCT01555463|26599820|P2|Follow up|Death|1
7645637|NCT01555463|26599821|P1|Follow up|Death|0
7645638|NCT01555463|26599820|P2|Follow up|Adverse Event|5
7645639|NCT01555463|26599821|P1|Follow up|Adverse Event|2
7645640|NCT01555463|26599820|P2|Treatment|Other reason|3
7645641|NCT01555463|26599821|P1|Treatment|Other reason|2
7645642|NCT01555463|26599820|P2|Treatment|Protocol Violation|5
7645643|NCT01555463|26599821|P1|Treatment|Protocol Violation|4
7645644|NCT01555463|26599820|P2|Treatment|Lost to Follow-up|23
7645645|NCT01555463|26599821|P1|Treatment|Lost to Follow-up|28
7645646|NCT01555463|26599820|P2|Treatment|Withdrawal by Subject|36
7645647|NCT01555463|26599821|P1|Treatment|Withdrawal by Subject|24
7645648|NCT01555463|26599820|P2|Treatment|Adverse Event|12
7645649|NCT01555463|26599821|P1|Treatment|Adverse Event|6
7645650|NCT01555164|26599863|P2|Overall Study|Subject Withdrew Consent|11
7645651|NCT01555164|26599864|P1|Overall Study|Subject Withdrew Consent|6
7645652|NCT01555164|26599863|P2|Overall Study|Subject Non-compliance|6
7645653|NCT01555164|26599864|P1|Overall Study|Subject Non-compliance|14
7645654|NCT01555164|26599863|P2|Overall Study|Protocol Violation|5
7645655|NCT01555164|26599864|P1|Overall Study|Protocol Violation|9
7645656|NCT01555164|26599863|P2|Overall Study|Lost to Follow-up|3
7645657|NCT01555164|26599864|P1|Overall Study|Lost to Follow-up|4
7645658|NCT01555164|26599863|P2|Overall Study|Investigator's Discretion|2
7645659|NCT01555164|26599864|P1|Overall Study|Investigator's Discretion|2
7645660|NCT01555164|26599863|P2|Overall Study|Hyperglycemia|1
7645661|NCT01555164|26599864|P1|Overall Study|Hyperglycemia|0
7645662|NCT01555164|26599863|P2|Overall Study|Adverse Event|7
7645663|NCT01555164|26599864|P1|Overall Study|Adverse Event|5
7645664|NCT01555151|26599878|P4|Overall Study|Lost to Follow-up|1
7645665|NCT01555151|26599879|P3|Overall Study|Lost to Follow-up|0
7645666|NCT01555151|26599880|P2|Overall Study|Lost to Follow-up|0
7645667|NCT01555151|26599881|P1|Overall Study|Lost to Follow-up|0
7645668|NCT01555151|26599878|P4|Overall Study|Adverse Event|2
7645669|NCT01555151|26599879|P3|Overall Study|Adverse Event|1
7645670|NCT01555151|26599880|P2|Overall Study|Adverse Event|2
7645671|NCT01555151|26599881|P1|Overall Study|Adverse Event|1
7645672|NCT01555151|26599878|P4|Overall Study|Protocol Violation|5
7645673|NCT01555151|26599879|P3|Overall Study|Protocol Violation|3
7645674|NCT01555151|26599880|P2|Overall Study|Protocol Violation|3
7645675|NCT01555151|26599881|P1|Overall Study|Protocol Violation|3
7645676|NCT01555151|26599878|P4|Overall Study|Administrative|0
7645677|NCT01555151|26599879|P3|Overall Study|Administrative|2
7645678|NCT01555151|26599880|P2|Overall Study|Administrative|1
7645679|NCT01555151|26599881|P1|Overall Study|Administrative|3
7645680|NCT01555151|26599878|P4|Overall Study|Withdrawal by Subject|2
7645681|NCT01555151|26599879|P3|Overall Study|Withdrawal by Subject|0
7645682|NCT01555151|26599880|P2|Overall Study|Withdrawal by Subject|2
7645683|NCT01555151|26599881|P1|Overall Study|Withdrawal by Subject|6
7645684|NCT01555138|26599934|P2|Overall Study|Adverse Event|14
7645685|NCT01555138|26599935|P1|Overall Study|Adverse Event|14
7645686|NCT01555138|26599934|P2|Overall Study|Withdrawal by Subject|15
7645687|NCT01555138|26599935|P1|Overall Study|Withdrawal by Subject|16
7645688|NCT01555138|26599934|P2|Overall Study|Administrative problems|0
7645689|NCT01555138|26599935|P1|Overall Study|Administrative problems|8
7645690|NCT01555138|26599934|P2|Overall Study|Protocol Violation|3
7645691|NCT01555138|26599935|P1|Overall Study|Protocol Violation|5
7645692|NCT01555138|26599934|P2|Overall Study|Lack of Efficacy|2
7645693|NCT01555138|26599935|P1|Overall Study|Lack of Efficacy|2
7645694|NCT01555138|26599934|P2|Overall Study|Abnormal Lab reults|3
7645695|NCT01555138|26599935|P1|Overall Study|Abnormal Lab reults|1
7645696|NCT01555138|26599934|P2|Overall Study|Lost to Follow-up|0
7645697|NCT01555138|26599935|P1|Overall Study|Lost to Follow-up|1
7645698|NCT01555138|26599934|P2|Overall Study|Death|1
7645699|NCT01555138|26599935|P1|Overall Study|Death|0
7645700|NCT01555125|26599964|P5|Follow-Up Period|Subject / guardian decision|0
7645701|NCT01555125|26599965|P4|Follow-Up Period|Subject / guardian decision|1
7645702|NCT01555125|26599966|P3|Follow-Up Period|Subject / guardian decision|1
7645703|NCT01555125|26599967|P2|Follow-Up Period|Subject / guardian decision|1
7645704|NCT01555125|26599968|P1|Follow-Up Period|Subject / guardian decision|3
7645705|NCT01555125|26599964|P5|Follow-Up Period|Lost to Follow-up|0
7645706|NCT01555125|26599965|P4|Follow-Up Period|Lost to Follow-up|0
7645707|NCT01555125|26599966|P3|Follow-Up Period|Lost to Follow-up|0
7645708|NCT01555125|26599967|P2|Follow-Up Period|Lost to Follow-up|0
7645709|NCT01555125|26599968|P1|Follow-Up Period|Lost to Follow-up|1
7645710|NCT01555125|26599964|P5|Extension|Technical Problems|0
7645711|NCT01555125|26599965|P4|Extension|Technical Problems|1
7645712|NCT01555125|26599966|P3|Extension|Technical Problems|0
7645713|NCT01555125|26599967|P2|Extension|Technical Problems|0
7645714|NCT01555125|26599968|P1|Extension|Technical Problems|1
7645715|NCT01555125|26599964|P5|Extension|Subject/guardian decision|0
7645716|NCT01555125|26599965|P4|Extension|Subject/guardian decision|0
7645717|NCT01555125|26599966|P3|Extension|Subject/guardian decision|1
7645718|NCT01555125|26599967|P2|Extension|Subject/guardian decision|9
7645719|NCT01555125|26599968|P1|Extension|Subject/guardian decision|1
7645720|NCT01555125|26599964|P5|Extension|Study terminated by sponsor|0
7645721|NCT01555125|26599965|P4|Extension|Study terminated by sponsor|20
7645722|NCT01555125|26599966|P3|Extension|Study terminated by sponsor|16
7645723|NCT01555125|26599967|P2|Extension|Study terminated by sponsor|33
7645724|NCT01555125|26599968|P1|Extension|Study terminated by sponsor|32
7645725|NCT01555125|26599964|P5|Extension|Lost to Follow-up|0
7645726|NCT01555125|26599965|P4|Extension|Lost to Follow-up|0
7645727|NCT01555125|26599966|P3|Extension|Lost to Follow-up|2
7645728|NCT01555125|26599967|P2|Extension|Lost to Follow-up|1
7645729|NCT01555125|26599968|P1|Extension|Lost to Follow-up|2
7645730|NCT01555125|26599964|P5|Extension|Lack of Efficacy|0
7645731|NCT01555125|26599965|P4|Extension|Lack of Efficacy|0
7645732|NCT01555125|26599966|P3|Extension|Lack of Efficacy|3
7645733|NCT01555125|26599967|P2|Extension|Lack of Efficacy|6
7645734|NCT01555125|26599968|P1|Extension|Lack of Efficacy|7
7645735|NCT01555125|26599964|P5|Extension|Protocol deviation|0
7645736|NCT01555125|26599965|P4|Extension|Protocol deviation|0
7645737|NCT01555125|26599966|P3|Extension|Protocol deviation|0
7645738|NCT01555125|26599967|P2|Extension|Protocol deviation|0
7645739|NCT01555125|26599968|P1|Extension|Protocol deviation|1
7645740|NCT01555125|26599964|P5|Extension|Adverse Event|0
7645741|NCT01555125|26599965|P4|Extension|Adverse Event|1
7645742|NCT01555125|26599966|P3|Extension|Adverse Event|1
7645743|NCT01555125|26599967|P2|Extension|Adverse Event|2
7645744|NCT01555125|26599968|P1|Extension|Adverse Event|1
7645745|NCT01555125|26599964|P5|Maintenance Period|Death|0
7645746|NCT01555125|26599965|P4|Maintenance Period|Death|1
7645747|NCT01555125|26599966|P3|Maintenance Period|Death|0
7645748|NCT01555125|26599967|P2|Maintenance Period|Death|0
7645749|NCT01555125|26599968|P1|Maintenance Period|Death|0
7645750|NCT01555125|26599964|P5|Maintenance Period|Physician Decision|0
7645751|NCT01555125|26599965|P4|Maintenance Period|Physician Decision|0
7645752|NCT01555125|26599966|P3|Maintenance Period|Physician Decision|1
7645753|NCT01555125|26599967|P2|Maintenance Period|Physician Decision|0
7645754|NCT01555125|26599968|P1|Maintenance Period|Physician Decision|0
7645755|NCT01555125|26599964|P5|Maintenance Period|Lack of Efficacy|0
7645756|NCT01555125|26599965|P4|Maintenance Period|Lack of Efficacy|0
7645757|NCT01555125|26599966|P3|Maintenance Period|Lack of Efficacy|3
7645758|NCT01555125|26599967|P2|Maintenance Period|Lack of Efficacy|1
7645759|NCT01555125|26599968|P1|Maintenance Period|Lack of Efficacy|6
7645760|NCT01555125|26599964|P5|Maintenance Period|Lost to Follow-up|0
7645761|NCT01555125|26599965|P4|Maintenance Period|Lost to Follow-up|1
7645762|NCT01555125|26599966|P3|Maintenance Period|Lost to Follow-up|0
7645763|NCT01555125|26599967|P2|Maintenance Period|Lost to Follow-up|0
7645764|NCT01555125|26599968|P1|Maintenance Period|Lost to Follow-up|2
7645765|NCT01555125|26599964|P5|Maintenance Period|Subject / guardian decision|0
7645766|NCT01555125|26599965|P4|Maintenance Period|Subject / guardian decision|0
7645767|NCT01555125|26599966|P3|Maintenance Period|Subject / guardian decision|0
7645768|NCT01555125|26599967|P2|Maintenance Period|Subject / guardian decision|2
7645769|NCT01555125|26599968|P1|Maintenance Period|Subject / guardian decision|1
7645770|NCT01555125|26599964|P5|Maintenance Period|Adverse Event|0
7645771|NCT01555125|26599965|P4|Maintenance Period|Adverse Event|0
7645772|NCT01555125|26599966|P3|Maintenance Period|Adverse Event|0
7645773|NCT01555125|26599967|P2|Maintenance Period|Adverse Event|1
7645774|NCT01555125|26599968|P1|Maintenance Period|Adverse Event|1
7645775|NCT01555125|26599964|P5|Induction Period|Death|0
7645776|NCT01555125|26599965|P4|Induction Period|Death|0
7645777|NCT01555125|26599966|P3|Induction Period|Death|0
7645778|NCT01555125|26599967|P2|Induction Period|Death|0
7645779|NCT01555125|26599968|P1|Induction Period|Death|1
7645780|NCT01555125|26599964|P5|Induction Period|Subject / guardian decision|2
7645781|NCT01555125|26599965|P4|Induction Period|Subject / guardian decision|0
7645782|NCT01555125|26599966|P3|Induction Period|Subject / guardian decision|0
7645783|NCT01555125|26599967|P2|Induction Period|Subject / guardian decision|0
7645784|NCT01555125|26599968|P1|Induction Period|Subject / guardian decision|0
7645785|NCT01555125|26599964|P5|Induction Period|Adverse Event|1
7645786|NCT01555125|26599965|P4|Induction Period|Adverse Event|0
7645787|NCT01555125|26599966|P3|Induction Period|Adverse Event|0
7645788|NCT01555125|26599967|P2|Induction Period|Adverse Event|1
7645789|NCT01555125|26599968|P1|Induction Period|Adverse Event|0
7645790|NCT01555125|26599964|P5|Induction Period|Lost to Follow-up|0
7645791|NCT01555125|26599965|P4|Induction Period|Lost to Follow-up|0
7645792|NCT01555125|26599966|P3|Induction Period|Lost to Follow-up|0
7645793|NCT01555125|26599967|P2|Induction Period|Lost to Follow-up|2
7645794|NCT01555125|26599968|P1|Induction Period|Lost to Follow-up|0
7645795|NCT01555073|26600061|P4|Overall Study|Lost to Follow-up|5
7645796|NCT01555073|26600062|P3|Overall Study|Lost to Follow-up|0
7645797|NCT01555073|26600063|P2|Overall Study|Lost to Follow-up|2
7645798|NCT01555073|26600064|P1|Overall Study|Lost to Follow-up|1
7645799|NCT01555021|26600080|P2|Overall Study|Lost to Follow-up|2
7645800|NCT01555021|26600081|P1|Overall Study|Lost to Follow-up|1
7645801|NCT01554904|26600106|P1|Overall Study|Had sleep apnea on Home Study 1|1
7645802|NCT01554904|26600106|P1|Overall Study|Withdrawal by Subject|3
7645803|NCT01554618|26600151|P2|Open-Label Extension Period|Lost to Follow-up|1
7645804|NCT01554618|26600152|P1|Open-Label Extension Period|Lost to Follow-up|1
7645805|NCT01554618|26600151|P2|Open-Label Extension Period|Physician Decision|1
7645806|NCT01554618|26600152|P1|Open-Label Extension Period|Physician Decision|0
7645807|NCT01554618|26600151|P2|Open-Label Extension Period|Withdrawal by Subject|3
7645808|NCT01554618|26600152|P1|Open-Label Extension Period|Withdrawal by Subject|2
7645809|NCT01554618|26600151|P2|Controlled Assessment Period|Withdrawal by Subject|0
7645810|NCT01554618|26600152|P1|Controlled Assessment Period|Withdrawal by Subject|6
7645811|NCT01554618|26600151|P2|Controlled Assessment Period|Lost to Follow-up|1
7645812|NCT01554618|26600152|P1|Controlled Assessment Period|Lost to Follow-up|2
7645813|NCT01554618|26600151|P2|Randomized Through Start of Treatment|Adverse Event|0
7645814|NCT01554618|26600152|P1|Randomized Through Start of Treatment|Adverse Event|1
7645815|NCT01554579|26600204|P2|Overall Study|Withdrawal by Subject|1
7645816|NCT01554579|26600205|P1|Overall Study|Withdrawal by Subject|2
7645817|NCT01554579|26600204|P2|Overall Study|Lack of Efficacy|1
7645818|NCT01554579|26600205|P1|Overall Study|Lack of Efficacy|2
7645819|NCT01554579|26600204|P2|Overall Study|Adverse Event|25
7645820|NCT01554579|26600205|P1|Overall Study|Adverse Event|6
7645821|NCT01554527|26600218|P3|Overall Study|Physician Decision|1
7645822|NCT01554527|26600219|P2|Overall Study|Physician Decision|0
7645823|NCT01554527|26600220|P1|Overall Study|Physician Decision|0
7645824|NCT01554527|26600218|P3|Overall Study|Lost to Follow-up|4
7645825|NCT01554527|26600219|P2|Overall Study|Lost to Follow-up|0
7645826|NCT01554527|26600220|P1|Overall Study|Lost to Follow-up|0
7645827|NCT01554527|26600218|P3|Overall Study|Withdrawal by Subject|3
7645828|NCT01554527|26600219|P2|Overall Study|Withdrawal by Subject|0
7645829|NCT01554527|26600220|P1|Overall Study|Withdrawal by Subject|1
7645830|NCT01554514|26600247|P1|Overall Study|Physician Decision|1
7645831|NCT01554514|26600247|P1|Overall Study|1 patient ineligible with congenital TTP|1
7645832|NCT01554241|26600305|P4|Overall Study|Withdrawal by Subject|0
7645833|NCT01554241|26600306|P3|Overall Study|Withdrawal by Subject|2
7645834|NCT01554241|26600307|P2|Overall Study|Withdrawal by Subject|0
7645835|NCT01554241|26600308|P1|Overall Study|Withdrawal by Subject|0
7645836|NCT01554241|26600305|P4|Overall Study|protocol specified change in eGFR|0
7645837|NCT01554241|26600306|P3|Overall Study|protocol specified change in eGFR|1
7645838|NCT01554241|26600307|P2|Overall Study|protocol specified change in eGFR|0
7645839|NCT01554241|26600308|P1|Overall Study|protocol specified change in eGFR|0
7645840|NCT01554241|26600305|P4|Overall Study|protocol specified renal stone|1
7645841|NCT01554241|26600306|P3|Overall Study|protocol specified renal stone|0
7645842|NCT01554241|26600307|P2|Overall Study|protocol specified renal stone|0
7645843|NCT01554241|26600308|P1|Overall Study|protocol specified renal stone|0
7645844|NCT01554241|26600305|P4|Overall Study|Death|0
7645845|NCT01554241|26600306|P3|Overall Study|Death|1
7645846|NCT01554241|26600307|P2|Overall Study|Death|1
7645847|NCT01554241|26600308|P1|Overall Study|Death|3
7645848|NCT01554176|26600324|P5|Run-out Phase|Protocol Violation|0
7645849|NCT01554176|26600325|P4|Run-out Phase|Protocol Violation|1
7645850|NCT01554176|26600326|P3|Run-out Phase|Protocol Violation|0
7645851|NCT01554176|26600327|P2|Run-out Phase|Protocol Violation|0
7645852|NCT01554176|26600328|P1|Run-out Phase|Protocol Violation|0
7645853|NCT01554176|26600324|P5|Treatment Phase|Lost to Follow-up|0
7645854|NCT01554176|26600325|P4|Treatment Phase|Lost to Follow-up|0
7645855|NCT01554176|26600326|P3|Treatment Phase|Lost to Follow-up|0
7645856|NCT01554176|26600327|P2|Treatment Phase|Lost to Follow-up|0
7645857|NCT01554176|26600328|P1|Treatment Phase|Lost to Follow-up|3
7645858|NCT01554176|26600324|P5|Treatment Phase|Withdrawal by Subject|0
7645859|NCT01554176|26600325|P4|Treatment Phase|Withdrawal by Subject|0
7645860|NCT01554176|26600326|P3|Treatment Phase|Withdrawal by Subject|0
7645861|NCT01554176|26600327|P2|Treatment Phase|Withdrawal by Subject|0
7645862|NCT01554176|26600328|P1|Treatment Phase|Withdrawal by Subject|1
7645863|NCT01554176|26600324|P5|Treatment Phase|Non-compliance with study drug|0
7645864|NCT01554176|26600325|P4|Treatment Phase|Non-compliance with study drug|0
7645865|NCT01554176|26600326|P3|Treatment Phase|Non-compliance with study drug|0
7645866|NCT01554176|26600327|P2|Treatment Phase|Non-compliance with study drug|0
7645867|NCT01554176|26600328|P1|Treatment Phase|Non-compliance with study drug|1
7645868|NCT01554176|26600324|P5|Treatment Phase|Adverse event, non-fatal|0
7645869|NCT01554176|26600325|P4|Treatment Phase|Adverse event, non-fatal|0
7645870|NCT01554176|26600326|P3|Treatment Phase|Adverse event, non-fatal|0
7645871|NCT01554176|26600327|P2|Treatment Phase|Adverse event, non-fatal|1
7645872|NCT01554176|26600328|P1|Treatment Phase|Adverse event, non-fatal|1
7645873|NCT01554176|26600324|P5|Treatment Phase|Lack of Efficacy|0
7645874|NCT01554176|26600325|P4|Treatment Phase|Lack of Efficacy|0
7645875|NCT01554176|26600326|P3|Treatment Phase|Lack of Efficacy|0
7645876|NCT01554176|26600327|P2|Treatment Phase|Lack of Efficacy|1
7645877|NCT01554176|26600328|P1|Treatment Phase|Lack of Efficacy|0
7645878|NCT01554176|26600324|P5|Treatment Phase|Physician Decision|0
7645879|NCT01554176|26600325|P4|Treatment Phase|Physician Decision|0
7645880|NCT01554176|26600326|P3|Treatment Phase|Physician Decision|0
7645881|NCT01554176|26600327|P2|Treatment Phase|Physician Decision|1
7645882|NCT01554176|26600328|P1|Treatment Phase|Physician Decision|1
7645883|NCT01554176|26600324|P5|Treatment Phase|Protocol Violation|0
7645884|NCT01554176|26600325|P4|Treatment Phase|Protocol Violation|0
7645885|NCT01554176|26600326|P3|Treatment Phase|Protocol Violation|0
7645886|NCT01554176|26600327|P2|Treatment Phase|Protocol Violation|2
7645887|NCT01554176|26600328|P1|Treatment Phase|Protocol Violation|1
7645888|NCT01554163|26600355|P2|Overall Study|Not Treated|0
7645889|NCT01554163|26600356|P1|Overall Study|Not Treated|1
7645890|NCT01554163|26600355|P2|Overall Study|Withdrawal by Subject|5
7645891|NCT01554163|26600356|P1|Overall Study|Withdrawal by Subject|1
7645892|NCT01554163|26600355|P2|Overall Study|Protocol Violation|4
7645893|NCT01554163|26600356|P1|Overall Study|Protocol Violation|0
7645894|NCT01554163|26600355|P2|Overall Study|Non-Compliance With Study Drug|1
7645895|NCT01554163|26600356|P1|Overall Study|Non-Compliance With Study Drug|1
7645896|NCT01554163|26600355|P2|Overall Study|Lost to Follow-up|0
7645897|NCT01554163|26600356|P1|Overall Study|Lost to Follow-up|1
7645898|NCT01554163|26600355|P2|Overall Study|Lack of Efficacy|0
7645899|NCT01554163|26600356|P1|Overall Study|Lack of Efficacy|1
7645900|NCT01554163|26600355|P2|Overall Study|Adverse Event|0
7645901|NCT01554163|26600356|P1|Overall Study|Adverse Event|3
7645902|NCT01553916|26600374|P1|Overall Study|Pre-treatment MRI metastatic disease|1
7645903|NCT01553916|26600374|P1|Overall Study|Withdrawal by Subject|2
7645904|NCT01553851|26600391|P1|Overall Study|constipation|1
7645905|NCT01553851|26600391|P1|Overall Study|Adverse Event|2
7645906|NCT01553747|26600406|P3|Overall Study|Physician decision: lack of efficacy|3
7645907|NCT01553747|26600407|P2|Overall Study|Physician decision: lack of efficacy|5
7645908|NCT01553747|26600408|P1|Overall Study|Physician decision: lack of efficacy|1
7645909|NCT01553747|26600406|P3|Overall Study|Sponsor decision, specify|0
7645910|NCT01553747|26600407|P2|Overall Study|Sponsor decision, specify|5
7645911|NCT01553747|26600408|P1|Overall Study|Sponsor decision, specify|7
7645912|NCT01553747|26600406|P3|Overall Study|Lost to Follow-up|6
7645913|NCT01553747|26600407|P2|Overall Study|Lost to Follow-up|5
7645914|NCT01553747|26600408|P1|Overall Study|Lost to Follow-up|11
7645915|NCT01553747|26600406|P3|Overall Study|Physician decision: other|7
7645916|NCT01553747|26600407|P2|Overall Study|Physician decision: other|8
7645917|NCT01553747|26600408|P1|Overall Study|Physician decision: other|10
7645918|NCT01553747|26600406|P3|Overall Study|Adverse event or SAE|19
7645919|NCT01553747|26600407|P2|Overall Study|Adverse event or SAE|28
7645920|NCT01553747|26600408|P1|Overall Study|Adverse event or SAE|32
7645921|NCT01553747|26600406|P3|Overall Study|Voluntarily withdrew|74
7645922|NCT01553747|26600407|P2|Overall Study|Voluntarily withdrew|66
7645923|NCT01553747|26600408|P1|Overall Study|Voluntarily withdrew|70
7645924|NCT01553747|26600406|P3|Overall Study|Protocol Violation|0
7645925|NCT01553747|26600407|P2|Overall Study|Protocol Violation|2
7645926|NCT01553747|26600408|P1|Overall Study|Protocol Violation|0
7645927|NCT01553591|26600470|P3|Overall Study|Randomized and never dispensed drug|0
7645928|NCT01553591|26600471|P2|Overall Study|Randomized and never dispensed drug|1
7645929|NCT01553591|26600472|P1|Overall Study|Randomized and never dispensed drug|0
7645930|NCT01553591|26600470|P3|Overall Study|Sponsor decision|3
7645931|NCT01553591|26600471|P2|Overall Study|Sponsor decision|0
7645932|NCT01553591|26600472|P1|Overall Study|Sponsor decision|1
7645933|NCT01553591|26600470|P3|Overall Study|Protocol Violation|4
7645934|NCT01553591|26600471|P2|Overall Study|Protocol Violation|4
7645935|NCT01553591|26600472|P1|Overall Study|Protocol Violation|3
7645936|NCT01553591|26600470|P3|Overall Study|Physician decision: lack of efficacy|7
7645937|NCT01553591|26600471|P2|Overall Study|Physician decision: lack of efficacy|3
7645938|NCT01553591|26600472|P1|Overall Study|Physician decision: lack of efficacy|2
7645939|NCT01553591|26600470|P3|Overall Study|Physician decision: other|16
7645940|NCT01553591|26600471|P2|Overall Study|Physician decision: other|14
7645941|NCT01553591|26600472|P1|Overall Study|Physician decision: other|11
7645942|NCT01553591|26600470|P3|Overall Study|Lost to Follow-up|16
7645943|NCT01553591|26600471|P2|Overall Study|Lost to Follow-up|23
7645944|NCT01553591|26600472|P1|Overall Study|Lost to Follow-up|25
7645945|NCT01553591|26600470|P3|Overall Study|Adverse Event|16
7645946|NCT01553591|26600471|P2|Overall Study|Adverse Event|45
7645947|NCT01553591|26600472|P1|Overall Study|Adverse Event|36
7645948|NCT01553591|26600470|P3|Overall Study|Voluntarily withdrew|96
7645949|NCT01553591|26600471|P2|Overall Study|Voluntarily withdrew|79
7645950|NCT01553591|26600472|P1|Overall Study|Voluntarily withdrew|94
7645951|NCT01553318|26600532|P2|Overall Study|Protocol Violation|2
7645952|NCT01553318|26600533|P1|Overall Study|Protocol Violation|3
7645953|NCT01553279|26600563|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
7645954|NCT01553279|26600564|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
7645955|NCT01553279|26600563|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
7645956|NCT01553279|26600564|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
7645957|NCT01553279|26600563|P2|Interim Period|Lost to Follow-up|0
7645958|NCT01553279|26600564|P1|Interim Period|Lost to Follow-up|1
7645959|NCT01553279|26600563|P2|Interim Period|Withdrawal by Subject|2
7645960|NCT01553279|26600564|P1|Interim Period|Withdrawal by Subject|2
7645961|NCT01553279|26600563|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7645962|NCT01553279|26600564|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7645963|NCT01553279|26600563|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
7645964|NCT01553279|26600564|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
7645965|NCT01553188|26600639|P4|Overall Study|Intercurrent illness and adverse event|0
7645966|NCT01553188|26600640|P3|Overall Study|Intercurrent illness and adverse event|2
7645967|NCT01553188|26600641|P2|Overall Study|Intercurrent illness and adverse event|1
7645968|NCT01553188|26600642|P1|Overall Study|Intercurrent illness and adverse event|0
7645969|NCT01553188|26600639|P4|Overall Study|Patient choice|0
7645970|NCT01553188|26600640|P3|Overall Study|Patient choice|0
7645971|NCT01553188|26600641|P2|Overall Study|Patient choice|0
7645972|NCT01553188|26600642|P1|Overall Study|Patient choice|1
7645973|NCT01553136|26600669|P2|Overall Study|Scheduling Difficulties|4
7645974|NCT01553136|26600670|P1|Overall Study|Scheduling Difficulties|5
7645975|NCT01553136|26600669|P2|Overall Study|Physician Decision|3
7645976|NCT01553136|26600670|P1|Overall Study|Physician Decision|2
7645977|NCT01553136|26600669|P2|Overall Study|Lost to Follow-up|10
7645978|NCT01553136|26600670|P1|Overall Study|Lost to Follow-up|4
7645979|NCT01553136|26600669|P2|Overall Study|Withdrawal by Subject|3
7645980|NCT01553136|26600670|P1|Overall Study|Withdrawal by Subject|2
7645981|NCT01553136|26600669|P2|Overall Study|Adverse Event|2
7645982|NCT01553136|26600670|P1|Overall Study|Adverse Event|3
7645983|NCT01553084|26600687|P3|Overall Study|Withdrawal by Subject|35
7645984|NCT01553084|26600688|P2|Overall Study|Withdrawal by Subject|13
7645985|NCT01553084|26600689|P1|Overall Study|Withdrawal by Subject|15
7645986|NCT01552954|26600771|P2|Overall Study|diagnosed DM|0
7645987|NCT01552954|26600772|P1|Overall Study|diagnosed DM|1
7645988|NCT01552954|26600771|P2|Overall Study|Protocol Violation|2
7645989|NCT01552954|26600772|P1|Overall Study|Protocol Violation|1
7645990|NCT01552954|26600771|P2|Overall Study|Withdrawal by Subject|1
7645991|NCT01552954|26600772|P1|Overall Study|Withdrawal by Subject|1
7645992|NCT01552954|26600771|P2|Overall Study|Lost to Follow-up|1
7645993|NCT01552954|26600772|P1|Overall Study|Lost to Follow-up|1
7645994|NCT01552954|26600771|P2|Overall Study|Adverse Event|2
7645995|NCT01552954|26600772|P1|Overall Study|Adverse Event|1
7645996|NCT01552928|26600788|P4|Period 3|Adverse Event|0
7645997|NCT01552928|26600789|P3|Period 3|Adverse Event|1
7645998|NCT01552928|26600790|P2|Period 3|Adverse Event|0
7645999|NCT01552928|26600791|P1|Period 3|Adverse Event|0
7646000|NCT01552915|26600838|P3|Overall Study|Other|6
7646001|NCT01552915|26600839|P2|Overall Study|Other|0
7646002|NCT01552915|26600840|P1|Overall Study|Other|2
7646003|NCT01552915|26600838|P3|Overall Study|Lack of Efficacy|4
7646004|NCT01552915|26600839|P2|Overall Study|Lack of Efficacy|1
7646005|NCT01552915|26600840|P1|Overall Study|Lack of Efficacy|8
7646006|NCT01552915|26600838|P3|Overall Study|Protocol Violation|4
7646007|NCT01552915|26600839|P2|Overall Study|Protocol Violation|4
7646008|NCT01552915|26600840|P1|Overall Study|Protocol Violation|0
7646009|NCT01552915|26600838|P3|Overall Study|Withdrawal by Subject|5
7646010|NCT01552915|26600839|P2|Overall Study|Withdrawal by Subject|4
7646011|NCT01552915|26600840|P1|Overall Study|Withdrawal by Subject|6
7646012|NCT01552915|26600838|P3|Overall Study|Lost to Follow-up|5
7646013|NCT01552915|26600839|P2|Overall Study|Lost to Follow-up|6
7646014|NCT01552915|26600840|P1|Overall Study|Lost to Follow-up|4
7646015|NCT01552915|26600838|P3|Overall Study|Adverse Event|3
7646016|NCT01552915|26600839|P2|Overall Study|Adverse Event|14
7646017|NCT01552915|26600840|P1|Overall Study|Adverse Event|3
7646018|NCT01552902|26600863|P3|Overall Study|Other|3
7646019|NCT01552902|26600864|P2|Overall Study|Other|4
7646020|NCT01552902|26600865|P1|Overall Study|Other|3
7646021|NCT01552902|26600863|P3|Overall Study|Lost to Follow-up|6
7646022|NCT01552902|26600864|P2|Overall Study|Lost to Follow-up|3
7646023|NCT01552902|26600865|P1|Overall Study|Lost to Follow-up|1
7646024|NCT01552902|26600863|P3|Overall Study|Withdrawal by Subject|6
7646025|NCT01552902|26600864|P2|Overall Study|Withdrawal by Subject|9
7646026|NCT01552902|26600865|P1|Overall Study|Withdrawal by Subject|1
7646027|NCT01552902|26600863|P3|Overall Study|Lack of Efficacy|1
7646028|NCT01552902|26600864|P2|Overall Study|Lack of Efficacy|3
7646029|NCT01552902|26600865|P1|Overall Study|Lack of Efficacy|4
7646030|NCT01552902|26600863|P3|Overall Study|Protocol Violation|3
7646031|NCT01552902|26600864|P2|Overall Study|Protocol Violation|3
7646032|NCT01552902|26600865|P1|Overall Study|Protocol Violation|3
7646033|NCT01552902|26600863|P3|Overall Study|Adverse Event|14
7646034|NCT01552902|26600864|P2|Overall Study|Adverse Event|15
7646035|NCT01552902|26600865|P1|Overall Study|Adverse Event|1
7646036|NCT01552772|26600915|P1|Overall Study|Protocol Deviation|1
7646037|NCT01552772|26600915|P1|Overall Study|Adverse Event|1
7646038|NCT01552772|26600915|P1|Overall Study|Lost to Follow-up|2
7646039|NCT01552694|26600931|P2|Overall Study|Protocol Violation|1
7646040|NCT01552694|26600932|P1|Overall Study|Protocol Violation|0
7646041|NCT01552694|26600931|P2|Overall Study|Lost to Follow-up|1
7646042|NCT01552694|26600932|P1|Overall Study|Lost to Follow-up|0
7646043|NCT01552681|26600948|P2|Overall Study|Subject moved away|1
7646044|NCT01552681|26600949|P1|Overall Study|Subject moved away|0
7646045|NCT01552681|26600948|P2|Overall Study|Physician Decision|0
7646046|NCT01552681|26600949|P1|Overall Study|Physician Decision|1
7646047|NCT01552681|26600948|P2|Overall Study|Withdrawal by Subject|0
7646048|NCT01552681|26600949|P1|Overall Study|Withdrawal by Subject|4
7646049|NCT01552603|26600997|P1|Overall Study|Physician Decision|1
7646050|NCT01552408|26601004|P2|Overall Study|Withdrawal by Subject|1
7646051|NCT01552408|26601005|P1|Overall Study|Withdrawal by Subject|2
7646052|NCT01552408|26601004|P2|Overall Study|Relocation|1
7646053|NCT01552408|26601005|P1|Overall Study|Relocation|0
7646054|NCT01552408|26601004|P2|Overall Study|Lost to Follow-up|0
7646055|NCT01552408|26601005|P1|Overall Study|Lost to Follow-up|2
7646056|NCT01552369|26601027|P2|Overall Study|Did not consent to extended follow up|9
7646057|NCT01552369|26601028|P1|Overall Study|Did not consent to extended follow up|8
7646058|NCT01552057|26601117|P2|Overall Study|Physician Decision|0
7646059|NCT01552057|26601118|P1|Overall Study|Physician Decision|1
7646060|NCT01552057|26601117|P2|Overall Study|Entry Criteria Not Met|2
7646061|NCT01552057|26601118|P1|Overall Study|Entry Criteria Not Met|2
7646062|NCT01552057|26601117|P2|Overall Study|Withdrawal by Subject|8
7646063|NCT01552057|26601118|P1|Overall Study|Withdrawal by Subject|5
7646064|NCT01552057|26601117|P2|Overall Study|Lack of Efficacy|23
7646065|NCT01552057|26601118|P1|Overall Study|Lack of Efficacy|8
7646066|NCT01552057|26601117|P2|Overall Study|Adverse Event|15
7646067|NCT01552057|26601118|P1|Overall Study|Adverse Event|14
7646068|NCT01551758|26601184|P2|Overall Study|Withdrawal by Subject|17
7646069|NCT01551758|26601185|P1|Overall Study|Withdrawal by Subject|14
7646070|NCT01551758|26601184|P2|Overall Study|Physician Decision|3
7646071|NCT01551758|26601185|P1|Overall Study|Physician Decision|9
7646072|NCT01551758|26601184|P2|Overall Study|Lost to Follow-up|25
7646073|NCT01551758|26601185|P1|Overall Study|Lost to Follow-up|29
7646074|NCT01551758|26601184|P2|Overall Study|Met Protocol-defined stopping criteria|10
7646075|NCT01551758|26601185|P1|Overall Study|Met Protocol-defined stopping criteria|8
7646076|NCT01551758|26601184|P2|Overall Study|Protocol Violation|6
7646077|NCT01551758|26601185|P1|Overall Study|Protocol Violation|5
7646078|NCT01551758|26601184|P2|Overall Study|Lack of Efficacy|1
7646079|NCT01551758|26601185|P1|Overall Study|Lack of Efficacy|0
7646080|NCT01551758|26601184|P2|Overall Study|Adverse Event|43
7646081|NCT01551758|26601185|P1|Overall Study|Adverse Event|29
7646084|NCT01551693|26601232|P2|Overall Study|Withdrawal by Subject|1
7646085|NCT01551693|26601233|P1|Overall Study|Withdrawal by Subject|0
7646086|NCT01551693|26601232|P2|Overall Study|Adverse Event|1
7646087|NCT01551693|26601233|P1|Overall Study|Adverse Event|0
7646088|NCT01551693|26601232|P2|Overall Study|Disease Progression|0
7646089|NCT01551693|26601233|P1|Overall Study|Disease Progression|1
7646090|NCT01551420|26601254|P2|Home Use (Part B)|Withdrawal by staff|1
7646091|NCT01551420|26601255|P1|Home Use (Part B)|Withdrawal by staff|0
7646092|NCT01551420|26601254|P2|Home Use (Part B)|Withdrawal by Subject|0
7646093|NCT01551420|26601255|P1|Home Use (Part B)|Withdrawal by Subject|6
7646094|NCT01551420|26601254|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
7646095|NCT01551420|26601255|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
7646096|NCT01551420|26601254|P2|Screened for Part B Eligibility|Declined participation|1
7646097|NCT01551420|26601255|P1|Screened for Part B Eligibility|Declined participation|8
7646098|NCT01551420|26601254|P2|In-laboratory (Part A)|Scheduling conflict|1
7646099|NCT01551420|26601255|P1|In-laboratory (Part A)|Scheduling conflict|2
7646100|NCT01551420|26601254|P2|In-laboratory (Part A)|Withdrawal by Subject|0
7646101|NCT01551420|26601255|P1|In-laboratory (Part A)|Withdrawal by Subject|2
7646102|NCT01551420|26601254|P2|In-laboratory (Part A)|Lost to Follow-up|1
7646103|NCT01551420|26601255|P1|In-laboratory (Part A)|Lost to Follow-up|2
7646104|NCT01551355|26601285|P6|Overall Study|Lost to Follow-up|6
7646105|NCT01551355|26601286|P5|Overall Study|Lost to Follow-up|9
7646106|NCT01551355|26601287|P4|Overall Study|Lost to Follow-up|24
7646107|NCT01551355|26601288|P3|Overall Study|Lost to Follow-up|34
7646108|NCT01551355|26601289|P2|Overall Study|Lost to Follow-up|49
7646109|NCT01551355|26601290|P1|Overall Study|Lost to Follow-up|51
7646110|NCT01551303|26601304|P2|Overall Study|failed awareness check on vision test|7
7646111|NCT01551303|26601305|P1|Overall Study|failed awareness check on vision test|4
7646112|NCT01551212|26601313|P2|Overall Study|Never Received Study Treatment|4
7646113|NCT01551212|26601314|P1|Overall Study|Never Received Study Treatment|2
7646114|NCT01551212|26601313|P2|Overall Study|Death|4
7646115|NCT01551212|26601314|P1|Overall Study|Death|2
7646116|NCT01551212|26601313|P2|Overall Study|Withdrawal by Subject|7
7646117|NCT01551212|26601314|P1|Overall Study|Withdrawal by Subject|0
7646118|NCT01551212|26601313|P2|Overall Study|Protocol Violation|1
7646119|NCT01551212|26601314|P1|Overall Study|Protocol Violation|0
7646120|NCT01551212|26601313|P2|Overall Study|Lost to Follow-up|1
7646121|NCT01551212|26601314|P1|Overall Study|Lost to Follow-up|0
7646122|NCT01551212|26601313|P2|Overall Study|Administrative problems|2
7646123|NCT01551212|26601314|P1|Overall Study|Administrative problems|1
7646124|NCT01551212|26601313|P2|Overall Study|Graft loss/Retransplantation|1
7646125|NCT01551212|26601314|P1|Overall Study|Graft loss/Retransplantation|0
7646126|NCT01551173|26601349|P2|Overall Study|Other|3
7646127|NCT01551173|26601350|P1|Overall Study|Other|5
7646128|NCT01551173|26601349|P2|Overall Study|Lost to Follow-up|7
7646129|NCT01551173|26601350|P1|Overall Study|Lost to Follow-up|5
7646130|NCT01551173|26601349|P2|Overall Study|Adverse Event|6
7646131|NCT01551173|26601350|P1|Overall Study|Adverse Event|7
7646132|NCT01551173|26601349|P2|Overall Study|Withdrawal by Subject|16
7646133|NCT01551173|26601350|P1|Overall Study|Withdrawal by Subject|11
7646134|NCT01550965|26601434|P1|Overall Study|Other|13
7646135|NCT01550965|26601434|P1|Overall Study|Lack of Efficacy|59
7646136|NCT01550965|26601434|P1|Overall Study|Lost to Follow-up|2
7646137|NCT01550965|26601434|P1|Overall Study|Withdrawal by Subject|10
7646138|NCT01550965|26601434|P1|Overall Study|Adverse Event|26
7646139|NCT01550757|26601478|P4|Overall Study|Withdrawal by Subject|1
7646140|NCT01550757|26601479|P3|Overall Study|Withdrawal by Subject|3
7646141|NCT01550757|26601480|P2|Overall Study|Withdrawal by Subject|0
7646142|NCT01550757|26601481|P1|Overall Study|Withdrawal by Subject|2
7646143|NCT01550757|26601478|P4|Overall Study|Lost to Follow-up|53
7646144|NCT01550757|26601479|P3|Overall Study|Lost to Follow-up|42
7646145|NCT01550757|26601480|P2|Overall Study|Lost to Follow-up|14
7646146|NCT01550757|26601481|P1|Overall Study|Lost to Follow-up|21
7646147|NCT01550744|26601491|P3|Double-Blind|Other|10
7646148|NCT01550744|26601492|P2|Double-Blind|Other|2
7646149|NCT01550744|26601493|P1|Double-Blind|Other|0
7646150|NCT01550744|26601491|P3|Double-Blind|Pregnancy|3
7646151|NCT01550744|26601492|P2|Double-Blind|Pregnancy|0
7646152|NCT01550744|26601493|P1|Double-Blind|Pregnancy|0
7646153|NCT01550744|26601491|P3|Double-Blind|Protocol Violation|4
7646154|NCT01550744|26601492|P2|Double-Blind|Protocol Violation|0
7646155|NCT01550744|26601493|P1|Double-Blind|Protocol Violation|0
7646156|NCT01550744|26601491|P3|Double-Blind|Lack of Efficacy|8
7646157|NCT01550744|26601492|P2|Double-Blind|Lack of Efficacy|2
7646158|NCT01550744|26601493|P1|Double-Blind|Lack of Efficacy|0
7646159|NCT01550744|26601491|P3|Double-Blind|Death|0
7646160|NCT01550744|26601492|P2|Double-Blind|Death|1
7646161|NCT01550744|26601493|P1|Double-Blind|Death|0
7646162|NCT01550744|26601491|P3|Double-Blind|Adverse Event|15
7646163|NCT01550744|26601492|P2|Double-Blind|Adverse Event|4
7646164|NCT01550744|26601493|P1|Double-Blind|Adverse Event|0
7646165|NCT01550744|26601491|P3|Double-Blind|Withdrawal by Subject|15
7646166|NCT01550744|26601492|P2|Double-Blind|Withdrawal by Subject|2
7646167|NCT01550744|26601493|P1|Double-Blind|Withdrawal by Subject|0
7646168|NCT01550744|26601491|P3|Double-Blind|Lost to Follow-up|12
7646169|NCT01550744|26601492|P2|Double-Blind|Lost to Follow-up|6
7646170|NCT01550744|26601493|P1|Double-Blind|Lost to Follow-up|0
7646171|NCT01550744|26601491|P3|Open-Label|Other|0
7646172|NCT01550744|26601492|P2|Open-Label|Other|0
7646173|NCT01550744|26601493|P1|Open-Label|Other|1
7646174|NCT01550744|26601491|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
7646175|NCT01550744|26601492|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
7646176|NCT01550744|26601493|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
7646177|NCT01550744|26601491|P3|Open-Label|Not all 3 study drug injections received|0
7646178|NCT01550744|26601492|P2|Open-Label|Not all 3 study drug injections received|0
7646179|NCT01550744|26601493|P1|Open-Label|Not all 3 study drug injections received|2
7646180|NCT01550744|26601491|P3|Open-Label|Protocol Violation|0
7646181|NCT01550744|26601492|P2|Open-Label|Protocol Violation|0
7646182|NCT01550744|26601493|P1|Open-Label|Protocol Violation|4
7646183|NCT01550744|26601491|P3|Open-Label|Lack of Efficacy|0
7646184|NCT01550744|26601492|P2|Open-Label|Lack of Efficacy|0
7646185|NCT01550744|26601493|P1|Open-Label|Lack of Efficacy|4
7646186|NCT01550744|26601491|P3|Open-Label|Adverse Event|0
7646187|NCT01550744|26601492|P2|Open-Label|Adverse Event|0
7646188|NCT01550744|26601493|P1|Open-Label|Adverse Event|11
7646189|NCT01550744|26601491|P3|Open-Label|Withdrawal by Subject|0
7646190|NCT01550744|26601492|P2|Open-Label|Withdrawal by Subject|0
7646191|NCT01550744|26601493|P1|Open-Label|Withdrawal by Subject|13
7646192|NCT01550744|26601491|P3|Open-Label|Lost to Follow-up|0
7646193|NCT01550744|26601492|P2|Open-Label|Lost to Follow-up|0
7646194|NCT01550744|26601493|P1|Open-Label|Lost to Follow-up|7
7646195|NCT01550289|26601651|P2|Overall Study|Withdrawal by Subject|3
7646196|NCT01550289|26601652|P1|Overall Study|Withdrawal by Subject|11
7646197|NCT01550289|26601651|P2|Overall Study|Lost to Follow-up|1
7646198|NCT01550289|26601652|P1|Overall Study|Lost to Follow-up|1
7646199|NCT01550289|26601651|P2|Overall Study|Protocol Violation|0
7646200|NCT01550289|26601652|P1|Overall Study|Protocol Violation|1
7646201|NCT01549964|26601728|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
7646202|NCT01549964|26601729|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
7646203|NCT01549964|26601730|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7646204|NCT01549964|26601731|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7646205|NCT01549964|26601728|P4|80-Week Extension Period|Lost to Follow-up|1
7646206|NCT01549964|26601729|P3|80-Week Extension Period|Lost to Follow-up|2
7646207|NCT01549964|26601730|P2|80-Week Extension Period|Lost to Follow-up|0
7646208|NCT01549964|26601731|P1|80-Week Extension Period|Lost to Follow-up|1
7646209|NCT01549964|26601728|P4|80-Week Extension Period|Voluntary Withdrawal|2
7646210|NCT01549964|26601729|P3|80-Week Extension Period|Voluntary Withdrawal|4
7646211|NCT01549964|26601730|P2|80-Week Extension Period|Voluntary Withdrawal|1
7646212|NCT01549964|26601731|P1|80-Week Extension Period|Voluntary Withdrawal|0
7646213|NCT01549964|26601728|P4|80-Week Extension Period|Study Terminated by Sponsor|132
7646214|NCT01549964|26601729|P3|80-Week Extension Period|Study Terminated by Sponsor|132
7646215|NCT01549964|26601730|P2|80-Week Extension Period|Study Terminated by Sponsor|137
7646216|NCT01549964|26601731|P1|80-Week Extension Period|Study Terminated by Sponsor|65
7646217|NCT01549964|26601728|P4|80-Week Extension Period|Pregnancy|0
7646218|NCT01549964|26601729|P3|80-Week Extension Period|Pregnancy|1
7646219|NCT01549964|26601730|P2|80-Week Extension Period|Pregnancy|0
7646220|NCT01549964|26601731|P1|80-Week Extension Period|Pregnancy|0
7646221|NCT01549964|26601728|P4|24-Week Treatment Period|Completion Status Unknown|0
7646222|NCT01549964|26601729|P3|24-Week Treatment Period|Completion Status Unknown|1
7646223|NCT01549964|26601730|P2|24-Week Treatment Period|Completion Status Unknown|0
7646224|NCT01549964|26601731|P1|24-Week Treatment Period|Completion Status Unknown|1
7646225|NCT01549964|26601728|P4|24-Week Treatment Period|Randomized but Not Treated|1
7646226|NCT01549964|26601729|P3|24-Week Treatment Period|Randomized but Not Treated|0
7646227|NCT01549964|26601730|P2|24-Week Treatment Period|Randomized but Not Treated|0
7646228|NCT01549964|26601731|P1|24-Week Treatment Period|Randomized but Not Treated|0
7646229|NCT01549964|26601728|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7646230|NCT01549964|26601729|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
7646231|NCT01549964|26601730|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7646232|NCT01549964|26601731|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7646233|NCT01549964|26601728|P4|24-Week Treatment Period|Other|0
7646234|NCT01549964|26601729|P3|24-Week Treatment Period|Other|1
7646235|NCT01549964|26601730|P2|24-Week Treatment Period|Other|0
7646236|NCT01549964|26601731|P1|24-Week Treatment Period|Other|1
7646237|NCT01549964|26601728|P4|24-Week Treatment Period|Lack of Efficacy|1
7646238|NCT01549964|26601729|P3|24-Week Treatment Period|Lack of Efficacy|1
7646239|NCT01549964|26601730|P2|24-Week Treatment Period|Lack of Efficacy|0
7646240|NCT01549964|26601731|P1|24-Week Treatment Period|Lack of Efficacy|1
7646241|NCT01549964|26601728|P4|24-Week Treatment Period|Lost to Follow-up|2
7646242|NCT01549964|26601729|P3|24-Week Treatment Period|Lost to Follow-up|1
7646243|NCT01549964|26601730|P2|24-Week Treatment Period|Lost to Follow-up|0
7646244|NCT01549964|26601731|P1|24-Week Treatment Period|Lost to Follow-up|1
7646245|NCT01549964|26601728|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7646246|NCT01549964|26601729|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7646247|NCT01549964|26601730|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7646248|NCT01549964|26601731|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
7646249|NCT01549964|26601728|P4|24-Week Treatment Period|Voluntary Withdrawal|8
7646250|NCT01549964|26601729|P3|24-Week Treatment Period|Voluntary Withdrawal|3
7646251|NCT01549964|26601730|P2|24-Week Treatment Period|Voluntary Withdrawal|3
7646252|NCT01549964|26601731|P1|24-Week Treatment Period|Voluntary Withdrawal|6
7646253|NCT01549964|26601728|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
7646254|NCT01549964|26601729|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
7646255|NCT01549964|26601730|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
7646256|NCT01549964|26601731|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
7646257|NCT01549951|26601749|P1|Overall Study|Other|2
7646258|NCT01549951|26601749|P1|Overall Study|Symptomatic deterioration|1
7646259|NCT01549951|26601749|P1|Overall Study|Progressive disease|29
7646260|NCT01549951|26601749|P1|Overall Study|Unsatisfactory therapeutic response|1
7646261|NCT01549951|26601749|P1|Overall Study|Withdrawal by Subject|2
7646262|NCT01549951|26601749|P1|Overall Study|Adverse Event|15
7646263|NCT01549886|26601776|P2|Overall Study|Sponsor's decision|3
7646264|NCT01549886|26601777|P1|Overall Study|Sponsor's decision|2
7646265|NCT01549873|26601789|P2|Overall Study|Physician Decision|1
7646266|NCT01549873|26601790|P1|Overall Study|Physician Decision|0
7646267|NCT01549860|26601802|P2|Overall Study|Physician Decision|1
7646268|NCT01549860|26601803|P1|Overall Study|Physician Decision|1
7646269|NCT01549860|26601802|P2|Overall Study|Withdrawal by Subject|0
7646270|NCT01549860|26601803|P1|Overall Study|Withdrawal by Subject|1
7646271|NCT01549652|26601816|P4|Overall Study|Withdrawal by Subject|3
7646272|NCT01549652|26601817|P3|Overall Study|Withdrawal by Subject|5
7646273|NCT01549652|26601818|P2|Overall Study|Withdrawal by Subject|0
7646274|NCT01549652|26601819|P1|Overall Study|Withdrawal by Subject|0
7646275|NCT01549652|26601816|P4|Overall Study|Titration Side Effects|3
7646276|NCT01549652|26601817|P3|Overall Study|Titration Side Effects|6
7646277|NCT01549652|26601818|P2|Overall Study|Titration Side Effects|0
7646278|NCT01549652|26601819|P1|Overall Study|Titration Side Effects|0
7646279|NCT01549652|26601816|P4|Overall Study|Titration Non-Compliance|5
7646280|NCT01549652|26601817|P3|Overall Study|Titration Non-Compliance|4
7646281|NCT01549652|26601818|P2|Overall Study|Titration Non-Compliance|3
7646282|NCT01549652|26601819|P1|Overall Study|Titration Non-Compliance|1
7646283|NCT01549652|26601816|P4|Overall Study|Problem with Infusion|0
7646284|NCT01549652|26601817|P3|Overall Study|Problem with Infusion|0
7646285|NCT01549652|26601818|P2|Overall Study|Problem with Infusion|0
7646286|NCT01549652|26601819|P1|Overall Study|Problem with Infusion|1
7646287|NCT01549652|26601816|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
7646288|NCT01549652|26601817|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
7646289|NCT01549652|26601818|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
7646290|NCT01549652|26601819|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
7646291|NCT01549652|26601816|P4|Overall Study|Withdrawal Effect|0
7646292|NCT01549652|26601817|P3|Overall Study|Withdrawal Effect|0
7646293|NCT01549652|26601818|P2|Overall Study|Withdrawal Effect|2
7646294|NCT01549652|26601819|P1|Overall Study|Withdrawal Effect|0
7646295|NCT01549652|26601816|P4|Overall Study|Study Drug Titration Failure|0
7646296|NCT01549652|26601817|P3|Overall Study|Study Drug Titration Failure|0
7646297|NCT01549652|26601818|P2|Overall Study|Study Drug Titration Failure|6
7646298|NCT01549652|26601819|P1|Overall Study|Study Drug Titration Failure|5
7646299|NCT01549652|26601816|P4|Overall Study|Did Not Receive Allocated Intervention|0
7646300|NCT01549652|26601817|P3|Overall Study|Did Not Receive Allocated Intervention|2
7646301|NCT01549652|26601818|P2|Overall Study|Did Not Receive Allocated Intervention|0
7646302|NCT01549652|26601819|P1|Overall Study|Did Not Receive Allocated Intervention|0
7646303|NCT01549613|26601837|P2|Overall Study|Lost to Follow-up|11
7646304|NCT01549613|26601838|P1|Overall Study|Lost to Follow-up|11
7646305|NCT01549392|26601876|P2|Overall Study|Withdrawal by Subject|0
7646306|NCT01549392|26601877|P1|Overall Study|Withdrawal by Subject|1
7646307|NCT01549275|26601915|P2|Overall Study|Lost to Follow-up|0
7646308|NCT01549275|26601916|P1|Overall Study|Lost to Follow-up|1
7646309|NCT01549041|26601939|P2|Overall Study|Adverse Event|4
7646310|NCT01549041|26601940|P1|Overall Study|Adverse Event|0
7646311|NCT01549041|26601939|P2|Overall Study|Lack of Efficacy|4
7646312|NCT01549041|26601940|P1|Overall Study|Lack of Efficacy|2
7646313|NCT01549002|26601950|P2|Overall Study|Moderate sedation required|2
7646314|NCT01549002|26601951|P1|Overall Study|Moderate sedation required|0
7646315|NCT01549002|26601950|P2|Overall Study|Excessive pain|2
7646316|NCT01549002|26601951|P1|Overall Study|Excessive pain|0
7646317|NCT01548768|26601978|P4|Overall Study|Non-Compliance|3
7646318|NCT01548768|26601979|P3|Overall Study|Non-Compliance|0
7646319|NCT01548768|26601980|P2|Overall Study|Non-Compliance|0
7646320|NCT01548768|26601981|P1|Overall Study|Non-Compliance|0
7646321|NCT01548768|26601978|P4|Overall Study|Adverse Event|1
7646322|NCT01548768|26601979|P3|Overall Study|Adverse Event|0
7646323|NCT01548768|26601980|P2|Overall Study|Adverse Event|0
7646324|NCT01548768|26601981|P1|Overall Study|Adverse Event|0
7646325|NCT01548768|26601978|P4|Overall Study|Physician Decision|0
7646326|NCT01548768|26601979|P3|Overall Study|Physician Decision|0
7646327|NCT01548768|26601980|P2|Overall Study|Physician Decision|0
7646328|NCT01548768|26601981|P1|Overall Study|Physician Decision|1
7646329|NCT01548768|26601978|P4|Overall Study|Withdrawal by Subject|0
7646330|NCT01548768|26601979|P3|Overall Study|Withdrawal by Subject|1
7646331|NCT01548768|26601980|P2|Overall Study|Withdrawal by Subject|2
7646332|NCT01548768|26601981|P1|Overall Study|Withdrawal by Subject|0
7646333|NCT01548638|26602059|P1|Overall Study|Withdrawal by Subject|1
7646334|NCT01548638|26602059|P1|Overall Study|Protocol Violation|3
7646335|NCT01548599|26602071|P2|Overall Study|Death|1
7646336|NCT01548599|26602072|P1|Overall Study|Death|2
7646337|NCT01548599|26602071|P2|Overall Study|Withdrawal by Subject|0
7646338|NCT01548599|26602072|P1|Overall Study|Withdrawal by Subject|4
7646339|NCT01548599|26602071|P2|Overall Study|Lost to Follow-up|1
7646340|NCT01548599|26602072|P1|Overall Study|Lost to Follow-up|0
7646341|NCT01548573|26602088|P1|Overall Study|Withdrawal by Subject|2
7646342|NCT01548573|26602088|P1|Overall Study|Death|3
7646343|NCT01548417|26602097|P2|Overall Study|Withdrawal by Subject|2
7646344|NCT01548417|26602098|P1|Overall Study|Withdrawal by Subject|0
7646345|NCT01548404|26602108|P2|Overall Study|Other than specified above|2
7646346|NCT01548404|26602109|P1|Overall Study|Other than specified above|0
7646347|NCT01548404|26602108|P2|Overall Study|Withdrawal by Subject|3
7646348|NCT01548404|26602109|P1|Overall Study|Withdrawal by Subject|0
7646349|NCT01548404|26602108|P2|Overall Study|Lost to Follow-up|0
7646350|NCT01548404|26602109|P1|Overall Study|Lost to Follow-up|2
7646351|NCT01548404|26602108|P2|Overall Study|Inadequate response to study treatment|7
7646352|NCT01548404|26602109|P1|Overall Study|Inadequate response to study treatment|23
7646353|NCT01548404|26602108|P2|Overall Study|Physician Decision|1
7646354|NCT01548404|26602109|P1|Overall Study|Physician Decision|2
7646355|NCT01548404|26602108|P2|Overall Study|Adverse Event|1
7646356|NCT01548404|26602109|P1|Overall Study|Adverse Event|3
7646357|NCT01548287|26602148|P5|Randomized Period|Adverse Event|0
7646358|NCT01548287|26602149|P4|Randomized Period|Adverse Event|0
7646359|NCT01548287|26602150|P3|Randomized Period|Adverse Event|5
7646360|NCT01548287|26602151|P2|Randomized Period|Adverse Event|2
7646361|NCT01548287|26602152|P1|Randomized Period|Adverse Event|0
7646362|NCT01548287|26602148|P5|Randomized Period|Did not meet inclusion criteria|0
7646363|NCT01548287|26602149|P4|Randomized Period|Did not meet inclusion criteria|0
7646364|NCT01548287|26602150|P3|Randomized Period|Did not meet inclusion criteria|2
7646365|NCT01548287|26602151|P2|Randomized Period|Did not meet inclusion criteria|0
7646366|NCT01548287|26602152|P1|Randomized Period|Did not meet inclusion criteria|0
7646367|NCT01548287|26602148|P5|Screening|Did not meet eligibility criteria|74
7646368|NCT01548287|26602149|P4|Screening|Did not meet eligibility criteria|0
7646369|NCT01548287|26602150|P3|Screening|Did not meet eligibility criteria|0
7646370|NCT01548287|26602151|P2|Screening|Did not meet eligibility criteria|0
7646371|NCT01548287|26602152|P1|Screening|Did not meet eligibility criteria|0
7646372|NCT01548287|26602148|P5|Screening|No reason provided|9
7646373|NCT01548287|26602149|P4|Screening|No reason provided|0
7646374|NCT01548287|26602150|P3|Screening|No reason provided|0
7646375|NCT01548287|26602151|P2|Screening|No reason provided|0
7646376|NCT01548287|26602152|P1|Screening|No reason provided|0
7646377|NCT01547780|26602212|P4|Baseline PET Scan|Withdrawal by Subject|0
7646378|NCT01547780|26602213|P3|Baseline PET Scan|Withdrawal by Subject|1
7646379|NCT01547780|26602214|P2|Baseline PET Scan|Withdrawal by Subject|0
7646380|NCT01547780|26602215|P1|Baseline PET Scan|Withdrawal by Subject|2
7646381|NCT01547780|26602212|P4|Baseline PET Scan|Physician Decision|0
7646382|NCT01547780|26602213|P3|Baseline PET Scan|Physician Decision|1
7646383|NCT01547780|26602214|P2|Baseline PET Scan|Physician Decision|0
7646384|NCT01547780|26602215|P1|Baseline PET Scan|Physician Decision|1
7646385|NCT01547728|26602229|P1|Overall Study|Screen failure|39
7646386|NCT01547728|26602229|P1|Overall Study|Drug not ready for subject|1
7646387|NCT01547728|26602229|P1|Overall Study|Change in procedure and equipment|1
7646388|NCT01547598|26602338|P2|Overall Study|Other Miscellaneous Reasons|1
7646389|NCT01547598|26602339|P1|Overall Study|Other Miscellaneous Reasons|2
7646390|NCT01547598|26602338|P2|Overall Study|Protocol Violation|1
7646391|NCT01547598|26602339|P1|Overall Study|Protocol Violation|1
7646392|NCT01547598|26602338|P2|Overall Study|Adverse Event|1
7646393|NCT01547598|26602339|P1|Overall Study|Adverse Event|1
7646394|NCT01547598|26602338|P2|Overall Study|Lost to Follow-up|1
7646395|NCT01547598|26602339|P1|Overall Study|Lost to Follow-up|1
7646396|NCT01547598|26602338|P2|Overall Study|Withdrew consent|1
7646397|NCT01547598|26602339|P1|Overall Study|Withdrew consent|1
7646398|NCT01547390|26602356|P2|Overall Study|Adverse Event|0
7646399|NCT01547390|26602357|P1|Overall Study|Adverse Event|3
7646400|NCT01547390|26602356|P2|Overall Study|Lost to Follow-up|2
7646401|NCT01547390|26602357|P1|Overall Study|Lost to Follow-up|0
7646402|NCT01547390|26602356|P2|Overall Study|termination of pregnancy|1
7646403|NCT01547390|26602357|P1|Overall Study|termination of pregnancy|0
7646404|NCT01547390|26602356|P2|Overall Study|Withdrawal by Subject|7
7646405|NCT01547390|26602357|P1|Overall Study|Withdrawal by Subject|10
7646406|NCT01547299|26602367|P2|Overall Study|Withdrawal by Subject|2
7646407|NCT01547299|26602368|P1|Overall Study|Withdrawal by Subject|2
7646408|NCT01547286|26602434|P1|Overall Study|Physician Decision|1
7646409|NCT01547286|26602434|P1|Overall Study|Did not meet all eligibility criteria|1
7646410|NCT01547130|26602454|P2|Overall Study|Lost to Follow-up|5
7646411|NCT01547130|26602455|P1|Overall Study|Lost to Follow-up|9
7646412|NCT01546922|26602478|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
7646413|NCT01546922|26602479|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
7646414|NCT01546922|26602478|P2|Second Period of 10 Weeks|Protocol Violation|1
7646415|NCT01546922|26602479|P1|Second Period of 10 Weeks|Protocol Violation|3
7646416|NCT01546922|26602478|P2|First Period of 10 Weeks|Investigator's judgment|0
7646417|NCT01546922|26602479|P1|First Period of 10 Weeks|Investigator's judgment|1
7646418|NCT01546922|26602478|P2|First Period of 10 Weeks|Withdrawal by Subject|1
7646419|NCT01546922|26602479|P1|First Period of 10 Weeks|Withdrawal by Subject|1
7646420|NCT01546922|26602478|P2|First Period of 10 Weeks|Protocol Violation|1
7646421|NCT01546922|26602479|P1|First Period of 10 Weeks|Protocol Violation|3
7646422|NCT01546883|26602485|P1|Overall Study|other unrelated illness|1
7646423|NCT01546883|26602485|P1|Overall Study|early closure of study|2
7646424|NCT01546883|26602485|P1|Overall Study|Lost to Follow-up|2
7646425|NCT01546883|26602485|P1|Overall Study|Adverse Event|4
7646426|NCT01546883|26602485|P1|Overall Study|Withdrawal by Subject|3
7646427|NCT01546857|26602491|P2|Overall Study|Withdrawal by Subject|3
7646428|NCT01546857|26602492|P1|Overall Study|Withdrawal by Subject|2
7646429|NCT01546688|26602506|P2|Overall Study|Lack of Efficacy|0
7646430|NCT01546688|26602507|P1|Overall Study|Lack of Efficacy|1
7646431|NCT01546688|26602506|P2|Overall Study|Withdrawal by Subject|1
7646432|NCT01546688|26602507|P1|Overall Study|Withdrawal by Subject|2
7646433|NCT01546688|26602506|P2|Overall Study|Adverse Event|4
7646434|NCT01546688|26602507|P1|Overall Study|Adverse Event|0
7646435|NCT01546649|26602539|P2|Overall Study|Withdrawal by Subject|2
7646436|NCT01546649|26602540|P1|Overall Study|Withdrawal by Subject|1
7646437|NCT01546649|26602539|P2|Overall Study|Discovery of secondary cancer|1
7646438|NCT01546649|26602540|P1|Overall Study|Discovery of secondary cancer|0
7646439|NCT01546649|26602539|P2|Overall Study|Recurrence|1
7646440|NCT01546649|26602540|P1|Overall Study|Recurrence|1
7646441|NCT01546649|26602539|P2|Overall Study|Lack of Efficacy|0
7646442|NCT01546649|26602540|P1|Overall Study|Lack of Efficacy|1
7646443|NCT01546649|26602539|P2|Overall Study|Protocol Violation|0
7646444|NCT01546649|26602540|P1|Overall Study|Protocol Violation|1
7646445|NCT01546649|26602539|P2|Overall Study|Adverse Event|5
7646446|NCT01546649|26602540|P1|Overall Study|Adverse Event|4
7646447|NCT01546623|26602575|P2|Overall Study|Did Not Receive Study Drug|1
7646448|NCT01546623|26602576|P1|Overall Study|Did Not Receive Study Drug|1
7646449|NCT01546623|26602575|P2|Overall Study|High Prostate specific antigen|1
7646450|NCT01546623|26602576|P1|Overall Study|High Prostate specific antigen|2
7646451|NCT01546623|26602575|P2|Overall Study|Major Protocol Deviation|1
7646452|NCT01546623|26602576|P1|Overall Study|Major Protocol Deviation|1
7646453|NCT01546623|26602575|P2|Overall Study|Adverse Event|3
7646454|NCT01546623|26602576|P1|Overall Study|Adverse Event|2
7646455|NCT01546519|26602606|P4|Overall Study|Withdrawal by Subject|0
7646456|NCT01546519|26602607|P3|Overall Study|Withdrawal by Subject|0
7646457|NCT01546519|26602608|P2|Overall Study|Withdrawal by Subject|0
7646458|NCT01546519|26602609|P1|Overall Study|Withdrawal by Subject|1
7646459|NCT01546519|26602606|P4|Overall Study|Physician Decision|3
7646460|NCT01546519|26602607|P3|Overall Study|Physician Decision|2
7646461|NCT01546519|26602608|P2|Overall Study|Physician Decision|5
7646462|NCT01546519|26602609|P1|Overall Study|Physician Decision|6
7646463|NCT01546519|26602606|P4|Overall Study|related to disease progression|1
7646464|NCT01546519|26602607|P3|Overall Study|related to disease progression|2
7646465|NCT01546519|26602608|P2|Overall Study|related to disease progression|2
7646466|NCT01546519|26602609|P1|Overall Study|related to disease progression|2
7646467|NCT01546519|26602606|P4|Overall Study|Death|1
7646468|NCT01546519|26602607|P3|Overall Study|Death|3
7646469|NCT01546519|26602608|P2|Overall Study|Death|1
7646470|NCT01546519|26602609|P1|Overall Study|Death|0
7646471|NCT01546519|26602606|P4|Overall Study|Adverse Event|1
7646472|NCT01546519|26602607|P3|Overall Study|Adverse Event|1
7646473|NCT01546519|26602608|P2|Overall Study|Adverse Event|0
7646474|NCT01546519|26602609|P1|Overall Study|Adverse Event|0
7646475|NCT01546207|26602674|P1|Overall Study|Death|1
7646476|NCT01546168|26602689|P2|Overall Study|ineligible after signing consent|0
7646477|NCT01546168|26602690|P1|Overall Study|ineligible after signing consent|2
7646478|NCT01546168|26602689|P2|Overall Study|Withdrawal by Subject|0
7646479|NCT01546168|26602690|P1|Overall Study|Withdrawal by Subject|1
7646480|NCT01546168|26602689|P2|Overall Study|Lost to Follow-up|0
7646481|NCT01546168|26602690|P1|Overall Study|Lost to Follow-up|1
7646482|NCT01546155|26602702|P1|Overall Study|could not tolerate long scan duration|3
7646483|NCT01546142|26602708|P2|Overall Study|Subject Randomized but Not Treated|0
7646484|NCT01546142|26602709|P1|Overall Study|Subject Randomized but Not Treated|1
7646485|NCT01546142|26602708|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
7646486|NCT01546142|26602709|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
7646487|NCT01546142|26602708|P2|Overall Study|Lost to Follow-up|15
7646488|NCT01546142|26602709|P1|Overall Study|Lost to Follow-up|20
7646489|NCT01546142|26602708|P2|Overall Study|Adverse Event|3
7646490|NCT01546142|26602709|P1|Overall Study|Adverse Event|6
7646491|NCT01546142|26602708|P2|Overall Study|Subject Noncompliance|1
7646492|NCT01546142|26602709|P1|Overall Study|Subject Noncompliance|1
7646493|NCT01546142|26602708|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
7646494|NCT01546142|26602709|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
7646495|NCT01546038|26602727|P9|Overall Study|: Randomized, not treated|3
7646496|NCT01546038|26602728|P8|Overall Study|: Randomized, not treated|4
7646497|NCT01546038|26602729|P7|Overall Study|: Randomized, not treated|2
7646498|NCT01546038|26602730|P6|Overall Study|: Randomized, not treated|0
7646499|NCT01546038|26602731|P5|Overall Study|: Randomized, not treated|0
7646500|NCT01546038|26602732|P4|Overall Study|: Randomized, not treated|0
7646501|NCT01546038|26602733|P3|Overall Study|: Randomized, not treated|0
7646502|NCT01546038|26602734|P2|Overall Study|: Randomized, not treated|0
7646503|NCT01546038|26602735|P1|Overall Study|: Randomized, not treated|0
7646504|NCT01546038|26602727|P9|Overall Study|Withdrawal by Subject|1
7646505|NCT01546038|26602728|P8|Overall Study|Withdrawal by Subject|3
7646506|NCT01546038|26602729|P7|Overall Study|Withdrawal by Subject|3
7646507|NCT01546038|26602730|P6|Overall Study|Withdrawal by Subject|1
7646508|NCT01546038|26602731|P5|Overall Study|Withdrawal by Subject|0
7646509|NCT01546038|26602732|P4|Overall Study|Withdrawal by Subject|1
7646510|NCT01546038|26602733|P3|Overall Study|Withdrawal by Subject|0
7646511|NCT01546038|26602734|P2|Overall Study|Withdrawal by Subject|0
7646512|NCT01546038|26602735|P1|Overall Study|Withdrawal by Subject|1
7646513|NCT01546038|26602727|P9|Overall Study|Lost to Follow-up|0
7646514|NCT01546038|26602728|P8|Overall Study|Lost to Follow-up|1
7646515|NCT01546038|26602729|P7|Overall Study|Lost to Follow-up|2
7646516|NCT01546038|26602730|P6|Overall Study|Lost to Follow-up|0
7646517|NCT01546038|26602731|P5|Overall Study|Lost to Follow-up|1
7646518|NCT01546038|26602732|P4|Overall Study|Lost to Follow-up|0
7646519|NCT01546038|26602733|P3|Overall Study|Lost to Follow-up|0
7646520|NCT01546038|26602734|P2|Overall Study|Lost to Follow-up|0
7646521|NCT01546038|26602735|P1|Overall Study|Lost to Follow-up|0
7646522|NCT01546038|26602727|P9|Overall Study|Death|39
7646523|NCT01546038|26602728|P8|Overall Study|Death|76
7646524|NCT01546038|26602729|P7|Overall Study|Death|46
7646525|NCT01546038|26602730|P6|Overall Study|Death|3
7646526|NCT01546038|26602731|P5|Overall Study|Death|9
7646527|NCT01546038|26602732|P4|Overall Study|Death|2
7646528|NCT01546038|26602733|P3|Overall Study|Death|4
7646529|NCT01546038|26602734|P2|Overall Study|Death|6
7646530|NCT01546038|26602735|P1|Overall Study|Death|15
7646531|NCT01545934|26602897|P2|Overall Study|Lost to Follow-up|0
7646532|NCT01545934|26602898|P1|Overall Study|Lost to Follow-up|1
7646533|NCT01545934|26602897|P2|Overall Study|Withdrawal by Subject|3
7646534|NCT01545934|26602898|P1|Overall Study|Withdrawal by Subject|4
7646535|NCT01545817|26602946|P2|Everolimus|Adverse Event|6
7646536|NCT01545817|26602947|P1|Everolimus|Adverse Event|0
7646537|NCT01545817|26602946|P2|Everolimus|Disease progression|25
7646538|NCT01545817|26602947|P1|Everolimus|Disease progression|0
7646539|NCT01545817|26602946|P2|Everolimus|Other reason|7
7646540|NCT01545817|26602947|P1|Everolimus|Other reason|0
7646541|NCT01545817|26602946|P2|Pazopanib|Other reason|0
7646542|NCT01545817|26602947|P1|Pazopanib|Other reason|4
7646543|NCT01545817|26602946|P2|Pazopanib|Adverse Event|0
7646544|NCT01545817|26602947|P1|Pazopanib|Adverse Event|19
7646545|NCT01545817|26602946|P2|Pazopanib|Disease progression|0
7646546|NCT01545817|26602947|P1|Pazopanib|Disease progression|51
7646547|NCT01545388|26603096|P3|Overall Study|Other|0
7646548|NCT01545388|26603097|P2|Overall Study|Other|1
7646549|NCT01545388|26603098|P1|Overall Study|Other|1
7646550|NCT01545388|26603096|P3|Overall Study|Withdrawal by Subject|2
7646551|NCT01545388|26603097|P2|Overall Study|Withdrawal by Subject|4
7646552|NCT01545388|26603098|P1|Overall Study|Withdrawal by Subject|1
7646553|NCT01545388|26603096|P3|Overall Study|Participant moved or relocated|0
7646554|NCT01545388|26603097|P2|Overall Study|Participant moved or relocated|0
7646555|NCT01545388|26603098|P1|Overall Study|Participant moved or relocated|1
7646556|NCT01545388|26603096|P3|Overall Study|Lack of Efficacy|5
7646557|NCT01545388|26603097|P2|Overall Study|Lack of Efficacy|2
7646558|NCT01545388|26603098|P1|Overall Study|Lack of Efficacy|3
7646559|NCT01545388|26603096|P3|Overall Study|Adverse Event|1
7646560|NCT01545388|26603097|P2|Overall Study|Adverse Event|4
7646561|NCT01545388|26603098|P1|Overall Study|Adverse Event|2
7646562|NCT01545375|26603117|P2|Overall Study|Withdrawal by Subject|55
7646563|NCT01545375|26603118|P1|Overall Study|Withdrawal by Subject|58
7646564|NCT01545375|26603117|P2|Overall Study|Protocol Violation|3
7646565|NCT01545375|26603118|P1|Overall Study|Protocol Violation|3
7646566|NCT01545375|26603117|P2|Overall Study|Lost to Follow-up|31
7646567|NCT01545375|26603118|P1|Overall Study|Lost to Follow-up|34
7646568|NCT01545375|26603117|P2|Overall Study|Adverse Event|1
7646569|NCT01545375|26603118|P1|Overall Study|Adverse Event|2
7646570|NCT01545076|26603250|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7646571|NCT01545076|26603251|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
7646572|NCT01545076|26603252|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
7646573|NCT01545076|26603253|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
7646574|NCT01545076|26603254|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7646575|NCT01545076|26603250|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7646576|NCT01545076|26603251|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7646577|NCT01545076|26603252|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7646578|NCT01545076|26603253|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7646579|NCT01545076|26603254|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7646580|NCT01545076|26603250|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7646581|NCT01545076|26603251|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
7646582|NCT01545076|26603252|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
7646583|NCT01545076|26603253|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
7646584|NCT01545076|26603254|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7646585|NCT01545076|26603250|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7646586|NCT01545076|26603251|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
7646587|NCT01545076|26603252|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7646588|NCT01545076|26603253|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7646589|NCT01545076|26603254|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7646590|NCT01545076|26603250|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
7646591|NCT01545076|26603251|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
7646592|NCT01545076|26603252|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
7646593|NCT01545076|26603253|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
7646594|NCT01545076|26603254|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
7646595|NCT01545076|26603250|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7646596|NCT01545076|26603251|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7646597|NCT01545076|26603252|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7646598|NCT01545076|26603253|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7646599|NCT01545076|26603254|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
7646600|NCT01545076|26603250|P5|IgPro10 Restabilization Period|Protocol Violation|0
7646601|NCT01545076|26603251|P4|IgPro10 Restabilization Period|Protocol Violation|0
7646602|NCT01545076|26603252|P3|IgPro10 Restabilization Period|Protocol Violation|0
7646603|NCT01545076|26603253|P2|IgPro10 Restabilization Period|Protocol Violation|0
7646604|NCT01545076|26603254|P1|IgPro10 Restabilization Period|Protocol Violation|1
7646605|NCT01545076|26603250|P5|IgPro10 Restabilization Period|Physician Decision|0
7646606|NCT01545076|26603251|P4|IgPro10 Restabilization Period|Physician Decision|0
7646607|NCT01545076|26603252|P3|IgPro10 Restabilization Period|Physician Decision|0
7646608|NCT01545076|26603253|P2|IgPro10 Restabilization Period|Physician Decision|0
7646609|NCT01545076|26603254|P1|IgPro10 Restabilization Period|Physician Decision|2
7646610|NCT01545076|26603250|P5|IgPro10 Restabilization Period|Adverse Event|0
7646611|NCT01545076|26603251|P4|IgPro10 Restabilization Period|Adverse Event|0
7646612|NCT01545076|26603252|P3|IgPro10 Restabilization Period|Adverse Event|0
7646613|NCT01545076|26603253|P2|IgPro10 Restabilization Period|Adverse Event|0
7646614|NCT01545076|26603254|P1|IgPro10 Restabilization Period|Adverse Event|4
7646615|NCT01544920|26603325|P2|Overall Study|Withdrawal by Subject|4
7646616|NCT01544920|26603326|P1|Overall Study|Withdrawal by Subject|4
7646617|NCT01544920|26603325|P2|Overall Study|Physician Decision|1
7646618|NCT01544920|26603326|P1|Overall Study|Physician Decision|4
7646619|NCT01544920|26603325|P2|Overall Study|Protocol Violation|2
7646620|NCT01544920|26603326|P1|Overall Study|Protocol Violation|0
7646621|NCT01544920|26603325|P2|Overall Study|Lost to Follow-up|12
7646622|NCT01544920|26603326|P1|Overall Study|Lost to Follow-up|11
7646623|NCT01544920|26603325|P2|Overall Study|Death|1
7646624|NCT01544920|26603326|P1|Overall Study|Death|0
7646625|NCT01544920|26603325|P2|Overall Study|Adverse Event|3
7646626|NCT01544920|26603326|P1|Overall Study|Adverse Event|0
7646627|NCT01544595|26603340|P6|Status at Week 156|Lack of Efficacy|5
7646628|NCT01544595|26603341|P5|Status at Week 156|Lack of Efficacy|10
7646629|NCT01544595|26603342|P4|Status at Week 156|Lack of Efficacy|4
7646630|NCT01544595|26603343|P3|Status at Week 156|Lack of Efficacy|1
7646631|NCT01544595|26603344|P2|Status at Week 156|Lack of Efficacy|0
7646632|NCT01544595|26603345|P1|Status at Week 156|Lack of Efficacy|1
7646633|NCT01544595|26603340|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
7646634|NCT01544595|26603341|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
7646885|NCT01544127|26603756|P3|Overall Study|Withdrawal by Subject|1
7646635|NCT01544595|26603342|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
7646636|NCT01544595|26603343|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
7646637|NCT01544595|26603344|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
7646638|NCT01544595|26603345|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
7646639|NCT01544595|26603340|P6|Status at Week 156|Technical problems|0
7646640|NCT01544595|26603341|P5|Status at Week 156|Technical problems|0
7646641|NCT01544595|26603342|P4|Status at Week 156|Technical problems|1
7646642|NCT01544595|26603343|P3|Status at Week 156|Technical problems|0
7646643|NCT01544595|26603344|P2|Status at Week 156|Technical problems|1
7646644|NCT01544595|26603345|P1|Status at Week 156|Technical problems|3
7646645|NCT01544595|26603340|P6|Status at Week 156|Protocol Violation|0
7646646|NCT01544595|26603341|P5|Status at Week 156|Protocol Violation|0
7646647|NCT01544595|26603342|P4|Status at Week 156|Protocol Violation|2
7646648|NCT01544595|26603343|P3|Status at Week 156|Protocol Violation|2
7646649|NCT01544595|26603344|P2|Status at Week 156|Protocol Violation|1
7646650|NCT01544595|26603345|P1|Status at Week 156|Protocol Violation|3
7646651|NCT01544595|26603340|P6|Status at Week 156|Pregnancy|0
7646652|NCT01544595|26603341|P5|Status at Week 156|Pregnancy|0
7646653|NCT01544595|26603342|P4|Status at Week 156|Pregnancy|0
7646654|NCT01544595|26603343|P3|Status at Week 156|Pregnancy|0
7646655|NCT01544595|26603344|P2|Status at Week 156|Pregnancy|3
7646656|NCT01544595|26603345|P1|Status at Week 156|Pregnancy|2
7646657|NCT01544595|26603340|P6|Status at Week 156|Physician Decision|0
7646658|NCT01544595|26603341|P5|Status at Week 156|Physician Decision|0
7646659|NCT01544595|26603342|P4|Status at Week 156|Physician Decision|0
7646660|NCT01544595|26603343|P3|Status at Week 156|Physician Decision|1
7646661|NCT01544595|26603344|P2|Status at Week 156|Physician Decision|3
7646662|NCT01544595|26603345|P1|Status at Week 156|Physician Decision|0
7646663|NCT01544595|26603340|P6|Status at Week 156|Non-compliance with study treatement|1
7646664|NCT01544595|26603341|P5|Status at Week 156|Non-compliance with study treatement|0
7646665|NCT01544595|26603342|P4|Status at Week 156|Non-compliance with study treatement|1
7646666|NCT01544595|26603343|P3|Status at Week 156|Non-compliance with study treatement|0
7646667|NCT01544595|26603344|P2|Status at Week 156|Non-compliance with study treatement|1
7646668|NCT01544595|26603345|P1|Status at Week 156|Non-compliance with study treatement|0
7646669|NCT01544595|26603340|P6|Status at Week 156|Lost to Follow-up|1
7646670|NCT01544595|26603341|P5|Status at Week 156|Lost to Follow-up|4
7646671|NCT01544595|26603342|P4|Status at Week 156|Lost to Follow-up|1
7646672|NCT01544595|26603343|P3|Status at Week 156|Lost to Follow-up|0
7646673|NCT01544595|26603344|P2|Status at Week 156|Lost to Follow-up|4
7646674|NCT01544595|26603345|P1|Status at Week 156|Lost to Follow-up|4
7646675|NCT01544595|26603340|P6|Status at Week 156|Adverse Event|2
7646676|NCT01544595|26603341|P5|Status at Week 156|Adverse Event|4
7646677|NCT01544595|26603342|P4|Status at Week 156|Adverse Event|3
7646678|NCT01544595|26603343|P3|Status at Week 156|Adverse Event|1
7646679|NCT01544595|26603344|P2|Status at Week 156|Adverse Event|11
7646680|NCT01544595|26603345|P1|Status at Week 156|Adverse Event|9
7646681|NCT01544595|26603340|P6|Status at Week 156|Withdrawal by Subject|6
7646682|NCT01544595|26603341|P5|Status at Week 156|Withdrawal by Subject|20
7646683|NCT01544595|26603342|P4|Status at Week 156|Withdrawal by Subject|9
7646684|NCT01544595|26603343|P3|Status at Week 156|Withdrawal by Subject|4
7646685|NCT01544595|26603344|P2|Status at Week 156|Withdrawal by Subject|10
7646686|NCT01544595|26603345|P1|Status at Week 156|Withdrawal by Subject|9
7646687|NCT01544595|26603340|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
7646688|NCT01544595|26603341|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
7646689|NCT01544595|26603342|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
7646690|NCT01544595|26603343|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
7646691|NCT01544595|26603344|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
7646692|NCT01544595|26603345|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
7646693|NCT01544595|26603340|P6|Status at Week 68|Withdrawal by Subject|0
7646694|NCT01544595|26603341|P5|Status at Week 68|Withdrawal by Subject|0
7646695|NCT01544595|26603342|P4|Status at Week 68|Withdrawal by Subject|2
7646696|NCT01544595|26603343|P3|Status at Week 68|Withdrawal by Subject|1
7646697|NCT01544595|26603344|P2|Status at Week 68|Withdrawal by Subject|1
7646698|NCT01544595|26603345|P1|Status at Week 68|Withdrawal by Subject|0
7646699|NCT01544595|26603340|P6|Status at Week 68|Technical problems|0
7646700|NCT01544595|26603341|P5|Status at Week 68|Technical problems|0
7646701|NCT01544595|26603342|P4|Status at Week 68|Technical problems|1
7646702|NCT01544595|26603343|P3|Status at Week 68|Technical problems|0
7646703|NCT01544595|26603344|P2|Status at Week 68|Technical problems|0
7646704|NCT01544595|26603345|P1|Status at Week 68|Technical problems|1
7646705|NCT01544595|26603340|P6|Status at Week 68|Protocol Violation|0
7646706|NCT01544595|26603341|P5|Status at Week 68|Protocol Violation|0
7646707|NCT01544595|26603342|P4|Status at Week 68|Protocol Violation|1
7646708|NCT01544595|26603343|P3|Status at Week 68|Protocol Violation|1
7646709|NCT01544595|26603344|P2|Status at Week 68|Protocol Violation|0
7646710|NCT01544595|26603345|P1|Status at Week 68|Protocol Violation|2
7646711|NCT01544595|26603340|P6|Status at Week 68|Non-compliance with study treatment|0
7646712|NCT01544595|26603341|P5|Status at Week 68|Non-compliance with study treatment|0
7646713|NCT01544595|26603342|P4|Status at Week 68|Non-compliance with study treatment|1
7646714|NCT01544595|26603343|P3|Status at Week 68|Non-compliance with study treatment|0
7646715|NCT01544595|26603344|P2|Status at Week 68|Non-compliance with study treatment|0
7646716|NCT01544595|26603345|P1|Status at Week 68|Non-compliance with study treatment|1
7646717|NCT01544595|26603340|P6|Status at Week 68|Lost to Follow-up|0
7646718|NCT01544595|26603341|P5|Status at Week 68|Lost to Follow-up|0
7646719|NCT01544595|26603342|P4|Status at Week 68|Lost to Follow-up|0
7646720|NCT01544595|26603343|P3|Status at Week 68|Lost to Follow-up|0
7646721|NCT01544595|26603344|P2|Status at Week 68|Lost to Follow-up|1
7646722|NCT01544595|26603345|P1|Status at Week 68|Lost to Follow-up|1
7646723|NCT01544595|26603340|P6|Status at Week 68|Lack of Efficacy|0
7646724|NCT01544595|26603341|P5|Status at Week 68|Lack of Efficacy|0
7646725|NCT01544595|26603342|P4|Status at Week 68|Lack of Efficacy|0
7646726|NCT01544595|26603343|P3|Status at Week 68|Lack of Efficacy|0
7646727|NCT01544595|26603344|P2|Status at Week 68|Lack of Efficacy|0
7646728|NCT01544595|26603345|P1|Status at Week 68|Lack of Efficacy|1
7646729|NCT01544595|26603340|P6|Status at Week 68|Adverse Event|0
7646730|NCT01544595|26603341|P5|Status at Week 68|Adverse Event|0
7646731|NCT01544595|26603342|P4|Status at Week 68|Adverse Event|0
7646732|NCT01544595|26603343|P3|Status at Week 68|Adverse Event|1
7646733|NCT01544595|26603344|P2|Status at Week 68|Adverse Event|2
7646734|NCT01544595|26603345|P1|Status at Week 68|Adverse Event|3
7646735|NCT01544582|26603421|P4|Analysis Population|Participant in Jail|0
7646736|NCT01544582|26603422|P3|Analysis Population|Participant in Jail|1
7646737|NCT01544582|26603423|P2|Analysis Population|Participant in Jail|0
7646738|NCT01544582|26603424|P1|Analysis Population|Participant in Jail|0
7646739|NCT01544582|26603421|P4|Analysis Population|Programmed Surgery|0
7646740|NCT01544582|26603422|P3|Analysis Population|Programmed Surgery|0
7646741|NCT01544582|26603423|P2|Analysis Population|Programmed Surgery|1
7646742|NCT01544582|26603424|P1|Analysis Population|Programmed Surgery|0
7646743|NCT01544582|26603421|P4|Analysis Population|Poor Participant Compliance|0
7646744|NCT01544582|26603422|P3|Analysis Population|Poor Participant Compliance|0
7646745|NCT01544582|26603423|P2|Analysis Population|Poor Participant Compliance|1
7646746|NCT01544582|26603424|P1|Analysis Population|Poor Participant Compliance|0
7646747|NCT01544582|26603421|P4|Analysis Population|Poor Adherence|0
7646748|NCT01544582|26603422|P3|Analysis Population|Poor Adherence|1
7646749|NCT01544582|26603423|P2|Analysis Population|Poor Adherence|0
7646750|NCT01544582|26603424|P1|Analysis Population|Poor Adherence|0
7646751|NCT01544582|26603421|P4|Analysis Population|No Social Insurance|0
7646752|NCT01544582|26603422|P3|Analysis Population|No Social Insurance|1
7646753|NCT01544582|26603423|P2|Analysis Population|No Social Insurance|0
7646754|NCT01544582|26603424|P1|Analysis Population|No Social Insurance|0
7646755|NCT01544582|26603421|P4|Analysis Population|Liver Transplantation|0
7646756|NCT01544582|26603422|P3|Analysis Population|Liver Transplantation|1
7646757|NCT01544582|26603423|P2|Analysis Population|Liver Transplantation|0
7646758|NCT01544582|26603424|P1|Analysis Population|Liver Transplantation|0
7646759|NCT01544582|26603421|P4|Analysis Population|Intolerance|0
7646760|NCT01544582|26603422|P3|Analysis Population|Intolerance|0
7646761|NCT01544582|26603423|P2|Analysis Population|Intolerance|1
7646762|NCT01544582|26603424|P1|Analysis Population|Intolerance|0
7646763|NCT01544582|26603421|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
7646764|NCT01544582|26603422|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
7646765|NCT01544582|26603423|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
7646766|NCT01544582|26603424|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
7646767|NCT01544582|26603421|P4|Analysis Population|Bad Tolerance to Treatment|0
7646768|NCT01544582|26603422|P3|Analysis Population|Bad Tolerance to Treatment|2
7646769|NCT01544582|26603423|P2|Analysis Population|Bad Tolerance to Treatment|0
7646770|NCT01544582|26603424|P1|Analysis Population|Bad Tolerance to Treatment|0
7646771|NCT01544582|26603421|P4|Analysis Population|Lost to Follow-up|5
7646772|NCT01544582|26603422|P3|Analysis Population|Lost to Follow-up|6
7646773|NCT01544582|26603423|P2|Analysis Population|Lost to Follow-up|6
7646774|NCT01544582|26603424|P1|Analysis Population|Lost to Follow-up|0
7646775|NCT01544582|26603421|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
7646776|NCT01544582|26603422|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
7646777|NCT01544582|26603423|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
7646778|NCT01544582|26603424|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
7646779|NCT01544582|26603421|P4|Analysis Population|Effectiveness Reason|12
7646780|NCT01544582|26603422|P3|Analysis Population|Effectiveness Reason|29
7646781|NCT01544582|26603423|P2|Analysis Population|Effectiveness Reason|48
7646782|NCT01544582|26603424|P1|Analysis Population|Effectiveness Reason|0
7646783|NCT01544582|26603421|P4|Analysis Population|Safety Reason|8
7646784|NCT01544582|26603422|P3|Analysis Population|Safety Reason|31
7646785|NCT01544582|26603423|P2|Analysis Population|Safety Reason|33
7646786|NCT01544582|26603424|P1|Analysis Population|Safety Reason|0
7646787|NCT01544582|26603421|P4|Analysis Population|Physician Decision|9
7646788|NCT01544582|26603422|P3|Analysis Population|Physician Decision|10
7646789|NCT01544582|26603423|P2|Analysis Population|Physician Decision|13
7646790|NCT01544582|26603424|P1|Analysis Population|Physician Decision|0
7646791|NCT01544582|26603421|P4|Analysis Population|Participant Refuses to Continue Study|4
7646792|NCT01544582|26603422|P3|Analysis Population|Participant Refuses to Continue Study|17
7646793|NCT01544582|26603423|P2|Analysis Population|Participant Refuses to Continue Study|15
7646794|NCT01544582|26603424|P1|Analysis Population|Participant Refuses to Continue Study|0
7646795|NCT01544582|26603421|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
7646796|NCT01544582|26603422|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
7646797|NCT01544582|26603423|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
7646798|NCT01544582|26603424|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
7646799|NCT01544582|26603421|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
7646800|NCT01544582|26603422|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
7646801|NCT01544582|26603423|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
7646802|NCT01544582|26603424|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
7646803|NCT01544491|26603484|P2|Overall Study|administrative problems|0
7646804|NCT01544491|26603485|P1|Overall Study|administrative problems|2
7646805|NCT01544491|26603484|P2|Overall Study|Lost to Follow-up|1
7646806|NCT01544491|26603485|P1|Overall Study|Lost to Follow-up|0
7646807|NCT01544491|26603484|P2|Overall Study|Withdrawal by Subject|2
7646808|NCT01544491|26603485|P1|Overall Study|Withdrawal by Subject|3
7646809|NCT01544478|26603511|P1|Overall Study|Withdrawal by Subject|52
7646810|NCT01544478|26603511|P1|Overall Study|Pregnancy|1
7646811|NCT01544478|26603511|P1|Overall Study|Physician Decision|15
7646812|NCT01544478|26603511|P1|Overall Study|Lost to Follow-up|48
7646813|NCT01544478|26603511|P1|Overall Study|Death|1
7646814|NCT01544478|26603511|P1|Overall Study|Adverse Event|1
7646815|NCT01544348|26603554|P8|Overall Study|Physician Decision|0
7646816|NCT01544348|26603555|P7|Overall Study|Physician Decision|0
7646817|NCT01544348|26603556|P6|Overall Study|Physician Decision|1
7646818|NCT01544348|26603557|P5|Overall Study|Physician Decision|0
7646819|NCT01544348|26603558|P4|Overall Study|Physician Decision|0
7646820|NCT01544348|26603559|P3|Overall Study|Physician Decision|0
7646821|NCT01544348|26603560|P2|Overall Study|Physician Decision|0
7646822|NCT01544348|26603561|P1|Overall Study|Physician Decision|0
7646823|NCT01544348|26603554|P8|Overall Study|Withdrawal by Subject|0
7646824|NCT01544348|26603555|P7|Overall Study|Withdrawal by Subject|1
7646825|NCT01544348|26603556|P6|Overall Study|Withdrawal by Subject|2
7646826|NCT01544348|26603557|P5|Overall Study|Withdrawal by Subject|1
7646827|NCT01544348|26603558|P4|Overall Study|Withdrawal by Subject|0
7646828|NCT01544348|26603559|P3|Overall Study|Withdrawal by Subject|0
7646829|NCT01544348|26603560|P2|Overall Study|Withdrawal by Subject|0
7646830|NCT01544348|26603561|P1|Overall Study|Withdrawal by Subject|1
7646831|NCT01544348|26603554|P8|Overall Study|Lost to Follow-up|0
7646832|NCT01544348|26603555|P7|Overall Study|Lost to Follow-up|1
7646833|NCT01544348|26603556|P6|Overall Study|Lost to Follow-up|0
7646834|NCT01544348|26603557|P5|Overall Study|Lost to Follow-up|0
7646835|NCT01544348|26603558|P4|Overall Study|Lost to Follow-up|0
7646836|NCT01544348|26603559|P3|Overall Study|Lost to Follow-up|0
7646837|NCT01544348|26603560|P2|Overall Study|Lost to Follow-up|0
7646838|NCT01544348|26603561|P1|Overall Study|Lost to Follow-up|1
7646839|NCT01544309|26603603|P2|Overall Study|Administered prohibit prior medication|0
7646840|NCT01544309|26603604|P1|Overall Study|Administered prohibit prior medication|1
7646841|NCT01544309|26603603|P2|Overall Study|Not performed pre-dose examination|2
7646842|NCT01544309|26603604|P1|Overall Study|Not performed pre-dose examination|1
7646843|NCT01544309|26603603|P2|Overall Study|Physician Decision|1
7646844|NCT01544309|26603604|P1|Overall Study|Physician Decision|4
7646845|NCT01544309|26603603|P2|Overall Study|Protocol Violation|1
7646846|NCT01544309|26603604|P1|Overall Study|Protocol Violation|2
7646847|NCT01544309|26603603|P2|Overall Study|Withdrawal by Subject|7
7646848|NCT01544309|26603604|P1|Overall Study|Withdrawal by Subject|12
7646849|NCT01544179|26603642|P2|Overall Study|Eligibility criteria not fulfilled|0
7646850|NCT01544179|26603643|P1|Overall Study|Eligibility criteria not fulfilled|1
7646851|NCT01544179|26603642|P2|Overall Study|Withdrawal by Subject|7
7646852|NCT01544179|26603643|P1|Overall Study|Withdrawal by Subject|12
7646853|NCT01544179|26603642|P2|Overall Study|Adverse Event|1
7646854|NCT01544179|26603643|P1|Overall Study|Adverse Event|0
7646855|NCT01544179|26603642|P2|Overall Study|Lost to Follow-up|1
7646856|NCT01544179|26603643|P1|Overall Study|Lost to Follow-up|0
7646857|NCT01544179|26603642|P2|Overall Study|Death|37
7646858|NCT01544179|26603643|P1|Overall Study|Death|50
7646859|NCT01544153|26603736|P4|Overall Study|Non-smoker|0
7646860|NCT01544153|26603737|P3|Overall Study|Non-smoker|1
7646861|NCT01544153|26603738|P2|Overall Study|Non-smoker|0
7646862|NCT01544153|26603739|P1|Overall Study|Non-smoker|0
7646863|NCT01544153|26603736|P4|Overall Study|Under 18|0
7646864|NCT01544153|26603737|P3|Overall Study|Under 18|0
7646865|NCT01544153|26603738|P2|Overall Study|Under 18|1
7646866|NCT01544153|26603739|P1|Overall Study|Under 18|0
7646867|NCT01544127|26603756|P3|Overall Study|Went active duty|1
7646868|NCT01544127|26603757|P2|Overall Study|Went active duty|0
7646869|NCT01544127|26603758|P1|Overall Study|Went active duty|0
7646870|NCT01544127|26603756|P3|Overall Study|Researcher withdrew|0
7646871|NCT01544127|26603757|P2|Overall Study|Researcher withdrew|0
7646872|NCT01544127|26603758|P1|Overall Study|Researcher withdrew|1
7646873|NCT01544127|26603756|P3|Overall Study|Became Psychotic|0
7646874|NCT01544127|26603757|P2|Overall Study|Became Psychotic|0
7646875|NCT01544127|26603758|P1|Overall Study|Became Psychotic|1
7646876|NCT01544127|26603756|P3|Overall Study|Jail or Prison|2
7646877|NCT01544127|26603757|P2|Overall Study|Jail or Prison|1
7646878|NCT01544127|26603758|P1|Overall Study|Jail or Prison|1
7646879|NCT01544127|26603756|P3|Overall Study|Death|0
7646880|NCT01544127|26603757|P2|Overall Study|Death|0
7646881|NCT01544127|26603758|P1|Overall Study|Death|1
7646882|NCT01544127|26603756|P3|Overall Study|Discharged out of catchment area|1
7646883|NCT01544127|26603757|P2|Overall Study|Discharged out of catchment area|1
7646884|NCT01544127|26603758|P1|Overall Study|Discharged out of catchment area|1
7646886|NCT01544127|26603757|P2|Overall Study|Withdrawal by Subject|2
7646887|NCT01544127|26603758|P1|Overall Study|Withdrawal by Subject|2
7646888|NCT01544127|26603756|P3|Overall Study|Lost to Follow-up|9
7646889|NCT01544127|26603757|P2|Overall Study|Lost to Follow-up|2
7646890|NCT01544127|26603758|P1|Overall Study|Lost to Follow-up|4
7646891|NCT01544114|26603778|P3|Overall Study|Protocol Violation|0
7646892|NCT01544114|26603779|P2|Overall Study|Protocol Violation|1
7646893|NCT01544114|26603780|P1|Overall Study|Protocol Violation|0
7646894|NCT01544114|26603778|P3|Overall Study|Adverse Event|2
7646895|NCT01544114|26603779|P2|Overall Study|Adverse Event|1
7646896|NCT01544114|26603780|P1|Overall Study|Adverse Event|1
7646897|NCT01544114|26603778|P3|Overall Study|Lost to Follow-up|0
7646898|NCT01544114|26603779|P2|Overall Study|Lost to Follow-up|2
7646899|NCT01544114|26603780|P1|Overall Study|Lost to Follow-up|0
7646900|NCT01544114|26603778|P3|Overall Study|Withdrawal by Subject|3
7646901|NCT01544114|26603779|P2|Overall Study|Withdrawal by Subject|0
7646902|NCT01544114|26603780|P1|Overall Study|Withdrawal by Subject|0
7646903|NCT01543958|26603878|P1|Overall Study|ART initiation|1
7646904|NCT01543958|26603878|P1|Overall Study|Loss to follow-up|3
7646905|NCT01543828|26603933|P2|Treatment 2|Lost to Follow-up|0
7646906|NCT01543828|26603934|P1|Treatment 2|Lost to Follow-up|1
7646907|NCT01543776|26603944|P2|Overall Study|Withdrawal by Subject|2
7646908|NCT01543776|26603945|P1|Overall Study|Withdrawal by Subject|2
7646909|NCT01543685|26603964|P5|Overall Study|Adverse Event|2
7646910|NCT01543685|26603965|P4|Overall Study|Adverse Event|0
7646911|NCT01543685|26603966|P3|Overall Study|Adverse Event|0
7646912|NCT01543685|26603967|P2|Overall Study|Adverse Event|1
7646913|NCT01543685|26603968|P1|Overall Study|Adverse Event|2
7646914|NCT01543685|26603964|P5|Overall Study|Lack of Efficacy|2
7646915|NCT01543685|26603965|P4|Overall Study|Lack of Efficacy|0
7646916|NCT01543685|26603966|P3|Overall Study|Lack of Efficacy|2
7646917|NCT01543685|26603967|P2|Overall Study|Lack of Efficacy|2
7646918|NCT01543685|26603968|P1|Overall Study|Lack of Efficacy|1
7646919|NCT01543503|26604040|P2|Overall Study|Screen failure|0
7646920|NCT01543503|26604041|P1|Overall Study|Screen failure|1
7646921|NCT01543503|26604040|P2|Overall Study|Participant went to United States|0
7646922|NCT01543503|26604041|P1|Overall Study|Participant went to United States|1
7646923|NCT01543503|26604040|P2|Overall Study|Participant consented to another study|2
7646924|NCT01543503|26604041|P1|Overall Study|Participant consented to another study|0
7646925|NCT01543503|26604040|P2|Overall Study|Moved to other rheumatologic site|1
7646926|NCT01543503|26604041|P1|Overall Study|Moved to other rheumatologic site|0
7646927|NCT01543503|26604040|P2|Overall Study|Participant did not attend a visit|0
7646928|NCT01543503|26604041|P1|Overall Study|Participant did not attend a visit|1
7646929|NCT01543503|26604040|P2|Overall Study|Site stopped participation|1
7646930|NCT01543503|26604041|P1|Overall Study|Site stopped participation|5
7646931|NCT01543503|26604040|P2|Overall Study|Participant recruited after closing date|1
7646932|NCT01543503|26604041|P1|Overall Study|Participant recruited after closing date|0
7646933|NCT01543503|26604040|P2|Overall Study|Investigator did not wish to participate|1
7646934|NCT01543503|26604041|P1|Overall Study|Investigator did not wish to participate|1
7646935|NCT01543503|26604040|P2|Overall Study|Participant decision to stop treatment|0
7646936|NCT01543503|26604041|P1|Overall Study|Participant decision to stop treatment|1
7646937|NCT01543503|26604040|P2|Overall Study|Participant moved to Scotland|0
7646938|NCT01543503|26604041|P1|Overall Study|Participant moved to Scotland|1
7646939|NCT01543503|26604040|P2|Overall Study|Participant transferred to another city|0
7646940|NCT01543503|26604041|P1|Overall Study|Participant transferred to another city|1
7646941|NCT01543503|26604040|P2|Overall Study|Participant will not return for visits|2
7646942|NCT01543503|26604041|P1|Overall Study|Participant will not return for visits|0
7646943|NCT01543503|26604040|P2|Overall Study|Participant moved to another city|0
7646944|NCT01543503|26604041|P1|Overall Study|Participant moved to another city|2
7646945|NCT01543503|26604040|P2|Overall Study|Incorrect medication received|0
7646946|NCT01543503|26604041|P1|Overall Study|Incorrect medication received|1
7646947|NCT01543503|26604040|P2|Overall Study|Refused to continue treatment|0
7646948|NCT01543503|26604041|P1|Overall Study|Refused to continue treatment|7
7646949|NCT01543503|26604040|P2|Overall Study|Participant did not complete last visit|2
7646950|NCT01543503|26604041|P1|Overall Study|Participant did not complete last visit|0
7646951|NCT01543503|26604040|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
7646952|NCT01543503|26604041|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
7646953|NCT01543503|26604040|P2|Overall Study|Intolerance to the biologic treatment|1
7646954|NCT01543503|26604041|P1|Overall Study|Intolerance to the biologic treatment|0
7646955|NCT01543503|26604040|P2|Overall Study|Change of jobs|1
7646956|NCT01543503|26604041|P1|Overall Study|Change of jobs|0
7646957|NCT01543503|26604040|P2|Overall Study|Participant withdrew informed consent|10
7646958|NCT01543503|26604041|P1|Overall Study|Participant withdrew informed consent|8
7646959|NCT01543503|26604040|P2|Overall Study|Lack of Efficacy|16
7646960|NCT01543503|26604041|P1|Overall Study|Lack of Efficacy|4
7646961|NCT01543503|26604040|P2|Overall Study|Adverse Event|13
7646962|NCT01543503|26604041|P1|Overall Study|Adverse Event|9
7646963|NCT01543503|26604040|P2|Overall Study|Lost to Follow-up|36
7646964|NCT01543503|26604041|P1|Overall Study|Lost to Follow-up|32
7646965|NCT01543490|26604087|P2|Overall Study|Other-Various Administrative Reasons|2
7646966|NCT01543490|26604088|P1|Overall Study|Other-Various Administrative Reasons|1
7646967|NCT01543490|26604087|P2|Overall Study|Withdrawal by Subject|0
7646968|NCT01543490|26604088|P1|Overall Study|Withdrawal by Subject|2
7646969|NCT01543490|26604087|P2|Overall Study|Lost to Follow-up|0
7646970|NCT01543490|26604088|P1|Overall Study|Lost to Follow-up|5
7646971|NCT01543490|26604087|P2|Overall Study|Lack of Efficacy|3
7646972|NCT01543490|26604088|P1|Overall Study|Lack of Efficacy|3
7646973|NCT01543490|26604087|P2|Overall Study|Physician Decision|0
7646974|NCT01543490|26604088|P1|Overall Study|Physician Decision|1
7646975|NCT01543490|26604087|P2|Overall Study|Adverse Event|0
7646976|NCT01543490|26604088|P1|Overall Study|Adverse Event|4
7646977|NCT01543204|26604096|P1|Overall Study|Lost to Follow-up|1
7646978|NCT01543204|26604096|P1|Overall Study|Requirement for Alternative Therapy|1
7646979|NCT01543204|26604096|P1|Overall Study|Withdrawal by Subject|4
7646980|NCT01543204|26604096|P1|Overall Study|Adverse Event|1
7646981|NCT01543204|26604096|P1|Overall Study|Non-compliance|1
7646982|NCT01543152|26604157|P5|Overall Study|Withdrawal by Subject|0
7646983|NCT01543152|26604158|P4|Overall Study|Withdrawal by Subject|0
7646984|NCT01543152|26604159|P3|Overall Study|Withdrawal by Subject|0
7646985|NCT01543152|26604160|P2|Overall Study|Withdrawal by Subject|2
7646986|NCT01543152|26604161|P1|Overall Study|Withdrawal by Subject|0
7646987|NCT01543087|26604194|P6|Booster Stage (26 Months)|Lost to Follow-up|0
7646988|NCT01543087|26604195|P5|Booster Stage (26 Months)|Lost to Follow-up|0
7646989|NCT01543087|26604196|P4|Booster Stage (26 Months)|Lost to Follow-up|0
7646990|NCT01543087|26604197|P3|Booster Stage (26 Months)|Lost to Follow-up|1
7646991|NCT01543087|26604198|P2|Booster Stage (26 Months)|Lost to Follow-up|0
7646992|NCT01543087|26604199|P1|Booster Stage (26 Months)|Lost to Follow-up|0
7646993|NCT01543087|26604194|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7646994|NCT01543087|26604195|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
7646995|NCT01543087|26604196|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7646996|NCT01543087|26604197|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7646997|NCT01543087|26604198|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
7646998|NCT01543087|26604199|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7646999|NCT01543087|26604194|P6|Stage 1 (48 Months)|Protocol Violation|0
7647000|NCT01543087|26604195|P5|Stage 1 (48 Months)|Protocol Violation|0
7647001|NCT01543087|26604196|P4|Stage 1 (48 Months)|Protocol Violation|0
7647002|NCT01543087|26604197|P3|Stage 1 (48 Months)|Protocol Violation|0
7647003|NCT01543087|26604198|P2|Stage 1 (48 Months)|Protocol Violation|3
7647004|NCT01543087|26604199|P1|Stage 1 (48 Months)|Protocol Violation|0
7647005|NCT01543087|26604194|P6|Stage 1 (48 Months)|Other than specified|0
7647006|NCT01543087|26604195|P5|Stage 1 (48 Months)|Other than specified|0
7647007|NCT01543087|26604196|P4|Stage 1 (48 Months)|Other than specified|0
7647008|NCT01543087|26604197|P3|Stage 1 (48 Months)|Other than specified|9
7647009|NCT01543087|26604198|P2|Stage 1 (48 Months)|Other than specified|0
7647010|NCT01543087|26604199|P1|Stage 1 (48 Months)|Other than specified|5
7647011|NCT01543087|26604194|P6|Stage 1 (48 Months)|No longer willing to participate|0
7647012|NCT01543087|26604195|P5|Stage 1 (48 Months)|No longer willing to participate|3
7647013|NCT01543087|26604196|P4|Stage 1 (48 Months)|No longer willing to participate|6
7647014|NCT01543087|26604197|P3|Stage 1 (48 Months)|No longer willing to participate|18
7647015|NCT01543087|26604198|P2|Stage 1 (48 Months)|No longer willing to participate|3
7647016|NCT01543087|26604199|P1|Stage 1 (48 Months)|No longer willing to participate|5
7647017|NCT01543087|26604194|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
7647018|NCT01543087|26604195|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
7647019|NCT01543087|26604196|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
7647020|NCT01543087|26604197|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
7647021|NCT01543087|26604198|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
7647022|NCT01543087|26604199|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
7647023|NCT01543087|26604194|P6|Stage 1 (48 Months)|Lost to Follow-up|0
7647024|NCT01543087|26604195|P5|Stage 1 (48 Months)|Lost to Follow-up|0
7647025|NCT01543087|26604196|P4|Stage 1 (48 Months)|Lost to Follow-up|0
7647026|NCT01543087|26604197|P3|Stage 1 (48 Months)|Lost to Follow-up|12
7647027|NCT01543087|26604198|P2|Stage 1 (48 Months)|Lost to Follow-up|4
7647028|NCT01543087|26604199|P1|Stage 1 (48 Months)|Lost to Follow-up|3
7647029|NCT01542788|26604376|P2|Overall Study|Withdrawal by Subject|0
7647030|NCT01542788|26604377|P1|Overall Study|Withdrawal by Subject|1
7647031|NCT01542788|26604376|P2|Overall Study|Physician Decision|0
7647032|NCT01542788|26604377|P1|Overall Study|Physician Decision|1
7647033|NCT01542788|26604376|P2|Overall Study|Protocol Violation|0
7647034|NCT01542788|26604377|P1|Overall Study|Protocol Violation|2
7647035|NCT01542788|26604376|P2|Overall Study|Death|0
7647036|NCT01542788|26604377|P1|Overall Study|Death|3
7647037|NCT01542788|26604376|P2|Overall Study|Lost to Follow-up|0
7647038|NCT01542788|26604377|P1|Overall Study|Lost to Follow-up|5
7647039|NCT01542788|26604376|P2|Overall Study|Lack of Efficacy|71
7647040|NCT01542788|26604377|P1|Overall Study|Lack of Efficacy|41
7647041|NCT01542788|26604376|P2|Overall Study|Randomized but Not Treated|0
7647042|NCT01542788|26604377|P1|Overall Study|Randomized but Not Treated|2
7647043|NCT01542632|26604424|P6|Overall Study|Sponsor/Investigator Decision|0
7647044|NCT01542632|26604425|P5|Overall Study|Sponsor/Investigator Decision|1
7647045|NCT01542632|26604426|P4|Overall Study|Sponsor/Investigator Decision|0
7647046|NCT01542632|26604427|P3|Overall Study|Sponsor/Investigator Decision|0
7647047|NCT01542632|26604428|P2|Overall Study|Sponsor/Investigator Decision|0
7647048|NCT01542632|26604429|P1|Overall Study|Sponsor/Investigator Decision|0
7647049|NCT01542632|26604424|P6|Overall Study|Lost to Follow-up|0
7647050|NCT01542632|26604425|P5|Overall Study|Lost to Follow-up|0
7647051|NCT01542632|26604426|P4|Overall Study|Lost to Follow-up|0
7647052|NCT01542632|26604427|P3|Overall Study|Lost to Follow-up|0
7647053|NCT01542632|26604428|P2|Overall Study|Lost to Follow-up|1
7647054|NCT01542632|26604429|P1|Overall Study|Lost to Follow-up|0
7647055|NCT01542632|26604424|P6|Overall Study|Adverse Event|0
7647056|NCT01542632|26604425|P5|Overall Study|Adverse Event|0
7647057|NCT01542632|26604426|P4|Overall Study|Adverse Event|0
7647058|NCT01542632|26604427|P3|Overall Study|Adverse Event|1
7647059|NCT01542632|26604428|P2|Overall Study|Adverse Event|0
7647060|NCT01542632|26604429|P1|Overall Study|Adverse Event|0
7647061|NCT01542632|26604424|P6|Overall Study|Withdrawal of Consent|0
7647062|NCT01542632|26604425|P5|Overall Study|Withdrawal of Consent|3
7647063|NCT01542632|26604426|P4|Overall Study|Withdrawal of Consent|2
7647064|NCT01542632|26604427|P3|Overall Study|Withdrawal of Consent|0
7647065|NCT01542632|26604428|P2|Overall Study|Withdrawal of Consent|0
7647066|NCT01542632|26604429|P1|Overall Study|Withdrawal of Consent|0
7647067|NCT01542528|26604486|P2|Overall Study|Withdrawal by Subject|6
7647068|NCT01542528|26604487|P1|Overall Study|Withdrawal by Subject|9
7647069|NCT01542528|26604486|P2|Overall Study|Physician Decision|0
7647070|NCT01542528|26604487|P1|Overall Study|Physician Decision|1
7647071|NCT01542528|26604486|P2|Overall Study|Lost to Follow-up|1
7647072|NCT01542528|26604487|P1|Overall Study|Lost to Follow-up|2
7647073|NCT01542034|26604595|P2|Overall Study|Lost to Follow-up|6
7647074|NCT01542034|26604596|P1|Overall Study|Lost to Follow-up|7
7647075|NCT01542034|26604595|P2|Overall Study|Adverse Event|2
7647076|NCT01542034|26604596|P1|Overall Study|Adverse Event|2
7647077|NCT01542034|26604595|P2|Overall Study|Subject Noncompliance|0
7647078|NCT01542034|26604596|P1|Overall Study|Subject Noncompliance|1
7647079|NCT01542034|26604595|P2|Overall Study|Administrative decision|3
7647080|NCT01542034|26604596|P1|Overall Study|Administrative decision|0
7647081|NCT01542034|26604595|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
7647082|NCT01542034|26604596|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
7647083|NCT01541969|26604610|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
7647084|NCT01541969|26604611|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
7647085|NCT01541969|26604610|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
7647086|NCT01541969|26604611|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
7647087|NCT01541969|26604610|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7647088|NCT01541969|26604611|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7647089|NCT01541969|26604610|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
7647090|NCT01541969|26604611|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
7647091|NCT01541969|26604610|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7647092|NCT01541969|26604611|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7647093|NCT01541969|26604610|P2|Double-blind (0-12 Weeks)|Adverse Event|0
7647094|NCT01541969|26604611|P1|Double-blind (0-12 Weeks)|Adverse Event|2
7647095|NCT01541969|26604610|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
7647096|NCT01541969|26604611|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
7647097|NCT01541969|26604610|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
7647098|NCT01541969|26604611|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
7647099|NCT01541969|26604610|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7647100|NCT01541969|26604611|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7647101|NCT01541969|26604610|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
7647102|NCT01541969|26604611|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
7647103|NCT01541930|26604627|P1|Overall Study|Withdrawal by Subject|1
7647104|NCT01541917|26604649|P2|Overall Study|Withdrawal by Subject|7
7647105|NCT01541917|26604650|P1|Overall Study|Withdrawal by Subject|13
7647106|NCT01541917|26604649|P2|Overall Study|Lost to Follow-up|2
7647107|NCT01541917|26604650|P1|Overall Study|Lost to Follow-up|2
7647108|NCT01541865|26604679|P1|Overall Study|Protocol Violation|1
7647109|NCT01541865|26604679|P1|Overall Study|Adverse Event|1
7647110|NCT01541865|26604679|P1|Overall Study|Withdrawal by Subject|9
7647111|NCT01541865|26604679|P1|Overall Study|Lost to Follow-up|11
7647112|NCT01541826|26604697|P3|Overall Study|Withdrawal by Subject|0
7647113|NCT01541826|26604698|P2|Overall Study|Withdrawal by Subject|0
7647114|NCT01541826|26604699|P1|Overall Study|Withdrawal by Subject|2
7647115|NCT01541826|26604697|P3|Overall Study|Lost to Follow-up|0
7647116|NCT01541826|26604698|P2|Overall Study|Lost to Follow-up|3
7647117|NCT01541826|26604699|P1|Overall Study|Lost to Follow-up|2
7647118|NCT01541748|26604766|P1|Overall Study|Did not receive study device|1
7647119|NCT01541748|26604766|P1|Overall Study|Screen failure|5
7647120|NCT01541748|26604766|P1|Overall Study|Withdrawal by Subject|7
7647121|NCT01541748|26604766|P1|Overall Study|Moved out of state|1
7647122|NCT01541748|26604766|P1|Overall Study|Lost to Follow-up|17
7647123|NCT01541644|26604802|P1|Overall Study|Withdrawal by Subject|3
7647124|NCT01541397|26604821|P2|Overall Study|Study ended prior to data collection|2
7647125|NCT01541397|26604822|P1|Overall Study|Study ended prior to data collection|4
7647126|NCT01541371|26604847|P1|Overall Study|Other|6
7647127|NCT01541371|26604847|P1|Overall Study|Study medication non-compliance|3
7647128|NCT01541371|26604847|P1|Overall Study|Protocol Violation|6
7647129|NCT01541371|26604847|P1|Overall Study|Lack of Efficacy|12
7647130|NCT01541371|26604847|P1|Overall Study|Adverse Event|15
7647131|NCT01541371|26604847|P1|Overall Study|Lost to Follow-up|21
7647132|NCT01541371|26604847|P1|Overall Study|Withdrawal by Subject|14
7647133|NCT01541254|26604876|P1|Overall Study|alternate stent used|1
7647134|NCT01541254|26604876|P1|Overall Study|stent not required|1
7647135|NCT01541254|26604876|P1|Overall Study|GI bleed prior to procedure|1
7647136|NCT01541254|26604876|P1|Overall Study|enrolled after study closed|1
7647137|NCT01541254|26604876|P1|Overall Study|excluded - metal allergy|1
7647138|NCT01541254|26604876|P1|Overall Study|Withdrawal by Subject|1
7647139|NCT01541215|26604883|P2|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
7647140|NCT01541215|26604884|P1|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
7647141|NCT01541215|26604883|P2|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
7647142|NCT01541215|26604884|P1|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
7647143|NCT01541215|26604883|P2|Treatment Period (52 Weeks)|Unclassified|3
7647144|NCT01541215|26604884|P1|Treatment Period (52 Weeks)|Unclassified|0
7647145|NCT01541215|26604883|P2|Treatment Period (52 Weeks)|Adverse Event|1
7647146|NCT01541215|26604884|P1|Treatment Period (52 Weeks)|Adverse Event|0
7647147|NCT01541215|26604883|P2|Treatment Period (52 Weeks)|Non-compliance|4
7647148|NCT01541215|26604884|P1|Treatment Period (52 Weeks)|Non-compliance|4
7647149|NCT01541215|26604883|P2|Treatment Period (52 Weeks)|Withdrawal criteria|8
7647150|NCT01541215|26604884|P1|Treatment Period (52 Weeks)|Withdrawal criteria|6
7647151|NCT01540981|26605038|P2|Overall Study|Withdrawal by Subject|0
7647152|NCT01540981|26605039|P1|Overall Study|Withdrawal by Subject|1
7647153|NCT01540851|26605049|P2|Overall Study|Withdrawal by Subject|3
7647154|NCT01540851|26605050|P1|Overall Study|Withdrawal by Subject|7
7647155|NCT01540851|26605049|P2|Overall Study|Lost to Follow-up|15
7647156|NCT01540851|26605050|P1|Overall Study|Lost to Follow-up|14
7647157|NCT01540838|26605062|P2|Overall Study|Not BM. Other treatment|1
7647158|NCT01540838|26605063|P1|Overall Study|Not BM. Other treatment|3
7647159|NCT01540838|26605062|P2|Overall Study|Died before treatment initiation|1
7647160|NCT01540838|26605063|P1|Overall Study|Died before treatment initiation|1
7647161|NCT01540838|26605062|P2|Overall Study|Additional antibiotic treatment|2
7647162|NCT01540838|26605063|P1|Overall Study|Additional antibiotic treatment|1
7647163|NCT01540838|26605062|P2|Overall Study|Treatment doses missing|12
7647164|NCT01540838|26605063|P1|Overall Study|Treatment doses missing|8
7647165|NCT01540838|26605062|P2|Overall Study|Open nasogastric tube|7
7647166|NCT01540838|26605063|P1|Overall Study|Open nasogastric tube|9
7647167|NCT01540565|26605213|P1|Overall Study|Ineligible|2
7647168|NCT01540487|26605232|P2|Overall Study|Protocol Violation|0
7647169|NCT01540487|26605233|P1|Overall Study|Protocol Violation|1
7647170|NCT01540474|26605271|P4|Vaccination Period|Lost to Follow-up|0
7647171|NCT01540474|26605272|P3|Vaccination Period|Lost to Follow-up|0
7647172|NCT01540474|26605273|P2|Vaccination Period|Lost to Follow-up|1
7647173|NCT01540474|26605274|P1|Vaccination Period|Lost to Follow-up|0
7647174|NCT01539863|26605412|P2|Overall Study|Lost to Follow-up|4
7647175|NCT01539863|26605413|P1|Overall Study|Lost to Follow-up|5
7647176|NCT01539837|26605422|P3|Overall Study|bad compliance|1
7647177|NCT01539837|26605423|P2|Overall Study|bad compliance|0
7647178|NCT01539837|26605424|P1|Overall Study|bad compliance|0
7647179|NCT01539837|26605422|P3|Overall Study|reduce neutrophil level|1
7647180|NCT01539837|26605423|P2|Overall Study|reduce neutrophil level|1
7647181|NCT01539837|26605424|P1|Overall Study|reduce neutrophil level|0
7647182|NCT01539759|26605446|P2|Overall Study|Lost to Follow-up|8
7647183|NCT01539759|26605447|P1|Overall Study|Lost to Follow-up|6
7647184|NCT01539642|26605468|P2|Overall Study|Withdrawal by Subject|2
7647185|NCT01539642|26605469|P1|Overall Study|Withdrawal by Subject|2
7647186|NCT01539642|26605468|P2|Overall Study|Adverse Event|4
7647187|NCT01539642|26605469|P1|Overall Study|Adverse Event|6
7647188|NCT01539642|26605468|P2|Overall Study|Patient ready for early discharge|7
7647189|NCT01539642|26605469|P1|Overall Study|Patient ready for early discharge|8
7647190|NCT01539642|26605468|P2|Overall Study|Lack of Efficacy|18
7647191|NCT01539642|26605469|P1|Overall Study|Lack of Efficacy|20
7647192|NCT01539538|26605486|P2|Overall Study|PCA no longer required or PCA problem|7
7647193|NCT01539538|26605487|P1|Overall Study|PCA no longer required or PCA problem|3
7647194|NCT01539538|26605486|P2|Overall Study|Withdrawal by Subject|3
7647195|NCT01539538|26605487|P1|Overall Study|Withdrawal by Subject|2
7647196|NCT01539538|26605486|P2|Overall Study|Lack of Efficacy|16
7647197|NCT01539538|26605487|P1|Overall Study|Lack of Efficacy|13
7647198|NCT01539538|26605486|P2|Overall Study|Adverse Event|18
7647199|NCT01539538|26605487|P1|Overall Study|Adverse Event|13
7647200|NCT01539525|26605496|P3|Overall Study|Protocol Violation|4
7647201|NCT01539525|26605497|P2|Overall Study|Protocol Violation|1
7647202|NCT01539525|26605498|P1|Overall Study|Protocol Violation|1
7647203|NCT01539525|26605496|P3|Overall Study|Withdrawal by Subject|2
7647204|NCT01539525|26605497|P2|Overall Study|Withdrawal by Subject|3
7647205|NCT01539525|26605498|P1|Overall Study|Withdrawal by Subject|0
7647206|NCT01539525|26605496|P3|Overall Study|Lost to Follow-up|11
7647207|NCT01539525|26605497|P2|Overall Study|Lost to Follow-up|12
7647208|NCT01539525|26605498|P1|Overall Study|Lost to Follow-up|19
7647209|NCT01539512|26605517|P2|Overall Study|Richter's Transformation|0
7647210|NCT01539512|26605518|P1|Overall Study|Richter's Transformation|1
7647211|NCT01539512|26605517|P2|Overall Study|Withdrawal by Subject|5
7647212|NCT01539512|26605518|P1|Overall Study|Withdrawal by Subject|12
7647213|NCT01539512|26605517|P2|Overall Study|Physician Decision|1
7647214|NCT01539512|26605518|P1|Overall Study|Physician Decision|1
7647215|NCT01539512|26605517|P2|Overall Study|Adverse Event|7
7647216|NCT01539512|26605518|P1|Overall Study|Adverse Event|9
7647217|NCT01539317|26605534|P2|Overall Study|Screening Error. Deleted from analysis.|0
7647218|NCT01539317|26605535|P1|Overall Study|Screening Error. Deleted from analysis.|1
7647219|NCT01539291|26605553|P4|Study GS-US-312-0117|Other|1
7647220|NCT01539291|26605554|P3|Study GS-US-312-0117|Other|1
7647221|NCT01539291|26605555|P2|Study GS-US-312-0117|Other|1
7647222|NCT01539291|26605556|P1|Study GS-US-312-0117|Other|2
7647223|NCT01539291|26605553|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
7647224|NCT01539291|26605554|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
7647225|NCT01539291|26605555|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
7647226|NCT01539291|26605556|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
7647227|NCT01539291|26605553|P4|Study GS-US-312-0117|Withdrawal by Subject|4
7647228|NCT01539291|26605554|P3|Study GS-US-312-0117|Withdrawal by Subject|6
7647229|NCT01539291|26605555|P2|Study GS-US-312-0117|Withdrawal by Subject|0
7647230|NCT01539291|26605556|P1|Study GS-US-312-0117|Withdrawal by Subject|5
7647231|NCT01539291|26605553|P4|Study GS-US-312-0117|Physician Decision|4
7647232|NCT01539291|26605554|P3|Study GS-US-312-0117|Physician Decision|6
7647233|NCT01539291|26605555|P2|Study GS-US-312-0117|Physician Decision|0
7647234|NCT01539291|26605556|P1|Study GS-US-312-0117|Physician Decision|9
7647235|NCT01539291|26605553|P4|Study GS-US-312-0117|Adverse Event|12
7647236|NCT01539291|26605554|P3|Study GS-US-312-0117|Adverse Event|9
7647237|NCT01539291|26605555|P2|Study GS-US-312-0117|Adverse Event|1
7647238|NCT01539291|26605556|P1|Study GS-US-312-0117|Adverse Event|22
7647239|NCT01539291|26605553|P4|Study GS-US-312-0116|Other|0
7647240|NCT01539291|26605554|P3|Study GS-US-312-0116|Other|0
7647241|NCT01539291|26605555|P2|Study GS-US-312-0116|Other|0
7647242|NCT01539291|26605556|P1|Study GS-US-312-0116|Other|1
7647243|NCT01539291|26605553|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
7647244|NCT01539291|26605554|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
7647245|NCT01539291|26605555|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
7647246|NCT01539291|26605556|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
7647247|NCT01539291|26605553|P4|Study GS-US-312-0116|Withdrawal by Subject|0
7647248|NCT01539291|26605554|P3|Study GS-US-312-0116|Withdrawal by Subject|0
7647249|NCT01539291|26605555|P2|Study GS-US-312-0116|Withdrawal by Subject|0
7647250|NCT01539291|26605556|P1|Study GS-US-312-0116|Withdrawal by Subject|12
7647251|NCT01539291|26605553|P4|Study GS-US-312-0116|Physician Decision|0
7647252|NCT01539291|26605554|P3|Study GS-US-312-0116|Physician Decision|0
7647253|NCT01539291|26605555|P2|Study GS-US-312-0116|Physician Decision|0
7647254|NCT01539291|26605556|P1|Study GS-US-312-0116|Physician Decision|1
7647255|NCT01539291|26605553|P4|Study GS-US-312-0116|Adverse Event|0
7647256|NCT01539291|26605554|P3|Study GS-US-312-0116|Adverse Event|0
7647257|NCT01539291|26605555|P2|Study GS-US-312-0116|Adverse Event|0
7647258|NCT01539291|26605556|P1|Study GS-US-312-0116|Adverse Event|9
7647259|NCT01539239|26605628|P2|Overall Study|Lost to Follow-up|12
7647260|NCT01539239|26605629|P1|Overall Study|Lost to Follow-up|7
7647261|NCT01539239|26605628|P2|Overall Study|Death|5
7647262|NCT01539239|26605629|P1|Overall Study|Death|5
7647263|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Death|11
7647264|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Death|6
7647265|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Death|0
7647266|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Progressive Disease|3
7647267|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Progressive Disease|6
7647268|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Progressive Disease|0
7647269|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
7647270|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
7647271|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
7647272|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
7647273|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
7647274|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
7647275|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Adverse Event|1
7647276|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Adverse Event|1
7647277|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Adverse Event|0
7647278|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Other|1
7647279|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Other|1
7647280|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Other|0
7647281|NCT01539083|26605652|P3|After Randomization (TP and VTP)|Physician Decision|1
7647282|NCT01539083|26605653|P2|After Randomization (TP and VTP)|Physician Decision|0
7647283|NCT01539083|26605654|P1|After Randomization (TP and VTP)|Physician Decision|0
7647284|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Other|0
7647285|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Other|0
7647286|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Other|5
7647287|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Progressive Disease|0
7647288|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Progressive Disease|0
7647289|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Progressive Disease|8
7647290|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Physician Decision|0
7647291|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Physician Decision|0
7647292|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Physician Decision|14
7647293|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Protocol Violation|0
7647294|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Protocol Violation|0
7647295|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Protocol Violation|2
7647296|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Death|0
7647297|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Death|0
7647298|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Death|6
7647299|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Adverse Event|0
7647300|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Adverse Event|0
7647301|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Adverse Event|14
7647302|NCT01539083|26605652|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7647303|NCT01539083|26605653|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7647304|NCT01539083|26605654|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
7647305|NCT01538719|26605717|P2|Overall Study|Lost to Follow-up|0
7647306|NCT01538719|26605718|P1|Overall Study|Lost to Follow-up|2
7647307|NCT01538628|26605728|P2|Overall Study|Lost to Follow-up|1
7647308|NCT01538628|26605729|P1|Overall Study|Lost to Follow-up|0
7647309|NCT01538628|26605728|P2|Overall Study|Withdrawal by Subject|1
7647310|NCT01538628|26605729|P1|Overall Study|Withdrawal by Subject|1
7647311|NCT01538472|26605760|P1|Overall Study|Death|1
7647312|NCT01538472|26605760|P1|Overall Study|Disease Progression|3
7647313|NCT01538199|26605771|P4|Overall Study|Lack of Efficacy|0
7647314|NCT01538199|26605772|P3|Overall Study|Lack of Efficacy|0
7647315|NCT01538199|26605773|P2|Overall Study|Lack of Efficacy|1
7647316|NCT01538199|26605774|P1|Overall Study|Lack of Efficacy|0
7647317|NCT01538199|26605771|P4|Overall Study|participant did not have time|2
7647318|NCT01538199|26605772|P3|Overall Study|participant did not have time|0
7647319|NCT01538199|26605773|P2|Overall Study|participant did not have time|0
7647320|NCT01538199|26605774|P1|Overall Study|participant did not have time|1
7647321|NCT01538199|26605771|P4|Overall Study|Lost to Follow-up|0
7647322|NCT01538199|26605772|P3|Overall Study|Lost to Follow-up|1
7647323|NCT01538199|26605773|P2|Overall Study|Lost to Follow-up|2
7647324|NCT01538199|26605774|P1|Overall Study|Lost to Follow-up|1
7647325|NCT01537887|26605808|P6|Period 3|Withdrawal by Subject|0
7647326|NCT01537887|26605809|P5|Period 3|Withdrawal by Subject|0
7647327|NCT01537887|26605810|P4|Period 3|Withdrawal by Subject|0
7647328|NCT01537887|26605811|P3|Period 3|Withdrawal by Subject|0
7647329|NCT01537887|26605812|P2|Period 3|Withdrawal by Subject|1
7647330|NCT01537887|26605813|P1|Period 3|Withdrawal by Subject|0
7647331|NCT01537887|26605808|P6|Period 3|Adverse Event|0
7647332|NCT01537887|26605809|P5|Period 3|Adverse Event|0
7647333|NCT01537887|26605810|P4|Period 3|Adverse Event|0
7647334|NCT01537887|26605811|P3|Period 3|Adverse Event|1
7647335|NCT01537887|26605812|P2|Period 3|Adverse Event|0
7647336|NCT01537887|26605813|P1|Period 3|Adverse Event|0
7647337|NCT01537887|26605808|P6|Period 2|Withdrawal by Subject|0
7647338|NCT01537887|26605809|P5|Period 2|Withdrawal by Subject|0
7647339|NCT01537887|26605810|P4|Period 2|Withdrawal by Subject|0
7647340|NCT01537887|26605811|P3|Period 2|Withdrawal by Subject|0
7647341|NCT01537887|26605812|P2|Period 2|Withdrawal by Subject|1
7647342|NCT01537887|26605813|P1|Period 2|Withdrawal by Subject|0
7647343|NCT01537887|26605808|P6|Period 1|Did not receive treatment|0
7647344|NCT01537887|26605809|P5|Period 1|Did not receive treatment|0
7647345|NCT01537887|26605810|P4|Period 1|Did not receive treatment|0
7647346|NCT01537887|26605811|P3|Period 1|Did not receive treatment|1
7647347|NCT01537887|26605812|P2|Period 1|Did not receive treatment|0
7647348|NCT01537887|26605813|P1|Period 1|Did not receive treatment|0
7647349|NCT01537887|26605808|P6|Period 1|Physician Decision|1
7647350|NCT01537887|26605809|P5|Period 1|Physician Decision|1
7647351|NCT01537887|26605810|P4|Period 1|Physician Decision|0
7647352|NCT01537887|26605811|P3|Period 1|Physician Decision|0
7647353|NCT01537887|26605812|P2|Period 1|Physician Decision|0
7647354|NCT01537887|26605813|P1|Period 1|Physician Decision|0
7647355|NCT01537783|26605842|P2|Overall Study|Lost to Follow-up|2
7647356|NCT01537783|26605843|P1|Overall Study|Lost to Follow-up|11
7647357|NCT01537549|26605894|P1|Overall Study|Withdrawal by Subject|2
7647358|NCT01537549|26605894|P1|Overall Study|Lost to Follow-up|1
7647359|NCT01537432|26605902|P2|Overall Study|Unsatisfactory therapeutic effect|0
7647360|NCT01537432|26605903|P1|Overall Study|Unsatisfactory therapeutic effect|1
7647361|NCT01537432|26605902|P2|Overall Study|Adverse Event|0
7647362|NCT01537432|26605903|P1|Overall Study|Adverse Event|1
7647363|NCT01537432|26605902|P2|Overall Study|Administrative problems|0
7647364|NCT01537432|26605903|P1|Overall Study|Administrative problems|1
7647365|NCT01537432|26605902|P2|Overall Study|Withdrawal by Subject|1
7647366|NCT01537432|26605903|P1|Overall Study|Withdrawal by Subject|0
7647367|NCT01537432|26605902|P2|Overall Study|Lost to Follow-up|1
7647368|NCT01537432|26605903|P1|Overall Study|Lost to Follow-up|3
7647369|NCT01537393|26605926|P2|Overall Study|Censored (severe event unrelated to PT)|1
7647370|NCT01537393|26605927|P1|Overall Study|Censored (severe event unrelated to PT)|1
7647371|NCT01537393|26605926|P2|Overall Study|Failure - Not regrafted|6
7647372|NCT01537393|26605927|P1|Overall Study|Failure - Not regrafted|2
7647373|NCT01537393|26605926|P2|Overall Study|Failure - Regrafted|43
7647374|NCT01537393|26605927|P1|Overall Study|Failure - Regrafted|28
7647375|NCT01537393|26605926|P2|Overall Study|Lost to Follow-up|48
7647376|NCT01537393|26605927|P1|Overall Study|Lost to Follow-up|53
7647377|NCT01537393|26605926|P2|Overall Study|Withdrawal by Subject|17
7647378|NCT01537393|26605927|P1|Overall Study|Withdrawal by Subject|18
7647379|NCT01537393|26605926|P2|Overall Study|Death|32
7647380|NCT01537393|26605927|P1|Overall Study|Death|20
7647381|NCT01537393|26605926|P2|Overall Study|Exclude prior to study|44
7647382|NCT01537393|26605927|P1|Overall Study|Exclude prior to study|32
7647383|NCT01537211|26605978|P2|Overall Study|Lost to Follow-up|1
7647384|NCT01537211|26605979|P1|Overall Study|Lost to Follow-up|0
7647385|NCT01537198|26606013|P1|Overall Study|Other|111
7647386|NCT01537198|26606013|P1|Overall Study|No Further Visits to the Clinic|37
7647387|NCT01537198|26606013|P1|Overall Study|Adverse Event|4
7647388|NCT01537198|26606013|P1|Overall Study|RSV infection|2
7647389|NCT01537133|26606042|P4|Overall Study|Lost to Follow-up|0
7647390|NCT01537133|26606043|P3|Overall Study|Lost to Follow-up|0
7647391|NCT01537133|26606044|P2|Overall Study|Lost to Follow-up|0
7647392|NCT01537133|26606045|P1|Overall Study|Lost to Follow-up|1
7647393|NCT01537133|26606042|P4|Overall Study|Withdrawal by Subject|0
7647394|NCT01537133|26606043|P3|Overall Study|Withdrawal by Subject|0
7647395|NCT01537133|26606044|P2|Overall Study|Withdrawal by Subject|0
7647396|NCT01537133|26606045|P1|Overall Study|Withdrawal by Subject|2
7647397|NCT01537120|26606061|P1|3 Weeks Placebo|Withdrawal by Subject|1
7647398|NCT01537120|26606061|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
7647399|NCT01537081|26606074|P3|Overall Study|Assigned but never dosed|0
7647400|NCT01537081|26606075|P2|Overall Study|Assigned but never dosed|0
7647401|NCT01537081|26606076|P1|Overall Study|Assigned but never dosed|1
7647402|NCT01537081|26606074|P3|Overall Study|Sponsor decision|0
7647403|NCT01537081|26606075|P2|Overall Study|Sponsor decision|1
7647404|NCT01537081|26606076|P1|Overall Study|Sponsor decision|0
7647405|NCT01537081|26606074|P3|Overall Study|Physician Decision|0
7647406|NCT01537081|26606075|P2|Overall Study|Physician Decision|6
7647407|NCT01537081|26606076|P1|Overall Study|Physician Decision|5
7647408|NCT01537081|26606074|P3|Overall Study|Withdrawal by Subject|3
7647409|NCT01537081|26606075|P2|Overall Study|Withdrawal by Subject|11
7647410|NCT01537081|26606076|P1|Overall Study|Withdrawal by Subject|6
7647411|NCT01537081|26606074|P3|Overall Study|Protocol Violation|2
7647412|NCT01537081|26606075|P2|Overall Study|Protocol Violation|2
7647413|NCT01537081|26606076|P1|Overall Study|Protocol Violation|3
7647414|NCT01537081|26606074|P3|Overall Study|Lost to Follow-up|9
7647415|NCT01537081|26606075|P2|Overall Study|Lost to Follow-up|15
7647416|NCT01537081|26606076|P1|Overall Study|Lost to Follow-up|17
7647417|NCT01537081|26606074|P3|Overall Study|Lack of Efficacy|0
7647418|NCT01537081|26606075|P2|Overall Study|Lack of Efficacy|1
7647419|NCT01537081|26606076|P1|Overall Study|Lack of Efficacy|2
7647420|NCT01537081|26606074|P3|Overall Study|Adverse Event|2
7647421|NCT01537081|26606075|P2|Overall Study|Adverse Event|2
7647422|NCT01537081|26606076|P1|Overall Study|Adverse Event|5
7647423|NCT01537068|26606089|P2|Overall Study|Lack of Efficacy|0
7647424|NCT01537068|26606090|P1|Overall Study|Lack of Efficacy|1
7647425|NCT01537068|26606089|P2|Overall Study|Withdrawal by Subject|1
7647426|NCT01537068|26606090|P1|Overall Study|Withdrawal by Subject|1
7647427|NCT01537068|26606089|P2|Overall Study|Adverse Event|1
7647428|NCT01537068|26606090|P1|Overall Study|Adverse Event|0
7647429|NCT01537068|26606089|P2|Overall Study|Lost to Follow-up|1
7647430|NCT01537068|26606090|P1|Overall Study|Lost to Follow-up|2
7647431|NCT01537042|26606102|P2|Overall Study|Other|1
7647432|NCT01537042|26606103|P1|Overall Study|Other|0
7647433|NCT01537042|26606102|P2|Overall Study|Protocol Violation|1
7647434|NCT01537042|26606103|P1|Overall Study|Protocol Violation|0
7647435|NCT01537042|26606102|P2|Overall Study|Lack of Efficacy|1
7647436|NCT01537042|26606103|P1|Overall Study|Lack of Efficacy|0
7647437|NCT01537042|26606102|P2|Overall Study|Adverse Event|2
7647438|NCT01537042|26606103|P1|Overall Study|Adverse Event|0
7647439|NCT01536951|26606145|P9|Second Intervention and Washout Period 2|Adverse Event|0
7647440|NCT01536951|26606146|P8|Second Intervention and Washout Period 2|Adverse Event|1
7647441|NCT01536951|26606147|P7|Second Intervention and Washout Period 2|Adverse Event|0
7647442|NCT01536951|26606148|P6|Second Intervention and Washout Period 2|Adverse Event|0
7647443|NCT01536951|26606149|P5|Second Intervention and Washout Period 2|Adverse Event|0
7647444|NCT01536951|26606150|P4|Second Intervention and Washout Period 2|Adverse Event|0
7647445|NCT01536951|26606151|P3|Second Intervention and Washout Period 2|Adverse Event|0
7647446|NCT01536951|26606152|P2|Second Intervention and Washout Period 2|Adverse Event|0
7647447|NCT01536951|26606153|P1|Second Intervention and Washout Period 2|Adverse Event|0
7647448|NCT01536951|26606145|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647449|NCT01536951|26606146|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647450|NCT01536951|26606147|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647451|NCT01536951|26606148|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647452|NCT01536951|26606149|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647453|NCT01536951|26606150|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647454|NCT01536951|26606151|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
7647455|NCT01536951|26606152|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647456|NCT01536951|26606153|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
7647457|NCT01536860|26606210|P3|Washout Period (3 Days)|Lost to Follow-up|0
7647458|NCT01536860|26606211|P2|Washout Period (3 Days)|Lost to Follow-up|0
7647459|NCT01536860|26606212|P1|Washout Period (3 Days)|Lost to Follow-up|1
7647460|NCT01536795|26606222|P2|Overall Study|Lack of Efficacy|0
7647461|NCT01536795|26606223|P1|Overall Study|Lack of Efficacy|1
7647462|NCT01536795|26606222|P2|Overall Study|Lost to Follow-up|2
7647463|NCT01536795|26606223|P1|Overall Study|Lost to Follow-up|0
7647464|NCT01536704|26606237|P4|Washout Period 3|Adverse Event|0
7647465|NCT01536704|26606238|P3|Washout Period 3|Adverse Event|1
7647466|NCT01536704|26606239|P2|Washout Period 3|Adverse Event|0
7647467|NCT01536704|26606240|P1|Washout Period 3|Adverse Event|0
7647468|NCT01536704|26606237|P4|Period 3|Adverse Event|1
7647469|NCT01536704|26606238|P3|Period 3|Adverse Event|0
7647470|NCT01536704|26606239|P2|Period 3|Adverse Event|0
7647471|NCT01536704|26606240|P1|Period 3|Adverse Event|0
7647472|NCT01536704|26606237|P4|Washout Period 2|Withdrawal by Subject|1
7647473|NCT01536704|26606238|P3|Washout Period 2|Withdrawal by Subject|0
7647474|NCT01536704|26606239|P2|Washout Period 2|Withdrawal by Subject|0
7647475|NCT01536704|26606240|P1|Washout Period 2|Withdrawal by Subject|0
7647476|NCT01536704|26606237|P4|Washout Period 2|Adverse Event|0
7647477|NCT01536704|26606238|P3|Washout Period 2|Adverse Event|0
7647478|NCT01536704|26606239|P2|Washout Period 2|Adverse Event|0
7647479|NCT01536704|26606240|P1|Washout Period 2|Adverse Event|1
7647480|NCT01536704|26606237|P4|Washout Period 1|Withdrawal by Subject|0
7647481|NCT01536704|26606238|P3|Washout Period 1|Withdrawal by Subject|0
7647482|NCT01536704|26606239|P2|Washout Period 1|Withdrawal by Subject|2
7647483|NCT01536704|26606240|P1|Washout Period 1|Withdrawal by Subject|1
7647484|NCT01536587|26606270|P1|Overall Study|Adverse Event|2
7647485|NCT01536574|26606309|P2|Overall Study|Lack of Efficacy|0
7647486|NCT01536574|26606310|P1|Overall Study|Lack of Efficacy|1
7647487|NCT01536574|26606309|P2|Overall Study|Withdrawal by Subject|2
7647488|NCT01536574|26606310|P1|Overall Study|Withdrawal by Subject|1
7647489|NCT01536574|26606309|P2|Overall Study|Adverse Event|5
7647490|NCT01536574|26606310|P1|Overall Study|Adverse Event|4
7647491|NCT01536561|26606328|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
7647492|NCT01536561|26606328|P1|Dosimetric and Therapeutic Treatment|Death|2
7647493|NCT01536561|26606328|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
7647494|NCT01536561|26606328|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
7647495|NCT01536561|26606328|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
7647496|NCT01536561|26606328|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
7647497|NCT01536535|26606368|P2|Overall Study|Participant moved|1
7647498|NCT01536535|26606369|P1|Overall Study|Participant moved|0
7647499|NCT01536535|26606368|P2|Overall Study|Physician Decision|1
7647500|NCT01536535|26606369|P1|Overall Study|Physician Decision|1
7647501|NCT01536535|26606368|P2|Overall Study|Lost to Follow-up|6
7647502|NCT01536535|26606369|P1|Overall Study|Lost to Follow-up|4
7647503|NCT01536535|26606368|P2|Overall Study|Withdrawal by Subject|5
7647504|NCT01536535|26606369|P1|Overall Study|Withdrawal by Subject|10
7647505|NCT01536418|26606418|P2|Overall Study|Withdrawal by Subject|3
7647506|NCT01536418|26606419|P1|Overall Study|Withdrawal by Subject|5
7647507|NCT01536418|26606418|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
7647508|NCT01536418|26606419|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
7647509|NCT01536418|26606418|P2|Overall Study|Adverse Event|4
7647510|NCT01536418|26606419|P1|Overall Study|Adverse Event|9
7647511|NCT01536418|26606418|P2|Overall Study|Lack of Efficacy|16
7647512|NCT01536418|26606419|P1|Overall Study|Lack of Efficacy|10
7647513|NCT01536418|26606418|P2|Overall Study|Study closed/terminated|37
7647514|NCT01536418|26606419|P1|Overall Study|Study closed/terminated|41
7647515|NCT01536418|26606418|P2|Overall Study|Physician Decision|3
7647516|NCT01536418|26606419|P1|Overall Study|Physician Decision|1
7647517|NCT01536418|26606418|P2|Overall Study|Protocol Violation|3
7647518|NCT01536418|26606419|P1|Overall Study|Protocol Violation|2
7647519|NCT01536405|26606439|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7647520|NCT01536405|26606440|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7647521|NCT01536405|26606439|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
7647522|NCT01536405|26606440|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
7647523|NCT01536405|26606439|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
7647524|NCT01536405|26606440|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
7647525|NCT01536405|26606439|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
7647526|NCT01536405|26606440|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
7647527|NCT01536405|26606439|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
7647528|NCT01536405|26606440|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
7647529|NCT01536405|26606439|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
7647530|NCT01536405|26606440|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
7647531|NCT01536405|26606439|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7647532|NCT01536405|26606440|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7647533|NCT01536405|26606439|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
7647534|NCT01536405|26606440|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
7647535|NCT01536405|26606439|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7647536|NCT01536405|26606440|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7647537|NCT01536405|26606439|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
7647538|NCT01536405|26606440|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
7647539|NCT01536405|26606439|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
7647540|NCT01536405|26606440|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
7647541|NCT01536405|26606439|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
7647542|NCT01536405|26606440|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
7647543|NCT01536405|26606439|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
7647544|NCT01536405|26606440|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
7647545|NCT01536392|26606478|P2|Overall Study|Completed therapy early|0
7647546|NCT01536392|26606479|P1|Overall Study|Completed therapy early|3
7647547|NCT01536392|26606478|P2|Overall Study|Non Compliance|4
7647548|NCT01536392|26606479|P1|Overall Study|Non Compliance|3
7647549|NCT01536392|26606478|P2|Overall Study|Withdrawal by Subject|6
7647550|NCT01536392|26606479|P1|Overall Study|Withdrawal by Subject|3
7647551|NCT01536392|26606478|P2|Overall Study|Physician Decision|3
7647552|NCT01536392|26606479|P1|Overall Study|Physician Decision|2
7647553|NCT01536392|26606478|P2|Overall Study|Adverse Event|2
7647554|NCT01536392|26606479|P1|Overall Study|Adverse Event|2
7647555|NCT01536379|26606489|P2|Overall Study|Withdrawal by Subject|1
7647556|NCT01536379|26606490|P1|Overall Study|Withdrawal by Subject|1
7647557|NCT01536379|26606489|P2|Overall Study|Adverse Event|2
7647558|NCT01536379|26606490|P1|Overall Study|Adverse Event|1
7647559|NCT01536262|26606582|P3|Overall Study|Other than stated above|0
7647560|NCT01536262|26606583|P2|Overall Study|Other than stated above|0
7647561|NCT01536262|26606584|P1|Overall Study|Other than stated above|1
7647562|NCT01536262|26606582|P3|Overall Study|Withdrawal by Subject|0
7647563|NCT01536262|26606583|P2|Overall Study|Withdrawal by Subject|1
7647564|NCT01536262|26606584|P1|Overall Study|Withdrawal by Subject|1
7647565|NCT01536262|26606582|P3|Overall Study|Adverse Event|2
7647566|NCT01536262|26606583|P2|Overall Study|Adverse Event|1
7647567|NCT01536262|26606584|P1|Overall Study|Adverse Event|6
7647568|NCT01536171|26606626|P1|Overall Study|Withdrawal by Subject|1
7647569|NCT01536145|26606631|P11|Overall Study|Adverse Event|3
7647570|NCT01536145|26606632|P10|Overall Study|Adverse Event|0
7647571|NCT01536145|26606633|P9|Overall Study|Adverse Event|0
7647572|NCT01536145|26606634|P8|Overall Study|Adverse Event|2
7647573|NCT01536145|26606635|P7|Overall Study|Adverse Event|0
7647574|NCT01536145|26606636|P6|Overall Study|Adverse Event|0
7647575|NCT01536145|26606637|P5|Overall Study|Adverse Event|0
7647576|NCT01536145|26606638|P4|Overall Study|Adverse Event|0
7647577|NCT01536145|26606639|P3|Overall Study|Adverse Event|0
7647578|NCT01536145|26606640|P2|Overall Study|Adverse Event|0
7647579|NCT01536145|26606641|P1|Overall Study|Adverse Event|0
7647580|NCT01536145|26606631|P11|Overall Study|Death|0
7647581|NCT01536145|26606632|P10|Overall Study|Death|0
7647582|NCT01536145|26606633|P9|Overall Study|Death|0
7647583|NCT01536145|26606634|P8|Overall Study|Death|0
7647584|NCT01536145|26606635|P7|Overall Study|Death|1
7647585|NCT01536145|26606636|P6|Overall Study|Death|0
7647586|NCT01536145|26606637|P5|Overall Study|Death|0
7647587|NCT01536145|26606638|P4|Overall Study|Death|0
7647588|NCT01536145|26606639|P3|Overall Study|Death|0
7647589|NCT01536145|26606640|P2|Overall Study|Death|0
7647590|NCT01536145|26606641|P1|Overall Study|Death|0
7647591|NCT01536145|26606631|P11|Overall Study|Other|2
7647592|NCT01536145|26606632|P10|Overall Study|Other|3
7647593|NCT01536145|26606633|P9|Overall Study|Other|0
7647594|NCT01536145|26606634|P8|Overall Study|Other|0
7647595|NCT01536145|26606635|P7|Overall Study|Other|0
7647596|NCT01536145|26606636|P6|Overall Study|Other|0
7647597|NCT01536145|26606637|P5|Overall Study|Other|1
7647598|NCT01536145|26606638|P4|Overall Study|Other|0
7647599|NCT01536145|26606639|P3|Overall Study|Other|0
7647600|NCT01536145|26606640|P2|Overall Study|Other|0
7647601|NCT01536145|26606641|P1|Overall Study|Other|0
7647602|NCT01536145|26606631|P11|Overall Study|Withdrawal by Subject|2
7647603|NCT01536145|26606632|P10|Overall Study|Withdrawal by Subject|0
7647604|NCT01536145|26606633|P9|Overall Study|Withdrawal by Subject|2
7647605|NCT01536145|26606634|P8|Overall Study|Withdrawal by Subject|0
7647606|NCT01536145|26606635|P7|Overall Study|Withdrawal by Subject|0
7647607|NCT01536145|26606636|P6|Overall Study|Withdrawal by Subject|1
7647608|NCT01536145|26606637|P5|Overall Study|Withdrawal by Subject|0
7647609|NCT01536145|26606638|P4|Overall Study|Withdrawal by Subject|0
7647610|NCT01536145|26606639|P3|Overall Study|Withdrawal by Subject|1
7647611|NCT01536145|26606640|P2|Overall Study|Withdrawal by Subject|0
7647612|NCT01536145|26606641|P1|Overall Study|Withdrawal by Subject|0
7647613|NCT01536145|26606631|P11|Overall Study|Progressive disease|3
7647614|NCT01536145|26606632|P10|Overall Study|Progressive disease|3
7647615|NCT01536145|26606633|P9|Overall Study|Progressive disease|1
7647616|NCT01536145|26606634|P8|Overall Study|Progressive disease|2
7647617|NCT01536145|26606635|P7|Overall Study|Progressive disease|1
7647618|NCT01536145|26606636|P6|Overall Study|Progressive disease|2
7647619|NCT01536145|26606637|P5|Overall Study|Progressive disease|1
7647620|NCT01536145|26606638|P4|Overall Study|Progressive disease|2
7647621|NCT01536145|26606639|P3|Overall Study|Progressive disease|1
7647622|NCT01536145|26606640|P2|Overall Study|Progressive disease|4
7647623|NCT01536145|26606641|P1|Overall Study|Progressive disease|3
7647624|NCT01536119|26606748|P2|Overall Study|Lost to Follow-up|14
7647625|NCT01536119|26606749|P1|Overall Study|Lost to Follow-up|17
7647626|NCT01536093|26606775|P2|Overall Study|Withdrawal by Subject|1
7647627|NCT01536093|26606776|P1|Overall Study|Withdrawal by Subject|0
7647628|NCT01536093|26606775|P2|Overall Study|absence of maternal colostrum|0
7647629|NCT01536093|26606776|P1|Overall Study|absence of maternal colostrum|2
7647630|NCT01536093|26606775|P2|Overall Study|Death|2
7647631|NCT01536093|26606776|P1|Overall Study|Death|1
7647632|NCT01536067|26606792|P1|Overall Study|Disease Progression|1
7647633|NCT01536015|26606805|P2|Overall Study|Study closure|5
7647634|NCT01536015|26606806|P1|Overall Study|Study closure|5
7647635|NCT01536015|26606805|P2|Overall Study|Inclusion Criterion not met|0
7647636|NCT01536015|26606806|P1|Overall Study|Inclusion Criterion not met|2
7647637|NCT01536015|26606805|P2|Overall Study|Lost to Follow-up|1
7647638|NCT01536015|26606806|P1|Overall Study|Lost to Follow-up|0
7647639|NCT01536015|26606805|P2|Overall Study|Adverse Event|4
7647640|NCT01536015|26606806|P1|Overall Study|Adverse Event|1
7647641|NCT01535807|26606844|P2|Overall Study|Data collection error|1
7647642|NCT01535807|26606845|P1|Overall Study|Data collection error|1
7647643|NCT01535807|26606844|P2|Overall Study|Withdrawal by Subject|1
7647644|NCT01535807|26606845|P1|Overall Study|Withdrawal by Subject|1
7647645|NCT01535729|26606851|P1|Overall Study|No participant record available|5
7647646|NCT01535729|26606851|P1|Overall Study|Not treated|9
7647647|NCT01535729|26606851|P1|Overall Study|Screening failure|1
7647648|NCT01535729|26606851|P1|Overall Study|Protocol Violation|11
7647649|NCT01535729|26606851|P1|Overall Study|NSCLC grade IV histology not confirmed|20
7647650|NCT01535729|26606851|P1|Overall Study|No previous chemotherapy|33
7647651|NCT01535729|26606851|P1|Overall Study|Did not sign informed consent|1
7647652|NCT01535729|26606851|P1|Overall Study|Other|19
7647653|NCT01535729|26606851|P1|Overall Study|Death|52
7647654|NCT01535729|26606851|P1|Overall Study|Lost to Follow-up|8
7647655|NCT01535729|26606851|P1|Overall Study|Discontinued treatment|25
7647656|NCT01535729|26606851|P1|Overall Study|Disease progression|230
7647657|NCT01535729|26606851|P1|Overall Study|Withdrawal by Subject|2
7647658|NCT01535638|26606892|P6|Treatment 3 (Single Dose)|Protocol Violation|0
7647659|NCT01535638|26606893|P5|Treatment 3 (Single Dose)|Protocol Violation|0
7647660|NCT01535638|26606894|P4|Treatment 3 (Single Dose)|Protocol Violation|1
7647661|NCT01535638|26606895|P3|Treatment 3 (Single Dose)|Protocol Violation|0
7647662|NCT01535638|26606896|P2|Treatment 3 (Single Dose)|Protocol Violation|0
7647663|NCT01535638|26606897|P1|Treatment 3 (Single Dose)|Protocol Violation|0
7647664|NCT01535638|26606892|P6|Treatment 1 (Single Dose)|Protocol Violation|1
7647665|NCT01535638|26606893|P5|Treatment 1 (Single Dose)|Protocol Violation|0
7647666|NCT01535638|26606894|P4|Treatment 1 (Single Dose)|Protocol Violation|0
7647667|NCT01535638|26606895|P3|Treatment 1 (Single Dose)|Protocol Violation|0
7647668|NCT01535638|26606896|P2|Treatment 1 (Single Dose)|Protocol Violation|0
7647669|NCT01535638|26606897|P1|Treatment 1 (Single Dose)|Protocol Violation|0
7647670|NCT01535599|26606911|P2|Overall Study|Noncompliance|1
7647671|NCT01535599|26606912|P1|Overall Study|Noncompliance|0
7647672|NCT01535599|26606911|P2|Overall Study|Stopped medication|1
7647673|NCT01535599|26606912|P1|Overall Study|Stopped medication|0
7647674|NCT01535599|26606911|P2|Overall Study|Other|0
7647675|NCT01535599|26606912|P1|Overall Study|Other|1
7647676|NCT01535599|26606911|P2|Overall Study|Did not use product|0
7647677|NCT01535599|26606912|P1|Overall Study|Did not use product|1
7647678|NCT01535599|26606911|P2|Overall Study|Randomized in Error|4
7647679|NCT01535599|26606912|P1|Overall Study|Randomized in Error|2
7647680|NCT01535599|26606911|P2|Overall Study|BL Culture + for Yeast//Fungi|1
7647681|NCT01535599|26606912|P1|Overall Study|BL Culture + for Yeast//Fungi|0
7647682|NCT01535599|26606911|P2|Overall Study|BL Culture + for Group A Strep|1
7647683|NCT01535599|26606912|P1|Overall Study|BL Culture + for Group A Strep|0
7647684|NCT01535599|26606911|P2|Overall Study|Treatment Failure|66
7647685|NCT01535599|26606912|P1|Overall Study|Treatment Failure|33
7647686|NCT01535599|26606911|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
7647687|NCT01535599|26606912|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
7647688|NCT01535599|26606911|P2|Overall Study|Lost to Follow-up|4
7647689|NCT01535599|26606912|P1|Overall Study|Lost to Follow-up|3
7647690|NCT01535599|26606911|P2|Overall Study|Adverse Event|15
7647691|NCT01535599|26606912|P1|Overall Study|Adverse Event|6
7647692|NCT01535560|26606946|P2|Overall Study|Randomized in Error|1
7647693|NCT01535560|26606947|P1|Overall Study|Randomized in Error|0
7647694|NCT01535560|26606946|P2|Overall Study|Other|1
7647695|NCT01535560|26606947|P1|Overall Study|Other|0
7647696|NCT01535560|26606946|P2|Overall Study|Treatment Failure|83
7647697|NCT01535560|26606947|P1|Overall Study|Treatment Failure|21
7647698|NCT01535560|26606946|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
7647699|NCT01535560|26606947|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
7647700|NCT01535560|26606946|P2|Overall Study|Lost to Follow-up|3
7647701|NCT01535560|26606947|P1|Overall Study|Lost to Follow-up|1
7647702|NCT01535560|26606946|P2|Overall Study|Adverse Event|7
7647703|NCT01535560|26606947|P1|Overall Study|Adverse Event|12
7647704|NCT01535443|26606957|P1|Overall Study|Physician Decision|3
7647705|NCT01535287|26607007|P2|Overall Study|drug not prepared in time|6
7647706|NCT01535287|26607008|P1|Overall Study|drug not prepared in time|5
7647707|NCT01535261|26607024|P1|Overall Study|Adverse Event|12
7647708|NCT01535261|26607024|P1|Overall Study|Withdrawal by Subject|14
7647709|NCT01535261|26607024|P1|Overall Study|Lost to Follow-up|8
7647710|NCT01535261|26607024|P1|Overall Study|Death|5
7647711|NCT01535261|26607024|P1|Overall Study|Protocol Violation|3
7647712|NCT01535261|26607024|P1|Overall Study|Physician Decision|8
7647713|NCT01535235|26607037|P2|Overall Study|Adverse Event|0
7647714|NCT01535235|26607038|P1|Overall Study|Adverse Event|1
7647715|NCT01535222|26607052|P6|Overall Study|Inclusion/exclusion|0
7647716|NCT01535222|26607053|P5|Overall Study|Inclusion/exclusion|0
7647717|NCT01535222|26607054|P4|Overall Study|Inclusion/exclusion|0
7647718|NCT01535222|26607055|P3|Overall Study|Inclusion/exclusion|1
7647719|NCT01535222|26607056|P2|Overall Study|Inclusion/exclusion|0
7647720|NCT01535222|26607057|P1|Overall Study|Inclusion/exclusion|0
7647723|NCT01535040|26607107|P2|Overall Study|Multiple Reasons|1
7647724|NCT01535040|26607108|P1|Overall Study|Multiple Reasons|1
7647725|NCT01535040|26607107|P2|Overall Study|Toxicity|5
7647726|NCT01535040|26607108|P1|Overall Study|Toxicity|7
7647727|NCT01535040|26607107|P2|Overall Study|Never Started|4
7647728|NCT01535040|26607108|P1|Overall Study|Never Started|9
7647729|NCT01535040|26607107|P2|Overall Study|Withdrawal by Subject|10
7647730|NCT01535040|26607108|P1|Overall Study|Withdrawal by Subject|13
7647731|NCT01535040|26607107|P2|Overall Study|Physician Decision|1
7647732|NCT01535040|26607108|P1|Overall Study|Physician Decision|0
7647733|NCT01534962|26607205|P4|Overall Study|Discontinued at AF recurrence|31
7647734|NCT01534962|26607206|P3|Overall Study|Discontinued at AF recurrence|24
7647735|NCT01534962|26607207|P2|Overall Study|Discontinued at AF recurrence|26
7647736|NCT01534962|26607208|P1|Overall Study|Discontinued at AF recurrence|35
7647737|NCT01534962|26607205|P4|Overall Study|Randomized but did not start treatment|1
7647738|NCT01534962|26607206|P3|Overall Study|Randomized but did not start treatment|0
7647739|NCT01534962|26607207|P2|Overall Study|Randomized but did not start treatment|0
7647740|NCT01534962|26607208|P1|Overall Study|Randomized but did not start treatment|2
7647741|NCT01534676|26607265|P2|Overall Study|Study closed due to poor enrollment|1
7647742|NCT01534676|26607266|P1|Overall Study|Study closed due to poor enrollment|2
7647743|NCT01534663|26607274|P2|Overall Study|Adverse Event|1
7647744|NCT01534663|26607275|P1|Overall Study|Adverse Event|2
7647745|NCT01534663|26607274|P2|Overall Study|Lost to Follow-up|2
7647746|NCT01534663|26607275|P1|Overall Study|Lost to Follow-up|0
7647747|NCT01534637|26607309|P1|Overall Study|Liver Mets before treatment|1
7647748|NCT01534637|26607309|P1|Overall Study|Adverse Event|1
7647749|NCT01534637|26607309|P1|Overall Study|Withdrawal by Subject|1
7647750|NCT01534637|26607309|P1|Overall Study|Lack of Efficacy|3
7647751|NCT01534637|26607309|P1|Overall Study|Physician Decision|3
7647752|NCT01534533|26607319|P4|Overall Study|Withdrawal by Subject|1
7647753|NCT01534533|26607320|P3|Overall Study|Withdrawal by Subject|4
7647754|NCT01534533|26607321|P2|Overall Study|Withdrawal by Subject|3
7647755|NCT01534533|26607322|P1|Overall Study|Withdrawal by Subject|5
7647756|NCT01534533|26607319|P4|Overall Study|Lost to Follow-up|3
7647757|NCT01534533|26607320|P3|Overall Study|Lost to Follow-up|4
7647758|NCT01534533|26607321|P2|Overall Study|Lost to Follow-up|0
7647759|NCT01534533|26607322|P1|Overall Study|Lost to Follow-up|3
7647760|NCT01534520|26607350|P2|Overall Study|Adverse Event|1
7647761|NCT01534520|26607351|P1|Overall Study|Adverse Event|0
7647762|NCT01534351|26607385|P3|Overall Study|Study Terminated Early|0
7647763|NCT01534351|26607386|P2|Overall Study|Study Terminated Early|0
7647764|NCT01534351|26607387|P1|Overall Study|Study Terminated Early|1
7647765|NCT01534273|26607408|P7|Period 1|Physician Decision|0
7647766|NCT01534273|26607409|P6|Period 1|Physician Decision|0
7647767|NCT01534273|26607410|P5|Period 1|Physician Decision|0
7647768|NCT01534273|26607411|P4|Period 1|Physician Decision|1
7647769|NCT01534273|26607412|P3|Period 1|Physician Decision|0
7647770|NCT01534273|26607413|P2|Period 1|Physician Decision|0
7647771|NCT01534273|26607414|P1|Period 1|Physician Decision|0
7647772|NCT01534260|26607441|P2|Overall Study|No treatment, per protocol|1
7647773|NCT01534260|26607442|P1|Overall Study|No treatment, per protocol|0
7647774|NCT01534260|26607441|P2|Overall Study|Physician Decision|1
7647775|NCT01534260|26607442|P1|Overall Study|Physician Decision|3
7647776|NCT01534260|26607441|P2|Overall Study|Disease Progression|6
7647777|NCT01534260|26607442|P1|Overall Study|Disease Progression|8
7647778|NCT01534260|26607441|P2|Overall Study|Withdrawal by Subject|3
7647779|NCT01534260|26607442|P1|Overall Study|Withdrawal by Subject|1
7647780|NCT01534260|26607441|P2|Overall Study|Lack of Efficacy|1
7647781|NCT01534260|26607442|P1|Overall Study|Lack of Efficacy|1
7647782|NCT01534260|26607441|P2|Overall Study|Death|0
7647783|NCT01534260|26607442|P1|Overall Study|Death|2
7647784|NCT01534260|26607441|P2|Overall Study|Adverse Event|8
7647785|NCT01534260|26607442|P1|Overall Study|Adverse Event|1
7647786|NCT01534208|26607452|P2|Overall Study|Needed prohibited meds|0
7647787|NCT01534208|26607453|P1|Overall Study|Needed prohibited meds|1
7647788|NCT01534208|26607452|P2|Overall Study|PCP decision|0
7647789|NCT01534208|26607453|P1|Overall Study|PCP decision|1
7647790|NCT01534208|26607452|P2|Overall Study|Eligibility error|0
7647791|NCT01534208|26607453|P1|Overall Study|Eligibility error|3
7647792|NCT01534208|26607452|P2|Overall Study|Lab assessment|1
7647793|NCT01534208|26607453|P1|Overall Study|Lab assessment|2
7647794|NCT01534208|26607452|P2|Overall Study|Subject relocation|0
7647795|NCT01534208|26607453|P1|Overall Study|Subject relocation|2
7647796|NCT01534208|26607452|P2|Overall Study|Sponsor decision|1
7647797|NCT01534208|26607453|P1|Overall Study|Sponsor decision|4
7647798|NCT01534208|26607452|P2|Overall Study|Protocol Violation|2
7647799|NCT01534208|26607453|P1|Overall Study|Protocol Violation|2
7647800|NCT01534208|26607452|P2|Overall Study|Lack of Efficacy|3
7647801|NCT01534208|26607453|P1|Overall Study|Lack of Efficacy|0
7647802|NCT01534208|26607452|P2|Overall Study|Physician Decision|0
7647803|NCT01534208|26607453|P1|Overall Study|Physician Decision|2
7647804|NCT01534208|26607452|P2|Overall Study|Adverse Event|8
7647805|NCT01534208|26607453|P1|Overall Study|Adverse Event|15
7647806|NCT01534208|26607452|P2|Overall Study|Withdrawal by Subject|20
7647807|NCT01534208|26607453|P1|Overall Study|Withdrawal by Subject|6
7647808|NCT01534208|26607452|P2|Overall Study|Lost to Follow-up|14
7647809|NCT01534208|26607453|P1|Overall Study|Lost to Follow-up|19
7647810|NCT01534195|26607471|P2|Overall Study|Withdrawal by Subject|1
7647811|NCT01534195|26607472|P1|Overall Study|Withdrawal by Subject|1
7647812|NCT01534182|26607486|P2|Overall Study|Adverse Event|3
7647813|NCT01534182|26607487|P1|Overall Study|Adverse Event|7
7647814|NCT01534182|26607486|P2|Overall Study|Withdrawal by Subject|7
7647815|NCT01534182|26607487|P1|Overall Study|Withdrawal by Subject|4
7647816|NCT01534182|26607486|P2|Overall Study|Administrative problems|0
7647817|NCT01534182|26607487|P1|Overall Study|Administrative problems|1
7647818|NCT01534078|26607518|P1|Overall Study|Withdrawal by Subject|1
7647819|NCT01534078|26607518|P1|Overall Study|Death|1
7647820|NCT01533935|26607555|P5|Overall Study|Other reason not defined above|1
7647821|NCT01533935|26607556|P4|Overall Study|Other reason not defined above|0
7647822|NCT01533935|26607557|P3|Overall Study|Other reason not defined above|1
7647823|NCT01533935|26607558|P2|Overall Study|Other reason not defined above|0
7647824|NCT01533935|26607559|P1|Overall Study|Other reason not defined above|1
7647825|NCT01533935|26607555|P5|Overall Study|Withdrawal by Subject|4
7647826|NCT01533935|26607556|P4|Overall Study|Withdrawal by Subject|2
7647827|NCT01533935|26607557|P3|Overall Study|Withdrawal by Subject|5
7647828|NCT01533935|26607558|P2|Overall Study|Withdrawal by Subject|4
7647829|NCT01533935|26607559|P1|Overall Study|Withdrawal by Subject|0
7647830|NCT01533935|26607555|P5|Overall Study|Lost to Follow-up|0
7647831|NCT01533935|26607556|P4|Overall Study|Lost to Follow-up|0
7647832|NCT01533935|26607557|P3|Overall Study|Lost to Follow-up|1
7647833|NCT01533935|26607558|P2|Overall Study|Lost to Follow-up|0
7647834|NCT01533935|26607559|P1|Overall Study|Lost to Follow-up|0
7647835|NCT01533935|26607555|P5|Overall Study|Protocol Violation|0
7647836|NCT01533935|26607556|P4|Overall Study|Protocol Violation|0
7647837|NCT01533935|26607557|P3|Overall Study|Protocol Violation|0
7647838|NCT01533935|26607558|P2|Overall Study|Protocol Violation|2
7647839|NCT01533935|26607559|P1|Overall Study|Protocol Violation|0
7647840|NCT01533935|26607555|P5|Overall Study|Adverse Event|3
7647841|NCT01533935|26607556|P4|Overall Study|Adverse Event|5
7647842|NCT01533935|26607557|P3|Overall Study|Adverse Event|1
7647843|NCT01533935|26607558|P2|Overall Study|Adverse Event|7
7647844|NCT01533935|26607559|P1|Overall Study|Adverse Event|5
7647845|NCT01533922|26607586|P5|Overall Study|Other reason not defined above|0
7647846|NCT01533922|26607587|P4|Overall Study|Other reason not defined above|0
7647847|NCT01533922|26607588|P3|Overall Study|Other reason not defined above|1
7647848|NCT01533922|26607589|P2|Overall Study|Other reason not defined above|0
7647849|NCT01533922|26607590|P1|Overall Study|Other reason not defined above|2
7647850|NCT01533922|26607586|P5|Overall Study|Withdrawal by Subject|1
7647851|NCT01533922|26607587|P4|Overall Study|Withdrawal by Subject|2
7647852|NCT01533922|26607588|P3|Overall Study|Withdrawal by Subject|2
7647853|NCT01533922|26607589|P2|Overall Study|Withdrawal by Subject|1
7647854|NCT01533922|26607590|P1|Overall Study|Withdrawal by Subject|3
7647855|NCT01533922|26607586|P5|Overall Study|Protocol Violation|1
7647856|NCT01533922|26607587|P4|Overall Study|Protocol Violation|0
7647857|NCT01533922|26607588|P3|Overall Study|Protocol Violation|0
7647858|NCT01533922|26607589|P2|Overall Study|Protocol Violation|3
7647859|NCT01533922|26607590|P1|Overall Study|Protocol Violation|0
7647860|NCT01533922|26607586|P5|Overall Study|Lack of Efficacy|0
7647861|NCT01533922|26607587|P4|Overall Study|Lack of Efficacy|0
7647862|NCT01533922|26607588|P3|Overall Study|Lack of Efficacy|1
7647863|NCT01533922|26607589|P2|Overall Study|Lack of Efficacy|0
7647864|NCT01533922|26607590|P1|Overall Study|Lack of Efficacy|0
7647865|NCT01533922|26607586|P5|Overall Study|Adverse Event|4
7647866|NCT01533922|26607587|P4|Overall Study|Adverse Event|3
7647867|NCT01533922|26607588|P3|Overall Study|Adverse Event|6
7647868|NCT01533922|26607589|P2|Overall Study|Adverse Event|8
7647869|NCT01533922|26607590|P1|Overall Study|Adverse Event|5
7647870|NCT01533688|26607635|P3|Overall Study|Had colonoscopy at outside hospital|2
7647871|NCT01533688|26607636|P2|Overall Study|Had colonoscopy at outside hospital|3
7647872|NCT01533688|26607637|P1|Overall Study|Had colonoscopy at outside hospital|2
7647873|NCT01533688|26607635|P3|Overall Study|Medically unstable|3
7647874|NCT01533688|26607636|P2|Overall Study|Medically unstable|3
7647875|NCT01533688|26607637|P1|Overall Study|Medically unstable|1
7647876|NCT01533688|26607635|P3|Overall Study|Withdrawal by Subject|3
7647877|NCT01533688|26607636|P2|Overall Study|Withdrawal by Subject|4
7647878|NCT01533688|26607637|P1|Overall Study|Withdrawal by Subject|5
7647879|NCT01533493|26607669|P2|Overall Study|Lost to Follow-up|0
7647880|NCT01533493|26607670|P1|Overall Study|Lost to Follow-up|2
7647881|NCT01533493|26607669|P2|Overall Study|Withdrawal by Subject|2
7647882|NCT01533493|26607670|P1|Overall Study|Withdrawal by Subject|1
7647883|NCT01533493|26607669|P2|Overall Study|Adverse Event|1
7647884|NCT01533493|26607670|P1|Overall Study|Adverse Event|2
7647885|NCT01533428|26607678|P2|Overall Study|Withdrawal by Subject|6
7647886|NCT01533428|26607679|P1|Overall Study|Withdrawal by Subject|7
7647887|NCT01533428|26607678|P2|Overall Study|Lost to Follow-up|1
7647888|NCT01533428|26607679|P1|Overall Study|Lost to Follow-up|2
7647889|NCT01533428|26607678|P2|Overall Study|Adverse Event|1
7647890|NCT01533428|26607679|P1|Overall Study|Adverse Event|0
7647891|NCT01533246|26607725|P1|Overall Study|Withdrawal by Subject|1
7647892|NCT01533246|26607725|P1|Overall Study|Adverse Event|1
7647893|NCT01533181|26607749|P2|Overall Study|Patient withdrawal pre-active treatment|0
7647894|NCT01533181|26607750|P1|Overall Study|Patient withdrawal pre-active treatment|1
7647895|NCT01533181|26607749|P2|Overall Study|Disease progression pre-active treatment|1
7647896|NCT01533181|26607750|P1|Overall Study|Disease progression pre-active treatment|0
7647897|NCT01532999|26607867|P2|Overall Study|New job|2
7647898|NCT01532999|26607868|P1|Overall Study|New job|0
7647899|NCT01532999|26607867|P2|Overall Study|incarcerated|1
7647900|NCT01532999|26607868|P1|Overall Study|incarcerated|0
7647901|NCT01532999|26607867|P2|Overall Study|Adverse Event|1
7647902|NCT01532999|26607868|P1|Overall Study|Adverse Event|0
7647903|NCT01532999|26607867|P2|Overall Study|no show for week 9 assessments|4
7647904|NCT01532999|26607868|P1|Overall Study|no show for week 9 assessments|6
7647905|NCT01532999|26607867|P2|Overall Study|substantial noncompliance|0
7647906|NCT01532999|26607868|P1|Overall Study|substantial noncompliance|2
7647907|NCT01532999|26607867|P2|Overall Study|should not have been randomized|0
7647908|NCT01532999|26607868|P1|Overall Study|should not have been randomized|1
7647909|NCT01532999|26607867|P2|Overall Study|Relocated|0
7647910|NCT01532999|26607868|P1|Overall Study|Relocated|2
7647911|NCT01532999|26607867|P2|Overall Study|Withdrawal by Subject|0
7647912|NCT01532999|26607868|P1|Overall Study|Withdrawal by Subject|5
7647913|NCT01532999|26607867|P2|Overall Study|Physician Decision|2
7647914|NCT01532999|26607868|P1|Overall Study|Physician Decision|1
7647915|NCT01532999|26607867|P2|Overall Study|Lost to Follow-up|8
7647916|NCT01532999|26607868|P1|Overall Study|Lost to Follow-up|14
7647917|NCT01532986|26607892|P2|Overall Study|Physician Decision|5
7647918|NCT01532986|26607893|P1|Overall Study|Physician Decision|7
7647919|NCT01532986|26607892|P2|Overall Study|Withdrawal by Subject|10
7647920|NCT01532986|26607893|P1|Overall Study|Withdrawal by Subject|7
7647921|NCT01532986|26607892|P2|Overall Study|Death|9
7647922|NCT01532986|26607893|P1|Overall Study|Death|9
7647923|NCT01532934|26607977|P2|Overall Study|In controlled environment|2
7647924|NCT01532934|26607978|P1|Overall Study|In controlled environment|3
7647925|NCT01532934|26607977|P2|Overall Study|Lost to Follow-up|11
7647926|NCT01532934|26607978|P1|Overall Study|Lost to Follow-up|11
7647927|NCT01532921|26607988|P1|Overall Study|Device was explanted during procedure|1
7647928|NCT01532921|26607988|P1|Overall Study|Physician Decision|7
7647929|NCT01532921|26607988|P1|Overall Study|Lost to Follow-up|3
7647930|NCT01532921|26607988|P1|Overall Study|Withdrawal by Subject|2
7647931|NCT01532921|26607988|P1|Overall Study|Death|3
7647932|NCT01532908|26608010|P2|Overall Study|Not Transplanted|0
7647933|NCT01532908|26608011|P1|Overall Study|Not Transplanted|1
7647934|NCT01532869|26608029|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7647935|NCT01532869|26608030|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7647936|NCT01532869|26608029|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7647937|NCT01532869|26608030|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7647938|NCT01532869|26608029|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
7647939|NCT01532869|26608030|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
7647940|NCT01532869|26608029|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
7647941|NCT01532869|26608030|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
7647942|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
7647943|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
7647944|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
7647945|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
7647946|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
7647947|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
7647948|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
7647949|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
7647950|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
7647951|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
7647952|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
7647953|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
7647954|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
7647955|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
7647956|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
7647957|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
7647958|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7647959|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7647960|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
7647961|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
7647962|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
7647963|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
7647964|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
7647965|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
7647966|NCT01532869|26608029|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
7647967|NCT01532869|26608030|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
7647968|NCT01532687|26608089|P2|Overall Study|Protocol-defined delay > 3 weeks|0
7647969|NCT01532687|26608090|P1|Overall Study|Protocol-defined delay > 3 weeks|3
7647970|NCT01532687|26608089|P2|Overall Study|Physician Decision|1
7647971|NCT01532687|26608090|P1|Overall Study|Physician Decision|2
7647972|NCT01532687|26608089|P2|Overall Study|Withdrawal by Subject|0
7647973|NCT01532687|26608090|P1|Overall Study|Withdrawal by Subject|1
7647974|NCT01532687|26608089|P2|Overall Study|Adverse Event|1
7647975|NCT01532687|26608090|P1|Overall Study|Adverse Event|6
7647976|NCT01532687|26608089|P2|Overall Study|Death|0
7647977|NCT01532687|26608090|P1|Overall Study|Death|2
7647978|NCT01532648|26608104|P2|Overall Study|Withdrawal by Subject|2
7647979|NCT01532648|26608105|P1|Overall Study|Withdrawal by Subject|16
7647980|NCT01532648|26608104|P2|Overall Study|Adverse Event|9
7647981|NCT01532648|26608105|P1|Overall Study|Adverse Event|12
7647982|NCT01532648|26608104|P2|Overall Study|Protocol Violation|1
7647983|NCT01532648|26608105|P1|Overall Study|Protocol Violation|1
7647984|NCT01532648|26608104|P2|Overall Study|Lack of Efficacy|1
7647985|NCT01532648|26608105|P1|Overall Study|Lack of Efficacy|4
7647986|NCT01532648|26608104|P2|Overall Study|Lost to Follow-up|4
7647987|NCT01532648|26608105|P1|Overall Study|Lost to Follow-up|3
7647988|NCT01532570|26608139|P4|Overall Study|Withdrawal by Subject|0
7647989|NCT01532570|26608140|P3|Overall Study|Withdrawal by Subject|0
7647990|NCT01532570|26608141|P2|Overall Study|Withdrawal by Subject|1
7647991|NCT01532570|26608142|P1|Overall Study|Withdrawal by Subject|0
7647992|NCT01532570|26608139|P4|Overall Study|Lack of Efficacy|0
7647993|NCT01532570|26608140|P3|Overall Study|Lack of Efficacy|0
7647994|NCT01532570|26608141|P2|Overall Study|Lack of Efficacy|0
7647995|NCT01532570|26608142|P1|Overall Study|Lack of Efficacy|1
7647996|NCT01532414|26608187|P3|Overall Study|Withdrawn by sponsor|0
7647997|NCT01532414|26608188|P2|Overall Study|Withdrawn by sponsor|0
7647998|NCT01532414|26608189|P1|Overall Study|Withdrawn by sponsor|1
7647999|NCT01532414|26608187|P3|Overall Study|Unable to complete 24 hour PK|1
7648000|NCT01532414|26608188|P2|Overall Study|Unable to complete 24 hour PK|0
7648001|NCT01532414|26608189|P1|Overall Study|Unable to complete 24 hour PK|0
7648002|NCT01532414|26608187|P3|Overall Study|Adverse Event|1
7648003|NCT01532414|26608188|P2|Overall Study|Adverse Event|1
7648004|NCT01532414|26608189|P1|Overall Study|Adverse Event|0
7648005|NCT01532414|26608187|P3|Overall Study|No V6 semen sample|0
7648006|NCT01532414|26608188|P2|Overall Study|No V6 semen sample|1
7648007|NCT01532414|26608189|P1|Overall Study|No V6 semen sample|0
7648008|NCT01532414|26608187|P3|Overall Study|Withdrawal by Subject|0
7648009|NCT01532414|26608188|P2|Overall Study|Withdrawal by Subject|0
7648010|NCT01532414|26608189|P1|Overall Study|Withdrawal by Subject|3
7648011|NCT01532414|26608187|P3|Overall Study|Lost to Follow-up|1
7648012|NCT01532414|26608188|P2|Overall Study|Lost to Follow-up|0
7648013|NCT01532414|26608189|P1|Overall Study|Lost to Follow-up|3
7648014|NCT01532388|26608199|P2|12-month Follow-up|Lost to Follow-up|67
7648015|NCT01532388|26608200|P1|12-month Follow-up|Lost to Follow-up|69
7648016|NCT01532388|26608199|P2|6-month Follow-up|Lost to Follow-up|66
7648017|NCT01532388|26608200|P1|6-month Follow-up|Lost to Follow-up|74
7648018|NCT01532388|26608199|P2|3-month Follow-up|Lost to Follow-up|68
7648019|NCT01532388|26608200|P1|3-month Follow-up|Lost to Follow-up|68
7648020|NCT01531998|26608305|P1|Overall Study|Withdrawal by Subject|3
7648021|NCT01531894|26608327|P1|Overall Study|Death|1
7648022|NCT01531894|26608327|P1|Overall Study|Physician Decision|8
7648023|NCT01531725|26608357|P1|Overall Study|Protocol Violation|5
7648024|NCT01531673|26608375|P13|Overall Study|Other|0
7648025|NCT01531673|26608376|P12|Overall Study|Other|0
7648026|NCT01531673|26608377|P11|Overall Study|Other|0
7648027|NCT01531673|26608378|P10|Overall Study|Other|1
7648028|NCT01531673|26608379|P9|Overall Study|Other|0
7648029|NCT01531673|26608380|P8|Overall Study|Other|0
7648030|NCT01531673|26608381|P7|Overall Study|Other|0
7648031|NCT01531673|26608382|P6|Overall Study|Other|0
7648032|NCT01531673|26608383|P5|Overall Study|Other|0
7648033|NCT01531673|26608384|P4|Overall Study|Other|1
7648034|NCT01531673|26608385|P3|Overall Study|Other|0
7648035|NCT01531673|26608386|P2|Overall Study|Other|0
7648036|NCT01531673|26608387|P1|Overall Study|Other|0
7648037|NCT01531673|26608375|P13|Overall Study|Lost to Follow-up|0
7648038|NCT01531673|26608376|P12|Overall Study|Lost to Follow-up|0
7648039|NCT01531673|26608377|P11|Overall Study|Lost to Follow-up|0
7648040|NCT01531673|26608378|P10|Overall Study|Lost to Follow-up|0
7648041|NCT01531673|26608379|P9|Overall Study|Lost to Follow-up|0
7648042|NCT01531673|26608380|P8|Overall Study|Lost to Follow-up|0
7648043|NCT01531673|26608381|P7|Overall Study|Lost to Follow-up|0
7648044|NCT01531673|26608382|P6|Overall Study|Lost to Follow-up|0
7648045|NCT01531673|26608383|P5|Overall Study|Lost to Follow-up|1
7648046|NCT01531673|26608384|P4|Overall Study|Lost to Follow-up|0
7648047|NCT01531673|26608385|P3|Overall Study|Lost to Follow-up|0
7648048|NCT01531673|26608386|P2|Overall Study|Lost to Follow-up|0
7648049|NCT01531673|26608387|P1|Overall Study|Lost to Follow-up|0
7648050|NCT01531673|26608375|P13|Overall Study|Adverse Event|0
7648051|NCT01531673|26608376|P12|Overall Study|Adverse Event|0
7648052|NCT01531673|26608377|P11|Overall Study|Adverse Event|0
7648053|NCT01531673|26608378|P10|Overall Study|Adverse Event|0
7648054|NCT01531673|26608379|P9|Overall Study|Adverse Event|0
7648055|NCT01531673|26608380|P8|Overall Study|Adverse Event|0
7648056|NCT01531673|26608381|P7|Overall Study|Adverse Event|0
7648057|NCT01531673|26608382|P6|Overall Study|Adverse Event|0
7648058|NCT01531673|26608383|P5|Overall Study|Adverse Event|0
7648059|NCT01531673|26608384|P4|Overall Study|Adverse Event|0
7648060|NCT01531673|26608385|P3|Overall Study|Adverse Event|0
7648061|NCT01531673|26608386|P2|Overall Study|Adverse Event|1
7648062|NCT01531673|26608387|P1|Overall Study|Adverse Event|0
7648063|NCT01531673|26608375|P13|Overall Study|Non-Compliance|0
7648064|NCT01531673|26608376|P12|Overall Study|Non-Compliance|0
7648065|NCT01531673|26608377|P11|Overall Study|Non-Compliance|0
7648066|NCT01531673|26608378|P10|Overall Study|Non-Compliance|0
7648067|NCT01531673|26608379|P9|Overall Study|Non-Compliance|0
7648068|NCT01531673|26608380|P8|Overall Study|Non-Compliance|0
7648069|NCT01531673|26608381|P7|Overall Study|Non-Compliance|0
7648070|NCT01531673|26608382|P6|Overall Study|Non-Compliance|1
7648071|NCT01531673|26608383|P5|Overall Study|Non-Compliance|0
7648072|NCT01531673|26608384|P4|Overall Study|Non-Compliance|0
7648073|NCT01531673|26608385|P3|Overall Study|Non-Compliance|0
7648074|NCT01531673|26608386|P2|Overall Study|Non-Compliance|0
7648075|NCT01531673|26608387|P1|Overall Study|Non-Compliance|0
7648076|NCT01531387|26608513|P2|Overall Study|Early termination of study|11
7648077|NCT01531387|26608514|P1|Overall Study|Early termination of study|11
7648078|NCT01531205|26608606|P1|Overall Study|Did not proceed to surgery|1
7648079|NCT01531153|26608618|P3|Overall Study|Withdrawal by Subject|15
7648080|NCT01531153|26608619|P2|Overall Study|Withdrawal by Subject|9
7648081|NCT01531153|26608620|P1|Overall Study|Withdrawal by Subject|10
7648082|NCT01530997|26608676|P1|Overall Study|Withdrawal by Subject|1
7648083|NCT01530997|26608676|P1|Overall Study|Physician Decision|1
7648084|NCT01530464|26608720|P2|Washout (24h)|Withdrawal by Subject|1
7648085|NCT01530464|26608721|P1|Washout (24h)|Withdrawal by Subject|0
7648086|NCT01530464|26608720|P2|Washout (24h)|Withdrawal by Subject|0
7648087|NCT01530464|26608721|P1|Washout (24h)|Withdrawal by Subject|1
7648088|NCT01530334|26608773|P1|Overall Study|Progressive disease|47
7648089|NCT01530334|26608773|P1|Overall Study|unknown reason|1
7648090|NCT01530334|26608773|P1|Overall Study|Adverse Event|3
7648091|NCT01530256|26608782|P1|Overall Study|Death|2
7648092|NCT01530087|26608828|P1|Overall Study|Physician Decision|2
7648093|NCT01529749|26608844|P4|Overall Study|Protocol Violation|1
7648094|NCT01529749|26608845|P3|Overall Study|Protocol Violation|0
7648095|NCT01529749|26608846|P2|Overall Study|Protocol Violation|0
7648096|NCT01529749|26608847|P1|Overall Study|Protocol Violation|0
7648097|NCT01529749|26608844|P4|Overall Study|Withdrawal by Subject|0
7648098|NCT01529749|26608845|P3|Overall Study|Withdrawal by Subject|1
7648099|NCT01529749|26608846|P2|Overall Study|Withdrawal by Subject|1
7648100|NCT01529749|26608847|P1|Overall Study|Withdrawal by Subject|0
7648101|NCT01529749|26608844|P4|Overall Study|Physician Decision|1
7648102|NCT01529749|26608845|P3|Overall Study|Physician Decision|0
7648103|NCT01529749|26608846|P2|Overall Study|Physician Decision|0
7648104|NCT01529749|26608847|P1|Overall Study|Physician Decision|0
7648105|NCT01529749|26608844|P4|Overall Study|Lost to Follow-up|0
7648106|NCT01529749|26608845|P3|Overall Study|Lost to Follow-up|1
7648107|NCT01529749|26608846|P2|Overall Study|Lost to Follow-up|1
7648108|NCT01529749|26608847|P1|Overall Study|Lost to Follow-up|0
7648109|NCT01529645|26608931|P10|Overall Study|Withdrawal by Subject|0
7648110|NCT01529645|26608932|P9|Overall Study|Withdrawal by Subject|0
7648111|NCT01529645|26608933|P8|Overall Study|Withdrawal by Subject|0
7648112|NCT01529645|26608934|P7|Overall Study|Withdrawal by Subject|0
7648113|NCT01529645|26608935|P6|Overall Study|Withdrawal by Subject|1
7648114|NCT01529645|26608936|P5|Overall Study|Withdrawal by Subject|1
7648115|NCT01529645|26608937|P4|Overall Study|Withdrawal by Subject|1
7648116|NCT01529645|26608938|P3|Overall Study|Withdrawal by Subject|0
7648117|NCT01529645|26608939|P2|Overall Study|Withdrawal by Subject|0
7648118|NCT01529645|26608940|P1|Overall Study|Withdrawal by Subject|2
7648119|NCT01529645|26608931|P10|Overall Study|SAE - Premature contractions|0
7648120|NCT01529645|26608932|P9|Overall Study|SAE - Premature contractions|0
7648121|NCT01529645|26608933|P8|Overall Study|SAE - Premature contractions|0
7648122|NCT01529645|26608934|P7|Overall Study|SAE - Premature contractions|0
7648123|NCT01529645|26608935|P6|Overall Study|SAE - Premature contractions|0
7648124|NCT01529645|26608936|P5|Overall Study|SAE - Premature contractions|0
7648125|NCT01529645|26608937|P4|Overall Study|SAE - Premature contractions|0
7648126|NCT01529645|26608938|P3|Overall Study|SAE - Premature contractions|1
7648127|NCT01529645|26608939|P2|Overall Study|SAE - Premature contractions|0
7648128|NCT01529645|26608940|P1|Overall Study|SAE - Premature contractions|0
7648129|NCT01529645|26608931|P10|Overall Study|Lost to Follow-up|0
7648130|NCT01529645|26608932|P9|Overall Study|Lost to Follow-up|1
7648131|NCT01529645|26608933|P8|Overall Study|Lost to Follow-up|0
7648132|NCT01529645|26608934|P7|Overall Study|Lost to Follow-up|2
7648133|NCT01529645|26608935|P6|Overall Study|Lost to Follow-up|0
7648134|NCT01529645|26608936|P5|Overall Study|Lost to Follow-up|1
7648135|NCT01529645|26608937|P4|Overall Study|Lost to Follow-up|1
7648136|NCT01529645|26608938|P3|Overall Study|Lost to Follow-up|1
7648137|NCT01529645|26608939|P2|Overall Study|Lost to Follow-up|1
7648138|NCT01529645|26608940|P1|Overall Study|Lost to Follow-up|0
7648139|NCT01529632|26609038|P2|Overall Study|Adverse Event|1
7648140|NCT01529632|26609039|P1|Overall Study|Adverse Event|1
7648141|NCT01529632|26609038|P2|Overall Study|Protocol Violation|1
7648142|NCT01529632|26609039|P1|Overall Study|Protocol Violation|0
7648143|NCT01529632|26609038|P2|Overall Study|Administrative problem|1
7648144|NCT01529632|26609039|P1|Overall Study|Administrative problem|2
7648145|NCT01529606|26609059|P2|Overall Study|Lost to Follow-up|18
7648146|NCT01529606|26609060|P1|Overall Study|Lost to Follow-up|21
7648147|NCT01529515|26609072|P4|DOUBLE BLIND PHASE|Other|2
7648148|NCT01529515|26609073|P3|DOUBLE BLIND PHASE|Other|9
7648149|NCT01529515|26609074|P2|DOUBLE BLIND PHASE|Other|0
7648150|NCT01529515|26609075|P1|DOUBLE BLIND PHASE|Other|0
7648151|NCT01529515|26609072|P4|DOUBLE BLIND PHASE|Protocol Violation|0
7648152|NCT01529515|26609073|P3|DOUBLE BLIND PHASE|Protocol Violation|1
7648153|NCT01529515|26609074|P2|DOUBLE BLIND PHASE|Protocol Violation|0
7648154|NCT01529515|26609075|P1|DOUBLE BLIND PHASE|Protocol Violation|0
7648155|NCT01529515|26609072|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
7648156|NCT01529515|26609073|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
7648157|NCT01529515|26609074|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7648158|NCT01529515|26609075|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7648159|NCT01529515|26609072|P4|DOUBLE BLIND PHASE|Pregnancy|0
7648160|NCT01529515|26609073|P3|DOUBLE BLIND PHASE|Pregnancy|1
7648161|NCT01529515|26609074|P2|DOUBLE BLIND PHASE|Pregnancy|0
7648162|NCT01529515|26609075|P1|DOUBLE BLIND PHASE|Pregnancy|0
7648163|NCT01529515|26609072|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
7648164|NCT01529515|26609073|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
7648165|NCT01529515|26609074|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
7648166|NCT01529515|26609075|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
7648167|NCT01529515|26609072|P4|DOUBLE BLIND PHASE|Adverse Event|0
7648168|NCT01529515|26609073|P3|DOUBLE BLIND PHASE|Adverse Event|1
7648169|NCT01529515|26609074|P2|DOUBLE BLIND PHASE|Adverse Event|0
7648170|NCT01529515|26609075|P1|DOUBLE BLIND PHASE|Adverse Event|0
7648171|NCT01529515|26609072|P4|MAINTENANCE PHASE|Other|0
7648172|NCT01529515|26609073|P3|MAINTENANCE PHASE|Other|0
7648173|NCT01529515|26609074|P2|MAINTENANCE PHASE|Other|10
7648174|NCT01529515|26609075|P1|MAINTENANCE PHASE|Other|0
7648175|NCT01529515|26609072|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
7648176|NCT01529515|26609073|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
7648177|NCT01529515|26609074|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
7648178|NCT01529515|26609075|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
7648179|NCT01529515|26609072|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
7648180|NCT01529515|26609073|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
7648181|NCT01529515|26609074|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
7648182|NCT01529515|26609075|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
7648183|NCT01529515|26609072|P4|MAINTENANCE PHASE|Protocol Violation|0
7648184|NCT01529515|26609073|P3|MAINTENANCE PHASE|Protocol Violation|0
7648185|NCT01529515|26609074|P2|MAINTENANCE PHASE|Protocol Violation|12
7648186|NCT01529515|26609075|P1|MAINTENANCE PHASE|Protocol Violation|0
7648187|NCT01529515|26609072|P4|MAINTENANCE PHASE|Lost to Follow-up|0
7648188|NCT01529515|26609073|P3|MAINTENANCE PHASE|Lost to Follow-up|0
7648189|NCT01529515|26609074|P2|MAINTENANCE PHASE|Lost to Follow-up|5
7648190|NCT01529515|26609075|P1|MAINTENANCE PHASE|Lost to Follow-up|0
7648191|NCT01529515|26609072|P4|MAINTENANCE PHASE|Lack of Efficacy|0
7648192|NCT01529515|26609073|P3|MAINTENANCE PHASE|Lack of Efficacy|0
7648193|NCT01529515|26609074|P2|MAINTENANCE PHASE|Lack of Efficacy|9
7648194|NCT01529515|26609075|P1|MAINTENANCE PHASE|Lack of Efficacy|0
7648195|NCT01529515|26609072|P4|MAINTENANCE PHASE|Adverse Event|0
7648196|NCT01529515|26609073|P3|MAINTENANCE PHASE|Adverse Event|0
7648197|NCT01529515|26609074|P2|MAINTENANCE PHASE|Adverse Event|10
7648198|NCT01529515|26609075|P1|MAINTENANCE PHASE|Adverse Event|0
7648199|NCT01529515|26609072|P4|TRANSITION PHASE|Other|0
7648200|NCT01529515|26609073|P3|TRANSITION PHASE|Other|0
7648201|NCT01529515|26609074|P2|TRANSITION PHASE|Other|0
7648202|NCT01529515|26609075|P1|TRANSITION PHASE|Other|9
7648203|NCT01529515|26609072|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7648204|NCT01529515|26609073|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7648205|NCT01529515|26609074|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7648206|NCT01529515|26609075|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
7648207|NCT01529515|26609072|P4|TRANSITION PHASE|Withdrawal by Subject|0
7648208|NCT01529515|26609073|P3|TRANSITION PHASE|Withdrawal by Subject|0
7648209|NCT01529515|26609074|P2|TRANSITION PHASE|Withdrawal by Subject|0
7648210|NCT01529515|26609075|P1|TRANSITION PHASE|Withdrawal by Subject|51
7648211|NCT01529515|26609072|P4|TRANSITION PHASE|Protocol Violation|0
7648212|NCT01529515|26609073|P3|TRANSITION PHASE|Protocol Violation|0
7648213|NCT01529515|26609074|P2|TRANSITION PHASE|Protocol Violation|0
7648214|NCT01529515|26609075|P1|TRANSITION PHASE|Protocol Violation|4
7648215|NCT01529515|26609072|P4|TRANSITION PHASE|Lost to Follow-up|0
7648216|NCT01529515|26609073|P3|TRANSITION PHASE|Lost to Follow-up|0
7648217|NCT01529515|26609074|P2|TRANSITION PHASE|Lost to Follow-up|0
7648218|NCT01529515|26609075|P1|TRANSITION PHASE|Lost to Follow-up|19
7648219|NCT01529515|26609072|P4|TRANSITION PHASE|Lack of Efficacy|0
7648220|NCT01529515|26609073|P3|TRANSITION PHASE|Lack of Efficacy|0
7648221|NCT01529515|26609074|P2|TRANSITION PHASE|Lack of Efficacy|0
7648222|NCT01529515|26609075|P1|TRANSITION PHASE|Lack of Efficacy|19
7648223|NCT01529515|26609072|P4|TRANSITION PHASE|Death|0
7648224|NCT01529515|26609073|P3|TRANSITION PHASE|Death|0
7648225|NCT01529515|26609074|P2|TRANSITION PHASE|Death|0
7648226|NCT01529515|26609075|P1|TRANSITION PHASE|Death|1
7648227|NCT01529515|26609072|P4|TRANSITION PHASE|Adverse Event|0
7648228|NCT01529515|26609073|P3|TRANSITION PHASE|Adverse Event|0
7648229|NCT01529515|26609074|P2|TRANSITION PHASE|Adverse Event|0
7648230|NCT01529515|26609075|P1|TRANSITION PHASE|Adverse Event|16
7648231|NCT01529385|26609122|P2|Overall Study|Lost to Follow-up|1
7648232|NCT01529385|26609123|P1|Overall Study|Lost to Follow-up|2
7648233|NCT01529346|26609152|P5|Overall Study|Other|0
7648234|NCT01529346|26609153|P4|Overall Study|Other|0
7648235|NCT01529346|26609154|P3|Overall Study|Other|1
7648236|NCT01529346|26609155|P2|Overall Study|Other|1
7648237|NCT01529346|26609156|P1|Overall Study|Other|0
7648238|NCT01529346|26609152|P5|Overall Study|Lost to Follow-up|0
7648239|NCT01529346|26609153|P4|Overall Study|Lost to Follow-up|0
7648240|NCT01529346|26609154|P3|Overall Study|Lost to Follow-up|1
7648241|NCT01529346|26609155|P2|Overall Study|Lost to Follow-up|0
7648242|NCT01529346|26609156|P1|Overall Study|Lost to Follow-up|2
7648243|NCT01529268|26609244|P2|Overall Study|Moved|0
7648244|NCT01529268|26609245|P1|Overall Study|Moved|3
7648245|NCT01529268|26609244|P2|Overall Study|Lost to Follow-up|3
7648246|NCT01529268|26609245|P1|Overall Study|Lost to Follow-up|9
7648247|NCT01529112|26609307|P2|Overall Study|Withdrawal by Subject|3
7648248|NCT01529112|26609308|P1|Overall Study|Withdrawal by Subject|7
7648249|NCT01529112|26609307|P2|Overall Study|Protocol Violation|0
7648250|NCT01529112|26609308|P1|Overall Study|Protocol Violation|1
7648251|NCT01529112|26609307|P2|Overall Study|Death|38
7648252|NCT01529112|26609308|P1|Overall Study|Death|59
7648253|NCT01529112|26609307|P2|Overall Study|Adverse Event|0
7648254|NCT01529112|26609308|P1|Overall Study|Adverse Event|2
7648255|NCT01529034|26609344|P1|Overall Study|Study drug not available|2
7648256|NCT01529034|26609344|P1|Overall Study|Investigator no longer available|2
7648257|NCT01529034|26609344|P1|Overall Study|Lack of Efficacy|4
7648258|NCT01529034|26609344|P1|Overall Study|Protocol Violation|4
7648259|NCT01529034|26609344|P1|Overall Study|Adverse Event|4
7648260|NCT01529034|26609344|P1|Overall Study|Caregiver no longer available|7
7648261|NCT01529034|26609344|P1|Overall Study|Noncompliance|8
7648262|NCT01529034|26609344|P1|Overall Study|No treated SCs within protocol window|13
7648263|NCT01529034|26609344|P1|Overall Study|Withdrawal by Subject|25
7648264|NCT01529034|26609344|P1|Overall Study|Study termination|29
7648265|NCT01529034|26609344|P1|Overall Study|Site closure|62
7648266|NCT01529034|26609344|P1|Overall Study|Discontinued prior to study treatment|14
7648267|NCT01528969|26609359|P2|Overall Study|absent from the school at baseline|0
7648268|NCT01528969|26609360|P1|Overall Study|absent from the school at baseline|2
7648269|NCT01528787|26609393|P4|Overall Study|Family Emergency|0
7648270|NCT01528787|26609394|P3|Overall Study|Family Emergency|1
7648271|NCT01528787|26609395|P2|Overall Study|Family Emergency|0
7648272|NCT01528787|26609396|P1|Overall Study|Family Emergency|0
7648273|NCT01528787|26609393|P4|Overall Study|Withdrawal by Subject|1
7648274|NCT01528787|26609394|P3|Overall Study|Withdrawal by Subject|0
7648275|NCT01528787|26609395|P2|Overall Study|Withdrawal by Subject|0
7648276|NCT01528787|26609396|P1|Overall Study|Withdrawal by Subject|0
7648277|NCT01528735|26609408|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
7648278|NCT01528735|26609409|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
7648279|NCT01528735|26609408|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7648280|NCT01528735|26609409|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7648281|NCT01528709|26609511|P2|Overall Study|allergy|0
7648282|NCT01528709|26609512|P1|Overall Study|allergy|1
7648283|NCT01528709|26609511|P2|Overall Study|Withdrawal by Subject|15
7648284|NCT01528709|26609512|P1|Overall Study|Withdrawal by Subject|10
7648285|NCT01528709|26609511|P2|Overall Study|Death|0
7648286|NCT01528709|26609512|P1|Overall Study|Death|2
7648287|NCT01528696|26609522|P2|Overall Study|See detailed description|19
7648288|NCT01528696|26609523|P1|Overall Study|See detailed description|18
7648289|NCT01528605|26609539|P6|Overall Study|Death|0
7648290|NCT01528605|26609540|P5|Overall Study|Death|0
7648291|NCT01528605|26609541|P4|Overall Study|Death|0
7648292|NCT01528605|26609542|P3|Overall Study|Death|0
7648293|NCT01528605|26609543|P2|Overall Study|Death|0
7648294|NCT01528605|26609544|P1|Overall Study|Death|1
7648295|NCT01528605|26609539|P6|Overall Study|Lost to Follow-up|0
7648296|NCT01528605|26609540|P5|Overall Study|Lost to Follow-up|0
7648297|NCT01528605|26609541|P4|Overall Study|Lost to Follow-up|1
7648298|NCT01528605|26609542|P3|Overall Study|Lost to Follow-up|1
7648299|NCT01528605|26609543|P2|Overall Study|Lost to Follow-up|0
7648300|NCT01528605|26609544|P1|Overall Study|Lost to Follow-up|1
7648301|NCT01528345|26609574|P2|Overall Study|Subject/Guardian Decision|0
7648302|NCT01528345|26609575|P1|Overall Study|Subject/Guardian Decision|5
7648303|NCT01528345|26609574|P2|Overall Study|Study Terminated by Sponsor|8
7648304|NCT01528345|26609575|P1|Overall Study|Study Terminated by Sponsor|4
7648305|NCT01528345|26609574|P2|Overall Study|Progressive Disease|40
7648306|NCT01528345|26609575|P1|Overall Study|Progressive Disease|26
7648307|NCT01528345|26609574|P2|Overall Study|Non-compliance with study treatment|0
7648308|NCT01528345|26609575|P1|Overall Study|Non-compliance with study treatment|1
7648309|NCT01528345|26609574|P2|Overall Study|Death|1
7648310|NCT01528345|26609575|P1|Overall Study|Death|1
7648311|NCT01528345|26609574|P2|Overall Study|Adverse Event|1
7648312|NCT01528345|26609575|P1|Overall Study|Adverse Event|10
7648313|NCT01528254|26609626|P2|Overall Study|No longer requires study drug|1
7648314|NCT01528254|26609627|P1|Overall Study|No longer requires study drug|1
7648315|NCT01528254|26609626|P2|Overall Study|Abnormal test procedure result(s)|0
7648316|NCT01528254|26609627|P1|Overall Study|Abnormal test procedure result(s)|1
7648317|NCT01528254|26609626|P2|Overall Study|Abnormal laboratory value(s)|7
7648318|NCT01528254|26609627|P1|Overall Study|Abnormal laboratory value(s)|3
7648319|NCT01528254|26609626|P2|Overall Study|Withdrawal by Subject|4
7648320|NCT01528254|26609627|P1|Overall Study|Withdrawal by Subject|5
7648321|NCT01528254|26609626|P2|Overall Study|Unsatisfactory therapeutic effect|8
7648322|NCT01528254|26609627|P1|Overall Study|Unsatisfactory therapeutic effect|6
7648323|NCT01528254|26609626|P2|Overall Study|New therapy for study indication|6
7648324|NCT01528254|26609627|P1|Overall Study|New therapy for study indication|8
7648325|NCT01528254|26609626|P2|Overall Study|Protocol deviation|19
7648326|NCT01528254|26609627|P1|Overall Study|Protocol deviation|9
7648327|NCT01528254|26609626|P2|Overall Study|Death|9
7648328|NCT01528254|26609627|P1|Overall Study|Death|13
7648329|NCT01528254|26609626|P2|Overall Study|Lost to Follow-up|24
7648330|NCT01528254|26609627|P1|Overall Study|Lost to Follow-up|17
7648331|NCT01528254|26609626|P2|Overall Study|Adverse Event|44
7648332|NCT01528254|26609627|P1|Overall Study|Adverse Event|28
7648333|NCT01528254|26609626|P2|Overall Study|Administrative problems|94
7648334|NCT01528254|26609627|P1|Overall Study|Administrative problems|96
7648335|NCT01528215|26609659|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
7648336|NCT01528215|26609660|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
7648337|NCT01528215|26609659|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
7648338|NCT01528215|26609660|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
7648339|NCT01528215|26609659|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7648340|NCT01528215|26609660|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7648341|NCT01528215|26609659|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
7648342|NCT01528215|26609660|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
7648343|NCT01528072|26609719|P1|Overall Study|Early Termination of Study|52
7648344|NCT01528072|26609719|P1|Overall Study|Death|2
7648345|NCT01528072|26609719|P1|Overall Study|Site Closure|4
7648346|NCT01528072|26609719|P1|Overall Study|Explanted|2
7648347|NCT01528072|26609719|P1|Overall Study|Lost to Follow-up|5
7648348|NCT01528072|26609719|P1|Overall Study|Missed Visit|2
7648349|NCT01528072|26609719|P1|Overall Study|Determined not eligible by AEAC|1
7648350|NCT01528072|26609719|P1|Overall Study|Physician Decision|1
7648351|NCT01528072|26609719|P1|Overall Study|Withdrawal by Subject|5
7648352|NCT01528033|26609725|P2|Follow Up|No data available|44
7648353|NCT01528033|26609726|P1|Follow Up|No data available|46
7648354|NCT01528033|26609725|P2|Primary Endpoint Assessment ITT|No post baseline documentation|2
7648355|NCT01528033|26609726|P1|Primary Endpoint Assessment ITT|No post baseline documentation|2
7648356|NCT01528033|26609725|P2|Primary Endpoint Assessment ITT|Physician Decision|1
7648357|NCT01528033|26609726|P1|Primary Endpoint Assessment ITT|Physician Decision|2
7648358|NCT01528033|26609725|P2|Primary Endpoint Assessment ITT|Death|2
7648359|NCT01528033|26609726|P1|Primary Endpoint Assessment ITT|Death|2
7648360|NCT01528033|26609725|P2|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7648361|NCT01528033|26609726|P1|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7648362|NCT01528033|26609725|P2|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
7648363|NCT01528033|26609726|P1|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
7648364|NCT01527682|26609749|P1|Overall Study|Protocol Violation|8
7648365|NCT01527500|26609772|P2|Part B|Adverse Event|0
7648366|NCT01527500|26609773|P1|Part B|Adverse Event|1
7648367|NCT01527500|26609772|P2|Part A|Withdrawal by Subject|0
7648368|NCT01527500|26609773|P1|Part A|Withdrawal by Subject|2
7648369|NCT01527500|26609772|P2|Part A|Protocol Deviation|2
7648370|NCT01527500|26609773|P1|Part A|Protocol Deviation|9
7648371|NCT01527500|26609772|P2|Part A|Lost to Follow-up|1
7648372|NCT01527500|26609773|P1|Part A|Lost to Follow-up|0
7648373|NCT01527500|26609772|P2|Part A|Death|1
7648374|NCT01527500|26609773|P1|Part A|Death|4
7648375|NCT01527500|26609772|P2|Part A|Adverse Event|2
7648376|NCT01527500|26609773|P1|Part A|Adverse Event|4
7648377|NCT01527500|26609772|P2|Part A|Administrative|7
7648378|NCT01527500|26609773|P1|Part A|Administrative|11
7648379|NCT01527487|26609803|P2|Overall Study|Death|1
7648380|NCT01527487|26609804|P1|Overall Study|Death|0
7648381|NCT01527487|26609803|P2|Overall Study|Adverse Event|1
7648382|NCT01527487|26609804|P1|Overall Study|Adverse Event|1
7648383|NCT01527487|26609803|P2|Overall Study|Disease Progression|1
7648384|NCT01527487|26609804|P1|Overall Study|Disease Progression|4
7648385|NCT01527487|26609803|P2|Overall Study|MD Discretion/Lack of Efficacy|4
7648386|NCT01527487|26609804|P1|Overall Study|MD Discretion/Lack of Efficacy|3
7648387|NCT01527383|26609818|P2|Overall Study|Withdrawal by Subject|3
7648388|NCT01527383|26609819|P1|Overall Study|Withdrawal by Subject|2
7648389|NCT01527383|26609818|P2|Overall Study|Participant moved|1
7648390|NCT01527383|26609819|P1|Overall Study|Participant moved|0
7648391|NCT01527383|26609818|P2|Overall Study|Screen failure|0
7648392|NCT01527383|26609819|P1|Overall Study|Screen failure|1
7648393|NCT01527383|26609818|P2|Overall Study|Protocol Violation|0
7648394|NCT01527383|26609819|P1|Overall Study|Protocol Violation|1
7648395|NCT01527383|26609818|P2|Overall Study|Pregnancy|0
7648396|NCT01527383|26609819|P1|Overall Study|Pregnancy|1
7648397|NCT01527383|26609818|P2|Overall Study|Physician Decision|0
7648398|NCT01527383|26609819|P1|Overall Study|Physician Decision|2
7648399|NCT01527383|26609818|P2|Overall Study|Lost to Follow-up|0
7648400|NCT01527383|26609819|P1|Overall Study|Lost to Follow-up|3
7648401|NCT01527383|26609818|P2|Overall Study|Adverse Event|0
7648402|NCT01527383|26609819|P1|Overall Study|Adverse Event|5
7648403|NCT01527370|26609833|P1|Overall Study|Death|1
7648404|NCT01527370|26609833|P1|Overall Study|Physician Decision|1
7648405|NCT01527370|26609833|P1|Overall Study|Withdrawal by Subject|4
7648406|NCT01527357|26609841|P2|Overall Study|Did Not Receive Treatment|0
7648407|NCT01527357|26609842|P1|Overall Study|Did Not Receive Treatment|2
7648408|NCT01527357|26609841|P2|Overall Study|No Day 29 Visit|1
7648409|NCT01527357|26609842|P1|Overall Study|No Day 29 Visit|0
7648410|NCT01527357|26609841|P2|Overall Study|Non-compliance|1
7648411|NCT01527357|26609842|P1|Overall Study|Non-compliance|0
7648412|NCT01527357|26609841|P2|Overall Study|Withdrew Consent|1
7648413|NCT01527357|26609842|P1|Overall Study|Withdrew Consent|1
7648414|NCT01527357|26609841|P2|Overall Study|Lost to Follow-up|4
7648415|NCT01527357|26609842|P1|Overall Study|Lost to Follow-up|6
7648416|NCT01527357|26609841|P2|Overall Study|Death|2
7648417|NCT01527357|26609842|P1|Overall Study|Death|8
7648418|NCT01527292|26609864|P2|Overall Study|Physician Decision|3
7648419|NCT01527292|26609865|P1|Overall Study|Physician Decision|0
7648420|NCT01527149|26609892|P1|Overall Study|Death|2
7648421|NCT01527110|26609907|P1|Overall Study|Adverse Event|1
7648422|NCT01527006|26609988|P2|Extension Phase|Other|3
7648423|NCT01527006|26609989|P1|Extension Phase|Other|0
7648424|NCT01527006|26609988|P2|Extension Phase|Inadequate therapeutic effect|1
7648425|NCT01527006|26609989|P1|Extension Phase|Inadequate therapeutic effect|1
7648426|NCT01527006|26609988|P2|Extension Phase|Subject Choice|1
7648427|NCT01527006|26609989|P1|Extension Phase|Subject Choice|1
7648428|NCT01527006|26609988|P2|Extension Phase|Lost to Follow-up|1
7648429|NCT01527006|26609989|P1|Extension Phase|Lost to Follow-up|0
7648430|NCT01527006|26609988|P2|Extension Phase|Adverse Event|2
7648431|NCT01527006|26609989|P1|Extension Phase|Adverse Event|4
7648432|NCT01527006|26609988|P2|Core Study|Other|2
7648433|NCT01527006|26609989|P1|Core Study|Other|0
7648434|NCT01527006|26609988|P2|Core Study|Withdrawal by Subject|1
7648435|NCT01527006|26609989|P1|Core Study|Withdrawal by Subject|0
7648436|NCT01527006|26609988|P2|Core Study|Inadequate Therapeutic Effect|0
7648437|NCT01527006|26609989|P1|Core Study|Inadequate Therapeutic Effect|1
7648438|NCT01527006|26609988|P2|Core Study|Subject Choice|0
7648439|NCT01527006|26609989|P1|Core Study|Subject Choice|1
7648440|NCT01527006|26609988|P2|Core Study|Lost to Follow-up|1
7648441|NCT01527006|26609989|P1|Core Study|Lost to Follow-up|0
7648442|NCT01527006|26609988|P2|Core Study|Adverse Event|2
7648443|NCT01527006|26609989|P1|Core Study|Adverse Event|0
7648444|NCT01526928|26610045|P6|Overall Study|Missing|0
7648445|NCT01526928|26610046|P5|Overall Study|Missing|2
7648446|NCT01526928|26610047|P4|Overall Study|Missing|0
7648447|NCT01526928|26610048|P3|Overall Study|Missing|1
7648448|NCT01526928|26610049|P2|Overall Study|Missing|0
7648449|NCT01526928|26610050|P1|Overall Study|Missing|0
7648450|NCT01526928|26610045|P6|Overall Study|Protocol Deviation|0
7648451|NCT01526928|26610046|P5|Overall Study|Protocol Deviation|0
7648452|NCT01526928|26610047|P4|Overall Study|Protocol Deviation|2
7648453|NCT01526928|26610048|P3|Overall Study|Protocol Deviation|0
7648454|NCT01526928|26610049|P2|Overall Study|Protocol Deviation|0
7648455|NCT01526928|26610050|P1|Overall Study|Protocol Deviation|0
7648456|NCT01526928|26610045|P6|Overall Study|Lost to Follow-up|0
7648457|NCT01526928|26610046|P5|Overall Study|Lost to Follow-up|0
7648458|NCT01526928|26610047|P4|Overall Study|Lost to Follow-up|1
7648459|NCT01526928|26610048|P3|Overall Study|Lost to Follow-up|0
7648460|NCT01526928|26610049|P2|Overall Study|Lost to Follow-up|0
7648461|NCT01526928|26610050|P1|Overall Study|Lost to Follow-up|0
7648462|NCT01526928|26610045|P6|Overall Study|Other Reason|0
7648463|NCT01526928|26610046|P5|Overall Study|Other Reason|1
7648464|NCT01526928|26610047|P4|Overall Study|Other Reason|4
7648465|NCT01526928|26610048|P3|Overall Study|Other Reason|11
7648466|NCT01526928|26610049|P2|Overall Study|Other Reason|1
7648467|NCT01526928|26610050|P1|Overall Study|Other Reason|0
7648468|NCT01526928|26610045|P6|Overall Study|Physician Decision|0
7648469|NCT01526928|26610046|P5|Overall Study|Physician Decision|0
7648470|NCT01526928|26610047|P4|Overall Study|Physician Decision|5
7648471|NCT01526928|26610048|P3|Overall Study|Physician Decision|2
7648472|NCT01526928|26610049|P2|Overall Study|Physician Decision|0
7648473|NCT01526928|26610050|P1|Overall Study|Physician Decision|0
7648474|NCT01526928|26610045|P6|Overall Study|Withdrawal by Subject|0
7648475|NCT01526928|26610046|P5|Overall Study|Withdrawal by Subject|3
7648476|NCT01526928|26610047|P4|Overall Study|Withdrawal by Subject|11
7648477|NCT01526928|26610048|P3|Overall Study|Withdrawal by Subject|13
7648478|NCT01526928|26610049|P2|Overall Study|Withdrawal by Subject|0
7648479|NCT01526928|26610050|P1|Overall Study|Withdrawal by Subject|1
7648480|NCT01526928|26610045|P6|Overall Study|Death|0
7648481|NCT01526928|26610046|P5|Overall Study|Death|0
7648482|NCT01526928|26610047|P4|Overall Study|Death|0
7648483|NCT01526928|26610048|P3|Overall Study|Death|3
7648484|NCT01526928|26610049|P2|Overall Study|Death|0
7648485|NCT01526928|26610050|P1|Overall Study|Death|0
7648486|NCT01526928|26610045|P6|Overall Study|Adverse Event|2
7648487|NCT01526928|26610046|P5|Overall Study|Adverse Event|13
7648488|NCT01526928|26610047|P4|Overall Study|Adverse Event|40
7648489|NCT01526928|26610048|P3|Overall Study|Adverse Event|29
7648490|NCT01526928|26610049|P2|Overall Study|Adverse Event|1
7648491|NCT01526928|26610050|P1|Overall Study|Adverse Event|2
7648492|NCT01526928|26610045|P6|Overall Study|Progressive Disease|4
7648493|NCT01526928|26610046|P5|Overall Study|Progressive Disease|76
7648494|NCT01526928|26610047|P4|Overall Study|Progressive Disease|182
7648495|NCT01526928|26610048|P3|Overall Study|Progressive Disease|150
7648496|NCT01526928|26610049|P2|Overall Study|Progressive Disease|17
7648497|NCT01526928|26610050|P1|Overall Study|Progressive Disease|35
7648498|NCT01526889|26610188|P2|Treatment Extension Period|Administrative problems|0
7648499|NCT01526889|26610189|P1|Treatment Extension Period|Administrative problems|1
7648500|NCT01526889|26610188|P2|Treatment Period|Adverse Event|0
7648501|NCT01526889|26610189|P1|Treatment Period|Adverse Event|2
7648502|NCT01526785|26610210|P1|Overall Study|Withdrawal by Subject|2
7648503|NCT01526785|26610210|P1|Overall Study|Physician Decision|1
7648504|NCT01526785|26610210|P1|Overall Study|Death|2
7648505|NCT01526785|26610210|P1|Overall Study|Study Terminated by Sponsor|8
7648506|NCT01526733|26610220|P2|Phase 1|Withdrawal by Subject|1
7648507|NCT01526733|26610221|P1|Phase 1|Withdrawal by Subject|1
7648508|NCT01526733|26610220|P2|Phase 1|Protocol Violation|0
7648509|NCT01526733|26610221|P1|Phase 1|Protocol Violation|1
7648510|NCT01526551|26610260|P1|Overall Study|Lack of returned parental consent form|424
7648511|NCT01526148|26610349|P2|Overall Study|Incarcerated|2
7648512|NCT01526148|26610350|P1|Overall Study|Incarcerated|0
7648513|NCT01526148|26610349|P2|Overall Study|Moved out of state|0
7648514|NCT01526148|26610350|P1|Overall Study|Moved out of state|1
7648515|NCT01526148|26610349|P2|Overall Study|Unable to discontinue concomitant med|0
7648516|NCT01526148|26610350|P1|Overall Study|Unable to discontinue concomitant med|1
7648517|NCT01526148|26610349|P2|Overall Study|Unstable Medical Condition|0
7648518|NCT01526148|26610350|P1|Overall Study|Unstable Medical Condition|1
7648519|NCT01526148|26610349|P2|Overall Study|Withdrawal by Subject|0
7648520|NCT01526148|26610350|P1|Overall Study|Withdrawal by Subject|2
7648521|NCT01526148|26610349|P2|Overall Study|Lost to Follow-up|6
7648522|NCT01526148|26610350|P1|Overall Study|Lost to Follow-up|3
7648523|NCT01526148|26610349|P2|Overall Study|Adverse Event|5
7648524|NCT01526148|26610350|P1|Overall Study|Adverse Event|6
7648525|NCT01526057|26610361|P3|Overall Study|Protocol Violation|1
7648526|NCT01526057|26610362|P2|Overall Study|Protocol Violation|0
7648527|NCT01526057|26610363|P1|Overall Study|Protocol Violation|0
7648528|NCT01526057|26610361|P3|Overall Study|Other|1
7648529|NCT01526057|26610362|P2|Overall Study|Other|0
7648530|NCT01526057|26610363|P1|Overall Study|Other|1
7648531|NCT01526057|26610361|P3|Overall Study|Lost to Follow-up|1
7648532|NCT01526057|26610362|P2|Overall Study|Lost to Follow-up|0
7648533|NCT01526057|26610363|P1|Overall Study|Lost to Follow-up|1
7648534|NCT01526057|26610361|P3|Overall Study|Death|0
7648535|NCT01526057|26610362|P2|Overall Study|Death|0
7648536|NCT01526057|26610363|P1|Overall Study|Death|1
7648537|NCT01526057|26610361|P3|Overall Study|Adverse Event|1
7648538|NCT01526057|26610362|P2|Overall Study|Adverse Event|1
7648539|NCT01526057|26610363|P1|Overall Study|Adverse Event|3
7648540|NCT01526057|26610361|P3|Overall Study|Withdrawal by Subject|2
7648541|NCT01526057|26610362|P2|Overall Study|Withdrawal by Subject|2
7648542|NCT01526057|26610363|P1|Overall Study|Withdrawal by Subject|3
7648543|NCT01525875|26610462|P2|Open-label Period|Lost to Follow-up|2
7648544|NCT01525875|26610463|P1|Open-label Period|Lost to Follow-up|0
7648545|NCT01525875|26610462|P2|Placebo-controlled Period|Withdrawal by Subject|2
7648546|NCT01525875|26610463|P1|Placebo-controlled Period|Withdrawal by Subject|1
7648547|NCT01525849|26610486|P2|Overall Study|Anatomic exclusion criteria identified|3
7648548|NCT01525849|26610487|P1|Overall Study|Anatomic exclusion criteria identified|0
7648549|NCT01525849|26610486|P2|Overall Study|Unrelated medical issue (not treated)|2
7648550|NCT01525849|26610487|P1|Overall Study|Unrelated medical issue (not treated)|1
7648551|NCT01525849|26610486|P2|Overall Study|Withdrawal by Subject|9
7648552|NCT01525849|26610487|P1|Overall Study|Withdrawal by Subject|1
7648553|NCT01525849|26610486|P2|Overall Study|Lost to Follow-up|2
7648554|NCT01525849|26610487|P1|Overall Study|Lost to Follow-up|3
7648555|NCT01525641|26610543|P1|Overall Study|Other than stated above|7
7648556|NCT01525641|26610543|P1|Overall Study|Lost to follow-up (Changing hospital)|19
7648557|NCT01525641|26610543|P1|Overall Study|Lost to follow-up (Unknown reason)|10
7648558|NCT01525641|26610543|P1|Overall Study|Lost to follow-up (relocation)|1
7648559|NCT01525641|26610543|P1|Overall Study|Improvement|5
7648560|NCT01525641|26610543|P1|Overall Study|Lack of Efficacy|24
7648561|NCT01525641|26610543|P1|Overall Study|Adverse Event|73
7648562|NCT01525641|26610543|P1|Overall Study|No visit since the first visit|16
7648563|NCT01525641|26610543|P1|Overall Study|Case report form not collected|25
7648564|NCT01525628|26610557|P5|Overall Study|Other reason not defined above|0
7648565|NCT01525628|26610558|P4|Overall Study|Other reason not defined above|3
7648566|NCT01525628|26610559|P3|Overall Study|Other reason not defined above|0
7648567|NCT01525628|26610560|P2|Overall Study|Other reason not defined above|0
7648568|NCT01525628|26610561|P1|Overall Study|Other reason not defined above|0
7648569|NCT01525628|26610557|P5|Overall Study|Withdrawal by Subject|0
7648570|NCT01525628|26610558|P4|Overall Study|Withdrawal by Subject|0
7648571|NCT01525628|26610559|P3|Overall Study|Withdrawal by Subject|0
7648572|NCT01525628|26610560|P2|Overall Study|Withdrawal by Subject|1
7648573|NCT01525628|26610561|P1|Overall Study|Withdrawal by Subject|0
7648574|NCT01525628|26610557|P5|Overall Study|Lost to Follow-up|0
7648575|NCT01525628|26610558|P4|Overall Study|Lost to Follow-up|0
7648576|NCT01525628|26610559|P3|Overall Study|Lost to Follow-up|0
7648577|NCT01525628|26610560|P2|Overall Study|Lost to Follow-up|1
7648578|NCT01525628|26610561|P1|Overall Study|Lost to Follow-up|1
7648579|NCT01525628|26610557|P5|Overall Study|Protocol Violation|0
7648580|NCT01525628|26610558|P4|Overall Study|Protocol Violation|0
7648581|NCT01525628|26610559|P3|Overall Study|Protocol Violation|1
7648582|NCT01525628|26610560|P2|Overall Study|Protocol Violation|0
7648583|NCT01525628|26610561|P1|Overall Study|Protocol Violation|0
7648584|NCT01525628|26610557|P5|Overall Study|Lack of Efficacy|2
7648585|NCT01525628|26610558|P4|Overall Study|Lack of Efficacy|1
7648586|NCT01525628|26610559|P3|Overall Study|Lack of Efficacy|2
7648587|NCT01525628|26610560|P2|Overall Study|Lack of Efficacy|2
7648588|NCT01525628|26610561|P1|Overall Study|Lack of Efficacy|0
7648589|NCT01525628|26610557|P5|Overall Study|Adverse Event|1
7648590|NCT01525628|26610558|P4|Overall Study|Adverse Event|0
7648591|NCT01525628|26610559|P3|Overall Study|Adverse Event|2
7648592|NCT01525628|26610560|P2|Overall Study|Adverse Event|1
7648593|NCT01525628|26610561|P1|Overall Study|Adverse Event|1
7648594|NCT01525615|26610628|P3|Overall Study|Other reason not described above|1
7648595|NCT01525615|26610629|P2|Overall Study|Other reason not described above|0
7648596|NCT01525615|26610630|P1|Overall Study|Other reason not described above|1
7648597|NCT01525615|26610628|P3|Overall Study|Withdrawal by Subject|0
7648598|NCT01525615|26610629|P2|Overall Study|Withdrawal by Subject|0
7648599|NCT01525615|26610630|P1|Overall Study|Withdrawal by Subject|1
7648600|NCT01525615|26610628|P3|Overall Study|Lost to Follow-up|0
7648601|NCT01525615|26610629|P2|Overall Study|Lost to Follow-up|0
7648602|NCT01525615|26610630|P1|Overall Study|Lost to Follow-up|1
7648603|NCT01525615|26610628|P3|Overall Study|Adverse Event|5
7648604|NCT01525615|26610629|P2|Overall Study|Adverse Event|7
7648605|NCT01525615|26610630|P1|Overall Study|Adverse Event|11
7648606|NCT01525602|26610682|P8|Overall Study|Unqualified based on biopsy; not dosed|1
7648607|NCT01525602|26610683|P7|Overall Study|Unqualified based on biopsy; not dosed|1
7648699|NCT01525550|26610819|P1|Overall Study|Other|0
7648608|NCT01525602|26610684|P6|Overall Study|Unqualified based on biopsy; not dosed|0
7648609|NCT01525602|26610685|P5|Overall Study|Unqualified based on biopsy; not dosed|0
7648610|NCT01525602|26610686|P4|Overall Study|Unqualified based on biopsy; not dosed|0
7648611|NCT01525602|26610687|P3|Overall Study|Unqualified based on biopsy; not dosed|0
7648612|NCT01525602|26610688|P2|Overall Study|Unqualified based on biopsy; not dosed|0
7648613|NCT01525602|26610689|P1|Overall Study|Unqualified based on biopsy; not dosed|0
7648614|NCT01525602|26610682|P8|Overall Study|Death|0
7648615|NCT01525602|26610683|P7|Overall Study|Death|0
7648616|NCT01525602|26610684|P6|Overall Study|Death|1
7648617|NCT01525602|26610685|P5|Overall Study|Death|1
7648618|NCT01525602|26610686|P4|Overall Study|Death|0
7648619|NCT01525602|26610687|P3|Overall Study|Death|0
7648620|NCT01525602|26610688|P2|Overall Study|Death|0
7648621|NCT01525602|26610689|P1|Overall Study|Death|0
7648622|NCT01525602|26610682|P8|Overall Study|Physician Decision|0
7648623|NCT01525602|26610683|P7|Overall Study|Physician Decision|1
7648624|NCT01525602|26610684|P6|Overall Study|Physician Decision|0
7648625|NCT01525602|26610685|P5|Overall Study|Physician Decision|3
7648626|NCT01525602|26610686|P4|Overall Study|Physician Decision|0
7648627|NCT01525602|26610687|P3|Overall Study|Physician Decision|0
7648628|NCT01525602|26610688|P2|Overall Study|Physician Decision|0
7648629|NCT01525602|26610689|P1|Overall Study|Physician Decision|0
7648630|NCT01525602|26610682|P8|Overall Study|Withdrawal by Subject|1
7648631|NCT01525602|26610683|P7|Overall Study|Withdrawal by Subject|0
7648632|NCT01525602|26610684|P6|Overall Study|Withdrawal by Subject|1
7648633|NCT01525602|26610685|P5|Overall Study|Withdrawal by Subject|3
7648634|NCT01525602|26610686|P4|Overall Study|Withdrawal by Subject|0
7648635|NCT01525602|26610687|P3|Overall Study|Withdrawal by Subject|0
7648636|NCT01525602|26610688|P2|Overall Study|Withdrawal by Subject|0
7648637|NCT01525602|26610689|P1|Overall Study|Withdrawal by Subject|0
7648638|NCT01525602|26610682|P8|Overall Study|Non-compliance|0
7648639|NCT01525602|26610683|P7|Overall Study|Non-compliance|0
7648640|NCT01525602|26610684|P6|Overall Study|Non-compliance|0
7648641|NCT01525602|26610685|P5|Overall Study|Non-compliance|1
7648642|NCT01525602|26610686|P4|Overall Study|Non-compliance|0
7648643|NCT01525602|26610687|P3|Overall Study|Non-compliance|0
7648644|NCT01525602|26610688|P2|Overall Study|Non-compliance|0
7648645|NCT01525602|26610689|P1|Overall Study|Non-compliance|0
7648646|NCT01525602|26610682|P8|Overall Study|Clinical progression|1
7648647|NCT01525602|26610683|P7|Overall Study|Clinical progression|1
7648648|NCT01525602|26610684|P6|Overall Study|Clinical progression|0
7648649|NCT01525602|26610685|P5|Overall Study|Clinical progression|0
7648650|NCT01525602|26610686|P4|Overall Study|Clinical progression|0
7648651|NCT01525602|26610687|P3|Overall Study|Clinical progression|0
7648652|NCT01525602|26610688|P2|Overall Study|Clinical progression|0
7648653|NCT01525602|26610689|P1|Overall Study|Clinical progression|2
7648654|NCT01525602|26610682|P8|Overall Study|Disease progression|3
7648655|NCT01525602|26610683|P7|Overall Study|Disease progression|3
7648656|NCT01525602|26610684|P6|Overall Study|Disease progression|2
7648657|NCT01525602|26610685|P5|Overall Study|Disease progression|22
7648658|NCT01525602|26610686|P4|Overall Study|Disease progression|5
7648659|NCT01525602|26610687|P3|Overall Study|Disease progression|2
7648660|NCT01525602|26610688|P2|Overall Study|Disease progression|3
7648661|NCT01525602|26610689|P1|Overall Study|Disease progression|6
7648662|NCT01525602|26610682|P8|Overall Study|Adverse Event|1
7648663|NCT01525602|26610683|P7|Overall Study|Adverse Event|0
7648664|NCT01525602|26610684|P6|Overall Study|Adverse Event|3
7648665|NCT01525602|26610685|P5|Overall Study|Adverse Event|3
7648666|NCT01525602|26610686|P4|Overall Study|Adverse Event|1
7648667|NCT01525602|26610687|P3|Overall Study|Adverse Event|1
7648668|NCT01525602|26610688|P2|Overall Study|Adverse Event|0
7648669|NCT01525602|26610689|P1|Overall Study|Adverse Event|1
7648670|NCT01525589|26610760|P3|Overall Study|Withdrawal by Subject|0
7648671|NCT01525589|26610761|P2|Overall Study|Withdrawal by Subject|1
7648672|NCT01525589|26610762|P1|Overall Study|Withdrawal by Subject|0
7648673|NCT01525589|26610760|P3|Overall Study|Other reasons|0
7648674|NCT01525589|26610761|P2|Overall Study|Other reasons|1
7648675|NCT01525589|26610762|P1|Overall Study|Other reasons|0
7648676|NCT01525589|26610760|P3|Overall Study|Treatment-related AE|2
7648677|NCT01525589|26610761|P2|Overall Study|Treatment-related AE|1
7648678|NCT01525589|26610762|P1|Overall Study|Treatment-related AE|1
7648679|NCT01525589|26610760|P3|Overall Study|Death|2
7648680|NCT01525589|26610761|P2|Overall Study|Death|0
7648681|NCT01525589|26610762|P1|Overall Study|Death|0
7648682|NCT01525589|26610760|P3|Overall Study|Physician Decision|2
7648683|NCT01525589|26610761|P2|Overall Study|Physician Decision|2
7648684|NCT01525589|26610762|P1|Overall Study|Physician Decision|4
7648685|NCT01525589|26610760|P3|Overall Study|Never treated|0
7648686|NCT01525589|26610761|P2|Overall Study|Never treated|0
7648687|NCT01525589|26610762|P1|Overall Study|Never treated|2
7648688|NCT01525589|26610760|P3|Overall Study|Progressive disease|29
7648689|NCT01525589|26610761|P2|Overall Study|Progressive disease|15
7648690|NCT01525589|26610762|P1|Overall Study|Progressive disease|48
7648691|NCT01525589|26610760|P3|Overall Study|Non-treatment-related AE|0
7648692|NCT01525589|26610761|P2|Overall Study|Non-treatment-related AE|0
7648693|NCT01525589|26610762|P1|Overall Study|Non-treatment-related AE|1
7648694|NCT01525550|26610818|P2|Overall Study|Withdrawal by Subject|0
7648695|NCT01525550|26610819|P1|Overall Study|Withdrawal by Subject|4
7648696|NCT01525550|26610818|P2|Overall Study|Sponsor's Decision|11
7648697|NCT01525550|26610819|P1|Overall Study|Sponsor's Decision|30
7648698|NCT01525550|26610818|P2|Overall Study|Other|4
7648700|NCT01525550|26610818|P2|Overall Study|Death|28
7648701|NCT01525550|26610819|P1|Overall Study|Death|19
7648702|NCT01525550|26610818|P2|Overall Study|Lost to Follow-up|2
7648703|NCT01525550|26610819|P1|Overall Study|Lost to Follow-up|8
7648704|NCT01525407|26610890|P2|Overall Study|Delay in Transplant|0
7648705|NCT01525407|26610891|P1|Overall Study|Delay in Transplant|1
7648706|NCT01525407|26610890|P2|Overall Study|Transplant was delayed|1
7648707|NCT01525407|26610891|P1|Overall Study|Transplant was delayed|0
7648708|NCT01525407|26610890|P2|Overall Study|Withdrawal by Subject|1
7648709|NCT01525407|26610891|P1|Overall Study|Withdrawal by Subject|0
7648710|NCT01525407|26610890|P2|Overall Study|Change in recipient treatment plan|2
7648711|NCT01525407|26610891|P1|Overall Study|Change in recipient treatment plan|2
7648712|NCT01525238|26610925|P3|Overall Study|Withdrawal by Subject|0
7648713|NCT01525238|26610926|P2|Overall Study|Withdrawal by Subject|0
7648714|NCT01525238|26610927|P1|Overall Study|Withdrawal by Subject|1
7648715|NCT01525225|26610992|P1|Enrollment|Other|1
7648716|NCT01525225|26610992|P1|Enrollment|No longer met study criteria|1
7648717|NCT01525082|26611006|P1|Overall Study|Death|1
7648718|NCT01524991|26611017|P1|Overall Study|Symptomatic Deterioration|1
7648719|NCT01524991|26611017|P1|Overall Study|Withdrawal by Subject|2
7648720|NCT01524991|26611017|P1|Overall Study|Other complicating disease|1
7648721|NCT01524991|26611017|P1|Overall Study|Disease ProgressionDu|17
7648722|NCT01524991|26611017|P1|Overall Study|Death|1
7648723|NCT01524991|26611017|P1|Overall Study|Adverse Event|12
7648724|NCT01524978|26611035|P11|Overall Study|Death|17
7648725|NCT01524978|26611036|P10|Overall Study|Death|6
7648726|NCT01524978|26611037|P9|Overall Study|Death|5
7648727|NCT01524978|26611038|P8|Overall Study|Death|9
7648728|NCT01524978|26611039|P7|Overall Study|Death|1
7648729|NCT01524978|26611040|P6|Overall Study|Death|4
7648730|NCT01524978|26611041|P5|Overall Study|Death|4
7648731|NCT01524978|26611042|P4|Overall Study|Death|24
7648732|NCT01524978|26611043|P3|Overall Study|Death|5
7648733|NCT01524978|26611044|P2|Overall Study|Death|2
7648734|NCT01524978|26611045|P1|Overall Study|Death|34
7648735|NCT01524978|26611035|P11|Overall Study|Lost to Follow-up|1
7648736|NCT01524978|26611036|P10|Overall Study|Lost to Follow-up|1
7648737|NCT01524978|26611037|P9|Overall Study|Lost to Follow-up|1
7648738|NCT01524978|26611038|P8|Overall Study|Lost to Follow-up|0
7648739|NCT01524978|26611039|P7|Overall Study|Lost to Follow-up|2
7648740|NCT01524978|26611040|P6|Overall Study|Lost to Follow-up|1
7648741|NCT01524978|26611041|P5|Overall Study|Lost to Follow-up|1
7648742|NCT01524978|26611042|P4|Overall Study|Lost to Follow-up|0
7648743|NCT01524978|26611043|P3|Overall Study|Lost to Follow-up|3
7648744|NCT01524978|26611044|P2|Overall Study|Lost to Follow-up|0
7648745|NCT01524978|26611045|P1|Overall Study|Lost to Follow-up|0
7648746|NCT01524978|26611035|P11|Overall Study|Withdrawal by Subject|5
7648747|NCT01524978|26611036|P10|Overall Study|Withdrawal by Subject|0
7648748|NCT01524978|26611037|P9|Overall Study|Withdrawal by Subject|4
7648749|NCT01524978|26611038|P8|Overall Study|Withdrawal by Subject|2
7648750|NCT01524978|26611039|P7|Overall Study|Withdrawal by Subject|6
7648751|NCT01524978|26611040|P6|Overall Study|Withdrawal by Subject|1
7648752|NCT01524978|26611041|P5|Overall Study|Withdrawal by Subject|3
7648753|NCT01524978|26611042|P4|Overall Study|Withdrawal by Subject|1
7648754|NCT01524978|26611043|P3|Overall Study|Withdrawal by Subject|1
7648755|NCT01524978|26611044|P2|Overall Study|Withdrawal by Subject|0
7648756|NCT01524978|26611045|P1|Overall Study|Withdrawal by Subject|12
7648757|NCT01524978|26611035|P11|Overall Study|Other|5
7648758|NCT01524978|26611036|P10|Overall Study|Other|2
7648759|NCT01524978|26611037|P9|Overall Study|Other|2
7648760|NCT01524978|26611038|P8|Overall Study|Other|1
7648761|NCT01524978|26611039|P7|Overall Study|Other|17
7648762|NCT01524978|26611040|P6|Overall Study|Other|3
7648763|NCT01524978|26611041|P5|Overall Study|Other|1
7648764|NCT01524978|26611042|P4|Overall Study|Other|2
7648765|NCT01524978|26611043|P3|Overall Study|Other|1
7648766|NCT01524978|26611044|P2|Overall Study|Other|2
7648767|NCT01524978|26611045|P1|Overall Study|Other|16
7648768|NCT01524913|26611173|P3|Overall Study|Lost to Follow-up|0
7648769|NCT01524913|26611174|P2|Overall Study|Lost to Follow-up|0
7648770|NCT01524913|26611175|P1|Overall Study|Lost to Follow-up|4
7648771|NCT01524900|26611197|P5|Overall Study|No reason documented|0
7648772|NCT01524900|26611198|P4|Overall Study|No reason documented|1
7648773|NCT01524900|26611199|P3|Overall Study|No reason documented|0
7648774|NCT01524900|26611200|P2|Overall Study|No reason documented|1
7648775|NCT01524900|26611201|P1|Overall Study|No reason documented|2
7648776|NCT01524900|26611197|P5|Overall Study|Other reason than stated above|0
7648777|NCT01524900|26611198|P4|Overall Study|Other reason than stated above|0
7648778|NCT01524900|26611199|P3|Overall Study|Other reason than stated above|0
7648779|NCT01524900|26611200|P2|Overall Study|Other reason than stated above|1
7648780|NCT01524900|26611201|P1|Overall Study|Other reason than stated above|1
7648781|NCT01524900|26611197|P5|Overall Study|Lost to Follow-up|0
7648782|NCT01524900|26611198|P4|Overall Study|Lost to Follow-up|0
7648783|NCT01524900|26611199|P3|Overall Study|Lost to Follow-up|1
7648784|NCT01524900|26611200|P2|Overall Study|Lost to Follow-up|12
7648785|NCT01524900|26611201|P1|Overall Study|Lost to Follow-up|3
7648786|NCT01524887|26611246|P3|Overall Study|Use of prohibited medication|0
7648787|NCT01524887|26611247|P2|Overall Study|Use of prohibited medication|0
7648788|NCT01524887|26611248|P1|Overall Study|Use of prohibited medication|1
7648789|NCT01524887|26611246|P3|Overall Study|Withdrawal by Caregiver|2
7648790|NCT01524887|26611247|P2|Overall Study|Withdrawal by Caregiver|0
7648791|NCT01524887|26611248|P1|Overall Study|Withdrawal by Caregiver|0
7648792|NCT01524887|26611246|P3|Overall Study|Study termination|79
7648793|NCT01524887|26611247|P2|Overall Study|Study termination|87
7648794|NCT01524887|26611248|P1|Overall Study|Study termination|73
7648795|NCT01524887|26611246|P3|Overall Study|Protocol Violation|1
7648796|NCT01524887|26611247|P2|Overall Study|Protocol Violation|0
7648797|NCT01524887|26611248|P1|Overall Study|Protocol Violation|0
7648798|NCT01524887|26611246|P3|Overall Study|Adverse Event|1
7648799|NCT01524887|26611247|P2|Overall Study|Adverse Event|1
7648800|NCT01524887|26611248|P1|Overall Study|Adverse Event|5
7648801|NCT01524887|26611246|P3|Overall Study|Withdrawal by Subject|3
7648802|NCT01524887|26611247|P2|Overall Study|Withdrawal by Subject|2
7648803|NCT01524887|26611248|P1|Overall Study|Withdrawal by Subject|6
7648804|NCT01524796|26611292|P1|Overall Study|Adverse Event and Lack of Efficacy|1
7648805|NCT01524796|26611292|P1|Overall Study|Switch to carbamazapine|1
7648806|NCT01524796|26611292|P1|Overall Study|Nervous about confidentiality|1
7648807|NCT01524796|26611292|P1|Overall Study|Gall stone surgery|1
7648808|NCT01524796|26611292|P1|Overall Study|Deterioration of pains|1
7648809|NCT01524796|26611292|P1|Overall Study|Move|1
7648810|NCT01524796|26611292|P1|Overall Study|Withdrawal by Subject|4
7648811|NCT01524796|26611292|P1|Overall Study|The price|1
7648812|NCT01524796|26611292|P1|Overall Study|Lost to Follow-up|1
7648813|NCT01524796|26611292|P1|Overall Study|Lack of Efficacy|3
7648814|NCT01524796|26611292|P1|Overall Study|Adverse Event|13
7648815|NCT01524783|26611307|P3|Open-label Period|Protocol deviation|0
7648816|NCT01524783|26611308|P2|Open-label Period|Protocol deviation|0
7648817|NCT01524783|26611309|P1|Open-label Period|Protocol deviation|1
7648818|NCT01524783|26611307|P3|Open-label Period|Withdrawal by Subject|1
7648819|NCT01524783|26611308|P2|Open-label Period|Withdrawal by Subject|0
7648820|NCT01524783|26611309|P1|Open-label Period|Withdrawal by Subject|2
7648821|NCT01524783|26611307|P3|Open-label Period|Adverse Event|1
7648822|NCT01524783|26611308|P2|Open-label Period|Adverse Event|0
7648823|NCT01524783|26611309|P1|Open-label Period|Adverse Event|5
7648824|NCT01524783|26611307|P3|Open-label Period|Administrative problems|2
7648825|NCT01524783|26611308|P2|Open-label Period|Administrative problems|0
7648826|NCT01524783|26611309|P1|Open-label Period|Administrative problems|5
7648827|NCT01524783|26611307|P3|Open-label Period|Disease progression|2
7648828|NCT01524783|26611308|P2|Open-label Period|Disease progression|0
7648829|NCT01524783|26611309|P1|Open-label Period|Disease progression|13
7648830|NCT01524783|26611307|P3|Blinded Period|Death|0
7648831|NCT01524783|26611308|P2|Blinded Period|Death|2
7648832|NCT01524783|26611309|P1|Blinded Period|Death|5
7648833|NCT01524783|26611307|P3|Blinded Period|Protocol deviation|0
7648834|NCT01524783|26611308|P2|Blinded Period|Protocol deviation|1
7648835|NCT01524783|26611309|P1|Blinded Period|Protocol deviation|2
7648836|NCT01524783|26611307|P3|Blinded Period|Withdrawal by Subject|0
7648837|NCT01524783|26611308|P2|Blinded Period|Withdrawal by Subject|6
7648838|NCT01524783|26611309|P1|Blinded Period|Withdrawal by Subject|19
7648839|NCT01524783|26611307|P3|Blinded Period|Disease Progression|0
7648840|NCT01524783|26611308|P2|Blinded Period|Disease Progression|75
7648841|NCT01524783|26611309|P1|Blinded Period|Disease Progression|89
7648842|NCT01524783|26611307|P3|Blinded Period|Adverse Event|0
7648843|NCT01524783|26611308|P2|Blinded Period|Adverse Event|7
7648844|NCT01524783|26611309|P1|Blinded Period|Adverse Event|64
7648845|NCT01524770|26611336|P2|First Intervention|Protocol Violation|0
7648846|NCT01524770|26611337|P1|First Intervention|Protocol Violation|1
7648847|NCT01524770|26611336|P2|First Intervention|Adverse Event|1
7648848|NCT01524770|26611337|P1|First Intervention|Adverse Event|1
7648849|NCT01524770|26611336|P2|First Intervention|Withdrawal by Subject|0
7648850|NCT01524770|26611337|P1|First Intervention|Withdrawal by Subject|1
7648851|NCT01524692|26611347|P1|Overall Study|Withdrawal by Subject|3
7648852|NCT01524679|26611357|P2|Overall Study|e.g.wish for children, relocation|1
7648853|NCT01524679|26611358|P1|Overall Study|e.g.wish for children, relocation|6
7648854|NCT01524679|26611357|P2|Overall Study|Lack of Efficacy|0
7648855|NCT01524679|26611358|P1|Overall Study|Lack of Efficacy|2
7648856|NCT01524679|26611357|P2|Overall Study|Protocol Violation|0
7648857|NCT01524679|26611358|P1|Overall Study|Protocol Violation|1
7648858|NCT01524679|26611357|P2|Overall Study|Adverse Event|0
7648859|NCT01524679|26611358|P1|Overall Study|Adverse Event|9
7648860|NCT01524679|26611357|P2|Overall Study|Withdrawal by Subject|4
7648861|NCT01524679|26611358|P1|Overall Study|Withdrawal by Subject|4
7648862|NCT01524679|26611357|P2|Overall Study|Lost to Follow-up|4
7648863|NCT01524679|26611358|P1|Overall Study|Lost to Follow-up|1
7648864|NCT01524627|26611370|P2|Overall Study|Lost to Follow-up|1
7648865|NCT01524627|26611371|P1|Overall Study|Lost to Follow-up|1
7648866|NCT01524627|26611370|P2|Overall Study|Physician Decision|1
7648867|NCT01524627|26611371|P1|Overall Study|Physician Decision|0
7648868|NCT01524289|26611398|P2|Overall Study|Did not take study medication|0
7648869|NCT01524289|26611399|P1|Overall Study|Did not take study medication|1
7648870|NCT01524289|26611398|P2|Overall Study|Adverse Event|5
7648871|NCT01524289|26611399|P1|Overall Study|Adverse Event|12
7648872|NCT01524289|26611398|P2|Overall Study|Withdrawal by Subject|7
7648873|NCT01524289|26611399|P1|Overall Study|Withdrawal by Subject|11
7648874|NCT01524289|26611398|P2|Overall Study|Protocol Violation|1
7648875|NCT01524289|26611399|P1|Overall Study|Protocol Violation|5
7648876|NCT01524289|26611398|P2|Overall Study|Physician Decision|0
7648877|NCT01524289|26611399|P1|Overall Study|Physician Decision|1
7648878|NCT01524289|26611398|P2|Overall Study|Lost to Follow-up|1
7648879|NCT01524289|26611399|P1|Overall Study|Lost to Follow-up|0
7648880|NCT01524224|26611457|P8|Overall Study|Sponsor Decision|0
7648881|NCT01524224|26611458|P7|Overall Study|Sponsor Decision|0
7648882|NCT01524224|26611459|P6|Overall Study|Sponsor Decision|0
7648883|NCT01524224|26611460|P5|Overall Study|Sponsor Decision|1
7648884|NCT01524224|26611461|P4|Overall Study|Sponsor Decision|0
7648885|NCT01524224|26611462|P3|Overall Study|Sponsor Decision|0
7648886|NCT01524224|26611463|P2|Overall Study|Sponsor Decision|0
7648887|NCT01524224|26611464|P1|Overall Study|Sponsor Decision|0
7648888|NCT01524224|26611457|P8|Overall Study|Physician Decision|1
7648889|NCT01524224|26611458|P7|Overall Study|Physician Decision|0
7648890|NCT01524224|26611459|P6|Overall Study|Physician Decision|0
7648891|NCT01524224|26611460|P5|Overall Study|Physician Decision|1
7648892|NCT01524224|26611461|P4|Overall Study|Physician Decision|1
7648893|NCT01524224|26611462|P3|Overall Study|Physician Decision|0
7648894|NCT01524224|26611463|P2|Overall Study|Physician Decision|0
7648895|NCT01524224|26611464|P1|Overall Study|Physician Decision|0
7648896|NCT01524224|26611457|P8|Overall Study|Adverse Event|0
7648897|NCT01524224|26611458|P7|Overall Study|Adverse Event|0
7648898|NCT01524224|26611459|P6|Overall Study|Adverse Event|1
7648899|NCT01524224|26611460|P5|Overall Study|Adverse Event|0
7648900|NCT01524224|26611461|P4|Overall Study|Adverse Event|0
7648901|NCT01524224|26611462|P3|Overall Study|Adverse Event|0
7648902|NCT01524224|26611463|P2|Overall Study|Adverse Event|1
7648903|NCT01524224|26611464|P1|Overall Study|Adverse Event|0
7648904|NCT01524224|26611457|P8|Overall Study|Withdrawal by Subject|0
7648905|NCT01524224|26611458|P7|Overall Study|Withdrawal by Subject|2
7648906|NCT01524224|26611459|P6|Overall Study|Withdrawal by Subject|0
7648907|NCT01524224|26611460|P5|Overall Study|Withdrawal by Subject|0
7648908|NCT01524224|26611461|P4|Overall Study|Withdrawal by Subject|0
7648909|NCT01524224|26611462|P3|Overall Study|Withdrawal by Subject|0
7648910|NCT01524224|26611463|P2|Overall Study|Withdrawal by Subject|0
7648911|NCT01524224|26611464|P1|Overall Study|Withdrawal by Subject|2
7648912|NCT01524224|26611457|P8|Overall Study|Progressive Disease|5
7648913|NCT01524224|26611458|P7|Overall Study|Progressive Disease|1
7648914|NCT01524224|26611459|P6|Overall Study|Progressive Disease|1
7648915|NCT01524224|26611460|P5|Overall Study|Progressive Disease|2
7648916|NCT01524224|26611461|P4|Overall Study|Progressive Disease|1
7648917|NCT01524224|26611462|P3|Overall Study|Progressive Disease|2
7648918|NCT01524224|26611463|P2|Overall Study|Progressive Disease|0
7648919|NCT01524224|26611464|P1|Overall Study|Progressive Disease|1
7648920|NCT01524198|26611500|P2|Overall Study|Withdrawal by Subject|10
7648921|NCT01524198|26611501|P1|Overall Study|Withdrawal by Subject|15
7648922|NCT01524198|26611500|P2|Overall Study|Protocol Violation|6
7648923|NCT01524198|26611501|P1|Overall Study|Protocol Violation|8
7648924|NCT01524133|26611512|P3|Overall Study 52 Weeks|Lost to Follow-up|15
7648925|NCT01524133|26611513|P2|Overall Study 52 Weeks|Lost to Follow-up|15
7648926|NCT01524133|26611514|P1|Overall Study 52 Weeks|Lost to Follow-up|16
7648927|NCT01524133|26611512|P3|Overall Study 52 Weeks|Physician Decision|2
7648928|NCT01524133|26611513|P2|Overall Study 52 Weeks|Physician Decision|0
7648929|NCT01524133|26611514|P1|Overall Study 52 Weeks|Physician Decision|1
7648930|NCT01524133|26611512|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
7648931|NCT01524133|26611513|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
7648932|NCT01524133|26611514|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
7648933|NCT01524133|26611512|P3|Treatment Phase|Lost to Follow-up|2
7648934|NCT01524133|26611513|P2|Treatment Phase|Lost to Follow-up|1
7648935|NCT01524133|26611514|P1|Treatment Phase|Lost to Follow-up|0
7648936|NCT01524133|26611512|P3|Treatment Phase|Physician Decision|3
7648937|NCT01524133|26611513|P2|Treatment Phase|Physician Decision|3
7648938|NCT01524133|26611514|P1|Treatment Phase|Physician Decision|6
7648939|NCT01524133|26611512|P3|Treatment Phase|Withdrawal by Subject|31
7648940|NCT01524133|26611513|P2|Treatment Phase|Withdrawal by Subject|28
7648941|NCT01524133|26611514|P1|Treatment Phase|Withdrawal by Subject|13
7648942|NCT01523886|26611557|P2|Overall Study|surgery cancelled|1
7648943|NCT01523886|26611558|P1|Overall Study|surgery cancelled|0
7648944|NCT01523873|26611564|P1|Overall Study|Protocol Violation|422
7648945|NCT01523756|26611702|P2|Test Period 2|Withdrawal by Subject|1
7648946|NCT01523756|26611703|P1|Test Period 2|Withdrawal by Subject|0
7648947|NCT01523756|26611702|P2|Test Period 1|Adverse Event|0
7648948|NCT01523756|26611703|P1|Test Period 1|Adverse Event|1
7648949|NCT01523756|26611702|P2|Baseline Period|Adverse Event|1
7648950|NCT01523756|26611703|P1|Baseline Period|Adverse Event|0
7648951|NCT01523743|26611711|P2|Period 2|Adverse Event|0
7648952|NCT01523743|26611712|P1|Period 2|Adverse Event|1
7648953|NCT01523743|26611711|P2|Period 2|Withdrawal by Subject|2
7648954|NCT01523743|26611712|P1|Period 2|Withdrawal by Subject|0
7648955|NCT01523743|26611711|P2|Period 1|Felt unable to empty bladder|0
7648956|NCT01523743|26611712|P1|Period 1|Felt unable to empty bladder|1
7648957|NCT01523743|26611711|P2|Period 1|Lack of Efficacy|0
7648958|NCT01523743|26611712|P1|Period 1|Lack of Efficacy|1
7648959|NCT01523743|26611711|P2|Period 1|Lost to Follow-up|0
7648960|NCT01523743|26611712|P1|Period 1|Lost to Follow-up|1
7648961|NCT01523743|26611711|P2|Period 1|Withdrawal by Subject|2
7648962|NCT01523743|26611712|P1|Period 1|Withdrawal by Subject|6
7648963|NCT01523743|26611711|P2|Period 1|Adverse Event|0
7648964|NCT01523743|26611712|P1|Period 1|Adverse Event|1
7648965|NCT01523587|26611748|P2|Overall Study|Randomised but bot treated|2
7648966|NCT01523587|26611749|P1|Overall Study|Randomised but bot treated|6
7648967|NCT01523587|26611748|P2|Overall Study|Withdrew due to Progressive disease|279
7648968|NCT01523587|26611749|P1|Overall Study|Withdrew due to Progressive disease|265
7648969|NCT01523587|26611748|P2|Overall Study|Withdrawal by Subject|20
7648970|NCT01523587|26611749|P1|Overall Study|Withdrawal by Subject|28
7648971|NCT01523587|26611748|P2|Overall Study|Lost to Follow-up|2
7648972|NCT01523587|26611749|P1|Overall Study|Lost to Follow-up|2
7648973|NCT01523587|26611748|P2|Overall Study|Protocol Violation|3
7648974|NCT01523587|26611749|P1|Overall Study|Protocol Violation|5
7648975|NCT01523587|26611748|P2|Overall Study|Adverse Event|52
7648976|NCT01523587|26611749|P1|Overall Study|Adverse Event|68
7648977|NCT01523587|26611748|P2|Overall Study|Worsening of underlying cancer disease|34
7648978|NCT01523587|26611749|P1|Overall Study|Worsening of underlying cancer disease|19
7648979|NCT01523587|26611748|P2|Overall Study|Other than listed|5
7648980|NCT01523587|26611749|P1|Overall Study|Other than listed|5
7648981|NCT01523457|26611792|P2|Overall Study|Withdrawal by Subject|2
7648982|NCT01523457|26611793|P1|Overall Study|Withdrawal by Subject|7
7648983|NCT01523392|26611811|P2|Washout Period - 10 to 14 Days|Adverse Event|0
7648984|NCT01523392|26611812|P1|Washout Period - 10 to 14 Days|Adverse Event|1
7648985|NCT01523392|26611811|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
7648986|NCT01523392|26611812|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
7648987|NCT01523392|26611811|P2|Treatment Period 1|Withdrawal by Subject|0
7648988|NCT01523392|26611812|P1|Treatment Period 1|Withdrawal by Subject|2
7648989|NCT01523366|26611828|P2|Treatment Period 2|Not completed at least 7 days treatment|0
7648990|NCT01523366|26611829|P1|Treatment Period 2|Not completed at least 7 days treatment|1
7648991|NCT01523366|26611828|P2|Treatment Period 1|Withdrawal by Subject|0
7648992|NCT01523366|26611829|P1|Treatment Period 1|Withdrawal by Subject|1
7648993|NCT01523301|26611845|P2|Overall Study|Other Reason|2
7648994|NCT01523301|26611846|P1|Overall Study|Other Reason|0
7648995|NCT01523301|26611845|P2|Overall Study|Withdrawal by Subject|8
7648996|NCT01523301|26611846|P1|Overall Study|Withdrawal by Subject|6
7648997|NCT01523301|26611845|P2|Overall Study|Lost to Follow-up|0
7648998|NCT01523301|26611846|P1|Overall Study|Lost to Follow-up|1
7648999|NCT01523301|26611845|P2|Overall Study|Protocol Violation|4
7649000|NCT01523301|26611846|P1|Overall Study|Protocol Violation|3
7649001|NCT01523301|26611845|P2|Overall Study|Lack of Efficacy|2
7649002|NCT01523301|26611846|P1|Overall Study|Lack of Efficacy|0
7649003|NCT01523301|26611845|P2|Overall Study|Adverse Event|16
7649004|NCT01523301|26611846|P1|Overall Study|Adverse Event|25
7649005|NCT01523275|26611866|P2|Overall Study|Withdrawal by Subject|0
7649006|NCT01523275|26611867|P1|Overall Study|Withdrawal by Subject|1
7649007|NCT01523275|26611866|P2|Overall Study|Lost to Follow-up|2
7649008|NCT01523275|26611867|P1|Overall Study|Lost to Follow-up|1
7649009|NCT01522976|26611880|P3|Overall Study|Not protocol specified|27
7649010|NCT01522976|26611881|P2|Overall Study|Not protocol specified|27
7649011|NCT01522976|26611882|P1|Overall Study|Not protocol specified|22
7649012|NCT01522976|26611880|P3|Overall Study|Refusal unrelated to adverse event|14
7649013|NCT01522976|26611881|P2|Overall Study|Refusal unrelated to adverse event|13
7649014|NCT01522976|26611882|P1|Overall Study|Refusal unrelated to adverse event|10
7649015|NCT01522976|26611880|P3|Overall Study|Adverse Event|18
7649016|NCT01522976|26611881|P2|Overall Study|Adverse Event|7
7649017|NCT01522976|26611882|P1|Overall Study|Adverse Event|17
7649018|NCT01522976|26611880|P3|Overall Study|Disease progression|25
7649019|NCT01522976|26611881|P2|Overall Study|Disease progression|30
7649020|NCT01522976|26611882|P1|Overall Study|Disease progression|28
7649021|NCT01522976|26611880|P3|Overall Study|Still on treatment|6
7649022|NCT01522976|26611881|P2|Overall Study|Still on treatment|9
7649023|NCT01522976|26611882|P1|Overall Study|Still on treatment|9
7649024|NCT01522976|26611880|P3|Overall Study|Death|2
7649025|NCT01522976|26611881|P2|Overall Study|Death|6
7649026|NCT01522976|26611882|P1|Overall Study|Death|7
7649027|NCT01522976|26611880|P3|Overall Study|Ineligible|1
7649028|NCT01522976|26611881|P2|Overall Study|Ineligible|0
7649029|NCT01522976|26611882|P1|Overall Study|Ineligible|4
7649030|NCT01522950|26611927|P3|Overall Study|Study Medication Sensitivity|0
7649031|NCT01522950|26611928|P2|Overall Study|Study Medication Sensitivity|1
7649032|NCT01522950|26611929|P1|Overall Study|Study Medication Sensitivity|0
7649033|NCT01522950|26611927|P3|Overall Study|Death|1
7649034|NCT01522950|26611928|P2|Overall Study|Death|1
7649035|NCT01522950|26611929|P1|Overall Study|Death|0
7649036|NCT01522950|26611927|P3|Overall Study|Protocol Violation|2
7649037|NCT01522950|26611928|P2|Overall Study|Protocol Violation|0
7649038|NCT01522950|26611929|P1|Overall Study|Protocol Violation|0
7649039|NCT01522950|26611927|P3|Overall Study|Adverse Event|1
7649040|NCT01522950|26611928|P2|Overall Study|Adverse Event|1
7649041|NCT01522950|26611929|P1|Overall Study|Adverse Event|3
7649042|NCT01522950|26611927|P3|Overall Study|Withdrawal by Subject|1
7649043|NCT01522950|26611928|P2|Overall Study|Withdrawal by Subject|2
7649044|NCT01522950|26611929|P1|Overall Study|Withdrawal by Subject|3
7649045|NCT01522651|26611997|P5|Overall Study|Randomized but Never Treated|1
7649046|NCT01522651|26611998|P4|Overall Study|Randomized but Never Treated|1
7649047|NCT01522651|26611999|P3|Overall Study|Randomized but Never Treated|0
7649048|NCT01522651|26612000|P2|Overall Study|Randomized but Never Treated|1
7649049|NCT01522651|26612001|P1|Overall Study|Randomized but Never Treated|0
7649050|NCT01522651|26611997|P5|Overall Study|Withdrew Consent|1
7649051|NCT01522651|26611998|P4|Overall Study|Withdrew Consent|1
7649052|NCT01522651|26611999|P3|Overall Study|Withdrew Consent|0
7649053|NCT01522651|26612000|P2|Overall Study|Withdrew Consent|1
7649054|NCT01522651|26612001|P1|Overall Study|Withdrew Consent|1
7649055|NCT01522651|26611997|P5|Overall Study|Participant Non-Compliance|0
7649056|NCT01522651|26611998|P4|Overall Study|Participant Non-Compliance|0
7649057|NCT01522651|26611999|P3|Overall Study|Participant Non-Compliance|0
7649058|NCT01522651|26612000|P2|Overall Study|Participant Non-Compliance|0
7649059|NCT01522651|26612001|P1|Overall Study|Participant Non-Compliance|1
7649060|NCT01522651|26611997|P5|Overall Study|Reason Not Specified|0
7649061|NCT01522651|26611998|P4|Overall Study|Reason Not Specified|1
7649062|NCT01522651|26611999|P3|Overall Study|Reason Not Specified|0
7649063|NCT01522651|26612000|P2|Overall Study|Reason Not Specified|0
7649064|NCT01522651|26612001|P1|Overall Study|Reason Not Specified|0
7649065|NCT01522651|26611997|P5|Overall Study|Protocol Violation|0
7649066|NCT01522651|26611998|P4|Overall Study|Protocol Violation|0
7649067|NCT01522651|26611999|P3|Overall Study|Protocol Violation|0
7649068|NCT01522651|26612000|P2|Overall Study|Protocol Violation|0
7649069|NCT01522651|26612001|P1|Overall Study|Protocol Violation|3
7649070|NCT01522651|26611997|P5|Overall Study|Investigator's Discretion|0
7649071|NCT01522651|26611998|P4|Overall Study|Investigator's Discretion|0
7649072|NCT01522651|26611999|P3|Overall Study|Investigator's Discretion|0
7649073|NCT01522651|26612000|P2|Overall Study|Investigator's Discretion|1
7649074|NCT01522651|26612001|P1|Overall Study|Investigator's Discretion|0
7649075|NCT01522651|26611997|P5|Overall Study|Device Malfunction|0
7649076|NCT01522651|26611998|P4|Overall Study|Device Malfunction|0
7649077|NCT01522651|26611999|P3|Overall Study|Device Malfunction|0
7649078|NCT01522651|26612000|P2|Overall Study|Device Malfunction|1
7649079|NCT01522651|26612001|P1|Overall Study|Device Malfunction|0
7649080|NCT01522651|26611997|P5|Overall Study|Cardioversion|0
7649081|NCT01522651|26611998|P4|Overall Study|Cardioversion|0
7649082|NCT01522651|26611999|P3|Overall Study|Cardioversion|0
7649083|NCT01522651|26612000|P2|Overall Study|Cardioversion|0
7649084|NCT01522651|26612001|P1|Overall Study|Cardioversion|1
7649085|NCT01522651|26611997|P5|Overall Study|Adverse Event|4
7649086|NCT01522651|26611998|P4|Overall Study|Adverse Event|5
7649087|NCT01522651|26611999|P3|Overall Study|Adverse Event|4
7649088|NCT01522651|26612000|P2|Overall Study|Adverse Event|4
7649089|NCT01522651|26612001|P1|Overall Study|Adverse Event|3
7649090|NCT01522456|26612028|P1|Overall Study|Tolerability Assessment|1
7649091|NCT01522456|26612028|P1|Overall Study|Pregnancy|1
7649092|NCT01522456|26612028|P1|Overall Study|Withdrawal by Subject|2
7649093|NCT01522456|26612028|P1|Overall Study|Lost to Follow-up|2
7649094|NCT01522456|26612028|P1|Overall Study|Adverse Event|2
7649095|NCT01522443|26612091|P2|Overall Study|Other|3
7649096|NCT01522443|26612092|P1|Overall Study|Other|1
7649097|NCT01522443|26612091|P2|Overall Study|No study treatment given|1
7649098|NCT01522443|26612092|P1|Overall Study|No study treatment given|1
7649099|NCT01522443|26612091|P2|Overall Study|Withdrawal by Subject|8
7649100|NCT01522443|26612092|P1|Overall Study|Withdrawal by Subject|5
7649101|NCT01522443|26612091|P2|Overall Study|Adverse Event|15
7649102|NCT01522443|26612092|P1|Overall Study|Adverse Event|10
7649103|NCT01522443|26612091|P2|Overall Study|No longer receiving clinical benefit|28
7649104|NCT01522443|26612092|P1|Overall Study|No longer receiving clinical benefit|36
7649105|NCT01522404|26612129|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
7649106|NCT01522404|26612130|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
7649107|NCT01522404|26612129|P2|First Intervention (up to Week 29)|Adverse Event|0
7649108|NCT01522404|26612130|P1|First Intervention (up to Week 29)|Adverse Event|1
7649109|NCT01522404|26612129|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
7649110|NCT01522404|26612130|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
7649111|NCT01522248|26612216|P2|Overall Study|Lost to Follow-up|0
7649112|NCT01522248|26612217|P1|Overall Study|Lost to Follow-up|1
7649113|NCT01522235|26612232|P2|Overall Study|Physician Decision|1
7649114|NCT01522235|26612233|P1|Overall Study|Physician Decision|1
7649115|NCT01521923|26612269|P4|Overall Study|AE, captured in Period 1|1
7649116|NCT01521923|26612270|P3|Overall Study|AE, captured in Period 1|0
7649117|NCT01521923|26612271|P2|Overall Study|AE, captured in Period 1|1
7649118|NCT01521923|26612272|P1|Overall Study|AE, captured in Period 1|0
7649119|NCT01521923|26612269|P4|Overall Study|Other|6
7649120|NCT01521923|26612270|P3|Overall Study|Other|3
7649121|NCT01521923|26612271|P2|Overall Study|Other|1
7649122|NCT01521923|26612272|P1|Overall Study|Other|2
7649123|NCT01521923|26612269|P4|Overall Study|Withdrawal by Subject|2
7649124|NCT01521923|26612270|P3|Overall Study|Withdrawal by Subject|1
7649125|NCT01521923|26612271|P2|Overall Study|Withdrawal by Subject|1
7649126|NCT01521923|26612272|P1|Overall Study|Withdrawal by Subject|1
7649127|NCT01521923|26612269|P4|Overall Study|Lost to Follow-up|1
7649128|NCT01521923|26612270|P3|Overall Study|Lost to Follow-up|2
7649129|NCT01521923|26612271|P2|Overall Study|Lost to Follow-up|0
7649130|NCT01521923|26612272|P1|Overall Study|Lost to Follow-up|1
7649131|NCT01521923|26612269|P4|Overall Study|Protocol Violation|0
7649132|NCT01521923|26612270|P3|Overall Study|Protocol Violation|1
7649133|NCT01521923|26612271|P2|Overall Study|Protocol Violation|0
7649134|NCT01521923|26612272|P1|Overall Study|Protocol Violation|0
7649135|NCT01521923|26612269|P4|Overall Study|Lack of Efficacy|0
7649136|NCT01521923|26612270|P3|Overall Study|Lack of Efficacy|0
7649137|NCT01521923|26612271|P2|Overall Study|Lack of Efficacy|1
7649138|NCT01521923|26612272|P1|Overall Study|Lack of Efficacy|1
7649139|NCT01521923|26612269|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
7649140|NCT01521923|26612270|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7649141|NCT01521923|26612271|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7649142|NCT01521923|26612272|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7649143|NCT01521923|26612269|P4|Overall Study|AE, non-serious, non-fatal|2
7649144|NCT01521923|26612270|P3|Overall Study|AE, non-serious, non-fatal|6
7649145|NCT01521923|26612271|P2|Overall Study|AE, non-serious, non-fatal|3
7649146|NCT01521923|26612272|P1|Overall Study|AE, non-serious, non-fatal|1
7649147|NCT01521923|26612269|P4|Overall Study|SAE, non-fatal|0
7649148|NCT01521923|26612270|P3|Overall Study|SAE, non-fatal|2
7649149|NCT01521923|26612271|P2|Overall Study|SAE, non-fatal|2
7649150|NCT01521923|26612272|P1|Overall Study|SAE, non-fatal|0
7649151|NCT01521923|26612269|P4|Overall Study|AE, serious fatal|0
7649152|NCT01521923|26612270|P3|Overall Study|AE, serious fatal|0
7649153|NCT01521923|26612271|P2|Overall Study|AE, serious fatal|0
7649154|NCT01521923|26612272|P1|Overall Study|AE, serious fatal|1
7649155|NCT01521897|26612392|P1|Overall Study|Lost to Follow-up|5
7649156|NCT01521897|26612392|P1|Overall Study|Protocol Violation|18
7649157|NCT01521884|26612404|P1|Overall Study|Lost to Follow-up|4
7649158|NCT01521884|26612404|P1|Overall Study|Participant non-eligible|1
7649159|NCT01521884|26612404|P1|Overall Study|Protocol Violation|3
7649160|NCT01521884|26612404|P1|Overall Study|Physician Decision|2
7649161|NCT01521884|26612404|P1|Overall Study|Withdrawal by Subject|1
7649162|NCT01521884|26612404|P1|Overall Study|Pregnancy|1
7649163|NCT01521884|26612404|P1|Overall Study|Adverse Event|5
7649164|NCT01521884|26612404|P1|Overall Study|Non Responders|10
7649165|NCT01521559|26612501|P2|Overall Study|Other|2
7649166|NCT01521559|26612502|P1|Overall Study|Other|1
7649167|NCT01521559|26612501|P2|Overall Study|Protocol Violation|0
7649168|NCT01521559|26612502|P1|Overall Study|Protocol Violation|1
7649169|NCT01521559|26612501|P2|Overall Study|Lost to Follow-up|1
7649170|NCT01521559|26612502|P1|Overall Study|Lost to Follow-up|3
7649171|NCT01521559|26612501|P2|Overall Study|Withdrawal by Subject|11
7649172|NCT01521559|26612502|P1|Overall Study|Withdrawal by Subject|9
7649173|NCT01521559|26612501|P2|Overall Study|Death|0
7649174|NCT01521559|26612502|P1|Overall Study|Death|1
7649175|NCT01521559|26612501|P2|Overall Study|Adverse Event|4
7649176|NCT01521559|26612502|P1|Overall Study|Adverse Event|0
7649177|NCT01521507|26612525|P2|Stage 2: Observational Design|Physician Decision|0
7649178|NCT01521507|26612526|P1|Stage 2: Observational Design|Physician Decision|1
7649179|NCT01521507|26612525|P2|Stage 2: Observational Design|Withdrawal by Subject|1
7649180|NCT01521507|26612526|P1|Stage 2: Observational Design|Withdrawal by Subject|3
7649181|NCT01521507|26612525|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
7649182|NCT01521507|26612526|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
7649183|NCT01521507|26612525|P2|Stage 1: Randomized Design|Lost to Follow-up|2
7649184|NCT01521507|26612526|P1|Stage 1: Randomized Design|Lost to Follow-up|0
7649185|NCT01521507|26612525|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
7649186|NCT01521507|26612526|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
7649187|NCT01521507|26612525|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
7649188|NCT01521507|26612526|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
7649189|NCT01521494|26612548|P5|Overall Study|Physician Decision|2
7649190|NCT01521494|26612549|P4|Overall Study|Physician Decision|0
7649191|NCT01521494|26612550|P3|Overall Study|Physician Decision|0
7649192|NCT01521494|26612551|P2|Overall Study|Physician Decision|0
7649193|NCT01521494|26612552|P1|Overall Study|Physician Decision|0
7649194|NCT01521494|26612548|P5|Overall Study|Decrease in serum calcium|1
7649195|NCT01521494|26612549|P4|Overall Study|Decrease in serum calcium|1
7649196|NCT01521494|26612550|P3|Overall Study|Decrease in serum calcium|0
7649197|NCT01521494|26612551|P2|Overall Study|Decrease in serum calcium|0
7649198|NCT01521494|26612552|P1|Overall Study|Decrease in serum calcium|0
7649199|NCT01521494|26612548|P5|Overall Study|Decrease in serum phosphate|0
7649200|NCT01521494|26612549|P4|Overall Study|Decrease in serum phosphate|12
7649201|NCT01521494|26612550|P3|Overall Study|Decrease in serum phosphate|3
7649202|NCT01521494|26612551|P2|Overall Study|Decrease in serum phosphate|2
7649203|NCT01521494|26612552|P1|Overall Study|Decrease in serum phosphate|0
7649204|NCT01521494|26612548|P5|Overall Study|Withdrawal by Subject|0
7649205|NCT01521494|26612549|P4|Overall Study|Withdrawal by Subject|2
7649206|NCT01521494|26612550|P3|Overall Study|Withdrawal by Subject|0
7649207|NCT01521494|26612551|P2|Overall Study|Withdrawal by Subject|1
7649208|NCT01521494|26612552|P1|Overall Study|Withdrawal by Subject|1
7649209|NCT01521494|26612548|P5|Overall Study|Lack of Efficacy|2
7649210|NCT01521494|26612549|P4|Overall Study|Lack of Efficacy|0
7649211|NCT01521494|26612550|P3|Overall Study|Lack of Efficacy|0
7649212|NCT01521494|26612551|P2|Overall Study|Lack of Efficacy|0
7649213|NCT01521494|26612552|P1|Overall Study|Lack of Efficacy|0
7649214|NCT01521494|26612548|P5|Overall Study|Adverse Event|2
7649215|NCT01521494|26612549|P4|Overall Study|Adverse Event|6
7649216|NCT01521494|26612550|P3|Overall Study|Adverse Event|9
7649217|NCT01521494|26612551|P2|Overall Study|Adverse Event|2
7649218|NCT01521494|26612552|P1|Overall Study|Adverse Event|1
7649219|NCT01521364|26612574|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
7649220|NCT01521364|26612574|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
7649221|NCT01521117|26612631|P2|Second Intervention (6 Weeks)|Adverse Event|3
7649222|NCT01521117|26612632|P1|Second Intervention (6 Weeks)|Adverse Event|0
7649223|NCT01521117|26612631|P2|First Intervention (6 Weeks)|Scheduling Issues|2
7649224|NCT01521117|26612632|P1|First Intervention (6 Weeks)|Scheduling Issues|0
7649225|NCT01521117|26612631|P2|First Intervention (6 Weeks)|Adverse Event|1
7649226|NCT01521117|26612632|P1|First Intervention (6 Weeks)|Adverse Event|5
7649227|NCT01520987|26612661|P8|Overall Study|Withdrawal by Subject|0
7649228|NCT01520987|26612662|P7|Overall Study|Withdrawal by Subject|0
7649229|NCT01520987|26612663|P6|Overall Study|Withdrawal by Subject|1
7649230|NCT01520987|26612664|P5|Overall Study|Withdrawal by Subject|0
7649231|NCT01520987|26612665|P4|Overall Study|Withdrawal by Subject|0
7649232|NCT01520987|26612666|P3|Overall Study|Withdrawal by Subject|0
7649233|NCT01520987|26612667|P2|Overall Study|Withdrawal by Subject|0
7649234|NCT01520987|26612668|P1|Overall Study|Withdrawal by Subject|1
7649235|NCT01520922|26612728|P2|Survival Follow-up|Withdrawal by Subject|0
7649236|NCT01520922|26612729|P1|Survival Follow-up|Withdrawal by Subject|1
7649237|NCT01520922|26612728|P2|Follow up|Lost to Follow-up|1
7649238|NCT01520922|26612729|P1|Follow up|Lost to Follow-up|0
7649239|NCT01520922|26612728|P2|Treatment Phase|Adverse Event|5
7649240|NCT01520922|26612729|P1|Treatment Phase|Adverse Event|3
7649241|NCT01520922|26612728|P2|Treatment Phase|Progression|2
7649242|NCT01520922|26612729|P1|Treatment Phase|Progression|0
7649243|NCT01520922|26612728|P2|Treatment Phase|Physician Decision|1
7649244|NCT01520922|26612729|P1|Treatment Phase|Physician Decision|2
7649245|NCT01520909|26612791|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
7649246|NCT01520909|26612792|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7649247|NCT01520909|26612793|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7649248|NCT01520909|26612791|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
7649249|NCT01520909|26612792|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7649250|NCT01520909|26612793|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7649251|NCT01520909|26612791|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
7649252|NCT01520909|26612792|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7649253|NCT01520909|26612793|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7649254|NCT01520909|26612791|P3|Part 1 (Randomized Period)|Adverse Event|0
7649255|NCT01520909|26612792|P2|Part 1 (Randomized Period)|Adverse Event|2
7649256|NCT01520909|26612793|P1|Part 1 (Randomized Period)|Adverse Event|1
7649257|NCT01520870|26612855|P1|Overall Study|Withdrawal by Subject|2
7649258|NCT01520714|26612920|P2|Overall Study|Lack of Efficacy|1
7649259|NCT01520714|26612921|P1|Overall Study|Lack of Efficacy|0
7649260|NCT01520714|26612920|P2|Overall Study|Adverse Event|2
7649261|NCT01520714|26612921|P1|Overall Study|Adverse Event|0
7649262|NCT01520714|26612920|P2|Overall Study|Protocol Violation|3
7649263|NCT01520714|26612921|P1|Overall Study|Protocol Violation|0
7649264|NCT01520506|26612966|P1|Overall Study|Withdrawal by Subject|1
7649265|NCT01520506|26612966|P1|Overall Study|Lost to Follow-up|1
7649266|NCT01520506|26612966|P1|Overall Study|Missed Visit|4
7649267|NCT01520402|26613021|P1|Overall Study|Physician Decision|3
7649268|NCT01520402|26613021|P1|Overall Study|Withdrawal by Subject|2
7649269|NCT01520363|26613034|P2|Overall Study|Withdrawal by Subject|0
7649270|NCT01520363|26613035|P1|Overall Study|Withdrawal by Subject|2
7649271|NCT01520324|26613109|P1|Overall Study|Subject discontinued (moderate illness)|1
7649272|NCT01519960|26613138|P3|Overall Study|Lost to Follow-up|0
7649273|NCT01519960|26613139|P2|Overall Study|Lost to Follow-up|1
7649274|NCT01519960|26613140|P1|Overall Study|Lost to Follow-up|0
7649275|NCT01519960|26613138|P3|Overall Study|Withdrawal by Subject|0
7649276|NCT01519960|26613139|P2|Overall Study|Withdrawal by Subject|4
7649277|NCT01519960|26613140|P1|Overall Study|Withdrawal by Subject|0
7649278|NCT01519960|26613138|P3|Overall Study|Adverse Event|0
7649279|NCT01519960|26613139|P2|Overall Study|Adverse Event|1
7649280|NCT01519960|26613140|P1|Overall Study|Adverse Event|0
7649281|NCT01519960|26613138|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
7649282|NCT01519960|26613139|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
7649283|NCT01519960|26613140|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
7649284|NCT01519960|26613138|P3|Overall Study|Ongoing in Follow-Up|10
7649285|NCT01519960|26613139|P2|Overall Study|Ongoing in Follow-Up|11
7649286|NCT01519960|26613140|P1|Overall Study|Ongoing in Follow-Up|101
7649287|NCT01519947|26613250|P4|Overall Study|Adverse Event|1
7649288|NCT01519947|26613251|P3|Overall Study|Adverse Event|1
7649289|NCT01519947|26613252|P2|Overall Study|Adverse Event|0
7649290|NCT01519947|26613253|P1|Overall Study|Adverse Event|1
7649291|NCT01519947|26613250|P4|Overall Study|Poor Response|1
7649292|NCT01519947|26613251|P3|Overall Study|Poor Response|0
7649293|NCT01519947|26613252|P2|Overall Study|Poor Response|0
7649294|NCT01519947|26613253|P1|Overall Study|Poor Response|1
7649295|NCT01519947|26613250|P4|Overall Study|Lost to Follow-up|2
7649296|NCT01519947|26613251|P3|Overall Study|Lost to Follow-up|3
7649297|NCT01519947|26613252|P2|Overall Study|Lost to Follow-up|0
7649298|NCT01519947|26613253|P1|Overall Study|Lost to Follow-up|0
7649299|NCT01519947|26613250|P4|Overall Study|Withdrawal by Subject|1
7649300|NCT01519947|26613251|P3|Overall Study|Withdrawal by Subject|0
7649301|NCT01519947|26613252|P2|Overall Study|Withdrawal by Subject|1
7649302|NCT01519947|26613253|P1|Overall Study|Withdrawal by Subject|0
7649303|NCT01519947|26613250|P4|Overall Study|Blood Transfusion|0
7649304|NCT01519947|26613251|P3|Overall Study|Blood Transfusion|1
7649305|NCT01519947|26613252|P2|Overall Study|Blood Transfusion|1
7649306|NCT01519947|26613253|P1|Overall Study|Blood Transfusion|0
7649307|NCT01519947|26613250|P4|Overall Study|Development of Anemia|1
7649308|NCT01519947|26613251|P3|Overall Study|Development of Anemia|0
7649309|NCT01519947|26613252|P2|Overall Study|Development of Anemia|1
7649310|NCT01519947|26613253|P1|Overall Study|Development of Anemia|0
7649311|NCT01519947|26613250|P4|Overall Study|Peritoneal Dialysis Needed|0
7649312|NCT01519947|26613251|P3|Overall Study|Peritoneal Dialysis Needed|0
7649313|NCT01519947|26613252|P2|Overall Study|Peritoneal Dialysis Needed|1
7649314|NCT01519947|26613253|P1|Overall Study|Peritoneal Dialysis Needed|0
7649315|NCT01519947|26613250|P4|Overall Study|Protocol Violation|1
7649316|NCT01519947|26613251|P3|Overall Study|Protocol Violation|2
7649317|NCT01519947|26613252|P2|Overall Study|Protocol Violation|0
7649318|NCT01519947|26613253|P1|Overall Study|Protocol Violation|0
7649319|NCT01519947|26613250|P4|Overall Study|Death|1
7649320|NCT01519947|26613251|P3|Overall Study|Death|0
7649321|NCT01519947|26613252|P2|Overall Study|Death|0
7649322|NCT01519947|26613253|P1|Overall Study|Death|0
7649323|NCT01519934|26613283|P1|Overall Study|Lost to Follow-up|3
7649324|NCT01519921|26613292|P2|Overall Study|High alanine aminotransferase (ALT)|1
7649325|NCT01519921|26613293|P1|Overall Study|High alanine aminotransferase (ALT)|0
7649326|NCT01519921|26613292|P2|Overall Study|Treatment refusal|1
7649327|NCT01519921|26613293|P1|Overall Study|Treatment refusal|2
7649328|NCT01519921|26613292|P2|Overall Study|Lost to Follow-up|1
7649329|NCT01519921|26613293|P1|Overall Study|Lost to Follow-up|2
7649330|NCT01519921|26613292|P2|Overall Study|Withdrawal by Subject|0
7649331|NCT01519921|26613293|P1|Overall Study|Withdrawal by Subject|3
7649332|NCT01519921|26613292|P2|Overall Study|Lack of Efficacy|3
7649333|NCT01519921|26613293|P1|Overall Study|Lack of Efficacy|4
7649334|NCT01519921|26613292|P2|Overall Study|Adverse Event|9
7649335|NCT01519921|26613293|P1|Overall Study|Adverse Event|10
7649336|NCT01519869|26613342|P1|Overall Study|Lost to Follow-up|1
7649337|NCT01519817|26613346|P4|Overall Study|Off study due to infection|1
7649338|NCT01519817|26613347|P3|Overall Study|Off study due to infection|0
7649339|NCT01519817|26613348|P2|Overall Study|Off study due to infection|0
7649340|NCT01519817|26613349|P1|Overall Study|Off study due to infection|0
7649341|NCT01519817|26613346|P4|Overall Study|Withdrawal by Subject|0
7649342|NCT01519817|26613347|P3|Overall Study|Withdrawal by Subject|0
7649343|NCT01519817|26613348|P2|Overall Study|Withdrawal by Subject|0
7649344|NCT01519817|26613349|P1|Overall Study|Withdrawal by Subject|1
7649345|NCT01519791|26613389|P2|Overall Study|Lost to Follow-up|14
7649346|NCT01519791|26613390|P1|Overall Study|Lost to Follow-up|6
7649347|NCT01519791|26613389|P2|Overall Study|Withdrawal by Subject|37
7649348|NCT01519791|26613390|P1|Overall Study|Withdrawal by Subject|15
7649349|NCT01519791|26613389|P2|Overall Study|AE, non-serious non-fatal|31
7649350|NCT01519791|26613390|P1|Overall Study|AE, non-serious non-fatal|12
7649351|NCT01519791|26613389|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
7649352|NCT01519791|26613390|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
7649353|NCT01519791|26613389|P2|Overall Study|AE, serious fatal|1
7649354|NCT01519791|26613390|P1|Overall Study|AE, serious fatal|0
7649355|NCT01519791|26613389|P2|Overall Study|SAE, non-fatal|22
7649356|NCT01519791|26613390|P1|Overall Study|SAE, non-fatal|6
7649357|NCT01519791|26613389|P2|Overall Study|Lack of Efficacy|20
7649358|NCT01519791|26613390|P1|Overall Study|Lack of Efficacy|16
7649359|NCT01519791|26613389|P2|Overall Study|subjects randomized in error|0
7649360|NCT01519791|26613390|P1|Overall Study|subjects randomized in error|2
7649361|NCT01519791|26613389|P2|Overall Study|Other Reason|222
7649362|NCT01519791|26613390|P1|Overall Study|Other Reason|87
7649363|NCT01519791|26613389|P2|Overall Study|Protocol Violation|19
7649364|NCT01519791|26613390|P1|Overall Study|Protocol Violation|6
7649365|NCT01519791|26613389|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
7649366|NCT01519791|26613390|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
7649367|NCT01519778|26613454|P1|Overall Study|Physician Decision|1
7649368|NCT01519778|26613454|P1|Overall Study|Lost to Follow-up|10
7649369|NCT01519778|26613454|P1|Overall Study|Withdrawal by Subject|3
7649370|NCT01519765|26613460|P2|Overall Study|Withdrawal by Subject|1
7649371|NCT01519765|26613461|P1|Overall Study|Withdrawal by Subject|0
7649372|NCT01519765|26613460|P2|Overall Study|Protocol Violation|0
7649373|NCT01519765|26613461|P1|Overall Study|Protocol Violation|1
7649374|NCT01519765|26613460|P2|Overall Study|Lack of Efficacy|0
7649375|NCT01519765|26613461|P1|Overall Study|Lack of Efficacy|2
7649376|NCT01519765|26613460|P2|Overall Study|Adverse Event|1
7649377|NCT01519765|26613461|P1|Overall Study|Adverse Event|0
7649378|NCT01519700|26613539|P4|Overall Study|Other Reason|4
7649379|NCT01519700|26613540|P3|Overall Study|Other Reason|0
7649380|NCT01519700|26613541|P2|Overall Study|Other Reason|2
7649381|NCT01519700|26613542|P1|Overall Study|Other Reason|2
7649382|NCT01519700|26613539|P4|Overall Study|Withdrawal by Subject|2
7649383|NCT01519700|26613540|P3|Overall Study|Withdrawal by Subject|3
7649384|NCT01519700|26613541|P2|Overall Study|Withdrawal by Subject|3
7649385|NCT01519700|26613542|P1|Overall Study|Withdrawal by Subject|5
7649386|NCT01519700|26613539|P4|Overall Study|Physician Decision|0
7649387|NCT01519700|26613540|P3|Overall Study|Physician Decision|3
7649388|NCT01519700|26613541|P2|Overall Study|Physician Decision|1
7649389|NCT01519700|26613542|P1|Overall Study|Physician Decision|1
7649390|NCT01519700|26613539|P4|Overall Study|Lost to Follow-up|1
7649391|NCT01519700|26613540|P3|Overall Study|Lost to Follow-up|1
7649392|NCT01519700|26613541|P2|Overall Study|Lost to Follow-up|0
7649393|NCT01519700|26613542|P1|Overall Study|Lost to Follow-up|0
7649394|NCT01519700|26613539|P4|Overall Study|Death|0
7649395|NCT01519700|26613540|P3|Overall Study|Death|0
7649396|NCT01519700|26613541|P2|Overall Study|Death|0
7649397|NCT01519700|26613542|P1|Overall Study|Death|1
7649398|NCT01519674|26613577|P3|Overall Study|Unsclassified|3
7649399|NCT01519674|26613578|P2|Overall Study|Unsclassified|4
7649400|NCT01519674|26613579|P1|Overall Study|Unsclassified|10
7649401|NCT01519674|26613577|P3|Overall Study|Withdrawal Criteria|7
7649402|NCT01519674|26613578|P2|Overall Study|Withdrawal Criteria|2
7649403|NCT01519674|26613579|P1|Overall Study|Withdrawal Criteria|7
7649404|NCT01519674|26613577|P3|Overall Study|Protocol Violation|1
7649405|NCT01519674|26613578|P2|Overall Study|Protocol Violation|3
7649406|NCT01519674|26613579|P1|Overall Study|Protocol Violation|0
7649407|NCT01519674|26613577|P3|Overall Study|Lack of Efficacy|1
7649408|NCT01519674|26613578|P2|Overall Study|Lack of Efficacy|1
7649409|NCT01519674|26613579|P1|Overall Study|Lack of Efficacy|1
7649410|NCT01519674|26613577|P3|Overall Study|Adverse Event|0
7649411|NCT01519674|26613578|P2|Overall Study|Adverse Event|3
7649412|NCT01519674|26613579|P1|Overall Study|Adverse Event|3
7649413|NCT01519661|26613617|P1|Overall Study|Adverse Event|29
7649414|NCT01519661|26613617|P1|Overall Study|Lack of Efficacy|6
7649415|NCT01519661|26613617|P1|Overall Study|Withdrawal by Subject|17
7649416|NCT01519661|26613617|P1|Overall Study|Lost to Follow-up|3
7649417|NCT01519661|26613617|P1|Overall Study|Protocol deviation|6
7649418|NCT01519635|26613643|P2|Overall Study|No possibility to put a catheter|2
7649419|NCT01519635|26613644|P1|Overall Study|No possibility to put a catheter|1
7649420|NCT01519635|26613643|P2|Overall Study|Withdrawal by Subject|1
7649421|NCT01519635|26613644|P1|Overall Study|Withdrawal by Subject|0
7649422|NCT01519518|26613661|P2|Overall Study|Consent not available|10
7649423|NCT01519518|26613662|P1|Overall Study|Consent not available|7
7649424|NCT01519427|26613700|P1|Overall Study|disease progression|2
7649425|NCT01519323|26613732|P2|Overall Study|Study terminated by sponsor|1
7649426|NCT01519323|26613733|P1|Overall Study|Study terminated by sponsor|0
7649427|NCT01519323|26613732|P2|Overall Study|Death|2
7649428|NCT01519323|26613733|P1|Overall Study|Death|3
7649429|NCT01519245|26613793|P2|Overall Study|Met exclusion criteria, not analysed|2
7649430|NCT01519245|26613794|P1|Overall Study|Met exclusion criteria, not analysed|1
7649431|NCT01519206|26613806|P1|Overall Study|Missed Visit|2
7649432|NCT01519206|26613806|P1|Overall Study|Lost to Follow-up|3
7649433|NCT01519167|26613820|P2|Overall Study|Physician Decision|1
7649434|NCT01519167|26613821|P1|Overall Study|Physician Decision|0
7649435|NCT01519167|26613820|P2|Overall Study|Medical condition changes&deep sedation|2
7649436|NCT01519167|26613821|P1|Overall Study|Medical condition changes&deep sedation|0
7649437|NCT01519167|26613820|P2|Overall Study|Lack of Efficacy|1
7649438|NCT01519167|26613821|P1|Overall Study|Lack of Efficacy|0
7649439|NCT01519167|26613820|P2|Overall Study|Adverse Event|1
7649440|NCT01519167|26613821|P1|Overall Study|Adverse Event|0
7649441|NCT01519167|26613820|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
7649442|NCT01519167|26613821|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
7649443|NCT01519089|26613847|P2|Overall Study|Not received study drug|1
7649444|NCT01519089|26613848|P1|Overall Study|Not received study drug|0
7649445|NCT01519089|26613847|P2|Overall Study|Other|6
7649446|NCT01519089|26613848|P1|Overall Study|Other|2
7649447|NCT01519089|26613847|P2|Overall Study|Withdrawal by Subject|2
7649448|NCT01519089|26613848|P1|Overall Study|Withdrawal by Subject|0
7649449|NCT01519089|26613847|P2|Overall Study|Lost to Follow-up|0
7649450|NCT01519089|26613848|P1|Overall Study|Lost to Follow-up|1
7649451|NCT01519089|26613847|P2|Overall Study|Lack of Efficacy|2
7649452|NCT01519089|26613848|P1|Overall Study|Lack of Efficacy|0
7649453|NCT01519089|26613847|P2|Overall Study|Adverse Event|4
7649454|NCT01519089|26613848|P1|Overall Study|Adverse Event|4
7649455|NCT01518972|26613990|P2|Overall Study|Declined medication starting on day 12|1
7649456|NCT01518972|26613991|P1|Overall Study|Declined medication starting on day 12|0
7649457|NCT01518972|26613990|P2|Overall Study|Exclusionary medication|1
7649458|NCT01518972|26613991|P1|Overall Study|Exclusionary medication|0
7649459|NCT01518972|26613990|P2|Overall Study|Missed safety visits|1
7649460|NCT01518972|26613991|P1|Overall Study|Missed safety visits|0
7649461|NCT01518972|26613990|P2|Overall Study|Exclusionary medical condition|0
7649462|NCT01518972|26613991|P1|Overall Study|Exclusionary medical condition|1
7649463|NCT01518972|26613990|P2|Overall Study|Transportation problems|0
7649464|NCT01518972|26613991|P1|Overall Study|Transportation problems|1
7649465|NCT01518972|26613990|P2|Overall Study|Moved from area|0
7649466|NCT01518972|26613991|P1|Overall Study|Moved from area|1
7649467|NCT01518972|26613990|P2|Overall Study|Withdrawal by Subject|0
7649468|NCT01518972|26613991|P1|Overall Study|Withdrawal by Subject|1
7649469|NCT01518972|26613990|P2|Overall Study|Lost to Follow-up|1
7649470|NCT01518972|26613991|P1|Overall Study|Lost to Follow-up|2
7649471|NCT01518946|26614005|P3|Randomized Phase (First Intervention)|Other|0
7649472|NCT01518946|26614006|P2|Randomized Phase (First Intervention)|Other|1
7649473|NCT01518946|26614007|P1|Randomized Phase (First Intervention)|Other|0
7649474|NCT01518946|26614005|P3|Open-label Phase|Other|0
7649475|NCT01518946|26614006|P2|Open-label Phase|Other|0
7649476|NCT01518946|26614007|P1|Open-label Phase|Other|4
7649477|NCT01518699|26614029|P6|Period 2|Adverse Event|0
7649478|NCT01518699|26614030|P5|Period 2|Adverse Event|0
7649479|NCT01518699|26614031|P4|Period 2|Adverse Event|0
7649480|NCT01518699|26614032|P3|Period 2|Adverse Event|0
7649481|NCT01518699|26614033|P2|Period 2|Adverse Event|0
7649482|NCT01518699|26614034|P1|Period 2|Adverse Event|1
7649483|NCT01518699|26614029|P6|Period 2|Lost to Follow-up|0
7649484|NCT01518699|26614030|P5|Period 2|Lost to Follow-up|0
7649485|NCT01518699|26614031|P4|Period 2|Lost to Follow-up|0
7649486|NCT01518699|26614032|P3|Period 2|Lost to Follow-up|0
7649487|NCT01518699|26614033|P2|Period 2|Lost to Follow-up|1
7649488|NCT01518699|26614034|P1|Period 2|Lost to Follow-up|0
7649489|NCT01518699|26614029|P6|Period 2|Protocol Violation|0
7649490|NCT01518699|26614030|P5|Period 2|Protocol Violation|0
7649491|NCT01518699|26614031|P4|Period 2|Protocol Violation|0
7649492|NCT01518699|26614032|P3|Period 2|Protocol Violation|0
7649493|NCT01518699|26614033|P2|Period 2|Protocol Violation|1
7649494|NCT01518699|26614034|P1|Period 2|Protocol Violation|1
7649495|NCT01518374|26614046|P1|Overall Study|Lost to Follow-up|2
7649496|NCT01518374|26614046|P1|Overall Study|Protocol Violation|3
7649497|NCT01518374|26614046|P1|Overall Study|Withdrawal by Subject|2
7649498|NCT01518322|26614050|P1|Overall Study|FeNO measurement was missing|13
7649499|NCT01518309|26614063|P1|Overall Study|Not in Predefined Categories|9
7649500|NCT01518309|26614063|P1|Overall Study|Sponsor Decision|2
7649501|NCT01518309|26614063|P1|Overall Study|Physician Decision|3
7649502|NCT01518309|26614063|P1|Overall Study|Withdrawal by Subject|6
7649503|NCT01518309|26614063|P1|Overall Study|Lack of Efficacy|7
7649504|NCT01518309|26614063|P1|Overall Study|Death|6
7649505|NCT01518309|26614063|P1|Overall Study|Adverse Event|6
7649506|NCT01518257|26614075|P2|Overall Study|Other Miscellaneous Reason|0
7649507|NCT01518257|26614076|P1|Overall Study|Other Miscellaneous Reason|1
7649508|NCT01518257|26614075|P2|Overall Study|Lost to Follow-up|0
7649509|NCT01518257|26614076|P1|Overall Study|Lost to Follow-up|1
7649510|NCT01518244|26614098|P1|Overall Study|Adverse Event|3
7649511|NCT01518192|26614106|P3|Overall Study|Lost to Follow-up|35
7649512|NCT01518192|26614107|P2|Overall Study|Lost to Follow-up|26
7649513|NCT01518192|26614108|P1|Overall Study|Lost to Follow-up|29
7649514|NCT01518153|26614129|P3|Donor Lymphocyte Infusion|Death|1
7649515|NCT01518153|26614130|P2|Donor Lymphocyte Infusion|Death|2
7649516|NCT01518153|26614131|P1|Donor Lymphocyte Infusion|Death|0
7649517|NCT01518153|26614129|P3|Stem Cell Transplant|Adverse Event|0
7649518|NCT01518153|26614130|P2|Stem Cell Transplant|Adverse Event|0
7649519|NCT01518153|26614131|P1|Stem Cell Transplant|Adverse Event|1
7649520|NCT01518153|26614129|P3|Stem Cell Transplant|Secondary graft failure|0
7649521|NCT01518153|26614130|P2|Stem Cell Transplant|Secondary graft failure|0
7649522|NCT01518153|26614131|P1|Stem Cell Transplant|Secondary graft failure|1
7649523|NCT01518153|26614129|P3|Stem Cell Transplant|Death|0
7649524|NCT01518153|26614130|P2|Stem Cell Transplant|Death|0
7649525|NCT01518153|26614131|P1|Stem Cell Transplant|Death|2
7649526|NCT01518153|26614129|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7649527|NCT01518153|26614130|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7649528|NCT01518153|26614131|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
7649529|NCT01517984|26614142|P4|Overall Study|Ineligible for randomization|0
7649530|NCT01517984|26614143|P3|Overall Study|Ineligible for randomization|0
7649531|NCT01517984|26614144|P2|Overall Study|Ineligible for randomization|14
7649532|NCT01517984|26614145|P1|Overall Study|Ineligible for randomization|0
7649533|NCT01517984|26614142|P4|Overall Study|Screen Failure|0
7649534|NCT01517984|26614143|P3|Overall Study|Screen Failure|0
7649535|NCT01517984|26614144|P2|Overall Study|Screen Failure|0
7649536|NCT01517984|26614145|P1|Overall Study|Screen Failure|4
7649537|NCT01517984|26614142|P4|Overall Study|Withdrawal by Subject|1
7649538|NCT01517984|26614143|P3|Overall Study|Withdrawal by Subject|4
7649539|NCT01517984|26614144|P2|Overall Study|Withdrawal by Subject|8
7649540|NCT01517984|26614145|P1|Overall Study|Withdrawal by Subject|1
7649541|NCT01517984|26614142|P4|Overall Study|Lost to Follow-up|0
7649542|NCT01517984|26614143|P3|Overall Study|Lost to Follow-up|0
7649543|NCT01517984|26614144|P2|Overall Study|Lost to Follow-up|1
7649544|NCT01517984|26614145|P1|Overall Study|Lost to Follow-up|0
7649545|NCT01517893|26614171|P2|Overall Study|Withdrawal by Subject|0
7649546|NCT01517893|26614172|P1|Overall Study|Withdrawal by Subject|3
7649547|NCT01517867|26614194|P2|Overall Study|Still in treatment at study end|3
7649548|NCT01517867|26614195|P1|Overall Study|Still in treatment at study end|0
7649549|NCT01517867|26614194|P2|Overall Study|Withdrawal by Subject|30
7649550|NCT01517867|26614195|P1|Overall Study|Withdrawal by Subject|34
7649551|NCT01517867|26614194|P2|Overall Study|never started treatment|32
7649552|NCT01517867|26614195|P1|Overall Study|never started treatment|29
7649553|NCT01517750|26614223|P4|Overall Study|Lost to Follow-up|1
7649554|NCT01517750|26614224|P3|Overall Study|Lost to Follow-up|4
7649555|NCT01517750|26614225|P2|Overall Study|Lost to Follow-up|2
7649556|NCT01517750|26614226|P1|Overall Study|Lost to Follow-up|1
7649557|NCT01517412|26614270|P2|Overall Study|Other than specified above|5
7649558|NCT01517412|26614271|P1|Overall Study|Other than specified above|8
7649559|NCT01517412|26614270|P2|Overall Study|Poor compliance to protocol|3
7649560|NCT01517412|26614271|P1|Overall Study|Poor compliance to protocol|8
7649561|NCT01517412|26614270|P2|Overall Study|Lack of Efficacy|5
7649562|NCT01517412|26614271|P1|Overall Study|Lack of Efficacy|10
7649563|NCT01517412|26614270|P2|Overall Study|Adverse Event|11
7649564|NCT01517412|26614271|P1|Overall Study|Adverse Event|10
7649565|NCT01517373|26614300|P6|Treatment Period|Medication error without AEs|2
7649566|NCT01517373|26614301|P5|Treatment Period|Medication error without AEs|0
7649567|NCT01517373|26614302|P4|Treatment Period|Medication error without AEs|1
7649568|NCT01517373|26614303|P3|Treatment Period|Medication error without AEs|2
7649569|NCT01517373|26614304|P2|Treatment Period|Medication error without AEs|0
7649570|NCT01517373|26614305|P1|Treatment Period|Medication error without AEs|0
7649571|NCT01517373|26614300|P6|Treatment Period|Lack of Efficacy|0
7649572|NCT01517373|26614301|P5|Treatment Period|Lack of Efficacy|2
7649573|NCT01517373|26614302|P4|Treatment Period|Lack of Efficacy|3
7649574|NCT01517373|26614303|P3|Treatment Period|Lack of Efficacy|1
7649575|NCT01517373|26614304|P2|Treatment Period|Lack of Efficacy|1
7649576|NCT01517373|26614305|P1|Treatment Period|Lack of Efficacy|0
7649577|NCT01517373|26614300|P6|Treatment Period|Protocol Violation|0
7649578|NCT01517373|26614301|P5|Treatment Period|Protocol Violation|1
7649579|NCT01517373|26614302|P4|Treatment Period|Protocol Violation|0
7649580|NCT01517373|26614303|P3|Treatment Period|Protocol Violation|0
7649581|NCT01517373|26614304|P2|Treatment Period|Protocol Violation|0
7649582|NCT01517373|26614305|P1|Treatment Period|Protocol Violation|0
7649583|NCT01517373|26614300|P6|Treatment Period|Other|0
7649584|NCT01517373|26614301|P5|Treatment Period|Other|1
7649585|NCT01517373|26614302|P4|Treatment Period|Other|0
7649586|NCT01517373|26614303|P3|Treatment Period|Other|0
7649587|NCT01517373|26614304|P2|Treatment Period|Other|0
7649588|NCT01517373|26614305|P1|Treatment Period|Other|0
7649589|NCT01517373|26614300|P6|Treatment Period|Withdrawal by Subject|3
7649590|NCT01517373|26614301|P5|Treatment Period|Withdrawal by Subject|2
7649591|NCT01517373|26614302|P4|Treatment Period|Withdrawal by Subject|2
7649592|NCT01517373|26614303|P3|Treatment Period|Withdrawal by Subject|2
7649593|NCT01517373|26614304|P2|Treatment Period|Withdrawal by Subject|3
7649594|NCT01517373|26614305|P1|Treatment Period|Withdrawal by Subject|0
7649595|NCT01517373|26614300|P6|Treatment Period|Lost to Follow-up|0
7649596|NCT01517373|26614301|P5|Treatment Period|Lost to Follow-up|0
7649597|NCT01517373|26614302|P4|Treatment Period|Lost to Follow-up|1
7649598|NCT01517373|26614303|P3|Treatment Period|Lost to Follow-up|1
7649599|NCT01517373|26614304|P2|Treatment Period|Lost to Follow-up|0
7649600|NCT01517373|26614305|P1|Treatment Period|Lost to Follow-up|0
7649601|NCT01517373|26614300|P6|Treatment Period|Adverse Event|2
7649602|NCT01517373|26614301|P5|Treatment Period|Adverse Event|0
7649603|NCT01517373|26614302|P4|Treatment Period|Adverse Event|0
7649604|NCT01517373|26614303|P3|Treatment Period|Adverse Event|0
7649605|NCT01517373|26614304|P2|Treatment Period|Adverse Event|0
7649606|NCT01517373|26614305|P1|Treatment Period|Adverse Event|0
7649607|NCT01517373|26614300|P6|Run-in Period|Other|0
7649608|NCT01517373|26614301|P5|Run-in Period|Other|0
7649609|NCT01517373|26614302|P4|Run-in Period|Other|0
7649610|NCT01517373|26614303|P3|Run-in Period|Other|0
7649611|NCT01517373|26614304|P2|Run-in Period|Other|0
7649612|NCT01517373|26614305|P1|Run-in Period|Other|1
7649613|NCT01517373|26614300|P6|Run-in Period|Sponsor Decision|0
7649614|NCT01517373|26614301|P5|Run-in Period|Sponsor Decision|0
7649615|NCT01517373|26614302|P4|Run-in Period|Sponsor Decision|0
7649616|NCT01517373|26614303|P3|Run-in Period|Sponsor Decision|0
7649617|NCT01517373|26614304|P2|Run-in Period|Sponsor Decision|0
7649618|NCT01517373|26614305|P1|Run-in Period|Sponsor Decision|3
7649619|NCT01517373|26614300|P6|Run-in Period|Withdrawal by Subject|0
7649620|NCT01517373|26614301|P5|Run-in Period|Withdrawal by Subject|0
7649621|NCT01517373|26614302|P4|Run-in Period|Withdrawal by Subject|0
7649622|NCT01517373|26614303|P3|Run-in Period|Withdrawal by Subject|0
7649623|NCT01517373|26614304|P2|Run-in Period|Withdrawal by Subject|0
7649624|NCT01517373|26614305|P1|Run-in Period|Withdrawal by Subject|12
7649625|NCT01517373|26614300|P6|Run-in Period|Lost to Follow-up|0
7649626|NCT01517373|26614301|P5|Run-in Period|Lost to Follow-up|0
7649627|NCT01517373|26614302|P4|Run-in Period|Lost to Follow-up|0
7649628|NCT01517373|26614303|P3|Run-in Period|Lost to Follow-up|0
7649629|NCT01517373|26614304|P2|Run-in Period|Lost to Follow-up|0
7649630|NCT01517373|26614305|P1|Run-in Period|Lost to Follow-up|1
7649631|NCT01517373|26614300|P6|Run-in Period|Did not meet eligibility criteria|0
7649632|NCT01517373|26614301|P5|Run-in Period|Did not meet eligibility criteria|0
7649633|NCT01517373|26614302|P4|Run-in Period|Did not meet eligibility criteria|0
7649634|NCT01517373|26614303|P3|Run-in Period|Did not meet eligibility criteria|0
7649635|NCT01517373|26614304|P2|Run-in Period|Did not meet eligibility criteria|0
7649636|NCT01517373|26614305|P1|Run-in Period|Did not meet eligibility criteria|34
7649637|NCT01517373|26614300|P6|Run-in Period|Adverse Event|0
7649638|NCT01517373|26614301|P5|Run-in Period|Adverse Event|0
7649639|NCT01517373|26614302|P4|Run-in Period|Adverse Event|0
7649640|NCT01517373|26614303|P3|Run-in Period|Adverse Event|0
7649641|NCT01517373|26614304|P2|Run-in Period|Adverse Event|0
7649642|NCT01517373|26614305|P1|Run-in Period|Adverse Event|5
7649643|NCT01517373|26614300|P6|Run-in Period|Death|0
7649644|NCT01517373|26614301|P5|Run-in Period|Death|0
7649645|NCT01517373|26614302|P4|Run-in Period|Death|0
7649646|NCT01517373|26614303|P3|Run-in Period|Death|0
7649647|NCT01517373|26614304|P2|Run-in Period|Death|0
7649648|NCT01517373|26614305|P1|Run-in Period|Death|1
7649649|NCT01517295|26614375|P2|Overall Study|Physician Decision|0
7649650|NCT01517295|26614376|P1|Overall Study|Physician Decision|1
7649651|NCT01517282|26614390|P4|Overall Study|Physician Decision|0
7649652|NCT01517282|26614391|P3|Overall Study|Physician Decision|0
7649653|NCT01517282|26614392|P2|Overall Study|Physician Decision|0
7649654|NCT01517282|26614393|P1|Overall Study|Physician Decision|1
7649655|NCT01517282|26614390|P4|Overall Study|Consent withdrawn|1
7649656|NCT01517282|26614391|P3|Overall Study|Consent withdrawn|1
7649657|NCT01517282|26614392|P2|Overall Study|Consent withdrawn|1
7649658|NCT01517282|26614393|P1|Overall Study|Consent withdrawn|0
7649659|NCT01517178|26614427|P2|Period 2|E.g. study termination|2
7649660|NCT01517178|26614428|P1|Period 2|E.g. study termination|2
7649661|NCT01517178|26614427|P2|Period 2|Withdrawal by Subject|0
7649662|NCT01517178|26614428|P1|Period 2|Withdrawal by Subject|3
7649663|NCT01517178|26614427|P2|Period 2|Adverse Event|0
7649664|NCT01517178|26614428|P1|Period 2|Adverse Event|1
7649665|NCT01517178|26614427|P2|Period 1|Withdrawal by Subject|1
7649666|NCT01517178|26614428|P1|Period 1|Withdrawal by Subject|0
7649667|NCT01517178|26614427|P2|Period 1|E.g. study termination|1
7649668|NCT01517178|26614428|P1|Period 1|E.g. study termination|3
7649669|NCT01517178|26614427|P2|Period 1|Lack of Efficacy|1
7649670|NCT01517178|26614428|P1|Period 1|Lack of Efficacy|0
7649671|NCT01517178|26614427|P2|Period 1|Adverse Event|2
7649672|NCT01517178|26614428|P1|Period 1|Adverse Event|1
7649673|NCT01516970|26614456|P2|Overall Study|Other|7
7649674|NCT01516970|26614457|P1|Overall Study|Other|9
7649675|NCT01516970|26614456|P2|Overall Study|Withdrawal by Subject|1
7649676|NCT01516970|26614457|P1|Overall Study|Withdrawal by Subject|1
7649677|NCT01516970|26614456|P2|Overall Study|Adverse Event|5
7649678|NCT01516970|26614457|P1|Overall Study|Adverse Event|1
7649679|NCT01516970|26614456|P2|Overall Study|Lost to Follow-up|8
7649680|NCT01516970|26614457|P1|Overall Study|Lost to Follow-up|7
7649681|NCT01516892|26614496|P1|Overall Study|Missing|1
7649682|NCT01516892|26614496|P1|Overall Study|Other Miscellaneous Reasons|43
7649683|NCT01516892|26614496|P1|Overall Study|Protocol Violation|60
7649684|NCT01516892|26614496|P1|Overall Study|Subject Withdrew Consent|92
7649685|NCT01516892|26614496|P1|Overall Study|Lost to Follow-up|82
7649686|NCT01516892|26614496|P1|Overall Study|Pregnancy|5
7649687|NCT01516892|26614496|P1|Overall Study|Lack of Efficacy|35
7649688|NCT01516892|26614496|P1|Overall Study|Adverse Event|25
7649689|NCT01516879|26614504|P2|Overall Study|Other|10
7649690|NCT01516879|26614505|P1|Overall Study|Other|5
7649691|NCT01516879|26614504|P2|Overall Study|Lost to Follow-up|11
7649692|NCT01516879|26614505|P1|Overall Study|Lost to Follow-up|2
7649693|NCT01516879|26614504|P2|Overall Study|Death|2
7649694|NCT01516879|26614505|P1|Overall Study|Death|0
7649695|NCT01516879|26614504|P2|Overall Study|Withdrawal by Subject|11
7649696|NCT01516879|26614505|P1|Overall Study|Withdrawal by Subject|9
7649697|NCT01516749|26614539|P1|Follow-up Off Therapy|Lost to Follow-up|1
7649698|NCT01516749|26614539|P1|Active Therapy|Lost to Follow-up|1
7649699|NCT01516736|26614548|P2|Overall Study|Other (not specified)|1
7649700|NCT01516736|26614549|P1|Overall Study|Other (not specified)|0
7649701|NCT01516736|26614548|P2|Overall Study|Protocol Violation|1
7649702|NCT01516736|26614549|P1|Overall Study|Protocol Violation|0
7649703|NCT01516736|26614548|P2|Overall Study|Lack of Efficacy|0
7649704|NCT01516736|26614549|P1|Overall Study|Lack of Efficacy|1
7649705|NCT01516736|26614548|P2|Overall Study|Physician Decision|1
7649706|NCT01516736|26614549|P1|Overall Study|Physician Decision|2
7649707|NCT01516736|26614548|P2|Overall Study|Death|1
7649708|NCT01516736|26614549|P1|Overall Study|Death|3
7649709|NCT01516736|26614548|P2|Overall Study|Adverse Event|5
7649710|NCT01516736|26614549|P1|Overall Study|Adverse Event|4
7649711|NCT01516736|26614548|P2|Overall Study|Withdrawal by Subject|4
7649712|NCT01516736|26614549|P1|Overall Study|Withdrawal by Subject|10
7649713|NCT01516437|26614603|P4|Overall Study|Reason not specified|1
7649714|NCT01516437|26614604|P3|Overall Study|Reason not specified|1
7649715|NCT01516437|26614605|P2|Overall Study|Reason not specified|0
7649716|NCT01516437|26614606|P1|Overall Study|Reason not specified|0
7649717|NCT01516034|26614678|P1|Overall Study|Lack of Efficacy|7
7649718|NCT01516034|26614678|P1|Overall Study|Physician Decision|1
7649719|NCT01516008|26614685|P3|Overall Study|Reason not specified|1
7649720|NCT01516008|26614686|P2|Overall Study|Reason not specified|0
7649721|NCT01516008|26614687|P1|Overall Study|Reason not specified|0
7649722|NCT01516008|26614685|P3|Overall Study|Protocol Violation|0
7649723|NCT01516008|26614686|P2|Overall Study|Protocol Violation|0
7649724|NCT01516008|26614687|P1|Overall Study|Protocol Violation|1
7649725|NCT01516008|26614685|P3|Overall Study|Lack of Efficacy|10
7649726|NCT01516008|26614686|P2|Overall Study|Lack of Efficacy|14
7649727|NCT01516008|26614687|P1|Overall Study|Lack of Efficacy|44
7649728|NCT01516008|26614685|P3|Overall Study|Adverse Event|7
7649729|NCT01516008|26614686|P2|Overall Study|Adverse Event|2
7649730|NCT01516008|26614687|P1|Overall Study|Adverse Event|0
7649731|NCT01515865|26614792|P3|Part B (Open-label)|Other|0
7649732|NCT01515865|26614793|P2|Part B (Open-label)|Other|0
7649733|NCT01515865|26614794|P1|Part B (Open-label)|Other|1
7649734|NCT01515865|26614792|P3|Part B (Open-label)|Withdrawal by Subject|0
7649735|NCT01515865|26614793|P2|Part B (Open-label)|Withdrawal by Subject|0
7649736|NCT01515865|26614794|P1|Part B (Open-label)|Withdrawal by Subject|1
7649737|NCT01515865|26614792|P3|Part A (Open-label)|Other|0
7649738|NCT01515865|26614793|P2|Part A (Open-label)|Other|0
7649739|NCT01515865|26614794|P1|Part A (Open-label)|Other|3
7649746|NCT01515475|26614888|P4|Overall Study|Lost to Follow-up|12
7649747|NCT01515475|26614889|P3|Overall Study|Lost to Follow-up|12
7649748|NCT01515475|26614890|P2|Overall Study|Lost to Follow-up|15
7649749|NCT01515475|26614891|P1|Overall Study|Lost to Follow-up|20
7649750|NCT01515423|26614965|P3|DOUBLE BLIND|Blind broken by investigator|0
7649751|NCT01515423|26614966|P2|DOUBLE BLIND|Blind broken by investigator|1
7649752|NCT01515423|26614967|P1|DOUBLE BLIND|Blind broken by investigator|0
7649753|NCT01515423|26614965|P3|DOUBLE BLIND|Other|12
7649754|NCT01515423|26614966|P2|DOUBLE BLIND|Other|6
7649755|NCT01515423|26614967|P1|DOUBLE BLIND|Other|0
7649756|NCT01515423|26614965|P3|DOUBLE BLIND|Withdrawal by Subject|53
7649757|NCT01515423|26614966|P2|DOUBLE BLIND|Withdrawal by Subject|50
7649758|NCT01515423|26614967|P1|DOUBLE BLIND|Withdrawal by Subject|0
7649759|NCT01515423|26614965|P3|DOUBLE BLIND|Pregnancy|0
7649760|NCT01515423|26614966|P2|DOUBLE BLIND|Pregnancy|2
7649761|NCT01515423|26614967|P1|DOUBLE BLIND|Pregnancy|0
7649762|NCT01515423|26614965|P3|DOUBLE BLIND|Lost to Follow-up|12
7649763|NCT01515423|26614966|P2|DOUBLE BLIND|Lost to Follow-up|7
7649764|NCT01515423|26614967|P1|DOUBLE BLIND|Lost to Follow-up|0
7649765|NCT01515423|26614965|P3|DOUBLE BLIND|Death|2
7649766|NCT01515423|26614966|P2|DOUBLE BLIND|Death|1
7649767|NCT01515423|26614967|P1|DOUBLE BLIND|Death|0
7649768|NCT01515423|26614965|P3|DOUBLE BLIND|Adverse Event|13
7649769|NCT01515423|26614966|P2|DOUBLE BLIND|Adverse Event|15
7649770|NCT01515423|26614967|P1|DOUBLE BLIND|Adverse Event|0
7649771|NCT01515423|26614965|P3|Open Label Phase|Other|0
7649772|NCT01515423|26614966|P2|Open Label Phase|Other|0
7649773|NCT01515423|26614967|P1|Open Label Phase|Other|28
7649774|NCT01515423|26614965|P3|Open Label Phase|excluded from DB Phase|0
7649775|NCT01515423|26614966|P2|Open Label Phase|excluded from DB Phase|0
7649776|NCT01515423|26614967|P1|Open Label Phase|excluded from DB Phase|70
7649777|NCT01515423|26614965|P3|Open Label Phase|Withdrawal by Subject|0
7649778|NCT01515423|26614966|P2|Open Label Phase|Withdrawal by Subject|0
7649779|NCT01515423|26614967|P1|Open Label Phase|Withdrawal by Subject|118
7649780|NCT01515423|26614965|P3|Open Label Phase|Lost to Follow-up|0
7649781|NCT01515423|26614966|P2|Open Label Phase|Lost to Follow-up|0
7649782|NCT01515423|26614967|P1|Open Label Phase|Lost to Follow-up|21
7649783|NCT01515423|26614965|P3|Open Label Phase|Lack of Efficacy|0
7649784|NCT01515423|26614966|P2|Open Label Phase|Lack of Efficacy|0
7649785|NCT01515423|26614967|P1|Open Label Phase|Lack of Efficacy|117
7649786|NCT01515423|26614965|P3|Open Label Phase|Death|0
7649787|NCT01515423|26614966|P2|Open Label Phase|Death|0
7649788|NCT01515423|26614967|P1|Open Label Phase|Death|2
7649789|NCT01515423|26614965|P3|Open Label Phase|Adverse Event|0
7649790|NCT01515423|26614966|P2|Open Label Phase|Adverse Event|0
7649791|NCT01515423|26614967|P1|Open Label Phase|Adverse Event|57
7649792|NCT01515319|26615016|P10|Overall Study|Protocol Violation|0
7649793|NCT01515319|26615017|P9|Overall Study|Protocol Violation|2
7649794|NCT01515319|26615018|P8|Overall Study|Protocol Violation|0
7649795|NCT01515319|26615019|P7|Overall Study|Protocol Violation|0
7649796|NCT01515319|26615020|P6|Overall Study|Protocol Violation|0
7649797|NCT01515319|26615021|P5|Overall Study|Protocol Violation|0
7649798|NCT01515319|26615022|P4|Overall Study|Protocol Violation|0
7649799|NCT01515319|26615023|P3|Overall Study|Protocol Violation|0
7649800|NCT01515319|26615024|P2|Overall Study|Protocol Violation|0
7649801|NCT01515319|26615025|P1|Overall Study|Protocol Violation|0
7649802|NCT01515319|26615016|P10|Overall Study|Adverse Event|0
7649803|NCT01515319|26615017|P9|Overall Study|Adverse Event|3
7649804|NCT01515319|26615018|P8|Overall Study|Adverse Event|0
7649805|NCT01515319|26615019|P7|Overall Study|Adverse Event|0
7649806|NCT01515319|26615020|P6|Overall Study|Adverse Event|0
7649807|NCT01515319|26615021|P5|Overall Study|Adverse Event|0
7649808|NCT01515319|26615022|P4|Overall Study|Adverse Event|0
7649809|NCT01515319|26615023|P3|Overall Study|Adverse Event|0
7649810|NCT01515319|26615024|P2|Overall Study|Adverse Event|0
7649811|NCT01515319|26615025|P1|Overall Study|Adverse Event|0
7649812|NCT01515319|26615016|P10|Overall Study|Withdrawal by Subject|0
7649813|NCT01515319|26615017|P9|Overall Study|Withdrawal by Subject|0
7649814|NCT01515319|26615018|P8|Overall Study|Withdrawal by Subject|0
7649815|NCT01515319|26615019|P7|Overall Study|Withdrawal by Subject|1
7649816|NCT01515319|26615020|P6|Overall Study|Withdrawal by Subject|0
7649817|NCT01515319|26615021|P5|Overall Study|Withdrawal by Subject|0
7649818|NCT01515319|26615022|P4|Overall Study|Withdrawal by Subject|0
7649819|NCT01515319|26615023|P3|Overall Study|Withdrawal by Subject|0
7649820|NCT01515319|26615024|P2|Overall Study|Withdrawal by Subject|0
7649821|NCT01515319|26615025|P1|Overall Study|Withdrawal by Subject|0
7649822|NCT01515306|26615059|P2|Overall Study|Ongoing receiving treatment|14
7649823|NCT01515306|26615060|P1|Overall Study|Ongoing receiving treatment|9
7649824|NCT01515306|26615059|P2|Overall Study|Progressive Disease|0
7649825|NCT01515306|26615060|P1|Overall Study|Progressive Disease|1
7649826|NCT01515306|26615059|P2|Overall Study|Adverse Event|0
7649827|NCT01515306|26615060|P1|Overall Study|Adverse Event|2
7649828|NCT01515189|26615073|P2|First Re-Induction Phase|Other|0
7649829|NCT01515189|26615074|P1|First Re-Induction Phase|Other|1
7649830|NCT01515189|26615073|P2|First Re-Induction Phase|No longer meets study criteria|0
7649831|NCT01515189|26615074|P1|First Re-Induction Phase|No longer meets study criteria|1
7649832|NCT01515189|26615073|P2|First Re-Induction Phase|Withdrawal by Subject|1
7649833|NCT01515189|26615074|P1|First Re-Induction Phase|Withdrawal by Subject|1
7649834|NCT01515189|26615073|P2|First Re-Induction Phase|Study drug toxicity|0
7649835|NCT01515189|26615074|P1|First Re-Induction Phase|Study drug toxicity|5
7649836|NCT01515189|26615073|P2|First Re-Induction Phase|Disease progression|14
7649837|NCT01515189|26615074|P1|First Re-Induction Phase|Disease progression|6
7649838|NCT01515189|26615073|P2|Induction|Other|4
7649839|NCT01515189|26615074|P1|Induction|Other|0
7649840|NCT01515189|26615073|P2|Induction|Lost to Follow-up|0
7649841|NCT01515189|26615074|P1|Induction|Lost to Follow-up|1
7649842|NCT01515189|26615073|P2|Induction|No longer meets study criteria|2
7649843|NCT01515189|26615074|P1|Induction|No longer meets study criteria|0
7649844|NCT01515189|26615073|P2|Induction|Withdrawal by Subject|9
7649845|NCT01515189|26615074|P1|Induction|Withdrawal by Subject|3
7649846|NCT01515189|26615073|P2|Induction|Adverse Event|9
7649847|NCT01515189|26615074|P1|Induction|Adverse Event|14
7649848|NCT01515189|26615073|P2|Induction|Death|17
7649849|NCT01515189|26615074|P1|Induction|Death|24
7649850|NCT01515189|26615073|P2|Induction|Study drug toxicity|36
7649851|NCT01515189|26615074|P1|Induction|Study drug toxicity|86
7649852|NCT01515189|26615073|P2|Induction|Disease Progression|155
7649853|NCT01515189|26615074|P1|Induction|Disease Progression|109
7649854|NCT01514864|26615162|P2|Overall Study|Study drug toxicity|0
7649855|NCT01514864|26615163|P1|Overall Study|Study drug toxicity|2
7649856|NCT01514864|26615162|P2|Overall Study|Disease progression|5
7649857|NCT01514864|26615163|P1|Overall Study|Disease progression|7
7649858|NCT01514760|26615188|P1|Overall Study|Lost to Follow-up|2
7649859|NCT01514682|26615201|P2|Overall Study|Physician Decision|3
7649860|NCT01514682|26615202|P1|Overall Study|Physician Decision|4
7649861|NCT01514682|26615201|P2|Overall Study|Withdrawal by Subject|3
7649862|NCT01514682|26615202|P1|Overall Study|Withdrawal by Subject|2
7649863|NCT01514461|26615236|P3|Overall Study|Death|0
7649864|NCT01514461|26615237|P2|Overall Study|Death|0
7649865|NCT01514461|26615238|P1|Overall Study|Death|1
7649866|NCT01514461|26615236|P3|Overall Study|Patient/guardian decision|1
7649867|NCT01514461|26615237|P2|Overall Study|Patient/guardian decision|1
7649868|NCT01514461|26615238|P1|Overall Study|Patient/guardian decision|1
7649869|NCT01514461|26615236|P3|Overall Study|Physician Decision|0
7649870|NCT01514461|26615237|P2|Overall Study|Physician Decision|1
7649871|NCT01514461|26615238|P1|Overall Study|Physician Decision|1
7649872|NCT01514461|26615236|P3|Overall Study|Adverse Event|3
7649873|NCT01514461|26615237|P2|Overall Study|Adverse Event|1
7649874|NCT01514461|26615238|P1|Overall Study|Adverse Event|2
7649875|NCT01514448|26615277|P2|Overall Study|New Cancer Therapy|0
7649876|NCT01514448|26615278|P1|Overall Study|New Cancer Therapy|1
7649877|NCT01514448|26615277|P2|Overall Study|Lost to Follow-up|0
7649878|NCT01514448|26615278|P1|Overall Study|Lost to Follow-up|2
7649879|NCT01514448|26615277|P2|Overall Study|Withdrawal by Subject|0
7649880|NCT01514448|26615278|P1|Overall Study|Withdrawal by Subject|2
7649881|NCT01514448|26615277|P2|Overall Study|Death|8
7649882|NCT01514448|26615278|P1|Overall Study|Death|7
7649883|NCT01514422|26615293|P1|Overall Study|Lost to Follow-up|1
7649884|NCT01514370|26615311|P2|Overall Study|Other|7
7649885|NCT01514370|26615312|P1|Overall Study|Other|6
7649886|NCT01514370|26615311|P2|Overall Study|Adverse Event|3
7649887|NCT01514370|26615312|P1|Overall Study|Adverse Event|1
7649888|NCT01514370|26615311|P2|Overall Study|Withdrawal by Subject|1
7649889|NCT01514370|26615312|P1|Overall Study|Withdrawal by Subject|2
7649890|NCT01514370|26615311|P2|Overall Study|Lost to Follow-up|2
7649891|NCT01514370|26615312|P1|Overall Study|Lost to Follow-up|0
7649892|NCT01514370|26615311|P2|Overall Study|Protocol Violation|3
7649893|NCT01514370|26615312|P1|Overall Study|Protocol Violation|2
7649894|NCT01514357|26615358|P2|Overall Study|Withdrawal by Subject|0
7649895|NCT01514357|26615359|P1|Overall Study|Withdrawal by Subject|2
7649896|NCT01514357|26615358|P2|Overall Study|Screen failure|0
7649897|NCT01514357|26615359|P1|Overall Study|Screen failure|2
7649898|NCT01514240|26615444|P2|Overall Study|Subject Decision|7
7649899|NCT01514240|26615445|P1|Overall Study|Subject Decision|2
7649900|NCT01514240|26615444|P2|Overall Study|Adverse Event|4
7649901|NCT01514240|26615445|P1|Overall Study|Adverse Event|4
7649902|NCT01514201|26615523|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
7649903|NCT01514201|26615524|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7649904|NCT01514201|26615525|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7649905|NCT01514201|26615526|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7649906|NCT01514201|26615523|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
7649907|NCT01514201|26615524|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7649908|NCT01514201|26615525|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7649909|NCT01514201|26615526|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7649910|NCT01514201|26615523|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
7649911|NCT01514201|26615524|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7649912|NCT01514201|26615525|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7649913|NCT01514201|26615526|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7649914|NCT01514201|26615523|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
7649915|NCT01514201|26615524|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7649916|NCT01514201|26615525|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7649917|NCT01514201|26615526|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7649918|NCT01514201|26615523|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
7649919|NCT01514201|26615524|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7649920|NCT01514201|26615525|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7649921|NCT01514201|26615526|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7649922|NCT01514201|26615523|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
7649923|NCT01514201|26615524|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
7649924|NCT01514201|26615525|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
7649925|NCT01514201|26615526|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
7649926|NCT01514201|26615523|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
7649927|NCT01514201|26615524|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7649928|NCT01514201|26615525|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7649929|NCT01514201|26615526|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7649930|NCT01514201|26615523|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
7649931|NCT01514201|26615524|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7649932|NCT01514201|26615525|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7649933|NCT01514201|26615526|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7649934|NCT01514201|26615523|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7649935|NCT01514201|26615524|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7649936|NCT01514201|26615525|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7649937|NCT01514201|26615526|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7649938|NCT01514201|26615523|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7649939|NCT01514201|26615524|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
7649940|NCT01514201|26615525|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7649941|NCT01514201|26615526|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7649942|NCT01514201|26615523|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7649943|NCT01514201|26615524|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7649944|NCT01514201|26615525|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7649945|NCT01514201|26615526|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7649946|NCT01514201|26615523|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7649947|NCT01514201|26615524|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7649948|NCT01514201|26615525|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7649949|NCT01514201|26615526|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
7649950|NCT01514136|26615624|P8|Test Period 2; Test C*|Protocol Violation|0
7649951|NCT01514136|26615625|P7|Test Period 2; Test C*|Protocol Violation|1
7649952|NCT01514136|26615626|P6|Test Period 2; Test C*|Protocol Violation|0
7649953|NCT01514136|26615627|P5|Test Period 2; Test C*|Protocol Violation|0
7649954|NCT01514136|26615628|P4|Test Period 2; Test C*|Protocol Violation|0
7649955|NCT01514136|26615629|P3|Test Period 2; Test C*|Protocol Violation|0
7649956|NCT01514136|26615630|P2|Test Period 2; Test C*|Protocol Violation|0
7649957|NCT01514136|26615631|P1|Test Period 2; Test C*|Protocol Violation|0
7649958|NCT01514136|26615624|P8|Test Period 2; Test C*|holiday|0
7649959|NCT01514136|26615625|P7|Test Period 2; Test C*|holiday|1
7649960|NCT01514136|26615626|P6|Test Period 2; Test C*|holiday|0
7649961|NCT01514136|26615627|P5|Test Period 2; Test C*|holiday|0
7649962|NCT01514136|26615628|P4|Test Period 2; Test C*|holiday|0
7649963|NCT01514136|26615629|P3|Test Period 2; Test C*|holiday|0
7649964|NCT01514136|26615630|P2|Test Period 2; Test C*|holiday|0
7649965|NCT01514136|26615631|P1|Test Period 2; Test C*|holiday|0
7649966|NCT01514136|26615624|P8|Test Period 2; Test C*|Withdrawal by Subject|0
7649967|NCT01514136|26615625|P7|Test Period 2; Test C*|Withdrawal by Subject|1
7649968|NCT01514136|26615626|P6|Test Period 2; Test C*|Withdrawal by Subject|0
7649969|NCT01514136|26615627|P5|Test Period 2; Test C*|Withdrawal by Subject|0
7649970|NCT01514136|26615628|P4|Test Period 2; Test C*|Withdrawal by Subject|0
7649971|NCT01514136|26615629|P3|Test Period 2; Test C*|Withdrawal by Subject|0
7649972|NCT01514136|26615630|P2|Test Period 2; Test C*|Withdrawal by Subject|0
7649973|NCT01514136|26615631|P1|Test Period 2; Test C*|Withdrawal by Subject|0
7649974|NCT01514136|26615624|P8|Test Period 2; Test B*|Withdrawal by Subject|0
7649975|NCT01514136|26615625|P7|Test Period 2; Test B*|Withdrawal by Subject|0
7649976|NCT01514136|26615626|P6|Test Period 2; Test B*|Withdrawal by Subject|2
7649977|NCT01514136|26615627|P5|Test Period 2; Test B*|Withdrawal by Subject|0
7649978|NCT01514136|26615628|P4|Test Period 2; Test B*|Withdrawal by Subject|0
7649979|NCT01514136|26615629|P3|Test Period 2; Test B*|Withdrawal by Subject|0
7649980|NCT01514136|26615630|P2|Test Period 2; Test B*|Withdrawal by Subject|0
7649981|NCT01514136|26615631|P1|Test Period 2; Test B*|Withdrawal by Subject|0
7649982|NCT01514136|26615624|P8|Test Period 2; Test A*|Holiday|0
7649983|NCT01514136|26615625|P7|Test Period 2; Test A*|Holiday|0
7649984|NCT01514136|26615626|P6|Test Period 2; Test A*|Holiday|0
7649985|NCT01514136|26615627|P5|Test Period 2; Test A*|Holiday|1
7649986|NCT01514136|26615628|P4|Test Period 2; Test A*|Holiday|0
7649987|NCT01514136|26615629|P3|Test Period 2; Test A*|Holiday|0
7649988|NCT01514136|26615630|P2|Test Period 2; Test A*|Holiday|0
7649989|NCT01514136|26615631|P1|Test Period 2; Test A*|Holiday|0
7649990|NCT01514136|26615624|P8|Test Period 2; Test A*|Adverse Event|0
7649991|NCT01514136|26615625|P7|Test Period 2; Test A*|Adverse Event|0
7649992|NCT01514136|26615626|P6|Test Period 2; Test A*|Adverse Event|0
7649993|NCT01514136|26615627|P5|Test Period 2; Test A*|Adverse Event|1
7649994|NCT01514136|26615628|P4|Test Period 2; Test A*|Adverse Event|0
7649995|NCT01514136|26615629|P3|Test Period 2; Test A*|Adverse Event|0
7649996|NCT01514136|26615630|P2|Test Period 2; Test A*|Adverse Event|0
7649997|NCT01514136|26615631|P1|Test Period 2; Test A*|Adverse Event|0
7649998|NCT01514136|26615624|P8|Test Period 1; Test D|Subject took a break due to holiday|0
7649999|NCT01514136|26615625|P7|Test Period 1; Test D|Subject took a break due to holiday|0
7650000|NCT01514136|26615626|P6|Test Period 1; Test D|Subject took a break due to holiday|0
7650001|NCT01514136|26615627|P5|Test Period 1; Test D|Subject took a break due to holiday|0
7650002|NCT01514136|26615628|P4|Test Period 1; Test D|Subject took a break due to holiday|2
7650003|NCT01514136|26615629|P3|Test Period 1; Test D|Subject took a break due to holiday|0
7650004|NCT01514136|26615630|P2|Test Period 1; Test D|Subject took a break due to holiday|0
7650005|NCT01514136|26615631|P1|Test Period 1; Test D|Subject took a break due to holiday|0
7650006|NCT01514136|26615624|P8|Test Period 1; Test B|Withdrawal by Subject|0
7650007|NCT01514136|26615625|P7|Test Period 1; Test B|Withdrawal by Subject|0
7650008|NCT01514136|26615626|P6|Test Period 1; Test B|Withdrawal by Subject|0
7650009|NCT01514136|26615627|P5|Test Period 1; Test B|Withdrawal by Subject|0
7650010|NCT01514136|26615628|P4|Test Period 1; Test B|Withdrawal by Subject|0
7650011|NCT01514136|26615629|P3|Test Period 1; Test B|Withdrawal by Subject|0
7650012|NCT01514136|26615630|P2|Test Period 1; Test B|Withdrawal by Subject|1
7650013|NCT01514136|26615631|P1|Test Period 1; Test B|Withdrawal by Subject|0
7650014|NCT01514136|26615624|P8|Test Period 1; Test A|Break from study holiday|0
7650015|NCT01514136|26615625|P7|Test Period 1; Test A|Break from study holiday|0
7650016|NCT01514136|26615626|P6|Test Period 1; Test A|Break from study holiday|0
7650017|NCT01514136|26615627|P5|Test Period 1; Test A|Break from study holiday|0
7650018|NCT01514136|26615628|P4|Test Period 1; Test A|Break from study holiday|0
7650019|NCT01514136|26615629|P3|Test Period 1; Test A|Break from study holiday|0
7650020|NCT01514136|26615630|P2|Test Period 1; Test A|Break from study holiday|0
7650021|NCT01514136|26615631|P1|Test Period 1; Test A|Break from study holiday|2
7650022|NCT01514136|26615624|P8|Test Period 1; Test A|Protocol Violation|0
7650023|NCT01514136|26615625|P7|Test Period 1; Test A|Protocol Violation|0
7650024|NCT01514136|26615626|P6|Test Period 1; Test A|Protocol Violation|0
7650025|NCT01514136|26615627|P5|Test Period 1; Test A|Protocol Violation|0
7650026|NCT01514136|26615628|P4|Test Period 1; Test A|Protocol Violation|0
7650027|NCT01514136|26615629|P3|Test Period 1; Test A|Protocol Violation|0
7650028|NCT01514136|26615630|P2|Test Period 1; Test A|Protocol Violation|0
7650029|NCT01514136|26615631|P1|Test Period 1; Test A|Protocol Violation|1
7650030|NCT01513967|26615665|P8|Overall Study|Physician Decision|0
7650031|NCT01513967|26615666|P7|Overall Study|Physician Decision|0
7650032|NCT01513967|26615667|P6|Overall Study|Physician Decision|1
7650033|NCT01513967|26615668|P5|Overall Study|Physician Decision|0
7650034|NCT01513967|26615669|P4|Overall Study|Physician Decision|0
7650035|NCT01513967|26615670|P3|Overall Study|Physician Decision|0
7650036|NCT01513967|26615671|P2|Overall Study|Physician Decision|0
7650037|NCT01513967|26615672|P1|Overall Study|Physician Decision|0
7650038|NCT01513967|26615665|P8|Overall Study|excluded due to positive drug screen|2
7650039|NCT01513967|26615666|P7|Overall Study|excluded due to positive drug screen|0
7650040|NCT01513967|26615667|P6|Overall Study|excluded due to positive drug screen|0
7650041|NCT01513967|26615668|P5|Overall Study|excluded due to positive drug screen|0
7650042|NCT01513967|26615669|P4|Overall Study|excluded due to positive drug screen|0
7650043|NCT01513967|26615670|P3|Overall Study|excluded due to positive drug screen|0
7650044|NCT01513967|26615671|P2|Overall Study|excluded due to positive drug screen|0
7650045|NCT01513967|26615672|P1|Overall Study|excluded due to positive drug screen|0
7650046|NCT01513967|26615665|P8|Overall Study|missed a study visit|0
7650047|NCT01513967|26615666|P7|Overall Study|missed a study visit|1
7650048|NCT01513967|26615667|P6|Overall Study|missed a study visit|0
7650049|NCT01513967|26615668|P5|Overall Study|missed a study visit|0
7650050|NCT01513967|26615669|P4|Overall Study|missed a study visit|0
7650051|NCT01513967|26615670|P3|Overall Study|missed a study visit|0
7650052|NCT01513967|26615671|P2|Overall Study|missed a study visit|0
7650053|NCT01513967|26615672|P1|Overall Study|missed a study visit|0
7650054|NCT01513967|26615665|P8|Overall Study|Pregnancy|0
7650055|NCT01513967|26615666|P7|Overall Study|Pregnancy|1
7650056|NCT01513967|26615667|P6|Overall Study|Pregnancy|0
7650057|NCT01513967|26615668|P5|Overall Study|Pregnancy|0
7650058|NCT01513967|26615669|P4|Overall Study|Pregnancy|0
7650059|NCT01513967|26615670|P3|Overall Study|Pregnancy|0
7650060|NCT01513967|26615671|P2|Overall Study|Pregnancy|0
7650061|NCT01513967|26615672|P1|Overall Study|Pregnancy|0
7650062|NCT01513759|26615730|P1|Overall Study|Death during catheter placement|1
7650063|NCT01513759|26615730|P1|Overall Study|Protocol Violation|4
7650064|NCT01513590|26615741|P2|Overall Study|Unclassified|10
7650065|NCT01513590|26615742|P1|Overall Study|Unclassified|5
7650066|NCT01513590|26615741|P2|Overall Study|Withdrawal Criteria|0
7650067|NCT01513590|26615742|P1|Overall Study|Withdrawal Criteria|3
7650068|NCT01513590|26615741|P2|Overall Study|Adverse Event|3
7650069|NCT01513590|26615742|P1|Overall Study|Adverse Event|2
7650070|NCT01513551|26615763|P3|Overall Study|Randomized but not vaccinated|1
7650071|NCT01513551|26615764|P2|Overall Study|Randomized but not vaccinated|0
7650072|NCT01513551|26615765|P1|Overall Study|Randomized but not vaccinated|0
7650073|NCT01513551|26615763|P3|Overall Study|Withdrawal by Subject|2
7650074|NCT01513551|26615764|P2|Overall Study|Withdrawal by Subject|0
7650075|NCT01513551|26615765|P1|Overall Study|Withdrawal by Subject|1
7650076|NCT01513551|26615763|P3|Overall Study|Lost to Follow-up|2
7650077|NCT01513551|26615764|P2|Overall Study|Lost to Follow-up|5
7650078|NCT01513551|26615765|P1|Overall Study|Lost to Follow-up|3
7650079|NCT01513551|26615763|P3|Overall Study|Death|0
7650080|NCT01513551|26615764|P2|Overall Study|Death|1
7650081|NCT01513551|26615765|P1|Overall Study|Death|0
7650082|NCT01513473|26615797|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
7650083|NCT01513473|26615798|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
7650084|NCT01513473|26615797|P2|Extension Trial (26 Weeks)|Adverse Event|1
7650085|NCT01513473|26615798|P1|Extension Trial (26 Weeks)|Adverse Event|0
7650086|NCT01513473|26615797|P2|Main Trial (26 Weeks)|Unclassified|2
7650087|NCT01513473|26615798|P1|Main Trial (26 Weeks)|Unclassified|0
7650088|NCT01513473|26615797|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
7650089|NCT01513473|26615798|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
7650090|NCT01513473|26615797|P2|Main Trial (26 Weeks)|Adverse Event|2
7650091|NCT01513473|26615798|P1|Main Trial (26 Weeks)|Adverse Event|0
7650092|NCT01513460|26615825|P3|Overall Study|Abnormal test procedure|0
7650093|NCT01513460|26615826|P2|Overall Study|Abnormal test procedure|0
7650094|NCT01513460|26615827|P1|Overall Study|Abnormal test procedure|1
7650095|NCT01513460|26615825|P3|Overall Study|Adverse Event|23
7650096|NCT01513460|26615826|P2|Overall Study|Adverse Event|18
7650097|NCT01513460|26615827|P1|Overall Study|Adverse Event|16
7650098|NCT01513460|26615825|P3|Overall Study|Withdrawal by Subject|21
7650099|NCT01513460|26615826|P2|Overall Study|Withdrawal by Subject|8
7650100|NCT01513460|26615827|P1|Overall Study|Withdrawal by Subject|7
7650101|NCT01513460|26615825|P3|Overall Study|Protocol deviations|3
7650102|NCT01513460|26615826|P2|Overall Study|Protocol deviations|4
7650103|NCT01513460|26615827|P1|Overall Study|Protocol deviations|3
7650104|NCT01513460|26615825|P3|Overall Study|Lack of Efficacy|5
7650105|NCT01513460|26615826|P2|Overall Study|Lack of Efficacy|2
7650106|NCT01513460|26615827|P1|Overall Study|Lack of Efficacy|1
7650107|NCT01513460|26615825|P3|Overall Study|Abnormal laboratory value|1
7650108|NCT01513460|26615826|P2|Overall Study|Abnormal laboratory value|0
7650109|NCT01513460|26615827|P1|Overall Study|Abnormal laboratory value|1
7650110|NCT01513460|26615825|P3|Overall Study|Lost to Follow-up|2
7650111|NCT01513460|26615826|P2|Overall Study|Lost to Follow-up|0
7650112|NCT01513460|26615827|P1|Overall Study|Lost to Follow-up|0
7650113|NCT01513460|26615825|P3|Overall Study|Death|1
7650114|NCT01513460|26615826|P2|Overall Study|Death|0
7650115|NCT01513460|26615827|P1|Overall Study|Death|0
7650116|NCT01513330|26615862|P2|Standard Care First,|Other|0
7650117|NCT01513330|26615863|P1|Standard Care First,|Other|1
7650118|NCT01513330|26615862|P2|Standard Care First,|Withdrawal by Subject|2
7650119|NCT01513330|26615863|P1|Standard Care First,|Withdrawal by Subject|1
7650120|NCT01513330|26615862|P2|Standard Care First,|Lack of Efficacy|2
7650121|NCT01513330|26615863|P1|Standard Care First,|Lack of Efficacy|2
7650122|NCT01513330|26615862|P2|SenSura Mio First,|Other|0
7650123|NCT01513330|26615863|P1|SenSura Mio First,|Other|1
7650124|NCT01513330|26615862|P2|SenSura Mio First,|Withdrawal by Subject|1
7650125|NCT01513330|26615863|P1|SenSura Mio First,|Withdrawal by Subject|1
7650126|NCT01513330|26615862|P2|SenSura Mio First,|Lack of Efficacy|1
7650127|NCT01513330|26615863|P1|SenSura Mio First,|Lack of Efficacy|0
7650128|NCT01513330|26615862|P2|SenSura Mio First,|Adverse Event|0
7650129|NCT01513330|26615863|P1|SenSura Mio First,|Adverse Event|2
7650130|NCT01513317|26615871|P2|Overall Study|Other|1
7650131|NCT01513317|26615872|P1|Overall Study|Other|0
7650132|NCT01513317|26615871|P2|Overall Study|Study terminated by sponsor|18
7650133|NCT01513317|26615872|P1|Overall Study|Study terminated by sponsor|18
7650134|NCT01513317|26615871|P2|Overall Study|Death|1
7650135|NCT01513317|26615872|P1|Overall Study|Death|1
7650136|NCT01513317|26615871|P2|Overall Study|Withdrawal by Subject|4
7650137|NCT01513317|26615872|P1|Overall Study|Withdrawal by Subject|15
7650138|NCT01513291|26615890|P5|Run-out Period|Withdrawal by Subject|0
7650139|NCT01513291|26615891|P4|Run-out Period|Withdrawal by Subject|1
7650140|NCT01513291|26615892|P3|Run-out Period|Withdrawal by Subject|0
7650141|NCT01513291|26615893|P2|Run-out Period|Withdrawal by Subject|0
7650142|NCT01513291|26615894|P1|Run-out Period|Withdrawal by Subject|0
7650143|NCT01513291|26615890|P5|Run-out Period|Lost to Follow-up|0
7650144|NCT01513291|26615891|P4|Run-out Period|Lost to Follow-up|1
7650145|NCT01513291|26615892|P3|Run-out Period|Lost to Follow-up|0
7650146|NCT01513291|26615893|P2|Run-out Period|Lost to Follow-up|0
7650147|NCT01513291|26615894|P1|Run-out Period|Lost to Follow-up|0
7650148|NCT01513291|26615890|P5|Treatment Period|Randomized not treated|0
7650149|NCT01513291|26615891|P4|Treatment Period|Randomized not treated|0
7650150|NCT01513291|26615892|P3|Treatment Period|Randomized not treated|0
7650151|NCT01513291|26615893|P2|Treatment Period|Randomized not treated|2
7650152|NCT01513291|26615894|P1|Treatment Period|Randomized not treated|0
7650153|NCT01513291|26615890|P5|Treatment Period|Withdrawal by Subject|0
7650154|NCT01513291|26615891|P4|Treatment Period|Withdrawal by Subject|0
7650155|NCT01513291|26615892|P3|Treatment Period|Withdrawal by Subject|0
7650156|NCT01513291|26615893|P2|Treatment Period|Withdrawal by Subject|5
7650157|NCT01513291|26615894|P1|Treatment Period|Withdrawal by Subject|8
7650158|NCT01513291|26615890|P5|Treatment Period|Protocol Violation|0
7650159|NCT01513291|26615891|P4|Treatment Period|Protocol Violation|0
7650160|NCT01513291|26615892|P3|Treatment Period|Protocol Violation|0
7650161|NCT01513291|26615893|P2|Treatment Period|Protocol Violation|2
7650162|NCT01513291|26615894|P1|Treatment Period|Protocol Violation|1
7650163|NCT01513291|26615890|P5|Treatment Period|Physician Decision|0
7650164|NCT01513291|26615891|P4|Treatment Period|Physician Decision|0
7650165|NCT01513291|26615892|P3|Treatment Period|Physician Decision|0
7650166|NCT01513291|26615893|P2|Treatment Period|Physician Decision|0
7650167|NCT01513291|26615894|P1|Treatment Period|Physician Decision|1
7650168|NCT01513291|26615890|P5|Treatment Period|Lost to Follow-up|0
7650169|NCT01513291|26615891|P4|Treatment Period|Lost to Follow-up|0
7650170|NCT01513291|26615892|P3|Treatment Period|Lost to Follow-up|0
7650171|NCT01513291|26615893|P2|Treatment Period|Lost to Follow-up|3
7650172|NCT01513291|26615894|P1|Treatment Period|Lost to Follow-up|2
7650173|NCT01513291|26615890|P5|Treatment Period|Lack of Efficacy|0
7650174|NCT01513291|26615891|P4|Treatment Period|Lack of Efficacy|0
7650175|NCT01513291|26615892|P3|Treatment Period|Lack of Efficacy|0
7650176|NCT01513291|26615893|P2|Treatment Period|Lack of Efficacy|0
7650177|NCT01513291|26615894|P1|Treatment Period|Lack of Efficacy|3
7650178|NCT01513291|26615890|P5|Treatment Period|Adverse Event|0
7650179|NCT01513291|26615891|P4|Treatment Period|Adverse Event|0
7650180|NCT01513291|26615892|P3|Treatment Period|Adverse Event|0
7650181|NCT01513291|26615893|P2|Treatment Period|Adverse Event|4
7650182|NCT01513291|26615894|P1|Treatment Period|Adverse Event|8
7650183|NCT01513239|26615922|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
7650184|NCT01513239|26615923|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
7650185|NCT01513239|26615924|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
7650186|NCT01513239|26615925|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
7650187|NCT01513239|26615926|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
7650188|NCT01513239|26615927|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
7650189|NCT01513239|26615922|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
7650190|NCT01513239|26615923|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
7650191|NCT01513239|26615924|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
7650192|NCT01513239|26615925|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
7650193|NCT01513239|26615926|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
7650194|NCT01513239|26615927|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
7650195|NCT01513239|26615922|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7650196|NCT01513239|26615923|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
7650197|NCT01513239|26615924|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
7650198|NCT01513239|26615925|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7650199|NCT01513239|26615926|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7650200|NCT01513239|26615927|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7650201|NCT01513239|26615922|P6|Period 2: 9 Month Extension Phase|Death|2
7650202|NCT01513239|26615923|P5|Period 2: 9 Month Extension Phase|Death|5
7650203|NCT01513239|26615924|P4|Period 2: 9 Month Extension Phase|Death|2
7650204|NCT01513239|26615925|P3|Period 2: 9 Month Extension Phase|Death|0
7650205|NCT01513239|26615926|P2|Period 2: 9 Month Extension Phase|Death|0
7650206|NCT01513239|26615927|P1|Period 2: 9 Month Extension Phase|Death|0
7650207|NCT01513239|26615922|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
7650208|NCT01513239|26615923|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
7650209|NCT01513239|26615924|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
7650210|NCT01513239|26615925|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7650211|NCT01513239|26615926|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7650212|NCT01513239|26615927|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7650213|NCT01513239|26615922|P6|Period 1: Main Phase|Withdrawal by Subject|0
7650214|NCT01513239|26615923|P5|Period 1: Main Phase|Withdrawal by Subject|0
7650215|NCT01513239|26615924|P4|Period 1: Main Phase|Withdrawal by Subject|0
7650216|NCT01513239|26615925|P3|Period 1: Main Phase|Withdrawal by Subject|42
7650217|NCT01513239|26615926|P2|Period 1: Main Phase|Withdrawal by Subject|29
7650218|NCT01513239|26615927|P1|Period 1: Main Phase|Withdrawal by Subject|27
7650219|NCT01513239|26615922|P6|Period 1: Main Phase|Technical Problems|0
7650220|NCT01513239|26615923|P5|Period 1: Main Phase|Technical Problems|0
7650221|NCT01513239|26615924|P4|Period 1: Main Phase|Technical Problems|0
7650222|NCT01513239|26615925|P3|Period 1: Main Phase|Technical Problems|0
7650223|NCT01513239|26615926|P2|Period 1: Main Phase|Technical Problems|2
7650224|NCT01513239|26615927|P1|Period 1: Main Phase|Technical Problems|1
7650225|NCT01513239|26615922|P6|Period 1: Main Phase|Protocol Violation|0
7650226|NCT01513239|26615923|P5|Period 1: Main Phase|Protocol Violation|0
7650227|NCT01513239|26615924|P4|Period 1: Main Phase|Protocol Violation|0
7650228|NCT01513239|26615925|P3|Period 1: Main Phase|Protocol Violation|2
7650229|NCT01513239|26615926|P2|Period 1: Main Phase|Protocol Violation|2
7650230|NCT01513239|26615927|P1|Period 1: Main Phase|Protocol Violation|2
7650231|NCT01513239|26615922|P6|Period 1: Main Phase|Physician Decision|0
7650232|NCT01513239|26615923|P5|Period 1: Main Phase|Physician Decision|0
7650233|NCT01513239|26615924|P4|Period 1: Main Phase|Physician Decision|0
7650234|NCT01513239|26615925|P3|Period 1: Main Phase|Physician Decision|4
7650235|NCT01513239|26615926|P2|Period 1: Main Phase|Physician Decision|4
7650236|NCT01513239|26615927|P1|Period 1: Main Phase|Physician Decision|4
7650237|NCT01513239|26615922|P6|Period 1: Main Phase|Lost to Follow-up|0
7650238|NCT01513239|26615923|P5|Period 1: Main Phase|Lost to Follow-up|0
7650239|NCT01513239|26615924|P4|Period 1: Main Phase|Lost to Follow-up|0
7650240|NCT01513239|26615925|P3|Period 1: Main Phase|Lost to Follow-up|6
7650241|NCT01513239|26615926|P2|Period 1: Main Phase|Lost to Follow-up|10
7650242|NCT01513239|26615927|P1|Period 1: Main Phase|Lost to Follow-up|11
7650243|NCT01513239|26615922|P6|Period 1: Main Phase|Death|0
7650244|NCT01513239|26615923|P5|Period 1: Main Phase|Death|0
7650245|NCT01513239|26615924|P4|Period 1: Main Phase|Death|0
7650246|NCT01513239|26615925|P3|Period 1: Main Phase|Death|32
7650247|NCT01513239|26615926|P2|Period 1: Main Phase|Death|22
7650248|NCT01513239|26615927|P1|Period 1: Main Phase|Death|29
7650249|NCT01513239|26615922|P6|Period 1: Main Phase|Adverse Event|0
7650250|NCT01513239|26615923|P5|Period 1: Main Phase|Adverse Event|0
7650251|NCT01513239|26615924|P4|Period 1: Main Phase|Adverse Event|0
7650252|NCT01513239|26615925|P3|Period 1: Main Phase|Adverse Event|2
7650253|NCT01513239|26615926|P2|Period 1: Main Phase|Adverse Event|1
7650254|NCT01513239|26615927|P1|Period 1: Main Phase|Adverse Event|1
7650255|NCT01513148|26615980|P2|Overall Study|Protocol Violation|2
7650256|NCT01513148|26615981|P1|Overall Study|Protocol Violation|2
7650257|NCT01512979|26616048|P2|Overall Study|Reason other than stated above|9
7650258|NCT01512979|26616049|P1|Overall Study|Reason other than stated above|13
7650259|NCT01512979|26616048|P2|Overall Study|Withdrawal by Subject|2
7650260|NCT01512979|26616049|P1|Overall Study|Withdrawal by Subject|1
7650261|NCT01512979|26616048|P2|Overall Study|Lost to Follow-up|5
7650262|NCT01512979|26616049|P1|Overall Study|Lost to Follow-up|2
7650263|NCT01512979|26616048|P2|Overall Study|Protocol Violation|4
7650264|NCT01512979|26616049|P1|Overall Study|Protocol Violation|1
7650265|NCT01512979|26616048|P2|Overall Study|Adverse Event|2
7650266|NCT01512979|26616049|P1|Overall Study|Adverse Event|2
7650267|NCT01512745|26616149|P2|Overall Study|Protocol Violation|0
7650268|NCT01512745|26616150|P1|Overall Study|Protocol Violation|1
7650269|NCT01512745|26616149|P2|Overall Study|Lack of Efficacy|2
7650270|NCT01512745|26616150|P1|Overall Study|Lack of Efficacy|2
7650271|NCT01512745|26616149|P2|Overall Study|Lost to Follow-up|0
7650272|NCT01512745|26616150|P1|Overall Study|Lost to Follow-up|4
7650273|NCT01512745|26616149|P2|Overall Study|Withdrawal by Subject|2
7650274|NCT01512745|26616150|P1|Overall Study|Withdrawal by Subject|2
7650275|NCT01512745|26616149|P2|Overall Study|Death|13
7650276|NCT01512745|26616150|P1|Overall Study|Death|9
7650277|NCT01512745|26616149|P2|Overall Study|Adverse Event|3
7650278|NCT01512745|26616150|P1|Overall Study|Adverse Event|22
7650279|NCT01512693|26616166|P2|Overall Study|Withdrawal by Subject|1
7650280|NCT01512693|26616167|P1|Overall Study|Withdrawal by Subject|0
7650281|NCT01512368|26616207|P1|Overall Study|Protocol Violation|3
7650282|NCT01512264|26616220|P4|Overall Study|Lost to Follow-up|1
7650283|NCT01512264|26616221|P3|Overall Study|Lost to Follow-up|0
7650284|NCT01512264|26616222|P2|Overall Study|Lost to Follow-up|0
7650285|NCT01512264|26616223|P1|Overall Study|Lost to Follow-up|0
7650286|NCT01512160|26616362|P4|Overall Study|Withdrawal by Subject|1
7650287|NCT01512160|26616363|P3|Overall Study|Withdrawal by Subject|0
7650288|NCT01512160|26616364|P2|Overall Study|Withdrawal by Subject|0
7650289|NCT01512160|26616365|P1|Overall Study|Withdrawal by Subject|1
7650290|NCT01512160|26616362|P4|Overall Study|Lost to Follow-up|0
7650291|NCT01512160|26616363|P3|Overall Study|Lost to Follow-up|0
7650292|NCT01512160|26616364|P2|Overall Study|Lost to Follow-up|0
7650293|NCT01512160|26616365|P1|Overall Study|Lost to Follow-up|1
7650294|NCT01512108|26616457|P2|Overall Study|Unclassified|3
7650295|NCT01512108|26616458|P1|Overall Study|Unclassified|11
7650296|NCT01512108|26616457|P2|Overall Study|Withdrawal Criteria|0
7650297|NCT01512108|26616458|P1|Overall Study|Withdrawal Criteria|1
7650298|NCT01512108|26616457|P2|Overall Study|Protocol Violation|2
7650299|NCT01512108|26616458|P1|Overall Study|Protocol Violation|1
7650300|NCT01512108|26616457|P2|Overall Study|Adverse Event|4
7650301|NCT01512108|26616458|P1|Overall Study|Adverse Event|9
7650302|NCT01511939|26616484|P3|Overall Study|Withdrawal by Subject|0
7650303|NCT01511939|26616485|P2|Overall Study|Withdrawal by Subject|1
7650304|NCT01511939|26616486|P1|Overall Study|Withdrawal by Subject|2
7650305|NCT01511536|26616532|P3|Phase 2|Other|9
7650306|NCT01511536|26616533|P2|Phase 2|Other|0
7650307|NCT01511536|26616534|P1|Phase 2|Other|0
7650308|NCT01511536|26616532|P3|Phase 1|Other|0
7650309|NCT01511536|26616533|P2|Phase 1|Other|1
7650310|NCT01511536|26616534|P1|Phase 1|Other|0
7650311|NCT01511445|26616556|P2|Overall Study|Protocol Violation|0
7650312|NCT01511445|26616557|P1|Overall Study|Protocol Violation|1
7650313|NCT01511445|26616556|P2|Overall Study|Protocol Violation|3
7650314|NCT01511445|26616557|P1|Overall Study|Protocol Violation|1
7650315|NCT01511445|26616556|P2|Overall Study|Lost to Follow-up|1
7650316|NCT01511445|26616557|P1|Overall Study|Lost to Follow-up|3
7650317|NCT01511419|26616567|P2|Dose 2|Physician Decision|0
7650318|NCT01511419|26616568|P1|Dose 2|Physician Decision|1
7650319|NCT01511250|26616680|P10|Overall Study|Protocol Violation|0
7650320|NCT01511250|26616681|P9|Overall Study|Protocol Violation|0
7650321|NCT01511250|26616682|P8|Overall Study|Protocol Violation|0
7650322|NCT01511250|26616683|P7|Overall Study|Protocol Violation|0
7650323|NCT01511250|26616684|P6|Overall Study|Protocol Violation|0
7650324|NCT01511250|26616685|P5|Overall Study|Protocol Violation|0
7650325|NCT01511250|26616686|P4|Overall Study|Protocol Violation|0
7650326|NCT01511250|26616687|P3|Overall Study|Protocol Violation|1
7650327|NCT01511250|26616688|P2|Overall Study|Protocol Violation|2
7650328|NCT01511250|26616689|P1|Overall Study|Protocol Violation|0
7650329|NCT01511250|26616680|P10|Overall Study|Lost to Follow-up|5
7650330|NCT01511250|26616681|P9|Overall Study|Lost to Follow-up|13
7650331|NCT01511250|26616682|P8|Overall Study|Lost to Follow-up|3
7650332|NCT01511250|26616683|P7|Overall Study|Lost to Follow-up|2
7650333|NCT01511250|26616684|P6|Overall Study|Lost to Follow-up|0
7650334|NCT01511250|26616685|P5|Overall Study|Lost to Follow-up|0
7650335|NCT01511250|26616686|P4|Overall Study|Lost to Follow-up|3
7650336|NCT01511250|26616687|P3|Overall Study|Lost to Follow-up|3
7650337|NCT01511250|26616688|P2|Overall Study|Lost to Follow-up|3
7650338|NCT01511250|26616689|P1|Overall Study|Lost to Follow-up|7
7650339|NCT01511250|26616680|P10|Overall Study|Sponsor/Investigator Decision|0
7650340|NCT01511250|26616681|P9|Overall Study|Sponsor/Investigator Decision|0
7650341|NCT01511250|26616682|P8|Overall Study|Sponsor/Investigator Decision|0
7650342|NCT01511250|26616683|P7|Overall Study|Sponsor/Investigator Decision|0
7650343|NCT01511250|26616684|P6|Overall Study|Sponsor/Investigator Decision|0
7650344|NCT01511250|26616685|P5|Overall Study|Sponsor/Investigator Decision|0
7650345|NCT01511250|26616686|P4|Overall Study|Sponsor/Investigator Decision|0
7650346|NCT01511250|26616687|P3|Overall Study|Sponsor/Investigator Decision|0
7650347|NCT01511250|26616688|P2|Overall Study|Sponsor/Investigator Decision|0
7650348|NCT01511250|26616689|P1|Overall Study|Sponsor/Investigator Decision|1
7650349|NCT01511250|26616680|P10|Overall Study|Withdrawal of Consent|0
7650350|NCT01511250|26616681|P9|Overall Study|Withdrawal of Consent|1
7650351|NCT01511250|26616682|P8|Overall Study|Withdrawal of Consent|1
7650352|NCT01511250|26616683|P7|Overall Study|Withdrawal of Consent|0
7650353|NCT01511250|26616684|P6|Overall Study|Withdrawal of Consent|0
7650354|NCT01511250|26616685|P5|Overall Study|Withdrawal of Consent|0
7650355|NCT01511250|26616686|P4|Overall Study|Withdrawal of Consent|0
7650356|NCT01511250|26616687|P3|Overall Study|Withdrawal of Consent|0
7650357|NCT01511250|26616688|P2|Overall Study|Withdrawal of Consent|0
7650358|NCT01511250|26616689|P1|Overall Study|Withdrawal of Consent|1
7650359|NCT01511107|26616837|P2|Overall Study|Withdrawal by Subject|20
7650360|NCT01511107|26616838|P1|Overall Study|Withdrawal by Subject|9
7650361|NCT01511107|26616837|P2|Overall Study|Lost to Follow-up|19
7650362|NCT01511107|26616838|P1|Overall Study|Lost to Follow-up|10
7650363|NCT01511107|26616837|P2|Overall Study|Ineligible|2
7650364|NCT01511107|26616838|P1|Overall Study|Ineligible|3
7650365|NCT01511055|26616910|P1|Overall Study|Withdrawal by Subject|6
7650366|NCT01510912|26616934|P1|Overall Study|Other, including joint replacement|5
7650367|NCT01510912|26616934|P1|Overall Study|Lost to Follow-up|26
7650368|NCT01510912|26616934|P1|Overall Study|Protocol Violation|27
7650369|NCT01510912|26616934|P1|Overall Study|Physician Decision|1
7650370|NCT01510912|26616934|P1|Overall Study|Withdrawal by Subject|49
7650371|NCT01510912|26616934|P1|Overall Study|Non-compliance with trial drug|23
7650372|NCT01510912|26616934|P1|Overall Study|Lack of Efficacy|12
7650373|NCT01510912|26616934|P1|Overall Study|Adverse Event|99
7650374|NCT01510769|26616950|P3|Overall Study|Death|0
7650375|NCT01510769|26616951|P2|Overall Study|Death|1
7650376|NCT01510769|26616952|P1|Overall Study|Death|1
7650377|NCT01510769|26616950|P3|Overall Study|Withdrawal by Subject|3
7650378|NCT01510769|26616951|P2|Overall Study|Withdrawal by Subject|4
7650379|NCT01510769|26616952|P1|Overall Study|Withdrawal by Subject|3
7650380|NCT01510769|26616950|P3|Overall Study|Lost to Follow-up|5
7650381|NCT01510769|26616951|P2|Overall Study|Lost to Follow-up|1
7650382|NCT01510769|26616952|P1|Overall Study|Lost to Follow-up|5
7650383|NCT01510769|26616950|P3|Overall Study|Protocol Violation|9
7650384|NCT01510769|26616951|P2|Overall Study|Protocol Violation|10
7650385|NCT01510769|26616952|P1|Overall Study|Protocol Violation|11
7650386|NCT01510769|26616950|P3|Overall Study|Gout Flare|1
7650387|NCT01510769|26616951|P2|Overall Study|Gout Flare|3
7650388|NCT01510769|26616952|P1|Overall Study|Gout Flare|0
7650389|NCT01510769|26616950|P3|Overall Study|Adverse Event|4
7650390|NCT01510769|26616951|P2|Overall Study|Adverse Event|6
7650391|NCT01510769|26616952|P1|Overall Study|Adverse Event|7
7650392|NCT01510756|26616969|P1|Overall Study|Physician Decision|1
7650393|NCT01510756|26616969|P1|Overall Study|Lack of Efficacy|2
7650394|NCT01510756|26616969|P1|Overall Study|Death|1
7650395|NCT01510717|26616977|P2|Overall Study|Withdrawal by Subject|2
7650396|NCT01510717|26616978|P1|Overall Study|Withdrawal by Subject|0
7650397|NCT01510717|26616977|P2|Overall Study|Lost to Follow-up|1
7650398|NCT01510717|26616978|P1|Overall Study|Lost to Follow-up|0
7650399|NCT01510717|26616977|P2|Overall Study|Death|0
7650400|NCT01510717|26616978|P1|Overall Study|Death|1
7650401|NCT01510717|26616977|P2|Overall Study|Adverse Event|2
7650402|NCT01510717|26616978|P1|Overall Study|Adverse Event|1
7650403|NCT01510158|26617098|P3|Overall Study|Death|0
7650404|NCT01510158|26617099|P2|Overall Study|Death|0
7650405|NCT01510158|26617100|P1|Overall Study|Death|1
7650406|NCT01510158|26617098|P3|Overall Study|Withdrawal by Subject|10
7650407|NCT01510158|26617099|P2|Overall Study|Withdrawal by Subject|13
7650408|NCT01510158|26617100|P1|Overall Study|Withdrawal by Subject|10
7650409|NCT01510158|26617098|P3|Overall Study|Lost to Follow-up|9
7650410|NCT01510158|26617099|P2|Overall Study|Lost to Follow-up|16
7650411|NCT01510158|26617100|P1|Overall Study|Lost to Follow-up|13
7650412|NCT01510158|26617098|P3|Overall Study|Sponsor terminated study.|2
7650413|NCT01510158|26617099|P2|Overall Study|Sponsor terminated study.|0
7650414|NCT01510158|26617100|P1|Overall Study|Sponsor terminated study.|2
7650415|NCT01510158|26617098|P3|Overall Study|Protocol Violation|24
7650416|NCT01510158|26617099|P2|Overall Study|Protocol Violation|16
7650417|NCT01510158|26617100|P1|Overall Study|Protocol Violation|17
7650418|NCT01510158|26617098|P3|Overall Study|Gout flare|0
7650419|NCT01510158|26617099|P2|Overall Study|Gout flare|0
7650420|NCT01510158|26617100|P1|Overall Study|Gout flare|1
7650421|NCT01510158|26617098|P3|Overall Study|Adverse Event|5
7650422|NCT01510158|26617099|P2|Overall Study|Adverse Event|8
7650423|NCT01510158|26617100|P1|Overall Study|Adverse Event|7
7650424|NCT01510145|26617114|P1|Overall Study|Relative reported subject withdrew|1
7650425|NCT01510145|26617114|P1|Overall Study|Withdrawal by Subject|6
7650426|NCT01510145|26617114|P1|Overall Study|Lost to Follow-up|5
7650427|NCT01510145|26617114|P1|Overall Study|Adverse Event|6
7650428|NCT01510028|26617123|P4|Overall Study|Lack of Efficacy|0
7650429|NCT01510028|26617124|P3|Overall Study|Lack of Efficacy|0
7650430|NCT01510028|26617125|P2|Overall Study|Lack of Efficacy|0
7650431|NCT01510028|26617126|P1|Overall Study|Lack of Efficacy|1
7650432|NCT01509846|26617290|P5|Received Vaccination 3|Lost to Follow-up|0
7650433|NCT01509846|26617291|P4|Received Vaccination 3|Lost to Follow-up|0
7650434|NCT01509846|26617292|P3|Received Vaccination 3|Lost to Follow-up|1
7650435|NCT01509846|26617293|P2|Received Vaccination 3|Lost to Follow-up|0
7650436|NCT01509846|26617294|P1|Received Vaccination 3|Lost to Follow-up|0
7650437|NCT01509846|26617290|P5|Received Vaccination 3|Pregnancy|0
7650438|NCT01509846|26617291|P4|Received Vaccination 3|Pregnancy|1
7650439|NCT01509846|26617292|P3|Received Vaccination 3|Pregnancy|0
7650440|NCT01509846|26617293|P2|Received Vaccination 3|Pregnancy|0
7650441|NCT01509846|26617294|P1|Received Vaccination 3|Pregnancy|0
7650442|NCT01509846|26617290|P5|Received Vaccination 3|Withdrawal by Subject|0
7650443|NCT01509846|26617291|P4|Received Vaccination 3|Withdrawal by Subject|0
7650444|NCT01509846|26617292|P3|Received Vaccination 3|Withdrawal by Subject|0
7650445|NCT01509846|26617293|P2|Received Vaccination 3|Withdrawal by Subject|1
7650446|NCT01509846|26617294|P1|Received Vaccination 3|Withdrawal by Subject|0
7650447|NCT01509846|26617290|P5|Received Vaccination 2|Not vaccinated per protocol|2
7650448|NCT01509846|26617291|P4|Received Vaccination 2|Not vaccinated per protocol|0
7650449|NCT01509846|26617292|P3|Received Vaccination 2|Not vaccinated per protocol|0
7650450|NCT01509846|26617293|P2|Received Vaccination 2|Not vaccinated per protocol|0
7650451|NCT01509846|26617294|P1|Received Vaccination 2|Not vaccinated per protocol|5
7650452|NCT01509846|26617290|P5|Received Vaccination 2|Illness|1
7650453|NCT01509846|26617291|P4|Received Vaccination 2|Illness|0
7650454|NCT01509846|26617292|P3|Received Vaccination 2|Illness|0
7650455|NCT01509846|26617293|P2|Received Vaccination 2|Illness|0
7650456|NCT01509846|26617294|P1|Received Vaccination 2|Illness|0
7650457|NCT01509846|26617290|P5|Received Vaccination 2|Withdrawal by Subject|0
7650458|NCT01509846|26617291|P4|Received Vaccination 2|Withdrawal by Subject|0
7650459|NCT01509846|26617292|P3|Received Vaccination 2|Withdrawal by Subject|1
7650460|NCT01509846|26617293|P2|Received Vaccination 2|Withdrawal by Subject|0
7650461|NCT01509846|26617294|P1|Received Vaccination 2|Withdrawal by Subject|0
7650462|NCT01509664|26617464|P2|Overall Study|Lost to Follow-up|21
7650463|NCT01509664|26617465|P1|Overall Study|Lost to Follow-up|15
7650464|NCT01509547|26617541|P2|Overall Study|Physician Decision|1
7650465|NCT01509547|26617542|P1|Overall Study|Physician Decision|0
7650466|NCT01509547|26617541|P2|Overall Study|Withdrawal by Subject|24
7650467|NCT01509547|26617542|P1|Overall Study|Withdrawal by Subject|11
7650468|NCT01509547|26617541|P2|Overall Study|Lost to Follow-up|14
7650469|NCT01509547|26617542|P1|Overall Study|Lost to Follow-up|24
7650470|NCT01509079|26617609|P2|Overall Study|started an excluded medication|1
7650471|NCT01509079|26617610|P1|Overall Study|started an excluded medication|0
7650472|NCT01509079|26617609|P2|Overall Study|Lack of Efficacy|2
7650473|NCT01509079|26617610|P1|Overall Study|Lack of Efficacy|0
7650474|NCT01509053|26617630|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
7650475|NCT01509053|26617630|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
7650476|NCT01509053|26617630|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
7650477|NCT01509053|26617630|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
7650478|NCT01509053|26617630|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
7650479|NCT01509053|26617630|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
7650480|NCT01508936|26617692|P2|Overall Study|Data from 2 sites deemed invalid|11
7650481|NCT01508936|26617693|P1|Overall Study|Data from 2 sites deemed invalid|4
7650482|NCT01508936|26617692|P2|Overall Study|Other|5
7650483|NCT01508936|26617693|P1|Overall Study|Other|0
7650484|NCT01508936|26617692|P2|Overall Study|Lost to Follow-up|9
7650485|NCT01508936|26617693|P1|Overall Study|Lost to Follow-up|2
7650486|NCT01508936|26617692|P2|Overall Study|Protocol Violation|3
7650487|NCT01508936|26617693|P1|Overall Study|Protocol Violation|2
7650488|NCT01508936|26617692|P2|Overall Study|Withdrawal by Subject|18
7650489|NCT01508936|26617693|P1|Overall Study|Withdrawal by Subject|4
7650490|NCT01508936|26617692|P2|Overall Study|Lack of Efficacy|1
7650491|NCT01508936|26617693|P1|Overall Study|Lack of Efficacy|0
7650492|NCT01508936|26617692|P2|Overall Study|Adverse Event|32
7650493|NCT01508936|26617693|P1|Overall Study|Adverse Event|11
7650494|NCT01508910|26617732|P4|Treatment|Sponsor Decision|1
7650495|NCT01508910|26617733|P3|Treatment|Sponsor Decision|0
7650496|NCT01508910|26617734|P2|Treatment|Sponsor Decision|0
7650497|NCT01508910|26617735|P1|Treatment|Sponsor Decision|0
7650498|NCT01508910|26617732|P4|Treatment|Withdrawal by Subject|1
7650499|NCT01508910|26617733|P3|Treatment|Withdrawal by Subject|6
7650500|NCT01508910|26617734|P2|Treatment|Withdrawal by Subject|1
7650501|NCT01508910|26617735|P1|Treatment|Withdrawal by Subject|0
7650502|NCT01508910|26617732|P4|Treatment|Lost to Follow-up|1
7650503|NCT01508910|26617733|P3|Treatment|Lost to Follow-up|2
7650504|NCT01508910|26617734|P2|Treatment|Lost to Follow-up|0
7650505|NCT01508910|26617735|P1|Treatment|Lost to Follow-up|0
7650506|NCT01508910|26617732|P4|Treatment|Death|0
7650507|NCT01508910|26617733|P3|Treatment|Death|2
7650508|NCT01508910|26617734|P2|Treatment|Death|3
7650509|NCT01508910|26617735|P1|Treatment|Death|2
7650510|NCT01508702|26617768|P2|Overall Study|Withdrawal by Subject|7
7650511|NCT01508702|26617769|P1|Overall Study|Withdrawal by Subject|11
7650512|NCT01508702|26617768|P2|Overall Study|Lost to Follow-up|2
7650513|NCT01508702|26617769|P1|Overall Study|Lost to Follow-up|1
7650514|NCT01508702|26617768|P2|Overall Study|Protocol Violation|1
7650515|NCT01508702|26617769|P1|Overall Study|Protocol Violation|2
7650516|NCT01508702|26617768|P2|Overall Study|Gout flare|0
7650517|NCT01508702|26617769|P1|Overall Study|Gout flare|2
7650518|NCT01508702|26617768|P2|Overall Study|Adverse Event|3
7650519|NCT01508702|26617769|P1|Overall Study|Adverse Event|7
7650520|NCT01508676|26617777|P2|Phase II (2 Weeks)|Medication Exclusion|0
7650521|NCT01508676|26617778|P1|Phase II (2 Weeks)|Medication Exclusion|1
7650522|NCT01508676|26617777|P2|Phase II (2 Weeks)|Skin Sensitivity|1
7650523|NCT01508676|26617778|P1|Phase II (2 Weeks)|Skin Sensitivity|0
7650524|NCT01508676|26617777|P2|Phase I (2 Weeks)|Positive Drug Screen|2
7650525|NCT01508676|26617778|P1|Phase I (2 Weeks)|Positive Drug Screen|0
7650526|NCT01508676|26617777|P2|Phase I (2 Weeks)|Wrong Pain Type|0
7650527|NCT01508676|26617778|P1|Phase I (2 Weeks)|Wrong Pain Type|1
7650528|NCT01508676|26617777|P2|Phase I (2 Weeks)|Medication Exclusion|1
7650529|NCT01508676|26617778|P1|Phase I (2 Weeks)|Medication Exclusion|1
7650530|NCT01508650|26617790|P2|Overall Study|Lost to Follow-up|3
7650531|NCT01508650|26617791|P1|Overall Study|Lost to Follow-up|0
7650532|NCT01508325|26617810|P2|Overall Study|Other|2
7650533|NCT01508325|26617811|P1|Overall Study|Other|2
7650534|NCT01508325|26617810|P2|Overall Study|Lost to Follow-up|6
7650535|NCT01508325|26617811|P1|Overall Study|Lost to Follow-up|5
7650536|NCT01508325|26617810|P2|Overall Study|Adverse Event|0
7650537|NCT01508325|26617811|P1|Overall Study|Adverse Event|1
7650538|NCT01508325|26617810|P2|Overall Study|Physician Decision|1
7650539|NCT01508325|26617811|P1|Overall Study|Physician Decision|2
7650540|NCT01508325|26617810|P2|Overall Study|Protocol Violation|3
7650541|NCT01508325|26617811|P1|Overall Study|Protocol Violation|0
7650542|NCT01508325|26617810|P2|Overall Study|Withdrawal by Subject|9
7650543|NCT01508325|26617811|P1|Overall Study|Withdrawal by Subject|8
7650544|NCT01508169|26617841|P2|Overall Study|Lost to Follow-up|2
7650545|NCT01508169|26617842|P1|Overall Study|Lost to Follow-up|1
7650546|NCT01508169|26617841|P2|Overall Study|Withdrawal by Subject|0
7650547|NCT01508169|26617842|P1|Overall Study|Withdrawal by Subject|1
7650548|NCT01508169|26617841|P2|Overall Study|Adverse Event|0
7650549|NCT01508169|26617842|P1|Overall Study|Adverse Event|1
7650550|NCT01508130|26617856|P2|Overall Study|Administrative|3
7650551|NCT01508130|26617857|P1|Overall Study|Administrative|14
7650552|NCT01508130|26617856|P2|Overall Study|Insufficient therapeutic response|23
7650553|NCT01508130|26617857|P1|Overall Study|Insufficient therapeutic response|74
7650554|NCT01508130|26617856|P2|Overall Study|Subject's substantial non-compliance|9
7650555|NCT01508130|26617857|P1|Overall Study|Subject's substantial non-compliance|25
7650556|NCT01508130|26617856|P2|Overall Study|Withdrawal by Subject|3
7650557|NCT01508130|26617857|P1|Overall Study|Withdrawal by Subject|3
7650558|NCT01508130|26617856|P2|Overall Study|Lost to Follow-up|2
7650559|NCT01508130|26617857|P1|Overall Study|Lost to Follow-up|25
7650560|NCT01508130|26617856|P2|Overall Study|Protocol Violation|0
7650561|NCT01508130|26617857|P1|Overall Study|Protocol Violation|2
7650562|NCT01508130|26617856|P2|Overall Study|Death|1
7650563|NCT01508130|26617857|P1|Overall Study|Death|3
7650564|NCT01508130|26617856|P2|Overall Study|Adverse Event|28
7650565|NCT01508130|26617857|P1|Overall Study|Adverse Event|81
7650566|NCT01507896|26618026|P1|Overall Study|The surgery was denied by the sponsor.|1
7650567|NCT01507896|26618026|P1|Overall Study|Withdrawal by Subject|1
7650568|NCT01507831|26618069|P2|Overall Study|Other|6
7650569|NCT01507831|26618070|P1|Overall Study|Other|3
7650570|NCT01507831|26618069|P2|Overall Study|Potential lost to follow-up|0
7650571|NCT01507831|26618070|P1|Overall Study|Potential lost to follow-up|3
7650572|NCT01507831|26618069|P2|Overall Study|Site closure|3
7650573|NCT01507831|26618070|P1|Overall Study|Site closure|0
7650574|NCT01507831|26618069|P2|Overall Study|Selection criteria finally not met|1
7650575|NCT01507831|26618070|P1|Overall Study|Selection criteria finally not met|0
7650576|NCT01507831|26618069|P2|Overall Study|Last visit outside protocol visit window|143
7650577|NCT01507831|26618070|P1|Overall Study|Last visit outside protocol visit window|51
7650578|NCT01507831|26618069|P2|Overall Study|Related to study drug administration|14
7650579|NCT01507831|26618070|P1|Overall Study|Related to study drug administration|5
7650580|NCT01507831|26618069|P2|Overall Study|Consent withdrawn by participant|72
7650581|NCT01507831|26618070|P1|Overall Study|Consent withdrawn by participant|34
7650582|NCT01507831|26618069|P2|Overall Study|Participant moved|19
7650583|NCT01507831|26618070|P1|Overall Study|Participant moved|5
7650584|NCT01507831|26618069|P2|Overall Study|Physician Decision|4
7650585|NCT01507831|26618070|P1|Overall Study|Physician Decision|0
7650586|NCT01507831|26618069|P2|Overall Study|Poor compliance to protocol|60
7650587|NCT01507831|26618070|P1|Overall Study|Poor compliance to protocol|38
7650588|NCT01507831|26618069|P2|Overall Study|Death|2
7650589|NCT01507831|26618070|P1|Overall Study|Death|6
7650590|NCT01507831|26618069|P2|Overall Study|Adverse Event|113
7650591|NCT01507831|26618070|P1|Overall Study|Adverse Event|48
7650592|NCT01507831|26618069|P2|Overall Study|Randomized but not treated|3
7650593|NCT01507831|26618070|P1|Overall Study|Randomized but not treated|0
7650594|NCT01507662|26618190|P2|Overall Study|Proxy interview done|3
7650595|NCT01507662|26618191|P1|Overall Study|Proxy interview done|2
7650596|NCT01507662|26618190|P2|Overall Study|Lost to Follow-up|523
7650597|NCT01507662|26618191|P1|Overall Study|Lost to Follow-up|498
7650598|NCT01507662|26618190|P2|Overall Study|Withdrawal by Subject|287
7650599|NCT01507662|26618191|P1|Overall Study|Withdrawal by Subject|290
7650600|NCT01507662|26618190|P2|Overall Study|Death|18
7650601|NCT01507662|26618191|P1|Overall Study|Death|26
7650602|NCT01507298|26618226|P2|Overall Study|Protocol Violation|6
7650603|NCT01507298|26618227|P1|Overall Study|Protocol Violation|0
7650604|NCT01507246|26618237|P2|Overall Study|Required different surgical procedures|1
7650605|NCT01507246|26618238|P1|Overall Study|Required different surgical procedures|2
7650606|NCT01507090|26618336|P1|Overall Study|incomplete dataset|18
7650607|NCT01507051|26618375|P4|Overall Study|Adverse Event|0
7650608|NCT01507051|26618376|P3|Overall Study|Adverse Event|0
7650609|NCT01507051|26618377|P2|Overall Study|Adverse Event|0
7650610|NCT01507051|26618378|P1|Overall Study|Adverse Event|1
7650611|NCT01507051|26618375|P4|Overall Study|Physician Decision|1
7650612|NCT01507051|26618376|P3|Overall Study|Physician Decision|0
7650613|NCT01507051|26618377|P2|Overall Study|Physician Decision|0
7650614|NCT01507051|26618378|P1|Overall Study|Physician Decision|0
7650615|NCT01507051|26618375|P4|Overall Study|Withdrawal by Subject|6
7650616|NCT01507051|26618376|P3|Overall Study|Withdrawal by Subject|1
7650617|NCT01507051|26618377|P2|Overall Study|Withdrawal by Subject|3
7650618|NCT01507051|26618378|P1|Overall Study|Withdrawal by Subject|1
7650619|NCT01506960|26618496|P1|Overall Study|Did not meet angiographic criteria|47
7650620|NCT01506947|26618502|P1|Overall Study|Did Not Meet Eligibility Criteria|3
7650621|NCT01506947|26618502|P1|Overall Study|Death|1
7650622|NCT01506947|26618502|P1|Overall Study|Adverse Event|5
7650623|NCT01506947|26618502|P1|Overall Study|Lost to Follow-up|7
7650624|NCT01506908|26618520|P2|Overall Study|Adverse Event|0
7650625|NCT01506908|26618521|P1|Overall Study|Adverse Event|1
7650626|NCT01506882|26618539|P2|Overall Study|Other Reason|0
7650627|NCT01506882|26618540|P1|Overall Study|Other Reason|2
7650628|NCT01506882|26618539|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7650629|NCT01506882|26618540|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7650630|NCT01506882|26618539|P2|Overall Study|AE, non-serious non-fatal|1
7650631|NCT01506882|26618540|P1|Overall Study|AE, non-serious non-fatal|3
7650632|NCT01506882|26618539|P2|Overall Study|SAE, non-fatal|0
7650633|NCT01506882|26618540|P1|Overall Study|SAE, non-fatal|2
7650634|NCT01506882|26618539|P2|Overall Study|Withdrawal by Subject|3
7650635|NCT01506882|26618540|P1|Overall Study|Withdrawal by Subject|9
7650636|NCT01506882|26618539|P2|Overall Study|Lost to Follow-up|0
7650637|NCT01506882|26618540|P1|Overall Study|Lost to Follow-up|1
7650638|NCT01506882|26618539|P2|Overall Study|Lack of Efficacy|3
7650639|NCT01506882|26618540|P1|Overall Study|Lack of Efficacy|4
7650640|NCT01506726|26618554|P2|Overall Study|Adverse Event|2
7650641|NCT01506726|26618555|P1|Overall Study|Adverse Event|1
7650642|NCT01506596|26618595|P1|Overall Study|ineligible pathology|1
7650643|NCT01506479|26618606|P3|Overall Study|Adverse Event|0
7650644|NCT01506479|26618607|P2|Overall Study|Adverse Event|1
7650645|NCT01506479|26618608|P1|Overall Study|Adverse Event|0
7650646|NCT01506479|26618606|P3|Overall Study|Missing assessment|0
7650647|NCT01506479|26618607|P2|Overall Study|Missing assessment|0
7650648|NCT01506479|26618608|P1|Overall Study|Missing assessment|1
7650649|NCT01506479|26618606|P3|Overall Study|Withdrawal by Subject|1
7650650|NCT01506479|26618607|P2|Overall Study|Withdrawal by Subject|2
7650651|NCT01506479|26618608|P1|Overall Study|Withdrawal by Subject|1
7650652|NCT01506479|26618606|P3|Overall Study|Lost to Follow-up|2
7650653|NCT01506479|26618607|P2|Overall Study|Lost to Follow-up|2
7650654|NCT01506479|26618608|P1|Overall Study|Lost to Follow-up|1
7650655|NCT01506453|26618622|P2|Overall Study|Withdrawal prior to treatment|2
7650656|NCT01506453|26618623|P1|Overall Study|Withdrawal prior to treatment|0
7650657|NCT01506323|26618639|P2|Overall Study|Started another treatment|0
7650658|NCT01506323|26618640|P1|Overall Study|Started another treatment|1
7650659|NCT01506323|26618639|P2|Overall Study|Schedule or Transportation conflict|0
7650660|NCT01506323|26618640|P1|Overall Study|Schedule or Transportation conflict|8
7650661|NCT01506323|26618639|P2|Overall Study|Moved out of area|2
7650662|NCT01506323|26618640|P1|Overall Study|Moved out of area|5
7650663|NCT01506323|26618639|P2|Overall Study|Lack of Efficacy|3
7650664|NCT01506323|26618640|P1|Overall Study|Lack of Efficacy|1
7650665|NCT01506323|26618639|P2|Overall Study|Withdrawal by Subject|4
7650666|NCT01506323|26618640|P1|Overall Study|Withdrawal by Subject|4
7650667|NCT01506323|26618639|P2|Overall Study|Lost to Follow-up|4
7650668|NCT01506323|26618640|P1|Overall Study|Lost to Follow-up|5
7650669|NCT01506271|26618669|P3|Overall Study|Lost to Follow-up|2
7650670|NCT01506271|26618670|P2|Overall Study|Lost to Follow-up|1
7650671|NCT01506271|26618671|P1|Overall Study|Lost to Follow-up|0
7650672|NCT01506271|26618669|P3|Overall Study|Withdrawal by Subject|1
7650673|NCT01506271|26618670|P2|Overall Study|Withdrawal by Subject|1
7650674|NCT01506271|26618671|P1|Overall Study|Withdrawal by Subject|0
7650675|NCT01506271|26618669|P3|Overall Study|Insufficient supply of study drug|0
7650676|NCT01506271|26618670|P2|Overall Study|Insufficient supply of study drug|0
7650677|NCT01506271|26618671|P1|Overall Study|Insufficient supply of study drug|1
7650678|NCT01506271|26618669|P3|Overall Study|Adverse Event|0
7650679|NCT01506271|26618670|P2|Overall Study|Adverse Event|2
7650680|NCT01506271|26618671|P1|Overall Study|Adverse Event|0
7650681|NCT01506271|26618669|P3|Overall Study|Death|0
7650682|NCT01506271|26618670|P2|Overall Study|Death|1
7650683|NCT01506271|26618671|P1|Overall Study|Death|0
7650684|NCT01506271|26618669|P3|Overall Study|Protocol Violation|0
7650685|NCT01506271|26618670|P2|Overall Study|Protocol Violation|1
7650686|NCT01506271|26618671|P1|Overall Study|Protocol Violation|3
7650687|NCT01506271|26618669|P3|Overall Study|Progressive disease|0
7650688|NCT01506271|26618670|P2|Overall Study|Progressive disease|1
7650689|NCT01506271|26618671|P1|Overall Study|Progressive disease|0
7650690|NCT01506193|26618733|P3|Overall Study|Lost to Follow-up|3
7650691|NCT01506193|26618734|P2|Overall Study|Lost to Follow-up|3
7650692|NCT01506193|26618735|P1|Overall Study|Lost to Follow-up|8
7650693|NCT01506193|26618733|P3|Overall Study|Withdrawal by Subject|8
7650694|NCT01506193|26618734|P2|Overall Study|Withdrawal by Subject|1
7650695|NCT01506193|26618735|P1|Overall Study|Withdrawal by Subject|5
7650696|NCT01506193|26618733|P3|Overall Study|Adverse event, non-fatal|1
7650697|NCT01506193|26618734|P2|Overall Study|Adverse event, non-fatal|0
7650698|NCT01506193|26618735|P1|Overall Study|Adverse event, non-fatal|0
7650699|NCT01506193|26618733|P3|Overall Study|Migrated/moved from study area|1
7650700|NCT01506193|26618734|P2|Overall Study|Migrated/moved from study area|0
7650701|NCT01506193|26618735|P1|Overall Study|Migrated/moved from study area|0
7650702|NCT01506193|26618733|P3|Overall Study|Protocol Violation|1
7650703|NCT01506193|26618734|P2|Overall Study|Protocol Violation|0
7650704|NCT01506193|26618735|P1|Overall Study|Protocol Violation|1
7650705|NCT01505881|26618781|P2|Overall Study|Withdrawal by Subject|0
7650706|NCT01505881|26618782|P1|Overall Study|Withdrawal by Subject|2
7650707|NCT01505881|26618781|P2|Overall Study|Lost to Follow-up|0
7650708|NCT01505881|26618782|P1|Overall Study|Lost to Follow-up|2
7650709|NCT01505881|26618781|P2|Overall Study|Adverse Event|1
7650710|NCT01505881|26618782|P1|Overall Study|Adverse Event|0
7650711|NCT01505868|26618799|P5|Overall Study|Withdrawal by Subject|0
7650712|NCT01505868|26618800|P4|Overall Study|Withdrawal by Subject|0
7650713|NCT01505868|26618801|P3|Overall Study|Withdrawal by Subject|0
7650714|NCT01505868|26618802|P2|Overall Study|Withdrawal by Subject|0
7650715|NCT01505868|26618803|P1|Overall Study|Withdrawal by Subject|1
7650716|NCT01505647|26618919|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
7650717|NCT01505647|26618920|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
7650718|NCT01505647|26618919|P2|Day 43 Through Day 182 Follow-up|Death|1
7650719|NCT01505647|26618920|P1|Day 43 Through Day 182 Follow-up|Death|0
7650720|NCT01505647|26618919|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
7650721|NCT01505647|26618920|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
7650722|NCT01505647|26618919|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
7650723|NCT01505647|26618920|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
7650724|NCT01505647|26618919|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
7650725|NCT01505647|26618920|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
7650726|NCT01505634|26618937|P3|Overall Study|In a conflict zone|1
7650727|NCT01505634|26618938|P2|Overall Study|In a conflict zone|0
7650728|NCT01505634|26618939|P1|Overall Study|In a conflict zone|0
7650729|NCT01505634|26618937|P3|Overall Study|Death|0
7650730|NCT01505634|26618938|P2|Overall Study|Death|0
7650731|NCT01505634|26618939|P1|Overall Study|Death|1
7650732|NCT01505634|26618937|P3|Overall Study|Lost to Follow-up|4
7650733|NCT01505634|26618938|P2|Overall Study|Lost to Follow-up|4
7650734|NCT01505634|26618939|P1|Overall Study|Lost to Follow-up|1
7650735|NCT01505634|26618937|P3|Overall Study|Protocol Violation|0
7650736|NCT01505634|26618938|P2|Overall Study|Protocol Violation|0
7650737|NCT01505634|26618939|P1|Overall Study|Protocol Violation|2
7650738|NCT01505634|26618937|P3|Overall Study|Insufficient supply of drug at site|0
7650739|NCT01505634|26618938|P2|Overall Study|Insufficient supply of drug at site|0
7650740|NCT01505634|26618939|P1|Overall Study|Insufficient supply of drug at site|1
7650741|NCT01505634|26618937|P3|Overall Study|Adverse Event|0
7650742|NCT01505634|26618938|P2|Overall Study|Adverse Event|0
7650743|NCT01505634|26618939|P1|Overall Study|Adverse Event|1
7650744|NCT01505634|26618937|P3|Overall Study|Physician Decision|0
7650745|NCT01505634|26618938|P2|Overall Study|Physician Decision|1
7650746|NCT01505634|26618939|P1|Overall Study|Physician Decision|1
7650747|NCT01505634|26618937|P3|Overall Study|Withdrawal by Subject|1
7650748|NCT01505634|26618938|P2|Overall Study|Withdrawal by Subject|5
7650749|NCT01505634|26618939|P1|Overall Study|Withdrawal by Subject|2
7650750|NCT01505608|26618994|P2|Phase II|Protocol Violation|1
7650751|NCT01505608|26618995|P1|Phase II|Protocol Violation|0
7650752|NCT01505608|26618994|P2|Phase II|Lack of Efficacy|1
7650753|NCT01505608|26618995|P1|Phase II|Lack of Efficacy|2
7650754|NCT01505608|26618994|P2|Phase I|Withdrawal by Subject|1
7650755|NCT01505608|26618995|P1|Phase I|Withdrawal by Subject|0
7650756|NCT01505608|26618994|P2|Phase I|Adverse Event|1
7650757|NCT01505608|26618995|P1|Phase I|Adverse Event|0
7650758|NCT01505608|26618994|P2|Phase I|Lack of Efficacy|4
7650759|NCT01505608|26618995|P1|Phase I|Lack of Efficacy|0
7650760|NCT01505530|26619014|P3|Overall Study|entry criteria not met|0
7650761|NCT01505530|26619015|P2|Overall Study|entry criteria not met|1
7650762|NCT01505530|26619016|P1|Overall Study|entry criteria not met|0
7650763|NCT01505530|26619014|P3|Overall Study|Death|5
7650764|NCT01505530|26619015|P2|Overall Study|Death|6
7650765|NCT01505530|26619016|P1|Overall Study|Death|7
7650766|NCT01505530|26619014|P3|Overall Study|Sponsor Decision|7
7650767|NCT01505530|26619015|P2|Overall Study|Sponsor Decision|8
7650768|NCT01505530|26619016|P1|Overall Study|Sponsor Decision|1
7650769|NCT01505530|26619014|P3|Overall Study|Physician Decision|5
7650770|NCT01505530|26619015|P2|Overall Study|Physician Decision|2
7650771|NCT01505530|26619016|P1|Overall Study|Physician Decision|6
7650772|NCT01505530|26619014|P3|Overall Study|Withdrawal by Subject|6
7650773|NCT01505530|26619015|P2|Overall Study|Withdrawal by Subject|8
7650774|NCT01505530|26619016|P1|Overall Study|Withdrawal by Subject|7
7650775|NCT01505530|26619014|P3|Overall Study|Adverse Event|0
7650776|NCT01505530|26619015|P2|Overall Study|Adverse Event|1
7650777|NCT01505530|26619016|P1|Overall Study|Adverse Event|1
7650778|NCT01505530|26619014|P3|Overall Study|Progressive Disease|18
7650779|NCT01505530|26619015|P2|Overall Study|Progressive Disease|17
7650780|NCT01505530|26619016|P1|Overall Study|Progressive Disease|19
7650781|NCT01505491|26619060|P3|Overall Study|Lost to Follow-up|1
7650782|NCT01505491|26619061|P2|Overall Study|Lost to Follow-up|0
7650783|NCT01505491|26619062|P1|Overall Study|Lost to Follow-up|0
7650784|NCT01505491|26619060|P3|Overall Study|Withdrawal by Subject|4
7650785|NCT01505491|26619061|P2|Overall Study|Withdrawal by Subject|1
7650786|NCT01505491|26619062|P1|Overall Study|Withdrawal by Subject|1
7650787|NCT01505491|26619060|P3|Overall Study|Other reason not listed|0
7650788|NCT01505491|26619061|P2|Overall Study|Other reason not listed|0
7650789|NCT01505491|26619062|P1|Overall Study|Other reason not listed|1
7650790|NCT01505387|26619101|P2|Overall Study|Withdrawal by Subject|1
7650791|NCT01505387|26619102|P1|Overall Study|Withdrawal by Subject|1
7650792|NCT01505387|26619101|P2|Overall Study|Protocol Violation|0
7650793|NCT01505387|26619102|P1|Overall Study|Protocol Violation|1
7650794|NCT01505374|26619108|P2|Overall Study|Lost to Follow-up|0
7650795|NCT01505374|26619109|P1|Overall Study|Lost to Follow-up|1
7650796|NCT01505114|26619159|P4|Overall Study|investigator decision|0
7650797|NCT01505114|26619160|P3|Overall Study|investigator decision|1
7650798|NCT01505114|26619161|P2|Overall Study|investigator decision|0
7650799|NCT01505114|26619162|P1|Overall Study|investigator decision|1
7650800|NCT01505114|26619159|P4|Overall Study|staff safety concerns|1
7650801|NCT01505114|26619160|P3|Overall Study|staff safety concerns|0
7650802|NCT01505114|26619161|P2|Overall Study|staff safety concerns|0
7650803|NCT01505114|26619162|P1|Overall Study|staff safety concerns|0
7650804|NCT01505114|26619159|P4|Overall Study|inadvertent enrollment due to peanut all|1
7650805|NCT01505114|26619160|P3|Overall Study|inadvertent enrollment due to peanut all|0
7650806|NCT01505114|26619161|P2|Overall Study|inadvertent enrollment due to peanut all|0
7650807|NCT01505114|26619162|P1|Overall Study|inadvertent enrollment due to peanut all|0
7650808|NCT01505114|26619159|P4|Overall Study|relocated|3
7650809|NCT01505114|26619160|P3|Overall Study|relocated|2
7650810|NCT01505114|26619161|P2|Overall Study|relocated|2
7650811|NCT01505114|26619162|P1|Overall Study|relocated|4
7650812|NCT01505114|26619159|P4|Overall Study|Lost to Follow-up|7
7650813|NCT01505114|26619160|P3|Overall Study|Lost to Follow-up|8
7650814|NCT01505114|26619161|P2|Overall Study|Lost to Follow-up|5
7650815|NCT01505114|26619162|P1|Overall Study|Lost to Follow-up|11
7650816|NCT01505114|26619159|P4|Overall Study|unable to adhere to visit schedule|3
7650817|NCT01505114|26619160|P3|Overall Study|unable to adhere to visit schedule|3
7650818|NCT01505114|26619161|P2|Overall Study|unable to adhere to visit schedule|2
7650819|NCT01505114|26619162|P1|Overall Study|unable to adhere to visit schedule|3
7650820|NCT01505114|26619159|P4|Overall Study|Death|1
7650821|NCT01505114|26619160|P3|Overall Study|Death|0
7650822|NCT01505114|26619161|P2|Overall Study|Death|0
7650823|NCT01505114|26619162|P1|Overall Study|Death|1
7650824|NCT01505114|26619159|P4|Overall Study|Withdrawal by Subject|7
7650825|NCT01505114|26619160|P3|Overall Study|Withdrawal by Subject|4
7650826|NCT01505114|26619161|P2|Overall Study|Withdrawal by Subject|4
7650827|NCT01505114|26619162|P1|Overall Study|Withdrawal by Subject|5
7650828|NCT01505010|26619190|P2|Overall Study|Lost to Follow-up|1
7650829|NCT01505010|26619191|P1|Overall Study|Lost to Follow-up|0
7650830|NCT01505010|26619190|P2|Overall Study|Protocol Violation|1
7650831|NCT01505010|26619191|P1|Overall Study|Protocol Violation|0
7650832|NCT01504971|26619205|P1|Overall Study|Physician Decision|13
7650833|NCT01504867|26619234|P2|Overall Study|Consent revoked|1
7650834|NCT01504867|26619235|P1|Overall Study|Consent revoked|5
7650835|NCT01504867|26619234|P2|Overall Study|Inclusion criteria not met|2
7650836|NCT01504867|26619235|P1|Overall Study|Inclusion criteria not met|2
7650837|NCT01504841|26619273|P3|Overall Study|Withdrawal by Subject|0
7650838|NCT01504841|26619274|P2|Overall Study|Withdrawal by Subject|1
7650839|NCT01504841|26619275|P1|Overall Study|Withdrawal by Subject|1
7650840|NCT01504412|26619347|P5|Overall Study|Death|0
7650841|NCT01504412|26619348|P4|Overall Study|Death|1
7650842|NCT01504412|26619349|P3|Overall Study|Death|0
7650843|NCT01504412|26619350|P2|Overall Study|Death|0
7650844|NCT01504412|26619351|P1|Overall Study|Death|0
7650845|NCT01504412|26619347|P5|Overall Study|Lack of Efficacy|1
7650846|NCT01504412|26619348|P4|Overall Study|Lack of Efficacy|0
7650847|NCT01504412|26619349|P3|Overall Study|Lack of Efficacy|1
7650848|NCT01504412|26619350|P2|Overall Study|Lack of Efficacy|0
7650849|NCT01504412|26619351|P1|Overall Study|Lack of Efficacy|0
7650850|NCT01504412|26619347|P5|Overall Study|Lost to Follow-up|0
7650851|NCT01504412|26619348|P4|Overall Study|Lost to Follow-up|0
7650852|NCT01504412|26619349|P3|Overall Study|Lost to Follow-up|0
7650853|NCT01504412|26619350|P2|Overall Study|Lost to Follow-up|2
7650854|NCT01504412|26619351|P1|Overall Study|Lost to Follow-up|0
7650855|NCT01504412|26619347|P5|Overall Study|Other|1
7650856|NCT01504412|26619348|P4|Overall Study|Other|6
7650857|NCT01504412|26619349|P3|Overall Study|Other|1
7650858|NCT01504412|26619350|P2|Overall Study|Other|1
7650859|NCT01504412|26619351|P1|Overall Study|Other|2
7650860|NCT01504412|26619347|P5|Overall Study|Withdrawal by Subject|1
7650861|NCT01504412|26619348|P4|Overall Study|Withdrawal by Subject|5
7650862|NCT01504412|26619349|P3|Overall Study|Withdrawal by Subject|1
7650863|NCT01504412|26619350|P2|Overall Study|Withdrawal by Subject|1
7650864|NCT01504412|26619351|P1|Overall Study|Withdrawal by Subject|2
7650865|NCT01504412|26619347|P5|Overall Study|Adverse Event|10
7650866|NCT01504412|26619348|P4|Overall Study|Adverse Event|7
7650867|NCT01504412|26619349|P3|Overall Study|Adverse Event|1
7650868|NCT01504412|26619350|P2|Overall Study|Adverse Event|8
7650869|NCT01504412|26619351|P1|Overall Study|Adverse Event|1
7650870|NCT01504204|26619370|P2|Overall Study|Lost to Follow-up|1
7650871|NCT01504204|26619371|P1|Overall Study|Lost to Follow-up|1
7650872|NCT01503515|26619399|P2|Overall Study|Ineligible|1
7650873|NCT01503515|26619400|P1|Overall Study|Ineligible|1
7650874|NCT01503515|26619399|P2|Overall Study|Institutional dx of proven/probable IFI|4
7650875|NCT01503515|26619400|P1|Overall Study|Institutional dx of proven/probable IFI|2
7650876|NCT01503515|26619399|P2|Overall Study|Withdrawal by Subject|1
7650877|NCT01503515|26619400|P1|Overall Study|Withdrawal by Subject|0
7650878|NCT01503515|26619399|P2|Overall Study|Physician Decision|23
7650879|NCT01503515|26619400|P1|Overall Study|Physician Decision|14
7650880|NCT01503515|26619399|P2|Overall Study|Death|1
7650881|NCT01503515|26619400|P1|Overall Study|Death|0
7650882|NCT01503515|26619399|P2|Overall Study|Adverse Event|5
7650883|NCT01503515|26619400|P1|Overall Study|Adverse Event|4
7650884|NCT01503229|26619435|P1|Overall Study|Withdrew consent|1
7650885|NCT01503164|26619441|P2|Overall Study|Withdrawal by Subject|1
7650886|NCT01503164|26619442|P1|Overall Study|Withdrawal by Subject|2
7650887|NCT01503021|26619472|P2|Overall Study|Moved, received transplant, etc.|7
7650888|NCT01503021|26619473|P1|Overall Study|Moved, received transplant, etc.|5
7650889|NCT01503021|26619472|P2|Overall Study|Withdrawal by Subject|8
7650890|NCT01503021|26619473|P1|Overall Study|Withdrawal by Subject|9
7650891|NCT01503021|26619472|P2|Overall Study|Protocol Violation|3
7650892|NCT01503021|26619473|P1|Overall Study|Protocol Violation|1
7650893|NCT01503021|26619472|P2|Overall Study|Physician Decision|0
7650894|NCT01503021|26619473|P1|Overall Study|Physician Decision|3
7650895|NCT01503021|26619472|P2|Overall Study|Lost to Follow-up|0
7650896|NCT01503021|26619473|P1|Overall Study|Lost to Follow-up|2
7650897|NCT01503021|26619472|P2|Overall Study|Death|2
7650898|NCT01503021|26619473|P1|Overall Study|Death|0
7650899|NCT01503021|26619472|P2|Overall Study|Adverse Event|6
7650900|NCT01503021|26619473|P1|Overall Study|Adverse Event|7
7650901|NCT01502956|26619522|P2|Overall Study|Withdrawal by Subject|10
7650902|NCT01502956|26619523|P1|Overall Study|Withdrawal by Subject|8
7650903|NCT01502956|26619522|P2|Overall Study|Physician Decision|3
7650904|NCT01502956|26619523|P1|Overall Study|Physician Decision|2
7650905|NCT01502956|26619522|P2|Overall Study|Lost to Follow-up|11
7650906|NCT01502956|26619523|P1|Overall Study|Lost to Follow-up|14
7650907|NCT01502956|26619522|P2|Overall Study|Death|2
7650908|NCT01502956|26619523|P1|Overall Study|Death|0
7650909|NCT01502709|26619586|P2|Overall Study|Lost to Follow-up|0
7650910|NCT01502709|26619587|P1|Overall Study|Lost to Follow-up|4
7650911|NCT01502644|26619600|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7650912|NCT01502644|26619601|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7650913|NCT01502644|26619602|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7650914|NCT01502644|26619603|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7650915|NCT01502644|26619600|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
7650916|NCT01502644|26619601|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
7650917|NCT01502644|26619602|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
7650918|NCT01502644|26619603|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
7650919|NCT01502644|26619600|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7650920|NCT01502644|26619601|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7650921|NCT01502644|26619602|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7650922|NCT01502644|26619603|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
7650923|NCT01502644|26619600|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7650924|NCT01502644|26619601|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7650925|NCT01502644|26619602|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7650926|NCT01502644|26619603|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
7650927|NCT01502644|26619600|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7650928|NCT01502644|26619601|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7650929|NCT01502644|26619602|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7650930|NCT01502644|26619603|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
7650931|NCT01502631|26619613|P2|Overall Study|Other|5
7650932|NCT01502631|26619614|P1|Overall Study|Other|10
7650933|NCT01502631|26619613|P2|Overall Study|Investigator's decision|1
7650934|NCT01502631|26619614|P1|Overall Study|Investigator's decision|0
7650935|NCT01502631|26619613|P2|Overall Study|Participant non-compliant|0
7650936|NCT01502631|26619614|P1|Overall Study|Participant non-compliant|1
7650937|NCT01502631|26619613|P2|Overall Study|Participant withdrew consent|4
7650938|NCT01502631|26619614|P1|Overall Study|Participant withdrew consent|2
7650939|NCT01502631|26619613|P2|Overall Study|Lost to Follow-up|2
7650940|NCT01502631|26619614|P1|Overall Study|Lost to Follow-up|2
7650941|NCT01502631|26619613|P2|Overall Study|Adverse Event|8
7650942|NCT01502631|26619614|P1|Overall Study|Adverse Event|5
7650943|NCT01502423|26619634|P2|Overall Study|Withdrawal by Subject|1
7650944|NCT01502423|26619635|P1|Overall Study|Withdrawal by Subject|0
7650945|NCT01502410|26619657|P4|Overall Study|Withdrawal by Subject|0
7650946|NCT01502410|26619658|P3|Overall Study|Withdrawal by Subject|0
7650947|NCT01502410|26619659|P2|Overall Study|Withdrawal by Subject|0
7650948|NCT01502410|26619660|P1|Overall Study|Withdrawal by Subject|2
7650949|NCT01502410|26619657|P4|Overall Study|Physician Decision|0
7650950|NCT01502410|26619658|P3|Overall Study|Physician Decision|0
7650951|NCT01502410|26619659|P2|Overall Study|Physician Decision|1
7650952|NCT01502410|26619660|P1|Overall Study|Physician Decision|0
7650953|NCT01502410|26619657|P4|Overall Study|Lack of Efficacy|0
7650954|NCT01502410|26619658|P3|Overall Study|Lack of Efficacy|0
7650955|NCT01502410|26619659|P2|Overall Study|Lack of Efficacy|7
7650956|NCT01502410|26619660|P1|Overall Study|Lack of Efficacy|7
7650957|NCT01502410|26619657|P4|Overall Study|Adverse Event|0
7650958|NCT01502410|26619658|P3|Overall Study|Adverse Event|0
7650959|NCT01502410|26619659|P2|Overall Study|Adverse Event|2
7650960|NCT01502410|26619660|P1|Overall Study|Adverse Event|1
7650961|NCT01502371|26619678|P5|Overall Study|Excluded Medication|1
7650962|NCT01502371|26619679|P4|Overall Study|Excluded Medication|0
7650963|NCT01502371|26619680|P3|Overall Study|Excluded Medication|1
7650964|NCT01502371|26619681|P2|Overall Study|Excluded Medication|1
7650965|NCT01502371|26619682|P1|Overall Study|Excluded Medication|0
7650966|NCT01502371|26619678|P5|Overall Study|Protocol Violation|10
7650967|NCT01502371|26619679|P4|Overall Study|Protocol Violation|5
7650968|NCT01502371|26619680|P3|Overall Study|Protocol Violation|6
7650969|NCT01502371|26619681|P2|Overall Study|Protocol Violation|5
7650970|NCT01502371|26619682|P1|Overall Study|Protocol Violation|9
7650971|NCT01502371|26619678|P5|Overall Study|Technical Problems|1
7650972|NCT01502371|26619679|P4|Overall Study|Technical Problems|4
7650973|NCT01502371|26619680|P3|Overall Study|Technical Problems|2
7650974|NCT01502371|26619681|P2|Overall Study|Technical Problems|0
7650975|NCT01502371|26619682|P1|Overall Study|Technical Problems|1
7650976|NCT01502371|26619678|P5|Overall Study|Noncompliance with Study Drug|1
7650977|NCT01502371|26619679|P4|Overall Study|Noncompliance with Study Drug|2
7650978|NCT01502371|26619680|P3|Overall Study|Noncompliance with Study Drug|1
7650979|NCT01502371|26619681|P2|Overall Study|Noncompliance with Study Drug|0
7650980|NCT01502371|26619682|P1|Overall Study|Noncompliance with Study Drug|0
7650981|NCT01502371|26619678|P5|Overall Study|Physician Decision|1
7650982|NCT01502371|26619679|P4|Overall Study|Physician Decision|0
7650983|NCT01502371|26619680|P3|Overall Study|Physician Decision|0
7650984|NCT01502371|26619681|P2|Overall Study|Physician Decision|0
7650985|NCT01502371|26619682|P1|Overall Study|Physician Decision|3
7650986|NCT01502371|26619678|P5|Overall Study|Lack of Efficacy|4
7650987|NCT01502371|26619679|P4|Overall Study|Lack of Efficacy|2
7650988|NCT01502371|26619680|P3|Overall Study|Lack of Efficacy|2
7650989|NCT01502371|26619681|P2|Overall Study|Lack of Efficacy|3
7650990|NCT01502371|26619682|P1|Overall Study|Lack of Efficacy|3
7650991|NCT01502371|26619678|P5|Overall Study|Treatment Failure|30
7650992|NCT01502371|26619679|P4|Overall Study|Treatment Failure|19
7650993|NCT01502371|26619680|P3|Overall Study|Treatment Failure|12
7650994|NCT01502371|26619681|P2|Overall Study|Treatment Failure|20
7650995|NCT01502371|26619682|P1|Overall Study|Treatment Failure|22
7650996|NCT01502371|26619678|P5|Overall Study|Adverse Event|3
7650997|NCT01502371|26619679|P4|Overall Study|Adverse Event|4
7650998|NCT01502371|26619680|P3|Overall Study|Adverse Event|0
7650999|NCT01502371|26619681|P2|Overall Study|Adverse Event|1
7651000|NCT01502371|26619682|P1|Overall Study|Adverse Event|2
7651001|NCT01502371|26619678|P5|Overall Study|Withdrawal by Subject|1
7651002|NCT01502371|26619679|P4|Overall Study|Withdrawal by Subject|1
7651003|NCT01502371|26619680|P3|Overall Study|Withdrawal by Subject|1
7651004|NCT01502371|26619681|P2|Overall Study|Withdrawal by Subject|2
7651005|NCT01502371|26619682|P1|Overall Study|Withdrawal by Subject|1
7651006|NCT01502293|26619747|P3|Overall Study|Physician Decision|1
7651007|NCT01502293|26619748|P2|Overall Study|Physician Decision|0
7651008|NCT01502293|26619749|P1|Overall Study|Physician Decision|0
7651009|NCT01502293|26619747|P3|Overall Study|Reason Not Specified|0
7651010|NCT01502293|26619748|P2|Overall Study|Reason Not Specified|0
7651011|NCT01502293|26619749|P1|Overall Study|Reason Not Specified|2
7651012|NCT01502293|26619747|P3|Overall Study|Adverse Event|0
7651013|NCT01502293|26619748|P2|Overall Study|Adverse Event|2
7651014|NCT01502293|26619749|P1|Overall Study|Adverse Event|0
7651015|NCT01502293|26619747|P3|Overall Study|Withdrawal by Subject|1
7651016|NCT01502293|26619748|P2|Overall Study|Withdrawal by Subject|3
7651017|NCT01502293|26619749|P1|Overall Study|Withdrawal by Subject|3
7651018|NCT01502293|26619747|P3|Overall Study|Progressive Disease|2
7651019|NCT01502293|26619748|P2|Overall Study|Progressive Disease|12
7651020|NCT01502293|26619749|P1|Overall Study|Progressive Disease|20
7651021|NCT01502228|26619778|P1|Overall Study|Death|1
7651022|NCT01502072|26619786|P3|Overall Study|Death|0
7651023|NCT01502072|26619787|P2|Overall Study|Death|1
7651024|NCT01502072|26619788|P1|Overall Study|Death|0
7651025|NCT01502072|26619786|P3|Overall Study|Withdrawal by Subject|0
7651026|NCT01502072|26619787|P2|Overall Study|Withdrawal by Subject|0
7651027|NCT01502072|26619788|P1|Overall Study|Withdrawal by Subject|1
7651028|NCT01502033|26619796|P1|Overall Study|1 participant went back to school|1
7651029|NCT01502033|26619796|P1|Overall Study|1 participant had worsening depression|1
7651030|NCT01502033|26619796|P1|Overall Study|1 participant had scalp discomfort|1
7651031|NCT01501955|26619804|P2|Overall Study|Adverse Event|3
7651032|NCT01501955|26619805|P1|Overall Study|Adverse Event|1
7651033|NCT01501955|26619804|P2|Overall Study|Withdrawal by Subject|0
7651034|NCT01501955|26619805|P1|Overall Study|Withdrawal by Subject|1
7651035|NCT01501110|26619869|P2|Overall Study|Death|1
7651036|NCT01501110|26619870|P1|Overall Study|Death|0
7651037|NCT01500720|26619955|P2|Overall Study|Other|8
7651038|NCT01500720|26619956|P1|Overall Study|Other|4
7651039|NCT01500720|26619955|P2|Overall Study|Randomized But Not Treated|1
7651040|NCT01500720|26619956|P1|Overall Study|Randomized But Not Treated|1
7651041|NCT01500694|26619970|P2|Overall Study|Other|3
7651042|NCT01500694|26619971|P1|Overall Study|Other|9
7651043|NCT01500694|26619970|P2|Overall Study|Lack of Efficacy|5
7651044|NCT01500694|26619971|P1|Overall Study|Lack of Efficacy|14
7651045|NCT01500694|26619970|P2|Overall Study|Lost to Follow-up|3
7651046|NCT01500694|26619971|P1|Overall Study|Lost to Follow-up|2
7651047|NCT01500694|26619970|P2|Overall Study|Withdrawal by Subject|14
7651048|NCT01500694|26619971|P1|Overall Study|Withdrawal by Subject|23
7651049|NCT01500694|26619970|P2|Overall Study|Protocol Violation|1
7651050|NCT01500694|26619971|P1|Overall Study|Protocol Violation|0
7651051|NCT01500694|26619970|P2|Overall Study|Adverse Event|3
7651052|NCT01500694|26619971|P1|Overall Study|Adverse Event|4
7651053|NCT01500629|26619997|P2|Washout Period of 14 to 30 Days|Pregnancy|0
7651054|NCT01500629|26619998|P1|Washout Period of 14 to 30 Days|Pregnancy|1
7651055|NCT01500434|26620091|P1|Overall Study|Missed 12-month follow-up|5
7651056|NCT01500434|26620091|P1|Overall Study|Withdrawal by Subject|1
7651057|NCT01500434|26620091|P1|Overall Study|Death|1
7651058|NCT01500382|26620124|P4|Washout Period|Study site went out of business|0
7651059|NCT01500382|26620125|P3|Washout Period|Study site went out of business|1
7651060|NCT01500382|26620126|P2|Washout Period|Study site went out of business|0
7651061|NCT01500382|26620127|P1|Washout Period|Study site went out of business|0
7651062|NCT01500317|26620152|P3|Overall Study|Withdrawal by Subject|0
7651063|NCT01500317|26620153|P2|Overall Study|Withdrawal by Subject|2
7651064|NCT01500317|26620154|P1|Overall Study|Withdrawal by Subject|3
7651065|NCT01500278|26620176|P2|Week 13 - Week 104|Adverse Event|54
7651066|NCT01500278|26620177|P1|Week 13 - Week 104|Adverse Event|54
7651067|NCT01500278|26620176|P2|Week 13 - Week 104|Death|4
7651068|NCT01500278|26620177|P1|Week 13 - Week 104|Death|2
7651069|NCT01500278|26620176|P2|Week 13 - Week 104|Not completed|1
7651070|NCT01500278|26620177|P1|Week 13 - Week 104|Not completed|0
7651071|NCT01500278|26620176|P2|Week 13 - Week 104|Personal reason|1
7651072|NCT01500278|26620177|P1|Week 13 - Week 104|Personal reason|0
7651073|NCT01500278|26620176|P2|Week 13 - Week 104|Medical monitor decision|2
7651074|NCT01500278|26620177|P1|Week 13 - Week 104|Medical monitor decision|0
7651075|NCT01500278|26620176|P2|Week 13 - Week 104|Sponsor decision|2
7651076|NCT01500278|26620177|P1|Week 13 - Week 104|Sponsor decision|0
7651077|NCT01500278|26620176|P2|Week 13 - Week 104|Relocation|1
7651078|NCT01500278|26620177|P1|Week 13 - Week 104|Relocation|0
7651079|NCT01500278|26620176|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
7651080|NCT01500278|26620177|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
7651081|NCT01500278|26620176|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
7651082|NCT01500278|26620177|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
7651083|NCT01500278|26620176|P2|Week 13 - Week 104|Principal investigator retiring|0
7651084|NCT01500278|26620177|P1|Week 13 - Week 104|Principal investigator retiring|1
7651085|NCT01500278|26620176|P2|Week 13 - Week 104|Protocol deviation|0
7651086|NCT01500278|26620177|P1|Week 13 - Week 104|Protocol deviation|1
7651087|NCT01500278|26620176|P2|Week 13 - Week 104|Exclusion criteria not met|0
7651088|NCT01500278|26620177|P1|Week 13 - Week 104|Exclusion criteria not met|1
7651089|NCT01500278|26620176|P2|Week 13 - Week 104|Withdrawn in error|0
7651090|NCT01500278|26620177|P1|Week 13 - Week 104|Withdrawn in error|1
7651091|NCT01500278|26620176|P2|Week 13 - Week 104|Sponsor request|0
7651092|NCT01500278|26620177|P1|Week 13 - Week 104|Sponsor request|4
7651093|NCT01500278|26620176|P2|Week 13 - Week 104|False positive test|2
7651094|NCT01500278|26620177|P1|Week 13 - Week 104|False positive test|1
7651095|NCT01500278|26620176|P2|Week 13 - Week 104|Recurrent infections|0
7651096|NCT01500278|26620177|P1|Week 13 - Week 104|Recurrent infections|1
7651097|NCT01500278|26620176|P2|Week 13 - Week 104|Non/bad compliance|5
7651098|NCT01500278|26620177|P1|Week 13 - Week 104|Non/bad compliance|7
7651099|NCT01500278|26620176|P2|Week 13 - Week 104|Week 24 Non-Responder|16
7651100|NCT01500278|26620177|P1|Week 13 - Week 104|Week 24 Non-Responder|20
7651101|NCT01500278|26620176|P2|Week 13 - Week 104|Withdrawal by Subject|13
7651102|NCT01500278|26620177|P1|Week 13 - Week 104|Withdrawal by Subject|22
7651103|NCT01500278|26620176|P2|Week 13 - Week 104|Lost to Follow-up|5
7651104|NCT01500278|26620177|P1|Week 13 - Week 104|Lost to Follow-up|6
7651105|NCT01500278|26620176|P2|Week 13 - Week 104|Protocol Violation|6
7651106|NCT01500278|26620177|P1|Week 13 - Week 104|Protocol Violation|6
7651107|NCT01500278|26620176|P2|Week 13 - Week 104|Lack of Efficacy|12
7651108|NCT01500278|26620177|P1|Week 13 - Week 104|Lack of Efficacy|11
7651109|NCT01500278|26620176|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
7651110|NCT01500278|26620177|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
7651111|NCT01500278|26620176|P2|Week 0 - Week 12|Other serious disease|1
7651112|NCT01500278|26620177|P1|Week 0 - Week 12|Other serious disease|0
7651113|NCT01500278|26620176|P2|Week 0 - Week 12|Personal reason|1
7651114|NCT01500278|26620177|P1|Week 0 - Week 12|Personal reason|0
7651115|NCT01500278|26620176|P2|Week 0 - Week 12|Sponsor decision|0
7651116|NCT01500278|26620177|P1|Week 0 - Week 12|Sponsor decision|1
7651117|NCT01500278|26620176|P2|Week 0 - Week 12|Prior history of serious disease|0
7651118|NCT01500278|26620177|P1|Week 0 - Week 12|Prior history of serious disease|1
7651119|NCT01500278|26620176|P2|Week 0 - Week 12|Investigator decision|0
7651120|NCT01500278|26620177|P1|Week 0 - Week 12|Investigator decision|1
7651121|NCT01500278|26620176|P2|Week 0 - Week 12|Exclusion criteria not met|0
7651122|NCT01500278|26620177|P1|Week 0 - Week 12|Exclusion criteria not met|1
7651123|NCT01500278|26620176|P2|Week 0 - Week 12|Patient decision|0
7651124|NCT01500278|26620177|P1|Week 0 - Week 12|Patient decision|1
7651125|NCT01500278|26620176|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
7651126|NCT01500278|26620177|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
7651127|NCT01500278|26620176|P2|Week 0 - Week 12|Withdrawal by Subject|2
7651128|NCT01500278|26620177|P1|Week 0 - Week 12|Withdrawal by Subject|7
7651129|NCT01500278|26620176|P2|Week 0 - Week 12|Lost to Follow-up|1
7651130|NCT01500278|26620177|P1|Week 0 - Week 12|Lost to Follow-up|1
7651131|NCT01500278|26620176|P2|Week 0 - Week 12|Protocol Violation|16
7651132|NCT01500278|26620177|P1|Week 0 - Week 12|Protocol Violation|10
7651133|NCT01500278|26620176|P2|Week 0 - Week 12|Lack of Efficacy|1
7651134|NCT01500278|26620177|P1|Week 0 - Week 12|Lack of Efficacy|0
7651135|NCT01500252|26620201|P2|Overall Study|Lost to Follow-up|4
7651136|NCT01500252|26620202|P1|Overall Study|Lost to Follow-up|5
7651137|NCT01500252|26620201|P2|Overall Study|Death|2
7651138|NCT01500252|26620202|P1|Overall Study|Death|4
7651139|NCT01500226|26620228|P2|Overall Study|Other Reasons|16
7651140|NCT01500226|26620229|P1|Overall Study|Other Reasons|19
7651141|NCT01500226|26620228|P2|Overall Study|Lost to Follow-up|5
7651142|NCT01500226|26620229|P1|Overall Study|Lost to Follow-up|9
7651143|NCT01500226|26620228|P2|Overall Study|Lack of Efficacy|30
7651144|NCT01500226|26620229|P1|Overall Study|Lack of Efficacy|14
7651145|NCT01500226|26620228|P2|Overall Study|Physician Decision|15
7651146|NCT01500226|26620229|P1|Overall Study|Physician Decision|17
7651147|NCT01500226|26620228|P2|Overall Study|Protocol Violation|39
7651148|NCT01500226|26620229|P1|Overall Study|Protocol Violation|53
7651149|NCT01500226|26620228|P2|Overall Study|Disease Progression|14
7651150|NCT01500226|26620229|P1|Overall Study|Disease Progression|16
7651151|NCT01500226|26620228|P2|Overall Study|Death|4
7651152|NCT01500226|26620229|P1|Overall Study|Death|12
7651153|NCT01500226|26620228|P2|Overall Study|Withdrawal by Subject|96
7651154|NCT01500226|26620229|P1|Overall Study|Withdrawal by Subject|93
7651155|NCT01500226|26620228|P2|Overall Study|Chemo Completed or Change in Therapy|237
7651156|NCT01500226|26620229|P1|Overall Study|Chemo Completed or Change in Therapy|235
7651157|NCT01500226|26620228|P2|Overall Study|Adverse Event|38
7651158|NCT01500226|26620229|P1|Overall Study|Adverse Event|31
7651159|NCT01500213|26620241|P2|Overall Study|Other Reasons|5
7651160|NCT01500213|26620242|P1|Overall Study|Other Reasons|7
7651161|NCT01500213|26620241|P2|Overall Study|Lost to Follow-up|6
7651162|NCT01500213|26620242|P1|Overall Study|Lost to Follow-up|3
7651163|NCT01500213|26620241|P2|Overall Study|Lack of Efficacy|7
7651164|NCT01500213|26620242|P1|Overall Study|Lack of Efficacy|9
7651165|NCT01500213|26620241|P2|Overall Study|Physician Decision|10
7651166|NCT01500213|26620242|P1|Overall Study|Physician Decision|12
7651167|NCT01500213|26620241|P2|Overall Study|Protocol Violation|19
7651168|NCT01500213|26620242|P1|Overall Study|Protocol Violation|19
7651169|NCT01500213|26620241|P2|Overall Study|Disease Progression|21
7651170|NCT01500213|26620242|P1|Overall Study|Disease Progression|13
7651171|NCT01500213|26620241|P2|Overall Study|Death|3
7651172|NCT01500213|26620242|P1|Overall Study|Death|7
7651173|NCT01500213|26620241|P2|Overall Study|Withdrawal by Subject|37
7651174|NCT01500213|26620242|P1|Overall Study|Withdrawal by Subject|28
7651175|NCT01500213|26620241|P2|Overall Study|Chemo Completed or Change in Therapy|81
7651176|NCT01500213|26620242|P1|Overall Study|Chemo Completed or Change in Therapy|84
7651177|NCT01500213|26620241|P2|Overall Study|Adverse Event|35
7651178|NCT01500213|26620242|P1|Overall Study|Adverse Event|35
7651179|NCT01500200|26620255|P6|Stage 2|Adverse Event|4
7651180|NCT01500200|26620256|P5|Stage 2|Adverse Event|5
7651181|NCT01500200|26620257|P4|Stage 2|Adverse Event|0
7651182|NCT01500200|26620258|P3|Stage 2|Adverse Event|0
7651183|NCT01500200|26620259|P2|Stage 2|Adverse Event|0
7651184|NCT01500200|26620260|P1|Stage 2|Adverse Event|0
7651185|NCT01500200|26620255|P6|Stage 1|Physician Decision|0
7651186|NCT01500200|26620256|P5|Stage 1|Physician Decision|0
7651187|NCT01500200|26620257|P4|Stage 1|Physician Decision|0
7651188|NCT01500200|26620258|P3|Stage 1|Physician Decision|0
7651189|NCT01500200|26620259|P2|Stage 1|Physician Decision|0
7651190|NCT01500200|26620260|P1|Stage 1|Physician Decision|1
7651191|NCT01500200|26620255|P6|Stage 1|Noncompliance with Study Drug|0
7651192|NCT01500200|26620256|P5|Stage 1|Noncompliance with Study Drug|0
7651193|NCT01500200|26620257|P4|Stage 1|Noncompliance with Study Drug|0
7651194|NCT01500200|26620258|P3|Stage 1|Noncompliance with Study Drug|0
7651195|NCT01500200|26620259|P2|Stage 1|Noncompliance with Study Drug|0
7651196|NCT01500200|26620260|P1|Stage 1|Noncompliance with Study Drug|1
7651197|NCT01500200|26620255|P6|Stage 1|Withdrawal by Subject|0
7651198|NCT01500200|26620256|P5|Stage 1|Withdrawal by Subject|0
7651199|NCT01500200|26620257|P4|Stage 1|Withdrawal by Subject|0
7651200|NCT01500200|26620258|P3|Stage 1|Withdrawal by Subject|0
7651201|NCT01500200|26620259|P2|Stage 1|Withdrawal by Subject|0
7651202|NCT01500200|26620260|P1|Stage 1|Withdrawal by Subject|3
7651203|NCT01500200|26620255|P6|Stage 1|Lost to Follow-up|0
7651204|NCT01500200|26620256|P5|Stage 1|Lost to Follow-up|0
7651205|NCT01500200|26620257|P4|Stage 1|Lost to Follow-up|0
7651206|NCT01500200|26620258|P3|Stage 1|Lost to Follow-up|1
7651207|NCT01500200|26620259|P2|Stage 1|Lost to Follow-up|2
7651208|NCT01500200|26620260|P1|Stage 1|Lost to Follow-up|2
7651209|NCT01500200|26620255|P6|Stage 1|Adverse Event|0
7651210|NCT01500200|26620256|P5|Stage 1|Adverse Event|0
7651211|NCT01500200|26620257|P4|Stage 1|Adverse Event|0
7651212|NCT01500200|26620258|P3|Stage 1|Adverse Event|5
7651213|NCT01500200|26620259|P2|Stage 1|Adverse Event|4
7651214|NCT01500200|26620260|P1|Stage 1|Adverse Event|1
7651215|NCT01500187|26620294|P2|Overall Study|Lost to Follow-up|0
7651216|NCT01500187|26620295|P1|Overall Study|Lost to Follow-up|6
7651217|NCT01500135|26620303|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
7651218|NCT01500135|26620304|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
7651219|NCT01500135|26620303|P2|Overall Study|Participant was a Safety Concern|0
7651220|NCT01500135|26620304|P1|Overall Study|Participant was a Safety Concern|1
7651221|NCT01500135|26620303|P2|Overall Study|Patient Missed Scheduled Appointments|1
7651222|NCT01500135|26620304|P1|Overall Study|Patient Missed Scheduled Appointments|0
7651223|NCT01500135|26620303|P2|Overall Study|Principal Investigator (PI) Discretion|0
7651224|NCT01500135|26620304|P1|Overall Study|Principal Investigator (PI) Discretion|1
7651225|NCT01500135|26620303|P2|Overall Study|Fatal Adverse Event (AE)|5
7651226|NCT01500135|26620304|P1|Overall Study|Fatal Adverse Event (AE)|5
7651227|NCT01500135|26620303|P2|Overall Study|Lost to Follow-up|4
7651228|NCT01500135|26620304|P1|Overall Study|Lost to Follow-up|6
7651229|NCT01500135|26620303|P2|Overall Study|Withdrawal of Consent|0
7651230|NCT01500135|26620304|P1|Overall Study|Withdrawal of Consent|4
7651231|NCT01500096|26620331|P4|Overall Study|Lost to Follow-up|2
7651232|NCT01500096|26620332|P3|Overall Study|Lost to Follow-up|0
7651233|NCT01500096|26620333|P2|Overall Study|Lost to Follow-up|0
7651234|NCT01500096|26620334|P1|Overall Study|Lost to Follow-up|1
7651235|NCT01500083|26620390|P2|Overall Study|Other Reasons|5
7651236|NCT01500083|26620391|P1|Overall Study|Other Reasons|2
7651237|NCT01500083|26620390|P2|Overall Study|Investigator Discretion|8
7651238|NCT01500083|26620391|P1|Overall Study|Investigator Discretion|3
7651239|NCT01500083|26620390|P2|Overall Study|Disease Progression|10
7651240|NCT01500083|26620391|P1|Overall Study|Disease Progression|2
7651241|NCT01500083|26620390|P2|Overall Study|Withdrawal of Consent|1
7651242|NCT01500083|26620391|P1|Overall Study|Withdrawal of Consent|0
7651243|NCT01500083|26620390|P2|Overall Study|Lost to Follow-up|0
7651244|NCT01500083|26620391|P1|Overall Study|Lost to Follow-up|1
7651245|NCT01500083|26620390|P2|Overall Study|Death|2
7651246|NCT01500083|26620391|P1|Overall Study|Death|0
7651247|NCT01500083|26620390|P2|Overall Study|Adverse Event|17
7651248|NCT01500083|26620391|P1|Overall Study|Adverse Event|4
7651249|NCT01500057|26620399|P2|Overall Study|Lost to Follow-up|4
7651250|NCT01500057|26620400|P1|Overall Study|Lost to Follow-up|6
7651251|NCT01500031|26620410|P1|Overall Study|Withdrawal by Subject|4
7651252|NCT01500031|26620410|P1|Overall Study|Death|1
7651253|NCT01499940|26620425|P1|Overall Study|Study was withdrawn before completion.|9
7651254|NCT01499849|26620449|P2|Overall Study|Other Reasons|30
7651255|NCT01499849|26620450|P1|Overall Study|Other Reasons|27
7651256|NCT01499849|26620449|P2|Overall Study|Lost to Follow-up|3
7651257|NCT01499849|26620450|P1|Overall Study|Lost to Follow-up|6
7651258|NCT01499849|26620449|P2|Overall Study|Lack of Efficacy|4
7651259|NCT01499849|26620450|P1|Overall Study|Lack of Efficacy|3
7651260|NCT01499849|26620449|P2|Overall Study|Physician Decision|19
7651261|NCT01499849|26620450|P1|Overall Study|Physician Decision|20
7651262|NCT01499849|26620449|P2|Overall Study|Protocol Violation|11
7651263|NCT01499849|26620450|P1|Overall Study|Protocol Violation|11
7651264|NCT01499849|26620449|P2|Overall Study|Disease Progression|10
7651265|NCT01499849|26620450|P1|Overall Study|Disease Progression|11
7651266|NCT01499849|26620449|P2|Overall Study|Death|7
7651267|NCT01499849|26620450|P1|Overall Study|Death|5
7651268|NCT01499849|26620449|P2|Overall Study|Withdrawal by Subject|43
7651269|NCT01499849|26620450|P1|Overall Study|Withdrawal by Subject|43
7651270|NCT01499849|26620449|P2|Overall Study|Chemo completed or Change in Therapy|67
7651271|NCT01499849|26620450|P1|Overall Study|Chemo completed or Change in Therapy|70
7651272|NCT01499849|26620449|P2|Overall Study|Adverse Event|32
7651273|NCT01499849|26620450|P1|Overall Study|Adverse Event|28
7651277|NCT01499667|26620510|P3|Overall Study|Lack of Efficacy|0
7651278|NCT01499667|26620511|P2|Overall Study|Lack of Efficacy|0
7651279|NCT01499667|26620512|P1|Overall Study|Lack of Efficacy|2
7651280|NCT01499667|26620510|P3|Overall Study|Withdrawal by Subject|1
7651281|NCT01499667|26620511|P2|Overall Study|Withdrawal by Subject|1
7651282|NCT01499667|26620512|P1|Overall Study|Withdrawal by Subject|2
7651283|NCT01499667|26620510|P3|Overall Study|Adverse Event|2
7651284|NCT01499667|26620511|P2|Overall Study|Adverse Event|2
7651285|NCT01499667|26620512|P1|Overall Study|Adverse Event|0
7651286|NCT01499667|26620510|P3|Overall Study|Protocol Violation|2
7651287|NCT01499667|26620511|P2|Overall Study|Protocol Violation|3
7651288|NCT01499667|26620512|P1|Overall Study|Protocol Violation|1
7651289|NCT01499667|26620510|P3|Overall Study|administrative problems|5
7651290|NCT01499667|26620511|P2|Overall Study|administrative problems|5
7651291|NCT01499667|26620512|P1|Overall Study|administrative problems|4
7651292|NCT01499576|26620560|P1|Overall Study|Withdrawal by Subject|9
7651293|NCT01499576|26620560|P1|Overall Study|Physician Decision|12
7651294|NCT01499511|26620568|P2|Overall Study|Death|0
7651295|NCT01499511|26620569|P1|Overall Study|Death|1
7651296|NCT01499368|26620597|P3|Overall Study|Error of Prescriptions|1
7651297|NCT01499368|26620598|P2|Overall Study|Error of Prescriptions|0
7651298|NCT01499368|26620599|P1|Overall Study|Error of Prescriptions|0
7651299|NCT01499368|26620597|P3|Overall Study|Deviation from visit window|1
7651300|NCT01499368|26620598|P2|Overall Study|Deviation from visit window|0
7651301|NCT01499368|26620599|P1|Overall Study|Deviation from visit window|0
7651302|NCT01499368|26620597|P3|Overall Study|Physician Decision|0
7651303|NCT01499368|26620598|P2|Overall Study|Physician Decision|1
7651304|NCT01499368|26620599|P1|Overall Study|Physician Decision|0
7651305|NCT01499368|26620597|P3|Overall Study|Adverse Event|2
7651306|NCT01499368|26620598|P2|Overall Study|Adverse Event|0
7651307|NCT01499368|26620599|P1|Overall Study|Adverse Event|4
7651308|NCT01499368|26620597|P3|Overall Study|Lost to Follow-up|5
7651309|NCT01499368|26620598|P2|Overall Study|Lost to Follow-up|2
7651310|NCT01499368|26620599|P1|Overall Study|Lost to Follow-up|3
7651311|NCT01499368|26620597|P3|Overall Study|Withdrawal by Subject|8
7651312|NCT01499368|26620598|P2|Overall Study|Withdrawal by Subject|10
7651313|NCT01499368|26620599|P1|Overall Study|Withdrawal by Subject|11
7651314|NCT01499368|26620597|P3|Overall Study|Prohibited Concomitant medication|0
7651315|NCT01499368|26620598|P2|Overall Study|Prohibited Concomitant medication|1
7651316|NCT01499368|26620599|P1|Overall Study|Prohibited Concomitant medication|1
7651317|NCT01499368|26620597|P3|Overall Study|Did not meet I/E criteria|4
7651318|NCT01499368|26620598|P2|Overall Study|Did not meet I/E criteria|4
7651319|NCT01499368|26620599|P1|Overall Study|Did not meet I/E criteria|8
7651320|NCT01499355|26620616|P4|Double-Blind Period|Lost to Follow-up|0
7651321|NCT01499355|26620617|P3|Double-Blind Period|Lost to Follow-up|0
7651322|NCT01499355|26620618|P2|Double-Blind Period|Lost to Follow-up|1
7651323|NCT01499355|26620619|P1|Double-Blind Period|Lost to Follow-up|0
7651324|NCT01499355|26620616|P4|Double-Blind Period|Consent Withdrawn|2
7651325|NCT01499355|26620617|P3|Double-Blind Period|Consent Withdrawn|1
7651326|NCT01499355|26620618|P2|Double-Blind Period|Consent Withdrawn|0
7651327|NCT01499355|26620619|P1|Double-Blind Period|Consent Withdrawn|0
7651328|NCT01499355|26620616|P4|Double-Blind Period|Investigator Decision|3
7651329|NCT01499355|26620617|P3|Double-Blind Period|Investigator Decision|3
7651330|NCT01499355|26620618|P2|Double-Blind Period|Investigator Decision|0
7651331|NCT01499355|26620619|P1|Double-Blind Period|Investigator Decision|0
7651332|NCT01499355|26620616|P4|Double-Blind Period|Death|0
7651333|NCT01499355|26620617|P3|Double-Blind Period|Death|0
7651334|NCT01499355|26620618|P2|Double-Blind Period|Death|1
7651335|NCT01499355|26620619|P1|Double-Blind Period|Death|0
7651336|NCT01499355|26620616|P4|Double-Blind Period|Other|2
7651337|NCT01499355|26620617|P3|Double-Blind Period|Other|2
7651338|NCT01499355|26620618|P2|Double-Blind Period|Other|1
7651339|NCT01499355|26620619|P1|Double-Blind Period|Other|0
7651340|NCT01499355|26620616|P4|Double-Blind Period|Study Termination|14
7651341|NCT01499355|26620617|P3|Double-Blind Period|Study Termination|16
7651342|NCT01499355|26620618|P2|Double-Blind Period|Study Termination|18
7651343|NCT01499355|26620619|P1|Double-Blind Period|Study Termination|0
7651344|NCT01499355|26620616|P4|Double-Blind Period|Adverse Event|2
7651345|NCT01499355|26620617|P3|Double-Blind Period|Adverse Event|3
7651346|NCT01499355|26620618|P2|Double-Blind Period|Adverse Event|2
7651347|NCT01499355|26620619|P1|Double-Blind Period|Adverse Event|0
7651348|NCT01499355|26620616|P4|Run-In Period|Adverse Event|0
7651349|NCT01499355|26620617|P3|Run-In Period|Adverse Event|0
7651350|NCT01499355|26620618|P2|Run-In Period|Adverse Event|0
7651351|NCT01499355|26620619|P1|Run-In Period|Adverse Event|8
7651352|NCT01499355|26620616|P4|Run-In Period|Consent Withdrawn|0
7651353|NCT01499355|26620617|P3|Run-In Period|Consent Withdrawn|0
7651354|NCT01499355|26620618|P2|Run-In Period|Consent Withdrawn|0
7651355|NCT01499355|26620619|P1|Run-In Period|Consent Withdrawn|1
7651356|NCT01499355|26620616|P4|Run-In Period|Investigator Decision|0
7651357|NCT01499355|26620617|P3|Run-In Period|Investigator Decision|0
7651358|NCT01499355|26620618|P2|Run-In Period|Investigator Decision|0
7651359|NCT01499355|26620619|P1|Run-In Period|Investigator Decision|2
7651360|NCT01499355|26620616|P4|Run-In Period|Death|0
7651361|NCT01499355|26620617|P3|Run-In Period|Death|0
7651362|NCT01499355|26620618|P2|Run-In Period|Death|0
7651363|NCT01499355|26620619|P1|Run-In Period|Death|2
7651364|NCT01499355|26620616|P4|Run-In Period|Other|0
7651365|NCT01499355|26620617|P3|Run-In Period|Other|0
7651366|NCT01499355|26620618|P2|Run-In Period|Other|0
7651367|NCT01499355|26620619|P1|Run-In Period|Other|3
7651368|NCT01499355|26620616|P4|Run-In Period|Study Termination|0
7651369|NCT01499355|26620617|P3|Run-In Period|Study Termination|0
7651370|NCT01499355|26620618|P2|Run-In Period|Study Termination|0
7651371|NCT01499355|26620619|P1|Run-In Period|Study Termination|15
7651372|NCT01499303|26620652|P2|Overall Study|Other|1
7651373|NCT01499303|26620653|P1|Overall Study|Other|0
7651374|NCT01499303|26620652|P2|Overall Study|Adverse Event|4
7651375|NCT01499303|26620653|P1|Overall Study|Adverse Event|1
7651376|NCT01499303|26620652|P2|Overall Study|Withdrawal by Subject|1
7651377|NCT01499303|26620653|P1|Overall Study|Withdrawal by Subject|0
7651378|NCT01499303|26620652|P2|Overall Study|Ongoing|1
7651379|NCT01499303|26620653|P1|Overall Study|Ongoing|2
7651380|NCT01499290|26620661|P2|Overall Study|Adverse Event|7
7651381|NCT01499290|26620662|P1|Overall Study|Adverse Event|14
7651382|NCT01499290|26620661|P2|Overall Study|Lack of Efficacy|8
7651383|NCT01499290|26620662|P1|Overall Study|Lack of Efficacy|7
7651384|NCT01499290|26620661|P2|Overall Study|Condition improved/subject recovered|0
7651385|NCT01499290|26620662|P1|Overall Study|Condition improved/subject recovered|1
7651386|NCT01499290|26620661|P2|Overall Study|Not specified in study report|5
7651387|NCT01499290|26620662|P1|Overall Study|Not specified in study report|11
7651388|NCT01499290|26620661|P2|Overall Study|Withdrawal by Subject|15
7651389|NCT01499290|26620662|P1|Overall Study|Withdrawal by Subject|22
7651390|NCT01499277|26620712|P2|Overall Study|Lack of therapeutic response and other|7
7651391|NCT01499277|26620713|P1|Overall Study|Lack of therapeutic response and other|8
7651392|NCT01499277|26620712|P2|Overall Study|Withdrawal by Subject|6
7651393|NCT01499277|26620713|P1|Overall Study|Withdrawal by Subject|16
7651394|NCT01499277|26620712|P2|Overall Study|Protocol Violation|3
7651395|NCT01499277|26620713|P1|Overall Study|Protocol Violation|2
7651396|NCT01499277|26620712|P2|Overall Study|Lost to Follow-up|8
7651397|NCT01499277|26620713|P1|Overall Study|Lost to Follow-up|15
7651398|NCT01499277|26620712|P2|Overall Study|Death|2
7651399|NCT01499277|26620713|P1|Overall Study|Death|3
7651400|NCT01499277|26620712|P2|Overall Study|Adverse Event|6
7651401|NCT01499277|26620713|P1|Overall Study|Adverse Event|3
7651402|NCT01499199|26620735|P1|Overall Study|Lack of Efficacy|1
7651403|NCT01499199|26620735|P1|Overall Study|Adverse Event|1
7651404|NCT01499160|26620764|P1|Overall Study|Withdrawal by Subject|1
7651405|NCT01499160|26620764|P1|Overall Study|Adverse Event|1
7651406|NCT01499134|26620787|P2|Overall Study|Withdrawal by Subject|1
7651407|NCT01499134|26620788|P1|Overall Study|Withdrawal by Subject|0
7651408|NCT01499095|26620810|P2|Overall Study|Perceived Lack of Efficacy|1
7651409|NCT01499095|26620811|P1|Overall Study|Perceived Lack of Efficacy|1
7651410|NCT01499095|26620810|P2|Overall Study|Change in Injection Schedule|0
7651411|NCT01499095|26620811|P1|Overall Study|Change in Injection Schedule|2
7651412|NCT01499095|26620810|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
7651413|NCT01499095|26620811|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
7651414|NCT01499095|26620810|P2|Overall Study|Hypoglycemia|1
7651415|NCT01499095|26620811|P1|Overall Study|Hypoglycemia|3
7651416|NCT01499095|26620810|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
7651417|NCT01499095|26620811|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
7651418|NCT01499095|26620810|P2|Overall Study|Lost to Follow-up|4
7651419|NCT01499095|26620811|P1|Overall Study|Lost to Follow-up|6
7651420|NCT01499095|26620810|P2|Overall Study|Diverse Reasons|25
7651421|NCT01499095|26620811|P1|Overall Study|Diverse Reasons|22
7651422|NCT01499095|26620810|P2|Overall Study|Received Rescue Therapy|40
7651423|NCT01499095|26620811|P1|Overall Study|Received Rescue Therapy|32
7651424|NCT01499095|26620810|P2|Overall Study|Protocol Violation|7
7651425|NCT01499095|26620811|P1|Overall Study|Protocol Violation|6
7651426|NCT01499095|26620810|P2|Overall Study|Lack of Efficacy|1
7651427|NCT01499095|26620811|P1|Overall Study|Lack of Efficacy|2
7651428|NCT01499095|26620810|P2|Overall Study|Adverse Event|7
7651429|NCT01499095|26620811|P1|Overall Study|Adverse Event|12
7651430|NCT01499095|26620810|P2|Overall Study|Randomized But Not Treated|1
7651431|NCT01499095|26620811|P1|Overall Study|Randomized But Not Treated|1
7651432|NCT01499082|26620841|P2|Overall Study|Lost to Follow-up|3
7651433|NCT01499082|26620842|P1|Overall Study|Lost to Follow-up|1
7651434|NCT01499082|26620841|P2|Overall Study|Hypoglycemia|3
7651435|NCT01499082|26620842|P1|Overall Study|Hypoglycemia|2
7651436|NCT01499082|26620841|P2|Overall Study|Site Closure for Noncompliance|2
7651437|NCT01499082|26620842|P1|Overall Study|Site Closure for Noncompliance|5
7651438|NCT01499082|26620841|P2|Overall Study|Diverse Reasons|14
7651439|NCT01499082|26620842|P1|Overall Study|Diverse Reasons|18
7651440|NCT01499082|26620841|P2|Overall Study|Protocol Violation|8
7651441|NCT01499082|26620842|P1|Overall Study|Protocol Violation|6
7651442|NCT01499082|26620841|P2|Overall Study|Lack of Efficacy|1
7651443|NCT01499082|26620842|P1|Overall Study|Lack of Efficacy|1
7651444|NCT01499082|26620841|P2|Overall Study|Adverse Event|16
7651445|NCT01499082|26620842|P1|Overall Study|Adverse Event|12
7651446|NCT01499082|26620841|P2|Overall Study|Randomized but not Treated|1
7651447|NCT01499082|26620842|P1|Overall Study|Randomized but not Treated|0
7651448|NCT01499043|26620870|P1|Overall Study|Adverse Event|1
7651449|NCT01499043|26620870|P1|Overall Study|Withdrawal by Subject|2
7651450|NCT01499043|26620870|P1|Overall Study|Progressive disease (clinical)|1
7651451|NCT01499043|26620870|P1|Overall Study|Progressive disease (radiographic)|2
7651452|NCT01498952|26620913|P5|Overall Study|Death|0
7651453|NCT01498952|26620914|P4|Overall Study|Death|0
7651454|NCT01498952|26620915|P3|Overall Study|Death|0
7651455|NCT01498952|26620916|P2|Overall Study|Death|2
7651456|NCT01498952|26620917|P1|Overall Study|Death|2
7651457|NCT01498887|26620959|P2|Overall Study|Adverse Event|1
7651458|NCT01498887|26620960|P1|Overall Study|Adverse Event|4
7651459|NCT01498887|26620959|P2|Overall Study|Abnormal laboratory value|2
7651460|NCT01498887|26620960|P1|Overall Study|Abnormal laboratory value|2
7651461|NCT01498887|26620959|P2|Overall Study|Abnormal result from test procedure|1
7651462|NCT01498887|26620960|P1|Overall Study|Abnormal result from test procedure|1
7651463|NCT01498887|26620959|P2|Overall Study|Lack of Efficacy|3
7651464|NCT01498887|26620960|P1|Overall Study|Lack of Efficacy|5
7651465|NCT01498887|26620959|P2|Overall Study|Protocol Violation|3
7651466|NCT01498887|26620960|P1|Overall Study|Protocol Violation|1
7651467|NCT01498887|26620959|P2|Overall Study|Withdrawal by Subject|0
7651468|NCT01498887|26620960|P1|Overall Study|Withdrawal by Subject|1
7651469|NCT01498887|26620959|P2|Overall Study|Lost to Follow-up|1
7651470|NCT01498887|26620960|P1|Overall Study|Lost to Follow-up|1
7651471|NCT01498887|26620959|P2|Overall Study|Administrative problems|0
7651472|NCT01498887|26620960|P1|Overall Study|Administrative problems|1
7651473|NCT01498822|26620981|P2|Overall Study|Lost to Follow-up|3
7651474|NCT01498822|26620982|P1|Overall Study|Lost to Follow-up|8
7651475|NCT01498822|26620981|P2|Overall Study|Withdrawal by Subject|25
7651476|NCT01498822|26620982|P1|Overall Study|Withdrawal by Subject|15
7651477|NCT01498822|26620981|P2|Overall Study|Adverse Event, serious fatal|1
7651478|NCT01498822|26620982|P1|Overall Study|Adverse Event, serious fatal|1
7651479|NCT01498822|26620981|P2|Overall Study|SAE, non-fatal|2
7651480|NCT01498822|26620982|P1|Overall Study|SAE, non-fatal|2
7651481|NCT01498822|26620981|P2|Overall Study|AE, non-serious non-fatal|17
7651482|NCT01498822|26620982|P1|Overall Study|AE, non-serious non-fatal|8
7651483|NCT01498822|26620981|P2|Overall Study|Lack of Efficacy|2
7651484|NCT01498822|26620982|P1|Overall Study|Lack of Efficacy|7
7651485|NCT01498822|26620981|P2|Overall Study|Other Reason|2
7651486|NCT01498822|26620982|P1|Overall Study|Other Reason|5
7651487|NCT01498822|26620981|P2|Overall Study|Protocol Violation|4
7651488|NCT01498822|26620982|P1|Overall Study|Protocol Violation|8
7651489|NCT01498692|26621009|P1|Overall Study|Missed 12-month visit|3
7651490|NCT01498692|26621009|P1|Overall Study|Withdrawal by Subject|1
7651491|NCT01498692|26621009|P1|Overall Study|Death|4
7651492|NCT01498679|26621040|P2|Overall Study|Withdrawal by Subject|4
7651493|NCT01498679|26621041|P1|Overall Study|Withdrawal by Subject|12
7651494|NCT01498679|26621040|P2|Overall Study|Physician Decision|2
7651495|NCT01498679|26621041|P1|Overall Study|Physician Decision|0
7651496|NCT01498679|26621040|P2|Overall Study|Protocol Violation|0
7651497|NCT01498679|26621041|P1|Overall Study|Protocol Violation|4
7651498|NCT01498679|26621040|P2|Overall Study|Lack of Efficacy|12
7651499|NCT01498679|26621041|P1|Overall Study|Lack of Efficacy|72
7651500|NCT01498679|26621040|P2|Overall Study|Adverse Event|4
7651501|NCT01498679|26621041|P1|Overall Study|Adverse Event|1
7651502|NCT01498653|26621057|P2|Overall Study|Withdrawal by Subject|3
7651503|NCT01498653|26621058|P1|Overall Study|Withdrawal by Subject|2
7651504|NCT01498653|26621057|P2|Overall Study|Physician Decision|0
7651505|NCT01498653|26621058|P1|Overall Study|Physician Decision|2
7651506|NCT01498653|26621057|P2|Overall Study|Lost to Follow-up|0
7651507|NCT01498653|26621058|P1|Overall Study|Lost to Follow-up|1
7651508|NCT01498653|26621057|P2|Overall Study|Protocol Violation|4
7651509|NCT01498653|26621058|P1|Overall Study|Protocol Violation|0
7651510|NCT01498653|26621057|P2|Overall Study|Lack of Efficacy|26
7651511|NCT01498653|26621058|P1|Overall Study|Lack of Efficacy|12
7651512|NCT01498653|26621057|P2|Overall Study|Adverse Event|2
7651513|NCT01498653|26621058|P1|Overall Study|Adverse Event|2
7651514|NCT01498640|26621072|P1|Overall Study|Other|3
7651515|NCT01498640|26621072|P1|Overall Study|Death|1
7651516|NCT01498640|26621072|P1|Overall Study|Lost to Follow-up|1
7651517|NCT01498575|26621102|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
7651518|NCT01498575|26621103|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
7651519|NCT01498575|26621102|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
7651520|NCT01498575|26621103|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
7651521|NCT01498575|26621102|P2|Overall Sample|Withdrawal by Subject|14
7651522|NCT01498575|26621103|P1|Overall Sample|Withdrawal by Subject|60
7651523|NCT01498458|26621120|P1|Overall Study|Physician Decision|3
7651524|NCT01498458|26621120|P1|Overall Study|Adverse Event|4
7651525|NCT01498445|26621135|P6|Overall Study|Screen Failure|1
7651526|NCT01498445|26621136|P5|Overall Study|Screen Failure|1
7651527|NCT01498445|26621137|P4|Overall Study|Screen Failure|0
7651528|NCT01498445|26621138|P3|Overall Study|Screen Failure|0
7651529|NCT01498445|26621139|P2|Overall Study|Screen Failure|0
7651530|NCT01498445|26621140|P1|Overall Study|Screen Failure|0
7651531|NCT01498445|26621135|P6|Overall Study|Lack of Efficacy|0
7651532|NCT01498445|26621136|P5|Overall Study|Lack of Efficacy|0
7651533|NCT01498445|26621137|P4|Overall Study|Lack of Efficacy|2
7651534|NCT01498445|26621138|P3|Overall Study|Lack of Efficacy|1
7651535|NCT01498445|26621139|P2|Overall Study|Lack of Efficacy|0
7651536|NCT01498445|26621140|P1|Overall Study|Lack of Efficacy|0
7651537|NCT01498289|26621215|P2|Overall Study|Reason under review|1
7651538|NCT01498289|26621216|P1|Overall Study|Reason under review|0
7651539|NCT01498289|26621215|P2|Overall Study|Not protocol specified|2
7651540|NCT01498289|26621216|P1|Overall Study|Not protocol specified|7
7651541|NCT01498289|26621215|P2|Overall Study|Progression/relapse|59
7651542|NCT01498289|26621216|P1|Overall Study|Progression/relapse|53
7651543|NCT01498289|26621215|P2|Overall Study|Withdrawal unrelated to AE|16
7651544|NCT01498289|26621216|P1|Overall Study|Withdrawal unrelated to AE|16
7651545|NCT01498289|26621215|P2|Overall Study|Death|8
7651546|NCT01498289|26621216|P1|Overall Study|Death|6
7651547|NCT01498289|26621215|P2|Overall Study|Adverse Event|18
7651548|NCT01498289|26621216|P1|Overall Study|Adverse Event|16
7651549|NCT01498185|26621237|P5|Overall Study|No longer met criteria, etc|2
7651550|NCT01498185|26621238|P4|Overall Study|No longer met criteria, etc|0
7651551|NCT01498185|26621239|P3|Overall Study|No longer met criteria, etc|0
7651552|NCT01498185|26621240|P2|Overall Study|No longer met criteria, etc|0
7651553|NCT01498185|26621241|P1|Overall Study|No longer met criteria, etc|0
7651554|NCT01498185|26621237|P5|Overall Study|Withdrawal by Subject|1
7651555|NCT01498185|26621238|P4|Overall Study|Withdrawal by Subject|2
7651556|NCT01498185|26621239|P3|Overall Study|Withdrawal by Subject|0
7651557|NCT01498185|26621240|P2|Overall Study|Withdrawal by Subject|1
7651558|NCT01498185|26621241|P1|Overall Study|Withdrawal by Subject|1
7651559|NCT01498185|26621237|P5|Overall Study|Adverse Event|0
7651560|NCT01498185|26621238|P4|Overall Study|Adverse Event|1
7651561|NCT01498185|26621239|P3|Overall Study|Adverse Event|0
7651562|NCT01498185|26621240|P2|Overall Study|Adverse Event|0
7651563|NCT01498185|26621241|P1|Overall Study|Adverse Event|0
7651564|NCT01498120|26621281|P1|Overall Study|Other|4
7651565|NCT01498120|26621281|P1|Overall Study|AE, non-serious non-fatal|3
7651566|NCT01498120|26621281|P1|Overall Study|Withdrawal by Subject|5
7651567|NCT01498120|26621281|P1|Overall Study|Lost to Follow-up|1
7651568|NCT01498068|26621288|P2|Overall Study|Withdrawal by Subject|1
7651569|NCT01498068|26621289|P1|Overall Study|Withdrawal by Subject|1
7651570|NCT01497938|26621307|P2|Overall Study|Device Violation|0
7651571|NCT01497938|26621308|P1|Overall Study|Device Violation|1
7651572|NCT01497938|26621307|P2|Overall Study|Withdrawal by Subject|0
7651573|NCT01497938|26621308|P1|Overall Study|Withdrawal by Subject|4
7651574|NCT01497938|26621307|P2|Overall Study|Physician Decision|1
7651575|NCT01497938|26621308|P1|Overall Study|Physician Decision|0
7651576|NCT01497938|26621307|P2|Overall Study|Adverse Event|1
7651577|NCT01497938|26621308|P1|Overall Study|Adverse Event|0
7651578|NCT01497899|26621320|P4|Open-Label Extension Phase|Lost to Follow-up|5
7651579|NCT01497899|26621321|P3|Open-Label Extension Phase|Lost to Follow-up|5
7651580|NCT01497899|26621322|P2|Open-Label Extension Phase|Lost to Follow-up|3
7651581|NCT01497899|26621323|P1|Open-Label Extension Phase|Lost to Follow-up|9
7651582|NCT01497899|26621320|P4|Open-Label Extension Phase|Protocol Violation|0
7651583|NCT01497899|26621321|P3|Open-Label Extension Phase|Protocol Violation|1
7651584|NCT01497899|26621322|P2|Open-Label Extension Phase|Protocol Violation|0
7651585|NCT01497899|26621323|P1|Open-Label Extension Phase|Protocol Violation|0
7651586|NCT01497899|26621320|P4|Open-Label Extension Phase|Pregnancy|0
7651587|NCT01497899|26621321|P3|Open-Label Extension Phase|Pregnancy|1
7651588|NCT01497899|26621322|P2|Open-Label Extension Phase|Pregnancy|1
7651589|NCT01497899|26621323|P1|Open-Label Extension Phase|Pregnancy|0
7651590|NCT01497899|26621320|P4|Open-Label Extension Phase|Withdrew Consent|0
7651591|NCT01497899|26621321|P3|Open-Label Extension Phase|Withdrew Consent|2
7651592|NCT01497899|26621322|P2|Open-Label Extension Phase|Withdrew Consent|3
7651593|NCT01497899|26621323|P1|Open-Label Extension Phase|Withdrew Consent|8
7651594|NCT01497899|26621320|P4|Open-Label Extension Phase|Death|0
7651595|NCT01497899|26621321|P3|Open-Label Extension Phase|Death|0
7651596|NCT01497899|26621322|P2|Open-Label Extension Phase|Death|0
7651597|NCT01497899|26621323|P1|Open-Label Extension Phase|Death|1
7651598|NCT01497899|26621320|P4|Open-Label Extension Phase|Adverse Event|0
7651599|NCT01497899|26621321|P3|Open-Label Extension Phase|Adverse Event|0
7651600|NCT01497899|26621322|P2|Open-Label Extension Phase|Adverse Event|0
7651601|NCT01497899|26621323|P1|Open-Label Extension Phase|Adverse Event|1
7651602|NCT01497899|26621320|P4|Double-Blind Phase|Subject Non-Compliance|0
7651603|NCT01497899|26621321|P3|Double-Blind Phase|Subject Non-Compliance|0
7651604|NCT01497899|26621322|P2|Double-Blind Phase|Subject Non-Compliance|1
7651605|NCT01497899|26621323|P1|Double-Blind Phase|Subject Non-Compliance|0
7651606|NCT01497899|26621320|P4|Double-Blind Phase|Lost to Follow-up|0
7651607|NCT01497899|26621321|P3|Double-Blind Phase|Lost to Follow-up|0
7651608|NCT01497899|26621322|P2|Double-Blind Phase|Lost to Follow-up|2
7651609|NCT01497899|26621323|P1|Double-Blind Phase|Lost to Follow-up|3
7651610|NCT01497899|26621320|P4|Double-Blind Phase|Withdrew Consent|0
7651611|NCT01497899|26621321|P3|Double-Blind Phase|Withdrew Consent|0
7651612|NCT01497899|26621322|P2|Double-Blind Phase|Withdrew Consent|1
7651613|NCT01497899|26621323|P1|Double-Blind Phase|Withdrew Consent|0
7651614|NCT01497899|26621320|P4|Double-Blind Phase|Investigator's Discretion|0
7651615|NCT01497899|26621321|P3|Double-Blind Phase|Investigator's Discretion|0
7651616|NCT01497899|26621322|P2|Double-Blind Phase|Investigator's Discretion|0
7651617|NCT01497899|26621323|P1|Double-Blind Phase|Investigator's Discretion|1
7651618|NCT01497899|26621320|P4|Double-Blind Phase|Lack of Efficacy|0
7651619|NCT01497899|26621321|P3|Double-Blind Phase|Lack of Efficacy|0
7651620|NCT01497899|26621322|P2|Double-Blind Phase|Lack of Efficacy|1
7651621|NCT01497899|26621323|P1|Double-Blind Phase|Lack of Efficacy|0
7651622|NCT01497899|26621320|P4|Double-Blind Phase|Adverse Event|0
7651623|NCT01497899|26621321|P3|Double-Blind Phase|Adverse Event|0
7651624|NCT01497899|26621322|P2|Double-Blind Phase|Adverse Event|0
7651625|NCT01497899|26621323|P1|Double-Blind Phase|Adverse Event|1
7651626|NCT01497899|26621320|P4|Double-Blind Phase|Randomized but not Treated|0
7651627|NCT01497899|26621321|P3|Double-Blind Phase|Randomized but not Treated|0
7651628|NCT01497899|26621322|P2|Double-Blind Phase|Randomized but not Treated|0
7651629|NCT01497899|26621323|P1|Double-Blind Phase|Randomized but not Treated|1
7651630|NCT01497366|26621421|P2|Overall Study|Randomized but not treated|21
7651631|NCT01497366|26621422|P1|Overall Study|Randomized but not treated|7
7651632|NCT01497366|26621421|P2|Overall Study|Death|1
7651633|NCT01497366|26621422|P1|Overall Study|Death|1
7651634|NCT01497366|26621421|P2|Overall Study|Other|0
7651635|NCT01497366|26621422|P1|Overall Study|Other|5
7651636|NCT01497366|26621421|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
7651637|NCT01497366|26621422|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
7651638|NCT01497366|26621421|P2|Overall Study|Withdrawal by Subject|6
7651639|NCT01497366|26621422|P1|Overall Study|Withdrawal by Subject|6
7651640|NCT01497366|26621421|P2|Overall Study|Lost to Follow-up|10
7651641|NCT01497366|26621422|P1|Overall Study|Lost to Follow-up|11
7651642|NCT01497366|26621421|P2|Overall Study|Virologic failure|50
7651643|NCT01497366|26621422|P1|Overall Study|Virologic failure|2
7651644|NCT01497275|26621440|P1|Overall Study|Adverse Event|1
7651645|NCT01497275|26621440|P1|Overall Study|Death|1
7651646|NCT01497262|26621447|P1|Overall Study|Protocol Violation|1
7651647|NCT01497262|26621447|P1|Overall Study|Adverse Event|2
7651648|NCT01497262|26621447|P1|Overall Study|Withdrawal by Subject|2
7651649|NCT01497262|26621447|P1|Overall Study|Physician Decision|1
7651650|NCT01497262|26621447|P1|Overall Study|Abnormal Test Procedure Result|1
7651651|NCT01497262|26621447|P1|Overall Study|Abnormal Lab Values|4
7651652|NCT01497197|26621454|P2|Overall Study|Other|1
7651653|NCT01497197|26621455|P1|Overall Study|Other|3
7651654|NCT01497197|26621454|P2|Overall Study|All embryos discarded|3
7651655|NCT01497197|26621455|P1|Overall Study|All embryos discarded|0
7651656|NCT01497197|26621454|P2|Overall Study|Intention to freeze all embryos|1
7651657|NCT01497197|26621455|P1|Overall Study|Intention to freeze all embryos|0
7651658|NCT01497197|26621454|P2|Overall Study|No fertilisation|5
7651659|NCT01497197|26621455|P1|Overall Study|No fertilisation|6
7651660|NCT01497197|26621454|P2|Overall Study|No oocytes retrieved|2
7651661|NCT01497197|26621455|P1|Overall Study|No oocytes retrieved|3
7651662|NCT01497197|26621454|P2|Overall Study|Risk of OHSS|0
7651663|NCT01497197|26621455|P1|Overall Study|Risk of OHSS|1
7651664|NCT01497197|26621454|P2|Overall Study|Excessive/lack of response to treatment|0
7651665|NCT01497197|26621455|P1|Overall Study|Excessive/lack of response to treatment|1
7651666|NCT01497197|26621454|P2|Overall Study|Withdrawal by Subject|1
7651667|NCT01497197|26621455|P1|Overall Study|Withdrawal by Subject|2
7651668|NCT01497197|26621454|P2|Overall Study|Protocol Violation|2
7651669|NCT01497197|26621455|P1|Overall Study|Protocol Violation|0
7651670|NCT01497197|26621454|P2|Overall Study|Lost to Follow-up|0
7651671|NCT01497197|26621455|P1|Overall Study|Lost to Follow-up|1
7651672|NCT01497067|26621490|P1|Overall Study|Other|13
7651673|NCT01497067|26621490|P1|Overall Study|Patient decision unrel to Adverse Event|10
7651674|NCT01497067|26621490|P1|Overall Study|Adverse Event|3
7651675|NCT01497067|26621490|P1|Overall Study|Lost to Follow-up|56
7651676|NCT01496885|26621495|P1|Overall Study|Death|1
7651677|NCT01496885|26621495|P1|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
7651678|NCT01496885|26621495|P1|Overall Study|Withdrawal by Subject|7
7651679|NCT01496885|26621495|P1|Overall Study|Lost to Follow-up|13
7651680|NCT01496846|26621510|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7651681|NCT01496846|26621511|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7651682|NCT01496846|26621512|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7651683|NCT01496846|26621513|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7651684|NCT01496846|26621514|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7651685|NCT01496846|26621515|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7651686|NCT01496807|26621526|P1|Overall Study|Change in diagnosis|1
7651687|NCT01496807|26621526|P1|Overall Study|Participant preference/toxicity|8
7651688|NCT01496807|26621526|P1|Overall Study|Progressive Disease|21
7651689|NCT01496612|26621536|P2|1st Intervention|Withdrawal by Subject|0
7651690|NCT01496612|26621537|P1|1st Intervention|Withdrawal by Subject|1
7651691|NCT01496612|26621536|P2|1st Intervention|Adverse Event|0
7651692|NCT01496612|26621537|P1|1st Intervention|Adverse Event|1
7651693|NCT01496469|26621559|P2|Overall Study|Other|1
7651694|NCT01496469|26621560|P1|Overall Study|Other|1
7651695|NCT01496469|26621559|P2|Overall Study|BP exceeds protocol limits|2
7651696|NCT01496469|26621560|P1|Overall Study|BP exceeds protocol limits|1
7651697|NCT01496469|26621559|P2|Overall Study|Withdrawal by Subject|4
7651698|NCT01496469|26621560|P1|Overall Study|Withdrawal by Subject|4
7651699|NCT01496469|26621559|P2|Overall Study|Lost to Follow-up|1
7651700|NCT01496469|26621560|P1|Overall Study|Lost to Follow-up|1
7651701|NCT01496469|26621559|P2|Overall Study|Protocol Violation|0
7651702|NCT01496469|26621560|P1|Overall Study|Protocol Violation|2
7651703|NCT01496469|26621559|P2|Overall Study|Adverse Event|0
7651704|NCT01496469|26621560|P1|Overall Study|Adverse Event|1
7651705|NCT01496456|26621570|P1|Overall Study|Lost to Follow-up|7
7651706|NCT01496456|26621570|P1|Overall Study|Protocol Violation|1
7651707|NCT01496430|26621583|P3|Overall Study|Other|0
7651708|NCT01496430|26621584|P2|Overall Study|Other|0
7651709|NCT01496430|26621585|P1|Overall Study|Other|2
7651710|NCT01496430|26621583|P3|Overall Study|Principal Investigator Discretion|1
7651711|NCT01496430|26621584|P2|Overall Study|Principal Investigator Discretion|1
7651712|NCT01496430|26621585|P1|Overall Study|Principal Investigator Discretion|0
7651713|NCT01496430|26621583|P3|Overall Study|Voluntary Withdrawal|6
7651714|NCT01496430|26621584|P2|Overall Study|Voluntary Withdrawal|1
7651715|NCT01496430|26621585|P1|Overall Study|Voluntary Withdrawal|2
7651716|NCT01496430|26621583|P3|Overall Study|Lost to Follow-up|1
7651717|NCT01496430|26621584|P2|Overall Study|Lost to Follow-up|3
7651718|NCT01496430|26621585|P1|Overall Study|Lost to Follow-up|2
7651719|NCT01496430|26621583|P3|Overall Study|Major Protocol Deviation|1
7651720|NCT01496430|26621584|P2|Overall Study|Major Protocol Deviation|0
7651721|NCT01496430|26621585|P1|Overall Study|Major Protocol Deviation|0
7651722|NCT01496430|26621583|P3|Overall Study|Adverse Event|1
7651723|NCT01496430|26621584|P2|Overall Study|Adverse Event|0
7651724|NCT01496430|26621585|P1|Overall Study|Adverse Event|0
7651725|NCT01496365|26621666|P7|Overall Study|Other|1
7651726|NCT01496365|26621667|P6|Overall Study|Other|0
7651727|NCT01496365|26621668|P5|Overall Study|Other|3
7651728|NCT01496365|26621669|P4|Overall Study|Other|1
7651729|NCT01496365|26621670|P3|Overall Study|Other|2
7651730|NCT01496365|26621671|P2|Overall Study|Other|4
7651731|NCT01496365|26621672|P1|Overall Study|Other|4
7651732|NCT01496365|26621666|P7|Overall Study|Lost to Follow-up|0
7651733|NCT01496365|26621667|P6|Overall Study|Lost to Follow-up|0
7651734|NCT01496365|26621668|P5|Overall Study|Lost to Follow-up|2
7651735|NCT01496365|26621669|P4|Overall Study|Lost to Follow-up|0
7651736|NCT01496365|26621670|P3|Overall Study|Lost to Follow-up|0
7651737|NCT01496365|26621671|P2|Overall Study|Lost to Follow-up|1
7651738|NCT01496365|26621672|P1|Overall Study|Lost to Follow-up|0
7651739|NCT01496365|26621666|P7|Overall Study|Lack of Efficacy|0
7651740|NCT01496365|26621667|P6|Overall Study|Lack of Efficacy|1
7651741|NCT01496365|26621668|P5|Overall Study|Lack of Efficacy|0
7651742|NCT01496365|26621669|P4|Overall Study|Lack of Efficacy|0
7651743|NCT01496365|26621670|P3|Overall Study|Lack of Efficacy|0
7651744|NCT01496365|26621671|P2|Overall Study|Lack of Efficacy|0
7651745|NCT01496365|26621672|P1|Overall Study|Lack of Efficacy|1
7651746|NCT01496365|26621666|P7|Overall Study|Protocol Violation|0
7651747|NCT01496365|26621667|P6|Overall Study|Protocol Violation|1
7651748|NCT01496365|26621668|P5|Overall Study|Protocol Violation|0
7651749|NCT01496365|26621669|P4|Overall Study|Protocol Violation|0
7651750|NCT01496365|26621670|P3|Overall Study|Protocol Violation|1
7651751|NCT01496365|26621671|P2|Overall Study|Protocol Violation|1
7651752|NCT01496365|26621672|P1|Overall Study|Protocol Violation|2
7651753|NCT01496365|26621666|P7|Overall Study|Withdrawal by Subject|1
7651754|NCT01496365|26621667|P6|Overall Study|Withdrawal by Subject|2
7651755|NCT01496365|26621668|P5|Overall Study|Withdrawal by Subject|3
7651756|NCT01496365|26621669|P4|Overall Study|Withdrawal by Subject|1
7651757|NCT01496365|26621670|P3|Overall Study|Withdrawal by Subject|0
7651758|NCT01496365|26621671|P2|Overall Study|Withdrawal by Subject|6
7651759|NCT01496365|26621672|P1|Overall Study|Withdrawal by Subject|6
7651760|NCT01496365|26621666|P7|Overall Study|Adverse Event|4
7651761|NCT01496365|26621667|P6|Overall Study|Adverse Event|6
7651762|NCT01496365|26621668|P5|Overall Study|Adverse Event|5
7651763|NCT01496365|26621669|P4|Overall Study|Adverse Event|2
7651764|NCT01496365|26621670|P3|Overall Study|Adverse Event|3
7651765|NCT01496365|26621671|P2|Overall Study|Adverse Event|3
7651766|NCT01496365|26621672|P1|Overall Study|Adverse Event|2
7651767|NCT01496287|26621810|P1|Overall Study|Incomplete anesthesia|5
7651768|NCT01496287|26621810|P1|Overall Study|Lost to Follow-up|1
7651769|NCT01496274|26621820|P2|Overall Study|Lost to Follow-up|3
7651770|NCT01496274|26621821|P1|Overall Study|Lost to Follow-up|0
7651771|NCT01496274|26621820|P2|Overall Study|Withdrawal by Subject|0
7651772|NCT01496274|26621821|P1|Overall Study|Withdrawal by Subject|2
7651773|NCT01496274|26621820|P2|Overall Study|Adverse Event|1
7651774|NCT01496274|26621821|P1|Overall Study|Adverse Event|1
7651775|NCT01496274|26621820|P2|Overall Study|Protocol Violation|1
7651776|NCT01496274|26621821|P1|Overall Study|Protocol Violation|0
7651777|NCT01496183|26621866|P2|Overall Study|Withdrawal by Subject|1
7651778|NCT01496183|26621867|P1|Overall Study|Withdrawal by Subject|0
7651779|NCT01496183|26621866|P2|Overall Study|Physician Decision|1
7651780|NCT01496183|26621867|P1|Overall Study|Physician Decision|3
7651781|NCT01496066|26621919|P2|Overall Study|Death|4
7651782|NCT01496066|26621920|P1|Overall Study|Death|1
7651783|NCT01496066|26621919|P2|Overall Study|Explant|0
7651784|NCT01496066|26621920|P1|Overall Study|Explant|3
7651785|NCT01496066|26621919|P2|Overall Study|Lost to Follow-up|5
7651786|NCT01496066|26621920|P1|Overall Study|Lost to Follow-up|8
7651787|NCT01495975|26621982|P2|Overall Study|Lost to Follow-up|0
7651788|NCT01495975|26621983|P1|Overall Study|Lost to Follow-up|1
7651789|NCT01495793|26622118|P1|Overall Study|Violation of inclusion criteria|1
7651790|NCT01495793|26622118|P1|Overall Study|Lost to Follow-up|1
7651791|NCT01495702|26622131|P2|Randomized Phase|Protocol Violation|1
7651792|NCT01495702|26622132|P1|Randomized Phase|Protocol Violation|3
7651793|NCT01495702|26622131|P2|Randomized Phase|Participant Noncompliance|0
7651794|NCT01495702|26622132|P1|Randomized Phase|Participant Noncompliance|1
7651795|NCT01495702|26622131|P2|Randomized Phase|Lost to Follow-up|3
7651796|NCT01495702|26622132|P1|Randomized Phase|Lost to Follow-up|4
7651797|NCT01495702|26622131|P2|Randomized Phase|Withdrew Consent|18
7651798|NCT01495702|26622132|P1|Randomized Phase|Withdrew Consent|10
7651799|NCT01495702|26622131|P2|Randomized Phase|Investigators Discretion|0
7651800|NCT01495702|26622132|P1|Randomized Phase|Investigators Discretion|2
7651801|NCT01495702|26622131|P2|Randomized Phase|Lack of Efficacy|0
7651802|NCT01495702|26622132|P1|Randomized Phase|Lack of Efficacy|2
7651803|NCT01495702|26622131|P2|Randomized Phase|Death|0
7651804|NCT01495702|26622132|P1|Randomized Phase|Death|1
7651805|NCT01495702|26622131|P2|Randomized Phase|Adverse Event|2
7651806|NCT01495702|26622132|P1|Randomized Phase|Adverse Event|2
7651807|NCT01495702|26622131|P2|Randomized Phase|Randomized But Not Treated|4
7651808|NCT01495702|26622132|P1|Randomized Phase|Randomized But Not Treated|1
7651809|NCT01495000|26622210|P2|Overall Study|Withdrawal by Subject|10
7651810|NCT01495000|26622211|P1|Overall Study|Withdrawal by Subject|10
7651811|NCT01495000|26622210|P2|Overall Study|Protocol Violation|0
7651812|NCT01495000|26622211|P1|Overall Study|Protocol Violation|1
7651813|NCT01495000|26622210|P2|Overall Study|Lost to Follow-up|2
7651814|NCT01495000|26622211|P1|Overall Study|Lost to Follow-up|2
7651815|NCT01494987|26622253|P2|Overall Study|Subject Withdrew Consent|3
7651816|NCT01494987|26622254|P1|Overall Study|Subject Withdrew Consent|2
7651817|NCT01494987|26622253|P2|Overall Study|Subject Non-Compliance|10
7651818|NCT01494987|26622254|P1|Overall Study|Subject Non-Compliance|9
7651819|NCT01494987|26622253|P2|Overall Study|Protocol Violation|3
7651820|NCT01494987|26622254|P1|Overall Study|Protocol Violation|3
7651821|NCT01494987|26622253|P2|Overall Study|Lost to Follow-up|1
7651822|NCT01494987|26622254|P1|Overall Study|Lost to Follow-up|1
7651823|NCT01494987|26622253|P2|Overall Study|Investigator's Discretion|2
7651824|NCT01494987|26622254|P1|Overall Study|Investigator's Discretion|1
7651825|NCT01494987|26622253|P2|Overall Study|Hyperglycemia|4
7651826|NCT01494987|26622254|P1|Overall Study|Hyperglycemia|6
7651827|NCT01494987|26622253|P2|Overall Study|Adverse Event|5
7651828|NCT01494987|26622254|P1|Overall Study|Adverse Event|6
7651829|NCT01494922|26622266|P1|Overall Study|Adverse Event|1
7651830|NCT01494818|26622281|P2|Overall Study|Lost to Follow-up|0
7651831|NCT01494818|26622282|P1|Overall Study|Lost to Follow-up|1
7651832|NCT01494818|26622281|P2|Overall Study|Relocation|2
7651833|NCT01494818|26622282|P1|Overall Study|Relocation|1
7651834|NCT01494649|26622313|P2|Overall Study|Lost to Follow-up|1
7651835|NCT01494649|26622314|P1|Overall Study|Lost to Follow-up|0
7651836|NCT01494610|26622330|P2|Period 4|Protocol Violation|0
7651837|NCT01494610|26622331|P1|Period 4|Protocol Violation|1
7651838|NCT01494610|26622330|P2|Period 3|Withdrawal by Subject|0
7651839|NCT01494610|26622331|P1|Period 3|Withdrawal by Subject|1
7651840|NCT01494610|26622330|P2|Period 3|Adverse Event|0
7651841|NCT01494610|26622331|P1|Period 3|Adverse Event|1
7651842|NCT01494610|26622330|P2|Period 1|Withdrawal by Subject|1
7651843|NCT01494610|26622331|P1|Period 1|Withdrawal by Subject|1
7651844|NCT01494584|26622399|P1|Overall Study|Study Closed/Terminated|1
7651845|NCT01494532|26622531|P6|Overall Study|Withdrawal by Subject|0
7651846|NCT01494532|26622532|P5|Overall Study|Withdrawal by Subject|2
7651847|NCT01494532|26622533|P4|Overall Study|Withdrawal by Subject|3
7651848|NCT01494532|26622534|P3|Overall Study|Withdrawal by Subject|4
7651849|NCT01494532|26622535|P2|Overall Study|Withdrawal by Subject|1
7651850|NCT01494532|26622536|P1|Overall Study|Withdrawal by Subject|3
7651851|NCT01494532|26622531|P6|Overall Study|Physician Decision|0
7651852|NCT01494532|26622532|P5|Overall Study|Physician Decision|0
7651853|NCT01494532|26622533|P4|Overall Study|Physician Decision|2
7651854|NCT01494532|26622534|P3|Overall Study|Physician Decision|1
7651855|NCT01494532|26622535|P2|Overall Study|Physician Decision|1
7651856|NCT01494532|26622536|P1|Overall Study|Physician Decision|0
7651857|NCT01494532|26622531|P6|Overall Study|Lost to Follow-up|0
7651858|NCT01494532|26622532|P5|Overall Study|Lost to Follow-up|0
7651859|NCT01494532|26622533|P4|Overall Study|Lost to Follow-up|2
7651860|NCT01494532|26622534|P3|Overall Study|Lost to Follow-up|0
7651861|NCT01494532|26622535|P2|Overall Study|Lost to Follow-up|0
7651862|NCT01494532|26622536|P1|Overall Study|Lost to Follow-up|1
7651863|NCT01494532|26622531|P6|Overall Study|Protocol-defined stopping criteria|0
7651864|NCT01494532|26622532|P5|Overall Study|Protocol-defined stopping criteria|0
7651865|NCT01494532|26622533|P4|Overall Study|Protocol-defined stopping criteria|0
7651866|NCT01494532|26622534|P3|Overall Study|Protocol-defined stopping criteria|1
7651867|NCT01494532|26622535|P2|Overall Study|Protocol-defined stopping criteria|0
7651868|NCT01494532|26622536|P1|Overall Study|Protocol-defined stopping criteria|0
7651869|NCT01494532|26622531|P6|Overall Study|Protocol deviation|0
7651870|NCT01494532|26622532|P5|Overall Study|Protocol deviation|3
7651871|NCT01494532|26622533|P4|Overall Study|Protocol deviation|2
7651872|NCT01494532|26622534|P3|Overall Study|Protocol deviation|3
7651873|NCT01494532|26622535|P2|Overall Study|Protocol deviation|1
7651874|NCT01494532|26622536|P1|Overall Study|Protocol deviation|2
7651875|NCT01494532|26622531|P6|Overall Study|Lack of Efficacy|0
7651876|NCT01494532|26622532|P5|Overall Study|Lack of Efficacy|2
7651877|NCT01494532|26622533|P4|Overall Study|Lack of Efficacy|0
7651878|NCT01494532|26622534|P3|Overall Study|Lack of Efficacy|0
7651879|NCT01494532|26622535|P2|Overall Study|Lack of Efficacy|0
7651880|NCT01494532|26622536|P1|Overall Study|Lack of Efficacy|0
7651881|NCT01494532|26622531|P6|Overall Study|Adverse Event|0
7651882|NCT01494532|26622532|P5|Overall Study|Adverse Event|5
7651883|NCT01494532|26622533|P4|Overall Study|Adverse Event|6
7651884|NCT01494532|26622534|P3|Overall Study|Adverse Event|8
7651885|NCT01494532|26622535|P2|Overall Study|Adverse Event|1
7651886|NCT01494532|26622536|P1|Overall Study|Adverse Event|4
7651887|NCT01494506|26622691|P3|Overall Study|Other|1
7651888|NCT01494506|26622692|P2|Overall Study|Other|3
7651889|NCT01494506|26622693|P1|Overall Study|Other|0
7651890|NCT01494506|26622691|P3|Overall Study|Sponsor Decision|1
7651891|NCT01494506|26622692|P2|Overall Study|Sponsor Decision|0
7651892|NCT01494506|26622693|P1|Overall Study|Sponsor Decision|0
7651893|NCT01494506|26622691|P3|Overall Study|Clinical Deterioration|13
7651894|NCT01494506|26622692|P2|Overall Study|Clinical Deterioration|17
7651895|NCT01494506|26622693|P1|Overall Study|Clinical Deterioration|21
7651896|NCT01494506|26622691|P3|Overall Study|Withdrawal by Subject|14
7651897|NCT01494506|26622692|P2|Overall Study|Withdrawal by Subject|20
7651898|NCT01494506|26622693|P1|Overall Study|Withdrawal by Subject|17
7651899|NCT01494506|26622691|P3|Overall Study|Physician Decision|4
7651900|NCT01494506|26622692|P2|Overall Study|Physician Decision|5
7651901|NCT01494506|26622693|P1|Overall Study|Physician Decision|7
7651902|NCT01494506|26622691|P3|Overall Study|Death|2
7651903|NCT01494506|26622692|P2|Overall Study|Death|5
7651904|NCT01494506|26622693|P1|Overall Study|Death|9
7651905|NCT01494506|26622691|P3|Overall Study|Adverse Event|11
7651906|NCT01494506|26622692|P2|Overall Study|Adverse Event|10
7651907|NCT01494506|26622693|P1|Overall Study|Adverse Event|17
7651908|NCT01494506|26622691|P3|Overall Study|Lack of Efficacy|57
7651909|NCT01494506|26622692|P2|Overall Study|Lack of Efficacy|83
7651910|NCT01494506|26622693|P1|Overall Study|Lack of Efficacy|77
7651911|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
7651912|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
7651913|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7651914|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
7651915|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
7651916|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
7651917|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
7651918|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
7651919|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7651920|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
7651921|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7651922|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
7651923|NCT01494467|26622730|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
7651924|NCT01494467|26622731|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
7651925|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7651926|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7651927|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Other|1
7651928|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Other|1
7651929|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7651930|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7651931|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
7651932|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
7651933|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
7651934|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
7651935|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7651936|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
7651937|NCT01494467|26622730|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7651938|NCT01494467|26622731|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
7651939|NCT01494350|26622747|P1|Overall Study|Worsening of lesion|1
7651940|NCT01494298|26622757|P2|Overall Study|Protocol Violation|8
7651941|NCT01494298|26622758|P1|Overall Study|Protocol Violation|2
7651942|NCT01494038|26622781|P2|Overall Study|Death|4
7651943|NCT01494038|26622782|P1|Overall Study|Death|2
7651944|NCT01494038|26622781|P2|Overall Study|Not willing to adhere to reqs|9
7651945|NCT01494038|26622782|P1|Overall Study|Not willing to adhere to reqs|2
7651946|NCT01494038|26622781|P2|Overall Study|Not able to get to clinic|15
7651947|NCT01494038|26622782|P1|Overall Study|Not able to get to clinic|21
7651948|NCT01494038|26622781|P2|Overall Study|Withdrawal by Subject|34
7651949|NCT01494038|26622782|P1|Overall Study|Withdrawal by Subject|44
7651950|NCT01494038|26622781|P2|Overall Study|Lost to Follow-up|20
7651951|NCT01494038|26622782|P1|Overall Study|Lost to Follow-up|18
7651952|NCT01494038|26622781|P2|Overall Study|Protocol Violation|1
7651953|NCT01494038|26622782|P1|Overall Study|Protocol Violation|1
7651954|NCT01493960|26622870|P2|Overall Study|Non-specified|4
7651955|NCT01493960|26622871|P1|Overall Study|Non-specified|4
7651956|NCT01493960|26622870|P2|Overall Study|Withdrawal by Subject|4
7651957|NCT01493960|26622871|P1|Overall Study|Withdrawal by Subject|10
7651958|NCT01493960|26622870|P2|Overall Study|Protocol Violation|0
7651959|NCT01493960|26622871|P1|Overall Study|Protocol Violation|3
7651960|NCT01493960|26622870|P2|Overall Study|Lack of Efficacy|9
7651961|NCT01493960|26622871|P1|Overall Study|Lack of Efficacy|15
7651962|NCT01493960|26622870|P2|Overall Study|Adverse Event|1
7651963|NCT01493960|26622871|P1|Overall Study|Adverse Event|0
7651964|NCT01493778|26622902|P1|Overall Study|Withdrawal by Subject|8
7651965|NCT01493687|26622964|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
7651966|NCT01493687|26622965|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
7651967|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
7651968|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
7651969|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7651970|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
7651971|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
7651972|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
7651973|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
7651974|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
7651975|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
7651976|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7651977|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7651978|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
7651979|NCT01493687|26622964|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
7651980|NCT01493687|26622965|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
7651981|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7651982|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7651983|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7651984|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
7651985|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
7651986|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
7651987|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
7651988|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
7651989|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7651990|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
7651991|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7651992|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7651993|NCT01493687|26622964|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7651994|NCT01493687|26622965|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
7651995|NCT01493557|26623011|P3|Adding the Second Strategy|Withdrawal by Subject|0
7651996|NCT01493557|26623012|P2|Adding the Second Strategy|Withdrawal by Subject|1
7651997|NCT01493557|26623013|P1|Adding the Second Strategy|Withdrawal by Subject|0
7651998|NCT01493557|26623011|P3|Adding the Second Strategy|Other adverse event|0
7651999|NCT01493557|26623012|P2|Adding the Second Strategy|Other adverse event|2
7652000|NCT01493557|26623013|P1|Adding the Second Strategy|Other adverse event|1
7652001|NCT01493557|26623011|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
7652002|NCT01493557|26623012|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
7652003|NCT01493557|26623013|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
7652004|NCT01493557|26623011|P3|Randomized to Management Strategies|Other than stated above|0
7652005|NCT01493557|26623012|P2|Randomized to Management Strategies|Other than stated above|3
7652006|NCT01493557|26623013|P1|Randomized to Management Strategies|Other than stated above|1
7652007|NCT01493557|26623011|P3|Randomized to Management Strategies|Withdrawal by Subject|0
7652008|NCT01493557|26623012|P2|Randomized to Management Strategies|Withdrawal by Subject|1
7652009|NCT01493557|26623013|P1|Randomized to Management Strategies|Withdrawal by Subject|0
7652010|NCT01493557|26623011|P3|Randomized to Management Strategies|Protocol Violation|0
7652011|NCT01493557|26623012|P2|Randomized to Management Strategies|Protocol Violation|0
7652012|NCT01493557|26623013|P1|Randomized to Management Strategies|Protocol Violation|3
7652013|NCT01493557|26623011|P3|Randomized to Management Strategies|Other adverse event|0
7652014|NCT01493557|26623012|P2|Randomized to Management Strategies|Other adverse event|5
7652015|NCT01493557|26623013|P1|Randomized to Management Strategies|Other adverse event|8
7652016|NCT01493557|26623011|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
7652017|NCT01493557|26623012|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
7652018|NCT01493557|26623013|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
7652019|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Other than stated above|21
7652020|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Other than stated above|0
7652021|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Other than stated above|0
7652022|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Early termination|34
7652023|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Early termination|0
7652024|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Early termination|0
7652025|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
7652026|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
7652027|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
7652028|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
7652029|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
7652030|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
7652031|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Protocol Violation|1
7652032|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Protocol Violation|0
7652033|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Protocol Violation|0
7652034|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Other adverse event|54
7652035|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Other adverse event|0
7652036|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Other adverse event|0
7652037|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
7652038|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7652039|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7652040|NCT01493557|26623011|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
7652041|NCT01493557|26623012|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7652042|NCT01493557|26623013|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7652043|NCT01493531|26623041|P3|Overall Study|Death|0
7652044|NCT01493531|26623042|P2|Overall Study|Death|1
7652045|NCT01493531|26623043|P1|Overall Study|Death|0
7652046|NCT01493531|26623041|P3|Overall Study|Withdrawal by Subject|11
7652047|NCT01493531|26623042|P2|Overall Study|Withdrawal by Subject|13
7652048|NCT01493531|26623043|P1|Overall Study|Withdrawal by Subject|16
7652049|NCT01493531|26623041|P3|Overall Study|Lost to Follow-up|11
7652050|NCT01493531|26623042|P2|Overall Study|Lost to Follow-up|7
7652051|NCT01493531|26623043|P1|Overall Study|Lost to Follow-up|5
7652052|NCT01493531|26623041|P3|Overall Study|Sponsor terminated study|3
7652053|NCT01493531|26623042|P2|Overall Study|Sponsor terminated study|2
7652054|NCT01493531|26623043|P1|Overall Study|Sponsor terminated study|5
7652055|NCT01493531|26623041|P3|Overall Study|Protocol Violation|12
7652056|NCT01493531|26623042|P2|Overall Study|Protocol Violation|15
7652057|NCT01493531|26623043|P1|Overall Study|Protocol Violation|8
7652058|NCT01493531|26623041|P3|Overall Study|Gout flare|2
7652059|NCT01493531|26623042|P2|Overall Study|Gout flare|0
7652060|NCT01493531|26623043|P1|Overall Study|Gout flare|3
7652061|NCT01493531|26623041|P3|Overall Study|Adverse Event|9
7652062|NCT01493531|26623042|P2|Overall Study|Adverse Event|12
7652063|NCT01493531|26623043|P1|Overall Study|Adverse Event|4
7652064|NCT01493427|26623057|P1|Overall Study|Other|2
7652065|NCT01493427|26623057|P1|Overall Study|Inability to Follow Instructions|2
7652066|NCT01493427|26623057|P1|Overall Study|Lost to Follow-up|2
7652067|NCT01493427|26623057|P1|Overall Study|Personal Reasons|4
7652068|NCT01493427|26623057|P1|Overall Study|Adverse Event|10
7652069|NCT01493414|26623062|P1|Overall Study|Lost to Follow-up|16
7652070|NCT01493414|26623062|P1|Overall Study|Administrative problems|25
7652071|NCT01493414|26623062|P1|Overall Study|Protocol deviation|27
7652072|NCT01493414|26623062|P1|Overall Study|Withdrawal by Subject|79
7652073|NCT01493414|26623062|P1|Overall Study|Physician Decision|93
7652074|NCT01493414|26623062|P1|Overall Study|Death|101
7652075|NCT01493414|26623062|P1|Overall Study|Disease progression|204
7652076|NCT01493414|26623062|P1|Overall Study|Adverse Event|405
7652077|NCT01493284|26623075|P1|Overall Study|Withdrawal by Subject|32
7652078|NCT01493284|26623075|P1|Overall Study|Death|29
7652079|NCT01493089|26623097|P2|Overall Study|Physician Decision|1
7652080|NCT01493089|26623098|P1|Overall Study|Physician Decision|0
7652081|NCT01493089|26623097|P2|Overall Study|Withdrawal by Subject|0
7652082|NCT01493089|26623098|P1|Overall Study|Withdrawal by Subject|1
7652083|NCT01493089|26623097|P2|Overall Study|Protocol Violation|2
7652084|NCT01493089|26623098|P1|Overall Study|Protocol Violation|2
7652085|NCT01492686|26623197|P2|Open-label Phase|Due to a discontinuation criterion|9
7652086|NCT01492686|26623198|P1|Open-label Phase|Due to a discontinuation criterion|4
7652087|NCT01492686|26623197|P2|Open-label Phase|Withdrawal by Subject|7
7652088|NCT01492686|26623198|P1|Open-label Phase|Withdrawal by Subject|6
7652089|NCT01492686|26623197|P2|Open-label Phase|Physician Decision|0
7652090|NCT01492686|26623198|P1|Open-label Phase|Physician Decision|1
7652091|NCT01492686|26623197|P2|Open-label Phase|Adverse Event|2
7652092|NCT01492686|26623198|P1|Open-label Phase|Adverse Event|1
7652093|NCT01492686|26623197|P2|Double-blind Phase|Due to a discontinuation criterion|3
7652094|NCT01492686|26623198|P1|Double-blind Phase|Due to a discontinuation criterion|2
7652095|NCT01492686|26623197|P2|Double-blind Phase|Withdrawal by Subject|2
7652096|NCT01492686|26623198|P1|Double-blind Phase|Withdrawal by Subject|0
7652097|NCT01492686|26623197|P2|Double-blind Phase|Physician Decision|1
7652098|NCT01492686|26623198|P1|Double-blind Phase|Physician Decision|0
7652099|NCT01492686|26623197|P2|Double-blind Phase|Adverse Event|2
7652100|NCT01492686|26623198|P1|Double-blind Phase|Adverse Event|0
7652101|NCT01492439|26623255|P2|Overall Study|Withdrew from RTE|9
7652102|NCT01492439|26623256|P1|Overall Study|Withdrew from RTE|4
7652103|NCT01492426|26623304|P2|Follow-Up|Lost to Follow-up|6
7652104|NCT01492426|26623305|P1|Follow-Up|Lost to Follow-up|12
7652105|NCT01492426|26623304|P2|Follow-Up|Participant Withdrew Consent|1
7652106|NCT01492426|26623305|P1|Follow-Up|Participant Withdrew Consent|6
7652107|NCT01492426|26623304|P2|Follow-Up|Other|2
7652108|NCT01492426|26623305|P1|Follow-Up|Other|4
7652109|NCT01492426|26623304|P2|Follow-Up|Death|0
7652110|NCT01492426|26623305|P1|Follow-Up|Death|1
7652111|NCT01492426|26623304|P2|Follow-Up|Protocol Requires no Follow-Up|1
7652112|NCT01492426|26623305|P1|Follow-Up|Protocol Requires no Follow-Up|2
7652113|NCT01492426|26623304|P2|Treatment|Participant does not meet study criteria|0
7652114|NCT01492426|26623305|P1|Treatment|Participant does not meet study criteria|1
7652115|NCT01492426|26623304|P2|Treatment|Lost to Follow-up|4
7652116|NCT01492426|26623305|P1|Treatment|Lost to Follow-up|9
7652117|NCT01492426|26623304|P2|Treatment|Subject requested discontinue study drug|3
7652118|NCT01492426|26623305|P1|Treatment|Subject requested discontinue study drug|7
7652119|NCT01492426|26623304|P2|Treatment|Poor compliance/noncompliance|0
7652120|NCT01492426|26623305|P1|Treatment|Poor compliance/noncompliance|1
7652121|NCT01492426|26623304|P2|Treatment|Participant withdrew consent|2
7652122|NCT01492426|26623305|P1|Treatment|Participant withdrew consent|1
7652123|NCT01492426|26623304|P2|Treatment|Lack of Efficacy|5
7652124|NCT01492426|26623305|P1|Treatment|Lack of Efficacy|38
7652125|NCT01492426|26623304|P2|Treatment|Adverse Event|25
7652126|NCT01492426|26623305|P1|Treatment|Adverse Event|25
7652127|NCT01492426|26623304|P2|Treatment|Other|0
7652128|NCT01492426|26623305|P1|Treatment|Other|1
7652129|NCT01492426|26623304|P2|Treatment|Death|1
7652130|NCT01492426|26623305|P1|Treatment|Death|0
7652131|NCT01492400|26623323|P2|Overall Study|Adverse Event|5
7652132|NCT01492400|26623324|P1|Overall Study|Adverse Event|10
7652133|NCT01492400|26623323|P2|Overall Study|Lack of Efficacy|1
7652134|NCT01492400|26623324|P1|Overall Study|Lack of Efficacy|1
7652135|NCT01492400|26623323|P2|Overall Study|Pregnancy|1
7652136|NCT01492400|26623324|P1|Overall Study|Pregnancy|0
7652137|NCT01492400|26623323|P2|Overall Study|Lost to Follow-up|1
7652138|NCT01492400|26623324|P1|Overall Study|Lost to Follow-up|3
7652139|NCT01492400|26623323|P2|Overall Study|Personal Reasons|5
7652140|NCT01492400|26623324|P1|Overall Study|Personal Reasons|0
7652141|NCT01492400|26623323|P2|Overall Study|Miscellaneous Reasons|3
7652142|NCT01492400|26623324|P1|Overall Study|Miscellaneous Reasons|2
7652143|NCT01492101|26623347|P2|Overall Study|Lost to Follow-up|2
7652144|NCT01492101|26623348|P1|Overall Study|Lost to Follow-up|0
7652145|NCT01492101|26623347|P2|Overall Study|Withdrawal by Subject|18
7652146|NCT01492101|26623348|P1|Overall Study|Withdrawal by Subject|14
7652147|NCT01492101|26623347|P2|Overall Study|Death|322
7652148|NCT01492101|26623348|P1|Overall Study|Death|323
7652149|NCT01492088|26623378|P3|Overall Study|Alive at Last Follow-up|11
7652150|NCT01492088|26623379|P2|Overall Study|Alive at Last Follow-up|6
7652151|NCT01492088|26623380|P1|Overall Study|Alive at Last Follow-up|0
7652152|NCT01492088|26623378|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
7652153|NCT01492088|26623379|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
7652154|NCT01492088|26623380|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
7652155|NCT01492088|26623378|P3|Overall Study|Death|2
7652156|NCT01492088|26623379|P2|Overall Study|Death|6
7652157|NCT01492088|26623380|P1|Overall Study|Death|1
7652158|NCT01492088|26623378|P3|Overall Study|Withdrawal by Patient|0
7652159|NCT01492088|26623379|P2|Overall Study|Withdrawal by Patient|2
7652160|NCT01492088|26623380|P1|Overall Study|Withdrawal by Patient|0
7652161|NCT01491945|26623458|P1|Overall Study|Missed Visit|1
7652162|NCT01491945|26623458|P1|Overall Study|Conversion|4
7652163|NCT01491945|26623458|P1|Overall Study|Withdrwan/LTF|16
7652164|NCT01491945|26623458|P1|Overall Study|Death|30
7652165|NCT01491919|26623477|P3|Overall Study|Insufficient PK sampling|1
7652166|NCT01491919|26623478|P2|Overall Study|Insufficient PK sampling|2
7652167|NCT01491919|26623479|P1|Overall Study|Insufficient PK sampling|1
7652168|NCT01491854|26623550|P1|Overall Study|Lost to Follow-up|33
7652169|NCT01491854|26623550|P1|Overall Study|Withdrawal by Subject|3
7652170|NCT01491854|26623550|P1|Overall Study|Death|1
7652171|NCT01491854|26623550|P1|Overall Study|mainly due to premature termination|93
7652172|NCT01491841|26623561|P1|Overall Study|Withdrawal by Subject|1
7652173|NCT01491841|26623561|P1|Overall Study|Screen Failure|10
7652174|NCT01491802|26623575|P2|Overall Study|Withdrawal by Subject|1
7652175|NCT01491802|26623576|P1|Overall Study|Withdrawal by Subject|0
7652176|NCT01491802|26623575|P2|Overall Study|Adverse Event|1
7652177|NCT01491802|26623576|P1|Overall Study|Adverse Event|1
7652178|NCT01491737|26623603|P2|Overall Study|Reason Not Specified|9
7652179|NCT01491737|26623604|P1|Overall Study|Reason Not Specified|8
7652180|NCT01491737|26623603|P2|Overall Study|Study Termination by Sponsor|36
7652181|NCT01491737|26623604|P1|Overall Study|Study Termination by Sponsor|36
7652182|NCT01491737|26623603|P2|Overall Study|Death|57
7652183|NCT01491737|26623604|P1|Overall Study|Death|63
7652184|NCT01491737|26623603|P2|Overall Study|Lost to Follow-up|10
7652185|NCT01491737|26623604|P1|Overall Study|Lost to Follow-up|2
7652186|NCT01491737|26623603|P2|Overall Study|Withdrawal by Subject|17
7652187|NCT01491737|26623604|P1|Overall Study|Withdrawal by Subject|20
7652188|NCT01491672|26623631|P3|Overall Study|Death|0
7652189|NCT01491672|26623632|P2|Overall Study|Death|4
7652190|NCT01491672|26623633|P1|Overall Study|Death|0
7652191|NCT01491672|26623631|P3|Overall Study|Protocol deviation|0
7652192|NCT01491672|26623632|P2|Overall Study|Protocol deviation|1
7652193|NCT01491672|26623633|P1|Overall Study|Protocol deviation|0
7652194|NCT01491672|26623631|P3|Overall Study|Disease progression|6
7652195|NCT01491672|26623632|P2|Overall Study|Disease progression|34
7652196|NCT01491672|26623633|P1|Overall Study|Disease progression|42
7652197|NCT01491672|26623631|P3|Overall Study|Adverse Event|4
7652198|NCT01491672|26623632|P2|Overall Study|Adverse Event|10
7652199|NCT01491672|26623633|P1|Overall Study|Adverse Event|8
7652200|NCT01491672|26623631|P3|Overall Study|Withdrawal by Subject|0
7652201|NCT01491672|26623632|P2|Overall Study|Withdrawal by Subject|7
7652202|NCT01491672|26623633|P1|Overall Study|Withdrawal by Subject|6
7652203|NCT01491672|26623631|P3|Overall Study|Lost to Follow-up|1
7652204|NCT01491672|26623632|P2|Overall Study|Lost to Follow-up|4
7652205|NCT01491672|26623633|P1|Overall Study|Lost to Follow-up|0
7652206|NCT01491607|26623670|P1|Overall Study|Withdrawal by Subject|3
7652207|NCT01491607|26623670|P1|Overall Study|Lost to Follow-up|7
7652208|NCT01491178|26623775|P1|Overall Study|Other than specified above|657
7652209|NCT01491178|26623775|P1|Overall Study|To take a contraindication|20
7652210|NCT01491178|26623775|P1|Overall Study|Lost to follow-up (changing hospital)|545
7652211|NCT01491178|26623775|P1|Overall Study|Lost to follow-up (unknown reason)|287
7652212|NCT01491178|26623775|P1|Overall Study|To conduct invasive treatment|59
7652213|NCT01491178|26623775|P1|Overall Study|Improvement of NVAF|210
7652214|NCT01491178|26623775|P1|Overall Study|Adverse Event|1016
7652215|NCT01491035|26623884|P8|Overall Study|Lost to Follow-up|0
7652216|NCT01491035|26623885|P7|Overall Study|Lost to Follow-up|0
7652217|NCT01491035|26623886|P6|Overall Study|Lost to Follow-up|0
7652218|NCT01491035|26623887|P5|Overall Study|Lost to Follow-up|1
7652219|NCT01491035|26623888|P4|Overall Study|Lost to Follow-up|0
7652220|NCT01491035|26623889|P3|Overall Study|Lost to Follow-up|0
7652221|NCT01491035|26623890|P2|Overall Study|Lost to Follow-up|0
7652222|NCT01491035|26623891|P1|Overall Study|Lost to Follow-up|0
7652223|NCT01490918|26623995|P3|Overall Study|other cause|8
7652224|NCT01490918|26623996|P2|Overall Study|other cause|5
7652225|NCT01490918|26623997|P1|Overall Study|other cause|4
7652226|NCT01490918|26623995|P3|Overall Study|Adverse Event|1
7652227|NCT01490918|26623996|P2|Overall Study|Adverse Event|0
7652228|NCT01490918|26623997|P1|Overall Study|Adverse Event|0
7652229|NCT01490918|26623995|P3|Overall Study|Withdrawal by Subject|3
7652230|NCT01490918|26623996|P2|Overall Study|Withdrawal by Subject|8
7652231|NCT01490918|26623997|P1|Overall Study|Withdrawal by Subject|7
7652232|NCT01490918|26623995|P3|Overall Study|Lost to Follow-up|0
7652233|NCT01490918|26623996|P2|Overall Study|Lost to Follow-up|1
7652234|NCT01490918|26623997|P1|Overall Study|Lost to Follow-up|2
7652235|NCT01490866|26624035|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
7652236|NCT01490866|26624035|P1|Axitinib Maintenance Therapy|Protocol Violation|2
7652237|NCT01490866|26624035|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
7652238|NCT01490866|26624035|P1|Axitinib Maintenance Therapy|Adverse Event|12
7652239|NCT01490866|26624035|P1|Axitinib Maintenance Therapy|Disease Progression|30
7652240|NCT01490866|26624035|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
7652241|NCT01490866|26624035|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
7652242|NCT01490866|26624035|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
7652243|NCT01490866|26624035|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
7652244|NCT01490866|26624035|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
7652245|NCT01490866|26624035|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
7652246|NCT01490840|26624046|P2|Phase 2|Adverse Event|1
7652247|NCT01490840|26624047|P1|Phase 2|Adverse Event|1
7652248|NCT01490840|26624046|P2|Phase 2|Lost to Follow-up|1
7652249|NCT01490840|26624047|P1|Phase 2|Lost to Follow-up|1
7652250|NCT01490840|26624046|P2|Phase 2|Permanent interruption of fingolimod|1
7652251|NCT01490840|26624047|P1|Phase 2|Permanent interruption of fingolimod|0
7652252|NCT01490840|26624046|P2|Phase 2|Withdrawal by Subject|3
7652253|NCT01490840|26624047|P1|Phase 2|Withdrawal by Subject|4
7652254|NCT01490840|26624046|P2|Phase 1|Visit 6a omitted|0
7652255|NCT01490840|26624047|P1|Phase 1|Visit 6a omitted|1
7652256|NCT01490840|26624046|P2|Phase 1|Withdrawal by Subject|5
7652257|NCT01490840|26624047|P1|Phase 1|Withdrawal by Subject|6
7652258|NCT01490840|26624046|P2|Phase 1|Adverse Event|1
7652259|NCT01490840|26624047|P1|Phase 1|Adverse Event|2
7652260|NCT01490840|26624046|P2|Phase 1|Lost to Follow-up|0
7652261|NCT01490840|26624047|P1|Phase 1|Lost to Follow-up|1
7652262|NCT01490814|26624071|P2|Overall Study|Withdrawal by Subject|5
7652263|NCT01490814|26624072|P1|Overall Study|Withdrawal by Subject|0
7652264|NCT01490814|26624071|P2|Overall Study|Physician Decision|0
7652265|NCT01490814|26624072|P1|Overall Study|Physician Decision|1
7652266|NCT01490814|26624071|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
7652267|NCT01490814|26624072|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
7652268|NCT01490697|26624115|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
7652269|NCT01490697|26624116|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
7652270|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
7652271|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
7652272|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
7652273|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652274|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652275|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652276|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652277|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652278|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652279|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652280|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652281|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652282|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652283|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652284|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652285|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652286|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652287|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652288|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652289|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
7652290|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Protocol Violation|0
7652291|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Protocol Violation|1
7652292|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Protocol Violation|0
7652293|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Protocol Violation|0
7652294|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Protocol Violation|0
7652295|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Protocol Violation|0
7652296|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Protocol Violation|0
7652297|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Protocol Violation|0
7652298|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Protocol Violation|0
7652299|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Protocol Violation|0
7652300|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Protocol Violation|0
7652301|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Protocol Violation|0
7652302|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Protocol Violation|0
7652303|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Protocol Violation|0
7652304|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Protocol Violation|0
7652305|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Protocol Violation|0
7652306|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Protocol Violation|0
7652307|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Protocol Violation|0
7652308|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Protocol Violation|0
7652309|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Protocol Violation|0
7652310|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Physician Decision|1
7652311|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Physician Decision|1
7652312|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Physician Decision|0
7652313|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Physician Decision|0
7652314|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Physician Decision|0
7652315|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Physician Decision|0
7652316|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Physician Decision|0
7652317|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Physician Decision|0
7652318|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Physician Decision|0
7652319|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Physician Decision|0
7652320|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Physician Decision|0
7652321|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Physician Decision|0
7652322|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Physician Decision|0
7652323|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Physician Decision|0
7652324|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Physician Decision|0
7652325|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Physician Decision|0
7652326|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Physician Decision|0
7652327|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Physician Decision|0
7652328|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Physician Decision|0
7652329|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Physician Decision|0
7652330|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
7652331|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
7652332|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
7652333|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
7652334|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
7652335|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
7652336|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
7652337|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
7652338|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
7652339|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
7652340|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
7652341|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
7652342|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
7652343|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
7652344|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
7652345|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
7652346|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
7652347|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
7652348|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
7652349|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
7652350|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
7652351|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
7652352|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
7652353|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
7652354|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
7652355|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
7652356|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
7652357|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
7652358|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
7652359|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
7652360|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
7652361|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
7652362|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
7652363|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
7652364|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
7652365|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
7652366|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
7652367|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
7652368|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
7652369|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
7652370|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Death|0
7652371|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Death|1
7652372|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Death|0
7652373|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Death|0
7652374|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Death|0
7652375|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Death|0
7652376|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Death|0
7652377|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Death|0
7652378|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Death|0
7652379|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Death|0
7652380|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Death|0
7652381|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Death|0
7652382|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Death|0
7652383|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Death|0
7652384|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Death|0
7652385|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Death|0
7652386|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Death|0
7652387|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Death|0
7652388|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Death|0
7652389|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Death|0
7652390|NCT01490632|26624136|P20|Part D: Re-Treatment Period|Adverse Event|3
7652391|NCT01490632|26624137|P19|Part D: Re-Treatment Period|Adverse Event|1
7652392|NCT01490632|26624138|P18|Part D: Re-Treatment Period|Adverse Event|1
7652393|NCT01490632|26624139|P17|Part D: Re-Treatment Period|Adverse Event|0
7652394|NCT01490632|26624140|P16|Part D: Re-Treatment Period|Adverse Event|0
7652395|NCT01490632|26624141|P15|Part D: Re-Treatment Period|Adverse Event|0
7652396|NCT01490632|26624142|P14|Part D: Re-Treatment Period|Adverse Event|0
7652397|NCT01490632|26624143|P13|Part D: Re-Treatment Period|Adverse Event|0
7652398|NCT01490632|26624144|P12|Part D: Re-Treatment Period|Adverse Event|0
7652399|NCT01490632|26624145|P11|Part D: Re-Treatment Period|Adverse Event|0
7652400|NCT01490632|26624146|P10|Part D: Re-Treatment Period|Adverse Event|0
7652401|NCT01490632|26624147|P9|Part D: Re-Treatment Period|Adverse Event|0
7652402|NCT01490632|26624148|P8|Part D: Re-Treatment Period|Adverse Event|0
7652403|NCT01490632|26624149|P7|Part D: Re-Treatment Period|Adverse Event|0
7652404|NCT01490632|26624150|P6|Part D: Re-Treatment Period|Adverse Event|0
7652405|NCT01490632|26624151|P5|Part D: Re-Treatment Period|Adverse Event|0
7652406|NCT01490632|26624152|P4|Part D: Re-Treatment Period|Adverse Event|0
7652407|NCT01490632|26624153|P3|Part D: Re-Treatment Period|Adverse Event|0
7652408|NCT01490632|26624154|P2|Part D: Re-Treatment Period|Adverse Event|0
7652409|NCT01490632|26624155|P1|Part D: Re-Treatment Period|Adverse Event|0
7652410|NCT01490632|26624136|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652411|NCT01490632|26624137|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652412|NCT01490632|26624138|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652944|NCT01489527|26624909|P1|Overall Study|Pregnancy|9
7652413|NCT01490632|26624139|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652414|NCT01490632|26624140|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
7652415|NCT01490632|26624141|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
7652416|NCT01490632|26624142|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
7652417|NCT01490632|26624143|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
7652418|NCT01490632|26624144|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652419|NCT01490632|26624145|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652420|NCT01490632|26624146|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652421|NCT01490632|26624147|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652422|NCT01490632|26624148|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652423|NCT01490632|26624149|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652424|NCT01490632|26624150|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652425|NCT01490632|26624151|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652426|NCT01490632|26624152|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652427|NCT01490632|26624153|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652428|NCT01490632|26624154|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652429|NCT01490632|26624155|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7652430|NCT01490632|26624136|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652431|NCT01490632|26624137|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652432|NCT01490632|26624138|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652433|NCT01490632|26624139|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652434|NCT01490632|26624140|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
7652435|NCT01490632|26624141|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
7652436|NCT01490632|26624142|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652437|NCT01490632|26624143|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652438|NCT01490632|26624144|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652439|NCT01490632|26624145|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652440|NCT01490632|26624146|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652441|NCT01490632|26624147|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652442|NCT01490632|26624148|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652443|NCT01490632|26624149|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652444|NCT01490632|26624150|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652445|NCT01490632|26624151|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652446|NCT01490632|26624152|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652447|NCT01490632|26624153|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652448|NCT01490632|26624154|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652449|NCT01490632|26624155|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7652450|NCT01490632|26624136|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652451|NCT01490632|26624137|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652452|NCT01490632|26624138|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652453|NCT01490632|26624139|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652454|NCT01490632|26624140|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652455|NCT01490632|26624141|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652456|NCT01490632|26624142|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
7652457|NCT01490632|26624143|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652458|NCT01490632|26624144|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652459|NCT01490632|26624145|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652460|NCT01490632|26624146|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652461|NCT01490632|26624147|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652462|NCT01490632|26624148|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652463|NCT01490632|26624149|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652464|NCT01490632|26624150|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652465|NCT01490632|26624151|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652466|NCT01490632|26624152|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652467|NCT01490632|26624153|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652468|NCT01490632|26624154|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652469|NCT01490632|26624155|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7652470|NCT01490632|26624136|P20|Part C: Washout or Step-Down Period|Adverse Event|0
7652471|NCT01490632|26624137|P19|Part C: Washout or Step-Down Period|Adverse Event|0
7652472|NCT01490632|26624138|P18|Part C: Washout or Step-Down Period|Adverse Event|0
7652473|NCT01490632|26624139|P17|Part C: Washout or Step-Down Period|Adverse Event|0
7652474|NCT01490632|26624140|P16|Part C: Washout or Step-Down Period|Adverse Event|2
7652475|NCT01490632|26624141|P15|Part C: Washout or Step-Down Period|Adverse Event|2
7652476|NCT01490632|26624142|P14|Part C: Washout or Step-Down Period|Adverse Event|0
7652477|NCT01490632|26624143|P13|Part C: Washout or Step-Down Period|Adverse Event|0
7652478|NCT01490632|26624144|P12|Part C: Washout or Step-Down Period|Adverse Event|0
7652479|NCT01490632|26624145|P11|Part C: Washout or Step-Down Period|Adverse Event|0
7652480|NCT01490632|26624146|P10|Part C: Washout or Step-Down Period|Adverse Event|0
7652481|NCT01490632|26624147|P9|Part C: Washout or Step-Down Period|Adverse Event|0
7652482|NCT01490632|26624148|P8|Part C: Washout or Step-Down Period|Adverse Event|0
7652483|NCT01490632|26624149|P7|Part C: Washout or Step-Down Period|Adverse Event|0
7652484|NCT01490632|26624150|P6|Part C: Washout or Step-Down Period|Adverse Event|0
7652485|NCT01490632|26624151|P5|Part C: Washout or Step-Down Period|Adverse Event|0
7652486|NCT01490632|26624152|P4|Part C: Washout or Step-Down Period|Adverse Event|0
7652487|NCT01490632|26624153|P3|Part C: Washout or Step-Down Period|Adverse Event|0
7652488|NCT01490632|26624154|P2|Part C: Washout or Step-Down Period|Adverse Event|0
7652489|NCT01490632|26624155|P1|Part C: Washout or Step-Down Period|Adverse Event|0
7652490|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652491|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652492|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652493|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652494|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652495|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652496|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652497|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652498|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
7652499|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
7652500|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
7652501|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
7652502|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7652503|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7652504|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
7652505|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652506|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652507|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652508|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652509|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7652510|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652511|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652512|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652513|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652514|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652515|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652516|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652517|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652518|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
7652519|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7652520|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652521|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7652522|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652523|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7652524|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652525|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652526|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652527|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652528|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652529|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7652530|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652531|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652532|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652533|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652534|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652535|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652536|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652537|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652538|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652539|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652540|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652541|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652542|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652543|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652544|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
7652545|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652546|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652547|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652548|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652549|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
7652550|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Physician Decision|0
7652551|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Physician Decision|0
7652552|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Physician Decision|0
7652553|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Physician Decision|0
7652554|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Physician Decision|0
7652555|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Physician Decision|0
7652556|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Physician Decision|0
7652557|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Physician Decision|0
7652558|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Physician Decision|0
7652559|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Physician Decision|0
7652560|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Physician Decision|0
7652561|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Physician Decision|0
7652562|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Physician Decision|0
7652563|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Physician Decision|1
7652564|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Physician Decision|0
7652565|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Physician Decision|0
7652566|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Physician Decision|0
7652567|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Physician Decision|0
7652568|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Physician Decision|0
7652569|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Physician Decision|0
7652570|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652571|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652572|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652573|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652574|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652575|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652576|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652577|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652578|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652579|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652580|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
7652581|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652582|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652583|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
7652584|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652585|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652586|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652587|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652588|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652589|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7652590|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652591|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652592|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652593|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652594|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652595|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652596|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652597|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652598|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652599|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7652600|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
7652601|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7652602|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652603|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7652604|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652605|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652606|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652607|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652608|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652609|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7652610|NCT01490632|26624136|P20|Part B: Extension or Step-Up Period|Adverse Event|0
7652611|NCT01490632|26624137|P19|Part B: Extension or Step-Up Period|Adverse Event|0
7652612|NCT01490632|26624138|P18|Part B: Extension or Step-Up Period|Adverse Event|0
7652613|NCT01490632|26624139|P17|Part B: Extension or Step-Up Period|Adverse Event|0
7652614|NCT01490632|26624140|P16|Part B: Extension or Step-Up Period|Adverse Event|0
7652615|NCT01490632|26624141|P15|Part B: Extension or Step-Up Period|Adverse Event|0
7652616|NCT01490632|26624142|P14|Part B: Extension or Step-Up Period|Adverse Event|0
7652617|NCT01490632|26624143|P13|Part B: Extension or Step-Up Period|Adverse Event|0
7652618|NCT01490632|26624144|P12|Part B: Extension or Step-Up Period|Adverse Event|1
7652619|NCT01490632|26624145|P11|Part B: Extension or Step-Up Period|Adverse Event|3
7652620|NCT01490632|26624146|P10|Part B: Extension or Step-Up Period|Adverse Event|2
7652621|NCT01490632|26624147|P9|Part B: Extension or Step-Up Period|Adverse Event|0
7652622|NCT01490632|26624148|P8|Part B: Extension or Step-Up Period|Adverse Event|0
7652623|NCT01490632|26624149|P7|Part B: Extension or Step-Up Period|Adverse Event|2
7652624|NCT01490632|26624150|P6|Part B: Extension or Step-Up Period|Adverse Event|2
7652625|NCT01490632|26624151|P5|Part B: Extension or Step-Up Period|Adverse Event|0
7652626|NCT01490632|26624152|P4|Part B: Extension or Step-Up Period|Adverse Event|0
7652627|NCT01490632|26624153|P3|Part B: Extension or Step-Up Period|Adverse Event|0
7652628|NCT01490632|26624154|P2|Part B: Extension or Step-Up Period|Adverse Event|0
7652629|NCT01490632|26624155|P1|Part B: Extension or Step-Up Period|Adverse Event|0
7652630|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652631|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652632|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652633|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652634|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652635|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652636|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652637|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652638|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652639|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652640|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652641|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652642|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652643|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652644|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652645|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
7652646|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652647|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652648|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652649|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7652650|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652651|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652652|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652653|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652654|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652655|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652656|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652657|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652658|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652659|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652660|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652661|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652662|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652663|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652664|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652665|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
7652666|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
7652667|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
7652668|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
7652669|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
7652670|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Sponsor Decision|0
7652671|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Sponsor Decision|0
7652672|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Sponsor Decision|0
7652673|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Sponsor Decision|0
7652674|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Sponsor Decision|0
7652675|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Sponsor Decision|0
7652676|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Sponsor Decision|0
7652677|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Sponsor Decision|0
7652678|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Sponsor Decision|0
7652679|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Sponsor Decision|0
7652680|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Sponsor Decision|0
7652681|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Sponsor Decision|0
7652682|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Sponsor Decision|0
7652683|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Sponsor Decision|0
7652684|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Sponsor Decision|0
7652685|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Sponsor Decision|0
7652686|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Sponsor Decision|0
7652687|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Sponsor Decision|0
7652688|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Sponsor Decision|0
7652689|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Sponsor Decision|2
7652690|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Physician Decision|0
7652691|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Physician Decision|0
7652692|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Physician Decision|0
7652693|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Physician Decision|0
7652694|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Physician Decision|0
7652695|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Physician Decision|0
7652696|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Physician Decision|0
7652697|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Physician Decision|0
7652698|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Physician Decision|0
7652699|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Physician Decision|0
7652700|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Physician Decision|0
7652701|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Physician Decision|0
7652702|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Physician Decision|0
7652703|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Physician Decision|0
7652704|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Physician Decision|0
7652705|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Physician Decision|0
7652706|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Physician Decision|1
7652707|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Physician Decision|0
7652708|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Physician Decision|1
7652709|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Physician Decision|0
7652710|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
7652711|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
7652712|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
7652713|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
7652714|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
7652715|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
7652716|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
7652717|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
7652718|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
7652719|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
7652720|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
7652721|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
7652722|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
7652723|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
7652724|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
7652725|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
7652726|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
7652727|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
7652728|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
7652729|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
7652730|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
7652731|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
7652732|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
7652733|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
7652734|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
7652735|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
7652736|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
7652737|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
7652738|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
7652739|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
7652740|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
7652741|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
7652742|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
7652743|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
7652744|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
7652745|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
7652746|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
7652747|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
7652748|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
7652749|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
7652750|NCT01490632|26624136|P20|Part A: Initial Treatment Period|Adverse Event|0
7652751|NCT01490632|26624137|P19|Part A: Initial Treatment Period|Adverse Event|0
7652752|NCT01490632|26624138|P18|Part A: Initial Treatment Period|Adverse Event|0
7652753|NCT01490632|26624139|P17|Part A: Initial Treatment Period|Adverse Event|0
7652754|NCT01490632|26624140|P16|Part A: Initial Treatment Period|Adverse Event|0
7652755|NCT01490632|26624141|P15|Part A: Initial Treatment Period|Adverse Event|0
7652756|NCT01490632|26624142|P14|Part A: Initial Treatment Period|Adverse Event|0
7652757|NCT01490632|26624143|P13|Part A: Initial Treatment Period|Adverse Event|0
7652758|NCT01490632|26624144|P12|Part A: Initial Treatment Period|Adverse Event|0
7652759|NCT01490632|26624145|P11|Part A: Initial Treatment Period|Adverse Event|0
7652760|NCT01490632|26624146|P10|Part A: Initial Treatment Period|Adverse Event|0
7652761|NCT01490632|26624147|P9|Part A: Initial Treatment Period|Adverse Event|0
7652762|NCT01490632|26624148|P8|Part A: Initial Treatment Period|Adverse Event|0
7652763|NCT01490632|26624149|P7|Part A: Initial Treatment Period|Adverse Event|0
7652764|NCT01490632|26624150|P6|Part A: Initial Treatment Period|Adverse Event|0
7652765|NCT01490632|26624151|P5|Part A: Initial Treatment Period|Adverse Event|4
7652766|NCT01490632|26624152|P4|Part A: Initial Treatment Period|Adverse Event|4
7652767|NCT01490632|26624153|P3|Part A: Initial Treatment Period|Adverse Event|2
7652768|NCT01490632|26624154|P2|Part A: Initial Treatment Period|Adverse Event|0
7652769|NCT01490632|26624155|P1|Part A: Initial Treatment Period|Adverse Event|0
7652770|NCT01490580|26624285|P2|Overall Study|Parents withdrew consent|2
7652771|NCT01490580|26624286|P1|Overall Study|Parents withdrew consent|0
7652772|NCT01490294|26624335|P4|Overall Study|Adverse Event|0
7652773|NCT01490294|26624336|P3|Overall Study|Adverse Event|0
7652774|NCT01490294|26624337|P2|Overall Study|Adverse Event|0
7652775|NCT01490294|26624338|P1|Overall Study|Adverse Event|1
7652776|NCT01490294|26624335|P4|Overall Study|Prematurely discontinuation|1
7652777|NCT01490294|26624336|P3|Overall Study|Prematurely discontinuation|1
7652778|NCT01490294|26624337|P2|Overall Study|Prematurely discontinuation|0
7652779|NCT01490294|26624338|P1|Overall Study|Prematurely discontinuation|4
7652780|NCT01490190|26624572|P1|Overall Study|Ring expulsion|2
7652781|NCT01490190|26624572|P1|Overall Study|Inconvenience|1
7652782|NCT01490190|26624572|P1|Overall Study|Relocation|1
7652783|NCT01490190|26624572|P1|Overall Study|Lost to Follow-up|13
7652784|NCT01490190|26624572|P1|Overall Study|Protocol Violation|5
7652785|NCT01490190|26624572|P1|Overall Study|Adverse Event|17
7652786|NCT01490190|26624572|P1|Overall Study|Withdrawal by Subject|9
7652787|NCT01490125|26624599|P6|Period III|Lack of Efficacy|0
7652788|NCT01490125|26624600|P5|Period III|Lack of Efficacy|1
7652789|NCT01490125|26624601|P4|Period III|Lack of Efficacy|0
7652790|NCT01490125|26624602|P3|Period III|Lack of Efficacy|0
7652791|NCT01490125|26624603|P2|Period III|Lack of Efficacy|0
7652792|NCT01490125|26624604|P1|Period III|Lack of Efficacy|0
7652793|NCT01490125|26624599|P6|Period III|Death|0
7652794|NCT01490125|26624600|P5|Period III|Death|0
7652795|NCT01490125|26624601|P4|Period III|Death|1
7652796|NCT01490125|26624602|P3|Period III|Death|0
7652797|NCT01490125|26624603|P2|Period III|Death|0
7652798|NCT01490125|26624604|P1|Period III|Death|0
7652799|NCT01490125|26624599|P6|Period III|Adverse Event|0
7652800|NCT01490125|26624600|P5|Period III|Adverse Event|0
7652801|NCT01490125|26624601|P4|Period III|Adverse Event|1
7652802|NCT01490125|26624602|P3|Period III|Adverse Event|0
7652803|NCT01490125|26624603|P2|Period III|Adverse Event|1
7652804|NCT01490125|26624604|P1|Period III|Adverse Event|3
7652805|NCT01490125|26624599|P6|Period II|Withdrawal by Subject|0
7652806|NCT01490125|26624600|P5|Period II|Withdrawal by Subject|0
7652807|NCT01490125|26624601|P4|Period II|Withdrawal by Subject|0
7652808|NCT01490125|26624602|P3|Period II|Withdrawal by Subject|0
7652809|NCT01490125|26624603|P2|Period II|Withdrawal by Subject|0
7652810|NCT01490125|26624604|P1|Period II|Withdrawal by Subject|1
7652811|NCT01490125|26624599|P6|Period II|Lost to Follow-up|0
7652812|NCT01490125|26624600|P5|Period II|Lost to Follow-up|0
7652813|NCT01490125|26624601|P4|Period II|Lost to Follow-up|0
7652814|NCT01490125|26624602|P3|Period II|Lost to Follow-up|0
7652815|NCT01490125|26624603|P2|Period II|Lost to Follow-up|1
7652816|NCT01490125|26624604|P1|Period II|Lost to Follow-up|0
7652817|NCT01490125|26624599|P6|Period II|Protocol Violation|0
7652818|NCT01490125|26624600|P5|Period II|Protocol Violation|0
7652819|NCT01490125|26624601|P4|Period II|Protocol Violation|1
7652820|NCT01490125|26624602|P3|Period II|Protocol Violation|1
7652821|NCT01490125|26624603|P2|Period II|Protocol Violation|0
7652822|NCT01490125|26624604|P1|Period II|Protocol Violation|0
7652823|NCT01490125|26624599|P6|Period II|Adverse Event|2
7652824|NCT01490125|26624600|P5|Period II|Adverse Event|4
7652825|NCT01490125|26624601|P4|Period II|Adverse Event|2
7652826|NCT01490125|26624602|P3|Period II|Adverse Event|2
7652827|NCT01490125|26624603|P2|Period II|Adverse Event|3
7652828|NCT01490125|26624604|P1|Period II|Adverse Event|2
7652829|NCT01490125|26624599|P6|Period I|Withdrawal by Subject|1
7652830|NCT01490125|26624600|P5|Period I|Withdrawal by Subject|2
7652831|NCT01490125|26624601|P4|Period I|Withdrawal by Subject|1
7652832|NCT01490125|26624602|P3|Period I|Withdrawal by Subject|2
7652833|NCT01490125|26624603|P2|Period I|Withdrawal by Subject|3
7652834|NCT01490125|26624604|P1|Period I|Withdrawal by Subject|1
7652835|NCT01490125|26624599|P6|Period I|Protocol Violation|0
7652836|NCT01490125|26624600|P5|Period I|Protocol Violation|0
7652837|NCT01490125|26624601|P4|Period I|Protocol Violation|1
7652838|NCT01490125|26624602|P3|Period I|Protocol Violation|1
7652839|NCT01490125|26624603|P2|Period I|Protocol Violation|1
7652840|NCT01490125|26624604|P1|Period I|Protocol Violation|1
7652841|NCT01490125|26624599|P6|Period I|Adverse Event|4
7652842|NCT01490125|26624600|P5|Period I|Adverse Event|2
7652843|NCT01490125|26624601|P4|Period I|Adverse Event|3
7652844|NCT01490125|26624602|P3|Period I|Adverse Event|1
7652845|NCT01490125|26624603|P2|Period I|Adverse Event|1
7652846|NCT01490125|26624604|P1|Period I|Adverse Event|4
7652847|NCT01490086|26624632|P5|Overall Study|Subject left hospital|0
7652848|NCT01490086|26624633|P4|Overall Study|Subject left hospital|1
7652849|NCT01490086|26624634|P3|Overall Study|Subject left hospital|0
7652850|NCT01490086|26624635|P2|Overall Study|Subject left hospital|1
7652851|NCT01490086|26624636|P1|Overall Study|Subject left hospital|0
7652852|NCT01490086|26624632|P5|Overall Study|Subject uncontrollable and abusive|0
7652853|NCT01490086|26624633|P4|Overall Study|Subject uncontrollable and abusive|0
7652854|NCT01490086|26624634|P3|Overall Study|Subject uncontrollable and abusive|0
7652945|NCT01489358|26624926|P3|Overall Study|Lost to Follow-up|2
7652855|NCT01490086|26624635|P2|Overall Study|Subject uncontrollable and abusive|1
7652856|NCT01490086|26624636|P1|Overall Study|Subject uncontrollable and abusive|0
7652857|NCT01490086|26624632|P5|Overall Study|Worsening of symptoms|0
7652858|NCT01490086|26624633|P4|Overall Study|Worsening of symptoms|1
7652859|NCT01490086|26624634|P3|Overall Study|Worsening of symptoms|0
7652860|NCT01490086|26624635|P2|Overall Study|Worsening of symptoms|1
7652861|NCT01490086|26624636|P1|Overall Study|Worsening of symptoms|0
7652862|NCT01490086|26624632|P5|Overall Study|Lack of Efficacy|8
7652863|NCT01490086|26624633|P4|Overall Study|Lack of Efficacy|0
7652864|NCT01490086|26624634|P3|Overall Study|Lack of Efficacy|1
7652865|NCT01490086|26624635|P2|Overall Study|Lack of Efficacy|3
7652866|NCT01490086|26624636|P1|Overall Study|Lack of Efficacy|0
7652867|NCT01490086|26624632|P5|Overall Study|Adverse Event|0
7652868|NCT01490086|26624633|P4|Overall Study|Adverse Event|2
7652869|NCT01490086|26624634|P3|Overall Study|Adverse Event|1
7652870|NCT01490086|26624635|P2|Overall Study|Adverse Event|0
7652871|NCT01490086|26624636|P1|Overall Study|Adverse Event|0
7652872|NCT01490086|26624632|P5|Overall Study|Physician Decision|1
7652873|NCT01490086|26624633|P4|Overall Study|Physician Decision|3
7652874|NCT01490086|26624634|P3|Overall Study|Physician Decision|2
7652875|NCT01490086|26624635|P2|Overall Study|Physician Decision|4
7652876|NCT01490086|26624636|P1|Overall Study|Physician Decision|3
7652877|NCT01490086|26624632|P5|Overall Study|Lost to Follow-up|1
7652878|NCT01490086|26624633|P4|Overall Study|Lost to Follow-up|0
7652879|NCT01490086|26624634|P3|Overall Study|Lost to Follow-up|0
7652880|NCT01490086|26624635|P2|Overall Study|Lost to Follow-up|0
7652881|NCT01490086|26624636|P1|Overall Study|Lost to Follow-up|0
7652882|NCT01490086|26624632|P5|Overall Study|Abnormal laboratory findings|0
7652883|NCT01490086|26624633|P4|Overall Study|Abnormal laboratory findings|0
7652884|NCT01490086|26624634|P3|Overall Study|Abnormal laboratory findings|0
7652885|NCT01490086|26624635|P2|Overall Study|Abnormal laboratory findings|0
7652886|NCT01490086|26624636|P1|Overall Study|Abnormal laboratory findings|1
7652887|NCT01490086|26624632|P5|Overall Study|Non-compliance|0
7652888|NCT01490086|26624633|P4|Overall Study|Non-compliance|0
7652889|NCT01490086|26624634|P3|Overall Study|Non-compliance|0
7652890|NCT01490086|26624635|P2|Overall Study|Non-compliance|1
7652891|NCT01490086|26624636|P1|Overall Study|Non-compliance|0
7652892|NCT01490086|26624632|P5|Overall Study|Consent withdrawn|1
7652893|NCT01490086|26624633|P4|Overall Study|Consent withdrawn|0
7652894|NCT01490086|26624634|P3|Overall Study|Consent withdrawn|3
7652895|NCT01490086|26624635|P2|Overall Study|Consent withdrawn|4
7652896|NCT01490086|26624636|P1|Overall Study|Consent withdrawn|4
7652897|NCT01490060|26624681|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
7652898|NCT01490060|26624682|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
7652899|NCT01490060|26624683|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
7652900|NCT01490060|26624684|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
7652901|NCT01490060|26624681|P4|Cycle 2|Non-Compliance|0
7652902|NCT01490060|26624682|P3|Cycle 2|Non-Compliance|1
7652903|NCT01490060|26624683|P2|Cycle 2|Non-Compliance|0
7652904|NCT01490060|26624684|P1|Cycle 2|Non-Compliance|0
7652905|NCT01490060|26624681|P4|Cycle 2|Change of Treatment|0
7652906|NCT01490060|26624682|P3|Cycle 2|Change of Treatment|0
7652907|NCT01490060|26624683|P2|Cycle 2|Change of Treatment|1
7652908|NCT01490060|26624684|P1|Cycle 2|Change of Treatment|1
7652909|NCT01490060|26624681|P4|Cycle 1|Treatment at Another Facility|1
7652910|NCT01490060|26624682|P3|Cycle 1|Treatment at Another Facility|0
7652911|NCT01490060|26624683|P2|Cycle 1|Treatment at Another Facility|0
7652912|NCT01490060|26624684|P1|Cycle 1|Treatment at Another Facility|0
7652913|NCT01490060|26624681|P4|Cycle 1|Withdrawal by Subject|1
7652914|NCT01490060|26624682|P3|Cycle 1|Withdrawal by Subject|0
7652915|NCT01490060|26624683|P2|Cycle 1|Withdrawal by Subject|0
7652916|NCT01490060|26624684|P1|Cycle 1|Withdrawal by Subject|0
7652917|NCT01490060|26624681|P4|Cycle 1|Insurance Denied|0
7652918|NCT01490060|26624682|P3|Cycle 1|Insurance Denied|2
7652919|NCT01490060|26624683|P2|Cycle 1|Insurance Denied|0
7652920|NCT01490060|26624684|P1|Cycle 1|Insurance Denied|0
7652921|NCT01490060|26624681|P4|Cycle 1|Change of Treatment|1
7652922|NCT01490060|26624682|P3|Cycle 1|Change of Treatment|1
7652923|NCT01490060|26624683|P2|Cycle 1|Change of Treatment|1
7652924|NCT01490060|26624684|P1|Cycle 1|Change of Treatment|0
7652925|NCT01489956|26624713|P3|Overall Study|Withdrawal by Subject|1
7652926|NCT01489956|26624714|P2|Overall Study|Withdrawal by Subject|0
7652927|NCT01489956|26624715|P1|Overall Study|Withdrawal by Subject|0
7652928|NCT01489956|26624713|P3|Overall Study|Lost to Follow-up|0
7652929|NCT01489956|26624714|P2|Overall Study|Lost to Follow-up|0
7652930|NCT01489956|26624715|P1|Overall Study|Lost to Follow-up|1
7652931|NCT01489891|26624752|P2|Overall Study|Endoscopy failure|0
7652932|NCT01489891|26624753|P1|Overall Study|Endoscopy failure|1
7652933|NCT01489527|26624908|P2|Overall Study|Not compliant|0
7652934|NCT01489527|26624909|P1|Overall Study|Not compliant|1
7652935|NCT01489527|26624908|P2|Overall Study|Procedures|0
7652936|NCT01489527|26624909|P1|Overall Study|Procedures|1
7652937|NCT01489527|26624908|P2|Overall Study|Lost to Follow-up|1
7652938|NCT01489527|26624909|P1|Overall Study|Lost to Follow-up|5
7652939|NCT01489527|26624908|P2|Overall Study|Withdrawal by Subject|4
7652940|NCT01489527|26624909|P1|Overall Study|Withdrawal by Subject|0
7652941|NCT01489527|26624908|P2|Overall Study|Participant moved|7
7652942|NCT01489527|26624909|P1|Overall Study|Participant moved|6
7652943|NCT01489527|26624908|P2|Overall Study|Pregnancy|14
7652946|NCT01489358|26624927|P2|Overall Study|Lost to Follow-up|0
7652947|NCT01489358|26624928|P1|Overall Study|Lost to Follow-up|0
7652948|NCT01489254|26624978|P4|Open-label Extension Part|Other reasons for not completing study|5
7652949|NCT01489254|26624979|P3|Open-label Extension Part|Other reasons for not completing study|0
7652950|NCT01489254|26624980|P2|Open-label Extension Part|Other reasons for not completing study|0
7652951|NCT01489254|26624981|P1|Open-label Extension Part|Other reasons for not completing study|0
7652952|NCT01489254|26624978|P4|Open-label Extension Part|Lost to Follow-up|9
7652953|NCT01489254|26624979|P3|Open-label Extension Part|Lost to Follow-up|0
7652954|NCT01489254|26624980|P2|Open-label Extension Part|Lost to Follow-up|0
7652955|NCT01489254|26624981|P1|Open-label Extension Part|Lost to Follow-up|0
7652956|NCT01489254|26624978|P4|Open-label Extension Part|Protocol Violation|1
7652957|NCT01489254|26624979|P3|Open-label Extension Part|Protocol Violation|0
7652958|NCT01489254|26624980|P2|Open-label Extension Part|Protocol Violation|0
7652959|NCT01489254|26624981|P1|Open-label Extension Part|Protocol Violation|0
7652960|NCT01489254|26624978|P4|Open-label Extension Part|Withdrawal by Subject|30
7652961|NCT01489254|26624979|P3|Open-label Extension Part|Withdrawal by Subject|0
7652962|NCT01489254|26624980|P2|Open-label Extension Part|Withdrawal by Subject|0
7652963|NCT01489254|26624981|P1|Open-label Extension Part|Withdrawal by Subject|0
7652964|NCT01489254|26624978|P4|Open-label Extension Part|Pregnancy|3
7652965|NCT01489254|26624979|P3|Open-label Extension Part|Pregnancy|0
7652966|NCT01489254|26624980|P2|Open-label Extension Part|Pregnancy|0
7652967|NCT01489254|26624981|P1|Open-label Extension Part|Pregnancy|0
7652968|NCT01489254|26624978|P4|Open-label Extension Part|Adverse Event|10
7652969|NCT01489254|26624979|P3|Open-label Extension Part|Adverse Event|0
7652970|NCT01489254|26624980|P2|Open-label Extension Part|Adverse Event|0
7652971|NCT01489254|26624981|P1|Open-label Extension Part|Adverse Event|0
7652972|NCT01489254|26624978|P4|Double-blind Part|Other reasons for not completing study|0
7652973|NCT01489254|26624979|P3|Double-blind Part|Other reasons for not completing study|0
7652974|NCT01489254|26624980|P2|Double-blind Part|Other reasons for not completing study|6
7652975|NCT01489254|26624981|P1|Double-blind Part|Other reasons for not completing study|4
7652976|NCT01489254|26624978|P4|Double-blind Part|Lost to Follow-up|0
7652977|NCT01489254|26624979|P3|Double-blind Part|Lost to Follow-up|0
7652978|NCT01489254|26624980|P2|Double-blind Part|Lost to Follow-up|2
7652979|NCT01489254|26624981|P1|Double-blind Part|Lost to Follow-up|1
7652980|NCT01489254|26624978|P4|Double-blind Part|Withdrawal by Subject|0
7652981|NCT01489254|26624979|P3|Double-blind Part|Withdrawal by Subject|1
7652982|NCT01489254|26624980|P2|Double-blind Part|Withdrawal by Subject|20
7652983|NCT01489254|26624981|P1|Double-blind Part|Withdrawal by Subject|12
7652984|NCT01489254|26624978|P4|Double-blind Part|Pregnancy|0
7652985|NCT01489254|26624979|P3|Double-blind Part|Pregnancy|0
7652986|NCT01489254|26624980|P2|Double-blind Part|Pregnancy|3
7652987|NCT01489254|26624981|P1|Double-blind Part|Pregnancy|1
7652988|NCT01489254|26624978|P4|Double-blind Part|Adverse Event|0
7652989|NCT01489254|26624979|P3|Double-blind Part|Adverse Event|2
7652990|NCT01489254|26624980|P2|Double-blind Part|Adverse Event|2
7652991|NCT01489254|26624981|P1|Double-blind Part|Adverse Event|7
7652998|NCT01489111|26625018|P1|Overall Study|Withdrawal criterion|1
7652999|NCT01489020|26625039|P6|Overall Study|Concomitant disease|0
7653000|NCT01489020|26625040|P5|Overall Study|Concomitant disease|3
7653001|NCT01489020|26625041|P4|Overall Study|Concomitant disease|0
7653002|NCT01489020|26625042|P3|Overall Study|Concomitant disease|0
7653003|NCT01489020|26625043|P2|Overall Study|Concomitant disease|0
7653004|NCT01489020|26625044|P1|Overall Study|Concomitant disease|0
7653005|NCT01489020|26625039|P6|Overall Study|Adverse Event|0
7653006|NCT01489020|26625040|P5|Overall Study|Adverse Event|3
7653007|NCT01489020|26625041|P4|Overall Study|Adverse Event|0
7653008|NCT01489020|26625042|P3|Overall Study|Adverse Event|3
7653009|NCT01489020|26625043|P2|Overall Study|Adverse Event|0
7653010|NCT01489020|26625044|P1|Overall Study|Adverse Event|0
7653011|NCT01489020|26625039|P6|Overall Study|Withdrawal by Subject|0
7653012|NCT01489020|26625040|P5|Overall Study|Withdrawal by Subject|0
7653013|NCT01489020|26625041|P4|Overall Study|Withdrawal by Subject|0
7653014|NCT01489020|26625042|P3|Overall Study|Withdrawal by Subject|0
7653015|NCT01489020|26625043|P2|Overall Study|Withdrawal by Subject|0
7653016|NCT01489020|26625044|P1|Overall Study|Withdrawal by Subject|1
7653017|NCT01488994|26625078|P2|Overall Study|Withdrawal by Subject|1
7653018|NCT01488994|26625079|P1|Overall Study|Withdrawal by Subject|0
7653019|NCT01488890|26625170|P4|Overall Study|Withdrawal by Subject|2
7653020|NCT01488890|26625171|P3|Overall Study|Withdrawal by Subject|11
7653021|NCT01488890|26625172|P2|Overall Study|Withdrawal by Subject|10
7653022|NCT01488890|26625173|P1|Overall Study|Withdrawal by Subject|14
7653023|NCT01488890|26625170|P4|Overall Study|Lost to Follow-up|3
7653024|NCT01488890|26625171|P3|Overall Study|Lost to Follow-up|20
7653025|NCT01488890|26625172|P2|Overall Study|Lost to Follow-up|10
7653026|NCT01488890|26625173|P1|Overall Study|Lost to Follow-up|13
7653027|NCT01488890|26625170|P4|Overall Study|Protocol Violation|0
7653028|NCT01488890|26625171|P3|Overall Study|Protocol Violation|4
7653029|NCT01488890|26625172|P2|Overall Study|Protocol Violation|0
7653030|NCT01488890|26625173|P1|Overall Study|Protocol Violation|3
7653031|NCT01488890|26625170|P4|Overall Study|Serious adverse event|0
7653032|NCT01488890|26625171|P3|Overall Study|Serious adverse event|0
7653033|NCT01488890|26625172|P2|Overall Study|Serious adverse event|0
7653034|NCT01488890|26625173|P1|Overall Study|Serious adverse event|2
7653035|NCT01488578|26625251|P1|Overall Study|Protocol Violation|1836
7653036|NCT01488487|26625285|P1|Overall Study|Withdrawal by Subject|2
7653037|NCT01488487|26625285|P1|Overall Study|Death|1
7653038|NCT01488487|26625285|P1|Overall Study|Adverse Event|6
7653039|NCT01488448|26625294|P2|Overall Study|Protocol Violation|3
7653040|NCT01488448|26625295|P1|Overall Study|Protocol Violation|4
7653041|NCT01488448|26625294|P2|Overall Study|Physician Decision|9
7653042|NCT01488448|26625295|P1|Overall Study|Physician Decision|4
7653043|NCT01488448|26625294|P2|Overall Study|Adverse Event|4
7653044|NCT01488448|26625295|P1|Overall Study|Adverse Event|9
7653045|NCT01488448|26625294|P2|Overall Study|Withdrawal by Subject|1
7653046|NCT01488448|26625295|P1|Overall Study|Withdrawal by Subject|3
7653047|NCT01488370|26625337|P3|Overall Study|Protocol Violation|1
7653048|NCT01488370|26625338|P2|Overall Study|Protocol Violation|1
7653049|NCT01488370|26625339|P1|Overall Study|Protocol Violation|0
7653050|NCT01488097|26625398|P1|Overall Study|Lost to Follow-up|1
7653051|NCT01488071|26625411|P2|Overall Study|Administrative or Other Reason(s)|4
7653052|NCT01488071|26625412|P1|Overall Study|Administrative or Other Reason(s)|5
7653053|NCT01488071|26625411|P2|Overall Study|Lost to Follow-up|0
7653054|NCT01488071|26625412|P1|Overall Study|Lost to Follow-up|1
7653055|NCT01488071|26625411|P2|Overall Study|Withdrawal of Consent|12
7653056|NCT01488071|26625412|P1|Overall Study|Withdrawal of Consent|14
7653057|NCT01488071|26625411|P2|Overall Study|Protocol Violation|7
7653058|NCT01488071|26625412|P1|Overall Study|Protocol Violation|5
7653059|NCT01488071|26625411|P2|Overall Study|Non-compliance with study drug|0
7653060|NCT01488071|26625412|P1|Overall Study|Non-compliance with study drug|2
7653061|NCT01488071|26625411|P2|Overall Study|Lack of Efficacy|17
7653062|NCT01488071|26625412|P1|Overall Study|Lack of Efficacy|11
7653063|NCT01488071|26625411|P2|Overall Study|Adverse Event|23
7653064|NCT01488071|26625412|P1|Overall Study|Adverse Event|15
7653065|NCT01487863|26625492|P2|Overall Study|Death|19
7653066|NCT01487863|26625493|P1|Overall Study|Death|19
7653067|NCT01487577|26625510|P1|Overall Study|Became ineligible after signing consent|1
7653068|NCT01487525|26625524|P2|Overall Study|Withdrawal by Subject|1
7653069|NCT01487525|26625525|P1|Overall Study|Withdrawal by Subject|0
7653070|NCT01487265|26625541|P1|Overall Study|Still on Treatment|1
7653071|NCT01487265|26625541|P1|Overall Study|Death|2
7653072|NCT01487265|26625541|P1|Overall Study|Disease Progression|21
7653073|NCT01487265|26625541|P1|Overall Study|Withdrawal by Subject|5
7653074|NCT01487265|26625541|P1|Overall Study|Adverse Event|8
7653075|NCT01487200|26625553|P4|Overall Study|Withdrawal by Subject|0
7653076|NCT01487200|26625554|P3|Overall Study|Withdrawal by Subject|0
7653077|NCT01487200|26625555|P2|Overall Study|Withdrawal by Subject|1
7653078|NCT01487200|26625556|P1|Overall Study|Withdrawal by Subject|0
7653079|NCT01487161|26625586|P4|Overall Study|missing data|0
7653080|NCT01487161|26625587|P3|Overall Study|missing data|0
7653081|NCT01487161|26625588|P2|Overall Study|missing data|1
7653082|NCT01487161|26625589|P1|Overall Study|missing data|0
7653083|NCT01487161|26625586|P4|Overall Study|Withdrawal by Subject|2
7653084|NCT01487161|26625587|P3|Overall Study|Withdrawal by Subject|1
7653085|NCT01487161|26625588|P2|Overall Study|Withdrawal by Subject|1
7653086|NCT01487161|26625589|P1|Overall Study|Withdrawal by Subject|1
7653087|NCT01487161|26625586|P4|Overall Study|Adverse Event|0
7653088|NCT01487161|26625587|P3|Overall Study|Adverse Event|0
7653089|NCT01487161|26625588|P2|Overall Study|Adverse Event|0
7653090|NCT01487161|26625589|P1|Overall Study|Adverse Event|1
7653091|NCT01486966|26625654|P2|Overall Study|Withdrawal by Subject|1
7653092|NCT01486966|26625655|P1|Overall Study|Withdrawal by Subject|0
7653093|NCT01486966|26625654|P2|Overall Study|Adverse Event|1
7653094|NCT01486966|26625655|P1|Overall Study|Adverse Event|0
7653095|NCT01486927|26625679|P1|Overall Study|Subject did not reach 6 mo of treatment|1
7653096|NCT01486927|26625679|P1|Overall Study|Withdrawal by Subject|8
7653097|NCT01486927|26625679|P1|Overall Study|50 Exposure days not reached|2
7653098|NCT01486927|26625679|P1|Overall Study|Physician Decision|1
7653099|NCT01486927|26625679|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
7653100|NCT01486784|26625721|P6|Overall Study|Death|1
7653101|NCT01486784|26625722|P5|Overall Study|Death|0
7653102|NCT01486784|26625723|P4|Overall Study|Death|0
7653103|NCT01486784|26625724|P3|Overall Study|Death|0
7653104|NCT01486784|26625725|P2|Overall Study|Death|0
7653105|NCT01486784|26625726|P1|Overall Study|Death|0
7653106|NCT01486784|26625721|P6|Overall Study|Subject did not meet entry criteria|0
7653107|NCT01486784|26625722|P5|Overall Study|Subject did not meet entry criteria|1
7653108|NCT01486784|26625723|P4|Overall Study|Subject did not meet entry criteria|0
7653109|NCT01486784|26625724|P3|Overall Study|Subject did not meet entry criteria|0
7653110|NCT01486784|26625725|P2|Overall Study|Subject did not meet entry criteria|0
7653111|NCT01486784|26625726|P1|Overall Study|Subject did not meet entry criteria|0
7653112|NCT01486784|26625721|P6|Overall Study|Withdrawal by Subject|2
7653113|NCT01486784|26625722|P5|Overall Study|Withdrawal by Subject|1
7653114|NCT01486784|26625723|P4|Overall Study|Withdrawal by Subject|0
7653115|NCT01486784|26625724|P3|Overall Study|Withdrawal by Subject|1
7653116|NCT01486784|26625725|P2|Overall Study|Withdrawal by Subject|0
7653117|NCT01486784|26625726|P1|Overall Study|Withdrawal by Subject|0
7653118|NCT01486758|26625748|P2|Overall Study|Lost to Follow-up|1
7653119|NCT01486758|26625749|P1|Overall Study|Lost to Follow-up|0
7653120|NCT01486446|26625816|P2|Overall Study|Adverse Event|0
7653121|NCT01486446|26625817|P1|Overall Study|Adverse Event|1
7653122|NCT01486316|26625840|P4|Overall Study|Death|0
7653123|NCT01486316|26625841|P3|Overall Study|Death|0
7653124|NCT01486316|26625842|P2|Overall Study|Death|1
7653125|NCT01486316|26625843|P1|Overall Study|Death|0
7653126|NCT01486316|26625840|P4|Overall Study|Physician Decision|0
7653127|NCT01486316|26625841|P3|Overall Study|Physician Decision|1
7653128|NCT01486316|26625842|P2|Overall Study|Physician Decision|0
7653129|NCT01486316|26625843|P1|Overall Study|Physician Decision|0
7653130|NCT01486316|26625840|P4|Overall Study|Withdrawal by Subject|0
7653131|NCT01486316|26625841|P3|Overall Study|Withdrawal by Subject|3
7653132|NCT01486316|26625842|P2|Overall Study|Withdrawal by Subject|0
7653133|NCT01486316|26625843|P1|Overall Study|Withdrawal by Subject|1
7653134|NCT01486316|26625840|P4|Overall Study|Not meeting eligibility criteria|0
7653135|NCT01486316|26625841|P3|Overall Study|Not meeting eligibility criteria|1
7653136|NCT01486316|26625842|P2|Overall Study|Not meeting eligibility criteria|0
7653137|NCT01486316|26625843|P1|Overall Study|Not meeting eligibility criteria|0
7653138|NCT01486316|26625840|P4|Overall Study|Device explanted with/without re-implant|2
7653139|NCT01486316|26625841|P3|Overall Study|Device explanted with/without re-implant|0
7653140|NCT01486316|26625842|P2|Overall Study|Device explanted with/without re-implant|2
7653141|NCT01486316|26625843|P1|Overall Study|Device explanted with/without re-implant|3
7653142|NCT01486264|26625855|P2|Overall Study|Not treated|1
7653143|NCT01486264|26625856|P1|Overall Study|Not treated|0
7653144|NCT01486264|26625855|P2|Overall Study|Other|11
7653145|NCT01486264|26625856|P1|Overall Study|Other|5
7653146|NCT01486264|26625855|P2|Overall Study|Lost to Follow-up|2
7653147|NCT01486264|26625856|P1|Overall Study|Lost to Follow-up|3
7653148|NCT01486264|26625855|P2|Overall Study|Protocol Violation|0
7653149|NCT01486264|26625856|P1|Overall Study|Protocol Violation|3
7653150|NCT01486264|26625855|P2|Overall Study|Physician Decision|1
7653151|NCT01486264|26625856|P1|Overall Study|Physician Decision|1
7653152|NCT01486264|26625855|P2|Overall Study|Withdrawal by Subject|18
7653153|NCT01486264|26625856|P1|Overall Study|Withdrawal by Subject|7
7653154|NCT01486264|26625855|P2|Overall Study|Lack of Efficacy|10
7653155|NCT01486264|26625856|P1|Overall Study|Lack of Efficacy|6
7653156|NCT01486264|26625855|P2|Overall Study|Adverse Event|3
7653157|NCT01486264|26625856|P1|Overall Study|Adverse Event|3
7653158|NCT01486264|26625855|P2|Overall Study|Death|1
7653159|NCT01486264|26625856|P1|Overall Study|Death|1
7653160|NCT01486238|26625888|P2|Overall Study|Lost to Follow-up|3
7653161|NCT01486238|26625889|P1|Overall Study|Lost to Follow-up|0
7653162|NCT01486238|26625888|P2|Overall Study|Withdrawal by Subject|1
7653163|NCT01486238|26625889|P1|Overall Study|Withdrawal by Subject|2
7653164|NCT01486238|26625888|P2|Overall Study|Death|2
7653165|NCT01486238|26625889|P1|Overall Study|Death|0
7653166|NCT01486199|26625897|P2|Two Year Period Between Study Days|Physician Decision|0
7653167|NCT01486199|26625898|P1|Two Year Period Between Study Days|Physician Decision|1
7653168|NCT01485991|26625918|P2|Overall Study|randomized but not treated|2
7653169|NCT01485991|26625919|P1|Overall Study|randomized but not treated|6
7653170|NCT01485991|26625918|P2|Overall Study|Withdrawal by Subject|20
7653171|NCT01485991|26625919|P1|Overall Study|Withdrawal by Subject|13
7653172|NCT01485991|26625918|P2|Overall Study|Lost to Follow-up|10
7653173|NCT01485991|26625919|P1|Overall Study|Lost to Follow-up|13
7653174|NCT01485991|26625918|P2|Overall Study|Adverse Event|4
7653175|NCT01485991|26625919|P1|Overall Study|Adverse Event|0
7653176|NCT01485887|26625929|P1|Overall Study|Primary disease markedly improved|1
7653177|NCT01485887|26625929|P1|Overall Study|Deterioration of primary disease|1
7653178|NCT01485887|26625929|P1|Overall Study|Adverse Event|8
7653179|NCT01485887|26625929|P1|Overall Study|Withdrawal by Subject|2
7653180|NCT01485796|26625941|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
7653181|NCT01485796|26625941|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
7653182|NCT01485796|26625941|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
7653183|NCT01485796|26625941|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
7653184|NCT01485796|26625941|P1|Period 2: Epoch 2|Switch to safety follow-up|26
7653185|NCT01485796|26625941|P1|Period 2: Epoch 2|Adverse Event|3
7653186|NCT01485796|26625941|P1|Period 2: Epoch 2|Withdrawal by Subject|6
7653187|NCT01485796|26625941|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
7653188|NCT01485640|26625980|P1|Overall Study|Terminated by Sponsor|95
7653189|NCT01485640|26625980|P1|Overall Study|Withdrawal by Subject|14
7653190|NCT01485640|26625980|P1|Overall Study|Protocol Violation|1
7653191|NCT01485640|26625980|P1|Overall Study|Lack of Efficacy|2
7653192|NCT01485640|26625980|P1|Overall Study|Adverse Event|10
7653193|NCT01485627|26625987|P2|Overall Study|caregiver was not bereaved|35
7653194|NCT01485627|26625988|P1|Overall Study|caregiver was not bereaved|42
7653195|NCT01485627|26625987|P2|Overall Study|Caregiver died|0
7653196|NCT01485627|26625988|P1|Overall Study|Caregiver died|1
7653197|NCT01485627|26625987|P2|Overall Study|Caregiver lost to follow up|12
7653198|NCT01485627|26625988|P1|Overall Study|Caregiver lost to follow up|11
7653199|NCT01485627|26625987|P2|Overall Study|Caregiver withdrew|3
7653200|NCT01485627|26625988|P1|Overall Study|Caregiver withdrew|3
7653201|NCT01485627|26625987|P2|Overall Study|Patient lost to followup|1
7653202|NCT01485627|26625988|P1|Overall Study|Patient lost to followup|0
7653203|NCT01485627|26625987|P2|Overall Study|Patient died|1
7653204|NCT01485627|26625988|P1|Overall Study|Patient died|3
7653205|NCT01485627|26625987|P2|Overall Study|Patient withdrew|5
7653206|NCT01485627|26625988|P1|Overall Study|Patient withdrew|6
7653207|NCT01485614|26626010|P4|Weeks 20-54|Withdrawal by Subject|0
7653208|NCT01485614|26626011|P3|Weeks 20-54|Withdrawal by Subject|0
7653209|NCT01485614|26626012|P2|Weeks 20-54|Withdrawal by Subject|3
7653210|NCT01485614|26626013|P1|Weeks 20-54|Withdrawal by Subject|5
7653211|NCT01485614|26626010|P4|Weeks 20-54|Withdrawal by Parent/Guardian|0
7653212|NCT01485614|26626011|P3|Weeks 20-54|Withdrawal by Parent/Guardian|1
7653213|NCT01485614|26626012|P2|Weeks 20-54|Withdrawal by Parent/Guardian|2
7653214|NCT01485614|26626013|P1|Weeks 20-54|Withdrawal by Parent/Guardian|2
7653215|NCT01485614|26626010|P4|Weeks 20-54|Lost to Follow-up|0
7653216|NCT01485614|26626011|P3|Weeks 20-54|Lost to Follow-up|1
7653217|NCT01485614|26626012|P2|Weeks 20-54|Lost to Follow-up|3
7653218|NCT01485614|26626013|P1|Weeks 20-54|Lost to Follow-up|4
7653219|NCT01485614|26626010|P4|Weeks 0-20|Withdrawal by Subject|0
7653220|NCT01485614|26626011|P3|Weeks 0-20|Withdrawal by Subject|1
7653221|NCT01485614|26626012|P2|Weeks 0-20|Withdrawal by Subject|2
7653222|NCT01485614|26626013|P1|Weeks 0-20|Withdrawal by Subject|3
7653223|NCT01485614|26626010|P4|Weeks 0-20|Withdrawal by Parent/Guardian|0
7653224|NCT01485614|26626011|P3|Weeks 0-20|Withdrawal by Parent/Guardian|0
7653225|NCT01485614|26626012|P2|Weeks 0-20|Withdrawal by Parent/Guardian|2
7653226|NCT01485614|26626013|P1|Weeks 0-20|Withdrawal by Parent/Guardian|5
7653227|NCT01485614|26626010|P4|Weeks 0-20|Lost to Follow-up|0
7653228|NCT01485614|26626011|P3|Weeks 0-20|Lost to Follow-up|0
7653229|NCT01485614|26626012|P2|Weeks 0-20|Lost to Follow-up|0
7653230|NCT01485614|26626013|P1|Weeks 0-20|Lost to Follow-up|2
7653231|NCT01485614|26626010|P4|Randomization|Not Treated|0
7653232|NCT01485614|26626011|P3|Randomization|Not Treated|0
7653233|NCT01485614|26626012|P2|Randomization|Not Treated|0
7653234|NCT01485614|26626013|P1|Randomization|Not Treated|1
7653235|NCT01485536|26626385|P1|Overall Study|Adverse Event|1
7653236|NCT01485536|26626385|P1|Overall Study|Withdrawal by Subject|3
7653237|NCT01485354|26626403|P1|Overall Study|Withdrawal by Subject|5
7653238|NCT01485172|26626417|P6|Overall Study|Withdrawal by Subject|1
7653239|NCT01485172|26626418|P5|Overall Study|Withdrawal by Subject|1
7653240|NCT01485172|26626419|P4|Overall Study|Withdrawal by Subject|1
7653241|NCT01485172|26626420|P3|Overall Study|Withdrawal by Subject|0
7653242|NCT01485172|26626421|P2|Overall Study|Withdrawal by Subject|0
7653243|NCT01485172|26626422|P1|Overall Study|Withdrawal by Subject|2
7653244|NCT01485172|26626417|P6|Overall Study|Physician Decision|0
7653245|NCT01485172|26626418|P5|Overall Study|Physician Decision|1
7653246|NCT01485172|26626419|P4|Overall Study|Physician Decision|0
7653247|NCT01485172|26626420|P3|Overall Study|Physician Decision|0
7653248|NCT01485172|26626421|P2|Overall Study|Physician Decision|0
7653249|NCT01485172|26626422|P1|Overall Study|Physician Decision|0
7653250|NCT01485172|26626417|P6|Overall Study|Lost to Follow-up|1
7653251|NCT01485172|26626418|P5|Overall Study|Lost to Follow-up|0
7653252|NCT01485172|26626419|P4|Overall Study|Lost to Follow-up|0
7653253|NCT01485172|26626420|P3|Overall Study|Lost to Follow-up|1
7653254|NCT01485172|26626421|P2|Overall Study|Lost to Follow-up|0
7653255|NCT01485172|26626422|P1|Overall Study|Lost to Follow-up|0
7653256|NCT01485172|26626417|P6|Overall Study|Protocol defined stopping criteria|0
7653257|NCT01485172|26626418|P5|Overall Study|Protocol defined stopping criteria|1
7653258|NCT01485172|26626419|P4|Overall Study|Protocol defined stopping criteria|0
7653259|NCT01485172|26626420|P3|Overall Study|Protocol defined stopping criteria|0
7653260|NCT01485172|26626421|P2|Overall Study|Protocol defined stopping criteria|0
7653261|NCT01485172|26626422|P1|Overall Study|Protocol defined stopping criteria|1
7653262|NCT01485172|26626417|P6|Overall Study|Protocol Violation|0
7653263|NCT01485172|26626418|P5|Overall Study|Protocol Violation|1
7653264|NCT01485172|26626419|P4|Overall Study|Protocol Violation|5
7653265|NCT01485172|26626420|P3|Overall Study|Protocol Violation|4
7653266|NCT01485172|26626421|P2|Overall Study|Protocol Violation|0
7653267|NCT01485172|26626422|P1|Overall Study|Protocol Violation|0
7653268|NCT01485172|26626417|P6|Overall Study|Lack of Efficacy|0
7653269|NCT01485172|26626418|P5|Overall Study|Lack of Efficacy|0
7653270|NCT01485172|26626419|P4|Overall Study|Lack of Efficacy|0
7653271|NCT01485172|26626420|P3|Overall Study|Lack of Efficacy|0
7653272|NCT01485172|26626421|P2|Overall Study|Lack of Efficacy|0
7653273|NCT01485172|26626422|P1|Overall Study|Lack of Efficacy|2
7653274|NCT01485172|26626417|P6|Overall Study|Adverse Event|2
7653275|NCT01485172|26626418|P5|Overall Study|Adverse Event|1
7653276|NCT01485172|26626419|P4|Overall Study|Adverse Event|2
7653277|NCT01485172|26626420|P3|Overall Study|Adverse Event|2
7653278|NCT01485172|26626421|P2|Overall Study|Adverse Event|1
7653279|NCT01485172|26626422|P1|Overall Study|Adverse Event|2
7653280|NCT01485120|26626496|P1|Overall Study|Withdrawal by Subject|2
7653281|NCT01485094|26626504|P3|Overall Study|Withdrawal by Subject|0
7653282|NCT01485094|26626505|P2|Overall Study|Withdrawal by Subject|1
7653283|NCT01485094|26626506|P1|Overall Study|Withdrawal by Subject|1
7653284|NCT01485094|26626504|P3|Overall Study|Lost to Follow-up|0
7653285|NCT01485094|26626505|P2|Overall Study|Lost to Follow-up|0
7653286|NCT01485094|26626506|P1|Overall Study|Lost to Follow-up|1
7653287|NCT01485094|26626504|P3|Overall Study|Adverse Event|1
7653288|NCT01485094|26626505|P2|Overall Study|Adverse Event|1
7653289|NCT01485094|26626506|P1|Overall Study|Adverse Event|1
7653290|NCT01484977|26626551|P1|Overall Study|Lack of Compliance|1
7653291|NCT01484977|26626551|P1|Overall Study|Low White Blood Cell Count|1
7653292|NCT01484977|26626551|P1|Overall Study|Moving Overseas|1
7653293|NCT01484977|26626551|P1|Overall Study|Subject Protocol Non-compliant|1
7653294|NCT01484977|26626551|P1|Overall Study|Withdrawal by Subject|4
7653295|NCT01484977|26626551|P1|Overall Study|Lost to Follow-up|1
7653296|NCT01484977|26626551|P1|Overall Study|Protocol Violation|6
7653297|NCT01484977|26626551|P1|Overall Study|Lack of Efficacy|4
7653298|NCT01484977|26626551|P1|Overall Study|Adverse Event|8
7653299|NCT01484951|26626555|P1|Overall Study|Non-Compliance|1
7653300|NCT01484951|26626555|P1|Overall Study|Personal Reasons|1
7653301|NCT01484951|26626555|P1|Overall Study|Adverse Event|3
7653302|NCT01484938|26626560|P1|Overall Study|Noncompliance|1
7653303|NCT01484938|26626560|P1|Overall Study|Lost to Follow-up|1
7653304|NCT01484938|26626560|P1|Overall Study|Adverse Event|2
7653305|NCT01484912|26626567|P2|Overall Study|Physician Decision|1
7653306|NCT01484912|26626568|P1|Overall Study|Physician Decision|0
7653307|NCT01484912|26626567|P2|Overall Study|Withdrawal by Subject|0
7653308|NCT01484912|26626568|P1|Overall Study|Withdrawal by Subject|1
7653309|NCT01484873|26626578|P1|Overall Study|Withdrawal by Subject|2
7653310|NCT01484834|26626590|P4|Overall Study|Lost to Follow-up|4
7653311|NCT01484834|26626591|P3|Overall Study|Lost to Follow-up|1
7653312|NCT01484834|26626592|P2|Overall Study|Lost to Follow-up|8
7653313|NCT01484834|26626593|P1|Overall Study|Lost to Follow-up|5
7653314|NCT01484561|26626634|P2|Overall Study|Adverse Event|4
7653315|NCT01484561|26626635|P1|Overall Study|Adverse Event|1
7653316|NCT01484561|26626634|P2|Overall Study|Other|1
7653317|NCT01484561|26626635|P1|Overall Study|Other|1
7653318|NCT01484561|26626634|P2|Overall Study|Withdrawal by Subject|0
7653319|NCT01484561|26626635|P1|Overall Study|Withdrawal by Subject|3
7653320|NCT01484561|26626634|P2|Overall Study|Lost to Follow-up|0
7653321|NCT01484561|26626635|P1|Overall Study|Lost to Follow-up|1
7653322|NCT01484561|26626634|P2|Overall Study|Lack of Efficacy|1
7653323|NCT01484561|26626635|P1|Overall Study|Lack of Efficacy|3
7653324|NCT01484496|26626725|P4|Period 2|Other|6
7653325|NCT01484496|26626726|P3|Period 2|Other|9
7653326|NCT01484496|26626727|P2|Period 2|Other|0
7653327|NCT01484496|26626728|P1|Period 2|Other|0
7653328|NCT01484496|26626725|P4|Period 2|Adverse Event|13
7653329|NCT01484496|26626726|P3|Period 2|Adverse Event|5
7653330|NCT01484496|26626727|P2|Period 2|Adverse Event|0
7653331|NCT01484496|26626728|P1|Period 2|Adverse Event|0
7653332|NCT01484496|26626725|P4|Period 2|Lack of Efficacy|3
7653333|NCT01484496|26626726|P3|Period 2|Lack of Efficacy|1
7653334|NCT01484496|26626727|P2|Period 2|Lack of Efficacy|0
7653335|NCT01484496|26626728|P1|Period 2|Lack of Efficacy|0
7653336|NCT01484496|26626725|P4|Period 1|Unable to Visit Site|0
7653337|NCT01484496|26626726|P3|Period 1|Unable to Visit Site|0
7653338|NCT01484496|26626727|P2|Period 1|Unable to Visit Site|2
7653339|NCT01484496|26626728|P1|Period 1|Unable to Visit Site|0
7653340|NCT01484496|26626725|P4|Period 1|Lack of Compliance|0
7653341|NCT01484496|26626726|P3|Period 1|Lack of Compliance|0
7653342|NCT01484496|26626727|P2|Period 1|Lack of Compliance|1
7653343|NCT01484496|26626728|P1|Period 1|Lack of Compliance|2
7653344|NCT01484496|26626725|P4|Period 1|Treatment Failure|0
7653345|NCT01484496|26626726|P3|Period 1|Treatment Failure|0
7653346|NCT01484496|26626727|P2|Period 1|Treatment Failure|6
7653347|NCT01484496|26626728|P1|Period 1|Treatment Failure|3
7653348|NCT01484496|26626725|P4|Period 1|Positive Pregnancy|0
7653349|NCT01484496|26626726|P3|Period 1|Positive Pregnancy|0
7653350|NCT01484496|26626727|P2|Period 1|Positive Pregnancy|6
7653351|NCT01484496|26626728|P1|Period 1|Positive Pregnancy|1
7653352|NCT01484496|26626725|P4|Period 1|Lost to Follow-up|0
7653353|NCT01484496|26626726|P3|Period 1|Lost to Follow-up|0
7653354|NCT01484496|26626727|P2|Period 1|Lost to Follow-up|6
7653355|NCT01484496|26626728|P1|Period 1|Lost to Follow-up|2
7653356|NCT01484496|26626725|P4|Period 1|Withdrawal by Subject|0
7653357|NCT01484496|26626726|P3|Period 1|Withdrawal by Subject|0
7653358|NCT01484496|26626727|P2|Period 1|Withdrawal by Subject|12
7653359|NCT01484496|26626728|P1|Period 1|Withdrawal by Subject|15
7653360|NCT01484496|26626725|P4|Period 1|Adverse Event|0
7653361|NCT01484496|26626726|P3|Period 1|Adverse Event|0
7653362|NCT01484496|26626727|P2|Period 1|Adverse Event|40
7653363|NCT01484496|26626728|P1|Period 1|Adverse Event|25
7653364|NCT01484496|26626725|P4|Period 1|Lack of Efficacy|0
7653365|NCT01484496|26626726|P3|Period 1|Lack of Efficacy|0
7653366|NCT01484496|26626727|P2|Period 1|Lack of Efficacy|15
7653367|NCT01484496|26626728|P1|Period 1|Lack of Efficacy|10
7653368|NCT01484496|26626725|P4|Period 1|Physician Decision|0
7653369|NCT01484496|26626726|P3|Period 1|Physician Decision|0
7653370|NCT01484496|26626727|P2|Period 1|Physician Decision|1
7653371|NCT01484496|26626728|P1|Period 1|Physician Decision|5
7653372|NCT01484496|26626725|P4|Period 1|Protocol Violation|0
7653373|NCT01484496|26626726|P3|Period 1|Protocol Violation|0
7653374|NCT01484496|26626727|P2|Period 1|Protocol Violation|4
7653375|NCT01484496|26626728|P1|Period 1|Protocol Violation|3
7653376|NCT01484431|26626743|P3|Period 2|Non-Compliance with Study Drug|0
7653377|NCT01484431|26626744|P2|Period 2|Non-Compliance with Study Drug|0
7653378|NCT01484431|26626745|P1|Period 2|Non-Compliance with Study Drug|1
7653379|NCT01484431|26626743|P3|Period 2|Physician Decision|1
7653380|NCT01484431|26626744|P2|Period 2|Physician Decision|0
7653381|NCT01484431|26626745|P1|Period 2|Physician Decision|0
7653382|NCT01484431|26626743|P3|Period 2|Death|1
7653383|NCT01484431|26626744|P2|Period 2|Death|1
7653384|NCT01484431|26626745|P1|Period 2|Death|0
7653385|NCT01484431|26626743|P3|Period 1: High Dose|Physician Decision|0
7653386|NCT01484431|26626744|P2|Period 1: High Dose|Physician Decision|1
7653387|NCT01484431|26626745|P1|Period 1: High Dose|Physician Decision|0
7653388|NCT01484275|26626795|P2|Overall Study|Lost to Follow-up|1
7653389|NCT01484275|26626796|P1|Overall Study|Lost to Follow-up|1
7653390|NCT01484275|26626795|P2|Overall Study|Withdrawal by Subject|5
7653391|NCT01484275|26626796|P1|Overall Study|Withdrawal by Subject|1
7653392|NCT01484275|26626795|P2|Overall Study|Death|4
7653393|NCT01484275|26626796|P1|Overall Study|Death|3
7653394|NCT01484275|26626795|P2|Overall Study|Other|0
7653395|NCT01484275|26626796|P1|Overall Study|Other|10
7653396|NCT01484275|26626795|P2|Overall Study|Study terminated by sponsor|32
7653397|NCT01484275|26626796|P1|Overall Study|Study terminated by sponsor|28
7653398|NCT01484197|26626818|P4|Treatment Period 2|Subject withdrew consent|1
7653399|NCT01484197|26626819|P3|Treatment Period 2|Subject withdrew consent|0
7653400|NCT01484197|26626820|P2|Treatment Period 2|Subject withdrew consent|0
7653401|NCT01484197|26626821|P1|Treatment Period 2|Subject withdrew consent|0
7653402|NCT01484197|26626818|P4|Treatment Period 1|Adverse Event|0
7653403|NCT01484197|26626819|P3|Treatment Period 1|Adverse Event|0
7653404|NCT01484197|26626820|P2|Treatment Period 1|Adverse Event|0
7653405|NCT01484197|26626821|P1|Treatment Period 1|Adverse Event|1
7653406|NCT01484132|26626904|P1|Overall Study|No post-treatment urine sample collected|10
7653407|NCT01484132|26626904|P1|Overall Study|No pre-treatment urine sample collected|1
7653408|NCT01484132|26626904|P1|Overall Study|Ineligible|1
7653409|NCT01484132|26626904|P1|Overall Study|Difficulty with time commitment|2
7653410|NCT01484132|26626904|P1|Overall Study|Lost to Follow-up|8
7653411|NCT01484054|26626912|P2|Period 1|Withdrawal by Subject|1
7653412|NCT01484054|26626913|P1|Period 1|Withdrawal by Subject|0
7653413|NCT01484028|26626931|P4|Period 1|Lens Discomfort|0
7653414|NCT01484028|26626932|P3|Period 1|Lens Discomfort|0
7653415|NCT01484028|26626933|P2|Period 1|Lens Discomfort|1
7653416|NCT01484028|26626934|P1|Period 1|Lens Discomfort|0
7653417|NCT01484028|26626931|P4|Period 1|Non-Compliance to Protocol|1
7653418|NCT01484028|26626932|P3|Period 1|Non-Compliance to Protocol|0
7653419|NCT01484028|26626933|P2|Period 1|Non-Compliance to Protocol|1
7653420|NCT01484028|26626934|P1|Period 1|Non-Compliance to Protocol|0
7653421|NCT01484028|26626931|P4|Period 1|Lost to Follow-up|0
7653422|NCT01484028|26626932|P3|Period 1|Lost to Follow-up|0
7653423|NCT01484028|26626933|P2|Period 1|Lost to Follow-up|1
7653424|NCT01484028|26626934|P1|Period 1|Lost to Follow-up|0
7653425|NCT01483937|26627027|P2|Overall Study|Withdrawal by Subject|3
7653426|NCT01483937|26627028|P1|Overall Study|Withdrawal by Subject|4
7653427|NCT01483924|26627055|P5|Overall Study|Sponsor concern over ECG result|0
7653428|NCT01483924|26627056|P4|Overall Study|Sponsor concern over ECG result|1
7653429|NCT01483924|26627057|P3|Overall Study|Sponsor concern over ECG result|0
7653430|NCT01483924|26627058|P2|Overall Study|Sponsor concern over ECG result|0
7653431|NCT01483924|26627059|P1|Overall Study|Sponsor concern over ECG result|0
7653432|NCT01483924|26627055|P5|Overall Study|Non-compliance|1
7653433|NCT01483924|26627056|P4|Overall Study|Non-compliance|1
7653434|NCT01483924|26627057|P3|Overall Study|Non-compliance|0
7653435|NCT01483924|26627058|P2|Overall Study|Non-compliance|0
7653436|NCT01483924|26627059|P1|Overall Study|Non-compliance|0
7653437|NCT01483924|26627055|P5|Overall Study|Adverse Event|0
7653438|NCT01483924|26627056|P4|Overall Study|Adverse Event|1
7653439|NCT01483924|26627057|P3|Overall Study|Adverse Event|1
7653440|NCT01483924|26627058|P2|Overall Study|Adverse Event|0
7653441|NCT01483924|26627059|P1|Overall Study|Adverse Event|0
7653442|NCT01483924|26627055|P5|Overall Study|Withdrawal by Subject|1
7653443|NCT01483924|26627056|P4|Overall Study|Withdrawal by Subject|1
7653444|NCT01483924|26627057|P3|Overall Study|Withdrawal by Subject|0
7653445|NCT01483924|26627058|P2|Overall Study|Withdrawal by Subject|0
7653446|NCT01483924|26627059|P1|Overall Study|Withdrawal by Subject|2
7653447|NCT01483820|26627112|P1|Overall Study|Death|1
7653448|NCT01483820|26627112|P1|Overall Study|Adverse Event|1
7653449|NCT01483820|26627112|P1|Overall Study|Lack of Efficacy|6
7653450|NCT01483690|26627135|P2|Overall Study|exclusionary procedure|1
7653451|NCT01483690|26627136|P1|Overall Study|exclusionary procedure|0
7653452|NCT01483690|26627135|P2|Overall Study|Physician Decision|2
7653453|NCT01483690|26627136|P1|Overall Study|Physician Decision|0
7653454|NCT01483690|26627135|P2|Overall Study|clinical deterioration|0
7653455|NCT01483690|26627136|P1|Overall Study|clinical deterioration|1
7653456|NCT01483690|26627135|P2|Overall Study|Adverse Event|2
7653457|NCT01483690|26627136|P1|Overall Study|Adverse Event|1
7653458|NCT01483651|26627144|P6|Overall Study|Withdrawal by Subject|1
7653459|NCT01483651|26627145|P5|Overall Study|Withdrawal by Subject|0
7653460|NCT01483651|26627146|P4|Overall Study|Withdrawal by Subject|0
7653461|NCT01483651|26627147|P3|Overall Study|Withdrawal by Subject|1
7653462|NCT01483651|26627148|P2|Overall Study|Withdrawal by Subject|1
7653463|NCT01483651|26627149|P1|Overall Study|Withdrawal by Subject|0
7653464|NCT01483625|26627159|P2|Overall Study|Due to other reason|0
7653465|NCT01483625|26627160|P1|Overall Study|Due to other reason|1
7653466|NCT01483625|26627159|P2|Overall Study|Refused to continue medication|1
7653467|NCT01483625|26627160|P1|Overall Study|Refused to continue medication|2
7653468|NCT01483625|26627159|P2|Overall Study|Adverse Event|1
7653469|NCT01483625|26627160|P1|Overall Study|Adverse Event|1
7653470|NCT01483599|26627183|P14|After Controlled Period(Week 16-Week 40)|Other|0
7653471|NCT01483599|26627184|P13|After Controlled Period(Week 16-Week 40)|Other|1
7653472|NCT01483599|26627185|P12|After Controlled Period(Week 16-Week 40)|Other|0
7653473|NCT01483599|26627186|P11|After Controlled Period(Week 16-Week 40)|Other|0
7653474|NCT01483599|26627187|P10|After Controlled Period(Week 16-Week 40)|Other|4
7653475|NCT01483599|26627188|P9|After Controlled Period(Week 16-Week 40)|Other|0
7653476|NCT01483599|26627189|P8|After Controlled Period(Week 16-Week 40)|Other|1
7653477|NCT01483599|26627190|P7|After Controlled Period(Week 16-Week 40)|Other|0
7653478|NCT01483599|26627191|P6|After Controlled Period(Week 16-Week 40)|Other|0
7653479|NCT01483599|26627192|P5|After Controlled Period(Week 16-Week 40)|Other|0
7653480|NCT01483599|26627193|P4|After Controlled Period(Week 16-Week 40)|Other|0
7653481|NCT01483599|26627194|P3|After Controlled Period(Week 16-Week 40)|Other|0
7653482|NCT01483599|26627195|P2|After Controlled Period(Week 16-Week 40)|Other|0
7653483|NCT01483599|26627196|P1|After Controlled Period(Week 16-Week 40)|Other|0
7653484|NCT01483599|26627183|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
7653485|NCT01483599|26627184|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
7653486|NCT01483599|26627185|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653487|NCT01483599|26627186|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653488|NCT01483599|26627187|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653489|NCT01483599|26627188|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
7653490|NCT01483599|26627189|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653491|NCT01483599|26627190|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653492|NCT01483599|26627191|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653493|NCT01483599|26627192|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653494|NCT01483599|26627193|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653495|NCT01483599|26627194|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653496|NCT01483599|26627195|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653497|NCT01483599|26627196|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7653498|NCT01483599|26627183|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7653499|NCT01483599|26627184|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653500|NCT01483599|26627185|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653501|NCT01483599|26627186|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
7653502|NCT01483599|26627187|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653503|NCT01483599|26627188|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7653504|NCT01483599|26627189|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653505|NCT01483599|26627190|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653506|NCT01483599|26627191|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653507|NCT01483599|26627192|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653508|NCT01483599|26627193|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653509|NCT01483599|26627194|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653510|NCT01483599|26627195|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653511|NCT01483599|26627196|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7653512|NCT01483599|26627183|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7653513|NCT01483599|26627184|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653514|NCT01483599|26627185|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7653515|NCT01483599|26627186|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653516|NCT01483599|26627187|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653517|NCT01483599|26627188|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7653518|NCT01483599|26627189|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653519|NCT01483599|26627190|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653520|NCT01483599|26627191|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653521|NCT01483599|26627192|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653522|NCT01483599|26627193|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653523|NCT01483599|26627194|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653524|NCT01483599|26627195|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653525|NCT01483599|26627196|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7653526|NCT01483599|26627183|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7653527|NCT01483599|26627184|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7653528|NCT01483599|26627185|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653529|NCT01483599|26627186|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653530|NCT01483599|26627187|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653531|NCT01483599|26627188|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7653532|NCT01483599|26627189|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7653533|NCT01483599|26627190|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653534|NCT01483599|26627191|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653535|NCT01483599|26627192|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653536|NCT01483599|26627193|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653537|NCT01483599|26627194|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653538|NCT01483599|26627195|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653539|NCT01483599|26627196|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7653540|NCT01483599|26627183|P14|After Controlled Period(Week 16-Week 40)|Death|0
7653541|NCT01483599|26627184|P13|After Controlled Period(Week 16-Week 40)|Death|0
7653542|NCT01483599|26627185|P12|After Controlled Period(Week 16-Week 40)|Death|0
7653543|NCT01483599|26627186|P11|After Controlled Period(Week 16-Week 40)|Death|0
7653544|NCT01483599|26627187|P10|After Controlled Period(Week 16-Week 40)|Death|0
7653545|NCT01483599|26627188|P9|After Controlled Period(Week 16-Week 40)|Death|1
7653546|NCT01483599|26627189|P8|After Controlled Period(Week 16-Week 40)|Death|0
7653547|NCT01483599|26627190|P7|After Controlled Period(Week 16-Week 40)|Death|0
7653548|NCT01483599|26627191|P6|After Controlled Period(Week 16-Week 40)|Death|0
7653549|NCT01483599|26627192|P5|After Controlled Period(Week 16-Week 40)|Death|0
7653550|NCT01483599|26627193|P4|After Controlled Period(Week 16-Week 40)|Death|0
7653551|NCT01483599|26627194|P3|After Controlled Period(Week 16-Week 40)|Death|0
7653552|NCT01483599|26627195|P2|After Controlled Period(Week 16-Week 40)|Death|0
7653553|NCT01483599|26627196|P1|After Controlled Period(Week 16-Week 40)|Death|0
7653554|NCT01483599|26627183|P14|Controlled Period (CP) (up to Week 16)|Other|0
7653555|NCT01483599|26627184|P13|Controlled Period (CP) (up to Week 16)|Other|0
7653556|NCT01483599|26627185|P12|Controlled Period (CP) (up to Week 16)|Other|0
7653557|NCT01483599|26627186|P11|Controlled Period (CP) (up to Week 16)|Other|0
7653558|NCT01483599|26627187|P10|Controlled Period (CP) (up to Week 16)|Other|0
7653559|NCT01483599|26627188|P9|Controlled Period (CP) (up to Week 16)|Other|0
7653560|NCT01483599|26627189|P8|Controlled Period (CP) (up to Week 16)|Other|0
7653561|NCT01483599|26627190|P7|Controlled Period (CP) (up to Week 16)|Other|0
7653562|NCT01483599|26627191|P6|Controlled Period (CP) (up to Week 16)|Other|0
7653563|NCT01483599|26627192|P5|Controlled Period (CP) (up to Week 16)|Other|1
7653564|NCT01483599|26627193|P4|Controlled Period (CP) (up to Week 16)|Other|1
7653565|NCT01483599|26627194|P3|Controlled Period (CP) (up to Week 16)|Other|0
7653566|NCT01483599|26627195|P2|Controlled Period (CP) (up to Week 16)|Other|2
7653567|NCT01483599|26627196|P1|Controlled Period (CP) (up to Week 16)|Other|0
7653568|NCT01483599|26627183|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653569|NCT01483599|26627184|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653570|NCT01483599|26627185|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653571|NCT01483599|26627186|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653572|NCT01483599|26627187|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653573|NCT01483599|26627188|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653574|NCT01483599|26627189|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653575|NCT01483599|26627190|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653576|NCT01483599|26627191|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653577|NCT01483599|26627192|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653578|NCT01483599|26627193|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653579|NCT01483599|26627194|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653580|NCT01483599|26627195|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7653581|NCT01483599|26627196|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
7653582|NCT01483599|26627183|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653583|NCT01483599|26627184|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653584|NCT01483599|26627185|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653585|NCT01483599|26627186|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653586|NCT01483599|26627187|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653587|NCT01483599|26627188|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653588|NCT01483599|26627189|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653589|NCT01483599|26627190|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7653590|NCT01483599|26627191|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653591|NCT01483599|26627192|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653592|NCT01483599|26627193|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7653593|NCT01483599|26627194|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653594|NCT01483599|26627195|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7653595|NCT01483599|26627196|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7653596|NCT01483599|26627183|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653597|NCT01483599|26627184|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653598|NCT01483599|26627185|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653599|NCT01483599|26627186|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653600|NCT01483599|26627187|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653601|NCT01483599|26627188|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653602|NCT01483599|26627189|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653603|NCT01483599|26627190|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
7653604|NCT01483599|26627191|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
7653605|NCT01483599|26627192|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7653606|NCT01483599|26627193|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7653607|NCT01483599|26627194|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653608|NCT01483599|26627195|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7653609|NCT01483599|26627196|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
7653610|NCT01483183|26627309|P10|Overall Study|Withdrawal by Subject|1
7653611|NCT01483183|26627310|P9|Overall Study|Withdrawal by Subject|0
7653612|NCT01483183|26627311|P8|Overall Study|Withdrawal by Subject|0
7653613|NCT01483183|26627312|P7|Overall Study|Withdrawal by Subject|0
7653614|NCT01483183|26627313|P6|Overall Study|Withdrawal by Subject|0
7653615|NCT01483183|26627314|P5|Overall Study|Withdrawal by Subject|0
7653616|NCT01483183|26627315|P4|Overall Study|Withdrawal by Subject|0
7653617|NCT01483183|26627316|P3|Overall Study|Withdrawal by Subject|0
7653618|NCT01483183|26627317|P2|Overall Study|Withdrawal by Subject|0
7653619|NCT01483183|26627318|P1|Overall Study|Withdrawal by Subject|0
7653620|NCT01483183|26627309|P10|Overall Study|Physician Decision|0
7653621|NCT01483183|26627310|P9|Overall Study|Physician Decision|0
7653622|NCT01483183|26627311|P8|Overall Study|Physician Decision|0
7653623|NCT01483183|26627312|P7|Overall Study|Physician Decision|2
7653624|NCT01483183|26627313|P6|Overall Study|Physician Decision|0
7653625|NCT01483183|26627314|P5|Overall Study|Physician Decision|0
7653626|NCT01483183|26627315|P4|Overall Study|Physician Decision|0
7653627|NCT01483183|26627316|P3|Overall Study|Physician Decision|0
7653628|NCT01483183|26627317|P2|Overall Study|Physician Decision|0
7653629|NCT01483183|26627318|P1|Overall Study|Physician Decision|0
7653630|NCT01483144|26627389|P3|Overall Study|Protocol Violation|3
7653631|NCT01483144|26627390|P2|Overall Study|Protocol Violation|3
7653632|NCT01483144|26627391|P1|Overall Study|Protocol Violation|3
7653633|NCT01483144|26627389|P3|Overall Study|Lost to Follow-up|1
7653634|NCT01483144|26627390|P2|Overall Study|Lost to Follow-up|4
7653635|NCT01483144|26627391|P1|Overall Study|Lost to Follow-up|2
7653636|NCT01483144|26627389|P3|Overall Study|Physician Decision|0
7653637|NCT01483144|26627390|P2|Overall Study|Physician Decision|0
7653638|NCT01483144|26627391|P1|Overall Study|Physician Decision|1
7653639|NCT01483144|26627389|P3|Overall Study|Withdrawal by Subject|5
7653640|NCT01483144|26627390|P2|Overall Study|Withdrawal by Subject|2
7653641|NCT01483144|26627391|P1|Overall Study|Withdrawal by Subject|0
7653642|NCT01483144|26627389|P3|Overall Study|Adverse Event|6
7653643|NCT01483144|26627390|P2|Overall Study|Adverse Event|4
7653644|NCT01483144|26627391|P1|Overall Study|Adverse Event|9
7653645|NCT01483118|26627407|P2|Overall Study|Lost to Follow-up|16
7653646|NCT01483118|26627408|P1|Overall Study|Lost to Follow-up|12
7653647|NCT01482962|26627420|P2|Overall Study|Did not Receive Study Drug|6
7653648|NCT01482962|26627421|P1|Overall Study|Did not Receive Study Drug|1
7653649|NCT01482962|26627420|P2|Overall Study|Study Terminated by Sponsor|2
7653650|NCT01482962|26627421|P1|Overall Study|Study Terminated by Sponsor|5
7653651|NCT01482962|26627420|P2|Overall Study|Other Reason|5
7653652|NCT01482962|26627421|P1|Overall Study|Other Reason|1
7653653|NCT01482962|26627420|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
7653654|NCT01482962|26627421|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
7653655|NCT01482962|26627420|P2|Overall Study|Withdrawal by Participant|13
7653656|NCT01482962|26627421|P1|Overall Study|Withdrawal by Participant|8
7653657|NCT01482962|26627420|P2|Overall Study|Adverse Event|22
7653658|NCT01482962|26627421|P1|Overall Study|Adverse Event|18
7653659|NCT01482962|26627420|P2|Overall Study|Unsatisfactory Therapeutic Response|23
7653660|NCT01482962|26627421|P1|Overall Study|Unsatisfactory Therapeutic Response|37
7653661|NCT01482962|26627420|P2|Overall Study|Progressive Disease|53
7653662|NCT01482962|26627421|P1|Overall Study|Progressive Disease|65
7653663|NCT01482910|26627454|P2|Overall Study|Death|0
7653664|NCT01482910|26627455|P1|Overall Study|Death|1
7653665|NCT01482910|26627454|P2|Overall Study|Withdrawal by Subject|2
7653666|NCT01482910|26627455|P1|Overall Study|Withdrawal by Subject|7
7653667|NCT01482910|26627454|P2|Overall Study|Protocol Violation|1
7653668|NCT01482910|26627455|P1|Overall Study|Protocol Violation|1
7653669|NCT01482910|26627454|P2|Overall Study|Lost to Follow-up|1
7653670|NCT01482910|26627455|P1|Overall Study|Lost to Follow-up|0
7653671|NCT01482910|26627454|P2|Overall Study|Adverse Event|5
7653672|NCT01482910|26627455|P1|Overall Study|Adverse Event|6
7653673|NCT01482884|26627467|P2|Overall Study|Withdrawal by Subject|13
7653674|NCT01482884|26627468|P1|Overall Study|Withdrawal by Subject|8
7653675|NCT01482884|26627467|P2|Overall Study|Adverse Event|1
7653676|NCT01482884|26627468|P1|Overall Study|Adverse Event|2
7653677|NCT01482884|26627467|P2|Overall Study|Lack of Efficacy|1
7653678|NCT01482884|26627468|P1|Overall Study|Lack of Efficacy|0
7653679|NCT01482884|26627467|P2|Overall Study|Lost to Follow-up|2
7653680|NCT01482884|26627468|P1|Overall Study|Lost to Follow-up|2
7653681|NCT01482884|26627467|P2|Overall Study|Protocol Violation|0
7653682|NCT01482884|26627468|P1|Overall Study|Protocol Violation|1
7653683|NCT01482884|26627467|P2|Overall Study|Medical decision due to lack of efficacy|1
7653684|NCT01482884|26627468|P1|Overall Study|Medical decision due to lack of efficacy|0
7653685|NCT01482819|26627494|P1|Overall Study|Lost to Follow-up|2
7653686|NCT01482767|26627514|P2|Overall Study|Nurse error|0
7653687|NCT01482767|26627515|P1|Overall Study|Nurse error|1
7653688|NCT01482767|26627514|P2|Overall Study|Ineligible|5
7653689|NCT01482767|26627515|P1|Overall Study|Ineligible|0
7653690|NCT01482767|26627514|P2|Overall Study|Alternate HCV treatment|8
7653691|NCT01482767|26627515|P1|Overall Study|Alternate HCV treatment|7
7653692|NCT01482767|26627514|P2|Overall Study|Non-adherence to study requirements|7
7653693|NCT01482767|26627515|P1|Overall Study|Non-adherence to study requirements|4
7653694|NCT01482767|26627514|P2|Overall Study|Site closure|14
7653695|NCT01482767|26627515|P1|Overall Study|Site closure|22
7653696|NCT01482767|26627514|P2|Overall Study|Adverse Event|3
7653697|NCT01482767|26627515|P1|Overall Study|Adverse Event|0
7653698|NCT01482767|26627514|P2|Overall Study|Lost to Follow-up|6
7653699|NCT01482767|26627515|P1|Overall Study|Lost to Follow-up|12
7653700|NCT01482767|26627514|P2|Overall Study|Withdrawal by Subject|5
7653701|NCT01482767|26627515|P1|Overall Study|Withdrawal by Subject|7
7653702|NCT01482767|26627514|P2|Overall Study|Death|1
7653703|NCT01482767|26627515|P1|Overall Study|Death|1
7653704|NCT01482598|26627643|P2|Overall Study|Lost to Follow-up|4
7653705|NCT01482598|26627644|P1|Overall Study|Lost to Follow-up|5
7653706|NCT01482598|26627643|P2|Overall Study|Withdrawal by Subject|5
7653707|NCT01482598|26627644|P1|Overall Study|Withdrawal by Subject|4
7653708|NCT01482598|26627643|P2|Overall Study|Physician Decision|3
7653709|NCT01482598|26627644|P1|Overall Study|Physician Decision|0
7653710|NCT01482598|26627643|P2|Overall Study|Death|10
7653711|NCT01482598|26627644|P1|Overall Study|Death|7
7653712|NCT01482429|26627652|P2|Protocol|Protocol Violation|0
7653713|NCT01482429|26627653|P1|Protocol|Protocol Violation|275
7653714|NCT01482429|26627652|P2|Care Usual|Lost to Follow-up|1
7653715|NCT01482429|26627653|P1|Care Usual|Lost to Follow-up|0
7653716|NCT01482429|26627652|P2|Care Usual|Protocol Violation|172
7653717|NCT01482429|26627653|P1|Care Usual|Protocol Violation|0
7653718|NCT01482312|26627689|P3|Period 2, 90 Minutes of Wear|Other|0
7653719|NCT01482312|26627690|P2|Period 2, 90 Minutes of Wear|Other|0
7653720|NCT01482312|26627691|P1|Period 2, 90 Minutes of Wear|Other|1
7653721|NCT01482312|26627689|P3|Period 1, 90 Minutes of Wear|Other|0
7653722|NCT01482312|26627690|P2|Period 1, 90 Minutes of Wear|Other|0
7653723|NCT01482312|26627691|P1|Period 1, 90 Minutes of Wear|Other|1
7653724|NCT01482221|26627705|P3|Overall Study|Physician Decision|0
7653725|NCT01482221|26627706|P2|Overall Study|Physician Decision|1
7653726|NCT01482221|26627707|P1|Overall Study|Physician Decision|0
7653727|NCT01482221|26627705|P3|Overall Study|Incorrect randomization|0
7653728|NCT01482221|26627706|P2|Overall Study|Incorrect randomization|1
7653729|NCT01482221|26627707|P1|Overall Study|Incorrect randomization|0
7653730|NCT01482221|26627705|P3|Overall Study|Withdrawal by Subject|12
7653731|NCT01482221|26627706|P2|Overall Study|Withdrawal by Subject|7
7653732|NCT01482221|26627707|P1|Overall Study|Withdrawal by Subject|10
7653733|NCT01482221|26627705|P3|Overall Study|Adverse Event|3
7653734|NCT01482221|26627706|P2|Overall Study|Adverse Event|7
7653735|NCT01482221|26627707|P1|Overall Study|Adverse Event|1
7653736|NCT01482221|26627705|P3|Overall Study|Severe Non-Compliance to Protocol|1
7653737|NCT01482221|26627706|P2|Overall Study|Severe Non-Compliance to Protocol|0
7653738|NCT01482221|26627707|P1|Overall Study|Severe Non-Compliance to Protocol|1
7653739|NCT01482221|26627705|P3|Overall Study|Condition under Investigation Worsened|4
7653740|NCT01482221|26627706|P2|Overall Study|Condition under Investigation Worsened|2
7653741|NCT01482221|26627707|P1|Overall Study|Condition under Investigation Worsened|3
7653742|NCT01482221|26627705|P3|Overall Study|Study-Specific Withdrawal Criteria|1
7653743|NCT01482221|26627706|P2|Overall Study|Study-Specific Withdrawal Criteria|0
7653744|NCT01482221|26627707|P1|Overall Study|Study-Specific Withdrawal Criteria|2
7653745|NCT01482221|26627705|P3|Overall Study|Lost to Follow-up|1
7653746|NCT01482221|26627706|P2|Overall Study|Lost to Follow-up|2
7653747|NCT01482221|26627707|P1|Overall Study|Lost to Follow-up|3
7653748|NCT01482221|26627705|P3|Overall Study|Lack of Efficacy|1
7653749|NCT01482221|26627706|P2|Overall Study|Lack of Efficacy|0
7653750|NCT01482221|26627707|P1|Overall Study|Lack of Efficacy|1
7653751|NCT01482169|26627761|P1|Overall Study|Physician Decision|2
7653752|NCT01482065|26627803|P2|Overall Study|Withdrawal by Subject|1
7653753|NCT01482065|26627804|P1|Overall Study|Withdrawal by Subject|0
7653754|NCT01481896|26627825|P1|Overall Study|Lost to Follow-up|12
7653755|NCT01481779|26627841|P2|Overall Study|Sponsor Decision|1
7653756|NCT01481779|26627842|P1|Overall Study|Sponsor Decision|3
7653757|NCT01481779|26627841|P2|Overall Study|Physician Decision|4
7653758|NCT01481779|26627842|P1|Overall Study|Physician Decision|13
7653759|NCT01481779|26627841|P2|Overall Study|Withdrawal by Subject|13
7653760|NCT01481779|26627842|P1|Overall Study|Withdrawal by Subject|26
7653761|NCT01481779|26627841|P2|Overall Study|Protocol Violation|3
7653762|NCT01481779|26627842|P1|Overall Study|Protocol Violation|2
7653763|NCT01481779|26627841|P2|Overall Study|Lost to Follow-up|2
7653764|NCT01481779|26627842|P1|Overall Study|Lost to Follow-up|3
7653765|NCT01481779|26627841|P2|Overall Study|Adverse Event|5
7653766|NCT01481779|26627842|P1|Overall Study|Adverse Event|23
7653767|NCT01481324|26627948|P3|Overall Study|Missing Data|2
7653768|NCT01481324|26627949|P2|Overall Study|Missing Data|2
7653769|NCT01481324|26627950|P1|Overall Study|Missing Data|0
7653770|NCT01481116|26627969|P3|Overall Study|Hypoglycemic Event|0
7653771|NCT01481116|26627970|P2|Overall Study|Hypoglycemic Event|0
7653772|NCT01481116|26627971|P1|Overall Study|Hypoglycemic Event|4
7653773|NCT01481116|26627969|P3|Overall Study|Death|0
7653774|NCT01481116|26627970|P2|Overall Study|Death|1
7653775|NCT01481116|26627971|P1|Overall Study|Death|2
7653776|NCT01481116|26627969|P3|Overall Study|Investigator's Discretion|0
7653777|NCT01481116|26627970|P2|Overall Study|Investigator's Discretion|0
7653778|NCT01481116|26627971|P1|Overall Study|Investigator's Discretion|2
7653779|NCT01481116|26627969|P3|Overall Study|Non-Compliant With Study Drug|1
7653780|NCT01481116|26627970|P2|Overall Study|Non-Compliant With Study Drug|1
7653781|NCT01481116|26627971|P1|Overall Study|Non-Compliant With Study Drug|0
7653782|NCT01481116|26627969|P3|Overall Study|Sponsor Decision|3
7653783|NCT01481116|26627970|P2|Overall Study|Sponsor Decision|1
7653784|NCT01481116|26627971|P1|Overall Study|Sponsor Decision|0
7653785|NCT01481116|26627969|P3|Overall Study|Investigator Decision|1
7653786|NCT01481116|26627970|P2|Overall Study|Investigator Decision|2
7653787|NCT01481116|26627971|P1|Overall Study|Investigator Decision|3
7653788|NCT01481116|26627969|P3|Overall Study|Participant Moved Out of Country|1
7653789|NCT01481116|26627970|P2|Overall Study|Participant Moved Out of Country|0
7653790|NCT01481116|26627971|P1|Overall Study|Participant Moved Out of Country|1
7653791|NCT01481116|26627969|P3|Overall Study|Participant Moved Out of Area|1
7653792|NCT01481116|26627970|P2|Overall Study|Participant Moved Out of Area|0
7653793|NCT01481116|26627971|P1|Overall Study|Participant Moved Out of Area|2
7653794|NCT01481116|26627969|P3|Overall Study|Participant Started Taking Glipizide|0
7653795|NCT01481116|26627970|P2|Overall Study|Participant Started Taking Glipizide|0
7653796|NCT01481116|26627971|P1|Overall Study|Participant Started Taking Glipizide|1
7653797|NCT01481116|26627969|P3|Overall Study|Other|0
7653798|NCT01481116|26627970|P2|Overall Study|Other|1
7653799|NCT01481116|26627971|P1|Overall Study|Other|1
7653800|NCT01481116|26627969|P3|Overall Study|Contraindications|0
7653801|NCT01481116|26627970|P2|Overall Study|Contraindications|1
7653802|NCT01481116|26627971|P1|Overall Study|Contraindications|1
7653803|NCT01481116|26627969|P3|Overall Study|Lack of Efficacy|1
7653804|NCT01481116|26627970|P2|Overall Study|Lack of Efficacy|3
7653805|NCT01481116|26627971|P1|Overall Study|Lack of Efficacy|3
7653806|NCT01481116|26627969|P3|Overall Study|Pregnancy|1
7653807|NCT01481116|26627970|P2|Overall Study|Pregnancy|0
7653808|NCT01481116|26627971|P1|Overall Study|Pregnancy|0
7653809|NCT01481116|26627969|P3|Overall Study|Study Termination|713
7653810|NCT01481116|26627970|P2|Overall Study|Study Termination|729
7653811|NCT01481116|26627971|P1|Overall Study|Study Termination|730
7653812|NCT01481116|26627969|P3|Overall Study|Withdrawal by Subject|37
7653813|NCT01481116|26627970|P2|Overall Study|Withdrawal by Subject|33
7653814|NCT01481116|26627971|P1|Overall Study|Withdrawal by Subject|37
7653815|NCT01481116|26627969|P3|Overall Study|Lost to Follow-up|11
7653816|NCT01481116|26627970|P2|Overall Study|Lost to Follow-up|12
7653817|NCT01481116|26627971|P1|Overall Study|Lost to Follow-up|8
7653818|NCT01481116|26627969|P3|Overall Study|Major Protocol Deviation|1
7653819|NCT01481116|26627970|P2|Overall Study|Major Protocol Deviation|7
7653820|NCT01481116|26627971|P1|Overall Study|Major Protocol Deviation|3
7653821|NCT01481116|26627969|P3|Overall Study|Adverse Event|42
7653822|NCT01481116|26627970|P2|Overall Study|Adverse Event|26
7653823|NCT01481116|26627971|P1|Overall Study|Adverse Event|26
7653824|NCT01480674|26628002|P1|Overall Study|visit not done|10
7653825|NCT01480674|26628002|P1|Overall Study|Lost to Follow-up|2
7653826|NCT01480674|26628002|P1|Overall Study|Death|23
7653827|NCT01480596|26628016|P2|Overall Study|MG exacerbation or change in medication|2
7653828|NCT01480596|26628017|P1|Overall Study|MG exacerbation or change in medication|2
7653829|NCT01480596|26628016|P2|Overall Study|Adverse Event|0
7653830|NCT01480596|26628017|P1|Overall Study|Adverse Event|3
7653831|NCT01480284|26628065|P2|Overall Study|Physician Decision|0
7653832|NCT01480284|26628066|P1|Overall Study|Physician Decision|1
7653833|NCT01480284|26628065|P2|Overall Study|Lost to Follow-up|0
7653834|NCT01480284|26628066|P1|Overall Study|Lost to Follow-up|1
7653835|NCT01480284|26628065|P2|Overall Study|Study closed/terminated|0
7653836|NCT01480284|26628066|P1|Overall Study|Study closed/terminated|3
7653837|NCT01480284|26628065|P2|Overall Study|Adverse Event|0
7653838|NCT01480284|26628066|P1|Overall Study|Adverse Event|1
7653839|NCT01480284|26628065|P2|Overall Study|Withdrawal by Subject|0
7653840|NCT01480284|26628066|P1|Overall Study|Withdrawal by Subject|2
7653841|NCT01480258|26628096|P2|Interim Period|Withdrawal by Subject|6
7653842|NCT01480258|26628097|P1|Interim Period|Withdrawal by Subject|9
7653843|NCT01480258|26628096|P2|Interim Period|Protocol Violation|1
7653844|NCT01480258|26628097|P1|Interim Period|Protocol Violation|0
7653845|NCT01480258|26628096|P2|Interim Period|Physician Decision|0
7653846|NCT01480258|26628097|P1|Interim Period|Physician Decision|1
7653847|NCT01480258|26628096|P2|Interim Period|Lost to Follow-up|2
7653848|NCT01480258|26628097|P1|Interim Period|Lost to Follow-up|0
7653849|NCT01480258|26628096|P2|Infant Series|Withdrawal by Subject|6
7653850|NCT01480258|26628097|P1|Infant Series|Withdrawal by Subject|1
7653851|NCT01480258|26628096|P2|Infant Series|Adverse Event|1
7653852|NCT01480258|26628097|P1|Infant Series|Adverse Event|1
7653853|NCT01480258|26628096|P2|Infant Series|Not Vaccinated|0
7653854|NCT01480258|26628097|P1|Infant Series|Not Vaccinated|3
7653855|NCT01480258|26628096|P2|Infant Series|Physician Decision|1
7653856|NCT01480258|26628097|P1|Infant Series|Physician Decision|0
7653857|NCT01480258|26628096|P2|Infant Series|Protocol Violation|0
7653858|NCT01480258|26628097|P1|Infant Series|Protocol Violation|2
7653859|NCT01480180|26628163|P6|Extension Phase, Part 2|Unclassified|0
7653860|NCT01480180|26628164|P5|Extension Phase, Part 2|Unclassified|1
7653861|NCT01480180|26628165|P4|Extension Phase, Part 2|Unclassified|1
7653862|NCT01480180|26628166|P3|Extension Phase, Part 2|Unclassified|3
7653863|NCT01480180|26628167|P2|Extension Phase, Part 2|Unclassified|0
7653864|NCT01480180|26628168|P1|Extension Phase, Part 2|Unclassified|0
7653865|NCT01480180|26628163|P6|Extension Phase, Part 2|Lack of Efficacy|0
7653866|NCT01480180|26628164|P5|Extension Phase, Part 2|Lack of Efficacy|0
7653867|NCT01480180|26628165|P4|Extension Phase, Part 2|Lack of Efficacy|0
7653868|NCT01480180|26628166|P3|Extension Phase, Part 2|Lack of Efficacy|4
7653869|NCT01480180|26628167|P2|Extension Phase, Part 2|Lack of Efficacy|0
7653870|NCT01480180|26628168|P1|Extension Phase, Part 2|Lack of Efficacy|0
7653871|NCT01480180|26628163|P6|Extension Phase, Part 2|Withdrawal criteria|0
7653872|NCT01480180|26628164|P5|Extension Phase, Part 2|Withdrawal criteria|1
7653873|NCT01480180|26628165|P4|Extension Phase, Part 2|Withdrawal criteria|6
7653874|NCT01480180|26628166|P3|Extension Phase, Part 2|Withdrawal criteria|10
7653875|NCT01480180|26628167|P2|Extension Phase, Part 2|Withdrawal criteria|0
7653876|NCT01480180|26628168|P1|Extension Phase, Part 2|Withdrawal criteria|0
7653877|NCT01480180|26628163|P6|Extension Phase, Part 1|Change of treatment|0
7653878|NCT01480180|26628164|P5|Extension Phase, Part 1|Change of treatment|0
7653879|NCT01480180|26628165|P4|Extension Phase, Part 1|Change of treatment|9
7653880|NCT01480180|26628166|P3|Extension Phase, Part 1|Change of treatment|0
7653881|NCT01480180|26628167|P2|Extension Phase, Part 1|Change of treatment|0
7653882|NCT01480180|26628168|P1|Extension Phase, Part 1|Change of treatment|0
7653883|NCT01480180|26628163|P6|Extension Phase, Part 1|Adverse Event|0
7653884|NCT01480180|26628164|P5|Extension Phase, Part 1|Adverse Event|0
7653885|NCT01480180|26628165|P4|Extension Phase, Part 1|Adverse Event|1
7653886|NCT01480180|26628166|P3|Extension Phase, Part 1|Adverse Event|4
7653887|NCT01480180|26628167|P2|Extension Phase, Part 1|Adverse Event|0
7653888|NCT01480180|26628168|P1|Extension Phase, Part 1|Adverse Event|0
7653889|NCT01480180|26628163|P6|Extension Phase, Part 1|Unclassified|0
7653890|NCT01480180|26628164|P5|Extension Phase, Part 1|Unclassified|0
7653891|NCT01480180|26628165|P4|Extension Phase, Part 1|Unclassified|0
7653892|NCT01480180|26628166|P3|Extension Phase, Part 1|Unclassified|1
7653893|NCT01480180|26628167|P2|Extension Phase, Part 1|Unclassified|0
7653894|NCT01480180|26628168|P1|Extension Phase, Part 1|Unclassified|0
7653895|NCT01480180|26628163|P6|Extension Phase, Part 1|Withdrawal criteria|0
7653896|NCT01480180|26628164|P5|Extension Phase, Part 1|Withdrawal criteria|0
7653897|NCT01480180|26628165|P4|Extension Phase, Part 1|Withdrawal criteria|0
7653898|NCT01480180|26628166|P3|Extension Phase, Part 1|Withdrawal criteria|5
7653899|NCT01480180|26628167|P2|Extension Phase, Part 1|Withdrawal criteria|0
7653900|NCT01480180|26628168|P1|Extension Phase, Part 1|Withdrawal criteria|0
7653901|NCT01480180|26628163|P6|Main Phase|Unclassified|0
7653902|NCT01480180|26628164|P5|Main Phase|Unclassified|0
7653903|NCT01480180|26628165|P4|Main Phase|Unclassified|0
7653904|NCT01480180|26628166|P3|Main Phase|Unclassified|0
7653905|NCT01480180|26628167|P2|Main Phase|Unclassified|0
7653906|NCT01480180|26628168|P1|Main Phase|Unclassified|3
7653907|NCT01480180|26628163|P6|Main Phase|Non-compliance|0
7653908|NCT01480180|26628164|P5|Main Phase|Non-compliance|0
7653909|NCT01480180|26628165|P4|Main Phase|Non-compliance|0
7653910|NCT01480180|26628166|P3|Main Phase|Non-compliance|0
7653911|NCT01480180|26628167|P2|Main Phase|Non-compliance|0
7653912|NCT01480180|26628168|P1|Main Phase|Non-compliance|3
7653913|NCT01480180|26628163|P6|Main Phase|Lack of Efficacy|0
7653914|NCT01480180|26628164|P5|Main Phase|Lack of Efficacy|0
7653915|NCT01480180|26628165|P4|Main Phase|Lack of Efficacy|0
7653916|NCT01480180|26628166|P3|Main Phase|Lack of Efficacy|0
7653917|NCT01480180|26628167|P2|Main Phase|Lack of Efficacy|0
7653918|NCT01480180|26628168|P1|Main Phase|Lack of Efficacy|1
7653919|NCT01480180|26628163|P6|Main Phase|Withdrawal criteria|0
7653920|NCT01480180|26628164|P5|Main Phase|Withdrawal criteria|0
7653921|NCT01480180|26628165|P4|Main Phase|Withdrawal criteria|0
7653922|NCT01480180|26628166|P3|Main Phase|Withdrawal criteria|0
7653923|NCT01480180|26628167|P2|Main Phase|Withdrawal criteria|1
7653924|NCT01480180|26628168|P1|Main Phase|Withdrawal criteria|12
7653925|NCT01480076|26628336|P1|Overall Study|Other|52
7653926|NCT01480076|26628336|P1|Overall Study|Investigator Decision|13
7653927|NCT01480076|26628336|P1|Overall Study|Lost to Follow-up|7
7653928|NCT01480076|26628336|P1|Overall Study|Withdrawal by Subject|105
7653929|NCT01480076|26628336|P1|Overall Study|Non-compliance With Study Protocol|15
7653930|NCT01480076|26628336|P1|Overall Study|Disease Progression|5
7653931|NCT01480076|26628336|P1|Overall Study|Death|2
7653932|NCT01480076|26628336|P1|Overall Study|Adverse Event|39
7653933|NCT01480076|26628336|P1|Overall Study|Run-in Failure|52
7653934|NCT01479985|26628457|P2|Overall Study|No post-visit survey|3
7653935|NCT01479985|26628458|P1|Overall Study|No post-visit survey|5
7653936|NCT01479985|26628457|P2|Overall Study|No decisional conflict scale responses|2
7653937|NCT01479985|26628458|P1|Overall Study|No decisional conflict scale responses|0
7653938|NCT01479985|26628457|P2|Overall Study|Tablet malfunction, no data saved|1
7653939|NCT01479985|26628458|P1|Overall Study|Tablet malfunction, no data saved|1
7653940|NCT01479868|26628466|P1|Overall Study|Initiation of new HCV Therapy|1
7653941|NCT01479868|26628466|P1|Overall Study|Sponsor's Decision|1
7653942|NCT01479868|26628466|P1|Overall Study|Withdrawal by Subject|1
7653943|NCT01479868|26628466|P1|Overall Study|Protocol Violation|1
7653944|NCT01479868|26628466|P1|Overall Study|Lost to Follow-up|4
7653945|NCT01479868|26628466|P1|Overall Study|Adverse Event|1
7653946|NCT01479777|26628481|P1|Overall Study|Physician Decision|2
7653947|NCT01479764|26628493|P2|Treated|Lost to Follow-up|2
7653948|NCT01479764|26628494|P1|Treated|Lost to Follow-up|0
7653949|NCT01479764|26628493|P2|Randomized|Withdrawal by Subject|0
7653950|NCT01479764|26628494|P1|Randomized|Withdrawal by Subject|1
7653951|NCT01479764|26628493|P2|Randomized|Adverse Event|1
7653952|NCT01479764|26628494|P1|Randomized|Adverse Event|1
7653953|NCT01479621|26628517|P7|Treatment Period|Met stopping criteria|6
7653954|NCT01479621|26628518|P6|Treatment Period|Met stopping criteria|20
7653955|NCT01479621|26628519|P5|Treatment Period|Met stopping criteria|9
7653956|NCT01479621|26628520|P4|Treatment Period|Met stopping criteria|4
7653957|NCT01479621|26628521|P3|Treatment Period|Met stopping criteria|7
7653958|NCT01479621|26628522|P2|Treatment Period|Met stopping criteria|8
7653959|NCT01479621|26628523|P1|Treatment Period|Met stopping criteria|0
7653960|NCT01479621|26628517|P7|Treatment Period|Lost to Follow-up|1
7653961|NCT01479621|26628518|P6|Treatment Period|Lost to Follow-up|2
7653962|NCT01479621|26628519|P5|Treatment Period|Lost to Follow-up|2
7653963|NCT01479621|26628520|P4|Treatment Period|Lost to Follow-up|0
7653964|NCT01479621|26628521|P3|Treatment Period|Lost to Follow-up|1
7653965|NCT01479621|26628522|P2|Treatment Period|Lost to Follow-up|0
7653966|NCT01479621|26628523|P1|Treatment Period|Lost to Follow-up|0
7653967|NCT01479621|26628517|P7|Treatment Period|Sponsor request subject to be withdrawn|3
7653968|NCT01479621|26628518|P6|Treatment Period|Sponsor request subject to be withdrawn|1
7653969|NCT01479621|26628519|P5|Treatment Period|Sponsor request subject to be withdrawn|1
7653970|NCT01479621|26628520|P4|Treatment Period|Sponsor request subject to be withdrawn|1
7653971|NCT01479621|26628521|P3|Treatment Period|Sponsor request subject to be withdrawn|3
7653972|NCT01479621|26628522|P2|Treatment Period|Sponsor request subject to be withdrawn|2
7653973|NCT01479621|26628523|P1|Treatment Period|Sponsor request subject to be withdrawn|0
7653974|NCT01479621|26628517|P7|Treatment Period|Pregnancy|0
7653975|NCT01479621|26628518|P6|Treatment Period|Pregnancy|0
7653976|NCT01479621|26628519|P5|Treatment Period|Pregnancy|0
7653977|NCT01479621|26628520|P4|Treatment Period|Pregnancy|0
7653978|NCT01479621|26628521|P3|Treatment Period|Pregnancy|2
7653979|NCT01479621|26628522|P2|Treatment Period|Pregnancy|0
7653980|NCT01479621|26628523|P1|Treatment Period|Pregnancy|0
7653981|NCT01479621|26628517|P7|Treatment Period|Protocol Violation|6
7653982|NCT01479621|26628518|P6|Treatment Period|Protocol Violation|10
7653983|NCT01479621|26628519|P5|Treatment Period|Protocol Violation|2
7653984|NCT01479621|26628520|P4|Treatment Period|Protocol Violation|5
7653985|NCT01479621|26628521|P3|Treatment Period|Protocol Violation|6
7653986|NCT01479621|26628522|P2|Treatment Period|Protocol Violation|9
7653987|NCT01479621|26628523|P1|Treatment Period|Protocol Violation|0
7653988|NCT01479621|26628517|P7|Treatment Period|Non-compliance to study drug|1
7653989|NCT01479621|26628518|P6|Treatment Period|Non-compliance to study drug|0
7653990|NCT01479621|26628519|P5|Treatment Period|Non-compliance to study drug|0
7653991|NCT01479621|26628520|P4|Treatment Period|Non-compliance to study drug|0
7653992|NCT01479621|26628521|P3|Treatment Period|Non-compliance to study drug|0
7653993|NCT01479621|26628522|P2|Treatment Period|Non-compliance to study drug|1
7653994|NCT01479621|26628523|P1|Treatment Period|Non-compliance to study drug|0
7653995|NCT01479621|26628517|P7|Treatment Period|Physician Decision|0
7653996|NCT01479621|26628518|P6|Treatment Period|Physician Decision|1
7653997|NCT01479621|26628519|P5|Treatment Period|Physician Decision|1
7653998|NCT01479621|26628520|P4|Treatment Period|Physician Decision|0
7653999|NCT01479621|26628521|P3|Treatment Period|Physician Decision|0
7654000|NCT01479621|26628522|P2|Treatment Period|Physician Decision|0
7654001|NCT01479621|26628523|P1|Treatment Period|Physician Decision|0
7654002|NCT01479621|26628517|P7|Treatment Period|Withdrawal by Subject|1
7654003|NCT01479621|26628518|P6|Treatment Period|Withdrawal by Subject|5
7654004|NCT01479621|26628519|P5|Treatment Period|Withdrawal by Subject|5
7654005|NCT01479621|26628520|P4|Treatment Period|Withdrawal by Subject|2
7654006|NCT01479621|26628521|P3|Treatment Period|Withdrawal by Subject|2
7654007|NCT01479621|26628522|P2|Treatment Period|Withdrawal by Subject|4
7654008|NCT01479621|26628523|P1|Treatment Period|Withdrawal by Subject|0
7654009|NCT01479621|26628517|P7|Treatment Period|Adverse Event|2
7654010|NCT01479621|26628518|P6|Treatment Period|Adverse Event|2
7654011|NCT01479621|26628519|P5|Treatment Period|Adverse Event|1
7654012|NCT01479621|26628520|P4|Treatment Period|Adverse Event|0
7654013|NCT01479621|26628521|P3|Treatment Period|Adverse Event|0
7654014|NCT01479621|26628522|P2|Treatment Period|Adverse Event|0
7654015|NCT01479621|26628523|P1|Treatment Period|Adverse Event|0
7654016|NCT01479621|26628517|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
7654017|NCT01479621|26628518|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
7654018|NCT01479621|26628519|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
7654019|NCT01479621|26628520|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
7654020|NCT01479621|26628521|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
7654021|NCT01479621|26628522|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
7654022|NCT01479621|26628523|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
7654023|NCT01479621|26628517|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7654024|NCT01479621|26628518|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7654025|NCT01479621|26628519|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7654026|NCT01479621|26628520|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7654027|NCT01479621|26628521|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7654028|NCT01479621|26628522|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7654029|NCT01479621|26628523|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
7654030|NCT01479621|26628517|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7654031|NCT01479621|26628518|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7654032|NCT01479621|26628519|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7654033|NCT01479621|26628520|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7654034|NCT01479621|26628521|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7654035|NCT01479621|26628522|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7654036|NCT01479621|26628523|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
7654037|NCT01479621|26628517|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7654038|NCT01479621|26628518|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7654039|NCT01479621|26628519|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7654040|NCT01479621|26628520|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7654041|NCT01479621|26628521|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7654042|NCT01479621|26628522|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7654043|NCT01479621|26628523|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
7654044|NCT01479621|26628517|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7654045|NCT01479621|26628518|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7654046|NCT01479621|26628519|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7654047|NCT01479621|26628520|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7654136|NCT01478958|26628910|P3|Overall Study|Weight loss|0
7654048|NCT01479621|26628521|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7654049|NCT01479621|26628522|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7654050|NCT01479621|26628523|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
7654051|NCT01479595|26628611|P2|Overall Study|Adverse Event|1
7654052|NCT01479595|26628612|P1|Overall Study|Adverse Event|2
7654053|NCT01479595|26628611|P2|Overall Study|Protocol deviation|1
7654054|NCT01479595|26628612|P1|Overall Study|Protocol deviation|0
7654055|NCT01479530|26628657|P2|Overall Study|Withdrawal of Consent|2
7654056|NCT01479530|26628658|P1|Overall Study|Withdrawal of Consent|3
7654057|NCT01479530|26628657|P2|Overall Study|Protocol Violation|3
7654058|NCT01479530|26628658|P1|Overall Study|Protocol Violation|2
7654059|NCT01479530|26628657|P2|Overall Study|Lack of Efficacy|1
7654060|NCT01479530|26628658|P1|Overall Study|Lack of Efficacy|0
7654061|NCT01479530|26628657|P2|Overall Study|Adverse Event|6
7654062|NCT01479530|26628658|P1|Overall Study|Adverse Event|5
7654063|NCT01479465|26628739|P4|Overall Study|Lost to Follow-up|0
7654064|NCT01479465|26628740|P3|Overall Study|Lost to Follow-up|1
7654065|NCT01479465|26628741|P2|Overall Study|Lost to Follow-up|0
7654066|NCT01479465|26628742|P1|Overall Study|Lost to Follow-up|0
7654067|NCT01479465|26628739|P4|Overall Study|Death|1
7654068|NCT01479465|26628740|P3|Overall Study|Death|0
7654069|NCT01479465|26628741|P2|Overall Study|Death|0
7654070|NCT01479465|26628742|P1|Overall Study|Death|0
7654071|NCT01479465|26628739|P4|Overall Study|Protocol Violation|0
7654072|NCT01479465|26628740|P3|Overall Study|Protocol Violation|1
7654073|NCT01479465|26628741|P2|Overall Study|Protocol Violation|1
7654074|NCT01479465|26628742|P1|Overall Study|Protocol Violation|0
7654075|NCT01479465|26628739|P4|Overall Study|Subject Withdrew Consent|1
7654076|NCT01479465|26628740|P3|Overall Study|Subject Withdrew Consent|2
7654077|NCT01479465|26628741|P2|Overall Study|Subject Withdrew Consent|5
7654078|NCT01479465|26628742|P1|Overall Study|Subject Withdrew Consent|0
7654079|NCT01479465|26628739|P4|Overall Study|Subject Request|2
7654080|NCT01479465|26628740|P3|Overall Study|Subject Request|4
7654081|NCT01479465|26628741|P2|Overall Study|Subject Request|3
7654082|NCT01479465|26628742|P1|Overall Study|Subject Request|1
7654083|NCT01479465|26628739|P4|Overall Study|Investigator Discretion|4
7654084|NCT01479465|26628740|P3|Overall Study|Investigator Discretion|2
7654085|NCT01479465|26628741|P2|Overall Study|Investigator Discretion|4
7654086|NCT01479465|26628742|P1|Overall Study|Investigator Discretion|1
7654087|NCT01479465|26628739|P4|Overall Study|Adverse Event|4
7654088|NCT01479465|26628740|P3|Overall Study|Adverse Event|6
7654089|NCT01479465|26628741|P2|Overall Study|Adverse Event|3
7654090|NCT01479465|26628742|P1|Overall Study|Adverse Event|0
7654091|NCT01479465|26628739|P4|Overall Study|Study Discontinued by Sponsor|3
7654092|NCT01479465|26628740|P3|Overall Study|Study Discontinued by Sponsor|5
7654093|NCT01479465|26628741|P2|Overall Study|Study Discontinued by Sponsor|7
7654094|NCT01479465|26628742|P1|Overall Study|Study Discontinued by Sponsor|0
7654095|NCT01479465|26628739|P4|Overall Study|Disease Progression|70
7654096|NCT01479465|26628740|P3|Overall Study|Disease Progression|65
7654097|NCT01479465|26628741|P2|Overall Study|Disease Progression|61
7654098|NCT01479465|26628742|P1|Overall Study|Disease Progression|9
7654099|NCT01479439|26628763|P3|Overall Study|Protocol Violation|2
7654100|NCT01479439|26628764|P2|Overall Study|Protocol Violation|0
7654101|NCT01479439|26628765|P1|Overall Study|Protocol Violation|0
7654102|NCT01479439|26628763|P3|Overall Study|Lost to Follow-up|0
7654103|NCT01479439|26628764|P2|Overall Study|Lost to Follow-up|1
7654104|NCT01479439|26628765|P1|Overall Study|Lost to Follow-up|0
7654105|NCT01479439|26628763|P3|Overall Study|Adverse Event|0
7654106|NCT01479439|26628764|P2|Overall Study|Adverse Event|0
7654107|NCT01479439|26628765|P1|Overall Study|Adverse Event|1
7654108|NCT01479374|26628797|P3|Overall Study|Other|5
7654109|NCT01479374|26628798|P2|Overall Study|Other|4
7654110|NCT01479374|26628799|P1|Overall Study|Other|0
7654111|NCT01479374|26628797|P3|Overall Study|Decision Unrelated to Adverse Event|0
7654112|NCT01479374|26628798|P2|Overall Study|Decision Unrelated to Adverse Event|1
7654113|NCT01479374|26628799|P1|Overall Study|Decision Unrelated to Adverse Event|0
7654114|NCT01479374|26628797|P3|Overall Study|Lost to Follow-up|0
7654115|NCT01479374|26628798|P2|Overall Study|Lost to Follow-up|2
7654116|NCT01479374|26628799|P1|Overall Study|Lost to Follow-up|1
7654117|NCT01479374|26628797|P3|Overall Study|Adverse Event|0
7654118|NCT01479374|26628798|P2|Overall Study|Adverse Event|1
7654119|NCT01479374|26628799|P1|Overall Study|Adverse Event|2
7654120|NCT01478971|26628893|P1|Peginesatide Treatment Period|Other|4
7654121|NCT01478971|26628893|P1|Peginesatide Treatment Period|Lost to Follow-up|4
7654122|NCT01478971|26628893|P1|Peginesatide Treatment Period|Death|4
7654123|NCT01478971|26628893|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
7654124|NCT01478971|26628893|P1|Peginesatide Treatment Period|Adverse Event|1
7654125|NCT01478971|26628893|P1|Standard of Care Period|Other|4
7654126|NCT01478971|26628893|P1|Standard of Care Period|Lost to Follow-up|9
7654127|NCT01478971|26628893|P1|Standard of Care Period|Death|8
7654128|NCT01478971|26628893|P1|Standard of Care Period|Withdrawal by Subject|3
7654129|NCT01478971|26628893|P1|Standard of Care Period|Adverse Event|1
7654130|NCT01478958|26628910|P3|Overall Study|Unable to comply|2
7654131|NCT01478958|26628911|P2|Overall Study|Unable to comply|0
7654132|NCT01478958|26628912|P1|Overall Study|Unable to comply|0
7654133|NCT01478958|26628910|P3|Overall Study|Re-located|0
7654134|NCT01478958|26628911|P2|Overall Study|Re-located|1
7654135|NCT01478958|26628912|P1|Overall Study|Re-located|0
7654137|NCT01478958|26628911|P2|Overall Study|Weight loss|0
7654138|NCT01478958|26628912|P1|Overall Study|Weight loss|1
7654139|NCT01478958|26628910|P3|Overall Study|Withdrawal by Subject|1
7654140|NCT01478958|26628911|P2|Overall Study|Withdrawal by Subject|1
7654141|NCT01478958|26628912|P1|Overall Study|Withdrawal by Subject|1
7654142|NCT01478828|26628932|P1|Overall Study|Adverse Event|1
7654143|NCT01478620|26628943|P1|Overall Study|Lost to Follow-up|6
7654144|NCT01478594|26628949|P2|Overall Study|Study Closed by Sponsor|5
7654145|NCT01478594|26628950|P1|Overall Study|Study Closed by Sponsor|8
7654146|NCT01478594|26628949|P2|Overall Study|Withdrawal by Subject|3
7654147|NCT01478594|26628950|P1|Overall Study|Withdrawal by Subject|9
7654148|NCT01478594|26628949|P2|Overall Study|Lost to Follow-up|1
7654149|NCT01478594|26628950|P1|Overall Study|Lost to Follow-up|3
7654150|NCT01478594|26628949|P2|Overall Study|Death|18
7654151|NCT01478594|26628950|P1|Overall Study|Death|45
7654152|NCT01478594|26628949|P2|Overall Study|Randomized but Never Received Study Drug|1
7654153|NCT01478594|26628950|P1|Overall Study|Randomized but Never Received Study Drug|0
7654154|NCT01478373|26629079|P1|Survival Phase|Progressive Disease|27
7654155|NCT01478373|26629079|P1|Survival Phase|crossover to another study|2
7654156|NCT01478373|26629079|P1|Survival Phase|Protocol Violation|1
7654157|NCT01478373|26629079|P1|Survival Phase|Adverse Event|8
7654158|NCT01478373|26629079|P1|Treatment Phase|Protocol Violation|1
7654159|NCT01478360|26629092|P2|Overall Study|Administrative problems|2
7654160|NCT01478360|26629093|P1|Overall Study|Administrative problems|1
7654161|NCT01478360|26629092|P2|Overall Study|Adverse Event|1
7654162|NCT01478360|26629093|P1|Overall Study|Adverse Event|0
7654163|NCT01478360|26629092|P2|Overall Study|Lost to Follow-up|0
7654164|NCT01478360|26629093|P1|Overall Study|Lost to Follow-up|1
7654165|NCT01478347|26629099|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
7654166|NCT01478347|26629099|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
7654167|NCT01478347|26629099|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
7654168|NCT01478321|26629104|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
7654169|NCT01478321|26629104|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
7654170|NCT01478321|26629104|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
7654171|NCT01478321|26629104|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
7654172|NCT01478321|26629104|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
7654173|NCT01478321|26629104|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
7654174|NCT01478321|26629104|P1|Concurrent Therapy (5 Weeks)|Death|2
7654175|NCT01478321|26629104|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
7654176|NCT01478113|26629127|P2|Overall Study|Physician Decision|0
7654177|NCT01478113|26629128|P1|Overall Study|Physician Decision|1
7654178|NCT01478113|26629127|P2|Overall Study|Withdrawal by Subject|1
7654179|NCT01478113|26629128|P1|Overall Study|Withdrawal by Subject|0
7654180|NCT01478087|26629146|P1|Overall Study|due to sponsor closing study|1
7654181|NCT01478048|26629153|P2|Overall Study|no longer meets study criteria|0
7654182|NCT01478048|26629154|P1|Overall Study|no longer meets study criteria|1
7654183|NCT01478048|26629153|P2|Overall Study|poor/non-compliance|1
7654184|NCT01478048|26629154|P1|Overall Study|poor/non-compliance|0
7654185|NCT01478048|26629153|P2|Overall Study|non-specified|4
7654186|NCT01478048|26629154|P1|Overall Study|non-specified|6
7654187|NCT01478048|26629153|P2|Overall Study|Withdrawal by Subject|5
7654188|NCT01478048|26629154|P1|Overall Study|Withdrawal by Subject|2
7654189|NCT01478048|26629153|P2|Overall Study|subject request to discontinue treatment|5
7654190|NCT01478048|26629154|P1|Overall Study|subject request to discontinue treatment|3
7654191|NCT01478048|26629153|P2|Overall Study|Adverse Event|11
7654192|NCT01478048|26629154|P1|Overall Study|Adverse Event|2
7654193|NCT01478048|26629153|P2|Overall Study|study drug toxicity|14
7654194|NCT01478048|26629154|P1|Overall Study|study drug toxicity|11
7654195|NCT01478048|26629153|P2|Overall Study|Disease Progression|35
7654196|NCT01478048|26629154|P1|Overall Study|Disease Progression|52
7654197|NCT01477892|26629183|P2|Overall Study|Withdrawal by Subject|2
7654198|NCT01477892|26629184|P1|Overall Study|Withdrawal by Subject|0
7654199|NCT01477853|26629195|P3|Phase B|Study terminated by sponsor|11
7654200|NCT01477853|26629196|P2|Phase B|Study terminated by sponsor|10
7654201|NCT01477853|26629197|P1|Phase B|Study terminated by sponsor|12
7654202|NCT01477853|26629195|P3|Phase B|Lost to Follow-up|0
7654203|NCT01477853|26629196|P2|Phase B|Lost to Follow-up|1
7654204|NCT01477853|26629197|P1|Phase B|Lost to Follow-up|0
7654205|NCT01477853|26629195|P3|Phase A|Study terminated by sponsor|39
7654206|NCT01477853|26629196|P2|Phase A|Study terminated by sponsor|40
7654207|NCT01477853|26629197|P1|Phase A|Study terminated by sponsor|37
7654208|NCT01477853|26629195|P3|Phase A|Physician Decision|1
7654209|NCT01477853|26629196|P2|Phase A|Physician Decision|0
7654210|NCT01477853|26629197|P1|Phase A|Physician Decision|1
7654211|NCT01477853|26629195|P3|Phase A|Lost to Follow-up|2
7654212|NCT01477853|26629196|P2|Phase A|Lost to Follow-up|3
7654213|NCT01477853|26629197|P1|Phase A|Lost to Follow-up|4
7654214|NCT01477853|26629195|P3|Phase A|Adverse Event|2
7654215|NCT01477853|26629196|P2|Phase A|Adverse Event|2
7654216|NCT01477853|26629197|P1|Phase A|Adverse Event|1
7654217|NCT01477749|26629264|P1|Overall Study|Physician Decision|4
7654218|NCT01477333|26629372|P1|Overall Study|Clinical Deterioration|1
7654219|NCT01477333|26629372|P1|Overall Study|Withdrawal by Subject|1
7654220|NCT01477333|26629372|P1|Overall Study|Adverse Event|1
7654221|NCT01476722|26629423|P1|Overall Study|Adverse Event|1
7654222|NCT01476696|26629430|P3|Overall Study|Withdrawal by Subject|0
7654223|NCT01476696|26629431|P2|Overall Study|Withdrawal by Subject|0
7654224|NCT01476696|26629432|P1|Overall Study|Withdrawal by Subject|1
7654225|NCT01476696|26629430|P3|Overall Study|Sponsor decision|0
7654226|NCT01476696|26629431|P2|Overall Study|Sponsor decision|1
7654227|NCT01476696|26629432|P1|Overall Study|Sponsor decision|2
7654228|NCT01476644|26629446|P1|Overall Study|Withdrawal by Subject|13
7654229|NCT01476644|26629446|P1|Overall Study|Lost to Follow-up|19
7654230|NCT01476644|26629446|P1|Overall Study|moved to another state|2
7654231|NCT01476644|26629446|P1|Overall Study|Death|5
7654232|NCT01476475|26629453|P2|Overall Study|Other reasons|2
7654233|NCT01476475|26629454|P1|Overall Study|Other reasons|4
7654234|NCT01476475|26629453|P2|Overall Study|Poor compliance to protocol|1
7654235|NCT01476475|26629454|P1|Overall Study|Poor compliance to protocol|1
7654236|NCT01476475|26629453|P2|Overall Study|Adverse Event|0
7654237|NCT01476475|26629454|P1|Overall Study|Adverse Event|6
7654238|NCT01475851|26629905|P2|Overall Study|Protocol defined stopping criteria|0
7654239|NCT01475851|26629906|P1|Overall Study|Protocol defined stopping criteria|1
7654240|NCT01475838|26629934|P2|Extension Phase|Participant Noncompliance|0
7654241|NCT01475838|26629935|P1|Extension Phase|Participant Noncompliance|1
7654242|NCT01475838|26629934|P2|Randomized Phase|Protocol Violation|4
7654243|NCT01475838|26629935|P1|Randomized Phase|Protocol Violation|9
7654244|NCT01475838|26629934|P2|Randomized Phase|Participant Noncompliance|5
7654245|NCT01475838|26629935|P1|Randomized Phase|Participant Noncompliance|1
7654246|NCT01475838|26629934|P2|Randomized Phase|Lost to Follow-up|4
7654247|NCT01475838|26629935|P1|Randomized Phase|Lost to Follow-up|3
7654248|NCT01475838|26629934|P2|Randomized Phase|Withdrew Consent|14
7654249|NCT01475838|26629935|P1|Randomized Phase|Withdrew Consent|10
7654250|NCT01475838|26629934|P2|Randomized Phase|Investigators Discretion|2
7654251|NCT01475838|26629935|P1|Randomized Phase|Investigators Discretion|1
7654252|NCT01475838|26629934|P2|Randomized Phase|Pregnancy|1
7654253|NCT01475838|26629935|P1|Randomized Phase|Pregnancy|0
7654254|NCT01475838|26629934|P2|Randomized Phase|Adverse Event|1
7654255|NCT01475838|26629935|P1|Randomized Phase|Adverse Event|6
7654256|NCT01475838|26629934|P2|Randomized Phase|Randomized but Not Treated|5
7654257|NCT01475838|26629935|P1|Randomized Phase|Randomized but Not Treated|0
7654258|NCT01475825|26629952|P4|Overall Study|Did not enter OLC|11
7654259|NCT01475825|26629953|P3|Overall Study|Did not enter OLC|15
7654260|NCT01475825|26629954|P2|Overall Study|Did not enter OLC|11
7654261|NCT01475825|26629955|P1|Overall Study|Did not enter OLC|15
7654262|NCT01475825|26629952|P4|Overall Study|Withdrawal by Subject|7
7654263|NCT01475825|26629953|P3|Overall Study|Withdrawal by Subject|11
7654264|NCT01475825|26629954|P2|Overall Study|Withdrawal by Subject|3
7654265|NCT01475825|26629955|P1|Overall Study|Withdrawal by Subject|8
7654266|NCT01475825|26629952|P4|Overall Study|Physician Decision|0
7654267|NCT01475825|26629953|P3|Overall Study|Physician Decision|0
7654268|NCT01475825|26629954|P2|Overall Study|Physician Decision|1
7654269|NCT01475825|26629955|P1|Overall Study|Physician Decision|0
7654270|NCT01475825|26629952|P4|Overall Study|Protocol Violation|0
7654271|NCT01475825|26629953|P3|Overall Study|Protocol Violation|0
7654272|NCT01475825|26629954|P2|Overall Study|Protocol Violation|0
7654273|NCT01475825|26629955|P1|Overall Study|Protocol Violation|1
7654274|NCT01475825|26629952|P4|Overall Study|Other: Not available|0
7654275|NCT01475825|26629953|P3|Overall Study|Other: Not available|2
7654276|NCT01475825|26629954|P2|Overall Study|Other: Not available|0
7654277|NCT01475825|26629955|P1|Overall Study|Other: Not available|0
7654278|NCT01475825|26629952|P4|Overall Study|Non-compliance with Study Drug|0
7654279|NCT01475825|26629953|P3|Overall Study|Non-compliance with Study Drug|4
7654280|NCT01475825|26629954|P2|Overall Study|Non-compliance with Study Drug|2
7654281|NCT01475825|26629955|P1|Overall Study|Non-compliance with Study Drug|1
7654282|NCT01475825|26629952|P4|Overall Study|Lost to Follow-up|1
7654283|NCT01475825|26629953|P3|Overall Study|Lost to Follow-up|3
7654284|NCT01475825|26629954|P2|Overall Study|Lost to Follow-up|0
7654285|NCT01475825|26629955|P1|Overall Study|Lost to Follow-up|0
7654286|NCT01475825|26629952|P4|Overall Study|Lack of Efficacy|0
7654287|NCT01475825|26629953|P3|Overall Study|Lack of Efficacy|1
7654288|NCT01475825|26629954|P2|Overall Study|Lack of Efficacy|0
7654289|NCT01475825|26629955|P1|Overall Study|Lack of Efficacy|0
7654290|NCT01475825|26629952|P4|Overall Study|Death|0
7654291|NCT01475825|26629953|P3|Overall Study|Death|1
7654292|NCT01475825|26629954|P2|Overall Study|Death|0
7654293|NCT01475825|26629955|P1|Overall Study|Death|1
7654294|NCT01475825|26629952|P4|Overall Study|Adverse Event|11
7654295|NCT01475825|26629953|P3|Overall Study|Adverse Event|27
7654296|NCT01475825|26629954|P2|Overall Study|Adverse Event|15
7654297|NCT01475825|26629955|P1|Overall Study|Adverse Event|41
7654298|NCT01475734|26629987|P2|Overall Study|Physician Decision|1
7654299|NCT01475734|26629988|P1|Overall Study|Physician Decision|0
7654300|NCT01475734|26629987|P2|Overall Study|Protocol Violation|0
7654301|NCT01475734|26629988|P1|Overall Study|Protocol Violation|1
7654302|NCT01475734|26629987|P2|Overall Study|Withdrawal by Subject|0
7654303|NCT01475734|26629988|P1|Overall Study|Withdrawal by Subject|1
7654304|NCT01475721|26630016|P2|Overall Study|Withdrawal by Subject|8
7654305|NCT01475721|26630017|P1|Overall Study|Withdrawal by Subject|8
7654306|NCT01475721|26630016|P2|Overall Study|Death|6
7654307|NCT01475721|26630017|P1|Overall Study|Death|3
7654308|NCT01475487|26630083|P2|Overall Study|had to leave early for personal reasons|1
7654309|NCT01475487|26630084|P1|Overall Study|had to leave early for personal reasons|2
7654310|NCT01475474|26630096|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
7654311|NCT01475474|26630096|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
7654312|NCT01475461|26630107|P7|Treatment Period|Adverse Event|0
7654313|NCT01475461|26630108|P6|Treatment Period|Adverse Event|0
7654314|NCT01475461|26630109|P5|Treatment Period|Adverse Event|0
7654315|NCT01475461|26630110|P4|Treatment Period|Adverse Event|1
7654316|NCT01475461|26630111|P3|Treatment Period|Adverse Event|0
7654317|NCT01475461|26630112|P2|Treatment Period|Adverse Event|0
7654318|NCT01475461|26630113|P1|Treatment Period|Adverse Event|0
7654319|NCT01475461|26630107|P7|Treatment Period|Medication Error|0
7654320|NCT01475461|26630108|P6|Treatment Period|Medication Error|0
7654321|NCT01475461|26630109|P5|Treatment Period|Medication Error|0
7654322|NCT01475461|26630110|P4|Treatment Period|Medication Error|1
7654323|NCT01475461|26630111|P3|Treatment Period|Medication Error|0
7654324|NCT01475461|26630112|P2|Treatment Period|Medication Error|0
7654325|NCT01475461|26630113|P1|Treatment Period|Medication Error|0
7654326|NCT01475461|26630107|P7|Treatment Period|Lack of Efficacy|0
7654327|NCT01475461|26630108|P6|Treatment Period|Lack of Efficacy|1
7654328|NCT01475461|26630109|P5|Treatment Period|Lack of Efficacy|1
7654329|NCT01475461|26630110|P4|Treatment Period|Lack of Efficacy|2
7654330|NCT01475461|26630111|P3|Treatment Period|Lack of Efficacy|0
7654331|NCT01475461|26630112|P2|Treatment Period|Lack of Efficacy|2
7654332|NCT01475461|26630113|P1|Treatment Period|Lack of Efficacy|0
7654333|NCT01475461|26630107|P7|Treatment Period|Protocol Violation|1
7654334|NCT01475461|26630108|P6|Treatment Period|Protocol Violation|0
7654335|NCT01475461|26630109|P5|Treatment Period|Protocol Violation|0
7654336|NCT01475461|26630110|P4|Treatment Period|Protocol Violation|0
7654337|NCT01475461|26630111|P3|Treatment Period|Protocol Violation|0
7654338|NCT01475461|26630112|P2|Treatment Period|Protocol Violation|1
7654339|NCT01475461|26630113|P1|Treatment Period|Protocol Violation|0
7654340|NCT01475461|26630107|P7|Treatment Period|Other|0
7654341|NCT01475461|26630108|P6|Treatment Period|Other|0
7654342|NCT01475461|26630109|P5|Treatment Period|Other|0
7654343|NCT01475461|26630110|P4|Treatment Period|Other|0
7654344|NCT01475461|26630111|P3|Treatment Period|Other|0
7654345|NCT01475461|26630112|P2|Treatment Period|Other|1
7654346|NCT01475461|26630113|P1|Treatment Period|Other|0
7654347|NCT01475461|26630107|P7|Treatment Period|Withdrawal by Subject|0
7654348|NCT01475461|26630108|P6|Treatment Period|Withdrawal by Subject|2
7654349|NCT01475461|26630109|P5|Treatment Period|Withdrawal by Subject|2
7654350|NCT01475461|26630110|P4|Treatment Period|Withdrawal by Subject|0
7654351|NCT01475461|26630111|P3|Treatment Period|Withdrawal by Subject|2
7654352|NCT01475461|26630112|P2|Treatment Period|Withdrawal by Subject|2
7654353|NCT01475461|26630113|P1|Treatment Period|Withdrawal by Subject|0
7654354|NCT01475461|26630107|P7|Treatment Period|Lost to Follow-up|1
7654355|NCT01475461|26630108|P6|Treatment Period|Lost to Follow-up|2
7654356|NCT01475461|26630109|P5|Treatment Period|Lost to Follow-up|1
7654357|NCT01475461|26630110|P4|Treatment Period|Lost to Follow-up|3
7654358|NCT01475461|26630111|P3|Treatment Period|Lost to Follow-up|2
7654359|NCT01475461|26630112|P2|Treatment Period|Lost to Follow-up|3
7654360|NCT01475461|26630113|P1|Treatment Period|Lost to Follow-up|0
7654361|NCT01475461|26630107|P7|Treatment Period|Death|0
7654362|NCT01475461|26630108|P6|Treatment Period|Death|0
7654363|NCT01475461|26630109|P5|Treatment Period|Death|0
7654364|NCT01475461|26630110|P4|Treatment Period|Death|1
7654365|NCT01475461|26630111|P3|Treatment Period|Death|0
7654366|NCT01475461|26630112|P2|Treatment Period|Death|0
7654367|NCT01475461|26630113|P1|Treatment Period|Death|0
7654368|NCT01475461|26630107|P7|Run-in Period|Protocol Violation|0
7654369|NCT01475461|26630108|P6|Run-in Period|Protocol Violation|0
7654370|NCT01475461|26630109|P5|Run-in Period|Protocol Violation|0
7654371|NCT01475461|26630110|P4|Run-in Period|Protocol Violation|0
7654372|NCT01475461|26630111|P3|Run-in Period|Protocol Violation|0
7654373|NCT01475461|26630112|P2|Run-in Period|Protocol Violation|0
7654374|NCT01475461|26630113|P1|Run-in Period|Protocol Violation|4
7654375|NCT01475461|26630107|P7|Run-in Period|Other|0
7654376|NCT01475461|26630108|P6|Run-in Period|Other|0
7654377|NCT01475461|26630109|P5|Run-in Period|Other|0
7654378|NCT01475461|26630110|P4|Run-in Period|Other|0
7654379|NCT01475461|26630111|P3|Run-in Period|Other|0
7654380|NCT01475461|26630112|P2|Run-in Period|Other|0
7654381|NCT01475461|26630113|P1|Run-in Period|Other|3
7654382|NCT01475461|26630107|P7|Run-in Period|Withdrawal by Subject|0
7654383|NCT01475461|26630108|P6|Run-in Period|Withdrawal by Subject|0
7654384|NCT01475461|26630109|P5|Run-in Period|Withdrawal by Subject|0
7654385|NCT01475461|26630110|P4|Run-in Period|Withdrawal by Subject|0
7654386|NCT01475461|26630111|P3|Run-in Period|Withdrawal by Subject|0
7654387|NCT01475461|26630112|P2|Run-in Period|Withdrawal by Subject|0
7654388|NCT01475461|26630113|P1|Run-in Period|Withdrawal by Subject|11
7654389|NCT01475461|26630107|P7|Run-in Period|Lost to Follow-up|0
7654390|NCT01475461|26630108|P6|Run-in Period|Lost to Follow-up|0
7654391|NCT01475461|26630109|P5|Run-in Period|Lost to Follow-up|0
7654392|NCT01475461|26630110|P4|Run-in Period|Lost to Follow-up|0
7654393|NCT01475461|26630111|P3|Run-in Period|Lost to Follow-up|0
7654394|NCT01475461|26630112|P2|Run-in Period|Lost to Follow-up|0
7654395|NCT01475461|26630113|P1|Run-in Period|Lost to Follow-up|7
7654396|NCT01475461|26630107|P7|Run-in Period|Not meet eligibility criteria|0
7654397|NCT01475461|26630108|P6|Run-in Period|Not meet eligibility criteria|0
7654398|NCT01475461|26630109|P5|Run-in Period|Not meet eligibility criteria|0
7654399|NCT01475461|26630110|P4|Run-in Period|Not meet eligibility criteria|0
7654400|NCT01475461|26630111|P3|Run-in Period|Not meet eligibility criteria|0
7654401|NCT01475461|26630112|P2|Run-in Period|Not meet eligibility criteria|0
7654402|NCT01475461|26630113|P1|Run-in Period|Not meet eligibility criteria|16
7654403|NCT01475370|26630194|P3|Overall Study|Other than specified|0
7654404|NCT01475370|26630195|P2|Overall Study|Other than specified|0
7654405|NCT01475370|26630196|P1|Overall Study|Other than specified|1
7654406|NCT01475370|26630194|P3|Overall Study|Study drug administration difficult|1
7654407|NCT01475370|26630195|P2|Overall Study|Study drug administration difficult|1
7654408|NCT01475370|26630196|P1|Overall Study|Study drug administration difficult|0
7654409|NCT01475370|26630194|P3|Overall Study|Exacerbation of primary disease|2
7654410|NCT01475370|26630195|P2|Overall Study|Exacerbation of primary disease|2
7654411|NCT01475370|26630196|P1|Overall Study|Exacerbation of primary disease|2
7654412|NCT01475331|26630206|P2|Overall Study|cyst found to be prohibitively small|1
7654413|NCT01475331|26630207|P1|Overall Study|cyst found to be prohibitively small|0
7654414|NCT01475331|26630206|P2|Overall Study|Sign of malignancy during the procedure|0
7654415|NCT01475331|26630207|P1|Overall Study|Sign of malignancy during the procedure|2
7654416|NCT01475331|26630206|P2|Overall Study|Loss of needle positioning due pt. cough|0
7654417|NCT01475331|26630207|P1|Overall Study|Loss of needle positioning due pt. cough|1
7654418|NCT01475331|26630206|P2|Overall Study|excessive main duct communication|1
7654419|NCT01475331|26630207|P1|Overall Study|excessive main duct communication|1
7654420|NCT01475331|26630206|P2|Overall Study|Osteophyte obstruction of the proximal|0
7654421|NCT01475331|26630207|P1|Overall Study|Osteophyte obstruction of the proximal|1
7654422|NCT01475253|26630259|P4|Randomized, Blinded Study|Lost to Follow-up|0
7654423|NCT01475253|26630260|P3|Randomized, Blinded Study|Lost to Follow-up|0
7654424|NCT01475253|26630261|P2|Randomized, Blinded Study|Lost to Follow-up|0
7654425|NCT01475253|26630262|P1|Randomized, Blinded Study|Lost to Follow-up|1
7654426|NCT01475253|26630259|P4|Randomized, Blinded Study|Withdrawal by Subject|0
7654427|NCT01475253|26630260|P3|Randomized, Blinded Study|Withdrawal by Subject|0
7654428|NCT01475253|26630261|P2|Randomized, Blinded Study|Withdrawal by Subject|1
7654429|NCT01475253|26630262|P1|Randomized, Blinded Study|Withdrawal by Subject|1
7654430|NCT01475214|26630291|P3|Overall Study|Withdrawal by Subject|1
7654431|NCT01475214|26630292|P2|Overall Study|Withdrawal by Subject|4
7654432|NCT01475214|26630293|P1|Overall Study|Withdrawal by Subject|2
7654433|NCT01475214|26630291|P3|Overall Study|Physician Decision|0
7654434|NCT01475214|26630292|P2|Overall Study|Physician Decision|0
7654435|NCT01475214|26630293|P1|Overall Study|Physician Decision|2
7654436|NCT01475214|26630291|P3|Overall Study|Lost to Follow-up|1
7654437|NCT01475214|26630292|P2|Overall Study|Lost to Follow-up|0
7654438|NCT01475214|26630293|P1|Overall Study|Lost to Follow-up|1
7654439|NCT01475162|26630316|P1|Overall Study|Study closed for safety|3
7654440|NCT01475162|26630316|P1|Overall Study|Death|10
7654441|NCT01475162|26630316|P1|Overall Study|Physician Decision|1
7654442|NCT01475136|26630331|P4|Overall Study|Death|1
7654443|NCT01475136|26630332|P3|Overall Study|Death|0
7654444|NCT01475136|26630333|P2|Overall Study|Death|0
7654445|NCT01475136|26630334|P1|Overall Study|Death|0
7654446|NCT01475136|26630331|P4|Overall Study|Adverse Event|1
7654447|NCT01475136|26630332|P3|Overall Study|Adverse Event|0
7654448|NCT01475136|26630333|P2|Overall Study|Adverse Event|0
7654449|NCT01475136|26630334|P1|Overall Study|Adverse Event|1
7654450|NCT01475136|26630331|P4|Overall Study|Withdrawal by Subject|2
7654451|NCT01475136|26630332|P3|Overall Study|Withdrawal by Subject|0
7654452|NCT01475136|26630333|P2|Overall Study|Withdrawal by Subject|0
7654453|NCT01475136|26630334|P1|Overall Study|Withdrawal by Subject|0
7654454|NCT01475136|26630331|P4|Overall Study|Entry Criteria Not Met|1
7654455|NCT01475136|26630332|P3|Overall Study|Entry Criteria Not Met|3
7654456|NCT01475136|26630333|P2|Overall Study|Entry Criteria Not Met|2
7654457|NCT01475136|26630334|P1|Overall Study|Entry Criteria Not Met|0
7654458|NCT01475136|26630331|P4|Overall Study|Sponsor Decision|0
7654459|NCT01475136|26630332|P3|Overall Study|Sponsor Decision|0
7654460|NCT01475136|26630333|P2|Overall Study|Sponsor Decision|1
7654461|NCT01475136|26630334|P1|Overall Study|Sponsor Decision|0
7654462|NCT01475097|26630354|P2|Overall Study|Protocol Violation|1
7654463|NCT01475097|26630355|P1|Overall Study|Protocol Violation|1
7654464|NCT01475071|26630363|P1|Overall Study|Lost to Follow-up|1
7654465|NCT01475071|26630363|P1|Overall Study|Withdrawal by Subject|6
7654466|NCT01475071|26630363|P1|Overall Study|Physician Decision|1
7654467|NCT01474993|26630373|P2|Overall Study|Adverse Event|1
7654468|NCT01474993|26630374|P1|Overall Study|Adverse Event|0
7654469|NCT01474993|26630373|P2|Overall Study|Lost to Follow-up|2
7654470|NCT01474993|26630374|P1|Overall Study|Lost to Follow-up|1
7654471|NCT01474876|26630416|P3|Overall Study|Investigator's decision and pt request|0
7654472|NCT01474876|26630417|P2|Overall Study|Investigator's decision and pt request|0
7654473|NCT01474876|26630418|P1|Overall Study|Investigator's decision and pt request|1
7654474|NCT01474876|26630416|P3|Overall Study|Patient's request|0
7654475|NCT01474876|26630417|P2|Overall Study|Patient's request|5
7654476|NCT01474876|26630418|P1|Overall Study|Patient's request|19
7654477|NCT01474876|26630416|P3|Overall Study|Investigator's decision|0
7654478|NCT01474876|26630417|P2|Overall Study|Investigator's decision|6
7654479|NCT01474876|26630418|P1|Overall Study|Investigator's decision|28
7654480|NCT01474876|26630416|P3|Overall Study|Lost to Follow-up|0
7654481|NCT01474876|26630417|P2|Overall Study|Lost to Follow-up|4
7654482|NCT01474876|26630418|P1|Overall Study|Lost to Follow-up|5
7654483|NCT01474876|26630416|P3|Overall Study|Serious Adverse Event|0
7654484|NCT01474876|26630417|P2|Overall Study|Serious Adverse Event|3
7654485|NCT01474876|26630418|P1|Overall Study|Serious Adverse Event|2
7654486|NCT01474876|26630416|P3|Overall Study|Adverse Event|0
7654487|NCT01474876|26630417|P2|Overall Study|Adverse Event|5
7654488|NCT01474876|26630418|P1|Overall Study|Adverse Event|11
7654489|NCT01474772|26630464|P2|Follow-up|AE not Related to Study Drug|1
7654490|NCT01474772|26630465|P1|Follow-up|AE not Related to Study Drug|0
7654491|NCT01474772|26630464|P2|Period 2|Reason not Specified|2
7654492|NCT01474772|26630465|P1|Period 2|Reason not Specified|0
7654493|NCT01474772|26630464|P2|Period 2|Lost to Follow-up|1
7654494|NCT01474772|26630465|P1|Period 2|Lost to Follow-up|1
7654495|NCT01474772|26630464|P2|Period 2|Withdrawal by Subject|4
7654496|NCT01474772|26630465|P1|Period 2|Withdrawal by Subject|3
7654497|NCT01474772|26630464|P2|Period 2|Lack of Efficacy|0
7654498|NCT01474772|26630465|P1|Period 2|Lack of Efficacy|1
7654499|NCT01474772|26630464|P2|Period 2|AE not Related to Study Drug|1
7654500|NCT01474772|26630465|P1|Period 2|AE not Related to Study Drug|4
7654501|NCT01474772|26630464|P2|Period 2|AE Related to Study Drug|1
7654502|NCT01474772|26630465|P1|Period 2|AE Related to Study Drug|0
7654503|NCT01474772|26630464|P2|Period 2|Death|1
7654504|NCT01474772|26630465|P1|Period 2|Death|0
7654505|NCT01474772|26630464|P2|Washout|Reason not Specified|1
7654506|NCT01474772|26630465|P1|Washout|Reason not Specified|0
7654507|NCT01474772|26630464|P2|Washout|Lost to Follow-up|1
7654508|NCT01474772|26630465|P1|Washout|Lost to Follow-up|0
7654509|NCT01474772|26630464|P2|Washout|Withdrawal by Subject|0
7654510|NCT01474772|26630465|P1|Washout|Withdrawal by Subject|1
7654511|NCT01474772|26630464|P2|Washout|AE not Related to Study Drug|0
7654512|NCT01474772|26630465|P1|Washout|AE not Related to Study Drug|2
7654513|NCT01474772|26630464|P2|Period 1|Reason not Specified|1
7654514|NCT01474772|26630465|P1|Period 1|Reason not Specified|1
7654515|NCT01474772|26630464|P2|Period 1|Lost to Follow-up|0
7654516|NCT01474772|26630465|P1|Period 1|Lost to Follow-up|1
7654517|NCT01474772|26630464|P2|Period 1|Withdrawal by Subject|1
7654518|NCT01474772|26630465|P1|Period 1|Withdrawal by Subject|3
7654519|NCT01474772|26630464|P2|Period 1|AE not Related to Study Drug|0
7654520|NCT01474772|26630465|P1|Period 1|AE not Related to Study Drug|1
7654521|NCT01474772|26630464|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
7654522|NCT01474772|26630465|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
7654523|NCT01474746|26630515|P2|Overall Study|Withdrawal by Subject|1
7654524|NCT01474746|26630516|P1|Overall Study|Withdrawal by Subject|2
7654525|NCT01474746|26630515|P2|Overall Study|Lost to Follow-up|1
7654526|NCT01474746|26630516|P1|Overall Study|Lost to Follow-up|1
7654527|NCT01474681|26630580|P4|Overall Study|Death|6
7654528|NCT01474681|26630581|P3|Overall Study|Death|2
7654529|NCT01474681|26630582|P2|Overall Study|Death|3
7654530|NCT01474681|26630583|P1|Overall Study|Death|0
7654531|NCT01474551|26630634|P1|Overall Study|Death|1
7654532|NCT01474538|26630640|P2|Treatment Period 2|Protocol Violation|0
7654533|NCT01474538|26630641|P1|Treatment Period 2|Protocol Violation|1
7654534|NCT01474538|26630640|P2|Treatment Period 2|Physician Decision|1
7654535|NCT01474538|26630641|P1|Treatment Period 2|Physician Decision|0
7654536|NCT01474538|26630640|P2|Treatment Period 2|Sponsor decision|0
7654537|NCT01474538|26630641|P1|Treatment Period 2|Sponsor decision|1
7654538|NCT01474538|26630640|P2|Treatment Period 2|Withdrawal by Subject|0
7654539|NCT01474538|26630641|P1|Treatment Period 2|Withdrawal by Subject|2
7654540|NCT01474538|26630640|P2|Treatment Period 2|Adverse Event|1
7654541|NCT01474538|26630641|P1|Treatment Period 2|Adverse Event|1
7654542|NCT01474538|26630640|P2|Treatment Period 2|Death|0
7654543|NCT01474538|26630641|P1|Treatment Period 2|Death|1
7654544|NCT01474538|26630640|P2|Treatment Period 1|Protocol Violation|1
7654545|NCT01474538|26630641|P1|Treatment Period 1|Protocol Violation|0
7654546|NCT01474538|26630640|P2|Treatment Period 1|Withdrawal by Subject|3
7654547|NCT01474538|26630641|P1|Treatment Period 1|Withdrawal by Subject|1
7654548|NCT01474538|26630640|P2|Treatment Period 1|Physician Decision|0
7654549|NCT01474538|26630641|P1|Treatment Period 1|Physician Decision|1
7654550|NCT01474538|26630640|P2|Treatment Period 1|Death|0
7654551|NCT01474538|26630641|P1|Treatment Period 1|Death|1
7654552|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Death|0
7654553|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Death|1
7654554|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Death|0
7654555|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Death|0
7654556|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Death|0
7654557|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Death|0
7654558|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Death|0
7654559|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Death|0
7654560|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Death|0
7654561|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Death|0
7654562|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Death|0
7654563|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Death|0
7654564|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Death|0
7654565|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Death|0
7654566|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Death|0
7654567|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Death|0
7654568|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Death|0
7654569|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Death|0
7654570|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7654571|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654572|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654573|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7654574|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654575|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654576|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654577|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654578|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654579|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654580|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654581|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654582|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654583|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654584|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654585|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654586|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654587|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7654588|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Sponsor Decision|0
7654589|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Sponsor Decision|4
7654590|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Sponsor Decision|0
7654591|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Sponsor Decision|1
7654592|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Sponsor Decision|0
7654593|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Sponsor Decision|0
7654594|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Sponsor Decision|0
7654595|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Sponsor Decision|0
7654596|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Sponsor Decision|0
7654597|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Sponsor Decision|0
7654598|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Sponsor Decision|0
7654599|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Sponsor Decision|0
7654600|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Sponsor Decision|0
7654601|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Sponsor Decision|0
7654602|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Sponsor Decision|0
7654603|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Sponsor Decision|0
7654604|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Sponsor Decision|0
7654605|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Sponsor Decision|0
7654606|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Protocol Violation|0
7654607|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Protocol Violation|4
7654608|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Protocol Violation|2
7654609|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Protocol Violation|2
7654610|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Protocol Violation|0
7654611|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Protocol Violation|0
7654612|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Protocol Violation|0
7654613|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Protocol Violation|0
7654614|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Protocol Violation|0
7654615|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Protocol Violation|0
7654616|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Protocol Violation|0
7654617|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Protocol Violation|0
7654618|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Protocol Violation|0
7654619|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Protocol Violation|0
7654620|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Protocol Violation|0
7654621|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Protocol Violation|0
7654622|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Protocol Violation|0
7654623|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Protocol Violation|0
7654624|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Clinical Relapse|2
7654625|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Clinical Relapse|6
7654626|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Clinical Relapse|0
7654627|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Clinical Relapse|0
7654628|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Clinical Relapse|0
7654629|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Clinical Relapse|0
7654630|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Clinical Relapse|0
7654631|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Clinical Relapse|0
7654632|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Clinical Relapse|0
7654633|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Clinical Relapse|0
7654634|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Clinical Relapse|0
7654635|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Clinical Relapse|0
7654636|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Clinical Relapse|0
7654637|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Clinical Relapse|0
7654638|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Clinical Relapse|0
7654639|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Clinical Relapse|0
7654640|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Clinical Relapse|0
7654641|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Clinical Relapse|0
7654642|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Physician Decision|5
7654643|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Physician Decision|4
7654644|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Physician Decision|0
7654645|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Physician Decision|0
7654646|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Physician Decision|0
7654647|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Physician Decision|0
7654648|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Physician Decision|0
7654649|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Physician Decision|0
7654650|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Physician Decision|0
7654651|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Physician Decision|0
7654652|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Physician Decision|0
7654653|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Physician Decision|0
7654654|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Physician Decision|0
7654655|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Physician Decision|0
7654656|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Physician Decision|0
7654657|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Physician Decision|0
7654658|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Physician Decision|0
7654659|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Physician Decision|0
7654660|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
7654661|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
7654662|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
7654663|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
7654664|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
7654665|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
7654666|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
7654667|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
7654668|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
7654669|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
7654670|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
7654671|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
7654672|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
7654673|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
7654674|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
7654675|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
7654676|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
7654677|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
7654678|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
7654679|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
7654680|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
7654681|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
7654682|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
7654683|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
7654684|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
7654685|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
7654686|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
7654687|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
7654688|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
7654689|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
7654690|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
7654691|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
7654692|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
7654693|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
7654694|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
7654695|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
7654696|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
7654697|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
7654698|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
7654699|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
7654700|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654701|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654702|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654703|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654704|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654705|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654706|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654707|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654708|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654709|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654710|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654711|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654712|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654713|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
7654714|NCT01474512|26630658|P18|Post-Treatment Follow-Up|Adverse Event|11
7654715|NCT01474512|26630659|P17|Post-Treatment Follow-Up|Adverse Event|58
7654716|NCT01474512|26630660|P16|Post-Treatment Follow-Up|Adverse Event|2
7654717|NCT01474512|26630661|P15|Post-Treatment Follow-Up|Adverse Event|8
7654718|NCT01474512|26630662|P14|Post-Treatment Follow-Up|Adverse Event|0
7654719|NCT01474512|26630663|P13|Post-Treatment Follow-Up|Adverse Event|0
7654720|NCT01474512|26630664|P12|Post-Treatment Follow-Up|Adverse Event|0
7654721|NCT01474512|26630665|P11|Post-Treatment Follow-Up|Adverse Event|0
7654722|NCT01474512|26630666|P10|Post-Treatment Follow-Up|Adverse Event|0
7654723|NCT01474512|26630667|P9|Post-Treatment Follow-Up|Adverse Event|0
7654724|NCT01474512|26630668|P8|Post-Treatment Follow-Up|Adverse Event|0
7654725|NCT01474512|26630669|P7|Post-Treatment Follow-Up|Adverse Event|0
7654726|NCT01474512|26630670|P6|Post-Treatment Follow-Up|Adverse Event|0
7654727|NCT01474512|26630671|P5|Post-Treatment Follow-Up|Adverse Event|0
7654728|NCT01474512|26630672|P4|Post-Treatment Follow-Up|Adverse Event|0
7654729|NCT01474512|26630673|P3|Post-Treatment Follow-Up|Adverse Event|0
7654730|NCT01474512|26630674|P2|Post-Treatment Follow-Up|Adverse Event|0
7654731|NCT01474512|26630675|P1|Post-Treatment Follow-Up|Adverse Event|0
7654732|NCT01474512|26630658|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
7654733|NCT01474512|26630659|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
7654734|NCT01474512|26630660|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
7654735|NCT01474512|26630661|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
7654736|NCT01474512|26630662|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
7654737|NCT01474512|26630663|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
7654738|NCT01474512|26630664|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
7654739|NCT01474512|26630665|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
7654740|NCT01474512|26630666|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
7654741|NCT01474512|26630667|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
7654742|NCT01474512|26630668|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
7654743|NCT01474512|26630669|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
7654744|NCT01474512|26630670|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
7654745|NCT01474512|26630671|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
7654746|NCT01474512|26630672|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
7654747|NCT01474512|26630673|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
7654748|NCT01474512|26630674|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
7654749|NCT01474512|26630675|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
7654750|NCT01474512|26630658|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
7654751|NCT01474512|26630659|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
7654752|NCT01474512|26630660|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
7654753|NCT01474512|26630661|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
7654754|NCT01474512|26630662|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
7654755|NCT01474512|26630663|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
7654756|NCT01474512|26630664|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
7654757|NCT01474512|26630665|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
7654758|NCT01474512|26630666|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
7654759|NCT01474512|26630667|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
7654760|NCT01474512|26630668|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
7654761|NCT01474512|26630669|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
7654762|NCT01474512|26630670|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
7654763|NCT01474512|26630671|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
7654764|NCT01474512|26630672|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
7654765|NCT01474512|26630673|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
7654766|NCT01474512|26630674|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
7654767|NCT01474512|26630675|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
7654768|NCT01474512|26630658|P18|Long-Term Extension Period|Protocol Violation|0
7654769|NCT01474512|26630659|P17|Long-Term Extension Period|Protocol Violation|0
7654770|NCT01474512|26630660|P16|Long-Term Extension Period|Protocol Violation|0
7654771|NCT01474512|26630661|P15|Long-Term Extension Period|Protocol Violation|0
7654772|NCT01474512|26630662|P14|Long-Term Extension Period|Protocol Violation|5
7654773|NCT01474512|26630663|P13|Long-Term Extension Period|Protocol Violation|5
7654774|NCT01474512|26630664|P12|Long-Term Extension Period|Protocol Violation|0
7654775|NCT01474512|26630665|P11|Long-Term Extension Period|Protocol Violation|0
7654776|NCT01474512|26630666|P10|Long-Term Extension Period|Protocol Violation|0
7654777|NCT01474512|26630667|P9|Long-Term Extension Period|Protocol Violation|0
7654778|NCT01474512|26630668|P8|Long-Term Extension Period|Protocol Violation|0
7654779|NCT01474512|26630669|P7|Long-Term Extension Period|Protocol Violation|0
7654780|NCT01474512|26630670|P6|Long-Term Extension Period|Protocol Violation|0
7654781|NCT01474512|26630671|P5|Long-Term Extension Period|Protocol Violation|0
7654782|NCT01474512|26630672|P4|Long-Term Extension Period|Protocol Violation|0
7654783|NCT01474512|26630673|P3|Long-Term Extension Period|Protocol Violation|0
7654784|NCT01474512|26630674|P2|Long-Term Extension Period|Protocol Violation|0
7654785|NCT01474512|26630675|P1|Long-Term Extension Period|Protocol Violation|0
7654786|NCT01474512|26630658|P18|Long-Term Extension Period|Sponsor Decision|0
7654787|NCT01474512|26630659|P17|Long-Term Extension Period|Sponsor Decision|0
7654788|NCT01474512|26630660|P16|Long-Term Extension Period|Sponsor Decision|0
7654789|NCT01474512|26630661|P15|Long-Term Extension Period|Sponsor Decision|0
7654790|NCT01474512|26630662|P14|Long-Term Extension Period|Sponsor Decision|6
7654791|NCT01474512|26630663|P13|Long-Term Extension Period|Sponsor Decision|6
7654792|NCT01474512|26630664|P12|Long-Term Extension Period|Sponsor Decision|0
7654793|NCT01474512|26630665|P11|Long-Term Extension Period|Sponsor Decision|0
7654794|NCT01474512|26630666|P10|Long-Term Extension Period|Sponsor Decision|0
7654795|NCT01474512|26630667|P9|Long-Term Extension Period|Sponsor Decision|0
7654796|NCT01474512|26630668|P8|Long-Term Extension Period|Sponsor Decision|0
7654797|NCT01474512|26630669|P7|Long-Term Extension Period|Sponsor Decision|0
7654798|NCT01474512|26630670|P6|Long-Term Extension Period|Sponsor Decision|0
7654799|NCT01474512|26630671|P5|Long-Term Extension Period|Sponsor Decision|0
7654800|NCT01474512|26630672|P4|Long-Term Extension Period|Sponsor Decision|0
7654801|NCT01474512|26630673|P3|Long-Term Extension Period|Sponsor Decision|0
7654802|NCT01474512|26630674|P2|Long-Term Extension Period|Sponsor Decision|0
7654803|NCT01474512|26630675|P1|Long-Term Extension Period|Sponsor Decision|0
7654804|NCT01474512|26630658|P18|Long-Term Extension Period|Death|0
7654805|NCT01474512|26630659|P17|Long-Term Extension Period|Death|0
7654806|NCT01474512|26630660|P16|Long-Term Extension Period|Death|0
7654807|NCT01474512|26630661|P15|Long-Term Extension Period|Death|0
7654808|NCT01474512|26630662|P14|Long-Term Extension Period|Death|9
7654809|NCT01474512|26630663|P13|Long-Term Extension Period|Death|9
7654810|NCT01474512|26630664|P12|Long-Term Extension Period|Death|0
7654811|NCT01474512|26630665|P11|Long-Term Extension Period|Death|0
7654812|NCT01474512|26630666|P10|Long-Term Extension Period|Death|0
7654813|NCT01474512|26630667|P9|Long-Term Extension Period|Death|0
7654814|NCT01474512|26630668|P8|Long-Term Extension Period|Death|0
7654815|NCT01474512|26630669|P7|Long-Term Extension Period|Death|0
7654816|NCT01474512|26630670|P6|Long-Term Extension Period|Death|0
7654817|NCT01474512|26630671|P5|Long-Term Extension Period|Death|0
7654818|NCT01474512|26630672|P4|Long-Term Extension Period|Death|0
7654819|NCT01474512|26630673|P3|Long-Term Extension Period|Death|0
7654820|NCT01474512|26630674|P2|Long-Term Extension Period|Death|0
7654821|NCT01474512|26630675|P1|Long-Term Extension Period|Death|0
7654822|NCT01474512|26630658|P18|Long-Term Extension Period|Clinical Relapse|0
7654823|NCT01474512|26630659|P17|Long-Term Extension Period|Clinical Relapse|0
7654824|NCT01474512|26630660|P16|Long-Term Extension Period|Clinical Relapse|0
7654825|NCT01474512|26630661|P15|Long-Term Extension Period|Clinical Relapse|0
7654826|NCT01474512|26630662|P14|Long-Term Extension Period|Clinical Relapse|9
7654827|NCT01474512|26630663|P13|Long-Term Extension Period|Clinical Relapse|9
7654828|NCT01474512|26630664|P12|Long-Term Extension Period|Clinical Relapse|0
7654829|NCT01474512|26630665|P11|Long-Term Extension Period|Clinical Relapse|0
7654830|NCT01474512|26630666|P10|Long-Term Extension Period|Clinical Relapse|0
7654831|NCT01474512|26630667|P9|Long-Term Extension Period|Clinical Relapse|0
7654832|NCT01474512|26630668|P8|Long-Term Extension Period|Clinical Relapse|0
7654833|NCT01474512|26630669|P7|Long-Term Extension Period|Clinical Relapse|0
7654834|NCT01474512|26630670|P6|Long-Term Extension Period|Clinical Relapse|0
7654835|NCT01474512|26630671|P5|Long-Term Extension Period|Clinical Relapse|0
7654836|NCT01474512|26630672|P4|Long-Term Extension Period|Clinical Relapse|0
7654837|NCT01474512|26630673|P3|Long-Term Extension Period|Clinical Relapse|0
7654838|NCT01474512|26630674|P2|Long-Term Extension Period|Clinical Relapse|0
7654839|NCT01474512|26630675|P1|Long-Term Extension Period|Clinical Relapse|0
7654840|NCT01474512|26630658|P18|Long-Term Extension Period|Physician Decision|0
7654841|NCT01474512|26630659|P17|Long-Term Extension Period|Physician Decision|0
7654842|NCT01474512|26630660|P16|Long-Term Extension Period|Physician Decision|0
7654843|NCT01474512|26630661|P15|Long-Term Extension Period|Physician Decision|0
7654844|NCT01474512|26630662|P14|Long-Term Extension Period|Physician Decision|21
7654845|NCT01474512|26630663|P13|Long-Term Extension Period|Physician Decision|21
7654846|NCT01474512|26630664|P12|Long-Term Extension Period|Physician Decision|0
7654847|NCT01474512|26630665|P11|Long-Term Extension Period|Physician Decision|0
7654848|NCT01474512|26630666|P10|Long-Term Extension Period|Physician Decision|0
7654849|NCT01474512|26630667|P9|Long-Term Extension Period|Physician Decision|0
7654850|NCT01474512|26630668|P8|Long-Term Extension Period|Physician Decision|0
7654851|NCT01474512|26630669|P7|Long-Term Extension Period|Physician Decision|0
7654852|NCT01474512|26630670|P6|Long-Term Extension Period|Physician Decision|0
7654853|NCT01474512|26630671|P5|Long-Term Extension Period|Physician Decision|0
7654854|NCT01474512|26630672|P4|Long-Term Extension Period|Physician Decision|0
7654855|NCT01474512|26630673|P3|Long-Term Extension Period|Physician Decision|0
7654856|NCT01474512|26630674|P2|Long-Term Extension Period|Physician Decision|0
7654857|NCT01474512|26630675|P1|Long-Term Extension Period|Physician Decision|0
7654858|NCT01474512|26630658|P18|Long-Term Extension Period|Lack of Efficacy|0
7654859|NCT01474512|26630659|P17|Long-Term Extension Period|Lack of Efficacy|0
7654860|NCT01474512|26630660|P16|Long-Term Extension Period|Lack of Efficacy|0
7654861|NCT01474512|26630661|P15|Long-Term Extension Period|Lack of Efficacy|0
7654862|NCT01474512|26630662|P14|Long-Term Extension Period|Lack of Efficacy|25
7654863|NCT01474512|26630663|P13|Long-Term Extension Period|Lack of Efficacy|24
7654864|NCT01474512|26630664|P12|Long-Term Extension Period|Lack of Efficacy|1
7654865|NCT01474512|26630665|P11|Long-Term Extension Period|Lack of Efficacy|0
7654866|NCT01474512|26630666|P10|Long-Term Extension Period|Lack of Efficacy|0
7654867|NCT01474512|26630667|P9|Long-Term Extension Period|Lack of Efficacy|0
7654868|NCT01474512|26630668|P8|Long-Term Extension Period|Lack of Efficacy|0
7654869|NCT01474512|26630669|P7|Long-Term Extension Period|Lack of Efficacy|0
7654870|NCT01474512|26630670|P6|Long-Term Extension Period|Lack of Efficacy|0
7654871|NCT01474512|26630671|P5|Long-Term Extension Period|Lack of Efficacy|0
7654872|NCT01474512|26630672|P4|Long-Term Extension Period|Lack of Efficacy|0
7654873|NCT01474512|26630673|P3|Long-Term Extension Period|Lack of Efficacy|0
7654874|NCT01474512|26630674|P2|Long-Term Extension Period|Lack of Efficacy|0
7654875|NCT01474512|26630675|P1|Long-Term Extension Period|Lack of Efficacy|0
7654876|NCT01474512|26630658|P18|Long-Term Extension Period|Lost to Follow-up|0
7654877|NCT01474512|26630659|P17|Long-Term Extension Period|Lost to Follow-up|0
7654878|NCT01474512|26630660|P16|Long-Term Extension Period|Lost to Follow-up|0
7654879|NCT01474512|26630661|P15|Long-Term Extension Period|Lost to Follow-up|0
7654880|NCT01474512|26630662|P14|Long-Term Extension Period|Lost to Follow-up|25
7654881|NCT01474512|26630663|P13|Long-Term Extension Period|Lost to Follow-up|25
7654882|NCT01474512|26630664|P12|Long-Term Extension Period|Lost to Follow-up|0
7654883|NCT01474512|26630665|P11|Long-Term Extension Period|Lost to Follow-up|0
7654884|NCT01474512|26630666|P10|Long-Term Extension Period|Lost to Follow-up|0
7654885|NCT01474512|26630667|P9|Long-Term Extension Period|Lost to Follow-up|0
7654886|NCT01474512|26630668|P8|Long-Term Extension Period|Lost to Follow-up|0
7654887|NCT01474512|26630669|P7|Long-Term Extension Period|Lost to Follow-up|0
7654888|NCT01474512|26630670|P6|Long-Term Extension Period|Lost to Follow-up|0
7654889|NCT01474512|26630671|P5|Long-Term Extension Period|Lost to Follow-up|0
7654890|NCT01474512|26630672|P4|Long-Term Extension Period|Lost to Follow-up|0
7654891|NCT01474512|26630673|P3|Long-Term Extension Period|Lost to Follow-up|0
7654892|NCT01474512|26630674|P2|Long-Term Extension Period|Lost to Follow-up|0
7654893|NCT01474512|26630675|P1|Long-Term Extension Period|Lost to Follow-up|0
7654894|NCT01474512|26630658|P18|Long-Term Extension Period|Adverse Event|0
7654895|NCT01474512|26630659|P17|Long-Term Extension Period|Adverse Event|0
7654896|NCT01474512|26630660|P16|Long-Term Extension Period|Adverse Event|0
7654897|NCT01474512|26630661|P15|Long-Term Extension Period|Adverse Event|0
7654898|NCT01474512|26630662|P14|Long-Term Extension Period|Adverse Event|58
7654899|NCT01474512|26630663|P13|Long-Term Extension Period|Adverse Event|57
7654900|NCT01474512|26630664|P12|Long-Term Extension Period|Adverse Event|1
7654901|NCT01474512|26630665|P11|Long-Term Extension Period|Adverse Event|0
7654902|NCT01474512|26630666|P10|Long-Term Extension Period|Adverse Event|0
7654903|NCT01474512|26630667|P9|Long-Term Extension Period|Adverse Event|0
7654904|NCT01474512|26630668|P8|Long-Term Extension Period|Adverse Event|0
7654905|NCT01474512|26630669|P7|Long-Term Extension Period|Adverse Event|0
7654906|NCT01474512|26630670|P6|Long-Term Extension Period|Adverse Event|0
7654907|NCT01474512|26630671|P5|Long-Term Extension Period|Adverse Event|0
7654908|NCT01474512|26630672|P4|Long-Term Extension Period|Adverse Event|0
7654909|NCT01474512|26630673|P3|Long-Term Extension Period|Adverse Event|0
7654910|NCT01474512|26630674|P2|Long-Term Extension Period|Adverse Event|0
7654911|NCT01474512|26630675|P1|Long-Term Extension Period|Adverse Event|0
7654912|NCT01474512|26630658|P18|Long-Term Extension Period|Withdrawal by Subject|0
7654913|NCT01474512|26630659|P17|Long-Term Extension Period|Withdrawal by Subject|0
7654914|NCT01474512|26630660|P16|Long-Term Extension Period|Withdrawal by Subject|0
7654915|NCT01474512|26630661|P15|Long-Term Extension Period|Withdrawal by Subject|0
7654916|NCT01474512|26630662|P14|Long-Term Extension Period|Withdrawal by Subject|61
7654917|NCT01474512|26630663|P13|Long-Term Extension Period|Withdrawal by Subject|61
7654918|NCT01474512|26630664|P12|Long-Term Extension Period|Withdrawal by Subject|3
7654919|NCT01474512|26630665|P11|Long-Term Extension Period|Withdrawal by Subject|0
7654920|NCT01474512|26630666|P10|Long-Term Extension Period|Withdrawal by Subject|0
7654921|NCT01474512|26630667|P9|Long-Term Extension Period|Withdrawal by Subject|0
7654922|NCT01474512|26630668|P8|Long-Term Extension Period|Withdrawal by Subject|0
7654923|NCT01474512|26630669|P7|Long-Term Extension Period|Withdrawal by Subject|0
7654924|NCT01474512|26630670|P6|Long-Term Extension Period|Withdrawal by Subject|0
7654925|NCT01474512|26630671|P5|Long-Term Extension Period|Withdrawal by Subject|0
7654926|NCT01474512|26630672|P4|Long-Term Extension Period|Withdrawal by Subject|0
7654927|NCT01474512|26630673|P3|Long-Term Extension Period|Withdrawal by Subject|0
7654928|NCT01474512|26630674|P2|Long-Term Extension Period|Withdrawal by Subject|0
7654929|NCT01474512|26630675|P1|Long-Term Extension Period|Withdrawal by Subject|0
7654930|NCT01474512|26630658|P18|Maintenance Period|Treated but Discontinued in Induction|0
7654931|NCT01474512|26630659|P17|Maintenance Period|Treated but Discontinued in Induction|0
7654932|NCT01474512|26630660|P16|Maintenance Period|Treated but Discontinued in Induction|0
7654933|NCT01474512|26630661|P15|Maintenance Period|Treated but Discontinued in Induction|0
7654934|NCT01474512|26630662|P14|Maintenance Period|Treated but Discontinued in Induction|0
7654935|NCT01474512|26630663|P13|Maintenance Period|Treated but Discontinued in Induction|0
7654936|NCT01474512|26630664|P12|Maintenance Period|Treated but Discontinued in Induction|0
7654937|NCT01474512|26630665|P11|Maintenance Period|Treated but Discontinued in Induction|0
7654938|NCT01474512|26630666|P10|Maintenance Period|Treated but Discontinued in Induction|0
7654939|NCT01474512|26630667|P9|Maintenance Period|Treated but Discontinued in Induction|0
7654940|NCT01474512|26630668|P8|Maintenance Period|Treated but Discontinued in Induction|0
7654941|NCT01474512|26630669|P7|Maintenance Period|Treated but Discontinued in Induction|0
7654942|NCT01474512|26630670|P6|Maintenance Period|Treated but Discontinued in Induction|0
7654943|NCT01474512|26630671|P5|Maintenance Period|Treated but Discontinued in Induction|1
7654944|NCT01474512|26630672|P4|Maintenance Period|Treated but Discontinued in Induction|0
7654945|NCT01474512|26630673|P3|Maintenance Period|Treated but Discontinued in Induction|0
7654946|NCT01474512|26630674|P2|Maintenance Period|Treated but Discontinued in Induction|0
7654947|NCT01474512|26630675|P1|Maintenance Period|Treated but Discontinued in Induction|0
7654948|NCT01474512|26630658|P18|Maintenance Period|Protocol Violation|0
7654949|NCT01474512|26630659|P17|Maintenance Period|Protocol Violation|0
7654950|NCT01474512|26630660|P16|Maintenance Period|Protocol Violation|0
7654951|NCT01474512|26630661|P15|Maintenance Period|Protocol Violation|0
7654952|NCT01474512|26630662|P14|Maintenance Period|Protocol Violation|0
7654953|NCT01474512|26630663|P13|Maintenance Period|Protocol Violation|0
7654954|NCT01474512|26630664|P12|Maintenance Period|Protocol Violation|0
7654955|NCT01474512|26630665|P11|Maintenance Period|Protocol Violation|0
7654956|NCT01474512|26630666|P10|Maintenance Period|Protocol Violation|1
7654957|NCT01474512|26630667|P9|Maintenance Period|Protocol Violation|0
7654958|NCT01474512|26630668|P8|Maintenance Period|Protocol Violation|1
7654959|NCT01474512|26630669|P7|Maintenance Period|Protocol Violation|0
7654960|NCT01474512|26630670|P6|Maintenance Period|Protocol Violation|0
7654961|NCT01474512|26630671|P5|Maintenance Period|Protocol Violation|0
7654962|NCT01474512|26630672|P4|Maintenance Period|Protocol Violation|1
7654963|NCT01474512|26630673|P3|Maintenance Period|Protocol Violation|0
7654964|NCT01474512|26630674|P2|Maintenance Period|Protocol Violation|0
7654965|NCT01474512|26630675|P1|Maintenance Period|Protocol Violation|0
7654966|NCT01474512|26630658|P18|Maintenance Period|Lack of Efficacy|0
7654967|NCT01474512|26630659|P17|Maintenance Period|Lack of Efficacy|0
7654968|NCT01474512|26630660|P16|Maintenance Period|Lack of Efficacy|0
7654969|NCT01474512|26630661|P15|Maintenance Period|Lack of Efficacy|0
7654970|NCT01474512|26630662|P14|Maintenance Period|Lack of Efficacy|0
7654971|NCT01474512|26630663|P13|Maintenance Period|Lack of Efficacy|0
7654972|NCT01474512|26630664|P12|Maintenance Period|Lack of Efficacy|0
7654973|NCT01474512|26630665|P11|Maintenance Period|Lack of Efficacy|0
7654974|NCT01474512|26630666|P10|Maintenance Period|Lack of Efficacy|12
7654975|NCT01474512|26630667|P9|Maintenance Period|Lack of Efficacy|11
7654976|NCT01474512|26630668|P8|Maintenance Period|Lack of Efficacy|11
7654977|NCT01474512|26630669|P7|Maintenance Period|Lack of Efficacy|0
7654978|NCT01474512|26630670|P6|Maintenance Period|Lack of Efficacy|0
7654979|NCT01474512|26630671|P5|Maintenance Period|Lack of Efficacy|0
7654980|NCT01474512|26630672|P4|Maintenance Period|Lack of Efficacy|1
7654981|NCT01474512|26630673|P3|Maintenance Period|Lack of Efficacy|0
7654982|NCT01474512|26630674|P2|Maintenance Period|Lack of Efficacy|0
7654983|NCT01474512|26630675|P1|Maintenance Period|Lack of Efficacy|0
7654984|NCT01474512|26630658|P18|Maintenance Period|Clinical Relapse|0
7654985|NCT01474512|26630659|P17|Maintenance Period|Clinical Relapse|0
7654986|NCT01474512|26630660|P16|Maintenance Period|Clinical Relapse|0
7654987|NCT01474512|26630661|P15|Maintenance Period|Clinical Relapse|0
7654988|NCT01474512|26630662|P14|Maintenance Period|Clinical Relapse|0
7654989|NCT01474512|26630663|P13|Maintenance Period|Clinical Relapse|0
7654990|NCT01474512|26630664|P12|Maintenance Period|Clinical Relapse|0
7654991|NCT01474512|26630665|P11|Maintenance Period|Clinical Relapse|0
7654992|NCT01474512|26630666|P10|Maintenance Period|Clinical Relapse|0
7654993|NCT01474512|26630667|P9|Maintenance Period|Clinical Relapse|0
7654994|NCT01474512|26630668|P8|Maintenance Period|Clinical Relapse|0
7654995|NCT01474512|26630669|P7|Maintenance Period|Clinical Relapse|0
7654996|NCT01474512|26630670|P6|Maintenance Period|Clinical Relapse|0
7654997|NCT01474512|26630671|P5|Maintenance Period|Clinical Relapse|0
7654998|NCT01474512|26630672|P4|Maintenance Period|Clinical Relapse|1
7654999|NCT01474512|26630673|P3|Maintenance Period|Clinical Relapse|0
7655000|NCT01474512|26630674|P2|Maintenance Period|Clinical Relapse|0
7655001|NCT01474512|26630675|P1|Maintenance Period|Clinical Relapse|0
7655002|NCT01474512|26630658|P18|Maintenance Period|Physician Decision|0
7655003|NCT01474512|26630659|P17|Maintenance Period|Physician Decision|0
7655004|NCT01474512|26630660|P16|Maintenance Period|Physician Decision|0
7655005|NCT01474512|26630661|P15|Maintenance Period|Physician Decision|0
7655006|NCT01474512|26630662|P14|Maintenance Period|Physician Decision|0
7655007|NCT01474512|26630663|P13|Maintenance Period|Physician Decision|0
7655008|NCT01474512|26630664|P12|Maintenance Period|Physician Decision|0
7655009|NCT01474512|26630665|P11|Maintenance Period|Physician Decision|0
7655010|NCT01474512|26630666|P10|Maintenance Period|Physician Decision|0
7655011|NCT01474512|26630667|P9|Maintenance Period|Physician Decision|0
7655012|NCT01474512|26630668|P8|Maintenance Period|Physician Decision|2
7655013|NCT01474512|26630669|P7|Maintenance Period|Physician Decision|0
7655014|NCT01474512|26630670|P6|Maintenance Period|Physician Decision|1
7655015|NCT01474512|26630671|P5|Maintenance Period|Physician Decision|0
7655016|NCT01474512|26630672|P4|Maintenance Period|Physician Decision|0
7655017|NCT01474512|26630673|P3|Maintenance Period|Physician Decision|0
7655018|NCT01474512|26630674|P2|Maintenance Period|Physician Decision|0
7655019|NCT01474512|26630675|P1|Maintenance Period|Physician Decision|0
7655020|NCT01474512|26630658|P18|Maintenance Period|Death|0
7655021|NCT01474512|26630659|P17|Maintenance Period|Death|0
7655022|NCT01474512|26630660|P16|Maintenance Period|Death|0
7655023|NCT01474512|26630661|P15|Maintenance Period|Death|0
7655024|NCT01474512|26630662|P14|Maintenance Period|Death|0
7655025|NCT01474512|26630663|P13|Maintenance Period|Death|0
7655026|NCT01474512|26630664|P12|Maintenance Period|Death|0
7655027|NCT01474512|26630665|P11|Maintenance Period|Death|0
7655028|NCT01474512|26630666|P10|Maintenance Period|Death|0
7655029|NCT01474512|26630667|P9|Maintenance Period|Death|0
7655030|NCT01474512|26630668|P8|Maintenance Period|Death|0
7655031|NCT01474512|26630669|P7|Maintenance Period|Death|0
7655032|NCT01474512|26630670|P6|Maintenance Period|Death|2
7655033|NCT01474512|26630671|P5|Maintenance Period|Death|0
7655034|NCT01474512|26630672|P4|Maintenance Period|Death|0
7655035|NCT01474512|26630673|P3|Maintenance Period|Death|0
7655036|NCT01474512|26630674|P2|Maintenance Period|Death|0
7655037|NCT01474512|26630675|P1|Maintenance Period|Death|0
7655038|NCT01474512|26630658|P18|Maintenance Period|Lost to Follow-up|0
7655039|NCT01474512|26630659|P17|Maintenance Period|Lost to Follow-up|0
7655040|NCT01474512|26630660|P16|Maintenance Period|Lost to Follow-up|0
7655041|NCT01474512|26630661|P15|Maintenance Period|Lost to Follow-up|0
7655042|NCT01474512|26630662|P14|Maintenance Period|Lost to Follow-up|0
7655043|NCT01474512|26630663|P13|Maintenance Period|Lost to Follow-up|0
7655044|NCT01474512|26630664|P12|Maintenance Period|Lost to Follow-up|0
7655045|NCT01474512|26630665|P11|Maintenance Period|Lost to Follow-up|0
7655046|NCT01474512|26630666|P10|Maintenance Period|Lost to Follow-up|1
7655047|NCT01474512|26630667|P9|Maintenance Period|Lost to Follow-up|1
7655048|NCT01474512|26630668|P8|Maintenance Period|Lost to Follow-up|2
7655049|NCT01474512|26630669|P7|Maintenance Period|Lost to Follow-up|0
7655050|NCT01474512|26630670|P6|Maintenance Period|Lost to Follow-up|0
7655051|NCT01474512|26630671|P5|Maintenance Period|Lost to Follow-up|3
7655052|NCT01474512|26630672|P4|Maintenance Period|Lost to Follow-up|3
7655053|NCT01474512|26630673|P3|Maintenance Period|Lost to Follow-up|0
7655054|NCT01474512|26630674|P2|Maintenance Period|Lost to Follow-up|0
7655055|NCT01474512|26630675|P1|Maintenance Period|Lost to Follow-up|0
7655056|NCT01474512|26630658|P18|Maintenance Period|Withdrawal by Subject|0
7655057|NCT01474512|26630659|P17|Maintenance Period|Withdrawal by Subject|0
7655058|NCT01474512|26630660|P16|Maintenance Period|Withdrawal by Subject|0
7655059|NCT01474512|26630661|P15|Maintenance Period|Withdrawal by Subject|0
7655060|NCT01474512|26630662|P14|Maintenance Period|Withdrawal by Subject|0
7655061|NCT01474512|26630663|P13|Maintenance Period|Withdrawal by Subject|0
7655062|NCT01474512|26630664|P12|Maintenance Period|Withdrawal by Subject|0
7655063|NCT01474512|26630665|P11|Maintenance Period|Withdrawal by Subject|0
7655064|NCT01474512|26630666|P10|Maintenance Period|Withdrawal by Subject|1
7655065|NCT01474512|26630667|P9|Maintenance Period|Withdrawal by Subject|3
7655066|NCT01474512|26630668|P8|Maintenance Period|Withdrawal by Subject|6
7655067|NCT01474512|26630669|P7|Maintenance Period|Withdrawal by Subject|1
7655068|NCT01474512|26630670|P6|Maintenance Period|Withdrawal by Subject|3
7655069|NCT01474512|26630671|P5|Maintenance Period|Withdrawal by Subject|2
7655070|NCT01474512|26630672|P4|Maintenance Period|Withdrawal by Subject|6
7655071|NCT01474512|26630673|P3|Maintenance Period|Withdrawal by Subject|0
7655072|NCT01474512|26630674|P2|Maintenance Period|Withdrawal by Subject|0
7655073|NCT01474512|26630675|P1|Maintenance Period|Withdrawal by Subject|0
7655074|NCT01474512|26630658|P18|Maintenance Period|Adverse Event|0
7655075|NCT01474512|26630659|P17|Maintenance Period|Adverse Event|0
7655076|NCT01474512|26630660|P16|Maintenance Period|Adverse Event|0
7655077|NCT01474512|26630661|P15|Maintenance Period|Adverse Event|0
7655078|NCT01474512|26630662|P14|Maintenance Period|Adverse Event|0
7655079|NCT01474512|26630663|P13|Maintenance Period|Adverse Event|0
7655080|NCT01474512|26630664|P12|Maintenance Period|Adverse Event|0
7655081|NCT01474512|26630665|P11|Maintenance Period|Adverse Event|0
7655082|NCT01474512|26630666|P10|Maintenance Period|Adverse Event|3
7655083|NCT01474512|26630667|P9|Maintenance Period|Adverse Event|1
7655084|NCT01474512|26630668|P8|Maintenance Period|Adverse Event|19
7655085|NCT01474512|26630669|P7|Maintenance Period|Adverse Event|0
7655086|NCT01474512|26630670|P6|Maintenance Period|Adverse Event|7
7655087|NCT01474512|26630671|P5|Maintenance Period|Adverse Event|2
7655088|NCT01474512|26630672|P4|Maintenance Period|Adverse Event|4
7655089|NCT01474512|26630673|P3|Maintenance Period|Adverse Event|0
7655090|NCT01474512|26630674|P2|Maintenance Period|Adverse Event|0
7655091|NCT01474512|26630675|P1|Maintenance Period|Adverse Event|0
7655092|NCT01474512|26630658|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
7655093|NCT01474512|26630659|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
7655094|NCT01474512|26630660|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
7655095|NCT01474512|26630661|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
7655096|NCT01474512|26630662|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
7655097|NCT01474512|26630663|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
7655098|NCT01474512|26630664|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
7655099|NCT01474512|26630665|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
7655100|NCT01474512|26630666|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
7655101|NCT01474512|26630667|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
7655102|NCT01474512|26630668|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
7655103|NCT01474512|26630669|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
7655104|NCT01474512|26630670|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
7655105|NCT01474512|26630671|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
7655106|NCT01474512|26630672|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
7655107|NCT01474512|26630673|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
7655108|NCT01474512|26630674|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
7655109|NCT01474512|26630675|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
7655110|NCT01474512|26630658|P18|Induction Period|Lost to Follow-up|0
7655111|NCT01474512|26630659|P17|Induction Period|Lost to Follow-up|0
7655112|NCT01474512|26630660|P16|Induction Period|Lost to Follow-up|0
7655113|NCT01474512|26630661|P15|Induction Period|Lost to Follow-up|0
7655114|NCT01474512|26630662|P14|Induction Period|Lost to Follow-up|0
7655115|NCT01474512|26630663|P13|Induction Period|Lost to Follow-up|0
7655116|NCT01474512|26630664|P12|Induction Period|Lost to Follow-up|0
7655117|NCT01474512|26630665|P11|Induction Period|Lost to Follow-up|0
7655118|NCT01474512|26630666|P10|Induction Period|Lost to Follow-up|0
7655119|NCT01474512|26630667|P9|Induction Period|Lost to Follow-up|0
7655120|NCT01474512|26630668|P8|Induction Period|Lost to Follow-up|0
7655121|NCT01474512|26630669|P7|Induction Period|Lost to Follow-up|0
7655122|NCT01474512|26630670|P6|Induction Period|Lost to Follow-up|0
7655123|NCT01474512|26630671|P5|Induction Period|Lost to Follow-up|0
7655124|NCT01474512|26630672|P4|Induction Period|Lost to Follow-up|0
7655125|NCT01474512|26630673|P3|Induction Period|Lost to Follow-up|2
7655126|NCT01474512|26630674|P2|Induction Period|Lost to Follow-up|0
7655127|NCT01474512|26630675|P1|Induction Period|Lost to Follow-up|1
7655128|NCT01474512|26630658|P18|Induction Period|Sponsor Decision|0
7655129|NCT01474512|26630659|P17|Induction Period|Sponsor Decision|0
7655130|NCT01474512|26630660|P16|Induction Period|Sponsor Decision|0
7655131|NCT01474512|26630661|P15|Induction Period|Sponsor Decision|0
7655132|NCT01474512|26630662|P14|Induction Period|Sponsor Decision|0
7655133|NCT01474512|26630663|P13|Induction Period|Sponsor Decision|0
7655134|NCT01474512|26630664|P12|Induction Period|Sponsor Decision|0
7655135|NCT01474512|26630665|P11|Induction Period|Sponsor Decision|0
7655136|NCT01474512|26630666|P10|Induction Period|Sponsor Decision|0
7655137|NCT01474512|26630667|P9|Induction Period|Sponsor Decision|0
7655138|NCT01474512|26630668|P8|Induction Period|Sponsor Decision|0
7655139|NCT01474512|26630669|P7|Induction Period|Sponsor Decision|0
7655140|NCT01474512|26630670|P6|Induction Period|Sponsor Decision|0
7655141|NCT01474512|26630671|P5|Induction Period|Sponsor Decision|0
7655142|NCT01474512|26630672|P4|Induction Period|Sponsor Decision|0
7655143|NCT01474512|26630673|P3|Induction Period|Sponsor Decision|1
7655144|NCT01474512|26630674|P2|Induction Period|Sponsor Decision|1
7655145|NCT01474512|26630675|P1|Induction Period|Sponsor Decision|1
7655146|NCT01474512|26630658|P18|Induction Period|Protocol Violation|0
7655147|NCT01474512|26630659|P17|Induction Period|Protocol Violation|0
7655148|NCT01474512|26630660|P16|Induction Period|Protocol Violation|0
7655149|NCT01474512|26630661|P15|Induction Period|Protocol Violation|0
7655150|NCT01474512|26630662|P14|Induction Period|Protocol Violation|0
7655151|NCT01474512|26630663|P13|Induction Period|Protocol Violation|0
7655152|NCT01474512|26630664|P12|Induction Period|Protocol Violation|0
7655153|NCT01474512|26630665|P11|Induction Period|Protocol Violation|0
7655154|NCT01474512|26630666|P10|Induction Period|Protocol Violation|0
7655155|NCT01474512|26630667|P9|Induction Period|Protocol Violation|0
7655156|NCT01474512|26630668|P8|Induction Period|Protocol Violation|0
7655157|NCT01474512|26630669|P7|Induction Period|Protocol Violation|0
7655158|NCT01474512|26630670|P6|Induction Period|Protocol Violation|0
7655159|NCT01474512|26630671|P5|Induction Period|Protocol Violation|0
7655160|NCT01474512|26630672|P4|Induction Period|Protocol Violation|0
7655161|NCT01474512|26630673|P3|Induction Period|Protocol Violation|0
7655162|NCT01474512|26630674|P2|Induction Period|Protocol Violation|6
7655163|NCT01474512|26630675|P1|Induction Period|Protocol Violation|3
7655164|NCT01474512|26630658|P18|Induction Period|Withdrawal by Subject|0
7655165|NCT01474512|26630659|P17|Induction Period|Withdrawal by Subject|0
7655166|NCT01474512|26630660|P16|Induction Period|Withdrawal by Subject|0
7655167|NCT01474512|26630661|P15|Induction Period|Withdrawal by Subject|0
7655168|NCT01474512|26630662|P14|Induction Period|Withdrawal by Subject|0
7655169|NCT01474512|26630663|P13|Induction Period|Withdrawal by Subject|0
7655170|NCT01474512|26630664|P12|Induction Period|Withdrawal by Subject|0
7655171|NCT01474512|26630665|P11|Induction Period|Withdrawal by Subject|0
7655172|NCT01474512|26630666|P10|Induction Period|Withdrawal by Subject|0
7655173|NCT01474512|26630667|P9|Induction Period|Withdrawal by Subject|0
7655174|NCT01474512|26630668|P8|Induction Period|Withdrawal by Subject|0
7655175|NCT01474512|26630669|P7|Induction Period|Withdrawal by Subject|0
7655176|NCT01474512|26630670|P6|Induction Period|Withdrawal by Subject|0
7655177|NCT01474512|26630671|P5|Induction Period|Withdrawal by Subject|0
7655178|NCT01474512|26630672|P4|Induction Period|Withdrawal by Subject|0
7655179|NCT01474512|26630673|P3|Induction Period|Withdrawal by Subject|5
7655180|NCT01474512|26630674|P2|Induction Period|Withdrawal by Subject|6
7655181|NCT01474512|26630675|P1|Induction Period|Withdrawal by Subject|6
7655182|NCT01474512|26630658|P18|Induction Period|Lack of Efficacy|0
7655183|NCT01474512|26630659|P17|Induction Period|Lack of Efficacy|0
7655184|NCT01474512|26630660|P16|Induction Period|Lack of Efficacy|0
7655185|NCT01474512|26630661|P15|Induction Period|Lack of Efficacy|0
7655186|NCT01474512|26630662|P14|Induction Period|Lack of Efficacy|0
7655187|NCT01474512|26630663|P13|Induction Period|Lack of Efficacy|0
7655188|NCT01474512|26630664|P12|Induction Period|Lack of Efficacy|0
7655189|NCT01474512|26630665|P11|Induction Period|Lack of Efficacy|0
7655190|NCT01474512|26630666|P10|Induction Period|Lack of Efficacy|0
7655191|NCT01474512|26630667|P9|Induction Period|Lack of Efficacy|0
7655192|NCT01474512|26630668|P8|Induction Period|Lack of Efficacy|0
7655193|NCT01474512|26630669|P7|Induction Period|Lack of Efficacy|0
7655194|NCT01474512|26630670|P6|Induction Period|Lack of Efficacy|0
7655195|NCT01474512|26630671|P5|Induction Period|Lack of Efficacy|0
7655196|NCT01474512|26630672|P4|Induction Period|Lack of Efficacy|0
7655197|NCT01474512|26630673|P3|Induction Period|Lack of Efficacy|0
7655198|NCT01474512|26630674|P2|Induction Period|Lack of Efficacy|1
7655199|NCT01474512|26630675|P1|Induction Period|Lack of Efficacy|7
7655200|NCT01474512|26630658|P18|Induction Period|Adverse Event|0
7655201|NCT01474512|26630659|P17|Induction Period|Adverse Event|0
7655202|NCT01474512|26630660|P16|Induction Period|Adverse Event|0
7655203|NCT01474512|26630661|P15|Induction Period|Adverse Event|0
7655204|NCT01474512|26630662|P14|Induction Period|Adverse Event|0
7655205|NCT01474512|26630663|P13|Induction Period|Adverse Event|0
7655206|NCT01474512|26630664|P12|Induction Period|Adverse Event|0
7655207|NCT01474512|26630665|P11|Induction Period|Adverse Event|0
7655208|NCT01474512|26630666|P10|Induction Period|Adverse Event|0
7655209|NCT01474512|26630667|P9|Induction Period|Adverse Event|0
7655210|NCT01474512|26630668|P8|Induction Period|Adverse Event|0
7655211|NCT01474512|26630669|P7|Induction Period|Adverse Event|0
7655212|NCT01474512|26630670|P6|Induction Period|Adverse Event|0
7655213|NCT01474512|26630671|P5|Induction Period|Adverse Event|0
7655214|NCT01474512|26630672|P4|Induction Period|Adverse Event|0
7655215|NCT01474512|26630673|P3|Induction Period|Adverse Event|10
7655216|NCT01474512|26630674|P2|Induction Period|Adverse Event|10
7655217|NCT01474512|26630675|P1|Induction Period|Adverse Event|6
7655218|NCT01474486|26630747|P1|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
7655219|NCT01474486|26630747|P1|Overall Study|Withdrawal by Subject|4
7655220|NCT01474486|26630747|P1|Overall Study|Death|2
7655221|NCT01474434|26630762|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7655222|NCT01474434|26630763|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7655223|NCT01474434|26630764|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7655224|NCT01474434|26630765|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
7655225|NCT01474434|26630762|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
7655226|NCT01474434|26630763|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7655227|NCT01474434|26630764|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7655228|NCT01474434|26630765|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7655229|NCT01474434|26630762|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7655230|NCT01474434|26630763|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7655231|NCT01474434|26630764|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7655232|NCT01474434|26630765|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7655233|NCT01474317|26630807|P1|Overall Study|Subject ineligible for study|1
7655234|NCT01474317|26630807|P1|Overall Study|Adverse Event|1
7655235|NCT01474291|26630816|P1|Overall Study|Death|2
7655236|NCT01474291|26630816|P1|Overall Study|No Reason Reported|10
7655237|NCT01474291|26630816|P1|Overall Study|Patient No Longer Wanted to Participate|12
7655238|NCT01474291|26630816|P1|Overall Study|Lost to Follow-up|29
7655239|NCT01474291|26630816|P1|Overall Study|Adverse Event|53
7655240|NCT01474291|26630816|P1|Overall Study|Lack of Treatment Efficacy|88
7655241|NCT01474291|26630816|P1|Overall Study|Not Evaluable for Efficacy|26
7655242|NCT01474239|26630860|P2|Overall Study|Withdrawal for Economic Reason|0
7655243|NCT01474239|26630861|P1|Overall Study|Withdrawal for Economic Reason|1
7655244|NCT01474239|26630860|P2|Overall Study|Clinical Disease Progression|1
7655245|NCT01474239|26630861|P1|Overall Study|Clinical Disease Progression|7
7655246|NCT01474239|26630860|P2|Overall Study|Death|1
7655247|NCT01474239|26630861|P1|Overall Study|Death|1
7655248|NCT01474239|26630860|P2|Overall Study|Withdrawal by Subject|2
7655249|NCT01474239|26630861|P1|Overall Study|Withdrawal by Subject|1
7655250|NCT01474239|26630860|P2|Overall Study|Adverse Event|3
7655251|NCT01474239|26630861|P1|Overall Study|Adverse Event|12
7655252|NCT01474239|26630860|P2|Overall Study|Disease Progression|25
7655253|NCT01474239|26630861|P1|Overall Study|Disease Progression|37
7655254|NCT01474018|26631033|P2|Overall Study|Withdrawal by Subject|2
7655255|NCT01474018|26631034|P1|Overall Study|Withdrawal by Subject|0
7655256|NCT01474018|26631033|P2|Overall Study|Lost to Follow-up|1
7655257|NCT01474018|26631034|P1|Overall Study|Lost to Follow-up|0
7655258|NCT01473953|26631066|P5|Overall Study|Other|0
7655259|NCT01473953|26631067|P4|Overall Study|Other|0
7655260|NCT01473953|26631068|P3|Overall Study|Other|0
7655261|NCT01473953|26631069|P2|Overall Study|Other|0
7655262|NCT01473953|26631070|P1|Overall Study|Other|1
7655263|NCT01473940|26631116|P4|Maintenance Therapy|Progressive Disease|4
7655264|NCT01473940|26631117|P3|Maintenance Therapy|Progressive Disease|1
7655265|NCT01473940|26631118|P2|Maintenance Therapy|Progressive Disease|2
7655266|NCT01473940|26631119|P1|Maintenance Therapy|Progressive Disease|1
7655267|NCT01473940|26631116|P4|Induction Therapy|Progressive Disease|0
7655268|NCT01473940|26631117|P3|Induction Therapy|Progressive Disease|1
7655269|NCT01473940|26631118|P2|Induction Therapy|Progressive Disease|1
7655270|NCT01473940|26631119|P1|Induction Therapy|Progressive Disease|0
7655271|NCT01473940|26631116|P4|Induction Therapy|Death|1
7655272|NCT01473940|26631117|P3|Induction Therapy|Death|1
7655273|NCT01473940|26631118|P2|Induction Therapy|Death|0
7655274|NCT01473940|26631119|P1|Induction Therapy|Death|0
7655275|NCT01473836|26631149|P1|Overall Study|Does not meet entrance criteria|1
7655276|NCT01473836|26631149|P1|Overall Study|Lack of Efficacy|1
7655277|NCT01473836|26631149|P1|Overall Study|Adverse Event|4
7655278|NCT01473758|26631160|P4|Cycle 2|Adverse Event|0
7655279|NCT01473758|26631161|P3|Cycle 2|Adverse Event|5
7655280|NCT01473758|26631162|P2|Cycle 2|Adverse Event|0
7655281|NCT01473758|26631163|P1|Cycle 2|Adverse Event|0
7655282|NCT01473758|26631160|P4|Cycle 1|Withdrawal by Subject|0
7655283|NCT01473758|26631161|P3|Cycle 1|Withdrawal by Subject|0
7655284|NCT01473758|26631162|P2|Cycle 1|Withdrawal by Subject|1
7655285|NCT01473758|26631163|P1|Cycle 1|Withdrawal by Subject|1
7655286|NCT01473758|26631160|P4|Cycle 1|Adverse Event|0
7655287|NCT01473758|26631161|P3|Cycle 1|Adverse Event|0
7655288|NCT01473758|26631162|P2|Cycle 1|Adverse Event|2
7655289|NCT01473758|26631163|P1|Cycle 1|Adverse Event|10
7655290|NCT01473732|26631300|P2|Overall Study|Death|0
7655291|NCT01473732|26631301|P1|Overall Study|Death|1
7655292|NCT01473732|26631300|P2|Overall Study|Adverse Event|0
7655293|NCT01473732|26631301|P1|Overall Study|Adverse Event|1
7655294|NCT01473602|26631309|P2|Overall Study|Physician Decision|0
7655295|NCT01473602|26631310|P1|Overall Study|Physician Decision|1
7655296|NCT01473602|26631309|P2|Overall Study|Withdrawal by Subject|4
7655297|NCT01473602|26631310|P1|Overall Study|Withdrawal by Subject|5
7655298|NCT01473602|26631309|P2|Overall Study|Lost to Follow-up|1
7655299|NCT01473602|26631310|P1|Overall Study|Lost to Follow-up|1
7655300|NCT01473602|26631309|P2|Overall Study|Death|1
7655301|NCT01473602|26631310|P1|Overall Study|Death|0
7655302|NCT01473602|26631309|P2|Overall Study|Adverse Event|2
7655303|NCT01473602|26631310|P1|Overall Study|Adverse Event|1
7655304|NCT01473589|26631346|P2|Overall Study|Entry criteria not met|1
7655305|NCT01473589|26631347|P1|Overall Study|Entry criteria not met|0
7655306|NCT01473589|26631346|P2|Overall Study|Physician Decision|1
7655307|NCT01473589|26631347|P1|Overall Study|Physician Decision|0
7655308|NCT01473589|26631346|P2|Overall Study|Withdrawal by Subject|11
7655309|NCT01473589|26631347|P1|Overall Study|Withdrawal by Subject|5
7655310|NCT01473589|26631346|P2|Overall Study|Protocol Violation|0
7655311|NCT01473589|26631347|P1|Overall Study|Protocol Violation|1
7655312|NCT01473589|26631346|P2|Overall Study|Lost to Follow-up|2
7655313|NCT01473589|26631347|P1|Overall Study|Lost to Follow-up|2
7655314|NCT01473589|26631346|P2|Overall Study|Death|0
7655315|NCT01473589|26631347|P1|Overall Study|Death|2
7655316|NCT01473589|26631346|P2|Overall Study|Adverse Event|1
7655317|NCT01473589|26631347|P1|Overall Study|Adverse Event|1
7655318|NCT01473563|26631381|P1|Overall Study|Lost to FU post tx discontinuation|1
7655319|NCT01473524|26631403|P6|LTSE Phase|Protocol Violation|1
7655320|NCT01473524|26631404|P5|LTSE Phase|Protocol Violation|0
7655321|NCT01473524|26631405|P4|LTSE Phase|Protocol Violation|0
7655322|NCT01473524|26631406|P3|LTSE Phase|Protocol Violation|0
7655323|NCT01473524|26631407|P2|LTSE Phase|Protocol Violation|0
7655324|NCT01473524|26631408|P1|LTSE Phase|Protocol Violation|0
7655325|NCT01473524|26631403|P6|LTSE Phase|Pregnancy|0
7655326|NCT01473524|26631404|P5|LTSE Phase|Pregnancy|0
7655327|NCT01473524|26631405|P4|LTSE Phase|Pregnancy|1
7655328|NCT01473524|26631406|P3|LTSE Phase|Pregnancy|0
7655329|NCT01473524|26631407|P2|LTSE Phase|Pregnancy|0
7655330|NCT01473524|26631408|P1|LTSE Phase|Pregnancy|0
7655331|NCT01473524|26631403|P6|LTSE Phase|Liver Transplantation|1
7655332|NCT01473524|26631404|P5|LTSE Phase|Liver Transplantation|0
7655333|NCT01473524|26631405|P4|LTSE Phase|Liver Transplantation|0
7655334|NCT01473524|26631406|P3|LTSE Phase|Liver Transplantation|0
7655335|NCT01473524|26631407|P2|LTSE Phase|Liver Transplantation|0
7655336|NCT01473524|26631408|P1|LTSE Phase|Liver Transplantation|0
7655337|NCT01473524|26631403|P6|LTSE Phase|Principal Investigator Decision|3
7655338|NCT01473524|26631404|P5|LTSE Phase|Principal Investigator Decision|1
7655339|NCT01473524|26631405|P4|LTSE Phase|Principal Investigator Decision|1
7655340|NCT01473524|26631406|P3|LTSE Phase|Principal Investigator Decision|0
7655341|NCT01473524|26631407|P2|LTSE Phase|Principal Investigator Decision|0
7655342|NCT01473524|26631408|P1|LTSE Phase|Principal Investigator Decision|0
7655343|NCT01473524|26631403|P6|LTSE Phase|Lost to Follow-up|2
7655344|NCT01473524|26631404|P5|LTSE Phase|Lost to Follow-up|3
7655345|NCT01473524|26631405|P4|LTSE Phase|Lost to Follow-up|1
7655346|NCT01473524|26631406|P3|LTSE Phase|Lost to Follow-up|0
7655347|NCT01473524|26631407|P2|LTSE Phase|Lost to Follow-up|0
7655348|NCT01473524|26631408|P1|LTSE Phase|Lost to Follow-up|0
7655349|NCT01473524|26631403|P6|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
7655350|NCT01473524|26631404|P5|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
7655351|NCT01473524|26631405|P4|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
7655352|NCT01473524|26631406|P3|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7655353|NCT01473524|26631407|P2|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7655354|NCT01473524|26631408|P1|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7655355|NCT01473524|26631403|P6|LTSE Phase|Adverse Event of Pruritus|2
7655356|NCT01473524|26631404|P5|LTSE Phase|Adverse Event of Pruritus|5
7655357|NCT01473524|26631405|P4|LTSE Phase|Adverse Event of Pruritus|1
7655358|NCT01473524|26631406|P3|LTSE Phase|Adverse Event of Pruritus|0
7655359|NCT01473524|26631407|P2|LTSE Phase|Adverse Event of Pruritus|0
7655360|NCT01473524|26631408|P1|LTSE Phase|Adverse Event of Pruritus|0
7655361|NCT01473524|26631403|P6|LTSE Phase|Death|0
7655362|NCT01473524|26631404|P5|LTSE Phase|Death|1
7655363|NCT01473524|26631405|P4|LTSE Phase|Death|0
7655364|NCT01473524|26631406|P3|LTSE Phase|Death|0
7655365|NCT01473524|26631407|P2|LTSE Phase|Death|0
7655366|NCT01473524|26631408|P1|LTSE Phase|Death|0
7655367|NCT01473524|26631403|P6|LTSE Phase|Withdrawal by Subject|6
7655368|NCT01473524|26631404|P5|LTSE Phase|Withdrawal by Subject|3
7655369|NCT01473524|26631405|P4|LTSE Phase|Withdrawal by Subject|3
7655370|NCT01473524|26631406|P3|LTSE Phase|Withdrawal by Subject|0
7655371|NCT01473524|26631407|P2|LTSE Phase|Withdrawal by Subject|0
7655372|NCT01473524|26631408|P1|LTSE Phase|Withdrawal by Subject|0
7655373|NCT01473524|26631403|P6|DB Phase|Withdrawal by Subject|0
7655374|NCT01473524|26631404|P5|DB Phase|Withdrawal by Subject|0
7655375|NCT01473524|26631405|P4|DB Phase|Withdrawal by Subject|0
7655376|NCT01473524|26631406|P3|DB Phase|Withdrawal by Subject|1
7655377|NCT01473524|26631407|P2|DB Phase|Withdrawal by Subject|1
7655378|NCT01473524|26631408|P1|DB Phase|Withdrawal by Subject|2
7655379|NCT01473524|26631403|P6|DB Phase|Death|0
7655380|NCT01473524|26631404|P5|DB Phase|Death|0
7655381|NCT01473524|26631405|P4|DB Phase|Death|0
7655382|NCT01473524|26631406|P3|DB Phase|Death|0
7655383|NCT01473524|26631407|P2|DB Phase|Death|0
7655384|NCT01473524|26631408|P1|DB Phase|Death|1
7655385|NCT01473524|26631403|P6|DB Phase|Adverse Event|0
7655386|NCT01473524|26631404|P5|DB Phase|Adverse Event|0
7655387|NCT01473524|26631405|P4|DB Phase|Adverse Event|0
7655388|NCT01473524|26631406|P3|DB Phase|Adverse Event|2
7655389|NCT01473524|26631407|P2|DB Phase|Adverse Event|8
7655390|NCT01473524|26631408|P1|DB Phase|Adverse Event|4
7655391|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
7655392|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
7655393|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
7655394|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
7655395|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
7655396|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
7655397|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
7655398|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
7655399|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Site closure|1
7655400|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Site closure|3
7655401|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
7655402|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
7655403|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
7655404|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
7655405|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
7655406|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
7655407|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
7655408|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
7655409|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Physician Decision|2
7655410|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Physician Decision|1
7655411|NCT01473420|26631457|P2|Maintenance Period (16 Weeks)|Adverse Event|2
7655412|NCT01473420|26631458|P1|Maintenance Period (16 Weeks)|Adverse Event|3
7655413|NCT01473420|26631457|P2|Titration Period (18 Weeks)|Did not meet criteria|32
7655414|NCT01473420|26631458|P1|Titration Period (18 Weeks)|Did not meet criteria|32
7655415|NCT01473420|26631457|P2|Titration Period (18 Weeks)|Adverse Event|6
7655416|NCT01473420|26631458|P1|Titration Period (18 Weeks)|Adverse Event|4
7655417|NCT01473407|26631542|P2|Overall Study|Site Closure|0
7655418|NCT01473407|26631543|P1|Overall Study|Site Closure|1
7655419|NCT01473407|26631542|P2|Overall Study|Sponsor's Decision|10
7655420|NCT01473407|26631543|P1|Overall Study|Sponsor's Decision|10
7655421|NCT01473407|26631542|P2|Overall Study|Transfer to Another Facility/Unit|3
7655422|NCT01473407|26631543|P1|Overall Study|Transfer to Another Facility/Unit|4
7655423|NCT01473407|26631542|P2|Overall Study|Temperature Excursion|3
7655424|NCT01473407|26631543|P1|Overall Study|Temperature Excursion|2
7655425|NCT01473407|26631542|P2|Overall Study|Patient Lost Green Card Status|0
7655426|NCT01473407|26631543|P1|Overall Study|Patient Lost Green Card Status|1
7655427|NCT01473407|26631542|P2|Overall Study|Patient Received Aranesp|0
7655428|NCT01473407|26631543|P1|Overall Study|Patient Received Aranesp|1
7655429|NCT01473407|26631542|P2|Overall Study|Elevated Hemoglobin|0
7655430|NCT01473407|26631543|P1|Overall Study|Elevated Hemoglobin|1
7655431|NCT01473407|26631542|P2|Overall Study|Vacation/Travel|1
7655432|NCT01473407|26631543|P1|Overall Study|Vacation/Travel|1
7655433|NCT01473407|26631542|P2|Overall Study|Kidney Transplant|6
7655434|NCT01473407|26631543|P1|Overall Study|Kidney Transplant|7
7655435|NCT01473407|26631542|P2|Overall Study|Withdrawal by Subject|7
7655436|NCT01473407|26631543|P1|Overall Study|Withdrawal by Subject|4
7655437|NCT01473407|26631542|P2|Overall Study|Randomization Error|1
7655438|NCT01473407|26631543|P1|Overall Study|Randomization Error|3
7655439|NCT01473407|26631542|P2|Overall Study|Adverse Event|8
7655440|NCT01473407|26631543|P1|Overall Study|Adverse Event|8
7655441|NCT01473407|26631542|P2|Overall Study|Lost to Follow-up|4
7655442|NCT01473407|26631543|P1|Overall Study|Lost to Follow-up|10
7655443|NCT01473407|26631542|P2|Overall Study|Physician Decision|4
7655444|NCT01473407|26631543|P1|Overall Study|Physician Decision|1
7655445|NCT01473394|26631597|P2|Overall Study|Lost to Follow-up|11
7655446|NCT01473394|26631598|P1|Overall Study|Lost to Follow-up|9
7655447|NCT01473394|26631597|P2|Overall Study|Withdrew Consent|10
7655448|NCT01473394|26631598|P1|Overall Study|Withdrew Consent|12
7655449|NCT01473394|26631597|P2|Overall Study|Protocol Violation|5
7655450|NCT01473394|26631598|P1|Overall Study|Protocol Violation|7
7655451|NCT01473394|26631597|P2|Overall Study|Insufficient Therapeutic Response|1
7655452|NCT01473394|26631598|P1|Overall Study|Insufficient Therapeutic Response|4
7655453|NCT01473394|26631597|P2|Overall Study|Adverse Event|16
7655454|NCT01473394|26631598|P1|Overall Study|Adverse Event|13
7655455|NCT01473381|26631612|P4|Overall Study|Other Reasons|3
7655456|NCT01473381|26631613|P3|Overall Study|Other Reasons|1
7655457|NCT01473381|26631614|P2|Overall Study|Other Reasons|0
7655458|NCT01473381|26631615|P1|Overall Study|Other Reasons|0
7655459|NCT01473381|26631612|P4|Overall Study|Lost to Follow-up|23
7655460|NCT01473381|26631613|P3|Overall Study|Lost to Follow-up|35
7655461|NCT01473381|26631614|P2|Overall Study|Lost to Follow-up|28
7655462|NCT01473381|26631615|P1|Overall Study|Lost to Follow-up|25
7655463|NCT01473381|26631612|P4|Overall Study|Withdrawal of Consent|26
7655464|NCT01473381|26631613|P3|Overall Study|Withdrawal of Consent|20
7655465|NCT01473381|26631614|P2|Overall Study|Withdrawal of Consent|21
7655466|NCT01473381|26631615|P1|Overall Study|Withdrawal of Consent|20
7655467|NCT01473381|26631612|P4|Overall Study|Protocol Violation|17
7655468|NCT01473381|26631613|P3|Overall Study|Protocol Violation|19
7655469|NCT01473381|26631614|P2|Overall Study|Protocol Violation|23
7655470|NCT01473381|26631615|P1|Overall Study|Protocol Violation|17
7655471|NCT01473381|26631612|P4|Overall Study|Insufficient Therapeutic Response|3
7655472|NCT01473381|26631613|P3|Overall Study|Insufficient Therapeutic Response|2
7655473|NCT01473381|26631614|P2|Overall Study|Insufficient Therapeutic Response|1
7655474|NCT01473381|26631615|P1|Overall Study|Insufficient Therapeutic Response|10
7655475|NCT01473381|26631612|P4|Overall Study|Adverse Event|17
7655476|NCT01473381|26631613|P3|Overall Study|Adverse Event|25
7655477|NCT01473381|26631614|P2|Overall Study|Adverse Event|20
7655478|NCT01473381|26631615|P1|Overall Study|Adverse Event|8
7655479|NCT01473355|26631677|P1|Overall Study|Lost to Follow-up|2
7655480|NCT01473355|26631677|P1|Overall Study|Adverse Event|2
7655481|NCT01473355|26631677|P1|Overall Study|Protocol Violation|2
7655482|NCT01472965|26631706|P2|Overall Study|Withdrawal by Subject|0
7655483|NCT01472965|26631707|P1|Overall Study|Withdrawal by Subject|1
7655484|NCT01472939|26631727|P4|Overall Study|Withdrawal by Subject|4
7655485|NCT01472939|26631728|P3|Overall Study|Withdrawal by Subject|1
7655486|NCT01472939|26631729|P2|Overall Study|Withdrawal by Subject|3
7655487|NCT01472939|26631730|P1|Overall Study|Withdrawal by Subject|9
7655488|NCT01472939|26631727|P4|Overall Study|Protocol Violation|1
7655489|NCT01472939|26631728|P3|Overall Study|Protocol Violation|0
7655490|NCT01472939|26631729|P2|Overall Study|Protocol Violation|3
7655491|NCT01472939|26631730|P1|Overall Study|Protocol Violation|3
7655492|NCT01472939|26631727|P4|Overall Study|Withdrawal By PI|0
7655493|NCT01472939|26631728|P3|Overall Study|Withdrawal By PI|0
7655494|NCT01472939|26631729|P2|Overall Study|Withdrawal By PI|0
7655495|NCT01472939|26631730|P1|Overall Study|Withdrawal By PI|1
7655496|NCT01472939|26631727|P4|Overall Study|Prohibited Medication|0
7655497|NCT01472939|26631728|P3|Overall Study|Prohibited Medication|0
7655498|NCT01472939|26631729|P2|Overall Study|Prohibited Medication|1
7655499|NCT01472939|26631730|P1|Overall Study|Prohibited Medication|0
7655500|NCT01472939|26631727|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
7655501|NCT01472939|26631728|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
7655502|NCT01472939|26631729|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
7655503|NCT01472939|26631730|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
7655504|NCT01472939|26631727|P4|Overall Study|Lost to Follow-up|0
7655505|NCT01472939|26631728|P3|Overall Study|Lost to Follow-up|2
7655506|NCT01472939|26631729|P2|Overall Study|Lost to Follow-up|0
7655507|NCT01472939|26631730|P1|Overall Study|Lost to Follow-up|3
7655508|NCT01472939|26631727|P4|Overall Study|Lack of Efficacy|1
7655509|NCT01472939|26631728|P3|Overall Study|Lack of Efficacy|0
7655510|NCT01472939|26631729|P2|Overall Study|Lack of Efficacy|0
7655511|NCT01472939|26631730|P1|Overall Study|Lack of Efficacy|1
7655512|NCT01472939|26631727|P4|Overall Study|Adverse Event|14
7655513|NCT01472939|26631728|P3|Overall Study|Adverse Event|7
7655514|NCT01472939|26631729|P2|Overall Study|Adverse Event|7
7655515|NCT01472939|26631730|P1|Overall Study|Adverse Event|3
7655516|NCT01472835|26631774|P2|Overall Study|Lost to Follow-up|0
7655517|NCT01472835|26631775|P1|Overall Study|Lost to Follow-up|2
7655518|NCT01472757|26631810|P4|Overall Study|Other reasons|2
7655519|NCT01472757|26631811|P3|Overall Study|Other reasons|2
7655520|NCT01472757|26631812|P2|Overall Study|Other reasons|0
7655521|NCT01472757|26631813|P1|Overall Study|Other reasons|1
7655522|NCT01472757|26631810|P4|Overall Study|Protocol Violation|4
7655523|NCT01472757|26631811|P3|Overall Study|Protocol Violation|4
7655524|NCT01472757|26631812|P2|Overall Study|Protocol Violation|2
7655525|NCT01472757|26631813|P1|Overall Study|Protocol Violation|3
7655526|NCT01472757|26631810|P4|Overall Study|Treatment period withdrawal criteria met|12
7655527|NCT01472757|26631811|P3|Overall Study|Treatment period withdrawal criteria met|9
7655528|NCT01472757|26631812|P2|Overall Study|Treatment period withdrawal criteria met|8
7655529|NCT01472757|26631813|P1|Overall Study|Treatment period withdrawal criteria met|21
7655530|NCT01472757|26631810|P4|Overall Study|Asthma exacerbation|1
7655531|NCT01472757|26631811|P3|Overall Study|Asthma exacerbation|2
7655532|NCT01472757|26631812|P2|Overall Study|Asthma exacerbation|1
7655533|NCT01472757|26631813|P1|Overall Study|Asthma exacerbation|4
7655534|NCT01472757|26631810|P4|Overall Study|Withdrawal by Subject|0
7655535|NCT01472757|26631811|P3|Overall Study|Withdrawal by Subject|2
7655536|NCT01472757|26631812|P2|Overall Study|Withdrawal by Subject|2
7655537|NCT01472757|26631813|P1|Overall Study|Withdrawal by Subject|1
7655538|NCT01472380|26631928|P1|1 Day Period Between Dosing|Protocol Violation|1
7655539|NCT01472380|26631928|P1|Efavirenz Alone|Withdrawal by Subject|1
7655540|NCT01472341|26631939|P1|Overall Study|Death|9
7655541|NCT01472341|26631939|P1|Overall Study|Laboratory parameters unavailable|25
7655542|NCT01472341|26631939|P1|Overall Study|Lost to Follow-up|52
7655543|NCT01472341|26631939|P1|Overall Study|Withdrawal by Subject|39
7655544|NCT01472341|26631939|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
7655545|NCT01472341|26631939|P1|Overall Study|Started insulin therapy|55
7655546|NCT01472289|26631945|P1|Overall Study|Death|2
7655547|NCT01472185|26631957|P2|Overall Study|Subject Withdrew Consent|3
7655548|NCT01472185|26631958|P1|Overall Study|Subject Withdrew Consent|6
7655549|NCT01472185|26631957|P2|Overall Study|Subject Noncompliance|15
7655550|NCT01472185|26631958|P1|Overall Study|Subject Noncompliance|8
7655551|NCT01472185|26631957|P2|Overall Study|Protocol Violation|1
7655552|NCT01472185|26631958|P1|Overall Study|Protocol Violation|5
7655553|NCT01472185|26631957|P2|Overall Study|Lost to Follow-up|1
7655554|NCT01472185|26631958|P1|Overall Study|Lost to Follow-up|4
7655555|NCT01472185|26631957|P2|Overall Study|Investigator's Discretion|1
7655556|NCT01472185|26631958|P1|Overall Study|Investigator's Discretion|3
7655557|NCT01472185|26631957|P2|Overall Study|Hyperglycemia|2
7655558|NCT01472185|26631958|P1|Overall Study|Hyperglycemia|5
7655559|NCT01472185|26631957|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
7655560|NCT01472185|26631958|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
7655561|NCT01472185|26631957|P2|Overall Study|Randomized but Not Treated|1
7655562|NCT01472185|26631958|P1|Overall Study|Randomized but Not Treated|0
7655563|NCT01472081|26631978|P6|Overall Study|Subject request to discontinue treatment|0
7655564|NCT01472081|26631979|P5|Overall Study|Subject request to discontinue treatment|0
7655565|NCT01472081|26631980|P4|Overall Study|Subject request to discontinue treatment|1
7655566|NCT01472081|26631981|P3|Overall Study|Subject request to discontinue treatment|1
7655567|NCT01472081|26631982|P2|Overall Study|Subject request to discontinue treatment|3
7655568|NCT01472081|26631983|P1|Overall Study|Subject request to discontinue treatment|0
7655569|NCT01472081|26631978|P6|Overall Study|No longer meets study criteria|0
7655570|NCT01472081|26631979|P5|Overall Study|No longer meets study criteria|0
7655571|NCT01472081|26631980|P4|Overall Study|No longer meets study criteria|0
7655572|NCT01472081|26631981|P3|Overall Study|No longer meets study criteria|1
7655573|NCT01472081|26631982|P2|Overall Study|No longer meets study criteria|0
7655574|NCT01472081|26631983|P1|Overall Study|No longer meets study criteria|0
7655575|NCT01472081|26631978|P6|Overall Study|Poor/non-compliance|0
7655576|NCT01472081|26631979|P5|Overall Study|Poor/non-compliance|1
7655577|NCT01472081|26631980|P4|Overall Study|Poor/non-compliance|0
7655578|NCT01472081|26631981|P3|Overall Study|Poor/non-compliance|1
7655579|NCT01472081|26631982|P2|Overall Study|Poor/non-compliance|0
7655580|NCT01472081|26631983|P1|Overall Study|Poor/non-compliance|0
7655581|NCT01472081|26631978|P6|Overall Study|Withdrawal by Subject|1
7655582|NCT01472081|26631979|P5|Overall Study|Withdrawal by Subject|0
7655583|NCT01472081|26631980|P4|Overall Study|Withdrawal by Subject|0
7655584|NCT01472081|26631981|P3|Overall Study|Withdrawal by Subject|0
7655585|NCT01472081|26631982|P2|Overall Study|Withdrawal by Subject|0
7655586|NCT01472081|26631983|P1|Overall Study|Withdrawal by Subject|0
7655587|NCT01472081|26631978|P6|Overall Study|Adverse Event unrelated to study drug|0
7655588|NCT01472081|26631979|P5|Overall Study|Adverse Event unrelated to study drug|1
7655589|NCT01472081|26631980|P4|Overall Study|Adverse Event unrelated to study drug|0
7655590|NCT01472081|26631981|P3|Overall Study|Adverse Event unrelated to study drug|0
7655591|NCT01472081|26631982|P2|Overall Study|Adverse Event unrelated to study drug|0
7655592|NCT01472081|26631983|P1|Overall Study|Adverse Event unrelated to study drug|0
7655593|NCT01472081|26631978|P6|Overall Study|Death|0
7655594|NCT01472081|26631979|P5|Overall Study|Death|1
7655595|NCT01472081|26631980|P4|Overall Study|Death|0
7655596|NCT01472081|26631981|P3|Overall Study|Death|0
7655597|NCT01472081|26631982|P2|Overall Study|Death|0
7655598|NCT01472081|26631983|P1|Overall Study|Death|0
7655599|NCT01472081|26631978|P6|Overall Study|Study drug toxicity|2
7655600|NCT01472081|26631979|P5|Overall Study|Study drug toxicity|13
7655601|NCT01472081|26631980|P4|Overall Study|Study drug toxicity|6
7655602|NCT01472081|26631981|P3|Overall Study|Study drug toxicity|4
7655603|NCT01472081|26631982|P2|Overall Study|Study drug toxicity|9
7655604|NCT01472081|26631983|P1|Overall Study|Study drug toxicity|2
7655605|NCT01472081|26631978|P6|Overall Study|Disease Progression|3
7655606|NCT01472081|26631979|P5|Overall Study|Disease Progression|22
7655607|NCT01472081|26631980|P4|Overall Study|Disease Progression|31
7655608|NCT01472081|26631981|P3|Overall Study|Disease Progression|12
7655609|NCT01472081|26631982|P2|Overall Study|Disease Progression|10
7655610|NCT01472081|26631983|P1|Overall Study|Disease Progression|4
7655611|NCT01472081|26631978|P6|Overall Study|Continuing treatment at time of analysis|0
7655612|NCT01472081|26631979|P5|Overall Study|Continuing treatment at time of analysis|9
7655613|NCT01472081|26631980|P4|Overall Study|Continuing treatment at time of analysis|8
7655614|NCT01472081|26631981|P3|Overall Study|Continuing treatment at time of analysis|1
7655615|NCT01472081|26631982|P2|Overall Study|Continuing treatment at time of analysis|4
7655616|NCT01472081|26631983|P1|Overall Study|Continuing treatment at time of analysis|1
7655617|NCT01471782|26632032|P6|Overall Study|Death|1
7655618|NCT01471782|26632033|P5|Overall Study|Death|0
7655619|NCT01471782|26632034|P4|Overall Study|Death|0
7655620|NCT01471782|26632035|P3|Overall Study|Death|0
7655621|NCT01471782|26632036|P2|Overall Study|Death|0
7655622|NCT01471782|26632037|P1|Overall Study|Death|0
7655623|NCT01471782|26632032|P6|Overall Study|Withdrawal by Parent/Guardian|0
7655624|NCT01471782|26632033|P5|Overall Study|Withdrawal by Parent/Guardian|1
7655625|NCT01471782|26632034|P4|Overall Study|Withdrawal by Parent/Guardian|0
7655626|NCT01471782|26632035|P3|Overall Study|Withdrawal by Parent/Guardian|0
7655627|NCT01471782|26632036|P2|Overall Study|Withdrawal by Parent/Guardian|0
7655628|NCT01471782|26632037|P1|Overall Study|Withdrawal by Parent/Guardian|0
7655629|NCT01471782|26632032|P6|Overall Study|Physician Decision|8
7655630|NCT01471782|26632033|P5|Overall Study|Physician Decision|3
7655631|NCT01471782|26632034|P4|Overall Study|Physician Decision|0
7655632|NCT01471782|26632035|P3|Overall Study|Physician Decision|0
7655633|NCT01471782|26632036|P2|Overall Study|Physician Decision|0
7655634|NCT01471782|26632037|P1|Overall Study|Physician Decision|0
7655635|NCT01471782|26632032|P6|Overall Study|Disease Relapse|1
7655636|NCT01471782|26632033|P5|Overall Study|Disease Relapse|2
7655637|NCT01471782|26632034|P4|Overall Study|Disease Relapse|1
7655638|NCT01471782|26632035|P3|Overall Study|Disease Relapse|0
7655639|NCT01471782|26632036|P2|Overall Study|Disease Relapse|0
7655640|NCT01471782|26632037|P1|Overall Study|Disease Relapse|0
7655641|NCT01471782|26632032|P6|Overall Study|Change of Chemotherapy|4
7655642|NCT01471782|26632033|P5|Overall Study|Change of Chemotherapy|1
7655643|NCT01471782|26632034|P4|Overall Study|Change of Chemotherapy|0
7655644|NCT01471782|26632035|P3|Overall Study|Change of Chemotherapy|0
7655645|NCT01471782|26632036|P2|Overall Study|Change of Chemotherapy|1
7655646|NCT01471782|26632037|P1|Overall Study|Change of Chemotherapy|1
7655647|NCT01471782|26632032|P6|Overall Study|Other|5
7655648|NCT01471782|26632033|P5|Overall Study|Other|6
7655649|NCT01471782|26632034|P4|Overall Study|Other|1
7655650|NCT01471782|26632035|P3|Overall Study|Other|1
7655651|NCT01471782|26632036|P2|Overall Study|Other|0
7655652|NCT01471782|26632037|P1|Overall Study|Other|0
7655653|NCT01471782|26632032|P6|Overall Study|Adverse Event|1
7655654|NCT01471782|26632033|P5|Overall Study|Adverse Event|3
7655655|NCT01471782|26632034|P4|Overall Study|Adverse Event|2
7655656|NCT01471782|26632035|P3|Overall Study|Adverse Event|2
7655657|NCT01471782|26632036|P2|Overall Study|Adverse Event|1
7655658|NCT01471782|26632037|P1|Overall Study|Adverse Event|1
7655659|NCT01471782|26632032|P6|Overall Study|Lack of Efficacy|18
7655660|NCT01471782|26632033|P5|Overall Study|Lack of Efficacy|5
7655661|NCT01471782|26632034|P4|Overall Study|Lack of Efficacy|1
7655662|NCT01471782|26632035|P3|Overall Study|Lack of Efficacy|1
7655663|NCT01471782|26632036|P2|Overall Study|Lack of Efficacy|2
7655664|NCT01471782|26632037|P1|Overall Study|Lack of Efficacy|1
7655665|NCT01471782|26632032|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
7655666|NCT01471782|26632033|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
7655667|NCT01471782|26632034|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
7655668|NCT01471782|26632035|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
7655669|NCT01471782|26632036|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
7655670|NCT01471782|26632037|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
7655671|NCT01471691|26632091|P2|Overall Study|Lack of Efficacy|1
7655672|NCT01471691|26632092|P1|Overall Study|Lack of Efficacy|0
7655673|NCT01471379|26632101|P3|Overall Study|Study terminated|0
7655674|NCT01471379|26632102|P2|Overall Study|Study terminated|1
7655675|NCT01471379|26632103|P1|Overall Study|Study terminated|0
7655676|NCT01471379|26632101|P3|Overall Study|Adverse Event|0
7655677|NCT01471379|26632102|P2|Overall Study|Adverse Event|0
7655678|NCT01471379|26632103|P1|Overall Study|Adverse Event|1
7655679|NCT01471353|26632123|P1|Overall Study|remain on study|3
7655680|NCT01471340|26632134|P2|Overall Study|Invalid informed consent|0
7655681|NCT01471340|26632135|P1|Overall Study|Invalid informed consent|1
7655682|NCT01471340|26632134|P2|Overall Study|Investigational site closure|1
7655683|NCT01471340|26632135|P1|Overall Study|Investigational site closure|0
7655684|NCT01471340|26632134|P2|Overall Study|Lost to Follow-up|1
7655685|NCT01471340|26632135|P1|Overall Study|Lost to Follow-up|0
7655686|NCT01471340|26632134|P2|Overall Study|Death|4
7655687|NCT01471340|26632135|P1|Overall Study|Death|5
7655688|NCT01471574|26632158|P4|Follow-up Period|Follow-up no longer required|0
7655689|NCT01471574|26632159|P3|Follow-up Period|Follow-up no longer required|0
7655690|NCT01471574|26632160|P2|Follow-up Period|Follow-up no longer required|1
7655691|NCT01471574|26632161|P1|Follow-up Period|Follow-up no longer required|0
7655692|NCT01471574|26632158|P4|Follow-up Period|Death|0
7655693|NCT01471574|26632159|P3|Follow-up Period|Death|1
7655694|NCT01471574|26632160|P2|Follow-up Period|Death|0
7655695|NCT01471574|26632161|P1|Follow-up Period|Death|0
7655696|NCT01471574|26632158|P4|Follow-up Period|Lost to Follow-up|2
7655697|NCT01471574|26632159|P3|Follow-up Period|Lost to Follow-up|3
7655698|NCT01471574|26632160|P2|Follow-up Period|Lost to Follow-up|1
7655699|NCT01471574|26632161|P1|Follow-up Period|Lost to Follow-up|4
7655700|NCT01471574|26632158|P4|Follow-up Period|Withdrawal by Subject|1
7655701|NCT01471574|26632159|P3|Follow-up Period|Withdrawal by Subject|3
7655702|NCT01471574|26632160|P2|Follow-up Period|Withdrawal by Subject|0
7655703|NCT01471574|26632161|P1|Follow-up Period|Withdrawal by Subject|3
7655704|NCT01471574|26632158|P4|Treatment Period|Other|0
7655705|NCT01471574|26632159|P3|Treatment Period|Other|0
7655706|NCT01471574|26632160|P2|Treatment Period|Other|0
7655707|NCT01471574|26632161|P1|Treatment Period|Other|1
7655708|NCT01471574|26632158|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
7655709|NCT01471574|26632159|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
7655710|NCT01471574|26632160|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
7655711|NCT01471574|26632161|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
7655712|NCT01471574|26632158|P4|Treatment Period|Lost to Follow-up|0
7655713|NCT01471574|26632159|P3|Treatment Period|Lost to Follow-up|2
7655714|NCT01471574|26632160|P2|Treatment Period|Lost to Follow-up|2
7655715|NCT01471574|26632161|P1|Treatment Period|Lost to Follow-up|1
7655716|NCT01471574|26632158|P4|Treatment Period|Patient Requested Discontinue Study drug|1
7655717|NCT01471574|26632159|P3|Treatment Period|Patient Requested Discontinue Study drug|1
7655718|NCT01471574|26632160|P2|Treatment Period|Patient Requested Discontinue Study drug|0
7655719|NCT01471574|26632161|P1|Treatment Period|Patient Requested Discontinue Study drug|4
7655720|NCT01471574|26632158|P4|Treatment Period|Withdrawal by Subject|0
7655721|NCT01471574|26632159|P3|Treatment Period|Withdrawal by Subject|1
7655722|NCT01471574|26632160|P2|Treatment Period|Withdrawal by Subject|1
7655723|NCT01471574|26632161|P1|Treatment Period|Withdrawal by Subject|5
7655724|NCT01471574|26632158|P4|Treatment Period|Adverse Event|1
7655725|NCT01471574|26632159|P3|Treatment Period|Adverse Event|6
7655726|NCT01471574|26632160|P2|Treatment Period|Adverse Event|3
7655727|NCT01471574|26632161|P1|Treatment Period|Adverse Event|7
7655728|NCT01471574|26632158|P4|Treatment Period|Lack of Efficacy|1
7655729|NCT01471574|26632159|P3|Treatment Period|Lack of Efficacy|14
7655730|NCT01471574|26632160|P2|Treatment Period|Lack of Efficacy|4
7655731|NCT01471574|26632161|P1|Treatment Period|Lack of Efficacy|12
7655732|NCT01471522|26632192|P2|Overall Study|Lost to Follow-up|26
7655733|NCT01471522|26632193|P1|Overall Study|Lost to Follow-up|36
7655734|NCT01471522|26632192|P2|Overall Study|Withdrawal by Subject|22
7655735|NCT01471522|26632193|P1|Overall Study|Withdrawal by Subject|28
7655736|NCT01471197|26632230|P2|Overall Study|Study Drug Toxicity|0
7655737|NCT01471197|26632231|P1|Overall Study|Study Drug Toxicity|1
7655738|NCT01471197|26632230|P2|Overall Study|Death|0
7655739|NCT01471197|26632231|P1|Overall Study|Death|1
7655740|NCT01471197|26632230|P2|Overall Study|Disease Progression|2
7655741|NCT01471197|26632231|P1|Overall Study|Disease Progression|4
7655742|NCT01471171|26632241|P2|Treatment Period 2|Adverse Event|0
7655743|NCT01471171|26632242|P1|Treatment Period 2|Adverse Event|1
7655744|NCT01471171|26632241|P2|Treatment Period 1|Adverse Event|1
7655745|NCT01471171|26632242|P1|Treatment Period 1|Adverse Event|4
7655746|NCT01471093|26632254|P4|Overall Study|Adverse Event|0
7655747|NCT01471093|26632255|P3|Overall Study|Adverse Event|0
7655748|NCT01471093|26632256|P2|Overall Study|Adverse Event|0
7655749|NCT01471093|26632257|P1|Overall Study|Adverse Event|1
7655750|NCT01471054|26632267|P2|Overall Study|Study terminated prematurely|0
7655751|NCT01471054|26632268|P1|Overall Study|Study terminated prematurely|4
7655752|NCT01471028|26632291|P2|VTI-208E|Lost to Follow-up|2
7655753|NCT01471028|26632292|P1|VTI-208E|Lost to Follow-up|0
7655754|NCT01471028|26632291|P2|VTI-208E|Withdrawal by Subject|0
7655755|NCT01471028|26632292|P1|VTI-208E|Withdrawal by Subject|1
7655756|NCT01471028|26632291|P2|VTI-208E|Death|10
7655757|NCT01471028|26632292|P1|VTI-208E|Death|7
7655758|NCT01471028|26632291|P2|VTI-208|Lost to Follow-up|1
7655759|NCT01471028|26632292|P1|VTI-208|Lost to Follow-up|1
7655760|NCT01471028|26632291|P2|VTI-208|Withdrawal by Subject|2
7655761|NCT01471028|26632292|P1|VTI-208|Withdrawal by Subject|0
7655762|NCT01471028|26632291|P2|VTI-208|Adverse Event|41
7655763|NCT01471028|26632292|P1|VTI-208|Adverse Event|39
7655764|NCT01471015|26632307|P3|Overall Study|Death|1
7655765|NCT01471015|26632308|P2|Overall Study|Death|1
7655766|NCT01471015|26632309|P1|Overall Study|Death|0
7655767|NCT01470989|26632323|P2|Overall Study|Protocol deviation|2
7655768|NCT01470989|26632324|P1|Overall Study|Protocol deviation|1
7655769|NCT01470989|26632323|P2|Overall Study|Death|2
7655770|NCT01470989|26632324|P1|Overall Study|Death|2
7655771|NCT01470989|26632323|P2|Overall Study|Administrative problems|4
7655772|NCT01470989|26632324|P1|Overall Study|Administrative problems|2
7655773|NCT01470989|26632323|P2|Overall Study|Lost to Follow-up|13
7655774|NCT01470989|26632324|P1|Overall Study|Lost to Follow-up|18
7655775|NCT01470989|26632323|P2|Overall Study|Withdrawal by Subject|17
7655776|NCT01470989|26632324|P1|Overall Study|Withdrawal by Subject|19
7655777|NCT01470989|26632323|P2|Overall Study|Unsatisfactory therapeutic effect|6
7655778|NCT01470989|26632324|P1|Overall Study|Unsatisfactory therapeutic effect|0
7655779|NCT01470989|26632323|P2|Overall Study|Abnormal laboratory value|1
7655780|NCT01470989|26632324|P1|Overall Study|Abnormal laboratory value|1
7655781|NCT01470989|26632323|P2|Overall Study|Adverse Event|5
7655782|NCT01470989|26632324|P1|Overall Study|Adverse Event|2
7655783|NCT01470989|26632323|P2|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
7655784|NCT01470989|26632324|P1|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
7655785|NCT01470612|26632383|P2|Overall Study|Other|156
7655786|NCT01470612|26632384|P1|Overall Study|Other|14
7655787|NCT01470612|26632383|P2|Overall Study|Withdrawal by Subject|79
7655788|NCT01470612|26632384|P1|Overall Study|Withdrawal by Subject|24
7655789|NCT01470612|26632383|P2|Overall Study|Protocol Violation|7
7655790|NCT01470612|26632384|P1|Overall Study|Protocol Violation|2
7655791|NCT01470612|26632383|P2|Overall Study|Pregnancy|10
7655792|NCT01470612|26632384|P1|Overall Study|Pregnancy|2
7655793|NCT01470612|26632383|P2|Overall Study|Did not meet entrance criteria|1
7655794|NCT01470612|26632384|P1|Overall Study|Did not meet entrance criteria|0
7655795|NCT01470612|26632383|P2|Overall Study|Lost to Follow-up|5
7655796|NCT01470612|26632384|P1|Overall Study|Lost to Follow-up|2
7655797|NCT01470612|26632383|P2|Overall Study|Lack of Efficacy|326
7655798|NCT01470612|26632384|P1|Overall Study|Lack of Efficacy|20
7655799|NCT01470612|26632383|P2|Overall Study|Death|1
7655800|NCT01470612|26632384|P1|Overall Study|Death|0
7655801|NCT01470612|26632383|P2|Overall Study|Adverse Event|80
7655802|NCT01470612|26632384|P1|Overall Study|Adverse Event|20
7655803|NCT01470599|26632422|P2|Overall Study|Adverse event not related to study drug|5
7655804|NCT01470599|26632423|P1|Overall Study|Adverse event not related to study drug|1
7655805|NCT01470599|26632422|P2|Overall Study|Insufficient clinical response|27
7655806|NCT01470599|26632423|P1|Overall Study|Insufficient clinical response|6
7655807|NCT01470599|26632422|P2|Overall Study|Adverse event related to study drug|5
7655808|NCT01470599|26632423|P1|Overall Study|Adverse event related to study drug|2
7655809|NCT01470599|26632422|P2|Overall Study|Protocol Violation|1
7655810|NCT01470599|26632423|P1|Overall Study|Protocol Violation|3
7655811|NCT01470599|26632422|P2|Overall Study|Other|0
7655812|NCT01470599|26632423|P1|Overall Study|Other|1
7655813|NCT01470599|26632422|P2|Overall Study|Withdrawal by Subject|4
7655814|NCT01470599|26632423|P1|Overall Study|Withdrawal by Subject|3
7655815|NCT01470599|26632422|P2|Overall Study|Lost to Follow-up|1
7655816|NCT01470599|26632423|P1|Overall Study|Lost to Follow-up|2
7655817|NCT01470599|26632422|P2|Overall Study|Did not meet entrance criteria|0
7655818|NCT01470599|26632423|P1|Overall Study|Did not meet entrance criteria|1
7655819|NCT01470469|26632487|P2|Overall Study|Other|1
7655820|NCT01470469|26632488|P1|Overall Study|Other|2
7655821|NCT01470469|26632487|P2|Overall Study|Protocol Violation|1
7655822|NCT01470469|26632488|P1|Overall Study|Protocol Violation|1
7655823|NCT01470469|26632487|P2|Overall Study|Lost to Follow-up|2
7655824|NCT01470469|26632488|P1|Overall Study|Lost to Follow-up|2
7655825|NCT01470469|26632487|P2|Overall Study|Adverse Event|7
7655826|NCT01470469|26632488|P1|Overall Study|Adverse Event|0
7655827|NCT01470469|26632487|P2|Overall Study|Lack of Efficacy|7
7655828|NCT01470469|26632488|P1|Overall Study|Lack of Efficacy|1
7655829|NCT01470469|26632487|P2|Overall Study|Withdrawal by Subject|6
7655830|NCT01470469|26632488|P1|Overall Study|Withdrawal by Subject|4
7655831|NCT01470417|26632508|P2|Overall Study|Disease progression|2
7655832|NCT01470417|26632509|P1|Overall Study|Disease progression|0
7655833|NCT01470326|26632521|P1|Overall Study|No Visit After 1st Day of Treatment|119
7655834|NCT01470326|26632521|P1|Overall Study|No Drug Administration Information|2
7655835|NCT01470326|26632521|P1|Overall Study|Protocol Violation|32
7655836|NCT01470248|26632532|P1|Overall Study|Withdrawal by Subject|1
7655837|NCT01470144|26632588|P1|Overall Study|Patient's and investigator's decision|1
7655838|NCT01470144|26632588|P1|Overall Study|Lung transplant|6
7655839|NCT01470144|26632588|P1|Overall Study|Death|1
7655840|NCT01470144|26632588|P1|Overall Study|Adverse Event|2
7655841|NCT01470001|26632693|P2|Overall Study|Withdrawal by Subject|1
7655842|NCT01470001|26632694|P1|Overall Study|Withdrawal by Subject|2
7655843|NCT01470001|26632693|P2|Overall Study|Physician Decision|0
7655844|NCT01470001|26632694|P1|Overall Study|Physician Decision|2
7655845|NCT01470001|26632693|P2|Overall Study|Lost to Follow-up|1
7655846|NCT01470001|26632694|P1|Overall Study|Lost to Follow-up|1
7655847|NCT01469819|26632704|P1|Overall Study|Technical malfunction of SmartPill data|3
7655848|NCT01469819|26632704|P1|Overall Study|Could not swallow SmartPill|2
7655849|NCT01469819|26632704|P1|Overall Study|Did not meet inclusionary criteria|2
7655850|NCT01469819|26632704|P1|Overall Study|Withdrawal by Subject|1
7655851|NCT01469637|26632728|P2|Second Intervention|Incarcerated|0
7655852|NCT01469637|26632729|P1|Second Intervention|Incarcerated|1
7655853|NCT01469637|26632728|P2|First Intervention|Unacceptable behavior|1
7655854|NCT01469637|26632729|P1|First Intervention|Unacceptable behavior|0
7655855|NCT01469546|26632748|P1|Received 5 mg Dose|Physician Decision|3
7655856|NCT01469546|26632748|P1|Received 5 mg Dose|Progressive Disease|3
7655857|NCT01469546|26632748|P1|Received 5 mg Dose|Protocol Violation|2
7655858|NCT01469546|26632748|P1|Received 5 mg Dose|Death|2
7655859|NCT01469546|26632748|P1|Received 5 mg Dose|Adverse Event|13
7655860|NCT01469377|26632758|P3|Overall Study|Other Miscellaneous Reasons|0
7655861|NCT01469377|26632759|P2|Overall Study|Other Miscellaneous Reasons|0
7655862|NCT01469377|26632760|P1|Overall Study|Other Miscellaneous Reasons|2
7655863|NCT01469377|26632758|P3|Overall Study|Insufficient Therapeutic Response|0
7655864|NCT01469377|26632759|P2|Overall Study|Insufficient Therapeutic Response|4
7655865|NCT01469377|26632760|P1|Overall Study|Insufficient Therapeutic Response|3
7655866|NCT01469377|26632758|P3|Overall Study|Adverse Event|36
7655867|NCT01469377|26632759|P2|Overall Study|Adverse Event|18
7655868|NCT01469377|26632760|P1|Overall Study|Adverse Event|8
7655869|NCT01469377|26632758|P3|Overall Study|Withdrawal of Consent|15
7655870|NCT01469377|26632759|P2|Overall Study|Withdrawal of Consent|14
7655871|NCT01469377|26632760|P1|Overall Study|Withdrawal of Consent|12
7655872|NCT01469377|26632758|P3|Overall Study|Lost to Follow-up|5
7655873|NCT01469377|26632759|P2|Overall Study|Lost to Follow-up|2
7655874|NCT01469377|26632760|P1|Overall Study|Lost to Follow-up|3
7655875|NCT01469377|26632758|P3|Overall Study|Protocol Deviation|10
7655876|NCT01469377|26632759|P2|Overall Study|Protocol Deviation|10
7655877|NCT01469377|26632760|P1|Overall Study|Protocol Deviation|7
7655878|NCT01469364|26632771|P1|Overall Study|Withdrawal by Subject|1
7655879|NCT01469364|26632771|P1|Overall Study|Adverse Event|1
7655880|NCT01469221|26632822|P3|Double Blind Phase|Sponsor Terminate Study|0
7655881|NCT01469221|26632823|P2|Double Blind Phase|Sponsor Terminate Study|16
7655882|NCT01469221|26632824|P1|Double Blind Phase|Sponsor Terminate Study|12
7655883|NCT01469221|26632822|P3|Double Blind Phase|Physician Decision|0
7655884|NCT01469221|26632823|P2|Double Blind Phase|Physician Decision|1
7655885|NCT01469221|26632824|P1|Double Blind Phase|Physician Decision|1
7655886|NCT01469221|26632822|P3|Double Blind Phase|Protocol Violation|0
7655887|NCT01469221|26632823|P2|Double Blind Phase|Protocol Violation|0
7655888|NCT01469221|26632824|P1|Double Blind Phase|Protocol Violation|1
7655889|NCT01469182|26632835|P2|Overall Study|Did not meet Protocol Eligibility|0
7655890|NCT01469182|26632836|P1|Overall Study|Did not meet Protocol Eligibility|3
7655891|NCT01469182|26632835|P2|Overall Study|Protocol Violation|2
7655892|NCT01469182|26632836|P1|Overall Study|Protocol Violation|4
7655893|NCT01469182|26632835|P2|Overall Study|Withdrawal by Subject|1
7655894|NCT01469182|26632836|P1|Overall Study|Withdrawal by Subject|4
7655895|NCT01469182|26632835|P2|Overall Study|Lost to Follow-up|0
7655896|NCT01469182|26632836|P1|Overall Study|Lost to Follow-up|3
7655897|NCT01469182|26632835|P2|Overall Study|Adverse Event|3
7655898|NCT01469182|26632836|P1|Overall Study|Adverse Event|21
7655899|NCT01469065|26632863|P5|Overall Study|Other|0
7655900|NCT01469065|26632864|P4|Overall Study|Other|0
7655901|NCT01469065|26632865|P3|Overall Study|Other|0
7655902|NCT01469065|26632866|P2|Overall Study|Other|1
7655903|NCT01469065|26632867|P1|Overall Study|Other|0
7655904|NCT01469065|26632863|P5|Overall Study|Lack of Efficacy|1
7655905|NCT01469065|26632864|P4|Overall Study|Lack of Efficacy|0
7655906|NCT01469065|26632865|P3|Overall Study|Lack of Efficacy|0
7655907|NCT01469065|26632866|P2|Overall Study|Lack of Efficacy|0
7655908|NCT01469065|26632867|P1|Overall Study|Lack of Efficacy|0
7655909|NCT01469052|26632963|P6|Overall Study|Other|0
7655910|NCT01469052|26632964|P5|Overall Study|Other|1
7655911|NCT01469052|26632965|P4|Overall Study|Other|0
7655912|NCT01469052|26632966|P3|Overall Study|Other|0
7655913|NCT01469052|26632967|P2|Overall Study|Other|1
7655914|NCT01469052|26632968|P1|Overall Study|Other|0
7655915|NCT01469052|26632963|P6|Overall Study|Moved to rollover protocol|1
7655916|NCT01469052|26632964|P5|Overall Study|Moved to rollover protocol|0
7655917|NCT01469052|26632965|P4|Overall Study|Moved to rollover protocol|0
7655918|NCT01469052|26632966|P3|Overall Study|Moved to rollover protocol|1
7655919|NCT01469052|26632967|P2|Overall Study|Moved to rollover protocol|0
7655920|NCT01469052|26632968|P1|Overall Study|Moved to rollover protocol|1
7655921|NCT01469052|26632963|P6|Overall Study|Lack of Efficacy|2
7655922|NCT01469052|26632964|P5|Overall Study|Lack of Efficacy|0
7655923|NCT01469052|26632965|P4|Overall Study|Lack of Efficacy|0
7655924|NCT01469052|26632966|P3|Overall Study|Lack of Efficacy|0
7655925|NCT01469052|26632967|P2|Overall Study|Lack of Efficacy|0
7655926|NCT01469052|26632968|P1|Overall Study|Lack of Efficacy|0
7655927|NCT01469052|26632963|P6|Overall Study|Progressive disease|2
7655928|NCT01469052|26632964|P5|Overall Study|Progressive disease|7
7655929|NCT01469052|26632965|P4|Overall Study|Progressive disease|3
7655930|NCT01469052|26632966|P3|Overall Study|Progressive disease|5
7655931|NCT01469052|26632967|P2|Overall Study|Progressive disease|0
7655932|NCT01469052|26632968|P1|Overall Study|Progressive disease|3
7655933|NCT01469052|26632963|P6|Overall Study|Adverse Event|1
7655934|NCT01469052|26632964|P5|Overall Study|Adverse Event|0
7655935|NCT01469052|26632965|P4|Overall Study|Adverse Event|2
7655936|NCT01469052|26632966|P3|Overall Study|Adverse Event|0
7655937|NCT01469052|26632967|P2|Overall Study|Adverse Event|3
7655938|NCT01469052|26632968|P1|Overall Study|Adverse Event|2
7655939|NCT01469013|26633033|P13|Part B (Extension Period)|Withdrawal by Subject|3
7655940|NCT01469013|26633034|P12|Part B (Extension Period)|Withdrawal by Subject|0
7655941|NCT01469013|26633035|P11|Part B (Extension Period)|Withdrawal by Subject|1
7655942|NCT01469013|26633036|P10|Part B (Extension Period)|Withdrawal by Subject|0
7655943|NCT01469013|26633037|P9|Part B (Extension Period)|Withdrawal by Subject|1
7655944|NCT01469013|26633038|P8|Part B (Extension Period)|Withdrawal by Subject|0
7655945|NCT01469013|26633039|P7|Part B (Extension Period)|Withdrawal by Subject|0
7655946|NCT01469013|26633040|P6|Part B (Extension Period)|Withdrawal by Subject|0
7655947|NCT01469013|26633041|P5|Part B (Extension Period)|Withdrawal by Subject|0
7655948|NCT01469013|26633042|P4|Part B (Extension Period)|Withdrawal by Subject|0
7655949|NCT01469013|26633043|P3|Part B (Extension Period)|Withdrawal by Subject|0
7655950|NCT01469013|26633044|P2|Part B (Extension Period)|Withdrawal by Subject|0
7655951|NCT01469013|26633045|P1|Part B (Extension Period)|Withdrawal by Subject|0
7655952|NCT01469013|26633033|P13|Part B (Extension Period)|Adverse Event|3
7655953|NCT01469013|26633034|P12|Part B (Extension Period)|Adverse Event|6
7655954|NCT01469013|26633035|P11|Part B (Extension Period)|Adverse Event|1
7655955|NCT01469013|26633036|P10|Part B (Extension Period)|Adverse Event|3
7655956|NCT01469013|26633037|P9|Part B (Extension Period)|Adverse Event|3
7655957|NCT01469013|26633038|P8|Part B (Extension Period)|Adverse Event|5
7655958|NCT01469013|26633039|P7|Part B (Extension Period)|Adverse Event|5
7655959|NCT01469013|26633040|P6|Part B (Extension Period)|Adverse Event|2
7655960|NCT01469013|26633041|P5|Part B (Extension Period)|Adverse Event|0
7655961|NCT01469013|26633042|P4|Part B (Extension Period)|Adverse Event|0
7655962|NCT01469013|26633043|P3|Part B (Extension Period)|Adverse Event|0
7655963|NCT01469013|26633044|P2|Part B (Extension Period)|Adverse Event|0
7655964|NCT01469013|26633045|P1|Part B (Extension Period)|Adverse Event|0
7655965|NCT01469013|26633033|P13|Part A (Treatment Period)|Withdrawal by Subject|0
7655966|NCT01469013|26633034|P12|Part A (Treatment Period)|Withdrawal by Subject|0
7655967|NCT01469013|26633035|P11|Part A (Treatment Period)|Withdrawal by Subject|0
7655968|NCT01469013|26633036|P10|Part A (Treatment Period)|Withdrawal by Subject|0
7655969|NCT01469013|26633037|P9|Part A (Treatment Period)|Withdrawal by Subject|0
7655970|NCT01469013|26633038|P8|Part A (Treatment Period)|Withdrawal by Subject|0
7655971|NCT01469013|26633039|P7|Part A (Treatment Period)|Withdrawal by Subject|0
7655972|NCT01469013|26633040|P6|Part A (Treatment Period)|Withdrawal by Subject|0
7655973|NCT01469013|26633041|P5|Part A (Treatment Period)|Withdrawal by Subject|0
7655974|NCT01469013|26633042|P4|Part A (Treatment Period)|Withdrawal by Subject|0
7655975|NCT01469013|26633043|P3|Part A (Treatment Period)|Withdrawal by Subject|1
7655976|NCT01469013|26633044|P2|Part A (Treatment Period)|Withdrawal by Subject|0
7655977|NCT01469013|26633045|P1|Part A (Treatment Period)|Withdrawal by Subject|0
7655978|NCT01469013|26633033|P13|Part A (Treatment Period)|Adverse Event|0
7655979|NCT01469013|26633034|P12|Part A (Treatment Period)|Adverse Event|0
7655980|NCT01469013|26633035|P11|Part A (Treatment Period)|Adverse Event|0
7655981|NCT01469013|26633036|P10|Part A (Treatment Period)|Adverse Event|0
7655982|NCT01469013|26633037|P9|Part A (Treatment Period)|Adverse Event|0
7655983|NCT01469013|26633038|P8|Part A (Treatment Period)|Adverse Event|0
7655984|NCT01469013|26633039|P7|Part A (Treatment Period)|Adverse Event|0
7655985|NCT01469013|26633040|P6|Part A (Treatment Period)|Adverse Event|0
7655986|NCT01469013|26633041|P5|Part A (Treatment Period)|Adverse Event|1
7655987|NCT01469013|26633042|P4|Part A (Treatment Period)|Adverse Event|0
7655988|NCT01469013|26633043|P3|Part A (Treatment Period)|Adverse Event|0
7655989|NCT01469013|26633044|P2|Part A (Treatment Period)|Adverse Event|0
7655990|NCT01469013|26633045|P1|Part A (Treatment Period)|Adverse Event|1
7655991|NCT01469000|26633130|P2|Overall Study|Sponsor Decision|1
7655992|NCT01469000|26633131|P1|Overall Study|Sponsor Decision|4
7655993|NCT01469000|26633130|P2|Overall Study|Withdrawal by Subject|3
7655994|NCT01469000|26633131|P1|Overall Study|Withdrawal by Subject|16
7655995|NCT01468987|26633151|P2|Overall Study|Sponsor Decision|0
7655996|NCT01468987|26633152|P1|Overall Study|Sponsor Decision|1
7655997|NCT01468987|26633151|P2|Overall Study|Physician Decision|15
7655998|NCT01468987|26633152|P1|Overall Study|Physician Decision|8
7655999|NCT01468987|26633151|P2|Overall Study|Withdrawal by Subject|28
7656000|NCT01468987|26633152|P1|Overall Study|Withdrawal by Subject|28
7656001|NCT01468987|26633151|P2|Overall Study|Protocol Violation|2
7656002|NCT01468987|26633152|P1|Overall Study|Protocol Violation|8
7656003|NCT01468987|26633151|P2|Overall Study|Lost to Follow-up|5
7656004|NCT01468987|26633152|P1|Overall Study|Lost to Follow-up|10
7656005|NCT01468987|26633151|P2|Overall Study|Death|1
7656006|NCT01468987|26633152|P1|Overall Study|Death|4
7656007|NCT01468987|26633151|P2|Overall Study|Adverse Event|9
7656008|NCT01468987|26633152|P1|Overall Study|Adverse Event|12
7656009|NCT01468909|26633329|P2|Overall Study|Never Treated|2
7656010|NCT01468909|26633330|P1|Overall Study|Never Treated|2
7656011|NCT01468844|26633365|P2|Overall Study|Withdrawal by Subject|0
7656012|NCT01468844|26633366|P1|Overall Study|Withdrawal by Subject|1
7656013|NCT01468844|26633365|P2|Overall Study|Adverse Event|0
7656014|NCT01468844|26633366|P1|Overall Study|Adverse Event|1
7656015|NCT01468818|26633404|P1|Overall Study|Death during treatment|2
7656016|NCT01468701|26633426|P17|Overall Study|Not being followed up|0
7656017|NCT01468701|26633427|P16|Overall Study|Not being followed up|0
7656018|NCT01468701|26633428|P15|Overall Study|Not being followed up|0
7656019|NCT01468701|26633429|P14|Overall Study|Not being followed up|0
7656020|NCT01468701|26633430|P13|Overall Study|Not being followed up|0
7656021|NCT01468701|26633431|P12|Overall Study|Not being followed up|0
7656022|NCT01468701|26633432|P11|Overall Study|Not being followed up|0
7656023|NCT01468701|26633433|P10|Overall Study|Not being followed up|0
7656024|NCT01468701|26633434|P9|Overall Study|Not being followed up|0
7656025|NCT01468701|26633435|P8|Overall Study|Not being followed up|4
7656026|NCT01468701|26633436|P7|Overall Study|Not being followed up|1170
7656027|NCT01468701|26633437|P6|Overall Study|Not being followed up|126
7656028|NCT01468701|26633438|P5|Overall Study|Not being followed up|1714
7656029|NCT01468701|26633439|P4|Overall Study|Not being followed up|703
7656030|NCT01468701|26633440|P3|Overall Study|Not being followed up|1755
7656031|NCT01468701|26633441|P2|Overall Study|Not being followed up|4963
7656032|NCT01468701|26633442|P1|Overall Study|Not being followed up|0
7656033|NCT01468701|26633426|P17|Overall Study|No end of study case report form|0
7656034|NCT01468701|26633427|P16|Overall Study|No end of study case report form|0
7656035|NCT01468701|26633428|P15|Overall Study|No end of study case report form|0
7656036|NCT01468701|26633429|P14|Overall Study|No end of study case report form|1
7656037|NCT01468701|26633430|P13|Overall Study|No end of study case report form|0
7656038|NCT01468701|26633431|P12|Overall Study|No end of study case report form|3
7656039|NCT01468701|26633432|P11|Overall Study|No end of study case report form|2
7656040|NCT01468701|26633433|P10|Overall Study|No end of study case report form|1
7656041|NCT01468701|26633434|P9|Overall Study|No end of study case report form|4
7656042|NCT01468701|26633435|P8|Overall Study|No end of study case report form|0
7656043|NCT01468701|26633436|P7|Overall Study|No end of study case report form|0
7656044|NCT01468701|26633437|P6|Overall Study|No end of study case report form|0
7656045|NCT01468701|26633438|P5|Overall Study|No end of study case report form|0
7656046|NCT01468701|26633439|P4|Overall Study|No end of study case report form|0
7656047|NCT01468701|26633440|P3|Overall Study|No end of study case report form|0
7656048|NCT01468701|26633441|P2|Overall Study|No end of study case report form|0
7656049|NCT01468701|26633442|P1|Overall Study|No end of study case report form|0
7656050|NCT01468701|26633426|P17|Overall Study|Other reasons than listed|0
7656051|NCT01468701|26633427|P16|Overall Study|Other reasons than listed|172
7656052|NCT01468701|26633428|P15|Overall Study|Other reasons than listed|39
7656053|NCT01468701|26633429|P14|Overall Study|Other reasons than listed|239
7656054|NCT01468701|26633430|P13|Overall Study|Other reasons than listed|28
7656055|NCT01468701|26633431|P12|Overall Study|Other reasons than listed|504
7656056|NCT01468701|26633432|P11|Overall Study|Other reasons than listed|433
7656057|NCT01468701|26633433|P10|Overall Study|Other reasons than listed|658
7656058|NCT01468701|26633434|P9|Overall Study|Other reasons than listed|318
7656059|NCT01468701|26633435|P8|Overall Study|Other reasons than listed|0
7656060|NCT01468701|26633436|P7|Overall Study|Other reasons than listed|0
7656061|NCT01468701|26633437|P6|Overall Study|Other reasons than listed|0
7656062|NCT01468701|26633438|P5|Overall Study|Other reasons than listed|0
7656063|NCT01468701|26633439|P4|Overall Study|Other reasons than listed|0
7656064|NCT01468701|26633440|P3|Overall Study|Other reasons than listed|0
7656065|NCT01468701|26633441|P2|Overall Study|Other reasons than listed|0
7656066|NCT01468701|26633442|P1|Overall Study|Other reasons than listed|437
7656067|NCT01468701|26633426|P17|Overall Study|Withdrawal by Subject|0
7656068|NCT01468701|26633427|P16|Overall Study|Withdrawal by Subject|31
7656069|NCT01468701|26633428|P15|Overall Study|Withdrawal by Subject|6
7656070|NCT01468701|26633429|P14|Overall Study|Withdrawal by Subject|47
7656071|NCT01468701|26633430|P13|Overall Study|Withdrawal by Subject|9
7656072|NCT01468701|26633431|P12|Overall Study|Withdrawal by Subject|114
7656073|NCT01468701|26633432|P11|Overall Study|Withdrawal by Subject|100
7656074|NCT01468701|26633433|P10|Overall Study|Withdrawal by Subject|88
7656075|NCT01468701|26633434|P9|Overall Study|Withdrawal by Subject|83
7656076|NCT01468701|26633435|P8|Overall Study|Withdrawal by Subject|0
7656077|NCT01468701|26633436|P7|Overall Study|Withdrawal by Subject|0
7656078|NCT01468701|26633437|P6|Overall Study|Withdrawal by Subject|0
7656079|NCT01468701|26633438|P5|Overall Study|Withdrawal by Subject|0
7656080|NCT01468701|26633439|P4|Overall Study|Withdrawal by Subject|0
7656081|NCT01468701|26633440|P3|Overall Study|Withdrawal by Subject|0
7656082|NCT01468701|26633441|P2|Overall Study|Withdrawal by Subject|0
7656083|NCT01468701|26633442|P1|Overall Study|Withdrawal by Subject|165
7656084|NCT01468701|26633426|P17|Overall Study|Lost to Follow-up|1
7656085|NCT01468701|26633427|P16|Overall Study|Lost to Follow-up|127
7656086|NCT01468701|26633428|P15|Overall Study|Lost to Follow-up|17
7656087|NCT01468701|26633429|P14|Overall Study|Lost to Follow-up|164
7656088|NCT01468701|26633430|P13|Overall Study|Lost to Follow-up|11
7656089|NCT01468701|26633431|P12|Overall Study|Lost to Follow-up|212
7656090|NCT01468701|26633432|P11|Overall Study|Lost to Follow-up|224
7656091|NCT01468701|26633433|P10|Overall Study|Lost to Follow-up|309
7656092|NCT01468701|26633434|P9|Overall Study|Lost to Follow-up|215
7656093|NCT01468701|26633435|P8|Overall Study|Lost to Follow-up|0
7656094|NCT01468701|26633436|P7|Overall Study|Lost to Follow-up|0
7656095|NCT01468701|26633437|P6|Overall Study|Lost to Follow-up|0
7656096|NCT01468701|26633438|P5|Overall Study|Lost to Follow-up|0
7656097|NCT01468701|26633439|P4|Overall Study|Lost to Follow-up|0
7656098|NCT01468701|26633440|P3|Overall Study|Lost to Follow-up|0
7656099|NCT01468701|26633441|P2|Overall Study|Lost to Follow-up|0
7656100|NCT01468701|26633442|P1|Overall Study|Lost to Follow-up|306
7656101|NCT01468701|26633426|P17|Overall Study|Not eligible|0
7656102|NCT01468701|26633427|P16|Overall Study|Not eligible|32
7656103|NCT01468701|26633428|P15|Overall Study|Not eligible|1
7656104|NCT01468701|26633429|P14|Overall Study|Not eligible|19
7656105|NCT01468701|26633430|P13|Overall Study|Not eligible|1
7656106|NCT01468701|26633431|P12|Overall Study|Not eligible|33
7656107|NCT01468701|26633432|P11|Overall Study|Not eligible|39
7656108|NCT01468701|26633433|P10|Overall Study|Not eligible|126
7656109|NCT01468701|26633434|P9|Overall Study|Not eligible|40
7656110|NCT01468701|26633435|P8|Overall Study|Not eligible|1
7656111|NCT01468701|26633436|P7|Overall Study|Not eligible|39
7656112|NCT01468701|26633437|P6|Overall Study|Not eligible|2
7656113|NCT01468701|26633438|P5|Overall Study|Not eligible|22
7656114|NCT01468701|26633439|P4|Overall Study|Not eligible|12
7656115|NCT01468701|26633440|P3|Overall Study|Not eligible|29
7656116|NCT01468701|26633441|P2|Overall Study|Not eligible|140
7656117|NCT01468701|26633442|P1|Overall Study|Not eligible|91
7656118|NCT01468597|26633496|P1|Overall Study|no platelet function data|5
7656119|NCT01468597|26633496|P1|Overall Study|off-pump CABG|1
7656120|NCT01468597|26633496|P1|Overall Study|concomitant valves|12
7656121|NCT01468597|26633496|P1|Overall Study|Found ineligible|17
7656122|NCT01468454|26633528|P1|Overall Study|Did not have surgery after PET|9
7656123|NCT01468311|26633562|P1|Overall Study|Withdrawal by Subject|1
7656124|NCT01468311|26633562|P1|Overall Study|mobilization failure|1
7656125|NCT01468233|26633574|P6|Treatment Period 2|Other|0
7656126|NCT01468233|26633575|P5|Treatment Period 2|Other|1
7656127|NCT01468233|26633576|P4|Treatment Period 2|Other|0
7656128|NCT01468233|26633577|P3|Treatment Period 2|Other|3
7656129|NCT01468233|26633578|P2|Treatment Period 2|Other|0
7656130|NCT01468233|26633579|P1|Treatment Period 2|Other|0
7656131|NCT01468233|26633574|P6|Treatment Period 2|Lost to Follow-up|0
7656132|NCT01468233|26633575|P5|Treatment Period 2|Lost to Follow-up|2
7656133|NCT01468233|26633576|P4|Treatment Period 2|Lost to Follow-up|0
7656134|NCT01468233|26633577|P3|Treatment Period 2|Lost to Follow-up|3
7656135|NCT01468233|26633578|P2|Treatment Period 2|Lost to Follow-up|0
7656136|NCT01468233|26633579|P1|Treatment Period 2|Lost to Follow-up|0
7656137|NCT01468233|26633574|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
7656138|NCT01468233|26633575|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
7656139|NCT01468233|26633576|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
7656140|NCT01468233|26633577|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
7656141|NCT01468233|26633578|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
7656142|NCT01468233|26633579|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
7656143|NCT01468233|26633574|P6|Treatment Period 2|Withdrawal by Subject|1
7656144|NCT01468233|26633575|P5|Treatment Period 2|Withdrawal by Subject|1
7656145|NCT01468233|26633576|P4|Treatment Period 2|Withdrawal by Subject|1
7656146|NCT01468233|26633577|P3|Treatment Period 2|Withdrawal by Subject|9
7656147|NCT01468233|26633578|P2|Treatment Period 2|Withdrawal by Subject|0
7656148|NCT01468233|26633579|P1|Treatment Period 2|Withdrawal by Subject|0
7656149|NCT01468233|26633574|P6|Treatment Period 2|Lack of Efficacy|1
7656150|NCT01468233|26633575|P5|Treatment Period 2|Lack of Efficacy|0
7656151|NCT01468233|26633576|P4|Treatment Period 2|Lack of Efficacy|2
7656152|NCT01468233|26633577|P3|Treatment Period 2|Lack of Efficacy|9
7656153|NCT01468233|26633578|P2|Treatment Period 2|Lack of Efficacy|0
7656154|NCT01468233|26633579|P1|Treatment Period 2|Lack of Efficacy|0
7656155|NCT01468233|26633574|P6|Treatment Period 2|Adverse Event|1
7656156|NCT01468233|26633575|P5|Treatment Period 2|Adverse Event|2
7656157|NCT01468233|26633576|P4|Treatment Period 2|Adverse Event|0
7656158|NCT01468233|26633577|P3|Treatment Period 2|Adverse Event|3
7656159|NCT01468233|26633578|P2|Treatment Period 2|Adverse Event|0
7656160|NCT01468233|26633579|P1|Treatment Period 2|Adverse Event|0
7656161|NCT01468233|26633574|P6|Treatment Period 1|Other|0
7656162|NCT01468233|26633575|P5|Treatment Period 1|Other|0
7656163|NCT01468233|26633576|P4|Treatment Period 1|Other|0
7656164|NCT01468233|26633577|P3|Treatment Period 1|Other|0
7656165|NCT01468233|26633578|P2|Treatment Period 1|Other|1
7656166|NCT01468233|26633579|P1|Treatment Period 1|Other|1
7656167|NCT01468233|26633574|P6|Treatment Period 1|Lost to Follow-up|0
7656168|NCT01468233|26633575|P5|Treatment Period 1|Lost to Follow-up|0
7656169|NCT01468233|26633576|P4|Treatment Period 1|Lost to Follow-up|0
7656170|NCT01468233|26633577|P3|Treatment Period 1|Lost to Follow-up|0
7656171|NCT01468233|26633578|P2|Treatment Period 1|Lost to Follow-up|0
7656172|NCT01468233|26633579|P1|Treatment Period 1|Lost to Follow-up|3
7656173|NCT01468233|26633574|P6|Treatment Period 1|Withdrawal by Subject|0
7656174|NCT01468233|26633575|P5|Treatment Period 1|Withdrawal by Subject|0
7656175|NCT01468233|26633576|P4|Treatment Period 1|Withdrawal by Subject|0
7656176|NCT01468233|26633577|P3|Treatment Period 1|Withdrawal by Subject|0
7656177|NCT01468233|26633578|P2|Treatment Period 1|Withdrawal by Subject|4
7656178|NCT01468233|26633579|P1|Treatment Period 1|Withdrawal by Subject|3
7656179|NCT01468233|26633574|P6|Treatment Period 1|Adverse Event|0
7656180|NCT01468233|26633575|P5|Treatment Period 1|Adverse Event|0
7656181|NCT01468233|26633576|P4|Treatment Period 1|Adverse Event|0
7656182|NCT01468233|26633577|P3|Treatment Period 1|Adverse Event|0
7656183|NCT01468233|26633578|P2|Treatment Period 1|Adverse Event|3
7656184|NCT01468233|26633579|P1|Treatment Period 1|Adverse Event|5
7656185|NCT01468207|26633601|P6|Treatment Period 2|Other|2
7656186|NCT01468207|26633602|P5|Treatment Period 2|Other|1
7656187|NCT01468207|26633603|P4|Treatment Period 2|Other|1
7656188|NCT01468207|26633604|P3|Treatment Period 2|Other|5
7656189|NCT01468207|26633605|P2|Treatment Period 2|Other|0
7656190|NCT01468207|26633606|P1|Treatment Period 2|Other|0
7656191|NCT01468207|26633601|P6|Treatment Period 2|Lost to Follow-up|0
7656192|NCT01468207|26633602|P5|Treatment Period 2|Lost to Follow-up|0
7656193|NCT01468207|26633603|P4|Treatment Period 2|Lost to Follow-up|1
7656194|NCT01468207|26633604|P3|Treatment Period 2|Lost to Follow-up|5
7656195|NCT01468207|26633605|P2|Treatment Period 2|Lost to Follow-up|0
7656196|NCT01468207|26633606|P1|Treatment Period 2|Lost to Follow-up|0
7656197|NCT01468207|26633601|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
7656198|NCT01468207|26633602|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
7656199|NCT01468207|26633603|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
7656200|NCT01468207|26633604|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
7656201|NCT01468207|26633605|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
7656202|NCT01468207|26633606|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
7656203|NCT01468207|26633601|P6|Treatment Period 2|Withdrawal by Subject|2
7656204|NCT01468207|26633602|P5|Treatment Period 2|Withdrawal by Subject|0
7656205|NCT01468207|26633603|P4|Treatment Period 2|Withdrawal by Subject|0
7656206|NCT01468207|26633604|P3|Treatment Period 2|Withdrawal by Subject|5
7656207|NCT01468207|26633605|P2|Treatment Period 2|Withdrawal by Subject|0
7656208|NCT01468207|26633606|P1|Treatment Period 2|Withdrawal by Subject|0
7656209|NCT01468207|26633601|P6|Treatment Period 2|Lack of Efficacy|2
7656210|NCT01468207|26633602|P5|Treatment Period 2|Lack of Efficacy|0
7656211|NCT01468207|26633603|P4|Treatment Period 2|Lack of Efficacy|1
7656212|NCT01468207|26633604|P3|Treatment Period 2|Lack of Efficacy|1
7656213|NCT01468207|26633605|P2|Treatment Period 2|Lack of Efficacy|0
7656214|NCT01468207|26633606|P1|Treatment Period 2|Lack of Efficacy|0
7656215|NCT01468207|26633601|P6|Treatment Period 2|Adverse Event|1
7656216|NCT01468207|26633602|P5|Treatment Period 2|Adverse Event|2
7656217|NCT01468207|26633603|P4|Treatment Period 2|Adverse Event|1
7656218|NCT01468207|26633604|P3|Treatment Period 2|Adverse Event|6
7656219|NCT01468207|26633605|P2|Treatment Period 2|Adverse Event|0
7656220|NCT01468207|26633606|P1|Treatment Period 2|Adverse Event|0
7656221|NCT01468207|26633601|P6|Treatment Period 1|Other|0
7656222|NCT01468207|26633602|P5|Treatment Period 1|Other|0
7656223|NCT01468207|26633603|P4|Treatment Period 1|Other|0
7656224|NCT01468207|26633604|P3|Treatment Period 1|Other|0
7656225|NCT01468207|26633605|P2|Treatment Period 1|Other|2
7656226|NCT01468207|26633606|P1|Treatment Period 1|Other|0
7656227|NCT01468207|26633601|P6|Treatment Period 1|Lost to Follow-up|0
7656228|NCT01468207|26633602|P5|Treatment Period 1|Lost to Follow-up|0
7656229|NCT01468207|26633603|P4|Treatment Period 1|Lost to Follow-up|0
7656230|NCT01468207|26633604|P3|Treatment Period 1|Lost to Follow-up|0
7656231|NCT01468207|26633605|P2|Treatment Period 1|Lost to Follow-up|1
7656232|NCT01468207|26633606|P1|Treatment Period 1|Lost to Follow-up|2
7656233|NCT01468207|26633601|P6|Treatment Period 1|Withdrawal by Subject|0
7656234|NCT01468207|26633602|P5|Treatment Period 1|Withdrawal by Subject|0
7656235|NCT01468207|26633603|P4|Treatment Period 1|Withdrawal by Subject|0
7656236|NCT01468207|26633604|P3|Treatment Period 1|Withdrawal by Subject|0
7656237|NCT01468207|26633605|P2|Treatment Period 1|Withdrawal by Subject|4
7656238|NCT01468207|26633606|P1|Treatment Period 1|Withdrawal by Subject|5
7656239|NCT01468207|26633601|P6|Treatment Period 1|Protocol Violation|0
7656240|NCT01468207|26633602|P5|Treatment Period 1|Protocol Violation|0
7656241|NCT01468207|26633603|P4|Treatment Period 1|Protocol Violation|0
7656242|NCT01468207|26633604|P3|Treatment Period 1|Protocol Violation|0
7656243|NCT01468207|26633605|P2|Treatment Period 1|Protocol Violation|1
7656244|NCT01468207|26633606|P1|Treatment Period 1|Protocol Violation|1
7656245|NCT01468207|26633601|P6|Treatment Period 1|Adverse Event|0
7656246|NCT01468207|26633602|P5|Treatment Period 1|Adverse Event|0
7656247|NCT01468207|26633603|P4|Treatment Period 1|Adverse Event|0
7656248|NCT01468207|26633604|P3|Treatment Period 1|Adverse Event|0
7656249|NCT01468207|26633605|P2|Treatment Period 1|Adverse Event|0
7656250|NCT01468207|26633606|P1|Treatment Period 1|Adverse Event|1
7656251|NCT01468181|26633631|P5|Overall Study|Withdrawal by Subject|0
7656252|NCT01468181|26633632|P4|Overall Study|Withdrawal by Subject|0
7656253|NCT01468181|26633633|P3|Overall Study|Withdrawal by Subject|0
7656254|NCT01468181|26633634|P2|Overall Study|Withdrawal by Subject|1
7656255|NCT01468181|26633635|P1|Overall Study|Withdrawal by Subject|0
7656256|NCT01468181|26633631|P5|Overall Study|Lost to Follow-up|1
7656257|NCT01468181|26633632|P4|Overall Study|Lost to Follow-up|0
7656258|NCT01468181|26633633|P3|Overall Study|Lost to Follow-up|1
7656259|NCT01468181|26633634|P2|Overall Study|Lost to Follow-up|0
7656260|NCT01468181|26633635|P1|Overall Study|Lost to Follow-up|0
7656261|NCT01468181|26633631|P5|Overall Study|Physician Decision|1
7656262|NCT01468181|26633632|P4|Overall Study|Physician Decision|1
7656263|NCT01468181|26633633|P3|Overall Study|Physician Decision|0
7656264|NCT01468181|26633634|P2|Overall Study|Physician Decision|0
7656265|NCT01468181|26633635|P1|Overall Study|Physician Decision|0
7656266|NCT01468181|26633631|P5|Overall Study|Protocol Violation|1
7656267|NCT01468181|26633632|P4|Overall Study|Protocol Violation|0
7656268|NCT01468181|26633633|P3|Overall Study|Protocol Violation|1
7656269|NCT01468181|26633634|P2|Overall Study|Protocol Violation|0
7656270|NCT01468181|26633635|P1|Overall Study|Protocol Violation|2
7656271|NCT01468181|26633631|P5|Overall Study|Adverse Event|2
7656272|NCT01468181|26633632|P4|Overall Study|Adverse Event|2
7656273|NCT01468181|26633633|P3|Overall Study|Adverse Event|6
7656274|NCT01468181|26633634|P2|Overall Study|Adverse Event|1
7656275|NCT01468181|26633635|P1|Overall Study|Adverse Event|8
7656276|NCT01468077|26633684|P2|Overall Study|Physician Decision|0
7656277|NCT01468077|26633685|P1|Overall Study|Physician Decision|1
7656278|NCT01468077|26633684|P2|Overall Study|Lack of Efficacy|1
7656279|NCT01468077|26633685|P1|Overall Study|Lack of Efficacy|1
7656280|NCT01468077|26633684|P2|Overall Study|Adverse Event|2
7656281|NCT01468077|26633685|P1|Overall Study|Adverse Event|2
7656282|NCT01467960|26633747|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
7656283|NCT01467960|26633748|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
7656284|NCT01467960|26633749|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
7656285|NCT01467960|26633750|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
7656286|NCT01467960|26633751|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
7656287|NCT01467960|26633752|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
7656288|NCT01467713|26633811|P4|Overall Study|Reason not Specified|7
7656289|NCT01467713|26633812|P3|Overall Study|Reason not Specified|8
7656290|NCT01467713|26633813|P2|Overall Study|Reason not Specified|11
7656291|NCT01467713|26633814|P1|Overall Study|Reason not Specified|6
7656292|NCT01467713|26633811|P4|Overall Study|Relapse|35
7656293|NCT01467713|26633812|P3|Overall Study|Relapse|28
7656294|NCT01467713|26633813|P2|Overall Study|Relapse|25
7656295|NCT01467713|26633814|P1|Overall Study|Relapse|35
7656296|NCT01467713|26633811|P4|Overall Study|Pregnancy|3
7656297|NCT01467713|26633812|P3|Overall Study|Pregnancy|1
7656298|NCT01467713|26633813|P2|Overall Study|Pregnancy|1
7656299|NCT01467713|26633814|P1|Overall Study|Pregnancy|0
7656300|NCT01467713|26633811|P4|Overall Study|Study Termination|29
7656301|NCT01467713|26633812|P3|Overall Study|Study Termination|28
7656302|NCT01467713|26633813|P2|Overall Study|Study Termination|33
7656303|NCT01467713|26633814|P1|Overall Study|Study Termination|23
7656304|NCT01467713|26633811|P4|Overall Study|Voluntary Withdrawal|20
7656305|NCT01467713|26633812|P3|Overall Study|Voluntary Withdrawal|21
7656306|NCT01467713|26633813|P2|Overall Study|Voluntary Withdrawal|14
7656307|NCT01467713|26633814|P1|Overall Study|Voluntary Withdrawal|18
7656308|NCT01467713|26633811|P4|Overall Study|Lost to Follow-up|9
7656309|NCT01467713|26633812|P3|Overall Study|Lost to Follow-up|6
7656310|NCT01467713|26633813|P2|Overall Study|Lost to Follow-up|12
7656311|NCT01467713|26633814|P1|Overall Study|Lost to Follow-up|9
7656312|NCT01467713|26633811|P4|Overall Study|Major Protocol Deviation|1
7656313|NCT01467713|26633812|P3|Overall Study|Major Protocol Deviation|4
7656314|NCT01467713|26633813|P2|Overall Study|Major Protocol Deviation|4
7656315|NCT01467713|26633814|P1|Overall Study|Major Protocol Deviation|2
7656316|NCT01467713|26633811|P4|Overall Study|Pretreatment Event or Adverse Event|5
7656317|NCT01467713|26633812|P3|Overall Study|Pretreatment Event or Adverse Event|6
7656318|NCT01467713|26633813|P2|Overall Study|Pretreatment Event or Adverse Event|4
7656319|NCT01467713|26633814|P1|Overall Study|Pretreatment Event or Adverse Event|9
7656320|NCT01467700|26633868|P4|Overall Study|Reason not Specified|8
7656321|NCT01467700|26633869|P3|Overall Study|Reason not Specified|2
7656322|NCT01467700|26633870|P2|Overall Study|Reason not Specified|3
7656323|NCT01467700|26633871|P1|Overall Study|Reason not Specified|1
7656324|NCT01467700|26633868|P4|Overall Study|Lack of Efficacy|1
7656325|NCT01467700|26633869|P3|Overall Study|Lack of Efficacy|2
7656326|NCT01467700|26633870|P2|Overall Study|Lack of Efficacy|0
7656327|NCT01467700|26633871|P1|Overall Study|Lack of Efficacy|2
7656328|NCT01467700|26633868|P4|Overall Study|Pregnancy|0
7656329|NCT01467700|26633869|P3|Overall Study|Pregnancy|1
7656330|NCT01467700|26633870|P2|Overall Study|Pregnancy|1
7656331|NCT01467700|26633871|P1|Overall Study|Pregnancy|0
7656332|NCT01467700|26633868|P4|Overall Study|Study Termination|7
7656333|NCT01467700|26633869|P3|Overall Study|Study Termination|10
7656334|NCT01467700|26633870|P2|Overall Study|Study Termination|5
7656335|NCT01467700|26633871|P1|Overall Study|Study Termination|6
7656336|NCT01467700|26633868|P4|Overall Study|Voluntary Withdrawal|2
7656337|NCT01467700|26633869|P3|Overall Study|Voluntary Withdrawal|6
7656338|NCT01467700|26633870|P2|Overall Study|Voluntary Withdrawal|7
7656339|NCT01467700|26633871|P1|Overall Study|Voluntary Withdrawal|5
7656340|NCT01467700|26633868|P4|Overall Study|Lost to Follow-up|3
7656341|NCT01467700|26633869|P3|Overall Study|Lost to Follow-up|2
7656342|NCT01467700|26633870|P2|Overall Study|Lost to Follow-up|5
7656343|NCT01467700|26633871|P1|Overall Study|Lost to Follow-up|6
7656344|NCT01467700|26633868|P4|Overall Study|Major Protocol Deviation|3
7656345|NCT01467700|26633869|P3|Overall Study|Major Protocol Deviation|2
7656346|NCT01467700|26633870|P2|Overall Study|Major Protocol Deviation|3
7656347|NCT01467700|26633871|P1|Overall Study|Major Protocol Deviation|3
7656348|NCT01467700|26633868|P4|Overall Study|Pretreatment Event or Adverse Event|3
7656349|NCT01467700|26633869|P3|Overall Study|Pretreatment Event or Adverse Event|2
7656350|NCT01467700|26633870|P2|Overall Study|Pretreatment Event or Adverse Event|4
7656351|NCT01467700|26633871|P1|Overall Study|Pretreatment Event or Adverse Event|6
7656352|NCT01467661|26633913|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
7656353|NCT01467661|26633913|P1|Overall Study|Lack of Efficacy|3
7656354|NCT01467661|26633913|P1|Overall Study|Withdrawal by Subject|1
7656355|NCT01467661|26633913|P1|Overall Study|Adverse Event|16
7656356|NCT01467583|26633933|P3|Overall Study|Protocol Violation|2
7656357|NCT01467583|26633934|P2|Overall Study|Protocol Violation|0
7656358|NCT01467583|26633935|P1|Overall Study|Protocol Violation|0
7656359|NCT01467583|26633933|P3|Overall Study|Withdrawal by Subject|0
7656360|NCT01467583|26633934|P2|Overall Study|Withdrawal by Subject|0
7656361|NCT01467583|26633935|P1|Overall Study|Withdrawal by Subject|1
7656362|NCT01467583|26633933|P3|Overall Study|Death|0
7656363|NCT01467583|26633934|P2|Overall Study|Death|1
7656364|NCT01467583|26633935|P1|Overall Study|Death|1
7656365|NCT01467570|26633948|P2|Overall Study|Lost to Follow-up|9
7656366|NCT01467570|26633949|P1|Overall Study|Lost to Follow-up|8
7656367|NCT01467505|26633986|P2|Overall Study|Study Terminated by Sponsor|3
7656368|NCT01467505|26633987|P1|Overall Study|Study Terminated by Sponsor|28
7656369|NCT01467505|26633986|P2|Overall Study|Withdrawal by Subject|0
7656370|NCT01467505|26633987|P1|Overall Study|Withdrawal by Subject|4
7656371|NCT01467505|26633986|P2|Overall Study|Adverse Event|0
7656372|NCT01467505|26633987|P1|Overall Study|Adverse Event|1
7656373|NCT01467492|26634019|P2|Overall Study|Enrolled But Not Treated|0
7656374|NCT01467492|26634020|P1|Overall Study|Enrolled But Not Treated|1
7656375|NCT01467492|26634019|P2|Overall Study|Undefined|0
7656376|NCT01467492|26634020|P1|Overall Study|Undefined|2
7656377|NCT01467492|26634019|P2|Overall Study|Lost to Follow-up|2
7656378|NCT01467492|26634020|P1|Overall Study|Lost to Follow-up|3
7656379|NCT01467492|26634019|P2|Overall Study|Adverse Event|3
7656380|NCT01467492|26634020|P1|Overall Study|Adverse Event|4
7656381|NCT01467492|26634019|P2|Overall Study|Study Terminated by Sponsor|4
7656382|NCT01467492|26634020|P1|Overall Study|Study Terminated by Sponsor|6
7656383|NCT01467492|26634019|P2|Overall Study|Withdrawal by Subject|4
7656384|NCT01467492|26634020|P1|Overall Study|Withdrawal by Subject|6
7656385|NCT01467479|26634044|P3|Overall Study|Other|0
7656386|NCT01467479|26634045|P2|Overall Study|Other|0
7656387|NCT01467479|26634046|P1|Overall Study|Other|1
7656388|NCT01467479|26634044|P3|Overall Study|Study Terminated by Sponsor|3
7656389|NCT01467479|26634045|P2|Overall Study|Study Terminated by Sponsor|3
7656390|NCT01467479|26634046|P1|Overall Study|Study Terminated by Sponsor|1
7656391|NCT01467479|26634044|P3|Overall Study|Withdrawal of Consent|7
7656392|NCT01467479|26634045|P2|Overall Study|Withdrawal of Consent|7
7656393|NCT01467479|26634046|P1|Overall Study|Withdrawal of Consent|3
7656394|NCT01467479|26634044|P3|Overall Study|Lost to Follow-up|3
7656395|NCT01467479|26634045|P2|Overall Study|Lost to Follow-up|5
7656396|NCT01467479|26634046|P1|Overall Study|Lost to Follow-up|2
7656397|NCT01467479|26634044|P3|Overall Study|Death|1
7656398|NCT01467479|26634045|P2|Overall Study|Death|0
7656399|NCT01467479|26634046|P1|Overall Study|Death|0
7656400|NCT01467479|26634044|P3|Overall Study|Adverse Event|0
7656401|NCT01467479|26634045|P2|Overall Study|Adverse Event|2
7656402|NCT01467479|26634046|P1|Overall Study|Adverse Event|1
7656403|NCT01467479|26634044|P3|Overall Study|No Study Medication|2
7656404|NCT01467479|26634045|P2|Overall Study|No Study Medication|0
7656405|NCT01467479|26634046|P1|Overall Study|No Study Medication|1
7656406|NCT01467466|26634077|P4|Overall Study|No Endpoint Blood Draw|43
7656407|NCT01467466|26634078|P3|Overall Study|No Endpoint Blood Draw|51
7656408|NCT01467466|26634079|P2|Overall Study|No Endpoint Blood Draw|32
7656409|NCT01467466|26634080|P1|Overall Study|No Endpoint Blood Draw|38
7656410|NCT01467466|26634077|P4|Overall Study|Procedure Cancelled|29
7656411|NCT01467466|26634078|P3|Overall Study|Procedure Cancelled|25
7656412|NCT01467466|26634079|P2|Overall Study|Procedure Cancelled|45
7656413|NCT01467466|26634080|P1|Overall Study|Procedure Cancelled|46
7656414|NCT01467466|26634077|P4|Overall Study|Revoked Consent Prior To Procedure|5
7656415|NCT01467466|26634078|P3|Overall Study|Revoked Consent Prior To Procedure|15
7656416|NCT01467466|26634079|P2|Overall Study|Revoked Consent Prior To Procedure|9
7656417|NCT01467466|26634080|P1|Overall Study|Revoked Consent Prior To Procedure|10
7656418|NCT01467466|26634077|P4|Overall Study|Withdrawal by Subject|11
7656419|NCT01467466|26634078|P3|Overall Study|Withdrawal by Subject|13
7656420|NCT01467466|26634079|P2|Overall Study|Withdrawal by Subject|18
7656421|NCT01467466|26634080|P1|Overall Study|Withdrawal by Subject|15
7656422|NCT01467427|26634092|P2|Overall Study|Not continuing in extension phase|2
7656423|NCT01467427|26634093|P1|Overall Study|Not continuing in extension phase|0
7656424|NCT01467427|26634092|P2|Overall Study|Entered extension phase|11
7656425|NCT01467427|26634093|P1|Overall Study|Entered extension phase|11
7656426|NCT01467427|26634092|P2|Overall Study|Withdrawal by Subject|0
7656427|NCT01467427|26634093|P1|Overall Study|Withdrawal by Subject|1
7656428|NCT01467271|26634111|P1|Overall Study|Other reason|14
7656429|NCT01467271|26634111|P1|Overall Study|Retraction of patient's consent|21
7656430|NCT01467271|26634111|P1|Overall Study|Lost to Follow-up|83
7656431|NCT01467271|26634111|P1|Overall Study|Death|84
7656432|NCT01467076|26634118|P3|Overall Study|Lost to Follow-up|0
7656433|NCT01467076|26634119|P2|Overall Study|Lost to Follow-up|0
7656434|NCT01467076|26634120|P1|Overall Study|Lost to Follow-up|1
7656435|NCT01466881|26634201|P1|Overall Study|Other reason not protocol specified|5
7656436|NCT01466881|26634201|P1|Overall Study|Death|4
7656437|NCT01466881|26634201|P1|Overall Study|Progression/relapse|20
7656438|NCT01466881|26634201|P1|Overall Study|Adverse Event|6
7656439|NCT01466881|26634201|P1|Overall Study|Ineligible|5
7656440|NCT01466790|26634218|P8|Overall Study|Withdrawal by Subject|1
7656441|NCT01466790|26634219|P7|Overall Study|Withdrawal by Subject|1
7656442|NCT01466790|26634220|P6|Overall Study|Withdrawal by Subject|0
7656443|NCT01466790|26634221|P5|Overall Study|Withdrawal by Subject|1
7656444|NCT01466790|26634222|P4|Overall Study|Withdrawal by Subject|0
7656445|NCT01466790|26634223|P3|Overall Study|Withdrawal by Subject|0
7656446|NCT01466790|26634224|P2|Overall Study|Withdrawal by Subject|1
7656447|NCT01466790|26634225|P1|Overall Study|Withdrawal by Subject|1
7656448|NCT01466790|26634218|P8|Overall Study|Lost to Follow-up|0
7656449|NCT01466790|26634219|P7|Overall Study|Lost to Follow-up|0
7656450|NCT01466790|26634220|P6|Overall Study|Lost to Follow-up|0
7656451|NCT01466790|26634221|P5|Overall Study|Lost to Follow-up|0
7656452|NCT01466790|26634222|P4|Overall Study|Lost to Follow-up|0
7656453|NCT01466790|26634223|P3|Overall Study|Lost to Follow-up|0
7656454|NCT01466790|26634224|P2|Overall Study|Lost to Follow-up|0
7656455|NCT01466790|26634225|P1|Overall Study|Lost to Follow-up|2
7656456|NCT01466790|26634218|P8|Overall Study|Adverse Event|0
7656457|NCT01466790|26634219|P7|Overall Study|Adverse Event|0
7656458|NCT01466790|26634220|P6|Overall Study|Adverse Event|0
7656459|NCT01466790|26634221|P5|Overall Study|Adverse Event|2
7656460|NCT01466790|26634222|P4|Overall Study|Adverse Event|0
7656461|NCT01466790|26634223|P3|Overall Study|Adverse Event|0
7656462|NCT01466790|26634224|P2|Overall Study|Adverse Event|0
7656463|NCT01466790|26634225|P1|Overall Study|Adverse Event|1
7656464|NCT01466673|26634321|P2|Overall Study|Adverse Event|1
7656465|NCT01466673|26634322|P1|Overall Study|Adverse Event|2
7656466|NCT01466673|26634321|P2|Overall Study|Lost to Follow-up|5
7656467|NCT01466673|26634322|P1|Overall Study|Lost to Follow-up|3
7656468|NCT01466673|26634321|P2|Overall Study|Non-compliance with study treatment|0
7656469|NCT01466673|26634322|P1|Overall Study|Non-compliance with study treatment|2
7656470|NCT01466660|26634348|P2|Overall Study|Other reason not defined above|8
7656471|NCT01466660|26634349|P1|Overall Study|Other reason not defined above|10
7656472|NCT01466660|26634348|P2|Overall Study|Refused continuation of trial medication|3
7656473|NCT01466660|26634349|P1|Overall Study|Refused continuation of trial medication|4
7656474|NCT01466660|26634348|P2|Overall Study|Protocol Violation|1
7656475|NCT01466660|26634349|P1|Overall Study|Protocol Violation|2
7656476|NCT01466660|26634348|P2|Overall Study|Other adverse event|18
7656477|NCT01466660|26634349|P1|Overall Study|Other adverse event|19
7656478|NCT01466660|26634348|P2|Overall Study|Worsening of underlying cancer disease|2
7656479|NCT01466660|26634349|P1|Overall Study|Worsening of underlying cancer disease|5
7656480|NCT01466660|26634348|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
7656481|NCT01466660|26634349|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
7656482|NCT01466595|26634375|P2|Overall Study|Withdrawal by Subject|1
7656483|NCT01466595|26634376|P1|Overall Study|Withdrawal by Subject|0
7656484|NCT01466491|26634470|P4|Overall Study|Missing Data|0
7656485|NCT01466491|26634471|P3|Overall Study|Missing Data|1
7656486|NCT01466491|26634472|P2|Overall Study|Missing Data|0
7656487|NCT01466491|26634473|P1|Overall Study|Missing Data|0
7656488|NCT01466491|26634470|P4|Overall Study|Protocol Violation|0
7656489|NCT01466491|26634471|P3|Overall Study|Protocol Violation|2
7656490|NCT01466491|26634472|P2|Overall Study|Protocol Violation|3
7656491|NCT01466491|26634473|P1|Overall Study|Protocol Violation|0
7656492|NCT01466387|26634493|P6|Overall Study|Protocol Violation|0
7656493|NCT01466387|26634494|P5|Overall Study|Protocol Violation|0
7656494|NCT01466387|26634495|P4|Overall Study|Protocol Violation|1
7656495|NCT01466387|26634496|P3|Overall Study|Protocol Violation|0
7656496|NCT01466387|26634497|P2|Overall Study|Protocol Violation|0
7656497|NCT01466387|26634498|P1|Overall Study|Protocol Violation|1
7656498|NCT01466387|26634493|P6|Overall Study|Lost to Follow-up|1
7656499|NCT01466387|26634494|P5|Overall Study|Lost to Follow-up|0
7656500|NCT01466387|26634495|P4|Overall Study|Lost to Follow-up|0
7656501|NCT01466387|26634496|P3|Overall Study|Lost to Follow-up|0
7656502|NCT01466387|26634497|P2|Overall Study|Lost to Follow-up|0
7656503|NCT01466387|26634498|P1|Overall Study|Lost to Follow-up|0
7656504|NCT01466387|26634493|P6|Overall Study|Adverse Event|0
7656505|NCT01466387|26634494|P5|Overall Study|Adverse Event|0
7656506|NCT01466387|26634495|P4|Overall Study|Adverse Event|1
7656507|NCT01466387|26634496|P3|Overall Study|Adverse Event|1
7656508|NCT01466387|26634497|P2|Overall Study|Adverse Event|0
7656509|NCT01466387|26634498|P1|Overall Study|Adverse Event|0
7656510|NCT01466348|26634559|P2|Period I - First Intervention|Withdrawal by Subject|1
7656511|NCT01466348|26634560|P1|Period I - First Intervention|Withdrawal by Subject|0
7656524|NCT01466192|26634601|P1|Overall Study|Withdrawal by Subject|3
7656525|NCT01466192|26634601|P1|Overall Study|Physician Decision|1
7656526|NCT01466179|26634605|P1|Overall Study|Other|3
7656527|NCT01466179|26634605|P1|Overall Study|Protocol Violation|2
7656528|NCT01466179|26634605|P1|Overall Study|Withdrawal by Subject|7
7656529|NCT01466179|26634605|P1|Overall Study|Death|7
7656530|NCT01466179|26634605|P1|Overall Study|Lack of Efficacy|14
7656531|NCT01466179|26634605|P1|Overall Study|Disease relapse|23
7656532|NCT01466179|26634605|P1|Overall Study|Adverse Event|32
7656533|NCT01466179|26634605|P1|Overall Study|Progressive disease|43
7656534|NCT01466179|26634605|P1|Overall Study|Physician Decision|46
7656535|NCT01466179|26634605|P1|Overall Study|Ongoing in core study|2
7656536|NCT01466166|26634625|P1|Overall Study|Other|20
7656537|NCT01466166|26634625|P1|Overall Study|Protocol Violation/Noncompliance|2
7656538|NCT01466166|26634625|P1|Overall Study|Sponsor Decision|4
7656539|NCT01466166|26634625|P1|Overall Study|Withdrawal by Subject|13
7656540|NCT01466166|26634625|P1|Overall Study|Elevated Serum Uric Acid|78
7656541|NCT01466166|26634625|P1|Overall Study|Adverse Event (Other than IR)|11
7656542|NCT01466166|26634625|P1|Overall Study|Infusion Reaction (IR)|27
7656543|NCT01466166|26634625|P1|Overall Study|Lost to Follow-up|7
7656544|NCT01466166|26634625|P1|Overall Study|Death|1
7656545|NCT01466153|26634639|P3|Overall Study|Other-Unspecified|2
7656546|NCT01466153|26634640|P2|Overall Study|Other-Unspecified|4
7656547|NCT01466153|26634641|P1|Overall Study|Other-Unspecified|6
7656548|NCT01466153|26634639|P3|Overall Study|Randomized-Not Treated|4
7656549|NCT01466153|26634640|P2|Overall Study|Randomized-Not Treated|3
7656550|NCT01466153|26634641|P1|Overall Study|Randomized-Not Treated|2
7656551|NCT01466153|26634639|P3|Overall Study|Investigator Discretion|2
7656552|NCT01466153|26634640|P2|Overall Study|Investigator Discretion|2
7656553|NCT01466153|26634641|P1|Overall Study|Investigator Discretion|3
7656554|NCT01466153|26634639|P3|Overall Study|Withdrawal of Consent|0
7656555|NCT01466153|26634640|P2|Overall Study|Withdrawal of Consent|0
7656556|NCT01466153|26634641|P1|Overall Study|Withdrawal of Consent|2
7656557|NCT01466153|26634639|P3|Overall Study|Adverse Event|17
7656558|NCT01466153|26634640|P2|Overall Study|Adverse Event|13
7656559|NCT01466153|26634641|P1|Overall Study|Adverse Event|14
7656560|NCT01466153|26634639|P3|Overall Study|Disease Progression|0
7656561|NCT01466153|26634640|P2|Overall Study|Disease Progression|2
7656562|NCT01466153|26634641|P1|Overall Study|Disease Progression|2
7656563|NCT01466062|26634696|P1|Overall Study|Withdrawal by Subject|1
7656564|NCT01466062|26634696|P1|Overall Study|Adverse Event|1
7656565|NCT01465997|26634719|P2|Overall Study|subject left participation SP0993|1
7656566|NCT01465997|26634720|P1|Overall Study|subject left participation SP0993|0
7656567|NCT01465997|26634719|P2|Overall Study|decision by site staff|1
7656568|NCT01465997|26634720|P1|Overall Study|decision by site staff|0
7656569|NCT01465997|26634719|P2|Overall Study|withdrew before follow-up|13
7656570|NCT01465997|26634720|P1|Overall Study|withdrew before follow-up|0
7656571|NCT01465997|26634719|P2|Overall Study|local lab unblinded site|0
7656572|NCT01465997|26634720|P1|Overall Study|local lab unblinded site|1
7656573|NCT01465997|26634719|P2|Overall Study|subject withdrew consent|0
7656574|NCT01465997|26634720|P1|Overall Study|subject withdrew consent|1
7656575|NCT01465997|26634719|P2|Overall Study|sponsor's decision|1
7656576|NCT01465997|26634720|P1|Overall Study|sponsor's decision|1
7656577|NCT01465997|26634719|P2|Overall Study|Death|1
7656578|NCT01465997|26634720|P1|Overall Study|Death|0
7656579|NCT01465997|26634719|P2|Overall Study|investigator's decision|1
7656580|NCT01465997|26634720|P1|Overall Study|investigator's decision|1
7656581|NCT01465997|26634719|P2|Overall Study|Withdrawal by Subject|35
7656582|NCT01465997|26634720|P1|Overall Study|Withdrawal by Subject|32
7656583|NCT01465997|26634719|P2|Overall Study|Lost to Follow-up|9
7656584|NCT01465997|26634720|P1|Overall Study|Lost to Follow-up|6
7656585|NCT01465997|26634719|P2|Overall Study|Protocol Violation|4
7656586|NCT01465997|26634720|P1|Overall Study|Protocol Violation|1
7656587|NCT01465997|26634719|P2|Overall Study|Lack of Efficacy|1
7656588|NCT01465997|26634720|P1|Overall Study|Lack of Efficacy|13
7656589|NCT01465997|26634719|P2|Overall Study|Adverse Event|22
7656590|NCT01465997|26634720|P1|Overall Study|Adverse Event|12
7656591|NCT01465958|26634730|P2|Subcutaneous (SC) Phase|Adverse Event|1
7656592|NCT01465958|26634731|P1|Subcutaneous (SC) Phase|Adverse Event|0
7656593|NCT01465958|26634730|P2|Run-in Phase|Protocol Violation|0
7656594|NCT01465958|26634731|P1|Run-in Phase|Protocol Violation|1
7656595|NCT01465802|26634752|P5|Overall Study|Death|2
7656596|NCT01465802|26634753|P4|Overall Study|Death|10
7656597|NCT01465802|26634754|P3|Overall Study|Death|0
7656598|NCT01465802|26634755|P2|Overall Study|Death|12
7656599|NCT01465802|26634756|P1|Overall Study|Death|15
7656600|NCT01465802|26634752|P5|Overall Study|Reason not specified|2
7656601|NCT01465802|26634753|P4|Overall Study|Reason not specified|10
7656602|NCT01465802|26634754|P3|Overall Study|Reason not specified|0
7656603|NCT01465802|26634755|P2|Overall Study|Reason not specified|4
7656604|NCT01465802|26634756|P1|Overall Study|Reason not specified|9
7656605|NCT01465802|26634752|P5|Overall Study|Lost to Follow-up|0
7656606|NCT01465802|26634753|P4|Overall Study|Lost to Follow-up|0
7656607|NCT01465802|26634754|P3|Overall Study|Lost to Follow-up|0
7656608|NCT01465802|26634755|P2|Overall Study|Lost to Follow-up|1
7656609|NCT01465802|26634756|P1|Overall Study|Lost to Follow-up|1
7656610|NCT01465802|26634752|P5|Overall Study|Withdrawal by Subject|1
7656611|NCT01465802|26634753|P4|Overall Study|Withdrawal by Subject|8
7656612|NCT01465802|26634754|P3|Overall Study|Withdrawal by Subject|0
7656613|NCT01465802|26634755|P2|Overall Study|Withdrawal by Subject|7
7656614|NCT01465802|26634756|P1|Overall Study|Withdrawal by Subject|7
7656615|NCT01465802|26634752|P5|Overall Study|Study terminated by sponsor|7
7656616|NCT01465802|26634753|P4|Overall Study|Study terminated by sponsor|1
7656617|NCT01465802|26634754|P3|Overall Study|Study terminated by sponsor|0
7656618|NCT01465802|26634755|P2|Overall Study|Study terminated by sponsor|0
7656619|NCT01465802|26634756|P1|Overall Study|Study terminated by sponsor|1
7656620|NCT01465763|26634808|P3|Overall Study|Death|0
7656621|NCT01465763|26634809|P2|Overall Study|Death|0
7656622|NCT01465763|26634810|P1|Overall Study|Death|1
7656623|NCT01465763|26634808|P3|Overall Study|Protocol Violation|1
7656624|NCT01465763|26634809|P2|Overall Study|Protocol Violation|1
7656625|NCT01465763|26634810|P1|Overall Study|Protocol Violation|4
7656626|NCT01465763|26634808|P3|Overall Study|Other|0
7656627|NCT01465763|26634809|P2|Overall Study|Other|0
7656628|NCT01465763|26634810|P1|Overall Study|Other|2
7656629|NCT01465763|26634808|P3|Overall Study|Adverse Event|1
7656630|NCT01465763|26634809|P2|Overall Study|Adverse Event|0
7656631|NCT01465763|26634810|P1|Overall Study|Adverse Event|9
7656632|NCT01465763|26634808|P3|Overall Study|Insufficient Clinical Response|1
7656633|NCT01465763|26634809|P2|Overall Study|Insufficient Clinical Response|0
7656634|NCT01465763|26634810|P1|Overall Study|Insufficient Clinical Response|11
7656635|NCT01465763|26634808|P3|Overall Study|Withdrawal by Subject|1
7656636|NCT01465763|26634809|P2|Overall Study|Withdrawal by Subject|0
7656637|NCT01465763|26634810|P1|Overall Study|Withdrawal by Subject|4
7656638|NCT01465659|26634839|P4|Completed Follow for 1 Year|Death|4
7656639|NCT01465659|26634840|P3|Completed Follow for 1 Year|Death|2
7656640|NCT01465659|26634841|P2|Completed Follow for 1 Year|Death|3
7656641|NCT01465659|26634842|P1|Completed Follow for 1 Year|Death|6
7656642|NCT01465659|26634839|P4|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7656643|NCT01465659|26634840|P3|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7656644|NCT01465659|26634841|P2|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7656645|NCT01465659|26634842|P1|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7656646|NCT01465659|26634839|P4|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7656647|NCT01465659|26634840|P3|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7656648|NCT01465659|26634841|P2|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
7656649|NCT01465659|26634842|P1|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7656650|NCT01465659|26634839|P4|Completed 1 Cycle of Treatment|Adverse Event|1
7656651|NCT01465659|26634840|P3|Completed 1 Cycle of Treatment|Adverse Event|0
7656652|NCT01465659|26634841|P2|Completed 1 Cycle of Treatment|Adverse Event|0
7656653|NCT01465659|26634842|P1|Completed 1 Cycle of Treatment|Adverse Event|0
7656654|NCT01465659|26634839|P4|Completed 1 Cycle of Treatment|Death|0
7656655|NCT01465659|26634840|P3|Completed 1 Cycle of Treatment|Death|0
7656656|NCT01465659|26634841|P2|Completed 1 Cycle of Treatment|Death|1
7656657|NCT01465659|26634842|P1|Completed 1 Cycle of Treatment|Death|0
7656658|NCT01465464|26634861|P2|Overall Study|Ongoing treatment at cutoff date|166
7656659|NCT01465464|26634862|P1|Overall Study|Ongoing treatment at cutoff date|140
7656660|NCT01465464|26634861|P2|Overall Study|Other|3
7656661|NCT01465464|26634862|P1|Overall Study|Other|9
7656662|NCT01465464|26634861|P2|Overall Study|Withdrawal by Subject|30
7656663|NCT01465464|26634862|P1|Overall Study|Withdrawal by Subject|46
7656664|NCT01465464|26634861|P2|Overall Study|Protocol Violation|1
7656665|NCT01465464|26634862|P1|Overall Study|Protocol Violation|1
7656666|NCT01465464|26634861|P2|Overall Study|Physician Decision|5
7656667|NCT01465464|26634862|P1|Overall Study|Physician Decision|13
7656668|NCT01465464|26634861|P2|Overall Study|Lack of Efficacy|190
7656669|NCT01465464|26634862|P1|Overall Study|Lack of Efficacy|139
7656670|NCT01465464|26634861|P2|Overall Study|Adverse Event|49
7656671|NCT01465464|26634862|P1|Overall Study|Adverse Event|96
7656672|NCT01465386|26634915|P1|Overall Study|Adverse Event|1
7656673|NCT01465386|26634915|P1|Overall Study|Lack of Efficacy|3
7656674|NCT01465347|26634919|P2|Overall Study|Admitted to hospice|1
7656675|NCT01465347|26634920|P1|Overall Study|Admitted to hospice|0
7656676|NCT01465347|26634919|P2|Overall Study|Physician Decision|1
7656677|NCT01465347|26634920|P1|Overall Study|Physician Decision|0
7656678|NCT01465347|26634919|P2|Overall Study|Withdrawal by Subject|1
7656679|NCT01465347|26634920|P1|Overall Study|Withdrawal by Subject|1
7656680|NCT01465334|26634932|P2|Overall Study|Refractory Disease|3
7656681|NCT01465334|26634933|P1|Overall Study|Refractory Disease|0
7656682|NCT01465334|26634932|P2|Overall Study|Richter's transformation|3
7656683|NCT01465334|26634933|P1|Overall Study|Richter's transformation|0
7656684|NCT01465334|26634932|P2|Overall Study|Adverse Event|0
7656685|NCT01465334|26634933|P1|Overall Study|Adverse Event|1
7656686|NCT01465334|26634932|P2|Overall Study|Disease Progression|0
7656687|NCT01465334|26634933|P1|Overall Study|Disease Progression|1
7656688|NCT01465230|26634959|P1|Overall Study|Withdrawal by Subject|2
7656689|NCT01465191|26634966|P3|Overall Study|Lost to Follow-up|4
7656690|NCT01465191|26634967|P2|Overall Study|Lost to Follow-up|6
7656691|NCT01465191|26634968|P1|Overall Study|Lost to Follow-up|3
7656692|NCT01465191|26634966|P3|Overall Study|Protocol Violation|3
7656693|NCT01465191|26634967|P2|Overall Study|Protocol Violation|3
7656694|NCT01465191|26634968|P1|Overall Study|Protocol Violation|6
7656695|NCT01465178|26635017|P2|Overall Study|Withdrawal by Subject|0
7656696|NCT01465178|26635018|P1|Overall Study|Withdrawal by Subject|1
7656697|NCT01465022|26635042|P3|Overall Study|Not Randomized|70
7656698|NCT01465022|26635043|P2|Overall Study|Not Randomized|0
7656699|NCT01465022|26635044|P1|Overall Study|Not Randomized|0
7656700|NCT01465022|26635042|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
7656701|NCT01465022|26635043|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
7656702|NCT01465022|26635044|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
7656703|NCT01465022|26635042|P3|Overall Study|Lost to Follow-up|0
7656704|NCT01465022|26635043|P2|Overall Study|Lost to Follow-up|14
7656705|NCT01465022|26635044|P1|Overall Study|Lost to Follow-up|15
7656706|NCT01464931|26635078|P2|Overall Study|Withdrawal by Subject|0
7656707|NCT01464931|26635079|P1|Overall Study|Withdrawal by Subject|1
7656708|NCT01464879|26635116|P1|Overall Study|Non-compliance|1
7656709|NCT01464879|26635116|P1|Overall Study|Physician Decision|1
7656710|NCT01464827|26635177|P14|Overall Study|Not Treated|2
7656711|NCT01464827|26635178|P13|Overall Study|Not Treated|0
7656712|NCT01464827|26635179|P12|Overall Study|Not Treated|1
7656713|NCT01464827|26635180|P11|Overall Study|Not Treated|0
7656714|NCT01464827|26635181|P10|Overall Study|Not Treated|2
7656715|NCT01464827|26635182|P9|Overall Study|Not Treated|0
7656716|NCT01464827|26635183|P8|Overall Study|Not Treated|0
7656717|NCT01464827|26635184|P7|Overall Study|Not Treated|1
7656718|NCT01464827|26635185|P6|Overall Study|Not Treated|0
7656719|NCT01464827|26635186|P5|Overall Study|Not Treated|1
7656720|NCT01464827|26635187|P4|Overall Study|Not Treated|0
7656721|NCT01464827|26635188|P3|Overall Study|Not Treated|0
7656722|NCT01464827|26635189|P2|Overall Study|Not Treated|2
7656723|NCT01464827|26635190|P1|Overall Study|Not Treated|0
7656724|NCT01464827|26635177|P14|Overall Study|Other|0
7656725|NCT01464827|26635178|P13|Overall Study|Other|1
7656726|NCT01464827|26635179|P12|Overall Study|Other|0
7656727|NCT01464827|26635180|P11|Overall Study|Other|2
7656728|NCT01464827|26635181|P10|Overall Study|Other|1
7656729|NCT01464827|26635182|P9|Overall Study|Other|3
7656730|NCT01464827|26635183|P8|Overall Study|Other|0
7656731|NCT01464827|26635184|P7|Overall Study|Other|1
7656732|NCT01464827|26635185|P6|Overall Study|Other|0
7656733|NCT01464827|26635186|P5|Overall Study|Other|3
7656734|NCT01464827|26635187|P4|Overall Study|Other|2
7656735|NCT01464827|26635188|P3|Overall Study|Other|0
7656736|NCT01464827|26635189|P2|Overall Study|Other|3
7656737|NCT01464827|26635190|P1|Overall Study|Other|2
7656738|NCT01464827|26635177|P14|Overall Study|Lost to Follow-up|1
7656739|NCT01464827|26635178|P13|Overall Study|Lost to Follow-up|0
7656740|NCT01464827|26635179|P12|Overall Study|Lost to Follow-up|1
7656741|NCT01464827|26635180|P11|Overall Study|Lost to Follow-up|0
7656742|NCT01464827|26635181|P10|Overall Study|Lost to Follow-up|0
7656743|NCT01464827|26635182|P9|Overall Study|Lost to Follow-up|0
7656744|NCT01464827|26635183|P8|Overall Study|Lost to Follow-up|2
7656745|NCT01464827|26635184|P7|Overall Study|Lost to Follow-up|2
7656746|NCT01464827|26635185|P6|Overall Study|Lost to Follow-up|1
7656747|NCT01464827|26635186|P5|Overall Study|Lost to Follow-up|3
7656748|NCT01464827|26635187|P4|Overall Study|Lost to Follow-up|2
7656749|NCT01464827|26635188|P3|Overall Study|Lost to Follow-up|0
7656750|NCT01464827|26635189|P2|Overall Study|Lost to Follow-up|2
7656751|NCT01464827|26635190|P1|Overall Study|Lost to Follow-up|0
7656752|NCT01464827|26635177|P14|Overall Study|Withdrawal by Subject|0
7656753|NCT01464827|26635178|P13|Overall Study|Withdrawal by Subject|0
7656754|NCT01464827|26635179|P12|Overall Study|Withdrawal by Subject|0
7656755|NCT01464827|26635180|P11|Overall Study|Withdrawal by Subject|0
7656756|NCT01464827|26635181|P10|Overall Study|Withdrawal by Subject|0
7656757|NCT01464827|26635182|P9|Overall Study|Withdrawal by Subject|0
7656758|NCT01464827|26635183|P8|Overall Study|Withdrawal by Subject|1
7656759|NCT01464827|26635184|P7|Overall Study|Withdrawal by Subject|0
7656760|NCT01464827|26635185|P6|Overall Study|Withdrawal by Subject|0
7656761|NCT01464827|26635186|P5|Overall Study|Withdrawal by Subject|1
7656762|NCT01464827|26635187|P4|Overall Study|Withdrawal by Subject|0
7656763|NCT01464827|26635188|P3|Overall Study|Withdrawal by Subject|0
7656764|NCT01464827|26635189|P2|Overall Study|Withdrawal by Subject|0
7656765|NCT01464827|26635190|P1|Overall Study|Withdrawal by Subject|1
7656766|NCT01464827|26635177|P14|Overall Study|Adverse Event|0
7656767|NCT01464827|26635178|P13|Overall Study|Adverse Event|1
7656768|NCT01464827|26635179|P12|Overall Study|Adverse Event|0
7656769|NCT01464827|26635180|P11|Overall Study|Adverse Event|0
7656770|NCT01464827|26635181|P10|Overall Study|Adverse Event|0
7656771|NCT01464827|26635182|P9|Overall Study|Adverse Event|0
7656772|NCT01464827|26635183|P8|Overall Study|Adverse Event|0
7656773|NCT01464827|26635184|P7|Overall Study|Adverse Event|0
7656774|NCT01464827|26635185|P6|Overall Study|Adverse Event|0
7656775|NCT01464827|26635186|P5|Overall Study|Adverse Event|0
7656776|NCT01464827|26635187|P4|Overall Study|Adverse Event|0
7656777|NCT01464827|26635188|P3|Overall Study|Adverse Event|0
7656778|NCT01464827|26635189|P2|Overall Study|Adverse Event|0
7656779|NCT01464827|26635190|P1|Overall Study|Adverse Event|0
7656780|NCT01464788|26635237|P3|Overall Study|Patient had hemorrhage after tPA started|0
7656781|NCT01464788|26635238|P2|Overall Study|Patient had hemorrhage after tPA started|1
7656782|NCT01464788|26635239|P1|Overall Study|Patient had hemorrhage after tPA started|0
7656783|NCT01464788|26635237|P3|Overall Study|Lost to Follow-up|0
7656784|NCT01464788|26635238|P2|Overall Study|Lost to Follow-up|1
7656785|NCT01464788|26635239|P1|Overall Study|Lost to Follow-up|0
7656786|NCT01464619|26635325|P2|Overall Study|Lost to Follow-up|4
7656787|NCT01464619|26635326|P1|Overall Study|Lost to Follow-up|3
7656788|NCT01464424|26635346|P2|Period 1, First 6 Weeks|Adverse Event|1
7656789|NCT01464424|26635347|P1|Period 1, First 6 Weeks|Adverse Event|0
7656790|NCT01464346|26635367|P3|Overall Study|Withdrawal by Subject|1
7656791|NCT01464346|26635368|P2|Overall Study|Withdrawal by Subject|0
7656792|NCT01464346|26635369|P1|Overall Study|Withdrawal by Subject|0
7656793|NCT01464333|26635378|P1|Overall Study|No Hospital Visit|42
7656794|NCT01464333|26635378|P1|Overall Study|Other|4
7656795|NCT01464333|26635378|P1|Overall Study|Withdrawal by Subject|11
7656796|NCT01464333|26635378|P1|Overall Study|Lack of Efficacy|72
7656797|NCT01464333|26635378|P1|Overall Study|Adverse Event|34
7656798|NCT01464307|26635391|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
7656799|NCT01464307|26635392|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
7656800|NCT01464307|26635391|P2|Open-Label Extension Period|Non-compliance|0
7656801|NCT01464307|26635392|P1|Open-Label Extension Period|Non-compliance|9
7656802|NCT01464307|26635391|P2|Open-Label Extension Period|Lost to Follow-up|0
7656803|NCT01464307|26635392|P1|Open-Label Extension Period|Lost to Follow-up|1
7656804|NCT01464307|26635391|P2|Open-Label Extension Period|Death|0
7656805|NCT01464307|26635392|P1|Open-Label Extension Period|Death|1
7656806|NCT01464307|26635391|P2|Open-Label Extension Period|Lack of Efficacy|0
7656807|NCT01464307|26635392|P1|Open-Label Extension Period|Lack of Efficacy|5
7656808|NCT01464307|26635391|P2|Open-Label Extension Period|Withdrawal by Subject|0
7656809|NCT01464307|26635392|P1|Open-Label Extension Period|Withdrawal by Subject|14
7656810|NCT01464307|26635391|P2|Open-Label Extension Period|Adverse Event|0
7656811|NCT01464307|26635392|P1|Open-Label Extension Period|Adverse Event|15
7656812|NCT01464307|26635391|P2|Main Period|Predefined discontinuation criteria|1
7656813|NCT01464307|26635392|P1|Main Period|Predefined discontinuation criteria|2
7656814|NCT01464307|26635391|P2|Main Period|Withdrawal by Subject|2
7656815|NCT01464307|26635392|P1|Main Period|Withdrawal by Subject|5
7656816|NCT01464307|26635391|P2|Main Period|Lack of Efficacy|0
7656817|NCT01464307|26635392|P1|Main Period|Lack of Efficacy|2
7656818|NCT01464307|26635391|P2|Main Period|Adverse Event|1
7656819|NCT01464307|26635392|P1|Main Period|Adverse Event|6
7656820|NCT01464307|26635391|P2|Main Period|Death|1
7656821|NCT01464307|26635392|P1|Main Period|Death|0
7656822|NCT01464255|26635407|P2|Overall Study|unresolve corneal staining|1
7656823|NCT01464255|26635408|P1|Overall Study|unresolve corneal staining|0
7656824|NCT01464021|26635453|P1|Overall Study|various|11
7656825|NCT01464021|26635453|P1|Overall Study|Lack of Efficacy|1
7656826|NCT01464021|26635453|P1|Overall Study|Lost to Follow-up|1
7656827|NCT01464021|26635453|P1|Overall Study|Withdrawal by Subject|13
7656828|NCT01463982|26635469|P4|Overall Study|Treatment delay over 5 week|0
7656829|NCT01463982|26635470|P3|Overall Study|Treatment delay over 5 week|1
7656830|NCT01463982|26635471|P2|Overall Study|Treatment delay over 5 week|0
7656831|NCT01463982|26635472|P1|Overall Study|Treatment delay over 5 week|0
7656832|NCT01463982|26635469|P4|Overall Study|Withdrawal by Subject|0
7656833|NCT01463982|26635470|P3|Overall Study|Withdrawal by Subject|1
7656834|NCT01463982|26635471|P2|Overall Study|Withdrawal by Subject|1
7656835|NCT01463982|26635472|P1|Overall Study|Withdrawal by Subject|0
7656836|NCT01463878|26635488|P2|Overall Study|no longer met criteria for tube feed|2
7656837|NCT01463878|26635489|P1|Overall Study|no longer met criteria for tube feed|2
7656838|NCT01463696|26635503|P8|Overall Study|Not Treated|0
7656839|NCT01463696|26635504|P7|Overall Study|Not Treated|1
7656840|NCT01463696|26635505|P6|Overall Study|Not Treated|0
7656841|NCT01463696|26635506|P5|Overall Study|Not Treated|0
7656842|NCT01463696|26635507|P4|Overall Study|Not Treated|0
7656843|NCT01463696|26635508|P3|Overall Study|Not Treated|0
7656844|NCT01463696|26635509|P2|Overall Study|Not Treated|0
7656845|NCT01463696|26635510|P1|Overall Study|Not Treated|0
7656846|NCT01463696|26635503|P8|Overall Study|Withdrawal by Subject|0
7656847|NCT01463696|26635504|P7|Overall Study|Withdrawal by Subject|2
7656848|NCT01463696|26635505|P6|Overall Study|Withdrawal by Subject|1
7656849|NCT01463696|26635506|P5|Overall Study|Withdrawal by Subject|1
7656850|NCT01463696|26635507|P4|Overall Study|Withdrawal by Subject|1
7656851|NCT01463696|26635508|P3|Overall Study|Withdrawal by Subject|0
7656852|NCT01463696|26635509|P2|Overall Study|Withdrawal by Subject|0
7656853|NCT01463696|26635510|P1|Overall Study|Withdrawal by Subject|0
7656854|NCT01463696|26635503|P8|Overall Study|Progressive Disease|2
7656855|NCT01463696|26635504|P7|Overall Study|Progressive Disease|4
7656856|NCT01463696|26635505|P6|Overall Study|Progressive Disease|1
7656857|NCT01463696|26635506|P5|Overall Study|Progressive Disease|0
7656858|NCT01463696|26635507|P4|Overall Study|Progressive Disease|1
7656859|NCT01463696|26635508|P3|Overall Study|Progressive Disease|0
7656860|NCT01463696|26635509|P2|Overall Study|Progressive Disease|1
7656861|NCT01463696|26635510|P1|Overall Study|Progressive Disease|0
7656862|NCT01463696|26635503|P8|Overall Study|Lost to Follow-up|0
7656863|NCT01463696|26635504|P7|Overall Study|Lost to Follow-up|0
7656864|NCT01463696|26635505|P6|Overall Study|Lost to Follow-up|0
7656865|NCT01463696|26635506|P5|Overall Study|Lost to Follow-up|0
7656866|NCT01463696|26635507|P4|Overall Study|Lost to Follow-up|0
7656867|NCT01463696|26635508|P3|Overall Study|Lost to Follow-up|1
7656868|NCT01463696|26635509|P2|Overall Study|Lost to Follow-up|0
7656869|NCT01463696|26635510|P1|Overall Study|Lost to Follow-up|0
7656870|NCT01463696|26635503|P8|Overall Study|Adverse Event|2
7656871|NCT01463696|26635504|P7|Overall Study|Adverse Event|3
7656872|NCT01463696|26635505|P6|Overall Study|Adverse Event|1
7656873|NCT01463696|26635506|P5|Overall Study|Adverse Event|0
7656874|NCT01463696|26635507|P4|Overall Study|Adverse Event|2
7656875|NCT01463696|26635508|P3|Overall Study|Adverse Event|0
7656876|NCT01463696|26635509|P2|Overall Study|Adverse Event|1
7656877|NCT01463696|26635510|P1|Overall Study|Adverse Event|0
7656878|NCT01463683|26635563|P3|Overall Study|Withdrawal by Subject|2
7656879|NCT01463683|26635564|P2|Overall Study|Withdrawal by Subject|17
7656880|NCT01463683|26635565|P1|Overall Study|Withdrawal by Subject|5
7656881|NCT01463683|26635563|P3|Overall Study|Pregnancy|1
7656882|NCT01463683|26635564|P2|Overall Study|Pregnancy|2
7656883|NCT01463683|26635565|P1|Overall Study|Pregnancy|2
7656884|NCT01463683|26635563|P3|Overall Study|Physician Decision|1
7656885|NCT01463683|26635564|P2|Overall Study|Physician Decision|3
7656886|NCT01463683|26635565|P1|Overall Study|Physician Decision|0
7656887|NCT01463683|26635563|P3|Overall Study|Lost to Follow-up|7
7656888|NCT01463683|26635564|P2|Overall Study|Lost to Follow-up|9
7656889|NCT01463683|26635565|P1|Overall Study|Lost to Follow-up|10
7656890|NCT01463683|26635563|P3|Overall Study|Adverse Event|0
7656891|NCT01463683|26635564|P2|Overall Study|Adverse Event|0
7656892|NCT01463683|26635565|P1|Overall Study|Adverse Event|2
7656893|NCT01463631|26635582|P4|Overall Study|Progressive Disease|5
7656894|NCT01463631|26635583|P3|Overall Study|Progressive Disease|0
7656895|NCT01463631|26635584|P2|Overall Study|Progressive Disease|0
7656896|NCT01463631|26635585|P1|Overall Study|Progressive Disease|0
7656897|NCT01463631|26635582|P4|Overall Study|Death|0
7656898|NCT01463631|26635583|P3|Overall Study|Death|1
7656899|NCT01463631|26635584|P2|Overall Study|Death|0
7656900|NCT01463631|26635585|P1|Overall Study|Death|0
7656901|NCT01463631|26635582|P4|Overall Study|Withdrawal by Subject|1
7656902|NCT01463631|26635583|P3|Overall Study|Withdrawal by Subject|0
7656903|NCT01463631|26635584|P2|Overall Study|Withdrawal by Subject|0
7656904|NCT01463631|26635585|P1|Overall Study|Withdrawal by Subject|0
7656905|NCT01463527|26635607|P2|Overall Study|Crying >20% of sedation|6
7656906|NCT01463527|26635608|P1|Overall Study|Crying >20% of sedation|5
7656907|NCT01463527|26635607|P2|Overall Study|Protocol Violation|1
7656908|NCT01463527|26635608|P1|Overall Study|Protocol Violation|1
7656909|NCT01463306|26635644|P3|Overall Study|Approval expiry at site|0
7656910|NCT01463306|26635645|P2|Overall Study|Approval expiry at site|0
7656911|NCT01463306|26635646|P1|Overall Study|Approval expiry at site|1
7656912|NCT01463306|26635644|P3|Overall Study|Other|0
7656913|NCT01463306|26635645|P2|Overall Study|Other|13
7656914|NCT01463306|26635646|P1|Overall Study|Other|26
7656915|NCT01463306|26635644|P3|Overall Study|Withdrawal by Subject|1
7656916|NCT01463306|26635645|P2|Overall Study|Withdrawal by Subject|9
7656917|NCT01463306|26635646|P1|Overall Study|Withdrawal by Subject|19
7656918|NCT01463306|26635644|P3|Overall Study|Protocol Violation|0
7656919|NCT01463306|26635645|P2|Overall Study|Protocol Violation|0
7656920|NCT01463306|26635646|P1|Overall Study|Protocol Violation|4
7656921|NCT01463306|26635644|P3|Overall Study|Lost to Follow-up|0
7656922|NCT01463306|26635645|P2|Overall Study|Lost to Follow-up|2
7656923|NCT01463306|26635646|P1|Overall Study|Lost to Follow-up|5
7656924|NCT01463306|26635644|P3|Overall Study|Lack of Efficacy|1
7656925|NCT01463306|26635645|P2|Overall Study|Lack of Efficacy|16
7656926|NCT01463306|26635646|P1|Overall Study|Lack of Efficacy|22
7656927|NCT01463306|26635644|P3|Overall Study|Death|0
7656928|NCT01463306|26635645|P2|Overall Study|Death|3
7656929|NCT01463306|26635646|P1|Overall Study|Death|3
7656930|NCT01463306|26635644|P3|Overall Study|Adverse Event|3
7656931|NCT01463306|26635645|P2|Overall Study|Adverse Event|9
7656932|NCT01463306|26635646|P1|Overall Study|Adverse Event|6
7656933|NCT01463293|26635717|P3|Overall Study|Other|2
7656934|NCT01463293|26635718|P2|Overall Study|Other|0
7656935|NCT01463293|26635719|P1|Overall Study|Other|0
7656936|NCT01463293|26635717|P3|Overall Study|Withdrawal by Subject|5
7656937|NCT01463293|26635718|P2|Overall Study|Withdrawal by Subject|10
7656938|NCT01463293|26635719|P1|Overall Study|Withdrawal by Subject|4
7656939|NCT01463293|26635717|P3|Overall Study|Adverse Event|0
7656940|NCT01463293|26635718|P2|Overall Study|Adverse Event|2
7656941|NCT01463293|26635719|P1|Overall Study|Adverse Event|1
7656942|NCT01463293|26635717|P3|Overall Study|Lost to Follow-up|5
7656943|NCT01463293|26635718|P2|Overall Study|Lost to Follow-up|4
7656944|NCT01463293|26635719|P1|Overall Study|Lost to Follow-up|1
7656945|NCT01463111|26635763|P1|Overall Study|Physician Decision|2
7656946|NCT01463111|26635763|P1|Overall Study|Lost to Follow-up|5
7656947|NCT01463111|26635763|P1|Overall Study|Withdrawal by Subject|2
7656948|NCT01463098|26635785|P14|Part B (11 Days)|Participant Choice|0
7656949|NCT01463098|26635786|P13|Part B (11 Days)|Participant Choice|0
7656950|NCT01463098|26635787|P12|Part B (11 Days)|Participant Choice|1
7656951|NCT01463098|26635788|P11|Part B (11 Days)|Participant Choice|0
7656952|NCT01463098|26635789|P10|Part B (11 Days)|Participant Choice|0
7656953|NCT01463098|26635790|P9|Part B (11 Days)|Participant Choice|0
7656954|NCT01463098|26635791|P8|Part B (11 Days)|Participant Choice|0
7656955|NCT01463098|26635792|P7|Part B (11 Days)|Participant Choice|0
7656956|NCT01463098|26635793|P6|Part B (11 Days)|Participant Choice|0
7656957|NCT01463098|26635794|P5|Part B (11 Days)|Participant Choice|0
7656958|NCT01463098|26635795|P4|Part B (11 Days)|Participant Choice|0
7656959|NCT01463098|26635796|P3|Part B (11 Days)|Participant Choice|0
7656960|NCT01463098|26635797|P2|Part B (11 Days)|Participant Choice|0
7656961|NCT01463098|26635798|P1|Part B (11 Days)|Participant Choice|0
7656962|NCT01463098|26635785|P14|Part A (11 Days)|Lost to Follow-up|0
7656963|NCT01463098|26635786|P13|Part A (11 Days)|Lost to Follow-up|0
7656964|NCT01463098|26635787|P12|Part A (11 Days)|Lost to Follow-up|0
7656965|NCT01463098|26635788|P11|Part A (11 Days)|Lost to Follow-up|0
7656966|NCT01463098|26635789|P10|Part A (11 Days)|Lost to Follow-up|0
7656967|NCT01463098|26635790|P9|Part A (11 Days)|Lost to Follow-up|0
7656968|NCT01463098|26635791|P8|Part A (11 Days)|Lost to Follow-up|0
7656969|NCT01463098|26635792|P7|Part A (11 Days)|Lost to Follow-up|0
7656970|NCT01463098|26635793|P6|Part A (11 Days)|Lost to Follow-up|0
7656971|NCT01463098|26635794|P5|Part A (11 Days)|Lost to Follow-up|1
7656972|NCT01463098|26635795|P4|Part A (11 Days)|Lost to Follow-up|0
7656973|NCT01463098|26635796|P3|Part A (11 Days)|Lost to Follow-up|0
7656974|NCT01463098|26635797|P2|Part A (11 Days)|Lost to Follow-up|0
7656975|NCT01463098|26635798|P1|Part A (11 Days)|Lost to Follow-up|0
7656976|NCT01463098|26635785|P14|Part A (11 Days)|Participant Choice|0
7656977|NCT01463098|26635786|P13|Part A (11 Days)|Participant Choice|0
7656978|NCT01463098|26635787|P12|Part A (11 Days)|Participant Choice|0
7656979|NCT01463098|26635788|P11|Part A (11 Days)|Participant Choice|0
7656980|NCT01463098|26635789|P10|Part A (11 Days)|Participant Choice|0
7656981|NCT01463098|26635790|P9|Part A (11 Days)|Participant Choice|1
7656982|NCT01463098|26635791|P8|Part A (11 Days)|Participant Choice|0
7656983|NCT01463098|26635792|P7|Part A (11 Days)|Participant Choice|0
7656984|NCT01463098|26635793|P6|Part A (11 Days)|Participant Choice|0
7656985|NCT01463098|26635794|P5|Part A (11 Days)|Participant Choice|0
7656986|NCT01463098|26635795|P4|Part A (11 Days)|Participant Choice|0
7656987|NCT01463098|26635796|P3|Part A (11 Days)|Participant Choice|0
7656988|NCT01463098|26635797|P2|Part A (11 Days)|Participant Choice|0
7656989|NCT01463098|26635798|P1|Part A (11 Days)|Participant Choice|2
7656990|NCT01463033|26636121|P2|Overall Study|Death|2
7656991|NCT01463033|26636122|P1|Overall Study|Death|3
7656992|NCT01463033|26636121|P2|Overall Study|Lost to Follow-up|4
7656993|NCT01463033|26636122|P1|Overall Study|Lost to Follow-up|4
7656994|NCT01463007|26636129|P1|Overall Study|Physician Decision|1
7656995|NCT01462942|26636140|P5|Overall Study|Protocol Violation|6
7656996|NCT01462942|26636141|P4|Overall Study|Protocol Violation|9
7656997|NCT01462942|26636142|P3|Overall Study|Protocol Violation|9
7656998|NCT01462942|26636143|P2|Overall Study|Protocol Violation|6
7656999|NCT01462942|26636144|P1|Overall Study|Protocol Violation|4
7657000|NCT01462942|26636140|P5|Overall Study|Lost to Follow-up|1
7657001|NCT01462942|26636141|P4|Overall Study|Lost to Follow-up|1
7657002|NCT01462942|26636142|P3|Overall Study|Lost to Follow-up|1
7657003|NCT01462942|26636143|P2|Overall Study|Lost to Follow-up|1
7657004|NCT01462942|26636144|P1|Overall Study|Lost to Follow-up|0
7657005|NCT01462942|26636140|P5|Overall Study|Lack of Efficacy|3
7657006|NCT01462942|26636141|P4|Overall Study|Lack of Efficacy|5
7657007|NCT01462942|26636142|P3|Overall Study|Lack of Efficacy|4
7657008|NCT01462942|26636143|P2|Overall Study|Lack of Efficacy|0
7657009|NCT01462942|26636144|P1|Overall Study|Lack of Efficacy|6
7657010|NCT01462942|26636140|P5|Overall Study|Withdrawal by Subject|19
7657011|NCT01462942|26636141|P4|Overall Study|Withdrawal by Subject|16
7657012|NCT01462942|26636142|P3|Overall Study|Withdrawal by Subject|14
7657013|NCT01462942|26636143|P2|Overall Study|Withdrawal by Subject|10
7657014|NCT01462942|26636144|P1|Overall Study|Withdrawal by Subject|14
7657015|NCT01462942|26636140|P5|Overall Study|Other, including COPD exacerbation|5
7657016|NCT01462942|26636141|P4|Overall Study|Other, including COPD exacerbation|8
7657017|NCT01462942|26636142|P3|Overall Study|Other, including COPD exacerbation|2
7657018|NCT01462942|26636143|P2|Overall Study|Other, including COPD exacerbation|5
7657019|NCT01462942|26636144|P1|Overall Study|Other, including COPD exacerbation|3
7657020|NCT01462942|26636140|P5|Overall Study|Adverse Event|11
7657021|NCT01462942|26636141|P4|Overall Study|Adverse Event|11
7657022|NCT01462942|26636142|P3|Overall Study|Adverse Event|10
7657023|NCT01462942|26636143|P2|Overall Study|Adverse Event|12
7657024|NCT01462942|26636144|P1|Overall Study|Adverse Event|7
7657025|NCT01462929|26636174|P3|Overall Study|Lack of Efficacy|1
7657026|NCT01462929|26636175|P2|Overall Study|Lack of Efficacy|0
7657027|NCT01462929|26636176|P1|Overall Study|Lack of Efficacy|0
7657028|NCT01462929|26636174|P3|Overall Study|Withdrawal by Subject|0
7657029|NCT01462929|26636175|P2|Overall Study|Withdrawal by Subject|1
7657030|NCT01462929|26636176|P1|Overall Study|Withdrawal by Subject|2
7657031|NCT01462929|26636174|P3|Overall Study|Adverse Event|4
7657032|NCT01462929|26636175|P2|Overall Study|Adverse Event|3
7657033|NCT01462929|26636176|P1|Overall Study|Adverse Event|3
7657034|NCT01462695|26636217|P2|Overall Study|Inevaluable (did not receive study drug)|0
7657035|NCT01462695|26636218|P1|Overall Study|Inevaluable (did not receive study drug)|1
7657036|NCT01462695|26636217|P2|Overall Study|Withdrawal by Subject|0
7657037|NCT01462695|26636218|P1|Overall Study|Withdrawal by Subject|2
7657038|NCT01462695|26636217|P2|Overall Study|Physician Decision|0
7657039|NCT01462695|26636218|P1|Overall Study|Physician Decision|5
7657040|NCT01462695|26636217|P2|Overall Study|Lack of Efficacy|12
7657041|NCT01462695|26636218|P1|Overall Study|Lack of Efficacy|6
7657042|NCT01462695|26636217|P2|Overall Study|Death|0
7657043|NCT01462695|26636218|P1|Overall Study|Death|2
7657044|NCT01462695|26636217|P2|Overall Study|Adverse Event|1
7657045|NCT01462695|26636218|P1|Overall Study|Adverse Event|1
7657046|NCT01462435|26636246|P4|Overall Study|Lost to Follow-up|1
7657047|NCT01462435|26636247|P3|Overall Study|Lost to Follow-up|0
7657048|NCT01462435|26636248|P2|Overall Study|Lost to Follow-up|0
7657049|NCT01462435|26636249|P1|Overall Study|Lost to Follow-up|0
7657050|NCT01462435|26636246|P4|Overall Study|Withdrawal by Subject|1
7657051|NCT01462435|26636247|P3|Overall Study|Withdrawal by Subject|0
7657052|NCT01462435|26636248|P2|Overall Study|Withdrawal by Subject|0
7657053|NCT01462435|26636249|P1|Overall Study|Withdrawal by Subject|0
7657054|NCT01462435|26636246|P4|Overall Study|Physician Decision|0
7657055|NCT01462435|26636247|P3|Overall Study|Physician Decision|1
7657056|NCT01462435|26636248|P2|Overall Study|Physician Decision|0
7657057|NCT01462435|26636249|P1|Overall Study|Physician Decision|0
7657058|NCT01462435|26636246|P4|Overall Study|Lack of Efficacy|3
7657059|NCT01462435|26636247|P3|Overall Study|Lack of Efficacy|0
7657060|NCT01462435|26636248|P2|Overall Study|Lack of Efficacy|0
7657061|NCT01462435|26636249|P1|Overall Study|Lack of Efficacy|1
7657062|NCT01462370|26636287|P2|Overall Study|Withdrawal by Subject|3
7657063|NCT01462370|26636288|P1|Overall Study|Withdrawal by Subject|0
7657064|NCT01462370|26636287|P2|Overall Study|Physician Decision|1
7657065|NCT01462370|26636288|P1|Overall Study|Physician Decision|0
7657066|NCT01462370|26636287|P2|Overall Study|Lack of Qualifying Event|1
7657067|NCT01462370|26636288|P1|Overall Study|Lack of Qualifying Event|1
7657068|NCT01462357|26636323|P3|Overall Study|Lost to Follow-up|7
7657069|NCT01462357|26636324|P2|Overall Study|Lost to Follow-up|5
7657070|NCT01462357|26636325|P1|Overall Study|Lost to Follow-up|3
7657071|NCT01462357|26636323|P3|Overall Study|Migrated/moved from study area|1
7657072|NCT01462357|26636324|P2|Overall Study|Migrated/moved from study area|3
7657073|NCT01462357|26636325|P1|Overall Study|Migrated/moved from study area|2
7657074|NCT01462357|26636323|P3|Overall Study|Withdrawal by Subject|3
7657075|NCT01462357|26636324|P2|Overall Study|Withdrawal by Subject|11
7657076|NCT01462357|26636325|P1|Overall Study|Withdrawal by Subject|3
7657077|NCT01462357|26636323|P3|Overall Study|Death|1
7657078|NCT01462357|26636324|P2|Overall Study|Death|0
7657079|NCT01462357|26636325|P1|Overall Study|Death|0
7657080|NCT01462344|26636398|P2|Overall Study|Lost to Follow-up|7
7657081|NCT01462344|26636399|P1|Overall Study|Lost to Follow-up|7
7657082|NCT01462344|26636398|P2|Overall Study|Protocol Violation|53
7657083|NCT01462344|26636399|P1|Overall Study|Protocol Violation|68
7657084|NCT01462344|26636398|P2|Overall Study|Lack of Efficacy|6
7657085|NCT01462344|26636399|P1|Overall Study|Lack of Efficacy|5
7657086|NCT01462344|26636398|P2|Overall Study|Asthma Exacerbation|35
7657087|NCT01462344|26636399|P1|Overall Study|Asthma Exacerbation|34
7657088|NCT01462344|26636398|P2|Overall Study|Adverse Event|23
7657089|NCT01462344|26636399|P1|Overall Study|Adverse Event|24
7657090|NCT01462344|26636398|P2|Overall Study|Withdrawal by Subject|226
7657091|NCT01462344|26636399|P1|Overall Study|Withdrawal by Subject|245
7657092|NCT01462318|26636421|P3|Extension Phase|Adverse Event|22
7657093|NCT01462318|26636422|P2|Extension Phase|Adverse Event|0
7657094|NCT01462318|26636423|P1|Extension Phase|Adverse Event|0
7657095|NCT01462318|26636421|P3|Extension Phase|Investigator Decision|5
7657096|NCT01462318|26636422|P2|Extension Phase|Investigator Decision|0
7657097|NCT01462318|26636423|P1|Extension Phase|Investigator Decision|0
7657098|NCT01462318|26636421|P3|Extension Phase|Withdrawal by Subject|15
7657099|NCT01462318|26636422|P2|Extension Phase|Withdrawal by Subject|0
7657100|NCT01462318|26636423|P1|Extension Phase|Withdrawal by Subject|0
7657101|NCT01462318|26636421|P3|Extension Phase|Disease Progression|1
7657102|NCT01462318|26636422|P2|Extension Phase|Disease Progression|0
7657103|NCT01462318|26636423|P1|Extension Phase|Disease Progression|0
7657104|NCT01462318|26636421|P3|Extension Phase|Other|1
7657105|NCT01462318|26636422|P2|Extension Phase|Other|0
7657106|NCT01462318|26636423|P1|Extension Phase|Other|0
7657107|NCT01462318|26636421|P3|Extension Phase|Lost to Follow-up|1
7657108|NCT01462318|26636422|P2|Extension Phase|Lost to Follow-up|0
7657109|NCT01462318|26636423|P1|Extension Phase|Lost to Follow-up|0
7657110|NCT01462318|26636421|P3|Main Study / TP-DI Study|Adverse Event|0
7657111|NCT01462318|26636422|P2|Main Study / TP-DI Study|Adverse Event|0
7657112|NCT01462318|26636423|P1|Main Study / TP-DI Study|Adverse Event|4
7657113|NCT01462318|26636421|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
7657114|NCT01462318|26636422|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
7657115|NCT01462318|26636423|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
7657116|NCT01462318|26636421|P3|Main Study / TP-DI Study|Other|0
7657117|NCT01462318|26636422|P2|Main Study / TP-DI Study|Other|0
7657118|NCT01462318|26636423|P1|Main Study / TP-DI Study|Other|2
7657119|NCT01462266|26636524|P2|Overall Study|Screen failure|1
7657120|NCT01462266|26636525|P1|Overall Study|Screen failure|1
7657121|NCT01462266|26636524|P2|Overall Study|Withdrawal by Subject|2
7657122|NCT01462266|26636525|P1|Overall Study|Withdrawal by Subject|7
7657123|NCT01462266|26636524|P2|Overall Study|Protocol Violation|3
7657124|NCT01462266|26636525|P1|Overall Study|Protocol Violation|1
7657125|NCT01462266|26636524|P2|Overall Study|Physician Decision|5
7657126|NCT01462266|26636525|P1|Overall Study|Physician Decision|2
7657127|NCT01462266|26636524|P2|Overall Study|Creatinine and eGFR, excluded medication|4
7657128|NCT01462266|26636525|P1|Overall Study|Creatinine and eGFR, excluded medication|8
7657129|NCT01462266|26636524|P2|Overall Study|Non-compliance with study drug|0
7657130|NCT01462266|26636525|P1|Overall Study|Non-compliance with study drug|3
7657131|NCT01462266|26636524|P2|Overall Study|Lost to Follow-up|3
7657132|NCT01462266|26636525|P1|Overall Study|Lost to Follow-up|4
7657133|NCT01462266|26636524|P2|Overall Study|Lack of Efficacy|2
7657134|NCT01462266|26636525|P1|Overall Study|Lack of Efficacy|0
7657135|NCT01462266|26636524|P2|Overall Study|Death|1
7657136|NCT01462266|26636525|P1|Overall Study|Death|2
7657137|NCT01462266|26636524|P2|Overall Study|Adverse Event|6
7657138|NCT01462266|26636525|P1|Overall Study|Adverse Event|7
7657139|NCT01462227|26636550|P4|Second Assignment|Protocol Violation|0
7657140|NCT01462227|26636551|P3|Second Assignment|Protocol Violation|1
7657141|NCT01462227|26636552|P2|Second Assignment|Protocol Violation|1
7657142|NCT01462227|26636553|P1|Second Assignment|Protocol Violation|0
7657143|NCT01462227|26636550|P4|Second Assignment|Lost to Follow-up|0
7657144|NCT01462227|26636551|P3|Second Assignment|Lost to Follow-up|0
7657145|NCT01462227|26636552|P2|Second Assignment|Lost to Follow-up|0
7657146|NCT01462227|26636553|P1|Second Assignment|Lost to Follow-up|1
7657147|NCT01462162|26636571|P1|Overall Study|Other|2
7657148|NCT01462162|26636571|P1|Overall Study|Abnormal laboratory parameters|1
7657149|NCT01462162|26636571|P1|Overall Study|Lack of Efficacy|4
7657150|NCT01462162|26636571|P1|Overall Study|Adverse Event|5
7657151|NCT01462110|26636598|P2|Overall Study|Adverse Event|0
7657152|NCT01462110|26636599|P1|Overall Study|Adverse Event|1
7657153|NCT01462084|26636619|P2|Overall Study|Protocol Violation|1
7657154|NCT01462084|26636620|P1|Overall Study|Protocol Violation|1
7657155|NCT01462084|26636619|P2|Overall Study|Withdrawal by Subject|0
7657156|NCT01462084|26636620|P1|Overall Study|Withdrawal by Subject|1
7657157|NCT01462045|26636631|P3|Overall Study|Family matter|0
7657158|NCT01462045|26636632|P2|Overall Study|Family matter|1
7657159|NCT01462045|26636633|P1|Overall Study|Family matter|0
7657160|NCT01461993|26636647|P3|Overall Study|Other|6
7657161|NCT01461993|26636648|P2|Overall Study|Other|15
7657162|NCT01461993|26636649|P1|Overall Study|Other|13
7657163|NCT01461993|26636647|P3|Overall Study|Did not meet entrance criteria|0
7657164|NCT01461993|26636648|P2|Overall Study|Did not meet entrance criteria|3
7657165|NCT01461993|26636649|P1|Overall Study|Did not meet entrance criteria|2
7657166|NCT01461993|26636647|P3|Overall Study|No longer met eligibility criteria|10
7657167|NCT01461993|26636648|P2|Overall Study|No longer met eligibility criteria|18
7657168|NCT01461993|26636649|P1|Overall Study|No longer met eligibility criteria|13
7657169|NCT01461993|26636647|P3|Overall Study|Adverse Event|3
7657170|NCT01461993|26636648|P2|Overall Study|Adverse Event|11
7657171|NCT01461993|26636649|P1|Overall Study|Adverse Event|9
7657172|NCT01461993|26636647|P3|Overall Study|Protocol Violation|7
7657173|NCT01461993|26636648|P2|Overall Study|Protocol Violation|9
7657174|NCT01461993|26636649|P1|Overall Study|Protocol Violation|10
7657175|NCT01461993|26636647|P3|Overall Study|Lost to Follow-up|22
7657176|NCT01461993|26636648|P2|Overall Study|Lost to Follow-up|48
7657177|NCT01461993|26636649|P1|Overall Study|Lost to Follow-up|44
7657178|NCT01461993|26636647|P3|Overall Study|Withdrawal by Subject|16
7657179|NCT01461993|26636648|P2|Overall Study|Withdrawal by Subject|53
7657180|NCT01461993|26636649|P1|Overall Study|Withdrawal by Subject|60
7657181|NCT01461980|26636674|P3|Overall Study|Randomized but not vaccinated|7
7657182|NCT01461980|26636675|P2|Overall Study|Randomized but not vaccinated|8
7657183|NCT01461980|26636676|P1|Overall Study|Randomized but not vaccinated|4
7657184|NCT01461980|26636674|P3|Overall Study|No longer willing to participate|54
7657185|NCT01461980|26636675|P2|Overall Study|No longer willing to participate|38
7657186|NCT01461980|26636676|P1|Overall Study|No longer willing to participate|52
7657187|NCT01461980|26636674|P3|Overall Study|Lost to Follow-up|51
7657188|NCT01461980|26636675|P2|Overall Study|Lost to Follow-up|53
7657189|NCT01461980|26636676|P1|Overall Study|Lost to Follow-up|52
7657190|NCT01461980|26636674|P3|Overall Study|No longer meets eligibility criteria|19
7657191|NCT01461980|26636675|P2|Overall Study|No longer meets eligibility criteria|9
7657192|NCT01461980|26636676|P1|Overall Study|No longer meets eligibility criteria|18
7657193|NCT01461980|26636674|P3|Overall Study|Protocol Violation|16
7657194|NCT01461980|26636675|P2|Overall Study|Protocol Violation|19
7657195|NCT01461980|26636676|P1|Overall Study|Protocol Violation|12
7657196|NCT01461980|26636674|P3|Overall Study|Adverse Event|6
7657197|NCT01461980|26636675|P2|Overall Study|Adverse Event|5
7657198|NCT01461980|26636676|P1|Overall Study|Adverse Event|12
7657199|NCT01461980|26636674|P3|Overall Study|Medication error|6
7657200|NCT01461980|26636675|P2|Overall Study|Medication error|5
7657201|NCT01461980|26636676|P1|Overall Study|Medication error|7
7657202|NCT01461980|26636674|P3|Overall Study|Other|6
7657203|NCT01461980|26636675|P2|Overall Study|Other|8
7657204|NCT01461980|26636676|P1|Overall Study|Other|9
7657205|NCT01461928|26636706|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
7657206|NCT01461928|26636707|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
7657207|NCT01461928|26636708|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
7657208|NCT01461928|26636706|P3|Maintenance II (15 Months)|Withdrew informed consent|1
7657209|NCT01461928|26636707|P2|Maintenance II (15 Months)|Withdrew informed consent|0
7657210|NCT01461928|26636708|P1|Maintenance II (15 Months)|Withdrew informed consent|0
7657211|NCT01461928|26636706|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
7657212|NCT01461928|26636707|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
7657213|NCT01461928|26636708|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
7657214|NCT01461928|26636706|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
7657215|NCT01461928|26636707|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
7657216|NCT01461928|26636708|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
7657217|NCT01461928|26636706|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
7657218|NCT01461928|26636707|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
7657219|NCT01461928|26636708|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
7657220|NCT01461928|26636706|P3|Maintenance II (15 Months)|Disease progression|3
7657221|NCT01461928|26636707|P2|Maintenance II (15 Months)|Disease progression|0
7657222|NCT01461928|26636708|P1|Maintenance II (15 Months)|Disease progression|0
7657223|NCT01461928|26636706|P3|Maintenance II (15 Months)|Moved to another town|0
7657224|NCT01461928|26636707|P2|Maintenance II (15 Months)|Moved to another town|1
7657225|NCT01461928|26636708|P1|Maintenance II (15 Months)|Moved to another town|0
7657226|NCT01461928|26636706|P3|Maintenance II (15 Months)|Lost to Follow-up|0
7657227|NCT01461928|26636707|P2|Maintenance II (15 Months)|Lost to Follow-up|1
7657228|NCT01461928|26636708|P1|Maintenance II (15 Months)|Lost to Follow-up|0
7657229|NCT01461928|26636706|P3|Maintenance II (15 Months)|Physician Decision|4
7657230|NCT01461928|26636707|P2|Maintenance II (15 Months)|Physician Decision|0
7657231|NCT01461928|26636708|P1|Maintenance II (15 Months)|Physician Decision|0
7657232|NCT01461928|26636706|P3|Maintenance II (15 Months)|Death|8
7657233|NCT01461928|26636707|P2|Maintenance II (15 Months)|Death|10
7657234|NCT01461928|26636708|P1|Maintenance II (15 Months)|Death|0
7657235|NCT01461928|26636706|P3|Maintenance II (15 Months)|Adverse Event|0
7657236|NCT01461928|26636707|P2|Maintenance II (15 Months)|Adverse Event|2
7657237|NCT01461928|26636708|P1|Maintenance II (15 Months)|Adverse Event|0
7657238|NCT01461928|26636706|P3|Maintenance I (24 Months)|Did not meet criteria|0
7657239|NCT01461928|26636707|P2|Maintenance I (24 Months)|Did not meet criteria|0
7657240|NCT01461928|26636708|P1|Maintenance I (24 Months)|Did not meet criteria|5
7657241|NCT01461928|26636706|P3|Maintenance I (24 Months)|Not compliant|0
7657242|NCT01461928|26636707|P2|Maintenance I (24 Months)|Not compliant|0
7657243|NCT01461928|26636708|P1|Maintenance I (24 Months)|Not compliant|1
7657244|NCT01461928|26636706|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
7657245|NCT01461928|26636707|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
7657246|NCT01461928|26636708|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
7657247|NCT01461928|26636706|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7657248|NCT01461928|26636707|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7657249|NCT01461928|26636708|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
7657250|NCT01461928|26636706|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
7657251|NCT01461928|26636707|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
7657252|NCT01461928|26636708|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
7657253|NCT01461928|26636706|P3|Maintenance I (24 Months)|Physician Decision|0
7657254|NCT01461928|26636707|P2|Maintenance I (24 Months)|Physician Decision|0
7657255|NCT01461928|26636708|P1|Maintenance I (24 Months)|Physician Decision|9
7657256|NCT01461928|26636706|P3|Maintenance I (24 Months)|Adverse Event|0
7657257|NCT01461928|26636707|P2|Maintenance I (24 Months)|Adverse Event|0
7657258|NCT01461928|26636708|P1|Maintenance I (24 Months)|Adverse Event|70
7657259|NCT01461928|26636706|P3|Maintenance I (24 Months)|Diseases progression|0
7657260|NCT01461928|26636707|P2|Maintenance I (24 Months)|Diseases progression|0
7657261|NCT01461928|26636708|P1|Maintenance I (24 Months)|Diseases progression|91
7657262|NCT01461928|26636706|P3|Maintenance I (24 Months)|Lost to Follow-up|0
7657263|NCT01461928|26636707|P2|Maintenance I (24 Months)|Lost to Follow-up|0
7657264|NCT01461928|26636708|P1|Maintenance I (24 Months)|Lost to Follow-up|2
7657265|NCT01461928|26636706|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
7657266|NCT01461928|26636707|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
7657267|NCT01461928|26636708|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
7657268|NCT01461928|26636706|P3|Maintenance I (24 Months)|Death|0
7657269|NCT01461928|26636707|P2|Maintenance I (24 Months)|Death|0
7657270|NCT01461928|26636708|P1|Maintenance I (24 Months)|Death|3
7657271|NCT01461928|26636706|P3|Induction (up to 8 Months)|Medical advisor request|0
7657272|NCT01461928|26636707|P2|Induction (up to 8 Months)|Medical advisor request|0
7657273|NCT01461928|26636708|P1|Induction (up to 8 Months)|Medical advisor request|1
7657274|NCT01461928|26636706|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7657275|NCT01461928|26636707|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7657276|NCT01461928|26636708|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
7657277|NCT01461928|26636706|P3|Induction (up to 8 Months)|Promotor request|0
7657278|NCT01461928|26636707|P2|Induction (up to 8 Months)|Promotor request|0
7657279|NCT01461928|26636708|P1|Induction (up to 8 Months)|Promotor request|1
7657280|NCT01461928|26636706|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7657281|NCT01461928|26636707|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7657282|NCT01461928|26636708|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
7657283|NCT01461928|26636706|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7657284|NCT01461928|26636707|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7657285|NCT01461928|26636708|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
7657286|NCT01461928|26636706|P3|Induction (up to 8 Months)|Protocol deviation|0
7657287|NCT01461928|26636707|P2|Induction (up to 8 Months)|Protocol deviation|0
7657288|NCT01461928|26636708|P1|Induction (up to 8 Months)|Protocol deviation|2
7657289|NCT01461928|26636706|P3|Induction (up to 8 Months)|Sponsor decision|0
7657290|NCT01461928|26636707|P2|Induction (up to 8 Months)|Sponsor decision|0
7657291|NCT01461928|26636708|P1|Induction (up to 8 Months)|Sponsor decision|1
7657292|NCT01461928|26636706|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7657293|NCT01461928|26636707|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7657294|NCT01461928|26636708|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
7657295|NCT01461928|26636706|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
7657296|NCT01461928|26636707|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
7657297|NCT01461928|26636708|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
7657298|NCT01461928|26636706|P3|Induction (up to 8 Months)|Not responding to treatment|0
7657299|NCT01461928|26636707|P2|Induction (up to 8 Months)|Not responding to treatment|0
7657300|NCT01461928|26636708|P1|Induction (up to 8 Months)|Not responding to treatment|11
7657301|NCT01461928|26636706|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7657302|NCT01461928|26636707|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7657303|NCT01461928|26636708|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
7657304|NCT01461928|26636706|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
7657305|NCT01461928|26636707|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
7657306|NCT01461928|26636708|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
7657307|NCT01461928|26636706|P3|Induction (up to 8 Months)|Disease progression|0
7657308|NCT01461928|26636707|P2|Induction (up to 8 Months)|Disease progression|0
7657309|NCT01461928|26636708|P1|Induction (up to 8 Months)|Disease progression|45
7657310|NCT01461928|26636706|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
7657311|NCT01461928|26636707|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
7657312|NCT01461928|26636708|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
7657313|NCT01461928|26636706|P3|Induction (up to 8 Months)|Physician Decision|0
7657314|NCT01461928|26636707|P2|Induction (up to 8 Months)|Physician Decision|0
7657315|NCT01461928|26636708|P1|Induction (up to 8 Months)|Physician Decision|9
7657316|NCT01461928|26636706|P3|Induction (up to 8 Months)|Lost to Follow-up|0
7657317|NCT01461928|26636707|P2|Induction (up to 8 Months)|Lost to Follow-up|0
7657318|NCT01461928|26636708|P1|Induction (up to 8 Months)|Lost to Follow-up|5
7657319|NCT01461928|26636706|P3|Induction (up to 8 Months)|Death|0
7657320|NCT01461928|26636707|P2|Induction (up to 8 Months)|Death|0
7657321|NCT01461928|26636708|P1|Induction (up to 8 Months)|Death|3
7657322|NCT01461928|26636706|P3|Induction (up to 8 Months)|Adverse Event|0
7657323|NCT01461928|26636707|P2|Induction (up to 8 Months)|Adverse Event|0
7657324|NCT01461928|26636708|P1|Induction (up to 8 Months)|Adverse Event|76
7657325|NCT01461811|26636759|P2|Overall Study|Noncompliance|1
7657326|NCT01461811|26636760|P1|Overall Study|Noncompliance|1
7657327|NCT01461811|26636759|P2|Overall Study|Subject decision unrelated to an AE|1
7657328|NCT01461811|26636760|P1|Overall Study|Subject decision unrelated to an AE|1
7657329|NCT01461811|26636759|P2|Overall Study|Adverse Event|1
7657330|NCT01461811|26636760|P1|Overall Study|Adverse Event|2
7657331|NCT01461707|26636799|P2|Overall Study|Withdrawal by Subject|0
7657332|NCT01461707|26636800|P1|Overall Study|Withdrawal by Subject|1
7657333|NCT01461551|26636837|P3|Overall Study|Physician Decision|2
7657334|NCT01461551|26636838|P2|Overall Study|Physician Decision|1
7657335|NCT01461551|26636839|P1|Overall Study|Physician Decision|2
7657336|NCT01461538|26636850|P3|Overall Study|Withdrawal by Subject|0
7657337|NCT01461538|26636851|P2|Overall Study|Withdrawal by Subject|1
7657338|NCT01461538|26636852|P1|Overall Study|Withdrawal by Subject|1
7657339|NCT01461538|26636850|P3|Overall Study|Study Stopped by Sponsor|0
7657340|NCT01461538|26636851|P2|Overall Study|Study Stopped by Sponsor|1
7657341|NCT01461538|26636852|P1|Overall Study|Study Stopped by Sponsor|2
7657342|NCT01461538|26636850|P3|Overall Study|Death|2
7657343|NCT01461538|26636851|P2|Overall Study|Death|6
7657344|NCT01461538|26636852|P1|Overall Study|Death|15
7657345|NCT01461369|26636921|P3|Overall Study|Withdrawal by Subject|2
7657346|NCT01461369|26636922|P2|Overall Study|Withdrawal by Subject|3
7657347|NCT01461369|26636923|P1|Overall Study|Withdrawal by Subject|1
7657348|NCT01461369|26636921|P3|Overall Study|Protocol Violation|2
7657349|NCT01461369|26636922|P2|Overall Study|Protocol Violation|2
7657350|NCT01461369|26636923|P1|Overall Study|Protocol Violation|1
7657351|NCT01461369|26636921|P3|Overall Study|Adverse Event|4
7657352|NCT01461369|26636922|P2|Overall Study|Adverse Event|12
7657353|NCT01461369|26636923|P1|Overall Study|Adverse Event|9
7657354|NCT01461369|26636921|P3|Overall Study|Lost to Follow-up|3
7657355|NCT01461369|26636922|P2|Overall Study|Lost to Follow-up|0
7657356|NCT01461369|26636923|P1|Overall Study|Lost to Follow-up|0
7657357|NCT01461369|26636921|P3|Overall Study|Lack of Efficacy|6
7657358|NCT01461369|26636922|P2|Overall Study|Lack of Efficacy|0
7657359|NCT01461369|26636923|P1|Overall Study|Lack of Efficacy|2
7657360|NCT01461096|26636948|P2|Overall Study|Lost to Follow-up|4
7657361|NCT01461096|26636949|P1|Overall Study|Lost to Follow-up|8
7657362|NCT01461096|26636948|P2|Overall Study|Subj not willing to adhere to reqs|4
7657363|NCT01461096|26636949|P1|Overall Study|Subj not willing to adhere to reqs|3
7657364|NCT01461096|26636948|P2|Overall Study|Withdrawal by Subject|3
7657365|NCT01461096|26636949|P1|Overall Study|Withdrawal by Subject|5
7657366|NCT01461096|26636948|P2|Overall Study|Site is closing|30
7657367|NCT01461096|26636949|P1|Overall Study|Site is closing|27
7657368|NCT01461096|26636948|P2|Overall Study|Subj not able to get to clinic|13
7657369|NCT01461096|26636949|P1|Overall Study|Subj not able to get to clinic|15
7657370|NCT01461096|26636948|P2|Overall Study|Severe debilitation, unable to continue|1
7657371|NCT01461096|26636949|P1|Overall Study|Severe debilitation, unable to continue|1
7657372|NCT01461096|26636948|P2|Overall Study|Death|6
7657373|NCT01461096|26636949|P1|Overall Study|Death|3
7657374|NCT01461057|26636965|P2|Overall Study|Study Terminated by Sponsor|0
7657375|NCT01461057|26636966|P1|Overall Study|Study Terminated by Sponsor|2
7657376|NCT01461057|26636965|P2|Overall Study|Progression of Disease|0
7657377|NCT01461057|26636966|P1|Overall Study|Progression of Disease|1
7657378|NCT01461057|26636965|P2|Overall Study|Adverse Event|1
7657379|NCT01461057|26636966|P1|Overall Study|Adverse Event|0
7657380|NCT01461057|26636965|P2|Overall Study|Physician Decision|2
7657381|NCT01461057|26636966|P1|Overall Study|Physician Decision|0
7657382|NCT01461057|26636965|P2|Overall Study|Withdrawal by Subject|3
7657383|NCT01461057|26636966|P1|Overall Study|Withdrawal by Subject|2
7657384|NCT01461057|26636965|P2|Overall Study|Death|9
7657385|NCT01461057|26636966|P1|Overall Study|Death|10
7657386|NCT01461044|26636976|P2|Overall Study|Lost to Follow-up|5
7657387|NCT01461044|26636977|P1|Overall Study|Lost to Follow-up|12
7657388|NCT01461044|26636976|P2|Overall Study|Death|35
7657389|NCT01461044|26636977|P1|Overall Study|Death|58
7657390|NCT01461005|26637050|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
7657391|NCT01460901|26637073|P1|Overall Study|Withdrawal by Subject|2
7657392|NCT01460719|26637105|P1|Overall Study|Withdrawal by Subject|1
7657393|NCT01460719|26637105|P1|Overall Study|Adverse Event|1
7657394|NCT01460628|26637115|P1|Overall Study|Withdrawal by Subject|2
7657395|NCT01460628|26637115|P1|Overall Study|Adverse Event|3
7657396|NCT01460446|26637127|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
7657397|NCT01460446|26637128|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
7657398|NCT01460446|26637127|P2|Overall Study|Pregnancy|0
7657399|NCT01460446|26637128|P1|Overall Study|Pregnancy|1
7657400|NCT01460446|26637127|P2|Overall Study|Surgery/Illness|1
7657401|NCT01460446|26637128|P1|Overall Study|Surgery/Illness|1
7657402|NCT01460446|26637127|P2|Overall Study|Non-compliance & Consent Withdrawn|3
7657403|NCT01460446|26637128|P1|Overall Study|Non-compliance & Consent Withdrawn|1
7657404|NCT01460446|26637127|P2|Overall Study|Consent Withdrawn|4
7657405|NCT01460446|26637128|P1|Overall Study|Consent Withdrawn|0
7657406|NCT01460446|26637127|P2|Overall Study|Non-compliance|9
7657407|NCT01460446|26637128|P1|Overall Study|Non-compliance|2
7657408|NCT01460407|26637155|P2|Period 2: Day 6 to Day 14|Adverse Event|1
7657409|NCT01460407|26637156|P1|Period 2: Day 6 to Day 14|Adverse Event|0
7657410|NCT01460381|26637169|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
7657411|NCT01460381|26637170|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
7657412|NCT01460368|26637186|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7657413|NCT01460368|26637187|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7657414|NCT01460368|26637188|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7657415|NCT01460368|26637189|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7657416|NCT01460368|26637190|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7657417|NCT01460368|26637191|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7657418|NCT01460368|26637192|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7657419|NCT01460368|26637186|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
7657420|NCT01460368|26637187|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
7657421|NCT01460368|26637188|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
7657422|NCT01460368|26637189|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
7657423|NCT01460368|26637190|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
7657424|NCT01460368|26637191|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
7657425|NCT01460368|26637192|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
7657426|NCT01460368|26637186|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7657427|NCT01460368|26637187|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7657428|NCT01460368|26637188|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7657429|NCT01460368|26637189|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7657430|NCT01460368|26637190|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7657431|NCT01460368|26637191|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
7657432|NCT01460368|26637192|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7657433|NCT01460368|26637186|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7657434|NCT01460368|26637187|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7657435|NCT01460368|26637188|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7657436|NCT01460368|26637189|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7657437|NCT01460368|26637190|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7657438|NCT01460368|26637191|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7657439|NCT01460368|26637192|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7657440|NCT01460368|26637186|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7657441|NCT01460368|26637187|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7657442|NCT01460368|26637188|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
7657443|NCT01460368|26637189|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7657444|NCT01460368|26637190|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7657445|NCT01460368|26637191|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7657446|NCT01460368|26637192|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7657447|NCT01460342|26637204|P2|Overall Study|Lack of Efficacy|0
7657448|NCT01460342|26637205|P1|Overall Study|Lack of Efficacy|1
7657449|NCT01460342|26637204|P2|Overall Study|Physician Decision|3
7657450|NCT01460342|26637205|P1|Overall Study|Physician Decision|1
7657451|NCT01460342|26637204|P2|Overall Study|Withdrawal by Subject|4
7657452|NCT01460342|26637205|P1|Overall Study|Withdrawal by Subject|3
7657453|NCT01460342|26637204|P2|Overall Study|Protocol Violation|1
7657454|NCT01460342|26637205|P1|Overall Study|Protocol Violation|0
7657455|NCT01460342|26637204|P2|Overall Study|Lost to Follow-up|2
7657456|NCT01460342|26637205|P1|Overall Study|Lost to Follow-up|1
7657457|NCT01460342|26637204|P2|Overall Study|Adverse Event|4
7657458|NCT01460342|26637205|P1|Overall Study|Adverse Event|5
7657459|NCT01460290|26637236|P1|Overall Study|Elevated liver function|1
7657460|NCT01460290|26637236|P1|Overall Study|Adverse Event|3
7657461|NCT01460160|26637263|P2|Follow-up|Lost to Follow-up|0
7657462|NCT01460160|26637264|P1|Follow-up|Lost to Follow-up|1
7657463|NCT01460160|26637263|P2|Follow-up|Death|2
7657464|NCT01460160|26637264|P1|Follow-up|Death|7
7657465|NCT01460160|26637263|P2|Follow-up|Withdrawal by Subject|0
7657466|NCT01460160|26637264|P1|Follow-up|Withdrawal by Subject|3
7657467|NCT01460160|26637263|P2|Treatment|Subject refused to continue Chemo|0
7657468|NCT01460160|26637264|P1|Treatment|Subject refused to continue Chemo|1
7657469|NCT01460160|26637263|P2|Treatment|Family did not wish to restart after SCT|0
7657470|NCT01460160|26637264|P1|Treatment|Family did not wish to restart after SCT|1
7657471|NCT01460160|26637263|P2|Treatment|PI decision to pursue other options|1
7657472|NCT01460160|26637264|P1|Treatment|PI decision to pursue other options|1
7657473|NCT01460160|26637263|P2|Treatment|PI not to follow protocol therapy|0
7657474|NCT01460160|26637264|P1|Treatment|PI not to follow protocol therapy|1
7657475|NCT01460160|26637263|P2|Treatment|PI decision to not re-initiate after SCT|2
7657476|NCT01460160|26637264|P1|Treatment|PI decision to not re-initiate after SCT|2
7657477|NCT01460160|26637263|P2|Treatment|Death|2
7657478|NCT01460160|26637264|P1|Treatment|Death|0
7657479|NCT01460160|26637263|P2|Treatment|Withdrawal by Subject|0
7657480|NCT01460160|26637264|P1|Treatment|Withdrawal by Subject|4
7657481|NCT01460160|26637263|P2|Treatment|Adverse Event|0
7657482|NCT01460160|26637264|P1|Treatment|Adverse Event|8
7657483|NCT01460160|26637263|P2|Treatment|Study Drug Toxicity|0
7657484|NCT01460160|26637264|P1|Treatment|Study Drug Toxicity|2
7657485|NCT01460160|26637263|P2|Treatment|Lack of Efficacy|0
7657486|NCT01460160|26637264|P1|Treatment|Lack of Efficacy|3
7657487|NCT01459913|26637305|P4|Overall Study|Did Not Meet Inclusion Criteria|1
7657488|NCT01459913|26637306|P3|Overall Study|Did Not Meet Inclusion Criteria|0
7657489|NCT01459913|26637307|P2|Overall Study|Did Not Meet Inclusion Criteria|0
7657490|NCT01459913|26637308|P1|Overall Study|Did Not Meet Inclusion Criteria|0
7657491|NCT01459913|26637305|P4|Overall Study|Other|1
7657492|NCT01459913|26637306|P3|Overall Study|Other|3
7657493|NCT01459913|26637307|P2|Overall Study|Other|0
7657494|NCT01459913|26637308|P1|Overall Study|Other|0
7657495|NCT01459913|26637305|P4|Overall Study|Study Terminated by Sponsor|11
7657496|NCT01459913|26637306|P3|Overall Study|Study Terminated by Sponsor|9
7657497|NCT01459913|26637307|P2|Overall Study|Study Terminated by Sponsor|15
7657498|NCT01459913|26637308|P1|Overall Study|Study Terminated by Sponsor|30
7657499|NCT01459913|26637305|P4|Overall Study|Physician Decision|0
7657500|NCT01459913|26637306|P3|Overall Study|Physician Decision|0
7657501|NCT01459913|26637307|P2|Overall Study|Physician Decision|1
7657502|NCT01459913|26637308|P1|Overall Study|Physician Decision|0
7657503|NCT01459913|26637305|P4|Overall Study|Non- Compliance|3
7657504|NCT01459913|26637306|P3|Overall Study|Non- Compliance|0
7657505|NCT01459913|26637307|P2|Overall Study|Non- Compliance|0
7657506|NCT01459913|26637308|P1|Overall Study|Non- Compliance|0
7657507|NCT01459913|26637305|P4|Overall Study|Death|1
7657508|NCT01459913|26637306|P3|Overall Study|Death|0
7657509|NCT01459913|26637307|P2|Overall Study|Death|0
7657510|NCT01459913|26637308|P1|Overall Study|Death|0
7657511|NCT01459913|26637305|P4|Overall Study|Lost to Follow-up|8
7657512|NCT01459913|26637306|P3|Overall Study|Lost to Follow-up|1
7657513|NCT01459913|26637307|P2|Overall Study|Lost to Follow-up|4
7657514|NCT01459913|26637308|P1|Overall Study|Lost to Follow-up|7
7657515|NCT01459913|26637305|P4|Overall Study|Withdrawal by Subject|5
7657516|NCT01459913|26637306|P3|Overall Study|Withdrawal by Subject|0
7657517|NCT01459913|26637307|P2|Overall Study|Withdrawal by Subject|0
7657518|NCT01459913|26637308|P1|Overall Study|Withdrawal by Subject|4
7657519|NCT01459913|26637305|P4|Overall Study|Adverse Event|3
7657520|NCT01459913|26637306|P3|Overall Study|Adverse Event|0
7657521|NCT01459913|26637307|P2|Overall Study|Adverse Event|0
7657522|NCT01459913|26637308|P1|Overall Study|Adverse Event|0
7657523|NCT01459796|26637339|P2|Overall Study|Decision by the sponsor|108
7657524|NCT01459796|26637340|P1|Overall Study|Decision by the sponsor|75
7657525|NCT01459796|26637339|P2|Overall Study|Reason unspecified|2
7657526|NCT01459796|26637340|P1|Overall Study|Reason unspecified|1
7657527|NCT01459796|26637339|P2|Overall Study|Lost to Follow-up|4
7657528|NCT01459796|26637340|P1|Overall Study|Lost to Follow-up|5
7657529|NCT01459796|26637339|P2|Overall Study|Withdrawal by Subject|3
7657530|NCT01459796|26637340|P1|Overall Study|Withdrawal by Subject|6
7657531|NCT01459796|26637339|P2|Overall Study|Adverse Event|5
7657532|NCT01459796|26637340|P1|Overall Study|Adverse Event|5
7657533|NCT01459796|26637339|P2|Overall Study|Non compliance with protocol|4
7657534|NCT01459796|26637340|P1|Overall Study|Non compliance with protocol|2
7657535|NCT01459783|26637358|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
7657536|NCT01459783|26637359|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
7657537|NCT01459783|26637358|P2|6 Months to 12 Months|Lost to Follow-up|7
7657538|NCT01459783|26637359|P1|6 Months to 12 Months|Lost to Follow-up|2
7657539|NCT01459783|26637358|P2|6 Months to 12 Months|Withdrawal by Subject|5
7657540|NCT01459783|26637359|P1|6 Months to 12 Months|Withdrawal by Subject|6
7657541|NCT01459783|26637358|P2|6 Months to 12 Months|Death|1
7657542|NCT01459783|26637359|P1|6 Months to 12 Months|Death|0
7657543|NCT01459783|26637358|P2|Baseline to 6 Months|Lost to Follow-up|14
7657544|NCT01459783|26637359|P1|Baseline to 6 Months|Lost to Follow-up|19
7657545|NCT01459783|26637358|P2|Baseline to 6 Months|Withdrawal by Subject|6
7657546|NCT01459783|26637359|P1|Baseline to 6 Months|Withdrawal by Subject|12
7657547|NCT01459783|26637358|P2|Baseline to 6 Months|Death|0
7657548|NCT01459783|26637359|P1|Baseline to 6 Months|Death|1
7657549|NCT01459718|26637367|P1|Overall Study|Adverse Event|1
7657550|NCT01459718|26637367|P1|Overall Study|Lost to Follow-up|1
7657551|NCT01459718|26637367|P1|Overall Study|Physician Decision|1
7657552|NCT01459614|26637549|P2|Overall Study|Adverse Event|0
7657553|NCT01459614|26637550|P1|Overall Study|Adverse Event|1
7657554|NCT01459068|26637597|P2|Overall Study|Death|1
7657555|NCT01459068|26637598|P1|Overall Study|Death|0
7657556|NCT01459068|26637597|P2|Overall Study|Lost to Follow-up|15
7657557|NCT01459068|26637598|P1|Overall Study|Lost to Follow-up|31
7657558|NCT01459068|26637597|P2|Overall Study|Withdrawal by Subject|18
7657559|NCT01459068|26637598|P1|Overall Study|Withdrawal by Subject|8
7657560|NCT01459016|26637614|P1|Overall Study|Amendment Discontinuation Criteria|4
7657561|NCT01459016|26637614|P1|Overall Study|Withdrawal by Subject|11
7657562|NCT01458951|26637642|P3|Overall Study|Insufficient Clinical Response|11
7657563|NCT01458951|26637643|P2|Overall Study|Insufficient Clinical Response|0
7657564|NCT01458951|26637644|P1|Overall Study|Insufficient Clinical Response|17
7657565|NCT01458951|26637642|P3|Overall Study|Adverse Event|2
7657566|NCT01458951|26637643|P2|Overall Study|Adverse Event|0
7657567|NCT01458951|26637644|P1|Overall Study|Adverse Event|7
7657568|NCT01458951|26637642|P3|Overall Study|Withdrawal by Subject|2
7657569|NCT01458951|26637643|P2|Overall Study|Withdrawal by Subject|0
7657570|NCT01458951|26637644|P1|Overall Study|Withdrawal by Subject|2
7657571|NCT01458951|26637642|P3|Overall Study|Protocol Violation|0
7657572|NCT01458951|26637643|P2|Overall Study|Protocol Violation|1
7657573|NCT01458951|26637644|P1|Overall Study|Protocol Violation|5
7657574|NCT01458951|26637642|P3|Overall Study|Other|0
7657575|NCT01458951|26637643|P2|Overall Study|Other|0
7657576|NCT01458951|26637644|P1|Overall Study|Other|1
7657577|NCT01458639|26637669|P1|Overall Study|Inability to obtain subject blood sample|1
7657578|NCT01458639|26637669|P1|Overall Study|Equipment issue|1
7657579|NCT01458639|26637669|P1|Overall Study|Physician Decision|4
7657580|NCT01458587|26637681|P2|Overall Study|Withdrawal by Subject|0
7657581|NCT01458587|26637682|P1|Overall Study|Withdrawal by Subject|1
7657582|NCT01458574|26637845|P3|Overall Study|Randomized but not treated|0
7657583|NCT01458574|26637846|P2|Overall Study|Randomized but not treated|1
7657584|NCT01458574|26637847|P1|Overall Study|Randomized but not treated|0
7657585|NCT01458574|26637845|P3|Overall Study|Other|0
7657586|NCT01458574|26637846|P2|Overall Study|Other|1
7657587|NCT01458574|26637847|P1|Overall Study|Other|2
7657588|NCT01458574|26637845|P3|Overall Study|Withdrawal by Subject|5
7657589|NCT01458574|26637846|P2|Overall Study|Withdrawal by Subject|3
7657590|NCT01458574|26637847|P1|Overall Study|Withdrawal by Subject|6
7657591|NCT01458574|26637845|P3|Overall Study|Protocol Violation|0
7657592|NCT01458574|26637846|P2|Overall Study|Protocol Violation|1
7657593|NCT01458574|26637847|P1|Overall Study|Protocol Violation|0
7657594|NCT01458574|26637845|P3|Overall Study|Pregnancy|0
7657595|NCT01458574|26637846|P2|Overall Study|Pregnancy|1
7657596|NCT01458574|26637847|P1|Overall Study|Pregnancy|1
7657597|NCT01458574|26637845|P3|Overall Study|Lost to Follow-up|1
7657598|NCT01458574|26637846|P2|Overall Study|Lost to Follow-up|2
7657599|NCT01458574|26637847|P1|Overall Study|Lost to Follow-up|3
7657600|NCT01458574|26637845|P3|Overall Study|Lack of Efficacy|132
7657601|NCT01458574|26637846|P2|Overall Study|Lack of Efficacy|53
7657602|NCT01458574|26637847|P1|Overall Study|Lack of Efficacy|70
7657603|NCT01458574|26637845|P3|Overall Study|Adverse Event|7
7657604|NCT01458574|26637846|P2|Overall Study|Adverse Event|9
7657605|NCT01458574|26637847|P1|Overall Study|Adverse Event|5
7657606|NCT01458535|26637977|P6|Overall Study|Adverse Event|0
7657607|NCT01458535|26637978|P5|Overall Study|Adverse Event|0
7657608|NCT01458535|26637979|P4|Overall Study|Adverse Event|1
7657609|NCT01458535|26637980|P3|Overall Study|Adverse Event|0
7657610|NCT01458535|26637981|P2|Overall Study|Adverse Event|0
7657611|NCT01458535|26637982|P1|Overall Study|Adverse Event|0
7657612|NCT01458535|26637977|P6|Overall Study|Lost to Follow-up|2
7657613|NCT01458535|26637978|P5|Overall Study|Lost to Follow-up|2
7657614|NCT01458535|26637979|P4|Overall Study|Lost to Follow-up|3
7657615|NCT01458535|26637980|P3|Overall Study|Lost to Follow-up|0
7657616|NCT01458535|26637981|P2|Overall Study|Lost to Follow-up|2
7657617|NCT01458535|26637982|P1|Overall Study|Lost to Follow-up|0
7657618|NCT01458535|26637977|P6|Overall Study|Withdrawal by Subject|1
7657619|NCT01458535|26637978|P5|Overall Study|Withdrawal by Subject|1
7657620|NCT01458535|26637979|P4|Overall Study|Withdrawal by Subject|0
7657621|NCT01458535|26637980|P3|Overall Study|Withdrawal by Subject|2
7657622|NCT01458535|26637981|P2|Overall Study|Withdrawal by Subject|0
7657623|NCT01458535|26637982|P1|Overall Study|Withdrawal by Subject|0
7657624|NCT01458535|26637977|P6|Overall Study|Other|1
7657625|NCT01458535|26637978|P5|Overall Study|Other|1
7657626|NCT01458535|26637979|P4|Overall Study|Other|0
7657627|NCT01458535|26637980|P3|Overall Study|Other|0
7657628|NCT01458535|26637981|P2|Overall Study|Other|0
7657629|NCT01458535|26637982|P1|Overall Study|Other|0
7657630|NCT01458522|26638034|P2|Overall Study|Physician Decision|9
7657631|NCT01458522|26638035|P1|Overall Study|Physician Decision|1
7657632|NCT01458522|26638034|P2|Overall Study|Withdrawal by Subject|2
7657633|NCT01458522|26638035|P1|Overall Study|Withdrawal by Subject|2
7657634|NCT01458392|26638081|P3|Overall Study|Patient unwilling to comply with protoco|2
7657635|NCT01458392|26638082|P2|Overall Study|Patient unwilling to comply with protoco|0
7657636|NCT01458392|26638083|P1|Overall Study|Patient unwilling to comply with protoco|0
7657637|NCT01458392|26638081|P3|Overall Study|At the discretion of the sponsor|7
7657638|NCT01458392|26638082|P2|Overall Study|At the discretion of the sponsor|2
7657639|NCT01458392|26638083|P1|Overall Study|At the discretion of the sponsor|0
7657640|NCT01458392|26638081|P3|Overall Study|Death|22
7657641|NCT01458392|26638082|P2|Overall Study|Death|11
7657642|NCT01458392|26638083|P1|Overall Study|Death|2
7657643|NCT01458366|26638108|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
7657644|NCT01458366|26638109|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7657645|NCT01458366|26638110|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7657646|NCT01458366|26638111|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7657647|NCT01458366|26638112|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7657648|NCT01458366|26638108|P5|Period 1: 70mg/m^2|Physician Decision|0
7657649|NCT01458366|26638109|P4|Period 1: 70mg/m^2|Physician Decision|0
7657650|NCT01458366|26638110|P3|Period 1: 70mg/m^2|Physician Decision|0
7657651|NCT01458366|26638111|P2|Period 1: 70mg/m^2|Physician Decision|0
7657652|NCT01458366|26638112|P1|Period 1: 70mg/m^2|Physician Decision|2
7657653|NCT01458275|26638139|P3|Overall Study|Withdrawal by Subject|1
7657654|NCT01458275|26638140|P2|Overall Study|Withdrawal by Subject|2
7657655|NCT01458275|26638141|P1|Overall Study|Withdrawal by Subject|3
7657656|NCT01458275|26638139|P3|Overall Study|Protocol Violation|2
7657657|NCT01458275|26638140|P2|Overall Study|Protocol Violation|5
7657658|NCT01458275|26638141|P1|Overall Study|Protocol Violation|5
7657659|NCT01458275|26638139|P3|Overall Study|Lost to Follow-up|5
7657660|NCT01458275|26638140|P2|Overall Study|Lost to Follow-up|2
7657661|NCT01458275|26638141|P1|Overall Study|Lost to Follow-up|3
7657662|NCT01458275|26638139|P3|Overall Study|Adverse Event|1
7657663|NCT01458275|26638140|P2|Overall Study|Adverse Event|4
7657664|NCT01458275|26638141|P1|Overall Study|Adverse Event|3
7657665|NCT01458249|26638183|P1|Overall Study|Ongoing|1
7657666|NCT01458249|26638183|P1|Overall Study|Other|2
7657667|NCT01458249|26638183|P1|Overall Study|Adverse Event|4
7657668|NCT01458249|26638183|P1|Overall Study|Not treated|1
7657669|NCT01458210|26638202|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
7657670|NCT01458210|26638202|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
7657671|NCT01458210|26638202|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
7657672|NCT01458210|26638202|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
7657673|NCT01458171|26638219|P1|Overall Study|Adverse Event|1
7657674|NCT01458132|26638242|P2|Overall Study|Other|3
7657675|NCT01458132|26638243|P1|Overall Study|Other|15
7657676|NCT01458119|26638251|P1|Overall Study|Non-compliance With Study Drug|3
7657677|NCT01458119|26638251|P1|Overall Study|Consent Withdrawn by Participant|8
7657678|NCT01458119|26638251|P1|Overall Study|Adverse Event|1
7657679|NCT01458119|26638251|P1|Overall Study|Death|2
7657680|NCT01458119|26638251|P1|Overall Study|Pregnancy|1
7657681|NCT01458119|26638251|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
7657682|NCT01458119|26638251|P1|Overall Study|Physician Decision|4
7657683|NCT01458106|26638258|P2|Overall Study|Withdrawn Per Protocol|1
7657684|NCT01458106|26638259|P1|Overall Study|Withdrawn Per Protocol|0
7657685|NCT01458106|26638258|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
7657686|NCT01458106|26638259|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
7657687|NCT01458106|26638258|P2|Overall Study|Withdrawal by Subject|0
7657688|NCT01458106|26638259|P1|Overall Study|Withdrawal by Subject|2
7657689|NCT01457950|26638336|P4|Open-Label Phase|Withdrawal by Subject|0
7657690|NCT01457950|26638337|P3|Open-Label Phase|Withdrawal by Subject|2
7657691|NCT01457950|26638338|P2|Open-Label Phase|Withdrawal by Subject|0
7657692|NCT01457950|26638339|P1|Open-Label Phase|Withdrawal by Subject|0
7657693|NCT01457950|26638336|P4|Open-Label Phase|Protocol Violation|1
7657694|NCT01457950|26638337|P3|Open-Label Phase|Protocol Violation|0
7657695|NCT01457950|26638338|P2|Open-Label Phase|Protocol Violation|0
7657696|NCT01457950|26638339|P1|Open-Label Phase|Protocol Violation|0
7657697|NCT01457950|26638336|P4|Open-Label Phase|Adverse Event|1
7657698|NCT01457950|26638337|P3|Open-Label Phase|Adverse Event|0
7657699|NCT01457950|26638338|P2|Open-Label Phase|Adverse Event|0
7657700|NCT01457950|26638339|P1|Open-Label Phase|Adverse Event|0
7657701|NCT01457950|26638336|P4|Double-Blind Phase|Withdrawal by Subject|0
7657702|NCT01457950|26638337|P3|Double-Blind Phase|Withdrawal by Subject|0
7657703|NCT01457950|26638338|P2|Double-Blind Phase|Withdrawal by Subject|2
7657704|NCT01457950|26638339|P1|Double-Blind Phase|Withdrawal by Subject|6
7657705|NCT01457950|26638336|P4|Double-Blind Phase|Protocol Violation|0
7657706|NCT01457950|26638337|P3|Double-Blind Phase|Protocol Violation|0
7657707|NCT01457950|26638338|P2|Double-Blind Phase|Protocol Violation|1
7657708|NCT01457950|26638339|P1|Double-Blind Phase|Protocol Violation|2
7657709|NCT01457950|26638336|P4|Double-Blind Phase|Continuation Criteria Not Met|0
7657710|NCT01457950|26638337|P3|Double-Blind Phase|Continuation Criteria Not Met|0
7657711|NCT01457950|26638338|P2|Double-Blind Phase|Continuation Criteria Not Met|0
7657712|NCT01457950|26638339|P1|Double-Blind Phase|Continuation Criteria Not Met|1
7657713|NCT01457924|26638418|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7657714|NCT01457924|26638419|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
7657715|NCT01457924|26638420|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7657716|NCT01457924|26638421|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
7657717|NCT01457924|26638422|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7657718|NCT01457924|26638418|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
7657719|NCT01457924|26638419|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7657720|NCT01457924|26638420|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
7657721|NCT01457924|26638421|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
7657722|NCT01457924|26638422|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7657723|NCT01457924|26638418|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7657724|NCT01457924|26638419|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7657725|NCT01457924|26638420|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7657726|NCT01457924|26638421|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7657727|NCT01457924|26638422|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7657728|NCT01457924|26638418|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
7657729|NCT01457924|26638419|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
7657730|NCT01457924|26638420|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
7657731|NCT01457924|26638421|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
7657732|NCT01457924|26638422|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
7657733|NCT01457924|26638418|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
7657734|NCT01457924|26638419|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
7657735|NCT01457924|26638420|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
7657736|NCT01457924|26638421|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
7657737|NCT01457924|26638422|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
7657738|NCT01457924|26638418|P5|FUP (Weeks 24-48)|Physician Decision|0
7657739|NCT01457924|26638419|P4|FUP (Weeks 24-48)|Physician Decision|0
7657740|NCT01457924|26638420|P3|FUP (Weeks 24-48)|Physician Decision|1
7657741|NCT01457924|26638421|P2|FUP (Weeks 24-48)|Physician Decision|0
7657742|NCT01457924|26638422|P1|FUP (Weeks 24-48)|Physician Decision|1
7657743|NCT01457924|26638418|P5|FUP (Weeks 24-48)|Adverse Event|0
7657744|NCT01457924|26638419|P4|FUP (Weeks 24-48)|Adverse Event|0
7657745|NCT01457924|26638420|P3|FUP (Weeks 24-48)|Adverse Event|1
7657746|NCT01457924|26638421|P2|FUP (Weeks 24-48)|Adverse Event|0
7657747|NCT01457924|26638422|P1|FUP (Weeks 24-48)|Adverse Event|0
7657748|NCT01457924|26638418|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
7657749|NCT01457924|26638419|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7657750|NCT01457924|26638420|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7657751|NCT01457924|26638421|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7657752|NCT01457924|26638422|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7657753|NCT01457924|26638418|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7657754|NCT01457924|26638419|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7657755|NCT01457924|26638420|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7657756|NCT01457924|26638421|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7657757|NCT01457924|26638422|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7657758|NCT01457924|26638418|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7657759|NCT01457924|26638419|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7657760|NCT01457924|26638420|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7657761|NCT01457924|26638421|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7657762|NCT01457924|26638422|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7657763|NCT01457924|26638418|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7657764|NCT01457924|26638419|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7657765|NCT01457924|26638420|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7657766|NCT01457924|26638421|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7657767|NCT01457924|26638422|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
7657768|NCT01457924|26638418|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
7657769|NCT01457924|26638419|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
7657770|NCT01457924|26638420|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
7657771|NCT01457924|26638421|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
7657772|NCT01457924|26638422|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
7657773|NCT01457924|26638418|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
7657774|NCT01457924|26638419|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
7657775|NCT01457924|26638420|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
7657776|NCT01457924|26638421|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
7657777|NCT01457924|26638422|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
7657778|NCT01457846|26638492|P2|Overall Study|Lost to Follow-up|0
7657779|NCT01457846|26638493|P1|Overall Study|Lost to Follow-up|1
7657780|NCT01457846|26638492|P2|Overall Study|Withdrawal by Subject|1
7657781|NCT01457846|26638493|P1|Overall Study|Withdrawal by Subject|1
7657782|NCT01457846|26638492|P2|Overall Study|Unclassified reason for not completed|10
7657783|NCT01457846|26638493|P1|Overall Study|Unclassified reason for not completed|11
7657784|NCT01457846|26638492|P2|Overall Study|Death|16
7657785|NCT01457846|26638493|P1|Overall Study|Death|27
7657786|NCT01457846|26638492|P2|Overall Study|Did not receive treatment|1
7657787|NCT01457846|26638493|P1|Overall Study|Did not receive treatment|0
7657788|NCT01457846|26638492|P2|Overall Study|Death before treatment|2
7657789|NCT01457846|26638493|P1|Overall Study|Death before treatment|1
7657790|NCT01457703|26638509|P2|Overall Study|Withdrawal by Subject|4
7657791|NCT01457703|26638510|P1|Overall Study|Withdrawal by Subject|1
7657792|NCT01457703|26638509|P2|Overall Study|Screen Failure|7
7657793|NCT01457703|26638510|P1|Overall Study|Screen Failure|5
7657794|NCT01457352|26638621|P2|Period 3|Sponsor's withdrawal|1
7657795|NCT01457352|26638622|P1|Period 3|Sponsor's withdrawal|0
7657796|NCT01457352|26638621|P2|Period 3|incorrect treatment|1
7657797|NCT01457352|26638622|P1|Period 3|incorrect treatment|0
7657798|NCT01457352|26638621|P2|Period 3|Withdrawal by Subject|2
7657799|NCT01457352|26638622|P1|Period 3|Withdrawal by Subject|0
7657800|NCT01457352|26638621|P2|Period 3|Adverse Event|1
7657801|NCT01457352|26638622|P1|Period 3|Adverse Event|1
7657802|NCT01457352|26638621|P2|Period 2|Did not meet eligibility criteria|0
7657803|NCT01457352|26638622|P1|Period 2|Did not meet eligibility criteria|3
7657804|NCT01457352|26638621|P2|Period 2|Physician Decision|0
7657805|NCT01457352|26638622|P1|Period 2|Physician Decision|1
7657806|NCT01457352|26638621|P2|Period 2|dose change|0
7657807|NCT01457352|26638622|P1|Period 2|dose change|1
7657808|NCT01457352|26638621|P2|Period 2|Lost to Follow-up|0
7657809|NCT01457352|26638622|P1|Period 2|Lost to Follow-up|1
7657810|NCT01457352|26638621|P2|Period 2|Sponsor's withdrawal|0
7657811|NCT01457352|26638622|P1|Period 2|Sponsor's withdrawal|7
7657812|NCT01457352|26638621|P2|Period 2|Protocol Violation|0
7657813|NCT01457352|26638622|P1|Period 2|Protocol Violation|4
7657814|NCT01457352|26638621|P2|Period 2|Lack of Efficacy|0
7657815|NCT01457352|26638622|P1|Period 2|Lack of Efficacy|8
7657816|NCT01457352|26638621|P2|Period 2|no analysis|0
7657817|NCT01457352|26638622|P1|Period 2|no analysis|10
7657818|NCT01457352|26638621|P2|Period 2|Adverse Event|0
7657819|NCT01457352|26638622|P1|Period 2|Adverse Event|22
7657820|NCT01457352|26638621|P2|Period 2|Withdrawal by Subject|0
7657821|NCT01457352|26638622|P1|Period 2|Withdrawal by Subject|23
7657822|NCT01457352|26638621|P2|Period 1|Did not meet eligibility criteria|0
7657823|NCT01457352|26638622|P1|Period 1|Did not meet eligibility criteria|3
7657824|NCT01457352|26638621|P2|Period 1|Protocol Violation|0
7657825|NCT01457352|26638622|P1|Period 1|Protocol Violation|4
7657826|NCT01457352|26638621|P2|Period 1|withdrew per sponsor|0
7657827|NCT01457352|26638622|P1|Period 1|withdrew per sponsor|1
7657828|NCT01457352|26638621|P2|Period 1|Withdrawn|0
7657829|NCT01457352|26638622|P1|Period 1|Withdrawn|1
7657830|NCT01457352|26638621|P2|Period 1|MS related disease progression|0
7657831|NCT01457352|26638622|P1|Period 1|MS related disease progression|1
7657832|NCT01457352|26638621|P2|Period 1|Physician Decision|0
7657833|NCT01457352|26638622|P1|Period 1|Physician Decision|2
7657834|NCT01457352|26638621|P2|Period 1|Withdrawal by Subject|0
7657835|NCT01457352|26638622|P1|Period 1|Withdrawal by Subject|2
7657836|NCT01457352|26638621|P2|Period 1|Adverse Event|0
7657837|NCT01457352|26638622|P1|Period 1|Adverse Event|2
7657838|NCT01457339|26638634|P2|Period 6 (250 mg)|Personal appointment|1
7657839|NCT01457339|26638635|P1|Period 6 (250 mg)|Personal appointment|0
7657840|NCT01457339|26638634|P2|Period 6 (250 mg)|Family Emergency|0
7657841|NCT01457339|26638635|P1|Period 6 (250 mg)|Family Emergency|1
7657842|NCT01457339|26638634|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
7657843|NCT01457339|26638635|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
7657844|NCT01457339|26638634|P2|Period 3 (100 mg)|Adverse Event|1
7657845|NCT01457339|26638635|P1|Period 3 (100 mg)|Adverse Event|0
7657846|NCT01457118|26638811|P4|Overall Study|Withdrawal by Subject|0
7657847|NCT01457118|26638812|P3|Overall Study|Withdrawal by Subject|0
7657848|NCT01457118|26638813|P2|Overall Study|Withdrawal by Subject|0
7657849|NCT01457118|26638814|P1|Overall Study|Withdrawal by Subject|5
7657850|NCT01457118|26638811|P4|Overall Study|Progressive Disease by RECIST|0
7657851|NCT01457118|26638812|P3|Overall Study|Progressive Disease by RECIST|1
7657852|NCT01457118|26638813|P2|Overall Study|Progressive Disease by RECIST|3
7657853|NCT01457118|26638814|P1|Overall Study|Progressive Disease by RECIST|12
7657854|NCT01457118|26638811|P4|Overall Study|Physician Decision|0
7657855|NCT01457118|26638812|P3|Overall Study|Physician Decision|0
7657856|NCT01457118|26638813|P2|Overall Study|Physician Decision|0
7657857|NCT01457118|26638814|P1|Overall Study|Physician Decision|2
7657858|NCT01457118|26638811|P4|Overall Study|Clinical Progression|1
7657859|NCT01457118|26638812|P3|Overall Study|Clinical Progression|0
7657860|NCT01457118|26638813|P2|Overall Study|Clinical Progression|1
7657861|NCT01457118|26638814|P1|Overall Study|Clinical Progression|0
7657862|NCT01457118|26638811|P4|Overall Study|Adverse Event|1
7657863|NCT01457118|26638812|P3|Overall Study|Adverse Event|0
7657864|NCT01457118|26638813|P2|Overall Study|Adverse Event|0
7657865|NCT01457118|26638814|P1|Overall Study|Adverse Event|1
7657866|NCT01457053|26638836|P2|Overall Study|Unable to undergo selected treatment|1
7657867|NCT01457053|26638837|P1|Overall Study|Unable to undergo selected treatment|1
7657868|NCT01457014|26638843|P4|First Night|Withdrawal by Subject|0
7657869|NCT01457014|26638844|P3|First Night|Withdrawal by Subject|0
7657870|NCT01457014|26638845|P2|First Night|Withdrawal by Subject|0
7657871|NCT01457014|26638846|P1|First Night|Withdrawal by Subject|3
7657872|NCT01457014|26638843|P4|First Night|Didn't meet inclusion/exclusion criteria|0
7657873|NCT01457014|26638844|P3|First Night|Didn't meet inclusion/exclusion criteria|0
7657874|NCT01457014|26638845|P2|First Night|Didn't meet inclusion/exclusion criteria|0
7657875|NCT01457014|26638846|P1|First Night|Didn't meet inclusion/exclusion criteria|37
7657876|NCT01456962|26638863|P2|Overall Study|Lost to Follow-up|1
7657877|NCT01456962|26638864|P1|Overall Study|Lost to Follow-up|2
7657878|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
7657879|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
7657880|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
7657881|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
7657882|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
7657883|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
7657884|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
7657885|NCT01456949|26638870|P1|Study Cryoablation Procedure & Follow-up|Death|5
7657886|NCT01456949|26638870|P1|Enrollment|Withdrawal by Subject|7
7657887|NCT01456949|26638870|P1|Enrollment|Physician Decision|10
7657888|NCT01456949|26638870|P1|Enrollment|I/E criteria not met prior to procedure|13
7657889|NCT01456949|26638870|P1|Enrollment|Death|1
7657890|NCT01456949|26638870|P1|Enrollment|PI death- incomplete data|6
7657891|NCT01456936|26638881|P4|Overall Study|Randomized but not treated|21
7657892|NCT01456936|26638882|P3|Overall Study|Randomized but not treated|16
7657893|NCT01456936|26638883|P2|Overall Study|Randomized but not treated|28
7657894|NCT01456936|26638884|P1|Overall Study|Randomized but not treated|21
7657895|NCT01456936|26638881|P4|Overall Study|Death|3
7657896|NCT01456936|26638882|P3|Overall Study|Death|1
7657897|NCT01456936|26638883|P2|Overall Study|Death|3
7657898|NCT01456936|26638884|P1|Overall Study|Death|0
7657899|NCT01456936|26638881|P4|Overall Study|Adverse event (study drug unrelated)|9
7657900|NCT01456936|26638882|P3|Overall Study|Adverse event (study drug unrelated)|9
7657988|NCT01456169|26639102|P2|Overall Study|Adverse Event|2
7657901|NCT01456936|26638883|P2|Overall Study|Adverse event (study drug unrelated)|7
7657902|NCT01456936|26638884|P1|Overall Study|Adverse event (study drug unrelated)|9
7657903|NCT01456936|26638881|P4|Overall Study|Adverse event (study drug)|17
7657904|NCT01456936|26638882|P3|Overall Study|Adverse event (study drug)|26
7657905|NCT01456936|26638883|P2|Overall Study|Adverse event (study drug)|21
7657906|NCT01456936|26638884|P1|Overall Study|Adverse event (study drug)|25
7657907|NCT01456936|26638881|P4|Overall Study|Medication error|1
7657908|NCT01456936|26638882|P3|Overall Study|Medication error|0
7657909|NCT01456936|26638883|P2|Overall Study|Medication error|1
7657910|NCT01456936|26638884|P1|Overall Study|Medication error|0
7657911|NCT01456936|26638881|P4|Overall Study|Lost to Follow-up|127
7657912|NCT01456936|26638882|P3|Overall Study|Lost to Follow-up|144
7657913|NCT01456936|26638883|P2|Overall Study|Lost to Follow-up|126
7657914|NCT01456936|26638884|P1|Overall Study|Lost to Follow-up|135
7657915|NCT01456936|26638881|P4|Overall Study|No longer willing to participate|248
7657916|NCT01456936|26638882|P3|Overall Study|No longer willing to participate|224
7657917|NCT01456936|26638883|P2|Overall Study|No longer willing to participate|218
7657918|NCT01456936|26638884|P1|Overall Study|No longer willing to participate|195
7657919|NCT01456936|26638881|P4|Overall Study|Insufficient clinical response|13
7657920|NCT01456936|26638882|P3|Overall Study|Insufficient clinical response|14
7657921|NCT01456936|26638883|P2|Overall Study|Insufficient clinical response|4
7657922|NCT01456936|26638884|P1|Overall Study|Insufficient clinical response|4
7657923|NCT01456936|26638881|P4|Overall Study|Pregnancy|1
7657924|NCT01456936|26638882|P3|Overall Study|Pregnancy|0
7657925|NCT01456936|26638883|P2|Overall Study|Pregnancy|0
7657926|NCT01456936|26638884|P1|Overall Study|Pregnancy|1
7657927|NCT01456936|26638881|P4|Overall Study|Protocol Violation|5
7657928|NCT01456936|26638882|P3|Overall Study|Protocol Violation|5
7657929|NCT01456936|26638883|P2|Overall Study|Protocol Violation|2
7657930|NCT01456936|26638884|P1|Overall Study|Protocol Violation|4
7657931|NCT01456936|26638881|P4|Overall Study|No longer meets eligibility criteria|5
7657932|NCT01456936|26638882|P3|Overall Study|No longer meets eligibility criteria|6
7657933|NCT01456936|26638883|P2|Overall Study|No longer meets eligibility criteria|8
7657934|NCT01456936|26638884|P1|Overall Study|No longer meets eligibility criteria|4
7657935|NCT01456936|26638881|P4|Overall Study|Other reason|33
7657936|NCT01456936|26638882|P3|Overall Study|Other reason|36
7657937|NCT01456936|26638883|P2|Overall Study|Other reason|30
7657938|NCT01456936|26638884|P1|Overall Study|Other reason|41
7657939|NCT01456897|26638992|P2|Overall Study|Lack of Efficacy|11
7657940|NCT01456897|26638993|P1|Overall Study|Lack of Efficacy|4
7657941|NCT01456897|26638992|P2|Overall Study|Withdrawal by Subject|17
7657942|NCT01456897|26638993|P1|Overall Study|Withdrawal by Subject|44
7657943|NCT01456897|26638992|P2|Overall Study|Physician Decision|3
7657944|NCT01456897|26638993|P1|Overall Study|Physician Decision|5
7657945|NCT01456897|26638992|P2|Overall Study|Protocol Violation|4
7657946|NCT01456897|26638993|P1|Overall Study|Protocol Violation|3
7657947|NCT01456897|26638992|P2|Overall Study|Adverse Event|22
7657948|NCT01456897|26638993|P1|Overall Study|Adverse Event|19
7657949|NCT01456780|26639012|P3|Overall Study|Lost to Follow-up|0
7657950|NCT01456780|26639013|P2|Overall Study|Lost to Follow-up|3
7657951|NCT01456780|26639014|P1|Overall Study|Lost to Follow-up|3
7657952|NCT01456221|26639063|P2|Overall Study|Incomplete data|2
7657953|NCT01456221|26639064|P1|Overall Study|Incomplete data|4
7657954|NCT01456221|26639063|P2|Overall Study|Received medication|2
7657955|NCT01456221|26639064|P1|Overall Study|Received medication|3
7657956|NCT01456221|26639063|P2|Overall Study|Lost to Follow-up|4
7657957|NCT01456221|26639064|P1|Overall Study|Lost to Follow-up|1
7657958|NCT01456221|26639063|P2|Overall Study|Withdrawal by Subject|49
7657959|NCT01456221|26639064|P1|Overall Study|Withdrawal by Subject|56
7657960|NCT01456195|26639079|P3|Overall Study|Other Reasons|3
7657961|NCT01456195|26639080|P2|Overall Study|Other Reasons|1
7657962|NCT01456195|26639081|P1|Overall Study|Other Reasons|2
7657963|NCT01456195|26639079|P3|Overall Study|Lack of Efficacy|0
7657964|NCT01456195|26639080|P2|Overall Study|Lack of Efficacy|1
7657965|NCT01456195|26639081|P1|Overall Study|Lack of Efficacy|0
7657966|NCT01456195|26639079|P3|Overall Study|Voluntary Withdrawal|7
7657967|NCT01456195|26639080|P2|Overall Study|Voluntary Withdrawal|3
7657968|NCT01456195|26639081|P1|Overall Study|Voluntary Withdrawal|5
7657969|NCT01456195|26639079|P3|Overall Study|Lost to Follow-up|3
7657970|NCT01456195|26639080|P2|Overall Study|Lost to Follow-up|1
7657971|NCT01456195|26639081|P1|Overall Study|Lost to Follow-up|3
7657972|NCT01456195|26639079|P3|Overall Study|Pretreatment Event/Adverse Event|1
7657973|NCT01456195|26639080|P2|Overall Study|Pretreatment Event/Adverse Event|4
7657974|NCT01456195|26639081|P1|Overall Study|Pretreatment Event/Adverse Event|1
7657975|NCT01456169|26639101|P3|Overall Study|Other|0
7657976|NCT01456169|26639102|P2|Overall Study|Other|1
7657977|NCT01456169|26639103|P1|Overall Study|Other|1
7657978|NCT01456169|26639101|P3|Overall Study|Lack of Efficacy|0
7657979|NCT01456169|26639102|P2|Overall Study|Lack of Efficacy|0
7657980|NCT01456169|26639103|P1|Overall Study|Lack of Efficacy|2
7657981|NCT01456169|26639101|P3|Overall Study|Voluntary Withdrawal|2
7657982|NCT01456169|26639102|P2|Overall Study|Voluntary Withdrawal|0
7657983|NCT01456169|26639103|P1|Overall Study|Voluntary Withdrawal|3
7657984|NCT01456169|26639101|P3|Overall Study|Major Protocol Deviation|3
7657985|NCT01456169|26639102|P2|Overall Study|Major Protocol Deviation|2
7657986|NCT01456169|26639103|P1|Overall Study|Major Protocol Deviation|3
7657987|NCT01456169|26639101|P3|Overall Study|Adverse Event|7
7657989|NCT01456169|26639103|P1|Overall Study|Adverse Event|1
7657990|NCT01456130|26639163|P1|Overall Study|Other|1
7657991|NCT01456130|26639163|P1|Overall Study|Lack of Efficacy|4
7657992|NCT01456130|26639163|P1|Overall Study|Voluntary Withdrawal|1
7657993|NCT01456130|26639163|P1|Overall Study|Adverse Event|4
7657994|NCT01456052|26639173|P3|Overall Study|Treatment Failure|1
7657995|NCT01456052|26639174|P2|Overall Study|Treatment Failure|1
7657996|NCT01456052|26639175|P1|Overall Study|Treatment Failure|0
7657997|NCT01456052|26639173|P3|Overall Study|Physician Decision|1
7657998|NCT01456052|26639174|P2|Overall Study|Physician Decision|0
7657999|NCT01456052|26639175|P1|Overall Study|Physician Decision|1
7658000|NCT01456052|26639173|P3|Overall Study|Protocol Violation|0
7658001|NCT01456052|26639174|P2|Overall Study|Protocol Violation|1
7658002|NCT01456052|26639175|P1|Overall Study|Protocol Violation|0
7658003|NCT01456052|26639173|P3|Overall Study|Consent withdrawn|1
7658004|NCT01456052|26639174|P2|Overall Study|Consent withdrawn|2
7658005|NCT01456052|26639175|P1|Overall Study|Consent withdrawn|0
7658006|NCT01456052|26639173|P3|Overall Study|Adverse Event|2
7658007|NCT01456052|26639174|P2|Overall Study|Adverse Event|1
7658008|NCT01456052|26639175|P1|Overall Study|Adverse Event|1
7658009|NCT01456039|26639195|P3|Phase 2 (Second Step)|Other|1
7658010|NCT01456039|26639196|P2|Phase 2 (Second Step)|Other|0
7658011|NCT01456039|26639197|P1|Phase 2 (Second Step)|Other|0
7658012|NCT01456039|26639195|P3|Phase 2 (Second Step)|Protocol Violation|1
7658013|NCT01456039|26639196|P2|Phase 2 (Second Step)|Protocol Violation|0
7658014|NCT01456039|26639197|P1|Phase 2 (Second Step)|Protocol Violation|0
7658015|NCT01456039|26639195|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
7658016|NCT01456039|26639196|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
7658017|NCT01456039|26639197|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
7658018|NCT01456039|26639195|P3|Phase 2 (Second Step)|Adverse Event|10
7658019|NCT01456039|26639196|P2|Phase 2 (Second Step)|Adverse Event|0
7658020|NCT01456039|26639197|P1|Phase 2 (Second Step)|Adverse Event|0
7658021|NCT01456039|26639195|P3|Phase 2 (Second Step)|Disease Progression|17
7658022|NCT01456039|26639196|P2|Phase 2 (Second Step)|Disease Progression|0
7658023|NCT01456039|26639197|P1|Phase 2 (Second Step)|Disease Progression|0
7658024|NCT01456039|26639195|P3|Phase 1 (First Step)|Other|0
7658025|NCT01456039|26639196|P2|Phase 1 (First Step)|Other|1
7658026|NCT01456039|26639197|P1|Phase 1 (First Step)|Other|0
7658027|NCT01456039|26639195|P3|Phase 1 (First Step)|Adverse Event|0
7658028|NCT01456039|26639196|P2|Phase 1 (First Step)|Adverse Event|3
7658029|NCT01456039|26639197|P1|Phase 1 (First Step)|Adverse Event|0
7658030|NCT01456039|26639195|P3|Phase 1 (First Step)|Withdrawal by Subject|0
7658031|NCT01456039|26639196|P2|Phase 1 (First Step)|Withdrawal by Subject|2
7658032|NCT01456039|26639197|P1|Phase 1 (First Step)|Withdrawal by Subject|1
7658033|NCT01456039|26639195|P3|Phase 1 (First Step)|Disease Progression|0
7658034|NCT01456039|26639196|P2|Phase 1 (First Step)|Disease Progression|1
7658035|NCT01456039|26639197|P1|Phase 1 (First Step)|Disease Progression|1
7658036|NCT01455428|26639340|P2|Overall Study|Other|4
7658037|NCT01455428|26639341|P1|Overall Study|Other|2
7658038|NCT01455428|26639340|P2|Overall Study|Did not receive treatment|1
7658039|NCT01455428|26639341|P1|Overall Study|Did not receive treatment|1
7658040|NCT01455428|26639340|P2|Overall Study|Insufficient clinical response|2
7658041|NCT01455428|26639341|P1|Overall Study|Insufficient clinical response|0
7658042|NCT01455428|26639340|P2|Overall Study|Did not meet entrance criteria|2
7658043|NCT01455428|26639341|P1|Overall Study|Did not meet entrance criteria|0
7658044|NCT01455428|26639340|P2|Overall Study|Withdrawal by Subject|5
7658045|NCT01455428|26639341|P1|Overall Study|Withdrawal by Subject|2
7658046|NCT01455428|26639340|P2|Overall Study|Lost to Follow-up|1
7658047|NCT01455428|26639341|P1|Overall Study|Lost to Follow-up|1
7658048|NCT01455428|26639340|P2|Overall Study|Adverse Event|2
7658049|NCT01455428|26639341|P1|Overall Study|Adverse Event|6
7658050|NCT01455428|26639340|P2|Overall Study|Protocol Violation|1
7658051|NCT01455428|26639341|P1|Overall Study|Protocol Violation|2
7658052|NCT01455415|26639397|P2|Follow-up|Unspecified Reason|0
7658053|NCT01455415|26639398|P1|Follow-up|Unspecified Reason|1
7658054|NCT01455415|26639397|P2|Follow-up|Withdrawal by Subject|0
7658055|NCT01455415|26639398|P1|Follow-up|Withdrawal by Subject|2
7658056|NCT01455415|26639397|P2|Follow-up|Lack of Efficacy|1
7658057|NCT01455415|26639398|P1|Follow-up|Lack of Efficacy|0
7658058|NCT01455415|26639397|P2|Follow-up|AE Related to Study Drug|1
7658059|NCT01455415|26639398|P1|Follow-up|AE Related to Study Drug|0
7658060|NCT01455415|26639397|P2|Period 2|Protocol Violation|0
7658061|NCT01455415|26639398|P1|Period 2|Protocol Violation|2
7658062|NCT01455415|26639397|P2|Period 2|Unspecified Reason|3
7658063|NCT01455415|26639398|P1|Period 2|Unspecified Reason|2
7658064|NCT01455415|26639397|P2|Period 2|Withdrawal by Subject|3
7658065|NCT01455415|26639398|P1|Period 2|Withdrawal by Subject|2
7658066|NCT01455415|26639397|P2|Period 2|Lack of Efficacy|0
7658067|NCT01455415|26639398|P1|Period 2|Lack of Efficacy|2
7658068|NCT01455415|26639397|P2|Period 2|AE Not Related to Study Drug|1
7658069|NCT01455415|26639398|P1|Period 2|AE Not Related to Study Drug|2
7658070|NCT01455415|26639397|P2|Period 2|Lost to Follow-up|1
7658071|NCT01455415|26639398|P1|Period 2|Lost to Follow-up|2
7658072|NCT01455415|26639397|P2|Period 2|AE Related to Study Drug|2
7658073|NCT01455415|26639398|P1|Period 2|AE Related to Study Drug|1
7658074|NCT01455415|26639397|P2|Washout|Protocol Violation|1
7658075|NCT01455415|26639398|P1|Washout|Protocol Violation|0
7658076|NCT01455415|26639397|P2|Washout|Unspecified Reason|2
7658077|NCT01455415|26639398|P1|Washout|Unspecified Reason|1
7658078|NCT01455415|26639397|P2|Washout|AE Not Related to Study Drug|3
7658079|NCT01455415|26639398|P1|Washout|AE Not Related to Study Drug|2
7658080|NCT01455415|26639397|P2|Washout|Drug Error not Associated to AE|1
7658081|NCT01455415|26639398|P1|Washout|Drug Error not Associated to AE|2
7658082|NCT01455415|26639397|P2|Washout|Lost to Follow-up|0
7658083|NCT01455415|26639398|P1|Washout|Lost to Follow-up|1
7658084|NCT01455415|26639397|P2|Washout|AE Related to Study Drug|0
7658085|NCT01455415|26639398|P1|Washout|AE Related to Study Drug|2
7658086|NCT01455415|26639397|P2|Period 1|Protocol Violation|2
7658087|NCT01455415|26639398|P1|Period 1|Protocol Violation|0
7658088|NCT01455415|26639397|P2|Period 1|Unspecified Reason|1
7658089|NCT01455415|26639398|P1|Period 1|Unspecified Reason|1
7658090|NCT01455415|26639397|P2|Period 1|Withdrawal by Subject|5
7658091|NCT01455415|26639398|P1|Period 1|Withdrawal by Subject|4
7658092|NCT01455415|26639397|P2|Period 1|AE Not Related to Study Drug|6
7658093|NCT01455415|26639398|P1|Period 1|AE Not Related to Study Drug|2
7658094|NCT01455415|26639397|P2|Period 1|Drug Error not Associated to AE|1
7658095|NCT01455415|26639398|P1|Period 1|Drug Error not Associated to AE|0
7658096|NCT01455415|26639397|P2|Period 1|Lost To Follow-up Related to Study Drug|3
7658097|NCT01455415|26639398|P1|Period 1|Lost To Follow-up Related to Study Drug|3
7658098|NCT01455415|26639397|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
7658099|NCT01455415|26639398|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
7658100|NCT01455220|26639448|P1|Overall Study|screen fail|30
7658101|NCT01455194|26639458|P4|Overall Study|Miscellaneous|4
7658102|NCT01455194|26639459|P3|Overall Study|Miscellaneous|1
7658103|NCT01455194|26639460|P2|Overall Study|Miscellaneous|5
7658104|NCT01455194|26639461|P1|Overall Study|Miscellaneous|4
7658105|NCT01455194|26639458|P4|Overall Study|Discontinuation criterion fulfilled|2
7658106|NCT01455194|26639459|P3|Overall Study|Discontinuation criterion fulfilled|0
7658107|NCT01455194|26639460|P2|Overall Study|Discontinuation criterion fulfilled|2
7658108|NCT01455194|26639461|P1|Overall Study|Discontinuation criterion fulfilled|3
7658109|NCT01455194|26639458|P4|Overall Study|Pregnancy|0
7658110|NCT01455194|26639459|P3|Overall Study|Pregnancy|1
7658111|NCT01455194|26639460|P2|Overall Study|Pregnancy|1
7658112|NCT01455194|26639461|P1|Overall Study|Pregnancy|0
7658113|NCT01455194|26639458|P4|Overall Study|Lost to Follow-up|1
7658114|NCT01455194|26639459|P3|Overall Study|Lost to Follow-up|1
7658115|NCT01455194|26639460|P2|Overall Study|Lost to Follow-up|0
7658116|NCT01455194|26639461|P1|Overall Study|Lost to Follow-up|2
7658117|NCT01455194|26639458|P4|Overall Study|Withdrawal by Subject|9
7658118|NCT01455194|26639459|P3|Overall Study|Withdrawal by Subject|12
7658119|NCT01455194|26639460|P2|Overall Study|Withdrawal by Subject|16
7658120|NCT01455194|26639461|P1|Overall Study|Withdrawal by Subject|21
7658121|NCT01455194|26639458|P4|Overall Study|Adverse Event|3
7658122|NCT01455194|26639459|P3|Overall Study|Adverse Event|1
7658123|NCT01455194|26639460|P2|Overall Study|Adverse Event|1
7658124|NCT01455194|26639461|P1|Overall Study|Adverse Event|1
7658125|NCT01455194|26639458|P4|Overall Study|Deterioration in asthma|9
7658126|NCT01455194|26639459|P3|Overall Study|Deterioration in asthma|14
7658127|NCT01455194|26639460|P2|Overall Study|Deterioration in asthma|6
7658128|NCT01455194|26639461|P1|Overall Study|Deterioration in asthma|12
7658129|NCT01455194|26639458|P4|Overall Study|Randomisation Failure|0
7658130|NCT01455194|26639459|P3|Overall Study|Randomisation Failure|0
7658131|NCT01455194|26639460|P2|Overall Study|Randomisation Failure|0
7658132|NCT01455194|26639461|P1|Overall Study|Randomisation Failure|90
7658133|NCT01455194|26639458|P4|Overall Study|Screen Failure|0
7658134|NCT01455194|26639459|P3|Overall Study|Screen Failure|0
7658135|NCT01455194|26639460|P2|Overall Study|Screen Failure|0
7658136|NCT01455194|26639461|P1|Overall Study|Screen Failure|20
7658137|NCT01455012|26639524|P2|Overall Study|Unknown reason|0
7658138|NCT01455012|26639525|P1|Overall Study|Unknown reason|2
7658139|NCT01455012|26639524|P2|Overall Study|Withdrawal by Subject|1
7658140|NCT01455012|26639525|P1|Overall Study|Withdrawal by Subject|3
7658141|NCT01455012|26639524|P2|Overall Study|Lack of Efficacy|1
7658142|NCT01455012|26639525|P1|Overall Study|Lack of Efficacy|6
7658143|NCT01455012|26639524|P2|Overall Study|Adverse Event|2
7658144|NCT01455012|26639525|P1|Overall Study|Adverse Event|0
7658145|NCT01454934|26639592|P2|Overall Study|Not treated|2
7658146|NCT01454934|26639593|P1|Overall Study|Not treated|1
7658147|NCT01454934|26639592|P2|Overall Study|Lost to Follow-up|1
7658148|NCT01454934|26639593|P1|Overall Study|Lost to Follow-up|0
7658149|NCT01454934|26639592|P2|Overall Study|Disease progression|181
7658150|NCT01454934|26639593|P1|Overall Study|Disease progression|194
7658151|NCT01454934|26639592|P2|Overall Study|Withdrawal by Subject|15
7658152|NCT01454934|26639593|P1|Overall Study|Withdrawal by Subject|11
7658153|NCT01454934|26639592|P2|Overall Study|Withdrawn consent|5
7658154|NCT01454934|26639593|P1|Overall Study|Withdrawn consent|2
7658155|NCT01454934|26639592|P2|Overall Study|Adverse Event|24
7658156|NCT01454934|26639593|P1|Overall Study|Adverse Event|28
7658157|NCT01454934|26639592|P2|Overall Study|Other|17
7658158|NCT01454934|26639593|P1|Overall Study|Other|6
7658159|NCT01454934|26639592|P2|Overall Study|Clinical progression|25
7658160|NCT01454934|26639593|P1|Overall Study|Clinical progression|28
7658161|NCT01454830|26639605|P2|Overall Study|Withdrawal - no polysomnography|2
7658162|NCT01454830|26639606|P1|Overall Study|Withdrawal - no polysomnography|3
7658163|NCT01454830|26639605|P2|Overall Study|Post-allocation Exclude-other treatment|7
7658164|NCT01454830|26639606|P1|Overall Study|Post-allocation Exclude-other treatment|6
7658165|NCT01454830|26639605|P2|Overall Study|Post-allocation Exclude-refused PAP|2
7658166|NCT01454830|26639606|P1|Overall Study|Post-allocation Exclude-refused PAP|0
7658167|NCT01454830|26639605|P2|Overall Study|Post-allocation Exclude- AHI<10|12
7658168|NCT01454830|26639606|P1|Overall Study|Post-allocation Exclude- AHI<10|18
7658169|NCT01454830|26639605|P2|Overall Study|Withdrawal by Subject|4
7658170|NCT01454830|26639606|P1|Overall Study|Withdrawal by Subject|4
7658171|NCT01454778|26639637|P1|Overall Study|Death|1
7658172|NCT01454778|26639637|P1|Overall Study|Lost to Follow-up|2
7658173|NCT01454739|26639648|P2|Overall Study|Adverse Event|1
7658174|NCT01454739|26639649|P1|Overall Study|Adverse Event|0
7658175|NCT01454739|26639648|P2|Overall Study|Lost to Follow-up|1
7658176|NCT01454739|26639649|P1|Overall Study|Lost to Follow-up|0
7658177|NCT01454739|26639648|P2|Overall Study|Physician Decision|5
7658178|NCT01454739|26639649|P1|Overall Study|Physician Decision|0
7658179|NCT01454739|26639648|P2|Overall Study|Other|5
7658180|NCT01454739|26639649|P1|Overall Study|Other|3
7658181|NCT01454739|26639648|P2|Overall Study|Withdrawal by Subject|6
7658182|NCT01454739|26639649|P1|Overall Study|Withdrawal by Subject|2
7658183|NCT01454739|26639648|P2|Overall Study|Protocol Violation|3
7658184|NCT01454739|26639649|P1|Overall Study|Protocol Violation|2
7658185|NCT01454726|26639678|P2|Overall Study|Withdrawal by Subject|1
7658186|NCT01454726|26639679|P1|Overall Study|Withdrawal by Subject|0
7658187|NCT01454596|26639697|P12|Overall Study|Death|0
7658188|NCT01454596|26639698|P11|Overall Study|Death|1
7658189|NCT01454596|26639699|P10|Overall Study|Death|1
7658190|NCT01454596|26639700|P9|Overall Study|Death|0
7658191|NCT01454596|26639701|P8|Overall Study|Death|0
7658192|NCT01454596|26639702|P7|Overall Study|Death|0
7658193|NCT01454596|26639703|P6|Overall Study|Death|0
7658194|NCT01454596|26639704|P5|Overall Study|Death|0
7658195|NCT01454596|26639705|P4|Overall Study|Death|0
7658196|NCT01454596|26639706|P3|Overall Study|Death|0
7658197|NCT01454596|26639707|P2|Overall Study|Death|0
7658198|NCT01454596|26639708|P1|Overall Study|Death|0
7658199|NCT01454583|26639785|P3|3rd Year|Lost to Follow-up|297
7658200|NCT01454583|26639786|P2|3rd Year|Lost to Follow-up|512
7658201|NCT01454583|26639787|P1|3rd Year|Lost to Follow-up|1959
7658202|NCT01454583|26639785|P3|2nd Year|Lost to Follow-up|737
7658203|NCT01454583|26639786|P2|2nd Year|Lost to Follow-up|1049
7658204|NCT01454583|26639787|P1|2nd Year|Lost to Follow-up|3965
7658205|NCT01454583|26639785|P3|1st Year|Lost to Follow-up|180
7658206|NCT01454583|26639786|P2|1st Year|Lost to Follow-up|318
7658207|NCT01454583|26639787|P1|1st Year|Lost to Follow-up|1057
7658208|NCT01454570|26639855|P1|Overall Study|Screen Failure|7
7658209|NCT01454570|26639855|P1|Overall Study|Withdrawal by Subject|2
7658210|NCT01454531|26639859|P1|Overall Study|Other|1
7658211|NCT01454531|26639859|P1|Overall Study|Delay in IMP administration|1
7658212|NCT01454531|26639859|P1|Overall Study|Physician Decision|1
7658213|NCT01454531|26639859|P1|Overall Study|Lost to Follow-up|1
7658214|NCT01454531|26639859|P1|Overall Study|Withdrawal by Subject|5
7658215|NCT01454531|26639859|P1|Overall Study|Adverse Event|14
7658216|NCT01454401|26639895|P1|Overall Study|non-adherence|1
7658217|NCT01454401|26639895|P1|Overall Study|osteomyelitis|2
7658218|NCT01454401|26639895|P1|Overall Study|hospitalised|1
7658219|NCT01454401|26639895|P1|Overall Study|Death|1
7658220|NCT01454284|26639919|P2|Overall Study|Sponsor Decision|2
7658221|NCT01454284|26639920|P1|Overall Study|Sponsor Decision|0
7658222|NCT01454284|26639919|P2|Overall Study|Physician Decision|11
7658223|NCT01454284|26639920|P1|Overall Study|Physician Decision|16
7658224|NCT01454284|26639919|P2|Overall Study|Withdrawal by Subject|36
7658225|NCT01454284|26639920|P1|Overall Study|Withdrawal by Subject|58
7658226|NCT01454284|26639919|P2|Overall Study|Protocol Violation|6
7658227|NCT01454284|26639920|P1|Overall Study|Protocol Violation|9
7658228|NCT01454284|26639919|P2|Overall Study|Lost to Follow-up|8
7658229|NCT01454284|26639920|P1|Overall Study|Lost to Follow-up|13
7658230|NCT01454284|26639919|P2|Overall Study|Death|3
7658231|NCT01454284|26639920|P1|Overall Study|Death|0
7658232|NCT01454284|26639919|P2|Overall Study|Adverse Event|7
7658233|NCT01454284|26639920|P1|Overall Study|Adverse Event|20
7658234|NCT01454102|26639990|P16|Overall Study|Continuing in the treatment period|1
7658235|NCT01454102|26639991|P15|Overall Study|Continuing in the treatment period|3
7658236|NCT01454102|26639992|P14|Overall Study|Continuing in the treatment period|4
7658237|NCT01454102|26639993|P13|Overall Study|Continuing in the treatment period|7
7658238|NCT01454102|26639994|P12|Overall Study|Continuing in the treatment period|4
7658239|NCT01454102|26639995|P11|Overall Study|Continuing in the treatment period|0
7658240|NCT01454102|26639996|P10|Overall Study|Continuing in the treatment period|0
7658241|NCT01454102|26639997|P9|Overall Study|Continuing in the treatment period|1
7658242|NCT01454102|26639998|P8|Overall Study|Continuing in the treatment period|0
7658243|NCT01454102|26639999|P7|Overall Study|Continuing in the treatment period|2
7658244|NCT01454102|26640000|P6|Overall Study|Continuing in the treatment period|3
7658245|NCT01454102|26640001|P5|Overall Study|Continuing in the treatment period|3
7658246|NCT01454102|26640002|P4|Overall Study|Continuing in the treatment period|0
7658247|NCT01454102|26640003|P3|Overall Study|Continuing in the treatment period|0
7658248|NCT01454102|26640004|P2|Overall Study|Continuing in the treatment period|0
7658249|NCT01454102|26640005|P1|Overall Study|Continuing in the treatment period|0
7658250|NCT01454076|26640125|P5|Overall Study|Adverse Event|2
7658251|NCT01454076|26640126|P4|Overall Study|Adverse Event|0
7658252|NCT01454076|26640127|P3|Overall Study|Adverse Event|7
7658253|NCT01454076|26640128|P2|Overall Study|Adverse Event|2
7658254|NCT01454076|26640129|P1|Overall Study|Adverse Event|8
7658255|NCT01454076|26640125|P5|Overall Study|Withdrawal by Subject|2
7658256|NCT01454076|26640126|P4|Overall Study|Withdrawal by Subject|1
7658257|NCT01454076|26640127|P3|Overall Study|Withdrawal by Subject|2
7658258|NCT01454076|26640128|P2|Overall Study|Withdrawal by Subject|4
7658259|NCT01454076|26640129|P1|Overall Study|Withdrawal by Subject|3
7658260|NCT01454076|26640125|P5|Overall Study|Other|2
7658261|NCT01454076|26640126|P4|Overall Study|Other|1
7658262|NCT01454076|26640127|P3|Overall Study|Other|0
7658263|NCT01454076|26640128|P2|Overall Study|Other|0
7658264|NCT01454076|26640129|P1|Overall Study|Other|2
7658265|NCT01454063|26640182|P2|Randomized|Protocol Violation|1
7658266|NCT01454063|26640183|P1|Randomized|Protocol Violation|0
7658267|NCT01454063|26640182|P2|Randomized|Adverse Event|1
7658268|NCT01454063|26640183|P1|Randomized|Adverse Event|1
7658269|NCT01453998|26640204|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
7658270|NCT01453998|26640205|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
7658271|NCT01453998|26640206|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
7658272|NCT01453946|26640370|P1|Overall Study|Adverse Event|3
7658273|NCT01453946|26640370|P1|Overall Study|Lack of Efficacy|3
7658274|NCT01453946|26640370|P1|Overall Study|Protocol Violation|2
7658275|NCT01453946|26640370|P1|Overall Study|Did not receive drug for the taper phase|1
7658276|NCT01453855|26640387|P2|Overall Study|Other|1
7658277|NCT01453855|26640388|P1|Overall Study|Other|0
7658278|NCT01453855|26640387|P2|Overall Study|Inadequate Control of IOP|5
7658279|NCT01453855|26640388|P1|Overall Study|Inadequate Control of IOP|1
7658280|NCT01453855|26640387|P2|Overall Study|Noncompliance|0
7658281|NCT01453855|26640388|P1|Overall Study|Noncompliance|1
7658282|NCT01453855|26640387|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
7658283|NCT01453855|26640388|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
7658284|NCT01453855|26640387|P2|Overall Study|Lost to Follow-up|1
7658285|NCT01453855|26640388|P1|Overall Study|Lost to Follow-up|2
7658286|NCT01453855|26640387|P2|Overall Study|Adverse Event|4
7658287|NCT01453855|26640388|P1|Overall Study|Adverse Event|3
7658288|NCT01453725|26640396|P2|Overall Study|Physician Decision|1
7658289|NCT01453725|26640397|P1|Overall Study|Physician Decision|1
7658290|NCT01453725|26640396|P2|Overall Study|Pregnancy|0
7658291|NCT01453725|26640397|P1|Overall Study|Pregnancy|1
7658292|NCT01453725|26640396|P2|Overall Study|Pregnancy Wish|2
7658293|NCT01453725|26640397|P1|Overall Study|Pregnancy Wish|0
7658294|NCT01453725|26640396|P2|Overall Study|Withdrawal by Subject|3
7658295|NCT01453725|26640397|P1|Overall Study|Withdrawal by Subject|2
7658296|NCT01453725|26640396|P2|Overall Study|Protocol Violation|0
7658297|NCT01453725|26640397|P1|Overall Study|Protocol Violation|1
7658298|NCT01453725|26640396|P2|Overall Study|Non-compliance With Protocol|2
7658299|NCT01453725|26640397|P1|Overall Study|Non-compliance With Protocol|1
7658300|NCT01453725|26640396|P2|Overall Study|Lost to Follow-up|0
7658301|NCT01453725|26640397|P1|Overall Study|Lost to Follow-up|4
7658302|NCT01453725|26640396|P2|Overall Study|Adverse Event|3
7658303|NCT01453725|26640397|P1|Overall Study|Adverse Event|3
7658304|NCT01453595|26640420|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
7658305|NCT01453595|26640421|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
7658306|NCT01453595|26640422|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
7658307|NCT01453439|26640452|P2|Follow-up|Lost to Follow-up|10
7658308|NCT01453439|26640453|P1|Follow-up|Lost to Follow-up|5
7658309|NCT01453439|26640452|P2|Follow-up|Withdrawal by Subject|1
7658310|NCT01453439|26640453|P1|Follow-up|Withdrawal by Subject|0
7658311|NCT01453439|26640452|P2|Treatment Phase|Therapist conflict of interest|0
7658312|NCT01453439|26640453|P1|Treatment Phase|Therapist conflict of interest|1
7658313|NCT01453439|26640452|P2|Treatment Phase|Need for higher level of care|1
7658314|NCT01453439|26640453|P1|Treatment Phase|Need for higher level of care|1
7658315|NCT01453439|26640452|P2|Treatment Phase|Suicidal Ideation|0
7658316|NCT01453439|26640453|P1|Treatment Phase|Suicidal Ideation|2
7658317|NCT01453439|26640452|P2|Treatment Phase|Withdrawal by Subject|10
7658318|NCT01453439|26640453|P1|Treatment Phase|Withdrawal by Subject|13
7658319|NCT01453374|26640564|P1|Overall Study|Incarcerated|2
7658320|NCT01453374|26640564|P1|Overall Study|Withdrawal by Subject|5
7658321|NCT01453374|26640564|P1|Overall Study|Lost to Follow-up|3
7658322|NCT01453374|26640564|P1|Overall Study|Lack of Efficacy|1
7658323|NCT01453374|26640564|P1|Overall Study|Adverse Event|7
7658324|NCT01453361|26640580|P1|Overall Study|Screen-Failures|10
7658325|NCT01453361|26640580|P1|Overall Study|Disease Progression|6
7658326|NCT01453348|26640588|P3|Overall Study|Protocol Violation|0
7658327|NCT01453348|26640589|P2|Overall Study|Protocol Violation|0
7658328|NCT01453348|26640590|P1|Overall Study|Protocol Violation|1
7658329|NCT01453348|26640588|P3|Overall Study|Withdrawal by Subject|0
7658330|NCT01453348|26640589|P2|Overall Study|Withdrawal by Subject|1
7658331|NCT01453348|26640590|P1|Overall Study|Withdrawal by Subject|0
7658332|NCT01453348|26640588|P3|Overall Study|Death|1
7658333|NCT01453348|26640589|P2|Overall Study|Death|0
7658334|NCT01453348|26640590|P1|Overall Study|Death|0
7658335|NCT01453296|26640606|P2|Treatment Period 2|Withdrawal by Subject|0
7658336|NCT01453296|26640607|P1|Treatment Period 2|Withdrawal by Subject|1
7658337|NCT01453296|26640606|P2|Treatment Period 2|Adverse Event|0
7658338|NCT01453296|26640607|P1|Treatment Period 2|Adverse Event|1
7658339|NCT01453296|26640606|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
7658340|NCT01453296|26640607|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
7658341|NCT01453296|26640606|P2|Treatment Period 1|Adverse Event|1
7658342|NCT01453296|26640607|P1|Treatment Period 1|Adverse Event|0
7658343|NCT01453205|26640674|P3|Overall Study|Other|35
7658344|NCT01453205|26640675|P2|Overall Study|Other|27
7658345|NCT01453205|26640676|P1|Overall Study|Other|45
7658346|NCT01453205|26640674|P3|Overall Study|Death|18
7658347|NCT01453205|26640675|P2|Overall Study|Death|22
7658348|NCT01453205|26640676|P1|Overall Study|Death|24
7658349|NCT01453205|26640674|P3|Overall Study|Withdrawal by Subject|0
7658350|NCT01453205|26640675|P2|Overall Study|Withdrawal by Subject|3
7658351|NCT01453205|26640676|P1|Overall Study|Withdrawal by Subject|8
7658352|NCT01453205|26640674|P3|Overall Study|Lost to Follow-up|1
7658353|NCT01453205|26640675|P2|Overall Study|Lost to Follow-up|0
7658354|NCT01453205|26640676|P1|Overall Study|Lost to Follow-up|3
7658355|NCT01453153|26640752|P3|Overall Study|Adverse Event|1
7658356|NCT01453153|26640753|P2|Overall Study|Adverse Event|1
7658357|NCT01453153|26640754|P1|Overall Study|Adverse Event|1
7658358|NCT01453153|26640752|P3|Overall Study|Withdrawal by Subject|2
7658359|NCT01453153|26640753|P2|Overall Study|Withdrawal by Subject|1
7658360|NCT01453153|26640754|P1|Overall Study|Withdrawal by Subject|0
7658361|NCT01453153|26640752|P3|Overall Study|Progressive Disease|16
7658362|NCT01453153|26640753|P2|Overall Study|Progressive Disease|2
7658363|NCT01453153|26640754|P1|Overall Study|Progressive Disease|3
7658364|NCT01453153|26640752|P3|Overall Study|Physician Decision|1
7658365|NCT01453153|26640753|P2|Overall Study|Physician Decision|0
7658366|NCT01453153|26640754|P1|Overall Study|Physician Decision|0
7658367|NCT01453049|26640836|P2|Overall Study|Randomized in Error|0
7658368|NCT01453049|26640837|P1|Overall Study|Randomized in Error|1
7658369|NCT01453049|26640836|P2|Overall Study|Withdrawal by Subject|0
7658370|NCT01453049|26640837|P1|Overall Study|Withdrawal by Subject|1
7658371|NCT01453049|26640836|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
7658372|NCT01453049|26640837|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
7658373|NCT01453049|26640836|P2|Overall Study|Lost to Follow-up|1
7658374|NCT01453049|26640837|P1|Overall Study|Lost to Follow-up|2
7658375|NCT01453049|26640836|P2|Overall Study|Protocol Violation|5
7658376|NCT01453049|26640837|P1|Overall Study|Protocol Violation|2
7658377|NCT01453036|26640910|P3|Overall Study|Lost to Follow-up|31
7658378|NCT01453036|26640911|P2|Overall Study|Lost to Follow-up|115
7658379|NCT01453036|26640912|P1|Overall Study|Lost to Follow-up|26
7658380|NCT01453023|26640920|P2|Treatment Period 2|Protocol Violation|1
7658381|NCT01453023|26640921|P1|Treatment Period 2|Protocol Violation|0
7658382|NCT01453023|26640920|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
7658383|NCT01453023|26640921|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
7658384|NCT01453023|26640920|P2|Treatment Period (TP) 1|Protocol Violation|0
7658385|NCT01453023|26640921|P1|Treatment Period (TP) 1|Protocol Violation|1
7658386|NCT01452919|26640989|P3|Randomization Treatment|Subject is moving or has moved|0
7658387|NCT01452919|26640990|P2|Randomization Treatment|Subject is moving or has moved|1
7658388|NCT01452919|26640991|P1|Randomization Treatment|Subject is moving or has moved|0
7658389|NCT01452919|26640989|P3|Randomization Treatment|Withdrawal by Subject|0
7658390|NCT01452919|26640990|P2|Randomization Treatment|Withdrawal by Subject|1
7658391|NCT01452919|26640991|P1|Randomization Treatment|Withdrawal by Subject|0
7658392|NCT01452919|26640989|P3|Randomization Treatment|Sponsor Decision|0
7658393|NCT01452919|26640990|P2|Randomization Treatment|Sponsor Decision|1
7658394|NCT01452919|26640991|P1|Randomization Treatment|Sponsor Decision|0
7658395|NCT01452919|26640989|P3|Randomization Treatment|Adverse Event|2
7658396|NCT01452919|26640990|P2|Randomization Treatment|Adverse Event|0
7658397|NCT01452919|26640991|P1|Randomization Treatment|Adverse Event|0
7658398|NCT01452919|26640989|P3|Open-Label Treatment|Subject is moving or has moved|0
7658399|NCT01452919|26640990|P2|Open-Label Treatment|Subject is moving or has moved|0
7658400|NCT01452919|26640991|P1|Open-Label Treatment|Subject is moving or has moved|1
7658401|NCT01452919|26640989|P3|Open-Label Treatment|Withdrawal by Subject|0
7658402|NCT01452919|26640990|P2|Open-Label Treatment|Withdrawal by Subject|0
7658403|NCT01452919|26640991|P1|Open-Label Treatment|Withdrawal by Subject|2
7658404|NCT01452919|26640989|P3|Open-Label Treatment|Sponsor Decision|0
7658405|NCT01452919|26640990|P2|Open-Label Treatment|Sponsor Decision|0
7658406|NCT01452919|26640991|P1|Open-Label Treatment|Sponsor Decision|1
7658407|NCT01452919|26640989|P3|Open-Label Treatment|Protocol Violation|0
7658408|NCT01452919|26640990|P2|Open-Label Treatment|Protocol Violation|0
7658409|NCT01452919|26640991|P1|Open-Label Treatment|Protocol Violation|4
7658410|NCT01452919|26640989|P3|Open-Label Treatment|Perceived lack of efficacy|0
7658411|NCT01452919|26640990|P2|Open-Label Treatment|Perceived lack of efficacy|0
7658412|NCT01452919|26640991|P1|Open-Label Treatment|Perceived lack of efficacy|3
7658413|NCT01452919|26640989|P3|Open-Label Treatment|Lost to Follow-up|0
7658414|NCT01452919|26640990|P2|Open-Label Treatment|Lost to Follow-up|0
7658415|NCT01452919|26640991|P1|Open-Label Treatment|Lost to Follow-up|4
7658416|NCT01452919|26640989|P3|Open-Label Treatment|Adverse Event|0
7658417|NCT01452919|26640990|P2|Open-Label Treatment|Adverse Event|0
7658418|NCT01452919|26640991|P1|Open-Label Treatment|Adverse Event|5
7658419|NCT01452789|26641019|P2|Overall Study|Withdrawal by Subject|2
7658420|NCT01452789|26641020|P1|Overall Study|Withdrawal by Subject|3
7658421|NCT01452529|26641034|P3|Double-blind (DB) Period|Administrative|7
7658422|NCT01452529|26641035|P2|Double-blind (DB) Period|Administrative|11
7658423|NCT01452529|26641036|P1|Double-blind (DB) Period|Administrative|0
7658424|NCT01452529|26641034|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
7658425|NCT01452529|26641035|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
7658426|NCT01452529|26641036|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
7658427|NCT01452529|26641034|P3|Double-blind (DB) Period|Lack of Efficacy|44
7658428|NCT01452529|26641035|P2|Double-blind (DB) Period|Lack of Efficacy|16
7658429|NCT01452529|26641036|P1|Double-blind (DB) Period|Lack of Efficacy|0
7658430|NCT01452529|26641034|P3|Double-blind (DB) Period|Lost to Follow-up|3
7658431|NCT01452529|26641035|P2|Double-blind (DB) Period|Lost to Follow-up|5
7658432|NCT01452529|26641036|P1|Double-blind (DB) Period|Lost to Follow-up|0
7658433|NCT01452529|26641034|P3|Double-blind (DB) Period|Withdrawal by Subject|14
7658434|NCT01452529|26641035|P2|Double-blind (DB) Period|Withdrawal by Subject|15
7658435|NCT01452529|26641036|P1|Double-blind (DB) Period|Withdrawal by Subject|0
7658436|NCT01452529|26641034|P3|Double-blind (DB) Period|Adverse Event|11
7658437|NCT01452529|26641035|P2|Double-blind (DB) Period|Adverse Event|18
7658438|NCT01452529|26641036|P1|Double-blind (DB) Period|Adverse Event|0
7658439|NCT01452529|26641034|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
7658440|NCT01452529|26641035|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
7658441|NCT01452529|26641036|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
7658442|NCT01452529|26641034|P3|Run-in Period|Administrative|0
7658443|NCT01452529|26641035|P2|Run-in Period|Administrative|0
7658444|NCT01452529|26641036|P1|Run-in Period|Administrative|21
7658445|NCT01452529|26641034|P3|Run-in Period|Confirmed or suspected diversion|0
7658446|NCT01452529|26641035|P2|Run-in Period|Confirmed or suspected diversion|0
7658447|NCT01452529|26641036|P1|Run-in Period|Confirmed or suspected diversion|23
7658448|NCT01452529|26641034|P3|Run-in Period|Lack of Efficacy|0
7658449|NCT01452529|26641035|P2|Run-in Period|Lack of Efficacy|0
7658450|NCT01452529|26641036|P1|Run-in Period|Lack of Efficacy|46
7658451|NCT01452529|26641034|P3|Run-in Period|Lost to Follow-up|0
7658452|NCT01452529|26641035|P2|Run-in Period|Lost to Follow-up|0
7658453|NCT01452529|26641036|P1|Run-in Period|Lost to Follow-up|19
7658454|NCT01452529|26641034|P3|Run-in Period|Withdrawal by Subject|0
7658455|NCT01452529|26641035|P2|Run-in Period|Withdrawal by Subject|0
7658456|NCT01452529|26641036|P1|Run-in Period|Withdrawal by Subject|49
7658457|NCT01452529|26641034|P3|Run-in Period|Adverse Event|0
7658458|NCT01452529|26641035|P2|Run-in Period|Adverse Event|0
7658459|NCT01452529|26641036|P1|Run-in Period|Adverse Event|96
7658460|NCT01452412|26641058|P2|Overall Study|Other|0
7658461|NCT01452412|26641059|P1|Overall Study|Other|2
7658462|NCT01452412|26641058|P2|Overall Study|Initiated dialysis|0
7658463|NCT01452412|26641059|P1|Overall Study|Initiated dialysis|1
7658464|NCT01452412|26641058|P2|Overall Study|Death|0
7658465|NCT01452412|26641059|P1|Overall Study|Death|1
7658466|NCT01452412|26641058|P2|Overall Study|Lost to Follow-up|3
7658467|NCT01452412|26641059|P1|Overall Study|Lost to Follow-up|5
7658468|NCT01452412|26641058|P2|Overall Study|Adverse Event|3
7658469|NCT01452412|26641059|P1|Overall Study|Adverse Event|4
7658470|NCT01452412|26641058|P2|Overall Study|Withdrawal by Subject|11
7658471|NCT01452412|26641059|P1|Overall Study|Withdrawal by Subject|15
7658472|NCT01452347|26641075|P2|Overall Study|Other reason not defined above|0
7658473|NCT01452347|26641076|P1|Overall Study|Other reason not defined above|2
7658474|NCT01452347|26641075|P2|Overall Study|Not treated|3
7658475|NCT01452347|26641076|P1|Overall Study|Not treated|6
7658476|NCT01452347|26641075|P2|Overall Study|Withdrawal by Subject|3
7658477|NCT01452347|26641076|P1|Overall Study|Withdrawal by Subject|3
7658478|NCT01452347|26641075|P2|Overall Study|Lost to Follow-up|0
7658479|NCT01452347|26641076|P1|Overall Study|Lost to Follow-up|2
7658480|NCT01452347|26641075|P2|Overall Study|Non compliance protocol|0
7658481|NCT01452347|26641076|P1|Overall Study|Non compliance protocol|2
7658482|NCT01452347|26641075|P2|Overall Study|Adverse Event|1
7658483|NCT01452347|26641076|P1|Overall Study|Adverse Event|2
7658484|NCT01452152|26641136|P3|Overall Study|Study termination by sponsor|4
7658485|NCT01452152|26641137|P2|Overall Study|Study termination by sponsor|0
7658486|NCT01452152|26641138|P1|Overall Study|Study termination by sponsor|5
7658487|NCT01451931|26641210|P3|Overall Study|Withdrawal by Subject|22
7658488|NCT01451931|26641211|P2|Overall Study|Withdrawal by Subject|22
7658489|NCT01451931|26641212|P1|Overall Study|Withdrawal by Subject|16
7658490|NCT01451931|26641210|P3|Overall Study|Lost to Follow-up|21
7658491|NCT01451931|26641211|P2|Overall Study|Lost to Follow-up|36
7658492|NCT01451931|26641212|P1|Overall Study|Lost to Follow-up|17
7658493|NCT01451827|26641236|P4|Overall Study|Withdrawal by Subject|1
7658494|NCT01451827|26641237|P3|Overall Study|Withdrawal by Subject|1
7658495|NCT01451827|26641238|P2|Overall Study|Withdrawal by Subject|0
7658496|NCT01451827|26641239|P1|Overall Study|Withdrawal by Subject|0
7658497|NCT01451827|26641236|P4|Overall Study|Participant met withdrawal criteria|0
7658498|NCT01451827|26641237|P3|Overall Study|Participant met withdrawal criteria|0
7658499|NCT01451827|26641238|P2|Overall Study|Participant met withdrawal criteria|2
7658500|NCT01451827|26641239|P1|Overall Study|Participant met withdrawal criteria|0
7658501|NCT01451827|26641236|P4|Overall Study|Lost to Follow-up|2
7658502|NCT01451827|26641237|P3|Overall Study|Lost to Follow-up|0
7658503|NCT01451827|26641238|P2|Overall Study|Lost to Follow-up|3
7658504|NCT01451827|26641239|P1|Overall Study|Lost to Follow-up|0
7658505|NCT01451827|26641236|P4|Overall Study|Protocol deviation|0
7658506|NCT01451827|26641237|P3|Overall Study|Protocol deviation|0
7658507|NCT01451827|26641238|P2|Overall Study|Protocol deviation|0
7658508|NCT01451827|26641239|P1|Overall Study|Protocol deviation|1
7658509|NCT01451827|26641236|P4|Overall Study|Adverse Event|1
7658510|NCT01451827|26641237|P3|Overall Study|Adverse Event|1
7658511|NCT01451827|26641238|P2|Overall Study|Adverse Event|0
7658512|NCT01451827|26641239|P1|Overall Study|Adverse Event|2
7658513|NCT01451814|26641259|P2|Overall Study|Lost to Follow-up|4
7658514|NCT01451814|26641260|P1|Overall Study|Lost to Follow-up|5
7658515|NCT01451814|26641259|P2|Overall Study|Withdrawal by Subject|1
7658516|NCT01451814|26641260|P1|Overall Study|Withdrawal by Subject|1
7658517|NCT01451762|26641292|P3|Overall Study|Lost to Follow-up|6
7658518|NCT01451762|26641293|P2|Overall Study|Lost to Follow-up|6
7658519|NCT01451762|26641294|P1|Overall Study|Lost to Follow-up|3
7658520|NCT01451749|26641304|P2|Overall Study|Withdrawal by Subject|1
7658521|NCT01451749|26641305|P1|Overall Study|Withdrawal by Subject|0
7658522|NCT01451749|26641304|P2|Overall Study|Adverse Event|0
7658523|NCT01451749|26641305|P1|Overall Study|Adverse Event|2
7658524|NCT01451749|26641304|P2|Overall Study|Meet the exclusion criteria,and|1
7658525|NCT01451749|26641305|P1|Overall Study|Meet the exclusion criteria,and|1
7658526|NCT01451749|26641304|P2|Overall Study|Lost to Follow-up|5
7658527|NCT01451749|26641305|P1|Overall Study|Lost to Follow-up|15
7658528|NCT01451749|26641304|P2|Overall Study|Protocol Violation|7
7658529|NCT01451749|26641305|P1|Overall Study|Protocol Violation|14
7658530|NCT01451723|26641317|P2|Overall Study|study halted|5
7658531|NCT01451723|26641318|P1|Overall Study|study halted|6
7658532|NCT01451645|26641328|P2|Overall Study|Lost to Follow-up|3
7658533|NCT01451645|26641329|P1|Overall Study|Lost to Follow-up|4
7658534|NCT01451645|26641328|P2|Overall Study|Withdrawal by Subject|2
7658535|NCT01451645|26641329|P1|Overall Study|Withdrawal by Subject|4
7658536|NCT01451645|26641328|P2|Overall Study|Adverse Event|3
7658537|NCT01451645|26641329|P1|Overall Study|Adverse Event|0
7658538|NCT01451645|26641328|P2|Overall Study|Protocol Violation|0
7658539|NCT01451645|26641329|P1|Overall Study|Protocol Violation|1
7658540|NCT01451606|26641400|P2|Overall Study|Withdrawal by Subject|3
7658541|NCT01451606|26641401|P1|Overall Study|Withdrawal by Subject|4
7658542|NCT01451554|26641411|P2|Overall Study|Withdrawal by Subject|9
7658543|NCT01451554|26641412|P1|Overall Study|Withdrawal by Subject|14
7658544|NCT01451541|26641423|P3|Overall Study|randomization error, noncompliance|8
7658545|NCT01451541|26641424|P2|Overall Study|randomization error, noncompliance|10
7658546|NCT01451541|26641425|P1|Overall Study|randomization error, noncompliance|11
7658547|NCT01451541|26641423|P3|Overall Study|Withdrawal by Subject|6
7658548|NCT01451541|26641424|P2|Overall Study|Withdrawal by Subject|8
7658549|NCT01451541|26641425|P1|Overall Study|Withdrawal by Subject|15
7658550|NCT01451541|26641423|P3|Overall Study|Lost to Follow-up|7
7658551|NCT01451541|26641424|P2|Overall Study|Lost to Follow-up|4
7658552|NCT01451541|26641425|P1|Overall Study|Lost to Follow-up|4
7658553|NCT01451541|26641423|P3|Overall Study|Lack of Efficacy|0
7658554|NCT01451541|26641424|P2|Overall Study|Lack of Efficacy|0
7658555|NCT01451541|26641425|P1|Overall Study|Lack of Efficacy|2
7658556|NCT01451541|26641423|P3|Overall Study|Adverse Event|6
7658557|NCT01451541|26641424|P2|Overall Study|Adverse Event|3
7658558|NCT01451541|26641425|P1|Overall Study|Adverse Event|4
7658559|NCT01451437|26641483|P9|Overall Study|Withdrawal by Subject|0
7658560|NCT01451437|26641484|P8|Overall Study|Withdrawal by Subject|0
7658561|NCT01451437|26641485|P7|Overall Study|Withdrawal by Subject|1
7658562|NCT01451437|26641486|P6|Overall Study|Withdrawal by Subject|0
7658563|NCT01451437|26641487|P5|Overall Study|Withdrawal by Subject|1
7658564|NCT01451437|26641488|P4|Overall Study|Withdrawal by Subject|0
7658565|NCT01451437|26641489|P3|Overall Study|Withdrawal by Subject|0
7658566|NCT01451437|26641490|P2|Overall Study|Withdrawal by Subject|0
7658567|NCT01451437|26641491|P1|Overall Study|Withdrawal by Subject|0
7658568|NCT01451437|26641483|P9|Overall Study|Protocol Violation|0
7658569|NCT01451437|26641484|P8|Overall Study|Protocol Violation|0
7658570|NCT01451437|26641485|P7|Overall Study|Protocol Violation|1
7658571|NCT01451437|26641486|P6|Overall Study|Protocol Violation|0
7658572|NCT01451437|26641487|P5|Overall Study|Protocol Violation|0
7658573|NCT01451437|26641488|P4|Overall Study|Protocol Violation|0
7658574|NCT01451437|26641489|P3|Overall Study|Protocol Violation|0
7658575|NCT01451437|26641490|P2|Overall Study|Protocol Violation|0
7658576|NCT01451437|26641491|P1|Overall Study|Protocol Violation|0
7658577|NCT01451437|26641483|P9|Overall Study|Disease Progression|3
7658578|NCT01451437|26641484|P8|Overall Study|Disease Progression|1
7658579|NCT01451437|26641485|P7|Overall Study|Disease Progression|3
7658580|NCT01451437|26641486|P6|Overall Study|Disease Progression|2
7658581|NCT01451437|26641487|P5|Overall Study|Disease Progression|3
7658582|NCT01451437|26641488|P4|Overall Study|Disease Progression|1
7658583|NCT01451437|26641489|P3|Overall Study|Disease Progression|1
7658584|NCT01451437|26641490|P2|Overall Study|Disease Progression|0
7658585|NCT01451437|26641491|P1|Overall Study|Disease Progression|0
7658586|NCT01451437|26641483|P9|Overall Study|Physician Decision|0
7658587|NCT01451437|26641484|P8|Overall Study|Physician Decision|0
7658588|NCT01451437|26641485|P7|Overall Study|Physician Decision|0
7658589|NCT01451437|26641486|P6|Overall Study|Physician Decision|0
7658590|NCT01451437|26641487|P5|Overall Study|Physician Decision|0
7658591|NCT01451437|26641488|P4|Overall Study|Physician Decision|0
7658592|NCT01451437|26641489|P3|Overall Study|Physician Decision|2
7658593|NCT01451437|26641490|P2|Overall Study|Physician Decision|1
7658594|NCT01451437|26641491|P1|Overall Study|Physician Decision|1
7658595|NCT01451437|26641483|P9|Overall Study|Adverse Event|1
7658596|NCT01451437|26641484|P8|Overall Study|Adverse Event|2
7658597|NCT01451437|26641485|P7|Overall Study|Adverse Event|1
7658598|NCT01451437|26641486|P6|Overall Study|Adverse Event|1
7658599|NCT01451437|26641487|P5|Overall Study|Adverse Event|0
7658600|NCT01451437|26641488|P4|Overall Study|Adverse Event|0
7658601|NCT01451437|26641489|P3|Overall Study|Adverse Event|0
7658602|NCT01451437|26641490|P2|Overall Study|Adverse Event|0
7658603|NCT01451437|26641491|P1|Overall Study|Adverse Event|0
7658604|NCT01451424|26641623|P4|Overall Study|Adverse Event|1
7658605|NCT01451424|26641624|P3|Overall Study|Adverse Event|0
7658606|NCT01451424|26641625|P2|Overall Study|Adverse Event|0
7658607|NCT01451424|26641626|P1|Overall Study|Adverse Event|0
7658608|NCT01451424|26641623|P4|Overall Study|Physician Decision|1
7658609|NCT01451424|26641624|P3|Overall Study|Physician Decision|1
7658610|NCT01451424|26641625|P2|Overall Study|Physician Decision|0
7658611|NCT01451424|26641626|P1|Overall Study|Physician Decision|0
7658612|NCT01451424|26641623|P4|Overall Study|Lost to Follow-up|1
7658613|NCT01451424|26641624|P3|Overall Study|Lost to Follow-up|0
7658614|NCT01451424|26641625|P2|Overall Study|Lost to Follow-up|1
7658615|NCT01451424|26641626|P1|Overall Study|Lost to Follow-up|0
7658616|NCT01451424|26641623|P4|Overall Study|Withdrawal by Subject|2
7658617|NCT01451424|26641624|P3|Overall Study|Withdrawal by Subject|0
7658618|NCT01451424|26641625|P2|Overall Study|Withdrawal by Subject|1
7658619|NCT01451424|26641626|P1|Overall Study|Withdrawal by Subject|1
7658620|NCT01451398|26641684|P2|Overall Study|Lack of Efficacy|1
7658621|NCT01451398|26641685|P1|Overall Study|Lack of Efficacy|0
7658622|NCT01451398|26641684|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
7658623|NCT01451398|26641685|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
7658624|NCT01451398|26641684|P2|Overall Study|Moved out of country|1
7658625|NCT01451398|26641685|P1|Overall Study|Moved out of country|0
7658626|NCT01451398|26641684|P2|Overall Study|Non-compliance with protocol|1
7658627|NCT01451398|26641685|P1|Overall Study|Non-compliance with protocol|1
7658628|NCT01451398|26641684|P2|Overall Study|Non-compliance with study drug|3
7658629|NCT01451398|26641685|P1|Overall Study|Non-compliance with study drug|1
7658630|NCT01451398|26641684|P2|Overall Study|Lost to Follow-up|4
7658631|NCT01451398|26641685|P1|Overall Study|Lost to Follow-up|6
7658632|NCT01451398|26641684|P2|Overall Study|Withdrawal by Subject|14
7658633|NCT01451398|26641685|P1|Overall Study|Withdrawal by Subject|10
7658634|NCT01451398|26641684|P2|Overall Study|Physician Decision|1
7658635|NCT01451398|26641685|P1|Overall Study|Physician Decision|1
7658636|NCT01451398|26641684|P2|Overall Study|Protocol Violation|2
7658637|NCT01451398|26641685|P1|Overall Study|Protocol Violation|1
7658638|NCT01451398|26641684|P2|Overall Study|Adverse Event|9
7658639|NCT01451398|26641685|P1|Overall Study|Adverse Event|7
7658640|NCT01451203|26641736|P2|Post-treatment Period|Investigator decision|1
7658641|NCT01451203|26641737|P1|Post-treatment Period|Investigator decision|0
7658642|NCT01451203|26641736|P2|Post-treatment Period|Adverse Event|1
7658643|NCT01451203|26641737|P1|Post-treatment Period|Adverse Event|0
7658644|NCT01451203|26641736|P2|Post-treatment Period|Lack of Efficacy|28
7658645|NCT01451203|26641737|P1|Post-treatment Period|Lack of Efficacy|12
7658646|NCT01451203|26641736|P2|Post-treatment Period|Consent withdrawn|4
7658647|NCT01451203|26641737|P1|Post-treatment Period|Consent withdrawn|2
7658648|NCT01451203|26641736|P2|Double-blind Treatment Period|Investigator decision|0
7658649|NCT01451203|26641737|P1|Double-blind Treatment Period|Investigator decision|2
7658650|NCT01451203|26641736|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
7658651|NCT01451203|26641737|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
7658652|NCT01451203|26641736|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
7658653|NCT01451203|26641737|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
7658654|NCT01451203|26641736|P2|Double-blind Treatment Period|Adverse Event|9
7658655|NCT01451203|26641737|P1|Double-blind Treatment Period|Adverse Event|6
7658656|NCT01451203|26641736|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
7658657|NCT01451203|26641737|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
7658658|NCT01451203|26641736|P2|Double-blind Treatment Period|Lack of Efficacy|36
7658659|NCT01451203|26641737|P1|Double-blind Treatment Period|Lack of Efficacy|71
7658660|NCT01451203|26641736|P2|Double-blind Treatment Period|Consent Withdrawn|2
7658661|NCT01451203|26641737|P1|Double-blind Treatment Period|Consent Withdrawn|3
7658662|NCT01451203|26641736|P2|Double-blind Treatment Period|Did not receive treatment|2
7658663|NCT01451203|26641737|P1|Double-blind Treatment Period|Did not receive treatment|1
7658664|NCT01451164|26641755|P4|Overall Study|Lack of Efficacy|7
7658665|NCT01451164|26641756|P3|Overall Study|Lack of Efficacy|9
7658666|NCT01451164|26641757|P2|Overall Study|Lack of Efficacy|9
7658667|NCT01451164|26641758|P1|Overall Study|Lack of Efficacy|7
7658668|NCT01451164|26641755|P4|Overall Study|Protocol Violation|0
7658669|NCT01451164|26641756|P3|Overall Study|Protocol Violation|0
7658670|NCT01451164|26641757|P2|Overall Study|Protocol Violation|1
7658671|NCT01451164|26641758|P1|Overall Study|Protocol Violation|0
7658672|NCT01451164|26641755|P4|Overall Study|Withdrawal by Subject|17
7658673|NCT01451164|26641756|P3|Overall Study|Withdrawal by Subject|16
7658674|NCT01451164|26641757|P2|Overall Study|Withdrawal by Subject|11
7658675|NCT01451164|26641758|P1|Overall Study|Withdrawal by Subject|14
7658676|NCT01451164|26641755|P4|Overall Study|Physician Decision|0
7658677|NCT01451164|26641756|P3|Overall Study|Physician Decision|1
7658678|NCT01451164|26641757|P2|Overall Study|Physician Decision|0
7658679|NCT01451164|26641758|P1|Overall Study|Physician Decision|2
7658680|NCT01451164|26641755|P4|Overall Study|Withdrawal Criteria|1
7658681|NCT01451164|26641756|P3|Overall Study|Withdrawal Criteria|1
7658682|NCT01451164|26641757|P2|Overall Study|Withdrawal Criteria|1
7658683|NCT01451164|26641758|P1|Overall Study|Withdrawal Criteria|1
7658684|NCT01451164|26641755|P4|Overall Study|Adverse Event|21
7658685|NCT01451164|26641756|P3|Overall Study|Adverse Event|18
7658686|NCT01451164|26641757|P2|Overall Study|Adverse Event|12
7658687|NCT01451164|26641758|P1|Overall Study|Adverse Event|19
7658688|NCT01450943|26641787|P3|Overall Study|Screen failure, loss to follow-up|6
7658689|NCT01450943|26641788|P2|Overall Study|Screen failure, loss to follow-up|7
7658690|NCT01450943|26641789|P1|Overall Study|Screen failure, loss to follow-up|2
7658691|NCT01450813|26641822|P4|Overall Study|Physician Decision|3
7658692|NCT01450813|26641823|P3|Overall Study|Physician Decision|0
7658693|NCT01450813|26641824|P2|Overall Study|Physician Decision|1
7658694|NCT01450813|26641825|P1|Overall Study|Physician Decision|1
7658695|NCT01450800|26641839|P2|Overall Study|Protocol Violation|3
7658696|NCT01450800|26641840|P1|Overall Study|Protocol Violation|1
7658697|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
7658698|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
7658699|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
7658700|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
7658701|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Not reported|2
7658702|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Not reported|2
7658703|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
7658704|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
7658705|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
7658706|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
7658707|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
7658708|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
7658709|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
7658710|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
7658711|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Death|6
7658712|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Death|5
7658713|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
7658714|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
7658715|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
7658716|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
7658717|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
7658718|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
7658719|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
7658720|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
7658721|NCT01450761|26641875|P2|Treatment With Blinded Study Therapy|Disease progression|415
7658722|NCT01450761|26641876|P1|Treatment With Blinded Study Therapy|Disease progression|318
7658723|NCT01450761|26641875|P2|Lead-in Chemotherapy|Lost to Follow-up|0
7658724|NCT01450761|26641876|P1|Lead-in Chemotherapy|Lost to Follow-up|2
7658725|NCT01450761|26641875|P2|Lead-in Chemotherapy|Other|2
7658726|NCT01450761|26641876|P1|Lead-in Chemotherapy|Other|2
7658727|NCT01450761|26641875|P2|Lead-in Chemotherapy|Death|3
7658728|NCT01450761|26641876|P1|Lead-in Chemotherapy|Death|3
7658729|NCT01450761|26641875|P2|Lead-in Chemotherapy|No longer meets study criteria|7
7658730|NCT01450761|26641876|P1|Lead-in Chemotherapy|No longer meets study criteria|3
7658731|NCT01450761|26641875|P2|Lead-in Chemotherapy|Study drug toxicity|10
7658732|NCT01450761|26641876|P1|Lead-in Chemotherapy|Study drug toxicity|6
7658733|NCT01450761|26641875|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
7658734|NCT01450761|26641876|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
7658735|NCT01450761|26641875|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
7658736|NCT01450761|26641876|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
7658737|NCT01450761|26641875|P2|Lead-in Chemotherapy|Disease progression|32
7658738|NCT01450761|26641876|P1|Lead-in Chemotherapy|Disease progression|33
7658739|NCT01450761|26641875|P2|Randomization|Other|1
7658740|NCT01450761|26641876|P1|Randomization|Other|0
7658741|NCT01450761|26641875|P2|Randomization|Adverse Event unrelated to study drug|0
7658742|NCT01450761|26641876|P1|Randomization|Adverse Event unrelated to study drug|1
7658743|NCT01450761|26641875|P2|Randomization|Disease progression|2
7658744|NCT01450761|26641876|P1|Randomization|Disease progression|0
7658745|NCT01450761|26641875|P2|Randomization|Withdrawal by Subject|0
7658746|NCT01450761|26641876|P1|Randomization|Withdrawal by Subject|2
7658747|NCT01450761|26641875|P2|Randomization|Subject no longer meets study criteria|2
7658748|NCT01450761|26641876|P1|Randomization|Subject no longer meets study criteria|1
7658749|NCT01450696|26641888|P2|Overall Study|Study Terminated by Sponsor|58
7658750|NCT01450696|26641889|P1|Overall Study|Study Terminated by Sponsor|53
7658751|NCT01450696|26641888|P2|Overall Study|Withdrawal by Subject|2
7658752|NCT01450696|26641889|P1|Overall Study|Withdrawal by Subject|13
7658753|NCT01450696|26641888|P2|Overall Study|Non-Compliance|0
7658754|NCT01450696|26641889|P1|Overall Study|Non-Compliance|1
7658755|NCT01450696|26641888|P2|Overall Study|Lost to Follow-up|3
7658756|NCT01450696|26641889|P1|Overall Study|Lost to Follow-up|3
7658757|NCT01450696|26641888|P2|Overall Study|Death|84
7658758|NCT01450696|26641889|P1|Overall Study|Death|77
7658759|NCT01450696|26641888|P2|Overall Study|Never Treated|1
7658760|NCT01450696|26641889|P1|Overall Study|Never Treated|1
7658761|NCT01450683|26641911|P1|Overall Study|Adverse Event|2
7658762|NCT01450631|26641917|P2|Overall Study|Withdrawal by Subject|0
7658763|NCT01450631|26641918|P1|Overall Study|Withdrawal by Subject|1
7658764|NCT01450631|26641917|P2|Overall Study|Lost to Follow-up|4
7658765|NCT01450631|26641918|P1|Overall Study|Lost to Follow-up|2
7658766|NCT01450540|26641928|P2|Overall Study|protocol deviation|23
7658767|NCT01450540|26641929|P1|Overall Study|protocol deviation|3
7658768|NCT01450540|26641928|P2|Overall Study|Withdrawal by Subject|13
7658769|NCT01450540|26641929|P1|Overall Study|Withdrawal by Subject|19
7658770|NCT01450137|26642061|P2|Week 12 to Study End|Withdrawal by Subject|1
7658771|NCT01450137|26642062|P1|Week 12 to Study End|Withdrawal by Subject|0
7658772|NCT01450137|26642061|P2|Week 12 to Study End|Death|1
7658773|NCT01450137|26642062|P1|Week 12 to Study End|Death|0
7658774|NCT01450137|26642061|P2|Up to Week 12|Withdrawal by Subject|2
7658775|NCT01450137|26642062|P1|Up to Week 12|Withdrawal by Subject|0
7658776|NCT01450137|26642061|P2|Up to Week 12|Adverse Event|1
7658777|NCT01450137|26642062|P1|Up to Week 12|Adverse Event|2
7658778|NCT01450098|26642076|P2|Period 3|Withdrawal by Subject|2
7658779|NCT01450098|26642077|P1|Period 3|Withdrawal by Subject|0
7658780|NCT01450098|26642076|P2|Period 3|Protocol Violation|1
7658781|NCT01450098|26642077|P1|Period 3|Protocol Violation|0
7658782|NCT01450007|26642096|P3|Overall Study|Adverse Event|0
7658783|NCT01450007|26642097|P2|Overall Study|Adverse Event|1
7658784|NCT01450007|26642098|P1|Overall Study|Adverse Event|0
7658785|NCT01450007|26642096|P3|Overall Study|Protocol Violation|1
7658786|NCT01450007|26642097|P2|Overall Study|Protocol Violation|1
7658787|NCT01450007|26642098|P1|Overall Study|Protocol Violation|0
7658788|NCT01450007|26642096|P3|Overall Study|Late exclusion before treatment|2
7658789|NCT01450007|26642097|P2|Overall Study|Late exclusion before treatment|3
7658790|NCT01450007|26642098|P1|Overall Study|Late exclusion before treatment|2
7658791|NCT01449955|26642117|P2|Overall Study|Withdrawal by Subject|2
7658792|NCT01449955|26642118|P1|Overall Study|Withdrawal by Subject|1
7658793|NCT01449929|26642146|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
7658794|NCT01449929|26642147|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7658795|NCT01449929|26642148|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7658796|NCT01449929|26642146|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
7658797|NCT01449929|26642147|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7658798|NCT01449929|26642148|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7658799|NCT01449929|26642146|P3|Extension Phase Approximately 3 Years|Adverse Event|2
7658800|NCT01449929|26642147|P2|Extension Phase Approximately 3 Years|Adverse Event|0
7658801|NCT01449929|26642148|P1|Extension Phase Approximately 3 Years|Adverse Event|0
7658802|NCT01449929|26642146|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
7658803|NCT01449929|26642147|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
7658804|NCT01449929|26642148|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
7658805|NCT01449929|26642146|P3|Randomization Phase 96 Week|Physician Decision|0
7658806|NCT01449929|26642147|P2|Randomization Phase 96 Week|Physician Decision|3
7658807|NCT01449929|26642148|P1|Randomization Phase 96 Week|Physician Decision|2
7658808|NCT01449929|26642146|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
7658809|NCT01449929|26642147|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
7658810|NCT01449929|26642148|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
7658811|NCT01449929|26642146|P3|Randomization Phase 96 Week|Lost to Follow-up|0
7658812|NCT01449929|26642147|P2|Randomization Phase 96 Week|Lost to Follow-up|18
7658813|NCT01449929|26642148|P1|Randomization Phase 96 Week|Lost to Follow-up|15
7658814|NCT01449929|26642146|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7658815|NCT01449929|26642147|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7658816|NCT01449929|26642148|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
7658817|NCT01449929|26642146|P3|Randomization Phase 96 Week|Protocol Violation|0
7658818|NCT01449929|26642147|P2|Randomization Phase 96 Week|Protocol Violation|6
7658819|NCT01449929|26642148|P1|Randomization Phase 96 Week|Protocol Violation|5
7658820|NCT01449929|26642146|P3|Randomization Phase 96 Week|Lack of Efficacy|0
7658821|NCT01449929|26642147|P2|Randomization Phase 96 Week|Lack of Efficacy|4
7658822|NCT01449929|26642148|P1|Randomization Phase 96 Week|Lack of Efficacy|3
7658823|NCT01449929|26642146|P3|Randomization Phase 96 Week|Adverse Event|0
7658824|NCT01449929|26642147|P2|Randomization Phase 96 Week|Adverse Event|13
7658825|NCT01449929|26642148|P1|Randomization Phase 96 Week|Adverse Event|5
7658826|NCT01449812|26642193|P3|Overall Study|Lost to Follow-up|0
7658827|NCT01449812|26642194|P2|Overall Study|Lost to Follow-up|0
7658828|NCT01449812|26642195|P1|Overall Study|Lost to Follow-up|1
7658829|NCT01449812|26642193|P3|Overall Study|Withdrawal by Subject|1
7658830|NCT01449812|26642194|P2|Overall Study|Withdrawal by Subject|0
7658831|NCT01449812|26642195|P1|Overall Study|Withdrawal by Subject|0
7658832|NCT01449812|26642193|P3|Overall Study|Migrated/moved from study area|0
7658833|NCT01449812|26642194|P2|Overall Study|Migrated/moved from study area|0
7658834|NCT01449812|26642195|P1|Overall Study|Migrated/moved from study area|1
7658835|NCT01449721|26642310|P2|Overall Study|Physician Decision|1
7658836|NCT01449721|26642311|P1|Overall Study|Physician Decision|0
7658837|NCT01449721|26642310|P2|Overall Study|Physician Decision|1
7658838|NCT01449721|26642311|P1|Overall Study|Physician Decision|0
7658839|NCT01449708|26642323|P2|Overall Study|respiratory failure|0
7658840|NCT01449708|26642324|P1|Overall Study|respiratory failure|1
7658841|NCT01449708|26642323|P2|Overall Study|surgical complication|2
7658842|NCT01449708|26642324|P1|Overall Study|surgical complication|1
7658843|NCT01449708|26642323|P2|Overall Study|Protocol Violation|1
7658844|NCT01449708|26642324|P1|Overall Study|Protocol Violation|0
7658845|NCT01449682|26642335|P2|Overall Study|Adverse Event|0
7658846|NCT01449682|26642336|P1|Overall Study|Adverse Event|1
7658847|NCT01449682|26642335|P2|Overall Study|Death|1
7658848|NCT01449682|26642336|P1|Overall Study|Death|0
7658849|NCT01449630|26642357|P9|Period 2|Sponsor Decision|0
7658850|NCT01449630|26642358|P8|Period 2|Sponsor Decision|0
7658851|NCT01449630|26642359|P7|Period 2|Sponsor Decision|1
7658852|NCT01449630|26642360|P6|Period 2|Sponsor Decision|0
7658853|NCT01449630|26642361|P5|Period 2|Sponsor Decision|0
7658854|NCT01449630|26642362|P4|Period 2|Sponsor Decision|0
7658855|NCT01449630|26642363|P3|Period 2|Sponsor Decision|0
7658856|NCT01449630|26642364|P2|Period 2|Sponsor Decision|0
7658857|NCT01449630|26642365|P1|Period 2|Sponsor Decision|0
7658858|NCT01449630|26642357|P9|Period 1|Sponsor Decision|0
7658859|NCT01449630|26642358|P8|Period 1|Sponsor Decision|0
7658860|NCT01449630|26642359|P7|Period 1|Sponsor Decision|0
7658861|NCT01449630|26642360|P6|Period 1|Sponsor Decision|1
7658862|NCT01449630|26642361|P5|Period 1|Sponsor Decision|0
7658863|NCT01449630|26642362|P4|Period 1|Sponsor Decision|0
7658864|NCT01449630|26642363|P3|Period 1|Sponsor Decision|0
7658865|NCT01449630|26642364|P2|Period 1|Sponsor Decision|0
7658866|NCT01449630|26642365|P1|Period 1|Sponsor Decision|0
7658867|NCT01449630|26642357|P9|Period 1|Physician Decision|0
7658868|NCT01449630|26642358|P8|Period 1|Physician Decision|0
7658869|NCT01449630|26642359|P7|Period 1|Physician Decision|0
7658870|NCT01449630|26642360|P6|Period 1|Physician Decision|0
7658871|NCT01449630|26642361|P5|Period 1|Physician Decision|0
7658872|NCT01449630|26642362|P4|Period 1|Physician Decision|1
7658873|NCT01449630|26642363|P3|Period 1|Physician Decision|0
7658874|NCT01449630|26642364|P2|Period 1|Physician Decision|0
7658875|NCT01449630|26642365|P1|Period 1|Physician Decision|1
7658876|NCT01449539|26642435|P1|Overall Study|Toxicity not study related|1
7658877|NCT01449539|26642435|P1|Overall Study|Withdrawal by Subject|3
7658878|NCT01449526|26642441|P2|Overall Study|Cannot maintain visits|1
7658879|NCT01449526|26642442|P1|Overall Study|Cannot maintain visits|0
7658880|NCT01449526|26642441|P2|Overall Study|Lack of Motivation|1
7658881|NCT01449526|26642442|P1|Overall Study|Lack of Motivation|0
7658882|NCT01449526|26642441|P2|Overall Study|Symptoms/complaints|1
7658883|NCT01449526|26642442|P1|Overall Study|Symptoms/complaints|0
7658884|NCT01449526|26642441|P2|Overall Study|Withdrawal by Subject|1
7658885|NCT01449526|26642442|P1|Overall Study|Withdrawal by Subject|1
7658886|NCT01449526|26642441|P2|Overall Study|Lost to Follow-up|2
7658887|NCT01449526|26642442|P1|Overall Study|Lost to Follow-up|1
7658888|NCT01449461|26642511|P6|Overall Study|Reason not Specified|1
7658889|NCT01449461|26642512|P5|Overall Study|Reason not Specified|2
7658890|NCT01449461|26642513|P4|Overall Study|Reason not Specified|3
7658891|NCT01449461|26642514|P3|Overall Study|Reason not Specified|0
7658892|NCT01449461|26642515|P2|Overall Study|Reason not Specified|1
7658893|NCT01449461|26642516|P1|Overall Study|Reason not Specified|0
7658894|NCT01449461|26642511|P6|Overall Study|Withdrawal by Subject|1
7658895|NCT01449461|26642512|P5|Overall Study|Withdrawal by Subject|2
7658896|NCT01449461|26642513|P4|Overall Study|Withdrawal by Subject|0
7658897|NCT01449461|26642514|P3|Overall Study|Withdrawal by Subject|0
7658898|NCT01449461|26642515|P2|Overall Study|Withdrawal by Subject|1
7658899|NCT01449461|26642516|P1|Overall Study|Withdrawal by Subject|0
7658900|NCT01449461|26642511|P6|Overall Study|Site Terminated by Sponsor|1
7658901|NCT01449461|26642512|P5|Overall Study|Site Terminated by Sponsor|4
7658902|NCT01449461|26642513|P4|Overall Study|Site Terminated by Sponsor|3
7658903|NCT01449461|26642514|P3|Overall Study|Site Terminated by Sponsor|2
7658904|NCT01449461|26642515|P2|Overall Study|Site Terminated by Sponsor|1
7658905|NCT01449461|26642516|P1|Overall Study|Site Terminated by Sponsor|0
7658906|NCT01449461|26642511|P6|Overall Study|Protocol Violation|0
7658907|NCT01449461|26642512|P5|Overall Study|Protocol Violation|0
7658908|NCT01449461|26642513|P4|Overall Study|Protocol Violation|1
7658909|NCT01449461|26642514|P3|Overall Study|Protocol Violation|0
7658910|NCT01449461|26642515|P2|Overall Study|Protocol Violation|0
7658911|NCT01449461|26642516|P1|Overall Study|Protocol Violation|0
7658912|NCT01449461|26642511|P6|Overall Study|Clinical Progressive Disease|2
7658913|NCT01449461|26642512|P5|Overall Study|Clinical Progressive Disease|4
7658914|NCT01449461|26642513|P4|Overall Study|Clinical Progressive Disease|3
7658915|NCT01449461|26642514|P3|Overall Study|Clinical Progressive Disease|0
7658916|NCT01449461|26642515|P2|Overall Study|Clinical Progressive Disease|2
7658917|NCT01449461|26642516|P1|Overall Study|Clinical Progressive Disease|2
7658918|NCT01449461|26642511|P6|Overall Study|Documented Progressive Disease|5
7658919|NCT01449461|26642512|P5|Overall Study|Documented Progressive Disease|24
7658920|NCT01449461|26642513|P4|Overall Study|Documented Progressive Disease|15
7658921|NCT01449461|26642514|P3|Overall Study|Documented Progressive Disease|14
7658922|NCT01449461|26642515|P2|Overall Study|Documented Progressive Disease|7
7658923|NCT01449461|26642516|P1|Overall Study|Documented Progressive Disease|4
7658924|NCT01449461|26642511|P6|Overall Study|Physician Decision|0
7658925|NCT01449461|26642512|P5|Overall Study|Physician Decision|1
7658926|NCT01449461|26642513|P4|Overall Study|Physician Decision|4
7658927|NCT01449461|26642514|P3|Overall Study|Physician Decision|0
7658928|NCT01449461|26642515|P2|Overall Study|Physician Decision|1
7658929|NCT01449461|26642516|P1|Overall Study|Physician Decision|0
7658930|NCT01449461|26642511|P6|Overall Study|Death|1
7658931|NCT01449461|26642512|P5|Overall Study|Death|7
7658932|NCT01449461|26642513|P4|Overall Study|Death|0
7658933|NCT01449461|26642514|P3|Overall Study|Death|0
7658934|NCT01449461|26642515|P2|Overall Study|Death|2
7658935|NCT01449461|26642516|P1|Overall Study|Death|0
7658936|NCT01449461|26642511|P6|Overall Study|Adverse Event|4
7658937|NCT01449461|26642512|P5|Overall Study|Adverse Event|4
7658938|NCT01449461|26642513|P4|Overall Study|Adverse Event|3
7658939|NCT01449461|26642514|P3|Overall Study|Adverse Event|2
7658940|NCT01449461|26642515|P2|Overall Study|Adverse Event|3
7658941|NCT01449461|26642516|P1|Overall Study|Adverse Event|0
7658942|NCT01449370|26642661|P25|Overall Study|Death|1
7658943|NCT01449370|26642662|P24|Overall Study|Death|0
7658944|NCT01449370|26642663|P23|Overall Study|Death|0
7658945|NCT01449370|26642664|P22|Overall Study|Death|0
7658946|NCT01449370|26642665|P21|Overall Study|Death|0
7658947|NCT01449370|26642666|P20|Overall Study|Death|0
7658948|NCT01449370|26642667|P19|Overall Study|Death|0
7658949|NCT01449370|26642668|P18|Overall Study|Death|0
7658950|NCT01449370|26642669|P17|Overall Study|Death|0
7658951|NCT01449370|26642670|P16|Overall Study|Death|0
7658952|NCT01449370|26642671|P15|Overall Study|Death|0
7658953|NCT01449370|26642672|P14|Overall Study|Death|0
7658954|NCT01449370|26642673|P13|Overall Study|Death|0
7658955|NCT01449370|26642674|P12|Overall Study|Death|0
7658956|NCT01449370|26642675|P11|Overall Study|Death|0
7658957|NCT01449370|26642676|P10|Overall Study|Death|0
7658958|NCT01449370|26642677|P9|Overall Study|Death|0
7658959|NCT01449370|26642678|P8|Overall Study|Death|0
7658960|NCT01449370|26642679|P7|Overall Study|Death|0
7658961|NCT01449370|26642680|P6|Overall Study|Death|0
7658962|NCT01449370|26642681|P5|Overall Study|Death|0
7658963|NCT01449370|26642682|P4|Overall Study|Death|0
7658964|NCT01449370|26642683|P3|Overall Study|Death|0
7658965|NCT01449370|26642684|P2|Overall Study|Death|0
7658966|NCT01449370|26642685|P1|Overall Study|Death|0
7658967|NCT01449370|26642661|P25|Overall Study|Medication Prohibited by Protocol|0
7658968|NCT01449370|26642662|P24|Overall Study|Medication Prohibited by Protocol|1
7658969|NCT01449370|26642663|P23|Overall Study|Medication Prohibited by Protocol|0
7658970|NCT01449370|26642664|P22|Overall Study|Medication Prohibited by Protocol|0
7658971|NCT01449370|26642665|P21|Overall Study|Medication Prohibited by Protocol|0
7658972|NCT01449370|26642666|P20|Overall Study|Medication Prohibited by Protocol|0
7658973|NCT01449370|26642667|P19|Overall Study|Medication Prohibited by Protocol|0
7658974|NCT01449370|26642668|P18|Overall Study|Medication Prohibited by Protocol|0
7658975|NCT01449370|26642669|P17|Overall Study|Medication Prohibited by Protocol|0
7658976|NCT01449370|26642670|P16|Overall Study|Medication Prohibited by Protocol|0
7658977|NCT01449370|26642671|P15|Overall Study|Medication Prohibited by Protocol|0
7658978|NCT01449370|26642672|P14|Overall Study|Medication Prohibited by Protocol|0
7658979|NCT01449370|26642673|P13|Overall Study|Medication Prohibited by Protocol|0
7658980|NCT01449370|26642674|P12|Overall Study|Medication Prohibited by Protocol|0
7658981|NCT01449370|26642675|P11|Overall Study|Medication Prohibited by Protocol|0
7658982|NCT01449370|26642676|P10|Overall Study|Medication Prohibited by Protocol|0
7658983|NCT01449370|26642677|P9|Overall Study|Medication Prohibited by Protocol|0
7658984|NCT01449370|26642678|P8|Overall Study|Medication Prohibited by Protocol|0
7658985|NCT01449370|26642679|P7|Overall Study|Medication Prohibited by Protocol|0
7658986|NCT01449370|26642680|P6|Overall Study|Medication Prohibited by Protocol|0
7658987|NCT01449370|26642681|P5|Overall Study|Medication Prohibited by Protocol|0
7658988|NCT01449370|26642682|P4|Overall Study|Medication Prohibited by Protocol|0
7658989|NCT01449370|26642683|P3|Overall Study|Medication Prohibited by Protocol|0
7658990|NCT01449370|26642684|P2|Overall Study|Medication Prohibited by Protocol|0
7658991|NCT01449370|26642685|P1|Overall Study|Medication Prohibited by Protocol|0
7658992|NCT01449370|26642661|P25|Overall Study|Other|0
7658993|NCT01449370|26642662|P24|Overall Study|Other|1
7658994|NCT01449370|26642663|P23|Overall Study|Other|1
7658995|NCT01449370|26642664|P22|Overall Study|Other|0
7658996|NCT01449370|26642665|P21|Overall Study|Other|0
7658997|NCT01449370|26642666|P20|Overall Study|Other|0
7658998|NCT01449370|26642667|P19|Overall Study|Other|0
7658999|NCT01449370|26642668|P18|Overall Study|Other|0
7659000|NCT01449370|26642669|P17|Overall Study|Other|0
7659001|NCT01449370|26642670|P16|Overall Study|Other|0
7659002|NCT01449370|26642671|P15|Overall Study|Other|0
7659003|NCT01449370|26642672|P14|Overall Study|Other|0
7659004|NCT01449370|26642673|P13|Overall Study|Other|0
7659005|NCT01449370|26642674|P12|Overall Study|Other|0
7659006|NCT01449370|26642675|P11|Overall Study|Other|0
7659007|NCT01449370|26642676|P10|Overall Study|Other|1
7659008|NCT01449370|26642677|P9|Overall Study|Other|1
7659009|NCT01449370|26642678|P8|Overall Study|Other|0
7659010|NCT01449370|26642679|P7|Overall Study|Other|0
7659011|NCT01449370|26642680|P6|Overall Study|Other|0
7659012|NCT01449370|26642681|P5|Overall Study|Other|0
7659013|NCT01449370|26642682|P4|Overall Study|Other|0
7659014|NCT01449370|26642683|P3|Overall Study|Other|0
7659015|NCT01449370|26642684|P2|Overall Study|Other|0
7659016|NCT01449370|26642685|P1|Overall Study|Other|0
7659017|NCT01449370|26642661|P25|Overall Study|Lost to Follow-up|0
7659018|NCT01449370|26642662|P24|Overall Study|Lost to Follow-up|0
7659019|NCT01449370|26642663|P23|Overall Study|Lost to Follow-up|0
7659020|NCT01449370|26642664|P22|Overall Study|Lost to Follow-up|0
7659021|NCT01449370|26642665|P21|Overall Study|Lost to Follow-up|1
7659022|NCT01449370|26642666|P20|Overall Study|Lost to Follow-up|0
7659023|NCT01449370|26642667|P19|Overall Study|Lost to Follow-up|0
7659024|NCT01449370|26642668|P18|Overall Study|Lost to Follow-up|0
7659025|NCT01449370|26642669|P17|Overall Study|Lost to Follow-up|0
7659026|NCT01449370|26642670|P16|Overall Study|Lost to Follow-up|0
7659027|NCT01449370|26642671|P15|Overall Study|Lost to Follow-up|0
7659028|NCT01449370|26642672|P14|Overall Study|Lost to Follow-up|0
7659029|NCT01449370|26642673|P13|Overall Study|Lost to Follow-up|0
7659030|NCT01449370|26642674|P12|Overall Study|Lost to Follow-up|0
7659031|NCT01449370|26642675|P11|Overall Study|Lost to Follow-up|0
7659032|NCT01449370|26642676|P10|Overall Study|Lost to Follow-up|0
7659033|NCT01449370|26642677|P9|Overall Study|Lost to Follow-up|0
7659034|NCT01449370|26642678|P8|Overall Study|Lost to Follow-up|0
7659035|NCT01449370|26642679|P7|Overall Study|Lost to Follow-up|0
7659036|NCT01449370|26642680|P6|Overall Study|Lost to Follow-up|0
7659037|NCT01449370|26642681|P5|Overall Study|Lost to Follow-up|0
7659038|NCT01449370|26642682|P4|Overall Study|Lost to Follow-up|0
7659039|NCT01449370|26642683|P3|Overall Study|Lost to Follow-up|0
7659040|NCT01449370|26642684|P2|Overall Study|Lost to Follow-up|0
7659041|NCT01449370|26642685|P1|Overall Study|Lost to Follow-up|0
7659042|NCT01449370|26642661|P25|Overall Study|Participant Decision|1
7659043|NCT01449370|26642662|P24|Overall Study|Participant Decision|0
7659044|NCT01449370|26642663|P23|Overall Study|Participant Decision|0
7659045|NCT01449370|26642664|P22|Overall Study|Participant Decision|1
7659046|NCT01449370|26642665|P21|Overall Study|Participant Decision|0
7659047|NCT01449370|26642666|P20|Overall Study|Participant Decision|0
7659048|NCT01449370|26642667|P19|Overall Study|Participant Decision|1
7659049|NCT01449370|26642668|P18|Overall Study|Participant Decision|0
7659050|NCT01449370|26642669|P17|Overall Study|Participant Decision|3
7659051|NCT01449370|26642670|P16|Overall Study|Participant Decision|1
7659052|NCT01449370|26642671|P15|Overall Study|Participant Decision|0
7659053|NCT01449370|26642672|P14|Overall Study|Participant Decision|1
7659054|NCT01449370|26642673|P13|Overall Study|Participant Decision|1
7659055|NCT01449370|26642674|P12|Overall Study|Participant Decision|0
7659056|NCT01449370|26642675|P11|Overall Study|Participant Decision|0
7659057|NCT01449370|26642676|P10|Overall Study|Participant Decision|0
7659058|NCT01449370|26642677|P9|Overall Study|Participant Decision|1
7659059|NCT01449370|26642678|P8|Overall Study|Participant Decision|1
7659060|NCT01449370|26642679|P7|Overall Study|Participant Decision|0
7659061|NCT01449370|26642680|P6|Overall Study|Participant Decision|0
7659062|NCT01449370|26642681|P5|Overall Study|Participant Decision|0
7659063|NCT01449370|26642682|P4|Overall Study|Participant Decision|0
7659064|NCT01449370|26642683|P3|Overall Study|Participant Decision|0
7659065|NCT01449370|26642684|P2|Overall Study|Participant Decision|0
7659066|NCT01449370|26642685|P1|Overall Study|Participant Decision|0
7659067|NCT01449370|26642661|P25|Overall Study|Adverse Event|3
7659068|NCT01449370|26642662|P24|Overall Study|Adverse Event|1
7659069|NCT01449370|26642663|P23|Overall Study|Adverse Event|0
7659070|NCT01449370|26642664|P22|Overall Study|Adverse Event|1
7659071|NCT01449370|26642665|P21|Overall Study|Adverse Event|0
7659072|NCT01449370|26642666|P20|Overall Study|Adverse Event|1
7659073|NCT01449370|26642667|P19|Overall Study|Adverse Event|1
7659074|NCT01449370|26642668|P18|Overall Study|Adverse Event|0
7659075|NCT01449370|26642669|P17|Overall Study|Adverse Event|0
7659076|NCT01449370|26642670|P16|Overall Study|Adverse Event|1
7659077|NCT01449370|26642671|P15|Overall Study|Adverse Event|0
7659078|NCT01449370|26642672|P14|Overall Study|Adverse Event|2
7659079|NCT01449370|26642673|P13|Overall Study|Adverse Event|0
7659080|NCT01449370|26642674|P12|Overall Study|Adverse Event|0
7659081|NCT01449370|26642675|P11|Overall Study|Adverse Event|0
7659082|NCT01449370|26642676|P10|Overall Study|Adverse Event|1
7659083|NCT01449370|26642677|P9|Overall Study|Adverse Event|1
7659084|NCT01449370|26642678|P8|Overall Study|Adverse Event|0
7659085|NCT01449370|26642679|P7|Overall Study|Adverse Event|0
7659086|NCT01449370|26642680|P6|Overall Study|Adverse Event|0
7659087|NCT01449370|26642681|P5|Overall Study|Adverse Event|0
7659088|NCT01449370|26642682|P4|Overall Study|Adverse Event|1
7659089|NCT01449370|26642683|P3|Overall Study|Adverse Event|0
7659090|NCT01449370|26642684|P2|Overall Study|Adverse Event|2
7659091|NCT01449370|26642685|P1|Overall Study|Adverse Event|1
7659092|NCT01449370|26642661|P25|Overall Study|Disease Progression|3
7659093|NCT01449370|26642662|P24|Overall Study|Disease Progression|7
7659094|NCT01449370|26642663|P23|Overall Study|Disease Progression|3
7659095|NCT01449370|26642664|P22|Overall Study|Disease Progression|2
7659096|NCT01449370|26642665|P21|Overall Study|Disease Progression|5
7659097|NCT01449370|26642666|P20|Overall Study|Disease Progression|2
7659098|NCT01449370|26642667|P19|Overall Study|Disease Progression|1
7659099|NCT01449370|26642668|P18|Overall Study|Disease Progression|3
7659100|NCT01449370|26642669|P17|Overall Study|Disease Progression|4
7659101|NCT01449370|26642670|P16|Overall Study|Disease Progression|1
7659102|NCT01449370|26642671|P15|Overall Study|Disease Progression|3
7659103|NCT01449370|26642672|P14|Overall Study|Disease Progression|8
7659104|NCT01449370|26642673|P13|Overall Study|Disease Progression|2
7659105|NCT01449370|26642674|P12|Overall Study|Disease Progression|3
7659106|NCT01449370|26642675|P11|Overall Study|Disease Progression|3
7659107|NCT01449370|26642676|P10|Overall Study|Disease Progression|1
7659108|NCT01449370|26642677|P9|Overall Study|Disease Progression|9
7659109|NCT01449370|26642678|P8|Overall Study|Disease Progression|2
7659110|NCT01449370|26642679|P7|Overall Study|Disease Progression|3
7659111|NCT01449370|26642680|P6|Overall Study|Disease Progression|3
7659112|NCT01449370|26642681|P5|Overall Study|Disease Progression|3
7659113|NCT01449370|26642682|P4|Overall Study|Disease Progression|3
7659114|NCT01449370|26642683|P3|Overall Study|Disease Progression|8
7659115|NCT01449370|26642684|P2|Overall Study|Disease Progression|4
7659116|NCT01449370|26642685|P1|Overall Study|Disease Progression|5
7659117|NCT01449279|26643063|P1|Overall Study|Toxicity|2
7659118|NCT01449279|26643063|P1|Overall Study|Lack of Efficacy|5
7659119|NCT01449006|26643088|P2|Overall Study|Protocol Violation|0
7659120|NCT01449006|26643089|P1|Overall Study|Protocol Violation|1
7659121|NCT01449006|26643088|P2|Overall Study|Withdrawal by Subject|0
7659122|NCT01449006|26643089|P1|Overall Study|Withdrawal by Subject|1
7659123|NCT01449006|26643088|P2|Overall Study|Lost to Follow-up|0
7659124|NCT01449006|26643089|P1|Overall Study|Lost to Follow-up|1
7659125|NCT01448850|26643103|P2|Overall Study|Other|12
7659126|NCT01448850|26643104|P1|Overall Study|Other|15
7659127|NCT01448850|26643103|P2|Overall Study|Lost to Follow-up|1
7659128|NCT01448850|26643104|P1|Overall Study|Lost to Follow-up|3
7659129|NCT01448850|26643103|P2|Overall Study|Withdrawal by Subject|21
7659130|NCT01448850|26643104|P1|Overall Study|Withdrawal by Subject|13
7659131|NCT01448850|26643103|P2|Overall Study|Death|6
7659132|NCT01448850|26643104|P1|Overall Study|Death|3
7659133|NCT01448824|26643135|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
7659134|NCT01448824|26643136|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659135|NCT01448824|26643137|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659136|NCT01448824|26643138|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659137|NCT01448824|26643139|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659138|NCT01448824|26643140|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659139|NCT01448824|26643141|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659140|NCT01448824|26643142|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7659141|NCT01448824|26643135|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
7659142|NCT01448824|26643136|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659143|NCT01448824|26643137|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659144|NCT01448824|26643138|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659145|NCT01448824|26643139|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659146|NCT01448824|26643140|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659147|NCT01448824|26643141|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659148|NCT01448824|26643142|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7659149|NCT01448824|26643135|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
7659150|NCT01448824|26643136|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659151|NCT01448824|26643137|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659152|NCT01448824|26643138|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659153|NCT01448824|26643139|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659154|NCT01448824|26643140|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659155|NCT01448824|26643141|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659156|NCT01448824|26643142|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7659157|NCT01448824|26643135|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
7659158|NCT01448824|26643136|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659159|NCT01448824|26643137|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659160|NCT01448824|26643138|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659161|NCT01448824|26643139|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659162|NCT01448824|26643140|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659163|NCT01448824|26643141|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659164|NCT01448824|26643142|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7659165|NCT01448824|26643135|P8|Part 1: Washout Period|Lost to Follow-up|0
7659166|NCT01448824|26643136|P7|Part 1: Washout Period|Lost to Follow-up|0
7659167|NCT01448824|26643137|P6|Part 1: Washout Period|Lost to Follow-up|0
7659168|NCT01448824|26643138|P5|Part 1: Washout Period|Lost to Follow-up|0
7659169|NCT01448824|26643139|P4|Part 1: Washout Period|Lost to Follow-up|0
7659170|NCT01448824|26643140|P3|Part 1: Washout Period|Lost to Follow-up|0
7659171|NCT01448824|26643141|P2|Part 1: Washout Period|Lost to Follow-up|0
7659172|NCT01448824|26643142|P1|Part 1: Washout Period|Lost to Follow-up|1
7659173|NCT01448824|26643135|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659174|NCT01448824|26643136|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659175|NCT01448824|26643137|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
7659176|NCT01448824|26643138|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659177|NCT01448824|26643139|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659178|NCT01448824|26643140|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659179|NCT01448824|26643141|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659180|NCT01448824|26643142|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7659181|NCT01448824|26643135|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7659182|NCT01448824|26643136|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7659183|NCT01448824|26643137|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7659184|NCT01448824|26643138|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
7659185|NCT01448824|26643139|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7659186|NCT01448824|26643140|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7659187|NCT01448824|26643141|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7659188|NCT01448824|26643142|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7659189|NCT01448824|26643135|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659190|NCT01448824|26643136|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
7659191|NCT01448824|26643137|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659192|NCT01448824|26643138|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659193|NCT01448824|26643139|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659194|NCT01448824|26643140|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659195|NCT01448824|26643141|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659278|NCT01447446|26643430|P3|Overall Study|Reason not Specified|1
7659196|NCT01448824|26643142|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7659197|NCT01448707|26643193|P2|Overall Study|Other|4
7659198|NCT01448707|26643194|P1|Overall Study|Other|7
7659199|NCT01448707|26643193|P2|Overall Study|Withdrawal by Subject|7
7659200|NCT01448707|26643194|P1|Overall Study|Withdrawal by Subject|6
7659201|NCT01448707|26643193|P2|Overall Study|Lost to Follow-up|6
7659202|NCT01448707|26643194|P1|Overall Study|Lost to Follow-up|2
7659203|NCT01448707|26643193|P2|Overall Study|Adverse Event|1
7659204|NCT01448707|26643194|P1|Overall Study|Adverse Event|3
7659205|NCT01448616|26643215|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7659206|NCT01448616|26643216|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7659207|NCT01448616|26643217|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
7659208|NCT01448616|26643218|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
7659209|NCT01448616|26643215|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
7659210|NCT01448616|26643216|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
7659211|NCT01448616|26643217|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
7659212|NCT01448616|26643218|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
7659213|NCT01448616|26643215|P4|Study Drug (Treatment Phase)|Adverse Event|0
7659214|NCT01448616|26643216|P3|Study Drug (Treatment Phase)|Adverse Event|1
7659215|NCT01448616|26643217|P2|Study Drug (Treatment Phase)|Adverse Event|1
7659216|NCT01448616|26643218|P1|Study Drug (Treatment Phase)|Adverse Event|0
7659217|NCT01448616|26643215|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7659218|NCT01448616|26643216|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7659219|NCT01448616|26643217|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7659220|NCT01448616|26643218|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
7659221|NCT01448616|26643215|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
7659222|NCT01448616|26643216|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
7659223|NCT01448616|26643217|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
7659224|NCT01448616|26643218|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
7659225|NCT01448213|26643283|P2|Overall Study|Protocol Violation|2
7659226|NCT01448213|26643284|P1|Overall Study|Protocol Violation|1
7659227|NCT01448213|26643283|P2|Overall Study|Adverse Event|10
7659228|NCT01448213|26643284|P1|Overall Study|Adverse Event|4
7659229|NCT01448213|26643283|P2|Overall Study|Lost to Follow-up|10
7659230|NCT01448213|26643284|P1|Overall Study|Lost to Follow-up|12
7659231|NCT01448057|26643294|P2|Overall Study|Withdrawal by Subject|0
7659232|NCT01448057|26643295|P1|Overall Study|Withdrawal by Subject|2
7659233|NCT01448057|26643294|P2|Overall Study|Adverse Event|2
7659234|NCT01448057|26643295|P1|Overall Study|Adverse Event|0
7659235|NCT01448057|26643294|P2|Overall Study|Lost to Follow-up|0
7659236|NCT01448057|26643295|P1|Overall Study|Lost to Follow-up|3
7659237|NCT01448057|26643294|P2|Overall Study|Protocol Violation|2
7659238|NCT01448057|26643295|P1|Overall Study|Protocol Violation|3
7659239|NCT01448044|26643305|P2|Follow Up Period|Other|11
7659240|NCT01448044|26643306|P1|Follow Up Period|Other|5
7659241|NCT01448044|26643305|P2|Follow Up Period|Lost to Follow-up|2
7659242|NCT01448044|26643306|P1|Follow Up Period|Lost to Follow-up|6
7659243|NCT01448044|26643305|P2|Follow Up Period|Withdrawal by Subject|1
7659244|NCT01448044|26643306|P1|Follow Up Period|Withdrawal by Subject|1
7659245|NCT01448044|26643305|P2|Treatment Period|Other reason|0
7659246|NCT01448044|26643306|P1|Treatment Period|Other reason|2
7659247|NCT01448044|26643305|P2|Treatment Period|Lost to Follow-up|1
7659248|NCT01448044|26643306|P1|Treatment Period|Lost to Follow-up|2
7659249|NCT01448044|26643305|P2|Treatment Period|Participant does not meet study criteria|0
7659250|NCT01448044|26643306|P1|Treatment Period|Participant does not meet study criteria|1
7659251|NCT01448044|26643305|P2|Treatment Period|Completed 24 weeks treatment period only|0
7659252|NCT01448044|26643306|P1|Treatment Period|Completed 24 weeks treatment period only|8
7659253|NCT01448044|26643305|P2|Treatment Period|Subject requested discontinue study drug|0
7659254|NCT01448044|26643306|P1|Treatment Period|Subject requested discontinue study drug|1
7659255|NCT01448044|26643305|P2|Treatment Period|Lack of Efficacy|12
7659256|NCT01448044|26643306|P1|Treatment Period|Lack of Efficacy|5
7659257|NCT01448044|26643305|P2|Treatment Period|Adverse Event|3
7659258|NCT01448044|26643306|P1|Treatment Period|Adverse Event|4
7659259|NCT01447927|26643322|P2|Overall Study|Withdrawal by Subject|0
7659260|NCT01447927|26643323|P1|Overall Study|Withdrawal by Subject|1
7659261|NCT01447927|26643322|P2|Overall Study|Adverse Event|3
7659262|NCT01447927|26643323|P1|Overall Study|Adverse Event|4
7659263|NCT01447719|26643368|P1|Overall Study|Family withdrew autopsy consent|7
7659264|NCT01447719|26643368|P1|Overall Study|Withdrawal by Subject|2
7659265|NCT01447719|26643368|P1|Overall Study|Subject still living at end of study|79
7659266|NCT01447719|26643368|P1|Overall Study|Invalid image or not imaged|3
7659267|NCT01447719|26643368|P1|Overall Study|Image acquisition failure|2
7659268|NCT01447576|26643394|P1|Overall Study|Physician Decision|6
7659269|NCT01447576|26643394|P1|Overall Study|Lack of Efficacy|68
7659270|NCT01447576|26643394|P1|Overall Study|Protocol deviation|83
7659271|NCT01447576|26643394|P1|Overall Study|Withdrawal by Subject|100
7659272|NCT01447576|26643394|P1|Overall Study|Participant met withdrawal criteria|40
7659273|NCT01447576|26643394|P1|Overall Study|Adverse Event|127
7659274|NCT01447576|26643394|P1|Overall Study|Lost to Follow-up|52
7659275|NCT01447446|26643427|P6|Overall Study|Reason not Specified|0
7659276|NCT01447446|26643428|P5|Overall Study|Reason not Specified|1
7659277|NCT01447446|26643429|P4|Overall Study|Reason not Specified|1
7659279|NCT01447446|26643431|P2|Overall Study|Reason not Specified|1
7659280|NCT01447446|26643432|P1|Overall Study|Reason not Specified|1
7659281|NCT01447446|26643427|P6|Overall Study|New Treatment Started|0
7659282|NCT01447446|26643428|P5|Overall Study|New Treatment Started|2
7659283|NCT01447446|26643429|P4|Overall Study|New Treatment Started|0
7659284|NCT01447446|26643430|P3|Overall Study|New Treatment Started|1
7659285|NCT01447446|26643431|P2|Overall Study|New Treatment Started|2
7659286|NCT01447446|26643432|P1|Overall Study|New Treatment Started|8
7659287|NCT01447446|26643427|P6|Overall Study|SVR12 Assessment|5
7659288|NCT01447446|26643428|P5|Overall Study|SVR12 Assessment|5
7659289|NCT01447446|26643429|P4|Overall Study|SVR12 Assessment|1
7659290|NCT01447446|26643430|P3|Overall Study|SVR12 Assessment|2
7659291|NCT01447446|26643431|P2|Overall Study|SVR12 Assessment|1
7659292|NCT01447446|26643432|P1|Overall Study|SVR12 Assessment|13
7659293|NCT01447446|26643427|P6|Overall Study|Administrative/Other|4
7659294|NCT01447446|26643428|P5|Overall Study|Administrative/Other|33
7659295|NCT01447446|26643429|P4|Overall Study|Administrative/Other|2
7659296|NCT01447446|26643430|P3|Overall Study|Administrative/Other|10
7659297|NCT01447446|26643431|P2|Overall Study|Administrative/Other|9
7659298|NCT01447446|26643432|P1|Overall Study|Administrative/Other|34
7659299|NCT01447446|26643427|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
7659300|NCT01447446|26643428|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
7659301|NCT01447446|26643429|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
7659302|NCT01447446|26643430|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
7659303|NCT01447446|26643431|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
7659304|NCT01447446|26643432|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
7659305|NCT01447446|26643427|P6|Overall Study|Failure to Return/Consent Withdrawn|9
7659306|NCT01447446|26643428|P5|Overall Study|Failure to Return/Consent Withdrawn|69
7659307|NCT01447446|26643429|P4|Overall Study|Failure to Return/Consent Withdrawn|7
7659308|NCT01447446|26643430|P3|Overall Study|Failure to Return/Consent Withdrawn|31
7659309|NCT01447446|26643431|P2|Overall Study|Failure to Return/Consent Withdrawn|78
7659310|NCT01447446|26643432|P1|Overall Study|Failure to Return/Consent Withdrawn|357
7659311|NCT01447446|26643427|P6|Overall Study|Adverse Event|0
7659312|NCT01447446|26643428|P5|Overall Study|Adverse Event|2
7659313|NCT01447446|26643429|P4|Overall Study|Adverse Event|0
7659314|NCT01447446|26643430|P3|Overall Study|Adverse Event|1
7659315|NCT01447446|26643431|P2|Overall Study|Adverse Event|0
7659316|NCT01447446|26643432|P1|Overall Study|Adverse Event|3
7659317|NCT01447446|26643427|P6|Overall Study|Death|0
7659318|NCT01447446|26643428|P5|Overall Study|Death|7
7659319|NCT01447446|26643429|P4|Overall Study|Death|1
7659320|NCT01447446|26643430|P3|Overall Study|Death|2
7659321|NCT01447446|26643431|P2|Overall Study|Death|3
7659322|NCT01447446|26643432|P1|Overall Study|Death|6
7659323|NCT01447433|26643522|P2|Overall Study|Protocol Violation|1
7659324|NCT01447433|26643523|P1|Overall Study|Protocol Violation|1
7659325|NCT01447433|26643522|P2|Overall Study|Withdrawal by Subject|3
7659326|NCT01447433|26643523|P1|Overall Study|Withdrawal by Subject|3
7659327|NCT01447433|26643522|P2|Overall Study|Lost to Follow-up|2
7659328|NCT01447433|26643523|P1|Overall Study|Lost to Follow-up|0
7659329|NCT01447420|26643550|P3|Overall Study|Lack of Efficacy|8
7659330|NCT01447420|26643551|P2|Overall Study|Lack of Efficacy|19
7659331|NCT01447420|26643552|P1|Overall Study|Lack of Efficacy|1
7659332|NCT01447420|26643550|P3|Overall Study|Withdrawal by Subject|0
7659333|NCT01447420|26643551|P2|Overall Study|Withdrawal by Subject|1
7659334|NCT01447420|26643552|P1|Overall Study|Withdrawal by Subject|4
7659335|NCT01447420|26643550|P3|Overall Study|Protocol Violation|0
7659336|NCT01447420|26643551|P2|Overall Study|Protocol Violation|3
7659337|NCT01447420|26643552|P1|Overall Study|Protocol Violation|3
7659338|NCT01447420|26643550|P3|Overall Study|Adverse Event|2
7659339|NCT01447420|26643551|P2|Overall Study|Adverse Event|4
7659340|NCT01447420|26643552|P1|Overall Study|Adverse Event|2
7659341|NCT01447407|26643572|P4|Overall Study|Physician Decision|1
7659342|NCT01447407|26643573|P3|Overall Study|Physician Decision|1
7659343|NCT01447407|26643574|P2|Overall Study|Physician Decision|0
7659344|NCT01447407|26643575|P1|Overall Study|Physician Decision|0
7659345|NCT01447407|26643572|P4|Overall Study|Withdrawal by Subject|1
7659346|NCT01447407|26643573|P3|Overall Study|Withdrawal by Subject|0
7659347|NCT01447407|26643574|P2|Overall Study|Withdrawal by Subject|0
7659348|NCT01447407|26643575|P1|Overall Study|Withdrawal by Subject|2
7659349|NCT01446965|26643708|P2|Participants Followed and Analyzed|Lost to Follow-up|12
7659350|NCT01446965|26643709|P1|Participants Followed and Analyzed|Lost to Follow-up|10
7659351|NCT01446965|26643708|P2|Randominization|One site was dismissed due to IRB irregularity|16
7659352|NCT01446965|26643709|P1|Randominization|One site was dismissed due to IRB irregularity|30
7659353|NCT01446913|26643722|P3|Overall Study|Lost to Follow-up|3
7659354|NCT01446913|26643723|P2|Overall Study|Lost to Follow-up|5
7659355|NCT01446913|26643724|P1|Overall Study|Lost to Follow-up|3
7659356|NCT01446913|26643722|P3|Overall Study|Physician Decision|2
7659357|NCT01446913|26643723|P2|Overall Study|Physician Decision|0
7659358|NCT01446913|26643724|P1|Overall Study|Physician Decision|0
7659359|NCT01446913|26643722|P3|Overall Study|Withdrawal by Subject|5
7659360|NCT01446913|26643723|P2|Overall Study|Withdrawal by Subject|3
7659361|NCT01446913|26643724|P1|Overall Study|Withdrawal by Subject|5
7659362|NCT01446913|26643722|P3|Overall Study|Significant illness|1
7659363|NCT01446913|26643723|P2|Overall Study|Significant illness|1
7659364|NCT01446913|26643724|P1|Overall Study|Significant illness|1
7659365|NCT01446874|26643785|P3|Overall Study|Withdrawal by Subject|4
7659366|NCT01446874|26643786|P2|Overall Study|Withdrawal by Subject|0
7659367|NCT01446874|26643787|P1|Overall Study|Withdrawal by Subject|0
7659368|NCT01446874|26643785|P3|Overall Study|Antibiotics for pre-op infection|2
7659369|NCT01446874|26643786|P2|Overall Study|Antibiotics for pre-op infection|0
7659370|NCT01446874|26643787|P1|Overall Study|Antibiotics for pre-op infection|0
7659371|NCT01446874|26643785|P3|Overall Study|Non-compliance|0
7659372|NCT01446874|26643786|P2|Overall Study|Non-compliance|4
7659373|NCT01446874|26643787|P1|Overall Study|Non-compliance|0
7659374|NCT01446874|26643785|P3|Overall Study|No surgery/No qualifying surgery|12
7659375|NCT01446874|26643786|P2|Overall Study|No surgery/No qualifying surgery|0
7659376|NCT01446874|26643787|P1|Overall Study|No surgery/No qualifying surgery|1
7659377|NCT01446874|26643785|P3|Overall Study|Not eligible|0
7659378|NCT01446874|26643786|P2|Overall Study|Not eligible|0
7659379|NCT01446874|26643787|P1|Overall Study|Not eligible|1
7659380|NCT01446809|26643815|P3|Overall Study|Failure to complete study procedures|1
7659381|NCT01446809|26643816|P2|Overall Study|Failure to complete study procedures|0
7659382|NCT01446809|26643817|P1|Overall Study|Failure to complete study procedures|0
7659383|NCT01446809|26643815|P3|Overall Study|Adverse Event|1
7659384|NCT01446809|26643816|P2|Overall Study|Adverse Event|0
7659385|NCT01446809|26643817|P1|Overall Study|Adverse Event|0
7659386|NCT01446796|26643840|P2|Overall Study|Withdrawal by Subject|0
7659387|NCT01446796|26643841|P1|Overall Study|Withdrawal by Subject|1
7659388|NCT01446419|26643887|P2|Overall Study|Terminated per protocol|0
7659389|NCT01446419|26643888|P1|Overall Study|Terminated per protocol|3
7659390|NCT01446419|26643887|P2|Overall Study|Withdrawal by Subject|1
7659391|NCT01446419|26643888|P1|Overall Study|Withdrawal by Subject|1
7659392|NCT01446419|26643887|P2|Overall Study|Death|0
7659393|NCT01446419|26643888|P1|Overall Study|Death|1
7659394|NCT01446289|26643902|P4|Overall Study|Withdrawal by Subject|0
7659395|NCT01446289|26643903|P3|Overall Study|Withdrawal by Subject|1
7659396|NCT01446289|26643904|P2|Overall Study|Withdrawal by Subject|0
7659397|NCT01446289|26643905|P1|Overall Study|Withdrawal by Subject|1
7659398|NCT01446237|26643948|P1|Overall Study|Withdrawal by Subject|7
7659399|NCT01446237|26643948|P1|Overall Study|Lost to Follow-up|2
7659400|NCT01446237|26643948|P1|Overall Study|Adverse Event|1
7659401|NCT01446159|26643960|P4|Overall Study|Other|13
7659402|NCT01446159|26643961|P3|Overall Study|Other|13
7659403|NCT01446159|26643962|P2|Overall Study|Other|0
7659404|NCT01446159|26643963|P1|Overall Study|Other|0
7659405|NCT01446159|26643960|P4|Overall Study|Death|36
7659406|NCT01446159|26643961|P3|Overall Study|Death|43
7659407|NCT01446159|26643962|P2|Overall Study|Death|3
7659408|NCT01446159|26643963|P1|Overall Study|Death|2
7659409|NCT01446159|26643960|P4|Overall Study|Lost to Follow-up|2
7659410|NCT01446159|26643961|P3|Overall Study|Lost to Follow-up|1
7659411|NCT01446159|26643962|P2|Overall Study|Lost to Follow-up|0
7659412|NCT01446159|26643963|P1|Overall Study|Lost to Follow-up|0
7659413|NCT01446159|26643960|P4|Overall Study|Withdrawal by Subject|11
7659414|NCT01446159|26643961|P3|Overall Study|Withdrawal by Subject|14
7659415|NCT01446159|26643962|P2|Overall Study|Withdrawal by Subject|0
7659416|NCT01446159|26643963|P1|Overall Study|Withdrawal by Subject|1
7659417|NCT01446042|26644038|P3|Overall Study|Other reasons|1
7659418|NCT01446042|26644039|P2|Overall Study|Other reasons|1
7659419|NCT01446042|26644040|P1|Overall Study|Other reasons|2
7659420|NCT01446042|26644038|P3|Overall Study|Lost to Follow-up|0
7659421|NCT01446042|26644039|P2|Overall Study|Lost to Follow-up|0
7659422|NCT01446042|26644040|P1|Overall Study|Lost to Follow-up|5
7659423|NCT01446042|26644038|P3|Overall Study|Adverse Event|4
7659424|NCT01446042|26644039|P2|Overall Study|Adverse Event|0
7659425|NCT01446042|26644040|P1|Overall Study|Adverse Event|1
7659426|NCT01446042|26644038|P3|Overall Study|Withdrawal by Subject|4
7659427|NCT01446042|26644039|P2|Overall Study|Withdrawal by Subject|2
7659428|NCT01446042|26644040|P1|Overall Study|Withdrawal by Subject|12
7659429|NCT01446003|26644051|P2|Period 2|Adverse Event|0
7659430|NCT01446003|26644052|P1|Period 2|Adverse Event|1
7659431|NCT01446003|26644051|P2|Period 1|Protocol Violation|0
7659432|NCT01446003|26644052|P1|Period 1|Protocol Violation|2
7659433|NCT01445951|26644073|P3|Overall Study|Cough|0
7659434|NCT01445951|26644074|P2|Overall Study|Cough|1
7659435|NCT01445951|26644075|P1|Overall Study|Cough|0
7659436|NCT01445951|26644073|P3|Overall Study|Sponsor decision - subject travel|0
7659437|NCT01445951|26644074|P2|Overall Study|Sponsor decision - subject travel|1
7659438|NCT01445951|26644075|P1|Overall Study|Sponsor decision - subject travel|0
7659439|NCT01445951|26644073|P3|Overall Study|Non-compliance with protocol|0
7659440|NCT01445951|26644074|P2|Overall Study|Non-compliance with protocol|1
7659441|NCT01445951|26644075|P1|Overall Study|Non-compliance with protocol|0
7659442|NCT01445951|26644073|P3|Overall Study|Non-compliance with study drug|0
7659443|NCT01445951|26644074|P2|Overall Study|Non-compliance with study drug|2
7659444|NCT01445951|26644075|P1|Overall Study|Non-compliance with study drug|1
7659445|NCT01445951|26644073|P3|Overall Study|Death|1
7659446|NCT01445951|26644074|P2|Overall Study|Death|0
7659447|NCT01445951|26644075|P1|Overall Study|Death|0
7659448|NCT01445951|26644073|P3|Overall Study|Pregnancy|4
7659449|NCT01445951|26644074|P2|Overall Study|Pregnancy|1
7659450|NCT01445951|26644075|P1|Overall Study|Pregnancy|0
7659451|NCT01445951|26644073|P3|Overall Study|Lost to Follow-up|4
7659452|NCT01445951|26644074|P2|Overall Study|Lost to Follow-up|2
7659453|NCT01445951|26644075|P1|Overall Study|Lost to Follow-up|1
7659454|NCT01445951|26644073|P3|Overall Study|Physician Decision|0
7659455|NCT01445951|26644074|P2|Overall Study|Physician Decision|1
7659456|NCT01445951|26644075|P1|Overall Study|Physician Decision|3
7659457|NCT01445951|26644073|P3|Overall Study|Withdrawal by Subject|8
7659458|NCT01445951|26644074|P2|Overall Study|Withdrawal by Subject|16
7659459|NCT01445951|26644075|P1|Overall Study|Withdrawal by Subject|21
7659460|NCT01445951|26644073|P3|Overall Study|Protocol Violation|2
7659461|NCT01445951|26644074|P2|Overall Study|Protocol Violation|2
7659462|NCT01445951|26644075|P1|Overall Study|Protocol Violation|2
7659463|NCT01445951|26644073|P3|Overall Study|Adverse Event|0
7659464|NCT01445951|26644074|P2|Overall Study|Adverse Event|9
7659465|NCT01445951|26644075|P1|Overall Study|Adverse Event|16
7659466|NCT01445886|26644113|P1|Overall Study|Protocol Violation|3
7659467|NCT01445886|26644113|P1|Overall Study|Lost to Follow-up|2
7659468|NCT01445847|26644153|P2|Overall Study|Missed Data|0
7659469|NCT01445847|26644154|P1|Overall Study|Missed Data|1
7659470|NCT01445847|26644153|P2|Overall Study|Protocol Violation|14
7659471|NCT01445847|26644154|P1|Overall Study|Protocol Violation|13
7659472|NCT01445769|26644171|P1|Overall Study|Lost to Follow-up|5
7659473|NCT01445769|26644171|P1|Overall Study|Disease Progression|1
7659474|NCT01445769|26644171|P1|Overall Study|Consent Withdrawn|2
7659475|NCT01445730|26644189|P1|Overall Study|The data from magnetic resonance examinations were not sufficient|9
7659476|NCT01445730|26644189|P1|Overall Study|For the advice of a dentist|1
7659477|NCT01445730|26644189|P1|Overall Study|Adverse Event|1
7659478|NCT01445678|26644201|P2|Overall Study|Withdrawal by Subject|5
7659479|NCT01445678|26644202|P1|Overall Study|Withdrawal by Subject|9
7659480|NCT01445678|26644201|P2|Overall Study|Protocol Violation|1
7659481|NCT01445678|26644202|P1|Overall Study|Protocol Violation|1
7659482|NCT01445678|26644201|P2|Overall Study|Lost to Follow-up|5
7659483|NCT01445678|26644202|P1|Overall Study|Lost to Follow-up|8
7659484|NCT01445678|26644201|P2|Overall Study|Lack of Efficacy|2
7659485|NCT01445678|26644202|P1|Overall Study|Lack of Efficacy|0
7659486|NCT01445678|26644201|P2|Overall Study|Adverse Event|8
7659487|NCT01445678|26644202|P1|Overall Study|Adverse Event|12
7659488|NCT01445652|26644220|P2|Overall Study|Adverse Event|0
7659489|NCT01445652|26644221|P1|Overall Study|Adverse Event|1
7659490|NCT01445652|26644220|P2|Overall Study|Failed teach session|0
7659491|NCT01445652|26644221|P1|Overall Study|Failed teach session|2
7659492|NCT01445652|26644220|P2|Overall Study|Failed to attend scheduled visit|3
7659493|NCT01445652|26644221|P1|Overall Study|Failed to attend scheduled visit|2
7659494|NCT01445652|26644220|P2|Overall Study|Not comfortable in lenses|0
7659495|NCT01445652|26644221|P1|Overall Study|Not comfortable in lenses|5
7659496|NCT01445613|26644239|P1|1-year Follow-up|Received a non-study stent|2
7659497|NCT01445613|26644239|P1|1-year Follow-up|Physician Decision|2
7659498|NCT01445613|26644239|P1|1-year Follow-up|Death|30
7659499|NCT01445613|26644239|P1|1-year Follow-up|Lost to Follow-up|2
7659500|NCT01445613|26644239|P1|1-year Follow-up|Missed visit|29
7659501|NCT01445613|26644239|P1|1-year Follow-up|Withdrawal by Subject|12
7659502|NCT01445613|26644239|P1|30-day Follow-up|Death|3
7659503|NCT01445613|26644239|P1|30-day Follow-up|Missed visit|23
7659504|NCT01445613|26644239|P1|30-day Follow-up|Physician Decision|3
7659505|NCT01445613|26644239|P1|30-day Follow-up|Withdrawal by Subject|6
7659506|NCT01445548|26644257|P1|Overall Study|Adverse Event|1
7659507|NCT01445535|26644283|P4|Overall Study|PI discretion|1
7659508|NCT01445535|26644284|P3|Overall Study|PI discretion|0
7659509|NCT01445535|26644285|P2|Overall Study|PI discretion|0
7659510|NCT01445535|26644286|P1|Overall Study|PI discretion|0
7659511|NCT01445535|26644283|P4|Overall Study|Disease progression|0
7659512|NCT01445535|26644284|P3|Overall Study|Disease progression|1
7659513|NCT01445535|26644285|P2|Overall Study|Disease progression|0
7659514|NCT01445535|26644286|P1|Overall Study|Disease progression|1
7659515|NCT01445535|26644283|P4|Overall Study|Enrolled/taken off study, no drug avail.|1
7659516|NCT01445535|26644284|P3|Overall Study|Enrolled/taken off study, no drug avail.|0
7659517|NCT01445535|26644285|P2|Overall Study|Enrolled/taken off study, no drug avail.|0
7659518|NCT01445535|26644286|P1|Overall Study|Enrolled/taken off study, no drug avail.|0
7659519|NCT01445301|26644310|P3|Overall Study|Withdrawal by Subject|4
7659520|NCT01445301|26644311|P2|Overall Study|Withdrawal by Subject|6
7659521|NCT01445301|26644312|P1|Overall Study|Withdrawal by Subject|5
7659522|NCT01445301|26644310|P3|Overall Study|Physician Decision|0
7659523|NCT01445301|26644311|P2|Overall Study|Physician Decision|2
7659524|NCT01445301|26644312|P1|Overall Study|Physician Decision|0
7659525|NCT01445301|26644310|P3|Overall Study|Protocol-Defined Stopping Criteria|1
7659526|NCT01445301|26644311|P2|Overall Study|Protocol-Defined Stopping Criteria|1
7659527|NCT01445301|26644312|P1|Overall Study|Protocol-Defined Stopping Criteria|0
7659528|NCT01445301|26644310|P3|Overall Study|Protocol Violation|0
7659529|NCT01445301|26644311|P2|Overall Study|Protocol Violation|0
7659530|NCT01445301|26644312|P1|Overall Study|Protocol Violation|1
7659531|NCT01445301|26644310|P3|Overall Study|Lack of Efficacy|0
7659532|NCT01445301|26644311|P2|Overall Study|Lack of Efficacy|1
7659533|NCT01445301|26644312|P1|Overall Study|Lack of Efficacy|0
7659534|NCT01445301|26644310|P3|Overall Study|Adverse Event|4
7659535|NCT01445301|26644311|P2|Overall Study|Adverse Event|25
7659536|NCT01445301|26644312|P1|Overall Study|Adverse Event|15
7659537|NCT01445171|26644347|P1|Overall Study|Consented but did not receive device|8
7659538|NCT01445171|26644347|P1|Overall Study|Subjects declined to return for followup|9
7659539|NCT01445171|26644347|P1|Overall Study|Death|51
7659540|NCT01445171|26644347|P1|Overall Study|Withdrawal by Subject|16
7659541|NCT01445171|26644347|P1|Overall Study|Lost to Follow-up|11
7659542|NCT01445080|26644377|P9|Overall Study|Ineligible/Inevaluable|6
7659543|NCT01445080|26644378|P8|Overall Study|Ineligible/Inevaluable|0
7659544|NCT01445080|26644379|P7|Overall Study|Ineligible/Inevaluable|0
7659545|NCT01445080|26644380|P6|Overall Study|Ineligible/Inevaluable|3
7659546|NCT01445080|26644381|P5|Overall Study|Ineligible/Inevaluable|2
7659547|NCT01445080|26644382|P4|Overall Study|Ineligible/Inevaluable|1
7659548|NCT01445080|26644383|P3|Overall Study|Ineligible/Inevaluable|0
7659549|NCT01445080|26644384|P2|Overall Study|Ineligible/Inevaluable|2
7659550|NCT01445080|26644385|P1|Overall Study|Ineligible/Inevaluable|1
7659551|NCT01445080|26644377|P9|Overall Study|Withdrawal by Subject|2
7659552|NCT01445080|26644378|P8|Overall Study|Withdrawal by Subject|0
7659553|NCT01445080|26644379|P7|Overall Study|Withdrawal by Subject|0
7659554|NCT01445080|26644380|P6|Overall Study|Withdrawal by Subject|0
7659555|NCT01445080|26644381|P5|Overall Study|Withdrawal by Subject|0
7659556|NCT01445080|26644382|P4|Overall Study|Withdrawal by Subject|1
7659557|NCT01445080|26644383|P3|Overall Study|Withdrawal by Subject|0
7659558|NCT01445080|26644384|P2|Overall Study|Withdrawal by Subject|0
7659559|NCT01445080|26644385|P1|Overall Study|Withdrawal by Subject|1
7659560|NCT01445080|26644377|P9|Overall Study|Physician Decision|0
7659561|NCT01445080|26644378|P8|Overall Study|Physician Decision|2
7659562|NCT01445080|26644379|P7|Overall Study|Physician Decision|2
7659563|NCT01445080|26644380|P6|Overall Study|Physician Decision|3
7659564|NCT01445080|26644381|P5|Overall Study|Physician Decision|0
7659565|NCT01445080|26644382|P4|Overall Study|Physician Decision|0
7659566|NCT01445080|26644383|P3|Overall Study|Physician Decision|1
7659567|NCT01445080|26644384|P2|Overall Study|Physician Decision|0
7659568|NCT01445080|26644385|P1|Overall Study|Physician Decision|0
7659569|NCT01445080|26644377|P9|Overall Study|Adverse Event|10
7659570|NCT01445080|26644378|P8|Overall Study|Adverse Event|3
7659571|NCT01445080|26644379|P7|Overall Study|Adverse Event|0
7659572|NCT01445080|26644380|P6|Overall Study|Adverse Event|3
7659573|NCT01445080|26644381|P5|Overall Study|Adverse Event|2
7659574|NCT01445080|26644382|P4|Overall Study|Adverse Event|6
7659575|NCT01445080|26644383|P3|Overall Study|Adverse Event|11
7659576|NCT01445080|26644384|P2|Overall Study|Adverse Event|3
7659577|NCT01445080|26644385|P1|Overall Study|Adverse Event|5
7659578|NCT01444898|26644504|P1|Overall Study|Withdrawal by Subject|1
7659579|NCT01444781|26644519|P3|Overall Study|Withdrawal by Subject|2
7659580|NCT01444781|26644520|P2|Overall Study|Withdrawal by Subject|1
7659581|NCT01444781|26644521|P1|Overall Study|Withdrawal by Subject|3
7659582|NCT01444781|26644519|P3|Overall Study|Lost to Follow-up|1
7659583|NCT01444781|26644520|P2|Overall Study|Lost to Follow-up|3
7659584|NCT01444781|26644521|P1|Overall Study|Lost to Follow-up|0
7659585|NCT01444742|26644559|P1|Overall Study|Death|1
7659586|NCT01444651|26644572|P2|Overall Study|Missing data|1
7659587|NCT01444651|26644573|P1|Overall Study|Missing data|1
7659588|NCT01444651|26644572|P2|Overall Study|Non-fasting|1
7659589|NCT01444651|26644573|P1|Overall Study|Non-fasting|2
7659590|NCT01444651|26644572|P2|Overall Study|Lost to Follow-up|5
7659591|NCT01444651|26644573|P1|Overall Study|Lost to Follow-up|5
7659592|NCT01444651|26644572|P2|Overall Study|Adverse Event|2
7659593|NCT01444651|26644573|P1|Overall Study|Adverse Event|3
7659594|NCT01444456|26644589|P1|Overall Study|Not treated|104
7659595|NCT01444456|26644589|P1|Overall Study|Other|18
7659596|NCT01444456|26644589|P1|Overall Study|Ineligibility determined|23
7659597|NCT01444456|26644589|P1|Overall Study|Death|73
7659598|NCT01444456|26644589|P1|Overall Study|Lost to Follow-up|37
7659599|NCT01444456|26644589|P1|Overall Study|Physician Decision|9
7659600|NCT01444456|26644589|P1|Overall Study|Withdrawal by Subject|21
7659601|NCT01444430|26644600|P2|Overall Study|CRF termination module not completed.|1
7659602|NCT01444430|26644601|P1|Overall Study|CRF termination module not completed.|0
7659603|NCT01444430|26644600|P2|Overall Study|Lost to Follow-up|0
7659604|NCT01444430|26644601|P1|Overall Study|Lost to Follow-up|2
7659605|NCT01444430|26644600|P2|Overall Study|Death|8
7659606|NCT01444430|26644601|P1|Overall Study|Death|6
7659607|NCT01444430|26644600|P2|Overall Study|Withdrawal by Subject|72
7659608|NCT01444430|26644601|P1|Overall Study|Withdrawal by Subject|53
7659609|NCT01444417|26644623|P2|Overall Study|Withdrawal by Subject|0
7659610|NCT01444417|26644624|P1|Overall Study|Withdrawal by Subject|2
7659611|NCT01444417|26644623|P2|Overall Study|Ineligibility Determined|1
7659612|NCT01444417|26644624|P1|Overall Study|Ineligibility Determined|0
7659613|NCT01444391|26644640|P1|Overall Study|Death|1
7659614|NCT01444378|26644648|P1|Overall Study|Missed Visits|10
7659615|NCT01444378|26644648|P1|Overall Study|Administrative Closure Of The Study|2
7659616|NCT01444378|26644648|P1|Overall Study|Death|3
7659617|NCT01444378|26644648|P1|Overall Study|Withdrawal by Subject|1
7659618|NCT01444378|26644648|P1|Overall Study|Lost to Follow-up|1
7659619|NCT01444300|26644760|P2|Overall Study|Adverse Event|0
7659620|NCT01444300|26644761|P1|Overall Study|Adverse Event|4
7659621|NCT01444092|26644793|P1|Overall Study|Other Eligibility criteria|7
7659622|NCT01444092|26644793|P1|Overall Study|Withdrawal by Subject|1
7659623|NCT01444092|26644793|P1|Overall Study|Protocol Violation|1
7659624|NCT01444092|26644793|P1|Overall Study|Adverse Event|8
7659625|NCT01444027|26644802|P3|Overall Study|Lost to Follow-up|14
7659626|NCT01444027|26644803|P2|Overall Study|Lost to Follow-up|20
7659627|NCT01444027|26644804|P1|Overall Study|Lost to Follow-up|26
7659628|NCT01444027|26644802|P3|Overall Study|Withdrawal by Subject|24
7659629|NCT01444027|26644803|P2|Overall Study|Withdrawal by Subject|10
7659630|NCT01444027|26644804|P1|Overall Study|Withdrawal by Subject|4
7659631|NCT01443923|26644826|P2|Overall Study|Adverse Event|0
7659632|NCT01443923|26644827|P1|Overall Study|Adverse Event|1
7659633|NCT01443858|26644844|P3|Overall Study|Lost to Follow-up|2
7659634|NCT01443858|26644845|P2|Overall Study|Lost to Follow-up|5
7659635|NCT01443858|26644846|P1|Overall Study|Lost to Follow-up|5
7659636|NCT01443858|26644844|P3|Overall Study|Lack of Efficacy|0
7659637|NCT01443858|26644845|P2|Overall Study|Lack of Efficacy|0
7659638|NCT01443858|26644846|P1|Overall Study|Lack of Efficacy|1
7659639|NCT01443858|26644844|P3|Overall Study|Withdrawal by Subject|5
7659640|NCT01443858|26644845|P2|Overall Study|Withdrawal by Subject|8
7659641|NCT01443858|26644846|P1|Overall Study|Withdrawal by Subject|9
7659642|NCT01443845|26644868|P2|Overall Study|Lost to Follow-up|13
7659643|NCT01443845|26644869|P1|Overall Study|Lost to Follow-up|9
7659644|NCT01443845|26644868|P2|Overall Study|Military Conflict - Site Terminated|21
7659645|NCT01443845|26644869|P1|Overall Study|Military Conflict - Site Terminated|20
7659646|NCT01443845|26644868|P2|Overall Study|Withdrawal by Subject|67
7659647|NCT01443845|26644869|P1|Overall Study|Withdrawal by Subject|63
7659648|NCT01443845|26644868|P2|Overall Study|Adverse Event|138
7659649|NCT01443845|26644869|P1|Overall Study|Adverse Event|64
7659650|NCT01443845|26644868|P2|Overall Study|Lack of Efficacy|5
7659651|NCT01443845|26644869|P1|Overall Study|Lack of Efficacy|10
7659652|NCT01443845|26644868|P2|Overall Study|Deterioration in pulmonary function|4
7659653|NCT01443845|26644869|P1|Overall Study|Deterioration in pulmonary function|1
7659654|NCT01443845|26644868|P2|Overall Study|Other reasons, such as COPD exacerbation|44
7659655|NCT01443845|26644869|P1|Overall Study|Other reasons, such as COPD exacerbation|44
7659656|NCT01443845|26644868|P2|Overall Study|Protocol Violation|45
7659657|NCT01443845|26644869|P1|Overall Study|Protocol Violation|43
7659658|NCT01443403|26644924|P4|Overall Study|Other - Miscellaneous|1
7659659|NCT01443403|26644925|P3|Overall Study|Other - Miscellaneous|0
7659660|NCT01443403|26644926|P2|Overall Study|Other - Miscellaneous|0
7659661|NCT01443403|26644927|P1|Overall Study|Other - Miscellaneous|1
7659662|NCT01443403|26644924|P4|Overall Study|Use of Prohibited Treatment|0
7659663|NCT01443403|26644925|P3|Overall Study|Use of Prohibited Treatment|0
7659664|NCT01443403|26644926|P2|Overall Study|Use of Prohibited Treatment|3
7659665|NCT01443403|26644927|P1|Overall Study|Use of Prohibited Treatment|2
7659666|NCT01443403|26644924|P4|Overall Study|Protocol Violation|1
7659667|NCT01443403|26644925|P3|Overall Study|Protocol Violation|1
7659668|NCT01443403|26644926|P2|Overall Study|Protocol Violation|1
7659669|NCT01443403|26644927|P1|Overall Study|Protocol Violation|2
7659670|NCT01443403|26644924|P4|Overall Study|Lost to Follow-up|1
7659671|NCT01443403|26644925|P3|Overall Study|Lost to Follow-up|0
7659672|NCT01443403|26644926|P2|Overall Study|Lost to Follow-up|0
7659673|NCT01443403|26644927|P1|Overall Study|Lost to Follow-up|0
7659674|NCT01443403|26644924|P4|Overall Study|Withdrawal by Subject|1
7659675|NCT01443403|26644925|P3|Overall Study|Withdrawal by Subject|2
7659676|NCT01443403|26644926|P2|Overall Study|Withdrawal by Subject|1
7659677|NCT01443403|26644927|P1|Overall Study|Withdrawal by Subject|0
7659678|NCT01443403|26644924|P4|Overall Study|Adverse Event|5
7659679|NCT01443403|26644925|P3|Overall Study|Adverse Event|4
7659680|NCT01443403|26644926|P2|Overall Study|Adverse Event|1
7659681|NCT01443403|26644927|P1|Overall Study|Adverse Event|1
7659682|NCT01443364|26645074|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7659683|NCT01443364|26645074|P1|Overall Study|AE, non-serious non-fatal|8
7659684|NCT01443364|26645074|P1|Overall Study|SAE, non-fatal|6
7659685|NCT01443364|26645074|P1|Overall Study|Other Reason|4
7659686|NCT01443364|26645074|P1|Overall Study|Withdrawal by Subject|5
7659687|NCT01443364|26645074|P1|Overall Study|Lost to Follow-up|3
7659688|NCT01443364|26645074|P1|Overall Study|Lack of Efficacy|14
7659689|NCT01443130|26645203|P6|Overall Study|Death of Subject's Infant|0
7659690|NCT01443130|26645204|P5|Overall Study|Death of Subject's Infant|0
7659691|NCT01443130|26645205|P4|Overall Study|Death of Subject's Infant|0
7659692|NCT01443130|26645206|P3|Overall Study|Death of Subject's Infant|11
7659693|NCT01443130|26645207|P2|Overall Study|Death of Subject's Infant|10
7659694|NCT01443130|26645208|P1|Overall Study|Death of Subject's Infant|5
7659695|NCT01443130|26645203|P6|Overall Study|Withdrawal by Subject|2
7659696|NCT01443130|26645204|P5|Overall Study|Withdrawal by Subject|7
7659697|NCT01443130|26645205|P4|Overall Study|Withdrawal by Subject|7
7659698|NCT01443130|26645206|P3|Overall Study|Withdrawal by Subject|12
7659699|NCT01443130|26645207|P2|Overall Study|Withdrawal by Subject|14
7659700|NCT01443130|26645208|P1|Overall Study|Withdrawal by Subject|15
7659701|NCT01443130|26645203|P6|Overall Study|Protocol Violation|3
7659702|NCT01443130|26645204|P5|Overall Study|Protocol Violation|2
7659703|NCT01443130|26645205|P4|Overall Study|Protocol Violation|2
7659704|NCT01443130|26645206|P3|Overall Study|Protocol Violation|3
7659705|NCT01443130|26645207|P2|Overall Study|Protocol Violation|1
7659706|NCT01443130|26645208|P1|Overall Study|Protocol Violation|2
7659707|NCT01443130|26645203|P6|Overall Study|Adverse Event|0
7659708|NCT01443130|26645204|P5|Overall Study|Adverse Event|0
7659709|NCT01443130|26645205|P4|Overall Study|Adverse Event|0
7659710|NCT01443130|26645206|P3|Overall Study|Adverse Event|1
7659711|NCT01443130|26645207|P2|Overall Study|Adverse Event|1
7659712|NCT01443130|26645208|P1|Overall Study|Adverse Event|2
7659713|NCT01443130|26645203|P6|Overall Study|Death|8
7659714|NCT01443130|26645204|P5|Overall Study|Death|10
7659715|NCT01443130|26645205|P4|Overall Study|Death|7
7659716|NCT01443130|26645206|P3|Overall Study|Death|0
7659717|NCT01443130|26645207|P2|Overall Study|Death|1
7659718|NCT01443130|26645208|P1|Overall Study|Death|0
7659719|NCT01443130|26645203|P6|Overall Study|Lost to Follow-up|21
7659720|NCT01443130|26645204|P5|Overall Study|Lost to Follow-up|25
7659721|NCT01443130|26645205|P4|Overall Study|Lost to Follow-up|23
7659722|NCT01443130|26645206|P3|Overall Study|Lost to Follow-up|50
7659723|NCT01443130|26645207|P2|Overall Study|Lost to Follow-up|42
7659724|NCT01443130|26645208|P1|Overall Study|Lost to Follow-up|44
7659725|NCT01443078|26645258|P1|Overall Study|Patient had brain mets|1
7659726|NCT01443078|26645258|P1|Overall Study|Withdrawal by Subject|1
7659727|NCT01443078|26645258|P1|Overall Study|Responded to neoadjuvant platinum txt|27
7659728|NCT01443026|26645265|P2|Overall Study|Lost to Follow-up|1
7659729|NCT01443026|26645266|P1|Overall Study|Lost to Follow-up|2
7659730|NCT01443026|26645265|P2|Overall Study|Withdrawal by Subject|3
7659731|NCT01443026|26645266|P1|Overall Study|Withdrawal by Subject|0
7659732|NCT01443026|26645265|P2|Overall Study|Death|1
7659733|NCT01443026|26645266|P1|Overall Study|Death|0
7659734|NCT01443026|26645265|P2|Overall Study|Physician Decision|0
7659735|NCT01443026|26645266|P1|Overall Study|Physician Decision|1
7659736|NCT01442779|26645281|P1|Overall Study|Non-compliance|1
7659737|NCT01442779|26645281|P1|Overall Study|Death|3
7659738|NCT01442779|26645281|P1|Overall Study|Withdrawal by Subject|3
7659739|NCT01442714|26645287|P1|Overall Study|Withdrawal by Subject|1
7659740|NCT01442714|26645287|P1|Overall Study|Death|11
7659741|NCT01442688|26645295|P2|Second Intervention|Adverse Event|0
7659742|NCT01442688|26645296|P1|Second Intervention|Adverse Event|1
7659743|NCT01442688|26645295|P2|First Intervention|subject incarcerated|0
7659744|NCT01442688|26645296|P1|First Intervention|subject incarcerated|1
7659745|NCT01442688|26645295|P2|First Intervention|Withdrawal by Subject|0
7659746|NCT01442688|26645296|P1|First Intervention|Withdrawal by Subject|1
7659747|NCT01442675|26645304|P1|Overall Study|Withdrawal by Subject|4
7659748|NCT01442675|26645304|P1|Overall Study|Lost to Follow-up|2
7659749|NCT01442675|26645304|P1|Overall Study|Protocol Violation|6
7659750|NCT01442493|26645316|P2|Overall Study|withdrawn from study|2
7659751|NCT01442493|26645317|P1|Overall Study|withdrawn from study|3
7659752|NCT01442376|26645338|P3|Overall Study|Not eligible for subsequent cycles|0
7659753|NCT01442376|26645339|P2|Overall Study|Not eligible for subsequent cycles|2
7659754|NCT01442376|26645340|P1|Overall Study|Not eligible for subsequent cycles|1
7659755|NCT01442376|26645338|P3|Overall Study|Patients not treated|1
7659756|NCT01442376|26645339|P2|Overall Study|Patients not treated|3
7659757|NCT01442376|26645340|P1|Overall Study|Patients not treated|2
7659758|NCT01442376|26645338|P3|Overall Study|Withdrawal of consent|1
7659759|NCT01442376|26645339|P2|Overall Study|Withdrawal of consent|0
7659760|NCT01442376|26645340|P1|Overall Study|Withdrawal of consent|0
7659761|NCT01442376|26645338|P3|Overall Study|Death|1
7659762|NCT01442376|26645339|P2|Overall Study|Death|1
7659763|NCT01442376|26645340|P1|Overall Study|Death|0
7659764|NCT01442376|26645338|P3|Overall Study|Adverse Event|2
7659765|NCT01442376|26645339|P2|Overall Study|Adverse Event|3
7659766|NCT01442376|26645340|P1|Overall Study|Adverse Event|0
7659767|NCT01442181|26645353|P2|Overall Study|atrial fibrillation not noted|1
7659768|NCT01442181|26645354|P1|Overall Study|atrial fibrillation not noted|0
7659769|NCT01442181|26645353|P2|Overall Study|patient in an additional study|0
7659770|NCT01442181|26645354|P1|Overall Study|patient in an additional study|1
7659771|NCT01442181|26645353|P2|Overall Study|Lost to Follow-up|1
7659772|NCT01442181|26645354|P1|Overall Study|Lost to Follow-up|1
7659773|NCT01442181|26645353|P2|Overall Study|low ejection factor|1
7659774|NCT01442181|26645354|P1|Overall Study|low ejection factor|0
7659775|NCT01442181|26645353|P2|Overall Study|no insurance for surgery|0
7659776|NCT01442181|26645354|P1|Overall Study|no insurance for surgery|1
7659777|NCT01442181|26645353|P2|Overall Study|patient refused surgery|0
7659778|NCT01442181|26645354|P1|Overall Study|patient refused surgery|1
7659779|NCT01442155|26645378|P1|Overall Study|Lost to Follow-up|2
7659780|NCT01442155|26645378|P1|Overall Study|Adverse Event|2
7659781|NCT01442155|26645378|P1|Overall Study|Recurrence|26
7659782|NCT01442155|26645378|P1|Overall Study|Complete remission|35
7659783|NCT01442103|26645394|P1|Overall Study|Lost to Follow-up|2
7659784|NCT01442064|26645404|P6|Overall Study|Condition mandated other intervention|2
7659785|NCT01442064|26645405|P5|Overall Study|Condition mandated other intervention|0
7659786|NCT01442064|26645406|P4|Overall Study|Condition mandated other intervention|0
7659787|NCT01442064|26645407|P3|Overall Study|Condition mandated other intervention|2
7659788|NCT01442064|26645408|P2|Overall Study|Condition mandated other intervention|1
7659789|NCT01442064|26645409|P1|Overall Study|Condition mandated other intervention|1
7659790|NCT01442064|26645404|P6|Overall Study|Subject non-compliance|2
7659791|NCT01442064|26645405|P5|Overall Study|Subject non-compliance|0
7659792|NCT01442064|26645406|P4|Overall Study|Subject non-compliance|0
7659793|NCT01442064|26645407|P3|Overall Study|Subject non-compliance|0
7659794|NCT01442064|26645408|P2|Overall Study|Subject non-compliance|0
7659795|NCT01442064|26645409|P1|Overall Study|Subject non-compliance|0
7659796|NCT01442064|26645404|P6|Overall Study|Sponsor decision|87
7659797|NCT01442064|26645405|P5|Overall Study|Sponsor decision|95
7659798|NCT01442064|26645406|P4|Overall Study|Sponsor decision|88
7659799|NCT01442064|26645407|P3|Overall Study|Sponsor decision|92
7659800|NCT01442064|26645408|P2|Overall Study|Sponsor decision|88
7659801|NCT01442064|26645409|P1|Overall Study|Sponsor decision|82
7659802|NCT01442064|26645404|P6|Overall Study|Withdrawal by Subject|1
7659803|NCT01442064|26645405|P5|Overall Study|Withdrawal by Subject|2
7659804|NCT01442064|26645406|P4|Overall Study|Withdrawal by Subject|2
7659805|NCT01442064|26645407|P3|Overall Study|Withdrawal by Subject|2
7659806|NCT01442064|26645408|P2|Overall Study|Withdrawal by Subject|3
7659807|NCT01442064|26645409|P1|Overall Study|Withdrawal by Subject|6
7659808|NCT01442064|26645404|P6|Overall Study|Physician Decision|1
7659809|NCT01442064|26645405|P5|Overall Study|Physician Decision|3
7659810|NCT01442064|26645406|P4|Overall Study|Physician Decision|3
7659811|NCT01442064|26645407|P3|Overall Study|Physician Decision|2
7659812|NCT01442064|26645408|P2|Overall Study|Physician Decision|1
7659813|NCT01442064|26645409|P1|Overall Study|Physician Decision|1
7659814|NCT01442064|26645404|P6|Overall Study|Lost to Follow-up|3
7659815|NCT01442064|26645405|P5|Overall Study|Lost to Follow-up|3
7659816|NCT01442064|26645406|P4|Overall Study|Lost to Follow-up|1
7659817|NCT01442064|26645407|P3|Overall Study|Lost to Follow-up|1
7659818|NCT01442064|26645408|P2|Overall Study|Lost to Follow-up|5
7659819|NCT01442064|26645409|P1|Overall Study|Lost to Follow-up|5
7659820|NCT01442064|26645404|P6|Overall Study|Death|3
7659821|NCT01442064|26645405|P5|Overall Study|Death|1
7659822|NCT01442064|26645406|P4|Overall Study|Death|3
7659823|NCT01442064|26645407|P3|Overall Study|Death|3
7659824|NCT01442064|26645408|P2|Overall Study|Death|1
7659825|NCT01442064|26645409|P1|Overall Study|Death|0
7659826|NCT01442064|26645404|P6|Overall Study|Adverse Event|0
7659827|NCT01442064|26645405|P5|Overall Study|Adverse Event|2
7659828|NCT01442064|26645406|P4|Overall Study|Adverse Event|1
7659829|NCT01442064|26645407|P3|Overall Study|Adverse Event|2
7659830|NCT01442064|26645408|P2|Overall Study|Adverse Event|2
7659831|NCT01442064|26645409|P1|Overall Study|Adverse Event|2
7659832|NCT01442038|26645446|P2|Overall Study|Study Terminated By Sponsor|3
7659833|NCT01442038|26645447|P1|Overall Study|Study Terminated By Sponsor|2
7659834|NCT01442038|26645446|P2|Overall Study|Investigator's Discretion|16
7659835|NCT01442038|26645447|P1|Overall Study|Investigator's Discretion|13
7659836|NCT01442038|26645446|P2|Overall Study|Protocol Deviation|20
7659837|NCT01442038|26645447|P1|Overall Study|Protocol Deviation|9
7659838|NCT01442038|26645446|P2|Overall Study|Adverse Event|15
7659839|NCT01442038|26645447|P1|Overall Study|Adverse Event|26
7659840|NCT01442038|26645446|P2|Overall Study|Lost to Follow-up|51
7659841|NCT01442038|26645447|P1|Overall Study|Lost to Follow-up|37
7659842|NCT01442038|26645446|P2|Overall Study|Participant Withdrew Consent|102
7659843|NCT01442038|26645447|P1|Overall Study|Participant Withdrew Consent|137
7659844|NCT01442038|26645446|P2|Overall Study|Investigator-Initiated Early Closure|43
7659845|NCT01442038|26645447|P1|Overall Study|Investigator-Initiated Early Closure|44
7659846|NCT01442038|26645446|P2|Overall Study|Death|29
7659847|NCT01442038|26645447|P1|Overall Study|Death|35
7659848|NCT01441973|26645461|P2|Overall Study|Participant withdrew consent|1
7659849|NCT01441973|26645462|P1|Overall Study|Participant withdrew consent|0
7659850|NCT01441973|26645461|P2|Overall Study|Administrative reason by sponsor|5
7659851|NCT01441973|26645462|P1|Overall Study|Administrative reason by sponsor|3
7659852|NCT01441973|26645461|P2|Overall Study|Poor compliance/noncompliance|1
7659853|NCT01441973|26645462|P1|Overall Study|Poor compliance/noncompliance|0
7659854|NCT01441973|26645461|P2|Overall Study|Participant request to discontinue|1
7659855|NCT01441973|26645462|P1|Overall Study|Participant request to discontinue|1
7659856|NCT01441973|26645461|P2|Overall Study|Adverse event unrelated to study drug|2
7659857|NCT01441973|26645462|P1|Overall Study|Adverse event unrelated to study drug|3
7659858|NCT01441973|26645461|P2|Overall Study|Disease progression|6
7659859|NCT01441973|26645462|P1|Overall Study|Disease progression|8
7659860|NCT01441960|26645484|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
7659861|NCT01441960|26645485|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
7659862|NCT01441960|26645484|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
7659863|NCT01441960|26645485|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
7659864|NCT01441960|26645484|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
7659865|NCT01441960|26645485|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
7659866|NCT01441765|26645514|P2|Overall Study|Death|0
7659867|NCT01441765|26645515|P1|Overall Study|Death|1
7659868|NCT01441635|26645539|P10|Overall Study|Other|0
7659869|NCT01441635|26645540|P9|Overall Study|Other|0
7659870|NCT01441635|26645541|P8|Overall Study|Other|1
7659871|NCT01441635|26645542|P7|Overall Study|Other|0
7659872|NCT01441635|26645543|P6|Overall Study|Other|0
7659873|NCT01441635|26645544|P5|Overall Study|Other|0
7659874|NCT01441635|26645545|P4|Overall Study|Other|0
7659875|NCT01441635|26645546|P3|Overall Study|Other|0
7659876|NCT01441635|26645547|P2|Overall Study|Other|0
7659877|NCT01441635|26645548|P1|Overall Study|Other|0
7659878|NCT01441635|26645539|P10|Overall Study|Received Exclusionary Medication|0
7659879|NCT01441635|26645540|P9|Overall Study|Received Exclusionary Medication|0
7659880|NCT01441635|26645541|P8|Overall Study|Received Exclusionary Medication|0
7659881|NCT01441635|26645542|P7|Overall Study|Received Exclusionary Medication|0
7659882|NCT01441635|26645543|P6|Overall Study|Received Exclusionary Medication|0
7659883|NCT01441635|26645544|P5|Overall Study|Received Exclusionary Medication|0
7659884|NCT01441635|26645545|P4|Overall Study|Received Exclusionary Medication|0
7659885|NCT01441635|26645546|P3|Overall Study|Received Exclusionary Medication|0
7659886|NCT01441635|26645547|P2|Overall Study|Received Exclusionary Medication|0
7659887|NCT01441635|26645548|P1|Overall Study|Received Exclusionary Medication|1
7659888|NCT01441635|26645539|P10|Overall Study|Surgery or Invasive Intervention|0
7659889|NCT01441635|26645540|P9|Overall Study|Surgery or Invasive Intervention|0
7659890|NCT01441635|26645541|P8|Overall Study|Surgery or Invasive Intervention|0
7659891|NCT01441635|26645542|P7|Overall Study|Surgery or Invasive Intervention|0
7659892|NCT01441635|26645543|P6|Overall Study|Surgery or Invasive Intervention|0
7659893|NCT01441635|26645544|P5|Overall Study|Surgery or Invasive Intervention|0
7659894|NCT01441635|26645545|P4|Overall Study|Surgery or Invasive Intervention|0
7659895|NCT01441635|26645546|P3|Overall Study|Surgery or Invasive Intervention|1
7659896|NCT01441635|26645547|P2|Overall Study|Surgery or Invasive Intervention|0
7659897|NCT01441635|26645548|P1|Overall Study|Surgery or Invasive Intervention|0
7659898|NCT01441635|26645539|P10|Overall Study|Noncompliance|0
7659899|NCT01441635|26645540|P9|Overall Study|Noncompliance|0
7659900|NCT01441635|26645541|P8|Overall Study|Noncompliance|0
7659901|NCT01441635|26645542|P7|Overall Study|Noncompliance|1
7659902|NCT01441635|26645543|P6|Overall Study|Noncompliance|0
7659903|NCT01441635|26645544|P5|Overall Study|Noncompliance|0
7659904|NCT01441635|26645545|P4|Overall Study|Noncompliance|0
7659905|NCT01441635|26645546|P3|Overall Study|Noncompliance|0
7659906|NCT01441635|26645547|P2|Overall Study|Noncompliance|1
7659907|NCT01441635|26645548|P1|Overall Study|Noncompliance|0
7659908|NCT01441635|26645539|P10|Overall Study|Lost to Follow-up|1
7659909|NCT01441635|26645540|P9|Overall Study|Lost to Follow-up|0
7659910|NCT01441635|26645541|P8|Overall Study|Lost to Follow-up|1
7659911|NCT01441635|26645542|P7|Overall Study|Lost to Follow-up|1
7659912|NCT01441635|26645543|P6|Overall Study|Lost to Follow-up|3
7659913|NCT01441635|26645544|P5|Overall Study|Lost to Follow-up|1
7659914|NCT01441635|26645545|P4|Overall Study|Lost to Follow-up|1
7659915|NCT01441635|26645546|P3|Overall Study|Lost to Follow-up|1
7659916|NCT01441635|26645547|P2|Overall Study|Lost to Follow-up|1
7659917|NCT01441635|26645548|P1|Overall Study|Lost to Follow-up|0
7659918|NCT01441635|26645539|P10|Overall Study|Withdrawal by Subject|1
7659919|NCT01441635|26645540|P9|Overall Study|Withdrawal by Subject|1
7659920|NCT01441635|26645541|P8|Overall Study|Withdrawal by Subject|0
7659921|NCT01441635|26645542|P7|Overall Study|Withdrawal by Subject|2
7659922|NCT01441635|26645543|P6|Overall Study|Withdrawal by Subject|0
7659923|NCT01441635|26645544|P5|Overall Study|Withdrawal by Subject|0
7659924|NCT01441635|26645545|P4|Overall Study|Withdrawal by Subject|1
7659925|NCT01441635|26645546|P3|Overall Study|Withdrawal by Subject|0
7659926|NCT01441635|26645547|P2|Overall Study|Withdrawal by Subject|1
7659927|NCT01441635|26645548|P1|Overall Study|Withdrawal by Subject|1
7659928|NCT01441635|26645539|P10|Overall Study|Adverse Event|0
7659929|NCT01441635|26645540|P9|Overall Study|Adverse Event|1
7659930|NCT01441635|26645541|P8|Overall Study|Adverse Event|2
7659931|NCT01441635|26645542|P7|Overall Study|Adverse Event|2
7659932|NCT01441635|26645543|P6|Overall Study|Adverse Event|2
7659933|NCT01441635|26645544|P5|Overall Study|Adverse Event|1
7659934|NCT01441635|26645545|P4|Overall Study|Adverse Event|5
7659935|NCT01441635|26645546|P3|Overall Study|Adverse Event|1
7659936|NCT01441635|26645547|P2|Overall Study|Adverse Event|3
7659937|NCT01441635|26645548|P1|Overall Study|Adverse Event|4
7659938|NCT01441596|26645763|P3|Overall Study|Not treated|1
7659939|NCT01441596|26645764|P2|Overall Study|Not treated|1
7659940|NCT01441596|26645765|P1|Overall Study|Not treated|0
7659941|NCT01441596|26645763|P3|Overall Study|Withdrawal by Subject|2
7659942|NCT01441596|26645764|P2|Overall Study|Withdrawal by Subject|0
7659943|NCT01441596|26645765|P1|Overall Study|Withdrawal by Subject|4
7659944|NCT01441596|26645763|P3|Overall Study|Other reason not defined below|1
7659945|NCT01441596|26645764|P2|Overall Study|Other reason not defined below|2
7659946|NCT01441596|26645765|P1|Overall Study|Other reason not defined below|0
7659947|NCT01441440|26645839|P3|Overall Study|Difficllty in keeping the schedule|0
7659948|NCT01441440|26645840|P2|Overall Study|Difficllty in keeping the schedule|1
7659949|NCT01441440|26645841|P1|Overall Study|Difficllty in keeping the schedule|1
7659950|NCT01441440|26645839|P3|Overall Study|Work-related matter|0
7659951|NCT01441440|26645840|P2|Overall Study|Work-related matter|1
7659952|NCT01441440|26645841|P1|Overall Study|Work-related matter|0
7659953|NCT01441440|26645839|P3|Overall Study|Moving|1
7659954|NCT01441440|26645840|P2|Overall Study|Moving|1
7659955|NCT01441440|26645841|P1|Overall Study|Moving|0
7659956|NCT01441440|26645839|P3|Overall Study|Lack of Efficacy|1
7659957|NCT01441440|26645840|P2|Overall Study|Lack of Efficacy|0
7659958|NCT01441440|26645841|P1|Overall Study|Lack of Efficacy|1
7659959|NCT01441440|26645839|P3|Overall Study|Pregnancy|0
7659960|NCT01441440|26645840|P2|Overall Study|Pregnancy|0
7659961|NCT01441440|26645841|P1|Overall Study|Pregnancy|1
7659962|NCT01441440|26645839|P3|Overall Study|Withdrawal by Subject|9
7659963|NCT01441440|26645840|P2|Overall Study|Withdrawal by Subject|9
7659964|NCT01441440|26645841|P1|Overall Study|Withdrawal by Subject|11
7659965|NCT01441440|26645839|P3|Overall Study|Lost to Follow-up|1
7659966|NCT01441440|26645840|P2|Overall Study|Lost to Follow-up|2
7659967|NCT01441440|26645841|P1|Overall Study|Lost to Follow-up|0
7659968|NCT01441440|26645839|P3|Overall Study|Adverse Event|9
7659969|NCT01441440|26645840|P2|Overall Study|Adverse Event|9
7659970|NCT01441440|26645841|P1|Overall Study|Adverse Event|2
7659971|NCT01441440|26645839|P3|Overall Study|Death|1
7659972|NCT01441440|26645840|P2|Overall Study|Death|0
7659973|NCT01441440|26645841|P1|Overall Study|Death|1
7659974|NCT01441414|26645864|P1|Overall Study|Subject refused further follow-up|1
7659975|NCT01441414|26645864|P1|Overall Study|Study terminated by sponsor|2
7659976|NCT01441414|26645864|P1|Overall Study|Other reasons|3
7659977|NCT01441414|26645864|P1|Overall Study|Participant died|9
7659978|NCT01441180|26645943|P3|Overall Study|Discontinued|2
7659979|NCT01441180|26645944|P2|Overall Study|Discontinued|0
7659980|NCT01441180|26645945|P1|Overall Study|Discontinued|0
7659981|NCT01441180|26645943|P3|Overall Study|Lost to Follow-up|1
7659982|NCT01441180|26645944|P2|Overall Study|Lost to Follow-up|1
7659983|NCT01441180|26645945|P1|Overall Study|Lost to Follow-up|1
7659984|NCT01441102|26645956|P1|Overall Study|Withdrawal by Subject|2
7659985|NCT01441102|26645956|P1|Overall Study|Adverse Event|1
7659986|NCT01441063|26645994|P1|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
7659987|NCT01441063|26645994|P1|Tocilizumab Alone|Required AZT/VGC addition|3
7659988|NCT01440972|26646029|P2|Overall Study|Withdrawal by Subject|2
7659989|NCT01440972|26646030|P1|Overall Study|Withdrawal by Subject|3
7659990|NCT01440946|26646054|P2|Overall Study|Physician Decision|0
7659991|NCT01440946|26646055|P1|Overall Study|Physician Decision|1
7659992|NCT01440946|26646054|P2|Overall Study|Lost to Follow-up|1
7659993|NCT01440946|26646055|P1|Overall Study|Lost to Follow-up|1
7659994|NCT01440881|26646110|P2|Overall Study|Death|1
7659995|NCT01440881|26646111|P1|Overall Study|Death|0
7659996|NCT01440816|26646125|P2|Overall Study|To Be Seen By Local Oncologist|2
7659997|NCT01440816|26646126|P1|Overall Study|To Be Seen By Local Oncologist|1
7659998|NCT01440816|26646125|P2|Overall Study|Disease Progression|9
7659999|NCT01440816|26646126|P1|Overall Study|Disease Progression|0
7660000|NCT01440803|26646142|P2|Overall Study|Withdrawal by Subject|1
7660001|NCT01440803|26646143|P1|Overall Study|Withdrawal by Subject|0
7660002|NCT01440803|26646142|P2|Overall Study|Lost to Follow-up|2
7660003|NCT01440803|26646143|P1|Overall Study|Lost to Follow-up|0
7660004|NCT01440803|26646142|P2|Overall Study|Met study stopping rule|1
7660005|NCT01440803|26646143|P1|Overall Study|Met study stopping rule|2
7660006|NCT01440647|26646179|P2|Overall Study|Death|3
7660007|NCT01440647|26646180|P1|Overall Study|Death|2
7660008|NCT01440595|26646199|P3|Overall Study|Study terminated by sponsor.|1
7660009|NCT01440595|26646200|P2|Overall Study|Study terminated by sponsor.|2
7660010|NCT01440595|26646201|P1|Overall Study|Study terminated by sponsor.|1
7660011|NCT01440595|26646199|P3|Overall Study|Lost to Follow-up|0
7660012|NCT01440595|26646200|P2|Overall Study|Lost to Follow-up|1
7660013|NCT01440595|26646201|P1|Overall Study|Lost to Follow-up|0
7660014|NCT01440569|26646221|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
7660015|NCT01440569|26646222|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
7660016|NCT01440569|26646221|P2|Open-Label Rollover Phase|Lost to Follow-up|3
7660017|NCT01440569|26646222|P1|Open-Label Rollover Phase|Lost to Follow-up|26
7660018|NCT01440569|26646221|P2|Open-Label Rollover Phase|Withdrew Consent|1
7660019|NCT01440569|26646222|P1|Open-Label Rollover Phase|Withdrew Consent|11
7660020|NCT01440569|26646221|P2|Open-Label Rollover Phase|Investigator's Discretion|1
7660021|NCT01440569|26646222|P1|Open-Label Rollover Phase|Investigator's Discretion|3
7660022|NCT01440569|26646221|P2|Open-Label Rollover Phase|Lack of Efficacy|0
7660023|NCT01440569|26646222|P1|Open-Label Rollover Phase|Lack of Efficacy|2
7660024|NCT01440569|26646221|P2|Open-Label Rollover Phase|Pregnancy|0
7660025|NCT01440569|26646222|P1|Open-Label Rollover Phase|Pregnancy|1
7660026|NCT01440569|26646221|P2|Open-Label Rollover Phase|Adverse Event|0
7660027|NCT01440569|26646222|P1|Open-Label Rollover Phase|Adverse Event|3
7660028|NCT01440569|26646221|P2|Main Study|Protocol Violation|0
7660029|NCT01440569|26646222|P1|Main Study|Protocol Violation|1
7660030|NCT01440569|26646221|P2|Main Study|Subject Non-Compliance|0
7660031|NCT01440569|26646222|P1|Main Study|Subject Non-Compliance|3
7660032|NCT01440569|26646221|P2|Main Study|Lost to Follow-up|2
7660033|NCT01440569|26646222|P1|Main Study|Lost to Follow-up|13
7660034|NCT01440569|26646221|P2|Main Study|Withdrew Consent|1
7660035|NCT01440569|26646222|P1|Main Study|Withdrew Consent|7
7660036|NCT01440569|26646221|P2|Main Study|Investigator's Discretion|1
7660037|NCT01440569|26646222|P1|Main Study|Investigator's Discretion|1
7660038|NCT01440569|26646221|P2|Main Study|Pregnancy|0
7660039|NCT01440569|26646222|P1|Main Study|Pregnancy|1
7660040|NCT01440569|26646221|P2|Main Study|Adverse Event|0
7660041|NCT01440569|26646222|P1|Main Study|Adverse Event|9
7660042|NCT01440569|26646221|P2|Main Study|Enrolled but not treated|0
7660043|NCT01440569|26646222|P1|Main Study|Enrolled but not treated|1
7660044|NCT01440517|26646257|P1|Overall Study|Subject withdrawn prior to dosing|1
7660045|NCT01440374|26646333|P4|Part 3: Extension|Physician Decision|14
7660046|NCT01440374|26646334|P3|Part 3: Extension|Physician Decision|0
7660047|NCT01440374|26646335|P2|Part 3: Extension|Physician Decision|0
7660048|NCT01440374|26646336|P1|Part 3: Extension|Physician Decision|0
7660049|NCT01440374|26646333|P4|Part 3: Extension|Adverse Event|13
7660050|NCT01440374|26646334|P3|Part 3: Extension|Adverse Event|0
7660051|NCT01440374|26646335|P2|Part 3: Extension|Adverse Event|0
7660052|NCT01440374|26646336|P1|Part 3: Extension|Adverse Event|0
7660053|NCT01440374|26646333|P4|Part 3: Extension|Withdrawal by Subject|5
7660054|NCT01440374|26646334|P3|Part 3: Extension|Withdrawal by Subject|0
7660055|NCT01440374|26646335|P2|Part 3: Extension|Withdrawal by Subject|0
7660056|NCT01440374|26646336|P1|Part 3: Extension|Withdrawal by Subject|0
7660057|NCT01440374|26646333|P4|Part 2; Double-blind Phase|Not treated|0
7660058|NCT01440374|26646334|P3|Part 2; Double-blind Phase|Not treated|1
7660059|NCT01440374|26646335|P2|Part 2; Double-blind Phase|Not treated|0
7660060|NCT01440374|26646336|P1|Part 2; Double-blind Phase|Not treated|0
7660061|NCT01440374|26646333|P4|Part 2; Double-blind Phase|Adverse Event|0
7660062|NCT01440374|26646334|P3|Part 2; Double-blind Phase|Adverse Event|31
7660063|NCT01440374|26646335|P2|Part 2; Double-blind Phase|Adverse Event|7
7660064|NCT01440374|26646336|P1|Part 2; Double-blind Phase|Adverse Event|0
7660065|NCT01440374|26646333|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
7660066|NCT01440374|26646334|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
7660067|NCT01440374|26646335|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
7660068|NCT01440374|26646336|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
7660069|NCT01440374|26646333|P4|Part 2; Double-blind Phase|Protocol Violation|0
7660070|NCT01440374|26646334|P3|Part 2; Double-blind Phase|Protocol Violation|1
7660071|NCT01440374|26646335|P2|Part 2; Double-blind Phase|Protocol Violation|0
7660072|NCT01440374|26646336|P1|Part 2; Double-blind Phase|Protocol Violation|0
7660073|NCT01440374|26646333|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
7660074|NCT01440374|26646334|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
7660075|NCT01440374|26646335|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
7660076|NCT01440374|26646336|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
7660077|NCT01440374|26646333|P4|Part 2; Double-blind Phase|Physician Decision|0
7660078|NCT01440374|26646334|P3|Part 2; Double-blind Phase|Physician Decision|17
7660079|NCT01440374|26646335|P2|Part 2; Double-blind Phase|Physician Decision|8
7660080|NCT01440374|26646336|P1|Part 2; Double-blind Phase|Physician Decision|0
7660081|NCT01440374|26646333|P4|Part 1: Open-label Phase|Physician Decision|0
7660082|NCT01440374|26646334|P3|Part 1: Open-label Phase|Physician Decision|0
7660083|NCT01440374|26646335|P2|Part 1: Open-label Phase|Physician Decision|0
7660084|NCT01440374|26646336|P1|Part 1: Open-label Phase|Physician Decision|1
7660085|NCT01440374|26646333|P4|Part 1: Open-label Phase|Adverse Event|0
7660086|NCT01440374|26646334|P3|Part 1: Open-label Phase|Adverse Event|0
7660087|NCT01440374|26646335|P2|Part 1: Open-label Phase|Adverse Event|0
7660088|NCT01440374|26646336|P1|Part 1: Open-label Phase|Adverse Event|5
7660089|NCT01440322|26646371|P2|Overall Study|Other Non-Product Related|0
7660090|NCT01440322|26646372|P1|Overall Study|Other Non-Product Related|1
7660091|NCT01440322|26646371|P2|Overall Study|Unrelated Medical Problem|1
7660092|NCT01440322|26646372|P1|Overall Study|Unrelated Medical Problem|0
7660093|NCT01440322|26646371|P2|Overall Study|Other Product Related|0
7660094|NCT01440322|26646372|P1|Overall Study|Other Product Related|1
7660095|NCT01440322|26646371|P2|Overall Study|Unacceptable Subjective Vision|0
7660096|NCT01440322|26646372|P1|Overall Study|Unacceptable Subjective Vision|1
7660097|NCT01440322|26646371|P2|Overall Study|Symptoms and Problems|0
7660098|NCT01440322|26646372|P1|Overall Study|Symptoms and Problems|1
7660099|NCT01440322|26646371|P2|Overall Study|Biomicroscopy|0
7660100|NCT01440322|26646372|P1|Overall Study|Biomicroscopy|1
7660101|NCT01440322|26646371|P2|Overall Study|Discomfort|0
7660102|NCT01440322|26646372|P1|Overall Study|Discomfort|2
7660103|NCT01440283|26646394|P1|Overall Study|Physician Decision|3
7660104|NCT01440283|26646394|P1|Overall Study|Withdrawal by Subject|4
7660105|NCT01440283|26646394|P1|Overall Study|Death|3
7660106|NCT01440101|26646409|P3|Overall Study|Other|0
7660107|NCT01440101|26646410|P2|Overall Study|Other|1
7660108|NCT01440101|26646411|P1|Overall Study|Other|0
7660109|NCT01440101|26646409|P3|Overall Study|Withdrawal by Subject|1
7660110|NCT01440101|26646410|P2|Overall Study|Withdrawal by Subject|3
7660111|NCT01440101|26646411|P1|Overall Study|Withdrawal by Subject|0
7660112|NCT01440101|26646409|P3|Overall Study|Adverse Event|0
7660113|NCT01440101|26646410|P2|Overall Study|Adverse Event|0
7660114|NCT01440101|26646411|P1|Overall Study|Adverse Event|2
7660115|NCT01440049|26646444|P1|Overall Study|Adverse Event|5
7660116|NCT01439971|26646476|P5|Overall Study|Required number in cohort dosed|1
7660117|NCT01439971|26646477|P4|Overall Study|Required number in cohort dosed|0
7660118|NCT01439971|26646478|P3|Overall Study|Required number in cohort dosed|2
7660119|NCT01439971|26646479|P2|Overall Study|Required number in cohort dosed|1
7660120|NCT01439971|26646480|P1|Overall Study|Required number in cohort dosed|0
7660121|NCT01439945|26646660|P4|Double-Blind Treatment Phase|Ineligible|1
7660122|NCT01439945|26646661|P3|Double-Blind Treatment Phase|Ineligible|0
7660123|NCT01439945|26646662|P2|Double-Blind Treatment Phase|Ineligible|2
7660124|NCT01439945|26646663|P1|Double-Blind Treatment Phase|Ineligible|1
7660125|NCT01439945|26646660|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
7660126|NCT01439945|26646661|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
7660127|NCT01439945|26646662|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
7660128|NCT01439945|26646663|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
7660129|NCT01439880|26646688|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
7660130|NCT01439880|26646689|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
7660131|NCT01439880|26646688|P2|All-IP Period (Years 2 to 5)|Other|31
7660132|NCT01439880|26646689|P1|All-IP Period (Years 2 to 5)|Other|14
7660133|NCT01439880|26646688|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
7660134|NCT01439880|26646689|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
7660135|NCT01439880|26646688|P2|All-IP Period (Years 2 to 5)|Death|13
7660136|NCT01439880|26646689|P1|All-IP Period (Years 2 to 5)|Death|3
7660137|NCT01439880|26646688|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
7660138|NCT01439880|26646689|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
7660139|NCT01439880|26646688|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
7660140|NCT01439880|26646689|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
7660141|NCT01439880|26646688|P2|SOC-controlled Period (Year 1)|Reason Missing|2
7660142|NCT01439880|26646689|P1|SOC-controlled Period (Year 1)|Reason Missing|0
7660143|NCT01439880|26646688|P2|SOC-controlled Period (Year 1)|Other|13
7660144|NCT01439880|26646689|P1|SOC-controlled Period (Year 1)|Other|8
7660145|NCT01439880|26646688|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
7660146|NCT01439880|26646689|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
7660147|NCT01439880|26646688|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
7660148|NCT01439880|26646689|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
7660149|NCT01439880|26646688|P2|SOC-controlled Period (Year 1)|Death|1
7660150|NCT01439880|26646689|P1|SOC-controlled Period (Year 1)|Death|2
7660151|NCT01439880|26646688|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
7660152|NCT01439880|26646689|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
7660153|NCT01439867|26646732|P2|Overall Study|Protocol-specified Criteria|0
7660154|NCT01439867|26646733|P1|Overall Study|Protocol-specified Criteria|1
7660155|NCT01439867|26646732|P2|Overall Study|Administrative Decision|5
7660156|NCT01439867|26646733|P1|Overall Study|Administrative Decision|4
7660157|NCT01439867|26646732|P2|Overall Study|Withdrawal by Subject|2
7660158|NCT01439867|26646733|P1|Overall Study|Withdrawal by Subject|1
7660159|NCT01439867|26646732|P2|Overall Study|Non-compliance|1
7660160|NCT01439867|26646733|P1|Overall Study|Non-compliance|0
7660161|NCT01439724|26646802|P2|Overall Study|missing consultation|8
7660162|NCT01439724|26646803|P1|Overall Study|missing consultation|9
7660163|NCT01439711|26646809|P1|Overall Study|No MRI|9
7660164|NCT01439711|26646809|P1|Overall Study|Noncompliance|3
7660165|NCT01439711|26646809|P1|Overall Study|Progression During Active Tx|3
7660166|NCT01439711|26646809|P1|Overall Study|Withdrawal by Subject|3
7660167|NCT01439711|26646809|P1|Overall Study|Adverse Event|5
7660168|NCT01439711|26646809|P1|Overall Study|Progression Prior to Beginning Tx|1
7660169|NCT01439711|26646809|P1|Overall Study|Cancel|3
7660170|NCT01439711|26646809|P1|Overall Study|Ineligible|13
7660171|NCT01439568|26646847|P2|Overall Study|Withdrawal by Subject|2
7660172|NCT01439568|26646848|P1|Overall Study|Withdrawal by Subject|2
7660173|NCT01439568|26646847|P2|Overall Study|Lost to Follow-up|0
7660174|NCT01439568|26646848|P1|Overall Study|Lost to Follow-up|1
7660175|NCT01439555|26646860|P1|Overall Study|Protocol Violation|1
7660176|NCT01439373|26646872|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
7660177|NCT01439373|26646873|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
7660178|NCT01439373|26646872|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
7660179|NCT01439373|26646873|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
7660180|NCT01439360|26646916|P2|Overall Study|Withdrawal by Subject|129
7660181|NCT01439360|26646917|P1|Overall Study|Withdrawal by Subject|140
7660182|NCT01439360|26646916|P2|Overall Study|Protocol Violation|0
7660183|NCT01439360|26646917|P1|Overall Study|Protocol Violation|1
7660184|NCT01439360|26646916|P2|Overall Study|Others|5
7660185|NCT01439360|26646917|P1|Overall Study|Others|10
7660186|NCT01439360|26646916|P2|Overall Study|Lost to Follow-up|58
7660187|NCT01439360|26646917|P1|Overall Study|Lost to Follow-up|43
7660188|NCT01439360|26646916|P2|Overall Study|Adverse Event|16
7660189|NCT01439360|26646917|P1|Overall Study|Adverse Event|4
7660190|NCT01439347|26646967|P2|Overall Study|Sponsor Terminated Study|3
7660191|NCT01439347|26646968|P1|Overall Study|Sponsor Terminated Study|2
7660192|NCT01439347|26646967|P2|Overall Study|Physician Decision|0
7660193|NCT01439347|26646968|P1|Overall Study|Physician Decision|1
7660194|NCT01439347|26646967|P2|Overall Study|Withdrawal by Subject|1
7660195|NCT01439347|26646968|P1|Overall Study|Withdrawal by Subject|0
7660196|NCT01439347|26646967|P2|Overall Study|Death|9
7660197|NCT01439347|26646968|P1|Overall Study|Death|10
7660198|NCT01439282|26646976|P2|Overall Study|Other|1
7660199|NCT01439282|26646977|P1|Overall Study|Other|1
7660200|NCT01439282|26646976|P2|Overall Study|Withdrawal by Subject|0
7660201|NCT01439282|26646977|P1|Overall Study|Withdrawal by Subject|2
7660202|NCT01439282|26646976|P2|Overall Study|Adverse Event|0
7660203|NCT01439282|26646977|P1|Overall Study|Adverse Event|5
7660204|NCT01439204|26646989|P2|Overall Study|poor/non-compliance|0
7660205|NCT01439204|26646990|P1|Overall Study|poor/non-compliance|3
7660206|NCT01439204|26646989|P2|Overall Study|No longer meets study criteria|0
7660207|NCT01439204|26646990|P1|Overall Study|No longer meets study criteria|1
7660208|NCT01439204|26646989|P2|Overall Study|Lost to Follow-up|2
7660209|NCT01439204|26646990|P1|Overall Study|Lost to Follow-up|0
7660210|NCT01439204|26646989|P2|Overall Study|Withdrawal by Subject|1
7660211|NCT01439204|26646990|P1|Overall Study|Withdrawal by Subject|0
7660212|NCT01439165|26647024|P2|Overall Study|Withdrawal by Subject|1
7660213|NCT01439165|26647025|P1|Overall Study|Withdrawal by Subject|7
7660214|NCT01439165|26647024|P2|Overall Study|Lost to Follow-up|1
7660215|NCT01439165|26647025|P1|Overall Study|Lost to Follow-up|11
7660216|NCT01439165|26647024|P2|Overall Study|Protocol Violation|0
7660217|NCT01439165|26647025|P1|Overall Study|Protocol Violation|3
7660218|NCT01439126|26647039|P2|Overall Study|Other-Miscellaneous|12
7660219|NCT01439126|26647040|P1|Overall Study|Other-Miscellaneous|12
7660220|NCT01439126|26647039|P2|Overall Study|Other-Use of prohibited treatment|2
7660221|NCT01439126|26647040|P1|Overall Study|Other-Use of prohibited treatment|0
7660222|NCT01439126|26647039|P2|Overall Study|Lost to Follow-up|3
7660223|NCT01439126|26647040|P1|Overall Study|Lost to Follow-up|6
7660224|NCT01439126|26647039|P2|Overall Study|Protocol Violation|4
7660225|NCT01439126|26647040|P1|Overall Study|Protocol Violation|6
7660226|NCT01439126|26647039|P2|Overall Study|Withdrawal by Subject|21
7660227|NCT01439126|26647040|P1|Overall Study|Withdrawal by Subject|5
7660228|NCT01439126|26647039|P2|Overall Study|Adverse Event|0
7660229|NCT01439126|26647040|P1|Overall Study|Adverse Event|2
7660230|NCT01439074|26647066|P2|Overall Study|Other|4
7660231|NCT01439074|26647067|P1|Overall Study|Other|4
7660232|NCT01439074|26647066|P2|Overall Study|Withdrawal by Subject|5
7660233|NCT01439074|26647067|P1|Overall Study|Withdrawal by Subject|1
7660234|NCT01439074|26647066|P2|Overall Study|Subject shedding|0
7660235|NCT01439074|26647067|P1|Overall Study|Subject shedding|1
7660236|NCT01439074|26647066|P2|Overall Study|Lost to Follow-up|4
7660237|NCT01439074|26647067|P1|Overall Study|Lost to Follow-up|3
7660238|NCT01439009|26647085|P2|Overall Study|Deviation of exclusion criteria|0
7660239|NCT01439009|26647086|P1|Overall Study|Deviation of exclusion criteria|1
7660240|NCT01439009|26647085|P2|Overall Study|Protocol Violation|0
7660241|NCT01439009|26647086|P1|Overall Study|Protocol Violation|2
7660242|NCT01439009|26647085|P2|Overall Study|Physician Decision|3
7660243|NCT01439009|26647086|P1|Overall Study|Physician Decision|5
7660244|NCT01438996|26647119|P3|Overall Study|Not meeting Inclusion Criteria|0
7660245|NCT01438996|26647120|P2|Overall Study|Not meeting Inclusion Criteria|1
7660246|NCT01438996|26647121|P1|Overall Study|Not meeting Inclusion Criteria|4
7660247|NCT01438957|26647158|P5|Overall Study|Physician Decision|0
7660248|NCT01438957|26647159|P4|Overall Study|Physician Decision|1
7660249|NCT01438957|26647160|P3|Overall Study|Physician Decision|0
7660250|NCT01438957|26647161|P2|Overall Study|Physician Decision|1
7660251|NCT01438957|26647162|P1|Overall Study|Physician Decision|1
7660252|NCT01438840|26647271|P3|Extension Phase|Other|1
7660253|NCT01438840|26647272|P2|Extension Phase|Other|0
7660254|NCT01438840|26647273|P1|Extension Phase|Other|0
7660255|NCT01438840|26647271|P3|Extension Phase|Lack of Efficacy|2
7660256|NCT01438840|26647272|P2|Extension Phase|Lack of Efficacy|0
7660257|NCT01438840|26647273|P1|Extension Phase|Lack of Efficacy|0
7660258|NCT01438840|26647271|P3|Extension Phase|Withdrawal by Subject|3
7660259|NCT01438840|26647272|P2|Extension Phase|Withdrawal by Subject|0
7660260|NCT01438840|26647273|P1|Extension Phase|Withdrawal by Subject|0
7660261|NCT01438840|26647271|P3|Extension Phase|Lost to Follow-up|1
7660262|NCT01438840|26647272|P2|Extension Phase|Lost to Follow-up|0
7660263|NCT01438840|26647273|P1|Extension Phase|Lost to Follow-up|0
7660264|NCT01438840|26647271|P3|Extension Phase|Adverse Event|3
7660265|NCT01438840|26647272|P2|Extension Phase|Adverse Event|0
7660266|NCT01438840|26647273|P1|Extension Phase|Adverse Event|0
7660267|NCT01438840|26647271|P3|Core Study|Withdrawal of consent|0
7660268|NCT01438840|26647272|P2|Core Study|Withdrawal of consent|0
7660269|NCT01438840|26647273|P1|Core Study|Withdrawal of consent|1
7660270|NCT01438840|26647271|P3|Core Study|Lack of Efficacy|0
7660271|NCT01438840|26647272|P2|Core Study|Lack of Efficacy|7
7660272|NCT01438840|26647273|P1|Core Study|Lack of Efficacy|15
7660273|NCT01438840|26647271|P3|Core Study|Adverse Event|0
7660274|NCT01438840|26647272|P2|Core Study|Adverse Event|3
7660275|NCT01438840|26647273|P1|Core Study|Adverse Event|0
7660276|NCT01438814|26647286|P2|Overall Study|Other|4
7660277|NCT01438814|26647287|P1|Overall Study|Other|2
7660278|NCT01438814|26647286|P2|Overall Study|Withdrawal by Subject|2
7660279|NCT01438814|26647287|P1|Overall Study|Withdrawal by Subject|4
7660280|NCT01438814|26647286|P2|Overall Study|Lost to Follow-up|3
7660281|NCT01438814|26647287|P1|Overall Study|Lost to Follow-up|4
7660282|NCT01438814|26647286|P2|Overall Study|Protocol Violation|2
7660283|NCT01438814|26647287|P1|Overall Study|Protocol Violation|1
7660284|NCT01438814|26647286|P2|Overall Study|Adverse Event|3
7660285|NCT01438814|26647287|P1|Overall Study|Adverse Event|3
7660286|NCT01438541|26647323|P1|Overall Study|discharge from the hospital|5
7660287|NCT01438541|26647323|P1|Overall Study|Withdrawal by Subject|1
7660288|NCT01438541|26647323|P1|Overall Study|Physician Decision|1
7660289|NCT01438489|26647332|P3|Overall Study|Inadequate venous access|0
7660290|NCT01438489|26647333|P2|Overall Study|Inadequate venous access|2
7660291|NCT01438489|26647334|P1|Overall Study|Inadequate venous access|0
7660292|NCT01438489|26647332|P3|Overall Study|Did not complete all 3 follow-up visits|2
7660293|NCT01438489|26647333|P2|Overall Study|Did not complete all 3 follow-up visits|5
7660294|NCT01438489|26647334|P1|Overall Study|Did not complete all 3 follow-up visits|2
7660295|NCT01438489|26647332|P3|Overall Study|Received prohibited medication|0
7660296|NCT01438489|26647333|P2|Overall Study|Received prohibited medication|0
7660297|NCT01438489|26647334|P1|Overall Study|Received prohibited medication|1
7660298|NCT01438489|26647332|P3|Overall Study|AE/SAEs|1
7660299|NCT01438489|26647333|P2|Overall Study|AE/SAEs|1
7660300|NCT01438489|26647334|P1|Overall Study|AE/SAEs|2
7660301|NCT01438489|26647332|P3|Overall Study|Investigator decision|0
7660302|NCT01438489|26647333|P2|Overall Study|Investigator decision|1
7660303|NCT01438489|26647334|P1|Overall Study|Investigator decision|0
7660304|NCT01438489|26647332|P3|Overall Study|Subject choice/Subject moved|1
7660305|NCT01438489|26647333|P2|Overall Study|Subject choice/Subject moved|1
7660306|NCT01438489|26647334|P1|Overall Study|Subject choice/Subject moved|2
7660307|NCT01438489|26647332|P3|Overall Study|Sponsor decision|4
7660308|NCT01438489|26647333|P2|Overall Study|Sponsor decision|1
7660309|NCT01438489|26647334|P1|Overall Study|Sponsor decision|4
7660310|NCT01438489|26647332|P3|Overall Study|Death|1
7660311|NCT01438489|26647333|P2|Overall Study|Death|0
7660312|NCT01438489|26647334|P1|Overall Study|Death|0
7660313|NCT01438489|26647332|P3|Overall Study|Withdrawal by Subject|8
7660314|NCT01438489|26647333|P2|Overall Study|Withdrawal by Subject|3
7660315|NCT01438489|26647334|P1|Overall Study|Withdrawal by Subject|11
7660316|NCT01438489|26647332|P3|Overall Study|Lost to Follow-up|2
7660317|NCT01438489|26647333|P2|Overall Study|Lost to Follow-up|2
7660318|NCT01438489|26647334|P1|Overall Study|Lost to Follow-up|4
7660319|NCT01438476|26647379|P2|Overall Study|Communication barrier|1
7660320|NCT01438476|26647380|P1|Overall Study|Communication barrier|0
7660321|NCT01438476|26647379|P2|Overall Study|No Surgery- Disease|10
7660322|NCT01438476|26647380|P1|Overall Study|No Surgery- Disease|8
7660323|NCT01438476|26647379|P2|Overall Study|Withdrawal by Subject|0
7660324|NCT01438476|26647380|P1|Overall Study|Withdrawal by Subject|1
7660325|NCT01438476|26647379|P2|Overall Study|Protocol Violation|0
7660326|NCT01438476|26647380|P1|Overall Study|Protocol Violation|1
7660327|NCT01438424|26647386|P1|Overall Study|Participant noncompliance|20
7660328|NCT01438424|26647386|P1|Overall Study|No longer met inclusion criteria|1
7660329|NCT01438424|26647386|P1|Overall Study|Pregnancy|7
7660330|NCT01438424|26647386|P1|Overall Study|Need for drug prohibited by protocol|14
7660331|NCT01438424|26647386|P1|Overall Study|Abnormal laboratory test result|14
7660332|NCT01438424|26647386|P1|Overall Study|Lost to Follow-up|17
7660333|NCT01438424|26647386|P1|Overall Study|Adverse Event|17
7660334|NCT01438424|26647386|P1|Overall Study|Death|22
7660335|NCT01438424|26647386|P1|Overall Study|Progression of chronic hepatitis B|22
7660336|NCT01438424|26647386|P1|Overall Study|Withdrawal by Subject|104
7660337|NCT01438424|26647386|P1|Overall Study|Not identified|55
7660338|NCT01438424|26647386|P1|Overall Study|Minimal virologic response|95
7660339|NCT01438424|26647386|P1|Overall Study|Continuing treatment|29
7660340|NCT01438411|26647422|P1|Overall Study|Withdrawal by Subject|3
7660341|NCT01438411|26647422|P1|Overall Study|Lack of Efficacy|1
7660342|NCT01438411|26647422|P1|Overall Study|Lost to Follow-up|1
7660343|NCT01438411|26647422|P1|Overall Study|Adverse Event|8
7660344|NCT01438307|26647437|P2|Overall Study|Death|1
7660345|NCT01438307|26647438|P1|Overall Study|Death|1
7660346|NCT01438294|26647452|P2|Overall Study|Lost to Follow-up|7
7660347|NCT01438294|26647453|P1|Overall Study|Lost to Follow-up|3
7660348|NCT01438177|26647496|P1|Overall Study|Initiation of new therapy|1
7660349|NCT01438177|26647496|P1|Overall Study|Withdrawal by Subject|1
7660350|NCT01438151|26647503|P1|Overall Study|study terminated|8
7660351|NCT01438060|26647509|P2|On Study Beyond Week 140|Other Reason|3
7660352|NCT01438060|26647510|P1|On Study Beyond Week 140|Other Reason|0
7660353|NCT01438060|26647509|P2|On Study Beyond Week 140|Death|1
7660354|NCT01438060|26647510|P1|On Study Beyond Week 140|Death|0
7660355|NCT01438060|26647509|P2|On Study Beyond Week 140|Withdrawal by Subject|1
7660356|NCT01438060|26647510|P1|On Study Beyond Week 140|Withdrawal by Subject|0
7660357|NCT01438060|26647509|P2|On Study Beyond Week 140|Lack of Efficacy|1
7660358|NCT01438060|26647510|P1|On Study Beyond Week 140|Lack of Efficacy|0
7660359|NCT01438060|26647509|P2|On Study Beyond Week 140|Adverse Event|2
7660360|NCT01438060|26647510|P1|On Study Beyond Week 140|Adverse Event|0
7660361|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
7660362|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
7660363|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Death|12
7660364|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Death|22
7660365|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
7660366|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
7660367|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
7660368|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
7660369|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
7660370|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
7660371|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7660372|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7660373|NCT01438060|26647509|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
7660374|NCT01438060|26647510|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
7660375|NCT01438060|26647509|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
7660376|NCT01438060|26647510|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
7660377|NCT01438060|26647509|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
7660378|NCT01438060|26647510|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
7660379|NCT01438060|26647509|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
7660380|NCT01438060|26647510|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
7660381|NCT01438060|26647509|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
7660382|NCT01438060|26647510|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
7660383|NCT01438060|26647509|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
7660384|NCT01438060|26647510|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
7660385|NCT01438060|26647509|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
7660386|NCT01438060|26647510|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
7660387|NCT01437995|26647602|P3|Overall Study|Lost to Follow-up|20
7660388|NCT01437995|26647603|P2|Overall Study|Lost to Follow-up|18
7660389|NCT01437995|26647604|P1|Overall Study|Lost to Follow-up|11
7660390|NCT01437943|26647626|P2|Overall Study|Adverse Event|0
7660391|NCT01437943|26647627|P1|Overall Study|Adverse Event|2
7660392|NCT01437943|26647626|P2|Overall Study|Subject expressed pregnancy plans|0
7660393|NCT01437943|26647627|P1|Overall Study|Subject expressed pregnancy plans|1
7660394|NCT01437943|26647626|P2|Overall Study|Aliskiren trials terminated by Novartis|2
7660395|NCT01437943|26647627|P1|Overall Study|Aliskiren trials terminated by Novartis|4
7660396|NCT01437878|26647635|P2|Overall Study|Withdrawal by Subject|0
7660397|NCT01437878|26647636|P1|Overall Study|Withdrawal by Subject|1
7660398|NCT01437540|26647703|P2|Overall Study|Withdrawal by Subject|15
7660399|NCT01437540|26647704|P1|Overall Study|Withdrawal by Subject|31
7660400|NCT01437540|26647703|P2|Overall Study|Adverse Event|13
7660401|NCT01437540|26647704|P1|Overall Study|Adverse Event|26
7660402|NCT01437540|26647703|P2|Overall Study|Protocol Violation|12
7660403|NCT01437540|26647704|P1|Overall Study|Protocol Violation|24
7660404|NCT01437540|26647703|P2|Overall Study|Lack of Efficacy|11
7660405|NCT01437540|26647704|P1|Overall Study|Lack of Efficacy|23
7660406|NCT01437540|26647703|P2|Overall Study|Lost to Follow-up|5
7660407|NCT01437540|26647704|P1|Overall Study|Lost to Follow-up|3
7660408|NCT01437540|26647703|P2|Overall Study|COPD exacerbation|3
7660409|NCT01437540|26647704|P1|Overall Study|COPD exacerbation|13
7660410|NCT01437540|26647703|P2|Overall Study|Not listed below|6
7660411|NCT01437540|26647704|P1|Overall Study|Not listed below|7
7660412|NCT01437423|26647741|P1|Overall Study|Off label usage|3
7660413|NCT01437423|26647741|P1|Overall Study|Lost to Follow-up|12
7660414|NCT01437397|26647753|P5|Overall Study|Site termination/COPD exacerbation/other|14
7660415|NCT01437397|26647754|P4|Overall Study|Site termination/COPD exacerbation/other|9
7660416|NCT01437397|26647755|P3|Overall Study|Site termination/COPD exacerbation/other|9
7660417|NCT01437397|26647756|P2|Overall Study|Site termination/COPD exacerbation/other|8
7660418|NCT01437397|26647757|P1|Overall Study|Site termination/COPD exacerbation/other|10
7660419|NCT01437397|26647753|P5|Overall Study|Adverse Event|21
7660420|NCT01437397|26647754|P4|Overall Study|Adverse Event|14
7660421|NCT01437397|26647755|P3|Overall Study|Adverse Event|16
7660422|NCT01437397|26647756|P2|Overall Study|Adverse Event|22
7660423|NCT01437397|26647757|P1|Overall Study|Adverse Event|21
7660424|NCT01437397|26647753|P5|Overall Study|Lack of Efficacy|20
7660425|NCT01437397|26647754|P4|Overall Study|Lack of Efficacy|10
7660426|NCT01437397|26647755|P3|Overall Study|Lack of Efficacy|8
7660427|NCT01437397|26647756|P2|Overall Study|Lack of Efficacy|4
7660428|NCT01437397|26647757|P1|Overall Study|Lack of Efficacy|5
7660429|NCT01437397|26647753|P5|Overall Study|Protocol Violation|19
7660430|NCT01437397|26647754|P4|Overall Study|Protocol Violation|21
7660431|NCT01437397|26647755|P3|Overall Study|Protocol Violation|13
7660432|NCT01437397|26647756|P2|Overall Study|Protocol Violation|12
7660433|NCT01437397|26647757|P1|Overall Study|Protocol Violation|10
7660434|NCT01437397|26647753|P5|Overall Study|Withdrawal by Subject|22
7660435|NCT01437397|26647754|P4|Overall Study|Withdrawal by Subject|11
7660436|NCT01437397|26647755|P3|Overall Study|Withdrawal by Subject|24
7660437|NCT01437397|26647756|P2|Overall Study|Withdrawal by Subject|12
7660438|NCT01437397|26647757|P1|Overall Study|Withdrawal by Subject|11
7660439|NCT01437397|26647753|P5|Overall Study|Lost to Follow-up|5
7660440|NCT01437397|26647754|P4|Overall Study|Lost to Follow-up|4
7660441|NCT01437397|26647755|P3|Overall Study|Lost to Follow-up|2
7660442|NCT01437397|26647756|P2|Overall Study|Lost to Follow-up|4
7660443|NCT01437397|26647757|P1|Overall Study|Lost to Follow-up|9
7660444|NCT01437319|26647784|P3|Phase II|Protocol Violation|0
7660445|NCT01437319|26647785|P2|Phase II|Protocol Violation|1
7660446|NCT01437319|26647786|P1|Phase II|Protocol Violation|0
7660447|NCT01437319|26647784|P3|Phase II|Study related symptoms/complaints|19
7660448|NCT01437319|26647785|P2|Phase II|Study related symptoms/complaints|28
7660449|NCT01437319|26647786|P1|Phase II|Study related symptoms/complaints|0
7660450|NCT01437319|26647784|P3|Phase II|Lost to Follow-up|2
7660451|NCT01437319|26647785|P2|Phase II|Lost to Follow-up|7
7660452|NCT01437319|26647786|P1|Phase II|Lost to Follow-up|0
7660453|NCT01437319|26647784|P3|Phase II|Withdrawal by Subject|16
7660454|NCT01437319|26647785|P2|Phase II|Withdrawal by Subject|8
7660455|NCT01437319|26647786|P1|Phase II|Withdrawal by Subject|0
7660456|NCT01437319|26647784|P3|Phase I|Withdrawal by Subject|0
7660457|NCT01437319|26647785|P2|Phase I|Withdrawal by Subject|0
7660458|NCT01437319|26647786|P1|Phase I|Withdrawal by Subject|25
7660459|NCT01437319|26647784|P3|Phase I|Study related symptoms/complaints|0
7660460|NCT01437319|26647785|P2|Phase I|Study related symptoms/complaints|0
7660461|NCT01437319|26647786|P1|Phase I|Study related symptoms/complaints|27
7660462|NCT01437319|26647784|P3|Phase I|Protocol Violation|0
7660463|NCT01437319|26647785|P2|Phase I|Protocol Violation|0
7660464|NCT01437319|26647786|P1|Phase I|Protocol Violation|1
7660465|NCT01437319|26647784|P3|Phase I|Lost to Follow-up|0
7660466|NCT01437319|26647785|P2|Phase I|Lost to Follow-up|0
7660467|NCT01437319|26647786|P1|Phase I|Lost to Follow-up|2
7660468|NCT01437267|26647801|P6|Overall Study|Protocol Violation|0
7660469|NCT01437267|26647802|P5|Overall Study|Protocol Violation|0
7660470|NCT01437267|26647803|P4|Overall Study|Protocol Violation|0
7660471|NCT01437267|26647804|P3|Overall Study|Protocol Violation|0
7660472|NCT01437267|26647805|P2|Overall Study|Protocol Violation|1
7660473|NCT01437267|26647806|P1|Overall Study|Protocol Violation|0
7660474|NCT01437267|26647801|P6|Overall Study|Withdrawal by Subject|0
7660475|NCT01437267|26647802|P5|Overall Study|Withdrawal by Subject|0
7660476|NCT01437267|26647803|P4|Overall Study|Withdrawal by Subject|1
7660477|NCT01437267|26647804|P3|Overall Study|Withdrawal by Subject|0
7660478|NCT01437267|26647805|P2|Overall Study|Withdrawal by Subject|0
7660479|NCT01437267|26647806|P1|Overall Study|Withdrawal by Subject|0
7660480|NCT01437111|26647849|P1|Overall Study|Protocol Violation|1
7660481|NCT01437111|26647849|P1|Overall Study|Lost to Follow-up|5
7660482|NCT01437111|26647849|P1|Overall Study|Physician Decision|1
7660483|NCT01437111|26647849|P1|Overall Study|Not reported|5
7660484|NCT01437111|26647849|P1|Overall Study|Withdrawal by Subject|4
7660485|NCT01437111|26647849|P1|Overall Study|Adverse Event|2
7660486|NCT01436643|26647927|P4|Core Phase (16 Weeks)|Protocol Violation|0
7660487|NCT01436643|26647928|P3|Core Phase (16 Weeks)|Protocol Violation|1
7660488|NCT01436643|26647929|P2|Core Phase (16 Weeks)|Protocol Violation|1
7660489|NCT01436643|26647930|P1|Core Phase (16 Weeks)|Protocol Violation|1
7660490|NCT01436643|26647927|P4|Core Phase (16 Weeks)|Abnormal Test result|0
7660491|NCT01436643|26647928|P3|Core Phase (16 Weeks)|Abnormal Test result|1
7660492|NCT01436643|26647929|P2|Core Phase (16 Weeks)|Abnormal Test result|0
7660493|NCT01436643|26647930|P1|Core Phase (16 Weeks)|Abnormal Test result|0
7660494|NCT01436643|26647927|P4|Core Phase (16 Weeks)|Adverse Event|0
7660495|NCT01436643|26647928|P3|Core Phase (16 Weeks)|Adverse Event|1
7660496|NCT01436643|26647929|P2|Core Phase (16 Weeks)|Adverse Event|3
7660497|NCT01436643|26647930|P1|Core Phase (16 Weeks)|Adverse Event|0
7660498|NCT01436643|26647927|P4|2-week Pre-treatment|Protocol Violation|4
7660499|NCT01436643|26647928|P3|2-week Pre-treatment|Protocol Violation|0
7660500|NCT01436643|26647929|P2|2-week Pre-treatment|Protocol Violation|0
7660501|NCT01436643|26647930|P1|2-week Pre-treatment|Protocol Violation|0
7660502|NCT01436643|26647927|P4|2-week Pre-treatment|Adverse Event|5
7660503|NCT01436643|26647928|P3|2-week Pre-treatment|Adverse Event|0
7660504|NCT01436643|26647929|P2|2-week Pre-treatment|Adverse Event|0
7660505|NCT01436643|26647930|P1|2-week Pre-treatment|Adverse Event|0
7660506|NCT01436643|26647927|P4|2-week Pre-treatment|Abnormal test result|1
7660507|NCT01436643|26647928|P3|2-week Pre-treatment|Abnormal test result|0
7660508|NCT01436643|26647929|P2|2-week Pre-treatment|Abnormal test result|0
7660509|NCT01436643|26647930|P1|2-week Pre-treatment|Abnormal test result|0
7660510|NCT01436500|26647965|P5|Overall Study|Other|0
7660511|NCT01436500|26647966|P4|Overall Study|Other|1
7660512|NCT01436500|26647967|P3|Overall Study|Other|0
7660513|NCT01436500|26647968|P2|Overall Study|Other|1
7660514|NCT01436500|26647969|P1|Overall Study|Other|0
7660515|NCT01436500|26647965|P5|Overall Study|discontinued study drug|0
7660516|NCT01436500|26647966|P4|Overall Study|discontinued study drug|0
7660517|NCT01436500|26647967|P3|Overall Study|discontinued study drug|0
7660518|NCT01436500|26647968|P2|Overall Study|discontinued study drug|0
7660519|NCT01436500|26647969|P1|Overall Study|discontinued study drug|1
7660520|NCT01436500|26647965|P5|Overall Study|initiation of dialysis|1
7660521|NCT01436500|26647966|P4|Overall Study|initiation of dialysis|0
7660522|NCT01436500|26647967|P3|Overall Study|initiation of dialysis|0
7660523|NCT01436500|26647968|P2|Overall Study|initiation of dialysis|0
7660524|NCT01436500|26647969|P1|Overall Study|initiation of dialysis|0
7660525|NCT01436500|26647965|P5|Overall Study|liver transplant|0
7660526|NCT01436500|26647966|P4|Overall Study|liver transplant|0
7660527|NCT01436500|26647967|P3|Overall Study|liver transplant|0
7660528|NCT01436500|26647968|P2|Overall Study|liver transplant|0
7660529|NCT01436500|26647969|P1|Overall Study|liver transplant|1
7660530|NCT01436500|26647965|P5|Overall Study|Physician Decision|0
7660531|NCT01436500|26647966|P4|Overall Study|Physician Decision|0
7660532|NCT01436500|26647967|P3|Overall Study|Physician Decision|1
7660533|NCT01436500|26647968|P2|Overall Study|Physician Decision|0
7660534|NCT01436500|26647969|P1|Overall Study|Physician Decision|0
7660535|NCT01436500|26647965|P5|Overall Study|Withdrawal by Subject|2
7660536|NCT01436500|26647966|P4|Overall Study|Withdrawal by Subject|0
7660537|NCT01436500|26647967|P3|Overall Study|Withdrawal by Subject|2
7660538|NCT01436500|26647968|P2|Overall Study|Withdrawal by Subject|0
7660539|NCT01436500|26647969|P1|Overall Study|Withdrawal by Subject|0
7660540|NCT01436500|26647965|P5|Overall Study|Adverse Event|1
7660541|NCT01436500|26647966|P4|Overall Study|Adverse Event|0
7660542|NCT01436500|26647967|P3|Overall Study|Adverse Event|2
7660543|NCT01436500|26647968|P2|Overall Study|Adverse Event|2
7660544|NCT01436500|26647969|P1|Overall Study|Adverse Event|0
7660545|NCT01436500|26647965|P5|Overall Study|Death|0
7660546|NCT01436500|26647966|P4|Overall Study|Death|0
7660547|NCT01436500|26647967|P3|Overall Study|Death|0
7660548|NCT01436500|26647968|P2|Overall Study|Death|0
7660549|NCT01436500|26647969|P1|Overall Study|Death|1
7660550|NCT01436396|26648013|P2|Overall Study|Lost to Follow-up|3
7660551|NCT01436396|26648014|P1|Overall Study|Lost to Follow-up|3
7660552|NCT01436396|26648013|P2|Overall Study|Serious adverse event|3
7660553|NCT01436396|26648014|P1|Overall Study|Serious adverse event|2
7660554|NCT01436396|26648013|P2|Overall Study|Withdrawal by Subject|29
7660555|NCT01436396|26648014|P1|Overall Study|Withdrawal by Subject|19
7660556|NCT01436396|26648013|P2|Overall Study|Adverse Event|2
7660557|NCT01436396|26648014|P1|Overall Study|Adverse Event|1
7660558|NCT01436396|26648013|P2|Overall Study|Protocol Violation|5
7660559|NCT01436396|26648014|P1|Overall Study|Protocol Violation|7
7660560|NCT01436370|26648054|P8|Overall Study|Lost to Follow-up|0
7660561|NCT01436370|26648055|P7|Overall Study|Lost to Follow-up|0
7660562|NCT01436370|26648056|P6|Overall Study|Lost to Follow-up|0
7660563|NCT01436370|26648057|P5|Overall Study|Lost to Follow-up|1
7660564|NCT01436370|26648058|P4|Overall Study|Lost to Follow-up|0
7660565|NCT01436370|26648059|P3|Overall Study|Lost to Follow-up|0
7660566|NCT01436370|26648060|P2|Overall Study|Lost to Follow-up|0
7660567|NCT01436370|26648061|P1|Overall Study|Lost to Follow-up|0
7660568|NCT01436357|26648141|P2|Overall Study|Subject in rehab|1
7660569|NCT01436357|26648142|P1|Overall Study|Subject in rehab|0
7660570|NCT01436357|26648141|P2|Overall Study|Moved out of area|2
7660571|NCT01436357|26648142|P1|Overall Study|Moved out of area|1
7660572|NCT01436357|26648141|P2|Overall Study|Physician Decision|4
7660573|NCT01436357|26648142|P1|Overall Study|Physician Decision|3
7660574|NCT01436357|26648141|P2|Overall Study|Withdrawal by Subject|38
7660575|NCT01436357|26648142|P1|Overall Study|Withdrawal by Subject|26
7660576|NCT01436357|26648141|P2|Overall Study|Protocol Violation|0
7660577|NCT01436357|26648142|P1|Overall Study|Protocol Violation|1
7660578|NCT01436357|26648141|P2|Overall Study|Lost to Follow-up|61
7660579|NCT01436357|26648142|P1|Overall Study|Lost to Follow-up|67
7660580|NCT01436357|26648141|P2|Overall Study|Incarceration|20
7660581|NCT01436357|26648142|P1|Overall Study|Incarceration|18
7660582|NCT01436357|26648141|P2|Overall Study|Enrolled but not vaccinated|1
7660583|NCT01436357|26648142|P1|Overall Study|Enrolled but not vaccinated|1
7660584|NCT01436357|26648141|P2|Overall Study|Death|1
7660585|NCT01436357|26648142|P1|Overall Study|Death|5
7660586|NCT01436305|26648163|P3|Overall Study|Withdrawal by Subject|0
7660587|NCT01436305|26648164|P2|Overall Study|Withdrawal by Subject|3
7660588|NCT01436305|26648165|P1|Overall Study|Withdrawal by Subject|1
7660589|NCT01436305|26648163|P3|Overall Study|Lost to Follow-up|0
7660590|NCT01436305|26648164|P2|Overall Study|Lost to Follow-up|1
7660591|NCT01436305|26648165|P1|Overall Study|Lost to Follow-up|0
7660592|NCT01436305|26648163|P3|Overall Study|Death|0
7660593|NCT01436305|26648164|P2|Overall Study|Death|0
7660594|NCT01436305|26648165|P1|Overall Study|Death|1
7660595|NCT01436253|26648292|P1|Overall Study|Not meeting all eligibility criteria|117
7660596|NCT01436253|26648292|P1|Overall Study|Lost to Follow-up|182
7660597|NCT01436201|26648297|P1|Overall Study|Protocol Violation|1
7660598|NCT01436201|26648297|P1|Overall Study|Withdrawal by Subject|1
7660599|NCT01436201|26648297|P1|Overall Study|Adverse Event|2
7660600|NCT01436175|26648307|P1|Overall Study|Other|826
7660601|NCT01436175|26648307|P1|Overall Study|Met blood pressure or pulse withdrawal|63
7660602|NCT01436175|26648307|P1|Overall Study|Lack of Efficacy|24
7660603|NCT01436175|26648307|P1|Overall Study|Lost to Follow-up|89
7660604|NCT01436175|26648307|P1|Overall Study|Withdrawal by Subject|108
7660605|NCT01436175|26648307|P1|Overall Study|Protocol Violation|49
7660606|NCT01436175|26648307|P1|Overall Study|Adverse Event|111
7660607|NCT01436162|26648334|P3|Randomized Phase|Other|4
7660608|NCT01436162|26648335|P2|Randomized Phase|Other|5
7660609|NCT01436162|26648336|P1|Randomized Phase|Other|2
7660610|NCT01436162|26648334|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
7660611|NCT01436162|26648335|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7660612|NCT01436162|26648336|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
7660613|NCT01436162|26648334|P3|Randomized Phase|Lack of Efficacy|1
7660614|NCT01436162|26648335|P2|Randomized Phase|Lack of Efficacy|1
7660615|NCT01436162|26648336|P1|Randomized Phase|Lack of Efficacy|0
7660616|NCT01436162|26648334|P3|Randomized Phase|Lost to Follow-up|4
7660617|NCT01436162|26648335|P2|Randomized Phase|Lost to Follow-up|5
7660618|NCT01436162|26648336|P1|Randomized Phase|Lost to Follow-up|17
7660619|NCT01436162|26648334|P3|Randomized Phase|Withdrawal by Subject|8
7660620|NCT01436162|26648335|P2|Randomized Phase|Withdrawal by Subject|9
7660621|NCT01436162|26648336|P1|Randomized Phase|Withdrawal by Subject|16
7660622|NCT01436162|26648334|P3|Randomized Phase|Protocol Violation|2
7660623|NCT01436162|26648335|P2|Randomized Phase|Protocol Violation|4
7660624|NCT01436162|26648336|P1|Randomized Phase|Protocol Violation|4
7660625|NCT01436162|26648334|P3|Randomized Phase|Adverse Event|6
7660626|NCT01436162|26648335|P2|Randomized Phase|Adverse Event|5
7660627|NCT01436162|26648336|P1|Randomized Phase|Adverse Event|1
7660628|NCT01436162|26648334|P3|Single-blind Lead-in Phase|Other|0
7660629|NCT01436162|26648335|P2|Single-blind Lead-in Phase|Other|0
7660630|NCT01436162|26648336|P1|Single-blind Lead-in Phase|Other|107
7660631|NCT01436162|26648334|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660632|NCT01436162|26648335|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660633|NCT01436162|26648336|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
7660634|NCT01436162|26648334|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
7660635|NCT01436162|26648335|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
7660636|NCT01436162|26648336|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
7660637|NCT01436162|26648334|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
7660638|NCT01436162|26648335|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
7660639|NCT01436162|26648336|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
7660640|NCT01436162|26648334|P3|Single-blind Lead-in Phase|Protocol Violation|0
7660641|NCT01436162|26648335|P2|Single-blind Lead-in Phase|Protocol Violation|0
7660642|NCT01436162|26648336|P1|Single-blind Lead-in Phase|Protocol Violation|24
7660643|NCT01436162|26648334|P3|Single-blind Lead-in Phase|Adverse Event|0
7660644|NCT01436162|26648335|P2|Single-blind Lead-in Phase|Adverse Event|0
7660645|NCT01436162|26648336|P1|Single-blind Lead-in Phase|Adverse Event|26
7660646|NCT01436149|26648370|P3|Randomized Phase|Other|11
7660647|NCT01436149|26648371|P2|Randomized Phase|Other|5
7660648|NCT01436149|26648372|P1|Randomized Phase|Other|12
7660649|NCT01436149|26648370|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7660650|NCT01436149|26648371|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7660651|NCT01436149|26648372|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7660652|NCT01436149|26648370|P3|Randomized Phase|Lack of Efficacy|1
7660653|NCT01436149|26648371|P2|Randomized Phase|Lack of Efficacy|0
7660654|NCT01436149|26648372|P1|Randomized Phase|Lack of Efficacy|0
7660655|NCT01436149|26648370|P3|Randomized Phase|Lost to Follow-up|6
7660656|NCT01436149|26648371|P2|Randomized Phase|Lost to Follow-up|5
7660657|NCT01436149|26648372|P1|Randomized Phase|Lost to Follow-up|34
7660658|NCT01436149|26648370|P3|Randomized Phase|Withdrawal by Subject|10
7660659|NCT01436149|26648371|P2|Randomized Phase|Withdrawal by Subject|10
7660660|NCT01436149|26648372|P1|Randomized Phase|Withdrawal by Subject|16
7660661|NCT01436149|26648370|P3|Randomized Phase|Protocol Violation|0
7660662|NCT01436149|26648371|P2|Randomized Phase|Protocol Violation|5
7660663|NCT01436149|26648372|P1|Randomized Phase|Protocol Violation|4
7660664|NCT01436149|26648370|P3|Randomized Phase|Adverse Event|11
7660665|NCT01436149|26648371|P2|Randomized Phase|Adverse Event|10
7660666|NCT01436149|26648372|P1|Randomized Phase|Adverse Event|9
7660667|NCT01436149|26648370|P3|Antidepressant Lead-in Phase|Other|0
7660668|NCT01436149|26648371|P2|Antidepressant Lead-in Phase|Other|0
7660669|NCT01436149|26648372|P1|Antidepressant Lead-in Phase|Other|119
7660670|NCT01436149|26648370|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7660916|NCT01435031|26648925|P1|ITT at 4 Years|Lost to Follow-up|1
7660671|NCT01436149|26648371|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7660672|NCT01436149|26648372|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
7660673|NCT01436149|26648370|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660674|NCT01436149|26648371|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660675|NCT01436149|26648372|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
7660676|NCT01436149|26648370|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660677|NCT01436149|26648371|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660678|NCT01436149|26648372|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
7660679|NCT01436149|26648370|P3|Antidepressant Lead-in Phase|Protocol Violation|0
7660680|NCT01436149|26648371|P2|Antidepressant Lead-in Phase|Protocol Violation|0
7660681|NCT01436149|26648372|P1|Antidepressant Lead-in Phase|Protocol Violation|29
7660682|NCT01436149|26648370|P3|Antidepressant Lead-in Phase|Adverse Event|0
7660683|NCT01436149|26648371|P2|Antidepressant Lead-in Phase|Adverse Event|0
7660684|NCT01436149|26648372|P1|Antidepressant Lead-in Phase|Adverse Event|39
7660685|NCT01436110|26648403|P3|Overall Study|Did Not Receive Trial Medication|3
7660686|NCT01436110|26648404|P2|Overall Study|Did Not Receive Trial Medication|0
7660687|NCT01436110|26648405|P1|Overall Study|Did Not Receive Trial Medication|1
7660688|NCT01436110|26648403|P3|Overall Study|Protocol Violation|1
7660689|NCT01436110|26648404|P2|Overall Study|Protocol Violation|1
7660690|NCT01436110|26648405|P1|Overall Study|Protocol Violation|3
7660691|NCT01436110|26648403|P3|Overall Study|Lost to Follow-up|3
7660692|NCT01436110|26648404|P2|Overall Study|Lost to Follow-up|1
7660693|NCT01436110|26648405|P1|Overall Study|Lost to Follow-up|1
7660694|NCT01436110|26648403|P3|Overall Study|Physician Decision|1
7660695|NCT01436110|26648404|P2|Overall Study|Physician Decision|1
7660696|NCT01436110|26648405|P1|Overall Study|Physician Decision|3
7660697|NCT01436110|26648403|P3|Overall Study|Adverse Event|2
7660698|NCT01436110|26648404|P2|Overall Study|Adverse Event|1
7660699|NCT01436110|26648405|P1|Overall Study|Adverse Event|2
7660700|NCT01436110|26648403|P3|Overall Study|Withdrawal by Subject|4
7660701|NCT01436110|26648404|P2|Overall Study|Withdrawal by Subject|8
7660702|NCT01436110|26648405|P1|Overall Study|Withdrawal by Subject|6
7660703|NCT01436110|26648403|P3|Overall Study|Lack of Efficacy|9
7660704|NCT01436110|26648404|P2|Overall Study|Lack of Efficacy|14
7660705|NCT01436110|26648405|P1|Overall Study|Lack of Efficacy|23
7660706|NCT01436084|26648428|P1|Overall Study|Early Closure of Study|1
7660707|NCT01436084|26648428|P1|Overall Study|Withdrawal by Subject|1
7660708|NCT01436084|26648428|P1|Overall Study|Disease Progression|2
7660709|NCT01436071|26648434|P2|Overall Study|Did Not Receive Trial Medication|3
7660710|NCT01436071|26648435|P1|Overall Study|Did Not Receive Trial Medication|3
7660711|NCT01436071|26648434|P2|Overall Study|Withdrawal by Subject|2
7660712|NCT01436071|26648435|P1|Overall Study|Withdrawal by Subject|2
7660713|NCT01436071|26648434|P2|Overall Study|Physician Decision|0
7660714|NCT01436071|26648435|P1|Overall Study|Physician Decision|1
7660715|NCT01436071|26648434|P2|Overall Study|Lost to Follow-up|1
7660716|NCT01436071|26648435|P1|Overall Study|Lost to Follow-up|3
7660717|NCT01436071|26648434|P2|Overall Study|Protocol Violation|1
7660718|NCT01436071|26648435|P1|Overall Study|Protocol Violation|0
7660719|NCT01436071|26648434|P2|Overall Study|Lack of Efficacy|7
7660720|NCT01436071|26648435|P1|Overall Study|Lack of Efficacy|16
7660721|NCT01436071|26648434|P2|Overall Study|Adverse Event|0
7660722|NCT01436071|26648435|P1|Overall Study|Adverse Event|1
7660723|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Administrative|2
7660724|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Administrative|5
7660725|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Administrative|0
7660726|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
7660727|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
7660728|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
7660729|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
7660730|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
7660731|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
7660732|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
7660733|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
7660734|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
7660735|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
7660736|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
7660737|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
7660738|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
7660739|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
7660740|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
7660741|NCT01435928|26648477|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
7660742|NCT01435928|26648478|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
7660743|NCT01435928|26648479|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
7660744|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Administrative|0
7660745|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Administrative|0
7660746|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Administrative|14
7660747|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7660748|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7660749|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
7660750|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7660751|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7660752|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
7660753|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7660754|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7660755|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
7660756|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7660757|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7660758|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
7660759|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7660760|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7660761|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
7660762|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7660763|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7660764|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
7660765|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Death|0
7660766|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Death|0
7660767|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Death|1
7660768|NCT01435928|26648477|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
7660769|NCT01435928|26648478|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
7660770|NCT01435928|26648479|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
7660771|NCT01435798|26648525|P1|Overall Study|Withdrawal by Subject|1
7660772|NCT01435772|26648542|P3|Overall Study|Other - study termination|10
7660773|NCT01435772|26648543|P2|Overall Study|Other - study termination|2
7660774|NCT01435772|26648544|P1|Overall Study|Other - study termination|2
7660775|NCT01435772|26648542|P3|Overall Study|Withdrawal by Subject|3
7660776|NCT01435772|26648543|P2|Overall Study|Withdrawal by Subject|1
7660777|NCT01435772|26648544|P1|Overall Study|Withdrawal by Subject|0
7660778|NCT01435772|26648542|P3|Overall Study|Adverse Event|2
7660779|NCT01435772|26648543|P2|Overall Study|Adverse Event|0
7660780|NCT01435772|26648544|P1|Overall Study|Adverse Event|1
7660781|NCT01435759|26648594|P6|Double-blind Phase|Other|0
7660782|NCT01435759|26648595|P5|Double-blind Phase|Other|0
7660783|NCT01435759|26648596|P4|Double-blind Phase|Other|2
7660784|NCT01435759|26648597|P3|Double-blind Phase|Other|0
7660785|NCT01435759|26648598|P2|Double-blind Phase|Other|2
7660786|NCT01435759|26648599|P1|Double-blind Phase|Other|8
7660787|NCT01435759|26648594|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7660788|NCT01435759|26648595|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
7660789|NCT01435759|26648596|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7660790|NCT01435759|26648597|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7660791|NCT01435759|26648598|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7660792|NCT01435759|26648599|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
7660793|NCT01435759|26648594|P6|Double-blind Phase|Lost to Follow-up|3
7660794|NCT01435759|26648595|P5|Double-blind Phase|Lost to Follow-up|3
7660795|NCT01435759|26648596|P4|Double-blind Phase|Lost to Follow-up|0
7660796|NCT01435759|26648597|P3|Double-blind Phase|Lost to Follow-up|2
7660797|NCT01435759|26648598|P2|Double-blind Phase|Lost to Follow-up|1
7660798|NCT01435759|26648599|P1|Double-blind Phase|Lost to Follow-up|31
7660799|NCT01435759|26648594|P6|Double-blind Phase|Withdrawal by Subject|2
7660800|NCT01435759|26648595|P5|Double-blind Phase|Withdrawal by Subject|2
7660801|NCT01435759|26648596|P4|Double-blind Phase|Withdrawal by Subject|4
7660802|NCT01435759|26648597|P3|Double-blind Phase|Withdrawal by Subject|3
7660803|NCT01435759|26648598|P2|Double-blind Phase|Withdrawal by Subject|4
7660804|NCT01435759|26648599|P1|Double-blind Phase|Withdrawal by Subject|17
7660805|NCT01435759|26648594|P6|Double-blind Phase|Protocol Violation|1
7660806|NCT01435759|26648595|P5|Double-blind Phase|Protocol Violation|0
7660807|NCT01435759|26648596|P4|Double-blind Phase|Protocol Violation|2
7660808|NCT01435759|26648597|P3|Double-blind Phase|Protocol Violation|1
7660809|NCT01435759|26648598|P2|Double-blind Phase|Protocol Violation|0
7660810|NCT01435759|26648599|P1|Double-blind Phase|Protocol Violation|2
7660811|NCT01435759|26648594|P6|Double-blind Phase|Adverse Event|3
7660812|NCT01435759|26648595|P5|Double-blind Phase|Adverse Event|1
7660813|NCT01435759|26648596|P4|Double-blind Phase|Adverse Event|1
7660814|NCT01435759|26648597|P3|Double-blind Phase|Adverse Event|1
7660815|NCT01435759|26648598|P2|Double-blind Phase|Adverse Event|0
7660816|NCT01435759|26648599|P1|Double-blind Phase|Adverse Event|7
7660817|NCT01435759|26648594|P6|Antidepressant Lead-in Phase|Other|0
7660818|NCT01435759|26648595|P5|Antidepressant Lead-in Phase|Other|0
7660819|NCT01435759|26648596|P4|Antidepressant Lead-in Phase|Other|0
7660820|NCT01435759|26648597|P3|Antidepressant Lead-in Phase|Other|0
7660821|NCT01435759|26648598|P2|Antidepressant Lead-in Phase|Other|0
7660822|NCT01435759|26648599|P1|Antidepressant Lead-in Phase|Other|119
7660823|NCT01435759|26648594|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660824|NCT01435759|26648595|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660825|NCT01435759|26648596|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660826|NCT01435759|26648597|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660827|NCT01435759|26648598|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7660828|NCT01435759|26648599|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
7660829|NCT01435759|26648594|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660830|NCT01435759|26648595|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660831|NCT01435759|26648596|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660832|NCT01435759|26648597|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660833|NCT01435759|26648598|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
7660834|NCT01435759|26648599|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
7660835|NCT01435759|26648594|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660836|NCT01435759|26648595|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660837|NCT01435759|26648596|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660838|NCT01435759|26648597|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660839|NCT01435759|26648598|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7660840|NCT01435759|26648599|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
7660841|NCT01435759|26648594|P6|Antidepressant Lead-in Phase|Protocol Violation|0
7660842|NCT01435759|26648595|P5|Antidepressant Lead-in Phase|Protocol Violation|0
7660843|NCT01435759|26648596|P4|Antidepressant Lead-in Phase|Protocol Violation|0
7660844|NCT01435759|26648597|P3|Antidepressant Lead-in Phase|Protocol Violation|0
7660845|NCT01435759|26648598|P2|Antidepressant Lead-in Phase|Protocol Violation|0
7660846|NCT01435759|26648599|P1|Antidepressant Lead-in Phase|Protocol Violation|16
7660847|NCT01435759|26648594|P6|Antidepressant Lead-in Phase|Adverse Event|0
7660848|NCT01435759|26648595|P5|Antidepressant Lead-in Phase|Adverse Event|0
7660849|NCT01435759|26648596|P4|Antidepressant Lead-in Phase|Adverse Event|0
7660850|NCT01435759|26648597|P3|Antidepressant Lead-in Phase|Adverse Event|0
7660851|NCT01435759|26648598|P2|Antidepressant Lead-in Phase|Adverse Event|0
7660852|NCT01435759|26648599|P1|Antidepressant Lead-in Phase|Adverse Event|40
7660853|NCT01435655|26648626|P1|Overall Study|Other|1
7660854|NCT01435655|26648626|P1|Overall Study|Death|2
7660855|NCT01435616|26648640|P2|Overall Study|Sponsor Decision|0
7660856|NCT01435616|26648641|P1|Overall Study|Sponsor Decision|1
7660857|NCT01435616|26648640|P2|Overall Study|Physician Decision|7
7660858|NCT01435616|26648641|P1|Overall Study|Physician Decision|20
7660859|NCT01435616|26648640|P2|Overall Study|Withdrawal by Subject|24
7660860|NCT01435616|26648641|P1|Overall Study|Withdrawal by Subject|66
7660861|NCT01435616|26648640|P2|Overall Study|Protocol Violation|13
7660862|NCT01435616|26648641|P1|Overall Study|Protocol Violation|16
7660863|NCT01435616|26648640|P2|Overall Study|Lost to Follow-up|13
7660864|NCT01435616|26648641|P1|Overall Study|Lost to Follow-up|22
7660865|NCT01435616|26648640|P2|Overall Study|Death|2
7660866|NCT01435616|26648641|P1|Overall Study|Death|7
7660867|NCT01435616|26648640|P2|Overall Study|Adverse Event|21
7660868|NCT01435616|26648641|P1|Overall Study|Adverse Event|39
7660869|NCT01435577|26648696|P2|Overall Study|Alternative treatment started|1
7660870|NCT01435577|26648697|P1|Overall Study|Alternative treatment started|0
7660871|NCT01435577|26648696|P2|Overall Study|Lack of Efficacy|51
7660872|NCT01435577|26648697|P1|Overall Study|Lack of Efficacy|7
7660873|NCT01435577|26648696|P2|Overall Study|Adverse Event|0
7660874|NCT01435577|26648697|P1|Overall Study|Adverse Event|10
7660875|NCT01435460|26648758|P2|Overall Study|Did not meet eligibility criteria|0
7660876|NCT01435460|26648759|P1|Overall Study|Did not meet eligibility criteria|2
7660877|NCT01435460|26648758|P2|Overall Study|Protocol Violation|1
7660878|NCT01435460|26648759|P1|Overall Study|Protocol Violation|0
7660879|NCT01435460|26648758|P2|Overall Study|Withdrawal by Subject|3
7660880|NCT01435460|26648759|P1|Overall Study|Withdrawal by Subject|1
7660881|NCT01435460|26648758|P2|Overall Study|Lost to Follow-up|1
7660882|NCT01435460|26648759|P1|Overall Study|Lost to Follow-up|6
7660883|NCT01435460|26648758|P2|Overall Study|Adverse Event|1
7660884|NCT01435460|26648759|P1|Overall Study|Adverse Event|2
7660885|NCT01435382|26648775|P4|Overall Study|Withdrawal by Subject|1
7660886|NCT01435382|26648776|P3|Overall Study|Withdrawal by Subject|0
7660887|NCT01435382|26648777|P2|Overall Study|Withdrawal by Subject|2
7660888|NCT01435382|26648778|P1|Overall Study|Withdrawal by Subject|0
7660889|NCT01435382|26648775|P4|Overall Study|Lost to Follow-up|0
7660890|NCT01435382|26648776|P3|Overall Study|Lost to Follow-up|1
7660891|NCT01435382|26648777|P2|Overall Study|Lost to Follow-up|0
7660892|NCT01435382|26648778|P1|Overall Study|Lost to Follow-up|1
7660893|NCT01435356|26648867|P2|Overall Study|Patient moved to another city|1
7660894|NCT01435356|26648868|P1|Overall Study|Patient moved to another city|1
7660895|NCT01435356|26648867|P2|Overall Study|Patient decision|0
7660896|NCT01435356|26648868|P1|Overall Study|Patient decision|3
7660897|NCT01435356|26648867|P2|Overall Study|Physician Decision|0
7660898|NCT01435356|26648868|P1|Overall Study|Physician Decision|1
7660899|NCT01435356|26648867|P2|Overall Study|IC withdrawal due to study cancellation|0
7660900|NCT01435356|26648868|P1|Overall Study|IC withdrawal due to study cancellation|1
7660901|NCT01435356|26648867|P2|Overall Study|Facial palsy|0
7660902|NCT01435356|26648868|P1|Overall Study|Facial palsy|1
7660903|NCT01435356|26648867|P2|Overall Study|Withdrawal by Subject|1
7660904|NCT01435356|26648868|P1|Overall Study|Withdrawal by Subject|1
7660905|NCT01435356|26648867|P2|Overall Study|Study Discontinuation, amendment 4|11
7660906|NCT01435356|26648868|P1|Overall Study|Study Discontinuation, amendment 4|5
7660907|NCT01435356|26648867|P2|Overall Study|Protocol Violation|1
7660908|NCT01435356|26648868|P1|Overall Study|Protocol Violation|0
7660909|NCT01435356|26648867|P2|Overall Study|Disease progression/recurrence|10
7660910|NCT01435356|26648868|P1|Overall Study|Disease progression/recurrence|17
7660911|NCT01435356|26648867|P2|Overall Study|Adverse Event|0
7660912|NCT01435356|26648868|P1|Overall Study|Adverse Event|2
7660913|NCT01435265|26648901|P2|Overall Study|Lost to Follow-up|1
7660914|NCT01435265|26648902|P1|Overall Study|Lost to Follow-up|0
7660915|NCT01435122|26648916|P1|Overall Study|Early withdrawal due to toxicity|8
7660917|NCT01435031|26648925|P1|ITT at 4 Years|Withdrawal by Subject|2
7660918|NCT01435031|26648925|P1|ITT at 4 Years|Death|4
7660919|NCT01435031|26648925|P1|ITT at 3 Years|Lost to Follow-up|4
7660920|NCT01435031|26648925|P1|ITT at 3 Years|Withdrawal by Subject|2
7660921|NCT01435031|26648925|P1|ITT at 3 Years|Death|5
7660922|NCT01435031|26648925|P1|ITT at 2 Years|Lost to Follow-up|4
7660923|NCT01435031|26648925|P1|ITT at 2 Years|Withdrawal by Subject|2
7660924|NCT01435031|26648925|P1|ITT at 2 Years|Death|7
7660925|NCT01435031|26648925|P1|ITT at 1 Year|Lost to Follow-up|6
7660926|NCT01435031|26648925|P1|ITT at 1 Year|Withdrawal by Subject|2
7660927|NCT01435031|26648925|P1|ITT at 1 Year|Death|1
7660928|NCT01435031|26648925|P1|ITT at 6 Months|Lost to Follow-up|3
7660929|NCT01435031|26648925|P1|ITT at 6 Months|Death|2
7660930|NCT01435031|26648925|P1|ITT at 1 Month|Lost to Follow-up|4
7660931|NCT01435031|26648925|P1|ITT at 1 Month|Death|1
7660932|NCT01435031|26648925|P1|ITT at 1 Month|Withdrawal by Subject|1
7660960|NCT01434823|26649121|P2|Overall Study|Incomplete data in medical record|7
7660961|NCT01434823|26649122|P1|Overall Study|Incomplete data in medical record|4
7660962|NCT01434810|26649140|P2|Overall Study|Missing data/received <5hr phototherapy|7
7660963|NCT01434810|26649141|P1|Overall Study|Missing data/received <5hr phototherapy|12
7660964|NCT01434810|26649140|P2|Overall Study|Did not receive treatment|3
7660965|NCT01434810|26649141|P1|Overall Study|Did not receive treatment|11
7660966|NCT01434693|26649176|P4|Overall Study|Lost to Follow-up|0
7660967|NCT01434693|26649177|P3|Overall Study|Lost to Follow-up|0
7660968|NCT01434693|26649178|P2|Overall Study|Lost to Follow-up|0
7660969|NCT01434693|26649179|P1|Overall Study|Lost to Follow-up|1
7660970|NCT01434693|26649176|P4|Overall Study|Withdrawal by Subject|1
7660971|NCT01434693|26649177|P3|Overall Study|Withdrawal by Subject|1
7660972|NCT01434693|26649178|P2|Overall Study|Withdrawal by Subject|0
7660973|NCT01434693|26649179|P1|Overall Study|Withdrawal by Subject|1
7660974|NCT01434693|26649176|P4|Overall Study|Adverse Event|0
7660975|NCT01434693|26649177|P3|Overall Study|Adverse Event|0
7660976|NCT01434693|26649178|P2|Overall Study|Adverse Event|0
7660977|NCT01434693|26649179|P1|Overall Study|Adverse Event|1
7660978|NCT01434680|26649193|P4|Overall Study|Protocol Violation|0
7660979|NCT01434680|26649194|P3|Overall Study|Protocol Violation|0
7660980|NCT01434680|26649195|P2|Overall Study|Protocol Violation|1
7660981|NCT01434680|26649196|P1|Overall Study|Protocol Violation|1
7660982|NCT01434680|26649193|P4|Overall Study|Lost to Follow-up|0
7660983|NCT01434680|26649194|P3|Overall Study|Lost to Follow-up|0
7660984|NCT01434680|26649195|P2|Overall Study|Lost to Follow-up|1
7660985|NCT01434680|26649196|P1|Overall Study|Lost to Follow-up|1
7660986|NCT01434680|26649193|P4|Overall Study|Withdrawal by Subject|0
7660987|NCT01434680|26649194|P3|Overall Study|Withdrawal by Subject|2
7660988|NCT01434680|26649195|P2|Overall Study|Withdrawal by Subject|0
7660989|NCT01434680|26649196|P1|Overall Study|Withdrawal by Subject|1
7660990|NCT01434667|26649213|P2|Overall Study|Lost to Follow-up|10
7660991|NCT01434667|26649214|P1|Overall Study|Lost to Follow-up|5
7660992|NCT01434654|26649240|P2|Overall Study|Lost to Follow-up|0
7660993|NCT01434654|26649241|P1|Overall Study|Lost to Follow-up|1
7660994|NCT01434654|26649240|P2|Overall Study|Withdrawal by Subject|0
7660995|NCT01434654|26649241|P1|Overall Study|Withdrawal by Subject|1
7660996|NCT01434290|26649298|P2|Overall Study|No protocol treatment|4
7660997|NCT01434290|26649299|P1|Overall Study|No protocol treatment|2
7660998|NCT01434290|26649298|P2|Overall Study|Protocol Violation|3
7660999|NCT01434290|26649299|P1|Overall Study|Protocol Violation|6
7661000|NCT01433991|26649376|P4|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7661001|NCT01433991|26649377|P3|Treatment Phase (Combination Agent)|Terminated by sponsor|1
7661002|NCT01433991|26649378|P2|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7661003|NCT01433991|26649379|P1|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7661004|NCT01433991|26649376|P4|Treatment Phase (Combination Agent)|Progressive disease|0
7661005|NCT01433991|26649377|P3|Treatment Phase (Combination Agent)|Progressive disease|0
7661006|NCT01433991|26649378|P2|Treatment Phase (Combination Agent)|Progressive disease|0
7661007|NCT01433991|26649379|P1|Treatment Phase (Combination Agent)|Progressive disease|1
7661008|NCT01433991|26649376|P4|Treatment Phase (Combination Agent)|Clinical progression|3
7661009|NCT01433991|26649377|P3|Treatment Phase (Combination Agent)|Clinical progression|2
7661010|NCT01433991|26649378|P2|Treatment Phase (Combination Agent)|Clinical progression|1
7661011|NCT01433991|26649379|P1|Treatment Phase (Combination Agent)|Clinical progression|0
7661012|NCT01433991|26649376|P4|Treatment Phase (Combination Agent)|Participant Choice|1
7661013|NCT01433991|26649377|P3|Treatment Phase (Combination Agent)|Participant Choice|0
7661014|NCT01433991|26649378|P2|Treatment Phase (Combination Agent)|Participant Choice|0
7661015|NCT01433991|26649379|P1|Treatment Phase (Combination Agent)|Participant Choice|0
7661016|NCT01433991|26649376|P4|Treatment Phase (Combination Agent)|Lost to Follow-up|1
7661017|NCT01433991|26649377|P3|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7661018|NCT01433991|26649378|P2|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7661019|NCT01433991|26649379|P1|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7661020|NCT01433991|26649376|P4|Treatment Phase (Combination Agent)|Adverse Event|1
7661021|NCT01433991|26649377|P3|Treatment Phase (Combination Agent)|Adverse Event|3
7661022|NCT01433991|26649378|P2|Treatment Phase (Combination Agent)|Adverse Event|0
7661023|NCT01433991|26649379|P1|Treatment Phase (Combination Agent)|Adverse Event|1
7661024|NCT01433991|26649376|P4|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7661025|NCT01433991|26649377|P3|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7661026|NCT01433991|26649378|P2|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7661027|NCT01433991|26649379|P1|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
7661028|NCT01433978|26649521|P3|Extension Phase|Study Terminated by Sponsor|4
7661029|NCT01433978|26649522|P2|Extension Phase|Study Terminated by Sponsor|0
7661030|NCT01433978|26649523|P1|Extension Phase|Study Terminated by Sponsor|0
7661031|NCT01433978|26649521|P3|Extension Phase|Lack of Efficacy|1
7661032|NCT01433978|26649522|P2|Extension Phase|Lack of Efficacy|0
7661033|NCT01433978|26649523|P1|Extension Phase|Lack of Efficacy|0
7661034|NCT01433978|26649521|P3|Extension Phase|Adverse Event, Non-Fatal|1
7661035|NCT01433978|26649522|P2|Extension Phase|Adverse Event, Non-Fatal|0
7661036|NCT01433978|26649523|P1|Extension Phase|Adverse Event, Non-Fatal|0
7661037|NCT01433978|26649521|P3|Core Study|Study Terminated by Sponsor|0
7661038|NCT01433978|26649522|P2|Core Study|Study Terminated by Sponsor|9
7661039|NCT01433978|26649523|P1|Core Study|Study Terminated by Sponsor|6
7661040|NCT01433978|26649521|P3|Core Study|Lack of Efficacy|0
7661041|NCT01433978|26649522|P2|Core Study|Lack of Efficacy|1
7661042|NCT01433978|26649523|P1|Core Study|Lack of Efficacy|5
7661043|NCT01433978|26649521|P3|Core Study|Adverse Event, Non-Fatal|0
7661044|NCT01433978|26649522|P2|Core Study|Adverse Event, Non-Fatal|1
7661045|NCT01433978|26649523|P1|Core Study|Adverse Event, Non-Fatal|0
7661046|NCT01433549|26649580|P2|Phase 2: Second Study Product|Adverse Event|1
7661047|NCT01433549|26649581|P1|Phase 2: Second Study Product|Adverse Event|0
7661048|NCT01433471|26649591|P2|Overall Study|Withdrawal by Subject|1
7661049|NCT01433471|26649592|P1|Overall Study|Withdrawal by Subject|0
7661050|NCT01433354|26649608|P1|Overall Study|Subject Withdrew Consent|3
7661051|NCT01433354|26649608|P1|Overall Study|Lack of Efficacy|17
7661052|NCT01433354|26649608|P1|Overall Study|Protocol Violation|2
7661053|NCT01433354|26649608|P1|Overall Study|Administrative problems|90
7661054|NCT01433354|26649608|P1|Overall Study|Lost to Follow-up|1
7661055|NCT01433354|26649608|P1|Overall Study|Adverse Event|6
7661056|NCT01433263|26649624|P2|Overall Study|Withdrawal by Subject|7
7661057|NCT01433263|26649625|P1|Overall Study|Withdrawal by Subject|10
7661058|NCT01433263|26649624|P2|Overall Study|Protocol Deviation|0
7661059|NCT01433263|26649625|P1|Overall Study|Protocol Deviation|1
7661060|NCT01433263|26649624|P2|Overall Study|Lost to Follow-up|1
7661061|NCT01433263|26649625|P1|Overall Study|Lost to Follow-up|0
7661062|NCT01433263|26649624|P2|Overall Study|Death|3
7661063|NCT01433263|26649625|P1|Overall Study|Death|5
7661064|NCT01433263|26649624|P2|Overall Study|Adverse Event|1
7661065|NCT01433263|26649625|P1|Overall Study|Adverse Event|3
7661066|NCT01433250|26649654|P2|Overall Study|Withdrawal by Subject|2
7661067|NCT01433250|26649655|P1|Overall Study|Withdrawal by Subject|3
7661068|NCT01433250|26649654|P2|Overall Study|Protocol Violation|1
7661069|NCT01433250|26649655|P1|Overall Study|Protocol Violation|0
7661070|NCT01433172|26649674|P3|Overall Study|Death|0
7661071|NCT01433172|26649675|P2|Overall Study|Death|2
7661072|NCT01433172|26649676|P1|Overall Study|Death|0
7661073|NCT01433172|26649674|P3|Overall Study|Disease Progression|1
7661074|NCT01433172|26649675|P2|Overall Study|Disease Progression|0
7661075|NCT01433172|26649676|P1|Overall Study|Disease Progression|0
7661076|NCT01433172|26649674|P3|Overall Study|Withdrawal by Subject|0
7661077|NCT01433172|26649675|P2|Overall Study|Withdrawal by Subject|1
7661078|NCT01433172|26649676|P1|Overall Study|Withdrawal by Subject|0
7661079|NCT01433159|26649688|P2|Overall Study|Protocol Violation|1
7661080|NCT01433159|26649689|P1|Overall Study|Protocol Violation|0
7661081|NCT01433159|26649688|P2|Overall Study|Physician Decision|0
7661082|NCT01433159|26649689|P1|Overall Study|Physician Decision|1
7661083|NCT01433159|26649688|P2|Overall Study|Adverse Event|0
7661084|NCT01433159|26649689|P1|Overall Study|Adverse Event|1
7661085|NCT01433055|26649721|P2|Overall Study|Severely elevated triglycerides at entry|0
7661086|NCT01433055|26649722|P1|Overall Study|Severely elevated triglycerides at entry|1
7661087|NCT01433055|26649721|P2|Overall Study|Diagnosed with cancer unrelated to study|0
7661088|NCT01433055|26649722|P1|Overall Study|Diagnosed with cancer unrelated to study|1
7661089|NCT01432951|26649744|P1|Treatment Phase (Day 1 to 30)|Never Treated|1
7661090|NCT01432938|26649753|P2|Second Intervention|Adverse Event|0
7661091|NCT01432938|26649754|P1|Second Intervention|Adverse Event|1
7661092|NCT01432938|26649753|P2|First Intervention|Physician Decision|0
7661093|NCT01432938|26649754|P1|First Intervention|Physician Decision|1
7661094|NCT01432938|26649753|P2|First Intervention|Protocol Violation|0
7661095|NCT01432938|26649754|P1|First Intervention|Protocol Violation|1
7661096|NCT01432756|26649784|P4|Overall Study|Lost to Follow-up|1
7661097|NCT01432756|26649785|P3|Overall Study|Lost to Follow-up|2
7661098|NCT01432756|26649786|P2|Overall Study|Lost to Follow-up|0
7661099|NCT01432756|26649787|P1|Overall Study|Lost to Follow-up|1
7661100|NCT01432730|26649795|P2|Period 2|Adverse Event|4
7661101|NCT01432730|26649796|P1|Period 2|Adverse Event|0
7661102|NCT01432730|26649795|P2|Period 1|Adverse Event|0
7661103|NCT01432730|26649796|P1|Period 1|Adverse Event|2
7661104|NCT01432626|26649832|P1|Overall Study|Imaging agent not available|1
7661105|NCT01432626|26649832|P1|Overall Study|Only 1 image competed|2
7661106|NCT01432626|26649832|P1|Overall Study|Withdrawal by Subject|2
7661107|NCT01432626|26649832|P1|Overall Study|LV function recovered|2
7661108|NCT01432600|26649839|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
7661109|NCT01432600|26649840|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
7661110|NCT01432600|26649841|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
7661111|NCT01432574|26649857|P1|Overall Study|Not interested|1
7661112|NCT01432574|26649857|P1|Overall Study|Moved|2
7661113|NCT01432457|26649903|P3|Overall Study|Did not take study drug|3
7661114|NCT01432457|26649904|P2|Overall Study|Did not take study drug|6
7661115|NCT01432457|26649905|P1|Overall Study|Did not take study drug|6
7661116|NCT01432457|26649903|P3|Overall Study|Reasons not defined|4
7661117|NCT01432457|26649904|P2|Overall Study|Reasons not defined|3
7661118|NCT01432457|26649905|P1|Overall Study|Reasons not defined|2
7661119|NCT01432457|26649903|P3|Overall Study|Withdrawal by Subject|9
7661120|NCT01432457|26649904|P2|Overall Study|Withdrawal by Subject|11
7661121|NCT01432457|26649905|P1|Overall Study|Withdrawal by Subject|6
7661122|NCT01432457|26649903|P3|Overall Study|Protocol Violation|6
7661123|NCT01432457|26649904|P2|Overall Study|Protocol Violation|2
7661124|NCT01432457|26649905|P1|Overall Study|Protocol Violation|3
7661125|NCT01432457|26649903|P3|Overall Study|Lost to Follow-up|20
7661126|NCT01432457|26649904|P2|Overall Study|Lost to Follow-up|15
7661127|NCT01432457|26649905|P1|Overall Study|Lost to Follow-up|11
7661128|NCT01432457|26649903|P3|Overall Study|Lack of Efficacy|1
7661129|NCT01432457|26649904|P2|Overall Study|Lack of Efficacy|1
7661130|NCT01432457|26649905|P1|Overall Study|Lack of Efficacy|2
7661131|NCT01432457|26649903|P3|Overall Study|Adverse Event|16
7661132|NCT01432457|26649904|P2|Overall Study|Adverse Event|10
7661133|NCT01432457|26649905|P1|Overall Study|Adverse Event|7
7661134|NCT01432444|26649934|P3|Extension Phase|Withdrawal by Subject|13
7661135|NCT01432444|26649935|P2|Extension Phase|Withdrawal by Subject|0
7661136|NCT01432444|26649936|P1|Extension Phase|Withdrawal by Subject|0
7661137|NCT01432444|26649934|P3|Extension Phase|Physician Decision|1
7661138|NCT01432444|26649935|P2|Extension Phase|Physician Decision|0
7661139|NCT01432444|26649936|P1|Extension Phase|Physician Decision|0
7661140|NCT01432444|26649934|P3|Extension Phase|Met Withdrawal Criteria|144
7661141|NCT01432444|26649935|P2|Extension Phase|Met Withdrawal Criteria|0
7661142|NCT01432444|26649936|P1|Extension Phase|Met Withdrawal Criteria|0
7661143|NCT01432444|26649934|P3|Extension Phase|Sponsor Discontinued Trial|7
7661144|NCT01432444|26649935|P2|Extension Phase|Sponsor Discontinued Trial|0
7661145|NCT01432444|26649936|P1|Extension Phase|Sponsor Discontinued Trial|0
7661146|NCT01432444|26649934|P3|Extension Phase|Adverse Event|10
7661147|NCT01432444|26649935|P2|Extension Phase|Adverse Event|0
7661148|NCT01432444|26649936|P1|Extension Phase|Adverse Event|0
7661149|NCT01432444|26649934|P3|Extension Phase|Lost to Follow-up|17
7661150|NCT01432444|26649935|P2|Extension Phase|Lost to Follow-up|0
7661151|NCT01432444|26649936|P1|Extension Phase|Lost to Follow-up|0
7661152|NCT01432444|26649934|P3|Treatment Phase|Lack of Efficacy|0
7661153|NCT01432444|26649935|P2|Treatment Phase|Lack of Efficacy|10
7661154|NCT01432444|26649936|P1|Treatment Phase|Lack of Efficacy|0
7661155|NCT01432444|26649934|P3|Treatment Phase|Protocol Deviation|0
7661156|NCT01432444|26649935|P2|Treatment Phase|Protocol Deviation|3
7661157|NCT01432444|26649936|P1|Treatment Phase|Protocol Deviation|0
7661158|NCT01432444|26649934|P3|Treatment Phase|Withdrawal by Subject|0
7661159|NCT01432444|26649935|P2|Treatment Phase|Withdrawal by Subject|41
7661160|NCT01432444|26649936|P1|Treatment Phase|Withdrawal by Subject|0
7661161|NCT01432444|26649934|P3|Treatment Phase|Physician Decision|0
7661162|NCT01432444|26649935|P2|Treatment Phase|Physician Decision|5
7661163|NCT01432444|26649936|P1|Treatment Phase|Physician Decision|0
7661164|NCT01432444|26649934|P3|Treatment Phase|Met Withdrawal Criteria|0
7661165|NCT01432444|26649935|P2|Treatment Phase|Met Withdrawal Criteria|11
7661166|NCT01432444|26649936|P1|Treatment Phase|Met Withdrawal Criteria|0
7661167|NCT01432444|26649934|P3|Treatment Phase|Adverse Event|0
7661168|NCT01432444|26649935|P2|Treatment Phase|Adverse Event|37
7661169|NCT01432444|26649936|P1|Treatment Phase|Adverse Event|0
7661170|NCT01432444|26649934|P3|Treatment Phase|Lost to Follow-up|0
7661171|NCT01432444|26649935|P2|Treatment Phase|Lost to Follow-up|33
7661172|NCT01432444|26649936|P1|Treatment Phase|Lost to Follow-up|0
7661173|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7661174|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7661175|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
7661176|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
7661177|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
7661178|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
7661179|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7661180|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7661181|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
7661182|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Physician Decision|0
7661183|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Physician Decision|0
7661184|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Physician Decision|8
7661185|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7661186|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7661187|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
7661188|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Adverse Event|0
7661189|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Adverse Event|0
7661190|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Adverse Event|16
7661191|NCT01432444|26649934|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7661192|NCT01432444|26649935|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7661193|NCT01432444|26649936|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
7661194|NCT01432366|26649962|P1|Overall Study|Other|14
7661195|NCT01432366|26649962|P1|Overall Study|Investigator Forget to Complete Visits|1
7661196|NCT01432366|26649962|P1|Overall Study|Site Closed|20
7661197|NCT01432366|26649962|P1|Overall Study|Lack of Efficacy|1
7661198|NCT01432366|26649962|P1|Overall Study|Lost to Follow-up|13
7661199|NCT01432366|26649962|P1|Overall Study|Pregnancy|1
7661200|NCT01432366|26649962|P1|Overall Study|Withdrawal Due to Non-Compliance|3
7661201|NCT01432366|26649962|P1|Overall Study|Adverse Event|8
7661202|NCT01432366|26649962|P1|Overall Study|Non-Responder|7
7661203|NCT01432327|26649984|P4|Posttest 1 Year|Allergic reaction|1
7661204|NCT01432327|26649985|P3|Posttest 1 Year|Allergic reaction|1
7661205|NCT01432327|26649986|P2|Posttest 1 Year|Allergic reaction|0
7661206|NCT01432327|26649987|P1|Posttest 1 Year|Allergic reaction|0
7661207|NCT01432327|26649984|P4|Posttest 1 Year|Lost to Follow-up|2
7661208|NCT01432327|26649985|P3|Posttest 1 Year|Lost to Follow-up|4
7661209|NCT01432327|26649986|P2|Posttest 1 Year|Lost to Follow-up|0
7661210|NCT01432327|26649987|P1|Posttest 1 Year|Lost to Follow-up|0
7661211|NCT01432327|26649984|P4|Posttest 1 Year|Measurement have to take place in future|20
7661212|NCT01432327|26649985|P3|Posttest 1 Year|Measurement have to take place in future|15
7661213|NCT01432327|26649986|P2|Posttest 1 Year|Measurement have to take place in future|28
7661214|NCT01432327|26649987|P1|Posttest 1 Year|Measurement have to take place in future|24
7661215|NCT01432327|26649984|P4|Posttest 6 Months|Withdrawal by Subject|0
7661216|NCT01432327|26649985|P3|Posttest 6 Months|Withdrawal by Subject|1
7661217|NCT01432327|26649986|P2|Posttest 6 Months|Withdrawal by Subject|0
7661218|NCT01432327|26649987|P1|Posttest 6 Months|Withdrawal by Subject|0
7661219|NCT01432327|26649984|P4|Posttest 6 Months|Allergic reaction|0
7661220|NCT01432327|26649985|P3|Posttest 6 Months|Allergic reaction|1
7661221|NCT01432327|26649986|P2|Posttest 6 Months|Allergic reaction|0
7661222|NCT01432327|26649987|P1|Posttest 6 Months|Allergic reaction|0
7661223|NCT01432327|26649984|P4|Posttest 6 Months|Lost to Follow-up|2
7661224|NCT01432327|26649985|P3|Posttest 6 Months|Lost to Follow-up|3
7661225|NCT01432327|26649986|P2|Posttest 6 Months|Lost to Follow-up|0
7661226|NCT01432327|26649987|P1|Posttest 6 Months|Lost to Follow-up|0
7661227|NCT01432327|26649984|P4|Posttest 3 Months|Allergic reaction|0
7661228|NCT01432327|26649985|P3|Posttest 3 Months|Allergic reaction|0
7661229|NCT01432327|26649986|P2|Posttest 3 Months|Allergic reaction|2
7661230|NCT01432327|26649987|P1|Posttest 3 Months|Allergic reaction|0
7661231|NCT01432327|26649984|P4|Posttest 3 Months|Lost to Follow-up|1
7661232|NCT01432327|26649985|P3|Posttest 3 Months|Lost to Follow-up|2
7661233|NCT01432327|26649986|P2|Posttest 3 Months|Lost to Follow-up|0
7661234|NCT01432327|26649987|P1|Posttest 3 Months|Lost to Follow-up|1
7661235|NCT01432327|26649984|P4|Posttest 3 Months|depression|0
7661236|NCT01432327|26649985|P3|Posttest 3 Months|depression|0
7661237|NCT01432327|26649986|P2|Posttest 3 Months|depression|0
7661238|NCT01432327|26649987|P1|Posttest 3 Months|depression|3
7661239|NCT01432275|26649997|P2|ADC With Calculator (10 Days)|Protocol Violation|1
7661240|NCT01432275|26649998|P1|ADC With Calculator (10 Days)|Protocol Violation|0
7661241|NCT01432275|26649997|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
7661242|NCT01432275|26649998|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
7661243|NCT01432275|26649997|P2|ADC With Calculator (10 Days)|Physician Decision|1
7661244|NCT01432275|26649998|P1|ADC With Calculator (10 Days)|Physician Decision|1
7661245|NCT01432275|26649997|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
7661246|NCT01432275|26649998|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
7661247|NCT01432275|26649997|P2|Second BG Meter System (7 Days)|Physician Decision|1
7661248|NCT01432275|26649998|P1|Second BG Meter System (7 Days)|Physician Decision|0
7661249|NCT01432275|26649997|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
7661250|NCT01432275|26649998|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
7661251|NCT01432275|26649997|P2|Second BG Meter System (7 Days)|Adverse Event|1
7661252|NCT01432275|26649998|P1|Second BG Meter System (7 Days)|Adverse Event|1
7661253|NCT01432275|26649997|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
7661254|NCT01432275|26649998|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
7661255|NCT01432275|26649997|P2|First BG Meter System (7 Days)|Adverse Event|2
7661256|NCT01432275|26649998|P1|First BG Meter System (7 Days)|Adverse Event|0
7661257|NCT01432262|26650007|P2|Overall Study|Withdrawal by Subject|1
7661258|NCT01432262|26650008|P1|Overall Study|Withdrawal by Subject|2
7661259|NCT01432171|26650074|P2|Overall Study|Patient moved to palliative care|0
7661260|NCT01432171|26650075|P1|Overall Study|Patient moved to palliative care|1
7661261|NCT01432171|26650074|P2|Overall Study|Insurance denial trial coverage|0
7661262|NCT01432171|26650075|P1|Overall Study|Insurance denial trial coverage|1
7661263|NCT01432171|26650074|P2|Overall Study|Noncompliance|3
7661264|NCT01432171|26650075|P1|Overall Study|Noncompliance|2
7661265|NCT01432171|26650074|P2|Overall Study|Withdrawal by Subject|1
7661266|NCT01432171|26650075|P1|Overall Study|Withdrawal by Subject|3
7661267|NCT01432171|26650074|P2|Overall Study|Lost to Follow-up|5
7661268|NCT01432171|26650075|P1|Overall Study|Lost to Follow-up|6
7661269|NCT01432171|26650074|P2|Overall Study|Death|2
7661270|NCT01432171|26650075|P1|Overall Study|Death|1
7661271|NCT01431976|26650116|P1|Overall Study|Withdrawal by Subject|1
7661272|NCT01431976|26650116|P1|Overall Study|Physician Decision|1
7661273|NCT01431976|26650116|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
7661274|NCT01431976|26650116|P1|Overall Study|Lack of Efficacy|2
7661275|NCT01431976|26650116|P1|Overall Study|Adverse Event|6
7661276|NCT01431963|26650127|P1|Overall Study|Withdrawal by Subject|3
7661277|NCT01431963|26650127|P1|Overall Study|Physician Decision|4
7661278|NCT01431963|26650127|P1|Overall Study|Protocol-defined Stopping Criteria|2
7661279|NCT01431963|26650127|P1|Overall Study|Protocol Violation|1
7661280|NCT01431963|26650127|P1|Overall Study|Lack of Efficacy|7
7661281|NCT01431963|26650127|P1|Overall Study|Adverse Event|18
7661282|NCT01431950|26650135|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
7661283|NCT01431950|26650136|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
7661284|NCT01431950|26650135|P2|Overall Study|Lost to Follow-up|1
7661285|NCT01431950|26650136|P1|Overall Study|Lost to Follow-up|0
7661286|NCT01431950|26650135|P2|Overall Study|Lack of Efficacy|1
7661287|NCT01431950|26650136|P1|Overall Study|Lack of Efficacy|2
7661288|NCT01431950|26650135|P2|Overall Study|Physician Decision|1
7661289|NCT01431950|26650136|P1|Overall Study|Physician Decision|2
7661290|NCT01431950|26650135|P2|Overall Study|Adverse Event|2
7661291|NCT01431950|26650136|P1|Overall Study|Adverse Event|2
7661292|NCT01431950|26650135|P2|Overall Study|Protocol Violation|3
7661293|NCT01431950|26650136|P1|Overall Study|Protocol Violation|2
7661294|NCT01431950|26650135|P2|Overall Study|Withdrawal by Subject|3
7661295|NCT01431950|26650136|P1|Overall Study|Withdrawal by Subject|4
7661296|NCT01431950|26650135|P2|Overall Study|Study Site Closed/Terminated|3
7661297|NCT01431950|26650136|P1|Overall Study|Study Site Closed/Terminated|7
7661298|NCT01431716|26650201|P1|Overall Study|Withdrawal of consent|1
7661299|NCT01431638|26650225|P3|Overall Study|Participants Did not enter extension study from core study|32
7661300|NCT01431638|26650226|P2|Overall Study|Participants Did not enter extension study from core study|46
7661301|NCT01431638|26650227|P1|Overall Study|Participants Did not enter extension study from core study|39
7661302|NCT01431638|26650225|P3|Overall Study|Protocol deviation|4
7661303|NCT01431638|26650226|P2|Overall Study|Protocol deviation|1
7661304|NCT01431638|26650227|P1|Overall Study|Protocol deviation|1
7661305|NCT01431638|26650225|P3|Overall Study|Death|0
7661306|NCT01431638|26650226|P2|Overall Study|Death|0
7661307|NCT01431638|26650227|P1|Overall Study|Death|1
7661308|NCT01431638|26650225|P3|Overall Study|Administrative problems|6
7661309|NCT01431638|26650226|P2|Overall Study|Administrative problems|4
7661310|NCT01431638|26650227|P1|Overall Study|Administrative problems|1
7661311|NCT01431638|26650225|P3|Overall Study|Lost to Follow-up|7
7661312|NCT01431638|26650226|P2|Overall Study|Lost to Follow-up|9
7661313|NCT01431638|26650227|P1|Overall Study|Lost to Follow-up|7
7661314|NCT01431638|26650225|P3|Overall Study|Participant withdrew consent|8
7661315|NCT01431638|26650226|P2|Overall Study|Participant withdrew consent|5
7661316|NCT01431638|26650227|P1|Overall Study|Participant withdrew consent|14
7661317|NCT01431638|26650225|P3|Overall Study|Participants condition no longer requires study drug|0
7661318|NCT01431638|26650226|P2|Overall Study|Participants condition no longer requires study drug|1
7661319|NCT01431638|26650227|P1|Overall Study|Participants condition no longer requires study drug|0
7661320|NCT01431638|26650225|P3|Overall Study|Unsatisfactory therapeutic effect|4
7661321|NCT01431638|26650226|P2|Overall Study|Unsatisfactory therapeutic effect|2
7661322|NCT01431638|26650227|P1|Overall Study|Unsatisfactory therapeutic effect|2
7661323|NCT01431638|26650225|P3|Overall Study|Adverse Event|1
7661324|NCT01431638|26650226|P2|Overall Study|Adverse Event|3
7661325|NCT01431638|26650227|P1|Overall Study|Adverse Event|1
7661326|NCT01431534|26650268|P3|Treatment Phase|Progressive Disease|10
7661327|NCT01431534|26650269|P2|Treatment Phase|Progressive Disease|3
7661328|NCT01431534|26650270|P1|Treatment Phase|Progressive Disease|4
7661329|NCT01431534|26650268|P3|Treatment Phase|Adverse Event|1
7661330|NCT01431534|26650269|P2|Treatment Phase|Adverse Event|0
7661331|NCT01431534|26650270|P1|Treatment Phase|Adverse Event|0
7661332|NCT01431521|26650285|P4|Overall Study|Withdrawal by Subject|0
7661333|NCT01431521|26650286|P3|Overall Study|Withdrawal by Subject|1
7661334|NCT01431521|26650287|P2|Overall Study|Withdrawal by Subject|0
7661335|NCT01431521|26650288|P1|Overall Study|Withdrawal by Subject|0
7661336|NCT01431508|26650309|P1|Overall Study|Unable to Follow Protocol Procedures|1
7661337|NCT01431508|26650309|P1|Overall Study|Lack of Efficacy|1
7661338|NCT01431287|26650394|P5|Overall Study|not stated above|1
7661339|NCT01431287|26650395|P4|Overall Study|not stated above|2
7661340|NCT01431287|26650396|P3|Overall Study|not stated above|2
7661341|NCT01431287|26650397|P2|Overall Study|not stated above|2
7661342|NCT01431287|26650398|P1|Overall Study|not stated above|4
7661343|NCT01431287|26650394|P5|Overall Study|Consent withdrawn not due to AE|29
7661344|NCT01431287|26650395|P4|Overall Study|Consent withdrawn not due to AE|19
7661345|NCT01431287|26650396|P3|Overall Study|Consent withdrawn not due to AE|34
7661346|NCT01431287|26650397|P2|Overall Study|Consent withdrawn not due to AE|30
7661347|NCT01431287|26650398|P1|Overall Study|Consent withdrawn not due to AE|29
7661348|NCT01431287|26650394|P5|Overall Study|Lost to Follow-up|1
7661349|NCT01431287|26650395|P4|Overall Study|Lost to Follow-up|3
7661350|NCT01431287|26650396|P3|Overall Study|Lost to Follow-up|2
7661351|NCT01431287|26650397|P2|Overall Study|Lost to Follow-up|3
7661352|NCT01431287|26650398|P1|Overall Study|Lost to Follow-up|0
7661353|NCT01431287|26650394|P5|Overall Study|Non compliant with protocol|5
7661354|NCT01431287|26650395|P4|Overall Study|Non compliant with protocol|6
7661355|NCT01431287|26650396|P3|Overall Study|Non compliant with protocol|5
7661356|NCT01431287|26650397|P2|Overall Study|Non compliant with protocol|6
7661357|NCT01431287|26650398|P1|Overall Study|Non compliant with protocol|6
7661358|NCT01431287|26650394|P5|Overall Study|Adverse Event|41
7661359|NCT01431287|26650395|P4|Overall Study|Adverse Event|33
7661360|NCT01431287|26650396|P3|Overall Study|Adverse Event|53
7661361|NCT01431287|26650397|P2|Overall Study|Adverse Event|57
7661362|NCT01431287|26650398|P1|Overall Study|Adverse Event|59
7661363|NCT01431287|26650394|P5|Overall Study|not treated|0
7661364|NCT01431287|26650395|P4|Overall Study|not treated|0
7661365|NCT01431287|26650396|P3|Overall Study|not treated|1
7661366|NCT01431287|26650397|P2|Overall Study|not treated|0
7661367|NCT01431287|26650398|P1|Overall Study|not treated|0
7661368|NCT01431274|26650560|P5|Overall Study|Other reason not stated above|4
7661369|NCT01431274|26650561|P4|Overall Study|Other reason not stated above|2
7661370|NCT01431274|26650562|P3|Overall Study|Other reason not stated above|7
7661371|NCT01431274|26650563|P2|Overall Study|Other reason not stated above|5
7661372|NCT01431274|26650564|P1|Overall Study|Other reason not stated above|6
7661373|NCT01431274|26650560|P5|Overall Study|Lost to Follow-up|0
7661374|NCT01431274|26650561|P4|Overall Study|Lost to Follow-up|4
7661375|NCT01431274|26650562|P3|Overall Study|Lost to Follow-up|1
7661376|NCT01431274|26650563|P2|Overall Study|Lost to Follow-up|7
7661377|NCT01431274|26650564|P1|Overall Study|Lost to Follow-up|6
7661378|NCT01431274|26650560|P5|Overall Study|Non compliant with protocol|4
7661379|NCT01431274|26650561|P4|Overall Study|Non compliant with protocol|4
7661380|NCT01431274|26650562|P3|Overall Study|Non compliant with protocol|4
7661381|NCT01431274|26650563|P2|Overall Study|Non compliant with protocol|8
7661382|NCT01431274|26650564|P1|Overall Study|Non compliant with protocol|5
7661383|NCT01431274|26650560|P5|Overall Study|Consent withdrawn not due to AE|11
7661384|NCT01431274|26650561|P4|Overall Study|Consent withdrawn not due to AE|20
7661385|NCT01431274|26650562|P3|Overall Study|Consent withdrawn not due to AE|17
7661386|NCT01431274|26650563|P2|Overall Study|Consent withdrawn not due to AE|20
7661387|NCT01431274|26650564|P1|Overall Study|Consent withdrawn not due to AE|29
7661388|NCT01431274|26650560|P5|Overall Study|Adverse Event|37
7661389|NCT01431274|26650561|P4|Overall Study|Adverse Event|30
7661390|NCT01431274|26650562|P3|Overall Study|Adverse Event|43
7661391|NCT01431274|26650563|P2|Overall Study|Adverse Event|37
7661392|NCT01431274|26650564|P1|Overall Study|Adverse Event|51
7661393|NCT01431144|26650755|P2|Overall Study|Implant mobility and removal|0
7661394|NCT01431144|26650756|P1|Overall Study|Implant mobility and removal|2
7661395|NCT01431079|26650779|P2|Overall Study|Lost to Follow-up|39
7661396|NCT01431079|26650780|P1|Overall Study|Lost to Follow-up|35
7661397|NCT01430754|26650859|P2|Run-In Phase|Lost to Follow-up|0
7661398|NCT01430754|26650860|P1|Run-In Phase|Lost to Follow-up|1
7661399|NCT01430754|26650859|P2|Run-In Phase|Withdrawal by Subject|0
7661400|NCT01430754|26650860|P1|Run-In Phase|Withdrawal by Subject|2
7661401|NCT01430754|26650859|P2|Run-In Phase|Other|0
7661402|NCT01430754|26650860|P1|Run-In Phase|Other|2
7661403|NCT01430754|26650859|P2|Run-In Phase|Adverse Event|0
7661404|NCT01430754|26650860|P1|Run-In Phase|Adverse Event|2
7661405|NCT01430754|26650859|P2|Run-In Phase|Protocol Violation|0
7661406|NCT01430754|26650860|P1|Run-In Phase|Protocol Violation|6
7661407|NCT01430754|26650859|P2|Run-In Phase|Circadian Period Ineligible|0
7661408|NCT01430754|26650860|P1|Run-In Phase|Circadian Period Ineligible|24
7661409|NCT01430624|26650918|P3|Overall Study|technical or eligibility|2
7661410|NCT01430624|26650919|P2|Overall Study|technical or eligibility|5
7661411|NCT01430624|26650920|P1|Overall Study|technical or eligibility|5
7661412|NCT01430624|26650918|P3|Overall Study|Lost to Follow-up|27
7661413|NCT01430624|26650919|P2|Overall Study|Lost to Follow-up|29
7661414|NCT01430624|26650920|P1|Overall Study|Lost to Follow-up|23
7661415|NCT01430611|26650951|P2|Overall Study|Withdrawal by Subject|14
7661416|NCT01430611|26650952|P1|Overall Study|Withdrawal by Subject|15
7661417|NCT01430611|26650951|P2|Overall Study|Lost to Follow-up|0
7661418|NCT01430611|26650952|P1|Overall Study|Lost to Follow-up|1
7661419|NCT01430611|26650951|P2|Overall Study|Protocol Violation|0
7661420|NCT01430611|26650952|P1|Overall Study|Protocol Violation|1
7661421|NCT01430611|26650951|P2|Overall Study|Adverse Event|1
7661422|NCT01430611|26650952|P1|Overall Study|Adverse Event|0
7661423|NCT01430585|26650970|P1|Overall Study|Other|7
7661424|NCT01430585|26650970|P1|Overall Study|Study Terminated by Sponsor|3
7661425|NCT01430585|26650970|P1|Overall Study|Objective Progression or Relapse|3
7661426|NCT01430585|26650970|P1|Overall Study|Death|1
7661427|NCT01430559|26651005|P2|Overall Study|Randomized, Not Treated|3
7661428|NCT01430559|26651006|P1|Overall Study|Randomized, Not Treated|3
7661429|NCT01430559|26651005|P2|Overall Study|Other|3
7661430|NCT01430559|26651006|P1|Overall Study|Other|3
7661431|NCT01430559|26651005|P2|Overall Study|Protocol Violation|0
7661432|NCT01430559|26651006|P1|Overall Study|Protocol Violation|1
7661433|NCT01430559|26651005|P2|Overall Study|Withdrawal by Subject|2
7661434|NCT01430559|26651006|P1|Overall Study|Withdrawal by Subject|3
7661435|NCT01430559|26651005|P2|Overall Study|Medication error|0
7661436|NCT01430559|26651006|P1|Overall Study|Medication error|1
7661437|NCT01430559|26651005|P2|Overall Study|Lost to Follow-up|0
7661438|NCT01430559|26651006|P1|Overall Study|Lost to Follow-up|1
7661439|NCT01430559|26651005|P2|Overall Study|Entry criteria not met|1
7661440|NCT01430559|26651006|P1|Overall Study|Entry criteria not met|1
7661441|NCT01430559|26651005|P2|Overall Study|Adverse Event|3
7661442|NCT01430559|26651006|P1|Overall Study|Adverse Event|7
7661443|NCT01430468|26651042|P2|Overall Study|Withdrawal by Subject|5
7661444|NCT01430468|26651043|P1|Overall Study|Withdrawal by Subject|5
7661445|NCT01430468|26651042|P2|Overall Study|Physician Decision|1
7661446|NCT01430468|26651043|P1|Overall Study|Physician Decision|2
7661447|NCT01430455|26651051|P1|Overall Study|Switched to follow-up phase|1
7661448|NCT01430455|26651051|P1|Overall Study|Withdrawal by Subject|1
7661449|NCT01430442|26651063|P8|Overall Study|Patient No Longer Meets Study Criteria|6
7661450|NCT01430442|26651064|P7|Overall Study|Patient No Longer Meets Study Criteria|9
7661451|NCT01430442|26651065|P6|Overall Study|Patient No Longer Meets Study Criteria|5
7661452|NCT01430442|26651066|P5|Overall Study|Patient No Longer Meets Study Criteria|5
7661453|NCT01430442|26651067|P4|Overall Study|Patient No Longer Meets Study Criteria|2
7661454|NCT01430442|26651068|P3|Overall Study|Patient No Longer Meets Study Criteria|3
7661455|NCT01430442|26651069|P2|Overall Study|Patient No Longer Meets Study Criteria|6
7661456|NCT01430442|26651070|P1|Overall Study|Patient No Longer Meets Study Criteria|7
7661457|NCT01430442|26651063|P8|Overall Study|Pregnancy|0
7661458|NCT01430442|26651064|P7|Overall Study|Pregnancy|0
7661459|NCT01430442|26651065|P6|Overall Study|Pregnancy|1
7661460|NCT01430442|26651066|P5|Overall Study|Pregnancy|0
7661461|NCT01430442|26651067|P4|Overall Study|Pregnancy|0
7661462|NCT01430442|26651068|P3|Overall Study|Pregnancy|0
7661463|NCT01430442|26651069|P2|Overall Study|Pregnancy|0
7661464|NCT01430442|26651070|P1|Overall Study|Pregnancy|1
7661465|NCT01430442|26651063|P8|Overall Study|Lost to Follow-up|1
7661466|NCT01430442|26651064|P7|Overall Study|Lost to Follow-up|5
7661467|NCT01430442|26651065|P6|Overall Study|Lost to Follow-up|1
7661468|NCT01430442|26651066|P5|Overall Study|Lost to Follow-up|2
7661469|NCT01430442|26651067|P4|Overall Study|Lost to Follow-up|2
7661470|NCT01430442|26651068|P3|Overall Study|Lost to Follow-up|1
7661471|NCT01430442|26651069|P2|Overall Study|Lost to Follow-up|0
7661472|NCT01430442|26651070|P1|Overall Study|Lost to Follow-up|2
7661473|NCT01430442|26651063|P8|Overall Study|Subject Withdrew Consent|2
7661474|NCT01430442|26651064|P7|Overall Study|Subject Withdrew Consent|5
7661475|NCT01430442|26651065|P6|Overall Study|Subject Withdrew Consent|1
7661476|NCT01430442|26651066|P5|Overall Study|Subject Withdrew Consent|2
7661477|NCT01430442|26651067|P4|Overall Study|Subject Withdrew Consent|0
7661478|NCT01430442|26651068|P3|Overall Study|Subject Withdrew Consent|1
7661479|NCT01430442|26651069|P2|Overall Study|Subject Withdrew Consent|0
7661480|NCT01430442|26651070|P1|Overall Study|Subject Withdrew Consent|3
7661481|NCT01430403|26651123|P3|Overall Study|Withdrawal by Subject|3
7661482|NCT01430403|26651124|P2|Overall Study|Withdrawal by Subject|1
7661483|NCT01430403|26651125|P1|Overall Study|Withdrawal by Subject|9
7661484|NCT01430403|26651123|P3|Overall Study|Protocol Violation|2
7661485|NCT01430403|26651124|P2|Overall Study|Protocol Violation|3
7661486|NCT01430403|26651125|P1|Overall Study|Protocol Violation|2
7661487|NCT01430403|26651123|P3|Overall Study|Physician Decision|0
7661488|NCT01430403|26651124|P2|Overall Study|Physician Decision|0
7661489|NCT01430403|26651125|P1|Overall Study|Physician Decision|1
7661490|NCT01430403|26651123|P3|Overall Study|Lost to Follow-up|3
7661491|NCT01430403|26651124|P2|Overall Study|Lost to Follow-up|5
7661492|NCT01430403|26651125|P1|Overall Study|Lost to Follow-up|5
7661493|NCT01430130|26651232|P1|Overall Study|Infection on Control Side of Incision|1
7661494|NCT01430130|26651232|P1|Overall Study|Lost to Follow-up|1
7661495|NCT01430104|26651238|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
7661496|NCT01429792|26651305|P1|Overall Study|Lost to Follow-up|88
7661497|NCT01429792|26651305|P1|Overall Study|Withdrawal by Subject|70
7661498|NCT01429792|26651305|P1|Overall Study|Positive HCV-RNA at Week 24|50
7661499|NCT01429792|26651305|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
7661500|NCT01429792|26651305|P1|Overall Study|Negative HCV-RNA at Week 12|4
7661501|NCT01429792|26651305|P1|Overall Study|Negative HCV-RNA at Week 4|1
7661502|NCT01429792|26651305|P1|Overall Study|Unknown Disposition|94
7661503|NCT01429792|26651305|P1|Overall Study|Other Reasons|67
7661504|NCT01429623|26651319|P2|Overall Study|No post baseline data|4
7661505|NCT01429623|26651320|P1|Overall Study|No post baseline data|4
7661506|NCT01429623|26651319|P2|Overall Study|Conversion to Alzheimer's disease|21
7661507|NCT01429623|26651320|P1|Overall Study|Conversion to Alzheimer's disease|14
7661508|NCT01429623|26651319|P2|Overall Study|Assorted|2
7661509|NCT01429623|26651320|P1|Overall Study|Assorted|1
7661510|NCT01429623|26651319|P2|Overall Study|Protocol Violation|2
7661511|NCT01429623|26651320|P1|Overall Study|Protocol Violation|3
7661512|NCT01429623|26651319|P2|Overall Study|Physician Decision|3
7661513|NCT01429623|26651320|P1|Overall Study|Physician Decision|2
7661514|NCT01429623|26651319|P2|Overall Study|Withdrawal by Subject|13
7661515|NCT01429623|26651320|P1|Overall Study|Withdrawal by Subject|19
7661516|NCT01429623|26651319|P2|Overall Study|Adverse Event|14
7661517|NCT01429623|26651320|P1|Overall Study|Adverse Event|7
7661518|NCT01429623|26651319|P2|Overall Study|Death|0
7661519|NCT01429623|26651320|P1|Overall Study|Death|1
7661520|NCT01429584|26651334|P2|Overall Study|Protocol Violation|1
7661521|NCT01429584|26651335|P1|Overall Study|Protocol Violation|0
7661522|NCT01429584|26651334|P2|Overall Study|Withdrawal by Subject|0
7661523|NCT01429584|26651335|P1|Overall Study|Withdrawal by Subject|1
7661524|NCT01429441|26651377|P2|Overall Study|Withdrawal by Subject|18
7661525|NCT01429441|26651378|P1|Overall Study|Withdrawal by Subject|27
7661526|NCT01429441|26651377|P2|Overall Study|Physician Decision|0
7661527|NCT01429441|26651378|P1|Overall Study|Physician Decision|1
7661528|NCT01429441|26651377|P2|Overall Study|Lost to Follow-up|2
7661529|NCT01429441|26651378|P1|Overall Study|Lost to Follow-up|5
7661530|NCT01429441|26651377|P2|Overall Study|Death|2
7661531|NCT01429441|26651378|P1|Overall Study|Death|0
7661532|NCT01429441|26651377|P2|Overall Study|Adverse Event|1
7661533|NCT01429441|26651378|P1|Overall Study|Adverse Event|5
7661534|NCT01429298|26651403|P2|Overall Study|Protocol Violation|6
7661535|NCT01429298|26651404|P1|Overall Study|Protocol Violation|4
7661536|NCT01429285|26651420|P2|Overall Study|Erroneously Enrolled Twice|2
7661537|NCT01429285|26651421|P1|Overall Study|Erroneously Enrolled Twice|8
7661538|NCT01429285|26651420|P2|Overall Study|Missing Data|3
7661539|NCT01429285|26651421|P1|Overall Study|Missing Data|5
7661540|NCT01429285|26651420|P2|Overall Study|Protocol Violation|4
7661541|NCT01429285|26651421|P1|Overall Study|Protocol Violation|9
7661542|NCT01429077|26651467|P2|Overall Study|Lost to Follow-up|3
7661543|NCT01429077|26651468|P1|Overall Study|Lost to Follow-up|0
7661544|NCT01429051|26651491|P1|Tolerability Phase|Other|2
7661545|NCT01429051|26651491|P1|Tolerability Phase|Physician Decision|1
7661546|NCT01429051|26651491|P1|Tolerability Phase|Withdrawal by Subject|5
7661547|NCT01429051|26651491|P1|Tolerability Phase|Adverse Event|2
7661548|NCT01429051|26651491|P1|Tolerability Phase|Death|5
7661549|NCT01429051|26651491|P1|Efficacy Phase|Death|1
7661550|NCT01429051|26651491|P1|Efficacy Phase|Adverse Event|1
7661551|NCT01429051|26651491|P1|Titration Phase|Less than 3 BTP episodes per week|2
7661552|NCT01429051|26651491|P1|Titration Phase|Unsuccessful titration at any dose|1
7661553|NCT01429051|26651491|P1|Titration Phase|Physician Decision|1
7661554|NCT01429051|26651491|P1|Titration Phase|Withdrawal by Subject|7
7661555|NCT01429051|26651491|P1|Titration Phase|Death|1
7661556|NCT01428882|26651514|P2|Overall Study|Protocol Violation|3
7661557|NCT01428882|26651515|P1|Overall Study|Protocol Violation|4
7661558|NCT01428882|26651514|P2|Overall Study|Lack of Efficacy|7
7661559|NCT01428882|26651515|P1|Overall Study|Lack of Efficacy|2
7661560|NCT01428713|26651538|P2|Overall Study|Adverse Event|2
7661561|NCT01428713|26651539|P1|Overall Study|Adverse Event|0
7661562|NCT01428713|26651538|P2|Overall Study|Withdrawal by Subject|1
7661563|NCT01428713|26651539|P1|Overall Study|Withdrawal by Subject|1
7661564|NCT01428713|26651538|P2|Overall Study|Non-compliance|2
7661565|NCT01428713|26651539|P1|Overall Study|Non-compliance|2
7661566|NCT01428661|26651548|P3|Open Label Extension|**Various|185
7661567|NCT01428661|26651549|P2|Open Label Extension|**Various|0
7661568|NCT01428661|26651550|P1|Open Label Extension|**Various|0
7661569|NCT01428661|26651548|P3|Open Label Extension|Lack of Efficacy|24
7661570|NCT01428661|26651549|P2|Open Label Extension|Lack of Efficacy|0
7661571|NCT01428661|26651550|P1|Open Label Extension|Lack of Efficacy|0
7661572|NCT01428661|26651548|P3|Open Label Extension|Withdrawal by Subject|49
7661573|NCT01428661|26651549|P2|Open Label Extension|Withdrawal by Subject|0
7661574|NCT01428661|26651550|P1|Open Label Extension|Withdrawal by Subject|0
7661575|NCT01428661|26651548|P3|Open Label Extension|Lost to Follow-up|38
7661576|NCT01428661|26651549|P2|Open Label Extension|Lost to Follow-up|0
7661577|NCT01428661|26651550|P1|Open Label Extension|Lost to Follow-up|0
7661578|NCT01428661|26651548|P3|Open Label Extension|Adverse Event|15
7661579|NCT01428661|26651549|P2|Open Label Extension|Adverse Event|0
7661580|NCT01428661|26651550|P1|Open Label Extension|Adverse Event|0
7661581|NCT01428661|26651548|P3|Open Label Extension|Protocol Violation|9
7661582|NCT01428661|26651549|P2|Open Label Extension|Protocol Violation|0
7661583|NCT01428661|26651550|P1|Open Label Extension|Protocol Violation|0
7661584|NCT01428661|26651548|P3|Double-Masked Phase|*Various|0
7661585|NCT01428661|26651549|P2|Double-Masked Phase|*Various|6
7661586|NCT01428661|26651550|P1|Double-Masked Phase|*Various|1
7661587|NCT01428661|26651548|P3|Double-Masked Phase|Lack of Efficacy|0
7661588|NCT01428661|26651549|P2|Double-Masked Phase|Lack of Efficacy|1
7661589|NCT01428661|26651550|P1|Double-Masked Phase|Lack of Efficacy|2
7661590|NCT01428661|26651548|P3|Double-Masked Phase|Withdrawal by Subject|0
7661591|NCT01428661|26651549|P2|Double-Masked Phase|Withdrawal by Subject|20
7661592|NCT01428661|26651550|P1|Double-Masked Phase|Withdrawal by Subject|18
7661593|NCT01428661|26651548|P3|Double-Masked Phase|Lost to Follow-up|0
7661594|NCT01428661|26651549|P2|Double-Masked Phase|Lost to Follow-up|14
7661595|NCT01428661|26651550|P1|Double-Masked Phase|Lost to Follow-up|14
7661596|NCT01428661|26651548|P3|Double-Masked Phase|Adverse Event|0
7661597|NCT01428661|26651549|P2|Double-Masked Phase|Adverse Event|4
7661598|NCT01428661|26651550|P1|Double-Masked Phase|Adverse Event|13
7661599|NCT01428661|26651548|P3|Double-Masked Phase|Protocol Violation|0
7661600|NCT01428661|26651549|P2|Double-Masked Phase|Protocol Violation|4
7661601|NCT01428661|26651550|P1|Double-Masked Phase|Protocol Violation|9
7661602|NCT01428583|26651558|P1|Overall Study|Other|6
7661603|NCT01428583|26651558|P1|Overall Study|Sponsor's request|3
7661604|NCT01428583|26651558|P1|Overall Study|Confirmed positive urine drug test|8
7661605|NCT01428583|26651558|P1|Overall Study|Non-compliant|25
7661606|NCT01428583|26651558|P1|Overall Study|Physician Decision|12
7661607|NCT01428583|26651558|P1|Overall Study|Protocol Violation|1
7661608|NCT01428583|26651558|P1|Overall Study|Pregnancy|1
7661609|NCT01428583|26651558|P1|Overall Study|Death|1
7661610|NCT01428583|26651558|P1|Overall Study|Lost to Follow-up|17
7661611|NCT01428583|26651558|P1|Overall Study|Lack of Efficacy|37
7661612|NCT01428583|26651558|P1|Overall Study|Withdrawal by Subject|51
7661613|NCT01428583|26651558|P1|Overall Study|Adverse Event|75
7661614|NCT01428453|26651582|P2|Overall Study|Withdrawal by Subject|1
7661615|NCT01428453|26651583|P1|Overall Study|Withdrawal by Subject|3
7661616|NCT01428453|26651582|P2|Overall Study|Lost to Follow-up|1
7661617|NCT01428453|26651583|P1|Overall Study|Lost to Follow-up|0
7661618|NCT01428453|26651582|P2|Overall Study|Protocol Violation|0
7661619|NCT01428453|26651583|P1|Overall Study|Protocol Violation|1
7661620|NCT01428453|26651582|P2|Overall Study|Adverse Event|7
7661621|NCT01428453|26651583|P1|Overall Study|Adverse Event|2
7661622|NCT01428258|26651622|P2|Intervention 1|Withdrawal by Subject|0
7661623|NCT01428258|26651623|P1|Intervention 1|Withdrawal by Subject|2
7661624|NCT01428219|26651645|P1|Overall Study|25 patients enrolled, 3 were not treated|3
7661625|NCT01428193|26651656|P1|Overall Study|Elevated screening liver enzymes|1
7661626|NCT01428193|26651656|P1|Overall Study|Physician Decision|1
7661627|NCT01428128|26651660|P1|Overall Study|Adverse Event|1
7661628|NCT01428128|26651660|P1|Overall Study|Received Neulasta in one cycle|2
7661629|NCT01428128|26651660|P1|Overall Study|Screen failure by p53|10
7661630|NCT01428128|26651660|P1|Overall Study|Withdrawal by Subject|4
7661631|NCT01428115|26651665|P1|Overall Study|Withdrawal by Subject|4
7661632|NCT01428115|26651665|P1|Overall Study|Protocol Violation|3
7661633|NCT01428115|26651665|P1|Overall Study|Pregnancy|1
7661634|NCT01428115|26651665|P1|Overall Study|Lost to Follow-up|10
7661635|NCT01428115|26651665|P1|Overall Study|Lack of Efficacy|3
7661636|NCT01428076|26651680|P2|Overall Study|Adverse Event|1
7661637|NCT01428076|26651681|P1|Overall Study|Adverse Event|0
7661638|NCT01428063|26651692|P3|Overall Study|No longer meets study criteria|0
7661639|NCT01428063|26651693|P2|Overall Study|No longer meets study criteria|1
7661640|NCT01428063|26651694|P1|Overall Study|No longer meets study criteria|0
7661641|NCT01428063|26651692|P3|Overall Study|Lost to Follow-up|0
7661642|NCT01428063|26651693|P2|Overall Study|Lost to Follow-up|2
7661643|NCT01428063|26651694|P1|Overall Study|Lost to Follow-up|0
7661644|NCT01428063|26651692|P3|Overall Study|Adverse Event|0
7661645|NCT01428063|26651693|P2|Overall Study|Adverse Event|3
7661646|NCT01428063|26651694|P1|Overall Study|Adverse Event|2
7661647|NCT01428063|26651692|P3|Overall Study|Lack of Efficacy|1
7661648|NCT01428063|26651693|P2|Overall Study|Lack of Efficacy|4
7661649|NCT01428063|26651694|P1|Overall Study|Lack of Efficacy|8
7661650|NCT01427972|26651795|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661651|NCT01427972|26651796|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661652|NCT01427972|26651797|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661653|NCT01427972|26651798|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661654|NCT01427972|26651799|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661655|NCT01427972|26651800|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661656|NCT01427972|26651801|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661657|NCT01427972|26651802|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661658|NCT01427972|26651803|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661659|NCT01427972|26651804|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661660|NCT01427972|26651805|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
7661661|NCT01427972|26651806|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7661662|NCT01427972|26651795|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661663|NCT01427972|26651796|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661664|NCT01427972|26651797|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661665|NCT01427972|26651798|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661666|NCT01427972|26651799|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661667|NCT01427972|26651800|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661668|NCT01427972|26651801|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
7661669|NCT01427972|26651802|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661670|NCT01427972|26651803|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661671|NCT01427972|26651804|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661672|NCT01427972|26651805|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661673|NCT01427972|26651806|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
7661674|NCT01427972|26651795|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
7661675|NCT01427972|26651796|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
7661676|NCT01427972|26651797|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
7661677|NCT01427972|26651798|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
7661678|NCT01427972|26651799|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
7661679|NCT01427972|26651800|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
7661680|NCT01427972|26651801|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
7661681|NCT01427972|26651802|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
7661682|NCT01427972|26651803|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
7661683|NCT01427972|26651804|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
7661684|NCT01427972|26651805|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
7661685|NCT01427972|26651806|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
7661686|NCT01427933|26651832|P2|Overall Study|Investigator's Decision|0
7661687|NCT01427933|26651833|P1|Overall Study|Investigator's Decision|1
7661688|NCT01427933|26651832|P2|Overall Study|Other|0
7661689|NCT01427933|26651833|P1|Overall Study|Other|1
7661690|NCT01427933|26651832|P2|Overall Study|Lost to Follow-up|5
7661691|NCT01427933|26651833|P1|Overall Study|Lost to Follow-up|1
7661692|NCT01427933|26651832|P2|Overall Study|Withdrawal by Subject|8
7661693|NCT01427933|26651833|P1|Overall Study|Withdrawal by Subject|5
7661694|NCT01427920|26651853|P2|Overall Study|Unclassified|8
7661695|NCT01427920|26651854|P1|Overall Study|Unclassified|2
7661696|NCT01427920|26651853|P2|Overall Study|Withdrawal Criteria|4
7661697|NCT01427920|26651854|P1|Overall Study|Withdrawal Criteria|4
7661698|NCT01427920|26651853|P2|Overall Study|Protocol Violation|3
7661699|NCT01427920|26651854|P1|Overall Study|Protocol Violation|1
7661700|NCT01427920|26651853|P2|Overall Study|Lack of Efficacy|0
7661701|NCT01427920|26651854|P1|Overall Study|Lack of Efficacy|1
7661702|NCT01427920|26651853|P2|Overall Study|Adverse Event|2
7661703|NCT01427920|26651854|P1|Overall Study|Adverse Event|1
7661704|NCT01427907|26651874|P2|Overall Study|Withdrawal by Subject|4
7661705|NCT01427907|26651875|P1|Overall Study|Withdrawal by Subject|3
7661706|NCT01427803|26651896|P2|Overall Study|did not take product|0
7661707|NCT01427803|26651897|P1|Overall Study|did not take product|1
7661708|NCT01427803|26651896|P2|Overall Study|Physician Decision|0
7661709|NCT01427803|26651897|P1|Overall Study|Physician Decision|3
7661710|NCT01427803|26651896|P2|Overall Study|Protocol Violation|0
7661711|NCT01427803|26651897|P1|Overall Study|Protocol Violation|1
7661712|NCT01427803|26651896|P2|Overall Study|Unable to complete full treatment period|0
7661713|NCT01427803|26651897|P1|Overall Study|Unable to complete full treatment period|6
7661714|NCT01427803|26651896|P2|Overall Study|Withdrawal by Subject|0
7661715|NCT01427803|26651897|P1|Overall Study|Withdrawal by Subject|20
7661716|NCT01427803|26651896|P2|Overall Study|Lost to Follow-up|26
7661717|NCT01427803|26651897|P1|Overall Study|Lost to Follow-up|32
7661718|NCT01427751|26651911|P2|Overall Study|Other miscellaneous reasons|4
7661719|NCT01427751|26651912|P1|Overall Study|Other miscellaneous reasons|6
7661720|NCT01427751|26651911|P2|Overall Study|Death|0
7661721|NCT01427751|26651912|P1|Overall Study|Death|2
7661722|NCT01427751|26651911|P2|Overall Study|Protocol Violation|4
7661723|NCT01427751|26651912|P1|Overall Study|Protocol Violation|6
7661724|NCT01427751|26651911|P2|Overall Study|Withdrawal of consent|2
7661725|NCT01427751|26651912|P1|Overall Study|Withdrawal of consent|2
7661726|NCT01427751|26651911|P2|Overall Study|Lost to Follow-up|1
7661727|NCT01427751|26651912|P1|Overall Study|Lost to Follow-up|3
7661728|NCT01427751|26651911|P2|Overall Study|No further treatment benefit expected|1
7661729|NCT01427751|26651912|P1|Overall Study|No further treatment benefit expected|5
7661730|NCT01427751|26651911|P2|Overall Study|Adverse Event|2
7661731|NCT01427751|26651912|P1|Overall Study|Adverse Event|18
7661732|NCT01427738|26651932|P2|Overall Study|Lost to Follow-up|5
7661733|NCT01427738|26651933|P1|Overall Study|Lost to Follow-up|1
7661734|NCT01427738|26651932|P2|Overall Study|Subject not willing to adhere to reqs|2
7661735|NCT01427738|26651933|P1|Overall Study|Subject not willing to adhere to reqs|1
7661736|NCT01427738|26651932|P2|Overall Study|Withdrawal by Subject|2
7661737|NCT01427738|26651933|P1|Overall Study|Withdrawal by Subject|0
7661738|NCT01427738|26651932|P2|Overall Study|Subject unable to get to clinic|2
7661739|NCT01427738|26651933|P1|Overall Study|Subject unable to get to clinic|5
7661740|NCT01427738|26651932|P2|Overall Study|Severe debilitation, unable to continue|1
7661741|NCT01427738|26651933|P1|Overall Study|Severe debilitation, unable to continue|0
7661742|NCT01427738|26651932|P2|Overall Study|Death|9
7661743|NCT01427738|26651933|P1|Overall Study|Death|12
7661744|NCT01427608|26651953|P2|Overall Study|Events not attributed to study meds|1
7661745|NCT01427608|26651954|P1|Overall Study|Events not attributed to study meds|0
7661746|NCT01427608|26651953|P2|Overall Study|Relapsed-all cause|34
7661747|NCT01427608|26651954|P1|Overall Study|Relapsed-all cause|13
7661748|NCT01427608|26651953|P2|Overall Study|Withdrawal by Subject|3
7661749|NCT01427608|26651954|P1|Overall Study|Withdrawal by Subject|7
7661750|NCT01427608|26651953|P2|Overall Study|Death|0
7661751|NCT01427608|26651954|P1|Overall Study|Death|1
7661752|NCT01427309|26652015|P4|Overall Study|Withdrawal by Subject|55
7661753|NCT01427309|26652016|P3|Overall Study|Withdrawal by Subject|61
7661754|NCT01427309|26652017|P2|Overall Study|Withdrawal by Subject|148
7661755|NCT01427309|26652018|P1|Overall Study|Withdrawal by Subject|148
7661756|NCT01427309|26652015|P4|Overall Study|Serious adverse event|61
7661757|NCT01427309|26652016|P3|Overall Study|Serious adverse event|50
7661758|NCT01427309|26652017|P2|Overall Study|Serious adverse event|45
7661759|NCT01427309|26652018|P1|Overall Study|Serious adverse event|52
7661760|NCT01427309|26652015|P4|Overall Study|Adverse Event|1
7661761|NCT01427309|26652016|P3|Overall Study|Adverse Event|3
7661762|NCT01427309|26652017|P2|Overall Study|Adverse Event|0
7661763|NCT01427309|26652018|P1|Overall Study|Adverse Event|0
7661764|NCT01427309|26652015|P4|Overall Study|Protocol Violation|124
7661765|NCT01427309|26652016|P3|Overall Study|Protocol Violation|125
7661766|NCT01427309|26652017|P2|Overall Study|Protocol Violation|69
7661767|NCT01427309|26652018|P1|Overall Study|Protocol Violation|42
7661768|NCT01427309|26652015|P4|Overall Study|Lost to Follow-up|135
7661769|NCT01427309|26652016|P3|Overall Study|Lost to Follow-up|122
7661770|NCT01427309|26652017|P2|Overall Study|Lost to Follow-up|145
7661771|NCT01427309|26652018|P1|Overall Study|Lost to Follow-up|130
7661772|NCT01426958|26652065|P1|Overall Study|Adverse Event|2
7661773|NCT01426854|26652094|P2|Overall Study|Other|2
7661774|NCT01426854|26652095|P1|Overall Study|Other|3
7661775|NCT01426854|26652094|P2|Overall Study|Protocol Deviation|1
7661776|NCT01426854|26652095|P1|Overall Study|Protocol Deviation|0
7661777|NCT01426854|26652094|P2|Overall Study|Treatment Failure|16
7661778|NCT01426854|26652095|P1|Overall Study|Treatment Failure|0
7661779|NCT01426854|26652094|P2|Overall Study|Noncompliance|1
7661780|NCT01426854|26652095|P1|Overall Study|Noncompliance|0
7661781|NCT01426854|26652094|P2|Overall Study|Lost to Follow-up|0
7661782|NCT01426854|26652095|P1|Overall Study|Lost to Follow-up|3
7661783|NCT01426854|26652094|P2|Overall Study|Subject Decision Unrelated to AE|6
7661784|NCT01426854|26652095|P1|Overall Study|Subject Decision Unrelated to AE|5
7661785|NCT01426854|26652094|P2|Overall Study|Adverse Event|5
7661786|NCT01426854|26652095|P1|Overall Study|Adverse Event|1
7661787|NCT01426789|26652114|P6|Part 2|Adverse Event|0
7661788|NCT01426789|26652115|P5|Part 2|Adverse Event|1
7661789|NCT01426789|26652116|P4|Part 2|Adverse Event|0
7661790|NCT01426789|26652117|P3|Part 2|Adverse Event|2
7661791|NCT01426789|26652118|P2|Part 2|Adverse Event|0
7661792|NCT01426789|26652119|P1|Part 2|Adverse Event|0
7661793|NCT01426789|26652114|P6|Part 2|Lack of Efficacy|0
7661794|NCT01426789|26652115|P5|Part 2|Lack of Efficacy|2
7661795|NCT01426789|26652116|P4|Part 2|Lack of Efficacy|0
7661796|NCT01426789|26652117|P3|Part 2|Lack of Efficacy|5
7661797|NCT01426789|26652118|P2|Part 2|Lack of Efficacy|0
7661798|NCT01426789|26652119|P1|Part 2|Lack of Efficacy|0
7661799|NCT01426789|26652114|P6|Part 2|Withdrawal by Subject|0
7661800|NCT01426789|26652115|P5|Part 2|Withdrawal by Subject|2
7661801|NCT01426789|26652116|P4|Part 2|Withdrawal by Subject|1
7661802|NCT01426789|26652117|P3|Part 2|Withdrawal by Subject|0
7661803|NCT01426789|26652118|P2|Part 2|Withdrawal by Subject|0
7661804|NCT01426789|26652119|P1|Part 2|Withdrawal by Subject|0
7661805|NCT01426789|26652114|P6|Part 2|Lost to Follow-up|0
7661806|NCT01426789|26652115|P5|Part 2|Lost to Follow-up|1
7661807|NCT01426789|26652116|P4|Part 2|Lost to Follow-up|0
7661808|NCT01426789|26652117|P3|Part 2|Lost to Follow-up|4
7661809|NCT01426789|26652118|P2|Part 2|Lost to Follow-up|0
7661810|NCT01426789|26652119|P1|Part 2|Lost to Follow-up|0
7661811|NCT01426789|26652114|P6|Part 2|Administrative problems|0
7661812|NCT01426789|26652115|P5|Part 2|Administrative problems|1
7661813|NCT01426789|26652116|P4|Part 2|Administrative problems|0
7661814|NCT01426789|26652117|P3|Part 2|Administrative problems|2
7661815|NCT01426789|26652118|P2|Part 2|Administrative problems|0
7661816|NCT01426789|26652119|P1|Part 2|Administrative problems|0
7661817|NCT01426789|26652114|P6|Part 2|Death|0
7661818|NCT01426789|26652115|P5|Part 2|Death|1
7661819|NCT01426789|26652116|P4|Part 2|Death|0
7661820|NCT01426789|26652117|P3|Part 2|Death|1
7661821|NCT01426789|26652118|P2|Part 2|Death|0
7661822|NCT01426789|26652119|P1|Part 2|Death|0
7661823|NCT01426789|26652114|P6|Part 2|Protocol deviation|0
7661824|NCT01426789|26652115|P5|Part 2|Protocol deviation|0
7661825|NCT01426789|26652116|P4|Part 2|Protocol deviation|0
7661826|NCT01426789|26652117|P3|Part 2|Protocol deviation|1
7661827|NCT01426789|26652118|P2|Part 2|Protocol deviation|0
7661828|NCT01426789|26652119|P1|Part 2|Protocol deviation|0
7661829|NCT01426789|26652114|P6|Part 1|Adverse Event|0
7661830|NCT01426789|26652115|P5|Part 1|Adverse Event|0
7661831|NCT01426789|26652116|P4|Part 1|Adverse Event|0
7661832|NCT01426789|26652117|P3|Part 1|Adverse Event|0
7661833|NCT01426789|26652118|P2|Part 1|Adverse Event|0
7661834|NCT01426789|26652119|P1|Part 1|Adverse Event|3
7661835|NCT01426789|26652114|P6|Part 1|Lack of Efficacy|0
7661836|NCT01426789|26652115|P5|Part 1|Lack of Efficacy|0
7661837|NCT01426789|26652116|P4|Part 1|Lack of Efficacy|0
7661838|NCT01426789|26652117|P3|Part 1|Lack of Efficacy|0
7661839|NCT01426789|26652118|P2|Part 1|Lack of Efficacy|1
7661840|NCT01426789|26652119|P1|Part 1|Lack of Efficacy|2
7661841|NCT01426789|26652114|P6|Part 1|Lost to Follow-up|0
7661842|NCT01426789|26652115|P5|Part 1|Lost to Follow-up|0
7661843|NCT01426789|26652116|P4|Part 1|Lost to Follow-up|0
7661844|NCT01426789|26652117|P3|Part 1|Lost to Follow-up|0
7661845|NCT01426789|26652118|P2|Part 1|Lost to Follow-up|2
7661846|NCT01426789|26652119|P1|Part 1|Lost to Follow-up|1
7661847|NCT01426789|26652114|P6|Part 1|Protocol deviation|0
7661848|NCT01426789|26652115|P5|Part 1|Protocol deviation|0
7661849|NCT01426789|26652116|P4|Part 1|Protocol deviation|0
7661850|NCT01426789|26652117|P3|Part 1|Protocol deviation|0
7661851|NCT01426789|26652118|P2|Part 1|Protocol deviation|1
7661852|NCT01426789|26652119|P1|Part 1|Protocol deviation|0
7661853|NCT01426438|26652195|P2|Overall Study|Missed Scan|2
7661854|NCT01426438|26652196|P1|Overall Study|Missed Scan|2
7661855|NCT01426438|26652195|P2|Overall Study|Poor scan quality|2
7661856|NCT01426438|26652196|P1|Overall Study|Poor scan quality|3
7661857|NCT01426438|26652195|P2|Overall Study|Off study Treatment|3
7661858|NCT01426438|26652196|P1|Overall Study|Off study Treatment|9
7661859|NCT01426438|26652195|P2|Overall Study|Lost to Follow-up|3
7661860|NCT01426438|26652196|P1|Overall Study|Lost to Follow-up|1
7661861|NCT01426425|26652228|P1|Overall Study|Met inclusion/exclusion, not treated|2
7661862|NCT01426425|26652228|P1|Overall Study|Inclusion/exclusion criteria not met|151
7661863|NCT01426425|26652228|P1|Overall Study|Exited prior to EP study|22
7661864|NCT01426412|26652243|P9|Overall Study|Withdrawal by Subject|1
7661865|NCT01426412|26652244|P8|Overall Study|Withdrawal by Subject|3
7661866|NCT01426412|26652245|P7|Overall Study|Withdrawal by Subject|0
7661867|NCT01426412|26652246|P6|Overall Study|Withdrawal by Subject|0
7661868|NCT01426412|26652247|P5|Overall Study|Withdrawal by Subject|1
7661869|NCT01426412|26652248|P4|Overall Study|Withdrawal by Subject|0
7661870|NCT01426412|26652249|P3|Overall Study|Withdrawal by Subject|0
7661871|NCT01426412|26652250|P2|Overall Study|Withdrawal by Subject|0
7661872|NCT01426412|26652251|P1|Overall Study|Withdrawal by Subject|1
7661873|NCT01426386|26652314|P6|Overall Study|Personal reasons|0
7661874|NCT01426386|26652315|P5|Overall Study|Personal reasons|1
7661875|NCT01426386|26652316|P4|Overall Study|Personal reasons|0
7661876|NCT01426386|26652317|P3|Overall Study|Personal reasons|0
7661877|NCT01426386|26652318|P2|Overall Study|Personal reasons|0
7661878|NCT01426386|26652319|P1|Overall Study|Personal reasons|0
7661879|NCT01426386|26652314|P6|Overall Study|Poor response|0
7661880|NCT01426386|26652315|P5|Overall Study|Poor response|1
7661881|NCT01426386|26652316|P4|Overall Study|Poor response|0
7661882|NCT01426386|26652317|P3|Overall Study|Poor response|2
7661883|NCT01426386|26652318|P2|Overall Study|Poor response|1
7661884|NCT01426386|26652319|P1|Overall Study|Poor response|2
7661885|NCT01426386|26652314|P6|Overall Study|Did not attend scheduled visit|1
7661886|NCT01426386|26652315|P5|Overall Study|Did not attend scheduled visit|2
7661887|NCT01426386|26652316|P4|Overall Study|Did not attend scheduled visit|0
7661888|NCT01426386|26652317|P3|Overall Study|Did not attend scheduled visit|0
7661889|NCT01426386|26652318|P2|Overall Study|Did not attend scheduled visit|4
7661890|NCT01426386|26652319|P1|Overall Study|Did not attend scheduled visit|1
7661891|NCT01426386|26652314|P6|Overall Study|Adverse Event|0
7661892|NCT01426386|26652315|P5|Overall Study|Adverse Event|0
7661893|NCT01426386|26652316|P4|Overall Study|Adverse Event|0
7661894|NCT01426386|26652317|P3|Overall Study|Adverse Event|0
7661895|NCT01426386|26652318|P2|Overall Study|Adverse Event|1
7661896|NCT01426386|26652319|P1|Overall Study|Adverse Event|0
7661897|NCT01426373|26652375|P1|Overall Study|Miscellaneous Reasons|4
7661898|NCT01426373|26652375|P1|Overall Study|Participant Convenience|10
7661899|NCT01426373|26652375|P1|Overall Study|Lost to Follow-up|14
7661900|NCT01426373|26652375|P1|Overall Study|Adverse Event|6
7661901|NCT01426347|26652408|P2|Overall Study|Withdrawal by Subject|0
7661902|NCT01426347|26652409|P1|Overall Study|Withdrawal by Subject|5
7661903|NCT01426347|26652408|P2|Overall Study|Protocol Violation|0
7661904|NCT01426347|26652409|P1|Overall Study|Protocol Violation|2
7661905|NCT01426347|26652408|P2|Overall Study|Lost to Follow-up|3
7661906|NCT01426347|26652409|P1|Overall Study|Lost to Follow-up|0
7661907|NCT01426269|26652417|P3|Period 2: 40 Weeks|Relapsed|18
7661908|NCT01426269|26652418|P2|Period 2: 40 Weeks|Relapsed|9
7661909|NCT01426269|26652419|P1|Period 2: 40 Weeks|Relapsed|0
7661910|NCT01426269|26652417|P3|Period 2: 40 Weeks|Site closed|5
7661911|NCT01426269|26652418|P2|Period 2: 40 Weeks|Site closed|6
7661912|NCT01426269|26652419|P1|Period 2: 40 Weeks|Site closed|0
7661913|NCT01426269|26652417|P3|Period 2: 40 Weeks|Lost to Follow-up|6
7661914|NCT01426269|26652418|P2|Period 2: 40 Weeks|Lost to Follow-up|8
7661915|NCT01426269|26652419|P1|Period 2: 40 Weeks|Lost to Follow-up|0
7661916|NCT01426269|26652417|P3|Period 2: 40 Weeks|Protocol Violation|5
7661917|NCT01426269|26652418|P2|Period 2: 40 Weeks|Protocol Violation|5
7661918|NCT01426269|26652419|P1|Period 2: 40 Weeks|Protocol Violation|0
7661919|NCT01426269|26652417|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
7661920|NCT01426269|26652418|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
7661921|NCT01426269|26652419|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
7661922|NCT01426269|26652417|P3|Period 2: 40 Weeks|Adverse Event|2
7661923|NCT01426269|26652418|P2|Period 2: 40 Weeks|Adverse Event|1
7661924|NCT01426269|26652419|P1|Period 2: 40 Weeks|Adverse Event|0
7661925|NCT01426269|26652417|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
7661926|NCT01426269|26652418|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
7661927|NCT01426269|26652419|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
7661928|NCT01426269|26652417|P3|Eligibility for Period 2, Randomization|Did not qualify|0
7661929|NCT01426269|26652418|P2|Eligibility for Period 2, Randomization|Did not qualify|0
7661930|NCT01426269|26652419|P1|Eligibility for Period 2, Randomization|Did not qualify|42
7661931|NCT01426269|26652417|P3|Period 1: 12 Weeks|Pregnancy|0
7661932|NCT01426269|26652418|P2|Period 1: 12 Weeks|Pregnancy|0
7661933|NCT01426269|26652419|P1|Period 1: 12 Weeks|Pregnancy|1
7661934|NCT01426269|26652417|P3|Period 1: 12 Weeks|Lost to Follow-up|0
7661935|NCT01426269|26652418|P2|Period 1: 12 Weeks|Lost to Follow-up|0
7661936|NCT01426269|26652419|P1|Period 1: 12 Weeks|Lost to Follow-up|22
7661937|NCT01426269|26652417|P3|Period 1: 12 Weeks|Protocol Violation|0
7661938|NCT01426269|26652418|P2|Period 1: 12 Weeks|Protocol Violation|0
7661939|NCT01426269|26652419|P1|Period 1: 12 Weeks|Protocol Violation|5
7661940|NCT01426269|26652417|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
7661941|NCT01426269|26652418|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
7661942|NCT01426269|26652419|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
7661943|NCT01426269|26652417|P3|Period 1: 12 Weeks|Adverse Event|0
7661944|NCT01426269|26652418|P2|Period 1: 12 Weeks|Adverse Event|0
7661945|NCT01426269|26652419|P1|Period 1: 12 Weeks|Adverse Event|5
7661946|NCT01426217|26652454|P2|Overall Study|lost sample|14
7661947|NCT01426217|26652455|P1|Overall Study|lost sample|8
7661948|NCT01426113|26652468|P2|Overall Study|Adverse Event|1
7661949|NCT01426113|26652469|P1|Overall Study|Adverse Event|0
7661950|NCT01426113|26652468|P2|Overall Study|Study Discontinued|1
7661951|NCT01426113|26652469|P1|Overall Study|Study Discontinued|1
7661952|NCT01426009|26652475|P1|Washout 4|Lost to Follow-up|1
7661953|NCT01426009|26652475|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
7661954|NCT01426009|26652475|P1|Washout 3|personal reasons|1
7661955|NCT01426009|26652475|P1|Washout 2|electrive surgery|1
7661956|NCT01426009|26652475|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
7661957|NCT01426009|26652475|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
7661958|NCT01426009|26652475|P1|Washout 1|Personal Reasons|1
7661959|NCT01426009|26652475|P1|Washout 1|Withdrawal by Subject|1
7661960|NCT01426009|26652475|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
7661961|NCT01426009|26652475|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
7661962|NCT01425814|26652571|P6|Period 5|Stability criteria not fulfilled|1
7661963|NCT01425814|26652572|P5|Period 5|Stability criteria not fulfilled|0
7661964|NCT01425814|26652573|P4|Period 5|Stability criteria not fulfilled|0
7661965|NCT01425814|26652574|P3|Period 5|Stability criteria not fulfilled|1
7661966|NCT01425814|26652575|P2|Period 5|Stability criteria not fulfilled|0
7661967|NCT01425814|26652576|P1|Period 5|Stability criteria not fulfilled|0
7661968|NCT01425814|26652571|P6|Period 4|Adverse Event|0
7661969|NCT01425814|26652572|P5|Period 4|Adverse Event|0
7661970|NCT01425814|26652573|P4|Period 4|Adverse Event|0
7661971|NCT01425814|26652574|P3|Period 4|Adverse Event|1
7661972|NCT01425814|26652575|P2|Period 4|Adverse Event|0
7661973|NCT01425814|26652576|P1|Period 4|Adverse Event|1
7661974|NCT01425814|26652571|P6|Period 3|Adverse Event|1
7661975|NCT01425814|26652572|P5|Period 3|Adverse Event|0
7661976|NCT01425814|26652573|P4|Period 3|Adverse Event|0
7661977|NCT01425814|26652574|P3|Period 3|Adverse Event|0
7661978|NCT01425814|26652575|P2|Period 3|Adverse Event|0
7661979|NCT01425814|26652576|P1|Period 3|Adverse Event|0
7661980|NCT01425814|26652571|P6|Period 2|Stability criteria not fulfilled|0
7661981|NCT01425814|26652572|P5|Period 2|Stability criteria not fulfilled|0
7661982|NCT01425814|26652573|P4|Period 2|Stability criteria not fulfilled|0
7661983|NCT01425814|26652574|P3|Period 2|Stability criteria not fulfilled|0
7661984|NCT01425814|26652575|P2|Period 2|Stability criteria not fulfilled|1
7661985|NCT01425814|26652576|P1|Period 2|Stability criteria not fulfilled|0
7661986|NCT01425814|26652571|P6|Period 1|Stability criteria not fulfilled|0
7661987|NCT01425814|26652572|P5|Period 1|Stability criteria not fulfilled|0
7661988|NCT01425814|26652573|P4|Period 1|Stability criteria not fulfilled|0
7661989|NCT01425814|26652574|P3|Period 1|Stability criteria not fulfilled|0
7661990|NCT01425814|26652575|P2|Period 1|Stability criteria not fulfilled|1
7661991|NCT01425814|26652576|P1|Period 1|Stability criteria not fulfilled|0
7661992|NCT01425801|26652668|P6|Period 4|Not able to maintain visit schedule|0
7661993|NCT01425801|26652669|P5|Period 4|Not able to maintain visit schedule|0
7661994|NCT01425801|26652670|P4|Period 4|Not able to maintain visit schedule|0
7661995|NCT01425801|26652671|P3|Period 4|Not able to maintain visit schedule|1
7661996|NCT01425801|26652672|P2|Period 4|Not able to maintain visit schedule|0
7661997|NCT01425801|26652673|P1|Period 4|Not able to maintain visit schedule|0
7661998|NCT01425801|26652668|P6|Period 3|Stability criteria not fullfilled|0
7661999|NCT01425801|26652669|P5|Period 3|Stability criteria not fullfilled|0
7662000|NCT01425801|26652670|P4|Period 3|Stability criteria not fullfilled|0
7662001|NCT01425801|26652671|P3|Period 3|Stability criteria not fullfilled|1
7662002|NCT01425801|26652672|P2|Period 3|Stability criteria not fullfilled|0
7662003|NCT01425801|26652673|P1|Period 3|Stability criteria not fullfilled|0
7662004|NCT01425801|26652668|P6|Period 2|Withdrawal by Subject|0
7662005|NCT01425801|26652669|P5|Period 2|Withdrawal by Subject|1
7662006|NCT01425801|26652670|P4|Period 2|Withdrawal by Subject|0
7662007|NCT01425801|26652671|P3|Period 2|Withdrawal by Subject|0
7662008|NCT01425801|26652672|P2|Period 2|Withdrawal by Subject|0
7662009|NCT01425801|26652673|P1|Period 2|Withdrawal by Subject|0
7662010|NCT01425801|26652668|P6|Period 1|Withdrawal by Subject|0
7662011|NCT01425801|26652669|P5|Period 1|Withdrawal by Subject|1
7662012|NCT01425801|26652670|P4|Period 1|Withdrawal by Subject|0
7662013|NCT01425801|26652671|P3|Period 1|Withdrawal by Subject|0
7662014|NCT01425801|26652672|P2|Period 1|Withdrawal by Subject|0
7662015|NCT01425801|26652673|P1|Period 1|Withdrawal by Subject|0
7662016|NCT01425749|26652779|P2|Overall Study|progression of melanoma|1
7662017|NCT01425749|26652780|P1|Overall Study|progression of melanoma|0
7662018|NCT01425723|26652797|P2|Overall Study|Other|10
7662019|NCT01425723|26652798|P1|Overall Study|Other|1
7662020|NCT01425723|26652797|P2|Overall Study|Physician Decision|0
7662021|NCT01425723|26652798|P1|Overall Study|Physician Decision|2
7662022|NCT01425723|26652797|P2|Overall Study|Lost to Follow-up|3
7662023|NCT01425723|26652798|P1|Overall Study|Lost to Follow-up|0
7662024|NCT01425723|26652797|P2|Overall Study|Withdrawal by Subject|4
7662025|NCT01425723|26652798|P1|Overall Study|Withdrawal by Subject|1
7662026|NCT01425723|26652797|P2|Overall Study|Lack of Efficacy|1
7662027|NCT01425723|26652798|P1|Overall Study|Lack of Efficacy|0
7662028|NCT01425632|26652828|P3|Overall Study|Withdrawal by Subject|1
7662029|NCT01425632|26652829|P2|Overall Study|Withdrawal by Subject|0
7662030|NCT01425632|26652830|P1|Overall Study|Withdrawal by Subject|0
7662031|NCT01425632|26652828|P3|Overall Study|Protocol Violation|2
7662032|NCT01425632|26652829|P2|Overall Study|Protocol Violation|0
7662033|NCT01425632|26652830|P1|Overall Study|Protocol Violation|0
7662034|NCT01425632|26652828|P3|Overall Study|Physician Decision|0
7662035|NCT01425632|26652829|P2|Overall Study|Physician Decision|0
7662036|NCT01425632|26652830|P1|Overall Study|Physician Decision|1
7662037|NCT01425632|26652828|P3|Overall Study|Adverse Event|1
7662038|NCT01425632|26652829|P2|Overall Study|Adverse Event|1
7662039|NCT01425632|26652830|P1|Overall Study|Adverse Event|0
7662040|NCT01425528|26652840|P2|Overall Study|Withdrawal by Subject|1
7662041|NCT01425528|26652841|P1|Overall Study|Withdrawal by Subject|1
7662042|NCT01425463|26652849|P2|Overall Study|Unknown Reason|7
7662043|NCT01425463|26652850|P1|Overall Study|Unknown Reason|4
7662044|NCT01425463|26652849|P2|Overall Study|Withdrawal by Subject|5
7662045|NCT01425463|26652850|P1|Overall Study|Withdrawal by Subject|7
7662046|NCT01425463|26652849|P2|Overall Study|Lost to Follow-up|2
7662047|NCT01425463|26652850|P1|Overall Study|Lost to Follow-up|5
7662048|NCT01425463|26652849|P2|Overall Study|Protocol Violation|2
7662049|NCT01425463|26652850|P1|Overall Study|Protocol Violation|2
7662050|NCT01425463|26652849|P2|Overall Study|Lack of Efficacy|1
7662051|NCT01425463|26652850|P1|Overall Study|Lack of Efficacy|1
7662052|NCT01425463|26652849|P2|Overall Study|Adverse Event|7
7662053|NCT01425463|26652850|P1|Overall Study|Adverse Event|5
7662054|NCT01425359|26652866|P2|Overall Study|Did Not Meet Qualifying Criteria|5
7662055|NCT01425359|26652867|P1|Overall Study|Did Not Meet Qualifying Criteria|3
7662056|NCT01425359|26652866|P2|Overall Study|Investigator's Discretion|0
7662057|NCT01425359|26652867|P1|Overall Study|Investigator's Discretion|2
7662058|NCT01425359|26652866|P2|Overall Study|Subject Withdrew Consent|2
7662059|NCT01425359|26652867|P1|Overall Study|Subject Withdrew Consent|1
7662060|NCT01425359|26652866|P2|Overall Study|Protocol Violation|2
7662061|NCT01425359|26652867|P1|Overall Study|Protocol Violation|1
7662062|NCT01425359|26652866|P2|Overall Study|Unsatisfactory Response|0
7662063|NCT01425359|26652867|P1|Overall Study|Unsatisfactory Response|1
7662064|NCT01425359|26652866|P2|Overall Study|Death|1
7662065|NCT01425359|26652867|P1|Overall Study|Death|0
7662066|NCT01425359|26652866|P2|Overall Study|Revascularization|1
7662067|NCT01425359|26652867|P1|Overall Study|Revascularization|0
7662068|NCT01425359|26652866|P2|Overall Study|Adverse Event|8
7662069|NCT01425359|26652867|P1|Overall Study|Adverse Event|9
7662070|NCT01425359|26652866|P2|Overall Study|Randomized but Not Treated|3
7662071|NCT01425359|26652867|P1|Overall Study|Randomized but Not Treated|2
7662072|NCT01425281|26652898|P2|At 5-year Clinical Follow-up|Refused/terminated|3
7662073|NCT01425281|26652899|P1|At 5-year Clinical Follow-up|Refused/terminated|9
7662074|NCT01425281|26652898|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
7662075|NCT01425281|26652899|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
7662076|NCT01425281|26652898|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
7662077|NCT01425281|26652899|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
7662078|NCT01425281|26652898|P2|At 5-year Clinical Follow-up|Death|0
7662079|NCT01425281|26652899|P1|At 5-year Clinical Follow-up|Death|2
7662080|NCT01425281|26652898|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
7662081|NCT01425281|26652899|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
7662082|NCT01425281|26652898|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
7662083|NCT01425281|26652899|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
7662084|NCT01425281|26652898|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7662085|NCT01425281|26652899|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7662086|NCT01425281|26652898|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
7662087|NCT01425281|26652899|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
7662088|NCT01425281|26652898|P2|At 4-year Clinical Follow-up|Death|3
7662089|NCT01425281|26652899|P1|At 4-year Clinical Follow-up|Death|7
7662090|NCT01425281|26652898|P2|At 3-year Clinical Follow-up|Death|3
7662091|NCT01425281|26652899|P1|At 3-year Clinical Follow-up|Death|2
7662092|NCT01425281|26652898|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7662093|NCT01425281|26652899|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7662094|NCT01425281|26652898|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
7662095|NCT01425281|26652899|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
7662096|NCT01425281|26652898|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
7662097|NCT01425281|26652899|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
7662098|NCT01425281|26652898|P2|At 2-year Clinical Follow-up|Death|0
7662099|NCT01425281|26652899|P1|At 2-year Clinical Follow-up|Death|2
7662100|NCT01425281|26652898|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
7662101|NCT01425281|26652899|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
7662102|NCT01425281|26652898|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
7662103|NCT01425281|26652899|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
7662104|NCT01425281|26652898|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7662105|NCT01425281|26652899|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7662106|NCT01425281|26652898|P2|At 180-day Clinical Follow-up|Death|1
7662107|NCT01425281|26652899|P1|At 180-day Clinical Follow-up|Death|0
7662108|NCT01425281|26652898|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
7662109|NCT01425281|26652899|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
7662110|NCT01425281|26652898|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
7662111|NCT01425281|26652899|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
7662112|NCT01425268|26653117|P2|Overall Study|Physician Decision|0
7662113|NCT01425268|26653118|P1|Overall Study|Physician Decision|1
7662114|NCT01425268|26653117|P2|Overall Study|Sponsor Decision|0
7662115|NCT01425268|26653118|P1|Overall Study|Sponsor Decision|5
7662116|NCT01425268|26653117|P2|Overall Study|Withdrawal by Subject|0
7662117|NCT01425268|26653118|P1|Overall Study|Withdrawal by Subject|2
7662118|NCT01425203|26653139|P3|Crossover Phase|Other virologic failure criteria|3
7662119|NCT01425203|26653140|P2|Crossover Phase|Other virologic failure criteria|0
7662120|NCT01425203|26653141|P1|Crossover Phase|Other virologic failure criteria|0
7662121|NCT01425203|26653139|P3|Crossover Phase|Failure at futility timepoint|3
7662122|NCT01425203|26653140|P2|Crossover Phase|Failure at futility timepoint|0
7662123|NCT01425203|26653141|P1|Crossover Phase|Failure at futility timepoint|0
7662124|NCT01425203|26653139|P3|Treatment Phase|Did not receive treatment|0
7662125|NCT01425203|26653140|P2|Treatment Phase|Did not receive treatment|1
7662126|NCT01425203|26653141|P1|Treatment Phase|Did not receive treatment|0
7662127|NCT01425203|26653139|P3|Treatment Phase|Unidentified reasons|0
7662128|NCT01425203|26653140|P2|Treatment Phase|Unidentified reasons|5
7662129|NCT01425203|26653141|P1|Treatment Phase|Unidentified reasons|11
7662130|NCT01425203|26653139|P3|Treatment Phase|Other virologic failure criteria|0
7662131|NCT01425203|26653140|P2|Treatment Phase|Other virologic failure criteria|3
7662132|NCT01425203|26653141|P1|Treatment Phase|Other virologic failure criteria|5
7662133|NCT01425203|26653139|P3|Treatment Phase|Failure at futility timepoint|0
7662134|NCT01425203|26653140|P2|Treatment Phase|Failure at futility timepoint|27
7662135|NCT01425203|26653141|P1|Treatment Phase|Failure at futility timepoint|8
7662136|NCT01425203|26653139|P3|Treatment Phase|DC during PR Lead-in Phase|0
7662137|NCT01425203|26653140|P2|Treatment Phase|DC during PR Lead-in Phase|1
7662138|NCT01425203|26653141|P1|Treatment Phase|DC during PR Lead-in Phase|3
7662139|NCT01425190|26653158|P3|Overall Study|Full dose not consumed.|0
7662140|NCT01425190|26653159|P2|Overall Study|Full dose not consumed.|0
7662141|NCT01425190|26653160|P1|Overall Study|Full dose not consumed.|1
7662142|NCT01425008|26653196|P19|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
7662143|NCT01425008|26653197|P18|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662144|NCT01425008|26653198|P17|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662145|NCT01425008|26653199|P16|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662146|NCT01425008|26653200|P15|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662147|NCT01425008|26653201|P14|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662148|NCT01425008|26653202|P13|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662149|NCT01425008|26653203|P12|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662150|NCT01425008|26653204|P11|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662151|NCT01425008|26653205|P10|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662152|NCT01425008|26653206|P9|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662153|NCT01425008|26653207|P8|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662154|NCT01425008|26653208|P7|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662155|NCT01425008|26653209|P6|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662156|NCT01425008|26653210|P5|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662157|NCT01425008|26653211|P4|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662158|NCT01425008|26653212|P3|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662159|NCT01425008|26653213|P2|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662160|NCT01425008|26653214|P1|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7662161|NCT01425008|26653196|P19|Dose Expansion Phase|Lost to Follow-up|0
7662162|NCT01425008|26653197|P18|Dose Expansion Phase|Lost to Follow-up|0
7662163|NCT01425008|26653198|P17|Dose Expansion Phase|Lost to Follow-up|1
7662164|NCT01425008|26653199|P16|Dose Expansion Phase|Lost to Follow-up|0
7662165|NCT01425008|26653200|P15|Dose Expansion Phase|Lost to Follow-up|0
7662166|NCT01425008|26653201|P14|Dose Expansion Phase|Lost to Follow-up|0
7662167|NCT01425008|26653202|P13|Dose Expansion Phase|Lost to Follow-up|0
7662168|NCT01425008|26653203|P12|Dose Expansion Phase|Lost to Follow-up|0
7662169|NCT01425008|26653204|P11|Dose Expansion Phase|Lost to Follow-up|0
7662170|NCT01425008|26653205|P10|Dose Expansion Phase|Lost to Follow-up|0
7662171|NCT01425008|26653206|P9|Dose Expansion Phase|Lost to Follow-up|0
7662172|NCT01425008|26653207|P8|Dose Expansion Phase|Lost to Follow-up|0
7662173|NCT01425008|26653208|P7|Dose Expansion Phase|Lost to Follow-up|0
7662174|NCT01425008|26653209|P6|Dose Expansion Phase|Lost to Follow-up|0
7662175|NCT01425008|26653210|P5|Dose Expansion Phase|Lost to Follow-up|0
7662176|NCT01425008|26653211|P4|Dose Expansion Phase|Lost to Follow-up|0
7662177|NCT01425008|26653212|P3|Dose Expansion Phase|Lost to Follow-up|0
7662178|NCT01425008|26653213|P2|Dose Expansion Phase|Lost to Follow-up|0
7662179|NCT01425008|26653214|P1|Dose Expansion Phase|Lost to Follow-up|0
7662180|NCT01425008|26653196|P19|Dose Expansion Phase|Adverse Event|3
7662181|NCT01425008|26653197|P18|Dose Expansion Phase|Adverse Event|0
7662182|NCT01425008|26653198|P17|Dose Expansion Phase|Adverse Event|5
7662183|NCT01425008|26653199|P16|Dose Expansion Phase|Adverse Event|1
7662184|NCT01425008|26653200|P15|Dose Expansion Phase|Adverse Event|1
7662185|NCT01425008|26653201|P14|Dose Expansion Phase|Adverse Event|0
7662186|NCT01425008|26653202|P13|Dose Expansion Phase|Adverse Event|3
7662187|NCT01425008|26653203|P12|Dose Expansion Phase|Adverse Event|3
7662188|NCT01425008|26653204|P11|Dose Expansion Phase|Adverse Event|2
7662189|NCT01425008|26653205|P10|Dose Expansion Phase|Adverse Event|0
7662190|NCT01425008|26653206|P9|Dose Expansion Phase|Adverse Event|0
7662191|NCT01425008|26653207|P8|Dose Expansion Phase|Adverse Event|0
7662192|NCT01425008|26653208|P7|Dose Expansion Phase|Adverse Event|0
7662193|NCT01425008|26653209|P6|Dose Expansion Phase|Adverse Event|0
7662194|NCT01425008|26653210|P5|Dose Expansion Phase|Adverse Event|0
7662195|NCT01425008|26653211|P4|Dose Expansion Phase|Adverse Event|0
7662196|NCT01425008|26653212|P3|Dose Expansion Phase|Adverse Event|0
7662197|NCT01425008|26653213|P2|Dose Expansion Phase|Adverse Event|0
7662198|NCT01425008|26653214|P1|Dose Expansion Phase|Adverse Event|0
7662199|NCT01425008|26653196|P19|Dose Expansion Phase|Symptomatic Deterioration|1
7662200|NCT01425008|26653197|P18|Dose Expansion Phase|Symptomatic Deterioration|0
7662201|NCT01425008|26653198|P17|Dose Expansion Phase|Symptomatic Deterioration|2
7662202|NCT01425008|26653199|P16|Dose Expansion Phase|Symptomatic Deterioration|1
7662203|NCT01425008|26653200|P15|Dose Expansion Phase|Symptomatic Deterioration|0
7662204|NCT01425008|26653201|P14|Dose Expansion Phase|Symptomatic Deterioration|0
7662205|NCT01425008|26653202|P13|Dose Expansion Phase|Symptomatic Deterioration|0
7662206|NCT01425008|26653203|P12|Dose Expansion Phase|Symptomatic Deterioration|1
7662207|NCT01425008|26653204|P11|Dose Expansion Phase|Symptomatic Deterioration|2
7662208|NCT01425008|26653205|P10|Dose Expansion Phase|Symptomatic Deterioration|0
7662209|NCT01425008|26653206|P9|Dose Expansion Phase|Symptomatic Deterioration|0
7662210|NCT01425008|26653207|P8|Dose Expansion Phase|Symptomatic Deterioration|0
7662211|NCT01425008|26653208|P7|Dose Expansion Phase|Symptomatic Deterioration|0
7662212|NCT01425008|26653209|P6|Dose Expansion Phase|Symptomatic Deterioration|0
7662213|NCT01425008|26653210|P5|Dose Expansion Phase|Symptomatic Deterioration|0
7662214|NCT01425008|26653211|P4|Dose Expansion Phase|Symptomatic Deterioration|0
7662215|NCT01425008|26653212|P3|Dose Expansion Phase|Symptomatic Deterioration|0
7662216|NCT01425008|26653213|P2|Dose Expansion Phase|Symptomatic Deterioration|0
7662217|NCT01425008|26653214|P1|Dose Expansion Phase|Symptomatic Deterioration|0
7662218|NCT01425008|26653196|P19|Dose Expansion Phase|Other|4
7662219|NCT01425008|26653197|P18|Dose Expansion Phase|Other|0
7662220|NCT01425008|26653198|P17|Dose Expansion Phase|Other|2
7662221|NCT01425008|26653199|P16|Dose Expansion Phase|Other|0
7662222|NCT01425008|26653200|P15|Dose Expansion Phase|Other|0
7662223|NCT01425008|26653201|P14|Dose Expansion Phase|Other|0
7662224|NCT01425008|26653202|P13|Dose Expansion Phase|Other|1
7662225|NCT01425008|26653203|P12|Dose Expansion Phase|Other|0
7662226|NCT01425008|26653204|P11|Dose Expansion Phase|Other|0
7662227|NCT01425008|26653205|P10|Dose Expansion Phase|Other|0
7662228|NCT01425008|26653206|P9|Dose Expansion Phase|Other|0
7662229|NCT01425008|26653207|P8|Dose Expansion Phase|Other|0
7662230|NCT01425008|26653208|P7|Dose Expansion Phase|Other|0
7662231|NCT01425008|26653209|P6|Dose Expansion Phase|Other|0
7662232|NCT01425008|26653210|P5|Dose Expansion Phase|Other|0
7662233|NCT01425008|26653211|P4|Dose Expansion Phase|Other|0
7662234|NCT01425008|26653212|P3|Dose Expansion Phase|Other|0
7662235|NCT01425008|26653213|P2|Dose Expansion Phase|Other|0
7662236|NCT01425008|26653214|P1|Dose Expansion Phase|Other|0
7662237|NCT01425008|26653196|P19|Dose Expansion Phase|Withdrawal by Subject|0
7662238|NCT01425008|26653197|P18|Dose Expansion Phase|Withdrawal by Subject|0
7662239|NCT01425008|26653198|P17|Dose Expansion Phase|Withdrawal by Subject|1
7662240|NCT01425008|26653199|P16|Dose Expansion Phase|Withdrawal by Subject|1
7662241|NCT01425008|26653200|P15|Dose Expansion Phase|Withdrawal by Subject|0
7662242|NCT01425008|26653201|P14|Dose Expansion Phase|Withdrawal by Subject|0
7662243|NCT01425008|26653202|P13|Dose Expansion Phase|Withdrawal by Subject|0
7662244|NCT01425008|26653203|P12|Dose Expansion Phase|Withdrawal by Subject|0
7662245|NCT01425008|26653204|P11|Dose Expansion Phase|Withdrawal by Subject|1
7662246|NCT01425008|26653205|P10|Dose Expansion Phase|Withdrawal by Subject|0
7662247|NCT01425008|26653206|P9|Dose Expansion Phase|Withdrawal by Subject|0
7662248|NCT01425008|26653207|P8|Dose Expansion Phase|Withdrawal by Subject|0
7662249|NCT01425008|26653208|P7|Dose Expansion Phase|Withdrawal by Subject|0
7662250|NCT01425008|26653209|P6|Dose Expansion Phase|Withdrawal by Subject|0
7662251|NCT01425008|26653210|P5|Dose Expansion Phase|Withdrawal by Subject|0
7662252|NCT01425008|26653211|P4|Dose Expansion Phase|Withdrawal by Subject|0
7662253|NCT01425008|26653212|P3|Dose Expansion Phase|Withdrawal by Subject|0
7662254|NCT01425008|26653213|P2|Dose Expansion Phase|Withdrawal by Subject|0
7662255|NCT01425008|26653214|P1|Dose Expansion Phase|Withdrawal by Subject|0
7662256|NCT01425008|26653196|P19|Dose Expansion Phase|Progressive Disease|10
7662257|NCT01425008|26653197|P18|Dose Expansion Phase|Progressive Disease|2
7662258|NCT01425008|26653198|P17|Dose Expansion Phase|Progressive Disease|9
7662259|NCT01425008|26653199|P16|Dose Expansion Phase|Progressive Disease|8
7662260|NCT01425008|26653200|P15|Dose Expansion Phase|Progressive Disease|5
7662261|NCT01425008|26653201|P14|Dose Expansion Phase|Progressive Disease|1
7662262|NCT01425008|26653202|P13|Dose Expansion Phase|Progressive Disease|12
7662263|NCT01425008|26653203|P12|Dose Expansion Phase|Progressive Disease|4
7662264|NCT01425008|26653204|P11|Dose Expansion Phase|Progressive Disease|10
7662265|NCT01425008|26653205|P10|Dose Expansion Phase|Progressive Disease|0
7662266|NCT01425008|26653206|P9|Dose Expansion Phase|Progressive Disease|0
7662267|NCT01425008|26653207|P8|Dose Expansion Phase|Progressive Disease|0
7662268|NCT01425008|26653208|P7|Dose Expansion Phase|Progressive Disease|0
7662269|NCT01425008|26653209|P6|Dose Expansion Phase|Progressive Disease|0
7662270|NCT01425008|26653210|P5|Dose Expansion Phase|Progressive Disease|0
7662271|NCT01425008|26653211|P4|Dose Expansion Phase|Progressive Disease|0
7662272|NCT01425008|26653212|P3|Dose Expansion Phase|Progressive Disease|0
7662273|NCT01425008|26653213|P2|Dose Expansion Phase|Progressive Disease|0
7662274|NCT01425008|26653214|P1|Dose Expansion Phase|Progressive Disease|0
7662275|NCT01425008|26653196|P19|Dose Escalation Phase|Other|0
7662276|NCT01425008|26653197|P18|Dose Escalation Phase|Other|0
7662277|NCT01425008|26653198|P17|Dose Escalation Phase|Other|0
7662278|NCT01425008|26653199|P16|Dose Escalation Phase|Other|0
7662279|NCT01425008|26653200|P15|Dose Escalation Phase|Other|0
7662280|NCT01425008|26653201|P14|Dose Escalation Phase|Other|0
7662281|NCT01425008|26653202|P13|Dose Escalation Phase|Other|0
7662282|NCT01425008|26653203|P12|Dose Escalation Phase|Other|0
7662283|NCT01425008|26653204|P11|Dose Escalation Phase|Other|0
7662284|NCT01425008|26653205|P10|Dose Escalation Phase|Other|0
7662285|NCT01425008|26653206|P9|Dose Escalation Phase|Other|1
7662286|NCT01425008|26653207|P8|Dose Escalation Phase|Other|0
7662287|NCT01425008|26653208|P7|Dose Escalation Phase|Other|0
7662288|NCT01425008|26653209|P6|Dose Escalation Phase|Other|0
7662289|NCT01425008|26653210|P5|Dose Escalation Phase|Other|0
7662290|NCT01425008|26653211|P4|Dose Escalation Phase|Other|0
7662291|NCT01425008|26653212|P3|Dose Escalation Phase|Other|0
7662292|NCT01425008|26653213|P2|Dose Escalation Phase|Other|0
7662293|NCT01425008|26653214|P1|Dose Escalation Phase|Other|0
7662294|NCT01425008|26653196|P19|Dose Escalation Phase|Symptomatic Deterioration|0
7662295|NCT01425008|26653197|P18|Dose Escalation Phase|Symptomatic Deterioration|0
7662296|NCT01425008|26653198|P17|Dose Escalation Phase|Symptomatic Deterioration|0
7662297|NCT01425008|26653199|P16|Dose Escalation Phase|Symptomatic Deterioration|0
7662298|NCT01425008|26653200|P15|Dose Escalation Phase|Symptomatic Deterioration|0
7662299|NCT01425008|26653201|P14|Dose Escalation Phase|Symptomatic Deterioration|0
7662300|NCT01425008|26653202|P13|Dose Escalation Phase|Symptomatic Deterioration|0
7662301|NCT01425008|26653203|P12|Dose Escalation Phase|Symptomatic Deterioration|0
7662302|NCT01425008|26653204|P11|Dose Escalation Phase|Symptomatic Deterioration|0
7662303|NCT01425008|26653205|P10|Dose Escalation Phase|Symptomatic Deterioration|2
7662304|NCT01425008|26653206|P9|Dose Escalation Phase|Symptomatic Deterioration|2
7662305|NCT01425008|26653207|P8|Dose Escalation Phase|Symptomatic Deterioration|0
7662306|NCT01425008|26653208|P7|Dose Escalation Phase|Symptomatic Deterioration|0
7662307|NCT01425008|26653209|P6|Dose Escalation Phase|Symptomatic Deterioration|0
7662308|NCT01425008|26653210|P5|Dose Escalation Phase|Symptomatic Deterioration|0
7662309|NCT01425008|26653211|P4|Dose Escalation Phase|Symptomatic Deterioration|0
7662310|NCT01425008|26653212|P3|Dose Escalation Phase|Symptomatic Deterioration|1
7662311|NCT01425008|26653213|P2|Dose Escalation Phase|Symptomatic Deterioration|0
7662312|NCT01425008|26653214|P1|Dose Escalation Phase|Symptomatic Deterioration|0
7662313|NCT01425008|26653196|P19|Dose Escalation Phase|Withdrawal by Subject|0
7662314|NCT01425008|26653197|P18|Dose Escalation Phase|Withdrawal by Subject|0
7662315|NCT01425008|26653198|P17|Dose Escalation Phase|Withdrawal by Subject|0
7662316|NCT01425008|26653199|P16|Dose Escalation Phase|Withdrawal by Subject|0
7662317|NCT01425008|26653200|P15|Dose Escalation Phase|Withdrawal by Subject|0
7662318|NCT01425008|26653201|P14|Dose Escalation Phase|Withdrawal by Subject|0
7662319|NCT01425008|26653202|P13|Dose Escalation Phase|Withdrawal by Subject|0
7662320|NCT01425008|26653203|P12|Dose Escalation Phase|Withdrawal by Subject|0
7662321|NCT01425008|26653204|P11|Dose Escalation Phase|Withdrawal by Subject|0
7662322|NCT01425008|26653205|P10|Dose Escalation Phase|Withdrawal by Subject|0
7662323|NCT01425008|26653206|P9|Dose Escalation Phase|Withdrawal by Subject|1
7662324|NCT01425008|26653207|P8|Dose Escalation Phase|Withdrawal by Subject|0
7662325|NCT01425008|26653208|P7|Dose Escalation Phase|Withdrawal by Subject|1
7662326|NCT01425008|26653209|P6|Dose Escalation Phase|Withdrawal by Subject|1
7662327|NCT01425008|26653210|P5|Dose Escalation Phase|Withdrawal by Subject|1
7662328|NCT01425008|26653211|P4|Dose Escalation Phase|Withdrawal by Subject|0
7662329|NCT01425008|26653212|P3|Dose Escalation Phase|Withdrawal by Subject|0
7662330|NCT01425008|26653213|P2|Dose Escalation Phase|Withdrawal by Subject|0
7662331|NCT01425008|26653214|P1|Dose Escalation Phase|Withdrawal by Subject|0
7662332|NCT01425008|26653196|P19|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662333|NCT01425008|26653197|P18|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662334|NCT01425008|26653198|P17|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662335|NCT01425008|26653199|P16|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662336|NCT01425008|26653200|P15|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662337|NCT01425008|26653201|P14|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662338|NCT01425008|26653202|P13|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662339|NCT01425008|26653203|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662340|NCT01425008|26653204|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662341|NCT01425008|26653205|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662342|NCT01425008|26653206|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7662343|NCT01425008|26653207|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7662344|NCT01425008|26653208|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
7662345|NCT01425008|26653209|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662346|NCT01425008|26653210|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7662347|NCT01425008|26653211|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662348|NCT01425008|26653212|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662349|NCT01425008|26653213|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662350|NCT01425008|26653214|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7662351|NCT01425008|26653196|P19|Dose Escalation Phase|Adverse Event|0
7662352|NCT01425008|26653197|P18|Dose Escalation Phase|Adverse Event|0
7662353|NCT01425008|26653198|P17|Dose Escalation Phase|Adverse Event|0
7662354|NCT01425008|26653199|P16|Dose Escalation Phase|Adverse Event|0
7662355|NCT01425008|26653200|P15|Dose Escalation Phase|Adverse Event|0
7662356|NCT01425008|26653201|P14|Dose Escalation Phase|Adverse Event|0
7662357|NCT01425008|26653202|P13|Dose Escalation Phase|Adverse Event|0
7662358|NCT01425008|26653203|P12|Dose Escalation Phase|Adverse Event|0
7662359|NCT01425008|26653204|P11|Dose Escalation Phase|Adverse Event|0
7662360|NCT01425008|26653205|P10|Dose Escalation Phase|Adverse Event|0
7662361|NCT01425008|26653206|P9|Dose Escalation Phase|Adverse Event|2
7662362|NCT01425008|26653207|P8|Dose Escalation Phase|Adverse Event|0
7662363|NCT01425008|26653208|P7|Dose Escalation Phase|Adverse Event|0
7662364|NCT01425008|26653209|P6|Dose Escalation Phase|Adverse Event|2
7662365|NCT01425008|26653210|P5|Dose Escalation Phase|Adverse Event|0
7662366|NCT01425008|26653211|P4|Dose Escalation Phase|Adverse Event|0
7662367|NCT01425008|26653212|P3|Dose Escalation Phase|Adverse Event|0
7662368|NCT01425008|26653213|P2|Dose Escalation Phase|Adverse Event|0
7662369|NCT01425008|26653214|P1|Dose Escalation Phase|Adverse Event|2
7662370|NCT01425008|26653196|P19|Dose Escalation Phase|Progressive Disease|0
7662371|NCT01425008|26653197|P18|Dose Escalation Phase|Progressive Disease|0
7662372|NCT01425008|26653198|P17|Dose Escalation Phase|Progressive Disease|0
7662373|NCT01425008|26653199|P16|Dose Escalation Phase|Progressive Disease|0
7662374|NCT01425008|26653200|P15|Dose Escalation Phase|Progressive Disease|0
7662375|NCT01425008|26653201|P14|Dose Escalation Phase|Progressive Disease|0
7662376|NCT01425008|26653202|P13|Dose Escalation Phase|Progressive Disease|0
7662377|NCT01425008|26653203|P12|Dose Escalation Phase|Progressive Disease|0
7662378|NCT01425008|26653204|P11|Dose Escalation Phase|Progressive Disease|0
7662379|NCT01425008|26653205|P10|Dose Escalation Phase|Progressive Disease|2
7662380|NCT01425008|26653206|P9|Dose Escalation Phase|Progressive Disease|6
7662381|NCT01425008|26653207|P8|Dose Escalation Phase|Progressive Disease|2
7662382|NCT01425008|26653208|P7|Dose Escalation Phase|Progressive Disease|0
7662383|NCT01425008|26653209|P6|Dose Escalation Phase|Progressive Disease|4
7662384|NCT01425008|26653210|P5|Dose Escalation Phase|Progressive Disease|5
7662385|NCT01425008|26653211|P4|Dose Escalation Phase|Progressive Disease|3
7662386|NCT01425008|26653212|P3|Dose Escalation Phase|Progressive Disease|2
7662387|NCT01425008|26653213|P2|Dose Escalation Phase|Progressive Disease|3
7662388|NCT01425008|26653214|P1|Dose Escalation Phase|Progressive Disease|2
7662389|NCT01424930|26653517|P2|Overall Study|Reason not specified|6
7662390|NCT01424930|26653518|P1|Overall Study|Reason not specified|0
7662391|NCT01424930|26653517|P2|Overall Study|Screen Failure|1
7662392|NCT01424930|26653518|P1|Overall Study|Screen Failure|0
7662393|NCT01424930|26653517|P2|Overall Study|Progressive Disease|6
7662394|NCT01424930|26653518|P1|Overall Study|Progressive Disease|3
7662395|NCT01424930|26653517|P2|Overall Study|Death|0
7662396|NCT01424930|26653518|P1|Overall Study|Death|1
7662397|NCT01424930|26653517|P2|Overall Study|Adverse Event|1
7662398|NCT01424930|26653518|P1|Overall Study|Adverse Event|0
7662399|NCT01424813|26653532|P2|Overall Study|Other|2
7662400|NCT01424813|26653533|P1|Overall Study|Other|1
7662401|NCT01424813|26653532|P2|Overall Study|Protocol Violation|0
7662402|NCT01424813|26653533|P1|Overall Study|Protocol Violation|1
7662403|NCT01424813|26653532|P2|Overall Study|Withdrawal by Subject|0
7662404|NCT01424813|26653533|P1|Overall Study|Withdrawal by Subject|3
7662405|NCT01424722|26653551|P1|Overall Study|Sponsor terminated investigation|2258
7662406|NCT01424670|26653557|P2|Continuation Period|Withdrawal by Subject|4
7662407|NCT01424670|26653558|P1|Continuation Period|Withdrawal by Subject|13
7662408|NCT01424670|26653557|P2|Continuation Period|Physician Decision|4
7662409|NCT01424670|26653558|P1|Continuation Period|Physician Decision|5
7662410|NCT01424670|26653557|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
7662411|NCT01424670|26653558|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
7662412|NCT01424670|26653557|P2|Continuation Period|Lost to Follow-up|0
7662413|NCT01424670|26653558|P1|Continuation Period|Lost to Follow-up|2
7662414|NCT01424670|26653557|P2|Continuation Period|Adverse Event|5
7662415|NCT01424670|26653558|P1|Continuation Period|Adverse Event|13
7662416|NCT01424670|26653557|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
7662417|NCT01424670|26653558|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
7662418|NCT01424670|26653557|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
7662419|NCT01424670|26653558|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
7662420|NCT01424670|26653557|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
7662421|NCT01424670|26653558|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
7662422|NCT01424670|26653557|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
7662423|NCT01424670|26653558|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
7662424|NCT01424670|26653557|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
7662425|NCT01424670|26653558|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
7662426|NCT01424644|26653580|P2|Overall Study|Unable to Classify|0
7662427|NCT01424644|26653581|P1|Overall Study|Unable to Classify|1
7662428|NCT01424644|26653580|P2|Overall Study|Administrative Reason|0
7662429|NCT01424644|26653581|P1|Overall Study|Administrative Reason|1
7662430|NCT01424644|26653580|P2|Overall Study|Protocol Violation|3
7662431|NCT01424644|26653581|P1|Overall Study|Protocol Violation|4
7662432|NCT01424644|26653580|P2|Overall Study|Lost to Follow-up|12
7662433|NCT01424644|26653581|P1|Overall Study|Lost to Follow-up|16
7662434|NCT01424644|26653580|P2|Overall Study|Withdrawal by Subject|12
7662435|NCT01424644|26653581|P1|Overall Study|Withdrawal by Subject|9
7662436|NCT01424644|26653580|P2|Overall Study|Adverse Event|0
7662437|NCT01424644|26653581|P1|Overall Study|Adverse Event|2
7662438|NCT01424566|26653595|P3|Double-blind Treatment|Lack of Efficacy|1
7662439|NCT01424566|26653596|P2|Double-blind Treatment|Lack of Efficacy|1
7662440|NCT01424566|26653597|P1|Double-blind Treatment|Lack of Efficacy|0
7662441|NCT01424566|26653595|P3|Double-blind Treatment|Withdrawal by Investigator|1
7662442|NCT01424566|26653596|P2|Double-blind Treatment|Withdrawal by Investigator|1
7662443|NCT01424566|26653597|P1|Double-blind Treatment|Withdrawal by Investigator|0
7662444|NCT01424566|26653595|P3|Double-blind Treatment|Withdrawal by Subject|0
7662445|NCT01424566|26653596|P2|Double-blind Treatment|Withdrawal by Subject|2
7662446|NCT01424566|26653597|P1|Double-blind Treatment|Withdrawal by Subject|0
7662447|NCT01424566|26653595|P3|Double-blind Treatment|Adverse Event|13
7662448|NCT01424566|26653596|P2|Double-blind Treatment|Adverse Event|21
7662449|NCT01424566|26653597|P1|Double-blind Treatment|Adverse Event|0
7662450|NCT01424566|26653595|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
7662451|NCT01424566|26653596|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
7662452|NCT01424566|26653597|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
7662453|NCT01424566|26653595|P3|Single-blind Treatment|Met Exclusion Criteria|0
7662454|NCT01424566|26653596|P2|Single-blind Treatment|Met Exclusion Criteria|0
7662455|NCT01424566|26653597|P1|Single-blind Treatment|Met Exclusion Criteria|1
7662456|NCT01424566|26653595|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7662457|NCT01424566|26653596|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7662458|NCT01424566|26653597|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
7662459|NCT01424566|26653595|P3|Single-blind Treatment|Withdrawal by Investigator|0
7662460|NCT01424566|26653596|P2|Single-blind Treatment|Withdrawal by Investigator|0
7662461|NCT01424566|26653597|P1|Single-blind Treatment|Withdrawal by Investigator|2
7662462|NCT01424566|26653595|P3|Single-blind Treatment|Withdrawal by Subject|0
7662463|NCT01424566|26653596|P2|Single-blind Treatment|Withdrawal by Subject|0
7662464|NCT01424566|26653597|P1|Single-blind Treatment|Withdrawal by Subject|16
7662465|NCT01424566|26653595|P3|Single-blind Treatment|Adverse Event|0
7662466|NCT01424566|26653596|P2|Single-blind Treatment|Adverse Event|0
7662467|NCT01424566|26653597|P1|Single-blind Treatment|Adverse Event|71
7662468|NCT01424514|26653624|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
7662469|NCT01424514|26653625|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
7662470|NCT01424514|26653624|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7662471|NCT01424514|26653625|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7662472|NCT01424501|26653670|P6|Overall Study|Lost to Follow-up|0
7662473|NCT01424501|26653671|P5|Overall Study|Lost to Follow-up|0
7662474|NCT01424501|26653672|P4|Overall Study|Lost to Follow-up|0
7662475|NCT01424501|26653673|P3|Overall Study|Lost to Follow-up|1
7662476|NCT01424501|26653674|P2|Overall Study|Lost to Follow-up|1
7662477|NCT01424501|26653675|P1|Overall Study|Lost to Follow-up|0
7662478|NCT01424501|26653670|P6|Overall Study|Withdrawal by Subject|0
7662479|NCT01424501|26653671|P5|Overall Study|Withdrawal by Subject|0
7662480|NCT01424501|26653672|P4|Overall Study|Withdrawal by Subject|0
7662481|NCT01424501|26653673|P3|Overall Study|Withdrawal by Subject|1
7662482|NCT01424501|26653674|P2|Overall Study|Withdrawal by Subject|0
7662483|NCT01424501|26653675|P1|Overall Study|Withdrawal by Subject|1
7662484|NCT01424397|26653851|P12|Period-2 (8 Days)|Withdrawal by Subject|0
7662485|NCT01424397|26653852|P11|Period-2 (8 Days)|Withdrawal by Subject|0
7662486|NCT01424397|26653853|P10|Period-2 (8 Days)|Withdrawal by Subject|0
7662487|NCT01424397|26653854|P9|Period-2 (8 Days)|Withdrawal by Subject|0
7662488|NCT01424397|26653855|P8|Period-2 (8 Days)|Withdrawal by Subject|0
7662489|NCT01424397|26653856|P7|Period-2 (8 Days)|Withdrawal by Subject|0
7662490|NCT01424397|26653857|P6|Period-2 (8 Days)|Withdrawal by Subject|0
7662491|NCT01424397|26653858|P5|Period-2 (8 Days)|Withdrawal by Subject|0
7662492|NCT01424397|26653859|P4|Period-2 (8 Days)|Withdrawal by Subject|0
7662493|NCT01424397|26653860|P3|Period-2 (8 Days)|Withdrawal by Subject|1
7662494|NCT01424397|26653861|P2|Period-2 (8 Days)|Withdrawal by Subject|0
7662495|NCT01424397|26653862|P1|Period-2 (8 Days)|Withdrawal by Subject|0
7662496|NCT01424306|26653908|P6|Overall Study|Protocol Violation|0
7662497|NCT01424306|26653909|P5|Overall Study|Protocol Violation|1
7662498|NCT01424306|26653910|P4|Overall Study|Protocol Violation|0
7662499|NCT01424306|26653911|P3|Overall Study|Protocol Violation|0
7662500|NCT01424306|26653912|P2|Overall Study|Protocol Violation|0
7662501|NCT01424306|26653913|P1|Overall Study|Protocol Violation|0
7662502|NCT01424228|26653966|P2|Overall Study|Unplanned journey|1
7662503|NCT01424228|26653967|P1|Overall Study|Unplanned journey|0
7662504|NCT01424228|26653966|P2|Overall Study|Worsening of symptoms|0
7662505|NCT01424228|26653967|P1|Overall Study|Worsening of symptoms|1
7662506|NCT01424228|26653966|P2|Overall Study|Non-compliance|0
7662507|NCT01424228|26653967|P1|Overall Study|Non-compliance|2
7662508|NCT01424228|26653966|P2|Overall Study|inclusion/exclusion criteria not met|2
7662509|NCT01424228|26653967|P1|Overall Study|inclusion/exclusion criteria not met|2
7662510|NCT01424228|26653966|P2|Overall Study|Lack of Efficacy|7
7662511|NCT01424228|26653967|P1|Overall Study|Lack of Efficacy|5
7662512|NCT01424228|26653966|P2|Overall Study|Sponsor's decision|12
7662513|NCT01424228|26653967|P1|Overall Study|Sponsor's decision|9
7662514|NCT01424228|26653966|P2|Overall Study|Adverse Event|14
7662515|NCT01424228|26653967|P1|Overall Study|Adverse Event|10
7662516|NCT01424228|26653966|P2|Overall Study|Withdrawal by Subject|11
7662517|NCT01424228|26653967|P1|Overall Study|Withdrawal by Subject|27
7662518|NCT01424189|26654018|P2|Overall Study|Death|1
7662519|NCT01424189|26654019|P1|Overall Study|Death|3
7662520|NCT01424189|26654018|P2|Overall Study|Subject moved|0
7662521|NCT01424189|26654019|P1|Overall Study|Subject moved|1
7662522|NCT01424189|26654018|P2|Overall Study|Withdrawal by Subject|4
7662523|NCT01424189|26654019|P1|Overall Study|Withdrawal by Subject|4
7662524|NCT01424189|26654018|P2|Overall Study|Lost to Follow-up|1
7662525|NCT01424189|26654019|P1|Overall Study|Lost to Follow-up|4
7662526|NCT01424189|26654018|P2|Overall Study|Adverse Event|0
7662527|NCT01424189|26654019|P1|Overall Study|Adverse Event|1
7662528|NCT01423916|26654060|P3|Overall Study|Protocol Deviation|0
7662529|NCT01423916|26654061|P2|Overall Study|Protocol Deviation|0
7662530|NCT01423916|26654062|P1|Overall Study|Protocol Deviation|1
7662531|NCT01423916|26654060|P3|Overall Study|Withdrawal by Subject|3
7662532|NCT01423916|26654061|P2|Overall Study|Withdrawal by Subject|10
7662533|NCT01423916|26654062|P1|Overall Study|Withdrawal by Subject|3
7662534|NCT01423916|26654060|P3|Overall Study|Physician Decision|1
7662535|NCT01423916|26654061|P2|Overall Study|Physician Decision|0
7662536|NCT01423916|26654062|P1|Overall Study|Physician Decision|1
7662537|NCT01423916|26654060|P3|Overall Study|Met Withdrawal Criteria|1
7662538|NCT01423916|26654061|P2|Overall Study|Met Withdrawal Criteria|1
7662539|NCT01423916|26654062|P1|Overall Study|Met Withdrawal Criteria|1
7662540|NCT01423916|26654060|P3|Overall Study|Adverse Event|2
7662541|NCT01423916|26654061|P2|Overall Study|Adverse Event|9
7662542|NCT01423916|26654062|P1|Overall Study|Adverse Event|5
7662543|NCT01423812|26654118|P2|Overall Study|Withdrawal by Subject|2
7662544|NCT01423812|26654119|P1|Overall Study|Withdrawal by Subject|1
7662545|NCT01423812|26654118|P2|Overall Study|Lost to Follow-up|2
7662546|NCT01423812|26654119|P1|Overall Study|Lost to Follow-up|2
7662547|NCT01423617|26654147|P2|Overall Study|Lost to Follow-up|1
7662548|NCT01423617|26654148|P1|Overall Study|Lost to Follow-up|0
7662549|NCT01423604|26654165|P2|Randomized|Patient decision|9
7662550|NCT01423604|26654166|P1|Randomized|Patient decision|5
7662551|NCT01423604|26654165|P2|Randomized|Other - unspecified|31
7662552|NCT01423604|26654166|P1|Randomized|Other - unspecified|37
7662553|NCT01423604|26654165|P2|Randomized|Physician Decision|13
7662554|NCT01423604|26654166|P1|Randomized|Physician Decision|16
7662555|NCT01423604|26654165|P2|Randomized|Death|0
7662556|NCT01423604|26654166|P1|Randomized|Death|1
7662557|NCT01423604|26654165|P2|Randomized|Adverse Event|10
7662558|NCT01423604|26654166|P1|Randomized|Adverse Event|4
7662559|NCT01423604|26654165|P2|Safety Run-In|Patient decision|0
7662560|NCT01423604|26654166|P1|Safety Run-In|Patient decision|1
7662561|NCT01423604|26654165|P2|Safety Run-In|Disease progression|0
7662562|NCT01423604|26654166|P1|Safety Run-In|Disease progression|3
7662563|NCT01423604|26654165|P2|Safety Run-In|Physician Decision|0
7662564|NCT01423604|26654166|P1|Safety Run-In|Physician Decision|1
7662565|NCT01423604|26654165|P2|Safety Run-In|Death|0
7662566|NCT01423604|26654166|P1|Safety Run-In|Death|1
7662567|NCT01423604|26654165|P2|Safety Run-In|Adverse Event|0
7662568|NCT01423604|26654166|P1|Safety Run-In|Adverse Event|3
7662569|NCT01423253|26654181|P1|Overall Study|Withdrawal by Subject|2
7662570|NCT01423253|26654181|P1|Overall Study|Protocol Violation|2
7662571|NCT01423253|26654181|P1|Overall Study|Lost to Follow-up|1
7662572|NCT01423253|26654181|P1|Overall Study|Lack of Efficacy|2
7662573|NCT01423253|26654181|P1|Overall Study|Adverse Event|2
7662574|NCT01423084|26654203|P2|Overall Study|Withdrawal by Subject|3
7662575|NCT01423084|26654204|P1|Overall Study|Withdrawal by Subject|2
7662576|NCT01423084|26654203|P2|Overall Study|Adverse Event|1
7662577|NCT01423084|26654204|P1|Overall Study|Adverse Event|0
7662578|NCT01422915|26654234|P1|Overall Study|Adverse Event|1
7662579|NCT01422889|26654239|P1|Overall Study|No Data Entered for Study Stent|9
7662580|NCT01422876|26654254|P10|Week 52|Death|0
7662581|NCT01422876|26654255|P9|Week 52|Death|1
7662582|NCT01422876|26654256|P8|Week 52|Death|3
7662583|NCT01422876|26654257|P7|Week 52|Death|1
7662584|NCT01422876|26654258|P6|Week 52|Death|0
7662585|NCT01422876|26654259|P5|Week 52|Death|0
7662586|NCT01422876|26654260|P4|Week 52|Death|1
7662587|NCT01422876|26654261|P3|Week 52|Death|0
7662588|NCT01422876|26654262|P2|Week 52|Death|1
7662589|NCT01422876|26654263|P1|Week 52|Death|0
7662590|NCT01422876|26654254|P10|Week 52|Consent withdrawn|9
7662591|NCT01422876|26654255|P9|Week 52|Consent withdrawn|13
7662592|NCT01422876|26654256|P8|Week 52|Consent withdrawn|12
7662593|NCT01422876|26654257|P7|Week 52|Consent withdrawn|10
7662594|NCT01422876|26654258|P6|Week 52|Consent withdrawn|12
7662595|NCT01422876|26654259|P5|Week 52|Consent withdrawn|7
7662596|NCT01422876|26654260|P4|Week 52|Consent withdrawn|12
7662597|NCT01422876|26654261|P3|Week 52|Consent withdrawn|6
7662598|NCT01422876|26654262|P2|Week 52|Consent withdrawn|4
7662599|NCT01422876|26654263|P1|Week 52|Consent withdrawn|9
7662600|NCT01422876|26654254|P10|Week 52|Lost to Follow-up|8
7662601|NCT01422876|26654255|P9|Week 52|Lost to Follow-up|7
7662602|NCT01422876|26654256|P8|Week 52|Lost to Follow-up|8
7662603|NCT01422876|26654257|P7|Week 52|Lost to Follow-up|5
7662604|NCT01422876|26654258|P6|Week 52|Lost to Follow-up|5
7662605|NCT01422876|26654259|P5|Week 52|Lost to Follow-up|8
7662606|NCT01422876|26654260|P4|Week 52|Lost to Follow-up|5
7662607|NCT01422876|26654261|P3|Week 52|Lost to Follow-up|7
7662608|NCT01422876|26654262|P2|Week 52|Lost to Follow-up|5
7662609|NCT01422876|26654263|P1|Week 52|Lost to Follow-up|3
7662610|NCT01422876|26654254|P10|Week 24|Death|0
7662611|NCT01422876|26654255|P9|Week 24|Death|0
7662612|NCT01422876|26654256|P8|Week 24|Death|0
7662613|NCT01422876|26654257|P7|Week 24|Death|0
7662614|NCT01422876|26654258|P6|Week 24|Death|0
7662615|NCT01422876|26654259|P5|Week 24|Death|0
7662616|NCT01422876|26654260|P4|Week 24|Death|0
7662617|NCT01422876|26654261|P3|Week 24|Death|0
7662618|NCT01422876|26654262|P2|Week 24|Death|1
7662619|NCT01422876|26654263|P1|Week 24|Death|0
7662620|NCT01422876|26654254|P10|Week 24|Consent withdrawn|6
7662621|NCT01422876|26654255|P9|Week 24|Consent withdrawn|3
7662622|NCT01422876|26654256|P8|Week 24|Consent withdrawn|4
7662623|NCT01422876|26654257|P7|Week 24|Consent withdrawn|5
7662624|NCT01422876|26654258|P6|Week 24|Consent withdrawn|6
7662625|NCT01422876|26654259|P5|Week 24|Consent withdrawn|5
7662626|NCT01422876|26654260|P4|Week 24|Consent withdrawn|4
7662627|NCT01422876|26654261|P3|Week 24|Consent withdrawn|3
7662628|NCT01422876|26654262|P2|Week 24|Consent withdrawn|1
7662629|NCT01422876|26654263|P1|Week 24|Consent withdrawn|5
7662630|NCT01422876|26654254|P10|Week 24|Lost to Follow-up|4
7662631|NCT01422876|26654255|P9|Week 24|Lost to Follow-up|3
7662632|NCT01422876|26654256|P8|Week 24|Lost to Follow-up|3
7662633|NCT01422876|26654257|P7|Week 24|Lost to Follow-up|1
7662634|NCT01422876|26654258|P6|Week 24|Lost to Follow-up|0
7662635|NCT01422876|26654259|P5|Week 24|Lost to Follow-up|2
7662636|NCT01422876|26654260|P4|Week 24|Lost to Follow-up|4
7662637|NCT01422876|26654261|P3|Week 24|Lost to Follow-up|2
7662638|NCT01422876|26654262|P2|Week 24|Lost to Follow-up|1
7662639|NCT01422876|26654263|P1|Week 24|Lost to Follow-up|1
7662640|NCT01422850|26654310|P1|Overall Study|Physician Decision|3
7662641|NCT01422824|26654316|P1|Overall Study|Lost to Follow-up|37
7662642|NCT01422824|26654316|P1|Overall Study|Case record form not evaluated|1
7662643|NCT01422720|26654321|P1|Overall Study|Ineligibility|1
7662644|NCT01422720|26654321|P1|Overall Study|Withdrawal by Subject|4
7662645|NCT01422720|26654321|P1|Overall Study|Lack of Efficacy|1
7662646|NCT01422720|26654321|P1|Overall Study|Adverse Event|16
7662647|NCT01422538|26654332|P3|Overall Study|Missed visit|1
7662648|NCT01422538|26654333|P2|Overall Study|Missed visit|1
7662649|NCT01422538|26654334|P1|Overall Study|Missed visit|0
7662650|NCT01422538|26654332|P3|Overall Study|Lost to Follow-up|1
7662651|NCT01422538|26654333|P2|Overall Study|Lost to Follow-up|1
7662652|NCT01422538|26654334|P1|Overall Study|Lost to Follow-up|0
7662653|NCT01422408|26654378|P1|Overall Study|Withdrawal by Subject|3
7662654|NCT01422408|26654378|P1|Overall Study|Adverse Event|1
7662655|NCT01422382|26654407|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
7662656|NCT01422304|26654423|P2|Overall Study|Not Treated|11
7662657|NCT01422304|26654424|P1|Overall Study|Not Treated|3
7662658|NCT01422304|26654423|P2|Overall Study|Did Not Meet Protocol Eligibility|2
7662659|NCT01422304|26654424|P1|Overall Study|Did Not Meet Protocol Eligibility|0
7662660|NCT01422304|26654423|P2|Overall Study|Withdrawal by Subject|2
7662661|NCT01422304|26654424|P1|Overall Study|Withdrawal by Subject|4
7662662|NCT01422304|26654423|P2|Overall Study|Protocol Violation|0
7662663|NCT01422304|26654424|P1|Overall Study|Protocol Violation|1
7662664|NCT01422304|26654423|P2|Overall Study|Never Entered Follow-up|1
7662665|NCT01422304|26654424|P1|Overall Study|Never Entered Follow-up|2
7662666|NCT01422304|26654423|P2|Overall Study|Lost to Follow-up|20
7662667|NCT01422304|26654424|P1|Overall Study|Lost to Follow-up|14
7662668|NCT01422304|26654423|P2|Overall Study|Adverse Event|1
7662669|NCT01422304|26654424|P1|Overall Study|Adverse Event|0
7662670|NCT01422239|26654456|P2|Overall Study|Lost to Follow-up|3
7662671|NCT01422239|26654457|P1|Overall Study|Lost to Follow-up|4
7662672|NCT01422213|26654479|P3|Overall Study|Administrative or Other Reason(s)|2
7662673|NCT01422213|26654480|P2|Overall Study|Administrative or Other Reason(s)|4
7662674|NCT01422213|26654481|P1|Overall Study|Administrative or Other Reason(s)|5
7662675|NCT01422213|26654479|P3|Overall Study|Lost to Follow-up|5
7662676|NCT01422213|26654480|P2|Overall Study|Lost to Follow-up|3
7662677|NCT01422213|26654481|P1|Overall Study|Lost to Follow-up|3
7662678|NCT01422213|26654479|P3|Overall Study|Withdrawal of Consent|5
7662679|NCT01422213|26654480|P2|Overall Study|Withdrawal of Consent|3
7662680|NCT01422213|26654481|P1|Overall Study|Withdrawal of Consent|7
7662681|NCT01422213|26654479|P3|Overall Study|Protocol Violation|4
7662682|NCT01422213|26654480|P2|Overall Study|Protocol Violation|2
7662683|NCT01422213|26654481|P1|Overall Study|Protocol Violation|0
7662684|NCT01422213|26654479|P3|Overall Study|Non-compliance with study drug|0
7662685|NCT01422213|26654480|P2|Overall Study|Non-compliance with study drug|1
7662686|NCT01422213|26654481|P1|Overall Study|Non-compliance with study drug|0
7662687|NCT01422213|26654479|P3|Overall Study|Lack of Efficacy|2
7662688|NCT01422213|26654480|P2|Overall Study|Lack of Efficacy|2
7662689|NCT01422213|26654481|P1|Overall Study|Lack of Efficacy|10
7662690|NCT01422213|26654479|P3|Overall Study|Adverse Event|11
7662691|NCT01422213|26654480|P2|Overall Study|Adverse Event|7
7662692|NCT01422213|26654481|P1|Overall Study|Adverse Event|8
7662693|NCT01422187|26654553|P3|Overall Study|Lost to Follow-up|0
7662694|NCT01422187|26654554|P2|Overall Study|Lost to Follow-up|1
7662695|NCT01422187|26654555|P1|Overall Study|Lost to Follow-up|0
7662696|NCT01422187|26654553|P3|Overall Study|Personal reason|0
7662697|NCT01422187|26654554|P2|Overall Study|Personal reason|0
7662698|NCT01422187|26654555|P1|Overall Study|Personal reason|1
7662699|NCT01421719|26654619|P1|Overall Study|Withdrawal by Subject|4
7662700|NCT01421667|26654628|P4|Overall Study|Lost to Follow-up|0
7662701|NCT01421667|26654629|P3|Overall Study|Lost to Follow-up|0
7662702|NCT01421667|26654630|P2|Overall Study|Lost to Follow-up|1
7662703|NCT01421667|26654631|P1|Overall Study|Lost to Follow-up|0
7662704|NCT01421667|26654628|P4|Overall Study|Withdrawal by Subject|1
7662705|NCT01421667|26654629|P3|Overall Study|Withdrawal by Subject|2
7662706|NCT01421667|26654630|P2|Overall Study|Withdrawal by Subject|1
7662707|NCT01421667|26654631|P1|Overall Study|Withdrawal by Subject|0
7662708|NCT01421641|26654692|P2|Overall Study|Protocol Violation|2
7662709|NCT01421641|26654693|P1|Overall Study|Protocol Violation|2
7662710|NCT01421511|26654715|P2|Overall Study|Death|1
7662711|NCT01421511|26654716|P1|Overall Study|Death|1
7662712|NCT01421511|26654715|P2|Overall Study|Withdrawal by Subject|5
7662713|NCT01421511|26654716|P1|Overall Study|Withdrawal by Subject|6
7662714|NCT01421511|26654715|P2|Overall Study|Physician Decision|1
7662715|NCT01421511|26654716|P1|Overall Study|Physician Decision|0
7662716|NCT01421511|26654715|P2|Overall Study|Randomized but didn't receive study drug|7
7662717|NCT01421511|26654716|P1|Overall Study|Randomized but didn't receive study drug|1
7662718|NCT01421511|26654715|P2|Overall Study|Lost to Follow-up|14
7662719|NCT01421511|26654716|P1|Overall Study|Lost to Follow-up|11
7662720|NCT01421459|26654766|P2|Overall Study|Withdrawal by Subject|16
7662721|NCT01421459|26654767|P1|Overall Study|Withdrawal by Subject|12
7662722|NCT01421459|26654766|P2|Overall Study|Protocol Violation|5
7662723|NCT01421459|26654767|P1|Overall Study|Protocol Violation|8
7662724|NCT01421459|26654766|P2|Overall Study|Physician Decision|9
7662725|NCT01421459|26654767|P1|Overall Study|Physician Decision|9
7662726|NCT01421459|26654766|P2|Overall Study|Lost to Follow-up|9
7662727|NCT01421459|26654767|P1|Overall Study|Lost to Follow-up|8
7662728|NCT01421459|26654766|P2|Overall Study|Lack of Efficacy|2
7662729|NCT01421459|26654767|P1|Overall Study|Lack of Efficacy|1
7662730|NCT01421459|26654766|P2|Overall Study|Death|1
7662731|NCT01421459|26654767|P1|Overall Study|Death|1
7662732|NCT01421459|26654766|P2|Overall Study|Adverse Event|10
7662733|NCT01421459|26654767|P1|Overall Study|Adverse Event|6
7662734|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
7662735|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
7662736|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
7662737|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7662738|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7662739|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7662740|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
7662741|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
7662742|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
7662743|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
7662744|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
7662745|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
7662746|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
7662747|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
7662748|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
7662749|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
7662750|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
7662751|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
7662752|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
7662753|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
7662754|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
7662755|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
7662756|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
7662757|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
7662758|NCT01421342|26654808|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7662759|NCT01421342|26654809|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
7662760|NCT01421342|26654810|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7662761|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
7662762|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7662763|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7662764|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
7662765|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7662766|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7662767|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7662768|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7662769|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
7662770|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
7662771|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
7662772|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
7662773|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7662774|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
7662775|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7662776|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7662777|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7662778|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
7662779|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
7662780|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
7662861|NCT01420965|26654937|P3|Overall Study|Withdrawal by Subject|0
7662781|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
7662782|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
7662783|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
7662784|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
7662785|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
7662786|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
7662787|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
7662788|NCT01421342|26654808|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
7662789|NCT01421342|26654809|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
7662790|NCT01421342|26654810|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
7662791|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
7662792|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
7662793|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
7662794|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7662795|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
7662796|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7662797|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
7662798|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
7662799|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
7662800|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
7662801|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
7662802|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
7662803|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
7662804|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
7662805|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
7662806|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Death|3
7662807|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Death|0
7662808|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Death|0
7662809|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
7662810|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
7662811|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
7662812|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
7662813|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
7662814|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
7662815|NCT01421342|26654808|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
7662816|NCT01421342|26654809|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
7662817|NCT01421342|26654810|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
7662818|NCT01421303|26654827|P1|Overall Study|Withdrawal by Subject|1
7662819|NCT01421303|26654827|P1|Overall Study|Other|7
7662820|NCT01421303|26654827|P1|Overall Study|Non compliance with study procedure|1
7662821|NCT01421303|26654827|P1|Overall Study|Lost to Follow-up|13
7662822|NCT01421277|26654854|P2|Overall Study|Incomplete baseline data|31
7662823|NCT01421277|26654855|P1|Overall Study|Incomplete baseline data|0
7662824|NCT01421277|26654854|P2|Overall Study|Lack of qualifying event|61
7662825|NCT01421277|26654855|P1|Overall Study|Lack of qualifying event|0
7662826|NCT01421225|26654867|P2|Overall Study|Withdrawal by Subject|1
7662827|NCT01421225|26654868|P1|Overall Study|Withdrawal by Subject|0
7662828|NCT01421147|26654882|P2|Extension Period|Withdrawal by Subject|3
7662829|NCT01421147|26654883|P1|Extension Period|Withdrawal by Subject|5
7662830|NCT01421147|26654882|P2|Extension Period|Physician Decision|0
7662831|NCT01421147|26654883|P1|Extension Period|Physician Decision|1
7662832|NCT01421147|26654882|P2|Extension Period|Lost to Follow-up|5
7662833|NCT01421147|26654883|P1|Extension Period|Lost to Follow-up|2
7662834|NCT01421147|26654882|P2|Extension Period|Death|1
7662835|NCT01421147|26654883|P1|Extension Period|Death|0
7662836|NCT01421147|26654882|P2|Extension Period|Adverse Event|2
7662837|NCT01421147|26654883|P1|Extension Period|Adverse Event|0
7662838|NCT01421147|26654882|P2|Treatment Period|Withdrawal by Subject|5
7662839|NCT01421147|26654883|P1|Treatment Period|Withdrawal by Subject|10
7662840|NCT01421147|26654882|P2|Treatment Period|Physician Decision|2
7662841|NCT01421147|26654883|P1|Treatment Period|Physician Decision|2
7662842|NCT01421147|26654882|P2|Treatment Period|Lost to Follow-up|1
7662843|NCT01421147|26654883|P1|Treatment Period|Lost to Follow-up|2
7662844|NCT01421147|26654882|P2|Treatment Period|Adverse Event|3
7662845|NCT01421147|26654883|P1|Treatment Period|Adverse Event|2
7662846|NCT01421134|26654915|P2|Overall Study|Lost to Follow-up|1
7662847|NCT01421134|26654916|P1|Overall Study|Lost to Follow-up|1
7662848|NCT01421134|26654915|P2|Overall Study|Administrative|1
7662849|NCT01421134|26654916|P1|Overall Study|Administrative|0
7662850|NCT01421134|26654915|P2|Overall Study|Withdrawal by Subject|1
7662851|NCT01421134|26654916|P1|Overall Study|Withdrawal by Subject|1
7662852|NCT01421134|26654915|P2|Overall Study|Protocol Violation|3
7662853|NCT01421134|26654916|P1|Overall Study|Protocol Violation|0
7662854|NCT01421134|26654915|P2|Overall Study|Lack of Efficacy|4
7662855|NCT01421134|26654916|P1|Overall Study|Lack of Efficacy|2
7662856|NCT01421134|26654915|P2|Overall Study|Adverse Event|5
7662857|NCT01421134|26654916|P1|Overall Study|Adverse Event|3
7662858|NCT01420965|26654937|P3|Overall Study|Adverse Event|0
7662859|NCT01420965|26654938|P2|Overall Study|Adverse Event|1
7662860|NCT01420965|26654939|P1|Overall Study|Adverse Event|0
7662862|NCT01420965|26654938|P2|Overall Study|Withdrawal by Subject|0
7662863|NCT01420965|26654939|P1|Overall Study|Withdrawal by Subject|1
7662864|NCT01420926|26654952|P2|Overall Study|Continues on active treatment|3
7662865|NCT01420926|26654953|P1|Overall Study|Continues on active treatment|1
7662866|NCT01420926|26654952|P2|Overall Study|Physician Decision|5
7662867|NCT01420926|26654953|P1|Overall Study|Physician Decision|7
7662868|NCT01420926|26654952|P2|Overall Study|Non-protocol treatment|20
7662869|NCT01420926|26654953|P1|Overall Study|Non-protocol treatment|17
7662870|NCT01420926|26654952|P2|Overall Study|Withdrawal by Subject|16
7662871|NCT01420926|26654953|P1|Overall Study|Withdrawal by Subject|11
7662872|NCT01420926|26654952|P2|Overall Study|Death|17
7662873|NCT01420926|26654953|P1|Overall Study|Death|18
7662874|NCT01420926|26654952|P2|Overall Study|Adverse Event|4
7662875|NCT01420926|26654953|P1|Overall Study|Adverse Event|6
7662876|NCT01420627|26655000|P1|EZN-2279 Treatment Period|Adverse Event|1
7662877|NCT01420549|26655016|P2|Overall Study|Non-adherence to medication|1
7662878|NCT01420549|26655017|P1|Overall Study|Non-adherence to medication|4
7662879|NCT01420549|26655016|P2|Overall Study|Protocol Violation|1
7662880|NCT01420549|26655017|P1|Overall Study|Protocol Violation|0
7662881|NCT01420549|26655016|P2|Overall Study|Lost to Follow-up|2
7662882|NCT01420549|26655017|P1|Overall Study|Lost to Follow-up|2
7662883|NCT01420549|26655016|P2|Overall Study|Adverse Event|1
7662884|NCT01420549|26655017|P1|Overall Study|Adverse Event|1
7662885|NCT01420536|26655025|P2|Period 1 (30 Days)|Withdrawal by Subject|0
7662886|NCT01420536|26655026|P1|Period 1 (30 Days)|Withdrawal by Subject|3
7662887|NCT01420081|26655084|P9|Overall Study|Other Reasons|0
7662888|NCT01420081|26655085|P8|Overall Study|Other Reasons|0
7662889|NCT01420081|26655086|P7|Overall Study|Other Reasons|0
7662890|NCT01420081|26655087|P6|Overall Study|Other Reasons|0
7662891|NCT01420081|26655088|P5|Overall Study|Other Reasons|0
7662892|NCT01420081|26655089|P4|Overall Study|Other Reasons|0
7662893|NCT01420081|26655090|P3|Overall Study|Other Reasons|1
7662894|NCT01420081|26655091|P2|Overall Study|Other Reasons|0
7662895|NCT01420081|26655092|P1|Overall Study|Other Reasons|0
7662896|NCT01420081|26655084|P9|Overall Study|Subject Refused Futher Follow-up|0
7662897|NCT01420081|26655085|P8|Overall Study|Subject Refused Futher Follow-up|0
7662898|NCT01420081|26655086|P7|Overall Study|Subject Refused Futher Follow-up|0
7662899|NCT01420081|26655087|P6|Overall Study|Subject Refused Futher Follow-up|0
7662900|NCT01420081|26655088|P5|Overall Study|Subject Refused Futher Follow-up|1
7662901|NCT01420081|26655089|P4|Overall Study|Subject Refused Futher Follow-up|0
7662902|NCT01420081|26655090|P3|Overall Study|Subject Refused Futher Follow-up|1
7662903|NCT01420081|26655091|P2|Overall Study|Subject Refused Futher Follow-up|0
7662904|NCT01420081|26655092|P1|Overall Study|Subject Refused Futher Follow-up|0
7662905|NCT01420081|26655084|P9|Overall Study|Study Terminated by Sponsor|2
7662906|NCT01420081|26655085|P8|Overall Study|Study Terminated by Sponsor|2
7662907|NCT01420081|26655086|P7|Overall Study|Study Terminated by Sponsor|3
7662908|NCT01420081|26655087|P6|Overall Study|Study Terminated by Sponsor|7
7662909|NCT01420081|26655088|P5|Overall Study|Study Terminated by Sponsor|11
7662910|NCT01420081|26655089|P4|Overall Study|Study Terminated by Sponsor|3
7662911|NCT01420081|26655090|P3|Overall Study|Study Terminated by Sponsor|1
7662912|NCT01420081|26655091|P2|Overall Study|Study Terminated by Sponsor|1
7662913|NCT01420081|26655092|P1|Overall Study|Study Terminated by Sponsor|2
7662914|NCT01420081|26655084|P9|Overall Study|Lost to Follow-up|0
7662915|NCT01420081|26655085|P8|Overall Study|Lost to Follow-up|0
7662916|NCT01420081|26655086|P7|Overall Study|Lost to Follow-up|0
7662917|NCT01420081|26655087|P6|Overall Study|Lost to Follow-up|1
7662918|NCT01420081|26655088|P5|Overall Study|Lost to Follow-up|1
7662919|NCT01420081|26655089|P4|Overall Study|Lost to Follow-up|0
7662920|NCT01420081|26655090|P3|Overall Study|Lost to Follow-up|0
7662921|NCT01420081|26655091|P2|Overall Study|Lost to Follow-up|0
7662922|NCT01420081|26655092|P1|Overall Study|Lost to Follow-up|0
7662923|NCT01420081|26655084|P9|Overall Study|Death|1
7662924|NCT01420081|26655085|P8|Overall Study|Death|1
7662925|NCT01420081|26655086|P7|Overall Study|Death|0
7662926|NCT01420081|26655087|P6|Overall Study|Death|12
7662927|NCT01420081|26655088|P5|Overall Study|Death|7
7662928|NCT01420081|26655089|P4|Overall Study|Death|0
7662929|NCT01420081|26655090|P3|Overall Study|Death|8
7662930|NCT01420081|26655091|P2|Overall Study|Death|0
7662931|NCT01420081|26655092|P1|Overall Study|Death|1
7662932|NCT01420068|26655173|P2|Overall Study|Withdrawal by Subject|2
7662933|NCT01420068|26655174|P1|Overall Study|Withdrawal by Subject|1
7662934|NCT01420068|26655173|P2|Overall Study|Administrative problems|3
7662935|NCT01420068|26655174|P1|Overall Study|Administrative problems|1
7662936|NCT01419769|26655245|P1|Overall Study|Not evaluable due to pigtail stents|1
7662937|NCT01419769|26655245|P1|Overall Study|Did not receive the AXIOS stent|3
7662938|NCT01419717|26655258|P1|Overall Study|Noncompliance|1
7662939|NCT01419717|26655258|P1|Overall Study|Administrative Decision|1
7662940|NCT01419717|26655258|P1|Overall Study|Lost to Follow-up|2
7662941|NCT01419717|26655258|P1|Overall Study|Other|4
7662942|NCT01419717|26655258|P1|Overall Study|Disease Progression|9
7662943|NCT01419717|26655258|P1|Overall Study|Withdrawal by Subject|10
7662944|NCT01419717|26655258|P1|Overall Study|Death|17
7662945|NCT01419717|26655258|P1|Overall Study|Adverse Event|19
7662946|NCT01419717|26655258|P1|Overall Study|Protocol-specified Criteria|62
7662947|NCT01419665|26655265|P2|Open Label Phase|disease progression|1
7662948|NCT01419665|26655266|P1|Open Label Phase|disease progression|0
7662949|NCT01419665|26655265|P2|Open Label Phase|Death|0
7662950|NCT01419665|26655266|P1|Open Label Phase|Death|1
7662951|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
7662952|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
7662953|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|Adverse Event|7
7662954|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|Adverse Event|11
7662955|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|Death|2
7662956|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|Death|1
7662957|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|disease progression|37
7662958|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|disease progression|53
7662959|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|Physician Decision|2
7662960|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|Physician Decision|5
7662961|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|Protocol Violation|1
7662962|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|Protocol Violation|1
7662963|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7662964|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7662965|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|administrative problems|6
7662966|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|administrative problems|0
7662967|NCT01419665|26655265|P2|Maintenance Treatment and/or Follow up|switch to open label|39
7662968|NCT01419665|26655266|P1|Maintenance Treatment and/or Follow up|switch to open label|44
7662969|NCT01419665|26655265|P2|Combination Treatment|Withdrawal by Subject|4
7662970|NCT01419665|26655266|P1|Combination Treatment|Withdrawal by Subject|5
7662971|NCT01419665|26655265|P2|Combination Treatment|administrative problems|1
7662972|NCT01419665|26655266|P1|Combination Treatment|administrative problems|0
7662973|NCT01419665|26655265|P2|Combination Treatment|Death|7
7662974|NCT01419665|26655266|P1|Combination Treatment|Death|5
7662975|NCT01419665|26655265|P2|Combination Treatment|disease progression|9
7662976|NCT01419665|26655266|P1|Combination Treatment|disease progression|10
7662977|NCT01419665|26655265|P2|Combination Treatment|Protocol Violation|2
7662978|NCT01419665|26655266|P1|Combination Treatment|Protocol Violation|6
7662979|NCT01419665|26655265|P2|Combination Treatment|Physician Decision|8
7662980|NCT01419665|26655266|P1|Combination Treatment|Physician Decision|5
7662981|NCT01419665|26655265|P2|Combination Treatment|Adverse Event|10
7662982|NCT01419665|26655266|P1|Combination Treatment|Adverse Event|7
7662983|NCT01419626|26655301|P3|Overall Study|Lost to Follow-up|1
7662984|NCT01419626|26655302|P2|Overall Study|Lost to Follow-up|1
7662985|NCT01419626|26655303|P1|Overall Study|Lost to Follow-up|0
7662986|NCT01419626|26655301|P3|Overall Study|Withdrawal by Subject|0
7662987|NCT01419626|26655302|P2|Overall Study|Withdrawal by Subject|0
7662988|NCT01419626|26655303|P1|Overall Study|Withdrawal by Subject|1
7662989|NCT01419626|26655301|P3|Overall Study|Protocol Violation|2
7662990|NCT01419626|26655302|P2|Overall Study|Protocol Violation|2
7662991|NCT01419626|26655303|P1|Overall Study|Protocol Violation|3
7662992|NCT01419535|26655334|P2|Overall Study|Withdrawal by Subject|1
7662993|NCT01419535|26655335|P1|Overall Study|Withdrawal by Subject|0
7662994|NCT01419535|26655334|P2|Overall Study|could not maintain iv line|1
7662995|NCT01419535|26655335|P1|Overall Study|could not maintain iv line|1
7662996|NCT01419314|26655353|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
7662997|NCT01419314|26655354|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
7662998|NCT01419314|26655353|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
7662999|NCT01419314|26655354|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
7663000|NCT01419314|26655353|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
7663001|NCT01419314|26655354|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
7663002|NCT01419236|26655395|P2|Overall Study|Entry Criteria Not Met|0
7663003|NCT01419236|26655396|P1|Overall Study|Entry Criteria Not Met|1
7663004|NCT01419236|26655395|P2|Overall Study|Withdrawal by Subject|4
7663005|NCT01419236|26655396|P1|Overall Study|Withdrawal by Subject|1
7663006|NCT01419236|26655395|P2|Overall Study|Physician Decision|0
7663007|NCT01419236|26655396|P1|Overall Study|Physician Decision|1
7663008|NCT01419236|26655395|P2|Overall Study|Lost to Follow-up|0
7663009|NCT01419236|26655396|P1|Overall Study|Lost to Follow-up|1
7663010|NCT01419236|26655395|P2|Overall Study|Lack of Efficacy|1
7663011|NCT01419236|26655396|P1|Overall Study|Lack of Efficacy|0
7663012|NCT01419236|26655395|P2|Overall Study|Adverse Event|0
7663013|NCT01419236|26655396|P1|Overall Study|Adverse Event|1
7663014|NCT01419197|26655420|P2|Overall Study|Lost to Follow-up|4
7663015|NCT01419197|26655421|P1|Overall Study|Lost to Follow-up|14
7663016|NCT01419197|26655420|P2|Overall Study|Reason Not Specified|1
7663017|NCT01419197|26655421|P1|Overall Study|Reason Not Specified|0
7663018|NCT01419197|26655420|P2|Overall Study|Study Completed by Sponsor|34
7663019|NCT01419197|26655421|P1|Overall Study|Study Completed by Sponsor|103
7663020|NCT01419197|26655420|P2|Overall Study|Withdrawal by Subject|32
7663021|NCT01419197|26655421|P1|Overall Study|Withdrawal by Subject|33
7663022|NCT01419197|26655420|P2|Overall Study|Non-compliance|1
7663023|NCT01419197|26655421|P1|Overall Study|Non-compliance|3
7663024|NCT01419197|26655420|P2|Overall Study|Physician Decision|4
7663025|NCT01419197|26655421|P1|Overall Study|Physician Decision|4
7663026|NCT01419197|26655420|P2|Overall Study|Death|122
7663027|NCT01419197|26655421|P1|Overall Study|Death|247
7663028|NCT01419184|26655446|P2|Overall Study|Participant randomized, not treated|0
7663029|NCT01419184|26655447|P1|Overall Study|Participant randomized, not treated|1
7663030|NCT01419184|26655446|P2|Overall Study|No IRLOS-No adverse event treatment date|1
7663113|NCT01417156|26655896|P1|Overall Study|Adverse Event|12
7663031|NCT01419184|26655447|P1|Overall Study|No IRLOS-No adverse event treatment date|0
7663032|NCT01419184|26655446|P2|Overall Study|No IRLOS-non trial antibiotic used|2
7663033|NCT01419184|26655447|P1|Overall Study|No IRLOS-non trial antibiotic used|1
7663034|NCT01419184|26655446|P2|Overall Study|No IRLOS-randomized, not treated|4
7663035|NCT01419184|26655447|P1|Overall Study|No IRLOS-randomized, not treated|2
7663036|NCT01419184|26655446|P2|Overall Study|No IRLOS-No in-patient end date reported|6
7663037|NCT01419184|26655447|P1|Overall Study|No IRLOS-No in-patient end date reported|3
7663038|NCT01419184|26655446|P2|Overall Study|Site data not available|2
7663039|NCT01419184|26655447|P1|Overall Study|Site data not available|3
7663044|NCT01419015|26655491|P1|Overall Study|Death|2
7663045|NCT01418937|26655495|P1|Overall Study|Withdrawal by Subject|1
7663046|NCT01418937|26655495|P1|Overall Study|Pregnancy|1
7663047|NCT01418937|26655495|P1|Overall Study|Protocol Violation|1
7663048|NCT01418937|26655495|P1|Overall Study|Lost to Follow-up|5
7663049|NCT01418378|26655526|P2|Overall Study|developed chronic myopathy|1
7663050|NCT01418378|26655527|P1|Overall Study|developed chronic myopathy|0
7663051|NCT01418378|26655526|P2|Overall Study|ligament imbalance|1
7663052|NCT01418378|26655527|P1|Overall Study|ligament imbalance|0
7663053|NCT01418378|26655526|P2|Overall Study|Physician Decision|1
7663054|NCT01418378|26655527|P1|Overall Study|Physician Decision|0
7663055|NCT01418378|26655526|P2|Overall Study|Death|2
7663056|NCT01418378|26655527|P1|Overall Study|Death|1
7663057|NCT01418365|26655601|P2|Second Intervention|Withdrawal by Subject|1
7663058|NCT01418365|26655602|P1|Second Intervention|Withdrawal by Subject|0
7663059|NCT01418365|26655601|P2|First Intervention|Non-compliance|0
7663060|NCT01418365|26655602|P1|First Intervention|Non-compliance|1
7663061|NCT01418365|26655601|P2|First Intervention|Withdrawal by Subject|1
7663062|NCT01418365|26655602|P1|First Intervention|Withdrawal by Subject|0
7663063|NCT01418352|26655614|P4|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7663064|NCT01418352|26655615|P3|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7663065|NCT01418352|26655616|P2|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7663066|NCT01418352|26655617|P1|Overall Study|Lack of Efficacy as Determined by the Investigator|1
7663067|NCT01418352|26655614|P4|Overall Study|Protocol Deviation|0
7663068|NCT01418352|26655615|P3|Overall Study|Protocol Deviation|1
7663069|NCT01418352|26655616|P2|Overall Study|Protocol Deviation|0
7663070|NCT01418352|26655617|P1|Overall Study|Protocol Deviation|0
7663071|NCT01418352|26655614|P4|Overall Study|Subject Withdrew Consent|1
7663072|NCT01418352|26655615|P3|Overall Study|Subject Withdrew Consent|2
7663073|NCT01418352|26655616|P2|Overall Study|Subject Withdrew Consent|1
7663074|NCT01418352|26655617|P1|Overall Study|Subject Withdrew Consent|0
7663075|NCT01418352|26655614|P4|Overall Study|Sponsor Discontinued Trial Site|2
7663076|NCT01418352|26655615|P3|Overall Study|Sponsor Discontinued Trial Site|2
7663077|NCT01418352|26655616|P2|Overall Study|Sponsor Discontinued Trial Site|2
7663078|NCT01418352|26655617|P1|Overall Study|Sponsor Discontinued Trial Site|0
7663079|NCT01418352|26655614|P4|Overall Study|Adverse Event|0
7663080|NCT01418352|26655615|P3|Overall Study|Adverse Event|0
7663081|NCT01418352|26655616|P2|Overall Study|Adverse Event|1
7663082|NCT01418352|26655617|P1|Overall Study|Adverse Event|0
7663083|NCT01418352|26655614|P4|Overall Study|Lost to Follow-up|0
7663084|NCT01418352|26655615|P3|Overall Study|Lost to Follow-up|0
7663085|NCT01418352|26655616|P2|Overall Study|Lost to Follow-up|0
7663086|NCT01418352|26655617|P1|Overall Study|Lost to Follow-up|2
7663087|NCT01418339|26655637|P2|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7663088|NCT01418339|26655638|P1|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7663089|NCT01418339|26655637|P2|Overall Study|Subject Withdrew Consent|2
7663090|NCT01418339|26655638|P1|Overall Study|Subject Withdrew Consent|1
7663091|NCT01418339|26655637|P2|Overall Study|Adverse Event|2
7663092|NCT01418339|26655638|P1|Overall Study|Adverse Event|5
7663093|NCT01418209|26655651|P3|Overall Study|Did not provide hot flash diary data|3
7663094|NCT01418209|26655652|P2|Overall Study|Did not provide hot flash diary data|3
7663095|NCT01418209|26655653|P1|Overall Study|Did not provide hot flash diary data|1
7663096|NCT01418209|26655651|P3|Overall Study|Withdrawal by Subject|1
7663097|NCT01418209|26655652|P2|Overall Study|Withdrawal by Subject|0
7663098|NCT01418209|26655653|P1|Overall Study|Withdrawal by Subject|1
7663099|NCT01417481|26655797|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
7663100|NCT01417481|26655798|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
7663101|NCT01417377|26655863|P1|Overall Study|Enrolled, but not treated|1
7663102|NCT01417377|26655863|P1|Overall Study|Lost to Follow-up|12
7663103|NCT01417234|26655870|P1|Overall Study|Subject non-compliant|3
7663104|NCT01417195|26655879|P2|Overall Study|No transfer due to elevated progesterone|0
7663105|NCT01417195|26655880|P1|Overall Study|No transfer due to elevated progesterone|1
7663106|NCT01417195|26655879|P2|Overall Study|No transfer due to risk of OHSS|0
7663107|NCT01417195|26655880|P1|Overall Study|No transfer due to risk of OHSS|1
7663108|NCT01417195|26655879|P2|Overall Study|No embryos for transfer|1
7663109|NCT01417195|26655880|P1|Overall Study|No embryos for transfer|0
7663110|NCT01417195|26655879|P2|Overall Study|Stimulation failure|0
7663111|NCT01417195|26655880|P1|Overall Study|Stimulation failure|1
7663112|NCT01417156|26655896|P1|Overall Study|Protocol Violation|2
7663114|NCT01417104|26655906|P2|Overall Study|Adverse Event|0
7663115|NCT01417104|26655907|P1|Overall Study|Adverse Event|1
7663116|NCT01417104|26655906|P2|Overall Study|Failure to make contact|1
7663117|NCT01417104|26655907|P1|Overall Study|Failure to make contact|0
7663118|NCT01417104|26655906|P2|Overall Study|Withdrawal by Subject|1
7663119|NCT01417104|26655907|P1|Overall Study|Withdrawal by Subject|5
7663120|NCT01417078|26655917|P1|Overall Study|Withdrawal by Subject|1
7663121|NCT01417000|26655942|P2|Overall Study|Study Terminated by Sponsor|1
7663122|NCT01417000|26655943|P1|Overall Study|Study Terminated by Sponsor|1
7663123|NCT01417000|26655942|P2|Overall Study|Lost to Follow-up|0
7663124|NCT01417000|26655943|P1|Overall Study|Lost to Follow-up|1
7663125|NCT01417000|26655942|P2|Overall Study|Death|28
7663126|NCT01417000|26655943|P1|Overall Study|Death|59
7663127|NCT01416805|26655960|P2|Overall Study|Lost to Follow-up|4
7663128|NCT01416805|26655961|P1|Overall Study|Lost to Follow-up|4
7663129|NCT01416610|26656000|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
7663130|NCT01416610|26656000|P1|Overall Study|Lost to Follow-up|7
7663131|NCT01416610|26656000|P1|Overall Study|Withdrawal by Subject|13
7663132|NCT01416610|26656000|P1|Overall Study|No reason given|5
7663133|NCT01416610|26656000|P1|Overall Study|Lack of Efficacy|4
7663134|NCT01416610|26656000|P1|Overall Study|Adverse Event -Patient decision|3
7663135|NCT01416610|26656000|P1|Overall Study|Adverse Event|4
7663136|NCT01416571|26656054|P1|Overall Study|Lost to Follow-up|2
7663137|NCT01416441|26656081|P1|Overall Study|Lack of Efficacy as Determined by the Investigator|3
7663138|NCT01416441|26656081|P1|Overall Study|Subject Withdrew Consent|12
7663139|NCT01416441|26656081|P1|Overall Study|Investigator Withdrew Subject|2
7663140|NCT01416441|26656081|P1|Overall Study|Subject Met Withdrawal Criteria|10
7663141|NCT01416441|26656081|P1|Overall Study|Sponsor Discontinued Trial Site|43
7663142|NCT01416441|26656081|P1|Overall Study|Adverse Event|6
7663143|NCT01416441|26656081|P1|Overall Study|Lost to Follow-up|5
7663144|NCT01416389|26656107|P2|Overall Study|Started New Therapy|0
7663145|NCT01416389|26656108|P1|Overall Study|Started New Therapy|2
7663146|NCT01416389|26656107|P2|Overall Study|Lost to Follow-up|0
7663147|NCT01416389|26656108|P1|Overall Study|Lost to Follow-up|1
7663148|NCT01416272|26656125|P1|Overall Study|Study related complaints|1
7663149|NCT01416272|26656125|P1|Overall Study|Lost to Follow-up|1
7663150|NCT01416272|26656125|P1|Overall Study|Unacceptable distance visual acuity|2
7663151|NCT01416181|26656182|P2|Part 2|Lost to Follow-up|2
7663152|NCT01416181|26656183|P1|Part 2|Lost to Follow-up|2
7663153|NCT01416181|26656182|P2|Part 2|Lack of Efficacy|1
7663154|NCT01416181|26656183|P1|Part 2|Lack of Efficacy|4
7663155|NCT01416181|26656182|P2|Part 2|Withdrawal by Subject|5
7663156|NCT01416181|26656183|P1|Part 2|Withdrawal by Subject|14
7663157|NCT01416181|26656182|P2|Part 2|Investigator Decision|7
7663158|NCT01416181|26656183|P1|Part 2|Investigator Decision|6
7663159|NCT01416181|26656182|P2|Part 2|Other|267
7663160|NCT01416181|26656183|P1|Part 2|Other|234
7663161|NCT01416181|26656182|P2|Part 2|Adverse Event|4
7663162|NCT01416181|26656183|P1|Part 2|Adverse Event|11
7663163|NCT01416181|26656182|P2|Part 1|Ongoing in Follow-Up|8
7663164|NCT01416181|26656183|P1|Part 1|Ongoing in Follow-Up|14
7663165|NCT01416181|26656182|P2|Part 1|Adverse Event|18
7663166|NCT01416181|26656183|P1|Part 1|Adverse Event|15
7663167|NCT01416181|26656182|P2|Part 1|Lost to Follow-up|1
7663168|NCT01416181|26656183|P1|Part 1|Lost to Follow-up|1
7663169|NCT01416181|26656182|P2|Part 1|Lack of Efficacy|8
7663170|NCT01416181|26656183|P1|Part 1|Lack of Efficacy|16
7663171|NCT01416181|26656182|P2|Part 1|Withdrawal by Subject|48
7663172|NCT01416181|26656183|P1|Part 1|Withdrawal by Subject|74
7663173|NCT01416181|26656182|P2|Part 1|Investigator Decision|6
7663174|NCT01416181|26656183|P1|Part 1|Investigator Decision|7
7663175|NCT01416181|26656182|P2|Part 1|Death|1
7663176|NCT01416181|26656183|P1|Part 1|Death|0
7663177|NCT01416181|26656182|P2|Part 1|Other|24
7663178|NCT01416181|26656183|P1|Part 1|Other|10
7663179|NCT01416155|26656245|P1|Overall Study|Other|7
7663180|NCT01416155|26656245|P1|Overall Study|Investigator decision|8
7663181|NCT01416155|26656245|P1|Overall Study|Withdrawal by Subject|33
7663182|NCT01416155|26656245|P1|Overall Study|Positive for anti-BG00002 antibodies|2
7663183|NCT01416155|26656245|P1|Overall Study|Adverse Event|8
7663184|NCT01416142|26656252|P3|PureVision2 HD|Inability to maintain lens wear|1
7663185|NCT01416142|26656253|P2|PureVision2 HD|Inability to maintain lens wear|0
7663186|NCT01416142|26656254|P1|PureVision2 HD|Inability to maintain lens wear|0
7663187|NCT01415986|26656281|P1|Overall Study|Lost to Follow-up|1
7663188|NCT01415921|26656307|P2|Overall Study|Other|0
7663189|NCT01415921|26656308|P1|Overall Study|Other|2
7663190|NCT01415921|26656307|P2|Overall Study|Withdrawal by Subject|1
7663191|NCT01415921|26656308|P1|Overall Study|Withdrawal by Subject|0
7663192|NCT01415921|26656307|P2|Overall Study|Physician Decision|1
7663193|NCT01415921|26656308|P1|Overall Study|Physician Decision|1
7663194|NCT01415921|26656307|P2|Overall Study|Adverse Event|1
7663195|NCT01415921|26656308|P1|Overall Study|Adverse Event|0
7663196|NCT01415908|26656318|P2|Overall Study|Withdrawal by Subject|0
7663197|NCT01415908|26656319|P1|Overall Study|Withdrawal by Subject|1
7663198|NCT01415531|26656356|P2|Overall Study|Other Reasons|2
7663199|NCT01415531|26656357|P1|Overall Study|Other Reasons|3
7663200|NCT01415531|26656356|P2|Overall Study|Lack of Compliance|4
7663201|NCT01415531|26656357|P1|Overall Study|Lack of Compliance|1
7663202|NCT01415531|26656356|P2|Overall Study|Lost to Follow-up|14
7663203|NCT01415531|26656357|P1|Overall Study|Lost to Follow-up|6
7663204|NCT01415531|26656356|P2|Overall Study|Withdrawal by Subject|4
7663205|NCT01415531|26656357|P1|Overall Study|Withdrawal by Subject|5
7663206|NCT01415531|26656356|P2|Overall Study|Protocol Violation|1
7663207|NCT01415531|26656357|P1|Overall Study|Protocol Violation|0
7663208|NCT01415531|26656356|P2|Overall Study|Lack of Efficacy|2
7663209|NCT01415531|26656357|P1|Overall Study|Lack of Efficacy|3
7663210|NCT01415531|26656356|P2|Overall Study|Adverse Event|10
7663211|NCT01415531|26656357|P1|Overall Study|Adverse Event|7
7663212|NCT01415518|26656367|P2|Overall Study|Condition under Investigation Worsened|1
7663213|NCT01415518|26656368|P1|Overall Study|Condition under Investigation Worsened|1
7663214|NCT01415518|26656367|P2|Overall Study|Death|1
7663215|NCT01415518|26656368|P1|Overall Study|Death|1
7663216|NCT01415518|26656367|P2|Overall Study|Adverse Event|4
7663217|NCT01415518|26656368|P1|Overall Study|Adverse Event|3
7663218|NCT01415518|26656367|P2|Overall Study|Lost to Follow-up|5
7663219|NCT01415518|26656368|P1|Overall Study|Lost to Follow-up|3
7663220|NCT01415518|26656367|P2|Overall Study|Protocol Violation|8
7663221|NCT01415518|26656368|P1|Overall Study|Protocol Violation|6
7663222|NCT01415518|26656367|P2|Overall Study|Withdrawal by Subject|12
7663223|NCT01415518|26656368|P1|Overall Study|Withdrawal by Subject|2
7663224|NCT01415440|26656427|P3|Overall Study|Withdrawal by Subject|0
7663225|NCT01415440|26656428|P2|Overall Study|Withdrawal by Subject|0
7663226|NCT01415440|26656429|P1|Overall Study|Withdrawal by Subject|1
7663227|NCT01415440|26656427|P3|Overall Study|Physician Decision|0
7663228|NCT01415440|26656428|P2|Overall Study|Physician Decision|0
7663229|NCT01415440|26656429|P1|Overall Study|Physician Decision|3
7663230|NCT01415440|26656427|P3|Overall Study|Lost to Follow-up|2
7663231|NCT01415440|26656428|P2|Overall Study|Lost to Follow-up|1
7663232|NCT01415440|26656429|P1|Overall Study|Lost to Follow-up|0
7663233|NCT01415401|26656480|P1|Overall Study|Terminated by Sponsor|1
7663234|NCT01415401|26656480|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
7663235|NCT01415401|26656480|P1|Overall Study|Adverse Event|5
7663236|NCT01415349|26656485|P2|Treatment Period 1|Withdrawal by Subject|1
7663237|NCT01415349|26656486|P1|Treatment Period 1|Withdrawal by Subject|0
7663238|NCT01415349|26656485|P2|Treatment Period 1|Adverse Event|1
7663239|NCT01415349|26656486|P1|Treatment Period 1|Adverse Event|0
7663240|NCT01414855|26656498|P1|Overall Study|Withdrawal by Subject|7
7663241|NCT01414855|26656498|P1|Overall Study|Lost to Follow-up|5
7663242|NCT01414855|26656498|P1|Overall Study|Death|17
7663243|NCT01414738|26656514|P1|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
7663244|NCT01414738|26656514|P1|Overall Study|Refused, disease progression|8
7663245|NCT01414738|26656514|P1|Overall Study|Lost to Follow-up|2
7663246|NCT01414738|26656514|P1|Overall Study|Refused testing|5
7663247|NCT01414738|26656514|P1|Overall Study|Death|26
7663248|NCT01414257|26656585|P1|Overall Study|Protocol Violation|10
7663249|NCT01414257|26656585|P1|Overall Study|No Visit After First Day of Treatment|12
7663250|NCT01414205|26656613|P2|Overall Study|Randomized but not Treated|1
7663251|NCT01414205|26656614|P1|Overall Study|Randomized but not Treated|1
7663252|NCT01414205|26656613|P2|Overall Study|Physician Decision|1
7663253|NCT01414205|26656614|P1|Overall Study|Physician Decision|0
7663254|NCT01414205|26656613|P2|Overall Study|Lost to Follow-up|4
7663255|NCT01414205|26656614|P1|Overall Study|Lost to Follow-up|1
7663256|NCT01414205|26656613|P2|Overall Study|Death|1
7663257|NCT01414205|26656614|P1|Overall Study|Death|5
7663258|NCT01414166|26656683|P2|Overall Study|Withdrawal by Subject|5
7663259|NCT01414166|26656684|P1|Overall Study|Withdrawal by Subject|3
7663260|NCT01414166|26656683|P2|Overall Study|Study terminated by Sponsor|75
7663261|NCT01414166|26656684|P1|Overall Study|Study terminated by Sponsor|68
7663262|NCT01414166|26656683|P2|Overall Study|Protocol Violation|0
7663263|NCT01414166|26656684|P1|Overall Study|Protocol Violation|2
7663264|NCT01414166|26656683|P2|Overall Study|Physician Decision|0
7663265|NCT01414166|26656684|P1|Overall Study|Physician Decision|2
7663266|NCT01414166|26656683|P2|Overall Study|Non-compliance with study drug|0
7663267|NCT01414166|26656684|P1|Overall Study|Non-compliance with study drug|2
7663268|NCT01414166|26656683|P2|Overall Study|Lost to Follow-up|1
7663269|NCT01414166|26656684|P1|Overall Study|Lost to Follow-up|4
7663270|NCT01414166|26656683|P2|Overall Study|Adverse Event|2
7663271|NCT01414166|26656684|P1|Overall Study|Adverse Event|10
7663272|NCT01414114|26656747|P1|Overall Study|Other|2
7663273|NCT01414114|26656747|P1|Overall Study|Withdrawal by Subject|1
7663274|NCT01414114|26656747|P1|Overall Study|Adverse Event|2
7663275|NCT01414075|26656769|P4|Overall Study|Other than specified|0
7663276|NCT01414075|26656770|P3|Overall Study|Other than specified|1
7663277|NCT01414075|26656771|P2|Overall Study|Other than specified|0
7663278|NCT01414075|26656772|P1|Overall Study|Other than specified|1
7663279|NCT01414075|26656769|P4|Overall Study|Withdrawal by Subject|1
7663280|NCT01414075|26656770|P3|Overall Study|Withdrawal by Subject|0
7663281|NCT01414075|26656771|P2|Overall Study|Withdrawal by Subject|0
7663282|NCT01414075|26656772|P1|Overall Study|Withdrawal by Subject|0
7663283|NCT01414075|26656769|P4|Overall Study|Death|1
7663284|NCT01414075|26656770|P3|Overall Study|Death|0
7663285|NCT01414075|26656771|P2|Overall Study|Death|0
7663286|NCT01414075|26656772|P1|Overall Study|Death|1
7663287|NCT01414075|26656769|P4|Overall Study|Adverse Event|0
7663288|NCT01414075|26656770|P3|Overall Study|Adverse Event|1
7663289|NCT01414075|26656771|P2|Overall Study|Adverse Event|0
7663290|NCT01414075|26656772|P1|Overall Study|Adverse Event|1
7663291|NCT01413958|26656920|P2|Overall Study|Lost to Follow-up|1
7663292|NCT01413958|26656921|P1|Overall Study|Lost to Follow-up|0
7663293|NCT01413542|26656972|P4|Overall Study|Adverse Event|1
7663294|NCT01413542|26656973|P3|Overall Study|Adverse Event|0
7663295|NCT01413542|26656974|P2|Overall Study|Adverse Event|0
7663296|NCT01413542|26656975|P1|Overall Study|Adverse Event|0
7663297|NCT01413542|26656972|P4|Overall Study|Physician Decision|0
7663298|NCT01413542|26656973|P3|Overall Study|Physician Decision|3
7663299|NCT01413542|26656974|P2|Overall Study|Physician Decision|0
7663300|NCT01413542|26656975|P1|Overall Study|Physician Decision|1
7663301|NCT01413503|26656997|P1|Overall Study|Lost to Follow-up|1
7663302|NCT01413360|26657001|P1|Overall Study|Adverse Event|1
7663303|NCT01413360|26657001|P1|Overall Study|Lost to Follow-up|2
7663304|NCT01413204|26657009|P3|Overall Study|Fasting plasma glucose level increased|10
7663305|NCT01413204|26657010|P2|Overall Study|Fasting plasma glucose level increased|0
7663306|NCT01413204|26657011|P1|Overall Study|Fasting plasma glucose level increased|1
7663307|NCT01413204|26657009|P3|Overall Study|Clearly not eligible for the study|1
7663308|NCT01413204|26657010|P2|Overall Study|Clearly not eligible for the study|0
7663309|NCT01413204|26657011|P1|Overall Study|Clearly not eligible for the study|0
7663310|NCT01413204|26657009|P3|Overall Study|Withdrawal by Subject|4
7663311|NCT01413204|26657010|P2|Overall Study|Withdrawal by Subject|4
7663312|NCT01413204|26657011|P1|Overall Study|Withdrawal by Subject|1
7663313|NCT01413204|26657009|P3|Overall Study|Physician Decision|2
7663314|NCT01413204|26657010|P2|Overall Study|Physician Decision|0
7663315|NCT01413204|26657011|P1|Overall Study|Physician Decision|3
7663316|NCT01413204|26657009|P3|Overall Study|Adverse Event|2
7663317|NCT01413204|26657010|P2|Overall Study|Adverse Event|2
7663318|NCT01413204|26657011|P1|Overall Study|Adverse Event|1
7663319|NCT01413191|26657019|P1|Overall Study|Death|1
7663320|NCT01413191|26657019|P1|Overall Study|Disease Progression|5
7663321|NCT01413191|26657019|P1|Overall Study|Lost to Follow-up|5
7663322|NCT01413178|26657031|P2|Overall Study|Ineligible|2
7663323|NCT01413178|26657032|P1|Overall Study|Ineligible|0
7663324|NCT01413178|26657031|P2|Overall Study|Toxicity|0
7663325|NCT01413178|26657032|P1|Overall Study|Toxicity|1
7663326|NCT01412983|26657075|P2|1st Period|Inability to maintain wear|1
7663327|NCT01412983|26657076|P1|1st Period|Inability to maintain wear|0
7663328|NCT01412983|26657075|P2|1st Period|Unacceptable lens movement|1
7663329|NCT01412983|26657076|P1|1st Period|Unacceptable lens movement|0
7663330|NCT01412983|26657075|P2|1st Period|Positive slit lamp finding|1
7663331|NCT01412983|26657076|P1|1st Period|Positive slit lamp finding|0
7663332|NCT01412983|26657075|P2|1st Period|Ineligible|1
7663333|NCT01412983|26657076|P1|1st Period|Ineligible|0
7663334|NCT01412957|26657086|P2|Overall Study|Death|133
7663335|NCT01412957|26657087|P1|Overall Study|Death|136
7663336|NCT01412957|26657086|P2|Overall Study|Lost to Follow-up|2
7663337|NCT01412957|26657087|P1|Overall Study|Lost to Follow-up|7
7663338|NCT01412957|26657086|P2|Overall Study|Withdrawal by Subject|22
7663339|NCT01412957|26657087|P1|Overall Study|Withdrawal by Subject|6
7663340|NCT01412944|26657109|P6|Entire: IV + Maintenance|Adverse Event|0
7663341|NCT01412944|26657110|P5|Entire: IV + Maintenance|Adverse Event|0
7663342|NCT01412944|26657111|P4|Entire: IV + Maintenance|Adverse Event|0
7663343|NCT01412944|26657112|P3|Entire: IV + Maintenance|Adverse Event|0
7663344|NCT01412944|26657113|P2|Entire: IV + Maintenance|Adverse Event|1
7663345|NCT01412944|26657114|P1|Entire: IV + Maintenance|Adverse Event|0
7663346|NCT01412944|26657109|P6|Entire: IV + Maintenance|Lack of Efficacy|0
7663347|NCT01412944|26657110|P5|Entire: IV + Maintenance|Lack of Efficacy|0
7663348|NCT01412944|26657111|P4|Entire: IV + Maintenance|Lack of Efficacy|0
7663349|NCT01412944|26657112|P3|Entire: IV + Maintenance|Lack of Efficacy|0
7663350|NCT01412944|26657113|P2|Entire: IV + Maintenance|Lack of Efficacy|1
7663351|NCT01412944|26657114|P1|Entire: IV + Maintenance|Lack of Efficacy|0
7663352|NCT01412944|26657109|P6|Entire: IV + Maintenance|Lost to Follow-up|0
7663353|NCT01412944|26657110|P5|Entire: IV + Maintenance|Lost to Follow-up|0
7663354|NCT01412944|26657111|P4|Entire: IV + Maintenance|Lost to Follow-up|0
7663355|NCT01412944|26657112|P3|Entire: IV + Maintenance|Lost to Follow-up|0
7663356|NCT01412944|26657113|P2|Entire: IV + Maintenance|Lost to Follow-up|1
7663357|NCT01412944|26657114|P1|Entire: IV + Maintenance|Lost to Follow-up|0
7663358|NCT01412944|26657109|P6|Entire: IV + Maintenance|Protocol deviation|0
7663359|NCT01412944|26657110|P5|Entire: IV + Maintenance|Protocol deviation|0
7663360|NCT01412944|26657111|P4|Entire: IV + Maintenance|Protocol deviation|0
7663361|NCT01412944|26657112|P3|Entire: IV + Maintenance|Protocol deviation|0
7663362|NCT01412944|26657113|P2|Entire: IV + Maintenance|Protocol deviation|1
7663363|NCT01412944|26657114|P1|Entire: IV + Maintenance|Protocol deviation|0
7663364|NCT01412944|26657109|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
7663365|NCT01412944|26657110|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
7663366|NCT01412944|26657111|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
7663367|NCT01412944|26657112|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
7663368|NCT01412944|26657113|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
7663369|NCT01412944|26657114|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
7663370|NCT01412944|26657109|P6|Entire: IV + Maintenance|Lack of Efficacy|0
7663371|NCT01412944|26657110|P5|Entire: IV + Maintenance|Lack of Efficacy|1
7663372|NCT01412944|26657111|P4|Entire: IV + Maintenance|Lack of Efficacy|0
7663373|NCT01412944|26657112|P3|Entire: IV + Maintenance|Lack of Efficacy|0
7663374|NCT01412944|26657113|P2|Entire: IV + Maintenance|Lack of Efficacy|0
7663375|NCT01412944|26657114|P1|Entire: IV + Maintenance|Lack of Efficacy|0
7663376|NCT01412944|26657109|P6|Entire: IV + Maintenance|Lost to Follow-up|1
7663377|NCT01412944|26657110|P5|Entire: IV + Maintenance|Lost to Follow-up|0
7663378|NCT01412944|26657111|P4|Entire: IV + Maintenance|Lost to Follow-up|0
7663379|NCT01412944|26657112|P3|Entire: IV + Maintenance|Lost to Follow-up|0
7663380|NCT01412944|26657113|P2|Entire: IV + Maintenance|Lost to Follow-up|0
7663381|NCT01412944|26657114|P1|Entire: IV + Maintenance|Lost to Follow-up|0
7663382|NCT01412944|26657109|P6|Entire: IV + Maintenance|Protocol deviation|1
7663383|NCT01412944|26657110|P5|Entire: IV + Maintenance|Protocol deviation|0
7663384|NCT01412944|26657111|P4|Entire: IV + Maintenance|Protocol deviation|0
7663385|NCT01412944|26657112|P3|Entire: IV + Maintenance|Protocol deviation|0
7663386|NCT01412944|26657113|P2|Entire: IV + Maintenance|Protocol deviation|0
7663387|NCT01412944|26657114|P1|Entire: IV + Maintenance|Protocol deviation|0
7663388|NCT01412944|26657109|P6|Entire: IV + Maintenance|Adverse Event|0
7663389|NCT01412944|26657110|P5|Entire: IV + Maintenance|Adverse Event|1
7663390|NCT01412944|26657111|P4|Entire: IV + Maintenance|Adverse Event|0
7663391|NCT01412944|26657112|P3|Entire: IV + Maintenance|Adverse Event|0
7663392|NCT01412944|26657113|P2|Entire: IV + Maintenance|Adverse Event|0
7663393|NCT01412944|26657114|P1|Entire: IV + Maintenance|Adverse Event|0
7663394|NCT01412944|26657109|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
7663395|NCT01412944|26657110|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
7663396|NCT01412944|26657111|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
7663397|NCT01412944|26657112|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
7663398|NCT01412944|26657113|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
7663399|NCT01412944|26657114|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
7663400|NCT01412944|26657109|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
7663401|NCT01412944|26657110|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
7663402|NCT01412944|26657111|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
7663403|NCT01412944|26657112|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
7663404|NCT01412944|26657113|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
7663405|NCT01412944|26657114|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
7663406|NCT01412944|26657109|P6|IV: Per CAIN457A2307|Protocol deviation|0
7663407|NCT01412944|26657110|P5|IV: Per CAIN457A2307|Protocol deviation|0
7663408|NCT01412944|26657111|P4|IV: Per CAIN457A2307|Protocol deviation|0
7663409|NCT01412944|26657112|P3|IV: Per CAIN457A2307|Protocol deviation|0
7663410|NCT01412944|26657113|P2|IV: Per CAIN457A2307|Protocol deviation|1
7663411|NCT01412944|26657114|P1|IV: Per CAIN457A2307|Protocol deviation|0
7663412|NCT01412944|26657109|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
7663413|NCT01412944|26657110|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
7663414|NCT01412944|26657111|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
7663415|NCT01412944|26657112|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
7663416|NCT01412944|26657113|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
7663417|NCT01412944|26657114|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
7663418|NCT01412944|26657109|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
7663419|NCT01412944|26657110|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7663420|NCT01412944|26657111|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7663421|NCT01412944|26657112|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7663422|NCT01412944|26657113|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7663423|NCT01412944|26657114|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7663424|NCT01412944|26657109|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
7663425|NCT01412944|26657110|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7663426|NCT01412944|26657111|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7663427|NCT01412944|26657112|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7663428|NCT01412944|26657113|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7663429|NCT01412944|26657114|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7663430|NCT01412944|26657109|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7663431|NCT01412944|26657110|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7663432|NCT01412944|26657111|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7663433|NCT01412944|26657112|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
7663434|NCT01412944|26657113|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7663435|NCT01412944|26657114|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7663451|NCT01412801|26657191|P6|Overall Study|Relocated to another area|0
7663452|NCT01412801|26657192|P5|Overall Study|Relocated to another area|0
7663453|NCT01412801|26657193|P4|Overall Study|Relocated to another area|0
7663454|NCT01412801|26657194|P3|Overall Study|Relocated to another area|2
7663455|NCT01412801|26657195|P2|Overall Study|Relocated to another area|0
7663456|NCT01412801|26657196|P1|Overall Study|Relocated to another area|0
7663457|NCT01412801|26657191|P6|Overall Study|Withdrawal by Subject|0
7663458|NCT01412801|26657192|P5|Overall Study|Withdrawal by Subject|0
7663459|NCT01412801|26657193|P4|Overall Study|Withdrawal by Subject|0
7663460|NCT01412801|26657194|P3|Overall Study|Withdrawal by Subject|1
7663461|NCT01412801|26657195|P2|Overall Study|Withdrawal by Subject|2
7663462|NCT01412801|26657196|P1|Overall Study|Withdrawal by Subject|3
7663463|NCT01412801|26657191|P6|Overall Study|Lost to Follow-up|1
7663464|NCT01412801|26657192|P5|Overall Study|Lost to Follow-up|1
7663465|NCT01412801|26657193|P4|Overall Study|Lost to Follow-up|0
7663466|NCT01412801|26657194|P3|Overall Study|Lost to Follow-up|4
7663467|NCT01412801|26657195|P2|Overall Study|Lost to Follow-up|2
7663468|NCT01412801|26657196|P1|Overall Study|Lost to Follow-up|1
7663469|NCT01412801|26657191|P6|Overall Study|Death|2
7663470|NCT01412801|26657192|P5|Overall Study|Death|2
7663471|NCT01412801|26657193|P4|Overall Study|Death|4
7663472|NCT01412801|26657194|P3|Overall Study|Death|0
7663473|NCT01412801|26657195|P2|Overall Study|Death|1
7663474|NCT01412801|26657196|P1|Overall Study|Death|0
7663475|NCT01412424|26657291|P1|Extension Treatment Period|Patient Request|2
7663476|NCT01412424|26657291|P1|Extension Treatment Period|Treatment Failure|2
7663477|NCT01412424|26657291|P1|Extension Treatment Period|Adverse Event|2
7663478|NCT01412424|26657291|P1|Core Treatment Period|Sponsor Request|1
7663479|NCT01412424|26657291|P1|Core Treatment Period|Lost to Follow-up|2
7663480|NCT01412424|26657291|P1|Core Treatment Period|Patient Request|5
7663481|NCT01412424|26657291|P1|Core Treatment Period|Adverse Event|21
7663482|NCT01412424|26657291|P1|Core Treatment Period|Treatment Failure|24
7663483|NCT01412333|26657328|P2|Overall Study|Lost to Follow-up|6
7663484|NCT01412333|26657329|P1|Overall Study|Lost to Follow-up|10
7663485|NCT01412333|26657328|P2|Overall Study|Adverse Event|16
7663486|NCT01412333|26657329|P1|Overall Study|Adverse Event|25
7663487|NCT01412333|26657328|P2|Overall Study|Consent withdrawn by participant|12
7663488|NCT01412333|26657329|P1|Overall Study|Consent withdrawn by participant|25
7663489|NCT01412333|26657328|P2|Overall Study|Pregnancy|0
7663490|NCT01412333|26657329|P1|Overall Study|Pregnancy|3
7663491|NCT01412333|26657328|P2|Overall Study|Lack of Efficacy|6
7663492|NCT01412333|26657329|P1|Overall Study|Lack of Efficacy|15
7663493|NCT01412333|26657328|P2|Overall Study|Non-compliance|3
7663494|NCT01412333|26657329|P1|Overall Study|Non-compliance|1
7663495|NCT01412333|26657328|P2|Overall Study|Protocol Violation|1
7663496|NCT01412333|26657329|P1|Overall Study|Protocol Violation|1
7663497|NCT01412333|26657328|P2|Overall Study|Non-compliance with study drug|1
7663498|NCT01412333|26657329|P1|Overall Study|Non-compliance with study drug|1
7663499|NCT01412333|26657328|P2|Overall Study|Reason not specified|10
7663500|NCT01412333|26657329|P1|Overall Study|Reason not specified|16
7663501|NCT01412333|26657328|P2|Overall Study|Physician Decision|1
7663502|NCT01412333|26657329|P1|Overall Study|Physician Decision|0
7663503|NCT01412333|26657328|P2|Overall Study|Death|1
7663504|NCT01412333|26657329|P1|Overall Study|Death|1
7663505|NCT01412229|26657389|P1|Overall Study|Physician Decision|1
7663506|NCT01412151|26657412|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
7663507|NCT01412151|26657412|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
7663508|NCT01412151|26657412|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
7663509|NCT01412151|26657412|P1|Week 0 - 306 - Treatment Period|Death|1
7663510|NCT01412060|26657423|P3|Double-blind Treatment Phase (DBP)|Relapse|25
7663511|NCT01412060|26657424|P2|Double-blind Treatment Phase (DBP)|Relapse|47
7663512|NCT01412060|26657425|P1|Double-blind Treatment Phase (DBP)|Relapse|0
7663513|NCT01412060|26657423|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
7663514|NCT01412060|26657424|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
7663515|NCT01412060|26657425|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
7663516|NCT01412060|26657423|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
7663517|NCT01412060|26657424|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
7663518|NCT01412060|26657425|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
7663519|NCT01412060|26657423|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
7663520|NCT01412060|26657424|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
7663521|NCT01412060|26657425|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
7663522|NCT01412060|26657423|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
7663523|NCT01412060|26657424|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
7663524|NCT01412060|26657425|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
7663525|NCT01412060|26657423|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
7663526|NCT01412060|26657424|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
7663527|NCT01412060|26657425|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
7663528|NCT01412060|26657423|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
7663529|NCT01412060|26657424|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
7663530|NCT01412060|26657425|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
7663531|NCT01412060|26657423|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7663532|NCT01412060|26657424|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7663533|NCT01412060|26657425|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
7663534|NCT01412060|26657423|P3|Period Between SP and DBP|Lost to Follow-up|0
7663535|NCT01412060|26657424|P2|Period Between SP and DBP|Lost to Follow-up|0
7663536|NCT01412060|26657425|P1|Period Between SP and DBP|Lost to Follow-up|1
7663537|NCT01412060|26657423|P3|Period Between SP and DBP|Withdrawal of Consent|0
7663538|NCT01412060|26657424|P2|Period Between SP and DBP|Withdrawal of Consent|0
7663539|NCT01412060|26657425|P1|Period Between SP and DBP|Withdrawal of Consent|2
7663540|NCT01412060|26657423|P3|Period Between SP and DBP|Protocol Violation|0
7663541|NCT01412060|26657424|P2|Period Between SP and DBP|Protocol Violation|0
7663542|NCT01412060|26657425|P1|Period Between SP and DBP|Protocol Violation|2
7663543|NCT01412060|26657423|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7663544|NCT01412060|26657424|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7663545|NCT01412060|26657425|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
7663546|NCT01412060|26657423|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7663547|NCT01412060|26657424|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7663548|NCT01412060|26657425|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
7663549|NCT01412060|26657423|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7663550|NCT01412060|26657424|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7663551|NCT01412060|26657425|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
7663552|NCT01412060|26657423|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
7663553|NCT01412060|26657424|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
7663554|NCT01412060|26657425|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
7663555|NCT01412060|26657423|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7663556|NCT01412060|26657424|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7663557|NCT01412060|26657425|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
7663558|NCT01412060|26657423|P3|Open-label Stabilization Period (SP)|Adverse Event|0
7663559|NCT01412060|26657424|P2|Open-label Stabilization Period (SP)|Adverse Event|0
7663560|NCT01412060|26657425|P1|Open-label Stabilization Period (SP)|Adverse Event|9
7663561|NCT01412060|26657423|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
7663562|NCT01412060|26657424|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
7663563|NCT01412060|26657425|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
7663564|NCT01412060|26657423|P3|Period Between RIP and SP|Lost to Follow-up|0
7663565|NCT01412060|26657424|P2|Period Between RIP and SP|Lost to Follow-up|0
7663566|NCT01412060|26657425|P1|Period Between RIP and SP|Lost to Follow-up|5
7663567|NCT01412060|26657423|P3|Period Between RIP and SP|Withdrawal of Consent|0
7663568|NCT01412060|26657424|P2|Period Between RIP and SP|Withdrawal of Consent|0
7663569|NCT01412060|26657425|P1|Period Between RIP and SP|Withdrawal of Consent|1
7663570|NCT01412060|26657423|P3|Period Between RIP and SP|Protocol Violation|0
7663571|NCT01412060|26657424|P2|Period Between RIP and SP|Protocol Violation|0
7663572|NCT01412060|26657425|P1|Period Between RIP and SP|Protocol Violation|2
7663573|NCT01412060|26657423|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
7663574|NCT01412060|26657424|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
7663575|NCT01412060|26657425|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
7663576|NCT01412060|26657423|P3|Period Between RIP and SP|Adverse Event|0
7663577|NCT01412060|26657424|P2|Period Between RIP and SP|Adverse Event|0
7663578|NCT01412060|26657425|P1|Period Between RIP and SP|Adverse Event|4
7663579|NCT01412060|26657423|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7663580|NCT01412060|26657424|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7663581|NCT01412060|26657425|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
7663582|NCT01412060|26657423|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7663583|NCT01412060|26657424|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7663584|NCT01412060|26657425|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
7663585|NCT01412060|26657423|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7663586|NCT01412060|26657424|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7663587|NCT01412060|26657425|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
7663588|NCT01412060|26657423|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
7663589|NCT01412060|26657424|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
7663590|NCT01412060|26657425|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
7663591|NCT01412060|26657423|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7663592|NCT01412060|26657424|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7663593|NCT01412060|26657425|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
7663594|NCT01412060|26657423|P3|Open-label Run-in Period (RIP)|Adverse Event|0
7663595|NCT01412060|26657424|P2|Open-label Run-in Period (RIP)|Adverse Event|0
7663596|NCT01412060|26657425|P1|Open-label Run-in Period (RIP)|Adverse Event|86
7663597|NCT01412021|26657435|P1|Overall Study|Transferred to Other Hospital|9
7663598|NCT01412021|26657435|P1|Overall Study|Treatment Prior to Approval|3
7663599|NCT01412021|26657435|P1|Overall Study|Case Report Forms Not Retrieved|7
7663600|NCT01411995|26657472|P2|Overall Study|Failed IUD insertion|1
7663601|NCT01411995|26657473|P1|Overall Study|Failed IUD insertion|0
7663602|NCT01411917|26657481|P2|Overall Study|Patient did not undergo scheduled surger|1
7663603|NCT01411917|26657482|P1|Overall Study|Patient did not undergo scheduled surger|0
7663604|NCT01411891|26657504|P2|Overall Study|Catheter dislodgement or loss to follow-|2
7663605|NCT01411891|26657505|P1|Overall Study|Catheter dislodgement or loss to follow-|3
7663606|NCT01411852|26657515|P2|Hospital Intervention Phase|Vascular access failed|0
7663607|NCT01411852|26657516|P1|Hospital Intervention Phase|Vascular access failed|1
7663608|NCT01411852|26657515|P2|Hospital Intervention Phase|Withdrawal by Subject|0
7663609|NCT01411852|26657516|P1|Hospital Intervention Phase|Withdrawal by Subject|1
7663610|NCT01411852|26657515|P2|Hospital Intervention Phase|Spinal cord injury|0
7663611|NCT01411852|26657516|P1|Hospital Intervention Phase|Spinal cord injury|2
7663612|NCT01411852|26657515|P2|Hospital Intervention Phase|Other ineligible|2
7663613|NCT01411852|26657516|P1|Hospital Intervention Phase|Other ineligible|2
7663614|NCT01411852|26657515|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
7663615|NCT01411852|26657516|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
7663616|NCT01411852|26657515|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
7663617|NCT01411852|26657516|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
7663618|NCT01411852|26657515|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
7663619|NCT01411852|26657516|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
7663620|NCT01411852|26657515|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
7663621|NCT01411852|26657516|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
7663622|NCT01411852|26657515|P2|Hospital Intervention Phase|CPR administered|1
7663623|NCT01411852|26657516|P1|Hospital Intervention Phase|CPR administered|3
7663624|NCT01411852|26657515|P2|Hospital Intervention Phase|Miscommunication error|2
7663625|NCT01411852|26657516|P1|Hospital Intervention Phase|Miscommunication error|1
7663626|NCT01411852|26657515|P2|Hospital Intervention Phase|No qualifying SBP|1
7663627|NCT01411852|26657516|P1|Hospital Intervention Phase|No qualifying SBP|5
7663628|NCT01411852|26657515|P2|Hospital Intervention Phase|Severe head injury|4
7663629|NCT01411852|26657516|P1|Hospital Intervention Phase|Severe head injury|5
7663630|NCT01411852|26657515|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
7663631|NCT01411852|26657516|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
7663632|NCT01411852|26657515|P2|Prehospital Intervention Phase|Found to be under age|1
7663633|NCT01411852|26657516|P1|Prehospital Intervention Phase|Found to be under age|0
7663634|NCT01411852|26657515|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7663635|NCT01411852|26657516|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7663636|NCT01411852|26657515|P2|Prehospital Intervention Phase|No qualifying SBP|4
7663637|NCT01411852|26657516|P1|Prehospital Intervention Phase|No qualifying SBP|5
7663638|NCT01411839|26657561|P2|Overall Study|Lost to Follow-up|3
7663639|NCT01411839|26657562|P1|Overall Study|Lost to Follow-up|4
7663640|NCT01411774|26657574|P2|Overall Study|Withdrawal by Subject|3
7663641|NCT01411774|26657575|P1|Overall Study|Withdrawal by Subject|0
7663642|NCT01411332|26657657|P2|Overall Study|Withdrawal by Subject|1
7663643|NCT01411332|26657658|P1|Overall Study|Withdrawal by Subject|0
7663644|NCT01411332|26657657|P2|Overall Study|Protocol Violation|1
7663645|NCT01411332|26657658|P1|Overall Study|Protocol Violation|1
7663646|NCT01411332|26657657|P2|Overall Study|Lost to Follow-up|0
7663647|NCT01411332|26657658|P1|Overall Study|Lost to Follow-up|1
7663648|NCT01411319|26657664|P1|Overall Study|Lost to Follow-up|1
7663649|NCT01411241|26657710|P2|Overall Study|Lost to Follow-up|4
7663650|NCT01411241|26657711|P1|Overall Study|Lost to Follow-up|2
7663651|NCT01411241|26657710|P2|Overall Study|Serious Adverse Event|3
7663652|NCT01411241|26657711|P1|Overall Study|Serious Adverse Event|0
7663653|NCT01411241|26657710|P2|Overall Study|Withdrawal by Subject|10
7663654|NCT01411241|26657711|P1|Overall Study|Withdrawal by Subject|9
7663655|NCT01411241|26657710|P2|Overall Study|Protocol Violation|5
7663656|NCT01411241|26657711|P1|Overall Study|Protocol Violation|0
7663657|NCT01411228|26657736|P3|Overall Study|Withdrawal by Subject|0
7663658|NCT01411228|26657737|P2|Overall Study|Withdrawal by Subject|0
7663659|NCT01411228|26657738|P1|Overall Study|Withdrawal by Subject|1
7663660|NCT01411228|26657736|P3|Overall Study|Lost to Follow-up|1
7663661|NCT01411228|26657737|P2|Overall Study|Lost to Follow-up|0
7663662|NCT01411228|26657738|P1|Overall Study|Lost to Follow-up|0
7663663|NCT01411215|26657760|P2|Overall Study|Screen failure|1
7663664|NCT01411215|26657761|P1|Overall Study|Screen failure|0
7663665|NCT01411215|26657760|P2|Overall Study|Other|17
7663666|NCT01411215|26657761|P1|Overall Study|Other|12
7663667|NCT01411215|26657760|P2|Overall Study|Withdrawal by Subject|21
7663668|NCT01411215|26657761|P1|Overall Study|Withdrawal by Subject|34
7663669|NCT01411215|26657760|P2|Overall Study|Protocol Violation|5
7663670|NCT01411215|26657761|P1|Overall Study|Protocol Violation|3
7663671|NCT01411215|26657760|P2|Overall Study|Study terminated by sponsor|15
7663672|NCT01411215|26657761|P1|Overall Study|Study terminated by sponsor|2
7663673|NCT01411215|26657760|P2|Overall Study|Did not meet entrance criteria|1
7663674|NCT01411215|26657761|P1|Overall Study|Did not meet entrance criteria|0
7663675|NCT01411215|26657760|P2|Overall Study|Lost to Follow-up|18
7663676|NCT01411215|26657761|P1|Overall Study|Lost to Follow-up|12
7663677|NCT01411215|26657760|P2|Overall Study|Lack of Efficacy|4
7663678|NCT01411215|26657761|P1|Overall Study|Lack of Efficacy|2
7663679|NCT01411215|26657760|P2|Overall Study|Adverse Event|2
7663680|NCT01411215|26657761|P1|Overall Study|Adverse Event|1
7663681|NCT01411085|26657813|P1|Overall Study|Adverse Event|1
7663682|NCT01411085|26657813|P1|Overall Study|Protocol Violation|1
7663683|NCT01411085|26657813|P1|Overall Study|Physician Decision|1
7663686|NCT01410799|26657868|P1|Overall Study|PI decision|13
7663687|NCT01410604|26657884|P2|Overall Study|Physician Decision|1
7663688|NCT01410604|26657885|P1|Overall Study|Physician Decision|0
7663689|NCT01410604|26657884|P2|Overall Study|Lost to Follow-up|0
7663690|NCT01410604|26657885|P1|Overall Study|Lost to Follow-up|1
7663691|NCT01410604|26657884|P2|Overall Study|Adverse Event|1
7663692|NCT01410604|26657885|P1|Overall Study|Adverse Event|2
7663693|NCT01410474|26657926|P2|Overall Study|Withdrawal by Subject|1
7663694|NCT01410474|26657927|P1|Overall Study|Withdrawal by Subject|0
7663695|NCT01410448|26657950|P2|Overall Study|Death|3
7663696|NCT01410448|26657951|P1|Overall Study|Death|2
7663697|NCT01410448|26657950|P2|Overall Study|Protocol Violation|4
7663698|NCT01410448|26657951|P1|Overall Study|Protocol Violation|0
7663699|NCT01410448|26657950|P2|Overall Study|Withdrawal by Subject|2
7663700|NCT01410448|26657951|P1|Overall Study|Withdrawal by Subject|3
7663701|NCT01410448|26657950|P2|Overall Study|Lost to Follow-up|0
7663702|NCT01410448|26657951|P1|Overall Study|Lost to Follow-up|1
7663703|NCT01410448|26657950|P2|Overall Study|Administrative issues|1
7663704|NCT01410448|26657951|P1|Overall Study|Administrative issues|2
7663705|NCT01410448|26657950|P2|Overall Study|Graft loss|1
7663706|NCT01410448|26657951|P1|Overall Study|Graft loss|4
7663707|NCT01410448|26657950|P2|Overall Study|No conversion to everolimus|24
7663708|NCT01410448|26657951|P1|Overall Study|No conversion to everolimus|0
7663709|NCT01410357|26658016|P2|Overall Study|Lost to Follow-up|21
7663710|NCT01410357|26658017|P1|Overall Study|Lost to Follow-up|23
7663711|NCT01410357|26658016|P2|Overall Study|Withdrawal by Subject|2
7663712|NCT01410357|26658017|P1|Overall Study|Withdrawal by Subject|1
7663713|NCT01410357|26658016|P2|Overall Study|Death|1
7663714|NCT01410357|26658017|P1|Overall Study|Death|2
7663715|NCT01410240|26658088|P3|Overall Study|Missed week 6 assessments|1
7663716|NCT01410240|26658089|P2|Overall Study|Missed week 6 assessments|1
7663717|NCT01410240|26658090|P1|Overall Study|Missed week 6 assessments|1
7663718|NCT01410240|26658088|P3|Overall Study|Physician Decision|1
7663719|NCT01410240|26658089|P2|Overall Study|Physician Decision|0
7663720|NCT01410240|26658090|P1|Overall Study|Physician Decision|0
7663721|NCT01410227|26658161|P4|Overall Study|Met Excl. Criteria After Starting Study|0
7663722|NCT01410227|26658162|P3|Overall Study|Met Excl. Criteria After Starting Study|1
7663723|NCT01410227|26658163|P2|Overall Study|Met Excl. Criteria After Starting Study|0
7663724|NCT01410227|26658164|P1|Overall Study|Met Excl. Criteria After Starting Study|0
7663725|NCT01410227|26658161|P4|Overall Study|Pregnancy|1
7663726|NCT01410227|26658162|P3|Overall Study|Pregnancy|0
7663727|NCT01410227|26658163|P2|Overall Study|Pregnancy|0
7663728|NCT01410227|26658164|P1|Overall Study|Pregnancy|0
7663729|NCT01410227|26658161|P4|Overall Study|Withdrawal by Subject|0
7663730|NCT01410227|26658162|P3|Overall Study|Withdrawal by Subject|1
7663731|NCT01410227|26658163|P2|Overall Study|Withdrawal by Subject|0
7663732|NCT01410227|26658164|P1|Overall Study|Withdrawal by Subject|3
7663733|NCT01410227|26658161|P4|Overall Study|Adverse Event|0
7663734|NCT01410227|26658162|P3|Overall Study|Adverse Event|0
7663735|NCT01410227|26658163|P2|Overall Study|Adverse Event|0
7663736|NCT01410227|26658164|P1|Overall Study|Adverse Event|1
7663737|NCT01410110|26658236|P2|Overall Study|Withdrawal by Subject|2
7663738|NCT01410110|26658237|P1|Overall Study|Withdrawal by Subject|4
7663739|NCT01409993|26658312|P4|Overall Study|Lost to Follow-up|0
7663740|NCT01409993|26658313|P3|Overall Study|Lost to Follow-up|0
7663741|NCT01409993|26658314|P2|Overall Study|Lost to Follow-up|1
7663742|NCT01409993|26658315|P1|Overall Study|Lost to Follow-up|0
7663743|NCT01409993|26658312|P4|Overall Study|Withdrawal by Subject|4
7663744|NCT01409993|26658313|P3|Overall Study|Withdrawal by Subject|0
7663745|NCT01409993|26658314|P2|Overall Study|Withdrawal by Subject|0
7663746|NCT01409993|26658315|P1|Overall Study|Withdrawal by Subject|0
7663747|NCT01409993|26658312|P4|Overall Study|Adverse Event|1
7663748|NCT01409993|26658313|P3|Overall Study|Adverse Event|3
7663749|NCT01409993|26658314|P2|Overall Study|Adverse Event|4
7663750|NCT01409993|26658315|P1|Overall Study|Adverse Event|4
7663751|NCT01409928|26658333|P1|Overall Study|Physician Decision|12
7663752|NCT01409915|26658339|P2|Overall Study|Protocol Violation|0
7663753|NCT01409915|26658340|P1|Overall Study|Protocol Violation|1
7663754|NCT01409915|26658339|P2|Overall Study|Withdrawal by Subject|1
7663755|NCT01409915|26658340|P1|Overall Study|Withdrawal by Subject|0
7663756|NCT01409915|26658339|P2|Overall Study|Adverse Event|2
7663757|NCT01409915|26658340|P1|Overall Study|Adverse Event|0
7663758|NCT01409837|26658358|P2|Overall Study|Physician Decision|1
7663759|NCT01409837|26658359|P1|Overall Study|Physician Decision|0
7663760|NCT01409837|26658358|P2|Overall Study|Lost to Follow-up|0
7663761|NCT01409837|26658359|P1|Overall Study|Lost to Follow-up|1
7663762|NCT01409837|26658358|P2|Overall Study|Withdrawal by Subject|1
7663763|NCT01409837|26658359|P1|Overall Study|Withdrawal by Subject|2
7663764|NCT01409811|26658381|P1|Overall Study|Insurance denial|1
7663765|NCT01409707|26658388|P3|Overall Study|Withdrawal by Subject|16
7663766|NCT01409707|26658389|P2|Overall Study|Withdrawal by Subject|17
7663767|NCT01409707|26658390|P1|Overall Study|Withdrawal by Subject|5
7663768|NCT01409564|26658402|P2|Overall Study|brain abnormalities found in T1 MR|2
7663769|NCT01409564|26658403|P1|Overall Study|brain abnormalities found in T1 MR|1
7663770|NCT01409564|26658402|P2|Overall Study|low medication compliance|3
7663771|NCT01409564|26658403|P1|Overall Study|low medication compliance|4
7663772|NCT01409434|26658421|P1|Overall Study|Protocol Violation|4
7663773|NCT01409382|26658431|P2|Overall Study|Had a 2nd trimester loss after accident|0
7663774|NCT01409382|26658432|P1|Overall Study|Had a 2nd trimester loss after accident|1
7663775|NCT01409382|26658431|P2|Overall Study|Did not manage to get pregnant|70
7663776|NCT01409382|26658432|P1|Overall Study|Did not manage to get pregnant|64
7663777|NCT01409382|26658431|P2|Overall Study|Still pregnant when study ended|2
7663778|NCT01409382|26658432|P1|Overall Study|Still pregnant when study ended|13
7663779|NCT01409382|26658431|P2|Overall Study|Multiple pregnancy|4
7663780|NCT01409382|26658432|P1|Overall Study|Multiple pregnancy|2
7663781|NCT01409382|26658431|P2|Overall Study|Protocol Violation|3
7663782|NCT01409382|26658432|P1|Overall Study|Protocol Violation|0
7663783|NCT01409382|26658431|P2|Overall Study|Lost to Follow-up|1
7663784|NCT01409382|26658432|P1|Overall Study|Lost to Follow-up|1
7663785|NCT01409031|26658486|P2|Overall Study|transferred to other hosp|0
7663786|NCT01409031|26658487|P1|Overall Study|transferred to other hosp|1
7663787|NCT01408914|26658518|P3|Overall Study|Change in local TB/HIV norms|1
7663788|NCT01408914|26658519|P2|Overall Study|Change in local TB/HIV norms|1
7663789|NCT01408914|26658520|P1|Overall Study|Change in local TB/HIV norms|0
7663790|NCT01408914|26658518|P3|Overall Study|Late exclusion|3
7663791|NCT01408914|26658519|P2|Overall Study|Late exclusion|3
7663792|NCT01408914|26658520|P1|Overall Study|Late exclusion|0
7663793|NCT01408914|26658518|P3|Overall Study|Moved out of study jurisdiction|0
7663794|NCT01408914|26658519|P2|Overall Study|Moved out of study jurisdiction|1
7663795|NCT01408914|26658520|P1|Overall Study|Moved out of study jurisdiction|1
7663796|NCT01408914|26658518|P3|Overall Study|Withdrawal by Subject|1
7663797|NCT01408914|26658519|P2|Overall Study|Withdrawal by Subject|0
7663798|NCT01408914|26658520|P1|Overall Study|Withdrawal by Subject|1
7663799|NCT01408914|26658518|P3|Overall Study|Physician Decision|0
7663800|NCT01408914|26658519|P2|Overall Study|Physician Decision|1
7663801|NCT01408914|26658520|P1|Overall Study|Physician Decision|1
7663802|NCT01408914|26658518|P3|Overall Study|Lost to Follow-up|2
7663803|NCT01408914|26658519|P2|Overall Study|Lost to Follow-up|1
7663804|NCT01408914|26658520|P1|Overall Study|Lost to Follow-up|4
7663805|NCT01408914|26658518|P3|Overall Study|Could not complete tx in protocol period|6
7663806|NCT01408914|26658519|P2|Overall Study|Could not complete tx in protocol period|5
7663807|NCT01408914|26658520|P1|Overall Study|Could not complete tx in protocol period|5
7663808|NCT01408901|26658538|P4|26-Week Follow-Up|Death|0
7663809|NCT01408901|26658539|P3|26-Week Follow-Up|Death|0
7663810|NCT01408901|26658540|P2|26-Week Follow-Up|Death|1
7663811|NCT01408901|26658541|P1|26-Week Follow-Up|Death|0
7663812|NCT01408901|26658538|P4|26-Week Follow-Up|Lost to Follow-up|1
7663813|NCT01408901|26658539|P3|26-Week Follow-Up|Lost to Follow-up|0
7663814|NCT01408901|26658540|P2|26-Week Follow-Up|Lost to Follow-up|1
7663815|NCT01408901|26658541|P1|26-Week Follow-Up|Lost to Follow-up|1
7663816|NCT01408901|26658538|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
7663817|NCT01408901|26658539|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7663818|NCT01408901|26658540|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
7663819|NCT01408901|26658541|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7663820|NCT01408901|26658538|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
7663821|NCT01408901|26658539|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
7663822|NCT01408901|26658540|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
7663823|NCT01408901|26658541|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
7663824|NCT01408901|26658538|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
7663825|NCT01408901|26658539|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7663826|NCT01408901|26658540|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7663827|NCT01408901|26658541|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7663828|NCT01408901|26658538|P4|6-Week Follow-Up|Cancelled visit|2
7663829|NCT01408901|26658539|P3|6-Week Follow-Up|Cancelled visit|0
7663830|NCT01408901|26658540|P2|6-Week Follow-Up|Cancelled visit|1
7663831|NCT01408901|26658541|P1|6-Week Follow-Up|Cancelled visit|0
7663832|NCT01408901|26658538|P4|6-Week Follow-Up|Death|0
7663833|NCT01408901|26658539|P3|6-Week Follow-Up|Death|0
7663834|NCT01408901|26658540|P2|6-Week Follow-Up|Death|0
7663835|NCT01408901|26658541|P1|6-Week Follow-Up|Death|1
7663836|NCT01408901|26658538|P4|6-Week Follow-Up|Lost to Follow-up|2
7663837|NCT01408901|26658539|P3|6-Week Follow-Up|Lost to Follow-up|3
7663838|NCT01408901|26658540|P2|6-Week Follow-Up|Lost to Follow-up|1
7663839|NCT01408901|26658541|P1|6-Week Follow-Up|Lost to Follow-up|2
7663840|NCT01408888|26658567|P2|Second Intervention|Adverse Event|0
7663841|NCT01408888|26658568|P1|Second Intervention|Adverse Event|1
7663842|NCT01408888|26658567|P2|Second Intervention|Withdrawal by Subject|0
7663843|NCT01408888|26658568|P1|Second Intervention|Withdrawal by Subject|1
7663844|NCT01408888|26658567|P2|First Intervention|Withdrawal by Subject|2
7663845|NCT01408888|26658568|P1|First Intervention|Withdrawal by Subject|0
7663846|NCT01408888|26658567|P2|First Intervention|Adverse Event|1
7663847|NCT01408888|26658568|P1|First Intervention|Adverse Event|0
7663848|NCT01408732|26658596|P2|Overall Study|Withdrawal by Subject|2
7663849|NCT01408732|26658597|P1|Overall Study|Withdrawal by Subject|2
7663850|NCT01408706|26658654|P2|Overall Study|Physician Decision|0
7663851|NCT01408706|26658655|P1|Overall Study|Physician Decision|1
7663852|NCT01408641|26658667|P2|Overall Study|Physician Decision|0
7663853|NCT01408641|26658668|P1|Overall Study|Physician Decision|1
7663854|NCT01408628|26658676|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
7663855|NCT01408628|26658676|P1|Completed 6 Month Follow-Up|Protocol Violation|6
7663856|NCT01408628|26658676|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
7663857|NCT01408628|26658676|P1|Consented|Withdrawal by Subject|12
7663858|NCT01408576|26658685|P3|Overall Study|Other|18
7663859|NCT01408576|26658686|P2|Overall Study|Other|16
7663860|NCT01408576|26658687|P1|Overall Study|Other|10
7663861|NCT01408576|26658685|P3|Overall Study|AE, unknown type|0
7663862|NCT01408576|26658686|P2|Overall Study|AE, unknown type|1
7663863|NCT01408576|26658687|P1|Overall Study|AE, unknown type|0
7663864|NCT01408576|26658685|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7663865|NCT01408576|26658686|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7663866|NCT01408576|26658687|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7663867|NCT01408576|26658685|P3|Overall Study|AE, non-serious non-fatal|11
7663868|NCT01408576|26658686|P2|Overall Study|AE, non-serious non-fatal|19
7663869|NCT01408576|26658687|P1|Overall Study|AE, non-serious non-fatal|12
7663870|NCT01408576|26658685|P3|Overall Study|SAE, non-fatal|14
7663871|NCT01408576|26658686|P2|Overall Study|SAE, non-fatal|23
7663872|NCT01408576|26658687|P1|Overall Study|SAE, non-fatal|11
7663873|NCT01408576|26658685|P3|Overall Study|AE, serious fatal|1
7663874|NCT01408576|26658686|P2|Overall Study|AE, serious fatal|4
7663875|NCT01408576|26658687|P1|Overall Study|AE, serious fatal|4
7663876|NCT01408576|26658685|P3|Overall Study|Sponsor terminated study|330
7663877|NCT01408576|26658686|P2|Overall Study|Sponsor terminated study|333
7663878|NCT01408576|26658687|P1|Overall Study|Sponsor terminated study|89
7663879|NCT01408576|26658685|P3|Overall Study|Withdrawal by Subject|66
7663880|NCT01408576|26658686|P2|Overall Study|Withdrawal by Subject|60
7663881|NCT01408576|26658687|P1|Overall Study|Withdrawal by Subject|34
7663882|NCT01408576|26658685|P3|Overall Study|Lost to Follow-up|17
7663883|NCT01408576|26658686|P2|Overall Study|Lost to Follow-up|9
7663884|NCT01408576|26658687|P1|Overall Study|Lost to Follow-up|10
7663885|NCT01408576|26658685|P3|Overall Study|Protocol Violation|2
7663886|NCT01408576|26658686|P2|Overall Study|Protocol Violation|2
7663887|NCT01408576|26658687|P1|Overall Study|Protocol Violation|1
7663888|NCT01408576|26658685|P3|Overall Study|Lack of Efficacy|48
7663889|NCT01408576|26658686|P2|Overall Study|Lack of Efficacy|30
7663890|NCT01408576|26658687|P1|Overall Study|Lack of Efficacy|17
7663891|NCT01408563|26658734|P1|Overall Study|Ineligible after consent/ registration|2
7663892|NCT01408537|26658750|P1|Overall Study|Lost to Follow-up|3
7663893|NCT01408537|26658750|P1|Overall Study|Protocol Violation|3
7663894|NCT01408537|26658750|P1|Overall Study|Withdrawal by Subject|2
7663895|NCT01408485|26658766|P1|Overall Study|Withdrawal by Subject|21
7663896|NCT01408459|26658774|P2|Overall Study|Withdrawal by Subject|1
7663897|NCT01408459|26658775|P1|Overall Study|Withdrawal by Subject|1
7663898|NCT01408303|26658801|P3|Overall Study|Noncompliance|1
7663899|NCT01408303|26658802|P2|Overall Study|Noncompliance|0
7663900|NCT01408303|26658803|P1|Overall Study|Noncompliance|1
7663901|NCT01408303|26658801|P3|Overall Study|Protocol Violation|0
7663902|NCT01408303|26658802|P2|Overall Study|Protocol Violation|1
7663903|NCT01408303|26658803|P1|Overall Study|Protocol Violation|0
7663904|NCT01408303|26658801|P3|Overall Study|Withdrawal by Subject|1
7663905|NCT01408303|26658802|P2|Overall Study|Withdrawal by Subject|3
7663906|NCT01408303|26658803|P1|Overall Study|Withdrawal by Subject|2
7663907|NCT01408303|26658801|P3|Overall Study|Lost to Follow-up|2
7663908|NCT01408303|26658802|P2|Overall Study|Lost to Follow-up|1
7663909|NCT01408303|26658803|P1|Overall Study|Lost to Follow-up|0
7663910|NCT01408303|26658801|P3|Overall Study|Adverse Event|2
7663911|NCT01408303|26658802|P2|Overall Study|Adverse Event|7
7663912|NCT01408303|26658803|P1|Overall Study|Adverse Event|3
7663913|NCT01408277|26658813|P2|Overall Study|Protocol Violation|0
7663914|NCT01408277|26658814|P1|Overall Study|Protocol Violation|2
7663915|NCT01408277|26658813|P2|Overall Study|Withdrawal by Subject|0
7663916|NCT01408277|26658814|P1|Overall Study|Withdrawal by Subject|2
7663917|NCT01408277|26658813|P2|Overall Study|Lost to Follow-up|0
7663918|NCT01408277|26658814|P1|Overall Study|Lost to Follow-up|1
7663919|NCT01408277|26658813|P2|Overall Study|Adverse Event|4
7663920|NCT01408277|26658814|P1|Overall Study|Adverse Event|3
7663921|NCT01408147|26658822|P2|Overall Study|Withdrawal by Subject|1
7663922|NCT01408147|26658823|P1|Overall Study|Withdrawal by Subject|0
7663923|NCT01408043|26658831|P1|Overall Study|unable to collect cells|1
7663924|NCT01408030|26658850|P4|Observation Phase (Off Drug)|Other|1
7663925|NCT01408030|26658851|P3|Observation Phase (Off Drug)|Other|1
7663926|NCT01408030|26658852|P2|Observation Phase (Off Drug)|Other|1
7663927|NCT01408030|26658853|P1|Observation Phase (Off Drug)|Other|1
7663928|NCT01408030|26658850|P4|Observation Phase (Off Drug)|Physician Decision|0
7663929|NCT01408030|26658851|P3|Observation Phase (Off Drug)|Physician Decision|2
7663930|NCT01408030|26658852|P2|Observation Phase (Off Drug)|Physician Decision|1
7663931|NCT01408030|26658853|P1|Observation Phase (Off Drug)|Physician Decision|0
7663932|NCT01408030|26658850|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
7663933|NCT01408030|26658851|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
7663934|NCT01408030|26658852|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
7663935|NCT01408030|26658853|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
7663936|NCT01408030|26658850|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
7663937|NCT01408030|26658851|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
7663938|NCT01408030|26658852|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
7663939|NCT01408030|26658853|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
7663940|NCT01408030|26658850|P4|Treatment Phase (on Drug)|Protocol Violation|0
7663941|NCT01408030|26658851|P3|Treatment Phase (on Drug)|Protocol Violation|0
7663942|NCT01408030|26658852|P2|Treatment Phase (on Drug)|Protocol Violation|1
7663943|NCT01408030|26658853|P1|Treatment Phase (on Drug)|Protocol Violation|0
7663944|NCT01408030|26658850|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
7663945|NCT01408030|26658851|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
7663946|NCT01408030|26658852|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
7663947|NCT01408030|26658853|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
7663948|NCT01408030|26658850|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
7663949|NCT01408030|26658851|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
7663950|NCT01408030|26658852|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
7663951|NCT01408030|26658853|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
7663952|NCT01407926|26658912|P1|Overall Study|Lost to Follow-up|55
7663953|NCT01407367|26658960|P2|Overall Study|Lost to Follow-up|2
7663954|NCT01407367|26658961|P1|Overall Study|Lost to Follow-up|0
7663955|NCT01407367|26658960|P2|Overall Study|Withdrawal by Subject|15
7663956|NCT01407367|26658961|P1|Overall Study|Withdrawal by Subject|4
7663957|NCT01407367|26658960|P2|Overall Study|Renal Replacement Therapy (RRT)|29
7663958|NCT01407367|26658961|P1|Overall Study|Renal Replacement Therapy (RRT)|12
7663959|NCT01407367|26658960|P2|Overall Study|Death|32
7663960|NCT01407367|26658961|P1|Overall Study|Death|24
7663961|NCT01407354|26658975|P2|First Intervention|Physician Decision|0
7663962|NCT01407354|26658976|P1|First Intervention|Physician Decision|1
7663963|NCT01407354|26658975|P2|First Intervention|Adverse Event|0
7663964|NCT01407354|26658976|P1|First Intervention|Adverse Event|1
7663965|NCT01407354|26658975|P2|First Intervention|Withdrawal by Subject|2
7663966|NCT01407354|26658976|P1|First Intervention|Withdrawal by Subject|0
7663967|NCT01407276|26658992|P8|Overall Study|Withdrawal by Subject|1
7663968|NCT01407276|26658993|P7|Overall Study|Withdrawal by Subject|0
7663969|NCT01407276|26658994|P6|Overall Study|Withdrawal by Subject|0
7663970|NCT01407276|26658995|P5|Overall Study|Withdrawal by Subject|0
7663971|NCT01407276|26658996|P4|Overall Study|Withdrawal by Subject|0
7663972|NCT01407276|26658997|P3|Overall Study|Withdrawal by Subject|0
7663973|NCT01407276|26658998|P2|Overall Study|Withdrawal by Subject|0
7663974|NCT01407276|26658999|P1|Overall Study|Withdrawal by Subject|0
7663975|NCT01406938|26659167|P6|Follow up|Lost to Follow-up|1
7663976|NCT01406938|26659168|P5|Follow up|Lost to Follow-up|2
7663977|NCT01406938|26659169|P4|Follow up|Lost to Follow-up|1
7663978|NCT01406938|26659170|P3|Follow up|Lost to Follow-up|0
7663979|NCT01406938|26659171|P2|Follow up|Lost to Follow-up|1
7663980|NCT01406938|26659172|P1|Follow up|Lost to Follow-up|1
7663981|NCT01406938|26659167|P6|Follow up|Physician Decision|1
7663982|NCT01406938|26659168|P5|Follow up|Physician Decision|3
7663983|NCT01406938|26659169|P4|Follow up|Physician Decision|0
7663984|NCT01406938|26659170|P3|Follow up|Physician Decision|2
7663985|NCT01406938|26659171|P2|Follow up|Physician Decision|0
7663986|NCT01406938|26659172|P1|Follow up|Physician Decision|0
7663987|NCT01406938|26659167|P6|Follow up|Protocol Violation|0
7663988|NCT01406938|26659168|P5|Follow up|Protocol Violation|0
7663989|NCT01406938|26659169|P4|Follow up|Protocol Violation|0
7663990|NCT01406938|26659170|P3|Follow up|Protocol Violation|1
7663991|NCT01406938|26659171|P2|Follow up|Protocol Violation|0
7663992|NCT01406938|26659172|P1|Follow up|Protocol Violation|0
7663993|NCT01406938|26659167|P6|Follow up|Patient/guardian decision|1
7663994|NCT01406938|26659168|P5|Follow up|Patient/guardian decision|4
7663995|NCT01406938|26659169|P4|Follow up|Patient/guardian decision|2
7663996|NCT01406938|26659170|P3|Follow up|Patient/guardian decision|4
7663997|NCT01406938|26659171|P2|Follow up|Patient/guardian decision|2
7663998|NCT01406938|26659172|P1|Follow up|Patient/guardian decision|4
7663999|NCT01406938|26659167|P6|Follow up|Lack of Efficacy|0
7664000|NCT01406938|26659168|P5|Follow up|Lack of Efficacy|0
7664001|NCT01406938|26659169|P4|Follow up|Lack of Efficacy|0
7664002|NCT01406938|26659170|P3|Follow up|Lack of Efficacy|1
7664003|NCT01406938|26659171|P2|Follow up|Lack of Efficacy|2
7664004|NCT01406938|26659172|P1|Follow up|Lack of Efficacy|3
7664005|NCT01406938|26659167|P6|Maintenance Period|Lack of Efficacy|5
7664006|NCT01406938|26659168|P5|Maintenance Period|Lack of Efficacy|3
7664007|NCT01406938|26659169|P4|Maintenance Period|Lack of Efficacy|1
7664008|NCT01406938|26659170|P3|Maintenance Period|Lack of Efficacy|2
7664009|NCT01406938|26659171|P2|Maintenance Period|Lack of Efficacy|0
7664010|NCT01406938|26659172|P1|Maintenance Period|Lack of Efficacy|0
7664011|NCT01406938|26659167|P6|Maintenance Period|Lost to Follow-up|0
7664012|NCT01406938|26659168|P5|Maintenance Period|Lost to Follow-up|4
7664013|NCT01406938|26659169|P4|Maintenance Period|Lost to Follow-up|0
7664014|NCT01406938|26659170|P3|Maintenance Period|Lost to Follow-up|0
7664015|NCT01406938|26659171|P2|Maintenance Period|Lost to Follow-up|0
7664016|NCT01406938|26659172|P1|Maintenance Period|Lost to Follow-up|0
7664017|NCT01406938|26659167|P6|Maintenance Period|Pregnancy|0
7664018|NCT01406938|26659168|P5|Maintenance Period|Pregnancy|1
7664019|NCT01406938|26659169|P4|Maintenance Period|Pregnancy|0
7664020|NCT01406938|26659170|P3|Maintenance Period|Pregnancy|0
7664021|NCT01406938|26659171|P2|Maintenance Period|Pregnancy|0
7664022|NCT01406938|26659172|P1|Maintenance Period|Pregnancy|0
7664023|NCT01406938|26659167|P6|Maintenance Period|Protocol Violation|2
7664024|NCT01406938|26659168|P5|Maintenance Period|Protocol Violation|2
7664025|NCT01406938|26659169|P4|Maintenance Period|Protocol Violation|2
7664026|NCT01406938|26659170|P3|Maintenance Period|Protocol Violation|2
7664027|NCT01406938|26659171|P2|Maintenance Period|Protocol Violation|0
7664028|NCT01406938|26659172|P1|Maintenance Period|Protocol Violation|0
7664029|NCT01406938|26659167|P6|Maintenance Period|Subject/guardian decision|7
7664030|NCT01406938|26659168|P5|Maintenance Period|Subject/guardian decision|10
7664031|NCT01406938|26659169|P4|Maintenance Period|Subject/guardian decision|7
7664032|NCT01406938|26659170|P3|Maintenance Period|Subject/guardian decision|11
7664033|NCT01406938|26659171|P2|Maintenance Period|Subject/guardian decision|0
7664034|NCT01406938|26659172|P1|Maintenance Period|Subject/guardian decision|0
7664035|NCT01406938|26659167|P6|Maintenance Period|Death|0
7664036|NCT01406938|26659168|P5|Maintenance Period|Death|1
7664037|NCT01406938|26659169|P4|Maintenance Period|Death|0
7664038|NCT01406938|26659170|P3|Maintenance Period|Death|0
7664039|NCT01406938|26659171|P2|Maintenance Period|Death|0
7664040|NCT01406938|26659172|P1|Maintenance Period|Death|0
7664041|NCT01406938|26659167|P6|Maintenance Period|Adverse Event|2
7664042|NCT01406938|26659168|P5|Maintenance Period|Adverse Event|4
7664043|NCT01406938|26659169|P4|Maintenance Period|Adverse Event|8
7664044|NCT01406938|26659170|P3|Maintenance Period|Adverse Event|2
7664045|NCT01406938|26659171|P2|Maintenance Period|Adverse Event|0
7664046|NCT01406938|26659172|P1|Maintenance Period|Adverse Event|0
7664047|NCT01406938|26659167|P6|Induction Period|Lost to Follow-up|0
7664048|NCT01406938|26659168|P5|Induction Period|Lost to Follow-up|0
7664049|NCT01406938|26659169|P4|Induction Period|Lost to Follow-up|0
7664050|NCT01406938|26659170|P3|Induction Period|Lost to Follow-up|0
7664051|NCT01406938|26659171|P2|Induction Period|Lost to Follow-up|3
7664052|NCT01406938|26659172|P1|Induction Period|Lost to Follow-up|2
7664053|NCT01406938|26659167|P6|Induction Period|Lack of Efficacy|0
7664054|NCT01406938|26659168|P5|Induction Period|Lack of Efficacy|0
7664055|NCT01406938|26659169|P4|Induction Period|Lack of Efficacy|0
7664056|NCT01406938|26659170|P3|Induction Period|Lack of Efficacy|0
7664057|NCT01406938|26659171|P2|Induction Period|Lack of Efficacy|0
7664058|NCT01406938|26659172|P1|Induction Period|Lack of Efficacy|1
7664059|NCT01406938|26659167|P6|Induction Period|Adverse Event|0
7664060|NCT01406938|26659168|P5|Induction Period|Adverse Event|0
7664061|NCT01406938|26659169|P4|Induction Period|Adverse Event|0
7664062|NCT01406938|26659170|P3|Induction Period|Adverse Event|0
7664063|NCT01406938|26659171|P2|Induction Period|Adverse Event|9
7664064|NCT01406938|26659172|P1|Induction Period|Adverse Event|8
7664065|NCT01406938|26659167|P6|Induction Period|Protocol deviation|0
7664066|NCT01406938|26659168|P5|Induction Period|Protocol deviation|0
7664067|NCT01406938|26659169|P4|Induction Period|Protocol deviation|0
7664068|NCT01406938|26659170|P3|Induction Period|Protocol deviation|0
7664069|NCT01406938|26659171|P2|Induction Period|Protocol deviation|0
7664070|NCT01406938|26659172|P1|Induction Period|Protocol deviation|1
7664071|NCT01406938|26659167|P6|Induction Period|Subject/guardian decision|0
7664072|NCT01406938|26659168|P5|Induction Period|Subject/guardian decision|0
7664073|NCT01406938|26659169|P4|Induction Period|Subject/guardian decision|0
7664074|NCT01406938|26659170|P3|Induction Period|Subject/guardian decision|0
7664075|NCT01406938|26659171|P2|Induction Period|Subject/guardian decision|8
7664076|NCT01406938|26659172|P1|Induction Period|Subject/guardian decision|6
7664077|NCT01406873|26659290|P2|Overall Study|Withdrawal by Subject|1
7664078|NCT01406873|26659291|P1|Overall Study|Withdrawal by Subject|1
7664079|NCT01406795|26659322|P1|Overall Study|Withdrawal by Subject|1
7664080|NCT01406717|26659338|P2|Overall Study|Non-completion of visit activity|1
7664081|NCT01406717|26659339|P1|Overall Study|Non-completion of visit activity|0
7664082|NCT01406717|26659338|P2|Overall Study|Lack of Efficacy|1
7664083|NCT01406717|26659339|P1|Overall Study|Lack of Efficacy|0
7664084|NCT01406717|26659338|P2|Overall Study|Adverse Event|2
7664085|NCT01406717|26659339|P1|Overall Study|Adverse Event|1
7664086|NCT01406717|26659338|P2|Overall Study|Withdrawal by Subject|15
7664087|NCT01406717|26659339|P1|Overall Study|Withdrawal by Subject|19
7664088|NCT01406717|26659338|P2|Overall Study|Lost to Follow-up|8
7664089|NCT01406717|26659339|P1|Overall Study|Lost to Follow-up|14
7664090|NCT01406717|26659338|P2|Overall Study|Protocol Violation|1
7664091|NCT01406717|26659339|P1|Overall Study|Protocol Violation|5
7664092|NCT01406717|26659338|P2|Overall Study|Subject non-compliance|3
7664093|NCT01406717|26659339|P1|Overall Study|Subject non-compliance|4
7664094|NCT01406652|26659369|P2|Overall Study|Infection not sure|10
7664095|NCT01406652|26659370|P1|Overall Study|Infection not sure|10
7664096|NCT01406652|26659369|P2|Overall Study|Insufficient follow-up|4
7664097|NCT01406652|26659370|P1|Overall Study|Insufficient follow-up|5
7664098|NCT01406652|26659369|P2|Overall Study|Withdrawal by Subject|2
7664099|NCT01406652|26659370|P1|Overall Study|Withdrawal by Subject|2
7664100|NCT01406652|26659369|P2|Overall Study|Lost-to-follow-up|4
7664101|NCT01406652|26659370|P1|Overall Study|Lost-to-follow-up|3
7664102|NCT01406574|26659378|P4|Overall Study|Definite progression of primary disease|0
7664103|NCT01406574|26659379|P3|Overall Study|Definite progression of primary disease|0
7664104|NCT01406574|26659380|P2|Overall Study|Definite progression of primary disease|0
7664105|NCT01406574|26659381|P1|Overall Study|Definite progression of primary disease|1
7664106|NCT01406574|26659378|P4|Overall Study|Withdrawal by Subject|0
7664107|NCT01406574|26659379|P3|Overall Study|Withdrawal by Subject|0
7664108|NCT01406574|26659380|P2|Overall Study|Withdrawal by Subject|1
7664109|NCT01406574|26659381|P1|Overall Study|Withdrawal by Subject|0
7664110|NCT01406574|26659378|P4|Overall Study|Physician Decision|1
7664111|NCT01406574|26659379|P3|Overall Study|Physician Decision|0
7664112|NCT01406574|26659380|P2|Overall Study|Physician Decision|0
7664113|NCT01406574|26659381|P1|Overall Study|Physician Decision|0
7664114|NCT01406574|26659378|P4|Overall Study|Adverse Event|3
7664115|NCT01406574|26659379|P3|Overall Study|Adverse Event|1
7664116|NCT01406574|26659380|P2|Overall Study|Adverse Event|0
7664117|NCT01406574|26659381|P1|Overall Study|Adverse Event|0
7664118|NCT01406015|26659432|P2|Overall Study|Withdrawal by Subject|3
7664119|NCT01406015|26659433|P1|Overall Study|Withdrawal by Subject|3
7664120|NCT01405950|26659449|P4|Overall Study|Withdrawal by Subject|0
7664121|NCT01405950|26659450|P3|Overall Study|Withdrawal by Subject|0
7664122|NCT01405950|26659451|P2|Overall Study|Withdrawal by Subject|0
7664123|NCT01405950|26659452|P1|Overall Study|Withdrawal by Subject|1
7664124|NCT01405924|26659487|P1|Overall Study|Missing/Incomplete Data|2
7664125|NCT01405924|26659487|P1|Overall Study|Protocol Violation|8
7664126|NCT01405911|26659500|P3|Overall Study|Withdrawal by Subject|1
7664127|NCT01405911|26659501|P2|Overall Study|Withdrawal by Subject|1
7664128|NCT01405911|26659502|P1|Overall Study|Withdrawal by Subject|3
7664129|NCT01405911|26659500|P3|Overall Study|Protocol Violation|0
7664130|NCT01405911|26659501|P2|Overall Study|Protocol Violation|0
7664131|NCT01405911|26659502|P1|Overall Study|Protocol Violation|1
7664132|NCT01405911|26659500|P3|Overall Study|Lost to Follow-up|0
7664133|NCT01405911|26659501|P2|Overall Study|Lost to Follow-up|1
7664134|NCT01405911|26659502|P1|Overall Study|Lost to Follow-up|0
7664135|NCT01405911|26659500|P3|Overall Study|Pre-treatment lab AE|0
7664136|NCT01405911|26659501|P2|Overall Study|Pre-treatment lab AE|1
7664137|NCT01405911|26659502|P1|Overall Study|Pre-treatment lab AE|0
7664138|NCT01405898|26659521|P2|Overall Study|Withdrawal by Subject|2
7664139|NCT01405898|26659522|P1|Overall Study|Withdrawal by Subject|2
7664140|NCT01405820|26659546|P6|Open-Label Treatment Period|Adverse Event|0
7664141|NCT01405820|26659547|P5|Open-Label Treatment Period|Adverse Event|0
7664142|NCT01405820|26659548|P4|Open-Label Treatment Period|Adverse Event|1
7664143|NCT01405820|26659549|P3|Open-Label Treatment Period|Adverse Event|0
7664144|NCT01405820|26659550|P2|Open-Label Treatment Period|Adverse Event|0
7664145|NCT01405820|26659551|P1|Open-Label Treatment Period|Adverse Event|0
7664146|NCT01405820|26659546|P6|Open-Label Treatment Period|Physician Decision|0
7664147|NCT01405820|26659547|P5|Open-Label Treatment Period|Physician Decision|1
7664148|NCT01405820|26659548|P4|Open-Label Treatment Period|Physician Decision|2
7664149|NCT01405820|26659549|P3|Open-Label Treatment Period|Physician Decision|1
7664150|NCT01405820|26659550|P2|Open-Label Treatment Period|Physician Decision|0
7664151|NCT01405820|26659551|P1|Open-Label Treatment Period|Physician Decision|0
7664152|NCT01405820|26659546|P6|Open-Label Treatment Period|Other|1
7664153|NCT01405820|26659547|P5|Open-Label Treatment Period|Other|1
7664154|NCT01405820|26659548|P4|Open-Label Treatment Period|Other|1
7664155|NCT01405820|26659549|P3|Open-Label Treatment Period|Other|1
7664156|NCT01405820|26659550|P2|Open-Label Treatment Period|Other|1
7664157|NCT01405820|26659551|P1|Open-Label Treatment Period|Other|1
7664158|NCT01405820|26659546|P6|Open-Label Treatment Period|Withdrawal by Subject|1
7664159|NCT01405820|26659547|P5|Open-Label Treatment Period|Withdrawal by Subject|0
7664160|NCT01405820|26659548|P4|Open-Label Treatment Period|Withdrawal by Subject|1
7664161|NCT01405820|26659549|P3|Open-Label Treatment Period|Withdrawal by Subject|1
7664162|NCT01405820|26659550|P2|Open-Label Treatment Period|Withdrawal by Subject|1
7664163|NCT01405820|26659551|P1|Open-Label Treatment Period|Withdrawal by Subject|3
7664164|NCT01405820|26659546|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
7664165|NCT01405820|26659547|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
7664166|NCT01405820|26659548|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
7664167|NCT01405820|26659549|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
7664168|NCT01405820|26659550|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
7664169|NCT01405820|26659551|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
7664170|NCT01405820|26659546|P6|Randomized Treatment Period|Death|0
7664171|NCT01405820|26659547|P5|Randomized Treatment Period|Death|0
7664172|NCT01405820|26659548|P4|Randomized Treatment Period|Death|1
7664173|NCT01405820|26659549|P3|Randomized Treatment Period|Death|0
7664174|NCT01405820|26659550|P2|Randomized Treatment Period|Death|0
7664175|NCT01405820|26659551|P1|Randomized Treatment Period|Death|0
7664176|NCT01405820|26659546|P6|Randomized Treatment Period|Treatment Arm Closed|28
7664177|NCT01405820|26659547|P5|Randomized Treatment Period|Treatment Arm Closed|33
7664178|NCT01405820|26659548|P4|Randomized Treatment Period|Treatment Arm Closed|36
7664179|NCT01405820|26659549|P3|Randomized Treatment Period|Treatment Arm Closed|20
7664180|NCT01405820|26659550|P2|Randomized Treatment Period|Treatment Arm Closed|0
7664181|NCT01405820|26659551|P1|Randomized Treatment Period|Treatment Arm Closed|0
7664182|NCT01405820|26659546|P6|Randomized Treatment Period|Incorrect Study Treatment|0
7664183|NCT01405820|26659547|P5|Randomized Treatment Period|Incorrect Study Treatment|2
7664184|NCT01405820|26659548|P4|Randomized Treatment Period|Incorrect Study Treatment|0
7664185|NCT01405820|26659549|P3|Randomized Treatment Period|Incorrect Study Treatment|3
7664186|NCT01405820|26659550|P2|Randomized Treatment Period|Incorrect Study Treatment|0
7664187|NCT01405820|26659551|P1|Randomized Treatment Period|Incorrect Study Treatment|0
7664188|NCT01405820|26659546|P6|Randomized Treatment Period|Rescue|8
7664189|NCT01405820|26659547|P5|Randomized Treatment Period|Rescue|8
7664190|NCT01405820|26659548|P4|Randomized Treatment Period|Rescue|10
7664191|NCT01405820|26659549|P3|Randomized Treatment Period|Rescue|13
7664192|NCT01405820|26659550|P2|Randomized Treatment Period|Rescue|1
7664193|NCT01405820|26659551|P1|Randomized Treatment Period|Rescue|0
7664194|NCT01405820|26659546|P6|Randomized Treatment Period|Physician Decision|0
7664195|NCT01405820|26659547|P5|Randomized Treatment Period|Physician Decision|0
7664196|NCT01405820|26659548|P4|Randomized Treatment Period|Physician Decision|0
7664197|NCT01405820|26659549|P3|Randomized Treatment Period|Physician Decision|1
7664198|NCT01405820|26659550|P2|Randomized Treatment Period|Physician Decision|2
7664199|NCT01405820|26659551|P1|Randomized Treatment Period|Physician Decision|0
7664200|NCT01405820|26659546|P6|Randomized Treatment Period|Other|0
7664201|NCT01405820|26659547|P5|Randomized Treatment Period|Other|0
7664202|NCT01405820|26659548|P4|Randomized Treatment Period|Other|1
7664203|NCT01405820|26659549|P3|Randomized Treatment Period|Other|1
7664204|NCT01405820|26659550|P2|Randomized Treatment Period|Other|2
7664205|NCT01405820|26659551|P1|Randomized Treatment Period|Other|2
7664206|NCT01405820|26659546|P6|Randomized Treatment Period|Withdrawal by Subject|0
7664207|NCT01405820|26659547|P5|Randomized Treatment Period|Withdrawal by Subject|0
7664208|NCT01405820|26659548|P4|Randomized Treatment Period|Withdrawal by Subject|2
7664209|NCT01405820|26659549|P3|Randomized Treatment Period|Withdrawal by Subject|2
7664210|NCT01405820|26659550|P2|Randomized Treatment Period|Withdrawal by Subject|2
7664211|NCT01405820|26659551|P1|Randomized Treatment Period|Withdrawal by Subject|6
7664212|NCT01405820|26659546|P6|Randomized Treatment Period|Adverse Event|1
7664213|NCT01405820|26659547|P5|Randomized Treatment Period|Adverse Event|2
7664214|NCT01405820|26659548|P4|Randomized Treatment Period|Adverse Event|0
7664215|NCT01405820|26659549|P3|Randomized Treatment Period|Adverse Event|3
7664216|NCT01405820|26659550|P2|Randomized Treatment Period|Adverse Event|3
7664217|NCT01405820|26659551|P1|Randomized Treatment Period|Adverse Event|3
7664218|NCT01405768|26659647|P2|Overall Study|Didn't complete questionnaire correctly|0
7664219|NCT01405768|26659648|P1|Overall Study|Didn't complete questionnaire correctly|4
7664220|NCT01405742|26659660|P2|Overall Study|Lost to Follow-up|0
7664221|NCT01405742|26659661|P1|Overall Study|Lost to Follow-up|1
7664222|NCT01405560|26659671|P1|Overall Study|Physician Decision|1
7664223|NCT01405508|26659686|P4|Overall Study|AE, non-serious non-fatal|0
7664224|NCT01405508|26659687|P3|Overall Study|AE, non-serious non-fatal|0
7664225|NCT01405508|26659688|P2|Overall Study|AE, non-serious non-fatal|1
7664226|NCT01405508|26659689|P1|Overall Study|AE, non-serious non-fatal|1
7664227|NCT01405456|26659721|P2|Overall Study|Physician Decision|0
7664228|NCT01405456|26659722|P1|Overall Study|Physician Decision|1
7664229|NCT01405456|26659721|P2|Overall Study|Lost to Follow-up|1
7664230|NCT01405456|26659722|P1|Overall Study|Lost to Follow-up|2
7664231|NCT01405196|26659762|P4|Overall Study|Lost to Follow-up|1
7664232|NCT01405196|26659763|P3|Overall Study|Lost to Follow-up|3
7664233|NCT01405196|26659764|P2|Overall Study|Lost to Follow-up|2
7664234|NCT01405196|26659765|P1|Overall Study|Lost to Follow-up|2
7664235|NCT01405196|26659762|P4|Overall Study|Death|0
7664236|NCT01405196|26659763|P3|Overall Study|Death|3
7664237|NCT01405196|26659764|P2|Overall Study|Death|0
7664238|NCT01405196|26659765|P1|Overall Study|Death|1
7664239|NCT01405196|26659762|P4|Overall Study|Adverse Event|2
7664240|NCT01405196|26659763|P3|Overall Study|Adverse Event|0
7664241|NCT01405196|26659764|P2|Overall Study|Adverse Event|2
7664242|NCT01405196|26659765|P1|Overall Study|Adverse Event|2
7664243|NCT01405196|26659762|P4|Overall Study|Withdrawal by Subject|6
7664244|NCT01405196|26659763|P3|Overall Study|Withdrawal by Subject|3
7664245|NCT01405196|26659764|P2|Overall Study|Withdrawal by Subject|6
7664246|NCT01405196|26659765|P1|Overall Study|Withdrawal by Subject|4
7664247|NCT01405196|26659762|P4|Overall Study|Other|0
7664248|NCT01405196|26659763|P3|Overall Study|Other|5
7664249|NCT01405196|26659764|P2|Overall Study|Other|2
7664250|NCT01405196|26659765|P1|Overall Study|Other|2
7664251|NCT01405196|26659762|P4|Overall Study|Study Terminated by Sponsor|0
7664252|NCT01405196|26659763|P3|Overall Study|Study Terminated by Sponsor|9
7664253|NCT01405196|26659764|P2|Overall Study|Study Terminated by Sponsor|0
7664254|NCT01405196|26659765|P1|Overall Study|Study Terminated by Sponsor|0
7664255|NCT01405053|26659852|P2|Overall Study|Other|1
7664256|NCT01405053|26659853|P1|Overall Study|Other|0
7664257|NCT01405053|26659852|P2|Overall Study|Withdrawal by Subject|4
7664258|NCT01405053|26659853|P1|Overall Study|Withdrawal by Subject|3
7664259|NCT01405053|26659852|P2|Overall Study|Inadequate therapeutic effect|1
7664260|NCT01405053|26659853|P1|Overall Study|Inadequate therapeutic effect|2
7664261|NCT01405053|26659852|P2|Overall Study|Participant choice|1
7664262|NCT01405053|26659853|P1|Overall Study|Participant choice|2
7664263|NCT01405053|26659852|P2|Overall Study|Lost to Follow-up|1
7664264|NCT01405053|26659853|P1|Overall Study|Lost to Follow-up|0
7664265|NCT01405053|26659852|P2|Overall Study|Adverse Event|0
7664266|NCT01405053|26659853|P1|Overall Study|Adverse Event|3
7664267|NCT01405027|26659879|P2|Overall Study|Other or Unknown|25
7664268|NCT01405027|26659880|P1|Overall Study|Other or Unknown|12
7664269|NCT01405027|26659879|P2|Overall Study|Death|0
7664270|NCT01405027|26659880|P1|Overall Study|Death|1
7664271|NCT01405027|26659879|P2|Overall Study|Investigator judgement|2
7664272|NCT01405027|26659880|P1|Overall Study|Investigator judgement|0
7664273|NCT01405027|26659879|P2|Overall Study|Lost to Follow-up|24
7664274|NCT01405027|26659880|P1|Overall Study|Lost to Follow-up|16
7664275|NCT01405027|26659879|P2|Overall Study|Withdrawn consent|0
7664276|NCT01405027|26659880|P1|Overall Study|Withdrawn consent|3
7664277|NCT01404988|26659897|P3|Overall Study|Lost to Follow-up|1
7664278|NCT01404988|26659898|P2|Overall Study|Lost to Follow-up|2
7664279|NCT01404988|26659899|P1|Overall Study|Lost to Follow-up|1
7664280|NCT01404988|26659897|P3|Overall Study|Withdrawal by Subject|0
7664281|NCT01404988|26659898|P2|Overall Study|Withdrawal by Subject|2
7664282|NCT01404988|26659899|P1|Overall Study|Withdrawal by Subject|2
7664283|NCT01404988|26659897|P3|Overall Study|Adverse Event|0
7664284|NCT01404988|26659898|P2|Overall Study|Adverse Event|0
7664285|NCT01404988|26659899|P1|Overall Study|Adverse Event|1
7664286|NCT01404988|26659897|P3|Overall Study|Death|2
7664287|NCT01404988|26659898|P2|Overall Study|Death|0
7664288|NCT01404988|26659899|P1|Overall Study|Death|2
7664289|NCT01404325|26660020|P2|Overall Study|non-specified reason|2
7664290|NCT01404325|26660021|P1|Overall Study|non-specified reason|0
7664291|NCT01404325|26660020|P2|Overall Study|Graft loss/Retransplantation|0
7664292|NCT01404325|26660021|P1|Overall Study|Graft loss/Retransplantation|1
7664293|NCT01404325|26660020|P2|Overall Study|Death|0
7664294|NCT01404325|26660021|P1|Overall Study|Death|2
7664295|NCT01404325|26660020|P2|Overall Study|Lost to Follow-up|0
7664296|NCT01404325|26660021|P1|Overall Study|Lost to Follow-up|1
7664297|NCT01404312|26660079|P2|Overall Study|Severe debilitation, unable to continue|2
7664298|NCT01404312|26660080|P1|Overall Study|Severe debilitation, unable to continue|1
7664299|NCT01404312|26660079|P2|Overall Study|Participant not willing to adhere to req|29
7664300|NCT01404312|26660080|P1|Overall Study|Participant not willing to adhere to req|31
7664301|NCT01404312|26660079|P2|Overall Study|Site closed|21
7664302|NCT01404312|26660080|P1|Overall Study|Site closed|22
7664303|NCT01404312|26660079|P2|Overall Study|Lost to Follow-up|111
7664304|NCT01404312|26660080|P1|Overall Study|Lost to Follow-up|115
7664305|NCT01404312|26660079|P2|Overall Study|Participant Unable to get to clinic|103
7664306|NCT01404312|26660080|P1|Overall Study|Participant Unable to get to clinic|93
7664307|NCT01404312|26660079|P2|Overall Study|Withdrawal by Subject|18
7664308|NCT01404312|26660080|P1|Overall Study|Withdrawal by Subject|15
7664309|NCT01404312|26660079|P2|Overall Study|Death|27
7664310|NCT01404312|26660080|P1|Overall Study|Death|21
7664311|NCT01404234|26660110|P1|Overall Study|Withdrawal by Subject|2
7664312|NCT01404208|26660126|P2|Overall Study|Discontinued|0
7664313|NCT01404208|26660127|P1|Overall Study|Discontinued|3
7664314|NCT01403987|26660192|P3|Overall Study|Residents forgot their secret PIN|18
7664315|NCT01403987|26660193|P2|Overall Study|Residents forgot their secret PIN|17
7664316|NCT01403987|26660194|P1|Overall Study|Residents forgot their secret PIN|18
7664317|NCT01403948|26660218|P10|Overall Study|other than above|0
7664318|NCT01403948|26660219|P9|Overall Study|other than above|0
7664319|NCT01403948|26660220|P8|Overall Study|other than above|0
7664320|NCT01403948|26660221|P7|Overall Study|other than above|2
7664321|NCT01403948|26660222|P6|Overall Study|other than above|1
7664322|NCT01403948|26660223|P5|Overall Study|other than above|1
7664323|NCT01403948|26660224|P4|Overall Study|other than above|0
7664324|NCT01403948|26660225|P3|Overall Study|other than above|1
7664325|NCT01403948|26660226|P2|Overall Study|other than above|2
7664326|NCT01403948|26660227|P1|Overall Study|other than above|1
7664327|NCT01403948|26660218|P10|Overall Study|Refused cont. medication|1
7664328|NCT01403948|26660219|P9|Overall Study|Refused cont. medication|0
7664329|NCT01403948|26660220|P8|Overall Study|Refused cont. medication|0
7664330|NCT01403948|26660221|P7|Overall Study|Refused cont. medication|0
7664331|NCT01403948|26660222|P6|Overall Study|Refused cont. medication|0
7664332|NCT01403948|26660223|P5|Overall Study|Refused cont. medication|1
7664333|NCT01403948|26660224|P4|Overall Study|Refused cont. medication|0
7664334|NCT01403948|26660225|P3|Overall Study|Refused cont. medication|0
7664335|NCT01403948|26660226|P2|Overall Study|Refused cont. medication|0
7664336|NCT01403948|26660227|P1|Overall Study|Refused cont. medication|0
7664337|NCT01403948|26660218|P10|Overall Study|Lost to Follow-up|1
7664338|NCT01403948|26660219|P9|Overall Study|Lost to Follow-up|0
7664339|NCT01403948|26660220|P8|Overall Study|Lost to Follow-up|0
7664340|NCT01403948|26660221|P7|Overall Study|Lost to Follow-up|0
7664341|NCT01403948|26660222|P6|Overall Study|Lost to Follow-up|0
7664342|NCT01403948|26660223|P5|Overall Study|Lost to Follow-up|0
7664343|NCT01403948|26660224|P4|Overall Study|Lost to Follow-up|0
7664344|NCT01403948|26660225|P3|Overall Study|Lost to Follow-up|0
7664345|NCT01403948|26660226|P2|Overall Study|Lost to Follow-up|0
7664346|NCT01403948|26660227|P1|Overall Study|Lost to Follow-up|0
7664347|NCT01403948|26660218|P10|Overall Study|Other Adverse Event (Other than DLT)|0
7664348|NCT01403948|26660219|P9|Overall Study|Other Adverse Event (Other than DLT)|1
7664349|NCT01403948|26660220|P8|Overall Study|Other Adverse Event (Other than DLT)|0
7664350|NCT01403948|26660221|P7|Overall Study|Other Adverse Event (Other than DLT)|2
7664351|NCT01403948|26660222|P6|Overall Study|Other Adverse Event (Other than DLT)|0
7664352|NCT01403948|26660223|P5|Overall Study|Other Adverse Event (Other than DLT)|2
7664353|NCT01403948|26660224|P4|Overall Study|Other Adverse Event (Other than DLT)|0
7664354|NCT01403948|26660225|P3|Overall Study|Other Adverse Event (Other than DLT)|0
7664355|NCT01403948|26660226|P2|Overall Study|Other Adverse Event (Other than DLT)|0
7664356|NCT01403948|26660227|P1|Overall Study|Other Adverse Event (Other than DLT)|0
7664357|NCT01403948|26660218|P10|Overall Study|Progressive disease|5
7664358|NCT01403948|26660219|P9|Overall Study|Progressive disease|5
7664359|NCT01403948|26660220|P8|Overall Study|Progressive disease|4
7664360|NCT01403948|26660221|P7|Overall Study|Progressive disease|2
7664361|NCT01403948|26660222|P6|Overall Study|Progressive disease|6
7664362|NCT01403948|26660223|P5|Overall Study|Progressive disease|2
7664363|NCT01403948|26660224|P4|Overall Study|Progressive disease|4
7664364|NCT01403948|26660225|P3|Overall Study|Progressive disease|2
7664365|NCT01403948|26660226|P2|Overall Study|Progressive disease|2
7664366|NCT01403948|26660227|P1|Overall Study|Progressive disease|0
7664367|NCT01403805|26660300|P2|Overall Study|Death|1
7664368|NCT01403805|26660301|P1|Overall Study|Death|0
7664369|NCT01403805|26660300|P2|Overall Study|Lost to Follow-up|2
7664370|NCT01403805|26660301|P1|Overall Study|Lost to Follow-up|0
7664371|NCT01403805|26660300|P2|Overall Study|Withdrawal by Subject|4
7664372|NCT01403805|26660301|P1|Overall Study|Withdrawal by Subject|0
7664373|NCT01403610|26660317|P4|Overall Study|Didn't recover from surgery sufficiently|0
7664374|NCT01403610|26660318|P3|Overall Study|Didn't recover from surgery sufficiently|0
7664375|NCT01403610|26660319|P2|Overall Study|Didn't recover from surgery sufficiently|3
7664376|NCT01403610|26660320|P1|Overall Study|Didn't recover from surgery sufficiently|0
7664377|NCT01403610|26660317|P4|Overall Study|Withdrawal by Subject|0
7664378|NCT01403610|26660318|P3|Overall Study|Withdrawal by Subject|0
7664379|NCT01403610|26660319|P2|Overall Study|Withdrawal by Subject|0
7664380|NCT01403610|26660320|P1|Overall Study|Withdrawal by Subject|2
7664381|NCT01403194|26660375|P1|Overall Study|Lost to Follow-up|8
7664382|NCT01403194|26660375|P1|Overall Study|Screen Failure|2
7664383|NCT01403116|26660383|P2|Overall Study|unable to keep appointments|2
7664384|NCT01403116|26660384|P1|Overall Study|unable to keep appointments|0
7664385|NCT01403116|26660383|P2|Overall Study|Hct >54%|0
7664386|NCT01403116|26660384|P1|Overall Study|Hct >54%|2
7664387|NCT01403116|26660383|P2|Overall Study|undisclosed Hx of Prostate Ca|0
7664388|NCT01403116|26660384|P1|Overall Study|undisclosed Hx of Prostate Ca|1
7664389|NCT01403116|26660383|P2|Overall Study|Protocol Violation|1
7664390|NCT01403116|26660384|P1|Overall Study|Protocol Violation|0
7664391|NCT01403116|26660383|P2|Overall Study|Non-compliance of study drug|0
7664392|NCT01403116|26660384|P1|Overall Study|Non-compliance of study drug|3
7664393|NCT01403116|26660383|P2|Overall Study|Withdrawal by Subject|15
7664394|NCT01403116|26660384|P1|Overall Study|Withdrawal by Subject|12
7664395|NCT01403116|26660383|P2|Overall Study|Lost to Follow-up|5
7664396|NCT01403116|26660384|P1|Overall Study|Lost to Follow-up|7
7664397|NCT01403116|26660383|P2|Overall Study|Adverse Event|4
7664398|NCT01403116|26660384|P1|Overall Study|Adverse Event|7
7664399|NCT01403064|26660399|P4|Overall Study|Other|1
7664400|NCT01403064|26660400|P3|Overall Study|Other|2
7664401|NCT01403064|26660401|P2|Overall Study|Other|0
7664402|NCT01403064|26660402|P1|Overall Study|Other|1
7664403|NCT01403064|26660399|P4|Overall Study|Withdrawal by Subject|1
7664404|NCT01403064|26660400|P3|Overall Study|Withdrawal by Subject|1
7664405|NCT01403064|26660401|P2|Overall Study|Withdrawal by Subject|0
7664406|NCT01403064|26660402|P1|Overall Study|Withdrawal by Subject|0
7664407|NCT01403064|26660399|P4|Overall Study|Death|1
7664408|NCT01403064|26660400|P3|Overall Study|Death|1
7664409|NCT01403064|26660401|P2|Overall Study|Death|0
7664410|NCT01403064|26660402|P1|Overall Study|Death|0
7664411|NCT01403051|26660465|P2|Overall Study|Lost to Follow-up|5
7664412|NCT01403051|26660466|P1|Overall Study|Lost to Follow-up|5
7664413|NCT01403051|26660465|P2|Overall Study|Withdrawal by Subject|1
7664414|NCT01403051|26660466|P1|Overall Study|Withdrawal by Subject|2
7664415|NCT01403051|26660465|P2|Overall Study|Death|0
7664416|NCT01403051|26660466|P1|Overall Study|Death|1
7664417|NCT01403051|26660465|P2|Overall Study|Protocol Violation|0
7664418|NCT01403051|26660466|P1|Overall Study|Protocol Violation|2
7664419|NCT01402986|26660502|P4|Overall Study|Other|6
7664420|NCT01402986|26660503|P3|Overall Study|Other|1
7664421|NCT01402986|26660504|P2|Overall Study|Other|5
7664422|NCT01402986|26660505|P1|Overall Study|Other|2
7664423|NCT01402986|26660502|P4|Overall Study|Lost to Follow-up|1
7664424|NCT01402986|26660503|P3|Overall Study|Lost to Follow-up|0
7664425|NCT01402986|26660504|P2|Overall Study|Lost to Follow-up|0
7664426|NCT01402986|26660505|P1|Overall Study|Lost to Follow-up|0
7664427|NCT01402986|26660502|P4|Overall Study|Death|2
7664428|NCT01402986|26660503|P3|Overall Study|Death|0
7664429|NCT01402986|26660504|P2|Overall Study|Death|0
7664430|NCT01402986|26660505|P1|Overall Study|Death|0
7664431|NCT01402986|26660502|P4|Overall Study|Withdrawal by Subject|13
7664432|NCT01402986|26660503|P3|Overall Study|Withdrawal by Subject|7
7664433|NCT01402986|26660504|P2|Overall Study|Withdrawal by Subject|10
7664434|NCT01402986|26660505|P1|Overall Study|Withdrawal by Subject|7
7664435|NCT01402947|26660640|P2|First Intervention|Adverse Event|1
7664436|NCT01402947|26660641|P1|First Intervention|Adverse Event|0
7664437|NCT01402908|26660651|P2|Overall Study|Physician Decision|0
7664438|NCT01402908|26660652|P1|Overall Study|Physician Decision|1
7664439|NCT01402908|26660651|P2|Overall Study|Lost to Follow-up|1
7664440|NCT01402908|26660652|P1|Overall Study|Lost to Follow-up|3
7664441|NCT01402908|26660651|P2|Overall Study|Withdrawal by Subject|17
7664442|NCT01402908|26660652|P1|Overall Study|Withdrawal by Subject|30
7664443|NCT01402869|26660667|P3|Overall Study|Required Tooth Extraction|1
7664444|NCT01402869|26660668|P2|Overall Study|Required Tooth Extraction|0
7664445|NCT01402869|26660669|P1|Overall Study|Required Tooth Extraction|0
7664446|NCT01402817|26660683|P1|Overall Study|Study Suspended by FDA|8
7664447|NCT01402817|26660683|P1|Overall Study|Withdrawal by Subject|3
7664448|NCT01402700|26660688|P1|Overall Study|Missed Visit|1
7664449|NCT01402700|26660688|P1|Overall Study|Withdrawal by Subject|3
7664450|NCT01402700|26660688|P1|Overall Study|Death|3
7664451|NCT01402570|26660692|P1|Overall Study|Adverse Event|1
7664452|NCT01402544|26660699|P1|Overall Study|Withdrawal by Subject|6
7664453|NCT01402284|26660773|P1|Overall Study|Disease progression on study|10
7664454|NCT01402284|26660773|P1|Overall Study|Physician Decision|1
7664455|NCT01402284|26660773|P1|Overall Study|Follows up at Memorial Sloan Kettering|1
7664456|NCT01402284|26660773|P1|Overall Study|Withdrawal consent|2
7664457|NCT01402102|26660855|P2|Overall Study|Withdrawal by Subject|2
7664458|NCT01402102|26660856|P1|Overall Study|Withdrawal by Subject|0
7664459|NCT01402102|26660855|P2|Overall Study|Insufficiency of compliance|1
7664460|NCT01402102|26660856|P1|Overall Study|Insufficiency of compliance|1
7664461|NCT01402102|26660855|P2|Overall Study|Protocol Violation|0
7664462|NCT01402102|26660856|P1|Overall Study|Protocol Violation|1
7664463|NCT01402063|26660876|P2|Overall Study|Withdrawal by Subject|3
7664464|NCT01402063|26660877|P1|Overall Study|Withdrawal by Subject|3
7664465|NCT01402011|26660895|P3|Nine Month Follow-up|Withdrawal by Subject|0
7664466|NCT01402011|26660896|P2|Nine Month Follow-up|Withdrawal by Subject|1
7664467|NCT01402011|26660897|P1|Nine Month Follow-up|Withdrawal by Subject|0
7664468|NCT01402011|26660895|P3|Active Treatment Period|Withdrawal by Subject|0
7664469|NCT01402011|26660896|P2|Active Treatment Period|Withdrawal by Subject|3
7664470|NCT01402011|26660897|P1|Active Treatment Period|Withdrawal by Subject|1
7664471|NCT01402011|26660895|P3|Delayed Treatment Period|Withdrawal by Subject|0
7664472|NCT01402011|26660896|P2|Delayed Treatment Period|Withdrawal by Subject|0
7664473|NCT01402011|26660897|P1|Delayed Treatment Period|Withdrawal by Subject|1
7664474|NCT01401959|26660926|P3|Treated|Protocol Violation|0
7664475|NCT01401959|26660927|P2|Treated|Protocol Violation|1
7664476|NCT01401959|26660928|P1|Treated|Protocol Violation|0
7664477|NCT01401959|26660926|P3|Treated|Withdrawal by Subject|2
7664478|NCT01401959|26660927|P2|Treated|Withdrawal by Subject|2
7664479|NCT01401959|26660928|P1|Treated|Withdrawal by Subject|1
7664480|NCT01401959|26660926|P3|Treated|Adverse Event|2
7664481|NCT01401959|26660927|P2|Treated|Adverse Event|3
7664482|NCT01401959|26660928|P1|Treated|Adverse Event|4
7664483|NCT01401959|26660926|P3|Treated|Disease Progression|1
7664484|NCT01401959|26660927|P2|Treated|Disease Progression|2
7664485|NCT01401959|26660928|P1|Treated|Disease Progression|2
7664486|NCT01401959|26660926|P3|Enrolled|Withdrawal by Subject|0
7664487|NCT01401959|26660927|P2|Enrolled|Withdrawal by Subject|0
7664488|NCT01401959|26660928|P1|Enrolled|Withdrawal by Subject|1
7664489|NCT01401842|26660967|P2|Overall Study|other/unknown|17
7664490|NCT01401842|26660968|P1|Overall Study|other/unknown|28
7664491|NCT01401842|26660967|P2|Overall Study|on profile|5
7664492|NCT01401842|26660968|P1|Overall Study|on profile|9
7664493|NCT01401842|26660967|P2|Overall Study|invalid follow-up strength data|4
7664494|NCT01401842|26660968|P1|Overall Study|invalid follow-up strength data|1
7664495|NCT01401842|26660967|P2|Overall Study|discharged from US Army|4
7664496|NCT01401842|26660968|P1|Overall Study|discharged from US Army|3
7664497|NCT01401842|26660967|P2|Overall Study|changed companies|34
7664498|NCT01401842|26660968|P1|Overall Study|changed companies|20
7664499|NCT01401842|26660967|P2|Overall Study|academic reason|1
7664500|NCT01401842|26660968|P1|Overall Study|academic reason|4
7664501|NCT01401842|26660967|P2|Overall Study|Withdrawal by Subject|2
7664502|NCT01401842|26660968|P1|Overall Study|Withdrawal by Subject|3
7664503|NCT01401647|26660985|P3|Overall Study|Lost to Follow-up|1
7664504|NCT01401647|26660986|P2|Overall Study|Lost to Follow-up|3
7664505|NCT01401647|26660987|P1|Overall Study|Lost to Follow-up|3
7664506|NCT01401647|26660985|P3|Overall Study|Withdrawal by Subject|2
7664507|NCT01401647|26660986|P2|Overall Study|Withdrawal by Subject|5
7664508|NCT01401647|26660987|P1|Overall Study|Withdrawal by Subject|1
7664509|NCT01401530|26661057|P3|Overall Study|Physician Decision|0
7664510|NCT01401530|26661058|P2|Overall Study|Physician Decision|1
7664511|NCT01401530|26661059|P1|Overall Study|Physician Decision|0
7664512|NCT01401530|26661057|P3|Overall Study|Participant Choice|1
7664513|NCT01401530|26661058|P2|Overall Study|Participant Choice|2
7664514|NCT01401530|26661059|P1|Overall Study|Participant Choice|1
7664515|NCT01401530|26661057|P3|Overall Study|Adverse Event|1
7664516|NCT01401530|26661058|P2|Overall Study|Adverse Event|1
7664517|NCT01401530|26661059|P1|Overall Study|Adverse Event|1
7664518|NCT01401530|26661057|P3|Overall Study|Disease Progression|1
7664519|NCT01401530|26661058|P2|Overall Study|Disease Progression|2
7664520|NCT01401530|26661059|P1|Overall Study|Disease Progression|1
7664521|NCT01401478|26661118|P1|Overall Study|Serious adverse event|1
7664522|NCT01401478|26661118|P1|Overall Study|Low intact parathyroid hormone|1
7664523|NCT01401478|26661118|P1|Overall Study|Hyperphosphatemia and adverse event|1
7664524|NCT01401478|26661118|P1|Overall Study|Blood samples not available|1
7664525|NCT01401478|26661118|P1|Overall Study|Withdrawal by Subject|3
7664526|NCT01401478|26661118|P1|Overall Study|Kidney transplantation|3
7664527|NCT01401478|26661118|P1|Overall Study|Lost to Follow-up|5
7664528|NCT01401478|26661118|P1|Overall Study|Hyperphosphatemia|5
7664529|NCT01401478|26661118|P1|Overall Study|Adverse Event|5
7664530|NCT01401478|26661118|P1|Overall Study|Study drug not available|6
7664531|NCT01401465|26661131|P2|Treatment Period 2|Withdrawal by Subject|1
7664532|NCT01401465|26661132|P1|Treatment Period 2|Withdrawal by Subject|0
7664533|NCT01401465|26661131|P2|Treatment Period 2|Lost to Follow-up|1
7664534|NCT01401465|26661132|P1|Treatment Period 2|Lost to Follow-up|0
7664535|NCT01401465|26661131|P2|Treatment Period 1|Scheduling Difficulties|1
7664536|NCT01401465|26661132|P1|Treatment Period 1|Scheduling Difficulties|1
7664537|NCT01401465|26661131|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
7664538|NCT01401465|26661132|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
7664539|NCT01401465|26661131|P2|Treatment Period 1|Non-Compliance to Study Drug|0
7664540|NCT01401465|26661132|P1|Treatment Period 1|Non-Compliance to Study Drug|1
7664541|NCT01401465|26661131|P2|Treatment Period 1|Withdrawal by Subject|4
7664542|NCT01401465|26661132|P1|Treatment Period 1|Withdrawal by Subject|1
7664543|NCT01401465|26661131|P2|Treatment Period 1|Protocol Violation|0
7664544|NCT01401465|26661132|P1|Treatment Period 1|Protocol Violation|5
7664545|NCT01401465|26661131|P2|Treatment Period 1|Pregnancy|1
7664546|NCT01401465|26661132|P1|Treatment Period 1|Pregnancy|0
7664547|NCT01401465|26661131|P2|Treatment Period 1|Adverse Event|1
7664548|NCT01401465|26661132|P1|Treatment Period 1|Adverse Event|4
7664549|NCT01401452|26661195|P1|Overall Study|Participant withdrew consent|1
7664550|NCT01401452|26661195|P1|Overall Study|Subject chose to discontinue treatment|1
7664551|NCT01401452|26661195|P1|Overall Study|Subject withdrew because of Tx success|1
7664552|NCT01401452|26661195|P1|Overall Study|Unsatisfactory output|1
7664553|NCT01401452|26661195|P1|Overall Study|Treatment failure|1
7664554|NCT01401452|26661195|P1|Overall Study|Discontinuation for personal reasons|1
7664555|NCT01401452|26661195|P1|Overall Study|Participant stopped Tx|2
7664556|NCT01401452|26661195|P1|Overall Study|Psoriatic arthritis|1
7664557|NCT01401452|26661195|P1|Overall Study|Subject's wife wants to get pregnant|1
7664558|NCT01401452|26661195|P1|Overall Study|Subject moved to another city|1
7664559|NCT01401452|26661195|P1|Overall Study|Subject didn't return for routine visits|1
7664560|NCT01401452|26661195|P1|Overall Study|Subject did not come to follow up visits|2
7664561|NCT01401452|26661195|P1|Overall Study|No more visits within the 36 wk followup|4
7664562|NCT01401452|26661195|P1|Overall Study|Tx stopped by psychiatrist|1
7664563|NCT01401452|26661195|P1|Overall Study|Tx stopped due to financial reasons|1
7664564|NCT01401452|26661195|P1|Overall Study|Participant developed breast cancer|1
7664565|NCT01401452|26661195|P1|Overall Study|Lack of Efficacy|30
7664566|NCT01401452|26661195|P1|Overall Study|Lost to Follow-up|12
7664567|NCT01401452|26661195|P1|Overall Study|Adverse reaction|9
7664568|NCT01401361|26661207|P1|Overall Study|Subject/family decision post procedure|2
7664569|NCT01401361|26661207|P1|Overall Study|Lost to Follow-up|3
7664570|NCT01401361|26661207|P1|Overall Study|Physician Decision|1
7664571|NCT01401361|26661207|P1|Overall Study|Lack of Efficacy|6
7664572|NCT01401361|26661207|P1|Overall Study|Withdrawal by Subject|16
7664573|NCT01401322|26661213|P1|Overall Study|Physician Decision|1
7664574|NCT01401322|26661213|P1|Overall Study|Withdrawal by Subject|1
7664575|NCT01401283|26661219|P2|Overall Study|suspicion of malignant hyperthermia|1
7664576|NCT01401283|26661220|P1|Overall Study|suspicion of malignant hyperthermia|0
7664577|NCT01401283|26661219|P2|Overall Study|no central venous access|1
7664578|NCT01401283|26661220|P1|Overall Study|no central venous access|0
7664579|NCT01401283|26661219|P2|Overall Study|preoperative arrhythmia|0
7664580|NCT01401283|26661220|P1|Overall Study|preoperative arrhythmia|5
7664581|NCT01401283|26661219|P2|Overall Study|surgery cancelled|8
7664582|NCT01401283|26661220|P1|Overall Study|surgery cancelled|5
7664583|NCT01401153|26661286|P2|Second Test Day|illness|5
7664584|NCT01401153|26661287|P1|Second Test Day|illness|0
7664585|NCT01401153|26661286|P2|First Test Day|Learning disabilities; illness|10
7664586|NCT01401153|26661287|P1|First Test Day|Learning disabilities; illness|1
7664587|NCT01401062|26661334|P2|Overall Study|Withdrawal by Subject|1
7664588|NCT01401062|26661335|P1|Overall Study|Withdrawal by Subject|1
7664589|NCT01401062|26661334|P2|Overall Study|Physician Decision|0
7664590|NCT01401062|26661335|P1|Overall Study|Physician Decision|1
7664591|NCT01401062|26661334|P2|Overall Study|Death|7
7664592|NCT01401062|26661335|P1|Overall Study|Death|9
7664593|NCT01401010|26661362|P2|Overall Study|Could not interpret assay results|0
7664594|NCT01401010|26661363|P1|Overall Study|Could not interpret assay results|1
7664595|NCT01400971|26661386|P1|Overall Study|Other|422
7664596|NCT01400971|26661386|P1|Overall Study|Withdrawal by Subject|158
7664597|NCT01400971|26661386|P1|Overall Study|Physician Decision|57
7664598|NCT01400971|26661386|P1|Overall Study|Lost to follow up + Subject Decision|2
7664599|NCT01400971|26661386|P1|Overall Study|Lost to Follow-up|196
7664600|NCT01400971|26661386|P1|Overall Study|Death|82
7664601|NCT01400958|26661395|P2|Overall Study|Adverse Event|0
7664602|NCT01400958|26661396|P1|Overall Study|Adverse Event|1
7664603|NCT01400958|26661395|P2|Overall Study|Withdrawal by Subject|1
7664604|NCT01400958|26661396|P1|Overall Study|Withdrawal by Subject|0
7664605|NCT01400958|26661395|P2|Overall Study|Physician Decision|1
7664606|NCT01400958|26661396|P1|Overall Study|Physician Decision|0
7664607|NCT01400932|26661406|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
7664608|NCT01400932|26661407|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
7664609|NCT01400932|26661406|P2|Overall Study|Protocol Deviation|1
7664610|NCT01400932|26661407|P1|Overall Study|Protocol Deviation|0
7664611|NCT01400932|26661406|P2|Overall Study|Lost to Follow-up|0
7664612|NCT01400932|26661407|P1|Overall Study|Lost to Follow-up|1
7664613|NCT01400932|26661406|P2|Overall Study|Withdrawal by Subject|6
7664614|NCT01400932|26661407|P1|Overall Study|Withdrawal by Subject|2
7664615|NCT01400932|26661406|P2|Overall Study|Lack of Efficacy|3
7664616|NCT01400932|26661407|P1|Overall Study|Lack of Efficacy|0
7664617|NCT01400932|26661406|P2|Overall Study|Adverse Event|5
7664618|NCT01400932|26661407|P1|Overall Study|Adverse Event|10
7664619|NCT01400919|26661429|P1|Overall Study|Missed visit|2
7664620|NCT01400919|26661429|P1|Overall Study|Lost to Follow-up|2
7664621|NCT01400919|26661429|P1|Overall Study|Withdrawal by Subject|4
7664622|NCT01400893|26661472|P2|Overall Study|Lost to Follow-up|6
7664623|NCT01400893|26661473|P1|Overall Study|Lost to Follow-up|0
7664624|NCT01400893|26661472|P2|Overall Study|Death|21
7664625|NCT01400893|26661473|P1|Overall Study|Death|27
7664626|NCT01400841|26661485|P1|Extended Study Phase (2 Years)|Adverse Event|2
7664627|NCT01400841|26661485|P1|Initial Study Phase (6 Months)|Death|1
7664628|NCT01400698|26661523|P6|Overall Study|Other|0
7664629|NCT01400698|26661524|P5|Overall Study|Other|1
7664630|NCT01400698|26661525|P4|Overall Study|Other|2
7664631|NCT01400698|26661526|P3|Overall Study|Other|0
7664632|NCT01400698|26661527|P2|Overall Study|Other|2
7664633|NCT01400698|26661528|P1|Overall Study|Other|4
7664634|NCT01400698|26661523|P6|Overall Study|Adverse Event|0
7664635|NCT01400698|26661524|P5|Overall Study|Adverse Event|0
7664636|NCT01400698|26661525|P4|Overall Study|Adverse Event|0
7664637|NCT01400698|26661526|P3|Overall Study|Adverse Event|0
7664638|NCT01400698|26661527|P2|Overall Study|Adverse Event|0
7664639|NCT01400698|26661528|P1|Overall Study|Adverse Event|1
7664640|NCT01400698|26661523|P6|Overall Study|Non-compliance|0
7664641|NCT01400698|26661524|P5|Overall Study|Non-compliance|0
7664642|NCT01400698|26661525|P4|Overall Study|Non-compliance|1
7664643|NCT01400698|26661526|P3|Overall Study|Non-compliance|0
7664644|NCT01400698|26661527|P2|Overall Study|Non-compliance|1
7664645|NCT01400698|26661528|P1|Overall Study|Non-compliance|0
7664646|NCT01400698|26661523|P6|Overall Study|Protocol Violation|0
7664647|NCT01400698|26661524|P5|Overall Study|Protocol Violation|1
7664648|NCT01400698|26661525|P4|Overall Study|Protocol Violation|0
7664649|NCT01400698|26661526|P3|Overall Study|Protocol Violation|0
7664650|NCT01400698|26661527|P2|Overall Study|Protocol Violation|1
7664651|NCT01400698|26661528|P1|Overall Study|Protocol Violation|0
7664652|NCT01400698|26661523|P6|Overall Study|Withdrawal by Subject|3
7664653|NCT01400698|26661524|P5|Overall Study|Withdrawal by Subject|1
7664654|NCT01400698|26661525|P4|Overall Study|Withdrawal by Subject|4
7664655|NCT01400698|26661526|P3|Overall Study|Withdrawal by Subject|0
7664656|NCT01400698|26661527|P2|Overall Study|Withdrawal by Subject|2
7664657|NCT01400698|26661528|P1|Overall Study|Withdrawal by Subject|8
7664658|NCT01400698|26661523|P6|Overall Study|Lost to Follow-up|3
7664659|NCT01400698|26661524|P5|Overall Study|Lost to Follow-up|4
7664660|NCT01400698|26661525|P4|Overall Study|Lost to Follow-up|1
7664661|NCT01400698|26661526|P3|Overall Study|Lost to Follow-up|2
7664662|NCT01400698|26661527|P2|Overall Study|Lost to Follow-up|5
7664663|NCT01400698|26661528|P1|Overall Study|Lost to Follow-up|2
7664664|NCT01400516|26661552|P2|Primary Trial|Withdrawal by Subject|2
7664665|NCT01400516|26661553|P1|Primary Trial|Withdrawal by Subject|0
7664666|NCT01400503|26661563|P1|Overall Study|Other|1
7664667|NCT01400503|26661563|P1|Overall Study|Study Terminated by Sponsor|58
7664668|NCT01400503|26661563|P1|Overall Study|Withdrawal by Subject|1
7664669|NCT01400451|26661586|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7664670|NCT01400451|26661587|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
7664671|NCT01400451|26661588|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7664672|NCT01400451|26661586|P3|Combination Treatment (or Intended)|Disease Progression|1
7664673|NCT01400451|26661587|P2|Combination Treatment (or Intended)|Disease Progression|1
7664674|NCT01400451|26661588|P1|Combination Treatment (or Intended)|Disease Progression|3
7664675|NCT01400451|26661586|P3|Combination Treatment (or Intended)|Adverse Event|0
7664676|NCT01400451|26661587|P2|Combination Treatment (or Intended)|Adverse Event|0
7664677|NCT01400451|26661588|P1|Combination Treatment (or Intended)|Adverse Event|1
7664678|NCT01400451|26661586|P3|Combination Treatment (or Intended)|Drug Toxicity|0
7664679|NCT01400451|26661587|P2|Combination Treatment (or Intended)|Drug Toxicity|1
7664680|NCT01400451|26661588|P1|Combination Treatment (or Intended)|Drug Toxicity|0
7664681|NCT01400451|26661586|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
7664682|NCT01400451|26661587|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
7664683|NCT01400451|26661588|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
7664684|NCT01400425|26661602|P1|Overall Study|Withdrawal by Subject|10
7664685|NCT01400412|26661615|P2|Overall Study|Never started study treatment|3
7664686|NCT01400412|26661616|P1|Overall Study|Never started study treatment|0
7664687|NCT01400412|26661615|P2|Overall Study|Unable to complete|3
7664688|NCT01400412|26661616|P1|Overall Study|Unable to complete|3
7664689|NCT01400412|26661615|P2|Overall Study|Withdrawal by Subject|4
7664690|NCT01400412|26661616|P1|Overall Study|Withdrawal by Subject|3
7664691|NCT01400412|26661615|P2|Overall Study|Lost to Follow-up|7
7664692|NCT01400412|26661616|P1|Overall Study|Lost to Follow-up|4
7664693|NCT01400243|26661662|P2|Overall Study|Protocol Violation|11
7664694|NCT01400243|26661663|P1|Overall Study|Protocol Violation|8
7664695|NCT01400139|26661685|P1|HYD Extension Period|Administrative|10
7664696|NCT01400139|26661685|P1|HYD Extension Period|Withdrawal by Subject|5
7664697|NCT01400139|26661685|P1|HYD Extension Period|Adverse Event|8
7664698|NCT01400139|26661685|P1|HYD Core Study|Did not qualify for Maintenance Period|14
7664699|NCT01400139|26661685|P1|HYD Core Study|Administrative|56
7664700|NCT01400139|26661685|P1|HYD Core Study|Confirmed or suspected diversion|20
7664701|NCT01400139|26661685|P1|HYD Core Study|Lost to Follow-up|39
7664702|NCT01400139|26661685|P1|HYD Core Study|Withdrawal by Subject|114
7664703|NCT01400139|26661685|P1|HYD Core Study|Lack of Efficacy|59
7664704|NCT01400139|26661685|P1|HYD Core Study|Adverse Event|210
7664705|NCT01400113|26661708|P2|Overall Study|Withdrawal by Subject|1
7664706|NCT01400113|26661709|P1|Overall Study|Withdrawal by Subject|1
7664707|NCT01399905|26661717|P2|Overall Study|Withdrawal by Subject|1
7664708|NCT01399905|26661718|P1|Overall Study|Withdrawal by Subject|1
7664709|NCT01399788|26661766|P2|First Intervention Period|Adverse Event|0
7664710|NCT01399788|26661767|P1|First Intervention Period|Adverse Event|1
7664711|NCT01399736|26661789|P2|Overall Study|Lost to Follow-up|2
7664712|NCT01399736|26661790|P1|Overall Study|Lost to Follow-up|0
7664713|NCT01399736|26661789|P2|Overall Study|Withdrawal by Subject|2
7664714|NCT01399736|26661790|P1|Overall Study|Withdrawal by Subject|4
7664715|NCT01399723|26661866|P2|Overall Study|Lost to Follow-up|1
7664716|NCT01399723|26661867|P1|Overall Study|Lost to Follow-up|0
7664717|NCT01399697|26661880|P3|Overall Study|Sponsor Decision|0
7664718|NCT01399697|26661881|P2|Overall Study|Sponsor Decision|0
7664719|NCT01399697|26661882|P1|Overall Study|Sponsor Decision|1
7664720|NCT01399697|26661880|P3|Overall Study|Clinical RA remission|0
7664721|NCT01399697|26661881|P2|Overall Study|Clinical RA remission|0
7664722|NCT01399697|26661882|P1|Overall Study|Clinical RA remission|1
7664723|NCT01399697|26661880|P3|Overall Study|Positive result for hepatitis B|0
7664724|NCT01399697|26661881|P2|Overall Study|Positive result for hepatitis B|0
7664725|NCT01399697|26661882|P1|Overall Study|Positive result for hepatitis B|1
7664726|NCT01399697|26661880|P3|Overall Study|Inclusion Error|0
7664727|NCT01399697|26661881|P2|Overall Study|Inclusion Error|0
7664728|NCT01399697|26661882|P1|Overall Study|Inclusion Error|2
7664729|NCT01399697|26661880|P3|Overall Study|Non-Compliant|0
7664730|NCT01399697|26661881|P2|Overall Study|Non-Compliant|0
7664731|NCT01399697|26661882|P1|Overall Study|Non-Compliant|1
7664732|NCT01399697|26661880|P3|Overall Study|Protocol Violation|0
7664733|NCT01399697|26661881|P2|Overall Study|Protocol Violation|0
7664734|NCT01399697|26661882|P1|Overall Study|Protocol Violation|2
7664735|NCT01399697|26661880|P3|Overall Study|Lack of Efficacy|1
7664736|NCT01399697|26661881|P2|Overall Study|Lack of Efficacy|0
7664737|NCT01399697|26661882|P1|Overall Study|Lack of Efficacy|9
7664738|NCT01399697|26661880|P3|Overall Study|Investigator Decisión|2
7664739|NCT01399697|26661881|P2|Overall Study|Investigator Decisión|0
7664740|NCT01399697|26661882|P1|Overall Study|Investigator Decisión|1
7664741|NCT01399697|26661880|P3|Overall Study|Withdrawal by Subject|0
7664742|NCT01399697|26661881|P2|Overall Study|Withdrawal by Subject|0
7664743|NCT01399697|26661882|P1|Overall Study|Withdrawal by Subject|8
7664744|NCT01399697|26661880|P3|Overall Study|Lost to Follow-up|0
7664745|NCT01399697|26661881|P2|Overall Study|Lost to Follow-up|0
7664746|NCT01399697|26661882|P1|Overall Study|Lost to Follow-up|2
7664747|NCT01399697|26661880|P3|Overall Study|Adverse Event|1
7664748|NCT01399697|26661881|P2|Overall Study|Adverse Event|3
7664749|NCT01399697|26661882|P1|Overall Study|Adverse Event|13
7664750|NCT01399619|26661909|P4|Overall Study|Not treated|2
7664751|NCT01399619|26661910|P3|Overall Study|Not treated|0
7664752|NCT01399619|26661911|P2|Overall Study|Not treated|0
7664753|NCT01399619|26661912|P1|Overall Study|Not treated|0
7664754|NCT01399619|26661909|P4|Overall Study|Protocol Violation|1
7664755|NCT01399619|26661910|P3|Overall Study|Protocol Violation|0
7664756|NCT01399619|26661911|P2|Overall Study|Protocol Violation|0
7664757|NCT01399619|26661912|P1|Overall Study|Protocol Violation|0
7664758|NCT01399619|26661909|P4|Overall Study|Withdrawal by Subject|4
7664759|NCT01399619|26661910|P3|Overall Study|Withdrawal by Subject|3
7664760|NCT01399619|26661911|P2|Overall Study|Withdrawal by Subject|0
7664761|NCT01399619|26661912|P1|Overall Study|Withdrawal by Subject|6
7664762|NCT01399619|26661909|P4|Overall Study|Lack of Efficacy|0
7664763|NCT01399619|26661910|P3|Overall Study|Lack of Efficacy|5
7664764|NCT01399619|26661911|P2|Overall Study|Lack of Efficacy|0
7664765|NCT01399619|26661912|P1|Overall Study|Lack of Efficacy|9
7664766|NCT01399619|26661909|P4|Overall Study|Adverse Event|10
7664767|NCT01399619|26661910|P3|Overall Study|Adverse Event|4
7664768|NCT01399619|26661911|P2|Overall Study|Adverse Event|0
7664769|NCT01399619|26661912|P1|Overall Study|Adverse Event|10
7664770|NCT01399593|26661975|P2|Overall Study|Transplantectomy|1
7664771|NCT01399593|26661976|P1|Overall Study|Transplantectomy|0
7664772|NCT01399593|26661975|P2|Overall Study|Death|1
7664773|NCT01399593|26661976|P1|Overall Study|Death|1
7664774|NCT01399593|26661975|P2|Overall Study|Adverse Event|0
7664775|NCT01399593|26661976|P1|Overall Study|Adverse Event|1
7664776|NCT01399593|26661975|P2|Overall Study|Physician Decision|0
7664777|NCT01399593|26661976|P1|Overall Study|Physician Decision|1
7664778|NCT01399372|26661984|P2|Overall Study|Protocol Violation|1
7664779|NCT01399372|26661985|P1|Overall Study|Protocol Violation|3
7664780|NCT01399190|26662024|P1|Overall Study|Physician Decision|2
7664781|NCT01399190|26662024|P1|Overall Study|Participant's Request|5
7664782|NCT01399190|26662024|P1|Overall Study|Adverse Event|8
7664783|NCT01399190|26662024|P1|Overall Study|Not Eligible for Final Analysis|5
7664784|NCT01399125|26662032|P2|Overall Study|Protocol Deviation|2
7664785|NCT01399125|26662033|P1|Overall Study|Protocol Deviation|5
7664786|NCT01399125|26662032|P2|Overall Study|Death|1
7664787|NCT01399125|26662033|P1|Overall Study|Death|0
7664788|NCT01399125|26662032|P2|Overall Study|Administrative Problems|11
7664789|NCT01399125|26662033|P1|Overall Study|Administrative Problems|7
7664790|NCT01399125|26662032|P2|Overall Study|Lost to Follow-up|3
7664791|NCT01399125|26662033|P1|Overall Study|Lost to Follow-up|2
7664792|NCT01399125|26662032|P2|Overall Study|Withdrawal by Subject|8
7664793|NCT01399125|26662033|P1|Overall Study|Withdrawal by Subject|5
7664794|NCT01399125|26662032|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
7664795|NCT01399125|26662033|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
7664796|NCT01399125|26662032|P2|Overall Study|Abnormal Lab values|1
7664797|NCT01399125|26662033|P1|Overall Study|Abnormal Lab values|0
7664798|NCT01399125|26662032|P2|Overall Study|Adverse Event|30
7664799|NCT01399125|26662033|P1|Overall Study|Adverse Event|32
7664800|NCT01399099|26662047|P1|Overall Study|Miscellaneous|4
7664801|NCT01399099|26662047|P1|Overall Study|Infection|1
7664802|NCT01399099|26662047|P1|Overall Study|Skin Irritation|13
7664803|NCT01399099|26662047|P1|Overall Study|Protocol Violation|1
7664804|NCT01399099|26662047|P1|Overall Study|Physician Decision|1
7664805|NCT01399099|26662047|P1|Overall Study|Lost to Follow-up|11
7664806|NCT01399047|26662054|P2|Overall Study|Withdrawal by Subject|1
7664807|NCT01399047|26662055|P1|Overall Study|Withdrawal by Subject|0
7664808|NCT01398956|26662091|P1|Overall Study|Subject moved a long distance|1
7664809|NCT01398956|26662091|P1|Overall Study|Withdrawal Criteria No.3|1
7664810|NCT01398956|26662091|P1|Overall Study|AE, non-serious non-fatal|4
7664811|NCT01398956|26662091|P1|Overall Study|Withdrawal by Subject|4
7664812|NCT01398787|26662123|P1|Overall Study|Adverse Event|1
7664813|NCT01398514|26662146|P2|Overall Study|Failure to show a conditioned response|3
7664814|NCT01398514|26662147|P1|Overall Study|Failure to show a conditioned response|4
7664815|NCT01398514|26662146|P2|Overall Study|Physiologic non-responsiveness|3
7664816|NCT01398514|26662147|P1|Overall Study|Physiologic non-responsiveness|1
7664817|NCT01398514|26662146|P2|Overall Study|Non-compliance with study procedures|0
7664818|NCT01398514|26662147|P1|Overall Study|Non-compliance with study procedures|2
7664819|NCT01398514|26662146|P2|Overall Study|Adverse Event|0
7664820|NCT01398514|26662147|P1|Overall Study|Adverse Event|1
7664821|NCT01398410|26662182|P2|Overall Study|Other|29
7664822|NCT01398410|26662183|P1|Overall Study|Other|36
7664823|NCT01398410|26662182|P2|Overall Study|Inadequate Therapeutic Effect|0
7664824|NCT01398410|26662183|P1|Overall Study|Inadequate Therapeutic Effect|2
7664825|NCT01398410|26662182|P2|Overall Study|Participants Choice|11
7664826|NCT01398410|26662183|P1|Overall Study|Participants Choice|8
7664827|NCT01398410|26662182|P2|Overall Study|Adverse Event|16
7664828|NCT01398410|26662183|P1|Overall Study|Adverse Event|12
7664829|NCT01398358|26662194|P3|Overall Study|no longer eligible|1
7664830|NCT01398358|26662195|P2|Overall Study|no longer eligible|0
7664831|NCT01398358|26662196|P1|Overall Study|no longer eligible|1
7664832|NCT01398358|26662194|P3|Overall Study|Withdrawal by Subject|2
7664833|NCT01398358|26662195|P2|Overall Study|Withdrawal by Subject|2
7664834|NCT01398358|26662196|P1|Overall Study|Withdrawal by Subject|3
7664835|NCT01398358|26662194|P3|Overall Study|Lost to Follow-up|18
7664836|NCT01398358|26662195|P2|Overall Study|Lost to Follow-up|21
7664837|NCT01398358|26662196|P1|Overall Study|Lost to Follow-up|11
7664838|NCT01398176|26662218|P2|Overall Study|Physician Decision|3
7664839|NCT01398176|26662219|P1|Overall Study|Physician Decision|2
7664840|NCT01398176|26662218|P2|Overall Study|Lost to Follow-up|3
7664841|NCT01398176|26662219|P1|Overall Study|Lost to Follow-up|1
7664842|NCT01397890|26662252|P2|Overall Study|Others|1
7664843|NCT01397890|26662253|P1|Overall Study|Others|2
7664844|NCT01397890|26662252|P2|Overall Study|Severe Non-Compliance to Protocol|1
7664845|NCT01397890|26662253|P1|Overall Study|Severe Non-Compliance to Protocol|2
7664846|NCT01397890|26662252|P2|Overall Study|Adverse Event|2
7664847|NCT01397890|26662253|P1|Overall Study|Adverse Event|1
7664848|NCT01397890|26662252|P2|Overall Study|Condition under Investigation Worsened|3
7664849|NCT01397890|26662253|P1|Overall Study|Condition under Investigation Worsened|1
7664850|NCT01397890|26662252|P2|Overall Study|Lost to Follow-up|4
7664851|NCT01397890|26662253|P1|Overall Study|Lost to Follow-up|1
7664852|NCT01397890|26662252|P2|Overall Study|Death|3
7664853|NCT01397890|26662253|P1|Overall Study|Death|2
7664854|NCT01397890|26662252|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
7664855|NCT01397890|26662253|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
7664856|NCT01397890|26662252|P2|Overall Study|Withdrawal by Subject|11
7664857|NCT01397890|26662253|P1|Overall Study|Withdrawal by Subject|7
7664858|NCT01397825|26662324|P5|Overall Study|Withdrawal by Subject|0
7664859|NCT01397825|26662325|P4|Overall Study|Withdrawal by Subject|1
7664860|NCT01397825|26662326|P3|Overall Study|Withdrawal by Subject|5
7664861|NCT01397825|26662327|P2|Overall Study|Withdrawal by Subject|0
7664862|NCT01397825|26662328|P1|Overall Study|Withdrawal by Subject|1
7664863|NCT01397825|26662324|P5|Overall Study|Adverse Event|0
7664864|NCT01397825|26662325|P4|Overall Study|Adverse Event|1
7664865|NCT01397825|26662326|P3|Overall Study|Adverse Event|5
7664866|NCT01397825|26662327|P2|Overall Study|Adverse Event|1
7664867|NCT01397825|26662328|P1|Overall Study|Adverse Event|0
7664868|NCT01397825|26662324|P5|Overall Study|Symptomatic Deterioration|0
7664869|NCT01397825|26662325|P4|Overall Study|Symptomatic Deterioration|0
7664870|NCT01397825|26662326|P3|Overall Study|Symptomatic Deterioration|4
7664871|NCT01397825|26662327|P2|Overall Study|Symptomatic Deterioration|0
7664872|NCT01397825|26662328|P1|Overall Study|Symptomatic Deterioration|2
7664873|NCT01397825|26662324|P5|Overall Study|Progressive Disease|0
7664874|NCT01397825|26662325|P4|Overall Study|Progressive Disease|1
7664875|NCT01397825|26662326|P3|Overall Study|Progressive Disease|11
7664876|NCT01397825|26662327|P2|Overall Study|Progressive Disease|3
7664877|NCT01397825|26662328|P1|Overall Study|Progressive Disease|10
7664878|NCT01397786|26662398|P3|Phase B|Lack of Efficacy|14
7664879|NCT01397786|26662399|P2|Phase B|Lack of Efficacy|7
7664880|NCT01397786|26662400|P1|Phase B|Lack of Efficacy|22
7664881|NCT01397786|26662398|P3|Phase B|Protocol Deviation|4
7664882|NCT01397786|26662399|P2|Phase B|Protocol Deviation|2
7664883|NCT01397786|26662400|P1|Phase B|Protocol Deviation|1
7664884|NCT01397786|26662398|P3|Phase B|Withdrawal by Subject|30
7664885|NCT01397786|26662399|P2|Phase B|Withdrawal by Subject|45
7664886|NCT01397786|26662400|P1|Phase B|Withdrawal by Subject|102
7664887|NCT01397786|26662398|P3|Phase B|Physician Decision|3
7664888|NCT01397786|26662399|P2|Phase B|Physician Decision|1
7664889|NCT01397786|26662400|P1|Phase B|Physician Decision|9
7664890|NCT01397786|26662398|P3|Phase B|Subject Met Withdrawal Criteria|38
7664891|NCT01397786|26662399|P2|Phase B|Subject Met Withdrawal Criteria|5
7664892|NCT01397786|26662400|P1|Phase B|Subject Met Withdrawal Criteria|38
7664893|NCT01397786|26662398|P3|Phase B|Adverse Event|27
7664894|NCT01397786|26662399|P2|Phase B|Adverse Event|23
7664895|NCT01397786|26662400|P1|Phase B|Adverse Event|109
7664896|NCT01397786|26662398|P3|Phase B|Lost to Follow-up|22
7664897|NCT01397786|26662399|P2|Phase B|Lost to Follow-up|12
7664898|NCT01397786|26662400|P1|Phase B|Lost to Follow-up|22
7664899|NCT01397786|26662398|P3|Phase A|Lack of Efficacy|1
7664900|NCT01397786|26662399|P2|Phase A|Lack of Efficacy|0
7664901|NCT01397786|26662400|P1|Phase A|Lack of Efficacy|0
7664902|NCT01397786|26662398|P3|Phase A|Withdrawal by Subject|5
7664903|NCT01397786|26662399|P2|Phase A|Withdrawal by Subject|0
7664904|NCT01397786|26662400|P1|Phase A|Withdrawal by Subject|0
7664905|NCT01397786|26662398|P3|Phase A|Physician Decision|1
7664906|NCT01397786|26662399|P2|Phase A|Physician Decision|0
7664907|NCT01397786|26662400|P1|Phase A|Physician Decision|0
7664908|NCT01397786|26662398|P3|Phase A|Subject Met Withdrawal Criteria|7
7664909|NCT01397786|26662399|P2|Phase A|Subject Met Withdrawal Criteria|0
7664910|NCT01397786|26662400|P1|Phase A|Subject Met Withdrawal Criteria|0
7664911|NCT01397786|26662398|P3|Phase A|Adverse Event|8
7664912|NCT01397786|26662399|P2|Phase A|Adverse Event|0
7664913|NCT01397786|26662400|P1|Phase A|Adverse Event|0
7664914|NCT01397786|26662398|P3|Phase A|Lost to Follow-up|6
7664915|NCT01397786|26662399|P2|Phase A|Lost to Follow-up|0
7664916|NCT01397786|26662400|P1|Phase A|Lost to Follow-up|0
7664917|NCT01397747|26662466|P1|Overall Study|FIT excluded|34
7664918|NCT01397747|26662466|P1|Overall Study|Colonoscopy excluded|304
7664919|NCT01397747|26662466|P1|Overall Study|Multitarget DNA test excluded|689
7664920|NCT01397552|26662516|P2|Overall Study|Withdrawal by Subject|1
7664921|NCT01397552|26662517|P1|Overall Study|Withdrawal by Subject|2
7664922|NCT01397552|26662516|P2|Overall Study|Adverse Event|0
7664923|NCT01397552|26662517|P1|Overall Study|Adverse Event|1
7664924|NCT01397461|26662526|P3|Overall Study|Not treated|1
7664925|NCT01397461|26662527|P2|Overall Study|Not treated|0
7664926|NCT01397461|26662528|P1|Overall Study|Not treated|0
7664927|NCT01397461|26662526|P3|Overall Study|Lack of Efficacy|0
7664928|NCT01397461|26662527|P2|Overall Study|Lack of Efficacy|3
7664929|NCT01397461|26662528|P1|Overall Study|Lack of Efficacy|0
7664930|NCT01397461|26662526|P3|Overall Study|Lost to Follow-up|1
7664931|NCT01397461|26662527|P2|Overall Study|Lost to Follow-up|2
7664932|NCT01397461|26662528|P1|Overall Study|Lost to Follow-up|0
7664933|NCT01397461|26662526|P3|Overall Study|Withdrawal by Subject|0
7664934|NCT01397461|26662527|P2|Overall Study|Withdrawal by Subject|1
7664935|NCT01397461|26662528|P1|Overall Study|Withdrawal by Subject|2
7664936|NCT01397448|26662539|P3|Overall Study|Other|4
7664937|NCT01397448|26662540|P2|Overall Study|Other|7
7664938|NCT01397448|26662541|P1|Overall Study|Other|8
7664939|NCT01397448|26662539|P3|Overall Study|Lack of Efficacy|5
7664940|NCT01397448|26662540|P2|Overall Study|Lack of Efficacy|0
7664941|NCT01397448|26662541|P1|Overall Study|Lack of Efficacy|2
7664942|NCT01397448|26662539|P3|Overall Study|Withdrawal by Subject|3
7664943|NCT01397448|26662540|P2|Overall Study|Withdrawal by Subject|4
7664944|NCT01397448|26662541|P1|Overall Study|Withdrawal by Subject|4
7664945|NCT01397448|26662539|P3|Overall Study|Adverse Event|6
7664946|NCT01397448|26662540|P2|Overall Study|Adverse Event|4
7664947|NCT01397448|26662541|P1|Overall Study|Adverse Event|4
7664948|NCT01397422|26662556|P4|Overall Study|Increased bradykinesia related to PD|0
7664949|NCT01397422|26662557|P3|Overall Study|Increased bradykinesia related to PD|0
7664950|NCT01397422|26662558|P2|Overall Study|Increased bradykinesia related to PD|0
7664951|NCT01397422|26662559|P1|Overall Study|Increased bradykinesia related to PD|1
7664952|NCT01397422|26662556|P4|Overall Study|Withdrawal by Subject|0
7664953|NCT01397422|26662557|P3|Overall Study|Withdrawal by Subject|0
7664954|NCT01397422|26662558|P2|Overall Study|Withdrawal by Subject|0
7664955|NCT01397422|26662559|P1|Overall Study|Withdrawal by Subject|1
7664956|NCT01397422|26662556|P4|Overall Study|Adverse Event|8
7664957|NCT01397422|26662557|P3|Overall Study|Adverse Event|3
7664958|NCT01397422|26662558|P2|Overall Study|Adverse Event|3
7664959|NCT01397422|26662559|P1|Overall Study|Adverse Event|0
7664960|NCT01397409|26662599|P10|Stage 3|Other Miscellaneous Reasons|0
7664961|NCT01397409|26662600|P9|Stage 3|Other Miscellaneous Reasons|0
7664962|NCT01397409|26662601|P8|Stage 3|Other Miscellaneous Reasons|1
7664963|NCT01397409|26662602|P7|Stage 3|Other Miscellaneous Reasons|0
7664964|NCT01397409|26662603|P6|Stage 3|Other Miscellaneous Reasons|0
7664965|NCT01397409|26662604|P5|Stage 3|Other Miscellaneous Reasons|0
7664966|NCT01397409|26662605|P4|Stage 3|Other Miscellaneous Reasons|0
7664967|NCT01397409|26662606|P3|Stage 3|Other Miscellaneous Reasons|0
7664968|NCT01397409|26662607|P2|Stage 3|Other Miscellaneous Reasons|0
7664969|NCT01397409|26662608|P1|Stage 3|Other Miscellaneous Reasons|0
7664970|NCT01397409|26662599|P10|Stage 3|Adverse Event|0
7664971|NCT01397409|26662600|P9|Stage 3|Adverse Event|0
7664972|NCT01397409|26662601|P8|Stage 3|Adverse Event|1
7664973|NCT01397409|26662602|P7|Stage 3|Adverse Event|0
7664974|NCT01397409|26662603|P6|Stage 3|Adverse Event|0
7664975|NCT01397409|26662604|P5|Stage 3|Adverse Event|0
7664976|NCT01397409|26662605|P4|Stage 3|Adverse Event|0
7664977|NCT01397409|26662606|P3|Stage 3|Adverse Event|0
7664978|NCT01397409|26662607|P2|Stage 3|Adverse Event|0
7664979|NCT01397409|26662608|P1|Stage 3|Adverse Event|0
7664980|NCT01397409|26662599|P10|Stage 2|Other Miscellaneous Reasons|0
7664981|NCT01397409|26662600|P9|Stage 2|Other Miscellaneous Reasons|0
7664982|NCT01397409|26662601|P8|Stage 2|Other Miscellaneous Reasons|0
7664983|NCT01397409|26662602|P7|Stage 2|Other Miscellaneous Reasons|0
7664984|NCT01397409|26662603|P6|Stage 2|Other Miscellaneous Reasons|1
7664985|NCT01397409|26662604|P5|Stage 2|Other Miscellaneous Reasons|1
7664986|NCT01397409|26662605|P4|Stage 2|Other Miscellaneous Reasons|0
7664987|NCT01397409|26662606|P3|Stage 2|Other Miscellaneous Reasons|0
7664988|NCT01397409|26662607|P2|Stage 2|Other Miscellaneous Reasons|0
7664989|NCT01397409|26662608|P1|Stage 2|Other Miscellaneous Reasons|0
7664990|NCT01397409|26662599|P10|Stage 2|Personal Reasons|0
7664991|NCT01397409|26662600|P9|Stage 2|Personal Reasons|0
7664992|NCT01397409|26662601|P8|Stage 2|Personal Reasons|0
7664993|NCT01397409|26662602|P7|Stage 2|Personal Reasons|0
7664994|NCT01397409|26662603|P6|Stage 2|Personal Reasons|0
7664995|NCT01397409|26662604|P5|Stage 2|Personal Reasons|1
7664996|NCT01397409|26662605|P4|Stage 2|Personal Reasons|0
7664997|NCT01397409|26662606|P3|Stage 2|Personal Reasons|0
7664998|NCT01397409|26662607|P2|Stage 2|Personal Reasons|0
7664999|NCT01397409|26662608|P1|Stage 2|Personal Reasons|0
7665000|NCT01397409|26662599|P10|Stage 2|Adverse Event|0
7665001|NCT01397409|26662600|P9|Stage 2|Adverse Event|0
7665002|NCT01397409|26662601|P8|Stage 2|Adverse Event|0
7665003|NCT01397409|26662602|P7|Stage 2|Adverse Event|0
7665004|NCT01397409|26662603|P6|Stage 2|Adverse Event|3
7665005|NCT01397409|26662604|P5|Stage 2|Adverse Event|6
7665006|NCT01397409|26662605|P4|Stage 2|Adverse Event|0
7665007|NCT01397409|26662606|P3|Stage 2|Adverse Event|0
7665008|NCT01397409|26662607|P2|Stage 2|Adverse Event|0
7665009|NCT01397409|26662608|P1|Stage 2|Adverse Event|0
7665010|NCT01397253|26662648|P2|Overall Study|Reviewed by only 1 pharmacist|149
7665011|NCT01397253|26662649|P1|Overall Study|Reviewed by only 1 pharmacist|126
7665012|NCT01397084|26662655|P1|Overall Study|Used other proton pump inhibitor|1
7665013|NCT01397084|26662655|P1|Overall Study|Lost to Follow-up|1
7665014|NCT01397084|26662655|P1|Overall Study|Withdrawal by Subject|1
7665015|NCT01397084|26662655|P1|Overall Study|Adverse Event|2
7665016|NCT01397084|26662655|P1|Overall Study|Protocol Violation|2
7665017|NCT01397084|26662655|P1|Overall Study|Severe Non-Compliance to Protocol|1
7665018|NCT01396525|26662681|P1|Overall Study|Lost to Follow-up|4
7665019|NCT01396525|26662681|P1|Overall Study|Death|14
7665020|NCT01396525|26662681|P1|Overall Study|Withdrawal by Subject|8
7665021|NCT01396512|26662781|P2|Overall Study|Withdrawal by Subject|1
7665022|NCT01396512|26662782|P1|Overall Study|Withdrawal by Subject|0
7665023|NCT01396447|26662814|P4|Overall Study|Other Miscellaneous Reasons|0
7665024|NCT01396447|26662815|P3|Overall Study|Other Miscellaneous Reasons|1
7665025|NCT01396447|26662816|P2|Overall Study|Other Miscellaneous Reasons|2
7665026|NCT01396447|26662817|P1|Overall Study|Other Miscellaneous Reasons|0
7665027|NCT01396447|26662814|P4|Overall Study|Lost to Follow-up|9
7665028|NCT01396447|26662815|P3|Overall Study|Lost to Follow-up|7
7665029|NCT01396447|26662816|P2|Overall Study|Lost to Follow-up|8
7665030|NCT01396447|26662817|P1|Overall Study|Lost to Follow-up|4
7665031|NCT01396447|26662814|P4|Overall Study|Withdrawal of Consent|15
7665032|NCT01396447|26662815|P3|Overall Study|Withdrawal of Consent|4
7665033|NCT01396447|26662816|P2|Overall Study|Withdrawal of Consent|9
7665034|NCT01396447|26662817|P1|Overall Study|Withdrawal of Consent|11
7665035|NCT01396447|26662814|P4|Overall Study|Protocol Violation|7
7665036|NCT01396447|26662815|P3|Overall Study|Protocol Violation|3
7665037|NCT01396447|26662816|P2|Overall Study|Protocol Violation|2
7665038|NCT01396447|26662817|P1|Overall Study|Protocol Violation|5
7665039|NCT01396447|26662814|P4|Overall Study|Insufficient Therapeutic Response|4
7665040|NCT01396447|26662815|P3|Overall Study|Insufficient Therapeutic Response|2
7665041|NCT01396447|26662816|P2|Overall Study|Insufficient Therapeutic Response|5
7665042|NCT01396447|26662817|P1|Overall Study|Insufficient Therapeutic Response|5
7665043|NCT01396447|26662814|P4|Overall Study|Adverse Event|17
7665044|NCT01396447|26662815|P3|Overall Study|Adverse Event|12
7665045|NCT01396447|26662816|P2|Overall Study|Adverse Event|12
7665046|NCT01396447|26662817|P1|Overall Study|Adverse Event|15
7665047|NCT01396447|26662814|P4|Overall Study|Did Not Receive Treatment|0
7665048|NCT01396447|26662815|P3|Overall Study|Did Not Receive Treatment|1
7665049|NCT01396447|26662816|P2|Overall Study|Did Not Receive Treatment|2
7665050|NCT01396447|26662817|P1|Overall Study|Did Not Receive Treatment|3
7665051|NCT01396434|26662834|P3|Overall Study|Other|0
7665052|NCT01396434|26662835|P2|Overall Study|Other|0
7665053|NCT01396434|26662836|P1|Overall Study|Other|10
7665054|NCT01396434|26662834|P3|Overall Study|Lost to Follow-up|0
7665055|NCT01396434|26662835|P2|Overall Study|Lost to Follow-up|0
7665056|NCT01396434|26662836|P1|Overall Study|Lost to Follow-up|1
7665057|NCT01396421|26662848|P4|Overall Study|Lack of Efficacy|18
7665058|NCT01396421|26662849|P3|Overall Study|Lack of Efficacy|7
7665059|NCT01396421|26662850|P2|Overall Study|Lack of Efficacy|17
7665060|NCT01396421|26662851|P1|Overall Study|Lack of Efficacy|7
7665061|NCT01396421|26662848|P4|Overall Study|Protocol Deviation|0
7665062|NCT01396421|26662849|P3|Overall Study|Protocol Deviation|1
7665063|NCT01396421|26662850|P2|Overall Study|Protocol Deviation|1
7665064|NCT01396421|26662851|P1|Overall Study|Protocol Deviation|2
7665065|NCT01396421|26662848|P4|Overall Study|Withdrawal by Subject|21
7665066|NCT01396421|26662849|P3|Overall Study|Withdrawal by Subject|13
7665067|NCT01396421|26662850|P2|Overall Study|Withdrawal by Subject|24
7665068|NCT01396421|26662851|P1|Overall Study|Withdrawal by Subject|31
7665069|NCT01396421|26662848|P4|Overall Study|Physician Decision|3
7665070|NCT01396421|26662849|P3|Overall Study|Physician Decision|0
7665071|NCT01396421|26662850|P2|Overall Study|Physician Decision|1
7665072|NCT01396421|26662851|P1|Overall Study|Physician Decision|1
7665073|NCT01396421|26662848|P4|Overall Study|Participant Met Withdrawal Criteria|0
7665074|NCT01396421|26662849|P3|Overall Study|Participant Met Withdrawal Criteria|1
7665075|NCT01396421|26662850|P2|Overall Study|Participant Met Withdrawal Criteria|0
7665076|NCT01396421|26662851|P1|Overall Study|Participant Met Withdrawal Criteria|1
7665077|NCT01396421|26662848|P4|Overall Study|Adverse Event|32
7665078|NCT01396421|26662849|P3|Overall Study|Adverse Event|12
7665079|NCT01396421|26662850|P2|Overall Study|Adverse Event|15
7665080|NCT01396421|26662851|P1|Overall Study|Adverse Event|17
7665081|NCT01396421|26662848|P4|Overall Study|Lost to Follow-up|1
7665082|NCT01396421|26662849|P3|Overall Study|Lost to Follow-up|0
7665083|NCT01396421|26662850|P2|Overall Study|Lost to Follow-up|0
7665084|NCT01396421|26662851|P1|Overall Study|Lost to Follow-up|0
7665085|NCT01396395|26662923|P2|Overall Study|Other|1
7665086|NCT01396395|26662924|P1|Overall Study|Other|0
7665087|NCT01396395|26662923|P2|Overall Study|Lost to Follow-up|11
7665088|NCT01396395|26662924|P1|Overall Study|Lost to Follow-up|17
7665089|NCT01396395|26662923|P2|Overall Study|Adverse Event|2
7665090|NCT01396395|26662924|P1|Overall Study|Adverse Event|10
7665091|NCT01396395|26662923|P2|Overall Study|Protocol Violation|1
7665092|NCT01396395|26662924|P1|Overall Study|Protocol Violation|3
7665093|NCT01396395|26662923|P2|Overall Study|Withdrawal by Subject|12
7665094|NCT01396395|26662924|P1|Overall Study|Withdrawal by Subject|10
7665095|NCT01396317|26662966|P2|Overall Study|Adverse Event|0
7665096|NCT01396317|26662967|P1|Overall Study|Adverse Event|1
7665097|NCT01396265|26662981|P1|Rifa+Afatinib|Withdrawal by Subject|1
7665098|NCT01396187|26663070|P5|Overall Study|Other|1
7665099|NCT01396187|26663071|P4|Overall Study|Other|0
7665100|NCT01396187|26663072|P3|Overall Study|Other|0
7665101|NCT01396187|26663073|P2|Overall Study|Other|1
7665102|NCT01396187|26663074|P1|Overall Study|Other|1
7665103|NCT01396187|26663070|P5|Overall Study|Withdrawal by Subject|0
7665104|NCT01396187|26663071|P4|Overall Study|Withdrawal by Subject|0
7665105|NCT01396187|26663072|P3|Overall Study|Withdrawal by Subject|1
7665106|NCT01396187|26663073|P2|Overall Study|Withdrawal by Subject|1
7665107|NCT01396187|26663074|P1|Overall Study|Withdrawal by Subject|0
7665108|NCT01396187|26663070|P5|Overall Study|Adverse Event|0
7665109|NCT01396187|26663071|P4|Overall Study|Adverse Event|0
7665110|NCT01396187|26663072|P3|Overall Study|Adverse Event|0
7665111|NCT01396187|26663073|P2|Overall Study|Adverse Event|1
7665112|NCT01396187|26663074|P1|Overall Study|Adverse Event|0
7665113|NCT01396161|26663174|P7|Overall Study|Other|1
7665114|NCT01396161|26663175|P6|Overall Study|Other|0
7665115|NCT01396161|26663176|P5|Overall Study|Other|0
7665116|NCT01396161|26663177|P4|Overall Study|Other|0
7665117|NCT01396161|26663178|P3|Overall Study|Other|0
7665118|NCT01396161|26663179|P2|Overall Study|Other|0
7665119|NCT01396161|26663180|P1|Overall Study|Other|0
7665120|NCT01396161|26663174|P7|Overall Study|Withdrawal by Subject|0
7665121|NCT01396161|26663175|P6|Overall Study|Withdrawal by Subject|0
7665122|NCT01396161|26663176|P5|Overall Study|Withdrawal by Subject|1
7665123|NCT01396161|26663177|P4|Overall Study|Withdrawal by Subject|0
7665124|NCT01396161|26663178|P3|Overall Study|Withdrawal by Subject|0
7665125|NCT01396161|26663179|P2|Overall Study|Withdrawal by Subject|0
7665126|NCT01396161|26663180|P1|Overall Study|Withdrawal by Subject|0
7665127|NCT01396148|26663233|P1|Overall Study|Patient Decision|1
7665128|NCT01396083|26663263|P2|Overall Study|Lost to Follow-up|0
7665129|NCT01396083|26663264|P1|Overall Study|Lost to Follow-up|1
7665130|NCT01396083|26663263|P2|Overall Study|Administrative problems|0
7665131|NCT01396083|26663264|P1|Overall Study|Administrative problems|1
7665132|NCT01396083|26663263|P2|Overall Study|Abnormal laboratory value(s)|0
7665133|NCT01396083|26663264|P1|Overall Study|Abnormal laboratory value(s)|1
7665134|NCT01396083|26663263|P2|Overall Study|Protocol deviation(s)|1
7665135|NCT01396083|26663264|P1|Overall Study|Protocol deviation(s)|0
7665136|NCT01396083|26663263|P2|Overall Study|Consent withdrawn|5
7665137|NCT01396083|26663264|P1|Overall Study|Consent withdrawn|4
7665138|NCT01396083|26663263|P2|Overall Study|Unsatisfactory therapeutic effect|13
7665139|NCT01396083|26663264|P1|Overall Study|Unsatisfactory therapeutic effect|2
7665140|NCT01396083|26663263|P2|Overall Study|Adverse Event|28
7665141|NCT01396083|26663264|P1|Overall Study|Adverse Event|2
7665142|NCT01396070|26663288|P1|Overall Study|Lack of Efficacy|4
7665143|NCT01396070|26663288|P1|Overall Study|Physician Decision|3
7665144|NCT01396070|26663288|P1|Overall Study|Adverse Event|8
7665145|NCT01396070|26663288|P1|Overall Study|Death|2
7665146|NCT01396070|26663288|P1|Overall Study|Withdrawal by Subject|2
7665147|NCT01396057|26663297|P2|Overall Study|Consent withdrawn|2
7665148|NCT01396057|26663298|P1|Overall Study|Consent withdrawn|3
7665149|NCT01396057|26663297|P2|Overall Study|Protocol deviation|4
7665150|NCT01396057|26663298|P1|Overall Study|Protocol deviation|4
7665151|NCT01396057|26663297|P2|Overall Study|Unsatisfactory therapeutic effect|6
7665152|NCT01396057|26663298|P1|Overall Study|Unsatisfactory therapeutic effect|2
7665153|NCT01396057|26663297|P2|Overall Study|Adverse Event|6
7665154|NCT01396057|26663298|P1|Overall Study|Adverse Event|2
7665155|NCT01396005|26663347|P2|Overall Study|Non-compliance with protocol|1
7665156|NCT01396005|26663348|P1|Overall Study|Non-compliance with protocol|0
7665157|NCT01396005|26663347|P2|Overall Study|Withdrawal by Subject|1
7665158|NCT01396005|26663348|P1|Overall Study|Withdrawal by Subject|0
7665159|NCT01395914|26663379|P2|Overall Study|Lost to Follow-up|2
7665160|NCT01395914|26663380|P1|Overall Study|Lost to Follow-up|6
7665161|NCT01395914|26663379|P2|Overall Study|Study drug-related AE|0
7665162|NCT01395914|26663380|P1|Overall Study|Study drug-related AE|1
7665163|NCT01395914|26663379|P2|Overall Study|Withdrawal by patient|14
7665164|NCT01395914|26663380|P1|Overall Study|Withdrawal by patient|27
7665165|NCT01395914|26663379|P2|Overall Study|Other|3
7665166|NCT01395914|26663380|P1|Overall Study|Other|9
7665167|NCT01395914|26663379|P2|Overall Study|Death|17
7665168|NCT01395914|26663380|P1|Overall Study|Death|23
7665169|NCT01395914|26663379|P2|Overall Study|Unrelated to study drug AE|1
7665170|NCT01395914|26663380|P1|Overall Study|Unrelated to study drug AE|6
7665171|NCT01395901|26663394|P2|Overall Study|Withdrawal of consent|0
7665172|NCT01395901|26663395|P1|Overall Study|Withdrawal of consent|1
7665173|NCT01395901|26663394|P2|Overall Study|Adverse Event|1
7665174|NCT01395901|26663395|P1|Overall Study|Adverse Event|0
7665175|NCT01395901|26663394|P2|Overall Study|Randomized but not received study drug|4
7665176|NCT01395901|26663395|P1|Overall Study|Randomized but not received study drug|5
7665177|NCT01395901|26663394|P2|Overall Study|Lost to Follow-up|0
7665178|NCT01395901|26663395|P1|Overall Study|Lost to Follow-up|4
7665179|NCT01395888|26663411|P3|Treatment Period (TP)|Withdrawal by Subject|3
7665180|NCT01395888|26663412|P2|Treatment Period (TP)|Withdrawal by Subject|2
7665181|NCT01395888|26663413|P1|Treatment Period (TP)|Withdrawal by Subject|0
7665182|NCT01395888|26663411|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7665183|NCT01395888|26663412|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
7665184|NCT01395888|26663413|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7665185|NCT01395888|26663411|P3|Treatment Period (TP)|Protocol Violation|5
7665186|NCT01395888|26663412|P2|Treatment Period (TP)|Protocol Violation|1
7665187|NCT01395888|26663413|P1|Treatment Period (TP)|Protocol Violation|0
7665188|NCT01395888|26663411|P3|Treatment Period (TP)|Lack of Efficacy|3
7665189|NCT01395888|26663412|P2|Treatment Period (TP)|Lack of Efficacy|4
7665190|NCT01395888|26663413|P1|Treatment Period (TP)|Lack of Efficacy|0
7665191|NCT01395888|26663411|P3|Treatment Period (TP)|Adverse Event|6
7665192|NCT01395888|26663412|P2|Treatment Period (TP)|Adverse Event|7
7665193|NCT01395888|26663413|P1|Treatment Period (TP)|Adverse Event|0
7665194|NCT01395888|26663411|P3|2-week Run-in Period|Withdrawal by Subject|0
7665195|NCT01395888|26663412|P2|2-week Run-in Period|Withdrawal by Subject|0
7665196|NCT01395888|26663413|P1|2-week Run-in Period|Withdrawal by Subject|4
7665197|NCT01395888|26663411|P3|2-week Run-in Period|Protocol Violation|0
7665198|NCT01395888|26663412|P2|2-week Run-in Period|Protocol Violation|0
7665199|NCT01395888|26663413|P1|2-week Run-in Period|Protocol Violation|2
7665200|NCT01395888|26663411|P3|2-week Run-in Period|Lost to Follow-up|0
7665201|NCT01395888|26663412|P2|2-week Run-in Period|Lost to Follow-up|0
7665202|NCT01395888|26663413|P1|2-week Run-in Period|Lost to Follow-up|1
7665203|NCT01395888|26663411|P3|2-week Run-in Period|Continuation Criteria Not Met|0
7665204|NCT01395888|26663412|P2|2-week Run-in Period|Continuation Criteria Not Met|0
7665205|NCT01395888|26663413|P1|2-week Run-in Period|Continuation Criteria Not Met|13
7665206|NCT01395888|26663411|P3|2-week Run-in Period|Adverse Event|0
7665207|NCT01395888|26663412|P2|2-week Run-in Period|Adverse Event|0
7665208|NCT01395888|26663413|P1|2-week Run-in Period|Adverse Event|2
7665209|NCT01395823|26663421|P2|Overall Study|Withdrawal by Subject|4
7665210|NCT01395823|26663422|P1|Overall Study|Withdrawal by Subject|5
7665211|NCT01395823|26663421|P2|Overall Study|GI symptoms|0
7665212|NCT01395823|26663422|P1|Overall Study|GI symptoms|1
7665213|NCT01395823|26663421|P2|Overall Study|Transplant|0
7665214|NCT01395823|26663422|P1|Overall Study|Transplant|1
7665215|NCT01395823|26663421|P2|Overall Study|Lost to Follow-up|0
7665216|NCT01395823|26663422|P1|Overall Study|Lost to Follow-up|1
7665217|NCT01395823|26663421|P2|Overall Study|Physician Decision|1
7665218|NCT01395823|26663422|P1|Overall Study|Physician Decision|3
7665219|NCT01395823|26663421|P2|Overall Study|Death|4
7665220|NCT01395823|26663422|P1|Overall Study|Death|4
7665221|NCT01395810|26663432|P4|Overall Study|Unclassified|0
7665222|NCT01395810|26663433|P3|Overall Study|Unclassified|0
7665223|NCT01395810|26663434|P2|Overall Study|Unclassified|0
7665224|NCT01395810|26663435|P1|Overall Study|Unclassified|2
7665225|NCT01395810|26663432|P4|Overall Study|Withdrawal criteria|0
7665226|NCT01395810|26663433|P3|Overall Study|Withdrawal criteria|0
7665227|NCT01395810|26663434|P2|Overall Study|Withdrawal criteria|2
7665228|NCT01395810|26663435|P1|Overall Study|Withdrawal criteria|0
7665229|NCT01395810|26663432|P4|Overall Study|Lack of Efficacy|0
7665230|NCT01395810|26663433|P3|Overall Study|Lack of Efficacy|0
7665231|NCT01395810|26663434|P2|Overall Study|Lack of Efficacy|1
7665232|NCT01395810|26663435|P1|Overall Study|Lack of Efficacy|0
7665233|NCT01395810|26663432|P4|Overall Study|Adverse Event|0
7665234|NCT01395810|26663433|P3|Overall Study|Adverse Event|0
7665235|NCT01395810|26663434|P2|Overall Study|Adverse Event|1
7665236|NCT01395810|26663435|P1|Overall Study|Adverse Event|0
7665237|NCT01395784|26663494|P1|Overall Study|Physician Decision|5
7665238|NCT01395784|26663494|P1|Overall Study|Withdrawal by Subject|3
7665239|NCT01395784|26663494|P1|Overall Study|Lost to Follow-up|7
7665240|NCT01395758|26663501|P3|Open-label Treatment Period|Withdrawal by Subject|0
7665241|NCT01395758|26663502|P2|Open-label Treatment Period|Withdrawal by Subject|0
7665242|NCT01395758|26663503|P1|Open-label Treatment Period|Withdrawal by Subject|4
7665243|NCT01395524|26663523|P3|Overall Study|Subject had spinal surgery|1
7665244|NCT01395524|26663524|P2|Overall Study|Subject had spinal surgery|0
7665245|NCT01395524|26663525|P1|Overall Study|Subject had spinal surgery|0
7665246|NCT01395524|26663523|P3|Overall Study|Did not receive treatment|3
7665247|NCT01395524|26663524|P2|Overall Study|Did not receive treatment|1
7665248|NCT01395524|26663525|P1|Overall Study|Did not receive treatment|1
7665249|NCT01395524|26663523|P3|Overall Study|Withdrawal by Subject|8
7665250|NCT01395524|26663524|P2|Overall Study|Withdrawal by Subject|8
7665251|NCT01395524|26663525|P1|Overall Study|Withdrawal by Subject|4
7665252|NCT01395524|26663523|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
7665253|NCT01395524|26663524|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
7665254|NCT01395524|26663525|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
7665255|NCT01395524|26663523|P3|Overall Study|Death|0
7665256|NCT01395524|26663524|P2|Overall Study|Death|0
7665257|NCT01395524|26663525|P1|Overall Study|Death|1
7665258|NCT01395524|26663523|P3|Overall Study|Adverse Event|3
7665259|NCT01395524|26663524|P2|Overall Study|Adverse Event|4
7665260|NCT01395524|26663525|P1|Overall Study|Adverse Event|4
7665261|NCT01395524|26663523|P3|Overall Study|Severe noncompliance with protocol|0
7665262|NCT01395524|26663524|P2|Overall Study|Severe noncompliance with protocol|0
7665263|NCT01395524|26663525|P1|Overall Study|Severe noncompliance with protocol|1
7665264|NCT01395524|26663523|P3|Overall Study|Study-Specific Withdrawal Criteria|0
7665265|NCT01395524|26663524|P2|Overall Study|Study-Specific Withdrawal Criteria|2
7665266|NCT01395524|26663525|P1|Overall Study|Study-Specific Withdrawal Criteria|1
7665267|NCT01395524|26663523|P3|Overall Study|Lost to Follow-up|1
7665268|NCT01395524|26663524|P2|Overall Study|Lost to Follow-up|1
7665269|NCT01395524|26663525|P1|Overall Study|Lost to Follow-up|3
7665270|NCT01395524|26663523|P3|Overall Study|Non-compliance with study schedule|1
7665271|NCT01395524|26663524|P2|Overall Study|Non-compliance with study schedule|0
7665272|NCT01395524|26663525|P1|Overall Study|Non-compliance with study schedule|1
7665273|NCT01395394|26663548|P3|Baseline Study Visit|Protocol Violation|0
7665274|NCT01395394|26663549|P2|Baseline Study Visit|Protocol Violation|0
7665275|NCT01395394|26663550|P1|Baseline Study Visit|Protocol Violation|1
7665276|NCT01395368|26663561|P1|Overall Study|Withdrawal by Subject|2
7665277|NCT01395368|26663561|P1|Overall Study|Physician Decision|14
7665278|NCT01395316|26663617|P1|Overall Study|poor MRI quality|1
7665279|NCT01395316|26663617|P1|Overall Study|Lost to Follow-up|2
7665280|NCT01395030|26663637|P1|Overall Study|Did not complete FCH PET/CT|7
7665281|NCT01395017|26663647|P2|Overall Study|Sponsor discontinued study|4
7665282|NCT01395017|26663648|P1|Overall Study|Sponsor discontinued study|1
7665283|NCT01395017|26663647|P2|Overall Study|Disease progression|58
7665284|NCT01395017|26663648|P1|Overall Study|Disease progression|42
7665285|NCT01395017|26663647|P2|Overall Study|Death|3
7665286|NCT01395017|26663648|P1|Overall Study|Death|4
7665287|NCT01395017|26663647|P2|Overall Study|Protocol deviation|2
7665288|NCT01395017|26663648|P1|Overall Study|Protocol deviation|1
7665289|NCT01395017|26663647|P2|Overall Study|Withdrawal by Subject|8
7665290|NCT01395017|26663648|P1|Overall Study|Withdrawal by Subject|14
7665291|NCT01395017|26663647|P2|Overall Study|Physician Decision|15
7665292|NCT01395017|26663648|P1|Overall Study|Physician Decision|11
7665293|NCT01395017|26663647|P2|Overall Study|Adverse Event|12
7665294|NCT01395017|26663648|P1|Overall Study|Adverse Event|26
7665295|NCT01395017|26663647|P2|Overall Study|Lost to Follow-up|0
7665296|NCT01395017|26663648|P1|Overall Study|Lost to Follow-up|1
7665297|NCT01394991|26663658|P2|Overall Study|Prematurely Termination of Trial|10
7665298|NCT01394991|26663659|P1|Overall Study|Prematurely Termination of Trial|9
7665299|NCT01394991|26663658|P2|Overall Study|Disease Progression|7
7665300|NCT01394991|26663659|P1|Overall Study|Disease Progression|7
7665301|NCT01394991|26663658|P2|Overall Study|Chemotherapy Termination|15
7665302|NCT01394991|26663659|P1|Overall Study|Chemotherapy Termination|10
7665303|NCT01394991|26663658|P2|Overall Study|Withdrawal by Subject|17
7665304|NCT01394991|26663659|P1|Overall Study|Withdrawal by Subject|20
7665305|NCT01394991|26663658|P2|Overall Study|Protocol Violation|1
7665306|NCT01394991|26663659|P1|Overall Study|Protocol Violation|1
7665307|NCT01394991|26663658|P2|Overall Study|Physician Decision|3
7665308|NCT01394991|26663659|P1|Overall Study|Physician Decision|1
7665309|NCT01394991|26663658|P2|Overall Study|Lost to Follow-up|8
7665310|NCT01394991|26663659|P1|Overall Study|Lost to Follow-up|6
7665311|NCT01394991|26663658|P2|Overall Study|Lack of Efficacy|7
7665312|NCT01394991|26663659|P1|Overall Study|Lack of Efficacy|5
7665313|NCT01394991|26663658|P2|Overall Study|Adverse Event|4
7665314|NCT01394991|26663659|P1|Overall Study|Adverse Event|0
7665315|NCT01394978|26663682|P2|Overall Study|Death|7
7665316|NCT01394978|26663683|P1|Overall Study|Death|6
7665317|NCT01394978|26663682|P2|Overall Study|Lost to Follow-up|20
7665318|NCT01394978|26663683|P1|Overall Study|Lost to Follow-up|13
7665319|NCT01394978|26663682|P2|Overall Study|Withdrawal by Subject|4
7665320|NCT01394978|26663683|P1|Overall Study|Withdrawal by Subject|2
7665321|NCT01394952|26663692|P2|Overall Study|Sponsor Decision|7
7665322|NCT01394952|26663693|P1|Overall Study|Sponsor Decision|5
7665323|NCT01394952|26663692|P2|Overall Study|Physician Decision|0
7665324|NCT01394952|26663693|P1|Overall Study|Physician Decision|2
7665325|NCT01394952|26663692|P2|Overall Study|Withdrawal by Subject|5
7665326|NCT01394952|26663693|P1|Overall Study|Withdrawal by Subject|10
7665327|NCT01394952|26663692|P2|Overall Study|Lost to Follow-up|5
7665328|NCT01394952|26663693|P1|Overall Study|Lost to Follow-up|0
7665329|NCT01394939|26663713|P4|Overall Study|Others|3
7665330|NCT01394939|26663714|P3|Overall Study|Others|0
7665331|NCT01394939|26663715|P2|Overall Study|Others|2
7665332|NCT01394939|26663716|P1|Overall Study|Others|0
7665333|NCT01394939|26663713|P4|Overall Study|Withdrawal by Subject|2
7665334|NCT01394939|26663714|P3|Overall Study|Withdrawal by Subject|0
7665335|NCT01394939|26663715|P2|Overall Study|Withdrawal by Subject|2
7665336|NCT01394939|26663716|P1|Overall Study|Withdrawal by Subject|0
7665337|NCT01394939|26663713|P4|Overall Study|Physician Decision|0
7665338|NCT01394939|26663714|P3|Overall Study|Physician Decision|0
7665339|NCT01394939|26663715|P2|Overall Study|Physician Decision|1
7665340|NCT01394939|26663716|P1|Overall Study|Physician Decision|0
7665341|NCT01394939|26663713|P4|Overall Study|Death|0
7665342|NCT01394939|26663714|P3|Overall Study|Death|0
7665343|NCT01394939|26663715|P2|Overall Study|Death|2
7665344|NCT01394939|26663716|P1|Overall Study|Death|0
7665345|NCT01394939|26663713|P4|Overall Study|Adverse Event|2
7665346|NCT01394939|26663714|P3|Overall Study|Adverse Event|0
7665347|NCT01394939|26663715|P2|Overall Study|Adverse Event|3
7665348|NCT01394939|26663716|P1|Overall Study|Adverse Event|1
7665349|NCT01394718|26663737|P2|Overall Study|Met protocol-specific stopping criteria|1
7665350|NCT01394718|26663738|P1|Overall Study|Met protocol-specific stopping criteria|2
7665351|NCT01394627|26663770|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
7665352|NCT01394627|26663771|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
7665353|NCT01394627|26663770|P2|First Intervention (1 Day)|poor intravenous access|1
7665354|NCT01394627|26663771|P1|First Intervention (1 Day)|poor intravenous access|0
7665355|NCT01394523|26663791|P3|Overall Study|Unable to place block|0
7665356|NCT01394523|26663792|P2|Overall Study|Unable to place block|0
7665357|NCT01394523|26663793|P1|Overall Study|Unable to place block|1
7665358|NCT01394276|26663807|P1|Overall Study|Symptoms of concurrent diseases|1
7665359|NCT01394276|26663807|P1|Overall Study|unavailability of drug at the Hospital|2
7665360|NCT01394276|26663807|P1|Overall Study|Pregnancy|1
7665361|NCT01394276|26663807|P1|Overall Study|Participant moved to another site|1
7665362|NCT01394276|26663807|P1|Overall Study|Lost to Follow-up|5
7665363|NCT01394276|26663807|P1|Overall Study|Insufficient compliance|9
7665364|NCT01394276|26663807|P1|Overall Study|Insufficient therapeutic effect|17
7665365|NCT01394276|26663807|P1|Overall Study|Remission of disease|2
7665366|NCT01394276|26663807|P1|Overall Study|Not related AEs|9
7665367|NCT01394276|26663807|P1|Overall Study|Related Adverse event (AEs)|15
7665368|NCT01394250|26663831|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
7665369|NCT01394250|26663832|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
7665370|NCT01394250|26663831|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
7665371|NCT01394250|26663832|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
7665372|NCT01394185|26663846|P6|Overall Study|Protocol Violation|1
7665373|NCT01394185|26663847|P5|Overall Study|Protocol Violation|0
7665374|NCT01394185|26663848|P4|Overall Study|Protocol Violation|1
7665375|NCT01394185|26663849|P3|Overall Study|Protocol Violation|0
7665376|NCT01394185|26663850|P2|Overall Study|Protocol Violation|0
7665377|NCT01394185|26663851|P1|Overall Study|Protocol Violation|1
7665378|NCT01394185|26663846|P6|Overall Study|Change in protocol|0
7665379|NCT01394185|26663847|P5|Overall Study|Change in protocol|3
7665380|NCT01394185|26663848|P4|Overall Study|Change in protocol|0
7665381|NCT01394185|26663849|P3|Overall Study|Change in protocol|0
7665382|NCT01394185|26663850|P2|Overall Study|Change in protocol|0
7665383|NCT01394185|26663851|P1|Overall Study|Change in protocol|3
7665384|NCT01394185|26663846|P6|Overall Study|Withdrawal by Subject|0
7665385|NCT01394185|26663847|P5|Overall Study|Withdrawal by Subject|1
7665386|NCT01394185|26663848|P4|Overall Study|Withdrawal by Subject|0
7665387|NCT01394185|26663849|P3|Overall Study|Withdrawal by Subject|0
7665388|NCT01394185|26663850|P2|Overall Study|Withdrawal by Subject|0
7665389|NCT01394185|26663851|P1|Overall Study|Withdrawal by Subject|2
7665390|NCT01393990|26663955|P18|Overall Study|Withdrawal by Subject|0
7665391|NCT01393990|26663956|P17|Overall Study|Withdrawal by Subject|0
7665392|NCT01393990|26663957|P16|Overall Study|Withdrawal by Subject|1
7665393|NCT01393990|26663958|P15|Overall Study|Withdrawal by Subject|1
7665394|NCT01393990|26663959|P14|Overall Study|Withdrawal by Subject|0
7665395|NCT01393990|26663960|P13|Overall Study|Withdrawal by Subject|0
7665396|NCT01393990|26663961|P12|Overall Study|Withdrawal by Subject|0
7665397|NCT01393990|26663962|P11|Overall Study|Withdrawal by Subject|0
7665398|NCT01393990|26663963|P10|Overall Study|Withdrawal by Subject|0
7665399|NCT01393990|26663964|P9|Overall Study|Withdrawal by Subject|0
7665400|NCT01393990|26663965|P8|Overall Study|Withdrawal by Subject|0
7665401|NCT01393990|26663966|P7|Overall Study|Withdrawal by Subject|0
7665402|NCT01393990|26663967|P6|Overall Study|Withdrawal by Subject|0
7665403|NCT01393990|26663968|P5|Overall Study|Withdrawal by Subject|0
7665404|NCT01393990|26663969|P4|Overall Study|Withdrawal by Subject|0
7665405|NCT01393990|26663970|P3|Overall Study|Withdrawal by Subject|0
7665406|NCT01393990|26663971|P2|Overall Study|Withdrawal by Subject|0
7665407|NCT01393990|26663972|P1|Overall Study|Withdrawal by Subject|0
7665408|NCT01393990|26663955|P18|Overall Study|Death|0
7665409|NCT01393990|26663956|P17|Overall Study|Death|0
7665410|NCT01393990|26663957|P16|Overall Study|Death|0
7665411|NCT01393990|26663958|P15|Overall Study|Death|1
7665412|NCT01393990|26663959|P14|Overall Study|Death|1
7665413|NCT01393990|26663960|P13|Overall Study|Death|0
7665414|NCT01393990|26663961|P12|Overall Study|Death|0
7665415|NCT01393990|26663962|P11|Overall Study|Death|0
7665416|NCT01393990|26663963|P10|Overall Study|Death|0
7665417|NCT01393990|26663964|P9|Overall Study|Death|0
7665418|NCT01393990|26663965|P8|Overall Study|Death|0
7665419|NCT01393990|26663966|P7|Overall Study|Death|0
7665420|NCT01393990|26663967|P6|Overall Study|Death|0
7665421|NCT01393990|26663968|P5|Overall Study|Death|1
7665422|NCT01393990|26663969|P4|Overall Study|Death|0
7665423|NCT01393990|26663970|P3|Overall Study|Death|0
7665424|NCT01393990|26663971|P2|Overall Study|Death|0
7665425|NCT01393990|26663972|P1|Overall Study|Death|0
7665426|NCT01393990|26663955|P18|Overall Study|Progressive Disease|0
7665427|NCT01393990|26663956|P17|Overall Study|Progressive Disease|0
7665428|NCT01393990|26663957|P16|Overall Study|Progressive Disease|1
7665429|NCT01393990|26663958|P15|Overall Study|Progressive Disease|6
7665430|NCT01393990|26663959|P14|Overall Study|Progressive Disease|1
7665431|NCT01393990|26663960|P13|Overall Study|Progressive Disease|0
7665432|NCT01393990|26663961|P12|Overall Study|Progressive Disease|0
7665433|NCT01393990|26663962|P11|Overall Study|Progressive Disease|0
7665434|NCT01393990|26663963|P10|Overall Study|Progressive Disease|1
7665435|NCT01393990|26663964|P9|Overall Study|Progressive Disease|3
7665436|NCT01393990|26663965|P8|Overall Study|Progressive Disease|1
7665437|NCT01393990|26663966|P7|Overall Study|Progressive Disease|1
7665438|NCT01393990|26663967|P6|Overall Study|Progressive Disease|1
7665439|NCT01393990|26663968|P5|Overall Study|Progressive Disease|1
7665440|NCT01393990|26663969|P4|Overall Study|Progressive Disease|1
7665441|NCT01393990|26663970|P3|Overall Study|Progressive Disease|0
7665442|NCT01393990|26663971|P2|Overall Study|Progressive Disease|0
7665443|NCT01393990|26663972|P1|Overall Study|Progressive Disease|1
7665444|NCT01393990|26663955|P18|Overall Study|Adverse Event|0
7665445|NCT01393990|26663956|P17|Overall Study|Adverse Event|0
7665446|NCT01393990|26663957|P16|Overall Study|Adverse Event|1
7665447|NCT01393990|26663958|P15|Overall Study|Adverse Event|1
7665448|NCT01393990|26663959|P14|Overall Study|Adverse Event|0
7665449|NCT01393990|26663960|P13|Overall Study|Adverse Event|0
7665450|NCT01393990|26663961|P12|Overall Study|Adverse Event|0
7665451|NCT01393990|26663962|P11|Overall Study|Adverse Event|0
7665452|NCT01393990|26663963|P10|Overall Study|Adverse Event|0
7665453|NCT01393990|26663964|P9|Overall Study|Adverse Event|0
7665454|NCT01393990|26663965|P8|Overall Study|Adverse Event|0
7665455|NCT01393990|26663966|P7|Overall Study|Adverse Event|0
7665456|NCT01393990|26663967|P6|Overall Study|Adverse Event|0
7665457|NCT01393990|26663968|P5|Overall Study|Adverse Event|0
7665458|NCT01393990|26663969|P4|Overall Study|Adverse Event|0
7665459|NCT01393990|26663970|P3|Overall Study|Adverse Event|0
7665460|NCT01393990|26663971|P2|Overall Study|Adverse Event|0
7665461|NCT01393990|26663972|P1|Overall Study|Adverse Event|0
7665462|NCT01393964|26664063|P3|Overall Study|Subject to receive non-protocol therapy|1
7665463|NCT01393964|26664064|P2|Overall Study|Subject to receive non-protocol therapy|0
7665464|NCT01393964|26664065|P1|Overall Study|Subject to receive non-protocol therapy|0
7665465|NCT01393964|26664063|P3|Overall Study|Subject converted to roll-over study|0
7665466|NCT01393964|26664064|P2|Overall Study|Subject converted to roll-over study|1
7665467|NCT01393964|26664065|P1|Overall Study|Subject converted to roll-over study|0
7665468|NCT01393964|26664063|P3|Overall Study|Investigator removed subject from study|0
7665469|NCT01393964|26664064|P2|Overall Study|Investigator removed subject from study|1
7665470|NCT01393964|26664065|P1|Overall Study|Investigator removed subject from study|0
7665471|NCT01393964|26664063|P3|Overall Study|Subject plateaued in terms of effect|0
7665472|NCT01393964|26664064|P2|Overall Study|Subject plateaued in terms of effect|0
7665473|NCT01393964|26664065|P1|Overall Study|Subject plateaued in terms of effect|1
7665474|NCT01393964|26664063|P3|Overall Study|Subject switched to commercial supply|2
7665475|NCT01393964|26664064|P2|Overall Study|Subject switched to commercial supply|0
7665476|NCT01393964|26664065|P1|Overall Study|Subject switched to commercial supply|1
7665477|NCT01393964|26664063|P3|Overall Study|Subject decided to move to transplant|0
7665478|NCT01393964|26664064|P2|Overall Study|Subject decided to move to transplant|0
7665479|NCT01393964|26664065|P1|Overall Study|Subject decided to move to transplant|1
7665480|NCT01393964|26664063|P3|Overall Study|Subject request stop study treatment|0
7665481|NCT01393964|26664064|P2|Overall Study|Subject request stop study treatment|1
7665482|NCT01393964|26664065|P1|Overall Study|Subject request stop study treatment|0
7665483|NCT01393964|26664063|P3|Overall Study|Adverse event unrelated to study drug|0
7665484|NCT01393964|26664064|P2|Overall Study|Adverse event unrelated to study drug|3
7665485|NCT01393964|26664065|P1|Overall Study|Adverse event unrelated to study drug|0
7665486|NCT01393964|26664063|P3|Overall Study|Withdrawal by Subject|1
7665487|NCT01393964|26664064|P2|Overall Study|Withdrawal by Subject|0
7665488|NCT01393964|26664065|P1|Overall Study|Withdrawal by Subject|0
7665489|NCT01393964|26664063|P3|Overall Study|Study drug toxicity|0
7665490|NCT01393964|26664064|P2|Overall Study|Study drug toxicity|0
7665491|NCT01393964|26664065|P1|Overall Study|Study drug toxicity|1
7665492|NCT01393964|26664063|P3|Overall Study|Disease Progression|5
7665493|NCT01393964|26664064|P2|Overall Study|Disease Progression|3
7665494|NCT01393964|26664065|P1|Overall Study|Disease Progression|4
7665495|NCT01393899|26664106|P3|Overall Study|Adverse Event|3
7665496|NCT01393899|26664107|P2|Overall Study|Adverse Event|5
7665497|NCT01393899|26664108|P1|Overall Study|Adverse Event|1
7665498|NCT01393899|26664106|P3|Overall Study|Lack of Efficacy|16
7665499|NCT01393899|26664107|P2|Overall Study|Lack of Efficacy|21
7665500|NCT01393899|26664108|P1|Overall Study|Lack of Efficacy|26
7665501|NCT01393899|26664106|P3|Overall Study|Does not meet entrance criteria|1
7665502|NCT01393899|26664107|P2|Overall Study|Does not meet entrance criteria|0
7665503|NCT01393899|26664108|P1|Overall Study|Does not meet entrance criteria|1
7665504|NCT01393899|26664106|P3|Overall Study|Lost to Follow-up|1
7665505|NCT01393899|26664107|P2|Overall Study|Lost to Follow-up|0
7665506|NCT01393899|26664108|P1|Overall Study|Lost to Follow-up|0
7665507|NCT01393899|26664106|P3|Overall Study|Withdrawal by Subject|1
7665508|NCT01393899|26664107|P2|Overall Study|Withdrawal by Subject|2
7665509|NCT01393899|26664108|P1|Overall Study|Withdrawal by Subject|2
7665510|NCT01393899|26664106|P3|Overall Study|Other|0
7665511|NCT01393899|26664107|P2|Overall Study|Other|0
7665512|NCT01393899|26664108|P1|Overall Study|Other|1
7665513|NCT01393899|26664106|P3|Overall Study|Study terminated by sponsor|1
7665514|NCT01393899|26664107|P2|Overall Study|Study terminated by sponsor|0
7665515|NCT01393899|26664108|P1|Overall Study|Study terminated by sponsor|1
7665520|NCT01393743|26664177|P3|Extension Phase|Other|14
7665521|NCT01393743|26664178|P2|Extension Phase|Other|0
7665522|NCT01393743|26664179|P1|Extension Phase|Other|0
7665523|NCT01393743|26664177|P3|Extension Phase|Pregnancy|1
7665524|NCT01393743|26664178|P2|Extension Phase|Pregnancy|0
7665525|NCT01393743|26664179|P1|Extension Phase|Pregnancy|0
7665526|NCT01393743|26664177|P3|Extension Phase|Withdrawal by Subject|8
7665527|NCT01393743|26664178|P2|Extension Phase|Withdrawal by Subject|0
7665528|NCT01393743|26664179|P1|Extension Phase|Withdrawal by Subject|0
7665529|NCT01393743|26664177|P3|Extension Phase|Inadequate therapeutic effect|7
7665530|NCT01393743|26664178|P2|Extension Phase|Inadequate therapeutic effect|0
7665531|NCT01393743|26664179|P1|Extension Phase|Inadequate therapeutic effect|0
7665532|NCT01393743|26664177|P3|Extension Phase|Participant choice|16
7665533|NCT01393743|26664178|P2|Extension Phase|Participant choice|0
7665534|NCT01393743|26664179|P1|Extension Phase|Participant choice|0
7665535|NCT01393743|26664177|P3|Extension Phase|Lost to Follow-up|2
7665536|NCT01393743|26664178|P2|Extension Phase|Lost to Follow-up|0
7665537|NCT01393743|26664179|P1|Extension Phase|Lost to Follow-up|0
7665538|NCT01393743|26664177|P3|Extension Phase|Adverse Event|12
7665539|NCT01393743|26664178|P2|Extension Phase|Adverse Event|0
7665540|NCT01393743|26664179|P1|Extension Phase|Adverse Event|0
7665541|NCT01393743|26664177|P3|Core Study|Inadequate therapeutic effect|0
7665542|NCT01393743|26664178|P2|Core Study|Inadequate therapeutic effect|0
7665543|NCT01393743|26664179|P1|Core Study|Inadequate therapeutic effect|2
7665544|NCT01393743|26664177|P3|Core Study|Participant's Choice|0
7665545|NCT01393743|26664178|P2|Core Study|Participant's Choice|3
7665546|NCT01393743|26664179|P1|Core Study|Participant's Choice|2
7665547|NCT01393743|26664177|P3|Core Study|Lost to Follow-up|0
7665548|NCT01393743|26664178|P2|Core Study|Lost to Follow-up|1
7665549|NCT01393743|26664179|P1|Core Study|Lost to Follow-up|1
7665550|NCT01393743|26664177|P3|Core Study|Adverse Event|0
7665551|NCT01393743|26664178|P2|Core Study|Adverse Event|9
7665552|NCT01393743|26664179|P1|Core Study|Adverse Event|5
7665553|NCT01393730|26664202|P1|Overall Study|Adverse Event|1
7665554|NCT01393730|26664202|P1|Overall Study|Other|2
7665555|NCT01393730|26664202|P1|Overall Study|Withdrawal by Subject|3
7665556|NCT01393626|26664248|P4|Overall Study|Protocol Violation|0
7665557|NCT01393626|26664249|P3|Overall Study|Protocol Violation|2
7665558|NCT01393626|26664250|P2|Overall Study|Protocol Violation|0
7665559|NCT01393626|26664251|P1|Overall Study|Protocol Violation|1
7665560|NCT01393626|26664248|P4|Overall Study|Other|0
7665561|NCT01393626|26664249|P3|Overall Study|Other|0
7665562|NCT01393626|26664250|P2|Overall Study|Other|0
7665563|NCT01393626|26664251|P1|Overall Study|Other|1
7665564|NCT01393626|26664248|P4|Overall Study|Withdrawal by Subject|0
7665565|NCT01393626|26664249|P3|Overall Study|Withdrawal by Subject|0
7665566|NCT01393626|26664250|P2|Overall Study|Withdrawal by Subject|4
7665567|NCT01393626|26664251|P1|Overall Study|Withdrawal by Subject|6
7665568|NCT01393626|26664248|P4|Overall Study|Lost to Follow-up|0
7665569|NCT01393626|26664249|P3|Overall Study|Lost to Follow-up|1
7665570|NCT01393626|26664250|P2|Overall Study|Lost to Follow-up|1
7665571|NCT01393626|26664251|P1|Overall Study|Lost to Follow-up|1
7665572|NCT01393626|26664248|P4|Overall Study|Lack of Efficacy|1
7665573|NCT01393626|26664249|P3|Overall Study|Lack of Efficacy|4
7665574|NCT01393626|26664250|P2|Overall Study|Lack of Efficacy|6
7665575|NCT01393626|26664251|P1|Overall Study|Lack of Efficacy|6
7665576|NCT01393626|26664248|P4|Overall Study|Did not meet entrance criteria|0
7665577|NCT01393626|26664249|P3|Overall Study|Did not meet entrance criteria|0
7665578|NCT01393626|26664250|P2|Overall Study|Did not meet entrance criteria|0
7665579|NCT01393626|26664251|P1|Overall Study|Did not meet entrance criteria|1
7665580|NCT01393626|26664248|P4|Overall Study|Adverse Event|0
7665581|NCT01393626|26664249|P3|Overall Study|Adverse Event|5
7665582|NCT01393626|26664250|P2|Overall Study|Adverse Event|1
7665583|NCT01393626|26664251|P1|Overall Study|Adverse Event|2
7665584|NCT01393613|26664331|P4|Overall Study|Lack of Efficacy|21
7665585|NCT01393613|26664332|P3|Overall Study|Lack of Efficacy|16
7665586|NCT01393613|26664333|P2|Overall Study|Lack of Efficacy|20
7665587|NCT01393613|26664334|P1|Overall Study|Lack of Efficacy|9
7665588|NCT01393613|26664331|P4|Overall Study|Protocol Deviation|0
7665589|NCT01393613|26664332|P3|Overall Study|Protocol Deviation|0
7665590|NCT01393613|26664333|P2|Overall Study|Protocol Deviation|1
7665591|NCT01393613|26664334|P1|Overall Study|Protocol Deviation|2
7665592|NCT01393613|26664331|P4|Overall Study|Withdrawal by Subject|21
7665593|NCT01393613|26664332|P3|Overall Study|Withdrawal by Subject|23
7665594|NCT01393613|26664333|P2|Overall Study|Withdrawal by Subject|25
7665595|NCT01393613|26664334|P1|Overall Study|Withdrawal by Subject|15
7665596|NCT01393613|26664331|P4|Overall Study|Physician Decision|1
7665597|NCT01393613|26664332|P3|Overall Study|Physician Decision|0
7665598|NCT01393613|26664333|P2|Overall Study|Physician Decision|0
7665599|NCT01393613|26664334|P1|Overall Study|Physician Decision|2
7665600|NCT01393613|26664331|P4|Overall Study|Participant Met Withdrawal Criteria|1
7665601|NCT01393613|26664332|P3|Overall Study|Participant Met Withdrawal Criteria|2
7665602|NCT01393613|26664333|P2|Overall Study|Participant Met Withdrawal Criteria|0
7665603|NCT01393613|26664334|P1|Overall Study|Participant Met Withdrawal Criteria|0
7665604|NCT01393613|26664331|P4|Overall Study|Adverse Event|22
7665605|NCT01393613|26664332|P3|Overall Study|Adverse Event|13
7665606|NCT01393613|26664333|P2|Overall Study|Adverse Event|11
7665607|NCT01393613|26664334|P1|Overall Study|Adverse Event|11
7665608|NCT01393600|26664396|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7665609|NCT01393600|26664397|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
7665610|NCT01393600|26664398|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7665611|NCT01393600|26664399|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7665612|NCT01393600|26664396|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7665613|NCT01393600|26664397|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
7665614|NCT01393600|26664398|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7665615|NCT01393600|26664399|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7665616|NCT01393600|26664396|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7665617|NCT01393600|26664397|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
7665618|NCT01393600|26664398|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7665619|NCT01393600|26664399|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7665620|NCT01393600|26664396|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
7665621|NCT01393600|26664397|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7665622|NCT01393600|26664398|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7665623|NCT01393600|26664399|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7665624|NCT01393600|26664396|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
7665625|NCT01393600|26664397|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7665626|NCT01393600|26664398|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7665627|NCT01393600|26664399|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7665628|NCT01393600|26664396|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7665629|NCT01393600|26664397|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
7665630|NCT01393600|26664398|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7665631|NCT01393600|26664399|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7665632|NCT01393600|26664396|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7665633|NCT01393600|26664397|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7665634|NCT01393600|26664398|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
7665635|NCT01393600|26664399|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7665636|NCT01393444|26664435|P1|Overall Study|Determined ineligible during screening.|2
7665637|NCT01393444|26664435|P1|Overall Study|Withdrawal by Subject|1
7665638|NCT01393405|26664440|P3|Maintenance Period Week|Lost to Follow-up|0
7665639|NCT01393405|26664441|P2|Maintenance Period Week|Lost to Follow-up|1
7665640|NCT01393405|26664442|P1|Maintenance Period Week|Lost to Follow-up|0
7665641|NCT01393405|26664440|P3|Maintenance Period Week|Withdrawal by Subject|0
7665642|NCT01393405|26664441|P2|Maintenance Period Week|Withdrawal by Subject|1
7665643|NCT01393405|26664442|P1|Maintenance Period Week|Withdrawal by Subject|0
7665644|NCT01393405|26664440|P3|Maintenance Period Week|Adverse Event|2
7665645|NCT01393405|26664441|P2|Maintenance Period Week|Adverse Event|5
7665646|NCT01393405|26664442|P1|Maintenance Period Week|Adverse Event|0
7665647|NCT01393405|26664440|P3|Maintenance Period Week|Lack of Efficacy|22
7665648|NCT01393405|26664441|P2|Maintenance Period Week|Lack of Efficacy|22
7665649|NCT01393405|26664442|P1|Maintenance Period Week|Lack of Efficacy|0
7665650|NCT01393405|26664440|P3|Induction Period (week1-16)|Withdrawal by Subject|0
7665651|NCT01393405|26664441|P2|Induction Period (week1-16)|Withdrawal by Subject|0
7665652|NCT01393405|26664442|P1|Induction Period (week1-16)|Withdrawal by Subject|9
7665653|NCT01393405|26664440|P3|Induction Period (week1-16)|Adverse Event|0
7665654|NCT01393405|26664441|P2|Induction Period (week1-16)|Adverse Event|0
7665655|NCT01393405|26664442|P1|Induction Period (week1-16)|Adverse Event|16
7665656|NCT01393405|26664440|P3|Induction Period (week1-16)|Lack of Efficacy|0
7665657|NCT01393405|26664441|P2|Induction Period (week1-16)|Lack of Efficacy|0
7665658|NCT01393405|26664442|P1|Induction Period (week1-16)|Lack of Efficacy|70
7665659|NCT01393301|26664480|P2|Overall Study|Completed <7 sessions (intervention)|0
7665660|NCT01393301|26664481|P1|Overall Study|Completed <7 sessions (intervention)|2
7665661|NCT01393301|26664480|P2|Overall Study|Withdrawal by Subject|0
7665662|NCT01393301|26664481|P1|Overall Study|Withdrawal by Subject|2
7665663|NCT01393301|26664480|P2|Overall Study|Lost to Follow-up|3
7665664|NCT01393301|26664481|P1|Overall Study|Lost to Follow-up|5
7665665|NCT01393158|26664494|P2|Overall Study|Adverse Event|0
7665666|NCT01393158|26664495|P1|Overall Study|Adverse Event|1
7665667|NCT01393106|26664522|P1|Overall Study|Lack of Efficacy|1
7665668|NCT01393106|26664522|P1|Overall Study|Withdrawal by Subject|1
7665669|NCT01393106|26664522|P1|Overall Study|Adverse Event|3
7665670|NCT01392963|26664549|P2|Week 24 Follow-up|Lost to Follow-up|0
7665671|NCT01392963|26664550|P1|Week 24 Follow-up|Lost to Follow-up|2
7665672|NCT01392963|26664549|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
7665673|NCT01392963|26664550|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
7665674|NCT01392963|26664549|P2|Week 0 (First Intervention)|Lost to Follow-up|1
7665675|NCT01392963|26664550|P1|Week 0 (First Intervention)|Lost to Follow-up|0
7665676|NCT01392742|26664566|P1|Overall Study|Missing information|13
7665677|NCT01392742|26664566|P1|Overall Study|Other|3
7665678|NCT01392742|26664566|P1|Overall Study|Protocol Violation|14
7665679|NCT01392742|26664566|P1|Overall Study|Adverse event/intercurrent illness|17
7665680|NCT01392742|26664566|P1|Overall Study|ITR and Protocol deviation|1
7665681|NCT01392742|26664566|P1|Overall Study|Insufficient therapeutic response (ITR)|30
7665682|NCT01392742|26664566|P1|Overall Study|Lost to Follow-up|34
7665683|NCT01392742|26664566|P1|Overall Study|No treatment/no cooperation/withdrew|12
7665684|NCT01392742|26664566|P1|Overall Study|Failure to return|35
7665685|NCT01392742|26664566|P1|Overall Study|Premature study termination|42
7665686|NCT01392677|26664612|P2|Overall Study|Other reason|2
7665687|NCT01392677|26664613|P1|Overall Study|Other reason|3
7665688|NCT01392677|26664612|P2|Overall Study|Incorrect enrollment|3
7665689|NCT01392677|26664613|P1|Overall Study|Incorrect enrollment|2
7665690|NCT01392677|26664612|P2|Overall Study|Withdrawal by Subject|2
7665691|NCT01392677|26664613|P1|Overall Study|Withdrawal by Subject|0
7665692|NCT01392677|26664612|P2|Overall Study|Adverse Event|1
7665693|NCT01392677|26664613|P1|Overall Study|Adverse Event|3
7665694|NCT01392573|26664648|P2|Overall Study|Unclassified|6
7665695|NCT01392573|26664649|P1|Overall Study|Unclassified|9
7665696|NCT01392573|26664648|P2|Overall Study|Site closure|7
7665697|NCT01392573|26664649|P1|Overall Study|Site closure|8
7665698|NCT01392573|26664648|P2|Overall Study|Withdrawal Criteria|15
7665699|NCT01392573|26664649|P1|Overall Study|Withdrawal Criteria|13
7665700|NCT01392573|26664648|P2|Overall Study|Protocol Violation|2
7665701|NCT01392573|26664649|P1|Overall Study|Protocol Violation|0
7665702|NCT01392573|26664648|P2|Overall Study|Lack of Efficacy|2
7665703|NCT01392573|26664649|P1|Overall Study|Lack of Efficacy|1
7665704|NCT01392573|26664648|P2|Overall Study|Adverse Event|3
7665705|NCT01392573|26664649|P1|Overall Study|Adverse Event|1
7665706|NCT01392560|26664657|P1|Overall Study|discontinued during placebo run-in|2
7665707|NCT01392560|26664657|P1|Overall Study|not entered|8
7665708|NCT01392560|26664657|P1|Overall Study|Adverse Event|2
7665709|NCT01392547|26664663|P1|Overall Study|Unclassified|1
7665710|NCT01392547|26664663|P1|Overall Study|Withdrawal criteria|3
7665711|NCT01392547|26664663|P1|Overall Study|Non-compliance|2
7665712|NCT01392547|26664663|P1|Overall Study|Adverse Event|2
7665713|NCT01392495|26664677|P1|Overall Study|Adverse Event|3
7665714|NCT01392495|26664677|P1|Overall Study|Withdrawal by Subject|2
7665715|NCT01392495|26664677|P1|Overall Study|Administrative problems|8
7665716|NCT01392495|26664677|P1|Overall Study|Death|3
7665717|NCT01392469|26664689|P1|Overall Study|Protocol Violation|1
7665718|NCT01392469|26664689|P1|Overall Study|Withdrawal by Subject|1
7665719|NCT01392469|26664689|P1|Overall Study|Adverse Event|2
7665720|NCT01392443|26664714|P1|Overall Study|Protocol Violation|1
7665721|NCT01392443|26664714|P1|Overall Study|Lost to Follow-up|1
7665722|NCT01392443|26664714|P1|Overall Study|Withdrawal by Subject|5
7665723|NCT01392443|26664714|P1|Overall Study|Death|7
7665724|NCT01392443|26664714|P1|Overall Study|Adverse Event|24
7665725|NCT01392443|26664714|P1|Overall Study|Disease progression|30
7665726|NCT01392378|26664727|P5|Toddler Dose|Withdrawal by Parent|1
7665727|NCT01392378|26664728|P4|Toddler Dose|Withdrawal by Parent|1
7665728|NCT01392378|26664729|P3|Toddler Dose|Withdrawal by Parent|0
7665729|NCT01392378|26664730|P2|Toddler Dose|Withdrawal by Parent|1
7665730|NCT01392378|26664731|P1|Toddler Dose|Withdrawal by Parent|0
7665731|NCT01392378|26664727|P5|Toddler Dose|Lost to Follow-up|0
7665732|NCT01392378|26664728|P4|Toddler Dose|Lost to Follow-up|1
7665733|NCT01392378|26664729|P3|Toddler Dose|Lost to Follow-up|0
7665734|NCT01392378|26664730|P2|Toddler Dose|Lost to Follow-up|0
7665735|NCT01392378|26664731|P1|Toddler Dose|Lost to Follow-up|0
7665736|NCT01392378|26664727|P5|After Infant Series|Withdrawal by Parent|1
7665737|NCT01392378|26664728|P4|After Infant Series|Withdrawal by Parent|0
7665738|NCT01392378|26664729|P3|After Infant Series|Withdrawal by Parent|1
7665739|NCT01392378|26664730|P2|After Infant Series|Withdrawal by Parent|1
7665740|NCT01392378|26664731|P1|After Infant Series|Withdrawal by Parent|0
7665741|NCT01392378|26664727|P5|After Infant Series|Lost to Follow-up|0
7665742|NCT01392378|26664728|P4|After Infant Series|Lost to Follow-up|0
7665743|NCT01392378|26664729|P3|After Infant Series|Lost to Follow-up|1
7665744|NCT01392378|26664730|P2|After Infant Series|Lost to Follow-up|0
7665745|NCT01392378|26664731|P1|After Infant Series|Lost to Follow-up|0
7665746|NCT01392378|26664727|P5|Infant Series|Withdrawal by Parent|0
7665747|NCT01392378|26664728|P4|Infant Series|Withdrawal by Parent|0
7665748|NCT01392378|26664729|P3|Infant Series|Withdrawal by Parent|0
7665749|NCT01392378|26664730|P2|Infant Series|Withdrawal by Parent|1
7665750|NCT01392378|26664731|P1|Infant Series|Withdrawal by Parent|4
7665751|NCT01392378|26664727|P5|Infant Series|Protocol Violation|0
7665752|NCT01392378|26664728|P4|Infant Series|Protocol Violation|0
7665753|NCT01392378|26664729|P3|Infant Series|Protocol Violation|0
7665754|NCT01392378|26664730|P2|Infant Series|Protocol Violation|1
7665755|NCT01392378|26664731|P1|Infant Series|Protocol Violation|0
7665756|NCT01392378|26664727|P5|Infant Series|Lost to Follow-up|0
7665757|NCT01392378|26664728|P4|Infant Series|Lost to Follow-up|1
7665758|NCT01392378|26664729|P3|Infant Series|Lost to Follow-up|0
7665759|NCT01392378|26664730|P2|Infant Series|Lost to Follow-up|0
7665760|NCT01392378|26664731|P1|Infant Series|Lost to Follow-up|0
7665761|NCT01392378|26664727|P5|Infant Series|Adverse Event|0
7665762|NCT01392378|26664728|P4|Infant Series|Adverse Event|1
7665763|NCT01392378|26664729|P3|Infant Series|Adverse Event|0
7665764|NCT01392378|26664730|P2|Infant Series|Adverse Event|0
7665765|NCT01392378|26664731|P1|Infant Series|Adverse Event|0
7665766|NCT01392326|26664871|P3|Overall Study|Adverse Event|11
7665767|NCT01392326|26664872|P2|Overall Study|Adverse Event|6
7665768|NCT01392326|26664873|P1|Overall Study|Adverse Event|9
7665769|NCT01392326|26664871|P3|Overall Study|Lack of Efficacy|15
7665770|NCT01392326|26664872|P2|Overall Study|Lack of Efficacy|10
7665771|NCT01392326|26664873|P1|Overall Study|Lack of Efficacy|14
7665772|NCT01392326|26664871|P3|Overall Study|Lost to Follow-up|4
7665773|NCT01392326|26664872|P2|Overall Study|Lost to Follow-up|3
7665774|NCT01392326|26664873|P1|Overall Study|Lost to Follow-up|1
7665775|NCT01392326|26664871|P3|Overall Study|Physician Decision|2
7665776|NCT01392326|26664872|P2|Overall Study|Physician Decision|5
7665777|NCT01392326|26664873|P1|Overall Study|Physician Decision|7
7665778|NCT01392326|26664871|P3|Overall Study|Pregnancy|1
7665779|NCT01392326|26664872|P2|Overall Study|Pregnancy|0
7665780|NCT01392326|26664873|P1|Overall Study|Pregnancy|0
7665781|NCT01392326|26664871|P3|Overall Study|Protocol Violation|0
7665782|NCT01392326|26664872|P2|Overall Study|Protocol Violation|0
7665783|NCT01392326|26664873|P1|Overall Study|Protocol Violation|2
7665784|NCT01392326|26664871|P3|Overall Study|Withdrawal by Subject|15
7665785|NCT01392326|26664872|P2|Overall Study|Withdrawal by Subject|11
7665786|NCT01392326|26664873|P1|Overall Study|Withdrawal by Subject|12
7665787|NCT01392326|26664871|P3|Overall Study|Death|0
7665788|NCT01392326|26664872|P2|Overall Study|Death|0
7665789|NCT01392326|26664873|P1|Overall Study|Death|2
7665790|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
7665791|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7665792|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7665793|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
7665794|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7665795|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7665796|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Adverse Event|7
7665797|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Adverse Event|0
7665798|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Adverse Event|0
7665799|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Death|4
7665800|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Death|0
7665801|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Death|0
7665802|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Non-compliance|1
7665803|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Non-compliance|0
7665804|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Non-compliance|0
7665805|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
7665806|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7665807|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7665808|NCT01392300|26664910|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
7665809|NCT01392300|26664911|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
7665810|NCT01392300|26664912|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
7665811|NCT01392300|26664910|P3|Main Period (MP)|Non-compliance|0
7665812|NCT01392300|26664911|P2|Main Period (MP)|Non-compliance|0
7665813|NCT01392300|26664912|P1|Main Period (MP)|Non-compliance|1
7665814|NCT01392300|26664910|P3|Main Period (MP)|Lost to Follow-up|0
7665815|NCT01392300|26664911|P2|Main Period (MP)|Lost to Follow-up|3
7665816|NCT01392300|26664912|P1|Main Period (MP)|Lost to Follow-up|3
7665817|NCT01392300|26664910|P3|Main Period (MP)|Withdrawal by Subject|0
7665818|NCT01392300|26664911|P2|Main Period (MP)|Withdrawal by Subject|1
7665819|NCT01392300|26664912|P1|Main Period (MP)|Withdrawal by Subject|5
7665820|NCT01392300|26664910|P3|Main Period (MP)|Predefined discontinuation criteria|0
7665821|NCT01392300|26664911|P2|Main Period (MP)|Predefined discontinuation criteria|3
7665822|NCT01392300|26664912|P1|Main Period (MP)|Predefined discontinuation criteria|2
7665823|NCT01392183|26665019|P2|First Drug Administration|Withdrawal by Subject|17
7665824|NCT01392183|26665020|P1|First Drug Administration|Withdrawal by Subject|10
7665825|NCT01392183|26665019|P2|First Drug Administration|Death|0
7665826|NCT01392183|26665020|P1|First Drug Administration|Death|1
7665827|NCT01392183|26665019|P2|First Drug Administration|Adverse Event|2
7665828|NCT01392183|26665020|P1|First Drug Administration|Adverse Event|3
7665829|NCT01392170|26665028|P1|Overall Study|Ineligible|1
7665830|NCT01392170|26665028|P1|Overall Study|Withdrawal by Subject|1
7665831|NCT01391832|26665078|P2|Overall Study|Lost to Follow-up|1
7665832|NCT01391832|26665079|P1|Overall Study|Lost to Follow-up|0
7665833|NCT01391832|26665078|P2|Overall Study|Withdrawal by Subject|22
7665834|NCT01391832|26665079|P1|Overall Study|Withdrawal by Subject|21
7665835|NCT01391819|26665087|P1|Overall Study|Other|9
7665836|NCT01391819|26665087|P1|Overall Study|Death|3
7665837|NCT01391819|26665087|P1|Overall Study|Lost to Follow-up|252
7665838|NCT01391819|26665087|P1|Overall Study|Migrated/moved from study area|82
7665839|NCT01391819|26665087|P1|Overall Study|Withdrawal by Subject|56
7665840|NCT01391793|26665131|P2|Overall Study|No DMSA|57
7665841|NCT01391793|26665132|P1|Overall Study|No DMSA|73
7665842|NCT01391793|26665131|P2|Overall Study|Urine Culture Negative or Indeterminate|87
7665843|NCT01391793|26665132|P1|Overall Study|Urine Culture Negative or Indeterminate|71
7665844|NCT01391793|26665131|P2|Overall Study|Ineligible|0
7665845|NCT01391793|26665132|P1|Overall Study|Ineligible|3
7665846|NCT01391663|26665146|P4|Overall Study|Withdrawal by Subject|0
7665847|NCT01391663|26665147|P3|Overall Study|Withdrawal by Subject|1
7665848|NCT01391663|26665148|P2|Overall Study|Withdrawal by Subject|0
7665849|NCT01391663|26665149|P1|Overall Study|Withdrawal by Subject|0
7665850|NCT01391546|26665193|P2|Overall Study|History of Herpes Zoster (HZ)|0
7665851|NCT01391546|26665194|P1|Overall Study|History of Herpes Zoster (HZ)|1
7665852|NCT01391507|26665216|P4|Overall Study|Protocol Violation|2
7665853|NCT01391507|26665217|P3|Overall Study|Protocol Violation|1
7665854|NCT01391507|26665218|P2|Overall Study|Protocol Violation|1
7665855|NCT01391507|26665219|P1|Overall Study|Protocol Violation|2
7665856|NCT01391507|26665216|P4|Overall Study|Lack of Efficacy|1
7665857|NCT01391507|26665217|P3|Overall Study|Lack of Efficacy|0
7665858|NCT01391507|26665218|P2|Overall Study|Lack of Efficacy|0
7665859|NCT01391507|26665219|P1|Overall Study|Lack of Efficacy|0
7665860|NCT01391507|26665216|P4|Overall Study|Withdrawal by Subject|1
7665861|NCT01391507|26665217|P3|Overall Study|Withdrawal by Subject|1
7665862|NCT01391507|26665218|P2|Overall Study|Withdrawal by Subject|2
7665863|NCT01391507|26665219|P1|Overall Study|Withdrawal by Subject|1
7665864|NCT01391507|26665216|P4|Overall Study|Adverse Event|2
7665865|NCT01391507|26665217|P3|Overall Study|Adverse Event|2
7665866|NCT01391507|26665218|P2|Overall Study|Adverse Event|1
7665867|NCT01391507|26665219|P1|Overall Study|Adverse Event|1
7665868|NCT01391507|26665216|P4|Overall Study|Death|1
7665869|NCT01391507|26665217|P3|Overall Study|Death|0
7665870|NCT01391507|26665218|P2|Overall Study|Death|0
7665871|NCT01391507|26665219|P1|Overall Study|Death|0
7665872|NCT01391130|26665370|P2|Overall Study|Did not Receive Drug|1
7665873|NCT01391130|26665371|P1|Overall Study|Did not Receive Drug|1
7665874|NCT01391130|26665370|P2|Overall Study|Physician Decision|3
7665875|NCT01391130|26665371|P1|Overall Study|Physician Decision|2
7665876|NCT01391130|26665370|P2|Overall Study|Withdrawal by Subject|2
7665877|NCT01391130|26665371|P1|Overall Study|Withdrawal by Subject|3
7665878|NCT01391000|26665428|P2|Overall Study|Lost to Follow-up|0
7665879|NCT01391000|26665429|P1|Overall Study|Lost to Follow-up|2
7665880|NCT01390948|26665442|P3|Overall Study|Death during follow-up|1
7665881|NCT01390948|26665443|P2|Overall Study|Death during follow-up|11
7665882|NCT01390948|26665444|P1|Overall Study|Death during follow-up|10
7665883|NCT01390948|26665442|P3|Overall Study|Progressive Disease|0
7665884|NCT01390948|26665443|P2|Overall Study|Progressive Disease|5
7665885|NCT01390948|26665444|P1|Overall Study|Progressive Disease|2
7665886|NCT01390948|26665442|P3|Overall Study|Withdrew consent|0
7665887|NCT01390948|26665443|P2|Overall Study|Withdrew consent|2
7665888|NCT01390948|26665444|P1|Overall Study|Withdrew consent|2
7665889|NCT01390948|26665442|P3|Overall Study|End of Study|0
7665890|NCT01390948|26665443|P2|Overall Study|End of Study|0
7665891|NCT01390948|26665444|P1|Overall Study|End of Study|1
7665892|NCT01390857|26665512|P1|Overall Study|No Visit after the First Visit|7
7665893|NCT01390857|26665512|P1|Overall Study|Lost to Follow-up|1
7665894|NCT01390857|26665512|P1|Overall Study|Protocol Violation|2
7665895|NCT01390844|26665523|P4|Follow-Up Phase|Non-Medical Reasons|0
7665896|NCT01390844|26665524|P3|Follow-Up Phase|Non-Medical Reasons|1
7665897|NCT01390844|26665525|P2|Follow-Up Phase|Non-Medical Reasons|1
7665898|NCT01390844|26665526|P1|Follow-Up Phase|Non-Medical Reasons|1
7665899|NCT01390844|26665523|P4|Treatment Phase|Non-GCP Compliant|3
7665900|NCT01390844|26665524|P3|Treatment Phase|Non-GCP Compliant|10
7665901|NCT01390844|26665525|P2|Treatment Phase|Non-GCP Compliant|0
7665902|NCT01390844|26665526|P1|Treatment Phase|Non-GCP Compliant|0
7665903|NCT01390844|26665523|P4|Treatment Phase|Non-Medical Reasons|1
7665904|NCT01390844|26665524|P3|Treatment Phase|Non-Medical Reasons|8
7665905|NCT01390844|26665525|P2|Treatment Phase|Non-Medical Reasons|1
7665906|NCT01390844|26665526|P1|Treatment Phase|Non-Medical Reasons|5
7665907|NCT01390844|26665523|P4|Treatment Phase|Treatment Failure|13
7665908|NCT01390844|26665524|P3|Treatment Phase|Treatment Failure|10
7665909|NCT01390844|26665525|P2|Treatment Phase|Treatment Failure|25
7665910|NCT01390844|26665526|P1|Treatment Phase|Treatment Failure|23
7665911|NCT01390844|26665523|P4|Treatment Phase|Adverse Event|2
7665912|NCT01390844|26665524|P3|Treatment Phase|Adverse Event|3
7665913|NCT01390844|26665525|P2|Treatment Phase|Adverse Event|2
7665914|NCT01390844|26665526|P1|Treatment Phase|Adverse Event|12
7665915|NCT01390779|26665853|P1|Overall Study|Physician Decision|1
7665916|NCT01390649|26665858|P1|Overall Study|Physician Decision|1
7665917|NCT01390584|26665865|P3|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
7665918|NCT01390584|26665866|P2|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7665919|NCT01390584|26665867|P1|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7665920|NCT01390441|26665889|P5|Extension Period|Protocol Violation|0
7665921|NCT01390441|26665890|P4|Extension Period|Protocol Violation|1
7665922|NCT01390441|26665891|P3|Extension Period|Protocol Violation|0
7665923|NCT01390441|26665892|P2|Extension Period|Protocol Violation|1
7665924|NCT01390441|26665893|P1|Extension Period|Protocol Violation|3
7665925|NCT01390441|26665889|P5|Treatment Period|Lost to Follow-up|0
7665926|NCT01390441|26665890|P4|Treatment Period|Lost to Follow-up|0
7665927|NCT01390441|26665891|P3|Treatment Period|Lost to Follow-up|0
7665928|NCT01390441|26665892|P2|Treatment Period|Lost to Follow-up|0
7665929|NCT01390441|26665893|P1|Treatment Period|Lost to Follow-up|1
7665930|NCT01390441|26665889|P5|Treatment Period|Withdrawal by Subject|1
7665931|NCT01390441|26665890|P4|Treatment Period|Withdrawal by Subject|0
7665932|NCT01390441|26665891|P3|Treatment Period|Withdrawal by Subject|1
7665933|NCT01390441|26665892|P2|Treatment Period|Withdrawal by Subject|0
7665934|NCT01390441|26665893|P1|Treatment Period|Withdrawal by Subject|0
7665935|NCT01390441|26665889|P5|Treatment Period|Adverse Event|2
7665936|NCT01390441|26665890|P4|Treatment Period|Adverse Event|1
7665937|NCT01390441|26665891|P3|Treatment Period|Adverse Event|1
7665938|NCT01390441|26665892|P2|Treatment Period|Adverse Event|0
7665939|NCT01390441|26665893|P1|Treatment Period|Adverse Event|0
7665940|NCT01390441|26665889|P5|Treatment Period|Unknown due to early stopping of study|7
7665941|NCT01390441|26665890|P4|Treatment Period|Unknown due to early stopping of study|11
7665942|NCT01390441|26665891|P3|Treatment Period|Unknown due to early stopping of study|8
7665943|NCT01390441|26665892|P2|Treatment Period|Unknown due to early stopping of study|0
7665944|NCT01390441|26665893|P1|Treatment Period|Unknown due to early stopping of study|0
7665945|NCT01390441|26665889|P5|Treatment Period|Lack of Efficacy|1
7665946|NCT01390441|26665890|P4|Treatment Period|Lack of Efficacy|0
7665947|NCT01390441|26665891|P3|Treatment Period|Lack of Efficacy|0
7665948|NCT01390441|26665892|P2|Treatment Period|Lack of Efficacy|0
7665949|NCT01390441|26665893|P1|Treatment Period|Lack of Efficacy|0
7665950|NCT01390441|26665889|P5|Treatment Period|Physician Decision|0
7665951|NCT01390441|26665890|P4|Treatment Period|Physician Decision|1
7665952|NCT01390441|26665891|P3|Treatment Period|Physician Decision|0
7665953|NCT01390441|26665892|P2|Treatment Period|Physician Decision|0
7665954|NCT01390441|26665893|P1|Treatment Period|Physician Decision|0
7665955|NCT01390441|26665889|P5|Treatment Period|Protocol Violation|0
7665956|NCT01390441|26665890|P4|Treatment Period|Protocol Violation|0
7665957|NCT01390441|26665891|P3|Treatment Period|Protocol Violation|0
7665958|NCT01390441|26665892|P2|Treatment Period|Protocol Violation|1
7665959|NCT01390441|26665893|P1|Treatment Period|Protocol Violation|0
7665960|NCT01390428|26665958|P6|Overall Study|Withdrawal by Subject|0
7665961|NCT01390428|26665959|P5|Overall Study|Withdrawal by Subject|0
7665962|NCT01390428|26665960|P4|Overall Study|Withdrawal by Subject|0
7665963|NCT01390428|26665961|P3|Overall Study|Withdrawal by Subject|1
7665964|NCT01390428|26665962|P2|Overall Study|Withdrawal by Subject|0
7665965|NCT01390428|26665963|P1|Overall Study|Withdrawal by Subject|0
7665966|NCT01390428|26665958|P6|Overall Study|Elective Surgery|0
7665967|NCT01390428|26665959|P5|Overall Study|Elective Surgery|1
7665968|NCT01390428|26665960|P4|Overall Study|Elective Surgery|0
7665969|NCT01390428|26665961|P3|Overall Study|Elective Surgery|0
7665970|NCT01390428|26665962|P2|Overall Study|Elective Surgery|0
7665971|NCT01390428|26665963|P1|Overall Study|Elective Surgery|0
7665972|NCT01390402|26666026|P1|Overall Study|Disease Progression|4
7665973|NCT01390402|26666026|P1|Overall Study|Death|1
7665974|NCT01390389|26666032|P2|Overall Study|Screen Fail|1
7665975|NCT01390389|26666033|P1|Overall Study|Screen Fail|2
7665976|NCT01390389|26666032|P2|Overall Study|Withdrawal by Subject|0
7665977|NCT01390389|26666033|P1|Overall Study|Withdrawal by Subject|2
7665978|NCT01390298|26666043|P1|Overall Study|Surgery cancelled|1
7665979|NCT01390298|26666043|P1|Overall Study|Lost to Follow-up|7
7665980|NCT01390298|26666043|P1|Overall Study|Withdrawal by Subject|14
7665981|NCT01390298|26666043|P1|Overall Study|long term ICU admission|1
7665982|NCT01390298|26666043|P1|Overall Study|Death|1
7665983|NCT01390272|26666049|P2|Overall Study|Patient moved, no longer eligible|8
7665984|NCT01390272|26666050|P1|Overall Study|Patient moved, no longer eligible|5
7665985|NCT01390272|26666049|P2|Overall Study|Withdrawal by Subject|5
7665986|NCT01390272|26666050|P1|Overall Study|Withdrawal by Subject|9
7665987|NCT01390272|26666049|P2|Overall Study|Death|2
7665988|NCT01390272|26666050|P1|Overall Study|Death|3
7665989|NCT01390220|26666118|P3|Comparative Phase|Withdrawal by Subject|0
7665990|NCT01390220|26666119|P2|Comparative Phase|Withdrawal by Subject|1
7665991|NCT01390220|26666120|P1|Comparative Phase|Withdrawal by Subject|0
7665992|NCT01390220|26666118|P3|Test Dose Phase|Logistical|0
7665993|NCT01390220|26666119|P2|Test Dose Phase|Logistical|0
7665994|NCT01390220|26666120|P1|Test Dose Phase|Logistical|6
7665995|NCT01390220|26666118|P3|Test Dose Phase|Noncompliance|0
7665996|NCT01390220|26666119|P2|Test Dose Phase|Noncompliance|0
7665997|NCT01390220|26666120|P1|Test Dose Phase|Noncompliance|2
7665998|NCT01390220|26666118|P3|Test Dose Phase|Caregiver no longer available|0
7665999|NCT01390220|26666119|P2|Test Dose Phase|Caregiver no longer available|0
7666000|NCT01390220|26666120|P1|Test Dose Phase|Caregiver no longer available|5
7666001|NCT01390220|26666118|P3|Test Dose Phase|Study/Site closure|0
7666002|NCT01390220|26666119|P2|Test Dose Phase|Study/Site closure|0
7666003|NCT01390220|26666120|P1|Test Dose Phase|Study/Site closure|6
7666004|NCT01390220|26666118|P3|Test Dose Phase|No treated seizure cluster episode|0
7666005|NCT01390220|26666119|P2|Test Dose Phase|No treated seizure cluster episode|0
7666006|NCT01390220|26666120|P1|Test Dose Phase|No treated seizure cluster episode|37
7666007|NCT01390220|26666118|P3|Test Dose Phase|Protocol Violation|0
7666008|NCT01390220|26666119|P2|Test Dose Phase|Protocol Violation|0
7666009|NCT01390220|26666120|P1|Test Dose Phase|Protocol Violation|8
7666010|NCT01390220|26666118|P3|Test Dose Phase|Lost to Follow-up|0
7666011|NCT01390220|26666119|P2|Test Dose Phase|Lost to Follow-up|0
7666012|NCT01390220|26666120|P1|Test Dose Phase|Lost to Follow-up|2
7666013|NCT01390220|26666118|P3|Test Dose Phase|Withdrawal by Subject|0
7666014|NCT01390220|26666119|P2|Test Dose Phase|Withdrawal by Subject|0
7666015|NCT01390220|26666120|P1|Test Dose Phase|Withdrawal by Subject|8
7666016|NCT01390220|26666118|P3|Test Dose Phase|Adverse Event|0
7666017|NCT01390220|26666119|P2|Test Dose Phase|Adverse Event|0
7666018|NCT01390220|26666120|P1|Test Dose Phase|Adverse Event|17
7666019|NCT01390181|26666135|P1|Overall Study|Study Terminated due to Low Accrual|3
7666020|NCT01390181|26666135|P1|Overall Study|Lost to Follow-up|1
7666021|NCT01390038|26666157|P1|Overall Study|Simpliciti System Removal|2
7666022|NCT01390038|26666157|P1|Overall Study|Withdrawal by Subject|4
7666023|NCT01390038|26666157|P1|Overall Study|Lost to Follow-up|1
7666024|NCT01390038|26666157|P1|Overall Study|Death|1
7666025|NCT01389973|26666167|P1|Overall Study|Other|10
7666026|NCT01389973|26666167|P1|Overall Study|Trial Stopped by Sponsor|9
7666027|NCT01389973|26666167|P1|Overall Study|Lost to Follow-up|1
7666028|NCT01389882|26666177|P2|Overall Study|Withdrawal by Subject|1
7666029|NCT01389882|26666178|P1|Overall Study|Withdrawal by Subject|0
7666030|NCT01389882|26666177|P2|Overall Study|Respiratory rate > 80/min during study|3
7666031|NCT01389882|26666178|P1|Overall Study|Respiratory rate > 80/min during study|1
7666032|NCT01389817|26666266|P2|Overall Study|Withdrawal by Subject|0
7666033|NCT01389817|26666267|P1|Overall Study|Withdrawal by Subject|2
7666034|NCT01389817|26666266|P2|Overall Study|Lost to Follow-up|0
7666035|NCT01389817|26666267|P1|Overall Study|Lost to Follow-up|1
7666036|NCT01389817|26666266|P2|Overall Study|Physician Decision|0
7666037|NCT01389817|26666267|P1|Overall Study|Physician Decision|1
7666038|NCT01389752|26666284|P2|Study Period 2|Sponsor decision|0
7666039|NCT01389752|26666285|P1|Study Period 2|Sponsor decision|1
7666040|NCT01389752|26666284|P2|Study Period 1|Sponsor decision|2
7666041|NCT01389752|26666285|P1|Study Period 1|Sponsor decision|0
7666042|NCT01389596|26666298|P3|Overall Study|Other Unspecified|0
7666043|NCT01389596|26666299|P2|Overall Study|Other Unspecified|1
7666044|NCT01389596|26666300|P1|Overall Study|Other Unspecified|2
7666045|NCT01389596|26666298|P3|Overall Study|Death|0
7666046|NCT01389596|26666299|P2|Overall Study|Death|1
7666047|NCT01389596|26666300|P1|Overall Study|Death|0
7666048|NCT01389596|26666298|P3|Overall Study|Adverse Event|0
7666049|NCT01389596|26666299|P2|Overall Study|Adverse Event|4
7666050|NCT01389596|26666300|P1|Overall Study|Adverse Event|1
7666051|NCT01389596|26666298|P3|Overall Study|Insufficient Clinical Response|5
7666052|NCT01389596|26666299|P2|Overall Study|Insufficient Clinical Response|4
7666053|NCT01389596|26666300|P1|Overall Study|Insufficient Clinical Response|3
7666054|NCT01389596|26666298|P3|Overall Study|Withdrawal by Subject|2
7666055|NCT01389596|26666299|P2|Overall Study|Withdrawal by Subject|2
7666056|NCT01389596|26666300|P1|Overall Study|Withdrawal by Subject|1
7666057|NCT01389596|26666298|P3|Overall Study|Protocol Violation|3
7666058|NCT01389596|26666299|P2|Overall Study|Protocol Violation|4
7666059|NCT01389596|26666300|P1|Overall Study|Protocol Violation|3
7666060|NCT01389323|26666359|P1|Follow-up Period (up to 48 Weeks)|Other|3
7666061|NCT01389323|26666359|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
7666062|NCT01389323|26666359|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
7666063|NCT01389323|26666359|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
7666064|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
7666065|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
7666066|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
7666067|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
7666068|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
7666069|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
7666070|NCT01389323|26666359|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
7666071|NCT01389258|26666416|P1|Overall Study|Lost to Follow-up|5
7666072|NCT01389245|26666426|P1|Overall Study|Withdrawal by Subject|2
7666073|NCT01389245|26666426|P1|Overall Study|Lost to Follow-up|3
7666074|NCT01389245|26666426|P1|Overall Study|Protocol Violation|10
7666075|NCT01389232|26666434|P1|Overall Study|Death|1
7666076|NCT01389232|26666434|P1|Overall Study|Adverse Event|1
7666077|NCT01389232|26666434|P1|Overall Study|Personal reasons|2
7666078|NCT01389232|26666434|P1|Overall Study|Had scaffold removed|15
7666079|NCT01389128|26666452|P2|Overall Study|Intolerance to procedure|2
7666080|NCT01389128|26666453|P1|Overall Study|Intolerance to procedure|0
7666081|NCT01389128|26666452|P2|Overall Study|Rapid labor evolution|2
7666082|NCT01389128|26666453|P1|Overall Study|Rapid labor evolution|3
7666083|NCT01389128|26666452|P2|Overall Study|Cervix dilation stop|2
7666084|NCT01389128|26666453|P1|Overall Study|Cervix dilation stop|1
7666085|NCT01389128|26666452|P2|Overall Study|Fetal distress|0
7666086|NCT01389128|26666453|P1|Overall Study|Fetal distress|1
7666087|NCT01389102|26666477|P6|Overall Study|Investigator Judgement|0
7666088|NCT01389102|26666478|P5|Overall Study|Investigator Judgement|0
7666089|NCT01389102|26666479|P4|Overall Study|Investigator Judgement|0
7666090|NCT01389102|26666480|P3|Overall Study|Investigator Judgement|0
7666091|NCT01389102|26666481|P2|Overall Study|Investigator Judgement|1
7666092|NCT01389102|26666482|P1|Overall Study|Investigator Judgement|0
7666093|NCT01389102|26666477|P6|Overall Study|Unavailable due to husband's illness|0
7666094|NCT01389102|26666478|P5|Overall Study|Unavailable due to husband's illness|0
7666095|NCT01389102|26666479|P4|Overall Study|Unavailable due to husband's illness|0
7666096|NCT01389102|26666480|P3|Overall Study|Unavailable due to husband's illness|0
7666097|NCT01389102|26666481|P2|Overall Study|Unavailable due to husband's illness|1
7666098|NCT01389102|26666482|P1|Overall Study|Unavailable due to husband's illness|0
7666099|NCT01389102|26666477|P6|Overall Study|Subject Moved|0
7666100|NCT01389102|26666478|P5|Overall Study|Subject Moved|0
7666101|NCT01389102|26666479|P4|Overall Study|Subject Moved|0
7666102|NCT01389102|26666480|P3|Overall Study|Subject Moved|1
7666103|NCT01389102|26666481|P2|Overall Study|Subject Moved|0
7666104|NCT01389102|26666482|P1|Overall Study|Subject Moved|2
7666105|NCT01389102|26666477|P6|Overall Study|Subject Traveling Out of Country|0
7666106|NCT01389102|26666478|P5|Overall Study|Subject Traveling Out of Country|0
7666107|NCT01389102|26666479|P4|Overall Study|Subject Traveling Out of Country|1
7666108|NCT01389102|26666480|P3|Overall Study|Subject Traveling Out of Country|0
7666109|NCT01389102|26666481|P2|Overall Study|Subject Traveling Out of Country|0
7666110|NCT01389102|26666482|P1|Overall Study|Subject Traveling Out of Country|0
7666111|NCT01389102|26666477|P6|Overall Study|Withdrawal by Subject|3
7666112|NCT01389102|26666478|P5|Overall Study|Withdrawal by Subject|3
7666113|NCT01389102|26666479|P4|Overall Study|Withdrawal by Subject|2
7666114|NCT01389102|26666480|P3|Overall Study|Withdrawal by Subject|9
7666115|NCT01389102|26666481|P2|Overall Study|Withdrawal by Subject|4
7666116|NCT01389102|26666482|P1|Overall Study|Withdrawal by Subject|7
7666117|NCT01389102|26666477|P6|Overall Study|Protocol Violation|1
7666118|NCT01389102|26666478|P5|Overall Study|Protocol Violation|1
7666119|NCT01389102|26666479|P4|Overall Study|Protocol Violation|0
7666120|NCT01389102|26666480|P3|Overall Study|Protocol Violation|3
7666121|NCT01389102|26666481|P2|Overall Study|Protocol Violation|0
7666122|NCT01389102|26666482|P1|Overall Study|Protocol Violation|0
7666123|NCT01389102|26666477|P6|Overall Study|Lost to Follow-up|1
7666124|NCT01389102|26666478|P5|Overall Study|Lost to Follow-up|4
7666125|NCT01389102|26666479|P4|Overall Study|Lost to Follow-up|2
7666126|NCT01389102|26666480|P3|Overall Study|Lost to Follow-up|1
7666127|NCT01389102|26666481|P2|Overall Study|Lost to Follow-up|1
7666128|NCT01389102|26666482|P1|Overall Study|Lost to Follow-up|4
7666129|NCT01389102|26666477|P6|Overall Study|Hurricane Katrina|1
7666130|NCT01389102|26666478|P5|Overall Study|Hurricane Katrina|3
7666131|NCT01389102|26666479|P4|Overall Study|Hurricane Katrina|0
7666132|NCT01389102|26666480|P3|Overall Study|Hurricane Katrina|3
7666133|NCT01389102|26666481|P2|Overall Study|Hurricane Katrina|2
7666134|NCT01389102|26666482|P1|Overall Study|Hurricane Katrina|4
7666135|NCT01389102|26666477|P6|Overall Study|Adverse Event|2
7666136|NCT01389102|26666478|P5|Overall Study|Adverse Event|2
7666137|NCT01389102|26666479|P4|Overall Study|Adverse Event|2
7666138|NCT01389102|26666480|P3|Overall Study|Adverse Event|2
7666139|NCT01389102|26666481|P2|Overall Study|Adverse Event|3
7666140|NCT01389102|26666482|P1|Overall Study|Adverse Event|1
7666141|NCT01388985|26666512|P2|Overall Study|Error of nurse|1
7666142|NCT01388985|26666513|P1|Overall Study|Error of nurse|5
7666143|NCT01388985|26666512|P2|Overall Study|Other (no reason)|1
7666144|NCT01388985|26666513|P1|Overall Study|Other (no reason)|0
7666145|NCT01388985|26666512|P2|Overall Study|Subject unavailable|1
7666146|NCT01388985|26666513|P1|Overall Study|Subject unavailable|1
7666147|NCT01388985|26666512|P2|Overall Study|Withdrawal by Subject|4
7666148|NCT01388985|26666513|P1|Overall Study|Withdrawal by Subject|13
7666149|NCT01388985|26666512|P2|Overall Study|Lost to Follow-up|30
7666150|NCT01388985|26666513|P1|Overall Study|Lost to Follow-up|30
7666151|NCT01388985|26666512|P2|Overall Study|Death|1
7666152|NCT01388985|26666513|P1|Overall Study|Death|0
7666153|NCT01388907|26666577|P2|Overall Study|Adverse Event|0
7666154|NCT01388907|26666578|P1|Overall Study|Adverse Event|2
7666155|NCT01388816|26666594|P4|Overall Study|Protocol Violation|0
7666156|NCT01388816|26666595|P3|Overall Study|Protocol Violation|2
7666157|NCT01388816|26666596|P2|Overall Study|Protocol Violation|0
7666158|NCT01388816|26666597|P1|Overall Study|Protocol Violation|0
7666159|NCT01388816|26666594|P4|Overall Study|Withdrawal by Subject|0
7666160|NCT01388816|26666595|P3|Overall Study|Withdrawal by Subject|1
7666161|NCT01388816|26666596|P2|Overall Study|Withdrawal by Subject|1
7666162|NCT01388816|26666597|P1|Overall Study|Withdrawal by Subject|2
7666163|NCT01388816|26666594|P4|Overall Study|Lost to Follow-up|0
7666164|NCT01388816|26666595|P3|Overall Study|Lost to Follow-up|0
7666165|NCT01388816|26666596|P2|Overall Study|Lost to Follow-up|1
7666166|NCT01388816|26666597|P1|Overall Study|Lost to Follow-up|0
7666167|NCT01388816|26666594|P4|Overall Study|Adverse Event|0
7666168|NCT01388816|26666595|P3|Overall Study|Adverse Event|0
7666169|NCT01388816|26666596|P2|Overall Study|Adverse Event|2
7666170|NCT01388816|26666597|P1|Overall Study|Adverse Event|0
7666171|NCT01388790|26666626|P1|Overall Study|Ongoing at data cut-off date|8
7666172|NCT01388647|26666637|P2|Overall Study|Adverse Event|2
7666173|NCT01388647|26666638|P1|Overall Study|Adverse Event|1
7666174|NCT01388543|26666651|P2|Day 14|Adverse Event|4
7666175|NCT01388543|26666652|P1|Day 14|Adverse Event|1
7666176|NCT01388530|26666658|P1|Overall Study|Lost to Follow-up|5
7666177|NCT01388491|26666667|P2|Overall Study|Pregnancy|0
7666178|NCT01388491|26666668|P1|Overall Study|Pregnancy|1
7666179|NCT01388491|26666667|P2|Overall Study|Noncompliance|0
7666180|NCT01388491|26666668|P1|Overall Study|Noncompliance|2
7666181|NCT01388491|26666667|P2|Overall Study|Protocol Violation|0
7666182|NCT01388491|26666668|P1|Overall Study|Protocol Violation|2
7666183|NCT01388491|26666667|P2|Overall Study|Lost to Follow-up|3
7666184|NCT01388491|26666668|P1|Overall Study|Lost to Follow-up|4
7666185|NCT01388491|26666667|P2|Overall Study|Withdrawal by Subject|10
7666186|NCT01388491|26666668|P1|Overall Study|Withdrawal by Subject|6
7666187|NCT01388491|26666667|P2|Overall Study|Sponsor Request|7
7666188|NCT01388491|26666668|P1|Overall Study|Sponsor Request|9
7666189|NCT01388491|26666667|P2|Overall Study|Adverse Event|9
7666190|NCT01388491|26666668|P1|Overall Study|Adverse Event|10
7666191|NCT01388478|26666700|P1|Overall Study|Withdrawal by Subject|1
7666192|NCT01388478|26666700|P1|Overall Study|Adverse Event|4
7666193|NCT01388361|26666707|P3|Overall Study|Unclassified|1
7666194|NCT01388361|26666708|P2|Overall Study|Unclassified|0
7666195|NCT01388361|26666709|P1|Overall Study|Unclassified|0
7666196|NCT01388361|26666707|P3|Overall Study|Withdrawal criteria|10
7666197|NCT01388361|26666708|P2|Overall Study|Withdrawal criteria|7
7666198|NCT01388361|26666709|P1|Overall Study|Withdrawal criteria|12
7666199|NCT01388361|26666707|P3|Overall Study|Protocol Violation|2
7666200|NCT01388361|26666708|P2|Overall Study|Protocol Violation|0
7666201|NCT01388361|26666709|P1|Overall Study|Protocol Violation|0
7666202|NCT01388361|26666707|P3|Overall Study|Adverse Event|1
7666203|NCT01388361|26666708|P2|Overall Study|Adverse Event|5
7666204|NCT01388361|26666709|P1|Overall Study|Adverse Event|0
7666205|NCT01388335|26666726|P1|Safety Extension|Progressive Disease|7
7666206|NCT01388335|26666726|P1|Period 2|Sponsor Decision|1
7666207|NCT01388335|26666726|P1|Period 2|Progressive Disease|2
7666208|NCT01388335|26666726|P1|Period 1|Progressive Disease|1
7666209|NCT01388166|26666753|P1|Overall Study|Others than specified above|13
7666210|NCT01388166|26666753|P1|Overall Study|Lost to Follow-up|30
7666211|NCT01388166|26666753|P1|Overall Study|Adverse Event|16
7666212|NCT01387789|26667056|P1|Overall Study|Lost to Follow-up|1
7666213|NCT01387789|26667056|P1|Overall Study|Lack of Efficacy|2
7666214|NCT01387789|26667056|P1|Overall Study|Adverse Event|5
7666215|NCT01387737|26667070|P2|Overall Study|Clearly not eligible for the study|3
7666216|NCT01387737|26667071|P1|Overall Study|Clearly not eligible for the study|1
7666217|NCT01387737|26667070|P2|Overall Study|Withdrawal by Subject|31
7666218|NCT01387737|26667071|P1|Overall Study|Withdrawal by Subject|27
7666219|NCT01387737|26667070|P2|Overall Study|Physician Decision|10
7666220|NCT01387737|26667071|P1|Overall Study|Physician Decision|3
7666221|NCT01387737|26667070|P2|Overall Study|Lack of Efficacy|0
7666222|NCT01387737|26667071|P1|Overall Study|Lack of Efficacy|1
7666223|NCT01387737|26667070|P2|Overall Study|Adverse Event|30
7666224|NCT01387737|26667071|P1|Overall Study|Adverse Event|20
7666225|NCT01387607|26667105|P2|Overall Study|Randomized, not treated|6
7666226|NCT01387607|26667106|P1|Overall Study|Randomized, not treated|3
7666227|NCT01387607|26667105|P2|Overall Study|Other|1
7666228|NCT01387607|26667106|P1|Overall Study|Other|1
7666229|NCT01387607|26667105|P2|Overall Study|Withdrawal by Subject|14
7666230|NCT01387607|26667106|P1|Overall Study|Withdrawal by Subject|13
7666231|NCT01387607|26667105|P2|Overall Study|Protocol Violation|5
7666232|NCT01387607|26667106|P1|Overall Study|Protocol Violation|1
7666233|NCT01387607|26667105|P2|Overall Study|No longer meets eligibility criteria|1
7666234|NCT01387607|26667106|P1|Overall Study|No longer meets eligibility criteria|0
7666235|NCT01387607|26667105|P2|Overall Study|Lost to Follow-up|1
7666236|NCT01387607|26667106|P1|Overall Study|Lost to Follow-up|2
7666237|NCT01387607|26667105|P2|Overall Study|Lack of Efficacy|6
7666238|NCT01387607|26667106|P1|Overall Study|Lack of Efficacy|8
7666239|NCT01387607|26667105|P2|Overall Study|Adverse Event|11
7666240|NCT01387607|26667106|P1|Overall Study|Adverse Event|23
7666241|NCT01387594|26667160|P2|Overall Study|Lost to Follow-up|1
7666242|NCT01387594|26667161|P1|Overall Study|Lost to Follow-up|0
7666243|NCT01387594|26667160|P2|Overall Study|Withdrawal by Subject|2
7666244|NCT01387594|26667161|P1|Overall Study|Withdrawal by Subject|0
7666245|NCT01387542|26667189|P1|Overall Study|Lost to Follow-up|1
7666246|NCT01387542|26667189|P1|Overall Study|Non-compliant|1
7666247|NCT01387542|26667189|P1|Overall Study|Insufficient response|1
7666248|NCT01387542|26667189|P1|Overall Study|Changed diagnosis|1
7666249|NCT01387542|26667189|P1|Overall Study|Withdrawal by Subject|1
7666250|NCT01387542|26667189|P1|Overall Study|Adverse Event|3
7666251|NCT01387516|26667200|P4|Overall Study|Death|1
7666252|NCT01387516|26667201|P3|Overall Study|Death|0
7666253|NCT01387516|26667202|P2|Overall Study|Death|0
7666254|NCT01387516|26667203|P1|Overall Study|Death|0
7666255|NCT01387516|26667200|P4|Overall Study|Withdrawal by Subject|0
7666256|NCT01387516|26667201|P3|Overall Study|Withdrawal by Subject|2
7666257|NCT01387516|26667202|P2|Overall Study|Withdrawal by Subject|1
7666258|NCT01387516|26667203|P1|Overall Study|Withdrawal by Subject|1
7666259|NCT01387516|26667200|P4|Overall Study|Lost to Follow-up|3
7666260|NCT01387516|26667201|P3|Overall Study|Lost to Follow-up|2
7666261|NCT01387516|26667202|P2|Overall Study|Lost to Follow-up|4
7666262|NCT01387516|26667203|P1|Overall Study|Lost to Follow-up|4
7666263|NCT01387347|26667236|P2|Overall Study|Lost to Follow-up|1
7666264|NCT01387347|26667237|P1|Overall Study|Lost to Follow-up|2
7666265|NCT01387282|26667249|P2|Overall Study|Lost to Follow-up|1
7666266|NCT01387282|26667250|P1|Overall Study|Lost to Follow-up|4
7666267|NCT01387282|26667249|P2|Overall Study|Study drug-related AE|2
7666268|NCT01387282|26667250|P1|Overall Study|Study drug-related AE|2
7666269|NCT01387282|26667249|P2|Overall Study|Withdrawal by patient|23
7666270|NCT01387282|26667250|P1|Overall Study|Withdrawal by patient|33
7666271|NCT01387282|26667249|P2|Overall Study|Unrelated AE|4
7666272|NCT01387282|26667250|P1|Overall Study|Unrelated AE|6
7666273|NCT01387282|26667249|P2|Overall Study|Other|1
7666274|NCT01387282|26667250|P1|Overall Study|Other|5
7666275|NCT01387282|26667249|P2|Overall Study|Death|16
7666276|NCT01387282|26667250|P1|Overall Study|Death|47
7666277|NCT01387269|26667266|P2|Overall Study|Lost to Follow-up|0
7666278|NCT01387269|26667267|P1|Overall Study|Lost to Follow-up|1
7666279|NCT01387269|26667266|P2|Overall Study|Study drug-related AE|0
7666280|NCT01387269|26667267|P1|Overall Study|Study drug-related AE|1
7666281|NCT01387269|26667266|P2|Overall Study|Withdrawal by patient|10
7666282|NCT01387269|26667267|P1|Overall Study|Withdrawal by patient|32
7666283|NCT01387269|26667266|P2|Overall Study|Unrelated AE|3
7666284|NCT01387269|26667267|P1|Overall Study|Unrelated AE|12
7666285|NCT01387269|26667266|P2|Overall Study|Other|7
7666286|NCT01387269|26667267|P1|Overall Study|Other|8
7666287|NCT01387269|26667266|P2|Overall Study|Death|20
7666288|NCT01387269|26667267|P1|Overall Study|Death|38
7666289|NCT01387230|26667284|P3|Overall Study|Withdrawal by Subject|0
7666290|NCT01387230|26667285|P2|Overall Study|Withdrawal by Subject|1
7666291|NCT01387230|26667286|P1|Overall Study|Withdrawal by Subject|4
7666292|NCT01387230|26667284|P3|Overall Study|Lost to Follow-up|1
7666293|NCT01387230|26667285|P2|Overall Study|Lost to Follow-up|0
7666294|NCT01387230|26667286|P1|Overall Study|Lost to Follow-up|0
7666295|NCT01387230|26667284|P3|Overall Study|Protocol-defined Stopping Criteria|5
7666296|NCT01387230|26667285|P2|Overall Study|Protocol-defined Stopping Criteria|0
7666297|NCT01387230|26667286|P1|Overall Study|Protocol-defined Stopping Criteria|6
7666298|NCT01387230|26667284|P3|Overall Study|Lack of Efficacy|4
7666299|NCT01387230|26667285|P2|Overall Study|Lack of Efficacy|5
7666300|NCT01387230|26667286|P1|Overall Study|Lack of Efficacy|8
7666301|NCT01387230|26667284|P3|Overall Study|Adverse Event|3
7666302|NCT01387230|26667285|P2|Overall Study|Adverse Event|1
7666303|NCT01387230|26667286|P1|Overall Study|Adverse Event|0
7666304|NCT01387074|26667332|P1|Overall Study|Lack of Efficacy|1
7666305|NCT01387074|26667332|P1|Overall Study|Lost to Follow-up|7
7666306|NCT01387022|26667345|P2|Overall Study|Lost to Follow-up|3
7666307|NCT01387022|26667346|P1|Overall Study|Lost to Follow-up|0
7666308|NCT01387022|26667345|P2|Overall Study|Death|1
7666309|NCT01387022|26667346|P1|Overall Study|Death|1
7666310|NCT01386970|26667375|P2|Overall Study|Adverse Event|1
7666311|NCT01386970|26667376|P1|Overall Study|Adverse Event|4
7666312|NCT01386970|26667375|P2|Overall Study|Withdrawal by Subject|1
7666313|NCT01386970|26667376|P1|Overall Study|Withdrawal by Subject|0
7666314|NCT01386944|26667384|P1|Overall Study|Unspecified reason|8
7666315|NCT01386944|26667384|P1|Overall Study|Lost to Follow-up|8
7666316|NCT01386944|26667384|P1|Overall Study|Lack of Efficacy|14
7666317|NCT01386944|26667384|P1|Overall Study|Adverse Event|26
7666318|NCT01386788|26667394|P1|Overall Study|Lost to Follow-up|2
7666319|NCT01386684|26667399|P1|Overall Study|Missing|3
7666320|NCT01386684|26667399|P1|Overall Study|Protocol Violation|4
7666321|NCT01386684|26667399|P1|Overall Study|Noncompliance|8
7666322|NCT01386684|26667399|P1|Overall Study|Adverse Event|20
7666323|NCT01386684|26667399|P1|Overall Study|Disease Progression|28
7666324|NCT01386684|26667399|P1|Overall Study|Alternative Therapy Required|37
7666325|NCT01386684|26667399|P1|Overall Study|Withdrawal of Consent|44
7666326|NCT01386684|26667399|P1|Overall Study|Death|47
7666327|NCT01386684|26667399|P1|Overall Study|Other|51
7666328|NCT01386684|26667399|P1|Overall Study|Lost to Follow-up|51
7666329|NCT01386658|26667440|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
7666330|NCT01386658|26667441|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
7666331|NCT01386658|26667440|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
7666332|NCT01386658|26667441|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
7666333|NCT01386645|26667507|P3|Overall Study|Withdrawal by Subject|1
7666334|NCT01386645|26667508|P2|Overall Study|Withdrawal by Subject|1
7666335|NCT01386645|26667509|P1|Overall Study|Withdrawal by Subject|0
7666336|NCT01386645|26667507|P3|Overall Study|Physician Decision|1
7666337|NCT01386645|26667508|P2|Overall Study|Physician Decision|0
7666338|NCT01386645|26667509|P1|Overall Study|Physician Decision|0
7666339|NCT01386606|26667538|P4|Overall Study|T levels too high|0
7666340|NCT01386606|26667539|P3|Overall Study|T levels too high|1
7666341|NCT01386606|26667540|P2|Overall Study|T levels too high|1
7666342|NCT01386606|26667541|P1|Overall Study|T levels too high|0
7666343|NCT01386606|26667538|P4|Overall Study|Unable to draw PK|0
7666344|NCT01386606|26667539|P3|Overall Study|Unable to draw PK|0
7666345|NCT01386606|26667540|P2|Overall Study|Unable to draw PK|0
7666346|NCT01386606|26667541|P1|Overall Study|Unable to draw PK|1
7666347|NCT01386606|26667538|P4|Overall Study|Subject incarcerated|0
7666348|NCT01386606|26667539|P3|Overall Study|Subject incarcerated|0
7666349|NCT01386606|26667540|P2|Overall Study|Subject incarcerated|1
7666350|NCT01386606|26667541|P1|Overall Study|Subject incarcerated|0
7666351|NCT01386606|26667538|P4|Overall Study|Lost to Follow-up|0
7666352|NCT01386606|26667539|P3|Overall Study|Lost to Follow-up|0
7666353|NCT01386606|26667540|P2|Overall Study|Lost to Follow-up|0
7666354|NCT01386606|26667541|P1|Overall Study|Lost to Follow-up|2
7666355|NCT01386606|26667538|P4|Overall Study|Protocol Violation|1
7666356|NCT01386606|26667539|P3|Overall Study|Protocol Violation|1
7666357|NCT01386606|26667540|P2|Overall Study|Protocol Violation|0
7666358|NCT01386606|26667541|P1|Overall Study|Protocol Violation|1
7666359|NCT01386606|26667538|P4|Overall Study|Withdrawal by Subject|0
7666360|NCT01386606|26667539|P3|Overall Study|Withdrawal by Subject|1
7666361|NCT01386606|26667540|P2|Overall Study|Withdrawal by Subject|1
7666362|NCT01386606|26667541|P1|Overall Study|Withdrawal by Subject|0
7666363|NCT01386606|26667538|P4|Overall Study|Adverse Event|0
7666364|NCT01386606|26667539|P3|Overall Study|Adverse Event|0
7666365|NCT01386606|26667540|P2|Overall Study|Adverse Event|1
7666366|NCT01386606|26667541|P1|Overall Study|Adverse Event|0
7666367|NCT01386554|26667572|P3|Overall Study|Reason not collected|0
7666368|NCT01386554|26667573|P2|Overall Study|Reason not collected|1
7666369|NCT01386554|26667574|P1|Overall Study|Reason not collected|0
7666370|NCT01386554|26667572|P3|Overall Study|Investigator discretion|1
7666371|NCT01386554|26667573|P2|Overall Study|Investigator discretion|0
7666372|NCT01386554|26667574|P1|Overall Study|Investigator discretion|0
7666373|NCT01386554|26667572|P3|Overall Study|Administration of live vaccines|0
7666374|NCT01386554|26667573|P2|Overall Study|Administration of live vaccines|1
7666375|NCT01386554|26667574|P1|Overall Study|Administration of live vaccines|0
7666376|NCT01386554|26667572|P3|Overall Study|Progressive disease|2
7666377|NCT01386554|26667573|P2|Overall Study|Progressive disease|2
7666378|NCT01386554|26667574|P1|Overall Study|Progressive disease|1
7666379|NCT01386554|26667572|P3|Overall Study|Adverse Event|2
7666380|NCT01386554|26667573|P2|Overall Study|Adverse Event|5
7666381|NCT01386554|26667574|P1|Overall Study|Adverse Event|2
7666382|NCT01386554|26667572|P3|Overall Study|Lost to Follow-up|1
7666383|NCT01386554|26667573|P2|Overall Study|Lost to Follow-up|0
7666384|NCT01386554|26667574|P1|Overall Study|Lost to Follow-up|0
7666385|NCT01386385|26667600|P8|Phase II: Consolidation Therapy|Progression/relapse|1
7666386|NCT01386385|26667601|P7|Phase II: Consolidation Therapy|Progression/relapse|1
7666387|NCT01386385|26667602|P6|Phase II: Consolidation Therapy|Progression/relapse|0
7666388|NCT01386385|26667603|P5|Phase II: Consolidation Therapy|Progression/relapse|0
7666389|NCT01386385|26667604|P4|Phase II: Consolidation Therapy|Progression/relapse|0
7666390|NCT01386385|26667605|P3|Phase II: Consolidation Therapy|Progression/relapse|0
7666391|NCT01386385|26667606|P2|Phase II: Consolidation Therapy|Progression/relapse|0
7666392|NCT01386385|26667607|P1|Phase II: Consolidation Therapy|Progression/relapse|0
7666393|NCT01386385|26667600|P8|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666394|NCT01386385|26667601|P7|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
7666395|NCT01386385|26667602|P6|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666396|NCT01386385|26667603|P5|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666397|NCT01386385|26667604|P4|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666398|NCT01386385|26667605|P3|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666399|NCT01386385|26667606|P2|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666400|NCT01386385|26667607|P1|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7666401|NCT01386385|26667600|P8|Phase II: Consolidation Therapy|Adverse Event|1
7666402|NCT01386385|26667601|P7|Phase II: Consolidation Therapy|Adverse Event|2
7666403|NCT01386385|26667602|P6|Phase II: Consolidation Therapy|Adverse Event|0
7666404|NCT01386385|26667603|P5|Phase II: Consolidation Therapy|Adverse Event|0
7666405|NCT01386385|26667604|P4|Phase II: Consolidation Therapy|Adverse Event|0
7666406|NCT01386385|26667605|P3|Phase II: Consolidation Therapy|Adverse Event|0
7666407|NCT01386385|26667606|P2|Phase II: Consolidation Therapy|Adverse Event|0
7666408|NCT01386385|26667607|P1|Phase II: Consolidation Therapy|Adverse Event|0
7666409|NCT01386385|26667600|P8|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666410|NCT01386385|26667601|P7|Phase II Concurrent CRT|Refusal unrelated to AE|3
7666411|NCT01386385|26667602|P6|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666412|NCT01386385|26667603|P5|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666413|NCT01386385|26667604|P4|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666414|NCT01386385|26667605|P3|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666415|NCT01386385|26667606|P2|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666416|NCT01386385|26667607|P1|Phase II Concurrent CRT|Refusal unrelated to AE|0
7666417|NCT01386385|26667600|P8|Phase II Concurrent CRT|Adverse Event|3
7666418|NCT01386385|26667601|P7|Phase II Concurrent CRT|Adverse Event|3
7666419|NCT01386385|26667602|P6|Phase II Concurrent CRT|Adverse Event|0
7666420|NCT01386385|26667603|P5|Phase II Concurrent CRT|Adverse Event|0
7666421|NCT01386385|26667604|P4|Phase II Concurrent CRT|Adverse Event|0
7666422|NCT01386385|26667605|P3|Phase II Concurrent CRT|Adverse Event|0
7666423|NCT01386385|26667606|P2|Phase II Concurrent CRT|Adverse Event|0
7666424|NCT01386385|26667607|P1|Phase II Concurrent CRT|Adverse Event|0
7666425|NCT01386385|26667600|P8|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666426|NCT01386385|26667601|P7|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666427|NCT01386385|26667602|P6|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666428|NCT01386385|26667603|P5|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
7666429|NCT01386385|26667604|P4|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666430|NCT01386385|26667605|P3|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666431|NCT01386385|26667606|P2|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666432|NCT01386385|26667607|P1|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7666433|NCT01386385|26667600|P8|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666434|NCT01386385|26667601|P7|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666435|NCT01386385|26667602|P6|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666436|NCT01386385|26667603|P5|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666437|NCT01386385|26667604|P4|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666438|NCT01386385|26667605|P3|Phase I 80mg: Concurrent CRT|Adverse Event|2
7666439|NCT01386385|26667606|P2|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666440|NCT01386385|26667607|P1|Phase I 80mg: Concurrent CRT|Adverse Event|0
7666441|NCT01386385|26667600|P8|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666442|NCT01386385|26667601|P7|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666443|NCT01386385|26667602|P6|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666444|NCT01386385|26667603|P5|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666445|NCT01386385|26667604|P4|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666446|NCT01386385|26667605|P3|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666447|NCT01386385|26667606|P2|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7666448|NCT01386385|26667607|P1|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
7666449|NCT01386385|26667600|P8|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666450|NCT01386385|26667601|P7|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666451|NCT01386385|26667602|P6|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666452|NCT01386385|26667603|P5|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666453|NCT01386385|26667604|P4|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666454|NCT01386385|26667605|P3|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666455|NCT01386385|26667606|P2|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7666456|NCT01386385|26667607|P1|Phase I 40mg: Concurrent CRT|Progression/relapse|1
7666457|NCT01386125|26667634|P2|Overall Study|Participant Leaving Country|0
7666458|NCT01386125|26667635|P1|Overall Study|Participant Leaving Country|1
7666459|NCT01386125|26667634|P2|Overall Study|Lack of Efficacy|1
7666460|NCT01386125|26667635|P1|Overall Study|Lack of Efficacy|0
7666461|NCT01386125|26667634|P2|Overall Study|Adverse Event|5
7666462|NCT01386125|26667635|P1|Overall Study|Adverse Event|2
7666463|NCT01386125|26667634|P2|Overall Study|Withdrawal by Subject|12
7666464|NCT01386125|26667635|P1|Overall Study|Withdrawal by Subject|13
7666465|NCT01386125|26667634|P2|Overall Study|Disease Progress|2
7666466|NCT01386125|26667635|P1|Overall Study|Disease Progress|1
7666467|NCT01386125|26667634|P2|Overall Study|Protocol Violation|7
7666468|NCT01386125|26667635|P1|Overall Study|Protocol Violation|5
7666469|NCT01386125|26667634|P2|Overall Study|Physician Decision|1
7666470|NCT01386125|26667635|P1|Overall Study|Physician Decision|0
7666471|NCT01386125|26667634|P2|Overall Study|Lost to Follow-up|9
7666472|NCT01386125|26667635|P1|Overall Study|Lost to Follow-up|3
7666473|NCT01386008|26667643|P1|Overall Study|Adverse Event|3
7666474|NCT01386008|26667643|P1|Overall Study|exited w/o incident /study discontinued|17
7666475|NCT01385995|26667652|P2|Period 1, 2 Months|Physician Decision|0
7666476|NCT01385995|26667653|P1|Period 1, 2 Months|Physician Decision|1
7666477|NCT01385748|26667670|P3|Overall Study|Adverse Event|1
7666478|NCT01385748|26667671|P2|Overall Study|Adverse Event|2
7666479|NCT01385748|26667672|P1|Overall Study|Adverse Event|4
7666480|NCT01385748|26667670|P3|Overall Study|Other|1
7666481|NCT01385748|26667671|P2|Overall Study|Other|7
7666482|NCT01385748|26667672|P1|Overall Study|Other|1
7666483|NCT01385748|26667670|P3|Overall Study|Noncompliance|6
7666484|NCT01385748|26667671|P2|Overall Study|Noncompliance|1
7666485|NCT01385748|26667672|P1|Overall Study|Noncompliance|3
7666486|NCT01385748|26667670|P3|Overall Study|Withdrawal by Subject|5
7666487|NCT01385748|26667671|P2|Overall Study|Withdrawal by Subject|4
7666488|NCT01385748|26667672|P1|Overall Study|Withdrawal by Subject|7
7666489|NCT01385566|26667757|P6|Overall Study|Withdrawal by Subject|0
7666490|NCT01385566|26667758|P5|Overall Study|Withdrawal by Subject|0
7666491|NCT01385566|26667759|P4|Overall Study|Withdrawal by Subject|1
7666492|NCT01385566|26667760|P3|Overall Study|Withdrawal by Subject|0
7666493|NCT01385566|26667761|P2|Overall Study|Withdrawal by Subject|0
7666494|NCT01385566|26667762|P1|Overall Study|Withdrawal by Subject|0
7666495|NCT01385566|26667757|P6|Overall Study|Lost to Follow-up|0
7666496|NCT01385566|26667758|P5|Overall Study|Lost to Follow-up|0
7666497|NCT01385566|26667759|P4|Overall Study|Lost to Follow-up|0
7666498|NCT01385566|26667760|P3|Overall Study|Lost to Follow-up|0
7666499|NCT01385566|26667761|P2|Overall Study|Lost to Follow-up|0
7666500|NCT01385566|26667762|P1|Overall Study|Lost to Follow-up|1
7666501|NCT01385371|26667816|P2|Overall Study|Administrative|2
7666502|NCT01385371|26667817|P1|Overall Study|Administrative|2
7666503|NCT01385371|26667816|P2|Overall Study|Protocol Violation|21
7666504|NCT01385371|26667817|P1|Overall Study|Protocol Violation|25
7666505|NCT01385371|26667816|P2|Overall Study|Withdrawal by Subject|39
7666506|NCT01385371|26667817|P1|Overall Study|Withdrawal by Subject|52
7666507|NCT01385371|26667816|P2|Overall Study|Lost to Follow-up|16
7666508|NCT01385371|26667817|P1|Overall Study|Lost to Follow-up|16
7666509|NCT01385371|26667816|P2|Overall Study|Adverse Event|19
7666510|NCT01385371|26667817|P1|Overall Study|Adverse Event|54
7666511|NCT01385202|26667865|P1|Overall Study|Withdrawn|1
7666512|NCT01385202|26667865|P1|Overall Study|Not Eligible|11
7666513|NCT01385202|26667865|P1|Overall Study|Lost to Follow-up|6
7666514|NCT01385176|26667902|P2|6-18 Month All VNS Active|Heart Transplant|0
7666515|NCT01385176|26667903|P1|6-18 Month All VNS Active|Heart Transplant|1
7666516|NCT01385176|26667902|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
7666517|NCT01385176|26667903|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
7666518|NCT01385176|26667902|P2|6-18 Month All VNS Active|Physician Decision|1
7666519|NCT01385176|26667903|P1|6-18 Month All VNS Active|Physician Decision|0
7666520|NCT01385176|26667902|P2|6-18 Month All VNS Active|Death|2
7666521|NCT01385176|26667903|P1|6-18 Month All VNS Active|Death|1
7666522|NCT01385176|26667902|P2|Randomization Phase|Death|2
7666523|NCT01385176|26667903|P1|Randomization Phase|Death|1
7666524|NCT01385098|26667934|P1|Overall Study|Lost to Follow-up|4
7666525|NCT01385098|26667934|P1|Overall Study|Adverse Event|10
7666526|NCT01384877|26667956|P2|Treatment 2|Lost to Follow-up|2
7666527|NCT01384877|26667957|P1|Treatment 2|Lost to Follow-up|2
7666528|NCT01384760|26667983|P2|Overall Study|Protocol Violation|0
7666529|NCT01384760|26667984|P1|Overall Study|Protocol Violation|16
7666530|NCT01384760|26667983|P2|Overall Study|Lost to Follow-up|6
7666531|NCT01384760|26667984|P1|Overall Study|Lost to Follow-up|0
7666532|NCT01384734|26667997|P5|Overall Study|Physician Decision|0
7666533|NCT01384734|26667998|P4|Overall Study|Physician Decision|0
7666534|NCT01384734|26667999|P3|Overall Study|Physician Decision|0
7666535|NCT01384734|26668000|P2|Overall Study|Physician Decision|0
7666536|NCT01384734|26668001|P1|Overall Study|Physician Decision|1
7666537|NCT01384734|26667997|P5|Overall Study|Early termination|1
7666538|NCT01384734|26667998|P4|Overall Study|Early termination|0
7666539|NCT01384734|26667999|P3|Overall Study|Early termination|0
7666540|NCT01384734|26668000|P2|Overall Study|Early termination|0
7666541|NCT01384734|26668001|P1|Overall Study|Early termination|0
7666542|NCT01384734|26667997|P5|Overall Study|Adhesion problem|0
7666543|NCT01384734|26667998|P4|Overall Study|Adhesion problem|1
7666544|NCT01384734|26667999|P3|Overall Study|Adhesion problem|0
7666545|NCT01384734|26668000|P2|Overall Study|Adhesion problem|0
7666546|NCT01384734|26668001|P1|Overall Study|Adhesion problem|0
7666547|NCT01384734|26667997|P5|Overall Study|Missed End of treatment visit|0
7666548|NCT01384734|26667998|P4|Overall Study|Missed End of treatment visit|1
7666549|NCT01384734|26667999|P3|Overall Study|Missed End of treatment visit|0
7666550|NCT01384734|26668000|P2|Overall Study|Missed End of treatment visit|0
7666551|NCT01384734|26668001|P1|Overall Study|Missed End of treatment visit|0
7666552|NCT01384734|26667997|P5|Overall Study|As per Exclusion criteria|0
7666553|NCT01384734|26667998|P4|Overall Study|As per Exclusion criteria|0
7666554|NCT01384734|26667999|P3|Overall Study|As per Exclusion criteria|0
7666555|NCT01384734|26668000|P2|Overall Study|As per Exclusion criteria|1
7666556|NCT01384734|26668001|P1|Overall Study|As per Exclusion criteria|0
7666557|NCT01384734|26667997|P5|Overall Study|Prison|0
7666558|NCT01384734|26667998|P4|Overall Study|Prison|0
7666559|NCT01384734|26667999|P3|Overall Study|Prison|1
7666560|NCT01384734|26668000|P2|Overall Study|Prison|0
7666561|NCT01384734|26668001|P1|Overall Study|Prison|0
7666562|NCT01384734|26667997|P5|Overall Study|Unable to come back for visit|0
7666563|NCT01384734|26667998|P4|Overall Study|Unable to come back for visit|1
7666564|NCT01384734|26667999|P3|Overall Study|Unable to come back for visit|1
7666565|NCT01384734|26668000|P2|Overall Study|Unable to come back for visit|0
7666566|NCT01384734|26668001|P1|Overall Study|Unable to come back for visit|1
7666567|NCT01384734|26667997|P5|Overall Study|Investigator relocating|1
7666568|NCT01384734|26667998|P4|Overall Study|Investigator relocating|3
7666569|NCT01384734|26667999|P3|Overall Study|Investigator relocating|0
7666570|NCT01384734|26668000|P2|Overall Study|Investigator relocating|2
7666571|NCT01384734|26668001|P1|Overall Study|Investigator relocating|0
7666572|NCT01384734|26667997|P5|Overall Study|Withdrawal by Subject|9
7666573|NCT01384734|26667998|P4|Overall Study|Withdrawal by Subject|7
7666574|NCT01384734|26667999|P3|Overall Study|Withdrawal by Subject|6
7666575|NCT01384734|26668000|P2|Overall Study|Withdrawal by Subject|5
7666576|NCT01384734|26668001|P1|Overall Study|Withdrawal by Subject|5
7666577|NCT01384734|26667997|P5|Overall Study|Sponsor terminated|1
7666578|NCT01384734|26667998|P4|Overall Study|Sponsor terminated|0
7666579|NCT01384734|26667999|P3|Overall Study|Sponsor terminated|0
7666580|NCT01384734|26668000|P2|Overall Study|Sponsor terminated|0
7666581|NCT01384734|26668001|P1|Overall Study|Sponsor terminated|0
7666582|NCT01384734|26667997|P5|Overall Study|Pregnancy|1
7666583|NCT01384734|26667998|P4|Overall Study|Pregnancy|0
7666584|NCT01384734|26667999|P3|Overall Study|Pregnancy|0
7666585|NCT01384734|26668000|P2|Overall Study|Pregnancy|1
7666586|NCT01384734|26668001|P1|Overall Study|Pregnancy|0
7666587|NCT01384734|26667997|P5|Overall Study|Non-compliance with study drug|2
7666588|NCT01384734|26667998|P4|Overall Study|Non-compliance with study drug|0
7666589|NCT01384734|26667999|P3|Overall Study|Non-compliance with study drug|6
7666590|NCT01384734|26668000|P2|Overall Study|Non-compliance with study drug|2
7666591|NCT01384734|26668001|P1|Overall Study|Non-compliance with study drug|1
7666592|NCT01384734|26667997|P5|Overall Study|Lost to Follow-up|5
7666593|NCT01384734|26667998|P4|Overall Study|Lost to Follow-up|8
7666594|NCT01384734|26667999|P3|Overall Study|Lost to Follow-up|3
7666595|NCT01384734|26668000|P2|Overall Study|Lost to Follow-up|3
7666596|NCT01384734|26668001|P1|Overall Study|Lost to Follow-up|5
7666597|NCT01384734|26667997|P5|Overall Study|Lack of Efficacy|2
7666598|NCT01384734|26667998|P4|Overall Study|Lack of Efficacy|4
7666599|NCT01384734|26667999|P3|Overall Study|Lack of Efficacy|4
7666600|NCT01384734|26668000|P2|Overall Study|Lack of Efficacy|7
7666601|NCT01384734|26668001|P1|Overall Study|Lack of Efficacy|3
7666602|NCT01384734|26667997|P5|Overall Study|Continuation criteria not met|0
7666603|NCT01384734|26667998|P4|Overall Study|Continuation criteria not met|1
7666604|NCT01384734|26667999|P3|Overall Study|Continuation criteria not met|1
7666605|NCT01384734|26668000|P2|Overall Study|Continuation criteria not met|0
7666606|NCT01384734|26668001|P1|Overall Study|Continuation criteria not met|0
7666607|NCT01384734|26667997|P5|Overall Study|Death|0
7666608|NCT01384734|26667998|P4|Overall Study|Death|0
7666609|NCT01384734|26667999|P3|Overall Study|Death|1
7666610|NCT01384734|26668000|P2|Overall Study|Death|0
7666611|NCT01384734|26668001|P1|Overall Study|Death|1
7666612|NCT01384734|26667997|P5|Overall Study|Adverse Event|7
7666613|NCT01384734|26667998|P4|Overall Study|Adverse Event|2
7666614|NCT01384734|26667999|P3|Overall Study|Adverse Event|0
7666615|NCT01384734|26668000|P2|Overall Study|Adverse Event|3
7666616|NCT01384734|26668001|P1|Overall Study|Adverse Event|0
7666617|NCT01384292|26668230|P3|Part B|Severe non-compliance to protocol|0
7666618|NCT01384292|26668231|P2|Part B|Severe non-compliance to protocol|0
7666619|NCT01384292|26668232|P1|Part B|Severe non-compliance to protocol|1
7666620|NCT01384019|26668244|P2|Overall Study|MRI refusal|6
7666621|NCT01384019|26668245|P1|Overall Study|MRI refusal|6
7666622|NCT01384019|26668244|P2|Overall Study|Death|0
7666623|NCT01384019|26668245|P1|Overall Study|Death|1
7666624|NCT01384019|26668244|P2|Overall Study|Withdrawal by Subject|0
7666625|NCT01384019|26668245|P1|Overall Study|Withdrawal by Subject|3
7666626|NCT01383993|26668254|P3|Overall Study|Marketed voriconazole in post-therapy|0
7666627|NCT01383993|26668255|P2|Overall Study|Marketed voriconazole in post-therapy|0
7666628|NCT01383993|26668256|P1|Overall Study|Marketed voriconazole in post-therapy|2
7666629|NCT01383993|26668254|P3|Overall Study|Withdrawal by Subject|1
7666630|NCT01383993|26668255|P2|Overall Study|Withdrawal by Subject|0
7666631|NCT01383993|26668256|P1|Overall Study|Withdrawal by Subject|0
7666632|NCT01383993|26668254|P3|Overall Study|Adverse Event|0
7666633|NCT01383993|26668255|P2|Overall Study|Adverse Event|1
7666634|NCT01383993|26668256|P1|Overall Study|Adverse Event|1
7666635|NCT01383954|26668303|P1|Overall Study|Reason Not Specified|9
7666636|NCT01383954|26668303|P1|Overall Study|Adverse Event|1
7666637|NCT01383954|26668303|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
7666638|NCT01383954|26668303|P1|Overall Study|Lack of Efficacy|2
7666639|NCT01383928|26668311|P3|Overall Study|Unsatisfactory Therapeutic Response|1
7666640|NCT01383928|26668312|P2|Overall Study|Unsatisfactory Therapeutic Response|0
7666641|NCT01383928|26668313|P1|Overall Study|Unsatisfactory Therapeutic Response|0
7666642|NCT01383928|26668311|P3|Overall Study|Withdrawal by Subject|4
7666643|NCT01383928|26668312|P2|Overall Study|Withdrawal by Subject|0
7666644|NCT01383928|26668313|P1|Overall Study|Withdrawal by Subject|0
7666645|NCT01383928|26668311|P3|Overall Study|Progressive Disease|5
7666646|NCT01383928|26668312|P2|Overall Study|Progressive Disease|1
7666647|NCT01383928|26668313|P1|Overall Study|Progressive Disease|1
7666648|NCT01383928|26668311|P3|Overall Study|Other|4
7666649|NCT01383928|26668312|P2|Overall Study|Other|3
7666650|NCT01383928|26668313|P1|Overall Study|Other|1
7666651|NCT01383928|26668311|P3|Overall Study|Adverse Event|8
7666652|NCT01383928|26668312|P2|Overall Study|Adverse Event|2
7666653|NCT01383928|26668313|P1|Overall Study|Adverse Event|1
7666654|NCT01383928|26668311|P3|Overall Study|Initiation of ASCT|18
7666655|NCT01383928|26668312|P2|Overall Study|Initiation of ASCT|1
7666656|NCT01383928|26668313|P1|Overall Study|Initiation of ASCT|2
7666657|NCT01383707|26668394|P1|Overall Study|Progressive disease|23
7666658|NCT01383707|26668394|P1|Overall Study|Adverse Event|14
7666659|NCT01383707|26668394|P1|Overall Study|Sponsor's decision|2
7666660|NCT01383707|26668394|P1|Overall Study|Other|8
7666661|NCT01383707|26668394|P1|Overall Study|Death|19
7666662|NCT01383707|26668394|P1|Overall Study|Consent withdrawal|6
7666663|NCT01383499|26668434|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
7666664|NCT01383499|26668435|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
7666665|NCT01383499|26668436|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
7666666|NCT01383499|26668437|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
7666667|NCT01383486|26668487|P1|Overall Study|Did not take any product|6
7666668|NCT01383486|26668487|P1|Overall Study|Incomplete information for analysis|2
7666669|NCT01383486|26668487|P1|Overall Study|Lost to Follow-up|10
7666670|NCT01383356|26668564|P2|Period 1|Personal|2
7666671|NCT01383356|26668565|P1|Period 1|Personal|0
7666672|NCT01383356|26668564|P2|Period 1|Out of Range Mid-study-Test|1
7666673|NCT01383356|26668565|P1|Period 1|Out of Range Mid-study-Test|0
7666674|NCT01383356|26668564|P2|Period 1|Non-compliance|0
7666675|NCT01383356|26668565|P1|Period 1|Non-compliance|3
7666676|NCT01383356|26668564|P2|Period 1|Adverse Event|3
7666677|NCT01383356|26668565|P1|Period 1|Adverse Event|5
7666678|NCT01383317|26668577|P2|Overall Study|Adverse Event|1
7666679|NCT01383317|26668578|P1|Overall Study|Adverse Event|0
7666680|NCT01383317|26668577|P2|Overall Study|Death|0
7666681|NCT01383317|26668578|P1|Overall Study|Death|1
7666682|NCT01383317|26668577|P2|Overall Study|Lost to Follow-up|1
7666683|NCT01383317|26668578|P1|Overall Study|Lost to Follow-up|2
7666684|NCT01383174|26668620|P2|6 Month Assessment|Refused to complete|0
7666685|NCT01383174|26668621|P1|6 Month Assessment|Refused to complete|4
7666686|NCT01383174|26668620|P2|6 Month Assessment|Lost to Follow-up|1
7666687|NCT01383174|26668621|P1|6 Month Assessment|Lost to Follow-up|1
7666688|NCT01383174|26668620|P2|3 Month Assessment|Refused to complete|0
7666689|NCT01383174|26668621|P1|3 Month Assessment|Refused to complete|4
7666690|NCT01383174|26668620|P2|3 Month Assessment|Lost to Follow-up|0
7666691|NCT01383174|26668621|P1|3 Month Assessment|Lost to Follow-up|2
7666692|NCT01383174|26668620|P2|3 Month Assessment|Death|1
7666693|NCT01383174|26668621|P1|3 Month Assessment|Death|0
7666694|NCT01383161|26668647|P2|Overall Study|Lack of Efficacy|1
7666695|NCT01383161|26668648|P1|Overall Study|Lack of Efficacy|0
7666696|NCT01383161|26668647|P2|Overall Study|Withdrawal by Subject|2
7666697|NCT01383161|26668648|P1|Overall Study|Withdrawal by Subject|0
7666698|NCT01383161|26668647|P2|Overall Study|Adverse Event|1
7666699|NCT01383161|26668648|P1|Overall Study|Adverse Event|5
7666700|NCT01383096|26668667|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7666701|NCT01383096|26668668|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7666702|NCT01383096|26668669|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
7666703|NCT01383096|26668667|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7666704|NCT01383096|26668668|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7666705|NCT01383096|26668669|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
7666706|NCT01383096|26668667|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7666707|NCT01383096|26668668|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7666708|NCT01383096|26668669|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
7666709|NCT01383096|26668667|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7666710|NCT01383096|26668668|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7666711|NCT01383096|26668669|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7666712|NCT01383096|26668667|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7666713|NCT01383096|26668668|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7666714|NCT01383096|26668669|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
7666715|NCT01383096|26668667|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
7666716|NCT01383096|26668668|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
7666717|NCT01383096|26668669|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
7666718|NCT01383096|26668667|P3|Third Intervention (8 Days)|Adverse Event|0
7666719|NCT01383096|26668668|P2|Third Intervention (8 Days)|Adverse Event|0
7666720|NCT01383096|26668669|P1|Third Intervention (8 Days)|Adverse Event|1
7666721|NCT01383096|26668667|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7666722|NCT01383096|26668668|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
7666723|NCT01383096|26668669|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7666724|NCT01383096|26668667|P3|Third Intervention (8 Days)|Elevated AST|0
7666725|NCT01383096|26668668|P2|Third Intervention (8 Days)|Elevated AST|1
7666726|NCT01383096|26668669|P1|Third Intervention (8 Days)|Elevated AST|0
7666727|NCT01383096|26668667|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7666728|NCT01383096|26668668|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7666729|NCT01383096|26668669|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7666730|NCT01383096|26668667|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7666731|NCT01383096|26668668|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7666732|NCT01383096|26668669|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7666733|NCT01383018|26668715|P1|Overall Study|Subject Incarcerated|1
7666734|NCT01383018|26668715|P1|Overall Study|Patient moved away from site|1
7666735|NCT01383018|26668715|P1|Overall Study|Site closed early-not compliance related|7
7666736|NCT01383018|26668715|P1|Overall Study|Missed Visit|247
7666737|NCT01383018|26668715|P1|Overall Study|Subject not implanted|76
7666738|NCT01383018|26668715|P1|Overall Study|Withdrawal by Subject|9
7666739|NCT01383018|26668715|P1|Overall Study|Physician Decision|5
7666740|NCT01383018|26668715|P1|Overall Study|Lost to Follow-up|5
7666741|NCT01383018|26668715|P1|Overall Study|Death|10
7666742|NCT01383018|26668715|P1|Overall Study|Adverse Event|14
7666743|NCT01382940|26668777|P1|Overall Study|Protocol Violation|20
7666744|NCT01382940|26668777|P1|Overall Study|Withdrawal by Subject|23
7666745|NCT01382940|26668777|P1|Overall Study|Physician Decision|7
7666746|NCT01382940|26668777|P1|Overall Study|Lost to Follow-up|4
7666747|NCT01382940|26668777|P1|Overall Study|Adverse Event|19
7666748|NCT01382602|26668839|P2|Overall Study|Withdrawal by Subject|1
7666749|NCT01382602|26668840|P1|Overall Study|Withdrawal by Subject|0
7666750|NCT01382602|26668839|P2|Overall Study|Protocol Violation|3
7666751|NCT01382602|26668840|P1|Overall Study|Protocol Violation|0
7666752|NCT01382446|26668848|P2|Overall Study|Removal from Mechanical Ventilation|3
7666753|NCT01382446|26668849|P1|Overall Study|Removal from Mechanical Ventilation|3
7666754|NCT01382446|26668848|P2|Overall Study|Withdrawal by Subject|1
7666755|NCT01382446|26668849|P1|Overall Study|Withdrawal by Subject|0
7666756|NCT01382251|26668876|P2|Overall Study|Contacted after study closed|1
7666757|NCT01382251|26668877|P1|Overall Study|Contacted after study closed|1
7666758|NCT01382251|26668876|P2|Overall Study|Lost to Follow-up|4
7666759|NCT01382251|26668877|P1|Overall Study|Lost to Follow-up|4
7666760|NCT01382251|26668876|P2|Overall Study|Surgeries cancelled or delayed|16
7666761|NCT01382251|26668877|P1|Overall Study|Surgeries cancelled or delayed|16
7666762|NCT01382225|26668890|P2|Overall Study|Other|2
7666763|NCT01382225|26668891|P1|Overall Study|Other|4
7666764|NCT01382225|26668890|P2|Overall Study|Subject Withdrew Consent|2
7666765|NCT01382225|26668891|P1|Overall Study|Subject Withdrew Consent|5
7666766|NCT01382225|26668890|P2|Overall Study|Protocol Violation|1
7666767|NCT01382225|26668891|P1|Overall Study|Protocol Violation|2
7666768|NCT01382225|26668890|P2|Overall Study|Adverse Event|2
7666769|NCT01382225|26668891|P1|Overall Study|Adverse Event|3
7666770|NCT01382212|26668913|P1|Overall Study|Withdrew consent|1
7666771|NCT01382212|26668913|P1|Overall Study|Kidney transplant|1
7666772|NCT01381926|26668976|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
7666773|NCT01381926|26668977|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
7666774|NCT01381926|26668976|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
7666775|NCT01381926|26668977|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
7666776|NCT01381900|26668990|P3|Overall Study|Early withdraw|1
7666777|NCT01381900|26668991|P2|Overall Study|Early withdraw|1
7666778|NCT01381900|26668992|P1|Overall Study|Early withdraw|3
7666779|NCT01381900|26668990|P3|Overall Study|Withdrawal by Subject|1
7666780|NCT01381900|26668991|P2|Overall Study|Withdrawal by Subject|0
7666781|NCT01381900|26668992|P1|Overall Study|Withdrawal by Subject|0
7666782|NCT01381900|26668990|P3|Overall Study|Protocol Violation|1
7666783|NCT01381900|26668991|P2|Overall Study|Protocol Violation|1
7666784|NCT01381900|26668992|P1|Overall Study|Protocol Violation|0
7666785|NCT01381900|26668990|P3|Overall Study|Physician Decision|1
7666786|NCT01381900|26668991|P2|Overall Study|Physician Decision|1
7666787|NCT01381900|26668992|P1|Overall Study|Physician Decision|0
7666788|NCT01381900|26668990|P3|Overall Study|Noncompliance with study drug|1
7666789|NCT01381900|26668991|P2|Overall Study|Noncompliance with study drug|0
7666790|NCT01381900|26668992|P1|Overall Study|Noncompliance with study drug|0
7666791|NCT01381900|26668990|P3|Overall Study|Adverse Event|7
7666792|NCT01381900|26668991|P2|Overall Study|Adverse Event|6
7666793|NCT01381900|26668992|P1|Overall Study|Adverse Event|4
7666794|NCT01381900|26668990|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
7666795|NCT01381900|26668991|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
7666796|NCT01381900|26668992|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
7666797|NCT01381874|26669015|P3|Overall Study|Other|67
7666798|NCT01381874|26669016|P2|Overall Study|Other|52
7666799|NCT01381874|26669017|P1|Overall Study|Other|67
7666800|NCT01381874|26669015|P3|Overall Study|Withdrawal by Subject|9
7666801|NCT01381874|26669016|P2|Overall Study|Withdrawal by Subject|10
7666802|NCT01381874|26669017|P1|Overall Study|Withdrawal by Subject|9
7666803|NCT01381874|26669015|P3|Overall Study|Lost to Follow-up|0
7666804|NCT01381874|26669016|P2|Overall Study|Lost to Follow-up|1
7666805|NCT01381874|26669017|P1|Overall Study|Lost to Follow-up|1
7666806|NCT01381718|26669056|P2|Overall Study|Toxicity, side effects or complications related to study|3
7666807|NCT01381718|26669057|P1|Overall Study|Toxicity, side effects or complications related to study|0
7666808|NCT01381718|26669056|P2|Overall Study|Lost to Follow-up|5
7666809|NCT01381718|26669057|P1|Overall Study|Lost to Follow-up|3
7666810|NCT01381718|26669056|P2|Overall Study|Withdrawal by Subject|5
7666811|NCT01381718|26669057|P1|Overall Study|Withdrawal by Subject|2
7666812|NCT01381692|26669071|P6|Overall Study|Adverse Event|0
7666813|NCT01381692|26669072|P5|Overall Study|Adverse Event|0
7666814|NCT01381692|26669073|P4|Overall Study|Adverse Event|0
7666815|NCT01381692|26669074|P3|Overall Study|Adverse Event|0
7666816|NCT01381692|26669075|P2|Overall Study|Adverse Event|0
7666817|NCT01381692|26669076|P1|Overall Study|Adverse Event|1
7666818|NCT01381679|26669098|P1|Overall Study|Lost to Follow-up|885
7666819|NCT01381679|26669098|P1|Overall Study|Adverse Event|3
7666820|NCT01381575|26669113|P3|Overall Study|Lost to Follow-up|9
7666821|NCT01381575|26669114|P2|Overall Study|Lost to Follow-up|17
7666822|NCT01381575|26669115|P1|Overall Study|Lost to Follow-up|8
7666823|NCT01381575|26669113|P3|Overall Study|Migrated/moved from study area|2
7666824|NCT01381575|26669114|P2|Overall Study|Migrated/moved from study area|12
7666825|NCT01381575|26669115|P1|Overall Study|Migrated/moved from study area|2
7666826|NCT01381575|26669113|P3|Overall Study|Withdrawal by Subject|7
7666827|NCT01381575|26669114|P2|Overall Study|Withdrawal by Subject|9
7666828|NCT01381575|26669115|P1|Overall Study|Withdrawal by Subject|15
7666829|NCT01381575|26669113|P3|Overall Study|Protocol Violation|1
7666830|NCT01381575|26669114|P2|Overall Study|Protocol Violation|1
7666831|NCT01381575|26669115|P1|Overall Study|Protocol Violation|0
7666832|NCT01381575|26669113|P3|Overall Study|Non-Serious Adverse Event|1
7666833|NCT01381575|26669114|P2|Overall Study|Non-Serious Adverse Event|0
7666834|NCT01381575|26669115|P1|Overall Study|Non-Serious Adverse Event|0
7666835|NCT01381575|26669113|P3|Overall Study|Serious Adverse Event|0
7666836|NCT01381575|26669114|P2|Overall Study|Serious Adverse Event|0
7666837|NCT01381575|26669115|P1|Overall Study|Serious Adverse Event|1
7666838|NCT01381562|26669172|P3|Overall Study|Adverse Event|0
7666839|NCT01381562|26669173|P2|Overall Study|Adverse Event|1
7666840|NCT01381562|26669174|P1|Overall Study|Adverse Event|0
7666841|NCT01381549|26669242|P3|Overall Study|Ineligible: No organisms isolated|1
7666842|NCT01381549|26669243|P2|Overall Study|Ineligible: No organisms isolated|0
7666843|NCT01381549|26669244|P1|Overall Study|Ineligible: No organisms isolated|0
7666844|NCT01381068|26669391|P2|Overall Study|Death|0
7666845|NCT01381068|26669392|P1|Overall Study|Death|1
7666846|NCT01381016|26669412|P2|Overall Study|Physician Decision|2
7666847|NCT01381016|26669413|P1|Overall Study|Physician Decision|0
7666848|NCT01381016|26669412|P2|Overall Study|Withdrawal by Subject|1
7666849|NCT01381016|26669413|P1|Overall Study|Withdrawal by Subject|0
7666850|NCT01381016|26669412|P2|Overall Study|Screen Failure|2
7666851|NCT01381016|26669413|P1|Overall Study|Screen Failure|2
7666852|NCT01381016|26669412|P2|Overall Study|Lost to Follow-up|1
7666853|NCT01381016|26669413|P1|Overall Study|Lost to Follow-up|1
7666854|NCT01380990|26669423|P2|Overall Study|Death|1
7666855|NCT01380990|26669424|P1|Overall Study|Death|0
7666856|NCT01380990|26669423|P2|Overall Study|Treatment Failure|0
7666857|NCT01380990|26669424|P1|Overall Study|Treatment Failure|1
7666858|NCT01380834|26669492|P2|Overall Study|Physician Decision|0
7666859|NCT01380834|26669493|P1|Overall Study|Physician Decision|1
7666860|NCT01380782|26669505|P4|Overall Study|Withdrawal by Subject|1
7666861|NCT01380782|26669506|P3|Overall Study|Withdrawal by Subject|1
7666862|NCT01380782|26669507|P2|Overall Study|Withdrawal by Subject|0
7666863|NCT01380782|26669508|P1|Overall Study|Withdrawal by Subject|0
7666864|NCT01380782|26669505|P4|Overall Study|Physician Decision|0
7666865|NCT01380782|26669506|P3|Overall Study|Physician Decision|0
7666866|NCT01380782|26669507|P2|Overall Study|Physician Decision|0
7666867|NCT01380782|26669508|P1|Overall Study|Physician Decision|1
7666868|NCT01380782|26669505|P4|Overall Study|Lack of Efficacy|3
7666869|NCT01380782|26669506|P3|Overall Study|Lack of Efficacy|10
7666870|NCT01380782|26669507|P2|Overall Study|Lack of Efficacy|9
7666871|NCT01380782|26669508|P1|Overall Study|Lack of Efficacy|10
7666872|NCT01380782|26669505|P4|Overall Study|Death|0
7666873|NCT01380782|26669506|P3|Overall Study|Death|0
7666874|NCT01380782|26669507|P2|Overall Study|Death|0
7666875|NCT01380782|26669508|P1|Overall Study|Death|1
7666876|NCT01380782|26669505|P4|Overall Study|Adverse Event|0
7666877|NCT01380782|26669506|P3|Overall Study|Adverse Event|0
7666878|NCT01380782|26669507|P2|Overall Study|Adverse Event|1
7666879|NCT01380782|26669508|P1|Overall Study|Adverse Event|0
7666880|NCT01380769|26669531|P2|Overall Study|Protocol Violation|1
7666881|NCT01380769|26669532|P1|Overall Study|Protocol Violation|0
7666882|NCT01380769|26669531|P2|Overall Study|Adverse Event|1
7666883|NCT01380769|26669532|P1|Overall Study|Adverse Event|1
7666884|NCT01380769|26669531|P2|Overall Study|Physician Decision|1
7666885|NCT01380769|26669532|P1|Overall Study|Physician Decision|1
7666886|NCT01380769|26669531|P2|Overall Study|Withdrawal by Subject|11
7666887|NCT01380769|26669532|P1|Overall Study|Withdrawal by Subject|7
7666888|NCT01380730|26669593|P8|Overall Study|Death|0
7666889|NCT01380730|26669594|P7|Overall Study|Death|0
7666890|NCT01380730|26669595|P6|Overall Study|Death|0
7666891|NCT01380730|26669596|P5|Overall Study|Death|1
7666892|NCT01380730|26669597|P4|Overall Study|Death|0
7666893|NCT01380730|26669598|P3|Overall Study|Death|0
7666894|NCT01380730|26669599|P2|Overall Study|Death|0
7666895|NCT01380730|26669600|P1|Overall Study|Death|0
7666896|NCT01380691|26669658|P4|Washout (7 Days)|Withdrawal by Subject|0
7666897|NCT01380691|26669659|P3|Washout (7 Days)|Withdrawal by Subject|1
7666898|NCT01380691|26669660|P2|Washout (7 Days)|Withdrawal by Subject|0
7666899|NCT01380691|26669661|P1|Washout (7 Days)|Withdrawal by Subject|0
7666900|NCT01380691|26669658|P4|Washout (7 Days)|Protocol Violation|1
7666901|NCT01380691|26669659|P3|Washout (7 Days)|Protocol Violation|0
7666902|NCT01380691|26669660|P2|Washout (7 Days)|Protocol Violation|0
7666903|NCT01380691|26669661|P1|Washout (7 Days)|Protocol Violation|0
7666904|NCT01380535|26669722|P2|Overall Study|Lack of Efficacy|3
7666905|NCT01380535|26669723|P1|Overall Study|Lack of Efficacy|0
7666906|NCT01380535|26669722|P2|Overall Study|Protocol Violation|2
7666907|NCT01380535|26669723|P1|Overall Study|Protocol Violation|0
7666908|NCT01380535|26669722|P2|Overall Study|Withdrawal by Subject|2
7666909|NCT01380535|26669723|P1|Overall Study|Withdrawal by Subject|1
7666910|NCT01380535|26669722|P2|Overall Study|Study site closed|5
7666911|NCT01380535|26669723|P1|Overall Study|Study site closed|0
7666912|NCT01380535|26669722|P2|Overall Study|Death|0
7666913|NCT01380535|26669723|P1|Overall Study|Death|3
7666914|NCT01380535|26669722|P2|Overall Study|Adverse Event|3
7666915|NCT01380535|26669723|P1|Overall Study|Adverse Event|3
7666916|NCT01380379|26669729|P1|Overall Study|Pregnancy|1
7666917|NCT01380327|26669742|P3|Overall Study|Questionable onset of epilepsy|1
7666918|NCT01380327|26669743|P2|Overall Study|Questionable onset of epilepsy|0
7666919|NCT01380327|26669744|P1|Overall Study|Questionable onset of epilepsy|0
7666920|NCT01380327|26669742|P3|Overall Study|Housing situation precluded ability to k|1
7666921|NCT01380327|26669743|P2|Overall Study|Housing situation precluded ability to k|0
7666922|NCT01380327|26669744|P1|Overall Study|Housing situation precluded ability to k|0
7666923|NCT01380327|26669742|P3|Overall Study|Withdrawal by Subject|1
7666924|NCT01380327|26669743|P2|Overall Study|Withdrawal by Subject|0
7666925|NCT01380327|26669744|P1|Overall Study|Withdrawal by Subject|0
7666926|NCT01380327|26669742|P3|Overall Study|Protocol Violation|3
7666927|NCT01380327|26669743|P2|Overall Study|Protocol Violation|2
7666928|NCT01380327|26669744|P1|Overall Study|Protocol Violation|3
7666929|NCT01380327|26669742|P3|Overall Study|Lost to Follow-up|1
7666930|NCT01380327|26669743|P2|Overall Study|Lost to Follow-up|1
7666931|NCT01380327|26669744|P1|Overall Study|Lost to Follow-up|0
7666932|NCT01380184|26669775|P1|Part 2|Lost to Follow-up|1
7666933|NCT01380184|26669775|P1|Part 2|Disease Progression|8
7666934|NCT01380184|26669775|P1|Part 2|Adverse Event|5
7666935|NCT01380184|26669775|P1|Part 1 (19 Days)|Adverse Event|1
7666936|NCT01380145|26669786|P1|Overall Study|Progressive disease|4
7666937|NCT01380093|26669805|P9|Treatment Phase: Third Intervention|Other|1
7666938|NCT01380093|26669806|P8|Treatment Phase: Third Intervention|Other|0
7666939|NCT01380093|26669807|P7|Treatment Phase: Third Intervention|Other|0
7666940|NCT01380093|26669808|P6|Treatment Phase: Third Intervention|Other|0
7666941|NCT01380093|26669809|P5|Treatment Phase: Third Intervention|Other|0
7666942|NCT01380093|26669810|P4|Treatment Phase: Third Intervention|Other|0
7666943|NCT01380093|26669811|P3|Treatment Phase: Third Intervention|Other|0
7666944|NCT01380093|26669812|P2|Treatment Phase: Third Intervention|Other|0
7666945|NCT01380093|26669813|P1|Treatment Phase: Third Intervention|Other|0
7666946|NCT01380093|26669805|P9|Treatment Phase: Third Intervention|Non-compliance|1
7666947|NCT01380093|26669806|P8|Treatment Phase: Third Intervention|Non-compliance|0
7666948|NCT01380093|26669807|P7|Treatment Phase: Third Intervention|Non-compliance|0
7666949|NCT01380093|26669808|P6|Treatment Phase: Third Intervention|Non-compliance|0
7666950|NCT01380093|26669809|P5|Treatment Phase: Third Intervention|Non-compliance|0
7666951|NCT01380093|26669810|P4|Treatment Phase: Third Intervention|Non-compliance|0
7666952|NCT01380093|26669811|P3|Treatment Phase: Third Intervention|Non-compliance|0
7666953|NCT01380093|26669812|P2|Treatment Phase: Third Intervention|Non-compliance|0
7666954|NCT01380093|26669813|P1|Treatment Phase: Third Intervention|Non-compliance|0
7666955|NCT01380093|26669805|P9|Treatment Phase: Second Intervention|Other|0
7666956|NCT01380093|26669806|P8|Treatment Phase: Second Intervention|Other|0
7666957|NCT01380093|26669807|P7|Treatment Phase: Second Intervention|Other|0
7666958|NCT01380093|26669808|P6|Treatment Phase: Second Intervention|Other|0
7666959|NCT01380093|26669809|P5|Treatment Phase: Second Intervention|Other|0
7666960|NCT01380093|26669810|P4|Treatment Phase: Second Intervention|Other|1
7666961|NCT01380093|26669811|P3|Treatment Phase: Second Intervention|Other|0
7666962|NCT01380093|26669812|P2|Treatment Phase: Second Intervention|Other|0
7666963|NCT01380093|26669813|P1|Treatment Phase: Second Intervention|Other|0
7666964|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666965|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666966|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666967|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666968|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666969|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666970|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
7666971|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666972|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
7666973|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 2|Backup participant|0
7666974|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 2|Backup participant|0
7666975|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 2|Backup participant|0
7666976|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 2|Backup participant|0
7666977|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 2|Backup participant|0
7666978|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 2|Backup participant|0
7666979|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 2|Backup participant|1
7666980|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 2|Backup participant|0
7666981|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 2|Backup participant|0
7666982|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666983|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666984|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666985|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666986|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666987|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666988|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7666989|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7666990|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7666991|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
7666992|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
7666993|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
7666994|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
7666995|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
7666996|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
7666997|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
7666998|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
7666999|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
7667000|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667001|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667002|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667003|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667004|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667005|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667006|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667007|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
7667008|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7667009|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
7667010|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
7667011|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
7667012|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
7667013|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
7667014|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
7667015|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
7667016|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
7667017|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
7667018|NCT01380093|26669805|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667019|NCT01380093|26669806|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667020|NCT01380093|26669807|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667021|NCT01380093|26669808|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667022|NCT01380093|26669809|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667023|NCT01380093|26669810|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667024|NCT01380093|26669811|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667025|NCT01380093|26669812|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
7667026|NCT01380093|26669813|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
7667027|NCT01380093|26669805|P9|Naloxone Challenge Phase|Screen failures|0
7667028|NCT01380093|26669806|P8|Naloxone Challenge Phase|Screen failures|0
7667029|NCT01380093|26669807|P7|Naloxone Challenge Phase|Screen failures|0
7667030|NCT01380093|26669808|P6|Naloxone Challenge Phase|Screen failures|0
7667031|NCT01380093|26669809|P5|Naloxone Challenge Phase|Screen failures|0
7667032|NCT01380093|26669810|P4|Naloxone Challenge Phase|Screen failures|0
7667033|NCT01380093|26669811|P3|Naloxone Challenge Phase|Screen failures|0
7667034|NCT01380093|26669812|P2|Naloxone Challenge Phase|Screen failures|0
7667035|NCT01380093|26669813|P1|Naloxone Challenge Phase|Screen failures|21
7667036|NCT01380080|26670105|P2|Overall Study|Lost to Follow-up|3
7667037|NCT01380080|26670106|P1|Overall Study|Lost to Follow-up|3
7667038|NCT01380080|26670105|P2|Overall Study|Withdrawal by Subject|2
7667039|NCT01380080|26670106|P1|Overall Study|Withdrawal by Subject|5
7667040|NCT01380080|26670105|P2|Overall Study|Not willing to adhere to requirements|2
7667041|NCT01380080|26670106|P1|Overall Study|Not willing to adhere to requirements|6
7667042|NCT01380080|26670105|P2|Overall Study|Not able to get to clinic|1
7667043|NCT01380080|26670106|P1|Overall Study|Not able to get to clinic|7
7667044|NCT01380080|26670105|P2|Overall Study|Site is closing|31
7667045|NCT01380080|26670106|P1|Overall Study|Site is closing|28
7667046|NCT01380080|26670105|P2|Overall Study|Death|44
7667047|NCT01380080|26670106|P1|Overall Study|Death|36
7667048|NCT01379937|26670151|P4|Overall Study|Lost to Follow-up|0
7667049|NCT01379937|26670152|P3|Overall Study|Lost to Follow-up|2
7667050|NCT01379937|26670153|P2|Overall Study|Lost to Follow-up|2
7667051|NCT01379937|26670154|P1|Overall Study|Lost to Follow-up|1
7667052|NCT01379937|26670151|P4|Overall Study|Consent withdrawal|0
7667053|NCT01379937|26670152|P3|Overall Study|Consent withdrawal|0
7667054|NCT01379937|26670153|P2|Overall Study|Consent withdrawal|1
7667055|NCT01379937|26670154|P1|Overall Study|Consent withdrawal|0
7667056|NCT01379937|26670151|P4|Overall Study|Protocol Violation|1
7667057|NCT01379937|26670152|P3|Overall Study|Protocol Violation|0
7667058|NCT01379937|26670153|P2|Overall Study|Protocol Violation|0
7667059|NCT01379937|26670154|P1|Overall Study|Protocol Violation|0
7667060|NCT01379781|26670274|P2|Overall Study|Lost to Follow-up|8
7667061|NCT01379781|26670275|P1|Overall Study|Lost to Follow-up|11
7667062|NCT01379768|26670284|P3|Overall Study|Lost to Follow-up|0
7667063|NCT01379768|26670285|P2|Overall Study|Lost to Follow-up|0
7667064|NCT01379768|26670286|P1|Overall Study|Lost to Follow-up|2
7667065|NCT01379768|26670284|P3|Overall Study|Adverse Event|0
7667066|NCT01379768|26670285|P2|Overall Study|Adverse Event|1
7667067|NCT01379768|26670286|P1|Overall Study|Adverse Event|1
7667068|NCT01379703|26670309|P3|9 Months Through 18 Months|Reason Unknown|0
7667069|NCT01379703|26670310|P2|9 Months Through 18 Months|Reason Unknown|23
7667070|NCT01379703|26670311|P1|9 Months Through 18 Months|Reason Unknown|0
7667071|NCT01379703|26670309|P3|9 Months Through 18 Months|Fatigue|0
7667072|NCT01379703|26670310|P2|9 Months Through 18 Months|Fatigue|1
7667073|NCT01379703|26670311|P1|9 Months Through 18 Months|Fatigue|0
7667074|NCT01379703|26670309|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7667075|NCT01379703|26670310|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
7667076|NCT01379703|26670311|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7667077|NCT01379703|26670309|P3|9 Months Through 18 Months|Patient Noncompliance|0
7667078|NCT01379703|26670310|P2|9 Months Through 18 Months|Patient Noncompliance|4
7667079|NCT01379703|26670311|P1|9 Months Through 18 Months|Patient Noncompliance|0
7667080|NCT01379703|26670309|P3|9 Months Through 18 Months|Treatment failure|0
7667081|NCT01379703|26670310|P2|9 Months Through 18 Months|Treatment failure|5
7667082|NCT01379703|26670311|P1|9 Months Through 18 Months|Treatment failure|0
7667083|NCT01379703|26670309|P3|9 Months Through 18 Months|Adverse Event|0
7667084|NCT01379703|26670310|P2|9 Months Through 18 Months|Adverse Event|6
7667085|NCT01379703|26670311|P1|9 Months Through 18 Months|Adverse Event|0
7667086|NCT01379703|26670309|P3|9 Months Through 18 Months|Withdrawal by Subject|0
7667087|NCT01379703|26670310|P2|9 Months Through 18 Months|Withdrawal by Subject|11
7667088|NCT01379703|26670311|P1|9 Months Through 18 Months|Withdrawal by Subject|0
7667089|NCT01379703|26670309|P3|9 Months Through 18 Months|Lost to Follow-up|0
7667090|NCT01379703|26670310|P2|9 Months Through 18 Months|Lost to Follow-up|178
7667091|NCT01379703|26670311|P1|9 Months Through 18 Months|Lost to Follow-up|0
7667092|NCT01379703|26670309|P3|Study Start Through 9 Months|Reason unknown|24
7667093|NCT01379703|26670310|P2|Study Start Through 9 Months|Reason unknown|31
7667094|NCT01379703|26670311|P1|Study Start Through 9 Months|Reason unknown|2
7667095|NCT01379703|26670309|P3|Study Start Through 9 Months|Increased triglycerides|0
7667096|NCT01379703|26670310|P2|Study Start Through 9 Months|Increased triglycerides|1
7667097|NCT01379703|26670311|P1|Study Start Through 9 Months|Increased triglycerides|0
7667098|NCT01379703|26670309|P3|Study Start Through 9 Months|Poor general condition|0
7667099|NCT01379703|26670310|P2|Study Start Through 9 Months|Poor general condition|1
7667100|NCT01379703|26670311|P1|Study Start Through 9 Months|Poor general condition|0
7667101|NCT01379703|26670309|P3|Study Start Through 9 Months|Medication not available|1
7667102|NCT01379703|26670310|P2|Study Start Through 9 Months|Medication not available|2
7667103|NCT01379703|26670311|P1|Study Start Through 9 Months|Medication not available|0
7667104|NCT01379703|26670309|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7667105|NCT01379703|26670310|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
7667106|NCT01379703|26670311|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7667107|NCT01379703|26670309|P3|Study Start Through 9 Months|Patient Noncompliance|1
7667108|NCT01379703|26670310|P2|Study Start Through 9 Months|Patient Noncompliance|0
7667109|NCT01379703|26670311|P1|Study Start Through 9 Months|Patient Noncompliance|0
7667110|NCT01379703|26670309|P3|Study Start Through 9 Months|Treatment Failure|2
7667111|NCT01379703|26670310|P2|Study Start Through 9 Months|Treatment Failure|2
7667112|NCT01379703|26670311|P1|Study Start Through 9 Months|Treatment Failure|0
7667113|NCT01379703|26670309|P3|Study Start Through 9 Months|Withdrawal by Subject|1
7667114|NCT01379703|26670310|P2|Study Start Through 9 Months|Withdrawal by Subject|6
7667115|NCT01379703|26670311|P1|Study Start Through 9 Months|Withdrawal by Subject|0
7667116|NCT01379703|26670309|P3|Study Start Through 9 Months|Adverse Event|10
7667117|NCT01379703|26670310|P2|Study Start Through 9 Months|Adverse Event|14
7667118|NCT01379703|26670311|P1|Study Start Through 9 Months|Adverse Event|0
7667119|NCT01379703|26670309|P3|Study Start Through 9 Months|Lost to Follow-up|104
7667120|NCT01379703|26670310|P2|Study Start Through 9 Months|Lost to Follow-up|61
7667121|NCT01379703|26670311|P1|Study Start Through 9 Months|Lost to Follow-up|2
7667122|NCT01379573|26670409|P1|Overall Study|Screen Failure|10
7667123|NCT01379573|26670409|P1|Overall Study|Lost to Follow-up|1
7667124|NCT01379534|26670423|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
7667125|NCT01379534|26670424|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
7667126|NCT01379534|26670423|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
7667127|NCT01379534|26670424|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
7667128|NCT01379534|26670423|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
7667129|NCT01379534|26670424|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
7667130|NCT01379534|26670423|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
7667131|NCT01379534|26670424|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
7667132|NCT01379534|26670423|P2|Treatment Phase|Adverse Event|7
7667133|NCT01379534|26670424|P1|Treatment Phase|Adverse Event|7
7667134|NCT01379534|26670423|P2|Treatment Phase|Progressive disease|22
7667135|NCT01379534|26670424|P1|Treatment Phase|Progressive disease|13
7667136|NCT01379534|26670423|P2|Treatment Phase|Withdrawal by Subject|2
7667137|NCT01379534|26670424|P1|Treatment Phase|Withdrawal by Subject|2
7667138|NCT01379521|26670444|P2|Post-Treatment Evaluations|Death|0
7667139|NCT01379521|26670445|P1|Post-Treatment Evaluations|Death|1
7667140|NCT01379521|26670444|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
7667141|NCT01379521|26670445|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
7667142|NCT01379521|26670444|P2|Post-Treatment Evaluations|Disease Progression|20
7667143|NCT01379521|26670445|P1|Post-Treatment Evaluations|Disease Progression|22
7667144|NCT01379521|26670444|P2|Overall Study -Treatment Period|Death|1
7667145|NCT01379521|26670445|P1|Overall Study -Treatment Period|Death|2
7667146|NCT01379521|26670444|P2|Overall Study -Treatment Period|Administrative Problems|0
7667147|NCT01379521|26670445|P1|Overall Study -Treatment Period|Administrative Problems|1
7667148|NCT01379521|26670444|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
7667149|NCT01379521|26670445|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
7667150|NCT01379521|26670444|P2|Overall Study -Treatment Period|Protocol Deviation|2
7667151|NCT01379521|26670445|P1|Overall Study -Treatment Period|Protocol Deviation|0
7667152|NCT01379521|26670444|P2|Overall Study -Treatment Period|New Cancer Therapy|0
7667153|NCT01379521|26670445|P1|Overall Study -Treatment Period|New Cancer Therapy|1
7667154|NCT01379521|26670444|P2|Overall Study -Treatment Period|Disease Progression|22
7667155|NCT01379521|26670445|P1|Overall Study -Treatment Period|Disease Progression|23
7667156|NCT01379521|26670444|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
7667157|NCT01379521|26670445|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
7667158|NCT01379521|26670444|P2|Overall Study -Treatment Period|Adverse Event|0
7667159|NCT01379521|26670445|P1|Overall Study -Treatment Period|Adverse Event|3
7667160|NCT01379508|26670467|P4|Extension Period Weeks 109-156|Protocol Violation|0
7667161|NCT01379508|26670468|P3|Extension Period Weeks 109-156|Protocol Violation|0
7667162|NCT01379508|26670469|P2|Extension Period Weeks 109-156|Protocol Violation|1
7667163|NCT01379508|26670470|P1|Extension Period Weeks 109-156|Protocol Violation|2
7667164|NCT01379508|26670467|P4|Extension Period Weeks 109-156|Administrative problems|0
7667165|NCT01379508|26670468|P3|Extension Period Weeks 109-156|Administrative problems|1
7667166|NCT01379508|26670469|P2|Extension Period Weeks 109-156|Administrative problems|0
7667167|NCT01379508|26670470|P1|Extension Period Weeks 109-156|Administrative problems|3
7667168|NCT01379508|26670467|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
7667169|NCT01379508|26670468|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
7667170|NCT01379508|26670469|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
7667171|NCT01379508|26670470|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
7667172|NCT01379508|26670467|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
7667173|NCT01379508|26670468|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
7667174|NCT01379508|26670469|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
7667175|NCT01379508|26670470|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
7667176|NCT01379508|26670467|P4|Treatment to Week 104|Protocol Violation|0
7667177|NCT01379508|26670468|P3|Treatment to Week 104|Protocol Violation|1
7667178|NCT01379508|26670469|P2|Treatment to Week 104|Protocol Violation|1
7667179|NCT01379508|26670470|P1|Treatment to Week 104|Protocol Violation|1
7667180|NCT01379508|26670467|P4|Treatment to Week 104|Administrative problems|0
7667181|NCT01379508|26670468|P3|Treatment to Week 104|Administrative problems|0
7667182|NCT01379508|26670469|P2|Treatment to Week 104|Administrative problems|1
7667183|NCT01379508|26670470|P1|Treatment to Week 104|Administrative problems|3
7667184|NCT01379508|26670467|P4|Treatment to Week 104|Lost to Follow-up|0
7667185|NCT01379508|26670468|P3|Treatment to Week 104|Lost to Follow-up|3
7667186|NCT01379508|26670469|P2|Treatment to Week 104|Lost to Follow-up|0
7667187|NCT01379508|26670470|P1|Treatment to Week 104|Lost to Follow-up|5
7667188|NCT01379508|26670467|P4|Treatment to Week 104|Withdrawal by Subject|0
7667189|NCT01379508|26670468|P3|Treatment to Week 104|Withdrawal by Subject|4
7667190|NCT01379508|26670469|P2|Treatment to Week 104|Withdrawal by Subject|1
7667191|NCT01379508|26670470|P1|Treatment to Week 104|Withdrawal by Subject|6
7667192|NCT01379508|26670467|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
7667193|NCT01379508|26670468|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
7667194|NCT01379508|26670469|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
7667195|NCT01379508|26670470|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
7667196|NCT01379508|26670467|P4|Treatment to Week 104|Abnormal lab value|0
7667197|NCT01379508|26670468|P3|Treatment to Week 104|Abnormal lab value|0
7667198|NCT01379508|26670469|P2|Treatment to Week 104|Abnormal lab value|0
7667199|NCT01379508|26670470|P1|Treatment to Week 104|Abnormal lab value|1
7667200|NCT01379508|26670467|P4|Treatment to Week 104|Adverse Event|0
7667201|NCT01379508|26670468|P3|Treatment to Week 104|Adverse Event|5
7667202|NCT01379508|26670469|P2|Treatment to Week 104|Adverse Event|0
7667203|NCT01379508|26670470|P1|Treatment to Week 104|Adverse Event|2
7667204|NCT01379274|26670507|P1|Overall Study|funding withdrawn|1
7667205|NCT01378975|26670567|P2|Overall Study|Withdrew Consent|3
7667206|NCT01378975|26670568|P1|Overall Study|Withdrew Consent|4
7667207|NCT01378975|26670567|P2|Overall Study|Lost to Follow-up|1
7667208|NCT01378975|26670568|P1|Overall Study|Lost to Follow-up|4
7667209|NCT01378975|26670567|P2|Overall Study|Investigator Request|0
7667210|NCT01378975|26670568|P1|Overall Study|Investigator Request|1
7667211|NCT01378975|26670567|P2|Overall Study|Death|46
7667212|NCT01378975|26670568|P1|Overall Study|Death|77
7667213|NCT01378962|26670594|P1|Overall Study|Other|2
7667214|NCT01378962|26670594|P1|Overall Study|Lost to Follow-up|1
7667215|NCT01378962|26670594|P1|Overall Study|Death|14
7667216|NCT01378858|26670609|P2|Overall Study|Withdrawal by Subject|4
7667217|NCT01378858|26670610|P1|Overall Study|Withdrawal by Subject|4
7667218|NCT01378429|26670633|P2|Overall Study|Noncompliance with study drug|0
7667219|NCT01378429|26670634|P1|Overall Study|Noncompliance with study drug|1
7667220|NCT01378325|26670747|P2|Overall Study|Protocol Violation|1
7667221|NCT01378325|26670748|P1|Overall Study|Protocol Violation|0
7667222|NCT01378195|26670817|P2|Overall Study|Lost to Follow-up|18
7667223|NCT01378195|26670818|P1|Overall Study|Lost to Follow-up|29
7667224|NCT01378117|26670831|P3|Overall Study|discharged before med given|1
7667225|NCT01378117|26670832|P2|Overall Study|discharged before med given|0
7667226|NCT01378117|26670833|P1|Overall Study|discharged before med given|2
7667227|NCT01378117|26670831|P3|Overall Study|withdrawal|2
7667228|NCT01378117|26670832|P2|Overall Study|withdrawal|1
7667229|NCT01378117|26670833|P1|Overall Study|withdrawal|2
7667230|NCT01378104|26670867|P2|Overall Study|Withdrawal by Subject|13
7667231|NCT01378104|26670868|P1|Overall Study|Withdrawal by Subject|12
7667232|NCT01378104|26670867|P2|Overall Study|Lack of Efficacy|5
7667233|NCT01378104|26670868|P1|Overall Study|Lack of Efficacy|7
7667234|NCT01378104|26670867|P2|Overall Study|Adverse Event|8
7667235|NCT01378104|26670868|P1|Overall Study|Adverse Event|8
7667236|NCT01377987|26670913|P2|Washout (7 Days)|Withdrawal by Subject|1
7667237|NCT01377987|26670914|P1|Washout (7 Days)|Withdrawal by Subject|1
7667238|NCT01377922|26670932|P2|Overall Study|rescue tx after part 2, entered part 4|0
7667239|NCT01377922|26670933|P1|Overall Study|rescue tx after part 2, entered part 4|1
7667240|NCT01377844|26670947|P2|Overall Study|Study terminated by Sponsor|1
7667241|NCT01377844|26670948|P1|Overall Study|Study terminated by Sponsor|0
7667242|NCT01377844|26670947|P2|Overall Study|Physician Decision|3
7667243|NCT01377844|26670948|P1|Overall Study|Physician Decision|6
7667244|NCT01377844|26670947|P2|Overall Study|Adverse Event|0
7667245|NCT01377844|26670948|P1|Overall Study|Adverse Event|3
7667246|NCT01377844|26670947|P2|Overall Study|Protocol Violation|3
7667247|NCT01377844|26670948|P1|Overall Study|Protocol Violation|2
7667248|NCT01377844|26670947|P2|Overall Study|Withdrawal by Subject|28
7667249|NCT01377844|26670948|P1|Overall Study|Withdrawal by Subject|25
7667250|NCT01377480|26671037|P4|Overall Study|Other|6
7667251|NCT01377480|26671038|P3|Overall Study|Other|7
7667252|NCT01377480|26671039|P2|Overall Study|Other|0
7667253|NCT01377480|26671040|P1|Overall Study|Other|0
7667254|NCT01377480|26671037|P4|Overall Study|Serious adverse event|1
7667255|NCT01377480|26671038|P3|Overall Study|Serious adverse event|1
7667256|NCT01377480|26671039|P2|Overall Study|Serious adverse event|0
7667257|NCT01377480|26671040|P1|Overall Study|Serious adverse event|0
7667258|NCT01377480|26671037|P4|Overall Study|Withdrawal by Subject|0
7667259|NCT01377480|26671038|P3|Overall Study|Withdrawal by Subject|1
7667260|NCT01377480|26671039|P2|Overall Study|Withdrawal by Subject|0
7667261|NCT01377480|26671040|P1|Overall Study|Withdrawal by Subject|0
7667262|NCT01377480|26671037|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
7667263|NCT01377480|26671038|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
7667264|NCT01377480|26671039|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
7667265|NCT01377480|26671040|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
7667266|NCT01377480|26671037|P4|Overall Study|Protocol Violation|4
7667267|NCT01377480|26671038|P3|Overall Study|Protocol Violation|0
7667268|NCT01377480|26671039|P2|Overall Study|Protocol Violation|0
7667269|NCT01377480|26671040|P1|Overall Study|Protocol Violation|0
7667270|NCT01377389|26671116|P1|Overall Study|Screen failure|2
7667271|NCT01377389|26671116|P1|Overall Study|Withdrawal by Subject|1
7667272|NCT01377233|26671130|P5|Double-blind|Administrative or other|1
7667273|NCT01377233|26671131|P4|Double-blind|Administrative or other|1
7667274|NCT01377233|26671132|P3|Double-blind|Administrative or other|0
7667275|NCT01377233|26671133|P2|Double-blind|Administrative or other|0
7667276|NCT01377233|26671134|P1|Double-blind|Administrative or other|0
7667277|NCT01377233|26671130|P5|Double-blind|Withdrawal by Subject|0
7667278|NCT01377233|26671131|P4|Double-blind|Withdrawal by Subject|1
7667279|NCT01377233|26671132|P3|Double-blind|Withdrawal by Subject|0
7667280|NCT01377233|26671133|P2|Double-blind|Withdrawal by Subject|0
7667281|NCT01377233|26671134|P1|Double-blind|Withdrawal by Subject|0
7667282|NCT01377233|26671130|P5|Double-blind|Protocol Violation|1
7667283|NCT01377233|26671131|P4|Double-blind|Protocol Violation|0
7667284|NCT01377233|26671132|P3|Double-blind|Protocol Violation|0
7667285|NCT01377233|26671133|P2|Double-blind|Protocol Violation|0
7667286|NCT01377233|26671134|P1|Double-blind|Protocol Violation|0
7667287|NCT01377233|26671130|P5|Double-blind|Adverse Event|0
7667288|NCT01377233|26671131|P4|Double-blind|Adverse Event|2
7667289|NCT01377233|26671132|P3|Double-blind|Adverse Event|2
7667290|NCT01377233|26671133|P2|Double-blind|Adverse Event|1
7667291|NCT01377233|26671134|P1|Double-blind|Adverse Event|0
7667292|NCT01377233|26671130|P5|Open-label|Withdrawal by Subject|0
7667293|NCT01377233|26671131|P4|Open-label|Withdrawal by Subject|0
7667294|NCT01377233|26671132|P3|Open-label|Withdrawal by Subject|0
7667295|NCT01377233|26671133|P2|Open-label|Withdrawal by Subject|0
7667296|NCT01377233|26671134|P1|Open-label|Withdrawal by Subject|3
7667297|NCT01377233|26671130|P5|Open-label|Adverse Event|0
7667298|NCT01377233|26671131|P4|Open-label|Adverse Event|0
7667299|NCT01377233|26671132|P3|Open-label|Adverse Event|0
7667300|NCT01377233|26671133|P2|Open-label|Adverse Event|0
7667301|NCT01377233|26671134|P1|Open-label|Adverse Event|1
7667302|NCT01377194|26671161|P3|Overall Study|Lost to Follow-up|11
7667303|NCT01377194|26671162|P2|Overall Study|Lost to Follow-up|8
7667304|NCT01377194|26671163|P1|Overall Study|Lost to Follow-up|14
7667305|NCT01377194|26671161|P3|Overall Study|Withdrawal by Subject|7
7667306|NCT01377194|26671162|P2|Overall Study|Withdrawal by Subject|10
7667307|NCT01377194|26671163|P1|Overall Study|Withdrawal by Subject|8
7667308|NCT01377194|26671161|P3|Overall Study|Protocol Violation|6
7667309|NCT01377194|26671162|P2|Overall Study|Protocol Violation|10
7667310|NCT01377194|26671163|P1|Overall Study|Protocol Violation|4
7667311|NCT01377194|26671161|P3|Overall Study|Lack of Efficacy|3
7667312|NCT01377194|26671162|P2|Overall Study|Lack of Efficacy|3
7667313|NCT01377194|26671163|P1|Overall Study|Lack of Efficacy|3
7667314|NCT01377194|26671161|P3|Overall Study|Adverse Event|19
7667315|NCT01377194|26671162|P2|Overall Study|Adverse Event|12
7667316|NCT01377194|26671163|P1|Overall Study|Adverse Event|3
7667317|NCT01377012|26671177|P3|Extension Study, Weeks 104-260|Adverse Event|1
7667318|NCT01377012|26671178|P2|Extension Study, Weeks 104-260|Adverse Event|2
7667319|NCT01377012|26671179|P1|Extension Study, Weeks 104-260|Adverse Event|0
7667320|NCT01377012|26671177|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
7667321|NCT01377012|26671178|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
7667322|NCT01377012|26671179|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
7667323|NCT01377012|26671177|P3|Extension Study, Weeks 104-260|Physician Decision|0
7667324|NCT01377012|26671178|P2|Extension Study, Weeks 104-260|Physician Decision|0
7667325|NCT01377012|26671179|P1|Extension Study, Weeks 104-260|Physician Decision|1
7667326|NCT01377012|26671177|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
7667327|NCT01377012|26671178|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
7667328|NCT01377012|26671179|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
7667329|NCT01377012|26671177|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
7667330|NCT01377012|26671178|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
7667331|NCT01377012|26671179|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
7667332|NCT01377012|26671177|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
7667333|NCT01377012|26671178|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
7667334|NCT01377012|26671179|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
7667335|NCT01377012|26671177|P3|Core Study|Adverse Event|13
7667336|NCT01377012|26671178|P2|Core Study|Adverse Event|14
7667337|NCT01377012|26671179|P1|Core Study|Adverse Event|10
7667338|NCT01377012|26671177|P3|Core Study|Death|1
7667339|NCT01377012|26671178|P2|Core Study|Death|1
7667340|NCT01377012|26671179|P1|Core Study|Death|1
7667341|NCT01377012|26671177|P3|Core Study|Lack of Efficacy|37
7667342|NCT01377012|26671178|P2|Core Study|Lack of Efficacy|28
7667343|NCT01377012|26671179|P1|Core Study|Lack of Efficacy|41
7667344|NCT01377012|26671177|P3|Core Study|Lost to Follow-up|4
7667345|NCT01377012|26671178|P2|Core Study|Lost to Follow-up|5
7667346|NCT01377012|26671179|P1|Core Study|Lost to Follow-up|7
7667347|NCT01377012|26671177|P3|Core Study|No Longer require treatment|1
7667348|NCT01377012|26671178|P2|Core Study|No Longer require treatment|0
7667349|NCT01377012|26671179|P1|Core Study|No Longer require treatment|0
7667350|NCT01377012|26671177|P3|Core Study|Non-Compliant with study treatment|1
7667351|NCT01377012|26671178|P2|Core Study|Non-Compliant with study treatment|0
7667352|NCT01377012|26671179|P1|Core Study|Non-Compliant with study treatment|0
7667353|NCT01377012|26671177|P3|Core Study|Physician Decision|10
7667354|NCT01377012|26671178|P2|Core Study|Physician Decision|4
7667355|NCT01377012|26671179|P1|Core Study|Physician Decision|5
7667356|NCT01377012|26671177|P3|Core Study|Pregnancy|1
7667357|NCT01377012|26671178|P2|Core Study|Pregnancy|0
7667358|NCT01377012|26671179|P1|Core Study|Pregnancy|0
7667359|NCT01377012|26671177|P3|Core Study|Protocol Violation|2
7667360|NCT01377012|26671178|P2|Core Study|Protocol Violation|3
7667361|NCT01377012|26671179|P1|Core Study|Protocol Violation|7
7667362|NCT01377012|26671177|P3|Core Study|Withdrawal by Subject|18
7667363|NCT01377012|26671178|P2|Core Study|Withdrawal by Subject|23
7667364|NCT01377012|26671179|P1|Core Study|Withdrawal by Subject|15
7667365|NCT01377012|26671177|P3|Core Study|Technical problems|0
7667366|NCT01377012|26671178|P2|Core Study|Technical problems|0
7667367|NCT01377012|26671179|P1|Core Study|Technical problems|1
7667368|NCT01377012|26671177|P3|Core Study|Study terminated by Sponsor|46
7667369|NCT01377012|26671178|P2|Core Study|Study terminated by Sponsor|54
7667370|NCT01377012|26671179|P1|Core Study|Study terminated by Sponsor|47
7667371|NCT01376908|26671216|P2|Overall Study|Withdrawal by Subject|2
7667372|NCT01376908|26671217|P1|Overall Study|Withdrawal by Subject|1
7667373|NCT01376908|26671216|P2|Overall Study|Protocol Violation|1
7667374|NCT01376908|26671217|P1|Overall Study|Protocol Violation|1
7667375|NCT01376804|26671250|P1|Treatment Period|Patient did not receive study drug|1
7667376|NCT01376804|26671250|P1|Treatment Period|Adverse Event|6
7667377|NCT01376804|26671250|P1|Treatment Period|Withdrawal by Subject|1
7667378|NCT01376700|26671261|P1|Overall Study|Low or high titer inhibitor|8
7667379|NCT01376700|26671261|P1|Overall Study|Sponsor terminated study early|8
7667380|NCT01376388|26671323|P1|Overall Study|Withdrawal by Subject|3
7667381|NCT01376388|26671323|P1|Overall Study|Lack of Efficacy|2
7667382|NCT01376388|26671323|P1|Overall Study|Adverse Event|13
7667383|NCT01376349|26671361|P3|Raondomized Treatment|Alternative Treatment|1
7667384|NCT01376349|26671362|P2|Raondomized Treatment|Alternative Treatment|0
7667385|NCT01376349|26671363|P1|Raondomized Treatment|Alternative Treatment|0
7667386|NCT01376349|26671361|P3|Raondomized Treatment|Unkown|1
7667387|NCT01376349|26671362|P2|Raondomized Treatment|Unkown|2
7667388|NCT01376349|26671363|P1|Raondomized Treatment|Unkown|1
7667389|NCT01376349|26671361|P3|Raondomized Treatment|Adverse Event|14
7667390|NCT01376349|26671362|P2|Raondomized Treatment|Adverse Event|17
7667391|NCT01376349|26671363|P1|Raondomized Treatment|Adverse Event|13
7667392|NCT01376349|26671361|P3|Raondomized Treatment|Withdrawal by Subject|13
7667393|NCT01376349|26671362|P2|Raondomized Treatment|Withdrawal by Subject|16
7667394|NCT01376349|26671363|P1|Raondomized Treatment|Withdrawal by Subject|10
7667395|NCT01376323|26671377|P5|Overall Study|Withdrawal by Subject|0
7667396|NCT01376323|26671378|P4|Overall Study|Withdrawal by Subject|0
7667397|NCT01376323|26671379|P3|Overall Study|Withdrawal by Subject|1
7667398|NCT01376323|26671380|P2|Overall Study|Withdrawal by Subject|1
7667399|NCT01376323|26671381|P1|Overall Study|Withdrawal by Subject|0
7667400|NCT01376323|26671377|P5|Overall Study|Physician Decision|1
7667401|NCT01376323|26671378|P4|Overall Study|Physician Decision|1
7667402|NCT01376323|26671379|P3|Overall Study|Physician Decision|2
7667403|NCT01376323|26671380|P2|Overall Study|Physician Decision|0
7667404|NCT01376323|26671381|P1|Overall Study|Physician Decision|1
7667405|NCT01376323|26671377|P5|Overall Study|Lost to Follow-up|0
7667406|NCT01376323|26671378|P4|Overall Study|Lost to Follow-up|2
7667407|NCT01376323|26671379|P3|Overall Study|Lost to Follow-up|0
7667408|NCT01376323|26671380|P2|Overall Study|Lost to Follow-up|0
7667409|NCT01376323|26671381|P1|Overall Study|Lost to Follow-up|0
7667410|NCT01376323|26671377|P5|Overall Study|Adverse Event|0
7667411|NCT01376323|26671378|P4|Overall Study|Adverse Event|2
7667412|NCT01376323|26671379|P3|Overall Study|Adverse Event|0
7667413|NCT01376323|26671380|P2|Overall Study|Adverse Event|0
7667414|NCT01376323|26671381|P1|Overall Study|Adverse Event|1
7667415|NCT01376310|26671465|P2|Overall Study|Lost to Follow-up|0
7667416|NCT01376310|26671466|P1|Overall Study|Lost to Follow-up|1
7667417|NCT01376310|26671465|P2|Overall Study|Physician Decision|7
7667418|NCT01376310|26671466|P1|Overall Study|Physician Decision|26
7667419|NCT01376310|26671465|P2|Overall Study|Withdrawal by Subject|2
7667420|NCT01376310|26671466|P1|Overall Study|Withdrawal by Subject|8
7667421|NCT01376310|26671465|P2|Overall Study|Study closed/terminated|2
7667422|NCT01376310|26671466|P1|Overall Study|Study closed/terminated|1
7667423|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
7667424|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
7667425|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7667426|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
7667427|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7667428|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Physician Decision|0
7667429|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Physician Decision|1
7667430|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Physician Decision|1
7667431|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Physician Decision|0
7667432|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Physician Decision|0
7667433|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7667434|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7667435|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7667436|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7667437|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7667438|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7667439|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
7667440|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
7667441|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
7667442|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7667443|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
7667444|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
7667445|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
7667446|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
7667447|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
7667448|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
7667449|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
7667450|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
7667451|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
7667452|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
7667453|NCT01376245|26671485|P5|24-week, Double-blind Treatment Period|Adverse Event|18
7667454|NCT01376245|26671486|P4|24-week, Double-blind Treatment Period|Adverse Event|8
7667455|NCT01376245|26671487|P3|24-week, Double-blind Treatment Period|Adverse Event|7
7667456|NCT01376245|26671488|P2|24-week, Double-blind Treatment Period|Adverse Event|16
7667457|NCT01376245|26671489|P1|24-week, Double-blind Treatment Period|Adverse Event|0
7667458|NCT01376245|26671485|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7667459|NCT01376245|26671486|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7667460|NCT01376245|26671487|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7667461|NCT01376245|26671488|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7667462|NCT01376245|26671489|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
7667463|NCT01376245|26671485|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7667464|NCT01376245|26671486|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7667465|NCT01376245|26671487|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7667466|NCT01376245|26671488|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7667467|NCT01376245|26671489|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
7667468|NCT01376245|26671485|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7667469|NCT01376245|26671486|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7667470|NCT01376245|26671487|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7667471|NCT01376245|26671488|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7667472|NCT01376245|26671489|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
7667473|NCT01376245|26671485|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7667474|NCT01376245|26671486|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7667475|NCT01376245|26671487|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7667476|NCT01376245|26671488|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7667477|NCT01376245|26671489|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
7667478|NCT01376245|26671485|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7667479|NCT01376245|26671486|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7667480|NCT01376245|26671487|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7667481|NCT01376245|26671488|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7667482|NCT01376245|26671489|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
7667483|NCT01376167|26671506|P3|Overall Study|Withdrawal by Subject|4
7667484|NCT01376167|26671507|P2|Overall Study|Withdrawal by Subject|5
7667485|NCT01376167|26671508|P1|Overall Study|Withdrawal by Subject|1
7667486|NCT01376167|26671506|P3|Overall Study|Physician Decision|0
7667487|NCT01376167|26671507|P2|Overall Study|Physician Decision|1
7667488|NCT01376167|26671508|P1|Overall Study|Physician Decision|1
7667489|NCT01376167|26671506|P3|Overall Study|Lost to Follow-up|2
7667490|NCT01376167|26671507|P2|Overall Study|Lost to Follow-up|4
7667491|NCT01376167|26671508|P1|Overall Study|Lost to Follow-up|2
7667492|NCT01376089|26671579|P2|Overall Study|Patient received no contrast media|4
7667493|NCT01376089|26671580|P1|Overall Study|Patient received no contrast media|3
7667494|NCT01376037|26671603|P2|Overall Study|Lost to Follow-up|2
7667495|NCT01376037|26671604|P1|Overall Study|Lost to Follow-up|0
7667496|NCT01375959|26671612|P2|Second Intervention (6 Weeks)|Adverse Event|2
7667497|NCT01375959|26671613|P1|Second Intervention (6 Weeks)|Adverse Event|0
7667498|NCT01375959|26671612|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7667499|NCT01375959|26671613|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7667500|NCT01375959|26671612|P2|First Intervention (6 Weeks)|Adverse Event|3
7667501|NCT01375959|26671613|P1|First Intervention (6 Weeks)|Adverse Event|2
7667502|NCT01375777|26671641|P9|Overall Study|Other|1
7667503|NCT01375777|26671642|P8|Overall Study|Other|0
7667504|NCT01375777|26671643|P7|Overall Study|Other|0
7667505|NCT01375777|26671644|P6|Overall Study|Other|0
7667506|NCT01375777|26671645|P5|Overall Study|Other|0
7667507|NCT01375777|26671646|P4|Overall Study|Other|0
7667508|NCT01375777|26671647|P3|Overall Study|Other|0
7667509|NCT01375777|26671648|P2|Overall Study|Other|1
7667510|NCT01375777|26671649|P1|Overall Study|Other|1
7667511|NCT01375777|26671641|P9|Overall Study|Lost to Follow-up|0
7667512|NCT01375777|26671642|P8|Overall Study|Lost to Follow-up|0
7667513|NCT01375777|26671643|P7|Overall Study|Lost to Follow-up|1
7667514|NCT01375777|26671644|P6|Overall Study|Lost to Follow-up|0
7667515|NCT01375777|26671645|P5|Overall Study|Lost to Follow-up|0
7667516|NCT01375777|26671646|P4|Overall Study|Lost to Follow-up|0
7667517|NCT01375777|26671647|P3|Overall Study|Lost to Follow-up|0
7667518|NCT01375777|26671648|P2|Overall Study|Lost to Follow-up|0
7667519|NCT01375777|26671649|P1|Overall Study|Lost to Follow-up|1
7667520|NCT01375777|26671641|P9|Overall Study|Withdrawal by Subject|1
7667521|NCT01375777|26671642|P8|Overall Study|Withdrawal by Subject|2
7667522|NCT01375777|26671643|P7|Overall Study|Withdrawal by Subject|1
7667523|NCT01375777|26671644|P6|Overall Study|Withdrawal by Subject|1
7667524|NCT01375777|26671645|P5|Overall Study|Withdrawal by Subject|1
7667525|NCT01375777|26671646|P4|Overall Study|Withdrawal by Subject|0
7667526|NCT01375777|26671647|P3|Overall Study|Withdrawal by Subject|1
7667527|NCT01375777|26671648|P2|Overall Study|Withdrawal by Subject|2
7667528|NCT01375777|26671649|P1|Overall Study|Withdrawal by Subject|0
7667529|NCT01375764|26671719|P5|Overall Study|Other|0
7667530|NCT01375764|26671720|P4|Overall Study|Other|1
7667531|NCT01375764|26671721|P3|Overall Study|Other|0
7667532|NCT01375764|26671722|P2|Overall Study|Other|0
7667533|NCT01375764|26671723|P1|Overall Study|Other|0
7667534|NCT01375764|26671719|P5|Overall Study|Withdrawal by Subject|1
7667535|NCT01375764|26671720|P4|Overall Study|Withdrawal by Subject|0
7667536|NCT01375764|26671721|P3|Overall Study|Withdrawal by Subject|0
7667537|NCT01375764|26671722|P2|Overall Study|Withdrawal by Subject|0
7667538|NCT01375764|26671723|P1|Overall Study|Withdrawal by Subject|2
7667539|NCT01375764|26671719|P5|Overall Study|Lost to Follow-up|0
7667540|NCT01375764|26671720|P4|Overall Study|Lost to Follow-up|0
7667541|NCT01375764|26671721|P3|Overall Study|Lost to Follow-up|0
7667542|NCT01375764|26671722|P2|Overall Study|Lost to Follow-up|1
7667543|NCT01375764|26671723|P1|Overall Study|Lost to Follow-up|0
7667544|NCT01375751|26671769|P3|Overall Study|Other|0
7667545|NCT01375751|26671770|P2|Overall Study|Other|1
7667546|NCT01375751|26671771|P1|Overall Study|Other|0
7667547|NCT01375673|26671796|P2|Overall Study|Withdrawal by Subject|1
7667548|NCT01375673|26671797|P1|Overall Study|Withdrawal by Subject|0
7667549|NCT01375608|26671828|P1|Overall Study|Withdrawal by Subject|2
7667550|NCT01375374|26671856|P1|Overall Study|Adverse Event|1
7667551|NCT01375205|26671865|P2|Overall Study|Withdrawal by Subject|1
7667552|NCT01375205|26671866|P1|Overall Study|Withdrawal by Subject|6
7667553|NCT01375205|26671865|P2|Overall Study|Lost to Follow-up|12
7667554|NCT01375205|26671866|P1|Overall Study|Lost to Follow-up|15
7667555|NCT01375075|26671939|P6|Overall Study|Withdrawal by Subject|1
7667556|NCT01375075|26671940|P5|Overall Study|Withdrawal by Subject|0
7667557|NCT01375075|26671941|P4|Overall Study|Withdrawal by Subject|0
7667558|NCT01375075|26671942|P3|Overall Study|Withdrawal by Subject|0
7667559|NCT01375075|26671943|P2|Overall Study|Withdrawal by Subject|1
7667560|NCT01375075|26671944|P1|Overall Study|Withdrawal by Subject|0
7667561|NCT01375075|26671939|P6|Overall Study|Entry Criterion Not Met|1
7667562|NCT01375075|26671940|P5|Overall Study|Entry Criterion Not Met|0
7667563|NCT01375075|26671941|P4|Overall Study|Entry Criterion Not Met|0
7667564|NCT01375075|26671942|P3|Overall Study|Entry Criterion Not Met|0
7667565|NCT01375075|26671943|P2|Overall Study|Entry Criterion Not Met|0
7667566|NCT01375075|26671944|P1|Overall Study|Entry Criterion Not Met|1
7667567|NCT01375075|26671939|P6|Overall Study|Adverse Event|1
7667568|NCT01375075|26671940|P5|Overall Study|Adverse Event|0
7667569|NCT01375075|26671941|P4|Overall Study|Adverse Event|1
7667570|NCT01375075|26671942|P3|Overall Study|Adverse Event|3
7667571|NCT01375075|26671943|P2|Overall Study|Adverse Event|0
7667572|NCT01375075|26671944|P1|Overall Study|Adverse Event|0
7667573|NCT01375049|26672028|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
7667574|NCT01375049|26672028|P1|Overall Study|Withdrawal by Subject|2
7667575|NCT01375049|26672028|P1|Overall Study|Lost to Follow-up|1
7667576|NCT01375049|26672028|P1|Overall Study|Adverse Event|2
7667577|NCT01375010|26672045|P2|Overall Study|Withdrawal by Subject|2
7667578|NCT01375010|26672046|P1|Overall Study|Withdrawal by Subject|4
7667579|NCT01375010|26672045|P2|Overall Study|Lost to Follow-up|2
7667580|NCT01375010|26672046|P1|Overall Study|Lost to Follow-up|8
7667581|NCT01374971|26672060|P1|Overall Study|Withdrawal by Subject|1
7667582|NCT01374919|26672065|P1|Overall Study|Withdrawal by Subject|2
7667583|NCT01374906|26672072|P2|Overall Study|Unsatisfactory therapeutic effect|19
7667584|NCT01374906|26672073|P1|Overall Study|Unsatisfactory therapeutic effect|11
7667585|NCT01374906|26672072|P2|Overall Study|Withdrawal by Subject|9
7667586|NCT01374906|26672073|P1|Overall Study|Withdrawal by Subject|15
7667587|NCT01374906|26672072|P2|Overall Study|Protocol Violation|2
7667588|NCT01374906|26672073|P1|Overall Study|Protocol Violation|2
7667589|NCT01374906|26672072|P2|Overall Study|Death|2
7667590|NCT01374906|26672073|P1|Overall Study|Death|0
7667591|NCT01374906|26672072|P2|Overall Study|Adverse Event|11
7667592|NCT01374906|26672073|P1|Overall Study|Adverse Event|10
7667593|NCT01374906|26672072|P2|Overall Study|Administrative problems|2
7667594|NCT01374906|26672073|P1|Overall Study|Administrative problems|2
7667595|NCT01374906|26672072|P2|Overall Study|Abnormal laboratory value(s)|3
7667596|NCT01374906|26672073|P1|Overall Study|Abnormal laboratory value(s)|0
7667597|NCT01374568|26672154|P2|Overall Study|Lab unable to analyze BTM|2
7667598|NCT01374568|26672155|P1|Overall Study|Lab unable to analyze BTM|0
7667599|NCT01374516|26672165|P2|Surveillance Expansion Period|Serious adverse event|5
7667600|NCT01374516|26672166|P1|Surveillance Expansion Period|Serious adverse event|20
7667601|NCT01374516|26672165|P2|Surveillance Expansion Period|Lost to Follow-up|45
7667602|NCT01374516|26672166|P1|Surveillance Expansion Period|Lost to Follow-up|73
7667603|NCT01374516|26672165|P2|Surveillance Expansion Period|Withdrawal by Subject|986
7667604|NCT01374516|26672166|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
7667605|NCT01374516|26672165|P2|Surveillance Expansion Period|Protocol Violation|217
7667606|NCT01374516|26672166|P1|Surveillance Expansion Period|Protocol Violation|386
7667607|NCT01374516|26672165|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
7667608|NCT01374516|26672166|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
7667609|NCT01374516|26672165|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
7667610|NCT01374516|26672166|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
7667611|NCT01374516|26672165|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
7667612|NCT01374516|26672166|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
7667613|NCT01374516|26672165|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
7667614|NCT01374516|26672166|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
7667615|NCT01374516|26672165|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
7667616|NCT01374516|26672166|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
7667617|NCT01374451|26672204|P2|Overall Study|Administrative problems|0
7667618|NCT01374451|26672205|P1|Overall Study|Administrative problems|1
7667619|NCT01374425|26672251|P2|Overall Study|Other|43
7667620|NCT01374425|26672252|P1|Overall Study|Other|41
7667621|NCT01374425|26672251|P2|Overall Study|Lost to Follow-up|1
7667622|NCT01374425|26672252|P1|Overall Study|Lost to Follow-up|2
7667623|NCT01374425|26672251|P2|Overall Study|Sponsor Decision|1
7667624|NCT01374425|26672252|P1|Overall Study|Sponsor Decision|0
7667625|NCT01374425|26672251|P2|Overall Study|Protocol Violation|3
7667626|NCT01374425|26672252|P1|Overall Study|Protocol Violation|2
7667627|NCT01374425|26672251|P2|Overall Study|Refused Treatment|24
7667628|NCT01374425|26672252|P1|Overall Study|Refused Treatment|10
7667629|NCT01374425|26672251|P2|Overall Study|Withdrawal by Subject|7
7667630|NCT01374425|26672252|P1|Overall Study|Withdrawal by Subject|6
7667631|NCT01374425|26672251|P2|Overall Study|Death (Adverse Event)|4
7667632|NCT01374425|26672252|P1|Overall Study|Death (Adverse Event)|2
7667633|NCT01374425|26672251|P2|Overall Study|Death (Progression of Disease)|0
7667634|NCT01374425|26672252|P1|Overall Study|Death (Progression of Disease)|1
7667635|NCT01374425|26672251|P2|Overall Study|Adverse Event|18
7667636|NCT01374425|26672252|P1|Overall Study|Adverse Event|29
7667637|NCT01374425|26672251|P2|Overall Study|Clinical Disease Progression|6
7667638|NCT01374425|26672252|P1|Overall Study|Clinical Disease Progression|9
7667639|NCT01374425|26672251|P2|Overall Study|Radiographic Disease Progression|81
7667640|NCT01374425|26672252|P1|Overall Study|Radiographic Disease Progression|86
7667641|NCT01374269|26672332|P2|Overall Study|closed research|2
7667642|NCT01374269|26672333|P1|Overall Study|closed research|1
7667643|NCT01374269|26672332|P2|Overall Study|Lost to Follow-up|3
7667644|NCT01374269|26672333|P1|Overall Study|Lost to Follow-up|1
7667645|NCT01374269|26672332|P2|Overall Study|Withdrawal by Subject|0
7667646|NCT01374269|26672333|P1|Overall Study|Withdrawal by Subject|4
7667647|NCT01374217|26672461|P1|Overall Study|Lack of Efficacy|13
7667648|NCT01374178|26672469|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
7667649|NCT01374178|26672470|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
7667650|NCT01374178|26672469|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
7667651|NCT01374178|26672470|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
7667652|NCT01374087|26672488|P2|Overall Study|Study discontinued|13
7667653|NCT01374087|26672489|P1|Overall Study|Study discontinued|13
7667654|NCT01374087|26672488|P2|Overall Study|Disease progression|2
7667655|NCT01374087|26672489|P1|Overall Study|Disease progression|2
7667656|NCT01374087|26672488|P2|Overall Study|Adverse Event|0
7667657|NCT01374087|26672489|P1|Overall Study|Adverse Event|1
7667658|NCT01373931|26672509|P2|Period 1|Withdrawal by Subject|2
7667659|NCT01373931|26672510|P1|Period 1|Withdrawal by Subject|0
7667660|NCT01373931|26672509|P2|Period 1|Adverse Event|0
7667661|NCT01373931|26672510|P1|Period 1|Adverse Event|2
7667662|NCT01373931|26672509|P2|Lead-in Period|Adverse Event|0
7667663|NCT01373931|26672510|P1|Lead-in Period|Adverse Event|2
7667664|NCT01373918|26672523|P2|Overall Study|Physician Decision|1
7667665|NCT01373918|26672524|P1|Overall Study|Physician Decision|0
7667666|NCT01373346|26672583|P1|Overall Study|Death|1
7667667|NCT01373294|26672606|P2|Overall Study|Adverse Event|0
7667668|NCT01373294|26672607|P1|Overall Study|Adverse Event|1
7667669|NCT01373281|26672616|P2|Surveillance Expansion Period|Serious adverse event|4
7667670|NCT01373281|26672617|P1|Surveillance Expansion Period|Serious adverse event|3
7667671|NCT01373281|26672616|P2|Surveillance Expansion Period|Lost to Follow-up|8
7667672|NCT01373281|26672617|P1|Surveillance Expansion Period|Lost to Follow-up|10
7667673|NCT01373281|26672616|P2|Surveillance Expansion Period|Protocol Violation|1
7667674|NCT01373281|26672617|P1|Surveillance Expansion Period|Protocol Violation|9
7667675|NCT01373281|26672616|P2|Surveillance Expansion Period|Withdrawal by Subject|105
7667676|NCT01373281|26672617|P1|Surveillance Expansion Period|Withdrawal by Subject|180
7667677|NCT01373281|26672616|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
7667678|NCT01373281|26672617|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
7667679|NCT01373281|26672616|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
7667680|NCT01373281|26672617|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
7667681|NCT01373281|26672616|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
7667682|NCT01373281|26672617|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
7667683|NCT01373281|26672616|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
7667684|NCT01373281|26672617|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
7667685|NCT01373229|26672665|P1|Overall Study|Physician Decision|3
7667686|NCT01373229|26672665|P1|Overall Study|Death|3
7667687|NCT01373164|26672679|P5|Overall Study|Withdrawal by Subject|2
7667688|NCT01373164|26672680|P4|Overall Study|Withdrawal by Subject|10
7667689|NCT01373164|26672681|P3|Overall Study|Withdrawal by Subject|0
7667690|NCT01373164|26672682|P2|Overall Study|Withdrawal by Subject|1
7667691|NCT01373164|26672683|P1|Overall Study|Withdrawal by Subject|0
7667692|NCT01373164|26672679|P5|Overall Study|Lost to Follow-up|0
7667693|NCT01373164|26672680|P4|Overall Study|Lost to Follow-up|2
7667694|NCT01373164|26672681|P3|Overall Study|Lost to Follow-up|1
7667695|NCT01373164|26672682|P2|Overall Study|Lost to Follow-up|0
7667696|NCT01373164|26672683|P1|Overall Study|Lost to Follow-up|0
7667697|NCT01372995|26672717|P3|Overall Study|Physician Decision|1
7667698|NCT01372995|26672718|P2|Overall Study|Physician Decision|0
7667699|NCT01372995|26672719|P1|Overall Study|Physician Decision|0
7667700|NCT01372995|26672717|P3|Overall Study|Spouse withdrew participant from study|0
7667701|NCT01372995|26672718|P2|Overall Study|Spouse withdrew participant from study|1
7667702|NCT01372995|26672719|P1|Overall Study|Spouse withdrew participant from study|0
7667703|NCT01372878|26672766|P1|Overall Study|incomplete study procedure|104
7667704|NCT01372878|26672766|P1|Overall Study|Protocol Violation|17
7667705|NCT01372878|26672766|P1|Overall Study|Withdrawal by Subject|63
7667706|NCT01372774|26672786|P2|Overall Study|Withdrawal prior to treatment|5
7667707|NCT01372774|26672787|P1|Overall Study|Withdrawal prior to treatment|4
7667708|NCT01372748|26672803|P2|Overall Study|Withdrawal by Subject|5
7667709|NCT01372748|26672804|P1|Overall Study|Withdrawal by Subject|7
7667710|NCT01372748|26672803|P2|Overall Study|Lost to Follow-up|34
7667711|NCT01372748|26672804|P1|Overall Study|Lost to Follow-up|16
7667712|NCT01372618|26672812|P1|Overall Study|PI Died. Study Terminated|9
7667713|NCT01372605|26672820|P2|Overall Study|Changed medical home|0
7667714|NCT01372605|26672821|P1|Overall Study|Changed medical home|2
7667715|NCT01372605|26672820|P2|Overall Study|Moved|0
7667716|NCT01372605|26672821|P1|Overall Study|Moved|3
7667717|NCT01372605|26672820|P2|Overall Study|Withdrawal by Subject|7
7667718|NCT01372605|26672821|P1|Overall Study|Withdrawal by Subject|4
7667719|NCT01372605|26672820|P2|Overall Study|Lost to Follow-up|1
7667720|NCT01372605|26672821|P1|Overall Study|Lost to Follow-up|2
7667721|NCT01372605|26672820|P2|Overall Study|Death|2
7667722|NCT01372605|26672821|P1|Overall Study|Death|1
7667723|NCT01372501|26672847|P1|Overall Study|Device migration|1
7667724|NCT01372501|26672847|P1|Overall Study|Adverse Event|4
7667725|NCT01372410|26672870|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667726|NCT01372410|26672871|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667727|NCT01372410|26672872|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
7667728|NCT01372410|26672873|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667729|NCT01372410|26672874|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667730|NCT01372410|26672875|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667731|NCT01372410|26672876|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667732|NCT01372410|26672877|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
7667733|NCT01372410|26672870|P8|Treatment Period 3 (7 Days)|Adverse Event|0
7667734|NCT01372410|26672871|P7|Treatment Period 3 (7 Days)|Adverse Event|0
7667735|NCT01372410|26672872|P6|Treatment Period 3 (7 Days)|Adverse Event|0
7667736|NCT01372410|26672873|P5|Treatment Period 3 (7 Days)|Adverse Event|0
7667737|NCT01372410|26672874|P4|Treatment Period 3 (7 Days)|Adverse Event|0
7667738|NCT01372410|26672875|P3|Treatment Period 3 (7 Days)|Adverse Event|1
7667739|NCT01372410|26672876|P2|Treatment Period 3 (7 Days)|Adverse Event|0
7667740|NCT01372410|26672877|P1|Treatment Period 3 (7 Days)|Adverse Event|0
7667741|NCT01372410|26672870|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
7667742|NCT01372410|26672871|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667743|NCT01372410|26672872|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667744|NCT01372410|26672873|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667745|NCT01372410|26672874|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667746|NCT01372410|26672875|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667747|NCT01372410|26672876|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667748|NCT01372410|26672877|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7667749|NCT01372410|26672870|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7667750|NCT01372410|26672871|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7667751|NCT01372410|26672872|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7667752|NCT01372410|26672873|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7667753|NCT01372410|26672874|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7667754|NCT01372410|26672875|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7667755|NCT01372410|26672876|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7667756|NCT01372410|26672877|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7667757|NCT01372410|26672870|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
7667758|NCT01372410|26672871|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
7667759|NCT01372410|26672872|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
7667760|NCT01372410|26672873|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
7667761|NCT01372410|26672874|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
7667762|NCT01372410|26672875|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
7667763|NCT01372410|26672876|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
7667764|NCT01372410|26672877|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
7667765|NCT01372410|26672870|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
7667766|NCT01372410|26672871|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7667767|NCT01372410|26672872|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7667768|NCT01372410|26672873|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7667769|NCT01372410|26672874|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7667770|NCT01372410|26672875|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7667771|NCT01372410|26672876|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7667772|NCT01372410|26672877|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
7667773|NCT01372410|26672870|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667774|NCT01372410|26672871|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
7667775|NCT01372410|26672872|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667776|NCT01372410|26672873|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667777|NCT01372410|26672874|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667778|NCT01372410|26672875|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667779|NCT01372410|26672876|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667780|NCT01372410|26672877|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7667781|NCT01372410|26672870|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667782|NCT01372410|26672871|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667783|NCT01372410|26672872|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667784|NCT01372410|26672873|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7667785|NCT01372410|26672874|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667786|NCT01372410|26672875|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667787|NCT01372410|26672876|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667788|NCT01372410|26672877|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7667789|NCT01372410|26672870|P8|Treatment Period 1 (7 Days)|Adverse Event|0
7667790|NCT01372410|26672871|P7|Treatment Period 1 (7 Days)|Adverse Event|1
7667791|NCT01372410|26672872|P6|Treatment Period 1 (7 Days)|Adverse Event|0
7667792|NCT01372410|26672873|P5|Treatment Period 1 (7 Days)|Adverse Event|0
7667793|NCT01372410|26672874|P4|Treatment Period 1 (7 Days)|Adverse Event|0
7667794|NCT01372410|26672875|P3|Treatment Period 1 (7 Days)|Adverse Event|0
7667795|NCT01372410|26672876|P2|Treatment Period 1 (7 Days)|Adverse Event|1
7667796|NCT01372410|26672877|P1|Treatment Period 1 (7 Days)|Adverse Event|0
7667797|NCT01372410|26672870|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7667798|NCT01372410|26672871|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7667799|NCT01372410|26672872|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7667800|NCT01372410|26672873|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7667801|NCT01372410|26672874|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7667802|NCT01372410|26672875|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7667803|NCT01372410|26672876|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7667804|NCT01372410|26672877|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7667805|NCT01372384|26672914|P1|Overall Study|Progression of disease|3
7667806|NCT01372150|26672955|P3|Overall Study|Randomized but not treated|0
7667807|NCT01372150|26672956|P2|Overall Study|Randomized but not treated|1
7667808|NCT01372150|26672957|P1|Overall Study|Randomized but not treated|0
7667809|NCT01372150|26672955|P3|Overall Study|Adverse Event|2
7667810|NCT01372150|26672956|P2|Overall Study|Adverse Event|1
7667811|NCT01372150|26672957|P1|Overall Study|Adverse Event|2
7667812|NCT01372150|26672955|P3|Overall Study|Other|2
7667813|NCT01372150|26672956|P2|Overall Study|Other|0
7667814|NCT01372150|26672957|P1|Overall Study|Other|1
7667815|NCT01372150|26672955|P3|Overall Study|Withdrawal by Subject|2
7667816|NCT01372150|26672956|P2|Overall Study|Withdrawal by Subject|7
7667817|NCT01372150|26672957|P1|Overall Study|Withdrawal by Subject|2
7667818|NCT01372150|26672955|P3|Overall Study|Protocol Violation|3
7667819|NCT01372150|26672956|P2|Overall Study|Protocol Violation|0
7667820|NCT01372150|26672957|P1|Overall Study|Protocol Violation|1
7667821|NCT01372150|26672955|P3|Overall Study|Lost to Follow-up|6
7667822|NCT01372150|26672956|P2|Overall Study|Lost to Follow-up|5
7667823|NCT01372150|26672957|P1|Overall Study|Lost to Follow-up|4
7667824|NCT01372150|26672955|P3|Overall Study|Lack of Efficacy|1
7667825|NCT01372150|26672956|P2|Overall Study|Lack of Efficacy|0
7667826|NCT01372150|26672957|P1|Overall Study|Lack of Efficacy|3
7667827|NCT01372085|26672984|P10|Washout Period 3|Withdrawal by Subject|0
7667828|NCT01372085|26672985|P9|Washout Period 3|Withdrawal by Subject|0
7667829|NCT01372085|26672986|P8|Washout Period 3|Withdrawal by Subject|0
7667830|NCT01372085|26672987|P7|Washout Period 3|Withdrawal by Subject|0
7667831|NCT01372085|26672988|P6|Washout Period 3|Withdrawal by Subject|2
7667832|NCT01372085|26672989|P5|Washout Period 3|Withdrawal by Subject|0
7667833|NCT01372085|26672990|P4|Washout Period 3|Withdrawal by Subject|0
7667834|NCT01372085|26672991|P3|Washout Period 3|Withdrawal by Subject|0
7667835|NCT01372085|26672992|P2|Washout Period 3|Withdrawal by Subject|0
7667836|NCT01372085|26672993|P1|Washout Period 3|Withdrawal by Subject|0
7667837|NCT01372085|26672984|P10|Washout Period 2|Physician Decision|0
7667838|NCT01372085|26672985|P9|Washout Period 2|Physician Decision|0
7667839|NCT01372085|26672986|P8|Washout Period 2|Physician Decision|0
7667840|NCT01372085|26672987|P7|Washout Period 2|Physician Decision|0
7667841|NCT01372085|26672988|P6|Washout Period 2|Physician Decision|0
7667842|NCT01372085|26672989|P5|Washout Period 2|Physician Decision|1
7667843|NCT01372085|26672990|P4|Washout Period 2|Physician Decision|0
7667844|NCT01372085|26672991|P3|Washout Period 2|Physician Decision|0
7667845|NCT01372085|26672992|P2|Washout Period 2|Physician Decision|0
7667846|NCT01372085|26672993|P1|Washout Period 2|Physician Decision|0
7667847|NCT01371994|26673025|P2|Overall Study|Miscellaneous Reasons|4
7667848|NCT01371994|26673026|P1|Overall Study|Miscellaneous Reasons|6
7667849|NCT01371994|26673025|P2|Overall Study|Physician Decision|1
7667850|NCT01371994|26673026|P1|Overall Study|Physician Decision|1
7667851|NCT01371994|26673025|P2|Overall Study|Randomized but Never Received Study Drug|6
7667852|NCT01371994|26673026|P1|Overall Study|Randomized but Never Received Study Drug|6
7667853|NCT01371994|26673025|P2|Overall Study|Protocol Violation|17
7667854|NCT01371994|26673026|P1|Overall Study|Protocol Violation|24
7667855|NCT01371994|26673025|P2|Overall Study|Lost to Follow-up|1
7667856|NCT01371994|26673026|P1|Overall Study|Lost to Follow-up|1
7667857|NCT01371994|26673025|P2|Overall Study|Withdrawal by Subject|7
7667858|NCT01371994|26673026|P1|Overall Study|Withdrawal by Subject|13
7667859|NCT01371994|26673025|P2|Overall Study|Lack of Efficacy|0
7667860|NCT01371994|26673026|P1|Overall Study|Lack of Efficacy|3
7667861|NCT01371994|26673025|P2|Overall Study|Adverse Event|6
7667862|NCT01371994|26673026|P1|Overall Study|Adverse Event|3
7667863|NCT01371981|26673074|P6|Overall Study|Did not start treatment|2
7667864|NCT01371981|26673075|P5|Overall Study|Did not start treatment|0
7667865|NCT01371981|26673076|P4|Overall Study|Did not start treatment|0
7667866|NCT01371981|26673077|P3|Overall Study|Did not start treatment|0
7667867|NCT01371981|26673078|P2|Overall Study|Did not start treatment|3
7667868|NCT01371981|26673079|P1|Overall Study|Did not start treatment|2
7667869|NCT01371981|26673074|P6|Overall Study|Ineligible|4
7667870|NCT01371981|26673075|P5|Overall Study|Ineligible|0
7667871|NCT01371981|26673076|P4|Overall Study|Ineligible|0
7667872|NCT01371981|26673077|P3|Overall Study|Ineligible|0
7667873|NCT01371981|26673078|P2|Overall Study|Ineligible|13
7667874|NCT01371981|26673079|P1|Overall Study|Ineligible|19
7667875|NCT01371981|26673074|P6|Overall Study|Withdrawal by Subject|3
7667876|NCT01371981|26673075|P5|Overall Study|Withdrawal by Subject|10
7667877|NCT01371981|26673076|P4|Overall Study|Withdrawal by Subject|2
7667878|NCT01371981|26673077|P3|Overall Study|Withdrawal by Subject|1
7667879|NCT01371981|26673078|P2|Overall Study|Withdrawal by Subject|19
7667880|NCT01371981|26673079|P1|Overall Study|Withdrawal by Subject|12
7667881|NCT01371981|26673074|P6|Overall Study|Physician Decision|3
7667882|NCT01371981|26673075|P5|Overall Study|Physician Decision|14
7667883|NCT01371981|26673076|P4|Overall Study|Physician Decision|7
7667884|NCT01371981|26673077|P3|Overall Study|Physician Decision|1
7667885|NCT01371981|26673078|P2|Overall Study|Physician Decision|63
7667886|NCT01371981|26673079|P1|Overall Study|Physician Decision|48
7667887|NCT01371981|26673074|P6|Overall Study|Lack of Efficacy|0
7667888|NCT01371981|26673075|P5|Overall Study|Lack of Efficacy|5
7667889|NCT01371981|26673076|P4|Overall Study|Lack of Efficacy|8
7667890|NCT01371981|26673077|P3|Overall Study|Lack of Efficacy|4
7667891|NCT01371981|26673078|P2|Overall Study|Lack of Efficacy|61
7667892|NCT01371981|26673079|P1|Overall Study|Lack of Efficacy|69
7667893|NCT01371981|26673074|P6|Overall Study|Death|2
7667894|NCT01371981|26673075|P5|Overall Study|Death|2
7667895|NCT01371981|26673076|P4|Overall Study|Death|0
7667896|NCT01371981|26673077|P3|Overall Study|Death|0
7667897|NCT01371981|26673078|P2|Overall Study|Death|16
7667898|NCT01371981|26673079|P1|Overall Study|Death|22
7667899|NCT01371981|26673074|P6|Overall Study|Adverse Event|0
7667900|NCT01371981|26673075|P5|Overall Study|Adverse Event|1
7667901|NCT01371981|26673076|P4|Overall Study|Adverse Event|4
7667902|NCT01371981|26673077|P3|Overall Study|Adverse Event|0
7667903|NCT01371981|26673078|P2|Overall Study|Adverse Event|17
7667904|NCT01371981|26673079|P1|Overall Study|Adverse Event|12
7667905|NCT01371877|26673138|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
7667906|NCT01371877|26673139|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
7667907|NCT01371851|26673151|P2|Overall Study|Blood Pressure outside study parameters|0
7667908|NCT01371851|26673152|P1|Overall Study|Blood Pressure outside study parameters|2
7667909|NCT01371851|26673151|P2|Overall Study|non study related adverse event|0
7667910|NCT01371851|26673152|P1|Overall Study|non study related adverse event|1
7667911|NCT01371851|26673151|P2|Overall Study|was arrested and put in jail|1
7667912|NCT01371851|26673152|P1|Overall Study|was arrested and put in jail|0
7667913|NCT01371851|26673151|P2|Overall Study|Lost to Follow-up|8
7667914|NCT01371851|26673152|P1|Overall Study|Lost to Follow-up|5
7667915|NCT01371838|26673160|P2|Overall Study|Surgery|0
7667916|NCT01371838|26673161|P1|Overall Study|Surgery|1
7667917|NCT01371838|26673160|P2|Overall Study|Lack of therapeutic response|1
7667918|NCT01371838|26673161|P1|Overall Study|Lack of therapeutic response|0
7667919|NCT01371838|26673160|P2|Overall Study|Last follow-up visit not conducted|0
7667920|NCT01371838|26673161|P1|Overall Study|Last follow-up visit not conducted|2
7667921|NCT01371838|26673160|P2|Overall Study|Investigator Decision|8
7667922|NCT01371838|26673161|P1|Overall Study|Investigator Decision|3
7667923|NCT01371838|26673160|P2|Overall Study|Protocol Violation|0
7667924|NCT01371838|26673161|P1|Overall Study|Protocol Violation|3
7667925|NCT01371838|26673160|P2|Overall Study|Death|4
7667926|NCT01371838|26673161|P1|Overall Study|Death|3
7667927|NCT01371838|26673160|P2|Overall Study|Lost to Follow-up|20
7667928|NCT01371838|26673161|P1|Overall Study|Lost to Follow-up|10
7667929|NCT01371838|26673160|P2|Overall Study|Withdrawal by Subject|33
7667930|NCT01371838|26673161|P1|Overall Study|Withdrawal by Subject|27
7667931|NCT01371825|26673197|P1|Overall Study|Death|4
7667932|NCT01371747|26673231|P6|Overall Study|Other Reasons|1
7667933|NCT01371747|26673232|P5|Overall Study|Other Reasons|0
7667934|NCT01371747|26673233|P4|Overall Study|Other Reasons|0
7667935|NCT01371747|26673234|P3|Overall Study|Other Reasons|2
7667936|NCT01371747|26673235|P2|Overall Study|Other Reasons|1
7667937|NCT01371747|26673236|P1|Overall Study|Other Reasons|2
7667938|NCT01371747|26673231|P6|Overall Study|Withdrawal by Subject|4
7667939|NCT01371747|26673232|P5|Overall Study|Withdrawal by Subject|2
7667940|NCT01371747|26673233|P4|Overall Study|Withdrawal by Subject|2
7667941|NCT01371747|26673234|P3|Overall Study|Withdrawal by Subject|5
7667942|NCT01371747|26673235|P2|Overall Study|Withdrawal by Subject|12
7667943|NCT01371747|26673236|P1|Overall Study|Withdrawal by Subject|6
7667944|NCT01371747|26673231|P6|Overall Study|Physician Decision|0
7667945|NCT01371747|26673232|P5|Overall Study|Physician Decision|1
7667946|NCT01371747|26673233|P4|Overall Study|Physician Decision|0
7667947|NCT01371747|26673234|P3|Overall Study|Physician Decision|0
7667948|NCT01371747|26673235|P2|Overall Study|Physician Decision|0
7667949|NCT01371747|26673236|P1|Overall Study|Physician Decision|0
7667950|NCT01371747|26673231|P6|Overall Study|Non-Compliance|1
7667951|NCT01371747|26673232|P5|Overall Study|Non-Compliance|0
7667952|NCT01371747|26673233|P4|Overall Study|Non-Compliance|0
7667953|NCT01371747|26673234|P3|Overall Study|Non-Compliance|3
7667954|NCT01371747|26673235|P2|Overall Study|Non-Compliance|4
7667955|NCT01371747|26673236|P1|Overall Study|Non-Compliance|3
7667956|NCT01371747|26673231|P6|Overall Study|Protocol Violation|0
7667957|NCT01371747|26673232|P5|Overall Study|Protocol Violation|0
7667958|NCT01371747|26673233|P4|Overall Study|Protocol Violation|0
7667959|NCT01371747|26673234|P3|Overall Study|Protocol Violation|1
7667960|NCT01371747|26673235|P2|Overall Study|Protocol Violation|0
7667961|NCT01371747|26673236|P1|Overall Study|Protocol Violation|0
7667962|NCT01371747|26673231|P6|Overall Study|Low Serum Potassium Results|3
7667963|NCT01371747|26673232|P5|Overall Study|Low Serum Potassium Results|0
7667964|NCT01371747|26673233|P4|Overall Study|Low Serum Potassium Results|1
7667965|NCT01371747|26673234|P3|Overall Study|Low Serum Potassium Results|1
7667966|NCT01371747|26673235|P2|Overall Study|Low Serum Potassium Results|1
7667967|NCT01371747|26673236|P1|Overall Study|Low Serum Potassium Results|1
7667968|NCT01371747|26673231|P6|Overall Study|High Serum Potassium Results|2
7667969|NCT01371747|26673232|P5|Overall Study|High Serum Potassium Results|0
7667970|NCT01371747|26673233|P4|Overall Study|High Serum Potassium Results|2
7667971|NCT01371747|26673234|P3|Overall Study|High Serum Potassium Results|1
7667972|NCT01371747|26673235|P2|Overall Study|High Serum Potassium Results|1
7667973|NCT01371747|26673236|P1|Overall Study|High Serum Potassium Results|1
7667974|NCT01371747|26673231|P6|Overall Study|Abnormal Renal Function|1
7667975|NCT01371747|26673232|P5|Overall Study|Abnormal Renal Function|0
7667976|NCT01371747|26673233|P4|Overall Study|Abnormal Renal Function|1
7667977|NCT01371747|26673234|P3|Overall Study|Abnormal Renal Function|0
7667978|NCT01371747|26673235|P2|Overall Study|Abnormal Renal Function|2
7667979|NCT01371747|26673236|P1|Overall Study|Abnormal Renal Function|0
7667980|NCT01371747|26673231|P6|Overall Study|Death|0
7667981|NCT01371747|26673232|P5|Overall Study|Death|2
7667982|NCT01371747|26673233|P4|Overall Study|Death|1
7667983|NCT01371747|26673234|P3|Overall Study|Death|4
7667984|NCT01371747|26673235|P2|Overall Study|Death|0
7667985|NCT01371747|26673236|P1|Overall Study|Death|1
7667986|NCT01371747|26673231|P6|Overall Study|Adverse Event|2
7667987|NCT01371747|26673232|P5|Overall Study|Adverse Event|2
7667988|NCT01371747|26673233|P4|Overall Study|Adverse Event|2
7667989|NCT01371747|26673234|P3|Overall Study|Adverse Event|7
7667990|NCT01371747|26673235|P2|Overall Study|Adverse Event|2
7667991|NCT01371747|26673236|P1|Overall Study|Adverse Event|4
7667992|NCT01371734|26673301|P3|Overall Study|Lack of Efficacy|0
7667993|NCT01371734|26673302|P2|Overall Study|Lack of Efficacy|2
7667994|NCT01371734|26673303|P1|Overall Study|Lack of Efficacy|2
7667995|NCT01371734|26673301|P3|Overall Study|Adverse Event|3
7667996|NCT01371734|26673302|P2|Overall Study|Adverse Event|8
7667997|NCT01371734|26673303|P1|Overall Study|Adverse Event|8
7667998|NCT01371734|26673301|P3|Overall Study|Protocol Violation|2
7667999|NCT01371734|26673302|P2|Overall Study|Protocol Violation|1
7668000|NCT01371734|26673303|P1|Overall Study|Protocol Violation|3
7668001|NCT01371734|26673301|P3|Overall Study|Lost to Follow-up|1
7668002|NCT01371734|26673302|P2|Overall Study|Lost to Follow-up|3
7668003|NCT01371734|26673303|P1|Overall Study|Lost to Follow-up|5
7668004|NCT01371734|26673301|P3|Overall Study|Withdrawal by Subject|9
7668005|NCT01371734|26673302|P2|Overall Study|Withdrawal by Subject|4
7668006|NCT01371734|26673303|P1|Overall Study|Withdrawal by Subject|3
7668007|NCT01371734|26673301|P3|Overall Study|Other|2
7668008|NCT01371734|26673302|P2|Overall Study|Other|1
7668009|NCT01371734|26673303|P1|Overall Study|Other|2
7668010|NCT01371721|26673323|P3|Overall Study|Randomized but not treated|0
7668011|NCT01371721|26673324|P2|Overall Study|Randomized but not treated|0
7668012|NCT01371721|26673325|P1|Overall Study|Randomized but not treated|1
7668013|NCT01371721|26673323|P3|Overall Study|Lack of Efficacy|3
7668014|NCT01371721|26673324|P2|Overall Study|Lack of Efficacy|4
7668015|NCT01371721|26673325|P1|Overall Study|Lack of Efficacy|2
7668016|NCT01371721|26673323|P3|Overall Study|Other|0
7668017|NCT01371721|26673324|P2|Overall Study|Other|3
7668018|NCT01371721|26673325|P1|Overall Study|Other|2
7668019|NCT01371721|26673323|P3|Overall Study|Withdrawal by Subject|11
7668020|NCT01371721|26673324|P2|Overall Study|Withdrawal by Subject|7
7668021|NCT01371721|26673325|P1|Overall Study|Withdrawal by Subject|5
7668022|NCT01371721|26673323|P3|Overall Study|Lost to Follow-up|6
7668023|NCT01371721|26673324|P2|Overall Study|Lost to Follow-up|2
7668024|NCT01371721|26673325|P1|Overall Study|Lost to Follow-up|8
7668025|NCT01371721|26673323|P3|Overall Study|Protocol Violation|5
7668026|NCT01371721|26673324|P2|Overall Study|Protocol Violation|4
7668027|NCT01371721|26673325|P1|Overall Study|Protocol Violation|6
7668028|NCT01371721|26673323|P3|Overall Study|Adverse Event|5
7668029|NCT01371721|26673324|P2|Overall Study|Adverse Event|4
7668030|NCT01371721|26673325|P1|Overall Study|Adverse Event|5
7668031|NCT01371708|26673358|P3|Overall Study|Started but did not receive treatment|1
7668032|NCT01371708|26673359|P2|Overall Study|Started but did not receive treatment|0
7668033|NCT01371708|26673360|P1|Overall Study|Started but did not receive treatment|1
7668034|NCT01371708|26673358|P3|Overall Study|Adverse Event|12
7668035|NCT01371708|26673359|P2|Overall Study|Adverse Event|8
7668036|NCT01371708|26673360|P1|Overall Study|Adverse Event|5
7668037|NCT01371708|26673358|P3|Overall Study|Other|4
7668038|NCT01371708|26673359|P2|Overall Study|Other|2
7668039|NCT01371708|26673360|P1|Overall Study|Other|3
7668040|NCT01371708|26673358|P3|Overall Study|Medication error/not related to AE|0
7668041|NCT01371708|26673359|P2|Overall Study|Medication error/not related to AE|1
7668042|NCT01371708|26673360|P1|Overall Study|Medication error/not related to AE|0
7668043|NCT01371708|26673358|P3|Overall Study|No longer willing to participate|13
7668044|NCT01371708|26673359|P2|Overall Study|No longer willing to participate|7
7668045|NCT01371708|26673360|P1|Overall Study|No longer willing to participate|7
7668046|NCT01371708|26673358|P3|Overall Study|Protocol Violation|2
7668047|NCT01371708|26673359|P2|Overall Study|Protocol Violation|1
7668048|NCT01371708|26673360|P1|Overall Study|Protocol Violation|2
7668049|NCT01371708|26673358|P3|Overall Study|Lost to Follow-up|7
7668050|NCT01371708|26673359|P2|Overall Study|Lost to Follow-up|9
7668051|NCT01371708|26673360|P1|Overall Study|Lost to Follow-up|5
7668052|NCT01371708|26673358|P3|Overall Study|Insufficient clinical response|0
7668053|NCT01371708|26673359|P2|Overall Study|Insufficient clinical response|2
7668054|NCT01371708|26673360|P1|Overall Study|Insufficient clinical response|3
7668055|NCT01371656|26673392|P2|Overall Study|Ineligible|3
7668056|NCT01371656|26673393|P1|Overall Study|Ineligible|4
7668057|NCT01371656|26673392|P2|Overall Study|Withdrawal by Subject|0
7668058|NCT01371656|26673393|P1|Overall Study|Withdrawal by Subject|7
7668059|NCT01371656|26673392|P2|Overall Study|Physician Decision|7
7668060|NCT01371656|26673393|P1|Overall Study|Physician Decision|46
7668061|NCT01371656|26673392|P2|Overall Study|Death|4
7668062|NCT01371656|26673393|P1|Overall Study|Death|7
7668063|NCT01371643|26673413|P2|Overall Study|Withdrawal by Subject|0
7668064|NCT01371643|26673414|P1|Overall Study|Withdrawal by Subject|3
7668065|NCT01371565|26673424|P1|Overall Study|Resection of neuroendocrine tumor|1
7668066|NCT01371565|26673424|P1|Overall Study|Death|1
7668067|NCT01371565|26673424|P1|Overall Study|Withdrawal by Subject|1
7668068|NCT01371552|26673428|P6|Part 1, First 3 Days|Inconvenience|0
7668069|NCT01371552|26673429|P5|Part 1, First 3 Days|Inconvenience|0
7668070|NCT01371552|26673430|P4|Part 1, First 3 Days|Inconvenience|0
7668071|NCT01371552|26673431|P3|Part 1, First 3 Days|Inconvenience|1
7668072|NCT01371552|26673432|P2|Part 1, First 3 Days|Inconvenience|0
7668073|NCT01371552|26673433|P1|Part 1, First 3 Days|Inconvenience|0
7668074|NCT01371539|26673460|P2|Period Two: One Week|Time/job conflict|1
7668075|NCT01371539|26673461|P1|Period Two: One Week|Time/job conflict|0
7668076|NCT01371539|26673460|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
7668077|NCT01371539|26673461|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
7668078|NCT01371539|26673460|P2|Period Two: One Week|Lost to Follow-up|1
7668079|NCT01371539|26673461|P1|Period Two: One Week|Lost to Follow-up|0
7668080|NCT01371539|26673460|P2|Period One: One Week|Lost to Follow-up|1
7668081|NCT01371539|26673461|P1|Period One: One Week|Lost to Follow-up|0
7668082|NCT01371305|26673475|P6|Overall Study|Subject request|1
7668083|NCT01371305|26673476|P5|Overall Study|Subject request|0
7668084|NCT01371305|26673477|P4|Overall Study|Subject request|0
7668085|NCT01371305|26673478|P3|Overall Study|Subject request|0
7668086|NCT01371305|26673479|P2|Overall Study|Subject request|0
7668087|NCT01371305|26673480|P1|Overall Study|Subject request|0
7668088|NCT01371305|26673475|P6|Overall Study|Study terminated by sponsor|1
7668089|NCT01371305|26673476|P5|Overall Study|Study terminated by sponsor|3
7668090|NCT01371305|26673477|P4|Overall Study|Study terminated by sponsor|0
7668091|NCT01371305|26673478|P3|Overall Study|Study terminated by sponsor|0
7668092|NCT01371305|26673479|P2|Overall Study|Study terminated by sponsor|0
7668093|NCT01371305|26673480|P1|Overall Study|Study terminated by sponsor|0
7668094|NCT01371305|26673475|P6|Overall Study|Adverse Event|0
7668095|NCT01371305|26673476|P5|Overall Study|Adverse Event|1
7668096|NCT01371305|26673477|P4|Overall Study|Adverse Event|2
7668097|NCT01371305|26673478|P3|Overall Study|Adverse Event|0
7668098|NCT01371305|26673479|P2|Overall Study|Adverse Event|0
7668099|NCT01371305|26673480|P1|Overall Study|Adverse Event|0
7668100|NCT01371006|26673583|P2|Overall Study|Adverse Event|0
7668101|NCT01371006|26673584|P1|Overall Study|Adverse Event|1
7668102|NCT01370863|26673625|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
7668103|NCT01370863|26673626|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
7668104|NCT01370863|26673625|P2|Overall Study|Did not want second pH/MII monitoring|1
7668105|NCT01370863|26673626|P1|Overall Study|Did not want second pH/MII monitoring|1
7668106|NCT01370863|26673625|P2|Overall Study|Adverse Event|1
7668107|NCT01370863|26673626|P1|Overall Study|Adverse Event|1
7668108|NCT01370733|26673651|P2|Overall Study|Protocol Violation|3
7668109|NCT01370733|26673652|P1|Overall Study|Protocol Violation|1
7668110|NCT01370733|26673651|P2|Overall Study|Physician Decision|2
7668111|NCT01370733|26673652|P1|Overall Study|Physician Decision|0
7668112|NCT01370733|26673651|P2|Overall Study|Lack of Efficacy|5
7668113|NCT01370733|26673652|P1|Overall Study|Lack of Efficacy|3
7668114|NCT01370733|26673651|P2|Overall Study|Adverse Event|4
7668115|NCT01370733|26673652|P1|Overall Study|Adverse Event|2
7668116|NCT01370733|26673651|P2|Overall Study|Lost to Follow-up|0
7668117|NCT01370733|26673652|P1|Overall Study|Lost to Follow-up|3
7668118|NCT01370733|26673651|P2|Overall Study|Withdrawal by Subject|8
7668119|NCT01370733|26673652|P1|Overall Study|Withdrawal by Subject|8
7668120|NCT01370694|26673674|P1|Overall Study|Progressive disease|2
7668121|NCT01370694|26673674|P1|Overall Study|Switched to rituximab|4
7668122|NCT01370655|26673696|P12|Period 2|Withdrawal by Subject|0
7668123|NCT01370655|26673697|P11|Period 2|Withdrawal by Subject|0
7668124|NCT01370655|26673698|P10|Period 2|Withdrawal by Subject|0
7668125|NCT01370655|26673699|P9|Period 2|Withdrawal by Subject|1
7668126|NCT01370655|26673700|P8|Period 2|Withdrawal by Subject|0
7668127|NCT01370655|26673701|P7|Period 2|Withdrawal by Subject|0
7668128|NCT01370655|26673702|P6|Period 2|Withdrawal by Subject|0
7668129|NCT01370655|26673703|P5|Period 2|Withdrawal by Subject|0
7668130|NCT01370655|26673704|P4|Period 2|Withdrawal by Subject|0
7668131|NCT01370655|26673705|P3|Period 2|Withdrawal by Subject|0
7668132|NCT01370655|26673706|P2|Period 2|Withdrawal by Subject|0
7668133|NCT01370655|26673707|P1|Period 2|Withdrawal by Subject|0
7668134|NCT01370655|26673696|P12|Period 2|met protocol specified stopping criteria|0
7668135|NCT01370655|26673697|P11|Period 2|met protocol specified stopping criteria|1
7668136|NCT01370655|26673698|P10|Period 2|met protocol specified stopping criteria|0
7668137|NCT01370655|26673699|P9|Period 2|met protocol specified stopping criteria|1
7668138|NCT01370655|26673700|P8|Period 2|met protocol specified stopping criteria|0
7668139|NCT01370655|26673701|P7|Period 2|met protocol specified stopping criteria|1
7668140|NCT01370655|26673702|P6|Period 2|met protocol specified stopping criteria|0
7668141|NCT01370655|26673703|P5|Period 2|met protocol specified stopping criteria|0
7668142|NCT01370655|26673704|P4|Period 2|met protocol specified stopping criteria|0
7668143|NCT01370655|26673705|P3|Period 2|met protocol specified stopping criteria|1
7668144|NCT01370655|26673706|P2|Period 2|met protocol specified stopping criteria|0
7668145|NCT01370655|26673707|P1|Period 2|met protocol specified stopping criteria|0
7668146|NCT01370655|26673696|P12|Period 2|Adverse Event|0
7668147|NCT01370655|26673697|P11|Period 2|Adverse Event|0
7668148|NCT01370655|26673698|P10|Period 2|Adverse Event|0
7668149|NCT01370655|26673699|P9|Period 2|Adverse Event|0
7668150|NCT01370655|26673700|P8|Period 2|Adverse Event|1
7668151|NCT01370655|26673701|P7|Period 2|Adverse Event|0
7668152|NCT01370655|26673702|P6|Period 2|Adverse Event|0
7668153|NCT01370655|26673703|P5|Period 2|Adverse Event|1
7668154|NCT01370655|26673704|P4|Period 2|Adverse Event|0
7668155|NCT01370655|26673705|P3|Period 2|Adverse Event|1
7668156|NCT01370655|26673706|P2|Period 2|Adverse Event|0
7668157|NCT01370655|26673707|P1|Period 2|Adverse Event|0
7668158|NCT01370655|26673696|P12|Period 1|Adverse Event|0
7668159|NCT01370655|26673697|P11|Period 1|Adverse Event|0
7668160|NCT01370655|26673698|P10|Period 1|Adverse Event|0
7668161|NCT01370655|26673699|P9|Period 1|Adverse Event|0
7668162|NCT01370655|26673700|P8|Period 1|Adverse Event|0
7668163|NCT01370655|26673701|P7|Period 1|Adverse Event|1
7668164|NCT01370655|26673702|P6|Period 1|Adverse Event|0
7668165|NCT01370655|26673703|P5|Period 1|Adverse Event|0
7668166|NCT01370655|26673704|P4|Period 1|Adverse Event|0
7668167|NCT01370655|26673705|P3|Period 1|Adverse Event|0
7668168|NCT01370655|26673706|P2|Period 1|Adverse Event|0
7668169|NCT01370655|26673707|P1|Period 1|Adverse Event|2
7668170|NCT01370642|26673744|P3|Overall Study|Withdrawal by Subject|3
7668171|NCT01370642|26673745|P2|Overall Study|Withdrawal by Subject|4
7668172|NCT01370642|26673746|P1|Overall Study|Withdrawal by Subject|2
7668173|NCT01370642|26673744|P3|Overall Study|Physician Decision|2
7668174|NCT01370642|26673745|P2|Overall Study|Physician Decision|1
7668175|NCT01370642|26673746|P1|Overall Study|Physician Decision|4
7668176|NCT01370642|26673744|P3|Overall Study|Lost to Follow-up|1
7668177|NCT01370642|26673745|P2|Overall Study|Lost to Follow-up|0
7668178|NCT01370642|26673746|P1|Overall Study|Lost to Follow-up|0
7668179|NCT01370642|26673744|P3|Overall Study|Detectable HCV RNA|22
7668180|NCT01370642|26673745|P2|Overall Study|Detectable HCV RNA|0
7668181|NCT01370642|26673746|P1|Overall Study|Detectable HCV RNA|0
7668182|NCT01370642|26673744|P3|Overall Study|Adverse Event|1
7668183|NCT01370642|26673745|P2|Overall Study|Adverse Event|1
7668184|NCT01370642|26673746|P1|Overall Study|Adverse Event|2
7668185|NCT01370616|26673785|P2|Overall Study|Withdrawal by Subject|34
7668186|NCT01370616|26673786|P1|Overall Study|Withdrawal by Subject|34
7668187|NCT01370616|26673785|P2|Overall Study|Technical Problems|5
7668188|NCT01370616|26673786|P1|Overall Study|Technical Problems|3
7668189|NCT01370616|26673785|P2|Overall Study|Recovery|0
7668190|NCT01370616|26673786|P1|Overall Study|Recovery|1
7668191|NCT01370616|26673785|P2|Overall Study|Progressive Disease|1
7668192|NCT01370616|26673786|P1|Overall Study|Progressive Disease|0
7668193|NCT01370616|26673785|P2|Overall Study|Physician Decision|6
7668194|NCT01370616|26673786|P1|Overall Study|Physician Decision|6
7668195|NCT01370616|26673785|P2|Overall Study|Lost to Follow-up|3
7668196|NCT01370616|26673786|P1|Overall Study|Lost to Follow-up|0
7668197|NCT01370616|26673785|P2|Overall Study|Lack of Efficacy|2
7668198|NCT01370616|26673786|P1|Overall Study|Lack of Efficacy|6
7668199|NCT01370616|26673785|P2|Overall Study|Death|0
7668200|NCT01370616|26673786|P1|Overall Study|Death|1
7668201|NCT01370616|26673785|P2|Overall Study|Adverse Event|16
7668202|NCT01370616|26673786|P1|Overall Study|Adverse Event|11
7668203|NCT01370603|26673810|P2|Period 2|Withdrawal by Subject|0
7668204|NCT01370603|26673811|P1|Period 2|Withdrawal by Subject|1
7668205|NCT01370603|26673810|P2|Period 2|Lost to Follow-up|0
7668206|NCT01370603|26673811|P1|Period 2|Lost to Follow-up|1
7668207|NCT01370603|26673810|P2|Period 2|Adverse Event|4
7668208|NCT01370603|26673811|P1|Period 2|Adverse Event|1
7668209|NCT01370603|26673810|P2|Crossover Washout|Non-compliance with Study Drug|2
7668210|NCT01370603|26673811|P1|Crossover Washout|Non-compliance with Study Drug|0
7668211|NCT01370603|26673810|P2|Crossover Washout|Withdrawal by Subject|1
7668212|NCT01370603|26673811|P1|Crossover Washout|Withdrawal by Subject|4
7668213|NCT01370603|26673810|P2|Crossover Washout|Protocol Violation|0
7668214|NCT01370603|26673811|P1|Crossover Washout|Protocol Violation|1
7668215|NCT01370603|26673810|P2|Crossover Washout|Lost to Follow-up|0
7668216|NCT01370603|26673811|P1|Crossover Washout|Lost to Follow-up|2
7668217|NCT01370603|26673810|P2|Crossover Washout|Adverse Event|1
7668218|NCT01370603|26673811|P1|Crossover Washout|Adverse Event|2
7668219|NCT01370603|26673810|P2|Period 1|Withdrawal by Subject|5
7668220|NCT01370603|26673811|P1|Period 1|Withdrawal by Subject|5
7668221|NCT01370603|26673810|P2|Period 1|Protocol Violation|2
7668222|NCT01370603|26673811|P1|Period 1|Protocol Violation|2
7668223|NCT01370603|26673810|P2|Period 1|Lost to Follow-up|0
7668224|NCT01370603|26673811|P1|Period 1|Lost to Follow-up|2
7668225|NCT01370603|26673810|P2|Period 1|Adverse Event|3
7668226|NCT01370603|26673811|P1|Period 1|Adverse Event|5
7668227|NCT01370590|26673829|P2|Period 2|Withdrawal by Subject|1
7668228|NCT01370590|26673830|P1|Period 2|Withdrawal by Subject|1
7668229|NCT01370590|26673829|P2|Period 2|Adverse Event|1
7668230|NCT01370590|26673830|P1|Period 2|Adverse Event|0
7668231|NCT01370590|26673829|P2|Crossover Washout Period|Withdrawal by Subject|2
7668232|NCT01370590|26673830|P1|Crossover Washout Period|Withdrawal by Subject|2
7668233|NCT01370590|26673829|P2|Crossover Washout Period|Non-compliance with Study Drug|0
7668234|NCT01370590|26673830|P1|Crossover Washout Period|Non-compliance with Study Drug|1
7668235|NCT01370590|26673829|P2|Crossover Washout Period|Lost to Follow-up|0
7668236|NCT01370590|26673830|P1|Crossover Washout Period|Lost to Follow-up|2
7668237|NCT01370590|26673829|P2|Crossover Washout Period|Adverse Event|4
7668238|NCT01370590|26673830|P1|Crossover Washout Period|Adverse Event|1
7668239|NCT01370590|26673829|P2|Period 1|Could not access randomization system|1
7668240|NCT01370590|26673830|P1|Period 1|Could not access randomization system|0
7668241|NCT01370590|26673829|P2|Period 1|Withdrawal by Subject|2
7668242|NCT01370590|26673830|P1|Period 1|Withdrawal by Subject|4
7668243|NCT01370590|26673829|P2|Period 1|Protocol Violation|2
7668244|NCT01370590|26673830|P1|Period 1|Protocol Violation|2
7668245|NCT01370590|26673829|P2|Period 1|Lost to Follow-up|2
7668246|NCT01370590|26673830|P1|Period 1|Lost to Follow-up|2
7668247|NCT01370590|26673829|P2|Period 1|Adverse Event|4
7668248|NCT01370590|26673830|P1|Period 1|Adverse Event|8
7668249|NCT01370538|26673858|P2|Overall Study|Lost to follow up|10
7668250|NCT01370538|26673859|P1|Overall Study|Lost to follow up|6
7668251|NCT01370538|26673858|P2|Overall Study|Development of study specific withdrawal|1
7668252|NCT01370538|26673859|P1|Overall Study|Development of study specific withdrawal|1
7668253|NCT01370538|26673858|P2|Overall Study|Protocol Violation|5
7668254|NCT01370538|26673859|P1|Overall Study|Protocol Violation|8
7668255|NCT01370538|26673858|P2|Overall Study|Adverse Event|0
7668256|NCT01370538|26673859|P1|Overall Study|Adverse Event|1
7668257|NCT01370538|26673858|P2|Overall Study|Eligibility criteria not fulfilled|1
7668258|NCT01370538|26673859|P1|Overall Study|Eligibility criteria not fulfilled|0
7668259|NCT01370538|26673858|P2|Overall Study|Voluntary Discontinuation by Subject|2
7668260|NCT01370538|26673859|P1|Overall Study|Voluntary Discontinuation by Subject|3
7668261|NCT01370525|26673875|P2|Overall Study|Lost to follow up|6
7668262|NCT01370525|26673876|P1|Overall Study|Lost to follow up|2
7668263|NCT01370525|26673875|P2|Overall Study|Protocol Violation|1
7668264|NCT01370525|26673876|P1|Overall Study|Protocol Violation|2
7668265|NCT01370525|26673875|P2|Overall Study|Adverse Event|1
7668266|NCT01370525|26673876|P1|Overall Study|Adverse Event|0
7668267|NCT01370525|26673875|P2|Overall Study|Eligibility criteria not fulfilled|0
7668268|NCT01370525|26673876|P1|Overall Study|Eligibility criteria not fulfilled|2
7668269|NCT01370525|26673875|P2|Overall Study|Voluntary Discontinuation by Subject|3
7668270|NCT01370525|26673876|P1|Overall Study|Voluntary Discontinuation by Subject|2
7668271|NCT01370499|26673892|P2|Overall Study|Sponsor Decision|15
7668272|NCT01370499|26673893|P1|Overall Study|Sponsor Decision|41
7668273|NCT01370499|26673892|P2|Overall Study|Withdrawal by Subject|7
7668274|NCT01370499|26673893|P1|Overall Study|Withdrawal by Subject|18
7668275|NCT01370499|26673892|P2|Overall Study|Protocol Violation|4
7668276|NCT01370499|26673893|P1|Overall Study|Protocol Violation|5
7668277|NCT01370499|26673892|P2|Overall Study|Physician Decision|3
7668278|NCT01370499|26673893|P1|Overall Study|Physician Decision|3
7668279|NCT01370499|26673892|P2|Overall Study|Lost to Follow-up|1
7668280|NCT01370499|26673893|P1|Overall Study|Lost to Follow-up|2
7668281|NCT01370499|26673892|P2|Overall Study|Lack of Efficacy|2
7668282|NCT01370499|26673893|P1|Overall Study|Lack of Efficacy|4
7668283|NCT01370499|26673892|P2|Overall Study|Adverse Event|12
7668284|NCT01370499|26673893|P1|Overall Study|Adverse Event|38
7668285|NCT01370408|26673935|P1|Overall Study|treatment failure|9
7668286|NCT01370356|26673995|P2|Overall Study|AE Not Related to Study Drug|4
7668287|NCT01370356|26673996|P1|Overall Study|AE Not Related to Study Drug|1
7668288|NCT01370356|26673995|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
7668289|NCT01370356|26673996|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
7668290|NCT01370356|26673995|P2|Overall Study|Protocol Violation|3
7668291|NCT01370356|26673996|P1|Overall Study|Protocol Violation|3
7668292|NCT01370356|26673995|P2|Overall Study|Reason not specified|43
7668293|NCT01370356|26673996|P1|Overall Study|Reason not specified|39
7668294|NCT01370356|26673995|P2|Overall Study|Withdrawal by Subject|59
7668295|NCT01370356|26673996|P1|Overall Study|Withdrawal by Subject|54
7668296|NCT01370356|26673995|P2|Overall Study|Lost to Follow-up|81
7668297|NCT01370356|26673996|P1|Overall Study|Lost to Follow-up|76
7668298|NCT01370356|26673995|P2|Overall Study|Lack of Efficacy|28
7668299|NCT01370356|26673996|P1|Overall Study|Lack of Efficacy|6
7668300|NCT01370356|26673995|P2|Overall Study|Death|0
7668301|NCT01370356|26673996|P1|Overall Study|Death|1
7668302|NCT01370317|26674012|P2|Overall Study|Protocol deviation|1
7668303|NCT01370317|26674013|P1|Overall Study|Protocol deviation|0
7668304|NCT01370317|26674012|P2|Overall Study|Participant withdrew consent|0
7668305|NCT01370317|26674013|P1|Overall Study|Participant withdrew consent|1
7668306|NCT01370265|26674024|P2|First Intervention|Adverse Event|1
7668307|NCT01370265|26674025|P1|First Intervention|Adverse Event|1
7668308|NCT01370213|26674045|P3|Overall Study|Not evaluable|0
7668309|NCT01370213|26674046|P2|Overall Study|Not evaluable|2
7668310|NCT01370213|26674047|P1|Overall Study|Not evaluable|0
7668311|NCT01370213|26674045|P3|Overall Study|Early Death|0
7668312|NCT01370213|26674046|P2|Overall Study|Early Death|0
7668313|NCT01370213|26674047|P1|Overall Study|Early Death|1
7668314|NCT01370083|26674092|P2|Overall Study|Adverse Event|1
7668315|NCT01370083|26674093|P1|Overall Study|Adverse Event|0
7668316|NCT01370083|26674092|P2|Overall Study|Lost to Follow-up|0
7668317|NCT01370083|26674093|P1|Overall Study|Lost to Follow-up|2
7668318|NCT01370018|26674103|P1|Overall Study|Did not meet criteria for analysis|1
7668319|NCT01370005|26674110|P3|Overall Study|Other reason not defined above|2
7668320|NCT01370005|26674111|P2|Overall Study|Other reason not defined above|0
7668321|NCT01370005|26674112|P1|Overall Study|Other reason not defined above|3
7668322|NCT01370005|26674110|P3|Overall Study|Patient refusal to continue,not due toAE|0
7668323|NCT01370005|26674111|P2|Overall Study|Patient refusal to continue,not due toAE|4
7668324|NCT01370005|26674112|P1|Overall Study|Patient refusal to continue,not due toAE|5
7668325|NCT01370005|26674110|P3|Overall Study|Lost to Follow-up|1
7668326|NCT01370005|26674111|P2|Overall Study|Lost to Follow-up|1
7668327|NCT01370005|26674112|P1|Overall Study|Lost to Follow-up|1
7668328|NCT01370005|26674110|P3|Overall Study|Non compliant with protocol|2
7668329|NCT01370005|26674111|P2|Overall Study|Non compliant with protocol|1
7668330|NCT01370005|26674112|P1|Overall Study|Non compliant with protocol|0
7668331|NCT01370005|26674110|P3|Overall Study|Lack of Efficacy|0
7668332|NCT01370005|26674111|P2|Overall Study|Lack of Efficacy|0
7668333|NCT01370005|26674112|P1|Overall Study|Lack of Efficacy|1
7668334|NCT01370005|26674110|P3|Overall Study|Adverse Event|6
7668335|NCT01370005|26674111|P2|Overall Study|Adverse Event|5
7668336|NCT01370005|26674112|P1|Overall Study|Adverse Event|5
7668337|NCT01370005|26674110|P3|Overall Study|Not treated|0
7668338|NCT01370005|26674111|P2|Overall Study|Not treated|0
7668339|NCT01370005|26674112|P1|Overall Study|Not treated|1
7668340|NCT01369849|26674194|P3|Overall Study|Ineligible after receiving treatment|0
7668341|NCT01369849|26674195|P2|Overall Study|Ineligible after receiving treatment|1
7668342|NCT01369849|26674196|P1|Overall Study|Ineligible after receiving treatment|0
7668343|NCT01369849|26674194|P3|Overall Study|Ineligible prior to treatment|1
7668344|NCT01369849|26674195|P2|Overall Study|Ineligible prior to treatment|0
7668345|NCT01369849|26674196|P1|Overall Study|Ineligible prior to treatment|0
7668346|NCT01369784|26674218|P1|Overall Study|Protocol Violation|12
7668347|NCT01369680|26674306|P4|Overall Study|Lost to Follow-up|2
7668348|NCT01369680|26674307|P3|Overall Study|Lost to Follow-up|1
7668349|NCT01369680|26674308|P2|Overall Study|Lost to Follow-up|0
7668350|NCT01369680|26674309|P1|Overall Study|Lost to Follow-up|0
7668351|NCT01369641|26674330|P1|Overall Study|Withdrawal by Subject|1
7668352|NCT01369615|26674336|P2|Overall Study|Lost to Follow-up|1
7668353|NCT01369615|26674337|P1|Overall Study|Lost to Follow-up|0
7668354|NCT01369615|26674336|P2|Overall Study|Withdrawal by Subject|1
7668355|NCT01369615|26674337|P1|Overall Study|Withdrawal by Subject|0
7668356|NCT01369511|26674347|P4|Overall Study|Withdrawal by Subject|6
7668357|NCT01369511|26674348|P3|Overall Study|Withdrawal by Subject|4
7668358|NCT01369511|26674349|P2|Overall Study|Withdrawal by Subject|6
7668359|NCT01369511|26674350|P1|Overall Study|Withdrawal by Subject|5
7668360|NCT01369511|26674347|P4|Overall Study|Sponsor decision|0
7668361|NCT01369511|26674348|P3|Overall Study|Sponsor decision|1
7668362|NCT01369511|26674349|P2|Overall Study|Sponsor decision|0
7668363|NCT01369511|26674350|P1|Overall Study|Sponsor decision|2
7668364|NCT01369511|26674347|P4|Overall Study|Physician Decision|0
7668365|NCT01369511|26674348|P3|Overall Study|Physician Decision|0
7668366|NCT01369511|26674349|P2|Overall Study|Physician Decision|4
7668367|NCT01369511|26674350|P1|Overall Study|Physician Decision|3
7668368|NCT01369511|26674347|P4|Overall Study|Protocol Violation|2
7668369|NCT01369511|26674348|P3|Overall Study|Protocol Violation|0
7668370|NCT01369511|26674349|P2|Overall Study|Protocol Violation|1
7668371|NCT01369511|26674350|P1|Overall Study|Protocol Violation|0
7668372|NCT01369511|26674347|P4|Overall Study|Lost to Follow-up|2
7668373|NCT01369511|26674348|P3|Overall Study|Lost to Follow-up|1
7668374|NCT01369511|26674349|P2|Overall Study|Lost to Follow-up|1
7668375|NCT01369511|26674350|P1|Overall Study|Lost to Follow-up|0
7668376|NCT01369511|26674347|P4|Overall Study|Entry criteria not met|1
7668377|NCT01369511|26674348|P3|Overall Study|Entry criteria not met|0
7668378|NCT01369511|26674349|P2|Overall Study|Entry criteria not met|0
7668379|NCT01369511|26674350|P1|Overall Study|Entry criteria not met|2
7668380|NCT01369511|26674347|P4|Overall Study|Adverse Event|0
7668381|NCT01369511|26674348|P3|Overall Study|Adverse Event|5
7668382|NCT01369511|26674349|P2|Overall Study|Adverse Event|1
7668383|NCT01369511|26674350|P1|Overall Study|Adverse Event|1
7668384|NCT01369498|26674368|P4|Overall Study|Disease Progression|1
7668385|NCT01369498|26674369|P3|Overall Study|Disease Progression|0
7668386|NCT01369498|26674370|P2|Overall Study|Disease Progression|0
7668387|NCT01369498|26674371|P1|Overall Study|Disease Progression|0
7668388|NCT01369498|26674368|P4|Overall Study|Unknown Reason|6
7668389|NCT01369498|26674369|P3|Overall Study|Unknown Reason|11
7668390|NCT01369498|26674370|P2|Overall Study|Unknown Reason|0
7668391|NCT01369498|26674371|P1|Overall Study|Unknown Reason|1
7668392|NCT01369498|26674368|P4|Overall Study|Investigator's Discretion|3
7668393|NCT01369498|26674369|P3|Overall Study|Investigator's Discretion|1
7668394|NCT01369498|26674370|P2|Overall Study|Investigator's Discretion|0
7668395|NCT01369498|26674371|P1|Overall Study|Investigator's Discretion|1
7668396|NCT01369498|26674368|P4|Overall Study|Death|0
7668397|NCT01369498|26674369|P3|Overall Study|Death|1
7668398|NCT01369498|26674370|P2|Overall Study|Death|0
7668399|NCT01369498|26674371|P1|Overall Study|Death|0
7668400|NCT01369498|26674368|P4|Overall Study|Withdrawal of Consent|1
7668401|NCT01369498|26674369|P3|Overall Study|Withdrawal of Consent|1
7668402|NCT01369498|26674370|P2|Overall Study|Withdrawal of Consent|1
7668403|NCT01369498|26674371|P1|Overall Study|Withdrawal of Consent|0
7668404|NCT01369498|26674368|P4|Overall Study|Adverse Event|1
7668405|NCT01369498|26674369|P3|Overall Study|Adverse Event|0
7668406|NCT01369498|26674370|P2|Overall Study|Adverse Event|2
7668407|NCT01369498|26674371|P1|Overall Study|Adverse Event|1
7668408|NCT01369498|26674368|P4|Overall Study|Lack of Efficacy|3
7668409|NCT01369498|26674369|P3|Overall Study|Lack of Efficacy|1
7668410|NCT01369498|26674370|P2|Overall Study|Lack of Efficacy|9
7668411|NCT01369498|26674371|P1|Overall Study|Lack of Efficacy|9
7668412|NCT01369485|26674403|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
7668413|NCT01369485|26674404|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
7668414|NCT01369485|26674403|P2|Open Label Phase (Week 12 to Month 12)|Death|1
7668415|NCT01369485|26674404|P1|Open Label Phase (Week 12 to Month 12)|Death|0
7668416|NCT01369485|26674403|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
7668417|NCT01369485|26674404|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
7668418|NCT01369485|26674403|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
7668419|NCT01369485|26674404|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
7668420|NCT01369485|26674403|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
7668421|NCT01369485|26674404|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
7668422|NCT01369485|26674403|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
7668423|NCT01369485|26674404|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
7668424|NCT01369485|26674403|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
7668425|NCT01369485|26674404|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
7668426|NCT01369485|26674403|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
7668427|NCT01369485|26674404|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
7668428|NCT01369485|26674403|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
7668429|NCT01369485|26674404|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
7668430|NCT01369485|26674403|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
7668431|NCT01369485|26674404|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
7668432|NCT01369433|26674446|P2|Overall Study|Progressive Disease|12
7668433|NCT01369433|26674447|P1|Overall Study|Progressive Disease|92
7668434|NCT01369433|26674446|P2|Overall Study|Investigator discretion|1
7668435|NCT01369433|26674447|P1|Overall Study|Investigator discretion|6
7668436|NCT01369433|26674446|P2|Overall Study|Death|0
7668437|NCT01369433|26674447|P1|Overall Study|Death|5
7668438|NCT01369433|26674446|P2|Overall Study|Lost to Follow-up|0
7668439|NCT01369433|26674447|P1|Overall Study|Lost to Follow-up|1
7668440|NCT01369433|26674446|P2|Overall Study|Study terminated by Sponsor|0
7668441|NCT01369433|26674447|P1|Overall Study|Study terminated by Sponsor|67
7668442|NCT01369433|26674446|P2|Overall Study|Withdrawal by Subject|2
7668443|NCT01369433|26674447|P1|Overall Study|Withdrawal by Subject|5
7668444|NCT01369433|26674446|P2|Overall Study|Non-compliance|0
7668445|NCT01369433|26674447|P1|Overall Study|Non-compliance|1
7668446|NCT01369433|26674446|P2|Overall Study|Required significant surgical procedure|0
7668447|NCT01369433|26674447|P1|Overall Study|Required significant surgical procedure|1
7668448|NCT01369433|26674446|P2|Overall Study|Adverse Event|1
7668449|NCT01369433|26674447|P1|Overall Study|Adverse Event|31
7668450|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Other|17
7668451|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Other|9
7668452|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Other|110
7668453|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Other|0
7668454|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Other|0
7668455|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Other|0
7668456|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Other|0
7668457|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Other|0
7668458|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Other|0
7668459|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
7668460|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
7668461|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
7668462|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7668463|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7668464|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7668465|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7668466|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7668467|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7668468|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Lost to Follow-up|9
7668469|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Lost to Follow-up|5
7668470|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Lost to Follow-up|1
7668471|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7668472|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7668473|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7668474|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7668475|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7668476|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7668477|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Physician Decision|11
7668478|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Physician Decision|5
7668479|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Physician Decision|1
7668480|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Physician Decision|0
7668481|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Physician Decision|0
7668482|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Physician Decision|0
7668483|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Physician Decision|0
7668484|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Physician Decision|0
7668485|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Physician Decision|0
7668486|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Protocol Violation|2
7668487|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Protocol Violation|1
7668488|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Protocol Violation|0
7668489|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Protocol Violation|0
7668490|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Protocol Violation|0
7668491|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Protocol Violation|0
7668492|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Protocol Violation|0
7668493|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Protocol Violation|0
7668494|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Protocol Violation|0
7668495|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Lack of Efficacy|29
7668496|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Lack of Efficacy|26
7668497|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Lack of Efficacy|12
7668498|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7668499|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7668500|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7668501|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7668502|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7668503|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7668504|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Death|3
7668505|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Death|1
7668506|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Death|0
7668507|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Death|0
7668508|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Death|0
7668509|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Death|0
7668510|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Death|0
7668511|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Death|0
7668512|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Death|0
7668513|NCT01369355|26674459|P9|Long-term Extension (Week 44-272)|Adverse Event|53
7668514|NCT01369355|26674460|P8|Long-term Extension (Week 44-272)|Adverse Event|29
7668515|NCT01369355|26674461|P7|Long-term Extension (Week 44-272)|Adverse Event|15
7668516|NCT01369355|26674462|P6|Long-term Extension (Week 44-272)|Adverse Event|0
7668517|NCT01369355|26674463|P5|Long-term Extension (Week 44-272)|Adverse Event|0
7668518|NCT01369355|26674464|P4|Long-term Extension (Week 44-272)|Adverse Event|0
7668519|NCT01369355|26674465|P3|Long-term Extension (Week 44-272)|Adverse Event|0
7668520|NCT01369355|26674466|P2|Long-term Extension (Week 44-272)|Adverse Event|0
7668521|NCT01369355|26674467|P1|Long-term Extension (Week 44-272)|Adverse Event|0
7668522|NCT01369355|26674459|P9|Week 0 - Week 44 (Maintenance)|Other|0
7668523|NCT01369355|26674460|P8|Week 0 - Week 44 (Maintenance)|Other|0
7668524|NCT01369355|26674461|P7|Week 0 - Week 44 (Maintenance)|Other|0
7668525|NCT01369355|26674462|P6|Week 0 - Week 44 (Maintenance)|Other|0
7668526|NCT01369355|26674463|P5|Week 0 - Week 44 (Maintenance)|Other|1
7668527|NCT01369355|26674464|P4|Week 0 - Week 44 (Maintenance)|Other|0
7668528|NCT01369355|26674465|P3|Week 0 - Week 44 (Maintenance)|Other|1
7668529|NCT01369355|26674466|P2|Week 0 - Week 44 (Maintenance)|Other|0
7668530|NCT01369355|26674467|P1|Week 0 - Week 44 (Maintenance)|Other|0
7668531|NCT01369355|26674459|P9|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7668532|NCT01369355|26674460|P8|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7668533|NCT01369355|26674461|P7|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7668534|NCT01369355|26674462|P6|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
7668535|NCT01369355|26674463|P5|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
7668536|NCT01369355|26674464|P4|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
7668537|NCT01369355|26674465|P3|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
7668538|NCT01369355|26674466|P2|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
7668539|NCT01369355|26674467|P1|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
7668540|NCT01369355|26674459|P9|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7668541|NCT01369355|26674460|P8|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7668542|NCT01369355|26674461|P7|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7668543|NCT01369355|26674462|P6|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
7668544|NCT01369355|26674463|P5|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
7668545|NCT01369355|26674464|P4|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
7668546|NCT01369355|26674465|P3|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
7668547|NCT01369355|26674466|P2|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7668548|NCT01369355|26674467|P1|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
7668549|NCT01369355|26674459|P9|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7668550|NCT01369355|26674460|P8|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7668551|NCT01369355|26674461|P7|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7668552|NCT01369355|26674462|P6|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
7668553|NCT01369355|26674463|P5|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7668554|NCT01369355|26674464|P4|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7668555|NCT01369355|26674465|P3|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
7668556|NCT01369355|26674466|P2|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
7668557|NCT01369355|26674467|P1|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7668558|NCT01369355|26674459|P9|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7668559|NCT01369355|26674460|P8|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7668560|NCT01369355|26674461|P7|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7668561|NCT01369355|26674462|P6|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
7668562|NCT01369355|26674463|P5|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
7668563|NCT01369355|26674464|P4|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7668564|NCT01369355|26674465|P3|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7668565|NCT01369355|26674466|P2|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
7668566|NCT01369355|26674467|P1|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7668567|NCT01369355|26674459|P9|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7668568|NCT01369355|26674460|P8|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7668569|NCT01369355|26674461|P7|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7668570|NCT01369355|26674462|P6|Week 0 - Week 44 (Maintenance)|Adverse Event|25
7668571|NCT01369355|26674463|P5|Week 0 - Week 44 (Maintenance)|Adverse Event|14
7668572|NCT01369355|26674464|P4|Week 0 - Week 44 (Maintenance)|Adverse Event|7
7668573|NCT01369355|26674465|P3|Week 0 - Week 44 (Maintenance)|Adverse Event|6
7668574|NCT01369355|26674466|P2|Week 0 - Week 44 (Maintenance)|Adverse Event|12
7668575|NCT01369355|26674467|P1|Week 0 - Week 44 (Maintenance)|Adverse Event|9
7668576|NCT01369342|26674499|P3|Overall Study|Not Treated|0
7668577|NCT01369342|26674500|P2|Overall Study|Not Treated|0
7668578|NCT01369342|26674501|P1|Overall Study|Not Treated|1
7668579|NCT01369342|26674499|P3|Overall Study|Lost to Follow-up|1
7668580|NCT01369342|26674500|P2|Overall Study|Lost to Follow-up|2
7668581|NCT01369342|26674501|P1|Overall Study|Lost to Follow-up|5
7668582|NCT01369342|26674499|P3|Overall Study|Withdrawal by Subject|2
7668583|NCT01369342|26674500|P2|Overall Study|Withdrawal by Subject|7
7668584|NCT01369342|26674501|P1|Overall Study|Withdrawal by Subject|7
7668585|NCT01369329|26674524|P3|Overall Study|Other|2
7668586|NCT01369329|26674525|P2|Overall Study|Other|3
7668587|NCT01369329|26674526|P1|Overall Study|Other|2
7668588|NCT01369329|26674524|P3|Overall Study|Lost to Follow-up|2
7668589|NCT01369329|26674525|P2|Overall Study|Lost to Follow-up|2
7668590|NCT01369329|26674526|P1|Overall Study|Lost to Follow-up|2
7668591|NCT01369329|26674524|P3|Overall Study|Withdrawal by Subject|10
7668592|NCT01369329|26674525|P2|Overall Study|Withdrawal by Subject|6
7668593|NCT01369329|26674526|P1|Overall Study|Withdrawal by Subject|8
7668594|NCT01369225|26674552|P6|Overall Study|Adverse Event|0
7668595|NCT01369225|26674553|P5|Overall Study|Adverse Event|1
7668596|NCT01369225|26674554|P4|Overall Study|Adverse Event|1
7668597|NCT01369225|26674555|P3|Overall Study|Adverse Event|0
7668598|NCT01369225|26674556|P2|Overall Study|Adverse Event|0
7668599|NCT01369225|26674557|P1|Overall Study|Adverse Event|0
7668600|NCT01369225|26674552|P6|Overall Study|Other|0
7668601|NCT01369225|26674553|P5|Overall Study|Other|1
7668602|NCT01369225|26674554|P4|Overall Study|Other|0
7668603|NCT01369225|26674555|P3|Overall Study|Other|0
7668604|NCT01369225|26674556|P2|Overall Study|Other|0
7668605|NCT01369225|26674557|P1|Overall Study|Other|1
7668606|NCT01369225|26674552|P6|Overall Study|Does Not Meet Entrance Criteria|0
7668607|NCT01369225|26674553|P5|Overall Study|Does Not Meet Entrance Criteria|0
7668608|NCT01369225|26674554|P4|Overall Study|Does Not Meet Entrance Criteria|0
7668609|NCT01369225|26674555|P3|Overall Study|Does Not Meet Entrance Criteria|1
7668610|NCT01369225|26674556|P2|Overall Study|Does Not Meet Entrance Criteria|0
7668611|NCT01369225|26674557|P1|Overall Study|Does Not Meet Entrance Criteria|0
7668612|NCT01369225|26674552|P6|Overall Study|Withdrawal by Subject|0
7668613|NCT01369225|26674553|P5|Overall Study|Withdrawal by Subject|0
7668614|NCT01369225|26674554|P4|Overall Study|Withdrawal by Subject|1
7668615|NCT01369225|26674555|P3|Overall Study|Withdrawal by Subject|2
7668616|NCT01369225|26674556|P2|Overall Study|Withdrawal by Subject|0
7668617|NCT01369225|26674557|P1|Overall Study|Withdrawal by Subject|1
7668618|NCT01369199|26674649|P1|Overall Study|Lost to Follow-up|2
7668619|NCT01369199|26674649|P1|Overall Study|Withdrawal by Subject|1
7668620|NCT01369069|26674681|P2|Overall Study|Withdrawal by Subject|7
7668621|NCT01369069|26674682|P1|Overall Study|Withdrawal by Subject|9
7668622|NCT01369069|26674681|P2|Overall Study|Lost to Follow-up|9
7668623|NCT01369069|26674682|P1|Overall Study|Lost to Follow-up|8
7668624|NCT01368965|26674704|P1|Overall Study|Lost to Follow-up|12
7668625|NCT01368900|26674713|P1|Overall Study|Lost to Follow-up|7
7668626|NCT01368835|26674788|P1|Overall Study|Lost to Follow-up|11
7668627|NCT01368835|26674788|P1|Overall Study|Inclusion criteria/photography quality|22
7668628|NCT01368614|26674827|P4|Study Period|Lost to Follow-up|0
7668629|NCT01368614|26674828|P3|Study Period|Lost to Follow-up|1
7668630|NCT01368614|26674829|P2|Study Period|Lost to Follow-up|0
7668631|NCT01368614|26674830|P1|Study Period|Lost to Follow-up|0
7668632|NCT01368614|26674827|P4|Study Period|Withdrawal by Subject|3
7668633|NCT01368614|26674828|P3|Study Period|Withdrawal by Subject|1
7668634|NCT01368614|26674829|P2|Study Period|Withdrawal by Subject|1
7668635|NCT01368614|26674830|P1|Study Period|Withdrawal by Subject|0
7668636|NCT01368614|26674827|P4|Screening Period|Screen Failure|0
7668637|NCT01368614|26674828|P3|Screening Period|Screen Failure|0
7668638|NCT01368614|26674829|P2|Screening Period|Screen Failure|0
7668639|NCT01368614|26674830|P1|Screening Period|Screen Failure|58
7668640|NCT01368562|26674883|P1|Overall Study|Other than specified|2
7668641|NCT01368562|26674883|P1|Overall Study|Other|3
7668642|NCT01368562|26674883|P1|Overall Study|Unresponsive to treatment|5
7668643|NCT01368562|26674883|P1|Overall Study|Death|6
7668644|NCT01368562|26674883|P1|Overall Study|Lost to Follow-up|1
7668645|NCT01368562|26674883|P1|Overall Study|Disease progression|1
7668646|NCT01368562|26674883|P1|Overall Study|Adverse Event|1
7668647|NCT01368536|26674890|P3|Overall Study|Protocol deviation|1
7668648|NCT01368536|26674891|P2|Overall Study|Protocol deviation|3
7668649|NCT01368536|26674892|P1|Overall Study|Protocol deviation|0
7668650|NCT01368536|26674890|P3|Overall Study|Administrative problems|35
7668651|NCT01368536|26674891|P2|Overall Study|Administrative problems|39
7668652|NCT01368536|26674892|P1|Overall Study|Administrative problems|34
7668653|NCT01368536|26674890|P3|Overall Study|Lost to Follow-up|5
7668654|NCT01368536|26674891|P2|Overall Study|Lost to Follow-up|3
7668655|NCT01368536|26674892|P1|Overall Study|Lost to Follow-up|3
7668656|NCT01368536|26674890|P3|Overall Study|Withdrawal by Subject|4
7668657|NCT01368536|26674891|P2|Overall Study|Withdrawal by Subject|5
7668658|NCT01368536|26674892|P1|Overall Study|Withdrawal by Subject|2
7668659|NCT01368536|26674890|P3|Overall Study|No longer required study medication|1
7668660|NCT01368536|26674891|P2|Overall Study|No longer required study medication|0
7668661|NCT01368536|26674892|P1|Overall Study|No longer required study medication|0
7668662|NCT01368536|26674890|P3|Overall Study|Unsatisfactory therapeutic effect|2
7668663|NCT01368536|26674891|P2|Overall Study|Unsatisfactory therapeutic effect|2
7668664|NCT01368536|26674892|P1|Overall Study|Unsatisfactory therapeutic effect|7
7668665|NCT01368536|26674890|P3|Overall Study|Abnormal test procedure result(s)|1
7668666|NCT01368536|26674891|P2|Overall Study|Abnormal test procedure result(s)|0
7668667|NCT01368536|26674892|P1|Overall Study|Abnormal test procedure result(s)|0
7668668|NCT01368536|26674890|P3|Overall Study|Abnormal laboratory value(s)|2
7668669|NCT01368536|26674891|P2|Overall Study|Abnormal laboratory value(s)|1
7668670|NCT01368536|26674892|P1|Overall Study|Abnormal laboratory value(s)|0
7668671|NCT01368536|26674890|P3|Overall Study|Adverse Event|8
7668672|NCT01368536|26674891|P2|Overall Study|Adverse Event|6
7668673|NCT01368536|26674892|P1|Overall Study|Adverse Event|5
7668674|NCT01368497|26674913|P1|Overall Study|Lost to Follow-up|2
7668675|NCT01368432|26674942|P2|Overall Study|Lost to Follow-up|1
7668676|NCT01368432|26674943|P1|Overall Study|Lost to Follow-up|0
7668677|NCT01368406|26674977|P2|Overall Study|started working|3
7668678|NCT01368406|26674978|P1|Overall Study|started working|2
7668679|NCT01368406|26674977|P2|Overall Study|relapse of the disease|2
7668680|NCT01368406|26674978|P1|Overall Study|relapse of the disease|3
7668681|NCT01368406|26674977|P2|Overall Study|Withdrawal by Subject|4
7668682|NCT01368406|26674978|P1|Overall Study|Withdrawal by Subject|8
7668683|NCT01368406|26674977|P2|Overall Study|Lost to Follow-up|4
7668684|NCT01368406|26674978|P1|Overall Study|Lost to Follow-up|8
7668685|NCT01368276|26674986|P2|Overall Study|Death|10
7668686|NCT01368276|26674987|P1|Overall Study|Death|1
7668687|NCT01368211|26675024|P2|Second Platelets Transfusion|No need for additional transfusion|2
7668688|NCT01368211|26675025|P1|Second Platelets Transfusion|No need for additional transfusion|1
7668689|NCT01368081|26675053|P13|Overall Study|Other reason not defined above|3
7668690|NCT01368081|26675054|P12|Overall Study|Other reason not defined above|0
7668691|NCT01368081|26675055|P11|Overall Study|Other reason not defined above|0
7668692|NCT01368081|26675056|P10|Overall Study|Other reason not defined above|1
7668693|NCT01368081|26675057|P9|Overall Study|Other reason not defined above|0
7668694|NCT01368081|26675058|P8|Overall Study|Other reason not defined above|0
7668695|NCT01368081|26675059|P7|Overall Study|Other reason not defined above|2
7668696|NCT01368081|26675060|P6|Overall Study|Other reason not defined above|1
7668697|NCT01368081|26675061|P5|Overall Study|Other reason not defined above|0
7668698|NCT01368081|26675062|P4|Overall Study|Other reason not defined above|1
7668699|NCT01368081|26675063|P3|Overall Study|Other reason not defined above|0
7668700|NCT01368081|26675064|P2|Overall Study|Other reason not defined above|0
7668701|NCT01368081|26675065|P1|Overall Study|Other reason not defined above|2
7668702|NCT01368081|26675053|P13|Overall Study|Withdrawal by Subject|0
7668703|NCT01368081|26675054|P12|Overall Study|Withdrawal by Subject|2
7668704|NCT01368081|26675055|P11|Overall Study|Withdrawal by Subject|3
7668705|NCT01368081|26675056|P10|Overall Study|Withdrawal by Subject|4
7668706|NCT01368081|26675057|P9|Overall Study|Withdrawal by Subject|5
7668707|NCT01368081|26675058|P8|Overall Study|Withdrawal by Subject|2
7668708|NCT01368081|26675059|P7|Overall Study|Withdrawal by Subject|4
7668709|NCT01368081|26675060|P6|Overall Study|Withdrawal by Subject|3
7668710|NCT01368081|26675061|P5|Overall Study|Withdrawal by Subject|0
7668711|NCT01368081|26675062|P4|Overall Study|Withdrawal by Subject|1
7668712|NCT01368081|26675063|P3|Overall Study|Withdrawal by Subject|1
7668713|NCT01368081|26675064|P2|Overall Study|Withdrawal by Subject|4
7668714|NCT01368081|26675065|P1|Overall Study|Withdrawal by Subject|4
7668715|NCT01368081|26675053|P13|Overall Study|Lost to Follow-up|1
7668716|NCT01368081|26675054|P12|Overall Study|Lost to Follow-up|0
7668717|NCT01368081|26675055|P11|Overall Study|Lost to Follow-up|0
7668718|NCT01368081|26675056|P10|Overall Study|Lost to Follow-up|0
7668719|NCT01368081|26675057|P9|Overall Study|Lost to Follow-up|0
7668720|NCT01368081|26675058|P8|Overall Study|Lost to Follow-up|0
7668721|NCT01368081|26675059|P7|Overall Study|Lost to Follow-up|0
7668722|NCT01368081|26675060|P6|Overall Study|Lost to Follow-up|0
7668723|NCT01368081|26675061|P5|Overall Study|Lost to Follow-up|0
7668724|NCT01368081|26675062|P4|Overall Study|Lost to Follow-up|0
7668725|NCT01368081|26675063|P3|Overall Study|Lost to Follow-up|0
7668726|NCT01368081|26675064|P2|Overall Study|Lost to Follow-up|0
7668727|NCT01368081|26675065|P1|Overall Study|Lost to Follow-up|0
7668728|NCT01368081|26675053|P13|Overall Study|Protocol Violation|0
7668729|NCT01368081|26675054|P12|Overall Study|Protocol Violation|0
7668730|NCT01368081|26675055|P11|Overall Study|Protocol Violation|0
7668731|NCT01368081|26675056|P10|Overall Study|Protocol Violation|0
7668732|NCT01368081|26675057|P9|Overall Study|Protocol Violation|0
7668733|NCT01368081|26675058|P8|Overall Study|Protocol Violation|1
7668734|NCT01368081|26675059|P7|Overall Study|Protocol Violation|0
7668735|NCT01368081|26675060|P6|Overall Study|Protocol Violation|1
7668736|NCT01368081|26675061|P5|Overall Study|Protocol Violation|0
7668737|NCT01368081|26675062|P4|Overall Study|Protocol Violation|0
7668738|NCT01368081|26675063|P3|Overall Study|Protocol Violation|0
7668739|NCT01368081|26675064|P2|Overall Study|Protocol Violation|0
7668740|NCT01368081|26675065|P1|Overall Study|Protocol Violation|0
7668741|NCT01368081|26675053|P13|Overall Study|Lack of Efficacy|0
7668742|NCT01368081|26675054|P12|Overall Study|Lack of Efficacy|0
7668743|NCT01368081|26675055|P11|Overall Study|Lack of Efficacy|0
7668744|NCT01368081|26675056|P10|Overall Study|Lack of Efficacy|0
7668745|NCT01368081|26675057|P9|Overall Study|Lack of Efficacy|0
7668746|NCT01368081|26675058|P8|Overall Study|Lack of Efficacy|2
7668747|NCT01368081|26675059|P7|Overall Study|Lack of Efficacy|0
7668748|NCT01368081|26675060|P6|Overall Study|Lack of Efficacy|0
7668749|NCT01368081|26675061|P5|Overall Study|Lack of Efficacy|0
7668750|NCT01368081|26675062|P4|Overall Study|Lack of Efficacy|1
7668751|NCT01368081|26675063|P3|Overall Study|Lack of Efficacy|0
7668752|NCT01368081|26675064|P2|Overall Study|Lack of Efficacy|1
7668753|NCT01368081|26675065|P1|Overall Study|Lack of Efficacy|0
7668754|NCT01368081|26675053|P13|Overall Study|Adverse Event|3
7668755|NCT01368081|26675054|P12|Overall Study|Adverse Event|1
7668756|NCT01368081|26675055|P11|Overall Study|Adverse Event|6
7668757|NCT01368081|26675056|P10|Overall Study|Adverse Event|5
7668758|NCT01368081|26675057|P9|Overall Study|Adverse Event|3
7668759|NCT01368081|26675058|P8|Overall Study|Adverse Event|2
7668760|NCT01368081|26675059|P7|Overall Study|Adverse Event|6
7668761|NCT01368081|26675060|P6|Overall Study|Adverse Event|5
7668762|NCT01368081|26675061|P5|Overall Study|Adverse Event|2
7668763|NCT01368081|26675062|P4|Overall Study|Adverse Event|2
7668764|NCT01368081|26675063|P3|Overall Study|Adverse Event|3
7668765|NCT01368081|26675064|P2|Overall Study|Adverse Event|4
7668766|NCT01368081|26675065|P1|Overall Study|Adverse Event|4
7668767|NCT01368042|26675119|P1|Overall Study|Transplanted|1
7668768|NCT01368042|26675119|P1|Overall Study|Lost to Follow-up|4
7668769|NCT01368042|26675119|P1|Overall Study|Protocol Violation|11
7668770|NCT01368042|26675119|P1|Overall Study|Death|14
7668771|NCT01367886|26675139|P1|Overall Study|Death|1
7668772|NCT01367886|26675139|P1|Overall Study|Lack of Efficacy|2
7668773|NCT01367886|26675139|P1|Overall Study|Lost to Follow-up|4
7668774|NCT01367847|26675189|P2|Overall Study|Withdrawal by Subject|2
7668775|NCT01367847|26675190|P1|Overall Study|Withdrawal by Subject|2
7668776|NCT01367834|26675206|P2|Overall Study|Study was ended.|1
7668777|NCT01367834|26675207|P1|Overall Study|Study was ended.|0
7668778|NCT01367834|26675206|P2|Overall Study|Withdrawal by Subject|2
7668779|NCT01367834|26675207|P1|Overall Study|Withdrawal by Subject|2
7668780|NCT01367704|26675231|P2|Overall Study|Lost to Follow-up|161
7668781|NCT01367704|26675232|P1|Overall Study|Lost to Follow-up|47
7668782|NCT01367665|26675244|P2|Overall Study|Not Done|14
7668783|NCT01367665|26675245|P1|Overall Study|Not Done|118
7668784|NCT01367665|26675244|P2|Overall Study|Lost to Follow-up|22
7668785|NCT01367665|26675245|P1|Overall Study|Lost to Follow-up|222
7668786|NCT01367665|26675244|P2|Overall Study|Death|19
7668787|NCT01367665|26675245|P1|Overall Study|Death|102
7668788|NCT01367457|26675276|P3|Overall Study|Suspected DP/suspected active infection|0
7668789|NCT01367457|26675277|P2|Overall Study|Suspected DP/suspected active infection|0
7668790|NCT01367457|26675278|P1|Overall Study|Suspected DP/suspected active infection|1
7668791|NCT01367457|26675276|P3|Overall Study|Palliative. Overall decline|0
7668792|NCT01367457|26675277|P2|Overall Study|Palliative. Overall decline|0
7668793|NCT01367457|26675278|P1|Overall Study|Palliative. Overall decline|1
7668794|NCT01367457|26675276|P3|Overall Study|Patient's Wish|0
7668795|NCT01367457|26675277|P2|Overall Study|Patient's Wish|0
7668796|NCT01367457|26675278|P1|Overall Study|Patient's Wish|1
7668797|NCT01367457|26675276|P3|Overall Study|CD, Suspected disease progression (DP)|0
7668798|NCT01367457|26675277|P2|Overall Study|CD, Suspected disease progression (DP)|0
7668799|NCT01367457|26675278|P1|Overall Study|CD, Suspected disease progression (DP)|1
7668800|NCT01367457|26675276|P3|Overall Study|Death from septic shock|0
7668801|NCT01367457|26675277|P2|Overall Study|Death from septic shock|0
7668802|NCT01367457|26675278|P1|Overall Study|Death from septic shock|1
7668803|NCT01367457|26675276|P3|Overall Study|Lost to Follow-up|0
7668804|NCT01367457|26675277|P2|Overall Study|Lost to Follow-up|0
7668805|NCT01367457|26675278|P1|Overall Study|Lost to Follow-up|1
7668806|NCT01367457|26675276|P3|Overall Study|Rejection of treatment|0
7668807|NCT01367457|26675277|P2|Overall Study|Rejection of treatment|0
7668808|NCT01367457|26675278|P1|Overall Study|Rejection of treatment|1
7668809|NCT01367457|26675276|P3|Overall Study|Overall decline|0
7668810|NCT01367457|26675277|P2|Overall Study|Overall decline|0
7668811|NCT01367457|26675278|P1|Overall Study|Overall decline|1
7668812|NCT01367457|26675276|P3|Overall Study|Intestinal obstruction with necrosis|0
7668813|NCT01367457|26675277|P2|Overall Study|Intestinal obstruction with necrosis|0
7668814|NCT01367457|26675278|P1|Overall Study|Intestinal obstruction with necrosis|1
7668815|NCT01367457|26675276|P3|Overall Study|No clinical benefit|0
7668816|NCT01367457|26675277|P2|Overall Study|No clinical benefit|0
7668817|NCT01367457|26675278|P1|Overall Study|No clinical benefit|1
7668818|NCT01367457|26675276|P3|Overall Study|Stabilisation + frequent infections|0
7668819|NCT01367457|26675277|P2|Overall Study|Stabilisation + frequent infections|0
7668820|NCT01367457|26675278|P1|Overall Study|Stabilisation + frequent infections|1
7668821|NCT01367457|26675276|P3|Overall Study|Overall status worsens to grade 4|0
7668822|NCT01367457|26675277|P2|Overall Study|Overall status worsens to grade 4|0
7668823|NCT01367457|26675278|P1|Overall Study|Overall status worsens to grade 4|1
7668824|NCT01367457|26675276|P3|Overall Study|Uncontrolled pain|0
7668825|NCT01367457|26675277|P2|Overall Study|Uncontrolled pain|0
7668826|NCT01367457|26675278|P1|Overall Study|Uncontrolled pain|1
7668827|NCT01367457|26675276|P3|Overall Study|CD, associated leukaemia|0
7668828|NCT01367457|26675277|P2|Overall Study|CD, associated leukaemia|0
7668829|NCT01367457|26675278|P1|Overall Study|CD, associated leukaemia|1
7668830|NCT01367457|26675276|P3|Overall Study|Withdrawal by Subject|0
7668831|NCT01367457|26675277|P2|Overall Study|Withdrawal by Subject|0
7668832|NCT01367457|26675278|P1|Overall Study|Withdrawal by Subject|1
7668833|NCT01367457|26675276|P3|Overall Study|Choledocolithiasis and pancreatitis|0
7668834|NCT01367457|26675277|P2|Overall Study|Choledocolithiasis and pancreatitis|0
7668835|NCT01367457|26675278|P1|Overall Study|Choledocolithiasis and pancreatitis|1
7668836|NCT01367457|26675276|P3|Overall Study|low grade toxicities + stable disease|0
7668837|NCT01367457|26675277|P2|Overall Study|low grade toxicities + stable disease|0
7668838|NCT01367457|26675278|P1|Overall Study|low grade toxicities + stable disease|1
7668839|NCT01367457|26675276|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
7668840|NCT01367457|26675277|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
7668841|NCT01367457|26675278|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
7668842|NCT01367457|26675276|P3|Overall Study|Bleeding from cavernous haemangioma|0
7668843|NCT01367457|26675277|P2|Overall Study|Bleeding from cavernous haemangioma|0
7668844|NCT01367457|26675278|P1|Overall Study|Bleeding from cavernous haemangioma|1
7668845|NCT01367457|26675276|P3|Overall Study|Investigator's opinion, stable disease|0
7668846|NCT01367457|26675277|P2|Overall Study|Investigator's opinion, stable disease|0
7668847|NCT01367457|26675278|P1|Overall Study|Investigator's opinion, stable disease|1
7668848|NCT01367457|26675276|P3|Overall Study|Patient asks for rest + slow progression|0
7668849|NCT01367457|26675277|P2|Overall Study|Patient asks for rest + slow progression|0
7668850|NCT01367457|26675278|P1|Overall Study|Patient asks for rest + slow progression|1
7668851|NCT01367457|26675276|P3|Overall Study|Progression|0
7668852|NCT01367457|26675277|P2|Overall Study|Progression|0
7668853|NCT01367457|26675278|P1|Overall Study|Progression|137
7668854|NCT01367457|26675276|P3|Overall Study|Toxicity|0
7668855|NCT01367457|26675277|P2|Overall Study|Toxicity|0
7668856|NCT01367457|26675278|P1|Overall Study|Toxicity|16
7668857|NCT01367457|26675276|P3|Overall Study|Progression and death|0
7668858|NCT01367457|26675277|P2|Overall Study|Progression and death|0
7668859|NCT01367457|26675278|P1|Overall Study|Progression and death|8
7668860|NCT01367457|26675276|P3|Overall Study|Clinical decline (CD)|0
7668861|NCT01367457|26675277|P2|Overall Study|Clinical decline (CD)|0
7668862|NCT01367457|26675278|P1|Overall Study|Clinical decline (CD)|2
7668863|NCT01367457|26675276|P3|Overall Study|Investigator's decision|0
7668864|NCT01367457|26675277|P2|Overall Study|Investigator's decision|0
7668865|NCT01367457|26675278|P1|Overall Study|Investigator's decision|2
7668866|NCT01367457|26675276|P3|Overall Study|Death|0
7668867|NCT01367457|26675277|P2|Overall Study|Death|0
7668868|NCT01367457|26675278|P1|Overall Study|Death|2
7668869|NCT01367275|26675334|P1|Overall Study|Disease Progression|2
7668870|NCT01367275|26675334|P1|Overall Study|Ineligible|1
7668871|NCT01367249|26675351|P2|Overall Study|Other|10
7668872|NCT01367249|26675352|P1|Overall Study|Other|3
7668873|NCT01367249|26675351|P2|Overall Study|Withdrawal by Subject|6
7668874|NCT01367249|26675352|P1|Overall Study|Withdrawal by Subject|6
7668875|NCT01367236|26675362|P2|Overall Study|Withdrawal by Subject|1
7668876|NCT01367236|26675363|P1|Overall Study|Withdrawal by Subject|3
7668877|NCT01367158|26675382|P11|Overall Study|Protocol Violation|0
7668878|NCT01367158|26675383|P10|Overall Study|Protocol Violation|0
7668879|NCT01367158|26675384|P9|Overall Study|Protocol Violation|0
7668880|NCT01367158|26675385|P8|Overall Study|Protocol Violation|0
7668881|NCT01367158|26675386|P7|Overall Study|Protocol Violation|0
7668882|NCT01367158|26675387|P6|Overall Study|Protocol Violation|0
7668883|NCT01367158|26675388|P5|Overall Study|Protocol Violation|0
7668884|NCT01367158|26675389|P4|Overall Study|Protocol Violation|0
7668885|NCT01367158|26675390|P3|Overall Study|Protocol Violation|0
7668886|NCT01367158|26675391|P2|Overall Study|Protocol Violation|1
7668887|NCT01367158|26675392|P1|Overall Study|Protocol Violation|0
7668888|NCT01367158|26675382|P11|Overall Study|Lost to Follow-up|1
7668889|NCT01367158|26675383|P10|Overall Study|Lost to Follow-up|0
7668890|NCT01367158|26675384|P9|Overall Study|Lost to Follow-up|0
7668891|NCT01367158|26675385|P8|Overall Study|Lost to Follow-up|1
7668892|NCT01367158|26675386|P7|Overall Study|Lost to Follow-up|0
7668893|NCT01367158|26675387|P6|Overall Study|Lost to Follow-up|2
7668894|NCT01367158|26675388|P5|Overall Study|Lost to Follow-up|0
7668895|NCT01367158|26675389|P4|Overall Study|Lost to Follow-up|1
7668896|NCT01367158|26675390|P3|Overall Study|Lost to Follow-up|0
7668897|NCT01367158|26675391|P2|Overall Study|Lost to Follow-up|0
7668898|NCT01367158|26675392|P1|Overall Study|Lost to Follow-up|0
7668899|NCT01367158|26675382|P11|Overall Study|Withdrew consent|0
7668900|NCT01367158|26675383|P10|Overall Study|Withdrew consent|0
7668901|NCT01367158|26675384|P9|Overall Study|Withdrew consent|0
7668902|NCT01367158|26675385|P8|Overall Study|Withdrew consent|1
7668903|NCT01367158|26675386|P7|Overall Study|Withdrew consent|0
7668904|NCT01367158|26675387|P6|Overall Study|Withdrew consent|0
7668905|NCT01367158|26675388|P5|Overall Study|Withdrew consent|2
7668906|NCT01367158|26675389|P4|Overall Study|Withdrew consent|0
7668907|NCT01367158|26675390|P3|Overall Study|Withdrew consent|1
7668908|NCT01367158|26675391|P2|Overall Study|Withdrew consent|2
7668909|NCT01367158|26675392|P1|Overall Study|Withdrew consent|0
7668910|NCT01367119|26675536|P2|Overall Study|Withdrawal by Subject|1
7668911|NCT01367119|26675537|P1|Overall Study|Withdrawal by Subject|1
7668912|NCT01367119|26675536|P2|Overall Study|Adverse Event|0
7668913|NCT01367119|26675537|P1|Overall Study|Adverse Event|1
7668914|NCT01366846|26675592|P4|Overall Study|Scheduling Conflicts|0
7668915|NCT01366846|26675593|P3|Overall Study|Scheduling Conflicts|1
7668916|NCT01366846|26675594|P2|Overall Study|Scheduling Conflicts|0
7668917|NCT01366846|26675595|P1|Overall Study|Scheduling Conflicts|0
7668918|NCT01366846|26675592|P4|Overall Study|Communication Difficulties|1
7668919|NCT01366846|26675593|P3|Overall Study|Communication Difficulties|0
7668920|NCT01366846|26675594|P2|Overall Study|Communication Difficulties|4
7668921|NCT01366846|26675595|P1|Overall Study|Communication Difficulties|1
7668922|NCT01366846|26675592|P4|Overall Study|Withdrawal by Subject|0
7668923|NCT01366846|26675593|P3|Overall Study|Withdrawal by Subject|0
7668924|NCT01366846|26675594|P2|Overall Study|Withdrawal by Subject|0
7668925|NCT01366846|26675595|P1|Overall Study|Withdrawal by Subject|2
7668926|NCT01366638|26675618|P3|Overall Study|Other|0
7668927|NCT01366638|26675619|P2|Overall Study|Other|0
7668928|NCT01366638|26675620|P1|Overall Study|Other|1
7668929|NCT01366638|26675618|P3|Overall Study|Withdrawal by Subject|6
7668930|NCT01366638|26675619|P2|Overall Study|Withdrawal by Subject|0
7668931|NCT01366638|26675620|P1|Overall Study|Withdrawal by Subject|0
7668932|NCT01366534|26675657|P3|Overall Study|Declined challenged|0
7668933|NCT01366534|26675658|P2|Overall Study|Declined challenged|1
7668934|NCT01366534|26675659|P1|Overall Study|Declined challenged|0
7668935|NCT01366534|26675657|P3|Overall Study|Migrated|0
7668936|NCT01366534|26675658|P2|Overall Study|Migrated|1
7668937|NCT01366534|26675659|P1|Overall Study|Migrated|1
7668938|NCT01366534|26675657|P3|Overall Study|Lost to Follow-up|0
7668939|NCT01366534|26675658|P2|Overall Study|Lost to Follow-up|0
7668940|NCT01366534|26675659|P1|Overall Study|Lost to Follow-up|1
7668941|NCT01366521|26675709|P4|Overall Study|Withdrawal by Subject|0
7668942|NCT01366521|26675710|P3|Overall Study|Withdrawal by Subject|0
7668943|NCT01366521|26675711|P2|Overall Study|Withdrawal by Subject|1
7668944|NCT01366521|26675712|P1|Overall Study|Withdrawal by Subject|0
7668945|NCT01366521|26675709|P4|Overall Study|Physician Decision|0
7668946|NCT01366521|26675710|P3|Overall Study|Physician Decision|1
7668947|NCT01366521|26675711|P2|Overall Study|Physician Decision|0
7668948|NCT01366521|26675712|P1|Overall Study|Physician Decision|0
7668949|NCT01366521|26675709|P4|Overall Study|Protocol Violation|0
7668950|NCT01366521|26675710|P3|Overall Study|Protocol Violation|1
7668951|NCT01366521|26675711|P2|Overall Study|Protocol Violation|0
7668952|NCT01366521|26675712|P1|Overall Study|Protocol Violation|0
7668953|NCT01366521|26675709|P4|Overall Study|Adverse Event|0
7668954|NCT01366521|26675710|P3|Overall Study|Adverse Event|0
7668955|NCT01366521|26675711|P2|Overall Study|Adverse Event|0
7668956|NCT01366521|26675712|P1|Overall Study|Adverse Event|1
7668957|NCT01366443|26675808|P1|Overall Study|Under 18 yo|1
7668958|NCT01366443|26675808|P1|Overall Study|Lost to Follow-up|2
7668959|NCT01366209|26675822|P2|Overall Study|Withdrew consent|3
7668960|NCT01366209|26675823|P1|Overall Study|Withdrew consent|4
7668961|NCT01366209|26675822|P2|Overall Study|Sponsors decision|1
7668962|NCT01366209|26675823|P1|Overall Study|Sponsors decision|0
7668963|NCT01366209|26675822|P2|Overall Study|Physician Decision|0
7668964|NCT01366209|26675823|P1|Overall Study|Physician Decision|1
7668965|NCT01366209|26675822|P2|Overall Study|Lost to Follow-up|1
7668966|NCT01366209|26675823|P1|Overall Study|Lost to Follow-up|2
7668967|NCT01366209|26675822|P2|Overall Study|Lung transplantation|1
7668968|NCT01366209|26675823|P1|Overall Study|Lung transplantation|6
7668969|NCT01366209|26675822|P2|Overall Study|Death|19
7668970|NCT01366209|26675823|P1|Overall Study|Death|12
7668971|NCT01366209|26675822|P2|Overall Study|Withdrawal by Subject|4
7668972|NCT01366209|26675823|P1|Overall Study|Withdrawal by Subject|4
7668973|NCT01366209|26675822|P2|Overall Study|Adverse Event|7
7668974|NCT01366209|26675823|P1|Overall Study|Adverse Event|6
7668975|NCT01366092|26675846|P1|Overall Study|Withdrawal by Subject|1
7668976|NCT01366092|26675846|P1|Overall Study|Physician Decision|1
7668977|NCT01366092|26675846|P1|Overall Study|Progressive cGVHD|2
7668978|NCT01365910|26675855|P1|Overall Study|pt did not get tx, nausea/vomiting|1
7668979|NCT01365910|26675855|P1|Overall Study|other complicating disease|1
7668980|NCT01365910|26675855|P1|Overall Study|Adverse Event|3
7668981|NCT01365910|26675855|P1|Overall Study|disease progression|18
7668982|NCT01365910|26675855|P1|Overall Study|Withdrawal by Subject|7
7668983|NCT01365546|26675991|P1|Overall Study|Study termination|1
7668984|NCT01365546|26675991|P1|Overall Study|Screen failure|9
7668985|NCT01365546|26675991|P1|Overall Study|Withdrawal by Subject|1
7668986|NCT01365507|26676001|P2|Overall Study|Unclassified|4
7668987|NCT01365507|26676002|P1|Overall Study|Unclassified|1
7668988|NCT01365507|26676001|P2|Overall Study|Withdrawal Criteria|5
7668989|NCT01365507|26676002|P1|Overall Study|Withdrawal Criteria|8
7668990|NCT01365494|26676018|P2|Overall Study|Lost to Follow-up|2
7668991|NCT01365494|26676019|P1|Overall Study|Lost to Follow-up|1
7668992|NCT01365494|26676018|P2|Overall Study|Withdrawal by Subject|1
7668993|NCT01365494|26676019|P1|Overall Study|Withdrawal by Subject|0
7668994|NCT01365494|26676018|P2|Overall Study|Adverse Event|0
7668995|NCT01365494|26676019|P1|Overall Study|Adverse Event|1
7668996|NCT01365481|26676035|P4|Overall Study|Unsatisfactory therapeutic effect|0
7668997|NCT01365481|26676036|P3|Overall Study|Unsatisfactory therapeutic effect|1
7668998|NCT01365481|26676037|P2|Overall Study|Unsatisfactory therapeutic effect|0
7668999|NCT01365481|26676038|P1|Overall Study|Unsatisfactory therapeutic effect|0
7669000|NCT01365481|26676035|P4|Overall Study|Protocol deviation|1
7669001|NCT01365481|26676036|P3|Overall Study|Protocol deviation|0
7669002|NCT01365481|26676037|P2|Overall Study|Protocol deviation|1
7669003|NCT01365481|26676038|P1|Overall Study|Protocol deviation|0
7669004|NCT01365481|26676035|P4|Overall Study|Administrative problems|0
7669005|NCT01365481|26676036|P3|Overall Study|Administrative problems|0
7669006|NCT01365481|26676037|P2|Overall Study|Administrative problems|1
7669007|NCT01365481|26676038|P1|Overall Study|Administrative problems|0
7669008|NCT01365481|26676035|P4|Overall Study|Abnormal laboratory value(s)|0
7669009|NCT01365481|26676036|P3|Overall Study|Abnormal laboratory value(s)|0
7669010|NCT01365481|26676037|P2|Overall Study|Abnormal laboratory value(s)|1
7669011|NCT01365481|26676038|P1|Overall Study|Abnormal laboratory value(s)|0
7669012|NCT01365481|26676035|P4|Overall Study|Lost to Follow-up|3
7669013|NCT01365481|26676036|P3|Overall Study|Lost to Follow-up|2
7669014|NCT01365481|26676037|P2|Overall Study|Lost to Follow-up|1
7669015|NCT01365481|26676038|P1|Overall Study|Lost to Follow-up|1
7669016|NCT01365481|26676035|P4|Overall Study|Withdrawal by Subject|1
7669017|NCT01365481|26676036|P3|Overall Study|Withdrawal by Subject|1
7669018|NCT01365481|26676037|P2|Overall Study|Withdrawal by Subject|2
7669019|NCT01365481|26676038|P1|Overall Study|Withdrawal by Subject|0
7669020|NCT01365481|26676035|P4|Overall Study|Adverse Event|2
7669021|NCT01365481|26676036|P3|Overall Study|Adverse Event|0
7669022|NCT01365481|26676037|P2|Overall Study|Adverse Event|9
7669023|NCT01365481|26676038|P1|Overall Study|Adverse Event|6
7669024|NCT01365468|26676058|P2|Overall Study|Lost to Follow-up|0
7669025|NCT01365468|26676059|P1|Overall Study|Lost to Follow-up|2
7669026|NCT01365468|26676058|P2|Overall Study|Disease progression|0
7669027|NCT01365468|26676059|P1|Overall Study|Disease progression|1
7669028|NCT01365468|26676058|P2|Overall Study|Physician Decision|0
7669029|NCT01365468|26676059|P1|Overall Study|Physician Decision|1
7669030|NCT01365455|26676074|P5|Maintenance Period|Subject/guardian decision|1
7669031|NCT01365455|26676075|P4|Maintenance Period|Subject/guardian decision|4
7669032|NCT01365455|26676076|P3|Maintenance Period|Subject/guardian decision|2
7669033|NCT01365455|26676077|P2|Maintenance Period|Subject/guardian decision|6
7669034|NCT01365455|26676078|P1|Maintenance Period|Subject/guardian decision|4
7669035|NCT01365455|26676074|P5|Maintenance Period|Protocol deviation|0
7669036|NCT01365455|26676075|P4|Maintenance Period|Protocol deviation|0
7669037|NCT01365455|26676076|P3|Maintenance Period|Protocol deviation|0
7669038|NCT01365455|26676077|P2|Maintenance Period|Protocol deviation|1
7669039|NCT01365455|26676078|P1|Maintenance Period|Protocol deviation|1
7669040|NCT01365455|26676074|P5|Maintenance Period|Pregnancy|2
7669041|NCT01365455|26676075|P4|Maintenance Period|Pregnancy|0
7669042|NCT01365455|26676076|P3|Maintenance Period|Pregnancy|0
7669043|NCT01365455|26676077|P2|Maintenance Period|Pregnancy|4
7669044|NCT01365455|26676078|P1|Maintenance Period|Pregnancy|0
7669045|NCT01365455|26676074|P5|Maintenance Period|Physician Decision|1
7669046|NCT01365455|26676075|P4|Maintenance Period|Physician Decision|0
7669047|NCT01365455|26676076|P3|Maintenance Period|Physician Decision|0
7669048|NCT01365455|26676077|P2|Maintenance Period|Physician Decision|1
7669049|NCT01365455|26676078|P1|Maintenance Period|Physician Decision|0
7669050|NCT01365455|26676074|P5|Maintenance Period|Non-compliance with study treatment|0
7669051|NCT01365455|26676075|P4|Maintenance Period|Non-compliance with study treatment|1
7669052|NCT01365455|26676076|P3|Maintenance Period|Non-compliance with study treatment|0
7669053|NCT01365455|26676077|P2|Maintenance Period|Non-compliance with study treatment|0
7669054|NCT01365455|26676078|P1|Maintenance Period|Non-compliance with study treatment|0
7669055|NCT01365455|26676074|P5|Maintenance Period|Lost to Follow-up|3
7669056|NCT01365455|26676075|P4|Maintenance Period|Lost to Follow-up|0
7669057|NCT01365455|26676076|P3|Maintenance Period|Lost to Follow-up|0
7669058|NCT01365455|26676077|P2|Maintenance Period|Lost to Follow-up|4
7669059|NCT01365455|26676078|P1|Maintenance Period|Lost to Follow-up|2
7669060|NCT01365455|26676074|P5|Maintenance Period|Lack of Efficacy|2
7669061|NCT01365455|26676075|P4|Maintenance Period|Lack of Efficacy|2
7669062|NCT01365455|26676076|P3|Maintenance Period|Lack of Efficacy|0
7669063|NCT01365455|26676077|P2|Maintenance Period|Lack of Efficacy|2
7669064|NCT01365455|26676078|P1|Maintenance Period|Lack of Efficacy|10
7669065|NCT01365455|26676074|P5|Maintenance Period|Adverse Event|4
7669066|NCT01365455|26676075|P4|Maintenance Period|Adverse Event|2
7669067|NCT01365455|26676076|P3|Maintenance Period|Adverse Event|1
7669068|NCT01365455|26676077|P2|Maintenance Period|Adverse Event|5
7669069|NCT01365455|26676078|P1|Maintenance Period|Adverse Event|12
7669070|NCT01365455|26676074|P5|Induction Period|Lost to Follow-up|0
7669071|NCT01365455|26676075|P4|Induction Period|Lost to Follow-up|0
7669072|NCT01365455|26676076|P3|Induction Period|Lost to Follow-up|3
7669073|NCT01365455|26676077|P2|Induction Period|Lost to Follow-up|0
7669074|NCT01365455|26676078|P1|Induction Period|Lost to Follow-up|0
7669075|NCT01365455|26676074|P5|Induction Period|Subject/guardian decision|0
7669076|NCT01365455|26676075|P4|Induction Period|Subject/guardian decision|0
7669077|NCT01365455|26676076|P3|Induction Period|Subject/guardian decision|8
7669078|NCT01365455|26676077|P2|Induction Period|Subject/guardian decision|1
7669079|NCT01365455|26676078|P1|Induction Period|Subject/guardian decision|9
7669080|NCT01365455|26676074|P5|Induction Period|Protocol deviation|0
7669081|NCT01365455|26676075|P4|Induction Period|Protocol deviation|0
7669082|NCT01365455|26676076|P3|Induction Period|Protocol deviation|1
7669083|NCT01365455|26676077|P2|Induction Period|Protocol deviation|1
7669084|NCT01365455|26676078|P1|Induction Period|Protocol deviation|0
7669085|NCT01365455|26676074|P5|Induction Period|Pregnancy|0
7669086|NCT01365455|26676075|P4|Induction Period|Pregnancy|0
7669087|NCT01365455|26676076|P3|Induction Period|Pregnancy|0
7669088|NCT01365455|26676077|P2|Induction Period|Pregnancy|1
7669089|NCT01365455|26676078|P1|Induction Period|Pregnancy|0
7669090|NCT01365455|26676074|P5|Induction Period|Lack of Efficacy|0
7669091|NCT01365455|26676075|P4|Induction Period|Lack of Efficacy|0
7669092|NCT01365455|26676076|P3|Induction Period|Lack of Efficacy|0
7669093|NCT01365455|26676077|P2|Induction Period|Lack of Efficacy|1
7669094|NCT01365455|26676078|P1|Induction Period|Lack of Efficacy|1
7669095|NCT01365455|26676074|P5|Induction Period|Adverse Event|0
7669096|NCT01365455|26676075|P4|Induction Period|Adverse Event|0
7669097|NCT01365455|26676076|P3|Induction Period|Adverse Event|4
7669098|NCT01365455|26676077|P2|Induction Period|Adverse Event|3
7669099|NCT01365455|26676078|P1|Induction Period|Adverse Event|5
7669100|NCT01365273|26676168|P2|Overall Study|Physician Decision|0
7669101|NCT01365273|26676169|P1|Overall Study|Physician Decision|1
7669102|NCT01365273|26676168|P2|Overall Study|Protocol Violation|1
7669103|NCT01365273|26676169|P1|Overall Study|Protocol Violation|0
7669104|NCT01365273|26676168|P2|Overall Study|Lost to Follow-up|0
7669105|NCT01365273|26676169|P1|Overall Study|Lost to Follow-up|1
7669106|NCT01365130|26676188|P1|Overall Study|Progression/worsening of Dx prior to txt|2
7669107|NCT01365091|26676197|P4|Period 2|Adverse Event|0
7669108|NCT01365091|26676198|P3|Period 2|Adverse Event|1
7669109|NCT01365091|26676199|P2|Period 2|Adverse Event|0
7669110|NCT01365091|26676200|P1|Period 2|Adverse Event|0
7669111|NCT01365091|26676197|P4|Period 2|Withdrawal by Subject|0
7669112|NCT01365091|26676198|P3|Period 2|Withdrawal by Subject|0
7669113|NCT01365091|26676199|P2|Period 2|Withdrawal by Subject|0
7669114|NCT01365091|26676200|P1|Period 2|Withdrawal by Subject|1
7669115|NCT01365091|26676197|P4|Period 1|Personal reasons|0
7669116|NCT01365091|26676198|P3|Period 1|Personal reasons|1
7669117|NCT01365091|26676199|P2|Period 1|Personal reasons|0
7669118|NCT01365091|26676200|P1|Period 1|Personal reasons|0
7669119|NCT01365091|26676197|P4|Period 1|Withdrawal by Subject|0
7669120|NCT01365091|26676198|P3|Period 1|Withdrawal by Subject|0
7669121|NCT01365091|26676199|P2|Period 1|Withdrawal by Subject|1
7669122|NCT01365091|26676200|P1|Period 1|Withdrawal by Subject|0
7669123|NCT01365091|26676197|P4|Period 1|No longer met study criteria|0
7669124|NCT01365091|26676198|P3|Period 1|No longer met study criteria|0
7669125|NCT01365091|26676199|P2|Period 1|No longer met study criteria|1
7669126|NCT01365091|26676200|P1|Period 1|No longer met study criteria|0
7669127|NCT01365091|26676197|P4|Period 1|Positive test result for drugs of abuse|0
7669128|NCT01365091|26676198|P3|Period 1|Positive test result for drugs of abuse|0
7669129|NCT01365091|26676199|P2|Period 1|Positive test result for drugs of abuse|0
7669130|NCT01365091|26676200|P1|Period 1|Positive test result for drugs of abuse|1
7669131|NCT01365091|26676197|P4|Period 1|Adverse Event|3
7669132|NCT01365091|26676198|P3|Period 1|Adverse Event|2
7669133|NCT01365091|26676199|P2|Period 1|Adverse Event|0
7669134|NCT01365091|26676200|P1|Period 1|Adverse Event|1
7669135|NCT01365052|26676228|P2|Overall Study|Adverse Event|4
7669136|NCT01365052|26676229|P1|Overall Study|Adverse Event|4
7669137|NCT01365039|26676245|P2|Overall Study|Study related symptoms and complaints|0
7669138|NCT01365039|26676246|P1|Overall Study|Study related symptoms and complaints|1
7669139|NCT01364922|26676257|P3|Double-Blind (DB) Period|Other, Unspecified|0
7669140|NCT01364922|26676258|P2|Double-Blind (DB) Period|Other, Unspecified|1
7669141|NCT01364922|26676259|P1|Double-Blind (DB) Period|Other, Unspecified|0
7669142|NCT01364922|26676257|P3|Double-Blind (DB) Period|Adverse Event|1
7669143|NCT01364922|26676258|P2|Double-Blind (DB) Period|Adverse Event|0
7669144|NCT01364922|26676259|P1|Double-Blind (DB) Period|Adverse Event|0
7669145|NCT01364922|26676257|P3|Double-Blind (DB) Period|Subject Noncompliant|0
7669146|NCT01364922|26676258|P2|Double-Blind (DB) Period|Subject Noncompliant|1
7669147|NCT01364922|26676259|P1|Double-Blind (DB) Period|Subject Noncompliant|0
7669148|NCT01364922|26676257|P3|Double-Blind (DB) Period|Lack of Efficacy|4
7669149|NCT01364922|26676258|P2|Double-Blind (DB) Period|Lack of Efficacy|3
7669150|NCT01364922|26676259|P1|Double-Blind (DB) Period|Lack of Efficacy|0
7669151|NCT01364922|26676257|P3|Open-label (OL) Period|Other, Unspecified|0
7669152|NCT01364922|26676258|P2|Open-label (OL) Period|Other, Unspecified|0
7669153|NCT01364922|26676259|P1|Open-label (OL) Period|Other, Unspecified|1
7669154|NCT01364922|26676257|P3|Open-label (OL) Period|Lost to Follow-up|0
7669155|NCT01364922|26676258|P2|Open-label (OL) Period|Lost to Follow-up|0
7669156|NCT01364922|26676259|P1|Open-label (OL) Period|Lost to Follow-up|1
7669157|NCT01364922|26676257|P3|Open-label (OL) Period|Lack of Efficacy|0
7669158|NCT01364922|26676258|P2|Open-label (OL) Period|Lack of Efficacy|0
7669159|NCT01364922|26676259|P1|Open-label (OL) Period|Lack of Efficacy|3
7669160|NCT01364922|26676257|P3|Open-label (OL) Period|Withdrawal by Subject|0
7669161|NCT01364922|26676258|P2|Open-label (OL) Period|Withdrawal by Subject|0
7669162|NCT01364922|26676259|P1|Open-label (OL) Period|Withdrawal by Subject|4
7669163|NCT01364922|26676257|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
7669164|NCT01364922|26676258|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
7669165|NCT01364922|26676259|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
7669166|NCT01364922|26676257|P3|Open-label (OL) Period|Adverse Event|0
7669167|NCT01364922|26676258|P2|Open-label (OL) Period|Adverse Event|0
7669168|NCT01364922|26676259|P1|Open-label (OL) Period|Adverse Event|7
7669169|NCT01364870|26676281|P3|Overall Study|Protocol Violation|0
7669170|NCT01364870|26676282|P2|Overall Study|Protocol Violation|0
7669171|NCT01364870|26676283|P1|Overall Study|Protocol Violation|1
7669172|NCT01364870|26676281|P3|Overall Study|Adverse Event|4
7669173|NCT01364870|26676282|P2|Overall Study|Adverse Event|6
7669174|NCT01364870|26676283|P1|Overall Study|Adverse Event|8
7669175|NCT01364870|26676281|P3|Overall Study|Withdrawal by Subject|10
7669176|NCT01364870|26676282|P2|Overall Study|Withdrawal by Subject|24
7669177|NCT01364870|26676283|P1|Overall Study|Withdrawal by Subject|13
7669178|NCT01364727|26676302|P1|Overall Study|Not Eligible|2
7669179|NCT01364649|26676310|P2|Overall Study|Other|1
7669180|NCT01364649|26676311|P1|Overall Study|Other|4
7669181|NCT01364649|26676310|P2|Overall Study|Lost to Follow-up|13
7669182|NCT01364649|26676311|P1|Overall Study|Lost to Follow-up|12
7669183|NCT01364649|26676310|P2|Overall Study|Withdrawal of Consent|7
7669184|NCT01364649|26676311|P1|Overall Study|Withdrawal of Consent|9
7669185|NCT01364649|26676310|P2|Overall Study|Protocol Deviations|8
7669186|NCT01364649|26676311|P1|Overall Study|Protocol Deviations|4
7669187|NCT01364649|26676310|P2|Overall Study|Non-compliance with Investigational Drug|0
7669188|NCT01364649|26676311|P1|Overall Study|Non-compliance with Investigational Drug|1
7669189|NCT01364649|26676310|P2|Overall Study|Lack of Efficacy|0
7669190|NCT01364649|26676311|P1|Overall Study|Lack of Efficacy|6
7669191|NCT01364649|26676310|P2|Overall Study|Pretreatment Event or Adverse Event|14
7669192|NCT01364649|26676311|P1|Overall Study|Pretreatment Event or Adverse Event|20
7669193|NCT01364467|26676399|P2|Overall Study|Lost to Follow-up|2
7669194|NCT01364467|26676400|P1|Overall Study|Lost to Follow-up|1
7669195|NCT01364428|26676412|P2|Overall Study|Other|3
7669196|NCT01364428|26676413|P1|Overall Study|Other|3
7669197|NCT01364428|26676412|P2|Overall Study|Withdrawal Criteria|10
7669198|NCT01364428|26676413|P1|Overall Study|Withdrawal Criteria|14
7669199|NCT01364428|26676412|P2|Overall Study|Protocol Violation|0
7669200|NCT01364428|26676413|P1|Overall Study|Protocol Violation|2
7669201|NCT01364428|26676412|P2|Overall Study|Adverse Event|2
7669202|NCT01364428|26676413|P1|Overall Study|Adverse Event|1
7669203|NCT01364389|26676430|P3|Overall Study|Adverse Event|0
7669204|NCT01364389|26676431|P2|Overall Study|Adverse Event|0
7669205|NCT01364389|26676432|P1|Overall Study|Adverse Event|1
7669206|NCT01364389|26676430|P3|Overall Study|Administrative problems|0
7669207|NCT01364389|26676431|P2|Overall Study|Administrative problems|0
7669208|NCT01364389|26676432|P1|Overall Study|Administrative problems|1
7669209|NCT01364389|26676430|P3|Overall Study|Protocol deviation|1
7669210|NCT01364389|26676431|P2|Overall Study|Protocol deviation|0
7669211|NCT01364389|26676432|P1|Overall Study|Protocol deviation|0
7669212|NCT01364389|26676430|P3|Overall Study|Withdrawal by Subject|0
7669213|NCT01364389|26676431|P2|Overall Study|Withdrawal by Subject|1
7669214|NCT01364389|26676432|P1|Overall Study|Withdrawal by Subject|0
7669215|NCT01364298|26676484|P2|Overall Study|Other|3
7669216|NCT01364298|26676485|P1|Overall Study|Other|1
7669217|NCT01364298|26676484|P2|Overall Study|Withdrawal by Subject|3
7669218|NCT01364298|26676485|P1|Overall Study|Withdrawal by Subject|3
7669219|NCT01364298|26676484|P2|Overall Study|Lost to Follow-up|10
7669220|NCT01364298|26676485|P1|Overall Study|Lost to Follow-up|5
7669221|NCT01364298|26676484|P2|Overall Study|Lack of Efficacy|0
7669222|NCT01364298|26676485|P1|Overall Study|Lack of Efficacy|1
7669223|NCT01364298|26676484|P2|Overall Study|Lack of adherence to treatment|3
7669224|NCT01364298|26676485|P1|Overall Study|Lack of adherence to treatment|1
7669225|NCT01364298|26676484|P2|Overall Study|Adverse Event|4
7669226|NCT01364298|26676485|P1|Overall Study|Adverse Event|3
7669227|NCT01364233|26676518|P1|Overall Study|Lost to Follow-up|1
7669228|NCT01363986|26676563|P1|Overall Study|Disease progression|1
7669229|NCT01363908|26676573|P2|Chronic Dosing (CD) Phase|Early study termination|3
7669230|NCT01363908|26676574|P1|Chronic Dosing (CD) Phase|Early study termination|9
7669231|NCT01363908|26676573|P2|Chronic Dosing (CD) Phase|Physician Decision|1
7669232|NCT01363908|26676574|P1|Chronic Dosing (CD) Phase|Physician Decision|0
7669233|NCT01363908|26676573|P2|Chronic Dosing (CD) Phase|Patient decision|1
7669234|NCT01363908|26676574|P1|Chronic Dosing (CD) Phase|Patient decision|0
7669235|NCT01363908|26676573|P2|Chronic Dosing (CD) Phase|Adverse Event|1
7669236|NCT01363908|26676574|P1|Chronic Dosing (CD) Phase|Adverse Event|1
7669237|NCT01363765|26676611|P2|Overall Study|smear during intervention|0
7669238|NCT01363765|26676612|P1|Overall Study|smear during intervention|2170
7669239|NCT01363765|26676611|P2|Overall Study|age not recorded (used for cross-linkage|354
7669240|NCT01363765|26676612|P1|Overall Study|age not recorded (used for cross-linkage|117
7669241|NCT01363765|26676611|P2|Overall Study|non-resident|76
7669242|NCT01363765|26676612|P1|Overall Study|non-resident|156
7669243|NCT01363765|26676611|P2|Overall Study|duplicate records|3177
7669244|NCT01363765|26676612|P1|Overall Study|duplicate records|736
7669245|NCT01363765|26676611|P2|Overall Study|non-diagnostic|1124
7669246|NCT01363765|26676612|P1|Overall Study|non-diagnostic|2621
7669247|NCT01363713|26676624|P1|Overall Study|Withdrawal by Subject|2
7669248|NCT01363713|26676624|P1|Overall Study|Protocol Violation|3
7669249|NCT01363713|26676624|P1|Overall Study|Adverse Event|1
7669250|NCT01363700|26676633|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7669251|NCT01363700|26676634|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7669252|NCT01363700|26676635|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7669253|NCT01363700|26676636|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
7669254|NCT01363700|26676637|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7669255|NCT01363661|26676656|P2|Overall Study|Lost to Follow-up|1
7669256|NCT01363661|26676657|P1|Overall Study|Lost to Follow-up|3
7669257|NCT01363661|26676656|P2|Overall Study|Protocol Violation|0
7669258|NCT01363661|26676657|P1|Overall Study|Protocol Violation|1
7669259|NCT01363661|26676656|P2|Overall Study|Withdrawal by Subject|1
7669260|NCT01363661|26676657|P1|Overall Study|Withdrawal by Subject|1
7669261|NCT01363661|26676656|P2|Overall Study|Adverse Event|2
7669262|NCT01363661|26676657|P1|Overall Study|Adverse Event|9
7669263|NCT01363440|26676702|P3|Overall Study|Other|2
7669264|NCT01363440|26676703|P2|Overall Study|Other|5
7669265|NCT01363440|26676704|P1|Overall Study|Other|4
7669266|NCT01363440|26676702|P3|Overall Study|Lost to Follow-up|5
7669267|NCT01363440|26676703|P2|Overall Study|Lost to Follow-up|4
7669268|NCT01363440|26676704|P1|Overall Study|Lost to Follow-up|2
7669269|NCT01363440|26676702|P3|Overall Study|Withdrawal by Subject|11
7669270|NCT01363440|26676703|P2|Overall Study|Withdrawal by Subject|11
7669271|NCT01363440|26676704|P1|Overall Study|Withdrawal by Subject|9
7669272|NCT01363440|26676702|P3|Overall Study|Death|5
7669273|NCT01363440|26676703|P2|Overall Study|Death|7
7669274|NCT01363440|26676704|P1|Overall Study|Death|3
7669275|NCT01363440|26676702|P3|Overall Study|Adverse Event|4
7669276|NCT01363440|26676703|P2|Overall Study|Adverse Event|4
7669277|NCT01363440|26676704|P1|Overall Study|Adverse Event|5
7669278|NCT01363349|26676763|P2|Overall Study|missing|2
7669279|NCT01363349|26676764|P1|Overall Study|missing|1
7669280|NCT01363349|26676763|P2|Overall Study|Not reported|37
7669281|NCT01363349|26676764|P1|Overall Study|Not reported|36
7669282|NCT01363349|26676763|P2|Overall Study|Lost to Follow-up|6
7669283|NCT01363349|26676764|P1|Overall Study|Lost to Follow-up|5
7669284|NCT01363349|26676763|P2|Overall Study|Withdrawal by Subject|6
7669285|NCT01363349|26676764|P1|Overall Study|Withdrawal by Subject|14
7669286|NCT01363349|26676763|P2|Overall Study|Non compliance/Protocol deviations|2
7669287|NCT01363349|26676764|P1|Overall Study|Non compliance/Protocol deviations|2
7669288|NCT01363349|26676763|P2|Overall Study|Lack of Efficacy|10
7669289|NCT01363349|26676764|P1|Overall Study|Lack of Efficacy|3
7669290|NCT01363349|26676763|P2|Overall Study|Adverse Event|7
7669291|NCT01363349|26676764|P1|Overall Study|Adverse Event|6
7669292|NCT01363297|26676775|P5|Overall Study|Death|30
7669293|NCT01363297|26676776|P4|Overall Study|Death|10
7669294|NCT01363297|26676777|P3|Overall Study|Death|6
7669295|NCT01363297|26676778|P2|Overall Study|Death|6
7669296|NCT01363297|26676779|P1|Overall Study|Death|3
7669297|NCT01363297|26676775|P5|Overall Study|Other|1
7669298|NCT01363297|26676776|P4|Overall Study|Other|0
7669299|NCT01363297|26676777|P3|Overall Study|Other|0
7669300|NCT01363297|26676778|P2|Overall Study|Other|0
7669301|NCT01363297|26676779|P1|Overall Study|Other|0
7669302|NCT01363076|26676888|P2|Overall Study|Withdrawal by Subject|1
7669303|NCT01363076|26676889|P1|Overall Study|Withdrawal by Subject|0
7669304|NCT01363011|26676921|P2|Extension Phase|Rolled Over to Another Gilead Study|1
7669305|NCT01363011|26676922|P1|Extension Phase|Rolled Over to Another Gilead Study|2
7669306|NCT01363011|26676921|P2|Extension Phase|Lost to Follow-up|2
7669307|NCT01363011|26676922|P1|Extension Phase|Lost to Follow-up|0
7669308|NCT01363011|26676921|P2|Extension Phase|Withdrew Consent|1
7669309|NCT01363011|26676922|P1|Extension Phase|Withdrew Consent|0
7669310|NCT01363011|26676921|P2|Extension Phase|Investigator's Discretion|2
7669311|NCT01363011|26676922|P1|Extension Phase|Investigator's Discretion|2
7669312|NCT01363011|26676921|P2|Extension Phase|Lack of Efficacy|1
7669313|NCT01363011|26676922|P1|Extension Phase|Lack of Efficacy|0
7669314|NCT01363011|26676921|P2|Extension Phase|Adverse Event|1
7669315|NCT01363011|26676922|P1|Extension Phase|Adverse Event|1
7669316|NCT01363011|26676921|P2|Main Study|Protocol Violation|1
7669317|NCT01363011|26676922|P1|Main Study|Protocol Violation|0
7669318|NCT01363011|26676921|P2|Main Study|Withdrew Consent|4
7669319|NCT01363011|26676922|P1|Main Study|Withdrew Consent|1
7669320|NCT01363011|26676921|P2|Main Study|Investigator's Discretion|1
7669321|NCT01363011|26676922|P1|Main Study|Investigator's Discretion|1
7669322|NCT01363011|26676921|P2|Main Study|Adverse Event|3
7669323|NCT01363011|26676922|P1|Main Study|Adverse Event|2
7669324|NCT01362790|26677049|P7|Dose De-escalation of Regimen A|Progressive disease|0
7669325|NCT01362790|26677050|P6|Dose De-escalation of Regimen A|Progressive disease|0
7669326|NCT01362790|26677051|P5|Dose De-escalation of Regimen A|Progressive disease|2
7669327|NCT01362790|26677052|P4|Dose De-escalation of Regimen A|Progressive disease|0
7669328|NCT01362790|26677053|P3|Dose De-escalation of Regimen A|Progressive disease|0
7669329|NCT01362790|26677054|P2|Dose De-escalation of Regimen A|Progressive disease|0
7669330|NCT01362790|26677055|P1|Dose De-escalation of Regimen A|Progressive disease|0
7669331|NCT01362790|26677049|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
7669332|NCT01362790|26677050|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
7669333|NCT01362790|26677051|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
7669334|NCT01362790|26677052|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
7669335|NCT01362790|26677053|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
7669336|NCT01362790|26677054|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
7669337|NCT01362790|26677055|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
7669338|NCT01362790|26677049|P7|Dose De-escalation of Regimen A|Adverse Event|0
7669339|NCT01362790|26677050|P6|Dose De-escalation of Regimen A|Adverse Event|0
7669340|NCT01362790|26677051|P5|Dose De-escalation of Regimen A|Adverse Event|1
7669341|NCT01362790|26677052|P4|Dose De-escalation of Regimen A|Adverse Event|0
7669342|NCT01362790|26677053|P3|Dose De-escalation of Regimen A|Adverse Event|0
7669343|NCT01362790|26677054|P2|Dose De-escalation of Regimen A|Adverse Event|0
7669344|NCT01362790|26677055|P1|Dose De-escalation of Regimen A|Adverse Event|0
7669345|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Death on study|0
7669346|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Death on study|0
7669347|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Death on study|0
7669348|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Death on study|1
7669349|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Death on study|0
7669350|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Death on study|0
7669351|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Death on study|0
7669352|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7669511|NCT01362244|26677369|P1|Overall Study|Lost to Follow-up|0
7669353|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7669354|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7669355|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7669356|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7669357|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
7669358|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7669359|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7669360|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7669361|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7669362|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7669363|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7669364|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7669365|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
7669366|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Progressive disease|0
7669367|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Progressive disease|2
7669368|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Progressive disease|0
7669369|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Progressive disease|3
7669370|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Progressive disease|2
7669371|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Progressive disease|2
7669372|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Progressive disease|1
7669373|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Refused further treatment|0
7669374|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Refused further treatment|0
7669375|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Refused further treatment|0
7669376|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Refused further treatment|0
7669377|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Refused further treatment|0
7669378|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Refused further treatment|1
7669379|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Refused further treatment|0
7669380|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Developed antibodies|0
7669381|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Developed antibodies|0
7669382|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Developed antibodies|0
7669383|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Developed antibodies|8
7669384|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Developed antibodies|3
7669385|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Developed antibodies|2
7669386|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Developed antibodies|7
7669387|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Physician Decision|0
7669388|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Physician Decision|0
7669389|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Physician Decision|0
7669390|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Physician Decision|1
7669391|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Physician Decision|0
7669392|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Physician Decision|0
7669393|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Physician Decision|0
7669394|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Adverse Event|0
7669395|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Adverse Event|2
7669396|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Adverse Event|0
7669397|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Adverse Event|1
7669398|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Adverse Event|0
7669399|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Adverse Event|1
7669400|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Adverse Event|0
7669401|NCT01362790|26677049|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7669402|NCT01362790|26677050|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7669403|NCT01362790|26677051|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7669404|NCT01362790|26677052|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7669405|NCT01362790|26677053|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7669406|NCT01362790|26677054|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7669407|NCT01362790|26677055|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
7669408|NCT01362608|26677123|P2|Overall Study|Adverse Event|2
7669409|NCT01362608|26677124|P1|Overall Study|Adverse Event|0
7669410|NCT01362608|26677123|P2|Overall Study|Lack of Efficacy|2
7669411|NCT01362608|26677124|P1|Overall Study|Lack of Efficacy|0
7669412|NCT01362608|26677123|P2|Overall Study|Withdrawal by Subject|2
7669413|NCT01362608|26677124|P1|Overall Study|Withdrawal by Subject|1
7669414|NCT01362608|26677123|P2|Overall Study|Lost to Follow-up|1
7669415|NCT01362608|26677124|P1|Overall Study|Lost to Follow-up|3
7669416|NCT01362608|26677123|P2|Overall Study|Protocol Violation|1
7669417|NCT01362608|26677124|P1|Overall Study|Protocol Violation|0
7669418|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
7669419|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
7669420|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
7669421|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
7669422|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
7669423|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
7669424|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
7669425|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
7669426|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
7669427|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
7669428|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
7669429|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
7669430|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
7669431|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
7669432|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
7669433|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
7669434|NCT01362530|26677162|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
7669435|NCT01362530|26677163|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
7669436|NCT01362530|26677162|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
7669437|NCT01362530|26677163|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
7669438|NCT01362530|26677162|P2|Base Study (Cycle 1)|Protocol Violation|0
7669439|NCT01362530|26677163|P1|Base Study (Cycle 1)|Protocol Violation|2
7669440|NCT01362530|26677162|P2|Base Study (Cycle 1)|Physician Decision|1
7669441|NCT01362530|26677163|P1|Base Study (Cycle 1)|Physician Decision|0
7669442|NCT01362530|26677162|P2|Base Study (Cycle 1)|Adverse Event|0
7669443|NCT01362530|26677163|P1|Base Study (Cycle 1)|Adverse Event|2
7669444|NCT01362517|26677176|P1|Overall Study|Lost to Follow-up|1
7669445|NCT01362517|26677176|P1|Overall Study|Protocol Violation|1
7669446|NCT01362491|26677187|P3|Overall Study|Ineligible|0
7669447|NCT01362491|26677188|P2|Overall Study|Ineligible|0
7669448|NCT01362491|26677189|P1|Overall Study|Ineligible|1
7669449|NCT01362439|26677237|P1|Overall Study|Participant who withdrew consent|8
7669450|NCT01362439|26677237|P1|Overall Study|Study medication non-compliant|1
7669451|NCT01362439|26677237|P1|Overall Study|Lost to Follow-up|2
7669452|NCT01362439|26677237|P1|Overall Study|Lack of Efficacy|3
7669453|NCT01362439|26677237|P1|Overall Study|Adverse Event|1
7669454|NCT01362348|26677252|P1|Overall Study|Study closed/terminated|5
7669455|NCT01362348|26677252|P1|Overall Study|Protocol-defined stopping criteria|9
7669456|NCT01362322|26677271|P2|Overall Study|Lost to Follow-up|6
7669457|NCT01362322|26677272|P1|Overall Study|Lost to Follow-up|2
7669458|NCT01362322|26677271|P2|Overall Study|Withdrawal by Subject|1
7669459|NCT01362322|26677272|P1|Overall Study|Withdrawal by Subject|3
7669460|NCT01362296|26677304|P4|Crossover Phase|Study Closed/Terminated|0
7669461|NCT01362296|26677305|P3|Crossover Phase|Study Closed/Terminated|1
7669462|NCT01362296|26677306|P2|Crossover Phase|Study Closed/Terminated|0
7669463|NCT01362296|26677307|P1|Crossover Phase|Study Closed/Terminated|0
7669464|NCT01362296|26677304|P4|Crossover Phase|Adverse Event|0
7669465|NCT01362296|26677305|P3|Crossover Phase|Adverse Event|4
7669466|NCT01362296|26677306|P2|Crossover Phase|Adverse Event|0
7669467|NCT01362296|26677307|P1|Crossover Phase|Adverse Event|0
7669468|NCT01362296|26677304|P4|Crossover Phase|Withdrawal by Subject|1
7669469|NCT01362296|26677305|P3|Crossover Phase|Withdrawal by Subject|2
7669470|NCT01362296|26677306|P2|Crossover Phase|Withdrawal by Subject|0
7669471|NCT01362296|26677307|P1|Crossover Phase|Withdrawal by Subject|0
7669472|NCT01362296|26677304|P4|Crossover Phase|PD including Death due to PD|1
7669473|NCT01362296|26677305|P3|Crossover Phase|PD including Death due to PD|16
7669474|NCT01362296|26677306|P2|Crossover Phase|PD including Death due to PD|0
7669475|NCT01362296|26677307|P1|Crossover Phase|PD including Death due to PD|0
7669476|NCT01362296|26677304|P4|Randomized Phase (RP)|Study Closed/Terminated|0
7669477|NCT01362296|26677305|P3|Randomized Phase (RP)|Study Closed/Terminated|0
7669478|NCT01362296|26677306|P2|Randomized Phase (RP)|Study Closed/Terminated|1
7669479|NCT01362296|26677307|P1|Randomized Phase (RP)|Study Closed/Terminated|8
7669480|NCT01362296|26677304|P4|Randomized Phase (RP)|Adverse Event|0
7669481|NCT01362296|26677305|P3|Randomized Phase (RP)|Adverse Event|0
7669482|NCT01362296|26677306|P2|Randomized Phase (RP)|Adverse Event|4
7669483|NCT01362296|26677307|P1|Randomized Phase (RP)|Adverse Event|20
7669484|NCT01362296|26677304|P4|Randomized Phase (RP)|Withdrawal by Subject|0
7669485|NCT01362296|26677305|P3|Randomized Phase (RP)|Withdrawal by Subject|0
7669486|NCT01362296|26677306|P2|Randomized Phase (RP)|Withdrawal by Subject|1
7669487|NCT01362296|26677307|P1|Randomized Phase (RP)|Withdrawal by Subject|2
7669488|NCT01362296|26677304|P4|Randomized Phase (RP)|Physician Decision|0
7669489|NCT01362296|26677305|P3|Randomized Phase (RP)|Physician Decision|0
7669490|NCT01362296|26677306|P2|Randomized Phase (RP)|Physician Decision|9
7669491|NCT01362296|26677307|P1|Randomized Phase (RP)|Physician Decision|1
7669492|NCT01362296|26677304|P4|Randomized Phase (RP)|PD including Death due to PD|0
7669493|NCT01362296|26677305|P3|Randomized Phase (RP)|PD including Death due to PD|0
7669494|NCT01362296|26677306|P2|Randomized Phase (RP)|PD including Death due to PD|28
7669495|NCT01362296|26677307|P1|Randomized Phase (RP)|PD including Death due to PD|56
7669496|NCT01362270|26677355|P2|Overall Study|Met excl. criteria before 1st session|1
7669497|NCT01362270|26677356|P1|Overall Study|Met excl. criteria before 1st session|1
7669498|NCT01362270|26677355|P2|Overall Study|Met exclusion criteria after 1st session|1
7669499|NCT01362270|26677356|P1|Overall Study|Met exclusion criteria after 1st session|0
7669500|NCT01362270|26677355|P2|Overall Study|Withdrawal by Subject|0
7669501|NCT01362270|26677356|P1|Overall Study|Withdrawal by Subject|1
7669502|NCT01362244|26677368|P2|Overall Study|Protocol Defined Stopping Criteria|1
7669503|NCT01362244|26677369|P1|Overall Study|Protocol Defined Stopping Criteria|0
7669504|NCT01362244|26677368|P2|Overall Study|Did not Meet Continuation Criteria|11
7669505|NCT01362244|26677369|P1|Overall Study|Did not Meet Continuation Criteria|17
7669506|NCT01362244|26677368|P2|Overall Study|Withdrawal by Subject|1
7669507|NCT01362244|26677369|P1|Overall Study|Withdrawal by Subject|2
7669508|NCT01362244|26677368|P2|Overall Study|Protocol Violation|1
7669509|NCT01362244|26677369|P1|Overall Study|Protocol Violation|5
7669510|NCT01362244|26677368|P2|Overall Study|Lost to Follow-up|2
7669512|NCT01362244|26677368|P2|Overall Study|Lack of Efficacy|11
7669513|NCT01362244|26677369|P1|Overall Study|Lack of Efficacy|5
7669514|NCT01362244|26677368|P2|Overall Study|Adverse Event|5
7669515|NCT01362244|26677369|P1|Overall Study|Adverse Event|3
7669516|NCT01362140|26677481|P2|Overall Study|Discontinued Without Receiving Treatment|1
7669517|NCT01362140|26677482|P1|Overall Study|Discontinued Without Receiving Treatment|0
7669518|NCT01362140|26677481|P2|Overall Study|Protocol-specified Criteria|2
7669519|NCT01362140|26677482|P1|Overall Study|Protocol-specified Criteria|1
7669520|NCT01362140|26677481|P2|Overall Study|Other|1
7669521|NCT01362140|26677482|P1|Overall Study|Other|1
7669522|NCT01362140|26677481|P2|Overall Study|Death|1
7669523|NCT01362140|26677482|P1|Overall Study|Death|2
7669524|NCT01362140|26677481|P2|Overall Study|Administrative Decision|1
7669525|NCT01362140|26677482|P1|Overall Study|Administrative Decision|0
7669526|NCT01362140|26677481|P2|Overall Study|Withdrawal by Subject|3
7669527|NCT01362140|26677482|P1|Overall Study|Withdrawal by Subject|3
7669528|NCT01362140|26677481|P2|Overall Study|Adverse Event|2
7669529|NCT01362140|26677482|P1|Overall Study|Adverse Event|2
7669530|NCT01362140|26677481|P2|Overall Study|Noncompliance|0
7669531|NCT01362140|26677482|P1|Overall Study|Noncompliance|1
7669532|NCT01362062|26677519|P2|Overall Study|Had significant improvement|0
7669533|NCT01362062|26677520|P1|Overall Study|Had significant improvement|9
7669534|NCT01362062|26677519|P2|Overall Study|Detected with Spondylo-arthritis|0
7669535|NCT01362062|26677520|P1|Overall Study|Detected with Spondylo-arthritis|1
7669536|NCT01362062|26677519|P2|Overall Study|Non-compliant participant|0
7669537|NCT01362062|26677520|P1|Overall Study|Non-compliant participant|2
7669538|NCT01362062|26677519|P2|Overall Study|Withdrawal by Subject|0
7669539|NCT01362062|26677520|P1|Overall Study|Withdrawal by Subject|2
7669540|NCT01362062|26677519|P2|Overall Study|Lost to Follow-up|0
7669541|NCT01362062|26677520|P1|Overall Study|Lost to Follow-up|11
7669542|NCT01362062|26677519|P2|Overall Study|Adverse Event|0
7669543|NCT01362062|26677520|P1|Overall Study|Adverse Event|1
7669544|NCT01362049|26677541|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
7669545|NCT01362049|26677542|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
7669546|NCT01362049|26677543|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
7669547|NCT01362049|26677544|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
7669548|NCT01362049|26677541|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
7669549|NCT01362049|26677542|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
7669550|NCT01362049|26677543|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
7669551|NCT01362049|26677544|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
7669552|NCT01361919|26677585|P3|Overall Study|technical issues|10
7669553|NCT01361919|26677586|P2|Overall Study|technical issues|12
7669554|NCT01361919|26677587|P1|Overall Study|technical issues|10
7669555|NCT01361711|26677613|P1|10 Year Follow-up|Progressive Disease|1
7669556|NCT01361711|26677613|P1|10 Year Follow-up|Progressive Disease and New treatment started|11
7669557|NCT01361711|26677613|P1|10 Year Follow-up|New treatment started|6
7669558|NCT01361711|26677613|P1|10 Year Follow-up|Lost to Follow-up|2
7669559|NCT01361711|26677613|P1|10 Year Follow-up|Developed new cancer|1
7669560|NCT01361711|26677613|P1|10 Year Follow-up|Death|7
7669561|NCT01361711|26677613|P1|10 Year Follow-up|Still in follow-up|22
7669562|NCT01361711|26677613|P1|Completed Week 18 of Treatment|Other|9
7669563|NCT01361711|26677613|P1|Completed Week 18 of Treatment|Complete Remission|2
7669564|NCT01361711|26677613|P1|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
7669565|NCT01361711|26677613|P1|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
7669566|NCT01361711|26677613|P1|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
7669567|NCT01361711|26677613|P1|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
7669568|NCT01361711|26677613|P1|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
7669569|NCT01361607|26677644|P2|Overall Study|Met Withdrawal Criteria|1
7669570|NCT01361607|26677645|P1|Overall Study|Met Withdrawal Criteria|1
7669571|NCT01361607|26677644|P2|Overall Study|Lost to Follow-up|0
7669572|NCT01361607|26677645|P1|Overall Study|Lost to Follow-up|1
7669573|NCT01361607|26677644|P2|Overall Study|Withdrawal by Investigator|3
7669574|NCT01361607|26677645|P1|Overall Study|Withdrawal by Investigator|5
7669575|NCT01361607|26677644|P2|Overall Study|Withdrawal by Subject|8
7669576|NCT01361607|26677645|P1|Overall Study|Withdrawal by Subject|19
7669577|NCT01361607|26677644|P2|Overall Study|Adverse Event|29
7669578|NCT01361607|26677645|P1|Overall Study|Adverse Event|38
7669579|NCT01361594|26677673|P2|Overall Study|Withdrawal by Subject|2
7669580|NCT01361594|26677674|P1|Overall Study|Withdrawal by Subject|1
7669581|NCT01361568|26677688|P6|Overall Study|Withdrawal by Subject|1
7669582|NCT01361568|26677689|P5|Overall Study|Withdrawal by Subject|0
7669583|NCT01361568|26677690|P4|Overall Study|Withdrawal by Subject|0
7669584|NCT01361568|26677691|P3|Overall Study|Withdrawal by Subject|0
7669585|NCT01361568|26677692|P2|Overall Study|Withdrawal by Subject|1
7669586|NCT01361568|26677693|P1|Overall Study|Withdrawal by Subject|2
7669587|NCT01361568|26677688|P6|Overall Study|Physician Decision|1
7669588|NCT01361568|26677689|P5|Overall Study|Physician Decision|0
7669589|NCT01361568|26677690|P4|Overall Study|Physician Decision|0
7669590|NCT01361568|26677691|P3|Overall Study|Physician Decision|0
7669591|NCT01361568|26677692|P2|Overall Study|Physician Decision|0
7669592|NCT01361568|26677693|P1|Overall Study|Physician Decision|0
7669593|NCT01361568|26677688|P6|Overall Study|Adverse Event|0
7669594|NCT01361568|26677689|P5|Overall Study|Adverse Event|1
7669595|NCT01361568|26677690|P4|Overall Study|Adverse Event|0
7669596|NCT01361568|26677691|P3|Overall Study|Adverse Event|0
7669597|NCT01361568|26677692|P2|Overall Study|Adverse Event|0
7669598|NCT01361568|26677693|P1|Overall Study|Adverse Event|0
7669599|NCT01361464|26677723|P1|Overall Study|Withdrawal by Subject|2
7669600|NCT01361464|26677723|P1|Overall Study|Death|1
7669601|NCT01361308|26677732|P2|Overall Study|Other|1
7669602|NCT01361308|26677733|P1|Overall Study|Other|0
7669603|NCT01361308|26677732|P2|Overall Study|Failed C-SSRS|2
7669604|NCT01361308|26677733|P1|Overall Study|Failed C-SSRS|5
7669605|NCT01361308|26677732|P2|Overall Study|Eligibility Criteria Not Met|3
7669606|NCT01361308|26677733|P1|Overall Study|Eligibility Criteria Not Met|2
7669607|NCT01361308|26677732|P2|Overall Study|Adverse Event|4
7669608|NCT01361308|26677733|P1|Overall Study|Adverse Event|8
7669609|NCT01361308|26677732|P2|Overall Study|Lost to Follow-up|4
7669610|NCT01361308|26677733|P1|Overall Study|Lost to Follow-up|5
7669611|NCT01361308|26677732|P2|Overall Study|Protocol Violation|0
7669612|NCT01361308|26677733|P1|Overall Study|Protocol Violation|1
7669613|NCT01361308|26677732|P2|Overall Study|Lack of Efficacy|0
7669614|NCT01361308|26677733|P1|Overall Study|Lack of Efficacy|2
7669615|NCT01361308|26677732|P2|Overall Study|Physician Decision|3
7669616|NCT01361308|26677733|P1|Overall Study|Physician Decision|3
7669617|NCT01361308|26677732|P2|Overall Study|Withdrawal by Subject|13
7669618|NCT01361308|26677733|P1|Overall Study|Withdrawal by Subject|9
7669619|NCT01361178|26677781|P2|Overall Study|Death|0
7669620|NCT01361178|26677782|P1|Overall Study|Death|13
7669621|NCT01361126|26677790|P2|Overall Study|Sponsor decision|2
7669622|NCT01361126|26677791|P1|Overall Study|Sponsor decision|0
7669623|NCT01361009|26677830|P1|Overall Study|Protocol Violation|116
7669624|NCT01360996|26677840|P3|Overall Study|Noncompliant|0
7669625|NCT01360996|26677841|P2|Overall Study|Noncompliant|0
7669626|NCT01360996|26677842|P1|Overall Study|Noncompliant|2
7669627|NCT01360996|26677840|P3|Overall Study|Withdrawal by Subject|2
7669628|NCT01360996|26677841|P2|Overall Study|Withdrawal by Subject|3
7669629|NCT01360996|26677842|P1|Overall Study|Withdrawal by Subject|4
7669630|NCT01360866|26677865|P4|Overall Study|Lack of Efficacy|4
7669631|NCT01360866|26677866|P3|Overall Study|Lack of Efficacy|30
7669632|NCT01360866|26677867|P2|Overall Study|Lack of Efficacy|40
7669633|NCT01360866|26677868|P1|Overall Study|Lack of Efficacy|30
7669634|NCT01360866|26677865|P4|Overall Study|Protocol Deviation|2
7669635|NCT01360866|26677866|P3|Overall Study|Protocol Deviation|61
7669636|NCT01360866|26677867|P2|Overall Study|Protocol Deviation|33
7669637|NCT01360866|26677868|P1|Overall Study|Protocol Deviation|25
7669638|NCT01360866|26677865|P4|Overall Study|Withdrawal by participant|8
7669639|NCT01360866|26677866|P3|Overall Study|Withdrawal by participant|168
7669640|NCT01360866|26677867|P2|Overall Study|Withdrawal by participant|89
7669641|NCT01360866|26677868|P1|Overall Study|Withdrawal by participant|79
7669642|NCT01360866|26677865|P4|Overall Study|Withdrawn by Investigator|2
7669643|NCT01360866|26677866|P3|Overall Study|Withdrawn by Investigator|31
7669644|NCT01360866|26677867|P2|Overall Study|Withdrawn by Investigator|8
7669645|NCT01360866|26677868|P1|Overall Study|Withdrawn by Investigator|9
7669646|NCT01360866|26677865|P4|Overall Study|Paticipant met withdrawal criteria|0
7669647|NCT01360866|26677866|P3|Overall Study|Paticipant met withdrawal criteria|54
7669648|NCT01360866|26677867|P2|Overall Study|Paticipant met withdrawal criteria|28
7669649|NCT01360866|26677868|P1|Overall Study|Paticipant met withdrawal criteria|11
7669650|NCT01360866|26677865|P4|Overall Study|Adverse Event|6
7669651|NCT01360866|26677866|P3|Overall Study|Adverse Event|134
7669652|NCT01360866|26677867|P2|Overall Study|Adverse Event|61
7669653|NCT01360866|26677868|P1|Overall Study|Adverse Event|56
7669654|NCT01360866|26677865|P4|Overall Study|Lost to Follow-up|0
7669655|NCT01360866|26677866|P3|Overall Study|Lost to Follow-up|41
7669656|NCT01360866|26677867|P2|Overall Study|Lost to Follow-up|28
7669657|NCT01360866|26677868|P1|Overall Study|Lost to Follow-up|11
7669658|NCT01360840|26677897|P3|Overall Study|Ongoing at data cut-off|9
7669659|NCT01360840|26677898|P2|Overall Study|Ongoing at data cut-off|10
7669660|NCT01360840|26677899|P1|Overall Study|Ongoing at data cut-off|10
7669661|NCT01360762|26677949|P1|Whole Study Period|Discontinuation of study drug for safety|1
7669662|NCT01360762|26677949|P1|Whole Study Period|Patient relapsed|18
7669663|NCT01360762|26677949|P1|Whole Study Period|Death|7
7669664|NCT01360762|26677949|P1|Whole Study Period|Lost to Follow-up|10
7669665|NCT01360762|26677949|P1|Main Study Period (12-month Treatment)|Discontinuation|1
7669666|NCT01360762|26677949|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
7669667|NCT01360762|26677949|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
7669668|NCT01360762|26677949|P1|Main Study Period (12-month Treatment)|Death|5
7669669|NCT01360762|26677949|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
7669670|NCT01360645|26677959|P4|Phase A+|Protocol Deviation|4
7669671|NCT01360645|26677960|P3|Phase A+|Protocol Deviation|0
7669672|NCT01360645|26677961|P2|Phase A+|Protocol Deviation|0
7669673|NCT01360645|26677962|P1|Phase A+|Protocol Deviation|0
7669674|NCT01360645|26677959|P4|Phase A+|Withdrawal by Subject|5
7669675|NCT01360645|26677960|P3|Phase A+|Withdrawal by Subject|0
7669676|NCT01360645|26677961|P2|Phase A+|Withdrawal by Subject|0
7669677|NCT01360645|26677962|P1|Phase A+|Withdrawal by Subject|0
7669678|NCT01360645|26677959|P4|Phase A+|Physician Decision|2
7669679|NCT01360645|26677960|P3|Phase A+|Physician Decision|0
7669680|NCT01360645|26677961|P2|Phase A+|Physician Decision|0
7669681|NCT01360645|26677962|P1|Phase A+|Physician Decision|0
7669682|NCT01360645|26677959|P4|Phase A+|Met Withdrawal Criteria|4
7669683|NCT01360645|26677960|P3|Phase A+|Met Withdrawal Criteria|0
7669684|NCT01360645|26677961|P2|Phase A+|Met Withdrawal Criteria|0
7669685|NCT01360645|26677962|P1|Phase A+|Met Withdrawal Criteria|0
7669686|NCT01360645|26677959|P4|Phase A+|Adverse Event|2
7669687|NCT01360645|26677960|P3|Phase A+|Adverse Event|0
7669688|NCT01360645|26677961|P2|Phase A+|Adverse Event|0
7669689|NCT01360645|26677962|P1|Phase A+|Adverse Event|0
7669690|NCT01360645|26677959|P4|Phase A+|Lost to Follow-up|7
7669691|NCT01360645|26677960|P3|Phase A+|Lost to Follow-up|0
7669692|NCT01360645|26677961|P2|Phase A+|Lost to Follow-up|0
7669693|NCT01360645|26677962|P1|Phase A+|Lost to Follow-up|0
7669694|NCT01360645|26677959|P4|Phase B (6 Weeks)|Protocol Deviation|0
7669695|NCT01360645|26677960|P3|Phase B (6 Weeks)|Protocol Deviation|3
7669696|NCT01360645|26677961|P2|Phase B (6 Weeks)|Protocol Deviation|1
7669697|NCT01360645|26677962|P1|Phase B (6 Weeks)|Protocol Deviation|0
7669698|NCT01360645|26677959|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
7669699|NCT01360645|26677960|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
7669700|NCT01360645|26677961|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
7669701|NCT01360645|26677962|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
7669702|NCT01360645|26677959|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7669703|NCT01360645|26677960|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
7669704|NCT01360645|26677961|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
7669705|NCT01360645|26677962|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7669706|NCT01360645|26677959|P4|Phase B (6 Weeks)|Adverse Event|0
7669707|NCT01360645|26677960|P3|Phase B (6 Weeks)|Adverse Event|0
7669708|NCT01360645|26677961|P2|Phase B (6 Weeks)|Adverse Event|6
7669709|NCT01360645|26677962|P1|Phase B (6 Weeks)|Adverse Event|0
7669710|NCT01360645|26677959|P4|Phase B (6 Weeks)|Lost to Follow-up|0
7669711|NCT01360645|26677960|P3|Phase B (6 Weeks)|Lost to Follow-up|0
7669712|NCT01360645|26677961|P2|Phase B (6 Weeks)|Lost to Follow-up|1
7669713|NCT01360645|26677962|P1|Phase B (6 Weeks)|Lost to Follow-up|0
7669714|NCT01360645|26677959|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7669715|NCT01360645|26677960|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7669716|NCT01360645|26677961|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7669717|NCT01360645|26677962|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
7669718|NCT01360645|26677959|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7669719|NCT01360645|26677960|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7669720|NCT01360645|26677961|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7669721|NCT01360645|26677962|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
7669722|NCT01360645|26677959|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7669723|NCT01360645|26677960|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7669724|NCT01360645|26677961|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7669725|NCT01360645|26677962|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
7669726|NCT01360645|26677959|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7669727|NCT01360645|26677960|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7669728|NCT01360645|26677961|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7669729|NCT01360645|26677962|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
7669730|NCT01360645|26677959|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7669731|NCT01360645|26677960|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7669732|NCT01360645|26677961|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7669733|NCT01360645|26677962|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
7669734|NCT01360645|26677959|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7669735|NCT01360645|26677960|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7669736|NCT01360645|26677961|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7669737|NCT01360645|26677962|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
7669738|NCT01360632|26678017|P5|Phase A+|Protocol Deviation|3
7669739|NCT01360632|26678018|P4|Phase A+|Protocol Deviation|0
7669740|NCT01360632|26678019|P3|Phase A+|Protocol Deviation|0
7669741|NCT01360632|26678020|P2|Phase A+|Protocol Deviation|0
7669742|NCT01360632|26678021|P1|Phase A+|Protocol Deviation|0
7669743|NCT01360632|26678017|P5|Phase A+|Withdrawal by Subject|8
7669744|NCT01360632|26678018|P4|Phase A+|Withdrawal by Subject|0
7669745|NCT01360632|26678019|P3|Phase A+|Withdrawal by Subject|0
7669746|NCT01360632|26678020|P2|Phase A+|Withdrawal by Subject|0
7669747|NCT01360632|26678021|P1|Phase A+|Withdrawal by Subject|0
7669748|NCT01360632|26678017|P5|Phase A+|Physician Decision|3
7669749|NCT01360632|26678018|P4|Phase A+|Physician Decision|0
7669750|NCT01360632|26678019|P3|Phase A+|Physician Decision|0
7669751|NCT01360632|26678020|P2|Phase A+|Physician Decision|0
7669752|NCT01360632|26678021|P1|Phase A+|Physician Decision|0
7669753|NCT01360632|26678017|P5|Phase A+|Met Withdrawal Criteria|7
7669754|NCT01360632|26678018|P4|Phase A+|Met Withdrawal Criteria|0
7669755|NCT01360632|26678019|P3|Phase A+|Met Withdrawal Criteria|0
7669756|NCT01360632|26678020|P2|Phase A+|Met Withdrawal Criteria|0
7669757|NCT01360632|26678021|P1|Phase A+|Met Withdrawal Criteria|0
7669758|NCT01360632|26678017|P5|Phase A+|Adverse Event|2
7669759|NCT01360632|26678018|P4|Phase A+|Adverse Event|0
7669760|NCT01360632|26678019|P3|Phase A+|Adverse Event|0
7669761|NCT01360632|26678020|P2|Phase A+|Adverse Event|0
7669762|NCT01360632|26678021|P1|Phase A+|Adverse Event|0
7669763|NCT01360632|26678017|P5|Phase A+|Lost to Follow-up|2
7669764|NCT01360632|26678018|P4|Phase A+|Lost to Follow-up|0
7669765|NCT01360632|26678019|P3|Phase A+|Lost to Follow-up|0
7669766|NCT01360632|26678020|P2|Phase A+|Lost to Follow-up|0
7669767|NCT01360632|26678021|P1|Phase A+|Lost to Follow-up|0
7669768|NCT01360632|26678017|P5|Phase B (6 Weeks)|Lack of Efficacy|0
7669769|NCT01360632|26678018|P4|Phase B (6 Weeks)|Lack of Efficacy|0
7669770|NCT01360632|26678019|P3|Phase B (6 Weeks)|Lack of Efficacy|0
7669771|NCT01360632|26678020|P2|Phase B (6 Weeks)|Lack of Efficacy|1
7669772|NCT01360632|26678021|P1|Phase B (6 Weeks)|Lack of Efficacy|0
7669773|NCT01360632|26678017|P5|Phase B (6 Weeks)|Protocol Deviation|0
7669774|NCT01360632|26678018|P4|Phase B (6 Weeks)|Protocol Deviation|1
7669775|NCT01360632|26678019|P3|Phase B (6 Weeks)|Protocol Deviation|4
7669776|NCT01360632|26678020|P2|Phase B (6 Weeks)|Protocol Deviation|1
7669777|NCT01360632|26678021|P1|Phase B (6 Weeks)|Protocol Deviation|0
7669778|NCT01360632|26678017|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
7669779|NCT01360632|26678018|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
7669780|NCT01360632|26678019|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
7669781|NCT01360632|26678020|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
7669782|NCT01360632|26678021|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
7669783|NCT01360632|26678017|P5|Phase B (6 Weeks)|Physician Decision|0
7669784|NCT01360632|26678018|P4|Phase B (6 Weeks)|Physician Decision|1
7669785|NCT01360632|26678019|P3|Phase B (6 Weeks)|Physician Decision|0
7669786|NCT01360632|26678020|P2|Phase B (6 Weeks)|Physician Decision|0
7669787|NCT01360632|26678021|P1|Phase B (6 Weeks)|Physician Decision|0
7669788|NCT01360632|26678017|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7669789|NCT01360632|26678018|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
7669790|NCT01360632|26678019|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
7669791|NCT01360632|26678020|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7669792|NCT01360632|26678021|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7669793|NCT01360632|26678017|P5|Phase B (6 Weeks)|Adverse Event|0
7669794|NCT01360632|26678018|P4|Phase B (6 Weeks)|Adverse Event|3
7669795|NCT01360632|26678019|P3|Phase B (6 Weeks)|Adverse Event|9
7669796|NCT01360632|26678020|P2|Phase B (6 Weeks)|Adverse Event|3
7669797|NCT01360632|26678021|P1|Phase B (6 Weeks)|Adverse Event|0
7669798|NCT01360632|26678017|P5|Phase B (6 Weeks)|Lost to Follow-up|0
7669799|NCT01360632|26678018|P4|Phase B (6 Weeks)|Lost to Follow-up|0
7669800|NCT01360632|26678019|P3|Phase B (6 Weeks)|Lost to Follow-up|1
7669801|NCT01360632|26678020|P2|Phase B (6 Weeks)|Lost to Follow-up|1
7669802|NCT01360632|26678021|P1|Phase B (6 Weeks)|Lost to Follow-up|0
7669803|NCT01360632|26678017|P5|Phase A (8 Weeks)|Protocol Deviation|0
7669804|NCT01360632|26678018|P4|Phase A (8 Weeks)|Protocol Deviation|0
7669805|NCT01360632|26678019|P3|Phase A (8 Weeks)|Protocol Deviation|0
7669806|NCT01360632|26678020|P2|Phase A (8 Weeks)|Protocol Deviation|0
7669807|NCT01360632|26678021|P1|Phase A (8 Weeks)|Protocol Deviation|39
7669808|NCT01360632|26678017|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
7669809|NCT01360632|26678018|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
7669810|NCT01360632|26678019|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
7669811|NCT01360632|26678020|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
7669812|NCT01360632|26678021|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
7669813|NCT01360632|26678017|P5|Phase A (8 Weeks)|Physician Decision|0
7669814|NCT01360632|26678018|P4|Phase A (8 Weeks)|Physician Decision|0
7669815|NCT01360632|26678019|P3|Phase A (8 Weeks)|Physician Decision|0
7669816|NCT01360632|26678020|P2|Phase A (8 Weeks)|Physician Decision|0
7669817|NCT01360632|26678021|P1|Phase A (8 Weeks)|Physician Decision|10
7669818|NCT01360632|26678017|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7669819|NCT01360632|26678018|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7669820|NCT01360632|26678019|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7669821|NCT01360632|26678020|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7669822|NCT01360632|26678021|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
7669823|NCT01360632|26678017|P5|Phase A (8 Weeks)|Adverse Event|0
7669824|NCT01360632|26678018|P4|Phase A (8 Weeks)|Adverse Event|0
7669825|NCT01360632|26678019|P3|Phase A (8 Weeks)|Adverse Event|0
7669826|NCT01360632|26678020|P2|Phase A (8 Weeks)|Adverse Event|0
7669827|NCT01360632|26678021|P1|Phase A (8 Weeks)|Adverse Event|60
7669828|NCT01360632|26678017|P5|Phase A (8 Weeks)|Lost to Follow-up|0
7669829|NCT01360632|26678018|P4|Phase A (8 Weeks)|Lost to Follow-up|0
7669830|NCT01360632|26678019|P3|Phase A (8 Weeks)|Lost to Follow-up|0
7669831|NCT01360632|26678020|P2|Phase A (8 Weeks)|Lost to Follow-up|0
7669832|NCT01360632|26678021|P1|Phase A (8 Weeks)|Lost to Follow-up|27
7669833|NCT01360554|26678100|P2|Overall Study|Randomized but not treated.|3
7669834|NCT01360554|26678101|P1|Overall Study|Randomized but not treated.|3
7669835|NCT01360554|26678100|P2|Overall Study|Other, not specified|0
7669836|NCT01360554|26678101|P1|Overall Study|Other, not specified|1
7669837|NCT01360554|26678100|P2|Overall Study|Study terminated by sponsor|37
7669838|NCT01360554|26678101|P1|Overall Study|Study terminated by sponsor|49
7669839|NCT01360554|26678100|P2|Overall Study|Withdrawal by Subject|24
7669840|NCT01360554|26678101|P1|Overall Study|Withdrawal by Subject|23
7669841|NCT01360554|26678100|P2|Overall Study|Lost to Follow-up|4
7669842|NCT01360554|26678101|P1|Overall Study|Lost to Follow-up|4
7669843|NCT01360554|26678100|P2|Overall Study|Death|371
7669844|NCT01360554|26678101|P1|Overall Study|Death|359
7669845|NCT01360398|26678150|P1|Overall Study|Migrated/moved from study area|1
7669846|NCT01360398|26678150|P1|Overall Study|Other|7
7669847|NCT01360398|26678150|P1|Overall Study|Withdrawal by Subject|14
7669848|NCT01360021|26678184|P3|Overall Study|Adverse Event|3
7669849|NCT01360021|26678185|P2|Overall Study|Adverse Event|3
7669850|NCT01360021|26678186|P1|Overall Study|Adverse Event|2
7669851|NCT01360021|26678184|P3|Overall Study|Withdrawal by Subject|2
7669852|NCT01360021|26678185|P2|Overall Study|Withdrawal by Subject|0
7669853|NCT01360021|26678186|P1|Overall Study|Withdrawal by Subject|4
7669854|NCT01360021|26678184|P3|Overall Study|Protocol Violation|1
7669855|NCT01360021|26678185|P2|Overall Study|Protocol Violation|0
7669856|NCT01360021|26678186|P1|Overall Study|Protocol Violation|0
7669857|NCT01360021|26678184|P3|Overall Study|Eligibility criteria + other|1
7669858|NCT01360021|26678185|P2|Overall Study|Eligibility criteria + other|1
7669859|NCT01360021|26678186|P1|Overall Study|Eligibility criteria + other|2
7669860|NCT01359956|26678213|P4|Overall Study|Death|58
7669861|NCT01359956|26678214|P3|Overall Study|Death|67
7669862|NCT01359956|26678215|P2|Overall Study|Death|64
7669863|NCT01359956|26678216|P1|Overall Study|Death|61
7669864|NCT01359943|26678241|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
7669865|NCT01359943|26678242|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
7669866|NCT01359943|26678243|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
7669867|NCT01359943|26678241|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
7669868|NCT01359943|26678242|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
7669869|NCT01359943|26678243|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
7669870|NCT01359943|26678241|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7669871|NCT01359943|26678242|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7669872|NCT01359943|26678243|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7669873|NCT01359943|26678241|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
7669874|NCT01359943|26678242|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
7669875|NCT01359943|26678243|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
7669876|NCT01359943|26678241|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
7669877|NCT01359943|26678242|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
7669878|NCT01359943|26678243|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
7669879|NCT01359943|26678241|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
7669880|NCT01359943|26678242|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
7669881|NCT01359943|26678243|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
7669882|NCT01359943|26678241|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
7669883|NCT01359943|26678242|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
7669884|NCT01359943|26678243|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
7669885|NCT01359943|26678241|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
7669886|NCT01359943|26678242|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
7669887|NCT01359943|26678243|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
7669888|NCT01359943|26678241|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7669889|NCT01359943|26678242|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7669890|NCT01359943|26678243|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7669891|NCT01359943|26678241|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
7669892|NCT01359943|26678242|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
7669893|NCT01359943|26678243|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
7669894|NCT01359943|26678241|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
7669895|NCT01359943|26678242|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
7669896|NCT01359943|26678243|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
7669897|NCT01359943|26678241|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
7669898|NCT01359943|26678242|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
7669899|NCT01359943|26678243|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
7669900|NCT01359943|26678241|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
7669901|NCT01359943|26678242|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
7669902|NCT01359943|26678243|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
7669903|NCT01359943|26678241|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
7669904|NCT01359943|26678242|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
7669905|NCT01359943|26678243|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
7669906|NCT01359943|26678241|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
7669907|NCT01359943|26678242|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
7669908|NCT01359943|26678243|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
7669909|NCT01359904|26678291|P2|Overall Study|Withdrawal by Subject|0
7669910|NCT01359904|26678292|P1|Overall Study|Withdrawal by Subject|1
7669911|NCT01359644|26678346|P10|Follow-up Period|Lost to Follow-up|0
7669912|NCT01359644|26678347|P9|Follow-up Period|Lost to Follow-up|0
7669913|NCT01359644|26678348|P8|Follow-up Period|Lost to Follow-up|2
7669914|NCT01359644|26678349|P7|Follow-up Period|Lost to Follow-up|1
7669915|NCT01359644|26678350|P6|Follow-up Period|Lost to Follow-up|0
7669916|NCT01359644|26678351|P5|Follow-up Period|Lost to Follow-up|0
7669917|NCT01359644|26678352|P4|Follow-up Period|Lost to Follow-up|0
7669918|NCT01359644|26678353|P3|Follow-up Period|Lost to Follow-up|0
7669919|NCT01359644|26678354|P2|Follow-up Period|Lost to Follow-up|0
7669920|NCT01359644|26678355|P1|Follow-up Period|Lost to Follow-up|0
7669921|NCT01359644|26678346|P10|Follow-up Period|Withdrawal by Subject|0
7669922|NCT01359644|26678347|P9|Follow-up Period|Withdrawal by Subject|0
7669923|NCT01359644|26678348|P8|Follow-up Period|Withdrawal by Subject|0
7669924|NCT01359644|26678349|P7|Follow-up Period|Withdrawal by Subject|0
7669925|NCT01359644|26678350|P6|Follow-up Period|Withdrawal by Subject|1
7669926|NCT01359644|26678351|P5|Follow-up Period|Withdrawal by Subject|0
7669927|NCT01359644|26678352|P4|Follow-up Period|Withdrawal by Subject|0
7669928|NCT01359644|26678353|P3|Follow-up Period|Withdrawal by Subject|0
7669929|NCT01359644|26678354|P2|Follow-up Period|Withdrawal by Subject|0
7669930|NCT01359644|26678355|P1|Follow-up Period|Withdrawal by Subject|0
7669931|NCT01359644|26678346|P10|Treatment Period|Lost to Follow-up|0
7669932|NCT01359644|26678347|P9|Treatment Period|Lost to Follow-up|0
7669933|NCT01359644|26678348|P8|Treatment Period|Lost to Follow-up|0
7669934|NCT01359644|26678349|P7|Treatment Period|Lost to Follow-up|0
7669935|NCT01359644|26678350|P6|Treatment Period|Lost to Follow-up|1
7669936|NCT01359644|26678351|P5|Treatment Period|Lost to Follow-up|0
7669937|NCT01359644|26678352|P4|Treatment Period|Lost to Follow-up|0
7669938|NCT01359644|26678353|P3|Treatment Period|Lost to Follow-up|0
7669939|NCT01359644|26678354|P2|Treatment Period|Lost to Follow-up|0
7669940|NCT01359644|26678355|P1|Treatment Period|Lost to Follow-up|0
7669941|NCT01359644|26678346|P10|Treatment Period|Adverse Event|0
7669942|NCT01359644|26678347|P9|Treatment Period|Adverse Event|0
7669943|NCT01359644|26678348|P8|Treatment Period|Adverse Event|0
7669944|NCT01359644|26678349|P7|Treatment Period|Adverse Event|0
7669945|NCT01359644|26678350|P6|Treatment Period|Adverse Event|1
7669946|NCT01359644|26678351|P5|Treatment Period|Adverse Event|0
7669947|NCT01359644|26678352|P4|Treatment Period|Adverse Event|0
7669948|NCT01359644|26678353|P3|Treatment Period|Adverse Event|1
7669949|NCT01359644|26678354|P2|Treatment Period|Adverse Event|0
7669950|NCT01359644|26678355|P1|Treatment Period|Adverse Event|0
7669951|NCT01359644|26678346|P10|Treatment Period|Lack of Efficacy|0
7669952|NCT01359644|26678347|P9|Treatment Period|Lack of Efficacy|0
7669953|NCT01359644|26678348|P8|Treatment Period|Lack of Efficacy|0
7669954|NCT01359644|26678349|P7|Treatment Period|Lack of Efficacy|0
7669955|NCT01359644|26678350|P6|Treatment Period|Lack of Efficacy|0
7669956|NCT01359644|26678351|P5|Treatment Period|Lack of Efficacy|0
7669957|NCT01359644|26678352|P4|Treatment Period|Lack of Efficacy|0
7669958|NCT01359644|26678353|P3|Treatment Period|Lack of Efficacy|0
7669959|NCT01359644|26678354|P2|Treatment Period|Lack of Efficacy|1
7669960|NCT01359644|26678355|P1|Treatment Period|Lack of Efficacy|0
7669961|NCT01359592|26678397|P4|PET-Directed Therapy|Ineligible|0
7669962|NCT01359592|26678398|P3|PET-Directed Therapy|Ineligible|24
7669963|NCT01359592|26678399|P2|PET-Directed Therapy|Ineligible|0
7669964|NCT01359592|26678400|P1|PET-Directed Therapy|Ineligible|0
7669965|NCT01359592|26678397|P4|PET-Directed Therapy|Refusal unrelated to adverse event|0
7669966|NCT01359592|26678398|P3|PET-Directed Therapy|Refusal unrelated to adverse event|1
7669967|NCT01359592|26678399|P2|PET-Directed Therapy|Refusal unrelated to adverse event|0
7669968|NCT01359592|26678400|P1|PET-Directed Therapy|Refusal unrelated to adverse event|0
7669969|NCT01359592|26678397|P4|PET-Directed Therapy|Adverse Event|0
7669970|NCT01359592|26678398|P3|PET-Directed Therapy|Adverse Event|1
7669971|NCT01359592|26678399|P2|PET-Directed Therapy|Adverse Event|0
7669972|NCT01359592|26678400|P1|PET-Directed Therapy|Adverse Event|0
7669973|NCT01359592|26678397|P4|Initial Registration|Ineligible|0
7669974|NCT01359592|26678398|P3|Initial Registration|Ineligible|0
7669975|NCT01359592|26678399|P2|Initial Registration|Ineligible|0
7669976|NCT01359592|26678400|P1|Initial Registration|Ineligible|26
7669977|NCT01359592|26678397|P4|Initial Registration|Other reason not protocol specified|0
7669978|NCT01359592|26678398|P3|Initial Registration|Other reason not protocol specified|0
7669979|NCT01359592|26678399|P2|Initial Registration|Other reason not protocol specified|0
7669980|NCT01359592|26678400|P1|Initial Registration|Other reason not protocol specified|1
7669981|NCT01359592|26678397|P4|Initial Registration|Death|0
7669982|NCT01359592|26678398|P3|Initial Registration|Death|0
7669983|NCT01359592|26678399|P2|Initial Registration|Death|0
7669984|NCT01359592|26678400|P1|Initial Registration|Death|1
7669985|NCT01359592|26678397|P4|Initial Registration|Adverse Event|0
7669986|NCT01359592|26678398|P3|Initial Registration|Adverse Event|0
7669987|NCT01359592|26678399|P2|Initial Registration|Adverse Event|0
7669988|NCT01359592|26678400|P1|Initial Registration|Adverse Event|1
7669989|NCT01359449|26678418|P2|Overall Study|Withdrawal by Subject|2
7669990|NCT01359449|26678419|P1|Overall Study|Withdrawal by Subject|3
7669991|NCT01359449|26678418|P2|Overall Study|Protocol Violation|2
7669992|NCT01359449|26678419|P1|Overall Study|Protocol Violation|0
7669993|NCT01359449|26678418|P2|Overall Study|Lost to Follow-up|0
7669994|NCT01359449|26678419|P1|Overall Study|Lost to Follow-up|1
7669995|NCT01359254|26678469|P2|Overall Study|Death|0
7669996|NCT01359254|26678470|P1|Overall Study|Death|1
7669997|NCT01359150|26678480|P2|Overall Study|Other|0
7669998|NCT01359150|26678481|P1|Overall Study|Other|1
7669999|NCT01359150|26678480|P2|Overall Study|Adverse Event|3
7670000|NCT01359150|26678481|P1|Overall Study|Adverse Event|4
7670001|NCT01359150|26678480|P2|Overall Study|Withdrawal by Subject|1
7670002|NCT01359150|26678481|P1|Overall Study|Withdrawal by Subject|1
7670003|NCT01359150|26678480|P2|Overall Study|Lack of Efficacy|1
7670004|NCT01359150|26678481|P1|Overall Study|Lack of Efficacy|1
7670005|NCT01359046|26678512|P2|Overall Study|Physician Decision|11
7670006|NCT01359046|26678513|P1|Overall Study|Physician Decision|1
7670007|NCT01359046|26678512|P2|Overall Study|Did not receive allocated intervention|6
7670008|NCT01359046|26678513|P1|Overall Study|Did not receive allocated intervention|6
7670009|NCT01358981|26678536|P7|Period 1|Withdrawal by Subject|0
7670010|NCT01358981|26678537|P6|Period 1|Withdrawal by Subject|0
7670011|NCT01358981|26678538|P5|Period 1|Withdrawal by Subject|0
7670012|NCT01358981|26678539|P4|Period 1|Withdrawal by Subject|1
7670013|NCT01358981|26678540|P3|Period 1|Withdrawal by Subject|0
7670014|NCT01358981|26678541|P2|Period 1|Withdrawal by Subject|0
7670015|NCT01358981|26678542|P1|Period 1|Withdrawal by Subject|0
7670016|NCT01358968|26678603|P4|Continued Access Phase|Death|1
7670017|NCT01358968|26678604|P3|Continued Access Phase|Death|1
7670018|NCT01358968|26678605|P2|Continued Access Phase|Death|0
7670019|NCT01358968|26678606|P1|Continued Access Phase|Death|0
7670020|NCT01358968|26678603|P4|Continued Access Phase|Withdrawal by Subject|0
7670021|NCT01358968|26678604|P3|Continued Access Phase|Withdrawal by Subject|3
7670022|NCT01358968|26678605|P2|Continued Access Phase|Withdrawal by Subject|0
7670023|NCT01358968|26678606|P1|Continued Access Phase|Withdrawal by Subject|0
7670024|NCT01358968|26678603|P4|Continued Access Phase|Protocol Violation|2
7670025|NCT01358968|26678604|P3|Continued Access Phase|Protocol Violation|0
7670026|NCT01358968|26678605|P2|Continued Access Phase|Protocol Violation|0
7670027|NCT01358968|26678606|P1|Continued Access Phase|Protocol Violation|0
7670028|NCT01358968|26678603|P4|Continued Access Phase|Progression of Disease|4
7670029|NCT01358968|26678604|P3|Continued Access Phase|Progression of Disease|8
7670030|NCT01358968|26678605|P2|Continued Access Phase|Progression of Disease|0
7670031|NCT01358968|26678606|P1|Continued Access Phase|Progression of Disease|0
7670032|NCT01358968|26678603|P4|Period 2|Adverse Event|0
7670033|NCT01358968|26678604|P3|Period 2|Adverse Event|0
7670034|NCT01358968|26678605|P2|Period 2|Adverse Event|1
7670035|NCT01358968|26678606|P1|Period 2|Adverse Event|0
7670036|NCT01358877|26678622|P2|Overall Study|Other|129
7670037|NCT01358877|26678623|P1|Overall Study|Other|142
7670038|NCT01358877|26678622|P2|Overall Study|Ongoing follow-up for overall survival|5
7670039|NCT01358877|26678623|P1|Overall Study|Ongoing follow-up for overall survival|7
7670040|NCT01358877|26678622|P2|Overall Study|Ongoing follow-up for IDFS event|2073
7670041|NCT01358877|26678623|P1|Overall Study|Ongoing follow-up for IDFS event|2084
7670042|NCT01358877|26678622|P2|Overall Study|Ongoing follow-up for post-recurrence|108
7670043|NCT01358877|26678623|P1|Overall Study|Ongoing follow-up for post-recurrence|87
7670044|NCT01358877|26678622|P2|Overall Study|Death|89
7670045|NCT01358877|26678623|P1|Overall Study|Death|80
7670046|NCT01358864|26678693|P8|Overall Study|Not treated|0
7670047|NCT01358864|26678694|P7|Overall Study|Not treated|1
7670048|NCT01358864|26678695|P6|Overall Study|Not treated|0
7670049|NCT01358864|26678696|P5|Overall Study|Not treated|0
7670050|NCT01358864|26678697|P4|Overall Study|Not treated|0
7670051|NCT01358864|26678698|P3|Overall Study|Not treated|0
7670052|NCT01358864|26678699|P2|Overall Study|Not treated|0
7670053|NCT01358864|26678700|P1|Overall Study|Not treated|0
7670054|NCT01358864|26678693|P8|Overall Study|Other reason not defined above|0
7670055|NCT01358864|26678694|P7|Overall Study|Other reason not defined above|2
7670056|NCT01358864|26678695|P6|Overall Study|Other reason not defined above|0
7670057|NCT01358864|26678696|P5|Overall Study|Other reason not defined above|0
7670058|NCT01358864|26678697|P4|Overall Study|Other reason not defined above|0
7670059|NCT01358864|26678698|P3|Overall Study|Other reason not defined above|0
7670060|NCT01358864|26678699|P2|Overall Study|Other reason not defined above|0
7670061|NCT01358864|26678700|P1|Overall Study|Other reason not defined above|2
7670062|NCT01358864|26678693|P8|Overall Study|Withdrawal by Subject|3
7670063|NCT01358864|26678694|P7|Overall Study|Withdrawal by Subject|1
7670064|NCT01358864|26678695|P6|Overall Study|Withdrawal by Subject|1
7670065|NCT01358864|26678696|P5|Overall Study|Withdrawal by Subject|0
7670066|NCT01358864|26678697|P4|Overall Study|Withdrawal by Subject|0
7670067|NCT01358864|26678698|P3|Overall Study|Withdrawal by Subject|2
7670068|NCT01358864|26678699|P2|Overall Study|Withdrawal by Subject|4
7670069|NCT01358864|26678700|P1|Overall Study|Withdrawal by Subject|3
7670070|NCT01358864|26678693|P8|Overall Study|Lost to Follow-up|1
7670071|NCT01358864|26678694|P7|Overall Study|Lost to Follow-up|0
7670072|NCT01358864|26678695|P6|Overall Study|Lost to Follow-up|0
7670073|NCT01358864|26678696|P5|Overall Study|Lost to Follow-up|0
7670074|NCT01358864|26678697|P4|Overall Study|Lost to Follow-up|0
7670075|NCT01358864|26678698|P3|Overall Study|Lost to Follow-up|1
7670076|NCT01358864|26678699|P2|Overall Study|Lost to Follow-up|0
7670077|NCT01358864|26678700|P1|Overall Study|Lost to Follow-up|0
7670078|NCT01358864|26678693|P8|Overall Study|Lack of Efficacy|44
7670079|NCT01358864|26678694|P7|Overall Study|Lack of Efficacy|49
7670080|NCT01358864|26678695|P6|Overall Study|Lack of Efficacy|4
7670081|NCT01358864|26678696|P5|Overall Study|Lack of Efficacy|7
7670082|NCT01358864|26678697|P4|Overall Study|Lack of Efficacy|19
7670083|NCT01358864|26678698|P3|Overall Study|Lack of Efficacy|4
7670084|NCT01358864|26678699|P2|Overall Study|Lack of Efficacy|3
7670085|NCT01358864|26678700|P1|Overall Study|Lack of Efficacy|26
7670086|NCT01358864|26678693|P8|Overall Study|Adverse Event|7
7670087|NCT01358864|26678694|P7|Overall Study|Adverse Event|12
7670088|NCT01358864|26678695|P6|Overall Study|Adverse Event|8
7670089|NCT01358864|26678696|P5|Overall Study|Adverse Event|4
7670090|NCT01358864|26678697|P4|Overall Study|Adverse Event|0
7670091|NCT01358864|26678698|P3|Overall Study|Adverse Event|9
7670092|NCT01358864|26678699|P2|Overall Study|Adverse Event|6
7670093|NCT01358864|26678700|P1|Overall Study|Adverse Event|0
7670094|NCT01358825|26678791|P2|Overall Study|Blood sample not drawn|1
7670095|NCT01358825|26678792|P1|Overall Study|Blood sample not drawn|0
7670096|NCT01358760|26678816|P3|Overall Study|Entry criteria not met/Non-compliance|16
7670097|NCT01358760|26678817|P2|Overall Study|Entry criteria not met/Non-compliance|12
7670098|NCT01358760|26678818|P1|Overall Study|Entry criteria not met/Non-compliance|12
7670099|NCT01358760|26678816|P3|Overall Study|Physician Decision|1
7670100|NCT01358760|26678817|P2|Overall Study|Physician Decision|0
7670101|NCT01358760|26678818|P1|Overall Study|Physician Decision|1
7670102|NCT01358760|26678816|P3|Overall Study|Withdrawal by Subject|2
7670103|NCT01358760|26678817|P2|Overall Study|Withdrawal by Subject|3
7670104|NCT01358760|26678818|P1|Overall Study|Withdrawal by Subject|5
7670105|NCT01358760|26678816|P3|Overall Study|Lost to Follow-up|3
7670106|NCT01358760|26678817|P2|Overall Study|Lost to Follow-up|1
7670107|NCT01358760|26678818|P1|Overall Study|Lost to Follow-up|1
7670108|NCT01358760|26678816|P3|Overall Study|Adverse Event|3
7670109|NCT01358760|26678817|P2|Overall Study|Adverse Event|4
7670110|NCT01358760|26678818|P1|Overall Study|Adverse Event|3
7670111|NCT01358734|26678853|P3|Overall Study|Protocol Violation|2
7670112|NCT01358734|26678854|P2|Overall Study|Protocol Violation|0
7670113|NCT01358734|26678855|P1|Overall Study|Protocol Violation|0
7670114|NCT01358734|26678853|P3|Overall Study|Other|4
7670115|NCT01358734|26678854|P2|Overall Study|Other|5
7670116|NCT01358734|26678855|P1|Overall Study|Other|2
7670117|NCT01358734|26678853|P3|Overall Study|Non-compliance with study drug|1
7670118|NCT01358734|26678854|P2|Overall Study|Non-compliance with study drug|0
7670119|NCT01358734|26678855|P1|Overall Study|Non-compliance with study drug|0
7670120|NCT01358734|26678853|P3|Overall Study|Progressive Disease|16
7670121|NCT01358734|26678854|P2|Overall Study|Progressive Disease|13
7670122|NCT01358734|26678855|P1|Overall Study|Progressive Disease|5
7670123|NCT01358734|26678853|P3|Overall Study|Death|2
7670124|NCT01358734|26678854|P2|Overall Study|Death|7
7670125|NCT01358734|26678855|P1|Overall Study|Death|3
7670126|NCT01358734|26678853|P3|Overall Study|Withdrawal by Subject|3
7670127|NCT01358734|26678854|P2|Overall Study|Withdrawal by Subject|6
7670128|NCT01358734|26678855|P1|Overall Study|Withdrawal by Subject|1
7670129|NCT01358734|26678853|P3|Overall Study|Lack of Efficacy|3
7670130|NCT01358734|26678854|P2|Overall Study|Lack of Efficacy|1
7670131|NCT01358734|26678855|P1|Overall Study|Lack of Efficacy|0
7670132|NCT01358734|26678853|P3|Overall Study|Adverse Event|3
7670133|NCT01358734|26678854|P2|Overall Study|Adverse Event|7
7670134|NCT01358734|26678855|P1|Overall Study|Adverse Event|4
7670167|NCT01358708|26678958|P2|Double-Blind Treatment Phase|Protocol Violation|0
7670168|NCT01358708|26678959|P1|Double-Blind Treatment Phase|Protocol Violation|1
7670169|NCT01358708|26678958|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
7670170|NCT01358708|26678959|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
7670171|NCT01358578|26678982|P6|Follow-up Period|Physician Decision|0
7670172|NCT01358578|26678983|P5|Follow-up Period|Physician Decision|0
7670173|NCT01358578|26678984|P4|Follow-up Period|Physician Decision|2
7670174|NCT01358578|26678985|P3|Follow-up Period|Physician Decision|0
7670175|NCT01358578|26678986|P2|Follow-up Period|Physician Decision|1
7670176|NCT01358578|26678987|P1|Follow-up Period|Physician Decision|1
7670177|NCT01358578|26678982|P6|Follow-up Period|Withdrawal by Subject|0
7670178|NCT01358578|26678983|P5|Follow-up Period|Withdrawal by Subject|0
7670179|NCT01358578|26678984|P4|Follow-up Period|Withdrawal by Subject|12
7670180|NCT01358578|26678985|P3|Follow-up Period|Withdrawal by Subject|1
7670181|NCT01358578|26678986|P2|Follow-up Period|Withdrawal by Subject|3
7670182|NCT01358578|26678987|P1|Follow-up Period|Withdrawal by Subject|3
7670183|NCT01358578|26678982|P6|Follow-up Period|Pregnancy|0
7670184|NCT01358578|26678983|P5|Follow-up Period|Pregnancy|0
7670185|NCT01358578|26678984|P4|Follow-up Period|Pregnancy|0
7670186|NCT01358578|26678985|P3|Follow-up Period|Pregnancy|0
7670187|NCT01358578|26678986|P2|Follow-up Period|Pregnancy|0
7670188|NCT01358578|26678987|P1|Follow-up Period|Pregnancy|1
7670189|NCT01358578|26678982|P6|Follow-up Period|non- compliance with study treatment|0
7670190|NCT01358578|26678983|P5|Follow-up Period|non- compliance with study treatment|0
7670191|NCT01358578|26678984|P4|Follow-up Period|non- compliance with study treatment|0
7670192|NCT01358578|26678985|P3|Follow-up Period|non- compliance with study treatment|0
7670193|NCT01358578|26678986|P2|Follow-up Period|non- compliance with study treatment|0
7670194|NCT01358578|26678987|P1|Follow-up Period|non- compliance with study treatment|1
7670195|NCT01358578|26678982|P6|Follow-up Period|Lost to Follow-up|0
7670196|NCT01358578|26678983|P5|Follow-up Period|Lost to Follow-up|0
7670197|NCT01358578|26678984|P4|Follow-up Period|Lost to Follow-up|4
7670198|NCT01358578|26678985|P3|Follow-up Period|Lost to Follow-up|0
7670199|NCT01358578|26678986|P2|Follow-up Period|Lost to Follow-up|1
7670200|NCT01358578|26678987|P1|Follow-up Period|Lost to Follow-up|0
7670201|NCT01358578|26678982|P6|Follow-up Period|Lack of Efficacy|0
7670202|NCT01358578|26678983|P5|Follow-up Period|Lack of Efficacy|0
7670203|NCT01358578|26678984|P4|Follow-up Period|Lack of Efficacy|1
7670204|NCT01358578|26678985|P3|Follow-up Period|Lack of Efficacy|4
7670205|NCT01358578|26678986|P2|Follow-up Period|Lack of Efficacy|0
7670206|NCT01358578|26678987|P1|Follow-up Period|Lack of Efficacy|3
7670207|NCT01358578|26678982|P6|Follow-up Period|Adverse Event|0
7670208|NCT01358578|26678983|P5|Follow-up Period|Adverse Event|0
7670209|NCT01358578|26678984|P4|Follow-up Period|Adverse Event|0
7670210|NCT01358578|26678985|P3|Follow-up Period|Adverse Event|0
7670211|NCT01358578|26678986|P2|Follow-up Period|Adverse Event|1
7670212|NCT01358578|26678987|P1|Follow-up Period|Adverse Event|1
7670213|NCT01358578|26678982|P6|Maintenance Period|Withdrawal by Subject|3
7670214|NCT01358578|26678983|P5|Maintenance Period|Withdrawal by Subject|6
7670215|NCT01358578|26678984|P4|Maintenance Period|Withdrawal by Subject|15
7670216|NCT01358578|26678985|P3|Maintenance Period|Withdrawal by Subject|2
7670217|NCT01358578|26678986|P2|Maintenance Period|Withdrawal by Subject|7
7670218|NCT01358578|26678987|P1|Maintenance Period|Withdrawal by Subject|12
7670219|NCT01358578|26678982|P6|Maintenance Period|Protocol deviation|2
7670220|NCT01358578|26678983|P5|Maintenance Period|Protocol deviation|2
7670221|NCT01358578|26678984|P4|Maintenance Period|Protocol deviation|2
7670222|NCT01358578|26678985|P3|Maintenance Period|Protocol deviation|0
7670223|NCT01358578|26678986|P2|Maintenance Period|Protocol deviation|4
7670224|NCT01358578|26678987|P1|Maintenance Period|Protocol deviation|7
7670225|NCT01358578|26678982|P6|Maintenance Period|Pregnancy|0
7670226|NCT01358578|26678983|P5|Maintenance Period|Pregnancy|0
7670227|NCT01358578|26678984|P4|Maintenance Period|Pregnancy|0
7670228|NCT01358578|26678985|P3|Maintenance Period|Pregnancy|0
7670229|NCT01358578|26678986|P2|Maintenance Period|Pregnancy|0
7670230|NCT01358578|26678987|P1|Maintenance Period|Pregnancy|1
7670231|NCT01358578|26678982|P6|Maintenance Period|Physician Decision|0
7670232|NCT01358578|26678983|P5|Maintenance Period|Physician Decision|0
7670233|NCT01358578|26678984|P4|Maintenance Period|Physician Decision|1
7670234|NCT01358578|26678985|P3|Maintenance Period|Physician Decision|0
7670235|NCT01358578|26678986|P2|Maintenance Period|Physician Decision|1
7670236|NCT01358578|26678987|P1|Maintenance Period|Physician Decision|0
7670237|NCT01358578|26678982|P6|Maintenance Period|Non-compliance with study treatment|2
7670238|NCT01358578|26678983|P5|Maintenance Period|Non-compliance with study treatment|1
7670239|NCT01358578|26678984|P4|Maintenance Period|Non-compliance with study treatment|2
7670240|NCT01358578|26678985|P3|Maintenance Period|Non-compliance with study treatment|0
7670241|NCT01358578|26678986|P2|Maintenance Period|Non-compliance with study treatment|1
7670242|NCT01358578|26678987|P1|Maintenance Period|Non-compliance with study treatment|3
7670243|NCT01358578|26678982|P6|Maintenance Period|Lost to Follow-up|1
7670244|NCT01358578|26678983|P5|Maintenance Period|Lost to Follow-up|1
7670245|NCT01358578|26678984|P4|Maintenance Period|Lost to Follow-up|5
7670246|NCT01358578|26678985|P3|Maintenance Period|Lost to Follow-up|0
7670247|NCT01358578|26678986|P2|Maintenance Period|Lost to Follow-up|0
7670248|NCT01358578|26678987|P1|Maintenance Period|Lost to Follow-up|4
7670249|NCT01358578|26678982|P6|Maintenance Period|Lack of Efficacy|0
7670250|NCT01358578|26678983|P5|Maintenance Period|Lack of Efficacy|3
7670251|NCT01358578|26678984|P4|Maintenance Period|Lack of Efficacy|11
7670252|NCT01358578|26678985|P3|Maintenance Period|Lack of Efficacy|0
7670253|NCT01358578|26678986|P2|Maintenance Period|Lack of Efficacy|2
7670254|NCT01358578|26678987|P1|Maintenance Period|Lack of Efficacy|10
7670255|NCT01358578|26678982|P6|Maintenance Period|Adverse Event|3
7670256|NCT01358578|26678983|P5|Maintenance Period|Adverse Event|4
7670257|NCT01358578|26678984|P4|Maintenance Period|Adverse Event|6
7670258|NCT01358578|26678985|P3|Maintenance Period|Adverse Event|0
7670259|NCT01358578|26678986|P2|Maintenance Period|Adverse Event|7
7670260|NCT01358578|26678987|P1|Maintenance Period|Adverse Event|2
7670261|NCT01358578|26678982|P6|Induction Period|Withdrawal by Subject|0
7670262|NCT01358578|26678983|P5|Induction Period|Withdrawal by Subject|0
7670263|NCT01358578|26678984|P4|Induction Period|Withdrawal by Subject|6
7670264|NCT01358578|26678985|P3|Induction Period|Withdrawal by Subject|10
7670265|NCT01358578|26678986|P2|Induction Period|Withdrawal by Subject|5
7670266|NCT01358578|26678987|P1|Induction Period|Withdrawal by Subject|5
7670267|NCT01358578|26678982|P6|Induction Period|technical problems|0
7670268|NCT01358578|26678983|P5|Induction Period|technical problems|0
7670269|NCT01358578|26678984|P4|Induction Period|technical problems|1
7670270|NCT01358578|26678985|P3|Induction Period|technical problems|1
7670271|NCT01358578|26678986|P2|Induction Period|technical problems|0
7670272|NCT01358578|26678987|P1|Induction Period|technical problems|0
7670273|NCT01358578|26678982|P6|Induction Period|Protocol Deviation|0
7670274|NCT01358578|26678983|P5|Induction Period|Protocol Deviation|0
7670275|NCT01358578|26678984|P4|Induction Period|Protocol Deviation|3
7670276|NCT01358578|26678985|P3|Induction Period|Protocol Deviation|0
7670277|NCT01358578|26678986|P2|Induction Period|Protocol Deviation|5
7670278|NCT01358578|26678987|P1|Induction Period|Protocol Deviation|3
7670279|NCT01358578|26678982|P6|Induction Period|Physician Decision|0
7670280|NCT01358578|26678983|P5|Induction Period|Physician Decision|0
7670281|NCT01358578|26678984|P4|Induction Period|Physician Decision|0
7670282|NCT01358578|26678985|P3|Induction Period|Physician Decision|2
7670283|NCT01358578|26678986|P2|Induction Period|Physician Decision|1
7670284|NCT01358578|26678987|P1|Induction Period|Physician Decision|2
7670285|NCT01358578|26678982|P6|Induction Period|Lost to Follow-up|0
7670286|NCT01358578|26678983|P5|Induction Period|Lost to Follow-up|0
7670287|NCT01358578|26678984|P4|Induction Period|Lost to Follow-up|4
7670288|NCT01358578|26678985|P3|Induction Period|Lost to Follow-up|1
7670289|NCT01358578|26678986|P2|Induction Period|Lost to Follow-up|0
7670290|NCT01358578|26678987|P1|Induction Period|Lost to Follow-up|0
7670291|NCT01358578|26678982|P6|Induction Period|Lack of Efficacy|0
7670292|NCT01358578|26678983|P5|Induction Period|Lack of Efficacy|0
7670293|NCT01358578|26678984|P4|Induction Period|Lack of Efficacy|1
7670294|NCT01358578|26678985|P3|Induction Period|Lack of Efficacy|9
7670295|NCT01358578|26678986|P2|Induction Period|Lack of Efficacy|0
7670296|NCT01358578|26678987|P1|Induction Period|Lack of Efficacy|0
7670297|NCT01358578|26678982|P6|Induction Period|Adverse Event|0
7670298|NCT01358578|26678983|P5|Induction Period|Adverse Event|0
7670299|NCT01358578|26678984|P4|Induction Period|Adverse Event|6
7670300|NCT01358578|26678985|P3|Induction Period|Adverse Event|2
7670301|NCT01358578|26678986|P2|Induction Period|Adverse Event|4
7670302|NCT01358578|26678987|P1|Induction Period|Adverse Event|2
7670303|NCT01358526|26679039|P3|Double-blind Phase|Administrative|10
7670304|NCT01358526|26679040|P2|Double-blind Phase|Administrative|6
7670305|NCT01358526|26679041|P1|Double-blind Phase|Administrative|0
7670306|NCT01358526|26679039|P3|Double-blind Phase|Confirmed or suspected diversion|6
7670307|NCT01358526|26679040|P2|Double-blind Phase|Confirmed or suspected diversion|5
7670308|NCT01358526|26679041|P1|Double-blind Phase|Confirmed or suspected diversion|0
7670309|NCT01358526|26679039|P3|Double-blind Phase|Lack of Efficacy|73
7670310|NCT01358526|26679040|P2|Double-blind Phase|Lack of Efficacy|31
7670311|NCT01358526|26679041|P1|Double-blind Phase|Lack of Efficacy|0
7670312|NCT01358526|26679039|P3|Double-blind Phase|Lost to Follow-up|1
7670313|NCT01358526|26679040|P2|Double-blind Phase|Lost to Follow-up|4
7670314|NCT01358526|26679041|P1|Double-blind Phase|Lost to Follow-up|0
7670315|NCT01358526|26679039|P3|Double-blind Phase|Withdrawal by Subject|8
7670316|NCT01358526|26679040|P2|Double-blind Phase|Withdrawal by Subject|10
7670317|NCT01358526|26679041|P1|Double-blind Phase|Withdrawal by Subject|0
7670318|NCT01358526|26679039|P3|Double-blind Phase|Adverse Event|23
7670319|NCT01358526|26679040|P2|Double-blind Phase|Adverse Event|24
7670320|NCT01358526|26679041|P1|Double-blind Phase|Adverse Event|0
7670321|NCT01358526|26679039|P3|Open-label Titration Period|Did not qualify|0
7670322|NCT01358526|26679040|P2|Open-label Titration Period|Did not qualify|0
7670323|NCT01358526|26679041|P1|Open-label Titration Period|Did not qualify|178
7670324|NCT01358526|26679039|P3|Open-label Titration Period|Administrative|0
7670325|NCT01358526|26679040|P2|Open-label Titration Period|Administrative|0
7670326|NCT01358526|26679041|P1|Open-label Titration Period|Administrative|8
7670327|NCT01358526|26679039|P3|Open-label Titration Period|Confirmed or suspected diversion|0
7670328|NCT01358526|26679040|P2|Open-label Titration Period|Confirmed or suspected diversion|0
7670329|NCT01358526|26679041|P1|Open-label Titration Period|Confirmed or suspected diversion|16
7670330|NCT01358526|26679039|P3|Open-label Titration Period|Lack of Efficacy|0
7670331|NCT01358526|26679040|P2|Open-label Titration Period|Lack of Efficacy|0
7670332|NCT01358526|26679041|P1|Open-label Titration Period|Lack of Efficacy|107
7670333|NCT01358526|26679039|P3|Open-label Titration Period|Lost to Follow-up|0
7670334|NCT01358526|26679040|P2|Open-label Titration Period|Lost to Follow-up|0
7670335|NCT01358526|26679041|P1|Open-label Titration Period|Lost to Follow-up|25
7670336|NCT01358526|26679039|P3|Open-label Titration Period|Withdrawal by Subject|0
7670337|NCT01358526|26679040|P2|Open-label Titration Period|Withdrawal by Subject|0
7670338|NCT01358526|26679041|P1|Open-label Titration Period|Withdrawal by Subject|65
7670339|NCT01358526|26679039|P3|Open-label Titration Period|Adverse Event|0
7670340|NCT01358526|26679040|P2|Open-label Titration Period|Adverse Event|0
7670341|NCT01358526|26679041|P1|Open-label Titration Period|Adverse Event|95
7670342|NCT01358357|26679058|P3|Double-Blind Phase|Administrative|0
7670343|NCT01358357|26679059|P2|Double-Blind Phase|Administrative|1
7670344|NCT01358357|26679060|P1|Double-Blind Phase|Administrative|0
7670345|NCT01358357|26679058|P3|Double-Blind Phase|Recurrence of mood event|0
7670346|NCT01358357|26679059|P2|Double-Blind Phase|Recurrence of mood event|64
7670347|NCT01358357|26679060|P1|Double-Blind Phase|Recurrence of mood event|48
7670348|NCT01358357|26679058|P3|Double-Blind Phase|Terminated at study completion|0
7670349|NCT01358357|26679059|P2|Double-Blind Phase|Terminated at study completion|0
7670350|NCT01358357|26679060|P1|Double-Blind Phase|Terminated at study completion|2
7670351|NCT01358357|26679058|P3|Double-Blind Phase|Protocol Violation|0
7670352|NCT01358357|26679059|P2|Double-Blind Phase|Protocol Violation|12
7670353|NCT01358357|26679060|P1|Double-Blind Phase|Protocol Violation|16
7670354|NCT01358357|26679058|P3|Double-Blind Phase|Protocol Violation|0
7670355|NCT01358357|26679059|P2|Double-Blind Phase|Protocol Violation|11
7670356|NCT01358357|26679060|P1|Double-Blind Phase|Protocol Violation|1
7670357|NCT01358357|26679058|P3|Double-Blind Phase|Lost to Follow-up|0
7670358|NCT01358357|26679059|P2|Double-Blind Phase|Lost to Follow-up|7
7670359|NCT01358357|26679060|P1|Double-Blind Phase|Lost to Follow-up|5
7670360|NCT01358357|26679058|P3|Double-Blind Phase|Adverse Event|0
7670361|NCT01358357|26679059|P2|Double-Blind Phase|Adverse Event|5
7670362|NCT01358357|26679060|P1|Double-Blind Phase|Adverse Event|8
7670363|NCT01358357|26679058|P3|Open Label Phase|Mood episode|42
7670364|NCT01358357|26679059|P2|Open Label Phase|Mood episode|0
7670365|NCT01358357|26679060|P1|Open Label Phase|Mood episode|0
7670366|NCT01358357|26679058|P3|Open Label Phase|Terminated at study completion|5
7670367|NCT01358357|26679059|P2|Open Label Phase|Terminated at study completion|0
7670368|NCT01358357|26679060|P1|Open Label Phase|Terminated at study completion|0
7670369|NCT01358357|26679058|P3|Open Label Phase|Did not meet criteria for DB phase|16
7670370|NCT01358357|26679059|P2|Open Label Phase|Did not meet criteria for DB phase|0
7670371|NCT01358357|26679060|P1|Open Label Phase|Did not meet criteria for DB phase|0
7670372|NCT01358357|26679058|P3|Open Label Phase|Withdrawal by Subject|112
7670373|NCT01358357|26679059|P2|Open Label Phase|Withdrawal by Subject|0
7670374|NCT01358357|26679060|P1|Open Label Phase|Withdrawal by Subject|0
7670375|NCT01358357|26679058|P3|Open Label Phase|Protocol Violation|45
7670376|NCT01358357|26679059|P2|Open Label Phase|Protocol Violation|0
7670377|NCT01358357|26679060|P1|Open Label Phase|Protocol Violation|0
7670378|NCT01358357|26679058|P3|Open Label Phase|Lost to Follow-up|76
7670379|NCT01358357|26679059|P2|Open Label Phase|Lost to Follow-up|0
7670380|NCT01358357|26679060|P1|Open Label Phase|Lost to Follow-up|0
7670381|NCT01358357|26679058|P3|Open Label Phase|Lack of Efficacy|107
7670382|NCT01358357|26679059|P2|Open Label Phase|Lack of Efficacy|0
7670383|NCT01358357|26679060|P1|Open Label Phase|Lack of Efficacy|0
7670384|NCT01358357|26679058|P3|Open Label Phase|Adverse Event|59
7670385|NCT01358357|26679059|P2|Open Label Phase|Adverse Event|0
7670386|NCT01358357|26679060|P1|Open Label Phase|Adverse Event|0
7670387|NCT01358331|26679099|P6|Overall Study|Progress of disease under investigation|0
7670388|NCT01358331|26679100|P5|Overall Study|Progress of disease under investigation|3
7670389|NCT01358331|26679101|P4|Overall Study|Progress of disease under investigation|1
7670390|NCT01358331|26679102|P3|Overall Study|Progress of disease under investigation|3
7670391|NCT01358331|26679103|P2|Overall Study|Progress of disease under investigation|2
7670392|NCT01358331|26679104|P1|Overall Study|Progress of disease under investigation|1
7670393|NCT01358331|26679099|P6|Overall Study|Participants did not wish to continue|0
7670394|NCT01358331|26679100|P5|Overall Study|Participants did not wish to continue|1
7670395|NCT01358331|26679101|P4|Overall Study|Participants did not wish to continue|0
7670396|NCT01358331|26679102|P3|Overall Study|Participants did not wish to continue|0
7670397|NCT01358331|26679103|P2|Overall Study|Participants did not wish to continue|0
7670398|NCT01358331|26679104|P1|Overall Study|Participants did not wish to continue|0
7670399|NCT01358331|26679099|P6|Overall Study|Symptomatic Deterioration|0
7670400|NCT01358331|26679100|P5|Overall Study|Symptomatic Deterioration|1
7670401|NCT01358331|26679101|P4|Overall Study|Symptomatic Deterioration|0
7670402|NCT01358331|26679102|P3|Overall Study|Symptomatic Deterioration|0
7670403|NCT01358331|26679103|P2|Overall Study|Symptomatic Deterioration|0
7670404|NCT01358331|26679104|P1|Overall Study|Symptomatic Deterioration|0
7670405|NCT01358331|26679099|P6|Overall Study|Adverse Events|5
7670406|NCT01358331|26679100|P5|Overall Study|Adverse Events|1
7670407|NCT01358331|26679101|P4|Overall Study|Adverse Events|0
7670408|NCT01358331|26679102|P3|Overall Study|Adverse Events|1
7670409|NCT01358331|26679103|P2|Overall Study|Adverse Events|1
7670410|NCT01358331|26679104|P1|Overall Study|Adverse Events|1
7670411|NCT01358331|26679099|P6|Overall Study|Withdrawal by Subject|1
7670412|NCT01358331|26679100|P5|Overall Study|Withdrawal by Subject|1
7670413|NCT01358331|26679101|P4|Overall Study|Withdrawal by Subject|1
7670414|NCT01358331|26679102|P3|Overall Study|Withdrawal by Subject|0
7670415|NCT01358331|26679103|P2|Overall Study|Withdrawal by Subject|0
7670416|NCT01358331|26679104|P1|Overall Study|Withdrawal by Subject|0
7670417|NCT01358331|26679099|P6|Overall Study|Lost to Follow-up|0
7670418|NCT01358331|26679100|P5|Overall Study|Lost to Follow-up|0
7670419|NCT01358331|26679101|P4|Overall Study|Lost to Follow-up|1
7670420|NCT01358331|26679102|P3|Overall Study|Lost to Follow-up|0
7670421|NCT01358331|26679103|P2|Overall Study|Lost to Follow-up|0
7670422|NCT01358331|26679104|P1|Overall Study|Lost to Follow-up|0
7670423|NCT01358175|26679156|P3|Overall Study|Adverse Event|11
7670424|NCT01358175|26679157|P2|Overall Study|Adverse Event|11
7670425|NCT01358175|26679158|P1|Overall Study|Adverse Event|6
7670426|NCT01358175|26679156|P3|Overall Study|Lack of Efficacy|6
7670427|NCT01358175|26679157|P2|Overall Study|Lack of Efficacy|8
7670428|NCT01358175|26679158|P1|Overall Study|Lack of Efficacy|3
7670429|NCT01358175|26679156|P3|Overall Study|Lost to Follow-up|3
7670430|NCT01358175|26679157|P2|Overall Study|Lost to Follow-up|1
7670431|NCT01358175|26679158|P1|Overall Study|Lost to Follow-up|1
7670432|NCT01358175|26679156|P3|Overall Study|Non Compliance with Study Treatment|1
7670433|NCT01358175|26679157|P2|Overall Study|Non Compliance with Study Treatment|1
7670434|NCT01358175|26679158|P1|Overall Study|Non Compliance with Study Treatment|0
7670435|NCT01358175|26679156|P3|Overall Study|Physician Decision|0
7670436|NCT01358175|26679157|P2|Overall Study|Physician Decision|0
7670437|NCT01358175|26679158|P1|Overall Study|Physician Decision|1
7670438|NCT01358175|26679156|P3|Overall Study|Pregnancy|0
7670439|NCT01358175|26679157|P2|Overall Study|Pregnancy|1
7670440|NCT01358175|26679158|P1|Overall Study|Pregnancy|0
7670441|NCT01358175|26679156|P3|Overall Study|Technical issues|0
7670442|NCT01358175|26679157|P2|Overall Study|Technical issues|1
7670443|NCT01358175|26679158|P1|Overall Study|Technical issues|0
7670444|NCT01358175|26679156|P3|Overall Study|Withdrawal by Subject|10
7670445|NCT01358175|26679157|P2|Overall Study|Withdrawal by Subject|5
7670446|NCT01358175|26679158|P1|Overall Study|Withdrawal by Subject|9
7670447|NCT01358175|26679156|P3|Overall Study|Death|1
7670448|NCT01358175|26679157|P2|Overall Study|Death|0
7670449|NCT01358175|26679158|P1|Overall Study|Death|1
7670450|NCT01357980|26679195|P4|Overall Study|Consent withdrawn|0
7670451|NCT01357980|26679196|P3|Overall Study|Consent withdrawn|1
7670452|NCT01357980|26679197|P2|Overall Study|Consent withdrawn|0
7670453|NCT01357980|26679198|P1|Overall Study|Consent withdrawn|0
7670454|NCT01357980|26679195|P4|Overall Study|Lack of Efficacy|0
7670455|NCT01357980|26679196|P3|Overall Study|Lack of Efficacy|0
7670456|NCT01357980|26679197|P2|Overall Study|Lack of Efficacy|1
7670457|NCT01357980|26679198|P1|Overall Study|Lack of Efficacy|0
7670458|NCT01357915|26679242|P2|Overall Study|Lost to Follow-up|0
7670459|NCT01357915|26679243|P1|Overall Study|Lost to Follow-up|3
7670460|NCT01357889|26679261|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
7670461|NCT01357889|26679262|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
7670462|NCT01357889|26679261|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
7670463|NCT01357889|26679262|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
7670464|NCT01357889|26679261|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
7670465|NCT01357889|26679262|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
7670466|NCT01357889|26679261|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
7670467|NCT01357889|26679262|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
7670468|NCT01357889|26679261|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
7670469|NCT01357889|26679262|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
7670470|NCT01357889|26679261|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
7670471|NCT01357889|26679262|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
7670472|NCT01357889|26679261|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
7670473|NCT01357889|26679262|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
7670474|NCT01357889|26679261|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
7670475|NCT01357889|26679262|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
7670476|NCT01357889|26679261|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
7670477|NCT01357889|26679262|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
7670478|NCT01357889|26679261|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
7670479|NCT01357889|26679262|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
7670480|NCT01357889|26679261|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
7670481|NCT01357889|26679262|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
7670482|NCT01357889|26679261|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
7670483|NCT01357889|26679262|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
7670484|NCT01357889|26679261|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
7670485|NCT01357889|26679262|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
7670486|NCT01357850|26679306|P4|Overall Study|Lost to Follow-up|0
7670487|NCT01357850|26679307|P3|Overall Study|Lost to Follow-up|0
7670488|NCT01357850|26679308|P2|Overall Study|Lost to Follow-up|0
7670489|NCT01357850|26679309|P1|Overall Study|Lost to Follow-up|1
7670490|NCT01357655|26679400|P2|Overall Study|Subject Withdrew Consent|0
7670491|NCT01357655|26679401|P1|Overall Study|Subject Withdrew Consent|1
7670492|NCT01357655|26679400|P2|Overall Study|Study Drug Toxicity|0
7670493|NCT01357655|26679401|P1|Overall Study|Study Drug Toxicity|11
7670494|NCT01357655|26679400|P2|Overall Study|Reason Unspecified|0
7670495|NCT01357655|26679401|P1|Overall Study|Reason Unspecified|1
7670496|NCT01357655|26679400|P2|Overall Study|Maximum Clinical Benefit|0
7670497|NCT01357655|26679401|P1|Overall Study|Maximum Clinical Benefit|2
7670498|NCT01357655|26679400|P2|Overall Study|Lost to Follow-up|0
7670499|NCT01357655|26679401|P1|Overall Study|Lost to Follow-up|2
7670500|NCT01357655|26679400|P2|Overall Study|Disease Progression|0
7670501|NCT01357655|26679401|P1|Overall Study|Disease Progression|1
7670502|NCT01357655|26679400|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
7670503|NCT01357655|26679401|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
7670504|NCT01357655|26679400|P2|Overall Study|Administrative Reason by Sponsor|0
7670505|NCT01357655|26679401|P1|Overall Study|Administrative Reason by Sponsor|45
7670506|NCT01357616|26679418|P2|Overall Study|Withdrawal by Subject|0
7670507|NCT01357616|26679419|P1|Overall Study|Withdrawal by Subject|1
7670508|NCT01357616|26679418|P2|Overall Study|Decision Unrelated to Adverse Event|1
7670509|NCT01357616|26679419|P1|Overall Study|Decision Unrelated to Adverse Event|3
7670510|NCT01357616|26679418|P2|Overall Study|Inadequate Control of IOP|2
7670511|NCT01357616|26679419|P1|Overall Study|Inadequate Control of IOP|1
7670512|NCT01357616|26679418|P2|Overall Study|Protocol Violation|2
7670513|NCT01357616|26679419|P1|Overall Study|Protocol Violation|0
7670514|NCT01357616|26679418|P2|Overall Study|Lost to Follow-up|3
7670515|NCT01357616|26679419|P1|Overall Study|Lost to Follow-up|4
7670516|NCT01357616|26679418|P2|Overall Study|Adverse Event|1
7670517|NCT01357616|26679419|P1|Overall Study|Adverse Event|1
7670518|NCT01357577|26679433|P2|Overall Study|look at data in database?|2
7670519|NCT01357577|26679434|P1|Overall Study|look at data in database?|1
7670520|NCT01357577|26679433|P2|Overall Study|Withdrawal by Subject|8
7670521|NCT01357577|26679434|P1|Overall Study|Withdrawal by Subject|16
7670522|NCT01357577|26679433|P2|Overall Study|Lost to Follow-up|16
7670523|NCT01357577|26679434|P1|Overall Study|Lost to Follow-up|20
7670524|NCT01357551|26679461|P2|Overall Study|Lost to Follow-up|6
7670525|NCT01357551|26679462|P1|Overall Study|Lost to Follow-up|16
7670526|NCT01357551|26679461|P2|Overall Study|Death|1
7670527|NCT01357551|26679462|P1|Overall Study|Death|0
7670528|NCT01357551|26679461|P2|Overall Study|Withdrawal by Subject|4
7670529|NCT01357551|26679462|P1|Overall Study|Withdrawal by Subject|6
7670530|NCT01357239|26679510|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
7670531|NCT01357239|26679511|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
7670532|NCT01357239|26679512|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
7670533|NCT01357239|26679513|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
7670534|NCT01357239|26679510|P4|Stratum II: Partially-Methylated|Adverse Event|1
7670535|NCT01357239|26679511|P3|Stratum II: Partially-Methylated|Adverse Event|0
7670536|NCT01357239|26679512|P2|Stratum II: Partially-Methylated|Adverse Event|0
7670537|NCT01357239|26679513|P1|Stratum II: Partially-Methylated|Adverse Event|0
7670538|NCT01357239|26679510|P4|Stratum I: Fully-Methylated|Adverse Event|0
7670539|NCT01357239|26679511|P3|Stratum I: Fully-Methylated|Adverse Event|1
7670540|NCT01357239|26679512|P2|Stratum I: Fully-Methylated|Adverse Event|0
7670541|NCT01357239|26679513|P1|Stratum I: Fully-Methylated|Adverse Event|0
7670542|NCT01357239|26679510|P4|Stratum: All Patients|Subject withdrew consent|1
7670543|NCT01357239|26679511|P3|Stratum: All Patients|Subject withdrew consent|1
7670544|NCT01357239|26679512|P2|Stratum: All Patients|Subject withdrew consent|0
7670545|NCT01357239|26679513|P1|Stratum: All Patients|Subject withdrew consent|0
7670546|NCT01357239|26679510|P4|Stratum: All Patients|Adverse Event|1
7670547|NCT01357239|26679511|P3|Stratum: All Patients|Adverse Event|1
7670548|NCT01357239|26679512|P2|Stratum: All Patients|Adverse Event|0
7670549|NCT01357239|26679513|P1|Stratum: All Patients|Adverse Event|0
7670550|NCT01357161|26679571|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
7670551|NCT01357161|26679572|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
7670552|NCT01357161|26679573|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
7670553|NCT01357161|26679571|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
7670554|NCT01357161|26679572|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
7670555|NCT01357161|26679573|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
7670556|NCT01357161|26679571|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
7670557|NCT01357161|26679572|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
7670558|NCT01357161|26679573|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
7670559|NCT01357161|26679571|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
7670560|NCT01357161|26679572|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
7670561|NCT01357161|26679573|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
7670562|NCT01357161|26679571|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
7670563|NCT01357161|26679572|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
7670564|NCT01357161|26679573|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
7670565|NCT01357161|26679571|P3|Part 2 (Double-Blind Comparison)|Death|19
7670566|NCT01357161|26679572|P2|Part 2 (Double-Blind Comparison)|Death|22
7670567|NCT01357161|26679573|P1|Part 2 (Double-Blind Comparison)|Death|0
7670568|NCT01357161|26679571|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
7670569|NCT01357161|26679572|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
7670570|NCT01357161|26679573|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
7670571|NCT01357161|26679571|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
7670572|NCT01357161|26679572|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
7670573|NCT01357161|26679573|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
7670574|NCT01357161|26679571|P3|Part 1 (Open Label Run-in)|Physician Decision|0
7670575|NCT01357161|26679572|P2|Part 1 (Open Label Run-in)|Physician Decision|0
7670576|NCT01357161|26679573|P1|Part 1 (Open Label Run-in)|Physician Decision|1
7670577|NCT01357161|26679571|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
7670578|NCT01357161|26679572|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
7670579|NCT01357161|26679573|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
7670580|NCT01357161|26679571|P3|Part 1 (Open Label Run-in)|Death|0
7670581|NCT01357161|26679572|P2|Part 1 (Open Label Run-in)|Death|0
7670582|NCT01357161|26679573|P1|Part 1 (Open Label Run-in)|Death|5
7670583|NCT01356966|26679625|P2|Overall Study|Physician Decision|0
7670584|NCT01356966|26679626|P1|Overall Study|Physician Decision|1
7670585|NCT01356966|26679625|P2|Overall Study|Withdrawal by Subject|2
7670586|NCT01356966|26679626|P1|Overall Study|Withdrawal by Subject|1
7670587|NCT01356940|26679638|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
7670588|NCT01356940|26679639|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
7670589|NCT01356940|26679638|P2|First Intervention (28 Days)|Adverse Event|0
7670590|NCT01356940|26679639|P1|First Intervention (28 Days)|Adverse Event|1
7670591|NCT01356602|26679668|P3|Overall Study|Adverse Event|1
7670592|NCT01356602|26679669|P2|Overall Study|Adverse Event|1
7670593|NCT01356602|26679670|P1|Overall Study|Adverse Event|0
7670594|NCT01356602|26679668|P3|Overall Study|Lack of Efficacy|4
7670595|NCT01356602|26679669|P2|Overall Study|Lack of Efficacy|1
7670596|NCT01356602|26679670|P1|Overall Study|Lack of Efficacy|0
7670597|NCT01356602|26679668|P3|Overall Study|Withdrawal by Subject|7
7670598|NCT01356602|26679669|P2|Overall Study|Withdrawal by Subject|3
7670599|NCT01356602|26679670|P1|Overall Study|Withdrawal by Subject|4
7670600|NCT01356602|26679668|P3|Overall Study|Lost to Follow-up|6
7670601|NCT01356602|26679669|P2|Overall Study|Lost to Follow-up|5
7670602|NCT01356602|26679670|P1|Overall Study|Lost to Follow-up|4
7670603|NCT01356602|26679668|P3|Overall Study|Administrative Problems|5
7670604|NCT01356602|26679669|P2|Overall Study|Administrative Problems|4
7670605|NCT01356602|26679670|P1|Overall Study|Administrative Problems|1
7670606|NCT01356602|26679668|P3|Overall Study|Protocol Deviation|1
7670607|NCT01356602|26679669|P2|Overall Study|Protocol Deviation|1
7670608|NCT01356602|26679670|P1|Overall Study|Protocol Deviation|0
7670609|NCT01356589|26679729|P1|Overall Study|Dose data not recorded|2
7670610|NCT01356589|26679729|P1|Overall Study|Enrolled, but not treated|3
7670611|NCT01356407|26679786|P2|Overall Study|Not complete Endoscopy|2
7670612|NCT01356407|26679787|P1|Overall Study|Not complete Endoscopy|2
7670613|NCT01356407|26679786|P2|Overall Study|Could not afford IMP administration|1
7670614|NCT01356407|26679787|P1|Overall Study|Could not afford IMP administration|0
7670615|NCT01356407|26679786|P2|Overall Study|Patient Withdrew Consent|1
7670616|NCT01356407|26679787|P1|Overall Study|Patient Withdrew Consent|2
7670617|NCT01356407|26679786|P2|Overall Study|Lost to Follow-up|0
7670618|NCT01356407|26679787|P1|Overall Study|Lost to Follow-up|2
7670619|NCT01355679|26679859|P1|Overall Study|benign tumor types found at biopsy|2
7670620|NCT01355627|26679868|P2|Overall Study|Other|1
7670621|NCT01355627|26679869|P1|Overall Study|Other|1
7670622|NCT01355627|26679868|P2|Overall Study|Fatal Adverse Event|23
7670623|NCT01355627|26679869|P1|Overall Study|Fatal Adverse Event|19
7670624|NCT01355627|26679868|P2|Overall Study|Lost to Follow-up|7
7670625|NCT01355627|26679869|P1|Overall Study|Lost to Follow-up|8
7670626|NCT01355627|26679868|P2|Overall Study|Request By the Patient to Discontinue|7
7670627|NCT01355627|26679869|P1|Overall Study|Request By the Patient to Discontinue|5
7670628|NCT01355575|26679906|P1|Overall Study|Withdrawal by Subject|2
7670629|NCT01355523|26679918|P2|Overall Study|Adverse Event|2
7670630|NCT01355523|26679919|P1|Overall Study|Adverse Event|0
7670631|NCT01355523|26679918|P2|Overall Study|Protocol Violation|2
7670632|NCT01355523|26679919|P1|Overall Study|Protocol Violation|0
7670633|NCT01355523|26679918|P2|Overall Study|Lost to Follow-up|2
7670634|NCT01355523|26679919|P1|Overall Study|Lost to Follow-up|0
7670635|NCT01355523|26679918|P2|Overall Study|Withdrawal by Subject|4
7670636|NCT01355523|26679919|P1|Overall Study|Withdrawal by Subject|1
7670637|NCT01355497|26679963|P2|Overall Study|Adverse Event|10
7670638|NCT01355497|26679964|P1|Overall Study|Adverse Event|11
7670639|NCT01355497|26679963|P2|Overall Study|progressive disease|8
7670640|NCT01355497|26679964|P1|Overall Study|progressive disease|11
7670641|NCT01355497|26679963|P2|Overall Study|noncompliance|2
7670642|NCT01355497|26679964|P1|Overall Study|noncompliance|1
7670643|NCT01355497|26679963|P2|Overall Study|Withdrawal by Subject|20
7670644|NCT01355497|26679964|P1|Overall Study|Withdrawal by Subject|12
7670645|NCT01355497|26679963|P2|Overall Study|other-not provided|4
7670646|NCT01355497|26679964|P1|Overall Study|other-not provided|9
7670647|NCT01355497|26679963|P2|Overall Study|Protocol Violation|1
7670648|NCT01355497|26679964|P1|Overall Study|Protocol Violation|0
7670649|NCT01355497|26679963|P2|Overall Study|Lost to Follow-up|0
7670650|NCT01355497|26679964|P1|Overall Study|Lost to Follow-up|3
7670651|NCT01355497|26679963|P2|Overall Study|Death|18
7670652|NCT01355497|26679964|P1|Overall Study|Death|19
7670653|NCT01355302|26680006|P3|Phase 1b|Study terminated by sponsor|0
7670654|NCT01355302|26680007|P2|Phase 1b|Study terminated by sponsor|0
7670655|NCT01355302|26680008|P1|Phase 1b|Study terminated by sponsor|2
7670656|NCT01355302|26680006|P3|Phase 1b|Death|0
7670657|NCT01355302|26680007|P2|Phase 1b|Death|0
7670658|NCT01355302|26680008|P1|Phase 1b|Death|4
7670659|NCT01355289|26680023|P5|Open Label Extension|Other|3
7670660|NCT01355289|26680024|P4|Open Label Extension|Other|0
7670661|NCT01355289|26680025|P3|Open Label Extension|Other|0
7670662|NCT01355289|26680026|P2|Open Label Extension|Other|0
7670663|NCT01355289|26680027|P1|Open Label Extension|Other|0
7670664|NCT01355289|26680023|P5|Open Label Extension|Inadequate Therapeutic Effect|29
7670665|NCT01355289|26680024|P4|Open Label Extension|Inadequate Therapeutic Effect|0
7670666|NCT01355289|26680025|P3|Open Label Extension|Inadequate Therapeutic Effect|0
7670667|NCT01355289|26680026|P2|Open Label Extension|Inadequate Therapeutic Effect|0
7670668|NCT01355289|26680027|P1|Open Label Extension|Inadequate Therapeutic Effect|0
7670669|NCT01355289|26680023|P5|Open Label Extension|Lost to Follow-up|1
7670670|NCT01355289|26680024|P4|Open Label Extension|Lost to Follow-up|0
7670671|NCT01355289|26680025|P3|Open Label Extension|Lost to Follow-up|0
7670672|NCT01355289|26680026|P2|Open Label Extension|Lost to Follow-up|0
7670673|NCT01355289|26680027|P1|Open Label Extension|Lost to Follow-up|0
7670674|NCT01355289|26680023|P5|Open Label Extension|Adverse Event, Non-Fatal|1
7670675|NCT01355289|26680024|P4|Open Label Extension|Adverse Event, Non-Fatal|0
7670676|NCT01355289|26680025|P3|Open Label Extension|Adverse Event, Non-Fatal|0
7670677|NCT01355289|26680026|P2|Open Label Extension|Adverse Event, Non-Fatal|0
7670678|NCT01355289|26680027|P1|Open Label Extension|Adverse Event, Non-Fatal|0
7670679|NCT01355289|26680023|P5|Core Study|Other|0
7670680|NCT01355289|26680024|P4|Core Study|Other|1
7670681|NCT01355289|26680025|P3|Core Study|Other|0
7670682|NCT01355289|26680026|P2|Core Study|Other|0
7670683|NCT01355289|26680027|P1|Core Study|Other|0
7670684|NCT01355289|26680023|P5|Core Study|Inadequate Therapeutic Effect|0
7670685|NCT01355289|26680024|P4|Core Study|Inadequate Therapeutic Effect|1
7670686|NCT01355289|26680025|P3|Core Study|Inadequate Therapeutic Effect|0
7670687|NCT01355289|26680026|P2|Core Study|Inadequate Therapeutic Effect|0
7670688|NCT01355289|26680027|P1|Core Study|Inadequate Therapeutic Effect|0
7670689|NCT01355289|26680023|P5|Core Study|Adverse Event, Non-Fatal|0
7670690|NCT01355289|26680024|P4|Core Study|Adverse Event, Non-Fatal|0
7670691|NCT01355289|26680025|P3|Core Study|Adverse Event, Non-Fatal|0
7670692|NCT01355289|26680026|P2|Core Study|Adverse Event, Non-Fatal|0
7670693|NCT01355289|26680027|P1|Core Study|Adverse Event, Non-Fatal|1
7670694|NCT01355159|26680079|P2|Overall Study|Early intrauterine fetal death|6
7670695|NCT01355159|26680080|P1|Overall Study|Early intrauterine fetal death|6
7670696|NCT01355159|26680079|P2|Overall Study|Spontaneous abortion (<20 weeks)|15
7670697|NCT01355159|26680080|P1|Overall Study|Spontaneous abortion (<20 weeks)|22
7670698|NCT01355159|26680079|P2|Overall Study|No primary outcome data|11
7670699|NCT01355159|26680080|P1|Overall Study|No primary outcome data|17
7670700|NCT01355159|26680079|P2|Overall Study|Withdrew consent|47
7670701|NCT01355159|26680080|P1|Overall Study|Withdrew consent|39
7670702|NCT01355081|26680137|P3|Overall Study|Non Compliance with Study Medication|0
7670703|NCT01355081|26680138|P2|Overall Study|Non Compliance with Study Medication|1
7670704|NCT01355081|26680139|P1|Overall Study|Non Compliance with Study Medication|0
7670705|NCT01355081|26680137|P3|Overall Study|Lack of Efficacy|1
7670706|NCT01355081|26680138|P2|Overall Study|Lack of Efficacy|1
7670707|NCT01355081|26680139|P1|Overall Study|Lack of Efficacy|2
7670708|NCT01355081|26680137|P3|Overall Study|Withdrawal of Consent|3
7670709|NCT01355081|26680138|P2|Overall Study|Withdrawal of Consent|3
7670710|NCT01355081|26680139|P1|Overall Study|Withdrawal of Consent|2
7670711|NCT01355081|26680137|P3|Overall Study|Lost to Follow-up|1
7670712|NCT01355081|26680138|P2|Overall Study|Lost to Follow-up|0
7670713|NCT01355081|26680139|P1|Overall Study|Lost to Follow-up|0
7670714|NCT01355081|26680137|P3|Overall Study|Major Protocol Deviation|0
7670715|NCT01355081|26680138|P2|Overall Study|Major Protocol Deviation|1
7670716|NCT01355081|26680139|P1|Overall Study|Major Protocol Deviation|0
7670717|NCT01355081|26680137|P3|Overall Study|Pretreatment Event or Adverse Event|6
7670718|NCT01355081|26680138|P2|Overall Study|Pretreatment Event or Adverse Event|4
7670719|NCT01355081|26680139|P1|Overall Study|Pretreatment Event or Adverse Event|3
7670720|NCT01355068|26680162|P2|First Intervention Period|Withdrawal by Subject|1
7670721|NCT01355068|26680163|P1|First Intervention Period|Withdrawal by Subject|0
7670722|NCT01355068|26680162|P2|First Intervention Period|Adverse Event|1
7670723|NCT01355068|26680163|P1|First Intervention Period|Adverse Event|0
7670724|NCT01354964|26680188|P2|Overall Study|Physician Decision|0
7670725|NCT01354964|26680189|P1|Overall Study|Physician Decision|1
7670726|NCT01354964|26680188|P2|Overall Study|IV access issues|1
7670727|NCT01354964|26680189|P1|Overall Study|IV access issues|1
7670728|NCT01354964|26680188|P2|Overall Study|Lost to Follow-up|0
7670729|NCT01354964|26680189|P1|Overall Study|Lost to Follow-up|2
7670730|NCT01354938|26680212|P1|Overall Study|Lost to Follow-up|1
7670731|NCT01354899|26680218|P1|Overall Study|Protocol Violation|1
7670732|NCT01354899|26680218|P1|Overall Study|discharge from the hospital|2
7670733|NCT01354496|26680270|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
7670734|NCT01354496|26680271|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
7670735|NCT01354496|26680272|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
7670736|NCT01354496|26680273|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
7670737|NCT01354496|26680274|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
7670738|NCT01354496|26680275|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
7670739|NCT01354496|26680270|P6|Period 2|Adverse Event|0
7670740|NCT01354496|26680271|P5|Period 2|Adverse Event|0
7670741|NCT01354496|26680272|P4|Period 2|Adverse Event|1
7670742|NCT01354496|26680273|P3|Period 2|Adverse Event|0
7670743|NCT01354496|26680274|P2|Period 2|Adverse Event|0
7670744|NCT01354496|26680275|P1|Period 2|Adverse Event|0
7670745|NCT01354496|26680270|P6|Period 1|Physician Decision|0
7670746|NCT01354496|26680271|P5|Period 1|Physician Decision|0
7670747|NCT01354496|26680272|P4|Period 1|Physician Decision|0
7670748|NCT01354496|26680273|P3|Period 1|Physician Decision|1
7670749|NCT01354496|26680274|P2|Period 1|Physician Decision|0
7670750|NCT01354496|26680275|P1|Period 1|Physician Decision|0
7670751|NCT01354496|26680270|P6|Period 1|Adverse Event|0
7670752|NCT01354496|26680271|P5|Period 1|Adverse Event|0
7670753|NCT01354496|26680272|P4|Period 1|Adverse Event|0
7670754|NCT01354496|26680273|P3|Period 1|Adverse Event|1
7670755|NCT01354496|26680274|P2|Period 1|Adverse Event|0
7670756|NCT01354496|26680275|P1|Period 1|Adverse Event|0
7670757|NCT01354431|26680318|P3|Participants Treated|Withdrawal by Subject|1
7670758|NCT01354431|26680319|P2|Participants Treated|Withdrawal by Subject|2
7670759|NCT01354431|26680320|P1|Participants Treated|Withdrawal by Subject|1
7670760|NCT01354431|26680318|P3|Participants Treated|Adverse Event|4
7670761|NCT01354431|26680319|P2|Participants Treated|Adverse Event|2
7670762|NCT01354431|26680320|P1|Participants Treated|Adverse Event|1
7670763|NCT01354431|26680318|P3|Participants Treated|Death|0
7670764|NCT01354431|26680319|P2|Participants Treated|Death|1
7670765|NCT01354431|26680320|P1|Participants Treated|Death|0
7670766|NCT01354431|26680318|P3|Participants Treated|Study Drug Toxicity|4
7670767|NCT01354431|26680319|P2|Participants Treated|Study Drug Toxicity|7
7670768|NCT01354431|26680320|P1|Participants Treated|Study Drug Toxicity|2
7670769|NCT01354431|26680318|P3|Participants Treated|Disease Progression|41
7670770|NCT01354431|26680319|P2|Participants Treated|Disease Progression|40
7670771|NCT01354431|26680320|P1|Participants Treated|Disease Progression|49
7670772|NCT01354431|26680318|P3|Participants Treated|Continuing Treatment|4
7670773|NCT01354431|26680319|P2|Participants Treated|Continuing Treatment|2
7670774|NCT01354431|26680320|P1|Participants Treated|Continuing Treatment|6
7670775|NCT01354431|26680318|P3|Randomized to Enter Treatment Period|No longer met criteria|0
7670776|NCT01354431|26680319|P2|Randomized to Enter Treatment Period|No longer met criteria|0
7670777|NCT01354431|26680320|P1|Randomized to Enter Treatment Period|No longer met criteria|1
7670778|NCT01354353|26680346|P6|Overall Study|Withdrawal by Subject|1
7670779|NCT01354353|26680347|P5|Overall Study|Withdrawal by Subject|0
7670780|NCT01354353|26680348|P4|Overall Study|Withdrawal by Subject|0
7670781|NCT01354353|26680349|P3|Overall Study|Withdrawal by Subject|1
7670782|NCT01354353|26680350|P2|Overall Study|Withdrawal by Subject|0
7670783|NCT01354353|26680351|P1|Overall Study|Withdrawal by Subject|2
7670784|NCT01354353|26680346|P6|Overall Study|Physician Decision|0
7670785|NCT01354353|26680347|P5|Overall Study|Physician Decision|0
7670786|NCT01354353|26680348|P4|Overall Study|Physician Decision|0
7670787|NCT01354353|26680349|P3|Overall Study|Physician Decision|1
7670788|NCT01354353|26680350|P2|Overall Study|Physician Decision|1
7670789|NCT01354353|26680351|P1|Overall Study|Physician Decision|0
7670790|NCT01354353|26680346|P6|Overall Study|Entry Criteria Not Met|0
7670791|NCT01354353|26680347|P5|Overall Study|Entry Criteria Not Met|1
7670792|NCT01354353|26680348|P4|Overall Study|Entry Criteria Not Met|1
7670793|NCT01354353|26680349|P3|Overall Study|Entry Criteria Not Met|0
7670794|NCT01354353|26680350|P2|Overall Study|Entry Criteria Not Met|0
7670795|NCT01354353|26680351|P1|Overall Study|Entry Criteria Not Met|0
7670796|NCT01354353|26680346|P6|Overall Study|Adverse Event|5
7670797|NCT01354353|26680347|P5|Overall Study|Adverse Event|0
7670798|NCT01354353|26680348|P4|Overall Study|Adverse Event|4
7670799|NCT01354353|26680349|P3|Overall Study|Adverse Event|0
7670800|NCT01354353|26680350|P2|Overall Study|Adverse Event|0
7670801|NCT01354353|26680351|P1|Overall Study|Adverse Event|1
7670802|NCT01354314|26680419|P4|Overall Study|Less than 90% Adherence|4
7670803|NCT01354314|26680420|P3|Overall Study|Less than 90% Adherence|6
7670804|NCT01354314|26680421|P2|Overall Study|Less than 90% Adherence|2
7670805|NCT01354314|26680422|P1|Overall Study|Less than 90% Adherence|4
7670806|NCT01354314|26680419|P4|Overall Study|Protocol Violation|0
7670807|NCT01354314|26680420|P3|Overall Study|Protocol Violation|0
7670808|NCT01354314|26680421|P2|Overall Study|Protocol Violation|1
7670809|NCT01354314|26680422|P1|Overall Study|Protocol Violation|1
7670810|NCT01354314|26680419|P4|Overall Study|Adverse Event|1
7670811|NCT01354314|26680420|P3|Overall Study|Adverse Event|0
7670812|NCT01354314|26680421|P2|Overall Study|Adverse Event|0
7670813|NCT01354314|26680422|P1|Overall Study|Adverse Event|0
7670814|NCT01354314|26680419|P4|Overall Study|Withdrawal by Subject|0
7670815|NCT01354314|26680420|P3|Overall Study|Withdrawal by Subject|1
7670816|NCT01354314|26680421|P2|Overall Study|Withdrawal by Subject|0
7670817|NCT01354314|26680422|P1|Overall Study|Withdrawal by Subject|0
7670818|NCT01354314|26680419|P4|Overall Study|Lost to Follow-up|1
7670819|NCT01354314|26680420|P3|Overall Study|Lost to Follow-up|1
7670820|NCT01354314|26680421|P2|Overall Study|Lost to Follow-up|0
7670821|NCT01354314|26680422|P1|Overall Study|Lost to Follow-up|1
7670822|NCT01354223|26680558|P2|Overall Study|Withdrawal by Subject|1
7670823|NCT01354223|26680559|P1|Overall Study|Withdrawal by Subject|3
7670824|NCT01354132|26680618|P2|1 Month Post Study Medication|Withdrawal by Subject|3
7670825|NCT01354132|26680619|P1|1 Month Post Study Medication|Withdrawal by Subject|1
7670826|NCT01354132|26680618|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
7670827|NCT01354132|26680619|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
7670828|NCT01354132|26680618|P2|Double Blind (Visits 1-7)|Adverse Event|0
7670829|NCT01354132|26680619|P1|Double Blind (Visits 1-7)|Adverse Event|1
7670830|NCT01354132|26680618|P2|Randomization|Withdrawal by Subject|1
7670831|NCT01354132|26680619|P1|Randomization|Withdrawal by Subject|0
7670832|NCT01354132|26680618|P2|Randomization|Physician Decision|0
7670833|NCT01354132|26680619|P1|Randomization|Physician Decision|1
7670834|NCT01354106|26680657|P1|Overall Study|Withdrawal by Subject|2
7670835|NCT01354028|26680663|P2|Overall Study|No quiet alert state|1
7670836|NCT01354028|26680664|P1|Overall Study|No quiet alert state|0
7670837|NCT01354028|26680663|P2|Overall Study|Discharged before study start|2
7670838|NCT01354028|26680664|P1|Overall Study|Discharged before study start|2
7670839|NCT01354028|26680663|P2|Overall Study|Physician Decision|2
7670840|NCT01354028|26680664|P1|Overall Study|Physician Decision|0
7670841|NCT01353963|26680700|P1|Overall Study|Adverse Event|2
7670842|NCT01353911|26680718|P8|Overall Study|Status Not Recorded|0
7670843|NCT01353911|26680719|P7|Overall Study|Status Not Recorded|0
7670844|NCT01353911|26680720|P6|Overall Study|Status Not Recorded|0
7670845|NCT01353911|26680721|P5|Overall Study|Status Not Recorded|0
7670846|NCT01353911|26680722|P4|Overall Study|Status Not Recorded|0
7670847|NCT01353911|26680723|P3|Overall Study|Status Not Recorded|1
7670848|NCT01353911|26680724|P2|Overall Study|Status Not Recorded|0
7670849|NCT01353911|26680725|P1|Overall Study|Status Not Recorded|4
7670850|NCT01353911|26680718|P8|Overall Study|Withdrawal by Subject|9
7670851|NCT01353911|26680719|P7|Overall Study|Withdrawal by Subject|3
7670852|NCT01353911|26680720|P6|Overall Study|Withdrawal by Subject|3
7670853|NCT01353911|26680721|P5|Overall Study|Withdrawal by Subject|2
7670854|NCT01353911|26680722|P4|Overall Study|Withdrawal by Subject|2
7670855|NCT01353911|26680723|P3|Overall Study|Withdrawal by Subject|4
7670856|NCT01353911|26680724|P2|Overall Study|Withdrawal by Subject|3
7670857|NCT01353911|26680725|P1|Overall Study|Withdrawal by Subject|2
7670858|NCT01353911|26680718|P8|Overall Study|Lost to Follow-up|6
7670859|NCT01353911|26680719|P7|Overall Study|Lost to Follow-up|3
7670860|NCT01353911|26680720|P6|Overall Study|Lost to Follow-up|4
7670861|NCT01353911|26680721|P5|Overall Study|Lost to Follow-up|4
7670862|NCT01353911|26680722|P4|Overall Study|Lost to Follow-up|0
7670863|NCT01353911|26680723|P3|Overall Study|Lost to Follow-up|4
7670864|NCT01353911|26680724|P2|Overall Study|Lost to Follow-up|6
7670865|NCT01353911|26680725|P1|Overall Study|Lost to Follow-up|2
7670866|NCT01353898|26680805|P6|Overall Study|Study site terminated|1
7670867|NCT01353898|26680806|P5|Overall Study|Study site terminated|0
7670868|NCT01353898|26680807|P4|Overall Study|Study site terminated|0
7670869|NCT01353898|26680808|P3|Overall Study|Study site terminated|0
7670870|NCT01353898|26680809|P2|Overall Study|Study site terminated|0
7670871|NCT01353898|26680810|P1|Overall Study|Study site terminated|0
7670872|NCT01353859|26680836|P1|Overall Study|Lack of Efficacy|1
7670873|NCT01353859|26680836|P1|Overall Study|Adverse Event|3
7670874|NCT01353703|26680851|P2|Overall Study|Migrated/moved from study area|0
7670875|NCT01353703|26680852|P1|Overall Study|Migrated/moved from study area|1
7670876|NCT01353664|26680898|P1|Overall Study|Disease Progression|16
7670877|NCT01353664|26680898|P1|Overall Study|Other|3
7670878|NCT01353586|26680904|P2|Overall Study|Neurological exam not done|1
7670879|NCT01353586|26680905|P1|Overall Study|Neurological exam not done|0
7670880|NCT01353586|26680904|P2|Overall Study|Never had insertion of study catheter|1
7670881|NCT01353586|26680905|P1|Overall Study|Never had insertion of study catheter|4
7670882|NCT01353586|26680904|P2|Overall Study|Procedure terminated prior to ablation|0
7670883|NCT01353586|26680905|P1|Overall Study|Procedure terminated prior to ablation|3
7670884|NCT01353508|26680923|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7670885|NCT01353508|26680924|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7670886|NCT01353508|26680925|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7670887|NCT01353508|26680926|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
7670888|NCT01353508|26680923|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
7670889|NCT01353508|26680924|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
7670890|NCT01353508|26680925|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
7670891|NCT01353508|26680926|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
7670892|NCT01353274|26681013|P1|Overall Study|No case report form (CRF) collected|28
7670893|NCT01353222|26681023|P2|Overall Study|Site closed research department|0
7670894|NCT01353222|26681024|P1|Overall Study|Site closed research department|1
7670895|NCT01353222|26681023|P2|Overall Study|Study Terminated|37
7670896|NCT01353222|26681024|P1|Overall Study|Study Terminated|31
7670897|NCT01353222|26681023|P2|Overall Study|Withdrawal by Subject|5
7670898|NCT01353222|26681024|P1|Overall Study|Withdrawal by Subject|8
7670899|NCT01353222|26681023|P2|Overall Study|Death|30
7670900|NCT01353222|26681024|P1|Overall Study|Death|30
7670901|NCT01352845|26681067|P2|Overall Study|Death|0
7670902|NCT01352845|26681068|P1|Overall Study|Death|3
7670903|NCT01352845|26681067|P2|Overall Study|Protocol Violation|6
7670904|NCT01352845|26681068|P1|Overall Study|Protocol Violation|12
7670905|NCT01352845|26681067|P2|Overall Study|Other|7
7670906|NCT01352845|26681068|P1|Overall Study|Other|17
7670907|NCT01352845|26681067|P2|Overall Study|Adverse Event|6
7670908|NCT01352845|26681068|P1|Overall Study|Adverse Event|22
7670909|NCT01352845|26681067|P2|Overall Study|Pregnancy|7
7670910|NCT01352845|26681068|P1|Overall Study|Pregnancy|27
7670911|NCT01352845|26681067|P2|Overall Study|No Longer Meets Eligibility Criteria|11
7670912|NCT01352845|26681068|P1|Overall Study|No Longer Meets Eligibility Criteria|24
7670913|NCT01352845|26681067|P2|Overall Study|Withdrawal by Subject|16
7670914|NCT01352845|26681068|P1|Overall Study|Withdrawal by Subject|48
7670915|NCT01352845|26681067|P2|Overall Study|No Longer Willing to Participate|58
7670916|NCT01352845|26681068|P1|Overall Study|No Longer Willing to Participate|205
7670917|NCT01352845|26681067|P2|Overall Study|Lost to Follow-up|92
7670918|NCT01352845|26681068|P1|Overall Study|Lost to Follow-up|313
7670919|NCT01352793|26681157|P2|Overall Study|No longer meets eligibility criteria|15
7670920|NCT01352793|26681158|P1|Overall Study|No longer meets eligibility criteria|25
7670921|NCT01352793|26681157|P2|Overall Study|Randomized but not vaccinated|0
7670922|NCT01352793|26681158|P1|Overall Study|Randomized but not vaccinated|8
7670923|NCT01352793|26681157|P2|Overall Study|Death|0
7670924|NCT01352793|26681158|P1|Overall Study|Death|1
7670925|NCT01352793|26681157|P2|Overall Study|Medication error|2
7670926|NCT01352793|26681158|P1|Overall Study|Medication error|2
7670927|NCT01352793|26681157|P2|Overall Study|Other|7
7670928|NCT01352793|26681158|P1|Overall Study|Other|25
7670929|NCT01352793|26681157|P2|Overall Study|Pregnancy|8
7670930|NCT01352793|26681158|P1|Overall Study|Pregnancy|26
7670931|NCT01352793|26681157|P2|Overall Study|Physician Decision|0
7670932|NCT01352793|26681158|P1|Overall Study|Physician Decision|1
7670933|NCT01352793|26681157|P2|Overall Study|Adverse Event|10
7670934|NCT01352793|26681158|P1|Overall Study|Adverse Event|44
7670935|NCT01352793|26681157|P2|Overall Study|Protocol Violation|23
7670936|NCT01352793|26681158|P1|Overall Study|Protocol Violation|44
7670937|NCT01352793|26681157|P2|Overall Study|Withdrawal by Subject|55
7670938|NCT01352793|26681158|P1|Overall Study|Withdrawal by Subject|120
7670939|NCT01352793|26681157|P2|Overall Study|Lost to Follow-up|125
7670940|NCT01352793|26681158|P1|Overall Study|Lost to Follow-up|289
7670941|NCT01352741|26681182|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
7670942|NCT01352741|26681183|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
7670943|NCT01352741|26681182|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
7670944|NCT01352741|26681183|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
7670945|NCT01352741|26681182|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
7670946|NCT01352741|26681183|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
7670947|NCT01352741|26681182|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
7670948|NCT01352741|26681183|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
7670949|NCT01352741|26681182|P2|Double-blind Comparative Period|Other|2
7670950|NCT01352741|26681183|P1|Double-blind Comparative Period|Other|1
7670951|NCT01352741|26681182|P2|Double-blind Comparative Period|Withdrawal of consent|3
7670952|NCT01352741|26681183|P1|Double-blind Comparative Period|Withdrawal of consent|8
7670953|NCT01352741|26681182|P2|Double-blind Comparative Period|Death|1
7670954|NCT01352741|26681183|P1|Double-blind Comparative Period|Death|0
7670955|NCT01352741|26681182|P2|Double-blind Comparative Period|Lost to Follow-up|0
7670956|NCT01352741|26681183|P1|Double-blind Comparative Period|Lost to Follow-up|1
7670957|NCT01352741|26681182|P2|Double-blind Comparative Period|Adverse Event|17
7670958|NCT01352741|26681183|P1|Double-blind Comparative Period|Adverse Event|16
7670959|NCT01352741|26681182|P2|Double-blind Comparative Period|Lack of Efficacy|3
7670960|NCT01352741|26681183|P1|Double-blind Comparative Period|Lack of Efficacy|0
7670961|NCT01352741|26681182|P2|Double-blind Comparative Period|Protocol Violation|0
7670962|NCT01352741|26681183|P1|Double-blind Comparative Period|Protocol Violation|2
7670963|NCT01352741|26681182|P2|Open-label Tapentadol Titration Period|Other|0
7670964|NCT01352741|26681183|P1|Open-label Tapentadol Titration Period|Other|4
7670965|NCT01352741|26681182|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
7670966|NCT01352741|26681183|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
7670967|NCT01352741|26681182|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
7670968|NCT01352741|26681183|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
7670969|NCT01352741|26681182|P2|Open-label Tapentadol Titration Period|Adverse Event|0
7670970|NCT01352741|26681183|P1|Open-label Tapentadol Titration Period|Adverse Event|34
7670971|NCT01352741|26681182|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
7670972|NCT01352741|26681183|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
7670973|NCT01352741|26681182|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
7670974|NCT01352741|26681183|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
7670975|NCT01352715|26681277|P2|Overall Study|major ineligibility|1
7670976|NCT01352715|26681278|P1|Overall Study|major ineligibility|2
7670977|NCT01352715|26681277|P2|Overall Study|no final visit in closeout period|12
7670978|NCT01352715|26681278|P1|Overall Study|no final visit in closeout period|15
7670979|NCT01352715|26681277|P2|Overall Study|site closure|15
7670980|NCT01352715|26681278|P1|Overall Study|site closure|16
7670981|NCT01352715|26681277|P2|Overall Study|Withdrawal by Subject|8
7670982|NCT01352715|26681278|P1|Overall Study|Withdrawal by Subject|4
7670983|NCT01352715|26681277|P2|Overall Study|Lost to Follow-up|7
7670984|NCT01352715|26681278|P1|Overall Study|Lost to Follow-up|5
7670985|NCT01352715|26681277|P2|Overall Study|Death|3
7670986|NCT01352715|26681278|P1|Overall Study|Death|3
7670987|NCT01352585|26681324|P2|Overall Study|Other|2
7670988|NCT01352585|26681325|P1|Overall Study|Other|5
7670989|NCT01352585|26681324|P2|Overall Study|Lost to Follow-up|0
7670990|NCT01352585|26681325|P1|Overall Study|Lost to Follow-up|1
7670991|NCT01352585|26681324|P2|Overall Study|Adverse Event|1
7670992|NCT01352585|26681325|P1|Overall Study|Adverse Event|2
7670993|NCT01352507|26681353|P2|Treatment Period 2|Lack of Efficacy|0
7670994|NCT01352507|26681354|P1|Treatment Period 2|Lack of Efficacy|1
7670995|NCT01352507|26681353|P2|Treatment Period 2|Withdrawal by Subject|3
7670996|NCT01352507|26681354|P1|Treatment Period 2|Withdrawal by Subject|4
7670997|NCT01352507|26681353|P2|Treatment Period 2|Entry Criteria Not Met|0
7670998|NCT01352507|26681354|P1|Treatment Period 2|Entry Criteria Not Met|1
7670999|NCT01352507|26681353|P2|Washout Period|Withdrawal by Subject|1
7671000|NCT01352507|26681354|P1|Washout Period|Withdrawal by Subject|0
7671001|NCT01352507|26681353|P2|Treatment Period 1|Physician Decision|0
7671002|NCT01352507|26681354|P1|Treatment Period 1|Physician Decision|1
7671003|NCT01352507|26681353|P2|Treatment Period 1|Withdrawal by Subject|5
7671004|NCT01352507|26681354|P1|Treatment Period 1|Withdrawal by Subject|7
7671005|NCT01352507|26681353|P2|Treatment Period 1|Lost to Follow-up|4
7671006|NCT01352507|26681354|P1|Treatment Period 1|Lost to Follow-up|3
7671007|NCT01352507|26681353|P2|Treatment Period 1|Adverse Event|0
7671008|NCT01352507|26681354|P1|Treatment Period 1|Adverse Event|3
7671009|NCT01352416|26681407|P4|Overall Study|Physician Decision|1
7671010|NCT01352416|26681408|P3|Overall Study|Physician Decision|2
7671011|NCT01352416|26681409|P2|Overall Study|Physician Decision|2
7671012|NCT01352416|26681410|P1|Overall Study|Physician Decision|1
7671013|NCT01352221|26681432|P4|Open-label Phase|Worsening of IBD|0
7671014|NCT01352221|26681433|P3|Open-label Phase|Worsening of IBD|1
7671015|NCT01352221|26681434|P2|Open-label Phase|Worsening of IBD|0
7671016|NCT01352221|26681435|P1|Open-label Phase|Worsening of IBD|0
7671017|NCT01352221|26681432|P4|Open-label Phase|Withdrawal by Subject|6
7671018|NCT01352221|26681433|P3|Open-label Phase|Withdrawal by Subject|1
7671019|NCT01352221|26681434|P2|Open-label Phase|Withdrawal by Subject|0
7671020|NCT01352221|26681435|P1|Open-label Phase|Withdrawal by Subject|0
7671021|NCT01352221|26681432|P4|Open-label Phase|Adverse Event|4
7671022|NCT01352221|26681433|P3|Open-label Phase|Adverse Event|8
7671023|NCT01352221|26681434|P2|Open-label Phase|Adverse Event|0
7671024|NCT01352221|26681435|P1|Open-label Phase|Adverse Event|0
7671025|NCT01352221|26681432|P4|Open-label Phase|Pregnancy|0
7671026|NCT01352221|26681433|P3|Open-label Phase|Pregnancy|1
7671027|NCT01352221|26681434|P2|Open-label Phase|Pregnancy|0
7671028|NCT01352221|26681435|P1|Open-label Phase|Pregnancy|0
7671029|NCT01352221|26681432|P4|Open-label Phase|Physician Decision|1
7671030|NCT01352221|26681433|P3|Open-label Phase|Physician Decision|2
7671031|NCT01352221|26681434|P2|Open-label Phase|Physician Decision|0
7671032|NCT01352221|26681435|P1|Open-label Phase|Physician Decision|0
7671033|NCT01352221|26681432|P4|Double-blind Phase|Protocol Violation|0
7671034|NCT01352221|26681433|P3|Double-blind Phase|Protocol Violation|0
7671035|NCT01352221|26681434|P2|Double-blind Phase|Protocol Violation|1
7671036|NCT01352221|26681435|P1|Double-blind Phase|Protocol Violation|0
7671037|NCT01352221|26681432|P4|Double-blind Phase|Lost to Follow-up|0
7671038|NCT01352221|26681433|P3|Double-blind Phase|Lost to Follow-up|0
7671039|NCT01352221|26681434|P2|Double-blind Phase|Lost to Follow-up|1
7671040|NCT01352221|26681435|P1|Double-blind Phase|Lost to Follow-up|0
7671041|NCT01352221|26681432|P4|Double-blind Phase|Withdrawal by Subject|0
7671042|NCT01352221|26681433|P3|Double-blind Phase|Withdrawal by Subject|0
7671043|NCT01352221|26681434|P2|Double-blind Phase|Withdrawal by Subject|5
7671044|NCT01352221|26681435|P1|Double-blind Phase|Withdrawal by Subject|3
7671045|NCT01352221|26681432|P4|Double-blind Phase|Adverse Event|0
7671046|NCT01352221|26681433|P3|Double-blind Phase|Adverse Event|0
7671047|NCT01352221|26681434|P2|Double-blind Phase|Adverse Event|4
7671048|NCT01352221|26681435|P1|Double-blind Phase|Adverse Event|6
7671049|NCT01352117|26681514|P2|Overall Study|Ineligible (no KS diagnosis)|0
7671050|NCT01352117|26681515|P1|Overall Study|Ineligible (no KS diagnosis)|1
7671051|NCT01352117|26681514|P2|Overall Study|Did not initiate study treatment|0
7671052|NCT01352117|26681515|P1|Overall Study|Did not initiate study treatment|1
7671053|NCT01352117|26681514|P2|Overall Study|Non-adherent to study requirements|1
7671054|NCT01352117|26681515|P1|Overall Study|Non-adherent to study requirements|1
7671055|NCT01352117|26681514|P2|Overall Study|Lost to Follow-up|7
7671056|NCT01352117|26681515|P1|Overall Study|Lost to Follow-up|2
7671057|NCT01352117|26681514|P2|Overall Study|Withdrawal by Subject|0
7671058|NCT01352117|26681515|P1|Overall Study|Withdrawal by Subject|1
7671059|NCT01352117|26681514|P2|Overall Study|Death|16
7671060|NCT01352117|26681515|P1|Overall Study|Death|15
7671061|NCT01351623|26681654|P1|Overall Study|Death|2
7671062|NCT01351623|26681654|P1|Overall Study|Withdrawal by Subject|1
7671063|NCT01351623|26681654|P1|Overall Study|Adverse Event|4
7671064|NCT01351623|26681654|P1|Overall Study|Protocol Violation|2
7671065|NCT01351415|26681680|P2|Overall Study|Never Started|5
7671066|NCT01351415|26681681|P1|Overall Study|Never Started|5
7671067|NCT01351415|26681680|P2|Overall Study|Reason unknown|2
7671068|NCT01351415|26681681|P1|Overall Study|Reason unknown|0
7671069|NCT01351415|26681680|P2|Overall Study|Physician Decision|3
7671070|NCT01351415|26681681|P1|Overall Study|Physician Decision|2
7671071|NCT01351415|26681680|P2|Overall Study|Death|187
7671072|NCT01351415|26681681|P1|Overall Study|Death|190
7671073|NCT01351415|26681680|P2|Overall Study|Lost to Follow-up|7
7671074|NCT01351415|26681681|P1|Overall Study|Lost to Follow-up|5
7671075|NCT01351415|26681680|P2|Overall Study|Trial termination by the Sponsor|19
7671076|NCT01351415|26681681|P1|Overall Study|Trial termination by the Sponsor|28
7671077|NCT01351415|26681680|P2|Overall Study|Withdrawal by Subject|17
7671078|NCT01351415|26681681|P1|Overall Study|Withdrawal by Subject|15
7671079|NCT01351350|26681717|P5|Overall Study|Enrolled but not Treated|0
7671080|NCT01351350|26681718|P4|Overall Study|Enrolled but not Treated|0
7671081|NCT01351350|26681719|P3|Overall Study|Enrolled but not Treated|1
7671082|NCT01351350|26681720|P2|Overall Study|Enrolled but not Treated|0
7671083|NCT01351350|26681721|P1|Overall Study|Enrolled but not Treated|0
7671084|NCT01351350|26681717|P5|Overall Study|Participant Decision|2
7671085|NCT01351350|26681718|P4|Overall Study|Participant Decision|3
7671086|NCT01351350|26681719|P3|Overall Study|Participant Decision|3
7671087|NCT01351350|26681720|P2|Overall Study|Participant Decision|6
7671088|NCT01351350|26681721|P1|Overall Study|Participant Decision|2
7671089|NCT01351350|26681717|P5|Overall Study|Adverse Event|0
7671090|NCT01351350|26681718|P4|Overall Study|Adverse Event|2
7671091|NCT01351350|26681719|P3|Overall Study|Adverse Event|1
7671092|NCT01351350|26681720|P2|Overall Study|Adverse Event|10
7671093|NCT01351350|26681721|P1|Overall Study|Adverse Event|1
7671094|NCT01351350|26681717|P5|Overall Study|Disease Progression|5
7671095|NCT01351350|26681718|P4|Overall Study|Disease Progression|8
7671096|NCT01351350|26681719|P3|Overall Study|Disease Progression|6
7671097|NCT01351350|26681720|P2|Overall Study|Disease Progression|13
7671098|NCT01351350|26681721|P1|Overall Study|Disease Progression|5
7671099|NCT01351025|26681892|P2|Week 24 - 44|unable to get to clinic|1
7671100|NCT01351025|26681893|P1|Week 24 - 44|unable to get to clinic|1
7671101|NCT01351025|26681892|P2|Week 24 - 44|Site closed|1
7671102|NCT01351025|26681893|P1|Week 24 - 44|Site closed|0
7671103|NCT01351025|26681892|P2|Week 24 - 44|Lost to Follow-up|2
7671104|NCT01351025|26681893|P1|Week 24 - 44|Lost to Follow-up|0
7671105|NCT01351025|26681892|P2|Week 0 - 20|Withdrawal by Subject|0
7671106|NCT01351025|26681893|P1|Week 0 - 20|Withdrawal by Subject|1
7671107|NCT01351025|26681892|P2|Week 0 - 20|Lost to Follow-up|1
7671108|NCT01351025|26681893|P1|Week 0 - 20|Lost to Follow-up|2
7671109|NCT01350999|26681926|P3|Overall Study|Difficulty Making it to Study Visit|5
7671110|NCT01350999|26681927|P2|Overall Study|Difficulty Making it to Study Visit|1
7671111|NCT01350999|26681928|P1|Overall Study|Difficulty Making it to Study Visit|1
7671112|NCT01350999|26681926|P3|Overall Study|Voluntary withdrawal|6
7671113|NCT01350999|26681927|P2|Overall Study|Voluntary withdrawal|4
7671114|NCT01350999|26681928|P1|Overall Study|Voluntary withdrawal|3
7671115|NCT01350999|26681926|P3|Overall Study|Adverse Event|10
7671116|NCT01350999|26681927|P2|Overall Study|Adverse Event|9
7671117|NCT01350999|26681928|P1|Overall Study|Adverse Event|4
7671118|NCT01350973|26681966|P3|Overall Study|Voluntary Withdrawal|1
7671119|NCT01350973|26681967|P2|Overall Study|Voluntary Withdrawal|1
7671120|NCT01350973|26681968|P1|Overall Study|Voluntary Withdrawal|2
7671121|NCT01350973|26681966|P3|Overall Study|Adverse Event|7
7671122|NCT01350973|26681967|P2|Overall Study|Adverse Event|7
7671123|NCT01350973|26681968|P1|Overall Study|Adverse Event|4
7671124|NCT01350934|26682009|P2|Extension Study|Withdrawal by Subject|1
7671125|NCT01350934|26682010|P1|Extension Study|Withdrawal by Subject|0
7671126|NCT01350934|26682009|P2|Extension Study|Lack of Efficacy|1
7671127|NCT01350934|26682010|P1|Extension Study|Lack of Efficacy|0
7671128|NCT01350934|26682009|P2|Extension Study|Protocol Violation|1
7671129|NCT01350934|26682010|P1|Extension Study|Protocol Violation|1
7671130|NCT01350934|26682009|P2|Extension Study|Lost to Follow-up|0
7671131|NCT01350934|26682010|P1|Extension Study|Lost to Follow-up|2
7671132|NCT01350934|26682009|P2|Extension Study|Adverse Event|1
7671133|NCT01350934|26682010|P1|Extension Study|Adverse Event|2
7671134|NCT01350934|26682009|P2|Base Study|Non-Compliance With Study Drug|0
7671135|NCT01350934|26682010|P1|Base Study|Non-Compliance With Study Drug|2
7671136|NCT01350934|26682009|P2|Base Study|Withdrawal by Subject|2
7671137|NCT01350934|26682010|P1|Base Study|Withdrawal by Subject|1
7671138|NCT01350934|26682009|P2|Base Study|Protocol Violation|1
7671139|NCT01350934|26682010|P1|Base Study|Protocol Violation|1
7671140|NCT01350934|26682009|P2|Base Study|Lost to Follow-up|0
7671141|NCT01350934|26682010|P1|Base Study|Lost to Follow-up|1
7671142|NCT01350934|26682009|P2|Base Study|Adverse Event|0
7671143|NCT01350934|26682010|P1|Base Study|Adverse Event|6
7671144|NCT01350804|26682032|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
7671145|NCT01350804|26682033|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
7671146|NCT01350804|26682034|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
7671147|NCT01350804|26682035|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
7671148|NCT01350804|26682032|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
7671149|NCT01350804|26682033|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
7671150|NCT01350804|26682034|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
7671151|NCT01350804|26682035|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
7671152|NCT01350804|26682032|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7671153|NCT01350804|26682033|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7671154|NCT01350804|26682034|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
7671155|NCT01350804|26682035|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7671156|NCT01350804|26682032|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
7671157|NCT01350804|26682033|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
7671158|NCT01350804|26682034|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
7671159|NCT01350804|26682035|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
7671160|NCT01350804|26682032|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
7671161|NCT01350804|26682033|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
7671162|NCT01350804|26682034|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
7671163|NCT01350804|26682035|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
7671164|NCT01350804|26682032|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
7671165|NCT01350804|26682033|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
7671166|NCT01350804|26682034|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
7671167|NCT01350804|26682035|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
7671168|NCT01350804|26682032|P4|Core Study|Adverse Event|8
7671169|NCT01350804|26682033|P3|Core Study|Adverse Event|8
7671170|NCT01350804|26682034|P2|Core Study|Adverse Event|10
7671171|NCT01350804|26682035|P1|Core Study|Adverse Event|8
7671172|NCT01350804|26682032|P4|Core Study|Death|0
7671173|NCT01350804|26682033|P3|Core Study|Death|1
7671174|NCT01350804|26682034|P2|Core Study|Death|1
7671175|NCT01350804|26682035|P1|Core Study|Death|1
7671176|NCT01350804|26682032|P4|Core Study|Lack of Efficacy|5
7671177|NCT01350804|26682033|P3|Core Study|Lack of Efficacy|18
7671178|NCT01350804|26682034|P2|Core Study|Lack of Efficacy|19
7671179|NCT01350804|26682035|P1|Core Study|Lack of Efficacy|16
7671180|NCT01350804|26682032|P4|Core Study|Lost to Follow-up|1
7671181|NCT01350804|26682033|P3|Core Study|Lost to Follow-up|2
7671182|NCT01350804|26682034|P2|Core Study|Lost to Follow-up|0
7671183|NCT01350804|26682035|P1|Core Study|Lost to Follow-up|3
7671184|NCT01350804|26682032|P4|Core Study|Physician Decision|3
7671185|NCT01350804|26682033|P3|Core Study|Physician Decision|1
7671186|NCT01350804|26682034|P2|Core Study|Physician Decision|0
7671187|NCT01350804|26682035|P1|Core Study|Physician Decision|1
7671188|NCT01350804|26682032|P4|Core Study|Protocol deviation|0
7671189|NCT01350804|26682033|P3|Core Study|Protocol deviation|1
7671190|NCT01350804|26682034|P2|Core Study|Protocol deviation|0
7671191|NCT01350804|26682035|P1|Core Study|Protocol deviation|1
7671192|NCT01350804|26682032|P4|Core Study|Study terminated by Sponsor|2
7671193|NCT01350804|26682033|P3|Core Study|Study terminated by Sponsor|0
7671194|NCT01350804|26682034|P2|Core Study|Study terminated by Sponsor|0
7671195|NCT01350804|26682035|P1|Core Study|Study terminated by Sponsor|0
7671196|NCT01350804|26682032|P4|Core Study|Withdrawal by Subject|7
7671197|NCT01350804|26682033|P3|Core Study|Withdrawal by Subject|16
7671198|NCT01350804|26682034|P2|Core Study|Withdrawal by Subject|17
7671199|NCT01350804|26682035|P1|Core Study|Withdrawal by Subject|11
7671200|NCT01350544|26682132|P2|Overall Study|Lost to Follow-up|15
7671201|NCT01350544|26682133|P1|Overall Study|Lost to Follow-up|18
7671202|NCT01350544|26682132|P2|Overall Study|Incarceration|0
7671203|NCT01350544|26682133|P1|Overall Study|Incarceration|1
7671204|NCT01350544|26682132|P2|Overall Study|Withdrawal by Subject|1
7671205|NCT01350544|26682133|P1|Overall Study|Withdrawal by Subject|0
7671206|NCT01350544|26682132|P2|Overall Study|Medical Issues|1
7671207|NCT01350544|26682133|P1|Overall Study|Medical Issues|1
7671208|NCT01350544|26682132|P2|Overall Study|Moved out of LA County|2
7671209|NCT01350544|26682133|P1|Overall Study|Moved out of LA County|2
7671210|NCT01350544|26682132|P2|Overall Study|Death|2
7671211|NCT01350544|26682133|P1|Overall Study|Death|1
7671212|NCT01350544|26682132|P2|Overall Study|Administrative Withdrawal|1
7671213|NCT01350544|26682133|P1|Overall Study|Administrative Withdrawal|0
7671214|NCT01350505|26682139|P1|Overall Study|Lost to Follow-up|4
7671215|NCT01350492|26682145|P2|Post Intervention Follow-Up|Withdrawal by Subject|1
7671216|NCT01350492|26682146|P1|Post Intervention Follow-Up|Withdrawal by Subject|0
7671217|NCT01350492|26682145|P2|Post Intervention Follow-Up|Lost to Follow-up|1
7671218|NCT01350492|26682146|P1|Post Intervention Follow-Up|Lost to Follow-up|6
7671219|NCT01350492|26682145|P2|Intervention|Withdrawal by Subject|1
7671220|NCT01350492|26682146|P1|Intervention|Withdrawal by Subject|3
7671221|NCT01350492|26682145|P2|Intervention|Lost to Follow-up|5
7671222|NCT01350492|26682146|P1|Intervention|Lost to Follow-up|2
7671223|NCT01350414|26682188|P1|Overall Study|Physician Decision|2
7671224|NCT01350414|26682188|P1|Overall Study|Withdrawal by Subject|4
7671225|NCT01350414|26682188|P1|Overall Study|Lost to Follow-up|13
7671226|NCT01350336|26682234|P1|Overall Study|Death|4
7671227|NCT01350336|26682234|P1|Overall Study|Physician Decision|8
7671228|NCT01350336|26682234|P1|Overall Study|Withdrawal by Subject|14
7671229|NCT01350336|26682234|P1|Overall Study|Lost to Follow-up|31
7671230|NCT01350271|26682300|P3|Overall Study|Lost to Follow-up|26
7671231|NCT01350271|26682301|P2|Overall Study|Lost to Follow-up|17
7671232|NCT01350271|26682302|P1|Overall Study|Lost to Follow-up|21
7671233|NCT01350141|26682344|P3|Overall Study|Randomized but not treated|0
7671234|NCT01350141|26682345|P2|Overall Study|Randomized but not treated|0
7671235|NCT01350141|26682346|P1|Overall Study|Randomized but not treated|1
7671236|NCT01350141|26682344|P3|Overall Study|Withdrawal by Subject|0
7671237|NCT01350141|26682345|P2|Overall Study|Withdrawal by Subject|0
7671238|NCT01350141|26682346|P1|Overall Study|Withdrawal by Subject|1
7671239|NCT01350141|26682344|P3|Overall Study|Lost to Follow-up|1
7671240|NCT01350141|26682345|P2|Overall Study|Lost to Follow-up|0
7671241|NCT01350141|26682346|P1|Overall Study|Lost to Follow-up|1
7671242|NCT01350128|26682380|P1|Overall Study|Lost to Follow-up|2
7671243|NCT01350128|26682380|P1|Overall Study|Physician Decision|1
7671244|NCT01350128|26682380|P1|Overall Study|Protocol discontinuation criteria|8
7671245|NCT01350128|26682380|P1|Overall Study|Withdrawal by Subject|3
7671246|NCT01350115|26682444|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
7671247|NCT01350115|26682445|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
7671248|NCT01350115|26682444|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
7671249|NCT01350115|26682445|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
7671250|NCT01350115|26682444|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
7671251|NCT01350115|26682445|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
7671252|NCT01350102|26682461|P4|Overall Study|Adverse Event|0
7671253|NCT01350102|26682462|P3|Overall Study|Adverse Event|1
7671254|NCT01350102|26682463|P2|Overall Study|Adverse Event|0
7671255|NCT01350102|26682464|P1|Overall Study|Adverse Event|0
7671256|NCT01349959|26682501|P1|Overall Study|Adverse Event|7
7671257|NCT01349907|26682542|P2|Overall Study|Administrative|1
7671258|NCT01349907|26682543|P1|Overall Study|Administrative|1
7671259|NCT01349907|26682542|P2|Overall Study|Protocol Violation|13
7671260|NCT01349907|26682543|P1|Overall Study|Protocol Violation|33
7671261|NCT01349907|26682542|P2|Overall Study|Withdrawal by Subject|8
7671262|NCT01349907|26682543|P1|Overall Study|Withdrawal by Subject|30
7671263|NCT01349907|26682542|P2|Overall Study|Lost to Follow-up|6
7671264|NCT01349907|26682543|P1|Overall Study|Lost to Follow-up|25
7671265|NCT01349907|26682542|P2|Overall Study|Treatment failure|4
7671266|NCT01349907|26682543|P1|Overall Study|Treatment failure|13
7671267|NCT01349907|26682542|P2|Overall Study|Adverse Event|11
7671268|NCT01349907|26682543|P1|Overall Study|Adverse Event|37
7671269|NCT01349829|26682581|P2|Overall Study|Migrated/moved|7
7671270|NCT01349829|26682582|P1|Overall Study|Migrated/moved|2
7671271|NCT01349829|26682581|P2|Overall Study|Consent withdrawal|8
7671272|NCT01349829|26682582|P1|Overall Study|Consent withdrawal|3
7671273|NCT01349829|26682581|P2|Overall Study|Lost to Follow-up|8
7671274|NCT01349829|26682582|P1|Overall Study|Lost to Follow-up|4
7671275|NCT01349816|26682600|P1|Overall Study|Protocol-specified criteria|8
7671276|NCT01349816|26682600|P1|Overall Study|Protocol Violation|1
7671277|NCT01349816|26682600|P1|Overall Study|Lost to Follow-up|2
7671278|NCT01349816|26682600|P1|Overall Study|Adverse Event|14
7671279|NCT01349816|26682600|P1|Overall Study|Physician Decision|1
7671280|NCT01349816|26682600|P1|Overall Study|Withdrawal by Subject|4
7671281|NCT01349803|26682666|P4|Overall Study|Protocol-specified criteria|0
7671282|NCT01349803|26682667|P3|Overall Study|Protocol-specified criteria|3
7671283|NCT01349803|26682668|P2|Overall Study|Protocol-specified criteria|1
7671284|NCT01349803|26682669|P1|Overall Study|Protocol-specified criteria|0
7671285|NCT01349803|26682666|P4|Overall Study|Withdrawal by Subject|0
7671286|NCT01349803|26682667|P3|Overall Study|Withdrawal by Subject|0
7671287|NCT01349803|26682668|P2|Overall Study|Withdrawal by Subject|0
7671288|NCT01349803|26682669|P1|Overall Study|Withdrawal by Subject|1
7671289|NCT01349803|26682666|P4|Overall Study|Adverse Event|2
7671290|NCT01349803|26682667|P3|Overall Study|Adverse Event|0
7671291|NCT01349803|26682668|P2|Overall Study|Adverse Event|0
7671292|NCT01349803|26682669|P1|Overall Study|Adverse Event|0
7671293|NCT01349790|26682739|P1|Overall Study|Lost to Follow-up|1
7671294|NCT01349790|26682739|P1|Overall Study|Adverse Event|1
7671295|NCT01349790|26682739|P1|Overall Study|Withdrawal by Patient|2
7671296|NCT01349790|26682739|P1|Overall Study|Death|2
7671297|NCT01349790|26682739|P1|Overall Study|Investigator Judgement|3
7671298|NCT01349673|26682758|P1|Overall Study|Lack of Efficacy|8
7671299|NCT01349673|26682758|P1|Overall Study|Study Terminated By Sponsor|50
7671300|NCT01349673|26682758|P1|Overall Study|Adverse Event|17
7671301|NCT01349673|26682758|P1|Overall Study|Lost to Follow-up|6
7671302|NCT01349673|26682758|P1|Overall Study|Withdrawal by Subject|21
7671303|NCT01349673|26682758|P1|Overall Study|Site Closure|10
7671304|NCT01349673|26682758|P1|Overall Study|No Longer Qualified For Study|1
7671305|NCT01349673|26682758|P1|Overall Study|Progression Of Disease Past 40 cm|1
7671306|NCT01349660|26682768|P3|Overall Study|Declining Performance Status|1
7671307|NCT01349660|26682769|P2|Overall Study|Declining Performance Status|0
7671308|NCT01349660|26682770|P1|Overall Study|Declining Performance Status|0
7671309|NCT01349660|26682768|P3|Overall Study|Study Compliance|1
7671310|NCT01349660|26682769|P2|Overall Study|Study Compliance|0
7671311|NCT01349660|26682770|P1|Overall Study|Study Compliance|0
7671312|NCT01349660|26682768|P3|Overall Study|Non-Permitted Interventions|2
7671313|NCT01349660|26682769|P2|Overall Study|Non-Permitted Interventions|0
7671314|NCT01349660|26682770|P1|Overall Study|Non-Permitted Interventions|0
7671315|NCT01349660|26682768|P3|Overall Study|Death|0
7671316|NCT01349660|26682769|P2|Overall Study|Death|1
7671317|NCT01349660|26682770|P1|Overall Study|Death|1
7671318|NCT01349660|26682768|P3|Overall Study|Withdrawal by Subject|9
7671319|NCT01349660|26682769|P2|Overall Study|Withdrawal by Subject|0
7671320|NCT01349660|26682770|P1|Overall Study|Withdrawal by Subject|2
7671321|NCT01349660|26682768|P3|Overall Study|Adverse Event|12
7671322|NCT01349660|26682769|P2|Overall Study|Adverse Event|1
7671323|NCT01349660|26682770|P1|Overall Study|Adverse Event|1
7671324|NCT01349660|26682768|P3|Overall Study|Disease Progression|50
7671325|NCT01349660|26682769|P2|Overall Study|Disease Progression|4
7671326|NCT01349660|26682770|P1|Overall Study|Disease Progression|2
7671327|NCT01349660|26682768|P3|Overall Study|Still Receiving Study Treatment|1
7671328|NCT01349660|26682769|P2|Overall Study|Still Receiving Study Treatment|0
7671329|NCT01349660|26682770|P1|Overall Study|Still Receiving Study Treatment|0
7671330|NCT01349595|26682788|P2|Overall Study|Lack of funding|2
7671331|NCT01349595|26682789|P1|Overall Study|Lack of funding|2
7671332|NCT01349569|26682795|P1|Overall Study|Lack of Efficacy|4
7671333|NCT01349465|26682816|P2|Overall Study|Subject Ineligible To Continue The Trial|19
7671334|NCT01349465|26682817|P1|Overall Study|Subject Ineligible To Continue The Trial|0
7671335|NCT01349465|26682816|P2|Overall Study|Withdrawal by Subject|2
7671336|NCT01349465|26682817|P1|Overall Study|Withdrawal by Subject|4
7671337|NCT01349465|26682816|P2|Overall Study|Lost to Follow-up|1
7671338|NCT01349465|26682817|P1|Overall Study|Lost to Follow-up|10
7671339|NCT01349465|26682816|P2|Overall Study|Death|0
7671340|NCT01349465|26682817|P1|Overall Study|Death|3
7671341|NCT01349465|26682816|P2|Overall Study|Adverse Event|0
7671342|NCT01349465|26682817|P1|Overall Study|Adverse Event|1
7671343|NCT01349192|26682838|P2|Overall Study|Failure to adhere to Protocol|0
7671344|NCT01349192|26682839|P1|Overall Study|Failure to adhere to Protocol|2
7671345|NCT01349192|26682838|P2|Overall Study|Lost to Follow-up|3
7671346|NCT01349192|26682839|P1|Overall Study|Lost to Follow-up|1
7671347|NCT01349192|26682838|P2|Overall Study|Withdrawal by Subject|2
7671348|NCT01349192|26682839|P1|Overall Study|Withdrawal by Subject|0
7671349|NCT01349192|26682838|P2|Overall Study|Protocol Violation|1
7671350|NCT01349192|26682839|P1|Overall Study|Protocol Violation|0
7671351|NCT01349049|26682876|P9|Overall Study|Withdrawal by Subject|6
7671352|NCT01349049|26682877|P8|Overall Study|Withdrawal by Subject|0
7671353|NCT01349049|26682878|P7|Overall Study|Withdrawal by Subject|0
7671354|NCT01349049|26682879|P6|Overall Study|Withdrawal by Subject|0
7671355|NCT01349049|26682880|P5|Overall Study|Withdrawal by Subject|0
7671356|NCT01349049|26682881|P4|Overall Study|Withdrawal by Subject|0
7671357|NCT01349049|26682882|P3|Overall Study|Withdrawal by Subject|0
7671358|NCT01349049|26682883|P2|Overall Study|Withdrawal by Subject|0
7671359|NCT01349049|26682884|P1|Overall Study|Withdrawal by Subject|0
7671360|NCT01349049|26682876|P9|Overall Study|Non-compliance|0
7671361|NCT01349049|26682877|P8|Overall Study|Non-compliance|0
7671362|NCT01349049|26682878|P7|Overall Study|Non-compliance|0
7671363|NCT01349049|26682879|P6|Overall Study|Non-compliance|0
7671364|NCT01349049|26682880|P5|Overall Study|Non-compliance|0
7671365|NCT01349049|26682881|P4|Overall Study|Non-compliance|1
7671366|NCT01349049|26682882|P3|Overall Study|Non-compliance|0
7671367|NCT01349049|26682883|P2|Overall Study|Non-compliance|0
7671368|NCT01349049|26682884|P1|Overall Study|Non-compliance|0
7671369|NCT01349049|26682876|P9|Overall Study|Death|5
7671370|NCT01349049|26682877|P8|Overall Study|Death|1
7671371|NCT01349049|26682878|P7|Overall Study|Death|0
7671372|NCT01349049|26682879|P6|Overall Study|Death|0
7671373|NCT01349049|26682880|P5|Overall Study|Death|0
7671374|NCT01349049|26682881|P4|Overall Study|Death|0
7671375|NCT01349049|26682882|P3|Overall Study|Death|0
7671376|NCT01349049|26682883|P2|Overall Study|Death|0
7671377|NCT01349049|26682884|P1|Overall Study|Death|0
7671378|NCT01349049|26682876|P9|Overall Study|Other|4
7671379|NCT01349049|26682877|P8|Overall Study|Other|0
7671380|NCT01349049|26682878|P7|Overall Study|Other|0
7671381|NCT01349049|26682879|P6|Overall Study|Other|1
7671382|NCT01349049|26682880|P5|Overall Study|Other|0
7671383|NCT01349049|26682881|P4|Overall Study|Other|0
7671384|NCT01349049|26682882|P3|Overall Study|Other|0
7671385|NCT01349049|26682883|P2|Overall Study|Other|0
7671386|NCT01349049|26682884|P1|Overall Study|Other|0
7671387|NCT01349049|26682876|P9|Overall Study|Hematopoietic stem cell transplant|0
7671388|NCT01349049|26682877|P8|Overall Study|Hematopoietic stem cell transplant|1
7671389|NCT01349049|26682878|P7|Overall Study|Hematopoietic stem cell transplant|1
7671390|NCT01349049|26682879|P6|Overall Study|Hematopoietic stem cell transplant|0
7671391|NCT01349049|26682880|P5|Overall Study|Hematopoietic stem cell transplant|1
7671392|NCT01349049|26682881|P4|Overall Study|Hematopoietic stem cell transplant|0
7671393|NCT01349049|26682882|P3|Overall Study|Hematopoietic stem cell transplant|0
7671394|NCT01349049|26682883|P2|Overall Study|Hematopoietic stem cell transplant|0
7671395|NCT01349049|26682884|P1|Overall Study|Hematopoietic stem cell transplant|0
7671396|NCT01349049|26682876|P9|Overall Study|Protocol Violation|1
7671397|NCT01349049|26682877|P8|Overall Study|Protocol Violation|0
7671398|NCT01349049|26682878|P7|Overall Study|Protocol Violation|0
7671399|NCT01349049|26682879|P6|Overall Study|Protocol Violation|0
7671400|NCT01349049|26682880|P5|Overall Study|Protocol Violation|0
7671401|NCT01349049|26682881|P4|Overall Study|Protocol Violation|0
7671402|NCT01349049|26682882|P3|Overall Study|Protocol Violation|0
7671403|NCT01349049|26682883|P2|Overall Study|Protocol Violation|0
7671404|NCT01349049|26682884|P1|Overall Study|Protocol Violation|0
7671405|NCT01349049|26682876|P9|Overall Study|Physician Decision|2
7671406|NCT01349049|26682877|P8|Overall Study|Physician Decision|0
7671407|NCT01349049|26682878|P7|Overall Study|Physician Decision|0
7671408|NCT01349049|26682879|P6|Overall Study|Physician Decision|0
7671409|NCT01349049|26682880|P5|Overall Study|Physician Decision|0
7671410|NCT01349049|26682881|P4|Overall Study|Physician Decision|0
7671411|NCT01349049|26682882|P3|Overall Study|Physician Decision|0
7671412|NCT01349049|26682883|P2|Overall Study|Physician Decision|1
7671413|NCT01349049|26682884|P1|Overall Study|Physician Decision|0
7671414|NCT01349049|26682876|P9|Overall Study|Adverse Event|4
7671415|NCT01349049|26682877|P8|Overall Study|Adverse Event|0
7671416|NCT01349049|26682878|P7|Overall Study|Adverse Event|1
7671417|NCT01349049|26682879|P6|Overall Study|Adverse Event|3
7671418|NCT01349049|26682880|P5|Overall Study|Adverse Event|0
7671419|NCT01349049|26682881|P4|Overall Study|Adverse Event|0
7671420|NCT01349049|26682882|P3|Overall Study|Adverse Event|0
7671421|NCT01349049|26682883|P2|Overall Study|Adverse Event|1
7671422|NCT01349049|26682884|P1|Overall Study|Adverse Event|0
7671423|NCT01349049|26682876|P9|Overall Study|Disease progression|33
7671424|NCT01349049|26682877|P8|Overall Study|Disease progression|2
7671425|NCT01349049|26682878|P7|Overall Study|Disease progression|3
7671426|NCT01349049|26682879|P6|Overall Study|Disease progression|2
7671427|NCT01349049|26682880|P5|Overall Study|Disease progression|2
7671428|NCT01349049|26682881|P4|Overall Study|Disease progression|2
7671429|NCT01349049|26682882|P3|Overall Study|Disease progression|3
7671430|NCT01349049|26682883|P2|Overall Study|Disease progression|5
7671431|NCT01349049|26682884|P1|Overall Study|Disease progression|3
7671432|NCT01349036|26682938|P2|Overall Study|Withdrawal by Subject|2
7671433|NCT01349036|26682939|P1|Overall Study|Withdrawal by Subject|0
7671434|NCT01349036|26682938|P2|Overall Study|Other|0
7671435|NCT01349036|26682939|P1|Overall Study|Other|1
7671436|NCT01349036|26682938|P2|Overall Study|Disease progression|22
7671437|NCT01349036|26682939|P1|Overall Study|Disease progression|13
7671438|NCT01348854|26682957|P2|Overall Study|Withdrawal by Subject|0
7671439|NCT01348854|26682958|P1|Overall Study|Withdrawal by Subject|1
7671440|NCT01348854|26682957|P2|Overall Study|Lost to Follow-up|1
7671441|NCT01348854|26682958|P1|Overall Study|Lost to Follow-up|2
7671442|NCT01348828|26682966|P1|Overall Study|missed visit|1
7671443|NCT01348828|26682966|P1|Overall Study|Conversion|2
7671444|NCT01348828|26682966|P1|Overall Study|Withdrawals/Lost to Follow-up|10
7671445|NCT01348828|26682966|P1|Overall Study|Death|20
7671446|NCT01348789|26682983|P1|Overall Study|Withdrawal by Subject|2
7671447|NCT01348789|26682983|P1|Overall Study|Protocol Violation|2
7671448|NCT01348776|26682994|P1|Overall Study|Lost to Follow-up|3
7671449|NCT01348763|26683007|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
7671450|NCT01348763|26683007|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
7671451|NCT01348698|26683012|P1|Overall Study|PI decision to close study|68
7671452|NCT01348698|26683012|P1|Overall Study|Death|3
7671453|NCT01348698|26683012|P1|Overall Study|Does not meet lesion size criteria|1
7671454|NCT01348542|26683037|P2|Overall Study|Withdrawal by Subject|0
7671455|NCT01348542|26683038|P1|Overall Study|Withdrawal by Subject|3
7671456|NCT01348490|26683054|P1|Overall Study|Other Unspecified|8
7671457|NCT01348490|26683054|P1|Overall Study|Termination of clinical trial by sponsor|1
7671458|NCT01348490|26683054|P1|Overall Study|Lost to Follow-up|1
7671459|NCT01348490|26683054|P1|Overall Study|Disease progression|3
7671460|NCT01348490|26683054|P1|Overall Study|Consent withdrawn|7
7671461|NCT01348490|26683054|P1|Overall Study|Adverse Event|3
7671462|NCT01348490|26683054|P1|Overall Study|Death|1
7671463|NCT01348425|26683112|P2|Overall Study|Imaging was not taken.|1
7671464|NCT01348425|26683113|P1|Overall Study|Imaging was not taken.|1
7671465|NCT01348347|26683121|P3|Overall Study|Progressive disease|5
7671466|NCT01348347|26683122|P2|Overall Study|Progressive disease|5
7671467|NCT01348347|26683123|P1|Overall Study|Progressive disease|2
7671468|NCT01348347|26683121|P3|Overall Study|Withdrawal by Subject|1
7671469|NCT01348347|26683122|P2|Overall Study|Withdrawal by Subject|1
7671470|NCT01348347|26683123|P1|Overall Study|Withdrawal by Subject|1
7671471|NCT01348165|26683154|P7|Overall Study|Adverse Event|1
7671472|NCT01348165|26683155|P6|Overall Study|Adverse Event|0
7671473|NCT01348165|26683156|P5|Overall Study|Adverse Event|0
7671474|NCT01348165|26683157|P4|Overall Study|Adverse Event|0
7671475|NCT01348165|26683158|P3|Overall Study|Adverse Event|0
7671476|NCT01348165|26683159|P2|Overall Study|Adverse Event|0
7671477|NCT01348165|26683160|P1|Overall Study|Adverse Event|0
7671478|NCT01348139|26683289|P6|Period 1|Adverse Event|0
7671479|NCT01348139|26683290|P5|Period 1|Adverse Event|0
7671480|NCT01348139|26683291|P4|Period 1|Adverse Event|0
7671481|NCT01348139|26683292|P3|Period 1|Adverse Event|0
7671482|NCT01348139|26683293|P2|Period 1|Adverse Event|0
7671483|NCT01348139|26683294|P1|Period 1|Adverse Event|1
7671484|NCT01348100|26683375|P7|Overall Study|Administrative Problems|1
7671485|NCT01348100|26683376|P6|Overall Study|Administrative Problems|1
7671486|NCT01348100|26683377|P5|Overall Study|Administrative Problems|0
7671487|NCT01348100|26683378|P4|Overall Study|Administrative Problems|0
7671488|NCT01348100|26683379|P3|Overall Study|Administrative Problems|0
7671489|NCT01348100|26683380|P2|Overall Study|Administrative Problems|0
7671490|NCT01348100|26683381|P1|Overall Study|Administrative Problems|0
7671491|NCT01348100|26683375|P7|Overall Study|Lost to Follow-up|1
7671492|NCT01348100|26683376|P6|Overall Study|Lost to Follow-up|0
7671493|NCT01348100|26683377|P5|Overall Study|Lost to Follow-up|0
7671494|NCT01348100|26683378|P4|Overall Study|Lost to Follow-up|0
7671495|NCT01348100|26683379|P3|Overall Study|Lost to Follow-up|0
7671496|NCT01348100|26683380|P2|Overall Study|Lost to Follow-up|0
7671497|NCT01348100|26683381|P1|Overall Study|Lost to Follow-up|0
7671498|NCT01348100|26683375|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
7671499|NCT01348100|26683376|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
7671500|NCT01348100|26683377|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
7671501|NCT01348100|26683378|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
7671502|NCT01348100|26683379|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
7671503|NCT01348100|26683380|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
7671504|NCT01348100|26683381|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
7671505|NCT01348100|26683375|P7|Overall Study|Protocol Deviation|0
7671506|NCT01348100|26683376|P6|Overall Study|Protocol Deviation|0
7671507|NCT01348100|26683377|P5|Overall Study|Protocol Deviation|0
7671508|NCT01348100|26683378|P4|Overall Study|Protocol Deviation|1
7671509|NCT01348100|26683379|P3|Overall Study|Protocol Deviation|0
7671510|NCT01348100|26683380|P2|Overall Study|Protocol Deviation|0
7671511|NCT01348100|26683381|P1|Overall Study|Protocol Deviation|0
7671512|NCT01348100|26683375|P7|Overall Study|Subject Withdrew Consent|1
7671513|NCT01348100|26683376|P6|Overall Study|Subject Withdrew Consent|0
7671514|NCT01348100|26683377|P5|Overall Study|Subject Withdrew Consent|1
7671515|NCT01348100|26683378|P4|Overall Study|Subject Withdrew Consent|0
7671516|NCT01348100|26683379|P3|Overall Study|Subject Withdrew Consent|2
7671517|NCT01348100|26683380|P2|Overall Study|Subject Withdrew Consent|0
7671518|NCT01348100|26683381|P1|Overall Study|Subject Withdrew Consent|0
7671519|NCT01348087|26683426|P1|Overall Study|Adverse Event|25
7671520|NCT01348087|26683426|P1|Overall Study|Subject withdrew consent|7
7671521|NCT01348087|26683426|P1|Overall Study|Lost to Follow-up|1
7671522|NCT01348087|26683426|P1|Overall Study|protocol deviation|1
7671523|NCT01348087|26683426|P1|Overall Study|Administrative problems|79
7671524|NCT01348087|26683426|P1|Overall Study|Unsatisfactory therapeutic effect|35
7671525|NCT01347931|26683440|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
7671526|NCT01347879|26683452|P2|Overall Study|Other|3
7671527|NCT01347879|26683453|P1|Overall Study|Other|2
7671528|NCT01347879|26683452|P2|Overall Study|Withdrawal by Subject|2
7671529|NCT01347879|26683453|P1|Overall Study|Withdrawal by Subject|3
7671530|NCT01347879|26683452|P2|Overall Study|Lost to Follow-up|0
7671531|NCT01347879|26683453|P1|Overall Study|Lost to Follow-up|2
7671532|NCT01347879|26683452|P2|Overall Study|Adverse Event|12
7671533|NCT01347879|26683453|P1|Overall Study|Adverse Event|0
7671534|NCT01347866|26683502|P17|Overall Study|Subject refused further follow-up|2
7671535|NCT01347866|26683503|P16|Overall Study|Subject refused further follow-up|0
7671536|NCT01347866|26683504|P15|Overall Study|Subject refused further follow-up|1
7671537|NCT01347866|26683505|P14|Overall Study|Subject refused further follow-up|3
7671538|NCT01347866|26683506|P13|Overall Study|Subject refused further follow-up|1
7671539|NCT01347866|26683507|P12|Overall Study|Subject refused further follow-up|0
7671540|NCT01347866|26683508|P11|Overall Study|Subject refused further follow-up|0
7671541|NCT01347866|26683509|P10|Overall Study|Subject refused further follow-up|1
7671542|NCT01347866|26683510|P9|Overall Study|Subject refused further follow-up|4
7671543|NCT01347866|26683511|P8|Overall Study|Subject refused further follow-up|0
7671544|NCT01347866|26683512|P7|Overall Study|Subject refused further follow-up|0
7671545|NCT01347866|26683513|P6|Overall Study|Subject refused further follow-up|1
7671546|NCT01347866|26683514|P5|Overall Study|Subject refused further follow-up|0
7671547|NCT01347866|26683515|P4|Overall Study|Subject refused further follow-up|2
7671548|NCT01347866|26683516|P3|Overall Study|Subject refused further follow-up|0
7671549|NCT01347866|26683517|P2|Overall Study|Subject refused further follow-up|0
7671550|NCT01347866|26683518|P1|Overall Study|Subject refused further follow-up|2
7671551|NCT01347866|26683502|P17|Overall Study|Other|0
7671552|NCT01347866|26683503|P16|Overall Study|Other|3
7671553|NCT01347866|26683504|P15|Overall Study|Other|2
7671554|NCT01347866|26683505|P14|Overall Study|Other|4
7671555|NCT01347866|26683506|P13|Overall Study|Other|4
7671556|NCT01347866|26683507|P12|Overall Study|Other|3
7671557|NCT01347866|26683508|P11|Overall Study|Other|0
7671558|NCT01347866|26683509|P10|Overall Study|Other|5
7671559|NCT01347866|26683510|P9|Overall Study|Other|22
7671560|NCT01347866|26683511|P8|Overall Study|Other|3
7671561|NCT01347866|26683512|P7|Overall Study|Other|5
7671562|NCT01347866|26683513|P6|Overall Study|Other|0
7671563|NCT01347866|26683514|P5|Overall Study|Other|5
7671564|NCT01347866|26683515|P4|Overall Study|Other|4
7671565|NCT01347866|26683516|P3|Overall Study|Other|1
7671566|NCT01347866|26683517|P2|Overall Study|Other|1
7671567|NCT01347866|26683518|P1|Overall Study|Other|3
7671568|NCT01347866|26683502|P17|Overall Study|Lost to Follow-up|0
7671569|NCT01347866|26683503|P16|Overall Study|Lost to Follow-up|0
7671570|NCT01347866|26683504|P15|Overall Study|Lost to Follow-up|0
7671571|NCT01347866|26683505|P14|Overall Study|Lost to Follow-up|0
7671572|NCT01347866|26683506|P13|Overall Study|Lost to Follow-up|0
7671573|NCT01347866|26683507|P12|Overall Study|Lost to Follow-up|0
7671574|NCT01347866|26683508|P11|Overall Study|Lost to Follow-up|0
7671575|NCT01347866|26683509|P10|Overall Study|Lost to Follow-up|0
7671576|NCT01347866|26683510|P9|Overall Study|Lost to Follow-up|1
7671577|NCT01347866|26683511|P8|Overall Study|Lost to Follow-up|1
7671578|NCT01347866|26683512|P7|Overall Study|Lost to Follow-up|0
7671579|NCT01347866|26683513|P6|Overall Study|Lost to Follow-up|0
7671580|NCT01347866|26683514|P5|Overall Study|Lost to Follow-up|0
7671581|NCT01347866|26683515|P4|Overall Study|Lost to Follow-up|0
7671582|NCT01347866|26683516|P3|Overall Study|Lost to Follow-up|0
7671583|NCT01347866|26683517|P2|Overall Study|Lost to Follow-up|0
7671584|NCT01347866|26683518|P1|Overall Study|Lost to Follow-up|0
7671585|NCT01347866|26683502|P17|Overall Study|Death|0
7671586|NCT01347866|26683503|P16|Overall Study|Death|1
7671587|NCT01347866|26683504|P15|Overall Study|Death|0
7671588|NCT01347866|26683505|P14|Overall Study|Death|0
7671589|NCT01347866|26683506|P13|Overall Study|Death|2
7671590|NCT01347866|26683507|P12|Overall Study|Death|1
7671591|NCT01347866|26683508|P11|Overall Study|Death|3
7671592|NCT01347866|26683509|P10|Overall Study|Death|1
7671593|NCT01347866|26683510|P9|Overall Study|Death|4
7671594|NCT01347866|26683511|P8|Overall Study|Death|0
7671595|NCT01347866|26683512|P7|Overall Study|Death|1
7671596|NCT01347866|26683513|P6|Overall Study|Death|2
7671597|NCT01347866|26683514|P5|Overall Study|Death|2
7671598|NCT01347866|26683515|P4|Overall Study|Death|1
7671599|NCT01347866|26683516|P3|Overall Study|Death|0
7671600|NCT01347866|26683517|P2|Overall Study|Death|0
7671601|NCT01347866|26683518|P1|Overall Study|Death|0
7671602|NCT01347840|26683892|P1|Overall Study|Withdrawal by Subject|1
7671603|NCT01347762|26683919|P4|Overall Study|Withdrawal by Subject|3
7671604|NCT01347762|26683920|P3|Overall Study|Withdrawal by Subject|3
7671605|NCT01347762|26683921|P2|Overall Study|Withdrawal by Subject|1
7671606|NCT01347762|26683922|P1|Overall Study|Withdrawal by Subject|4
7671607|NCT01347762|26683919|P4|Overall Study|Lost to Follow-up|5
7671608|NCT01347762|26683920|P3|Overall Study|Lost to Follow-up|6
7671609|NCT01347762|26683921|P2|Overall Study|Lost to Follow-up|1
7671610|NCT01347762|26683922|P1|Overall Study|Lost to Follow-up|0
7671611|NCT01347710|26683948|P1|Overall Study|Other|3
7671612|NCT01347710|26683948|P1|Overall Study|Physician Decision|2
7671613|NCT01347710|26683948|P1|Overall Study|Lost to Follow-up|1
7671614|NCT01347710|26683948|P1|Overall Study|issue with vitals prior to dosing|1
7671615|NCT01347710|26683948|P1|Overall Study|Angio or SPECT not completed|18
7671616|NCT01347710|26683948|P1|Overall Study|Adverse Event|4
7671617|NCT01347710|26683948|P1|Overall Study|Withdrawal by Subject|2
7671618|NCT01347580|26683970|P2|Overall Study|Had other reason|6
7671619|NCT01347580|26683971|P1|Overall Study|Had other reason|9
7671620|NCT01347580|26683970|P2|Overall Study|Lost to Follow-up|1
7671621|NCT01347580|26683971|P1|Overall Study|Lost to Follow-up|3
7671622|NCT01347580|26683970|P2|Overall Study|Protocol Violation|7
7671623|NCT01347580|26683971|P1|Overall Study|Protocol Violation|10
7671624|NCT01347580|26683970|P2|Overall Study|Death|19
7671625|NCT01347580|26683971|P1|Overall Study|Death|30
7671626|NCT01347580|26683970|P2|Overall Study|Withdrawal by Subject|23
7671627|NCT01347580|26683971|P1|Overall Study|Withdrawal by Subject|13
7671628|NCT01347554|26684001|P2|Overall Study|Lack of Efficacy|11
7671629|NCT01347554|26684002|P1|Overall Study|Lack of Efficacy|7
7671630|NCT01347307|26684046|P2|Overall Study|Physician Decision|1
7671631|NCT01347307|26684047|P1|Overall Study|Physician Decision|0
7671632|NCT01347307|26684046|P2|Overall Study|Death|4
7671633|NCT01347307|26684047|P1|Overall Study|Death|0
7671634|NCT01347112|26684082|P2|Overall Study|Lost to Follow-up|5
7671635|NCT01347112|26684083|P1|Overall Study|Lost to Follow-up|3
7671636|NCT01347112|26684082|P2|Overall Study|Withdrawal by Subject|7
7671637|NCT01347112|26684083|P1|Overall Study|Withdrawal by Subject|1
7671638|NCT01347086|26684103|P10|Overall Study|failed screening visit|1
7671639|NCT01347086|26684104|P9|Overall Study|failed screening visit|0
7671640|NCT01347086|26684105|P8|Overall Study|failed screening visit|1
7671641|NCT01347086|26684106|P7|Overall Study|failed screening visit|1
7671642|NCT01347086|26684107|P6|Overall Study|failed screening visit|0
7671643|NCT01347086|26684108|P5|Overall Study|failed screening visit|0
7671644|NCT01347086|26684109|P4|Overall Study|failed screening visit|0
7671645|NCT01347086|26684110|P3|Overall Study|failed screening visit|1
7671646|NCT01347086|26684111|P2|Overall Study|failed screening visit|0
7671647|NCT01347086|26684112|P1|Overall Study|failed screening visit|0
7671648|NCT01347073|26684211|P1|Overall Study|Liver Transplant|1
7671649|NCT01347073|26684211|P1|Overall Study|Adverse Event|1
7671650|NCT01346969|26684264|P4|Overall Study|Randomized but not treated|0
7671651|NCT01346969|26684265|P3|Overall Study|Randomized but not treated|0
7671652|NCT01346969|26684266|P2|Overall Study|Randomized but not treated|0
7671653|NCT01346969|26684267|P1|Overall Study|Randomized but not treated|1
7671654|NCT01346969|26684264|P4|Overall Study|Physician Decision|1
7671655|NCT01346969|26684265|P3|Overall Study|Physician Decision|0
7671656|NCT01346969|26684266|P2|Overall Study|Physician Decision|0
7671657|NCT01346969|26684267|P1|Overall Study|Physician Decision|0
7671658|NCT01346969|26684264|P4|Overall Study|Lost to Follow-up|0
7671659|NCT01346969|26684265|P3|Overall Study|Lost to Follow-up|2
7671660|NCT01346969|26684266|P2|Overall Study|Lost to Follow-up|0
7671661|NCT01346969|26684267|P1|Overall Study|Lost to Follow-up|1
7671662|NCT01346969|26684264|P4|Overall Study|Withdrawal by Subject|0
7671663|NCT01346969|26684265|P3|Overall Study|Withdrawal by Subject|1
7671664|NCT01346969|26684266|P2|Overall Study|Withdrawal by Subject|0
7671665|NCT01346969|26684267|P1|Overall Study|Withdrawal by Subject|0
7671666|NCT01346774|26684327|P2|Overall Study|Adverse Event|2
7671667|NCT01346774|26684328|P1|Overall Study|Adverse Event|1
7671668|NCT01346774|26684327|P2|Overall Study|Protocol Violation|3
7671669|NCT01346774|26684328|P1|Overall Study|Protocol Violation|2
7671670|NCT01346774|26684327|P2|Overall Study|Withdrawal by Subject|4
7671671|NCT01346774|26684328|P1|Overall Study|Withdrawal by Subject|1
7671672|NCT01346774|26684327|P2|Overall Study|Lost to Follow-up|4
7671673|NCT01346774|26684328|P1|Overall Study|Lost to Follow-up|3
7671674|NCT01346774|26684327|P2|Overall Study|Did not take a single dose|4
7671675|NCT01346774|26684328|P1|Overall Study|Did not take a single dose|6
7671676|NCT01346696|26684334|P1|Overall Study|Death|1
7671677|NCT01346592|26684356|P3|Overall Study|Unable to Classify|6
7671678|NCT01346592|26684357|P2|Overall Study|Unable to Classify|3
7671679|NCT01346592|26684358|P1|Overall Study|Unable to Classify|7
7671680|NCT01346592|26684356|P3|Overall Study|Administrative reason|0
7671681|NCT01346592|26684357|P2|Overall Study|Administrative reason|0
7671682|NCT01346592|26684358|P1|Overall Study|Administrative reason|1
7671683|NCT01346592|26684356|P3|Overall Study|Inappropriate enrollment|1
7671684|NCT01346592|26684357|P2|Overall Study|Inappropriate enrollment|1
7671685|NCT01346592|26684358|P1|Overall Study|Inappropriate enrollment|3
7671686|NCT01346592|26684356|P3|Overall Study|Withdrawal by Subject|38
7671687|NCT01346592|26684357|P2|Overall Study|Withdrawal by Subject|51
7671688|NCT01346592|26684358|P1|Overall Study|Withdrawal by Subject|77
7671689|NCT01346592|26684356|P3|Overall Study|Adverse Event|0
7671690|NCT01346592|26684357|P2|Overall Study|Adverse Event|1
7671691|NCT01346592|26684358|P1|Overall Study|Adverse Event|0
7671692|NCT01346592|26684356|P3|Overall Study|Death|4
7671693|NCT01346592|26684357|P2|Overall Study|Death|3
7671694|NCT01346592|26684358|P1|Overall Study|Death|1
7671695|NCT01346592|26684356|P3|Overall Study|Protocol Violation|0
7671696|NCT01346592|26684357|P2|Overall Study|Protocol Violation|1
7671697|NCT01346592|26684358|P1|Overall Study|Protocol Violation|2
7671698|NCT01346592|26684356|P3|Overall Study|Lost to Follow-up|29
7671699|NCT01346592|26684357|P2|Overall Study|Lost to Follow-up|29
7671700|NCT01346592|26684358|P1|Overall Study|Lost to Follow-up|62
7671701|NCT01346540|26684450|P2|Overall Study|Adverse Event|4
7671702|NCT01346540|26684451|P1|Overall Study|Adverse Event|0
7671703|NCT01346540|26684450|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
7671704|NCT01346540|26684451|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
7671705|NCT01346514|26684462|P2|Overall Study|Death|4
7671706|NCT01346514|26684463|P1|Overall Study|Death|3
7671707|NCT01346514|26684462|P2|Overall Study|Withdrawal by Subject|3
7671708|NCT01346514|26684463|P1|Overall Study|Withdrawal by Subject|7
7671709|NCT01346514|26684462|P2|Overall Study|Lost to Follow-up|30
7671710|NCT01346514|26684463|P1|Overall Study|Lost to Follow-up|19
7671711|NCT01346501|26684483|P2|Overall Study|Other|12
7671712|NCT01346501|26684484|P1|Overall Study|Other|8
7671713|NCT01346501|26684483|P2|Overall Study|Initiated Other Biological Agents|1
7671714|NCT01346501|26684484|P1|Overall Study|Initiated Other Biological Agents|3
7671715|NCT01346475|26684517|P2|First Intervention|Lost to Follow-up|3
7671716|NCT01346475|26684518|P1|First Intervention|Lost to Follow-up|4
7671717|NCT01346410|26684530|P1|Overall Study|Death|1
7671718|NCT01346371|26684548|P2|Overall Study|Lost to Follow-up|0
7671719|NCT01346371|26684549|P1|Overall Study|Lost to Follow-up|2
7671720|NCT01346293|26684557|P2|Overall Study|Other|0
7671721|NCT01346293|26684558|P1|Overall Study|Other|1
7671722|NCT01346293|26684557|P2|Overall Study|Withdrawal by Subject|4
7671723|NCT01346293|26684558|P1|Overall Study|Withdrawal by Subject|15
7671724|NCT01346293|26684557|P2|Overall Study|Lost to Follow-up|8
7671725|NCT01346293|26684558|P1|Overall Study|Lost to Follow-up|21
7671726|NCT01346293|26684557|P2|Overall Study|Protocol Violation|9
7671727|NCT01346293|26684558|P1|Overall Study|Protocol Violation|30
7671728|NCT01346189|26684601|P4|Overall Study|Travel|3
7671729|NCT01346189|26684602|P3|Overall Study|Travel|0
7671730|NCT01346189|26684603|P2|Overall Study|Travel|0
7671731|NCT01346189|26684604|P1|Overall Study|Travel|0
7671732|NCT01346189|26684601|P4|Overall Study|Non-health system primary care physician|0
7671733|NCT01346189|26684602|P3|Overall Study|Non-health system primary care physician|0
7671734|NCT01346189|26684603|P2|Overall Study|Non-health system primary care physician|5
7671735|NCT01346189|26684604|P1|Overall Study|Non-health system primary care physician|0
7671736|NCT01346189|26684601|P4|Overall Study|Death|0
7671737|NCT01346189|26684602|P3|Overall Study|Death|0
7671738|NCT01346189|26684603|P2|Overall Study|Death|3
7671739|NCT01346189|26684604|P1|Overall Study|Death|0
7671740|NCT01346189|26684601|P4|Overall Study|Other|3
7671741|NCT01346189|26684602|P3|Overall Study|Other|7
7671742|NCT01346189|26684603|P2|Overall Study|Other|4
7671743|NCT01346189|26684604|P1|Overall Study|Other|2
7671744|NCT01346189|26684601|P4|Overall Study|Moved|0
7671745|NCT01346189|26684602|P3|Overall Study|Moved|4
7671746|NCT01346189|26684603|P2|Overall Study|Moved|0
7671747|NCT01346189|26684604|P1|Overall Study|Moved|3
7671748|NCT01346189|26684601|P4|Overall Study|Physician Decision|0
7671749|NCT01346189|26684602|P3|Overall Study|Physician Decision|0
7671750|NCT01346189|26684603|P2|Overall Study|Physician Decision|0
7671751|NCT01346189|26684604|P1|Overall Study|Physician Decision|4
7671752|NCT01346189|26684601|P4|Overall Study|Withdrawal by Subject|5
7671753|NCT01346189|26684602|P3|Overall Study|Withdrawal by Subject|3
7671754|NCT01346189|26684603|P2|Overall Study|Withdrawal by Subject|5
7671755|NCT01346189|26684604|P1|Overall Study|Withdrawal by Subject|7
7671756|NCT01346176|26684621|P3|Completed Satisfaction Survey|Lost to Follow-up|4
7671757|NCT01346176|26684622|P2|Completed Satisfaction Survey|Lost to Follow-up|4
7671758|NCT01346176|26684623|P1|Completed Satisfaction Survey|Lost to Follow-up|3
7671759|NCT01346176|26684621|P3|Completed Satisfaction Survey|Death|2
7671760|NCT01346176|26684622|P2|Completed Satisfaction Survey|Death|0
7671761|NCT01346176|26684623|P1|Completed Satisfaction Survey|Death|3
7671762|NCT01346176|26684621|P3|Completed Advance Directive|Other reason did not complete AD|7
7671763|NCT01346176|26684622|P2|Completed Advance Directive|Other reason did not complete AD|12
7671764|NCT01346176|26684623|P1|Completed Advance Directive|Other reason did not complete AD|7
7671765|NCT01346176|26684621|P3|Completed Advance Directive|Became Ineligible|1
7671766|NCT01346176|26684622|P2|Completed Advance Directive|Became Ineligible|0
7671767|NCT01346176|26684623|P1|Completed Advance Directive|Became Ineligible|3
7671768|NCT01346176|26684621|P3|Completed Advance Directive|Death|2
7671769|NCT01346176|26684622|P2|Completed Advance Directive|Death|2
7671770|NCT01346176|26684623|P1|Completed Advance Directive|Death|3
7671771|NCT01346176|26684621|P3|Recruited|Protocol Violation|0
7671772|NCT01346176|26684622|P2|Recruited|Protocol Violation|0
7671773|NCT01346176|26684623|P1|Recruited|Protocol Violation|1
7671774|NCT01346059|26684652|P2|Overall Study|Withdrawal by Subject|0
7671775|NCT01346059|26684653|P1|Overall Study|Withdrawal by Subject|1
7671776|NCT01345929|26684665|P2|Overall Study|Patient withdrawal|1
7671777|NCT01345929|26684666|P1|Overall Study|Patient withdrawal|0
7671778|NCT01345929|26684665|P2|Overall Study|40,000 CFU/ML|0
7671779|NCT01345929|26684666|P1|Overall Study|40,000 CFU/ML|1
7671780|NCT01345929|26684665|P2|Overall Study|Didn't meet eligibility criteria|0
7671781|NCT01345929|26684666|P1|Overall Study|Didn't meet eligibility criteria|2
7671782|NCT01345929|26684665|P2|Overall Study|Adverse Event|1
7671783|NCT01345929|26684666|P1|Overall Study|Adverse Event|0
7671784|NCT01345929|26684665|P2|Overall Study|Lost to Follow-up|9
7671785|NCT01345929|26684666|P1|Overall Study|Lost to Follow-up|9
7671786|NCT01345929|26684665|P2|Overall Study|Withdrawal by Subject|8
7671787|NCT01345929|26684666|P1|Overall Study|Withdrawal by Subject|9
7671788|NCT01345786|26684678|P4|Overall Study|Lost to Follow-up|2
7671789|NCT01345786|26684679|P3|Overall Study|Lost to Follow-up|0
7671790|NCT01345786|26684680|P2|Overall Study|Lost to Follow-up|0
7671791|NCT01345786|26684681|P1|Overall Study|Lost to Follow-up|0
7671792|NCT01345786|26684678|P4|Overall Study|Administrative|0
7671793|NCT01345786|26684679|P3|Overall Study|Administrative|0
7671794|NCT01345786|26684680|P2|Overall Study|Administrative|5
7671795|NCT01345786|26684681|P1|Overall Study|Administrative|3
7671796|NCT01345786|26684678|P4|Overall Study|Noncompliance with protocol|0
7671797|NCT01345786|26684679|P3|Overall Study|Noncompliance with protocol|1
7671798|NCT01345786|26684680|P2|Overall Study|Noncompliance with protocol|0
7671799|NCT01345786|26684681|P1|Overall Study|Noncompliance with protocol|1
7671800|NCT01345786|26684678|P4|Overall Study|Subject withdrew consent|0
7671801|NCT01345786|26684679|P3|Overall Study|Subject withdrew consent|1
7671802|NCT01345786|26684680|P2|Overall Study|Subject withdrew consent|2
7671803|NCT01345786|26684681|P1|Overall Study|Subject withdrew consent|2
7671804|NCT01345786|26684678|P4|Overall Study|Adverse Event|1
7671805|NCT01345786|26684679|P3|Overall Study|Adverse Event|3
7671806|NCT01345786|26684680|P2|Overall Study|Adverse Event|1
7671807|NCT01345786|26684681|P1|Overall Study|Adverse Event|0
7671808|NCT01345682|26684761|P2|Overall Study|Reason other than those specified above|3
7671809|NCT01345682|26684762|P1|Overall Study|Reason other than those specified above|4
7671810|NCT01345682|26684761|P2|Overall Study|Not treated|1
7671811|NCT01345682|26684762|P1|Overall Study|Not treated|2
7671812|NCT01345682|26684761|P2|Overall Study|Refused to continue trial medication|9
7671813|NCT01345682|26684762|P1|Overall Study|Refused to continue trial medication|16
7671814|NCT01345682|26684761|P2|Overall Study|Lost to Follow-up|1
7671815|NCT01345682|26684762|P1|Overall Study|Lost to Follow-up|0
7671816|NCT01345682|26684761|P2|Overall Study|Non-compliance with protocol|1
7671817|NCT01345682|26684762|P1|Overall Study|Non-compliance with protocol|0
7671818|NCT01345682|26684761|P2|Overall Study|Adverse Event|41
7671819|NCT01345682|26684762|P1|Overall Study|Adverse Event|51
7671820|NCT01345682|26684761|P2|Overall Study|Worsening of underlying cancer disease|12
7671821|NCT01345682|26684762|P1|Overall Study|Worsening of underlying cancer disease|23
7671822|NCT01345682|26684761|P2|Overall Study|Progressive disease per RECIST|93
7671823|NCT01345682|26684762|P1|Overall Study|Progressive disease per RECIST|226
7671824|NCT01345669|26684796|P2|Overall Study|Other Reasons|60
7671825|NCT01345669|26684797|P1|Overall Study|Other Reasons|111
7671826|NCT01345669|26684796|P2|Overall Study|Withdrawal by Subject|13
7671827|NCT01345669|26684797|P1|Overall Study|Withdrawal by Subject|52
7671828|NCT01345669|26684796|P2|Overall Study|Lost to Follow-up|1
7671829|NCT01345669|26684797|P1|Overall Study|Lost to Follow-up|1
7671830|NCT01345669|26684796|P2|Overall Study|Protocol Violation|1
7671831|NCT01345669|26684797|P1|Overall Study|Protocol Violation|3
7671832|NCT01345669|26684796|P2|Overall Study|Adverse Event|9
7671833|NCT01345669|26684797|P1|Overall Study|Adverse Event|63
7671834|NCT01345669|26684796|P2|Overall Study|Second primary tumour|3
7671835|NCT01345669|26684797|P1|Overall Study|Second primary tumour|4
7671836|NCT01345669|26684796|P2|Overall Study|Primary tumour recurrence|32
7671837|NCT01345669|26684797|P1|Overall Study|Primary tumour recurrence|53
7671838|NCT01345630|26684815|P2|Overall Study|Insufficient clinical response|11
7671839|NCT01345630|26684816|P1|Overall Study|Insufficient clinical response|48
7671840|NCT01345630|26684815|P2|Overall Study|No longer willing to participate|12
7671841|NCT01345630|26684816|P1|Overall Study|No longer willing to participate|9
7671842|NCT01345630|26684815|P2|Overall Study|Withdrawn due to pregnancy|2
7671843|NCT01345630|26684816|P1|Overall Study|Withdrawn due to pregnancy|1
7671844|NCT01345630|26684815|P2|Overall Study|Other reasons|8
7671845|NCT01345630|26684816|P1|Overall Study|Other reasons|6
7671846|NCT01345630|26684815|P2|Overall Study|Study terminated by sponsor|285
7671847|NCT01345630|26684816|P1|Overall Study|Study terminated by sponsor|254
7671848|NCT01345630|26684815|P2|Overall Study|Medication error without associated AE|1
7671849|NCT01345630|26684816|P1|Overall Study|Medication error without associated AE|0
7671850|NCT01345630|26684815|P2|Overall Study|Protocol Violation|1
7671851|NCT01345630|26684816|P1|Overall Study|Protocol Violation|4
7671852|NCT01345630|26684815|P2|Overall Study|Lost to Follow-up|16
7671853|NCT01345630|26684816|P1|Overall Study|Lost to Follow-up|17
7671854|NCT01345630|26684815|P2|Overall Study|Adverse Event|23
7671855|NCT01345630|26684816|P1|Overall Study|Adverse Event|22
7671856|NCT01345591|26684872|P1|Overall Study|Lost to Follow-up|1
7671857|NCT01345318|26684888|P1|Overall Study|Other|3
7671858|NCT01345318|26684888|P1|Overall Study|Withdrawal by Subject|41
7671859|NCT01345318|26684888|P1|Overall Study|Protocol Violation|1
7671860|NCT01345318|26684888|P1|Overall Study|Lost to Follow-up|2
7671861|NCT01345318|26684888|P1|Overall Study|Lack of Efficacy|17
7671862|NCT01345318|26684888|P1|Overall Study|Adverse Event|16
7671863|NCT01345292|26684896|P3|Overall Study|Withdrawal by Subject|1
7671864|NCT01345292|26684897|P2|Overall Study|Withdrawal by Subject|0
7671865|NCT01345292|26684898|P1|Overall Study|Withdrawal by Subject|2
7671866|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
7671867|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
7671868|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
7671869|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
7671870|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
7671871|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
7671872|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
7671873|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
7671874|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
7671875|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
7671876|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
7671877|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
7671878|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
7671879|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
7671880|NCT01345253|26684929|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
7671881|NCT01345253|26684930|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
7671882|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
7671883|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
7671884|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
7671885|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
7671886|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
7671887|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
7671888|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
7671889|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
7671890|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
7671891|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
7671892|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
7671893|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
7671894|NCT01345253|26684929|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
7671895|NCT01345253|26684930|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
7671896|NCT01345240|26684951|P5|Overall Study|Lost to Follow-up|9
7671897|NCT01345240|26684952|P4|Overall Study|Lost to Follow-up|7
7671898|NCT01345240|26684953|P3|Overall Study|Lost to Follow-up|14
7671899|NCT01345240|26684954|P2|Overall Study|Lost to Follow-up|9
7671900|NCT01345240|26684955|P1|Overall Study|Lost to Follow-up|8
7671901|NCT01345240|26684951|P5|Overall Study|Adverse Event|1
7671902|NCT01345240|26684952|P4|Overall Study|Adverse Event|2
7671903|NCT01345240|26684953|P3|Overall Study|Adverse Event|4
7671904|NCT01345240|26684954|P2|Overall Study|Adverse Event|5
7671905|NCT01345240|26684955|P1|Overall Study|Adverse Event|3
7671906|NCT01345188|26685075|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
7671907|NCT01345188|26685075|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
7671908|NCT01345162|26685087|P2|Overall Study|Protocol Violation|4
7671909|NCT01345162|26685088|P1|Overall Study|Protocol Violation|2
7671910|NCT01345123|26685097|P3|Overall Study|participants no longer with health plan|88
7671911|NCT01345123|26685098|P2|Overall Study|participants no longer with health plan|85
7671912|NCT01345123|26685099|P1|Overall Study|participants no longer with health plan|79
7671913|NCT01345058|26685121|P2|Overall Study|Participant No-Show at Multiple Visits|0
7671914|NCT01345058|26685122|P1|Overall Study|Participant No-Show at Multiple Visits|1
7671915|NCT01345058|26685121|P2|Overall Study|Participant Stopped Taking Study Drug|0
7671916|NCT01345058|26685122|P1|Overall Study|Participant Stopped Taking Study Drug|1
7671917|NCT01345058|26685121|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
7671918|NCT01345058|26685122|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
7671919|NCT01345058|26685121|P2|Overall Study|Participant Reported Increase in Events|0
7671920|NCT01345058|26685122|P1|Overall Study|Participant Reported Increase in Events|1
7671921|NCT01345058|26685121|P2|Overall Study|Withdrawal by Subject|0
7671922|NCT01345058|26685122|P1|Overall Study|Withdrawal by Subject|1
7671923|NCT01345019|26685138|P2|Open Label Treatment Phase|Protocol Violation|1
7671924|NCT01345019|26685139|P1|Open Label Treatment Phase|Protocol Violation|0
7671925|NCT01345019|26685138|P2|Open Label Treatment Phase|Other, Not Specified|7
7671926|NCT01345019|26685139|P1|Open Label Treatment Phase|Other, Not Specified|9
7671927|NCT01345019|26685138|P2|Open Label Treatment Phase|Pregnancy|0
7671928|NCT01345019|26685139|P1|Open Label Treatment Phase|Pregnancy|1
7671929|NCT01345019|26685138|P2|Open Label Treatment Phase|Lost to Follow-up|2
7671930|NCT01345019|26685139|P1|Open Label Treatment Phase|Lost to Follow-up|1
7671931|NCT01345019|26685138|P2|Open Label Treatment Phase|Noncompliance|4
7671932|NCT01345019|26685139|P1|Open Label Treatment Phase|Noncompliance|5
7671933|NCT01345019|26685138|P2|Open Label Treatment Phase|Disease Progression|18
7671934|NCT01345019|26685139|P1|Open Label Treatment Phase|Disease Progression|17
7671935|NCT01345019|26685138|P2|Open Label Treatment Phase|Administrative Decision|15
7671936|NCT01345019|26685139|P1|Open Label Treatment Phase|Administrative Decision|30
7671937|NCT01345019|26685138|P2|Open Label Treatment Phase|Adverse Event|51
7671938|NCT01345019|26685139|P1|Open Label Treatment Phase|Adverse Event|30
7671939|NCT01345019|26685138|P2|Open Label Treatment Phase|Withdrawal by Subject|47
7671940|NCT01345019|26685139|P1|Open Label Treatment Phase|Withdrawal by Subject|49
7671941|NCT01345019|26685138|P2|Open Label Treatment Phase|Death|48
7671942|NCT01345019|26685139|P1|Open Label Treatment Phase|Death|49
7671943|NCT01345019|26685138|P2|Blinded Treatment Phase|Lost to Follow-up|3
7671944|NCT01345019|26685139|P1|Blinded Treatment Phase|Lost to Follow-up|6
7671945|NCT01345019|26685138|P2|Blinded Treatment Phase|Other, Not Specified|3
7671946|NCT01345019|26685139|P1|Blinded Treatment Phase|Other, Not Specified|2
7671947|NCT01345019|26685138|P2|Blinded Treatment Phase|Protocol Deviation|0
7671948|NCT01345019|26685139|P1|Blinded Treatment Phase|Protocol Deviation|5
7671949|NCT01345019|26685138|P2|Blinded Treatment Phase|Ineligibility Determined|6
7671950|NCT01345019|26685139|P1|Blinded Treatment Phase|Ineligibility Determined|1
7671951|NCT01345019|26685138|P2|Blinded Treatment Phase|Noncompliance|3
7671952|NCT01345019|26685139|P1|Blinded Treatment Phase|Noncompliance|5
7671953|NCT01345019|26685138|P2|Blinded Treatment Phase|Administrative Decision|8
7671954|NCT01345019|26685139|P1|Blinded Treatment Phase|Administrative Decision|10
7671955|NCT01345019|26685138|P2|Blinded Treatment Phase|Adverse Event|13
7671956|NCT01345019|26685139|P1|Blinded Treatment Phase|Adverse Event|6
7671957|NCT01345019|26685138|P2|Blinded Treatment Phase|Disease Progression|10
7671958|NCT01345019|26685139|P1|Blinded Treatment Phase|Disease Progression|12
7671959|NCT01345019|26685138|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
7671960|NCT01345019|26685139|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
7671961|NCT01345019|26685138|P2|Blinded Treatment Phase|Withdrawal by Subject|112
7671962|NCT01345019|26685139|P1|Blinded Treatment Phase|Withdrawal by Subject|103
7671963|NCT01345019|26685138|P2|Blinded Treatment Phase|Death|137
7671964|NCT01345019|26685139|P1|Blinded Treatment Phase|Death|147
7671965|NCT01344876|26685161|P5|Overall Study|Definite progression of primary disease|0
7671966|NCT01344876|26685162|P4|Overall Study|Definite progression of primary disease|3
7671967|NCT01344876|26685163|P3|Overall Study|Definite progression of primary disease|0
7671968|NCT01344876|26685164|P2|Overall Study|Definite progression of primary disease|0
7671969|NCT01344876|26685165|P1|Overall Study|Definite progression of primary disease|1
7671970|NCT01344876|26685161|P5|Overall Study|Withdrawal by Subject|0
7671971|NCT01344876|26685162|P4|Overall Study|Withdrawal by Subject|0
7671972|NCT01344876|26685163|P3|Overall Study|Withdrawal by Subject|1
7671973|NCT01344876|26685164|P2|Overall Study|Withdrawal by Subject|0
7671974|NCT01344876|26685165|P1|Overall Study|Withdrawal by Subject|0
7671975|NCT01344876|26685161|P5|Overall Study|Adverse Event|1
7671976|NCT01344876|26685162|P4|Overall Study|Adverse Event|0
7671977|NCT01344876|26685163|P3|Overall Study|Adverse Event|0
7671978|NCT01344876|26685164|P2|Overall Study|Adverse Event|0
7671979|NCT01344876|26685165|P1|Overall Study|Adverse Event|0
7671980|NCT01344824|26685179|P1|Overall Study|Progression|15
7671981|NCT01344824|26685179|P1|Overall Study|Other complicating disease|1
7671982|NCT01344824|26685179|P1|Overall Study|Withdrawal by Subject|6
7671983|NCT01344824|26685179|P1|Overall Study|Adverse Event|15
7671984|NCT01344759|26685187|P2|Overall Study|Patients failed to reach sedation level|2
7671985|NCT01344759|26685188|P1|Overall Study|Patients failed to reach sedation level|0
7671986|NCT01344629|26685220|P2|Crossover Period 2|Withdrawal by Subject|1
7671987|NCT01344629|26685221|P1|Crossover Period 2|Withdrawal by Subject|0
7671988|NCT01344538|26685250|P2|Overall Study|Lost to Follow-up|0
7671989|NCT01344538|26685251|P1|Overall Study|Lost to Follow-up|1
7671990|NCT01344538|26685250|P2|Overall Study|Adverse Event|1
7671991|NCT01344538|26685251|P1|Overall Study|Adverse Event|1
7671992|NCT01344460|26685257|P1|Overall Study|Lost to Follow-up|2
7671993|NCT01344460|26685257|P1|Overall Study|Withdrawal by Subject|1
7671994|NCT01344447|26685302|P1|Overall Study|Error of power injector|1
7671995|NCT01344447|26685302|P1|Overall Study|Bolus tracking failed|1
7671996|NCT01344447|26685302|P1|Overall Study|MRA unsuccessful|1
7671997|NCT01344447|26685302|P1|Overall Study|Physician Decision|1
7671998|NCT01344447|26685302|P1|Overall Study|The contrast was not seen|1
7671999|NCT01344447|26685302|P1|Overall Study|Withdrawal by Subject|1
7672000|NCT01344447|26685302|P1|Overall Study|Protocol Violation|1
7672001|NCT01344447|26685302|P1|Overall Study|Adverse Event|1
7672002|NCT01344369|26685346|P2|Second Intervention|Emesis within 2 x Tmax|1
7672003|NCT01344369|26685347|P1|Second Intervention|Emesis within 2 x Tmax|0
7672004|NCT01344369|26685346|P2|Washout of 28 Days|Physician Decision|1
7672005|NCT01344369|26685347|P1|Washout of 28 Days|Physician Decision|0
7672006|NCT01344369|26685346|P2|Washout of 28 Days|Withdrawal by Subject|0
7672007|NCT01344369|26685347|P1|Washout of 28 Days|Withdrawal by Subject|1
7672008|NCT01344356|26685365|P2|Overall Study|Lost to Follow-up|6
7672009|NCT01344356|26685366|P1|Overall Study|Lost to Follow-up|0
7672010|NCT01344356|26685365|P2|Overall Study|Physician Decision|3
7672011|NCT01344356|26685366|P1|Overall Study|Physician Decision|0
7672012|NCT01344226|26685378|P1|Overall Study|Lack of Efficacy|3
7672013|NCT01344226|26685378|P1|Overall Study|Withdrawal by Subject|3
7672014|NCT01344226|26685378|P1|Overall Study|Protocol Violation|2
7672015|NCT01344161|26685387|P2|Overall Study|Protocol Violation|1
7672016|NCT01344161|26685388|P1|Overall Study|Protocol Violation|1
7672017|NCT01344161|26685387|P2|Overall Study|Pregnancy|1
7672018|NCT01344161|26685388|P1|Overall Study|Pregnancy|0
7672019|NCT01344161|26685387|P2|Overall Study|Lost to Follow-up|1
7672020|NCT01344161|26685388|P1|Overall Study|Lost to Follow-up|4
7672021|NCT01344057|26685400|P1|Overall Study|Premature Withdrawal|1
7672022|NCT01343901|26685407|P1|Overall Study|Participant decision|1
7672023|NCT01343901|26685407|P1|Overall Study|Management by another medical team|11
7672024|NCT01343901|26685407|P1|Overall Study|Lost to Follow-up|12
7672025|NCT01343901|26685407|P1|Overall Study|Physician Decision|4
7672026|NCT01343901|26685407|P1|Overall Study|Death|85
7672027|NCT01343888|26685431|P3|Overall Study|other than stated above|1
7672028|NCT01343888|26685432|P2|Overall Study|other than stated above|0
7672029|NCT01343888|26685433|P1|Overall Study|other than stated above|0
7672030|NCT01343888|26685431|P3|Overall Study|Withdrawal by Subject|2
7672031|NCT01343888|26685432|P2|Overall Study|Withdrawal by Subject|4
7672032|NCT01343888|26685433|P1|Overall Study|Withdrawal by Subject|4
7672033|NCT01343888|26685431|P3|Overall Study|Protocol Violation|0
7672034|NCT01343888|26685432|P2|Overall Study|Protocol Violation|2
7672035|NCT01343888|26685433|P1|Overall Study|Protocol Violation|0
7672036|NCT01343888|26685431|P3|Overall Study|Lost to Follow-up|1
7672037|NCT01343888|26685432|P2|Overall Study|Lost to Follow-up|2
7672038|NCT01343888|26685433|P1|Overall Study|Lost to Follow-up|0
7672039|NCT01343888|26685431|P3|Overall Study|Lack of Efficacy|13
7672040|NCT01343888|26685432|P2|Overall Study|Lack of Efficacy|9
7672041|NCT01343888|26685433|P1|Overall Study|Lack of Efficacy|9
7672042|NCT01343888|26685431|P3|Overall Study|Adverse Event|5
7672043|NCT01343888|26685432|P2|Overall Study|Adverse Event|22
7672044|NCT01343888|26685433|P1|Overall Study|Adverse Event|12
7672045|NCT01343823|26685475|P4|Overall Study|Withdrawal by Subject|0
7672046|NCT01343823|26685476|P3|Overall Study|Withdrawal by Subject|0
7672047|NCT01343823|26685477|P2|Overall Study|Withdrawal by Subject|0
7672048|NCT01343823|26685478|P1|Overall Study|Withdrawal by Subject|1
7672049|NCT01343823|26685475|P4|Overall Study|Study Terminated|1
7672050|NCT01343823|26685476|P3|Overall Study|Study Terminated|0
7672051|NCT01343823|26685477|P2|Overall Study|Study Terminated|0
7672052|NCT01343823|26685478|P1|Overall Study|Study Terminated|1
7672053|NCT01343693|26685492|P1|Overall Study|Lost to Follow-up|9
7672054|NCT01343407|26685515|P6|Second Washout (Part 2)|Withdrawal by Subject|0
7672055|NCT01343407|26685516|P5|Second Washout (Part 2)|Withdrawal by Subject|0
7672056|NCT01343407|26685517|P4|Second Washout (Part 2)|Withdrawal by Subject|0
7672057|NCT01343407|26685518|P3|Second Washout (Part 2)|Withdrawal by Subject|1
7672058|NCT01343407|26685519|P2|Second Washout (Part 2)|Withdrawal by Subject|0
7672059|NCT01343407|26685520|P1|Second Washout (Part 2)|Withdrawal by Subject|0
7672060|NCT01343407|26685515|P6|Second Treatment Period (Part 2)|Adverse Event|0
7672061|NCT01343407|26685516|P5|Second Treatment Period (Part 2)|Adverse Event|0
7672062|NCT01343407|26685517|P4|Second Treatment Period (Part 2)|Adverse Event|0
7672063|NCT01343407|26685518|P3|Second Treatment Period (Part 2)|Adverse Event|1
7672064|NCT01343407|26685519|P2|Second Treatment Period (Part 2)|Adverse Event|0
7672065|NCT01343407|26685520|P1|Second Treatment Period (Part 2)|Adverse Event|0
7672066|NCT01343368|26685548|P2|Overall Study|Lost to Follow-up|0
7672067|NCT01343368|26685549|P1|Overall Study|Lost to Follow-up|1
7672068|NCT01343368|26685548|P2|Overall Study|Death|0
7672069|NCT01343368|26685549|P1|Overall Study|Death|1
7672070|NCT01343277|26685585|P2|Overall Study|Subsequent anticancer therapy|0
7672071|NCT01343277|26685586|P1|Overall Study|Subsequent anticancer therapy|1
7672072|NCT01343277|26685585|P2|Overall Study|Treatment ongoing|2
7672073|NCT01343277|26685586|P1|Overall Study|Treatment ongoing|8
7672074|NCT01343277|26685585|P2|Overall Study|Randomized not treated|21
7672075|NCT01343277|26685586|P1|Overall Study|Randomized not treated|6
7672076|NCT01343277|26685585|P2|Overall Study|Disease progression|138
7672077|NCT01343277|26685586|P1|Overall Study|Disease progression|270
7672078|NCT01343277|26685585|P2|Overall Study|Adverse Event|13
7672079|NCT01343277|26685586|P1|Overall Study|Adverse Event|67
7672080|NCT01343277|26685585|P2|Overall Study|Death|1
7672081|NCT01343277|26685586|P1|Overall Study|Death|10
7672082|NCT01343277|26685585|P2|Overall Study|Physician Decision|2
7672083|NCT01343277|26685586|P1|Overall Study|Physician Decision|1
7672084|NCT01343277|26685585|P2|Overall Study|Withdrawal by Subject|13
7672085|NCT01343277|26685586|P1|Overall Study|Withdrawal by Subject|18
7672086|NCT01343277|26685585|P2|Overall Study|Other|3
7672087|NCT01343277|26685586|P1|Overall Study|Other|3
7672088|NCT01343082|26685658|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
7672089|NCT01343082|26685659|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
7672090|NCT01343082|26685660|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
7672091|NCT01343082|26685658|P3|Treatment Period , Switched to DE-111|Physician Decision|2
7672092|NCT01343082|26685659|P2|Treatment Period , Switched to DE-111|Physician Decision|2
7672093|NCT01343082|26685660|P1|Treatment Period , Switched to DE-111|Physician Decision|0
7672094|NCT01343082|26685658|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
7672095|NCT01343082|26685659|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
7672096|NCT01343082|26685660|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
7672097|NCT01343082|26685658|P3|Treatment Period , Switched to DE-111|Adverse Event|3
7672098|NCT01343082|26685659|P2|Treatment Period , Switched to DE-111|Adverse Event|4
7672099|NCT01343082|26685660|P1|Treatment Period , Switched to DE-111|Adverse Event|1
7672100|NCT01343082|26685658|P3|The run-in Period|Not meeting criteria|5
7672101|NCT01343082|26685659|P2|The run-in Period|Not meeting criteria|4
7672102|NCT01343082|26685660|P1|The run-in Period|Not meeting criteria|3
7672103|NCT01343056|26685668|P4|Overall Study|Lost to Follow-up|9
7672104|NCT01343056|26685669|P3|Overall Study|Lost to Follow-up|3
7672105|NCT01343056|26685670|P2|Overall Study|Lost to Follow-up|5
7672106|NCT01343056|26685671|P1|Overall Study|Lost to Follow-up|7
7672107|NCT01343043|26685713|P4|Overall Study|Death|1
7672108|NCT01343043|26685714|P3|Overall Study|Death|0
7672109|NCT01343043|26685715|P2|Overall Study|Death|1
7672110|NCT01343043|26685716|P1|Overall Study|Death|1
7672111|NCT01343043|26685713|P4|Overall Study|Withdrawal by Subject|0
7672112|NCT01343043|26685714|P3|Overall Study|Withdrawal by Subject|0
7672113|NCT01343043|26685715|P2|Overall Study|Withdrawal by Subject|0
7672114|NCT01343043|26685716|P1|Overall Study|Withdrawal by Subject|1
7672115|NCT01343043|26685713|P4|Overall Study|Disease progression before treatment|0
7672116|NCT01343043|26685714|P3|Overall Study|Disease progression before treatment|0
7672117|NCT01343043|26685715|P2|Overall Study|Disease progression before treatment|0
7672118|NCT01343043|26685716|P1|Overall Study|Disease progression before treatment|1
7672119|NCT01342965|26685808|P2|Overall Study|Withdrawal by Subject|9
7672120|NCT01342965|26685809|P1|Overall Study|Withdrawal by Subject|2
7672121|NCT01342965|26685808|P2|Overall Study|Other Reasons- Unspecified|38
7672122|NCT01342965|26685809|P1|Overall Study|Other Reasons- Unspecified|44
7672123|NCT01342965|26685808|P2|Overall Study|Lost to Follow-up|3
7672124|NCT01342965|26685809|P1|Overall Study|Lost to Follow-up|5
7672125|NCT01342965|26685808|P2|Overall Study|Death|57
7672126|NCT01342965|26685809|P1|Overall Study|Death|58
7672127|NCT01342926|26685827|P4|Overall Study|Withdrawal by Subject|5
7672128|NCT01342926|26685828|P3|Overall Study|Withdrawal by Subject|3
7672129|NCT01342926|26685829|P2|Overall Study|Withdrawal by Subject|4
7672130|NCT01342926|26685830|P1|Overall Study|Withdrawal by Subject|2
7672131|NCT01342926|26685827|P4|Overall Study|Investigator Discretion|0
7672132|NCT01342926|26685828|P3|Overall Study|Investigator Discretion|0
7672133|NCT01342926|26685829|P2|Overall Study|Investigator Discretion|2
7672134|NCT01342926|26685830|P1|Overall Study|Investigator Discretion|2
7672135|NCT01342926|26685827|P4|Overall Study|Lost to Follow-up|0
7672136|NCT01342926|26685828|P3|Overall Study|Lost to Follow-up|1
7672137|NCT01342926|26685829|P2|Overall Study|Lost to Follow-up|1
7672138|NCT01342926|26685830|P1|Overall Study|Lost to Follow-up|0
7672139|NCT01342926|26685827|P4|Overall Study|Adverse Event|7
7672140|NCT01342926|26685828|P3|Overall Study|Adverse Event|10
7672141|NCT01342926|26685829|P2|Overall Study|Adverse Event|8
7672142|NCT01342926|26685830|P1|Overall Study|Adverse Event|5
7672143|NCT01342913|26685910|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
7672144|NCT01342913|26685911|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
7672145|NCT01342913|26685912|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7672146|NCT01342913|26685910|P3|Double-Blind Treatment Period|Physician Decision|0
7672147|NCT01342913|26685911|P2|Double-Blind Treatment Period|Physician Decision|2
7672148|NCT01342913|26685912|P1|Double-Blind Treatment Period|Physician Decision|0
7672149|NCT01342913|26685910|P3|Double-Blind Treatment Period|Lost to Follow-up|3
7672150|NCT01342913|26685911|P2|Double-Blind Treatment Period|Lost to Follow-up|1
7672151|NCT01342913|26685912|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7672152|NCT01342913|26685910|P3|Double-Blind Treatment Period|Protocol Violation|9
7672153|NCT01342913|26685911|P2|Double-Blind Treatment Period|Protocol Violation|6
7672154|NCT01342913|26685912|P1|Double-Blind Treatment Period|Protocol Violation|0
7672155|NCT01342913|26685910|P3|Double-Blind Treatment Period|Lack of Efficacy|3
7672156|NCT01342913|26685911|P2|Double-Blind Treatment Period|Lack of Efficacy|2
7672157|NCT01342913|26685912|P1|Double-Blind Treatment Period|Lack of Efficacy|0
7672158|NCT01342913|26685910|P3|Double-Blind Treatment Period|Adverse Event|6
7672159|NCT01342913|26685911|P2|Double-Blind Treatment Period|Adverse Event|3
7672160|NCT01342913|26685912|P1|Double-Blind Treatment Period|Adverse Event|0
7672161|NCT01342913|26685910|P3|2-week Run-in Period|Continuation Criteria Not Met|0
7672162|NCT01342913|26685911|P2|2-week Run-in Period|Continuation Criteria Not Met|0
7672163|NCT01342913|26685912|P1|2-week Run-in Period|Continuation Criteria Not Met|88
7672164|NCT01342913|26685910|P3|2-week Run-in Period|Protocol Violation|0
7672165|NCT01342913|26685911|P2|2-week Run-in Period|Protocol Violation|0
7672166|NCT01342913|26685912|P1|2-week Run-in Period|Protocol Violation|5
7672167|NCT01342913|26685910|P3|2-week Run-in Period|Adverse Event|0
7672168|NCT01342913|26685911|P2|2-week Run-in Period|Adverse Event|0
7672169|NCT01342913|26685912|P1|2-week Run-in Period|Adverse Event|2
7672170|NCT01342913|26685910|P3|2-week Run-in Period|Withdrawal by Subject|0
7672171|NCT01342913|26685911|P2|2-week Run-in Period|Withdrawal by Subject|0
7672172|NCT01342913|26685912|P1|2-week Run-in Period|Withdrawal by Subject|7
7672173|NCT01342913|26685910|P3|2-week Run-in Period|Physician Decision|0
7672174|NCT01342913|26685911|P2|2-week Run-in Period|Physician Decision|0
7672175|NCT01342913|26685912|P1|2-week Run-in Period|Physician Decision|6
7672176|NCT01342913|26685910|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7672177|NCT01342913|26685911|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7672178|NCT01342913|26685912|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
7672179|NCT01342887|26685922|P1|Overall Study|Death|2
7672180|NCT01342796|26685931|P2|Overall Study|Inappropriate enrollment|0
7672181|NCT01342796|26685932|P1|Overall Study|Inappropriate enrollment|1
7672182|NCT01342796|26685931|P2|Overall Study|Lost to Follow-up|3
7672183|NCT01342796|26685932|P1|Overall Study|Lost to Follow-up|0
7672184|NCT01342796|26685931|P2|Overall Study|Withdrawal by Subject|0
7672185|NCT01342796|26685932|P1|Overall Study|Withdrawal by Subject|2
7672186|NCT01342640|26685980|P1|Overall Study|Other|1
7672187|NCT01342640|26685980|P1|Overall Study|Lost to Follow-up|21
7672188|NCT01342640|26685980|P1|Overall Study|Protocol Violation|16
7672189|NCT01342640|26685980|P1|Overall Study|Adverse Event|3
7672190|NCT01342510|26686075|P4|Overall Study|Protocol Violation|11
7672191|NCT01342510|26686076|P3|Overall Study|Protocol Violation|13
7672192|NCT01342510|26686077|P2|Overall Study|Protocol Violation|6
7672193|NCT01342510|26686078|P1|Overall Study|Protocol Violation|12
7672194|NCT01342484|26686095|P3|Overall Study|Withdrawal by Subject|0
7672195|NCT01342484|26686096|P2|Overall Study|Withdrawal by Subject|0
7672196|NCT01342484|26686097|P1|Overall Study|Withdrawal by Subject|1
7672197|NCT01342484|26686095|P3|Overall Study|Protocol Violation|1
7672198|NCT01342484|26686096|P2|Overall Study|Protocol Violation|0
7672199|NCT01342484|26686097|P1|Overall Study|Protocol Violation|0
7672200|NCT01342484|26686095|P3|Overall Study|Other Reasons|0
7672201|NCT01342484|26686096|P2|Overall Study|Other Reasons|0
7672202|NCT01342484|26686097|P1|Overall Study|Other Reasons|1
7672203|NCT01342445|26686153|P2|Overall Study|Experienced side effects|2
7672204|NCT01342445|26686154|P1|Overall Study|Experienced side effects|0
7672205|NCT01342341|26686170|P2|Overall Study|Lost to Follow-up|4
7672206|NCT01342341|26686171|P1|Overall Study|Lost to Follow-up|4
7672207|NCT01342211|26686182|P5|Overall Study|Randomized, but not Treated|1
7672208|NCT01342211|26686183|P4|Overall Study|Randomized, but not Treated|0
7672209|NCT01342211|26686184|P3|Overall Study|Randomized, but not Treated|0
7672210|NCT01342211|26686185|P2|Overall Study|Randomized, but not Treated|2
7672211|NCT01342211|26686186|P1|Overall Study|Randomized, but not Treated|0
7672212|NCT01342211|26686182|P5|Overall Study|Withdrawal by Subject|0
7672213|NCT01342211|26686183|P4|Overall Study|Withdrawal by Subject|1
7672214|NCT01342211|26686184|P3|Overall Study|Withdrawal by Subject|0
7672215|NCT01342211|26686185|P2|Overall Study|Withdrawal by Subject|0
7672216|NCT01342211|26686186|P1|Overall Study|Withdrawal by Subject|0
7672217|NCT01342211|26686182|P5|Overall Study|Adverse Event|1
7672218|NCT01342211|26686183|P4|Overall Study|Adverse Event|0
7672219|NCT01342211|26686184|P3|Overall Study|Adverse Event|0
7672220|NCT01342211|26686185|P2|Overall Study|Adverse Event|0
7672221|NCT01342211|26686186|P1|Overall Study|Adverse Event|0
7672222|NCT01342211|26686182|P5|Overall Study|Lost to Follow-up|0
7672223|NCT01342211|26686183|P4|Overall Study|Lost to Follow-up|1
7672224|NCT01342211|26686184|P3|Overall Study|Lost to Follow-up|0
7672225|NCT01342211|26686185|P2|Overall Study|Lost to Follow-up|0
7672226|NCT01342211|26686186|P1|Overall Study|Lost to Follow-up|0
7672227|NCT01342094|26686274|P2|Overall Study|Withdrawal by Subject|2
7672228|NCT01342094|26686275|P1|Overall Study|Withdrawal by Subject|0
7672229|NCT01342094|26686274|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
7672230|NCT01342094|26686275|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
7672231|NCT01342094|26686274|P2|Overall Study|Adverse Event|0
7672232|NCT01342094|26686275|P1|Overall Study|Adverse Event|5
7672233|NCT01342081|26686284|P3|Overall Study|Withdrawal by Subject|0
7672234|NCT01342081|26686285|P2|Overall Study|Withdrawal by Subject|1
7672235|NCT01342081|26686286|P1|Overall Study|Withdrawal by Subject|1
7672236|NCT01342081|26686284|P3|Overall Study|Physician Decision|0
7672237|NCT01342081|26686285|P2|Overall Study|Physician Decision|1
7672238|NCT01342081|26686286|P1|Overall Study|Physician Decision|0
7672239|NCT01342081|26686284|P3|Overall Study|Adverse Event|0
7672240|NCT01342081|26686285|P2|Overall Study|Adverse Event|0
7672241|NCT01342081|26686286|P1|Overall Study|Adverse Event|1
7672242|NCT01342081|26686284|P3|Overall Study|Did not receive allocated intervention|1
7672243|NCT01342081|26686285|P2|Overall Study|Did not receive allocated intervention|0
7672244|NCT01342081|26686286|P1|Overall Study|Did not receive allocated intervention|0
7672245|NCT01341990|26686305|P2|Overall Study|Withdrawal by Subject|0
7672246|NCT01341990|26686306|P1|Overall Study|Withdrawal by Subject|2
7672247|NCT01341990|26686305|P2|Overall Study|Torn Study Lens|0
7672248|NCT01341990|26686306|P1|Overall Study|Torn Study Lens|1
7672249|NCT01341990|26686305|P2|Overall Study|Adverse Event|1
7672250|NCT01341990|26686306|P1|Overall Study|Adverse Event|0
7672251|NCT01341782|26686330|P2|Overall Study|Other|0
7672252|NCT01341782|26686331|P1|Overall Study|Other|5
7672253|NCT01341782|26686330|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
7672254|NCT01341782|26686331|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
7672255|NCT01341782|26686330|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
7672256|NCT01341782|26686331|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
7672257|NCT01341782|26686330|P2|Overall Study|Missed 3 consecutive doses|4
7672258|NCT01341782|26686331|P1|Overall Study|Missed 3 consecutive doses|0
7672259|NCT01341782|26686330|P2|Overall Study|Withdrawal by Subject|5
7672260|NCT01341782|26686331|P1|Overall Study|Withdrawal by Subject|6
7672261|NCT01341782|26686330|P2|Overall Study|Adverse Event|1
7672262|NCT01341782|26686331|P1|Overall Study|Adverse Event|1
7672263|NCT01341652|26686360|P2|Overall Study|ineligible; presence metastatic disease|1
7672264|NCT01341652|26686361|P1|Overall Study|ineligible; presence metastatic disease|0
7672265|NCT01341652|26686360|P2|Overall Study|Incorrect Random Assignment|1
7672266|NCT01341652|26686361|P1|Overall Study|Incorrect Random Assignment|0
7672267|NCT01341639|26686377|P2|Post-Treatment|Adverse Event|2
7672268|NCT01341639|26686378|P1|Post-Treatment|Adverse Event|0
7672269|NCT01341639|26686377|P2|Post-Treatment|Withdrawal by Subject|1
7672270|NCT01341639|26686378|P1|Post-Treatment|Withdrawal by Subject|0
7672271|NCT01341639|26686377|P2|Interim Period|Protocol Violation|1
7672272|NCT01341639|26686378|P1|Interim Period|Protocol Violation|0
7672273|NCT01341639|26686377|P2|Interim Period|Physician Decision|1
7672274|NCT01341639|26686378|P1|Interim Period|Physician Decision|0
7672275|NCT01341639|26686377|P2|Interim Period|Lost to Follow-up|0
7672276|NCT01341639|26686378|P1|Interim Period|Lost to Follow-up|2
7672277|NCT01341639|26686377|P2|Interim Period|Withdrawal by Subject|7
7672278|NCT01341639|26686378|P1|Interim Period|Withdrawal by Subject|6
7672279|NCT01341639|26686377|P2|Infant Series|Site 0048 Participants|16
7672280|NCT01341639|26686378|P1|Infant Series|Site 0048 Participants|17
7672281|NCT01341639|26686377|P2|Infant Series|Lost to Follow-up|2
7672282|NCT01341639|26686378|P1|Infant Series|Lost to Follow-up|0
7672283|NCT01341639|26686377|P2|Infant Series|Withdrawal by Subject|8
7672284|NCT01341639|26686378|P1|Infant Series|Withdrawal by Subject|11
7672285|NCT01341639|26686377|P2|Infant Series|Adverse Event|5
7672286|NCT01341639|26686378|P1|Infant Series|Adverse Event|0
7672287|NCT01341639|26686377|P2|Infant Series|Not Vaccinated|1
7672288|NCT01341639|26686378|P1|Infant Series|Not Vaccinated|0
7672289|NCT01341639|26686377|P2|Infant Series|Protocol Violation|0
7672290|NCT01341639|26686378|P1|Infant Series|Protocol Violation|1
7672291|NCT01341587|26686423|P2|Overall Study|stopped using the meters|10
7672292|NCT01341587|26686424|P1|Overall Study|stopped using the meters|2
7672293|NCT01341587|26686423|P2|Overall Study|Lost to Follow-up|0
7672294|NCT01341587|26686424|P1|Overall Study|Lost to Follow-up|2
7672295|NCT01341470|26686436|P6|Overall Study|Sponsor decision|1
7672296|NCT01341470|26686437|P5|Overall Study|Sponsor decision|0
7672297|NCT01341470|26686438|P4|Overall Study|Sponsor decision|1
7672298|NCT01341470|26686439|P3|Overall Study|Sponsor decision|1
7672299|NCT01341470|26686440|P2|Overall Study|Sponsor decision|0
7672300|NCT01341470|26686441|P1|Overall Study|Sponsor decision|0
7672301|NCT01341457|26686475|P2|Overall Study|Adverse Event|0
7672302|NCT01341457|26686476|P1|Overall Study|Adverse Event|2
7672303|NCT01340976|26686521|P6|Overall Study|Adverse Event|0
7672304|NCT01340976|26686522|P5|Overall Study|Adverse Event|0
7672305|NCT01340976|26686523|P4|Overall Study|Adverse Event|0
7672306|NCT01340976|26686524|P3|Overall Study|Adverse Event|0
7672307|NCT01340976|26686525|P2|Overall Study|Adverse Event|1
7672308|NCT01340976|26686526|P1|Overall Study|Adverse Event|0
7672309|NCT01340976|26686521|P6|Overall Study|Other anemia treatment|1
7672310|NCT01340976|26686522|P5|Overall Study|Other anemia treatment|0
7672311|NCT01340976|26686523|P4|Overall Study|Other anemia treatment|1
7672312|NCT01340976|26686524|P3|Overall Study|Other anemia treatment|2
7672313|NCT01340976|26686525|P2|Overall Study|Other anemia treatment|0
7672314|NCT01340976|26686526|P1|Overall Study|Other anemia treatment|1
7672315|NCT01340976|26686521|P6|Overall Study|Withdrawal by Subject|0
7672316|NCT01340976|26686522|P5|Overall Study|Withdrawal by Subject|1
7672317|NCT01340976|26686523|P4|Overall Study|Withdrawal by Subject|1
7672318|NCT01340976|26686524|P3|Overall Study|Withdrawal by Subject|0
7672319|NCT01340976|26686525|P2|Overall Study|Withdrawal by Subject|0
7672320|NCT01340976|26686526|P1|Overall Study|Withdrawal by Subject|0
7672321|NCT01340976|26686521|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7672322|NCT01340976|26686522|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7672323|NCT01340976|26686523|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7672324|NCT01340976|26686524|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7672325|NCT01340976|26686525|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7672326|NCT01340976|26686526|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
7672327|NCT01340976|26686521|P6|Overall Study|Death|0
7672328|NCT01340976|26686522|P5|Overall Study|Death|0
7672329|NCT01340976|26686523|P4|Overall Study|Death|0
7672330|NCT01340976|26686524|P3|Overall Study|Death|0
7672331|NCT01340976|26686525|P2|Overall Study|Death|1
7672332|NCT01340976|26686526|P1|Overall Study|Death|0
7672333|NCT01340976|26686521|P6|Overall Study|Physician Decision|0
7672334|NCT01340976|26686522|P5|Overall Study|Physician Decision|1
7672335|NCT01340976|26686523|P4|Overall Study|Physician Decision|1
7672336|NCT01340976|26686524|P3|Overall Study|Physician Decision|1
7672337|NCT01340976|26686525|P2|Overall Study|Physician Decision|0
7672338|NCT01340976|26686526|P1|Overall Study|Physician Decision|2
7672339|NCT01340937|26686564|P4|Period 3: Toddler Vaccinations|Technical problem|0
7672340|NCT01340937|26686565|P3|Period 3: Toddler Vaccinations|Technical problem|1
7672341|NCT01340937|26686566|P2|Period 3: Toddler Vaccinations|Technical problem|1
7672342|NCT01340937|26686567|P1|Period 3: Toddler Vaccinations|Technical problem|1
7672343|NCT01340937|26686564|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
7672344|NCT01340937|26686565|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
7672345|NCT01340937|26686566|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
7672346|NCT01340937|26686567|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
7672347|NCT01340937|26686564|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
7672348|NCT01340937|26686565|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
7672349|NCT01340937|26686566|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
7672350|NCT01340937|26686567|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
7672351|NCT01340937|26686564|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
7672352|NCT01340937|26686565|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
7672353|NCT01340937|26686566|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
7672354|NCT01340937|26686567|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
7672355|NCT01340937|26686564|P4|Period 2: Interim Period|Technical problems|3
7672356|NCT01340937|26686565|P3|Period 2: Interim Period|Technical problems|6
7672357|NCT01340937|26686566|P2|Period 2: Interim Period|Technical problems|4
7672358|NCT01340937|26686567|P1|Period 2: Interim Period|Technical problems|4
7672359|NCT01340937|26686564|P4|Period 2: Interim Period|Protocol Violation|3
7672360|NCT01340937|26686565|P3|Period 2: Interim Period|Protocol Violation|6
7672361|NCT01340937|26686566|P2|Period 2: Interim Period|Protocol Violation|3
7672362|NCT01340937|26686567|P1|Period 2: Interim Period|Protocol Violation|5
7672363|NCT01340937|26686564|P4|Period 2: Interim Period|Physician Decision|0
7672364|NCT01340937|26686565|P3|Period 2: Interim Period|Physician Decision|1
7672365|NCT01340937|26686566|P2|Period 2: Interim Period|Physician Decision|1
7672366|NCT01340937|26686567|P1|Period 2: Interim Period|Physician Decision|0
7672367|NCT01340937|26686564|P4|Period 2: Interim Period|Lost to Follow-up|23
7672368|NCT01340937|26686565|P3|Period 2: Interim Period|Lost to Follow-up|53
7672369|NCT01340937|26686566|P2|Period 2: Interim Period|Lost to Follow-up|48
7672370|NCT01340937|26686567|P1|Period 2: Interim Period|Lost to Follow-up|29
7672371|NCT01340937|26686564|P4|Period 2: Interim Period|Adverse Event|0
7672372|NCT01340937|26686565|P3|Period 2: Interim Period|Adverse Event|1
7672373|NCT01340937|26686566|P2|Period 2: Interim Period|Adverse Event|0
7672374|NCT01340937|26686567|P1|Period 2: Interim Period|Adverse Event|1
7672375|NCT01340937|26686564|P4|Period 2: Interim Period|Withdrawal by Subject|12
7672376|NCT01340937|26686565|P3|Period 2: Interim Period|Withdrawal by Subject|17
7672377|NCT01340937|26686566|P2|Period 2: Interim Period|Withdrawal by Subject|23
7672378|NCT01340937|26686567|P1|Period 2: Interim Period|Withdrawal by Subject|28
7672379|NCT01340937|26686564|P4|Period 1: Infant Series|Randomized but not vaccinated|1
7672380|NCT01340937|26686565|P3|Period 1: Infant Series|Randomized but not vaccinated|2
7672381|NCT01340937|26686566|P2|Period 1: Infant Series|Randomized but not vaccinated|5
7672382|NCT01340937|26686567|P1|Period 1: Infant Series|Randomized but not vaccinated|0
7672383|NCT01340937|26686564|P4|Period 1: Infant Series|Withdrawal by Subject|15
7672384|NCT01340937|26686565|P3|Period 1: Infant Series|Withdrawal by Subject|30
7672385|NCT01340937|26686566|P2|Period 1: Infant Series|Withdrawal by Subject|32
7672386|NCT01340937|26686567|P1|Period 1: Infant Series|Withdrawal by Subject|33
7672387|NCT01340937|26686564|P4|Period 1: Infant Series|Protocol Violation|3
7672388|NCT01340937|26686565|P3|Period 1: Infant Series|Protocol Violation|4
7672389|NCT01340937|26686566|P2|Period 1: Infant Series|Protocol Violation|4
7672390|NCT01340937|26686567|P1|Period 1: Infant Series|Protocol Violation|1
7672391|NCT01340937|26686564|P4|Period 1: Infant Series|Physician Decision|0
7672392|NCT01340937|26686565|P3|Period 1: Infant Series|Physician Decision|1
7672393|NCT01340937|26686566|P2|Period 1: Infant Series|Physician Decision|3
7672394|NCT01340937|26686567|P1|Period 1: Infant Series|Physician Decision|2
7672395|NCT01340937|26686564|P4|Period 1: Infant Series|Lost to Follow-up|13
7672396|NCT01340937|26686565|P3|Period 1: Infant Series|Lost to Follow-up|12
7672397|NCT01340937|26686566|P2|Period 1: Infant Series|Lost to Follow-up|14
7672398|NCT01340937|26686567|P1|Period 1: Infant Series|Lost to Follow-up|20
7672399|NCT01340937|26686564|P4|Period 1: Infant Series|Death|0
7672400|NCT01340937|26686565|P3|Period 1: Infant Series|Death|2
7672401|NCT01340937|26686566|P2|Period 1: Infant Series|Death|0
7672402|NCT01340937|26686567|P1|Period 1: Infant Series|Death|2
7672403|NCT01340937|26686564|P4|Period 1: Infant Series|Adverse Event|0
7672404|NCT01340937|26686565|P3|Period 1: Infant Series|Adverse Event|4
7672405|NCT01340937|26686566|P2|Period 1: Infant Series|Adverse Event|1
7672406|NCT01340937|26686567|P1|Period 1: Infant Series|Adverse Event|0
7672407|NCT01340937|26686564|P4|Period 1: Infant Series|Other protocol criterion not met|0
7672408|NCT01340937|26686565|P3|Period 1: Infant Series|Other protocol criterion not met|1
7672409|NCT01340937|26686566|P2|Period 1: Infant Series|Other protocol criterion not met|1
7672410|NCT01340937|26686567|P1|Period 1: Infant Series|Other protocol criterion not met|0
7672411|NCT01340898|26686727|P3|Booster Phase|Lost to Follow-up|3
7672412|NCT01340898|26686728|P2|Booster Phase|Lost to Follow-up|2
7672413|NCT01340898|26686729|P1|Booster Phase|Lost to Follow-up|4
7672414|NCT01340898|26686727|P3|Booster Phase|Migrated/moved from study area|0
7672415|NCT01340898|26686728|P2|Booster Phase|Migrated/moved from study area|0
7672416|NCT01340898|26686729|P1|Booster Phase|Migrated/moved from study area|3
7672417|NCT01340898|26686727|P3|Booster Phase|Withdrawal by Subject|4
7672418|NCT01340898|26686728|P2|Booster Phase|Withdrawal by Subject|0
7672419|NCT01340898|26686729|P1|Booster Phase|Withdrawal by Subject|3
7672420|NCT01340898|26686727|P3|Primary Phase|Lost to Follow-up|0
7672421|NCT01340898|26686728|P2|Primary Phase|Lost to Follow-up|1
7672422|NCT01340898|26686729|P1|Primary Phase|Lost to Follow-up|4
7672423|NCT01340898|26686727|P3|Primary Phase|Migrated/moved from study area|0
7672424|NCT01340898|26686728|P2|Primary Phase|Migrated/moved from study area|1
7672425|NCT01340898|26686729|P1|Primary Phase|Migrated/moved from study area|4
7672426|NCT01340898|26686727|P3|Primary Phase|Withdrawal by Subject|5
7672427|NCT01340898|26686728|P2|Primary Phase|Withdrawal by Subject|7
7672428|NCT01340898|26686729|P1|Primary Phase|Withdrawal by Subject|8
7672429|NCT01340898|26686727|P3|Primary Phase|Serious Adverse Events|1
7672430|NCT01340898|26686728|P2|Primary Phase|Serious Adverse Events|0
7672431|NCT01340898|26686729|P1|Primary Phase|Serious Adverse Events|0
7672432|NCT01340872|26686859|P4|Open-label Phase|Worsening of IBD|0
7672433|NCT01340872|26686860|P3|Open-label Phase|Worsening of IBD|1
7672434|NCT01340872|26686861|P2|Open-label Phase|Worsening of IBD|0
7672435|NCT01340872|26686862|P1|Open-label Phase|Worsening of IBD|0
7672436|NCT01340872|26686859|P4|Open-label Phase|Withdrawal by Subject|6
7672437|NCT01340872|26686860|P3|Open-label Phase|Withdrawal by Subject|1
7672438|NCT01340872|26686861|P2|Open-label Phase|Withdrawal by Subject|0
7672439|NCT01340872|26686862|P1|Open-label Phase|Withdrawal by Subject|0
7672440|NCT01340872|26686859|P4|Open-label Phase|Adverse Event|4
7672441|NCT01340872|26686860|P3|Open-label Phase|Adverse Event|8
7672442|NCT01340872|26686861|P2|Open-label Phase|Adverse Event|0
7672443|NCT01340872|26686862|P1|Open-label Phase|Adverse Event|0
7672444|NCT01340872|26686859|P4|Open-label Phase|Pregnancy|0
7672445|NCT01340872|26686860|P3|Open-label Phase|Pregnancy|1
7672446|NCT01340872|26686861|P2|Open-label Phase|Pregnancy|0
7672447|NCT01340872|26686862|P1|Open-label Phase|Pregnancy|0
7672448|NCT01340872|26686859|P4|Open-label Phase|Physician Decision|1
7672449|NCT01340872|26686860|P3|Open-label Phase|Physician Decision|2
7672450|NCT01340872|26686861|P2|Open-label Phase|Physician Decision|0
7672451|NCT01340872|26686862|P1|Open-label Phase|Physician Decision|0
7672452|NCT01340872|26686859|P4|Double-blind Phase|Protocol Violation|0
7672453|NCT01340872|26686860|P3|Double-blind Phase|Protocol Violation|0
7672454|NCT01340872|26686861|P2|Double-blind Phase|Protocol Violation|1
7672455|NCT01340872|26686862|P1|Double-blind Phase|Protocol Violation|0
7672456|NCT01340872|26686859|P4|Double-blind Phase|Lost to Follow-up|0
7672457|NCT01340872|26686860|P3|Double-blind Phase|Lost to Follow-up|0
7672458|NCT01340872|26686861|P2|Double-blind Phase|Lost to Follow-up|1
7672459|NCT01340872|26686862|P1|Double-blind Phase|Lost to Follow-up|0
7672460|NCT01340872|26686859|P4|Double-blind Phase|Withdrawal by Subject|0
7672461|NCT01340872|26686860|P3|Double-blind Phase|Withdrawal by Subject|0
7672462|NCT01340872|26686861|P2|Double-blind Phase|Withdrawal by Subject|5
7672463|NCT01340872|26686862|P1|Double-blind Phase|Withdrawal by Subject|3
7672464|NCT01340872|26686859|P4|Double-blind Phase|Adverse Event|0
7672465|NCT01340872|26686860|P3|Double-blind Phase|Adverse Event|0
7672466|NCT01340872|26686861|P2|Double-blind Phase|Adverse Event|4
7672467|NCT01340872|26686862|P1|Double-blind Phase|Adverse Event|6
7672468|NCT01340794|26686922|P2|Overall Study|Withdrawal by Subject|1
7672469|NCT01340794|26686923|P1|Overall Study|Withdrawal by Subject|0
7672470|NCT01340768|26686939|P2|Overall Study|Other|0
7672471|NCT01340768|26686940|P1|Overall Study|Other|2
7672472|NCT01340768|26686939|P2|Overall Study|Withdrawal by Subject|1
7672473|NCT01340768|26686940|P1|Overall Study|Withdrawal by Subject|5
7672474|NCT01340768|26686939|P2|Overall Study|Lost to Follow-up|4
7672475|NCT01340768|26686940|P1|Overall Study|Lost to Follow-up|10
7672476|NCT01340664|26686951|P3|Overall Study|Other|2
7672477|NCT01340664|26686952|P2|Overall Study|Other|2
7672478|NCT01340664|26686953|P1|Overall Study|Other|1
7672479|NCT01340664|26686951|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
7672480|NCT01340664|26686952|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
7672481|NCT01340664|26686953|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
7672482|NCT01340664|26686951|P3|Overall Study|Glycemic withdrawal criteria|0
7672483|NCT01340664|26686952|P2|Overall Study|Glycemic withdrawal criteria|0
7672484|NCT01340664|26686953|P1|Overall Study|Glycemic withdrawal criteria|2
7672485|NCT01340664|26686951|P3|Overall Study|Withdrawal by Subject|0
7672486|NCT01340664|26686952|P2|Overall Study|Withdrawal by Subject|4
7672487|NCT01340664|26686953|P1|Overall Study|Withdrawal by Subject|2
7672488|NCT01340664|26686951|P3|Overall Study|Lost to Follow-up|2
7672489|NCT01340664|26686952|P2|Overall Study|Lost to Follow-up|0
7672490|NCT01340664|26686953|P1|Overall Study|Lost to Follow-up|2
7672491|NCT01340664|26686951|P3|Overall Study|Adverse Event|7
7672492|NCT01340664|26686952|P2|Overall Study|Adverse Event|1
7672493|NCT01340664|26686953|P1|Overall Study|Adverse Event|0
7672494|NCT01340651|26686970|P1|Overall Study|Commercial Supply per Sponsor|12
7672495|NCT01340651|26686970|P1|Overall Study|Consent Withdrawn|2
7672496|NCT01340651|26686970|P1|Overall Study|Adverse Event|3
7672497|NCT01340625|26686986|P2|Washout Period of 28 Days|Withdrawal by Subject|0
7672498|NCT01340625|26686987|P1|Washout Period of 28 Days|Withdrawal by Subject|1
7672499|NCT01340625|26686986|P2|First Intervention|Adverse Event|0
7672500|NCT01340625|26686987|P1|First Intervention|Adverse Event|1
7672501|NCT01340495|26687092|P1|Overall Study|Withdrawal by Subject|1
7672502|NCT01340482|26687102|P3|Overall Study|Adverse Event|0
7672503|NCT01340482|26687103|P2|Overall Study|Adverse Event|0
7672504|NCT01340482|26687104|P1|Overall Study|Adverse Event|2
7672505|NCT01340300|26687119|P4|Overall Study|Unrelated sickness|1
7672506|NCT01340300|26687120|P3|Overall Study|Unrelated sickness|0
7672507|NCT01340300|26687121|P2|Overall Study|Unrelated sickness|2
7672508|NCT01340300|26687122|P1|Overall Study|Unrelated sickness|0
7672509|NCT01340300|26687119|P4|Overall Study|Physician Decision|0
7672510|NCT01340300|26687120|P3|Overall Study|Physician Decision|0
7672511|NCT01340300|26687121|P2|Overall Study|Physician Decision|1
7672512|NCT01340300|26687122|P1|Overall Study|Physician Decision|0
7672513|NCT01340300|26687119|P4|Overall Study|Adverse Event|0
7672514|NCT01340300|26687120|P3|Overall Study|Adverse Event|4
7672515|NCT01340300|26687121|P2|Overall Study|Adverse Event|0
7672516|NCT01340300|26687122|P1|Overall Study|Adverse Event|1
7672517|NCT01340300|26687119|P4|Overall Study|Withdrawal by Subject|3
7672518|NCT01340300|26687120|P3|Overall Study|Withdrawal by Subject|6
7672519|NCT01340300|26687121|P2|Overall Study|Withdrawal by Subject|6
7672520|NCT01340300|26687122|P1|Overall Study|Withdrawal by Subject|5
7672521|NCT01340300|26687119|P4|Overall Study|Lost to Follow-up|10
7672522|NCT01340300|26687120|P3|Overall Study|Lost to Follow-up|5
7672523|NCT01340300|26687121|P2|Overall Study|Lost to Follow-up|0
7672524|NCT01340300|26687122|P1|Overall Study|Lost to Follow-up|3
7672525|NCT01340209|26687155|P3|Overall Study|Other reason not defined above|4
7672526|NCT01340209|26687156|P2|Overall Study|Other reason not defined above|5
7672527|NCT01340209|26687157|P1|Overall Study|Other reason not defined above|3
7672528|NCT01340209|26687155|P3|Overall Study|Withdrawal by Subject|1
7672529|NCT01340209|26687156|P2|Overall Study|Withdrawal by Subject|0
7672530|NCT01340209|26687157|P1|Overall Study|Withdrawal by Subject|0
7672531|NCT01340209|26687155|P3|Overall Study|Protocol Violation|1
7672532|NCT01340209|26687156|P2|Overall Study|Protocol Violation|2
7672533|NCT01340209|26687157|P1|Overall Study|Protocol Violation|1
7672534|NCT01340209|26687155|P3|Overall Study|Adverse Event|2
7672535|NCT01340209|26687156|P2|Overall Study|Adverse Event|1
7672536|NCT01340209|26687157|P1|Overall Study|Adverse Event|1
7672537|NCT01340196|26687192|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
7672538|NCT01340066|26687232|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
7672539|NCT01340066|26687233|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
7672540|NCT01340066|26687234|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
7672541|NCT01340066|26687232|P3|5 Week Double Blind Randomization Period|Physician Decision|0
7672542|NCT01340066|26687233|P2|5 Week Double Blind Randomization Period|Physician Decision|1
7672543|NCT01340066|26687234|P1|5 Week Double Blind Randomization Period|Physician Decision|0
7672544|NCT01340066|26687232|P3|5 Week Double Blind Randomization Period|Adverse Event|2
7672545|NCT01340066|26687233|P2|5 Week Double Blind Randomization Period|Adverse Event|2
7672546|NCT01340066|26687234|P1|5 Week Double Blind Randomization Period|Adverse Event|0
7672547|NCT01340066|26687232|P3|Placebo Run in Period|Screen Failures|0
7672548|NCT01340066|26687233|P2|Placebo Run in Period|Screen Failures|0
7672549|NCT01340066|26687234|P1|Placebo Run in Period|Screen Failures|27
7672550|NCT01340027|26687274|P12|Overall Study|Miscellaneous|0
7672551|NCT01340027|26687275|P11|Overall Study|Miscellaneous|1
7672552|NCT01340027|26687276|P10|Overall Study|Miscellaneous|0
7672553|NCT01340027|26687277|P9|Overall Study|Miscellaneous|0
7672554|NCT01340027|26687278|P8|Overall Study|Miscellaneous|0
7672555|NCT01340027|26687279|P7|Overall Study|Miscellaneous|0
7672556|NCT01340027|26687280|P6|Overall Study|Miscellaneous|0
7672557|NCT01340027|26687281|P5|Overall Study|Miscellaneous|0
7672558|NCT01340027|26687282|P4|Overall Study|Miscellaneous|1
7672559|NCT01340027|26687283|P3|Overall Study|Miscellaneous|0
7672560|NCT01340027|26687284|P2|Overall Study|Miscellaneous|0
7672561|NCT01340027|26687285|P1|Overall Study|Miscellaneous|0
7672562|NCT01340027|26687274|P12|Overall Study|Withdrawal by Subject|1
7672563|NCT01340027|26687275|P11|Overall Study|Withdrawal by Subject|0
7672564|NCT01340027|26687276|P10|Overall Study|Withdrawal by Subject|2
7672565|NCT01340027|26687277|P9|Overall Study|Withdrawal by Subject|1
7672566|NCT01340027|26687278|P8|Overall Study|Withdrawal by Subject|4
7672567|NCT01340027|26687279|P7|Overall Study|Withdrawal by Subject|3
7672568|NCT01340027|26687280|P6|Overall Study|Withdrawal by Subject|2
7672569|NCT01340027|26687281|P5|Overall Study|Withdrawal by Subject|3
7672570|NCT01340027|26687282|P4|Overall Study|Withdrawal by Subject|3
7672571|NCT01340027|26687283|P3|Overall Study|Withdrawal by Subject|1
7672572|NCT01340027|26687284|P2|Overall Study|Withdrawal by Subject|3
7672573|NCT01340027|26687285|P1|Overall Study|Withdrawal by Subject|4
7672574|NCT01340027|26687274|P12|Overall Study|Protocol Violation|0
7672575|NCT01340027|26687275|P11|Overall Study|Protocol Violation|0
7672576|NCT01340027|26687276|P10|Overall Study|Protocol Violation|2
7672577|NCT01340027|26687277|P9|Overall Study|Protocol Violation|2
7672578|NCT01340027|26687278|P8|Overall Study|Protocol Violation|1
7672579|NCT01340027|26687279|P7|Overall Study|Protocol Violation|0
7672580|NCT01340027|26687280|P6|Overall Study|Protocol Violation|0
7672581|NCT01340027|26687281|P5|Overall Study|Protocol Violation|6
7672582|NCT01340027|26687282|P4|Overall Study|Protocol Violation|0
7672583|NCT01340027|26687283|P3|Overall Study|Protocol Violation|0
7672584|NCT01340027|26687284|P2|Overall Study|Protocol Violation|2
7672585|NCT01340027|26687285|P1|Overall Study|Protocol Violation|1
7672586|NCT01340027|26687274|P12|Overall Study|Lost to Follow-up|0
7672587|NCT01340027|26687275|P11|Overall Study|Lost to Follow-up|0
7672588|NCT01340027|26687276|P10|Overall Study|Lost to Follow-up|1
7672589|NCT01340027|26687277|P9|Overall Study|Lost to Follow-up|0
7672590|NCT01340027|26687278|P8|Overall Study|Lost to Follow-up|0
7672591|NCT01340027|26687279|P7|Overall Study|Lost to Follow-up|1
7672592|NCT01340027|26687280|P6|Overall Study|Lost to Follow-up|0
7672593|NCT01340027|26687281|P5|Overall Study|Lost to Follow-up|0
7672594|NCT01340027|26687282|P4|Overall Study|Lost to Follow-up|0
7672595|NCT01340027|26687283|P3|Overall Study|Lost to Follow-up|0
7672596|NCT01340027|26687284|P2|Overall Study|Lost to Follow-up|1
7672597|NCT01340027|26687285|P1|Overall Study|Lost to Follow-up|0
7672598|NCT01340027|26687274|P12|Overall Study|Lack of Efficacy|0
7672599|NCT01340027|26687275|P11|Overall Study|Lack of Efficacy|0
7672600|NCT01340027|26687276|P10|Overall Study|Lack of Efficacy|0
7672601|NCT01340027|26687277|P9|Overall Study|Lack of Efficacy|1
7672602|NCT01340027|26687278|P8|Overall Study|Lack of Efficacy|1
7672603|NCT01340027|26687279|P7|Overall Study|Lack of Efficacy|1
7672604|NCT01340027|26687280|P6|Overall Study|Lack of Efficacy|0
7672605|NCT01340027|26687281|P5|Overall Study|Lack of Efficacy|0
7672606|NCT01340027|26687282|P4|Overall Study|Lack of Efficacy|0
7672607|NCT01340027|26687283|P3|Overall Study|Lack of Efficacy|0
7672608|NCT01340027|26687284|P2|Overall Study|Lack of Efficacy|0
7672609|NCT01340027|26687285|P1|Overall Study|Lack of Efficacy|0
7672610|NCT01340027|26687274|P12|Overall Study|Adverse Event|3
7672611|NCT01340027|26687275|P11|Overall Study|Adverse Event|1
7672612|NCT01340027|26687276|P10|Overall Study|Adverse Event|1
7672613|NCT01340027|26687277|P9|Overall Study|Adverse Event|4
7672614|NCT01340027|26687278|P8|Overall Study|Adverse Event|1
7672615|NCT01340027|26687279|P7|Overall Study|Adverse Event|2
7672616|NCT01340027|26687280|P6|Overall Study|Adverse Event|2
7672617|NCT01340027|26687281|P5|Overall Study|Adverse Event|1
7672618|NCT01340027|26687282|P4|Overall Study|Adverse Event|0
7672619|NCT01340027|26687283|P3|Overall Study|Adverse Event|2
7672620|NCT01340027|26687284|P2|Overall Study|Adverse Event|1
7672621|NCT01340027|26687285|P1|Overall Study|Adverse Event|0
7672622|NCT01340027|26687274|P12|Overall Study|Randomized but Never Received Study Drug|0
7672623|NCT01340027|26687275|P11|Overall Study|Randomized but Never Received Study Drug|0
7672624|NCT01340027|26687276|P10|Overall Study|Randomized but Never Received Study Drug|0
7672625|NCT01340027|26687277|P9|Overall Study|Randomized but Never Received Study Drug|0
7672626|NCT01340027|26687278|P8|Overall Study|Randomized but Never Received Study Drug|0
7672627|NCT01340027|26687279|P7|Overall Study|Randomized but Never Received Study Drug|0
7672628|NCT01340027|26687280|P6|Overall Study|Randomized but Never Received Study Drug|0
7672629|NCT01340027|26687281|P5|Overall Study|Randomized but Never Received Study Drug|0
7672630|NCT01340027|26687282|P4|Overall Study|Randomized but Never Received Study Drug|0
7672631|NCT01340027|26687283|P3|Overall Study|Randomized but Never Received Study Drug|1
7672632|NCT01340027|26687284|P2|Overall Study|Randomized but Never Received Study Drug|0
7672633|NCT01340027|26687285|P1|Overall Study|Randomized but Never Received Study Drug|0
7672634|NCT01340014|26687661|P2|Period 2, Second 7 Days|Adverse Event|1
7672635|NCT01340014|26687662|P1|Period 2, Second 7 Days|Adverse Event|0
7672636|NCT01340014|26687661|P2|Period 1, First 7 Days|Personal Reasons|0
7672637|NCT01340014|26687662|P1|Period 1, First 7 Days|Personal Reasons|1
7672638|NCT01340014|26687661|P2|Period 1, First 7 Days|Adverse Event|0
7672639|NCT01340014|26687662|P1|Period 1, First 7 Days|Adverse Event|1
7672640|NCT01339923|26687683|P7|Overall Study|Withdrawal by Subject|2
7672641|NCT01339923|26687684|P6|Overall Study|Withdrawal by Subject|3
7672642|NCT01339923|26687685|P5|Overall Study|Withdrawal by Subject|4
7672643|NCT01339923|26687686|P4|Overall Study|Withdrawal by Subject|1
7672644|NCT01339923|26687687|P3|Overall Study|Withdrawal by Subject|6
7672645|NCT01339923|26687688|P2|Overall Study|Withdrawal by Subject|11
7672646|NCT01339923|26687689|P1|Overall Study|Withdrawal by Subject|7
7672647|NCT01339923|26687683|P7|Overall Study|Unable to Classify|5
7672648|NCT01339923|26687684|P6|Overall Study|Unable to Classify|1
7672649|NCT01339923|26687685|P5|Overall Study|Unable to Classify|0
7672650|NCT01339923|26687686|P4|Overall Study|Unable to Classify|0
7672651|NCT01339923|26687687|P3|Overall Study|Unable to Classify|1
7672652|NCT01339923|26687688|P2|Overall Study|Unable to Classify|0
7672653|NCT01339923|26687689|P1|Overall Study|Unable to Classify|1
7672654|NCT01339923|26687683|P7|Overall Study|Protocol Violation|1
7672655|NCT01339923|26687684|P6|Overall Study|Protocol Violation|3
7672656|NCT01339923|26687685|P5|Overall Study|Protocol Violation|0
7672657|NCT01339923|26687686|P4|Overall Study|Protocol Violation|0
7672658|NCT01339923|26687687|P3|Overall Study|Protocol Violation|0
7672659|NCT01339923|26687688|P2|Overall Study|Protocol Violation|0
7672660|NCT01339923|26687689|P1|Overall Study|Protocol Violation|0
7672661|NCT01339923|26687683|P7|Overall Study|Lost to Follow-up|5
7672662|NCT01339923|26687684|P6|Overall Study|Lost to Follow-up|1
7672663|NCT01339923|26687685|P5|Overall Study|Lost to Follow-up|1
7672664|NCT01339923|26687686|P4|Overall Study|Lost to Follow-up|3
7672665|NCT01339923|26687687|P3|Overall Study|Lost to Follow-up|0
7672666|NCT01339923|26687688|P2|Overall Study|Lost to Follow-up|4
7672667|NCT01339923|26687689|P1|Overall Study|Lost to Follow-up|4
7672668|NCT01339923|26687683|P7|Overall Study|Inappropriate Enrollment|0
7672669|NCT01339923|26687684|P6|Overall Study|Inappropriate Enrollment|1
7672670|NCT01339923|26687685|P5|Overall Study|Inappropriate Enrollment|0
7672671|NCT01339923|26687686|P4|Overall Study|Inappropriate Enrollment|0
7672672|NCT01339923|26687687|P3|Overall Study|Inappropriate Enrollment|0
7672673|NCT01339923|26687688|P2|Overall Study|Inappropriate Enrollment|0
7672674|NCT01339923|26687689|P1|Overall Study|Inappropriate Enrollment|1
7672675|NCT01339923|26687683|P7|Overall Study|Adverse Event|1
7672676|NCT01339923|26687684|P6|Overall Study|Adverse Event|0
7672677|NCT01339923|26687685|P5|Overall Study|Adverse Event|0
7672678|NCT01339923|26687686|P4|Overall Study|Adverse Event|0
7672679|NCT01339923|26687687|P3|Overall Study|Adverse Event|1
7672680|NCT01339923|26687688|P2|Overall Study|Adverse Event|1
7672681|NCT01339923|26687689|P1|Overall Study|Adverse Event|1
7672682|NCT01339910|26687760|P2|Overall Study|Disease relapse|4
7672683|NCT01339910|26687761|P1|Overall Study|Disease relapse|1
7672684|NCT01339910|26687760|P2|Overall Study|Physician Decision|0
7672685|NCT01339910|26687761|P1|Overall Study|Physician Decision|1
7672686|NCT01339910|26687760|P2|Overall Study|Withdrawal by Subject|0
7672687|NCT01339910|26687761|P1|Overall Study|Withdrawal by Subject|1
7672688|NCT01339897|26687799|P4|Overall Study|Adverse Event|1
7672689|NCT01339897|26687800|P3|Overall Study|Adverse Event|0
7672690|NCT01339897|26687801|P2|Overall Study|Adverse Event|0
7672691|NCT01339897|26687802|P1|Overall Study|Adverse Event|1
7672692|NCT01339832|26687855|P1|Overall Study|Death|11
7672693|NCT01339832|26687855|P1|Overall Study|Lost to Follow-up|3
7672694|NCT01339559|26687866|P1|Overall Study|PI decision|1
7672695|NCT01339559|26687866|P1|Overall Study|Patient didn't wish to continue|1
7672696|NCT01339559|26687866|P1|Overall Study|Investigator decision|2
7672697|NCT01339559|26687866|P1|Overall Study|Left the country|1
7672698|NCT01339559|26687866|P1|Overall Study|Pregnancy planned|2
7672699|NCT01339559|26687866|P1|Overall Study|Epilepsy surgery|1
7672700|NCT01339559|26687866|P1|Overall Study|Incarcerated|2
7672701|NCT01339559|26687866|P1|Overall Study|Study closure at site|1
7672702|NCT01339559|26687866|P1|Overall Study|Protocol Violation|15
7672703|NCT01339559|26687866|P1|Overall Study|Subject choice|89
7672704|NCT01339559|26687866|P1|Overall Study|Lost to Follow-up|22
7672705|NCT01339559|26687866|P1|Overall Study|Lack of Efficacy|164
7672706|NCT01339559|26687866|P1|Overall Study|Death|5
7672707|NCT01339559|26687866|P1|Overall Study|Adverse Event|92
7672708|NCT01339429|26687875|P1|Overall Study|Physician Decision|3
7672709|NCT01339429|26687875|P1|Overall Study|Withdrawal by Subject|1
7672710|NCT01339390|26687915|P2|Overall Study|Lost to Follow-up|127
7672711|NCT01339390|26687916|P1|Overall Study|Lost to Follow-up|125
7672712|NCT01339390|26687915|P2|Overall Study|Death|29
7672713|NCT01339390|26687916|P1|Overall Study|Death|32
7672714|NCT01339273|26687933|P2|Overall Study|Lost to Follow-up|8
7672715|NCT01339273|26687934|P1|Overall Study|Lost to Follow-up|8
7672716|NCT01339052|26688009|P2|Overall Study|Physician Decision|0
7672717|NCT01339052|26688010|P1|Overall Study|Physician Decision|1
7672718|NCT01339052|26688009|P2|Overall Study|Withdrawal by Subject|3
7672719|NCT01339052|26688010|P1|Overall Study|Withdrawal by Subject|0
7672720|NCT01339052|26688009|P2|Overall Study|Adverse Event|1
7672721|NCT01339052|26688010|P1|Overall Study|Adverse Event|1
7672722|NCT01339052|26688009|P2|Overall Study|Disease progression|46
7672723|NCT01339052|26688010|P1|Overall Study|Disease progression|13
7672724|NCT01339000|26688036|P2|Overall Study|study closed due to lack of drug supply|0
7672725|NCT01339000|26688037|P1|Overall Study|study closed due to lack of drug supply|1
7672726|NCT01338987|26688056|P5|Overall Study|Disease progression on study|0
7672727|NCT01338987|26688057|P4|Overall Study|Disease progression on study|0
7672728|NCT01338987|26688058|P3|Overall Study|Disease progression on study|1
7672729|NCT01338987|26688059|P2|Overall Study|Disease progression on study|1
7672730|NCT01338987|26688060|P1|Overall Study|Disease progression on study|2
7672731|NCT01338987|26688056|P5|Overall Study|enrolled on new protocol|0
7672732|NCT01338987|26688057|P4|Overall Study|enrolled on new protocol|0
7672733|NCT01338987|26688058|P3|Overall Study|enrolled on new protocol|1
7672734|NCT01338987|26688059|P2|Overall Study|enrolled on new protocol|0
7672735|NCT01338987|26688060|P1|Overall Study|enrolled on new protocol|0
7672736|NCT01338870|26688081|P6|Overall Study|Adverse Event|1
7672737|NCT01338870|26688082|P5|Overall Study|Adverse Event|4
7672738|NCT01338870|26688083|P4|Overall Study|Adverse Event|5
7672739|NCT01338870|26688084|P3|Overall Study|Adverse Event|1
7672740|NCT01338870|26688085|P2|Overall Study|Adverse Event|4
7672741|NCT01338870|26688086|P1|Overall Study|Adverse Event|4
7672742|NCT01338870|26688081|P6|Overall Study|Protocol Violation|1
7672743|NCT01338870|26688082|P5|Overall Study|Protocol Violation|1
7672744|NCT01338870|26688083|P4|Overall Study|Protocol Violation|2
7672745|NCT01338870|26688084|P3|Overall Study|Protocol Violation|2
7672746|NCT01338870|26688085|P2|Overall Study|Protocol Violation|2
7672747|NCT01338870|26688086|P1|Overall Study|Protocol Violation|0
7672748|NCT01338870|26688081|P6|Overall Study|Other|2
7672749|NCT01338870|26688082|P5|Overall Study|Other|0
7672750|NCT01338870|26688083|P4|Overall Study|Other|2
7672751|NCT01338870|26688084|P3|Overall Study|Other|3
7672752|NCT01338870|26688085|P2|Overall Study|Other|3
7672753|NCT01338870|26688086|P1|Overall Study|Other|3
7672754|NCT01338870|26688081|P6|Overall Study|Withdrawal by Subject|2
7672755|NCT01338870|26688082|P5|Overall Study|Withdrawal by Subject|0
7672756|NCT01338870|26688083|P4|Overall Study|Withdrawal by Subject|0
7672757|NCT01338870|26688084|P3|Overall Study|Withdrawal by Subject|4
7672758|NCT01338870|26688085|P2|Overall Study|Withdrawal by Subject|3
7672759|NCT01338870|26688086|P1|Overall Study|Withdrawal by Subject|2
7672760|NCT01338870|26688081|P6|Overall Study|Lost to Follow-up|0
7672761|NCT01338870|26688082|P5|Overall Study|Lost to Follow-up|1
7672762|NCT01338870|26688083|P4|Overall Study|Lost to Follow-up|0
7672763|NCT01338870|26688084|P3|Overall Study|Lost to Follow-up|1
7672764|NCT01338870|26688085|P2|Overall Study|Lost to Follow-up|0
7672765|NCT01338870|26688086|P1|Overall Study|Lost to Follow-up|0
7672766|NCT01338818|26688141|P1|Overall Study|Protocol Deviation|4
7672767|NCT01338818|26688141|P1|Overall Study|Administrative problems|3
7672768|NCT01338818|26688141|P1|Overall Study|Lost to Follow-up|4
7672769|NCT01338818|26688141|P1|Overall Study|Withdrawal by Subject|11
7672770|NCT01338818|26688141|P1|Overall Study|no longer require study drug|1
7672771|NCT01338818|26688141|P1|Overall Study|Lack of Efficacy|5
7672772|NCT01338818|26688141|P1|Overall Study|Adverse Event|8
7672773|NCT01338792|26688147|P1|Overall Study|Withdrawal by Subject|1
7672774|NCT01338792|26688147|P1|Overall Study|Death|1
7672775|NCT01338792|26688147|P1|Overall Study|Adverse Event|2
7672776|NCT01338636|26688162|P1|Overall Study|Withdrawn due to lack of improvement|8
7672777|NCT01338610|26688176|P3|Overall Study|Adverse Event|0
7672778|NCT01338610|26688177|P2|Overall Study|Adverse Event|0
7672779|NCT01338610|26688178|P1|Overall Study|Adverse Event|3
7672780|NCT01338610|26688176|P3|Overall Study|Protocol Violation|1
7672781|NCT01338610|26688177|P2|Overall Study|Protocol Violation|0
7672782|NCT01338610|26688178|P1|Overall Study|Protocol Violation|1
7672783|NCT01338610|26688176|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
7672784|NCT01338610|26688177|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
7672785|NCT01338610|26688178|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
7672786|NCT01338493|26688204|P1|12 Months Follow up|Lost to Follow-up|9
7672787|NCT01338493|26688204|P1|6 Months Follow up|Missed visit|8
7672788|NCT01338493|26688204|P1|6 Months Follow up|Lost to Follow-up|11
7672789|NCT01338493|26688204|P1|Discharge|Missed visit|1
7672790|NCT01338493|26688204|P1|Discharge|Death|1
7672791|NCT01338493|26688204|P1|Enrolled|Patient not implanted|4
7672792|NCT01338493|26688204|P1|Enrolled|Withdrawal by Subject|1
7672793|NCT01338415|26688211|P3|Exceptional Use Treatment Period|Death|1
7672794|NCT01338415|26688212|P2|Exceptional Use Treatment Period|Death|0
7672795|NCT01338415|26688213|P1|Exceptional Use Treatment Period|Death|0
7672796|NCT01338415|26688211|P3|Exceptional Use Treatment Period|Withdrawal by Subject|1
7672797|NCT01338415|26688212|P2|Exceptional Use Treatment Period|Withdrawal by Subject|0
7672798|NCT01338415|26688213|P1|Exceptional Use Treatment Period|Withdrawal by Subject|0
7672799|NCT01338415|26688211|P3|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
7672800|NCT01338415|26688212|P2|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
7672801|NCT01338415|26688213|P1|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
7672802|NCT01338415|26688211|P3|Exceptional Use Treatment Period|Administrative decision|1
7672803|NCT01338415|26688212|P2|Exceptional Use Treatment Period|Administrative decision|0
7672804|NCT01338415|26688213|P1|Exceptional Use Treatment Period|Administrative decision|0
7672805|NCT01338415|26688211|P3|Core + Extension|Other (administrative reason)|0
7672806|NCT01338415|26688212|P2|Core + Extension|Other (administrative reason)|0
7672807|NCT01338415|26688213|P1|Core + Extension|Other (administrative reason)|1
7672808|NCT01338415|26688211|P3|Core + Extension|Other (PAH not the main etiology of PH)|0
7672809|NCT01338415|26688212|P2|Core + Extension|Other (PAH not the main etiology of PH)|2
7672810|NCT01338415|26688213|P1|Core + Extension|Other (PAH not the main etiology of PH)|0
7672811|NCT01338415|26688211|P3|Core + Extension|Withdrawal by Subject|0
7672812|NCT01338415|26688212|P2|Core + Extension|Withdrawal by Subject|1
7672813|NCT01338415|26688213|P1|Core + Extension|Withdrawal by Subject|1
7672814|NCT01338415|26688211|P3|Core + Extension|Adverse Event|0
7672815|NCT01338415|26688212|P2|Core + Extension|Adverse Event|6
7672816|NCT01338415|26688213|P1|Core + Extension|Adverse Event|8
7672817|NCT01338298|26688245|P2|Overall Study|Non-adherence|0
7672818|NCT01338298|26688246|P1|Overall Study|Non-adherence|1
7672819|NCT01338298|26688245|P2|Overall Study|Depressive symptoms and nausea|0
7672820|NCT01338298|26688246|P1|Overall Study|Depressive symptoms and nausea|1
7672821|NCT01338298|26688245|P2|Overall Study|Positive symptom worsening|0
7672822|NCT01338298|26688246|P1|Overall Study|Positive symptom worsening|1
7672823|NCT01338298|26688245|P2|Overall Study|Administrative error|1
7672824|NCT01338298|26688246|P1|Overall Study|Administrative error|0
7672825|NCT01338298|26688245|P2|Overall Study|Abdominal Pain and scheduled surgery|1
7672826|NCT01338298|26688246|P1|Overall Study|Abdominal Pain and scheduled surgery|0
7672827|NCT01338298|26688245|P2|Overall Study|Withdrawal by Subject|1
7672828|NCT01338298|26688246|P1|Overall Study|Withdrawal by Subject|1
7672829|NCT01338025|26688256|P2|Overall Study|Found ineligible after starting|0
7672830|NCT01338025|26688257|P1|Overall Study|Found ineligible after starting|1
7672831|NCT01338025|26688256|P2|Overall Study|Withdrawal by Subject|2
7672832|NCT01338025|26688257|P1|Overall Study|Withdrawal by Subject|0
7672833|NCT01338025|26688256|P2|Overall Study|Unexpected closure of study|9
7672834|NCT01338025|26688257|P1|Overall Study|Unexpected closure of study|10
7672835|NCT01338012|26688269|P1|Overall Study|Study terminated|4
7672836|NCT01338012|26688269|P1|Overall Study|Death|4
7672837|NCT01337986|26688275|P2|Overall Study|Protocol Violation|3
7672838|NCT01337986|26688276|P1|Overall Study|Protocol Violation|0
7672839|NCT01337986|26688275|P2|Overall Study|Lost to Follow-up|0
7672840|NCT01337986|26688276|P1|Overall Study|Lost to Follow-up|1
7672841|NCT01337986|26688275|P2|Overall Study|Adverse Event|2
7672842|NCT01337986|26688276|P1|Overall Study|Adverse Event|2
7672843|NCT01337973|26688313|P3|Overall Study|missing data on primary outcome|3
7672844|NCT01337973|26688314|P2|Overall Study|missing data on primary outcome|1
7672845|NCT01337973|26688315|P1|Overall Study|missing data on primary outcome|3
7672846|NCT01337973|26688313|P3|Overall Study|Withdrawal by Subject|4
7672847|NCT01337973|26688314|P2|Overall Study|Withdrawal by Subject|8
7672848|NCT01337973|26688315|P1|Overall Study|Withdrawal by Subject|10
7672849|NCT01337973|26688313|P3|Overall Study|Death|1
7672850|NCT01337973|26688314|P2|Overall Study|Death|2
7672851|NCT01337973|26688315|P1|Overall Study|Death|1
7672852|NCT01337973|26688313|P3|Overall Study|Lost to Follow-up|3
7672853|NCT01337973|26688314|P2|Overall Study|Lost to Follow-up|4
7672854|NCT01337973|26688315|P1|Overall Study|Lost to Follow-up|2
7672855|NCT01337960|26688329|P3|Overall Study|Withdrawal by Subject|0
7672856|NCT01337960|26688330|P2|Overall Study|Withdrawal by Subject|0
7672857|NCT01337960|26688331|P1|Overall Study|Withdrawal by Subject|1
7672858|NCT01337960|26688329|P3|Overall Study|Lost to Follow-up|0
7672859|NCT01337960|26688330|P2|Overall Study|Lost to Follow-up|0
7672860|NCT01337960|26688331|P1|Overall Study|Lost to Follow-up|1
7672861|NCT01337674|26688396|P4|Treatment Period 2|Withdrawal by Subject|0
7672862|NCT01337674|26688397|P3|Treatment Period 2|Withdrawal by Subject|1
7672863|NCT01337674|26688398|P2|Treatment Period 2|Withdrawal by Subject|0
7672864|NCT01337674|26688399|P1|Treatment Period 2|Withdrawal by Subject|0
7672865|NCT01337674|26688396|P4|Treatment Period 1|Discontinued due to blood draws|1
7672866|NCT01337674|26688397|P3|Treatment Period 1|Discontinued due to blood draws|0
7672867|NCT01337674|26688398|P2|Treatment Period 1|Discontinued due to blood draws|0
7672868|NCT01337674|26688399|P1|Treatment Period 1|Discontinued due to blood draws|0
7672869|NCT01337674|26688396|P4|Treatment Period 1|Adverse Event|0
7672870|NCT01337674|26688397|P3|Treatment Period 1|Adverse Event|0
7672871|NCT01337674|26688398|P2|Treatment Period 1|Adverse Event|1
7672872|NCT01337674|26688399|P1|Treatment Period 1|Adverse Event|0
7672873|NCT01337635|26688417|P2|Overall Study|Lost to Follow-up|1
7672874|NCT01337635|26688418|P1|Overall Study|Lost to Follow-up|0
7672875|NCT01337596|26688460|P9|Overall Study|Withdrawal by Subject|0
7672876|NCT01337596|26688461|P8|Overall Study|Withdrawal by Subject|0
7672877|NCT01337596|26688462|P7|Overall Study|Withdrawal by Subject|0
7672878|NCT01337596|26688463|P6|Overall Study|Withdrawal by Subject|0
7672879|NCT01337596|26688464|P5|Overall Study|Withdrawal by Subject|2
7672880|NCT01337596|26688465|P4|Overall Study|Withdrawal by Subject|0
7672881|NCT01337596|26688466|P3|Overall Study|Withdrawal by Subject|0
7672882|NCT01337596|26688467|P2|Overall Study|Withdrawal by Subject|0
7672883|NCT01337596|26688468|P1|Overall Study|Withdrawal by Subject|0
7672884|NCT01337297|26688519|P2|Overall Study|Lost to Follow-up|3
7672885|NCT01337297|26688520|P1|Overall Study|Lost to Follow-up|1
7672886|NCT01337297|26688519|P2|Overall Study|They entered to single anodal tDCS|3
7672887|NCT01337297|26688520|P1|Overall Study|They entered to single anodal tDCS|4
7672888|NCT01337167|26688528|P2|Toddler Vaccinations|Withdrawal by Subject|0
7672889|NCT01337167|26688529|P1|Toddler Vaccinations|Withdrawal by Subject|3
7672890|NCT01337167|26688528|P2|Toddler Vaccinations|Protocol Violation|1
7672891|NCT01337167|26688529|P1|Toddler Vaccinations|Protocol Violation|0
7672892|NCT01337167|26688528|P2|Toddler Vaccinations|Lost to Follow-up|12
7672893|NCT01337167|26688529|P1|Toddler Vaccinations|Lost to Follow-up|11
7672894|NCT01337167|26688528|P2|Interim Period|Other protocol criterion not met|1
7672895|NCT01337167|26688529|P1|Interim Period|Other protocol criterion not met|0
7672896|NCT01337167|26688528|P2|Interim Period|Withdrawal by Subject|10
7672897|NCT01337167|26688529|P1|Interim Period|Withdrawal by Subject|18
7672898|NCT01337167|26688528|P2|Interim Period|Protocol Violation|3
7672899|NCT01337167|26688529|P1|Interim Period|Protocol Violation|5
7672900|NCT01337167|26688528|P2|Interim Period|Physician Decision|3
7672901|NCT01337167|26688529|P1|Interim Period|Physician Decision|6
7672902|NCT01337167|26688528|P2|Interim Period|Non-compliance with study drug|0
7672903|NCT01337167|26688529|P1|Interim Period|Non-compliance with study drug|1
7672904|NCT01337167|26688528|P2|Interim Period|Lost to Follow-up|23
7672905|NCT01337167|26688529|P1|Interim Period|Lost to Follow-up|51
7672906|NCT01337167|26688528|P2|Infant Series|Randomized but not vaccinated|3
7672907|NCT01337167|26688529|P1|Infant Series|Randomized but not vaccinated|5
7672908|NCT01337167|26688528|P2|Infant Series|Withdrawal by Subject|4
7672909|NCT01337167|26688529|P1|Infant Series|Withdrawal by Subject|15
7672910|NCT01337167|26688528|P2|Infant Series|Protocol Violation|9
7672911|NCT01337167|26688529|P1|Infant Series|Protocol Violation|22
7672912|NCT01337167|26688528|P2|Infant Series|Physician Decision|1
7672913|NCT01337167|26688529|P1|Infant Series|Physician Decision|3
7672914|NCT01337167|26688528|P2|Infant Series|Non-compliance with study drug|1
7672915|NCT01337167|26688529|P1|Infant Series|Non-compliance with study drug|2
7672916|NCT01337167|26688528|P2|Infant Series|Lost to Follow-up|7
7672917|NCT01337167|26688529|P1|Infant Series|Lost to Follow-up|13
7672918|NCT01337167|26688528|P2|Infant Series|Death|1
7672919|NCT01337167|26688529|P1|Infant Series|Death|1
7672920|NCT01337167|26688528|P2|Infant Series|Adverse Event|1
7672921|NCT01337167|26688529|P1|Infant Series|Adverse Event|1
7672922|NCT01337115|26688597|P2|Overall Study|Protocol Violation|0
7672923|NCT01337115|26688598|P1|Overall Study|Protocol Violation|2
7672924|NCT01337089|26688610|P1|Overall Study|Lost to Follow-up|2
7672925|NCT01337089|26688610|P1|Overall Study|Met Withdrawal Criteria|3
7672926|NCT01337089|26688610|P1|Overall Study|Withdrawal by Investigator|33
7672927|NCT01337089|26688610|P1|Overall Study|Withdrawal by Subject|129
7672928|NCT01337089|26688610|P1|Overall Study|Adverse Event|237
7672929|NCT01337050|26688625|P3|Overall Study|Participants refused further follow-up|7
7672930|NCT01337050|26688626|P2|Overall Study|Participants refused further follow-up|7
7672931|NCT01337050|26688627|P1|Overall Study|Participants refused further follow-up|0
7672932|NCT01337050|26688625|P3|Overall Study|Other|8
7672933|NCT01337050|26688626|P2|Overall Study|Other|6
7672934|NCT01337050|26688627|P1|Overall Study|Other|4
7672935|NCT01337050|26688625|P3|Overall Study|Death|4
7672936|NCT01337050|26688626|P2|Overall Study|Death|0
7672937|NCT01337050|26688627|P1|Overall Study|Death|0
7672938|NCT01336972|26688688|P3|Overall Study|Adverse Event|0
7672939|NCT01336972|26688689|P2|Overall Study|Adverse Event|1
7672940|NCT01336972|26688690|P1|Overall Study|Adverse Event|1
7672941|NCT01336894|26688752|P2|Follow-up|Study terminated prematurely|7
7672942|NCT01336894|26688753|P1|Follow-up|Study terminated prematurely|2
7672943|NCT01336764|26688785|P2|Overall Study|Withdrawal by Subject|5
7672944|NCT01336764|26688786|P1|Overall Study|Withdrawal by Subject|5
7672945|NCT01336738|26688797|P5|Overall Study|Other|4
7672946|NCT01336738|26688798|P4|Overall Study|Other|3
7672947|NCT01336738|26688799|P3|Overall Study|Other|2
7672948|NCT01336738|26688800|P2|Overall Study|Other|3
7672949|NCT01336738|26688801|P1|Overall Study|Other|3
7672950|NCT01336738|26688797|P5|Overall Study|Withdrawal by Subject|1
7672951|NCT01336738|26688798|P4|Overall Study|Withdrawal by Subject|1
7672952|NCT01336738|26688799|P3|Overall Study|Withdrawal by Subject|2
7672953|NCT01336738|26688800|P2|Overall Study|Withdrawal by Subject|0
7672954|NCT01336738|26688801|P1|Overall Study|Withdrawal by Subject|2
7672955|NCT01336738|26688797|P5|Overall Study|Protocol Violation|0
7672956|NCT01336738|26688798|P4|Overall Study|Protocol Violation|0
7672957|NCT01336738|26688799|P3|Overall Study|Protocol Violation|0
7672958|NCT01336738|26688800|P2|Overall Study|Protocol Violation|1
7672959|NCT01336738|26688801|P1|Overall Study|Protocol Violation|0
7672960|NCT01336738|26688797|P5|Overall Study|Did not meet entrance criteria|0
7672961|NCT01336738|26688798|P4|Overall Study|Did not meet entrance criteria|0
7672962|NCT01336738|26688799|P3|Overall Study|Did not meet entrance criteria|0
7672963|NCT01336738|26688800|P2|Overall Study|Did not meet entrance criteria|1
7672964|NCT01336738|26688801|P1|Overall Study|Did not meet entrance criteria|0
7672965|NCT01336738|26688797|P5|Overall Study|Lost to Follow-up|2
7672966|NCT01336738|26688798|P4|Overall Study|Lost to Follow-up|2
7672967|NCT01336738|26688799|P3|Overall Study|Lost to Follow-up|2
7672968|NCT01336738|26688800|P2|Overall Study|Lost to Follow-up|1
7672969|NCT01336738|26688801|P1|Overall Study|Lost to Follow-up|2
7672970|NCT01336738|26688797|P5|Overall Study|Adverse Event|3
7672971|NCT01336738|26688798|P4|Overall Study|Adverse Event|1
7672972|NCT01336738|26688799|P3|Overall Study|Adverse Event|2
7672973|NCT01336738|26688800|P2|Overall Study|Adverse Event|3
7672974|NCT01336738|26688801|P1|Overall Study|Adverse Event|0
7672975|NCT01336712|26688843|P1|Overall Study|Lack of Efficacy|1
7672976|NCT01336712|26688843|P1|Overall Study|Death|2
7672977|NCT01336647|26688856|P3|Overall Study|Lost to Follow-up|3
7672978|NCT01336647|26688857|P2|Overall Study|Lost to Follow-up|1
7672979|NCT01336647|26688858|P1|Overall Study|Lost to Follow-up|4
7672980|NCT01336634|26688872|P3|Overall Study|Ongoing|24
7672981|NCT01336634|26688873|P2|Overall Study|Ongoing|22
7672982|NCT01336634|26688874|P1|Overall Study|Ongoing|15
7672983|NCT01336634|26688872|P3|Overall Study|Physician Decision|0
7672984|NCT01336634|26688873|P2|Overall Study|Physician Decision|1
7672985|NCT01336634|26688874|P1|Overall Study|Physician Decision|1
7672986|NCT01336634|26688872|P3|Overall Study|Withdrawal by Subject|1
7672987|NCT01336634|26688873|P2|Overall Study|Withdrawal by Subject|0
7672988|NCT01336634|26688874|P1|Overall Study|Withdrawal by Subject|6
7672989|NCT01336634|26688872|P3|Overall Study|Lost to Follow-up|1
7672990|NCT01336634|26688873|P2|Overall Study|Lost to Follow-up|1
7672991|NCT01336634|26688874|P1|Overall Study|Lost to Follow-up|2
7672992|NCT01336634|26688872|P3|Overall Study|Death|10
7672993|NCT01336634|26688873|P2|Overall Study|Death|33
7672994|NCT01336634|26688874|P1|Overall Study|Death|60
7672995|NCT01336621|26688915|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
7672996|NCT01336621|26688915|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
7672997|NCT01336621|26688915|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
7672998|NCT01336621|26688915|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
7672999|NCT01336621|26688915|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
7673000|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
7673001|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
7673002|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
7673003|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
7673004|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
7673005|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
7673006|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
7673007|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
7673008|NCT01336621|26688915|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
7673009|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
7673010|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
7673011|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7673012|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7673013|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Physician Decision|1
7673014|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Physician Decision|1
7673089|NCT01336023|26689060|P2|Week 27 to 52|Protocol Violation|2
7673015|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Physician Decision|3
7673016|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Physician Decision|0
7673017|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7673018|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7673019|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7673020|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7673021|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
7673022|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
7673023|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
7673024|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
7673025|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
7673026|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
7673027|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
7673028|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
7673029|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
7673030|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7673031|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7673032|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7673033|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7673034|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7673035|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7673036|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7673037|NCT01336608|26688965|P4|24-week, Double-blind Treatment Period|Adverse Event|7
7673038|NCT01336608|26688966|P3|24-week, Double-blind Treatment Period|Adverse Event|6
7673039|NCT01336608|26688967|P2|24-week, Double-blind Treatment Period|Adverse Event|8
7673040|NCT01336608|26688968|P1|24-week, Double-blind Treatment Period|Adverse Event|0
7673041|NCT01336608|26688965|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7673042|NCT01336608|26688966|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7673043|NCT01336608|26688967|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7673044|NCT01336608|26688968|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
7673045|NCT01336608|26688965|P4|2-week, Single-blind Run-In Period|Physician Decision|0
7673046|NCT01336608|26688966|P3|2-week, Single-blind Run-In Period|Physician Decision|0
7673047|NCT01336608|26688967|P2|2-week, Single-blind Run-In Period|Physician Decision|0
7673048|NCT01336608|26688968|P1|2-week, Single-blind Run-In Period|Physician Decision|1
7673049|NCT01336608|26688965|P4|2-week, Single-blind Run-In Period|Adverse Event|0
7673050|NCT01336608|26688966|P3|2-week, Single-blind Run-In Period|Adverse Event|0
7673051|NCT01336608|26688967|P2|2-week, Single-blind Run-In Period|Adverse Event|0
7673052|NCT01336608|26688968|P1|2-week, Single-blind Run-In Period|Adverse Event|1
7673053|NCT01336608|26688965|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7673054|NCT01336608|26688966|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7673055|NCT01336608|26688967|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7673056|NCT01336608|26688968|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
7673057|NCT01336608|26688965|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7673058|NCT01336608|26688966|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7673059|NCT01336608|26688967|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7673060|NCT01336608|26688968|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
7673061|NCT01336569|26688982|P1|Overall Study|Lost to Follow-up|4
7673062|NCT01336205|26689030|P2|Overall Study|Did not receive treatment|0
7673063|NCT01336205|26689031|P1|Overall Study|Did not receive treatment|4
7673064|NCT01336205|26689030|P2|Overall Study|Withdrawal by Subject|38
7673065|NCT01336205|26689031|P1|Overall Study|Withdrawal by Subject|72
7673066|NCT01336205|26689030|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
7673067|NCT01336205|26689031|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
7673068|NCT01336205|26689030|P2|Overall Study|Death|1
7673069|NCT01336205|26689031|P1|Overall Study|Death|1
7673070|NCT01336205|26689030|P2|Overall Study|Adverse Event|6
7673071|NCT01336205|26689031|P1|Overall Study|Adverse Event|56
7673072|NCT01336205|26689030|P2|Overall Study|Severe noncompliance with protocol|2
7673073|NCT01336205|26689031|P1|Overall Study|Severe noncompliance with protocol|9
7673074|NCT01336205|26689030|P2|Overall Study|Lack of Efficacy|0
7673075|NCT01336205|26689031|P1|Overall Study|Lack of Efficacy|4
7673076|NCT01336205|26689030|P2|Overall Study|Study-Specific Withdrawal Criteria|7
7673077|NCT01336205|26689031|P1|Overall Study|Study-Specific Withdrawal Criteria|16
7673078|NCT01336205|26689030|P2|Overall Study|Lost to Follow-up|20
7673079|NCT01336205|26689031|P1|Overall Study|Lost to Follow-up|40
7673080|NCT01336205|26689030|P2|Overall Study|Other|9
7673081|NCT01336205|26689031|P1|Overall Study|Other|22
7673082|NCT01336023|26689059|P3|Week 27 to 52|Unclassified|9
7673083|NCT01336023|26689060|P2|Week 27 to 52|Unclassified|18
7673084|NCT01336023|26689061|P1|Week 27 to 52|Unclassified|13
7673085|NCT01336023|26689059|P3|Week 27 to 52|Withdrawal Criteria|16
7673086|NCT01336023|26689060|P2|Week 27 to 52|Withdrawal Criteria|19
7673087|NCT01336023|26689061|P1|Week 27 to 52|Withdrawal Criteria|14
7673088|NCT01336023|26689059|P3|Week 27 to 52|Protocol Violation|1
7673090|NCT01336023|26689061|P1|Week 27 to 52|Protocol Violation|0
7673091|NCT01336023|26689059|P3|Week 27 to 52|Adverse Event|2
7673092|NCT01336023|26689060|P2|Week 27 to 52|Adverse Event|5
7673093|NCT01336023|26689061|P1|Week 27 to 52|Adverse Event|1
7673094|NCT01336023|26689059|P3|Week 0 to Week 26|Unclassified|9
7673095|NCT01336023|26689060|P2|Week 0 to Week 26|Unclassified|16
7673096|NCT01336023|26689061|P1|Week 0 to Week 26|Unclassified|5
7673097|NCT01336023|26689059|P3|Week 0 to Week 26|Withdrawal Criteria|40
7673098|NCT01336023|26689060|P2|Week 0 to Week 26|Withdrawal Criteria|69
7673099|NCT01336023|26689061|P1|Week 0 to Week 26|Withdrawal Criteria|34
7673100|NCT01336023|26689059|P3|Week 0 to Week 26|Protocol Violation|0
7673101|NCT01336023|26689060|P2|Week 0 to Week 26|Protocol Violation|2
7673102|NCT01336023|26689061|P1|Week 0 to Week 26|Protocol Violation|1
7673103|NCT01336023|26689059|P3|Week 0 to Week 26|Lack of Efficacy|0
7673104|NCT01336023|26689060|P2|Week 0 to Week 26|Lack of Efficacy|1
7673105|NCT01336023|26689061|P1|Week 0 to Week 26|Lack of Efficacy|0
7673106|NCT01336023|26689059|P3|Week 0 to Week 26|Adverse Event|24
7673107|NCT01336023|26689060|P2|Week 0 to Week 26|Adverse Event|10
7673108|NCT01336023|26689061|P1|Week 0 to Week 26|Adverse Event|8
7673109|NCT01335997|26689082|P2|Period III|Lost to Follow-up|0
7673110|NCT01335997|26689083|P1|Period III|Lost to Follow-up|1
7673111|NCT01335997|26689082|P2|Period III|Protocol Violation|1
7673112|NCT01335997|26689083|P1|Period III|Protocol Violation|0
7673113|NCT01335997|26689082|P2|Period III|Study Terminated by Sponsor|76
7673114|NCT01335997|26689083|P1|Period III|Study Terminated by Sponsor|77
7673115|NCT01335997|26689082|P2|Period III|Adverse Event|2
7673116|NCT01335997|26689083|P1|Period III|Adverse Event|0
7673117|NCT01335997|26689082|P2|Period I and II|Physician Decision|1
7673118|NCT01335997|26689083|P1|Period I and II|Physician Decision|2
7673119|NCT01335997|26689082|P2|Period I and II|Protocol Violation|10
7673120|NCT01335997|26689083|P1|Period I and II|Protocol Violation|9
7673121|NCT01335997|26689082|P2|Period I and II|Study Terminated by Sponsor|415
7673122|NCT01335997|26689083|P1|Period I and II|Study Terminated by Sponsor|406
7673123|NCT01335997|26689082|P2|Period I and II|Withdrawal by Subject|4
7673124|NCT01335997|26689083|P1|Period I and II|Withdrawal by Subject|9
7673125|NCT01335997|26689082|P2|Period I and II|Lost to Follow-up|5
7673126|NCT01335997|26689083|P1|Period I and II|Lost to Follow-up|3
7673127|NCT01335997|26689082|P2|Period I and II|Noncompliance with Study Drug|1
7673128|NCT01335997|26689083|P1|Period I and II|Noncompliance with Study Drug|1
7673129|NCT01335997|26689082|P2|Period I and II|Adverse Event|43
7673130|NCT01335997|26689083|P1|Period I and II|Adverse Event|63
7673131|NCT01335971|26689096|P3|Overall Study|Did not complete bronchoscopy|1
7673132|NCT01335971|26689097|P2|Overall Study|Did not complete bronchoscopy|1
7673133|NCT01335971|26689098|P1|Overall Study|Did not complete bronchoscopy|1
7673134|NCT01335971|26689096|P3|Overall Study|Withdrawal by Subject|0
7673135|NCT01335971|26689097|P2|Overall Study|Withdrawal by Subject|0
7673136|NCT01335971|26689098|P1|Overall Study|Withdrawal by Subject|1
7673137|NCT01335698|26689341|P5|Treatment Stage 2|Switched to another formulation|0
7673138|NCT01335698|26689342|P4|Treatment Stage 2|Switched to another formulation|0
7673139|NCT01335698|26689343|P3|Treatment Stage 2|Switched to another formulation|0
7673140|NCT01335698|26689344|P2|Treatment Stage 2|Switched to another formulation|1
7673141|NCT01335698|26689345|P1|Treatment Stage 2|Switched to another formulation|1
7673142|NCT01335698|26689341|P5|Treatment Stage 2|Subject no longer meets study criteria|0
7673143|NCT01335698|26689342|P4|Treatment Stage 2|Subject no longer meets study criteria|1
7673144|NCT01335698|26689343|P3|Treatment Stage 2|Subject no longer meets study criteria|0
7673145|NCT01335698|26689344|P2|Treatment Stage 2|Subject no longer meets study criteria|0
7673146|NCT01335698|26689345|P1|Treatment Stage 2|Subject no longer meets study criteria|0
7673147|NCT01335698|26689341|P5|Treatment Stage 2|Capsules received at state hospital|0
7673148|NCT01335698|26689342|P4|Treatment Stage 2|Capsules received at state hospital|0
7673149|NCT01335698|26689343|P3|Treatment Stage 2|Capsules received at state hospital|0
7673150|NCT01335698|26689344|P2|Treatment Stage 2|Capsules received at state hospital|0
7673151|NCT01335698|26689345|P1|Treatment Stage 2|Capsules received at state hospital|1
7673152|NCT01335698|26689341|P5|Treatment Stage 2|Lost to Follow-up|0
7673153|NCT01335698|26689342|P4|Treatment Stage 2|Lost to Follow-up|0
7673154|NCT01335698|26689343|P3|Treatment Stage 2|Lost to Follow-up|0
7673155|NCT01335698|26689344|P2|Treatment Stage 2|Lost to Follow-up|0
7673156|NCT01335698|26689345|P1|Treatment Stage 2|Lost to Follow-up|1
7673157|NCT01335698|26689341|P5|Treatment Stage 2|Poor compliance/noncompliance|1
7673158|NCT01335698|26689342|P4|Treatment Stage 2|Poor compliance/noncompliance|3
7673159|NCT01335698|26689343|P3|Treatment Stage 2|Poor compliance/noncompliance|1
7673160|NCT01335698|26689344|P2|Treatment Stage 2|Poor compliance/noncompliance|0
7673161|NCT01335698|26689345|P1|Treatment Stage 2|Poor compliance/noncompliance|1
7673162|NCT01335698|26689341|P5|Treatment Stage 2|Withdrawal by Subject|0
7673163|NCT01335698|26689342|P4|Treatment Stage 2|Withdrawal by Subject|0
7673164|NCT01335698|26689343|P3|Treatment Stage 2|Withdrawal by Subject|1
7673165|NCT01335698|26689344|P2|Treatment Stage 2|Withdrawal by Subject|1
7673166|NCT01335698|26689345|P1|Treatment Stage 2|Withdrawal by Subject|3
7673167|NCT01335698|26689341|P5|Treatment Stage 2|Adverse Event|0
7673168|NCT01335698|26689342|P4|Treatment Stage 2|Adverse Event|3
7673169|NCT01335698|26689343|P3|Treatment Stage 2|Adverse Event|0
7673170|NCT01335698|26689344|P2|Treatment Stage 2|Adverse Event|0
7673171|NCT01335698|26689345|P1|Treatment Stage 2|Adverse Event|2
7673172|NCT01335698|26689341|P5|Treatment Stage 2|Lack of Efficacy|0
7673173|NCT01335698|26689342|P4|Treatment Stage 2|Lack of Efficacy|1
7673174|NCT01335698|26689343|P3|Treatment Stage 2|Lack of Efficacy|3
7673175|NCT01335698|26689344|P2|Treatment Stage 2|Lack of Efficacy|1
7673176|NCT01335698|26689345|P1|Treatment Stage 2|Lack of Efficacy|2
7673177|NCT01335698|26689341|P5|Treatment Stage 1|Other|0
7673178|NCT01335698|26689342|P4|Treatment Stage 1|Other|1
7673179|NCT01335698|26689343|P3|Treatment Stage 1|Other|0
7673180|NCT01335698|26689344|P2|Treatment Stage 1|Other|0
7673181|NCT01335698|26689345|P1|Treatment Stage 1|Other|1
7673182|NCT01335698|26689341|P5|Treatment Stage 1|No longer meets study criteria|0
7673183|NCT01335698|26689342|P4|Treatment Stage 1|No longer meets study criteria|1
7673184|NCT01335698|26689343|P3|Treatment Stage 1|No longer meets study criteria|0
7673185|NCT01335698|26689344|P2|Treatment Stage 1|No longer meets study criteria|1
7673186|NCT01335698|26689345|P1|Treatment Stage 1|No longer meets study criteria|1
7673187|NCT01335698|26689341|P5|Treatment Stage 1|Poor compliance/noncompliance|0
7673188|NCT01335698|26689342|P4|Treatment Stage 1|Poor compliance/noncompliance|2
7673189|NCT01335698|26689343|P3|Treatment Stage 1|Poor compliance/noncompliance|0
7673190|NCT01335698|26689344|P2|Treatment Stage 1|Poor compliance/noncompliance|1
7673191|NCT01335698|26689345|P1|Treatment Stage 1|Poor compliance/noncompliance|0
7673192|NCT01335698|26689341|P5|Treatment Stage 1|Lost to Follow-up|0
7673193|NCT01335698|26689342|P4|Treatment Stage 1|Lost to Follow-up|0
7673194|NCT01335698|26689343|P3|Treatment Stage 1|Lost to Follow-up|0
7673195|NCT01335698|26689344|P2|Treatment Stage 1|Lost to Follow-up|1
7673196|NCT01335698|26689345|P1|Treatment Stage 1|Lost to Follow-up|1
7673197|NCT01335698|26689341|P5|Treatment Stage 1|Withdrawal by Subject|0
7673198|NCT01335698|26689342|P4|Treatment Stage 1|Withdrawal by Subject|1
7673199|NCT01335698|26689343|P3|Treatment Stage 1|Withdrawal by Subject|0
7673200|NCT01335698|26689344|P2|Treatment Stage 1|Withdrawal by Subject|2
7673201|NCT01335698|26689345|P1|Treatment Stage 1|Withdrawal by Subject|1
7673202|NCT01335698|26689341|P5|Treatment Stage 1|Adverse Event|1
7673203|NCT01335698|26689342|P4|Treatment Stage 1|Adverse Event|1
7673204|NCT01335698|26689343|P3|Treatment Stage 1|Adverse Event|2
7673205|NCT01335698|26689344|P2|Treatment Stage 1|Adverse Event|2
7673206|NCT01335698|26689345|P1|Treatment Stage 1|Adverse Event|1
7673207|NCT01335698|26689341|P5|Treatment Stage 1|Lack of Efficacy|1
7673208|NCT01335698|26689342|P4|Treatment Stage 1|Lack of Efficacy|3
7673209|NCT01335698|26689343|P3|Treatment Stage 1|Lack of Efficacy|3
7673210|NCT01335698|26689344|P2|Treatment Stage 1|Lack of Efficacy|1
7673211|NCT01335698|26689345|P1|Treatment Stage 1|Lack of Efficacy|3
7673212|NCT01335685|26689410|P8|Overall Study|Reason not Specified|0
7673213|NCT01335685|26689411|P7|Overall Study|Reason not Specified|0
7673214|NCT01335685|26689412|P6|Overall Study|Reason not Specified|1
7673215|NCT01335685|26689413|P5|Overall Study|Reason not Specified|0
7673216|NCT01335685|26689414|P4|Overall Study|Reason not Specified|0
7673217|NCT01335685|26689415|P3|Overall Study|Reason not Specified|1
7673218|NCT01335685|26689416|P2|Overall Study|Reason not Specified|0
7673219|NCT01335685|26689417|P1|Overall Study|Reason not Specified|0
7673220|NCT01335685|26689410|P8|Overall Study|Withdrawal by Subject|0
7673221|NCT01335685|26689411|P7|Overall Study|Withdrawal by Subject|0
7673222|NCT01335685|26689412|P6|Overall Study|Withdrawal by Subject|0
7673223|NCT01335685|26689413|P5|Overall Study|Withdrawal by Subject|0
7673224|NCT01335685|26689414|P4|Overall Study|Withdrawal by Subject|1
7673225|NCT01335685|26689415|P3|Overall Study|Withdrawal by Subject|0
7673226|NCT01335685|26689416|P2|Overall Study|Withdrawal by Subject|0
7673227|NCT01335685|26689417|P1|Overall Study|Withdrawal by Subject|1
7673228|NCT01335685|26689410|P8|Overall Study|Study Terminated by Sponsor|3
7673229|NCT01335685|26689411|P7|Overall Study|Study Terminated by Sponsor|2
7673230|NCT01335685|26689412|P6|Overall Study|Study Terminated by Sponsor|4
7673231|NCT01335685|26689413|P5|Overall Study|Study Terminated by Sponsor|0
7673232|NCT01335685|26689414|P4|Overall Study|Study Terminated by Sponsor|10
7673233|NCT01335685|26689415|P3|Overall Study|Study Terminated by Sponsor|1
7673234|NCT01335685|26689416|P2|Overall Study|Study Terminated by Sponsor|1
7673235|NCT01335685|26689417|P1|Overall Study|Study Terminated by Sponsor|2
7673236|NCT01335477|26689541|P2|Overall Study|Reason other than those stated above|2
7673237|NCT01335477|26689542|P1|Overall Study|Reason other than those stated above|2
7673238|NCT01335477|26689541|P2|Overall Study|Not treated|2
7673239|NCT01335477|26689542|P1|Overall Study|Not treated|1
7673240|NCT01335477|26689541|P2|Overall Study|Consent withdrawn, not due to AE|9
7673241|NCT01335477|26689542|P1|Overall Study|Consent withdrawn, not due to AE|7
7673242|NCT01335477|26689541|P2|Overall Study|Lost to Follow-up|2
7673243|NCT01335477|26689542|P1|Overall Study|Lost to Follow-up|1
7673244|NCT01335477|26689541|P2|Overall Study|Non compliant with protocol|2
7673245|NCT01335477|26689542|P1|Overall Study|Non compliant with protocol|0
7673246|NCT01335477|26689541|P2|Overall Study|Adverse Event|42
7673247|NCT01335477|26689542|P1|Overall Study|Adverse Event|30
7673248|NCT01335464|26689606|P2|Overall Study|Reason other than those stated above|1
7673249|NCT01335464|26689607|P1|Overall Study|Reason other than those stated above|1
7673250|NCT01335464|26689606|P2|Overall Study|Not treated|0
7673251|NCT01335464|26689607|P1|Overall Study|Not treated|2
7673252|NCT01335464|26689606|P2|Overall Study|Consent withdrawn, not due to AE|23
7673253|NCT01335464|26689607|P1|Overall Study|Consent withdrawn, not due to AE|12
7673254|NCT01335464|26689606|P2|Overall Study|Non compliant with protocol|0
7673255|NCT01335464|26689607|P1|Overall Study|Non compliant with protocol|2
7673256|NCT01335464|26689606|P2|Overall Study|Adverse Event|25
7673257|NCT01335464|26689607|P1|Overall Study|Adverse Event|15
7673258|NCT01335399|26689671|P2|Treatment Period|Not reported|0
7673259|NCT01335399|26689672|P1|Treatment Period|Not reported|1
7673260|NCT01335399|26689671|P2|Treatment Period|No longer meet study criteria|1
7673261|NCT01335399|26689672|P1|Treatment Period|No longer meet study criteria|0
7673262|NCT01335399|26689671|P2|Treatment Period|Maximum clinical benefit|1
7673263|NCT01335399|26689672|P1|Treatment Period|Maximum clinical benefit|1
7673264|NCT01335399|26689671|P2|Treatment Period|Lost to Follow-up|2
7673265|NCT01335399|26689672|P1|Treatment Period|Lost to Follow-up|0
7673266|NCT01335399|26689671|P2|Treatment Period|Poor/Non-compliance|4
7673267|NCT01335399|26689672|P1|Treatment Period|Poor/Non-compliance|3
7673268|NCT01335399|26689671|P2|Treatment Period|Death|8
7673269|NCT01335399|26689672|P1|Treatment Period|Death|7
7673270|NCT01335399|26689671|P2|Treatment Period|Consent withdrawal|6
7673271|NCT01335399|26689672|P1|Treatment Period|Consent withdrawal|10
7673272|NCT01335399|26689671|P2|Treatment Period|Other reasons|26
7673273|NCT01335399|26689672|P1|Treatment Period|Other reasons|14
7673274|NCT01335399|26689671|P2|Treatment Period|Participant request to discontinue|21
7673275|NCT01335399|26689672|P1|Treatment Period|Participant request to discontinue|27
7673276|NCT01335399|26689671|P2|Treatment Period|Study drug toxicity|64
7673277|NCT01335399|26689672|P1|Treatment Period|Study drug toxicity|51
7673278|NCT01335399|26689671|P2|Treatment Period|Adverse event unrelated to study drug|65
7673279|NCT01335399|26689672|P1|Treatment Period|Adverse event unrelated to study drug|105
7673280|NCT01335399|26689671|P2|Treatment Period|Disease progression|141
7673281|NCT01335399|26689672|P1|Treatment Period|Disease progression|114
7673282|NCT01335399|26689671|P2|Pre-treatment Period|Consent withdrawal|0
7673283|NCT01335399|26689672|P1|Pre-treatment Period|Consent withdrawal|3
7673284|NCT01335399|26689671|P2|Pre-treatment Period|Adverse event unrelated to study drug|1
7673285|NCT01335399|26689672|P1|Pre-treatment Period|Adverse event unrelated to study drug|0
7673286|NCT01335399|26689671|P2|Pre-treatment Period|Participant request to discontinue|1
7673287|NCT01335399|26689672|P1|Pre-treatment Period|Participant request to discontinue|0
7673288|NCT01335399|26689671|P2|Pre-treatment Period|No longer meeting study criteria|1
7673289|NCT01335399|26689672|P1|Pre-treatment Period|No longer meeting study criteria|0
7673290|NCT01335009|26689760|P2|Overall Study|Lost to Follow-up|0
7673291|NCT01335009|26689761|P1|Overall Study|Lost to Follow-up|1
7673292|NCT01335009|26689760|P2|Overall Study|Withdrawal by Subject|1
7673293|NCT01335009|26689761|P1|Overall Study|Withdrawal by Subject|1
7673294|NCT01335009|26689760|P2|Overall Study|Death|32
7673295|NCT01335009|26689761|P1|Overall Study|Death|28
7673296|NCT01335009|26689760|P2|Overall Study|Too ill to travel to study sites|0
7673297|NCT01335009|26689761|P1|Overall Study|Too ill to travel to study sites|1
7673298|NCT01334918|26689810|P2|Overall Study|Withdrawal by Subject|1
7673299|NCT01334918|26689811|P1|Overall Study|Withdrawal by Subject|0
7673300|NCT01334918|26689810|P2|Overall Study|Adverse Event|0
7673301|NCT01334918|26689811|P1|Overall Study|Adverse Event|2
7673302|NCT01334918|26689810|P2|Overall Study|Did not receive study drug|0
7673303|NCT01334918|26689811|P1|Overall Study|Did not receive study drug|6
7673304|NCT01334866|26689837|P1|Overall Study|medically necessary post-procedure|1
7673305|NCT01334866|26689837|P1|Overall Study|medically necessary prior to procedure|2
7673306|NCT01334866|26689837|P1|Overall Study|Physician Decision|3
7673307|NCT01334866|26689837|P1|Overall Study|Lost to Follow-up|3
7673308|NCT01334866|26689837|P1|Overall Study|Withdrawal by Subject|10
7673309|NCT01334710|26689882|P1|Overall Study|Trial was terminated|3
7673310|NCT01334606|26689887|P1|Overall Study|Study Terminated due to slow enrolment|18
7673311|NCT01334554|26689895|P2|Overall Study|Adverse Event|2
7673312|NCT01334554|26689896|P1|Overall Study|Adverse Event|4
7673313|NCT01334515|26689906|P2|Overall Study|Withdrawal by Subject|1
7673314|NCT01334515|26689907|P1|Overall Study|Withdrawal by Subject|1
7673315|NCT01334515|26689906|P2|Overall Study|Physician Decision|1
7673316|NCT01334515|26689907|P1|Overall Study|Physician Decision|1
7673317|NCT01334515|26689906|P2|Overall Study|Lack of Efficacy|21
7673318|NCT01334515|26689907|P1|Overall Study|Lack of Efficacy|8
7673319|NCT01334515|26689906|P2|Overall Study|Death|0
7673320|NCT01334515|26689907|P1|Overall Study|Death|1
7673321|NCT01334515|26689906|P2|Overall Study|Adverse Event|6
7673322|NCT01334515|26689907|P1|Overall Study|Adverse Event|1
7673323|NCT01334125|26689945|P2|Overall Study|Lost to Follow-up|3
7673324|NCT01334125|26689946|P1|Overall Study|Lost to Follow-up|3
7673325|NCT01333956|26689970|P4|Overall Study|Withdrawal by Subject|0
7673326|NCT01333956|26689971|P3|Overall Study|Withdrawal by Subject|1
7673327|NCT01333956|26689972|P2|Overall Study|Withdrawal by Subject|2
7673328|NCT01333956|26689973|P1|Overall Study|Withdrawal by Subject|0
7673329|NCT01333956|26689970|P4|Overall Study|Unable to complete study procedure|1
7673330|NCT01333956|26689971|P3|Overall Study|Unable to complete study procedure|0
7673331|NCT01333956|26689972|P2|Overall Study|Unable to complete study procedure|0
7673332|NCT01333956|26689973|P1|Overall Study|Unable to complete study procedure|1
7673333|NCT01333956|26689970|P4|Overall Study|Lost to Follow-up|1
7673334|NCT01333956|26689971|P3|Overall Study|Lost to Follow-up|0
7673335|NCT01333956|26689972|P2|Overall Study|Lost to Follow-up|2
7673336|NCT01333956|26689973|P1|Overall Study|Lost to Follow-up|1
7673337|NCT01333943|26690009|P2|Overall Study|Known neuropathy|0
7673338|NCT01333943|26690010|P1|Overall Study|Known neuropathy|1
7673339|NCT01333865|26690026|P1|Overall Study|Adverse Event|2
7673340|NCT01333722|26690046|P2|Overall Study|Withdrawal by Subject|1
7673341|NCT01333722|26690047|P1|Overall Study|Withdrawal by Subject|0
7673342|NCT01333722|26690046|P2|Overall Study|Lack of Efficacy|2
7673343|NCT01333722|26690047|P1|Overall Study|Lack of Efficacy|0
7673344|NCT01333501|26690091|P2|Overall Study|Withdrawn consent|12
7673345|NCT01333501|26690092|P1|Overall Study|Withdrawn consent|3
7673346|NCT01333501|26690091|P2|Overall Study|Unsatisfactory therapeutic effect|7
7673347|NCT01333501|26690092|P1|Overall Study|Unsatisfactory therapeutic effect|1
7673348|NCT01333501|26690091|P2|Overall Study|Abnormal laboratory value|1
7673349|NCT01333501|26690092|P1|Overall Study|Abnormal laboratory value|2
7673350|NCT01333501|26690091|P2|Overall Study|Adverse Event|1
7673351|NCT01333501|26690092|P1|Overall Study|Adverse Event|3
7673352|NCT01333475|26690159|P2|Overall Study|Toxicity|3
7673353|NCT01333475|26690160|P1|Overall Study|Toxicity|1
7673354|NCT01333475|26690159|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
7673355|NCT01333475|26690160|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
7673356|NCT01333397|26690186|P5|Overall Study|Lost to Follow-up|0
7673357|NCT01333397|26690187|P4|Overall Study|Lost to Follow-up|1
7673358|NCT01333397|26690188|P3|Overall Study|Lost to Follow-up|0
7673359|NCT01333397|26690189|P2|Overall Study|Lost to Follow-up|0
7673360|NCT01333397|26690190|P1|Overall Study|Lost to Follow-up|1
7673361|NCT01333189|26690264|P2|Overall Study|Moved from region|1
7673362|NCT01333189|26690265|P1|Overall Study|Moved from region|0
7673363|NCT01333189|26690264|P2|Overall Study|Transportation difficulties|1
7673364|NCT01333189|26690265|P1|Overall Study|Transportation difficulties|0
7673365|NCT01333189|26690264|P2|Overall Study|Adverse Event|0
7673366|NCT01333189|26690265|P1|Overall Study|Adverse Event|1
7673367|NCT01333189|26690264|P2|Overall Study|Time constraints|0
7673368|NCT01333189|26690265|P1|Overall Study|Time constraints|1
7673369|NCT01333111|26690296|P3|Overall Study|Ineffective therapy|1
7673370|NCT01333111|26690297|P2|Overall Study|Ineffective therapy|0
7673371|NCT01333111|26690298|P1|Overall Study|Ineffective therapy|0
7673372|NCT01333111|26690296|P3|Overall Study|Non-compliance|0
7673373|NCT01333111|26690297|P2|Overall Study|Non-compliance|0
7673374|NCT01333111|26690298|P1|Overall Study|Non-compliance|1
7673375|NCT01333111|26690296|P3|Overall Study|withdrawal criteria|0
7673376|NCT01333111|26690297|P2|Overall Study|withdrawal criteria|1
7673377|NCT01333111|26690298|P1|Overall Study|withdrawal criteria|0
7673378|NCT01333111|26690296|P3|Overall Study|unclassified|0
7673379|NCT01333111|26690297|P2|Overall Study|unclassified|0
7673380|NCT01333111|26690298|P1|Overall Study|unclassified|1
7673381|NCT01333111|26690296|P3|Overall Study|personal reasons|1
7673382|NCT01333111|26690297|P2|Overall Study|personal reasons|0
7673383|NCT01333111|26690298|P1|Overall Study|personal reasons|0
7673384|NCT01333111|26690296|P3|Overall Study|patient undergoing major surgery|0
7673385|NCT01333111|26690297|P2|Overall Study|patient undergoing major surgery|2
7673386|NCT01333111|26690298|P1|Overall Study|patient undergoing major surgery|0
7673387|NCT01333072|26690333|P2|Overall Study|Physician Decision|0
7673388|NCT01333072|26690334|P1|Overall Study|Physician Decision|1
7673389|NCT01333072|26690333|P2|Overall Study|Adverse Event|4
7673390|NCT01333072|26690334|P1|Overall Study|Adverse Event|2
7673391|NCT01333072|26690333|P2|Overall Study|Lost to Follow-up|0
7673392|NCT01333072|26690334|P1|Overall Study|Lost to Follow-up|3
7673393|NCT01333059|26690342|P2|Overall Study|Protocol Violation|0
7673394|NCT01333059|26690343|P1|Overall Study|Protocol Violation|3
7673395|NCT01333059|26690342|P2|Overall Study|Physician Decision|3
7673396|NCT01333059|26690343|P1|Overall Study|Physician Decision|3
7673397|NCT01332994|26690353|P1|Overall Study|Other|8
7673398|NCT01332994|26690353|P1|Overall Study|Administrative Problem|2
7673399|NCT01332994|26690353|P1|Overall Study|Withdrawal by Subject|15
7673400|NCT01332994|26690353|P1|Overall Study|Protocol Violation|6
7673401|NCT01332994|26690353|P1|Overall Study|Lost to Follow-up|4
7673402|NCT01332994|26690353|P1|Overall Study|Lack of Efficacy|1
7673403|NCT01332994|26690353|P1|Overall Study|Death|1
7673404|NCT01332994|26690353|P1|Overall Study|Adverse Event|34
7673597|NCT01332331|26690664|P1|Overall Study|Physician Decision|1
7673589|NCT01332851|26690495|P2|Overall Study|Lost to Follow-up|11
7673590|NCT01332851|26690496|P1|Overall Study|Lost to Follow-up|7
7673591|NCT01332851|26690495|P2|Overall Study|Withdrawal by Subject|2
7673592|NCT01332851|26690496|P1|Overall Study|Withdrawal by Subject|4
7673593|NCT01332799|26690530|P2|Overall Study|Insufficient funding|10
7673594|NCT01332799|26690531|P1|Overall Study|Insufficient funding|10
7673595|NCT01332630|26690547|P1|Overall Study|Withdrawal by Subject|3
7673596|NCT01332331|26690663|P2|Overall Study|Physician Decision|0
7673598|NCT01332331|26690663|P2|Overall Study|Adverse Event|1
7673599|NCT01332331|26690664|P1|Overall Study|Adverse Event|1
7673600|NCT01332331|26690663|P2|Overall Study|Lost to Follow-up|1
7673601|NCT01332331|26690664|P1|Overall Study|Lost to Follow-up|0
7673602|NCT01332318|26690716|P4|Overall Study|Protocol Violation|1
7673603|NCT01332318|26690717|P3|Overall Study|Protocol Violation|1
7673604|NCT01332318|26690718|P2|Overall Study|Protocol Violation|0
7673605|NCT01332318|26690719|P1|Overall Study|Protocol Violation|1
7673606|NCT01332318|26690716|P4|Overall Study|Withdrawal by Subject|1
7673607|NCT01332318|26690717|P3|Overall Study|Withdrawal by Subject|0
7673608|NCT01332318|26690718|P2|Overall Study|Withdrawal by Subject|1
7673609|NCT01332318|26690719|P1|Overall Study|Withdrawal by Subject|1
7673610|NCT01332318|26690716|P4|Overall Study|Adverse Event|0
7673611|NCT01332318|26690717|P3|Overall Study|Adverse Event|0
7673612|NCT01332318|26690718|P2|Overall Study|Adverse Event|3
7673613|NCT01332318|26690719|P1|Overall Study|Adverse Event|0
7673614|NCT01332305|26690830|P5|Overall Study|Physician Decision|0
7673615|NCT01332305|26690831|P4|Overall Study|Physician Decision|1
7673616|NCT01332305|26690832|P3|Overall Study|Physician Decision|0
7673617|NCT01332305|26690833|P2|Overall Study|Physician Decision|0
7673618|NCT01332305|26690834|P1|Overall Study|Physician Decision|0
7673619|NCT01332305|26690830|P5|Overall Study|Treatment Failure|0
7673620|NCT01332305|26690831|P4|Overall Study|Treatment Failure|0
7673621|NCT01332305|26690832|P3|Overall Study|Treatment Failure|0
7673622|NCT01332305|26690833|P2|Overall Study|Treatment Failure|1
7673623|NCT01332305|26690834|P1|Overall Study|Treatment Failure|1
7673624|NCT01332305|26690830|P5|Overall Study|Withdrawal by Sponsor|1
7673625|NCT01332305|26690831|P4|Overall Study|Withdrawal by Sponsor|1
7673626|NCT01332305|26690832|P3|Overall Study|Withdrawal by Sponsor|0
7673627|NCT01332305|26690833|P2|Overall Study|Withdrawal by Sponsor|0
7673628|NCT01332305|26690834|P1|Overall Study|Withdrawal by Sponsor|1
7673629|NCT01332305|26690830|P5|Overall Study|Protocol Violation|3
7673630|NCT01332305|26690831|P4|Overall Study|Protocol Violation|0
7673631|NCT01332305|26690832|P3|Overall Study|Protocol Violation|1
7673632|NCT01332305|26690833|P2|Overall Study|Protocol Violation|2
7673633|NCT01332305|26690834|P1|Overall Study|Protocol Violation|1
7673634|NCT01332305|26690830|P5|Overall Study|Lost to Follow-up|3
7673635|NCT01332305|26690831|P4|Overall Study|Lost to Follow-up|2
7673636|NCT01332305|26690832|P3|Overall Study|Lost to Follow-up|3
7673637|NCT01332305|26690833|P2|Overall Study|Lost to Follow-up|2
7673638|NCT01332305|26690834|P1|Overall Study|Lost to Follow-up|0
7673639|NCT01332305|26690830|P5|Overall Study|Withdrawal by Subject|0
7673640|NCT01332305|26690831|P4|Overall Study|Withdrawal by Subject|1
7673641|NCT01332305|26690832|P3|Overall Study|Withdrawal by Subject|4
7673642|NCT01332305|26690833|P2|Overall Study|Withdrawal by Subject|5
7673643|NCT01332305|26690834|P1|Overall Study|Withdrawal by Subject|6
7673644|NCT01332305|26690830|P5|Overall Study|Adverse Event|5
7673645|NCT01332305|26690831|P4|Overall Study|Adverse Event|3
7673646|NCT01332305|26690832|P3|Overall Study|Adverse Event|6
7673647|NCT01332305|26690833|P2|Overall Study|Adverse Event|4
7673648|NCT01332305|26690834|P1|Overall Study|Adverse Event|1
7673649|NCT01332292|26690856|P2|Treatment Period 2 (14 Days)|Physician Decision|1
7673650|NCT01332292|26690857|P1|Treatment Period 2 (14 Days)|Physician Decision|1
7673651|NCT01332292|26690856|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
7673652|NCT01332292|26690857|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
7673653|NCT01332292|26690856|P2|Treatment Period 1 (14 Days)|Adverse Event|0
7673654|NCT01332292|26690857|P1|Treatment Period 1 (14 Days)|Adverse Event|1
7673655|NCT01332227|26690948|P2|Overall Study|Patient began prohibited medication|1
7673656|NCT01332227|26690949|P1|Overall Study|Patient began prohibited medication|0
7673657|NCT01332227|26690948|P2|Overall Study|Patient moved from area|0
7673658|NCT01332227|26690949|P1|Overall Study|Patient moved from area|1
7673659|NCT01332227|26690948|P2|Overall Study|Poor compliance/noncompliance|1
7673660|NCT01332227|26690949|P1|Overall Study|Poor compliance/noncompliance|1
7673661|NCT01332227|26690948|P2|Overall Study|Lack of Efficacy|1
7673662|NCT01332227|26690949|P1|Overall Study|Lack of Efficacy|3
7673663|NCT01332227|26690948|P2|Overall Study|Lost to Follow-up|0
7673664|NCT01332227|26690949|P1|Overall Study|Lost to Follow-up|2
7673665|NCT01332227|26690948|P2|Overall Study|Withdrawal by Subject|1
7673666|NCT01332227|26690949|P1|Overall Study|Withdrawal by Subject|5
7673667|NCT01332227|26690948|P2|Overall Study|Adverse Event|1
7673668|NCT01332227|26690949|P1|Overall Study|Adverse Event|4
7673669|NCT01332149|26691130|P2|Overall Study|Randomized but not treated|2
7673670|NCT01332149|26691131|P1|Overall Study|Randomized but not treated|1
7673671|NCT01332149|26691130|P2|Overall Study|Did not meet entrance criteria|4
7673672|NCT01332149|26691131|P1|Overall Study|Did not meet entrance criteria|3
7673673|NCT01332149|26691130|P2|Overall Study|Insufficient clinical response|7
7673674|NCT01332149|26691131|P1|Overall Study|Insufficient clinical response|4
7673675|NCT01332149|26691130|P2|Overall Study|Lost to Follow-up|1
7673676|NCT01332149|26691131|P1|Overall Study|Lost to Follow-up|1
7673677|NCT01332149|26691130|P2|Overall Study|Withdrawal by Subject|5
7673678|NCT01332149|26691131|P1|Overall Study|Withdrawal by Subject|4
7673679|NCT01332149|26691130|P2|Overall Study|Protocol Violation|3
7673680|NCT01332149|26691131|P1|Overall Study|Protocol Violation|1
7673681|NCT01332149|26691130|P2|Overall Study|Other unspecified|7
7673682|NCT01332149|26691131|P1|Overall Study|Other unspecified|5
7673683|NCT01332149|26691130|P2|Overall Study|Adverse Event|9
7673684|NCT01332149|26691131|P1|Overall Study|Adverse Event|11
7673685|NCT01332019|26691209|P2|Overall Study|Adverse Event|22
7673686|NCT01332019|26691210|P1|Overall Study|Adverse Event|13
7673687|NCT01332019|26691209|P2|Overall Study|Lost to Follow-up|7
7673688|NCT01332019|26691210|P1|Overall Study|Lost to Follow-up|4
7673689|NCT01332019|26691209|P2|Overall Study|Withdrawal by Subject|71
7673690|NCT01332019|26691210|P1|Overall Study|Withdrawal by Subject|73
7673691|NCT01332019|26691209|P2|Overall Study|Physician Decision|3
7673692|NCT01332019|26691210|P1|Overall Study|Physician Decision|4
7673693|NCT01332019|26691209|P2|Overall Study|Death|1
7673694|NCT01332019|26691210|P1|Overall Study|Death|2
7673695|NCT01332019|26691209|P2|Overall Study|Other|18
7673696|NCT01332019|26691210|P1|Overall Study|Other|16
7673697|NCT01332019|26691209|P2|Overall Study|Was Not Dosed|0
7673698|NCT01332019|26691210|P1|Overall Study|Was Not Dosed|1
7673699|NCT01331837|26691294|P2|Overall Study|Withdrawal by Subject|16
7673700|NCT01331837|26691295|P1|Overall Study|Withdrawal by Subject|13
7673701|NCT01331837|26691294|P2|Overall Study|Info not recorded|16
7673702|NCT01331837|26691295|P1|Overall Study|Info not recorded|10
7673703|NCT01331837|26691294|P2|Overall Study|Lost to Follow-up|1
7673704|NCT01331837|26691295|P1|Overall Study|Lost to Follow-up|3
7673705|NCT01331837|26691294|P2|Overall Study|Death|34
7673706|NCT01331837|26691295|P1|Overall Study|Death|30
7673707|NCT01331824|26691335|P1|Overall Study|Withdrawal by Subject|1
7673708|NCT01331824|26691335|P1|Overall Study|Disease Progression|9
7673709|NCT01331824|26691335|P1|Overall Study|Death|1
7673710|NCT01331824|26691335|P1|Overall Study|Adverse Event|2
7673711|NCT01331681|26691370|P3|Overall Study|Not Received Study Treatment|2
7673712|NCT01331681|26691371|P2|Overall Study|Not Received Study Treatment|0
7673713|NCT01331681|26691372|P1|Overall Study|Not Received Study Treatment|0
7673714|NCT01331681|26691370|P3|Overall Study|Switching to other therapy|1
7673715|NCT01331681|26691371|P2|Overall Study|Switching to other therapy|0
7673716|NCT01331681|26691372|P1|Overall Study|Switching to other therapy|0
7673717|NCT01331681|26691370|P3|Overall Study|Sponsor decision|0
7673718|NCT01331681|26691371|P2|Overall Study|Sponsor decision|1
7673719|NCT01331681|26691372|P1|Overall Study|Sponsor decision|1
7673720|NCT01331681|26691370|P3|Overall Study|Therapeutic procedure required|0
7673721|NCT01331681|26691371|P2|Overall Study|Therapeutic procedure required|0
7673722|NCT01331681|26691372|P1|Overall Study|Therapeutic procedure required|1
7673723|NCT01331681|26691370|P3|Overall Study|Physician Decision|4
7673724|NCT01331681|26691371|P2|Overall Study|Physician Decision|0
7673725|NCT01331681|26691372|P1|Overall Study|Physician Decision|2
7673726|NCT01331681|26691370|P3|Overall Study|Lost to Follow-up|1
7673727|NCT01331681|26691371|P2|Overall Study|Lost to Follow-up|4
7673728|NCT01331681|26691372|P1|Overall Study|Lost to Follow-up|2
7673729|NCT01331681|26691370|P3|Overall Study|Protocol Violation|0
7673730|NCT01331681|26691371|P2|Overall Study|Protocol Violation|1
7673731|NCT01331681|26691372|P1|Overall Study|Protocol Violation|1
7673732|NCT01331681|26691370|P3|Overall Study|Withdrawal by Subject|15
7673733|NCT01331681|26691371|P2|Overall Study|Withdrawal by Subject|8
7673734|NCT01331681|26691372|P1|Overall Study|Withdrawal by Subject|12
7673735|NCT01331681|26691370|P3|Overall Study|Lack of Efficacy|0
7673736|NCT01331681|26691371|P2|Overall Study|Lack of Efficacy|1
7673737|NCT01331681|26691372|P1|Overall Study|Lack of Efficacy|0
7673738|NCT01331681|26691370|P3|Overall Study|Death|2
7673739|NCT01331681|26691371|P2|Overall Study|Death|6
7673740|NCT01331681|26691372|P1|Overall Study|Death|6
7673741|NCT01331681|26691370|P3|Overall Study|Adverse Event|10
7673742|NCT01331681|26691371|P2|Overall Study|Adverse Event|13
7673743|NCT01331681|26691372|P1|Overall Study|Adverse Event|10
7673744|NCT01331291|26691421|P2|Overall Study|Death|1
7673745|NCT01331291|26691422|P1|Overall Study|Death|0
7673746|NCT01331291|26691421|P2|Overall Study|Lack of Efficacy|8
7673747|NCT01331291|26691422|P1|Overall Study|Lack of Efficacy|2
7673748|NCT01331239|26691435|P3|Part II: Core Study|Administrative problems|0
7673749|NCT01331239|26691436|P2|Part II: Core Study|Administrative problems|1
7673750|NCT01331239|26691437|P1|Part II: Core Study|Administrative problems|0
7673751|NCT01331239|26691435|P3|Part II: Core Study|Withdrawal by Subject|0
7673752|NCT01331239|26691436|P2|Part II: Core Study|Withdrawal by Subject|2
7673753|NCT01331239|26691437|P1|Part II: Core Study|Withdrawal by Subject|0
7673754|NCT01331239|26691435|P3|Part II: Core Study|Subj's cond. no longer require treatment|1
7673755|NCT01331239|26691436|P2|Part II: Core Study|Subj's cond. no longer require treatment|2
7673756|NCT01331239|26691437|P1|Part II: Core Study|Subj's cond. no longer require treatment|0
7673757|NCT01331239|26691435|P3|Part II: Core Study|Adverse Event|0
7673758|NCT01331239|26691436|P2|Part II: Core Study|Adverse Event|3
7673759|NCT01331239|26691437|P1|Part II: Core Study|Adverse Event|0
7673760|NCT01331161|26691530|P2|Overall Study|Pregnancy|1
7673761|NCT01331161|26691531|P1|Overall Study|Pregnancy|0
7673762|NCT01331161|26691530|P2|Overall Study|Lost to Follow-up|1
7673763|NCT01331161|26691531|P1|Overall Study|Lost to Follow-up|0
7673764|NCT01331161|26691530|P2|Overall Study|Physician Decision|0
7673765|NCT01331161|26691531|P1|Overall Study|Physician Decision|1
7673766|NCT01331109|26691539|P1|Overall Study|Study Terminated by Sponsor|38
7673767|NCT01331109|26691539|P1|Overall Study|Lost to Follow-up|1
7673768|NCT01331109|26691539|P1|Overall Study|Withdrawal by Subject|7
7673769|NCT01331109|26691539|P1|Overall Study|Protocol Violation|3
7673770|NCT01331109|26691539|P1|Overall Study|Lack of Efficacy|2
7673771|NCT01331109|26691539|P1|Overall Study|Adverse Event|6
7673772|NCT01331005|26691566|P2|Overall Study|Withdrawal by Subject|3
7673773|NCT01331005|26691567|P1|Overall Study|Withdrawal by Subject|2
7673774|NCT01331005|26691566|P2|Overall Study|Lost to Follow-up|1
7673775|NCT01331005|26691567|P1|Overall Study|Lost to Follow-up|2
7673776|NCT01330914|26691638|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
7673777|NCT01330914|26691638|P1|Overall Study|Withdrawal by Subject|4
7673778|NCT01330628|26691646|P2|Overall Study|Didn't receive study treatment|0
7673779|NCT01330628|26691647|P1|Overall Study|Didn't receive study treatment|1
7673780|NCT01330628|26691646|P2|Overall Study|Withdrawn|6
7673781|NCT01330628|26691647|P1|Overall Study|Withdrawn|18
7673782|NCT01330628|26691646|P2|Overall Study|Adverse Event|25
7673783|NCT01330628|26691647|P1|Overall Study|Adverse Event|44
7673784|NCT01330628|26691646|P2|Overall Study|Lost to Follow-up|6
7673785|NCT01330628|26691647|P1|Overall Study|Lost to Follow-up|5
7673786|NCT01330628|26691646|P2|Overall Study|Death|3
7673787|NCT01330628|26691647|P1|Overall Study|Death|2
7673788|NCT01330459|26691657|P2|Overall Study|Physician Decision|2
7673789|NCT01330459|26691658|P1|Overall Study|Physician Decision|0
7673790|NCT01330433|26691674|P2|Overall Study|Lost to Follow-up|0
7673791|NCT01330433|26691675|P1|Overall Study|Lost to Follow-up|1
7673792|NCT01330433|26691674|P2|Overall Study|Death|3
7673793|NCT01330433|26691675|P1|Overall Study|Death|1
7673794|NCT01330381|26691714|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
7673795|NCT01330381|26691715|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
7673796|NCT01330381|26691716|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
7673797|NCT01330381|26691714|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
7673798|NCT01330381|26691715|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
7673799|NCT01330381|26691716|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
7673800|NCT01330381|26691714|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
7673801|NCT01330381|26691715|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
7673802|NCT01330381|26691716|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
7673803|NCT01330381|26691714|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
7673804|NCT01330381|26691715|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
7673805|NCT01330381|26691716|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
7673806|NCT01330381|26691714|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7673807|NCT01330381|26691715|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7673808|NCT01330381|26691716|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7673809|NCT01330381|26691714|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
7673810|NCT01330381|26691715|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
7673811|NCT01330381|26691716|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
7673812|NCT01330381|26691714|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
7673813|NCT01330381|26691715|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
7673814|NCT01330381|26691716|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
7673815|NCT01330381|26691714|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
7673816|NCT01330381|26691715|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7673817|NCT01330381|26691716|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7673818|NCT01330381|26691714|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
7673819|NCT01330381|26691715|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
7673820|NCT01330381|26691716|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
7673821|NCT01330381|26691714|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
7673822|NCT01330381|26691715|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
7673823|NCT01330381|26691716|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
7673824|NCT01330316|26691777|P2|Overall Study|other than above|1
7673825|NCT01330316|26691778|P1|Overall Study|other than above|0
7673826|NCT01330316|26691777|P2|Overall Study|Withdrawal by Subject|1
7673827|NCT01330316|26691778|P1|Overall Study|Withdrawal by Subject|0
7673828|NCT01330316|26691777|P2|Overall Study|Lost to Follow-up|1
7673829|NCT01330316|26691778|P1|Overall Study|Lost to Follow-up|0
7673830|NCT01330316|26691777|P2|Overall Study|Lack of Efficacy|10
7673831|NCT01330316|26691778|P1|Overall Study|Lack of Efficacy|0
7673832|NCT01330316|26691777|P2|Overall Study|Adverse Event|2
7673833|NCT01330316|26691778|P1|Overall Study|Adverse Event|2
7673834|NCT01330303|26691814|P2|Period 1|Withdrawal by Subject|1
7673835|NCT01330303|26691815|P1|Period 1|Withdrawal by Subject|0
7673836|NCT01330303|26691814|P2|Period 1|Protocol Violation|1
7673837|NCT01330303|26691815|P1|Period 1|Protocol Violation|0
7673838|NCT01330303|26691814|P2|Period 1|Adverse Event|0
7673839|NCT01330303|26691815|P1|Period 1|Adverse Event|1
7673840|NCT01330108|26691862|P1|Overall Study|Withdrawal by Subject|4
7673841|NCT01330030|26691880|P2|Overall Study|Lost to Follow-up|17
7673842|NCT01330030|26691881|P1|Overall Study|Lost to Follow-up|16
7673843|NCT01330017|26691892|P5|Overall Study|Unknown Reason|2
7673844|NCT01330017|26691893|P4|Overall Study|Unknown Reason|7
7673845|NCT01330017|26691894|P3|Overall Study|Unknown Reason|5
7673846|NCT01330017|26691895|P2|Overall Study|Unknown Reason|3
7673847|NCT01330017|26691896|P1|Overall Study|Unknown Reason|5
7673848|NCT01330017|26691892|P5|Overall Study|Protocol Violation|0
7673849|NCT01330017|26691893|P4|Overall Study|Protocol Violation|1
7673850|NCT01330017|26691894|P3|Overall Study|Protocol Violation|0
7673851|NCT01330017|26691895|P2|Overall Study|Protocol Violation|0
7673852|NCT01330017|26691896|P1|Overall Study|Protocol Violation|0
7673853|NCT01330017|26691892|P5|Overall Study|Lost to Follow-up|0
7673854|NCT01330017|26691893|P4|Overall Study|Lost to Follow-up|0
7673855|NCT01330017|26691894|P3|Overall Study|Lost to Follow-up|1
7673856|NCT01330017|26691895|P2|Overall Study|Lost to Follow-up|0
7673857|NCT01330017|26691896|P1|Overall Study|Lost to Follow-up|0
7673858|NCT01330017|26691892|P5|Overall Study|Withdrawal by Subject|1
7673859|NCT01330017|26691893|P4|Overall Study|Withdrawal by Subject|0
7673860|NCT01330017|26691894|P3|Overall Study|Withdrawal by Subject|1
7673861|NCT01330017|26691895|P2|Overall Study|Withdrawal by Subject|0
7673862|NCT01330017|26691896|P1|Overall Study|Withdrawal by Subject|0
7673863|NCT01330017|26691892|P5|Overall Study|Adverse Event|0
7673864|NCT01330017|26691893|P4|Overall Study|Adverse Event|4
7673865|NCT01330017|26691894|P3|Overall Study|Adverse Event|1
7673866|NCT01330017|26691895|P2|Overall Study|Adverse Event|1
7673867|NCT01330017|26691896|P1|Overall Study|Adverse Event|0
7673868|NCT01329978|26691945|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
7673869|NCT01329978|26691946|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
7673870|NCT01329978|26691947|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
7673871|NCT01329978|26691948|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
7673872|NCT01329978|26691949|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
7673873|NCT01329978|26691945|P5|Rerandomization Treatment Period|Lost to Follow-up|3
7673874|NCT01329978|26691946|P4|Rerandomization Treatment Period|Lost to Follow-up|5
7673875|NCT01329978|26691947|P3|Rerandomization Treatment Period|Lost to Follow-up|0
7673876|NCT01329978|26691948|P2|Rerandomization Treatment Period|Lost to Follow-up|0
7673877|NCT01329978|26691949|P1|Rerandomization Treatment Period|Lost to Follow-up|0
7673878|NCT01329978|26691945|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7673879|NCT01329978|26691946|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7673880|NCT01329978|26691947|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7673881|NCT01329978|26691948|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
7673882|NCT01329978|26691949|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7673883|NCT01329978|26691945|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7673884|NCT01329978|26691946|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7673885|NCT01329978|26691947|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7673886|NCT01329978|26691948|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
7673887|NCT01329978|26691949|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7673888|NCT01329978|26691945|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
7673889|NCT01329978|26691946|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
7673890|NCT01329978|26691947|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
7673891|NCT01329978|26691948|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
7673892|NCT01329978|26691949|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
7673893|NCT01329978|26691945|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
7673894|NCT01329978|26691946|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
7673895|NCT01329978|26691947|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
7673896|NCT01329978|26691948|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
7673897|NCT01329978|26691949|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
7673898|NCT01329978|26691945|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7673899|NCT01329978|26691946|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7673900|NCT01329978|26691947|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7673901|NCT01329978|26691948|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
7673902|NCT01329978|26691949|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
7673903|NCT01329939|26692023|P4|Overall Study|Adverse Event|3
7673904|NCT01329939|26692024|P3|Overall Study|Adverse Event|0
7673905|NCT01329939|26692025|P2|Overall Study|Adverse Event|0
7673906|NCT01329939|26692026|P1|Overall Study|Adverse Event|0
7673907|NCT01329939|26692023|P4|Overall Study|Withdrawal by Subject|0
7673908|NCT01329939|26692024|P3|Overall Study|Withdrawal by Subject|0
7673909|NCT01329939|26692025|P2|Overall Study|Withdrawal by Subject|1
7673910|NCT01329939|26692026|P1|Overall Study|Withdrawal by Subject|0
7673911|NCT01329939|26692023|P4|Overall Study|Lost to Follow-up|2
7673912|NCT01329939|26692024|P3|Overall Study|Lost to Follow-up|1
7673913|NCT01329939|26692025|P2|Overall Study|Lost to Follow-up|0
7673914|NCT01329939|26692026|P1|Overall Study|Lost to Follow-up|3
7673915|NCT01329900|26692064|P1|Overall Study|Elevated creatinine/renal function|1
7673916|NCT01329562|26692094|P2|Overall Study|Physician Decision|1
7673917|NCT01329562|26692095|P1|Overall Study|Physician Decision|0
7673918|NCT01329562|26692094|P2|Overall Study|Subject withdrew due to personal issues.|2
7673919|NCT01329562|26692095|P1|Overall Study|Subject withdrew due to personal issues.|3
7673920|NCT01329562|26692094|P2|Overall Study|Lost to Follow-up|1
7673921|NCT01329562|26692095|P1|Overall Study|Lost to Follow-up|1
7673922|NCT01329562|26692094|P2|Overall Study|Protocol Violation|3
7673923|NCT01329562|26692095|P1|Overall Study|Protocol Violation|5
7673924|NCT01329549|26692144|P1|Overall Study|Adverse Event|1
7673925|NCT01329549|26692144|P1|Overall Study|Withdrawal by Subject|1
7673926|NCT01329419|26692155|P1|Overall Study|Protocol Violation|235
7673927|NCT01329341|26692171|P1|Overall Study|Withdrawal by Subject|44
7673928|NCT01329328|26692178|P3|Overall Study|Withdrawal by Subject|3
7673929|NCT01329328|26692179|P2|Overall Study|Withdrawal by Subject|4
7673930|NCT01329328|26692180|P1|Overall Study|Withdrawal by Subject|2
7673931|NCT01329263|26692193|P2|Overall Study|Withdrawal by Subject|2
7673932|NCT01329263|26692194|P1|Overall Study|Withdrawal by Subject|1
7673933|NCT01329263|26692193|P2|Overall Study|Lost to Follow-up|21
7673934|NCT01329263|26692194|P1|Overall Study|Lost to Follow-up|4
7673935|NCT01329029|26692231|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
7673936|NCT01329029|26692232|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
7673937|NCT01329029|26692231|P2|Overall Study|Lost to Follow-up|5
7673938|NCT01329029|26692232|P1|Overall Study|Lost to Follow-up|8
7673939|NCT01329029|26692231|P2|Overall Study|Physician Decision|13
7673940|NCT01329029|26692232|P1|Overall Study|Physician Decision|16
7673941|NCT01329029|26692231|P2|Overall Study|COPD Exacerbation|18
7673942|NCT01329029|26692232|P1|Overall Study|COPD Exacerbation|11
7673943|NCT01329029|26692231|P2|Overall Study|Other|20
7673944|NCT01329029|26692232|P1|Overall Study|Other|14
7673945|NCT01329029|26692231|P2|Overall Study|Death|19
7673946|NCT01329029|26692232|P1|Overall Study|Death|16
7673947|NCT01329029|26692231|P2|Overall Study|Adverse Event|29
7673948|NCT01329029|26692232|P1|Overall Study|Adverse Event|82
7673949|NCT01329029|26692231|P2|Overall Study|Withdrawal by Subject|87
7673950|NCT01329029|26692232|P1|Overall Study|Withdrawal by Subject|117
7673951|NCT01328951|26692322|P2|Overall Study|Other|6
7673952|NCT01328951|26692323|P1|Overall Study|Other|11
7673953|NCT01328951|26692322|P2|Overall Study|Study Closed by the Sponsor|31
7673954|NCT01328951|26692323|P1|Overall Study|Study Closed by the Sponsor|36
7673955|NCT01328951|26692322|P2|Overall Study|Withdrawal by Subject|6
7673956|NCT01328951|26692323|P1|Overall Study|Withdrawal by Subject|6
7673957|NCT01328951|26692322|P2|Overall Study|Lost to Follow-up|7
7673958|NCT01328951|26692323|P1|Overall Study|Lost to Follow-up|6
7673959|NCT01328951|26692322|P2|Overall Study|Death|258
7673960|NCT01328951|26692323|P1|Overall Study|Death|243
7673961|NCT01328951|26692322|P2|Overall Study|Adverse Event|0
7673962|NCT01328951|26692323|P1|Overall Study|Adverse Event|2
7673963|NCT01328951|26692322|P2|Overall Study|Disease Progression|14
7673964|NCT01328951|26692323|P1|Overall Study|Disease Progression|17
7673965|NCT01328756|26692392|P1|Overall Study|Other|29
7673966|NCT01328756|26692392|P1|Overall Study|Lost to Follow-up|5
7673967|NCT01328756|26692392|P1|Overall Study|Withdrawal by Subject|41
7673968|NCT01328756|26692392|P1|Overall Study|Lack of Efficacy|5
7673969|NCT01328756|26692392|P1|Overall Study|Adverse Event|39
7673970|NCT01328756|26692392|P1|Overall Study|Protocol Violation|4
7673971|NCT01328717|26692428|P1|Overall Study|Adverse Event|1
7673972|NCT01328574|26692437|P1|Overall Study|Refused further treatment|1
7673973|NCT01328548|26692451|P2|Overall Study|Protocol Violation|0
7673974|NCT01328548|26692452|P1|Overall Study|Protocol Violation|1
7673975|NCT01328548|26692451|P2|Overall Study|Death|0
7673976|NCT01328548|26692452|P1|Overall Study|Death|3
7673977|NCT01328535|26692470|P1|Overall Study|Ineligible|1
7673978|NCT01328496|26692481|P2|Overall Study|Significant Change in Health Status|0
7673979|NCT01328496|26692482|P1|Overall Study|Significant Change in Health Status|1
7673980|NCT01328444|26692500|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7673981|NCT01328444|26692501|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7673982|NCT01328444|26692502|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7673983|NCT01328444|26692503|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7673984|NCT01328444|26692504|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7673985|NCT01328444|26692505|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7673986|NCT01328444|26692500|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
7673987|NCT01328444|26692501|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7673988|NCT01328444|26692502|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7673989|NCT01328444|26692503|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7673990|NCT01328444|26692504|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7673991|NCT01328444|26692505|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7673992|NCT01328444|26692500|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7673993|NCT01328444|26692501|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
7673994|NCT01328444|26692502|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
7673995|NCT01328444|26692503|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7673996|NCT01328444|26692504|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7673997|NCT01328444|26692505|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7673998|NCT01328444|26692500|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7673999|NCT01328444|26692501|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
7674000|NCT01328444|26692502|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7674001|NCT01328444|26692503|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7674002|NCT01328444|26692504|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7674003|NCT01328444|26692505|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
7674004|NCT01328444|26692500|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
7674005|NCT01328444|26692501|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
7674006|NCT01328444|26692502|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7674007|NCT01328444|26692503|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7674008|NCT01328444|26692504|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7674009|NCT01328444|26692505|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
7674010|NCT01328444|26692500|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
7674011|NCT01328444|26692501|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
7674012|NCT01328444|26692502|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
7674013|NCT01328444|26692503|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
7674014|NCT01328444|26692504|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
7674015|NCT01328444|26692505|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
7674016|NCT01328444|26692500|P6|Washout Period (14 Days)|Withdrawal by Subject|1
7674017|NCT01328444|26692501|P5|Washout Period (14 Days)|Withdrawal by Subject|0
7674018|NCT01328444|26692502|P4|Washout Period (14 Days)|Withdrawal by Subject|0
7674019|NCT01328444|26692503|P3|Washout Period (14 Days)|Withdrawal by Subject|0
7674020|NCT01328444|26692504|P2|Washout Period (14 Days)|Withdrawal by Subject|0
7674021|NCT01328444|26692505|P1|Washout Period (14 Days)|Withdrawal by Subject|0
7674022|NCT01328444|26692500|P6|Washout Period (14 Days)|Lack of Efficacy|1
7674023|NCT01328444|26692501|P5|Washout Period (14 Days)|Lack of Efficacy|0
7674024|NCT01328444|26692502|P4|Washout Period (14 Days)|Lack of Efficacy|0
7674025|NCT01328444|26692503|P3|Washout Period (14 Days)|Lack of Efficacy|0
7674026|NCT01328444|26692504|P2|Washout Period (14 Days)|Lack of Efficacy|0
7674027|NCT01328444|26692505|P1|Washout Period (14 Days)|Lack of Efficacy|0
7674028|NCT01328444|26692500|P6|Washout Period (14 Days)|Adverse Event|2
7674029|NCT01328444|26692501|P5|Washout Period (14 Days)|Adverse Event|1
7674030|NCT01328444|26692502|P4|Washout Period (14 Days)|Adverse Event|1
7674031|NCT01328444|26692503|P3|Washout Period (14 Days)|Adverse Event|0
7674032|NCT01328444|26692504|P2|Washout Period (14 Days)|Adverse Event|1
7674033|NCT01328444|26692505|P1|Washout Period (14 Days)|Adverse Event|1
7674034|NCT01328444|26692500|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7674035|NCT01328444|26692501|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7674036|NCT01328444|26692502|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
7674037|NCT01328444|26692503|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7674038|NCT01328444|26692504|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
7674039|NCT01328444|26692505|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7674040|NCT01328444|26692500|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7674041|NCT01328444|26692501|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674042|NCT01328444|26692502|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7674043|NCT01328444|26692503|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674044|NCT01328444|26692504|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674045|NCT01328444|26692505|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
7674046|NCT01328444|26692500|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7674047|NCT01328444|26692501|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
7674048|NCT01328444|26692502|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7674049|NCT01328444|26692503|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7674050|NCT01328444|26692504|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
7674051|NCT01328444|26692505|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7674052|NCT01328444|26692500|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7674053|NCT01328444|26692501|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7674054|NCT01328444|26692502|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7674055|NCT01328444|26692503|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7674056|NCT01328444|26692504|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7674057|NCT01328444|26692505|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7674058|NCT01328444|26692500|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
7674059|NCT01328444|26692501|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7674060|NCT01328444|26692502|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7674061|NCT01328444|26692503|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7674062|NCT01328444|26692504|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7674063|NCT01328444|26692505|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7674064|NCT01328444|26692500|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
7674065|NCT01328444|26692501|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
7674066|NCT01328444|26692502|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
7674067|NCT01328444|26692503|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
7674068|NCT01328444|26692504|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
7674069|NCT01328444|26692505|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
7674070|NCT01328431|26692551|P2|12 Month (12M)|Lost to Follow-up|91
7674071|NCT01328431|26692552|P1|12 Month (12M)|Lost to Follow-up|82
7674072|NCT01328431|26692551|P2|12 Month (12M)|Death|6
7674073|NCT01328431|26692552|P1|12 Month (12M)|Death|2
7674074|NCT01328431|26692551|P2|3 Month (3M)|Lost to Follow-up|70
7674075|NCT01328431|26692552|P1|3 Month (3M)|Lost to Follow-up|75
7674076|NCT01328431|26692551|P2|3 Month (3M)|Death|2
7674077|NCT01328431|26692552|P1|3 Month (3M)|Death|2
7674078|NCT01328431|26692551|P2|1 Month (1M)|Lost to Follow-up|58
7674079|NCT01328431|26692552|P1|1 Month (1M)|Lost to Follow-up|55
7674080|NCT01328431|26692551|P2|Baseline|Protocol Violation|2
7674081|NCT01328431|26692552|P1|Baseline|Protocol Violation|0
7674082|NCT01328366|26692608|P1|Overall Study|Lost to Follow-up|7
7674083|NCT01328366|26692608|P1|Overall Study|Withdrawal by Subject|2
7674084|NCT01328366|26692608|P1|Overall Study|Death|1
7674085|NCT01328249|26692628|P2|Overall Study|Protocol Violation|1
7674086|NCT01328249|26692629|P1|Overall Study|Protocol Violation|0
7674087|NCT01328249|26692628|P2|Overall Study|Subject choice|1
7674088|NCT01328249|26692629|P1|Overall Study|Subject choice|1
7674089|NCT01328249|26692628|P2|Overall Study|Moved before end of treatment visit|0
7674090|NCT01328249|26692629|P1|Overall Study|Moved before end of treatment visit|1
7674091|NCT01328249|26692628|P2|Overall Study|Withdrawal by Subject|1
7674092|NCT01328249|26692629|P1|Overall Study|Withdrawal by Subject|1
7674093|NCT01328249|26692628|P2|Overall Study|Disease progression|0
7674094|NCT01328249|26692629|P1|Overall Study|Disease progression|1
7674095|NCT01328249|26692628|P2|Overall Study|Adverse Event|0
7674096|NCT01328249|26692629|P1|Overall Study|Adverse Event|3
7674097|NCT01328080|26692715|P1|Overall Study|Lost to Follow-up|5
7674098|NCT01328054|26692719|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
7674099|NCT01328054|26692720|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
7674100|NCT01328054|26692719|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
7674101|NCT01328054|26692720|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
7674102|NCT01328054|26692719|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
7674103|NCT01328054|26692720|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
7674104|NCT01328041|26692745|P1|Overall Study|Withdrawal by Subject|7
7674105|NCT01328041|26692745|P1|Overall Study|Physician Decision|2
7674106|NCT01328041|26692745|P1|Overall Study|Lost to Follow-up|7
7674107|NCT01328041|26692745|P1|Overall Study|Protocol Violation|7
7674108|NCT01328041|26692745|P1|Overall Study|Lack of Efficacy|27
7674109|NCT01328041|26692745|P1|Overall Study|Adverse Event|7
7674110|NCT01328002|26692767|P2|Double-Blind Period|Lack of Efficacy|0
7674111|NCT01328002|26692768|P1|Double-Blind Period|Lack of Efficacy|1
7674112|NCT01328002|26692767|P2|Double-Blind Period|Adverse Event|0
7674113|NCT01328002|26692768|P1|Double-Blind Period|Adverse Event|1
7674114|NCT01328002|26692767|P2|Open-Label Period|Other Reason|0
7674115|NCT01328002|26692768|P1|Open-Label Period|Other Reason|2
7674116|NCT01328002|26692767|P2|Open-Label Period|Lost to Follow-up|0
7674117|NCT01328002|26692768|P1|Open-Label Period|Lost to Follow-up|6
7674118|NCT01328002|26692767|P2|Open-Label Period|Withdrawal by Subject|0
7674119|NCT01328002|26692768|P1|Open-Label Period|Withdrawal by Subject|9
7674120|NCT01328002|26692767|P2|Open-Label Period|Protocol Violation|0
7674121|NCT01328002|26692768|P1|Open-Label Period|Protocol Violation|2
7674122|NCT01328002|26692767|P2|Open-Label Period|Lack of Efficacy|0
7674123|NCT01328002|26692768|P1|Open-Label Period|Lack of Efficacy|3
7674124|NCT01328002|26692767|P2|Open-Label Period|Adverse Event|0
7674125|NCT01328002|26692768|P1|Open-Label Period|Adverse Event|8
7674126|NCT01328002|26692767|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
7674127|NCT01328002|26692768|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
7674128|NCT01327885|26692813|P2|Overall Study|Administrative decision|1
7674129|NCT01327885|26692814|P1|Overall Study|Administrative decision|0
7674130|NCT01327885|26692813|P2|Overall Study|Not treated|1
7674131|NCT01327885|26692814|P1|Overall Study|Not treated|1
7674132|NCT01327885|26692813|P2|Overall Study|Withdrawal of consent from study|4
7674133|NCT01327885|26692814|P1|Overall Study|Withdrawal of consent from study|3
7674134|NCT01327885|26692813|P2|Overall Study|Other|6
7674135|NCT01327885|26692814|P1|Overall Study|Other|8
7674136|NCT01327885|26692813|P2|Overall Study|Subject choice|10
7674137|NCT01327885|26692814|P1|Overall Study|Subject choice|5
7674138|NCT01327885|26692813|P2|Overall Study|Adverse Event|10
7674139|NCT01327885|26692814|P1|Overall Study|Adverse Event|14
7674140|NCT01327885|26692813|P2|Overall Study|Clinical progression|27
7674141|NCT01327885|26692814|P1|Overall Study|Clinical progression|24
7674142|NCT01327885|26692813|P2|Overall Study|Disease progression-according to RECIST|165
7674143|NCT01327885|26692814|P1|Overall Study|Disease progression-according to RECIST|173
7674144|NCT01327846|26692830|P4|Extension Phase|Technical Problems|2
7674145|NCT01327846|26692831|P3|Extension Phase|Technical Problems|2
7674146|NCT01327846|26692832|P2|Extension Phase|Technical Problems|4
7674147|NCT01327846|26692833|P1|Extension Phase|Technical Problems|2
7674148|NCT01327846|26692830|P4|Extension Phase|Lost to Follow-up|7
7674149|NCT01327846|26692831|P3|Extension Phase|Lost to Follow-up|4
7674150|NCT01327846|26692832|P2|Extension Phase|Lost to Follow-up|3
7674151|NCT01327846|26692833|P1|Extension Phase|Lost to Follow-up|4
7674152|NCT01327846|26692830|P4|Extension Phase|Withdrawal by Subject|37
7674153|NCT01327846|26692831|P3|Extension Phase|Withdrawal by Subject|19
7674154|NCT01327846|26692832|P2|Extension Phase|Withdrawal by Subject|13
7674155|NCT01327846|26692833|P1|Extension Phase|Withdrawal by Subject|20
7674156|NCT01327846|26692830|P4|Extension Phase|Study terminated by sponsor|1660
7674157|NCT01327846|26692831|P3|Extension Phase|Study terminated by sponsor|1067
7674158|NCT01327846|26692832|P2|Extension Phase|Study terminated by sponsor|1124
7674159|NCT01327846|26692833|P1|Extension Phase|Study terminated by sponsor|1073
7674160|NCT01327846|26692830|P4|Core Phase|Lost to Follow-up|5
7674161|NCT01327846|26692831|P3|Core Phase|Lost to Follow-up|4
7674162|NCT01327846|26692832|P2|Core Phase|Lost to Follow-up|3
7674163|NCT01327846|26692833|P1|Core Phase|Lost to Follow-up|3
7674164|NCT01327846|26692830|P4|Core Phase|Subject decision (vital stat: alive)|20
7674165|NCT01327846|26692831|P3|Core Phase|Subject decision (vital stat: alive)|13
7674166|NCT01327846|26692832|P2|Core Phase|Subject decision (vital stat: alive)|24
7674167|NCT01327846|26692833|P1|Core Phase|Subject decision (vital stat: alive)|23
7674168|NCT01327846|26692830|P4|Core Phase|Subject decision (vital stat: dead)|4
7674169|NCT01327846|26692831|P3|Core Phase|Subject decision (vital stat: dead)|4
7674170|NCT01327846|26692832|P2|Core Phase|Subject decision (vital stat: dead)|3
7674171|NCT01327846|26692833|P1|Core Phase|Subject decision (vital stat: dead)|1
7674172|NCT01327846|26692830|P4|Core Phase|Subject decision (vital stat: unkn)|3
7674173|NCT01327846|26692831|P3|Core Phase|Subject decision (vital stat: unkn)|3
7674174|NCT01327846|26692832|P2|Core Phase|Subject decision (vital stat: unkn)|0
7674175|NCT01327846|26692833|P1|Core Phase|Subject decision (vital stat: unkn)|0
7674176|NCT01327846|26692830|P4|Core Phase|Subject decision (vital status: missing)|1
7674177|NCT01327846|26692831|P3|Core Phase|Subject decision (vital status: missing)|2
7674178|NCT01327846|26692832|P2|Core Phase|Subject decision (vital status: missing)|2
7674179|NCT01327846|26692833|P1|Core Phase|Subject decision (vital status: missing)|1
7674180|NCT01327703|26692908|P2|Second Treatment Period|Protocol Violation|1
7674181|NCT01327703|26692909|P1|Second Treatment Period|Protocol Violation|0
7674182|NCT01327703|26692908|P2|Second Treatment Period|Adverse Event|1
7674183|NCT01327703|26692909|P1|Second Treatment Period|Adverse Event|1
7674184|NCT01327651|26692965|P9|Post Study Follow-up|Lost to Follow-up|2
7674185|NCT01327651|26692966|P8|Post Study Follow-up|Lost to Follow-up|1
7674186|NCT01327651|26692967|P7|Post Study Follow-up|Lost to Follow-up|4
7674187|NCT01327651|26692968|P6|Post Study Follow-up|Lost to Follow-up|0
7674188|NCT01327651|26692969|P5|Post Study Follow-up|Lost to Follow-up|0
7674189|NCT01327651|26692970|P4|Post Study Follow-up|Lost to Follow-up|0
7674190|NCT01327651|26692971|P3|Post Study Follow-up|Lost to Follow-up|1
7674191|NCT01327651|26692972|P2|Post Study Follow-up|Lost to Follow-up|1
7674192|NCT01327651|26692973|P1|Post Study Follow-up|Lost to Follow-up|0
7674193|NCT01327651|26692965|P9|Self-administered Dosing Period|Withdrawal by Subject|1
7674194|NCT01327651|26692966|P8|Self-administered Dosing Period|Withdrawal by Subject|1
7674195|NCT01327651|26692967|P7|Self-administered Dosing Period|Withdrawal by Subject|2
7674196|NCT01327651|26692968|P6|Self-administered Dosing Period|Withdrawal by Subject|0
7674197|NCT01327651|26692969|P5|Self-administered Dosing Period|Withdrawal by Subject|0
7674198|NCT01327651|26692970|P4|Self-administered Dosing Period|Withdrawal by Subject|1
7674199|NCT01327651|26692971|P3|Self-administered Dosing Period|Withdrawal by Subject|0
7674200|NCT01327651|26692972|P2|Self-administered Dosing Period|Withdrawal by Subject|1
7674201|NCT01327651|26692973|P1|Self-administered Dosing Period|Withdrawal by Subject|0
7674202|NCT01327651|26692965|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674203|NCT01327651|26692966|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674204|NCT01327651|26692967|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674205|NCT01327651|26692968|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674206|NCT01327651|26692969|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674207|NCT01327651|26692970|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674208|NCT01327651|26692971|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674209|NCT01327651|26692972|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
7674210|NCT01327651|26692973|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
7674211|NCT01327651|26692965|P9|Self-administered Dosing Period|Lost to Follow-up|10
7674212|NCT01327651|26692966|P8|Self-administered Dosing Period|Lost to Follow-up|9
7674213|NCT01327651|26692967|P7|Self-administered Dosing Period|Lost to Follow-up|8
7674214|NCT01327651|26692968|P6|Self-administered Dosing Period|Lost to Follow-up|0
7674215|NCT01327651|26692969|P5|Self-administered Dosing Period|Lost to Follow-up|3
7674216|NCT01327651|26692970|P4|Self-administered Dosing Period|Lost to Follow-up|2
7674217|NCT01327651|26692971|P3|Self-administered Dosing Period|Lost to Follow-up|4
7674218|NCT01327651|26692972|P2|Self-administered Dosing Period|Lost to Follow-up|2
7674219|NCT01327651|26692973|P1|Self-administered Dosing Period|Lost to Follow-up|3
7674220|NCT01327612|26693099|P7|Overall Study|Death|0
7674221|NCT01327612|26693100|P6|Overall Study|Death|0
7674222|NCT01327612|26693101|P5|Overall Study|Death|1
7674223|NCT01327612|26693102|P4|Overall Study|Death|0
7674224|NCT01327612|26693103|P3|Overall Study|Death|0
7674225|NCT01327612|26693104|P2|Overall Study|Death|0
7674226|NCT01327612|26693105|P1|Overall Study|Death|0
7674227|NCT01327612|26693099|P7|Overall Study|Administrative Decision|0
7674228|NCT01327612|26693100|P6|Overall Study|Administrative Decision|0
7674229|NCT01327612|26693101|P5|Overall Study|Administrative Decision|0
7674230|NCT01327612|26693102|P4|Overall Study|Administrative Decision|1
7674231|NCT01327612|26693103|P3|Overall Study|Administrative Decision|0
7674232|NCT01327612|26693104|P2|Overall Study|Administrative Decision|0
7674233|NCT01327612|26693105|P1|Overall Study|Administrative Decision|0
7674234|NCT01327612|26693099|P7|Overall Study|Disease Progression|2
7674235|NCT01327612|26693100|P6|Overall Study|Disease Progression|2
7674236|NCT01327612|26693101|P5|Overall Study|Disease Progression|1
7674237|NCT01327612|26693102|P4|Overall Study|Disease Progression|0
7674238|NCT01327612|26693103|P3|Overall Study|Disease Progression|1
7674239|NCT01327612|26693104|P2|Overall Study|Disease Progression|1
7674240|NCT01327612|26693105|P1|Overall Study|Disease Progression|1
7674241|NCT01327612|26693099|P7|Overall Study|Withdrawal by Subject|0
7674242|NCT01327612|26693100|P6|Overall Study|Withdrawal by Subject|1
7674243|NCT01327612|26693101|P5|Overall Study|Withdrawal by Subject|0
7674244|NCT01327612|26693102|P4|Overall Study|Withdrawal by Subject|0
7674245|NCT01327612|26693103|P3|Overall Study|Withdrawal by Subject|0
7674246|NCT01327612|26693104|P2|Overall Study|Withdrawal by Subject|0
7674247|NCT01327612|26693105|P1|Overall Study|Withdrawal by Subject|0
7674248|NCT01327599|26693163|P1|Overall Study|Withdrawal of Consent|1
7674249|NCT01327599|26693163|P1|Overall Study|Could Not Attend Visit|1
7674250|NCT01327599|26693163|P1|Overall Study|Adverse Event|1
7674251|NCT01327573|26693173|P2|Overall Study|Physician Decision|1
7674252|NCT01327573|26693174|P1|Overall Study|Physician Decision|3
7674253|NCT01327547|26693185|P2|Overall Study|By investigator in subject's interest|1
7674254|NCT01327547|26693186|P1|Overall Study|By investigator in subject's interest|0
7674255|NCT01327547|26693185|P2|Overall Study|Non-compliance with study procedures|0
7674256|NCT01327547|26693186|P1|Overall Study|Non-compliance with study procedures|1
7674257|NCT01327547|26693185|P2|Overall Study|Required prohibited medication|0
7674258|NCT01327547|26693186|P1|Overall Study|Required prohibited medication|2
7674259|NCT01327547|26693185|P2|Overall Study|Non-compliance due to alcohol intake|1
7674260|NCT01327547|26693186|P1|Overall Study|Non-compliance due to alcohol intake|0
7674261|NCT01327547|26693185|P2|Overall Study|Protocol Violation|0
7674262|NCT01327547|26693186|P1|Overall Study|Protocol Violation|1
7674263|NCT01327547|26693185|P2|Overall Study|Does Not Meet Entrance Criteria|2
7674264|NCT01327547|26693186|P1|Overall Study|Does Not Meet Entrance Criteria|2
7674265|NCT01327547|26693185|P2|Overall Study|Withdrawal by Subject|7
7674266|NCT01327547|26693186|P1|Overall Study|Withdrawal by Subject|3
7674267|NCT01327547|26693185|P2|Overall Study|Non-Compliance With Study Treatment|2
7674268|NCT01327547|26693186|P1|Overall Study|Non-Compliance With Study Treatment|0
7674269|NCT01327547|26693185|P2|Overall Study|Lost to Follow-up|6
7674270|NCT01327547|26693186|P1|Overall Study|Lost to Follow-up|6
7674271|NCT01327547|26693185|P2|Overall Study|Death|2
7674272|NCT01327547|26693186|P1|Overall Study|Death|1
7674273|NCT01327547|26693185|P2|Overall Study|Adverse Event|1
7674274|NCT01327547|26693186|P1|Overall Study|Adverse Event|4
7674275|NCT01327495|26693254|P6|Overall Study|Physician Decision|0
7674276|NCT01327495|26693255|P5|Overall Study|Physician Decision|2
7674277|NCT01327495|26693256|P4|Overall Study|Physician Decision|0
7674278|NCT01327495|26693257|P3|Overall Study|Physician Decision|0
7674279|NCT01327495|26693258|P2|Overall Study|Physician Decision|0
7674280|NCT01327495|26693259|P1|Overall Study|Physician Decision|0
7674281|NCT01327495|26693254|P6|Overall Study|Withdrawal by Subject|0
7674282|NCT01327495|26693255|P5|Overall Study|Withdrawal by Subject|1
7674283|NCT01327495|26693256|P4|Overall Study|Withdrawal by Subject|0
7674284|NCT01327495|26693257|P3|Overall Study|Withdrawal by Subject|1
7674285|NCT01327495|26693258|P2|Overall Study|Withdrawal by Subject|1
7674286|NCT01327495|26693259|P1|Overall Study|Withdrawal by Subject|0
7674287|NCT01327495|26693254|P6|Overall Study|Adverse Event|2
7674288|NCT01327495|26693255|P5|Overall Study|Adverse Event|0
7674289|NCT01327495|26693256|P4|Overall Study|Adverse Event|0
7674290|NCT01327495|26693257|P3|Overall Study|Adverse Event|1
7674291|NCT01327495|26693258|P2|Overall Study|Adverse Event|1
7674292|NCT01327495|26693259|P1|Overall Study|Adverse Event|2
7674293|NCT01327482|26693351|P1|Overall Study|Adverse Event|1
7674294|NCT01327339|26693356|P1|Overall Study|Protocol Violation|8
7674295|NCT01327300|26693491|P2|Washout (3 Weeks)|Withdrawal by Subject|0
7674296|NCT01327300|26693492|P1|Washout (3 Weeks)|Withdrawal by Subject|1
7674297|NCT01327053|26693532|P2|Overall Study|Untreated|1
7674298|NCT01327053|26693533|P1|Overall Study|Untreated|0
7674299|NCT01327053|26693532|P2|Overall Study|Protocol Violation|1
7674300|NCT01327053|26693533|P1|Overall Study|Protocol Violation|0
7674301|NCT01327053|26693532|P2|Overall Study|Progressive disease|26
7674302|NCT01327053|26693533|P1|Overall Study|Progressive disease|31
7674303|NCT01327053|26693532|P2|Overall Study|Study terminated by Sponsor|3
7674304|NCT01327053|26693533|P1|Overall Study|Study terminated by Sponsor|1
7674305|NCT01327053|26693532|P2|Overall Study|Non-compliance with study treatment|5
7674306|NCT01327053|26693533|P1|Overall Study|Non-compliance with study treatment|0
7674307|NCT01327053|26693532|P2|Overall Study|Lost to Follow-up|4
7674308|NCT01327053|26693533|P1|Overall Study|Lost to Follow-up|2
7674309|NCT01327053|26693532|P2|Overall Study|Death|5
7674310|NCT01327053|26693533|P1|Overall Study|Death|1
7674311|NCT01327053|26693532|P2|Overall Study|Physician Decision|14
7674312|NCT01327053|26693533|P1|Overall Study|Physician Decision|10
7674313|NCT01327053|26693532|P2|Overall Study|Patient/guardian decision|35
7674314|NCT01327053|26693533|P1|Overall Study|Patient/guardian decision|11
7674315|NCT01327053|26693532|P2|Overall Study|Adverse Event|57
7674316|NCT01327053|26693533|P1|Overall Study|Adverse Event|23
7674317|NCT01326962|26693607|P1|Overall Study|Other|2
7674318|NCT01326962|26693607|P1|Overall Study|Lost to Follow-up|3
7674319|NCT01326962|26693607|P1|Overall Study|Withdrawal by Subject|1
7674320|NCT01326962|26693607|P1|Overall Study|Adverse Event|1
7674321|NCT01326910|26693630|P2|Overall Study|Protocol Violation|1
7674322|NCT01326910|26693631|P1|Overall Study|Protocol Violation|1
7674323|NCT01326910|26693630|P2|Overall Study|Withdrawal by Subject|2
7674324|NCT01326910|26693631|P1|Overall Study|Withdrawal by Subject|3
7674325|NCT01326845|26693645|P2|Overall Study|Misisng|3
7674326|NCT01326845|26693646|P1|Overall Study|Misisng|1
7674327|NCT01326845|26693645|P2|Overall Study|Adverse Event|0
7674328|NCT01326845|26693646|P1|Overall Study|Adverse Event|1
7674329|NCT01326845|26693645|P2|Overall Study|Administrative Problems|2
7674330|NCT01326845|26693646|P1|Overall Study|Administrative Problems|5
7674331|NCT01326728|26693707|P2|Overall Study|Early closure of study|9
7674332|NCT01326728|26693708|P1|Overall Study|Early closure of study|34
7674333|NCT01326728|26693707|P2|Overall Study|Death|0
7674334|NCT01326728|26693708|P1|Overall Study|Death|13
7674335|NCT01326702|26693732|P7|Overall Study|Not Treated|0
7674336|NCT01326702|26693733|P6|Overall Study|Not Treated|1
7674337|NCT01326702|26693734|P5|Overall Study|Not Treated|0
7674338|NCT01326702|26693735|P4|Overall Study|Not Treated|1
7674339|NCT01326702|26693736|P3|Overall Study|Not Treated|0
7674340|NCT01326702|26693737|P2|Overall Study|Not Treated|0
7674341|NCT01326702|26693738|P1|Overall Study|Not Treated|0
7674342|NCT01326702|26693732|P7|Overall Study|Withdrawal by Subject|3
7674343|NCT01326702|26693733|P6|Overall Study|Withdrawal by Subject|1
7674344|NCT01326702|26693734|P5|Overall Study|Withdrawal by Subject|1
7674345|NCT01326702|26693735|P4|Overall Study|Withdrawal by Subject|0
7674346|NCT01326702|26693736|P3|Overall Study|Withdrawal by Subject|1
7674347|NCT01326702|26693737|P2|Overall Study|Withdrawal by Subject|0
7674348|NCT01326702|26693738|P1|Overall Study|Withdrawal by Subject|0
7674349|NCT01326702|26693732|P7|Overall Study|Adverse Event|1
7674350|NCT01326702|26693733|P6|Overall Study|Adverse Event|3
7674351|NCT01326702|26693734|P5|Overall Study|Adverse Event|0
7674352|NCT01326702|26693735|P4|Overall Study|Adverse Event|1
7674353|NCT01326702|26693736|P3|Overall Study|Adverse Event|1
7674354|NCT01326702|26693737|P2|Overall Study|Adverse Event|0
7674355|NCT01326702|26693738|P1|Overall Study|Adverse Event|0
7674356|NCT01326702|26693732|P7|Overall Study|Death|0
7674357|NCT01326702|26693733|P6|Overall Study|Death|0
7674358|NCT01326702|26693734|P5|Overall Study|Death|0
7674359|NCT01326702|26693735|P4|Overall Study|Death|0
7674360|NCT01326702|26693736|P3|Overall Study|Death|0
7674361|NCT01326702|26693737|P2|Overall Study|Death|1
7674362|NCT01326702|26693738|P1|Overall Study|Death|0
7674363|NCT01326702|26693732|P7|Overall Study|progressive disease|3
7674364|NCT01326702|26693733|P6|Overall Study|progressive disease|2
7674365|NCT01326702|26693734|P5|Overall Study|progressive disease|3
7674366|NCT01326702|26693735|P4|Overall Study|progressive disease|1
7674367|NCT01326702|26693736|P3|Overall Study|progressive disease|3
7674368|NCT01326702|26693737|P2|Overall Study|progressive disease|1
7674369|NCT01326702|26693738|P1|Overall Study|progressive disease|1
7674370|NCT01326702|26693732|P7|Overall Study|Other|0
7674371|NCT01326702|26693733|P6|Overall Study|Other|1
7674372|NCT01326702|26693734|P5|Overall Study|Other|0
7674373|NCT01326702|26693735|P4|Overall Study|Other|0
7674374|NCT01326702|26693736|P3|Overall Study|Other|0
7674375|NCT01326702|26693737|P2|Overall Study|Other|0
7674376|NCT01326702|26693738|P1|Overall Study|Other|1
7674377|NCT01326546|26693794|P2|Overall Study|Withdrawal by Subject|1
7674378|NCT01326546|26693795|P1|Overall Study|Withdrawal by Subject|5
7674379|NCT01326546|26693794|P2|Overall Study|Adverse Event|0
7674380|NCT01326546|26693795|P1|Overall Study|Adverse Event|1
7674381|NCT01326546|26693794|P2|Overall Study|Pregnancy|1
7674382|NCT01326546|26693795|P1|Overall Study|Pregnancy|0
7674383|NCT01326546|26693794|P2|Overall Study|Protocol Violation|4
7674384|NCT01326546|26693795|P1|Overall Study|Protocol Violation|3
7674385|NCT01326546|26693794|P2|Overall Study|Lost to Follow-up|7
7674386|NCT01326546|26693795|P1|Overall Study|Lost to Follow-up|8
7674387|NCT01326533|26693803|P2|Overall Study|Adverse Event|0
7674388|NCT01326533|26693804|P1|Overall Study|Adverse Event|1
7674389|NCT01326533|26693803|P2|Overall Study|Withdrawal by Subject|0
7674390|NCT01326533|26693804|P1|Overall Study|Withdrawal by Subject|1
7674391|NCT01326533|26693803|P2|Overall Study|Lost to Follow-up|0
7674392|NCT01326533|26693804|P1|Overall Study|Lost to Follow-up|2
7674393|NCT01326481|26693812|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
7674394|NCT01326026|26693821|P2|Overall Study|Other|3
7674395|NCT01326026|26693822|P1|Overall Study|Other|3
7674396|NCT01326026|26693821|P2|Overall Study|Withdrawal Criteria|7
7674397|NCT01326026|26693822|P1|Overall Study|Withdrawal Criteria|5
7674398|NCT01326026|26693821|P2|Overall Study|Adverse Event|3
7674399|NCT01326026|26693822|P1|Overall Study|Adverse Event|4
7674400|NCT01325701|26693887|P2|Overall Study|Rollerover Extension Study|0
7674401|NCT01325701|26693888|P1|Overall Study|Rollerover Extension Study|4
7674402|NCT01325701|26693887|P2|Overall Study|Withdrawal by Subject|1
7674403|NCT01325701|26693888|P1|Overall Study|Withdrawal by Subject|2
7674404|NCT01325701|26693887|P2|Overall Study|Physician Decision|2
7674405|NCT01325701|26693888|P1|Overall Study|Physician Decision|2
7674406|NCT01325701|26693887|P2|Overall Study|Protocol Violation|0
7674407|NCT01325701|26693888|P1|Overall Study|Protocol Violation|1
7674408|NCT01325701|26693887|P2|Overall Study|Adverse Event|0
7674409|NCT01325701|26693888|P1|Overall Study|Adverse Event|12
7674410|NCT01325623|26693898|P1|Overall Study|Withdrawal by Subject|3
7674411|NCT01325584|26693940|P1|Overall Study|Death|1
7674412|NCT01325532|26693950|P2|Overall Study|Withdrawal by Subject|0
7674413|NCT01325532|26693951|P1|Overall Study|Withdrawal by Subject|2
7674414|NCT01325493|26693963|P2|Overall Study|Allergy|0
7674415|NCT01325493|26693964|P1|Overall Study|Allergy|1
7674416|NCT01325493|26693963|P2|Overall Study|loss of neuromonitoring signals|2
7674417|NCT01325493|26693964|P1|Overall Study|loss of neuromonitoring signals|0
7674418|NCT01325493|26693963|P2|Overall Study|Protocol Violation|1
7674419|NCT01325493|26693964|P1|Overall Study|Protocol Violation|0
7674420|NCT01325428|26693976|P1|Part B|Other reason not defined above|1
7674421|NCT01325428|26693976|P1|Part B|Refused continue taking trial medication|2
7674422|NCT01325428|26693976|P1|Part A|Other reason not defined above|2
7674423|NCT01325428|26693976|P1|Part A|Refused continue taking trial medication|2
7674424|NCT01325428|26693976|P1|Part A|Other adverse event|1
7674425|NCT01325428|26693976|P1|Part A|Clinical signs, symptoms of progression|2
7674426|NCT01325428|26693976|P1|Part A|Progressive disease according to RECIST|9
7674427|NCT01325350|26693996|P5|Overall Study|Did Not Receive Treatment|1
7674428|NCT01325350|26693997|P4|Overall Study|Did Not Receive Treatment|0
7674429|NCT01325350|26693998|P3|Overall Study|Did Not Receive Treatment|1
7674430|NCT01325350|26693999|P2|Overall Study|Did Not Receive Treatment|1
7674431|NCT01325350|26694000|P1|Overall Study|Did Not Receive Treatment|0
7674432|NCT01325350|26693996|P5|Overall Study|Withdrawal by Subject|0
7674433|NCT01325350|26693997|P4|Overall Study|Withdrawal by Subject|1
7674434|NCT01325350|26693998|P3|Overall Study|Withdrawal by Subject|1
7674435|NCT01325350|26693999|P2|Overall Study|Withdrawal by Subject|0
7674436|NCT01325350|26694000|P1|Overall Study|Withdrawal by Subject|0
7674437|NCT01325350|26693996|P5|Overall Study|Protocol Violation|0
7674438|NCT01325350|26693997|P4|Overall Study|Protocol Violation|1
7674439|NCT01325350|26693998|P3|Overall Study|Protocol Violation|0
7674440|NCT01325350|26693999|P2|Overall Study|Protocol Violation|0
7674441|NCT01325350|26694000|P1|Overall Study|Protocol Violation|0
7674442|NCT01325350|26693996|P5|Overall Study|Personal Reasons|3
7674443|NCT01325350|26693997|P4|Overall Study|Personal Reasons|5
7674444|NCT01325350|26693998|P3|Overall Study|Personal Reasons|6
7674445|NCT01325350|26693999|P2|Overall Study|Personal Reasons|1
7674446|NCT01325350|26694000|P1|Overall Study|Personal Reasons|2
7674447|NCT01325350|26693996|P5|Overall Study|Lost to Follow-up|5
7674448|NCT01325350|26693997|P4|Overall Study|Lost to Follow-up|1
7674449|NCT01325350|26693998|P3|Overall Study|Lost to Follow-up|5
7674450|NCT01325350|26693999|P2|Overall Study|Lost to Follow-up|0
7674451|NCT01325350|26694000|P1|Overall Study|Lost to Follow-up|1
7674452|NCT01325350|26693996|P5|Overall Study|Pregnancy|1
7674453|NCT01325350|26693997|P4|Overall Study|Pregnancy|0
7674454|NCT01325350|26693998|P3|Overall Study|Pregnancy|1
7674455|NCT01325350|26693999|P2|Overall Study|Pregnancy|0
7674456|NCT01325350|26694000|P1|Overall Study|Pregnancy|0
7674457|NCT01325350|26693996|P5|Overall Study|Adverse Event|2
7674458|NCT01325350|26693997|P4|Overall Study|Adverse Event|1
7674459|NCT01325350|26693998|P3|Overall Study|Adverse Event|3
7674460|NCT01325350|26693999|P2|Overall Study|Adverse Event|3
7674461|NCT01325350|26694000|P1|Overall Study|Adverse Event|3
7674462|NCT01325337|26694042|P5|Overall Study|Withdrawal by Subject|1
7674463|NCT01325337|26694043|P4|Overall Study|Withdrawal by Subject|0
7674464|NCT01325337|26694044|P3|Overall Study|Withdrawal by Subject|1
7674465|NCT01325337|26694045|P2|Overall Study|Withdrawal by Subject|0
7674466|NCT01325337|26694046|P1|Overall Study|Withdrawal by Subject|1
7674467|NCT01325337|26694042|P5|Overall Study|Personal Reasons|3
7674468|NCT01325337|26694043|P4|Overall Study|Personal Reasons|8
7674469|NCT01325337|26694044|P3|Overall Study|Personal Reasons|4
7674470|NCT01325337|26694045|P2|Overall Study|Personal Reasons|5
7674471|NCT01325337|26694046|P1|Overall Study|Personal Reasons|2
7674472|NCT01325337|26694042|P5|Overall Study|Lost to Follow-up|2
7674473|NCT01325337|26694043|P4|Overall Study|Lost to Follow-up|1
7674474|NCT01325337|26694044|P3|Overall Study|Lost to Follow-up|2
7674475|NCT01325337|26694045|P2|Overall Study|Lost to Follow-up|2
7674476|NCT01325337|26694046|P1|Overall Study|Lost to Follow-up|2
7674477|NCT01325337|26694042|P5|Overall Study|Adverse Event|2
7674478|NCT01325337|26694043|P4|Overall Study|Adverse Event|1
7674479|NCT01325337|26694044|P3|Overall Study|Adverse Event|2
7674480|NCT01325337|26694045|P2|Overall Study|Adverse Event|2
7674481|NCT01325337|26694046|P1|Overall Study|Adverse Event|0
7674482|NCT01325207|26694126|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7674483|NCT01325207|26694127|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
7674484|NCT01325207|26694128|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7674485|NCT01325207|26694129|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7674486|NCT01325207|26694130|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7674487|NCT01325207|26694131|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7674488|NCT01325207|26694126|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
7674489|NCT01325207|26694127|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7674490|NCT01325207|26694128|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7674491|NCT01325207|26694129|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7674492|NCT01325207|26694130|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7674493|NCT01325207|26694131|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7674494|NCT01325207|26694126|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
7674495|NCT01325207|26694127|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7674496|NCT01325207|26694128|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7674497|NCT01325207|26694129|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7674498|NCT01325207|26694130|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7674499|NCT01325207|26694131|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7674500|NCT01325207|26694126|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7674501|NCT01325207|26694127|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7674502|NCT01325207|26694128|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7674503|NCT01325207|26694129|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7674504|NCT01325207|26694130|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
7674505|NCT01325207|26694131|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7674506|NCT01325207|26694126|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
7674507|NCT01325207|26694127|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
7674508|NCT01325207|26694128|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7674509|NCT01325207|26694129|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7674510|NCT01325207|26694130|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7674511|NCT01325207|26694131|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7674512|NCT01325207|26694126|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
7674513|NCT01325207|26694127|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
7674514|NCT01325207|26694128|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
7674515|NCT01325207|26694129|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
7674516|NCT01325207|26694130|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
7674517|NCT01325207|26694131|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
7674518|NCT01325207|26694126|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7674519|NCT01325207|26694127|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
7674520|NCT01325207|26694128|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7674521|NCT01325207|26694129|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7674522|NCT01325207|26694130|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7674523|NCT01325207|26694131|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7674524|NCT01324999|26694163|P1|Overall Study|Withdrawal by Subject|2
7674525|NCT01324999|26694163|P1|Overall Study|Adverse Event|3
7674526|NCT01324947|26694174|P1|Overall Study|1 discontinued before starting drug|1
7674527|NCT01324947|26694174|P1|Overall Study|Withdrawal by Subject|3
7674528|NCT01324947|26694174|P1|Overall Study|Progressive Disease|50
7674529|NCT01324947|26694174|P1|Overall Study|Other|3
7674530|NCT01324947|26694174|P1|Overall Study|Death|10
7674531|NCT01324947|26694174|P1|Overall Study|Adverse Event|7
7674532|NCT01324830|26694215|P19|Overall Study|Withdrawal by Subject|1
7674533|NCT01324830|26694216|P18|Overall Study|Withdrawal by Subject|0
7674534|NCT01324830|26694217|P17|Overall Study|Withdrawal by Subject|0
7674535|NCT01324830|26694218|P16|Overall Study|Withdrawal by Subject|0
7674536|NCT01324830|26694219|P15|Overall Study|Withdrawal by Subject|0
7674537|NCT01324830|26694220|P14|Overall Study|Withdrawal by Subject|0
7674538|NCT01324830|26694221|P13|Overall Study|Withdrawal by Subject|0
7674539|NCT01324830|26694222|P12|Overall Study|Withdrawal by Subject|0
7674540|NCT01324830|26694223|P11|Overall Study|Withdrawal by Subject|1
7674541|NCT01324830|26694224|P10|Overall Study|Withdrawal by Subject|0
7674542|NCT01324830|26694225|P9|Overall Study|Withdrawal by Subject|0
7674543|NCT01324830|26694226|P8|Overall Study|Withdrawal by Subject|0
7674544|NCT01324830|26694227|P7|Overall Study|Withdrawal by Subject|0
7674545|NCT01324830|26694228|P6|Overall Study|Withdrawal by Subject|1
7674546|NCT01324830|26694229|P5|Overall Study|Withdrawal by Subject|0
7674547|NCT01324830|26694230|P4|Overall Study|Withdrawal by Subject|0
7674548|NCT01324830|26694231|P3|Overall Study|Withdrawal by Subject|0
7674549|NCT01324830|26694232|P2|Overall Study|Withdrawal by Subject|0
7674550|NCT01324830|26694233|P1|Overall Study|Withdrawal by Subject|0
7674551|NCT01324830|26694215|P19|Overall Study|Adverse Event, non-fatal|0
7674552|NCT01324830|26694216|P18|Overall Study|Adverse Event, non-fatal|1
7674553|NCT01324830|26694217|P17|Overall Study|Adverse Event, non-fatal|0
7674554|NCT01324830|26694218|P16|Overall Study|Adverse Event, non-fatal|0
7674555|NCT01324830|26694219|P15|Overall Study|Adverse Event, non-fatal|0
7674556|NCT01324830|26694220|P14|Overall Study|Adverse Event, non-fatal|0
7674557|NCT01324830|26694221|P13|Overall Study|Adverse Event, non-fatal|0
7674558|NCT01324830|26694222|P12|Overall Study|Adverse Event, non-fatal|0
7674559|NCT01324830|26694223|P11|Overall Study|Adverse Event, non-fatal|1
7674560|NCT01324830|26694224|P10|Overall Study|Adverse Event, non-fatal|0
7674561|NCT01324830|26694225|P9|Overall Study|Adverse Event, non-fatal|2
7674562|NCT01324830|26694226|P8|Overall Study|Adverse Event, non-fatal|0
7674563|NCT01324830|26694227|P7|Overall Study|Adverse Event, non-fatal|0
7674564|NCT01324830|26694228|P6|Overall Study|Adverse Event, non-fatal|0
7674565|NCT01324830|26694229|P5|Overall Study|Adverse Event, non-fatal|0
7674566|NCT01324830|26694230|P4|Overall Study|Adverse Event, non-fatal|0
7674567|NCT01324830|26694231|P3|Overall Study|Adverse Event, non-fatal|0
7674568|NCT01324830|26694232|P2|Overall Study|Adverse Event, non-fatal|0
7674569|NCT01324830|26694233|P1|Overall Study|Adverse Event, non-fatal|0
7674570|NCT01324830|26694215|P19|Overall Study|Adverse Event, serious fatal|0
7674571|NCT01324830|26694216|P18|Overall Study|Adverse Event, serious fatal|0
7674572|NCT01324830|26694217|P17|Overall Study|Adverse Event, serious fatal|0
7674573|NCT01324830|26694218|P16|Overall Study|Adverse Event, serious fatal|0
7674574|NCT01324830|26694219|P15|Overall Study|Adverse Event, serious fatal|0
7674575|NCT01324830|26694220|P14|Overall Study|Adverse Event, serious fatal|0
7674576|NCT01324830|26694221|P13|Overall Study|Adverse Event, serious fatal|0
7674577|NCT01324830|26694222|P12|Overall Study|Adverse Event, serious fatal|0
7674578|NCT01324830|26694223|P11|Overall Study|Adverse Event, serious fatal|0
7674579|NCT01324830|26694224|P10|Overall Study|Adverse Event, serious fatal|0
7674580|NCT01324830|26694225|P9|Overall Study|Adverse Event, serious fatal|0
7674581|NCT01324830|26694226|P8|Overall Study|Adverse Event, serious fatal|0
7674582|NCT01324830|26694227|P7|Overall Study|Adverse Event, serious fatal|0
7674583|NCT01324830|26694228|P6|Overall Study|Adverse Event, serious fatal|0
7674584|NCT01324830|26694229|P5|Overall Study|Adverse Event, serious fatal|0
7674585|NCT01324830|26694230|P4|Overall Study|Adverse Event, serious fatal|0
7674586|NCT01324830|26694231|P3|Overall Study|Adverse Event, serious fatal|0
7674587|NCT01324830|26694232|P2|Overall Study|Adverse Event, serious fatal|1
7674588|NCT01324830|26694233|P1|Overall Study|Adverse Event, serious fatal|0
7674589|NCT01324830|26694215|P19|Overall Study|Reason not mentioned above|0
7674590|NCT01324830|26694216|P18|Overall Study|Reason not mentioned above|1
7674591|NCT01324830|26694217|P17|Overall Study|Reason not mentioned above|0
7674592|NCT01324830|26694218|P16|Overall Study|Reason not mentioned above|0
7674593|NCT01324830|26694219|P15|Overall Study|Reason not mentioned above|0
7674594|NCT01324830|26694220|P14|Overall Study|Reason not mentioned above|0
7674595|NCT01324830|26694221|P13|Overall Study|Reason not mentioned above|0
7674596|NCT01324830|26694222|P12|Overall Study|Reason not mentioned above|0
7674597|NCT01324830|26694223|P11|Overall Study|Reason not mentioned above|0
7674598|NCT01324830|26694224|P10|Overall Study|Reason not mentioned above|0
7674599|NCT01324830|26694225|P9|Overall Study|Reason not mentioned above|0
7674600|NCT01324830|26694226|P8|Overall Study|Reason not mentioned above|0
7674601|NCT01324830|26694227|P7|Overall Study|Reason not mentioned above|0
7674602|NCT01324830|26694228|P6|Overall Study|Reason not mentioned above|0
7674603|NCT01324830|26694229|P5|Overall Study|Reason not mentioned above|0
7674604|NCT01324830|26694230|P4|Overall Study|Reason not mentioned above|0
7674605|NCT01324830|26694231|P3|Overall Study|Reason not mentioned above|0
7674606|NCT01324830|26694232|P2|Overall Study|Reason not mentioned above|0
7674607|NCT01324830|26694233|P1|Overall Study|Reason not mentioned above|0
7674608|NCT01324830|26694215|P19|Overall Study|Dose limiting toxicity|1
7674609|NCT01324830|26694216|P18|Overall Study|Dose limiting toxicity|1
7674610|NCT01324830|26694217|P17|Overall Study|Dose limiting toxicity|1
7674611|NCT01324830|26694218|P16|Overall Study|Dose limiting toxicity|0
7674612|NCT01324830|26694219|P15|Overall Study|Dose limiting toxicity|0
7674613|NCT01324830|26694220|P14|Overall Study|Dose limiting toxicity|0
7674614|NCT01324830|26694221|P13|Overall Study|Dose limiting toxicity|0
7674615|NCT01324830|26694222|P12|Overall Study|Dose limiting toxicity|0
7674616|NCT01324830|26694223|P11|Overall Study|Dose limiting toxicity|0
7674617|NCT01324830|26694224|P10|Overall Study|Dose limiting toxicity|0
7674618|NCT01324830|26694225|P9|Overall Study|Dose limiting toxicity|0
7674619|NCT01324830|26694226|P8|Overall Study|Dose limiting toxicity|0
7674620|NCT01324830|26694227|P7|Overall Study|Dose limiting toxicity|0
7674621|NCT01324830|26694228|P6|Overall Study|Dose limiting toxicity|0
7674622|NCT01324830|26694229|P5|Overall Study|Dose limiting toxicity|1
7674623|NCT01324830|26694230|P4|Overall Study|Dose limiting toxicity|0
7674624|NCT01324830|26694231|P3|Overall Study|Dose limiting toxicity|0
7674625|NCT01324830|26694232|P2|Overall Study|Dose limiting toxicity|0
7674626|NCT01324830|26694233|P1|Overall Study|Dose limiting toxicity|0
7674627|NCT01324830|26694215|P19|Overall Study|Progressive Disease|4
7674628|NCT01324830|26694216|P18|Overall Study|Progressive Disease|3
7674629|NCT01324830|26694217|P17|Overall Study|Progressive Disease|2
7674630|NCT01324830|26694218|P16|Overall Study|Progressive Disease|3
7674631|NCT01324830|26694219|P15|Overall Study|Progressive Disease|1
7674632|NCT01324830|26694220|P14|Overall Study|Progressive Disease|1
7674633|NCT01324830|26694221|P13|Overall Study|Progressive Disease|1
7674634|NCT01324830|26694222|P12|Overall Study|Progressive Disease|1
7674635|NCT01324830|26694223|P11|Overall Study|Progressive Disease|2
7674636|NCT01324830|26694224|P10|Overall Study|Progressive Disease|6
7674637|NCT01324830|26694225|P9|Overall Study|Progressive Disease|3
7674638|NCT01324830|26694226|P8|Overall Study|Progressive Disease|3
7674639|NCT01324830|26694227|P7|Overall Study|Progressive Disease|3
7674640|NCT01324830|26694228|P6|Overall Study|Progressive Disease|6
7674641|NCT01324830|26694229|P5|Overall Study|Progressive Disease|6
7674642|NCT01324830|26694230|P4|Overall Study|Progressive Disease|3
7674643|NCT01324830|26694231|P3|Overall Study|Progressive Disease|3
7674644|NCT01324830|26694232|P2|Overall Study|Progressive Disease|2
7674645|NCT01324830|26694233|P1|Overall Study|Progressive Disease|3
7674646|NCT01324622|26694379|P2|Overall Study|Lack of Efficacy|0
7674647|NCT01324622|26694380|P1|Overall Study|Lack of Efficacy|1
7674648|NCT01324622|26694379|P2|Overall Study|Death|0
7674649|NCT01324622|26694380|P1|Overall Study|Death|1
7674650|NCT01324622|26694379|P2|Overall Study|Lost to Follow-up|7
7674651|NCT01324622|26694380|P1|Overall Study|Lost to Follow-up|7
7674652|NCT01324570|26694410|P2|Overall Study|Administrative|2
7674653|NCT01324570|26694411|P1|Overall Study|Administrative|0
7674654|NCT01324570|26694410|P2|Overall Study|Confirmed or suspected diversion|1
7674655|NCT01324570|26694411|P1|Overall Study|Confirmed or suspected diversion|0
7674656|NCT01324570|26694410|P2|Overall Study|Lack of Efficacy|1
7674657|NCT01324570|26694411|P1|Overall Study|Lack of Efficacy|0
7674658|NCT01324570|26694410|P2|Overall Study|Withdrawal by Subject|3
7674659|NCT01324570|26694411|P1|Overall Study|Withdrawal by Subject|0
7674660|NCT01324570|26694410|P2|Overall Study|Adverse Event|7
7674661|NCT01324570|26694411|P1|Overall Study|Adverse Event|4
7674662|NCT01324440|26694488|P2|Overall Study|Subject moved|1
7674663|NCT01324440|26694489|P1|Overall Study|Subject moved|0
7674664|NCT01324401|26694503|P2|Overall Study|Adverse Event|3
7674665|NCT01324401|26694504|P1|Overall Study|Adverse Event|1
7674666|NCT01324401|26694503|P2|Overall Study|Withdrawn before any treatment|3
7674667|NCT01324401|26694504|P1|Overall Study|Withdrawn before any treatment|0
7674668|NCT01324388|26694515|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7674669|NCT01324388|26694516|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
7674670|NCT01324388|26694517|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7674671|NCT01324388|26694518|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7674672|NCT01324388|26694515|P4|Part 2 of Study: First Intervention|Protocol Violation|1
7674673|NCT01324388|26694516|P3|Part 2 of Study: First Intervention|Protocol Violation|0
7674674|NCT01324388|26694517|P2|Part 2 of Study: First Intervention|Protocol Violation|0
7674675|NCT01324388|26694518|P1|Part 2 of Study: First Intervention|Protocol Violation|0
7674676|NCT01324388|26694515|P4|Part 1 of Study|Physician Decision|0
7674677|NCT01324388|26694516|P3|Part 1 of Study|Physician Decision|0
7674678|NCT01324388|26694517|P2|Part 1 of Study|Physician Decision|0
7674679|NCT01324388|26694518|P1|Part 1 of Study|Physician Decision|1
7674680|NCT01324388|26694515|P4|Part 1 of Study|Protocol Violation|0
7674681|NCT01324388|26694516|P3|Part 1 of Study|Protocol Violation|0
7674682|NCT01324388|26694517|P2|Part 1 of Study|Protocol Violation|2
7674683|NCT01324388|26694518|P1|Part 1 of Study|Protocol Violation|1
7674684|NCT01324388|26694515|P4|Part 1 of Study|Adverse Event|0
7674685|NCT01324388|26694516|P3|Part 1 of Study|Adverse Event|0
7674686|NCT01324388|26694517|P2|Part 1 of Study|Adverse Event|0
7674687|NCT01324388|26694518|P1|Part 1 of Study|Adverse Event|2
7674688|NCT01324349|26694539|P2|Overall Study|Withdrawal by Subject|1
7674689|NCT01324349|26694540|P1|Overall Study|Withdrawal by Subject|0
7674690|NCT01324349|26694539|P2|Overall Study|Death|1
7674691|NCT01324349|26694540|P1|Overall Study|Death|1
7674692|NCT01324323|26694550|P1|Overall Study|Withdrawal by Subject|1
7674693|NCT01324310|26694570|P1|Overall Study|Disease Progression|1
7674694|NCT01324310|26694570|P1|Overall Study|Adverse Event|1
7674695|NCT01324271|26694590|P2|Overall Study|Physician Decision|0
7674696|NCT01324271|26694591|P1|Overall Study|Physician Decision|1
7674697|NCT01324271|26694590|P2|Overall Study|Lost to Follow-up|0
7674698|NCT01324271|26694591|P1|Overall Study|Lost to Follow-up|3
7674699|NCT01324102|26694614|P2|Overall Study|illness|6
7674700|NCT01324102|26694615|P1|Overall Study|illness|1
7674701|NCT01324024|26694622|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7674702|NCT01324024|26694623|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
7674703|NCT01323972|26694661|P4|Overall Study|Lost to Follow-up|1
7674704|NCT01323972|26694662|P3|Overall Study|Lost to Follow-up|1
7674705|NCT01323972|26694663|P2|Overall Study|Lost to Follow-up|1
7674706|NCT01323972|26694664|P1|Overall Study|Lost to Follow-up|0
7674707|NCT01323972|26694661|P4|Overall Study|Migrated/moved from study area|0
7674708|NCT01323972|26694662|P3|Overall Study|Migrated/moved from study area|0
7674709|NCT01323972|26694663|P2|Overall Study|Migrated/moved from study area|2
7674710|NCT01323972|26694664|P1|Overall Study|Migrated/moved from study area|1
7674711|NCT01323972|26694661|P4|Overall Study|Withdrawal by Subject|0
7674712|NCT01323972|26694662|P3|Overall Study|Withdrawal by Subject|1
7674713|NCT01323972|26694663|P2|Overall Study|Withdrawal by Subject|0
7674714|NCT01323972|26694664|P1|Overall Study|Withdrawal by Subject|1
7674715|NCT01323946|26694760|P3|Overall Study|Withdrawal by Subject|0
7674716|NCT01323946|26694761|P2|Overall Study|Withdrawal by Subject|2
7674717|NCT01323946|26694762|P1|Overall Study|Withdrawal by Subject|2
7674718|NCT01323946|26694760|P3|Overall Study|Parents refused the last blood draw|0
7674719|NCT01323946|26694761|P2|Overall Study|Parents refused the last blood draw|0
7674720|NCT01323946|26694762|P1|Overall Study|Parents refused the last blood draw|1
7674721|NCT01323946|26694760|P3|Overall Study|Lost to Follow-up|0
7674722|NCT01323946|26694761|P2|Overall Study|Lost to Follow-up|1
7674723|NCT01323946|26694762|P1|Overall Study|Lost to Follow-up|0
7674724|NCT01323920|26694883|P1|Overall Study|Withdrawal by Subject|1
7674725|NCT01323920|26694883|P1|Overall Study|Death|5
7674726|NCT01323790|26694924|P3|Overall Study|Severe non-compliance with protocol|2
7674727|NCT01323790|26694925|P2|Overall Study|Severe non-compliance with protocol|2
7674728|NCT01323790|26694926|P1|Overall Study|Severe non-compliance with protocol|2
7674729|NCT01323790|26694924|P3|Overall Study|Did Not Receive Treatment|1
7674730|NCT01323790|26694925|P2|Overall Study|Did Not Receive Treatment|0
7674731|NCT01323790|26694926|P1|Overall Study|Did Not Receive Treatment|2
7674732|NCT01323790|26694924|P3|Overall Study|Withdrawal by Subject|13
7674733|NCT01323790|26694925|P2|Overall Study|Withdrawal by Subject|20
7674734|NCT01323790|26694926|P1|Overall Study|Withdrawal by Subject|23
7674735|NCT01323790|26694924|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
7674736|NCT01323790|26694925|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
7674737|NCT01323790|26694926|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
7674738|NCT01323790|26694924|P3|Overall Study|Adverse Event|12
7674739|NCT01323790|26694925|P2|Overall Study|Adverse Event|24
7674740|NCT01323790|26694926|P1|Overall Study|Adverse Event|11
7674741|NCT01323790|26694924|P3|Overall Study|Lack of Efficacy|3
7674742|NCT01323790|26694925|P2|Overall Study|Lack of Efficacy|0
7674743|NCT01323790|26694926|P1|Overall Study|Lack of Efficacy|3
7674744|NCT01323790|26694924|P3|Overall Study|Study-Specific Withdrawal Criteria|3
7674745|NCT01323790|26694925|P2|Overall Study|Study-Specific Withdrawal Criteria|3
7674746|NCT01323790|26694926|P1|Overall Study|Study-Specific Withdrawal Criteria|0
7674747|NCT01323790|26694924|P3|Overall Study|Lost to Follow-up|9
7674748|NCT01323790|26694925|P2|Overall Study|Lost to Follow-up|9
7674749|NCT01323790|26694926|P1|Overall Study|Lost to Follow-up|11
7674750|NCT01323790|26694924|P3|Overall Study|Other|1
7674751|NCT01323790|26694925|P2|Overall Study|Other|2
7674752|NCT01323790|26694926|P1|Overall Study|Other|3
7674753|NCT01323673|26694977|P2|Overall Study|Withdrawal by Subject|3
7674754|NCT01323673|26694978|P1|Overall Study|Withdrawal by Subject|2
7674755|NCT01323673|26694977|P2|Overall Study|Protocol Violation|0
7674756|NCT01323673|26694978|P1|Overall Study|Protocol Violation|1
7674757|NCT01323673|26694977|P2|Overall Study|Lost to Follow-up|1
7674758|NCT01323673|26694978|P1|Overall Study|Lost to Follow-up|0
7674759|NCT01323673|26694977|P2|Overall Study|Adverse Event|1
7674760|NCT01323673|26694978|P1|Overall Study|Adverse Event|0
7674761|NCT01323660|26694998|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7674762|NCT01323660|26694999|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7674763|NCT01323660|26695000|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7674764|NCT01323660|26695001|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7674765|NCT01323660|26695002|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7674766|NCT01323660|26695003|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7674767|NCT01323660|26694998|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7674768|NCT01323660|26694999|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7674769|NCT01323660|26695000|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7674770|NCT01323660|26695001|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7674771|NCT01323660|26695002|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7674772|NCT01323660|26695003|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7674773|NCT01323660|26694998|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
7674774|NCT01323660|26694999|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7674775|NCT01323660|26695000|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7674776|NCT01323660|26695001|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7674777|NCT01323660|26695002|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7674778|NCT01323660|26695003|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7674779|NCT01323660|26694998|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
7674780|NCT01323660|26694999|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7674781|NCT01323660|26695000|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7674782|NCT01323660|26695001|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7674783|NCT01323660|26695002|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7674784|NCT01323660|26695003|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
7674785|NCT01323660|26694998|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
7674786|NCT01323660|26694999|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
7674787|NCT01323660|26695000|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
7674788|NCT01323660|26695001|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
7674789|NCT01323660|26695002|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
7674790|NCT01323660|26695003|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
7674791|NCT01323660|26694998|P6|Washout Period (14 Days)|Lack of Efficacy|2
7674792|NCT01323660|26694999|P5|Washout Period (14 Days)|Lack of Efficacy|2
7674793|NCT01323660|26695000|P4|Washout Period (14 Days)|Lack of Efficacy|3
7674794|NCT01323660|26695001|P3|Washout Period (14 Days)|Lack of Efficacy|1
7674795|NCT01323660|26695002|P2|Washout Period (14 Days)|Lack of Efficacy|0
7674796|NCT01323660|26695003|P1|Washout Period (14 Days)|Lack of Efficacy|0
7674797|NCT01323660|26694998|P6|Washout Period (14 Days)|Adverse Event|0
7674798|NCT01323660|26694999|P5|Washout Period (14 Days)|Adverse Event|1
7674799|NCT01323660|26695000|P4|Washout Period (14 Days)|Adverse Event|0
7674800|NCT01323660|26695001|P3|Washout Period (14 Days)|Adverse Event|0
7674801|NCT01323660|26695002|P2|Washout Period (14 Days)|Adverse Event|0
7674802|NCT01323660|26695003|P1|Washout Period (14 Days)|Adverse Event|0
7674803|NCT01323660|26694998|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7674804|NCT01323660|26694999|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
7674805|NCT01323660|26695000|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7674806|NCT01323660|26695001|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7674807|NCT01323660|26695002|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7674808|NCT01323660|26695003|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
7674809|NCT01323660|26694998|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674810|NCT01323660|26694999|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7674811|NCT01323660|26695000|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674812|NCT01323660|26695001|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674813|NCT01323660|26695002|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674814|NCT01323660|26695003|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7674815|NCT01323660|26694998|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7674816|NCT01323660|26694999|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
7674817|NCT01323660|26695000|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7674818|NCT01323660|26695001|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7674819|NCT01323660|26695002|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7674820|NCT01323660|26695003|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7674821|NCT01323660|26694998|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7674822|NCT01323660|26694999|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7674823|NCT01323660|26695000|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7674824|NCT01323660|26695001|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7674825|NCT01323660|26695002|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7674826|NCT01323660|26695003|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7674827|NCT01323660|26694998|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
7674828|NCT01323660|26694999|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7674829|NCT01323660|26695000|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
7674830|NCT01323660|26695001|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
7674831|NCT01323660|26695002|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
7674832|NCT01323660|26695003|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7674833|NCT01323660|26694998|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
7674834|NCT01323660|26694999|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
7674835|NCT01323660|26695000|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
7674836|NCT01323660|26695001|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
7674837|NCT01323660|26695002|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
7674838|NCT01323660|26695003|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
7674839|NCT01323647|26695049|P2|Overall Study|Lost to Follow-up|0
7674840|NCT01323647|26695050|P1|Overall Study|Lost to Follow-up|2
7674841|NCT01323647|26695049|P2|Overall Study|Withdrawal by Subject|0
7674842|NCT01323647|26695050|P1|Overall Study|Withdrawal by Subject|5
7674843|NCT01323647|26695049|P2|Overall Study|Migrated/moved from study area|0
7674844|NCT01323647|26695050|P1|Overall Study|Migrated/moved from study area|2
7674845|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
7674846|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
7674847|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
7674848|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
7674849|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
7674850|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7674851|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
7674852|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
7674853|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
7674854|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7674855|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7674856|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7674857|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
7674858|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
7674859|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
7674860|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7674861|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7674862|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7674863|NCT01323634|26695067|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
7674864|NCT01323634|26695068|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
7674865|NCT01323634|26695069|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
7674866|NCT01323634|26695067|P3|2-week Run-in Period|Adverse Event|0
7674867|NCT01323634|26695068|P2|2-week Run-in Period|Adverse Event|0
7674868|NCT01323634|26695069|P1|2-week Run-in Period|Adverse Event|1
7674869|NCT01323634|26695067|P3|2-week Run-in Period|Protocol Violation|0
7674870|NCT01323634|26695068|P2|2-week Run-in Period|Protocol Violation|0
7674871|NCT01323634|26695069|P1|2-week Run-in Period|Protocol Violation|1
7674872|NCT01323634|26695067|P3|2-week Run-in Period|Physician Decision|0
7674873|NCT01323634|26695068|P2|2-week Run-in Period|Physician Decision|0
7674874|NCT01323634|26695069|P1|2-week Run-in Period|Physician Decision|5
7674875|NCT01323634|26695067|P3|2-week Run-in Period|Withdrawal by Subject|0
7674876|NCT01323634|26695068|P2|2-week Run-in Period|Withdrawal by Subject|0
7674877|NCT01323634|26695069|P1|2-week Run-in Period|Withdrawal by Subject|7
7674878|NCT01323634|26695067|P3|2-week Run-in Period|Continuation Criteria not Met|0
7674879|NCT01323634|26695068|P2|2-week Run-in Period|Continuation Criteria not Met|0
7674880|NCT01323634|26695069|P1|2-week Run-in Period|Continuation Criteria not Met|73
7674881|NCT01323634|26695067|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
7674882|NCT01323634|26695068|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
7674883|NCT01323634|26695069|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
7674884|NCT01323621|26695079|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
7674885|NCT01323621|26695080|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
7674886|NCT01323621|26695081|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
7674887|NCT01323621|26695079|P3|12-week, Double-blind Treatment Period|Physician Decision|1
7674888|NCT01323621|26695080|P2|12-week, Double-blind Treatment Period|Physician Decision|2
7674889|NCT01323621|26695081|P1|12-week, Double-blind Treatment Period|Physician Decision|0
7674890|NCT01323621|26695079|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
7674891|NCT01323621|26695080|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
7674892|NCT01323621|26695081|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
7674893|NCT01323621|26695079|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
7674894|NCT01323621|26695080|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
7674895|NCT01323621|26695081|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
7674896|NCT01323621|26695079|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
7674897|NCT01323621|26695080|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
7674898|NCT01323621|26695081|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
7674899|NCT01323621|26695079|P3|12-week, Double-blind Treatment Period|Adverse Event|5
7674900|NCT01323621|26695080|P2|12-week, Double-blind Treatment Period|Adverse Event|1
7674901|NCT01323621|26695081|P1|12-week, Double-blind Treatment Period|Adverse Event|0
7674902|NCT01323621|26695079|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
7674903|NCT01323621|26695080|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
7674904|NCT01323621|26695081|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
7674905|NCT01323621|26695079|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
7674906|NCT01323621|26695080|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
7674907|NCT01323621|26695081|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
7674908|NCT01323621|26695079|P3|2-week, Single-blind Run In Period|Protocol Violation|0
7674909|NCT01323621|26695080|P2|2-week, Single-blind Run In Period|Protocol Violation|0
7674910|NCT01323621|26695081|P1|2-week, Single-blind Run In Period|Protocol Violation|1
7674911|NCT01323621|26695079|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
7674912|NCT01323621|26695080|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
7674913|NCT01323621|26695081|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
7674914|NCT01323621|26695079|P3|2-week, Single-blind Run In Period|Physician Decision|0
7674915|NCT01323621|26695080|P2|2-week, Single-blind Run In Period|Physician Decision|0
7674916|NCT01323621|26695081|P1|2-week, Single-blind Run In Period|Physician Decision|7
7674917|NCT01323621|26695079|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
7674918|NCT01323621|26695080|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
7674919|NCT01323621|26695081|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
7674920|NCT01323582|26695102|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
7674921|NCT01323582|26695103|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
7674922|NCT01323582|26695102|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
7674923|NCT01323582|26695103|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
7674924|NCT01323582|26695102|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
7674925|NCT01323582|26695103|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
7674926|NCT01323530|26695126|P7|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
7674927|NCT01323530|26695127|P6|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7674928|NCT01323530|26695128|P5|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7674929|NCT01323530|26695129|P4|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7674930|NCT01323530|26695130|P3|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7674931|NCT01323530|26695131|P2|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7674932|NCT01323530|26695132|P1|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7674933|NCT01323530|26695126|P7|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
7674934|NCT01323530|26695127|P6|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7674935|NCT01323530|26695128|P5|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7674936|NCT01323530|26695129|P4|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7674937|NCT01323530|26695130|P3|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7674938|NCT01323530|26695131|P2|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7674939|NCT01323530|26695132|P1|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7674940|NCT01323530|26695126|P7|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
7674941|NCT01323530|26695127|P6|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7674942|NCT01323530|26695128|P5|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7674943|NCT01323530|26695129|P4|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7674944|NCT01323530|26695130|P3|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7674945|NCT01323530|26695131|P2|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7674946|NCT01323530|26695132|P1|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7674947|NCT01323530|26695126|P7|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
7674948|NCT01323530|26695127|P6|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7674949|NCT01323530|26695128|P5|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7674950|NCT01323530|26695129|P4|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7674951|NCT01323530|26695130|P3|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7674952|NCT01323530|26695131|P2|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7674953|NCT01323530|26695132|P1|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7674954|NCT01323530|26695126|P7|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
7674955|NCT01323530|26695127|P6|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7674956|NCT01323530|26695128|P5|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7674957|NCT01323530|26695129|P4|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7674958|NCT01323530|26695130|P3|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7674959|NCT01323530|26695131|P2|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7674960|NCT01323530|26695132|P1|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7674961|NCT01323530|26695126|P7|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7674962|NCT01323530|26695127|P6|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7674963|NCT01323530|26695128|P5|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7674964|NCT01323530|26695129|P4|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7674965|NCT01323530|26695130|P3|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7674966|NCT01323530|26695131|P2|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7674967|NCT01323530|26695132|P1|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7674968|NCT01323530|26695126|P7|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7674969|NCT01323530|26695127|P6|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7674970|NCT01323530|26695128|P5|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
7674971|NCT01323530|26695129|P4|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7674972|NCT01323530|26695130|P3|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7674973|NCT01323530|26695131|P2|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7674974|NCT01323530|26695132|P1|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7674975|NCT01323530|26695126|P7|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7674976|NCT01323530|26695127|P6|Phase 1b (Dose Escalation Phase)|Adverse Event|2
7674977|NCT01323530|26695128|P5|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7674978|NCT01323530|26695129|P4|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7674979|NCT01323530|26695130|P3|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7674980|NCT01323530|26695131|P2|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7674981|NCT01323530|26695132|P1|Phase 1b (Dose Escalation Phase)|Adverse Event|2
7674982|NCT01323478|26695169|P1|Overall Study|Administrative or Other Reasons|8
7674983|NCT01323478|26695169|P1|Overall Study|Withdrawal of Consent|1
7674984|NCT01323478|26695169|P1|Overall Study|Protocol Violation|1
7674985|NCT01323478|26695169|P1|Overall Study|Non-compliance With Study Product|3
7674986|NCT01323478|26695169|P1|Overall Study|Lack of Efficacy|4
7674987|NCT01323478|26695169|P1|Overall Study|Adverse Event|7
7674988|NCT01323387|26695182|P1|Overall Study|Randomized but Never Treated|16
7674989|NCT01323387|26695182|P1|Overall Study|Protocol Violation|12
7674990|NCT01323387|26695182|P1|Overall Study|Revision|14
7674991|NCT01323387|26695182|P1|Overall Study|Radiographic Data Unavailable|1
7674992|NCT01323387|26695182|P1|Overall Study|Withdrawal by Subject|41
7674993|NCT01323270|26695195|P2|Overall Study|Randomized, but not vaccinated|0
7674994|NCT01323270|26695196|P1|Overall Study|Randomized, but not vaccinated|1
7674995|NCT01323270|26695195|P2|Overall Study|Death|0
7674996|NCT01323270|26695196|P1|Overall Study|Death|1
7674997|NCT01323270|26695195|P2|Overall Study|Not eligible|1
7674998|NCT01323270|26695196|P1|Overall Study|Not eligible|1
7674999|NCT01323270|26695195|P2|Overall Study|Physician Decision|2
7675000|NCT01323270|26695196|P1|Overall Study|Physician Decision|0
7675001|NCT01323270|26695195|P2|Overall Study|Other|3
7675002|NCT01323270|26695196|P1|Overall Study|Other|0
7675003|NCT01323270|26695195|P2|Overall Study|Adverse Event|0
7675004|NCT01323270|26695196|P1|Overall Study|Adverse Event|8
7675005|NCT01323270|26695195|P2|Overall Study|Lost to Follow-up|6
7675006|NCT01323270|26695196|P1|Overall Study|Lost to Follow-up|4
7675007|NCT01323270|26695195|P2|Overall Study|Protocol Violation|7
7675008|NCT01323270|26695196|P1|Overall Study|Protocol Violation|9
7675009|NCT01323270|26695195|P2|Overall Study|Withdrawal by Subject|10
7675010|NCT01323270|26695196|P1|Overall Study|Withdrawal by Subject|19
7675011|NCT01323192|26695218|P2|Overall Study|Nonmedical reasons|1
7675012|NCT01323192|26695219|P1|Overall Study|Nonmedical reasons|0
7675013|NCT01323192|26695218|P2|Overall Study|Noncompliance with study medication|3
7675014|NCT01323192|26695219|P1|Overall Study|Noncompliance with study medication|0
7675015|NCT01323192|26695218|P2|Overall Study|Withdrawal by Subject|1
7675016|NCT01323192|26695219|P1|Overall Study|Withdrawal by Subject|3
7675017|NCT01323192|26695218|P2|Overall Study|Adverse Event|1
7675018|NCT01323192|26695219|P1|Overall Study|Adverse Event|6
7675019|NCT01322490|26695468|P3|Long Term Follow-up Period|Unknown/Missing|1
7675020|NCT01322490|26695469|P2|Long Term Follow-up Period|Unknown/Missing|1
7675021|NCT01322490|26695470|P1|Long Term Follow-up Period|Unknown/Missing|0
7675022|NCT01322490|26695468|P3|Long Term Follow-up Period|Other per report|2
7675023|NCT01322490|26695469|P2|Long Term Follow-up Period|Other per report|2
7675024|NCT01322490|26695470|P1|Long Term Follow-up Period|Other per report|3
7675025|NCT01322490|26695468|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
7675026|NCT01322490|26695469|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
7675027|NCT01322490|26695470|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
7675028|NCT01322490|26695468|P3|Long Term Follow-up Period|Withdrawal by Subject|6
7675029|NCT01322490|26695469|P2|Long Term Follow-up Period|Withdrawal by Subject|6
7675030|NCT01322490|26695470|P1|Long Term Follow-up Period|Withdrawal by Subject|9
7675031|NCT01322490|26695468|P3|Long Term Follow-up Period|Lost to Follow-up|3
7675032|NCT01322490|26695469|P2|Long Term Follow-up Period|Lost to Follow-up|2
7675033|NCT01322490|26695470|P1|Long Term Follow-up Period|Lost to Follow-up|2
7675034|NCT01322490|26695468|P3|Long Term Follow-up Period|Death|236
7675035|NCT01322490|26695469|P2|Long Term Follow-up Period|Death|239
7675036|NCT01322490|26695470|P1|Long Term Follow-up Period|Death|235
7675037|NCT01322490|26695468|P3|Treatment Period|Randomized but Not Treated|5
7675038|NCT01322490|26695469|P2|Treatment Period|Randomized but Not Treated|3
7675039|NCT01322490|26695470|P1|Treatment Period|Randomized but Not Treated|3
7675040|NCT01322490|26695468|P3|Treatment Period|Other per report|1
7675041|NCT01322490|26695469|P2|Treatment Period|Other per report|2
7675042|NCT01322490|26695470|P1|Treatment Period|Other per report|2
7675043|NCT01322490|26695468|P3|Treatment Period|Non-compliance with study drug|1
7675044|NCT01322490|26695469|P2|Treatment Period|Non-compliance with study drug|0
7675045|NCT01322490|26695470|P1|Treatment Period|Non-compliance with study drug|0
7675046|NCT01322490|26695468|P3|Treatment Period|Withdrawal by Subject|11
7675047|NCT01322490|26695469|P2|Treatment Period|Withdrawal by Subject|16
7675048|NCT01322490|26695470|P1|Treatment Period|Withdrawal by Subject|14
7675049|NCT01322490|26695468|P3|Treatment Period|Protocol Violation|4
7675050|NCT01322490|26695469|P2|Treatment Period|Protocol Violation|5
7675051|NCT01322490|26695470|P1|Treatment Period|Protocol Violation|7
7675052|NCT01322490|26695468|P3|Treatment Period|Physician Decision|1
7675053|NCT01322490|26695469|P2|Treatment Period|Physician Decision|2
7675054|NCT01322490|26695470|P1|Treatment Period|Physician Decision|0
7675055|NCT01322490|26695468|P3|Treatment Period|Lack of Efficacy|112
7675056|NCT01322490|26695469|P2|Treatment Period|Lack of Efficacy|100
7675057|NCT01322490|26695470|P1|Treatment Period|Lack of Efficacy|89
7675058|NCT01322490|26695468|P3|Treatment Period|Death|3
7675059|NCT01322490|26695469|P2|Treatment Period|Death|7
7675060|NCT01322490|26695470|P1|Treatment Period|Death|5
7675061|NCT01322490|26695468|P3|Treatment Period|Adverse Event|15
7675062|NCT01322490|26695469|P2|Treatment Period|Adverse Event|18
7675063|NCT01322490|26695470|P1|Treatment Period|Adverse Event|12
7675064|NCT01322386|26695483|P2|Overall Study|Physician Decision|1
7675065|NCT01322386|26695484|P1|Overall Study|Physician Decision|0
7675066|NCT01322386|26695483|P2|Overall Study|Protocol Violation|1
7675067|NCT01322386|26695484|P1|Overall Study|Protocol Violation|0
7675068|NCT01322347|26695499|P2|Overall Study|moved/changed dialysis|4
7675069|NCT01322347|26695500|P1|Overall Study|moved/changed dialysis|2
7675070|NCT01322347|26695499|P2|Overall Study|study drug withheld > 12 wks|1
7675071|NCT01322347|26695500|P1|Overall Study|study drug withheld > 12 wks|0
7675072|NCT01322347|26695499|P2|Overall Study|kidney transplant|1
7675073|NCT01322347|26695500|P1|Overall Study|kidney transplant|3
7675074|NCT01322347|26695499|P2|Overall Study|ineligible|3
7675075|NCT01322347|26695500|P1|Overall Study|ineligible|6
7675076|NCT01322347|26695499|P2|Overall Study|sponsor decision|3
7675077|NCT01322347|26695500|P1|Overall Study|sponsor decision|1
7675078|NCT01322347|26695499|P2|Overall Study|blood transfusion|5
7675079|NCT01322347|26695500|P1|Overall Study|blood transfusion|5
7675080|NCT01322347|26695499|P2|Overall Study|non-protocol change to ESA or IV iron|6
7675081|NCT01322347|26695500|P1|Overall Study|non-protocol change to ESA or IV iron|14
7675082|NCT01322347|26695499|P2|Overall Study|Withdrawal by Subject|4
7675083|NCT01322347|26695500|P1|Overall Study|Withdrawal by Subject|1
7675084|NCT01322347|26695499|P2|Overall Study|Protocol Violation|2
7675085|NCT01322347|26695500|P1|Overall Study|Protocol Violation|5
7675086|NCT01322347|26695499|P2|Overall Study|Physician Decision|1
7675087|NCT01322347|26695500|P1|Overall Study|Physician Decision|2
7675088|NCT01322347|26695499|P2|Overall Study|Death|3
7675089|NCT01322347|26695500|P1|Overall Study|Death|5
7675090|NCT01322347|26695499|P2|Overall Study|Adverse Event|2
7675091|NCT01322347|26695500|P1|Overall Study|Adverse Event|7
7675092|NCT01322009|26695563|P2|Overall Study|ng tube discontinued|1
7675093|NCT01322009|26695564|P1|Overall Study|ng tube discontinued|0
7675094|NCT01322009|26695563|P2|Overall Study|Adverse Event|1
7675095|NCT01322009|26695564|P1|Overall Study|Adverse Event|0
7675096|NCT01322009|26695563|P2|Overall Study|Death|1
7675097|NCT01322009|26695564|P1|Overall Study|Death|0
7675098|NCT01321879|26695572|P1|Overall Study|Withdrawal by Subject|1
7675099|NCT01321879|26695572|P1|Overall Study|Death|3
7675100|NCT01321879|26695572|P1|Overall Study|Adverse Event|5
7675101|NCT01321879|26695572|P1|Overall Study|Lack of Efficacy|5
7675102|NCT01321749|26695578|P2|Overall Study|Withdrawal by Subject|4
7675103|NCT01321749|26695579|P1|Overall Study|Withdrawal by Subject|5
7675104|NCT01321749|26695578|P2|Overall Study|Protocol Violation|7
7675105|NCT01321749|26695579|P1|Overall Study|Protocol Violation|4
7675106|NCT01321749|26695578|P2|Overall Study|Lost to Follow-up|11
7675107|NCT01321749|26695579|P1|Overall Study|Lost to Follow-up|4
7675108|NCT01321723|26695588|P3|Overall Study|Withdrawal by Subject|2
7675109|NCT01321723|26695589|P2|Overall Study|Withdrawal by Subject|0
7675110|NCT01321723|26695590|P1|Overall Study|Withdrawal by Subject|2
7675111|NCT01321723|26695588|P3|Overall Study|Adverse Event|2
7675112|NCT01321723|26695589|P2|Overall Study|Adverse Event|5
7675113|NCT01321723|26695590|P1|Overall Study|Adverse Event|3
7675114|NCT01321710|26695612|P3|Overall Study|Lost to Follow-up|0
7675115|NCT01321710|26695613|P2|Overall Study|Lost to Follow-up|5
7675116|NCT01321710|26695614|P1|Overall Study|Lost to Follow-up|4
7675117|NCT01321697|26695629|P1|Overall Study|Study Terminated|7
7675118|NCT01321606|26695635|P4|Overall Study|Lost to Follow-up|1
7675119|NCT01321606|26695636|P3|Overall Study|Lost to Follow-up|0
7675120|NCT01321606|26695637|P2|Overall Study|Lost to Follow-up|0
7675121|NCT01321606|26695638|P1|Overall Study|Lost to Follow-up|0
7675122|NCT01321073|26695701|P1|Overall Study|Death|3
7675123|NCT01321073|26695701|P1|Overall Study|Did not attempt implant|4
7675124|NCT01321008|26695705|P1|Overall Study|Early Study Termination|1
7675125|NCT01320943|26695711|P2|Overall Study|Randomized but not Treated|1
7675126|NCT01320943|26695712|P1|Overall Study|Randomized but not Treated|0
7675127|NCT01320943|26695711|P2|Overall Study|Physician Decision|1
7675128|NCT01320943|26695712|P1|Overall Study|Physician Decision|0
7675129|NCT01320943|26695711|P2|Overall Study|Lost to Follow-up|0
7675130|NCT01320943|26695712|P1|Overall Study|Lost to Follow-up|1
7675131|NCT01320735|26695746|P1|Overall Study|Investigator Unable to be Contacted|17
7675132|NCT01320735|26695746|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
7675133|NCT01320735|26695746|P1|Overall Study|Other|1
7675134|NCT01320735|26695746|P1|Overall Study|Protocol Violation|1
7675135|NCT01320735|26695746|P1|Overall Study|Progression/Hormone-Refractory Pca|55
7675136|NCT01320735|26695746|P1|Overall Study|Administrative Reason|6
7675137|NCT01320735|26695746|P1|Overall Study|Lost to Follow-up|13
7675138|NCT01320735|26695746|P1|Overall Study|Withdrawal by Subject|3
7675139|NCT01320735|26695746|P1|Overall Study|Adverse Event|3
7675140|NCT01320722|26695768|P5|Overall Study|Withdrew due to Health Condition|1
7675141|NCT01320722|26695769|P4|Overall Study|Withdrew due to Health Condition|0
7675142|NCT01320722|26695770|P3|Overall Study|Withdrew due to Health Condition|0
7675143|NCT01320722|26695771|P2|Overall Study|Withdrew due to Health Condition|0
7675144|NCT01320722|26695772|P1|Overall Study|Withdrew due to Health Condition|0
7675145|NCT01320722|26695768|P5|Overall Study|Started an Exclusionary Medication|1
7675146|NCT01320722|26695769|P4|Overall Study|Started an Exclusionary Medication|0
7675147|NCT01320722|26695770|P3|Overall Study|Started an Exclusionary Medication|0
7675148|NCT01320722|26695771|P2|Overall Study|Started an Exclusionary Medication|0
7675149|NCT01320722|26695772|P1|Overall Study|Started an Exclusionary Medication|0
7675150|NCT01320722|26695768|P5|Overall Study|Pregnancy|0
7675151|NCT01320722|26695769|P4|Overall Study|Pregnancy|1
7675152|NCT01320722|26695770|P3|Overall Study|Pregnancy|0
7675153|NCT01320722|26695771|P2|Overall Study|Pregnancy|0
7675154|NCT01320722|26695772|P1|Overall Study|Pregnancy|0
7675155|NCT01320722|26695768|P5|Overall Study|Not Compliant with Study Procedures|0
7675156|NCT01320722|26695769|P4|Overall Study|Not Compliant with Study Procedures|4
7675157|NCT01320722|26695770|P3|Overall Study|Not Compliant with Study Procedures|0
7675158|NCT01320722|26695771|P2|Overall Study|Not Compliant with Study Procedures|0
7675159|NCT01320722|26695772|P1|Overall Study|Not Compliant with Study Procedures|0
7675160|NCT01320722|26695768|P5|Overall Study|Adverse Event|0
7675161|NCT01320722|26695769|P4|Overall Study|Adverse Event|6
7675162|NCT01320722|26695770|P3|Overall Study|Adverse Event|3
7675163|NCT01320722|26695771|P2|Overall Study|Adverse Event|0
7675164|NCT01320722|26695772|P1|Overall Study|Adverse Event|0
7675165|NCT01320722|26695768|P5|Overall Study|Non-compliant with Medication|0
7675166|NCT01320722|26695769|P4|Overall Study|Non-compliant with Medication|0
7675167|NCT01320722|26695770|P3|Overall Study|Non-compliant with Medication|1
7675168|NCT01320722|26695771|P2|Overall Study|Non-compliant with Medication|0
7675169|NCT01320722|26695772|P1|Overall Study|Non-compliant with Medication|0
7675170|NCT01320722|26695768|P5|Overall Study|Participant Developed a Rash|1
7675171|NCT01320722|26695769|P4|Overall Study|Participant Developed a Rash|1
7675172|NCT01320722|26695770|P3|Overall Study|Participant Developed a Rash|2
7675173|NCT01320722|26695771|P2|Overall Study|Participant Developed a Rash|0
7675174|NCT01320722|26695772|P1|Overall Study|Participant Developed a Rash|0
7675175|NCT01320722|26695768|P5|Overall Study|Not Available for the 8 Week Visit|0
7675176|NCT01320722|26695769|P4|Overall Study|Not Available for the 8 Week Visit|0
7675177|NCT01320722|26695770|P3|Overall Study|Not Available for the 8 Week Visit|0
7675178|NCT01320722|26695771|P2|Overall Study|Not Available for the 8 Week Visit|3
7675179|NCT01320722|26695772|P1|Overall Study|Not Available for the 8 Week Visit|0
7675180|NCT01320722|26695768|P5|Overall Study|Lost to Follow-up|3
7675181|NCT01320722|26695769|P4|Overall Study|Lost to Follow-up|1
7675182|NCT01320722|26695770|P3|Overall Study|Lost to Follow-up|0
7675183|NCT01320722|26695771|P2|Overall Study|Lost to Follow-up|1
7675184|NCT01320722|26695772|P1|Overall Study|Lost to Follow-up|0
7675185|NCT01320722|26695768|P5|Overall Study|Did not Receive Intervention|2
7675186|NCT01320722|26695769|P4|Overall Study|Did not Receive Intervention|1
7675187|NCT01320722|26695770|P3|Overall Study|Did not Receive Intervention|1
7675188|NCT01320722|26695771|P2|Overall Study|Did not Receive Intervention|2
7675189|NCT01320722|26695772|P1|Overall Study|Did not Receive Intervention|3
7675190|NCT01320683|26695809|P1|Overall Study|Positive antibody response|1
7675191|NCT01320293|26695835|P1|Overall Study|Adverse Event|1
7675192|NCT01320293|26695835|P1|Overall Study|Lack of Efficacy|1
7675193|NCT01320202|26695843|P2|Overall Study|regained renal function|0
7675194|NCT01320202|26695844|P1|Overall Study|regained renal function|1
7675195|NCT01320202|26695843|P2|Overall Study|ineligible|0
7675196|NCT01320202|26695844|P1|Overall Study|ineligible|3
7675197|NCT01320202|26695843|P2|Overall Study|sponsor request|0
7675198|NCT01320202|26695844|P1|Overall Study|sponsor request|2
7675199|NCT01320202|26695843|P2|Overall Study|moved/changed dialysis|2
7675200|NCT01320202|26695844|P1|Overall Study|moved/changed dialysis|5
7675201|NCT01320202|26695843|P2|Overall Study|blood transfusion|7
7675202|NCT01320202|26695844|P1|Overall Study|blood transfusion|1
7675203|NCT01320202|26695843|P2|Overall Study|kidney transplant|2
7675204|NCT01320202|26695844|P1|Overall Study|kidney transplant|1
7675205|NCT01320202|26695843|P2|Overall Study|non-protocol change to ESA or IV iron|20
7675206|NCT01320202|26695844|P1|Overall Study|non-protocol change to ESA or IV iron|17
7675207|NCT01320202|26695843|P2|Overall Study|Withdrawal by Subject|3
7675208|NCT01320202|26695844|P1|Overall Study|Withdrawal by Subject|10
7675209|NCT01320202|26695843|P2|Overall Study|Protocol Violation|1
7675210|NCT01320202|26695844|P1|Overall Study|Protocol Violation|2
7675211|NCT01320202|26695843|P2|Overall Study|Physician Decision|1
7675212|NCT01320202|26695844|P1|Overall Study|Physician Decision|3
7675213|NCT01320202|26695843|P2|Overall Study|Lost to Follow-up|0
7675214|NCT01320202|26695844|P1|Overall Study|Lost to Follow-up|1
7675215|NCT01320202|26695843|P2|Overall Study|Death|3
7675216|NCT01320202|26695844|P1|Overall Study|Death|5
7675217|NCT01320202|26695843|P2|Overall Study|Adverse Event|5
7675218|NCT01320202|26695844|P1|Overall Study|Adverse Event|5
7675219|NCT01320150|26695881|P1|Overall Study|Lost to Follow-up|44
7675220|NCT01320150|26695881|P1|Overall Study|Death|2
7675221|NCT01320150|26695881|P1|Overall Study|Withdrawal by Subject|5
7675222|NCT01320150|26695881|P1|Overall Study|Protocol Violation|15
7675223|NCT01320085|26695903|P3|Overall Study|Protocol Deviation|1
7675224|NCT01320085|26695904|P2|Overall Study|Protocol Deviation|0
7675225|NCT01320085|26695905|P1|Overall Study|Protocol Deviation|1
7675226|NCT01320085|26695903|P3|Overall Study|Withdrawal by Subject|1
7675227|NCT01320085|26695904|P2|Overall Study|Withdrawal by Subject|4
7675228|NCT01320085|26695905|P1|Overall Study|Withdrawal by Subject|2
7675229|NCT01320085|26695903|P3|Overall Study|Adverse Event|5
7675230|NCT01320085|26695904|P2|Overall Study|Adverse Event|14
7675231|NCT01320085|26695905|P1|Overall Study|Adverse Event|12
7675232|NCT01320085|26695903|P3|Overall Study|Disease Progression|16
7675233|NCT01320085|26695904|P2|Overall Study|Disease Progression|86
7675234|NCT01320085|26695905|P1|Overall Study|Disease Progression|26
7675235|NCT01320085|26695903|P3|Overall Study|Treatment Ongoing|2
7675236|NCT01320085|26695904|P2|Overall Study|Treatment Ongoing|13
7675237|NCT01320085|26695905|P1|Overall Study|Treatment Ongoing|0
7675238|NCT01320033|26696015|P3|Overall Study|Other|1
7675239|NCT01320033|26696016|P2|Overall Study|Other|3
7675240|NCT01320033|26696017|P1|Overall Study|Other|2
7675241|NCT01320033|26696015|P3|Overall Study|Lost to Follow-up|17
7675242|NCT01320033|26696016|P2|Overall Study|Lost to Follow-up|26
7675243|NCT01320033|26696017|P1|Overall Study|Lost to Follow-up|22
7675244|NCT01320033|26696015|P3|Overall Study|Protocol Violation|3
7675245|NCT01320033|26696016|P2|Overall Study|Protocol Violation|5
7675246|NCT01320033|26696017|P1|Overall Study|Protocol Violation|3
7675247|NCT01320033|26696015|P3|Overall Study|Withdrawal by Subject|23
7675248|NCT01320033|26696016|P2|Overall Study|Withdrawal by Subject|23
7675249|NCT01320033|26696017|P1|Overall Study|Withdrawal by Subject|22
7675250|NCT01320033|26696015|P3|Overall Study|Adverse Event|8
7675251|NCT01320033|26696016|P2|Overall Study|Adverse Event|7
7675252|NCT01320033|26696017|P1|Overall Study|Adverse Event|9
7675253|NCT01320033|26696015|P3|Overall Study|Lack of Efficacy|1
7675254|NCT01320033|26696016|P2|Overall Study|Lack of Efficacy|0
7675255|NCT01320033|26696017|P1|Overall Study|Lack of Efficacy|0
7675256|NCT01319994|26696045|P2|Overall Study|Protocol Violation|6
7675257|NCT01319994|26696046|P1|Overall Study|Protocol Violation|7
7675258|NCT01319929|26696056|P2|Second Treatment Period (4 Weeks)|Sponsor Decision|1
7675259|NCT01319929|26696057|P1|Second Treatment Period (4 Weeks)|Sponsor Decision|0
7675260|NCT01319929|26696056|P2|Second Treatment Period (4 Weeks)|Adverse Event|0
7675261|NCT01319929|26696057|P1|Second Treatment Period (4 Weeks)|Adverse Event|1
7675262|NCT01319929|26696056|P2|First Treatment Period (4 Weeks)|Protocol Violation|1
7675263|NCT01319929|26696057|P1|First Treatment Period (4 Weeks)|Protocol Violation|0
7675264|NCT01319929|26696056|P2|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
7675265|NCT01319929|26696057|P1|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
7675266|NCT01319929|26696056|P2|First Treatment Period (4 Weeks)|Adverse Event|0
7675267|NCT01319929|26696057|P1|First Treatment Period (4 Weeks)|Adverse Event|2
7675268|NCT01319877|26696089|P2|Overall Study|Reason Not Specified|5
7675269|NCT01319877|26696090|P1|Overall Study|Reason Not Specified|4
7675270|NCT01319877|26696089|P2|Overall Study|Withdrawal by Subject|1
7675271|NCT01319877|26696090|P1|Overall Study|Withdrawal by Subject|0
7675272|NCT01319877|26696089|P2|Overall Study|Disease Progression|2
7675273|NCT01319877|26696090|P1|Overall Study|Disease Progression|2
7675274|NCT01319877|26696089|P2|Overall Study|Physician Decision|0
7675275|NCT01319877|26696090|P1|Overall Study|Physician Decision|2
7675276|NCT01319877|26696089|P2|Overall Study|Lost to Follow-up|37
7675277|NCT01319877|26696090|P1|Overall Study|Lost to Follow-up|100
7675278|NCT01319721|26696258|P2|Overall Study|Lost to Follow-up|6
7675279|NCT01319721|26696259|P1|Overall Study|Lost to Follow-up|1
7675280|NCT01319422|26696312|P2|Overall Study|Withdrawal by Subject|0
7675281|NCT01319422|26696313|P1|Overall Study|Withdrawal by Subject|1
7675282|NCT01319383|26696331|P2|Overall Study|No in vivo response to interval doses|1
7675283|NCT01319383|26696332|P1|Overall Study|No in vivo response to interval doses|0
7675284|NCT01319383|26696331|P2|Overall Study|Lack of Efficacy|9
7675285|NCT01319383|26696332|P1|Overall Study|Lack of Efficacy|5
7675286|NCT01319383|26696331|P2|Overall Study|Physician Decision|0
7675287|NCT01319383|26696332|P1|Overall Study|Physician Decision|3
7675288|NCT01319383|26696331|P2|Overall Study|No ex vivo or in vivo response|0
7675289|NCT01319383|26696332|P1|Overall Study|No ex vivo or in vivo response|4
7675290|NCT01318993|26696371|P1|Overall Study|Withdrawal by Subject|24
7675291|NCT01318993|26696371|P1|Overall Study|Physician Decision|13
7675292|NCT01318993|26696371|P1|Overall Study|Lost to Follow-up|4
7675293|NCT01318993|26696371|P1|Overall Study|Study closed or terminated|174
7675294|NCT01318993|26696371|P1|Overall Study|Protocol based stopping criteria|6
7675295|NCT01318993|26696371|P1|Overall Study|Protocol Violation|3
7675296|NCT01318993|26696371|P1|Overall Study|Lack of Efficacy|121
7675297|NCT01318993|26696371|P1|Overall Study|Adverse Event|53
7675298|NCT01318915|26696392|P1|Overall Study|Lost to Follow-up|1
7675299|NCT01318902|26696421|P4|Overall Study|Terminated by Sponsor|0
7675300|NCT01318902|26696422|P3|Overall Study|Terminated by Sponsor|1
7675301|NCT01318902|26696423|P2|Overall Study|Terminated by Sponsor|0
7675302|NCT01318902|26696424|P1|Overall Study|Terminated by Sponsor|0
7675303|NCT01318902|26696421|P4|Overall Study|Adverse Event|0
7675304|NCT01318902|26696422|P3|Overall Study|Adverse Event|0
7675305|NCT01318902|26696423|P2|Overall Study|Adverse Event|1
7675306|NCT01318902|26696424|P1|Overall Study|Adverse Event|0
7675307|NCT01318902|26696421|P4|Overall Study|Unsatisfactory Therapeutic Response|1
7675308|NCT01318902|26696422|P3|Overall Study|Unsatisfactory Therapeutic Response|0
7675309|NCT01318902|26696423|P2|Overall Study|Unsatisfactory Therapeutic Response|0
7675310|NCT01318902|26696424|P1|Overall Study|Unsatisfactory Therapeutic Response|1
7675311|NCT01318902|26696421|P4|Overall Study|Withdrawal by Patient|3
7675312|NCT01318902|26696422|P3|Overall Study|Withdrawal by Patient|0
7675313|NCT01318902|26696423|P2|Overall Study|Withdrawal by Patient|1
7675314|NCT01318902|26696424|P1|Overall Study|Withdrawal by Patient|0
7675315|NCT01318902|26696421|P4|Overall Study|Symptomatic Deterioration|2
7675316|NCT01318902|26696422|P3|Overall Study|Symptomatic Deterioration|1
7675317|NCT01318902|26696423|P2|Overall Study|Symptomatic Deterioration|1
7675318|NCT01318902|26696424|P1|Overall Study|Symptomatic Deterioration|0
7675319|NCT01318876|26696501|P1|Day 29 Survey|survey not completed-don't know why|1825
7675320|NCT01318876|26696501|P1|Day 8 Survey|survey not completed-don't know why|1724
7675321|NCT01318876|26696501|P1|Day 8 Survey|email address invalid|96
7675322|NCT01318811|26696508|P2|Overall Study|CRRT stopped for head MRI|1
7675323|NCT01318811|26696509|P1|Overall Study|CRRT stopped for head MRI|0
7675324|NCT01318811|26696508|P2|Overall Study|Death|1
7675325|NCT01318811|26696509|P1|Overall Study|Death|0
7675326|NCT01318811|26696508|P2|Overall Study|CRRT stopped for head CT|1
7675327|NCT01318811|26696509|P1|Overall Study|CRRT stopped for head CT|0
7675328|NCT01318811|26696508|P2|Overall Study|Physician Decision|1
7675329|NCT01318811|26696509|P1|Overall Study|Physician Decision|1
7675330|NCT01318512|26696619|P1|Maintenance Period (6 Months)|Protocol Violation|9
7675331|NCT01318512|26696619|P1|Maintenance Period (6 Months)|Death|2
7675332|NCT01318499|26696638|P3|Overall Study|Other|22
7675333|NCT01318499|26696639|P2|Overall Study|Other|10
7675334|NCT01318499|26696640|P1|Overall Study|Other|7
7675335|NCT01318499|26696638|P3|Overall Study|Patient Did Not Use Study Medication|14
7675336|NCT01318499|26696639|P2|Overall Study|Patient Did Not Use Study Medication|28
7675337|NCT01318499|26696640|P1|Overall Study|Patient Did Not Use Study Medication|18
7675338|NCT01318499|26696638|P3|Overall Study|Protocol Violation|2
7675339|NCT01318499|26696639|P2|Overall Study|Protocol Violation|4
7675340|NCT01318499|26696640|P1|Overall Study|Protocol Violation|2
7675341|NCT01318499|26696638|P3|Overall Study|Treatment Failure|101
7675342|NCT01318499|26696639|P2|Overall Study|Treatment Failure|19
7675343|NCT01318499|26696640|P1|Overall Study|Treatment Failure|19
7675344|NCT01318499|26696638|P3|Overall Study|Noncompliance|0
7675345|NCT01318499|26696639|P2|Overall Study|Noncompliance|3
7675346|NCT01318499|26696640|P1|Overall Study|Noncompliance|2
7675347|NCT01318499|26696638|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
7675348|NCT01318499|26696639|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
7675349|NCT01318499|26696640|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
7675350|NCT01318499|26696638|P3|Overall Study|Adverse Event|6
7675351|NCT01318499|26696639|P2|Overall Study|Adverse Event|11
7675352|NCT01318499|26696640|P1|Overall Study|Adverse Event|16
7675353|NCT01318382|26696663|P1|Overall Study|Protocol Violation|1
7675354|NCT01318382|26696663|P1|Overall Study|Device Malfunction|10
7675355|NCT01318382|26696663|P1|Overall Study|Physician Decision|2
7675356|NCT01318135|26696740|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
7675357|NCT01318135|26696741|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675358|NCT01318135|26696742|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675359|NCT01318135|26696743|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675360|NCT01318135|26696744|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675361|NCT01318135|26696745|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675362|NCT01318135|26696746|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675363|NCT01318135|26696747|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7675364|NCT01318135|26696740|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
7675365|NCT01318135|26696741|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
7675366|NCT01318135|26696742|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
7675367|NCT01318135|26696743|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
7675368|NCT01318135|26696744|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
7675369|NCT01318135|26696745|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
7675370|NCT01318135|26696746|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
7675371|NCT01318135|26696747|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
7675372|NCT01318135|26696740|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7675373|NCT01318135|26696741|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7675374|NCT01318135|26696742|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7675375|NCT01318135|26696743|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7675376|NCT01318135|26696744|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7675377|NCT01318135|26696745|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7675378|NCT01318135|26696746|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7675379|NCT01318135|26696747|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7675380|NCT01318135|26696740|P8|Entered - Long-Term Extension Study|Protocol Violation|0
7675381|NCT01318135|26696741|P7|Entered - Long-Term Extension Study|Protocol Violation|0
7675382|NCT01318135|26696742|P6|Entered - Long-Term Extension Study|Protocol Violation|0
7675383|NCT01318135|26696743|P5|Entered - Long-Term Extension Study|Protocol Violation|1
7675384|NCT01318135|26696744|P4|Entered - Long-Term Extension Study|Protocol Violation|0
7675385|NCT01318135|26696745|P3|Entered - Long-Term Extension Study|Protocol Violation|0
7675386|NCT01318135|26696746|P2|Entered - Long-Term Extension Study|Protocol Violation|1
7675387|NCT01318135|26696747|P1|Entered - Long-Term Extension Study|Protocol Violation|1
7675388|NCT01318135|26696740|P8|Entered - Long-Term Extension Study|Adverse Event|0
7675389|NCT01318135|26696741|P7|Entered - Long-Term Extension Study|Adverse Event|0
7675390|NCT01318135|26696742|P6|Entered - Long-Term Extension Study|Adverse Event|2
7675391|NCT01318135|26696743|P5|Entered - Long-Term Extension Study|Adverse Event|4
7675392|NCT01318135|26696744|P4|Entered - Long-Term Extension Study|Adverse Event|3
7675393|NCT01318135|26696745|P3|Entered - Long-Term Extension Study|Adverse Event|4
7675394|NCT01318135|26696746|P2|Entered - Long-Term Extension Study|Adverse Event|3
7675395|NCT01318135|26696747|P1|Entered - Long-Term Extension Study|Adverse Event|9
7675396|NCT01318135|26696740|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675397|NCT01318135|26696741|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675398|NCT01318135|26696742|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675399|NCT01318135|26696743|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675400|NCT01318135|26696744|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675401|NCT01318135|26696745|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675402|NCT01318135|26696746|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
7675403|NCT01318135|26696747|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
7675404|NCT01318135|26696740|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
7675405|NCT01318135|26696741|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
7675406|NCT01318135|26696742|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
7675407|NCT01318135|26696743|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
7675408|NCT01318135|26696744|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
7675409|NCT01318135|26696745|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
7675410|NCT01318135|26696746|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
7675411|NCT01318135|26696747|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
7675412|NCT01318122|26696879|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
7675413|NCT01318122|26696880|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
7675414|NCT01318122|26696881|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
7675415|NCT01318122|26696882|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
7675416|NCT01318122|26696879|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7675417|NCT01318122|26696880|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7675418|NCT01318122|26696881|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
7675419|NCT01318122|26696882|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7675420|NCT01318122|26696879|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
7675421|NCT01318122|26696880|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
7675422|NCT01318122|26696881|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
7675423|NCT01318122|26696882|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
7675424|NCT01318122|26696879|P4|Entered - Long-Term Extension Study|Adverse Event|4
7675425|NCT01318122|26696880|P3|Entered - Long-Term Extension Study|Adverse Event|2
7675426|NCT01318122|26696881|P2|Entered - Long-Term Extension Study|Adverse Event|6
7675427|NCT01318122|26696882|P1|Entered - Long-Term Extension Study|Adverse Event|6
7675428|NCT01318122|26696879|P4|Enrolled - Long-Term Extension Study|Other|0
7675429|NCT01318122|26696880|P3|Enrolled - Long-Term Extension Study|Other|0
7675430|NCT01318122|26696881|P2|Enrolled - Long-Term Extension Study|Other|0
7675431|NCT01318122|26696882|P1|Enrolled - Long-Term Extension Study|Other|1
7675432|NCT01318122|26696879|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
7675433|NCT01318122|26696880|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
7675434|NCT01318122|26696881|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
7675435|NCT01318122|26696882|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
7675436|NCT01318109|26696951|P3|Overall Study|Schedule Conflict|0
7675437|NCT01318109|26696952|P2|Overall Study|Schedule Conflict|1
7675438|NCT01318109|26696953|P1|Overall Study|Schedule Conflict|0
7675439|NCT01318109|26696951|P3|Overall Study|Withdrawal by Subject|0
7675440|NCT01318109|26696952|P2|Overall Study|Withdrawal by Subject|0
7675441|NCT01318109|26696953|P1|Overall Study|Withdrawal by Subject|1
7675442|NCT01318109|26696951|P3|Overall Study|Adverse Event|0
7675443|NCT01318109|26696952|P2|Overall Study|Adverse Event|2
7675444|NCT01318109|26696953|P1|Overall Study|Adverse Event|0
7675445|NCT01318083|26696988|P3|Overall Study|Lack of Study Medication Compliance|0
7675446|NCT01318083|26696989|P2|Overall Study|Lack of Study Medication Compliance|1
7675447|NCT01318083|26696990|P1|Overall Study|Lack of Study Medication Compliance|0
7675448|NCT01318083|26696988|P3|Overall Study|Treatment Complications|0
7675449|NCT01318083|26696989|P2|Overall Study|Treatment Complications|0
7675450|NCT01318083|26696990|P1|Overall Study|Treatment Complications|1
7675451|NCT01318083|26696988|P3|Overall Study|Lack of Efficacy|1
7675452|NCT01318083|26696989|P2|Overall Study|Lack of Efficacy|0
7675453|NCT01318083|26696990|P1|Overall Study|Lack of Efficacy|0
7675454|NCT01318083|26696988|P3|Overall Study|Withdrawal by Subject|2
7675455|NCT01318083|26696989|P2|Overall Study|Withdrawal by Subject|0
7675456|NCT01318083|26696990|P1|Overall Study|Withdrawal by Subject|1
7675457|NCT01318083|26696988|P3|Overall Study|Adverse Event|2
7675458|NCT01318083|26696989|P2|Overall Study|Adverse Event|1
7675459|NCT01318083|26696990|P1|Overall Study|Adverse Event|4
7675460|NCT01318070|26697025|P3|Overall Study|Principal Investigator Discretion|0
7675461|NCT01318070|26697026|P2|Overall Study|Principal Investigator Discretion|0
7675462|NCT01318070|26697027|P1|Overall Study|Principal Investigator Discretion|1
7675463|NCT01318070|26697025|P3|Overall Study|Lack of Efficacy|1
7675464|NCT01318070|26697026|P2|Overall Study|Lack of Efficacy|0
7675465|NCT01318070|26697027|P1|Overall Study|Lack of Efficacy|0
7675466|NCT01318070|26697025|P3|Overall Study|Withdrawal by Subject|1
7675467|NCT01318070|26697026|P2|Overall Study|Withdrawal by Subject|1
7675468|NCT01318070|26697027|P1|Overall Study|Withdrawal by Subject|0
7675469|NCT01318070|26697025|P3|Overall Study|Adverse Event|5
7675470|NCT01318070|26697026|P2|Overall Study|Adverse Event|1
7675471|NCT01318070|26697027|P1|Overall Study|Adverse Event|1
7675472|NCT01317940|26697074|P6|Overall Study|Change in therapy plan|0
7675473|NCT01317940|26697075|P5|Overall Study|Change in therapy plan|0
7675474|NCT01317940|26697076|P4|Overall Study|Change in therapy plan|0
7675475|NCT01317940|26697077|P3|Overall Study|Change in therapy plan|3
7675476|NCT01317940|26697078|P2|Overall Study|Change in therapy plan|0
7675477|NCT01317940|26697079|P1|Overall Study|Change in therapy plan|0
7675478|NCT01317940|26697074|P6|Overall Study|Lost to Follow-up|0
7675479|NCT01317940|26697075|P5|Overall Study|Lost to Follow-up|1
7675480|NCT01317940|26697076|P4|Overall Study|Lost to Follow-up|1
7675481|NCT01317940|26697077|P3|Overall Study|Lost to Follow-up|1
7675482|NCT01317940|26697078|P2|Overall Study|Lost to Follow-up|0
7675483|NCT01317940|26697079|P1|Overall Study|Lost to Follow-up|0
7675484|NCT01317940|26697074|P6|Overall Study|Death|0
7675485|NCT01317940|26697075|P5|Overall Study|Death|0
7675486|NCT01317940|26697076|P4|Overall Study|Death|0
7675487|NCT01317940|26697077|P3|Overall Study|Death|1
7675488|NCT01317940|26697078|P2|Overall Study|Death|0
7675489|NCT01317940|26697079|P1|Overall Study|Death|1
7675490|NCT01317797|26697110|P3|Overall Study|Withdrawal of Patient|1
7675491|NCT01317797|26697111|P2|Overall Study|Withdrawal of Patient|0
7675492|NCT01317797|26697112|P1|Overall Study|Withdrawal of Patient|0
7675493|NCT01317797|26697110|P3|Overall Study|Other|0
7675494|NCT01317797|26697111|P2|Overall Study|Other|1
7675495|NCT01317797|26697112|P1|Overall Study|Other|0
7675496|NCT01317641|26697189|P9|Overall Study|Withdrawal by Subject|0
7675497|NCT01317641|26697190|P8|Overall Study|Withdrawal by Subject|0
7675498|NCT01317641|26697191|P7|Overall Study|Withdrawal by Subject|1
7675499|NCT01317641|26697192|P6|Overall Study|Withdrawal by Subject|0
7675500|NCT01317641|26697193|P5|Overall Study|Withdrawal by Subject|0
7675501|NCT01317641|26697194|P4|Overall Study|Withdrawal by Subject|0
7675502|NCT01317641|26697195|P3|Overall Study|Withdrawal by Subject|0
7675503|NCT01317641|26697196|P2|Overall Study|Withdrawal by Subject|0
7675504|NCT01317641|26697197|P1|Overall Study|Withdrawal by Subject|0
7675505|NCT01317641|26697189|P9|Overall Study|Disease progression|4
7675506|NCT01317641|26697190|P8|Overall Study|Disease progression|3
7675507|NCT01317641|26697191|P7|Overall Study|Disease progression|0
7675508|NCT01317641|26697192|P6|Overall Study|Disease progression|0
7675509|NCT01317641|26697193|P5|Overall Study|Disease progression|0
7675510|NCT01317641|26697194|P4|Overall Study|Disease progression|0
7675511|NCT01317641|26697195|P3|Overall Study|Disease progression|0
7675512|NCT01317641|26697196|P2|Overall Study|Disease progression|0
7675513|NCT01317641|26697197|P1|Overall Study|Disease progression|0
7675514|NCT01317641|26697189|P9|Overall Study|Protocol Violation|0
7675515|NCT01317641|26697190|P8|Overall Study|Protocol Violation|0
7675516|NCT01317641|26697191|P7|Overall Study|Protocol Violation|0
7675517|NCT01317641|26697192|P6|Overall Study|Protocol Violation|0
7675518|NCT01317641|26697193|P5|Overall Study|Protocol Violation|0
7675519|NCT01317641|26697194|P4|Overall Study|Protocol Violation|0
7675520|NCT01317641|26697195|P3|Overall Study|Protocol Violation|0
7675521|NCT01317641|26697196|P2|Overall Study|Protocol Violation|0
7675522|NCT01317641|26697197|P1|Overall Study|Protocol Violation|1
7675523|NCT01317641|26697189|P9|Overall Study|Adverse Event|0
7675524|NCT01317641|26697190|P8|Overall Study|Adverse Event|1
7675525|NCT01317641|26697191|P7|Overall Study|Adverse Event|2
7675526|NCT01317641|26697192|P6|Overall Study|Adverse Event|0
7675527|NCT01317641|26697193|P5|Overall Study|Adverse Event|0
7675528|NCT01317641|26697194|P4|Overall Study|Adverse Event|1
7675529|NCT01317641|26697195|P3|Overall Study|Adverse Event|0
7675530|NCT01317641|26697196|P2|Overall Study|Adverse Event|1
7675531|NCT01317641|26697197|P1|Overall Study|Adverse Event|0
7675532|NCT01317641|26697189|P9|Overall Study|Not treated|1
7675533|NCT01317641|26697190|P8|Overall Study|Not treated|1
7675534|NCT01317641|26697191|P7|Overall Study|Not treated|0
7675535|NCT01317641|26697192|P6|Overall Study|Not treated|0
7675536|NCT01317641|26697193|P5|Overall Study|Not treated|0
7675537|NCT01317641|26697194|P4|Overall Study|Not treated|0
7675538|NCT01317641|26697195|P3|Overall Study|Not treated|0
7675539|NCT01317641|26697196|P2|Overall Study|Not treated|0
7675540|NCT01317641|26697197|P1|Overall Study|Not treated|0
7675541|NCT01317615|26697299|P1|Overall Study|Adverse Event|7
7675542|NCT01317615|26697299|P1|Overall Study|Abnormal laboratory value(s)|1
7675543|NCT01317615|26697299|P1|Overall Study|Withdrawal by Subject|5
7675544|NCT01317615|26697299|P1|Overall Study|Death|6
7675545|NCT01317615|26697299|P1|Overall Study|New cancer therapy|5
7675546|NCT01317615|26697299|P1|Overall Study|Disease progression|25
7675547|NCT01317550|26697312|P4|Overall Study|Lack of compliance study med|0
7675548|NCT01317550|26697313|P3|Overall Study|Lack of compliance study med|0
7675549|NCT01317550|26697314|P2|Overall Study|Lack of compliance study med|0
7675550|NCT01317550|26697315|P1|Overall Study|Lack of compliance study med|1
7675551|NCT01317550|26697312|P4|Overall Study|Withdrawal by Subject|0
7675552|NCT01317550|26697313|P3|Overall Study|Withdrawal by Subject|0
7675553|NCT01317550|26697314|P2|Overall Study|Withdrawal by Subject|0
7675554|NCT01317550|26697315|P1|Overall Study|Withdrawal by Subject|1
7675555|NCT01317472|26697327|P2|Overall Study|Unrelated hospitalization|0
7675556|NCT01317472|26697328|P1|Overall Study|Unrelated hospitalization|1
7675557|NCT01317472|26697327|P2|Overall Study|Withdrawal by Subject|0
7675558|NCT01317472|26697328|P1|Overall Study|Withdrawal by Subject|1
7675559|NCT01317277|26697336|P2|Overall Study|Adverse Event|0
7675560|NCT01317277|26697337|P1|Overall Study|Adverse Event|1
7675561|NCT01317277|26697336|P2|Overall Study|Withdrawal by Subject|0
7675562|NCT01317277|26697337|P1|Overall Study|Withdrawal by Subject|1
7675563|NCT01317277|26697336|P2|Overall Study|Unable to comply with intervention|0
7675564|NCT01317277|26697337|P1|Overall Study|Unable to comply with intervention|1
7675565|NCT01317277|26697336|P2|Overall Study|Lost MEMS|1
7675566|NCT01317277|26697337|P1|Overall Study|Lost MEMS|1
7675567|NCT01317277|26697336|P2|Overall Study|Lost to Follow-up|1
7675568|NCT01317277|26697337|P1|Overall Study|Lost to Follow-up|3
7675569|NCT01317199|26697351|P4|Randomized Phase 2|Patient transferred to other facility|0
7675570|NCT01317199|26697352|P3|Randomized Phase 2|Patient transferred to other facility|1
7675571|NCT01317199|26697353|P2|Randomized Phase 2|Patient transferred to other facility|0
7675572|NCT01317199|26697354|P1|Randomized Phase 2|Patient transferred to other facility|0
7675573|NCT01317199|26697351|P4|Randomized Phase 2|Patient stopped taking study drug|1
7675574|NCT01317199|26697352|P3|Randomized Phase 2|Patient stopped taking study drug|0
7675575|NCT01317199|26697353|P2|Randomized Phase 2|Patient stopped taking study drug|0
7675576|NCT01317199|26697354|P1|Randomized Phase 2|Patient stopped taking study drug|0
7675577|NCT01317199|26697351|P4|Randomized Phase 2|Disenrolled before treatment|2
7675578|NCT01317199|26697352|P3|Randomized Phase 2|Disenrolled before treatment|1
7675579|NCT01317199|26697353|P2|Randomized Phase 2|Disenrolled before treatment|1
7675580|NCT01317199|26697354|P1|Randomized Phase 2|Disenrolled before treatment|0
7675581|NCT01317199|26697351|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
7675582|NCT01317199|26697352|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
7675583|NCT01317199|26697353|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
7675584|NCT01317199|26697354|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
7675585|NCT01317199|26697351|P4|Randomized Phase 2|Comorbidities|2
7675586|NCT01317199|26697352|P3|Randomized Phase 2|Comorbidities|2
7675587|NCT01317199|26697353|P2|Randomized Phase 2|Comorbidities|2
7675588|NCT01317199|26697354|P1|Randomized Phase 2|Comorbidities|0
7675589|NCT01317199|26697351|P4|Randomized Phase 2|Adverse Event|1
7675590|NCT01317199|26697352|P3|Randomized Phase 2|Adverse Event|0
7675591|NCT01317199|26697353|P2|Randomized Phase 2|Adverse Event|0
7675592|NCT01317199|26697354|P1|Randomized Phase 2|Adverse Event|0
7675593|NCT01317199|26697351|P4|Randomized Phase 2|Withdrawal by Subject|4
7675594|NCT01317199|26697352|P3|Randomized Phase 2|Withdrawal by Subject|5
7675595|NCT01317199|26697353|P2|Randomized Phase 2|Withdrawal by Subject|3
7675596|NCT01317199|26697354|P1|Randomized Phase 2|Withdrawal by Subject|0
7675597|NCT01317199|26697351|P4|Randomized Phase 2|Disease progression|5
7675598|NCT01317199|26697352|P3|Randomized Phase 2|Disease progression|7
7675599|NCT01317199|26697353|P2|Randomized Phase 2|Disease progression|3
7675600|NCT01317199|26697354|P1|Randomized Phase 2|Disease progression|0
7675601|NCT01317199|26697351|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7675602|NCT01317199|26697352|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7675603|NCT01317199|26697353|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7675604|NCT01317199|26697354|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
7675605|NCT01317199|26697351|P4|Dose-escalation Phase 1|Disease progression|0
7675606|NCT01317199|26697352|P3|Dose-escalation Phase 1|Disease progression|0
7675607|NCT01317199|26697353|P2|Dose-escalation Phase 1|Disease progression|0
7675608|NCT01317199|26697354|P1|Dose-escalation Phase 1|Disease progression|1
7675609|NCT01317199|26697351|P4|Dose-escalation Phase 1|Physician Decision|0
7675610|NCT01317199|26697352|P3|Dose-escalation Phase 1|Physician Decision|0
7675611|NCT01317199|26697353|P2|Dose-escalation Phase 1|Physician Decision|0
7675612|NCT01317199|26697354|P1|Dose-escalation Phase 1|Physician Decision|5
7675613|NCT01317160|26697383|P2|Overall Study|Withdrawal by Subject|2
7675614|NCT01317160|26697384|P1|Overall Study|Withdrawal by Subject|0
7675615|NCT01317160|26697383|P2|Overall Study|Lost to Follow-up|3
7675616|NCT01317160|26697384|P1|Overall Study|Lost to Follow-up|3
7675617|NCT01317160|26697383|P2|Overall Study|Incorrect inclusion|1
7675618|NCT01317160|26697384|P1|Overall Study|Incorrect inclusion|1
7675619|NCT01317004|26697426|P2|Overall Study|Adverse Event|3
7675620|NCT01317004|26697427|P1|Overall Study|Adverse Event|3
7675621|NCT01317004|26697426|P2|Overall Study|Protocol Violation|2
7675622|NCT01317004|26697427|P1|Overall Study|Protocol Violation|0
7675623|NCT01317004|26697426|P2|Overall Study|Withdrawal by Subject|4
7675624|NCT01317004|26697427|P1|Overall Study|Withdrawal by Subject|1
7675625|NCT01316939|26697448|P3|Overall Study|Protocol Violation|0
7675626|NCT01316939|26697449|P2|Overall Study|Protocol Violation|1
7675627|NCT01316939|26697450|P1|Overall Study|Protocol Violation|0
7675628|NCT01316939|26697448|P3|Overall Study|Met Liver chemistry stopping criteria|1
7675629|NCT01316939|26697449|P2|Overall Study|Met Liver chemistry stopping criteria|0
7675630|NCT01316939|26697450|P1|Overall Study|Met Liver chemistry stopping criteria|1
7675631|NCT01316939|26697448|P3|Overall Study|Lost to Follow-up|2
7675632|NCT01316939|26697449|P2|Overall Study|Lost to Follow-up|0
7675633|NCT01316939|26697450|P1|Overall Study|Lost to Follow-up|0
7675634|NCT01316939|26697448|P3|Overall Study|Physician Decision|1
7675635|NCT01316939|26697449|P2|Overall Study|Physician Decision|2
7675636|NCT01316939|26697450|P1|Overall Study|Physician Decision|2
7675637|NCT01316939|26697448|P3|Overall Study|Withdrawal by Subject|6
7675638|NCT01316939|26697449|P2|Overall Study|Withdrawal by Subject|3
7675639|NCT01316939|26697450|P1|Overall Study|Withdrawal by Subject|1
7675640|NCT01316939|26697448|P3|Overall Study|Adverse Event|11
7675641|NCT01316939|26697449|P2|Overall Study|Adverse Event|12
7675642|NCT01316939|26697450|P1|Overall Study|Adverse Event|9
7675643|NCT01316939|26697448|P3|Overall Study|Lack of Efficacy|25
7675644|NCT01316939|26697449|P2|Overall Study|Lack of Efficacy|25
7675645|NCT01316939|26697450|P1|Overall Study|Lack of Efficacy|24
7675646|NCT01316939|26697448|P3|Overall Study|Study closed/terminated|23
7675647|NCT01316939|26697449|P2|Overall Study|Study closed/terminated|25
7675648|NCT01316939|26697450|P1|Overall Study|Study closed/terminated|26
7675649|NCT01316913|26697545|P4|Overall Study|Withdrawal by Subject|6
7675650|NCT01316913|26697546|P3|Overall Study|Withdrawal by Subject|10
7675651|NCT01316913|26697547|P2|Overall Study|Withdrawal by Subject|9
7675652|NCT01316913|26697548|P1|Overall Study|Withdrawal by Subject|10
7675653|NCT01316913|26697545|P4|Overall Study|Lost to Follow-up|2
7675654|NCT01316913|26697546|P3|Overall Study|Lost to Follow-up|0
7675655|NCT01316913|26697547|P2|Overall Study|Lost to Follow-up|1
7675656|NCT01316913|26697548|P1|Overall Study|Lost to Follow-up|0
7675657|NCT01316913|26697545|P4|Overall Study|Protocol-defined Stopping Criteria|6
7675658|NCT01316913|26697546|P3|Overall Study|Protocol-defined Stopping Criteria|11
7675659|NCT01316913|26697547|P2|Overall Study|Protocol-defined Stopping Criteria|8
7675660|NCT01316913|26697548|P1|Overall Study|Protocol-defined Stopping Criteria|7
7675661|NCT01316913|26697545|P4|Overall Study|Protocol Violation|1
7675662|NCT01316913|26697546|P3|Overall Study|Protocol Violation|4
7675663|NCT01316913|26697547|P2|Overall Study|Protocol Violation|4
7675664|NCT01316913|26697548|P1|Overall Study|Protocol Violation|1
7675665|NCT01316913|26697545|P4|Overall Study|Lack of Efficacy|13
7675666|NCT01316913|26697546|P3|Overall Study|Lack of Efficacy|9
7675667|NCT01316913|26697547|P2|Overall Study|Lack of Efficacy|12
7675668|NCT01316913|26697548|P1|Overall Study|Lack of Efficacy|22
7675669|NCT01316913|26697545|P4|Overall Study|Adverse Event|11
7675670|NCT01316913|26697546|P3|Overall Study|Adverse Event|15
7675671|NCT01316913|26697547|P2|Overall Study|Adverse Event|20
7675672|NCT01316913|26697548|P1|Overall Study|Adverse Event|17
7675673|NCT01316900|26697570|P4|Overall Study|Withdrawal by Subject|9
7675674|NCT01316900|26697571|P3|Overall Study|Withdrawal by Subject|6
7675675|NCT01316900|26697572|P2|Overall Study|Withdrawal by Subject|8
7675676|NCT01316900|26697573|P1|Overall Study|Withdrawal by Subject|7
7675677|NCT01316900|26697570|P4|Overall Study|Lost to Follow-up|1
7675678|NCT01316900|26697571|P3|Overall Study|Lost to Follow-up|1
7675679|NCT01316900|26697572|P2|Overall Study|Lost to Follow-up|0
7675680|NCT01316900|26697573|P1|Overall Study|Lost to Follow-up|1
7675681|NCT01316900|26697570|P4|Overall Study|Protocol-defined Stopping Criteria|5
7675682|NCT01316900|26697571|P3|Overall Study|Protocol-defined Stopping Criteria|10
7675683|NCT01316900|26697572|P2|Overall Study|Protocol-defined Stopping Criteria|3
7675684|NCT01316900|26697573|P1|Overall Study|Protocol-defined Stopping Criteria|2
7675685|NCT01316900|26697570|P4|Overall Study|Protocol Violation|0
7675686|NCT01316900|26697571|P3|Overall Study|Protocol Violation|4
7675687|NCT01316900|26697572|P2|Overall Study|Protocol Violation|1
7675688|NCT01316900|26697573|P1|Overall Study|Protocol Violation|7
7675689|NCT01316900|26697570|P4|Overall Study|Lack of Efficacy|7
7675690|NCT01316900|26697571|P3|Overall Study|Lack of Efficacy|5
7675691|NCT01316900|26697572|P2|Overall Study|Lack of Efficacy|9
7675692|NCT01316900|26697573|P1|Overall Study|Lack of Efficacy|17
7675693|NCT01316900|26697570|P4|Overall Study|Adverse Event|9
7675694|NCT01316900|26697571|P3|Overall Study|Adverse Event|15
7675695|NCT01316900|26697572|P2|Overall Study|Adverse Event|10
7675696|NCT01316900|26697573|P1|Overall Study|Adverse Event|10
7675697|NCT01316887|26697594|P3|Overall Study|Withdrawal by Subject|15
7675698|NCT01316887|26697595|P2|Overall Study|Withdrawal by Subject|16
7675699|NCT01316887|26697596|P1|Overall Study|Withdrawal by Subject|8
7675700|NCT01316887|26697594|P3|Overall Study|Lost to Follow-up|5
7675701|NCT01316887|26697595|P2|Overall Study|Lost to Follow-up|7
7675702|NCT01316887|26697596|P1|Overall Study|Lost to Follow-up|1
7675703|NCT01316887|26697594|P3|Overall Study|Study Closed/Terminated|3
7675704|NCT01316887|26697595|P2|Overall Study|Study Closed/Terminated|4
7675705|NCT01316887|26697596|P1|Overall Study|Study Closed/Terminated|2
7675706|NCT01316887|26697594|P3|Overall Study|Protocol-defined Stopping Criteria|36
7675707|NCT01316887|26697595|P2|Overall Study|Protocol-defined Stopping Criteria|37
7675708|NCT01316887|26697596|P1|Overall Study|Protocol-defined Stopping Criteria|8
7675709|NCT01316887|26697594|P3|Overall Study|Protocol Violation|6
7675710|NCT01316887|26697595|P2|Overall Study|Protocol Violation|6
7675711|NCT01316887|26697596|P1|Overall Study|Protocol Violation|2
7675712|NCT01316887|26697594|P3|Overall Study|Lack of Efficacy|1
7675713|NCT01316887|26697595|P2|Overall Study|Lack of Efficacy|3
7675714|NCT01316887|26697596|P1|Overall Study|Lack of Efficacy|9
7675715|NCT01316887|26697594|P3|Overall Study|Adverse Event|17
7675716|NCT01316887|26697595|P2|Overall Study|Adverse Event|21
7675717|NCT01316887|26697596|P1|Overall Study|Adverse Event|13
7675718|NCT01316692|26697721|P1|Overall Study|Disease Progression|7
7675719|NCT01316692|26697721|P1|Overall Study|Adverse Event|5
7675720|NCT01316614|26697730|P1|Overall Study|Medically unstable|1
7675721|NCT01316614|26697730|P1|Overall Study|Inadequate number of passes|2
7675722|NCT01316614|26697730|P1|Overall Study|Cystic lesion|5
7675723|NCT01316614|26697730|P1|Overall Study|Cytology slides not available for review|4
7675724|NCT01316614|26697730|P1|Overall Study|No solid lesion and FNA not indicated|25
7675725|NCT01316575|26697747|P2|Overall Study|Required alternate treatment|1
7675726|NCT01316575|26697748|P1|Overall Study|Required alternate treatment|0
7675727|NCT01316575|26697747|P2|Overall Study|Withdrawal by Subject|0
7675728|NCT01316575|26697748|P1|Overall Study|Withdrawal by Subject|2
7675729|NCT01316419|26697771|P1|Overall Study|Lost to Follow-up|19
7675730|NCT01316419|26697771|P1|Overall Study|Violated inclusion/exclusion criterion|143
7675731|NCT01316419|26697771|P1|Overall Study|Not treated|103
7675732|NCT01316380|26697797|P3|Overall Study|Not treated|0
7675733|NCT01316380|26697798|P2|Overall Study|Not treated|0
7675734|NCT01316380|26697799|P1|Overall Study|Not treated|1
7675735|NCT01316380|26697797|P3|Overall Study|Other|1
7675736|NCT01316380|26697798|P2|Overall Study|Other|1
7675737|NCT01316380|26697799|P1|Overall Study|Other|0
7675738|NCT01316380|26697797|P3|Overall Study|Withdrawal by Subject|0
7675739|NCT01316380|26697798|P2|Overall Study|Withdrawal by Subject|2
7675740|NCT01316380|26697799|P1|Overall Study|Withdrawal by Subject|1
7675741|NCT01316380|26697797|P3|Overall Study|Protocol Violation|1
7675742|NCT01316380|26697798|P2|Overall Study|Protocol Violation|0
7675743|NCT01316380|26697799|P1|Overall Study|Protocol Violation|0
7675744|NCT01316380|26697797|P3|Overall Study|Adverse Event|1
7675745|NCT01316380|26697798|P2|Overall Study|Adverse Event|2
7675746|NCT01316380|26697799|P1|Overall Study|Adverse Event|0
7675747|NCT01316276|26697936|P1|Overall Study|Other|22
7675748|NCT01316276|26697936|P1|Overall Study|Lost to Follow-up|1
7675749|NCT01316276|26697936|P1|Overall Study|Withdrawal of consent|24
7675750|NCT01316276|26697936|P1|Overall Study|Adverse Event|19
7675751|NCT01316276|26697936|P1|Overall Study|Death|1
7675752|NCT01316224|26697984|P1|Overall Study|Other|1
7675753|NCT01316224|26697984|P1|Overall Study|Adverse Event With Treatment Failure|1
7675754|NCT01316224|26697984|P1|Overall Study|Withdrawal by Subject|1
7675755|NCT01316224|26697984|P1|Overall Study|Lack of Efficacy|1
7675756|NCT01316224|26697984|P1|Overall Study|Adverse Event|3
7675757|NCT01316224|26697984|P1|Overall Study|Protocol Violation|3
7675758|NCT01316055|26698037|P3|Overall Study|Lost to Follow-up|0
7675759|NCT01316055|26698038|P2|Overall Study|Lost to Follow-up|0
7675760|NCT01316055|26698039|P1|Overall Study|Lost to Follow-up|1
7675761|NCT01315847|26698070|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
7675762|NCT01315847|26698071|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
7675763|NCT01315847|26698070|P2|Part I, Period 1|Reached maximum number of arterial lines|0
7675764|NCT01315847|26698071|P1|Part I, Period 1|Reached maximum number of arterial lines|3
7675765|NCT01315678|26698085|P2|Overall Study|similar reason to those listed above|2
7675766|NCT01315678|26698086|P1|Overall Study|similar reason to those listed above|3
7675767|NCT01315678|26698085|P2|Overall Study|Lost to Follow-up|0
7675768|NCT01315678|26698086|P1|Overall Study|Lost to Follow-up|1
7675769|NCT01315678|26698085|P2|Overall Study|Adverse Event|1
7675770|NCT01315678|26698086|P1|Overall Study|Adverse Event|3
7675771|NCT01315678|26698085|P2|Overall Study|Withdrawal by Subject|3
7675772|NCT01315678|26698086|P1|Overall Study|Withdrawal by Subject|7
7675773|NCT01315353|26698137|P3|Overall Study|Inadvertent randomization/assignment|2
7675774|NCT01315353|26698138|P2|Overall Study|Inadvertent randomization/assignment|0
7675775|NCT01315353|26698139|P1|Overall Study|Inadvertent randomization/assignment|0
7675776|NCT01315353|26698137|P3|Overall Study|Taken off study by site in error|0
7675777|NCT01315353|26698138|P2|Overall Study|Taken off study by site in error|1
7675778|NCT01315353|26698139|P1|Overall Study|Taken off study by site in error|0
7675779|NCT01315353|26698137|P3|Overall Study|Site closing|0
7675780|NCT01315353|26698138|P2|Overall Study|Site closing|4
7675781|NCT01315353|26698139|P1|Overall Study|Site closing|7
7675782|NCT01315353|26698137|P3|Overall Study|Unwilling to adhere to requirements|4
7675783|NCT01315353|26698138|P2|Overall Study|Unwilling to adhere to requirements|5
7675784|NCT01315353|26698139|P1|Overall Study|Unwilling to adhere to requirements|5
7675785|NCT01315353|26698137|P3|Overall Study|Lost to Follow-up|6
7675786|NCT01315353|26698138|P2|Overall Study|Lost to Follow-up|6
7675787|NCT01315353|26698139|P1|Overall Study|Lost to Follow-up|13
7675788|NCT01315353|26698137|P3|Overall Study|Withdrawal by Subject|1
7675789|NCT01315353|26698138|P2|Overall Study|Withdrawal by Subject|6
7675790|NCT01315353|26698139|P1|Overall Study|Withdrawal by Subject|2
7675791|NCT01315353|26698137|P3|Overall Study|Death|0
7675792|NCT01315353|26698138|P2|Overall Study|Death|1
7675793|NCT01315353|26698139|P1|Overall Study|Death|2
7675794|NCT01315249|26698166|P2|Overall Study|Death|1
7675795|NCT01315249|26698167|P1|Overall Study|Death|0
7675796|NCT01315249|26698166|P2|Overall Study|Lost to Follow-up|2
7675797|NCT01315249|26698167|P1|Overall Study|Lost to Follow-up|0
7675798|NCT01315249|26698166|P2|Overall Study|Lack of Efficacy|1
7675799|NCT01315249|26698167|P1|Overall Study|Lack of Efficacy|0
7675800|NCT01315249|26698166|P2|Overall Study|inability to use device|0
7675801|NCT01315249|26698167|P1|Overall Study|inability to use device|1
7675802|NCT01315249|26698166|P2|Overall Study|Administrative problems|0
7675803|NCT01315249|26698167|P1|Overall Study|Administrative problems|1
7675804|NCT01315249|26698166|P2|Overall Study|Abnormal test results|2
7675805|NCT01315249|26698167|P1|Overall Study|Abnormal test results|1
7675806|NCT01315249|26698166|P2|Overall Study|Protocol Violation|5
7675807|NCT01315249|26698167|P1|Overall Study|Protocol Violation|8
7675808|NCT01315249|26698166|P2|Overall Study|Withdrawal by Subject|10
7675809|NCT01315249|26698167|P1|Overall Study|Withdrawal by Subject|11
7675810|NCT01315249|26698166|P2|Overall Study|Adverse Event|26
7675811|NCT01315249|26698167|P1|Overall Study|Adverse Event|22
7675812|NCT01315236|26698195|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
7675813|NCT01315236|26698196|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
7675814|NCT01315236|26698195|P2|12-Month Follow-up Period|Death|1
7675815|NCT01315236|26698196|P1|12-Month Follow-up Period|Death|0
7675816|NCT01315236|26698195|P2|Open-label Phase|Other|1
7675817|NCT01315236|26698196|P1|Open-label Phase|Other|0
7675818|NCT01315236|26698195|P2|Open-label Phase|Adverse Event|1
7675819|NCT01315236|26698196|P1|Open-label Phase|Adverse Event|0
7675820|NCT01315236|26698195|P2|Open-label Phase|Death|0
7675821|NCT01315236|26698196|P1|Open-label Phase|Death|1
7675822|NCT01315236|26698195|P2|Double-blind Phase|Lost to Follow-up|0
7675823|NCT01315236|26698196|P1|Double-blind Phase|Lost to Follow-up|1
7675824|NCT01315236|26698195|P2|Double-blind Phase|Withdrawal of Consent|0
7675825|NCT01315236|26698196|P1|Double-blind Phase|Withdrawal of Consent|1
7675826|NCT01315236|26698195|P2|Double-blind Phase|Adverse Event|0
7675827|NCT01315236|26698196|P1|Double-blind Phase|Adverse Event|1
7675828|NCT01315236|26698195|P2|Double-blind Phase|Death|0
7675829|NCT01315236|26698196|P1|Double-blind Phase|Death|1
7675830|NCT01315132|26698252|P1|Overall Study|not treated due to disease progression|1
7675831|NCT01315028|26698259|P2|Overall Study|Death|1
7675832|NCT01315028|26698260|P1|Overall Study|Death|0
7675833|NCT01315028|26698259|P2|Overall Study|Lost to Follow-up|0
7675834|NCT01315028|26698260|P1|Overall Study|Lost to Follow-up|1
7675835|NCT01314911|26698287|P2|Overall Study|Never Started Treatment|0
7675836|NCT01314911|26698288|P1|Overall Study|Never Started Treatment|1
7675837|NCT01314911|26698287|P2|Overall Study|Received Non-randomized Study Drug|1
7675838|NCT01314911|26698288|P1|Overall Study|Received Non-randomized Study Drug|0
7675839|NCT01314911|26698287|P2|Overall Study|Withdrawal by Subject|3
7675840|NCT01314911|26698288|P1|Overall Study|Withdrawal by Subject|1
7675841|NCT01314911|26698287|P2|Overall Study|Lost to Follow-up|2
7675842|NCT01314911|26698288|P1|Overall Study|Lost to Follow-up|3
7675843|NCT01314872|26698339|P15|Period 2|Lost to Follow-up|6
7675844|NCT01314872|26698340|P14|Period 2|Lost to Follow-up|2
7675845|NCT01314872|26698341|P13|Period 2|Lost to Follow-up|7
7675846|NCT01314872|26698342|P12|Period 2|Lost to Follow-up|6
7675847|NCT01314872|26698343|P11|Period 2|Lost to Follow-up|0
7675848|NCT01314872|26698344|P10|Period 2|Lost to Follow-up|0
7675849|NCT01314872|26698345|P9|Period 2|Lost to Follow-up|0
7675850|NCT01314872|26698346|P8|Period 2|Lost to Follow-up|0
7675851|NCT01314872|26698347|P7|Period 2|Lost to Follow-up|0
7675852|NCT01314872|26698348|P6|Period 2|Lost to Follow-up|0
7675853|NCT01314872|26698349|P5|Period 2|Lost to Follow-up|0
7675854|NCT01314872|26698350|P4|Period 2|Lost to Follow-up|0
7675855|NCT01314872|26698351|P3|Period 2|Lost to Follow-up|0
7675856|NCT01314872|26698352|P2|Period 2|Lost to Follow-up|0
7675857|NCT01314872|26698353|P1|Period 2|Lost to Follow-up|0
7675858|NCT01314872|26698339|P15|Period 2|Withdrawal by Subject|4
7675859|NCT01314872|26698340|P14|Period 2|Withdrawal by Subject|12
7675860|NCT01314872|26698341|P13|Period 2|Withdrawal by Subject|17
7675861|NCT01314872|26698342|P12|Period 2|Withdrawal by Subject|14
7675862|NCT01314872|26698343|P11|Period 2|Withdrawal by Subject|0
7675863|NCT01314872|26698344|P10|Period 2|Withdrawal by Subject|0
7675864|NCT01314872|26698345|P9|Period 2|Withdrawal by Subject|0
7675865|NCT01314872|26698346|P8|Period 2|Withdrawal by Subject|0
7675866|NCT01314872|26698347|P7|Period 2|Withdrawal by Subject|0
7675867|NCT01314872|26698348|P6|Period 2|Withdrawal by Subject|0
7675868|NCT01314872|26698349|P5|Period 2|Withdrawal by Subject|0
7675869|NCT01314872|26698350|P4|Period 2|Withdrawal by Subject|0
7675870|NCT01314872|26698351|P3|Period 2|Withdrawal by Subject|0
7675871|NCT01314872|26698352|P2|Period 2|Withdrawal by Subject|0
7675872|NCT01314872|26698353|P1|Period 2|Withdrawal by Subject|0
7675873|NCT01314872|26698339|P15|Period 2|Adverse event, non-fatal|9
7675874|NCT01314872|26698340|P14|Period 2|Adverse event, non-fatal|24
7675875|NCT01314872|26698341|P13|Period 2|Adverse event, non-fatal|16
7675876|NCT01314872|26698342|P12|Period 2|Adverse event, non-fatal|13
7675877|NCT01314872|26698343|P11|Period 2|Adverse event, non-fatal|0
7675878|NCT01314872|26698344|P10|Period 2|Adverse event, non-fatal|0
7675879|NCT01314872|26698345|P9|Period 2|Adverse event, non-fatal|0
7675880|NCT01314872|26698346|P8|Period 2|Adverse event, non-fatal|0
7675881|NCT01314872|26698347|P7|Period 2|Adverse event, non-fatal|0
7675882|NCT01314872|26698348|P6|Period 2|Adverse event, non-fatal|0
7675883|NCT01314872|26698349|P5|Period 2|Adverse event, non-fatal|0
7675884|NCT01314872|26698350|P4|Period 2|Adverse event, non-fatal|0
7675885|NCT01314872|26698351|P3|Period 2|Adverse event, non-fatal|0
7675886|NCT01314872|26698352|P2|Period 2|Adverse event, non-fatal|0
7675887|NCT01314872|26698353|P1|Period 2|Adverse event, non-fatal|0
7675888|NCT01314872|26698339|P15|Period 2|Study terminated by Sponsor|0
7675889|NCT01314872|26698340|P14|Period 2|Study terminated by Sponsor|3
7675890|NCT01314872|26698341|P13|Period 2|Study terminated by Sponsor|2
7675891|NCT01314872|26698342|P12|Period 2|Study terminated by Sponsor|2
7675892|NCT01314872|26698343|P11|Period 2|Study terminated by Sponsor|0
7675893|NCT01314872|26698344|P10|Period 2|Study terminated by Sponsor|0
7675894|NCT01314872|26698345|P9|Period 2|Study terminated by Sponsor|0
7675895|NCT01314872|26698346|P8|Period 2|Study terminated by Sponsor|0
7675896|NCT01314872|26698347|P7|Period 2|Study terminated by Sponsor|0
7675897|NCT01314872|26698348|P6|Period 2|Study terminated by Sponsor|0
7675898|NCT01314872|26698349|P5|Period 2|Study terminated by Sponsor|0
7675899|NCT01314872|26698350|P4|Period 2|Study terminated by Sponsor|0
7675900|NCT01314872|26698351|P3|Period 2|Study terminated by Sponsor|0
7675901|NCT01314872|26698352|P2|Period 2|Study terminated by Sponsor|0
7675902|NCT01314872|26698353|P1|Period 2|Study terminated by Sponsor|0
7675903|NCT01314872|26698339|P15|Period 2|Pregnancy|1
7675904|NCT01314872|26698340|P14|Period 2|Pregnancy|0
7675905|NCT01314872|26698341|P13|Period 2|Pregnancy|0
7675906|NCT01314872|26698342|P12|Period 2|Pregnancy|0
7675907|NCT01314872|26698343|P11|Period 2|Pregnancy|0
7675908|NCT01314872|26698344|P10|Period 2|Pregnancy|0
7675909|NCT01314872|26698345|P9|Period 2|Pregnancy|0
7675910|NCT01314872|26698346|P8|Period 2|Pregnancy|0
7675911|NCT01314872|26698347|P7|Period 2|Pregnancy|0
7675912|NCT01314872|26698348|P6|Period 2|Pregnancy|0
7675913|NCT01314872|26698349|P5|Period 2|Pregnancy|0
7675914|NCT01314872|26698350|P4|Period 2|Pregnancy|0
7675915|NCT01314872|26698351|P3|Period 2|Pregnancy|0
7675916|NCT01314872|26698352|P2|Period 2|Pregnancy|0
7675917|NCT01314872|26698353|P1|Period 2|Pregnancy|0
7675918|NCT01314872|26698339|P15|Period 2|Lack of Efficacy|2
7675919|NCT01314872|26698340|P14|Period 2|Lack of Efficacy|9
7675920|NCT01314872|26698341|P13|Period 2|Lack of Efficacy|12
7675921|NCT01314872|26698342|P12|Period 2|Lack of Efficacy|7
7675922|NCT01314872|26698343|P11|Period 2|Lack of Efficacy|0
7675923|NCT01314872|26698344|P10|Period 2|Lack of Efficacy|0
7675924|NCT01314872|26698345|P9|Period 2|Lack of Efficacy|0
7675925|NCT01314872|26698346|P8|Period 2|Lack of Efficacy|0
7675926|NCT01314872|26698347|P7|Period 2|Lack of Efficacy|0
7675927|NCT01314872|26698348|P6|Period 2|Lack of Efficacy|0
7675928|NCT01314872|26698349|P5|Period 2|Lack of Efficacy|0
7675929|NCT01314872|26698350|P4|Period 2|Lack of Efficacy|0
7675930|NCT01314872|26698351|P3|Period 2|Lack of Efficacy|0
7675931|NCT01314872|26698352|P2|Period 2|Lack of Efficacy|0
7675932|NCT01314872|26698353|P1|Period 2|Lack of Efficacy|0
7675933|NCT01314872|26698339|P15|Period 2|Non-compliance with study drug|2
7675934|NCT01314872|26698340|P14|Period 2|Non-compliance with study drug|1
7675935|NCT01314872|26698341|P13|Period 2|Non-compliance with study drug|3
7675936|NCT01314872|26698342|P12|Period 2|Non-compliance with study drug|3
7675937|NCT01314872|26698343|P11|Period 2|Non-compliance with study drug|0
7675938|NCT01314872|26698344|P10|Period 2|Non-compliance with study drug|0
7675939|NCT01314872|26698345|P9|Period 2|Non-compliance with study drug|0
7675940|NCT01314872|26698346|P8|Period 2|Non-compliance with study drug|0
7675941|NCT01314872|26698347|P7|Period 2|Non-compliance with study drug|0
7675942|NCT01314872|26698348|P6|Period 2|Non-compliance with study drug|0
7675943|NCT01314872|26698349|P5|Period 2|Non-compliance with study drug|0
7675944|NCT01314872|26698350|P4|Period 2|Non-compliance with study drug|0
7675945|NCT01314872|26698351|P3|Period 2|Non-compliance with study drug|0
7675946|NCT01314872|26698352|P2|Period 2|Non-compliance with study drug|0
7675947|NCT01314872|26698353|P1|Period 2|Non-compliance with study drug|0
7675948|NCT01314872|26698339|P15|Period 2|Protocol Violation|0
7675949|NCT01314872|26698340|P14|Period 2|Protocol Violation|2
7675950|NCT01314872|26698341|P13|Period 2|Protocol Violation|3
7675951|NCT01314872|26698342|P12|Period 2|Protocol Violation|3
7675952|NCT01314872|26698343|P11|Period 2|Protocol Violation|0
7675953|NCT01314872|26698344|P10|Period 2|Protocol Violation|0
7675954|NCT01314872|26698345|P9|Period 2|Protocol Violation|0
7675955|NCT01314872|26698346|P8|Period 2|Protocol Violation|0
7675956|NCT01314872|26698347|P7|Period 2|Protocol Violation|0
7675957|NCT01314872|26698348|P6|Period 2|Protocol Violation|0
7675958|NCT01314872|26698349|P5|Period 2|Protocol Violation|0
7675959|NCT01314872|26698350|P4|Period 2|Protocol Violation|0
7675960|NCT01314872|26698351|P3|Period 2|Protocol Violation|0
7675961|NCT01314872|26698352|P2|Period 2|Protocol Violation|0
7675962|NCT01314872|26698353|P1|Period 2|Protocol Violation|0
7675963|NCT01314872|26698339|P15|Treatment Period 1|Lost to Follow-up|0
7675964|NCT01314872|26698340|P14|Treatment Period 1|Lost to Follow-up|0
7675965|NCT01314872|26698341|P13|Treatment Period 1|Lost to Follow-up|0
7675966|NCT01314872|26698342|P12|Treatment Period 1|Lost to Follow-up|0
7675967|NCT01314872|26698343|P11|Treatment Period 1|Lost to Follow-up|0
7675968|NCT01314872|26698344|P10|Treatment Period 1|Lost to Follow-up|0
7675969|NCT01314872|26698345|P9|Treatment Period 1|Lost to Follow-up|1
7675970|NCT01314872|26698346|P8|Treatment Period 1|Lost to Follow-up|1
7675971|NCT01314872|26698347|P7|Treatment Period 1|Lost to Follow-up|1
7675972|NCT01314872|26698348|P6|Treatment Period 1|Lost to Follow-up|1
7675973|NCT01314872|26698349|P5|Treatment Period 1|Lost to Follow-up|1
7675974|NCT01314872|26698350|P4|Treatment Period 1|Lost to Follow-up|2
7675975|NCT01314872|26698351|P3|Treatment Period 1|Lost to Follow-up|2
7675976|NCT01314872|26698352|P2|Treatment Period 1|Lost to Follow-up|1
7675977|NCT01314872|26698353|P1|Treatment Period 1|Lost to Follow-up|0
7675978|NCT01314872|26698339|P15|Treatment Period 1|Withdrawal by Subject|0
7675979|NCT01314872|26698340|P14|Treatment Period 1|Withdrawal by Subject|0
7675980|NCT01314872|26698341|P13|Treatment Period 1|Withdrawal by Subject|0
7675981|NCT01314872|26698342|P12|Treatment Period 1|Withdrawal by Subject|0
7675982|NCT01314872|26698343|P11|Treatment Period 1|Withdrawal by Subject|1
7675983|NCT01314872|26698344|P10|Treatment Period 1|Withdrawal by Subject|2
7675984|NCT01314872|26698345|P9|Treatment Period 1|Withdrawal by Subject|2
7675985|NCT01314872|26698346|P8|Treatment Period 1|Withdrawal by Subject|2
7675986|NCT01314872|26698347|P7|Treatment Period 1|Withdrawal by Subject|3
7675987|NCT01314872|26698348|P6|Treatment Period 1|Withdrawal by Subject|1
7675988|NCT01314872|26698349|P5|Treatment Period 1|Withdrawal by Subject|3
7675989|NCT01314872|26698350|P4|Treatment Period 1|Withdrawal by Subject|2
7675990|NCT01314872|26698351|P3|Treatment Period 1|Withdrawal by Subject|0
7675991|NCT01314872|26698352|P2|Treatment Period 1|Withdrawal by Subject|1
7675992|NCT01314872|26698353|P1|Treatment Period 1|Withdrawal by Subject|3
7675993|NCT01314872|26698339|P15|Treatment Period 1|Adverse event, non-fatal|0
7675994|NCT01314872|26698340|P14|Treatment Period 1|Adverse event, non-fatal|0
7675995|NCT01314872|26698341|P13|Treatment Period 1|Adverse event, non-fatal|0
7675996|NCT01314872|26698342|P12|Treatment Period 1|Adverse event, non-fatal|0
7675997|NCT01314872|26698343|P11|Treatment Period 1|Adverse event, non-fatal|1
7675998|NCT01314872|26698344|P10|Treatment Period 1|Adverse event, non-fatal|0
7675999|NCT01314872|26698345|P9|Treatment Period 1|Adverse event, non-fatal|3
7676000|NCT01314872|26698346|P8|Treatment Period 1|Adverse event, non-fatal|2
7676001|NCT01314872|26698347|P7|Treatment Period 1|Adverse event, non-fatal|4
7676002|NCT01314872|26698348|P6|Treatment Period 1|Adverse event, non-fatal|4
7676003|NCT01314872|26698349|P5|Treatment Period 1|Adverse event, non-fatal|2
7676004|NCT01314872|26698350|P4|Treatment Period 1|Adverse event, non-fatal|2
7676005|NCT01314872|26698351|P3|Treatment Period 1|Adverse event, non-fatal|3
7676006|NCT01314872|26698352|P2|Treatment Period 1|Adverse event, non-fatal|2
7676007|NCT01314872|26698353|P1|Treatment Period 1|Adverse event, non-fatal|4
7676008|NCT01314872|26698339|P15|Treatment Period 1|Lack of Efficacy|0
7676009|NCT01314872|26698340|P14|Treatment Period 1|Lack of Efficacy|0
7676010|NCT01314872|26698341|P13|Treatment Period 1|Lack of Efficacy|0
7676011|NCT01314872|26698342|P12|Treatment Period 1|Lack of Efficacy|0
7676012|NCT01314872|26698343|P11|Treatment Period 1|Lack of Efficacy|0
7676013|NCT01314872|26698344|P10|Treatment Period 1|Lack of Efficacy|0
7676014|NCT01314872|26698345|P9|Treatment Period 1|Lack of Efficacy|0
7676015|NCT01314872|26698346|P8|Treatment Period 1|Lack of Efficacy|2
7676016|NCT01314872|26698347|P7|Treatment Period 1|Lack of Efficacy|0
7676017|NCT01314872|26698348|P6|Treatment Period 1|Lack of Efficacy|1
7676018|NCT01314872|26698349|P5|Treatment Period 1|Lack of Efficacy|0
7676019|NCT01314872|26698350|P4|Treatment Period 1|Lack of Efficacy|0
7676020|NCT01314872|26698351|P3|Treatment Period 1|Lack of Efficacy|0
7676021|NCT01314872|26698352|P2|Treatment Period 1|Lack of Efficacy|0
7676022|NCT01314872|26698353|P1|Treatment Period 1|Lack of Efficacy|1
7676023|NCT01314872|26698339|P15|Treatment Period 1|Physician Decision|0
7676024|NCT01314872|26698340|P14|Treatment Period 1|Physician Decision|0
7676025|NCT01314872|26698341|P13|Treatment Period 1|Physician Decision|0
7676026|NCT01314872|26698342|P12|Treatment Period 1|Physician Decision|0
7676027|NCT01314872|26698343|P11|Treatment Period 1|Physician Decision|0
7676028|NCT01314872|26698344|P10|Treatment Period 1|Physician Decision|1
7676029|NCT01314872|26698345|P9|Treatment Period 1|Physician Decision|0
7676030|NCT01314872|26698346|P8|Treatment Period 1|Physician Decision|0
7676031|NCT01314872|26698347|P7|Treatment Period 1|Physician Decision|0
7676032|NCT01314872|26698348|P6|Treatment Period 1|Physician Decision|0
7676033|NCT01314872|26698349|P5|Treatment Period 1|Physician Decision|0
7676034|NCT01314872|26698350|P4|Treatment Period 1|Physician Decision|1
7676035|NCT01314872|26698351|P3|Treatment Period 1|Physician Decision|0
7676036|NCT01314872|26698352|P2|Treatment Period 1|Physician Decision|1
7676037|NCT01314872|26698353|P1|Treatment Period 1|Physician Decision|0
7676038|NCT01314872|26698339|P15|Treatment Period 1|Protocol Violation|0
7676039|NCT01314872|26698340|P14|Treatment Period 1|Protocol Violation|0
7676040|NCT01314872|26698341|P13|Treatment Period 1|Protocol Violation|0
7676041|NCT01314872|26698342|P12|Treatment Period 1|Protocol Violation|0
7676042|NCT01314872|26698343|P11|Treatment Period 1|Protocol Violation|1
7676043|NCT01314872|26698344|P10|Treatment Period 1|Protocol Violation|1
7676044|NCT01314872|26698345|P9|Treatment Period 1|Protocol Violation|0
7676045|NCT01314872|26698346|P8|Treatment Period 1|Protocol Violation|0
7676046|NCT01314872|26698347|P7|Treatment Period 1|Protocol Violation|0
7676047|NCT01314872|26698348|P6|Treatment Period 1|Protocol Violation|0
7676048|NCT01314872|26698349|P5|Treatment Period 1|Protocol Violation|1
7676049|NCT01314872|26698350|P4|Treatment Period 1|Protocol Violation|0
7676050|NCT01314872|26698351|P3|Treatment Period 1|Protocol Violation|1
7676051|NCT01314872|26698352|P2|Treatment Period 1|Protocol Violation|1
7676052|NCT01314872|26698353|P1|Treatment Period 1|Protocol Violation|2
7676053|NCT01314716|26698457|P2|Open-Label Phase|Physician Decision|4
7676054|NCT01314716|26698458|P1|Open-Label Phase|Physician Decision|5
7676055|NCT01314716|26698457|P2|Open-Label Phase|Withdrawal by Subject|2
7676056|NCT01314716|26698458|P1|Open-Label Phase|Withdrawal by Subject|1
7676057|NCT01314716|26698457|P2|Open-Label Phase|Adverse Event|6
7676058|NCT01314716|26698458|P1|Open-Label Phase|Adverse Event|4
7676059|NCT01314716|26698457|P2|Double-Blind Phase|Physician Decision|1
7676060|NCT01314716|26698458|P1|Double-Blind Phase|Physician Decision|0
7676061|NCT01314716|26698457|P2|Double-Blind Phase|Sponsor request|2
7676062|NCT01314716|26698458|P1|Double-Blind Phase|Sponsor request|1
7676063|NCT01314716|26698457|P2|Double-Blind Phase|Lost to Follow-up|1
7676064|NCT01314716|26698458|P1|Double-Blind Phase|Lost to Follow-up|0
7676065|NCT01314716|26698457|P2|Double-Blind Phase|Withdrawal by Subject|6
7676066|NCT01314716|26698458|P1|Double-Blind Phase|Withdrawal by Subject|5
7676067|NCT01314716|26698457|P2|Double-Blind Phase|Adverse Event|4
7676068|NCT01314716|26698458|P1|Double-Blind Phase|Adverse Event|10
7676069|NCT01314716|26698457|P2|Double-Blind Phase|Randomized but not treated|1
7676070|NCT01314716|26698458|P1|Double-Blind Phase|Randomized but not treated|1
7676071|NCT01314703|26698470|P1|Overall Study|screen failure and closed enrollment|8
7676072|NCT01314443|26698479|P4|Overall Study|Protocol Violation|1
7676073|NCT01314443|26698480|P3|Overall Study|Protocol Violation|1
7676074|NCT01314443|26698481|P2|Overall Study|Protocol Violation|2
7676075|NCT01314443|26698482|P1|Overall Study|Protocol Violation|2
7676076|NCT01314443|26698479|P4|Overall Study|Withdrawal by Subject|1
7676077|NCT01314443|26698480|P3|Overall Study|Withdrawal by Subject|1
7676078|NCT01314443|26698481|P2|Overall Study|Withdrawal by Subject|1
7676079|NCT01314443|26698482|P1|Overall Study|Withdrawal by Subject|2
7676080|NCT01314261|26698552|P4|Overall Study|Virologic Failure|1
7676081|NCT01314261|26698553|P3|Overall Study|Virologic Failure|0
7676082|NCT01314261|26698554|P2|Overall Study|Virologic Failure|1
7676083|NCT01314261|26698555|P1|Overall Study|Virologic Failure|0
7676084|NCT01314261|26698552|P4|Overall Study|Lost to Follow-up|2
7676085|NCT01314261|26698553|P3|Overall Study|Lost to Follow-up|2
7676086|NCT01314261|26698554|P2|Overall Study|Lost to Follow-up|0
7676087|NCT01314261|26698555|P1|Overall Study|Lost to Follow-up|1
7676088|NCT01314261|26698552|P4|Overall Study|Withdrawal by Subject|0
7676089|NCT01314261|26698553|P3|Overall Study|Withdrawal by Subject|1
7676090|NCT01314261|26698554|P2|Overall Study|Withdrawal by Subject|3
7676091|NCT01314261|26698555|P1|Overall Study|Withdrawal by Subject|0
7676092|NCT01314261|26698552|P4|Overall Study|Adverse Event|0
7676093|NCT01314261|26698553|P3|Overall Study|Adverse Event|0
7676094|NCT01314261|26698554|P2|Overall Study|Adverse Event|0
7676095|NCT01314261|26698555|P1|Overall Study|Adverse Event|1
7676096|NCT01314118|26698606|P1|Overall Study|Ongoing|62
7676097|NCT01314118|26698606|P1|Overall Study|Other|2
7676098|NCT01314118|26698606|P1|Overall Study|Withdrawal by Subject|11
7676099|NCT01314118|26698606|P1|Overall Study|Protocol Violation|5
7676100|NCT01314118|26698606|P1|Overall Study|Death|4
7676101|NCT01314118|26698606|P1|Overall Study|Physician Decision|11
7676102|NCT01314118|26698606|P1|Overall Study|Progressive disease|27
7676103|NCT01314118|26698606|P1|Overall Study|Adverse Event|9
7676104|NCT01314105|26698615|P2|Overall Study|Other Adverse Event|1
7676105|NCT01314105|26698616|P1|Overall Study|Other Adverse Event|1
7676106|NCT01314105|26698615|P2|Overall Study|Refused to continue taking medication|1
7676107|NCT01314105|26698616|P1|Overall Study|Refused to continue taking medication|0
7676108|NCT01314105|26698615|P2|Overall Study|Progressive Disease|10
7676109|NCT01314105|26698616|P1|Overall Study|Progressive Disease|6
7676110|NCT01313923|26698734|P1|Overall Study|Physician Decision|3
7676111|NCT01313884|26698750|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
7676112|NCT01313858|26698758|P3|Overall Study|Lost to Follow-up|47
7676113|NCT01313858|26698759|P2|Overall Study|Lost to Follow-up|51
7676114|NCT01313858|26698760|P1|Overall Study|Lost to Follow-up|35
7676115|NCT01313858|26698758|P3|Overall Study|Premature Treatment Termination|191
7676116|NCT01313858|26698759|P2|Overall Study|Premature Treatment Termination|219
7676117|NCT01313858|26698760|P1|Overall Study|Premature Treatment Termination|251
7676118|NCT01313780|26698783|P2|Overall Study|missing data|3
7676119|NCT01313780|26698784|P1|Overall Study|missing data|3
7676120|NCT01313780|26698783|P2|Overall Study|Protocol Violation|4
7676121|NCT01313780|26698784|P1|Overall Study|Protocol Violation|10
7676122|NCT01313780|26698783|P2|Overall Study|Withdrawal by Subject|8
7676123|NCT01313780|26698784|P1|Overall Study|Withdrawal by Subject|2
7676124|NCT01313780|26698783|P2|Overall Study|Adverse Event|11
7676125|NCT01313780|26698784|P1|Overall Study|Adverse Event|6
7676126|NCT01313780|26698783|P2|Overall Study|Lack of Efficacy|2
7676127|NCT01313780|26698784|P1|Overall Study|Lack of Efficacy|4
7676128|NCT01313767|26698794|P2|Overall Study|Protocol Violation|1
7676129|NCT01313767|26698795|P1|Overall Study|Protocol Violation|3
7676130|NCT01313767|26698794|P2|Overall Study|Withdrawal by Subject|1
7676131|NCT01313767|26698795|P1|Overall Study|Withdrawal by Subject|2
7676132|NCT01313767|26698794|P2|Overall Study|Lost to Follow-up|0
7676133|NCT01313767|26698795|P1|Overall Study|Lost to Follow-up|1
7676134|NCT01313767|26698794|P2|Overall Study|Adverse Event|0
7676135|NCT01313767|26698795|P1|Overall Study|Adverse Event|1
7676136|NCT01313728|26698837|P1|Informed Consent to Baseline|Withdrawal by Subject|1
7676137|NCT01313689|26698857|P5|24-Week Randomization 2|Physician Decision|4
7676138|NCT01313689|26698858|P4|24-Week Randomization 2|Physician Decision|0
7676139|NCT01313689|26698859|P3|24-Week Randomization 2|Physician Decision|0
7676140|NCT01313689|26698860|P2|24-Week Randomization 2|Physician Decision|0
7676141|NCT01313689|26698861|P1|24-Week Randomization 2|Physician Decision|0
7676142|NCT01313689|26698857|P5|24-Week Randomization 2|Withdrawal by Subject|3
7676143|NCT01313689|26698858|P4|24-Week Randomization 2|Withdrawal by Subject|1
7676144|NCT01313689|26698859|P3|24-Week Randomization 2|Withdrawal by Subject|1
7676145|NCT01313689|26698860|P2|24-Week Randomization 2|Withdrawal by Subject|0
7676146|NCT01313689|26698861|P1|24-Week Randomization 2|Withdrawal by Subject|0
7676147|NCT01313689|26698857|P5|24-Week Randomization 2|Adverse Event|8
7676148|NCT01313689|26698858|P4|24-Week Randomization 2|Adverse Event|0
7676149|NCT01313689|26698859|P3|24-Week Randomization 2|Adverse Event|2
7676150|NCT01313689|26698860|P2|24-Week Randomization 2|Adverse Event|0
7676151|NCT01313689|26698861|P1|24-Week Randomization 2|Adverse Event|0
7676152|NCT01313689|26698857|P5|24-Week Randomization 1|Withdrawal by Subject|0
7676153|NCT01313689|26698858|P4|24-Week Randomization 1|Withdrawal by Subject|0
7676154|NCT01313689|26698859|P3|24-Week Randomization 1|Withdrawal by Subject|0
7676155|NCT01313689|26698860|P2|24-Week Randomization 1|Withdrawal by Subject|0
7676156|NCT01313689|26698861|P1|24-Week Randomization 1|Withdrawal by Subject|5
7676157|NCT01313689|26698857|P5|24-Week Randomization 1|Physician Decision|0
7676158|NCT01313689|26698858|P4|24-Week Randomization 1|Physician Decision|0
7676159|NCT01313689|26698859|P3|24-Week Randomization 1|Physician Decision|0
7676160|NCT01313689|26698860|P2|24-Week Randomization 1|Physician Decision|5
7676161|NCT01313689|26698861|P1|24-Week Randomization 1|Physician Decision|4
7676162|NCT01313689|26698857|P5|24-Week Randomization 1|Adverse Event|0
7676163|NCT01313689|26698858|P4|24-Week Randomization 1|Adverse Event|0
7676164|NCT01313689|26698859|P3|24-Week Randomization 1|Adverse Event|0
7676165|NCT01313689|26698860|P2|24-Week Randomization 1|Adverse Event|5
7676166|NCT01313689|26698861|P1|24-Week Randomization 1|Adverse Event|10
7676167|NCT01313676|26698940|P4|Overall Study|Missing|0
7676168|NCT01313676|26698941|P3|Overall Study|Missing|1
7676169|NCT01313676|26698942|P2|Overall Study|Missing|1
7676170|NCT01313676|26698943|P1|Overall Study|Missing|1
7676171|NCT01313676|26698940|P4|Overall Study|Investigator Site Closed|10
7676172|NCT01313676|26698941|P3|Overall Study|Investigator Site Closed|15
7676173|NCT01313676|26698942|P2|Overall Study|Investigator Site Closed|11
7676174|NCT01313676|26698943|P1|Overall Study|Investigator Site Closed|12
7676175|NCT01313676|26698940|P4|Overall Study|Sponsor Terminated Study Treatment|1
7676176|NCT01313676|26698941|P3|Overall Study|Sponsor Terminated Study Treatment|0
7676177|NCT01313676|26698942|P2|Overall Study|Sponsor Terminated Study Treatment|1
7676178|NCT01313676|26698943|P1|Overall Study|Sponsor Terminated Study Treatment|1
7676179|NCT01313676|26698940|P4|Overall Study|Decision by Participant or Proxy|492
7676180|NCT01313676|26698941|P3|Overall Study|Decision by Participant or Proxy|515
7676181|NCT01313676|26698942|P2|Overall Study|Decision by Participant or Proxy|527
7676182|NCT01313676|26698943|P1|Overall Study|Decision by Participant or Proxy|643
7676183|NCT01313676|26698940|P4|Overall Study|Physician Decision|48
7676184|NCT01313676|26698941|P3|Overall Study|Physician Decision|62
7676185|NCT01313676|26698942|P2|Overall Study|Physician Decision|64
7676186|NCT01313676|26698943|P1|Overall Study|Physician Decision|53
7676187|NCT01313676|26698940|P4|Overall Study|Lost to Follow-up|0
7676188|NCT01313676|26698941|P3|Overall Study|Lost to Follow-up|1
7676189|NCT01313676|26698942|P2|Overall Study|Lost to Follow-up|0
7676190|NCT01313676|26698943|P1|Overall Study|Lost to Follow-up|0
7676191|NCT01313676|26698940|P4|Overall Study|Study Closed/terminated|9
7676192|NCT01313676|26698941|P3|Overall Study|Study Closed/terminated|9
7676193|NCT01313676|26698942|P2|Overall Study|Study Closed/terminated|6
7676194|NCT01313676|26698943|P1|Overall Study|Study Closed/terminated|7
7676195|NCT01313676|26698940|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
7676196|NCT01313676|26698941|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
7676197|NCT01313676|26698942|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
7676198|NCT01313676|26698943|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
7676199|NCT01313676|26698940|P4|Overall Study|Protocol Violation|44
7676200|NCT01313676|26698941|P3|Overall Study|Protocol Violation|46
7676201|NCT01313676|26698942|P2|Overall Study|Protocol Violation|44
7676202|NCT01313676|26698943|P1|Overall Study|Protocol Violation|37
7676203|NCT01313676|26698940|P4|Overall Study|Lack of Efficacy|46
7676204|NCT01313676|26698941|P3|Overall Study|Lack of Efficacy|65
7676205|NCT01313676|26698942|P2|Overall Study|Lack of Efficacy|90
7676206|NCT01313676|26698943|P1|Overall Study|Lack of Efficacy|98
7676207|NCT01313676|26698940|P4|Overall Study|Adverse Event|333
7676208|NCT01313676|26698941|P3|Overall Study|Adverse Event|372
7676209|NCT01313676|26698942|P2|Overall Study|Adverse Event|365
7676210|NCT01313676|26698943|P1|Overall Study|Adverse Event|395
7676211|NCT01313663|26698963|P2|Overall Study|Withdrawal by Subject|1
7676212|NCT01313663|26698964|P1|Overall Study|Withdrawal by Subject|2
7676213|NCT01313663|26698963|P2|Overall Study|Physician Decision|2
7676214|NCT01313663|26698964|P1|Overall Study|Physician Decision|0
7676215|NCT01313663|26698963|P2|Overall Study|Lost to Follow-up|1
7676216|NCT01313663|26698964|P1|Overall Study|Lost to Follow-up|0
7676217|NCT01313663|26698963|P2|Overall Study|Study Closed/Terminated|4
7676218|NCT01313663|26698964|P1|Overall Study|Study Closed/Terminated|2
7676219|NCT01313650|26699002|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
7676220|NCT01313650|26699003|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
7676221|NCT01313650|26699004|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
7676222|NCT01313650|26699005|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
7676223|NCT01313650|26699002|P4|Overall Study|Protocol Violation|6
7676224|NCT01313650|26699003|P3|Overall Study|Protocol Violation|5
7676225|NCT01313650|26699004|P2|Overall Study|Protocol Violation|7
7676226|NCT01313650|26699005|P1|Overall Study|Protocol Violation|4
7676227|NCT01313650|26699002|P4|Overall Study|Withdrawal by Subject|15
7676228|NCT01313650|26699003|P3|Overall Study|Withdrawal by Subject|15
7676229|NCT01313650|26699004|P2|Overall Study|Withdrawal by Subject|20
7676230|NCT01313650|26699005|P1|Overall Study|Withdrawal by Subject|16
7676231|NCT01313650|26699002|P4|Overall Study|Lost to Follow-up|2
7676232|NCT01313650|26699003|P3|Overall Study|Lost to Follow-up|3
7676233|NCT01313650|26699004|P2|Overall Study|Lost to Follow-up|0
7676234|NCT01313650|26699005|P1|Overall Study|Lost to Follow-up|1
7676235|NCT01313650|26699002|P4|Overall Study|Lack of Efficacy|20
7676236|NCT01313650|26699003|P3|Overall Study|Lack of Efficacy|32
7676237|NCT01313650|26699004|P2|Overall Study|Lack of Efficacy|20
7676238|NCT01313650|26699005|P1|Overall Study|Lack of Efficacy|37
7676239|NCT01313650|26699002|P4|Overall Study|Adverse Event|23
7676240|NCT01313650|26699003|P3|Overall Study|Adverse Event|24
7676241|NCT01313650|26699004|P2|Overall Study|Adverse Event|34
7676242|NCT01313650|26699005|P1|Overall Study|Adverse Event|9
7676243|NCT01313637|26699031|P4|Overall Study|Withdrawal by Subject|15
7676244|NCT01313637|26699032|P3|Overall Study|Withdrawal by Subject|18
7676245|NCT01313637|26699033|P2|Overall Study|Withdrawal by Subject|13
7676246|NCT01313637|26699034|P1|Overall Study|Withdrawal by Subject|11
7676247|NCT01313637|26699031|P4|Overall Study|Lost to Follow-up|3
7676248|NCT01313637|26699032|P3|Overall Study|Lost to Follow-up|1
7676249|NCT01313637|26699033|P2|Overall Study|Lost to Follow-up|2
7676250|NCT01313637|26699034|P1|Overall Study|Lost to Follow-up|0
7676251|NCT01313637|26699031|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
7676252|NCT01313637|26699032|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
7676253|NCT01313637|26699033|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
7676254|NCT01313637|26699034|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
7676255|NCT01313637|26699031|P4|Overall Study|Protocol Violation|5
7676256|NCT01313637|26699032|P3|Overall Study|Protocol Violation|11
7676257|NCT01313637|26699033|P2|Overall Study|Protocol Violation|3
7676258|NCT01313637|26699034|P1|Overall Study|Protocol Violation|4
7676259|NCT01313637|26699031|P4|Overall Study|Lack of Efficacy|24
7676260|NCT01313637|26699032|P3|Overall Study|Lack of Efficacy|37
7676261|NCT01313637|26699033|P2|Overall Study|Lack of Efficacy|38
7676262|NCT01313637|26699034|P1|Overall Study|Lack of Efficacy|44
7676263|NCT01313637|26699031|P4|Overall Study|Adverse Event|18
7676264|NCT01313637|26699032|P3|Overall Study|Adverse Event|25
7676265|NCT01313637|26699033|P2|Overall Study|Adverse Event|24
7676266|NCT01313637|26699034|P1|Overall Study|Adverse Event|17
7676267|NCT01313624|26699058|P2|Open-Label Phase|Lost to Follow-up|1
7676268|NCT01313624|26699059|P1|Open-Label Phase|Lost to Follow-up|1
7676269|NCT01313624|26699058|P2|Open-Label Phase|Withdrawal by Subject|2
7676270|NCT01313624|26699059|P1|Open-Label Phase|Withdrawal by Subject|2
7676271|NCT01313624|26699058|P2|Open-Label Phase|Adverse Event|10
7676272|NCT01313624|26699059|P1|Open-Label Phase|Adverse Event|1
7676273|NCT01313624|26699058|P2|Double-Blind Phase|Lack of Efficacy|0
7676274|NCT01313624|26699059|P1|Double-Blind Phase|Lack of Efficacy|1
7676275|NCT01313624|26699058|P2|Double-Blind Phase|Physician Decision|0
7676276|NCT01313624|26699059|P1|Double-Blind Phase|Physician Decision|1
7676277|NCT01313624|26699058|P2|Double-Blind Phase|Lost to Follow-up|2
7676278|NCT01313624|26699059|P1|Double-Blind Phase|Lost to Follow-up|0
7676279|NCT01313624|26699058|P2|Double-Blind Phase|Withdrawal by Subject|4
7676280|NCT01313624|26699059|P1|Double-Blind Phase|Withdrawal by Subject|9
7676281|NCT01313624|26699058|P2|Double-Blind Phase|Adverse Event|4
7676282|NCT01313624|26699059|P1|Double-Blind Phase|Adverse Event|27
7676283|NCT01313559|26699073|P2|Overall Study|Rising PSA|0
7676284|NCT01313559|26699074|P1|Overall Study|Rising PSA|2
7676285|NCT01313559|26699073|P2|Overall Study|Disease progression|0
7676286|NCT01313559|26699074|P1|Overall Study|Disease progression|1
7676287|NCT01313559|26699073|P2|Overall Study|Withdrawal by Subject|2
7676288|NCT01313559|26699074|P1|Overall Study|Withdrawal by Subject|1
7676289|NCT01313312|26699175|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
7676290|NCT01313312|26699175|P1|Overall Study|Subject Withdrawn Early in Error|4
7676291|NCT01313312|26699175|P1|Overall Study|Observational Phase|1
7676292|NCT01313312|26699175|P1|Overall Study|Investigator Decision|1
7676293|NCT01313312|26699175|P1|Overall Study|Lack of Efficacy|3
7676294|NCT01313312|26699175|P1|Overall Study|Withdrawal by Subject|18
7676295|NCT01313312|26699175|P1|Overall Study|Adverse Event|5
7676296|NCT01313299|26699222|P3|Overall Study|Lack of subject compliance|1
7676297|NCT01313299|26699223|P2|Overall Study|Lack of subject compliance|0
7676298|NCT01313299|26699224|P1|Overall Study|Lack of subject compliance|0
7676299|NCT01313299|26699222|P3|Overall Study|Family reason and moved out of state|0
7676300|NCT01313299|26699223|P2|Overall Study|Family reason and moved out of state|2
7676301|NCT01313299|26699224|P1|Overall Study|Family reason and moved out of state|0
7676302|NCT01313299|26699222|P3|Overall Study|Withdrawal by Subject|2
7676303|NCT01313299|26699223|P2|Overall Study|Withdrawal by Subject|0
7676304|NCT01313299|26699224|P1|Overall Study|Withdrawal by Subject|1
7676305|NCT01313299|26699222|P3|Overall Study|Protocol Violation|0
7676306|NCT01313299|26699223|P2|Overall Study|Protocol Violation|0
7676307|NCT01313299|26699224|P1|Overall Study|Protocol Violation|2
7676308|NCT01313299|26699222|P3|Overall Study|Lost to Follow-up|0
7676309|NCT01313299|26699223|P2|Overall Study|Lost to Follow-up|0
7676310|NCT01313299|26699224|P1|Overall Study|Lost to Follow-up|1
7676311|NCT01313299|26699222|P3|Overall Study|Adverse Event|1
7676312|NCT01313299|26699223|P2|Overall Study|Adverse Event|1
7676313|NCT01313299|26699224|P1|Overall Study|Adverse Event|3
7676314|NCT01313286|26699238|P2|Period 1|Withdrawal by Subject|0
7676315|NCT01313286|26699239|P1|Period 1|Withdrawal by Subject|2
7676316|NCT01313273|26699249|P2|Overall Study|Screening Chromogranin A-in normal range|1
7676317|NCT01313273|26699250|P1|Overall Study|Screening Chromogranin A-in normal range|0
7676318|NCT01313273|26699249|P2|Overall Study|Withdrawal by Subject|0
7676319|NCT01313273|26699250|P1|Overall Study|Withdrawal by Subject|1
7676320|NCT01313273|26699249|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
7676321|NCT01313273|26699250|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
7676322|NCT01313221|26699265|P3|Overall Study|Pregnancy|2
7676323|NCT01313221|26699266|P2|Overall Study|Pregnancy|0
7676324|NCT01313221|26699267|P1|Overall Study|Pregnancy|0
7676325|NCT01313221|26699265|P3|Overall Study|Physician Decision|2
7676326|NCT01313221|26699266|P2|Overall Study|Physician Decision|0
7676327|NCT01313221|26699267|P1|Overall Study|Physician Decision|0
7676328|NCT01313221|26699265|P3|Overall Study|Disease progression|2
7676329|NCT01313221|26699266|P2|Overall Study|Disease progression|0
7676330|NCT01313221|26699267|P1|Overall Study|Disease progression|0
7676331|NCT01313221|26699265|P3|Overall Study|Adverse Event|7
7676332|NCT01313221|26699266|P2|Overall Study|Adverse Event|0
7676333|NCT01313221|26699267|P1|Overall Study|Adverse Event|0
7676334|NCT01313221|26699265|P3|Overall Study|Other|0
7676335|NCT01313221|26699266|P2|Overall Study|Other|0
7676336|NCT01313221|26699267|P1|Overall Study|Other|1
7676337|NCT01313221|26699265|P3|Overall Study|Lost to Follow-up|1
7676338|NCT01313221|26699266|P2|Overall Study|Lost to Follow-up|3
7676339|NCT01313221|26699267|P1|Overall Study|Lost to Follow-up|6
7676340|NCT01313221|26699265|P3|Overall Study|Requirement for alternative therapy|1
7676341|NCT01313221|26699266|P2|Overall Study|Requirement for alternative therapy|1
7676342|NCT01313221|26699267|P1|Overall Study|Requirement for alternative therapy|0
7676343|NCT01313221|26699265|P3|Overall Study|Withdrawal by Subject|5
7676344|NCT01313221|26699266|P2|Overall Study|Withdrawal by Subject|3
7676345|NCT01313221|26699267|P1|Overall Study|Withdrawal by Subject|2
7676346|NCT01313221|26699265|P3|Overall Study|Non-compliance|2
7676347|NCT01313221|26699266|P2|Overall Study|Non-compliance|0
7676348|NCT01313221|26699267|P1|Overall Study|Non-compliance|3
7676349|NCT01313221|26699265|P3|Overall Study|Protocol Violation|1
7676350|NCT01313221|26699266|P2|Overall Study|Protocol Violation|1
7676351|NCT01313221|26699267|P1|Overall Study|Protocol Violation|0
7676352|NCT01313208|26699319|P2|Open-label Phase (Weeks 13 - 24)|Other|0
7676353|NCT01313208|26699320|P1|Open-label Phase (Weeks 13 - 24)|Other|2
7676354|NCT01313208|26699319|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
7676355|NCT01313208|26699320|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
7676356|NCT01313208|26699319|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
7676357|NCT01313208|26699320|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
7676358|NCT01313208|26699319|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
7676359|NCT01313208|26699320|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
7676360|NCT01313208|26699319|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
7676361|NCT01313208|26699320|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
7676362|NCT01313208|26699319|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
7676363|NCT01313208|26699320|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
7676364|NCT01313208|26699319|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
7676365|NCT01313208|26699320|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
7676366|NCT01313208|26699319|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
7676367|NCT01313208|26699320|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
7676368|NCT01313208|26699319|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
7676369|NCT01313208|26699320|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
7676370|NCT01313182|26699410|P2|Overall Study|Protocol Violation|92
7676371|NCT01313182|26699411|P1|Overall Study|Protocol Violation|66
7676372|NCT01313117|26699423|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
7676373|NCT01313117|26699423|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
7676374|NCT01313078|26699430|P1|Overall Study|Withdrawal by Subject|1
7676375|NCT01313078|26699430|P1|Overall Study|Discontinued study drug|1
7676376|NCT01313078|26699430|P1|Overall Study|Death|1
7676377|NCT01313039|26699435|P1|Overall Study|Adverse Event|1
7676378|NCT01313039|26699435|P1|Overall Study|Physician Decision|1
7676379|NCT01312961|26699441|P2|Overall Study|Other than specified above|3
7676380|NCT01312961|26699442|P1|Overall Study|Other than specified above|2
7676381|NCT01312961|26699441|P2|Overall Study|Poor compliance to protocol|0
7676382|NCT01312961|26699442|P1|Overall Study|Poor compliance to protocol|1
7676383|NCT01312961|26699441|P2|Overall Study|Lack of Efficacy|1
7676384|NCT01312961|26699442|P1|Overall Study|Lack of Efficacy|11
7676385|NCT01312961|26699441|P2|Overall Study|Adverse Event|3
7676386|NCT01312961|26699442|P1|Overall Study|Adverse Event|3
7676387|NCT01312909|26699478|P3|Overall Study|Entrance criteria not met|2
7676388|NCT01312909|26699479|P2|Overall Study|Entrance criteria not met|0
7676389|NCT01312909|26699480|P1|Overall Study|Entrance criteria not met|0
7676390|NCT01312909|26699478|P3|Overall Study|Insufficient clinical response|1
7676391|NCT01312909|26699479|P2|Overall Study|Insufficient clinical response|0
7676392|NCT01312909|26699480|P1|Overall Study|Insufficient clinical response|0
7676393|NCT01312909|26699478|P3|Overall Study|Lost to Follow-up|20
7676394|NCT01312909|26699479|P2|Overall Study|Lost to Follow-up|17
7676395|NCT01312909|26699480|P1|Overall Study|Lost to Follow-up|21
7676396|NCT01312909|26699478|P3|Overall Study|Withdrawal by Subject|7
7676397|NCT01312909|26699479|P2|Overall Study|Withdrawal by Subject|10
7676398|NCT01312909|26699480|P1|Overall Study|Withdrawal by Subject|8
7676399|NCT01312909|26699478|P3|Overall Study|Other|11
7676400|NCT01312909|26699479|P2|Overall Study|Other|6
7676401|NCT01312909|26699480|P1|Overall Study|Other|9
7676402|NCT01312909|26699478|P3|Overall Study|Protocol Violation|2
7676403|NCT01312909|26699479|P2|Overall Study|Protocol Violation|0
7676404|NCT01312909|26699480|P1|Overall Study|Protocol Violation|2
7676405|NCT01312909|26699478|P3|Overall Study|Adverse Event|3
7676406|NCT01312909|26699479|P2|Overall Study|Adverse Event|0
7676407|NCT01312909|26699480|P1|Overall Study|Adverse Event|1
7676408|NCT01312909|26699478|P3|Overall Study|Randomized but not treated|1
7676409|NCT01312909|26699479|P2|Overall Study|Randomized but not treated|3
7676410|NCT01312909|26699480|P1|Overall Study|Randomized but not treated|1
7676411|NCT01312779|26699567|P1|Overall Study|Not Implanted with Device|27
7676412|NCT01312779|26699567|P1|Overall Study|Death|3
7676413|NCT01312779|26699567|P1|Overall Study|Withdrawal by Subject|2
7676414|NCT01312467|26699650|P1|Overall Study|Ineligible|4
7676415|NCT01312467|26699650|P1|Overall Study|Another medical condition|1
7676416|NCT01312467|26699650|P1|Overall Study|Deported to country of origin|1
7676417|NCT01312467|26699650|P1|Overall Study|Withdrawal by Subject|2
7676418|NCT01312467|26699650|P1|Overall Study|Lost to Follow-up|1
7676419|NCT01312467|26699650|P1|Overall Study|Adverse Event|4
7676420|NCT01312428|26699659|P2|Overall Study|Study Termination|4
7676421|NCT01312428|26699660|P1|Overall Study|Study Termination|3
7676422|NCT01312129|26699730|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
7676423|NCT01312129|26699731|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
7676424|NCT01311661|26699833|P1|Overall Study|Withdrawal by Subject|2
7676425|NCT01311661|26699833|P1|Overall Study|Protocol Violation|3
7676426|NCT01311661|26699833|P1|Overall Study|Adverse Event|2
7676427|NCT01311648|26699978|P2|Extension Study|Inhibitor management|2
7676428|NCT01311648|26699979|P1|Extension Study|Inhibitor management|0
7676429|NCT01311648|26699978|P2|Extension Study|Withdrawal by Subject|1
7676430|NCT01311648|26699979|P1|Extension Study|Withdrawal by Subject|0
7676431|NCT01311648|26699978|P2|Extension Study|Diagnosed with von Willebrand disease|0
7676432|NCT01311648|26699979|P1|Extension Study|Diagnosed with von Willebrand disease|1
7676433|NCT01311648|26699978|P2|Extension Study|Long travel|1
7676434|NCT01311648|26699979|P1|Extension Study|Long travel|0
7676435|NCT01311648|26699978|P2|Extension Study|Failure of ITI therapy|3
7676436|NCT01311648|26699979|P1|Extension Study|Failure of ITI therapy|0
7676437|NCT01311648|26699978|P2|Extension Study|Family's decision|1
7676438|NCT01311648|26699979|P1|Extension Study|Family's decision|0
7676439|NCT01311648|26699978|P2|Extension Study|Incorrect visit planning|1
7676440|NCT01311648|26699979|P1|Extension Study|Incorrect visit planning|0
7676441|NCT01311648|26699978|P2|Extension Study|ITI therapy with marketed product|1
7676442|NCT01311648|26699979|P1|Extension Study|ITI therapy with marketed product|0
7676443|NCT01311648|26699978|P2|Extension Study|Physician Decision|1
7676444|NCT01311648|26699979|P1|Extension Study|Physician Decision|0
7676445|NCT01311648|26699978|P2|Main Study|Withdrawal by Subject|2
7676446|NCT01311648|26699979|P1|Main Study|Withdrawal by Subject|0
7676447|NCT01311648|26699978|P2|Main Study|Inhibitor management|17
7676448|NCT01311648|26699979|P1|Main Study|Inhibitor management|0
7676449|NCT01311648|26699978|P2|Main Study|Adverse Event|1
7676450|NCT01311648|26699979|P1|Main Study|Adverse Event|0
7676451|NCT01311648|26699978|P2|Main Study|Protocol Violation|1
7676452|NCT01311648|26699979|P1|Main Study|Protocol Violation|0
7676453|NCT01311557|26700028|P2|Overall Study|Withdrawal by Subject|2
7676454|NCT01311557|26700029|P1|Overall Study|Withdrawal by Subject|1
7676455|NCT01311557|26700028|P2|Overall Study|Lost to Follow-up|1
7676456|NCT01311557|26700029|P1|Overall Study|Lost to Follow-up|0
7676457|NCT01311557|26700028|P2|Overall Study|Protocol Violation|2
7676458|NCT01311557|26700029|P1|Overall Study|Protocol Violation|4
7676459|NCT01311557|26700028|P2|Overall Study|Serious adverse event|1
7676460|NCT01311557|26700029|P1|Overall Study|Serious adverse event|0
7676461|NCT01311505|26700045|P2|First Intervention Period|Protocol Violation|1
7676462|NCT01311505|26700046|P1|First Intervention Period|Protocol Violation|0
7676463|NCT01311024|26700102|P2|Overall Study|Protocol Violation|22
7676464|NCT01311024|26700103|P1|Overall Study|Protocol Violation|35
7676465|NCT01310868|26700109|P1|Overall Study|Do not have histologically confirmed GBM|13
7676466|NCT01310803|26700126|P2|Overall Study|Subject terminated by Sponsor|0
7676467|NCT01310803|26700127|P1|Overall Study|Subject terminated by Sponsor|1
7676468|NCT01310777|26700138|P3|Overall Study|Other|2
7676469|NCT01310777|26700139|P2|Overall Study|Other|1
7676470|NCT01310777|26700140|P1|Overall Study|Other|4
7676471|NCT01310777|26700138|P3|Overall Study|Inadequate Control of IOP|10
7676472|NCT01310777|26700139|P2|Overall Study|Inadequate Control of IOP|7
7676473|NCT01310777|26700140|P1|Overall Study|Inadequate Control of IOP|5
7676474|NCT01310777|26700138|P3|Overall Study|Patient's Decision Unrelated to AE|2
7676475|NCT01310777|26700139|P2|Overall Study|Patient's Decision Unrelated to AE|1
7676476|NCT01310777|26700140|P1|Overall Study|Patient's Decision Unrelated to AE|1
7676477|NCT01310777|26700138|P3|Overall Study|Lost to Follow-up|1
7676478|NCT01310777|26700139|P2|Overall Study|Lost to Follow-up|4
7676479|NCT01310777|26700140|P1|Overall Study|Lost to Follow-up|0
7676480|NCT01310777|26700138|P3|Overall Study|Adverse Event|15
7676481|NCT01310777|26700139|P2|Overall Study|Adverse Event|1
7676482|NCT01310777|26700140|P1|Overall Study|Adverse Event|23
7676483|NCT01310699|26700150|P2|Overall Study|Patients did not complete tandem.|6
7676484|NCT01310699|26700151|P1|Overall Study|Patients did not complete tandem.|4
7676485|NCT01310413|26700178|P7|From Day U0 to Day U385|Lost to Follow-up|2
7676486|NCT01310413|26700179|P6|From Day U0 to Day U385|Lost to Follow-up|0
7676487|NCT01310413|26700180|P5|From Day U0 to Day U385|Lost to Follow-up|0
7676488|NCT01310413|26700181|P4|From Day U0 to Day U385|Lost to Follow-up|0
7676489|NCT01310413|26700182|P3|From Day U0 to Day U385|Lost to Follow-up|0
7676490|NCT01310413|26700183|P2|From Day U0 to Day U385|Lost to Follow-up|0
7676491|NCT01310413|26700184|P1|From Day U0 to Day U385|Lost to Follow-up|0
7676492|NCT01310413|26700178|P7|From Day U0 to Day U385|Withdrawal by Subject|1
7676493|NCT01310413|26700179|P6|From Day U0 to Day U385|Withdrawal by Subject|0
7676494|NCT01310413|26700180|P5|From Day U0 to Day U385|Withdrawal by Subject|0
7676495|NCT01310413|26700181|P4|From Day U0 to Day U385|Withdrawal by Subject|0
7676496|NCT01310413|26700182|P3|From Day U0 to Day U385|Withdrawal by Subject|0
7676497|NCT01310413|26700183|P2|From Day U0 to Day U385|Withdrawal by Subject|0
7676498|NCT01310413|26700184|P1|From Day U0 to Day U385|Withdrawal by Subject|0
7676499|NCT01310413|26700178|P7|Day 0 to Day 385|Other|0
7676500|NCT01310413|26700179|P6|Day 0 to Day 385|Other|0
7676501|NCT01310413|26700180|P5|Day 0 to Day 385|Other|0
7676502|NCT01310413|26700181|P4|Day 0 to Day 385|Other|0
7676503|NCT01310413|26700182|P3|Day 0 to Day 385|Other|3
7676504|NCT01310413|26700183|P2|Day 0 to Day 385|Other|0
7676505|NCT01310413|26700184|P1|Day 0 to Day 385|Other|1
7676506|NCT01310413|26700178|P7|Day 0 to Day 385|Migrated/moved from study area|0
7676507|NCT01310413|26700179|P6|Day 0 to Day 385|Migrated/moved from study area|0
7676508|NCT01310413|26700180|P5|Day 0 to Day 385|Migrated/moved from study area|1
7676509|NCT01310413|26700181|P4|Day 0 to Day 385|Migrated/moved from study area|1
7676510|NCT01310413|26700182|P3|Day 0 to Day 385|Migrated/moved from study area|1
7676511|NCT01310413|26700183|P2|Day 0 to Day 385|Migrated/moved from study area|3
7676512|NCT01310413|26700184|P1|Day 0 to Day 385|Migrated/moved from study area|3
7676513|NCT01310413|26700178|P7|Day 0 to Day 385|Lost to Follow-up|0
7676514|NCT01310413|26700179|P6|Day 0 to Day 385|Lost to Follow-up|2
7676515|NCT01310413|26700180|P5|Day 0 to Day 385|Lost to Follow-up|1
7676516|NCT01310413|26700181|P4|Day 0 to Day 385|Lost to Follow-up|5
7676517|NCT01310413|26700182|P3|Day 0 to Day 385|Lost to Follow-up|3
7676518|NCT01310413|26700183|P2|Day 0 to Day 385|Lost to Follow-up|3
7676519|NCT01310413|26700184|P1|Day 0 to Day 385|Lost to Follow-up|18
7676520|NCT01310413|26700178|P7|Day 0 to Day 385|Withdrawal by Subject|0
7676521|NCT01310413|26700179|P6|Day 0 to Day 385|Withdrawal by Subject|1
7676522|NCT01310413|26700180|P5|Day 0 to Day 385|Withdrawal by Subject|1
7676523|NCT01310413|26700181|P4|Day 0 to Day 385|Withdrawal by Subject|2
7676524|NCT01310413|26700182|P3|Day 0 to Day 385|Withdrawal by Subject|0
7676525|NCT01310413|26700183|P2|Day 0 to Day 385|Withdrawal by Subject|2
7676526|NCT01310413|26700184|P1|Day 0 to Day 385|Withdrawal by Subject|5
7676527|NCT01310127|26700393|P2|Overall Study|advanced psc cataract outlier|0
7676528|NCT01310127|26700394|P1|Overall Study|advanced psc cataract outlier|1
7676529|NCT01310127|26700393|P2|Overall Study|Protocol Violation|1
7676530|NCT01310127|26700394|P1|Overall Study|Protocol Violation|1
7676531|NCT01310075|26700408|P2|Overall Study|Withdrawal by Subject|1
7676532|NCT01310075|26700409|P1|Overall Study|Withdrawal by Subject|1
7676533|NCT01310075|26700408|P2|Overall Study|Protocol Violation|2
7676534|NCT01310075|26700409|P1|Overall Study|Protocol Violation|2
7676535|NCT01310075|26700408|P2|Overall Study|Physician Decision|7
7676536|NCT01310075|26700409|P1|Overall Study|Physician Decision|10
7676537|NCT01310075|26700408|P2|Overall Study|Lost to Follow-up|0
7676538|NCT01310075|26700409|P1|Overall Study|Lost to Follow-up|1
7676539|NCT01310036|26700415|P1|Overall Study|Adverse event or intercurrent illness|12
7676540|NCT01310036|26700415|P1|Overall Study|Death|1
7676541|NCT01310036|26700415|P1|Overall Study|Progression of Disease|164
7676542|NCT01310036|26700415|P1|Overall Study|Refused Treatment/Did not Cooperate|4
7676543|NCT01310036|26700415|P1|Overall Study|Withdrew Consent|11
7676544|NCT01310036|26700415|P1|Overall Study|Administrative/other|10
7676545|NCT01309997|26700428|P2|Overall Study|Withdrawal by Subject|1
7676546|NCT01309997|26700429|P1|Overall Study|Withdrawal by Subject|1
7676547|NCT01309997|26700428|P2|Overall Study|Lack of Efficacy|2
7676548|NCT01309997|26700429|P1|Overall Study|Lack of Efficacy|2
7676549|NCT01309997|26700428|P2|Overall Study|Death|3
7676550|NCT01309997|26700429|P1|Overall Study|Death|1
7676551|NCT01309997|26700428|P2|Overall Study|Adverse Event|0
7676552|NCT01309997|26700429|P1|Overall Study|Adverse Event|1
7676553|NCT01309919|26700453|P2|Overall Study|Did not receive a postpartum IUD|48
7676554|NCT01309919|26700454|P1|Overall Study|Did not receive a postpartum IUD|17
7676555|NCT01309893|26700477|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
7676556|NCT01309893|26700478|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
7676557|NCT01309893|26700477|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
7676558|NCT01309893|26700478|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
7676559|NCT01309841|26700515|P3|Overall Study|Severe non-compliance with protocol|2
7676560|NCT01309841|26700516|P2|Overall Study|Severe non-compliance with protocol|5
7676561|NCT01309841|26700517|P1|Overall Study|Severe non-compliance with protocol|0
7676562|NCT01309841|26700515|P3|Overall Study|Did Not Receive Treatment|1
7676563|NCT01309841|26700516|P2|Overall Study|Did Not Receive Treatment|0
7676564|NCT01309841|26700517|P1|Overall Study|Did Not Receive Treatment|2
7676565|NCT01309841|26700515|P3|Overall Study|Withdrawal by Subject|13
7676566|NCT01309841|26700516|P2|Overall Study|Withdrawal by Subject|6
7676567|NCT01309841|26700517|P1|Overall Study|Withdrawal by Subject|17
7676568|NCT01309841|26700515|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
7676569|NCT01309841|26700516|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
7676570|NCT01309841|26700517|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
7676571|NCT01309841|26700515|P3|Overall Study|Death|0
7676572|NCT01309841|26700516|P2|Overall Study|Death|0
7676573|NCT01309841|26700517|P1|Overall Study|Death|1
7676574|NCT01309841|26700515|P3|Overall Study|Adverse Event|11
7676575|NCT01309841|26700516|P2|Overall Study|Adverse Event|22
7676576|NCT01309841|26700517|P1|Overall Study|Adverse Event|9
7676577|NCT01309841|26700515|P3|Overall Study|Lack of Efficacy|2
7676578|NCT01309841|26700516|P2|Overall Study|Lack of Efficacy|0
7676579|NCT01309841|26700517|P1|Overall Study|Lack of Efficacy|0
7676580|NCT01309841|26700515|P3|Overall Study|Study-Specific Withdrawal Criteria|2
7676581|NCT01309841|26700516|P2|Overall Study|Study-Specific Withdrawal Criteria|1
7676582|NCT01309841|26700517|P1|Overall Study|Study-Specific Withdrawal Criteria|3
7676583|NCT01309841|26700515|P3|Overall Study|Lost to Follow-up|4
7676584|NCT01309841|26700516|P2|Overall Study|Lost to Follow-up|6
7676585|NCT01309841|26700517|P1|Overall Study|Lost to Follow-up|7
7676586|NCT01309841|26700515|P3|Overall Study|Other|1
7676587|NCT01309841|26700516|P2|Overall Study|Other|1
7676588|NCT01309841|26700517|P1|Overall Study|Other|0
7676589|NCT01309828|26700557|P2|Overall Study|Other|0
7676590|NCT01309828|26700558|P1|Overall Study|Other|1
7676591|NCT01309828|26700557|P2|Overall Study|Major Protocol Deviation|1
7676592|NCT01309828|26700558|P1|Overall Study|Major Protocol Deviation|0
7676593|NCT01309828|26700557|P2|Overall Study|Voluntary Withdrawal|4
7676594|NCT01309828|26700558|P1|Overall Study|Voluntary Withdrawal|5
7676595|NCT01309828|26700557|P2|Overall Study|Adverse Event|11
7676596|NCT01309828|26700558|P1|Overall Study|Adverse Event|10
7676597|NCT01309737|26700592|P5|Week 16 to 52|Other|0
7676598|NCT01309737|26700593|P4|Week 16 to 52|Other|2
7676599|NCT01309737|26700594|P3|Week 16 to 52|Other|0
7676600|NCT01309737|26700595|P2|Week 16 to 52|Other|12
7676601|NCT01309737|26700596|P1|Week 16 to 52|Other|10
7676602|NCT01309737|26700592|P5|Week 16 to 52|Withdrawal by Subject|2
7676603|NCT01309737|26700593|P4|Week 16 to 52|Withdrawal by Subject|0
7676604|NCT01309737|26700594|P3|Week 16 to 52|Withdrawal by Subject|0
7676605|NCT01309737|26700595|P2|Week 16 to 52|Withdrawal by Subject|6
7676606|NCT01309737|26700596|P1|Week 16 to 52|Withdrawal by Subject|5
7676607|NCT01309737|26700592|P5|Week 16 to 52|Lost to Follow-up|4
7676608|NCT01309737|26700593|P4|Week 16 to 52|Lost to Follow-up|1
7676609|NCT01309737|26700594|P3|Week 16 to 52|Lost to Follow-up|0
7676610|NCT01309737|26700595|P2|Week 16 to 52|Lost to Follow-up|2
7676611|NCT01309737|26700596|P1|Week 16 to 52|Lost to Follow-up|4
7676612|NCT01309737|26700592|P5|Week 16 to 52|Lack of Efficacy|21
7676613|NCT01309737|26700593|P4|Week 16 to 52|Lack of Efficacy|25
7676614|NCT01309737|26700594|P3|Week 16 to 52|Lack of Efficacy|0
7676615|NCT01309737|26700595|P2|Week 16 to 52|Lack of Efficacy|76
7676616|NCT01309737|26700596|P1|Week 16 to 52|Lack of Efficacy|107
7676617|NCT01309737|26700592|P5|Week 16 to 52|Adverse Event|5
7676618|NCT01309737|26700593|P4|Week 16 to 52|Adverse Event|6
7676619|NCT01309737|26700594|P3|Week 16 to 52|Adverse Event|0
7676620|NCT01309737|26700595|P2|Week 16 to 52|Adverse Event|7
7676621|NCT01309737|26700596|P1|Week 16 to 52|Adverse Event|7
7676622|NCT01309737|26700592|P5|Week 16 to 52|Death|1
7676623|NCT01309737|26700593|P4|Week 16 to 52|Death|0
7676624|NCT01309737|26700594|P3|Week 16 to 52|Death|0
7676625|NCT01309737|26700595|P2|Week 16 to 52|Death|0
7676626|NCT01309737|26700596|P1|Week 16 to 52|Death|0
7676627|NCT01309737|26700592|P5|Week 0 to 16|Randomized, but not treated|0
7676628|NCT01309737|26700593|P4|Week 0 to 16|Randomized, but not treated|0
7676629|NCT01309737|26700594|P3|Week 0 to 16|Randomized, but not treated|0
7676630|NCT01309737|26700595|P2|Week 0 to 16|Randomized, but not treated|0
7676631|NCT01309737|26700596|P1|Week 0 to 16|Randomized, but not treated|1
7676632|NCT01309737|26700592|P5|Week 0 to 16|Other|0
7676633|NCT01309737|26700593|P4|Week 0 to 16|Other|0
7676634|NCT01309737|26700594|P3|Week 0 to 16|Other|4
7676635|NCT01309737|26700595|P2|Week 0 to 16|Other|14
7676636|NCT01309737|26700596|P1|Week 0 to 16|Other|10
7676637|NCT01309737|26700592|P5|Week 0 to 16|Withdrawal by Subject|0
7676638|NCT01309737|26700593|P4|Week 0 to 16|Withdrawal by Subject|0
7676639|NCT01309737|26700594|P3|Week 0 to 16|Withdrawal by Subject|7
7676640|NCT01309737|26700595|P2|Week 0 to 16|Withdrawal by Subject|6
7676641|NCT01309737|26700596|P1|Week 0 to 16|Withdrawal by Subject|7
7676642|NCT01309737|26700592|P5|Week 0 to 16|Lost to Follow-up|0
7676643|NCT01309737|26700593|P4|Week 0 to 16|Lost to Follow-up|0
7676644|NCT01309737|26700594|P3|Week 0 to 16|Lost to Follow-up|3
7676645|NCT01309737|26700595|P2|Week 0 to 16|Lost to Follow-up|8
7676646|NCT01309737|26700596|P1|Week 0 to 16|Lost to Follow-up|7
7676647|NCT01309737|26700592|P5|Week 0 to 16|Lack of Efficacy|0
7676648|NCT01309737|26700593|P4|Week 0 to 16|Lack of Efficacy|0
7676649|NCT01309737|26700594|P3|Week 0 to 16|Lack of Efficacy|24
7676650|NCT01309737|26700595|P2|Week 0 to 16|Lack of Efficacy|2
7676651|NCT01309737|26700596|P1|Week 0 to 16|Lack of Efficacy|15
7676652|NCT01309737|26700592|P5|Week 0 to 16|Adverse Event|0
7676653|NCT01309737|26700593|P4|Week 0 to 16|Adverse Event|0
7676654|NCT01309737|26700594|P3|Week 0 to 16|Adverse Event|5
7676655|NCT01309737|26700595|P2|Week 0 to 16|Adverse Event|10
7676656|NCT01309737|26700596|P1|Week 0 to 16|Adverse Event|11
7676657|NCT01309737|26700592|P5|Week 0 to 16|Death|0
7676658|NCT01309737|26700593|P4|Week 0 to 16|Death|0
7676659|NCT01309737|26700594|P3|Week 0 to 16|Death|1
7676660|NCT01309737|26700595|P2|Week 0 to 16|Death|0
7676661|NCT01309737|26700596|P1|Week 0 to 16|Death|1
7676662|NCT01309672|26700791|P1|Overall Study|Withdrawal by Subject|3
7676663|NCT01309672|26700791|P1|Overall Study|Adverse Event|5
7676664|NCT01309672|26700791|P1|Overall Study|Other|9
7676665|NCT01309672|26700791|P1|Overall Study|Lack of Efficacy|20
7676666|NCT01309659|26700801|P2|Overall Study|Protocol Violation|1
7676667|NCT01309659|26700802|P1|Overall Study|Protocol Violation|0
7676668|NCT01309386|26700907|P2|Overall Study|Adverse Event|8
7676669|NCT01309386|26700908|P1|Overall Study|Adverse Event|5
7676670|NCT01309386|26700907|P2|Overall Study|Lack of Efficacy|1
7676671|NCT01309386|26700908|P1|Overall Study|Lack of Efficacy|3
7676672|NCT01309386|26700907|P2|Overall Study|Physician Decision|1
7676673|NCT01309386|26700908|P1|Overall Study|Physician Decision|1
7676674|NCT01309386|26700907|P2|Overall Study|Progressive disease|11
7676675|NCT01309386|26700908|P1|Overall Study|Progressive disease|9
7676676|NCT01309386|26700907|P2|Overall Study|Withdrawal by Subject|0
7676677|NCT01309386|26700908|P1|Overall Study|Withdrawal by Subject|2
7676678|NCT01309386|26700907|P2|Overall Study|Other|0
7676679|NCT01309386|26700908|P1|Overall Study|Other|2
7676680|NCT01309308|26700956|P2|Overall Study|Lost to Follow-up|4
7676681|NCT01309308|26700957|P1|Overall Study|Lost to Follow-up|6
7676682|NCT01309282|26700965|P1|Overall Study|Lost to Follow-up|1
7676683|NCT01309269|26700982|P1|Overall Study|Enrolled but not Treated|107
7676684|NCT01309269|26700982|P1|Overall Study|Study Completion Data Not Recorded|95
7676685|NCT01309269|26700982|P1|Overall Study|Other|1
7676686|NCT01309269|26700982|P1|Overall Study|Other|256
7676687|NCT01309269|26700982|P1|Overall Study|Administrative Problems|141
7676688|NCT01309269|26700982|P1|Overall Study|Kidney Transplant|25
7676689|NCT01309269|26700982|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
7676690|NCT01309269|26700982|P1|Overall Study|Lack of Acceptance|15
7676691|NCT01309269|26700982|P1|Overall Study|Withdrawal by Subject|25
7676692|NCT01309269|26700982|P1|Overall Study|Adverse Event|56
7676693|NCT01309243|26700990|P2|Extension Phase|Lost to Follow-up|0
7676694|NCT01309243|26700991|P1|Extension Phase|Lost to Follow-up|6
7676695|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Protocol Violation|1
7676696|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Protocol Violation|1
7676697|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
7676698|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
7676699|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
7676700|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
7676701|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Withdrew Consent|18
7676702|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Withdrew Consent|12
7676703|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Investigators Discretion|6
7676704|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Investigators Discretion|3
7676705|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
7676706|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
7676707|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Pregnancy|0
7676708|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Pregnancy|2
7676709|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Death|1
7676710|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Death|0
7676711|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Adverse Event|43
7676712|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Adverse Event|12
7676800|NCT01307501|26701492|P1|Overall Study|Treatment Failure|1
7676713|NCT01309243|26700990|P2|Randomized Phase Through Week 96|Randomized but not treated|7
7676714|NCT01309243|26700991|P1|Randomized Phase Through Week 96|Randomized but not treated|6
7676715|NCT01309204|26701017|P2|Overall Study|Other|1
7676716|NCT01309204|26701018|P1|Overall Study|Other|4
7676717|NCT01309204|26701017|P2|Overall Study|Inadequate control of IOP|4
7676718|NCT01309204|26701018|P1|Overall Study|Inadequate control of IOP|4
7676719|NCT01309204|26701017|P2|Overall Study|Subject's decision unrelated to an AE|10
7676720|NCT01309204|26701018|P1|Overall Study|Subject's decision unrelated to an AE|9
7676721|NCT01309204|26701017|P2|Overall Study|Lost to Follow-up|2
7676722|NCT01309204|26701018|P1|Overall Study|Lost to Follow-up|2
7676723|NCT01309204|26701017|P2|Overall Study|Adverse Event|58
7676724|NCT01309204|26701018|P1|Overall Study|Adverse Event|48
7676725|NCT01309165|26701026|P2|Overall Study|Admitted to hospital for second stroke|0
7676726|NCT01309165|26701027|P1|Overall Study|Admitted to hospital for second stroke|1
7676727|NCT01309165|26701026|P2|Overall Study|No transportation|1
7676728|NCT01309165|26701027|P1|Overall Study|No transportation|0
7676729|NCT01309165|26701026|P2|Overall Study|Left country|1
7676730|NCT01309165|26701027|P1|Overall Study|Left country|0
7676731|NCT01309165|26701026|P2|Overall Study|Return to work|2
7676732|NCT01309165|26701027|P1|Overall Study|Return to work|1
7676733|NCT01309165|26701026|P2|Overall Study|Lost to Follow-up|3
7676734|NCT01309165|26701027|P1|Overall Study|Lost to Follow-up|4
7676735|NCT01309100|26701039|P1|Overall Study|Positive Slit lamp finding|1
7676736|NCT01309100|26701039|P1|Overall Study|Protocol Violation|1
7676737|NCT01308853|26701057|P1|Overall Study|Insertion of permanent implants|1
7676738|NCT01308853|26701057|P1|Overall Study|Lost to Follow-up|2
7676739|NCT01308853|26701057|P1|Overall Study|Adverse Event|1
7676740|NCT01308788|26701092|P2|2-year Treatment|medication change by treating physician|11
7676741|NCT01308788|26701093|P1|2-year Treatment|medication change by treating physician|4
7676742|NCT01308762|26701128|P3|Overall Study|Protocol Violation|0
7676743|NCT01308762|26701129|P2|Overall Study|Protocol Violation|1
7676744|NCT01308762|26701130|P1|Overall Study|Protocol Violation|0
7676745|NCT01308749|26701143|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
7676746|NCT01308749|26701144|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
7676747|NCT01308749|26701143|P2|Period 2: Open Label Treatment|Adverse Event|1
7676748|NCT01308749|26701144|P1|Period 2: Open Label Treatment|Adverse Event|0
7676749|NCT01308749|26701143|P2|Period 1: Double Blind Treatment|Adverse Event|0
7676750|NCT01308749|26701144|P1|Period 1: Double Blind Treatment|Adverse Event|1
7676751|NCT01308736|26701174|P2|Overall Study|Did not attend a single session|5
7676752|NCT01308736|26701175|P1|Overall Study|Did not attend a single session|6
7676753|NCT01308580|26701198|P2|Overall Study|Lost to Follow-up|7
7676754|NCT01308580|26701199|P1|Overall Study|Lost to Follow-up|12
7676755|NCT01308567|26701242|P3|Overall Study|Lost to Follow-up|4
7676756|NCT01308567|26701243|P2|Overall Study|Lost to Follow-up|4
7676757|NCT01308567|26701244|P1|Overall Study|Lost to Follow-up|2
7676758|NCT01308476|26701284|P2|Overall Study|Other|0
7676759|NCT01308476|26701285|P1|Overall Study|Other|1
7676760|NCT01308476|26701284|P2|Overall Study|Lost to Follow-up|2
7676761|NCT01308476|26701285|P1|Overall Study|Lost to Follow-up|2
7676762|NCT01308463|26701305|P1|Overall Study|Revision|2
7676763|NCT01308463|26701305|P1|Overall Study|Death|4
7676764|NCT01308463|26701305|P1|Overall Study|Study Discontinued|23
7676765|NCT01308424|26701318|P3|Randomization|Physician Decision|1
7676766|NCT01308424|26701319|P2|Randomization|Physician Decision|1
7676767|NCT01308424|26701320|P1|Randomization|Physician Decision|0
7676768|NCT01308424|26701318|P3|Randomization|Lost to Follow-up|0
7676769|NCT01308424|26701319|P2|Randomization|Lost to Follow-up|1
7676770|NCT01308424|26701320|P1|Randomization|Lost to Follow-up|0
7676771|NCT01308424|26701318|P3|Randomization|Adverse Event|1
7676772|NCT01308424|26701319|P2|Randomization|Adverse Event|1
7676773|NCT01308424|26701320|P1|Randomization|Adverse Event|0
7676774|NCT01308424|26701318|P3|Baseline Eligibility|Screen Failures|0
7676775|NCT01308424|26701319|P2|Baseline Eligibility|Screen Failures|0
7676776|NCT01308424|26701320|P1|Baseline Eligibility|Screen Failures|71
7676777|NCT01308008|26701372|P2|4 Weeks|Illness, disinterest, time|2
7676778|NCT01308008|26701373|P1|4 Weeks|Illness, disinterest, time|9
7676779|NCT01307891|26701396|P2|Overall Study|Progressive Disease|1
7676780|NCT01307891|26701397|P1|Overall Study|Progressive Disease|3
7676781|NCT01307787|26701409|P2|Overall Study|Withdrawal by Subject|0
7676782|NCT01307787|26701410|P1|Overall Study|Withdrawal by Subject|2
7676783|NCT01307579|26701479|P2|Overall Study|Ineligible|4
7676784|NCT01307579|26701480|P1|Overall Study|Ineligible|3
7676785|NCT01307579|26701479|P2|Overall Study|Refractory or relapsed AML|23
7676786|NCT01307579|26701480|P1|Overall Study|Refractory or relapsed AML|38
7676787|NCT01307579|26701479|P2|Overall Study|Begin conditioning for HSCT|44
7676788|NCT01307579|26701480|P1|Overall Study|Begin conditioning for HSCT|42
7676789|NCT01307579|26701479|P2|Overall Study|Institutional diagnosis of IFD|36
7676790|NCT01307579|26701480|P1|Overall Study|Institutional diagnosis of IFD|21
7676791|NCT01307579|26701479|P2|Overall Study|Withdrawal by Subject|3
7676792|NCT01307579|26701480|P1|Overall Study|Withdrawal by Subject|7
7676793|NCT01307579|26701479|P2|Overall Study|Physician Decision|29
7676794|NCT01307579|26701480|P1|Overall Study|Physician Decision|26
7676795|NCT01307579|26701479|P2|Overall Study|Death|6
7676796|NCT01307579|26701480|P1|Overall Study|Death|3
7676797|NCT01307501|26701492|P1|Overall Study|Starting Hospice|1
7676798|NCT01307501|26701492|P1|Overall Study|Lost to Follow-up|1
7676799|NCT01307501|26701492|P1|Overall Study|Death|20
7676801|NCT01307449|26701522|P4|Overall Study|Adverse Event|0
7676802|NCT01307449|26701523|P3|Overall Study|Adverse Event|0
7676803|NCT01307449|26701524|P2|Overall Study|Adverse Event|0
7676804|NCT01307449|26701525|P1|Overall Study|Adverse Event|1
7676805|NCT01307423|26701558|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
7676806|NCT01307423|26701559|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
7676807|NCT01307423|26701560|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
7676808|NCT01307423|26701561|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
7676809|NCT01307423|26701562|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
7676810|NCT01307423|26701563|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
7676811|NCT01307423|26701564|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
7676812|NCT01307423|26701565|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
7676813|NCT01307423|26701566|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
7676814|NCT01307423|26701558|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676815|NCT01307423|26701559|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676816|NCT01307423|26701560|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676817|NCT01307423|26701561|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676818|NCT01307423|26701562|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676819|NCT01307423|26701563|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676820|NCT01307423|26701564|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676821|NCT01307423|26701565|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
7676822|NCT01307423|26701566|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7676823|NCT01307423|26701558|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7676824|NCT01307423|26701559|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7676825|NCT01307423|26701560|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7676826|NCT01307423|26701561|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7676827|NCT01307423|26701562|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7676828|NCT01307423|26701563|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7676829|NCT01307423|26701564|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7676830|NCT01307423|26701565|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
7676831|NCT01307423|26701566|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7676832|NCT01307423|26701558|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676833|NCT01307423|26701559|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676834|NCT01307423|26701560|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676835|NCT01307423|26701561|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676836|NCT01307423|26701562|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676837|NCT01307423|26701563|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676838|NCT01307423|26701564|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
7676839|NCT01307423|26701565|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
7676840|NCT01307423|26701566|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7676841|NCT01307423|26701558|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
7676842|NCT01307423|26701559|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
7676843|NCT01307423|26701560|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
7676844|NCT01307423|26701561|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
7676845|NCT01307423|26701562|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
7676846|NCT01307423|26701563|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
7676847|NCT01307423|26701564|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
7676848|NCT01307423|26701565|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
7676849|NCT01307423|26701566|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
7676850|NCT01307423|26701558|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676851|NCT01307423|26701559|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
7676852|NCT01307423|26701560|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676853|NCT01307423|26701561|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676854|NCT01307423|26701562|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676855|NCT01307423|26701563|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676856|NCT01307423|26701564|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676857|NCT01307423|26701565|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676858|NCT01307423|26701566|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
7676859|NCT01307423|26701558|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676860|NCT01307423|26701559|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676861|NCT01307423|26701560|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676862|NCT01307423|26701561|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676863|NCT01307423|26701562|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676864|NCT01307423|26701563|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676865|NCT01307423|26701564|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
7676866|NCT01307423|26701565|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676867|NCT01307423|26701566|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7676868|NCT01307423|26701558|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
7676869|NCT01307423|26701559|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
7676870|NCT01307423|26701560|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7676871|NCT01307423|26701561|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7676872|NCT01307423|26701562|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7676873|NCT01307423|26701563|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7676874|NCT01307423|26701564|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
7676875|NCT01307423|26701565|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
7676876|NCT01307423|26701566|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7676877|NCT01307423|26701558|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7676878|NCT01307423|26701559|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676879|NCT01307423|26701560|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676880|NCT01307423|26701561|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676881|NCT01307423|26701562|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676882|NCT01307423|26701563|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676883|NCT01307423|26701564|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676884|NCT01307423|26701565|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7676885|NCT01307423|26701566|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7676886|NCT01307423|26701558|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
7676887|NCT01307423|26701559|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
7676888|NCT01307423|26701560|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
7676889|NCT01307423|26701561|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
7676890|NCT01307423|26701562|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
7676891|NCT01307423|26701563|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
7676892|NCT01307423|26701564|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
7676893|NCT01307423|26701565|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
7676894|NCT01307423|26701566|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
7676895|NCT01307423|26701558|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676896|NCT01307423|26701559|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
7676897|NCT01307423|26701560|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676898|NCT01307423|26701561|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676899|NCT01307423|26701562|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676900|NCT01307423|26701563|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676901|NCT01307423|26701564|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676902|NCT01307423|26701565|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
7676903|NCT01307423|26701566|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
7676904|NCT01307423|26701558|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7676905|NCT01307423|26701559|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7676906|NCT01307423|26701560|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7676907|NCT01307423|26701561|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7676908|NCT01307423|26701562|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7676909|NCT01307423|26701563|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7676910|NCT01307423|26701564|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
7676911|NCT01307423|26701565|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
7676912|NCT01307423|26701566|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7676913|NCT01307423|26701558|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
7676914|NCT01307423|26701559|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
7676915|NCT01307423|26701560|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7676916|NCT01307423|26701561|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7676917|NCT01307423|26701562|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7676918|NCT01307423|26701563|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7676919|NCT01307423|26701564|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
7676920|NCT01307423|26701565|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
7676921|NCT01307423|26701566|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7676922|NCT01307423|26701558|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676923|NCT01307423|26701559|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676924|NCT01307423|26701560|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676925|NCT01307423|26701561|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676926|NCT01307423|26701562|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676927|NCT01307423|26701563|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676928|NCT01307423|26701564|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
7676929|NCT01307423|26701565|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
7676930|NCT01307423|26701566|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7676931|NCT01307423|26701558|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7676932|NCT01307423|26701559|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
7676933|NCT01307423|26701560|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7676934|NCT01307423|26701561|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7676935|NCT01307423|26701562|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7676936|NCT01307423|26701563|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7676937|NCT01307423|26701564|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
7676938|NCT01307423|26701565|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7676939|NCT01307423|26701566|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7676940|NCT01307423|26701558|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
7676941|NCT01307423|26701559|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
7676942|NCT01307423|26701560|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
7676943|NCT01307423|26701561|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
7676944|NCT01307423|26701562|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
7676945|NCT01307423|26701563|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
7676946|NCT01307423|26701564|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
7676947|NCT01307423|26701565|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
7676948|NCT01307423|26701566|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
7676949|NCT01307423|26701558|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
7676950|NCT01307423|26701559|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
7676951|NCT01307423|26701560|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
7676952|NCT01307423|26701561|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
7676953|NCT01307423|26701562|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
7676954|NCT01307423|26701563|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
7676955|NCT01307423|26701564|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
7676956|NCT01307423|26701565|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
7676957|NCT01307423|26701566|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
7676958|NCT01307423|26701558|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
7676959|NCT01307423|26701559|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
7676960|NCT01307423|26701560|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7676961|NCT01307423|26701561|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7676962|NCT01307423|26701562|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7676963|NCT01307423|26701563|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7676964|NCT01307423|26701564|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
7676965|NCT01307423|26701565|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
7676966|NCT01307423|26701566|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7676967|NCT01307423|26701558|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676968|NCT01307423|26701559|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676969|NCT01307423|26701560|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676970|NCT01307423|26701561|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676971|NCT01307423|26701562|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676972|NCT01307423|26701563|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676973|NCT01307423|26701564|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
7676974|NCT01307423|26701565|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676975|NCT01307423|26701566|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7676976|NCT01307423|26701558|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
7676977|NCT01307423|26701559|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
7676978|NCT01307423|26701560|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7676979|NCT01307423|26701561|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7676980|NCT01307423|26701562|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7676981|NCT01307423|26701563|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7676982|NCT01307423|26701564|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
7676983|NCT01307423|26701565|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
7676984|NCT01307423|26701566|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7676985|NCT01307423|26701558|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
7676986|NCT01307423|26701559|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
7676987|NCT01307423|26701560|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
7676988|NCT01307423|26701561|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
7676989|NCT01307423|26701562|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
7676990|NCT01307423|26701563|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
7676991|NCT01307423|26701564|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
7676992|NCT01307423|26701565|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
7676993|NCT01307423|26701566|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
7676994|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7676995|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7676996|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7676997|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
7676998|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7676999|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7677000|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7677001|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7677002|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7677003|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Other|0
7677004|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Other|0
7677005|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Other|0
7677006|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Other|0
7677007|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Other|0
7677008|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Other|1
7677009|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Other|0
7677010|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Other|0
7677011|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Other|0
7677012|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677013|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677014|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677015|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677016|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677017|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
7677018|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677019|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677020|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7677176|NCT01307267|26701817|P14|Overall Study|Withdrawal by Subject|0
7677021|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7677022|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7677023|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
7677024|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
7677025|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7677026|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7677027|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
7677028|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
7677029|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7677030|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677031|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677032|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677033|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
7677034|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677035|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677036|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677037|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677038|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7677039|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7677040|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7677041|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7677042|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7677043|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
7677044|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
7677045|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
7677046|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
7677047|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7677048|NCT01307423|26701558|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
7677049|NCT01307423|26701559|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
7677050|NCT01307423|26701560|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
7677051|NCT01307423|26701561|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
7677052|NCT01307423|26701562|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
7677053|NCT01307423|26701563|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
7677054|NCT01307423|26701564|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
7677055|NCT01307423|26701565|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
7677056|NCT01307423|26701566|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
7677057|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677058|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677059|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677060|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677061|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677062|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677063|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
7677064|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
7677065|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7677066|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677067|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677068|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677069|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677070|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677071|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677072|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
7677073|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
7677074|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
7677075|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677076|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677077|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677078|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677079|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677080|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677081|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677082|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7677083|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7677084|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7677085|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7677086|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7677087|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7677088|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7677089|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7677090|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
7677091|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7677092|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
7677093|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677094|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677095|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677096|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677097|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677098|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677099|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
7677100|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677101|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7677102|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7677103|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7677104|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7677105|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7677106|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7677107|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7677108|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
7677109|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7677110|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
7677111|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7677112|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7677113|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7677114|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7677115|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7677116|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7677117|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7677118|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7677119|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
7677120|NCT01307423|26701558|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7677121|NCT01307423|26701559|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7677122|NCT01307423|26701560|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7677123|NCT01307423|26701561|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7677124|NCT01307423|26701562|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7677125|NCT01307423|26701563|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7677126|NCT01307423|26701564|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
7677127|NCT01307423|26701565|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7677128|NCT01307423|26701566|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7677129|NCT01307319|26701772|P3|Overall Study|Other|3
7677130|NCT01307319|26701773|P2|Overall Study|Other|4
7677131|NCT01307319|26701774|P1|Overall Study|Other|0
7677132|NCT01307319|26701772|P3|Overall Study|Withdrawal by Subject|2
7677133|NCT01307319|26701773|P2|Overall Study|Withdrawal by Subject|1
7677134|NCT01307319|26701774|P1|Overall Study|Withdrawal by Subject|0
7677135|NCT01307319|26701772|P3|Overall Study|Protocol Violation|0
7677136|NCT01307319|26701773|P2|Overall Study|Protocol Violation|1
7677137|NCT01307319|26701774|P1|Overall Study|Protocol Violation|1
7677138|NCT01307319|26701772|P3|Overall Study|Lost to Follow-up|1
7677139|NCT01307319|26701773|P2|Overall Study|Lost to Follow-up|0
7677140|NCT01307319|26701774|P1|Overall Study|Lost to Follow-up|1
7677141|NCT01307319|26701772|P3|Overall Study|Adverse Event|1
7677142|NCT01307319|26701773|P2|Overall Study|Adverse Event|2
7677143|NCT01307319|26701774|P1|Overall Study|Adverse Event|2
7677144|NCT01307267|26701808|P23|Overall Study|Other|2
7677145|NCT01307267|26701809|P22|Overall Study|Other|3
7677146|NCT01307267|26701810|P21|Overall Study|Other|2
7677147|NCT01307267|26701811|P20|Overall Study|Other|19
7677148|NCT01307267|26701812|P19|Overall Study|Other|0
7677149|NCT01307267|26701813|P18|Overall Study|Other|0
7677150|NCT01307267|26701814|P17|Overall Study|Other|0
7677151|NCT01307267|26701815|P16|Overall Study|Other|1
7677152|NCT01307267|26701816|P15|Overall Study|Other|2
7677153|NCT01307267|26701817|P14|Overall Study|Other|0
7677154|NCT01307267|26701818|P13|Overall Study|Other|1
7677155|NCT01307267|26701819|P12|Overall Study|Other|1
7677156|NCT01307267|26701820|P11|Overall Study|Other|1
7677157|NCT01307267|26701821|P10|Overall Study|Other|0
7677158|NCT01307267|26701822|P9|Overall Study|Other|3
7677159|NCT01307267|26701823|P8|Overall Study|Other|1
7677160|NCT01307267|26701824|P7|Overall Study|Other|0
7677161|NCT01307267|26701825|P6|Overall Study|Other|7
7677162|NCT01307267|26701826|P5|Overall Study|Other|0
7677163|NCT01307267|26701827|P4|Overall Study|Other|0
7677164|NCT01307267|26701828|P3|Overall Study|Other|0
7677165|NCT01307267|26701829|P2|Overall Study|Other|0
7677166|NCT01307267|26701830|P1|Overall Study|Other|0
7677167|NCT01307267|26701808|P23|Overall Study|Withdrawal by Subject|0
7677168|NCT01307267|26701809|P22|Overall Study|Withdrawal by Subject|0
7677169|NCT01307267|26701810|P21|Overall Study|Withdrawal by Subject|0
7677170|NCT01307267|26701811|P20|Overall Study|Withdrawal by Subject|3
7677171|NCT01307267|26701812|P19|Overall Study|Withdrawal by Subject|0
7677172|NCT01307267|26701813|P18|Overall Study|Withdrawal by Subject|0
7677173|NCT01307267|26701814|P17|Overall Study|Withdrawal by Subject|0
7677174|NCT01307267|26701815|P16|Overall Study|Withdrawal by Subject|0
7677175|NCT01307267|26701816|P15|Overall Study|Withdrawal by Subject|0
7677177|NCT01307267|26701818|P13|Overall Study|Withdrawal by Subject|0
7677178|NCT01307267|26701819|P12|Overall Study|Withdrawal by Subject|1
7677179|NCT01307267|26701820|P11|Overall Study|Withdrawal by Subject|1
7677180|NCT01307267|26701821|P10|Overall Study|Withdrawal by Subject|1
7677181|NCT01307267|26701822|P9|Overall Study|Withdrawal by Subject|5
7677182|NCT01307267|26701823|P8|Overall Study|Withdrawal by Subject|1
7677183|NCT01307267|26701824|P7|Overall Study|Withdrawal by Subject|0
7677184|NCT01307267|26701825|P6|Overall Study|Withdrawal by Subject|1
7677185|NCT01307267|26701826|P5|Overall Study|Withdrawal by Subject|0
7677186|NCT01307267|26701827|P4|Overall Study|Withdrawal by Subject|0
7677187|NCT01307267|26701828|P3|Overall Study|Withdrawal by Subject|0
7677188|NCT01307267|26701829|P2|Overall Study|Withdrawal by Subject|0
7677189|NCT01307267|26701830|P1|Overall Study|Withdrawal by Subject|0
7677190|NCT01307267|26701808|P23|Overall Study|Lost to Follow-up|0
7677191|NCT01307267|26701809|P22|Overall Study|Lost to Follow-up|0
7677192|NCT01307267|26701810|P21|Overall Study|Lost to Follow-up|0
7677193|NCT01307267|26701811|P20|Overall Study|Lost to Follow-up|2
7677194|NCT01307267|26701812|P19|Overall Study|Lost to Follow-up|0
7677195|NCT01307267|26701813|P18|Overall Study|Lost to Follow-up|0
7677196|NCT01307267|26701814|P17|Overall Study|Lost to Follow-up|0
7677197|NCT01307267|26701815|P16|Overall Study|Lost to Follow-up|0
7677198|NCT01307267|26701816|P15|Overall Study|Lost to Follow-up|0
7677199|NCT01307267|26701817|P14|Overall Study|Lost to Follow-up|0
7677200|NCT01307267|26701818|P13|Overall Study|Lost to Follow-up|0
7677201|NCT01307267|26701819|P12|Overall Study|Lost to Follow-up|0
7677202|NCT01307267|26701820|P11|Overall Study|Lost to Follow-up|1
7677203|NCT01307267|26701821|P10|Overall Study|Lost to Follow-up|2
7677204|NCT01307267|26701822|P9|Overall Study|Lost to Follow-up|1
7677205|NCT01307267|26701823|P8|Overall Study|Lost to Follow-up|0
7677206|NCT01307267|26701824|P7|Overall Study|Lost to Follow-up|0
7677207|NCT01307267|26701825|P6|Overall Study|Lost to Follow-up|7
7677208|NCT01307267|26701826|P5|Overall Study|Lost to Follow-up|0
7677209|NCT01307267|26701827|P4|Overall Study|Lost to Follow-up|0
7677210|NCT01307267|26701828|P3|Overall Study|Lost to Follow-up|0
7677211|NCT01307267|26701829|P2|Overall Study|Lost to Follow-up|0
7677212|NCT01307267|26701830|P1|Overall Study|Lost to Follow-up|0
7677213|NCT01307267|26701808|P23|Overall Study|Death|2
7677214|NCT01307267|26701809|P22|Overall Study|Death|2
7677215|NCT01307267|26701810|P21|Overall Study|Death|1
7677216|NCT01307267|26701811|P20|Overall Study|Death|8
7677217|NCT01307267|26701812|P19|Overall Study|Death|2
7677218|NCT01307267|26701813|P18|Overall Study|Death|1
7677219|NCT01307267|26701814|P17|Overall Study|Death|1
7677220|NCT01307267|26701815|P16|Overall Study|Death|0
7677221|NCT01307267|26701816|P15|Overall Study|Death|0
7677222|NCT01307267|26701817|P14|Overall Study|Death|0
7677223|NCT01307267|26701818|P13|Overall Study|Death|0
7677224|NCT01307267|26701819|P12|Overall Study|Death|9
7677225|NCT01307267|26701820|P11|Overall Study|Death|3
7677226|NCT01307267|26701821|P10|Overall Study|Death|2
7677227|NCT01307267|26701822|P9|Overall Study|Death|21
7677228|NCT01307267|26701823|P8|Overall Study|Death|2
7677229|NCT01307267|26701824|P7|Overall Study|Death|2
7677230|NCT01307267|26701825|P6|Overall Study|Death|26
7677231|NCT01307267|26701826|P5|Overall Study|Death|1
7677232|NCT01307267|26701827|P4|Overall Study|Death|3
7677233|NCT01307267|26701828|P3|Overall Study|Death|5
7677234|NCT01307267|26701829|P2|Overall Study|Death|3
7677235|NCT01307267|26701830|P1|Overall Study|Death|4
7677236|NCT01307111|26702421|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
7677237|NCT01307111|26702422|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
7677238|NCT01307111|26702421|P2|IUD Insertion|Lost to Follow-up|0
7677239|NCT01307111|26702422|P1|IUD Insertion|Lost to Follow-up|2
7677240|NCT01307046|26702445|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
7677241|NCT01307046|26702446|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
7677242|NCT01307046|26702445|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
7677243|NCT01307046|26702446|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
7677244|NCT01307046|26702445|P2|Overall Study|Withdrawal by Subject|1
7677245|NCT01307046|26702446|P1|Overall Study|Withdrawal by Subject|1
7677246|NCT01307046|26702445|P2|Overall Study|Physician Decision|0
7677247|NCT01307046|26702446|P1|Overall Study|Physician Decision|2
7677248|NCT01307046|26702445|P2|Overall Study|Lack of Efficacy|2
7677249|NCT01307046|26702446|P1|Overall Study|Lack of Efficacy|0
7677250|NCT01307046|26702445|P2|Overall Study|Adverse Event|3
7677251|NCT01307046|26702446|P1|Overall Study|Adverse Event|3
7677252|NCT01307033|26702458|P4|44-week Open-label Extension|Death|1
7677253|NCT01307033|26702459|P3|44-week Open-label Extension|Death|0
7677254|NCT01307033|26702460|P2|44-week Open-label Extension|Death|0
7677255|NCT01307033|26702461|P1|44-week Open-label Extension|Death|0
7677256|NCT01307033|26702458|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
7677257|NCT01307033|26702459|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
7677258|NCT01307033|26702460|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
7677259|NCT01307033|26702461|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
7677260|NCT01307033|26702458|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
7677261|NCT01307033|26702459|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7677262|NCT01307033|26702460|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7677263|NCT01307033|26702461|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7677264|NCT01307033|26702458|P4|44-week Open-label Extension|Physician Decision|0
7677265|NCT01307033|26702459|P3|44-week Open-label Extension|Physician Decision|1
7677266|NCT01307033|26702460|P2|44-week Open-label Extension|Physician Decision|0
7677267|NCT01307033|26702461|P1|44-week Open-label Extension|Physician Decision|0
7677268|NCT01307033|26702458|P4|44-week Open-label Extension|Withdrawal by Subject|1
7677269|NCT01307033|26702459|P3|44-week Open-label Extension|Withdrawal by Subject|2
7677270|NCT01307033|26702460|P2|44-week Open-label Extension|Withdrawal by Subject|0
7677271|NCT01307033|26702461|P1|44-week Open-label Extension|Withdrawal by Subject|0
7677272|NCT01307033|26702458|P4|44-week Open-label Extension|Adverse Event|1
7677273|NCT01307033|26702459|P3|44-week Open-label Extension|Adverse Event|2
7677274|NCT01307033|26702460|P2|44-week Open-label Extension|Adverse Event|0
7677275|NCT01307033|26702461|P1|44-week Open-label Extension|Adverse Event|0
7677276|NCT01307033|26702458|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
7677277|NCT01307033|26702459|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
7677278|NCT01307033|26702460|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
7677279|NCT01307033|26702461|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
7677280|NCT01307033|26702458|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7677281|NCT01307033|26702459|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7677282|NCT01307033|26702460|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
7677283|NCT01307033|26702461|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7677284|NCT01307033|26702458|P4|8-week Double-blind Period|Lack of Efficacy|0
7677285|NCT01307033|26702459|P3|8-week Double-blind Period|Lack of Efficacy|0
7677286|NCT01307033|26702460|P2|8-week Double-blind Period|Lack of Efficacy|0
7677287|NCT01307033|26702461|P1|8-week Double-blind Period|Lack of Efficacy|1
7677288|NCT01307033|26702458|P4|8-week Double-blind Period|Withdrawal by Subject|0
7677289|NCT01307033|26702459|P3|8-week Double-blind Period|Withdrawal by Subject|0
7677290|NCT01307033|26702460|P2|8-week Double-blind Period|Withdrawal by Subject|1
7677291|NCT01307033|26702461|P1|8-week Double-blind Period|Withdrawal by Subject|4
7677292|NCT01307033|26702458|P4|8-week Double-blind Period|Adverse Event|0
7677293|NCT01307033|26702459|P3|8-week Double-blind Period|Adverse Event|0
7677294|NCT01307033|26702460|P2|8-week Double-blind Period|Adverse Event|0
7677295|NCT01307033|26702461|P1|8-week Double-blind Period|Adverse Event|2
7677296|NCT01307020|26702483|P10|Overall Study|Electronic data capture failure|0
7677297|NCT01307020|26702484|P9|Overall Study|Electronic data capture failure|0
7677298|NCT01307020|26702485|P8|Overall Study|Electronic data capture failure|0
7677299|NCT01307020|26702486|P7|Overall Study|Electronic data capture failure|0
7677300|NCT01307020|26702487|P6|Overall Study|Electronic data capture failure|0
7677301|NCT01307020|26702488|P5|Overall Study|Electronic data capture failure|0
7677302|NCT01307020|26702489|P4|Overall Study|Electronic data capture failure|0
7677303|NCT01307020|26702490|P3|Overall Study|Electronic data capture failure|0
7677304|NCT01307020|26702491|P2|Overall Study|Electronic data capture failure|1
7677305|NCT01307020|26702492|P1|Overall Study|Electronic data capture failure|0
7677306|NCT01307020|26702483|P10|Overall Study|Lost to Follow-up|0
7677307|NCT01307020|26702484|P9|Overall Study|Lost to Follow-up|0
7677308|NCT01307020|26702485|P8|Overall Study|Lost to Follow-up|0
7677309|NCT01307020|26702486|P7|Overall Study|Lost to Follow-up|1
7677310|NCT01307020|26702487|P6|Overall Study|Lost to Follow-up|0
7677311|NCT01307020|26702488|P5|Overall Study|Lost to Follow-up|0
7677312|NCT01307020|26702489|P4|Overall Study|Lost to Follow-up|1
7677313|NCT01307020|26702490|P3|Overall Study|Lost to Follow-up|1
7677314|NCT01307020|26702491|P2|Overall Study|Lost to Follow-up|0
7677315|NCT01307020|26702492|P1|Overall Study|Lost to Follow-up|0
7677316|NCT01306968|26702547|P4|Overall Study|Withdrew over privacy concerns|1
7677317|NCT01306968|26702548|P3|Overall Study|Withdrew over privacy concerns|0
7677318|NCT01306968|26702549|P2|Overall Study|Withdrew over privacy concerns|0
7677319|NCT01306968|26702550|P1|Overall Study|Withdrew over privacy concerns|0
7677320|NCT01306968|26702547|P4|Overall Study|Withdrew - time commitment|2
7677321|NCT01306968|26702548|P3|Overall Study|Withdrew - time commitment|0
7677322|NCT01306968|26702549|P2|Overall Study|Withdrew - time commitment|0
7677323|NCT01306968|26702550|P1|Overall Study|Withdrew - time commitment|0
7677324|NCT01306968|26702547|P4|Overall Study|Relocated and left active duty|1
7677325|NCT01306968|26702548|P3|Overall Study|Relocated and left active duty|1
7677326|NCT01306968|26702549|P2|Overall Study|Relocated and left active duty|1
7677327|NCT01306968|26702550|P1|Overall Study|Relocated and left active duty|0
7677328|NCT01306968|26702547|P4|Overall Study|Physician Decision|0
7677329|NCT01306968|26702548|P3|Overall Study|Physician Decision|0
7677330|NCT01306968|26702549|P2|Overall Study|Physician Decision|1
7677331|NCT01306968|26702550|P1|Overall Study|Physician Decision|0
7677332|NCT01306968|26702547|P4|Overall Study|Lost to Follow-up|0
7677333|NCT01306968|26702548|P3|Overall Study|Lost to Follow-up|0
7677334|NCT01306968|26702549|P2|Overall Study|Lost to Follow-up|1
7677335|NCT01306968|26702550|P1|Overall Study|Lost to Follow-up|1
7677336|NCT01306942|26702575|P4|Phase II|Protocol Violation|1
7677337|NCT01306942|26702576|P3|Phase II|Protocol Violation|0
7677338|NCT01306942|26702577|P2|Phase II|Protocol Violation|0
7677339|NCT01306942|26702578|P1|Phase II|Protocol Violation|0
7677340|NCT01306942|26702575|P4|Phase II|Not finished treatment|1
7677341|NCT01306942|26702576|P3|Phase II|Not finished treatment|0
7677342|NCT01306942|26702577|P2|Phase II|Not finished treatment|0
7677343|NCT01306942|26702578|P1|Phase II|Not finished treatment|0
7677344|NCT01306942|26702575|P4|Phase II|Death|1
7677345|NCT01306942|26702576|P3|Phase II|Death|0
7677346|NCT01306942|26702577|P2|Phase II|Death|0
7677347|NCT01306942|26702578|P1|Phase II|Death|0
7677348|NCT01306942|26702575|P4|Phase II|Withdrawal by Subject|2
7677349|NCT01306942|26702576|P3|Phase II|Withdrawal by Subject|0
7677350|NCT01306942|26702577|P2|Phase II|Withdrawal by Subject|0
7677351|NCT01306942|26702578|P1|Phase II|Withdrawal by Subject|0
7677352|NCT01306942|26702575|P4|Phase II|Physician Decision|5
7677353|NCT01306942|26702576|P3|Phase II|Physician Decision|0
7677354|NCT01306942|26702577|P2|Phase II|Physician Decision|0
7677355|NCT01306942|26702578|P1|Phase II|Physician Decision|2
7677356|NCT01306942|26702575|P4|Phase II|Adverse Event|6
7677357|NCT01306942|26702576|P3|Phase II|Adverse Event|0
7677358|NCT01306942|26702577|P2|Phase II|Adverse Event|0
7677359|NCT01306942|26702578|P1|Phase II|Adverse Event|0
7677360|NCT01306942|26702575|P4|Phase I|Physician Decision|0
7677361|NCT01306942|26702576|P3|Phase I|Physician Decision|0
7677362|NCT01306942|26702577|P2|Phase I|Physician Decision|1
7677363|NCT01306942|26702578|P1|Phase I|Physician Decision|3
7677364|NCT01306942|26702575|P4|Phase I|Adverse Event|0
7677365|NCT01306942|26702576|P3|Phase I|Adverse Event|0
7677366|NCT01306942|26702577|P2|Phase I|Adverse Event|2
7677367|NCT01306942|26702578|P1|Phase I|Adverse Event|2
7677368|NCT01306890|26702610|P1|Overall Study|No discontinuation documentation|41
7677369|NCT01306890|26702610|P1|Overall Study|Study Termination|3
7677370|NCT01306890|26702610|P1|Overall Study|Unspecified reasons|104
7677371|NCT01306890|26702610|P1|Overall Study|Withdrawal by Subject|88
7677372|NCT01306890|26702610|P1|Overall Study|Lost to Follow-up|58
7677373|NCT01306890|26702610|P1|Overall Study|Death|1223
7677374|NCT01306890|26702610|P1|Overall Study|Adverse Event|2
7677375|NCT01306877|26702617|P2|Overall Study|Physician Decision|1
7677376|NCT01306877|26702618|P1|Overall Study|Physician Decision|0
7677377|NCT01306877|26702617|P2|Overall Study|Lost to Follow-up|3
7677378|NCT01306877|26702618|P1|Overall Study|Lost to Follow-up|3
7677379|NCT01306656|26702638|P2|Overall Study|Lost to Follow-up|0
7677380|NCT01306656|26702639|P1|Overall Study|Lost to Follow-up|1
7677381|NCT01306643|26702651|P1|Overall Study|Other: Change in Eligibility Status|1
7677382|NCT01306643|26702651|P1|Overall Study|Disease Progression|7
7677383|NCT01306643|26702651|P1|Overall Study|Adverse Event|5
7677384|NCT01306617|26702663|P3|Overall Study|Non-compliance|0
7677385|NCT01306617|26702664|P2|Overall Study|Non-compliance|1
7677386|NCT01306617|26702665|P1|Overall Study|Non-compliance|0
7677387|NCT01306617|26702663|P3|Overall Study|Virologic Failure|5
7677388|NCT01306617|26702664|P2|Overall Study|Virologic Failure|0
7677389|NCT01306617|26702665|P1|Overall Study|Virologic Failure|0
7677390|NCT01306617|26702663|P3|Overall Study|Adverse Event|0
7677391|NCT01306617|26702664|P2|Overall Study|Adverse Event|0
7677392|NCT01306617|26702665|P1|Overall Study|Adverse Event|1
7677393|NCT01306331|26702708|P2|Overall Study|Other|32
7677394|NCT01306331|26702709|P1|Overall Study|Other|34
7677395|NCT01306331|26702708|P2|Overall Study|Meth. no longer prim. meth. birth cntrl|20
7677396|NCT01306331|26702709|P1|Overall Study|Meth. no longer prim. meth. birth cntrl|10
7677397|NCT01306331|26702708|P2|Overall Study|Not sexually active|28
7677398|NCT01306331|26702709|P1|Overall Study|Not sexually active|29
7677399|NCT01306331|26702708|P2|Overall Study|Withdrawal by Subject|152
7677400|NCT01306331|26702709|P1|Overall Study|Withdrawal by Subject|163
7677401|NCT01306331|26702708|P2|Overall Study|Protocol Violation|124
7677402|NCT01306331|26702709|P1|Overall Study|Protocol Violation|154
7677403|NCT01306331|26702708|P2|Overall Study|Pregnancy|151
7677404|NCT01306331|26702709|P1|Overall Study|Pregnancy|136
7677405|NCT01306331|26702708|P2|Overall Study|Physician Decision|22
7677406|NCT01306331|26702709|P1|Overall Study|Physician Decision|26
7677407|NCT01306331|26702708|P2|Overall Study|Lost to Follow-up|323
7677408|NCT01306331|26702709|P1|Overall Study|Lost to Follow-up|321
7677409|NCT01306331|26702708|P2|Overall Study|Adverse Event|25
7677410|NCT01306331|26702709|P1|Overall Study|Adverse Event|28
7677411|NCT01306305|26702719|P2|Overall Study|Withdrew consent|0
7677412|NCT01306305|26702720|P1|Overall Study|Withdrew consent|1
7677413|NCT01306305|26702719|P2|Overall Study|Lost to Follow-up|0
7677414|NCT01306305|26702720|P1|Overall Study|Lost to Follow-up|1
7677415|NCT01306253|26702757|P2|Overall Study|Lost to Follow-up|1
7677416|NCT01306253|26702758|P1|Overall Study|Lost to Follow-up|1
7677417|NCT01306214|26702775|P3|Overall Study|Not treated|1
7677418|NCT01306214|26702776|P2|Overall Study|Not treated|1
7677419|NCT01306214|26702777|P1|Overall Study|Not treated|1
7677420|NCT01306214|26702775|P3|Overall Study|Withdrawal by Subject|16
7677421|NCT01306214|26702776|P2|Overall Study|Withdrawal by Subject|22
7677422|NCT01306214|26702777|P1|Overall Study|Withdrawal by Subject|24
7677423|NCT01306214|26702775|P3|Overall Study|Lost to Follow-up|4
7677424|NCT01306214|26702776|P2|Overall Study|Lost to Follow-up|5
7677425|NCT01306214|26702777|P1|Overall Study|Lost to Follow-up|3
7677426|NCT01306214|26702775|P3|Overall Study|Death|1
7677427|NCT01306214|26702776|P2|Overall Study|Death|0
7677428|NCT01306214|26702777|P1|Overall Study|Death|0
7677429|NCT01306201|26702794|P1|Overall Study|Files unreadable|3
7677430|NCT01306201|26702794|P1|Overall Study|Files could not be processed|3
7677431|NCT01306201|26702794|P1|Overall Study|Arrhythmia|4
7677432|NCT01306162|26702816|P4|Washout 1|Non-compliance to protocol|0
7677433|NCT01306162|26702817|P3|Washout 1|Non-compliance to protocol|0
7677434|NCT01306162|26702818|P2|Washout 1|Non-compliance to protocol|1
7677435|NCT01306162|26702819|P1|Washout 1|Non-compliance to protocol|0
7677436|NCT01306162|26702816|P4|Period 1|Adverse Event|1
7677437|NCT01306162|26702817|P3|Period 1|Adverse Event|0
7677438|NCT01306162|26702818|P2|Period 1|Adverse Event|0
7677439|NCT01306162|26702819|P1|Period 1|Adverse Event|0
7677440|NCT01306058|26702847|P1|Overall Study|Enrolled but did not get treatment|1
7677441|NCT01306058|26702847|P1|Overall Study|Death|1
7677442|NCT01306032|26702874|P6|Disease Progression/Crossover|other/symptomatic progression|0
7677443|NCT01306032|26702875|P5|Disease Progression/Crossover|other/symptomatic progression|0
7677444|NCT01306032|26702876|P4|Disease Progression/Crossover|other/symptomatic progression|2
7677445|NCT01306032|26702877|P3|Disease Progression/Crossover|other/symptomatic progression|0
7677446|NCT01306032|26702878|P2|Disease Progression/Crossover|other/symptomatic progression|2
7677447|NCT01306032|26702879|P1|Disease Progression/Crossover|other/symptomatic progression|0
7677448|NCT01306032|26702874|P6|Disease Progression/Crossover|Withdrawal by Subject|0
7677449|NCT01306032|26702875|P5|Disease Progression/Crossover|Withdrawal by Subject|0
7677450|NCT01306032|26702876|P4|Disease Progression/Crossover|Withdrawal by Subject|1
7677451|NCT01306032|26702877|P3|Disease Progression/Crossover|Withdrawal by Subject|0
7677452|NCT01306032|26702878|P2|Disease Progression/Crossover|Withdrawal by Subject|0
7677453|NCT01306032|26702879|P1|Disease Progression/Crossover|Withdrawal by Subject|0
7677454|NCT01306032|26702874|P6|First Intervention|Progressive disease|0
7677455|NCT01306032|26702875|P5|First Intervention|Progressive disease|2
7677456|NCT01306032|26702876|P4|First Intervention|Progressive disease|0
7677457|NCT01306032|26702877|P3|First Intervention|Progressive disease|0
7677458|NCT01306032|26702878|P2|First Intervention|Progressive disease|0
7677459|NCT01306032|26702879|P1|First Intervention|Progressive disease|0
7677460|NCT01306032|26702874|P6|First Intervention|Ineligible|1
7677461|NCT01306032|26702875|P5|First Intervention|Ineligible|0
7677462|NCT01306032|26702876|P4|First Intervention|Ineligible|0
7677463|NCT01306032|26702877|P3|First Intervention|Ineligible|0
7677464|NCT01306032|26702878|P2|First Intervention|Ineligible|0
7677465|NCT01306032|26702879|P1|First Intervention|Ineligible|0
7677466|NCT01306032|26702874|P6|First Intervention|Death|0
7677467|NCT01306032|26702875|P5|First Intervention|Death|0
7677468|NCT01306032|26702876|P4|First Intervention|Death|0
7677469|NCT01306032|26702877|P3|First Intervention|Death|1
7677470|NCT01306032|26702878|P2|First Intervention|Death|0
7677471|NCT01306032|26702879|P1|First Intervention|Death|0
7677472|NCT01306032|26702874|P6|First Intervention|Withdrawal by Subject|0
7677473|NCT01306032|26702875|P5|First Intervention|Withdrawal by Subject|0
7677474|NCT01306032|26702876|P4|First Intervention|Withdrawal by Subject|1
7677475|NCT01306032|26702877|P3|First Intervention|Withdrawal by Subject|0
7677476|NCT01306032|26702878|P2|First Intervention|Withdrawal by Subject|2
7677477|NCT01306032|26702879|P1|First Intervention|Withdrawal by Subject|0
7677478|NCT01306032|26702874|P6|First Intervention|Adverse Event|1
7677479|NCT01306032|26702875|P5|First Intervention|Adverse Event|0
7677480|NCT01306032|26702876|P4|First Intervention|Adverse Event|0
7677481|NCT01306032|26702877|P3|First Intervention|Adverse Event|1
7677482|NCT01306032|26702878|P2|First Intervention|Adverse Event|0
7677483|NCT01306032|26702879|P1|First Intervention|Adverse Event|1
7677484|NCT01305941|26702931|P1|Overall Study|Death|1
7677485|NCT01305941|26702931|P1|Overall Study|Withdrawal by Subject|1
7677486|NCT01305941|26702931|P1|Overall Study|Clinical decline|2
7677487|NCT01305941|26702931|P1|Overall Study|Adverse Event|6
7677488|NCT01305577|26702971|P3|Overall Study|Protocol Deviation|1
7677489|NCT01305577|26702972|P2|Overall Study|Protocol Deviation|1
7677490|NCT01305577|26702973|P1|Overall Study|Protocol Deviation|0
7677491|NCT01305577|26702971|P3|Overall Study|Lost to Follow-up|2
7677492|NCT01305577|26702972|P2|Overall Study|Lost to Follow-up|3
7677493|NCT01305577|26702973|P1|Overall Study|Lost to Follow-up|4
7677494|NCT01305577|26702971|P3|Overall Study|Withdrawal by Subject|6
7677495|NCT01305577|26702972|P2|Overall Study|Withdrawal by Subject|5
7677496|NCT01305577|26702973|P1|Overall Study|Withdrawal by Subject|7
7677497|NCT01305577|26702971|P3|Overall Study|Adverse Event|1
7677498|NCT01305577|26702972|P2|Overall Study|Adverse Event|2
7677499|NCT01305577|26702973|P1|Overall Study|Adverse Event|2
7677500|NCT01305564|26703002|P1|Overall Study|Physician Decision|3
7677501|NCT01305564|26703002|P1|Overall Study|Withdrawal by Subject|1
7677502|NCT01305564|26703002|P1|Overall Study|Lost to Follow-up|12
7677503|NCT01305564|26703002|P1|Overall Study|Death|21
7677504|NCT01305408|26703029|P2|Overall Study|Other|0
7677505|NCT01305408|26703030|P1|Overall Study|Other|1
7677506|NCT01305408|26703029|P2|Overall Study|Noncompliance with study procedures|1
7677507|NCT01305408|26703030|P1|Overall Study|Noncompliance with study procedures|0
7677508|NCT01305408|26703029|P2|Overall Study|Noncompliance with study medication|1
7677509|NCT01305408|26703030|P1|Overall Study|Noncompliance with study medication|0
7677510|NCT01305408|26703029|P2|Overall Study|Lost to Follow-up|3
7677511|NCT01305408|26703030|P1|Overall Study|Lost to Follow-up|5
7677512|NCT01305408|26703029|P2|Overall Study|Protocol Violation|6
7677513|NCT01305408|26703030|P1|Overall Study|Protocol Violation|4
7677514|NCT01305408|26703029|P2|Overall Study|Withdrawal by Subject|9
7677515|NCT01305408|26703030|P1|Overall Study|Withdrawal by Subject|9
7677516|NCT01305408|26703029|P2|Overall Study|Lack of Efficacy|4
7677517|NCT01305408|26703030|P1|Overall Study|Lack of Efficacy|3
7677518|NCT01305408|26703029|P2|Overall Study|Adverse Event|7
7677519|NCT01305408|26703030|P1|Overall Study|Adverse Event|10
7677520|NCT01305239|26703123|P1|Overall Study|Exemestane taken prior to inclusion only|1
7677521|NCT01305239|26703123|P1|Overall Study|Adverse Event|22
7677522|NCT01305200|26703153|P3|Overall Study|Death|0
7677523|NCT01305200|26703154|P2|Overall Study|Death|2
7677524|NCT01305200|26703155|P1|Overall Study|Death|0
7677525|NCT01305200|26703153|P3|Overall Study|Ineligible|1
7677526|NCT01305200|26703154|P2|Overall Study|Ineligible|2
7677527|NCT01305200|26703155|P1|Overall Study|Ineligible|1
7677528|NCT01305200|26703153|P3|Overall Study|Withdrawal by Subject|1
7677529|NCT01305200|26703154|P2|Overall Study|Withdrawal by Subject|21
7677530|NCT01305200|26703155|P1|Overall Study|Withdrawal by Subject|24
7677531|NCT01305200|26703153|P3|Overall Study|Physician Decision|1
7677532|NCT01305200|26703154|P2|Overall Study|Physician Decision|6
7677533|NCT01305200|26703155|P1|Overall Study|Physician Decision|4
7677534|NCT01305044|26703185|P2|Overall Study|Withdrawal by Subject|6
7677535|NCT01305044|26703186|P1|Overall Study|Withdrawal by Subject|3
7677536|NCT01304940|26703218|P2|Overall Study|not meet symptom severity requirement|0
7677537|NCT01304940|26703219|P1|Overall Study|not meet symptom severity requirement|3
7677538|NCT01304706|26703225|P1|Overall Study|Discontinued due to failed drug admin.|1
7677539|NCT01304706|26703225|P1|Overall Study|Lost to Follow-up|7
7677540|NCT01304706|26703225|P1|Overall Study|Withdrawal by Subject|3
7677541|NCT01304706|26703225|P1|Overall Study|Death|3
7677542|NCT01304706|26703225|P1|Overall Study|Lack of Efficacy|1
7677543|NCT01304706|26703225|P1|Overall Study|Adverse Event|2
7677544|NCT01304693|26703234|P5|Overall Study|Decision Unrelated to an Adverse Event|0
7677545|NCT01304693|26703235|P4|Overall Study|Decision Unrelated to an Adverse Event|1
7677546|NCT01304693|26703236|P3|Overall Study|Decision Unrelated to an Adverse Event|1
7677547|NCT01304693|26703237|P2|Overall Study|Decision Unrelated to an Adverse Event|0
7677548|NCT01304693|26703238|P1|Overall Study|Decision Unrelated to an Adverse Event|0
7677549|NCT01304693|26703234|P5|Overall Study|Adverse Event|1
7677550|NCT01304693|26703235|P4|Overall Study|Adverse Event|0
7677551|NCT01304693|26703236|P3|Overall Study|Adverse Event|0
7677552|NCT01304693|26703237|P2|Overall Study|Adverse Event|0
7677553|NCT01304693|26703238|P1|Overall Study|Adverse Event|0
7677554|NCT01304498|26703285|P2|Overall Study|Lost to Follow-up|1
7677555|NCT01304498|26703286|P1|Overall Study|Lost to Follow-up|2
7677556|NCT01304498|26703285|P2|Overall Study|Protocol Violation|0
7677557|NCT01304498|26703286|P1|Overall Study|Protocol Violation|1
7677558|NCT01304498|26703285|P2|Overall Study|Withdrawal by Subject|3
7677559|NCT01304498|26703286|P1|Overall Study|Withdrawal by Subject|2
7677560|NCT01304498|26703285|P2|Overall Study|Adverse Event|1
7677561|NCT01304498|26703286|P1|Overall Study|Adverse Event|1
7677562|NCT01304329|26703310|P6|Third Intervention (3 Days)|Adverse Event|0
7677563|NCT01304329|26703311|P5|Third Intervention (3 Days)|Adverse Event|0
7677564|NCT01304329|26703312|P4|Third Intervention (3 Days)|Adverse Event|0
7677565|NCT01304329|26703313|P3|Third Intervention (3 Days)|Adverse Event|0
7677566|NCT01304329|26703314|P2|Third Intervention (3 Days)|Adverse Event|1
7677567|NCT01304329|26703315|P1|Third Intervention (3 Days)|Adverse Event|0
7677568|NCT01304147|26703449|P2|Second Intervention (7days)|Withdrawal by Subject|1
7677569|NCT01304147|26703450|P1|Second Intervention (7days)|Withdrawal by Subject|1
7677570|NCT01303965|26703481|P2|Overall Study|Disease Progression|6
7677571|NCT01303965|26703482|P1|Overall Study|Disease Progression|1
7677572|NCT01303965|26703481|P2|Overall Study|Withdrawal by Subject|0
7677573|NCT01303965|26703482|P1|Overall Study|Withdrawal by Subject|1
7677574|NCT01303965|26703481|P2|Overall Study|Death|3
7677575|NCT01303965|26703482|P1|Overall Study|Death|0
7677576|NCT01303965|26703481|P2|Overall Study|Adverse Event|1
7677577|NCT01303965|26703482|P1|Overall Study|Adverse Event|1
7677578|NCT01303861|26703510|P4|Overall Study|Pregnancy|0
7677579|NCT01303861|26703511|P3|Overall Study|Pregnancy|0
7677580|NCT01303861|26703512|P2|Overall Study|Pregnancy|0
7677581|NCT01303861|26703513|P1|Overall Study|Pregnancy|1
7677582|NCT01303861|26703510|P4|Overall Study|Adverse Event|5
7677583|NCT01303861|26703511|P3|Overall Study|Adverse Event|0
7677584|NCT01303861|26703512|P2|Overall Study|Adverse Event|1
7677585|NCT01303861|26703513|P1|Overall Study|Adverse Event|4
7677586|NCT01303861|26703510|P4|Overall Study|Withdrawal by Subject|23
7677587|NCT01303861|26703511|P3|Overall Study|Withdrawal by Subject|8
7677588|NCT01303861|26703512|P2|Overall Study|Withdrawal by Subject|8
7677589|NCT01303861|26703513|P1|Overall Study|Withdrawal by Subject|16
7677590|NCT01303861|26703510|P4|Overall Study|Lack of Efficacy|0
7677591|NCT01303861|26703511|P3|Overall Study|Lack of Efficacy|1
7677592|NCT01303861|26703512|P2|Overall Study|Lack of Efficacy|2
7677593|NCT01303861|26703513|P1|Overall Study|Lack of Efficacy|3
7677594|NCT01303861|26703510|P4|Overall Study|Lost to Follow-up|31
7677595|NCT01303861|26703511|P3|Overall Study|Lost to Follow-up|27
7677596|NCT01303861|26703512|P2|Overall Study|Lost to Follow-up|14
7677597|NCT01303861|26703513|P1|Overall Study|Lost to Follow-up|34
7677598|NCT01303627|26703572|P2|Overall Study|the failure while performing URS|1
7677599|NCT01303627|26703573|P1|Overall Study|the failure while performing URS|0
7677600|NCT01303510|26703581|P2|Overall Study|Lost to Follow-up|0
7677601|NCT01303510|26703582|P1|Overall Study|Lost to Follow-up|1
7677602|NCT01303445|26703596|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
7677603|NCT01303445|26703597|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
7677604|NCT01303445|26703596|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
7677605|NCT01303445|26703597|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
7677606|NCT01303445|26703596|P2|Washout (14 Days)|Lost to Follow-up|2
7677607|NCT01303445|26703597|P1|Washout (14 Days)|Lost to Follow-up|0
7677608|NCT01303445|26703596|P2|Washout (14 Days)|Protocol Violation|0
7677609|NCT01303445|26703597|P1|Washout (14 Days)|Protocol Violation|1
7677610|NCT01303445|26703596|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
7677611|NCT01303445|26703597|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
7677612|NCT01303445|26703596|P2|Second Intervention (7 Days)|Adverse Event|2
7677613|NCT01303445|26703597|P1|Second Intervention (7 Days)|Adverse Event|0
7677614|NCT01303445|26703596|P2|First Intervention (7 Days)|Withdrawal by Subject|0
7677615|NCT01303445|26703597|P1|First Intervention (7 Days)|Withdrawal by Subject|1
7677616|NCT01303419|26703627|P1|Overall Study|Did not meet all I/E after screening|31
7677617|NCT01303419|26703627|P1|Overall Study|Did not complete both imaging methods|5
7677618|NCT01303419|26703627|P1|Overall Study|Discontinuation of study|60
7677619|NCT01303380|26703646|P1|Overall Study|Lack of compliance to study procedures|1
7677620|NCT01303172|26703707|P2|Overall Study|Lack of Efficacy|17
7677621|NCT01303172|26703708|P1|Overall Study|Lack of Efficacy|25
7677622|NCT01303172|26703707|P2|Overall Study|Death|7
7677623|NCT01303172|26703708|P1|Overall Study|Death|20
7677624|NCT01303172|26703707|P2|Overall Study|Withdrawal by Subject|2
7677625|NCT01303172|26703708|P1|Overall Study|Withdrawal by Subject|4
7677626|NCT01303172|26703707|P2|Overall Study|Adverse Event|2
7677627|NCT01303172|26703708|P1|Overall Study|Adverse Event|5
7677628|NCT01303172|26703707|P2|Overall Study|Physician Decision|6
7677629|NCT01303172|26703708|P1|Overall Study|Physician Decision|9
7677630|NCT01303159|26703720|P1|Overall Study|Study Termination|7
7677631|NCT01303159|26703720|P1|Overall Study|Death|16
7677632|NCT01302964|26703749|P2|Overall Study|Adverse Event|0
7677633|NCT01302964|26703750|P1|Overall Study|Adverse Event|1
7677634|NCT01302938|26703760|P2|Overall Study|Adverse Event|0
7677635|NCT01302938|26703761|P1|Overall Study|Adverse Event|1
7677636|NCT01302938|26703760|P2|Overall Study|Withdrawal by Subject|0
7677637|NCT01302938|26703761|P1|Overall Study|Withdrawal by Subject|1
7677638|NCT01302899|26703806|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
7677639|NCT01302899|26703807|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
7677640|NCT01302899|26703806|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
7677641|NCT01302899|26703807|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
7677642|NCT01302834|26703871|P2|Overall Study|HIV positive|3
7677643|NCT01302834|26703872|P1|Overall Study|HIV positive|1
7677644|NCT01302834|26703871|P2|Overall Study|Protocol Violation|23
7677645|NCT01302834|26703872|P1|Overall Study|Protocol Violation|17
7677646|NCT01302691|26703951|P2|Overall Study|Protocol Violation|0
7677647|NCT01302691|26703952|P1|Overall Study|Protocol Violation|1
7677648|NCT01302691|26703951|P2|Overall Study|Physician Decision|1
7677649|NCT01302691|26703952|P1|Overall Study|Physician Decision|0
7677650|NCT01302691|26703951|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
7677651|NCT01302691|26703952|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
7677652|NCT01302691|26703951|P2|Overall Study|Lost to Follow-up|0
7677653|NCT01302691|26703952|P1|Overall Study|Lost to Follow-up|1
7677654|NCT01302691|26703951|P2|Overall Study|Death|1
7677655|NCT01302691|26703952|P1|Overall Study|Death|0
7677656|NCT01302691|26703951|P2|Overall Study|Adverse Event|0
7677657|NCT01302691|26703952|P1|Overall Study|Adverse Event|2
7677658|NCT01302548|26703972|P2|Overall Study|Lost to Follow-up|1
7677659|NCT01302548|26703973|P1|Overall Study|Lost to Follow-up|2
7677660|NCT01302418|26704023|P1|Overall Study|Non-evaluable|9
7677661|NCT01302418|26704023|P1|Overall Study|Protocol Violation|9
7677662|NCT01302392|26704029|P2|Overall Study|Withdrawal by Subject|1
7677663|NCT01302392|26704030|P1|Overall Study|Withdrawal by Subject|6
7677664|NCT01302392|26704029|P2|Overall Study|Lost to Follow-up|0
7677665|NCT01302392|26704030|P1|Overall Study|Lost to Follow-up|1
7677666|NCT01302366|26704081|P1|Overall Study|patient choice or noncompliance|5
7677667|NCT01302119|26704089|P2|Overall Study|Non-specific|1
7677668|NCT01302119|26704090|P1|Overall Study|Non-specific|4
7677669|NCT01302119|26704089|P2|Overall Study|Non-compliance|2
7677670|NCT01302119|26704090|P1|Overall Study|Non-compliance|4
7677671|NCT01302119|26704089|P2|Overall Study|Adverse Event|1
7677672|NCT01302119|26704090|P1|Overall Study|Adverse Event|2
7677673|NCT01302119|26704089|P2|Overall Study|Lost to Follow-up|4
7677674|NCT01302119|26704090|P1|Overall Study|Lost to Follow-up|10
7677675|NCT01302119|26704089|P2|Overall Study|Withdrawal by Subject|20
7677676|NCT01302119|26704090|P1|Overall Study|Withdrawal by Subject|30
7677677|NCT01302080|26704105|P2|Overall Study|Reason Missing For Discontinuation|0
7677678|NCT01302080|26704106|P1|Overall Study|Reason Missing For Discontinuation|1
7677679|NCT01302080|26704105|P2|Overall Study|Other|8
7677680|NCT01302080|26704106|P1|Overall Study|Other|52
7677681|NCT01302080|26704105|P2|Overall Study|Death|0
7677682|NCT01302080|26704106|P1|Overall Study|Death|1
7677683|NCT01302080|26704105|P2|Overall Study|Lost to Follow-up|93
7677684|NCT01302080|26704106|P1|Overall Study|Lost to Follow-up|192
7677685|NCT01302080|26704105|P2|Overall Study|Patient/Family Moved|3
7677686|NCT01302080|26704106|P1|Overall Study|Patient/Family Moved|28
7677687|NCT01302080|26704105|P2|Overall Study|Withdrew Consent|39
7677688|NCT01302080|26704106|P1|Overall Study|Withdrew Consent|92
7677689|NCT01302067|26704327|P3|Overall Study|Adverse Event|45
7677690|NCT01302067|26704328|P2|Overall Study|Adverse Event|14
7677691|NCT01302067|26704329|P1|Overall Study|Adverse Event|27
7677692|NCT01302067|26704327|P3|Overall Study|Protocol Violation|8
7677693|NCT01302067|26704328|P2|Overall Study|Protocol Violation|0
7677694|NCT01302067|26704329|P1|Overall Study|Protocol Violation|11
7677695|NCT01302067|26704327|P3|Overall Study|Other|3
7677696|NCT01302067|26704328|P2|Overall Study|Other|1
7677697|NCT01302067|26704329|P1|Overall Study|Other|1
7677698|NCT01302067|26704327|P3|Overall Study|Withdrawal by Subject|10
7677699|NCT01302067|26704328|P2|Overall Study|Withdrawal by Subject|6
7677700|NCT01302067|26704329|P1|Overall Study|Withdrawal by Subject|13
7677701|NCT01302067|26704327|P3|Overall Study|Lost to Follow-up|15
7677702|NCT01302067|26704328|P2|Overall Study|Lost to Follow-up|4
7677703|NCT01302067|26704329|P1|Overall Study|Lost to Follow-up|9
7677704|NCT01302067|26704327|P3|Overall Study|Lack of Efficacy|2
7677705|NCT01302067|26704328|P2|Overall Study|Lack of Efficacy|4
7677706|NCT01302067|26704329|P1|Overall Study|Lack of Efficacy|8
7677707|NCT01302067|26704327|P3|Overall Study|Physician Decision|14
7677708|NCT01302067|26704328|P2|Overall Study|Physician Decision|5
7677709|NCT01302067|26704329|P1|Overall Study|Physician Decision|9
7677710|NCT01302067|26704327|P3|Overall Study|Death|1
7677711|NCT01302067|26704328|P2|Overall Study|Death|0
7677712|NCT01302067|26704329|P1|Overall Study|Death|0
7677713|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Other|9
7677714|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Other|4
7677715|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Other|0
7677716|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
7677717|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
7677718|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
7677719|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Adverse Event|10
7677720|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Adverse Event|10
7677721|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Adverse Event|0
7677722|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Protocol Violation|6
7677723|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Protocol Violation|3
7677724|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Protocol Violation|0
7677725|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
7677726|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
7677727|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
7677728|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
7677729|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
7677730|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
7677731|NCT01302054|26704400|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
7677732|NCT01302054|26704401|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
7677733|NCT01302054|26704402|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
7677734|NCT01302054|26704400|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
7677735|NCT01302054|26704401|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
7677736|NCT01302054|26704402|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
7677737|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Other|0
7677738|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Other|0
7677739|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Other|7
7677740|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
7677741|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
7677742|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
7677743|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
7677744|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
7677745|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
7677746|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
7677747|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
7677748|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
7677749|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
7677750|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
7677751|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
7677752|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
7677753|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
7677754|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
7677755|NCT01302054|26704400|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
7677756|NCT01302054|26704401|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
7677757|NCT01302054|26704402|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
7677758|NCT01302041|26704429|P1|Overall Study|Other-Miscellaneous Reason|2
7677759|NCT01302041|26704429|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
7677760|NCT01302041|26704429|P1|Overall Study|Withdrawal by Subject|4
7677761|NCT01302041|26704429|P1|Overall Study|Death|5
7677762|NCT01301950|26704471|P2|Overall Study|Surgery was cancelled by patient|1
7677763|NCT01301950|26704472|P1|Overall Study|Surgery was cancelled by patient|0
7677764|NCT01301833|26704490|P4|Overall Study|Personal matter|0
7677765|NCT01301833|26704491|P3|Overall Study|Personal matter|0
7677766|NCT01301833|26704492|P2|Overall Study|Personal matter|0
7677767|NCT01301833|26704493|P1|Overall Study|Personal matter|1
7677768|NCT01301833|26704490|P4|Overall Study|Withdrawal by Subject|2
7677769|NCT01301833|26704491|P3|Overall Study|Withdrawal by Subject|1
7677770|NCT01301833|26704492|P2|Overall Study|Withdrawal by Subject|1
7677771|NCT01301833|26704493|P1|Overall Study|Withdrawal by Subject|3
7677772|NCT01301833|26704490|P4|Overall Study|Physician Decision|0
7677773|NCT01301833|26704491|P3|Overall Study|Physician Decision|1
7677774|NCT01301833|26704492|P2|Overall Study|Physician Decision|1
7677775|NCT01301833|26704493|P1|Overall Study|Physician Decision|3
7677776|NCT01301833|26704490|P4|Overall Study|Lack of Efficacy|0
7677777|NCT01301833|26704491|P3|Overall Study|Lack of Efficacy|0
7677778|NCT01301833|26704492|P2|Overall Study|Lack of Efficacy|1
7677779|NCT01301833|26704493|P1|Overall Study|Lack of Efficacy|1
7677780|NCT01301833|26704490|P4|Overall Study|Adverse Event|5
7677781|NCT01301833|26704491|P3|Overall Study|Adverse Event|5
7677782|NCT01301833|26704492|P2|Overall Study|Adverse Event|5
7677783|NCT01301833|26704493|P1|Overall Study|Adverse Event|7
7677784|NCT01301729|26704531|P1|Overall Study|Violated Selection Criteria|1
7677785|NCT01301729|26704531|P1|Overall Study|Participant did not Return for Treatment|1
7677786|NCT01301729|26704531|P1|Overall Study|Withdrawal by Subject|2
7677787|NCT01301625|26704542|P1|Overall Study|Lost to Follow-up|1
7677788|NCT01301625|26704542|P1|Overall Study|Expected|8
7677789|NCT01301625|26704542|P1|Overall Study|Not Due|21
7677790|NCT01301625|26704542|P1|Overall Study|Death|5
7677791|NCT01301508|26704614|P2|Overall Study|Lost to Follow-up|1
7677792|NCT01301508|26704615|P1|Overall Study|Lost to Follow-up|0
7677793|NCT01301508|26704614|P2|Overall Study|Withdrawal by Subject|2
7677794|NCT01301508|26704615|P1|Overall Study|Withdrawal by Subject|1
7677795|NCT01301456|26704645|P12|Stage 2|Adverse Event|0
7677796|NCT01301456|26704646|P11|Stage 2|Adverse Event|1
7677797|NCT01301456|26704647|P10|Stage 2|Adverse Event|0
7677798|NCT01301456|26704648|P9|Stage 2|Adverse Event|0
7677799|NCT01301456|26704649|P8|Stage 2|Adverse Event|0
7677800|NCT01301456|26704650|P7|Stage 2|Adverse Event|0
7677801|NCT01301456|26704651|P6|Stage 2|Adverse Event|0
7677802|NCT01301456|26704652|P5|Stage 2|Adverse Event|0
7677803|NCT01301456|26704653|P4|Stage 2|Adverse Event|0
7677804|NCT01301456|26704654|P3|Stage 2|Adverse Event|0
7677805|NCT01301456|26704655|P2|Stage 2|Adverse Event|0
7677806|NCT01301456|26704656|P1|Stage 2|Adverse Event|0
7677807|NCT01301456|26704645|P12|Stage 1|Randomized but not treated|0
7677808|NCT01301456|26704646|P11|Stage 1|Randomized but not treated|0
7677809|NCT01301456|26704647|P10|Stage 1|Randomized but not treated|0
7677810|NCT01301456|26704648|P9|Stage 1|Randomized but not treated|0
7677811|NCT01301456|26704649|P8|Stage 1|Randomized but not treated|0
7677812|NCT01301456|26704650|P7|Stage 1|Randomized but not treated|1
7677813|NCT01301456|26704651|P6|Stage 1|Randomized but not treated|0
7677814|NCT01301456|26704652|P5|Stage 1|Randomized but not treated|0
7677815|NCT01301456|26704653|P4|Stage 1|Randomized but not treated|0
7677816|NCT01301456|26704654|P3|Stage 1|Randomized but not treated|0
7677817|NCT01301456|26704655|P2|Stage 1|Randomized but not treated|0
7677818|NCT01301456|26704656|P1|Stage 1|Randomized but not treated|0
7677819|NCT01301456|26704645|P12|Stage 1|Withdrawal by Subject|0
7677820|NCT01301456|26704646|P11|Stage 1|Withdrawal by Subject|0
7677821|NCT01301456|26704647|P10|Stage 1|Withdrawal by Subject|0
7677822|NCT01301456|26704648|P9|Stage 1|Withdrawal by Subject|0
7677823|NCT01301456|26704649|P8|Stage 1|Withdrawal by Subject|0
7677824|NCT01301456|26704650|P7|Stage 1|Withdrawal by Subject|0
7677825|NCT01301456|26704651|P6|Stage 1|Withdrawal by Subject|0
7677826|NCT01301456|26704652|P5|Stage 1|Withdrawal by Subject|1
7677827|NCT01301456|26704653|P4|Stage 1|Withdrawal by Subject|0
7677828|NCT01301456|26704654|P3|Stage 1|Withdrawal by Subject|1
7677829|NCT01301456|26704655|P2|Stage 1|Withdrawal by Subject|0
7677830|NCT01301456|26704656|P1|Stage 1|Withdrawal by Subject|0
7677831|NCT01301391|26704882|P1|Overall Study|Sponsor's decision|8
7677832|NCT01301391|26704882|P1|Overall Study|Physician Decision|2
7677833|NCT01301391|26704882|P1|Overall Study|Lost to Follow-up|3
7677834|NCT01301391|26704882|P1|Overall Study|Death|13
7677835|NCT01301274|26704894|P2|Overall Study|Physician Decision|1
7677836|NCT01301274|26704895|P1|Overall Study|Physician Decision|2
7677837|NCT01301092|26704921|P3|Overall Study|Lost to Follow-up|1
7677838|NCT01301092|26704922|P2|Overall Study|Lost to Follow-up|0
7677839|NCT01301092|26704923|P1|Overall Study|Lost to Follow-up|0
7677840|NCT01301079|26704940|P2|Overall Study|Lost to Follow-up|2
7677841|NCT01301079|26704941|P1|Overall Study|Lost to Follow-up|2
7677842|NCT01301066|26705019|P2|Overall Study|Other|0
7677843|NCT01301066|26705020|P1|Overall Study|Other|2
7677844|NCT01301066|26705019|P2|Overall Study|Physician Decision|1
7677845|NCT01301066|26705020|P1|Overall Study|Physician Decision|0
7677846|NCT01301066|26705019|P2|Overall Study|Sponsor Decision|1
7677847|NCT01301066|26705020|P1|Overall Study|Sponsor Decision|2
7677848|NCT01301066|26705019|P2|Overall Study|Adverse Event|6
7677849|NCT01301066|26705020|P1|Overall Study|Adverse Event|6
7677850|NCT01301066|26705019|P2|Overall Study|Withdrawal by Subject|9
7677851|NCT01301066|26705020|P1|Overall Study|Withdrawal by Subject|4
7677852|NCT01301066|26705019|P2|Overall Study|Protocol Violation|7
7677853|NCT01301066|26705020|P1|Overall Study|Protocol Violation|8
7677854|NCT01301066|26705019|P2|Overall Study|Lost to Follow-up|11
7677855|NCT01301066|26705020|P1|Overall Study|Lost to Follow-up|5
7677856|NCT01301027|26705028|P2|Overall Study|Volume Overload|0
7677857|NCT01301027|26705029|P1|Overall Study|Volume Overload|3
7677858|NCT01301027|26705028|P2|Overall Study|Transplant|2
7677859|NCT01301027|26705029|P1|Overall Study|Transplant|0
7677860|NCT01301027|26705028|P2|Overall Study|Fracture|3
7677861|NCT01301027|26705029|P1|Overall Study|Fracture|1
7677862|NCT01301027|26705028|P2|Overall Study|Adverse Event|2
7677863|NCT01301027|26705029|P1|Overall Study|Adverse Event|0
7677864|NCT01301027|26705028|P2|Overall Study|Withdrawal by Subject|3
7677865|NCT01301027|26705029|P1|Overall Study|Withdrawal by Subject|2
7677866|NCT01301027|26705028|P2|Overall Study|Physician Decision|0
7677867|NCT01301027|26705029|P1|Overall Study|Physician Decision|2
7677868|NCT01301001|26705041|P2|Second Intervention|Withdrawal by Subject|0
7677869|NCT01301001|26705042|P1|Second Intervention|Withdrawal by Subject|2
7677870|NCT01301001|26705041|P2|Second Intervention|Adverse Event|0
7677871|NCT01301001|26705042|P1|Second Intervention|Adverse Event|2
7677872|NCT01301001|26705041|P2|First Intervention|Protocol Violation|1
7677873|NCT01301001|26705042|P1|First Intervention|Protocol Violation|0
7677874|NCT01301001|26705041|P2|First Intervention|Adverse Event|0
7677875|NCT01301001|26705042|P1|First Intervention|Adverse Event|5
7677876|NCT01301001|26705041|P2|First Intervention|Withdrawal by Subject|4
7677877|NCT01301001|26705042|P1|First Intervention|Withdrawal by Subject|1
7677878|NCT01301001|26705041|P2|First Intervention|Lost to Follow-up|4
7677879|NCT01301001|26705042|P1|First Intervention|Lost to Follow-up|4
7677880|NCT01300923|26705065|P2|Overall Study|Physician Decision|2
7677881|NCT01300923|26705066|P1|Overall Study|Physician Decision|0
7677882|NCT01300819|26705079|P2|Overall Study|Follow up call was not done|0
7677883|NCT01300819|26705080|P1|Overall Study|Follow up call was not done|1
7677884|NCT01300819|26705079|P2|Overall Study|Safety follow up not done by mistake|1
7677885|NCT01300819|26705080|P1|Overall Study|Safety follow up not done by mistake|0
7677886|NCT01300819|26705079|P2|Overall Study|Administrative reason|1
7677887|NCT01300819|26705080|P1|Overall Study|Administrative reason|0
7677888|NCT01300819|26705079|P2|Overall Study|Refusal to down titrate study drug|1
7677889|NCT01300819|26705080|P1|Overall Study|Refusal to down titrate study drug|0
7677890|NCT01300819|26705079|P2|Overall Study|Patient was 1 month late for Visit 10|1
7677891|NCT01300819|26705080|P1|Overall Study|Patient was 1 month late for Visit 10|0
7677892|NCT01300819|26705079|P2|Overall Study|Withdrawal by Subject|12
7677893|NCT01300819|26705080|P1|Overall Study|Withdrawal by Subject|10
7677894|NCT01300819|26705079|P2|Overall Study|Lack of Efficacy|1
7677895|NCT01300819|26705080|P1|Overall Study|Lack of Efficacy|2
7677896|NCT01300819|26705079|P2|Overall Study|Adverse Event|27
7677897|NCT01300819|26705080|P1|Overall Study|Adverse Event|9
7677898|NCT01300767|26705108|P1|Overall Study|Unacceptable fit|1
7677899|NCT01300767|26705108|P1|Overall Study|Biomicroscopy|1
7677900|NCT01300767|26705108|P1|Overall Study|Discomfort|2
7677901|NCT01300741|26705136|P1|Overall Study|Discomfort|1
7677902|NCT01300741|26705136|P1|Overall Study|Lost to Follow-up|1
7677903|NCT01300741|26705136|P1|Overall Study|Lens deposits|1
7677904|NCT01300728|26705166|P2|Overall Study|Physician Decision|0
7677905|NCT01300728|26705167|P1|Overall Study|Physician Decision|1
7677906|NCT01300728|26705166|P2|Overall Study|Withdrawal by Subject|1
7677907|NCT01300728|26705167|P1|Overall Study|Withdrawal by Subject|1
7677908|NCT01300650|26705181|P1|Overall Study|Adverse Event|1
7677909|NCT01300572|26705197|P1|Overall Study|HAMA + post dosimetry|1
7677910|NCT01300546|26705221|P2|Overall Study|Adverse Event|1
7677911|NCT01300546|26705222|P1|Overall Study|Adverse Event|0
7677912|NCT01300546|26705221|P2|Overall Study|Lack of Efficacy|3
7677913|NCT01300546|26705222|P1|Overall Study|Lack of Efficacy|0
7677914|NCT01300546|26705221|P2|Overall Study|Lost to Follow-up|2
7677915|NCT01300546|26705222|P1|Overall Study|Lost to Follow-up|0
7677916|NCT01300546|26705221|P2|Overall Study|Withdrawal by Subject|0
7677917|NCT01300546|26705222|P1|Overall Study|Withdrawal by Subject|1
7677918|NCT01300455|26705252|P2|Washout|Withdrawal by Subject|0
7677919|NCT01300455|26705253|P1|Washout|Withdrawal by Subject|1
7677920|NCT01300351|26705273|P2|Overall Study|Withdrawal by Subject|10
7677921|NCT01300351|26705274|P1|Overall Study|Withdrawal by Subject|7
7677922|NCT01300351|26705273|P2|Overall Study|Adverse Event|4
7677923|NCT01300351|26705274|P1|Overall Study|Adverse Event|0
7677924|NCT01300351|26705273|P2|Overall Study|Lost to Follow-up|1
7677925|NCT01300351|26705274|P1|Overall Study|Lost to Follow-up|0
7677926|NCT01300351|26705273|P2|Overall Study|Ongoing treatment at data cut-off|23
7677927|NCT01300351|26705274|P1|Overall Study|Ongoing treatment at data cut-off|27
7677928|NCT01300351|26705273|P2|Overall Study|Did not receive treatment|0
7677929|NCT01300351|26705274|P1|Overall Study|Did not receive treatment|2
7677930|NCT01300338|26705290|P2|Overall Study|Lost to Follow-up|0
7677931|NCT01300338|26705291|P1|Overall Study|Lost to Follow-up|5
7677932|NCT01300286|26705299|P1|Overall Study|did not get dosed|1
7677933|NCT01300260|26705309|P2|Period 2 of Study: Second Intervention|Adverse Event|1
7677934|NCT01300260|26705310|P1|Period 2 of Study: Second Intervention|Adverse Event|0
7677935|NCT01300260|26705309|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
7677936|NCT01300260|26705310|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
7677937|NCT01300260|26705309|P2|Period 1 of Study: First Intervention|Adverse Event|1
7677938|NCT01300260|26705310|P1|Period 1 of Study: First Intervention|Adverse Event|0
7677939|NCT01300247|26705342|P2|Overall Study|Non-Compliance|1
7677940|NCT01300247|26705343|P1|Overall Study|Non-Compliance|0
7677941|NCT01300247|26705342|P2|Overall Study|Withdrawal by Subject|0
7677942|NCT01300247|26705343|P1|Overall Study|Withdrawal by Subject|1
7677943|NCT01300247|26705342|P2|Overall Study|Lost to Follow-up|0
7677944|NCT01300247|26705343|P1|Overall Study|Lost to Follow-up|2
7677945|NCT01300247|26705342|P2|Overall Study|Death|1
7677946|NCT01300247|26705343|P1|Overall Study|Death|1
7677947|NCT01300234|26705375|P2|Overall Study|Participant refused return to hospital|0
7677948|NCT01300234|26705376|P1|Overall Study|Participant refused return to hospital|1
7677949|NCT01300234|26705375|P2|Overall Study|Participant stopped medication|1
7677950|NCT01300234|26705376|P1|Overall Study|Participant stopped medication|1
7677951|NCT01300234|26705375|P2|Overall Study|Participant reached stopping critera|0
7677952|NCT01300234|26705376|P1|Overall Study|Participant reached stopping critera|2
7677953|NCT01300234|26705375|P2|Overall Study|Pregnancy|1
7677954|NCT01300234|26705376|P1|Overall Study|Pregnancy|2
7677955|NCT01300234|26705375|P2|Overall Study|Lost to Follow-up|12
7677956|NCT01300234|26705376|P1|Overall Study|Lost to Follow-up|14
7677957|NCT01300234|26705375|P2|Overall Study|Withdrawal by Subject|9
7677958|NCT01300234|26705376|P1|Overall Study|Withdrawal by Subject|5
7677959|NCT01300234|26705375|P2|Overall Study|Protocol Violation|3
7677960|NCT01300234|26705376|P1|Overall Study|Protocol Violation|2
7677961|NCT01300234|26705375|P2|Overall Study|Adverse Event|1
7677962|NCT01300234|26705376|P1|Overall Study|Adverse Event|1
7677963|NCT01300052|26705423|P2|Overall Study|Protocol Violation|1
7677964|NCT01300052|26705424|P1|Overall Study|Protocol Violation|1
7677965|NCT01300052|26705423|P2|Overall Study|Withdrawal by Subject|2
7677966|NCT01300052|26705424|P1|Overall Study|Withdrawal by Subject|2
7677967|NCT01300052|26705423|P2|Overall Study|Adverse Event|0
7677968|NCT01300052|26705424|P1|Overall Study|Adverse Event|3
7677969|NCT01299961|26705442|P1|Overall Study|Lost to Follow-up|1
7677970|NCT01299961|26705442|P1|Overall Study|Lack of Efficacy|2
7677971|NCT01299961|26705442|P1|Overall Study|Adverse Event|3
7677972|NCT01299909|26705451|P3|Overall Study|Lost to Follow-up|17
7677973|NCT01299909|26705452|P2|Overall Study|Lost to Follow-up|18
7677974|NCT01299909|26705453|P1|Overall Study|Lost to Follow-up|22
7677975|NCT01299896|26705468|P2|Overall Study|Lost to Follow-up|11
7677976|NCT01299896|26705469|P1|Overall Study|Lost to Follow-up|0
7677977|NCT01299896|26705468|P2|Overall Study|Withdrawal by Subject|7
7677978|NCT01299896|26705469|P1|Overall Study|Withdrawal by Subject|1
7677979|NCT01299805|26705477|P2|Overall Study|Adverse Event|0
7677980|NCT01299805|26705478|P1|Overall Study|Adverse Event|2
7677981|NCT01299766|26705508|P2|Overall Study|Withdrawal by Subject|19
7677982|NCT01299766|26705509|P1|Overall Study|Withdrawal by Subject|29
7677983|NCT01299766|26705508|P2|Overall Study|Death|4
7677984|NCT01299766|26705509|P1|Overall Study|Death|5
7677985|NCT01299727|26705520|P3|Overall Study|Completed the Treatment Period|3
7677986|NCT01299727|26705521|P2|Overall Study|Completed the Treatment Period|4
7677987|NCT01299727|26705522|P1|Overall Study|Completed the Treatment Period|3
7677988|NCT01299727|26705520|P3|Overall Study|Adverse Event|1
7677989|NCT01299727|26705521|P2|Overall Study|Adverse Event|0
7677990|NCT01299727|26705522|P1|Overall Study|Adverse Event|0
7677991|NCT01299727|26705520|P3|Overall Study|Withdrawal by Subject|0
7677992|NCT01299727|26705521|P2|Overall Study|Withdrawal by Subject|0
7677993|NCT01299727|26705522|P1|Overall Study|Withdrawal by Subject|1
7677994|NCT01299584|26705616|P1|Overall Study|Protocol Violation|9
7677995|NCT01299571|26705623|P1|Overall Study|Protocol Violation|107
7677996|NCT01299480|26705634|P5|Overall Study|Started, but not vaccinated|0
7677997|NCT01299480|26705635|P4|Overall Study|Started, but not vaccinated|1
7677998|NCT01299480|26705636|P3|Overall Study|Started, but not vaccinated|1
7677999|NCT01299480|26705637|P2|Overall Study|Started, but not vaccinated|0
7678000|NCT01299480|26705638|P1|Overall Study|Started, but not vaccinated|0
7678001|NCT01299480|26705634|P5|Overall Study|Other|3
7678002|NCT01299480|26705635|P4|Overall Study|Other|0
7678003|NCT01299480|26705636|P3|Overall Study|Other|3
7678004|NCT01299480|26705637|P2|Overall Study|Other|2
7678005|NCT01299480|26705638|P1|Overall Study|Other|3
7678006|NCT01299480|26705634|P5|Overall Study|Lost to Follow-up|2
7678007|NCT01299480|26705635|P4|Overall Study|Lost to Follow-up|1
7678008|NCT01299480|26705636|P3|Overall Study|Lost to Follow-up|2
7678009|NCT01299480|26705637|P2|Overall Study|Lost to Follow-up|1
7678010|NCT01299480|26705638|P1|Overall Study|Lost to Follow-up|3
7678011|NCT01299480|26705634|P5|Overall Study|Physician Decision|0
7678012|NCT01299480|26705635|P4|Overall Study|Physician Decision|2
7678013|NCT01299480|26705636|P3|Overall Study|Physician Decision|0
7678014|NCT01299480|26705637|P2|Overall Study|Physician Decision|1
7678015|NCT01299480|26705638|P1|Overall Study|Physician Decision|1
7678016|NCT01299480|26705634|P5|Overall Study|Withdrawal due to pregnancy|0
7678017|NCT01299480|26705635|P4|Overall Study|Withdrawal due to pregnancy|0
7678018|NCT01299480|26705636|P3|Overall Study|Withdrawal due to pregnancy|1
7678019|NCT01299480|26705637|P2|Overall Study|Withdrawal due to pregnancy|1
7678020|NCT01299480|26705638|P1|Overall Study|Withdrawal due to pregnancy|0
7678021|NCT01299480|26705634|P5|Overall Study|Adverse Event|0
7678022|NCT01299480|26705635|P4|Overall Study|Adverse Event|4
7678023|NCT01299480|26705636|P3|Overall Study|Adverse Event|5
7678024|NCT01299480|26705637|P2|Overall Study|Adverse Event|4
7678025|NCT01299480|26705638|P1|Overall Study|Adverse Event|6
7678026|NCT01299480|26705634|P5|Overall Study|Withdrawal by Subject|4
7678027|NCT01299480|26705635|P4|Overall Study|Withdrawal by Subject|3
7678028|NCT01299480|26705636|P3|Overall Study|Withdrawal by Subject|7
7678029|NCT01299480|26705637|P2|Overall Study|Withdrawal by Subject|4
7678030|NCT01299480|26705638|P1|Overall Study|Withdrawal by Subject|3
7678031|NCT01299480|26705634|P5|Overall Study|Protocol Violation|1
7678032|NCT01299480|26705635|P4|Overall Study|Protocol Violation|1
7678033|NCT01299480|26705636|P3|Overall Study|Protocol Violation|8
7678034|NCT01299480|26705637|P2|Overall Study|Protocol Violation|5
7678035|NCT01299480|26705638|P1|Overall Study|Protocol Violation|7
7678036|NCT01299480|26705634|P5|Overall Study|No longer willing to participate|10
7678037|NCT01299480|26705635|P4|Overall Study|No longer willing to participate|13
7678038|NCT01299480|26705636|P3|Overall Study|No longer willing to participate|14
7678039|NCT01299480|26705637|P2|Overall Study|No longer willing to participate|17
7678040|NCT01299480|26705638|P1|Overall Study|No longer willing to participate|19
7678041|NCT01299389|26705840|P4|Post-observational|Other|6
7678042|NCT01299389|26705841|P3|Post-observational|Other|12
7678043|NCT01299389|26705842|P2|Post-observational|Other|0
7678044|NCT01299389|26705843|P1|Post-observational|Other|0
7678045|NCT01299389|26705840|P4|Double-blind|"fail to meet study population criteria"|0
7678046|NCT01299389|26705841|P3|Double-blind|"fail to meet study population criteria"|0
7678047|NCT01299389|26705842|P2|Double-blind|"fail to meet study population criteria"|1
7678048|NCT01299389|26705843|P1|Double-blind|"fail to meet study population criteria"|0
7678049|NCT01299389|26705840|P4|Double-blind|Other|0
7678050|NCT01299389|26705841|P3|Double-blind|Other|0
7678051|NCT01299389|26705842|P2|Double-blind|Other|1
7678052|NCT01299389|26705843|P1|Double-blind|Other|1
7678053|NCT01299389|26705840|P4|Double-blind|Withdrawal by Subject|0
7678054|NCT01299389|26705841|P3|Double-blind|Withdrawal by Subject|0
7678055|NCT01299389|26705842|P2|Double-blind|Withdrawal by Subject|13
7678056|NCT01299389|26705843|P1|Double-blind|Withdrawal by Subject|16
7678057|NCT01299389|26705840|P4|Double-blind|Lost to Follow-up|0
7678058|NCT01299389|26705841|P3|Double-blind|Lost to Follow-up|0
7678059|NCT01299389|26705842|P2|Double-blind|Lost to Follow-up|1
7678060|NCT01299389|26705843|P1|Double-blind|Lost to Follow-up|2
7678061|NCT01299389|26705840|P4|Double-blind|Lack of Efficacy|0
7678062|NCT01299389|26705841|P3|Double-blind|Lack of Efficacy|0
7678063|NCT01299389|26705842|P2|Double-blind|Lack of Efficacy|21
7678064|NCT01299389|26705843|P1|Double-blind|Lack of Efficacy|45
7678065|NCT01299389|26705840|P4|Double-blind|Adverse Event|0
7678066|NCT01299389|26705841|P3|Double-blind|Adverse Event|0
7678067|NCT01299389|26705842|P2|Double-blind|Adverse Event|27
7678068|NCT01299389|26705843|P1|Double-blind|Adverse Event|45
7678069|NCT01299376|26705865|P2|Extension (Weeks 9 to 52)|Physician Decision|0
7678070|NCT01299376|26705866|P1|Extension (Weeks 9 to 52)|Physician Decision|1
7678071|NCT01299376|26705865|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
7678072|NCT01299376|26705866|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
7678073|NCT01299376|26705865|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
7678074|NCT01299376|26705866|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
7678075|NCT01299376|26705865|P2|Extension (Weeks 9 to 52)|Adverse Event|3
7678076|NCT01299376|26705866|P1|Extension (Weeks 9 to 52)|Adverse Event|2
7678077|NCT01299376|26705865|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
7678078|NCT01299376|26705866|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
7678079|NCT01299376|26705865|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
7678080|NCT01299376|26705866|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
7678081|NCT01299376|26705865|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
7678082|NCT01299376|26705866|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
7678083|NCT01299376|26705865|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
7678084|NCT01299376|26705866|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
7678085|NCT01299376|26705865|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
7678086|NCT01299376|26705866|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
7678087|NCT01299376|26705865|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
7678088|NCT01299376|26705866|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
7678089|NCT01299376|26705865|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
7678090|NCT01299376|26705866|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
7678091|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
7678092|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
7678093|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
7678094|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
7678095|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Physician Decision|1
7678096|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Physician Decision|2
7678097|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Physician Decision|0
7678098|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Physician Decision|0
7678099|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
7678100|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
7678101|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
7678102|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
7678103|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
7678104|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
7678105|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
7678106|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
7678107|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
7678108|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
7678109|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
7678110|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
7678111|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Adverse Event|9
7678112|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Adverse Event|8
7678113|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Adverse Event|0
7678114|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Adverse Event|0
7678115|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
7678116|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
7678117|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
7678118|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
7678119|NCT01299272|26705909|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
7678120|NCT01299272|26705910|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
7678121|NCT01299272|26705911|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
7678122|NCT01299272|26705912|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
7678123|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Physician Decision|0
7678124|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Physician Decision|0
7678125|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Physician Decision|3
7678126|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Physician Decision|0
7678127|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7678128|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7678129|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
7678130|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7678131|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7678132|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7678133|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
7678134|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7678135|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7678136|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7678137|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
7678138|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7678139|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
7678140|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
7678141|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
7678142|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
7678143|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7678144|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7678145|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
7678146|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7678147|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Adverse Event|0
7678148|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Adverse Event|0
7678149|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Adverse Event|42
7678150|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Adverse Event|0
7678151|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
7678152|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
7678153|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
7678154|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
7678155|NCT01299272|26705909|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7678156|NCT01299272|26705910|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7678157|NCT01299272|26705911|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
7678158|NCT01299272|26705912|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7678159|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Physician Decision|0
7678160|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Physician Decision|0
7678161|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Physician Decision|0
7678162|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Physician Decision|5
7678163|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
7678164|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
7678165|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
7678166|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
7678167|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Sponsor Decision|0
7678168|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Sponsor Decision|0
7678169|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Sponsor Decision|0
7678170|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Sponsor Decision|13
7678171|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
7678172|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
7678173|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
7678174|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
7678175|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Protocol Violation|0
7678176|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Protocol Violation|0
7678177|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Protocol Violation|0
7678178|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Protocol Violation|36
7678179|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
7678180|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
7678181|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
7678182|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
7678183|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Adverse Event|0
7678184|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Adverse Event|0
7678185|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Adverse Event|0
7678186|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Adverse Event|140
7678187|NCT01299272|26705909|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7678188|NCT01299272|26705910|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7678189|NCT01299272|26705911|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7678190|NCT01299272|26705912|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
7678191|NCT01299116|26705967|P3|Overall Study|Lost to Follow-up|11
7678192|NCT01299116|26705968|P2|Overall Study|Lost to Follow-up|9
7678193|NCT01299116|26705969|P1|Overall Study|Lost to Follow-up|65
7678194|NCT01299038|26706014|P2|Overall Study|Withdrawal by Subject|0
7678195|NCT01299038|26706015|P1|Overall Study|Withdrawal by Subject|1
7678196|NCT01299025|26706023|P2|Overall Study|Lost to Follow-up|0
7678197|NCT01299025|26706024|P1|Overall Study|Lost to Follow-up|1
7678198|NCT01299025|26706023|P2|Overall Study|Withdrawal by Subject|1
7678199|NCT01299025|26706024|P1|Overall Study|Withdrawal by Subject|2
7678200|NCT01298778|26706049|P2|Overall Study|not meet inclusion/exclusion criteria|1
7678201|NCT01298778|26706050|P1|Overall Study|not meet inclusion/exclusion criteria|0
7678202|NCT01298778|26706049|P2|Overall Study|Protocol Violation|1
7678203|NCT01298778|26706050|P1|Overall Study|Protocol Violation|0
7678204|NCT01298778|26706049|P2|Overall Study|Withdrawal by Subject|1
7678205|NCT01298778|26706050|P1|Overall Study|Withdrawal by Subject|0
7678206|NCT01298778|26706049|P2|Overall Study|Incorrect use of VAS|0
7678207|NCT01298778|26706050|P1|Overall Study|Incorrect use of VAS|1
7678208|NCT01298778|26706049|P2|Overall Study|Lost to Follow-up|3
7678209|NCT01298778|26706050|P1|Overall Study|Lost to Follow-up|2
7678210|NCT01298765|26706070|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
7678211|NCT01298765|26706070|P1|Long-Term Treatment Period|Physician Decision|1
7678212|NCT01298765|26706070|P1|Long-Term Treatment Period|Withdrawal by Subject|19
7678213|NCT01298765|26706070|P1|Long-Term Treatment Period|Lost to Follow-up|8
7678214|NCT01298765|26706070|P1|Long-Term Treatment Period|Lack of Efficacy|6
7678215|NCT01298765|26706070|P1|Long-Term Treatment Period|Adverse Event|19
7678216|NCT01298765|26706070|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
7678217|NCT01298765|26706070|P1|Titration Period|Withdrawal by Subject|10
7678218|NCT01298765|26706070|P1|Titration Period|Physician Decision|1
7678219|NCT01298765|26706070|P1|Titration Period|Lost to Follow-up|9
7678220|NCT01298765|26706070|P1|Titration Period|Lack of Efficacy|21
7678221|NCT01298765|26706070|P1|Titration Period|Death|1
7678222|NCT01298765|26706070|P1|Titration Period|Adverse Event|26
7678223|NCT01298700|26706091|P2|Overall Study|Did not Receive Study Drug|5
7678224|NCT01298700|26706092|P1|Overall Study|Did not Receive Study Drug|3
7678225|NCT01298700|26706091|P2|Overall Study|Other Miscellaneous Reasons|15
7678226|NCT01298700|26706092|P1|Overall Study|Other Miscellaneous Reasons|16
7678227|NCT01298700|26706091|P2|Overall Study|Protocol Violation|4
7678228|NCT01298700|26706092|P1|Overall Study|Protocol Violation|6
7678229|NCT01298700|26706091|P2|Overall Study|Withdrawal by Subject|9
7678230|NCT01298700|26706092|P1|Overall Study|Withdrawal by Subject|12
7678231|NCT01298700|26706091|P2|Overall Study|Lost to Follow-up|2
7678232|NCT01298700|26706092|P1|Overall Study|Lost to Follow-up|5
7678233|NCT01298700|26706091|P2|Overall Study|Lack of Efficacy|14
7678234|NCT01298700|26706092|P1|Overall Study|Lack of Efficacy|9
7678235|NCT01298700|26706091|P2|Overall Study|Adverse Event|51
7678236|NCT01298700|26706092|P1|Overall Study|Adverse Event|50
7678237|NCT01298661|26706103|P3|Overall Study|Withdrawal by Subject|2
7678238|NCT01298661|26706104|P2|Overall Study|Withdrawal by Subject|0
7678239|NCT01298661|26706105|P1|Overall Study|Withdrawal by Subject|2
7678240|NCT01298648|26706183|P1|Overall Study|Lost to Follow-up|21
7678241|NCT01298648|26706183|P1|Overall Study|Withdrawal by Subject|2
7678242|NCT01298596|26706194|P2|Overall Study|Referred for further management|15
7678243|NCT01298596|26706195|P1|Overall Study|Referred for further management|16
7678244|NCT01298596|26706194|P2|Overall Study|Lost to Follow-up|14
7678245|NCT01298596|26706195|P1|Overall Study|Lost to Follow-up|6
7678246|NCT01298596|26706194|P2|Overall Study|Death|3
7678247|NCT01298596|26706195|P1|Overall Study|Death|5
7678248|NCT01298596|26706194|P2|Overall Study|Withdrawal by Subject|1
7678249|NCT01298596|26706195|P1|Overall Study|Withdrawal by Subject|1
7678250|NCT01298570|26706205|P2|Overall Study|Ineligibility|1
7678251|NCT01298570|26706206|P1|Overall Study|Ineligibility|0
7678252|NCT01298570|26706205|P2|Overall Study|Death|1
7678253|NCT01298570|26706206|P1|Overall Study|Death|0
7678254|NCT01298570|26706205|P2|Overall Study|Symptomatic progression/deterioration|2
7678255|NCT01298570|26706206|P1|Overall Study|Symptomatic progression/deterioration|3
7678256|NCT01298570|26706205|P2|Overall Study|Surgery|1
7678257|NCT01298570|26706206|P1|Overall Study|Surgery|2
7678258|NCT01298570|26706205|P2|Overall Study|Other complicating disease|1
7678259|NCT01298570|26706206|P1|Overall Study|Other complicating disease|2
7678260|NCT01298570|26706205|P2|Overall Study|Physician Decision|2
7678261|NCT01298570|26706206|P1|Overall Study|Physician Decision|4
7678262|NCT01298570|26706205|P2|Overall Study|Treatment delay > 4 weeks|5
7678263|NCT01298570|26706206|P1|Overall Study|Treatment delay > 4 weeks|4
7678264|NCT01298570|26706205|P2|Overall Study|Withdrawal by Subject|6
7678265|NCT01298570|26706206|P1|Overall Study|Withdrawal by Subject|21
7678266|NCT01298570|26706205|P2|Overall Study|Adverse Event|2
7678267|NCT01298570|26706206|P1|Overall Study|Adverse Event|20
7678268|NCT01298570|26706205|P2|Overall Study|Disease progression, relapse during acti|40
7678269|NCT01298570|26706206|P1|Overall Study|Disease progression, relapse during acti|64
7678270|NCT01298531|26706233|P2|Overall Study|Other|1
7678271|NCT01298531|26706234|P1|Overall Study|Other|2
7678272|NCT01298531|26706233|P2|Overall Study|Does not meet entrance criteria|1
7678273|NCT01298531|26706234|P1|Overall Study|Does not meet entrance criteria|0
7678274|NCT01298531|26706233|P2|Overall Study|Adverse Event|3
7678275|NCT01298531|26706234|P1|Overall Study|Adverse Event|4
7678276|NCT01298531|26706233|P2|Overall Study|Protocol Violation|1
7678277|NCT01298531|26706234|P1|Overall Study|Protocol Violation|1
7678278|NCT01298531|26706233|P2|Overall Study|Lost to Follow-up|0
7678279|NCT01298531|26706234|P1|Overall Study|Lost to Follow-up|2
7678280|NCT01298531|26706233|P2|Overall Study|Lack of Efficacy|1
7678281|NCT01298531|26706234|P1|Overall Study|Lack of Efficacy|0
7678282|NCT01298518|26706363|P3|Overall Study|Withdrawal by Subject|1
7678283|NCT01298518|26706364|P2|Overall Study|Withdrawal by Subject|0
7678284|NCT01298518|26706365|P1|Overall Study|Withdrawal by Subject|0
7678285|NCT01298492|26706417|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
7678286|NCT01298492|26706417|P1|Overall Study|Adverse Event(Related to Study Drug)|8
7678287|NCT01298492|26706417|P1|Overall Study|Protocol Violation|2
7678288|NCT01298492|26706417|P1|Overall Study|Withdrawn Due to Pregnancy|1
7678289|NCT01298492|26706417|P1|Overall Study|Other (Unspecified)|7
7678290|NCT01298492|26706417|P1|Overall Study|Withdrawal by Subject|47
7678291|NCT01298492|26706417|P1|Overall Study|Lost to Follow-up|12
7678292|NCT01298492|26706417|P1|Overall Study|Insufficient Clinical Response|22
7678293|NCT01298492|26706417|P1|Overall Study|Death|2
7678294|NCT01298362|26706425|P2|Overall Study|Did not provide 12month BMD measurements|43
7678295|NCT01298362|26706426|P1|Overall Study|Did not provide 12month BMD measurements|38
7678296|NCT01298323|26706446|P2|Overall Study|Eligibility criteria not fulfilled|1
7678297|NCT01298323|26706447|P1|Overall Study|Eligibility criteria not fulfilled|0
7678298|NCT01298323|26706446|P2|Overall Study|Ongoing|55
7678299|NCT01298323|26706447|P1|Overall Study|Ongoing|55
7678300|NCT01298323|26706446|P2|Overall Study|Other|9
7678301|NCT01298323|26706447|P1|Overall Study|Other|10
7678302|NCT01298323|26706446|P2|Overall Study|Protocol Violation|0
7678303|NCT01298323|26706447|P1|Overall Study|Protocol Violation|1
7678304|NCT01298323|26706446|P2|Overall Study|Withdrawal by Subject|3
7678305|NCT01298323|26706447|P1|Overall Study|Withdrawal by Subject|6
7678306|NCT01298323|26706446|P2|Overall Study|Lost to Follow-up|0
7678307|NCT01298323|26706447|P1|Overall Study|Lost to Follow-up|1
7678308|NCT01298323|26706446|P2|Overall Study|Death|16
7678309|NCT01298323|26706447|P1|Overall Study|Death|11
7678310|NCT01298323|26706446|P2|Overall Study|Adverse Event|4
7678311|NCT01298323|26706447|P1|Overall Study|Adverse Event|2
7678312|NCT01298193|26706470|P1|Efficacy Phase (Second Cycle)|Death|1
7678313|NCT01298193|26706470|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
7678314|NCT01298193|26706470|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
7678315|NCT01298193|26706470|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
7678316|NCT01298141|26706492|P1|Overall Study|Not treated|4
7678317|NCT01298141|26706492|P1|Overall Study|Death|6
7678318|NCT01298141|26706492|P1|Overall Study|Lost to Follow-up|1
7678319|NCT01298141|26706492|P1|Overall Study|Other|5
7678320|NCT01298141|26706492|P1|Overall Study|Termination of Study by the Investigator|5
7678321|NCT01298141|26706492|P1|Overall Study|Withdrawal by Subject|6
7678322|NCT01298141|26706492|P1|Overall Study|Refusal of Required Study Procedures|1
7678323|NCT01298141|26706492|P1|Overall Study|Adverse Event|3
7678324|NCT01297959|26706566|P2|Overall Study|Other|7
7678325|NCT01297959|26706567|P1|Overall Study|Other|13
7678326|NCT01297959|26706566|P2|Overall Study|Unrelated medical illness / complication|2
7678327|NCT01297959|26706567|P1|Overall Study|Unrelated medical illness / complication|0
7678328|NCT01297959|26706566|P2|Overall Study|Physician Decision|1
7678329|NCT01297959|26706567|P1|Overall Study|Physician Decision|0
7678330|NCT01297959|26706566|P2|Overall Study|Withdrawal by Subject|4
7678331|NCT01297959|26706567|P1|Overall Study|Withdrawal by Subject|5
7678332|NCT01297959|26706566|P2|Overall Study|Protocol Violation|1
7678333|NCT01297959|26706567|P1|Overall Study|Protocol Violation|2
7678334|NCT01297959|26706566|P2|Overall Study|Adverse Event|1
7678335|NCT01297959|26706567|P1|Overall Study|Adverse Event|0
7678336|NCT01297920|26706616|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
7678337|NCT01297920|26706617|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
7678338|NCT01297920|26706618|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
7678339|NCT01297920|26706616|P3|Overall Study|Inadequate Control of IOP|17
7678340|NCT01297920|26706617|P2|Overall Study|Inadequate Control of IOP|9
7678341|NCT01297920|26706618|P1|Overall Study|Inadequate Control of IOP|7
7678342|NCT01297920|26706616|P3|Overall Study|Protocol Violation|0
7678343|NCT01297920|26706617|P2|Overall Study|Protocol Violation|3
7678344|NCT01297920|26706618|P1|Overall Study|Protocol Violation|1
7678345|NCT01297920|26706616|P3|Overall Study|Noncompliance|0
7678346|NCT01297920|26706617|P2|Overall Study|Noncompliance|0
7678347|NCT01297920|26706618|P1|Overall Study|Noncompliance|1
7678348|NCT01297920|26706616|P3|Overall Study|Patient Decision Unrelated to AE|2
7678349|NCT01297920|26706617|P2|Overall Study|Patient Decision Unrelated to AE|5
7678350|NCT01297920|26706618|P1|Overall Study|Patient Decision Unrelated to AE|6
7678351|NCT01297920|26706616|P3|Overall Study|Adverse Event|38
7678352|NCT01297920|26706617|P2|Overall Study|Adverse Event|10
7678353|NCT01297920|26706618|P1|Overall Study|Adverse Event|42
7678354|NCT01297517|26706662|P3|Overall Study|Inadequate Control of IOP|2
7678355|NCT01297517|26706663|P2|Overall Study|Inadequate Control of IOP|1
7678356|NCT01297517|26706664|P1|Overall Study|Inadequate Control of IOP|1
7678357|NCT01297517|26706662|P3|Overall Study|Protocol Violation|1
7678358|NCT01297517|26706663|P2|Overall Study|Protocol Violation|1
7678359|NCT01297517|26706664|P1|Overall Study|Protocol Violation|1
7678360|NCT01297517|26706662|P3|Overall Study|Noncompliance|0
7678361|NCT01297517|26706663|P2|Overall Study|Noncompliance|0
7678362|NCT01297517|26706664|P1|Overall Study|Noncompliance|1
7678363|NCT01297517|26706662|P3|Overall Study|Patient Decision Unrelated to AE|7
7678364|NCT01297517|26706663|P2|Overall Study|Patient Decision Unrelated to AE|3
7678365|NCT01297517|26706664|P1|Overall Study|Patient Decision Unrelated to AE|2
7678366|NCT01297517|26706662|P3|Overall Study|Lost to Follow-up|1
7678367|NCT01297517|26706663|P2|Overall Study|Lost to Follow-up|0
7678368|NCT01297517|26706664|P1|Overall Study|Lost to Follow-up|1
7678369|NCT01297517|26706662|P3|Overall Study|Adverse Event|16
7678370|NCT01297517|26706663|P2|Overall Study|Adverse Event|7
7678371|NCT01297517|26706664|P1|Overall Study|Adverse Event|21
7678372|NCT01297504|26706672|P1|Overall Study|Protocol Violation|3
7678373|NCT01297504|26706672|P1|Overall Study|Site Closure|3
7678374|NCT01297504|26706672|P1|Overall Study|Withdrawal by Subject|9
7678375|NCT01297504|26706672|P1|Overall Study|Lost to Follow-up|43
7678376|NCT01297504|26706672|P1|Overall Study|Death|3
7678377|NCT01297504|26706672|P1|Overall Study|No Study Visits|4
7678378|NCT01297504|26706672|P1|Overall Study|Received Palivizumab in Previous Season|1
7678379|NCT01297504|26706672|P1|Overall Study|Invalid Consent|1
7678380|NCT01297491|26706686|P2|Overall Study|Death|1
7678381|NCT01297491|26706687|P1|Overall Study|Death|2
7678382|NCT01297491|26706686|P2|Overall Study|Patient/Guardian decision|4
7678383|NCT01297491|26706687|P1|Overall Study|Patient/Guardian decision|3
7678384|NCT01297491|26706686|P2|Overall Study|Progressive disease|20
7678385|NCT01297491|26706687|P1|Overall Study|Progressive disease|11
7678386|NCT01297491|26706686|P2|Overall Study|Physician Decision|2
7678387|NCT01297491|26706687|P1|Overall Study|Physician Decision|3
7678388|NCT01297491|26706686|P2|Overall Study|Adverse Event|6
7678389|NCT01297491|26706687|P1|Overall Study|Adverse Event|11
7678390|NCT01297465|26706705|P2|Overall Study|Intention to Freeze all Embryos|1
7678391|NCT01297465|26706706|P1|Overall Study|Intention to Freeze all Embryos|0
7678392|NCT01297465|26706705|P2|Overall Study|All Embryos Discarded|1
7678393|NCT01297465|26706706|P1|Overall Study|All Embryos Discarded|0
7678394|NCT01297465|26706705|P2|Overall Study|No Fertilization|4
7678395|NCT01297465|26706706|P1|Overall Study|No Fertilization|6
7678396|NCT01297465|26706705|P2|Overall Study|Poor oocyte quality|1
7678397|NCT01297465|26706706|P1|Overall Study|Poor oocyte quality|0
7678398|NCT01297465|26706705|P2|Overall Study|No Oocytes Retrieved|1
7678399|NCT01297465|26706706|P1|Overall Study|No Oocytes Retrieved|1
7678400|NCT01297465|26706705|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
7678401|NCT01297465|26706706|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
7678402|NCT01297465|26706705|P2|Overall Study|Lack of Ovarian Response|1
7678403|NCT01297465|26706706|P1|Overall Study|Lack of Ovarian Response|1
7678404|NCT01297322|26706759|P2|Overall Study|Protocol Violation|3
7678405|NCT01297322|26706760|P1|Overall Study|Protocol Violation|0
7678406|NCT01297322|26706759|P2|Overall Study|Withdrawal by Subject|1
7678407|NCT01297322|26706760|P1|Overall Study|Withdrawal by Subject|0
7678408|NCT01297322|26706759|P2|Overall Study|Lost to Follow-up|0
7678409|NCT01297322|26706760|P1|Overall Study|Lost to Follow-up|1
7678410|NCT01297309|26706779|P1|Overall Study|Participant not entering extensionperiod|1
7678411|NCT01297309|26706779|P1|Overall Study|Death|1
7678412|NCT01297309|26706779|P1|Overall Study|Investigator Decision|2
7678413|NCT01297309|26706779|P1|Overall Study|Adverse Event|1
7678414|NCT01297309|26706779|P1|Overall Study|Withdrawal by Subject|5
7678415|NCT01297309|26706779|P1|Overall Study|Screen failure|2
7678416|NCT01297309|26706779|P1|Overall Study|Eligibility failure|2
7678417|NCT01297270|26706804|P3|Overall Study|Not treated|0
7678418|NCT01297270|26706805|P2|Overall Study|Not treated|1
7678419|NCT01297270|26706806|P1|Overall Study|Not treated|0
7678420|NCT01297270|26706804|P3|Overall Study|Other reason not defined above|1
7678421|NCT01297270|26706805|P2|Overall Study|Other reason not defined above|3
7678422|NCT01297270|26706806|P1|Overall Study|Other reason not defined above|3
7678423|NCT01297270|26706804|P3|Overall Study|Withdrawal by Subject|7
7678424|NCT01297270|26706805|P2|Overall Study|Withdrawal by Subject|15
7678425|NCT01297270|26706806|P1|Overall Study|Withdrawal by Subject|7
7678426|NCT01297270|26706804|P3|Overall Study|Protocol Violation|0
7678427|NCT01297270|26706805|P2|Overall Study|Protocol Violation|2
7678428|NCT01297270|26706806|P1|Overall Study|Protocol Violation|0
7678429|NCT01297270|26706804|P3|Overall Study|Lost to Follow-up|1
7678430|NCT01297270|26706805|P2|Overall Study|Lost to Follow-up|2
7678431|NCT01297270|26706806|P1|Overall Study|Lost to Follow-up|1
7678432|NCT01297270|26706804|P3|Overall Study|Lack of Efficacy|15
7678433|NCT01297270|26706805|P2|Overall Study|Lack of Efficacy|17
7678434|NCT01297270|26706806|P1|Overall Study|Lack of Efficacy|15
7678435|NCT01297270|26706804|P3|Overall Study|Adverse Event|5
7678436|NCT01297270|26706805|P2|Overall Study|Adverse Event|32
7678437|NCT01297270|26706806|P1|Overall Study|Adverse Event|19
7678438|NCT01297244|26706851|P2|Overall Study|Withdrawal by Subject|0
7678439|NCT01297244|26706852|P1|Overall Study|Withdrawal by Subject|2
7678440|NCT01297244|26706851|P2|Overall Study|Clinical progression|1
7678441|NCT01297244|26706852|P1|Overall Study|Clinical progression|1
7678442|NCT01297244|26706851|P2|Overall Study|Death|1
7678443|NCT01297244|26706852|P1|Overall Study|Death|1
7678444|NCT01297244|26706851|P2|Overall Study|Adverse Event|1
7678445|NCT01297244|26706852|P1|Overall Study|Adverse Event|9
7678446|NCT01297244|26706851|P2|Overall Study|Progressive disease|3
7678447|NCT01297244|26706852|P1|Overall Study|Progressive disease|22
7678448|NCT01297062|26706872|P7|Overall Study|Subject Decision|2
7678449|NCT01297062|26706873|P6|Overall Study|Subject Decision|1
7678450|NCT01297062|26706874|P5|Overall Study|Subject Decision|1
7678451|NCT01297062|26706875|P4|Overall Study|Subject Decision|1
7678452|NCT01297062|26706876|P3|Overall Study|Subject Decision|0
7678453|NCT01297062|26706877|P2|Overall Study|Subject Decision|1
7678454|NCT01297062|26706878|P1|Overall Study|Subject Decision|1
7678455|NCT01297062|26706872|P7|Overall Study|Protocol Violation|0
7678456|NCT01297062|26706873|P6|Overall Study|Protocol Violation|0
7678457|NCT01297062|26706874|P5|Overall Study|Protocol Violation|1
7678458|NCT01297062|26706875|P4|Overall Study|Protocol Violation|0
7678459|NCT01297062|26706876|P3|Overall Study|Protocol Violation|0
7678460|NCT01297062|26706877|P2|Overall Study|Protocol Violation|0
7678461|NCT01297062|26706878|P1|Overall Study|Protocol Violation|0
7678462|NCT01297062|26706872|P7|Overall Study|Physician Decision|6
7678463|NCT01297062|26706873|P6|Overall Study|Physician Decision|0
7678464|NCT01297062|26706874|P5|Overall Study|Physician Decision|0
7678465|NCT01297062|26706875|P4|Overall Study|Physician Decision|0
7678466|NCT01297062|26706876|P3|Overall Study|Physician Decision|1
7678467|NCT01297062|26706877|P2|Overall Study|Physician Decision|0
7678468|NCT01297062|26706878|P1|Overall Study|Physician Decision|1
7678469|NCT01297062|26706872|P7|Overall Study|Adverse Event|0
7678470|NCT01297062|26706873|P6|Overall Study|Adverse Event|0
7678471|NCT01297062|26706874|P5|Overall Study|Adverse Event|0
7678472|NCT01297062|26706875|P4|Overall Study|Adverse Event|0
7678473|NCT01297062|26706876|P3|Overall Study|Adverse Event|1
7678474|NCT01297062|26706877|P2|Overall Study|Adverse Event|0
7678475|NCT01297062|26706878|P1|Overall Study|Adverse Event|2
7678476|NCT01296932|26706909|P9|Overall Study|Dosage already reduced, AE still present|1
7678477|NCT01296932|26706910|P8|Overall Study|Dosage already reduced, AE still present|0
7678478|NCT01296932|26706911|P7|Overall Study|Dosage already reduced, AE still present|0
7678479|NCT01296932|26706912|P6|Overall Study|Dosage already reduced, AE still present|0
7678480|NCT01296932|26706913|P5|Overall Study|Dosage already reduced, AE still present|0
7678481|NCT01296932|26706914|P4|Overall Study|Dosage already reduced, AE still present|0
7678482|NCT01296932|26706915|P3|Overall Study|Dosage already reduced, AE still present|0
7678483|NCT01296932|26706916|P2|Overall Study|Dosage already reduced, AE still present|0
7678484|NCT01296932|26706917|P1|Overall Study|Dosage already reduced, AE still present|0
7678485|NCT01296932|26706909|P9|Overall Study|No adequate treatment response|0
7678486|NCT01296932|26706910|P8|Overall Study|No adequate treatment response|1
7678487|NCT01296932|26706911|P7|Overall Study|No adequate treatment response|0
7678488|NCT01296932|26706912|P6|Overall Study|No adequate treatment response|0
7678489|NCT01296932|26706913|P5|Overall Study|No adequate treatment response|0
7678490|NCT01296932|26706914|P4|Overall Study|No adequate treatment response|0
7678491|NCT01296932|26706915|P3|Overall Study|No adequate treatment response|0
7678492|NCT01296932|26706916|P2|Overall Study|No adequate treatment response|0
7678493|NCT01296932|26706917|P1|Overall Study|No adequate treatment response|0
7678494|NCT01296932|26706909|P9|Overall Study|Low benefit and too many side effects|0
7678495|NCT01296932|26706910|P8|Overall Study|Low benefit and too many side effects|1
7678496|NCT01296932|26706911|P7|Overall Study|Low benefit and too many side effects|0
7678497|NCT01296932|26706912|P6|Overall Study|Low benefit and too many side effects|0
7678498|NCT01296932|26706913|P5|Overall Study|Low benefit and too many side effects|0
7678499|NCT01296932|26706914|P4|Overall Study|Low benefit and too many side effects|0
7678500|NCT01296932|26706915|P3|Overall Study|Low benefit and too many side effects|0
7678501|NCT01296932|26706916|P2|Overall Study|Low benefit and too many side effects|0
7678502|NCT01296932|26706917|P1|Overall Study|Low benefit and too many side effects|0
7678503|NCT01296932|26706909|P9|Overall Study|per protocol|0
7678504|NCT01296932|26706910|P8|Overall Study|per protocol|0
7678505|NCT01296932|26706911|P7|Overall Study|per protocol|0
7678506|NCT01296932|26706912|P6|Overall Study|per protocol|0
7678507|NCT01296932|26706913|P5|Overall Study|per protocol|0
7678508|NCT01296932|26706914|P4|Overall Study|per protocol|1
7678509|NCT01296932|26706915|P3|Overall Study|per protocol|1
7678510|NCT01296932|26706916|P2|Overall Study|per protocol|0
7678511|NCT01296932|26706917|P1|Overall Study|per protocol|0
7678512|NCT01296932|26706909|P9|Overall Study|IV problems, administration not possible|0
7678513|NCT01296932|26706910|P8|Overall Study|IV problems, administration not possible|0
7678514|NCT01296932|26706911|P7|Overall Study|IV problems, administration not possible|0
7678515|NCT01296932|26706912|P6|Overall Study|IV problems, administration not possible|0
7678516|NCT01296932|26706913|P5|Overall Study|IV problems, administration not possible|0
7678517|NCT01296932|26706914|P4|Overall Study|IV problems, administration not possible|0
7678518|NCT01296932|26706915|P3|Overall Study|IV problems, administration not possible|1
7678519|NCT01296932|26706916|P2|Overall Study|IV problems, administration not possible|0
7678520|NCT01296932|26706917|P1|Overall Study|IV problems, administration not possible|0
7678521|NCT01296932|26706909|P9|Overall Study|Physician Decision|0
7678522|NCT01296932|26706910|P8|Overall Study|Physician Decision|0
7678523|NCT01296932|26706911|P7|Overall Study|Physician Decision|0
7678524|NCT01296932|26706912|P6|Overall Study|Physician Decision|0
7678525|NCT01296932|26706913|P5|Overall Study|Physician Decision|0
7678526|NCT01296932|26706914|P4|Overall Study|Physician Decision|0
7678527|NCT01296932|26706915|P3|Overall Study|Physician Decision|1
7678528|NCT01296932|26706916|P2|Overall Study|Physician Decision|0
7678529|NCT01296932|26706917|P1|Overall Study|Physician Decision|0
7678530|NCT01296932|26706909|P9|Overall Study|No clinical benefit anymore|0
7678531|NCT01296932|26706910|P8|Overall Study|No clinical benefit anymore|0
7678532|NCT01296932|26706911|P7|Overall Study|No clinical benefit anymore|0
7678533|NCT01296932|26706912|P6|Overall Study|No clinical benefit anymore|0
7678534|NCT01296932|26706913|P5|Overall Study|No clinical benefit anymore|0
7678535|NCT01296932|26706914|P4|Overall Study|No clinical benefit anymore|0
7678536|NCT01296932|26706915|P3|Overall Study|No clinical benefit anymore|0
7678537|NCT01296932|26706916|P2|Overall Study|No clinical benefit anymore|1
7678538|NCT01296932|26706917|P1|Overall Study|No clinical benefit anymore|0
7678539|NCT01296932|26706909|P9|Overall Study|Investigator decision|1
7678540|NCT01296932|26706910|P8|Overall Study|Investigator decision|0
7678541|NCT01296932|26706911|P7|Overall Study|Investigator decision|1
7678542|NCT01296932|26706912|P6|Overall Study|Investigator decision|0
7678543|NCT01296932|26706913|P5|Overall Study|Investigator decision|0
7678544|NCT01296932|26706914|P4|Overall Study|Investigator decision|1
7678545|NCT01296932|26706915|P3|Overall Study|Investigator decision|0
7678546|NCT01296932|26706916|P2|Overall Study|Investigator decision|1
7678547|NCT01296932|26706917|P1|Overall Study|Investigator decision|0
7678548|NCT01296932|26706909|P9|Overall Study|Adverse Event|1
7678549|NCT01296932|26706910|P8|Overall Study|Adverse Event|0
7678550|NCT01296932|26706911|P7|Overall Study|Adverse Event|0
7678551|NCT01296932|26706912|P6|Overall Study|Adverse Event|0
7678552|NCT01296932|26706913|P5|Overall Study|Adverse Event|1
7678553|NCT01296932|26706914|P4|Overall Study|Adverse Event|2
7678554|NCT01296932|26706915|P3|Overall Study|Adverse Event|1
7678555|NCT01296932|26706916|P2|Overall Study|Adverse Event|1
7678556|NCT01296932|26706917|P1|Overall Study|Adverse Event|1
7678557|NCT01296932|26706909|P9|Overall Study|Withdrawal by Subject|0
7678558|NCT01296932|26706910|P8|Overall Study|Withdrawal by Subject|0
7678559|NCT01296932|26706911|P7|Overall Study|Withdrawal by Subject|3
7678560|NCT01296932|26706912|P6|Overall Study|Withdrawal by Subject|0
7678561|NCT01296932|26706913|P5|Overall Study|Withdrawal by Subject|0
7678562|NCT01296932|26706914|P4|Overall Study|Withdrawal by Subject|1
7678563|NCT01296932|26706915|P3|Overall Study|Withdrawal by Subject|1
7678564|NCT01296932|26706916|P2|Overall Study|Withdrawal by Subject|0
7678565|NCT01296932|26706917|P1|Overall Study|Withdrawal by Subject|0
7678566|NCT01296932|26706909|P9|Overall Study|Progressive disease|0
7678567|NCT01296932|26706910|P8|Overall Study|Progressive disease|0
7678568|NCT01296932|26706911|P7|Overall Study|Progressive disease|1
7678569|NCT01296932|26706912|P6|Overall Study|Progressive disease|3
7678570|NCT01296932|26706913|P5|Overall Study|Progressive disease|2
7678571|NCT01296932|26706914|P4|Overall Study|Progressive disease|1
7678572|NCT01296932|26706915|P3|Overall Study|Progressive disease|1
7678573|NCT01296932|26706916|P2|Overall Study|Progressive disease|0
7678574|NCT01296932|26706917|P1|Overall Study|Progressive disease|2
7678575|NCT01296932|26706909|P9|Overall Study|Dose limiting toxicity|1
7678576|NCT01296932|26706910|P8|Overall Study|Dose limiting toxicity|0
7678577|NCT01296932|26706911|P7|Overall Study|Dose limiting toxicity|1
7678578|NCT01296932|26706912|P6|Overall Study|Dose limiting toxicity|0
7678579|NCT01296932|26706913|P5|Overall Study|Dose limiting toxicity|0
7678580|NCT01296932|26706914|P4|Overall Study|Dose limiting toxicity|0
7678581|NCT01296932|26706915|P3|Overall Study|Dose limiting toxicity|0
7678582|NCT01296932|26706916|P2|Overall Study|Dose limiting toxicity|0
7678583|NCT01296932|26706917|P1|Overall Study|Dose limiting toxicity|0
7678584|NCT01296698|26707041|P2|Overall Study|Study Terminated by Sponsor|12
7678585|NCT01296698|26707042|P1|Overall Study|Study Terminated by Sponsor|209
7678586|NCT01296698|26707041|P2|Overall Study|Difficulty Contacting Subject|0
7678587|NCT01296698|26707042|P1|Overall Study|Difficulty Contacting Subject|2
7678588|NCT01296698|26707041|P2|Overall Study|Withdrawal by Subject|0
7678589|NCT01296698|26707042|P1|Overall Study|Withdrawal by Subject|12
7678590|NCT01296698|26707041|P2|Overall Study|Lost to Follow-up|1
7678591|NCT01296698|26707042|P1|Overall Study|Lost to Follow-up|19
7678592|NCT01296698|26707041|P2|Overall Study|Death|0
7678593|NCT01296698|26707042|P1|Overall Study|Death|1
7678594|NCT01296698|26707041|P2|Overall Study|Adverse Event|0
7678595|NCT01296698|26707042|P1|Overall Study|Adverse Event|1
7678596|NCT01296672|26707096|P2|Overall Study|Lost to Follow-up|18
7678597|NCT01296672|26707097|P1|Overall Study|Lost to Follow-up|73
7678598|NCT01296568|26707118|P1|Continued Access Phase|Disease Progression|1
7678599|NCT01296568|26707118|P1|Continued Access Phase|Withdrawal by Subject|1
7678600|NCT01296568|26707118|P1|Continued Access Phase|Lost to Follow-up|1
7678601|NCT01296412|26707143|P2|Overall Study|Withdrawal by Subject|13
7678602|NCT01296412|26707144|P1|Overall Study|Withdrawal by Subject|10
7678603|NCT01296412|26707143|P2|Overall Study|Pregnancy|1
7678604|NCT01296412|26707144|P1|Overall Study|Pregnancy|0
7678605|NCT01296412|26707143|P2|Overall Study|Physician Decision|3
7678606|NCT01296412|26707144|P1|Overall Study|Physician Decision|1
7678607|NCT01296412|26707143|P2|Overall Study|Other reason not specified|15
7678608|NCT01296412|26707144|P1|Overall Study|Other reason not specified|20
7678609|NCT01296412|26707143|P2|Overall Study|Non-compliance with study drug|2
7678610|NCT01296412|26707144|P1|Overall Study|Non-compliance with study drug|1
7678611|NCT01296412|26707143|P2|Overall Study|Lost to Follow-up|7
7678612|NCT01296412|26707144|P1|Overall Study|Lost to Follow-up|10
7678613|NCT01296412|26707143|P2|Overall Study|Lack of Efficacy|0
7678614|NCT01296412|26707144|P1|Overall Study|Lack of Efficacy|1
7678615|NCT01296412|26707143|P2|Overall Study|Adverse Event|29
7678616|NCT01296412|26707144|P1|Overall Study|Adverse Event|8
7678617|NCT01296347|26707167|P2|12 Month Follow up|Withdrawal by Subject|1
7678618|NCT01296347|26707168|P1|12 Month Follow up|Withdrawal by Subject|0
7678619|NCT01296347|26707167|P2|12 Month Follow up|Death|1
7678620|NCT01296347|26707168|P1|12 Month Follow up|Death|1
7678621|NCT01296347|26707167|P2|12 Month Follow up|Lost to Follow-up|1
7678622|NCT01296347|26707168|P1|12 Month Follow up|Lost to Follow-up|3
7678623|NCT01296347|26707167|P2|6 Month Follow up|Lost to Follow-up|1
7678624|NCT01296347|26707168|P1|6 Month Follow up|Lost to Follow-up|0
7678625|NCT01296347|26707167|P2|6 Month Follow up|Death|1
7678626|NCT01296347|26707168|P1|6 Month Follow up|Death|2
7678627|NCT01296347|26707167|P2|3 Month Follow up|Lost to Follow-up|1
7678628|NCT01296347|26707168|P1|3 Month Follow up|Lost to Follow-up|0
7678629|NCT01296347|26707167|P2|3 Month Follow up|Death|0
7678630|NCT01296347|26707168|P1|3 Month Follow up|Death|1
7678631|NCT01296347|26707167|P2|6 Week Follow up|Death|1
7678632|NCT01296347|26707168|P1|6 Week Follow up|Death|0
7678633|NCT01296347|26707167|P2|Allocation|not received infusion|0
7678634|NCT01296347|26707168|P1|Allocation|not received infusion|1
7678635|NCT01296347|26707167|P2|Allocation|Lack of Efficacy|2
7678636|NCT01296347|26707168|P1|Allocation|Lack of Efficacy|1
7678637|NCT01296347|26707167|P2|Allocation|Withdrawal by Subject|2
7678638|NCT01296347|26707168|P1|Allocation|Withdrawal by Subject|1
7678639|NCT01296152|26707193|P1|Overall Study|Unwilling to adhere to study requirement|1
7678640|NCT01296035|26707220|P1|Overall Study|Withdrawal by Subject|1
7678641|NCT01295905|26707227|P2|Overall Study|Met exclusion criteria|0
7678642|NCT01295905|26707228|P1|Overall Study|Met exclusion criteria|1
7678643|NCT01295905|26707227|P2|Overall Study|Did not meet inclusion criteria|0
7678644|NCT01295905|26707228|P1|Overall Study|Did not meet inclusion criteria|1
7678645|NCT01295827|26707272|P15|Overall Study|Other|0
7678646|NCT01295827|26707273|P14|Overall Study|Other|0
7678647|NCT01295827|26707274|P13|Overall Study|Other|0
7678648|NCT01295827|26707275|P12|Overall Study|Other|0
7678649|NCT01295827|26707276|P11|Overall Study|Other|2
7678650|NCT01295827|26707277|P10|Overall Study|Other|0
7678651|NCT01295827|26707278|P9|Overall Study|Other|1
7678652|NCT01295827|26707279|P8|Overall Study|Other|1
7678653|NCT01295827|26707280|P7|Overall Study|Other|1
7678654|NCT01295827|26707281|P6|Overall Study|Other|0
7678655|NCT01295827|26707282|P5|Overall Study|Other|0
7678656|NCT01295827|26707283|P4|Overall Study|Other|0
7678657|NCT01295827|26707284|P3|Overall Study|Other|0
7678658|NCT01295827|26707285|P2|Overall Study|Other|0
7678659|NCT01295827|26707286|P1|Overall Study|Other|0
7678660|NCT01295827|26707272|P15|Overall Study|Withdrawal by Subject|0
7678661|NCT01295827|26707273|P14|Overall Study|Withdrawal by Subject|0
7678662|NCT01295827|26707274|P13|Overall Study|Withdrawal by Subject|0
7678663|NCT01295827|26707275|P12|Overall Study|Withdrawal by Subject|13
7678664|NCT01295827|26707276|P11|Overall Study|Withdrawal by Subject|18
7678665|NCT01295827|26707277|P10|Overall Study|Withdrawal by Subject|2
7678666|NCT01295827|26707278|P9|Overall Study|Withdrawal by Subject|11
7678667|NCT01295827|26707279|P8|Overall Study|Withdrawal by Subject|35
7678668|NCT01295827|26707280|P7|Overall Study|Withdrawal by Subject|13
7678669|NCT01295827|26707281|P6|Overall Study|Withdrawal by Subject|1
7678670|NCT01295827|26707282|P5|Overall Study|Withdrawal by Subject|0
7678671|NCT01295827|26707283|P4|Overall Study|Withdrawal by Subject|0
7678672|NCT01295827|26707284|P3|Overall Study|Withdrawal by Subject|2
7678673|NCT01295827|26707285|P2|Overall Study|Withdrawal by Subject|0
7678674|NCT01295827|26707286|P1|Overall Study|Withdrawal by Subject|1
7678675|NCT01295827|26707272|P15|Overall Study|Screen Failure|0
7678676|NCT01295827|26707273|P14|Overall Study|Screen Failure|0
7678677|NCT01295827|26707274|P13|Overall Study|Screen Failure|0
7678678|NCT01295827|26707275|P12|Overall Study|Screen Failure|0
7678679|NCT01295827|26707276|P11|Overall Study|Screen Failure|1
7678680|NCT01295827|26707277|P10|Overall Study|Screen Failure|0
7678681|NCT01295827|26707278|P9|Overall Study|Screen Failure|2
7678682|NCT01295827|26707279|P8|Overall Study|Screen Failure|2
7678683|NCT01295827|26707280|P7|Overall Study|Screen Failure|2
7678684|NCT01295827|26707281|P6|Overall Study|Screen Failure|0
7678685|NCT01295827|26707282|P5|Overall Study|Screen Failure|0
7678686|NCT01295827|26707283|P4|Overall Study|Screen Failure|0
7678687|NCT01295827|26707284|P3|Overall Study|Screen Failure|0
7678688|NCT01295827|26707285|P2|Overall Study|Screen Failure|0
7678689|NCT01295827|26707286|P1|Overall Study|Screen Failure|0
7678690|NCT01295827|26707272|P15|Overall Study|Progressive Disease|0
7678691|NCT01295827|26707273|P14|Overall Study|Progressive Disease|0
7678692|NCT01295827|26707274|P13|Overall Study|Progressive Disease|0
7678693|NCT01295827|26707275|P12|Overall Study|Progressive Disease|136
7678694|NCT01295827|26707276|P11|Overall Study|Progressive Disease|175
7678695|NCT01295827|26707277|P10|Overall Study|Progressive Disease|40
7678696|NCT01295827|26707278|P9|Overall Study|Progressive Disease|85
7678697|NCT01295827|26707279|P8|Overall Study|Progressive Disease|144
7678698|NCT01295827|26707280|P7|Overall Study|Progressive Disease|87
7678699|NCT01295827|26707281|P6|Overall Study|Progressive Disease|1
7678700|NCT01295827|26707282|P5|Overall Study|Progressive Disease|0
7678701|NCT01295827|26707283|P4|Overall Study|Progressive Disease|2
7678702|NCT01295827|26707284|P3|Overall Study|Progressive Disease|5
7678703|NCT01295827|26707285|P2|Overall Study|Progressive Disease|1
7678704|NCT01295827|26707286|P1|Overall Study|Progressive Disease|2
7678705|NCT01295827|26707272|P15|Overall Study|Not Reported|0
7678706|NCT01295827|26707273|P14|Overall Study|Not Reported|0
7678707|NCT01295827|26707274|P13|Overall Study|Not Reported|0
7678708|NCT01295827|26707275|P12|Overall Study|Not Reported|13
7678709|NCT01295827|26707276|P11|Overall Study|Not Reported|23
7678710|NCT01295827|26707277|P10|Overall Study|Not Reported|2
7678711|NCT01295827|26707278|P9|Overall Study|Not Reported|41
7678712|NCT01295827|26707279|P8|Overall Study|Not Reported|58
7678713|NCT01295827|26707280|P7|Overall Study|Not Reported|24
7678714|NCT01295827|26707281|P6|Overall Study|Not Reported|0
7678715|NCT01295827|26707282|P5|Overall Study|Not Reported|0
7678716|NCT01295827|26707283|P4|Overall Study|Not Reported|1
7678717|NCT01295827|26707284|P3|Overall Study|Not Reported|0
7678718|NCT01295827|26707285|P2|Overall Study|Not Reported|0
7678719|NCT01295827|26707286|P1|Overall Study|Not Reported|0
7678720|NCT01295827|26707272|P15|Overall Study|Lost to Follow-up|0
7678721|NCT01295827|26707273|P14|Overall Study|Lost to Follow-up|0
7678722|NCT01295827|26707274|P13|Overall Study|Lost to Follow-up|0
7678723|NCT01295827|26707275|P12|Overall Study|Lost to Follow-up|3
7678724|NCT01295827|26707276|P11|Overall Study|Lost to Follow-up|7
7678725|NCT01295827|26707277|P10|Overall Study|Lost to Follow-up|4
7678726|NCT01295827|26707278|P9|Overall Study|Lost to Follow-up|7
7678727|NCT01295827|26707279|P8|Overall Study|Lost to Follow-up|8
7678728|NCT01295827|26707280|P7|Overall Study|Lost to Follow-up|4
7678729|NCT01295827|26707281|P6|Overall Study|Lost to Follow-up|0
7678730|NCT01295827|26707282|P5|Overall Study|Lost to Follow-up|1
7678731|NCT01295827|26707283|P4|Overall Study|Lost to Follow-up|0
7678732|NCT01295827|26707284|P3|Overall Study|Lost to Follow-up|3
7678733|NCT01295827|26707285|P2|Overall Study|Lost to Follow-up|0
7678734|NCT01295827|26707286|P1|Overall Study|Lost to Follow-up|0
7678735|NCT01295827|26707272|P15|Overall Study|Adverse Event|0
7678736|NCT01295827|26707273|P14|Overall Study|Adverse Event|0
7678737|NCT01295827|26707274|P13|Overall Study|Adverse Event|0
7678738|NCT01295827|26707275|P12|Overall Study|Adverse Event|21
7678739|NCT01295827|26707276|P11|Overall Study|Adverse Event|50
7678740|NCT01295827|26707277|P10|Overall Study|Adverse Event|7
7678741|NCT01295827|26707278|P9|Overall Study|Adverse Event|22
7678742|NCT01295827|26707279|P8|Overall Study|Adverse Event|49
7678743|NCT01295827|26707280|P7|Overall Study|Adverse Event|15
7678744|NCT01295827|26707281|P6|Overall Study|Adverse Event|4
7678745|NCT01295827|26707282|P5|Overall Study|Adverse Event|1
7678746|NCT01295827|26707283|P4|Overall Study|Adverse Event|1
7678747|NCT01295827|26707284|P3|Overall Study|Adverse Event|2
7678748|NCT01295827|26707285|P2|Overall Study|Adverse Event|2
7678749|NCT01295827|26707286|P1|Overall Study|Adverse Event|1
7678750|NCT01295814|26707659|P2|Overall Study|Withdrawal by Subject|0
7678751|NCT01295814|26707660|P1|Overall Study|Withdrawal by Subject|2
7678752|NCT01295814|26707659|P2|Overall Study|Lack of Efficacy|2
7678753|NCT01295814|26707660|P1|Overall Study|Lack of Efficacy|0
7678754|NCT01295671|26707740|P3|Overall Study|Withdrawal by Subject|0
7678755|NCT01295671|26707741|P2|Overall Study|Withdrawal by Subject|1
7678756|NCT01295671|26707742|P1|Overall Study|Withdrawal by Subject|3
7678757|NCT01295671|26707740|P3|Overall Study|Lost to Follow-up|3
7678758|NCT01295671|26707741|P2|Overall Study|Lost to Follow-up|6
7678759|NCT01295671|26707742|P1|Overall Study|Lost to Follow-up|4
7678760|NCT01295580|26707782|P2|Overall Study|Other: family objection|1
7678761|NCT01295580|26707783|P1|Overall Study|Other: family objection|0
7678762|NCT01295580|26707782|P2|Overall Study|Other: inconvenience|0
7678763|NCT01295580|26707783|P1|Overall Study|Other: inconvenience|1
7678764|NCT01295580|26707782|P2|Overall Study|Lack of Efficacy|0
7678765|NCT01295580|26707783|P1|Overall Study|Lack of Efficacy|1
7678766|NCT01295580|26707782|P2|Overall Study|Lost to Follow-up|0
7678767|NCT01295580|26707783|P1|Overall Study|Lost to Follow-up|1
7678768|NCT01295580|26707782|P2|Overall Study|Adverse Event|1
7678769|NCT01295580|26707783|P1|Overall Study|Adverse Event|2
7678770|NCT01295580|26707782|P2|Overall Study|Withdrawal by Subject|4
7678771|NCT01295580|26707783|P1|Overall Study|Withdrawal by Subject|1
7678772|NCT01295580|26707782|P2|Overall Study|Protocol Violation|2
7678773|NCT01295580|26707783|P1|Overall Study|Protocol Violation|4
7678774|NCT01295320|26707811|P1|Overall Study|Unable to travel|1
7678775|NCT01295320|26707811|P1|Overall Study|Subject was bedridden|1
7678776|NCT01295320|26707811|P1|Overall Study|Withdrawal by Subject|2
7678777|NCT01295320|26707811|P1|Overall Study|Lost to Follow-up|4
7678778|NCT01295320|26707811|P1|Overall Study|Adverse Event|2
7678779|NCT01295281|26707828|P2|First Intervention (7 Days)|Death|1
7678780|NCT01295281|26707829|P1|First Intervention (7 Days)|Death|0
7678781|NCT01295034|26707867|P2|Overall Study|Lost to Follow-up|5
7678782|NCT01295034|26707868|P1|Overall Study|Lost to Follow-up|5
7678783|NCT01294917|26707876|P1|Overall Study|Inconvenience|1
7678784|NCT01294917|26707876|P1|Overall Study|Relocation|5
7678785|NCT01294800|26707886|P4|Overall Study|Did Not Meet Protocol Eligibility|0
7678786|NCT01294800|26707887|P3|Overall Study|Did Not Meet Protocol Eligibility|1
7678787|NCT01294800|26707888|P2|Overall Study|Did Not Meet Protocol Eligibility|1
7678788|NCT01294800|26707889|P1|Overall Study|Did Not Meet Protocol Eligibility|2
7678789|NCT01294800|26707886|P4|Overall Study|Non-compliance With Protocol|0
7678790|NCT01294800|26707887|P3|Overall Study|Non-compliance With Protocol|1
7678791|NCT01294800|26707888|P2|Overall Study|Non-compliance With Protocol|1
7678792|NCT01294800|26707889|P1|Overall Study|Non-compliance With Protocol|0
7678793|NCT01294800|26707886|P4|Overall Study|Lost to Follow-up|0
7678794|NCT01294800|26707887|P3|Overall Study|Lost to Follow-up|1
7678795|NCT01294800|26707888|P2|Overall Study|Lost to Follow-up|0
7678796|NCT01294800|26707889|P1|Overall Study|Lost to Follow-up|0
7678797|NCT01294800|26707886|P4|Overall Study|Subject Withdrew Consent|11
7678798|NCT01294800|26707887|P3|Overall Study|Subject Withdrew Consent|2
7678799|NCT01294800|26707888|P2|Overall Study|Subject Withdrew Consent|2
7678800|NCT01294800|26707889|P1|Overall Study|Subject Withdrew Consent|2
7678801|NCT01294800|26707886|P4|Overall Study|Adverse Event|5
7678802|NCT01294800|26707887|P3|Overall Study|Adverse Event|12
7678803|NCT01294800|26707888|P2|Overall Study|Adverse Event|6
7678804|NCT01294800|26707889|P1|Overall Study|Adverse Event|7
7678805|NCT01294787|26707915|P6|Period 3|Adverse Event|0
7678806|NCT01294787|26707916|P5|Period 3|Adverse Event|1
7678807|NCT01294787|26707917|P4|Period 3|Adverse Event|0
7678808|NCT01294787|26707918|P3|Period 3|Adverse Event|0
7678809|NCT01294787|26707919|P2|Period 3|Adverse Event|0
7678810|NCT01294787|26707920|P1|Period 3|Adverse Event|0
7678811|NCT01294787|26707915|P6|Period 2|No longer needs study drug|0
7678812|NCT01294787|26707916|P5|Period 2|No longer needs study drug|0
7678813|NCT01294787|26707917|P4|Period 2|No longer needs study drug|1
7678814|NCT01294787|26707918|P3|Period 2|No longer needs study drug|0
7678815|NCT01294787|26707919|P2|Period 2|No longer needs study drug|0
7678816|NCT01294787|26707920|P1|Period 2|No longer needs study drug|0
7678817|NCT01294787|26707915|P6|Period 2|Adverse Event|0
7678818|NCT01294787|26707916|P5|Period 2|Adverse Event|0
7678819|NCT01294787|26707917|P4|Period 2|Adverse Event|1
7678820|NCT01294787|26707918|P3|Period 2|Adverse Event|0
7678821|NCT01294787|26707919|P2|Period 2|Adverse Event|3
7678822|NCT01294787|26707920|P1|Period 2|Adverse Event|0
7678823|NCT01294787|26707915|P6|Period 1|Administrative problem|1
7678824|NCT01294787|26707916|P5|Period 1|Administrative problem|0
7678825|NCT01294787|26707917|P4|Period 1|Administrative problem|0
7678826|NCT01294787|26707918|P3|Period 1|Administrative problem|1
7678827|NCT01294787|26707919|P2|Period 1|Administrative problem|0
7678828|NCT01294787|26707920|P1|Period 1|Administrative problem|0
7678829|NCT01294787|26707915|P6|Period 1|Withdrawal by Subject|1
7678830|NCT01294787|26707916|P5|Period 1|Withdrawal by Subject|1
7678831|NCT01294787|26707917|P4|Period 1|Withdrawal by Subject|1
7678832|NCT01294787|26707918|P3|Period 1|Withdrawal by Subject|0
7678833|NCT01294787|26707919|P2|Period 1|Withdrawal by Subject|0
7678834|NCT01294787|26707920|P1|Period 1|Withdrawal by Subject|0
7678835|NCT01294787|26707915|P6|Period 1|Adverse Event|0
7678836|NCT01294787|26707916|P5|Period 1|Adverse Event|1
7678837|NCT01294787|26707917|P4|Period 1|Adverse Event|0
7678838|NCT01294787|26707918|P3|Period 1|Adverse Event|0
7678839|NCT01294787|26707919|P2|Period 1|Adverse Event|0
7678840|NCT01294787|26707920|P1|Period 1|Adverse Event|0
7678841|NCT01294696|26708011|P1|Overall Study|Site closure|52
7678842|NCT01294696|26708011|P1|Overall Study|Missing BPI Response|7
7678843|NCT01294696|26708011|P1|Overall Study|Protocol Violation|8
7678844|NCT01294696|26708011|P1|Overall Study|Screening failures|7
7678845|NCT01294683|26708025|P2|Post Crossover (Period III)|Withdrawal by Subject|2
7678846|NCT01294683|26708026|P1|Post Crossover (Period III)|Withdrawal by Subject|3
7678847|NCT01294683|26708025|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
7678848|NCT01294683|26708026|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
7678849|NCT01294683|26708025|P2|Post Crossover (Period III)|Lost to Follow-up|3
7678850|NCT01294683|26708026|P1|Post Crossover (Period III)|Lost to Follow-up|1
7678851|NCT01294683|26708025|P2|Post Crossover (Period III)|Adverse Event|6
7678852|NCT01294683|26708026|P1|Post Crossover (Period III)|Adverse Event|6
7678853|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
7678854|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
7678855|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Technical Problems|1
7678856|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Technical Problems|0
7678857|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
7678858|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
7678859|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Protocol Violation|5
7678860|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Protocol Violation|5
7678861|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Physician Decision|0
7678862|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Physician Decision|1
7678863|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
7678864|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
7678865|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
7678866|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
7678867|NCT01294683|26708025|P2|Precrossover (Periods I/II)|Adverse Event|52
7678868|NCT01294683|26708026|P1|Precrossover (Periods I/II)|Adverse Event|49
7678869|NCT01294644|26708079|P3|Overall Study|Miscellaneous Reason|4
7678870|NCT01294644|26708080|P2|Overall Study|Miscellaneous Reason|1
7678871|NCT01294644|26708081|P1|Overall Study|Miscellaneous Reason|2
7678872|NCT01294644|26708079|P3|Overall Study|Lost to Follow-up|5
7678873|NCT01294644|26708080|P2|Overall Study|Lost to Follow-up|2
7678874|NCT01294644|26708081|P1|Overall Study|Lost to Follow-up|3
7678875|NCT01294644|26708079|P3|Overall Study|Withdrawal by Subject|4
7678876|NCT01294644|26708080|P2|Overall Study|Withdrawal by Subject|7
7678877|NCT01294644|26708081|P1|Overall Study|Withdrawal by Subject|3
7678878|NCT01294644|26708079|P3|Overall Study|Adverse Event|1
7678879|NCT01294644|26708080|P2|Overall Study|Adverse Event|0
7678880|NCT01294644|26708081|P1|Overall Study|Adverse Event|2
7678881|NCT01294592|26708112|P2|Overall Study|Withdrawal by Subject|28
7678882|NCT01294592|26708113|P1|Overall Study|Withdrawal by Subject|28
7678883|NCT01294592|26708112|P2|Overall Study|Physician Decision|11
7678884|NCT01294592|26708113|P1|Overall Study|Physician Decision|6
7678885|NCT01294592|26708112|P2|Overall Study|Lost to Follow-up|9
7678886|NCT01294592|26708113|P1|Overall Study|Lost to Follow-up|7
7678887|NCT01294592|26708112|P2|Overall Study|Protocol Violation|7
7678888|NCT01294592|26708113|P1|Overall Study|Protocol Violation|1
7678889|NCT01294592|26708112|P2|Overall Study|Lack of Efficacy|5
7678890|NCT01294592|26708113|P1|Overall Study|Lack of Efficacy|7
7678891|NCT01294592|26708112|P2|Overall Study|Adverse Event|13
7678892|NCT01294592|26708113|P1|Overall Study|Adverse Event|28
7678893|NCT01294579|26708141|P1|Overall Study|Withdrawal by Subject|5
7678894|NCT01294579|26708141|P1|Overall Study|Physician Decision|3
7678895|NCT01294579|26708141|P1|Overall Study|Lost to Follow-up|1
7678896|NCT01294579|26708141|P1|Overall Study|Study closed/terminated|3
7678897|NCT01294579|26708141|P1|Overall Study|Adverse Event|11
7678898|NCT01294579|26708141|P1|Overall Study|Disease progression|12
7678899|NCT01294553|26708151|P1|Overall Study|Protocol Violation|268
7678900|NCT01294553|26708151|P1|Overall Study|Duplicated Participants|1
7678901|NCT01294514|26708157|P1|Overall Study|Excluded due to Arrhythmia|1
7678902|NCT01294462|26708167|P2|Overall Study|Withdrawal by Subject|63
7678903|NCT01294462|26708168|P1|Overall Study|Withdrawal by Subject|65
7678904|NCT01294462|26708167|P2|Overall Study|Lost to Follow-up|0
7678905|NCT01294462|26708168|P1|Overall Study|Lost to Follow-up|1
7678906|NCT01294449|26708182|P2|Overall Study|Withdrawal by Subject|3
7678907|NCT01294449|26708183|P1|Overall Study|Withdrawal by Subject|1
7678908|NCT01294449|26708182|P2|Overall Study|Death|12
7678909|NCT01294449|26708183|P1|Overall Study|Death|11
7678910|NCT01294436|26708191|P2|Overall Study|poor/non-compliance|5
7678911|NCT01294436|26708192|P1|Overall Study|poor/non-compliance|2
7678912|NCT01294436|26708191|P2|Overall Study|subject no longer meets study criteria|20
7678913|NCT01294436|26708192|P1|Overall Study|subject no longer meets study criteria|5
7678914|NCT01294436|26708191|P2|Overall Study|Withdrawal by Subject|28
7678915|NCT01294436|26708192|P1|Overall Study|Withdrawal by Subject|11
7678916|NCT01294436|26708191|P2|Overall Study|Adverse Event|17
7678917|NCT01294436|26708192|P1|Overall Study|Adverse Event|10
7678918|NCT01294423|26708227|P3|Overall Study|poor/non-compliance|1
7678919|NCT01294423|26708228|P2|Overall Study|poor/non-compliance|0
7678920|NCT01294423|26708229|P1|Overall Study|poor/non-compliance|1
7678921|NCT01294423|26708227|P3|Overall Study|subject no longer meets study criteria|2
7678922|NCT01294423|26708228|P2|Overall Study|subject no longer meets study criteria|5
7678923|NCT01294423|26708229|P1|Overall Study|subject no longer meets study criteria|2
7678924|NCT01294423|26708227|P3|Overall Study|Withdrawal by Subject|2
7678925|NCT01294423|26708228|P2|Overall Study|Withdrawal by Subject|2
7678926|NCT01294423|26708229|P1|Overall Study|Withdrawal by Subject|1
7678927|NCT01294423|26708227|P3|Overall Study|Adverse Event|3
7678928|NCT01294423|26708228|P2|Overall Study|Adverse Event|2
7678929|NCT01294423|26708229|P1|Overall Study|Adverse Event|1
7678930|NCT01294397|26708243|P1|Overall Study|Administrative Decision|1
7678931|NCT01294397|26708243|P1|Overall Study|Withdrawal by Subject|1
7678932|NCT01294371|26708287|P1|Overall Study|Other|14
7678933|NCT01294371|26708287|P1|Overall Study|Administrative Reason|1
7678934|NCT01294371|26708287|P1|Overall Study|Lost to Follow-up|6
7678935|NCT01294371|26708287|P1|Overall Study|Withdrawal by Subject|12
7678936|NCT01294371|26708287|P1|Overall Study|Adverse Event|1
7678937|NCT01294358|26708295|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
7678938|NCT01294358|26708296|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7678939|NCT01294358|26708297|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7678940|NCT01294358|26708298|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7678941|NCT01294358|26708299|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7678942|NCT01294358|26708295|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7678943|NCT01294358|26708296|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
7678944|NCT01294358|26708297|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7678945|NCT01294358|26708298|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7678946|NCT01294358|26708299|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7678947|NCT01294358|26708295|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7678948|NCT01294358|26708296|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7678949|NCT01294358|26708297|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
7678950|NCT01294358|26708298|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7678951|NCT01294358|26708299|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7678952|NCT01294358|26708295|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7678953|NCT01294358|26708296|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7678954|NCT01294358|26708297|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7678955|NCT01294358|26708298|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
7678956|NCT01294358|26708299|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7678957|NCT01294150|26708427|P2|Overall Study|Physician Decision|2
7678958|NCT01294150|26708428|P1|Overall Study|Physician Decision|2
7678959|NCT01294046|26708457|P1|Overall Study|Stimulation response inadqequate|1
7678960|NCT01294046|26708457|P1|Overall Study|Eligibility criteria expanded|1
7678961|NCT01294046|26708457|P1|Overall Study|Infection and surgical explant|1
7678962|NCT01293968|26708472|P2|Overall Study|non-cooperation|3
7678963|NCT01293968|26708473|P1|Overall Study|non-cooperation|3
7678964|NCT01293695|26708493|P2|Overall Study|Lost to Follow-up|6
7678965|NCT01293695|26708494|P1|Overall Study|Lost to Follow-up|8
7678966|NCT01293695|26708493|P2|Overall Study|Withdrawal by Subject|1
7678967|NCT01293695|26708494|P1|Overall Study|Withdrawal by Subject|7
7678968|NCT01293539|26708513|P1|Overall Study|Physician Decision|1
7678969|NCT01293240|26708542|P1|Overall Study|Noncompliance|2
7678970|NCT01293123|26708559|P2|Overall Study|Lost to Follow-up|1
7678971|NCT01293123|26708560|P1|Overall Study|Lost to Follow-up|0
7678972|NCT01293084|26708574|P1|Overall Study|Withdrawal by Subject|2
7678973|NCT01293084|26708574|P1|Overall Study|Physician Decision|3
7678974|NCT01293032|26708586|P4|Treatment|Disease Progression, relapse|0
7678975|NCT01293032|26708587|P3|Treatment|Disease Progression, relapse|0
7678976|NCT01293032|26708588|P2|Treatment|Disease Progression, relapse|1
7678977|NCT01293032|26708589|P1|Treatment|Disease Progression, relapse|0
7678978|NCT01293032|26708586|P4|Treatment|Withdrawal by Subject|0
7678979|NCT01293032|26708587|P3|Treatment|Withdrawal by Subject|0
7678980|NCT01293032|26708588|P2|Treatment|Withdrawal by Subject|4
7678981|NCT01293032|26708589|P1|Treatment|Withdrawal by Subject|2
7678982|NCT01293032|26708586|P4|Treatment|Adverse Event|1
7678983|NCT01293032|26708587|P3|Treatment|Adverse Event|1
7678984|NCT01293032|26708588|P2|Treatment|Adverse Event|0
7678985|NCT01293032|26708589|P1|Treatment|Adverse Event|0
7678986|NCT01293032|26708586|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7678987|NCT01293032|26708587|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
7678988|NCT01293032|26708588|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7678989|NCT01293032|26708589|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7678990|NCT01293006|26708600|P4|Period 2|Lost to Follow-up|0
7678991|NCT01293006|26708601|P3|Period 2|Lost to Follow-up|0
7678992|NCT01293006|26708602|P2|Period 2|Lost to Follow-up|0
7678993|NCT01293006|26708603|P1|Period 2|Lost to Follow-up|1
7678994|NCT01292928|26708624|P1|Overall Study|Physician Decision|2
7678995|NCT01292928|26708624|P1|Overall Study|Lost to Follow-up|6
7678996|NCT01292928|26708624|P1|Overall Study|Withdrawal by Subject|8
7678997|NCT01292928|26708624|P1|Overall Study|Death|8
7678998|NCT01292876|26708641|P1|Overall Study|Physician Decision|4
7678999|NCT01292837|26708647|P1|Overall Study|Further treatment determined|1
7679000|NCT01292837|26708647|P1|Overall Study|Adverse Event|1
7679001|NCT01292603|26708684|P6|Overall Survival Status|Death|10
7679002|NCT01292603|26708685|P5|Overall Survival Status|Death|16
7679003|NCT01292603|26708686|P4|Overall Survival Status|Death|1
7679004|NCT01292603|26708687|P3|Overall Survival Status|Death|3
7679005|NCT01292603|26708688|P2|Overall Survival Status|Death|1
7679006|NCT01292603|26708689|P1|Overall Survival Status|Death|3
7679007|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Adverse Event|2
7679008|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Adverse Event|2
7679009|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Adverse Event|0
7679010|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Adverse Event|0
7679011|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Adverse Event|0
7679012|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Adverse Event|0
7679013|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
7679014|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
7679015|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
7679016|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
7679017|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
7679018|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
7679019|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Physician Decision|0
7679020|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Physician Decision|2
7679021|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Physician Decision|0
7679022|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Physician Decision|0
7679023|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Physician Decision|0
7679024|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Physician Decision|0
7679025|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Protocol Violation|0
7679026|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Protocol Violation|2
7679027|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Protocol Violation|0
7679028|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Protocol Violation|0
7679029|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Protocol Violation|0
7679030|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Protocol Violation|0
7679031|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
7679032|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7679033|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7679034|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7679035|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7679036|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7679037|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Noncompliance|0
7679038|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Noncompliance|1
7679039|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Noncompliance|0
7679040|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Noncompliance|0
7679041|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Noncompliance|0
7679042|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Noncompliance|0
7679043|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Disease Progression|5
7679044|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Disease Progression|5
7679045|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Disease Progression|0
7679046|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Disease Progression|0
7679047|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Disease Progression|0
7679048|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Disease Progression|0
7679049|NCT01292603|26708684|P6|Part 2: Regular Follow-Up|Death|3
7679050|NCT01292603|26708685|P5|Part 2: Regular Follow-Up|Death|6
7679051|NCT01292603|26708686|P4|Part 2: Regular Follow-Up|Death|0
7679052|NCT01292603|26708687|P3|Part 2: Regular Follow-Up|Death|0
7679053|NCT01292603|26708688|P2|Part 2: Regular Follow-Up|Death|0
7679054|NCT01292603|26708689|P1|Part 2: Regular Follow-Up|Death|0
7679055|NCT01292603|26708684|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
7679056|NCT01292603|26708685|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7679057|NCT01292603|26708686|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7679058|NCT01292603|26708687|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7679059|NCT01292603|26708688|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7679060|NCT01292603|26708689|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7679061|NCT01292603|26708684|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
7679062|NCT01292603|26708685|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
7679063|NCT01292603|26708686|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
7679064|NCT01292603|26708687|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
7679065|NCT01292603|26708688|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
7679066|NCT01292603|26708689|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
7679067|NCT01292603|26708684|P6|Part 2: Dose Confirmation Period|Adverse Event|9
7679068|NCT01292603|26708685|P5|Part 2: Dose Confirmation Period|Adverse Event|7
7679069|NCT01292603|26708686|P4|Part 2: Dose Confirmation Period|Adverse Event|0
7679070|NCT01292603|26708687|P3|Part 2: Dose Confirmation Period|Adverse Event|0
7679071|NCT01292603|26708688|P2|Part 2: Dose Confirmation Period|Adverse Event|0
7679072|NCT01292603|26708689|P1|Part 2: Dose Confirmation Period|Adverse Event|0
7679073|NCT01292603|26708684|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
7679074|NCT01292603|26708685|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
7679075|NCT01292603|26708686|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7679076|NCT01292603|26708687|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7679077|NCT01292603|26708688|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7679078|NCT01292603|26708689|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7679079|NCT01292603|26708684|P6|Part 2: Dose Confirmation Period|Physician Decision|0
7679080|NCT01292603|26708685|P5|Part 2: Dose Confirmation Period|Physician Decision|2
7679081|NCT01292603|26708686|P4|Part 2: Dose Confirmation Period|Physician Decision|0
7679082|NCT01292603|26708687|P3|Part 2: Dose Confirmation Period|Physician Decision|0
7679083|NCT01292603|26708688|P2|Part 2: Dose Confirmation Period|Physician Decision|0
7679084|NCT01292603|26708689|P1|Part 2: Dose Confirmation Period|Physician Decision|0
7679085|NCT01292603|26708684|P6|Part 2: Dose Confirmation Period|Death|0
7679086|NCT01292603|26708685|P5|Part 2: Dose Confirmation Period|Death|1
7679087|NCT01292603|26708686|P4|Part 2: Dose Confirmation Period|Death|0
7679088|NCT01292603|26708687|P3|Part 2: Dose Confirmation Period|Death|0
7679089|NCT01292603|26708688|P2|Part 2: Dose Confirmation Period|Death|0
7679090|NCT01292603|26708689|P1|Part 2: Dose Confirmation Period|Death|0
7679091|NCT01292603|26708684|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
7679092|NCT01292603|26708685|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
7679093|NCT01292603|26708686|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
7679094|NCT01292603|26708687|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
7679095|NCT01292603|26708688|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
7679096|NCT01292603|26708689|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
7679097|NCT01292603|26708684|P6|Part 1: Regular Follow-Up Period|Death|0
7679098|NCT01292603|26708685|P5|Part 1: Regular Follow-Up Period|Death|0
7679099|NCT01292603|26708686|P4|Part 1: Regular Follow-Up Period|Death|1
7679100|NCT01292603|26708687|P3|Part 1: Regular Follow-Up Period|Death|3
7679101|NCT01292603|26708688|P2|Part 1: Regular Follow-Up Period|Death|1
7679102|NCT01292603|26708689|P1|Part 1: Regular Follow-Up Period|Death|3
7679103|NCT01292603|26708684|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7679104|NCT01292603|26708685|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7679105|NCT01292603|26708686|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
7679106|NCT01292603|26708687|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7679107|NCT01292603|26708688|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7679108|NCT01292603|26708689|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7679109|NCT01292603|26708684|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7679110|NCT01292603|26708685|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7679111|NCT01292603|26708686|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
7679112|NCT01292603|26708687|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7679113|NCT01292603|26708688|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7679114|NCT01292603|26708689|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7679115|NCT01292603|26708684|P6|Part 1: Pilot Dose Selection Period|Death|0
7679116|NCT01292603|26708685|P5|Part 1: Pilot Dose Selection Period|Death|0
7679117|NCT01292603|26708686|P4|Part 1: Pilot Dose Selection Period|Death|1
7679118|NCT01292603|26708687|P3|Part 1: Pilot Dose Selection Period|Death|0
7679119|NCT01292603|26708688|P2|Part 1: Pilot Dose Selection Period|Death|0
7679120|NCT01292603|26708689|P1|Part 1: Pilot Dose Selection Period|Death|0
7679121|NCT01292603|26708684|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
7679122|NCT01292603|26708685|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
7679123|NCT01292603|26708686|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
7679124|NCT01292603|26708687|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
7679125|NCT01292603|26708688|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
7679126|NCT01292603|26708689|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
7679127|NCT01292486|26708742|P1|Overall Study|Physician Decision|1
7679128|NCT01292486|26708742|P1|Overall Study|Adverse Event|1
7679129|NCT01292486|26708742|P1|Overall Study|Did not meet screening criteria|2
7679130|NCT01292486|26708742|P1|Overall Study|Protocol Violation|2
7679131|NCT01292473|26708756|P4|Overall Study|Disease Progression|6
7679132|NCT01292473|26708757|P3|Overall Study|Disease Progression|3
7679133|NCT01292473|26708758|P2|Overall Study|Disease Progression|1
7679134|NCT01292473|26708759|P1|Overall Study|Disease Progression|0
7679135|NCT01292473|26708756|P4|Overall Study|Physician Decision|0
7679136|NCT01292473|26708757|P3|Overall Study|Physician Decision|0
7679137|NCT01292473|26708758|P2|Overall Study|Physician Decision|1
7679138|NCT01292473|26708759|P1|Overall Study|Physician Decision|0
7679139|NCT01292473|26708756|P4|Overall Study|Withdrawal by Subject|3
7679140|NCT01292473|26708757|P3|Overall Study|Withdrawal by Subject|3
7679141|NCT01292473|26708758|P2|Overall Study|Withdrawal by Subject|4
7679142|NCT01292473|26708759|P1|Overall Study|Withdrawal by Subject|3
7679143|NCT01292473|26708756|P4|Overall Study|Lost to Follow-up|2
7679144|NCT01292473|26708757|P3|Overall Study|Lost to Follow-up|2
7679145|NCT01292473|26708758|P2|Overall Study|Lost to Follow-up|1
7679146|NCT01292473|26708759|P1|Overall Study|Lost to Follow-up|1
7679147|NCT01292473|26708756|P4|Overall Study|Adverse Event|1
7679148|NCT01292473|26708757|P3|Overall Study|Adverse Event|1
7679149|NCT01292473|26708758|P2|Overall Study|Adverse Event|0
7679150|NCT01292473|26708759|P1|Overall Study|Adverse Event|1
7679151|NCT01292239|26708842|P2|Overall Study|Withdrawal by Subject|6
7679152|NCT01292239|26708843|P1|Overall Study|Withdrawal by Subject|3
7679153|NCT01292239|26708842|P2|Overall Study|Other|1
7679154|NCT01292239|26708843|P1|Overall Study|Other|1
7679155|NCT01292226|26708864|P1|Overall Study|Other|2
7679156|NCT01292226|26708864|P1|Overall Study|Withdrawal by Subject|1
7679157|NCT01292226|26708864|P1|Overall Study|Protocol Violation|3
7679158|NCT01292226|26708864|P1|Overall Study|Graft loss|1
7679159|NCT01292226|26708864|P1|Overall Study|Death|1
7679160|NCT01292226|26708864|P1|Overall Study|Adverse Event|5
7679161|NCT01292187|26708897|P2|Overall Study|All other reasons|3
7679162|NCT01292187|26708898|P1|Overall Study|All other reasons|1
7679163|NCT01292187|26708897|P2|Overall Study|Withdrawal by Subject|5
7679164|NCT01292187|26708898|P1|Overall Study|Withdrawal by Subject|6
7679165|NCT01292187|26708897|P2|Overall Study|Adverse Event|5
7679166|NCT01292187|26708898|P1|Overall Study|Adverse Event|10
7679167|NCT01292057|26708933|P2|Overall Study|Lost to Follow-up|1
7679168|NCT01292057|26708934|P1|Overall Study|Lost to Follow-up|1
7679169|NCT01292057|26708933|P2|Overall Study|Protocol Violation|1
7679170|NCT01292057|26708934|P1|Overall Study|Protocol Violation|1
7679171|NCT01291277|26709006|P2|Overall Study|Lost to Follow-up|1
7679172|NCT01291277|26709007|P1|Overall Study|Lost to Follow-up|3
7679173|NCT01291277|26709006|P2|Overall Study|Death|2
7679174|NCT01291277|26709007|P1|Overall Study|Death|2
7679175|NCT01291225|26709019|P2|Overall Study|Lost to Follow-up|39
7679176|NCT01291225|26709020|P1|Overall Study|Lost to Follow-up|85
7679177|NCT01291173|26709034|P4|Overall Study|Excluded therapy|0
7679178|NCT01291173|26709035|P3|Overall Study|Excluded therapy|1
7679179|NCT01291173|26709036|P2|Overall Study|Excluded therapy|0
7679180|NCT01291173|26709037|P1|Overall Study|Excluded therapy|0
7679181|NCT01291173|26709034|P4|Overall Study|Subject was unblinded|0
7679182|NCT01291173|26709035|P3|Overall Study|Subject was unblinded|1
7679183|NCT01291173|26709036|P2|Overall Study|Subject was unblinded|0
7679184|NCT01291173|26709037|P1|Overall Study|Subject was unblinded|0
7679185|NCT01291173|26709034|P4|Overall Study|Lack of compliance|1
7679186|NCT01291173|26709035|P3|Overall Study|Lack of compliance|0
7679187|NCT01291173|26709036|P2|Overall Study|Lack of compliance|0
7679188|NCT01291173|26709037|P1|Overall Study|Lack of compliance|0
7679189|NCT01291173|26709034|P4|Overall Study|Unable to meet visit schedule|0
7679190|NCT01291173|26709035|P3|Overall Study|Unable to meet visit schedule|1
7679191|NCT01291173|26709036|P2|Overall Study|Unable to meet visit schedule|0
7679192|NCT01291173|26709037|P1|Overall Study|Unable to meet visit schedule|0
7679193|NCT01291173|26709034|P4|Overall Study|Lost to Follow-up|2
7679194|NCT01291173|26709035|P3|Overall Study|Lost to Follow-up|3
7679195|NCT01291173|26709036|P2|Overall Study|Lost to Follow-up|6
7679196|NCT01291173|26709037|P1|Overall Study|Lost to Follow-up|4
7679197|NCT01291173|26709034|P4|Overall Study|Withdrawal by Subject|2
7679198|NCT01291173|26709035|P3|Overall Study|Withdrawal by Subject|4
7679199|NCT01291173|26709036|P2|Overall Study|Withdrawal by Subject|4
7679200|NCT01291173|26709037|P1|Overall Study|Withdrawal by Subject|6
7679201|NCT01291173|26709034|P4|Overall Study|Protocol Violation|5
7679202|NCT01291173|26709035|P3|Overall Study|Protocol Violation|2
7679203|NCT01291173|26709036|P2|Overall Study|Protocol Violation|2
7679204|NCT01291173|26709037|P1|Overall Study|Protocol Violation|7
7679205|NCT01291173|26709034|P4|Overall Study|Adverse Event|3
7679206|NCT01291173|26709035|P3|Overall Study|Adverse Event|1
7679207|NCT01291173|26709036|P2|Overall Study|Adverse Event|3
7679208|NCT01291173|26709037|P1|Overall Study|Adverse Event|0
7679209|NCT01291017|26709146|P1|Overall Study|Withdrawal by Subject|3
7679210|NCT01291017|26709146|P1|Overall Study|Lost to Follow-up|2
7679211|NCT01290887|26709179|P2|Overall Study|Other|6
7679212|NCT01290887|26709180|P1|Overall Study|Other|3
7679213|NCT01290887|26709179|P2|Overall Study|Sponsor closure of study|476
7679214|NCT01290887|26709180|P1|Overall Study|Sponsor closure of study|420
7679215|NCT01290887|26709179|P2|Overall Study|Non-compliance to study medications|0
7679216|NCT01290887|26709180|P1|Overall Study|Non-compliance to study medications|1
7679217|NCT01290887|26709179|P2|Overall Study|Non-compliance to study procedures|1
7679218|NCT01290887|26709180|P1|Overall Study|Non-compliance to study procedures|0
7679219|NCT01290887|26709179|P2|Overall Study|Lost to Follow-up|4
7679220|NCT01290887|26709180|P1|Overall Study|Lost to Follow-up|4
7679221|NCT01290887|26709179|P2|Overall Study|Protocol Violation|1
7679222|NCT01290887|26709180|P1|Overall Study|Protocol Violation|2
7679223|NCT01290887|26709179|P2|Overall Study|Withdrawal by Subject|32
7679224|NCT01290887|26709180|P1|Overall Study|Withdrawal by Subject|26
7679225|NCT01290887|26709179|P2|Overall Study|Lack of Efficacy|5
7679226|NCT01290887|26709180|P1|Overall Study|Lack of Efficacy|4
7679227|NCT01290887|26709179|P2|Overall Study|Adverse Event|11
7679228|NCT01290887|26709180|P1|Overall Study|Adverse Event|6
7679229|NCT01290822|26709241|P1|Overall Study|Physician Decision|10
7679230|NCT01290822|26709241|P1|Overall Study|Withdrawal by Subject|1
7679231|NCT01290796|26709250|P1|Overall Study|Withdrawal by Sponsor|1
7679232|NCT01290796|26709250|P1|Overall Study|Secondary Surgical Intervention|2
7679233|NCT01290796|26709250|P1|Overall Study|Physician Decision|2
7679234|NCT01290796|26709250|P1|Overall Study|Withdrawal by Subject|4
7679235|NCT01290796|26709250|P1|Overall Study|Lost to Follow-up|21
7679236|NCT01290757|26709266|P2|Overall Study|Other|1
7679237|NCT01290757|26709267|P1|Overall Study|Other|0
7679238|NCT01290757|26709266|P2|Overall Study|Protocol Violation|1
7679239|NCT01290757|26709267|P1|Overall Study|Protocol Violation|1
7679240|NCT01290757|26709266|P2|Overall Study|Adverse Event|0
7679241|NCT01290757|26709267|P1|Overall Study|Adverse Event|1
7679242|NCT01290731|26709283|P1|Overall Study|Withdrawal by Subject|1
7679243|NCT01290718|26709295|P1|Overall Study|Early termination of the study|4
7679244|NCT01290679|26709304|P2|Overall Study|Subject Entered Another Trial|5
7679245|NCT01290679|26709305|P1|Overall Study|Subject Entered Another Trial|0
7679246|NCT01290679|26709304|P2|Overall Study|Withdrawal by Subject|5
7679247|NCT01290679|26709305|P1|Overall Study|Withdrawal by Subject|6
7679248|NCT01290679|26709304|P2|Overall Study|Protocol Violation|1
7679249|NCT01290679|26709305|P1|Overall Study|Protocol Violation|0
7679250|NCT01290679|26709304|P2|Overall Study|Lost to Follow-up|10
7679251|NCT01290679|26709305|P1|Overall Study|Lost to Follow-up|8
7679252|NCT01290679|26709304|P2|Overall Study|Adverse Event|0
7679253|NCT01290679|26709305|P1|Overall Study|Adverse Event|2
7679254|NCT01290666|26709374|P1|Overall Study|Early Termination of Study|4
7679255|NCT01290666|26709374|P1|Overall Study|Withdrawal by Subject|23
7679256|NCT01290666|26709374|P1|Overall Study|Lost to Follow-up|11
7679257|NCT01290601|26709427|P4|Overall Study|Protocol Violation|0
7679258|NCT01290601|26709428|P3|Overall Study|Protocol Violation|0
7679259|NCT01290601|26709429|P2|Overall Study|Protocol Violation|0
7679260|NCT01290601|26709430|P1|Overall Study|Protocol Violation|1
7679261|NCT01290601|26709427|P4|Overall Study|Other|0
7679262|NCT01290601|26709428|P3|Overall Study|Other|0
7679263|NCT01290601|26709429|P2|Overall Study|Other|0
7679264|NCT01290601|26709430|P1|Overall Study|Other|1
7679265|NCT01290601|26709427|P4|Overall Study|Lost to Follow-up|0
7679266|NCT01290601|26709428|P3|Overall Study|Lost to Follow-up|0
7679267|NCT01290601|26709429|P2|Overall Study|Lost to Follow-up|2
7679268|NCT01290601|26709430|P1|Overall Study|Lost to Follow-up|7
7679269|NCT01290601|26709427|P4|Overall Study|Lack of Efficacy|0
7679270|NCT01290601|26709428|P3|Overall Study|Lack of Efficacy|0
7679271|NCT01290601|26709429|P2|Overall Study|Lack of Efficacy|1
7679272|NCT01290601|26709430|P1|Overall Study|Lack of Efficacy|2
7679273|NCT01290601|26709427|P4|Overall Study|Adverse Event|0
7679274|NCT01290601|26709428|P3|Overall Study|Adverse Event|0
7679275|NCT01290601|26709429|P2|Overall Study|Adverse Event|2
7679276|NCT01290601|26709430|P1|Overall Study|Adverse Event|0
7679277|NCT01290523|26709451|P1|Overall Study|Death|3
7679278|NCT01290341|26709490|P2|Overall Study|Negative baseline culture and others|11
7679279|NCT01290341|26709491|P1|Overall Study|Negative baseline culture and others|44
7679280|NCT01290341|26709490|P2|Overall Study|Withdrawal by Subject|5
7679281|NCT01290341|26709491|P1|Overall Study|Withdrawal by Subject|19
7679282|NCT01290341|26709490|P2|Overall Study|Lost to Follow-up|10
7679283|NCT01290341|26709491|P1|Overall Study|Lost to Follow-up|21
7679284|NCT01290341|26709490|P2|Overall Study|Adverse Event|0
7679285|NCT01290341|26709491|P1|Overall Study|Adverse Event|1
7679286|NCT01290341|26709490|P2|Overall Study|Protocol Violation|3
7679287|NCT01290341|26709491|P1|Overall Study|Protocol Violation|7
7679288|NCT01290315|26709503|P4|Overall Study|Withdrawal by Subject|0
7679289|NCT01290315|26709504|P3|Overall Study|Withdrawal by Subject|0
7679290|NCT01290315|26709505|P2|Overall Study|Withdrawal by Subject|1
7679291|NCT01290315|26709506|P1|Overall Study|Withdrawal by Subject|1
7679292|NCT01290315|26709503|P4|Overall Study|Lost to Follow-up|0
7679293|NCT01290315|26709504|P3|Overall Study|Lost to Follow-up|0
7679294|NCT01290315|26709505|P2|Overall Study|Lost to Follow-up|1
7679295|NCT01290315|26709506|P1|Overall Study|Lost to Follow-up|0
7679296|NCT01290315|26709503|P4|Overall Study|Selection criteria/compliance|2
7679297|NCT01290315|26709504|P3|Overall Study|Selection criteria/compliance|0
7679298|NCT01290315|26709505|P2|Overall Study|Selection criteria/compliance|1
7679299|NCT01290315|26709506|P1|Overall Study|Selection criteria/compliance|2
7679300|NCT01290315|26709503|P4|Overall Study|Adverse Event|3
7679301|NCT01290315|26709504|P3|Overall Study|Adverse Event|0
7679302|NCT01290315|26709505|P2|Overall Study|Adverse Event|0
7679303|NCT01290315|26709506|P1|Overall Study|Adverse Event|0
7679304|NCT01290263|26709528|P5|Overall Study|Participant Non-Compliance|1
7679305|NCT01290263|26709529|P4|Overall Study|Participant Non-Compliance|1
7679306|NCT01290263|26709530|P3|Overall Study|Participant Non-Compliance|0
7679307|NCT01290263|26709531|P2|Overall Study|Participant Non-Compliance|0
7679308|NCT01290263|26709532|P1|Overall Study|Participant Non-Compliance|0
7679309|NCT01290263|26709528|P5|Overall Study|Withdrawal by Subject|2
7679310|NCT01290263|26709529|P4|Overall Study|Withdrawal by Subject|1
7679311|NCT01290263|26709530|P3|Overall Study|Withdrawal by Subject|0
7679312|NCT01290263|26709531|P2|Overall Study|Withdrawal by Subject|1
7679313|NCT01290263|26709532|P1|Overall Study|Withdrawal by Subject|3
7679314|NCT01290263|26709528|P5|Overall Study|Lack of Efficacy|33
7679315|NCT01290263|26709529|P4|Overall Study|Lack of Efficacy|24
7679316|NCT01290263|26709530|P3|Overall Study|Lack of Efficacy|7
7679317|NCT01290263|26709531|P2|Overall Study|Lack of Efficacy|2
7679318|NCT01290263|26709532|P1|Overall Study|Lack of Efficacy|8
7679319|NCT01290263|26709528|P5|Overall Study|Adverse Event|1
7679320|NCT01290263|26709529|P4|Overall Study|Adverse Event|1
7679321|NCT01290263|26709530|P3|Overall Study|Adverse Event|0
7679322|NCT01290263|26709531|P2|Overall Study|Adverse Event|0
7679323|NCT01290263|26709532|P1|Overall Study|Adverse Event|0
7679324|NCT01290224|26709559|P1|Overall Study|Refused Further Treatment|4
7679325|NCT01290224|26709559|P1|Overall Study|Adverse Event|1
7679326|NCT01290094|26709570|P1|Overall Study|Lost to Follow-up|5
7679327|NCT01290094|26709570|P1|Overall Study|Withdrawal by Subject|1
7679328|NCT01290068|26709583|P2|Overall Study|Other|1
7679329|NCT01290068|26709584|P1|Overall Study|Other|3
7679330|NCT01290068|26709583|P2|Overall Study|Withdrawal by subject prior to implant|2
7679331|NCT01290068|26709584|P1|Overall Study|Withdrawal by subject prior to implant|0
7679332|NCT01290068|26709583|P2|Overall Study|Lost to Follow-up|0
7679333|NCT01290068|26709584|P1|Overall Study|Lost to Follow-up|3
7679334|NCT01290068|26709583|P2|Overall Study|Adverse Event|3
7679335|NCT01290068|26709584|P1|Overall Study|Adverse Event|1
7679336|NCT01290029|26709596|P1|Overall Study|Other|2
7679337|NCT01289990|26709622|P13|Overall Study|Not treated|0
7679338|NCT01289990|26709623|P12|Overall Study|Not treated|2
7679339|NCT01289990|26709624|P11|Overall Study|Not treated|1
7679340|NCT01289990|26709625|P10|Overall Study|Not treated|0
7679341|NCT01289990|26709626|P9|Overall Study|Not treated|1
7679342|NCT01289990|26709627|P8|Overall Study|Not treated|0
7679343|NCT01289990|26709628|P7|Overall Study|Not treated|1
7679344|NCT01289990|26709629|P6|Overall Study|Not treated|0
7679345|NCT01289990|26709630|P5|Overall Study|Not treated|0
7679346|NCT01289990|26709631|P4|Overall Study|Not treated|0
7679347|NCT01289990|26709632|P3|Overall Study|Not treated|0
7679348|NCT01289990|26709633|P2|Overall Study|Not treated|0
7679349|NCT01289990|26709634|P1|Overall Study|Not treated|0
7679350|NCT01289990|26709622|P13|Overall Study|did not continue in extension|56
7679351|NCT01289990|26709623|P12|Overall Study|did not continue in extension|34
7679352|NCT01289990|26709624|P11|Overall Study|did not continue in extension|45
7679353|NCT01289990|26709625|P10|Overall Study|did not continue in extension|48
7679354|NCT01289990|26709626|P9|Overall Study|did not continue in extension|44
7679355|NCT01289990|26709627|P8|Overall Study|did not continue in extension|36
7679356|NCT01289990|26709628|P7|Overall Study|did not continue in extension|54
7679357|NCT01289990|26709629|P6|Overall Study|did not continue in extension|50
7679358|NCT01289990|26709630|P5|Overall Study|did not continue in extension|48
7679359|NCT01289990|26709631|P4|Overall Study|did not continue in extension|51
7679360|NCT01289990|26709632|P3|Overall Study|did not continue in extension|51
7679361|NCT01289990|26709633|P2|Overall Study|did not continue in extension|45
7679362|NCT01289990|26709634|P1|Overall Study|did not continue in extension|41
7679363|NCT01289990|26709622|P13|Overall Study|discontinued in preceding trial|24
7679364|NCT01289990|26709623|P12|Overall Study|discontinued in preceding trial|17
7679365|NCT01289990|26709624|P11|Overall Study|discontinued in preceding trial|17
7679366|NCT01289990|26709625|P10|Overall Study|discontinued in preceding trial|21
7679367|NCT01289990|26709626|P9|Overall Study|discontinued in preceding trial|17
7679368|NCT01289990|26709627|P8|Overall Study|discontinued in preceding trial|8
7679369|NCT01289990|26709628|P7|Overall Study|discontinued in preceding trial|18
7679370|NCT01289990|26709629|P6|Overall Study|discontinued in preceding trial|12
7679371|NCT01289990|26709630|P5|Overall Study|discontinued in preceding trial|11
7679372|NCT01289990|26709631|P4|Overall Study|discontinued in preceding trial|17
7679373|NCT01289990|26709632|P3|Overall Study|discontinued in preceding trial|41
7679374|NCT01289990|26709633|P2|Overall Study|discontinued in preceding trial|20
7679375|NCT01289990|26709634|P1|Overall Study|discontinued in preceding trial|18
7679376|NCT01289990|26709622|P13|Overall Study|Withdrawal by Subject|16
7679377|NCT01289990|26709623|P12|Overall Study|Withdrawal by Subject|13
7679378|NCT01289990|26709624|P11|Overall Study|Withdrawal by Subject|11
7679379|NCT01289990|26709625|P10|Overall Study|Withdrawal by Subject|13
7679380|NCT01289990|26709626|P9|Overall Study|Withdrawal by Subject|12
7679381|NCT01289990|26709627|P8|Overall Study|Withdrawal by Subject|9
7679382|NCT01289990|26709628|P7|Overall Study|Withdrawal by Subject|13
7679383|NCT01289990|26709629|P6|Overall Study|Withdrawal by Subject|7
7679384|NCT01289990|26709630|P5|Overall Study|Withdrawal by Subject|8
7679385|NCT01289990|26709631|P4|Overall Study|Withdrawal by Subject|13
7679386|NCT01289990|26709632|P3|Overall Study|Withdrawal by Subject|12
7679387|NCT01289990|26709633|P2|Overall Study|Withdrawal by Subject|14
7679388|NCT01289990|26709634|P1|Overall Study|Withdrawal by Subject|15
7679389|NCT01289990|26709622|P13|Overall Study|Lost to Follow-up|2
7679390|NCT01289990|26709623|P12|Overall Study|Lost to Follow-up|1
7679391|NCT01289990|26709624|P11|Overall Study|Lost to Follow-up|2
7679392|NCT01289990|26709625|P10|Overall Study|Lost to Follow-up|4
7679393|NCT01289990|26709626|P9|Overall Study|Lost to Follow-up|1
7679394|NCT01289990|26709627|P8|Overall Study|Lost to Follow-up|2
7679395|NCT01289990|26709628|P7|Overall Study|Lost to Follow-up|2
7679396|NCT01289990|26709629|P6|Overall Study|Lost to Follow-up|4
7679397|NCT01289990|26709630|P5|Overall Study|Lost to Follow-up|3
7679398|NCT01289990|26709631|P4|Overall Study|Lost to Follow-up|5
7679399|NCT01289990|26709632|P3|Overall Study|Lost to Follow-up|5
7679400|NCT01289990|26709633|P2|Overall Study|Lost to Follow-up|2
7679401|NCT01289990|26709634|P1|Overall Study|Lost to Follow-up|3
7679402|NCT01289990|26709622|P13|Overall Study|Death|0
7679403|NCT01289990|26709623|P12|Overall Study|Death|1
7679404|NCT01289990|26709624|P11|Overall Study|Death|0
7679405|NCT01289990|26709625|P10|Overall Study|Death|0
7679406|NCT01289990|26709626|P9|Overall Study|Death|0
7679407|NCT01289990|26709627|P8|Overall Study|Death|0
7679408|NCT01289990|26709628|P7|Overall Study|Death|0
7679409|NCT01289990|26709629|P6|Overall Study|Death|1
7679410|NCT01289990|26709630|P5|Overall Study|Death|2
7679411|NCT01289990|26709631|P4|Overall Study|Death|1
7679412|NCT01289990|26709632|P3|Overall Study|Death|0
7679413|NCT01289990|26709633|P2|Overall Study|Death|0
7679414|NCT01289990|26709634|P1|Overall Study|Death|0
7679415|NCT01289847|26709851|P1|Overall Study|Patient could not comply with visits|1
7679416|NCT01289821|26709860|P1|Survival Follow-up Period|Clinical endpoint reached|16
7679417|NCT01289821|26709860|P1|Survival Follow-up Period|Lost to Follow-up|1
7679418|NCT01289821|26709860|P1|Survival Follow-up Period|Protocol Violation|1
7679419|NCT01289821|26709860|P1|Safety Follow-up Period|Unspecified reason|1
7679420|NCT01289821|26709860|P1|Safety Follow-up Period|Protocol Violation|3
7679421|NCT01289821|26709860|P1|Safety Follow-up Period|Withdrawal by Subject|1
7679422|NCT01289821|26709860|P1|Treatment Period|Therapeutic procedure required|1
7679423|NCT01289821|26709860|P1|Treatment Period|Clinical Progression|2
7679424|NCT01289821|26709860|P1|Treatment Period|Radiological Progression|43
7679425|NCT01289821|26709860|P1|Treatment Period|Adverse Event|4
7679426|NCT01289821|26709860|P1|Treatment Period|Physician Decision|3
7679427|NCT01289821|26709860|P1|Treatment Period|Withdrawal by Subject|1
7679428|NCT01289782|26709871|P2|Overall Study|Reason not specified|2
7679429|NCT01289782|26709872|P1|Overall Study|Reason not specified|1
7679430|NCT01289782|26709871|P2|Overall Study|Sponsor's Decision|0
7679431|NCT01289782|26709872|P1|Overall Study|Sponsor's Decision|1
7679432|NCT01289782|26709871|P2|Overall Study|Withdrawal by Subject|2
7679433|NCT01289782|26709872|P1|Overall Study|Withdrawal by Subject|8
7679434|NCT01289782|26709871|P2|Overall Study|Protocol Violation|1
7679435|NCT01289782|26709872|P1|Overall Study|Protocol Violation|1
7679436|NCT01289782|26709871|P2|Overall Study|Lost to Follow-up|7
7679437|NCT01289782|26709872|P1|Overall Study|Lost to Follow-up|14
7679438|NCT01289678|26709941|P1|Overall Study|Physician Decision|6
7679439|NCT01289639|26709957|P3|Overall Study|Lost to Follow-up|0
7679440|NCT01289639|26709958|P2|Overall Study|Lost to Follow-up|0
7679441|NCT01289639|26709959|P1|Overall Study|Lost to Follow-up|1
7679442|NCT01289574|26709985|P3|Overall Study|Subject wanted alternate treatment|0
7679443|NCT01289574|26709986|P2|Overall Study|Subject wanted alternate treatment|1
7679444|NCT01289574|26709987|P1|Overall Study|Subject wanted alternate treatment|0
7679445|NCT01289574|26709985|P3|Overall Study|Adverse Event|0
7679446|NCT01289574|26709986|P2|Overall Study|Adverse Event|1
7679447|NCT01289574|26709987|P1|Overall Study|Adverse Event|0
7679448|NCT01289574|26709985|P3|Overall Study|Withdrawal by Subject|1
7679449|NCT01289574|26709986|P2|Overall Study|Withdrawal by Subject|1
7679450|NCT01289574|26709987|P1|Overall Study|Withdrawal by Subject|1
7679451|NCT01289574|26709985|P3|Overall Study|Lost to Follow-up|1
7679452|NCT01289574|26709986|P2|Overall Study|Lost to Follow-up|0
7679453|NCT01289574|26709987|P1|Overall Study|Lost to Follow-up|2
7679454|NCT01289574|26709985|P3|Overall Study|Lack of Efficacy|1
7679455|NCT01289574|26709986|P2|Overall Study|Lack of Efficacy|0
7679456|NCT01289574|26709987|P1|Overall Study|Lack of Efficacy|4
7679457|NCT01289418|26710131|P1|Day 29 Survey|participants did not complete the survey|2185
7679458|NCT01289418|26710131|P1|Day 29 Survey|email address invalid|283
7679459|NCT01289418|26710131|P1|Day 8 Survey|participants did not complete the survey|1935
7679460|NCT01289418|26710131|P1|Day 8 Survey|email address invalid|283
7679461|NCT01289353|26710150|P1|Overall Study|Lost to Follow-up|2
7679462|NCT01289210|26710185|P1|Overall Study|Adverse Event|1
7679463|NCT01289119|26710195|P6|Overall Study|Other|0
7679464|NCT01289119|26710196|P5|Overall Study|Other|0
7679465|NCT01289119|26710197|P4|Overall Study|Other|0
7679466|NCT01289119|26710198|P3|Overall Study|Other|1
7679467|NCT01289119|26710199|P2|Overall Study|Other|0
7679468|NCT01289119|26710200|P1|Overall Study|Other|1
7679469|NCT01289119|26710195|P6|Overall Study|Lack of Efficacy|1
7679470|NCT01289119|26710196|P5|Overall Study|Lack of Efficacy|1
7679471|NCT01289119|26710197|P4|Overall Study|Lack of Efficacy|1
7679472|NCT01289119|26710198|P3|Overall Study|Lack of Efficacy|1
7679473|NCT01289119|26710199|P2|Overall Study|Lack of Efficacy|1
7679474|NCT01289119|26710200|P1|Overall Study|Lack of Efficacy|0
7679475|NCT01289119|26710195|P6|Overall Study|Pregnancy|0
7679476|NCT01289119|26710196|P5|Overall Study|Pregnancy|0
7679477|NCT01289119|26710197|P4|Overall Study|Pregnancy|0
7679478|NCT01289119|26710198|P3|Overall Study|Pregnancy|0
7679479|NCT01289119|26710199|P2|Overall Study|Pregnancy|1
7679480|NCT01289119|26710200|P1|Overall Study|Pregnancy|0
7679481|NCT01289119|26710195|P6|Overall Study|Withdrawal by Subject|1
7679482|NCT01289119|26710196|P5|Overall Study|Withdrawal by Subject|1
7679483|NCT01289119|26710197|P4|Overall Study|Withdrawal by Subject|3
7679484|NCT01289119|26710198|P3|Overall Study|Withdrawal by Subject|4
7679485|NCT01289119|26710199|P2|Overall Study|Withdrawal by Subject|2
7679486|NCT01289119|26710200|P1|Overall Study|Withdrawal by Subject|4
7679487|NCT01289119|26710195|P6|Overall Study|Lost to Follow-up|1
7679488|NCT01289119|26710196|P5|Overall Study|Lost to Follow-up|0
7679489|NCT01289119|26710197|P4|Overall Study|Lost to Follow-up|0
7679490|NCT01289119|26710198|P3|Overall Study|Lost to Follow-up|0
7679491|NCT01289119|26710199|P2|Overall Study|Lost to Follow-up|3
7679492|NCT01289119|26710200|P1|Overall Study|Lost to Follow-up|0
7679493|NCT01289119|26710195|P6|Overall Study|Major Protocol Deviation|1
7679494|NCT01289119|26710196|P5|Overall Study|Major Protocol Deviation|2
7679495|NCT01289119|26710197|P4|Overall Study|Major Protocol Deviation|0
7679496|NCT01289119|26710198|P3|Overall Study|Major Protocol Deviation|3
7679497|NCT01289119|26710199|P2|Overall Study|Major Protocol Deviation|1
7679498|NCT01289119|26710200|P1|Overall Study|Major Protocol Deviation|2
7679499|NCT01289119|26710195|P6|Overall Study|Adverse Event|0
7679500|NCT01289119|26710196|P5|Overall Study|Adverse Event|1
7679501|NCT01289119|26710197|P4|Overall Study|Adverse Event|2
7679502|NCT01289119|26710198|P3|Overall Study|Adverse Event|0
7679503|NCT01289119|26710199|P2|Overall Study|Adverse Event|1
7679504|NCT01289119|26710200|P1|Overall Study|Adverse Event|2
7679505|NCT01289041|26710321|P1|Overall Study|Death|1
7679506|NCT01289041|26710321|P1|Overall Study|Withdrawal by Subject|3
7679507|NCT01289041|26710321|P1|Overall Study|Progressive Disease|41
7679508|NCT01289041|26710321|P1|Overall Study|Physician Decision|1
7679509|NCT01289041|26710321|P1|Overall Study|Adverse Event|24
7679510|NCT01289028|26710333|P1|Overall Study|Missing reason for discon|1
7679511|NCT01289028|26710333|P1|Overall Study|Abnormal Lab Value|1
7679512|NCT01289028|26710333|P1|Overall Study|New Cancer Therapy|2
7679513|NCT01289028|26710333|P1|Overall Study|Lost to Follow-up|2
7679514|NCT01289028|26710333|P1|Overall Study|No longer required|2
7679515|NCT01289028|26710333|P1|Overall Study|Lack of Efficacy|2
7679516|NCT01289028|26710333|P1|Overall Study|Death|4
7679517|NCT01289028|26710333|P1|Overall Study|Withdrawal by Subject|6
7679518|NCT01289028|26710333|P1|Overall Study|Adverse Event|14
7679519|NCT01289028|26710333|P1|Overall Study|Progressive Disease|49
7679520|NCT01289015|26710347|P2|Overall Study|Negative baseline culture and others|20
7679521|NCT01289015|26710348|P1|Overall Study|Negative baseline culture and others|33
7679522|NCT01289015|26710347|P2|Overall Study|Disease progression|0
7679523|NCT01289015|26710348|P1|Overall Study|Disease progression|1
7679524|NCT01289015|26710347|P2|Overall Study|Withdrawal by Subject|8
7679525|NCT01289015|26710348|P1|Overall Study|Withdrawal by Subject|17
7679526|NCT01289015|26710347|P2|Overall Study|Lost to Follow-up|17
7679527|NCT01289015|26710348|P1|Overall Study|Lost to Follow-up|33
7679528|NCT01289015|26710347|P2|Overall Study|Adverse Event|0
7679529|NCT01289015|26710348|P1|Overall Study|Adverse Event|3
7679530|NCT01289015|26710347|P2|Overall Study|Protocol Violation|9
7679531|NCT01289015|26710348|P1|Overall Study|Protocol Violation|12
7679532|NCT01288989|26710361|P5|Overall Study|Withdrawal by Subject|3
7679533|NCT01288989|26710362|P4|Overall Study|Withdrawal by Subject|0
7679534|NCT01288989|26710363|P3|Overall Study|Withdrawal by Subject|0
7679535|NCT01288989|26710364|P2|Overall Study|Withdrawal by Subject|0
7679536|NCT01288989|26710365|P1|Overall Study|Withdrawal by Subject|0
7679537|NCT01288989|26710361|P5|Overall Study|Physician Decision|1
7679538|NCT01288989|26710362|P4|Overall Study|Physician Decision|0
7679539|NCT01288989|26710363|P3|Overall Study|Physician Decision|0
7679540|NCT01288989|26710364|P2|Overall Study|Physician Decision|0
7679541|NCT01288989|26710365|P1|Overall Study|Physician Decision|0
7679542|NCT01288989|26710361|P5|Overall Study|Adverse Event|2
7679543|NCT01288989|26710362|P4|Overall Study|Adverse Event|0
7679544|NCT01288989|26710363|P3|Overall Study|Adverse Event|0
7679545|NCT01288989|26710364|P2|Overall Study|Adverse Event|0
7679546|NCT01288989|26710365|P1|Overall Study|Adverse Event|0
7679547|NCT01288989|26710361|P5|Overall Study|Dose limiting toxicity|0
7679548|NCT01288989|26710362|P4|Overall Study|Dose limiting toxicity|0
7679549|NCT01288989|26710363|P3|Overall Study|Dose limiting toxicity|0
7679550|NCT01288989|26710364|P2|Overall Study|Dose limiting toxicity|0
7679551|NCT01288989|26710365|P1|Overall Study|Dose limiting toxicity|1
7679552|NCT01288989|26710361|P5|Overall Study|Death|0
7679553|NCT01288989|26710362|P4|Overall Study|Death|1
7679554|NCT01288989|26710363|P3|Overall Study|Death|0
7679555|NCT01288989|26710364|P2|Overall Study|Death|0
7679556|NCT01288989|26710365|P1|Overall Study|Death|0
7679557|NCT01288976|26710426|P3|Overall Study|Data unavailable|7
7679558|NCT01288976|26710427|P2|Overall Study|Data unavailable|9
7679559|NCT01288976|26710428|P1|Overall Study|Data unavailable|22
7679560|NCT01288976|26710426|P3|Overall Study|Death|4
7679561|NCT01288976|26710427|P2|Overall Study|Death|6
7679562|NCT01288976|26710428|P1|Overall Study|Death|98
7679563|NCT01288976|26710426|P3|Overall Study|Withdrawal by Subject|9
7679564|NCT01288976|26710427|P2|Overall Study|Withdrawal by Subject|12
7679565|NCT01288976|26710428|P1|Overall Study|Withdrawal by Subject|58
7679566|NCT01288937|26710457|P2|Overall Study|Adverse Event|0
7679567|NCT01288937|26710458|P1|Overall Study|Adverse Event|1
7679568|NCT01288911|26710466|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
7679569|NCT01288911|26710467|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
7679570|NCT01288911|26710466|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
7679571|NCT01288911|26710467|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
7679572|NCT01288911|26710466|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
7679573|NCT01288911|26710467|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
7679574|NCT01288911|26710466|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
7679575|NCT01288911|26710467|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
7679576|NCT01288911|26710466|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
7679577|NCT01288911|26710467|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
7679578|NCT01288911|26710466|P2|Open-label Period (All Enzalutamide)|Death|1
7679579|NCT01288911|26710467|P1|Open-label Period (All Enzalutamide)|Death|0
7679580|NCT01288911|26710466|P2|Double-blind Period|Randomized but never received study drug|2
7679581|NCT01288911|26710467|P1|Double-blind Period|Randomized but never received study drug|1
7679582|NCT01288911|26710466|P2|Double-blind Period|Miscellaneous Reason|42
7679583|NCT01288911|26710467|P1|Double-blind Period|Miscellaneous Reason|29
7679584|NCT01288911|26710466|P2|Double-blind Period|Withdrawal by Subject|26
7679585|NCT01288911|26710467|P1|Double-blind Period|Withdrawal by Subject|25
7679586|NCT01288911|26710466|P2|Double-blind Period|Protocol Violation|0
7679587|NCT01288911|26710467|P1|Double-blind Period|Protocol Violation|1
7679588|NCT01288911|26710466|P2|Double-blind Period|Progressive Disease|103
7679589|NCT01288911|26710467|P1|Double-blind Period|Progressive Disease|75
7679590|NCT01288911|26710466|P2|Double-blind Period|Lost to Follow-up|2
7679591|NCT01288911|26710467|P1|Double-blind Period|Lost to Follow-up|0
7679592|NCT01288911|26710466|P2|Double-blind Period|Death|7
7679593|NCT01288911|26710467|P1|Double-blind Period|Death|11
7679594|NCT01288729|26710577|P2|Overall Study|Withdrawal by Subject|0
7679595|NCT01288729|26710578|P1|Overall Study|Withdrawal by Subject|1
7679596|NCT01288612|26710587|P3|Overall Study|Unable to intubate|0
7679597|NCT01288612|26710588|P2|Overall Study|Unable to intubate|3
7679598|NCT01288612|26710589|P1|Overall Study|Unable to intubate|0
7679599|NCT01288612|26710587|P3|Overall Study|Declined|62
7679600|NCT01288612|26710588|P2|Overall Study|Declined|63
7679601|NCT01288612|26710589|P1|Overall Study|Declined|78
7679602|NCT01288612|26710587|P3|Overall Study|Unable to contact|20
7679603|NCT01288612|26710588|P2|Overall Study|Unable to contact|16
7679604|NCT01288612|26710589|P1|Overall Study|Unable to contact|11
7679605|NCT01288469|26710638|P3|Overall Study|Exclusion criteria finally met|0
7679606|NCT01288469|26710639|P2|Overall Study|Exclusion criteria finally met|0
7679607|NCT01288469|26710640|P1|Overall Study|Exclusion criteria finally met|1
7679608|NCT01288469|26710638|P3|Overall Study|Consent withdrawn by subject|1
7679609|NCT01288469|26710639|P2|Overall Study|Consent withdrawn by subject|1
7679610|NCT01288469|26710640|P1|Overall Study|Consent withdrawn by subject|1
7679611|NCT01288469|26710638|P3|Overall Study|Participant Moved|0
7679612|NCT01288469|26710639|P2|Overall Study|Participant Moved|0
7679613|NCT01288469|26710640|P1|Overall Study|Participant Moved|1
7679614|NCT01288469|26710638|P3|Overall Study|Poor compliance to protocol|0
7679615|NCT01288469|26710639|P2|Overall Study|Poor compliance to protocol|1
7679616|NCT01288469|26710640|P1|Overall Study|Poor compliance to protocol|0
7679617|NCT01288469|26710638|P3|Overall Study|Adverse Event|1
7679618|NCT01288469|26710639|P2|Overall Study|Adverse Event|1
7679619|NCT01288469|26710640|P1|Overall Study|Adverse Event|4
7679620|NCT01288443|26710672|P6|Overall Study|Other than above|0
7679621|NCT01288443|26710673|P5|Overall Study|Other than above|1
7679622|NCT01288443|26710674|P4|Overall Study|Other than above|2
7679623|NCT01288443|26710675|P3|Overall Study|Other than above|0
7679624|NCT01288443|26710676|P2|Overall Study|Other than above|0
7679625|NCT01288443|26710677|P1|Overall Study|Other than above|0
7679626|NCT01288443|26710672|P6|Overall Study|Study drug auto-injector administration|1
7679627|NCT01288443|26710673|P5|Overall Study|Study drug auto-injector administration|1
7679628|NCT01288443|26710674|P4|Overall Study|Study drug auto-injector administration|0
7679629|NCT01288443|26710675|P3|Overall Study|Study drug auto-injector administration|0
7679630|NCT01288443|26710676|P2|Overall Study|Study drug auto-injector administration|0
7679631|NCT01288443|26710677|P1|Overall Study|Study drug auto-injector administration|0
7679632|NCT01288443|26710672|P6|Overall Study|Lost to Follow-up|0
7679633|NCT01288443|26710673|P5|Overall Study|Lost to Follow-up|0
7679634|NCT01288443|26710674|P4|Overall Study|Lost to Follow-up|0
7679635|NCT01288443|26710675|P3|Overall Study|Lost to Follow-up|0
7679636|NCT01288443|26710676|P2|Overall Study|Lost to Follow-up|1
7679637|NCT01288443|26710677|P1|Overall Study|Lost to Follow-up|0
7679638|NCT01288443|26710672|P6|Overall Study|Consent withdrawn by Participant|1
7679639|NCT01288443|26710673|P5|Overall Study|Consent withdrawn by Participant|0
7679640|NCT01288443|26710674|P4|Overall Study|Consent withdrawn by Participant|0
7679641|NCT01288443|26710675|P3|Overall Study|Consent withdrawn by Participant|0
7679642|NCT01288443|26710676|P2|Overall Study|Consent withdrawn by Participant|0
7679643|NCT01288443|26710677|P1|Overall Study|Consent withdrawn by Participant|0
7679644|NCT01288443|26710672|P6|Overall Study|Participant Moved|1
7679645|NCT01288443|26710673|P5|Overall Study|Participant Moved|2
7679646|NCT01288443|26710674|P4|Overall Study|Participant Moved|1
7679647|NCT01288443|26710675|P3|Overall Study|Participant Moved|0
7679648|NCT01288443|26710676|P2|Overall Study|Participant Moved|0
7679649|NCT01288443|26710677|P1|Overall Study|Participant Moved|0
7679650|NCT01288443|26710672|P6|Overall Study|Poor compliance to protocol|1
7679651|NCT01288443|26710673|P5|Overall Study|Poor compliance to protocol|0
7679652|NCT01288443|26710674|P4|Overall Study|Poor compliance to protocol|0
7679653|NCT01288443|26710675|P3|Overall Study|Poor compliance to protocol|0
7679654|NCT01288443|26710676|P2|Overall Study|Poor compliance to protocol|0
7679655|NCT01288443|26710677|P1|Overall Study|Poor compliance to protocol|0
7679656|NCT01288443|26710672|P6|Overall Study|Adverse Event|1
7679657|NCT01288443|26710673|P5|Overall Study|Adverse Event|3
7679658|NCT01288443|26710674|P4|Overall Study|Adverse Event|1
7679659|NCT01288443|26710675|P3|Overall Study|Adverse Event|1
7679660|NCT01288443|26710676|P2|Overall Study|Adverse Event|0
7679661|NCT01288443|26710677|P1|Overall Study|Adverse Event|0
7679662|NCT01288430|26710737|P10|Part 2|Other|1
7679663|NCT01288430|26710738|P9|Part 2|Other|0
7679664|NCT01288430|26710739|P8|Part 2|Other|0
7679665|NCT01288430|26710740|P7|Part 2|Other|0
7679666|NCT01288430|26710741|P6|Part 2|Other|0
7679667|NCT01288430|26710742|P5|Part 2|Other|0
7679668|NCT01288430|26710743|P4|Part 2|Other|0
7679669|NCT01288430|26710744|P3|Part 2|Other|0
7679670|NCT01288430|26710745|P2|Part 2|Other|0
7679671|NCT01288430|26710746|P1|Part 2|Other|0
7679672|NCT01288430|26710737|P10|Part 2|Adverse Event|0
7679673|NCT01288430|26710738|P9|Part 2|Adverse Event|1
7679674|NCT01288430|26710739|P8|Part 2|Adverse Event|1
7679675|NCT01288430|26710740|P7|Part 2|Adverse Event|0
7679676|NCT01288430|26710741|P6|Part 2|Adverse Event|0
7679677|NCT01288430|26710742|P5|Part 2|Adverse Event|0
7679678|NCT01288430|26710743|P4|Part 2|Adverse Event|0
7679679|NCT01288430|26710744|P3|Part 2|Adverse Event|0
7679680|NCT01288430|26710745|P2|Part 2|Adverse Event|0
7679681|NCT01288430|26710746|P1|Part 2|Adverse Event|0
7679682|NCT01288430|26710737|P10|Part 2|Withdrawal by Subject|0
7679683|NCT01288430|26710738|P9|Part 2|Withdrawal by Subject|4
7679684|NCT01288430|26710739|P8|Part 2|Withdrawal by Subject|1
7679685|NCT01288430|26710740|P7|Part 2|Withdrawal by Subject|0
7679686|NCT01288430|26710741|P6|Part 2|Withdrawal by Subject|0
7679687|NCT01288430|26710742|P5|Part 2|Withdrawal by Subject|0
7679688|NCT01288430|26710743|P4|Part 2|Withdrawal by Subject|0
7679689|NCT01288430|26710744|P3|Part 2|Withdrawal by Subject|0
7679690|NCT01288430|26710745|P2|Part 2|Withdrawal by Subject|0
7679691|NCT01288430|26710746|P1|Part 2|Withdrawal by Subject|0
7679692|NCT01288430|26710737|P10|Part 2|Clinical disease progression|0
7679693|NCT01288430|26710738|P9|Part 2|Clinical disease progression|0
7679694|NCT01288430|26710739|P8|Part 2|Clinical disease progression|2
7679695|NCT01288430|26710740|P7|Part 2|Clinical disease progression|0
7679696|NCT01288430|26710741|P6|Part 2|Clinical disease progression|0
7679697|NCT01288430|26710742|P5|Part 2|Clinical disease progression|0
7679698|NCT01288430|26710743|P4|Part 2|Clinical disease progression|0
7679699|NCT01288430|26710744|P3|Part 2|Clinical disease progression|0
7679700|NCT01288430|26710745|P2|Part 2|Clinical disease progression|0
7679701|NCT01288430|26710746|P1|Part 2|Clinical disease progression|0
7679702|NCT01288430|26710737|P10|Part 2|Progressive disease|2
7679703|NCT01288430|26710738|P9|Part 2|Progressive disease|7
7679704|NCT01288430|26710739|P8|Part 2|Progressive disease|8
7679705|NCT01288430|26710740|P7|Part 2|Progressive disease|0
7679706|NCT01288430|26710741|P6|Part 2|Progressive disease|0
7679707|NCT01288430|26710742|P5|Part 2|Progressive disease|0
7679708|NCT01288430|26710743|P4|Part 2|Progressive disease|0
7679709|NCT01288430|26710744|P3|Part 2|Progressive disease|0
7679710|NCT01288430|26710745|P2|Part 2|Progressive disease|0
7679711|NCT01288430|26710746|P1|Part 2|Progressive disease|0
7679712|NCT01288430|26710737|P10|Part 1|Other|0
7679713|NCT01288430|26710738|P9|Part 1|Other|0
7679714|NCT01288430|26710739|P8|Part 1|Other|0
7679715|NCT01288430|26710740|P7|Part 1|Other|1
7679716|NCT01288430|26710741|P6|Part 1|Other|0
7679717|NCT01288430|26710742|P5|Part 1|Other|0
7679718|NCT01288430|26710743|P4|Part 1|Other|0
7679719|NCT01288430|26710744|P3|Part 1|Other|0
7679720|NCT01288430|26710745|P2|Part 1|Other|2
7679721|NCT01288430|26710746|P1|Part 1|Other|0
7679722|NCT01288430|26710737|P10|Part 1|Adverse Event|0
7679723|NCT01288430|26710738|P9|Part 1|Adverse Event|0
7679724|NCT01288430|26710739|P8|Part 1|Adverse Event|0
7679725|NCT01288430|26710740|P7|Part 1|Adverse Event|2
7679726|NCT01288430|26710741|P6|Part 1|Adverse Event|0
7679727|NCT01288430|26710742|P5|Part 1|Adverse Event|0
7679728|NCT01288430|26710743|P4|Part 1|Adverse Event|1
7679729|NCT01288430|26710744|P3|Part 1|Adverse Event|3
7679730|NCT01288430|26710745|P2|Part 1|Adverse Event|0
7679731|NCT01288430|26710746|P1|Part 1|Adverse Event|0
7679732|NCT01288430|26710737|P10|Part 1|Death due to disease progression|0
7679733|NCT01288430|26710738|P9|Part 1|Death due to disease progression|0
7679734|NCT01288430|26710739|P8|Part 1|Death due to disease progression|0
7679735|NCT01288430|26710740|P7|Part 1|Death due to disease progression|0
7679736|NCT01288430|26710741|P6|Part 1|Death due to disease progression|0
7679737|NCT01288430|26710742|P5|Part 1|Death due to disease progression|1
7679738|NCT01288430|26710743|P4|Part 1|Death due to disease progression|0
7679739|NCT01288430|26710744|P3|Part 1|Death due to disease progression|0
7679740|NCT01288430|26710745|P2|Part 1|Death due to disease progression|0
7679741|NCT01288430|26710746|P1|Part 1|Death due to disease progression|0
7679742|NCT01288430|26710737|P10|Part 1|Clinical disease progression|0
7679743|NCT01288430|26710738|P9|Part 1|Clinical disease progression|0
7679744|NCT01288430|26710739|P8|Part 1|Clinical disease progression|0
7679745|NCT01288430|26710740|P7|Part 1|Clinical disease progression|2
7679746|NCT01288430|26710741|P6|Part 1|Clinical disease progression|2
7679747|NCT01288430|26710742|P5|Part 1|Clinical disease progression|0
7679748|NCT01288430|26710743|P4|Part 1|Clinical disease progression|0
7679749|NCT01288430|26710744|P3|Part 1|Clinical disease progression|1
7679750|NCT01288430|26710745|P2|Part 1|Clinical disease progression|0
7679751|NCT01288430|26710746|P1|Part 1|Clinical disease progression|0
7679752|NCT01288430|26710737|P10|Part 1|Progressive disease|0
7679753|NCT01288430|26710738|P9|Part 1|Progressive disease|0
7679754|NCT01288430|26710739|P8|Part 1|Progressive disease|0
7679755|NCT01288430|26710740|P7|Part 1|Progressive disease|2
7679756|NCT01288430|26710741|P6|Part 1|Progressive disease|4
7679757|NCT01288430|26710742|P5|Part 1|Progressive disease|2
7679758|NCT01288430|26710743|P4|Part 1|Progressive disease|6
7679759|NCT01288430|26710744|P3|Part 1|Progressive disease|1
7679760|NCT01288430|26710745|P2|Part 1|Progressive disease|1
7679761|NCT01288430|26710746|P1|Part 1|Progressive disease|2
7679762|NCT01288287|26710870|P1|Overall Study|Unknown Status|7
7679763|NCT01288287|26710870|P1|Overall Study|Unknown Reason|1
7679764|NCT01288287|26710870|P1|Overall Study|Other Reason|13
7679765|NCT01288287|26710870|P1|Overall Study|Lack of Efficacy|13
7679766|NCT01288287|26710870|P1|Overall Study|Withdrawal by Subject|4
7679767|NCT01288287|26710870|P1|Overall Study|Lost to Follow-up|8
7679768|NCT01288209|26710885|P2|Overall Study|Other|0
7679769|NCT01288209|26710886|P1|Overall Study|Other|1
7679770|NCT01288209|26710885|P2|Overall Study|Withdrawal by Subject|3
7679771|NCT01288209|26710886|P1|Overall Study|Withdrawal by Subject|1
7679772|NCT01288079|26710916|P4|Overall Study|Other or Study Termination|8
7679773|NCT01288079|26710917|P3|Overall Study|Other or Study Termination|14
7679774|NCT01288079|26710918|P2|Overall Study|Other or Study Termination|15
7679775|NCT01288079|26710919|P1|Overall Study|Other or Study Termination|11
7679776|NCT01288079|26710916|P4|Overall Study|Lost to Follow-up|0
7679777|NCT01288079|26710917|P3|Overall Study|Lost to Follow-up|1
7679778|NCT01288079|26710918|P2|Overall Study|Lost to Follow-up|1
7679779|NCT01288079|26710919|P1|Overall Study|Lost to Follow-up|1
7679780|NCT01288079|26710916|P4|Overall Study|Study-Specific Withdrawal Criteria|0
7679781|NCT01288079|26710917|P3|Overall Study|Study-Specific Withdrawal Criteria|0
7679782|NCT01288079|26710918|P2|Overall Study|Study-Specific Withdrawal Criteria|1
7679783|NCT01288079|26710919|P1|Overall Study|Study-Specific Withdrawal Criteria|1
7679784|NCT01288079|26710916|P4|Overall Study|Lack of Efficacy|2
7679785|NCT01288079|26710917|P3|Overall Study|Lack of Efficacy|0
7679786|NCT01288079|26710918|P2|Overall Study|Lack of Efficacy|2
7679787|NCT01288079|26710919|P1|Overall Study|Lack of Efficacy|2
7679788|NCT01288079|26710916|P4|Overall Study|Condition under Investigation Worsened|1
7679789|NCT01288079|26710917|P3|Overall Study|Condition under Investigation Worsened|0
7679790|NCT01288079|26710918|P2|Overall Study|Condition under Investigation Worsened|0
7679791|NCT01288079|26710919|P1|Overall Study|Condition under Investigation Worsened|0
7679792|NCT01288079|26710916|P4|Overall Study|Severe Non-Compliance to Protocol|3
7679793|NCT01288079|26710917|P3|Overall Study|Severe Non-Compliance to Protocol|1
7679794|NCT01288079|26710918|P2|Overall Study|Severe Non-Compliance to Protocol|3
7679795|NCT01288079|26710919|P1|Overall Study|Severe Non-Compliance to Protocol|1
7679796|NCT01288079|26710916|P4|Overall Study|Adverse Event|3
7679797|NCT01288079|26710917|P3|Overall Study|Adverse Event|2
7679798|NCT01288079|26710918|P2|Overall Study|Adverse Event|1
7679799|NCT01288079|26710919|P1|Overall Study|Adverse Event|2
7679800|NCT01288079|26710916|P4|Overall Study|Withdrawal by Subject|0
7679801|NCT01288079|26710917|P3|Overall Study|Withdrawal by Subject|1
7679802|NCT01288079|26710918|P2|Overall Study|Withdrawal by Subject|4
7679803|NCT01288079|26710919|P1|Overall Study|Withdrawal by Subject|2
7679804|NCT01288053|26710929|P1|Overall Study|Death|1
7679805|NCT01287897|26710947|P4|Overall Study|Other|0
7679806|NCT01287897|26710948|P3|Overall Study|Other|1
7679807|NCT01287897|26710949|P2|Overall Study|Other|0
7679808|NCT01287897|26710950|P1|Overall Study|Other|1
7679809|NCT01287897|26710947|P4|Overall Study|Not meeting entrance criteria|0
7679810|NCT01287897|26710948|P3|Overall Study|Not meeting entrance criteria|0
7679811|NCT01287897|26710949|P2|Overall Study|Not meeting entrance criteria|1
7679812|NCT01287897|26710950|P1|Overall Study|Not meeting entrance criteria|1
7679813|NCT01287897|26710947|P4|Overall Study|Not consented properly|0
7679814|NCT01287897|26710948|P3|Overall Study|Not consented properly|0
7679815|NCT01287897|26710949|P2|Overall Study|Not consented properly|1
7679816|NCT01287897|26710950|P1|Overall Study|Not consented properly|0
7679817|NCT01287897|26710947|P4|Overall Study|Withdrawal by Subject|2
7679818|NCT01287897|26710948|P3|Overall Study|Withdrawal by Subject|3
7679819|NCT01287897|26710949|P2|Overall Study|Withdrawal by Subject|5
7679820|NCT01287897|26710950|P1|Overall Study|Withdrawal by Subject|1
7679821|NCT01287897|26710947|P4|Overall Study|Lost to Follow-up|0
7679822|NCT01287897|26710948|P3|Overall Study|Lost to Follow-up|2
7679823|NCT01287897|26710949|P2|Overall Study|Lost to Follow-up|0
7679824|NCT01287897|26710950|P1|Overall Study|Lost to Follow-up|0
7679825|NCT01287897|26710947|P4|Overall Study|Protocol Violation|1
7679826|NCT01287897|26710948|P3|Overall Study|Protocol Violation|0
7679827|NCT01287897|26710949|P2|Overall Study|Protocol Violation|1
7679828|NCT01287897|26710950|P1|Overall Study|Protocol Violation|1
7679829|NCT01287897|26710947|P4|Overall Study|Lack of Efficacy|0
7679830|NCT01287897|26710948|P3|Overall Study|Lack of Efficacy|0
7679831|NCT01287897|26710949|P2|Overall Study|Lack of Efficacy|0
7679832|NCT01287897|26710950|P1|Overall Study|Lack of Efficacy|2
7679833|NCT01287897|26710947|P4|Overall Study|Adverse Event|4
7679834|NCT01287897|26710948|P3|Overall Study|Adverse Event|6
7679835|NCT01287897|26710949|P2|Overall Study|Adverse Event|3
7679836|NCT01287897|26710950|P1|Overall Study|Adverse Event|5
7679837|NCT01287832|26711001|P2|Overall Study|Death|1
7679838|NCT01287832|26711002|P1|Overall Study|Death|0
7679839|NCT01287832|26711001|P2|Overall Study|Adverse Event|0
7679840|NCT01287832|26711002|P1|Overall Study|Adverse Event|1
7679841|NCT01287754|26711010|P2|Overall Study|Protocol Violation|3
7679842|NCT01287754|26711011|P1|Overall Study|Protocol Violation|0
7679843|NCT01287754|26711010|P2|Overall Study|Lost to Follow-up|6
7679844|NCT01287754|26711011|P1|Overall Study|Lost to Follow-up|1
7679845|NCT01287754|26711010|P2|Overall Study|Death|12
7679846|NCT01287754|26711011|P1|Overall Study|Death|2
7679847|NCT01287741|26711023|P2|Overall Study|Reason not specified|9
7679848|NCT01287741|26711024|P1|Overall Study|Reason not specified|23
7679849|NCT01287741|26711023|P2|Overall Study|Progressive disease|166
7679850|NCT01287741|26711024|P1|Overall Study|Progressive disease|190
7679851|NCT01287741|26711023|P2|Overall Study|Study terminated by Sponsor|315
7679852|NCT01287741|26711024|P1|Overall Study|Study terminated by Sponsor|307
7679853|NCT01287741|26711023|P2|Overall Study|Adverse Event|6
7679854|NCT01287741|26711024|P1|Overall Study|Adverse Event|4
7679855|NCT01287741|26711023|P2|Overall Study|Death|44
7679856|NCT01287741|26711024|P1|Overall Study|Death|32
7679857|NCT01287741|26711023|P2|Overall Study|Lost to Follow-up|8
7679858|NCT01287741|26711024|P1|Overall Study|Lost to Follow-up|10
7679859|NCT01287741|26711023|P2|Overall Study|Non-compliance|6
7679860|NCT01287741|26711024|P1|Overall Study|Non-compliance|8
7679861|NCT01287741|26711023|P2|Overall Study|Physician Decision|23
7679862|NCT01287741|26711024|P1|Overall Study|Physician Decision|15
7679863|NCT01287741|26711023|P2|Overall Study|Protocol Violation|0
7679864|NCT01287741|26711024|P1|Overall Study|Protocol Violation|2
7679865|NCT01287741|26711023|P2|Overall Study|Withdrawal by Subject|38
7679866|NCT01287741|26711024|P1|Overall Study|Withdrawal by Subject|35
7679867|NCT01287611|26711060|P2|Overall Study|Exclusion due to expanded Kerr incision|3
7679868|NCT01287611|26711061|P1|Overall Study|Exclusion due to expanded Kerr incision|4
7679869|NCT01287611|26711060|P2|Overall Study|Lost to Follow-up|16
7679870|NCT01287611|26711061|P1|Overall Study|Lost to Follow-up|29
7679871|NCT01287520|26711078|P9|Overall Study|Withdrawal by Subject|1
7679872|NCT01287520|26711079|P8|Overall Study|Withdrawal by Subject|0
7679873|NCT01287520|26711080|P7|Overall Study|Withdrawal by Subject|0
7679874|NCT01287520|26711081|P6|Overall Study|Withdrawal by Subject|1
7679875|NCT01287520|26711082|P5|Overall Study|Withdrawal by Subject|0
7679876|NCT01287520|26711083|P4|Overall Study|Withdrawal by Subject|0
7679877|NCT01287520|26711084|P3|Overall Study|Withdrawal by Subject|0
7679878|NCT01287520|26711085|P2|Overall Study|Withdrawal by Subject|0
7679879|NCT01287520|26711086|P1|Overall Study|Withdrawal by Subject|0
7679880|NCT01287520|26711078|P9|Overall Study|Progressive disease|4
7679881|NCT01287520|26711079|P8|Overall Study|Progressive disease|2
7679882|NCT01287520|26711080|P7|Overall Study|Progressive disease|2
7679883|NCT01287520|26711081|P6|Overall Study|Progressive disease|0
7679884|NCT01287520|26711082|P5|Overall Study|Progressive disease|1
7679885|NCT01287520|26711083|P4|Overall Study|Progressive disease|6
7679886|NCT01287520|26711084|P3|Overall Study|Progressive disease|1
7679887|NCT01287520|26711085|P2|Overall Study|Progressive disease|4
7679888|NCT01287520|26711086|P1|Overall Study|Progressive disease|0
7679889|NCT01287520|26711078|P9|Overall Study|Physician Decision|0
7679890|NCT01287520|26711079|P8|Overall Study|Physician Decision|1
7679891|NCT01287520|26711080|P7|Overall Study|Physician Decision|0
7679892|NCT01287520|26711081|P6|Overall Study|Physician Decision|1
7679893|NCT01287520|26711082|P5|Overall Study|Physician Decision|1
7679894|NCT01287520|26711083|P4|Overall Study|Physician Decision|0
7679895|NCT01287520|26711084|P3|Overall Study|Physician Decision|2
7679896|NCT01287520|26711085|P2|Overall Study|Physician Decision|1
7679897|NCT01287520|26711086|P1|Overall Study|Physician Decision|1
7679898|NCT01287520|26711078|P9|Overall Study|Adverse Event|0
7679899|NCT01287520|26711079|P8|Overall Study|Adverse Event|2
7679900|NCT01287520|26711080|P7|Overall Study|Adverse Event|0
7679901|NCT01287520|26711081|P6|Overall Study|Adverse Event|2
7679902|NCT01287520|26711082|P5|Overall Study|Adverse Event|1
7679903|NCT01287520|26711083|P4|Overall Study|Adverse Event|1
7679904|NCT01287520|26711084|P3|Overall Study|Adverse Event|2
7679905|NCT01287520|26711085|P2|Overall Study|Adverse Event|2
7679906|NCT01287520|26711086|P1|Overall Study|Adverse Event|2
7679907|NCT01287416|26711150|P2|6 Month Follow-up|Lost to Follow-up|2
7679908|NCT01287416|26711151|P1|6 Month Follow-up|Lost to Follow-up|3
7679909|NCT01287416|26711150|P2|Pre-post Training|Lost to Follow-up|1
7679910|NCT01287416|26711151|P1|Pre-post Training|Lost to Follow-up|5
7679911|NCT01287416|26711150|P2|Pre-post Training|Withdrawal by Subject|24
7679912|NCT01287416|26711151|P1|Pre-post Training|Withdrawal by Subject|17
7679913|NCT01287403|26711187|P1|1st Intervention (1 Day)|Adverse Event|1
7679914|NCT01287364|26711219|P2|Overall Study|Other Reason|2
7679915|NCT01287364|26711220|P1|Overall Study|Other Reason|4
7679916|NCT01287364|26711219|P2|Overall Study|Protocol Violation|5
7679917|NCT01287364|26711220|P1|Overall Study|Protocol Violation|5
7679918|NCT01287364|26711219|P2|Overall Study|Adverse Event|3
7679919|NCT01287364|26711220|P1|Overall Study|Adverse Event|0
7679920|NCT01287221|26711242|P2|Overall Study|Withdrawal by Subject|1
7679921|NCT01287221|26711243|P1|Overall Study|Withdrawal by Subject|0
7679922|NCT01287221|26711242|P2|Overall Study|Adverse Event|3
7679923|NCT01287221|26711243|P1|Overall Study|Adverse Event|3
7679924|NCT01287221|26711242|P2|Overall Study|Lack of Perceived Benefit|1
7679925|NCT01287221|26711243|P1|Overall Study|Lack of Perceived Benefit|1
7679926|NCT01287195|26711278|P1|Overall Study|Withdrawal by Subject|2
7679927|NCT01287117|26711293|P4|Overall Study|Disease Progression|5
7679928|NCT01287117|26711294|P3|Overall Study|Disease Progression|6
7679929|NCT01287117|26711295|P2|Overall Study|Disease Progression|5
7679930|NCT01287117|26711296|P1|Overall Study|Disease Progression|10
7679931|NCT01287117|26711293|P4|Overall Study|Patient/Legal Guardian's Decision|5
7679932|NCT01287117|26711294|P3|Overall Study|Patient/Legal Guardian's Decision|8
7679933|NCT01287117|26711295|P2|Overall Study|Patient/Legal Guardian's Decision|6
7679934|NCT01287117|26711296|P1|Overall Study|Patient/Legal Guardian's Decision|2
7679935|NCT01287117|26711293|P4|Overall Study|Physician Decision|1
7679936|NCT01287117|26711294|P3|Overall Study|Physician Decision|1
7679937|NCT01287117|26711295|P2|Overall Study|Physician Decision|1
7679938|NCT01287117|26711296|P1|Overall Study|Physician Decision|0
7679939|NCT01287117|26711293|P4|Overall Study|Lost to Follow-up|0
7679940|NCT01287117|26711294|P3|Overall Study|Lost to Follow-up|0
7679941|NCT01287117|26711295|P2|Overall Study|Lost to Follow-up|1
7679942|NCT01287117|26711296|P1|Overall Study|Lost to Follow-up|1
7679943|NCT01287117|26711293|P4|Overall Study|Adverse Event|1
7679944|NCT01287117|26711294|P3|Overall Study|Adverse Event|1
7679945|NCT01287117|26711295|P2|Overall Study|Adverse Event|1
7679946|NCT01287117|26711296|P1|Overall Study|Adverse Event|2
7679947|NCT01287104|26711346|P4|Overall Study|NK cells did not meet release criteria|0
7679948|NCT01287104|26711347|P3|Overall Study|NK cells did not meet release criteria|0
7679949|NCT01287104|26711348|P2|Overall Study|NK cells did not meet release criteria|1
7679950|NCT01287104|26711349|P1|Overall Study|NK cells did not meet release criteria|0
7679951|NCT01287104|26711346|P4|Overall Study|Low donor chimerism|0
7679952|NCT01287104|26711347|P3|Overall Study|Low donor chimerism|0
7679953|NCT01287104|26711348|P2|Overall Study|Low donor chimerism|1
7679954|NCT01287104|26711349|P1|Overall Study|Low donor chimerism|0
7679955|NCT01287104|26711346|P4|Overall Study|Developed GVHD or complications of BMT|0
7679956|NCT01287104|26711347|P3|Overall Study|Developed GVHD or complications of BMT|4
7679957|NCT01287104|26711348|P2|Overall Study|Developed GVHD or complications of BMT|1
7679958|NCT01287104|26711349|P1|Overall Study|Developed GVHD or complications of BMT|0
7679959|NCT01287104|26711346|P4|Overall Study|Donor anaphylaxis|1
7679960|NCT01287104|26711347|P3|Overall Study|Donor anaphylaxis|0
7679961|NCT01287104|26711348|P2|Overall Study|Donor anaphylaxis|1
7679962|NCT01287104|26711349|P1|Overall Study|Donor anaphylaxis|0
7679963|NCT01287104|26711346|P4|Overall Study|Patient developed progressive disease|2
7679964|NCT01287104|26711347|P3|Overall Study|Patient developed progressive disease|3
7679965|NCT01287104|26711348|P2|Overall Study|Patient developed progressive disease|1
7679966|NCT01287104|26711349|P1|Overall Study|Patient developed progressive disease|1
7679967|NCT01287065|26711405|P6|Treatment Period 1|Withdrawal by Subject|1
7679968|NCT01287065|26711406|P5|Treatment Period 1|Withdrawal by Subject|0
7679969|NCT01287065|26711407|P4|Treatment Period 1|Withdrawal by Subject|0
7679970|NCT01287065|26711408|P3|Treatment Period 1|Withdrawal by Subject|0
7679971|NCT01287065|26711409|P2|Treatment Period 1|Withdrawal by Subject|0
7679972|NCT01287065|26711410|P1|Treatment Period 1|Withdrawal by Subject|0
7679973|NCT01287065|26711405|P6|Treatment Period 1|Adverse Event|0
7679974|NCT01287065|26711406|P5|Treatment Period 1|Adverse Event|1
7679975|NCT01287065|26711407|P4|Treatment Period 1|Adverse Event|0
7679976|NCT01287065|26711408|P3|Treatment Period 1|Adverse Event|0
7679977|NCT01287065|26711409|P2|Treatment Period 1|Adverse Event|0
7679978|NCT01287065|26711410|P1|Treatment Period 1|Adverse Event|0
7679979|NCT01287039|26711429|P2|Overall Study|Lost to Follow-up|2
7679980|NCT01287039|26711430|P1|Overall Study|Lost to Follow-up|3
7679981|NCT01287039|26711429|P2|Overall Study|Withdrawal by Subject|11
7679982|NCT01287039|26711430|P1|Overall Study|Withdrawal by Subject|14
7679983|NCT01287039|26711429|P2|Overall Study|Adverse Event|4
7679984|NCT01287039|26711430|P1|Overall Study|Adverse Event|7
7679985|NCT01287039|26711429|P2|Overall Study|Change of residence|0
7679986|NCT01287039|26711430|P1|Overall Study|Change of residence|1
7679987|NCT01287039|26711429|P2|Overall Study|Death|0
7679988|NCT01287039|26711430|P1|Overall Study|Death|1
7679989|NCT01287039|26711429|P2|Overall Study|Problem with travel|1
7679990|NCT01287039|26711430|P1|Overall Study|Problem with travel|0
7679991|NCT01287039|26711429|P2|Overall Study|Noncompliance with study medication|1
7679992|NCT01287039|26711430|P1|Overall Study|Noncompliance with study medication|0
7679993|NCT01287039|26711429|P2|Overall Study|Excluded medication taken|0
7679994|NCT01287039|26711430|P1|Overall Study|Excluded medication taken|1
7679995|NCT01287039|26711429|P2|Overall Study|Protocol Violation|3
7679996|NCT01287039|26711430|P1|Overall Study|Protocol Violation|2
7679997|NCT01287039|26711429|P2|Overall Study|Elective surgery|1
7679998|NCT01287039|26711430|P1|Overall Study|Elective surgery|0
7679999|NCT01287039|26711429|P2|Overall Study|Change of location/residence|3
7680000|NCT01287039|26711430|P1|Overall Study|Change of location/residence|0
7680001|NCT01287039|26711429|P2|Overall Study|Noncompliance with study procedures|1
7680002|NCT01287039|26711430|P1|Overall Study|Noncompliance with study procedures|0
7680003|NCT01287013|26711463|P3|Overall Study|Non-evaluable|21
7680004|NCT01287013|26711464|P2|Overall Study|Non-evaluable|5
7680005|NCT01287013|26711465|P1|Overall Study|Non-evaluable|3
7680006|NCT01286987|26711495|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
7680007|NCT01286987|26711496|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
7680008|NCT01286987|26711497|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
7680009|NCT01286987|26711498|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
7680010|NCT01286987|26711499|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
7680011|NCT01286987|26711500|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
7680012|NCT01286987|26711501|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
7680013|NCT01286987|26711502|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
7680014|NCT01286987|26711503|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
7680015|NCT01286987|26711504|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
7680016|NCT01286987|26711505|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
7680017|NCT01286987|26711506|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
7680018|NCT01286987|26711507|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
7680019|NCT01286987|26711508|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
7680020|NCT01286987|26711509|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
7680021|NCT01286987|26711495|P15|Part 2: Dose Expansion|Clinical Progression|0
7680022|NCT01286987|26711496|P14|Part 2: Dose Expansion|Clinical Progression|2
7680023|NCT01286987|26711497|P13|Part 2: Dose Expansion|Clinical Progression|0
7680024|NCT01286987|26711498|P12|Part 2: Dose Expansion|Clinical Progression|2
7680025|NCT01286987|26711499|P11|Part 2: Dose Expansion|Clinical Progression|2
7680026|NCT01286987|26711500|P10|Part 2: Dose Expansion|Clinical Progression|0
7680027|NCT01286987|26711501|P9|Part 2: Dose Expansion|Clinical Progression|0
7680028|NCT01286987|26711502|P8|Part 2: Dose Expansion|Clinical Progression|0
7680029|NCT01286987|26711503|P7|Part 2: Dose Expansion|Clinical Progression|0
7680030|NCT01286987|26711504|P6|Part 2: Dose Expansion|Clinical Progression|0
7680031|NCT01286987|26711505|P5|Part 2: Dose Expansion|Clinical Progression|0
7680032|NCT01286987|26711506|P4|Part 2: Dose Expansion|Clinical Progression|0
7680033|NCT01286987|26711507|P3|Part 2: Dose Expansion|Clinical Progression|0
7680034|NCT01286987|26711508|P2|Part 2: Dose Expansion|Clinical Progression|0
7680035|NCT01286987|26711509|P1|Part 2: Dose Expansion|Clinical Progression|0
7680036|NCT01286987|26711495|P15|Part 2: Dose Expansion|Progressive Disease|2
7680037|NCT01286987|26711496|P14|Part 2: Dose Expansion|Progressive Disease|19
7680038|NCT01286987|26711497|P13|Part 2: Dose Expansion|Progressive Disease|11
7680039|NCT01286987|26711498|P12|Part 2: Dose Expansion|Progressive Disease|7
7680040|NCT01286987|26711499|P11|Part 2: Dose Expansion|Progressive Disease|6
7680041|NCT01286987|26711500|P10|Part 2: Dose Expansion|Progressive Disease|11
7680042|NCT01286987|26711501|P9|Part 2: Dose Expansion|Progressive Disease|0
7680043|NCT01286987|26711502|P8|Part 2: Dose Expansion|Progressive Disease|0
7680044|NCT01286987|26711503|P7|Part 2: Dose Expansion|Progressive Disease|0
7680045|NCT01286987|26711504|P6|Part 2: Dose Expansion|Progressive Disease|0
7680046|NCT01286987|26711505|P5|Part 2: Dose Expansion|Progressive Disease|0
7680047|NCT01286987|26711506|P4|Part 2: Dose Expansion|Progressive Disease|0
7680048|NCT01286987|26711507|P3|Part 2: Dose Expansion|Progressive Disease|0
7680049|NCT01286987|26711508|P2|Part 2: Dose Expansion|Progressive Disease|0
7680050|NCT01286987|26711509|P1|Part 2: Dose Expansion|Progressive Disease|0
7680051|NCT01286987|26711495|P15|Part 2: Dose Expansion|Other|0
7680052|NCT01286987|26711496|P14|Part 2: Dose Expansion|Other|1
7680053|NCT01286987|26711497|P13|Part 2: Dose Expansion|Other|0
7680054|NCT01286987|26711498|P12|Part 2: Dose Expansion|Other|0
7680055|NCT01286987|26711499|P11|Part 2: Dose Expansion|Other|0
7680056|NCT01286987|26711500|P10|Part 2: Dose Expansion|Other|0
7680057|NCT01286987|26711501|P9|Part 2: Dose Expansion|Other|0
7680058|NCT01286987|26711502|P8|Part 2: Dose Expansion|Other|0
7680059|NCT01286987|26711503|P7|Part 2: Dose Expansion|Other|0
7680060|NCT01286987|26711504|P6|Part 2: Dose Expansion|Other|0
7680061|NCT01286987|26711505|P5|Part 2: Dose Expansion|Other|0
7680062|NCT01286987|26711506|P4|Part 2: Dose Expansion|Other|0
7680063|NCT01286987|26711507|P3|Part 2: Dose Expansion|Other|0
7680064|NCT01286987|26711508|P2|Part 2: Dose Expansion|Other|0
7680065|NCT01286987|26711509|P1|Part 2: Dose Expansion|Other|0
7680066|NCT01286987|26711495|P15|Part 2: Dose Expansion|Physician Decision|0
7680067|NCT01286987|26711496|P14|Part 2: Dose Expansion|Physician Decision|1
7680068|NCT01286987|26711497|P13|Part 2: Dose Expansion|Physician Decision|0
7680069|NCT01286987|26711498|P12|Part 2: Dose Expansion|Physician Decision|1
7680070|NCT01286987|26711499|P11|Part 2: Dose Expansion|Physician Decision|1
7680071|NCT01286987|26711500|P10|Part 2: Dose Expansion|Physician Decision|0
7680072|NCT01286987|26711501|P9|Part 2: Dose Expansion|Physician Decision|0
7680073|NCT01286987|26711502|P8|Part 2: Dose Expansion|Physician Decision|0
7680074|NCT01286987|26711503|P7|Part 2: Dose Expansion|Physician Decision|0
7680075|NCT01286987|26711504|P6|Part 2: Dose Expansion|Physician Decision|0
7680076|NCT01286987|26711505|P5|Part 2: Dose Expansion|Physician Decision|0
7680077|NCT01286987|26711506|P4|Part 2: Dose Expansion|Physician Decision|0
7680078|NCT01286987|26711507|P3|Part 2: Dose Expansion|Physician Decision|0
7680079|NCT01286987|26711508|P2|Part 2: Dose Expansion|Physician Decision|0
7680080|NCT01286987|26711509|P1|Part 2: Dose Expansion|Physician Decision|0
7680081|NCT01286987|26711495|P15|Part 2: Dose Expansion|Death|0
7680082|NCT01286987|26711496|P14|Part 2: Dose Expansion|Death|1
7680083|NCT01286987|26711497|P13|Part 2: Dose Expansion|Death|1
7680084|NCT01286987|26711498|P12|Part 2: Dose Expansion|Death|0
7680085|NCT01286987|26711499|P11|Part 2: Dose Expansion|Death|0
7680086|NCT01286987|26711500|P10|Part 2: Dose Expansion|Death|0
7680087|NCT01286987|26711501|P9|Part 2: Dose Expansion|Death|0
7680088|NCT01286987|26711502|P8|Part 2: Dose Expansion|Death|0
7680089|NCT01286987|26711503|P7|Part 2: Dose Expansion|Death|0
7680090|NCT01286987|26711504|P6|Part 2: Dose Expansion|Death|0
7680091|NCT01286987|26711505|P5|Part 2: Dose Expansion|Death|0
7680092|NCT01286987|26711506|P4|Part 2: Dose Expansion|Death|0
7680093|NCT01286987|26711507|P3|Part 2: Dose Expansion|Death|0
7680094|NCT01286987|26711508|P2|Part 2: Dose Expansion|Death|0
7680095|NCT01286987|26711509|P1|Part 2: Dose Expansion|Death|0
7680096|NCT01286987|26711495|P15|Part 1: Dose Escalation|Physician Decision|0
7680097|NCT01286987|26711496|P14|Part 1: Dose Escalation|Physician Decision|0
7680098|NCT01286987|26711497|P13|Part 1: Dose Escalation|Physician Decision|0
7680099|NCT01286987|26711498|P12|Part 1: Dose Escalation|Physician Decision|0
7680100|NCT01286987|26711499|P11|Part 1: Dose Escalation|Physician Decision|0
7680101|NCT01286987|26711500|P10|Part 1: Dose Escalation|Physician Decision|0
7680102|NCT01286987|26711501|P9|Part 1: Dose Escalation|Physician Decision|0
7680103|NCT01286987|26711502|P8|Part 1: Dose Escalation|Physician Decision|0
7680104|NCT01286987|26711503|P7|Part 1: Dose Escalation|Physician Decision|0
7680105|NCT01286987|26711504|P6|Part 1: Dose Escalation|Physician Decision|0
7680106|NCT01286987|26711505|P5|Part 1: Dose Escalation|Physician Decision|1
7680107|NCT01286987|26711506|P4|Part 1: Dose Escalation|Physician Decision|0
7680108|NCT01286987|26711507|P3|Part 1: Dose Escalation|Physician Decision|0
7680109|NCT01286987|26711508|P2|Part 1: Dose Escalation|Physician Decision|0
7680110|NCT01286987|26711509|P1|Part 1: Dose Escalation|Physician Decision|0
7680111|NCT01286987|26711495|P15|Part 1: Dose Escalation|Progressive Disease|0
7680112|NCT01286987|26711496|P14|Part 1: Dose Escalation|Progressive Disease|0
7680113|NCT01286987|26711497|P13|Part 1: Dose Escalation|Progressive Disease|0
7680114|NCT01286987|26711498|P12|Part 1: Dose Escalation|Progressive Disease|0
7680115|NCT01286987|26711499|P11|Part 1: Dose Escalation|Progressive Disease|0
7680116|NCT01286987|26711500|P10|Part 1: Dose Escalation|Progressive Disease|0
7680117|NCT01286987|26711501|P9|Part 1: Dose Escalation|Progressive Disease|5
7680118|NCT01286987|26711502|P8|Part 1: Dose Escalation|Progressive Disease|3
7680119|NCT01286987|26711503|P7|Part 1: Dose Escalation|Progressive Disease|5
7680120|NCT01286987|26711504|P6|Part 1: Dose Escalation|Progressive Disease|5
7680121|NCT01286987|26711505|P5|Part 1: Dose Escalation|Progressive Disease|1
7680122|NCT01286987|26711506|P4|Part 1: Dose Escalation|Progressive Disease|2
7680123|NCT01286987|26711507|P3|Part 1: Dose Escalation|Progressive Disease|3
7680124|NCT01286987|26711508|P2|Part 1: Dose Escalation|Progressive Disease|2
7680125|NCT01286987|26711509|P1|Part 1: Dose Escalation|Progressive Disease|2
7680126|NCT01286987|26711495|P15|Part 1: Dose Escalation|Clinical Progression|0
7680127|NCT01286987|26711496|P14|Part 1: Dose Escalation|Clinical Progression|0
7680128|NCT01286987|26711497|P13|Part 1: Dose Escalation|Clinical Progression|0
7680129|NCT01286987|26711498|P12|Part 1: Dose Escalation|Clinical Progression|0
7680130|NCT01286987|26711499|P11|Part 1: Dose Escalation|Clinical Progression|0
7680131|NCT01286987|26711500|P10|Part 1: Dose Escalation|Clinical Progression|0
7680132|NCT01286987|26711501|P9|Part 1: Dose Escalation|Clinical Progression|1
7680133|NCT01286987|26711502|P8|Part 1: Dose Escalation|Clinical Progression|2
7680134|NCT01286987|26711503|P7|Part 1: Dose Escalation|Clinical Progression|0
7680135|NCT01286987|26711504|P6|Part 1: Dose Escalation|Clinical Progression|1
7680136|NCT01286987|26711505|P5|Part 1: Dose Escalation|Clinical Progression|1
7680137|NCT01286987|26711506|P4|Part 1: Dose Escalation|Clinical Progression|1
7680138|NCT01286987|26711507|P3|Part 1: Dose Escalation|Clinical Progression|0
7680139|NCT01286987|26711508|P2|Part 1: Dose Escalation|Clinical Progression|1
7680140|NCT01286987|26711509|P1|Part 1: Dose Escalation|Clinical Progression|1
7680141|NCT01286779|26711690|P1|Overall Study|Discontinued by sponsor|1
7680142|NCT01286779|26711690|P1|Overall Study|Participant moved to another country|1
7680143|NCT01286779|26711690|P1|Overall Study|Participant had scheduled surgery|1
7680144|NCT01286779|26711690|P1|Overall Study|Physician Decision|2
7680145|NCT01286779|26711690|P1|Overall Study|Protocol Violation|5
7680146|NCT01286779|26711690|P1|Overall Study|Withdrawal by Subject|9
7680147|NCT01286753|26711742|P2|Overall Study|Participant to Receive Radiotherapy|0
7680148|NCT01286753|26711743|P1|Overall Study|Participant to Receive Radiotherapy|1
7680149|NCT01286753|26711742|P2|Overall Study|Discontinued to Join Extension Study|4
7680150|NCT01286753|26711743|P1|Overall Study|Discontinued to Join Extension Study|6
7680151|NCT01286753|26711742|P2|Overall Study|Withdrawal of Consent|2
7680152|NCT01286753|26711743|P1|Overall Study|Withdrawal of Consent|0
7680153|NCT01286753|26711742|P2|Overall Study|Refused Treatment|0
7680154|NCT01286753|26711743|P1|Overall Study|Refused Treatment|1
7680155|NCT01286753|26711742|P2|Overall Study|Progression|13
7680156|NCT01286753|26711743|P1|Overall Study|Progression|11
7680157|NCT01286753|26711742|P2|Overall Study|Adverse Event|6
7680158|NCT01286753|26711743|P1|Overall Study|Adverse Event|7
7680159|NCT01286740|26711761|P1|Overall Study|Protocol Violation|1
7680160|NCT01286740|26711761|P1|Overall Study|Enrolled but not treated|1
7680161|NCT01286558|26711779|P2|Overall Study|Withdrawal by Subject|1
7680162|NCT01286558|26711780|P1|Overall Study|Withdrawal by Subject|0
7680163|NCT01286558|26711779|P2|Overall Study|Adverse Event|1
7680164|NCT01286558|26711780|P1|Overall Study|Adverse Event|1
7680165|NCT01286480|26711816|P2|Overall Study|Withdrawal by Subject|3
7680166|NCT01286480|26711817|P1|Overall Study|Withdrawal by Subject|5
7680167|NCT01286311|26711924|P2|Overall Study|Physician did not want outreach sent|0
7680168|NCT01286311|26711925|P1|Overall Study|Physician did not want outreach sent|14
7680171|NCT01286207|26711962|P3|Overall Study|Other|13
7680172|NCT01286207|26711963|P2|Overall Study|Other|47
7680173|NCT01286207|26711964|P1|Overall Study|Other|37
7680174|NCT01286207|26711962|P3|Overall Study|Lack of Response|8
7680175|NCT01286207|26711963|P2|Overall Study|Lack of Response|38
7680176|NCT01286207|26711964|P1|Overall Study|Lack of Response|92
7680177|NCT01286207|26711962|P3|Overall Study|Withdrawal by Subject|41
7680178|NCT01286207|26711963|P2|Overall Study|Withdrawal by Subject|79
7680179|NCT01286207|26711964|P1|Overall Study|Withdrawal by Subject|93
7680180|NCT01286207|26711962|P3|Overall Study|Lost to Follow-up|20
7680181|NCT01286207|26711963|P2|Overall Study|Lost to Follow-up|43
7680182|NCT01286207|26711964|P1|Overall Study|Lost to Follow-up|49
7680183|NCT01286207|26711962|P3|Overall Study|Adverse Event|8
7680184|NCT01286207|26711963|P2|Overall Study|Adverse Event|41
7680185|NCT01286207|26711964|P1|Overall Study|Adverse Event|27
7680186|NCT01286168|26711984|P1|Overall Study|Surgical Drains Fell Out at Home|2
7680187|NCT01286168|26711984|P1|Overall Study|Withdrawal by Subject|1
7680188|NCT01286129|26711998|P2|Overall Study|Could not comply with study requirements|4
7680516|NCT01283516|26713399|P3|Overall Study|Disease Progression|3
7680189|NCT01286129|26711999|P1|Overall Study|Could not comply with study requirements|4
7680190|NCT01286129|26711998|P2|Overall Study|Withdrawal by Subject|1
7680191|NCT01286129|26711999|P1|Overall Study|Withdrawal by Subject|4
7680192|NCT01286077|26712009|P2|Overall Study|refill medication not received in time|0
7680193|NCT01286077|26712010|P1|Overall Study|refill medication not received in time|1
7680194|NCT01286077|26712009|P2|Overall Study|Progression of disease|1
7680195|NCT01286077|26712010|P1|Overall Study|Progression of disease|0
7680196|NCT01286077|26712009|P2|Overall Study|Patient's decision to stop treatment|0
7680197|NCT01286077|26712010|P1|Overall Study|Patient's decision to stop treatment|3
7680198|NCT01286077|26712009|P2|Overall Study|The subject starts with alternative MMY|3
7680199|NCT01286077|26712010|P1|Overall Study|The subject starts with alternative MMY|0
7680200|NCT01286077|26712009|P2|Overall Study|Non-compliance|0
7680201|NCT01286077|26712010|P1|Overall Study|Non-compliance|1
7680202|NCT01286077|26712009|P2|Overall Study|Intercurrent illness|0
7680203|NCT01286077|26712010|P1|Overall Study|Intercurrent illness|1
7680204|NCT01286077|26712009|P2|Overall Study|Withdrawal by Subject|2
7680205|NCT01286077|26712010|P1|Overall Study|Withdrawal by Subject|0
7680206|NCT01286077|26712009|P2|Overall Study|Protocol Violation|1
7680207|NCT01286077|26712010|P1|Overall Study|Protocol Violation|1
7680208|NCT01286077|26712009|P2|Overall Study|Death|0
7680209|NCT01286077|26712010|P1|Overall Study|Death|1
7680210|NCT01286077|26712009|P2|Overall Study|Adverse Event|0
7680211|NCT01286077|26712010|P1|Overall Study|Adverse Event|2
7680212|NCT01286012|26712046|P2|Overall Study|peritoneal dialysis, randomized in error|3
7680213|NCT01286012|26712047|P1|Overall Study|peritoneal dialysis, randomized in error|1
7680214|NCT01286012|26712046|P2|Overall Study|Physician Decision|0
7680215|NCT01286012|26712047|P1|Overall Study|Physician Decision|2
7680216|NCT01286012|26712046|P2|Overall Study|Withdrawal by Subject|4
7680217|NCT01286012|26712047|P1|Overall Study|Withdrawal by Subject|4
7680218|NCT01286012|26712046|P2|Overall Study|Protocol Violation|1
7680219|NCT01286012|26712047|P1|Overall Study|Protocol Violation|1
7680220|NCT01286012|26712046|P2|Overall Study|Death|3
7680221|NCT01286012|26712047|P1|Overall Study|Death|2
7680222|NCT01286012|26712046|P2|Overall Study|Adverse Event|3
7680223|NCT01286012|26712047|P1|Overall Study|Adverse Event|3
7680224|NCT01285960|26712061|P1|Overall Study|2 subjects received less 10 sonications|2
7680225|NCT01285960|26712061|P1|Overall Study|Lost to Follow-up|2
7680226|NCT01285960|26712061|P1|Overall Study|Withdrawal by Subject|2
7680227|NCT01285908|26712074|P3|Baseline Measurement|unable to tolerate procedure|0
7680228|NCT01285908|26712075|P2|Baseline Measurement|unable to tolerate procedure|0
7680229|NCT01285908|26712076|P1|Baseline Measurement|unable to tolerate procedure|1
7680230|NCT01285908|26712074|P3|Baseline Measurement|History of stroke, exclusion criteria|0
7680231|NCT01285908|26712075|P2|Baseline Measurement|History of stroke, exclusion criteria|0
7680232|NCT01285908|26712076|P1|Baseline Measurement|History of stroke, exclusion criteria|1
7680233|NCT01285908|26712074|P3|Baseline Measurement|unable to insert catheter|0
7680234|NCT01285908|26712075|P2|Baseline Measurement|unable to insert catheter|0
7680235|NCT01285908|26712076|P1|Baseline Measurement|unable to insert catheter|1
7680236|NCT01285609|26712170|P2|Treated With Blinded Therapy|Worsening of general condition|1
7680237|NCT01285609|26712171|P1|Treated With Blinded Therapy|Worsening of general condition|0
7680238|NCT01285609|26712170|P2|Treated With Blinded Therapy|PI decision to discontinue|1
7680239|NCT01285609|26712171|P1|Treated With Blinded Therapy|PI decision to discontinue|0
7680240|NCT01285609|26712170|P2|Treated With Blinded Therapy|Investigator's assessment|0
7680241|NCT01285609|26712171|P1|Treated With Blinded Therapy|Investigator's assessment|1
7680242|NCT01285609|26712170|P2|Treated With Blinded Therapy|Participant hospitalized|0
7680243|NCT01285609|26712171|P1|Treated With Blinded Therapy|Participant hospitalized|1
7680244|NCT01285609|26712170|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
7680245|NCT01285609|26712171|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
7680246|NCT01285609|26712170|P2|Treated With Blinded Therapy|Participant refused participation|0
7680247|NCT01285609|26712171|P1|Treated With Blinded Therapy|Participant refused participation|1
7680248|NCT01285609|26712170|P2|Treated With Blinded Therapy|Physician and Patient decision|3
7680249|NCT01285609|26712171|P1|Treated With Blinded Therapy|Physician and Patient decision|1
7680250|NCT01285609|26712170|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
7680251|NCT01285609|26712171|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
7680252|NCT01285609|26712170|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
7680253|NCT01285609|26712171|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
7680254|NCT01285609|26712170|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
7680255|NCT01285609|26712171|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
7680256|NCT01285609|26712170|P2|Treated With Blinded Therapy|Not Reported|2
7680257|NCT01285609|26712171|P1|Treated With Blinded Therapy|Not Reported|0
7680258|NCT01285609|26712170|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
7680259|NCT01285609|26712171|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
7680260|NCT01285609|26712170|P2|Treated With Blinded Therapy|Death|3
7680261|NCT01285609|26712171|P1|Treated With Blinded Therapy|Death|11
7680262|NCT01285609|26712170|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
7680263|NCT01285609|26712171|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
7680264|NCT01285609|26712170|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
7680265|NCT01285609|26712171|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
7680266|NCT01285609|26712170|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
7680267|NCT01285609|26712171|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
7680268|NCT01285609|26712170|P2|Treated With Blinded Therapy|Progressive Disease|305
7680269|NCT01285609|26712171|P1|Treated With Blinded Therapy|Progressive Disease|223
7680270|NCT01285609|26712170|P2|Randomized|Randomized but not Treated|4
7680271|NCT01285609|26712171|P1|Randomized|Randomized but not Treated|4
7680272|NCT01285609|26712170|P2|Randomized|Undisclosed Reasons|0
7680273|NCT01285609|26712171|P1|Randomized|Undisclosed Reasons|1
7680274|NCT01285609|26712170|P2|Randomized|Subject No Longer Met Study Criteria|1
7680275|NCT01285609|26712171|P1|Randomized|Subject No Longer Met Study Criteria|1
7680276|NCT01285609|26712170|P2|Randomized|Withdrawal by Subject|11
7680277|NCT01285609|26712171|P1|Randomized|Withdrawal by Subject|8
7680278|NCT01285609|26712170|P2|Randomized|Death|7
7680279|NCT01285609|26712171|P1|Randomized|Death|5
7680280|NCT01285609|26712170|P2|Randomized|Study Drug Toxicity|14
7680281|NCT01285609|26712171|P1|Randomized|Study Drug Toxicity|13
7680282|NCT01285609|26712170|P2|Randomized|Adverse Event Unrelated to Study Drug|18
7680283|NCT01285609|26712171|P1|Randomized|Adverse Event Unrelated to Study Drug|18
7680284|NCT01285609|26712170|P2|Randomized|Progressive Disease|61
7680285|NCT01285609|26712171|P1|Randomized|Progressive Disease|41
7680286|NCT01285518|26712189|P8|Overall Study|Lost to Follow-up|0
7680287|NCT01285518|26712190|P7|Overall Study|Lost to Follow-up|0
7680288|NCT01285518|26712191|P6|Overall Study|Lost to Follow-up|1
7680289|NCT01285518|26712192|P5|Overall Study|Lost to Follow-up|0
7680290|NCT01285518|26712193|P4|Overall Study|Lost to Follow-up|0
7680291|NCT01285518|26712194|P3|Overall Study|Lost to Follow-up|0
7680292|NCT01285518|26712195|P2|Overall Study|Lost to Follow-up|0
7680293|NCT01285518|26712196|P1|Overall Study|Lost to Follow-up|0
7680294|NCT01285492|26712456|P2|Overall Study|Death|0
7680295|NCT01285492|26712457|P1|Overall Study|Death|1
7680296|NCT01285492|26712456|P2|Overall Study|Withdrawal by Subject|1
7680297|NCT01285492|26712457|P1|Overall Study|Withdrawal by Subject|2
7680298|NCT01285492|26712456|P2|Overall Study|Protocol Violation|0
7680299|NCT01285492|26712457|P1|Overall Study|Protocol Violation|3
7680300|NCT01285492|26712456|P2|Overall Study|Adverse Event|0
7680301|NCT01285492|26712457|P1|Overall Study|Adverse Event|11
7680302|NCT01285401|26712489|P2|Overall Study|Prematurely withdrawn from the study|29
7680303|NCT01285401|26712490|P1|Overall Study|Prematurely withdrawn from the study|17
7680304|NCT01285349|26712531|P3|Overall Study|Lost to Follow-up|27
7680305|NCT01285349|26712532|P2|Overall Study|Lost to Follow-up|20
7680306|NCT01285349|26712533|P1|Overall Study|Lost to Follow-up|27
7680307|NCT01285323|26712546|P2|Overall Study|Other|3
7680308|NCT01285323|26712547|P1|Overall Study|Other|1
7680309|NCT01285323|26712546|P2|Overall Study|Lost to Follow-up|1
7680310|NCT01285323|26712547|P1|Overall Study|Lost to Follow-up|1
7680311|NCT01285323|26712546|P2|Overall Study|Non-compliance with study procedures|3
7680312|NCT01285323|26712547|P1|Overall Study|Non-compliance with study procedures|2
7680313|NCT01285323|26712546|P2|Overall Study|Protocol Violation|2
7680314|NCT01285323|26712547|P1|Overall Study|Protocol Violation|1
7680315|NCT01285323|26712546|P2|Overall Study|Withdrawal by Subject|11
7680316|NCT01285323|26712547|P1|Overall Study|Withdrawal by Subject|15
7680317|NCT01285323|26712546|P2|Overall Study|Lack of Efficacy|2
7680318|NCT01285323|26712547|P1|Overall Study|Lack of Efficacy|4
7680319|NCT01285323|26712546|P2|Overall Study|Adverse Event|8
7680320|NCT01285323|26712547|P1|Overall Study|Adverse Event|9
7680321|NCT01285310|26712582|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
7680322|NCT01285310|26712583|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7680323|NCT01285310|26712584|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7680324|NCT01285310|26712585|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7680325|NCT01285310|26712586|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
7680326|NCT01285310|26712582|P5|Active Treatment Phase: Weeks 25-52|Other|0
7680327|NCT01285310|26712583|P4|Active Treatment Phase: Weeks 25-52|Other|0
7680328|NCT01285310|26712584|P3|Active Treatment Phase: Weeks 25-52|Other|0
7680329|NCT01285310|26712585|P2|Active Treatment Phase: Weeks 25-52|Other|1
7680330|NCT01285310|26712586|P1|Active Treatment Phase: Weeks 25-52|Other|0
7680331|NCT01285310|26712582|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
7680332|NCT01285310|26712583|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
7680333|NCT01285310|26712584|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
7680334|NCT01285310|26712585|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
7680335|NCT01285310|26712586|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
7680336|NCT01285310|26712582|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
7680337|NCT01285310|26712583|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
7680338|NCT01285310|26712584|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
7680339|NCT01285310|26712585|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
7680340|NCT01285310|26712586|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
7680341|NCT01285310|26712582|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
7680342|NCT01285310|26712583|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
7680343|NCT01285310|26712584|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
7680344|NCT01285310|26712585|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
7680345|NCT01285310|26712586|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
7680346|NCT01285310|26712582|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
7680347|NCT01285310|26712583|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
7680348|NCT01285310|26712584|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
7680349|NCT01285310|26712585|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
7680350|NCT01285310|26712586|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
7680351|NCT01285310|26712582|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
7680352|NCT01285310|26712583|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
7680353|NCT01285310|26712584|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
7680354|NCT01285310|26712585|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
7680355|NCT01285310|26712586|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
7680356|NCT01285310|26712582|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7680357|NCT01285310|26712583|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7680358|NCT01285310|26712584|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
7680359|NCT01285310|26712585|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
7680360|NCT01285310|26712586|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7680361|NCT01285310|26712582|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
7680362|NCT01285310|26712583|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
7680363|NCT01285310|26712584|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
7680364|NCT01285310|26712585|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
7680365|NCT01285310|26712586|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
7680366|NCT01285310|26712582|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7680367|NCT01285310|26712583|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7680368|NCT01285310|26712584|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
7680369|NCT01285310|26712585|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7680370|NCT01285310|26712586|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
7680371|NCT01285310|26712582|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
7680372|NCT01285310|26712583|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
7680373|NCT01285310|26712584|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
7680374|NCT01285310|26712585|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
7680375|NCT01285310|26712586|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
7680376|NCT01285310|26712582|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
7680377|NCT01285310|26712583|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
7680378|NCT01285310|26712584|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
7680379|NCT01285310|26712585|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
7680380|NCT01285310|26712586|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
7680381|NCT01284959|26712851|P3|Overall Study|Adverse Event|1
7680382|NCT01284959|26712852|P2|Overall Study|Adverse Event|0
7680383|NCT01284959|26712853|P1|Overall Study|Adverse Event|0
7680384|NCT01284959|26712851|P3|Overall Study|Withdrawal by Subject|0
7680385|NCT01284959|26712852|P2|Overall Study|Withdrawal by Subject|0
7680386|NCT01284959|26712853|P1|Overall Study|Withdrawal by Subject|1
7680387|NCT01284634|26712883|P4|Overall Study|Adverse Event|1
7680388|NCT01284634|26712884|P3|Overall Study|Adverse Event|2
7680389|NCT01284634|26712885|P2|Overall Study|Adverse Event|0
7680390|NCT01284634|26712886|P1|Overall Study|Adverse Event|1
7680391|NCT01284621|26712916|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7680392|NCT01284621|26712917|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
7680393|NCT01284621|26712918|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7680394|NCT01284621|26712919|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7680395|NCT01284621|26712920|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7680396|NCT01284621|26712921|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7680397|NCT01284491|26712989|P1|Overall Study|Study termination|13
7680398|NCT01284361|26712999|P1|Overall Study|Lost to Follow-up|2
7680399|NCT01284361|26712999|P1|Overall Study|Adverse Event|1
7680400|NCT01284361|26712999|P1|Overall Study|Protocol Violation|5
7680401|NCT01284361|26712999|P1|Overall Study|Withdrawal by Subject|1
7680402|NCT01284140|26713095|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
7680403|NCT01284140|26713096|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
7680404|NCT01284140|26713095|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
7680405|NCT01284140|26713096|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
7680406|NCT01284127|26713110|P1|Overall Study|Physician Decision|1
7680407|NCT01284127|26713110|P1|Overall Study|Withdrawal by Subject|4
7680408|NCT01284127|26713110|P1|Overall Study|Adverse Event|2
7680409|NCT01284114|26713119|P1|Overall Study|dizziness|1
7680410|NCT01284114|26713119|P1|Overall Study|Symptomatic hypotension|1
7680411|NCT01284114|26713119|P1|Overall Study|From the results of ALLTITUDE study|1
7680412|NCT01284114|26713119|P1|Overall Study|viral infection|1
7680413|NCT01284062|26713131|P4|Overall Study|Site Closed|0
7680414|NCT01284062|26713132|P3|Overall Study|Site Closed|1
7680415|NCT01284062|26713133|P2|Overall Study|Site Closed|0
7680416|NCT01284062|26713134|P1|Overall Study|Site Closed|0
7680417|NCT01284062|26713131|P4|Overall Study|Other|1
7680418|NCT01284062|26713132|P3|Overall Study|Other|0
7680419|NCT01284062|26713133|P2|Overall Study|Other|0
7680420|NCT01284062|26713134|P1|Overall Study|Other|0
7680421|NCT01284062|26713131|P4|Overall Study|Withdrawal by Subject|5
7680422|NCT01284062|26713132|P3|Overall Study|Withdrawal by Subject|2
7680423|NCT01284062|26713133|P2|Overall Study|Withdrawal by Subject|1
7680424|NCT01284062|26713134|P1|Overall Study|Withdrawal by Subject|3
7680425|NCT01284062|26713131|P4|Overall Study|Protocol Violation|2
7680426|NCT01284062|26713132|P3|Overall Study|Protocol Violation|0
7680427|NCT01284062|26713133|P2|Overall Study|Protocol Violation|0
7680428|NCT01284062|26713134|P1|Overall Study|Protocol Violation|1
7680429|NCT01284062|26713131|P4|Overall Study|Medication error without adverse event|0
7680430|NCT01284062|26713132|P3|Overall Study|Medication error without adverse event|1
7680431|NCT01284062|26713133|P2|Overall Study|Medication error without adverse event|0
7680432|NCT01284062|26713134|P1|Overall Study|Medication error without adverse event|0
7680433|NCT01284062|26713131|P4|Overall Study|Lack of Efficacy|1
7680434|NCT01284062|26713132|P3|Overall Study|Lack of Efficacy|2
7680435|NCT01284062|26713133|P2|Overall Study|Lack of Efficacy|2
7680436|NCT01284062|26713134|P1|Overall Study|Lack of Efficacy|3
7680437|NCT01284062|26713131|P4|Overall Study|Adverse Event|5
7680438|NCT01284062|26713132|P3|Overall Study|Adverse Event|0
7680439|NCT01284062|26713133|P2|Overall Study|Adverse Event|5
7680440|NCT01284062|26713134|P1|Overall Study|Adverse Event|4
7680441|NCT01283971|26713208|P2|Overall Study|Administrative reasons|1
7680442|NCT01283971|26713209|P1|Overall Study|Administrative reasons|1
7680443|NCT01283971|26713208|P2|Overall Study|Failure to return|1
7680444|NCT01283971|26713209|P1|Overall Study|Failure to return|0
7680445|NCT01283971|26713208|P2|Overall Study|Refused treatment|1
7680446|NCT01283971|26713209|P1|Overall Study|Refused treatment|3
7680447|NCT01283971|26713208|P2|Overall Study|Protocol Violation|1
7680448|NCT01283971|26713209|P1|Overall Study|Protocol Violation|5
7680449|NCT01283971|26713208|P2|Overall Study|Insufficient therapeutic responses|3
7680450|NCT01283971|26713209|P1|Overall Study|Insufficient therapeutic responses|3
7680451|NCT01283971|26713208|P2|Overall Study|Adverse Event|5
7680452|NCT01283971|26713209|P1|Overall Study|Adverse Event|3
7680453|NCT01283581|26713256|P3|Overall Study|"Early termination"|1
7680454|NCT01283581|26713257|P2|Overall Study|"Early termination"|0
7680455|NCT01283581|26713258|P1|Overall Study|"Early termination"|0
7680456|NCT01283581|26713256|P3|Overall Study|Investigator unblinded|1
7680457|NCT01283581|26713257|P2|Overall Study|Investigator unblinded|0
7680458|NCT01283581|26713258|P1|Overall Study|Investigator unblinded|0
7680459|NCT01283581|26713256|P3|Overall Study|Noncompliance|0
7680460|NCT01283581|26713257|P2|Overall Study|Noncompliance|0
7680461|NCT01283581|26713258|P1|Overall Study|Noncompliance|1
7680462|NCT01283581|26713256|P3|Overall Study|Protocol Violation|2
7680463|NCT01283581|26713257|P2|Overall Study|Protocol Violation|1
7680464|NCT01283581|26713258|P1|Overall Study|Protocol Violation|0
7680465|NCT01283581|26713256|P3|Overall Study|Physician Decision|2
7680466|NCT01283581|26713257|P2|Overall Study|Physician Decision|1
7680467|NCT01283581|26713258|P1|Overall Study|Physician Decision|0
7680468|NCT01283581|26713256|P3|Overall Study|Adverse Event|4
7680469|NCT01283581|26713257|P2|Overall Study|Adverse Event|1
7680470|NCT01283581|26713258|P1|Overall Study|Adverse Event|1
7680471|NCT01283581|26713256|P3|Overall Study|Withdrawal by Subject|2
7680472|NCT01283581|26713257|P2|Overall Study|Withdrawal by Subject|5
7680473|NCT01283581|26713258|P1|Overall Study|Withdrawal by Subject|2
7680474|NCT01283581|26713256|P3|Overall Study|Lost to Follow-up|8
7680475|NCT01283581|26713257|P2|Overall Study|Lost to Follow-up|6
7680476|NCT01283581|26713258|P1|Overall Study|Lost to Follow-up|8
7680477|NCT01283542|26713328|P1|Extension Phase|Administrative problems|1
7680478|NCT01283542|26713328|P1|Extension Phase|Adverse Event|1
7680479|NCT01283542|26713328|P1|Extension Phase|Physician Decision|1
7680480|NCT01283542|26713328|P1|Main Phase|abnormal laboratory values|5
7680481|NCT01283542|26713328|P1|Main Phase|Uncontrolled diabetes mellitus|1
7680482|NCT01283542|26713328|P1|Main Phase|Acute or progressive vision loss|1
7680483|NCT01283516|26713393|P9|Overall Study|Lost to Follow-up|1
7680484|NCT01283516|26713394|P8|Overall Study|Lost to Follow-up|0
7680485|NCT01283516|26713395|P7|Overall Study|Lost to Follow-up|0
7680486|NCT01283516|26713396|P6|Overall Study|Lost to Follow-up|0
7680487|NCT01283516|26713397|P5|Overall Study|Lost to Follow-up|0
7680488|NCT01283516|26713398|P4|Overall Study|Lost to Follow-up|0
7680489|NCT01283516|26713399|P3|Overall Study|Lost to Follow-up|0
7680490|NCT01283516|26713400|P2|Overall Study|Lost to Follow-up|0
7680491|NCT01283516|26713401|P1|Overall Study|Lost to Follow-up|0
7680492|NCT01283516|26713393|P9|Overall Study|Administrative problems|39
7680493|NCT01283516|26713394|P8|Overall Study|Administrative problems|1
7680494|NCT01283516|26713395|P7|Overall Study|Administrative problems|1
7680495|NCT01283516|26713396|P6|Overall Study|Administrative problems|1
7680496|NCT01283516|26713397|P5|Overall Study|Administrative problems|0
7680497|NCT01283516|26713398|P4|Overall Study|Administrative problems|0
7680498|NCT01283516|26713399|P3|Overall Study|Administrative problems|0
7680499|NCT01283516|26713400|P2|Overall Study|Administrative problems|0
7680500|NCT01283516|26713401|P1|Overall Study|Administrative problems|0
7680501|NCT01283516|26713393|P9|Overall Study|Withdrawal by Subject|36
7680502|NCT01283516|26713394|P8|Overall Study|Withdrawal by Subject|0
7680503|NCT01283516|26713395|P7|Overall Study|Withdrawal by Subject|1
7680504|NCT01283516|26713396|P6|Overall Study|Withdrawal by Subject|0
7680505|NCT01283516|26713397|P5|Overall Study|Withdrawal by Subject|1
7680506|NCT01283516|26713398|P4|Overall Study|Withdrawal by Subject|0
7680507|NCT01283516|26713399|P3|Overall Study|Withdrawal by Subject|0
7680508|NCT01283516|26713400|P2|Overall Study|Withdrawal by Subject|0
7680509|NCT01283516|26713401|P1|Overall Study|Withdrawal by Subject|0
7680510|NCT01283516|26713393|P9|Overall Study|Disease Progression|139
7680511|NCT01283516|26713394|P8|Overall Study|Disease Progression|3
7680512|NCT01283516|26713395|P7|Overall Study|Disease Progression|6
7680513|NCT01283516|26713396|P6|Overall Study|Disease Progression|8
7680514|NCT01283516|26713397|P5|Overall Study|Disease Progression|13
7680515|NCT01283516|26713398|P4|Overall Study|Disease Progression|3
7680517|NCT01283516|26713400|P2|Overall Study|Disease Progression|2
7680518|NCT01283516|26713401|P1|Overall Study|Disease Progression|2
7680519|NCT01283516|26713393|P9|Overall Study|Death|12
7680520|NCT01283516|26713394|P8|Overall Study|Death|1
7680521|NCT01283516|26713395|P7|Overall Study|Death|0
7680522|NCT01283516|26713396|P6|Overall Study|Death|1
7680523|NCT01283516|26713397|P5|Overall Study|Death|0
7680524|NCT01283516|26713398|P4|Overall Study|Death|0
7680525|NCT01283516|26713399|P3|Overall Study|Death|0
7680526|NCT01283516|26713400|P2|Overall Study|Death|0
7680527|NCT01283516|26713401|P1|Overall Study|Death|0
7680528|NCT01283516|26713393|P9|Overall Study|Adverse Event|28
7680529|NCT01283516|26713394|P8|Overall Study|Adverse Event|0
7680530|NCT01283516|26713395|P7|Overall Study|Adverse Event|2
7680531|NCT01283516|26713396|P6|Overall Study|Adverse Event|0
7680532|NCT01283516|26713397|P5|Overall Study|Adverse Event|0
7680533|NCT01283516|26713398|P4|Overall Study|Adverse Event|0
7680534|NCT01283516|26713399|P3|Overall Study|Adverse Event|0
7680535|NCT01283516|26713400|P2|Overall Study|Adverse Event|0
7680536|NCT01283516|26713401|P1|Overall Study|Adverse Event|0
7680537|NCT01283464|26713523|P2|Overall Study|Physician Decision|0
7680538|NCT01283464|26713524|P1|Overall Study|Physician Decision|1
7680539|NCT01283464|26713523|P2|Overall Study|Withdrawal by Subject|0
7680540|NCT01283464|26713524|P1|Overall Study|Withdrawal by Subject|1
7680541|NCT01283464|26713523|P2|Overall Study|Lost to Follow-up|1
7680542|NCT01283464|26713524|P1|Overall Study|Lost to Follow-up|0
7680543|NCT01283386|26713532|P2|Overall Study|Protocol Violation|1
7680544|NCT01283386|26713533|P1|Overall Study|Protocol Violation|0
7680545|NCT01283386|26713532|P2|Overall Study|Reason not specified|0
7680546|NCT01283386|26713533|P1|Overall Study|Reason not specified|1
7680547|NCT01283386|26713532|P2|Overall Study|Progression of underlying disease|7
7680548|NCT01283386|26713533|P1|Overall Study|Progression of underlying disease|2
7680549|NCT01283386|26713532|P2|Overall Study|Relapse of underlying disease|3
7680550|NCT01283386|26713533|P1|Overall Study|Relapse of underlying disease|1
7680551|NCT01283386|26713532|P2|Overall Study|Withdrawal by Subject|1
7680552|NCT01283386|26713533|P1|Overall Study|Withdrawal by Subject|2
7680553|NCT01283386|26713532|P2|Overall Study|Death|0
7680554|NCT01283386|26713533|P1|Overall Study|Death|2
7680555|NCT01283334|26713557|P1|Overall Study|Physician Decision|1
7680556|NCT01283334|26713557|P1|Overall Study|Adverse Event|4
7680557|NCT01283334|26713557|P1|Overall Study|Inability to Swallow Everolimus Pills|1
7680558|NCT01283334|26713557|P1|Overall Study|Withdrawal by Subject|1
7680559|NCT01283282|26713580|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
7680560|NCT01283282|26713581|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
7680561|NCT01283282|26713580|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
7680562|NCT01283282|26713581|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
7680563|NCT01283282|26713580|P2|First Intervention (6 Weeks)|Physician Decision|1
7680564|NCT01283282|26713581|P1|First Intervention (6 Weeks)|Physician Decision|0
7680565|NCT01283152|26713601|P2|Overall Study|Refused HESA|0
7680566|NCT01283152|26713602|P1|Overall Study|Refused HESA|1
7680567|NCT01283152|26713601|P2|Overall Study|Discharged prior to 24 hr assessment|0
7680568|NCT01283152|26713602|P1|Overall Study|Discharged prior to 24 hr assessment|1
7680569|NCT01283139|26713616|P4|Overall Study|Participant randomized in error|0
7680570|NCT01283139|26713617|P3|Overall Study|Participant randomized in error|1
7680571|NCT01283139|26713618|P2|Overall Study|Participant randomized in error|0
7680572|NCT01283139|26713619|P1|Overall Study|Participant randomized in error|0
7680573|NCT01283139|26713616|P4|Overall Study|Missed follow-up visit|2
7680574|NCT01283139|26713617|P3|Overall Study|Missed follow-up visit|2
7680575|NCT01283139|26713618|P2|Overall Study|Missed follow-up visit|1
7680576|NCT01283139|26713619|P1|Overall Study|Missed follow-up visit|0
7680577|NCT01283139|26713616|P4|Overall Study|Pregnancy|0
7680578|NCT01283139|26713617|P3|Overall Study|Pregnancy|1
7680579|NCT01283139|26713618|P2|Overall Study|Pregnancy|1
7680580|NCT01283139|26713619|P1|Overall Study|Pregnancy|0
7680581|NCT01283139|26713616|P4|Overall Study|Participant's refusal to continue|1
7680582|NCT01283139|26713617|P3|Overall Study|Participant's refusal to continue|1
7680583|NCT01283139|26713618|P2|Overall Study|Participant's refusal to continue|3
7680584|NCT01283139|26713619|P1|Overall Study|Participant's refusal to continue|0
7680585|NCT01283139|26713616|P4|Overall Study|Early termination due to AE/SAE|0
7680586|NCT01283139|26713617|P3|Overall Study|Early termination due to AE/SAE|0
7680587|NCT01283139|26713618|P2|Overall Study|Early termination due to AE/SAE|1
7680588|NCT01283139|26713619|P1|Overall Study|Early termination due to AE/SAE|1
7680589|NCT01283139|26713616|P4|Overall Study|Lack of Efficacy|1
7680590|NCT01283139|26713617|P3|Overall Study|Lack of Efficacy|2
7680591|NCT01283139|26713618|P2|Overall Study|Lack of Efficacy|2
7680592|NCT01283139|26713619|P1|Overall Study|Lack of Efficacy|1
7680593|NCT01283139|26713616|P4|Overall Study|Death|2
7680594|NCT01283139|26713617|P3|Overall Study|Death|2
7680595|NCT01283139|26713618|P2|Overall Study|Death|0
7680596|NCT01283139|26713619|P1|Overall Study|Death|2
7680597|NCT01283139|26713616|P4|Overall Study|Withdrawal by Subject|8
7680598|NCT01283139|26713617|P3|Overall Study|Withdrawal by Subject|6
7680599|NCT01283139|26713618|P2|Overall Study|Withdrawal by Subject|8
7680600|NCT01283139|26713619|P1|Overall Study|Withdrawal by Subject|8
7680601|NCT01283139|26713616|P4|Overall Study|Lost to Follow-up|1
7680602|NCT01283139|26713617|P3|Overall Study|Lost to Follow-up|3
7680603|NCT01283139|26713618|P2|Overall Study|Lost to Follow-up|2
7680604|NCT01283139|26713619|P1|Overall Study|Lost to Follow-up|5
7680605|NCT01283035|26713661|P1|Overall Study|Subject later found ineligible|1
7680606|NCT01283009|26713678|P2|Overall Study|Patient Withdrawn by LAR/DPOA|4
7680607|NCT01283009|26713679|P1|Overall Study|Patient Withdrawn by LAR/DPOA|0
7680608|NCT01283009|26713678|P2|Overall Study|Lost to Follow-up|0
7680609|NCT01283009|26713679|P1|Overall Study|Lost to Follow-up|1
7680610|NCT01283009|26713678|P2|Overall Study|Physician Decision|1
7680611|NCT01283009|26713679|P1|Overall Study|Physician Decision|1
7680612|NCT01283009|26713678|P2|Overall Study|Withdrawal by Subject|8
7680613|NCT01283009|26713679|P1|Overall Study|Withdrawal by Subject|10
7680614|NCT01283009|26713678|P2|Overall Study|Study ended early|26
7680615|NCT01283009|26713679|P1|Overall Study|Study ended early|23
7680616|NCT01283009|26713678|P2|Overall Study|Death|78
7680617|NCT01283009|26713679|P1|Overall Study|Death|83
7680618|NCT01282866|26713685|P1|Overall Study|Adverse Event|1
7680619|NCT01282814|26713693|P2|Washout of 7 Days|Withdrawal by Subject|0
7680620|NCT01282814|26713694|P1|Washout of 7 Days|Withdrawal by Subject|2
7680621|NCT01282814|26713693|P2|First Intervention|Emesis During Dosing Interval|3
7680622|NCT01282814|26713694|P1|First Intervention|Emesis During Dosing Interval|0
7680623|NCT01282801|26713706|P2|Second Intervention|Emesis During Critical Breakfast|1
7680624|NCT01282801|26713707|P1|Second Intervention|Emesis During Critical Breakfast|0
7680625|NCT01282476|26713731|P1|Overall Study|Death|11
7680626|NCT01282463|26713740|P3|Overall Study|Physician Decision|0
7680627|NCT01282463|26713741|P2|Overall Study|Physician Decision|0
7680628|NCT01282463|26713742|P1|Overall Study|Physician Decision|1
7680629|NCT01282463|26713740|P3|Overall Study|Protocol Violation|1
7680630|NCT01282463|26713741|P2|Overall Study|Protocol Violation|0
7680631|NCT01282463|26713742|P1|Overall Study|Protocol Violation|0
7680632|NCT01282463|26713740|P3|Overall Study|"Never Treated PD"|0
7680633|NCT01282463|26713741|P2|Overall Study|"Never Treated PD"|1
7680634|NCT01282463|26713742|P1|Overall Study|"Never Treated PD"|0
7680635|NCT01282463|26713740|P3|Overall Study|"Never Treated Death"|0
7680636|NCT01282463|26713741|P2|Overall Study|"Never Treated Death"|1
7680637|NCT01282463|26713742|P1|Overall Study|"Never Treated Death"|0
7680638|NCT01282463|26713740|P3|Overall Study|Withdrawal by Subject|3
7680639|NCT01282463|26713741|P2|Overall Study|Withdrawal by Subject|2
7680640|NCT01282463|26713742|P1|Overall Study|Withdrawal by Subject|6
7680641|NCT01282463|26713740|P3|Overall Study|Lost to Follow-up|0
7680642|NCT01282463|26713741|P2|Overall Study|Lost to Follow-up|0
7680643|NCT01282463|26713742|P1|Overall Study|Lost to Follow-up|1
7680644|NCT01282424|26713780|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
7680645|NCT01282424|26713780|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
7680646|NCT01282424|26713780|P1|Long-term Follow-up Period (5 Years)|Death|40
7680647|NCT01282424|26713780|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
7680648|NCT01282424|26713780|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
7680649|NCT01282424|26713780|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
7680650|NCT01282424|26713780|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
7680651|NCT01282424|26713780|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
7680652|NCT01282372|26713797|P1|Overall Study|Adverse Event|12
7680653|NCT01282372|26713797|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
7680654|NCT01282372|26713797|P1|Overall Study|Presence of AE, Regression of Symptoms|1
7680655|NCT01282372|26713797|P1|Overall Study|Presence of AE, Lack of Efficacy|1
7680656|NCT01282372|26713797|P1|Overall Study|Death|1
7680657|NCT01282372|26713797|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
7680658|NCT01282372|26713797|P1|Overall Study|Withdrawal by Subject|11
7680659|NCT01282372|26713797|P1|Overall Study|Lost to Follow-up|23
7680660|NCT01282372|26713797|P1|Overall Study|Lack of Efficacy / Exacerbation|25
7680661|NCT01282294|26713825|P1|Overall Study|Physician Decision|1
7680662|NCT01282294|26713825|P1|Overall Study|Patient non-compliance|2
7680663|NCT01282294|26713825|P1|Overall Study|Adverse Event|1
7680664|NCT01282294|26713825|P1|Overall Study|Screening failure|1
7680665|NCT01282294|26713825|P1|Overall Study|Lost to Follow-up|14
7680666|NCT01282229|26713854|P1|Overall Study|Protocol Violation|2
7680667|NCT01282216|26713886|P4|Overall Study|Death|0
7680668|NCT01282216|26713887|P3|Overall Study|Death|2
7680669|NCT01282216|26713888|P2|Overall Study|Death|0
7680670|NCT01282216|26713889|P1|Overall Study|Death|0
7680671|NCT01282216|26713886|P4|Overall Study|Relapse|6
7680672|NCT01282216|26713887|P3|Overall Study|Relapse|17
7680673|NCT01282216|26713888|P2|Overall Study|Relapse|0
7680674|NCT01282216|26713889|P1|Overall Study|Relapse|0
7680675|NCT01282216|26713886|P4|Overall Study|Physician Decision|0
7680676|NCT01282216|26713887|P3|Overall Study|Physician Decision|11
7680677|NCT01282216|26713888|P2|Overall Study|Physician Decision|0
7680678|NCT01282216|26713889|P1|Overall Study|Physician Decision|0
7680679|NCT01282216|26713886|P4|Overall Study|Graft failure|2
7680680|NCT01282216|26713887|P3|Overall Study|Graft failure|3
7680681|NCT01282216|26713888|P2|Overall Study|Graft failure|0
7680682|NCT01282216|26713889|P1|Overall Study|Graft failure|0
7680683|NCT01282203|26713899|P1|Overall Study|Adverse Event|1
7680684|NCT01282164|26713921|P2|Overall Study|Lack of hypoglycemia during ITT|0
7680685|NCT01282164|26713922|P1|Overall Study|Lack of hypoglycemia during ITT|1
7680686|NCT01281969|26713975|P3|Overall Study|not randomized, child consent not given|2
7680687|NCT01281969|26713976|P2|Overall Study|not randomized, child consent not given|0
7680688|NCT01281969|26713977|P1|Overall Study|not randomized, child consent not given|0
7680689|NCT01281969|26713975|P3|Overall Study|AE during LP prior to IVIG admin|3
7680690|NCT01281969|26713976|P2|Overall Study|AE during LP prior to IVIG admin|0
7680691|NCT01281969|26713977|P1|Overall Study|AE during LP prior to IVIG admin|1
7680692|NCT01281969|26713975|P3|Overall Study|not randomized didn't meet criteria|7
7680693|NCT01281969|26713976|P2|Overall Study|not randomized didn't meet criteria|0
7680694|NCT01281969|26713977|P1|Overall Study|not randomized didn't meet criteria|0
7680695|NCT01281956|26713989|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
7680696|NCT01281956|26713990|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
7680697|NCT01281917|26714021|P1|Overall Study|Withdrawal by Subject|1
7680698|NCT01281865|26714033|P2|Overall Study|Lack of Efficacy|0
7680699|NCT01281865|26714034|P1|Overall Study|Lack of Efficacy|1
7680700|NCT01281865|26714033|P2|Overall Study|Withdrawal by Subject|0
7680701|NCT01281865|26714034|P1|Overall Study|Withdrawal by Subject|1
7680702|NCT01281865|26714033|P2|Overall Study|Adverse Event|1
7680703|NCT01281865|26714034|P1|Overall Study|Adverse Event|1
7680704|NCT01281839|26714042|P2|Overall Study|Reason not specified|1
7680705|NCT01281839|26714043|P1|Overall Study|Reason not specified|0
7680706|NCT01281839|26714042|P2|Overall Study|Withdrawal by Subject|10
7680707|NCT01281839|26714043|P1|Overall Study|Withdrawal by Subject|4
7680708|NCT01281839|26714042|P2|Overall Study|Lost to Follow-up|3
7680709|NCT01281839|26714043|P1|Overall Study|Lost to Follow-up|6
7680710|NCT01281644|26714104|P1|Overall Study|Withdrawal by Subject|2
7680711|NCT01281644|26714104|P1|Overall Study|Lost to Follow-up|3
7680712|NCT01281306|26714145|P7|Overall Study|Randomized in error|0
7680713|NCT01281306|26714146|P6|Overall Study|Randomized in error|0
7680714|NCT01281306|26714147|P5|Overall Study|Randomized in error|0
7680715|NCT01281306|26714148|P4|Overall Study|Randomized in error|1
7680716|NCT01281306|26714149|P3|Overall Study|Randomized in error|0
7680717|NCT01281306|26714150|P2|Overall Study|Randomized in error|0
7680718|NCT01281306|26714151|P1|Overall Study|Randomized in error|1
7680719|NCT01281306|26714145|P7|Overall Study|Adverse Event|3
7680720|NCT01281306|26714146|P6|Overall Study|Adverse Event|3
7680721|NCT01281306|26714147|P5|Overall Study|Adverse Event|5
7680722|NCT01281306|26714148|P4|Overall Study|Adverse Event|3
7680723|NCT01281306|26714149|P3|Overall Study|Adverse Event|2
7680724|NCT01281306|26714150|P2|Overall Study|Adverse Event|2
7680725|NCT01281306|26714151|P1|Overall Study|Adverse Event|3
7680726|NCT01281306|26714145|P7|Overall Study|Death|0
7680727|NCT01281306|26714146|P6|Overall Study|Death|0
7680728|NCT01281306|26714147|P5|Overall Study|Death|0
7680729|NCT01281306|26714148|P4|Overall Study|Death|0
7680730|NCT01281306|26714149|P3|Overall Study|Death|0
7680731|NCT01281306|26714150|P2|Overall Study|Death|0
7680732|NCT01281306|26714151|P1|Overall Study|Death|1
7680733|NCT01281306|26714145|P7|Overall Study|Lost to Follow-up|1
7680734|NCT01281306|26714146|P6|Overall Study|Lost to Follow-up|0
7680735|NCT01281306|26714147|P5|Overall Study|Lost to Follow-up|0
7680736|NCT01281306|26714148|P4|Overall Study|Lost to Follow-up|2
7680737|NCT01281306|26714149|P3|Overall Study|Lost to Follow-up|0
7680738|NCT01281306|26714150|P2|Overall Study|Lost to Follow-up|0
7680739|NCT01281306|26714151|P1|Overall Study|Lost to Follow-up|1
7680740|NCT01281306|26714145|P7|Overall Study|Condition no longer requires study drug|1
7680741|NCT01281306|26714146|P6|Overall Study|Condition no longer requires study drug|1
7680742|NCT01281306|26714147|P5|Overall Study|Condition no longer requires study drug|0
7680743|NCT01281306|26714148|P4|Overall Study|Condition no longer requires study drug|0
7680744|NCT01281306|26714149|P3|Overall Study|Condition no longer requires study drug|0
7680745|NCT01281306|26714150|P2|Overall Study|Condition no longer requires study drug|0
7680746|NCT01281306|26714151|P1|Overall Study|Condition no longer requires study drug|1
7680747|NCT01281306|26714145|P7|Overall Study|Protocol deviation|0
7680748|NCT01281306|26714146|P6|Overall Study|Protocol deviation|0
7680749|NCT01281306|26714147|P5|Overall Study|Protocol deviation|1
7680750|NCT01281306|26714148|P4|Overall Study|Protocol deviation|1
7680751|NCT01281306|26714149|P3|Overall Study|Protocol deviation|1
7680752|NCT01281306|26714150|P2|Overall Study|Protocol deviation|1
7680753|NCT01281306|26714151|P1|Overall Study|Protocol deviation|0
7680754|NCT01281306|26714145|P7|Overall Study|Withdrawal by Subject|1
7680755|NCT01281306|26714146|P6|Overall Study|Withdrawal by Subject|3
7680756|NCT01281306|26714147|P5|Overall Study|Withdrawal by Subject|1
7680757|NCT01281306|26714148|P4|Overall Study|Withdrawal by Subject|4
7680758|NCT01281306|26714149|P3|Overall Study|Withdrawal by Subject|2
7680759|NCT01281306|26714150|P2|Overall Study|Withdrawal by Subject|0
7680760|NCT01281306|26714151|P1|Overall Study|Withdrawal by Subject|1
7680761|NCT01281306|26714145|P7|Overall Study|Lack of Efficacy|1
7680762|NCT01281306|26714146|P6|Overall Study|Lack of Efficacy|0
7680763|NCT01281306|26714147|P5|Overall Study|Lack of Efficacy|2
7680764|NCT01281306|26714148|P4|Overall Study|Lack of Efficacy|0
7680765|NCT01281306|26714149|P3|Overall Study|Lack of Efficacy|3
7680766|NCT01281306|26714150|P2|Overall Study|Lack of Efficacy|1
7680767|NCT01281306|26714151|P1|Overall Study|Lack of Efficacy|0
7680768|NCT01281202|26714267|P2|Overall Study|Incarceration|3
7680769|NCT01281202|26714268|P1|Overall Study|Incarceration|0
7680770|NCT01281202|26714267|P2|Overall Study|Lost to Follow-up|13
7680771|NCT01281202|26714268|P1|Overall Study|Lost to Follow-up|11
7680772|NCT01281202|26714267|P2|Overall Study|Administrative|8
7680773|NCT01281202|26714268|P1|Overall Study|Administrative|2
7680774|NCT01281202|26714267|P2|Overall Study|Protocol Violation|10
7680775|NCT01281202|26714268|P1|Overall Study|Protocol Violation|11
7680776|NCT01281202|26714267|P2|Overall Study|Withdrawal by Subject|2
7680777|NCT01281202|26714268|P1|Overall Study|Withdrawal by Subject|2
7680778|NCT01281202|26714267|P2|Overall Study|Adverse Event|0
7680779|NCT01281202|26714268|P1|Overall Study|Adverse Event|2
7680780|NCT01281189|26714278|P2|Overall Study|Other|12
7680781|NCT01281189|26714279|P1|Overall Study|Other|8
7680782|NCT01281189|26714278|P2|Overall Study|Death|91
7680783|NCT01281189|26714279|P1|Overall Study|Death|103
7680784|NCT01281189|26714278|P2|Overall Study|Physician Decision|3
7680785|NCT01281189|26714279|P1|Overall Study|Physician Decision|2
7680786|NCT01281189|26714278|P2|Overall Study|Withdrawal by Subject|24
7680787|NCT01281189|26714279|P1|Overall Study|Withdrawal by Subject|21
7680788|NCT01281189|26714278|P2|Overall Study|Lost to Follow-up|4
7680789|NCT01281189|26714279|P1|Overall Study|Lost to Follow-up|6
7680790|NCT01281189|26714278|P2|Overall Study|Adverse Event|9
7680791|NCT01281189|26714279|P1|Overall Study|Adverse Event|7
7680792|NCT01281137|26714297|P2|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
7680793|NCT01281137|26714298|P1|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
7680794|NCT01281137|26714297|P2|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
7680795|NCT01281137|26714298|P1|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
7680796|NCT01281137|26714297|P2|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
7680797|NCT01281137|26714298|P1|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
7680798|NCT01281137|26714297|P2|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
7680799|NCT01281137|26714298|P1|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
7680800|NCT01281137|26714297|P2|Baseline Population|No samples assayed (excluded from all analyses)|1
7680801|NCT01281137|26714298|P1|Baseline Population|No samples assayed (excluded from all analyses)|0
7680802|NCT01281124|26714322|P1|Overall Study|Death|1
7680803|NCT01280981|26714337|P1|Overall Study|Study site closure|1
7680804|NCT01280981|26714337|P1|Overall Study|Elective surgery|2
7680805|NCT01280981|26714337|P1|Overall Study|Withdrawal of consent|3
7680806|NCT01280981|26714337|P1|Overall Study|Non-compliance with protocol|3
7680807|NCT01280981|26714337|P1|Overall Study|Failed to return|45
7680808|NCT01280981|26714337|P1|Overall Study|Irregular or discontinued menses|3
7680809|NCT01280981|26714337|P1|Overall Study|Adverse Event|6
7680810|NCT01280981|26714337|P1|Overall Study|Lost to Follow-up|3
7680811|NCT01280981|26714337|P1|Overall Study|Lack of Efficacy|13
7680812|NCT01280981|26714337|P1|Overall Study|Protocol Violation|2
7680813|NCT01280981|26714337|P1|Overall Study|Withdrawal by Subject|11
7680814|NCT01280968|26714348|P2|Overall Study|Unable to Smoke in Supine Position|0
7680815|NCT01280968|26714349|P1|Overall Study|Unable to Smoke in Supine Position|1
7680816|NCT01280968|26714348|P2|Overall Study|Pre-existing Neurological Condition|0
7680817|NCT01280968|26714349|P1|Overall Study|Pre-existing Neurological Condition|1
7680818|NCT01280968|26714348|P2|Overall Study|Scheduling Conflicts|1
7680819|NCT01280968|26714349|P1|Overall Study|Scheduling Conflicts|1
7680820|NCT01280968|26714348|P2|Overall Study|Adverse Event|0
7680821|NCT01280968|26714349|P1|Overall Study|Adverse Event|1
7680822|NCT01280968|26714348|P2|Overall Study|Anxiety|0
7680823|NCT01280968|26714349|P1|Overall Study|Anxiety|2
7680824|NCT01280968|26714348|P2|Overall Study|Commuting Problems|0
7680825|NCT01280968|26714349|P1|Overall Study|Commuting Problems|2
7680826|NCT01280968|26714348|P2|Overall Study|Unable to Follow Experimental Protocol|0
7680827|NCT01280968|26714349|P1|Overall Study|Unable to Follow Experimental Protocol|2
7680828|NCT01280968|26714348|P2|Overall Study|Lost to Follow-up|2
7680829|NCT01280968|26714349|P1|Overall Study|Lost to Follow-up|8
7680830|NCT01280955|26714365|P1|Overall Study|Withdrawal by Subject|1
7680831|NCT01280955|26714365|P1|Overall Study|Death|2
7680832|NCT01280903|26714409|P2|Overall Study|Lost to Follow-up|16
7680833|NCT01280903|26714410|P1|Overall Study|Lost to Follow-up|23
7680834|NCT01280812|26714477|P3|Overall Study|Lost to Follow-up|1
7680835|NCT01280812|26714478|P2|Overall Study|Lost to Follow-up|1
7680836|NCT01280812|26714479|P1|Overall Study|Lost to Follow-up|1
7680837|NCT01280812|26714477|P3|Overall Study|Withdrawal by Subject|0
7680838|NCT01280812|26714478|P2|Overall Study|Withdrawal by Subject|1
7680839|NCT01280812|26714479|P1|Overall Study|Withdrawal by Subject|2
7680840|NCT01280721|26714502|P1|Overall Study|No tolerability for the lowest dose|2
7680841|NCT01280721|26714502|P1|Overall Study|eGFR under the withdrawal criteria|7
7680842|NCT01280721|26714502|P1|Overall Study|Withdrawal by Subject|6
7680843|NCT01280721|26714502|P1|Overall Study|Physician Decision|3
7680844|NCT01280721|26714502|P1|Overall Study|Adverse Event|4
7680845|NCT01280656|26714566|P3|Overall Study|Other|7
7680846|NCT01280656|26714567|P2|Overall Study|Other|7
7680847|NCT01280656|26714568|P1|Overall Study|Other|1
7680848|NCT01280656|26714566|P3|Overall Study|Treatment shortening (RGT)|5
7680849|NCT01280656|26714567|P2|Overall Study|Treatment shortening (RGT)|4
7680850|NCT01280656|26714568|P1|Overall Study|Treatment shortening (RGT)|0
7680851|NCT01280656|26714566|P3|Overall Study|Lack of Efficacy|38
7680852|NCT01280656|26714567|P2|Overall Study|Lack of Efficacy|22
7680853|NCT01280656|26714568|P1|Overall Study|Lack of Efficacy|1
7680854|NCT01280656|26714566|P3|Overall Study|Adverse Event|13
7680855|NCT01280656|26714567|P2|Overall Study|Adverse Event|14
7680856|NCT01280656|26714568|P1|Overall Study|Adverse Event|1
7680857|NCT01280617|26714678|P2|Overall Study|Adverse Event|1
7680858|NCT01280617|26714679|P1|Overall Study|Adverse Event|0
7680859|NCT01280591|26714710|P4|Overall Study|Does not meet exclusion #27 criteria|1
7680860|NCT01280591|26714711|P3|Overall Study|Does not meet exclusion #27 criteria|0
7680861|NCT01280591|26714712|P2|Overall Study|Does not meet exclusion #27 criteria|0
7680862|NCT01280591|26714713|P1|Overall Study|Does not meet exclusion #27 criteria|0
7680863|NCT01280591|26714710|P4|Overall Study|Withdrawal by Subject|2
7680864|NCT01280591|26714711|P3|Overall Study|Withdrawal by Subject|0
7680865|NCT01280591|26714712|P2|Overall Study|Withdrawal by Subject|0
7680866|NCT01280591|26714713|P1|Overall Study|Withdrawal by Subject|0
7680867|NCT01280357|26714851|P1|Overall Study|IInsufficient data/No data supplied|12
7680868|NCT01280357|26714851|P1|Overall Study|Excluded no internal monitoring|14
7680869|NCT01280266|26714860|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
7680870|NCT01280266|26714861|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
7680871|NCT01280266|26714860|P2|First Intervention (Week 1-4)|Adverse Event|0
7680872|NCT01280266|26714861|P1|First Intervention (Week 1-4)|Adverse Event|1
7680873|NCT01279954|26714952|P2|Overall Study|Lack of Efficacy|4
7680874|NCT01279954|26714953|P1|Overall Study|Lack of Efficacy|3
7680875|NCT01279850|26714964|P1|Overall Study|No Visit After Treatment|34
7680876|NCT01279850|26714964|P1|Overall Study|No Drug Administration Information|7
7680877|NCT01279850|26714964|P1|Overall Study|Protocol Violation|50
7680878|NCT01279681|26714980|P2|Overall Study|Other Reason|2
7680879|NCT01279681|26714981|P1|Overall Study|Other Reason|0
7680880|NCT01279681|26714980|P2|Overall Study|Physician Decision|0
7680881|NCT01279681|26714981|P1|Overall Study|Physician Decision|1
7680882|NCT01279681|26714980|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
7680883|NCT01279681|26714981|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
7680884|NCT01279681|26714980|P2|Overall Study|Death|1
7680885|NCT01279681|26714981|P1|Overall Study|Death|0
7680886|NCT01279681|26714980|P2|Overall Study|Adverse Event|3
7680887|NCT01279681|26714981|P1|Overall Study|Adverse Event|2
7680888|NCT01279681|26714980|P2|Overall Study|Withdrawal by Subject|4
7680889|NCT01279681|26714981|P1|Overall Study|Withdrawal by Subject|3
7680890|NCT01279681|26714980|P2|Overall Study|Disease Progression|6
7680891|NCT01279681|26714981|P1|Overall Study|Disease Progression|9
7680892|NCT01279616|26714993|P1|Overall Study|no signs of sickle cell disease|2
7680893|NCT01279616|26714993|P1|Overall Study|donor could not be located|5
7680894|NCT01279486|26715006|P1|Overall Study|Lost to Follow-up|1
7680895|NCT01279447|26715012|P2|Overall Study|Lost to Follow-up|1
7680896|NCT01279447|26715013|P1|Overall Study|Lost to Follow-up|3
7680897|NCT01279343|26715021|P2|Overall Study|Did not receive treatment|6
7680898|NCT01279343|26715022|P1|Overall Study|Did not receive treatment|2
7680899|NCT01279200|26715067|P2|Overall Study|Adverse Event|0
7680900|NCT01279200|26715068|P1|Overall Study|Adverse Event|1
7680901|NCT01279200|26715067|P2|Overall Study|Lost to Follow-up|1
7680902|NCT01279200|26715068|P1|Overall Study|Lost to Follow-up|0
7680903|NCT01279200|26715067|P2|Overall Study|ultrasound screening failure|1
7680904|NCT01279200|26715068|P1|Overall Study|ultrasound screening failure|0
7680905|NCT01279200|26715067|P2|Overall Study|Inconvenience of ultrasound visit|1
7680906|NCT01279200|26715068|P1|Overall Study|Inconvenience of ultrasound visit|0
7680907|NCT01279200|26715067|P2|Overall Study|Patient withdrawal due to high cost|1
7680908|NCT01279200|26715068|P1|Overall Study|Patient withdrawal due to high cost|0
7680909|NCT01279200|26715067|P2|Overall Study|Withdrawal by Subject|3
7680910|NCT01279200|26715068|P1|Overall Study|Withdrawal by Subject|1
7680911|NCT01279070|26715106|P2|Overall Study|Acute exacerbation|1
7680912|NCT01279070|26715107|P1|Overall Study|Acute exacerbation|3
7680913|NCT01279070|26715106|P2|Overall Study|Withdrawal by Subject|3
7680914|NCT01279070|26715107|P1|Overall Study|Withdrawal by Subject|2
7680915|NCT01279057|26715126|P3|Overall Study|Other|0
7680916|NCT01279057|26715127|P2|Overall Study|Other|3
7680917|NCT01279057|26715128|P1|Overall Study|Other|3
7680918|NCT01279057|26715126|P3|Overall Study|Pregnancy|0
7680919|NCT01279057|26715127|P2|Overall Study|Pregnancy|1
7680920|NCT01279057|26715128|P1|Overall Study|Pregnancy|0
7680921|NCT01279057|26715126|P3|Overall Study|Withdrew consent|1
7680922|NCT01279057|26715127|P2|Overall Study|Withdrew consent|0
7680923|NCT01279057|26715128|P1|Overall Study|Withdrew consent|2
7680924|NCT01279057|26715126|P3|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7680925|NCT01279057|26715127|P2|Overall Study|Restricted medication for seasonal allergic rhinitis|1
7680926|NCT01279057|26715128|P1|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7680927|NCT01279057|26715126|P3|Overall Study|Insufficient therapeutic response|1
7680928|NCT01279057|26715127|P2|Overall Study|Insufficient therapeutic response|0
7680929|NCT01279057|26715128|P1|Overall Study|Insufficient therapeutic response|0
7680930|NCT01279057|26715126|P3|Overall Study|Adverse Event|1
7680931|NCT01279057|26715127|P2|Overall Study|Adverse Event|0
7680932|NCT01279057|26715128|P1|Overall Study|Adverse Event|1
7680933|NCT01279044|26715156|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
7680934|NCT01279044|26715157|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
7680935|NCT01279044|26715158|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
7680936|NCT01279044|26715156|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
7680937|NCT01279044|26715157|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
7680938|NCT01279044|26715158|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
7680939|NCT01279044|26715156|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
7680940|NCT01279044|26715157|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
7680941|NCT01279044|26715158|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
7680942|NCT01278862|26715234|P2|Overall Study|Lost to Follow-up|1
7680943|NCT01278862|26715235|P1|Overall Study|Lost to Follow-up|1
7680944|NCT01278797|26715243|P2|Period 1|Protocol Violation|0
7680945|NCT01278797|26715244|P1|Period 1|Protocol Violation|1
7680946|NCT01278797|26715243|P2|Period 1|Adverse Event|1
7680947|NCT01278797|26715244|P1|Period 1|Adverse Event|0
7680948|NCT01278745|26715256|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
7680949|NCT01278745|26715257|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
7680950|NCT01278745|26715258|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
7680951|NCT01278745|26715259|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
7680952|NCT01278745|26715256|P4|Overall Study|Ineligible|61
7680953|NCT01278745|26715257|P3|Overall Study|Ineligible|42
7680954|NCT01278745|26715258|P2|Overall Study|Ineligible|0
7680955|NCT01278745|26715259|P1|Overall Study|Ineligible|0
7680956|NCT01278745|26715256|P4|Overall Study|Sponsor Decision|6
7680957|NCT01278745|26715257|P3|Overall Study|Sponsor Decision|62
7680958|NCT01278745|26715258|P2|Overall Study|Sponsor Decision|0
7680959|NCT01278745|26715259|P1|Overall Study|Sponsor Decision|1
7680960|NCT01278745|26715256|P4|Overall Study|Withdrawal by Subject|1
7680961|NCT01278745|26715257|P3|Overall Study|Withdrawal by Subject|5
7680962|NCT01278745|26715258|P2|Overall Study|Withdrawal by Subject|1
7680963|NCT01278745|26715259|P1|Overall Study|Withdrawal by Subject|1
7680964|NCT01278745|26715256|P4|Overall Study|Physician Decision|9
7680965|NCT01278745|26715257|P3|Overall Study|Physician Decision|0
7680966|NCT01278745|26715258|P2|Overall Study|Physician Decision|0
7680967|NCT01278745|26715259|P1|Overall Study|Physician Decision|1
7680968|NCT01278745|26715256|P4|Overall Study|Death|0
7680969|NCT01278745|26715257|P3|Overall Study|Death|7
7680970|NCT01278745|26715258|P2|Overall Study|Death|5
7680971|NCT01278745|26715259|P1|Overall Study|Death|2
7680972|NCT01278615|26715291|P1|Overall Study|Withdrawal by Subject|2
7680973|NCT01278407|26715317|P5|Extension Phase|Other|3
7680974|NCT01278407|26715318|P4|Extension Phase|Other|1
7680975|NCT01278407|26715319|P3|Extension Phase|Other|0
7680976|NCT01278407|26715320|P2|Extension Phase|Other|0
7680977|NCT01278407|26715321|P1|Extension Phase|Other|0
7680978|NCT01278407|26715317|P5|Extension Phase|Participant's Choice|11
7680979|NCT01278407|26715318|P4|Extension Phase|Participant's Choice|4
7680980|NCT01278407|26715319|P3|Extension Phase|Participant's Choice|0
7680981|NCT01278407|26715320|P2|Extension Phase|Participant's Choice|0
7680982|NCT01278407|26715321|P1|Extension Phase|Participant's Choice|0
7680983|NCT01278407|26715317|P5|Extension Phase|Adverse Event|16
7680984|NCT01278407|26715318|P4|Extension Phase|Adverse Event|7
7680985|NCT01278407|26715319|P3|Extension Phase|Adverse Event|0
7680986|NCT01278407|26715320|P2|Extension Phase|Adverse Event|0
7680987|NCT01278407|26715321|P1|Extension Phase|Adverse Event|0
7680988|NCT01278407|26715317|P5|Confirmatory Phase|Other|0
7680989|NCT01278407|26715318|P4|Confirmatory Phase|Other|0
7680990|NCT01278407|26715319|P3|Confirmatory Phase|Other|2
7680991|NCT01278407|26715320|P2|Confirmatory Phase|Other|1
7680992|NCT01278407|26715321|P1|Confirmatory Phase|Other|1
7680993|NCT01278407|26715317|P5|Confirmatory Phase|Participant's Choice|0
7680994|NCT01278407|26715318|P4|Confirmatory Phase|Participant's Choice|0
7680995|NCT01278407|26715319|P3|Confirmatory Phase|Participant's Choice|3
7680996|NCT01278407|26715320|P2|Confirmatory Phase|Participant's Choice|5
7680997|NCT01278407|26715321|P1|Confirmatory Phase|Participant's Choice|3
7680998|NCT01278407|26715317|P5|Confirmatory Phase|Adverse Event|0
7680999|NCT01278407|26715318|P4|Confirmatory Phase|Adverse Event|0
7681000|NCT01278407|26715319|P3|Confirmatory Phase|Adverse Event|1
7681001|NCT01278407|26715320|P2|Confirmatory Phase|Adverse Event|10
7681002|NCT01278407|26715321|P1|Confirmatory Phase|Adverse Event|5
7681003|NCT01278394|26715334|P1|Overall Study|Lost to Follow-up|1
7681004|NCT01278342|26715347|P3|Overall Study|Other|0
7681005|NCT01278342|26715348|P2|Overall Study|Other|0
7681006|NCT01278342|26715349|P1|Overall Study|Other|1
7681007|NCT01278342|26715347|P3|Overall Study|Administrative problems|0
7681008|NCT01278342|26715348|P2|Overall Study|Administrative problems|0
7681009|NCT01278342|26715349|P1|Overall Study|Administrative problems|2
7681010|NCT01278342|26715347|P3|Overall Study|Lost to Follow-up|0
7681011|NCT01278342|26715348|P2|Overall Study|Lost to Follow-up|0
7681012|NCT01278342|26715349|P1|Overall Study|Lost to Follow-up|1
7681013|NCT01278342|26715347|P3|Overall Study|Physician Decision|0
7681014|NCT01278342|26715348|P2|Overall Study|Physician Decision|1
7681015|NCT01278342|26715349|P1|Overall Study|Physician Decision|0
7681016|NCT01278173|26715369|P1|Overall Study|Withdrawal by Subject|1
7681017|NCT01278173|26715369|P1|Overall Study|Protocol Violation|1
7681018|NCT01278173|26715369|P1|Overall Study|Administrative or other reason|4
7681019|NCT01278173|26715369|P1|Overall Study|Adverse Event|8
7681020|NCT01278173|26715369|P1|Overall Study|Lack of Efficacy|13
7681021|NCT01278160|26715376|P2|Overall Study|Unclassified|2
7681022|NCT01278160|26715377|P1|Overall Study|Unclassified|1
7681023|NCT01278160|26715376|P2|Overall Study|Withdrawal by Subject|2
7681024|NCT01278160|26715377|P1|Overall Study|Withdrawal by Subject|3
7681025|NCT01278160|26715376|P2|Overall Study|Lost to Follow-up|1
7681026|NCT01278160|26715377|P1|Overall Study|Lost to Follow-up|0
7681027|NCT01278160|26715376|P2|Overall Study|Adverse Event|1
7681028|NCT01278160|26715377|P1|Overall Study|Adverse Event|1
7681029|NCT01278030|26715393|P2|Overall Study|Withdrawal by Subject|4
7681030|NCT01278030|26715394|P1|Overall Study|Withdrawal by Subject|8
7681031|NCT01277887|26715402|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
7681032|NCT01277887|26715403|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
7681033|NCT01277887|26715402|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
7681034|NCT01277887|26715403|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
7681035|NCT01277887|26715402|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
7681036|NCT01277887|26715403|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
7681037|NCT01277861|26715415|P2|Overall Study|Physician Decision|2
7681038|NCT01277861|26715416|P1|Overall Study|Physician Decision|2
7681039|NCT01277822|26715428|P2|Overall Study|Participant moved|0
7681040|NCT01277822|26715429|P1|Overall Study|Participant moved|1
7681041|NCT01277822|26715428|P2|Overall Study|Contraindicated medication used|1
7681042|NCT01277822|26715429|P1|Overall Study|Contraindicated medication used|2
7681043|NCT01277822|26715428|P2|Overall Study|Lost to Follow-up|1
7681044|NCT01277822|26715429|P1|Overall Study|Lost to Follow-up|2
7681045|NCT01277822|26715428|P2|Overall Study|Protocol Violation|0
7681046|NCT01277822|26715429|P1|Overall Study|Protocol Violation|1
7681047|NCT01277822|26715428|P2|Overall Study|Physician Decision|1
7681048|NCT01277822|26715429|P1|Overall Study|Physician Decision|1
7681049|NCT01277822|26715428|P2|Overall Study|Withdrawal by Subject|7
7681050|NCT01277822|26715429|P1|Overall Study|Withdrawal by Subject|6
7681051|NCT01277822|26715428|P2|Overall Study|Adverse Event|1
7681052|NCT01277822|26715429|P1|Overall Study|Adverse Event|2
7681053|NCT01277757|26715465|P1|Overall Study|Withdrawal by Subject|1
7681054|NCT01277757|26715465|P1|Overall Study|Disease Progression|1
7681055|NCT01277744|26715472|P1|Overall Study|Physician Decision|2
7681056|NCT01277718|26715477|P2|Period 2 - Second Intervention|Physician Decision|2
7681057|NCT01277718|26715478|P1|Period 2 - Second Intervention|Physician Decision|0
7681058|NCT01277718|26715477|P2|Period 2 - Second Intervention|Protocol Violation|1
7681059|NCT01277718|26715478|P1|Period 2 - Second Intervention|Protocol Violation|0
7681060|NCT01277666|26715492|P3|Overall Study|Death|1
7681061|NCT01277666|26715493|P2|Overall Study|Death|0
7681062|NCT01277666|26715494|P1|Overall Study|Death|0
7681063|NCT01277666|26715492|P3|Overall Study|Withdrawal by Subject|6
7681064|NCT01277666|26715493|P2|Overall Study|Withdrawal by Subject|8
7681065|NCT01277666|26715494|P1|Overall Study|Withdrawal by Subject|7
7681066|NCT01277666|26715492|P3|Overall Study|Lost to Follow-up|2
7681067|NCT01277666|26715493|P2|Overall Study|Lost to Follow-up|1
7681068|NCT01277666|26715494|P1|Overall Study|Lost to Follow-up|1
7681069|NCT01277666|26715492|P3|Overall Study|Protocol Defined Stopping criteria|6
7681070|NCT01277666|26715493|P2|Overall Study|Protocol Defined Stopping criteria|2
7681071|NCT01277666|26715494|P1|Overall Study|Protocol Defined Stopping criteria|1
7681072|NCT01277666|26715492|P3|Overall Study|Protocol Violation|2
7681073|NCT01277666|26715493|P2|Overall Study|Protocol Violation|3
7681074|NCT01277666|26715494|P1|Overall Study|Protocol Violation|2
7681075|NCT01277666|26715492|P3|Overall Study|Lack of Efficacy|12
7681076|NCT01277666|26715493|P2|Overall Study|Lack of Efficacy|20
7681077|NCT01277666|26715494|P1|Overall Study|Lack of Efficacy|8
7681078|NCT01277666|26715492|P3|Overall Study|Adverse Event|20
7681079|NCT01277666|26715493|P2|Overall Study|Adverse Event|25
7681080|NCT01277666|26715494|P1|Overall Study|Adverse Event|26
7681081|NCT01277601|26715527|P4|Overall Study|Subject Terminated from Study by Sponsor|2
7681082|NCT01277601|26715528|P3|Overall Study|Subject Terminated from Study by Sponsor|0
7681083|NCT01277601|26715529|P2|Overall Study|Subject Terminated from Study by Sponsor|1
7681084|NCT01277601|26715530|P1|Overall Study|Subject Terminated from Study by Sponsor|0
7681085|NCT01277601|26715527|P4|Overall Study|Protocol Violation|0
7681086|NCT01277601|26715528|P3|Overall Study|Protocol Violation|5
7681087|NCT01277601|26715529|P2|Overall Study|Protocol Violation|2
7681088|NCT01277601|26715530|P1|Overall Study|Protocol Violation|0
7681089|NCT01277601|26715527|P4|Overall Study|Subject Never Dosed with Study Drug|1
7681090|NCT01277601|26715528|P3|Overall Study|Subject Never Dosed with Study Drug|3
7681091|NCT01277601|26715529|P2|Overall Study|Subject Never Dosed with Study Drug|2
7681092|NCT01277601|26715530|P1|Overall Study|Subject Never Dosed with Study Drug|1
7681093|NCT01277601|26715527|P4|Overall Study|Noncompliance with Study Drug|0
7681094|NCT01277601|26715528|P3|Overall Study|Noncompliance with Study Drug|2
7681095|NCT01277601|26715529|P2|Overall Study|Noncompliance with Study Drug|3
7681096|NCT01277601|26715530|P1|Overall Study|Noncompliance with Study Drug|1
7681097|NCT01277601|26715527|P4|Overall Study|Pregnancy|1
7681098|NCT01277601|26715528|P3|Overall Study|Pregnancy|4
7681099|NCT01277601|26715529|P2|Overall Study|Pregnancy|2
7681100|NCT01277601|26715530|P1|Overall Study|Pregnancy|2
7681101|NCT01277601|26715527|P4|Overall Study|Physician Decision|6
7681102|NCT01277601|26715528|P3|Overall Study|Physician Decision|1
7681103|NCT01277601|26715529|P2|Overall Study|Physician Decision|5
7681104|NCT01277601|26715530|P1|Overall Study|Physician Decision|3
7681105|NCT01277601|26715527|P4|Overall Study|Lost to Follow-up|2
7681106|NCT01277601|26715528|P3|Overall Study|Lost to Follow-up|4
7681107|NCT01277601|26715529|P2|Overall Study|Lost to Follow-up|9
7681108|NCT01277601|26715530|P1|Overall Study|Lost to Follow-up|7
7681109|NCT01277601|26715527|P4|Overall Study|Withdrawal by Subject|17
7681110|NCT01277601|26715528|P3|Overall Study|Withdrawal by Subject|8
7681111|NCT01277601|26715529|P2|Overall Study|Withdrawal by Subject|21
7681112|NCT01277601|26715530|P1|Overall Study|Withdrawal by Subject|18
7681113|NCT01277601|26715527|P4|Overall Study|Adverse Event|7
7681114|NCT01277601|26715528|P3|Overall Study|Adverse Event|0
7681115|NCT01277601|26715529|P2|Overall Study|Adverse Event|3
7681116|NCT01277601|26715530|P1|Overall Study|Adverse Event|5
7681117|NCT01277549|26715621|P2|Overall Study|Physician Decision|1
7681118|NCT01277549|26715622|P1|Overall Study|Physician Decision|2
7681119|NCT01277549|26715621|P2|Overall Study|Protocol Violation|1
7681120|NCT01277549|26715622|P1|Overall Study|Protocol Violation|10
7681121|NCT01277549|26715621|P2|Overall Study|Withdrawal by Subject|3
7681122|NCT01277549|26715622|P1|Overall Study|Withdrawal by Subject|1
7681123|NCT01277549|26715621|P2|Overall Study|Failed to meet eligibility criteria|9
7681124|NCT01277549|26715622|P1|Overall Study|Failed to meet eligibility criteria|13
7681125|NCT01277523|26715639|P3|Overall Study|Other Reason not Defined|0
7681126|NCT01277523|26715640|P2|Overall Study|Other Reason not Defined|1
7681127|NCT01277523|26715641|P1|Overall Study|Other Reason not Defined|0
7681128|NCT01277523|26715639|P3|Overall Study|Protocol Violation|0
7681129|NCT01277523|26715640|P2|Overall Study|Protocol Violation|0
7681130|NCT01277523|26715641|P1|Overall Study|Protocol Violation|2
7681131|NCT01277523|26715639|P3|Overall Study|Adverse Event|0
7681132|NCT01277523|26715640|P2|Overall Study|Adverse Event|0
7681133|NCT01277523|26715641|P1|Overall Study|Adverse Event|1
7681134|NCT01277510|26715693|P2|Open-label Phase|Never received investigational product|0
7681135|NCT01277510|26715694|P1|Open-label Phase|Never received investigational product|2
7681136|NCT01277510|26715693|P2|Open-label Phase|Protocol-specified criteria|0
7681137|NCT01277510|26715694|P1|Open-label Phase|Protocol-specified criteria|1
7681138|NCT01277510|26715693|P2|Open-label Phase|Administrative decision|3
7681139|NCT01277510|26715694|P1|Open-label Phase|Administrative decision|4
7681140|NCT01277510|26715693|P2|Double-blind Phase|Other|1
7681141|NCT01277510|26715694|P1|Double-blind Phase|Other|1
7681142|NCT01277510|26715693|P2|Double-blind Phase|Protocol-specified criteria|6
7681143|NCT01277510|26715694|P1|Double-blind Phase|Protocol-specified criteria|2
7681144|NCT01277510|26715693|P2|Double-blind Phase|Death|1
7681145|NCT01277510|26715694|P1|Double-blind Phase|Death|0
7681146|NCT01277510|26715693|P2|Double-blind Phase|Administrative decision|9
7681147|NCT01277510|26715694|P1|Double-blind Phase|Administrative decision|7
7681148|NCT01277510|26715693|P2|Double-blind Phase|Withdrawal by Subject|0
7681149|NCT01277510|26715694|P1|Double-blind Phase|Withdrawal by Subject|2
7681150|NCT01277510|26715693|P2|Double-blind Phase|Adverse Event|0
7681151|NCT01277510|26715694|P1|Double-blind Phase|Adverse Event|1
7681152|NCT01277510|26715693|P2|Double-blind Phase|Non-compliance|1
7681153|NCT01277510|26715694|P1|Double-blind Phase|Non-compliance|0
7681154|NCT01277302|26715745|P3|8-Month Alternate Dose Regimen Period|Relocation|1
7681155|NCT01277302|26715746|P2|8-Month Alternate Dose Regimen Period|Relocation|0
7681156|NCT01277302|26715747|P1|8-Month Alternate Dose Regimen Period|Relocation|1
7681157|NCT01277302|26715745|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
7681158|NCT01277302|26715746|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
7681159|NCT01277302|26715747|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
7681160|NCT01277302|26715745|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
7681161|NCT01277302|26715746|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
7681162|NCT01277302|26715747|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
7681163|NCT01277302|26715745|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
7681164|NCT01277302|26715746|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
7681165|NCT01277302|26715747|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
7681166|NCT01277302|26715745|P3|8-Month Alternate Dose Regimen Period|Death|0
7681167|NCT01277302|26715746|P2|8-Month Alternate Dose Regimen Period|Death|1
7681168|NCT01277302|26715747|P1|8-Month Alternate Dose Regimen Period|Death|0
7681169|NCT01277302|26715745|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
7681170|NCT01277302|26715746|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
7681171|NCT01277302|26715747|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
7681172|NCT01277302|26715745|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
7681173|NCT01277302|26715746|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
7681174|NCT01277302|26715747|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
7681175|NCT01277302|26715745|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
7681176|NCT01277302|26715746|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
7681177|NCT01277302|26715747|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
7681178|NCT01277302|26715745|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
7681179|NCT01277302|26715746|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
7681180|NCT01277302|26715747|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
7681181|NCT01277211|26715779|P2|Overall Study|Discontinued prior to treatment|13
7681182|NCT01277211|26715780|P1|Overall Study|Discontinued prior to treatment|24
7681183|NCT01277211|26715779|P2|Overall Study|Pregnancy wish|2
7681184|NCT01277211|26715780|P1|Overall Study|Pregnancy wish|0
7681185|NCT01277211|26715779|P2|Overall Study|Administrative|0
7681186|NCT01277211|26715780|P1|Overall Study|Administrative|3
7681187|NCT01277211|26715779|P2|Overall Study|Did not meet protocol eligibility|0
7681188|NCT01277211|26715780|P1|Overall Study|Did not meet protocol eligibility|1
7681189|NCT01277211|26715779|P2|Overall Study|Non-compliance with protocol|4
7681190|NCT01277211|26715780|P1|Overall Study|Non-compliance with protocol|13
7681191|NCT01277211|26715779|P2|Overall Study|Withdrew Consent|9
7681192|NCT01277211|26715780|P1|Overall Study|Withdrew Consent|9
7681193|NCT01277211|26715779|P2|Overall Study|Did not wish to continue|0
7681194|NCT01277211|26715780|P1|Overall Study|Did not wish to continue|17
7681195|NCT01277211|26715779|P2|Overall Study|Lost to Follow-up|9
7681196|NCT01277211|26715780|P1|Overall Study|Lost to Follow-up|14
7681197|NCT01277211|26715779|P2|Overall Study|Pregnancy|4
7681198|NCT01277211|26715780|P1|Overall Study|Pregnancy|9
7681199|NCT01277211|26715779|P2|Overall Study|Adverse Event|22
7681200|NCT01277211|26715780|P1|Overall Study|Adverse Event|60
7681201|NCT01277042|26715832|P2|Overall Study|Withdrawal by Subject|0
7681202|NCT01277042|26715833|P1|Overall Study|Withdrawal by Subject|2
7681203|NCT01277042|26715832|P2|Overall Study|Lost to Follow-up|2
7681204|NCT01277042|26715833|P1|Overall Study|Lost to Follow-up|2
7681205|NCT01277042|26715832|P2|Overall Study|Adverse Event|3
7681206|NCT01277042|26715833|P1|Overall Study|Adverse Event|4
7681207|NCT01276847|26715869|P3|Overall Study|Withdrawal by Subject|0
7681208|NCT01276847|26715870|P2|Overall Study|Withdrawal by Subject|0
7681209|NCT01276847|26715871|P1|Overall Study|Withdrawal by Subject|1
7681210|NCT01276821|26715881|P2|Overall Study|Protocol Violation|1
7681211|NCT01276821|26715882|P1|Overall Study|Protocol Violation|0
7681212|NCT01276756|26715902|P2|Overall Study|Adverse Event|2
7681213|NCT01276756|26715903|P1|Overall Study|Adverse Event|3
7681214|NCT01276756|26715902|P2|Overall Study|Lost to Follow-up|0
7681215|NCT01276756|26715903|P1|Overall Study|Lost to Follow-up|2
7681216|NCT01276639|26715948|P5|Week 16 to 52|Other|3
7681217|NCT01276639|26715949|P4|Week 16 to 52|Other|1
7681218|NCT01276639|26715950|P3|Week 16 to 52|Other|0
7681219|NCT01276639|26715951|P2|Week 16 to 52|Other|12
7681220|NCT01276639|26715952|P1|Week 16 to 52|Other|10
7681221|NCT01276639|26715948|P5|Week 16 to 52|Withdrawal by Subject|1
7681222|NCT01276639|26715949|P4|Week 16 to 52|Withdrawal by Subject|0
7681223|NCT01276639|26715950|P3|Week 16 to 52|Withdrawal by Subject|0
7681224|NCT01276639|26715951|P2|Week 16 to 52|Withdrawal by Subject|4
7681225|NCT01276639|26715952|P1|Week 16 to 52|Withdrawal by Subject|4
7681226|NCT01276639|26715948|P5|Week 16 to 52|Lost to Follow-up|1
7681227|NCT01276639|26715949|P4|Week 16 to 52|Lost to Follow-up|0
7681228|NCT01276639|26715950|P3|Week 16 to 52|Lost to Follow-up|0
7681229|NCT01276639|26715951|P2|Week 16 to 52|Lost to Follow-up|1
7681230|NCT01276639|26715952|P1|Week 16 to 52|Lost to Follow-up|3
7681231|NCT01276639|26715948|P5|Week 16 to 52|Lack of Efficacy|13
7681232|NCT01276639|26715949|P4|Week 16 to 52|Lack of Efficacy|14
7681233|NCT01276639|26715950|P3|Week 16 to 52|Lack of Efficacy|0
7681234|NCT01276639|26715951|P2|Week 16 to 52|Lack of Efficacy|71
7681235|NCT01276639|26715952|P1|Week 16 to 52|Lack of Efficacy|99
7681236|NCT01276639|26715948|P5|Week 16 to 52|Adverse Event|3
7681237|NCT01276639|26715949|P4|Week 16 to 52|Adverse Event|1
7681238|NCT01276639|26715950|P3|Week 16 to 52|Adverse Event|0
7681239|NCT01276639|26715951|P2|Week 16 to 52|Adverse Event|13
7681240|NCT01276639|26715952|P1|Week 16 to 52|Adverse Event|10
7681241|NCT01276639|26715948|P5|Week 16 to 52|Death|0
7681242|NCT01276639|26715949|P4|Week 16 to 52|Death|0
7681243|NCT01276639|26715950|P3|Week 16 to 52|Death|0
7681244|NCT01276639|26715951|P2|Week 16 to 52|Death|0
7681245|NCT01276639|26715952|P1|Week 16 to 52|Death|1
7681246|NCT01276639|26715948|P5|Week 0 to 16|Randomized, But Not Treated|0
7681247|NCT01276639|26715949|P4|Week 0 to 16|Randomized, But Not Treated|0
7681248|NCT01276639|26715950|P3|Week 0 to 16|Randomized, But Not Treated|0
7681249|NCT01276639|26715951|P2|Week 0 to 16|Randomized, But Not Treated|1
7681250|NCT01276639|26715952|P1|Week 0 to 16|Randomized, But Not Treated|0
7681251|NCT01276639|26715948|P5|Week 0 to 16|Other|0
7681252|NCT01276639|26715949|P4|Week 0 to 16|Other|0
7681253|NCT01276639|26715950|P3|Week 0 to 16|Other|2
7681254|NCT01276639|26715951|P2|Week 0 to 16|Other|7
7681255|NCT01276639|26715952|P1|Week 0 to 16|Other|7
7681256|NCT01276639|26715948|P5|Week 0 to 16|Withdrawal by Subject|0
7681257|NCT01276639|26715949|P4|Week 0 to 16|Withdrawal by Subject|0
7681258|NCT01276639|26715950|P3|Week 0 to 16|Withdrawal by Subject|4
7681259|NCT01276639|26715951|P2|Week 0 to 16|Withdrawal by Subject|5
7681260|NCT01276639|26715952|P1|Week 0 to 16|Withdrawal by Subject|8
7681261|NCT01276639|26715948|P5|Week 0 to 16|Lost to Follow-up|0
7681262|NCT01276639|26715949|P4|Week 0 to 16|Lost to Follow-up|0
7681263|NCT01276639|26715950|P3|Week 0 to 16|Lost to Follow-up|3
7681264|NCT01276639|26715951|P2|Week 0 to 16|Lost to Follow-up|5
7681265|NCT01276639|26715952|P1|Week 0 to 16|Lost to Follow-up|3
7681266|NCT01276639|26715948|P5|Week 0 to 16|Lack of Efficacy|0
7681267|NCT01276639|26715949|P4|Week 0 to 16|Lack of Efficacy|0
7681268|NCT01276639|26715950|P3|Week 0 to 16|Lack of Efficacy|25
7681269|NCT01276639|26715951|P2|Week 0 to 16|Lack of Efficacy|15
7681270|NCT01276639|26715952|P1|Week 0 to 16|Lack of Efficacy|20
7681271|NCT01276639|26715948|P5|Week 0 to 16|Adverse Event|0
7681272|NCT01276639|26715949|P4|Week 0 to 16|Adverse Event|0
7681273|NCT01276639|26715950|P3|Week 0 to 16|Adverse Event|11
7681274|NCT01276639|26715951|P2|Week 0 to 16|Adverse Event|8
7681275|NCT01276639|26715952|P1|Week 0 to 16|Adverse Event|11
7681276|NCT01276639|26715948|P5|Week 0 to 16|Death|0
7681277|NCT01276639|26715949|P4|Week 0 to 16|Death|0
7681278|NCT01276639|26715950|P3|Week 0 to 16|Death|0
7681279|NCT01276639|26715951|P2|Week 0 to 16|Death|0
7681280|NCT01276639|26715952|P1|Week 0 to 16|Death|1
7681281|NCT01276509|26716157|P4|Overall Study|Other|0
7681282|NCT01276509|26716158|P3|Overall Study|Other|0
7681283|NCT01276509|26716159|P2|Overall Study|Other|1
7681284|NCT01276509|26716160|P1|Overall Study|Other|0
7681285|NCT01276509|26716157|P4|Overall Study|Withdrawal by Subject|0
7681286|NCT01276509|26716158|P3|Overall Study|Withdrawal by Subject|0
7681287|NCT01276509|26716159|P2|Overall Study|Withdrawal by Subject|2
7681288|NCT01276509|26716160|P1|Overall Study|Withdrawal by Subject|1
7681289|NCT01276509|26716157|P4|Overall Study|Pregnancy|0
7681290|NCT01276509|26716158|P3|Overall Study|Pregnancy|0
7681291|NCT01276509|26716159|P2|Overall Study|Pregnancy|0
7681292|NCT01276509|26716160|P1|Overall Study|Pregnancy|1
7681293|NCT01276509|26716157|P4|Overall Study|Lack of Efficacy|2
7681294|NCT01276509|26716158|P3|Overall Study|Lack of Efficacy|1
7681295|NCT01276509|26716159|P2|Overall Study|Lack of Efficacy|1
7681296|NCT01276509|26716160|P1|Overall Study|Lack of Efficacy|2
7681297|NCT01276509|26716157|P4|Overall Study|Adverse Event|3
7681298|NCT01276509|26716158|P3|Overall Study|Adverse Event|4
7681299|NCT01276509|26716159|P2|Overall Study|Adverse Event|8
7681300|NCT01276509|26716160|P1|Overall Study|Adverse Event|9
7681301|NCT01276457|26716213|P2|Extension Study|Lack of Efficacy|1
7681302|NCT01276457|26716214|P1|Extension Study|Lack of Efficacy|3
7681303|NCT01276457|26716213|P2|Extension Study|Death|1
7681304|NCT01276457|26716214|P1|Extension Study|Death|0
7681305|NCT01276457|26716213|P2|Extension Study|Lost to Follow-up|0
7681306|NCT01276457|26716214|P1|Extension Study|Lost to Follow-up|3
7681307|NCT01276457|26716213|P2|Core Study|Lack of Efficacy|12
7681308|NCT01276457|26716214|P1|Core Study|Lack of Efficacy|3
7681309|NCT01276457|26716213|P2|Core Study|Death|2
7681310|NCT01276457|26716214|P1|Core Study|Death|2
7681311|NCT01276457|26716213|P2|Core Study|Administrative problems|1
7681312|NCT01276457|26716214|P1|Core Study|Administrative problems|1
7681313|NCT01276457|26716213|P2|Core Study|Lost to Follow-up|2
7681314|NCT01276457|26716214|P1|Core Study|Lost to Follow-up|1
7681315|NCT01276457|26716213|P2|Core Study|Adverse Event|3
7681316|NCT01276457|26716214|P1|Core Study|Adverse Event|6
7681317|NCT01276379|26716228|P1|Overall Study|Screening failure|40
7681318|NCT01276353|26716242|P2|Extension|Prohibited concomitant medications|1
7681319|NCT01276353|26716243|P1|Extension|Prohibited concomitant medications|0
7681320|NCT01276353|26716242|P2|Extension|Physician Decision|0
7681321|NCT01276353|26716243|P1|Extension|Physician Decision|1
7681322|NCT01276353|26716242|P2|Extension|Withdrawal of study drug 4 days in a row|1
7681323|NCT01276353|26716243|P1|Extension|Withdrawal of study drug 4 days in a row|3
7681324|NCT01276353|26716242|P2|Extension|Withdrawal by Subject|2
7681325|NCT01276353|26716243|P1|Extension|Withdrawal by Subject|1
7681326|NCT01276353|26716242|P2|Extension|Adverse Event|5
7681327|NCT01276353|26716243|P1|Extension|Adverse Event|2
7681328|NCT01276353|26716242|P2|Double-blind|Withdrawal by Subject|0
7681329|NCT01276353|26716243|P1|Double-blind|Withdrawal by Subject|1
7681330|NCT01276353|26716242|P2|Double-blind|Adverse Event|0
7681331|NCT01276353|26716243|P1|Double-blind|Adverse Event|2
7681332|NCT01276327|26716255|P2|Overall Study|Withdrawal by Subject|0
7681333|NCT01276327|26716256|P1|Overall Study|Withdrawal by Subject|1
7681334|NCT01276327|26716255|P2|Overall Study|Adverse Event|3
7681335|NCT01276327|26716256|P1|Overall Study|Adverse Event|1
7681336|NCT01276288|26716323|P4|Overall Study|not treated|0
7681337|NCT01276288|26716324|P3|Overall Study|not treated|0
7681338|NCT01276288|26716325|P2|Overall Study|not treated|0
7681339|NCT01276288|26716326|P1|Overall Study|not treated|1
7681340|NCT01276288|26716323|P4|Overall Study|Adverse Event|0
7681341|NCT01276288|26716324|P3|Overall Study|Adverse Event|0
7681342|NCT01276288|26716325|P2|Overall Study|Adverse Event|1
7681343|NCT01276288|26716326|P1|Overall Study|Adverse Event|1
7681344|NCT01276236|26716450|P1|Overall Study|Withdrawal by Subject|4
7681345|NCT01276236|26716450|P1|Overall Study|Lack of Efficacy|2
7681346|NCT01276223|26716464|P3|Overall Study|Protocol Violation|0
7681347|NCT01276223|26716465|P2|Overall Study|Protocol Violation|0
7681348|NCT01276223|26716466|P1|Overall Study|Protocol Violation|1
7681349|NCT01276223|26716464|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
7681350|NCT01276223|26716465|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
7681351|NCT01276223|26716466|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
7681352|NCT01276223|26716464|P3|Overall Study|Other|1
7681353|NCT01276223|26716465|P2|Overall Study|Other|0
7681354|NCT01276223|26716466|P1|Overall Study|Other|0
7681355|NCT01276223|26716464|P3|Overall Study|Lost to Follow-up|1
7681356|NCT01276223|26716465|P2|Overall Study|Lost to Follow-up|0
7681357|NCT01276223|26716466|P1|Overall Study|Lost to Follow-up|0
7681358|NCT01276223|26716464|P3|Overall Study|Adverse Event|1
7681359|NCT01276223|26716465|P2|Overall Study|Adverse Event|4
7681360|NCT01276223|26716466|P1|Overall Study|Adverse Event|7
7681361|NCT01276106|26716516|P4|Overall Study|Insufficient therapeutic effects|0
7681362|NCT01276106|26716517|P3|Overall Study|Insufficient therapeutic effects|2
7681363|NCT01276106|26716518|P2|Overall Study|Insufficient therapeutic effects|0
7681364|NCT01276106|26716519|P1|Overall Study|Insufficient therapeutic effects|0
7681365|NCT01276106|26716516|P4|Overall Study|Protocol Violation|2
7681366|NCT01276106|26716517|P3|Overall Study|Protocol Violation|0
7681367|NCT01276106|26716518|P2|Overall Study|Protocol Violation|1
7681368|NCT01276106|26716519|P1|Overall Study|Protocol Violation|1
7681369|NCT01276106|26716516|P4|Overall Study|Physician Decision|1
7681370|NCT01276106|26716517|P3|Overall Study|Physician Decision|1
7681371|NCT01276106|26716518|P2|Overall Study|Physician Decision|0
7681372|NCT01276106|26716519|P1|Overall Study|Physician Decision|0
7681373|NCT01276106|26716516|P4|Overall Study|Lost to Follow-up|0
7681374|NCT01276106|26716517|P3|Overall Study|Lost to Follow-up|1
7681375|NCT01276106|26716518|P2|Overall Study|Lost to Follow-up|1
7681376|NCT01276106|26716519|P1|Overall Study|Lost to Follow-up|2
7681377|NCT01276106|26716516|P4|Overall Study|Lack of Efficacy|1
7681378|NCT01276106|26716517|P3|Overall Study|Lack of Efficacy|0
7681379|NCT01276106|26716518|P2|Overall Study|Lack of Efficacy|1
7681380|NCT01276106|26716519|P1|Overall Study|Lack of Efficacy|0
7681381|NCT01276106|26716516|P4|Overall Study|Withdrawal by Subject|6
7681382|NCT01276106|26716517|P3|Overall Study|Withdrawal by Subject|1
7681383|NCT01276106|26716518|P2|Overall Study|Withdrawal by Subject|3
7681384|NCT01276106|26716519|P1|Overall Study|Withdrawal by Subject|6
7681385|NCT01276106|26716516|P4|Overall Study|Adverse Event|3
7681386|NCT01276106|26716517|P3|Overall Study|Adverse Event|11
7681387|NCT01276106|26716518|P2|Overall Study|Adverse Event|3
7681388|NCT01276106|26716519|P1|Overall Study|Adverse Event|3
7681389|NCT01276054|26716531|P2|Overall Study|No one to oversee trial after P.I. left|2
7681390|NCT01276054|26716532|P1|Overall Study|No one to oversee trial after P.I. left|2
7681391|NCT01276041|26716538|P1|Overall Study|Protocol Violation|1
7681392|NCT01276041|26716538|P1|Overall Study|Adverse Event|2
7681393|NCT01275833|26716547|P2|Overall Study|Study terminated|1
7681394|NCT01275833|26716548|P1|Overall Study|Study terminated|1
7681395|NCT01275755|26716556|P2|Run-out Placebo Period|Lost to Follow-up|0
7681396|NCT01275755|26716557|P1|Run-out Placebo Period|Lost to Follow-up|1
7681397|NCT01275755|26716556|P2|Double-blind Treatment Period|Withdrawal by Subject|0
7681398|NCT01275755|26716557|P1|Double-blind Treatment Period|Withdrawal by Subject|1
7681399|NCT01275755|26716556|P2|Double-blind Treatment Period|Lost to Follow-up|1
7681400|NCT01275755|26716557|P1|Double-blind Treatment Period|Lost to Follow-up|1
7681401|NCT01275755|26716556|P2|Double-blind Treatment Period|Adverse Event|2
7681402|NCT01275755|26716557|P1|Double-blind Treatment Period|Adverse Event|0
7681403|NCT01275677|26716565|P2|Overall Study|No clinical follow up.|4
7681404|NCT01275677|26716566|P1|Overall Study|No clinical follow up.|1
7681405|NCT01275677|26716565|P2|Overall Study|No follow-up|37
7681406|NCT01275677|26716566|P1|Overall Study|No follow-up|26
7681407|NCT01275677|26716565|P2|Overall Study|Not at risk for recurrence.|1
7681408|NCT01275677|26716566|P1|Overall Study|Not at risk for recurrence.|1
7681409|NCT01275625|26716592|P1|Overall Study|Other|1
7681410|NCT01275625|26716592|P1|Overall Study|Adverse Event|4
7681411|NCT01275625|26716592|P1|Overall Study|Protocol Violation|1
7681412|NCT01275625|26716592|P1|Overall Study|Withdrawal by Subject|3
7681413|NCT01275625|26716592|P1|Overall Study|Lost to Follow-up|1
7681414|NCT01275625|26716592|P1|Overall Study|Lack of Efficacy|2
7681415|NCT01275625|26716592|P1|Overall Study|Death|1
7681416|NCT01275430|26716610|P1|Overall Study|Inability to achieve maximum p-wave|1
7681417|NCT01275430|26716610|P1|Overall Study|Device Malfunction|1
7681418|NCT01275430|26716610|P1|Overall Study|No Contrast Injection|6
7681419|NCT01275430|26716610|P1|Overall Study|Adverse Event|1
7681420|NCT01275339|26716675|P4|Overall Study|Withdrawal by Subject|0
7681421|NCT01275339|26716676|P3|Overall Study|Withdrawal by Subject|1
7681422|NCT01275339|26716677|P2|Overall Study|Withdrawal by Subject|0
7681423|NCT01275339|26716678|P1|Overall Study|Withdrawal by Subject|0
7681424|NCT01275339|26716675|P4|Overall Study|Referred for surgery for AS symptoms|0
7681425|NCT01275339|26716676|P3|Overall Study|Referred for surgery for AS symptoms|0
7681426|NCT01275339|26716677|P2|Overall Study|Referred for surgery for AS symptoms|0
7681427|NCT01275339|26716678|P1|Overall Study|Referred for surgery for AS symptoms|1
7681428|NCT01275222|26716710|P6|Phase ll by Stratum|Death|1
7681429|NCT01275222|26716711|P5|Phase ll by Stratum|Death|1
7681430|NCT01275222|26716712|P4|Phase ll by Stratum|Death|0
7681431|NCT01275222|26716713|P3|Phase ll by Stratum|Death|0
7681432|NCT01275222|26716714|P2|Phase ll by Stratum|Death|0
7681433|NCT01275222|26716715|P1|Phase ll by Stratum|Death|0
7681434|NCT01275222|26716710|P6|Phase ll by Stratum|Withdrawal by Subject|3
7681435|NCT01275222|26716711|P5|Phase ll by Stratum|Withdrawal by Subject|2
7681436|NCT01275222|26716712|P4|Phase ll by Stratum|Withdrawal by Subject|0
7681437|NCT01275222|26716713|P3|Phase ll by Stratum|Withdrawal by Subject|0
7681438|NCT01275222|26716714|P2|Phase ll by Stratum|Withdrawal by Subject|0
7681439|NCT01275222|26716715|P1|Phase ll by Stratum|Withdrawal by Subject|0
7681440|NCT01275222|26716710|P6|Phase ll by Stratum|Disease progression|31
7681441|NCT01275222|26716711|P5|Phase ll by Stratum|Disease progression|23
7681442|NCT01275222|26716712|P4|Phase ll by Stratum|Disease progression|0
7681443|NCT01275222|26716713|P3|Phase ll by Stratum|Disease progression|0
7681444|NCT01275222|26716714|P2|Phase ll by Stratum|Disease progression|0
7681445|NCT01275222|26716715|P1|Phase ll by Stratum|Disease progression|0
7681446|NCT01275222|26716710|P6|Phase ll by Stratum|Abnormal laboratory values|1
7681447|NCT01275222|26716711|P5|Phase ll by Stratum|Abnormal laboratory values|0
7681448|NCT01275222|26716712|P4|Phase ll by Stratum|Abnormal laboratory values|0
7681449|NCT01275222|26716713|P3|Phase ll by Stratum|Abnormal laboratory values|0
7681450|NCT01275222|26716714|P2|Phase ll by Stratum|Abnormal laboratory values|0
7681451|NCT01275222|26716715|P1|Phase ll by Stratum|Abnormal laboratory values|0
7681452|NCT01275222|26716710|P6|Phase ll by Stratum|Adverse Event|10
7681453|NCT01275222|26716711|P5|Phase ll by Stratum|Adverse Event|2
7681454|NCT01275222|26716712|P4|Phase ll by Stratum|Adverse Event|0
7681455|NCT01275222|26716713|P3|Phase ll by Stratum|Adverse Event|0
7681456|NCT01275222|26716714|P2|Phase ll by Stratum|Adverse Event|0
7681457|NCT01275222|26716715|P1|Phase ll by Stratum|Adverse Event|0
7681458|NCT01275222|26716710|P6|Phase l by Treatment|Death|0
7681459|NCT01275222|26716711|P5|Phase l by Treatment|Death|0
7681460|NCT01275222|26716712|P4|Phase l by Treatment|Death|1
7681461|NCT01275222|26716713|P3|Phase l by Treatment|Death|0
7681462|NCT01275222|26716714|P2|Phase l by Treatment|Death|1
7681463|NCT01275222|26716715|P1|Phase l by Treatment|Death|0
7681464|NCT01275222|26716710|P6|Phase l by Treatment|Withdrawal by Subject|0
7681465|NCT01275222|26716711|P5|Phase l by Treatment|Withdrawal by Subject|0
7681466|NCT01275222|26716712|P4|Phase l by Treatment|Withdrawal by Subject|1
7681467|NCT01275222|26716713|P3|Phase l by Treatment|Withdrawal by Subject|0
7681468|NCT01275222|26716714|P2|Phase l by Treatment|Withdrawal by Subject|0
7681469|NCT01275222|26716715|P1|Phase l by Treatment|Withdrawal by Subject|0
7681470|NCT01275222|26716710|P6|Phase l by Treatment|Disease progression|0
7681471|NCT01275222|26716711|P5|Phase l by Treatment|Disease progression|0
7681472|NCT01275222|26716712|P4|Phase l by Treatment|Disease progression|5
7681473|NCT01275222|26716713|P3|Phase l by Treatment|Disease progression|2
7681474|NCT01275222|26716714|P2|Phase l by Treatment|Disease progression|8
7681475|NCT01275222|26716715|P1|Phase l by Treatment|Disease progression|12
7681476|NCT01275222|26716710|P6|Phase l by Treatment|Abnormal test procedure result(s)|0
7681477|NCT01275222|26716711|P5|Phase l by Treatment|Abnormal test procedure result(s)|0
7681478|NCT01275222|26716712|P4|Phase l by Treatment|Abnormal test procedure result(s)|1
7681479|NCT01275222|26716713|P3|Phase l by Treatment|Abnormal test procedure result(s)|0
7681480|NCT01275222|26716714|P2|Phase l by Treatment|Abnormal test procedure result(s)|0
7681481|NCT01275222|26716715|P1|Phase l by Treatment|Abnormal test procedure result(s)|0
7681482|NCT01275222|26716710|P6|Phase l by Treatment|Abnormal laboratory value(s)|0
7681483|NCT01275222|26716711|P5|Phase l by Treatment|Abnormal laboratory value(s)|0
7681484|NCT01275222|26716712|P4|Phase l by Treatment|Abnormal laboratory value(s)|0
7681485|NCT01275222|26716713|P3|Phase l by Treatment|Abnormal laboratory value(s)|1
7681486|NCT01275222|26716714|P2|Phase l by Treatment|Abnormal laboratory value(s)|0
7681487|NCT01275222|26716715|P1|Phase l by Treatment|Abnormal laboratory value(s)|0
7681488|NCT01275222|26716710|P6|Phase l by Treatment|Adverse Event|0
7681489|NCT01275222|26716711|P5|Phase l by Treatment|Adverse Event|0
7681490|NCT01275222|26716712|P4|Phase l by Treatment|Adverse Event|3
7681491|NCT01275222|26716713|P3|Phase l by Treatment|Adverse Event|2
7681492|NCT01275222|26716714|P2|Phase l by Treatment|Adverse Event|4
7681493|NCT01275222|26716715|P1|Phase l by Treatment|Adverse Event|1
7681494|NCT01275196|26716773|P2|Overall Study|Suboptimal response/treatment failure|6
7681495|NCT01275196|26716774|P1|Overall Study|Suboptimal response/treatment failure|5
7681496|NCT01275196|26716773|P2|Overall Study|Protocol Violation|0
7681497|NCT01275196|26716774|P1|Overall Study|Protocol Violation|1
7681498|NCT01275196|26716773|P2|Overall Study|Disease Progression|5
7681499|NCT01275196|26716774|P1|Overall Study|Disease Progression|6
7681500|NCT01275196|26716773|P2|Overall Study|Lost to Follow-up|0
7681501|NCT01275196|26716774|P1|Overall Study|Lost to Follow-up|1
7681502|NCT01275196|26716773|P2|Overall Study|Withdrawal by Subject|5
7681503|NCT01275196|26716774|P1|Overall Study|Withdrawal by Subject|4
7681504|NCT01275196|26716773|P2|Overall Study|Adverse Event|5
7681505|NCT01275196|26716774|P1|Overall Study|Adverse Event|3
7681506|NCT01275170|26716821|P8|Part 1: Period 1|Equipment malfunction before study drug|0
7681507|NCT01275170|26716822|P7|Part 1: Period 1|Equipment malfunction before study drug|0
7681508|NCT01275170|26716823|P6|Part 1: Period 1|Equipment malfunction before study drug|0
7681509|NCT01275170|26716824|P5|Part 1: Period 1|Equipment malfunction before study drug|0
7681510|NCT01275170|26716825|P4|Part 1: Period 1|Equipment malfunction before study drug|0
7681511|NCT01275170|26716826|P3|Part 1: Period 1|Equipment malfunction before study drug|0
7681512|NCT01275170|26716827|P2|Part 1: Period 1|Equipment malfunction before study drug|0
7681513|NCT01275170|26716828|P1|Part 1: Period 1|Equipment malfunction before study drug|1
7681514|NCT01275144|26717046|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
7681515|NCT01275144|26717047|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
7681516|NCT01275131|26717105|P4|Period 2 (Crossover)|Withdrawal by Subject|2
7681517|NCT01275131|26717106|P3|Period 2 (Crossover)|Withdrawal by Subject|1
7681518|NCT01275131|26717107|P2|Period 2 (Crossover)|Withdrawal by Subject|0
7681519|NCT01275131|26717108|P1|Period 2 (Crossover)|Withdrawal by Subject|1
7681520|NCT01275131|26717105|P4|Period 2 (Crossover)|Adverse Event|0
7681521|NCT01275131|26717106|P3|Period 2 (Crossover)|Adverse Event|0
7681522|NCT01275131|26717107|P2|Period 2 (Crossover)|Adverse Event|1
7681523|NCT01275131|26717108|P1|Period 2 (Crossover)|Adverse Event|0
7681524|NCT01275131|26717105|P4|Period 1|Physician Decision|0
7681525|NCT01275131|26717106|P3|Period 1|Physician Decision|0
7681526|NCT01275131|26717107|P2|Period 1|Physician Decision|0
7681527|NCT01275131|26717108|P1|Period 1|Physician Decision|1
7681528|NCT01275131|26717105|P4|Period 1|Withdrawal by Subject|2
7681529|NCT01275131|26717106|P3|Period 1|Withdrawal by Subject|3
7681530|NCT01275131|26717107|P2|Period 1|Withdrawal by Subject|0
7681531|NCT01275131|26717108|P1|Period 1|Withdrawal by Subject|1
7681532|NCT01275066|26717151|P3|Overall Study|Not Diagnosed w/ Disease|0
7681533|NCT01275066|26717152|P2|Overall Study|Not Diagnosed w/ Disease|0
7681534|NCT01275066|26717153|P1|Overall Study|Not Diagnosed w/ Disease|1
7681535|NCT01275066|26717151|P3|Overall Study|Withdrawal by Subject|1
7681536|NCT01275066|26717152|P2|Overall Study|Withdrawal by Subject|0
7681537|NCT01275066|26717153|P1|Overall Study|Withdrawal by Subject|0
7681538|NCT01274715|26717186|P1|Overall Study|After consent, met exclusion criteria.|1
7681539|NCT01274715|26717186|P1|Overall Study|After consent, met exclusion criteria.|1
7681540|NCT01274715|26717186|P1|Overall Study|After consent, met exclusion criteria.|1
7681541|NCT01274715|26717186|P1|Overall Study|Lost to Follow-up|1
7681542|NCT01274637|26717193|P2|Overall Study|Lost to Follow-up|1
7681543|NCT01274637|26717194|P1|Overall Study|Lost to Follow-up|0
7681544|NCT01274637|26717193|P2|Overall Study|Withdrawal by Subject|1
7681545|NCT01274637|26717194|P1|Overall Study|Withdrawal by Subject|0
7681546|NCT01274559|26717233|P2|Overall Study|Withdrawal by Subject|13
7681547|NCT01274559|26717234|P1|Overall Study|Withdrawal by Subject|25
7681548|NCT01274559|26717233|P2|Overall Study|Study Terminated by Sponsor|87
7681549|NCT01274559|26717234|P1|Overall Study|Study Terminated by Sponsor|79
7681550|NCT01274559|26717233|P2|Overall Study|Protocol Violation|23
7681551|NCT01274559|26717234|P1|Overall Study|Protocol Violation|28
7681552|NCT01274559|26717233|P2|Overall Study|Physician Decision|1
7681553|NCT01274559|26717234|P1|Overall Study|Physician Decision|2
7681554|NCT01274559|26717233|P2|Overall Study|Non-compliance with Study Drug|4
7681555|NCT01274559|26717234|P1|Overall Study|Non-compliance with Study Drug|2
7681556|NCT01274559|26717233|P2|Overall Study|Lost to Follow-up|3
7681557|NCT01274559|26717234|P1|Overall Study|Lost to Follow-up|3
7681558|NCT01274559|26717233|P2|Overall Study|Death|1
7681559|NCT01274559|26717234|P1|Overall Study|Death|1
7681560|NCT01274559|26717233|P2|Overall Study|Adverse Event|13
7681561|NCT01274559|26717234|P1|Overall Study|Adverse Event|57
7681562|NCT01274533|26717284|P1|Overall Study|Disease progression|2
7681563|NCT01274533|26717284|P1|Overall Study|Non-compliance|1
7681564|NCT01274533|26717284|P1|Overall Study|Withdrawal by Subject|1
7681565|NCT01274429|26717320|P1|Overall Study|Study closed do to lack of funding|5
7681566|NCT01274351|26717325|P1|Overall Study|hospitalization|1
7681567|NCT01274351|26717325|P1|Overall Study|progression of disease|3
7681568|NCT01274351|26717325|P1|Overall Study|Adverse Event|8
7681569|NCT01274351|26717325|P1|Overall Study|Withdrawal by Subject|3
7681570|NCT01274351|26717325|P1|Overall Study|Death|2
7681571|NCT01274351|26717325|P1|Overall Study|Pregnancy|1
7681572|NCT01274351|26717325|P1|Overall Study|patient not compliant with the protocol|1
7681573|NCT01274351|26717325|P1|Overall Study|Lost to Follow-up|1
7681574|NCT01274338|26717340|P6|Overall Study|Reason not reported|0
7681575|NCT01274338|26717341|P5|Overall Study|Reason not reported|1
7681576|NCT01274338|26717342|P4|Overall Study|Reason not reported|0
7681577|NCT01274338|26717343|P3|Overall Study|Reason not reported|3
7681578|NCT01274338|26717344|P2|Overall Study|Reason not reported|21
7681579|NCT01274338|26717345|P1|Overall Study|Reason not reported|12
7681580|NCT01274338|26717340|P6|Overall Study|Pregnancy|0
7681581|NCT01274338|26717341|P5|Overall Study|Pregnancy|0
7681582|NCT01274338|26717342|P4|Overall Study|Pregnancy|0
7681583|NCT01274338|26717343|P3|Overall Study|Pregnancy|1
7681584|NCT01274338|26717344|P2|Overall Study|Pregnancy|0
7681585|NCT01274338|26717345|P1|Overall Study|Pregnancy|0
7681586|NCT01274338|26717340|P6|Overall Study|Treatment arm was suspended due to toxicity|0
7681587|NCT01274338|26717341|P5|Overall Study|Treatment arm was suspended due to toxicity|0
7681588|NCT01274338|26717342|P4|Overall Study|Treatment arm was suspended due to toxicity|0
7681589|NCT01274338|26717343|P3|Overall Study|Treatment arm was suspended due to toxicity|0
7681590|NCT01274338|26717344|P2|Overall Study|Treatment arm was suspended due to toxicity|0
7681591|NCT01274338|26717345|P1|Overall Study|Treatment arm was suspended due to toxicity|4
7681592|NCT01274338|26717340|P6|Overall Study|Other complicating diseases|0
7681593|NCT01274338|26717341|P5|Overall Study|Other complicating diseases|0
7681594|NCT01274338|26717342|P4|Overall Study|Other complicating diseases|0
7681595|NCT01274338|26717343|P3|Overall Study|Other complicating diseases|1
7681596|NCT01274338|26717344|P2|Overall Study|Other complicating diseases|3
7681597|NCT01274338|26717345|P1|Overall Study|Other complicating diseases|0
7681598|NCT01274338|26717340|P6|Overall Study|Alternative therapy|0
7681599|NCT01274338|26717341|P5|Overall Study|Alternative therapy|0
7681600|NCT01274338|26717342|P4|Overall Study|Alternative therapy|0
7681601|NCT01274338|26717343|P3|Overall Study|Alternative therapy|0
7681602|NCT01274338|26717344|P2|Overall Study|Alternative therapy|1
7681603|NCT01274338|26717345|P1|Overall Study|Alternative therapy|0
7681604|NCT01274338|26717340|P6|Overall Study|Did not start treatment|0
7681605|NCT01274338|26717341|P5|Overall Study|Did not start treatment|0
7681606|NCT01274338|26717342|P4|Overall Study|Did not start treatment|0
7681607|NCT01274338|26717343|P3|Overall Study|Did not start treatment|7
7681608|NCT01274338|26717344|P2|Overall Study|Did not start treatment|116
7681609|NCT01274338|26717345|P1|Overall Study|Did not start treatment|8
7681610|NCT01274338|26717340|P6|Overall Study|Withdrawal by Subject|0
7681611|NCT01274338|26717341|P5|Overall Study|Withdrawal by Subject|0
7681612|NCT01274338|26717342|P4|Overall Study|Withdrawal by Subject|0
7681613|NCT01274338|26717343|P3|Overall Study|Withdrawal by Subject|17
7681614|NCT01274338|26717344|P2|Overall Study|Withdrawal by Subject|99
7681615|NCT01274338|26717345|P1|Overall Study|Withdrawal by Subject|27
7681616|NCT01274338|26717340|P6|Overall Study|Death|0
7681617|NCT01274338|26717341|P5|Overall Study|Death|0
7681618|NCT01274338|26717342|P4|Overall Study|Death|0
7681619|NCT01274338|26717343|P3|Overall Study|Death|0
7681620|NCT01274338|26717344|P2|Overall Study|Death|1
7681621|NCT01274338|26717345|P1|Overall Study|Death|8
7681622|NCT01274338|26717340|P6|Overall Study|Adverse Event|0
7681623|NCT01274338|26717341|P5|Overall Study|Adverse Event|0
7681624|NCT01274338|26717342|P4|Overall Study|Adverse Event|1
7681625|NCT01274338|26717343|P3|Overall Study|Adverse Event|180
7681626|NCT01274338|26717344|P2|Overall Study|Adverse Event|105
7681627|NCT01274338|26717345|P1|Overall Study|Adverse Event|272
7681628|NCT01274338|26717340|P6|Overall Study|Lack of Efficacy|0
7681629|NCT01274338|26717341|P5|Overall Study|Lack of Efficacy|0
7681630|NCT01274338|26717342|P4|Overall Study|Lack of Efficacy|0
7681631|NCT01274338|26717343|P3|Overall Study|Lack of Efficacy|116
7681632|NCT01274338|26717344|P2|Overall Study|Lack of Efficacy|108
7681633|NCT01274338|26717345|P1|Overall Study|Lack of Efficacy|72
7681634|NCT01274182|26717373|P3|Overall Study|Death|1
7681635|NCT01274182|26717374|P2|Overall Study|Death|0
7681636|NCT01274182|26717375|P1|Overall Study|Death|1
7681637|NCT01274182|26717373|P3|Overall Study|Protocol Violation|0
7681638|NCT01274182|26717374|P2|Overall Study|Protocol Violation|2
7681639|NCT01274182|26717375|P1|Overall Study|Protocol Violation|3
7681640|NCT01274182|26717373|P3|Overall Study|Lost to Follow-up|1
7681641|NCT01274182|26717374|P2|Overall Study|Lost to Follow-up|3
7681642|NCT01274182|26717375|P1|Overall Study|Lost to Follow-up|2
7681643|NCT01274182|26717373|P3|Overall Study|Withdrawal by Subject|3
7681644|NCT01274182|26717374|P2|Overall Study|Withdrawal by Subject|5
7681645|NCT01274182|26717375|P1|Overall Study|Withdrawal by Subject|5
7681646|NCT01274182|26717373|P3|Overall Study|Adverse Event|3
7681647|NCT01274182|26717374|P2|Overall Study|Adverse Event|5
7681648|NCT01274182|26717375|P1|Overall Study|Adverse Event|4
7681649|NCT01274182|26717373|P3|Overall Study|Unsatisfactory therapeutic effect|4
7681650|NCT01274182|26717374|P2|Overall Study|Unsatisfactory therapeutic effect|3
7681651|NCT01274182|26717375|P1|Overall Study|Unsatisfactory therapeutic effect|6
7681652|NCT01273883|26717416|P2|Second Intervention|Lack of Efficacy|0
7681653|NCT01273883|26717417|P1|Second Intervention|Lack of Efficacy|1
7681654|NCT01273883|26717416|P2|Second Intervention|Lost to Follow-up|1
7681655|NCT01273883|26717417|P1|Second Intervention|Lost to Follow-up|1
7681656|NCT01273883|26717416|P2|First Intervention|Adverse Event|1
7681657|NCT01273883|26717417|P1|First Intervention|Adverse Event|2
7681658|NCT01273818|26717443|P3|Overall Study|Physician Decision|9
7681659|NCT01273818|26717444|P2|Overall Study|Physician Decision|2
7681660|NCT01273818|26717445|P1|Overall Study|Physician Decision|13
7681661|NCT01273805|26717455|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
7681662|NCT01273805|26717456|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
7681663|NCT01273623|26717487|P1|Overall Study|did not meet IVUS criteria|29
7681664|NCT01273597|26717494|P1|Overall Study|Reason Not Reported|1
7681665|NCT01273597|26717494|P1|Overall Study|Underwent Kidney Transplantation|2
7681666|NCT01273597|26717494|P1|Overall Study|Adverse Event|5
7681667|NCT01273519|26717509|P3|Overall Study|Other|1
7681668|NCT01273519|26717510|P2|Overall Study|Other|1
7681669|NCT01273519|26717511|P1|Overall Study|Other|6
7681670|NCT01273519|26717509|P3|Overall Study|Lack of Efficacy|4
7681671|NCT01273519|26717510|P2|Overall Study|Lack of Efficacy|3
7681672|NCT01273519|26717511|P1|Overall Study|Lack of Efficacy|8
7681673|NCT01273519|26717509|P3|Overall Study|Lost to Follow-up|3
7681674|NCT01273519|26717510|P2|Overall Study|Lost to Follow-up|1
7681675|NCT01273519|26717511|P1|Overall Study|Lost to Follow-up|2
7681676|NCT01273519|26717509|P3|Overall Study|Adverse Event|0
7681677|NCT01273519|26717510|P2|Overall Study|Adverse Event|0
7681678|NCT01273519|26717511|P1|Overall Study|Adverse Event|3
7681679|NCT01273181|26717554|P4|Phase 2, Dose 2|Death during treatment|1
7681680|NCT01273181|26717555|P3|Phase 2, Dose 2|Death during treatment|0
7681681|NCT01273181|26717556|P2|Phase 2, Dose 2|Death during treatment|0
7681682|NCT01273181|26717557|P1|Phase 2, Dose 2|Death during treatment|0
7681683|NCT01273181|26717554|P4|Phase 2, Dose 1|Study termination|0
7681684|NCT01273181|26717555|P3|Phase 2, Dose 1|Study termination|1
7681685|NCT01273181|26717556|P2|Phase 2, Dose 1|Study termination|0
7681686|NCT01273181|26717557|P1|Phase 2, Dose 1|Study termination|0
7681687|NCT01273181|26717554|P4|Phase I, Dose 2|Death during treatment|0
7681688|NCT01273181|26717555|P3|Phase I, Dose 2|Death during treatment|0
7681689|NCT01273181|26717556|P2|Phase I, Dose 2|Death during treatment|1
7681690|NCT01273181|26717557|P1|Phase I, Dose 2|Death during treatment|0
7681691|NCT01273181|26717554|P4|Phase I, Dose 1|Study termination|0
7681692|NCT01273181|26717555|P3|Phase I, Dose 1|Study termination|0
7681693|NCT01273181|26717556|P2|Phase I, Dose 1|Study termination|0
7681694|NCT01273181|26717557|P1|Phase I, Dose 1|Study termination|1
7681695|NCT01273155|26717575|P7|Overall Study|Withdrew during C1/refused further trmt|0
7681696|NCT01273155|26717576|P6|Overall Study|Withdrew during C1/refused further trmt|1
7681697|NCT01273155|26717577|P5|Overall Study|Withdrew during C1/refused further trmt|1
7681698|NCT01273155|26717578|P4|Overall Study|Withdrew during C1/refused further trmt|0
7681699|NCT01273155|26717579|P3|Overall Study|Withdrew during C1/refused further trmt|1
7681700|NCT01273155|26717580|P2|Overall Study|Withdrew during C1/refused further trmt|0
7681701|NCT01273155|26717581|P1|Overall Study|Withdrew during C1/refused further trmt|0
7681702|NCT01273155|26717575|P7|Overall Study|Died during Cycle 1|2
7681703|NCT01273155|26717576|P6|Overall Study|Died during Cycle 1|2
7681704|NCT01273155|26717577|P5|Overall Study|Died during Cycle 1|0
7681705|NCT01273155|26717578|P4|Overall Study|Died during Cycle 1|1
7681706|NCT01273155|26717579|P3|Overall Study|Died during Cycle 1|1
7681707|NCT01273155|26717580|P2|Overall Study|Died during Cycle 1|0
7681708|NCT01273155|26717581|P1|Overall Study|Died during Cycle 1|0
7681709|NCT01273155|26717575|P7|Overall Study|Off study prior to C1/due to toxicity|1
7681710|NCT01273155|26717576|P6|Overall Study|Off study prior to C1/due to toxicity|0
7681711|NCT01273155|26717577|P5|Overall Study|Off study prior to C1/due to toxicity|0
7681712|NCT01273155|26717578|P4|Overall Study|Off study prior to C1/due to toxicity|0
7681713|NCT01273155|26717579|P3|Overall Study|Off study prior to C1/due to toxicity|2
7681714|NCT01273155|26717580|P2|Overall Study|Off study prior to C1/due to toxicity|0
7681715|NCT01273155|26717581|P1|Overall Study|Off study prior to C1/due to toxicity|0
7681716|NCT01273155|26717575|P7|Overall Study|Change in liver function/no longer eval.|0
7681717|NCT01273155|26717576|P6|Overall Study|Change in liver function/no longer eval.|0
7681718|NCT01273155|26717577|P5|Overall Study|Change in liver function/no longer eval.|1
7681719|NCT01273155|26717578|P4|Overall Study|Change in liver function/no longer eval.|0
7681720|NCT01273155|26717579|P3|Overall Study|Change in liver function/no longer eval.|0
7681721|NCT01273155|26717580|P2|Overall Study|Change in liver function/no longer eval.|1
7681722|NCT01273155|26717581|P1|Overall Study|Change in liver function/no longer eval.|0
7681723|NCT01273155|26717575|P7|Overall Study|Off study trmt prior to end of C1/PD|3
7681724|NCT01273155|26717576|P6|Overall Study|Off study trmt prior to end of C1/PD|2
7681725|NCT01273155|26717577|P5|Overall Study|Off study trmt prior to end of C1/PD|0
7681726|NCT01273155|26717578|P4|Overall Study|Off study trmt prior to end of C1/PD|0
7681727|NCT01273155|26717579|P3|Overall Study|Off study trmt prior to end of C1/PD|8
7681728|NCT01273155|26717580|P2|Overall Study|Off study trmt prior to end of C1/PD|3
7681729|NCT01273155|26717581|P1|Overall Study|Off study trmt prior to end of C1/PD|2
7681730|NCT01273064|26717658|P5|Overall Study|Physician Decision|1
7681731|NCT01273064|26717659|P4|Overall Study|Physician Decision|0
7681732|NCT01273064|26717660|P3|Overall Study|Physician Decision|0
7681733|NCT01273064|26717661|P2|Overall Study|Physician Decision|0
7681734|NCT01273064|26717662|P1|Overall Study|Physician Decision|0
7681735|NCT01273064|26717658|P5|Overall Study|Lost to Follow-up|0
7681736|NCT01273064|26717659|P4|Overall Study|Lost to Follow-up|0
7681737|NCT01273064|26717660|P3|Overall Study|Lost to Follow-up|0
7681738|NCT01273064|26717661|P2|Overall Study|Lost to Follow-up|0
7681739|NCT01273064|26717662|P1|Overall Study|Lost to Follow-up|1
7681740|NCT01273064|26717658|P5|Overall Study|Study Termination|8
7681741|NCT01273064|26717659|P4|Overall Study|Study Termination|16
7681742|NCT01273064|26717660|P3|Overall Study|Study Termination|26
7681743|NCT01273064|26717661|P2|Overall Study|Study Termination|27
7681744|NCT01273064|26717662|P1|Overall Study|Study Termination|13
7681745|NCT01273064|26717658|P5|Overall Study|Withdrawal by Subject|0
7681746|NCT01273064|26717659|P4|Overall Study|Withdrawal by Subject|2
7681747|NCT01273064|26717660|P3|Overall Study|Withdrawal by Subject|2
7681748|NCT01273064|26717661|P2|Overall Study|Withdrawal by Subject|2
7681749|NCT01273064|26717662|P1|Overall Study|Withdrawal by Subject|4
7681750|NCT01273064|26717658|P5|Overall Study|Adverse Event|1
7681751|NCT01273064|26717659|P4|Overall Study|Adverse Event|2
7681752|NCT01273064|26717660|P3|Overall Study|Adverse Event|3
7681753|NCT01273064|26717661|P2|Overall Study|Adverse Event|1
7681754|NCT01273064|26717662|P1|Overall Study|Adverse Event|5
7681755|NCT01273038|26717681|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
7681756|NCT01273038|26717682|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
7681757|NCT01273038|26717681|P2|Second Intervention (14 Days)|Adverse Event|1
7681758|NCT01273038|26717682|P1|Second Intervention (14 Days)|Adverse Event|0
7681759|NCT01272947|26717732|P2|Overall Study|Abnormal Laboratory Value|2
7681760|NCT01272947|26717733|P1|Overall Study|Abnormal Laboratory Value|2
7681761|NCT01272934|26717743|P2|Overall Study|Abnormal Laboratory Value|1
7681762|NCT01272934|26717744|P1|Overall Study|Abnormal Laboratory Value|0
7681763|NCT01272934|26717743|P2|Overall Study|Adverse Event|1
7681764|NCT01272934|26717744|P1|Overall Study|Adverse Event|0
7681765|NCT01272921|26717754|P2|Overall Study|Protocol Violation|1
7681766|NCT01272921|26717755|P1|Overall Study|Protocol Violation|2
7681767|NCT01272908|26717763|P1|Re-Treatment Period|Withdrawal by Subject|1
7681768|NCT01272908|26717763|P1|Re-Treatment Period|Lack of Efficacy|3
7681769|NCT01272908|26717763|P1|Re-Treatment Period|Adverse Event|2
7681770|NCT01272908|26717763|P1|Initial Treatment Period|Withdrawal by Subject|1
7681771|NCT01272908|26717763|P1|Initial Treatment Period|Protocol Violation|1
7681772|NCT01272908|26717763|P1|Initial Treatment Period|Lack of Efficacy|5
7681773|NCT01272908|26717763|P1|Initial Treatment Period|Adverse Event|1
7681774|NCT01272869|26717803|P2|Period 2 (14 Days)|Adverse Event|0
7681775|NCT01272869|26717804|P1|Period 2 (14 Days)|Adverse Event|1
7681776|NCT01272804|26717831|P6|Overall Study|Adverse Event|1
7681777|NCT01272804|26717832|P5|Overall Study|Adverse Event|2
7681778|NCT01272804|26717833|P4|Overall Study|Adverse Event|0
7681779|NCT01272804|26717834|P3|Overall Study|Adverse Event|0
7681780|NCT01272804|26717835|P2|Overall Study|Adverse Event|0
7681781|NCT01272804|26717836|P1|Overall Study|Adverse Event|1
7681782|NCT01272661|26717994|P3|Overall Study|lost to followup/case closed/ no birth|72
7681783|NCT01272661|26717995|P2|Overall Study|lost to followup/case closed/ no birth|209
7681784|NCT01272661|26717996|P1|Overall Study|lost to followup/case closed/ no birth|126
7681785|NCT01272635|26718021|P4|Overall Study|Lost to Follow-up|23
7681786|NCT01272635|26718022|P3|Overall Study|Lost to Follow-up|31
7681787|NCT01272635|26718023|P2|Overall Study|Lost to Follow-up|20
7681788|NCT01272635|26718024|P1|Overall Study|Lost to Follow-up|31
7681789|NCT01272232|26718108|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
7681790|NCT01272232|26718109|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
7681791|NCT01272232|26718110|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
7681792|NCT01272232|26718108|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
7681793|NCT01272232|26718109|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
7681794|NCT01272232|26718110|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
7681795|NCT01272232|26718108|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
7681796|NCT01272232|26718109|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
7681797|NCT01272232|26718110|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
7681798|NCT01272232|26718108|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
7681799|NCT01272232|26718109|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
7681800|NCT01272232|26718110|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
7681801|NCT01272232|26718108|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
7681802|NCT01272232|26718109|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
7681803|NCT01272232|26718110|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
7681804|NCT01272232|26718108|P3|Weeks 0-56|Unclassified|12
7681805|NCT01272232|26718109|P2|Weeks 0-56|Unclassified|7
7681806|NCT01272232|26718110|P1|Weeks 0-56|Unclassified|16
7681807|NCT01272232|26718108|P3|Weeks 0-56|Withdrawal criteria|37
7681808|NCT01272232|26718109|P2|Weeks 0-56|Withdrawal criteria|14
7681809|NCT01272232|26718110|P1|Weeks 0-56|Withdrawal criteria|32
7681810|NCT01272232|26718108|P3|Weeks 0-56|Protocol Violation|13
7681811|NCT01272232|26718109|P2|Weeks 0-56|Protocol Violation|8
7681812|NCT01272232|26718110|P1|Weeks 0-56|Protocol Violation|12
7681813|NCT01272232|26718108|P3|Weeks 0-56|Lack of Efficacy|3
7681814|NCT01272232|26718109|P2|Weeks 0-56|Lack of Efficacy|0
7681815|NCT01272232|26718110|P1|Weeks 0-56|Lack of Efficacy|0
7681816|NCT01272232|26718108|P3|Weeks 0-56|Adverse Event|7
7681817|NCT01272232|26718109|P2|Weeks 0-56|Adverse Event|18
7681818|NCT01272232|26718110|P1|Weeks 0-56|Adverse Event|39
7681819|NCT01272219|26718155|P6|Main + Extension Period: Week 0-172|Unclassified|51
7681820|NCT01272219|26718156|P5|Main + Extension Period: Week 0-172|Unclassified|61
7681821|NCT01272219|26718157|P4|Main + Extension Period: Week 0-172|Unclassified|0
7681822|NCT01272219|26718158|P3|Main + Extension Period: Week 0-172|Unclassified|0
7681823|NCT01272219|26718159|P2|Main + Extension Period: Week 0-172|Unclassified|0
7681824|NCT01272219|26718160|P1|Main + Extension Period: Week 0-172|Unclassified|0
7681825|NCT01272219|26718155|P6|Main + Extension Period: Week 0-172|Missing reason|0
7681826|NCT01272219|26718156|P5|Main + Extension Period: Week 0-172|Missing reason|1
7681827|NCT01272219|26718157|P4|Main + Extension Period: Week 0-172|Missing reason|0
7681828|NCT01272219|26718158|P3|Main + Extension Period: Week 0-172|Missing reason|0
7681829|NCT01272219|26718159|P2|Main + Extension Period: Week 0-172|Missing reason|0
7681830|NCT01272219|26718160|P1|Main + Extension Period: Week 0-172|Missing reason|0
7681831|NCT01272219|26718155|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
7681832|NCT01272219|26718156|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
7681833|NCT01272219|26718157|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7681834|NCT01272219|26718158|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7681835|NCT01272219|26718159|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7681836|NCT01272219|26718160|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7681837|NCT01272219|26718155|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
7681838|NCT01272219|26718156|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
7681839|NCT01272219|26718157|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
7681840|NCT01272219|26718158|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
7681841|NCT01272219|26718159|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
7681842|NCT01272219|26718160|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
7681843|NCT01272219|26718155|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
7681844|NCT01272219|26718156|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
7681845|NCT01272219|26718157|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7681846|NCT01272219|26718158|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7681847|NCT01272219|26718159|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7681848|NCT01272219|26718160|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7681849|NCT01272219|26718155|P6|Main + Extension Period: Week 0-172|Adverse Event|43
7681850|NCT01272219|26718156|P5|Main + Extension Period: Week 0-172|Adverse Event|191
7681851|NCT01272219|26718157|P4|Main + Extension Period: Week 0-172|Adverse Event|0
7681852|NCT01272219|26718158|P3|Main + Extension Period: Week 0-172|Adverse Event|0
7681853|NCT01272219|26718159|P2|Main + Extension Period: Week 0-172|Adverse Event|0
7681854|NCT01272219|26718160|P1|Main + Extension Period: Week 0-172|Adverse Event|0
7681855|NCT01272219|26718155|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7681856|NCT01272219|26718156|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7681857|NCT01272219|26718157|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
7681858|NCT01272219|26718158|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
7681859|NCT01272219|26718159|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
7681860|NCT01272219|26718160|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7681861|NCT01272219|26718155|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7681862|NCT01272219|26718156|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7681863|NCT01272219|26718157|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
7681864|NCT01272219|26718158|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
7681865|NCT01272219|26718159|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
7681866|NCT01272219|26718160|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7681867|NCT01272219|26718155|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7681868|NCT01272219|26718156|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7681869|NCT01272219|26718157|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
7681870|NCT01272219|26718158|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7681871|NCT01272219|26718159|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
7681872|NCT01272219|26718160|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7681873|NCT01272219|26718155|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7681874|NCT01272219|26718156|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7681875|NCT01272219|26718157|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
7681876|NCT01272219|26718158|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7681877|NCT01272219|26718159|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7681878|NCT01272219|26718160|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7681879|NCT01272219|26718155|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7681880|NCT01272219|26718156|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7681881|NCT01272219|26718157|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
7681882|NCT01272219|26718158|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
7681883|NCT01272219|26718159|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
7681884|NCT01272219|26718160|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7681885|NCT01272219|26718155|P6|Main Period: Week 0 to Week 56|Unclassified|34
7681886|NCT01272219|26718156|P5|Main Period: Week 0 to Week 56|Unclassified|42
7681887|NCT01272219|26718157|P4|Main Period: Week 0 to Week 56|Unclassified|29
7681888|NCT01272219|26718158|P3|Main Period: Week 0 to Week 56|Unclassified|0
7681889|NCT01272219|26718159|P2|Main Period: Week 0 to Week 56|Unclassified|0
7681890|NCT01272219|26718160|P1|Main Period: Week 0 to Week 56|Unclassified|36
7681891|NCT01272219|26718155|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
7681892|NCT01272219|26718156|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
7681893|NCT01272219|26718157|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
7681894|NCT01272219|26718158|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
7681895|NCT01272219|26718159|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
7681896|NCT01272219|26718160|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
7681897|NCT01272219|26718155|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
7681898|NCT01272219|26718156|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
7681899|NCT01272219|26718157|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
7681900|NCT01272219|26718158|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
7681901|NCT01272219|26718159|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
7681902|NCT01272219|26718160|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
7681903|NCT01272219|26718155|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
7681904|NCT01272219|26718156|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
7681905|NCT01272219|26718157|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
7681906|NCT01272219|26718158|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
7681907|NCT01272219|26718159|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
7681908|NCT01272219|26718160|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
7681909|NCT01272219|26718155|P6|Main Period: Week 0 to Week 56|Adverse Event|29
7681910|NCT01272219|26718156|P5|Main Period: Week 0 to Week 56|Adverse Event|152
7681911|NCT01272219|26718157|P4|Main Period: Week 0 to Week 56|Adverse Event|16
7681912|NCT01272219|26718158|P3|Main Period: Week 0 to Week 56|Adverse Event|0
7681913|NCT01272219|26718159|P2|Main Period: Week 0 to Week 56|Adverse Event|0
7681914|NCT01272219|26718160|P1|Main Period: Week 0 to Week 56|Adverse Event|86
7681915|NCT01272193|26718194|P2|Overall Study|Unclassified|7
7681916|NCT01272193|26718195|P1|Overall Study|Unclassified|8
7681917|NCT01272193|26718194|P2|Overall Study|Withdrawal Criteria|1
7681918|NCT01272193|26718195|P1|Overall Study|Withdrawal Criteria|1
7681919|NCT01272193|26718194|P2|Overall Study|Lack of Efficacy|3
7681920|NCT01272193|26718195|P1|Overall Study|Lack of Efficacy|0
7681921|NCT01272193|26718194|P2|Overall Study|Adverse Event|1
7681922|NCT01272193|26718195|P1|Overall Study|Adverse Event|1
7681923|NCT01272180|26718215|P4|Overall Study|Protocol Violation|1
7681924|NCT01272180|26718216|P3|Overall Study|Protocol Violation|0
7681925|NCT01272180|26718217|P2|Overall Study|Protocol Violation|1
7681926|NCT01272180|26718218|P1|Overall Study|Protocol Violation|0
7681927|NCT01272180|26718215|P4|Overall Study|Inappropriate enrollment|1
7681928|NCT01272180|26718216|P3|Overall Study|Inappropriate enrollment|1
7681929|NCT01272180|26718217|P2|Overall Study|Inappropriate enrollment|0
7681930|NCT01272180|26718218|P1|Overall Study|Inappropriate enrollment|0
7681931|NCT01272180|26718215|P4|Overall Study|Lost to Follow-up|10
7681932|NCT01272180|26718216|P3|Overall Study|Lost to Follow-up|8
7681933|NCT01272180|26718217|P2|Overall Study|Lost to Follow-up|14
7681934|NCT01272180|26718218|P1|Overall Study|Lost to Follow-up|15
7681935|NCT01272180|26718215|P4|Overall Study|Withdrawal by Subject|2
7681936|NCT01272180|26718216|P3|Overall Study|Withdrawal by Subject|3
7681937|NCT01272180|26718217|P2|Overall Study|Withdrawal by Subject|6
7681938|NCT01272180|26718218|P1|Overall Study|Withdrawal by Subject|2
7681939|NCT01272180|26718215|P4|Overall Study|Adverse Event|0
7681940|NCT01272180|26718216|P3|Overall Study|Adverse Event|1
7681941|NCT01272180|26718217|P2|Overall Study|Adverse Event|0
7681942|NCT01272180|26718218|P1|Overall Study|Adverse Event|0
7681943|NCT01272011|26718270|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
7681944|NCT01272011|26718271|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
7681945|NCT01272011|26718272|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
7681946|NCT01271933|26718308|P3|Double-Blind Phase|Participant request-personal reason|0
7681947|NCT01271933|26718309|P2|Double-Blind Phase|Participant request-personal reason|1
7681948|NCT01271933|26718310|P1|Double-Blind Phase|Participant request-personal reason|0
7681949|NCT01271933|26718308|P3|Double-Blind Phase|Adverse Event|0
7681950|NCT01271933|26718309|P2|Double-Blind Phase|Adverse Event|3
7681951|NCT01271933|26718310|P1|Double-Blind Phase|Adverse Event|0
7681952|NCT01271933|26718308|P3|Double-Blind Phase|Withdrawal by Subject|1
7681953|NCT01271933|26718309|P2|Double-Blind Phase|Withdrawal by Subject|6
7681954|NCT01271933|26718310|P1|Double-Blind Phase|Withdrawal by Subject|0
7681955|NCT01271933|26718308|P3|Double-Blind Phase|Lost to Follow-up|1
7681956|NCT01271933|26718309|P2|Double-Blind Phase|Lost to Follow-up|1
7681957|NCT01271933|26718310|P1|Double-Blind Phase|Lost to Follow-up|0
7681958|NCT01271933|26718308|P3|Double-Blind Phase|Lack of Efficacy|9
7681959|NCT01271933|26718309|P2|Double-Blind Phase|Lack of Efficacy|6
7681960|NCT01271933|26718310|P1|Double-Blind Phase|Lack of Efficacy|0
7681961|NCT01271933|26718308|P3|Double-Blind Phase|Randomized but not treated|1
7681962|NCT01271933|26718309|P2|Double-Blind Phase|Randomized but not treated|0
7681963|NCT01271933|26718310|P1|Double-Blind Phase|Randomized but not treated|0
7681964|NCT01271933|26718308|P3|Single-Blind Phase|(Participant request-personal reason)|0
7681965|NCT01271933|26718309|P2|Single-Blind Phase|(Participant request-personal reason)|0
7681966|NCT01271933|26718310|P1|Single-Blind Phase|(Participant request-personal reason)|1
7681967|NCT01271933|26718308|P3|Single-Blind Phase|(Protocol non-compliance)|0
7681968|NCT01271933|26718309|P2|Single-Blind Phase|(Protocol non-compliance)|0
7681969|NCT01271933|26718310|P1|Single-Blind Phase|(Protocol non-compliance)|2
7681970|NCT01271933|26718308|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
7681971|NCT01271933|26718309|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
7681972|NCT01271933|26718310|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
7681973|NCT01271933|26718308|P3|Single-Blind Phase|Adverse Event|0
7681974|NCT01271933|26718309|P2|Single-Blind Phase|Adverse Event|0
7681975|NCT01271933|26718310|P1|Single-Blind Phase|Adverse Event|52
7681976|NCT01271933|26718308|P3|Single-Blind Phase|Protocol Violation|0
7681977|NCT01271933|26718309|P2|Single-Blind Phase|Protocol Violation|0
7681978|NCT01271933|26718310|P1|Single-Blind Phase|Protocol Violation|3
7681979|NCT01271933|26718308|P3|Single-Blind Phase|Withdrawal by Subject|0
7681980|NCT01271933|26718309|P2|Single-Blind Phase|Withdrawal by Subject|0
7681981|NCT01271933|26718310|P1|Single-Blind Phase|Withdrawal by Subject|15
7681982|NCT01271933|26718308|P3|Single-Blind Phase|Lost to Follow-up|0
7681983|NCT01271933|26718309|P2|Single-Blind Phase|Lost to Follow-up|0
7681984|NCT01271933|26718310|P1|Single-Blind Phase|Lost to Follow-up|10
7681985|NCT01271933|26718308|P3|Single-Blind Phase|Lack of Efficacy|0
7681986|NCT01271933|26718309|P2|Single-Blind Phase|Lack of Efficacy|0
7681987|NCT01271933|26718310|P1|Single-Blind Phase|Lack of Efficacy|37
7681988|NCT01271803|26718453|P3|Overall Study|Lost to Follow-up|0
7681989|NCT01271803|26718454|P2|Overall Study|Lost to Follow-up|0
7681990|NCT01271803|26718455|P1|Overall Study|Lost to Follow-up|1
7681991|NCT01271803|26718453|P3|Overall Study|Withdrawal by Subject|0
7681992|NCT01271803|26718454|P2|Overall Study|Withdrawal by Subject|5
7681993|NCT01271803|26718455|P1|Overall Study|Withdrawal by Subject|1
7681994|NCT01271803|26718453|P3|Overall Study|Death|0
7681995|NCT01271803|26718454|P2|Overall Study|Death|34
7681996|NCT01271803|26718455|P1|Overall Study|Death|53
7681997|NCT01271803|26718453|P3|Overall Study|Progressive disease|2
7681998|NCT01271803|26718454|P2|Overall Study|Progressive disease|0
7681999|NCT01271803|26718455|P1|Overall Study|Progressive disease|0
7682000|NCT01271725|26718617|P2|Part B|Withdrawal by Subject|6
7682001|NCT01271725|26718618|P1|Part B|Withdrawal by Subject|0
7682002|NCT01271725|26718617|P2|Part B|Protocol Violation|1
7682003|NCT01271725|26718618|P1|Part B|Protocol Violation|0
7682004|NCT01271725|26718617|P2|Part B|Other Adverse Event|1
7682005|NCT01271725|26718618|P1|Part B|Other Adverse Event|0
7682006|NCT01271725|26718617|P2|Part B|Clinical signs/symptoms of progression|2
7682007|NCT01271725|26718618|P1|Part B|Clinical signs/symptoms of progression|0
7682008|NCT01271725|26718617|P2|Part B|Other than specified|2
7682009|NCT01271725|26718618|P1|Part B|Other than specified|0
7682010|NCT01271725|26718617|P2|Part A|Protocol Violation|0
7682011|NCT01271725|26718618|P1|Part A|Protocol Violation|1
7682012|NCT01271725|26718617|P2|Part A|Other than specified|0
7682013|NCT01271725|26718618|P1|Part A|Other than specified|3
7682014|NCT01271725|26718617|P2|Part A|Withdrawal by Subject|0
7682015|NCT01271725|26718618|P1|Part A|Withdrawal by Subject|12
7682016|NCT01271725|26718617|P2|Part A|Lost to Follow-up|0
7682017|NCT01271725|26718618|P1|Part A|Lost to Follow-up|1
7682018|NCT01271725|26718617|P2|Part A|Other Adverse Event|0
7682019|NCT01271725|26718618|P1|Part A|Other Adverse Event|8
7682020|NCT01271725|26718617|P2|Part A|Clinical signs/symptoms of progression|0
7682021|NCT01271725|26718618|P1|Part A|Clinical signs/symptoms of progression|2
7682022|NCT01271725|26718617|P2|Part A|Progressive disease according to RECIST|0
7682023|NCT01271725|26718618|P1|Part A|Progressive disease according to RECIST|8
7682024|NCT01271712|26718647|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
7682025|NCT01271712|26718648|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
7682026|NCT01271712|26718647|P2|Safety Follow-up|Progressive disease|0
7682027|NCT01271712|26718648|P1|Safety Follow-up|Progressive disease|1
7682028|NCT01271712|26718647|P2|Safety Follow-up|No follow-up|1
7682029|NCT01271712|26718648|P1|Safety Follow-up|No follow-up|1
7682030|NCT01271712|26718647|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
7682031|NCT01271712|26718648|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
7682032|NCT01271712|26718647|P2|Safety Follow-up|Protocol Violation|1
7682033|NCT01271712|26718648|P1|Safety Follow-up|Protocol Violation|1
7682034|NCT01271712|26718647|P2|Safety Follow-up|Withdrawal by Subject|2
7682035|NCT01271712|26718648|P1|Safety Follow-up|Withdrawal by Subject|4
7682036|NCT01271712|26718647|P2|Safety Follow-up|Death|7
7682037|NCT01271712|26718648|P1|Safety Follow-up|Death|11
7682038|NCT01271712|26718647|P2|Open Label Treatment|Switching to other therapy|1
7682039|NCT01271712|26718648|P1|Open Label Treatment|Switching to other therapy|2
7682040|NCT01271712|26718647|P2|Open Label Treatment|Protocol Violation|1
7682041|NCT01271712|26718648|P1|Open Label Treatment|Protocol Violation|0
7682042|NCT01271712|26718647|P2|Open Label Treatment|Non-compliance with study drug|0
7682043|NCT01271712|26718648|P1|Open Label Treatment|Non-compliance with study drug|1
7682044|NCT01271712|26718647|P2|Open Label Treatment|transferred to rollover study|0
7682045|NCT01271712|26718648|P1|Open Label Treatment|transferred to rollover study|1
7682046|NCT01271712|26718647|P2|Open Label Treatment|Progressive disease|32
7682047|NCT01271712|26718648|P1|Open Label Treatment|Progressive disease|59
7682048|NCT01271712|26718647|P2|Open Label Treatment|Adverse Event|8
7682049|NCT01271712|26718648|P1|Open Label Treatment|Adverse Event|14
7682050|NCT01271712|26718647|P2|Open Label Treatment|Physician Decision|0
7682051|NCT01271712|26718648|P1|Open Label Treatment|Physician Decision|2
7682052|NCT01271712|26718647|P2|Open Label Treatment|Withdrawal by Subject|11
7682053|NCT01271712|26718648|P1|Open Label Treatment|Withdrawal by Subject|6
7682054|NCT01271712|26718647|P2|Open Label Treatment|Death|5
7682055|NCT01271712|26718648|P1|Open Label Treatment|Death|6
7682056|NCT01271712|26718647|P2|Double Blind Treatment|receive no study drug|0
7682057|NCT01271712|26718648|P1|Double Blind Treatment|receive no study drug|1
7682058|NCT01271712|26718647|P2|Double Blind Treatment|Non compliance with study drug|0
7682059|NCT01271712|26718648|P1|Double Blind Treatment|Non compliance with study drug|2
7682060|NCT01271712|26718647|P2|Double Blind Treatment|Withdrawal by Subject|1
7682061|NCT01271712|26718648|P1|Double Blind Treatment|Withdrawal by Subject|4
7682062|NCT01271712|26718647|P2|Double Blind Treatment|Progressive disease|3
7682063|NCT01271712|26718648|P1|Double Blind Treatment|Progressive disease|23
7682064|NCT01271712|26718647|P2|Double Blind Treatment|Adverse Event|4
7682065|NCT01271712|26718648|P1|Double Blind Treatment|Adverse Event|9
7682066|NCT01271712|26718647|P2|Double Blind Treatment|Lack of Efficacy|0
7682067|NCT01271712|26718648|P1|Double Blind Treatment|Lack of Efficacy|1
7682068|NCT01271712|26718647|P2|Double Blind Treatment|Death|0
7682069|NCT01271712|26718648|P1|Double Blind Treatment|Death|2
7682070|NCT01271504|26718688|P4|Overall Study|Other|0
7682071|NCT01271504|26718689|P3|Overall Study|Other|2
7682072|NCT01271504|26718690|P2|Overall Study|Other|1
7682073|NCT01271504|26718691|P1|Overall Study|Other|0
7682074|NCT01271504|26718688|P4|Overall Study|Withdrawal by Subject|3
7682075|NCT01271504|26718689|P3|Overall Study|Withdrawal by Subject|1
7682076|NCT01271504|26718690|P2|Overall Study|Withdrawal by Subject|0
7682077|NCT01271504|26718691|P1|Overall Study|Withdrawal by Subject|0
7682078|NCT01271504|26718688|P4|Overall Study|Administrative Reasons|5
7682079|NCT01271504|26718689|P3|Overall Study|Administrative Reasons|6
7682080|NCT01271504|26718690|P2|Overall Study|Administrative Reasons|0
7682081|NCT01271504|26718691|P1|Overall Study|Administrative Reasons|0
7682082|NCT01271504|26718688|P4|Overall Study|Protocol Violation|2
7682083|NCT01271504|26718689|P3|Overall Study|Protocol Violation|0
7682084|NCT01271504|26718690|P2|Overall Study|Protocol Violation|0
7682085|NCT01271504|26718691|P1|Overall Study|Protocol Violation|0
7682086|NCT01271504|26718688|P4|Overall Study|Lost to Follow-up|1
7682087|NCT01271504|26718689|P3|Overall Study|Lost to Follow-up|3
7682088|NCT01271504|26718690|P2|Overall Study|Lost to Follow-up|1
7682089|NCT01271504|26718691|P1|Overall Study|Lost to Follow-up|0
7682090|NCT01271504|26718688|P4|Overall Study|Death|32
7682091|NCT01271504|26718689|P3|Overall Study|Death|32
7682092|NCT01271504|26718690|P2|Overall Study|Death|6
7682093|NCT01271504|26718691|P1|Overall Study|Death|7
7682094|NCT01271010|26718803|P1|Overall Study|Disease progression|27
7682095|NCT01271010|26718803|P1|Overall Study|Withdrawal by Subject|18
7682096|NCT01271010|26718803|P1|Overall Study|Progression and relapse of disease|1
7682097|NCT01271010|26718803|P1|Overall Study|Death|2
7682098|NCT01271010|26718803|P1|Overall Study|Protocol Violation|1
7682099|NCT01271010|26718803|P1|Overall Study|Start of new CLL therapy|1
7682100|NCT01271010|26718803|P1|Overall Study|Reason not specified|11
7682101|NCT01270971|26718818|P2|Overall Study|Non-specific|3
7682102|NCT01270971|26718819|P1|Overall Study|Non-specific|7
7682103|NCT01270971|26718818|P2|Overall Study|Non compliance|2
7682104|NCT01270971|26718819|P1|Overall Study|Non compliance|2
7682105|NCT01270971|26718818|P2|Overall Study|Adverse Event|2
7682106|NCT01270971|26718819|P1|Overall Study|Adverse Event|1
7682107|NCT01270971|26718818|P2|Overall Study|Lost to Follow-up|5
7682108|NCT01270971|26718819|P1|Overall Study|Lost to Follow-up|18
7682109|NCT01270971|26718818|P2|Overall Study|Withdrawal by Subject|11
7682110|NCT01270971|26718819|P1|Overall Study|Withdrawal by Subject|24
7682111|NCT01270958|26718831|P1|Overall Study|Did not meet inclusion criteria for age|2
7682112|NCT01270958|26718831|P1|Overall Study|Lost to Follow-up|2
7682113|NCT01270880|26718860|P1|Overall Study|Never rec'd treatment, but registered.|1
7682114|NCT01270841|26718890|P4|Overall Study|Enrolled in error|0
7682115|NCT01270841|26718891|P3|Overall Study|Enrolled in error|0
7682116|NCT01270841|26718892|P2|Overall Study|Enrolled in error|1
7682117|NCT01270841|26718893|P1|Overall Study|Enrolled in error|0
7682118|NCT01270841|26718890|P4|Overall Study|Protocol Violation|0
7682119|NCT01270841|26718891|P3|Overall Study|Protocol Violation|0
7682120|NCT01270841|26718892|P2|Overall Study|Protocol Violation|5
7682121|NCT01270841|26718893|P1|Overall Study|Protocol Violation|1
7682122|NCT01270841|26718890|P4|Overall Study|Did not qualify|5
7682123|NCT01270841|26718891|P3|Overall Study|Did not qualify|4
7682124|NCT01270841|26718892|P2|Overall Study|Did not qualify|3
7682125|NCT01270841|26718893|P1|Overall Study|Did not qualify|6
7682126|NCT01270841|26718890|P4|Overall Study|Physician Decision|0
7682127|NCT01270841|26718891|P3|Overall Study|Physician Decision|0
7682128|NCT01270841|26718892|P2|Overall Study|Physician Decision|1
7682129|NCT01270841|26718893|P1|Overall Study|Physician Decision|0
7682130|NCT01270841|26718890|P4|Overall Study|Lost to Follow-up|2
7682131|NCT01270841|26718891|P3|Overall Study|Lost to Follow-up|4
7682132|NCT01270841|26718892|P2|Overall Study|Lost to Follow-up|1
7682133|NCT01270841|26718893|P1|Overall Study|Lost to Follow-up|3
7682134|NCT01270841|26718890|P4|Overall Study|Withdrawal by Subject|3
7682135|NCT01270841|26718891|P3|Overall Study|Withdrawal by Subject|3
7682136|NCT01270841|26718892|P2|Overall Study|Withdrawal by Subject|2
7682137|NCT01270841|26718893|P1|Overall Study|Withdrawal by Subject|3
7682138|NCT01270841|26718890|P4|Overall Study|Adverse Event|3
7682139|NCT01270841|26718891|P3|Overall Study|Adverse Event|0
7682140|NCT01270841|26718892|P2|Overall Study|Adverse Event|1
7682141|NCT01270841|26718893|P1|Overall Study|Adverse Event|0
7682142|NCT01270828|26718917|P3|Double Blind Phase|Adverse event related to study drug|0
7682143|NCT01270828|26718918|P2|Double Blind Phase|Adverse event related to study drug|7
7682144|NCT01270828|26718919|P1|Double Blind Phase|Adverse event related to study drug|5
7682145|NCT01270828|26718917|P3|Double Blind Phase|Adverse event not related to study drug|0
7682146|NCT01270828|26718918|P2|Double Blind Phase|Adverse event not related to study drug|1
7682147|NCT01270828|26718919|P1|Double Blind Phase|Adverse event not related to study drug|1
7682148|NCT01270828|26718917|P3|Double Blind Phase|Lack of Efficacy|0
7682149|NCT01270828|26718918|P2|Double Blind Phase|Lack of Efficacy|11
7682150|NCT01270828|26718919|P1|Double Blind Phase|Lack of Efficacy|2
7682151|NCT01270828|26718917|P3|Double Blind Phase|Lost to Follow-up|0
7682152|NCT01270828|26718918|P2|Double Blind Phase|Lost to Follow-up|2
7682153|NCT01270828|26718919|P1|Double Blind Phase|Lost to Follow-up|1
7682154|NCT01270828|26718917|P3|Double Blind Phase|Withdrawal by Subject|0
7682155|NCT01270828|26718918|P2|Double Blind Phase|Withdrawal by Subject|15
7682156|NCT01270828|26718919|P1|Double Blind Phase|Withdrawal by Subject|6
7682157|NCT01270828|26718917|P3|Double Blind Phase|Reason Unspecified|0
7682158|NCT01270828|26718918|P2|Double Blind Phase|Reason Unspecified|4
7682159|NCT01270828|26718919|P1|Double Blind Phase|Reason Unspecified|7
7682160|NCT01270828|26718917|P3|Double Blind Phase|Protocol and GCP non-compliance|0
7682161|NCT01270828|26718918|P2|Double Blind Phase|Protocol and GCP non-compliance|3
7682162|NCT01270828|26718919|P1|Double Blind Phase|Protocol and GCP non-compliance|4
7682163|NCT01270828|26718917|P3|Double Blind Phase|Protocol Violation|0
7682164|NCT01270828|26718918|P2|Double Blind Phase|Protocol Violation|1
7682165|NCT01270828|26718919|P1|Double Blind Phase|Protocol Violation|0
7682166|NCT01270828|26718917|P3|Double Blind Phase|Death|0
7682167|NCT01270828|26718918|P2|Double Blind Phase|Death|1
7682168|NCT01270828|26718919|P1|Double Blind Phase|Death|0
7682169|NCT01270828|26718917|P3|Pregabalin CR SB|Protocol Violation|8
7682170|NCT01270828|26718918|P2|Pregabalin CR SB|Protocol Violation|0
7682171|NCT01270828|26718919|P1|Pregabalin CR SB|Protocol Violation|0
7682172|NCT01270828|26718917|P3|Pregabalin CR SB|Unrelated AE|8
7682173|NCT01270828|26718918|P2|Pregabalin CR SB|Unrelated AE|0
7682174|NCT01270828|26718919|P1|Pregabalin CR SB|Unrelated AE|0
7682175|NCT01270828|26718917|P3|Pregabalin CR SB|Lost to Follow-up|10
7682176|NCT01270828|26718918|P2|Pregabalin CR SB|Lost to Follow-up|0
7682177|NCT01270828|26718919|P1|Pregabalin CR SB|Lost to Follow-up|0
7682178|NCT01270828|26718917|P3|Pregabalin CR SB|Withdrawal by Subject|29
7682179|NCT01270828|26718918|P2|Pregabalin CR SB|Withdrawal by Subject|0
7682180|NCT01270828|26718919|P1|Pregabalin CR SB|Withdrawal by Subject|0
7682181|NCT01270828|26718917|P3|Pregabalin CR SB|Lack of Efficacy|32
7682182|NCT01270828|26718918|P2|Pregabalin CR SB|Lack of Efficacy|0
7682183|NCT01270828|26718919|P1|Pregabalin CR SB|Lack of Efficacy|0
7682184|NCT01270828|26718917|P3|Pregabalin CR SB|Related adverse event|46
7682185|NCT01270828|26718918|P2|Pregabalin CR SB|Related adverse event|0
7682186|NCT01270828|26718919|P1|Pregabalin CR SB|Related adverse event|0
7682187|NCT01270828|26718917|P3|Pregabalin CR SB|Enrolled but not treated|5
7682188|NCT01270828|26718918|P2|Pregabalin CR SB|Enrolled but not treated|0
7682189|NCT01270828|26718919|P1|Pregabalin CR SB|Enrolled but not treated|0
7682190|NCT01270828|26718917|P3|Pregabalin CR SB|Reason Unspecified|8
7682191|NCT01270828|26718918|P2|Pregabalin CR SB|Reason Unspecified|0
7682192|NCT01270828|26718919|P1|Pregabalin CR SB|Reason Unspecified|0
7682193|NCT01270802|26718961|P2|Overall Study|Lost to Follow-up|1
7682194|NCT01270802|26718962|P1|Overall Study|Lost to Follow-up|0
7682195|NCT01270802|26718961|P2|Overall Study|Adverse Event|0
7682196|NCT01270802|26718962|P1|Overall Study|Adverse Event|1
7682197|NCT01270802|26718961|P2|Overall Study|Withdrawal by Subject|0
7682198|NCT01270802|26718962|P1|Overall Study|Withdrawal by Subject|1
7682199|NCT01270620|26719109|P2|Overall Study|Withdrawal by Subject|3
7682200|NCT01270620|26719110|P1|Overall Study|Withdrawal by Subject|1
7682201|NCT01270503|26719226|P1|Overall Study|Lost to Follow-up|1
7682202|NCT01270464|26719234|P3|Overall Study|Other|3
7682203|NCT01270464|26719235|P2|Overall Study|Other|1
7682204|NCT01270464|26719236|P1|Overall Study|Other|1
7682205|NCT01270464|26719234|P3|Overall Study|Lost to Follow-up|1
7682206|NCT01270464|26719235|P2|Overall Study|Lost to Follow-up|3
7682207|NCT01270464|26719236|P1|Overall Study|Lost to Follow-up|2
7682208|NCT01270464|26719234|P3|Overall Study|Withdrawal by Subject|4
7682209|NCT01270464|26719235|P2|Overall Study|Withdrawal by Subject|1
7682210|NCT01270464|26719236|P1|Overall Study|Withdrawal by Subject|2
7682211|NCT01270464|26719234|P3|Overall Study|Adverse Event|7
7682212|NCT01270464|26719235|P2|Overall Study|Adverse Event|1
7682213|NCT01270464|26719236|P1|Overall Study|Adverse Event|9
7682214|NCT01270464|26719234|P3|Overall Study|Lack of Efficacy|1
7682215|NCT01270464|26719235|P2|Overall Study|Lack of Efficacy|3
7682216|NCT01270464|26719236|P1|Overall Study|Lack of Efficacy|2
7682217|NCT01270464|26719234|P3|Overall Study|Protocol Violation|2
7682218|NCT01270464|26719235|P2|Overall Study|Protocol Violation|3
7682219|NCT01270464|26719236|P1|Overall Study|Protocol Violation|4
7682220|NCT01270321|26719286|P3|Overall Study|Adverse Event|5
7682221|NCT01270321|26719287|P2|Overall Study|Adverse Event|9
7682222|NCT01270321|26719288|P1|Overall Study|Adverse Event|7
7682223|NCT01270321|26719286|P3|Overall Study|Death|4
7682224|NCT01270321|26719287|P2|Overall Study|Death|1
7682225|NCT01270321|26719288|P1|Overall Study|Death|3
7682226|NCT01270256|26719301|P2|Overall Study|Withdrawal by Subject|0
7682227|NCT01270256|26719302|P1|Overall Study|Withdrawal by Subject|1
7682228|NCT01270139|26719311|P3|Overall Study|Lost to Follow-up|2
7682229|NCT01270139|26719312|P2|Overall Study|Lost to Follow-up|9
7682230|NCT01270139|26719313|P1|Overall Study|Lost to Follow-up|10
7682231|NCT01270139|26719311|P3|Overall Study|Adverse Event|18
7682232|NCT01270139|26719312|P2|Overall Study|Adverse Event|17
7682233|NCT01270139|26719313|P1|Overall Study|Adverse Event|8
7682234|NCT01269918|26719382|P2|Overall Study|Did not receive study drug|3
7682235|NCT01269918|26719383|P1|Overall Study|Did not receive study drug|0
7682236|NCT01269385|26719458|P4|Overall Study|Adverse Event|0
7682237|NCT01269385|26719459|P3|Overall Study|Adverse Event|0
7682238|NCT01269385|26719460|P2|Overall Study|Adverse Event|1
7682239|NCT01269385|26719461|P1|Overall Study|Adverse Event|1
7682240|NCT01269346|26719486|P1|Extension Phase|Started a prohibited con med|1
7682241|NCT01269346|26719486|P1|Extension Phase|Clinical progression|1
7682242|NCT01269346|26719486|P1|Extension Phase|Physician decision or participant choice|9
7682243|NCT01269346|26719486|P1|Extension Phase|Disease progression|22
7682244|NCT01269346|26719486|P1|Extension Phase|Withdrawal by Subject|4
7682245|NCT01269346|26719486|P1|Extension Phase|Adverse Event|6
7682246|NCT01269346|26719486|P1|Treatment Phase|Other|2
7682247|NCT01269346|26719486|P1|Treatment Phase|Withdrawal by Subject|1
7682248|NCT01269346|26719486|P1|Treatment Phase|Adverse Event|3
7682249|NCT01269346|26719486|P1|Treatment Phase|Disease progression|3
7682250|NCT01269125|26719497|P3|Overall Study|Lost to Follow-up|0
7682251|NCT01269125|26719498|P2|Overall Study|Lost to Follow-up|0
7682252|NCT01269125|26719499|P1|Overall Study|Lost to Follow-up|4
7682253|NCT01269125|26719497|P3|Overall Study|Adverse Event|0
7682254|NCT01269125|26719498|P2|Overall Study|Adverse Event|5
7682255|NCT01269125|26719499|P1|Overall Study|Adverse Event|3
7682256|NCT01268891|26719583|P2|Overall Study|Administrative or other reason(s)|0
7682257|NCT01268891|26719584|P1|Overall Study|Administrative or other reason(s)|1
7682258|NCT01268891|26719583|P2|Overall Study|Withdrawal of Consent|1
7682259|NCT01268891|26719584|P1|Overall Study|Withdrawal of Consent|3
7682260|NCT01268891|26719583|P2|Overall Study|Lack of Efficacy|0
7682261|NCT01268891|26719584|P1|Overall Study|Lack of Efficacy|1
7682262|NCT01268891|26719583|P2|Overall Study|Adverse Event|7
7682263|NCT01268891|26719584|P1|Overall Study|Adverse Event|3
7682264|NCT01268683|26719596|P1|Overall Study|Death|1
7682265|NCT01268683|26719596|P1|Overall Study|Lost to Follow-up|1
7682266|NCT01268566|26719626|P1|Overall Study|Death|30
7682267|NCT01268566|26719626|P1|Overall Study|Withdrawal by Subject|12
7682268|NCT01268566|26719626|P1|Overall Study|Lost to Follow-up|1
7682269|NCT01268514|26719714|P1|Overall Study|Withdrawal by Surgeon|5
7682270|NCT01268514|26719714|P1|Overall Study|Withdrawal by Subject|3
7682271|NCT01268514|26719714|P1|Overall Study|Lost to Follow-up|5
7682272|NCT01268514|26719714|P1|Overall Study|Death|8
7682273|NCT01268514|26719714|P1|Overall Study|Adverse Event|20
7682274|NCT01268501|26719723|P1|Overall Study|Handling Difficulties|2
7682275|NCT01268501|26719723|P1|Overall Study|Unacceptable Subjective Vision|3
7682276|NCT01268501|26719723|P1|Overall Study|Withdrawal by Subject|3
7682277|NCT01268501|26719723|P1|Overall Study|Lost to Follow-up|1
7682278|NCT01268488|26719727|P1|Overall Study|Physician Decision|2
7682279|NCT01268488|26719727|P1|Overall Study|Adverse Event|3
7682280|NCT01268306|26719734|P1|Overall Study|Lost to Follow-up|1
7682281|NCT01268293|26719738|P1|Overall Study|Subject choice|1
7682282|NCT01268293|26719738|P1|Overall Study|Adverse Event|1
7682283|NCT01268293|26719738|P1|Overall Study|Disease progression|7
7682284|NCT01268267|26719743|P1|Overall Study|Protocol Violation|1
7682285|NCT01268150|26719764|P1|Extension Phase|Other|6
7682286|NCT01268150|26719764|P1|Extension Phase|Disease progression|18
7682287|NCT01268150|26719764|P1|Extension Phase|Adverse Event|3
7682288|NCT01268150|26719764|P1|Treatment Phase|Other|4
7682289|NCT01268150|26719764|P1|Treatment Phase|Withdrawal by Subject|3
7682290|NCT01268150|26719764|P1|Treatment Phase|Adverse Event|3
7682291|NCT01268150|26719764|P1|Treatment Phase|Progression of disease|18
7682292|NCT01268098|26719783|P2|Overall Study|Adverse Event|0
7682293|NCT01268098|26719784|P1|Overall Study|Adverse Event|1
7682294|NCT01268059|26719796|P4|Overall Study|Progression of disease|0
7682295|NCT01268059|26719797|P3|Overall Study|Progression of disease|0
7682296|NCT01268059|26719798|P2|Overall Study|Progression of disease|0
7682297|NCT01268059|26719799|P1|Overall Study|Progression of disease|1
7682298|NCT01268059|26719796|P4|Overall Study|Death|5
7682299|NCT01268059|26719797|P3|Overall Study|Death|3
7682300|NCT01268059|26719798|P2|Overall Study|Death|30
7682301|NCT01268059|26719799|P1|Overall Study|Death|20
7682302|NCT01268059|26719796|P4|Overall Study|Withdrawal by Subject|0
7682303|NCT01268059|26719797|P3|Overall Study|Withdrawal by Subject|0
7682304|NCT01268059|26719798|P2|Overall Study|Withdrawal by Subject|4
7682305|NCT01268059|26719799|P1|Overall Study|Withdrawal by Subject|7
7682306|NCT01268059|26719796|P4|Overall Study|Lost to Follow-up|0
7682307|NCT01268059|26719797|P3|Overall Study|Lost to Follow-up|0
7682308|NCT01268059|26719798|P2|Overall Study|Lost to Follow-up|1
7682309|NCT01268059|26719799|P1|Overall Study|Lost to Follow-up|0
7682310|NCT01268046|26719860|P4|Overall Study|Lost to Follow-up|0
7682311|NCT01268046|26719861|P3|Overall Study|Lost to Follow-up|1
7682312|NCT01268046|26719862|P2|Overall Study|Lost to Follow-up|0
7682313|NCT01268046|26719863|P1|Overall Study|Lost to Follow-up|0
7682314|NCT01268046|26719860|P4|Overall Study|Withdrawal by Subject|1
7682315|NCT01268046|26719861|P3|Overall Study|Withdrawal by Subject|0
7682316|NCT01268046|26719862|P2|Overall Study|Withdrawal by Subject|0
7682317|NCT01268046|26719863|P1|Overall Study|Withdrawal by Subject|1
7682318|NCT01267994|26719873|P1|Overall Study|Adverse Event|2
7682319|NCT01267955|26719878|P1|Stage 2 (6 Months)|Protocol Violation|1
7682320|NCT01267955|26719878|P1|Stage 2 (6 Months)|Death|5
7682321|NCT01267955|26719878|P1|Stage 1 (6 Months)|Death|3
7682322|NCT01267825|26719915|P2|Overall Study|study terminated. no data collected.|0
7682323|NCT01267825|26719916|P1|Overall Study|study terminated. no data collected.|1
7682324|NCT01267266|26719998|P2|Lead-in Phase|Withdrawal by Subject|0
7682325|NCT01267266|26719999|P1|Lead-in Phase|Withdrawal by Subject|1
7682326|NCT01267266|26719998|P2|Lead-in Phase|Adverse Event|0
7682327|NCT01267266|26719999|P1|Lead-in Phase|Adverse Event|2
7682328|NCT01267266|26719998|P2|Lead-in Phase|Lack of Efficacy|0
7682329|NCT01267266|26719999|P1|Lead-in Phase|Lack of Efficacy|20
7682330|NCT01267266|26719998|P2|Enrollment Phase|Withdrawal by Subject|0
7682331|NCT01267266|26719999|P1|Enrollment Phase|Withdrawal by Subject|2
7682332|NCT01267253|26720012|P1|Overall Study|Inevaluable-never received study treatme|2
7682333|NCT01267253|26720012|P1|Overall Study|Ineligible - required test not done|1
7682334|NCT01267201|26720051|P6|Second Intervention Period|Withdrawal by Subject|0
7682335|NCT01267201|26720052|P5|Second Intervention Period|Withdrawal by Subject|0
7682336|NCT01267201|26720053|P4|Second Intervention Period|Withdrawal by Subject|0
7682337|NCT01267201|26720054|P3|Second Intervention Period|Withdrawal by Subject|0
7682338|NCT01267201|26720055|P2|Second Intervention Period|Withdrawal by Subject|1
7682339|NCT01267201|26720056|P1|Second Intervention Period|Withdrawal by Subject|0
7682340|NCT01267201|26720051|P6|First Intervention Period|Withdrawal by Subject|0
7682341|NCT01267201|26720052|P5|First Intervention Period|Withdrawal by Subject|0
7682342|NCT01267201|26720053|P4|First Intervention Period|Withdrawal by Subject|0
7682343|NCT01267201|26720054|P3|First Intervention Period|Withdrawal by Subject|0
7682344|NCT01267201|26720055|P2|First Intervention Period|Withdrawal by Subject|0
7682345|NCT01267201|26720056|P1|First Intervention Period|Withdrawal by Subject|1
7682346|NCT01267175|26720073|P1|Overall Study|Lost to Follow-up|1
7682347|NCT01267175|26720073|P1|Overall Study|Withdrawal by Subject|1
7682348|NCT01266993|26720145|P2|Booster Phase (Month 68-69)|Withdrawal by Subject|1
7682349|NCT01266993|26720146|P1|Booster Phase (Month 68-69)|Withdrawal by Subject|0
7682350|NCT01266993|26720145|P2|Booster Phase (Month 68-69)|Lost to Follow-up|1
7682351|NCT01266993|26720146|P1|Booster Phase (Month 68-69)|Lost to Follow-up|5
7682352|NCT01266967|26720216|P2|Overall Study|Withdrawal by Subject|3
7682353|NCT01266967|26720217|P1|Overall Study|Withdrawal by Subject|3
7682354|NCT01266967|26720216|P2|Overall Study|Physician Decision|1
7682355|NCT01266967|26720217|P1|Overall Study|Physician Decision|0
7682356|NCT01266967|26720216|P2|Overall Study|Lost to Follow-up|1
7682357|NCT01266967|26720217|P1|Overall Study|Lost to Follow-up|2
7682358|NCT01266967|26720216|P2|Overall Study|Study Closed/Terminated|17
7682359|NCT01266967|26720217|P1|Overall Study|Study Closed/Terminated|15
7682360|NCT01266967|26720216|P2|Overall Study|Death|61
7682361|NCT01266967|26720217|P1|Overall Study|Death|69
7682362|NCT01266902|26720266|P3|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
7682363|NCT01266902|26720267|P2|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
7682364|NCT01266902|26720268|P1|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
7682365|NCT01266902|26720266|P3|Period 2 (After Protocol Amendment 3)|Adverse Event|1
7682366|NCT01266902|26720267|P2|Period 2 (After Protocol Amendment 3)|Adverse Event|0
7682367|NCT01266902|26720268|P1|Period 2 (After Protocol Amendment 3)|Adverse Event|0
7682368|NCT01266902|26720266|P3|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
7682369|NCT01266902|26720267|P2|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
7682370|NCT01266902|26720268|P1|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
7682371|NCT01266902|26720266|P3|Period 1 (Main Study)|Continued RPV treatment|0
7682372|NCT01266902|26720267|P2|Period 1 (Main Study)|Continued RPV treatment|34
7682373|NCT01266902|26720268|P1|Period 1 (Main Study)|Continued RPV treatment|11
7682374|NCT01266902|26720266|P3|Period 1 (Main Study)|Subject non-compliant|0
7682375|NCT01266902|26720267|P2|Period 1 (Main Study)|Subject non-compliant|7
7682376|NCT01266902|26720268|P1|Period 1 (Main Study)|Subject non-compliant|3
7682377|NCT01266902|26720266|P3|Period 1 (Main Study)|Withdrawal by Subject|0
7682378|NCT01266902|26720267|P2|Period 1 (Main Study)|Withdrawal by Subject|12
7682379|NCT01266902|26720268|P1|Period 1 (Main Study)|Withdrawal by Subject|2
7682380|NCT01266902|26720266|P3|Period 1 (Main Study)|Adverse Event|0
7682381|NCT01266902|26720267|P2|Period 1 (Main Study)|Adverse Event|11
7682382|NCT01266902|26720268|P1|Period 1 (Main Study)|Adverse Event|3
7682383|NCT01266902|26720266|P3|Period 1 (Main Study)|Lack of Efficacy|0
7682384|NCT01266902|26720267|P2|Period 1 (Main Study)|Lack of Efficacy|2
7682385|NCT01266902|26720268|P1|Period 1 (Main Study)|Lack of Efficacy|4
7682386|NCT01266902|26720266|P3|Period 1 (Main Study)|Lost to Follow-up|0
7682387|NCT01266902|26720267|P2|Period 1 (Main Study)|Lost to Follow-up|12
7682388|NCT01266902|26720268|P1|Period 1 (Main Study)|Lost to Follow-up|5
7682389|NCT01266902|26720266|P3|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
7682390|NCT01266902|26720267|P2|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
7682391|NCT01266902|26720268|P1|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
7682392|NCT01266876|26720293|P5|Overall Study|Adverse Event|0
7682393|NCT01266876|26720294|P4|Overall Study|Adverse Event|1
7682394|NCT01266876|26720295|P3|Overall Study|Adverse Event|0
7682395|NCT01266876|26720296|P2|Overall Study|Adverse Event|0
7682396|NCT01266876|26720297|P1|Overall Study|Adverse Event|0
7682397|NCT01266850|26720404|P5|Overall Study|Site Closure|0
7682398|NCT01266850|26720405|P4|Overall Study|Site Closure|1
7682399|NCT01266850|26720406|P3|Overall Study|Site Closure|1
7682400|NCT01266850|26720407|P2|Overall Study|Site Closure|1
7682401|NCT01266850|26720408|P1|Overall Study|Site Closure|0
7682402|NCT01266850|26720404|P5|Overall Study|Adverse Event|1
7682403|NCT01266850|26720405|P4|Overall Study|Adverse Event|0
7682404|NCT01266850|26720406|P3|Overall Study|Adverse Event|0
7682405|NCT01266850|26720407|P2|Overall Study|Adverse Event|0
7682406|NCT01266850|26720408|P1|Overall Study|Adverse Event|0
7682407|NCT01266850|26720404|P5|Overall Study|Protocol Violation|2
7682408|NCT01266850|26720405|P4|Overall Study|Protocol Violation|1
7682409|NCT01266850|26720406|P3|Overall Study|Protocol Violation|0
7682410|NCT01266850|26720407|P2|Overall Study|Protocol Violation|1
7682411|NCT01266850|26720408|P1|Overall Study|Protocol Violation|0
7682412|NCT01266850|26720404|P5|Overall Study|Physician Decision|3
7682413|NCT01266850|26720405|P4|Overall Study|Physician Decision|4
7682414|NCT01266850|26720406|P3|Overall Study|Physician Decision|4
7682415|NCT01266850|26720407|P2|Overall Study|Physician Decision|6
7682416|NCT01266850|26720408|P1|Overall Study|Physician Decision|3
7682417|NCT01266850|26720404|P5|Overall Study|Withdrawal by Subject|12
7682418|NCT01266850|26720405|P4|Overall Study|Withdrawal by Subject|9
7682419|NCT01266850|26720406|P3|Overall Study|Withdrawal by Subject|6
7682420|NCT01266850|26720407|P2|Overall Study|Withdrawal by Subject|9
7682421|NCT01266850|26720408|P1|Overall Study|Withdrawal by Subject|8
7682422|NCT01266850|26720404|P5|Overall Study|Lost to Follow-up|12
7682423|NCT01266850|26720405|P4|Overall Study|Lost to Follow-up|13
7682424|NCT01266850|26720406|P3|Overall Study|Lost to Follow-up|13
7682425|NCT01266850|26720407|P2|Overall Study|Lost to Follow-up|19
7682426|NCT01266850|26720408|P1|Overall Study|Lost to Follow-up|19
7682427|NCT01266824|26720462|P2|Overall Study|Study terminated prior to completion|3
7682428|NCT01266824|26720463|P1|Overall Study|Study terminated prior to completion|2
7682429|NCT01266603|26720475|P1|Overall Study|Failed screening; MAGE-A3 negative|26
7682430|NCT01266603|26720475|P1|Overall Study|Withdrawal by Subject|1
7682431|NCT01266603|26720475|P1|Overall Study|Lack of Efficacy|14
7682432|NCT01266603|26720475|P1|Overall Study|Adverse Event|1
7682433|NCT01266590|26720481|P1|Overall Study|Physician Decision|1
7682434|NCT01266590|26720481|P1|Overall Study|Withdrawal by Subject|1
7682435|NCT01266590|26720481|P1|Overall Study|Lost to Follow-up|1
7682436|NCT01266590|26720481|P1|Overall Study|Adverse Event|3
7682437|NCT01266460|26720492|P1|Overall Study|Not otherwise specified|8
7682438|NCT01266460|26720492|P1|Overall Study|Disease Progression|18
7682439|NCT01266460|26720492|P1|Overall Study|Withdrawal by Subject|5
7682440|NCT01266460|26720492|P1|Overall Study|Adverse Event|3
7682441|NCT01266317|26720510|P1|Overall Study|Withdrawal by Subject|2
7682442|NCT01266291|26720515|P1|Overall Study|Adverse Event|1
7682443|NCT01266265|26720522|P2|Overall Study|Clinical worsening|1
7682444|NCT01266265|26720523|P1|Overall Study|Clinical worsening|1
7682445|NCT01266265|26720522|P2|Overall Study|Site closed early|3
7682446|NCT01266265|26720523|P1|Overall Study|Site closed early|4
7682447|NCT01266265|26720522|P2|Overall Study|Lung transplant|5
7682448|NCT01266265|26720523|P1|Overall Study|Lung transplant|6
7682449|NCT01266265|26720522|P2|Overall Study|Non-compliance|5
7682450|NCT01266265|26720523|P1|Overall Study|Non-compliance|8
7682451|NCT01266265|26720522|P2|Overall Study|Enrolled in another clinical study|26
7682452|NCT01266265|26720523|P1|Overall Study|Enrolled in another clinical study|15
7682453|NCT01266265|26720522|P2|Overall Study|Stopped/changed PAH medication(s)|9
7682454|NCT01266265|26720523|P1|Overall Study|Stopped/changed PAH medication(s)|16
7682455|NCT01266265|26720522|P2|Overall Study|Transferred care to another provider|28
7682456|NCT01266265|26720523|P1|Overall Study|Transferred care to another provider|22
7682457|NCT01266265|26720522|P2|Overall Study|Respiratory-related adverse event|1
7682458|NCT01266265|26720523|P1|Overall Study|Respiratory-related adverse event|2
7682459|NCT01266265|26720522|P2|Overall Study|Withdrawal by Subject|11
7682460|NCT01266265|26720523|P1|Overall Study|Withdrawal by Subject|13
7682461|NCT01266265|26720522|P2|Overall Study|Lost to Follow-up|28
7682462|NCT01266265|26720523|P1|Overall Study|Lost to Follow-up|23
7682463|NCT01266265|26720522|P2|Overall Study|Death|73
7682464|NCT01266265|26720523|P1|Overall Study|Death|95
7682465|NCT01266161|26720531|P2|Overall Study|Vomited within 4 hours of dosing|0
7682466|NCT01266161|26720532|P1|Overall Study|Vomited within 4 hours of dosing|3
7682467|NCT01266161|26720531|P2|Overall Study|Lack of Efficacy|1
7682468|NCT01266161|26720532|P1|Overall Study|Lack of Efficacy|0
7682469|NCT01266161|26720531|P2|Overall Study|Ineligible|0
7682470|NCT01266161|26720532|P1|Overall Study|Ineligible|1
7682471|NCT01266148|26720564|P2|Overall Study|missing mGFR value + AE|0
7682472|NCT01266148|26720565|P1|Overall Study|missing mGFR value + AE|1
7682473|NCT01266148|26720564|P2|Overall Study|Death|3
7682474|NCT01266148|26720565|P1|Overall Study|Death|2
7682475|NCT01266148|26720564|P2|Overall Study|2 2R rejections|0
7682476|NCT01266148|26720565|P1|Overall Study|2 2R rejections|1
7682477|NCT01266148|26720564|P2|Overall Study|Ongoing rejection|0
7682478|NCT01266148|26720565|P1|Overall Study|Ongoing rejection|1
7682479|NCT01266148|26720564|P2|Overall Study|Adverse Event|0
7682480|NCT01266148|26720565|P1|Overall Study|Adverse Event|2
7682481|NCT01266122|26720593|P2|Overall Study|Lost to Follow-up|6
7682482|NCT01266122|26720594|P1|Overall Study|Lost to Follow-up|6
7682483|NCT01266070|26720602|P1|Overall Study|Protocol Violation|1
7682484|NCT01266070|26720602|P1|Overall Study|Adverse Event|3
7682485|NCT01266031|26720610|P3|Overall Study|Not treated|2
7682486|NCT01266031|26720611|P2|Overall Study|Not treated|3
7682487|NCT01266031|26720612|P1|Overall Study|Not treated|0
7682488|NCT01266018|26720639|P2|Overall Study|Progressive disease|1
7682489|NCT01266018|26720640|P1|Overall Study|Progressive disease|0
7682490|NCT01266018|26720639|P2|Overall Study|Physician Decision|0
7682491|NCT01266018|26720640|P1|Overall Study|Physician Decision|1
7682492|NCT01265992|26720651|P1|Overall Study|Did not receive treatment|1
7682493|NCT01265992|26720651|P1|Overall Study|Stopped treatment|3
7682494|NCT01265992|26720651|P1|Overall Study|Administrative reasons|2
7682495|NCT01265992|26720651|P1|Overall Study|Adverse Event|1
7682496|NCT01265992|26720651|P1|Overall Study|Withdrawal by Subject|1
7682497|NCT01265992|26720651|P1|Overall Study|Lost to Follow-up|1
7682498|NCT01265953|26720679|P2|Overall Study|Non compliance|3
7682499|NCT01265953|26720680|P1|Overall Study|Non compliance|5
7682500|NCT01265875|26720692|P1|Overall Study|Uncooperative/unreliable|1
7682501|NCT01265823|26720700|P1|Overall Study|Participant Request|1
7682502|NCT01265823|26720700|P1|Overall Study|Protocol Violation|1
7682503|NCT01265823|26720700|P1|Overall Study|Failure to Return|4
7682504|NCT01265823|26720700|P1|Overall Study|Unsatisfactory Response Efficacy|1
7682505|NCT01265797|26720729|P2|Open Label Month|Lost to Follow-up|1
7682506|NCT01265797|26720730|P1|Open Label Month|Lost to Follow-up|0
7682507|NCT01265797|26720729|P2|Blinded Month|Diary data incomplete|1
7682508|NCT01265797|26720730|P1|Blinded Month|Diary data incomplete|0
7682509|NCT01265797|26720729|P2|Blinded Month|Adverse Event|0
7682510|NCT01265797|26720730|P1|Blinded Month|Adverse Event|2
7682511|NCT01265797|26720729|P2|Blinded Month|Protocol Violation|1
7682512|NCT01265797|26720730|P1|Blinded Month|Protocol Violation|2
7682513|NCT01265797|26720729|P2|Blinded Month|Lost to Follow-up|0
7682514|NCT01265797|26720730|P1|Blinded Month|Lost to Follow-up|1
7682515|NCT01265797|26720729|P2|Blinded Month|Lack of Efficacy|0
7682516|NCT01265797|26720730|P1|Blinded Month|Lack of Efficacy|5
7682517|NCT01265797|26720729|P2|Run-in Month|1st seizure during run-in month|1
7682518|NCT01265797|26720730|P1|Run-in Month|1st seizure during run-in month|0
7682519|NCT01265797|26720729|P2|Run-in Month|Withdrawal by Subject|4
7682520|NCT01265797|26720730|P1|Run-in Month|Withdrawal by Subject|0
7682521|NCT01265784|26720761|P3|Overall Study|Incorrectly Randomized|1
7682522|NCT01265784|26720762|P2|Overall Study|Incorrectly Randomized|0
7682523|NCT01265784|26720763|P1|Overall Study|Incorrectly Randomized|0
7682524|NCT01265784|26720761|P3|Overall Study|Protocol Violation|0
7682525|NCT01265784|26720762|P2|Overall Study|Protocol Violation|0
7682526|NCT01265784|26720763|P1|Overall Study|Protocol Violation|2
7682527|NCT01265784|26720761|P3|Overall Study|Death|0
7682528|NCT01265784|26720762|P2|Overall Study|Death|0
7682529|NCT01265784|26720763|P1|Overall Study|Death|3
7682530|NCT01265784|26720761|P3|Overall Study|Adverse Event|0
7682531|NCT01265784|26720762|P2|Overall Study|Adverse Event|0
7682532|NCT01265784|26720763|P1|Overall Study|Adverse Event|1
7682533|NCT01265784|26720761|P3|Overall Study|Physician Decision|1
7682534|NCT01265784|26720762|P2|Overall Study|Physician Decision|0
7682535|NCT01265784|26720763|P1|Overall Study|Physician Decision|1
7682536|NCT01265784|26720761|P3|Overall Study|Withdrawal by Subject|0
7682537|NCT01265784|26720762|P2|Overall Study|Withdrawal by Subject|5
7682538|NCT01265784|26720763|P1|Overall Study|Withdrawal by Subject|0
7682539|NCT01265784|26720761|P3|Overall Study|Lost to Follow-up|2
7682540|NCT01265784|26720762|P2|Overall Study|Lost to Follow-up|3
7682541|NCT01265784|26720763|P1|Overall Study|Lost to Follow-up|5
7682542|NCT01265719|26720831|P2|Overall Study|Adverse Event|0
7682543|NCT01265719|26720832|P1|Overall Study|Adverse Event|2
7682544|NCT01265719|26720831|P2|Overall Study|Lost to Follow-up|7
7682545|NCT01265719|26720832|P1|Overall Study|Lost to Follow-up|2
7682546|NCT01265719|26720831|P2|Overall Study|Withdrawal by Subject|3
7682547|NCT01265719|26720832|P1|Overall Study|Withdrawal by Subject|8
7682548|NCT01265719|26720831|P2|Overall Study|Other reasons|0
7682549|NCT01265719|26720832|P1|Overall Study|Other reasons|2
7682550|NCT01265719|26720831|P2|Overall Study|Does not meet entrance criteria|3
7682551|NCT01265719|26720832|P1|Overall Study|Does not meet entrance criteria|0
7682552|NCT01265615|26720883|P4|Overall Study|Protocol Violation|3
7682553|NCT01265615|26720884|P3|Overall Study|Protocol Violation|4
7682554|NCT01265615|26720885|P2|Overall Study|Protocol Violation|2
7682555|NCT01265615|26720886|P1|Overall Study|Protocol Violation|2
7682556|NCT01265563|26720937|P5|Overall Study|Withdrawal by Subject|2
7682557|NCT01265563|26720938|P4|Overall Study|Withdrawal by Subject|0
7682558|NCT01265563|26720939|P3|Overall Study|Withdrawal by Subject|1
7682559|NCT01265563|26720940|P2|Overall Study|Withdrawal by Subject|1
7682560|NCT01265563|26720941|P1|Overall Study|Withdrawal by Subject|0
7682561|NCT01265550|26720967|P4|Pre Randomization|Functional heartburn|99
7682562|NCT01265550|26720968|P3|Pre Randomization|Functional heartburn|0
7682563|NCT01265550|26720969|P2|Pre Randomization|Functional heartburn|0
7682564|NCT01265550|26720970|P1|Pre Randomization|Functional heartburn|0
7682565|NCT01265550|26720967|P4|Pre Randomization|Non-GERD organic disorders|23
7682566|NCT01265550|26720968|P3|Pre Randomization|Non-GERD organic disorders|0
7682567|NCT01265550|26720969|P2|Pre Randomization|Non-GERD organic disorders|0
7682568|NCT01265550|26720970|P1|Pre Randomization|Non-GERD organic disorders|0
7682569|NCT01265550|26720967|P4|Pre Randomization|GERD, PPI-Responsive|42
7682570|NCT01265550|26720968|P3|Pre Randomization|GERD, PPI-Responsive|0
7682571|NCT01265550|26720969|P2|Pre Randomization|GERD, PPI-Responsive|0
7682572|NCT01265550|26720970|P1|Pre Randomization|GERD, PPI-Responsive|0
7682573|NCT01265550|26720967|P4|Pre Randomization|Technical Exclusions|54
7682574|NCT01265550|26720968|P3|Pre Randomization|Technical Exclusions|0
7682575|NCT01265550|26720969|P2|Pre Randomization|Technical Exclusions|0
7682576|NCT01265550|26720970|P1|Pre Randomization|Technical Exclusions|0
7682577|NCT01265550|26720967|P4|Pre Randomization|Withdrawal by Subject|70
7682578|NCT01265550|26720968|P3|Pre Randomization|Withdrawal by Subject|0
7682579|NCT01265550|26720969|P2|Pre Randomization|Withdrawal by Subject|0
7682580|NCT01265550|26720970|P1|Pre Randomization|Withdrawal by Subject|0
7682581|NCT01265537|26721062|P2|Overall Study|Physician Decision|1
7682582|NCT01265537|26721063|P1|Overall Study|Physician Decision|0
7682583|NCT01265537|26721062|P2|Overall Study|Adverse Event|1
7682584|NCT01265537|26721063|P1|Overall Study|Adverse Event|2
7682585|NCT01265511|26721114|P2|Overall Study|Met stopping rules|2
7682586|NCT01265511|26721115|P1|Overall Study|Met stopping rules|0
7682587|NCT01265511|26721114|P2|Overall Study|Lack of Efficacy|1
7682588|NCT01265511|26721115|P1|Overall Study|Lack of Efficacy|2
7682589|NCT01265498|26721129|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
7682590|NCT01265498|26721130|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
7682591|NCT01265420|26721266|P1|Overall Study|Lost to Follow-up|1
7682592|NCT01265394|26721270|P1|Overall Study|Subjects withdrawn|37
7682593|NCT01265056|26721277|P2|Follow up|Lost to Follow-up|3
7682594|NCT01265056|26721278|P1|Follow up|Lost to Follow-up|7
7682595|NCT01265056|26721277|P2|Initial Study Period|Withdrawal by Subject|1
7682596|NCT01265056|26721278|P1|Initial Study Period|Withdrawal by Subject|1
7682597|NCT01265056|26721277|P2|Initial Study Period|Withdrawal by Subject|1
7682598|NCT01265056|26721278|P1|Initial Study Period|Withdrawal by Subject|1
7682599|NCT01264965|26721288|P1|Overall Study|Withdrawal by Subject|10
7682600|NCT01264939|26721314|P2|Overall Study|Disease Progression|11
7682601|NCT01264939|26721315|P1|Overall Study|Disease Progression|8
7682602|NCT01264939|26721314|P2|Overall Study|Patient/Guardian Decision|10
7682603|NCT01264939|26721315|P1|Overall Study|Patient/Guardian Decision|8
7682604|NCT01264939|26721314|P2|Overall Study|Physician Decision|1
7682605|NCT01264939|26721315|P1|Overall Study|Physician Decision|1
7682606|NCT01264939|26721314|P2|Overall Study|Lost to Follow-up|3
7682607|NCT01264939|26721315|P1|Overall Study|Lost to Follow-up|0
7682608|NCT01264939|26721314|P2|Overall Study|Adverse Event|3
7682609|NCT01264939|26721315|P1|Overall Study|Adverse Event|1
7682610|NCT01264887|26721341|P1|Overall Study|Other|2
7682611|NCT01264887|26721341|P1|Overall Study|Sponsor Decision Administrative Reasons|2
7682612|NCT01264887|26721341|P1|Overall Study|Withdrawal by Subject|6
7682613|NCT01264887|26721341|P1|Overall Study|Physician Decision|4
7682614|NCT01264887|26721341|P1|Overall Study|Lack of Efficacy|5
7682615|NCT01264887|26721341|P1|Overall Study|Death|7
7682616|NCT01264887|26721341|P1|Overall Study|Adverse Event|5
7682617|NCT01264835|26721352|P1|Overall Study|Lost to Follow-up|1
7682618|NCT01264770|26721362|P6|Overall Study|Adverse Event|1
7682619|NCT01264770|26721363|P5|Overall Study|Adverse Event|2
7682620|NCT01264770|26721364|P4|Overall Study|Adverse Event|0
7682621|NCT01264770|26721365|P3|Overall Study|Adverse Event|8
7682622|NCT01264770|26721366|P2|Overall Study|Adverse Event|7
7682623|NCT01264770|26721367|P1|Overall Study|Adverse Event|7
7682624|NCT01264770|26721362|P6|Overall Study|Lost to Follow-up|0
7682625|NCT01264770|26721363|P5|Overall Study|Lost to Follow-up|0
7682626|NCT01264770|26721364|P4|Overall Study|Lost to Follow-up|1
7682627|NCT01264770|26721365|P3|Overall Study|Lost to Follow-up|1
7682628|NCT01264770|26721366|P2|Overall Study|Lost to Follow-up|0
7682629|NCT01264770|26721367|P1|Overall Study|Lost to Follow-up|0
7682630|NCT01264770|26721362|P6|Overall Study|Dev. of study specific discont. criteria|1
7682631|NCT01264770|26721363|P5|Overall Study|Dev. of study specific discont. criteria|1
7682632|NCT01264770|26721364|P4|Overall Study|Dev. of study specific discont. criteria|0
7682633|NCT01264770|26721365|P3|Overall Study|Dev. of study specific discont. criteria|0
7682634|NCT01264770|26721366|P2|Overall Study|Dev. of study specific discont. criteria|0
7682635|NCT01264770|26721367|P1|Overall Study|Dev. of study specific discont. criteria|2
7682636|NCT01264770|26721362|P6|Overall Study|Lack of therapeutic response|0
7682637|NCT01264770|26721363|P5|Overall Study|Lack of therapeutic response|1
7682638|NCT01264770|26721364|P4|Overall Study|Lack of therapeutic response|1
7682639|NCT01264770|26721365|P3|Overall Study|Lack of therapeutic response|2
7682640|NCT01264770|26721366|P2|Overall Study|Lack of therapeutic response|0
7682641|NCT01264770|26721367|P1|Overall Study|Lack of therapeutic response|1
7682642|NCT01264770|26721362|P6|Overall Study|Severe non-compliance to protocol|0
7682643|NCT01264770|26721363|P5|Overall Study|Severe non-compliance to protocol|0
7682644|NCT01264770|26721364|P4|Overall Study|Severe non-compliance to protocol|1
7682645|NCT01264770|26721365|P3|Overall Study|Severe non-compliance to protocol|1
7682646|NCT01264770|26721366|P2|Overall Study|Severe non-compliance to protocol|0
7682647|NCT01264770|26721367|P1|Overall Study|Severe non-compliance to protocol|0
7682648|NCT01264770|26721362|P6|Overall Study|e.g., change in circumstances|4
7682649|NCT01264770|26721363|P5|Overall Study|e.g., change in circumstances|4
7682650|NCT01264770|26721364|P4|Overall Study|e.g., change in circumstances|3
7682651|NCT01264770|26721365|P3|Overall Study|e.g., change in circumstances|3
7682652|NCT01264770|26721366|P2|Overall Study|e.g., change in circumstances|3
7682653|NCT01264770|26721367|P1|Overall Study|e.g., change in circumstances|8
7682654|NCT01264770|26721362|P6|Overall Study|Not reported|0
7682655|NCT01264770|26721363|P5|Overall Study|Not reported|0
7682656|NCT01264770|26721364|P4|Overall Study|Not reported|0
7682657|NCT01264770|26721365|P3|Overall Study|Not reported|1
7682658|NCT01264770|26721366|P2|Overall Study|Not reported|0
7682659|NCT01264770|26721367|P1|Overall Study|Not reported|0
7682660|NCT01264718|26721453|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
7682661|NCT01264718|26721454|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
7682662|NCT01264718|26721453|P2|Overall Study|Withdrawal by Subject|15
7682663|NCT01264718|26721454|P1|Overall Study|Withdrawal by Subject|9
7682664|NCT01264718|26721453|P2|Overall Study|Lost to Follow-up|2
7682665|NCT01264718|26721454|P1|Overall Study|Lost to Follow-up|3
7682666|NCT01264679|26721491|P1|Overall Study|Withdrawal by Subject|1
7682667|NCT01264679|26721491|P1|Overall Study|Sponsor's Suspension of Dosing|2
7682668|NCT01264679|26721491|P1|Overall Study|Physician Decision|1
7682669|NCT01264679|26721491|P1|Overall Study|Participation in Another Clinical Trial|1
7682670|NCT01264419|26721525|P1|Overall Study|Lost to Follow-up|3
7682671|NCT01264380|26721530|P3|Period C|Adverse Event|1
7682672|NCT01264380|26721531|P2|Period C|Adverse Event|0
7682673|NCT01264380|26721532|P1|Period C|Adverse Event|0
7682674|NCT01264380|26721530|P3|Period C|Withdrawal by Subject|1
7682675|NCT01264380|26721531|P2|Period C|Withdrawal by Subject|0
7682676|NCT01264380|26721532|P1|Period C|Withdrawal by Subject|0
7682677|NCT01264380|26721530|P3|Period C|Follow-up for survival status|6
7682678|NCT01264380|26721531|P2|Period C|Follow-up for survival status|0
7682679|NCT01264380|26721532|P1|Period C|Follow-up for survival status|0
7682680|NCT01264380|26721530|P3|Period C|Death|2
7682681|NCT01264380|26721531|P2|Period C|Death|0
7682682|NCT01264380|26721532|P1|Period C|Death|0
7682683|NCT01264380|26721530|P3|Period C|Disease Progression|4
7682684|NCT01264380|26721531|P2|Period C|Disease Progression|0
7682685|NCT01264380|26721532|P1|Period C|Disease Progression|0
7682686|NCT01264081|26721553|P1|Started Treatment|Not complete cycle 1 due to death|1
7682687|NCT01264081|26721553|P1|Started Treatment|Withdrawal by Subject|1
7682688|NCT01264081|26721553|P1|Participants Screened|Screening failures|30
7682689|NCT01264016|26721558|P1|Overall Study|Felt faint at sight of blood|1
7682690|NCT01264016|26721558|P1|Overall Study|Withdrawal by Subject|1
7682691|NCT01263925|26721573|P2|Overall Study|Withdrawal/ Not specified|1
7682692|NCT01263925|26721574|P1|Overall Study|Withdrawal/ Not specified|0
7682693|NCT01263925|26721573|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
7682694|NCT01263925|26721574|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
7682695|NCT01263925|26721573|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
7682696|NCT01263925|26721574|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
7682697|NCT01263925|26721573|P2|Overall Study|AE/ Withdrawal|4
7682698|NCT01263925|26721574|P1|Overall Study|AE/ Withdrawal|1
7682699|NCT01263925|26721573|P2|Overall Study|AE/ Unsatisfactory Compliance|2
7682700|NCT01263925|26721574|P1|Overall Study|AE/ Unsatisfactory Compliance|2
7682701|NCT01263925|26721573|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
7682702|NCT01263925|26721574|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
7682703|NCT01263925|26721573|P2|Overall Study|Lost to Follow-up|1
7682704|NCT01263925|26721574|P1|Overall Study|Lost to Follow-up|3
7682705|NCT01263925|26721573|P2|Overall Study|Other|4
7682706|NCT01263925|26721574|P1|Overall Study|Other|4
7682707|NCT01263925|26721573|P2|Overall Study|Withdrawal by Subject|8
7682708|NCT01263925|26721574|P1|Overall Study|Withdrawal by Subject|6
7682709|NCT01263925|26721573|P2|Overall Study|Unsatisfactory Compliance of Subject|5
7682710|NCT01263925|26721574|P1|Overall Study|Unsatisfactory Compliance of Subject|8
7682711|NCT01263925|26721573|P2|Overall Study|Adverse Event|22
7682712|NCT01263925|26721574|P1|Overall Study|Adverse Event|23
7682713|NCT01263925|26721573|P2|Overall Study|Lack of Efficacy|1
7682714|NCT01263925|26721574|P1|Overall Study|Lack of Efficacy|0
7682715|NCT01263925|26721573|P2|Overall Study|Protocol Violation|0
7682716|NCT01263925|26721574|P1|Overall Study|Protocol Violation|1
7682717|NCT01263873|26721608|P2|Overall Study|One provider unable to complete numbers|1
7682718|NCT01263873|26721609|P1|Overall Study|One provider unable to complete numbers|1
7682719|NCT01263782|26721623|P4|Overall Study|Inevaluable|0
7682720|NCT01263782|26721624|P3|Overall Study|Inevaluable|1
7682721|NCT01263782|26721625|P2|Overall Study|Inevaluable|0
7682722|NCT01263782|26721626|P1|Overall Study|Inevaluable|0
7682723|NCT01263782|26721623|P4|Overall Study|Too early|0
7682724|NCT01263782|26721624|P3|Overall Study|Too early|1
7682725|NCT01263782|26721625|P2|Overall Study|Too early|0
7682726|NCT01263782|26721626|P1|Overall Study|Too early|0
7682727|NCT01263782|26721623|P4|Overall Study|Progressive disease|1
7682728|NCT01263782|26721624|P3|Overall Study|Progressive disease|0
7682729|NCT01263782|26721625|P2|Overall Study|Progressive disease|0
7682730|NCT01263782|26721626|P1|Overall Study|Progressive disease|0
7682731|NCT01263782|26721623|P4|Overall Study|Death|0
7682732|NCT01263782|26721624|P3|Overall Study|Death|1
7682733|NCT01263782|26721625|P2|Overall Study|Death|0
7682734|NCT01263782|26721626|P1|Overall Study|Death|0
7682735|NCT01263704|26721671|P1|Overall Study|Principal Investigator (PI) decision|1
7682736|NCT01263704|26721671|P1|Overall Study|Colon metastases|1
7682737|NCT01263704|26721671|P1|Overall Study|Lost to Follow-up|1
7682738|NCT01263704|26721671|P1|Overall Study|Eligibility criteria not fulfilled|1
7682739|NCT01263704|26721671|P1|Overall Study|Patient withdrew consent|2
7682740|NCT01263704|26721671|P1|Overall Study|Death|2
7682741|NCT01263704|26721671|P1|Overall Study|Adverse Event|3
7682742|NCT01263704|26721671|P1|Overall Study|Progressive disease|18
7682743|NCT01263691|26721686|P6|Overall Study|Adverse Event|0
7682744|NCT01263691|26721687|P5|Overall Study|Adverse Event|0
7682745|NCT01263691|26721688|P4|Overall Study|Adverse Event|0
7682746|NCT01263691|26721689|P3|Overall Study|Adverse Event|0
7682747|NCT01263691|26721690|P2|Overall Study|Adverse Event|0
7682748|NCT01263691|26721691|P1|Overall Study|Adverse Event|1
7682749|NCT01263691|26721686|P6|Overall Study|Withdrawal by Subject|0
7682750|NCT01263691|26721687|P5|Overall Study|Withdrawal by Subject|0
7682751|NCT01263691|26721688|P4|Overall Study|Withdrawal by Subject|0
7682752|NCT01263691|26721689|P3|Overall Study|Withdrawal by Subject|0
7682753|NCT01263691|26721690|P2|Overall Study|Withdrawal by Subject|0
7682754|NCT01263691|26721691|P1|Overall Study|Withdrawal by Subject|1
7682755|NCT01263691|26721686|P6|Overall Study|Lost to Follow-up|0
7682756|NCT01263691|26721687|P5|Overall Study|Lost to Follow-up|0
7682757|NCT01263691|26721688|P4|Overall Study|Lost to Follow-up|1
7682758|NCT01263691|26721689|P3|Overall Study|Lost to Follow-up|1
7682759|NCT01263691|26721690|P2|Overall Study|Lost to Follow-up|0
7682760|NCT01263691|26721691|P1|Overall Study|Lost to Follow-up|1
7682761|NCT01263665|26721801|P1|Overall Study|Surgical Bypass|2
7682762|NCT01263665|26721801|P1|Overall Study|Amputation above the ankle|1
7682763|NCT01263665|26721801|P1|Overall Study|Death|2
7682764|NCT01263665|26721801|P1|Overall Study|Lost to Follow-up|3
7682765|NCT01263665|26721801|P1|Overall Study|Withdrew Consent|1
7682766|NCT01263639|26721808|P2|Overall Study|Exclusion =Admission greater than 7 days|9
7682767|NCT01263639|26721809|P1|Overall Study|Exclusion =Admission greater than 7 days|7
7682768|NCT01263639|26721808|P2|Overall Study|Lost to Follow-up|70
7682769|NCT01263639|26721809|P1|Overall Study|Lost to Follow-up|66
7682770|NCT01263561|26721817|P2|Overall Study|Death|2
7682771|NCT01263561|26721818|P1|Overall Study|Death|1
7682772|NCT01263509|26721830|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
7682773|NCT01263509|26721831|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7682774|NCT01263509|26721832|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7682775|NCT01263509|26721833|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7682776|NCT01263509|26721830|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
7682777|NCT01263509|26721831|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
7682778|NCT01263509|26721832|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
7682779|NCT01263509|26721833|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
7682780|NCT01263509|26721830|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7682781|NCT01263509|26721831|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7682782|NCT01263509|26721832|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7682783|NCT01263509|26721833|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7682784|NCT01263509|26721830|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
7682785|NCT01263509|26721831|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
7682786|NCT01263509|26721832|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
7682787|NCT01263509|26721833|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
7682788|NCT01263509|26721830|P4|Entered - Long-Term Extension Study|Adverse Event|1
7682789|NCT01263509|26721831|P3|Entered - Long-Term Extension Study|Adverse Event|4
7682790|NCT01263509|26721832|P2|Entered - Long-Term Extension Study|Adverse Event|5
7682791|NCT01263509|26721833|P1|Entered - Long-Term Extension Study|Adverse Event|5
7682792|NCT01263496|26721962|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
7682793|NCT01263496|26721963|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
7682794|NCT01263496|26721964|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
7682795|NCT01263496|26721965|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
7682796|NCT01263496|26721966|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
7682797|NCT01263496|26721967|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
7682798|NCT01263496|26721968|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
7682799|NCT01263496|26721969|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
7682800|NCT01263496|26721970|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
7682801|NCT01263496|26721962|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
7682802|NCT01263496|26721963|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
7682803|NCT01263496|26721964|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
7682804|NCT01263496|26721965|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
7682805|NCT01263496|26721966|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
7682806|NCT01263496|26721967|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
7682807|NCT01263496|26721968|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
7682808|NCT01263496|26721969|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
7682809|NCT01263496|26721970|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
7682810|NCT01263496|26721962|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7682811|NCT01263496|26721963|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7682812|NCT01263496|26721964|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7682813|NCT01263496|26721965|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7682814|NCT01263496|26721966|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
7682815|NCT01263496|26721967|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7682816|NCT01263496|26721968|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7682817|NCT01263496|26721969|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7682818|NCT01263496|26721970|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7682819|NCT01263496|26721962|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682820|NCT01263496|26721963|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682821|NCT01263496|26721964|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682822|NCT01263496|26721965|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682823|NCT01263496|26721966|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682824|NCT01263496|26721967|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682825|NCT01263496|26721968|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682826|NCT01263496|26721969|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
7682827|NCT01263496|26721970|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
7682828|NCT01263496|26721962|P9|Entered - Long-Term Extension Study|Adverse Event|1
7682829|NCT01263496|26721963|P8|Entered - Long-Term Extension Study|Adverse Event|0
7682830|NCT01263496|26721964|P7|Entered - Long-Term Extension Study|Adverse Event|0
7682831|NCT01263496|26721965|P6|Entered - Long-Term Extension Study|Adverse Event|0
7682832|NCT01263496|26721966|P5|Entered - Long-Term Extension Study|Adverse Event|1
7682833|NCT01263496|26721967|P4|Entered - Long-Term Extension Study|Adverse Event|3
7682834|NCT01263496|26721968|P3|Entered - Long-Term Extension Study|Adverse Event|6
7682835|NCT01263496|26721969|P2|Entered - Long-Term Extension Study|Adverse Event|5
7682836|NCT01263496|26721970|P1|Entered - Long-Term Extension Study|Adverse Event|0
7682837|NCT01263496|26721962|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
7682838|NCT01263496|26721963|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
7682839|NCT01263496|26721964|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
7682840|NCT01263496|26721965|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
7682841|NCT01263496|26721966|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
7682842|NCT01263496|26721967|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
7682843|NCT01263496|26721968|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
7682844|NCT01263496|26721969|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
7682845|NCT01263496|26721970|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
7682846|NCT01263496|26721962|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682847|NCT01263496|26721963|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682848|NCT01263496|26721964|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682849|NCT01263496|26721965|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682850|NCT01263496|26721966|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682851|NCT01263496|26721967|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682852|NCT01263496|26721968|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682853|NCT01263496|26721969|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
7682854|NCT01263496|26721970|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
7682855|NCT01263483|26722265|P3|Overall Study|Participant Unavailability|1
7682856|NCT01263483|26722266|P2|Overall Study|Participant Unavailability|1
7682857|NCT01263483|26722267|P1|Overall Study|Participant Unavailability|0
7682858|NCT01263483|26722265|P3|Overall Study|Protocol Violation|1
7682859|NCT01263483|26722266|P2|Overall Study|Protocol Violation|1
7682860|NCT01263483|26722267|P1|Overall Study|Protocol Violation|0
7682861|NCT01263483|26722265|P3|Overall Study|Lack of Efficacy|0
7682862|NCT01263483|26722266|P2|Overall Study|Lack of Efficacy|0
7682863|NCT01263483|26722267|P1|Overall Study|Lack of Efficacy|2
7682864|NCT01263483|26722265|P3|Overall Study|Withdrawal by Subject|0
7682865|NCT01263483|26722266|P2|Overall Study|Withdrawal by Subject|0
7682866|NCT01263483|26722267|P1|Overall Study|Withdrawal by Subject|1
7682867|NCT01263483|26722265|P3|Overall Study|Adverse Event|3
7682868|NCT01263483|26722266|P2|Overall Study|Adverse Event|0
7682869|NCT01263483|26722267|P1|Overall Study|Adverse Event|4
7682870|NCT01263470|26722329|P6|Overall Study|Study Drug Non-compliance|0
7682871|NCT01263470|26722330|P5|Overall Study|Study Drug Non-compliance|1
7682872|NCT01263470|26722331|P4|Overall Study|Study Drug Non-compliance|0
7682873|NCT01263470|26722332|P3|Overall Study|Study Drug Non-compliance|0
7682874|NCT01263470|26722333|P2|Overall Study|Study Drug Non-compliance|0
7682875|NCT01263470|26722334|P1|Overall Study|Study Drug Non-compliance|0
7682876|NCT01263470|26722329|P6|Overall Study|Participant Unavailability|0
7682877|NCT01263470|26722330|P5|Overall Study|Participant Unavailability|0
7682878|NCT01263470|26722331|P4|Overall Study|Participant Unavailability|0
7682879|NCT01263470|26722332|P3|Overall Study|Participant Unavailability|0
7682880|NCT01263470|26722333|P2|Overall Study|Participant Unavailability|1
7682881|NCT01263470|26722334|P1|Overall Study|Participant Unavailability|0
7682882|NCT01263470|26722329|P6|Overall Study|Lack of Efficacy|0
7682883|NCT01263470|26722330|P5|Overall Study|Lack of Efficacy|0
7682884|NCT01263470|26722331|P4|Overall Study|Lack of Efficacy|0
7682885|NCT01263470|26722332|P3|Overall Study|Lack of Efficacy|2
7682886|NCT01263470|26722333|P2|Overall Study|Lack of Efficacy|0
7682887|NCT01263470|26722334|P1|Overall Study|Lack of Efficacy|0
7682888|NCT01263470|26722329|P6|Overall Study|Withdrawal by Subject|2
7682889|NCT01263470|26722330|P5|Overall Study|Withdrawal by Subject|0
7682890|NCT01263470|26722331|P4|Overall Study|Withdrawal by Subject|2
7682891|NCT01263470|26722332|P3|Overall Study|Withdrawal by Subject|1
7682892|NCT01263470|26722333|P2|Overall Study|Withdrawal by Subject|1
7682893|NCT01263470|26722334|P1|Overall Study|Withdrawal by Subject|0
7682894|NCT01263470|26722329|P6|Overall Study|Protocol Violation|1
7682895|NCT01263470|26722330|P5|Overall Study|Protocol Violation|0
7682896|NCT01263470|26722331|P4|Overall Study|Protocol Violation|0
7682897|NCT01263470|26722332|P3|Overall Study|Protocol Violation|0
7682898|NCT01263470|26722333|P2|Overall Study|Protocol Violation|1
7682899|NCT01263470|26722334|P1|Overall Study|Protocol Violation|0
7682900|NCT01263470|26722329|P6|Overall Study|Adverse Event|2
7682901|NCT01263470|26722330|P5|Overall Study|Adverse Event|2
7682902|NCT01263470|26722331|P4|Overall Study|Adverse Event|1
7682903|NCT01263470|26722332|P3|Overall Study|Adverse Event|1
7682904|NCT01263470|26722333|P2|Overall Study|Adverse Event|2
7682905|NCT01263470|26722334|P1|Overall Study|Adverse Event|2
7682906|NCT01263444|26722444|P1|Overall Study|Protocol Violation|1
7682907|NCT01263444|26722444|P1|Overall Study|Withdrawal by Subject|1
7682908|NCT01263444|26722444|P1|Overall Study|Adverse Event|8
7682909|NCT01263223|26722581|P2|7-day Follow-up|Lost to Follow-up|0
7682910|NCT01263223|26722582|P1|7-day Follow-up|Lost to Follow-up|1
7682911|NCT01263223|26722581|P2|7-day Follow-up|Withdrawal by Subject|1
7682912|NCT01263223|26722582|P1|7-day Follow-up|Withdrawal by Subject|0
7682913|NCT01263223|26722581|P2|Period 2|Withdrawal by Subject|1
7682914|NCT01263223|26722582|P1|Period 2|Withdrawal by Subject|0
7682915|NCT01263197|26722605|P6|Third Intervention (Period 3)|Adverse Event|0
7682916|NCT01263197|26722606|P5|Third Intervention (Period 3)|Adverse Event|0
7682917|NCT01263197|26722607|P4|Third Intervention (Period 3)|Adverse Event|0
7682918|NCT01263197|26722608|P3|Third Intervention (Period 3)|Adverse Event|0
7682919|NCT01263197|26722609|P2|Third Intervention (Period 3)|Adverse Event|1
7682920|NCT01263197|26722610|P1|Third Intervention (Period 3)|Adverse Event|0
7682921|NCT01263197|26722605|P6|Washout Period 2|Protocol Violation|0
7682922|NCT01263197|26722606|P5|Washout Period 2|Protocol Violation|0
7682923|NCT01263197|26722607|P4|Washout Period 2|Protocol Violation|1
7682924|NCT01263197|26722608|P3|Washout Period 2|Protocol Violation|0
7682925|NCT01263197|26722609|P2|Washout Period 2|Protocol Violation|0
7682926|NCT01263197|26722610|P1|Washout Period 2|Protocol Violation|0
7682927|NCT01263197|26722605|P6|Washout Period 2|Physician Decision|1
7682928|NCT01263197|26722606|P5|Washout Period 2|Physician Decision|0
7682929|NCT01263197|26722607|P4|Washout Period 2|Physician Decision|0
7682930|NCT01263197|26722608|P3|Washout Period 2|Physician Decision|0
7682931|NCT01263197|26722609|P2|Washout Period 2|Physician Decision|0
7682932|NCT01263197|26722610|P1|Washout Period 2|Physician Decision|0
7682933|NCT01263197|26722605|P6|Washout Period 1|Protocol Violation|0
7682934|NCT01263197|26722606|P5|Washout Period 1|Protocol Violation|1
7682935|NCT01263197|26722607|P4|Washout Period 1|Protocol Violation|0
7682936|NCT01263197|26722608|P3|Washout Period 1|Protocol Violation|0
7682937|NCT01263197|26722609|P2|Washout Period 1|Protocol Violation|0
7682938|NCT01263197|26722610|P1|Washout Period 1|Protocol Violation|0
7682939|NCT01263197|26722605|P6|First Intervention (Period 1)|Adverse Event|1
7682940|NCT01263197|26722606|P5|First Intervention (Period 1)|Adverse Event|0
7682941|NCT01263197|26722607|P4|First Intervention (Period 1)|Adverse Event|0
7682942|NCT01263197|26722608|P3|First Intervention (Period 1)|Adverse Event|0
7682943|NCT01263197|26722609|P2|First Intervention (Period 1)|Adverse Event|0
7682944|NCT01263197|26722610|P1|First Intervention (Period 1)|Adverse Event|0
7682945|NCT01263119|26722653|P1|Period 2|Adverse Event|2
7682946|NCT01263119|26722653|P1|Period 1|Protocol Violation|2
7682947|NCT01263106|26722674|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
7682948|NCT01263106|26722675|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
7682949|NCT01263093|26722690|P2|Period 2|Adverse Event|0
7682950|NCT01263093|26722691|P1|Period 2|Adverse Event|1
7682951|NCT01263093|26722690|P2|Washout|Physician Decision|0
7682952|NCT01263093|26722691|P1|Washout|Physician Decision|1
7682953|NCT01263054|26722708|P2|Overall Study|Other|1
7682954|NCT01263054|26722709|P1|Overall Study|Other|0
7682955|NCT01263054|26722708|P2|Overall Study|Qualification Violation|0
7682956|NCT01263054|26722709|P1|Overall Study|Qualification Violation|1
7682957|NCT01263054|26722708|P2|Overall Study|Withdrawal by Subject|3
7682958|NCT01263054|26722709|P1|Overall Study|Withdrawal by Subject|1
7682959|NCT01263054|26722708|P2|Overall Study|Lost to Follow-up|2
7682960|NCT01263054|26722709|P1|Overall Study|Lost to Follow-up|2
7682961|NCT01263054|26722708|P2|Overall Study|Death|0
7682962|NCT01263054|26722709|P1|Overall Study|Death|1
7682963|NCT01263028|26722727|P1|Overall Study|Study terminated due to low enrollment.|4
7682964|NCT01263028|26722727|P1|Overall Study|Adverse Event|1
7682965|NCT01263028|26722727|P1|Overall Study|Withdrawal by Subject|1
7682966|NCT01263015|26722737|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
7682967|NCT01263015|26722738|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
7682968|NCT01263015|26722737|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
7682969|NCT01263015|26722738|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
7682970|NCT01263015|26722737|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
7682971|NCT01263015|26722738|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
7682972|NCT01263015|26722737|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
7682973|NCT01263015|26722738|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
7682974|NCT01263015|26722737|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
7682975|NCT01263015|26722738|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
7682976|NCT01263015|26722737|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
7682977|NCT01263015|26722738|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
7682978|NCT01263015|26722737|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
7682979|NCT01263015|26722738|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
7682980|NCT01263015|26722737|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
7682981|NCT01263015|26722738|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
7682982|NCT01263015|26722737|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
7682983|NCT01263015|26722738|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
7682984|NCT01263015|26722737|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
7682985|NCT01263015|26722738|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
7682986|NCT01263015|26722737|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
7682987|NCT01263015|26722738|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
7682988|NCT01263015|26722737|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
7682989|NCT01263015|26722738|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
7682990|NCT01262989|26722764|P2|Period 2|Intercurrent disease|1
7682991|NCT01262989|26722765|P1|Period 2|Intercurrent disease|0
7682992|NCT01262989|26722764|P2|Period 1|Positive answer for exclusion criteria|1
7682993|NCT01262989|26722765|P1|Period 1|Positive answer for exclusion criteria|0
7682994|NCT01262989|26722764|P2|Period 1|Intercurrent disease|1
7682995|NCT01262989|26722765|P1|Period 1|Intercurrent disease|0
7682996|NCT01262989|26722764|P2|Period 1|Lost to Follow-up|1
7682997|NCT01262989|26722765|P1|Period 1|Lost to Follow-up|1
7682998|NCT01262976|26722781|P6|Up to Year 3|Other|0
7682999|NCT01262976|26722782|P5|Up to Year 3|Other|0
7683000|NCT01262976|26722783|P4|Up to Year 3|Other|0
7683001|NCT01262976|26722784|P3|Up to Year 3|Other|0
7683002|NCT01262976|26722785|P2|Up to Year 3|Other|0
7683003|NCT01262976|26722786|P1|Up to Year 3|Other|3
7683004|NCT01262976|26722781|P6|Up to Year 3|Subjects with unknown completion status|0
7683005|NCT01262976|26722782|P5|Up to Year 3|Subjects with unknown completion status|0
7683006|NCT01262976|26722783|P4|Up to Year 3|Subjects with unknown completion status|0
7683007|NCT01262976|26722784|P3|Up to Year 3|Subjects with unknown completion status|1
7683008|NCT01262976|26722785|P2|Up to Year 3|Subjects with unknown completion status|0
7683009|NCT01262976|26722786|P1|Up to Year 3|Subjects with unknown completion status|0
7683010|NCT01262976|26722781|P6|Up to Year 3|Lost to Follow-up|3
7683011|NCT01262976|26722782|P5|Up to Year 3|Lost to Follow-up|1
7683012|NCT01262976|26722783|P4|Up to Year 3|Lost to Follow-up|3
7683013|NCT01262976|26722784|P3|Up to Year 3|Lost to Follow-up|4
7683014|NCT01262976|26722785|P2|Up to Year 3|Lost to Follow-up|2
7683015|NCT01262976|26722786|P1|Up to Year 3|Lost to Follow-up|2
7683016|NCT01262976|26722781|P6|Up to Year 3|Migrated/moved from study area|1
7683017|NCT01262976|26722782|P5|Up to Year 3|Migrated/moved from study area|1
7683018|NCT01262976|26722783|P4|Up to Year 3|Migrated/moved from study area|2
7683019|NCT01262976|26722784|P3|Up to Year 3|Migrated/moved from study area|0
7683020|NCT01262976|26722785|P2|Up to Year 3|Migrated/moved from study area|0
7683021|NCT01262976|26722786|P1|Up to Year 3|Migrated/moved from study area|0
7683022|NCT01262976|26722781|P6|Up to Year 3|Withdrawal by Subject|0
7683023|NCT01262976|26722782|P5|Up to Year 3|Withdrawal by Subject|0
7683024|NCT01262976|26722783|P4|Up to Year 3|Withdrawal by Subject|0
7683025|NCT01262976|26722784|P3|Up to Year 3|Withdrawal by Subject|0
7683026|NCT01262976|26722785|P2|Up to Year 3|Withdrawal by Subject|0
7683027|NCT01262976|26722786|P1|Up to Year 3|Withdrawal by Subject|1
7683028|NCT01262976|26722781|P6|Up to Year 3|Serious Adverse Event|0
7683029|NCT01262976|26722782|P5|Up to Year 3|Serious Adverse Event|0
7683030|NCT01262976|26722783|P4|Up to Year 3|Serious Adverse Event|0
7683031|NCT01262976|26722784|P3|Up to Year 3|Serious Adverse Event|2
7683032|NCT01262976|26722785|P2|Up to Year 3|Serious Adverse Event|0
7683033|NCT01262976|26722786|P1|Up to Year 3|Serious Adverse Event|0
7683034|NCT01262976|26722781|P6|Up to Year 2|Other|0
7683035|NCT01262976|26722782|P5|Up to Year 2|Other|0
7683036|NCT01262976|26722783|P4|Up to Year 2|Other|0
7683037|NCT01262976|26722784|P3|Up to Year 2|Other|0
7683038|NCT01262976|26722785|P2|Up to Year 2|Other|0
7683039|NCT01262976|26722786|P1|Up to Year 2|Other|3
7683040|NCT01262976|26722781|P6|Up to Year 2|Subjects with unknown completion status|0
7683041|NCT01262976|26722782|P5|Up to Year 2|Subjects with unknown completion status|0
7683042|NCT01262976|26722783|P4|Up to Year 2|Subjects with unknown completion status|0
7683043|NCT01262976|26722784|P3|Up to Year 2|Subjects with unknown completion status|1
7683044|NCT01262976|26722785|P2|Up to Year 2|Subjects with unknown completion status|0
7683045|NCT01262976|26722786|P1|Up to Year 2|Subjects with unknown completion status|0
7683046|NCT01262976|26722781|P6|Up to Year 2|Lost to Follow-up|3
7683047|NCT01262976|26722782|P5|Up to Year 2|Lost to Follow-up|3
7683048|NCT01262976|26722783|P4|Up to Year 2|Lost to Follow-up|2
7683049|NCT01262976|26722784|P3|Up to Year 2|Lost to Follow-up|2
7683050|NCT01262976|26722785|P2|Up to Year 2|Lost to Follow-up|1
7683051|NCT01262976|26722786|P1|Up to Year 2|Lost to Follow-up|1
7683052|NCT01262976|26722781|P6|Up to Year 2|Migrated/moved from study area|2
7683053|NCT01262976|26722782|P5|Up to Year 2|Migrated/moved from study area|1
7683054|NCT01262976|26722783|P4|Up to Year 2|Migrated/moved from study area|2
7683055|NCT01262976|26722784|P3|Up to Year 2|Migrated/moved from study area|0
7683056|NCT01262976|26722785|P2|Up to Year 2|Migrated/moved from study area|0
7683057|NCT01262976|26722786|P1|Up to Year 2|Migrated/moved from study area|0
7683058|NCT01262976|26722781|P6|Up to Year 2|Withdrawal by Subject|0
7683059|NCT01262976|26722782|P5|Up to Year 2|Withdrawal by Subject|0
7683060|NCT01262976|26722783|P4|Up to Year 2|Withdrawal by Subject|0
7683061|NCT01262976|26722784|P3|Up to Year 2|Withdrawal by Subject|0
7683062|NCT01262976|26722785|P2|Up to Year 2|Withdrawal by Subject|0
7683063|NCT01262976|26722786|P1|Up to Year 2|Withdrawal by Subject|1
7683064|NCT01262976|26722781|P6|Up to Year 2|Serious Adverse Event|0
7683065|NCT01262976|26722782|P5|Up to Year 2|Serious Adverse Event|0
7683066|NCT01262976|26722783|P4|Up to Year 2|Serious Adverse Event|0
7683067|NCT01262976|26722784|P3|Up to Year 2|Serious Adverse Event|2
7683068|NCT01262976|26722785|P2|Up to Year 2|Serious Adverse Event|0
7683069|NCT01262976|26722786|P1|Up to Year 2|Serious Adverse Event|0
7683070|NCT01262976|26722781|P6|Up to Year 1|Subjects with unknown completion status|1
7683071|NCT01262976|26722782|P5|Up to Year 1|Subjects with unknown completion status|0
7683072|NCT01262976|26722783|P4|Up to Year 1|Subjects with unknown completion status|0
7683073|NCT01262976|26722784|P3|Up to Year 1|Subjects with unknown completion status|1
7683074|NCT01262976|26722785|P2|Up to Year 1|Subjects with unknown completion status|0
7683075|NCT01262976|26722786|P1|Up to Year 1|Subjects with unknown completion status|0
7683076|NCT01262976|26722781|P6|Up to Year 1|Other|1
7683077|NCT01262976|26722782|P5|Up to Year 1|Other|2
7683078|NCT01262976|26722783|P4|Up to Year 1|Other|0
7683079|NCT01262976|26722784|P3|Up to Year 1|Other|0
7683080|NCT01262976|26722785|P2|Up to Year 1|Other|1
7683081|NCT01262976|26722786|P1|Up to Year 1|Other|3
7683082|NCT01262976|26722781|P6|Up to Year 1|Lost to Follow-up|5
7683083|NCT01262976|26722782|P5|Up to Year 1|Lost to Follow-up|6
7683084|NCT01262976|26722783|P4|Up to Year 1|Lost to Follow-up|1
7683085|NCT01262976|26722784|P3|Up to Year 1|Lost to Follow-up|0
7683086|NCT01262976|26722785|P2|Up to Year 1|Lost to Follow-up|0
7683087|NCT01262976|26722786|P1|Up to Year 1|Lost to Follow-up|4
7683088|NCT01262976|26722781|P6|Up to Year 1|Migrated/moved from study area|2
7683089|NCT01262976|26722782|P5|Up to Year 1|Migrated/moved from study area|3
7683090|NCT01262976|26722783|P4|Up to Year 1|Migrated/moved from study area|3
7683091|NCT01262976|26722784|P3|Up to Year 1|Migrated/moved from study area|0
7683092|NCT01262976|26722785|P2|Up to Year 1|Migrated/moved from study area|0
7683093|NCT01262976|26722786|P1|Up to Year 1|Migrated/moved from study area|1
7683094|NCT01262976|26722781|P6|Up to Year 1|Withdrawal by Subject|0
7683095|NCT01262976|26722782|P5|Up to Year 1|Withdrawal by Subject|0
7683096|NCT01262976|26722783|P4|Up to Year 1|Withdrawal by Subject|0
7683097|NCT01262976|26722784|P3|Up to Year 1|Withdrawal by Subject|0
7683098|NCT01262976|26722785|P2|Up to Year 1|Withdrawal by Subject|0
7683099|NCT01262976|26722786|P1|Up to Year 1|Withdrawal by Subject|1
7683100|NCT01262976|26722781|P6|Up to Year 1|Serious Adverse Event|0
7683101|NCT01262976|26722782|P5|Up to Year 1|Serious Adverse Event|0
7683102|NCT01262976|26722783|P4|Up to Year 1|Serious Adverse Event|0
7683103|NCT01262976|26722784|P3|Up to Year 1|Serious Adverse Event|2
7683104|NCT01262976|26722785|P2|Up to Year 1|Serious Adverse Event|0
7683105|NCT01262976|26722786|P1|Up to Year 1|Serious Adverse Event|0
7683106|NCT01262976|26722781|P6|Up to Month 7|Other|0
7683107|NCT01262976|26722782|P5|Up to Month 7|Other|0
7683108|NCT01262976|26722783|P4|Up to Month 7|Other|0
7683109|NCT01262976|26722784|P3|Up to Month 7|Other|2
7683110|NCT01262976|26722785|P2|Up to Month 7|Other|0
7683111|NCT01262976|26722786|P1|Up to Month 7|Other|3
7683112|NCT01262976|26722781|P6|Up to Month 7|Lost to Follow-up|3
7683113|NCT01262976|26722782|P5|Up to Month 7|Lost to Follow-up|1
7683114|NCT01262976|26722783|P4|Up to Month 7|Lost to Follow-up|3
7683115|NCT01262976|26722784|P3|Up to Month 7|Lost to Follow-up|1
7683116|NCT01262976|26722785|P2|Up to Month 7|Lost to Follow-up|0
7683117|NCT01262976|26722786|P1|Up to Month 7|Lost to Follow-up|1
7683118|NCT01262976|26722781|P6|Up to Month 7|Migrated/moved from study area|1
7683119|NCT01262976|26722782|P5|Up to Month 7|Migrated/moved from study area|1
7683120|NCT01262976|26722783|P4|Up to Month 7|Migrated/moved from study area|3
7683121|NCT01262976|26722784|P3|Up to Month 7|Migrated/moved from study area|1
7683122|NCT01262976|26722785|P2|Up to Month 7|Migrated/moved from study area|0
7683123|NCT01262976|26722786|P1|Up to Month 7|Migrated/moved from study area|0
7683124|NCT01262976|26722781|P6|Up to Month 7|Withdrawal by Subject|0
7683125|NCT01262976|26722782|P5|Up to Month 7|Withdrawal by Subject|0
7683126|NCT01262976|26722783|P4|Up to Month 7|Withdrawal by Subject|0
7683127|NCT01262976|26722784|P3|Up to Month 7|Withdrawal by Subject|0
7683128|NCT01262976|26722785|P2|Up to Month 7|Withdrawal by Subject|0
7683129|NCT01262976|26722786|P1|Up to Month 7|Withdrawal by Subject|1
7683130|NCT01262976|26722781|P6|Up to Month 7|Serious Adverse Event|0
7683131|NCT01262976|26722782|P5|Up to Month 7|Serious Adverse Event|0
7683132|NCT01262976|26722783|P4|Up to Month 7|Serious Adverse Event|0
7683133|NCT01262976|26722784|P3|Up to Month 7|Serious Adverse Event|2
7683134|NCT01262976|26722785|P2|Up to Month 7|Serious Adverse Event|0
7683135|NCT01262976|26722786|P1|Up to Month 7|Serious Adverse Event|0
7683136|NCT01262976|26722781|P6|Up to Month 2|Other|2
7683137|NCT01262976|26722782|P5|Up to Month 2|Other|0
7683138|NCT01262976|26722783|P4|Up to Month 2|Other|1
7683139|NCT01262976|26722784|P3|Up to Month 2|Other|0
7683140|NCT01262976|26722785|P2|Up to Month 2|Other|0
7683141|NCT01262976|26722786|P1|Up to Month 2|Other|1
7683142|NCT01262976|26722781|P6|Up to Month 2|Lost to Follow-up|1
7683143|NCT01262976|26722782|P5|Up to Month 2|Lost to Follow-up|1
7683144|NCT01262976|26722783|P4|Up to Month 2|Lost to Follow-up|1
7683145|NCT01262976|26722784|P3|Up to Month 2|Lost to Follow-up|0
7683146|NCT01262976|26722785|P2|Up to Month 2|Lost to Follow-up|0
7683147|NCT01262976|26722786|P1|Up to Month 2|Lost to Follow-up|1
7683148|NCT01262976|26722781|P6|Up to Month 2|Migrated/moved from study area|1
7683149|NCT01262976|26722782|P5|Up to Month 2|Migrated/moved from study area|1
7683150|NCT01262976|26722783|P4|Up to Month 2|Migrated/moved from study area|0
7683151|NCT01262976|26722784|P3|Up to Month 2|Migrated/moved from study area|0
7683152|NCT01262976|26722785|P2|Up to Month 2|Migrated/moved from study area|1
7683153|NCT01262976|26722786|P1|Up to Month 2|Migrated/moved from study area|0
7683154|NCT01262976|26722781|P6|Up to Month 2|Withdrawal by Subject|0
7683155|NCT01262976|26722782|P5|Up to Month 2|Withdrawal by Subject|0
7683156|NCT01262976|26722783|P4|Up to Month 2|Withdrawal by Subject|0
7683157|NCT01262976|26722784|P3|Up to Month 2|Withdrawal by Subject|0
7683158|NCT01262976|26722785|P2|Up to Month 2|Withdrawal by Subject|0
7683159|NCT01262976|26722786|P1|Up to Month 2|Withdrawal by Subject|1
7683160|NCT01262976|26722781|P6|Up to Month 2|Serious Adverse Event|0
7683161|NCT01262976|26722782|P5|Up to Month 2|Serious Adverse Event|0
7683162|NCT01262976|26722783|P4|Up to Month 2|Serious Adverse Event|0
7683163|NCT01262976|26722784|P3|Up to Month 2|Serious Adverse Event|1
7683164|NCT01262976|26722785|P2|Up to Month 2|Serious Adverse Event|0
7683165|NCT01262976|26722786|P1|Up to Month 2|Serious Adverse Event|0
7683166|NCT01262898|26722942|P4|Overall Study|Withdrawal by Subject|0
7683167|NCT01262898|26722943|P3|Overall Study|Withdrawal by Subject|0
7683168|NCT01262898|26722944|P2|Overall Study|Withdrawal by Subject|1
7683169|NCT01262898|26722945|P1|Overall Study|Withdrawal by Subject|1
7683170|NCT01262898|26722942|P4|Overall Study|Lost to Follow-up|0
7683171|NCT01262898|26722943|P3|Overall Study|Lost to Follow-up|0
7683172|NCT01262898|26722944|P2|Overall Study|Lost to Follow-up|0
7683173|NCT01262898|26722945|P1|Overall Study|Lost to Follow-up|1
7683174|NCT01262898|26722942|P4|Overall Study|Protocol Violation|0
7683175|NCT01262898|26722943|P3|Overall Study|Protocol Violation|0
7683176|NCT01262898|26722944|P2|Overall Study|Protocol Violation|1
7683177|NCT01262898|26722945|P1|Overall Study|Protocol Violation|1
7683178|NCT01262872|26723073|P8|Step 2|Migrated/moved from study area|3
7683179|NCT01262872|26723074|P7|Step 2|Migrated/moved from study area|2
7683180|NCT01262872|26723075|P6|Step 2|Migrated/moved from study area|6
7683181|NCT01262872|26723076|P5|Step 2|Migrated/moved from study area|2
7683182|NCT01262872|26723077|P4|Step 2|Migrated/moved from study area|3
7683183|NCT01262872|26723078|P3|Step 2|Migrated/moved from study area|4
7683184|NCT01262872|26723079|P2|Step 2|Migrated/moved from study area|0
7683185|NCT01262872|26723080|P1|Step 2|Migrated/moved from study area|0
7683186|NCT01262872|26723073|P8|Step 2|Withdrawal by Subject|1
7683187|NCT01262872|26723074|P7|Step 2|Withdrawal by Subject|2
7683188|NCT01262872|26723075|P6|Step 2|Withdrawal by Subject|1
7683189|NCT01262872|26723076|P5|Step 2|Withdrawal by Subject|3
7683190|NCT01262872|26723077|P4|Step 2|Withdrawal by Subject|6
7683191|NCT01262872|26723078|P3|Step 2|Withdrawal by Subject|4
7683192|NCT01262872|26723079|P2|Step 2|Withdrawal by Subject|0
7683193|NCT01262872|26723080|P1|Step 2|Withdrawal by Subject|0
7683194|NCT01262872|26723073|P8|Step 2|Protocol Violation|1
7683195|NCT01262872|26723074|P7|Step 2|Protocol Violation|3
7683196|NCT01262872|26723075|P6|Step 2|Protocol Violation|0
7683197|NCT01262872|26723076|P5|Step 2|Protocol Violation|0
7683198|NCT01262872|26723077|P4|Step 2|Protocol Violation|0
7683199|NCT01262872|26723078|P3|Step 2|Protocol Violation|1
7683200|NCT01262872|26723079|P2|Step 2|Protocol Violation|0
7683201|NCT01262872|26723080|P1|Step 2|Protocol Violation|0
7683202|NCT01262872|26723073|P8|Step 2|Death|1
7683203|NCT01262872|26723074|P7|Step 2|Death|2
7683204|NCT01262872|26723075|P6|Step 2|Death|2
7683205|NCT01262872|26723076|P5|Step 2|Death|0
7683206|NCT01262872|26723077|P4|Step 2|Death|1
7683207|NCT01262872|26723078|P3|Step 2|Death|0
7683208|NCT01262872|26723079|P2|Step 2|Death|0
7683209|NCT01262872|26723080|P1|Step 2|Death|0
7683210|NCT01262820|26723354|P1|Overall Study|Drug held for 21+ days|1
7683211|NCT01262820|26723354|P1|Overall Study|Lack of Efficacy|9
7683212|NCT01262820|26723354|P1|Overall Study|Adverse Event|5
7683213|NCT01262677|26723368|P3|Overall Study|Adverse Event (AE) related to study drug|3
7683214|NCT01262677|26723369|P2|Overall Study|Adverse Event (AE) related to study drug|8
7683215|NCT01262677|26723370|P1|Overall Study|Adverse Event (AE) related to study drug|3
7683216|NCT01262677|26723368|P3|Overall Study|Protocol Violation|1
7683217|NCT01262677|26723369|P2|Overall Study|Protocol Violation|1
7683218|NCT01262677|26723370|P1|Overall Study|Protocol Violation|0
7683219|NCT01262677|26723368|P3|Overall Study|Reason not provided|3
7683220|NCT01262677|26723369|P2|Overall Study|Reason not provided|1
7683221|NCT01262677|26723370|P1|Overall Study|Reason not provided|2
7683222|NCT01262677|26723368|P3|Overall Study|No longer willing to participate|2
7683223|NCT01262677|26723369|P2|Overall Study|No longer willing to participate|3
7683224|NCT01262677|26723370|P1|Overall Study|No longer willing to participate|3
7683225|NCT01262677|26723368|P3|Overall Study|Lost to Follow-up|2
7683226|NCT01262677|26723369|P2|Overall Study|Lost to Follow-up|0
7683227|NCT01262677|26723370|P1|Overall Study|Lost to Follow-up|1
7683228|NCT01262677|26723368|P3|Overall Study|Insufficient clinical response|1
7683229|NCT01262677|26723369|P2|Overall Study|Insufficient clinical response|0
7683230|NCT01262677|26723370|P1|Overall Study|Insufficient clinical response|0
7683231|NCT01262677|26723368|P3|Overall Study|Does not meet entrance criteria|0
7683232|NCT01262677|26723369|P2|Overall Study|Does not meet entrance criteria|2
7683233|NCT01262677|26723370|P1|Overall Study|Does not meet entrance criteria|0
7683234|NCT01262651|26723461|P2|Overall Study|Met Withdrawal Criteria|0
7683235|NCT01262651|26723462|P1|Overall Study|Met Withdrawal Criteria|1
7683236|NCT01262651|26723461|P2|Overall Study|Withdrawal by Investigator|2
7683237|NCT01262651|26723462|P1|Overall Study|Withdrawal by Investigator|2
7683238|NCT01262651|26723461|P2|Overall Study|Withdrawal by Subject|11
7683239|NCT01262651|26723462|P1|Overall Study|Withdrawal by Subject|15
7683240|NCT01262651|26723461|P2|Overall Study|Adverse Event|35
7683241|NCT01262651|26723462|P1|Overall Study|Adverse Event|40
7683242|NCT01262638|26723492|P4|Overall Study|Participant Went Out of Town|0
7683243|NCT01262638|26723493|P3|Overall Study|Participant Went Out of Town|1
7683244|NCT01262638|26723494|P2|Overall Study|Participant Went Out of Town|0
7683245|NCT01262638|26723495|P1|Overall Study|Participant Went Out of Town|0
7683246|NCT01262638|26723492|P4|Overall Study|Lost to Follow-up|1
7683247|NCT01262638|26723493|P3|Overall Study|Lost to Follow-up|1
7683248|NCT01262638|26723494|P2|Overall Study|Lost to Follow-up|1
7683249|NCT01262638|26723495|P1|Overall Study|Lost to Follow-up|1
7683250|NCT01262638|26723492|P4|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7683251|NCT01262638|26723493|P3|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
7683252|NCT01262638|26723494|P2|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7683253|NCT01262638|26723495|P1|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7683254|NCT01262638|26723492|P4|Overall Study|Withdrawal by Subject|1
7683255|NCT01262638|26723493|P3|Overall Study|Withdrawal by Subject|0
7683256|NCT01262638|26723494|P2|Overall Study|Withdrawal by Subject|1
7683257|NCT01262638|26723495|P1|Overall Study|Withdrawal by Subject|2
7683258|NCT01262638|26723492|P4|Overall Study|Protocol Violation|1
7683259|NCT01262638|26723493|P3|Overall Study|Protocol Violation|0
7683260|NCT01262638|26723494|P2|Overall Study|Protocol Violation|0
7683261|NCT01262638|26723495|P1|Overall Study|Protocol Violation|1
7683262|NCT01262638|26723492|P4|Overall Study|Adverse Event|4
7683263|NCT01262638|26723493|P3|Overall Study|Adverse Event|3
7683264|NCT01262638|26723494|P2|Overall Study|Adverse Event|4
7683265|NCT01262638|26723495|P1|Overall Study|Adverse Event|3
7683266|NCT01262573|26723588|P2|Overall Study|Withdrawal by Subject|1
7683267|NCT01262573|26723589|P1|Overall Study|Withdrawal by Subject|0
7683268|NCT01262560|26723600|P3|Overall Study|Protocol Violation|2
7683269|NCT01262560|26723601|P2|Overall Study|Protocol Violation|1
7683270|NCT01262560|26723602|P1|Overall Study|Protocol Violation|0
7683271|NCT01262456|26723651|P3|1-Month Open-Label Extension Period|Other Reason|0
7683272|NCT01262456|26723652|P2|1-Month Open-Label Extension Period|Other Reason|1
7683273|NCT01262456|26723653|P1|1-Month Open-Label Extension Period|Other Reason|0
7683274|NCT01262456|26723651|P3|1-Month Open-Label Extension Period|Protocol Violation|2
7683275|NCT01262456|26723652|P2|1-Month Open-Label Extension Period|Protocol Violation|0
7683276|NCT01262456|26723653|P1|1-Month Open-Label Extension Period|Protocol Violation|1
7683277|NCT01262456|26723651|P3|1-Month Open-Label Extension Period|Adverse Event|2
7683278|NCT01262456|26723652|P2|1-Month Open-Label Extension Period|Adverse Event|0
7683279|NCT01262456|26723653|P1|1-Month Open-Label Extension Period|Adverse Event|2
7683280|NCT01262456|26723651|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
7683281|NCT01262456|26723652|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
7683282|NCT01262456|26723653|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
7683283|NCT01262456|26723651|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7683284|NCT01262456|26723652|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7683285|NCT01262456|26723653|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7683286|NCT01262456|26723651|P3|3-Month Double-Blind Period|Protocol Violation|6
7683287|NCT01262456|26723652|P2|3-Month Double-Blind Period|Protocol Violation|6
7683288|NCT01262456|26723653|P1|3-Month Double-Blind Period|Protocol Violation|3
7683289|NCT01262456|26723651|P3|3-Month Double-Blind Period|Adverse Event|8
7683290|NCT01262456|26723652|P2|3-Month Double-Blind Period|Adverse Event|4
7683291|NCT01262456|26723653|P1|3-Month Double-Blind Period|Adverse Event|6
7683292|NCT01262456|26723651|P3|3-Month Double-Blind Period|Lost to Follow-up|3
7683293|NCT01262456|26723652|P2|3-Month Double-Blind Period|Lost to Follow-up|5
7683294|NCT01262456|26723653|P1|3-Month Double-Blind Period|Lost to Follow-up|4
7683295|NCT01262456|26723651|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
7683296|NCT01262456|26723652|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
7683297|NCT01262456|26723653|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
7683298|NCT01262365|26723697|P3|Overall Study|Patient unavailable|1
7683299|NCT01262365|26723698|P2|Overall Study|Patient unavailable|0
7683300|NCT01262365|26723699|P1|Overall Study|Patient unavailable|0
7683301|NCT01262365|26723697|P3|Overall Study|Cannot tolerate the protocol|0
7683302|NCT01262365|26723698|P2|Overall Study|Cannot tolerate the protocol|1
7683303|NCT01262365|26723699|P1|Overall Study|Cannot tolerate the protocol|0
7683304|NCT01262365|26723697|P3|Overall Study|Toxicity related to study drug|0
7683305|NCT01262365|26723698|P2|Overall Study|Toxicity related to study drug|1
7683306|NCT01262365|26723699|P1|Overall Study|Toxicity related to study drug|0
7683307|NCT01262365|26723697|P3|Overall Study|Patient pregnant|1
7683308|NCT01262365|26723698|P2|Overall Study|Patient pregnant|0
7683309|NCT01262365|26723699|P1|Overall Study|Patient pregnant|1
7683310|NCT01262365|26723697|P3|Overall Study|Suspected pregnancy|0
7683311|NCT01262365|26723698|P2|Overall Study|Suspected pregnancy|0
7683312|NCT01262365|26723699|P1|Overall Study|Suspected pregnancy|1
7683313|NCT01262365|26723697|P3|Overall Study|Non-compliance|2
7683314|NCT01262365|26723698|P2|Overall Study|Non-compliance|0
7683315|NCT01262365|26723699|P1|Overall Study|Non-compliance|1
7683316|NCT01262365|26723697|P3|Overall Study|Randomization error|2
7683317|NCT01262365|26723698|P2|Overall Study|Randomization error|0
7683318|NCT01262365|26723699|P1|Overall Study|Randomization error|1
7683319|NCT01262365|26723697|P3|Overall Study|sponsor decision|0
7683320|NCT01262365|26723698|P2|Overall Study|sponsor decision|1
7683321|NCT01262365|26723699|P1|Overall Study|sponsor decision|1
7683322|NCT01262365|26723697|P3|Overall Study|Adverse Event|11
7683323|NCT01262365|26723698|P2|Overall Study|Adverse Event|16
7683324|NCT01262365|26723699|P1|Overall Study|Adverse Event|26
7683325|NCT01262365|26723697|P3|Overall Study|Death|1
7683326|NCT01262365|26723698|P2|Overall Study|Death|2
7683327|NCT01262365|26723699|P1|Overall Study|Death|1
7683328|NCT01262365|26723697|P3|Overall Study|Withdrawal by Subject|22
7683329|NCT01262365|26723698|P2|Overall Study|Withdrawal by Subject|22
7683330|NCT01262365|26723699|P1|Overall Study|Withdrawal by Subject|17
7683331|NCT01262365|26723697|P3|Overall Study|Lost to Follow-up|6
7683332|NCT01262365|26723698|P2|Overall Study|Lost to Follow-up|7
7683333|NCT01262365|26723699|P1|Overall Study|Lost to Follow-up|3
7683334|NCT01262365|26723697|P3|Overall Study|Protocol Violation|1
7683335|NCT01262365|26723698|P2|Overall Study|Protocol Violation|1
7683336|NCT01262365|26723699|P1|Overall Study|Protocol Violation|3
7683337|NCT01262365|26723697|P3|Overall Study|Lack of Efficacy|47
7683338|NCT01262365|26723698|P2|Overall Study|Lack of Efficacy|30
7683339|NCT01262365|26723699|P1|Overall Study|Lack of Efficacy|35
7683340|NCT01262352|26723724|P2|Washout|Extended Washout|1
7683341|NCT01262352|26723725|P1|Washout|Extended Washout|0
7683342|NCT01262352|26723724|P2|Washout|Adverse Event|1
7683343|NCT01262352|26723725|P1|Washout|Adverse Event|1
7683344|NCT01262352|26723724|P2|Period 1|Illness after randomization|0
7683345|NCT01262352|26723725|P1|Period 1|Illness after randomization|1
7683346|NCT01262287|26723743|P2|Overall Study|Lost to Follow-up|1
7683347|NCT01262287|26723744|P1|Overall Study|Lost to Follow-up|2
7683348|NCT01262092|26723805|P2|Gabapentin Taper|noncompliance - missed medications|0
7683349|NCT01262092|26723806|P1|Gabapentin Taper|noncompliance - missed medications|1
7683350|NCT01262092|26723805|P2|Buprenorphine Taper|noncompliance - missed medication|1
7683351|NCT01262092|26723806|P1|Buprenorphine Taper|noncompliance - missed medication|1
7683352|NCT01262092|26723805|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
7683353|NCT01262092|26723806|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
7683354|NCT01262092|26723805|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
7683355|NCT01262092|26723806|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
7683356|NCT01262027|26723812|P1|Overall Study|Protocol Violation|1
7683357|NCT01262027|26723812|P1|Overall Study|Withdrawal by Subject|3
7683358|NCT01262027|26723812|P1|Overall Study|Adverse Event|1
7683359|NCT01261975|26723817|P1|Overall Study|Surgical complication|1
7683360|NCT01261793|26723848|P3|Overall Study|Patient unable to start IV line|1
7683361|NCT01261793|26723849|P2|Overall Study|Patient unable to start IV line|0
7683362|NCT01261793|26723850|P1|Overall Study|Patient unable to start IV line|0
7683363|NCT01261793|26723848|P3|Overall Study|Randomization error|0
7683364|NCT01261793|26723849|P2|Overall Study|Randomization error|1
7683365|NCT01261793|26723850|P1|Overall Study|Randomization error|0
7683366|NCT01261793|26723848|P3|Overall Study|Patient withdrew after cardiology visit|0
7683367|NCT01261793|26723849|P2|Overall Study|Patient withdrew after cardiology visit|1
7683368|NCT01261793|26723850|P1|Overall Study|Patient withdrew after cardiology visit|0
7683369|NCT01261793|26723848|P3|Overall Study|Lack of efficacy & patient not available|0
7683370|NCT01261793|26723849|P2|Overall Study|Lack of efficacy & patient not available|1
7683371|NCT01261793|26723850|P1|Overall Study|Lack of efficacy & patient not available|0
7683372|NCT01261793|26723848|P3|Overall Study|Outside the study area|1
7683373|NCT01261793|26723849|P2|Overall Study|Outside the study area|2
7683374|NCT01261793|26723850|P1|Overall Study|Outside the study area|0
7683375|NCT01261793|26723848|P3|Overall Study|Patient pregnant|0
7683376|NCT01261793|26723849|P2|Overall Study|Patient pregnant|0
7683377|NCT01261793|26723850|P1|Overall Study|Patient pregnant|1
7683378|NCT01261793|26723848|P3|Overall Study|Patient non-compliance|1
7683379|NCT01261793|26723849|P2|Overall Study|Patient non-compliance|0
7683380|NCT01261793|26723850|P1|Overall Study|Patient non-compliance|1
7683381|NCT01261793|26723848|P3|Overall Study|Suspected pregnancy|0
7683382|NCT01261793|26723849|P2|Overall Study|Suspected pregnancy|1
7683383|NCT01261793|26723850|P1|Overall Study|Suspected pregnancy|1
7683384|NCT01261793|26723848|P3|Overall Study|Patient non-availability|1
7683385|NCT01261793|26723849|P2|Overall Study|Patient non-availability|1
7683386|NCT01261793|26723850|P1|Overall Study|Patient non-availability|1
7683387|NCT01261793|26723848|P3|Overall Study|Adverse Event|19
7683388|NCT01261793|26723849|P2|Overall Study|Adverse Event|24
7683389|NCT01261793|26723850|P1|Overall Study|Adverse Event|9
7683390|NCT01261793|26723848|P3|Overall Study|Death|0
7683391|NCT01261793|26723849|P2|Overall Study|Death|1
7683392|NCT01261793|26723850|P1|Overall Study|Death|3
7683393|NCT01261793|26723848|P3|Overall Study|Withdrawal by Subject|14
7683394|NCT01261793|26723849|P2|Overall Study|Withdrawal by Subject|14
7683395|NCT01261793|26723850|P1|Overall Study|Withdrawal by Subject|12
7683396|NCT01261793|26723848|P3|Overall Study|Lost to Follow-up|7
7683397|NCT01261793|26723849|P2|Overall Study|Lost to Follow-up|3
7683398|NCT01261793|26723850|P1|Overall Study|Lost to Follow-up|10
7683399|NCT01261793|26723848|P3|Overall Study|Protocol Violation|6
7683400|NCT01261793|26723849|P2|Overall Study|Protocol Violation|5
7683401|NCT01261793|26723850|P1|Overall Study|Protocol Violation|3
7683402|NCT01261793|26723848|P3|Overall Study|Lack of Efficacy|32
7683403|NCT01261793|26723849|P2|Overall Study|Lack of Efficacy|37
7683404|NCT01261793|26723850|P1|Overall Study|Lack of Efficacy|44
7683405|NCT01261780|26723875|P2|Overall Study|Event not related to subject|2
7683406|NCT01261780|26723876|P1|Overall Study|Event not related to subject|1
7683407|NCT01261780|26723875|P2|Overall Study|Withdrawal by Subject|0
7683408|NCT01261780|26723876|P1|Overall Study|Withdrawal by Subject|1
7683409|NCT01261624|26723886|P2|Week 13 to Week 24|Insufficient Response|1
7683410|NCT01261624|26723887|P1|Week 13 to Week 24|Insufficient Response|0
7683411|NCT01261624|26723886|P2|Week 0 to Week 12|Insufficient Response|2
7683412|NCT01261624|26723887|P1|Week 0 to Week 12|Insufficient Response|0
7683413|NCT01261624|26723886|P2|Week 0 to Week 12|Disease Progression|1
7683414|NCT01261624|26723887|P1|Week 0 to Week 12|Disease Progression|1
7683415|NCT01261611|26723907|P3|Treatment Cycle 5|Lost to Follow-up|0
7683416|NCT01261611|26723908|P2|Treatment Cycle 5|Lost to Follow-up|0
7683417|NCT01261611|26723909|P1|Treatment Cycle 5|Lost to Follow-up|1
7683418|NCT01261611|26723907|P3|Treatment Cycle 5|Adverse Event|0
7683419|NCT01261611|26723908|P2|Treatment Cycle 5|Adverse Event|0
7683420|NCT01261611|26723909|P1|Treatment Cycle 5|Adverse Event|1
7683421|NCT01261611|26723907|P3|Treatment Cycle 5|Withdrawal by Subject|0
7683422|NCT01261611|26723908|P2|Treatment Cycle 5|Withdrawal by Subject|0
7683423|NCT01261611|26723909|P1|Treatment Cycle 5|Withdrawal by Subject|1
7683424|NCT01261611|26723907|P3|Treatment Cycle 4|Not otherwise specified|0
7683425|NCT01261611|26723908|P2|Treatment Cycle 4|Not otherwise specified|0
7683426|NCT01261611|26723909|P1|Treatment Cycle 4|Not otherwise specified|3
7683427|NCT01261611|26723907|P3|Treatment Cycle 4|Lost to Follow-up|0
7683428|NCT01261611|26723908|P2|Treatment Cycle 4|Lost to Follow-up|0
7683429|NCT01261611|26723909|P1|Treatment Cycle 4|Lost to Follow-up|2
7683430|NCT01261611|26723907|P3|Treatment Cycle 4|Adverse Event|0
7683431|NCT01261611|26723908|P2|Treatment Cycle 4|Adverse Event|0
7683432|NCT01261611|26723909|P1|Treatment Cycle 4|Adverse Event|1
7683433|NCT01261611|26723907|P3|Treatment Cycle 4|Withdrawal by Subject|0
7683434|NCT01261611|26723908|P2|Treatment Cycle 4|Withdrawal by Subject|0
7683435|NCT01261611|26723909|P1|Treatment Cycle 4|Withdrawal by Subject|3
7683436|NCT01261611|26723907|P3|Treatment Cycle 4|Completed study|0
7683437|NCT01261611|26723908|P2|Treatment Cycle 4|Completed study|0
7683438|NCT01261611|26723909|P1|Treatment Cycle 4|Completed study|87
7683439|NCT01261611|26723907|P3|Treatment Cycle 3|Lost to Follow-up|0
7683440|NCT01261611|26723908|P2|Treatment Cycle 3|Lost to Follow-up|0
7683441|NCT01261611|26723909|P1|Treatment Cycle 3|Lost to Follow-up|1
7683442|NCT01261611|26723907|P3|Treatment Cycle 3|Adverse Event|0
7683443|NCT01261611|26723908|P2|Treatment Cycle 3|Adverse Event|0
7683444|NCT01261611|26723909|P1|Treatment Cycle 3|Adverse Event|1
7683445|NCT01261611|26723907|P3|Treatment Cycle 3|Withdrawal by Subject|0
7683446|NCT01261611|26723908|P2|Treatment Cycle 3|Withdrawal by Subject|0
7683447|NCT01261611|26723909|P1|Treatment Cycle 3|Withdrawal by Subject|4
7683448|NCT01261611|26723907|P3|Treatment Cycle 3|Completed study|0
7683449|NCT01261611|26723908|P2|Treatment Cycle 3|Completed study|0
7683450|NCT01261611|26723909|P1|Treatment Cycle 3|Completed study|24
7683451|NCT01261611|26723907|P3|Treatment Cycle 2|Not otherwise specified|0
7683452|NCT01261611|26723908|P2|Treatment Cycle 2|Not otherwise specified|0
7683453|NCT01261611|26723909|P1|Treatment Cycle 2|Not otherwise specified|2
7683454|NCT01261611|26723907|P3|Treatment Cycle 2|Protocol Violation|0
7683455|NCT01261611|26723908|P2|Treatment Cycle 2|Protocol Violation|0
7683456|NCT01261611|26723909|P1|Treatment Cycle 2|Protocol Violation|2
7683457|NCT01261611|26723907|P3|Treatment Cycle 2|Adverse Event|0
7683458|NCT01261611|26723908|P2|Treatment Cycle 2|Adverse Event|0
7683459|NCT01261611|26723909|P1|Treatment Cycle 2|Adverse Event|1
7683460|NCT01261611|26723907|P3|Treatment Cycle 2|Withdrawal by Subject|0
7683461|NCT01261611|26723908|P2|Treatment Cycle 2|Withdrawal by Subject|0
7683462|NCT01261611|26723909|P1|Treatment Cycle 2|Withdrawal by Subject|4
7683463|NCT01261611|26723907|P3|Treatment Cycle 2|Completed study|0
7683464|NCT01261611|26723908|P2|Treatment Cycle 2|Completed study|0
7683465|NCT01261611|26723909|P1|Treatment Cycle 2|Completed study|4
7683466|NCT01261611|26723907|P3|Treatment Cycle 1|Protocol Violation|2
7683467|NCT01261611|26723908|P2|Treatment Cycle 1|Protocol Violation|0
7683468|NCT01261611|26723909|P1|Treatment Cycle 1|Protocol Violation|0
7683469|NCT01261611|26723907|P3|Treatment Cycle 1|Adverse Event|0
7683470|NCT01261611|26723908|P2|Treatment Cycle 1|Adverse Event|1
7683471|NCT01261611|26723909|P1|Treatment Cycle 1|Adverse Event|0
7683472|NCT01261611|26723907|P3|Treatment Cycle 1|Lost to Follow-up|0
7683473|NCT01261611|26723908|P2|Treatment Cycle 1|Lost to Follow-up|0
7683474|NCT01261611|26723909|P1|Treatment Cycle 1|Lost to Follow-up|1
7683475|NCT01261611|26723907|P3|Treatment Cycle 1|Withdrawal by Subject|0
7683476|NCT01261611|26723908|P2|Treatment Cycle 1|Withdrawal by Subject|2
7683477|NCT01261611|26723909|P1|Treatment Cycle 1|Withdrawal by Subject|3
7683478|NCT01261390|26723973|P4|Overall Study|Lost to Follow-up|6
7683479|NCT01261390|26723974|P3|Overall Study|Lost to Follow-up|5
7683480|NCT01261390|26723975|P2|Overall Study|Lost to Follow-up|6
7683481|NCT01261390|26723976|P1|Overall Study|Lost to Follow-up|1
7683482|NCT01261390|26723973|P4|Overall Study|Loss of Interest in the Study|0
7683483|NCT01261390|26723974|P3|Overall Study|Loss of Interest in the Study|0
7683484|NCT01261390|26723975|P2|Overall Study|Loss of Interest in the Study|1
7683485|NCT01261390|26723976|P1|Overall Study|Loss of Interest in the Study|3
7683486|NCT01261390|26723973|P4|Overall Study|Relocation|0
7683487|NCT01261390|26723974|P3|Overall Study|Relocation|0
7683488|NCT01261390|26723975|P2|Overall Study|Relocation|1
7683489|NCT01261390|26723976|P1|Overall Study|Relocation|0
7683490|NCT01261390|26723973|P4|Overall Study|Dissatisfaction with Treatment|2
7683491|NCT01261390|26723974|P3|Overall Study|Dissatisfaction with Treatment|1
7683492|NCT01261390|26723975|P2|Overall Study|Dissatisfaction with Treatment|1
7683493|NCT01261390|26723976|P1|Overall Study|Dissatisfaction with Treatment|2
7683494|NCT01261390|26723973|P4|Overall Study|Significant Concurrent Illness|0
7683495|NCT01261390|26723974|P3|Overall Study|Significant Concurrent Illness|1
7683496|NCT01261390|26723975|P2|Overall Study|Significant Concurrent Illness|0
7683497|NCT01261390|26723976|P1|Overall Study|Significant Concurrent Illness|1
7683498|NCT01261338|26724140|P2|Overall Study|Withdrawal by Subject|2
7683499|NCT01261338|26724141|P1|Overall Study|Withdrawal by Subject|3
7683500|NCT01261325|26724152|P3|Overall Study|AE, serious fatal|2
7683501|NCT01261325|26724153|P2|Overall Study|AE, serious fatal|0
7683502|NCT01261325|26724154|P1|Overall Study|AE, serious fatal|0
7683503|NCT01261325|26724152|P3|Overall Study|Lost to Follow-up|3
7683504|NCT01261325|26724153|P2|Overall Study|Lost to Follow-up|1
7683505|NCT01261325|26724154|P1|Overall Study|Lost to Follow-up|0
7683506|NCT01261325|26724152|P3|Overall Study|Protocol Violation|1
7683507|NCT01261325|26724153|P2|Overall Study|Protocol Violation|3
7683508|NCT01261325|26724154|P1|Overall Study|Protocol Violation|0
7683509|NCT01261325|26724152|P3|Overall Study|Randomized in Error|1
7683510|NCT01261325|26724153|P2|Overall Study|Randomized in Error|0
7683511|NCT01261325|26724154|P1|Overall Study|Randomized in Error|0
7683512|NCT01261325|26724152|P3|Overall Study|Screen Failure|0
7683513|NCT01261325|26724153|P2|Overall Study|Screen Failure|0
7683514|NCT01261325|26724154|P1|Overall Study|Screen Failure|1
7683515|NCT01261325|26724152|P3|Overall Study|Erroneously Randomized|0
7683516|NCT01261325|26724153|P2|Overall Study|Erroneously Randomized|0
7683517|NCT01261325|26724154|P1|Overall Study|Erroneously Randomized|1
7683518|NCT01261325|26724152|P3|Overall Study|Patient Randomized by Mistake|0
7683519|NCT01261325|26724153|P2|Overall Study|Patient Randomized by Mistake|1
7683520|NCT01261325|26724154|P1|Overall Study|Patient Randomized by Mistake|0
7683521|NCT01261325|26724152|P3|Overall Study|Non Compliance|0
7683522|NCT01261325|26724153|P2|Overall Study|Non Compliance|0
7683523|NCT01261325|26724154|P1|Overall Study|Non Compliance|2
7683524|NCT01261325|26724152|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7683525|NCT01261325|26724153|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7683526|NCT01261325|26724154|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7683527|NCT01261325|26724152|P3|Overall Study|AE, non-serious non-fatal|13
7683528|NCT01261325|26724153|P2|Overall Study|AE, non-serious non-fatal|15
7683529|NCT01261325|26724154|P1|Overall Study|AE, non-serious non-fatal|9
7683530|NCT01261325|26724152|P3|Overall Study|SAE, non-fatal|1
7683531|NCT01261325|26724153|P2|Overall Study|SAE, non-fatal|5
7683532|NCT01261325|26724154|P1|Overall Study|SAE, non-fatal|1
7683533|NCT01261325|26724152|P3|Overall Study|Withdrawal by Subject|4
7683534|NCT01261325|26724153|P2|Overall Study|Withdrawal by Subject|2
7683535|NCT01261325|26724154|P1|Overall Study|Withdrawal by Subject|2
7683536|NCT01261325|26724152|P3|Overall Study|Lack of Efficacy|0
7683537|NCT01261325|26724153|P2|Overall Study|Lack of Efficacy|1
7683538|NCT01261325|26724154|P1|Overall Study|Lack of Efficacy|1
7683540|NCT01261000|26724199|P1|Overall Study|Screen failure|1
7683541|NCT01260948|26724205|P2|Second Intervention|Emesis|1
7683542|NCT01260948|26724206|P1|Second Intervention|Emesis|0
7683543|NCT01260948|26724205|P2|Washout of 28 Days|Withdrawal by Subject|3
7683544|NCT01260948|26724206|P1|Washout of 28 Days|Withdrawal by Subject|1
7683545|NCT01260922|26724216|P2|Second Intervention|Emesis|2
7683546|NCT01260922|26724217|P1|Second Intervention|Emesis|0
7683547|NCT01260922|26724216|P2|Washout of 28 Days|Withdrawal by Subject|2
7683548|NCT01260922|26724217|P1|Washout of 28 Days|Withdrawal by Subject|4
7683549|NCT01260922|26724216|P2|First Intervention|Withdrawal by Subject|1
7683550|NCT01260922|26724217|P1|First Intervention|Withdrawal by Subject|0
7683551|NCT01260896|26724227|P2|First Intervention|Withdrawn Due to Emesis|0
7683552|NCT01260896|26724228|P1|First Intervention|Withdrawn Due to Emesis|2
7683553|NCT01260701|26724286|P1|Overall Study|Did not begin protocol therapy|1
7683554|NCT01260701|26724286|P1|Overall Study|Ineligible|4
7683555|NCT01260701|26724286|P1|Overall Study|Under review|1
7683556|NCT01260701|26724286|P1|Overall Study|Not protocol specified|3
7683557|NCT01260701|26724286|P1|Overall Study|Death|2
7683558|NCT01260701|26724286|P1|Overall Study|Progression|53
7683559|NCT01260701|26724286|P1|Overall Study|Withdrawal by Subject|2
7683560|NCT01260701|26724286|P1|Overall Study|Adverse Event|9
7683561|NCT01260584|26724367|P4|Period 2|Withdrawal by Subject|0
7683562|NCT01260584|26724368|P3|Period 2|Withdrawal by Subject|0
7683563|NCT01260584|26724369|P2|Period 2|Withdrawal by Subject|1
7683564|NCT01260584|26724370|P1|Period 2|Withdrawal by Subject|0
7683565|NCT01260584|26724367|P4|Period 2|Adverse Event|0
7683566|NCT01260584|26724368|P3|Period 2|Adverse Event|2
7683567|NCT01260584|26724369|P2|Period 2|Adverse Event|0
7683568|NCT01260584|26724370|P1|Period 2|Adverse Event|1
7683569|NCT01260584|26724367|P4|Period 2|Protocol Violation|1
7683570|NCT01260584|26724368|P3|Period 2|Protocol Violation|3
7683571|NCT01260584|26724369|P2|Period 2|Protocol Violation|2
7683572|NCT01260584|26724370|P1|Period 2|Protocol Violation|0
7683573|NCT01260584|26724367|P4|Period 1|Adverse Event|0
7683574|NCT01260584|26724368|P3|Period 1|Adverse Event|1
7683575|NCT01260584|26724369|P2|Period 1|Adverse Event|0
7683576|NCT01260584|26724370|P1|Period 1|Adverse Event|0
7683577|NCT01260584|26724367|P4|Period 1|Protocol Violation|1
7683578|NCT01260584|26724368|P3|Period 1|Protocol Violation|1
7683579|NCT01260584|26724369|P2|Period 1|Protocol Violation|0
7683580|NCT01260584|26724370|P1|Period 1|Protocol Violation|0
7683581|NCT01260467|26724413|P1|Overall Study|Withdrawal by Subject|2
7683582|NCT01260350|26724445|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683583|NCT01260350|26724446|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683584|NCT01260350|26724447|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683585|NCT01260350|26724448|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683586|NCT01260350|26724449|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683587|NCT01260350|26724450|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683588|NCT01260350|26724451|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683589|NCT01260350|26724452|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683590|NCT01260350|26724453|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683591|NCT01260350|26724454|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683592|NCT01260350|26724455|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683593|NCT01260350|26724456|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683594|NCT01260350|26724457|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683595|NCT01260350|26724458|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
7683596|NCT01260350|26724459|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683597|NCT01260350|26724460|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683598|NCT01260350|26724461|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683599|NCT01260350|26724462|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683600|NCT01260350|26724463|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683601|NCT01260350|26724464|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683602|NCT01260350|26724465|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683603|NCT01260350|26724466|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
7683604|NCT01260350|26724445|P22|Overall Study|Lack of Efficacy|0
7683605|NCT01260350|26724446|P21|Overall Study|Lack of Efficacy|3
7683606|NCT01260350|26724447|P20|Overall Study|Lack of Efficacy|0
7683607|NCT01260350|26724448|P19|Overall Study|Lack of Efficacy|0
7683608|NCT01260350|26724449|P18|Overall Study|Lack of Efficacy|1
7683609|NCT01260350|26724450|P17|Overall Study|Lack of Efficacy|0
7683610|NCT01260350|26724451|P16|Overall Study|Lack of Efficacy|0
7683611|NCT01260350|26724452|P15|Overall Study|Lack of Efficacy|0
7683612|NCT01260350|26724453|P14|Overall Study|Lack of Efficacy|0
7683613|NCT01260350|26724454|P13|Overall Study|Lack of Efficacy|0
7683614|NCT01260350|26724455|P12|Overall Study|Lack of Efficacy|0
7683615|NCT01260350|26724456|P11|Overall Study|Lack of Efficacy|0
7683616|NCT01260350|26724457|P10|Overall Study|Lack of Efficacy|0
7683617|NCT01260350|26724458|P9|Overall Study|Lack of Efficacy|0
7683618|NCT01260350|26724459|P8|Overall Study|Lack of Efficacy|0
7683619|NCT01260350|26724460|P7|Overall Study|Lack of Efficacy|0
7683620|NCT01260350|26724461|P6|Overall Study|Lack of Efficacy|0
7683621|NCT01260350|26724462|P5|Overall Study|Lack of Efficacy|0
7683622|NCT01260350|26724463|P4|Overall Study|Lack of Efficacy|0
7683623|NCT01260350|26724464|P3|Overall Study|Lack of Efficacy|0
7683624|NCT01260350|26724465|P2|Overall Study|Lack of Efficacy|0
7683625|NCT01260350|26724466|P1|Overall Study|Lack of Efficacy|0
7683626|NCT01260311|26724673|P1|Overall Study|Fesoterodine Started Before Enrollment|1
7683627|NCT01260311|26724673|P1|Overall Study|Medication Stopped|1
7683628|NCT01260311|26724673|P1|Overall Study|Gone to Province|2
7683629|NCT01260311|26724673|P1|Overall Study|Financial Constraints|77
7683630|NCT01260311|26724673|P1|Overall Study|Withdrawal by Subject|6
7683631|NCT01260311|26724673|P1|Overall Study|Lost to Follow-up|25
7683632|NCT01260311|26724673|P1|Overall Study|Lack of Efficacy|4
7683633|NCT01260311|26724673|P1|Overall Study|Adverse Event|11
7683634|NCT01260194|26724704|P1|Overall Study|Withdrawal of Consent|1
7683635|NCT01260181|26724716|P1|Overall Study|Decision of Investigator|1
7683636|NCT01260142|26724731|P6|Treatment Period 1|Withdrawal by Subject|1
7683637|NCT01260142|26724732|P5|Treatment Period 1|Withdrawal by Subject|0
7683638|NCT01260142|26724733|P4|Treatment Period 1|Withdrawal by Subject|0
7683639|NCT01260142|26724734|P3|Treatment Period 1|Withdrawal by Subject|0
7683640|NCT01260142|26724735|P2|Treatment Period 1|Withdrawal by Subject|0
7683641|NCT01260142|26724736|P1|Treatment Period 1|Withdrawal by Subject|0
7683642|NCT01260142|26724731|P6|Treatment Period 1|Unexplained elevated sys. BP|0
7683643|NCT01260142|26724732|P5|Treatment Period 1|Unexplained elevated sys. BP|1
7683644|NCT01260142|26724733|P4|Treatment Period 1|Unexplained elevated sys. BP|0
7683645|NCT01260142|26724734|P3|Treatment Period 1|Unexplained elevated sys. BP|0
7683646|NCT01260142|26724735|P2|Treatment Period 1|Unexplained elevated sys. BP|0
7683647|NCT01260142|26724736|P1|Treatment Period 1|Unexplained elevated sys. BP|0
7683648|NCT01260142|26724731|P6|Treatment Period 1|Study on hold|2
7683649|NCT01260142|26724732|P5|Treatment Period 1|Study on hold|1
7683650|NCT01260142|26724733|P4|Treatment Period 1|Study on hold|0
7683651|NCT01260142|26724734|P3|Treatment Period 1|Study on hold|0
7683652|NCT01260142|26724735|P2|Treatment Period 1|Study on hold|1
7683653|NCT01260142|26724736|P1|Treatment Period 1|Study on hold|1
7683654|NCT01259869|26724786|P1|Overall Study|Duplicated registration|1
7683655|NCT01259856|26724792|P2|Overall Study|Unknown/missing|2
7683656|NCT01259856|26724793|P1|Overall Study|Unknown/missing|2
7683657|NCT01259856|26724792|P2|Overall Study|Transfer to another study|1
7683658|NCT01259856|26724793|P1|Overall Study|Transfer to another study|0
7683659|NCT01259856|26724792|P2|Overall Study|Patient developed other disease|1
7683660|NCT01259856|26724793|P1|Overall Study|Patient developed other disease|0
7683661|NCT01259856|26724792|P2|Overall Study|Study closure by sponsor|41
7683662|NCT01259856|26724793|P1|Overall Study|Study closure by sponsor|40
7683663|NCT01259856|26724792|P2|Overall Study|Treatment never started|6
7683664|NCT01259856|26724793|P1|Overall Study|Treatment never started|0
7683665|NCT01259856|26724792|P2|Overall Study|Withdrawal by Subject|10
7683666|NCT01259856|26724793|P1|Overall Study|Withdrawal by Subject|9
7683667|NCT01259856|26724792|P2|Overall Study|Physician Decision|1
7683668|NCT01259856|26724793|P1|Overall Study|Physician Decision|2
7683669|NCT01259856|26724792|P2|Overall Study|Lost to Follow-up|1
7683670|NCT01259856|26724793|P1|Overall Study|Lost to Follow-up|1
7683671|NCT01259856|26724792|P2|Overall Study|Lack of Efficacy|1
7683672|NCT01259856|26724793|P1|Overall Study|Lack of Efficacy|3
7683673|NCT01259856|26724792|P2|Overall Study|Death|1
7683674|NCT01259856|26724793|P1|Overall Study|Death|0
7683675|NCT01259856|26724792|P2|Overall Study|Adverse Event|9
7683676|NCT01259856|26724793|P1|Overall Study|Adverse Event|12
7683677|NCT01259726|26724817|P4|Overall Study|Lost to Follow-up|3
7683678|NCT01259726|26724818|P3|Overall Study|Lost to Follow-up|1
7683679|NCT01259726|26724819|P2|Overall Study|Lost to Follow-up|1
7683680|NCT01259726|26724820|P1|Overall Study|Lost to Follow-up|1
7683681|NCT01259726|26724817|P4|Overall Study|Withdrawal by Subject|1
7683682|NCT01259726|26724818|P3|Overall Study|Withdrawal by Subject|2
7683683|NCT01259726|26724819|P2|Overall Study|Withdrawal by Subject|3
7683684|NCT01259726|26724820|P1|Overall Study|Withdrawal by Subject|1
7683685|NCT01259726|26724817|P4|Overall Study|Physician Decision|1
7683686|NCT01259726|26724818|P3|Overall Study|Physician Decision|1
7683687|NCT01259726|26724819|P2|Overall Study|Physician Decision|0
7683688|NCT01259726|26724820|P1|Overall Study|Physician Decision|2
7683689|NCT01259726|26724817|P4|Overall Study|Death|0
7683690|NCT01259726|26724818|P3|Overall Study|Death|0
7683691|NCT01259726|26724819|P2|Overall Study|Death|0
7683692|NCT01259726|26724820|P1|Overall Study|Death|1
7683693|NCT01259713|26724852|P2|Overall Study|Subject Withdrew Consent|7
7683694|NCT01259713|26724853|P1|Overall Study|Subject Withdrew Consent|12
7683695|NCT01259713|26724852|P2|Overall Study|Protocol Violation|4
7683696|NCT01259713|26724853|P1|Overall Study|Protocol Violation|5
7683697|NCT01259713|26724852|P2|Overall Study|Lack of Efficacy|0
7683698|NCT01259713|26724853|P1|Overall Study|Lack of Efficacy|2
7683699|NCT01259713|26724852|P2|Overall Study|Investigators Discretion|6
7683700|NCT01259713|26724853|P1|Overall Study|Investigators Discretion|14
7683701|NCT01259713|26724852|P2|Overall Study|Death Not Related to IFI|1
7683702|NCT01259713|26724853|P1|Overall Study|Death Not Related to IFI|8
7683703|NCT01259713|26724852|P2|Overall Study|Adverse Event|23
7683704|NCT01259713|26724853|P1|Overall Study|Adverse Event|54
7683705|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
7683706|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
7683707|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
7683708|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
7683709|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7683710|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
7683711|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7683712|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7683713|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
7683714|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
7683715|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
7683716|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
7683717|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
7683718|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
7683719|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
7683720|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
7683721|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7683722|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7683723|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7683724|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
7683725|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
7683726|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
7683727|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
7683728|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
7683729|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7683730|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
7683731|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7683732|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7683733|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
7683734|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7683735|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7683736|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7683737|NCT01259492|26724900|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
7683738|NCT01259492|26724901|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
7683739|NCT01259492|26724902|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
7683740|NCT01259492|26724903|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
7683741|NCT01259492|26724900|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
7683742|NCT01259492|26724901|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
7683743|NCT01259492|26724902|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
7683744|NCT01259492|26724903|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
7683745|NCT01259492|26724900|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7683746|NCT01259492|26724901|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
7683747|NCT01259492|26724902|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7683748|NCT01259492|26724903|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7683749|NCT01259492|26724900|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
7683750|NCT01259492|26724901|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
7683751|NCT01259492|26724902|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
7683752|NCT01259492|26724903|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
7683753|NCT01259492|26724900|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
7683754|NCT01259492|26724901|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
7683755|NCT01259492|26724902|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
7683756|NCT01259492|26724903|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
7683757|NCT01259492|26724900|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
7683758|NCT01259492|26724901|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
7683759|NCT01259492|26724902|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
7683760|NCT01259492|26724903|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
7683761|NCT01259492|26724900|P4|Period 1 (9 Weeks)|Protocol Violation|1
7683762|NCT01259492|26724901|P3|Period 1 (9 Weeks)|Protocol Violation|3
7683763|NCT01259492|26724902|P2|Period 1 (9 Weeks)|Protocol Violation|6
7683764|NCT01259492|26724903|P1|Period 1 (9 Weeks)|Protocol Violation|5
7683765|NCT01259492|26724900|P4|Period 1 (9 Weeks)|Administrative Problems|2
7683766|NCT01259492|26724901|P3|Period 1 (9 Weeks)|Administrative Problems|1
7683767|NCT01259492|26724902|P2|Period 1 (9 Weeks)|Administrative Problems|1
7683768|NCT01259492|26724903|P1|Period 1 (9 Weeks)|Administrative Problems|0
7683769|NCT01259492|26724900|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
7683770|NCT01259492|26724901|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
7683771|NCT01259492|26724902|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
7683772|NCT01259492|26724903|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
7683773|NCT01259492|26724900|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
7683774|NCT01259492|26724901|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
7683775|NCT01259492|26724902|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
7683776|NCT01259492|26724903|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
7683777|NCT01259492|26724900|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
7683778|NCT01259492|26724901|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
7683779|NCT01259492|26724902|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
7683780|NCT01259492|26724903|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
7683781|NCT01259492|26724900|P4|Period 1 (9 Weeks)|Adverse Event|3
7683782|NCT01259492|26724901|P3|Period 1 (9 Weeks)|Adverse Event|26
7683783|NCT01259492|26724902|P2|Period 1 (9 Weeks)|Adverse Event|18
7683784|NCT01259492|26724903|P1|Period 1 (9 Weeks)|Adverse Event|13
7683785|NCT01259466|26724952|P2|Overall Study|Withdrawal by Subject|9
7683786|NCT01259466|26724953|P1|Overall Study|Withdrawal by Subject|1
7683787|NCT01259401|26724991|P2|4-month Follow-up|Lost to Follow-up|1
7683788|NCT01259401|26724992|P1|4-month Follow-up|Lost to Follow-up|0
7683789|NCT01259401|26724991|P2|4-month Follow-up|Death|1
7683790|NCT01259401|26724992|P1|4-month Follow-up|Death|0
7683791|NCT01259388|26725002|P2|Overall Study|Physician Decision|0
7683792|NCT01259388|26725003|P1|Overall Study|Physician Decision|1
7683793|NCT01259388|26725002|P2|Overall Study|Withdrawal by Subject|1
7683794|NCT01259388|26725003|P1|Overall Study|Withdrawal by Subject|1
7683795|NCT01259388|26725002|P2|Overall Study|Adverse Event|0
7683796|NCT01259388|26725003|P1|Overall Study|Adverse Event|3
7683797|NCT01259375|26725013|P1|Overall Study|Adverse Event|1
7683798|NCT01259297|26725030|P8|Double Blind Randomized Period|Other reasons|1
7683799|NCT01259297|26725031|P7|Double Blind Randomized Period|Other reasons|3
7683800|NCT01259297|26725032|P6|Double Blind Randomized Period|Other reasons|2
7683801|NCT01259297|26725033|P5|Double Blind Randomized Period|Other reasons|1
7683802|NCT01259297|26725034|P4|Double Blind Randomized Period|Other reasons|0
7683803|NCT01259297|26725035|P3|Double Blind Randomized Period|Other reasons|0
7683804|NCT01259297|26725036|P2|Double Blind Randomized Period|Other reasons|1
7683805|NCT01259297|26725037|P1|Double Blind Randomized Period|Other reasons|0
7683806|NCT01259297|26725030|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7683807|NCT01259297|26725031|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7683808|NCT01259297|26725032|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7683809|NCT01259297|26725033|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
7683810|NCT01259297|26725034|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
7683811|NCT01259297|26725035|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
7683812|NCT01259297|26725036|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7683813|NCT01259297|26725037|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7683814|NCT01259297|26725030|P8|Double Blind Randomized Period|Death|1
7683815|NCT01259297|26725031|P7|Double Blind Randomized Period|Death|2
7683816|NCT01259297|26725032|P6|Double Blind Randomized Period|Death|5
7683817|NCT01259297|26725033|P5|Double Blind Randomized Period|Death|1
7683818|NCT01259297|26725034|P4|Double Blind Randomized Period|Death|2
7683819|NCT01259297|26725035|P3|Double Blind Randomized Period|Death|1
7683820|NCT01259297|26725036|P2|Double Blind Randomized Period|Death|1
7683821|NCT01259297|26725037|P1|Double Blind Randomized Period|Death|1
7683822|NCT01259284|26725068|P3|Overall Study|Study Termination|0
7683823|NCT01259284|26725069|P2|Overall Study|Study Termination|0
7683824|NCT01259284|26725070|P1|Overall Study|Study Termination|2
7683825|NCT01259245|26725080|P2|Overall Study|Death|2
7683826|NCT01259245|26725081|P1|Overall Study|Death|1
7683827|NCT01259245|26725080|P2|Overall Study|Withdrawal by Subject|24
7683828|NCT01259245|26725081|P1|Overall Study|Withdrawal by Subject|27
7683829|NCT01259115|26725118|P2|Period 2|Adverse Event|0
7683830|NCT01259115|26725119|P1|Period 2|Adverse Event|1
7683831|NCT01259115|26725118|P2|Period 1|Lost to Follow-up|1
7683832|NCT01259115|26725119|P1|Period 1|Lost to Follow-up|0
7683833|NCT01259115|26725118|P2|Period 1|Protocol Violation|0
7683834|NCT01259115|26725119|P1|Period 1|Protocol Violation|2
7683835|NCT01259115|26725118|P2|Period 1|Adverse Event|0
7683836|NCT01259115|26725119|P1|Period 1|Adverse Event|1
7683837|NCT01259102|26725155|P5|Overall Study|Other|1
7683838|NCT01259102|26725156|P4|Overall Study|Other|1
7683839|NCT01259102|26725157|P3|Overall Study|Other|1
7683840|NCT01259102|26725158|P2|Overall Study|Other|0
7683841|NCT01259102|26725159|P1|Overall Study|Other|0
7683842|NCT01259102|26725155|P5|Overall Study|Adverse Event|0
7683843|NCT01259102|26725156|P4|Overall Study|Adverse Event|1
7683844|NCT01259102|26725157|P3|Overall Study|Adverse Event|1
7683845|NCT01259102|26725158|P2|Overall Study|Adverse Event|0
7683846|NCT01259102|26725159|P1|Overall Study|Adverse Event|1
7683847|NCT01259089|26725216|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
7683848|NCT01259089|26725217|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
7683849|NCT01259089|26725218|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
7683850|NCT01259089|26725219|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
7683851|NCT01259089|26725220|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
7683852|NCT01259089|26725221|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
7683853|NCT01259089|26725216|P6|Survival Follow up for Two Years|Lost to Follow-up|2
7683854|NCT01259089|26725217|P5|Survival Follow up for Two Years|Lost to Follow-up|0
7683855|NCT01259089|26725218|P4|Survival Follow up for Two Years|Lost to Follow-up|0
7683856|NCT01259089|26725219|P3|Survival Follow up for Two Years|Lost to Follow-up|0
7683857|NCT01259089|26725220|P2|Survival Follow up for Two Years|Lost to Follow-up|0
7683858|NCT01259089|26725221|P1|Survival Follow up for Two Years|Lost to Follow-up|0
7683859|NCT01259089|26725216|P6|Survival Follow up for Two Years|Death|13
7683860|NCT01259089|26725217|P5|Survival Follow up for Two Years|Death|6
7683861|NCT01259089|26725218|P4|Survival Follow up for Two Years|Death|3
7683862|NCT01259089|26725219|P3|Survival Follow up for Two Years|Death|2
7683863|NCT01259089|26725220|P2|Survival Follow up for Two Years|Death|2
7683864|NCT01259089|26725221|P1|Survival Follow up for Two Years|Death|3
7683865|NCT01259089|26725216|P6|Continued Treatment After 8 Weeks|Progressive disease|0
7683866|NCT01259089|26725217|P5|Continued Treatment After 8 Weeks|Progressive disease|0
7683867|NCT01259089|26725218|P4|Continued Treatment After 8 Weeks|Progressive disease|1
7683868|NCT01259089|26725219|P3|Continued Treatment After 8 Weeks|Progressive disease|1
7683869|NCT01259089|26725220|P2|Continued Treatment After 8 Weeks|Progressive disease|1
7683870|NCT01259089|26725221|P1|Continued Treatment After 8 Weeks|Progressive disease|1
7683871|NCT01259089|26725216|P6|Continued Treatment After 8 Weeks|Adverse Event|1
7683872|NCT01259089|26725217|P5|Continued Treatment After 8 Weeks|Adverse Event|2
7683873|NCT01259089|26725218|P4|Continued Treatment After 8 Weeks|Adverse Event|0
7683874|NCT01259089|26725219|P3|Continued Treatment After 8 Weeks|Adverse Event|0
7683875|NCT01259089|26725220|P2|Continued Treatment After 8 Weeks|Adverse Event|0
7683876|NCT01259089|26725221|P1|Continued Treatment After 8 Weeks|Adverse Event|0
7683877|NCT01259089|26725216|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7683878|NCT01259089|26725217|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7683879|NCT01259089|26725218|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7683880|NCT01259089|26725219|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7683881|NCT01259089|26725220|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7683882|NCT01259089|26725221|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
7683883|NCT01259089|26725216|P6|Confirmed Response at 8 Weeks|Progressive disease|7
7683884|NCT01259089|26725217|P5|Confirmed Response at 8 Weeks|Progressive disease|3
7683885|NCT01259089|26725218|P4|Confirmed Response at 8 Weeks|Progressive disease|1
7683886|NCT01259089|26725219|P3|Confirmed Response at 8 Weeks|Progressive disease|1
7683887|NCT01259089|26725220|P2|Confirmed Response at 8 Weeks|Progressive disease|0
7683888|NCT01259089|26725221|P1|Confirmed Response at 8 Weeks|Progressive disease|0
7683889|NCT01259089|26725216|P6|Confirmed Response at 8 Weeks|Adverse Event|2
7683890|NCT01259089|26725217|P5|Confirmed Response at 8 Weeks|Adverse Event|1
7683891|NCT01259089|26725218|P4|Confirmed Response at 8 Weeks|Adverse Event|0
7683892|NCT01259089|26725219|P3|Confirmed Response at 8 Weeks|Adverse Event|0
7683893|NCT01259089|26725220|P2|Confirmed Response at 8 Weeks|Adverse Event|0
7683894|NCT01259089|26725221|P1|Confirmed Response at 8 Weeks|Adverse Event|0
7683895|NCT01259089|26725216|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
7683896|NCT01259089|26725217|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7683897|NCT01259089|26725218|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7683898|NCT01259089|26725219|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7683899|NCT01259089|26725220|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7683900|NCT01259089|26725221|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7683901|NCT01259089|26725216|P6|Reached First Response at 4 Weeks|Adverse Event|1
7683902|NCT01259089|26725217|P5|Reached First Response at 4 Weeks|Adverse Event|0
7683903|NCT01259089|26725218|P4|Reached First Response at 4 Weeks|Adverse Event|0
7683904|NCT01259089|26725219|P3|Reached First Response at 4 Weeks|Adverse Event|0
7683905|NCT01259089|26725220|P2|Reached First Response at 4 Weeks|Adverse Event|0
7683906|NCT01259089|26725221|P1|Reached First Response at 4 Weeks|Adverse Event|0
7683907|NCT01259089|26725216|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
7683908|NCT01259089|26725217|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
7683909|NCT01259089|26725218|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
7683910|NCT01259089|26725219|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
7683911|NCT01259089|26725220|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
7683912|NCT01259089|26725221|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
7683913|NCT01259024|26725249|P1|Overall Study|Physician Decision|1
7683914|NCT01258998|26725269|P1|Overall Study|Ineligible|1
7683915|NCT01258803|26725330|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
7683916|NCT01258803|26725331|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
7683917|NCT01258803|26725332|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
7683918|NCT01258803|26725333|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
7683919|NCT01258803|26725334|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
7683920|NCT01258803|26725335|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
7683921|NCT01258803|26725330|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7683922|NCT01258803|26725331|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7683923|NCT01258803|26725332|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7683924|NCT01258803|26725333|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7683925|NCT01258803|26725334|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
7683926|NCT01258803|26725335|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7683927|NCT01258803|26725330|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
7683928|NCT01258803|26725331|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
7683929|NCT01258803|26725332|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
7683930|NCT01258803|26725333|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
7683931|NCT01258803|26725334|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
7683932|NCT01258803|26725335|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
7683933|NCT01258738|26725372|P2|Open-label Period|Withdrawn due to pregnancy|1
7683934|NCT01258738|26725373|P1|Open-label Period|Withdrawn due to pregnancy|1
7683935|NCT01258738|26725372|P2|Open-label Period|Other Reasons|1
7683936|NCT01258738|26725373|P1|Open-label Period|Other Reasons|0
7683937|NCT01258738|26725372|P2|Open-label Period|Adverse Event|5
7683938|NCT01258738|26725373|P1|Open-label Period|Adverse Event|4
7683939|NCT01258738|26725372|P2|Open-label Period|Protocol Violation|2
7683940|NCT01258738|26725373|P1|Open-label Period|Protocol Violation|2
7683941|NCT01258738|26725372|P2|Open-label Period|Withdrawal by Subject|6
7683942|NCT01258738|26725373|P1|Open-label Period|Withdrawal by Subject|5
7683943|NCT01258738|26725372|P2|Open-label Period|Lost to Follow-up|2
7683944|NCT01258738|26725373|P1|Open-label Period|Lost to Follow-up|0
7683945|NCT01258738|26725372|P2|Open-label Period|Insufficient clinical response|3
7683946|NCT01258738|26725373|P1|Open-label Period|Insufficient clinical response|5
7683947|NCT01258738|26725372|P2|Open-label Period|Did not meet inclusion criteria|1
7683948|NCT01258738|26725373|P1|Open-label Period|Did not meet inclusion criteria|0
7683949|NCT01258738|26725372|P2|Double-blind Period|Adverse Event|1
7683950|NCT01258738|26725373|P1|Double-blind Period|Adverse Event|3
7683951|NCT01258738|26725372|P2|Double-blind Period|Protocol Violation|1
7683952|NCT01258738|26725373|P1|Double-blind Period|Protocol Violation|1
7683953|NCT01258738|26725372|P2|Double-blind Period|Withdrawal by Subject|2
7683954|NCT01258738|26725373|P1|Double-blind Period|Withdrawal by Subject|2
7683955|NCT01258738|26725372|P2|Double-blind Period|Did not meet inclusion criteria|3
7683956|NCT01258738|26725373|P1|Double-blind Period|Did not meet inclusion criteria|3
7683957|NCT01258660|26725511|P2|Overall Study|Invalid for primary analysis data set|6
7683958|NCT01258660|26725512|P1|Overall Study|Invalid for primary analysis data set|4
7683959|NCT01258660|26725511|P2|Overall Study|Protocol Violation|1
7683960|NCT01258660|26725512|P1|Overall Study|Protocol Violation|0
7683961|NCT01258660|26725511|P2|Overall Study|due to relocation|0
7683962|NCT01258660|26725512|P1|Overall Study|due to relocation|2
7683963|NCT01258660|26725511|P2|Overall Study|Withdrawal by Subject|0
7683964|NCT01258660|26725512|P1|Overall Study|Withdrawal by Subject|3
7683965|NCT01258660|26725511|P2|Overall Study|Adverse Event|4
7683966|NCT01258660|26725512|P1|Overall Study|Adverse Event|2
7683967|NCT01258608|26725531|P2|Overall Study|Withdrawal by Subject|5
7683968|NCT01258608|26725532|P1|Overall Study|Withdrawal by Subject|6
7683969|NCT01258608|26725531|P2|Overall Study|Adverse Event|10
7683970|NCT01258608|26725532|P1|Overall Study|Adverse Event|6
7683971|NCT01258608|26725531|P2|Overall Study|Lack of Efficacy|1
7683972|NCT01258608|26725532|P1|Overall Study|Lack of Efficacy|0
7683973|NCT01258608|26725531|P2|Overall Study|Lack of compliance|0
7683974|NCT01258608|26725532|P1|Overall Study|Lack of compliance|1
7683975|NCT01258608|26725531|P2|Overall Study|Lost to Follow-up|1
7683976|NCT01258608|26725532|P1|Overall Study|Lost to Follow-up|0
7683977|NCT01258608|26725531|P2|Overall Study|Physician Decision|1
7683978|NCT01258608|26725532|P1|Overall Study|Physician Decision|6
7683979|NCT01258608|26725531|P2|Overall Study|Sponsor decision|1
7683980|NCT01258608|26725532|P1|Overall Study|Sponsor decision|0
7683981|NCT01258608|26725531|P2|Overall Study|Clinical progression|0
7683982|NCT01258608|26725532|P1|Overall Study|Clinical progression|1
7683983|NCT01258608|26725531|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
7683984|NCT01258608|26725532|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
7683985|NCT01258595|26725580|P2|Overall Study|Withdrawal by Subject|1
7683986|NCT01258595|26725581|P1|Overall Study|Withdrawal by Subject|0
7683987|NCT01258595|26725580|P2|Overall Study|Lost to Follow-up|0
7683988|NCT01258595|26725581|P1|Overall Study|Lost to Follow-up|1
7683989|NCT01258348|26725678|P5|Overall Study|Withdrawal by Subject|0
7683990|NCT01258348|26725679|P4|Overall Study|Withdrawal by Subject|0
7683991|NCT01258348|26725680|P3|Overall Study|Withdrawal by Subject|0
7683992|NCT01258348|26725681|P2|Overall Study|Withdrawal by Subject|1
7683993|NCT01258348|26725682|P1|Overall Study|Withdrawal by Subject|0
7683994|NCT01258348|26725678|P5|Overall Study|Physician Decision|0
7683995|NCT01258348|26725679|P4|Overall Study|Physician Decision|2
7683996|NCT01258348|26725680|P3|Overall Study|Physician Decision|0
7683997|NCT01258348|26725681|P2|Overall Study|Physician Decision|0
7683998|NCT01258348|26725682|P1|Overall Study|Physician Decision|0
7683999|NCT01258348|26725678|P5|Overall Study|Progressive Disease|2
7684000|NCT01258348|26725679|P4|Overall Study|Progressive Disease|2
7684001|NCT01258348|26725680|P3|Overall Study|Progressive Disease|0
7684002|NCT01258348|26725681|P2|Overall Study|Progressive Disease|3
7684003|NCT01258348|26725682|P1|Overall Study|Progressive Disease|0
7684004|NCT01258348|26725678|P5|Overall Study|Adverse Event|4
7684005|NCT01258348|26725679|P4|Overall Study|Adverse Event|2
7684006|NCT01258348|26725680|P3|Overall Study|Adverse Event|3
7684007|NCT01258348|26725681|P2|Overall Study|Adverse Event|1
7684008|NCT01258348|26725682|P1|Overall Study|Adverse Event|1
7684009|NCT01258101|26725739|P4|Overall Study|Other reason|8
7684010|NCT01258101|26725740|P3|Overall Study|Other reason|1
7684011|NCT01258101|26725741|P2|Overall Study|Other reason|8
7684012|NCT01258101|26725742|P1|Overall Study|Other reason|7
7684013|NCT01258101|26725739|P4|Overall Study|PCR positive at week 24|1
7684014|NCT01258101|26725740|P3|Overall Study|PCR positive at week 24|0
7684015|NCT01258101|26725741|P2|Overall Study|PCR positive at week 24|0
7684016|NCT01258101|26725742|P1|Overall Study|PCR positive at week 24|0
7684017|NCT01258101|26725739|P4|Overall Study|Lost to Follow-up|6
7684018|NCT01258101|26725740|P3|Overall Study|Lost to Follow-up|0
7684019|NCT01258101|26725741|P2|Overall Study|Lost to Follow-up|5
7684020|NCT01258101|26725742|P1|Overall Study|Lost to Follow-up|5
7684021|NCT01258101|26725739|P4|Overall Study|Patient´s compliance|2
7684022|NCT01258101|26725740|P3|Overall Study|Patient´s compliance|1
7684023|NCT01258101|26725741|P2|Overall Study|Patient´s compliance|3
7684024|NCT01258101|26725742|P1|Overall Study|Patient´s compliance|4
7684025|NCT01258101|26725739|P4|Overall Study|Patient is not able to attend visits|6
7684026|NCT01258101|26725740|P3|Overall Study|Patient is not able to attend visits|7
7684027|NCT01258101|26725741|P2|Overall Study|Patient is not able to attend visits|9
7684028|NCT01258101|26725742|P1|Overall Study|Patient is not able to attend visits|8
7684029|NCT01258101|26725739|P4|Overall Study|Informed consent has been withdrawn|1
7684030|NCT01258101|26725740|P3|Overall Study|Informed consent has been withdrawn|1
7684031|NCT01258101|26725741|P2|Overall Study|Informed consent has been withdrawn|2
7684032|NCT01258101|26725742|P1|Overall Study|Informed consent has been withdrawn|2
7684033|NCT01258101|26725739|P4|Overall Study|Extra exclusion criterion amended|1
7684034|NCT01258101|26725740|P3|Overall Study|Extra exclusion criterion amended|1
7684035|NCT01258101|26725741|P2|Overall Study|Extra exclusion criterion amended|1
7684036|NCT01258101|26725742|P1|Overall Study|Extra exclusion criterion amended|2
7684037|NCT01258101|26725739|P4|Overall Study|Adverse Event|0
7684038|NCT01258101|26725740|P3|Overall Study|Adverse Event|0
7684039|NCT01258101|26725741|P2|Overall Study|Adverse Event|6
7684040|NCT01258101|26725742|P1|Overall Study|Adverse Event|5
7684041|NCT01258075|26725794|P2|Overall Study|Other|5
7684042|NCT01258075|26725795|P1|Overall Study|Other|12
7684043|NCT01258075|26725794|P2|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
7684044|NCT01258075|26725795|P1|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
7684045|NCT01258075|26725794|P2|Overall Study|Withdrawal by Subject|7
7684046|NCT01258075|26725795|P1|Overall Study|Withdrawal by Subject|10
7684047|NCT01258075|26725794|P2|Overall Study|Lost to Follow-up|6
7684048|NCT01258075|26725795|P1|Overall Study|Lost to Follow-up|11
7684049|NCT01258075|26725794|P2|Overall Study|Adverse Event|3
7684050|NCT01258075|26725795|P1|Overall Study|Adverse Event|8
7684051|NCT01257737|26725893|P2|Overall Study|Withdrew from study|1
7684052|NCT01257737|26725894|P1|Overall Study|Withdrew from study|0
7684053|NCT01257737|26725893|P2|Overall Study|Relocation out of the country|1
7684054|NCT01257737|26725894|P1|Overall Study|Relocation out of the country|0
7684055|NCT01257737|26725893|P2|Overall Study|Liver transplant|0
7684056|NCT01257737|26725894|P1|Overall Study|Liver transplant|1
7684057|NCT01257737|26725893|P2|Overall Study|Lost to Follow-up|2
7684058|NCT01257737|26725894|P1|Overall Study|Lost to Follow-up|1
7684059|NCT01257698|26725914|P2|Overall Study|Protocol Violation|0
7684060|NCT01257698|26725915|P1|Overall Study|Protocol Violation|4
7684061|NCT01257581|26725924|P3|Overall Study|Death|4
7684062|NCT01257581|26725925|P2|Overall Study|Death|2
7684063|NCT01257581|26725926|P1|Overall Study|Death|2
7684064|NCT01257581|26725924|P3|Overall Study|Early Termination|2
7684065|NCT01257581|26725925|P2|Overall Study|Early Termination|1
7684066|NCT01257581|26725926|P1|Overall Study|Early Termination|3
7684067|NCT01257568|26725964|P1|Overall Study|Component Revision|24
7684068|NCT01257568|26725964|P1|Overall Study|Terminated|1
7684069|NCT01257568|26725964|P1|Overall Study|Withdrawal by Subject|6
7684070|NCT01257568|26725964|P1|Overall Study|Lost to Follow-up|2
7684071|NCT01257542|26725978|P2|Overall Study|Withdrawal by Subject|2
7684072|NCT01257542|26725979|P1|Overall Study|Withdrawal by Subject|0
7684073|NCT01257542|26725978|P2|Overall Study|Protocol Violation|5
7684074|NCT01257542|26725979|P1|Overall Study|Protocol Violation|3
7684075|NCT01257503|26725999|P2|Overall Study|strep culture positive at enrollment|0
7684076|NCT01257503|26726000|P1|Overall Study|strep culture positive at enrollment|1
7684077|NCT01257503|26725999|P2|Overall Study|Over 5 years old at enrollment|1
7684078|NCT01257503|26726000|P1|Overall Study|Over 5 years old at enrollment|0
7684079|NCT01257503|26725999|P2|Overall Study|Lost to Follow-up|10
7684080|NCT01257503|26726000|P1|Overall Study|Lost to Follow-up|7
7684081|NCT01257425|26726029|P2|Overall Study|Death|0
7684082|NCT01257425|26726030|P1|Overall Study|Death|1
7684083|NCT01257425|26726029|P2|Overall Study|Withdrawal by Subject|1
7684084|NCT01257425|26726030|P1|Overall Study|Withdrawal by Subject|0
7684085|NCT01257425|26726029|P2|Overall Study|Protocol Violation|1
7684086|NCT01257425|26726030|P1|Overall Study|Protocol Violation|1
7684087|NCT01257425|26726029|P2|Overall Study|Adverse Event|1
7684088|NCT01257425|26726030|P1|Overall Study|Adverse Event|1
7684089|NCT01257425|26726029|P2|Overall Study|Lack of Efficacy|3
7684090|NCT01257425|26726030|P1|Overall Study|Lack of Efficacy|3
7684091|NCT01257230|26726072|P3|Overall Study|Other reason not defined above|3
7684092|NCT01257230|26726073|P2|Overall Study|Other reason not defined above|5
7684093|NCT01257230|26726074|P1|Overall Study|Other reason not defined above|1
7684094|NCT01257230|26726072|P3|Overall Study|Withdrawal by Subject|1
7684095|NCT01257230|26726073|P2|Overall Study|Withdrawal by Subject|4
7684096|NCT01257230|26726074|P1|Overall Study|Withdrawal by Subject|0
7684097|NCT01257230|26726072|P3|Overall Study|Protocol Violation|1
7684098|NCT01257230|26726073|P2|Overall Study|Protocol Violation|0
7684099|NCT01257230|26726074|P1|Overall Study|Protocol Violation|3
7684100|NCT01257230|26726072|P3|Overall Study|Lack of Efficacy|0
7684101|NCT01257230|26726073|P2|Overall Study|Lack of Efficacy|1
7684102|NCT01257230|26726074|P1|Overall Study|Lack of Efficacy|0
7684103|NCT01257230|26726072|P3|Overall Study|Adverse Event|0
7684104|NCT01257230|26726073|P2|Overall Study|Adverse Event|0
7684105|NCT01257230|26726074|P1|Overall Study|Adverse Event|2
7684106|NCT01257230|26726072|P3|Overall Study|Not Treated|1
7684107|NCT01257230|26726073|P2|Overall Study|Not Treated|0
7684108|NCT01257230|26726074|P1|Overall Study|Not Treated|0
7684109|NCT01257204|26726151|P3|Follow-up Period (up to Week 48)|Other|5
7684110|NCT01257204|26726152|P2|Follow-up Period (up to Week 48)|Other|0
7684111|NCT01257204|26726153|P1|Follow-up Period (up to Week 48)|Other|0
7684112|NCT01257204|26726151|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
7684113|NCT01257204|26726152|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
7684114|NCT01257204|26726153|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
7684115|NCT01257204|26726151|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
7684116|NCT01257204|26726152|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
7684117|NCT01257204|26726153|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
7684118|NCT01257204|26726151|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
7684119|NCT01257204|26726152|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
7684120|NCT01257204|26726153|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
7684121|NCT01257204|26726151|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
7684122|NCT01257204|26726152|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
7684123|NCT01257204|26726153|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
7684124|NCT01257204|26726151|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
7684125|NCT01257204|26726152|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
7684126|NCT01257204|26726153|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
7684127|NCT01257204|26726151|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7684128|NCT01257204|26726152|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
7684129|NCT01257204|26726153|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7684130|NCT01257204|26726151|P3|Treatment Period (up to Week 24)|Adverse Event|2
7684131|NCT01257204|26726152|P2|Treatment Period (up to Week 24)|Adverse Event|1
7684132|NCT01257204|26726153|P1|Treatment Period (up to Week 24)|Adverse Event|3
7684133|NCT01257204|26726151|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
7684134|NCT01257204|26726152|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
7684135|NCT01257204|26726153|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
7684136|NCT01256879|26726261|P1|Overall Study|Withdrawal by Subject|1
7684137|NCT01256788|26726287|P3|Overall Study|Lost to Follow-up|3
7684138|NCT01256788|26726288|P2|Overall Study|Lost to Follow-up|8
7684139|NCT01256788|26726289|P1|Overall Study|Lost to Follow-up|5
7684140|NCT01256684|26726300|P3|Overall Study|Entry criteria not met/non-compliance|6
7684141|NCT01256684|26726301|P2|Overall Study|Entry criteria not met/non-compliance|7
7684142|NCT01256684|26726302|P1|Overall Study|Entry criteria not met/non-compliance|4
7684143|NCT01256684|26726300|P3|Overall Study|Lack of Efficacy|1
7684144|NCT01256684|26726301|P2|Overall Study|Lack of Efficacy|1
7684145|NCT01256684|26726302|P1|Overall Study|Lack of Efficacy|0
7684146|NCT01256684|26726300|P3|Overall Study|Physician Decision|0
7684147|NCT01256684|26726301|P2|Overall Study|Physician Decision|1
7684148|NCT01256684|26726302|P1|Overall Study|Physician Decision|0
7684149|NCT01256684|26726300|P3|Overall Study|Withdrawal by Subject|2
7684150|NCT01256684|26726301|P2|Overall Study|Withdrawal by Subject|0
7684151|NCT01256684|26726302|P1|Overall Study|Withdrawal by Subject|4
7684152|NCT01256684|26726300|P3|Overall Study|Adverse Event|2
7684153|NCT01256684|26726301|P2|Overall Study|Adverse Event|4
7684154|NCT01256684|26726302|P1|Overall Study|Adverse Event|1
7684155|NCT01256671|26726334|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
7684156|NCT01256671|26726334|P1|Overall Study|Lack of Efficacy|4
7684157|NCT01256671|26726334|P1|Overall Study|Physician Decision|3
7684158|NCT01256671|26726334|P1|Overall Study|Withdrawal by Subject|31
7684159|NCT01256671|26726334|P1|Overall Study|Lost to Follow-up|16
7684160|NCT01256671|26726334|P1|Overall Study|Adverse Event|29
7684161|NCT01256658|26726347|P2|Period 1|Death|44
7684162|NCT01256658|26726348|P1|Period 1|Death|48
7684163|NCT01256658|26726347|P2|Period 1|Withdrawal by Subject|43
7684164|NCT01256658|26726348|P1|Period 1|Withdrawal by Subject|35
7684165|NCT01256658|26726347|P2|Period 1|Lost to Follow-up|661
7684166|NCT01256658|26726348|P1|Period 1|Lost to Follow-up|837
7684167|NCT01256593|26726398|P1|Overall Study|No Visit After Treatment|186
7684168|NCT01256593|26726398|P1|Overall Study|No Drug Administration Information|2
7684169|NCT01256593|26726398|P1|Overall Study|Protocol Violation|26
7684170|NCT01256567|26726412|P1|Overall Study|Withdrawal by Subject|1
7684171|NCT01256502|26726422|P1|Overall Study|Protocol deviation|1
7684172|NCT01256502|26726422|P1|Overall Study|Personal reasons|5
7684173|NCT01256502|26726422|P1|Overall Study|Had scaffold removed|4
7684174|NCT01256476|26726434|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
7684175|NCT01256476|26726435|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
7684176|NCT01256476|26726434|P2|Overall Study|Subject non-compliance|1
7684177|NCT01256476|26726435|P1|Overall Study|Subject non-compliance|0
7684178|NCT01256476|26726434|P2|Overall Study|Physician Decision|1
7684179|NCT01256476|26726435|P1|Overall Study|Physician Decision|0
7684180|NCT01256476|26726434|P2|Overall Study|Persistent ALT or AST elevation|0
7684181|NCT01256476|26726435|P1|Overall Study|Persistent ALT or AST elevation|1
7684182|NCT01256476|26726434|P2|Overall Study|Lost to Follow-up|2
7684183|NCT01256476|26726435|P1|Overall Study|Lost to Follow-up|1
7684184|NCT01256476|26726434|P2|Overall Study|Withdrawal by Subject|1
7684185|NCT01256476|26726435|P1|Overall Study|Withdrawal by Subject|2
7684186|NCT01256476|26726434|P2|Overall Study|Adverse Event|1
7684187|NCT01256476|26726435|P1|Overall Study|Adverse Event|2
7684188|NCT01256450|26726443|P3|Double-blind Treatment|Other|12
7684189|NCT01256450|26726444|P2|Double-blind Treatment|Other|9
7684190|NCT01256450|26726445|P1|Double-blind Treatment|Other|0
7684191|NCT01256450|26726443|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
7684192|NCT01256450|26726444|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
7684193|NCT01256450|26726445|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
7684194|NCT01256450|26726443|P3|Double-blind Treatment|Non-compliance|4
7684195|NCT01256450|26726444|P2|Double-blind Treatment|Non-compliance|5
7684196|NCT01256450|26726445|P1|Double-blind Treatment|Non-compliance|0
7684197|NCT01256450|26726443|P3|Double-blind Treatment|Lack of analgesic effect|6
7684198|NCT01256450|26726444|P2|Double-blind Treatment|Lack of analgesic effect|5
7684199|NCT01256450|26726445|P1|Double-blind Treatment|Lack of analgesic effect|0
7684200|NCT01256450|26726443|P3|Double-blind Treatment|Withdrawal by Subject|1
7684201|NCT01256450|26726444|P2|Double-blind Treatment|Withdrawal by Subject|0
7684202|NCT01256450|26726445|P1|Double-blind Treatment|Withdrawal by Subject|0
7684203|NCT01256450|26726443|P3|Double-blind Treatment|Lost to Follow-up|7
7684204|NCT01256450|26726444|P2|Double-blind Treatment|Lost to Follow-up|1
7684205|NCT01256450|26726445|P1|Double-blind Treatment|Lost to Follow-up|0
7684206|NCT01256450|26726443|P3|Double-blind Treatment|Adverse Event|6
7684207|NCT01256450|26726444|P2|Double-blind Treatment|Adverse Event|8
7684208|NCT01256450|26726445|P1|Double-blind Treatment|Adverse Event|0
7684209|NCT01256450|26726443|P3|Open-label Titration|Other|0
7684210|NCT01256450|26726444|P2|Open-label Titration|Other|0
7684211|NCT01256450|26726445|P1|Open-label Titration|Other|13
7684212|NCT01256450|26726443|P3|Open-label Titration|Screen failure|0
7684213|NCT01256450|26726444|P2|Open-label Titration|Screen failure|0
7684214|NCT01256450|26726445|P1|Open-label Titration|Screen failure|1
7684215|NCT01256450|26726443|P3|Open-label Titration|Non-compliance|0
7684216|NCT01256450|26726444|P2|Open-label Titration|Non-compliance|0
7684217|NCT01256450|26726445|P1|Open-label Titration|Non-compliance|9
7684218|NCT01256450|26726443|P3|Open-label Titration|Lack of analgesic effect|0
7684219|NCT01256450|26726444|P2|Open-label Titration|Lack of analgesic effect|0
7684220|NCT01256450|26726445|P1|Open-label Titration|Lack of analgesic effect|30
7684221|NCT01256450|26726443|P3|Open-label Titration|Lost to Follow-up|0
7684222|NCT01256450|26726444|P2|Open-label Titration|Lost to Follow-up|0
7684223|NCT01256450|26726445|P1|Open-label Titration|Lost to Follow-up|7
7684224|NCT01256450|26726443|P3|Open-label Titration|Adverse Event|0
7684225|NCT01256450|26726444|P2|Open-label Titration|Adverse Event|0
7684226|NCT01256450|26726445|P1|Open-label Titration|Adverse Event|39
7684227|NCT01256411|26726503|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
7684228|NCT01256411|26726504|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
7684229|NCT01256411|26726505|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7684230|NCT01256411|26726506|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7684231|NCT01256411|26726507|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7684232|NCT01256411|26726508|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7684233|NCT01256411|26726503|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
7684234|NCT01256411|26726504|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
7684235|NCT01256411|26726505|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7684236|NCT01256411|26726506|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7684237|NCT01256411|26726507|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7684238|NCT01256411|26726508|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7684239|NCT01256411|26726503|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7684240|NCT01256411|26726504|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
7684241|NCT01256411|26726505|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7684242|NCT01256411|26726506|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7684243|NCT01256411|26726507|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7684244|NCT01256411|26726508|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7684245|NCT01256411|26726503|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
7684246|NCT01256411|26726504|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
7684247|NCT01256411|26726505|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
7684248|NCT01256411|26726506|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
7684249|NCT01256411|26726507|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
7684250|NCT01256411|26726508|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
7684251|NCT01256411|26726503|P6|Extension by Mono or Combination Therapy|Adverse Event|1
7684252|NCT01256411|26726504|P5|Extension by Mono or Combination Therapy|Adverse Event|6
7684253|NCT01256411|26726505|P4|Extension by Mono or Combination Therapy|Adverse Event|0
7684254|NCT01256411|26726506|P3|Extension by Mono or Combination Therapy|Adverse Event|0
7684255|NCT01256411|26726507|P2|Extension by Mono or Combination Therapy|Adverse Event|0
7684256|NCT01256411|26726508|P1|Extension by Mono or Combination Therapy|Adverse Event|0
7684257|NCT01256411|26726503|P6|Extension by Maximum Treatment|Adverse Event|0
7684258|NCT01256411|26726504|P5|Extension by Maximum Treatment|Adverse Event|0
7684259|NCT01256411|26726505|P4|Extension by Maximum Treatment|Adverse Event|0
7684260|NCT01256411|26726506|P3|Extension by Maximum Treatment|Adverse Event|1
7684261|NCT01256411|26726507|P2|Extension by Maximum Treatment|Adverse Event|2
7684262|NCT01256411|26726508|P1|Extension by Maximum Treatment|Adverse Event|4
7684263|NCT01256411|26726503|P6|Extension by Maximum Treatment|Lack of Efficacy|0
7684264|NCT01256411|26726504|P5|Extension by Maximum Treatment|Lack of Efficacy|0
7684265|NCT01256411|26726505|P4|Extension by Maximum Treatment|Lack of Efficacy|0
7684266|NCT01256411|26726506|P3|Extension by Maximum Treatment|Lack of Efficacy|1
7684267|NCT01256411|26726507|P2|Extension by Maximum Treatment|Lack of Efficacy|0
7684268|NCT01256411|26726508|P1|Extension by Maximum Treatment|Lack of Efficacy|1
7684269|NCT01256411|26726503|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
7684270|NCT01256411|26726504|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
7684271|NCT01256411|26726505|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
7684272|NCT01256411|26726506|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
7684273|NCT01256411|26726507|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
7684274|NCT01256411|26726508|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
7684275|NCT01256411|26726503|P6|Extension by Maximum Treatment|Lost to Follow-up|0
7684276|NCT01256411|26726504|P5|Extension by Maximum Treatment|Lost to Follow-up|0
7684277|NCT01256411|26726505|P4|Extension by Maximum Treatment|Lost to Follow-up|0
7684278|NCT01256411|26726506|P3|Extension by Maximum Treatment|Lost to Follow-up|0
7684279|NCT01256411|26726507|P2|Extension by Maximum Treatment|Lost to Follow-up|2
7684280|NCT01256411|26726508|P1|Extension by Maximum Treatment|Lost to Follow-up|1
7684281|NCT01256411|26726503|P6|Extension by Maximum Treatment|Protocol deviation|0
7684282|NCT01256411|26726504|P5|Extension by Maximum Treatment|Protocol deviation|0
7684283|NCT01256411|26726505|P4|Extension by Maximum Treatment|Protocol deviation|0
7684284|NCT01256411|26726506|P3|Extension by Maximum Treatment|Protocol deviation|1
7684285|NCT01256411|26726507|P2|Extension by Maximum Treatment|Protocol deviation|0
7684286|NCT01256411|26726508|P1|Extension by Maximum Treatment|Protocol deviation|0
7684287|NCT01256398|26726532|P1|Overall Study|Withdrawal by Subject|1
7684288|NCT01256385|26726538|P2|Overall Study|Withdrawal by Subject|2
7684289|NCT01256385|26726539|P1|Overall Study|Withdrawal by Subject|2
7684290|NCT01256385|26726538|P2|Overall Study|Physician Decision|1
7684291|NCT01256385|26726539|P1|Overall Study|Physician Decision|1
7684292|NCT01256294|26726559|P2|Overall Study|Protocol deviation|1
7684293|NCT01256294|26726560|P1|Overall Study|Protocol deviation|2
7684294|NCT01256294|26726559|P2|Overall Study|Withdrawal by Subject|1
7684295|NCT01256294|26726560|P1|Overall Study|Withdrawal by Subject|1
7684296|NCT01256294|26726559|P2|Overall Study|Adverse Event|0
7684297|NCT01256294|26726560|P1|Overall Study|Adverse Event|1
7684298|NCT01256190|26726582|P2|Overall Study|Lost to Follow-up|0
7684299|NCT01256190|26726583|P1|Overall Study|Lost to Follow-up|2
7684300|NCT01256177|26726599|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
7684301|NCT01256177|26726600|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
7684302|NCT01256177|26726599|P2|Overall Study|Lack of Efficacy|2
7684303|NCT01256177|26726600|P1|Overall Study|Lack of Efficacy|11
7684304|NCT01256177|26726599|P2|Overall Study|Condition under Investigation Worsened|0
7684305|NCT01256177|26726600|P1|Overall Study|Condition under Investigation Worsened|1
7684306|NCT01256177|26726599|P2|Overall Study|Severe Non-Compliance to Protocol|2
7684307|NCT01256177|26726600|P1|Overall Study|Severe Non-Compliance to Protocol|4
7684308|NCT01256177|26726599|P2|Overall Study|Adverse Event|9
7684309|NCT01256177|26726600|P1|Overall Study|Adverse Event|8
7684310|NCT01256177|26726599|P2|Overall Study|Lost to Follow-up|2
7684311|NCT01256177|26726600|P1|Overall Study|Lost to Follow-up|2
7684312|NCT01256177|26726599|P2|Overall Study|Withdrawal by Subject|22
7684313|NCT01256177|26726600|P1|Overall Study|Withdrawal by Subject|23
7684314|NCT01256060|26726656|P4|Overall Study|Lost to Follow-up|0
7684315|NCT01256060|26726657|P3|Overall Study|Lost to Follow-up|0
7684316|NCT01256060|26726658|P2|Overall Study|Lost to Follow-up|1
7684317|NCT01256060|26726659|P1|Overall Study|Lost to Follow-up|0
7684318|NCT01256008|26726678|P3|Overall Study|Withdrawal by Subject|10
7684319|NCT01256008|26726679|P2|Overall Study|Withdrawal by Subject|3
7684320|NCT01256008|26726680|P1|Overall Study|Withdrawal by Subject|2
7684321|NCT01256008|26726678|P3|Overall Study|Lost to Follow-up|11
7684322|NCT01256008|26726679|P2|Overall Study|Lost to Follow-up|4
7684323|NCT01256008|26726680|P1|Overall Study|Lost to Follow-up|6
7684324|NCT01255904|26726702|P2|Overall Study|Physician Decision|4
7684325|NCT01255904|26726703|P1|Overall Study|Physician Decision|1
7684326|NCT01255787|26726742|P4|Overall Study|Noncompliance with Study Drug|0
7684327|NCT01255787|26726743|P3|Overall Study|Noncompliance with Study Drug|0
7684328|NCT01255787|26726744|P2|Overall Study|Noncompliance with Study Drug|1
7684329|NCT01255787|26726745|P1|Overall Study|Noncompliance with Study Drug|3
7684330|NCT01255787|26726742|P4|Overall Study|Lack of Efficacy|2
7684331|NCT01255787|26726743|P3|Overall Study|Lack of Efficacy|2
7684332|NCT01255787|26726744|P2|Overall Study|Lack of Efficacy|2
7684333|NCT01255787|26726745|P1|Overall Study|Lack of Efficacy|2
7684334|NCT01255787|26726742|P4|Overall Study|Pregnancy|1
7684335|NCT01255787|26726743|P3|Overall Study|Pregnancy|0
7684336|NCT01255787|26726744|P2|Overall Study|Pregnancy|0
7684337|NCT01255787|26726745|P1|Overall Study|Pregnancy|0
7684338|NCT01255787|26726742|P4|Overall Study|Withdrawal of Consent|4
7684339|NCT01255787|26726743|P3|Overall Study|Withdrawal of Consent|3
7684340|NCT01255787|26726744|P2|Overall Study|Withdrawal of Consent|9
7684341|NCT01255787|26726745|P1|Overall Study|Withdrawal of Consent|3
7684342|NCT01255787|26726742|P4|Overall Study|Lost to Follow-up|2
7684343|NCT01255787|26726743|P3|Overall Study|Lost to Follow-up|4
7684344|NCT01255787|26726744|P2|Overall Study|Lost to Follow-up|2
7684345|NCT01255787|26726745|P1|Overall Study|Lost to Follow-up|1
7684346|NCT01255787|26726742|P4|Overall Study|Major Protocol Deviation|4
7684347|NCT01255787|26726743|P3|Overall Study|Major Protocol Deviation|0
7684348|NCT01255787|26726744|P2|Overall Study|Major Protocol Deviation|1
7684349|NCT01255787|26726745|P1|Overall Study|Major Protocol Deviation|1
7684350|NCT01255787|26726742|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
7684351|NCT01255787|26726743|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
7684352|NCT01255787|26726744|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
7684353|NCT01255787|26726745|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7684354|NCT01255761|26726773|P2|Overall Study|Other Reasons|18
7684355|NCT01255761|26726774|P1|Overall Study|Other Reasons|37
7684356|NCT01255761|26726773|P2|Overall Study|Withdrawal by Subject|27
7684357|NCT01255761|26726774|P1|Overall Study|Withdrawal by Subject|11
7684358|NCT01255761|26726773|P2|Overall Study|Lost to Follow-up|8
7684359|NCT01255761|26726774|P1|Overall Study|Lost to Follow-up|10
7684360|NCT01255761|26726773|P2|Overall Study|Protocol Violation|5
7684361|NCT01255761|26726774|P1|Overall Study|Protocol Violation|9
7684362|NCT01255761|26726773|P2|Overall Study|Lack of Efficacy|74
7684363|NCT01255761|26726774|P1|Overall Study|Lack of Efficacy|86
7684364|NCT01255761|26726773|P2|Overall Study|Adverse Event|43
7684365|NCT01255761|26726774|P1|Overall Study|Adverse Event|29
7684366|NCT01255722|26726859|P3|Overall Study|beta-blocker contraindicated|0
7684367|NCT01255722|26726860|P2|Overall Study|beta-blocker contraindicated|0
7684368|NCT01255722|26726861|P1|Overall Study|beta-blocker contraindicated|2
7684369|NCT01255722|26726859|P3|Overall Study|asymptomatic patient|0
7684370|NCT01255722|26726860|P2|Overall Study|asymptomatic patient|0
7684371|NCT01255722|26726861|P1|Overall Study|asymptomatic patient|1
7684372|NCT01255722|26726859|P3|Overall Study|Adverse Event|1
7684373|NCT01255722|26726860|P2|Overall Study|Adverse Event|1
7684374|NCT01255722|26726861|P1|Overall Study|Adverse Event|0
7684375|NCT01255670|26726886|P2|Overall Study|Lost to Follow-up|10
7684376|NCT01255670|26726887|P1|Overall Study|Lost to Follow-up|16
7684377|NCT01255670|26726886|P2|Overall Study|Adverse Event|10
7684378|NCT01255670|26726887|P1|Overall Study|Adverse Event|10
7684379|NCT01255631|26726897|P2|Overall Study|poor enrollment, no data analyzed|6
7684380|NCT01255631|26726898|P1|Overall Study|poor enrollment, no data analyzed|9
7684381|NCT01255592|26726916|P2|Overall Study|Other|1
7684382|NCT01255592|26726917|P1|Overall Study|Other|0
7684383|NCT01255592|26726916|P2|Overall Study|Withdrawal by Subject|0
7684384|NCT01255592|26726917|P1|Overall Study|Withdrawal by Subject|1
7684385|NCT01255592|26726916|P2|Overall Study|Adverse Event|0
7684386|NCT01255592|26726917|P1|Overall Study|Adverse Event|5
7684387|NCT01255436|26726980|P2|Overall Study|Death, stroke, or MI|3
7684388|NCT01255436|26726981|P1|Overall Study|Death, stroke, or MI|4
7684389|NCT01255436|26726980|P2|Overall Study|Lost to Follow-up|191
7684390|NCT01255436|26726981|P1|Overall Study|Lost to Follow-up|178
7684391|NCT01255423|26726995|P2|Overall Study|Use of prohibited medications|1
7684392|NCT01255423|26726996|P1|Overall Study|Use of prohibited medications|0
7684393|NCT01255423|26726995|P2|Overall Study|Abnormal Laboratory value|2
7684394|NCT01255423|26726996|P1|Overall Study|Abnormal Laboratory value|3
7684395|NCT01255306|26727012|P2|Overall Study|Physician Decision|1
7684396|NCT01255306|26727013|P1|Overall Study|Physician Decision|1
7684397|NCT01255163|26727024|P2|Overall Study|AstraZeneca stopped support of the study|3
7684398|NCT01255163|26727025|P1|Overall Study|AstraZeneca stopped support of the study|1
7684399|NCT01255163|26727024|P2|Overall Study|Adverse Event|2
7684400|NCT01255163|26727025|P1|Overall Study|Adverse Event|0
7684401|NCT01255163|26727024|P2|Overall Study|Lost to Follow-up|0
7684402|NCT01255163|26727025|P1|Overall Study|Lost to Follow-up|2
7684403|NCT01255163|26727024|P2|Overall Study|Withdrawal by Subject|0
7684404|NCT01255163|26727025|P1|Overall Study|Withdrawal by Subject|1
7684405|NCT01254890|26727054|P2|Overall Study|Disease Progression|5
7684406|NCT01254890|26727055|P1|Overall Study|Disease Progression|0
7684407|NCT01254890|26727054|P2|Overall Study|Withdrawal by Subject|2
7684408|NCT01254890|26727055|P1|Overall Study|Withdrawal by Subject|1
7684409|NCT01254890|26727054|P2|Overall Study|Ineligible|3
7684410|NCT01254890|26727055|P1|Overall Study|Ineligible|0
7684411|NCT01254747|26727117|P4|Overall Study|Discomfort|0
7684412|NCT01254747|26727118|P3|Overall Study|Discomfort|0
7684413|NCT01254747|26727119|P2|Overall Study|Discomfort|4
7684414|NCT01254747|26727120|P1|Overall Study|Discomfort|0
7684415|NCT01254747|26727117|P4|Overall Study|Biomicroscopy|0
7684416|NCT01254747|26727118|P3|Overall Study|Biomicroscopy|1
7684417|NCT01254747|26727119|P2|Overall Study|Biomicroscopy|0
7684418|NCT01254747|26727120|P1|Overall Study|Biomicroscopy|0
7684419|NCT01254747|26727117|P4|Overall Study|Lost to Follow-up|0
7684420|NCT01254747|26727118|P3|Overall Study|Lost to Follow-up|1
7684421|NCT01254747|26727119|P2|Overall Study|Lost to Follow-up|0
7684422|NCT01254747|26727120|P1|Overall Study|Lost to Follow-up|0
7684423|NCT01254747|26727117|P4|Overall Study|Symptoms and problems|0
7684424|NCT01254747|26727118|P3|Overall Study|Symptoms and problems|1
7684425|NCT01254747|26727119|P2|Overall Study|Symptoms and problems|2
7684426|NCT01254747|26727120|P1|Overall Study|Symptoms and problems|0
7684427|NCT01254747|26727117|P4|Overall Study|Difficult removal handling|0
7684428|NCT01254747|26727118|P3|Overall Study|Difficult removal handling|1
7684429|NCT01254747|26727119|P2|Overall Study|Difficult removal handling|0
7684430|NCT01254747|26727120|P1|Overall Study|Difficult removal handling|0
7684431|NCT01254747|26727117|P4|Overall Study|Unacceptable subjective vision|2
7684432|NCT01254747|26727118|P3|Overall Study|Unacceptable subjective vision|0
7684433|NCT01254747|26727119|P2|Overall Study|Unacceptable subjective vision|0
7684434|NCT01254747|26727120|P1|Overall Study|Unacceptable subjective vision|0
7684435|NCT01254721|26727160|P2|Overall Study|Wrongly randomization|1
7684436|NCT01254721|26727161|P1|Overall Study|Wrongly randomization|0
7684437|NCT01254721|26727160|P2|Overall Study|Withdrawal by Subject|11
7684438|NCT01254721|26727161|P1|Overall Study|Withdrawal by Subject|8
7684439|NCT01254721|26727160|P2|Overall Study|Adverse Event|3
7684440|NCT01254721|26727161|P1|Overall Study|Adverse Event|2
7684441|NCT01254721|26727160|P2|Overall Study|technical problum|0
7684442|NCT01254721|26727161|P1|Overall Study|technical problum|1
7684443|NCT01254721|26727160|P2|Overall Study|Death|1
7684444|NCT01254721|26727161|P1|Overall Study|Death|0
7684445|NCT01254721|26727160|P2|Overall Study|Lack of Efficacy|2
7684446|NCT01254721|26727161|P1|Overall Study|Lack of Efficacy|4
7684447|NCT01254721|26727160|P2|Overall Study|Lost to Follow-up|4
7684448|NCT01254721|26727161|P1|Overall Study|Lost to Follow-up|0
7684449|NCT01254669|26727171|P2|Overall Study|called to clinic during intervention|1
7684450|NCT01254669|26727172|P1|Overall Study|called to clinic during intervention|1
7684451|NCT01254669|26727171|P2|Overall Study|time constraint|2
7684452|NCT01254669|26727172|P1|Overall Study|time constraint|2
7684453|NCT01254669|26727171|P2|Overall Study|Withdrawal by Subject|1
7684454|NCT01254669|26727172|P1|Overall Study|Withdrawal by Subject|0
7684455|NCT01254656|26727183|P3|Overall Study|Death|0
7684456|NCT01254656|26727184|P2|Overall Study|Death|1
7684457|NCT01254656|26727185|P1|Overall Study|Death|0
7684458|NCT01254656|26727183|P3|Overall Study|Adverse Event|0
7684459|NCT01254656|26727184|P2|Overall Study|Adverse Event|1
7684460|NCT01254656|26727185|P1|Overall Study|Adverse Event|1
7684461|NCT01254656|26727183|P3|Overall Study|Pregnancy|2
7684462|NCT01254656|26727184|P2|Overall Study|Pregnancy|0
7684463|NCT01254656|26727185|P1|Overall Study|Pregnancy|0
7684464|NCT01254656|26727183|P3|Overall Study|Withdrawal by Subject|1
7684465|NCT01254656|26727184|P2|Overall Study|Withdrawal by Subject|2
7684466|NCT01254656|26727185|P1|Overall Study|Withdrawal by Subject|2
7684467|NCT01254656|26727183|P3|Overall Study|Lost to Follow-up|2
7684468|NCT01254656|26727184|P2|Overall Study|Lost to Follow-up|0
7684469|NCT01254656|26727185|P1|Overall Study|Lost to Follow-up|1
7684470|NCT01254656|26727183|P3|Overall Study|Lack of Efficacy|0
7684471|NCT01254656|26727184|P2|Overall Study|Lack of Efficacy|0
7684472|NCT01254656|26727185|P1|Overall Study|Lack of Efficacy|3
7684473|NCT01254656|26727183|P3|Overall Study|Discontinued due to termination of study|13
7684474|NCT01254656|26727184|P2|Overall Study|Discontinued due to termination of study|39
7684475|NCT01254656|26727185|P1|Overall Study|Discontinued due to termination of study|40
7684476|NCT01254643|26727211|P1|Overall Study|Withdrawal by Subject|1
7684477|NCT01254630|26727223|P4|Overall Study|Status not recorded|0
7684478|NCT01254630|26727224|P3|Overall Study|Status not recorded|1
7684479|NCT01254630|26727225|P2|Overall Study|Status not recorded|0
7684480|NCT01254630|26727226|P1|Overall Study|Status not recorded|0
7684481|NCT01254630|26727223|P4|Overall Study|Study terminated by sponsor|1010
7684482|NCT01254630|26727224|P3|Overall Study|Study terminated by sponsor|0
7684483|NCT01254630|26727225|P2|Overall Study|Study terminated by sponsor|994
7684484|NCT01254630|26727226|P1|Overall Study|Study terminated by sponsor|0
7684485|NCT01254630|26727223|P4|Overall Study|Withdrawal by Subject|89
7684486|NCT01254630|26727224|P3|Overall Study|Withdrawal by Subject|188
7684487|NCT01254630|26727225|P2|Overall Study|Withdrawal by Subject|94
7684488|NCT01254630|26727226|P1|Overall Study|Withdrawal by Subject|201
7684489|NCT01254630|26727223|P4|Overall Study|Physician Decision|7
7684490|NCT01254630|26727224|P3|Overall Study|Physician Decision|16
7684491|NCT01254630|26727225|P2|Overall Study|Physician Decision|8
7684492|NCT01254630|26727226|P1|Overall Study|Physician Decision|24
7684493|NCT01254630|26727223|P4|Overall Study|Lost to Follow-up|32
7684494|NCT01254630|26727224|P3|Overall Study|Lost to Follow-up|89
7684495|NCT01254630|26727225|P2|Overall Study|Lost to Follow-up|26
7684496|NCT01254630|26727226|P1|Overall Study|Lost to Follow-up|80
7684497|NCT01254630|26727223|P4|Overall Study|Death|139
7684498|NCT01254630|26727224|P3|Overall Study|Death|478
7684499|NCT01254630|26727225|P2|Overall Study|Death|151
7684500|NCT01254630|26727226|P1|Overall Study|Death|461
7684501|NCT01254630|26727223|P4|Overall Study|Adverse Event|8
7684502|NCT01254630|26727224|P3|Overall Study|Adverse Event|40
7684503|NCT01254630|26727225|P2|Overall Study|Adverse Event|15
7684504|NCT01254630|26727226|P1|Overall Study|Adverse Event|36
7684505|NCT01254604|26727246|P2|Overall Study|Adverse Event|2
7684506|NCT01254604|26727247|P1|Overall Study|Adverse Event|3
7684507|NCT01254604|26727246|P2|Overall Study|Withdrawal by Subject|4
7684508|NCT01254604|26727247|P1|Overall Study|Withdrawal by Subject|2
7684509|NCT01254604|26727246|P2|Overall Study|Protocol Violation|2
7684510|NCT01254604|26727247|P1|Overall Study|Protocol Violation|2
7684511|NCT01254604|26727246|P2|Overall Study|Lost to Follow-up|1
7684512|NCT01254604|26727247|P1|Overall Study|Lost to Follow-up|1
7684513|NCT01254565|26727265|P6|Overall Study|Other|0
7684514|NCT01254565|26727266|P5|Overall Study|Other|0
7684515|NCT01254565|26727267|P4|Overall Study|Other|1
7684516|NCT01254565|26727268|P3|Overall Study|Other|0
7684517|NCT01254565|26727269|P2|Overall Study|Other|0
7684518|NCT01254565|26727270|P1|Overall Study|Other|0
7684519|NCT01254565|26727265|P6|Overall Study|Did not Receive Treatment|4
7684520|NCT01254565|26727266|P5|Overall Study|Did not Receive Treatment|3
7684521|NCT01254565|26727267|P4|Overall Study|Did not Receive Treatment|0
7684522|NCT01254565|26727268|P3|Overall Study|Did not Receive Treatment|0
7684523|NCT01254565|26727269|P2|Overall Study|Did not Receive Treatment|1
7684524|NCT01254565|26727270|P1|Overall Study|Did not Receive Treatment|1
7684525|NCT01254565|26727265|P6|Overall Study|Non-compliance to Study Procedures|0
7684526|NCT01254565|26727266|P5|Overall Study|Non-compliance to Study Procedures|1
7684527|NCT01254565|26727267|P4|Overall Study|Non-compliance to Study Procedures|0
7684528|NCT01254565|26727268|P3|Overall Study|Non-compliance to Study Procedures|0
7684529|NCT01254565|26727269|P2|Overall Study|Non-compliance to Study Procedures|0
7684530|NCT01254565|26727270|P1|Overall Study|Non-compliance to Study Procedures|0
7684531|NCT01254422|26727330|P2|Overall Study|Lost to Follow-up|0
7684532|NCT01254422|26727331|P1|Overall Study|Lost to Follow-up|1
7684533|NCT01254422|26727330|P2|Overall Study|Serious adverse event|1
7684534|NCT01254422|26727331|P1|Overall Study|Serious adverse event|0
7684535|NCT01254422|26727330|P2|Overall Study|Adverse Event|0
7684536|NCT01254422|26727331|P1|Overall Study|Adverse Event|1
7684537|NCT01254422|26727330|P2|Overall Study|Protocol Violation|0
7684538|NCT01254422|26727331|P1|Overall Study|Protocol Violation|1
7684539|NCT01254409|26727359|P4|Overall Study|Adverse Event|0
7684540|NCT01254409|26727360|P3|Overall Study|Adverse Event|0
7684541|NCT01254409|26727361|P2|Overall Study|Adverse Event|1
7684542|NCT01254409|26727362|P1|Overall Study|Adverse Event|0
7684543|NCT01254344|26727431|P2|Overall Study|Withdrawal by Subject|6
7684544|NCT01254344|26727432|P1|Overall Study|Withdrawal by Subject|3
7684545|NCT01254344|26727431|P2|Overall Study|Protocol Violation|4
7684546|NCT01254344|26727432|P1|Overall Study|Protocol Violation|1
7684547|NCT01254344|26727431|P2|Overall Study|Physician Decision|4
7684548|NCT01254344|26727432|P1|Overall Study|Physician Decision|7
7684549|NCT01254344|26727431|P2|Overall Study|Adverse Event|5
7684550|NCT01254344|26727432|P1|Overall Study|Adverse Event|2
7684551|NCT01254331|26727440|P1|Extension Phase|Lost to Follow-up|3
7684552|NCT01254331|26727440|P1|Extension Phase|Lack of Efficacy|1
7684553|NCT01254331|26727440|P1|Initial Phase|Pregnancy|1
7684554|NCT01254331|26727440|P1|Initial Phase|Withdrawal by Subject|1
7684555|NCT01254331|26727440|P1|Initial Phase|Adverse Event|3
7684556|NCT01254318|26727458|P1|Overall Study|Death|47
7684557|NCT01254318|26727458|P1|Overall Study|Lost to Follow-up|5
7684558|NCT01254305|26727467|P3|Overall Study|Other Reasons|2
7684559|NCT01254305|26727468|P2|Overall Study|Other Reasons|0
7684560|NCT01254305|26727469|P1|Overall Study|Other Reasons|0
7684561|NCT01254305|26727467|P3|Overall Study|Lost to Follow-up|5
7684562|NCT01254305|26727468|P2|Overall Study|Lost to Follow-up|6
7684563|NCT01254305|26727469|P1|Overall Study|Lost to Follow-up|10
7684564|NCT01254305|26727467|P3|Overall Study|Withdrawal by Subject|4
7684565|NCT01254305|26727468|P2|Overall Study|Withdrawal by Subject|2
7684566|NCT01254305|26727469|P1|Overall Study|Withdrawal by Subject|4
7684567|NCT01254305|26727467|P3|Overall Study|Protocol Violation|3
7684568|NCT01254305|26727468|P2|Overall Study|Protocol Violation|7
7684569|NCT01254305|26727469|P1|Overall Study|Protocol Violation|1
7684570|NCT01254305|26727467|P3|Overall Study|Lack of Efficacy|1
7684571|NCT01254305|26727468|P2|Overall Study|Lack of Efficacy|0
7684572|NCT01254305|26727469|P1|Overall Study|Lack of Efficacy|1
7684573|NCT01254305|26727467|P3|Overall Study|Adverse Event|2
7684574|NCT01254305|26727468|P2|Overall Study|Adverse Event|3
7684575|NCT01254305|26727469|P1|Overall Study|Adverse Event|6
7684576|NCT01254292|26727485|P2|LCS12 Extension Phase|Lost to Follow-up|0
7684577|NCT01254292|26727486|P1|LCS12 Extension Phase|Lost to Follow-up|1
7684578|NCT01254292|26727485|P2|LCS12 Extension Phase|Pregnancy|0
7684579|NCT01254292|26727486|P1|LCS12 Extension Phase|Pregnancy|2
7684580|NCT01254292|26727485|P2|LCS12 Extension Phase|Other unknown|0
7684581|NCT01254292|26727486|P1|LCS12 Extension Phase|Other unknown|4
7684582|NCT01254292|26727485|P2|LCS12 Extension Phase|Withdrawal by Subject|0
7684583|NCT01254292|26727486|P1|LCS12 Extension Phase|Withdrawal by Subject|7
7684584|NCT01254292|26727485|P2|LCS12 Extension Phase|Adverse Event|0
7684585|NCT01254292|26727486|P1|LCS12 Extension Phase|Adverse Event|9
7684586|NCT01254292|26727485|P2|LCS12 Extension Phase|Wish for pregnancy|0
7684587|NCT01254292|26727486|P1|LCS12 Extension Phase|Wish for pregnancy|14
7684588|NCT01254292|26727485|P2|Comparative Phase|Wish for pregnancy|6
7684589|NCT01254292|26727486|P1|Comparative Phase|Wish for pregnancy|4
7684590|NCT01254292|26727485|P2|Comparative Phase|Protocol Violation|2
7684591|NCT01254292|26727486|P1|Comparative Phase|Protocol Violation|1
7684592|NCT01254292|26727485|P2|Comparative Phase|Withdrawal by Subject|21
7684593|NCT01254292|26727486|P1|Comparative Phase|Withdrawal by Subject|20
7684594|NCT01254292|26727485|P2|Comparative Phase|Pregnancy|6
7684595|NCT01254292|26727486|P1|Comparative Phase|Pregnancy|2
7684596|NCT01254292|26727485|P2|Comparative Phase|Lost to Follow-up|21
7684597|NCT01254292|26727486|P1|Comparative Phase|Lost to Follow-up|3
7684598|NCT01254292|26727485|P2|Comparative Phase|Adverse Event|25
7684599|NCT01254292|26727486|P1|Comparative Phase|Adverse Event|25
7684600|NCT01254227|26727546|P1|Overall Study|Protocol deviation|1
7684601|NCT01254227|26727546|P1|Overall Study|Death|1
7684602|NCT01254227|26727546|P1|Overall Study|Administrative problems|2
7684603|NCT01254227|26727546|P1|Overall Study|Abnormal test procedure result|5
7684604|NCT01254227|26727546|P1|Overall Study|Adverse Event|5
7684605|NCT01254227|26727546|P1|Overall Study|Lost to Follow-up|6
7684606|NCT01254227|26727546|P1|Overall Study|Withdrawal by Subject|6
7684607|NCT01254188|26727573|P1|Overall Study|per investigator discretion|20
7684608|NCT01254188|26727573|P1|Overall Study|Adverse Event|43
7684609|NCT01254188|26727573|P1|Overall Study|Withdrawal by Subject|7
7684610|NCT01254188|26727573|P1|Overall Study|Lost to Follow-up|5
7684611|NCT01254188|26727573|P1|Overall Study|Death|4
7684612|NCT01254188|26727573|P1|Overall Study|Pregnancy|2
7684613|NCT01254188|26727573|P1|Overall Study|Protocol Violation|6
7684614|NCT01254188|26727573|P1|Overall Study|Disease Progression|6
7684615|NCT01254045|26727584|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7684616|NCT01254045|26727585|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7684617|NCT01254045|26727586|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7684618|NCT01254045|26727587|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7684619|NCT01254045|26727588|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7684620|NCT01254045|26727589|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
7684621|NCT01254019|26727602|P2|Overall Study|Withdrawal by Subject|2
7684622|NCT01254019|26727603|P1|Overall Study|Withdrawal by Subject|0
7684623|NCT01254019|26727602|P2|Overall Study|Protocol Violation|0
7684624|NCT01254019|26727603|P1|Overall Study|Protocol Violation|1
7684625|NCT01254019|26727602|P2|Overall Study|Adverse Event|2
7684626|NCT01254019|26727603|P1|Overall Study|Adverse Event|0
7684627|NCT01253811|26727697|P1|Overall Study|Withdrawal criteria|1
7684628|NCT01253577|26727741|P1|Overall Study|Lost to Follow-up|3
7684629|NCT01253564|26727749|P1|Overall Study|Serious Adverse Event|1
7684630|NCT01253564|26727749|P1|Overall Study|Withdrawal by Subject|1
7684631|NCT01253564|26727749|P1|Overall Study|Disease Progression|22
7684632|NCT01253447|26727798|P1|Overall Study|Adverse Event|2
7684633|NCT01253421|26727808|P5|Drug+Scanning Visit|Physician Decision|1
7684634|NCT01253421|26727809|P4|Drug+Scanning Visit|Physician Decision|0
7684635|NCT01253421|26727810|P3|Drug+Scanning Visit|Physician Decision|0
7684636|NCT01253421|26727811|P2|Drug+Scanning Visit|Physician Decision|0
7684637|NCT01253421|26727812|P1|Drug+Scanning Visit|Physician Decision|0
7684638|NCT01253421|26727808|P5|Assessment and Scheduling|Physician Decision|0
7684639|NCT01253421|26727809|P4|Assessment and Scheduling|Physician Decision|0
7684640|NCT01253421|26727810|P3|Assessment and Scheduling|Physician Decision|0
7684641|NCT01253421|26727811|P2|Assessment and Scheduling|Physician Decision|0
7684642|NCT01253421|26727812|P1|Assessment and Scheduling|Physician Decision|1
7684643|NCT01253421|26727808|P5|Assessment and Scheduling|Withdrawal by Subject|0
7684644|NCT01253421|26727809|P4|Assessment and Scheduling|Withdrawal by Subject|0
7684645|NCT01253421|26727810|P3|Assessment and Scheduling|Withdrawal by Subject|0
7684646|NCT01253421|26727811|P2|Assessment and Scheduling|Withdrawal by Subject|0
7684647|NCT01253421|26727812|P1|Assessment and Scheduling|Withdrawal by Subject|7
7684648|NCT01253421|26727808|P5|Assessment and Scheduling|Lost to Follow-up|0
7684649|NCT01253421|26727809|P4|Assessment and Scheduling|Lost to Follow-up|0
7684650|NCT01253421|26727810|P3|Assessment and Scheduling|Lost to Follow-up|0
7684651|NCT01253421|26727811|P2|Assessment and Scheduling|Lost to Follow-up|0
7684652|NCT01253421|26727812|P1|Assessment and Scheduling|Lost to Follow-up|17
7684653|NCT01253421|26727808|P5|Assessment and Scheduling|Found to be Ineligible|0
7684654|NCT01253421|26727809|P4|Assessment and Scheduling|Found to be Ineligible|0
7684655|NCT01253421|26727810|P3|Assessment and Scheduling|Found to be Ineligible|0
7684656|NCT01253421|26727811|P2|Assessment and Scheduling|Found to be Ineligible|0
7684657|NCT01253421|26727812|P1|Assessment and Scheduling|Found to be Ineligible|74
7684658|NCT01253408|26727861|P3|Overall Study|Adverse Event|0
7684659|NCT01253408|26727862|P2|Overall Study|Adverse Event|1
7684660|NCT01253408|26727863|P1|Overall Study|Adverse Event|0
7684661|NCT01253369|26727886|P1|Overall Study|Not Evaluable|3
7684662|NCT01253369|26727886|P1|Overall Study|Progressive disease|23
7684663|NCT01253369|26727886|P1|Overall Study|Death|1
7684664|NCT01253369|26727886|P1|Overall Study|Withdrawal by Subject|2
7684665|NCT01253369|26727886|P1|Overall Study|Adverse Event|4
7684666|NCT01253317|26727916|P1|Overall Study|Adverse Event|2
7684667|NCT01253304|26727928|P4|Overall Study|Adverse Event|1
7684668|NCT01253304|26727929|P3|Overall Study|Adverse Event|0
7684669|NCT01253304|26727930|P2|Overall Study|Adverse Event|0
7684670|NCT01253304|26727931|P1|Overall Study|Adverse Event|0
7684671|NCT01253291|26727970|P5|Overall Study|Physician Decision|2
7684672|NCT01253291|26727971|P4|Overall Study|Physician Decision|0
7684673|NCT01253291|26727972|P3|Overall Study|Physician Decision|0
7684674|NCT01253291|26727973|P2|Overall Study|Physician Decision|0
7684675|NCT01253291|26727974|P1|Overall Study|Physician Decision|2
7684676|NCT01253291|26727970|P5|Overall Study|Lack of Efficacy|0
7684677|NCT01253291|26727971|P4|Overall Study|Lack of Efficacy|0
7684678|NCT01253291|26727972|P3|Overall Study|Lack of Efficacy|0
7684679|NCT01253291|26727973|P2|Overall Study|Lack of Efficacy|0
7684680|NCT01253291|26727974|P1|Overall Study|Lack of Efficacy|1
7684681|NCT01253291|26727970|P5|Overall Study|Adverse Event|0
7684682|NCT01253291|26727971|P4|Overall Study|Adverse Event|0
7684683|NCT01253291|26727972|P3|Overall Study|Adverse Event|0
7684684|NCT01253291|26727973|P2|Overall Study|Adverse Event|1
7684685|NCT01253291|26727974|P1|Overall Study|Adverse Event|0
7684686|NCT01253291|26727970|P5|Overall Study|Withdrawal by Subject|0
7684687|NCT01253291|26727971|P4|Overall Study|Withdrawal by Subject|0
7684688|NCT01253291|26727972|P3|Overall Study|Withdrawal by Subject|0
7684689|NCT01253291|26727973|P2|Overall Study|Withdrawal by Subject|1
7684690|NCT01253291|26727974|P1|Overall Study|Withdrawal by Subject|1
7684691|NCT01253265|26727998|P5|Overall Study|Withdrawal by Subject|1
7684692|NCT01253265|26727999|P4|Overall Study|Withdrawal by Subject|0
7684693|NCT01253265|26728000|P3|Overall Study|Withdrawal by Subject|0
7684694|NCT01253265|26728001|P2|Overall Study|Withdrawal by Subject|0
7684695|NCT01253265|26728002|P1|Overall Study|Withdrawal by Subject|0
7684696|NCT01253265|26727998|P5|Overall Study|Met Predefined Discontinuation Criteria|0
7684697|NCT01253265|26727999|P4|Overall Study|Met Predefined Discontinuation Criteria|0
7684698|NCT01253265|26728000|P3|Overall Study|Met Predefined Discontinuation Criteria|0
7684699|NCT01253265|26728001|P2|Overall Study|Met Predefined Discontinuation Criteria|0
7684700|NCT01253265|26728002|P1|Overall Study|Met Predefined Discontinuation Criteria|1
7684701|NCT01253226|26728051|P5|Overall Study|Withdrawal by Subject|0
7684702|NCT01253226|26728052|P4|Overall Study|Withdrawal by Subject|1
7684703|NCT01253226|26728053|P3|Overall Study|Withdrawal by Subject|0
7684704|NCT01253226|26728054|P2|Overall Study|Withdrawal by Subject|0
7684705|NCT01253226|26728055|P1|Overall Study|Withdrawal by Subject|0
7684706|NCT01253226|26728051|P5|Overall Study|Physician Decision|2
7684707|NCT01253226|26728052|P4|Overall Study|Physician Decision|0
7684708|NCT01253226|26728053|P3|Overall Study|Physician Decision|0
7684709|NCT01253226|26728054|P2|Overall Study|Physician Decision|0
7684710|NCT01253226|26728055|P1|Overall Study|Physician Decision|0
7684711|NCT01253226|26728051|P5|Overall Study|Death|0
7684712|NCT01253226|26728052|P4|Overall Study|Death|0
7684713|NCT01253226|26728053|P3|Overall Study|Death|0
7684714|NCT01253226|26728054|P2|Overall Study|Death|1
7684715|NCT01253226|26728055|P1|Overall Study|Death|0
7684716|NCT01253226|26728051|P5|Overall Study|Adverse Event|0
7684717|NCT01253226|26728052|P4|Overall Study|Adverse Event|0
7684718|NCT01253226|26728053|P3|Overall Study|Adverse Event|1
7684719|NCT01253226|26728054|P2|Overall Study|Adverse Event|0
7684720|NCT01253226|26728055|P1|Overall Study|Adverse Event|0
7684721|NCT01253200|26728115|P5|Overall Study|Attempts|0
7684722|NCT01253200|26728116|P4|Overall Study|Attempts|2
7684723|NCT01253200|26728117|P3|Overall Study|Attempts|1
7684724|NCT01253200|26728118|P2|Overall Study|Attempts|4
7684725|NCT01253200|26728119|P1|Overall Study|Attempts|6
7684726|NCT01253200|26728115|P5|Overall Study|intents|0
7684727|NCT01253200|26728116|P4|Overall Study|intents|3
7684728|NCT01253200|26728117|P3|Overall Study|intents|1
7684729|NCT01253200|26728118|P2|Overall Study|intents|10
7684730|NCT01253200|26728119|P1|Overall Study|intents|10
7684731|NCT01253200|26728115|P5|Overall Study|Protocol Violation|5
7684732|NCT01253200|26728116|P4|Overall Study|Protocol Violation|0
7684733|NCT01253200|26728117|P3|Overall Study|Protocol Violation|0
7684734|NCT01253200|26728118|P2|Overall Study|Protocol Violation|4
7684735|NCT01253200|26728119|P1|Overall Study|Protocol Violation|1
7684736|NCT01253200|26728115|P5|Overall Study|Withdrawal by Subject|0
7684737|NCT01253200|26728116|P4|Overall Study|Withdrawal by Subject|0
7684738|NCT01253200|26728117|P3|Overall Study|Withdrawal by Subject|0
7684739|NCT01253200|26728118|P2|Overall Study|Withdrawal by Subject|0
7684740|NCT01253200|26728119|P1|Overall Study|Withdrawal by Subject|2
7684741|NCT01253200|26728115|P5|Overall Study|Lost to Follow-up|0
7684742|NCT01253200|26728116|P4|Overall Study|Lost to Follow-up|0
7684743|NCT01253200|26728117|P3|Overall Study|Lost to Follow-up|0
7684744|NCT01253200|26728118|P2|Overall Study|Lost to Follow-up|1
7684745|NCT01253200|26728119|P1|Overall Study|Lost to Follow-up|1
7684746|NCT01253200|26728115|P5|Overall Study|Death|0
7684747|NCT01253200|26728116|P4|Overall Study|Death|0
7684748|NCT01253200|26728117|P3|Overall Study|Death|0
7684749|NCT01253200|26728118|P2|Overall Study|Death|0
7684750|NCT01253200|26728119|P1|Overall Study|Death|1
7684751|NCT01253187|26728134|P6|Period 3|non-compliance|0
7684752|NCT01253187|26728135|P5|Period 3|non-compliance|1
7684753|NCT01253187|26728136|P4|Period 3|non-compliance|0
7684754|NCT01253187|26728137|P3|Period 3|non-compliance|0
7684755|NCT01253187|26728138|P2|Period 3|non-compliance|0
7684756|NCT01253187|26728139|P1|Period 3|non-compliance|0
7684757|NCT01253187|26728134|P6|Period 3|difficulty with blood sampling|0
7684758|NCT01253187|26728135|P5|Period 3|difficulty with blood sampling|0
7684759|NCT01253187|26728136|P4|Period 3|difficulty with blood sampling|0
7684760|NCT01253187|26728137|P3|Period 3|difficulty with blood sampling|0
7684761|NCT01253187|26728138|P2|Period 3|difficulty with blood sampling|1
7684762|NCT01253187|26728139|P1|Period 3|difficulty with blood sampling|0
7684763|NCT01253187|26728134|P6|Period 3|Pregnancy|0
7684764|NCT01253187|26728135|P5|Period 3|Pregnancy|0
7684765|NCT01253187|26728136|P4|Period 3|Pregnancy|0
7684766|NCT01253187|26728137|P3|Period 3|Pregnancy|0
7684767|NCT01253187|26728138|P2|Period 3|Pregnancy|0
7684768|NCT01253187|26728139|P1|Period 3|Pregnancy|1
7684769|NCT01253187|26728134|P6|Period 2|Withdrawal by Subject|0
7684770|NCT01253187|26728135|P5|Period 2|Withdrawal by Subject|1
7684771|NCT01253187|26728136|P4|Period 2|Withdrawal by Subject|0
7684772|NCT01253187|26728137|P3|Period 2|Withdrawal by Subject|0
7684773|NCT01253187|26728138|P2|Period 2|Withdrawal by Subject|0
7684774|NCT01253187|26728139|P1|Period 2|Withdrawal by Subject|0
7684775|NCT01253174|26728168|P6|Period 3|Pregnancy|0
7684776|NCT01253174|26728169|P5|Period 3|Pregnancy|0
7684777|NCT01253174|26728170|P4|Period 3|Pregnancy|0
7684778|NCT01253174|26728171|P3|Period 3|Pregnancy|1
7684779|NCT01253174|26728172|P2|Period 3|Pregnancy|0
7684780|NCT01253174|26728173|P1|Period 3|Pregnancy|0
7684781|NCT01253174|26728168|P6|Period 3|Withdrawal by Subject|0
7684782|NCT01253174|26728169|P5|Period 3|Withdrawal by Subject|1
7684783|NCT01253174|26728170|P4|Period 3|Withdrawal by Subject|0
7684784|NCT01253174|26728171|P3|Period 3|Withdrawal by Subject|0
7684785|NCT01253174|26728172|P2|Period 3|Withdrawal by Subject|1
7684786|NCT01253174|26728173|P1|Period 3|Withdrawal by Subject|0
7684787|NCT01253174|26728168|P6|Period 2|Adverse Event|0
7684788|NCT01253174|26728169|P5|Period 2|Adverse Event|0
7684789|NCT01253174|26728170|P4|Period 2|Adverse Event|0
7684790|NCT01253174|26728171|P3|Period 2|Adverse Event|1
7684791|NCT01253174|26728172|P2|Period 2|Adverse Event|0
7684792|NCT01253174|26728173|P1|Period 2|Adverse Event|0
7684793|NCT01253174|26728168|P6|Period 1|Randomized but not treated|0
7684794|NCT01253174|26728169|P5|Period 1|Randomized but not treated|1
7684795|NCT01253174|26728170|P4|Period 1|Randomized but not treated|0
7684796|NCT01253174|26728171|P3|Period 1|Randomized but not treated|1
7684797|NCT01253174|26728172|P2|Period 1|Randomized but not treated|1
7684798|NCT01253174|26728173|P1|Period 1|Randomized but not treated|0
7684799|NCT01253135|26728208|P1|Amended Protocol|Non-compliance|1
7684800|NCT01253135|26728208|P1|Original Protocol|Protocol Amendment|15
7684801|NCT01253044|26728227|P2|Overall Study|Lost to Follow-up|29
7684802|NCT01253044|26728228|P1|Overall Study|Lost to Follow-up|38
7684803|NCT01253018|26728238|P2|Overall Study|Withdrawal by Subject|1
7684804|NCT01253018|26728239|P1|Overall Study|Withdrawal by Subject|1
7684805|NCT01253018|26728238|P2|Overall Study|Robot Repair Issues|0
7684806|NCT01253018|26728239|P1|Overall Study|Robot Repair Issues|2
7684807|NCT01253018|26728238|P2|Overall Study|Lost to Follow-up|1
7684808|NCT01253018|26728239|P1|Overall Study|Lost to Follow-up|1
7684809|NCT01252966|26728253|P2|Overall Study|Withdrawal by Subject|3
7684810|NCT01252966|26728254|P1|Overall Study|Withdrawal by Subject|7
7684811|NCT01252966|26728253|P2|Overall Study|Lost to Follow-up|10
7684812|NCT01252966|26728254|P1|Overall Study|Lost to Follow-up|16
7684817|NCT01252940|26728285|P2|Extension Phase|Withdrawal by Subject|1
7684818|NCT01252940|26728286|P1|Extension Phase|Withdrawal by Subject|1
7684819|NCT01252940|26728285|P2|Extension Phase|Subject Non-compliance|0
7684820|NCT01252940|26728286|P1|Extension Phase|Subject Non-compliance|1
7684821|NCT01252940|26728285|P2|Extension Phase|Physician Decision|1
7684822|NCT01252940|26728286|P1|Extension Phase|Physician Decision|0
7684823|NCT01252940|26728285|P2|Extension Phase|Lost to Follow-up|0
7684824|NCT01252940|26728286|P1|Extension Phase|Lost to Follow-up|5
7684825|NCT01252940|26728285|P2|Extension Phase|Lack of Efficacy|0
7684826|NCT01252940|26728286|P1|Extension Phase|Lack of Efficacy|1
7684827|NCT01252940|26728285|P2|Extension Phase|Adverse Event|1
7684828|NCT01252940|26728286|P1|Extension Phase|Adverse Event|2
7684829|NCT01252940|26728285|P2|Main Study Phase|Subject Non-compliance|1
7684830|NCT01252940|26728286|P1|Main Study Phase|Subject Non-compliance|1
7684831|NCT01252940|26728285|P2|Main Study Phase|Withdrawal by Subject|5
7684832|NCT01252940|26728286|P1|Main Study Phase|Withdrawal by Subject|6
7684833|NCT01252940|26728285|P2|Main Study Phase|Protocol Violation|2
7684834|NCT01252940|26728286|P1|Main Study Phase|Protocol Violation|4
7684835|NCT01252940|26728285|P2|Main Study Phase|Physician Decision|0
7684836|NCT01252940|26728286|P1|Main Study Phase|Physician Decision|1
7684837|NCT01252940|26728285|P2|Main Study Phase|Lost to Follow-up|1
7684838|NCT01252940|26728286|P1|Main Study Phase|Lost to Follow-up|6
7684839|NCT01252940|26728285|P2|Main Study Phase|Lack of Efficacy|0
7684840|NCT01252940|26728286|P1|Main Study Phase|Lack of Efficacy|1
7684841|NCT01252940|26728285|P2|Main Study Phase|Adverse Event|1
7684842|NCT01252940|26728286|P1|Main Study Phase|Adverse Event|3
7684843|NCT01252940|26728285|P2|Main Study Phase|Randomized but not treated|2
7684844|NCT01252940|26728286|P1|Main Study Phase|Randomized but not treated|4
7684845|NCT01252810|26728317|P2|Overall Study|Various reasons|0
7684846|NCT01252810|26728318|P1|Overall Study|Various reasons|8
7684847|NCT01252810|26728317|P2|Overall Study|Physician Decision|1
7684848|NCT01252810|26728318|P1|Overall Study|Physician Decision|2
7684849|NCT01252810|26728317|P2|Overall Study|Lost to Follow-up|1
7684850|NCT01252810|26728318|P1|Overall Study|Lost to Follow-up|0
7684851|NCT01252810|26728317|P2|Overall Study|Withdrawal by Subject|1
7684852|NCT01252810|26728318|P1|Overall Study|Withdrawal by Subject|4
7684853|NCT01252667|26728366|P6|Overall Study|Transplant aborted post-conditioning|1
7684854|NCT01252667|26728367|P5|Overall Study|Transplant aborted post-conditioning|0
7684855|NCT01252667|26728368|P4|Overall Study|Transplant aborted post-conditioning|0
7684856|NCT01252667|26728369|P3|Overall Study|Transplant aborted post-conditioning|0
7684857|NCT01252667|26728370|P2|Overall Study|Transplant aborted post-conditioning|0
7684858|NCT01252667|26728371|P1|Overall Study|Transplant aborted post-conditioning|0
7684859|NCT01252563|26728433|P1|Overall Study|No drug administration|6
7684860|NCT01252563|26728433|P1|Overall Study|No visit after first day of treatment|194
7684861|NCT01252563|26728433|P1|Overall Study|Lost to Follow-up|161
7684862|NCT01252563|26728433|P1|Overall Study|Centralized Registration Deviation|30
7684863|NCT01252563|26728433|P1|Overall Study|Contract Deviation|41
7684864|NCT01252355|26728473|P3|Overall Study|Other Than Above|7
7684865|NCT01252355|26728474|P2|Overall Study|Other Than Above|7
7684866|NCT01252355|26728475|P1|Overall Study|Other Than Above|8
7684867|NCT01252355|26728473|P3|Overall Study|Randomized but not Treated|0
7684868|NCT01252355|26728474|P2|Overall Study|Randomized but not Treated|0
7684869|NCT01252355|26728475|P1|Overall Study|Randomized but not Treated|2
7684870|NCT01252355|26728473|P3|Overall Study|Sponsor Early Termination of Study|146
7684871|NCT01252355|26728474|P2|Overall Study|Sponsor Early Termination of Study|149
7684872|NCT01252355|26728475|P1|Overall Study|Sponsor Early Termination of Study|149
7684873|NCT01252355|26728473|P3|Overall Study|Progressive Disease|0
7684874|NCT01252355|26728474|P2|Overall Study|Progressive Disease|0
7684875|NCT01252355|26728475|P1|Overall Study|Progressive Disease|2
7684876|NCT01252355|26728473|P3|Overall Study|Poor Compliance to Protocol|1
7684877|NCT01252355|26728474|P2|Overall Study|Poor Compliance to Protocol|1
7684878|NCT01252355|26728475|P1|Overall Study|Poor Compliance to Protocol|1
7684879|NCT01252355|26728473|P3|Overall Study|Lost to Follow-up|1
7684880|NCT01252355|26728474|P2|Overall Study|Lost to Follow-up|0
7684881|NCT01252355|26728475|P1|Overall Study|Lost to Follow-up|0
7684882|NCT01252355|26728473|P3|Overall Study|Lack of Efficacy|2
7684883|NCT01252355|26728474|P2|Overall Study|Lack of Efficacy|4
7684884|NCT01252355|26728475|P1|Overall Study|Lack of Efficacy|6
7684885|NCT01252355|26728473|P3|Overall Study|Adverse Event|22
7684886|NCT01252355|26728474|P2|Overall Study|Adverse Event|17
7684887|NCT01252355|26728475|P1|Overall Study|Adverse Event|9
7684888|NCT01252290|26728513|P1|Overall Study|Withdrawal by Subject|1
7684889|NCT01252251|26728529|P1|Overall Study|Withdrawal by Subject|1
7684890|NCT01252238|26728541|P3|Overall Study|Sponsor terminated study|4
7684891|NCT01252238|26728542|P2|Overall Study|Sponsor terminated study|4
7684892|NCT01252238|26728543|P1|Overall Study|Sponsor terminated study|4
7684893|NCT01252186|26728560|P3|Overall Study|Other - Miscellaneous Reasons|7
7684894|NCT01252186|26728561|P2|Overall Study|Other - Miscellaneous Reasons|5
7684895|NCT01252186|26728562|P1|Overall Study|Other - Miscellaneous Reasons|5
7684896|NCT01252186|26728560|P3|Overall Study|Lost to Follow-up|11
7684897|NCT01252186|26728561|P2|Overall Study|Lost to Follow-up|10
7684898|NCT01252186|26728562|P1|Overall Study|Lost to Follow-up|10
7684899|NCT01252186|26728560|P3|Overall Study|Sponsor Request|0
7684900|NCT01252186|26728561|P2|Overall Study|Sponsor Request|1
7684901|NCT01252186|26728562|P1|Overall Study|Sponsor Request|2
7684902|NCT01252186|26728560|P3|Overall Study|Pregnancy|0
7684903|NCT01252186|26728561|P2|Overall Study|Pregnancy|2
7684904|NCT01252186|26728562|P1|Overall Study|Pregnancy|2
7684905|NCT01252186|26728560|P3|Overall Study|Protocol Violation|1
7684906|NCT01252186|26728561|P2|Overall Study|Protocol Violation|0
7684907|NCT01252186|26728562|P1|Overall Study|Protocol Violation|0
7684908|NCT01252186|26728560|P3|Overall Study|Non-compliance|4
7684909|NCT01252186|26728561|P2|Overall Study|Non-compliance|3
7684910|NCT01252186|26728562|P1|Overall Study|Non-compliance|0
7684911|NCT01252186|26728560|P3|Overall Study|Physician Decision|1
7684912|NCT01252186|26728561|P2|Overall Study|Physician Decision|0
7684913|NCT01252186|26728562|P1|Overall Study|Physician Decision|0
7684914|NCT01252186|26728560|P3|Overall Study|Withdrawal by Subject|2
7684915|NCT01252186|26728561|P2|Overall Study|Withdrawal by Subject|5
7684916|NCT01252186|26728562|P1|Overall Study|Withdrawal by Subject|2
7684917|NCT01252186|26728560|P3|Overall Study|Adverse Event|8
7684918|NCT01252186|26728561|P2|Overall Study|Adverse Event|6
7684919|NCT01252186|26728562|P1|Overall Study|Adverse Event|9
7684920|NCT01252134|26728635|P6|Period 1, 8 Hours|Personal Reasons|0
7684921|NCT01252134|26728636|P5|Period 1, 8 Hours|Personal Reasons|0
7684922|NCT01252134|26728637|P4|Period 1, 8 Hours|Personal Reasons|0
7684923|NCT01252134|26728638|P3|Period 1, 8 Hours|Personal Reasons|1
7684924|NCT01252134|26728639|P2|Period 1, 8 Hours|Personal Reasons|1
7684925|NCT01252134|26728640|P1|Period 1, 8 Hours|Personal Reasons|0
7684926|NCT01252095|26728659|P2|Overall Study|Disease progression|0
7684927|NCT01252095|26728660|P1|Overall Study|Disease progression|1
7684928|NCT01251965|26728681|P3|Overall Study|Death|11
7684929|NCT01251965|26728682|P2|Overall Study|Death|0
7684930|NCT01251965|26728683|P1|Overall Study|Death|0
7684931|NCT01251965|26728681|P3|Overall Study|Participant/physician decision|0
7684932|NCT01251965|26728682|P2|Overall Study|Participant/physician decision|2
7684933|NCT01251965|26728683|P1|Overall Study|Participant/physician decision|1
7684934|NCT01251952|26728695|P1|Overall Study|Adverse Event|1
7684935|NCT01251887|26728702|P3|Overall Study|Physician Decision|0
7684936|NCT01251887|26728703|P2|Overall Study|Physician Decision|1
7684937|NCT01251887|26728704|P1|Overall Study|Physician Decision|0
7684938|NCT01251887|26728702|P3|Overall Study|Scheduling conflict|2
7684939|NCT01251887|26728703|P2|Overall Study|Scheduling conflict|2
7684940|NCT01251887|26728704|P1|Overall Study|Scheduling conflict|1
7684941|NCT01251861|26728759|P2|Overall Study|Potential interaction of drugs|1
7684942|NCT01251861|26728760|P1|Overall Study|Potential interaction of drugs|0
7684943|NCT01251861|26728759|P2|Overall Study|Never started therapy|1
7684944|NCT01251861|26728760|P1|Overall Study|Never started therapy|4
7684945|NCT01251861|26728759|P2|Overall Study|Other|0
7684946|NCT01251861|26728760|P1|Overall Study|Other|1
7684947|NCT01251861|26728759|P2|Overall Study|Continued treatment beyond 18 cycles|0
7684948|NCT01251861|26728760|P1|Overall Study|Continued treatment beyond 18 cycles|1
7684949|NCT01251861|26728759|P2|Overall Study|Physician Decision|0
7684950|NCT01251861|26728760|P1|Overall Study|Physician Decision|1
7684951|NCT01251861|26728759|P2|Overall Study|Other complicating disease|1
7684952|NCT01251861|26728760|P1|Overall Study|Other complicating disease|0
7684953|NCT01251861|26728759|P2|Overall Study|Alternative therapy|0
7684954|NCT01251861|26728760|P1|Overall Study|Alternative therapy|1
7684955|NCT01251861|26728759|P2|Overall Study|Withdrawal by Subject|2
7684956|NCT01251861|26728760|P1|Overall Study|Withdrawal by Subject|2
7684957|NCT01251861|26728759|P2|Overall Study|Adverse Event|17
7684958|NCT01251861|26728760|P1|Overall Study|Adverse Event|2
7684959|NCT01251861|26728759|P2|Overall Study|Disease progression|6
7684960|NCT01251861|26728760|P1|Overall Study|Disease progression|6
7684961|NCT01251770|26728788|P2|Overall Study|Protocol Violation|7
7684962|NCT01251770|26728789|P1|Overall Study|Protocol Violation|13
7684963|NCT01251744|26728833|P2|Overall Study|Lost to Follow-up|0
7684964|NCT01251744|26728834|P1|Overall Study|Lost to Follow-up|1
7684965|NCT01251653|26728892|P9|Overall Study|Other reason not mentioned above|0
7684966|NCT01251653|26728893|P8|Overall Study|Other reason not mentioned above|2
7684967|NCT01251653|26728894|P7|Overall Study|Other reason not mentioned above|0
7684968|NCT01251653|26728895|P6|Overall Study|Other reason not mentioned above|0
7684969|NCT01251653|26728896|P5|Overall Study|Other reason not mentioned above|0
7684970|NCT01251653|26728897|P4|Overall Study|Other reason not mentioned above|0
7684971|NCT01251653|26728898|P3|Overall Study|Other reason not mentioned above|0
7684972|NCT01251653|26728899|P2|Overall Study|Other reason not mentioned above|0
7684973|NCT01251653|26728900|P1|Overall Study|Other reason not mentioned above|0
7684974|NCT01251653|26728892|P9|Overall Study|Withdrawal by Subject|0
7684975|NCT01251653|26728893|P8|Overall Study|Withdrawal by Subject|1
7684976|NCT01251653|26728894|P7|Overall Study|Withdrawal by Subject|0
7684977|NCT01251653|26728895|P6|Overall Study|Withdrawal by Subject|1
7684978|NCT01251653|26728896|P5|Overall Study|Withdrawal by Subject|1
7684979|NCT01251653|26728897|P4|Overall Study|Withdrawal by Subject|0
7684980|NCT01251653|26728898|P3|Overall Study|Withdrawal by Subject|1
7684981|NCT01251653|26728899|P2|Overall Study|Withdrawal by Subject|0
7684982|NCT01251653|26728900|P1|Overall Study|Withdrawal by Subject|1
7684983|NCT01251653|26728892|P9|Overall Study|Adverse Event|1
7684984|NCT01251653|26728893|P8|Overall Study|Adverse Event|2
7684985|NCT01251653|26728894|P7|Overall Study|Adverse Event|2
7684986|NCT01251653|26728895|P6|Overall Study|Adverse Event|0
7684987|NCT01251653|26728896|P5|Overall Study|Adverse Event|1
7684988|NCT01251653|26728897|P4|Overall Study|Adverse Event|1
7684989|NCT01251653|26728898|P3|Overall Study|Adverse Event|2
7684990|NCT01251653|26728899|P2|Overall Study|Adverse Event|0
7684991|NCT01251653|26728900|P1|Overall Study|Adverse Event|1
7684992|NCT01251653|26728892|P9|Overall Study|Dose-limiting toxicity|0
7684993|NCT01251653|26728893|P8|Overall Study|Dose-limiting toxicity|0
7684994|NCT01251653|26728894|P7|Overall Study|Dose-limiting toxicity|2
7684995|NCT01251653|26728895|P6|Overall Study|Dose-limiting toxicity|0
7684996|NCT01251653|26728896|P5|Overall Study|Dose-limiting toxicity|0
7684997|NCT01251653|26728897|P4|Overall Study|Dose-limiting toxicity|1
7684998|NCT01251653|26728898|P3|Overall Study|Dose-limiting toxicity|1
7684999|NCT01251653|26728899|P2|Overall Study|Dose-limiting toxicity|1
7685000|NCT01251653|26728900|P1|Overall Study|Dose-limiting toxicity|0
7685001|NCT01251653|26728892|P9|Overall Study|Progressive Disease|5
7685002|NCT01251653|26728893|P8|Overall Study|Progressive Disease|7
7685003|NCT01251653|26728894|P7|Overall Study|Progressive Disease|14
7685004|NCT01251653|26728895|P6|Overall Study|Progressive Disease|17
7685005|NCT01251653|26728896|P5|Overall Study|Progressive Disease|0
7685006|NCT01251653|26728897|P4|Overall Study|Progressive Disease|4
7685007|NCT01251653|26728898|P3|Overall Study|Progressive Disease|16
7685008|NCT01251653|26728899|P2|Overall Study|Progressive Disease|7
7685009|NCT01251653|26728900|P1|Overall Study|Progressive Disease|1
7685010|NCT01251614|26729028|P3|Overall Study|Lost to Follow-up|0
7685011|NCT01251614|26729029|P2|Overall Study|Lost to Follow-up|1
7685012|NCT01251614|26729030|P1|Overall Study|Lost to Follow-up|0
7685013|NCT01251614|26729028|P3|Overall Study|Withdrawal by Subject|1
7685014|NCT01251614|26729029|P2|Overall Study|Withdrawal by Subject|2
7685015|NCT01251614|26729030|P1|Overall Study|Withdrawal by Subject|0
7685016|NCT01251614|26729028|P3|Overall Study|Loss of Disease Control|0
7685017|NCT01251614|26729029|P2|Overall Study|Loss of Disease Control|1
7685018|NCT01251614|26729030|P1|Overall Study|Loss of Disease Control|0
7685019|NCT01251614|26729028|P3|Overall Study|Pregnancy|2
7685020|NCT01251614|26729029|P2|Overall Study|Pregnancy|0
7685021|NCT01251614|26729030|P1|Overall Study|Pregnancy|0
7685022|NCT01251614|26729028|P3|Overall Study|Clearing of Psoriatic Lesions|0
7685023|NCT01251614|26729029|P2|Overall Study|Clearing of Psoriatic Lesions|0
7685024|NCT01251614|26729030|P1|Overall Study|Clearing of Psoriatic Lesions|1
7685025|NCT01251614|26729028|P3|Overall Study|Lack of Efficacy|4
7685026|NCT01251614|26729029|P2|Overall Study|Lack of Efficacy|9
7685027|NCT01251614|26729030|P1|Overall Study|Lack of Efficacy|1
7685028|NCT01251614|26729028|P3|Overall Study|Adverse Event|1
7685029|NCT01251614|26729029|P2|Overall Study|Adverse Event|0
7685030|NCT01251614|26729030|P1|Overall Study|Adverse Event|1
7685031|NCT01251380|26729228|P1|Overall Study|Lost to Follow-up|2
7685032|NCT01251380|26729228|P1|Overall Study|Adverse Event|1
7685033|NCT01251380|26729228|P1|Overall Study|Lack of Efficacy|1
7685034|NCT01251380|26729228|P1|Overall Study|Withdrawal by Subject|6
7685035|NCT01251380|26729228|P1|Overall Study|Other (Not otherwise specified)|12
7685036|NCT01251367|26729252|P1|Overall Study|End of Study Visit Performed in Error|1
7685037|NCT01251367|26729252|P1|Overall Study|Subject had Personal or Medical Issues|4
7685038|NCT01251367|26729252|P1|Overall Study|No Study Drug Available|1
7685039|NCT01251367|26729252|P1|Overall Study|Subject Required Alternative Treatment|7
7685040|NCT01251367|26729252|P1|Overall Study|Lost to Follow-up|5
7685041|NCT01251367|26729252|P1|Overall Study|Withdrawal by Subject|36
7685042|NCT01251367|26729252|P1|Overall Study|Adverse Event|19
7685043|NCT01251367|26729252|P1|Overall Study|Lack of Efficacy|2
7685044|NCT01251367|26729252|P1|Overall Study|Protocol Violation|1
7685045|NCT01251354|26729287|P1|Overall Study|Disease Progression|4
7685046|NCT01251354|26729287|P1|Overall Study|Investigator's Decision|1
7685047|NCT01251354|26729287|P1|Overall Study|Adverse Event|1
7685048|NCT01251276|26729330|P2|Overall Study|Lost to Follow-up|1
7685049|NCT01251276|26729331|P1|Overall Study|Lost to Follow-up|0
7685050|NCT01251276|26729330|P2|Overall Study|Protocol Violation|0
7685051|NCT01251276|26729331|P1|Overall Study|Protocol Violation|1
7685052|NCT01251146|26729349|P2|Overall Study|Lost to Follow-up|10
7685053|NCT01251146|26729350|P1|Overall Study|Lost to Follow-up|3
7685054|NCT01251120|26729372|P2|Overall Study|Lack of Efficacy|1
7685055|NCT01251120|26729373|P1|Overall Study|Lack of Efficacy|0
7685056|NCT01250925|26729453|P3|Overall Study|Adverse Event|1
7685057|NCT01250925|26729454|P2|Overall Study|Adverse Event|0
7685058|NCT01250925|26729455|P1|Overall Study|Adverse Event|0
7685059|NCT01250925|26729453|P3|Overall Study|Physician Decision|1
7685060|NCT01250925|26729454|P2|Overall Study|Physician Decision|2
7685061|NCT01250925|26729455|P1|Overall Study|Physician Decision|0
7685062|NCT01250925|26729453|P3|Overall Study|Protocol Violation|0
7685063|NCT01250925|26729454|P2|Overall Study|Protocol Violation|0
7685064|NCT01250925|26729455|P1|Overall Study|Protocol Violation|2
7685065|NCT01250925|26729453|P3|Overall Study|Withdrawal by Subject|0
7685066|NCT01250925|26729454|P2|Overall Study|Withdrawal by Subject|0
7685067|NCT01250925|26729455|P1|Overall Study|Withdrawal by Subject|2
7685068|NCT01250925|26729453|P3|Overall Study|Lost to Follow-up|0
7685069|NCT01250925|26729454|P2|Overall Study|Lost to Follow-up|1
7685070|NCT01250925|26729455|P1|Overall Study|Lost to Follow-up|1
7685071|NCT01250912|26729493|P1|Overall Study|Lost to Follow-up|1
7685072|NCT01250873|26729507|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
7685073|NCT01250873|26729507|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
7685074|NCT01250769|26729539|P4|Overall Study|Adverse Event|0
7685075|NCT01250769|26729540|P3|Overall Study|Adverse Event|1
7685076|NCT01250769|26729541|P2|Overall Study|Adverse Event|0
7685077|NCT01250769|26729542|P1|Overall Study|Adverse Event|0
7685078|NCT01250769|26729539|P4|Overall Study|Withdrawal by Subject|0
7685079|NCT01250769|26729540|P3|Overall Study|Withdrawal by Subject|1
7685080|NCT01250769|26729541|P2|Overall Study|Withdrawal by Subject|1
7685081|NCT01250769|26729542|P1|Overall Study|Withdrawal by Subject|0
7685082|NCT01250756|26729574|P2|After Toddler Dose|Adverse Event|1
7685083|NCT01250756|26729575|P1|After Toddler Dose|Adverse Event|0
7685084|NCT01250756|26729574|P2|Toddler Dose|Adverse Event|1
7685085|NCT01250756|26729575|P1|Toddler Dose|Adverse Event|0
7685086|NCT01250756|26729574|P2|After Infant Series|Other|1
7685087|NCT01250756|26729575|P1|After Infant Series|Other|2
7685088|NCT01250756|26729574|P2|After Infant Series|Withdrawal by Subject|1
7685089|NCT01250756|26729575|P1|After Infant Series|Withdrawal by Subject|4
7685090|NCT01250756|26729574|P2|After Infant Series|Adverse Event|2
7685091|NCT01250756|26729575|P1|After Infant Series|Adverse Event|5
7685092|NCT01250756|26729574|P2|Infant Series|Other|0
7685093|NCT01250756|26729575|P1|Infant Series|Other|22
7685094|NCT01250756|26729574|P2|Infant Series|Randomized, Not Vaccinated|2
7685095|NCT01250756|26729575|P1|Infant Series|Randomized, Not Vaccinated|2
7685096|NCT01250756|26729574|P2|Infant Series|Withdrawal by Subject|5
7685097|NCT01250756|26729575|P1|Infant Series|Withdrawal by Subject|4
7685098|NCT01250509|26729692|P2|Overall Study|Lost to Follow-up|2
7685099|NCT01250509|26729693|P1|Overall Study|Lost to Follow-up|5
7685100|NCT01250418|26729707|P2|Overall Study|monitor data failure|1
7685101|NCT01250418|26729708|P1|Overall Study|monitor data failure|1
7685102|NCT01250379|26729716|P2|Overall Study|Participant noncompliance|0
7685103|NCT01250379|26729717|P1|Overall Study|Participant noncompliance|2
7685104|NCT01250379|26729716|P2|Overall Study|Other|4
7685105|NCT01250379|26729717|P1|Overall Study|Other|0
7685106|NCT01250379|26729716|P2|Overall Study|Adverse Event|4
7685107|NCT01250379|26729717|P1|Overall Study|Adverse Event|5
7685108|NCT01250379|26729716|P2|Overall Study|Lost to Follow-up|6
7685109|NCT01250379|26729717|P1|Overall Study|Lost to Follow-up|9
7685110|NCT01250379|26729716|P2|Overall Study|Protocol Violation|8
7685111|NCT01250379|26729717|P1|Overall Study|Protocol Violation|2
7685112|NCT01250379|26729716|P2|Overall Study|Physician Decision|3
7685113|NCT01250379|26729717|P1|Overall Study|Physician Decision|11
7685114|NCT01250379|26729716|P2|Overall Study|Withdrawal by Subject|20
7685115|NCT01250379|26729717|P1|Overall Study|Withdrawal by Subject|32
7685116|NCT01250379|26729716|P2|Overall Study|Death|148
7685117|NCT01250379|26729717|P1|Overall Study|Death|141
7685118|NCT01250171|26729822|P3|Overall Study|Administrative reasons|0
7685119|NCT01250171|26729823|P2|Overall Study|Administrative reasons|0
7685120|NCT01250171|26729824|P1|Overall Study|Administrative reasons|1
7685121|NCT01250145|26729855|P2|Overall Study|Withdrawal by Subject|4
7685122|NCT01250145|26729856|P1|Overall Study|Withdrawal by Subject|0
7685123|NCT01250145|26729855|P2|Overall Study|Adverse Event|1
7685124|NCT01250145|26729856|P1|Overall Study|Adverse Event|2
7685125|NCT01250119|26729876|P2|Treatment Phase|Unknown reason|4
7685126|NCT01250119|26729877|P1|Treatment Phase|Unknown reason|0
7685127|NCT01250119|26729876|P2|Treatment Phase|Adverse Event|2
7685128|NCT01250119|26729877|P1|Treatment Phase|Adverse Event|0
7685129|NCT01250119|26729876|P2|Treatment Phase|Withdrawal by Subject|1
7685130|NCT01250119|26729877|P1|Treatment Phase|Withdrawal by Subject|0
7685131|NCT01250119|26729876|P2|Treatment Phase|Death|2
7685132|NCT01250119|26729877|P1|Treatment Phase|Death|0
7685133|NCT01250119|26729876|P2|Treatment Phase|Progressive Disease|32
7685134|NCT01250119|26729877|P1|Treatment Phase|Progressive Disease|0
7685135|NCT01250119|26729876|P2|Diagnostic Phase|Participants Not Tested|0
7685136|NCT01250119|26729877|P1|Diagnostic Phase|Participants Not Tested|44
7685137|NCT01250119|26729876|P2|Diagnostic Phase|Failed to Produce a Test Results|0
7685138|NCT01250119|26729877|P1|Diagnostic Phase|Failed to Produce a Test Results|69
7685139|NCT01250054|26729892|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
7685140|NCT01250054|26729893|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
7685141|NCT01250002|26729901|P2|Overall Study|Change to open surgical procedure|3
7685142|NCT01250002|26729902|P1|Overall Study|Change to open surgical procedure|4
7685143|NCT01249833|26729967|P2|Overall Study|Lost to Follow-up|1
7685144|NCT01249833|26729968|P1|Overall Study|Lost to Follow-up|0
7685145|NCT01249664|26729982|P2|Overall Study|Adverse Event|0
7685146|NCT01249664|26729983|P1|Overall Study|Adverse Event|1
7685147|NCT01249664|26729982|P2|Overall Study|Withdrawal by Subject|0
7685148|NCT01249664|26729983|P1|Overall Study|Withdrawal by Subject|5
7685149|NCT01249651|26730033|P1|Overall Study|Sponsor Decision|1
7685150|NCT01249651|26730033|P1|Overall Study|Protocol Violation|1
7685151|NCT01249651|26730033|P1|Overall Study|Adverse Event|1
7685152|NCT01249651|26730033|P1|Overall Study|Withdrawal by Subject|4
7685153|NCT01249417|26730062|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
7685154|NCT01249417|26730063|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
7685155|NCT01249417|26730064|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
7685156|NCT01249417|26730062|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
7685157|NCT01249417|26730063|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
7685158|NCT01249417|26730064|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
7685159|NCT01249417|26730062|P3|Treatment Phase - ITT Population|Adverse Event|1
7685160|NCT01249417|26730063|P2|Treatment Phase - ITT Population|Adverse Event|0
7685161|NCT01249417|26730064|P1|Treatment Phase - ITT Population|Adverse Event|0
7685162|NCT01249417|26730062|P3|Treatment Phase - ITT Population|Other|1
7685163|NCT01249417|26730063|P2|Treatment Phase - ITT Population|Other|0
7685164|NCT01249417|26730064|P1|Treatment Phase - ITT Population|Other|0
7685165|NCT01249417|26730062|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
7685166|NCT01249417|26730063|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
7685167|NCT01249417|26730064|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
7685168|NCT01249417|26730062|P3|Randomised Population|Study treatment not received|2
7685169|NCT01249417|26730063|P2|Randomised Population|Study treatment not received|0
7685170|NCT01249417|26730064|P1|Randomised Population|Study treatment not received|0
7685171|NCT01249404|26730081|P3|Overall Study|Non compliance to visit schedule|0
7685172|NCT01249404|26730082|P2|Overall Study|Non compliance to visit schedule|1
7685173|NCT01249404|26730083|P1|Overall Study|Non compliance to visit schedule|0
7685174|NCT01249404|26730081|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
7685175|NCT01249404|26730082|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
7685176|NCT01249404|26730083|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
7685177|NCT01249404|26730081|P3|Overall Study|Withdrawal by Subject|0
7685178|NCT01249404|26730082|P2|Overall Study|Withdrawal by Subject|2
7685179|NCT01249404|26730083|P1|Overall Study|Withdrawal by Subject|2
7685180|NCT01249404|26730081|P3|Overall Study|Adverse Event|2
7685181|NCT01249404|26730082|P2|Overall Study|Adverse Event|2
7685182|NCT01249404|26730083|P1|Overall Study|Adverse Event|2
7685183|NCT01249404|26730081|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
7685184|NCT01249404|26730082|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
7685185|NCT01249404|26730083|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
7685186|NCT01249404|26730081|P3|Overall Study|Study treatment not received|2
7685187|NCT01249404|26730082|P2|Overall Study|Study treatment not received|1
7685188|NCT01249404|26730083|P1|Overall Study|Study treatment not received|0
7685189|NCT01249365|26730160|P1|Overall Study|Lost to Follow-up|1
7685190|NCT01249274|26730168|P2|Overall Study|Received inpatient substance treatment|2
7685191|NCT01249274|26730169|P1|Overall Study|Received inpatient substance treatment|1
7685192|NCT01249274|26730168|P2|Overall Study|Lost to Follow-up|4
7685193|NCT01249274|26730169|P1|Overall Study|Lost to Follow-up|3
7685194|NCT01249261|26730195|P2|Overall Study|Withdrawal by Subject|0
7685195|NCT01249261|26730196|P1|Overall Study|Withdrawal by Subject|1
7685196|NCT01249157|26730224|P1|Overall Study|Withdrawal by Subject|1
7685197|NCT01249131|26730228|P6|Washout Period of 10 Days|Adverse Event|0
7685198|NCT01249131|26730229|P5|Washout Period of 10 Days|Adverse Event|1
7685199|NCT01249131|26730230|P4|Washout Period of 10 Days|Adverse Event|0
7685200|NCT01249131|26730231|P3|Washout Period of 10 Days|Adverse Event|0
7685201|NCT01249131|26730232|P2|Washout Period of 10 Days|Adverse Event|0
7685202|NCT01249131|26730233|P1|Washout Period of 10 Days|Adverse Event|0
7685203|NCT01249118|26730253|P3|First Washout Period|Physician Decision|0
7685204|NCT01249118|26730254|P2|First Washout Period|Physician Decision|1
7685205|NCT01249118|26730255|P1|First Washout Period|Physician Decision|0
7685206|NCT01249092|26730289|P1|Overall Study|Unable to tolerate expected SE -nausea|1
7685207|NCT01249092|26730289|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
7685208|NCT01248962|26730366|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
7685209|NCT01248962|26730367|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
7685210|NCT01248962|26730366|P2|Overall Study|Complete Response after 3 Cycles|1
7685211|NCT01248962|26730367|P1|Overall Study|Complete Response after 3 Cycles|0
7685212|NCT01248962|26730366|P2|Overall Study|Complete Response after 4 Cycles|0
7685213|NCT01248962|26730367|P1|Overall Study|Complete Response after 4 Cycles|1
7685214|NCT01248962|26730366|P2|Overall Study|Adverse Event|1
7685215|NCT01248962|26730367|P1|Overall Study|Adverse Event|2
7685216|NCT01248962|26730366|P2|Overall Study|Withdrawal by Subject|1
7685217|NCT01248962|26730367|P1|Overall Study|Withdrawal by Subject|1
7685218|NCT01248949|26730383|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7685219|NCT01248949|26730384|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7685220|NCT01248949|26730385|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
7685221|NCT01248949|26730386|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7685222|NCT01248949|26730387|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7685223|NCT01248949|26730383|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
7685224|NCT01248949|26730384|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
7685225|NCT01248949|26730385|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
7685226|NCT01248949|26730386|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
7685227|NCT01248949|26730387|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
7685228|NCT01248949|26730383|P5|Overall Study|Pi Decision Due To Declining Status|0
7685229|NCT01248949|26730384|P4|Overall Study|Pi Decision Due To Declining Status|0
7685230|NCT01248949|26730385|P3|Overall Study|Pi Decision Due To Declining Status|1
7685231|NCT01248949|26730386|P2|Overall Study|Pi Decision Due To Declining Status|0
7685232|NCT01248949|26730387|P1|Overall Study|Pi Decision Due To Declining Status|0
7685233|NCT01248949|26730383|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
7685234|NCT01248949|26730384|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
7685235|NCT01248949|26730385|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
7685236|NCT01248949|26730386|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
7685237|NCT01248949|26730387|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
7685238|NCT01248949|26730383|P5|Overall Study|Participant Went To Hospice|0
7685239|NCT01248949|26730384|P4|Overall Study|Participant Went To Hospice|0
7685240|NCT01248949|26730385|P3|Overall Study|Participant Went To Hospice|1
7685241|NCT01248949|26730386|P2|Overall Study|Participant Went To Hospice|0
7685242|NCT01248949|26730387|P1|Overall Study|Participant Went To Hospice|0
7685243|NCT01248949|26730383|P5|Overall Study|Entered Hospice And Refused Follow Up|1
7685244|NCT01248949|26730384|P4|Overall Study|Entered Hospice And Refused Follow Up|0
7685245|NCT01248949|26730385|P3|Overall Study|Entered Hospice And Refused Follow Up|0
7685246|NCT01248949|26730386|P2|Overall Study|Entered Hospice And Refused Follow Up|0
7685247|NCT01248949|26730387|P1|Overall Study|Entered Hospice And Refused Follow Up|0
7685248|NCT01248949|26730383|P5|Overall Study|Palliative Radiation To Brain Metastases|0
7685249|NCT01248949|26730384|P4|Overall Study|Palliative Radiation To Brain Metastases|0
7685250|NCT01248949|26730385|P3|Overall Study|Palliative Radiation To Brain Metastases|0
7685251|NCT01248949|26730386|P2|Overall Study|Palliative Radiation To Brain Metastases|0
7685252|NCT01248949|26730387|P1|Overall Study|Palliative Radiation To Brain Metastases|1
7685253|NCT01248949|26730383|P5|Overall Study|Alternative Therapy.|0
7685254|NCT01248949|26730384|P4|Overall Study|Alternative Therapy.|0
7685255|NCT01248949|26730385|P3|Overall Study|Alternative Therapy.|0
7685256|NCT01248949|26730386|P2|Overall Study|Alternative Therapy.|0
7685257|NCT01248949|26730387|P1|Overall Study|Alternative Therapy.|1
7685258|NCT01248949|26730383|P5|Overall Study|Alternative Therapy|0
7685259|NCT01248949|26730384|P4|Overall Study|Alternative Therapy|0
7685260|NCT01248949|26730385|P3|Overall Study|Alternative Therapy|0
7685261|NCT01248949|26730386|P2|Overall Study|Alternative Therapy|0
7685262|NCT01248949|26730387|P1|Overall Study|Alternative Therapy|1
7685263|NCT01248949|26730383|P5|Overall Study|Death|2
7685264|NCT01248949|26730384|P4|Overall Study|Death|6
7685265|NCT01248949|26730385|P3|Overall Study|Death|21
7685266|NCT01248949|26730386|P2|Overall Study|Death|7
7685267|NCT01248949|26730387|P1|Overall Study|Death|22
7685268|NCT01248949|26730383|P5|Overall Study|Withdrawal by Subject|1
7685269|NCT01248949|26730384|P4|Overall Study|Withdrawal by Subject|3
7685270|NCT01248949|26730385|P3|Overall Study|Withdrawal by Subject|11
7685271|NCT01248949|26730386|P2|Overall Study|Withdrawal by Subject|3
7685272|NCT01248949|26730387|P1|Overall Study|Withdrawal by Subject|5
7685273|NCT01248949|26730383|P5|Overall Study|Lost to Follow-up|0
7685274|NCT01248949|26730384|P4|Overall Study|Lost to Follow-up|1
7685275|NCT01248949|26730385|P3|Overall Study|Lost to Follow-up|2
7685276|NCT01248949|26730386|P2|Overall Study|Lost to Follow-up|2
7685277|NCT01248949|26730387|P1|Overall Study|Lost to Follow-up|2
7685278|NCT01248936|26730499|P1|Overall Study|Other reason|3
7685279|NCT01248936|26730499|P1|Overall Study|Refused Treatment|1
7685280|NCT01248936|26730499|P1|Overall Study|Lost to Follow-up|7
7685281|NCT01248936|26730499|P1|Overall Study|Adverse Event|8
7685282|NCT01248936|26730499|P1|Overall Study|Withdrawal of Consent|20
7685283|NCT01248936|26730499|P1|Overall Study|Death|26
7685284|NCT01248936|26730499|P1|Overall Study|Progression of Disease|50
7685285|NCT01248936|26730499|P1|Overall Study|Sponsor Decision|259
7685286|NCT01248884|26730512|P3|Overall Study|Adverse Event|0
7685287|NCT01248884|26730513|P2|Overall Study|Adverse Event|0
7685288|NCT01248884|26730514|P1|Overall Study|Adverse Event|1
7685289|NCT01248884|26730512|P3|Overall Study|Withdrawal by Subject|1
7685290|NCT01248884|26730513|P2|Overall Study|Withdrawal by Subject|3
7685291|NCT01248884|26730514|P1|Overall Study|Withdrawal by Subject|1
7685292|NCT01248793|26730572|P2|Overall Study|Withdrawal by Subject|3
7685293|NCT01248793|26730573|P1|Overall Study|Withdrawal by Subject|3
7685294|NCT01248793|26730572|P2|Overall Study|Protocol Violation|1
7685295|NCT01248793|26730573|P1|Overall Study|Protocol Violation|0
7685296|NCT01248793|26730572|P2|Overall Study|Adverse Event|1
7685297|NCT01248793|26730573|P1|Overall Study|Adverse Event|1
7685298|NCT01248793|26730572|P2|Overall Study|Lost to Follow-up|1
7685299|NCT01248793|26730573|P1|Overall Study|Lost to Follow-up|0
7685300|NCT01248780|26730587|P2|Overall Study|Not treated|1
7685301|NCT01248780|26730588|P1|Overall Study|Not treated|0
7685302|NCT01248780|26730587|P2|Overall Study|Withdrawal by Subject|4
7685303|NCT01248780|26730588|P1|Overall Study|Withdrawal by Subject|4
7685304|NCT01248780|26730587|P2|Overall Study|Protocol Violation|1
7685305|NCT01248780|26730588|P1|Overall Study|Protocol Violation|1
7685306|NCT01248780|26730587|P2|Overall Study|Adverse Event|7
7685307|NCT01248780|26730588|P1|Overall Study|Adverse Event|2
7685308|NCT01248780|26730587|P2|Overall Study|Death|1
7685309|NCT01248780|26730588|P1|Overall Study|Death|0
7685310|NCT01248780|26730587|P2|Overall Study|Lost to Follow-up|1
7685311|NCT01248780|26730588|P1|Overall Study|Lost to Follow-up|0
7685312|NCT01248780|26730587|P2|Overall Study|Lack of Efficacy|0
7685313|NCT01248780|26730588|P1|Overall Study|Lack of Efficacy|2
7685314|NCT01248728|26730606|P2|Overall Study|Lack of Efficacy|0
7685315|NCT01248728|26730607|P1|Overall Study|Lack of Efficacy|1
7685316|NCT01248728|26730606|P2|Overall Study|Withdrawal by Subject|1
7685317|NCT01248728|26730607|P1|Overall Study|Withdrawal by Subject|2
7685318|NCT01248728|26730606|P2|Overall Study|Adverse Event|1
7685319|NCT01248728|26730607|P1|Overall Study|Adverse Event|1
7685320|NCT01248715|26730623|P2|Overall Study|Not influenza positive|510
7685321|NCT01248715|26730624|P1|Overall Study|Not influenza positive|501
7685322|NCT01248468|26730662|P3|Overall Study|Withdrawal by Subject|0
7685323|NCT01248468|26730663|P2|Overall Study|Withdrawal by Subject|2
7685324|NCT01248468|26730664|P1|Overall Study|Withdrawal by Subject|4
7685325|NCT01248468|26730662|P3|Overall Study|Pregnancy|0
7685326|NCT01248468|26730663|P2|Overall Study|Pregnancy|0
7685327|NCT01248468|26730664|P1|Overall Study|Pregnancy|1
7685328|NCT01248468|26730662|P3|Overall Study|Lost to Follow-up|4
7685329|NCT01248468|26730663|P2|Overall Study|Lost to Follow-up|12
7685330|NCT01248468|26730664|P1|Overall Study|Lost to Follow-up|9
7685331|NCT01248468|26730662|P3|Overall Study|Administrative problem|0
7685332|NCT01248468|26730663|P2|Overall Study|Administrative problem|0
7685333|NCT01248468|26730664|P1|Overall Study|Administrative problem|1
7685334|NCT01248455|26730681|P1|Overall Study|switched to alternate treatment|1
7685335|NCT01248364|26730726|P4|Overall Study|Adverse Event|0
7685336|NCT01248364|26730727|P3|Overall Study|Adverse Event|0
7685337|NCT01248364|26730728|P2|Overall Study|Adverse Event|1
7685338|NCT01248364|26730729|P1|Overall Study|Adverse Event|0
7685339|NCT01248130|26730792|P2|Overall Study|Ineligible|0
7685340|NCT01248130|26730793|P1|Overall Study|Ineligible|1
7685341|NCT01248130|26730792|P2|Overall Study|Protocol Violation|0
7685342|NCT01248130|26730793|P1|Overall Study|Protocol Violation|1
7685343|NCT01248065|26730812|P2|Overall Study|Other|5
7685344|NCT01248065|26730813|P1|Overall Study|Other|3
7685345|NCT01248065|26730812|P2|Overall Study|Third treatment failure event|1
7685346|NCT01248065|26730813|P1|Overall Study|Third treatment failure event|3
7685347|NCT01248065|26730812|P2|Overall Study|Adverse Event|0
7685348|NCT01248065|26730813|P1|Overall Study|Adverse Event|3
7685349|NCT01248065|26730812|P2|Overall Study|Withdrawal by Subject|11
7685350|NCT01248065|26730813|P1|Overall Study|Withdrawal by Subject|14
7685351|NCT01248065|26730812|P2|Overall Study|Lost to Follow-up|5
7685352|NCT01248065|26730813|P1|Overall Study|Lost to Follow-up|3
7685353|NCT01248013|26730823|P1|Overall Study|Withdrawal by Subject|14
7685354|NCT01247922|26730838|P1|Overall Study|Disease progression|4
7685355|NCT01247350|26730936|P5|Overall Study|Entry criteria not met|1
7685356|NCT01247350|26730937|P4|Overall Study|Entry criteria not met|0
7685357|NCT01247350|26730938|P3|Overall Study|Entry criteria not met|0
7685358|NCT01247350|26730939|P2|Overall Study|Entry criteria not met|0
7685359|NCT01247350|26730940|P1|Overall Study|Entry criteria not met|0
7685360|NCT01247350|26730936|P5|Overall Study|Withdrawal by Subject|0
7685361|NCT01247350|26730937|P4|Overall Study|Withdrawal by Subject|1
7685362|NCT01247350|26730938|P3|Overall Study|Withdrawal by Subject|0
7685363|NCT01247350|26730939|P2|Overall Study|Withdrawal by Subject|0
7685364|NCT01247350|26730940|P1|Overall Study|Withdrawal by Subject|0
7685365|NCT01247350|26730936|P5|Overall Study|Adverse Event|0
7685366|NCT01247350|26730937|P4|Overall Study|Adverse Event|0
7685367|NCT01247350|26730938|P3|Overall Study|Adverse Event|1
7685368|NCT01247350|26730939|P2|Overall Study|Adverse Event|0
7685369|NCT01247350|26730940|P1|Overall Study|Adverse Event|0
7685370|NCT01247324|26730998|P2|Overall Study|Lost to Follow-up|1
7685371|NCT01247324|26730999|P1|Overall Study|Lost to Follow-up|1
7685372|NCT01247324|26730998|P2|Overall Study|Adverse Event|13
7685373|NCT01247324|26730999|P1|Overall Study|Adverse Event|25
7685374|NCT01247324|26730998|P2|Overall Study|Consent withdrawn by participant|8
7685375|NCT01247324|26730999|P1|Overall Study|Consent withdrawn by participant|13
7685376|NCT01247324|26730998|P2|Overall Study|Reason not specified|8
7685377|NCT01247324|26730999|P1|Overall Study|Reason not specified|11
7685378|NCT01247324|26730998|P2|Overall Study|Protocol Violation|2
7685379|NCT01247324|26730999|P1|Overall Study|Protocol Violation|1
7685380|NCT01247324|26730998|P2|Overall Study|Pregnancy|3
7685381|NCT01247324|26730999|P1|Overall Study|Pregnancy|2
7685382|NCT01247324|26730998|P2|Overall Study|Non-compliance|0
7685383|NCT01247324|26730999|P1|Overall Study|Non-compliance|2
7685384|NCT01247324|26730998|P2|Overall Study|Lack of Efficacy|8
7685385|NCT01247324|26730999|P1|Overall Study|Lack of Efficacy|12
7685386|NCT01247324|26730998|P2|Overall Study|Non-compliance with study drug|0
7685387|NCT01247324|26730999|P1|Overall Study|Non-compliance with study drug|3
7685388|NCT01247324|26730998|P2|Overall Study|Physician Decision|1
7685389|NCT01247324|26730999|P1|Overall Study|Physician Decision|0
7685390|NCT01247324|26730998|P2|Overall Study|Death|0
7685391|NCT01247324|26730999|P1|Overall Study|Death|1
7685392|NCT01247090|26731092|P3|Overall Study|Withdrawal by Subject|0
7685393|NCT01247090|26731093|P2|Overall Study|Withdrawal by Subject|1
7685394|NCT01247090|26731094|P1|Overall Study|Withdrawal by Subject|0
7685395|NCT01247090|26731092|P3|Overall Study|Physician Decision|0
7685396|NCT01247090|26731093|P2|Overall Study|Physician Decision|0
7685397|NCT01247090|26731094|P1|Overall Study|Physician Decision|1
7685398|NCT01246999|26731123|P4|Overall Study|Withdrawal by Subject|2
7685399|NCT01246999|26731124|P3|Overall Study|Withdrawal by Subject|0
7685400|NCT01246999|26731125|P2|Overall Study|Withdrawal by Subject|0
7685401|NCT01246999|26731126|P1|Overall Study|Withdrawal by Subject|0
7685402|NCT01246999|26731123|P4|Overall Study|Lost to Follow-up|0
7685403|NCT01246999|26731124|P3|Overall Study|Lost to Follow-up|0
7685404|NCT01246999|26731125|P2|Overall Study|Lost to Follow-up|1
7685405|NCT01246999|26731126|P1|Overall Study|Lost to Follow-up|0
7685406|NCT01246986|26731166|P7|Overall Study|Withdrawal by Subject|0
7685407|NCT01246986|26731167|P6|Overall Study|Withdrawal by Subject|0
7685408|NCT01246986|26731168|P5|Overall Study|Withdrawal by Subject|4
7685409|NCT01246986|26731169|P4|Overall Study|Withdrawal by Subject|0
7685410|NCT01246986|26731170|P3|Overall Study|Withdrawal by Subject|3
7685411|NCT01246986|26731171|P2|Overall Study|Withdrawal by Subject|4
7685412|NCT01246986|26731172|P1|Overall Study|Withdrawal by Subject|3
7685413|NCT01246986|26731166|P7|Overall Study|Lost to Follow-up|0
7685414|NCT01246986|26731167|P6|Overall Study|Lost to Follow-up|1
7685415|NCT01246986|26731168|P5|Overall Study|Lost to Follow-up|0
7685416|NCT01246986|26731169|P4|Overall Study|Lost to Follow-up|0
7685417|NCT01246986|26731170|P3|Overall Study|Lost to Follow-up|3
7685418|NCT01246986|26731171|P2|Overall Study|Lost to Follow-up|1
7685419|NCT01246986|26731172|P1|Overall Study|Lost to Follow-up|0
7685420|NCT01246973|26731232|P2|Overall Study|Withdrawal by Subject|13
7685421|NCT01246973|26731233|P1|Overall Study|Withdrawal by Subject|7
7685422|NCT01246973|26731232|P2|Overall Study|Adverse Event|9
7685423|NCT01246973|26731233|P1|Overall Study|Adverse Event|16
7685424|NCT01246973|26731232|P2|Overall Study|Other|25
7685425|NCT01246973|26731233|P1|Overall Study|Other|38
7685426|NCT01246960|26731243|P2|Overall Study|Withdrawal (by participant or physician)|3
7685427|NCT01246960|26731244|P1|Overall Study|Withdrawal (by participant or physician)|3
7685428|NCT01246960|26731243|P2|Overall Study|Lost to Follow-up|1
7685429|NCT01246960|26731244|P1|Overall Study|Lost to Follow-up|3
7685430|NCT01246583|26731305|P4|Overall Study|Withdrawal by Subject|0
7685431|NCT01246583|26731306|P3|Overall Study|Withdrawal by Subject|0
7685432|NCT01246583|26731307|P2|Overall Study|Withdrawal by Subject|0
7685433|NCT01246583|26731308|P1|Overall Study|Withdrawal by Subject|1
7685434|NCT01246583|26731305|P4|Overall Study|Protocol Violation|0
7685435|NCT01246583|26731306|P3|Overall Study|Protocol Violation|1
7685436|NCT01246583|26731307|P2|Overall Study|Protocol Violation|0
7685437|NCT01246583|26731308|P1|Overall Study|Protocol Violation|0
7685438|NCT01246583|26731305|P4|Overall Study|Lost to Follow-up|1
7685439|NCT01246583|26731306|P3|Overall Study|Lost to Follow-up|0
7685440|NCT01246583|26731307|P2|Overall Study|Lost to Follow-up|0
7685441|NCT01246583|26731308|P1|Overall Study|Lost to Follow-up|0
7685442|NCT01246466|26731400|P1|Overall Study|Withdrawal by Subject|1
7685443|NCT01246466|26731400|P1|Overall Study|Death|1
7685444|NCT01246206|26731458|P1|Overall Study|Patient did not receive study regiments.|1
7685445|NCT01246011|26731536|P3|Overall Study|Withdrawal by Subject|1
7685446|NCT01246011|26731537|P2|Overall Study|Withdrawal by Subject|0
7685447|NCT01246011|26731538|P1|Overall Study|Withdrawal by Subject|0
7685448|NCT01246011|26731536|P3|Overall Study|If needed warfarin clinically, withdrawn|3
7685449|NCT01246011|26731537|P2|Overall Study|If needed warfarin clinically, withdrawn|0
7685450|NCT01246011|26731538|P1|Overall Study|If needed warfarin clinically, withdrawn|0
7685451|NCT01245764|26731566|P4|Study Phase A|Lost to Follow-up|0
7685452|NCT01245764|26731567|P3|Study Phase A|Lost to Follow-up|5
7685453|NCT01245764|26731568|P2|Study Phase A|Lost to Follow-up|0
7685454|NCT01245764|26731569|P1|Study Phase A|Lost to Follow-up|0
7685455|NCT01245764|26731566|P4|Study Phase A|Protocol Violation|2
7685456|NCT01245764|26731567|P3|Study Phase A|Protocol Violation|2
7685457|NCT01245764|26731568|P2|Study Phase A|Protocol Violation|3
7685458|NCT01245764|26731569|P1|Study Phase A|Protocol Violation|6
7685459|NCT01245764|26731566|P4|Study Phase A|Other|1
7685460|NCT01245764|26731567|P3|Study Phase A|Other|3
7685461|NCT01245764|26731568|P2|Study Phase A|Other|2
7685462|NCT01245764|26731569|P1|Study Phase A|Other|3
7685463|NCT01245751|26731607|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7685464|NCT01245751|26731608|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7685465|NCT01245751|26731609|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
7685466|NCT01245751|26731610|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7685467|NCT01245751|26731607|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
7685468|NCT01245751|26731608|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7685469|NCT01245751|26731609|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7685470|NCT01245751|26731610|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7685471|NCT01245751|26731607|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
7685472|NCT01245751|26731608|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
7685473|NCT01245751|26731609|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
7685474|NCT01245751|26731610|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
7685475|NCT01245673|26731659|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
7685476|NCT01245387|26731727|P1|Overall Study|Missing discontinuation status|369
7685477|NCT01245387|26731727|P1|Overall Study|Other|131
7685478|NCT01245387|26731727|P1|Overall Study|Death|3
7685479|NCT01245387|26731727|P1|Overall Study|Adverse Event|9
7685480|NCT01245387|26731727|P1|Overall Study|Lack of Efficacy|195
7685481|NCT01245387|26731727|P1|Overall Study|Lost to Follow-up|106
7685482|NCT01245374|26731776|P1|Overall Study|Withdrawal by Subject|3
7685483|NCT01245374|26731776|P1|Overall Study|Protocol Violation|1
7685484|NCT01245283|26731799|P3|Overall Study|Lost to Follow-up|11
7685485|NCT01245283|26731800|P2|Overall Study|Lost to Follow-up|11
7685486|NCT01245283|26731801|P1|Overall Study|Lost to Follow-up|14
7685487|NCT01245140|26731846|P2|Overall Study|Refused Treatment/Did Not Coopera|1
7685488|NCT01245140|26731847|P1|Overall Study|Refused Treatment/Did Not Coopera|0
7685489|NCT01245140|26731846|P2|Overall Study|Withdrawal by Subject|1
7685490|NCT01245140|26731847|P1|Overall Study|Withdrawal by Subject|0
7685491|NCT01245140|26731846|P2|Overall Study|Protocol Violation|1
7685492|NCT01245140|26731847|P1|Overall Study|Protocol Violation|0
7685493|NCT01245140|26731846|P2|Overall Study|Lack of Efficacy|4
7685494|NCT01245140|26731847|P1|Overall Study|Lack of Efficacy|2
7685495|NCT01245140|26731846|P2|Overall Study|Adverse Event|3
7685496|NCT01245140|26731847|P1|Overall Study|Adverse Event|1
7685497|NCT01245101|26731903|P2|Period 3 (Treatment)|Withdrawal by Subject|0
7685498|NCT01245101|26731904|P1|Period 3 (Treatment)|Withdrawal by Subject|1
7685499|NCT01245101|26731903|P2|Period 2 (Washout)|Withdrawal by Subject|0
7685500|NCT01245101|26731904|P1|Period 2 (Washout)|Withdrawal by Subject|1
7685501|NCT01245101|26731903|P2|Period 1 (Treatment)|Withdrawal by Subject|0
7685502|NCT01245101|26731904|P1|Period 1 (Treatment)|Withdrawal by Subject|2
7685503|NCT01245062|26731914|P3|Cross-over Phase|Study closed/ terminated|11
7685504|NCT01245062|26731915|P2|Cross-over Phase|Study closed/ terminated|0
7685505|NCT01245062|26731916|P1|Cross-over Phase|Study closed/ terminated|0
7685506|NCT01245062|26731914|P3|Cross-over Phase|Withdrew Consent|4
7685507|NCT01245062|26731915|P2|Cross-over Phase|Withdrew Consent|0
7685508|NCT01245062|26731916|P1|Cross-over Phase|Withdrew Consent|0
7685509|NCT01245062|26731914|P3|Cross-over Phase|Physician Decision|1
7685510|NCT01245062|26731915|P2|Cross-over Phase|Physician Decision|0
7685511|NCT01245062|26731916|P1|Cross-over Phase|Physician Decision|0
7685512|NCT01245062|26731914|P3|Cross-over Phase|Lost to Follow-up|1
7685513|NCT01245062|26731915|P2|Cross-over Phase|Lost to Follow-up|0
7685514|NCT01245062|26731916|P1|Cross-over Phase|Lost to Follow-up|0
7685515|NCT01245062|26731914|P3|Randomization and Crossover Phase|Study closed/ terminated|0
7685516|NCT01245062|26731915|P2|Randomization and Crossover Phase|Study closed/ terminated|14
7685517|NCT01245062|26731916|P1|Randomization and Crossover Phase|Study closed/ terminated|23
7685518|NCT01245062|26731914|P3|Randomization and Crossover Phase|Withdrew Consent|0
7685519|NCT01245062|26731915|P2|Randomization and Crossover Phase|Withdrew Consent|11
7685520|NCT01245062|26731916|P1|Randomization and Crossover Phase|Withdrew Consent|12
7685521|NCT01245062|26731914|P3|Randomization and Crossover Phase|Physician Decision|0
7685522|NCT01245062|26731915|P2|Randomization and Crossover Phase|Physician Decision|4
7685523|NCT01245062|26731916|P1|Randomization and Crossover Phase|Physician Decision|2
7685524|NCT01245062|26731914|P3|Randomization and Crossover Phase|Lost to Follow-up|0
7685525|NCT01245062|26731915|P2|Randomization and Crossover Phase|Lost to Follow-up|2
7685526|NCT01245062|26731916|P1|Randomization and Crossover Phase|Lost to Follow-up|4
7685527|NCT01245049|26731954|P2|Overall Study|Lost to Follow-up|2
7685528|NCT01245049|26731955|P1|Overall Study|Lost to Follow-up|1
7685529|NCT01245049|26731954|P2|Overall Study|Withdrawal by Subject|1
7685530|NCT01245049|26731955|P1|Overall Study|Withdrawal by Subject|0
7685531|NCT01245049|26731954|P2|Overall Study|Migrated/moved from study area|1
7685532|NCT01245049|26731955|P1|Overall Study|Migrated/moved from study area|0
7685533|NCT01244984|26732008|P3|Overall Study|Withdrawal by Subject|2
7685534|NCT01244984|26732009|P2|Overall Study|Withdrawal by Subject|2
7685535|NCT01244984|26732010|P1|Overall Study|Withdrawal by Subject|1
7685536|NCT01244984|26732008|P3|Overall Study|Protocol Defined Stopping Criteria|0
7685537|NCT01244984|26732009|P2|Overall Study|Protocol Defined Stopping Criteria|1
7685538|NCT01244984|26732010|P1|Overall Study|Protocol Defined Stopping Criteria|1
7685539|NCT01244984|26732008|P3|Overall Study|Protocol Violation|0
7685540|NCT01244984|26732009|P2|Overall Study|Protocol Violation|0
7685541|NCT01244984|26732010|P1|Overall Study|Protocol Violation|1
7685542|NCT01244984|26732008|P3|Overall Study|Adverse Event|2
7685543|NCT01244984|26732009|P2|Overall Study|Adverse Event|11
7685544|NCT01244984|26732010|P1|Overall Study|Adverse Event|2
7685545|NCT01244906|26732084|P1|Overall Study|Progression of disease post treatment|6
7685546|NCT01244906|26732084|P1|Overall Study|Death|2
7685547|NCT01244893|26732093|P2|1-Week Follow Up|Lost to Follow-up|0
7685548|NCT01244893|26732094|P1|1-Week Follow Up|Lost to Follow-up|1
7685549|NCT01244893|26732093|P2|Baseline|Protocol Violation|1
7685550|NCT01244893|26732094|P1|Baseline|Protocol Violation|0
7685551|NCT01244828|26732106|P1|Overall Study|Other reason (not specified)|1
7685552|NCT01244828|26732106|P1|Overall Study|Lost to Follow-up|2
7685553|NCT01244828|26732106|P1|Overall Study|Lack of Efficacy|7
7685554|NCT01244828|26732106|P1|Overall Study|Withdrawal by Subject|31
7685555|NCT01244828|26732106|P1|Overall Study|Adverse Event|37
7685556|NCT01244815|26732122|P4|Overall Study|Did Not Meet Protocol Eligibility|0
7685557|NCT01244815|26732123|P3|Overall Study|Did Not Meet Protocol Eligibility|0
7685558|NCT01244815|26732124|P2|Overall Study|Did Not Meet Protocol Eligibility|1
7685559|NCT01244815|26732125|P1|Overall Study|Did Not Meet Protocol Eligibility|0
7685560|NCT01244815|26732122|P4|Overall Study|Protocol Violation|1
7685561|NCT01244815|26732123|P3|Overall Study|Protocol Violation|3
7685562|NCT01244815|26732124|P2|Overall Study|Protocol Violation|4
7685563|NCT01244815|26732125|P1|Overall Study|Protocol Violation|7
7685564|NCT01244815|26732122|P4|Overall Study|Withdrawal by Subject|3
7685565|NCT01244815|26732123|P3|Overall Study|Withdrawal by Subject|0
7685566|NCT01244815|26732124|P2|Overall Study|Withdrawal by Subject|2
7685567|NCT01244815|26732125|P1|Overall Study|Withdrawal by Subject|0
7685568|NCT01244815|26732122|P4|Overall Study|Lost to Follow-up|2
7685569|NCT01244815|26732123|P3|Overall Study|Lost to Follow-up|3
7685570|NCT01244815|26732124|P2|Overall Study|Lost to Follow-up|2
7685571|NCT01244815|26732125|P1|Overall Study|Lost to Follow-up|3
7685572|NCT01244815|26732122|P4|Overall Study|Treatment Failure|1
7685573|NCT01244815|26732123|P3|Overall Study|Treatment Failure|0
7685574|NCT01244815|26732124|P2|Overall Study|Treatment Failure|0
7685575|NCT01244815|26732125|P1|Overall Study|Treatment Failure|0
7685576|NCT01244815|26732122|P4|Overall Study|Adverse Event|5
7685577|NCT01244815|26732123|P3|Overall Study|Adverse Event|5
7685578|NCT01244815|26732124|P2|Overall Study|Adverse Event|7
7685579|NCT01244815|26732125|P1|Overall Study|Adverse Event|4
7685580|NCT01244815|26732122|P4|Overall Study|Not Treated|0
7685581|NCT01244815|26732123|P3|Overall Study|Not Treated|0
7685582|NCT01244815|26732124|P2|Overall Study|Not Treated|1
7685583|NCT01244815|26732125|P1|Overall Study|Not Treated|0
7685584|NCT01244620|26732212|P4|Overall Study|Study terminated|4
7685585|NCT01244620|26732213|P3|Overall Study|Study terminated|4
7685586|NCT01244620|26732214|P2|Overall Study|Study terminated|4
7685587|NCT01244620|26732215|P1|Overall Study|Study terminated|4
7685588|NCT01244516|26732274|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
7685589|NCT01244516|26732275|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
7685590|NCT01244516|26732276|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
7685591|NCT01244516|26732274|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
7685592|NCT01244516|26732275|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
7685593|NCT01244516|26732276|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
7685594|NCT01244516|26732274|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
7685595|NCT01244516|26732275|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
7685596|NCT01244516|26732276|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
7685597|NCT01244516|26732274|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
7685598|NCT01244516|26732275|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
7685599|NCT01244516|26732276|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
7685600|NCT01244516|26732274|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
7685601|NCT01244516|26732275|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
7685602|NCT01244516|26732276|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
7685603|NCT01244516|26732274|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
7685604|NCT01244516|26732275|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
7685605|NCT01244516|26732276|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
7685606|NCT01244516|26732274|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
7685607|NCT01244516|26732275|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
7685608|NCT01244516|26732276|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
7685609|NCT01244490|26732297|P3|Overall Study|Other|1
7685610|NCT01244490|26732298|P2|Overall Study|Other|0
7685611|NCT01244490|26732299|P1|Overall Study|Other|0
7685612|NCT01244490|26732297|P3|Overall Study|Lost to Follow-up|3
7685613|NCT01244490|26732298|P2|Overall Study|Lost to Follow-up|6
7685614|NCT01244490|26732299|P1|Overall Study|Lost to Follow-up|0
7685615|NCT01244490|26732297|P3|Overall Study|Adverse Event|5
7685616|NCT01244490|26732298|P2|Overall Study|Adverse Event|9
7685617|NCT01244490|26732299|P1|Overall Study|Adverse Event|1
7685618|NCT01244490|26732297|P3|Overall Study|Withdrawal by Subject|9
7685619|NCT01244490|26732298|P2|Overall Study|Withdrawal by Subject|4
7685620|NCT01244490|26732299|P1|Overall Study|Withdrawal by Subject|4
7685621|NCT01244490|26732297|P3|Overall Study|Lack of Efficacy|5
7685622|NCT01244490|26732298|P2|Overall Study|Lack of Efficacy|5
7685623|NCT01244490|26732299|P1|Overall Study|Lack of Efficacy|14
7685624|NCT01244425|26732376|P2|Overall Study|Adverse Event|1
7685625|NCT01244425|26732377|P1|Overall Study|Adverse Event|1
7685626|NCT01244425|26732376|P2|Overall Study|Withdrawal by Subject|2
7685627|NCT01244425|26732377|P1|Overall Study|Withdrawal by Subject|2
7685628|NCT01244191|26732408|P2|Overall Study|'Missing' or 'Terminated by sponsor'|8
7685629|NCT01244191|26732409|P1|Overall Study|'Missing' or 'Terminated by sponsor'|12
7685630|NCT01244191|26732408|P2|Overall Study|Withdrawal by Subject|23
7685631|NCT01244191|26732409|P1|Overall Study|Withdrawal by Subject|31
7685632|NCT01244191|26732408|P2|Overall Study|Protocol Violation|2
7685633|NCT01244191|26732409|P1|Overall Study|Protocol Violation|1
7685634|NCT01244191|26732408|P2|Overall Study|Lost to Follow-up|2
7685635|NCT01244191|26732409|P1|Overall Study|Lost to Follow-up|0
7685636|NCT01244191|26732408|P2|Overall Study|Death|29
7685637|NCT01244191|26732409|P1|Overall Study|Death|22
7685638|NCT01244191|26732408|P2|Overall Study|Adverse Event|48
7685639|NCT01244191|26732409|P1|Overall Study|Adverse Event|65
7685640|NCT01244191|26732408|P2|Overall Study|Clinical disease progression|36
7685641|NCT01244191|26732409|P1|Overall Study|Clinical disease progression|54
7685642|NCT01244191|26732408|P2|Overall Study|Progressive disease|350
7685643|NCT01244191|26732409|P1|Overall Study|Progressive disease|295
7685644|NCT01244126|26732432|P3|Overall Study|Protocol Violation|9
7685645|NCT01244126|26732433|P2|Overall Study|Protocol Violation|3
7685646|NCT01244126|26732434|P1|Overall Study|Protocol Violation|3
7685647|NCT01244061|26732447|P2|Overall Study|Randomized but not treated|2
7685648|NCT01244061|26732448|P1|Overall Study|Randomized but not treated|2
7685649|NCT01244061|26732447|P2|Overall Study|Adverse Event|2
7685650|NCT01244061|26732448|P1|Overall Study|Adverse Event|5
7685651|NCT01244061|26732447|P2|Overall Study|Protocol Violation|1
7685652|NCT01244061|26732448|P1|Overall Study|Protocol Violation|1
7685653|NCT01244061|26732447|P2|Overall Study|Other|19
7685654|NCT01244061|26732448|P1|Overall Study|Other|8
7685655|NCT01244061|26732447|P2|Overall Study|Withdrawal by Subject|46
7685656|NCT01244061|26732448|P1|Overall Study|Withdrawal by Subject|29
7685657|NCT01244061|26732447|P2|Overall Study|Lost to Follow-up|30
7685658|NCT01244061|26732448|P1|Overall Study|Lost to Follow-up|34
7685659|NCT01244061|26732447|P2|Overall Study|Lack of Efficacy|3
7685660|NCT01244061|26732448|P1|Overall Study|Lack of Efficacy|1
7685661|NCT01244061|26732447|P2|Overall Study|Did not meet entrance criteria|0
7685662|NCT01244061|26732448|P1|Overall Study|Did not meet entrance criteria|1
7685663|NCT01244061|26732447|P2|Overall Study|Death|0
7685664|NCT01244061|26732448|P1|Overall Study|Death|1
7685665|NCT01244035|26732460|P6|Part 1: Period 3|Protocol Deviation|0
7685666|NCT01244035|26732461|P5|Part 1: Period 3|Protocol Deviation|0
7685667|NCT01244035|26732462|P4|Part 1: Period 3|Protocol Deviation|0
7685668|NCT01244035|26732463|P3|Part 1: Period 3|Protocol Deviation|0
7685669|NCT01244035|26732464|P2|Part 1: Period 3|Protocol Deviation|1
7685670|NCT01244035|26732465|P1|Part 1: Period 3|Protocol Deviation|0
7685671|NCT01244035|26732460|P6|Part 1: Period 3|Withdrawal by Subject|0
7685672|NCT01244035|26732461|P5|Part 1: Period 3|Withdrawal by Subject|1
7685673|NCT01244035|26732462|P4|Part 1: Period 3|Withdrawal by Subject|0
7685674|NCT01244035|26732463|P3|Part 1: Period 3|Withdrawal by Subject|0
7685675|NCT01244035|26732464|P2|Part 1: Period 3|Withdrawal by Subject|0
7685676|NCT01244035|26732465|P1|Part 1: Period 3|Withdrawal by Subject|0
7685677|NCT01244035|26732460|P6|Part 1: Period 3|Adverse Event|1
7685678|NCT01244035|26732461|P5|Part 1: Period 3|Adverse Event|0
7685679|NCT01244035|26732462|P4|Part 1: Period 3|Adverse Event|0
7685680|NCT01244035|26732463|P3|Part 1: Period 3|Adverse Event|0
7685681|NCT01244035|26732464|P2|Part 1: Period 3|Adverse Event|0
7685682|NCT01244035|26732465|P1|Part 1: Period 3|Adverse Event|0
7685683|NCT01244035|26732460|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
7685684|NCT01244035|26732461|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
7685685|NCT01244035|26732462|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
7685686|NCT01244035|26732463|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
7685687|NCT01244035|26732464|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
7685688|NCT01244035|26732465|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
7685689|NCT01244035|26732460|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
7685690|NCT01244035|26732461|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
7685691|NCT01244035|26732462|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
7685692|NCT01244035|26732463|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
7685693|NCT01244035|26732464|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
7685694|NCT01244035|26732465|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
7685695|NCT01244035|26732460|P6|Part 1: Period 1|Withdrawal by Subject|0
7685696|NCT01244035|26732461|P5|Part 1: Period 1|Withdrawal by Subject|0
7685697|NCT01244035|26732462|P4|Part 1: Period 1|Withdrawal by Subject|0
7685698|NCT01244035|26732463|P3|Part 1: Period 1|Withdrawal by Subject|0
7685699|NCT01244035|26732464|P2|Part 1: Period 1|Withdrawal by Subject|2
7685700|NCT01244035|26732465|P1|Part 1: Period 1|Withdrawal by Subject|0
7685701|NCT01244035|26732460|P6|Part 1: Period 1|Adverse Event|1
7685702|NCT01244035|26732461|P5|Part 1: Period 1|Adverse Event|0
7685703|NCT01244035|26732462|P4|Part 1: Period 1|Adverse Event|0
7685704|NCT01244035|26732463|P3|Part 1: Period 1|Adverse Event|0
7685705|NCT01244035|26732464|P2|Part 1: Period 1|Adverse Event|0
7685706|NCT01244035|26732465|P1|Part 1: Period 1|Adverse Event|0
7685707|NCT01243944|26732506|P2|Overall Study|Non-compliance with study treatment|0
7685708|NCT01243944|26732507|P1|Overall Study|Non-compliance with study treatment|1
7685709|NCT01243944|26732506|P2|Overall Study|Death|3
7685710|NCT01243944|26732507|P1|Overall Study|Death|2
7685711|NCT01243944|26732506|P2|Overall Study|Participant decision|15
7685712|NCT01243944|26732507|P1|Overall Study|Participant decision|10
7685713|NCT01243944|26732506|P2|Overall Study|Protocol deviation|1
7685714|NCT01243944|26732507|P1|Overall Study|Protocol deviation|1
7685715|NCT01243944|26732506|P2|Overall Study|Disease progression|11
7685716|NCT01243944|26732507|P1|Overall Study|Disease progression|12
7685717|NCT01243944|26732506|P2|Overall Study|Physician Decision|7
7685718|NCT01243944|26732507|P1|Overall Study|Physician Decision|2
7685719|NCT01243944|26732506|P2|Overall Study|Lost to Follow-up|1
7685720|NCT01243944|26732507|P1|Overall Study|Lost to Follow-up|2
7685721|NCT01243944|26732506|P2|Overall Study|Adverse Event|13
7685722|NCT01243944|26732507|P1|Overall Study|Adverse Event|15
7685723|NCT01243892|26732535|P2|Overall Study|Did not meet eligibility criteria|0
7685724|NCT01243892|26732536|P1|Overall Study|Did not meet eligibility criteria|2
7685725|NCT01243775|26732546|P1|Overall Study|Withdrawal by Subject|2
7685726|NCT01243762|26732560|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7685727|NCT01243762|26732561|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7685728|NCT01243762|26732562|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
7685729|NCT01243762|26732563|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
7685730|NCT01243762|26732564|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7685731|NCT01243762|26732565|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7685732|NCT01243762|26732566|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7685733|NCT01243762|26732560|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7685734|NCT01243762|26732561|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7685735|NCT01243762|26732562|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
7685736|NCT01243762|26732563|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7685737|NCT01243762|26732564|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7685738|NCT01243762|26732565|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
7685739|NCT01243762|26732566|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7685740|NCT01243762|26732560|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
7685741|NCT01243762|26732561|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
7685742|NCT01243762|26732562|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
7685743|NCT01243762|26732563|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
7685744|NCT01243762|26732564|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
7685745|NCT01243762|26732565|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
7685746|NCT01243762|26732566|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
7685747|NCT01243762|26732560|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
7685748|NCT01243762|26732561|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7685749|NCT01243762|26732562|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7685750|NCT01243762|26732563|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7685751|NCT01243762|26732564|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7685752|NCT01243762|26732565|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
7685753|NCT01243762|26732566|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7685754|NCT01243762|26732560|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7685755|NCT01243762|26732561|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7685756|NCT01243762|26732562|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7685757|NCT01243762|26732563|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7685758|NCT01243762|26732564|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7685759|NCT01243762|26732565|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
7685760|NCT01243762|26732566|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7685761|NCT01243762|26732560|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
7685762|NCT01243762|26732561|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
7685763|NCT01243762|26732562|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
7685764|NCT01243762|26732563|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
7685765|NCT01243762|26732564|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
7685766|NCT01243762|26732565|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
7685767|NCT01243762|26732566|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
7685768|NCT01243762|26732560|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7685769|NCT01243762|26732561|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7685770|NCT01243762|26732562|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7685771|NCT01243762|26732563|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7685772|NCT01243762|26732564|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7685773|NCT01243762|26732565|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7685774|NCT01243762|26732566|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7685775|NCT01243762|26732560|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7685776|NCT01243762|26732561|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
7685777|NCT01243762|26732562|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
7685778|NCT01243762|26732563|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7685779|NCT01243762|26732564|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7685780|NCT01243762|26732565|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
7685781|NCT01243762|26732566|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7685782|NCT01243671|26732585|P1|Overall Study|Other|1
7685783|NCT01243671|26732585|P1|Overall Study|Anti-adalimumab antibody positive|1
7685784|NCT01243671|26732585|P1|Overall Study|Adverse Event|3
7685785|NCT01243424|26732677|P2|Discontinuation From Treatment|Other than listed above|211
7685786|NCT01243424|26732678|P1|Discontinuation From Treatment|Other than listed above|230
7685787|NCT01243424|26732677|P2|Discontinuation From Treatment|Withdrawal by Subject|328
7685788|NCT01243424|26732678|P1|Discontinuation From Treatment|Withdrawal by Subject|309
7685789|NCT01243424|26732677|P2|Discontinuation From Treatment|Lost to Follow-up|28
7685790|NCT01243424|26732678|P1|Discontinuation From Treatment|Lost to Follow-up|24
7685791|NCT01243424|26732677|P2|Discontinuation From Treatment|Protocol Violation|47
7685792|NCT01243424|26732678|P1|Discontinuation From Treatment|Protocol Violation|46
7685793|NCT01243424|26732677|P2|Discontinuation From Treatment|Lack of Efficacy|41
7685794|NCT01243424|26732678|P1|Discontinuation From Treatment|Lack of Efficacy|61
7685795|NCT01243424|26732677|P2|Discontinuation From Treatment|Adverse Event|523
7685796|NCT01243424|26732678|P1|Discontinuation From Treatment|Adverse Event|457
7685797|NCT01243424|26732677|P2|Discontinuation From Treatment|Not treated|4
7685798|NCT01243424|26732678|P1|Discontinuation From Treatment|Not treated|5
7685799|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|Not treated|4
7685800|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|Not treated|5
7685801|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
7685802|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
7685803|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
7685804|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
7685805|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
7685806|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
7685807|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
7685808|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
7685809|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
7685810|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
7685811|NCT01243424|26732677|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
7685812|NCT01243424|26732678|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
7685813|NCT01243411|26732720|P1|Overall Study|Other|8
7685814|NCT01243411|26732720|P1|Overall Study|Adverse Event|5
7685815|NCT01243411|26732720|P1|Overall Study|Lost to Follow-up|10
7685816|NCT01243411|26732720|P1|Overall Study|Withdrawal by Subject|18
7685817|NCT01243268|26732831|P1|Overall Study|Duplicate subject|2
7685818|NCT01243268|26732831|P1|Overall Study|Deviation with contract date|7
7685819|NCT01243268|26732831|P1|Overall Study|Protocol Violation|51
7685820|NCT01243268|26732831|P1|Overall Study|Lost to Follow-up|4
7685821|NCT01243242|26732841|P2|Overall Study|non compliance|0
7685822|NCT01243242|26732842|P1|Overall Study|non compliance|1
7685823|NCT01243242|26732841|P2|Overall Study|sponsor decision|1
7685824|NCT01243242|26732842|P1|Overall Study|sponsor decision|0
7685825|NCT01243242|26732841|P2|Overall Study|Physician Decision|1
7685826|NCT01243242|26732842|P1|Overall Study|Physician Decision|0
7685827|NCT01243242|26732841|P2|Overall Study|Withdrawal by Subject|1
7685828|NCT01243242|26732842|P1|Overall Study|Withdrawal by Subject|1
7685829|NCT01243242|26732841|P2|Overall Study|Adverse Event|1
7685830|NCT01243242|26732842|P1|Overall Study|Adverse Event|1
7685831|NCT01243177|26732856|P2|Overall Study|Other Reason|12
7685832|NCT01243177|26732857|P1|Overall Study|Other Reason|11
7685833|NCT01243177|26732856|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7685834|NCT01243177|26732857|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7685835|NCT01243177|26732856|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
7685836|NCT01243177|26732857|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
7685837|NCT01243177|26732856|P2|Overall Study|AE, non-serious non-fatal|58
7685838|NCT01243177|26732857|P1|Overall Study|AE, non-serious non-fatal|40
7685839|NCT01243177|26732856|P2|Overall Study|SAE, non-fatal|9
7685840|NCT01243177|26732857|P1|Overall Study|SAE, non-fatal|7
7685841|NCT01243177|26732856|P2|Overall Study|AE, serious fatal|1
7685842|NCT01243177|26732857|P1|Overall Study|AE, serious fatal|0
7685843|NCT01243177|26732856|P2|Overall Study|Withdrawal by Subject|38
7685844|NCT01243177|26732857|P1|Overall Study|Withdrawal by Subject|46
7685845|NCT01243177|26732856|P2|Overall Study|Lost to Follow-up|18
7685846|NCT01243177|26732857|P1|Overall Study|Lost to Follow-up|15
7685847|NCT01243177|26732856|P2|Overall Study|Protocol Violation|10
7685848|NCT01243177|26732857|P1|Overall Study|Protocol Violation|11
7685849|NCT01243177|26732856|P2|Overall Study|Lack of Efficacy|31
7685850|NCT01243177|26732857|P1|Overall Study|Lack of Efficacy|47
7685851|NCT01243151|26732878|P5|Overall Study|Randomized but not treated|0
7685852|NCT01243151|26732879|P4|Overall Study|Randomized but not treated|1
7685853|NCT01243151|26732880|P3|Overall Study|Randomized but not treated|0
7685854|NCT01243151|26732881|P2|Overall Study|Randomized but not treated|0
7685855|NCT01243151|26732882|P1|Overall Study|Randomized but not treated|0
7685856|NCT01243151|26732878|P5|Overall Study|Other|0
7685857|NCT01243151|26732879|P4|Overall Study|Other|1
7685858|NCT01243151|26732880|P3|Overall Study|Other|0
7685859|NCT01243151|26732881|P2|Overall Study|Other|0
7685860|NCT01243151|26732882|P1|Overall Study|Other|0
7685861|NCT01243151|26732878|P5|Overall Study|Protocol Violation|0
7685862|NCT01243151|26732879|P4|Overall Study|Protocol Violation|0
7685863|NCT01243151|26732880|P3|Overall Study|Protocol Violation|1
7685864|NCT01243151|26732881|P2|Overall Study|Protocol Violation|0
7685865|NCT01243151|26732882|P1|Overall Study|Protocol Violation|0
7685866|NCT01243151|26732878|P5|Overall Study|Adverse Event|0
7685867|NCT01243151|26732879|P4|Overall Study|Adverse Event|0
7685868|NCT01243151|26732880|P3|Overall Study|Adverse Event|0
7685869|NCT01243151|26732881|P2|Overall Study|Adverse Event|1
7685870|NCT01243151|26732882|P1|Overall Study|Adverse Event|0
7685871|NCT01242813|26733126|P1|Overall Study|Lost to Follow-up|2
7685872|NCT01242748|26733148|P2|Overall Study|Miscellaneous reasons|3
7685873|NCT01242748|26733149|P1|Overall Study|Miscellaneous reasons|8
7685874|NCT01242748|26733148|P2|Overall Study|Withdrawal by Subject|2
7685875|NCT01242748|26733149|P1|Overall Study|Withdrawal by Subject|10
7685876|NCT01242748|26733148|P2|Overall Study|Protocol Violation|0
7685877|NCT01242748|26733149|P1|Overall Study|Protocol Violation|1
7685878|NCT01242748|26733148|P2|Overall Study|Physician Decision|2
7685879|NCT01242748|26733149|P1|Overall Study|Physician Decision|3
7685880|NCT01242748|26733148|P2|Overall Study|Lost to Follow-up|2
7685881|NCT01242748|26733149|P1|Overall Study|Lost to Follow-up|6
7685882|NCT01242748|26733148|P2|Overall Study|Adverse Event|5
7685883|NCT01242748|26733149|P1|Overall Study|Adverse Event|10
7685884|NCT01242514|26733223|P3|Overall Study|Adverse Event|19
7685885|NCT01242514|26733224|P2|Overall Study|Adverse Event|18
7685886|NCT01242514|26733225|P1|Overall Study|Adverse Event|129
7685887|NCT01242514|26733223|P3|Overall Study|Lost to Follow-up|4
7685888|NCT01242514|26733224|P2|Overall Study|Lost to Follow-up|5
7685889|NCT01242514|26733225|P1|Overall Study|Lost to Follow-up|14
7685890|NCT01242514|26733223|P3|Overall Study|Dev. of study specific discont. criteria|5
7685891|NCT01242514|26733224|P2|Overall Study|Dev. of study specific discont. criteria|3
7685892|NCT01242514|26733225|P1|Overall Study|Dev. of study specific discont. criteria|21
7685893|NCT01242514|26733223|P3|Overall Study|Lack of therapeutic response|10
7685894|NCT01242514|26733224|P2|Overall Study|Lack of therapeutic response|16
7685895|NCT01242514|26733225|P1|Overall Study|Lack of therapeutic response|99
7685896|NCT01242514|26733223|P3|Overall Study|Severe non-compliance to protocol|1
7685897|NCT01242514|26733224|P2|Overall Study|Severe non-compliance to protocol|2
7685898|NCT01242514|26733225|P1|Overall Study|Severe non-compliance to protocol|5
7685899|NCT01242514|26733223|P3|Overall Study|Subject decision|2
7685900|NCT01242514|26733224|P2|Overall Study|Subject decision|8
7685901|NCT01242514|26733225|P1|Overall Study|Subject decision|33
7685902|NCT01242514|26733223|P3|Overall Study|e.g., project closure|171
7685903|NCT01242514|26733224|P2|Overall Study|e.g., project closure|305
7685904|NCT01242514|26733225|P1|Overall Study|e.g., project closure|1042
7685905|NCT01242371|26733244|P2|Overall Study|Protocol Violation|3
7685906|NCT01242371|26733245|P1|Overall Study|Protocol Violation|0
7685907|NCT01242371|26733244|P2|Overall Study|Withdrawal by Subject|2
7685908|NCT01242371|26733245|P1|Overall Study|Withdrawal by Subject|2
7685909|NCT01242176|26733262|P2|Washout Period of 7 Days|Non-compliant with protocol|0
7685910|NCT01242176|26733263|P1|Washout Period of 7 Days|Non-compliant with protocol|1
7685911|NCT01242176|26733262|P2|Washout Period of 7 Days|Adverse Event|2
7685912|NCT01242176|26733263|P1|Washout Period of 7 Days|Adverse Event|0
7685913|NCT01242111|26733273|P1|Overall Study|Did not consent to MOR-100 follow-up|1
7685914|NCT01242111|26733273|P1|Overall Study|Withdrawal by Subject|1
7685915|NCT01242111|26733273|P1|Overall Study|Adverse Event|1
7685916|NCT01242085|26733285|P3|Overall Study|medically unable to have surgery|0
7685917|NCT01242085|26733286|P2|Overall Study|medically unable to have surgery|5
7685918|NCT01242085|26733287|P1|Overall Study|medically unable to have surgery|4
7685919|NCT01242085|26733285|P3|Overall Study|Withdrawal by Subject|0
7685920|NCT01242085|26733286|P2|Overall Study|Withdrawal by Subject|2
7685921|NCT01242085|26733287|P1|Overall Study|Withdrawal by Subject|4
7685922|NCT01242020|26733297|P2|Overall Study|Failed screening|0
7685923|NCT01242020|26733298|P1|Overall Study|Failed screening|1
7685924|NCT01242020|26733297|P2|Overall Study|Withdrawal by Subject|0
7685925|NCT01242020|26733298|P1|Overall Study|Withdrawal by Subject|2
7685926|NCT01241760|26733328|P2|Overall Study|Other|1
7685927|NCT01241760|26733329|P1|Overall Study|Other|1
7685928|NCT01241760|26733328|P2|Overall Study|Switch To Commercially Available Medicat|4
7685929|NCT01241760|26733329|P1|Overall Study|Switch To Commercially Available Medicat|1
7685930|NCT01241760|26733328|P2|Overall Study|Withdrawal by Subject|13
7685931|NCT01241760|26733329|P1|Overall Study|Withdrawal by Subject|13
7685932|NCT01241760|26733328|P2|Overall Study|Lost to Follow-up|22
7685933|NCT01241760|26733329|P1|Overall Study|Lost to Follow-up|18
7685934|NCT01241760|26733328|P2|Overall Study|Adverse Event|0
7685935|NCT01241760|26733329|P1|Overall Study|Adverse Event|1
7685936|NCT01241604|26733348|P3|Screening Period|Screen Failure|0
7685937|NCT01241604|26733349|P2|Screening Period|Screen Failure|0
7685938|NCT01241604|26733350|P1|Screening Period|Screen Failure|3
7685939|NCT01241591|26733395|P4|Overall Study|Adverse Event|4
7685940|NCT01241591|26733396|P3|Overall Study|Adverse Event|12
7685941|NCT01241591|26733397|P2|Overall Study|Adverse Event|11
7685942|NCT01241591|26733398|P1|Overall Study|Adverse Event|3
7685943|NCT01241591|26733395|P4|Overall Study|Other|1
7685944|NCT01241591|26733396|P3|Overall Study|Other|0
7685945|NCT01241591|26733397|P2|Overall Study|Other|1
7685946|NCT01241591|26733398|P1|Overall Study|Other|0
7685947|NCT01241591|26733395|P4|Overall Study|Withdrawal by Subject|2
7685948|NCT01241591|26733396|P3|Overall Study|Withdrawal by Subject|2
7685949|NCT01241591|26733397|P2|Overall Study|Withdrawal by Subject|4
7685950|NCT01241591|26733398|P1|Overall Study|Withdrawal by Subject|6
7685951|NCT01241591|26733395|P4|Overall Study|Screen Failure|0
7685952|NCT01241591|26733396|P3|Overall Study|Screen Failure|1
7685953|NCT01241591|26733397|P2|Overall Study|Screen Failure|2
7685954|NCT01241591|26733398|P1|Overall Study|Screen Failure|3
7685955|NCT01241591|26733395|P4|Overall Study|Lost to Follow-up|2
7685956|NCT01241591|26733396|P3|Overall Study|Lost to Follow-up|2
7685957|NCT01241591|26733397|P2|Overall Study|Lost to Follow-up|2
7685958|NCT01241591|26733398|P1|Overall Study|Lost to Follow-up|1
7685959|NCT01241591|26733395|P4|Overall Study|Protocol Violation|0
7685960|NCT01241591|26733396|P3|Overall Study|Protocol Violation|3
7685961|NCT01241591|26733397|P2|Overall Study|Protocol Violation|2
7685962|NCT01241591|26733398|P1|Overall Study|Protocol Violation|5
7685963|NCT01241591|26733395|P4|Overall Study|Lack of Efficacy|3
7685964|NCT01241591|26733396|P3|Overall Study|Lack of Efficacy|2
7685965|NCT01241591|26733397|P2|Overall Study|Lack of Efficacy|2
7685966|NCT01241591|26733398|P1|Overall Study|Lack of Efficacy|5
7685967|NCT01241552|26733601|P4|Overall Study|Lost to Follow-up|16
7685968|NCT01241552|26733602|P3|Overall Study|Lost to Follow-up|15
7685969|NCT01241552|26733603|P2|Overall Study|Lost to Follow-up|11
7685970|NCT01241552|26733604|P1|Overall Study|Lost to Follow-up|2
7685971|NCT01241552|26733601|P4|Overall Study|Physician Decision|3
7685972|NCT01241552|26733602|P3|Overall Study|Physician Decision|2
7685973|NCT01241552|26733603|P2|Overall Study|Physician Decision|4
7685974|NCT01241552|26733604|P1|Overall Study|Physician Decision|2
7685975|NCT01241552|26733601|P4|Overall Study|Withdrawal by Subject|15
7685976|NCT01241552|26733602|P3|Overall Study|Withdrawal by Subject|14
7685977|NCT01241552|26733603|P2|Overall Study|Withdrawal by Subject|15
7685978|NCT01241552|26733604|P1|Overall Study|Withdrawal by Subject|7
7685979|NCT01241552|26733601|P4|Overall Study|Protocol Violation|1
7685980|NCT01241552|26733602|P3|Overall Study|Protocol Violation|6
7685981|NCT01241552|26733603|P2|Overall Study|Protocol Violation|2
7685982|NCT01241552|26733604|P1|Overall Study|Protocol Violation|0
7685983|NCT01241552|26733601|P4|Overall Study|Progressive Disease|2
7685984|NCT01241552|26733602|P3|Overall Study|Progressive Disease|1
7685985|NCT01241552|26733603|P2|Overall Study|Progressive Disease|0
7685986|NCT01241552|26733604|P1|Overall Study|Progressive Disease|0
7685987|NCT01241552|26733601|P4|Overall Study|Technical Problems|2
7685988|NCT01241552|26733602|P3|Overall Study|Technical Problems|2
7685989|NCT01241552|26733603|P2|Overall Study|Technical Problems|0
7685990|NCT01241552|26733604|P1|Overall Study|Technical Problems|2
7685991|NCT01241552|26733601|P4|Overall Study|Adverse Event|0
7685992|NCT01241552|26733602|P3|Overall Study|Adverse Event|0
7685993|NCT01241552|26733603|P2|Overall Study|Adverse Event|1
7685994|NCT01241552|26733604|P1|Overall Study|Adverse Event|1
7685995|NCT01241552|26733601|P4|Overall Study|Death|25
7685996|NCT01241552|26733602|P3|Overall Study|Death|20
7685997|NCT01241552|26733603|P2|Overall Study|Death|30
7685998|NCT01241552|26733604|P1|Overall Study|Death|26
7685999|NCT01241552|26733601|P4|Overall Study|Lack of Efficacy|0
7686000|NCT01241552|26733602|P3|Overall Study|Lack of Efficacy|0
7686001|NCT01241552|26733603|P2|Overall Study|Lack of Efficacy|0
7686002|NCT01241552|26733604|P1|Overall Study|Lack of Efficacy|1
7686003|NCT01241461|26733699|P2|Overall Study|Progressive Disease|6
7686004|NCT01241461|26733700|P1|Overall Study|Progressive Disease|3
7686005|NCT01241448|26733720|P4|Overall Study|Excluded due to data integrity issues|2
7686006|NCT01241448|26733721|P3|Overall Study|Excluded due to data integrity issues|2
7686007|NCT01241448|26733722|P2|Overall Study|Excluded due to data integrity issues|2
7686008|NCT01241448|26733723|P1|Overall Study|Excluded due to data integrity issues|3
7686009|NCT01241448|26733720|P4|Overall Study|Withdrawal by Subject|6
7686010|NCT01241448|26733721|P3|Overall Study|Withdrawal by Subject|3
7686011|NCT01241448|26733722|P2|Overall Study|Withdrawal by Subject|5
7686012|NCT01241448|26733723|P1|Overall Study|Withdrawal by Subject|4
7686013|NCT01241448|26733720|P4|Overall Study|Sponsor Decision|6
7686014|NCT01241448|26733721|P3|Overall Study|Sponsor Decision|12
7686015|NCT01241448|26733722|P2|Overall Study|Sponsor Decision|14
7686016|NCT01241448|26733723|P1|Overall Study|Sponsor Decision|17
7686017|NCT01241448|26733720|P4|Overall Study|Protocol Violation|6
7686018|NCT01241448|26733721|P3|Overall Study|Protocol Violation|3
7686019|NCT01241448|26733722|P2|Overall Study|Protocol Violation|5
7686020|NCT01241448|26733723|P1|Overall Study|Protocol Violation|10
7686021|NCT01241448|26733720|P4|Overall Study|Physician Decision|0
7686022|NCT01241448|26733721|P3|Overall Study|Physician Decision|0
7686023|NCT01241448|26733722|P2|Overall Study|Physician Decision|2
7686024|NCT01241448|26733723|P1|Overall Study|Physician Decision|0
7686025|NCT01241448|26733720|P4|Overall Study|Lost to Follow-up|1
7686026|NCT01241448|26733721|P3|Overall Study|Lost to Follow-up|1
7686027|NCT01241448|26733722|P2|Overall Study|Lost to Follow-up|1
7686028|NCT01241448|26733723|P1|Overall Study|Lost to Follow-up|2
7686029|NCT01241448|26733720|P4|Overall Study|Adverse Event|2
7686030|NCT01241448|26733721|P3|Overall Study|Adverse Event|2
7686031|NCT01241448|26733722|P2|Overall Study|Adverse Event|0
7686032|NCT01241448|26733723|P1|Overall Study|Adverse Event|1
7686033|NCT01241318|26733830|P2|Overall Study|Woman: Stillborn infant|146
7686034|NCT01241318|26733831|P1|Overall Study|Woman: Stillborn infant|129
7686035|NCT01241318|26733830|P2|Overall Study|Withdrew/Lost to Follow after delivery|38
7686036|NCT01241318|26733831|P1|Overall Study|Withdrew/Lost to Follow after delivery|60
7686037|NCT01241318|26733830|P2|Overall Study|Death|4
7686038|NCT01241318|26733831|P1|Overall Study|Death|2
7686039|NCT01241318|26733830|P2|Overall Study|Lost to Follow-up|455
7686040|NCT01241318|26733831|P1|Overall Study|Lost to Follow-up|740
7686041|NCT01241318|26733830|P2|Overall Study|Withdrawal by Subject|46
7686042|NCT01241318|26733831|P1|Overall Study|Withdrawal by Subject|175
7686043|NCT01241318|26733830|P2|Overall Study|Woman: miscarriage/abortion|38
7686044|NCT01241318|26733831|P1|Overall Study|Woman: miscarriage/abortion|46
7686045|NCT01241318|26733830|P2|Overall Study|Woman: false pregnancies|15
7686046|NCT01241318|26733831|P1|Overall Study|Woman: false pregnancies|27
7686047|NCT01241292|26733848|P2|Overall Study|Participant Discontinued Treatment|2
7686048|NCT01241292|26733849|P1|Overall Study|Participant Discontinued Treatment|0
7686049|NCT01241292|26733848|P2|Overall Study|Study Drug Toxicity|1
7686050|NCT01241292|26733849|P1|Overall Study|Study Drug Toxicity|0
7686051|NCT01241292|26733848|P2|Overall Study|Disease Progression|0
7686052|NCT01241292|26733849|P1|Overall Study|Disease Progression|2
7686053|NCT01241292|26733848|P2|Overall Study|Administrative Reason by Sponsor|0
7686054|NCT01241292|26733849|P1|Overall Study|Administrative Reason by Sponsor|1
7686055|NCT01241279|26733873|P2|Overall Study|Lost to Follow-up|1
7686056|NCT01241279|26733874|P1|Overall Study|Lost to Follow-up|0
7686057|NCT01241240|26733884|P2|Overall Study|Personal Reasons|1
7686058|NCT01241240|26733885|P1|Overall Study|Personal Reasons|1
7686059|NCT01241240|26733884|P2|Overall Study|Lost to Follow-up|4
7686060|NCT01241240|26733885|P1|Overall Study|Lost to Follow-up|2
7686061|NCT01241240|26733884|P2|Overall Study|Adverse Event|4
7686062|NCT01241240|26733885|P1|Overall Study|Adverse Event|5
7686063|NCT01240915|26733903|P9|Overall Study|Insufficient Clinical Response|3
7686064|NCT01240915|26733904|P8|Overall Study|Insufficient Clinical Response|0
7686065|NCT01240915|26733905|P7|Overall Study|Insufficient Clinical Response|6
7686066|NCT01240915|26733906|P6|Overall Study|Insufficient Clinical Response|3
7686067|NCT01240915|26733907|P5|Overall Study|Insufficient Clinical Response|1
7686068|NCT01240915|26733908|P4|Overall Study|Insufficient Clinical Response|0
7686069|NCT01240915|26733909|P3|Overall Study|Insufficient Clinical Response|0
7686070|NCT01240915|26733910|P2|Overall Study|Insufficient Clinical Response|0
7686071|NCT01240915|26733911|P1|Overall Study|Insufficient Clinical Response|0
7686072|NCT01240915|26733903|P9|Overall Study|Other|0
7686073|NCT01240915|26733904|P8|Overall Study|Other|0
7686074|NCT01240915|26733905|P7|Overall Study|Other|0
7686075|NCT01240915|26733906|P6|Overall Study|Other|0
7686076|NCT01240915|26733907|P5|Overall Study|Other|2
7686077|NCT01240915|26733908|P4|Overall Study|Other|0
7686078|NCT01240915|26733909|P3|Overall Study|Other|0
7686079|NCT01240915|26733910|P2|Overall Study|Other|0
7686080|NCT01240915|26733911|P1|Overall Study|Other|0
7686081|NCT01240915|26733903|P9|Overall Study|Withdrawal by Subject|3
7686082|NCT01240915|26733904|P8|Overall Study|Withdrawal by Subject|3
7686083|NCT01240915|26733905|P7|Overall Study|Withdrawal by Subject|2
7686084|NCT01240915|26733906|P6|Overall Study|Withdrawal by Subject|4
7686085|NCT01240915|26733907|P5|Overall Study|Withdrawal by Subject|0
7686086|NCT01240915|26733908|P4|Overall Study|Withdrawal by Subject|2
7686087|NCT01240915|26733909|P3|Overall Study|Withdrawal by Subject|0
7686088|NCT01240915|26733910|P2|Overall Study|Withdrawal by Subject|1
7686089|NCT01240915|26733911|P1|Overall Study|Withdrawal by Subject|2
7686090|NCT01240915|26733903|P9|Overall Study|Lost to Follow-up|1
7686091|NCT01240915|26733904|P8|Overall Study|Lost to Follow-up|1
7686092|NCT01240915|26733905|P7|Overall Study|Lost to Follow-up|0
7686093|NCT01240915|26733906|P6|Overall Study|Lost to Follow-up|1
7686094|NCT01240915|26733907|P5|Overall Study|Lost to Follow-up|1
7686095|NCT01240915|26733908|P4|Overall Study|Lost to Follow-up|0
7686096|NCT01240915|26733909|P3|Overall Study|Lost to Follow-up|0
7686097|NCT01240915|26733910|P2|Overall Study|Lost to Follow-up|0
7686098|NCT01240915|26733911|P1|Overall Study|Lost to Follow-up|0
7686099|NCT01240915|26733903|P9|Overall Study|Adverse Event|1
7686100|NCT01240915|26733904|P8|Overall Study|Adverse Event|0
7686101|NCT01240915|26733905|P7|Overall Study|Adverse Event|0
7686102|NCT01240915|26733906|P6|Overall Study|Adverse Event|2
7686103|NCT01240915|26733907|P5|Overall Study|Adverse Event|0
7686104|NCT01240915|26733908|P4|Overall Study|Adverse Event|1
7686105|NCT01240915|26733909|P3|Overall Study|Adverse Event|0
7686106|NCT01240915|26733910|P2|Overall Study|Adverse Event|0
7686107|NCT01240915|26733911|P1|Overall Study|Adverse Event|0
7686108|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
7686109|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
7686110|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
7686111|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Other|5
7686112|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Other|1
7686113|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Other|0
7686114|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
7686115|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
7686116|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
7686117|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
7686118|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
7686119|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7686120|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
7686121|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7686122|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7686123|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
7686124|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
7686125|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7686126|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7686127|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7686128|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7686129|NCT01240863|26734185|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
7686130|NCT01240863|26734186|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
7686131|NCT01240863|26734187|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7686132|NCT01240863|26734185|P3|Open-label Titration Period|Other|0
7686133|NCT01240863|26734186|P2|Open-label Titration Period|Other|0
7686134|NCT01240863|26734187|P1|Open-label Titration Period|Other|7
7686135|NCT01240863|26734185|P3|Open-label Titration Period|Dropped out prior to dosing|0
7686136|NCT01240863|26734186|P2|Open-label Titration Period|Dropped out prior to dosing|0
7686137|NCT01240863|26734187|P1|Open-label Titration Period|Dropped out prior to dosing|2
7686138|NCT01240863|26734185|P3|Open-label Titration Period|Noncompliance to study procedures|0
7686139|NCT01240863|26734186|P2|Open-label Titration Period|Noncompliance to study procedures|0
7686140|NCT01240863|26734187|P1|Open-label Titration Period|Noncompliance to study procedures|3
7686141|NCT01240863|26734185|P3|Open-label Titration Period|Noncompliance to study drug admin|0
7686142|NCT01240863|26734186|P2|Open-label Titration Period|Noncompliance to study drug admin|0
7686143|NCT01240863|26734187|P1|Open-label Titration Period|Noncompliance to study drug admin|3
7686144|NCT01240863|26734185|P3|Open-label Titration Period|Protocol Violation|0
7686145|NCT01240863|26734186|P2|Open-label Titration Period|Protocol Violation|0
7686146|NCT01240863|26734187|P1|Open-label Titration Period|Protocol Violation|7
7686147|NCT01240863|26734185|P3|Open-label Titration Period|Withdrawal by Subject|0
7686148|NCT01240863|26734186|P2|Open-label Titration Period|Withdrawal by Subject|0
7686149|NCT01240863|26734187|P1|Open-label Titration Period|Withdrawal by Subject|9
7686150|NCT01240863|26734185|P3|Open-label Titration Period|Lack of Efficacy|0
7686151|NCT01240863|26734186|P2|Open-label Titration Period|Lack of Efficacy|0
7686152|NCT01240863|26734187|P1|Open-label Titration Period|Lack of Efficacy|19
7686153|NCT01240863|26734185|P3|Open-label Titration Period|Adverse Event|0
7686154|NCT01240863|26734186|P2|Open-label Titration Period|Adverse Event|0
7686155|NCT01240863|26734187|P1|Open-label Titration Period|Adverse Event|47
7686156|NCT01240811|26734249|P3|Overall Study|Withdrawal by Subject|1
7686157|NCT01240811|26734250|P2|Overall Study|Withdrawal by Subject|0
7686158|NCT01240811|26734251|P1|Overall Study|Withdrawal by Subject|0
7686159|NCT01240811|26734249|P3|Overall Study|Physician Decision|0
7686160|NCT01240811|26734250|P2|Overall Study|Physician Decision|1
7686161|NCT01240811|26734251|P1|Overall Study|Physician Decision|0
7686162|NCT01240785|26734267|P2|Overall Study|Protocol Violation|3
7686163|NCT01240785|26734268|P1|Overall Study|Protocol Violation|0
7686164|NCT01240785|26734267|P2|Overall Study|Lost to Follow-up|0
7686165|NCT01240785|26734268|P1|Overall Study|Lost to Follow-up|1
7686166|NCT01240746|26734299|P3|Overall Study|Withdrawal by Subject|59
7686167|NCT01240746|26734300|P2|Overall Study|Withdrawal by Subject|13
7686168|NCT01240746|26734301|P1|Overall Study|Withdrawal by Subject|10
7686169|NCT01240746|26734299|P3|Overall Study|Protocol Violation|72
7686170|NCT01240746|26734300|P2|Overall Study|Protocol Violation|15
7686171|NCT01240746|26734301|P1|Overall Study|Protocol Violation|24
7686172|NCT01240746|26734299|P3|Overall Study|Lost to Follow-up|102
7686173|NCT01240746|26734300|P2|Overall Study|Lost to Follow-up|20
7686174|NCT01240746|26734301|P1|Overall Study|Lost to Follow-up|23
7686175|NCT01240746|26734299|P3|Overall Study|Adverse Event|10
7686176|NCT01240746|26734300|P2|Overall Study|Adverse Event|0
7686177|NCT01240746|26734301|P1|Overall Study|Adverse Event|2
7686178|NCT01240590|26734356|P5|Phase II|Refused further treatment|1
7686179|NCT01240590|26734357|P4|Phase II|Refused further treatment|2
7686180|NCT01240590|26734358|P3|Phase II|Refused further treatment|0
7686181|NCT01240590|26734359|P2|Phase II|Refused further treatment|0
7686182|NCT01240590|26734360|P1|Phase II|Refused further treatment|0
7686183|NCT01240590|26734356|P5|Phase I|Refused further treatment|0
7686184|NCT01240590|26734357|P4|Phase I|Refused further treatment|0
7686185|NCT01240590|26734358|P3|Phase I|Refused further treatment|3
7686186|NCT01240590|26734359|P2|Phase I|Refused further treatment|0
7686187|NCT01240590|26734360|P1|Phase I|Refused further treatment|0
7686188|NCT01240551|26734388|P2|Overall Study|Lost to Follow-up|1
7686189|NCT01240551|26734389|P1|Overall Study|Lost to Follow-up|1
7686190|NCT01240551|26734388|P2|Overall Study|Refused further treatment|2
7686191|NCT01240551|26734389|P1|Overall Study|Refused further treatment|3
7686192|NCT01240382|26734399|P2|Overall Study|Fear of adverse events|1
7686193|NCT01240382|26734400|P1|Overall Study|Fear of adverse events|0
7686194|NCT01240382|26734399|P2|Overall Study|Lack of Efficacy|2
7686195|NCT01240382|26734400|P1|Overall Study|Lack of Efficacy|0
7686196|NCT01240382|26734399|P2|Overall Study|Adverse Event|1
7686197|NCT01240382|26734400|P1|Overall Study|Adverse Event|2
7686198|NCT01240356|26734410|P2|Overall Study|MRI contraindication|0
7686199|NCT01240356|26734411|P1|Overall Study|MRI contraindication|1
7686200|NCT01240356|26734410|P2|Overall Study|Withdrawal by Subject|0
7686201|NCT01240356|26734411|P1|Overall Study|Withdrawal by Subject|2
7686202|NCT01240200|26734434|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
7686203|NCT01240200|26734435|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
7686204|NCT01240135|26734453|P2|Period Two, 14 Days of Wear|Adverse Event|1
7686205|NCT01240135|26734454|P1|Period Two, 14 Days of Wear|Adverse Event|0
7686206|NCT01240135|26734453|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
7686207|NCT01240135|26734454|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
7686208|NCT01239992|26734471|P1|Overall Study|Withdrawal by Subject|2
7686225|NCT01239745|26734489|P1|Overall Study|Adverse Event|1
7686226|NCT01239745|26734489|P1|Overall Study|Study terminated by sponsor|45
7686227|NCT01239732|26734500|P1|Overall Study|Other|19
7686228|NCT01239732|26734500|P1|Overall Study|Treatment failure|2
7686229|NCT01239732|26734500|P1|Overall Study|Investigator's decision|4
7686230|NCT01239732|26734500|P1|Overall Study|Study termination by sponsor|2
7686231|NCT01239732|26734500|P1|Overall Study|Participant non compliance|5
7686232|NCT01239732|26734500|P1|Overall Study|Protocol Violation|3
7686233|NCT01239732|26734500|P1|Overall Study|Adverse Event|6
7686234|NCT01239732|26734500|P1|Overall Study|Withdrawal by Subject|87
7686235|NCT01239732|26734500|P1|Overall Study|Death|226
7686236|NCT01239732|26734500|P1|Overall Study|Termination of study per protocol|667
7686237|NCT01239680|26734513|P2|Overall Study|Withdrawal by Subject|0
7686238|NCT01239680|26734514|P1|Overall Study|Withdrawal by Subject|2
7686239|NCT01239472|26734539|P2|Overall Study|Lack of Efficacy|1
7686240|NCT01239472|26734540|P1|Overall Study|Lack of Efficacy|0
7686241|NCT01239472|26734539|P2|Overall Study|Adverse Event|1
7686242|NCT01239472|26734540|P1|Overall Study|Adverse Event|0
7686243|NCT01239472|26734539|P2|Overall Study|Withdrawal by Subject|1
7686244|NCT01239472|26734540|P1|Overall Study|Withdrawal by Subject|5
7686245|NCT01239394|26734548|P1|Overall Study|Adverse Event|1
7686246|NCT01239381|26734555|P1|Overall Study|Withdrawal by Subject|1
7686247|NCT01239381|26734555|P1|Overall Study|Protocol Violation|1
7686248|NCT01239368|26734575|P10|Overall Study|Death|0
7686249|NCT01239368|26734576|P9|Overall Study|Death|0
7686250|NCT01239368|26734577|P8|Overall Study|Death|0
7686251|NCT01239368|26734578|P7|Overall Study|Death|1
7686252|NCT01239368|26734579|P6|Overall Study|Death|0
7686253|NCT01239368|26734580|P5|Overall Study|Death|0
7686254|NCT01239368|26734581|P4|Overall Study|Death|0
7686255|NCT01239368|26734582|P3|Overall Study|Death|0
7686256|NCT01239368|26734583|P2|Overall Study|Death|0
7686257|NCT01239368|26734584|P1|Overall Study|Death|0
7686258|NCT01239368|26734575|P10|Overall Study|Refused further treatment|1
7686259|NCT01239368|26734576|P9|Overall Study|Refused further treatment|0
7686260|NCT01239368|26734577|P8|Overall Study|Refused further treatment|0
7686261|NCT01239368|26734578|P7|Overall Study|Refused further treatment|0
7686262|NCT01239368|26734579|P6|Overall Study|Refused further treatment|0
7686263|NCT01239368|26734580|P5|Overall Study|Refused further treatment|0
7686264|NCT01239368|26734581|P4|Overall Study|Refused further treatment|0
7686265|NCT01239368|26734582|P3|Overall Study|Refused further treatment|0
7686266|NCT01239368|26734583|P2|Overall Study|Refused further treatment|0
7686267|NCT01239368|26734584|P1|Overall Study|Refused further treatment|0
7686268|NCT01239368|26734575|P10|Overall Study|Disease progression on study|2
7686269|NCT01239368|26734576|P9|Overall Study|Disease progression on study|0
7686270|NCT01239368|26734577|P8|Overall Study|Disease progression on study|0
7686271|NCT01239368|26734578|P7|Overall Study|Disease progression on study|5
7686272|NCT01239368|26734579|P6|Overall Study|Disease progression on study|2
7686273|NCT01239368|26734580|P5|Overall Study|Disease progression on study|4
7686274|NCT01239368|26734581|P4|Overall Study|Disease progression on study|1
7686275|NCT01239368|26734582|P3|Overall Study|Disease progression on study|1
7686276|NCT01239368|26734583|P2|Overall Study|Disease progression on study|1
7686277|NCT01239368|26734584|P1|Overall Study|Disease progression on study|1
7686278|NCT01239368|26734575|P10|Overall Study|Principal investigator discretion|1
7686279|NCT01239368|26734576|P9|Overall Study|Principal investigator discretion|0
7686280|NCT01239368|26734577|P8|Overall Study|Principal investigator discretion|0
7686281|NCT01239368|26734578|P7|Overall Study|Principal investigator discretion|0
7686282|NCT01239368|26734579|P6|Overall Study|Principal investigator discretion|2
7686283|NCT01239368|26734580|P5|Overall Study|Principal investigator discretion|1
7686284|NCT01239368|26734581|P4|Overall Study|Principal investigator discretion|0
7686285|NCT01239368|26734582|P3|Overall Study|Principal investigator discretion|0
7686286|NCT01239368|26734583|P2|Overall Study|Principal investigator discretion|0
7686287|NCT01239368|26734584|P1|Overall Study|Principal investigator discretion|1
7686288|NCT01239342|26734636|P2|Overall Study|Reason Unknown|1
7686289|NCT01239342|26734637|P1|Overall Study|Reason Unknown|1
7686290|NCT01239342|26734636|P2|Overall Study|Withdrawal by Subject|5
7686291|NCT01239342|26734637|P1|Overall Study|Withdrawal by Subject|1
7686292|NCT01239342|26734636|P2|Overall Study|Adverse Event|0
7686293|NCT01239342|26734637|P1|Overall Study|Adverse Event|1
7686294|NCT01239316|26734653|P1|Overall Study|Adverse Event|1
7686295|NCT01239316|26734653|P1|Overall Study|Progression/Relapse|11
7686296|NCT01239160|26734667|P3|Overall Study|Early Termination Due to Study Closure|6
7686297|NCT01239160|26734668|P2|Overall Study|Early Termination Due to Study Closure|1
7686298|NCT01239160|26734669|P1|Overall Study|Early Termination Due to Study Closure|0
7686299|NCT01239160|26734667|P3|Overall Study|Physician Decision|2
7686300|NCT01239160|26734668|P2|Overall Study|Physician Decision|7
7686301|NCT01239160|26734669|P1|Overall Study|Physician Decision|5
7686302|NCT01239160|26734667|P3|Overall Study|Withdrawal by Subject|2
7686303|NCT01239160|26734668|P2|Overall Study|Withdrawal by Subject|6
7686304|NCT01239160|26734669|P1|Overall Study|Withdrawal by Subject|17
7686305|NCT01239160|26734667|P3|Overall Study|Lost to Follow-up|0
7686306|NCT01239160|26734668|P2|Overall Study|Lost to Follow-up|5
7686307|NCT01239160|26734669|P1|Overall Study|Lost to Follow-up|3
7686308|NCT01239121|26734682|P3|Overall Study|Withdrawal by Subject|0
7686309|NCT01239121|26734683|P2|Overall Study|Withdrawal by Subject|4
7686310|NCT01239121|26734684|P1|Overall Study|Withdrawal by Subject|2
7686311|NCT01239043|26734706|P2|Overall Study|Protocol Violation|1
7686312|NCT01239043|26734707|P1|Overall Study|Protocol Violation|2
7686313|NCT01238991|26734735|P10|Overall Study|Admission to a nursing home|0
7686314|NCT01238991|26734736|P9|Overall Study|Admission to a nursing home|0
7686315|NCT01238991|26734737|P8|Overall Study|Admission to a nursing home|0
7686316|NCT01238991|26734738|P7|Overall Study|Admission to a nursing home|0
7686317|NCT01238991|26734739|P6|Overall Study|Admission to a nursing home|0
7686318|NCT01238991|26734740|P5|Overall Study|Admission to a nursing home|0
7686319|NCT01238991|26734741|P4|Overall Study|Admission to a nursing home|0
7686320|NCT01238991|26734742|P3|Overall Study|Admission to a nursing home|1
7686321|NCT01238991|26734743|P2|Overall Study|Admission to a nursing home|0
7686322|NCT01238991|26734744|P1|Overall Study|Admission to a nursing home|1
7686323|NCT01238991|26734735|P10|Overall Study|Caregiver's request|0
7686324|NCT01238991|26734736|P9|Overall Study|Caregiver's request|1
7686325|NCT01238991|26734737|P8|Overall Study|Caregiver's request|0
7686326|NCT01238991|26734738|P7|Overall Study|Caregiver's request|0
7686327|NCT01238991|26734739|P6|Overall Study|Caregiver's request|0
7686328|NCT01238991|26734740|P5|Overall Study|Caregiver's request|0
7686329|NCT01238991|26734741|P4|Overall Study|Caregiver's request|0
7686330|NCT01238991|26734742|P3|Overall Study|Caregiver's request|0
7686331|NCT01238991|26734743|P2|Overall Study|Caregiver's request|0
7686332|NCT01238991|26734744|P1|Overall Study|Caregiver's request|0
7686333|NCT01238991|26734735|P10|Overall Study|Study Terminated by Sponsor|2
7686334|NCT01238991|26734736|P9|Overall Study|Study Terminated by Sponsor|2
7686335|NCT01238991|26734737|P8|Overall Study|Study Terminated by Sponsor|4
7686336|NCT01238991|26734738|P7|Overall Study|Study Terminated by Sponsor|7
7686337|NCT01238991|26734739|P6|Overall Study|Study Terminated by Sponsor|0
7686338|NCT01238991|26734740|P5|Overall Study|Study Terminated by Sponsor|1
7686339|NCT01238991|26734741|P4|Overall Study|Study Terminated by Sponsor|0
7686340|NCT01238991|26734742|P3|Overall Study|Study Terminated by Sponsor|0
7686341|NCT01238991|26734743|P2|Overall Study|Study Terminated by Sponsor|0
7686342|NCT01238991|26734744|P1|Overall Study|Study Terminated by Sponsor|0
7686343|NCT01238991|26734735|P10|Overall Study|Withdrawal by Subject|0
7686344|NCT01238991|26734736|P9|Overall Study|Withdrawal by Subject|0
7686345|NCT01238991|26734737|P8|Overall Study|Withdrawal by Subject|0
7686346|NCT01238991|26734738|P7|Overall Study|Withdrawal by Subject|0
7686347|NCT01238991|26734739|P6|Overall Study|Withdrawal by Subject|0
7686348|NCT01238991|26734740|P5|Overall Study|Withdrawal by Subject|0
7686349|NCT01238991|26734741|P4|Overall Study|Withdrawal by Subject|0
7686350|NCT01238991|26734742|P3|Overall Study|Withdrawal by Subject|1
7686351|NCT01238991|26734743|P2|Overall Study|Withdrawal by Subject|0
7686352|NCT01238991|26734744|P1|Overall Study|Withdrawal by Subject|0
7686353|NCT01238991|26734735|P10|Overall Study|Lack of Efficacy|0
7686354|NCT01238991|26734736|P9|Overall Study|Lack of Efficacy|1
7686355|NCT01238991|26734737|P8|Overall Study|Lack of Efficacy|0
7686356|NCT01238991|26734738|P7|Overall Study|Lack of Efficacy|0
7686357|NCT01238991|26734739|P6|Overall Study|Lack of Efficacy|0
7686358|NCT01238991|26734740|P5|Overall Study|Lack of Efficacy|0
7686359|NCT01238991|26734741|P4|Overall Study|Lack of Efficacy|0
7686360|NCT01238991|26734742|P3|Overall Study|Lack of Efficacy|1
7686361|NCT01238991|26734743|P2|Overall Study|Lack of Efficacy|0
7686362|NCT01238991|26734744|P1|Overall Study|Lack of Efficacy|0
7686363|NCT01238991|26734735|P10|Overall Study|Death|0
7686364|NCT01238991|26734736|P9|Overall Study|Death|0
7686365|NCT01238991|26734737|P8|Overall Study|Death|0
7686366|NCT01238991|26734738|P7|Overall Study|Death|0
7686367|NCT01238991|26734739|P6|Overall Study|Death|0
7686368|NCT01238991|26734740|P5|Overall Study|Death|0
7686369|NCT01238991|26734741|P4|Overall Study|Death|1
7686370|NCT01238991|26734742|P3|Overall Study|Death|0
7686371|NCT01238991|26734743|P2|Overall Study|Death|0
7686372|NCT01238991|26734744|P1|Overall Study|Death|0
7686373|NCT01238991|26734735|P10|Overall Study|Adverse Event|0
7686374|NCT01238991|26734736|P9|Overall Study|Adverse Event|0
7686375|NCT01238991|26734737|P8|Overall Study|Adverse Event|1
7686376|NCT01238991|26734738|P7|Overall Study|Adverse Event|1
7686377|NCT01238991|26734739|P6|Overall Study|Adverse Event|0
7686378|NCT01238991|26734740|P5|Overall Study|Adverse Event|1
7686379|NCT01238991|26734741|P4|Overall Study|Adverse Event|1
7686380|NCT01238991|26734742|P3|Overall Study|Adverse Event|3
7686381|NCT01238991|26734743|P2|Overall Study|Adverse Event|0
7686382|NCT01238991|26734744|P1|Overall Study|Adverse Event|1
7686383|NCT01238900|26734831|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
7686384|NCT01238900|26734831|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
7686385|NCT01238861|26734845|P6|Overall Study|Withdrawal by Subject|9
7686386|NCT01238861|26734846|P5|Overall Study|Withdrawal by Subject|10
7686387|NCT01238861|26734847|P4|Overall Study|Withdrawal by Subject|8
7686388|NCT01238861|26734848|P3|Overall Study|Withdrawal by Subject|4
7686389|NCT01238861|26734849|P2|Overall Study|Withdrawal by Subject|5
7686390|NCT01238861|26734850|P1|Overall Study|Withdrawal by Subject|6
7686391|NCT01238861|26734845|P6|Overall Study|Adverse Event|0
7686392|NCT01238861|26734846|P5|Overall Study|Adverse Event|0
7686393|NCT01238861|26734847|P4|Overall Study|Adverse Event|0
7686394|NCT01238861|26734848|P3|Overall Study|Adverse Event|0
7686395|NCT01238861|26734849|P2|Overall Study|Adverse Event|1
7686396|NCT01238861|26734850|P1|Overall Study|Adverse Event|0
7686397|NCT01238861|26734845|P6|Overall Study|Lack of compliance|1
7686398|NCT01238861|26734846|P5|Overall Study|Lack of compliance|0
7686399|NCT01238861|26734847|P4|Overall Study|Lack of compliance|0
7686400|NCT01238861|26734848|P3|Overall Study|Lack of compliance|0
7686401|NCT01238861|26734849|P2|Overall Study|Lack of compliance|0
7686402|NCT01238861|26734850|P1|Overall Study|Lack of compliance|0
7686403|NCT01238861|26734845|P6|Overall Study|Serious adverse event|1
7686404|NCT01238861|26734846|P5|Overall Study|Serious adverse event|0
7686405|NCT01238861|26734847|P4|Overall Study|Serious adverse event|0
7686406|NCT01238861|26734848|P3|Overall Study|Serious adverse event|0
7686407|NCT01238861|26734849|P2|Overall Study|Serious adverse event|0
7686408|NCT01238861|26734850|P1|Overall Study|Serious adverse event|0
7686409|NCT01238861|26734845|P6|Overall Study|Unable to continue visits|1
7686410|NCT01238861|26734846|P5|Overall Study|Unable to continue visits|0
7686411|NCT01238861|26734847|P4|Overall Study|Unable to continue visits|1
7686412|NCT01238861|26734848|P3|Overall Study|Unable to continue visits|0
7686413|NCT01238861|26734849|P2|Overall Study|Unable to continue visits|0
7686414|NCT01238861|26734850|P1|Overall Study|Unable to continue visits|0
7686415|NCT01238861|26734845|P6|Overall Study|Personal problems|0
7686416|NCT01238861|26734846|P5|Overall Study|Personal problems|0
7686417|NCT01238861|26734847|P4|Overall Study|Personal problems|1
7686418|NCT01238861|26734848|P3|Overall Study|Personal problems|0
7686419|NCT01238861|26734849|P2|Overall Study|Personal problems|0
7686420|NCT01238861|26734850|P1|Overall Study|Personal problems|0
7686421|NCT01238861|26734845|P6|Overall Study|Strongyloides stercoralis antibodies +|0
7686422|NCT01238861|26734846|P5|Overall Study|Strongyloides stercoralis antibodies +|0
7686423|NCT01238861|26734847|P4|Overall Study|Strongyloides stercoralis antibodies +|1
7686424|NCT01238861|26734848|P3|Overall Study|Strongyloides stercoralis antibodies +|0
7686425|NCT01238861|26734849|P2|Overall Study|Strongyloides stercoralis antibodies +|0
7686426|NCT01238861|26734850|P1|Overall Study|Strongyloides stercoralis antibodies +|0
7686427|NCT01238861|26734845|P6|Overall Study|Subject moved out of state/area|0
7686428|NCT01238861|26734846|P5|Overall Study|Subject moved out of state/area|0
7686429|NCT01238861|26734847|P4|Overall Study|Subject moved out of state/area|1
7686430|NCT01238861|26734848|P3|Overall Study|Subject moved out of state/area|1
7686431|NCT01238861|26734849|P2|Overall Study|Subject moved out of state/area|0
7686432|NCT01238861|26734850|P1|Overall Study|Subject moved out of state/area|0
7686433|NCT01238861|26734845|P6|Overall Study|Subject traveled to Argentina by 1 year|0
7686434|NCT01238861|26734846|P5|Overall Study|Subject traveled to Argentina by 1 year|0
7686435|NCT01238861|26734847|P4|Overall Study|Subject traveled to Argentina by 1 year|0
7686436|NCT01238861|26734848|P3|Overall Study|Subject traveled to Argentina by 1 year|1
7686437|NCT01238861|26734849|P2|Overall Study|Subject traveled to Argentina by 1 year|0
7686438|NCT01238861|26734850|P1|Overall Study|Subject traveled to Argentina by 1 year|0
7686439|NCT01238861|26734845|P6|Overall Study|Incorrect enrollment/randomization|0
7686440|NCT01238861|26734846|P5|Overall Study|Incorrect enrollment/randomization|1
7686441|NCT01238861|26734847|P4|Overall Study|Incorrect enrollment/randomization|0
7686442|NCT01238861|26734848|P3|Overall Study|Incorrect enrollment/randomization|1
7686443|NCT01238861|26734849|P2|Overall Study|Incorrect enrollment/randomization|0
7686444|NCT01238861|26734850|P1|Overall Study|Incorrect enrollment/randomization|0
7686445|NCT01238861|26734845|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
7686446|NCT01238861|26734846|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
7686447|NCT01238861|26734847|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
7686448|NCT01238861|26734848|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
7686449|NCT01238861|26734849|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
7686450|NCT01238861|26734850|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
7686451|NCT01238861|26734845|P6|Overall Study|Unplanned surgery|0
7686452|NCT01238861|26734846|P5|Overall Study|Unplanned surgery|0
7686453|NCT01238861|26734847|P4|Overall Study|Unplanned surgery|0
7686454|NCT01238861|26734848|P3|Overall Study|Unplanned surgery|0
7686455|NCT01238861|26734849|P2|Overall Study|Unplanned surgery|0
7686456|NCT01238861|26734850|P1|Overall Study|Unplanned surgery|1
7686457|NCT01238861|26734845|P6|Overall Study|Lost to Follow-up|2
7686458|NCT01238861|26734846|P5|Overall Study|Lost to Follow-up|1
7686459|NCT01238861|26734847|P4|Overall Study|Lost to Follow-up|1
7686460|NCT01238861|26734848|P3|Overall Study|Lost to Follow-up|3
7686461|NCT01238861|26734849|P2|Overall Study|Lost to Follow-up|2
7686462|NCT01238861|26734850|P1|Overall Study|Lost to Follow-up|4
7686463|NCT01238848|26734930|P2|Overall Study|Physician Decision|5
7686464|NCT01238848|26734931|P1|Overall Study|Physician Decision|13
7686465|NCT01238835|26734939|P1|Overall Study|Site early discontinuation|2
7686466|NCT01238835|26734939|P1|Overall Study|Lost to Follow-up|1
7686467|NCT01238835|26734939|P1|Overall Study|Withdrawal by Subject|9
7686468|NCT01238835|26734939|P1|Overall Study|Death|124
7686469|NCT01238822|26734944|P1|Overall Study|COULD NOT SWALLOW PILLS|3
7686470|NCT01238588|26734971|P1|Overall Study|Physician Decision|2
7686471|NCT01238588|26734971|P1|Overall Study|Withdrawal by Subject|1
7686472|NCT01238575|26734984|P2|Overall Study|Adverse Event|0
7686473|NCT01238575|26734985|P1|Overall Study|Adverse Event|2
7686474|NCT01238575|26734984|P2|Overall Study|Lack of Efficacy|4
7686475|NCT01238575|26734985|P1|Overall Study|Lack of Efficacy|2
7686476|NCT01238211|26735069|P1|Overall Study|Investigator/Patient Decision|3
7686477|NCT01238211|26735069|P1|Overall Study|Non-protocol treatment|4
7686478|NCT01238211|26735069|P1|Overall Study|Withdrawal by Subject|7
7686479|NCT01238211|26735069|P1|Overall Study|Relapse/Progression|2
7686480|NCT01238211|26735069|P1|Overall Study|Death|4
7686481|NCT01238211|26735069|P1|Overall Study|Adverse Event|7
7686482|NCT01238211|26735069|P1|Overall Study|Continues active treatment|31
7686483|NCT01238172|26735075|P2|Overall Study|Ineligible: based on Central Path Review|19
7686484|NCT01238172|26735076|P1|Overall Study|Ineligible: based on Central Path Review|9
7686485|NCT01238172|26735075|P2|Overall Study|Ineligible: based on Eligibility Review|5
7686486|NCT01238172|26735076|P1|Overall Study|Ineligible: based on Eligibility Review|2
7686487|NCT01238120|26735092|P4|Overall Study|Withdrawn due to Medical Problem|0
7686488|NCT01238120|26735093|P3|Overall Study|Withdrawn due to Medical Problem|1
7686489|NCT01238120|26735094|P2|Overall Study|Withdrawn due to Medical Problem|0
7686490|NCT01238120|26735095|P1|Overall Study|Withdrawn due to Medical Problem|2
7686491|NCT01238120|26735092|P4|Overall Study|Lost to Follow-up|1
7686492|NCT01238120|26735093|P3|Overall Study|Lost to Follow-up|1
7686493|NCT01238120|26735094|P2|Overall Study|Lost to Follow-up|0
7686494|NCT01238120|26735095|P1|Overall Study|Lost to Follow-up|2
7686495|NCT01238120|26735092|P4|Overall Study|Withdrawal by Subject|5
7686496|NCT01238120|26735093|P3|Overall Study|Withdrawal by Subject|2
7686497|NCT01238120|26735094|P2|Overall Study|Withdrawal by Subject|1
7686498|NCT01238120|26735095|P1|Overall Study|Withdrawal by Subject|4
7686499|NCT01237951|26735109|P1|Overall Study|Death|1
7686500|NCT01237899|26735127|P11|Washout Period of at Least 7 Days|Adverse Event|0
7686501|NCT01237899|26735128|P10|Washout Period of at Least 7 Days|Adverse Event|0
7686502|NCT01237899|26735129|P9|Washout Period of at Least 7 Days|Adverse Event|0
7686503|NCT01237899|26735130|P8|Washout Period of at Least 7 Days|Adverse Event|0
7686504|NCT01237899|26735131|P7|Washout Period of at Least 7 Days|Adverse Event|0
7686505|NCT01237899|26735132|P6|Washout Period of at Least 7 Days|Adverse Event|0
7686506|NCT01237899|26735133|P5|Washout Period of at Least 7 Days|Adverse Event|0
7686507|NCT01237899|26735134|P4|Washout Period of at Least 7 Days|Adverse Event|0
7686508|NCT01237899|26735135|P3|Washout Period of at Least 7 Days|Adverse Event|1
7686509|NCT01237899|26735136|P2|Washout Period of at Least 7 Days|Adverse Event|0
7686510|NCT01237899|26735137|P1|Washout Period of at Least 7 Days|Adverse Event|0
7686511|NCT01237678|26735217|P3|Phase II|Randomized but were not treated|3
7686512|NCT01237678|26735218|P2|Phase II|Randomized but were not treated|4
7686513|NCT01237678|26735219|P1|Phase II|Randomized but were not treated|0
7686514|NCT01237678|26735217|P3|Phase II|Sponsor Decision/Study Closed|7
7686515|NCT01237678|26735218|P2|Phase II|Sponsor Decision/Study Closed|18
7686516|NCT01237678|26735219|P1|Phase II|Sponsor Decision/Study Closed|0
7686517|NCT01237678|26735217|P3|Phase II|Completed Cycles 4-6|21
7686518|NCT01237678|26735218|P2|Phase II|Completed Cycles 4-6|11
7686519|NCT01237678|26735219|P1|Phase II|Completed Cycles 4-6|0
7686520|NCT01237678|26735217|P3|Phase II|Withdrawal by Subject|5
7686521|NCT01237678|26735218|P2|Phase II|Withdrawal by Subject|1
7686522|NCT01237678|26735219|P1|Phase II|Withdrawal by Subject|0
7686523|NCT01237678|26735217|P3|Phase II|Lack of Efficacy|3
7686524|NCT01237678|26735218|P2|Phase II|Lack of Efficacy|25
7686525|NCT01237678|26735219|P1|Phase II|Lack of Efficacy|0
7686526|NCT01237678|26735217|P3|Phase II|Death|2
7686527|NCT01237678|26735218|P2|Phase II|Death|0
7686528|NCT01237678|26735219|P1|Phase II|Death|0
7686529|NCT01237678|26735217|P3|Phase II|Adverse Event|9
7686530|NCT01237678|26735218|P2|Phase II|Adverse Event|39
7686531|NCT01237678|26735219|P1|Phase II|Adverse Event|0
7686532|NCT01237678|26735217|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
7686533|NCT01237678|26735218|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
7686534|NCT01237678|26735219|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
7686535|NCT01237678|26735217|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
7686536|NCT01237678|26735218|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
7686537|NCT01237678|26735219|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
7686538|NCT01237678|26735217|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
7686539|NCT01237678|26735218|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
7686540|NCT01237678|26735219|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
7686541|NCT01237678|26735217|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
7686542|NCT01237678|26735218|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
7686543|NCT01237678|26735219|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
7686544|NCT01237587|26735264|P2|Taper Phase|Withdrawal by Subject|1
7686545|NCT01237587|26735265|P1|Taper Phase|Withdrawal by Subject|0
7686546|NCT01237587|26735264|P2|Taper Phase|Sponsor Decision|0
7686547|NCT01237587|26735265|P1|Taper Phase|Sponsor Decision|1
7686548|NCT01237587|26735264|P2|Taper Phase|Parent/Guardian Decision|2
7686549|NCT01237587|26735265|P1|Taper Phase|Parent/Guardian Decision|0
7686550|NCT01237587|26735264|P2|Taper Phase|Lack of Efficacy|5
7686551|NCT01237587|26735265|P1|Taper Phase|Lack of Efficacy|2
7686552|NCT01237587|26735264|P2|Taper Phase|Protocol Violation|0
7686553|NCT01237587|26735265|P1|Taper Phase|Protocol Violation|2
7686554|NCT01237587|26735264|P2|Taper Phase|Adverse Event|2
7686555|NCT01237587|26735265|P1|Taper Phase|Adverse Event|0
7686556|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
7686557|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
7686558|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
7686559|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
7686560|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
7686561|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
7686562|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
7686563|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
7686564|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
7686565|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
7686566|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
7686567|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
7686568|NCT01237587|26735264|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
7686569|NCT01237587|26735265|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
7686570|NCT01237587|26735264|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
7686571|NCT01237587|26735265|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
7686572|NCT01237587|26735264|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
7686573|NCT01237587|26735265|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
7686574|NCT01237587|26735264|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
7686575|NCT01237587|26735265|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
7686576|NCT01237587|26735264|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
7686577|NCT01237587|26735265|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
7686578|NCT01237587|26735264|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
7686579|NCT01237587|26735265|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
7686580|NCT01237587|26735264|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
7686581|NCT01237587|26735265|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
7686582|NCT01237340|26735317|P1|Overall Study|Early termination of the trial|36
7686583|NCT01237340|26735317|P1|Overall Study|Withdrawal by Subject|1
7686584|NCT01237340|26735317|P1|Overall Study|Adverse Event|3
7686585|NCT01237327|26735331|P2|Overall Study|Lost to Follow-up|0
7686586|NCT01237327|26735332|P1|Overall Study|Lost to Follow-up|3
7686587|NCT01237327|26735331|P2|Overall Study|Withdrawal by Subject|3
7686588|NCT01237327|26735332|P1|Overall Study|Withdrawal by Subject|1
7686589|NCT01237327|26735331|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
7686590|NCT01237327|26735332|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
7686591|NCT01237327|26735331|P2|Overall Study|Progression of Disease: Extension Study|13
7686592|NCT01237327|26735332|P1|Overall Study|Progression of Disease: Extension Study|15
7686593|NCT01237327|26735331|P2|Overall Study|Progression of Disease: Core Study|22
7686594|NCT01237327|26735332|P1|Overall Study|Progression of Disease: Core Study|18
7686595|NCT01237327|26735331|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
7686596|NCT01237327|26735332|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
7686597|NCT01237327|26735331|P2|Overall Study|Protocol Violation: Core Study|0
7686598|NCT01237327|26735332|P1|Overall Study|Protocol Violation: Core Study|1
7686599|NCT01237223|26735367|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7686600|NCT01237223|26735368|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7686601|NCT01237223|26735369|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
7686602|NCT01237223|26735370|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7686603|NCT01237223|26735371|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7686604|NCT01237223|26735372|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
7686605|NCT01237223|26735367|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
7686606|NCT01237223|26735368|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7686607|NCT01237223|26735369|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7686608|NCT01237223|26735370|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7686609|NCT01237223|26735371|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7686610|NCT01237223|26735372|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7686611|NCT01237223|26735367|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7686612|NCT01237223|26735368|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7686613|NCT01237223|26735369|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
7686614|NCT01237223|26735370|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
7686615|NCT01237223|26735371|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
7686616|NCT01237223|26735372|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7686617|NCT01237223|26735367|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
7686618|NCT01237223|26735368|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
7686619|NCT01237223|26735369|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
7686620|NCT01237223|26735370|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
7686621|NCT01237223|26735371|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
7686622|NCT01237223|26735372|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
7686623|NCT01237223|26735367|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
7686624|NCT01237223|26735368|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
7686625|NCT01237223|26735369|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
7686626|NCT01237223|26735370|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
7686627|NCT01237223|26735371|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
7686628|NCT01237223|26735372|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
7686629|NCT01237223|26735367|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7686630|NCT01237223|26735368|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7686631|NCT01237223|26735369|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7686632|NCT01237223|26735370|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7686633|NCT01237223|26735371|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7686634|NCT01237223|26735372|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
7686635|NCT01237223|26735367|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7686636|NCT01237223|26735368|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7686637|NCT01237223|26735369|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7686638|NCT01237223|26735370|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7686639|NCT01237223|26735371|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7686640|NCT01237223|26735372|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
7686641|NCT01237223|26735367|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7686642|NCT01237223|26735368|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7686643|NCT01237223|26735369|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7686644|NCT01237223|26735370|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7686645|NCT01237223|26735371|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7686646|NCT01237223|26735372|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
7686647|NCT01237223|26735367|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7686648|NCT01237223|26735368|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7686649|NCT01237223|26735369|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7686650|NCT01237223|26735370|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7686651|NCT01237223|26735371|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7686652|NCT01237223|26735372|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
7686653|NCT01237223|26735367|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7686654|NCT01237223|26735368|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7686655|NCT01237223|26735369|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7686656|NCT01237223|26735370|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7686657|NCT01237223|26735371|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7686658|NCT01237223|26735372|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
7686659|NCT01237054|26735431|P1|Overall Study|imaging 10C0096|1
7686660|NCT01236755|26735500|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
7686661|NCT01236755|26735500|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
7686662|NCT01236755|26735500|P1|Spectacles Wearing Phase|Lost to Follow-up|9
7686663|NCT01236755|26735500|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
7686664|NCT01236534|26735523|P2|Overall Study|Adverse Event|0
7686665|NCT01236534|26735524|P1|Overall Study|Adverse Event|3
7686666|NCT01236365|26735542|P2|Overall Study|Dropped at Randomization due to high LFT|0
7686667|NCT01236365|26735543|P1|Overall Study|Dropped at Randomization due to high LFT|1
7686668|NCT01236365|26735542|P2|Overall Study|Moved Out of State|0
7686669|NCT01236365|26735543|P1|Overall Study|Moved Out of State|1
7686670|NCT01236365|26735542|P2|Overall Study|Lost to Follow-up|2
7686671|NCT01236365|26735543|P1|Overall Study|Lost to Follow-up|0
7686672|NCT01236339|26735567|P2|Overall Study|Termination of study by sponsor|13
7686673|NCT01236339|26735568|P1|Overall Study|Termination of study by sponsor|11
7686674|NCT01235793|26735597|P1|Overall Study|Death|6
7686675|NCT01236573|26735613|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
7686676|NCT01236573|26735614|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686677|NCT01236573|26735615|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686678|NCT01236573|26735616|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686679|NCT01236573|26735617|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686680|NCT01236573|26735618|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686681|NCT01236573|26735619|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686682|NCT01236573|26735620|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686683|NCT01236573|26735621|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686684|NCT01236573|26735622|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686685|NCT01236573|26735623|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7686686|NCT01236573|26735613|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686687|NCT01236573|26735614|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686688|NCT01236573|26735615|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
7686689|NCT01236573|26735616|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686690|NCT01236573|26735617|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686691|NCT01236573|26735618|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686692|NCT01236573|26735619|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686693|NCT01236573|26735620|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686694|NCT01236573|26735621|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686695|NCT01236573|26735622|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686696|NCT01236573|26735623|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7686697|NCT01236573|26735613|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686698|NCT01236573|26735614|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7686699|NCT01236573|26735615|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7686700|NCT01236573|26735616|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686701|NCT01236573|26735617|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7686702|NCT01236573|26735618|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686703|NCT01236573|26735619|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686704|NCT01236573|26735620|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686705|NCT01236573|26735621|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686706|NCT01236573|26735622|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686707|NCT01236573|26735623|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7686708|NCT01236560|26735665|P6|Overall Study|Progressive disease|0
7686709|NCT01236560|26735666|P5|Overall Study|Progressive disease|0
7686710|NCT01236560|26735667|P4|Overall Study|Progressive disease|16
7686711|NCT01236560|26735668|P3|Overall Study|Progressive disease|9
7686712|NCT01236560|26735669|P2|Overall Study|Progressive disease|19
7686713|NCT01236560|26735670|P1|Overall Study|Progressive disease|5
7686714|NCT01236560|26735665|P6|Overall Study|Withdrawal by Subject|0
7686715|NCT01236560|26735666|P5|Overall Study|Withdrawal by Subject|0
7686716|NCT01236560|26735667|P4|Overall Study|Withdrawal by Subject|2
7686717|NCT01236560|26735668|P3|Overall Study|Withdrawal by Subject|1
7686718|NCT01236560|26735669|P2|Overall Study|Withdrawal by Subject|0
7686719|NCT01236560|26735670|P1|Overall Study|Withdrawal by Subject|0
7686720|NCT01236560|26735665|P6|Overall Study|Physician Decision|0
7686721|NCT01236560|26735666|P5|Overall Study|Physician Decision|0
7686722|NCT01236560|26735667|P4|Overall Study|Physician Decision|0
7686723|NCT01236560|26735668|P3|Overall Study|Physician Decision|8
7686724|NCT01236560|26735669|P2|Overall Study|Physician Decision|1
7686725|NCT01236560|26735670|P1|Overall Study|Physician Decision|0
7686726|NCT01236560|26735665|P6|Overall Study|Lost to Follow-up|0
7686727|NCT01236560|26735666|P5|Overall Study|Lost to Follow-up|0
7686728|NCT01236560|26735667|P4|Overall Study|Lost to Follow-up|0
7686729|NCT01236560|26735668|P3|Overall Study|Lost to Follow-up|1
7686730|NCT01236560|26735669|P2|Overall Study|Lost to Follow-up|1
7686731|NCT01236560|26735670|P1|Overall Study|Lost to Follow-up|0
7686732|NCT01236560|26735665|P6|Overall Study|Death|0
7686733|NCT01236560|26735666|P5|Overall Study|Death|0
7686734|NCT01236560|26735667|P4|Overall Study|Death|1
7686735|NCT01236560|26735668|P3|Overall Study|Death|0
7686736|NCT01236560|26735669|P2|Overall Study|Death|1
7686737|NCT01236560|26735670|P1|Overall Study|Death|0
7686738|NCT01236560|26735665|P6|Overall Study|Adverse Event|0
7686739|NCT01236560|26735666|P5|Overall Study|Adverse Event|0
7686740|NCT01236560|26735667|P4|Overall Study|Adverse Event|3
7686741|NCT01236560|26735668|P3|Overall Study|Adverse Event|1
7686742|NCT01236560|26735669|P2|Overall Study|Adverse Event|2
7686743|NCT01236560|26735670|P1|Overall Study|Adverse Event|0
7686755|NCT01236352|26735773|P11|Overall Study|Patient transferred to IST|6
7686756|NCT01236352|26735774|P10|Overall Study|Patient transferred to IST|2
7686757|NCT01236352|26735775|P9|Overall Study|Patient transferred to IST|0
7686758|NCT01236352|26735776|P8|Overall Study|Patient transferred to IST|0
7686759|NCT01236352|26735777|P7|Overall Study|Patient transferred to IST|0
7686760|NCT01236352|26735778|P6|Overall Study|Patient transferred to IST|0
7686761|NCT01236352|26735779|P5|Overall Study|Patient transferred to IST|0
7686762|NCT01236352|26735780|P4|Overall Study|Patient transferred to IST|0
7686763|NCT01236352|26735781|P3|Overall Study|Patient transferred to IST|0
7686764|NCT01236352|26735782|P2|Overall Study|Patient transferred to IST|0
7686765|NCT01236352|26735783|P1|Overall Study|Patient transferred to IST|0
7686766|NCT01236352|26735773|P11|Overall Study|Lack of response to drug|1
7686767|NCT01236352|26735774|P10|Overall Study|Lack of response to drug|1
7686768|NCT01236352|26735775|P9|Overall Study|Lack of response to drug|0
7686769|NCT01236352|26735776|P8|Overall Study|Lack of response to drug|0
7686770|NCT01236352|26735777|P7|Overall Study|Lack of response to drug|0
7686771|NCT01236352|26735778|P6|Overall Study|Lack of response to drug|0
7686772|NCT01236352|26735779|P5|Overall Study|Lack of response to drug|0
7686773|NCT01236352|26735780|P4|Overall Study|Lack of response to drug|0
7686774|NCT01236352|26735781|P3|Overall Study|Lack of response to drug|0
7686775|NCT01236352|26735782|P2|Overall Study|Lack of response to drug|0
7686776|NCT01236352|26735783|P1|Overall Study|Lack of response to drug|0
7686777|NCT01236352|26735773|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
7686778|NCT01236352|26735774|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
7686779|NCT01236352|26735775|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
7686780|NCT01236352|26735776|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
7686781|NCT01236352|26735777|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
7686782|NCT01236352|26735778|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
7686783|NCT01236352|26735779|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
7686784|NCT01236352|26735780|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
7686785|NCT01236352|26735781|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
7686786|NCT01236352|26735782|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
7686787|NCT01236352|26735783|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
7686788|NCT01236352|26735773|P11|Overall Study|Patient moving to allogeneic transplant|0
7686789|NCT01236352|26735774|P10|Overall Study|Patient moving to allogeneic transplant|0
7686790|NCT01236352|26735775|P9|Overall Study|Patient moving to allogeneic transplant|0
7686791|NCT01236352|26735776|P8|Overall Study|Patient moving to allogeneic transplant|0
7686792|NCT01236352|26735777|P7|Overall Study|Patient moving to allogeneic transplant|1
7686793|NCT01236352|26735778|P6|Overall Study|Patient moving to allogeneic transplant|0
7686794|NCT01236352|26735779|P5|Overall Study|Patient moving to allogeneic transplant|0
7686795|NCT01236352|26735780|P4|Overall Study|Patient moving to allogeneic transplant|0
7686796|NCT01236352|26735781|P3|Overall Study|Patient moving to allogeneic transplant|0
7686797|NCT01236352|26735782|P2|Overall Study|Patient moving to allogeneic transplant|0
7686798|NCT01236352|26735783|P1|Overall Study|Patient moving to allogeneic transplant|0
7686799|NCT01236352|26735773|P11|Overall Study|Subject to receive drug via EAP|0
7686800|NCT01236352|26735774|P10|Overall Study|Subject to receive drug via EAP|4
7686801|NCT01236352|26735775|P9|Overall Study|Subject to receive drug via EAP|0
7686802|NCT01236352|26735776|P8|Overall Study|Subject to receive drug via EAP|2
7686803|NCT01236352|26735777|P7|Overall Study|Subject to receive drug via EAP|0
7686804|NCT01236352|26735778|P6|Overall Study|Subject to receive drug via EAP|0
7686805|NCT01236352|26735779|P5|Overall Study|Subject to receive drug via EAP|0
7686806|NCT01236352|26735780|P4|Overall Study|Subject to receive drug via EAP|0
7686807|NCT01236352|26735781|P3|Overall Study|Subject to receive drug via EAP|1
7686808|NCT01236352|26735782|P2|Overall Study|Subject to receive drug via EAP|1
7686809|NCT01236352|26735783|P1|Overall Study|Subject to receive drug via EAP|1
7686810|NCT01236352|26735773|P11|Overall Study|Subject request to discontinue treatment|4
7686811|NCT01236352|26735774|P10|Overall Study|Subject request to discontinue treatment|1
7686812|NCT01236352|26735775|P9|Overall Study|Subject request to discontinue treatment|0
7686813|NCT01236352|26735776|P8|Overall Study|Subject request to discontinue treatment|0
7686814|NCT01236352|26735777|P7|Overall Study|Subject request to discontinue treatment|0
7686815|NCT01236352|26735778|P6|Overall Study|Subject request to discontinue treatment|1
7686816|NCT01236352|26735779|P5|Overall Study|Subject request to discontinue treatment|0
7686817|NCT01236352|26735780|P4|Overall Study|Subject request to discontinue treatment|1
7686818|NCT01236352|26735781|P3|Overall Study|Subject request to discontinue treatment|1
7686819|NCT01236352|26735782|P2|Overall Study|Subject request to discontinue treatment|0
7686820|NCT01236352|26735783|P1|Overall Study|Subject request to discontinue treatment|0
7686821|NCT01236352|26735773|P11|Overall Study|Maximum clinical benefit|2
7686822|NCT01236352|26735774|P10|Overall Study|Maximum clinical benefit|4
7686823|NCT01236352|26735775|P9|Overall Study|Maximum clinical benefit|1
7686824|NCT01236352|26735776|P8|Overall Study|Maximum clinical benefit|1
7686825|NCT01236352|26735777|P7|Overall Study|Maximum clinical benefit|3
7686826|NCT01236352|26735778|P6|Overall Study|Maximum clinical benefit|0
7686827|NCT01236352|26735779|P5|Overall Study|Maximum clinical benefit|2
7686828|NCT01236352|26735780|P4|Overall Study|Maximum clinical benefit|0
7686829|NCT01236352|26735781|P3|Overall Study|Maximum clinical benefit|1
7686830|NCT01236352|26735782|P2|Overall Study|Maximum clinical benefit|1
7686831|NCT01236352|26735783|P1|Overall Study|Maximum clinical benefit|1
7686832|NCT01236352|26735773|P11|Overall Study|Poor/Non-compliance|0
7686833|NCT01236352|26735774|P10|Overall Study|Poor/Non-compliance|0
7686834|NCT01236352|26735775|P9|Overall Study|Poor/Non-compliance|0
7686835|NCT01236352|26735776|P8|Overall Study|Poor/Non-compliance|0
7686836|NCT01236352|26735777|P7|Overall Study|Poor/Non-compliance|0
7686837|NCT01236352|26735778|P6|Overall Study|Poor/Non-compliance|0
7686838|NCT01236352|26735779|P5|Overall Study|Poor/Non-compliance|0
7686839|NCT01236352|26735780|P4|Overall Study|Poor/Non-compliance|0
7686840|NCT01236352|26735781|P3|Overall Study|Poor/Non-compliance|0
7686841|NCT01236352|26735782|P2|Overall Study|Poor/Non-compliance|0
7686842|NCT01236352|26735783|P1|Overall Study|Poor/Non-compliance|1
7686843|NCT01236352|26735773|P11|Overall Study|Disease progression|2
7686844|NCT01236352|26735774|P10|Overall Study|Disease progression|2
7686845|NCT01236352|26735775|P9|Overall Study|Disease progression|2
7686846|NCT01236352|26735776|P8|Overall Study|Disease progression|3
7686847|NCT01236352|26735777|P7|Overall Study|Disease progression|1
7686848|NCT01236352|26735778|P6|Overall Study|Disease progression|2
7686849|NCT01236352|26735779|P5|Overall Study|Disease progression|2
7686850|NCT01236352|26735780|P4|Overall Study|Disease progression|2
7686851|NCT01236352|26735781|P3|Overall Study|Disease progression|1
7686852|NCT01236352|26735782|P2|Overall Study|Disease progression|2
7686853|NCT01236352|26735783|P1|Overall Study|Disease progression|1
7686854|NCT01236352|26735773|P11|Overall Study|Study drug toxicity|2
7686855|NCT01236352|26735774|P10|Overall Study|Study drug toxicity|2
7686856|NCT01236352|26735775|P9|Overall Study|Study drug toxicity|0
7686857|NCT01236352|26735776|P8|Overall Study|Study drug toxicity|0
7686858|NCT01236352|26735777|P7|Overall Study|Study drug toxicity|1
7686859|NCT01236352|26735778|P6|Overall Study|Study drug toxicity|1
7686860|NCT01236352|26735779|P5|Overall Study|Study drug toxicity|0
7686861|NCT01236352|26735780|P4|Overall Study|Study drug toxicity|0
7686862|NCT01236352|26735781|P3|Overall Study|Study drug toxicity|0
7686863|NCT01236352|26735782|P2|Overall Study|Study drug toxicity|0
7686864|NCT01236352|26735783|P1|Overall Study|Study drug toxicity|0
7686865|NCT01236352|26735773|P11|Overall Study|Adverse Event|1
7686866|NCT01236352|26735774|P10|Overall Study|Adverse Event|4
7686867|NCT01236352|26735775|P9|Overall Study|Adverse Event|0
7686868|NCT01236352|26735776|P8|Overall Study|Adverse Event|0
7686869|NCT01236352|26735777|P7|Overall Study|Adverse Event|2
7686870|NCT01236352|26735778|P6|Overall Study|Adverse Event|0
7686871|NCT01236352|26735779|P5|Overall Study|Adverse Event|0
7686872|NCT01236352|26735780|P4|Overall Study|Adverse Event|0
7686873|NCT01236352|26735781|P3|Overall Study|Adverse Event|0
7686874|NCT01236352|26735782|P2|Overall Study|Adverse Event|0
7686875|NCT01236352|26735783|P1|Overall Study|Adverse Event|0
7686876|NCT01236352|26735773|P11|Overall Study|Withdrawal by Subject|1
7686877|NCT01236352|26735774|P10|Overall Study|Withdrawal by Subject|2
7686878|NCT01236352|26735775|P9|Overall Study|Withdrawal by Subject|0
7686879|NCT01236352|26735776|P8|Overall Study|Withdrawal by Subject|0
7686880|NCT01236352|26735777|P7|Overall Study|Withdrawal by Subject|0
7686881|NCT01236352|26735778|P6|Overall Study|Withdrawal by Subject|0
7686882|NCT01236352|26735779|P5|Overall Study|Withdrawal by Subject|0
7686883|NCT01236352|26735780|P4|Overall Study|Withdrawal by Subject|0
7686884|NCT01236352|26735781|P3|Overall Study|Withdrawal by Subject|0
7686885|NCT01236352|26735782|P2|Overall Study|Withdrawal by Subject|0
7686886|NCT01236352|26735783|P1|Overall Study|Withdrawal by Subject|0
7686887|NCT01236352|26735773|P11|Overall Study|Death|0
7686888|NCT01236352|26735774|P10|Overall Study|Death|0
7686889|NCT01236352|26735775|P9|Overall Study|Death|0
7686890|NCT01236352|26735776|P8|Overall Study|Death|1
7686891|NCT01236352|26735777|P7|Overall Study|Death|0
7686892|NCT01236352|26735778|P6|Overall Study|Death|0
7686893|NCT01236352|26735779|P5|Overall Study|Death|0
7686894|NCT01236352|26735780|P4|Overall Study|Death|0
7686895|NCT01236352|26735781|P3|Overall Study|Death|0
7686896|NCT01236352|26735782|P2|Overall Study|Death|0
7686897|NCT01236352|26735783|P1|Overall Study|Death|0
7686898|NCT01236118|26736001|P3|Overall Study|Withdrawal by Subject|1
7686899|NCT01236118|26736002|P2|Overall Study|Withdrawal by Subject|0
7686900|NCT01236118|26736003|P1|Overall Study|Withdrawal by Subject|0
7686901|NCT01236118|26736001|P3|Overall Study|Physician Decision|0
7686902|NCT01236118|26736002|P2|Overall Study|Physician Decision|1
7686903|NCT01236118|26736003|P1|Overall Study|Physician Decision|0
7686904|NCT01236118|26736001|P3|Overall Study|Adverse Event|2
7686905|NCT01236118|26736002|P2|Overall Study|Adverse Event|0
7686906|NCT01236118|26736003|P1|Overall Study|Adverse Event|2
7686907|NCT01236001|26736204|P2|Overall Study|Planned Visit After End of Study|1
7686908|NCT01236001|26736205|P1|Overall Study|Planned Visit After End of Study|0
7686909|NCT01236001|26736204|P2|Overall Study|Incompliance|0
7686910|NCT01236001|26736205|P1|Overall Study|Incompliance|1
7686911|NCT01236001|26736204|P2|Overall Study|Lost to Follow-up|1
7686912|NCT01236001|26736205|P1|Overall Study|Lost to Follow-up|6
7686913|NCT01236001|26736204|P2|Overall Study|Lack of Efficacy|6
7686914|NCT01236001|26736205|P1|Overall Study|Lack of Efficacy|6
7686915|NCT01236001|26736204|P2|Overall Study|Adverse Event|14
7686916|NCT01236001|26736205|P1|Overall Study|Adverse Event|5
7686917|NCT01235975|26736237|P2|Overall Study|Lost to Follow-up|3
7686918|NCT01235975|26736238|P1|Overall Study|Lost to Follow-up|7
7686919|NCT01235975|26736237|P2|Overall Study|Migrated/moved from study area|1
7686920|NCT01235975|26736238|P1|Overall Study|Migrated/moved from study area|2
7686921|NCT01235975|26736237|P2|Overall Study|Withdrawal by Subject|2
7686922|NCT01235975|26736238|P1|Overall Study|Withdrawal by Subject|8
7686923|NCT01235975|26736237|P2|Overall Study|Serious Adverse Event|1
7686924|NCT01235975|26736238|P1|Overall Study|Serious Adverse Event|0
7686925|NCT01235962|26736274|P4|Overall Study|Physician Decision|5
7686926|NCT01235962|26736275|P3|Overall Study|Physician Decision|9
7686927|NCT01235962|26736276|P2|Overall Study|Physician Decision|0
7686928|NCT01235962|26736277|P1|Overall Study|Physician Decision|5
7686929|NCT01235962|26736274|P4|Overall Study|Lost to Follow-up|32
7686930|NCT01235962|26736275|P3|Overall Study|Lost to Follow-up|47
7686931|NCT01235962|26736276|P2|Overall Study|Lost to Follow-up|16
7686932|NCT01235962|26736277|P1|Overall Study|Lost to Follow-up|21
7686933|NCT01235962|26736274|P4|Overall Study|Withdrawal by Subject|49
7686934|NCT01235962|26736275|P3|Overall Study|Withdrawal by Subject|62
7686935|NCT01235962|26736276|P2|Overall Study|Withdrawal by Subject|19
7686936|NCT01235962|26736277|P1|Overall Study|Withdrawal by Subject|20
7686937|NCT01235949|26736347|P18|Booster Phase|Lost to Follow-up|1
7686938|NCT01235949|26736348|P17|Booster Phase|Lost to Follow-up|0
7686939|NCT01235949|26736349|P16|Booster Phase|Lost to Follow-up|0
7686940|NCT01235949|26736350|P15|Booster Phase|Lost to Follow-up|0
7686941|NCT01235949|26736351|P14|Booster Phase|Lost to Follow-up|0
7686942|NCT01235949|26736352|P13|Booster Phase|Lost to Follow-up|0
7686943|NCT01235949|26736353|P12|Booster Phase|Lost to Follow-up|1
7686944|NCT01235949|26736354|P11|Booster Phase|Lost to Follow-up|1
7686945|NCT01235949|26736355|P10|Booster Phase|Lost to Follow-up|1
7686946|NCT01235949|26736356|P9|Booster Phase|Lost to Follow-up|1
7686947|NCT01235949|26736357|P8|Booster Phase|Lost to Follow-up|0
7686948|NCT01235949|26736358|P7|Booster Phase|Lost to Follow-up|0
7686949|NCT01235949|26736359|P6|Booster Phase|Lost to Follow-up|0
7686950|NCT01235949|26736360|P5|Booster Phase|Lost to Follow-up|0
7686951|NCT01235949|26736361|P4|Booster Phase|Lost to Follow-up|0
7686952|NCT01235949|26736362|P3|Booster Phase|Lost to Follow-up|0
7686953|NCT01235949|26736363|P2|Booster Phase|Lost to Follow-up|0
7686954|NCT01235949|26736364|P1|Booster Phase|Lost to Follow-up|0
7686955|NCT01235949|26736347|P18|Booster Phase|Withdrawal by Subject|0
7686956|NCT01235949|26736348|P17|Booster Phase|Withdrawal by Subject|0
7686957|NCT01235949|26736349|P16|Booster Phase|Withdrawal by Subject|0
7686958|NCT01235949|26736350|P15|Booster Phase|Withdrawal by Subject|2
7686959|NCT01235949|26736351|P14|Booster Phase|Withdrawal by Subject|0
7686960|NCT01235949|26736352|P13|Booster Phase|Withdrawal by Subject|2
7686961|NCT01235949|26736353|P12|Booster Phase|Withdrawal by Subject|1
7686962|NCT01235949|26736354|P11|Booster Phase|Withdrawal by Subject|1
7686963|NCT01235949|26736355|P10|Booster Phase|Withdrawal by Subject|0
7686964|NCT01235949|26736356|P9|Booster Phase|Withdrawal by Subject|1
7686965|NCT01235949|26736357|P8|Booster Phase|Withdrawal by Subject|1
7686966|NCT01235949|26736358|P7|Booster Phase|Withdrawal by Subject|0
7686967|NCT01235949|26736359|P6|Booster Phase|Withdrawal by Subject|0
7686968|NCT01235949|26736360|P5|Booster Phase|Withdrawal by Subject|0
7686969|NCT01235949|26736361|P4|Booster Phase|Withdrawal by Subject|0
7686970|NCT01235949|26736362|P3|Booster Phase|Withdrawal by Subject|0
7686971|NCT01235949|26736363|P2|Booster Phase|Withdrawal by Subject|0
7686972|NCT01235949|26736364|P1|Booster Phase|Withdrawal by Subject|0
7686973|NCT01235949|26736347|P18|Booster Phase|Adverse Event|0
7686974|NCT01235949|26736348|P17|Booster Phase|Adverse Event|0
7686975|NCT01235949|26736349|P16|Booster Phase|Adverse Event|1
7686976|NCT01235949|26736350|P15|Booster Phase|Adverse Event|0
7686977|NCT01235949|26736351|P14|Booster Phase|Adverse Event|0
7686978|NCT01235949|26736352|P13|Booster Phase|Adverse Event|0
7686979|NCT01235949|26736353|P12|Booster Phase|Adverse Event|0
7686980|NCT01235949|26736354|P11|Booster Phase|Adverse Event|0
7686981|NCT01235949|26736355|P10|Booster Phase|Adverse Event|0
7686982|NCT01235949|26736356|P9|Booster Phase|Adverse Event|0
7686983|NCT01235949|26736357|P8|Booster Phase|Adverse Event|0
7686984|NCT01235949|26736358|P7|Booster Phase|Adverse Event|0
7686985|NCT01235949|26736359|P6|Booster Phase|Adverse Event|0
7686986|NCT01235949|26736360|P5|Booster Phase|Adverse Event|0
7686987|NCT01235949|26736361|P4|Booster Phase|Adverse Event|0
7686988|NCT01235949|26736362|P3|Booster Phase|Adverse Event|0
7686989|NCT01235949|26736363|P2|Booster Phase|Adverse Event|0
7686990|NCT01235949|26736364|P1|Booster Phase|Adverse Event|0
7686991|NCT01235949|26736347|P18|Booster Phase|Migrated/moved from study area|1
7686992|NCT01235949|26736348|P17|Booster Phase|Migrated/moved from study area|0
7686993|NCT01235949|26736349|P16|Booster Phase|Migrated/moved from study area|0
7686994|NCT01235949|26736350|P15|Booster Phase|Migrated/moved from study area|0
7686995|NCT01235949|26736351|P14|Booster Phase|Migrated/moved from study area|0
7686996|NCT01235949|26736352|P13|Booster Phase|Migrated/moved from study area|1
7686997|NCT01235949|26736353|P12|Booster Phase|Migrated/moved from study area|1
7686998|NCT01235949|26736354|P11|Booster Phase|Migrated/moved from study area|0
7686999|NCT01235949|26736355|P10|Booster Phase|Migrated/moved from study area|0
7687000|NCT01235949|26736356|P9|Booster Phase|Migrated/moved from study area|0
7687001|NCT01235949|26736357|P8|Booster Phase|Migrated/moved from study area|0
7687002|NCT01235949|26736358|P7|Booster Phase|Migrated/moved from study area|0
7687003|NCT01235949|26736359|P6|Booster Phase|Migrated/moved from study area|0
7687004|NCT01235949|26736360|P5|Booster Phase|Migrated/moved from study area|0
7687005|NCT01235949|26736361|P4|Booster Phase|Migrated/moved from study area|0
7687006|NCT01235949|26736362|P3|Booster Phase|Migrated/moved from study area|0
7687007|NCT01235949|26736363|P2|Booster Phase|Migrated/moved from study area|0
7687008|NCT01235949|26736364|P1|Booster Phase|Migrated/moved from study area|0
7687009|NCT01235949|26736347|P18|Primary Phase|Lost to Follow-up|0
7687010|NCT01235949|26736348|P17|Primary Phase|Lost to Follow-up|0
7687011|NCT01235949|26736349|P16|Primary Phase|Lost to Follow-up|0
7687012|NCT01235949|26736350|P15|Primary Phase|Lost to Follow-up|0
7687013|NCT01235949|26736351|P14|Primary Phase|Lost to Follow-up|0
7687014|NCT01235949|26736352|P13|Primary Phase|Lost to Follow-up|0
7687015|NCT01235949|26736353|P12|Primary Phase|Lost to Follow-up|0
7687016|NCT01235949|26736354|P11|Primary Phase|Lost to Follow-up|0
7687017|NCT01235949|26736355|P10|Primary Phase|Lost to Follow-up|0
7687018|NCT01235949|26736356|P9|Primary Phase|Lost to Follow-up|0
7687019|NCT01235949|26736357|P8|Primary Phase|Lost to Follow-up|0
7687020|NCT01235949|26736358|P7|Primary Phase|Lost to Follow-up|0
7687021|NCT01235949|26736359|P6|Primary Phase|Lost to Follow-up|2
7687022|NCT01235949|26736360|P5|Primary Phase|Lost to Follow-up|0
7687023|NCT01235949|26736361|P4|Primary Phase|Lost to Follow-up|1
7687024|NCT01235949|26736362|P3|Primary Phase|Lost to Follow-up|1
7687025|NCT01235949|26736363|P2|Primary Phase|Lost to Follow-up|0
7687026|NCT01235949|26736364|P1|Primary Phase|Lost to Follow-up|0
7687027|NCT01235949|26736347|P18|Primary Phase|Withdrawal by Subject|0
7687028|NCT01235949|26736348|P17|Primary Phase|Withdrawal by Subject|0
7687029|NCT01235949|26736349|P16|Primary Phase|Withdrawal by Subject|0
7687030|NCT01235949|26736350|P15|Primary Phase|Withdrawal by Subject|0
7687031|NCT01235949|26736351|P14|Primary Phase|Withdrawal by Subject|0
7687032|NCT01235949|26736352|P13|Primary Phase|Withdrawal by Subject|0
7687033|NCT01235949|26736353|P12|Primary Phase|Withdrawal by Subject|0
7687034|NCT01235949|26736354|P11|Primary Phase|Withdrawal by Subject|0
7687035|NCT01235949|26736355|P10|Primary Phase|Withdrawal by Subject|0
7687036|NCT01235949|26736356|P9|Primary Phase|Withdrawal by Subject|0
7687037|NCT01235949|26736357|P8|Primary Phase|Withdrawal by Subject|0
7687038|NCT01235949|26736358|P7|Primary Phase|Withdrawal by Subject|0
7687039|NCT01235949|26736359|P6|Primary Phase|Withdrawal by Subject|3
7687040|NCT01235949|26736360|P5|Primary Phase|Withdrawal by Subject|0
7687041|NCT01235949|26736361|P4|Primary Phase|Withdrawal by Subject|0
7687042|NCT01235949|26736362|P3|Primary Phase|Withdrawal by Subject|2
7687043|NCT01235949|26736363|P2|Primary Phase|Withdrawal by Subject|2
7687044|NCT01235949|26736364|P1|Primary Phase|Withdrawal by Subject|3
7687045|NCT01235949|26736347|P18|Primary Phase|Adverse Event|0
7687046|NCT01235949|26736348|P17|Primary Phase|Adverse Event|0
7687047|NCT01235949|26736349|P16|Primary Phase|Adverse Event|0
7687048|NCT01235949|26736350|P15|Primary Phase|Adverse Event|0
7687049|NCT01235949|26736351|P14|Primary Phase|Adverse Event|0
7687050|NCT01235949|26736352|P13|Primary Phase|Adverse Event|0
7687051|NCT01235949|26736353|P12|Primary Phase|Adverse Event|0
7687052|NCT01235949|26736354|P11|Primary Phase|Adverse Event|0
7687053|NCT01235949|26736355|P10|Primary Phase|Adverse Event|0
7687054|NCT01235949|26736356|P9|Primary Phase|Adverse Event|0
7687055|NCT01235949|26736357|P8|Primary Phase|Adverse Event|0
7687056|NCT01235949|26736358|P7|Primary Phase|Adverse Event|0
7687057|NCT01235949|26736359|P6|Primary Phase|Adverse Event|0
7687058|NCT01235949|26736360|P5|Primary Phase|Adverse Event|0
7687059|NCT01235949|26736361|P4|Primary Phase|Adverse Event|1
7687060|NCT01235949|26736362|P3|Primary Phase|Adverse Event|0
7687061|NCT01235949|26736363|P2|Primary Phase|Adverse Event|0
7687062|NCT01235949|26736364|P1|Primary Phase|Adverse Event|0
7687063|NCT01235949|26736347|P18|Primary Phase|Migrated/moved from study area|0
7687064|NCT01235949|26736348|P17|Primary Phase|Migrated/moved from study area|0
7687065|NCT01235949|26736349|P16|Primary Phase|Migrated/moved from study area|0
7687066|NCT01235949|26736350|P15|Primary Phase|Migrated/moved from study area|0
7687067|NCT01235949|26736351|P14|Primary Phase|Migrated/moved from study area|0
7687068|NCT01235949|26736352|P13|Primary Phase|Migrated/moved from study area|0
7687069|NCT01235949|26736353|P12|Primary Phase|Migrated/moved from study area|0
7687070|NCT01235949|26736354|P11|Primary Phase|Migrated/moved from study area|0
7687071|NCT01235949|26736355|P10|Primary Phase|Migrated/moved from study area|0
7687072|NCT01235949|26736356|P9|Primary Phase|Migrated/moved from study area|0
7687073|NCT01235949|26736357|P8|Primary Phase|Migrated/moved from study area|0
7687074|NCT01235949|26736358|P7|Primary Phase|Migrated/moved from study area|0
7687075|NCT01235949|26736359|P6|Primary Phase|Migrated/moved from study area|2
7687076|NCT01235949|26736360|P5|Primary Phase|Migrated/moved from study area|1
7687077|NCT01235949|26736361|P4|Primary Phase|Migrated/moved from study area|0
7687078|NCT01235949|26736362|P3|Primary Phase|Migrated/moved from study area|0
7687079|NCT01235949|26736363|P2|Primary Phase|Migrated/moved from study area|1
7687080|NCT01235949|26736364|P1|Primary Phase|Migrated/moved from study area|1
7687081|NCT01235741|26736614|P3|Follow-Up Post Treatment up to Month 6|Other|0
7687082|NCT01235741|26736615|P2|Follow-Up Post Treatment up to Month 6|Other|1
7687083|NCT01235741|26736616|P1|Follow-Up Post Treatment up to Month 6|Other|0
7687084|NCT01235741|26736614|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
7687085|NCT01235741|26736615|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
7687086|NCT01235741|26736616|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
7687087|NCT01235741|26736614|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
7687088|NCT01235741|26736615|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
7687089|NCT01235741|26736616|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
7687090|NCT01235741|26736614|P3|Randomized to Treatment|Sponsor terminated study|34
7687091|NCT01235741|26736615|P2|Randomized to Treatment|Sponsor terminated study|35
7687092|NCT01235741|26736616|P1|Randomized to Treatment|Sponsor terminated study|0
7687093|NCT01235741|26736614|P3|Randomized to Treatment|Adverse Event|1
7687094|NCT01235741|26736615|P2|Randomized to Treatment|Adverse Event|1
7687095|NCT01235741|26736616|P1|Randomized to Treatment|Adverse Event|0
7687096|NCT01235741|26736614|P3|Randomized to Treatment|Withdrawal by Subject|1
7687097|NCT01235741|26736615|P2|Randomized to Treatment|Withdrawal by Subject|0
7687098|NCT01235741|26736616|P1|Randomized to Treatment|Withdrawal by Subject|0
7687099|NCT01235741|26736614|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
7687100|NCT01235741|26736615|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
7687101|NCT01235741|26736616|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
7687102|NCT01235741|26736614|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
7687103|NCT01235741|26736615|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
7687104|NCT01235741|26736616|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
7687105|NCT01235741|26736614|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
7687106|NCT01235741|26736615|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
7687107|NCT01235741|26736616|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
7687108|NCT01235741|26736614|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
7687109|NCT01235741|26736615|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
7687110|NCT01235741|26736616|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
7687111|NCT01235741|26736614|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
7687112|NCT01235741|26736615|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
7687113|NCT01235741|26736616|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
7687114|NCT01235741|26736614|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
7687115|NCT01235741|26736615|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
7687116|NCT01235741|26736616|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
7687117|NCT01235728|26736643|P8|Overall Study|Protocol Violation|0
7687118|NCT01235728|26736644|P7|Overall Study|Protocol Violation|0
7687119|NCT01235728|26736645|P6|Overall Study|Protocol Violation|0
7687120|NCT01235728|26736646|P5|Overall Study|Protocol Violation|0
7687121|NCT01235728|26736647|P4|Overall Study|Protocol Violation|1
7687122|NCT01235728|26736648|P3|Overall Study|Protocol Violation|0
7687123|NCT01235728|26736649|P2|Overall Study|Protocol Violation|0
7687124|NCT01235728|26736650|P1|Overall Study|Protocol Violation|0
7687125|NCT01235715|26736660|P2|Overall Study|Physician Decision|2
7687126|NCT01235715|26736661|P1|Overall Study|Physician Decision|0
7687127|NCT01235689|26736701|P2|Overall Study|Miscellaneous|5
7687128|NCT01235689|26736702|P1|Overall Study|Miscellaneous|1
7687129|NCT01235689|26736701|P2|Overall Study|Lost to Follow-up|2
7687130|NCT01235689|26736702|P1|Overall Study|Lost to Follow-up|1
7687131|NCT01235689|26736701|P2|Overall Study|Withdrawal by Subject|4
7687132|NCT01235689|26736702|P1|Overall Study|Withdrawal by Subject|3
7687133|NCT01235689|26736701|P2|Overall Study|Lack of Efficacy|5
7687134|NCT01235689|26736702|P1|Overall Study|Lack of Efficacy|12
7687135|NCT01235689|26736701|P2|Overall Study|Adverse Event|16
7687136|NCT01235689|26736702|P1|Overall Study|Adverse Event|12
7687137|NCT01235598|26736774|P2|Overall Study|Withdrawal by Subject|0
7687138|NCT01235598|26736775|P1|Overall Study|Withdrawal by Subject|1
7687139|NCT01235598|26736774|P2|Overall Study|Lack of Efficacy|1
7687140|NCT01235598|26736775|P1|Overall Study|Lack of Efficacy|0
7687141|NCT01235598|26736774|P2|Overall Study|Adverse Event|3
7687142|NCT01235598|26736775|P1|Overall Study|Adverse Event|0
7687143|NCT01235546|26736820|P2|Overall Study|Protocol Violation|1
7687144|NCT01235546|26736821|P1|Overall Study|Protocol Violation|1
7687145|NCT01235546|26736820|P2|Overall Study|Staff error, medication not administered|0
7687146|NCT01235546|26736821|P1|Overall Study|Staff error, medication not administered|1
7687147|NCT01235507|26736845|P1|Overall Study|Withdrawal by Subject|1
7687148|NCT01235507|26736845|P1|Overall Study|Adverse Event|1
7687149|NCT01235442|26736859|P2|Overall Study|Other unspecified|2
7687150|NCT01235442|26736860|P1|Overall Study|Other unspecified|1
7687151|NCT01235442|26736859|P2|Overall Study|Administrative decision|2
7687152|NCT01235442|26736860|P1|Overall Study|Administrative decision|1
7687153|NCT01235442|26736859|P2|Overall Study|Noncompliance|2
7687154|NCT01235442|26736860|P1|Overall Study|Noncompliance|1
7687155|NCT01235442|26736859|P2|Overall Study|Lack of Efficacy|3
7687156|NCT01235442|26736860|P1|Overall Study|Lack of Efficacy|1
7687157|NCT01235442|26736859|P2|Overall Study|Withdrawal by Subject|9
7687158|NCT01235442|26736860|P1|Overall Study|Withdrawal by Subject|15
7687159|NCT01235442|26736859|P2|Overall Study|Adverse Event|6
7687160|NCT01235442|26736860|P1|Overall Study|Adverse Event|4
7687161|NCT01235442|26736859|P2|Overall Study|Protocol Violation|3
7687162|NCT01235442|26736860|P1|Overall Study|Protocol Violation|3
7687163|NCT01235442|26736859|P2|Overall Study|Ineligibility determined|4
7687164|NCT01235442|26736860|P1|Overall Study|Ineligibility determined|5
7687165|NCT01235442|26736859|P2|Overall Study|Pregnancy|1
7687166|NCT01235442|26736860|P1|Overall Study|Pregnancy|1
7687167|NCT01235442|26736859|P2|Overall Study|Death|2
7687168|NCT01235442|26736860|P1|Overall Study|Death|0
7687169|NCT01235442|26736859|P2|Overall Study|Lost to Follow-up|10
7687170|NCT01235442|26736860|P1|Overall Study|Lost to Follow-up|12
7687171|NCT01235403|26736878|P1|Overall Study|Other reasons for premature termination|4
7687172|NCT01235403|26736878|P1|Overall Study|Lack of Efficacy|2
7687173|NCT01235403|26736878|P1|Overall Study|Withdrawal by Subject|4
7687174|NCT01235403|26736878|P1|Overall Study|Lost to Follow-up|2
7687175|NCT01235403|26736878|P1|Overall Study|Adverse Event|14
7687176|NCT01235351|26736895|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
7687177|NCT01235351|26736896|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
7687178|NCT01235338|26736908|P2|Overall Study|Prohibited meds|0
7687179|NCT01235338|26736909|P1|Overall Study|Prohibited meds|1
7687180|NCT01235338|26736908|P2|Overall Study|Positive drug screen|1
7687181|NCT01235338|26736909|P1|Overall Study|Positive drug screen|0
7687182|NCT01235338|26736908|P2|Overall Study|Exclusion criteria violations|1
7687183|NCT01235338|26736909|P1|Overall Study|Exclusion criteria violations|1
7687184|NCT01235338|26736908|P2|Overall Study|Withdrawal by Subject|0
7687185|NCT01235338|26736909|P1|Overall Study|Withdrawal by Subject|5
7687186|NCT01235338|26736908|P2|Overall Study|Protocol Violation|1
7687187|NCT01235338|26736909|P1|Overall Study|Protocol Violation|1
7687188|NCT01235338|26736908|P2|Overall Study|Adverse Event|2
7687189|NCT01235338|26736909|P1|Overall Study|Adverse Event|3
7687190|NCT01235234|26736954|P3|Overall Study|Adverse Event|1
7687191|NCT01235234|26736955|P2|Overall Study|Adverse Event|2
7687192|NCT01235234|26736956|P1|Overall Study|Adverse Event|2
7687193|NCT01234883|26737004|P2|Overall Study|Inclusion/exclusion failure|0
7687194|NCT01234883|26737005|P1|Overall Study|Inclusion/exclusion failure|1
7687195|NCT01234883|26737004|P2|Overall Study|Technical difficulties with IV infusion|1
7687196|NCT01234883|26737005|P1|Overall Study|Technical difficulties with IV infusion|0
7687197|NCT01234883|26737004|P2|Overall Study|Parent/guardian withdrew consent|2
7687198|NCT01234883|26737005|P1|Overall Study|Parent/guardian withdrew consent|1
7687199|NCT01234883|26737004|P2|Overall Study|Early treatment release|10
7687200|NCT01234883|26737005|P1|Overall Study|Early treatment release|8
7687201|NCT01234675|26737052|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
7687202|NCT01234675|26737053|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
7687203|NCT01234675|26737052|P2|First Intervention (6 Weeks)|Adverse Event|1
7687204|NCT01234675|26737053|P1|First Intervention (6 Weeks)|Adverse Event|0
7687205|NCT01234649|26737085|P2|Overall Study|Lack of Efficacy|3
7687206|NCT01234649|26737086|P1|Overall Study|Lack of Efficacy|0
7687207|NCT01234649|26737085|P2|Overall Study|Allergic reaction|0
7687208|NCT01234649|26737086|P1|Overall Study|Allergic reaction|1
7687209|NCT01234649|26737085|P2|Overall Study|intolerant to side effects|3
7687210|NCT01234649|26737086|P1|Overall Study|intolerant to side effects|4
7687211|NCT01234649|26737085|P2|Overall Study|Pregnancy|6
7687212|NCT01234649|26737086|P1|Overall Study|Pregnancy|6
7687213|NCT01234649|26737085|P2|Overall Study|Withdrawal by Subject|26
7687214|NCT01234649|26737086|P1|Overall Study|Withdrawal by Subject|32
7687215|NCT01234480|26737134|P1|Overall Study|Missing Sample|9
7687216|NCT01234480|26737134|P1|Overall Study|Site/Subject non-compliance|44
7687217|NCT01234480|26737134|P1|Overall Study|Site Amendment prohibited colposcopy|11
7687218|NCT01234480|26737134|P1|Overall Study|Sample Processing/Storage|92
7687219|NCT01234480|26737134|P1|Overall Study|Out of Window|42
7687220|NCT01234480|26737134|P1|Overall Study|No Florida Lab License|20
7687221|NCT01234480|26737134|P1|Overall Study|Incorrect Visit|3
7687222|NCT01234480|26737134|P1|Overall Study|Informed Consent Form Violation|30
7687223|NCT01234480|26737134|P1|Overall Study|Inclusion/Exclusion Violation|3
7687224|NCT01234480|26737134|P1|Overall Study|Hysterectomy post enrollment|1
7687225|NCT01234480|26737134|P1|Overall Study|Hysterectomy|2
7687226|NCT01234480|26737134|P1|Overall Study|HPV Vaccine after Enrollment|17
7687227|NCT01234480|26737134|P1|Overall Study|HPV Vaccine History|28
7687228|NCT01234480|26737134|P1|Overall Study|Age|3
7687229|NCT01234480|26737134|P1|Overall Study|>36/Normal History|50
7687230|NCT01234480|26737134|P1|Overall Study|Pregnancy|88
7687231|NCT01234467|26737141|P1|Overall Study|Other complicating disease (stroke)|1
7687232|NCT01234467|26737141|P1|Overall Study|Physician Decision|1
7687233|NCT01234467|26737141|P1|Overall Study|Clinical deterioration|1
7687234|NCT01234467|26737141|P1|Overall Study|Disease Progression|2
7687235|NCT01234467|26737141|P1|Overall Study|Withdrawal by Subject|2
7687236|NCT01234467|26737141|P1|Overall Study|Death|2
7687237|NCT01234467|26737141|P1|Overall Study|Adverse Event|3
7687238|NCT01234402|26737153|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
7687239|NCT01234402|26737154|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
7687240|NCT01234402|26737155|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
7687241|NCT01234402|26737153|P3|Overall Study|Never treated: Withdrawal By Subject|0
7687242|NCT01234402|26737154|P2|Overall Study|Never treated: Withdrawal By Subject|1
7687243|NCT01234402|26737155|P1|Overall Study|Never treated: Withdrawal By Subject|0
7687244|NCT01234402|26737153|P3|Overall Study|Never treated: Death|1
7687245|NCT01234402|26737154|P2|Overall Study|Never treated: Death|0
7687246|NCT01234402|26737155|P1|Overall Study|Never treated: Death|0
7687247|NCT01234402|26737153|P3|Overall Study|Withdrawal by Subject|4
7687248|NCT01234402|26737154|P2|Overall Study|Withdrawal by Subject|3
7687249|NCT01234402|26737155|P1|Overall Study|Withdrawal by Subject|1
7687250|NCT01234402|26737153|P3|Overall Study|Lost to Follow-up|3
7687251|NCT01234402|26737154|P2|Overall Study|Lost to Follow-up|1
7687252|NCT01234402|26737155|P1|Overall Study|Lost to Follow-up|0
7687253|NCT01234350|26737196|P2|Overall Study|Covers a diverse set of reasons|92
7687254|NCT01234350|26737197|P1|Overall Study|Covers a diverse set of reasons|234
7687255|NCT01234350|26737196|P2|Overall Study|Lost to Follow-up|47
7687256|NCT01234350|26737197|P1|Overall Study|Lost to Follow-up|115
7687257|NCT01234350|26737196|P2|Overall Study|Withdrawal by Subject|36
7687258|NCT01234350|26737197|P1|Overall Study|Withdrawal by Subject|61
7687259|NCT01234350|26737196|P2|Overall Study|Adverse Event|92
7687260|NCT01234350|26737197|P1|Overall Study|Adverse Event|277
7687261|NCT01234337|26737223|P2|Overall Study|Switch to commercial drug|1
7687262|NCT01234337|26737224|P1|Overall Study|Switch to commercial drug|0
7687263|NCT01234337|26737223|P2|Overall Study|Death|1
7687264|NCT01234337|26737224|P1|Overall Study|Death|0
7687265|NCT01234337|26737223|P2|Overall Study|Withdrawal by Subject|9
7687266|NCT01234337|26737224|P1|Overall Study|Withdrawal by Subject|11
7687267|NCT01234337|26737223|P2|Overall Study|Protocol Violation|3
7687268|NCT01234337|26737224|P1|Overall Study|Protocol Violation|2
7687269|NCT01234337|26737223|P2|Overall Study|Lost to Follow-up|1
7687270|NCT01234337|26737224|P1|Overall Study|Lost to Follow-up|0
7687271|NCT01234337|26737223|P2|Overall Study|Randomized but not treated|4
7687272|NCT01234337|26737224|P1|Overall Study|Randomized but not treated|6
7687273|NCT01234337|26737223|P2|Overall Study|Non-compliant with study medication|2
7687274|NCT01234337|26737224|P1|Overall Study|Non-compliant with study medication|3
7687275|NCT01234337|26737223|P2|Overall Study|Investi. decision not protocol driven|6
7687276|NCT01234337|26737224|P1|Overall Study|Investi. decision not protocol driven|5
7687277|NCT01234337|26737223|P2|Overall Study|Disease progression/recurrence/relapse|223
7687278|NCT01234337|26737224|P1|Overall Study|Disease progression/recurrence/relapse|181
7687279|NCT01234337|26737223|P2|Overall Study|Adverse Event|21
7687280|NCT01234337|26737224|P1|Overall Study|Adverse Event|58
7687281|NCT01233999|26737284|P1|Overall Study|Lost to Follow-up|1
7687282|NCT01233999|26737284|P1|Overall Study|Withdrawal by Subject|1
7687283|NCT01233869|26737303|P4|Extended Treatment Period (46 Months)|Adverse Event|1
7687284|NCT01233869|26737304|P3|Extended Treatment Period (46 Months)|Adverse Event|0
7687285|NCT01233869|26737305|P2|Extended Treatment Period (46 Months)|Adverse Event|0
7687286|NCT01233869|26737306|P1|Extended Treatment Period (46 Months)|Adverse Event|1
7687287|NCT01233869|26737303|P4|Extended Treatment Period (46 Months)|Other|3
7687288|NCT01233869|26737304|P3|Extended Treatment Period (46 Months)|Other|0
7687289|NCT01233869|26737305|P2|Extended Treatment Period (46 Months)|Other|0
7687290|NCT01233869|26737306|P1|Extended Treatment Period (46 Months)|Other|3
7687291|NCT01233869|26737303|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
7687292|NCT01233869|26737304|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
7687293|NCT01233869|26737305|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
7687294|NCT01233869|26737306|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
7687295|NCT01233869|26737303|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
7687296|NCT01233869|26737304|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7687297|NCT01233869|26737305|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7687298|NCT01233869|26737306|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7687299|NCT01233869|26737303|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
7687300|NCT01233869|26737304|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
7687301|NCT01233869|26737305|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
7687302|NCT01233869|26737306|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
7687303|NCT01233869|26737303|P4|Initial Treatment Period (24 Months)|Adverse Event|3
7687304|NCT01233869|26737304|P3|Initial Treatment Period (24 Months)|Adverse Event|0
7687305|NCT01233869|26737305|P2|Initial Treatment Period (24 Months)|Adverse Event|17
7687306|NCT01233869|26737306|P1|Initial Treatment Period (24 Months)|Adverse Event|9
7687307|NCT01233869|26737303|P4|Initial Treatment Period (24 Months)|Death|0
7687308|NCT01233869|26737304|P3|Initial Treatment Period (24 Months)|Death|0
7687309|NCT01233869|26737305|P2|Initial Treatment Period (24 Months)|Death|0
7687310|NCT01233869|26737306|P1|Initial Treatment Period (24 Months)|Death|1
7687311|NCT01233817|26737392|P1|Overall Study|Withdrawal by Subject|2
7687312|NCT01233817|26737392|P1|Overall Study|Lost to Follow-up|1
7687313|NCT01233687|26737439|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
7687314|NCT01233687|26737439|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
7687315|NCT01233687|26737439|P1|Phase II AMG 102 + Erlotinib|Death|1
7687316|NCT01233609|26737449|P2|Overall Study|Withdrawal by Subject|0
7687317|NCT01233609|26737450|P1|Overall Study|Withdrawal by Subject|3
7687318|NCT01233609|26737449|P2|Overall Study|Adverse Event|1
7687319|NCT01233609|26737450|P1|Overall Study|Adverse Event|2
7687320|NCT01233609|26737449|P2|Overall Study|Lost to Follow-up|1
7687321|NCT01233609|26737450|P1|Overall Study|Lost to Follow-up|3
7687322|NCT01233609|26737449|P2|Overall Study|Death|0
7687323|NCT01233609|26737450|P1|Overall Study|Death|1
7687324|NCT01233284|26737479|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
7687325|NCT01233284|26737480|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
7687326|NCT01233284|26737481|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
7687327|NCT01233284|26737482|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
7687328|NCT01233284|26737483|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
7687329|NCT01233284|26737479|P5|Period 4 (4 Weeks)|Adverse Event|0
7687330|NCT01233284|26737480|P4|Period 4 (4 Weeks)|Adverse Event|0
7687331|NCT01233284|26737481|P3|Period 4 (4 Weeks)|Adverse Event|0
7687332|NCT01233284|26737482|P2|Period 4 (4 Weeks)|Adverse Event|1
7687333|NCT01233284|26737483|P1|Period 4 (4 Weeks)|Adverse Event|0
7687334|NCT01233284|26737479|P5|Period 3 (4 Weeks)|Other|0
7687335|NCT01233284|26737480|P4|Period 3 (4 Weeks)|Other|1
7687336|NCT01233284|26737481|P3|Period 3 (4 Weeks)|Other|0
7687337|NCT01233284|26737482|P2|Period 3 (4 Weeks)|Other|0
7687338|NCT01233284|26737483|P1|Period 3 (4 Weeks)|Other|0
7687339|NCT01233284|26737479|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
7687340|NCT01233284|26737480|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
7687341|NCT01233284|26737481|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
7687342|NCT01233284|26737482|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
7687343|NCT01233284|26737483|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
7687344|NCT01233284|26737479|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
7687345|NCT01233284|26737480|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
7687346|NCT01233284|26737481|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
7687347|NCT01233284|26737482|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
7687348|NCT01233284|26737483|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
7687349|NCT01233284|26737479|P5|Period 1 (4 Weeks)|Other|0
7687350|NCT01233284|26737480|P4|Period 1 (4 Weeks)|Other|0
7687351|NCT01233284|26737481|P3|Period 1 (4 Weeks)|Other|1
7687352|NCT01233284|26737482|P2|Period 1 (4 Weeks)|Other|0
7687353|NCT01233284|26737483|P1|Period 1 (4 Weeks)|Other|0
7687354|NCT01233284|26737479|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
7687355|NCT01233284|26737480|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
7687356|NCT01233284|26737481|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
7687357|NCT01233284|26737482|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
7687358|NCT01233284|26737483|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
7687359|NCT01233284|26737479|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
7687360|NCT01233284|26737480|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
7687361|NCT01233284|26737481|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
7687362|NCT01233284|26737482|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
7687363|NCT01233284|26737483|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
7687364|NCT01233258|26737564|P6|First Intervention (6 Months)|Non-compliance with study medication|0
7687365|NCT01233258|26737565|P5|First Intervention (6 Months)|Non-compliance with study medication|0
7687366|NCT01233258|26737566|P4|First Intervention (6 Months)|Non-compliance with study medication|0
7687367|NCT01233258|26737567|P3|First Intervention (6 Months)|Non-compliance with study medication|0
7687368|NCT01233258|26737568|P2|First Intervention (6 Months)|Non-compliance with study medication|0
7687369|NCT01233258|26737569|P1|First Intervention (6 Months)|Non-compliance with study medication|1
7687370|NCT01233258|26737564|P6|First Intervention (6 Months)|Protocol Violation|0
7687371|NCT01233258|26737565|P5|First Intervention (6 Months)|Protocol Violation|0
7687372|NCT01233258|26737566|P4|First Intervention (6 Months)|Protocol Violation|0
7687373|NCT01233258|26737567|P3|First Intervention (6 Months)|Protocol Violation|1
7687374|NCT01233258|26737568|P2|First Intervention (6 Months)|Protocol Violation|0
7687375|NCT01233258|26737569|P1|First Intervention (6 Months)|Protocol Violation|0
7687376|NCT01233258|26737564|P6|First Intervention (6 Months)|Withdrawal by Subject|1
7687377|NCT01233258|26737565|P5|First Intervention (6 Months)|Withdrawal by Subject|0
7687378|NCT01233258|26737566|P4|First Intervention (6 Months)|Withdrawal by Subject|1
7687379|NCT01233258|26737567|P3|First Intervention (6 Months)|Withdrawal by Subject|0
7687380|NCT01233258|26737568|P2|First Intervention (6 Months)|Withdrawal by Subject|0
7687381|NCT01233258|26737569|P1|First Intervention (6 Months)|Withdrawal by Subject|0
7687382|NCT01233232|26737589|P3|Overall Study|Voluntary Discontinuation by Subject|0
7687383|NCT01233232|26737590|P2|Overall Study|Voluntary Discontinuation by Subject|0
7687384|NCT01233232|26737591|P1|Overall Study|Voluntary Discontinuation by Subject|1
7687385|NCT01233076|26737644|P2|Period 2, One Week|Lost to Follow-up|0
7687386|NCT01233076|26737645|P1|Period 2, One Week|Lost to Follow-up|1
7687387|NCT01233050|26737653|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
7687388|NCT01233050|26737654|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
7687389|NCT01232894|26737706|P2|Overall Study|Physician Decision|1
7687390|NCT01232894|26737707|P1|Overall Study|Physician Decision|2
7687391|NCT01232894|26737706|P2|Overall Study|Withdrawal by Subject|5
7687392|NCT01232894|26737707|P1|Overall Study|Withdrawal by Subject|8
7687393|NCT01232894|26737706|P2|Overall Study|Protocol Violation|1
7687394|NCT01232894|26737707|P1|Overall Study|Protocol Violation|1
7687395|NCT01232894|26737706|P2|Overall Study|Death|0
7687396|NCT01232894|26737707|P1|Overall Study|Death|1
7687397|NCT01232894|26737706|P2|Overall Study|Lost to Follow-up|1
7687398|NCT01232894|26737707|P1|Overall Study|Lost to Follow-up|0
7687399|NCT01232868|26737715|P2|Overall Study|Lost to Follow-up|4
7687400|NCT01232868|26737716|P1|Overall Study|Lost to Follow-up|2
7687401|NCT01232790|26737730|P2|Second Crossover|Withdrawal by Subject|2
7687402|NCT01232790|26737731|P1|Second Crossover|Withdrawal by Subject|1
7687403|NCT01232790|26737730|P2|First Crossover|Withdrawal by Subject|0
7687404|NCT01232790|26737731|P1|First Crossover|Withdrawal by Subject|1
7687405|NCT01232790|26737730|P2|Initial Assessment|Withdrawal by Subject|1
7687406|NCT01232790|26737731|P1|Initial Assessment|Withdrawal by Subject|0
7687407|NCT01232790|26737730|P2|Randomization|Physician Decision|1
7687408|NCT01232790|26737731|P1|Randomization|Physician Decision|0
7687409|NCT01232790|26737730|P2|Randomization|Protocol Violation|1
7687410|NCT01232790|26737731|P1|Randomization|Protocol Violation|0
7687411|NCT01232790|26737730|P2|Randomization|Withdrawal by Subject|0
7687412|NCT01232790|26737731|P1|Randomization|Withdrawal by Subject|2
7687413|NCT01232738|26737785|P1|Overall Study|Adverse Event|5
7687414|NCT01232738|26737785|P1|Overall Study|Withdrawal by Subject|2
7687415|NCT01232738|26737785|P1|Overall Study|Lost to Follow-up|1
7687416|NCT01232738|26737785|P1|Overall Study|Physician Decision|2
7687417|NCT01232738|26737785|P1|Overall Study|Death|3
7687418|NCT01232569|26737801|P4|Double-blind Treatment Period|Death|0
7687419|NCT01232569|26737802|P3|Double-blind Treatment Period|Death|0
7687420|NCT01232569|26737803|P2|Double-blind Treatment Period|Death|0
7687421|NCT01232569|26737804|P1|Double-blind Treatment Period|Death|2
7687422|NCT01232569|26737801|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
7687423|NCT01232569|26737802|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
7687424|NCT01232569|26737803|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
7687425|NCT01232569|26737804|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
7687426|NCT01232569|26737801|P4|Double-blind Treatment Period|Physician Decision|0
7687427|NCT01232569|26737802|P3|Double-blind Treatment Period|Physician Decision|0
7687428|NCT01232569|26737803|P2|Double-blind Treatment Period|Physician Decision|0
7687429|NCT01232569|26737804|P1|Double-blind Treatment Period|Physician Decision|1
7687430|NCT01232569|26737801|P4|Double-blind Treatment Period|Lack of Efficacy|0
7687431|NCT01232569|26737802|P3|Double-blind Treatment Period|Lack of Efficacy|0
7687432|NCT01232569|26737803|P2|Double-blind Treatment Period|Lack of Efficacy|2
7687433|NCT01232569|26737804|P1|Double-blind Treatment Period|Lack of Efficacy|1
7687434|NCT01232569|26737801|P4|Double-blind Treatment Period|Lost to Follow-up|0
7687435|NCT01232569|26737802|P3|Double-blind Treatment Period|Lost to Follow-up|0
7687436|NCT01232569|26737803|P2|Double-blind Treatment Period|Lost to Follow-up|0
7687437|NCT01232569|26737804|P1|Double-blind Treatment Period|Lost to Follow-up|4
7687438|NCT01232569|26737801|P4|Double-blind Treatment Period|Escape|0
7687439|NCT01232569|26737802|P3|Double-blind Treatment Period|Escape|0
7687440|NCT01232569|26737803|P2|Double-blind Treatment Period|Escape|2
7687441|NCT01232569|26737804|P1|Double-blind Treatment Period|Escape|2
7687442|NCT01232569|26737801|P4|Double-blind Treatment Period|Withdrawal by Subject|0
7687443|NCT01232569|26737802|P3|Double-blind Treatment Period|Withdrawal by Subject|0
7687444|NCT01232569|26737803|P2|Double-blind Treatment Period|Withdrawal by Subject|2
7687445|NCT01232569|26737804|P1|Double-blind Treatment Period|Withdrawal by Subject|9
7687446|NCT01232556|26737847|P2|Overall Study|Other|4
7687447|NCT01232556|26737848|P1|Overall Study|Other|6
7687448|NCT01232556|26737847|P2|Overall Study|Terminated by Sponsor|51
7687449|NCT01232556|26737848|P1|Overall Study|Terminated by Sponsor|35
7687450|NCT01232556|26737847|P2|Overall Study|Lost to Follow-up|2
7687451|NCT01232556|26737848|P1|Overall Study|Lost to Follow-up|0
7687452|NCT01232556|26737847|P2|Overall Study|Death|97
7687453|NCT01232556|26737848|P1|Overall Study|Death|97
7687454|NCT01232556|26737847|P2|Overall Study|Withdrawal by Subject|17
7687455|NCT01232556|26737848|P1|Overall Study|Withdrawal by Subject|21
7687456|NCT01232491|26737907|P2|Overall Study|Other|18
7687457|NCT01232491|26737908|P1|Overall Study|Other|21
7687458|NCT01232491|26737907|P2|Overall Study|Withdrawal Criteria|21
7687459|NCT01232491|26737908|P1|Overall Study|Withdrawal Criteria|12
7687460|NCT01232491|26737907|P2|Overall Study|Protocol Violation|11
7687461|NCT01232491|26737908|P1|Overall Study|Protocol Violation|13
7687462|NCT01232491|26737907|P2|Overall Study|Lack of Efficacy|5
7687463|NCT01232491|26737908|P1|Overall Study|Lack of Efficacy|1
7687464|NCT01232491|26737907|P2|Overall Study|Adverse Event|8
7687465|NCT01232491|26737908|P1|Overall Study|Adverse Event|13
7687466|NCT01232452|26737937|P2|Overall Study|Protocol Violation|1
7687467|NCT01232452|26737938|P1|Overall Study|Protocol Violation|0
7687468|NCT01232452|26737937|P2|Overall Study|Sponsor Decision|1
7687469|NCT01232452|26737938|P1|Overall Study|Sponsor Decision|3
7687470|NCT01232452|26737937|P2|Overall Study|Protocol entry criterion not met|2
7687471|NCT01232452|26737938|P1|Overall Study|Protocol entry criterion not met|0
7687472|NCT01232452|26737937|P2|Overall Study|Physician Decision|12
7687473|NCT01232452|26737938|P1|Overall Study|Physician Decision|8
7687474|NCT01232452|26737937|P2|Overall Study|Withdrawal by Subject|8
7687475|NCT01232452|26737938|P1|Overall Study|Withdrawal by Subject|11
7687476|NCT01232452|26737937|P2|Overall Study|Adverse Event|15
7687477|NCT01232452|26737938|P1|Overall Study|Adverse Event|17
7687478|NCT01232296|26737964|P2|Overall Study|Death|6
7687479|NCT01232296|26737965|P1|Overall Study|Death|1
7687480|NCT01232296|26737964|P2|Overall Study|Subject/guardian decision|2
7687481|NCT01232296|26737965|P1|Overall Study|Subject/guardian decision|10
7687482|NCT01232296|26737964|P2|Overall Study|Technical problems|0
7687483|NCT01232296|26737965|P1|Overall Study|Technical problems|3
7687484|NCT01232296|26737964|P2|Overall Study|Study terminated by sponsor|1
7687485|NCT01232296|26737965|P1|Overall Study|Study terminated by sponsor|0
7687486|NCT01232296|26737964|P2|Overall Study|Progressive disease|61
7687487|NCT01232296|26737965|P1|Overall Study|Progressive disease|43
7687488|NCT01232296|26737964|P2|Overall Study|Physician Decision|1
7687489|NCT01232296|26737965|P1|Overall Study|Physician Decision|1
7687490|NCT01232296|26737964|P2|Overall Study|Adverse Event|12
7687491|NCT01232296|26737965|P1|Overall Study|Adverse Event|24
7687492|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
7687493|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
7687494|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687495|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687496|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687497|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687498|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687499|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687500|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687501|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7687502|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687503|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
7687504|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687505|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687506|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687507|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687508|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687509|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687510|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687511|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7687512|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687513|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
7687514|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687515|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687516|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687517|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687518|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687519|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687520|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687521|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
7687522|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
7687523|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
7687524|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687525|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687526|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687527|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687528|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687529|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687530|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687531|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7687532|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
7687533|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
7687534|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687535|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687536|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687537|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687538|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687539|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687540|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687541|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7687542|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
7687543|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
7687544|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687545|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687546|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687547|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687548|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687549|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687550|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687551|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7687552|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
7687553|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
7687554|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687555|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687556|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687557|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687558|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687559|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687560|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687561|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7687562|NCT01232283|26737982|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
7687563|NCT01232283|26737983|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
7687564|NCT01232283|26737984|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687565|NCT01232283|26737985|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687566|NCT01232283|26737986|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687567|NCT01232283|26737987|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687568|NCT01232283|26737988|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687569|NCT01232283|26737989|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687570|NCT01232283|26737990|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687571|NCT01232283|26737991|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7687572|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687573|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687574|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687575|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687576|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
7687577|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687578|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687579|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687580|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687581|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7687582|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687583|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687584|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
7687585|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687586|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687587|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687588|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687589|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687590|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687591|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7687592|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687593|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687594|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
7687595|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
7687596|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687597|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
7687598|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687599|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687600|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687601|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7687602|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687603|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687604|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687605|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687606|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687607|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
7687608|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687609|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687610|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687611|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7687612|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7687613|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7687614|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
7687615|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7687616|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7687617|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7687618|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7687619|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7687620|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7687621|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7687622|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687623|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687624|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
7687625|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
7687626|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687627|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
7687628|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687629|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687630|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687631|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7687632|NCT01232283|26737982|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687633|NCT01232283|26737983|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687634|NCT01232283|26737984|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
7687635|NCT01232283|26737985|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687636|NCT01232283|26737986|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
7687637|NCT01232283|26737987|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
7687638|NCT01232283|26737988|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687639|NCT01232283|26737989|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687640|NCT01232283|26737990|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687641|NCT01232283|26737991|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7687642|NCT01232283|26737982|P10|Maintenance Phase (Weeks16-32)|Other|0
7687643|NCT01232283|26737983|P9|Maintenance Phase (Weeks16-32)|Other|0
7687644|NCT01232283|26737984|P8|Maintenance Phase (Weeks16-32)|Other|0
7687645|NCT01232283|26737985|P7|Maintenance Phase (Weeks16-32)|Other|0
7687646|NCT01232283|26737986|P6|Maintenance Phase (Weeks16-32)|Other|0
7687647|NCT01232283|26737987|P5|Maintenance Phase (Weeks16-32)|Other|0
7687648|NCT01232283|26737988|P4|Maintenance Phase (Weeks16-32)|Other|0
7687649|NCT01232283|26737989|P3|Maintenance Phase (Weeks16-32)|Other|2
7687650|NCT01232283|26737990|P2|Maintenance Phase (Weeks16-32)|Other|0
7687651|NCT01232283|26737991|P1|Maintenance Phase (Weeks16-32)|Other|0
7687652|NCT01232283|26737982|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687653|NCT01232283|26737983|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687654|NCT01232283|26737984|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687655|NCT01232283|26737985|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687656|NCT01232283|26737986|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687657|NCT01232283|26737987|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687658|NCT01232283|26737988|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
7687659|NCT01232283|26737989|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
7687660|NCT01232283|26737990|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687661|NCT01232283|26737991|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7687662|NCT01232283|26737982|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687663|NCT01232283|26737983|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687664|NCT01232283|26737984|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687665|NCT01232283|26737985|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687666|NCT01232283|26737986|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687667|NCT01232283|26737987|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687668|NCT01232283|26737988|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
7687669|NCT01232283|26737989|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
7687670|NCT01232283|26737990|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687671|NCT01232283|26737991|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7687672|NCT01232283|26737982|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687673|NCT01232283|26737983|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687674|NCT01232283|26737984|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687675|NCT01232283|26737985|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687676|NCT01232283|26737986|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687677|NCT01232283|26737987|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687678|NCT01232283|26737988|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687679|NCT01232283|26737989|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
7687680|NCT01232283|26737990|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687681|NCT01232283|26737991|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7687682|NCT01232283|26737982|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687683|NCT01232283|26737983|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687684|NCT01232283|26737984|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687685|NCT01232283|26737985|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687686|NCT01232283|26737986|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687687|NCT01232283|26737987|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687688|NCT01232283|26737988|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
7687689|NCT01232283|26737989|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
7687690|NCT01232283|26737990|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687691|NCT01232283|26737991|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7687692|NCT01232283|26737982|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687693|NCT01232283|26737983|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687694|NCT01232283|26737984|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687695|NCT01232283|26737985|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687696|NCT01232283|26737986|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687697|NCT01232283|26737987|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687698|NCT01232283|26737988|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
7687699|NCT01232283|26737989|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
7687700|NCT01232283|26737990|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687701|NCT01232283|26737991|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
7687702|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687703|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687704|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687705|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687706|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687707|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687708|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687709|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
7687710|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
7687711|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
7687712|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687713|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687714|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687715|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687716|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687717|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687718|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687719|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7687720|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
7687721|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
7687722|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687723|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687724|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687725|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687726|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687727|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687728|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687729|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7687730|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
7687731|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
7687732|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687733|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687734|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687735|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687736|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687737|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687738|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687739|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7687740|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
7687741|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
7687742|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687743|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687744|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687745|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687746|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687747|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687748|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687749|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687750|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7687751|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
7687752|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687753|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687754|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687755|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687756|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687757|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687758|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687759|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7687760|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
7687761|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
7687762|NCT01232283|26737982|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687763|NCT01232283|26737983|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687764|NCT01232283|26737984|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687765|NCT01232283|26737985|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687766|NCT01232283|26737986|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687767|NCT01232283|26737987|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687768|NCT01232283|26737988|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687769|NCT01232283|26737989|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7687770|NCT01232283|26737990|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
7687771|NCT01232283|26737991|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
7687772|NCT01232127|26738032|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
7687773|NCT01232127|26738033|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
7687774|NCT01232127|26738034|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
7687775|NCT01231984|26738058|P4|Study Period 2|Did not continue to meet I/E Criteria|1
7687776|NCT01231984|26738059|P3|Study Period 2|Did not continue to meet I/E Criteria|0
7687777|NCT01231984|26738060|P2|Study Period 2|Did not continue to meet I/E Criteria|1
7687778|NCT01231984|26738061|P1|Study Period 2|Did not continue to meet I/E Criteria|1
7687779|NCT01231984|26738058|P4|Study Period 2|Lost to Follow-up|3
7687780|NCT01231984|26738059|P3|Study Period 2|Lost to Follow-up|0
7687781|NCT01231984|26738060|P2|Study Period 2|Lost to Follow-up|0
7687782|NCT01231984|26738061|P1|Study Period 2|Lost to Follow-up|1
7687783|NCT01231984|26738058|P4|Study Period 2|Withdrawal by Subject|0
7687784|NCT01231984|26738059|P3|Study Period 2|Withdrawal by Subject|0
7687785|NCT01231984|26738060|P2|Study Period 2|Withdrawal by Subject|1
7687786|NCT01231984|26738061|P1|Study Period 2|Withdrawal by Subject|1
7687787|NCT01231984|26738058|P4|Study Period 1|Other|1
7687788|NCT01231984|26738059|P3|Study Period 1|Other|0
7687789|NCT01231984|26738060|P2|Study Period 1|Other|0
7687790|NCT01231984|26738061|P1|Study Period 1|Other|0
7687791|NCT01231984|26738058|P4|Study Period 1|Adverse Event|0
7687792|NCT01231984|26738059|P3|Study Period 1|Adverse Event|0
7687793|NCT01231984|26738060|P2|Study Period 1|Adverse Event|0
7687794|NCT01231984|26738061|P1|Study Period 1|Adverse Event|1
7687795|NCT01231984|26738058|P4|Study Period 1|Protocol Violation|3
7687796|NCT01231984|26738059|P3|Study Period 1|Protocol Violation|2
7687797|NCT01231984|26738060|P2|Study Period 1|Protocol Violation|4
7687798|NCT01231984|26738061|P1|Study Period 1|Protocol Violation|3
7687799|NCT01231984|26738058|P4|Study Period 1|Non-compliance with study requirements|1
7687800|NCT01231984|26738059|P3|Study Period 1|Non-compliance with study requirements|2
7687801|NCT01231984|26738060|P2|Study Period 1|Non-compliance with study requirements|0
7687802|NCT01231984|26738061|P1|Study Period 1|Non-compliance with study requirements|5
7687803|NCT01231984|26738058|P4|Study Period 1|Screen Failure|1
7687804|NCT01231984|26738059|P3|Study Period 1|Screen Failure|0
7687805|NCT01231984|26738060|P2|Study Period 1|Screen Failure|0
7687806|NCT01231984|26738061|P1|Study Period 1|Screen Failure|0
7687807|NCT01231984|26738058|P4|Study Period 1|Did not continue to meet I/E Criteria|2
7687808|NCT01231984|26738059|P3|Study Period 1|Did not continue to meet I/E Criteria|2
7687809|NCT01231984|26738060|P2|Study Period 1|Did not continue to meet I/E Criteria|2
7687810|NCT01231984|26738061|P1|Study Period 1|Did not continue to meet I/E Criteria|2
7687811|NCT01231984|26738058|P4|Study Period 1|Lost to Follow-up|0
7687812|NCT01231984|26738059|P3|Study Period 1|Lost to Follow-up|1
7687813|NCT01231984|26738060|P2|Study Period 1|Lost to Follow-up|1
7687814|NCT01231984|26738061|P1|Study Period 1|Lost to Follow-up|1
7687815|NCT01231984|26738058|P4|Study Period 1|Withdrawal by Subject|1
7687816|NCT01231984|26738059|P3|Study Period 1|Withdrawal by Subject|0
7687817|NCT01231984|26738060|P2|Study Period 1|Withdrawal by Subject|0
7687818|NCT01231984|26738061|P1|Study Period 1|Withdrawal by Subject|0
7687819|NCT01231906|26738084|P2|Overall Study|No treatment|2
7687820|NCT01231906|26738085|P1|Overall Study|No treatment|1
7687821|NCT01231906|26738084|P2|Overall Study|Ineligible|3
7687822|NCT01231906|26738085|P1|Overall Study|Ineligible|10
7687823|NCT01231906|26738084|P2|Overall Study|Withdrawal by Subject|4
7687824|NCT01231906|26738085|P1|Overall Study|Withdrawal by Subject|0
7687825|NCT01231906|26738084|P2|Overall Study|Physician Decision|24
7687826|NCT01231906|26738085|P1|Overall Study|Physician Decision|34
7687827|NCT01231906|26738084|P2|Overall Study|Lost to Follow-up|0
7687828|NCT01231906|26738085|P1|Overall Study|Lost to Follow-up|1
7687829|NCT01231906|26738084|P2|Overall Study|Lack of Efficacy|68
7687830|NCT01231906|26738085|P1|Overall Study|Lack of Efficacy|75
7687831|NCT01231659|26738114|P1|Overall Study|Other protocol defined criteria|12
7687832|NCT01231659|26738114|P1|Overall Study|Patient refused to complete study visit|1
7687833|NCT01231659|26738114|P1|Overall Study|Death|2
7687834|NCT01231659|26738114|P1|Overall Study|Disease Progression|48
7687835|NCT01231659|26738114|P1|Overall Study|Adverse Event|9
7687836|NCT01231620|26738148|P3|Overall Study|Lost to Follow-up|9
7687837|NCT01231620|26738149|P2|Overall Study|Lost to Follow-up|4
7687838|NCT01231620|26738150|P1|Overall Study|Lost to Follow-up|3
7687839|NCT01231620|26738148|P3|Overall Study|Withdrawal by Subject|8
7687840|NCT01231620|26738149|P2|Overall Study|Withdrawal by Subject|6
7687841|NCT01231620|26738150|P1|Overall Study|Withdrawal by Subject|6
7687842|NCT01231620|26738148|P3|Overall Study|Adverse Event|1
7687843|NCT01231620|26738149|P2|Overall Study|Adverse Event|2
7687844|NCT01231620|26738150|P1|Overall Study|Adverse Event|2
7687845|NCT01231620|26738148|P3|Overall Study|Death|11
7687846|NCT01231620|26738149|P2|Overall Study|Death|14
7687847|NCT01231620|26738150|P1|Overall Study|Death|12
7687848|NCT01231620|26738148|P3|Overall Study|Physician Decision|10
7687849|NCT01231620|26738149|P2|Overall Study|Physician Decision|5
7687850|NCT01231620|26738150|P1|Overall Study|Physician Decision|3
7687851|NCT01231607|26738256|P5|Overall Study|Withdrawal by Subject|9
7687852|NCT01231607|26738257|P4|Overall Study|Withdrawal by Subject|17
7687853|NCT01231607|26738258|P3|Overall Study|Withdrawal by Subject|14
7687854|NCT01231607|26738259|P2|Overall Study|Withdrawal by Subject|9
7687855|NCT01231607|26738260|P1|Overall Study|Withdrawal by Subject|9
7687856|NCT01231607|26738256|P5|Overall Study|Protocol Violation|2
7687857|NCT01231607|26738257|P4|Overall Study|Protocol Violation|2
7687858|NCT01231607|26738258|P3|Overall Study|Protocol Violation|0
7687859|NCT01231607|26738259|P2|Overall Study|Protocol Violation|2
7687860|NCT01231607|26738260|P1|Overall Study|Protocol Violation|3
7687861|NCT01231607|26738256|P5|Overall Study|Physician Decision|4
7687862|NCT01231607|26738257|P4|Overall Study|Physician Decision|5
7687863|NCT01231607|26738258|P3|Overall Study|Physician Decision|3
7687864|NCT01231607|26738259|P2|Overall Study|Physician Decision|4
7687865|NCT01231607|26738260|P1|Overall Study|Physician Decision|4
7687866|NCT01231607|26738256|P5|Overall Study|Lost to Follow-up|4
7687867|NCT01231607|26738257|P4|Overall Study|Lost to Follow-up|10
7687868|NCT01231607|26738258|P3|Overall Study|Lost to Follow-up|10
7687869|NCT01231607|26738259|P2|Overall Study|Lost to Follow-up|11
7687870|NCT01231607|26738260|P1|Overall Study|Lost to Follow-up|13
7687871|NCT01231607|26738256|P5|Overall Study|Adverse Event|5
7687872|NCT01231607|26738257|P4|Overall Study|Adverse Event|4
7687873|NCT01231607|26738258|P3|Overall Study|Adverse Event|4
7687874|NCT01231607|26738259|P2|Overall Study|Adverse Event|8
7687875|NCT01231607|26738260|P1|Overall Study|Adverse Event|0
7687876|NCT01231581|26738352|P2|Overall Study|Ongoing|0
7687877|NCT01231581|26738353|P1|Overall Study|Ongoing|1
7687878|NCT01231581|26738352|P2|Overall Study|Death|64
7687879|NCT01231581|26738353|P1|Overall Study|Death|65
7687880|NCT01231581|26738352|P2|Overall Study|Study Closed/Terminated|5
7687881|NCT01231581|26738353|P1|Overall Study|Study Closed/Terminated|6
7687882|NCT01231581|26738352|P2|Overall Study|Withdrawal by Subject|9
7687883|NCT01231581|26738353|P1|Overall Study|Withdrawal by Subject|6
7687884|NCT01231581|26738352|P2|Overall Study|Lost to Follow-up|2
7687885|NCT01231581|26738353|P1|Overall Study|Lost to Follow-up|2
7687886|NCT01231555|26738374|P3|Overall Study|Withdrawal by Subject|0
7687887|NCT01231555|26738375|P2|Overall Study|Withdrawal by Subject|2
7687888|NCT01231555|26738376|P1|Overall Study|Withdrawal by Subject|0
7687889|NCT01231555|26738374|P3|Overall Study|Study terminated|8
7687890|NCT01231555|26738375|P2|Overall Study|Study terminated|5
7687891|NCT01231555|26738376|P1|Overall Study|Study terminated|8
7687892|NCT01231516|26738407|P2|Open-label Phase|Ongoing at the time of analysis|23
7687893|NCT01231516|26738408|P1|Open-label Phase|Ongoing at the time of analysis|282
7687894|NCT01231516|26738407|P2|Open-label Phase|Withdrawal by Subject|0
7687895|NCT01231516|26738408|P1|Open-label Phase|Withdrawal by Subject|1
7687896|NCT01231516|26738407|P2|Open-label Phase|Lost to Follow-up|0
7687897|NCT01231516|26738408|P1|Open-label Phase|Lost to Follow-up|3
7687898|NCT01231516|26738407|P2|Open-label Phase|Protocol Violation|0
7687899|NCT01231516|26738408|P1|Open-label Phase|Protocol Violation|2
7687900|NCT01231516|26738407|P2|Open-label Phase|Lack of Efficacy|3
7687901|NCT01231516|26738408|P1|Open-label Phase|Lack of Efficacy|7
7687902|NCT01231516|26738407|P2|48 Week Double-blind Phase|Site Closed|1
7687903|NCT01231516|26738408|P1|48 Week Double-blind Phase|Site Closed|3
7687904|NCT01231516|26738407|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
7687905|NCT01231516|26738408|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
7687906|NCT01231516|26738407|P2|48 Week Double-blind Phase|Physician Decision|1
7687907|NCT01231516|26738408|P1|48 Week Double-blind Phase|Physician Decision|1
7687908|NCT01231516|26738407|P2|48 Week Double-blind Phase|Lost to Follow-up|10
7687909|NCT01231516|26738408|P1|48 Week Double-blind Phase|Lost to Follow-up|5
7687910|NCT01231516|26738407|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
7687911|NCT01231516|26738408|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
7687912|NCT01231516|26738407|P2|48 Week Double-blind Phase|Protocol Violation|6
7687913|NCT01231516|26738408|P1|48 Week Double-blind Phase|Protocol Violation|9
7687914|NCT01231516|26738407|P2|48 Week Double-blind Phase|Lack of Efficacy|42
7687915|NCT01231516|26738408|P1|48 Week Double-blind Phase|Lack of Efficacy|20
7687916|NCT01231516|26738407|P2|48 Week Double-blind Phase|Adverse Event|11
7687917|NCT01231516|26738408|P1|48 Week Double-blind Phase|Adverse Event|4
7687918|NCT01231503|26738438|P8|Overall Study|Protocol Violation|0
7687919|NCT01231503|26738439|P7|Overall Study|Protocol Violation|0
7687920|NCT01231503|26738440|P6|Overall Study|Protocol Violation|0
7687921|NCT01231503|26738441|P5|Overall Study|Protocol Violation|0
7687922|NCT01231503|26738442|P4|Overall Study|Protocol Violation|1
7687923|NCT01231503|26738443|P3|Overall Study|Protocol Violation|0
7687924|NCT01231503|26738444|P2|Overall Study|Protocol Violation|0
7687925|NCT01231503|26738445|P1|Overall Study|Protocol Violation|0
7687926|NCT01231503|26738438|P8|Overall Study|Lost to Follow-up|6
7687927|NCT01231503|26738439|P7|Overall Study|Lost to Follow-up|6
7687928|NCT01231503|26738440|P6|Overall Study|Lost to Follow-up|9
7687929|NCT01231503|26738441|P5|Overall Study|Lost to Follow-up|7
7687930|NCT01231503|26738442|P4|Overall Study|Lost to Follow-up|5
7687931|NCT01231503|26738443|P3|Overall Study|Lost to Follow-up|8
7687932|NCT01231503|26738444|P2|Overall Study|Lost to Follow-up|10
7687933|NCT01231503|26738445|P1|Overall Study|Lost to Follow-up|8
7687934|NCT01231503|26738438|P8|Overall Study|Withdrawal by Subject|2
7687935|NCT01231503|26738439|P7|Overall Study|Withdrawal by Subject|1
7687936|NCT01231503|26738440|P6|Overall Study|Withdrawal by Subject|5
7687937|NCT01231503|26738441|P5|Overall Study|Withdrawal by Subject|3
7687938|NCT01231503|26738442|P4|Overall Study|Withdrawal by Subject|1
7687939|NCT01231503|26738443|P3|Overall Study|Withdrawal by Subject|3
7687940|NCT01231503|26738444|P2|Overall Study|Withdrawal by Subject|3
7687941|NCT01231503|26738445|P1|Overall Study|Withdrawal by Subject|6
7687942|NCT01231503|26738438|P8|Overall Study|Adverse event, serious fatal|0
7687943|NCT01231503|26738439|P7|Overall Study|Adverse event, serious fatal|0
7687944|NCT01231503|26738440|P6|Overall Study|Adverse event, serious fatal|1
7687945|NCT01231503|26738441|P5|Overall Study|Adverse event, serious fatal|0
7687946|NCT01231503|26738442|P4|Overall Study|Adverse event, serious fatal|1
7687947|NCT01231503|26738443|P3|Overall Study|Adverse event, serious fatal|1
7687948|NCT01231503|26738444|P2|Overall Study|Adverse event, serious fatal|0
7687949|NCT01231503|26738445|P1|Overall Study|Adverse event, serious fatal|0
7687950|NCT01231503|26738438|P8|Overall Study|Adverse Event|0
7687951|NCT01231503|26738439|P7|Overall Study|Adverse Event|0
7687952|NCT01231503|26738440|P6|Overall Study|Adverse Event|1
7687953|NCT01231503|26738441|P5|Overall Study|Adverse Event|0
7687954|NCT01231503|26738442|P4|Overall Study|Adverse Event|0
7687955|NCT01231503|26738443|P3|Overall Study|Adverse Event|0
7687956|NCT01231503|26738444|P2|Overall Study|Adverse Event|0
7687957|NCT01231503|26738445|P1|Overall Study|Adverse Event|0
7687958|NCT01231464|26738685|P2|Overall Study|Withdrawal by Subject|2
7687959|NCT01231464|26738686|P1|Overall Study|Withdrawal by Subject|3
7687960|NCT01231464|26738685|P2|Overall Study|Lost to Follow-up|2
7687961|NCT01231464|26738686|P1|Overall Study|Lost to Follow-up|1
7687962|NCT01231464|26738685|P2|Overall Study|Protocol Violation|2
7687963|NCT01231464|26738686|P1|Overall Study|Protocol Violation|1
7687964|NCT01231464|26738685|P2|Overall Study|Adverse Event|1
7687965|NCT01231464|26738686|P1|Overall Study|Adverse Event|0
7687966|NCT01231373|26738735|P4|Overall Study|Withdrew Consent|0
7687967|NCT01231373|26738736|P3|Overall Study|Withdrew Consent|0
7687968|NCT01231373|26738737|P2|Overall Study|Withdrew Consent|0
7687969|NCT01231373|26738738|P1|Overall Study|Withdrew Consent|1
7687970|NCT01231373|26738735|P4|Overall Study|Lost to Follow-up|1
7687971|NCT01231373|26738736|P3|Overall Study|Lost to Follow-up|0
7687972|NCT01231373|26738737|P2|Overall Study|Lost to Follow-up|0
7687973|NCT01231373|26738738|P1|Overall Study|Lost to Follow-up|0
7687974|NCT01231373|26738735|P4|Overall Study|Withdrew consent prior to randomization|0
7687975|NCT01231373|26738736|P3|Overall Study|Withdrew consent prior to randomization|0
7687976|NCT01231373|26738737|P2|Overall Study|Withdrew consent prior to randomization|1
7687977|NCT01231373|26738738|P1|Overall Study|Withdrew consent prior to randomization|2
7687978|NCT01231321|26738777|P1|Overall Study|Lack of Efficacy|2
7687979|NCT01231321|26738777|P1|Overall Study|Adverse Event|3
7687980|NCT01230892|26738825|P2|Overall Study|Lost to Follow-up|0
7687981|NCT01230892|26738826|P1|Overall Study|Lost to Follow-up|2
7687982|NCT01230892|26738825|P2|Overall Study|Withdrawal by Subject|1
7687983|NCT01230892|26738826|P1|Overall Study|Withdrawal by Subject|1
7687984|NCT01230827|26738836|P4|Overall Study|Study terminated by Sponsor|63
7687985|NCT01230827|26738837|P3|Overall Study|Study terminated by Sponsor|56
7687986|NCT01230827|26738838|P2|Overall Study|Study terminated by Sponsor|2
7687987|NCT01230827|26738839|P1|Overall Study|Study terminated by Sponsor|0
7687988|NCT01230827|26738836|P4|Overall Study|Recovery|0
7687989|NCT01230827|26738837|P3|Overall Study|Recovery|0
7687990|NCT01230827|26738838|P2|Overall Study|Recovery|6
7687991|NCT01230827|26738839|P1|Overall Study|Recovery|0
7687992|NCT01230827|26738836|P4|Overall Study|Adverse Event|7
7687993|NCT01230827|26738837|P3|Overall Study|Adverse Event|3
7687994|NCT01230827|26738838|P2|Overall Study|Adverse Event|2
7687995|NCT01230827|26738839|P1|Overall Study|Adverse Event|4
7687996|NCT01230827|26738836|P4|Overall Study|Lack of Efficacy|3
7687997|NCT01230827|26738837|P3|Overall Study|Lack of Efficacy|2
7687998|NCT01230827|26738838|P2|Overall Study|Lack of Efficacy|1
7687999|NCT01230827|26738839|P1|Overall Study|Lack of Efficacy|14
7688000|NCT01230827|26738836|P4|Overall Study|Withdrawal by Subject|2
7688001|NCT01230827|26738837|P3|Overall Study|Withdrawal by Subject|3
7688002|NCT01230827|26738838|P2|Overall Study|Withdrawal by Subject|0
7688003|NCT01230827|26738839|P1|Overall Study|Withdrawal by Subject|1
7688004|NCT01230827|26738836|P4|Overall Study|Lost to Follow-up|3
7688005|NCT01230827|26738837|P3|Overall Study|Lost to Follow-up|1
7688006|NCT01230827|26738838|P2|Overall Study|Lost to Follow-up|0
7688007|NCT01230827|26738839|P1|Overall Study|Lost to Follow-up|0
7688008|NCT01230814|26738855|P2|Overall Study|Discontinued (not due to adverse event)|1
7688009|NCT01230814|26738856|P1|Overall Study|Discontinued (not due to adverse event)|2
7688010|NCT01230814|26738855|P2|Overall Study|Lost to Follow-up|3
7688011|NCT01230814|26738856|P1|Overall Study|Lost to Follow-up|11
7688012|NCT01230788|26738906|P1|Overall Study|Prescribed exclusion drug|1
7688013|NCT01230749|26738918|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
7688014|NCT01230749|26738919|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
7688015|NCT01230749|26738920|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
7688016|NCT01230749|26738921|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
7688017|NCT01230749|26738918|P4|Overall Study|Withdrawal by Subject|0
7688018|NCT01230749|26738919|P3|Overall Study|Withdrawal by Subject|0
7688019|NCT01230749|26738920|P2|Overall Study|Withdrawal by Subject|1
7688020|NCT01230749|26738921|P1|Overall Study|Withdrawal by Subject|0
7688021|NCT01230749|26738918|P4|Overall Study|Physician Decision|0
7688022|NCT01230749|26738919|P3|Overall Study|Physician Decision|1
7688023|NCT01230749|26738920|P2|Overall Study|Physician Decision|0
7688024|NCT01230749|26738921|P1|Overall Study|Physician Decision|0
7688025|NCT01230749|26738918|P4|Overall Study|Adverse Event|1
7688026|NCT01230749|26738919|P3|Overall Study|Adverse Event|0
7688027|NCT01230749|26738920|P2|Overall Study|Adverse Event|0
7688028|NCT01230749|26738921|P1|Overall Study|Adverse Event|0
7688029|NCT01230710|26738956|P1|Overall Study|Withdrawal of Consent|1
7688030|NCT01230710|26738956|P1|Overall Study|Death|4
7688031|NCT01230710|26738956|P1|Overall Study|Lost to Follow-up|3
7688032|NCT01230710|26738956|P1|Overall Study|Disease Progression|41
7688033|NCT01230554|26738980|P1|Overall Study|Inability to maintain visit schedule|1
7688034|NCT01230554|26738980|P1|Overall Study|Lost to Follow-up|2
7688035|NCT01230489|26739003|P1|Overall Study|Treatment modality changed|1
7688036|NCT01230489|26739003|P1|Overall Study|Adverse Event|2
7688037|NCT01230489|26739003|P1|Overall Study|Death|2
7688038|NCT01230307|26739038|P2|Overall Study|LVAD Placement|2
7688039|NCT01230307|26739039|P1|Overall Study|LVAD Placement|0
7688040|NCT01230060|26739072|P1|Overall Study|Withdrawal by Subject|1
7688041|NCT01229735|26739145|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7688042|NCT01229735|26739146|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7688043|NCT01229735|26739145|P2|Overall Study|AE, non-serious non-fatal|17
7688044|NCT01229735|26739146|P1|Overall Study|AE, non-serious non-fatal|13
7688045|NCT01229735|26739145|P2|Overall Study|SAE, non-fatal|4
7688046|NCT01229735|26739146|P1|Overall Study|SAE, non-fatal|0
7688047|NCT01229735|26739145|P2|Overall Study|Other Reason|10
7688048|NCT01229735|26739146|P1|Overall Study|Other Reason|13
7688049|NCT01229735|26739145|P2|Overall Study|Withdrawal by Subject|17
7688050|NCT01229735|26739146|P1|Overall Study|Withdrawal by Subject|18
7688051|NCT01229735|26739145|P2|Overall Study|Lost to Follow-up|2
7688052|NCT01229735|26739146|P1|Overall Study|Lost to Follow-up|0
7688053|NCT01229735|26739145|P2|Overall Study|Protocol Violation|8
7688054|NCT01229735|26739146|P1|Overall Study|Protocol Violation|13
7688055|NCT01229735|26739145|P2|Overall Study|Lack of Efficacy|8
7688056|NCT01229735|26739146|P1|Overall Study|Lack of Efficacy|8
7688057|NCT01229449|26739203|P5|Overall Study|Physician Decision|0
7688058|NCT01229449|26739204|P4|Overall Study|Physician Decision|0
7688059|NCT01229449|26739205|P3|Overall Study|Physician Decision|1
7688060|NCT01229449|26739206|P2|Overall Study|Physician Decision|0
7688061|NCT01229449|26739207|P1|Overall Study|Physician Decision|0
7688062|NCT01229449|26739203|P5|Overall Study|Lost to Follow-up|0
7688063|NCT01229449|26739204|P4|Overall Study|Lost to Follow-up|0
7688064|NCT01229449|26739205|P3|Overall Study|Lost to Follow-up|1
7688065|NCT01229449|26739206|P2|Overall Study|Lost to Follow-up|1
7688066|NCT01229449|26739207|P1|Overall Study|Lost to Follow-up|1
7688067|NCT01229449|26739203|P5|Overall Study|Withdrawal by Subject|1
7688068|NCT01229449|26739204|P4|Overall Study|Withdrawal by Subject|1
7688069|NCT01229449|26739205|P3|Overall Study|Withdrawal by Subject|0
7688070|NCT01229449|26739206|P2|Overall Study|Withdrawal by Subject|3
7688071|NCT01229449|26739207|P1|Overall Study|Withdrawal by Subject|0
7688072|NCT01229436|26739264|P1|Overall Study|Lost to Follow-up|3
7688073|NCT01229436|26739264|P1|Overall Study|Withdrawal by Subject|2
7688074|NCT01229397|26739326|P2|Overall Study|Migrated/moved from study area|0
7688075|NCT01229397|26739327|P1|Overall Study|Migrated/moved from study area|1
7688076|NCT01229397|26739326|P2|Overall Study|Lost to Follow-up|6
7688077|NCT01229397|26739327|P1|Overall Study|Lost to Follow-up|7
7688078|NCT01229397|26739326|P2|Overall Study|Withdrawal by Subject|3
7688079|NCT01229397|26739327|P1|Overall Study|Withdrawal by Subject|3
7688080|NCT01229371|26739345|P4|Overall Study|Withdrawal by Subject|0
7688081|NCT01229371|26739346|P3|Overall Study|Withdrawal by Subject|0
7688082|NCT01229371|26739347|P2|Overall Study|Withdrawal by Subject|1
7688083|NCT01229371|26739348|P1|Overall Study|Withdrawal by Subject|0
7688084|NCT01229267|26739375|P5|Overall Study|Lost to Follow-up|22
7688085|NCT01229267|26739376|P4|Overall Study|Lost to Follow-up|3
7688086|NCT01229267|26739377|P3|Overall Study|Lost to Follow-up|8
7688087|NCT01229267|26739378|P2|Overall Study|Lost to Follow-up|5
7688088|NCT01229267|26739379|P1|Overall Study|Lost to Follow-up|6
7688089|NCT01229267|26739375|P5|Overall Study|Physician Decision|25
7688090|NCT01229267|26739376|P4|Overall Study|Physician Decision|3
7688091|NCT01229267|26739377|P3|Overall Study|Physician Decision|8
7688092|NCT01229267|26739378|P2|Overall Study|Physician Decision|11
7688093|NCT01229267|26739379|P1|Overall Study|Physician Decision|8
7688094|NCT01229267|26739375|P5|Overall Study|Progressive disease|1
7688095|NCT01229267|26739376|P4|Overall Study|Progressive disease|0
7688096|NCT01229267|26739377|P3|Overall Study|Progressive disease|0
7688097|NCT01229267|26739378|P2|Overall Study|Progressive disease|0
7688098|NCT01229267|26739379|P1|Overall Study|Progressive disease|0
7688099|NCT01229267|26739375|P5|Overall Study|Protocol Violation|0
7688100|NCT01229267|26739376|P4|Overall Study|Protocol Violation|0
7688101|NCT01229267|26739377|P3|Overall Study|Protocol Violation|0
7688102|NCT01229267|26739378|P2|Overall Study|Protocol Violation|1
7688103|NCT01229267|26739379|P1|Overall Study|Protocol Violation|0
7688104|NCT01229267|26739375|P5|Overall Study|Withdrawal by Subject|59
7688105|NCT01229267|26739376|P4|Overall Study|Withdrawal by Subject|14
7688106|NCT01229267|26739377|P3|Overall Study|Withdrawal by Subject|32
7688107|NCT01229267|26739378|P2|Overall Study|Withdrawal by Subject|22
7688108|NCT01229267|26739379|P1|Overall Study|Withdrawal by Subject|23
7688109|NCT01229267|26739375|P5|Overall Study|Death|103
7688110|NCT01229267|26739376|P4|Overall Study|Death|13
7688111|NCT01229267|26739377|P3|Overall Study|Death|35
7688112|NCT01229267|26739378|P2|Overall Study|Death|37
7688113|NCT01229267|26739379|P1|Overall Study|Death|40
7688114|NCT01229267|26739375|P5|Overall Study|Adverse Event|10
7688115|NCT01229267|26739376|P4|Overall Study|Adverse Event|2
7688116|NCT01229267|26739377|P3|Overall Study|Adverse Event|3
7688117|NCT01229267|26739378|P2|Overall Study|Adverse Event|6
7688118|NCT01229267|26739379|P1|Overall Study|Adverse Event|4
7688119|NCT01229254|26739398|P3|Overall Study|Non-compliance with Study Drug|1
7688120|NCT01229254|26739399|P2|Overall Study|Non-compliance with Study Drug|1
7688121|NCT01229254|26739400|P1|Overall Study|Non-compliance with Study Drug|0
7688122|NCT01229254|26739398|P3|Overall Study|Withdrawal by Subject|1
7688123|NCT01229254|26739399|P2|Overall Study|Withdrawal by Subject|0
7688124|NCT01229254|26739400|P1|Overall Study|Withdrawal by Subject|1
7688125|NCT01229254|26739398|P3|Overall Study|Protocol Violation|5
7688126|NCT01229254|26739399|P2|Overall Study|Protocol Violation|6
7688127|NCT01229254|26739400|P1|Overall Study|Protocol Violation|4
7688128|NCT01229254|26739398|P3|Overall Study|Physician Decision|0
7688129|NCT01229254|26739399|P2|Overall Study|Physician Decision|3
7688130|NCT01229254|26739400|P1|Overall Study|Physician Decision|0
7688131|NCT01229254|26739398|P3|Overall Study|Lost to Follow-up|1
7688132|NCT01229254|26739399|P2|Overall Study|Lost to Follow-up|0
7688133|NCT01229254|26739400|P1|Overall Study|Lost to Follow-up|3
7688134|NCT01229254|26739398|P3|Overall Study|Adverse Event|3
7688135|NCT01229254|26739399|P2|Overall Study|Adverse Event|5
7688136|NCT01229254|26739400|P1|Overall Study|Adverse Event|4
7688137|NCT01229254|26739398|P3|Overall Study|Not Continuing Into Safety Extension|1
7688138|NCT01229254|26739399|P2|Overall Study|Not Continuing Into Safety Extension|1
7688139|NCT01229254|26739400|P1|Overall Study|Not Continuing Into Safety Extension|3
7688140|NCT01229176|26739438|P8|Overall Study|Lost to Follow-up|2
7688141|NCT01229176|26739439|P7|Overall Study|Lost to Follow-up|0
7688142|NCT01229176|26739440|P6|Overall Study|Lost to Follow-up|1
7688143|NCT01229176|26739441|P5|Overall Study|Lost to Follow-up|1
7688144|NCT01229176|26739442|P4|Overall Study|Lost to Follow-up|0
7688145|NCT01229176|26739443|P3|Overall Study|Lost to Follow-up|0
7688146|NCT01229176|26739444|P2|Overall Study|Lost to Follow-up|3
7688147|NCT01229176|26739445|P1|Overall Study|Lost to Follow-up|0
7688148|NCT01229176|26739438|P8|Overall Study|Withdrawal by Subject|1
7688149|NCT01229176|26739439|P7|Overall Study|Withdrawal by Subject|0
7688150|NCT01229176|26739440|P6|Overall Study|Withdrawal by Subject|1
7688151|NCT01229176|26739441|P5|Overall Study|Withdrawal by Subject|1
7688152|NCT01229176|26739442|P4|Overall Study|Withdrawal by Subject|1
7688153|NCT01229176|26739443|P3|Overall Study|Withdrawal by Subject|0
7688154|NCT01229176|26739444|P2|Overall Study|Withdrawal by Subject|0
7688155|NCT01229176|26739445|P1|Overall Study|Withdrawal by Subject|0
7688156|NCT01229150|26739499|P4|Overall Study|Toxicity|0
7688157|NCT01229150|26739500|P3|Overall Study|Toxicity|0
7688158|NCT01229150|26739501|P2|Overall Study|Toxicity|2
7688159|NCT01229150|26739502|P1|Overall Study|Toxicity|2
7688160|NCT01229111|26739559|P1|Overall Study|Death|1
7688161|NCT01228747|26739608|P2|Overall Study|Other Reason|5
7688162|NCT01228747|26739609|P1|Overall Study|Other Reason|2
7688163|NCT01228747|26739608|P2|Overall Study|Withdrawal by Subject|1
7688164|NCT01228747|26739609|P1|Overall Study|Withdrawal by Subject|5
7688165|NCT01228747|26739608|P2|Overall Study|Lost to Follow-up|3
7688166|NCT01228747|26739609|P1|Overall Study|Lost to Follow-up|4
7688167|NCT01228747|26739608|P2|Overall Study|Protocol Violation|5
7688168|NCT01228747|26739609|P1|Overall Study|Protocol Violation|6
7688169|NCT01228747|26739608|P2|Overall Study|Lack of Efficacy|27
7688170|NCT01228747|26739609|P1|Overall Study|Lack of Efficacy|40
7688171|NCT01228747|26739608|P2|Overall Study|Adverse Event|4
7688172|NCT01228747|26739609|P1|Overall Study|Adverse Event|8
7688173|NCT01228734|26739625|P2|Overall Study|Randomized, but not treated|4
7688174|NCT01228734|26739626|P1|Overall Study|Randomized, but not treated|0
7688175|NCT01228591|26739640|P2|Baseline|Lack of Efficacy|2
7688176|NCT01228591|26739641|P1|Baseline|Lack of Efficacy|1
7688177|NCT01228318|26739670|P2|Overall Study|Incarcerated|0
7688178|NCT01228318|26739671|P1|Overall Study|Incarcerated|1
7688179|NCT01228318|26739670|P2|Overall Study|Moved|2
7688180|NCT01228318|26739671|P1|Overall Study|Moved|0
7688181|NCT01228318|26739670|P2|Overall Study|Unable to contact|5
7688182|NCT01228318|26739671|P1|Overall Study|Unable to contact|2
7688183|NCT01228318|26739670|P2|Overall Study|Clinic no show to receive intervention|0
7688184|NCT01228318|26739671|P1|Overall Study|Clinic no show to receive intervention|1
7688185|NCT01228175|26739687|P2|Overall Study|Physician Decision|1
7688186|NCT01228175|26739688|P1|Overall Study|Physician Decision|1
7688187|NCT01228175|26739687|P2|Overall Study|Withdrawal by Subject|2
7688188|NCT01228175|26739688|P1|Overall Study|Withdrawal by Subject|1
7688189|NCT01228175|26739687|P2|Overall Study|Lost to Follow-up|50
7688190|NCT01228175|26739688|P1|Overall Study|Lost to Follow-up|64
7688191|NCT01228071|26739730|P1|Overall Study|Withdrawal by Subject|1
7688192|NCT01228071|26739730|P1|Overall Study|Protocol Violation|1
7688193|NCT01228019|26739736|P1|Overall Study|Violation of Entry Criterion|9
7688194|NCT01228019|26739736|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
7688195|NCT01228019|26739736|P1|Overall Study|Missing pre-treatment data|72
7688196|NCT01228019|26739736|P1|Overall Study|Duplicate enrollment|1
7688197|NCT01228019|26739736|P1|Overall Study|Dose Violation|70
7688198|NCT01227967|26739802|P2|Overall Study|Taking Additional Antiviral Drug|0
7688199|NCT01227967|26739803|P1|Overall Study|Taking Additional Antiviral Drug|1
7688200|NCT01227967|26739802|P2|Overall Study|Never Started Treatment|4
7688201|NCT01227967|26739803|P1|Overall Study|Never Started Treatment|0
7688202|NCT01227967|26739802|P2|Overall Study|Physician Decision|1
7688203|NCT01227967|26739803|P1|Overall Study|Physician Decision|0
7688204|NCT01227967|26739802|P2|Overall Study|Withdrawal by Subject|3
7688205|NCT01227967|26739803|P1|Overall Study|Withdrawal by Subject|4
7688206|NCT01227967|26739802|P2|Overall Study|Lost to Follow-up|3
7688207|NCT01227967|26739803|P1|Overall Study|Lost to Follow-up|8
7688208|NCT01227967|26739802|P2|Overall Study|Death|1
7688209|NCT01227967|26739803|P1|Overall Study|Death|0
7688210|NCT01227967|26739802|P2|Overall Study|Protocol Violation|1
7688211|NCT01227967|26739803|P1|Overall Study|Protocol Violation|3
7688212|NCT01227954|26739837|P1|Overall Study|No protocol treatment|7
7688213|NCT01227954|26739837|P1|Overall Study|Protocol Violation|6
7688214|NCT01227928|26739851|P2|Overall Study|Death|12
7688215|NCT01227928|26739852|P1|Overall Study|Death|14
7688216|NCT01227928|26739851|P2|Overall Study|Withdrawal by Subject|3
7688217|NCT01227928|26739852|P1|Overall Study|Withdrawal by Subject|4
7688218|NCT01227928|26739851|P2|Overall Study|Lost to Follow-up|2
7688219|NCT01227928|26739852|P1|Overall Study|Lost to Follow-up|4
7688220|NCT01227902|26739890|P4|Overall Study|Withdrawal by Subject|3
7688221|NCT01227902|26739891|P3|Overall Study|Withdrawal by Subject|4
7688222|NCT01227902|26739892|P2|Overall Study|Withdrawal by Subject|2
7688223|NCT01227902|26739893|P1|Overall Study|Withdrawal by Subject|4
7688224|NCT01227902|26739890|P4|Overall Study|Physician Decision|0
7688225|NCT01227902|26739891|P3|Overall Study|Physician Decision|1
7688226|NCT01227902|26739892|P2|Overall Study|Physician Decision|1
7688227|NCT01227902|26739893|P1|Overall Study|Physician Decision|0
7688228|NCT01227902|26739890|P4|Overall Study|Lost to Follow-up|2
7688229|NCT01227902|26739891|P3|Overall Study|Lost to Follow-up|1
7688230|NCT01227902|26739892|P2|Overall Study|Lost to Follow-up|0
7688231|NCT01227902|26739893|P1|Overall Study|Lost to Follow-up|0
7688232|NCT01227902|26739890|P4|Overall Study|Protocol Violation|0
7688233|NCT01227902|26739891|P3|Overall Study|Protocol Violation|0
7688234|NCT01227902|26739892|P2|Overall Study|Protocol Violation|0
7688235|NCT01227902|26739893|P1|Overall Study|Protocol Violation|1
7688236|NCT01227902|26739890|P4|Overall Study|Lack of Efficacy|1
7688237|NCT01227902|26739891|P3|Overall Study|Lack of Efficacy|2
7688238|NCT01227902|26739892|P2|Overall Study|Lack of Efficacy|2
7688239|NCT01227902|26739893|P1|Overall Study|Lack of Efficacy|1
7688240|NCT01227902|26739890|P4|Overall Study|Adverse Event|4
7688241|NCT01227902|26739891|P3|Overall Study|Adverse Event|11
7688242|NCT01227902|26739892|P2|Overall Study|Adverse Event|8
7688243|NCT01227902|26739893|P1|Overall Study|Adverse Event|12
7688244|NCT01227889|26739986|P2|Crossover Phase|Withdrawal by Subject|1
7688245|NCT01227889|26739987|P1|Crossover Phase|Withdrawal by Subject|0
7688246|NCT01227889|26739986|P2|Crossover Phase|Study Terminated By Sponsor|1
7688247|NCT01227889|26739987|P1|Crossover Phase|Study Terminated By Sponsor|0
7688248|NCT01227889|26739986|P2|Crossover Phase|Progressive Disease|31
7688249|NCT01227889|26739987|P1|Crossover Phase|Progressive Disease|0
7688250|NCT01227889|26739986|P2|Crossover Phase|Physician Decision|3
7688251|NCT01227889|26739987|P1|Crossover Phase|Physician Decision|0
7688252|NCT01227889|26739986|P2|Crossover Phase|Adverse Event|1
7688253|NCT01227889|26739987|P1|Crossover Phase|Adverse Event|0
7688254|NCT01227889|26739986|P2|Randomized Phase (RP)|Withdrawal by Subject|3
7688255|NCT01227889|26739987|P1|Randomized Phase (RP)|Withdrawal by Subject|15
7688256|NCT01227889|26739986|P2|Randomized Phase (RP)|Missing|3
7688257|NCT01227889|26739987|P1|Randomized Phase (RP)|Missing|1
7688258|NCT01227889|26739986|P2|Randomized Phase (RP)|Study terminated by sponsor|0
7688259|NCT01227889|26739987|P1|Randomized Phase (RP)|Study terminated by sponsor|10
7688260|NCT01227889|26739986|P2|Randomized Phase (RP)|Progressive Disease|52
7688261|NCT01227889|26739987|P1|Randomized Phase (RP)|Progressive Disease|135
7688262|NCT01227889|26739986|P2|Randomized Phase (RP)|Physician Decision|5
7688263|NCT01227889|26739987|P1|Randomized Phase (RP)|Physician Decision|13
7688264|NCT01227889|26739986|P2|Randomized Phase (RP)|Adverse Event|0
7688265|NCT01227889|26739987|P1|Randomized Phase (RP)|Adverse Event|13
7688266|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
7688267|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
7688268|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
7688269|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
7688270|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
7688271|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
7688272|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
7688273|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
7688274|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
7688275|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
7688276|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
7688277|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
7688278|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
7688279|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
7688280|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
7688281|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
7688282|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
7688283|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
7688284|NCT01227824|26740014|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
7688285|NCT01227824|26740015|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
7688286|NCT01227824|26740016|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
7688287|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
7688288|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
7688289|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
7688290|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
7688291|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
7688292|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
7688293|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
7688294|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
7688295|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
7688296|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
7688297|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
7688298|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
7688299|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
7688300|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
7688301|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
7688302|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
7688303|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
7688304|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
7688305|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
7688306|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
7688307|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
7688308|NCT01227824|26740014|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
7688309|NCT01227824|26740015|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
7688310|NCT01227824|26740016|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
7688311|NCT01227707|26740111|P1|Overall Study|Death|1
7688312|NCT01227707|26740111|P1|Overall Study|Medical decision|6
7688313|NCT01227707|26740111|P1|Overall Study|Patient non-compliance|3
7688314|NCT01227707|26740111|P1|Overall Study|Withdrawal by Subject|1
7688315|NCT01227707|26740111|P1|Overall Study|Progression of disease|3
7688316|NCT01227707|26740111|P1|Overall Study|Adverse Event|10
7688317|NCT01227668|26740138|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
7688318|NCT01227668|26740139|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
7688319|NCT01227668|26740138|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
7688320|NCT01227668|26740139|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
7688321|NCT01227668|26740138|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
7688322|NCT01227668|26740139|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
7688323|NCT01227668|26740138|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
7688324|NCT01227668|26740139|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
7688325|NCT01227668|26740138|P2|Phase 2 (Randomization Phase)|Adverse Event|1
7688326|NCT01227668|26740139|P1|Phase 2 (Randomization Phase)|Adverse Event|0
7688327|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
7688328|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
7688329|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
7688330|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
7688331|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
7688332|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
7688333|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
7688334|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
7688335|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
7688336|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
7688337|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
7688338|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
7688339|NCT01227668|26740138|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
7688340|NCT01227668|26740139|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
7688341|NCT01227629|26740185|P10|Overall Study|Other|1
7688342|NCT01227629|26740186|P9|Overall Study|Other|2
7688343|NCT01227629|26740187|P8|Overall Study|Other|0
7688344|NCT01227629|26740188|P7|Overall Study|Other|0
7688345|NCT01227629|26740189|P6|Overall Study|Other|0
7688346|NCT01227629|26740190|P5|Overall Study|Other|0
7688347|NCT01227629|26740191|P4|Overall Study|Other|1
7688348|NCT01227629|26740192|P3|Overall Study|Other|0
7688349|NCT01227629|26740193|P2|Overall Study|Other|0
7688350|NCT01227629|26740194|P1|Overall Study|Other|0
7688351|NCT01227629|26740185|P10|Overall Study|Withdrawal by Subject|1
7688352|NCT01227629|26740186|P9|Overall Study|Withdrawal by Subject|0
7688353|NCT01227629|26740187|P8|Overall Study|Withdrawal by Subject|0
7688354|NCT01227629|26740188|P7|Overall Study|Withdrawal by Subject|2
7688355|NCT01227629|26740189|P6|Overall Study|Withdrawal by Subject|0
7688356|NCT01227629|26740190|P5|Overall Study|Withdrawal by Subject|0
7688357|NCT01227629|26740191|P4|Overall Study|Withdrawal by Subject|0
7688358|NCT01227629|26740192|P3|Overall Study|Withdrawal by Subject|0
7688359|NCT01227629|26740193|P2|Overall Study|Withdrawal by Subject|0
7688360|NCT01227629|26740194|P1|Overall Study|Withdrawal by Subject|0
7688361|NCT01227629|26740185|P10|Overall Study|Lost to Follow-up|0
7688362|NCT01227629|26740186|P9|Overall Study|Lost to Follow-up|0
7688363|NCT01227629|26740187|P8|Overall Study|Lost to Follow-up|0
7688364|NCT01227629|26740188|P7|Overall Study|Lost to Follow-up|0
7688365|NCT01227629|26740189|P6|Overall Study|Lost to Follow-up|0
7688366|NCT01227629|26740190|P5|Overall Study|Lost to Follow-up|1
7688367|NCT01227629|26740191|P4|Overall Study|Lost to Follow-up|0
7688368|NCT01227629|26740192|P3|Overall Study|Lost to Follow-up|0
7688369|NCT01227629|26740193|P2|Overall Study|Lost to Follow-up|0
7688370|NCT01227629|26740194|P1|Overall Study|Lost to Follow-up|0
7688371|NCT01227629|26740185|P10|Overall Study|Protocol Violation|0
7688372|NCT01227629|26740186|P9|Overall Study|Protocol Violation|0
7688373|NCT01227629|26740187|P8|Overall Study|Protocol Violation|0
7688374|NCT01227629|26740188|P7|Overall Study|Protocol Violation|0
7688375|NCT01227629|26740189|P6|Overall Study|Protocol Violation|0
7688376|NCT01227629|26740190|P5|Overall Study|Protocol Violation|0
7688377|NCT01227629|26740191|P4|Overall Study|Protocol Violation|1
7688378|NCT01227629|26740192|P3|Overall Study|Protocol Violation|0
7688379|NCT01227629|26740193|P2|Overall Study|Protocol Violation|0
7688380|NCT01227629|26740194|P1|Overall Study|Protocol Violation|0
7688381|NCT01227629|26740185|P10|Overall Study|Adverse Event|0
7688382|NCT01227629|26740186|P9|Overall Study|Adverse Event|4
7688383|NCT01227629|26740187|P8|Overall Study|Adverse Event|6
7688384|NCT01227629|26740188|P7|Overall Study|Adverse Event|6
7688385|NCT01227629|26740189|P6|Overall Study|Adverse Event|1
7688386|NCT01227629|26740190|P5|Overall Study|Adverse Event|1
7688387|NCT01227629|26740191|P4|Overall Study|Adverse Event|6
7688388|NCT01227629|26740192|P3|Overall Study|Adverse Event|1
7688389|NCT01227629|26740193|P2|Overall Study|Adverse Event|2
7688390|NCT01227629|26740194|P1|Overall Study|Adverse Event|2
7688391|NCT01227577|26740443|P1|Overall Study|Adverse Event|17
7688392|NCT01227577|26740443|P1|Overall Study|Lack of Efficacy|5
7688393|NCT01227577|26740443|P1|Overall Study|Withdrawal by Subject|4
7688394|NCT01227577|26740443|P1|Overall Study|Lost to Follow-up|1
7688395|NCT01227577|26740443|P1|Overall Study|Administrative problems|2
7688396|NCT01227577|26740443|P1|Overall Study|Death|3
7688397|NCT01227577|26740443|P1|Overall Study|Protocol deviation|3
7688398|NCT01227564|26740458|P3|Overall Study|Participant moved to another town|1
7688399|NCT01227564|26740459|P2|Overall Study|Participant moved to another town|0
7688400|NCT01227564|26740460|P1|Overall Study|Participant moved to another town|0
7688401|NCT01227564|26740458|P3|Overall Study|No Longer Willing to Participate|5
7688402|NCT01227564|26740459|P2|Overall Study|No Longer Willing to Participate|2
7688403|NCT01227564|26740460|P1|Overall Study|No Longer Willing to Participate|4
7688404|NCT01227512|26740598|P2|Overall Study|Participant met withdrawal criteria|1
7688405|NCT01227512|26740599|P1|Overall Study|Participant met withdrawal criteria|0
7688406|NCT01227512|26740598|P2|Overall Study|Withdrawal by Subject|0
7688407|NCT01227512|26740599|P1|Overall Study|Withdrawal by Subject|3
7688408|NCT01227512|26740598|P2|Overall Study|Adverse Event|3
7688409|NCT01227512|26740599|P1|Overall Study|Adverse Event|4
7688410|NCT01227512|26740598|P2|Overall Study|Physician Decision|6
7688411|NCT01227512|26740599|P1|Overall Study|Physician Decision|6
7688412|NCT01227421|26740633|P3|Overall Study|Randomized in error|0
7688413|NCT01227421|26740634|P2|Overall Study|Randomized in error|1
7688414|NCT01227421|26740635|P1|Overall Study|Randomized in error|1
7688415|NCT01227421|26740633|P3|Overall Study|Protocol Violation|2
7688416|NCT01227421|26740634|P2|Overall Study|Protocol Violation|1
7688417|NCT01227421|26740635|P1|Overall Study|Protocol Violation|1
7688418|NCT01227421|26740633|P3|Overall Study|Withdrawal by Subject|1
7688419|NCT01227421|26740634|P2|Overall Study|Withdrawal by Subject|2
7688420|NCT01227421|26740635|P1|Overall Study|Withdrawal by Subject|1
7688421|NCT01227421|26740633|P3|Overall Study|Adverse Event|2
7688422|NCT01227421|26740634|P2|Overall Study|Adverse Event|7
7688423|NCT01227421|26740635|P1|Overall Study|Adverse Event|2
7688424|NCT01227421|26740633|P3|Overall Study|Lost to Follow-up|5
7688425|NCT01227421|26740634|P2|Overall Study|Lost to Follow-up|7
7688426|NCT01227421|26740635|P1|Overall Study|Lost to Follow-up|6
7688427|NCT01227395|26740687|P2|Overall Study|Protocol Violation|1
7688428|NCT01227395|26740688|P1|Overall Study|Protocol Violation|0
7688429|NCT01227278|26740728|P2|Overall Study|Other|2
7688430|NCT01227278|26740729|P1|Overall Study|Other|1
7688431|NCT01227278|26740728|P2|Overall Study|Death|2
7688432|NCT01227278|26740729|P1|Overall Study|Death|0
7688433|NCT01227278|26740728|P2|Overall Study|Withdrawal by Subject|4
7688434|NCT01227278|26740729|P1|Overall Study|Withdrawal by Subject|4
7688435|NCT01227265|26740756|P3|Overall Study|Adverse Event|5
7688436|NCT01227265|26740757|P2|Overall Study|Adverse Event|10
7688437|NCT01227265|26740758|P1|Overall Study|Adverse Event|6
7688438|NCT01227265|26740756|P3|Overall Study|Lost to Follow-up|3
7688439|NCT01227265|26740757|P2|Overall Study|Lost to Follow-up|0
7688440|NCT01227265|26740758|P1|Overall Study|Lost to Follow-up|2
7688441|NCT01227265|26740756|P3|Overall Study|Withdrawal by Subject|3
7688442|NCT01227265|26740757|P2|Overall Study|Withdrawal by Subject|7
7688443|NCT01227265|26740758|P1|Overall Study|Withdrawal by Subject|7
7688444|NCT01227265|26740756|P3|Overall Study|Protocol Violation|0
7688445|NCT01227265|26740757|P2|Overall Study|Protocol Violation|1
7688446|NCT01227265|26740758|P1|Overall Study|Protocol Violation|2
7688447|NCT01227265|26740756|P3|Overall Study|Did Not Meet Protocol Eligibility|1
7688448|NCT01227265|26740757|P2|Overall Study|Did Not Meet Protocol Eligibility|0
7688449|NCT01227265|26740758|P1|Overall Study|Did Not Meet Protocol Eligibility|0
7688450|NCT01227265|26740756|P3|Overall Study|Administrative|2
7688451|NCT01227265|26740757|P2|Overall Study|Administrative|0
7688452|NCT01227265|26740758|P1|Overall Study|Administrative|1
7688453|NCT01227265|26740756|P3|Overall Study|Did Not Receive Treatment|0
7688454|NCT01227265|26740757|P2|Overall Study|Did Not Receive Treatment|2
7688455|NCT01227265|26740758|P1|Overall Study|Did Not Receive Treatment|1
7688456|NCT01227252|26740788|P4|Overall Study|Withdrawal by Subject|0
7688457|NCT01227252|26740789|P3|Overall Study|Withdrawal by Subject|0
7688458|NCT01227252|26740790|P2|Overall Study|Withdrawal by Subject|1
7688459|NCT01227252|26740791|P1|Overall Study|Withdrawal by Subject|0
7688460|NCT01227252|26740788|P4|Overall Study|Lost to Follow-up|0
7688461|NCT01227252|26740789|P3|Overall Study|Lost to Follow-up|0
7688462|NCT01227252|26740790|P2|Overall Study|Lost to Follow-up|1
7688463|NCT01227252|26740791|P1|Overall Study|Lost to Follow-up|0
7688464|NCT01227252|26740788|P4|Overall Study|Sponsor Decision|0
7688465|NCT01227252|26740789|P3|Overall Study|Sponsor Decision|0
7688466|NCT01227252|26740790|P2|Overall Study|Sponsor Decision|1
7688467|NCT01227252|26740791|P1|Overall Study|Sponsor Decision|0
7688468|NCT01227044|26740833|P2|Overall Study|Discontinued Intervention|2
7688469|NCT01227044|26740834|P1|Overall Study|Discontinued Intervention|1
7688470|NCT01227044|26740833|P2|Overall Study|Lost to Follow-up|7
7688471|NCT01227044|26740834|P1|Overall Study|Lost to Follow-up|5
7688472|NCT01227018|26740842|P1|Overall Study|Withdrew after beginning treatment|4
7688473|NCT01227018|26740842|P1|Overall Study|Toxicity|2
7688474|NCT01227018|26740842|P1|Overall Study|Disease progression|9
7688475|NCT01226745|26740887|P6|Overall Study|Other|1
7688476|NCT01226745|26740888|P5|Overall Study|Other|3
7688477|NCT01226745|26740889|P4|Overall Study|Other|4
7688478|NCT01226745|26740890|P3|Overall Study|Other|8
7688479|NCT01226745|26740891|P2|Overall Study|Other|7
7688480|NCT01226745|26740892|P1|Overall Study|Other|6
7688481|NCT01226745|26740887|P6|Overall Study|Death|1
7688482|NCT01226745|26740888|P5|Overall Study|Death|0
7688483|NCT01226745|26740889|P4|Overall Study|Death|0
7688484|NCT01226745|26740890|P3|Overall Study|Death|0
7688485|NCT01226745|26740891|P2|Overall Study|Death|0
7688486|NCT01226745|26740892|P1|Overall Study|Death|1
7688487|NCT01226745|26740887|P6|Overall Study|Lost to Follow-up|2
7688488|NCT01226745|26740888|P5|Overall Study|Lost to Follow-up|1
7688489|NCT01226745|26740889|P4|Overall Study|Lost to Follow-up|1
7688490|NCT01226745|26740890|P3|Overall Study|Lost to Follow-up|6
7688491|NCT01226745|26740891|P2|Overall Study|Lost to Follow-up|6
7688492|NCT01226745|26740892|P1|Overall Study|Lost to Follow-up|2
7688493|NCT01226745|26740887|P6|Overall Study|Did not complete schedule of assessments|1
7688494|NCT01226745|26740888|P5|Overall Study|Did not complete schedule of assessments|0
7688495|NCT01226745|26740889|P4|Overall Study|Did not complete schedule of assessments|0
7688496|NCT01226745|26740890|P3|Overall Study|Did not complete schedule of assessments|6
7688497|NCT01226745|26740891|P2|Overall Study|Did not complete schedule of assessments|3
7688498|NCT01226745|26740892|P1|Overall Study|Did not complete schedule of assessments|8
7688499|NCT01226511|26741088|P2|Taper Period|Parent/Caregiver Decision|1
7688500|NCT01226511|26741089|P1|Taper Period|Parent/Caregiver Decision|1
7688501|NCT01226511|26741088|P2|Taper Period|Protocol Violation|0
7688502|NCT01226511|26741089|P1|Taper Period|Protocol Violation|1
7688503|NCT01226511|26741088|P2|Taper Period|Lost to Follow-up|2
7688504|NCT01226511|26741089|P1|Taper Period|Lost to Follow-up|2
7688505|NCT01226511|26741088|P2|Taper Period|Adverse Event|0
7688506|NCT01226511|26741089|P1|Taper Period|Adverse Event|1
7688507|NCT01226511|26741088|P2|Extension Treatment Period|Sponsor Decision|1
7688508|NCT01226511|26741089|P1|Extension Treatment Period|Sponsor Decision|1
7688509|NCT01226511|26741088|P2|Extension Treatment Period|Parent/Caregiver Decision|8
7688510|NCT01226511|26741089|P1|Extension Treatment Period|Parent/Caregiver Decision|8
7688511|NCT01226511|26741088|P2|Extension Treatment Period|Withdrawal by Subject|3
7688512|NCT01226511|26741089|P1|Extension Treatment Period|Withdrawal by Subject|1
7688513|NCT01226511|26741088|P2|Extension Treatment Period|Protocol Violation|2
7688514|NCT01226511|26741089|P1|Extension Treatment Period|Protocol Violation|2
7688515|NCT01226511|26741088|P2|Extension Treatment Period|Lost to Follow-up|3
7688516|NCT01226511|26741089|P1|Extension Treatment Period|Lost to Follow-up|4
7688517|NCT01226511|26741088|P2|Extension Treatment Period|Lack of Efficacy|2
7688518|NCT01226511|26741089|P1|Extension Treatment Period|Lack of Efficacy|3
7688519|NCT01226511|26741088|P2|Extension Treatment Period|Adverse Event|8
7688520|NCT01226511|26741089|P1|Extension Treatment Period|Adverse Event|8
7688521|NCT01226511|26741088|P2|Acute Treatment Period|Withdrawal by Subject|6
7688522|NCT01226511|26741089|P1|Acute Treatment Period|Withdrawal by Subject|10
7688523|NCT01226511|26741088|P2|Acute Treatment Period|Protocol Violation|5
7688524|NCT01226511|26741089|P1|Acute Treatment Period|Protocol Violation|5
7688525|NCT01226511|26741088|P2|Acute Treatment Period|Parent/caregiver decision|7
7688526|NCT01226511|26741089|P1|Acute Treatment Period|Parent/caregiver decision|5
7688527|NCT01226511|26741088|P2|Acute Treatment Period|Lost to Follow-up|6
7688528|NCT01226511|26741089|P1|Acute Treatment Period|Lost to Follow-up|3
7688529|NCT01226511|26741088|P2|Acute Treatment Period|Lack of Efficacy|1
7688530|NCT01226511|26741089|P1|Acute Treatment Period|Lack of Efficacy|2
7688531|NCT01226511|26741088|P2|Acute Treatment Period|Adverse Event|6
7688532|NCT01226511|26741089|P1|Acute Treatment Period|Adverse Event|7
7688533|NCT01226472|26741187|P1|Overall Study|Progressive Disease|1
7688534|NCT01226459|26741194|P2|Overall Study|Pregnancy|0
7688535|NCT01226459|26741195|P1|Overall Study|Pregnancy|1
7688536|NCT01226459|26741194|P2|Overall Study|Lost to Follow-up|8
7688537|NCT01226459|26741195|P1|Overall Study|Lost to Follow-up|4
7688538|NCT01226459|26741194|P2|Overall Study|Withdrawal by Subject|13
7688539|NCT01226459|26741195|P1|Overall Study|Withdrawal by Subject|10
7688540|NCT01226459|26741194|P2|Overall Study|Protocol Violation|3
7688541|NCT01226459|26741195|P1|Overall Study|Protocol Violation|4
7688542|NCT01226459|26741194|P2|Overall Study|Adverse Event|8
7688543|NCT01226459|26741195|P1|Overall Study|Adverse Event|2
7688544|NCT01226121|26741213|P3|Overall Study|Lost to Follow-up|1
7688545|NCT01226121|26741214|P2|Overall Study|Lost to Follow-up|0
7688546|NCT01226121|26741215|P1|Overall Study|Lost to Follow-up|2
7688547|NCT01226095|26741226|P1|Overall Study|Poor compliance|1
7688548|NCT01226043|26741251|P4|30-week Observational Phase|Physician Decision|2
7688549|NCT01226043|26741252|P3|30-week Observational Phase|Physician Decision|2
7688550|NCT01226043|26741253|P2|30-week Observational Phase|Physician Decision|0
7688551|NCT01226043|26741254|P1|30-week Observational Phase|Physician Decision|0
7688552|NCT01226043|26741251|P4|30-week Observational Phase|Withdrawal by Subject|7
7688553|NCT01226043|26741252|P3|30-week Observational Phase|Withdrawal by Subject|1
7688554|NCT01226043|26741253|P2|30-week Observational Phase|Withdrawal by Subject|0
7688555|NCT01226043|26741254|P1|30-week Observational Phase|Withdrawal by Subject|0
7688556|NCT01226043|26741251|P4|30-week Observational Phase|Lost to Follow-up|2
7688557|NCT01226043|26741252|P3|30-week Observational Phase|Lost to Follow-up|2
7688558|NCT01226043|26741253|P2|30-week Observational Phase|Lost to Follow-up|0
7688559|NCT01226043|26741254|P1|30-week Observational Phase|Lost to Follow-up|0
7688560|NCT01226043|26741251|P4|30-week Observational Phase|Protocol Violation|1
7688561|NCT01226043|26741252|P3|30-week Observational Phase|Protocol Violation|0
7688562|NCT01226043|26741253|P2|30-week Observational Phase|Protocol Violation|0
7688563|NCT01226043|26741254|P1|30-week Observational Phase|Protocol Violation|0
7688564|NCT01226043|26741251|P4|30-week Observational Phase|Adverse Event|1
7688565|NCT01226043|26741252|P3|30-week Observational Phase|Adverse Event|1
7688566|NCT01226043|26741253|P2|30-week Observational Phase|Adverse Event|0
7688567|NCT01226043|26741254|P1|30-week Observational Phase|Adverse Event|0
7688568|NCT01226043|26741251|P4|6-week Re-randomization Phase|completed in error|1
7688569|NCT01226043|26741252|P3|6-week Re-randomization Phase|completed in error|0
7688570|NCT01226043|26741253|P2|6-week Re-randomization Phase|completed in error|0
7688571|NCT01226043|26741254|P1|6-week Re-randomization Phase|completed in error|0
7688572|NCT01226043|26741251|P4|6-week Re-randomization Phase|Physician Decision|2
7688573|NCT01226043|26741252|P3|6-week Re-randomization Phase|Physician Decision|3
7688574|NCT01226043|26741253|P2|6-week Re-randomization Phase|Physician Decision|0
7688575|NCT01226043|26741254|P1|6-week Re-randomization Phase|Physician Decision|0
7688576|NCT01226043|26741251|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
7688577|NCT01226043|26741252|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
7688578|NCT01226043|26741253|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
7688579|NCT01226043|26741254|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
7688580|NCT01226043|26741251|P4|6-week Re-randomization Phase|Lost to Follow-up|3
7688581|NCT01226043|26741252|P3|6-week Re-randomization Phase|Lost to Follow-up|1
7688582|NCT01226043|26741253|P2|6-week Re-randomization Phase|Lost to Follow-up|0
7688583|NCT01226043|26741254|P1|6-week Re-randomization Phase|Lost to Follow-up|0
7688584|NCT01226043|26741251|P4|6-week Re-randomization Phase|Protocol Violation|1
7688585|NCT01226043|26741252|P3|6-week Re-randomization Phase|Protocol Violation|1
7688586|NCT01226043|26741253|P2|6-week Re-randomization Phase|Protocol Violation|0
7688587|NCT01226043|26741254|P1|6-week Re-randomization Phase|Protocol Violation|0
7688588|NCT01226043|26741251|P4|6-week Re-randomization Phase|Adverse Event|1
7688589|NCT01226043|26741252|P3|6-week Re-randomization Phase|Adverse Event|1
7688590|NCT01226043|26741253|P2|6-week Re-randomization Phase|Adverse Event|0
7688591|NCT01226043|26741254|P1|6-week Re-randomization Phase|Adverse Event|0
7688592|NCT01226043|26741251|P4|4-week Crossover Phase - Period 2|Physician Decision|0
7688593|NCT01226043|26741252|P3|4-week Crossover Phase - Period 2|Physician Decision|0
7688594|NCT01226043|26741253|P2|4-week Crossover Phase - Period 2|Physician Decision|5
7688595|NCT01226043|26741254|P1|4-week Crossover Phase - Period 2|Physician Decision|4
7688596|NCT01226043|26741251|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7688597|NCT01226043|26741252|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7688598|NCT01226043|26741253|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
7688599|NCT01226043|26741254|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7688600|NCT01226043|26741251|P4|4-week Crossover Phase - Period 1|Physician Decision|0
7688601|NCT01226043|26741252|P3|4-week Crossover Phase - Period 1|Physician Decision|0
7688602|NCT01226043|26741253|P2|4-week Crossover Phase - Period 1|Physician Decision|6
7688603|NCT01226043|26741254|P1|4-week Crossover Phase - Period 1|Physician Decision|0
7688604|NCT01226043|26741251|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7688605|NCT01226043|26741252|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7688606|NCT01226043|26741253|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7688607|NCT01226043|26741254|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
7688608|NCT01226043|26741251|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7688609|NCT01226043|26741252|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7688610|NCT01226043|26741253|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
7688611|NCT01226043|26741254|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7688612|NCT01226043|26741251|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
7688613|NCT01226043|26741252|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
7688614|NCT01226043|26741253|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
7688615|NCT01226043|26741254|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
7688616|NCT01225991|26741292|P1|Overall Study|Withdrawal by Subject|6
7688617|NCT01225952|26741303|P3|Overall Study|Surgical complications|0
7688618|NCT01225952|26741304|P2|Overall Study|Surgical complications|0
7688619|NCT01225952|26741305|P1|Overall Study|Surgical complications|1
7688620|NCT01225952|26741303|P3|Overall Study|Withdrawal by Subject|5
7688621|NCT01225952|26741304|P2|Overall Study|Withdrawal by Subject|4
7688622|NCT01225952|26741305|P1|Overall Study|Withdrawal by Subject|4
7688623|NCT01225952|26741303|P3|Overall Study|Study Eye Explanted|1
7688624|NCT01225952|26741304|P2|Overall Study|Study Eye Explanted|0
7688625|NCT01225952|26741305|P1|Overall Study|Study Eye Explanted|0
7688626|NCT01225952|26741303|P3|Overall Study|Lost to Follow-up|0
7688627|NCT01225952|26741304|P2|Overall Study|Lost to Follow-up|0
7688628|NCT01225952|26741305|P1|Overall Study|Lost to Follow-up|1
7688629|NCT01225887|26741397|P1|Overall Study|Ineligible:inadequate pathology|2
7688630|NCT01225887|26741397|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
7688631|NCT01225887|26741397|P1|Overall Study|Ineligible:required test not done|2
7688632|NCT01225835|26741407|P2|Overall Study|Other|1
7688633|NCT01225835|26741408|P1|Overall Study|Other|1
7688634|NCT01225835|26741407|P2|Overall Study|Adverse Event|1
7688635|NCT01225835|26741408|P1|Overall Study|Adverse Event|2
7688636|NCT01225835|26741407|P2|Overall Study|Did not meet hCG criterion|0
7688637|NCT01225835|26741408|P1|Overall Study|Did not meet hCG criterion|2
7688638|NCT01225835|26741407|P2|Overall Study|Completed protocol|1
7688639|NCT01225835|26741408|P1|Overall Study|Completed protocol|2
7688640|NCT01225822|26741456|P5|Overall Study|Other|7
7688641|NCT01225822|26741457|P4|Overall Study|Other|10
7688642|NCT01225822|26741458|P3|Overall Study|Other|7
7688643|NCT01225822|26741459|P2|Overall Study|Other|10
7688644|NCT01225822|26741460|P1|Overall Study|Other|13
7688645|NCT01225822|26741456|P5|Overall Study|Withdrawal by Subject|6
7688646|NCT01225822|26741457|P4|Overall Study|Withdrawal by Subject|11
7688647|NCT01225822|26741458|P3|Overall Study|Withdrawal by Subject|7
7688648|NCT01225822|26741459|P2|Overall Study|Withdrawal by Subject|7
7688649|NCT01225822|26741460|P1|Overall Study|Withdrawal by Subject|6
7688650|NCT01225822|26741456|P5|Overall Study|Lost to Follow-up|0
7688651|NCT01225822|26741457|P4|Overall Study|Lost to Follow-up|1
7688652|NCT01225822|26741458|P3|Overall Study|Lost to Follow-up|0
7688653|NCT01225822|26741459|P2|Overall Study|Lost to Follow-up|0
7688654|NCT01225822|26741460|P1|Overall Study|Lost to Follow-up|0
7688655|NCT01225822|26741456|P5|Overall Study|Protocol Violation|4
7688656|NCT01225822|26741457|P4|Overall Study|Protocol Violation|7
7688657|NCT01225822|26741458|P3|Overall Study|Protocol Violation|6
7688658|NCT01225822|26741459|P2|Overall Study|Protocol Violation|8
7688659|NCT01225822|26741460|P1|Overall Study|Protocol Violation|6
7688660|NCT01225822|26741456|P5|Overall Study|Adverse Event|14
7688661|NCT01225822|26741457|P4|Overall Study|Adverse Event|23
7688662|NCT01225822|26741458|P3|Overall Study|Adverse Event|18
7688663|NCT01225822|26741459|P2|Overall Study|Adverse Event|31
7688664|NCT01225822|26741460|P1|Overall Study|Adverse Event|13
7688665|NCT01225731|26741527|P13|Part 3|Withdrawal by Subject|4
7688666|NCT01225731|26741528|P12|Part 3|Withdrawal by Subject|6
7688667|NCT01225731|26741529|P11|Part 3|Withdrawal by Subject|4
7688668|NCT01225731|26741530|P10|Part 3|Withdrawal by Subject|0
7688669|NCT01225731|26741531|P9|Part 3|Withdrawal by Subject|0
7688670|NCT01225731|26741532|P8|Part 3|Withdrawal by Subject|0
7688671|NCT01225731|26741533|P7|Part 3|Withdrawal by Subject|0
7688672|NCT01225731|26741534|P6|Part 3|Withdrawal by Subject|0
7688673|NCT01225731|26741535|P5|Part 3|Withdrawal by Subject|0
7688674|NCT01225731|26741536|P4|Part 3|Withdrawal by Subject|0
7688675|NCT01225731|26741537|P3|Part 3|Withdrawal by Subject|0
7688676|NCT01225731|26741538|P2|Part 3|Withdrawal by Subject|0
7688677|NCT01225731|26741539|P1|Part 3|Withdrawal by Subject|0
7688678|NCT01225731|26741527|P13|Part 3|Physician Decision|2
7688679|NCT01225731|26741528|P12|Part 3|Physician Decision|1
7688680|NCT01225731|26741529|P11|Part 3|Physician Decision|0
7688681|NCT01225731|26741530|P10|Part 3|Physician Decision|0
7688682|NCT01225731|26741531|P9|Part 3|Physician Decision|0
7688683|NCT01225731|26741532|P8|Part 3|Physician Decision|0
7688684|NCT01225731|26741533|P7|Part 3|Physician Decision|0
7688685|NCT01225731|26741534|P6|Part 3|Physician Decision|0
7688686|NCT01225731|26741535|P5|Part 3|Physician Decision|0
7688687|NCT01225731|26741536|P4|Part 3|Physician Decision|0
7688688|NCT01225731|26741537|P3|Part 3|Physician Decision|0
7688689|NCT01225731|26741538|P2|Part 3|Physician Decision|0
7688690|NCT01225731|26741539|P1|Part 3|Physician Decision|0
7688691|NCT01225731|26741527|P13|Part 3|Lost to Follow-up|1
7688692|NCT01225731|26741528|P12|Part 3|Lost to Follow-up|2
7688693|NCT01225731|26741529|P11|Part 3|Lost to Follow-up|1
7688694|NCT01225731|26741530|P10|Part 3|Lost to Follow-up|0
7688695|NCT01225731|26741531|P9|Part 3|Lost to Follow-up|0
7688696|NCT01225731|26741532|P8|Part 3|Lost to Follow-up|0
7688697|NCT01225731|26741533|P7|Part 3|Lost to Follow-up|0
7688698|NCT01225731|26741534|P6|Part 3|Lost to Follow-up|0
7688699|NCT01225731|26741535|P5|Part 3|Lost to Follow-up|0
7688700|NCT01225731|26741536|P4|Part 3|Lost to Follow-up|0
7688701|NCT01225731|26741537|P3|Part 3|Lost to Follow-up|0
7688702|NCT01225731|26741538|P2|Part 3|Lost to Follow-up|0
7688703|NCT01225731|26741539|P1|Part 3|Lost to Follow-up|0
7688704|NCT01225731|26741527|P13|Part 3|Adverse Event|0
7688705|NCT01225731|26741528|P12|Part 3|Adverse Event|1
7688706|NCT01225731|26741529|P11|Part 3|Adverse Event|1
7688707|NCT01225731|26741530|P10|Part 3|Adverse Event|0
7688708|NCT01225731|26741531|P9|Part 3|Adverse Event|0
7688709|NCT01225731|26741532|P8|Part 3|Adverse Event|0
7688710|NCT01225731|26741533|P7|Part 3|Adverse Event|0
7688711|NCT01225731|26741534|P6|Part 3|Adverse Event|0
7688712|NCT01225731|26741535|P5|Part 3|Adverse Event|0
7688713|NCT01225731|26741536|P4|Part 3|Adverse Event|0
7688714|NCT01225731|26741537|P3|Part 3|Adverse Event|0
7688715|NCT01225731|26741538|P2|Part 3|Adverse Event|0
7688716|NCT01225731|26741539|P1|Part 3|Adverse Event|0
7688717|NCT01225731|26741527|P13|Part 2|Withdrawal by Subject|0
7688718|NCT01225731|26741528|P12|Part 2|Withdrawal by Subject|0
7688719|NCT01225731|26741529|P11|Part 2|Withdrawal by Subject|0
7688720|NCT01225731|26741530|P10|Part 2|Withdrawal by Subject|0
7688721|NCT01225731|26741531|P9|Part 2|Withdrawal by Subject|1
7688722|NCT01225731|26741532|P8|Part 2|Withdrawal by Subject|4
7688723|NCT01225731|26741533|P7|Part 2|Withdrawal by Subject|3
7688724|NCT01225731|26741534|P6|Part 2|Withdrawal by Subject|1
7688725|NCT01225731|26741535|P5|Part 2|Withdrawal by Subject|0
7688726|NCT01225731|26741536|P4|Part 2|Withdrawal by Subject|0
7688727|NCT01225731|26741537|P3|Part 2|Withdrawal by Subject|0
7688728|NCT01225731|26741538|P2|Part 2|Withdrawal by Subject|0
7688729|NCT01225731|26741539|P1|Part 2|Withdrawal by Subject|0
7688730|NCT01225731|26741527|P13|Part 2|Physician Decision|0
7688731|NCT01225731|26741528|P12|Part 2|Physician Decision|0
7688732|NCT01225731|26741529|P11|Part 2|Physician Decision|0
7688733|NCT01225731|26741530|P10|Part 2|Physician Decision|0
7688734|NCT01225731|26741531|P9|Part 2|Physician Decision|2
7688735|NCT01225731|26741532|P8|Part 2|Physician Decision|2
7688736|NCT01225731|26741533|P7|Part 2|Physician Decision|0
7688737|NCT01225731|26741534|P6|Part 2|Physician Decision|0
7688738|NCT01225731|26741535|P5|Part 2|Physician Decision|0
7688739|NCT01225731|26741536|P4|Part 2|Physician Decision|0
7688740|NCT01225731|26741537|P3|Part 2|Physician Decision|0
7688741|NCT01225731|26741538|P2|Part 2|Physician Decision|0
7688742|NCT01225731|26741539|P1|Part 2|Physician Decision|0
7688743|NCT01225731|26741527|P13|Part 2|Lost to Follow-up|0
7688744|NCT01225731|26741528|P12|Part 2|Lost to Follow-up|0
7688745|NCT01225731|26741529|P11|Part 2|Lost to Follow-up|0
7688746|NCT01225731|26741530|P10|Part 2|Lost to Follow-up|0
7688747|NCT01225731|26741531|P9|Part 2|Lost to Follow-up|1
7688748|NCT01225731|26741532|P8|Part 2|Lost to Follow-up|3
7688749|NCT01225731|26741533|P7|Part 2|Lost to Follow-up|0
7688750|NCT01225731|26741534|P6|Part 2|Lost to Follow-up|0
7688751|NCT01225731|26741535|P5|Part 2|Lost to Follow-up|0
7688752|NCT01225731|26741536|P4|Part 2|Lost to Follow-up|0
7688753|NCT01225731|26741537|P3|Part 2|Lost to Follow-up|0
7688754|NCT01225731|26741538|P2|Part 2|Lost to Follow-up|0
7688755|NCT01225731|26741539|P1|Part 2|Lost to Follow-up|0
7688756|NCT01225731|26741527|P13|Part 2|Pregnancy|0
7688757|NCT01225731|26741528|P12|Part 2|Pregnancy|0
7688758|NCT01225731|26741529|P11|Part 2|Pregnancy|0
7688759|NCT01225731|26741530|P10|Part 2|Pregnancy|0
7688760|NCT01225731|26741531|P9|Part 2|Pregnancy|1
7688761|NCT01225731|26741532|P8|Part 2|Pregnancy|0
7688762|NCT01225731|26741533|P7|Part 2|Pregnancy|1
7688763|NCT01225731|26741534|P6|Part 2|Pregnancy|0
7688764|NCT01225731|26741535|P5|Part 2|Pregnancy|0
7688765|NCT01225731|26741536|P4|Part 2|Pregnancy|0
7688766|NCT01225731|26741537|P3|Part 2|Pregnancy|0
7688767|NCT01225731|26741538|P2|Part 2|Pregnancy|0
7688768|NCT01225731|26741539|P1|Part 2|Pregnancy|0
7688769|NCT01225731|26741527|P13|Part 2|Lack of Efficacy|0
7688770|NCT01225731|26741528|P12|Part 2|Lack of Efficacy|0
7688771|NCT01225731|26741529|P11|Part 2|Lack of Efficacy|0
7688772|NCT01225731|26741530|P10|Part 2|Lack of Efficacy|0
7688773|NCT01225731|26741531|P9|Part 2|Lack of Efficacy|3
7688774|NCT01225731|26741532|P8|Part 2|Lack of Efficacy|12
7688775|NCT01225731|26741533|P7|Part 2|Lack of Efficacy|0
7688776|NCT01225731|26741534|P6|Part 2|Lack of Efficacy|1
7688777|NCT01225731|26741535|P5|Part 2|Lack of Efficacy|0
7688778|NCT01225731|26741536|P4|Part 2|Lack of Efficacy|0
7688779|NCT01225731|26741537|P3|Part 2|Lack of Efficacy|0
7688780|NCT01225731|26741538|P2|Part 2|Lack of Efficacy|0
7688781|NCT01225731|26741539|P1|Part 2|Lack of Efficacy|0
7688782|NCT01225731|26741527|P13|Part 2|Adverse Event|0
7688783|NCT01225731|26741528|P12|Part 2|Adverse Event|0
7688784|NCT01225731|26741529|P11|Part 2|Adverse Event|0
7688785|NCT01225731|26741530|P10|Part 2|Adverse Event|0
7688786|NCT01225731|26741531|P9|Part 2|Adverse Event|2
7688787|NCT01225731|26741532|P8|Part 2|Adverse Event|4
7688788|NCT01225731|26741533|P7|Part 2|Adverse Event|4
7688789|NCT01225731|26741534|P6|Part 2|Adverse Event|0
7688790|NCT01225731|26741535|P5|Part 2|Adverse Event|0
7688791|NCT01225731|26741536|P4|Part 2|Adverse Event|0
7688792|NCT01225731|26741537|P3|Part 2|Adverse Event|0
7688793|NCT01225731|26741538|P2|Part 2|Adverse Event|0
7688794|NCT01225731|26741539|P1|Part 2|Adverse Event|0
7688795|NCT01225731|26741527|P13|Part 2|Protocol Violation|0
7688796|NCT01225731|26741528|P12|Part 2|Protocol Violation|0
7688797|NCT01225731|26741529|P11|Part 2|Protocol Violation|0
7688798|NCT01225731|26741530|P10|Part 2|Protocol Violation|0
7688799|NCT01225731|26741531|P9|Part 2|Protocol Violation|1
7688800|NCT01225731|26741532|P8|Part 2|Protocol Violation|0
7688801|NCT01225731|26741533|P7|Part 2|Protocol Violation|0
7688802|NCT01225731|26741534|P6|Part 2|Protocol Violation|1
7688803|NCT01225731|26741535|P5|Part 2|Protocol Violation|0
7688804|NCT01225731|26741536|P4|Part 2|Protocol Violation|0
7688805|NCT01225731|26741537|P3|Part 2|Protocol Violation|0
7688806|NCT01225731|26741538|P2|Part 2|Protocol Violation|0
7688807|NCT01225731|26741539|P1|Part 2|Protocol Violation|0
7688808|NCT01225731|26741527|P13|Part 1|Protocol Violation|0
7688809|NCT01225731|26741528|P12|Part 1|Protocol Violation|0
7688810|NCT01225731|26741529|P11|Part 1|Protocol Violation|0
7688811|NCT01225731|26741530|P10|Part 1|Protocol Violation|0
7688812|NCT01225731|26741531|P9|Part 1|Protocol Violation|0
7688813|NCT01225731|26741532|P8|Part 1|Protocol Violation|0
7688814|NCT01225731|26741533|P7|Part 1|Protocol Violation|0
7688815|NCT01225731|26741534|P6|Part 1|Protocol Violation|0
7688816|NCT01225731|26741535|P5|Part 1|Protocol Violation|0
7688817|NCT01225731|26741536|P4|Part 1|Protocol Violation|1
7688818|NCT01225731|26741537|P3|Part 1|Protocol Violation|0
7688819|NCT01225731|26741538|P2|Part 1|Protocol Violation|0
7688820|NCT01225731|26741539|P1|Part 1|Protocol Violation|0
7688821|NCT01225731|26741527|P13|Part 1|Withdrawal by Subject|0
7688822|NCT01225731|26741528|P12|Part 1|Withdrawal by Subject|0
7688823|NCT01225731|26741529|P11|Part 1|Withdrawal by Subject|0
7688824|NCT01225731|26741530|P10|Part 1|Withdrawal by Subject|0
7688825|NCT01225731|26741531|P9|Part 1|Withdrawal by Subject|0
7688826|NCT01225731|26741532|P8|Part 1|Withdrawal by Subject|0
7688827|NCT01225731|26741533|P7|Part 1|Withdrawal by Subject|0
7688828|NCT01225731|26741534|P6|Part 1|Withdrawal by Subject|0
7688829|NCT01225731|26741535|P5|Part 1|Withdrawal by Subject|4
7688830|NCT01225731|26741536|P4|Part 1|Withdrawal by Subject|0
7688831|NCT01225731|26741537|P3|Part 1|Withdrawal by Subject|0
7688832|NCT01225731|26741538|P2|Part 1|Withdrawal by Subject|3
7688833|NCT01225731|26741539|P1|Part 1|Withdrawal by Subject|0
7688834|NCT01225731|26741527|P13|Part 1|Adverse Event|0
7688835|NCT01225731|26741528|P12|Part 1|Adverse Event|0
7688836|NCT01225731|26741529|P11|Part 1|Adverse Event|0
7688837|NCT01225731|26741530|P10|Part 1|Adverse Event|0
7688838|NCT01225731|26741531|P9|Part 1|Adverse Event|0
7688839|NCT01225731|26741532|P8|Part 1|Adverse Event|0
7688840|NCT01225731|26741533|P7|Part 1|Adverse Event|0
7688841|NCT01225731|26741534|P6|Part 1|Adverse Event|0
7688842|NCT01225731|26741535|P5|Part 1|Adverse Event|1
7688843|NCT01225731|26741536|P4|Part 1|Adverse Event|1
7688844|NCT01225731|26741537|P3|Part 1|Adverse Event|1
7688845|NCT01225731|26741538|P2|Part 1|Adverse Event|2
7688846|NCT01225731|26741539|P1|Part 1|Adverse Event|1
7688847|NCT01225731|26741527|P13|Part 1|Did not meet eligibility criteria|0
7688848|NCT01225731|26741528|P12|Part 1|Did not meet eligibility criteria|0
7688849|NCT01225731|26741529|P11|Part 1|Did not meet eligibility criteria|0
7688850|NCT01225731|26741530|P10|Part 1|Did not meet eligibility criteria|0
7688851|NCT01225731|26741531|P9|Part 1|Did not meet eligibility criteria|0
7688852|NCT01225731|26741532|P8|Part 1|Did not meet eligibility criteria|0
7688853|NCT01225731|26741533|P7|Part 1|Did not meet eligibility criteria|0
7688854|NCT01225731|26741534|P6|Part 1|Did not meet eligibility criteria|0
7688855|NCT01225731|26741535|P5|Part 1|Did not meet eligibility criteria|1
7688856|NCT01225731|26741536|P4|Part 1|Did not meet eligibility criteria|0
7688857|NCT01225731|26741537|P3|Part 1|Did not meet eligibility criteria|0
7688858|NCT01225731|26741538|P2|Part 1|Did not meet eligibility criteria|0
7688859|NCT01225731|26741539|P1|Part 1|Did not meet eligibility criteria|1
7688860|NCT01225562|26741634|P3|Overall Study|Lost to Follow-up|1
7688861|NCT01225562|26741635|P2|Overall Study|Lost to Follow-up|6
7688862|NCT01225562|26741636|P1|Overall Study|Lost to Follow-up|3
7688863|NCT01225562|26741634|P3|Overall Study|Withdrawal by Subject|52
7688864|NCT01225562|26741635|P2|Overall Study|Withdrawal by Subject|50
7688865|NCT01225562|26741636|P1|Overall Study|Withdrawal by Subject|52
7688866|NCT01225549|26741653|P10|Period 6 - Washout|Disallowed medication|0
7688867|NCT01225549|26741654|P9|Period 6 - Washout|Disallowed medication|0
7688868|NCT01225549|26741655|P8|Period 6 - Washout|Disallowed medication|0
7688869|NCT01225549|26741656|P7|Period 6 - Washout|Disallowed medication|0
7688870|NCT01225549|26741657|P6|Period 6 - Washout|Disallowed medication|0
7688871|NCT01225549|26741658|P5|Period 6 - Washout|Disallowed medication|0
7688872|NCT01225549|26741659|P4|Period 6 - Washout|Disallowed medication|1
7688873|NCT01225549|26741660|P3|Period 6 - Washout|Disallowed medication|0
7688874|NCT01225549|26741661|P2|Period 6 - Washout|Disallowed medication|0
7688875|NCT01225549|26741662|P1|Period 6 - Washout|Disallowed medication|0
7688876|NCT01225549|26741653|P10|Period 4 - Washout|Disallowed medication|0
7688877|NCT01225549|26741654|P9|Period 4 - Washout|Disallowed medication|0
7688878|NCT01225549|26741655|P8|Period 4 - Washout|Disallowed medication|0
7688879|NCT01225549|26741656|P7|Period 4 - Washout|Disallowed medication|0
7688880|NCT01225549|26741657|P6|Period 4 - Washout|Disallowed medication|0
7688881|NCT01225549|26741658|P5|Period 4 - Washout|Disallowed medication|0
7688882|NCT01225549|26741659|P4|Period 4 - Washout|Disallowed medication|0
7688883|NCT01225549|26741660|P3|Period 4 - Washout|Disallowed medication|0
7688884|NCT01225549|26741661|P2|Period 4 - Washout|Disallowed medication|1
7688885|NCT01225549|26741662|P1|Period 4 - Washout|Disallowed medication|0
7688886|NCT01225211|26741783|P10|Overall Study|Other|1
7688887|NCT01225211|26741784|P9|Overall Study|Other|0
7688888|NCT01225211|26741785|P8|Overall Study|Other|0
7688889|NCT01225211|26741786|P7|Overall Study|Other|0
7688890|NCT01225211|26741787|P6|Overall Study|Other|0
7688891|NCT01225211|26741788|P5|Overall Study|Other|0
7688892|NCT01225211|26741789|P4|Overall Study|Other|0
7688893|NCT01225211|26741790|P3|Overall Study|Other|0
7688894|NCT01225211|26741791|P2|Overall Study|Other|0
7688895|NCT01225211|26741792|P1|Overall Study|Other|0
7688896|NCT01225211|26741783|P10|Overall Study|Withdrawal by Subject|3
7688897|NCT01225211|26741784|P9|Overall Study|Withdrawal by Subject|1
7688898|NCT01225211|26741785|P8|Overall Study|Withdrawal by Subject|0
7688899|NCT01225211|26741786|P7|Overall Study|Withdrawal by Subject|1
7688900|NCT01225211|26741787|P6|Overall Study|Withdrawal by Subject|0
7688901|NCT01225211|26741788|P5|Overall Study|Withdrawal by Subject|0
7688902|NCT01225211|26741789|P4|Overall Study|Withdrawal by Subject|0
7688903|NCT01225211|26741790|P3|Overall Study|Withdrawal by Subject|0
7688904|NCT01225211|26741791|P2|Overall Study|Withdrawal by Subject|0
7688905|NCT01225211|26741792|P1|Overall Study|Withdrawal by Subject|0
7688906|NCT01225211|26741783|P10|Overall Study|Adverse Event|1
7688907|NCT01225211|26741784|P9|Overall Study|Adverse Event|0
7688908|NCT01225211|26741785|P8|Overall Study|Adverse Event|0
7688909|NCT01225211|26741786|P7|Overall Study|Adverse Event|0
7688910|NCT01225211|26741787|P6|Overall Study|Adverse Event|0
7688911|NCT01225211|26741788|P5|Overall Study|Adverse Event|0
7688912|NCT01225211|26741789|P4|Overall Study|Adverse Event|0
7688913|NCT01225211|26741790|P3|Overall Study|Adverse Event|1
7688914|NCT01225211|26741791|P2|Overall Study|Adverse Event|0
7688915|NCT01225211|26741792|P1|Overall Study|Adverse Event|0
7688916|NCT01225172|26741895|P2|Overall Study|Withdrawal by Subject|0
7688917|NCT01225172|26741896|P1|Overall Study|Withdrawal by Subject|1
7688918|NCT01225172|26741895|P2|Overall Study|Subject no longer meets study criteria|0
7688919|NCT01225172|26741896|P1|Overall Study|Subject no longer meets study criteria|1
7688920|NCT01225172|26741895|P2|Overall Study|Subject request to discontinue treatment|1
7688921|NCT01225172|26741896|P1|Overall Study|Subject request to discontinue treatment|3
7688922|NCT01225172|26741895|P2|Overall Study|Subject decision to stop|0
7688923|NCT01225172|26741896|P1|Overall Study|Subject decision to stop|1
7688924|NCT01225159|26741918|P2|Overall Study|Change operation|0
7688925|NCT01225159|26741919|P1|Overall Study|Change operation|1
7688926|NCT01225146|26741929|P2|Overall Study|Sponsor discontinued making 2mg drug|2
7688927|NCT01225146|26741930|P1|Overall Study|Sponsor discontinued making 2mg drug|0
7688928|NCT01224925|26741998|P2|Overall Study|Lost to Follow-up|2
7688929|NCT01224925|26741999|P1|Overall Study|Lost to Follow-up|3
7688930|NCT01224821|26742007|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
7688931|NCT01224821|26742007|P1|Long-Term Follow-Up|Death|2
7688932|NCT01224821|26742007|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
7688933|NCT01224821|26742007|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
7688934|NCT01224821|26742007|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7688935|NCT01224821|26742007|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
7688936|NCT01224821|26742007|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
7688937|NCT01224821|26742007|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
7688938|NCT01224782|26742026|P1|Overall Study|Transplantation|1
7688939|NCT01224782|26742026|P1|Overall Study|Deterioration|1
7688940|NCT01224782|26742026|P1|Overall Study|Financial Reasons|1
7688941|NCT01224782|26742026|P1|Overall Study|Change of Treatment|1
7688942|NCT01224782|26742026|P1|Overall Study|Start of Dialysis|3
7688943|NCT01224782|26742026|P1|Overall Study|Other|4
7688944|NCT01224782|26742026|P1|Overall Study|Noncompliance|10
7688945|NCT01224782|26742026|P1|Overall Study|Adverse Reaction|11
7688946|NCT01224782|26742026|P1|Overall Study|Adverse Event|12
7688947|NCT01224782|26742026|P1|Overall Study|Improvement|13
7688948|NCT01224782|26742026|P1|Overall Study|Death|14
7688949|NCT01224782|26742026|P1|Overall Study|Withdrawal by Subject|16
7688950|NCT01224782|26742026|P1|Overall Study|Lost to Follow-up|177
7688951|NCT01224639|26742052|P8|Overall Study|Adverse Event|1
7688952|NCT01224639|26742053|P7|Overall Study|Adverse Event|0
7688953|NCT01224639|26742054|P6|Overall Study|Adverse Event|0
7688954|NCT01224639|26742055|P5|Overall Study|Adverse Event|0
7688955|NCT01224639|26742056|P4|Overall Study|Adverse Event|0
7688956|NCT01224639|26742057|P3|Overall Study|Adverse Event|0
7688957|NCT01224639|26742058|P2|Overall Study|Adverse Event|0
7688958|NCT01224639|26742059|P1|Overall Study|Adverse Event|0
7688959|NCT01224639|26742052|P8|Overall Study|Withdrawal by Subject|1
7688960|NCT01224639|26742053|P7|Overall Study|Withdrawal by Subject|1
7688961|NCT01224639|26742054|P6|Overall Study|Withdrawal by Subject|0
7688962|NCT01224639|26742055|P5|Overall Study|Withdrawal by Subject|2
7688963|NCT01224639|26742056|P4|Overall Study|Withdrawal by Subject|0
7688964|NCT01224639|26742057|P3|Overall Study|Withdrawal by Subject|0
7688965|NCT01224639|26742058|P2|Overall Study|Withdrawal by Subject|0
7688966|NCT01224639|26742059|P1|Overall Study|Withdrawal by Subject|0
7688967|NCT01224431|26742177|P2|Overall Study|no video record|1
7688968|NCT01224431|26742178|P1|Overall Study|no video record|0
7688969|NCT01224431|26742177|P2|Overall Study|not randomized|4
7688970|NCT01224431|26742178|P1|Overall Study|not randomized|0
7688971|NCT01224171|26742204|P2|Overall Study|Lost to Follow-up|3
7688972|NCT01224171|26742205|P1|Overall Study|Lost to Follow-up|0
7688973|NCT01224171|26742204|P2|Overall Study|Withdrawal of Consent|4
7688974|NCT01224171|26742205|P1|Overall Study|Withdrawal of Consent|2
7688975|NCT01224171|26742204|P2|Overall Study|Lack of Efficacy|1
7688976|NCT01224171|26742205|P1|Overall Study|Lack of Efficacy|5
7688977|NCT01224171|26742204|P2|Overall Study|Protocol Violation|1
7688978|NCT01224171|26742205|P1|Overall Study|Protocol Violation|0
7688979|NCT01224171|26742204|P2|Overall Study|Adverse Event|4
7688980|NCT01224171|26742205|P1|Overall Study|Adverse Event|8
7688981|NCT01224158|26742227|P2|Overall Study|Withdrawal by Subject|0
7688982|NCT01224158|26742228|P1|Overall Study|Withdrawal by Subject|1
7688983|NCT01223937|26742272|P2|Overall Study|Other|1
7688984|NCT01223937|26742273|P1|Overall Study|Other|4
7688985|NCT01223937|26742272|P2|Overall Study|Protocol Violation|7
7688986|NCT01223937|26742273|P1|Overall Study|Protocol Violation|8
7688987|NCT01223937|26742272|P2|Overall Study|Adverse Event|4
7688988|NCT01223937|26742273|P1|Overall Study|Adverse Event|1
7688989|NCT01223937|26742272|P2|Overall Study|Lost to Follow-up|4
7688990|NCT01223937|26742273|P1|Overall Study|Lost to Follow-up|1
7688991|NCT01223937|26742272|P2|Overall Study|Withdrawal by Subject|2
7688992|NCT01223937|26742273|P1|Overall Study|Withdrawal by Subject|3
7688993|NCT01223404|26742319|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
7688994|NCT01223404|26742320|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
7688995|NCT01223404|26742321|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
7688996|NCT01223404|26742322|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
7688997|NCT01223404|26742323|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
7688998|NCT01223404|26742324|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
7688999|NCT01223404|26742319|P6|Second Intervention (1 Day)|Adverse Event|0
7689000|NCT01223404|26742320|P5|Second Intervention (1 Day)|Adverse Event|0
7689001|NCT01223404|26742321|P4|Second Intervention (1 Day)|Adverse Event|0
7689002|NCT01223404|26742322|P3|Second Intervention (1 Day)|Adverse Event|0
7689003|NCT01223404|26742323|P2|Second Intervention (1 Day)|Adverse Event|0
7689004|NCT01223404|26742324|P1|Second Intervention (1 Day)|Adverse Event|1
7689005|NCT01223404|26742319|P6|First Intervention (1 Day)|Adverse Event|0
7689006|NCT01223404|26742320|P5|First Intervention (1 Day)|Adverse Event|0
7689007|NCT01223404|26742321|P4|First Intervention (1 Day)|Adverse Event|1
7689008|NCT01223404|26742322|P3|First Intervention (1 Day)|Adverse Event|0
7689009|NCT01223404|26742323|P2|First Intervention (1 Day)|Adverse Event|0
7689010|NCT01223404|26742324|P1|First Intervention (1 Day)|Adverse Event|0
7689011|NCT01223365|26742388|P1|Open-label Treatment Period|Physician Decision|2
7689012|NCT01223365|26742388|P1|Open-label Treatment Period|Starting physical therapy|1
7689013|NCT01223365|26742388|P1|Open-label Treatment Period|"Out of window"|1
7689014|NCT01223365|26742388|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
7689015|NCT01223365|26742388|P1|Open-label Treatment Period|Moved out of area|2
7689016|NCT01223365|26742388|P1|Open-label Treatment Period|Noncompliance with study procedures|6
7689017|NCT01223365|26742388|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
7689018|NCT01223365|26742388|P1|Open-label Treatment Period|Lost to Follow-up|7
7689019|NCT01223365|26742388|P1|Open-label Treatment Period|Protocol Violation|15
7689020|NCT01223365|26742388|P1|Open-label Treatment Period|Withdrawal by Subject|19
7689021|NCT01223365|26742388|P1|Open-label Treatment Period|Lack of Efficacy|2
7689022|NCT01223365|26742388|P1|Open-label Treatment Period|Adverse Event|39
7689023|NCT01223365|26742388|P1|Open-label Titration Period|Starting physical therapy|1
7689024|NCT01223365|26742388|P1|Open-label Titration Period|Noncompliance with study procedures|2
7689025|NCT01223365|26742388|P1|Open-label Titration Period|Noncompliance with study drug admin|1
7689026|NCT01223365|26742388|P1|Open-label Titration Period|Lost to Follow-up|2
7689027|NCT01223365|26742388|P1|Open-label Titration Period|Protocol Violation|1
7689028|NCT01223365|26742388|P1|Open-label Titration Period|Withdrawal by Subject|5
7689029|NCT01223365|26742388|P1|Open-label Titration Period|Lack of Efficacy|3
7689030|NCT01223365|26742388|P1|Open-label Titration Period|Adverse Event|23
7689031|NCT01223365|26742388|P1|Open-label Titration Period|Enrolled but not treated|1
7689032|NCT01223235|26742452|P1|Overall Study|Withdrawal by Subject|1
7689033|NCT01223196|26742460|P2|Overall Study|Withdrawal by Subject|0
7689034|NCT01223196|26742461|P1|Overall Study|Withdrawal by Subject|1
7689035|NCT01223196|26742460|P2|Overall Study|Physician Decision|0
7689036|NCT01223196|26742461|P1|Overall Study|Physician Decision|1
7689037|NCT01223196|26742460|P2|Overall Study|Lost to Follow-up|0
7689038|NCT01223196|26742461|P1|Overall Study|Lost to Follow-up|2
7689039|NCT01223183|26742473|P2|Washout Period (5-24 Days)|Physician Decision|0
7689040|NCT01223183|26742474|P1|Washout Period (5-24 Days)|Physician Decision|1
7689041|NCT01223183|26742473|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
7689042|NCT01223183|26742474|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
7689043|NCT01223183|26742473|P2|Imaging Day 1|Physician Decision|1
7689044|NCT01223183|26742474|P1|Imaging Day 1|Physician Decision|0
7689045|NCT01223027|26742484|P2|Overall Study|Study terminated by sponsor|8
7689046|NCT01223027|26742485|P1|Overall Study|Study terminated by sponsor|2
7689047|NCT01223027|26742484|P2|Overall Study|New therapy for study indication|8
7689048|NCT01223027|26742485|P1|Overall Study|New therapy for study indication|17
7689049|NCT01223027|26742484|P2|Overall Study|Subject/guardian decicion|16
7689050|NCT01223027|26742485|P1|Overall Study|Subject/guardian decicion|18
7689051|NCT01223027|26742484|P2|Overall Study|Protocol Violation|1
7689052|NCT01223027|26742485|P1|Overall Study|Protocol Violation|2
7689053|NCT01223027|26742484|P2|Overall Study|Progressive Disease|183
7689054|NCT01223027|26742485|P1|Overall Study|Progressive Disease|167
7689055|NCT01223027|26742484|P2|Overall Study|Physician Decision|8
7689056|NCT01223027|26742485|P1|Overall Study|Physician Decision|4
7689057|NCT01223027|26742484|P2|Overall Study|Lost to Follow-up|1
7689058|NCT01223027|26742485|P1|Overall Study|Lost to Follow-up|2
7689059|NCT01223027|26742484|P2|Overall Study|Death|42
7689060|NCT01223027|26742485|P1|Overall Study|Death|42
7689061|NCT01223027|26742484|P2|Overall Study|Adverse Event|10
7689062|NCT01223027|26742485|P1|Overall Study|Adverse Event|20
7689063|NCT01222715|26742547|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
7689064|NCT01222715|26742548|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
7689065|NCT01222715|26742547|P2|Overall Study|Ineligible|1
7689066|NCT01222715|26742548|P1|Overall Study|Ineligible|0
7689067|NCT01222715|26742547|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
7689068|NCT01222715|26742548|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
7689069|NCT01222715|26742547|P2|Overall Study|Refusal of further protocol therapy|4
7689070|NCT01222715|26742548|P1|Overall Study|Refusal of further protocol therapy|0
7689071|NCT01222715|26742547|P2|Overall Study|Physician Decision|2
7689072|NCT01222715|26742548|P1|Overall Study|Physician Decision|12
7689073|NCT01222715|26742547|P2|Overall Study|Lack of Efficacy|14
7689074|NCT01222715|26742548|P1|Overall Study|Lack of Efficacy|22
7689075|NCT01222715|26742547|P2|Overall Study|Death|1
7689076|NCT01222715|26742548|P1|Overall Study|Death|0
7689077|NCT01222715|26742547|P2|Overall Study|Adverse Event|4
7689078|NCT01222715|26742548|P1|Overall Study|Adverse Event|0
7689079|NCT01222533|26742587|P1|Overall Study|Other|4
7689080|NCT01222533|26742587|P1|Overall Study|Withdrawal by Subject|5
7689081|NCT01222533|26742587|P1|Overall Study|Adverse Event|5
7689082|NCT01222520|26742726|P2|Double-blind Period|Study medication stolen|0
7689083|NCT01222520|26742727|P1|Double-blind Period|Study medication stolen|1
7689084|NCT01222520|26742726|P2|Double-blind Period|Lack of Efficacy|1
7689085|NCT01222520|26742727|P1|Double-blind Period|Lack of Efficacy|0
7689086|NCT01222520|26742726|P2|Double-blind Period|Adverse Event|1
7689087|NCT01222520|26742727|P1|Double-blind Period|Adverse Event|0
7689088|NCT01222520|26742726|P2|Open-label run-in Period|Number of patients fulfilled|3
7689089|NCT01222520|26742727|P1|Open-label run-in Period|Number of patients fulfilled|0
7689090|NCT01222520|26742726|P2|Open-label run-in Period|Blood pressure criteria not met|18
7689091|NCT01222520|26742727|P1|Open-label run-in Period|Blood pressure criteria not met|0
7689092|NCT01222520|26742726|P2|Open-label run-in Period|Withdrawal by Subject|2
7689093|NCT01222520|26742727|P1|Open-label run-in Period|Withdrawal by Subject|0
7689094|NCT01222507|26742745|P1|Overall Study|Withdrawal by Subject|1
7689095|NCT01222507|26742745|P1|Overall Study|Physician Decision|1
7689096|NCT01222416|26742773|P2|Overall Study|Death|0
7689097|NCT01222416|26742774|P1|Overall Study|Death|1
7689098|NCT01222416|26742773|P2|Overall Study|missed view/scan|0
7689099|NCT01222416|26742774|P1|Overall Study|missed view/scan|1
7689100|NCT01222416|26742773|P2|Overall Study|scheduling|0
7689101|NCT01222416|26742774|P1|Overall Study|scheduling|6
7689102|NCT01222416|26742773|P2|Overall Study|Withdrawal by Subject|0
7689103|NCT01222416|26742774|P1|Overall Study|Withdrawal by Subject|5
7689104|NCT01222416|26742773|P2|Overall Study|Adverse Event|0
7689105|NCT01222416|26742774|P1|Overall Study|Adverse Event|4
7689106|NCT01222416|26742773|P2|Overall Study|ineligible;metastasis|0
7689107|NCT01222416|26742774|P1|Overall Study|ineligible;metastasis|3
7689108|NCT01222403|26742784|P2|Overall Study|Inappropriate enrollment|2
7689109|NCT01222403|26742785|P1|Overall Study|Inappropriate enrollment|0
7689110|NCT01222247|26742846|P2|Overall Study|Lost to Follow-up|2
7689111|NCT01222247|26742847|P1|Overall Study|Lost to Follow-up|2
7689112|NCT01222104|26742983|P1|Overall Study|Death|10
7689113|NCT01222104|26742983|P1|Overall Study|Lost to Follow-up|37
7689114|NCT01222078|26743006|P1|Overall Study|Early termination of the study|1
7689115|NCT01221948|26743040|P1|Overall Study|Protocol Violation|4
7689116|NCT01221948|26743040|P1|Overall Study|Death|1
7689117|NCT01221948|26743040|P1|Overall Study|not disclosed|2
7689118|NCT01221948|26743040|P1|Overall Study|Withdrawal by Subject|2
7689119|NCT01221948|26743040|P1|Overall Study|Physician Decision|5
7689120|NCT01221753|26743059|P1|Overall Study|Adverse Event|1
7689121|NCT01221727|26743066|P2|Overall Study|Withdrawal by Subject|1
7689122|NCT01221727|26743067|P1|Overall Study|Withdrawal by Subject|1
7689123|NCT01221727|26743066|P2|Overall Study|Physician Decision|0
7689124|NCT01221727|26743067|P1|Overall Study|Physician Decision|2
7689125|NCT01221623|26743088|P2|Overall Study|Other|2
7689126|NCT01221623|26743089|P1|Overall Study|Other|5
7689127|NCT01221623|26743088|P2|Overall Study|Death|0
7689128|NCT01221623|26743089|P1|Overall Study|Death|1
7689129|NCT01221623|26743088|P2|Overall Study|Adverse Event|3
7689130|NCT01221623|26743089|P1|Overall Study|Adverse Event|6
7689131|NCT01221623|26743088|P2|Overall Study|Lost to Follow-up|1
7689132|NCT01221623|26743089|P1|Overall Study|Lost to Follow-up|7
7689133|NCT01221623|26743088|P2|Overall Study|Withdrawal by Subject|8
7689134|NCT01221623|26743089|P1|Overall Study|Withdrawal by Subject|19
7689135|NCT01221597|26743113|P2|Overall Study|Death|0
7689136|NCT01221597|26743114|P1|Overall Study|Death|2
7689137|NCT01221597|26743113|P2|Overall Study|Other|4
7689138|NCT01221597|26743114|P1|Overall Study|Other|3
7689139|NCT01221597|26743113|P2|Overall Study|Protocol Violation|0
7689140|NCT01221597|26743114|P1|Overall Study|Protocol Violation|1
7689141|NCT01221597|26743113|P2|Overall Study|Lost to Follow-up|5
7689142|NCT01221597|26743114|P1|Overall Study|Lost to Follow-up|6
7689143|NCT01221597|26743113|P2|Overall Study|Withdrawal by Subject|6
7689144|NCT01221597|26743114|P1|Overall Study|Withdrawal by Subject|20
7689145|NCT01221597|26743113|P2|Overall Study|Adverse Event|1
7689146|NCT01221597|26743114|P1|Overall Study|Adverse Event|4
7689147|NCT01221363|26743171|P2|Overall Study|Withdrawal by Subject|5
7689148|NCT01221363|26743172|P1|Overall Study|Withdrawal by Subject|11
7689149|NCT01221363|26743171|P2|Overall Study|Pregnancy|0
7689150|NCT01221363|26743172|P1|Overall Study|Pregnancy|1
7689151|NCT01221350|26743182|P2|Overall Study|Withdrawal by Subject|2
7689152|NCT01221350|26743183|P1|Overall Study|Withdrawal by Subject|4
7689153|NCT01221350|26743182|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
7689154|NCT01221350|26743183|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
7689155|NCT01221350|26743182|P2|Overall Study|Discontinued intervention (GERD)|0
7689156|NCT01221350|26743183|P1|Overall Study|Discontinued intervention (GERD)|1
7689157|NCT01221285|26743242|P1|Overall Study|Withdrawal by Subject|1
7689158|NCT01221272|26743251|P2|Period 2|Adverse Event|2
7689159|NCT01221272|26743252|P1|Period 2|Adverse Event|0
7689160|NCT01221272|26743251|P2|Period 1|Significant Dosing Noncompliance|1
7689161|NCT01221272|26743252|P1|Period 1|Significant Dosing Noncompliance|0
7689162|NCT01221272|26743251|P2|Period 1|Consent Withdrawal|1
7689163|NCT01221272|26743252|P1|Period 1|Consent Withdrawal|0
7689164|NCT01221272|26743251|P2|Period 1|Adverse Event|0
7689165|NCT01221272|26743252|P1|Period 1|Adverse Event|2
7689166|NCT01221233|26743269|P2|Overall Study|Withdrawal by Subject|1
7689167|NCT01221233|26743270|P1|Overall Study|Withdrawal by Subject|3
7689168|NCT01221181|26743298|P1|Overall Study|Lost to Follow-up|1
7689169|NCT01221090|26743306|P4|Overall Study|Withdrawal by Subject|2
7689170|NCT01221090|26743307|P3|Overall Study|Withdrawal by Subject|27
7689171|NCT01221090|26743308|P2|Overall Study|Withdrawal by Subject|22
7689172|NCT01221090|26743309|P1|Overall Study|Withdrawal by Subject|0
7689173|NCT01221090|26743306|P4|Overall Study|Non-Compliant or Unable to Contact|20
7689174|NCT01221090|26743307|P3|Overall Study|Non-Compliant or Unable to Contact|15
7689175|NCT01221090|26743308|P2|Overall Study|Non-Compliant or Unable to Contact|12
7689176|NCT01221090|26743309|P1|Overall Study|Non-Compliant or Unable to Contact|15
7689177|NCT01220999|26743340|P5|Overall Study|Progressive disease|0
7689178|NCT01220999|26743341|P4|Overall Study|Progressive disease|0
7689179|NCT01220999|26743342|P3|Overall Study|Progressive disease|1
7689180|NCT01220999|26743343|P2|Overall Study|Progressive disease|0
7689181|NCT01220999|26743344|P1|Overall Study|Progressive disease|0
7689182|NCT01220856|26743435|P2|Overall Study|Lost to Follow-up|0
7689183|NCT01220856|26743436|P1|Overall Study|Lost to Follow-up|1
7689184|NCT01220856|26743435|P2|Overall Study|graft loss|3
7689185|NCT01220856|26743436|P1|Overall Study|graft loss|3
7689186|NCT01220609|26743545|P1|Overall Study|Ineligible-Never treated|1
7689187|NCT01220609|26743545|P1|Overall Study|Ineligible- Wrong cell type|1
7689188|NCT01220609|26743545|P1|Overall Study|Ineligible-Wrong primary cancer site|1
7689189|NCT01220557|26743559|P2|Overall Study|attended less than 6 lessons|2
7689190|NCT01220557|26743560|P1|Overall Study|attended less than 6 lessons|1
7689191|NCT01220557|26743559|P2|Overall Study|Lost to Follow-up|3
7689192|NCT01220557|26743560|P1|Overall Study|Lost to Follow-up|5
7689193|NCT01220414|26743593|P4|Overall Study|Withdrawal by Subject|1
7689194|NCT01220414|26743594|P3|Overall Study|Withdrawal by Subject|0
7689195|NCT01220414|26743595|P2|Overall Study|Withdrawal by Subject|0
7689196|NCT01220414|26743596|P1|Overall Study|Withdrawal by Subject|1
7689197|NCT01220401|26743603|P1|Overall Study|Protocol Violation|1
7689198|NCT01220401|26743603|P1|Overall Study|Withdrawal by Subject|2
7689199|NCT01220297|26743612|P1|Overall Study|Lost to Follow-up|1
7689200|NCT01220297|26743612|P1|Overall Study|Death|2
7689201|NCT01220180|26743629|P1|Overall Study|Randomized but not treated|1
7689202|NCT01220180|26743629|P1|Overall Study|Death|1
7689203|NCT01220180|26743629|P1|Overall Study|Lack of Efficacy|22
7689204|NCT01220180|26743629|P1|Overall Study|Adverse Event|35
7689205|NCT01220180|26743629|P1|Overall Study|Other|72
7689206|NCT01220180|26743629|P1|Overall Study|Lost to Follow-up|76
7689207|NCT01220167|26743655|P3|Period 3|Urine positive for substance abuse|0
7689208|NCT01220167|26743656|P2|Period 3|Urine positive for substance abuse|1
7689209|NCT01220167|26743657|P1|Period 3|Urine positive for substance abuse|0
7689210|NCT01220128|26743670|P7|Overall Study|Consent withdrawn by subject|0
7689211|NCT01220128|26743671|P6|Overall Study|Consent withdrawn by subject|0
7689212|NCT01220128|26743672|P5|Overall Study|Consent withdrawn by subject|0
7689213|NCT01220128|26743673|P4|Overall Study|Consent withdrawn by subject|0
7689214|NCT01220128|26743674|P3|Overall Study|Consent withdrawn by subject|0
7689215|NCT01220128|26743675|P2|Overall Study|Consent withdrawn by subject|0
7689216|NCT01220128|26743676|P1|Overall Study|Consent withdrawn by subject|1
7689217|NCT01220128|26743670|P7|Overall Study|Other|0
7689218|NCT01220128|26743671|P6|Overall Study|Other|0
7689219|NCT01220128|26743672|P5|Overall Study|Other|0
7689220|NCT01220128|26743673|P4|Overall Study|Other|0
7689221|NCT01220128|26743674|P3|Overall Study|Other|1
7689222|NCT01220128|26743675|P2|Overall Study|Other|0
7689223|NCT01220128|26743676|P1|Overall Study|Other|0
7689224|NCT01220128|26743670|P7|Overall Study|Adverse event, non-fatal|3
7689225|NCT01220128|26743671|P6|Overall Study|Adverse event, non-fatal|0
7689226|NCT01220128|26743672|P5|Overall Study|Adverse event, non-fatal|0
7689227|NCT01220128|26743673|P4|Overall Study|Adverse event, non-fatal|0
7689228|NCT01220128|26743674|P3|Overall Study|Adverse event, non-fatal|0
7689229|NCT01220128|26743675|P2|Overall Study|Adverse event, non-fatal|0
7689230|NCT01220128|26743676|P1|Overall Study|Adverse event, non-fatal|1
7689231|NCT01220128|26743670|P7|Overall Study|Adverse event, serious fatal|1
7689232|NCT01220128|26743671|P6|Overall Study|Adverse event, serious fatal|0
7689233|NCT01220128|26743672|P5|Overall Study|Adverse event, serious fatal|0
7689234|NCT01220128|26743673|P4|Overall Study|Adverse event, serious fatal|0
7689235|NCT01220128|26743674|P3|Overall Study|Adverse event, serious fatal|0
7689236|NCT01220128|26743675|P2|Overall Study|Adverse event, serious fatal|0
7689237|NCT01220128|26743676|P1|Overall Study|Adverse event, serious fatal|2
7689238|NCT01220128|26743670|P7|Overall Study|Sponsor study termination|1
7689239|NCT01220128|26743671|P6|Overall Study|Sponsor study termination|0
7689240|NCT01220128|26743672|P5|Overall Study|Sponsor study termination|0
7689241|NCT01220128|26743673|P4|Overall Study|Sponsor study termination|0
7689242|NCT01220128|26743674|P3|Overall Study|Sponsor study termination|0
7689243|NCT01220128|26743675|P2|Overall Study|Sponsor study termination|1
7689244|NCT01220128|26743676|P1|Overall Study|Sponsor study termination|0
7689245|NCT01220128|26743670|P7|Overall Study|Progressive disease|0
7689246|NCT01220128|26743671|P6|Overall Study|Progressive disease|0
7689247|NCT01220128|26743672|P5|Overall Study|Progressive disease|0
7689248|NCT01220128|26743673|P4|Overall Study|Progressive disease|0
7689249|NCT01220128|26743674|P3|Overall Study|Progressive disease|2
7689250|NCT01220128|26743675|P2|Overall Study|Progressive disease|0
7689251|NCT01220128|26743676|P1|Overall Study|Progressive disease|0
7689252|NCT01220024|26743883|P2|Overall Study|Lost to Follow-up|1
7689253|NCT01220024|26743884|P1|Overall Study|Lost to Follow-up|1
7689254|NCT01219985|26743900|P1|Overall Study|Physician Decision|20
7689255|NCT01219959|26743908|P2|Overall Study|Other|0
7689256|NCT01219959|26743909|P1|Overall Study|Other|1
7689257|NCT01219959|26743908|P2|Overall Study|Renal Transplantation|3
7689258|NCT01219959|26743909|P1|Overall Study|Renal Transplantation|0
7689259|NCT01219959|26743908|P2|Overall Study|Withdrawal by Subject|2
7689260|NCT01219959|26743909|P1|Overall Study|Withdrawal by Subject|0
7689261|NCT01219959|26743908|P2|Overall Study|Physician Decision|4
7689262|NCT01219959|26743909|P1|Overall Study|Physician Decision|0
7689263|NCT01219959|26743908|P2|Overall Study|Adverse Event|14
7689264|NCT01219959|26743909|P1|Overall Study|Adverse Event|6
7689265|NCT01219933|26743957|P1|Overall Study|Lack of Efficacy|1
7689266|NCT01219933|26743957|P1|Overall Study|Protocol Violation|8
7689267|NCT01219933|26743957|P1|Overall Study|Withdrawal by Subject|5
7689268|NCT01219933|26743957|P1|Overall Study|GC free|1
7689269|NCT01219933|26743957|P1|Overall Study|Lost to Follow-up|3
7689270|NCT01219933|26743957|P1|Overall Study|No LDA maintained|7
7689271|NCT01219933|26743957|P1|Overall Study|No LDA reached|5
7689272|NCT01219933|26743957|P1|Overall Study|Adverse Event|8
7689273|NCT01218867|26744167|P11|Overall Study|Death during treatment|0
7689274|NCT01218867|26744168|P10|Overall Study|Death during treatment|0
7689275|NCT01218867|26744169|P9|Overall Study|Death during treatment|0
7689276|NCT01218867|26744170|P8|Overall Study|Death during treatment|0
7689277|NCT01218867|26744171|P7|Overall Study|Death during treatment|1
7689278|NCT01218867|26744172|P6|Overall Study|Death during treatment|0
7689279|NCT01218867|26744173|P5|Overall Study|Death during treatment|0
7689280|NCT01218867|26744174|P4|Overall Study|Death during treatment|0
7689281|NCT01218867|26744175|P3|Overall Study|Death during treatment|0
7689282|NCT01218867|26744176|P2|Overall Study|Death during treatment|0
7689283|NCT01218867|26744177|P1|Overall Study|Death during treatment|0
7689284|NCT01218802|26744225|P2|Overall Study|Incarcerated|0
7689285|NCT01218802|26744226|P1|Overall Study|Incarcerated|2
7689286|NCT01218802|26744225|P2|Overall Study|Adverse Event|2
7689287|NCT01218802|26744226|P1|Overall Study|Adverse Event|0
7689288|NCT01218802|26744225|P2|Overall Study|Withdrawal by Subject|10
7689289|NCT01218802|26744226|P1|Overall Study|Withdrawal by Subject|3
7689290|NCT01218802|26744225|P2|Overall Study|Lost to Follow-up|6
7689291|NCT01218802|26744226|P1|Overall Study|Lost to Follow-up|5
7689292|NCT01218659|26744263|P3|12-Month OLE|Declined to participate in the OLE|4
7689624|NCT01217606|26745553|P1|Initial Treatment Phase|Personal Reasons|0
7689293|NCT01218659|26744264|P2|12-Month OLE|Declined to participate in the OLE|0
7689294|NCT01218659|26744265|P1|12-Month OLE|Declined to participate in the OLE|0
7689295|NCT01218659|26744263|P3|12-Month OLE|Lack of Efficacy|1
7689296|NCT01218659|26744264|P2|12-Month OLE|Lack of Efficacy|0
7689297|NCT01218659|26744265|P1|12-Month OLE|Lack of Efficacy|0
7689298|NCT01218659|26744263|P3|12-Month OLE|Pregnancy|1
7689299|NCT01218659|26744264|P2|12-Month OLE|Pregnancy|0
7689300|NCT01218659|26744265|P1|12-Month OLE|Pregnancy|0
7689301|NCT01218659|26744263|P3|12-Month OLE|Lost to Follow-up|1
7689302|NCT01218659|26744264|P2|12-Month OLE|Lost to Follow-up|0
7689303|NCT01218659|26744265|P1|12-Month OLE|Lost to Follow-up|0
7689304|NCT01218659|26744263|P3|12-Month OLE|Physician Decision|1
7689305|NCT01218659|26744264|P2|12-Month OLE|Physician Decision|0
7689306|NCT01218659|26744265|P1|12-Month OLE|Physician Decision|0
7689307|NCT01218659|26744263|P3|12-Month OLE|Withdrawal by Subject|2
7689308|NCT01218659|26744264|P2|12-Month OLE|Withdrawal by Subject|0
7689309|NCT01218659|26744265|P1|12-Month OLE|Withdrawal by Subject|0
7689310|NCT01218659|26744263|P3|18-Month Randomized Period|Did not receive study drug|0
7689311|NCT01218659|26744264|P2|18-Month Randomized Period|Did not receive study drug|3
7689312|NCT01218659|26744265|P1|18-Month Randomized Period|Did not receive study drug|0
7689313|NCT01218659|26744263|P3|18-Month Randomized Period|Withdrawal by Subject|0
7689314|NCT01218659|26744264|P2|18-Month Randomized Period|Withdrawal by Subject|3
7689315|NCT01218659|26744265|P1|18-Month Randomized Period|Withdrawal by Subject|2
7689316|NCT01218646|26744280|P4|Overall Study|Protocol Violation|1
7689317|NCT01218646|26744281|P3|Overall Study|Protocol Violation|1
7689318|NCT01218646|26744282|P2|Overall Study|Protocol Violation|0
7689319|NCT01218646|26744283|P1|Overall Study|Protocol Violation|0
7689320|NCT01218646|26744280|P4|Overall Study|Lost to Follow-up|0
7689321|NCT01218646|26744281|P3|Overall Study|Lost to Follow-up|0
7689322|NCT01218646|26744282|P2|Overall Study|Lost to Follow-up|0
7689323|NCT01218646|26744283|P1|Overall Study|Lost to Follow-up|1
7689324|NCT01218646|26744280|P4|Overall Study|Adverse Event|0
7689325|NCT01218646|26744281|P3|Overall Study|Adverse Event|1
7689326|NCT01218646|26744282|P2|Overall Study|Adverse Event|0
7689327|NCT01218646|26744283|P1|Overall Study|Adverse Event|0
7689328|NCT01218594|26744321|P1|Overall Study|Physician Decision|6
7689329|NCT01218594|26744321|P1|Overall Study|Adverse Event|2
7689330|NCT01218594|26744321|P1|Overall Study|Withdrawal by Subject|3
7689331|NCT01218594|26744321|P1|Overall Study|Death|1
7689332|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
7689333|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
7689334|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
7689335|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
7689336|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
7689337|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
7689338|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
7689339|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
7689340|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7689341|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7689342|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
7689343|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7689344|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Other|0
7689345|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Other|0
7689346|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Other|4
7689347|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Other|3
7689348|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7689349|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7689350|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
7689351|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7689352|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7689353|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7689354|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
7689355|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7689356|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7689357|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7689358|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
7689359|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7689360|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
7689361|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
7689362|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
7689363|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
7689364|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7689365|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7689366|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7689367|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
7689368|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Physician Decision|0
7689369|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Physician Decision|0
7689370|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Physician Decision|2
7689371|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Physician Decision|2
7689372|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7689373|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7689374|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
7689375|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7689376|NCT01218516|26744335|P4|Combination Therapy (up to 4.5 Months)|Death|0
7689377|NCT01218516|26744336|P3|Combination Therapy (up to 4.5 Months)|Death|0
7689378|NCT01218516|26744337|P2|Combination Therapy (up to 4.5 Months)|Death|1
7689379|NCT01218516|26744338|P1|Combination Therapy (up to 4.5 Months)|Death|2
7689380|NCT01218477|26744360|P4|Overall Study|Maximum clinical benefit|0
7689381|NCT01218477|26744361|P3|Overall Study|Maximum clinical benefit|0
7689382|NCT01218477|26744362|P2|Overall Study|Maximum clinical benefit|2
7689383|NCT01218477|26744363|P1|Overall Study|Maximum clinical benefit|0
7689384|NCT01218477|26744360|P4|Overall Study|Administrative reason by sponsor|0
7689385|NCT01218477|26744361|P3|Overall Study|Administrative reason by sponsor|1
7689386|NCT01218477|26744362|P2|Overall Study|Administrative reason by sponsor|0
7689387|NCT01218477|26744363|P1|Overall Study|Administrative reason by sponsor|0
7689388|NCT01218477|26744360|P4|Overall Study|Prepared for cell transplantation|0
7689389|NCT01218477|26744361|P3|Overall Study|Prepared for cell transplantation|1
7689390|NCT01218477|26744362|P2|Overall Study|Prepared for cell transplantation|1
7689391|NCT01218477|26744363|P1|Overall Study|Prepared for cell transplantation|0
7689392|NCT01218477|26744360|P4|Overall Study|Withdrawal by Subject|0
7689393|NCT01218477|26744361|P3|Overall Study|Withdrawal by Subject|1
7689394|NCT01218477|26744362|P2|Overall Study|Withdrawal by Subject|0
7689395|NCT01218477|26744363|P1|Overall Study|Withdrawal by Subject|0
7689396|NCT01218477|26744360|P4|Overall Study|No longer meets study criteria|0
7689397|NCT01218477|26744361|P3|Overall Study|No longer meets study criteria|0
7689398|NCT01218477|26744362|P2|Overall Study|No longer meets study criteria|0
7689399|NCT01218477|26744363|P1|Overall Study|No longer meets study criteria|1
7689400|NCT01218477|26744360|P4|Overall Study|Study drug toxicity|0
7689401|NCT01218477|26744361|P3|Overall Study|Study drug toxicity|5
7689402|NCT01218477|26744362|P2|Overall Study|Study drug toxicity|2
7689403|NCT01218477|26744363|P1|Overall Study|Study drug toxicity|0
7689404|NCT01218477|26744360|P4|Overall Study|Disease progression|2
7689405|NCT01218477|26744361|P3|Overall Study|Disease progression|6
7689406|NCT01218477|26744362|P2|Overall Study|Disease progression|3
7689407|NCT01218477|26744363|P1|Overall Study|Disease progression|2
7689408|NCT01218438|26744380|P1|Epoch 4|Withdrawal by Subject|2
7689409|NCT01218438|26744380|P1|Epoch 4|Physician Decision|1
7689410|NCT01218438|26744380|P1|Epoch 3|Adverse Event|1
7689411|NCT01218438|26744380|P1|Epoch 3|Withdrawal by Subject|3
7689412|NCT01218438|26744380|P1|Epoch 1|Adverse Event|1
7689413|NCT01218438|26744380|P1|Epoch 1|Physician Decision|2
7689414|NCT01218308|26744698|P2|Overall Study|Other|21
7689415|NCT01218308|26744699|P1|Overall Study|Other|14
7689416|NCT01218308|26744698|P2|Overall Study|Lost to Follow-up|31
7689417|NCT01218308|26744699|P1|Overall Study|Lost to Follow-up|27
7689418|NCT01218308|26744698|P2|Overall Study|Withdrawal by Subject|64
7689419|NCT01218308|26744699|P1|Overall Study|Withdrawal by Subject|61
7689420|NCT01218308|26744698|P2|Overall Study|Protocol Violation|2
7689421|NCT01218308|26744699|P1|Overall Study|Protocol Violation|0
7689422|NCT01218308|26744698|P2|Overall Study|Adverse Event|2
7689423|NCT01218308|26744699|P1|Overall Study|Adverse Event|1
7689424|NCT01218243|26744743|P2|Overall Study|Protocol Violation|10
7689425|NCT01218243|26744744|P1|Overall Study|Protocol Violation|5
7689426|NCT01218243|26744743|P2|Overall Study|Lost to Follow-up|3
7689427|NCT01218243|26744744|P1|Overall Study|Lost to Follow-up|3
7689428|NCT01218243|26744743|P2|Overall Study|Lack of Efficacy|1
7689429|NCT01218243|26744744|P1|Overall Study|Lack of Efficacy|1
7689430|NCT01218204|26744760|P4|Part B Pooled Treatment Arm|Protocol Violation|1
7689431|NCT01218204|26744761|P3|Part B Pooled Treatment Arm|Protocol Violation|0
7689432|NCT01218204|26744762|P2|Part B Pooled Treatment Arm|Protocol Violation|0
7689433|NCT01218204|26744763|P1|Part B Pooled Treatment Arm|Protocol Violation|0
7689434|NCT01218204|26744760|P4|Part B Pooled Treatment Arm|Adverse Event|2
7689435|NCT01218204|26744761|P3|Part B Pooled Treatment Arm|Adverse Event|0
7689436|NCT01218204|26744762|P2|Part B Pooled Treatment Arm|Adverse Event|0
7689437|NCT01218204|26744763|P1|Part B Pooled Treatment Arm|Adverse Event|0
7689438|NCT01218204|26744760|P4|Part B Run-in|Withdrawal by Subject|0
7689439|NCT01218204|26744761|P3|Part B Run-in|Withdrawal by Subject|3
7689440|NCT01218204|26744762|P2|Part B Run-in|Withdrawal by Subject|0
7689441|NCT01218204|26744763|P1|Part B Run-in|Withdrawal by Subject|0
7689442|NCT01218204|26744760|P4|Part B Run-in|Protocol Violation|0
7689443|NCT01218204|26744761|P3|Part B Run-in|Protocol Violation|2
7689444|NCT01218204|26744762|P2|Part B Run-in|Protocol Violation|0
7689445|NCT01218204|26744763|P1|Part B Run-in|Protocol Violation|0
7689446|NCT01218204|26744760|P4|Part B Run-in|Adverse Event|0
7689447|NCT01218204|26744761|P3|Part B Run-in|Adverse Event|1
7689448|NCT01218204|26744762|P2|Part B Run-in|Adverse Event|0
7689449|NCT01218204|26744763|P1|Part B Run-in|Adverse Event|0
7689450|NCT01218204|26744760|P4|Part B Washout|Did not meet continuation criteria|0
7689451|NCT01218204|26744761|P3|Part B Washout|Did not meet continuation criteria|0
7689452|NCT01218204|26744762|P2|Part B Washout|Did not meet continuation criteria|112
7689453|NCT01218204|26744763|P1|Part B Washout|Did not meet continuation criteria|0
7689454|NCT01218204|26744760|P4|Part B Washout|Reached defined stopping criteria|0
7689455|NCT01218204|26744761|P3|Part B Washout|Reached defined stopping criteria|0
7689456|NCT01218204|26744762|P2|Part B Washout|Reached defined stopping criteria|2
7689457|NCT01218204|26744763|P1|Part B Washout|Reached defined stopping criteria|0
7689458|NCT01218204|26744760|P4|Part B Washout|Withdrawal by Subject|0
7689459|NCT01218204|26744761|P3|Part B Washout|Withdrawal by Subject|0
7689460|NCT01218204|26744762|P2|Part B Washout|Withdrawal by Subject|14
7689461|NCT01218204|26744763|P1|Part B Washout|Withdrawal by Subject|0
7689462|NCT01218204|26744760|P4|Part B Washout|Physician Decision|0
7689463|NCT01218204|26744761|P3|Part B Washout|Physician Decision|0
7689464|NCT01218204|26744762|P2|Part B Washout|Physician Decision|14
7689465|NCT01218204|26744763|P1|Part B Washout|Physician Decision|0
7689466|NCT01218204|26744760|P4|Part B Washout|Lost to Follow-up|0
7689467|NCT01218204|26744761|P3|Part B Washout|Lost to Follow-up|0
7689468|NCT01218204|26744762|P2|Part B Washout|Lost to Follow-up|2
7689469|NCT01218204|26744763|P1|Part B Washout|Lost to Follow-up|0
7689470|NCT01218204|26744760|P4|Part B Washout|Adverse Event|0
7689471|NCT01218204|26744761|P3|Part B Washout|Adverse Event|0
7689472|NCT01218204|26744762|P2|Part B Washout|Adverse Event|1
7689473|NCT01218204|26744763|P1|Part B Washout|Adverse Event|0
7689474|NCT01218126|26745027|P4|Overall Study|Withdrawal by Subject|6
7689475|NCT01218126|26745028|P3|Overall Study|Withdrawal by Subject|4
7689476|NCT01218126|26745029|P2|Overall Study|Withdrawal by Subject|5
7689477|NCT01218126|26745030|P1|Overall Study|Withdrawal by Subject|2
7689478|NCT01218126|26745027|P4|Overall Study|Physician Decision|2
7689479|NCT01218126|26745028|P3|Overall Study|Physician Decision|4
7689480|NCT01218126|26745029|P2|Overall Study|Physician Decision|2
7689481|NCT01218126|26745030|P1|Overall Study|Physician Decision|1
7689482|NCT01218126|26745027|P4|Overall Study|Lost to Follow-up|2
7689483|NCT01218126|26745028|P3|Overall Study|Lost to Follow-up|0
7689484|NCT01218126|26745029|P2|Overall Study|Lost to Follow-up|0
7689485|NCT01218126|26745030|P1|Overall Study|Lost to Follow-up|0
7689486|NCT01218126|26745027|P4|Overall Study|Protocol-defined stopping criteria|0
7689487|NCT01218126|26745028|P3|Overall Study|Protocol-defined stopping criteria|0
7689488|NCT01218126|26745029|P2|Overall Study|Protocol-defined stopping criteria|1
7689489|NCT01218126|26745030|P1|Overall Study|Protocol-defined stopping criteria|1
7689490|NCT01218126|26745027|P4|Overall Study|Protocol Violation|3
7689491|NCT01218126|26745028|P3|Overall Study|Protocol Violation|2
7689492|NCT01218126|26745029|P2|Overall Study|Protocol Violation|2
7689493|NCT01218126|26745030|P1|Overall Study|Protocol Violation|5
7689494|NCT01218126|26745027|P4|Overall Study|Lack of Efficacy|6
7689495|NCT01218126|26745028|P3|Overall Study|Lack of Efficacy|2
7689496|NCT01218126|26745029|P2|Overall Study|Lack of Efficacy|2
7689497|NCT01218126|26745030|P1|Overall Study|Lack of Efficacy|7
7689498|NCT01218126|26745027|P4|Overall Study|Adverse Event|16
7689499|NCT01218126|26745028|P3|Overall Study|Adverse Event|12
7689500|NCT01218126|26745029|P2|Overall Study|Adverse Event|10
7689501|NCT01218126|26745030|P1|Overall Study|Adverse Event|8
7689502|NCT01218113|26745071|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
7689503|NCT01218113|26745072|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
7689504|NCT01218113|26745073|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
7689505|NCT01218113|26745071|P3|Overall Study|Lost to Follow-up|4
7689506|NCT01218113|26745072|P2|Overall Study|Lost to Follow-up|1
7689507|NCT01218113|26745073|P1|Overall Study|Lost to Follow-up|4
7689508|NCT01218113|26745071|P3|Overall Study|Withdrawal by Subject|1
7689509|NCT01218113|26745072|P2|Overall Study|Withdrawal by Subject|0
7689510|NCT01218113|26745073|P1|Overall Study|Withdrawal by Subject|1
7689511|NCT01218100|26745254|P4|Overall Study|Other Reason|4
7689512|NCT01218100|26745255|P3|Overall Study|Other Reason|6
7689513|NCT01218100|26745256|P2|Overall Study|Other Reason|2
7689514|NCT01218100|26745257|P1|Overall Study|Other Reason|2
7689515|NCT01218100|26745254|P4|Overall Study|Lost to Follow-up|1
7689516|NCT01218100|26745255|P3|Overall Study|Lost to Follow-up|2
7689517|NCT01218100|26745256|P2|Overall Study|Lost to Follow-up|8
7689518|NCT01218100|26745257|P1|Overall Study|Lost to Follow-up|3
7689519|NCT01218100|26745254|P4|Overall Study|Withdrawal by Subject|7
7689520|NCT01218100|26745255|P3|Overall Study|Withdrawal by Subject|6
7689521|NCT01218100|26745256|P2|Overall Study|Withdrawal by Subject|2
7689522|NCT01218100|26745257|P1|Overall Study|Withdrawal by Subject|5
7689523|NCT01218100|26745254|P4|Overall Study|Protocol Violation|1
7689524|NCT01218100|26745255|P3|Overall Study|Protocol Violation|1
7689525|NCT01218100|26745256|P2|Overall Study|Protocol Violation|0
7689526|NCT01218100|26745257|P1|Overall Study|Protocol Violation|0
7689527|NCT01218100|26745254|P4|Overall Study|Lack of Efficacy|12
7689528|NCT01218100|26745255|P3|Overall Study|Lack of Efficacy|5
7689529|NCT01218100|26745256|P2|Overall Study|Lack of Efficacy|6
7689530|NCT01218100|26745257|P1|Overall Study|Lack of Efficacy|9
7689531|NCT01218100|26745254|P4|Overall Study|Adverse Event|7
7689532|NCT01218100|26745255|P3|Overall Study|Adverse Event|6
7689533|NCT01218100|26745256|P2|Overall Study|Adverse Event|6
7689534|NCT01218100|26745257|P1|Overall Study|Adverse Event|4
7689535|NCT01218100|26745254|P4|Overall Study|Did not meet InclusionExclusion criteria|2
7689536|NCT01218100|26745255|P3|Overall Study|Did not meet InclusionExclusion criteria|1
7689537|NCT01218100|26745256|P2|Overall Study|Did not meet InclusionExclusion criteria|1
7689538|NCT01218100|26745257|P1|Overall Study|Did not meet InclusionExclusion criteria|1
7689539|NCT01218087|26745273|P2|Overall Study|Transferred|5
7689540|NCT01218087|26745274|P1|Overall Study|Transferred|8
7689541|NCT01218087|26745273|P2|Overall Study|Withdrawal by Subject|0
7689542|NCT01218087|26745274|P1|Overall Study|Withdrawal by Subject|5
7689543|NCT01218087|26745273|P2|Overall Study|Death|1
7689544|NCT01218087|26745274|P1|Overall Study|Death|2
7689545|NCT01218009|26745296|P2|Overall Study|Sponsor terminated study|163
7689546|NCT01218009|26745297|P1|Overall Study|Sponsor terminated study|161
7689547|NCT01218009|26745296|P2|Overall Study|Withdrawal by Subject|1
7689548|NCT01218009|26745297|P1|Overall Study|Withdrawal by Subject|3
7689549|NCT01218009|26745296|P2|Overall Study|Protocol Violation|1
7689550|NCT01218009|26745297|P1|Overall Study|Protocol Violation|2
7689551|NCT01217957|26745320|P5|Phase 2|Withdrawal by Patient|1
7689552|NCT01217957|26745321|P4|Phase 2|Withdrawal by Patient|0
7689553|NCT01217957|26745322|P3|Phase 2|Withdrawal by Patient|0
7689554|NCT01217957|26745323|P2|Phase 2|Withdrawal by Patient|0
7689555|NCT01217957|26745324|P1|Phase 2|Withdrawal by Patient|0
7689556|NCT01217957|26745320|P5|Phase 1|Withdrawal by Patient|0
7689557|NCT01217957|26745321|P4|Phase 1|Withdrawal by Patient|1
7689558|NCT01217957|26745322|P3|Phase 1|Withdrawal by Patient|1
7689559|NCT01217957|26745323|P2|Phase 1|Withdrawal by Patient|0
7689560|NCT01217957|26745324|P1|Phase 1|Withdrawal by Patient|1
7689561|NCT01217944|26745383|P3|Overall Study|Lack of Efficacy|0
7689562|NCT01217944|26745384|P2|Overall Study|Lack of Efficacy|0
7689563|NCT01217944|26745385|P1|Overall Study|Lack of Efficacy|1
7689564|NCT01217944|26745383|P3|Overall Study|Withdrawal by Subject|0
7689565|NCT01217944|26745384|P2|Overall Study|Withdrawal by Subject|2
7689566|NCT01217944|26745385|P1|Overall Study|Withdrawal by Subject|1
7689567|NCT01217944|26745383|P3|Overall Study|Lost to Follow-up|0
7689568|NCT01217944|26745384|P2|Overall Study|Lost to Follow-up|1
7689569|NCT01217944|26745385|P1|Overall Study|Lost to Follow-up|3
7689570|NCT01217944|26745383|P3|Overall Study|Protocol Violation|0
7689571|NCT01217944|26745384|P2|Overall Study|Protocol Violation|1
7689572|NCT01217944|26745385|P1|Overall Study|Protocol Violation|1
7689573|NCT01217892|26745428|P4|Overall Study|Poor/Non-Compliance|0
7689574|NCT01217892|26745429|P3|Overall Study|Poor/Non-Compliance|1
7689575|NCT01217892|26745430|P2|Overall Study|Poor/Non-Compliance|0
7689576|NCT01217892|26745431|P1|Overall Study|Poor/Non-Compliance|0
7689577|NCT01217892|26745428|P4|Overall Study|Incorrect enrollment|0
7689578|NCT01217892|26745429|P3|Overall Study|Incorrect enrollment|1
7689579|NCT01217892|26745430|P2|Overall Study|Incorrect enrollment|1
7689580|NCT01217892|26745431|P1|Overall Study|Incorrect enrollment|0
7689581|NCT01217892|26745428|P4|Overall Study|Subject no longer meets study criteria|8
7689582|NCT01217892|26745429|P3|Overall Study|Subject no longer meets study criteria|4
7689583|NCT01217892|26745430|P2|Overall Study|Subject no longer meets study criteria|2
7689584|NCT01217892|26745431|P1|Overall Study|Subject no longer meets study criteria|5
7689585|NCT01217892|26745428|P4|Overall Study|Lab value|0
7689586|NCT01217892|26745429|P3|Overall Study|Lab value|1
7689587|NCT01217892|26745430|P2|Overall Study|Lab value|0
7689588|NCT01217892|26745431|P1|Overall Study|Lab value|1
7689589|NCT01217892|26745428|P4|Overall Study|Withdrawal by Subject|0
7689590|NCT01217892|26745429|P3|Overall Study|Withdrawal by Subject|1
7689591|NCT01217892|26745430|P2|Overall Study|Withdrawal by Subject|2
7689592|NCT01217892|26745431|P1|Overall Study|Withdrawal by Subject|0
7689593|NCT01217892|26745428|P4|Overall Study|Adverse Event|0
7689594|NCT01217892|26745429|P3|Overall Study|Adverse Event|1
7689595|NCT01217892|26745430|P2|Overall Study|Adverse Event|1
7689596|NCT01217892|26745431|P1|Overall Study|Adverse Event|1
7689597|NCT01217814|26745494|P3|Overall Study|Lack of Efficacy|1
7689598|NCT01217814|26745495|P2|Overall Study|Lack of Efficacy|0
7689599|NCT01217814|26745496|P1|Overall Study|Lack of Efficacy|0
7689600|NCT01217814|26745494|P3|Overall Study|Adverse Event|0
7689601|NCT01217814|26745495|P2|Overall Study|Adverse Event|1
7689602|NCT01217814|26745496|P1|Overall Study|Adverse Event|1
7689603|NCT01217801|26745522|P2|Period 1|Withdrawal by Subject|1
7689604|NCT01217801|26745523|P1|Period 1|Withdrawal by Subject|0
7689605|NCT01217801|26745522|P2|Period 1|Protocol Violation|1
7689606|NCT01217801|26745523|P1|Period 1|Protocol Violation|1
7689607|NCT01217606|26745552|P2|9-Month Masked Extension|Lack of Efficacy|0
7689608|NCT01217606|26745553|P1|9-Month Masked Extension|Lack of Efficacy|2
7689609|NCT01217606|26745552|P2|9-Month Masked Extension|Pregnancy|0
7689610|NCT01217606|26745553|P1|9-Month Masked Extension|Pregnancy|1
7689611|NCT01217606|26745552|P2|9-Month Masked Extension|Lost to Follow-up|0
7689612|NCT01217606|26745553|P1|9-Month Masked Extension|Lost to Follow-up|1
7689613|NCT01217606|26745552|P2|9-Month Masked Extension|Personal Reasons|1
7689614|NCT01217606|26745553|P1|9-Month Masked Extension|Personal Reasons|2
7689615|NCT01217606|26745552|P2|9-Month Masked Extension|Other Reasons|4
7689616|NCT01217606|26745553|P1|9-Month Masked Extension|Other Reasons|4
7689617|NCT01217606|26745552|P2|9-Month Masked Extension|Adverse Event|6
7689618|NCT01217606|26745553|P1|9-Month Masked Extension|Adverse Event|3
7689619|NCT01217606|26745552|P2|Initial Treatment Phase|Adverse Event|6
7689620|NCT01217606|26745553|P1|Initial Treatment Phase|Adverse Event|10
7689621|NCT01217606|26745552|P2|Initial Treatment Phase|Lack of Efficacy|0
7689622|NCT01217606|26745553|P1|Initial Treatment Phase|Lack of Efficacy|1
7689623|NCT01217606|26745552|P2|Initial Treatment Phase|Personal Reasons|2
7689625|NCT01217606|26745552|P2|Initial Treatment Phase|Protocol Violation|2
7689626|NCT01217606|26745553|P1|Initial Treatment Phase|Protocol Violation|3
7689627|NCT01217606|26745552|P2|Initial Treatment Phase|Other Reasons|2
7689628|NCT01217606|26745553|P1|Initial Treatment Phase|Other Reasons|0
7689629|NCT01217476|26745584|P2|Overall Study|Other|0
7689630|NCT01217476|26745585|P1|Overall Study|Other|2
7689631|NCT01217476|26745584|P2|Overall Study|Protocol Deviation|0
7689632|NCT01217476|26745585|P1|Overall Study|Protocol Deviation|1
7689633|NCT01217476|26745584|P2|Overall Study|Surgery on the Target Limb|2
7689634|NCT01217476|26745585|P1|Overall Study|Surgery on the Target Limb|0
7689635|NCT01217476|26745584|P2|Overall Study|Withdrawal by Subject|3
7689636|NCT01217476|26745585|P1|Overall Study|Withdrawal by Subject|3
7689637|NCT01217476|26745584|P2|Overall Study|Physician Decision|1
7689638|NCT01217476|26745585|P1|Overall Study|Physician Decision|0
7689639|NCT01217476|26745584|P2|Overall Study|Adverse Event|1
7689640|NCT01217476|26745585|P1|Overall Study|Adverse Event|6
7689641|NCT01217463|26745595|P2|Overall Study|Other|1
7689642|NCT01217463|26745596|P1|Overall Study|Other|1
7689643|NCT01217463|26745595|P2|Overall Study|Patient Non-compliant|0
7689644|NCT01217463|26745596|P1|Overall Study|Patient Non-compliant|1
7689645|NCT01217463|26745595|P2|Overall Study|Surgery on the Target Limb|1
7689646|NCT01217463|26745596|P1|Overall Study|Surgery on the Target Limb|0
7689647|NCT01217463|26745595|P2|Overall Study|Withdrawal by Subject|0
7689648|NCT01217463|26745596|P1|Overall Study|Withdrawal by Subject|3
7689649|NCT01217463|26745595|P2|Overall Study|Physician Decision|1
7689650|NCT01217463|26745596|P1|Overall Study|Physician Decision|0
7689651|NCT01217463|26745595|P2|Overall Study|Adverse Event|5
7689652|NCT01217463|26745596|P1|Overall Study|Adverse Event|8
7689653|NCT01217437|26745606|P2|Overall Study|Ineligible|1
7689654|NCT01217437|26745607|P1|Overall Study|Ineligible|1
7689655|NCT01217437|26745606|P2|Overall Study|Withdrawal by Subject|2
7689656|NCT01217437|26745607|P1|Overall Study|Withdrawal by Subject|0
7689657|NCT01217437|26745606|P2|Overall Study|Physician Decision|5
7689658|NCT01217437|26745607|P1|Overall Study|Physician Decision|8
7689659|NCT01217437|26745606|P2|Overall Study|Lack of Efficacy|25
7689660|NCT01217437|26745607|P1|Overall Study|Lack of Efficacy|29
7689661|NCT01217437|26745606|P2|Overall Study|Death|0
7689662|NCT01217437|26745607|P1|Overall Study|Death|5
7689663|NCT01217437|26745606|P2|Overall Study|Adverse Event|8
7689664|NCT01217437|26745607|P1|Overall Study|Adverse Event|0
7689665|NCT01217385|26745628|P1|Overall Study|Normal Breast TOI not available|10
7689666|NCT01217385|26745628|P1|Overall Study|Central Path not Available|1
7689667|NCT01217385|26745628|P1|Overall Study|DOSI not performed/not eval|12
7689668|NCT01217385|26745628|P1|Overall Study|Withdrawal by Subject|3
7689669|NCT01217307|26745640|P2|Overall Study|Withdrawal by Subject|1
7689670|NCT01217307|26745641|P1|Overall Study|Withdrawal by Subject|0
7689671|NCT01217229|26745647|P1|Overall Study|Disease progression not confirmed|2
7689672|NCT01217229|26745647|P1|Overall Study|Protocol Violation|1
7689673|NCT01217229|26745647|P1|Overall Study|Disease progression, Cheson criteria|14
7689674|NCT01217229|26745647|P1|Overall Study|Disease progression, deterioration|2
7689675|NCT01217229|26745647|P1|Overall Study|Adverse Event|1
7689676|NCT01217190|26745656|P2|Second Dosing|Withdrawal by Subject|2
7689677|NCT01217190|26745657|P1|Second Dosing|Withdrawal by Subject|0
7689678|NCT01217112|26745672|P5|Overall Study|Physician Decision|1
7689679|NCT01217112|26745673|P4|Overall Study|Physician Decision|0
7689680|NCT01217112|26745674|P3|Overall Study|Physician Decision|0
7689681|NCT01217112|26745675|P2|Overall Study|Physician Decision|0
7689682|NCT01217112|26745676|P1|Overall Study|Physician Decision|0
7689683|NCT01217112|26745672|P5|Overall Study|Withdrawal by Subject|0
7689684|NCT01217112|26745673|P4|Overall Study|Withdrawal by Subject|0
7689685|NCT01217112|26745674|P3|Overall Study|Withdrawal by Subject|1
7689686|NCT01217112|26745675|P2|Overall Study|Withdrawal by Subject|0
7689687|NCT01217112|26745676|P1|Overall Study|Withdrawal by Subject|0
7689688|NCT01217112|26745672|P5|Overall Study|Adverse Event|0
7689689|NCT01217112|26745673|P4|Overall Study|Adverse Event|2
7689690|NCT01217112|26745674|P3|Overall Study|Adverse Event|0
7689691|NCT01217112|26745675|P2|Overall Study|Adverse Event|2
7689692|NCT01217112|26745676|P1|Overall Study|Adverse Event|0
7689693|NCT01217073|26745909|P8|Extension Period|Withdrawal by Subject|8
7689694|NCT01217073|26745910|P7|Extension Period|Withdrawal by Subject|30
7689695|NCT01217073|26745911|P6|Extension Period|Withdrawal by Subject|0
7689696|NCT01217073|26745912|P5|Extension Period|Withdrawal by Subject|0
7689697|NCT01217073|26745913|P4|Extension Period|Withdrawal by Subject|0
7689698|NCT01217073|26745914|P3|Extension Period|Withdrawal by Subject|0
7689699|NCT01217073|26745915|P2|Extension Period|Withdrawal by Subject|0
7689700|NCT01217073|26745916|P1|Extension Period|Withdrawal by Subject|0
7689701|NCT01217073|26745909|P8|Extension Period|Site discontinued study participation|2
7689702|NCT01217073|26745910|P7|Extension Period|Site discontinued study participation|7
7689703|NCT01217073|26745911|P6|Extension Period|Site discontinued study participation|0
7689704|NCT01217073|26745912|P5|Extension Period|Site discontinued study participation|0
7689705|NCT01217073|26745913|P4|Extension Period|Site discontinued study participation|0
7689706|NCT01217073|26745914|P3|Extension Period|Site discontinued study participation|0
7689707|NCT01217073|26745915|P2|Extension Period|Site discontinued study participation|0
7689708|NCT01217073|26745916|P1|Extension Period|Site discontinued study participation|0
7689709|NCT01217073|26745909|P8|Extension Period|Protocol Violation|1
7689710|NCT01217073|26745910|P7|Extension Period|Protocol Violation|2
7689711|NCT01217073|26745911|P6|Extension Period|Protocol Violation|0
7689712|NCT01217073|26745912|P5|Extension Period|Protocol Violation|0
7689713|NCT01217073|26745913|P4|Extension Period|Protocol Violation|0
7689714|NCT01217073|26745914|P3|Extension Period|Protocol Violation|0
7689715|NCT01217073|26745915|P2|Extension Period|Protocol Violation|0
7689716|NCT01217073|26745916|P1|Extension Period|Protocol Violation|0
7689717|NCT01217073|26745909|P8|Extension Period|Physician Decision|1
7689718|NCT01217073|26745910|P7|Extension Period|Physician Decision|4
7689719|NCT01217073|26745911|P6|Extension Period|Physician Decision|0
7689720|NCT01217073|26745912|P5|Extension Period|Physician Decision|0
7689721|NCT01217073|26745913|P4|Extension Period|Physician Decision|0
7689722|NCT01217073|26745914|P3|Extension Period|Physician Decision|0
7689723|NCT01217073|26745915|P2|Extension Period|Physician Decision|0
7689724|NCT01217073|26745916|P1|Extension Period|Physician Decision|0
7689725|NCT01217073|26745909|P8|Extension Period|Non-compliance with study drug|1
7689726|NCT01217073|26745910|P7|Extension Period|Non-compliance with study drug|0
7689727|NCT01217073|26745911|P6|Extension Period|Non-compliance with study drug|0
7689728|NCT01217073|26745912|P5|Extension Period|Non-compliance with study drug|0
7689729|NCT01217073|26745913|P4|Extension Period|Non-compliance with study drug|0
7689730|NCT01217073|26745914|P3|Extension Period|Non-compliance with study drug|0
7689731|NCT01217073|26745915|P2|Extension Period|Non-compliance with study drug|0
7689732|NCT01217073|26745916|P1|Extension Period|Non-compliance with study drug|0
7689733|NCT01217073|26745909|P8|Extension Period|Lost to Follow-up|1
7689734|NCT01217073|26745910|P7|Extension Period|Lost to Follow-up|9
7689735|NCT01217073|26745911|P6|Extension Period|Lost to Follow-up|0
7689736|NCT01217073|26745912|P5|Extension Period|Lost to Follow-up|0
7689737|NCT01217073|26745913|P4|Extension Period|Lost to Follow-up|0
7689738|NCT01217073|26745914|P3|Extension Period|Lost to Follow-up|0
7689739|NCT01217073|26745915|P2|Extension Period|Lost to Follow-up|0
7689740|NCT01217073|26745916|P1|Extension Period|Lost to Follow-up|0
7689741|NCT01217073|26745909|P8|Extension Period|Lack of Efficacy|0
7689742|NCT01217073|26745910|P7|Extension Period|Lack of Efficacy|3
7689743|NCT01217073|26745911|P6|Extension Period|Lack of Efficacy|0
7689744|NCT01217073|26745912|P5|Extension Period|Lack of Efficacy|0
7689745|NCT01217073|26745913|P4|Extension Period|Lack of Efficacy|0
7689746|NCT01217073|26745914|P3|Extension Period|Lack of Efficacy|0
7689747|NCT01217073|26745915|P2|Extension Period|Lack of Efficacy|0
7689748|NCT01217073|26745916|P1|Extension Period|Lack of Efficacy|0
7689749|NCT01217073|26745909|P8|Extension Period|Excluded medication|0
7689750|NCT01217073|26745910|P7|Extension Period|Excluded medication|2
7689751|NCT01217073|26745911|P6|Extension Period|Excluded medication|0
7689752|NCT01217073|26745912|P5|Extension Period|Excluded medication|0
7689753|NCT01217073|26745913|P4|Extension Period|Excluded medication|0
7689754|NCT01217073|26745914|P3|Extension Period|Excluded medication|0
7689755|NCT01217073|26745915|P2|Extension Period|Excluded medication|0
7689756|NCT01217073|26745916|P1|Extension Period|Excluded medication|0
7689757|NCT01217073|26745909|P8|Extension Period|Death|0
7689758|NCT01217073|26745910|P7|Extension Period|Death|1
7689759|NCT01217073|26745911|P6|Extension Period|Death|0
7689760|NCT01217073|26745912|P5|Extension Period|Death|0
7689761|NCT01217073|26745913|P4|Extension Period|Death|0
7689762|NCT01217073|26745914|P3|Extension Period|Death|0
7689763|NCT01217073|26745915|P2|Extension Period|Death|0
7689764|NCT01217073|26745916|P1|Extension Period|Death|0
7689765|NCT01217073|26745909|P8|Extension Period|Creatinine/eGFR|1
7689766|NCT01217073|26745910|P7|Extension Period|Creatinine/eGFR|11
7689767|NCT01217073|26745911|P6|Extension Period|Creatinine/eGFR|0
7689768|NCT01217073|26745912|P5|Extension Period|Creatinine/eGFR|0
7689769|NCT01217073|26745913|P4|Extension Period|Creatinine/eGFR|0
7689770|NCT01217073|26745914|P3|Extension Period|Creatinine/eGFR|0
7689771|NCT01217073|26745915|P2|Extension Period|Creatinine/eGFR|0
7689772|NCT01217073|26745916|P1|Extension Period|Creatinine/eGFR|0
7689773|NCT01217073|26745909|P8|Extension Period|Contraindication to study medication|0
7689774|NCT01217073|26745910|P7|Extension Period|Contraindication to study medication|1
7689775|NCT01217073|26745911|P6|Extension Period|Contraindication to study medication|0
7689776|NCT01217073|26745912|P5|Extension Period|Contraindication to study medication|0
7689777|NCT01217073|26745913|P4|Extension Period|Contraindication to study medication|0
7689778|NCT01217073|26745914|P3|Extension Period|Contraindication to study medication|0
7689779|NCT01217073|26745915|P2|Extension Period|Contraindication to study medication|0
7689780|NCT01217073|26745916|P1|Extension Period|Contraindication to study medication|0
7689781|NCT01217073|26745909|P8|Extension Period|ALT/AST|0
7689782|NCT01217073|26745910|P7|Extension Period|ALT/AST|2
7689783|NCT01217073|26745911|P6|Extension Period|ALT/AST|0
7689784|NCT01217073|26745912|P5|Extension Period|ALT/AST|0
7689785|NCT01217073|26745913|P4|Extension Period|ALT/AST|0
7689786|NCT01217073|26745914|P3|Extension Period|ALT/AST|0
7689787|NCT01217073|26745915|P2|Extension Period|ALT/AST|0
7689788|NCT01217073|26745916|P1|Extension Period|ALT/AST|0
7689789|NCT01217073|26745909|P8|Extension Period|Adverse Event|5
7689790|NCT01217073|26745910|P7|Extension Period|Adverse Event|19
7689791|NCT01217073|26745911|P6|Extension Period|Adverse Event|0
7689792|NCT01217073|26745912|P5|Extension Period|Adverse Event|0
7689793|NCT01217073|26745913|P4|Extension Period|Adverse Event|0
7689794|NCT01217073|26745914|P3|Extension Period|Adverse Event|0
7689795|NCT01217073|26745915|P2|Extension Period|Adverse Event|0
7689796|NCT01217073|26745916|P1|Extension Period|Adverse Event|0
7689797|NCT01217073|26745909|P8|Base Period|Withdrawal by Subject|0
7689798|NCT01217073|26745910|P7|Base Period|Withdrawal by Subject|0
7689799|NCT01217073|26745911|P6|Base Period|Withdrawal by Subject|5
7689800|NCT01217073|26745912|P5|Base Period|Withdrawal by Subject|5
7689801|NCT01217073|26745913|P4|Base Period|Withdrawal by Subject|1
7689802|NCT01217073|26745914|P3|Base Period|Withdrawal by Subject|5
7689803|NCT01217073|26745915|P2|Base Period|Withdrawal by Subject|5
7689804|NCT01217073|26745916|P1|Base Period|Withdrawal by Subject|4
7689805|NCT01217073|26745909|P8|Base Period|Protocol Violation|0
7689806|NCT01217073|26745910|P7|Base Period|Protocol Violation|0
7689807|NCT01217073|26745911|P6|Base Period|Protocol Violation|2
7689808|NCT01217073|26745912|P5|Base Period|Protocol Violation|1
7689809|NCT01217073|26745913|P4|Base Period|Protocol Violation|0
7689810|NCT01217073|26745914|P3|Base Period|Protocol Violation|0
7689811|NCT01217073|26745915|P2|Base Period|Protocol Violation|0
7689812|NCT01217073|26745916|P1|Base Period|Protocol Violation|1
7689813|NCT01217073|26745909|P8|Base Period|Physician Decision|0
7689814|NCT01217073|26745910|P7|Base Period|Physician Decision|0
7689815|NCT01217073|26745911|P6|Base Period|Physician Decision|0
7689816|NCT01217073|26745912|P5|Base Period|Physician Decision|1
7689817|NCT01217073|26745913|P4|Base Period|Physician Decision|0
7689818|NCT01217073|26745914|P3|Base Period|Physician Decision|0
7689819|NCT01217073|26745915|P2|Base Period|Physician Decision|0
7689820|NCT01217073|26745916|P1|Base Period|Physician Decision|0
7689821|NCT01217073|26745909|P8|Base Period|Lost to Follow-up|0
7689822|NCT01217073|26745910|P7|Base Period|Lost to Follow-up|0
7689823|NCT01217073|26745911|P6|Base Period|Lost to Follow-up|0
7689824|NCT01217073|26745912|P5|Base Period|Lost to Follow-up|3
7689825|NCT01217073|26745913|P4|Base Period|Lost to Follow-up|1
7689826|NCT01217073|26745914|P3|Base Period|Lost to Follow-up|1
7689827|NCT01217073|26745915|P2|Base Period|Lost to Follow-up|0
7689828|NCT01217073|26745916|P1|Base Period|Lost to Follow-up|0
7689829|NCT01217073|26745909|P8|Base Period|Lack of Efficacy|0
7689830|NCT01217073|26745910|P7|Base Period|Lack of Efficacy|0
7689831|NCT01217073|26745911|P6|Base Period|Lack of Efficacy|1
7689832|NCT01217073|26745912|P5|Base Period|Lack of Efficacy|0
7689833|NCT01217073|26745913|P4|Base Period|Lack of Efficacy|0
7689834|NCT01217073|26745914|P3|Base Period|Lack of Efficacy|0
7689835|NCT01217073|26745915|P2|Base Period|Lack of Efficacy|0
7689836|NCT01217073|26745916|P1|Base Period|Lack of Efficacy|0
7689837|NCT01217073|26745909|P8|Base Period|Excluded medication|0
7689838|NCT01217073|26745910|P7|Base Period|Excluded medication|0
7689839|NCT01217073|26745911|P6|Base Period|Excluded medication|0
7689840|NCT01217073|26745912|P5|Base Period|Excluded medication|1
7689841|NCT01217073|26745913|P4|Base Period|Excluded medication|0
7689842|NCT01217073|26745914|P3|Base Period|Excluded medication|0
7689843|NCT01217073|26745915|P2|Base Period|Excluded medication|0
7689844|NCT01217073|26745916|P1|Base Period|Excluded medication|0
7689845|NCT01217073|26745909|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
7689846|NCT01217073|26745910|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
7689847|NCT01217073|26745911|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
7689848|NCT01217073|26745912|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
7689849|NCT01217073|26745913|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
7689850|NCT01217073|26745914|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
7689851|NCT01217073|26745915|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
7689852|NCT01217073|26745916|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
7689853|NCT01217073|26745909|P8|Base Period|Adverse Event|0
7689854|NCT01217073|26745910|P7|Base Period|Adverse Event|0
7689855|NCT01217073|26745911|P6|Base Period|Adverse Event|1
7689856|NCT01217073|26745912|P5|Base Period|Adverse Event|4
7689857|NCT01217073|26745913|P4|Base Period|Adverse Event|0
7689858|NCT01217073|26745914|P3|Base Period|Adverse Event|1
7689859|NCT01217073|26745915|P2|Base Period|Adverse Event|0
7689860|NCT01217073|26745916|P1|Base Period|Adverse Event|1
7689861|NCT01217060|26745984|P1|Overall Study|Withdrawal by Subject|1
7689862|NCT01217047|26745993|P3|Overall Study|Lost to Follow-up|0
7689863|NCT01217047|26745994|P2|Overall Study|Lost to Follow-up|1
7689864|NCT01217047|26745995|P1|Overall Study|Lost to Follow-up|0
7689865|NCT01216683|26746069|P3|Continuation|Never started treatment|5
7689866|NCT01216683|26746070|P2|Continuation|Never started treatment|1
7689867|NCT01216683|26746071|P1|Continuation|Never started treatment|0
7689868|NCT01216683|26746069|P3|Continuation|Not reported|1
7689869|NCT01216683|26746070|P2|Continuation|Not reported|0
7689870|NCT01216683|26746071|P1|Continuation|Not reported|0
7689871|NCT01216683|26746069|P3|Continuation|Mistakenly stayed on treatment for longer than expected|0
7689872|NCT01216683|26746070|P2|Continuation|Mistakenly stayed on treatment for longer than expected|1
7689873|NCT01216683|26746071|P1|Continuation|Mistakenly stayed on treatment for longer than expected|0
7689874|NCT01216683|26746069|P3|Continuation|Insurance change|0
7689875|NCT01216683|26746070|P2|Continuation|Insurance change|1
7689876|NCT01216683|26746071|P1|Continuation|Insurance change|0
7689877|NCT01216683|26746069|P3|Continuation|Non-compliance|1
7689878|NCT01216683|26746070|P2|Continuation|Non-compliance|0
7689879|NCT01216683|26746071|P1|Continuation|Non-compliance|1
7689880|NCT01216683|26746069|P3|Continuation|Physician Decision|1
7689881|NCT01216683|26746070|P2|Continuation|Physician Decision|0
7689882|NCT01216683|26746071|P1|Continuation|Physician Decision|1
7689883|NCT01216683|26746069|P3|Continuation|Other diseases|1
7689884|NCT01216683|26746070|P2|Continuation|Other diseases|2
7689885|NCT01216683|26746071|P1|Continuation|Other diseases|0
7689886|NCT01216683|26746069|P3|Continuation|Withdrawal by Subject|9
7689887|NCT01216683|26746070|P2|Continuation|Withdrawal by Subject|5
7689888|NCT01216683|26746071|P1|Continuation|Withdrawal by Subject|4
7689889|NCT01216683|26746069|P3|Continuation|Death|2
7689890|NCT01216683|26746070|P2|Continuation|Death|0
7689891|NCT01216683|26746071|P1|Continuation|Death|1
7689892|NCT01216683|26746069|P3|Continuation|Adverse Event|16
7689893|NCT01216683|26746070|P2|Continuation|Adverse Event|3
7689894|NCT01216683|26746071|P1|Continuation|Adverse Event|5
7689895|NCT01216683|26746069|P3|Continuation|Lack of Efficacy|7
7689896|NCT01216683|26746070|P2|Continuation|Lack of Efficacy|2
7689897|NCT01216683|26746071|P1|Continuation|Lack of Efficacy|3
7689898|NCT01216683|26746069|P3|Induction|Other disease|2
7689899|NCT01216683|26746070|P2|Induction|Other disease|1
7689900|NCT01216683|26746071|P1|Induction|Other disease|0
7689901|NCT01216683|26746069|P3|Induction|Withdrawal by Subject|2
7689902|NCT01216683|26746070|P2|Induction|Withdrawal by Subject|4
7689903|NCT01216683|26746071|P1|Induction|Withdrawal by Subject|0
7689904|NCT01216683|26746069|P3|Induction|Death|2
7689905|NCT01216683|26746070|P2|Induction|Death|0
7689906|NCT01216683|26746071|P1|Induction|Death|0
7689907|NCT01216683|26746069|P3|Induction|Adverse Event|5
7689908|NCT01216683|26746070|P2|Induction|Adverse Event|5
7689909|NCT01216683|26746071|P1|Induction|Adverse Event|0
7689910|NCT01216683|26746069|P3|Induction|Lack of Efficacy|7
7689911|NCT01216683|26746070|P2|Induction|Lack of Efficacy|3
7689912|NCT01216683|26746071|P1|Induction|Lack of Efficacy|4
7689913|NCT01216683|26746069|P3|Induction|Never started treatment|3
7689914|NCT01216683|26746070|P2|Induction|Never started treatment|6
7689915|NCT01216683|26746071|P1|Induction|Never started treatment|0
7689916|NCT01216332|26746236|P2|Overall Study|Withdrawal by Subject|0
7689917|NCT01216332|26746237|P1|Overall Study|Withdrawal by Subject|4
7689918|NCT01216319|26746255|P1|Overall Study|Unanticipated chemo for breast cancer|2
7689919|NCT01216319|26746255|P1|Overall Study|Lost to Follow-up|2
7689920|NCT01216202|26746271|P2|Overall Study|Lost to Follow-up|0
7689921|NCT01216202|26746272|P1|Overall Study|Lost to Follow-up|14
7689922|NCT01216202|26746271|P2|Overall Study|Death|2
7689923|NCT01216202|26746272|P1|Overall Study|Death|0
7689924|NCT01216202|26746271|P2|Overall Study|Withdrawal by Subject|0
7689925|NCT01216202|26746272|P1|Overall Study|Withdrawal by Subject|8
7689926|NCT01216189|26746282|P2|Overall Study|Death|2
7689927|NCT01216189|26746283|P1|Overall Study|Death|4
7689928|NCT01216189|26746282|P2|Overall Study|Lost to Follow-up|3
7689929|NCT01216189|26746283|P1|Overall Study|Lost to Follow-up|21
7689930|NCT01216176|26746294|P3|Overall Study|Physician Decision|1
7689931|NCT01216176|26746295|P2|Overall Study|Physician Decision|0
7689932|NCT01216176|26746296|P1|Overall Study|Physician Decision|0
7689933|NCT01216176|26746294|P3|Overall Study|Adverse Event|0
7689934|NCT01216176|26746295|P2|Overall Study|Adverse Event|8
7689935|NCT01216176|26746296|P1|Overall Study|Adverse Event|0
7689936|NCT01216163|26746319|P3|Overall Study|Withdrawal by Subject|0
7689937|NCT01216163|26746320|P2|Overall Study|Withdrawal by Subject|1
7689938|NCT01216163|26746321|P1|Overall Study|Withdrawal by Subject|1
7689939|NCT01216072|26746373|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
7689940|NCT01216072|26746374|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
7689941|NCT01216072|26746373|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
7689942|NCT01216072|26746374|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
7689943|NCT01216072|26746373|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
7689944|NCT01216072|26746374|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
7689945|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
7689946|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
7689947|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
7689948|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
7689949|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
7689950|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
7689951|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
7689952|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
7689953|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
7689954|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
7689955|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
7689956|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
7689957|NCT01216072|26746373|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
7689958|NCT01216072|26746374|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
7689959|NCT01215981|26746402|P2|Overall Study|Withdrawal by Subject|0
7689960|NCT01215981|26746403|P1|Overall Study|Withdrawal by Subject|1
7689961|NCT01215981|26746402|P2|Overall Study|Protocol Violation|0
7689962|NCT01215981|26746403|P1|Overall Study|Protocol Violation|1
7689963|NCT01215981|26746402|P2|Overall Study|Physician Decision|1
7689964|NCT01215981|26746403|P1|Overall Study|Physician Decision|0
7689965|NCT01215968|26746413|P2|Overall Study|Not received study drug|1
7689966|NCT01215968|26746414|P1|Overall Study|Not received study drug|0
7689967|NCT01215968|26746413|P2|Overall Study|Protocol Violation|4
7689968|NCT01215968|26746414|P1|Overall Study|Protocol Violation|2
7689969|NCT01215968|26746413|P2|Overall Study|Adverse Event|2
7689970|NCT01215968|26746414|P1|Overall Study|Adverse Event|0
7689971|NCT01215955|26746434|P4|Overall Study|Quality Issues|2
7689972|NCT01215955|26746435|P3|Overall Study|Quality Issues|3
7689973|NCT01215955|26746436|P2|Overall Study|Quality Issues|0
7689974|NCT01215955|26746437|P1|Overall Study|Quality Issues|0
7689975|NCT01215955|26746434|P4|Overall Study|Withdrawal by Subject|9
7689976|NCT01215955|26746435|P3|Overall Study|Withdrawal by Subject|13
7689977|NCT01215955|26746436|P2|Overall Study|Withdrawal by Subject|15
7689978|NCT01215955|26746437|P1|Overall Study|Withdrawal by Subject|14
7689979|NCT01215955|26746434|P4|Overall Study|Sponsor Decision|1
7689980|NCT01215955|26746435|P3|Overall Study|Sponsor Decision|0
7689981|NCT01215955|26746436|P2|Overall Study|Sponsor Decision|2
7689982|NCT01215955|26746437|P1|Overall Study|Sponsor Decision|1
7689983|NCT01215955|26746434|P4|Overall Study|Protocol Violation|8
7689984|NCT01215955|26746435|P3|Overall Study|Protocol Violation|8
7689985|NCT01215955|26746436|P2|Overall Study|Protocol Violation|13
7689986|NCT01215955|26746437|P1|Overall Study|Protocol Violation|17
7689987|NCT01215955|26746434|P4|Overall Study|Physician Decision|11
7689988|NCT01215955|26746435|P3|Overall Study|Physician Decision|8
7689989|NCT01215955|26746436|P2|Overall Study|Physician Decision|10
7689990|NCT01215955|26746437|P1|Overall Study|Physician Decision|4
7689991|NCT01215955|26746434|P4|Overall Study|Lost to Follow-up|9
7689992|NCT01215955|26746435|P3|Overall Study|Lost to Follow-up|8
7689993|NCT01215955|26746436|P2|Overall Study|Lost to Follow-up|4
7689994|NCT01215955|26746437|P1|Overall Study|Lost to Follow-up|4
7689995|NCT01215955|26746434|P4|Overall Study|Lack of Efficacy|0
7689996|NCT01215955|26746435|P3|Overall Study|Lack of Efficacy|1
7689997|NCT01215955|26746436|P2|Overall Study|Lack of Efficacy|2
7689998|NCT01215955|26746437|P1|Overall Study|Lack of Efficacy|1
7689999|NCT01215955|26746434|P4|Overall Study|Entry Criteria Not Met|7
7690000|NCT01215955|26746435|P3|Overall Study|Entry Criteria Not Met|4
7690001|NCT01215955|26746436|P2|Overall Study|Entry Criteria Not Met|3
7690002|NCT01215955|26746437|P1|Overall Study|Entry Criteria Not Met|1
7690003|NCT01215955|26746434|P4|Overall Study|Death|3
7690004|NCT01215955|26746435|P3|Overall Study|Death|1
7690005|NCT01215955|26746436|P2|Overall Study|Death|0
7690006|NCT01215955|26746437|P1|Overall Study|Death|2
7690007|NCT01215955|26746434|P4|Overall Study|Adverse Event|3
7690008|NCT01215955|26746435|P3|Overall Study|Adverse Event|2
7690009|NCT01215955|26746436|P2|Overall Study|Adverse Event|4
7690010|NCT01215955|26746437|P1|Overall Study|Adverse Event|1
7690011|NCT01215942|26746505|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
7690012|NCT01215942|26746506|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
7690013|NCT01215942|26746505|P2|Post-Treatment Follow-Up Period|Physician Decision|2
7690014|NCT01215942|26746506|P1|Post-Treatment Follow-Up Period|Physician Decision|1
7690015|NCT01215942|26746505|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
7690016|NCT01215942|26746506|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
7690017|NCT01215942|26746505|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7690018|NCT01215942|26746506|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7690019|NCT01215942|26746505|P2|Post-Treatment Follow-Up Period|Death|1
7690020|NCT01215942|26746506|P1|Post-Treatment Follow-Up Period|Death|0
7690021|NCT01215942|26746505|P2|Treatment Period|Sponsor Decision|530
7690022|NCT01215942|26746506|P1|Treatment Period|Sponsor Decision|349
7690023|NCT01215942|26746505|P2|Treatment Period|Protocol Violation|1
7690024|NCT01215942|26746506|P1|Treatment Period|Protocol Violation|0
7690025|NCT01215942|26746505|P2|Treatment Period|Physician Decision|5
7690026|NCT01215942|26746506|P1|Treatment Period|Physician Decision|5
7690027|NCT01215942|26746505|P2|Treatment Period|Withdrawal by Subject|40
7690028|NCT01215942|26746506|P1|Treatment Period|Withdrawal by Subject|17
7690029|NCT01215942|26746505|P2|Treatment Period|Lost to Follow-up|4
7690030|NCT01215942|26746506|P1|Treatment Period|Lost to Follow-up|3
7690031|NCT01215942|26746505|P2|Treatment Period|Lack of Efficacy|62
7690032|NCT01215942|26746506|P1|Treatment Period|Lack of Efficacy|23
7690033|NCT01215942|26746505|P2|Treatment Period|Death|4
7690034|NCT01215942|26746506|P1|Treatment Period|Death|2
7690035|NCT01215942|26746505|P2|Treatment Period|Adverse Event|26
7690036|NCT01215942|26746506|P1|Treatment Period|Adverse Event|15
7690037|NCT01215916|26746639|P9|Overall Study|Physician Decision|0
7690038|NCT01215916|26746640|P8|Overall Study|Physician Decision|0
7690039|NCT01215916|26746641|P7|Overall Study|Physician Decision|0
7690040|NCT01215916|26746642|P6|Overall Study|Physician Decision|0
7690041|NCT01215916|26746643|P5|Overall Study|Physician Decision|0
7690042|NCT01215916|26746644|P4|Overall Study|Physician Decision|1
7690043|NCT01215916|26746645|P3|Overall Study|Physician Decision|1
7690044|NCT01215916|26746646|P2|Overall Study|Physician Decision|0
7690045|NCT01215916|26746647|P1|Overall Study|Physician Decision|0
7690046|NCT01215916|26746639|P9|Overall Study|Death|1
7690047|NCT01215916|26746640|P8|Overall Study|Death|0
7690048|NCT01215916|26746641|P7|Overall Study|Death|0
7690049|NCT01215916|26746642|P6|Overall Study|Death|0
7690050|NCT01215916|26746643|P5|Overall Study|Death|1
7690051|NCT01215916|26746644|P4|Overall Study|Death|0
7690052|NCT01215916|26746645|P3|Overall Study|Death|0
7690053|NCT01215916|26746646|P2|Overall Study|Death|1
7690054|NCT01215916|26746647|P1|Overall Study|Death|0
7690055|NCT01215916|26746639|P9|Overall Study|Withdrawal by Subject|0
7690056|NCT01215916|26746640|P8|Overall Study|Withdrawal by Subject|0
7690057|NCT01215916|26746641|P7|Overall Study|Withdrawal by Subject|1
7690058|NCT01215916|26746642|P6|Overall Study|Withdrawal by Subject|0
7690059|NCT01215916|26746643|P5|Overall Study|Withdrawal by Subject|0
7690060|NCT01215916|26746644|P4|Overall Study|Withdrawal by Subject|2
7690061|NCT01215916|26746645|P3|Overall Study|Withdrawal by Subject|1
7690062|NCT01215916|26746646|P2|Overall Study|Withdrawal by Subject|1
7690063|NCT01215916|26746647|P1|Overall Study|Withdrawal by Subject|0
7690064|NCT01215916|26746639|P9|Overall Study|Adverse Event|0
7690065|NCT01215916|26746640|P8|Overall Study|Adverse Event|0
7690066|NCT01215916|26746641|P7|Overall Study|Adverse Event|3
7690067|NCT01215916|26746642|P6|Overall Study|Adverse Event|0
7690068|NCT01215916|26746643|P5|Overall Study|Adverse Event|0
7690069|NCT01215916|26746644|P4|Overall Study|Adverse Event|1
7690070|NCT01215916|26746645|P3|Overall Study|Adverse Event|0
7690071|NCT01215916|26746646|P2|Overall Study|Adverse Event|1
7690072|NCT01215916|26746647|P1|Overall Study|Adverse Event|1
7690073|NCT01215916|26746639|P9|Overall Study|Progressive Disease|1
7690074|NCT01215916|26746640|P8|Overall Study|Progressive Disease|3
7690075|NCT01215916|26746641|P7|Overall Study|Progressive Disease|5
7690076|NCT01215916|26746642|P6|Overall Study|Progressive Disease|4
7690077|NCT01215916|26746643|P5|Overall Study|Progressive Disease|5
7690078|NCT01215916|26746644|P4|Overall Study|Progressive Disease|2
7690079|NCT01215916|26746645|P3|Overall Study|Progressive Disease|1
7690080|NCT01215916|26746646|P2|Overall Study|Progressive Disease|2
7690081|NCT01215916|26746647|P1|Overall Study|Progressive Disease|0
7690082|NCT01215851|26746681|P6|Follow up Period|Lost to Follow-up|1
7690083|NCT01215851|26746682|P5|Follow up Period|Lost to Follow-up|0
7690084|NCT01215851|26746683|P4|Follow up Period|Lost to Follow-up|0
7690085|NCT01215851|26746684|P3|Follow up Period|Lost to Follow-up|0
7690086|NCT01215851|26746685|P2|Follow up Period|Lost to Follow-up|0
7690087|NCT01215851|26746686|P1|Follow up Period|Lost to Follow-up|0
7690088|NCT01215851|26746681|P6|Treatment Period|Adverse Event|1
7690089|NCT01215851|26746682|P5|Treatment Period|Adverse Event|0
7690090|NCT01215851|26746683|P4|Treatment Period|Adverse Event|3
7690091|NCT01215851|26746684|P3|Treatment Period|Adverse Event|1
7690092|NCT01215851|26746685|P2|Treatment Period|Adverse Event|1
7690093|NCT01215851|26746686|P1|Treatment Period|Adverse Event|1
7690094|NCT01215734|26746745|P2|Overall Study|Death|1
7690095|NCT01215734|26746746|P1|Overall Study|Death|0
7690096|NCT01215721|26746754|P1|Overall Study|Adverse Event|2
7690097|NCT01215513|26746886|P1|Overall Study|Miscellaneous reasons (CS42A)|2
7690098|NCT01215513|26746886|P1|Overall Study|Withdrawal by subject (CS42A)|5
7690099|NCT01215513|26746886|P1|Overall Study|Physician decision (CS42A)|6
7690100|NCT01215513|26746886|P1|Overall Study|Adverse event (CS42A)|2
7690101|NCT01215513|26746886|P1|Overall Study|Not enrolled from CS42 to CS42A|21
7690102|NCT01215513|26746886|P1|Overall Study|Not completed CS42|9
7690103|NCT01215435|26746895|P2|Overall Study|Unclassified|5
7690104|NCT01215435|26746896|P1|Overall Study|Unclassified|5
7690105|NCT01215435|26746895|P2|Overall Study|Lost to Follow-up|0
7690106|NCT01215435|26746896|P1|Overall Study|Lost to Follow-up|3
7690107|NCT01215435|26746895|P2|Overall Study|Withdrawal Criteria|11
7690108|NCT01215435|26746896|P1|Overall Study|Withdrawal Criteria|8
7690109|NCT01215435|26746895|P2|Overall Study|Protocol Violation|0
7690110|NCT01215435|26746896|P1|Overall Study|Protocol Violation|2
7690111|NCT01215435|26746895|P2|Overall Study|Adverse Event|0
7690112|NCT01215435|26746896|P1|Overall Study|Adverse Event|1
7690113|NCT01215422|26746910|P4|Overall Study|Did not complete all intubations|0
7690114|NCT01215422|26746911|P3|Overall Study|Did not complete all intubations|0
7690115|NCT01215422|26746912|P2|Overall Study|Did not complete all intubations|0
7690116|NCT01215422|26746913|P1|Overall Study|Did not complete all intubations|7
7690117|NCT01215422|26746910|P4|Overall Study|Failed intubations|8
7690118|NCT01215422|26746911|P3|Overall Study|Failed intubations|3
7690119|NCT01215422|26746912|P2|Overall Study|Failed intubations|0
7690120|NCT01215422|26746913|P1|Overall Study|Failed intubations|0
7690121|NCT01215422|26746910|P4|Overall Study|Relocation|0
7690122|NCT01215422|26746911|P3|Overall Study|Relocation|0
7690123|NCT01215422|26746912|P2|Overall Study|Relocation|0
7690124|NCT01215422|26746913|P1|Overall Study|Relocation|1
7690125|NCT01215357|26746935|P1|Overall Study|Protocol Violation|9
7690126|NCT01215357|26746935|P1|Overall Study|Withdrawal by Subject|3
7690127|NCT01215253|26747061|P2|Overall Study|Other|12
7690128|NCT01215253|26747062|P1|Overall Study|Other|14
7690129|NCT01215253|26747061|P2|Overall Study|Lost to Follow-up|4
7690130|NCT01215253|26747062|P1|Overall Study|Lost to Follow-up|6
7690131|NCT01215253|26747061|P2|Overall Study|Physician Decision|12
7690132|NCT01215253|26747062|P1|Overall Study|Physician Decision|9
7690133|NCT01215253|26747061|P2|Overall Study|Withdrawal by Subject|35
7690134|NCT01215253|26747062|P1|Overall Study|Withdrawal by Subject|57
7690135|NCT01215227|26747115|P6|Overall Study|Randomized but not treated|1
7690136|NCT01215227|26747116|P5|Overall Study|Randomized but not treated|0
7690137|NCT01215227|26747117|P4|Overall Study|Randomized but not treated|1
7690138|NCT01215227|26747118|P3|Overall Study|Randomized but not treated|1
7690139|NCT01215227|26747119|P2|Overall Study|Randomized but not treated|0
7690140|NCT01215227|26747120|P1|Overall Study|Randomized but not treated|0
7690141|NCT01215227|26747115|P6|Overall Study|Missing Status|0
7690142|NCT01215227|26747116|P5|Overall Study|Missing Status|0
7690143|NCT01215227|26747117|P4|Overall Study|Missing Status|0
7690144|NCT01215227|26747118|P3|Overall Study|Missing Status|0
7690145|NCT01215227|26747119|P2|Overall Study|Missing Status|1
7690146|NCT01215227|26747120|P1|Overall Study|Missing Status|0
7690147|NCT01215227|26747115|P6|Overall Study|Administrative|40
7690148|NCT01215227|26747116|P5|Overall Study|Administrative|28
7690149|NCT01215227|26747117|P4|Overall Study|Administrative|24
7690150|NCT01215227|26747118|P3|Overall Study|Administrative|42
7690151|NCT01215227|26747119|P2|Overall Study|Administrative|73
7690152|NCT01215227|26747120|P1|Overall Study|Administrative|83
7690153|NCT01215227|26747115|P6|Overall Study|Non-Compliance With Protocol|0
7690154|NCT01215227|26747116|P5|Overall Study|Non-Compliance With Protocol|0
7690155|NCT01215227|26747117|P4|Overall Study|Non-Compliance With Protocol|0
7690156|NCT01215227|26747118|P3|Overall Study|Non-Compliance With Protocol|1
7690157|NCT01215227|26747119|P2|Overall Study|Non-Compliance With Protocol|6
7690158|NCT01215227|26747120|P1|Overall Study|Non-Compliance With Protocol|2
7690159|NCT01215227|26747115|P6|Overall Study|Subject Withdrew Consent|8
7690160|NCT01215227|26747116|P5|Overall Study|Subject Withdrew Consent|11
7690161|NCT01215227|26747117|P4|Overall Study|Subject Withdrew Consent|10
7690162|NCT01215227|26747118|P3|Overall Study|Subject Withdrew Consent|7
7690163|NCT01215227|26747119|P2|Overall Study|Subject Withdrew Consent|20
7690164|NCT01215227|26747120|P1|Overall Study|Subject Withdrew Consent|16
7690165|NCT01215227|26747115|P6|Overall Study|Lost to Follow-up|2
7690166|NCT01215227|26747116|P5|Overall Study|Lost to Follow-up|1
7690167|NCT01215227|26747117|P4|Overall Study|Lost to Follow-up|1
7690168|NCT01215227|26747118|P3|Overall Study|Lost to Follow-up|1
7690169|NCT01215227|26747119|P2|Overall Study|Lost to Follow-up|4
7690170|NCT01215227|26747120|P1|Overall Study|Lost to Follow-up|1
7690171|NCT01215227|26747115|P6|Overall Study|Treatment Failure|1
7690172|NCT01215227|26747116|P5|Overall Study|Treatment Failure|1
7690173|NCT01215227|26747117|P4|Overall Study|Treatment Failure|5
7690174|NCT01215227|26747118|P3|Overall Study|Treatment Failure|1
7690175|NCT01215227|26747119|P2|Overall Study|Treatment Failure|4
7690176|NCT01215227|26747120|P1|Overall Study|Treatment Failure|8
7690177|NCT01215227|26747115|P6|Overall Study|Adverse Event|6
7690178|NCT01215227|26747116|P5|Overall Study|Adverse Event|7
7690179|NCT01215227|26747117|P4|Overall Study|Adverse Event|8
7690180|NCT01215227|26747118|P3|Overall Study|Adverse Event|4
7690181|NCT01215227|26747119|P2|Overall Study|Adverse Event|11
7690182|NCT01215227|26747120|P1|Overall Study|Adverse Event|11
7690183|NCT01215188|26747167|P3|Overall Study|Withdrawal by Subject|31
7690184|NCT01215188|26747168|P2|Overall Study|Withdrawal by Subject|34
7690185|NCT01215188|26747169|P1|Overall Study|Withdrawal by Subject|32
7690186|NCT01215188|26747167|P3|Overall Study|Protocol Violation|1
7690187|NCT01215188|26747168|P2|Overall Study|Protocol Violation|1
7690188|NCT01215188|26747169|P1|Overall Study|Protocol Violation|1
7690189|NCT01215188|26747167|P3|Overall Study|Lack of Efficacy|1
7690190|NCT01215188|26747168|P2|Overall Study|Lack of Efficacy|0
7690191|NCT01215188|26747169|P1|Overall Study|Lack of Efficacy|0
7690192|NCT01215188|26747167|P3|Overall Study|Physician Decision|0
7690193|NCT01215188|26747168|P2|Overall Study|Physician Decision|1
7690194|NCT01215188|26747169|P1|Overall Study|Physician Decision|2
7690195|NCT01215188|26747167|P3|Overall Study|Adverse Event|3
7690196|NCT01215188|26747168|P2|Overall Study|Adverse Event|1
7690197|NCT01215188|26747169|P1|Overall Study|Adverse Event|1
7690198|NCT01215188|26747167|P3|Overall Study|Lost to Follow-up|16
7690199|NCT01215188|26747168|P2|Overall Study|Lost to Follow-up|22
7690200|NCT01215188|26747169|P1|Overall Study|Lost to Follow-up|22
7690201|NCT01215175|26747221|P5|Overall Study|Lost to Follow-up|0
7690202|NCT01215175|26747222|P4|Overall Study|Lost to Follow-up|1
7690203|NCT01215175|26747223|P3|Overall Study|Lost to Follow-up|0
7690204|NCT01215175|26747224|P2|Overall Study|Lost to Follow-up|1
7690205|NCT01215175|26747225|P1|Overall Study|Lost to Follow-up|0
7690206|NCT01215097|26747342|P2|Overall Study|patient's private reason|1
7690207|NCT01215097|26747343|P1|Overall Study|patient's private reason|1
7690208|NCT01215097|26747342|P2|Overall Study|patient's refusal to come|2
7690209|NCT01215097|26747343|P1|Overall Study|patient's refusal to come|2
7690210|NCT01215097|26747342|P2|Overall Study|Lack of Efficacy|3
7690211|NCT01215097|26747343|P1|Overall Study|Lack of Efficacy|0
7690212|NCT01215097|26747342|P2|Overall Study|Withdrawal by Subject|3
7690213|NCT01215097|26747343|P1|Overall Study|Withdrawal by Subject|6
7690214|NCT01215097|26747342|P2|Overall Study|Lost to Follow-up|0
7690215|NCT01215097|26747343|P1|Overall Study|Lost to Follow-up|2
7690216|NCT01215097|26747342|P2|Overall Study|Protocol Violation|2
7690217|NCT01215097|26747343|P1|Overall Study|Protocol Violation|0
7690218|NCT01215097|26747342|P2|Overall Study|Adverse Event|3
7690219|NCT01215097|26747343|P1|Overall Study|Adverse Event|1
7690220|NCT01215032|26747375|P1|Overall Study|Lack of Efficacy|17
7690221|NCT01215032|26747375|P1|Overall Study|Adverse Event|3
7690222|NCT01214915|26747400|P1|Overall Study|Lack of Efficacy|3
7690223|NCT01214915|26747400|P1|Overall Study|Adverse Event|8
7690224|NCT01214850|26747411|P3|Overall Study|Unable to classify|1
7690225|NCT01214850|26747412|P2|Overall Study|Unable to classify|1
7690226|NCT01214850|26747413|P1|Overall Study|Unable to classify|2
7690227|NCT01214850|26747411|P3|Overall Study|Administrative reason|0
7690228|NCT01214850|26747412|P2|Overall Study|Administrative reason|0
7690229|NCT01214850|26747413|P1|Overall Study|Administrative reason|1
7690230|NCT01214850|26747411|P3|Overall Study|Inappropriate enrollment|0
7690231|NCT01214850|26747412|P2|Overall Study|Inappropriate enrollment|1
7690232|NCT01214850|26747413|P1|Overall Study|Inappropriate enrollment|2
7690233|NCT01214850|26747411|P3|Overall Study|Adverse event or death|3
7690234|NCT01214850|26747412|P2|Overall Study|Adverse event or death|8
7690235|NCT01214850|26747413|P1|Overall Study|Adverse event or death|11
7690236|NCT01214850|26747411|P3|Overall Study|Protocol Violation|6
7690237|NCT01214850|26747412|P2|Overall Study|Protocol Violation|5
7690238|NCT01214850|26747413|P1|Overall Study|Protocol Violation|5
7690239|NCT01214850|26747411|P3|Overall Study|Lost to Follow-up|123
7690240|NCT01214850|26747412|P2|Overall Study|Lost to Follow-up|98
7690241|NCT01214850|26747413|P1|Overall Study|Lost to Follow-up|124
7690242|NCT01214850|26747411|P3|Overall Study|Withdrawal by Subject|28
7690243|NCT01214850|26747412|P2|Overall Study|Withdrawal by Subject|31
7690244|NCT01214850|26747413|P1|Overall Study|Withdrawal by Subject|38
7690245|NCT01214837|26747497|P3|Overall Study|Unable to Classify|0
7690246|NCT01214837|26747498|P2|Overall Study|Unable to Classify|3
7690247|NCT01214837|26747499|P1|Overall Study|Unable to Classify|1
7690248|NCT01214837|26747497|P3|Overall Study|Protocol Violation|5
7690249|NCT01214837|26747498|P2|Overall Study|Protocol Violation|1
7690250|NCT01214837|26747499|P1|Overall Study|Protocol Violation|3
7690251|NCT01214837|26747497|P3|Overall Study|Administrative Reason|4
7690252|NCT01214837|26747498|P2|Overall Study|Administrative Reason|6
7690253|NCT01214837|26747499|P1|Overall Study|Administrative Reason|2
7690254|NCT01214837|26747497|P3|Overall Study|Inappropriate Enrolment|2
7690255|NCT01214837|26747498|P2|Overall Study|Inappropriate Enrolment|1
7690256|NCT01214837|26747499|P1|Overall Study|Inappropriate Enrolment|0
7690257|NCT01214837|26747497|P3|Overall Study|Lost to Follow-up|21
7690258|NCT01214837|26747498|P2|Overall Study|Lost to Follow-up|15
7690259|NCT01214837|26747499|P1|Overall Study|Lost to Follow-up|20
7690260|NCT01214837|26747497|P3|Overall Study|Withdrawal by Subject|28
7690261|NCT01214837|26747498|P2|Overall Study|Withdrawal by Subject|36
7690262|NCT01214837|26747499|P1|Overall Study|Withdrawal by Subject|27
7690263|NCT01214837|26747497|P3|Overall Study|Adverse Event|1
7690264|NCT01214837|26747498|P2|Overall Study|Adverse Event|2
7690265|NCT01214837|26747499|P1|Overall Study|Adverse Event|1
7690266|NCT01214837|26747497|P3|Overall Study|Death|1
7690267|NCT01214837|26747498|P2|Overall Study|Death|0
7690268|NCT01214837|26747499|P1|Overall Study|Death|0
7690269|NCT01214720|26747555|P2|Overall Study|Lost to Follow-up|2
7690270|NCT01214720|26747556|P1|Overall Study|Lost to Follow-up|6
7690271|NCT01214720|26747555|P2|Overall Study|Alive and in follow-up|48
7690272|NCT01214720|26747556|P1|Overall Study|Alive and in follow-up|45
7690273|NCT01214720|26747555|P2|Overall Study|Alive and still on treatment|18
7690274|NCT01214720|26747556|P1|Overall Study|Alive and still on treatment|34
7690275|NCT01214668|26747579|P6|Overall Study|Withdrawal by Subject|0
7690276|NCT01214668|26747580|P5|Overall Study|Withdrawal by Subject|1
7690277|NCT01214668|26747581|P4|Overall Study|Withdrawal by Subject|0
7690278|NCT01214668|26747582|P3|Overall Study|Withdrawal by Subject|0
7690279|NCT01214668|26747583|P2|Overall Study|Withdrawal by Subject|0
7690280|NCT01214668|26747584|P1|Overall Study|Withdrawal by Subject|0
7690281|NCT01214668|26747579|P6|Overall Study|Progressive Disease|5
7690282|NCT01214668|26747580|P5|Overall Study|Progressive Disease|4
7690283|NCT01214668|26747581|P4|Overall Study|Progressive Disease|4
7690284|NCT01214668|26747582|P3|Overall Study|Progressive Disease|5
7690285|NCT01214668|26747583|P2|Overall Study|Progressive Disease|2
7690286|NCT01214668|26747584|P1|Overall Study|Progressive Disease|4
7690287|NCT01214668|26747579|P6|Overall Study|Death|0
7690288|NCT01214668|26747580|P5|Overall Study|Death|0
7690289|NCT01214668|26747581|P4|Overall Study|Death|0
7690290|NCT01214668|26747582|P3|Overall Study|Death|1
7690291|NCT01214668|26747583|P2|Overall Study|Death|0
7690292|NCT01214668|26747584|P1|Overall Study|Death|0
7690293|NCT01214668|26747579|P6|Overall Study|Adverse Event|1
7690294|NCT01214668|26747580|P5|Overall Study|Adverse Event|1
7690295|NCT01214668|26747581|P4|Overall Study|Adverse Event|2
7690296|NCT01214668|26747582|P3|Overall Study|Adverse Event|0
7690297|NCT01214668|26747583|P2|Overall Study|Adverse Event|1
7690298|NCT01214668|26747584|P1|Overall Study|Adverse Event|0
7690299|NCT01214655|26747621|P3|Part C|Physician Decision|1
7690300|NCT01214655|26747622|P2|Part C|Physician Decision|0
7690301|NCT01214655|26747623|P1|Part C|Physician Decision|0
7690302|NCT01214655|26747621|P3|Part C|Death|1
7690303|NCT01214655|26747622|P2|Part C|Death|0
7690304|NCT01214655|26747623|P1|Part C|Death|0
7690305|NCT01214655|26747621|P3|Part C|Progressive Disease|5
7690306|NCT01214655|26747622|P2|Part C|Progressive Disease|0
7690307|NCT01214655|26747623|P1|Part C|Progressive Disease|0
7690308|NCT01214655|26747621|P3|Part B|Withdrawal by Subject|0
7690309|NCT01214655|26747622|P2|Part B|Withdrawal by Subject|2
7690310|NCT01214655|26747623|P1|Part B|Withdrawal by Subject|0
7690311|NCT01214655|26747621|P3|Part B|Death|0
7690312|NCT01214655|26747622|P2|Part B|Death|1
7690313|NCT01214655|26747623|P1|Part B|Death|0
7690314|NCT01214655|26747621|P3|Part B|Progressive disease|0
7690315|NCT01214655|26747622|P2|Part B|Progressive disease|10
7690316|NCT01214655|26747623|P1|Part B|Progressive disease|0
7690317|NCT01214655|26747621|P3|Part A|Physician Decision|0
7690318|NCT01214655|26747622|P2|Part A|Physician Decision|0
7690319|NCT01214655|26747623|P1|Part A|Physician Decision|1
7690320|NCT01214655|26747621|P3|Part A|Progressive Disease|0
7690321|NCT01214655|26747622|P2|Part A|Progressive Disease|0
7690322|NCT01214655|26747623|P1|Part A|Progressive Disease|7
7690323|NCT01214642|26747696|P12|Overall Study|Physician Decision|2
7690324|NCT01214642|26747697|P11|Overall Study|Physician Decision|0
7690325|NCT01214642|26747698|P10|Overall Study|Physician Decision|0
7690326|NCT01214642|26747699|P9|Overall Study|Physician Decision|0
7690327|NCT01214642|26747700|P8|Overall Study|Physician Decision|0
7690328|NCT01214642|26747701|P7|Overall Study|Physician Decision|0
7690329|NCT01214642|26747702|P6|Overall Study|Physician Decision|0
7690330|NCT01214642|26747703|P5|Overall Study|Physician Decision|1
7690331|NCT01214642|26747704|P4|Overall Study|Physician Decision|1
7690332|NCT01214642|26747705|P3|Overall Study|Physician Decision|1
7690333|NCT01214642|26747706|P2|Overall Study|Physician Decision|0
7690334|NCT01214642|26747707|P1|Overall Study|Physician Decision|0
7690335|NCT01214642|26747696|P12|Overall Study|Withdrawal by Subject|0
7690336|NCT01214642|26747697|P11|Overall Study|Withdrawal by Subject|1
7690337|NCT01214642|26747698|P10|Overall Study|Withdrawal by Subject|1
7690338|NCT01214642|26747699|P9|Overall Study|Withdrawal by Subject|3
7690339|NCT01214642|26747700|P8|Overall Study|Withdrawal by Subject|0
7690340|NCT01214642|26747701|P7|Overall Study|Withdrawal by Subject|0
7690341|NCT01214642|26747702|P6|Overall Study|Withdrawal by Subject|0
7690342|NCT01214642|26747703|P5|Overall Study|Withdrawal by Subject|0
7690343|NCT01214642|26747704|P4|Overall Study|Withdrawal by Subject|0
7690344|NCT01214642|26747705|P3|Overall Study|Withdrawal by Subject|1
7690345|NCT01214642|26747706|P2|Overall Study|Withdrawal by Subject|0
7690346|NCT01214642|26747707|P1|Overall Study|Withdrawal by Subject|0
7690347|NCT01214642|26747696|P12|Overall Study|Death|0
7690348|NCT01214642|26747697|P11|Overall Study|Death|1
7690349|NCT01214642|26747698|P10|Overall Study|Death|0
7690350|NCT01214642|26747699|P9|Overall Study|Death|0
7690351|NCT01214642|26747700|P8|Overall Study|Death|0
7690352|NCT01214642|26747701|P7|Overall Study|Death|0
7690353|NCT01214642|26747702|P6|Overall Study|Death|0
7690354|NCT01214642|26747703|P5|Overall Study|Death|0
7690355|NCT01214642|26747704|P4|Overall Study|Death|0
7690356|NCT01214642|26747705|P3|Overall Study|Death|1
7690357|NCT01214642|26747706|P2|Overall Study|Death|0
7690358|NCT01214642|26747707|P1|Overall Study|Death|0
7690359|NCT01214642|26747696|P12|Overall Study|Adverse Event|0
7690360|NCT01214642|26747697|P11|Overall Study|Adverse Event|1
7690361|NCT01214642|26747698|P10|Overall Study|Adverse Event|1
7690362|NCT01214642|26747699|P9|Overall Study|Adverse Event|0
7690363|NCT01214642|26747700|P8|Overall Study|Adverse Event|0
7690364|NCT01214642|26747701|P7|Overall Study|Adverse Event|1
7690365|NCT01214642|26747702|P6|Overall Study|Adverse Event|0
7690366|NCT01214642|26747703|P5|Overall Study|Adverse Event|0
7690367|NCT01214642|26747704|P4|Overall Study|Adverse Event|0
7690368|NCT01214642|26747705|P3|Overall Study|Adverse Event|0
7690369|NCT01214642|26747706|P2|Overall Study|Adverse Event|1
7690370|NCT01214642|26747707|P1|Overall Study|Adverse Event|0
7690371|NCT01214642|26747696|P12|Overall Study|Progressive Disease|4
7690372|NCT01214642|26747697|P11|Overall Study|Progressive Disease|1
7690373|NCT01214642|26747698|P10|Overall Study|Progressive Disease|2
7690374|NCT01214642|26747699|P9|Overall Study|Progressive Disease|10
7690375|NCT01214642|26747700|P8|Overall Study|Progressive Disease|3
7690376|NCT01214642|26747701|P7|Overall Study|Progressive Disease|5
7690377|NCT01214642|26747702|P6|Overall Study|Progressive Disease|3
7690378|NCT01214642|26747703|P5|Overall Study|Progressive Disease|5
7690379|NCT01214642|26747704|P4|Overall Study|Progressive Disease|5
7690380|NCT01214642|26747705|P3|Overall Study|Progressive Disease|3
7690381|NCT01214642|26747706|P2|Overall Study|Progressive Disease|2
7690382|NCT01214642|26747707|P1|Overall Study|Progressive Disease|3
7690383|NCT01214629|26747787|P11|Overall Study|Withdrawal by Subject|0
7690384|NCT01214629|26747788|P10|Overall Study|Withdrawal by Subject|1
7690385|NCT01214629|26747789|P9|Overall Study|Withdrawal by Subject|0
7690386|NCT01214629|26747790|P8|Overall Study|Withdrawal by Subject|0
7690387|NCT01214629|26747791|P7|Overall Study|Withdrawal by Subject|0
7690388|NCT01214629|26747792|P6|Overall Study|Withdrawal by Subject|0
7690389|NCT01214629|26747793|P5|Overall Study|Withdrawal by Subject|0
7690390|NCT01214629|26747794|P4|Overall Study|Withdrawal by Subject|0
7690391|NCT01214629|26747795|P3|Overall Study|Withdrawal by Subject|0
7690392|NCT01214629|26747796|P2|Overall Study|Withdrawal by Subject|0
7690393|NCT01214629|26747797|P1|Overall Study|Withdrawal by Subject|0
7690394|NCT01214629|26747787|P11|Overall Study|Physician Decision|1
7690395|NCT01214629|26747788|P10|Overall Study|Physician Decision|0
7690396|NCT01214629|26747789|P9|Overall Study|Physician Decision|0
7690397|NCT01214629|26747790|P8|Overall Study|Physician Decision|0
7690398|NCT01214629|26747791|P7|Overall Study|Physician Decision|0
7690399|NCT01214629|26747792|P6|Overall Study|Physician Decision|0
7690400|NCT01214629|26747793|P5|Overall Study|Physician Decision|0
7690401|NCT01214629|26747794|P4|Overall Study|Physician Decision|0
7690402|NCT01214629|26747795|P3|Overall Study|Physician Decision|0
7690403|NCT01214629|26747796|P2|Overall Study|Physician Decision|0
7690404|NCT01214629|26747797|P1|Overall Study|Physician Decision|0
7690405|NCT01214629|26747787|P11|Overall Study|Adverse Event|0
7690406|NCT01214629|26747788|P10|Overall Study|Adverse Event|1
7690407|NCT01214629|26747789|P9|Overall Study|Adverse Event|0
7690408|NCT01214629|26747790|P8|Overall Study|Adverse Event|0
7690409|NCT01214629|26747791|P7|Overall Study|Adverse Event|0
7690410|NCT01214629|26747792|P6|Overall Study|Adverse Event|1
7690411|NCT01214629|26747793|P5|Overall Study|Adverse Event|0
7690412|NCT01214629|26747794|P4|Overall Study|Adverse Event|1
7690413|NCT01214629|26747795|P3|Overall Study|Adverse Event|0
7690414|NCT01214629|26747796|P2|Overall Study|Adverse Event|0
7690415|NCT01214629|26747797|P1|Overall Study|Adverse Event|0
7690416|NCT01214629|26747787|P11|Overall Study|Progressive Disease|1
7690417|NCT01214629|26747788|P10|Overall Study|Progressive Disease|5
7690418|NCT01214629|26747789|P9|Overall Study|Progressive Disease|1
7690419|NCT01214629|26747790|P8|Overall Study|Progressive Disease|1
7690420|NCT01214629|26747791|P7|Overall Study|Progressive Disease|1
7690421|NCT01214629|26747792|P6|Overall Study|Progressive Disease|3
7690422|NCT01214629|26747793|P5|Overall Study|Progressive Disease|2
7690423|NCT01214629|26747794|P4|Overall Study|Progressive Disease|1
7690424|NCT01214629|26747795|P3|Overall Study|Progressive Disease|0
7690425|NCT01214629|26747796|P2|Overall Study|Progressive Disease|1
7690426|NCT01214629|26747797|P1|Overall Study|Progressive Disease|1
7690427|NCT01214616|26747862|P4|Overall Study|Withdrawal by Subject|1
7690428|NCT01214616|26747863|P3|Overall Study|Withdrawal by Subject|0
7690429|NCT01214616|26747864|P2|Overall Study|Withdrawal by Subject|0
7690430|NCT01214616|26747865|P1|Overall Study|Withdrawal by Subject|1
7690431|NCT01214616|26747862|P4|Overall Study|Other adverse events|1
7690432|NCT01214616|26747863|P3|Overall Study|Other adverse events|1
7690433|NCT01214616|26747864|P2|Overall Study|Other adverse events|1
7690434|NCT01214616|26747865|P1|Overall Study|Other adverse events|0
7690435|NCT01214616|26747862|P4|Overall Study|Dose limiting toxicity|0
7690436|NCT01214616|26747863|P3|Overall Study|Dose limiting toxicity|0
7690437|NCT01214616|26747864|P2|Overall Study|Dose limiting toxicity|2
7690438|NCT01214616|26747865|P1|Overall Study|Dose limiting toxicity|0
7690439|NCT01214616|26747862|P4|Overall Study|Progressive disease|4
7690440|NCT01214616|26747863|P3|Overall Study|Progressive disease|2
7690441|NCT01214616|26747864|P2|Overall Study|Progressive disease|2
7690442|NCT01214616|26747865|P1|Overall Study|Progressive disease|2
7690443|NCT01214603|26747902|P3|Overall Study|Progressive Disease|3
7690444|NCT01214603|26747903|P2|Overall Study|Progressive Disease|1
7690445|NCT01214603|26747904|P1|Overall Study|Progressive Disease|4
7690446|NCT01214603|26747902|P3|Overall Study|Death|0
7690447|NCT01214603|26747903|P2|Overall Study|Death|0
7690448|NCT01214603|26747904|P1|Overall Study|Death|1
7690449|NCT01214603|26747902|P3|Overall Study|Adverse Event|1
7690450|NCT01214603|26747903|P2|Overall Study|Adverse Event|0
7690451|NCT01214603|26747904|P1|Overall Study|Adverse Event|0
7690452|NCT01214434|26747927|P2|Overall Study|Site error|0
7690453|NCT01214434|26747928|P1|Overall Study|Site error|1
7690454|NCT01214434|26747927|P2|Overall Study|Lost to Follow-up|2
7690455|NCT01214434|26747928|P1|Overall Study|Lost to Follow-up|2
7690456|NCT01214434|26747927|P2|Overall Study|Withdrawal by Subject|0
7690457|NCT01214434|26747928|P1|Overall Study|Withdrawal by Subject|1
7690458|NCT01214395|26747944|P1|Overall Study|All patients had infection|5
7690459|NCT01214252|26747973|P1|Overall Study|Not eligible per protocol|82
7690460|NCT01214239|26747981|P2|Overall Study|patient's private reason|1
7690461|NCT01214239|26747982|P1|Overall Study|patient's private reason|1
7690462|NCT01214239|26747981|P2|Overall Study|Lack of Efficacy|2
7690463|NCT01214239|26747982|P1|Overall Study|Lack of Efficacy|1
7690464|NCT01214239|26747981|P2|Overall Study|Withdrawal by Subject|9
7690465|NCT01214239|26747982|P1|Overall Study|Withdrawal by Subject|4
7690466|NCT01214239|26747981|P2|Overall Study|Lost to Follow-up|1
7690467|NCT01214239|26747982|P1|Overall Study|Lost to Follow-up|1
7690468|NCT01214239|26747981|P2|Overall Study|Protocol Violation|1
7690469|NCT01214239|26747982|P1|Overall Study|Protocol Violation|2
7690470|NCT01214239|26747981|P2|Overall Study|Adverse Event|4
7690471|NCT01214239|26747982|P1|Overall Study|Adverse Event|3
7690472|NCT01214200|26748014|P1|Overall Study|Withdrawal by Subject|2
7690473|NCT01214200|26748014|P1|Overall Study|Did not meet inclusion/exclusion|9
7690474|NCT01214187|26748028|P2|Overall Study|Withdrawal by Subject|3
7690475|NCT01214187|26748029|P1|Overall Study|Withdrawal by Subject|0
7690476|NCT01214187|26748028|P2|Overall Study|Death|1
7690477|NCT01214187|26748029|P1|Overall Study|Death|1
7690478|NCT01214187|26748028|P2|Overall Study|Adverse Event|2
7690479|NCT01214187|26748029|P1|Overall Study|Adverse Event|6
7690480|NCT01214174|26748046|P3|Overall Study|Withdrawal by Subject|1
7690481|NCT01214174|26748047|P2|Overall Study|Withdrawal by Subject|0
7690482|NCT01214174|26748048|P1|Overall Study|Withdrawal by Subject|0
7690483|NCT01214044|26748198|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
7690484|NCT01214044|26748198|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
7690485|NCT01214044|26748198|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
7690486|NCT01214044|26748198|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
7690487|NCT01214044|26748198|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
7690488|NCT01214044|26748198|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
7690489|NCT01213966|26748212|P4|Overall Study|Protocol Violation|1
7690490|NCT01213966|26748213|P3|Overall Study|Protocol Violation|3
7690491|NCT01213966|26748214|P2|Overall Study|Protocol Violation|0
7690492|NCT01213966|26748215|P1|Overall Study|Protocol Violation|1
7690493|NCT01213836|26748236|P2|Period 1, First Intervention|Withdrawal by Subject|1
7690494|NCT01213836|26748237|P1|Period 1, First Intervention|Withdrawal by Subject|1
7690495|NCT01213836|26748236|P2|Period 1, First Intervention|Protocol Violation|1
7690496|NCT01213836|26748237|P1|Period 1, First Intervention|Protocol Violation|0
7690497|NCT01213836|26748236|P2|Period 1, First Intervention|Adverse Event|1
7690498|NCT01213836|26748237|P1|Period 1, First Intervention|Adverse Event|2
7690499|NCT01213524|26748324|P1|Session 4|Withdrawal by Subject|2
7690500|NCT01213524|26748324|P1|Session 4|Physician Decision|1
7690501|NCT01213524|26748324|P1|Session 3|Withdrawal by Subject|4
7690502|NCT01213524|26748324|P1|Session 2|Withdrawal by Subject|5
7690503|NCT01213524|26748324|P1|Baseline|Physician Decision|1
7690504|NCT01213524|26748324|P1|Baseline|high breath alcohol levels|1
7690505|NCT01213524|26748324|P1|Baseline|Withdrawal by Subject|5
7690506|NCT01213472|26748338|P1|Overall Study|Physician Decision|1
7690507|NCT01213472|26748338|P1|Overall Study|Withdrawal by Subject|1
7690508|NCT01213472|26748338|P1|Overall Study|Recurrence/Progressive disease|25
7690509|NCT01213264|26748387|P3|Overall Study|Lost to Follow-up|6
7690510|NCT01213264|26748388|P2|Overall Study|Lost to Follow-up|2
7690511|NCT01213264|26748389|P1|Overall Study|Lost to Follow-up|1
7690512|NCT01213264|26748387|P3|Overall Study|Adverse Event|0
7690513|NCT01213264|26748388|P2|Overall Study|Adverse Event|0
7690514|NCT01213264|26748389|P1|Overall Study|Adverse Event|1
7690515|NCT01213251|26748409|P3|Overall Study|Missed 18-Month Follow-up|1
7690516|NCT01213251|26748410|P2|Overall Study|Missed 18-Month Follow-up|0
7690517|NCT01213251|26748411|P1|Overall Study|Missed 18-Month Follow-up|0
7690518|NCT01213251|26748409|P3|Overall Study|Protocol Violation|0
7690519|NCT01213251|26748410|P2|Overall Study|Protocol Violation|1
7690520|NCT01213251|26748411|P1|Overall Study|Protocol Violation|1
7690521|NCT01213251|26748409|P3|Overall Study|Exit|8
7690522|NCT01213251|26748410|P2|Overall Study|Exit|2
7690523|NCT01213251|26748411|P1|Overall Study|Exit|3
7690524|NCT01213251|26748409|P3|Overall Study|Death|2
7690525|NCT01213251|26748410|P2|Overall Study|Death|1
7690526|NCT01213251|26748411|P1|Overall Study|Death|2
7690527|NCT01213173|26748438|P2|Overall Study|Incorrect Enrollment|3
7690528|NCT01213173|26748439|P1|Overall Study|Incorrect Enrollment|1
7690529|NCT01213173|26748438|P2|Overall Study|Withdrawal by Subject|5
7690530|NCT01213173|26748439|P1|Overall Study|Withdrawal by Subject|5
7690531|NCT01213173|26748438|P2|Overall Study|Adverse Event|8
7690532|NCT01213173|26748439|P1|Overall Study|Adverse Event|4
7690533|NCT01213173|26748438|P2|Overall Study|Protocol Violation|0
7690534|NCT01213173|26748439|P1|Overall Study|Protocol Violation|2
7690535|NCT01213082|26748472|P3|Overall Study|Physician Decision|1
7690536|NCT01213082|26748473|P2|Overall Study|Physician Decision|0
7690537|NCT01213082|26748474|P1|Overall Study|Physician Decision|0
7690538|NCT01213082|26748472|P3|Overall Study|Lost to Follow-up|4
7690539|NCT01213082|26748473|P2|Overall Study|Lost to Follow-up|7
7690540|NCT01213082|26748474|P1|Overall Study|Lost to Follow-up|6
7690541|NCT01212991|26748516|P3|Open-label|Other|3
7690542|NCT01212991|26748517|P2|Open-label|Other|0
7690543|NCT01212991|26748518|P1|Open-label|Other|0
7690544|NCT01212991|26748516|P3|Open-label|Sponsor decision|53
7690545|NCT01212991|26748517|P2|Open-label|Sponsor decision|0
7690546|NCT01212991|26748518|P1|Open-label|Sponsor decision|0
7690547|NCT01212991|26748516|P3|Open-label|Withdrawal by Subject|7
7690548|NCT01212991|26748517|P2|Open-label|Withdrawal by Subject|0
7690549|NCT01212991|26748518|P1|Open-label|Withdrawal by Subject|0
7690550|NCT01212991|26748516|P3|Open-label|Lost to Follow-up|5
7690551|NCT01212991|26748517|P2|Open-label|Lost to Follow-up|0
7690552|NCT01212991|26748518|P1|Open-label|Lost to Follow-up|0
7690553|NCT01212991|26748516|P3|Open-label|Death|166
7690554|NCT01212991|26748517|P2|Open-label|Death|0
7690555|NCT01212991|26748518|P1|Open-label|Death|0
7690556|NCT01212991|26748516|P3|Double-blind|Sponsor decision|0
7690557|NCT01212991|26748517|P2|Double-blind|Sponsor decision|38
7690558|NCT01212991|26748518|P1|Double-blind|Sponsor decision|142
7690559|NCT01212991|26748516|P3|Double-blind|Other|0
7690560|NCT01212991|26748517|P2|Double-blind|Other|0
7690561|NCT01212991|26748518|P1|Double-blind|Other|7
7690562|NCT01212991|26748516|P3|Double-blind|Withdrawal by Subject|0
7690563|NCT01212991|26748517|P2|Double-blind|Withdrawal by Subject|19
7690564|NCT01212991|26748518|P1|Double-blind|Withdrawal by Subject|16
7690565|NCT01212991|26748516|P3|Double-blind|Death|0
7690566|NCT01212991|26748517|P2|Double-blind|Death|550
7690567|NCT01212991|26748518|P1|Double-blind|Death|699
7690568|NCT01212991|26748516|P3|Double-blind|Lost to Follow-up|0
7690569|NCT01212991|26748517|P2|Double-blind|Lost to Follow-up|4
7690570|NCT01212991|26748518|P1|Double-blind|Lost to Follow-up|8
7690571|NCT01212770|26748590|P9|Long-term Safety Phase (Year 5)|Death|0
7690572|NCT01212770|26748591|P8|Long-term Safety Phase (Year 5)|Death|1
7690573|NCT01212770|26748592|P7|Long-term Safety Phase (Year 5)|Death|0
7690574|NCT01212770|26748593|P6|Long-term Safety Phase (Year 5)|Death|0
7690575|NCT01212770|26748594|P5|Long-term Safety Phase (Year 5)|Death|0
7690576|NCT01212770|26748595|P4|Long-term Safety Phase (Year 5)|Death|0
7690577|NCT01212770|26748596|P3|Long-term Safety Phase (Year 5)|Death|0
7690578|NCT01212770|26748597|P2|Long-term Safety Phase (Year 5)|Death|0
7690579|NCT01212770|26748598|P1|Long-term Safety Phase (Year 5)|Death|0
7690580|NCT01212770|26748590|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7690581|NCT01212770|26748591|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7690582|NCT01212770|26748592|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7690583|NCT01212770|26748593|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7690584|NCT01212770|26748594|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7690585|NCT01212770|26748595|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7690586|NCT01212770|26748596|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7690587|NCT01212770|26748597|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7690588|NCT01212770|26748598|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7690589|NCT01212770|26748590|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690590|NCT01212770|26748591|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690591|NCT01212770|26748592|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690592|NCT01212770|26748593|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690593|NCT01212770|26748594|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690594|NCT01212770|26748595|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690595|NCT01212770|26748596|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
7690596|NCT01212770|26748597|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690597|NCT01212770|26748598|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7690598|NCT01212770|26748590|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
7690599|NCT01212770|26748591|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
7690600|NCT01212770|26748592|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
7690601|NCT01212770|26748593|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
7690602|NCT01212770|26748594|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
7690603|NCT01212770|26748595|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
7690604|NCT01212770|26748596|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
7690605|NCT01212770|26748597|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
7690606|NCT01212770|26748598|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
7690607|NCT01212770|26748590|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690608|NCT01212770|26748591|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690609|NCT01212770|26748592|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690610|NCT01212770|26748593|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690611|NCT01212770|26748594|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690612|NCT01212770|26748595|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690613|NCT01212770|26748596|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
7690614|NCT01212770|26748597|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690615|NCT01212770|26748598|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
7690616|NCT01212770|26748590|P9|Long-term Safety Phase (Year 5)|Missing|0
7690617|NCT01212770|26748591|P8|Long-term Safety Phase (Year 5)|Missing|0
7690618|NCT01212770|26748592|P7|Long-term Safety Phase (Year 5)|Missing|0
7690619|NCT01212770|26748593|P6|Long-term Safety Phase (Year 5)|Missing|0
7690620|NCT01212770|26748594|P5|Long-term Safety Phase (Year 5)|Missing|0
7690621|NCT01212770|26748595|P4|Long-term Safety Phase (Year 5)|Missing|0
7690622|NCT01212770|26748596|P3|Long-term Safety Phase (Year 5)|Missing|1
7690623|NCT01212770|26748597|P2|Long-term Safety Phase (Year 5)|Missing|0
7690624|NCT01212770|26748598|P1|Long-term Safety Phase (Year 5)|Missing|0
7690625|NCT01212770|26748590|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
7690626|NCT01212770|26748591|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690627|NCT01212770|26748592|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690628|NCT01212770|26748593|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690629|NCT01212770|26748594|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690630|NCT01212770|26748595|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690631|NCT01212770|26748596|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690632|NCT01212770|26748597|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
7690633|NCT01212770|26748598|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
7690634|NCT01212770|26748590|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690635|NCT01212770|26748591|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690636|NCT01212770|26748592|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690637|NCT01212770|26748593|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690638|NCT01212770|26748594|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690639|NCT01212770|26748595|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690640|NCT01212770|26748596|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
7690641|NCT01212770|26748597|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690642|NCT01212770|26748598|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7690643|NCT01212770|26748590|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690644|NCT01212770|26748591|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690645|NCT01212770|26748592|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690646|NCT01212770|26748593|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690647|NCT01212770|26748594|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690648|NCT01212770|26748595|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690649|NCT01212770|26748596|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
7690650|NCT01212770|26748597|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
7690651|NCT01212770|26748598|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7690652|NCT01212770|26748590|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7690653|NCT01212770|26748591|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7690654|NCT01212770|26748592|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7690655|NCT01212770|26748593|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7690656|NCT01212770|26748594|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7690657|NCT01212770|26748595|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7690658|NCT01212770|26748596|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7690659|NCT01212770|26748597|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7690660|NCT01212770|26748598|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7690661|NCT01212770|26748590|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7690662|NCT01212770|26748591|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
7690663|NCT01212770|26748592|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7690664|NCT01212770|26748593|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7690665|NCT01212770|26748594|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7690666|NCT01212770|26748595|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7690667|NCT01212770|26748596|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
7690668|NCT01212770|26748597|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7690669|NCT01212770|26748598|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7690670|NCT01212770|26748590|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
7690671|NCT01212770|26748591|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
7690672|NCT01212770|26748592|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
7690673|NCT01212770|26748593|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
7690674|NCT01212770|26748594|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
7690675|NCT01212770|26748595|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
7690676|NCT01212770|26748596|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
7690677|NCT01212770|26748597|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
7690678|NCT01212770|26748598|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
7690679|NCT01212770|26748590|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
7690680|NCT01212770|26748591|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
7690681|NCT01212770|26748592|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
7690682|NCT01212770|26748593|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
7690683|NCT01212770|26748594|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
7690684|NCT01212770|26748595|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
7690685|NCT01212770|26748596|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
7690686|NCT01212770|26748597|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
7690687|NCT01212770|26748598|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
7690688|NCT01212770|26748590|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690689|NCT01212770|26748591|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
7690690|NCT01212770|26748592|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690691|NCT01212770|26748593|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690692|NCT01212770|26748594|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690693|NCT01212770|26748595|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690694|NCT01212770|26748596|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690695|NCT01212770|26748597|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690696|NCT01212770|26748598|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
7690697|NCT01212770|26748590|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690698|NCT01212770|26748591|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690699|NCT01212770|26748592|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690700|NCT01212770|26748593|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690701|NCT01212770|26748594|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690702|NCT01212770|26748595|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690703|NCT01212770|26748596|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690704|NCT01212770|26748597|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7690705|NCT01212770|26748598|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7690706|NCT01212770|26748590|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
7690707|NCT01212770|26748591|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
7690708|NCT01212770|26748592|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7690709|NCT01212770|26748593|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7690710|NCT01212770|26748594|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7690711|NCT01212770|26748595|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7690712|NCT01212770|26748596|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
7690713|NCT01212770|26748597|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
7690714|NCT01212770|26748598|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7690715|NCT01212770|26748590|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7690716|NCT01212770|26748591|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7690717|NCT01212770|26748592|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7690718|NCT01212770|26748593|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7690719|NCT01212770|26748594|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7690720|NCT01212770|26748595|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7690721|NCT01212770|26748596|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
7690722|NCT01212770|26748597|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
7690723|NCT01212770|26748598|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7690724|NCT01212770|26748590|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
7690725|NCT01212770|26748591|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
7690726|NCT01212770|26748592|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
7690727|NCT01212770|26748593|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
7690728|NCT01212770|26748594|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
7690729|NCT01212770|26748595|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
7690730|NCT01212770|26748596|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
7690731|NCT01212770|26748597|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
7690732|NCT01212770|26748598|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
7690733|NCT01212770|26748590|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
7690734|NCT01212770|26748591|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
7690735|NCT01212770|26748592|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
7690736|NCT01212770|26748593|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
7690737|NCT01212770|26748594|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
7690738|NCT01212770|26748595|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
7690739|NCT01212770|26748596|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
7690740|NCT01212770|26748597|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
7690741|NCT01212770|26748598|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
7690742|NCT01212770|26748590|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7690743|NCT01212770|26748591|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7690744|NCT01212770|26748592|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7690745|NCT01212770|26748593|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7691109|NCT01212757|26748802|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
7690746|NCT01212770|26748594|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7690747|NCT01212770|26748595|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7690748|NCT01212770|26748596|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7690749|NCT01212770|26748597|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
7690750|NCT01212770|26748598|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7690751|NCT01212770|26748590|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
7690752|NCT01212770|26748591|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
7690753|NCT01212770|26748592|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7690754|NCT01212770|26748593|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7690755|NCT01212770|26748594|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7690756|NCT01212770|26748595|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7690757|NCT01212770|26748596|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
7690758|NCT01212770|26748597|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
7690759|NCT01212770|26748598|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7690760|NCT01212770|26748590|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690761|NCT01212770|26748591|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690762|NCT01212770|26748592|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690763|NCT01212770|26748593|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690764|NCT01212770|26748594|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690765|NCT01212770|26748595|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690766|NCT01212770|26748596|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690767|NCT01212770|26748597|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
7690768|NCT01212770|26748598|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7690769|NCT01212770|26748590|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
7690770|NCT01212770|26748591|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
7690771|NCT01212770|26748592|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7690772|NCT01212770|26748593|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7690773|NCT01212770|26748594|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7690774|NCT01212770|26748595|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7690775|NCT01212770|26748596|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
7690776|NCT01212770|26748597|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
7690777|NCT01212770|26748598|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7690778|NCT01212770|26748590|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
7690779|NCT01212770|26748591|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
7690780|NCT01212770|26748592|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
7690781|NCT01212770|26748593|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
7690782|NCT01212770|26748594|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
7690783|NCT01212770|26748595|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
7690784|NCT01212770|26748596|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
7690785|NCT01212770|26748597|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
7690786|NCT01212770|26748598|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
7690787|NCT01212770|26748590|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690788|NCT01212770|26748591|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690789|NCT01212770|26748592|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690790|NCT01212770|26748593|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690791|NCT01212770|26748594|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690792|NCT01212770|26748595|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
7690793|NCT01212770|26748596|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
7690794|NCT01212770|26748597|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690795|NCT01212770|26748598|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7690796|NCT01212770|26748590|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690797|NCT01212770|26748591|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690798|NCT01212770|26748592|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690799|NCT01212770|26748593|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690800|NCT01212770|26748594|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690801|NCT01212770|26748595|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
7690802|NCT01212770|26748596|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690803|NCT01212770|26748597|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690804|NCT01212770|26748598|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7690805|NCT01212770|26748590|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690806|NCT01212770|26748591|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690807|NCT01212770|26748592|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690808|NCT01212770|26748593|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690809|NCT01212770|26748594|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690810|NCT01212770|26748595|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690811|NCT01212770|26748596|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
7690812|NCT01212770|26748597|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690813|NCT01212770|26748598|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7690814|NCT01212770|26748590|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7690815|NCT01212770|26748591|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7690816|NCT01212770|26748592|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7690817|NCT01212770|26748593|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7690818|NCT01212770|26748594|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7690819|NCT01212770|26748595|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
7690820|NCT01212770|26748596|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
7690821|NCT01212770|26748597|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
7690822|NCT01212770|26748598|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7690823|NCT01212770|26748590|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7690824|NCT01212770|26748591|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7690825|NCT01212770|26748592|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7690826|NCT01212770|26748593|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
7690827|NCT01212770|26748594|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
7690828|NCT01212770|26748595|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
7690829|NCT01212770|26748596|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
7690830|NCT01212770|26748597|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
7690831|NCT01212770|26748598|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7690832|NCT01212770|26748590|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7690833|NCT01212770|26748591|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7690834|NCT01212770|26748592|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
7690835|NCT01212770|26748593|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7690836|NCT01212770|26748594|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7690837|NCT01212770|26748595|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
7690838|NCT01212770|26748596|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
7690839|NCT01212770|26748597|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
7690840|NCT01212770|26748598|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7690841|NCT01212770|26748590|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7690842|NCT01212770|26748591|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7690843|NCT01212770|26748592|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7690844|NCT01212770|26748593|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7690845|NCT01212770|26748594|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7690846|NCT01212770|26748595|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7690847|NCT01212770|26748596|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
7690848|NCT01212770|26748597|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
7690849|NCT01212770|26748598|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
7690850|NCT01212770|26748590|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690851|NCT01212770|26748591|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690852|NCT01212770|26748592|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690853|NCT01212770|26748593|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690854|NCT01212770|26748594|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690855|NCT01212770|26748595|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690856|NCT01212770|26748596|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7690857|NCT01212770|26748597|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690858|NCT01212770|26748598|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7690859|NCT01212770|26748590|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690860|NCT01212770|26748591|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690861|NCT01212770|26748592|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690862|NCT01212770|26748593|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690863|NCT01212770|26748594|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690864|NCT01212770|26748595|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690865|NCT01212770|26748596|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
7690866|NCT01212770|26748597|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7690867|NCT01212770|26748598|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7690868|NCT01212770|26748590|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7690869|NCT01212770|26748591|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7690870|NCT01212770|26748592|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7690871|NCT01212770|26748593|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7690872|NCT01212770|26748594|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7690873|NCT01212770|26748595|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7690874|NCT01212770|26748596|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7690875|NCT01212770|26748597|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7690876|NCT01212770|26748598|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
7690877|NCT01212770|26748590|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7690878|NCT01212770|26748591|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7690879|NCT01212770|26748592|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7690880|NCT01212770|26748593|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7690881|NCT01212770|26748594|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7690882|NCT01212770|26748595|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7690883|NCT01212770|26748596|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
7690884|NCT01212770|26748597|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
7690885|NCT01212770|26748598|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7690886|NCT01212770|26748590|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7690887|NCT01212770|26748591|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7690888|NCT01212770|26748592|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691110|NCT01212757|26748803|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
7690889|NCT01212770|26748593|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7690890|NCT01212770|26748594|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7690891|NCT01212770|26748595|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7690892|NCT01212770|26748596|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
7690893|NCT01212770|26748597|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
7690894|NCT01212770|26748598|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7690895|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690896|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690897|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690898|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690899|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690900|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690901|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
7690902|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
7690903|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7690904|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690905|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690906|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690907|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690908|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690909|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690910|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690911|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
7690912|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7690913|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
7690914|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
7690915|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7690916|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7690917|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7690918|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7690919|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
7690920|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
7690921|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7690922|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
7690923|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
7690924|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
7690925|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
7690926|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
7690927|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
7690928|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
7690929|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
7690930|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
7690931|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
7690932|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
7690933|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7690934|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7690935|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7690936|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7690937|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
7690938|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
7690939|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7690940|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690941|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
7690942|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690943|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690944|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690945|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690946|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690947|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690948|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7690949|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 4)|Death|1
7690950|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 4)|Death|0
7690951|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 4)|Death|0
7690952|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 4)|Death|0
7690953|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 4)|Death|0
7690954|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 4)|Death|0
7690955|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 4)|Death|1
7690956|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 4)|Death|0
7690957|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 4)|Death|0
7690958|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
7690959|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
7690960|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7690961|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7691259|NCT01211665|26749345|P1|Overall Study|Death|1
7690962|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7690963|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7690964|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
7690965|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
7690966|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7690967|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
7690968|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
7690969|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7690970|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7690971|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7690972|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7690973|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
7690974|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
7690975|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7690976|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
7690977|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
7690978|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
7690979|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
7690980|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
7690981|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
7690982|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
7690983|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
7690984|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
7690985|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
7690986|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690987|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690988|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690989|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690990|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690991|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690992|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
7690993|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7690994|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
7690995|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7690996|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7690997|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7690998|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7690999|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7691000|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
7691001|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7691002|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7691003|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691004|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691005|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691006|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691007|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691008|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691009|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691010|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
7691011|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7691012|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
7691013|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691014|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691015|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691016|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691017|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691018|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691019|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691020|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7691021|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7691022|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7691023|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7691024|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7691025|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7691026|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7691027|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7691028|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
7691029|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7691030|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691031|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691032|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691033|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691034|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691035|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691036|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
7691037|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691038|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7691039|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
7691040|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
7691041|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7691042|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7691043|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7691044|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7691045|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
7691046|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
7691047|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7691048|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
7691049|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
7691050|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
7691051|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
7691052|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
7691053|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
7691054|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
7691055|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
7691056|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
7691057|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691058|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691059|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691060|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691061|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691062|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691063|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
7691064|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691065|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7691066|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
7691067|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
7691068|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7691069|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7691070|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7691071|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7691072|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
7691073|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
7691074|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7691075|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7691076|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
7691077|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7691078|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7691079|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7691080|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7691081|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
7691082|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
7691083|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7691084|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
7691085|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
7691086|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
7691087|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
7691088|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
7691089|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
7691090|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
7691091|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
7691092|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
7691093|NCT01212757|26748795|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
7691094|NCT01212757|26748796|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691095|NCT01212757|26748797|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691096|NCT01212757|26748798|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691097|NCT01212757|26748799|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691098|NCT01212757|26748800|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691099|NCT01212757|26748801|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691100|NCT01212757|26748802|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691101|NCT01212757|26748803|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7691102|NCT01212757|26748795|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
7691103|NCT01212757|26748796|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
7691104|NCT01212757|26748797|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
7691105|NCT01212757|26748798|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
7691106|NCT01212757|26748799|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
7691107|NCT01212757|26748800|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
7691108|NCT01212757|26748801|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
7691111|NCT01212757|26748795|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691112|NCT01212757|26748796|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691113|NCT01212757|26748797|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691114|NCT01212757|26748798|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691115|NCT01212757|26748799|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7691116|NCT01212757|26748800|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691117|NCT01212757|26748801|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691118|NCT01212757|26748802|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7691119|NCT01212757|26748803|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7691120|NCT01212757|26748795|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7691121|NCT01212757|26748796|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7691122|NCT01212757|26748797|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7691123|NCT01212757|26748798|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7691124|NCT01212757|26748799|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
7691125|NCT01212757|26748800|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7691126|NCT01212757|26748801|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
7691127|NCT01212757|26748802|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7691128|NCT01212757|26748803|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7691129|NCT01212757|26748795|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691130|NCT01212757|26748796|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691131|NCT01212757|26748797|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691132|NCT01212757|26748798|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691133|NCT01212757|26748799|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691134|NCT01212757|26748800|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691135|NCT01212757|26748801|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
7691136|NCT01212757|26748802|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691137|NCT01212757|26748803|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7691138|NCT01212757|26748795|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7691139|NCT01212757|26748796|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7691140|NCT01212757|26748797|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7691141|NCT01212757|26748798|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
7691142|NCT01212757|26748799|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7691143|NCT01212757|26748800|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
7691144|NCT01212757|26748801|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
7691145|NCT01212757|26748802|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
7691146|NCT01212757|26748803|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7691147|NCT01212757|26748795|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7691148|NCT01212757|26748796|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7691149|NCT01212757|26748797|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7691150|NCT01212757|26748798|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
7691151|NCT01212757|26748799|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7691152|NCT01212757|26748800|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
7691153|NCT01212757|26748801|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
7691154|NCT01212757|26748802|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
7691155|NCT01212757|26748803|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7691156|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691157|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691158|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691159|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691160|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691161|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691162|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
7691163|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
7691164|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
7691165|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691166|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691167|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691168|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691169|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691170|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691171|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7691172|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7691173|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7691174|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7691175|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7691176|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7691177|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7691178|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7691179|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7691180|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
7691181|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7691182|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7691183|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691184|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691185|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691186|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691187|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691188|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691189|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
7691190|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7691191|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
7691192|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7691193|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7691194|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7691195|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7691196|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7691197|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7691198|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
7691199|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
7691200|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
7691201|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7691202|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7691203|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7691204|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7691205|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7691206|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7691207|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7691208|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7691209|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7691210|NCT01212757|26748795|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691211|NCT01212757|26748796|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691212|NCT01212757|26748797|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691213|NCT01212757|26748798|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691214|NCT01212757|26748799|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691215|NCT01212757|26748800|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7691216|NCT01212757|26748801|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
7691217|NCT01212757|26748802|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7691218|NCT01212757|26748803|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7691219|NCT01212744|26748987|P1|Overall Study|Withdrawal by Subject|1
7691220|NCT01212588|26749006|P2|Overall Study|Protocol Violation|1
7691221|NCT01212588|26749007|P1|Overall Study|Protocol Violation|1
7691222|NCT01212588|26749006|P2|Overall Study|Physician Decision|1
7691223|NCT01212588|26749007|P1|Overall Study|Physician Decision|0
7691224|NCT01212185|26749105|P2|Overall Study|Protocol Violation|1
7691225|NCT01212185|26749106|P1|Overall Study|Protocol Violation|2
7691226|NCT01212159|26749125|P2|Overall Study|Withdrawal by Subject|12
7691227|NCT01212159|26749126|P1|Overall Study|Withdrawal by Subject|12
7691228|NCT01212094|26749225|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
7691229|NCT01212094|26749226|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
7691230|NCT01212094|26749227|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
7691231|NCT01212094|26749225|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
7691232|NCT01212094|26749226|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
7691233|NCT01212094|26749227|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
7691234|NCT01212094|26749225|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
7691235|NCT01212094|26749226|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
7691236|NCT01212094|26749227|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
7691237|NCT01212094|26749225|P3|Year 1: Baseline Monitoring|Started on DMT|0
7691238|NCT01212094|26749226|P2|Year 1: Baseline Monitoring|Started on DMT|0
7691239|NCT01212094|26749227|P1|Year 1: Baseline Monitoring|Started on DMT|2
7691240|NCT01212094|26749225|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
7691241|NCT01212094|26749226|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
7691242|NCT01212094|26749227|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
7691243|NCT01212094|26749225|P3|Year 1: Baseline Monitoring|Study terminated|0
7691244|NCT01212094|26749226|P2|Year 1: Baseline Monitoring|Study terminated|0
7691245|NCT01212094|26749227|P1|Year 1: Baseline Monitoring|Study terminated|7
7691246|NCT01211769|26749286|P4|Overall Study|Adverse Event|1
7691247|NCT01211769|26749287|P3|Overall Study|Adverse Event|1
7691248|NCT01211769|26749288|P2|Overall Study|Adverse Event|1
7691249|NCT01211769|26749289|P1|Overall Study|Adverse Event|0
7691250|NCT01211769|26749286|P4|Overall Study|Physician Decision|1
7691251|NCT01211769|26749287|P3|Overall Study|Physician Decision|2
7691252|NCT01211769|26749288|P2|Overall Study|Physician Decision|0
7691253|NCT01211769|26749289|P1|Overall Study|Physician Decision|2
7691254|NCT01211769|26749286|P4|Overall Study|Lost to Follow-up|9
7691255|NCT01211769|26749287|P3|Overall Study|Lost to Follow-up|5
7691256|NCT01211769|26749288|P2|Overall Study|Lost to Follow-up|9
7691257|NCT01211769|26749289|P1|Overall Study|Lost to Follow-up|7
7691258|NCT01211665|26749344|P2|Overall Study|Death|0
7691260|NCT01211665|26749344|P2|Overall Study|Withdrawal by Subject|0
7691261|NCT01211665|26749345|P1|Overall Study|Withdrawal by Subject|1
7691262|NCT01211613|26749372|P3|Overall Study|Withdrawal by Subject|0
7691263|NCT01211613|26749373|P2|Overall Study|Withdrawal by Subject|0
7691264|NCT01211613|26749374|P1|Overall Study|Withdrawal by Subject|1
7691265|NCT01211613|26749372|P3|Overall Study|Lost to Follow-up|2
7691266|NCT01211613|26749373|P2|Overall Study|Lost to Follow-up|2
7691267|NCT01211613|26749374|P1|Overall Study|Lost to Follow-up|2
7691268|NCT01211535|26749420|P2|Overall Study|Adverse Event|1
7691269|NCT01211535|26749421|P1|Overall Study|Adverse Event|0
7691270|NCT01211522|26749430|P3|Overall Study|Withdrawal by Subject|5
7691271|NCT01211522|26749431|P2|Overall Study|Withdrawal by Subject|7
7691272|NCT01211522|26749432|P1|Overall Study|Withdrawal by Subject|3
7691273|NCT01211483|26749471|P4|Phase 2|Study terminated by Sponsor|11
7691274|NCT01211483|26749472|P3|Phase 2|Study terminated by Sponsor|8
7691275|NCT01211483|26749473|P2|Phase 2|Study terminated by Sponsor|6
7691276|NCT01211483|26749474|P1|Phase 2|Study terminated by Sponsor|0
7691277|NCT01211483|26749471|P4|Phase 2|Withdrawal by Subject|5
7691278|NCT01211483|26749472|P3|Phase 2|Withdrawal by Subject|10
7691279|NCT01211483|26749473|P2|Phase 2|Withdrawal by Subject|1
7691280|NCT01211483|26749474|P1|Phase 2|Withdrawal by Subject|0
7691281|NCT01211483|26749471|P4|Phase 2|Death|53
7691282|NCT01211483|26749472|P3|Phase 2|Death|53
7691283|NCT01211483|26749473|P2|Phase 2|Death|64
7691284|NCT01211483|26749474|P1|Phase 2|Death|0
7691285|NCT01211483|26749471|P4|Phase 2|Lost to Follow-up|2
7691286|NCT01211483|26749472|P3|Phase 2|Lost to Follow-up|1
7691287|NCT01211483|26749473|P2|Phase 2|Lost to Follow-up|1
7691288|NCT01211483|26749474|P1|Phase 2|Lost to Follow-up|0
7691289|NCT01211483|26749471|P4|Phase 1b|Withdrawal by Subject|0
7691290|NCT01211483|26749472|P3|Phase 1b|Withdrawal by Subject|0
7691291|NCT01211483|26749473|P2|Phase 1b|Withdrawal by Subject|0
7691292|NCT01211483|26749474|P1|Phase 1b|Withdrawal by Subject|1
7691293|NCT01211483|26749471|P4|Phase 1b|Death|0
7691294|NCT01211483|26749472|P3|Phase 1b|Death|0
7691295|NCT01211483|26749473|P2|Phase 1b|Death|0
7691296|NCT01211483|26749474|P1|Phase 1b|Death|6
7691297|NCT01211288|26749533|P2|Overall Study|Lost to Follow-up|1
7691298|NCT01211288|26749534|P1|Overall Study|Lost to Follow-up|1
7691299|NCT01211262|26749552|P2|Overall Study|Other|1
7691300|NCT01211262|26749553|P1|Overall Study|Other|0
7691301|NCT01211262|26749552|P2|Overall Study|Withdrawal of Consent|0
7691302|NCT01211262|26749553|P1|Overall Study|Withdrawal of Consent|1
7691303|NCT01211262|26749552|P2|Overall Study|Adverse Event|0
7691304|NCT01211262|26749553|P1|Overall Study|Adverse Event|4
7691305|NCT01211262|26749552|P2|Overall Study|Progressive Disease|9
7691306|NCT01211262|26749553|P1|Overall Study|Progressive Disease|18
7691307|NCT01211197|26749593|P6|Washout Period 2 (7 Days)|Adverse Event|0
7691308|NCT01211197|26749594|P5|Washout Period 2 (7 Days)|Adverse Event|0
7691309|NCT01211197|26749595|P4|Washout Period 2 (7 Days)|Adverse Event|0
7691310|NCT01211197|26749596|P3|Washout Period 2 (7 Days)|Adverse Event|0
7691311|NCT01211197|26749597|P2|Washout Period 2 (7 Days)|Adverse Event|0
7691312|NCT01211197|26749598|P1|Washout Period 2 (7 Days)|Adverse Event|1
7691313|NCT01211197|26749593|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7691314|NCT01211197|26749594|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7691315|NCT01211197|26749595|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7691316|NCT01211197|26749596|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7691317|NCT01211197|26749597|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7691318|NCT01211197|26749598|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7691319|NCT01211184|26749645|P3|Overall Study|Withdrawal by Subject|1
7691320|NCT01211184|26749646|P2|Overall Study|Withdrawal by Subject|2
7691321|NCT01211184|26749647|P1|Overall Study|Withdrawal by Subject|0
7691322|NCT01211145|26749662|P4|Overall Study|Patient decision|2
7691323|NCT01211145|26749663|P3|Overall Study|Patient decision|0
7691324|NCT01211145|26749664|P2|Overall Study|Patient decision|1
7691325|NCT01211145|26749665|P1|Overall Study|Patient decision|2
7691326|NCT01211145|26749662|P4|Overall Study|Eligibility criteria not fulfilled|15
7691327|NCT01211145|26749663|P3|Overall Study|Eligibility criteria not fulfilled|10
7691328|NCT01211145|26749664|P2|Overall Study|Eligibility criteria not fulfilled|12
7691329|NCT01211145|26749665|P1|Overall Study|Eligibility criteria not fulfilled|16
7691330|NCT01211145|26749662|P4|Overall Study|Severe noncompliance to protocol|0
7691331|NCT01211145|26749663|P3|Overall Study|Severe noncompliance to protocol|0
7691332|NCT01211145|26749664|P2|Overall Study|Severe noncompliance to protocol|0
7691333|NCT01211145|26749665|P1|Overall Study|Severe noncompliance to protocol|1
7691334|NCT01211145|26749662|P4|Overall Study|Study-specific withdrawal criteria|0
7691335|NCT01211145|26749663|P3|Overall Study|Study-specific withdrawal criteria|0
7691336|NCT01211145|26749664|P2|Overall Study|Study-specific withdrawal criteria|0
7691337|NCT01211145|26749665|P1|Overall Study|Study-specific withdrawal criteria|1
7691338|NCT01211145|26749662|P4|Overall Study|Lost to Follow-up|2
7691339|NCT01211145|26749663|P3|Overall Study|Lost to Follow-up|1
7691340|NCT01211145|26749664|P2|Overall Study|Lost to Follow-up|2
7691341|NCT01211145|26749665|P1|Overall Study|Lost to Follow-up|3
7691342|NCT01211145|26749662|P4|Overall Study|Reason not specified|1
7691343|NCT01211145|26749663|P3|Overall Study|Reason not specified|2
7691344|NCT01211145|26749664|P2|Overall Study|Reason not specified|2
7691345|NCT01211145|26749665|P1|Overall Study|Reason not specified|3
7691346|NCT01210807|26749719|P2|Overall Study|Not implanted bilaterally|1
7691347|NCT01210807|26749720|P1|Overall Study|Not implanted bilaterally|2
7691348|NCT01210807|26749719|P2|Overall Study|Lost to Follow-up|2
7691349|NCT01210807|26749720|P1|Overall Study|Lost to Follow-up|1
7691350|NCT01210690|26749735|P1|Overall Study|Patient could not take glucose|1
7691351|NCT01210690|26749735|P1|Overall Study|Patient refused to swallow|1
7691352|NCT01210690|26749735|P1|Overall Study|Withdrawal by Subject|1
7691353|NCT01210690|26749735|P1|Overall Study|Disease Remission|1
7691354|NCT01210690|26749735|P1|Overall Study|Lost to Follow-up|3
7691355|NCT01210690|26749735|P1|Overall Study|Lack of Efficacy|12
7691356|NCT01210690|26749735|P1|Overall Study|Adverse Event|7
7691357|NCT01210664|26749748|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
7691358|NCT01210664|26749749|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7691359|NCT01210664|26749750|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7691360|NCT01210664|26749751|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7691361|NCT01210664|26749748|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7691362|NCT01210664|26749749|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
7691363|NCT01210664|26749750|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7691364|NCT01210664|26749751|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7691365|NCT01210664|26749748|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7691366|NCT01210664|26749749|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
7691367|NCT01210664|26749750|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7691368|NCT01210664|26749751|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7691369|NCT01210651|26749779|P2|Overall Study|Injury outside study|0
7691370|NCT01210651|26749780|P1|Overall Study|Injury outside study|2
7691371|NCT01210651|26749779|P2|Overall Study|Withdrawal by Subject|1
7691372|NCT01210651|26749780|P1|Overall Study|Withdrawal by Subject|1
7691373|NCT01210651|26749779|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
7691374|NCT01210651|26749780|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
7691375|NCT01210651|26749779|P2|Overall Study|schedule conflicts|5
7691376|NCT01210651|26749780|P1|Overall Study|schedule conflicts|1
7691377|NCT01210651|26749779|P2|Overall Study|Lost to Follow-up|1
7691378|NCT01210651|26749780|P1|Overall Study|Lost to Follow-up|1
7691379|NCT01210495|26749900|P4|Overall Study|Other unspecified|0
7691380|NCT01210495|26749901|P3|Overall Study|Other unspecified|6
7691381|NCT01210495|26749902|P2|Overall Study|Other unspecified|0
7691382|NCT01210495|26749903|P1|Overall Study|Other unspecified|0
7691383|NCT01210495|26749900|P4|Overall Study|Lost to Follow-up|1
7691384|NCT01210495|26749901|P3|Overall Study|Lost to Follow-up|1
7691385|NCT01210495|26749902|P2|Overall Study|Lost to Follow-up|0
7691386|NCT01210495|26749903|P1|Overall Study|Lost to Follow-up|0
7691387|NCT01210495|26749900|P4|Overall Study|Study Terminated by Sponsor|11
7691388|NCT01210495|26749901|P3|Overall Study|Study Terminated by Sponsor|4
7691389|NCT01210495|26749902|P2|Overall Study|Study Terminated by Sponsor|0
7691390|NCT01210495|26749903|P1|Overall Study|Study Terminated by Sponsor|0
7691391|NCT01210495|26749900|P4|Overall Study|Death|54
7691392|NCT01210495|26749901|P3|Overall Study|Death|112
7691393|NCT01210495|26749902|P2|Overall Study|Death|7
7691394|NCT01210495|26749903|P1|Overall Study|Death|14
7691395|NCT01210495|26749900|P4|Overall Study|Participant Refused Further Follow-Up|2
7691396|NCT01210495|26749901|P3|Overall Study|Participant Refused Further Follow-Up|11
7691397|NCT01210495|26749902|P2|Overall Study|Participant Refused Further Follow-Up|0
7691398|NCT01210495|26749903|P1|Overall Study|Participant Refused Further Follow-Up|1
7691399|NCT01210443|26749965|P1|Overall Study|Study terminated by sponsor|2
7691400|NCT01210352|26749982|P9|Overall Study|Patient Discharged Early|0
7691401|NCT01210352|26749983|P8|Overall Study|Patient Discharged Early|0
7691402|NCT01210352|26749984|P7|Overall Study|Patient Discharged Early|0
7691403|NCT01210352|26749985|P6|Overall Study|Patient Discharged Early|0
7691404|NCT01210352|26749986|P5|Overall Study|Patient Discharged Early|0
7691405|NCT01210352|26749987|P4|Overall Study|Patient Discharged Early|0
7691406|NCT01210352|26749988|P3|Overall Study|Patient Discharged Early|1
7691407|NCT01210352|26749989|P2|Overall Study|Patient Discharged Early|0
7691408|NCT01210352|26749990|P1|Overall Study|Patient Discharged Early|0
7691409|NCT01210352|26749982|P9|Overall Study|Withdrawal by Subject|1
7691410|NCT01210352|26749983|P8|Overall Study|Withdrawal by Subject|0
7691411|NCT01210352|26749984|P7|Overall Study|Withdrawal by Subject|1
7691412|NCT01210352|26749985|P6|Overall Study|Withdrawal by Subject|0
7691413|NCT01210352|26749986|P5|Overall Study|Withdrawal by Subject|0
7691414|NCT01210352|26749987|P4|Overall Study|Withdrawal by Subject|0
7691415|NCT01210352|26749988|P3|Overall Study|Withdrawal by Subject|1
7691416|NCT01210352|26749989|P2|Overall Study|Withdrawal by Subject|0
7691417|NCT01210352|26749990|P1|Overall Study|Withdrawal by Subject|0
7691418|NCT01210352|26749982|P9|Overall Study|Physician Decision|2
7691419|NCT01210352|26749983|P8|Overall Study|Physician Decision|1
7691420|NCT01210352|26749984|P7|Overall Study|Physician Decision|0
7691421|NCT01210352|26749985|P6|Overall Study|Physician Decision|0
7691422|NCT01210352|26749986|P5|Overall Study|Physician Decision|0
7691423|NCT01210352|26749987|P4|Overall Study|Physician Decision|0
7691424|NCT01210352|26749988|P3|Overall Study|Physician Decision|0
7691425|NCT01210352|26749989|P2|Overall Study|Physician Decision|0
7691426|NCT01210352|26749990|P1|Overall Study|Physician Decision|0
7691427|NCT01210352|26749982|P9|Overall Study|Lack of Efficacy|0
7691428|NCT01210352|26749983|P8|Overall Study|Lack of Efficacy|0
7691429|NCT01210352|26749984|P7|Overall Study|Lack of Efficacy|1
7691430|NCT01210352|26749985|P6|Overall Study|Lack of Efficacy|0
7691431|NCT01210352|26749986|P5|Overall Study|Lack of Efficacy|0
7691432|NCT01210352|26749987|P4|Overall Study|Lack of Efficacy|0
7691433|NCT01210352|26749988|P3|Overall Study|Lack of Efficacy|0
7691434|NCT01210352|26749989|P2|Overall Study|Lack of Efficacy|0
7691435|NCT01210352|26749990|P1|Overall Study|Lack of Efficacy|0
7691436|NCT01210352|26749982|P9|Overall Study|Adverse Event|1
7691437|NCT01210352|26749983|P8|Overall Study|Adverse Event|2
7691438|NCT01210352|26749984|P7|Overall Study|Adverse Event|0
7691439|NCT01210352|26749985|P6|Overall Study|Adverse Event|0
7691440|NCT01210352|26749986|P5|Overall Study|Adverse Event|0
7691441|NCT01210352|26749987|P4|Overall Study|Adverse Event|0
7691442|NCT01210352|26749988|P3|Overall Study|Adverse Event|0
7691443|NCT01210352|26749989|P2|Overall Study|Adverse Event|0
7691444|NCT01210352|26749990|P1|Overall Study|Adverse Event|0
7691445|NCT01210222|26750181|P1|Overall Study|Never treated|1
7691446|NCT01210222|26750181|P1|Overall Study|Ineligible|2
7691447|NCT01210144|26750217|P2|Overall Study|No transfer|0
7691448|NCT01210144|26750218|P1|Overall Study|No transfer|1
7691449|NCT01210144|26750217|P2|Overall Study|No fertilization|0
7691450|NCT01210144|26750218|P1|Overall Study|No fertilization|1
7691451|NCT01210144|26750217|P2|Overall Study|Lack of ovarian response|0
7691452|NCT01210144|26750218|P1|Overall Study|Lack of ovarian response|1
7691453|NCT01210118|26750240|P2|Overall Study|Spontaneous abortion|3
7691454|NCT01210118|26750241|P1|Overall Study|Spontaneous abortion|1
7691455|NCT01210118|26750240|P2|Overall Study|Protocol Violation|1
7691456|NCT01210118|26750241|P1|Overall Study|Protocol Violation|1
7691457|NCT01210118|26750240|P2|Overall Study|Lost to Follow-up|1
7691458|NCT01210118|26750241|P1|Overall Study|Lost to Follow-up|1
7691459|NCT01210001|26750265|P3|Overall Study|Other reason not defined above|1
7691460|NCT01210001|26750266|P2|Overall Study|Other reason not defined above|2
7691461|NCT01210001|26750267|P1|Overall Study|Other reason not defined above|2
7691462|NCT01210001|26750265|P3|Overall Study|Patient refusal to continue,not due toAE|1
7691463|NCT01210001|26750266|P2|Overall Study|Patient refusal to continue,not due toAE|2
7691464|NCT01210001|26750267|P1|Overall Study|Patient refusal to continue,not due toAE|6
7691465|NCT01210001|26750265|P3|Overall Study|Lost to Follow-up|2
7691466|NCT01210001|26750266|P2|Overall Study|Lost to Follow-up|3
7691467|NCT01210001|26750267|P1|Overall Study|Lost to Follow-up|4
7691468|NCT01210001|26750265|P3|Overall Study|Non compliant with protocol|3
7691469|NCT01210001|26750266|P2|Overall Study|Non compliant with protocol|2
7691470|NCT01210001|26750267|P1|Overall Study|Non compliant with protocol|2
7691471|NCT01210001|26750265|P3|Overall Study|Adverse Event|5
7691472|NCT01210001|26750266|P2|Overall Study|Adverse Event|2
7691473|NCT01210001|26750267|P1|Overall Study|Adverse Event|4
7691474|NCT01210001|26750265|P3|Overall Study|Not treated|0
7691475|NCT01210001|26750266|P2|Overall Study|Not treated|0
7691476|NCT01210001|26750267|P1|Overall Study|Not treated|1
7691477|NCT01209949|26750287|P1|Overall Study|Lost to Follow-up|3
7691478|NCT01209832|26750293|P1|Period 2|Sponsor Decision|1
7691479|NCT01209832|26750293|P1|Period 1|Sponsor Decision and was not dosed|1
7691480|NCT01209780|26750312|P5|Overall Study|Inappropriate enrollment|1
7691481|NCT01209780|26750313|P4|Overall Study|Inappropriate enrollment|0
7691482|NCT01209780|26750314|P3|Overall Study|Inappropriate enrollment|0
7691483|NCT01209780|26750315|P2|Overall Study|Inappropriate enrollment|2
7691484|NCT01209780|26750316|P1|Overall Study|Inappropriate enrollment|0
7691485|NCT01209780|26750312|P5|Overall Study|Protocol Violation|0
7691486|NCT01209780|26750313|P4|Overall Study|Protocol Violation|0
7691487|NCT01209780|26750314|P3|Overall Study|Protocol Violation|0
7691488|NCT01209780|26750315|P2|Overall Study|Protocol Violation|1
7691489|NCT01209780|26750316|P1|Overall Study|Protocol Violation|0
7691490|NCT01209780|26750312|P5|Overall Study|Lost to Follow-up|4
7691491|NCT01209780|26750313|P4|Overall Study|Lost to Follow-up|9
7691492|NCT01209780|26750314|P3|Overall Study|Lost to Follow-up|3
7691493|NCT01209780|26750315|P2|Overall Study|Lost to Follow-up|12
7691494|NCT01209780|26750316|P1|Overall Study|Lost to Follow-up|17
7691495|NCT01209780|26750312|P5|Overall Study|Withdrawal by Subject|0
7691496|NCT01209780|26750313|P4|Overall Study|Withdrawal by Subject|1
7691497|NCT01209780|26750314|P3|Overall Study|Withdrawal by Subject|1
7691498|NCT01209780|26750315|P2|Overall Study|Withdrawal by Subject|2
7691499|NCT01209780|26750316|P1|Overall Study|Withdrawal by Subject|9
7691500|NCT01209780|26750312|P5|Overall Study|Adverse Event|0
7691501|NCT01209780|26750313|P4|Overall Study|Adverse Event|0
7691502|NCT01209780|26750314|P3|Overall Study|Adverse Event|0
7691503|NCT01209780|26750315|P2|Overall Study|Adverse Event|1
7691504|NCT01209780|26750316|P1|Overall Study|Adverse Event|0
7691505|NCT01209767|26750342|P1|Overall Study|Lost to Follow-up|3
7691506|NCT01209767|26750342|P1|Overall Study|Withdrawal by Subject|1
7691507|NCT01209689|26750411|P2|Overall Study|Sponsor's Decision to Stop the Study|17
7691508|NCT01209689|26750412|P1|Overall Study|Sponsor's Decision to Stop the Study|68
7691509|NCT01209689|26750411|P2|Overall Study|Failure to Return|0
7691510|NCT01209689|26750412|P1|Overall Study|Failure to Return|3
7691511|NCT01209689|26750411|P2|Overall Study|Violation of Selection Criteria at Entry|0
7691512|NCT01209689|26750412|P1|Overall Study|Violation of Selection Criteria at Entry|1
7691513|NCT01209689|26750411|P2|Overall Study|Adverse Event|0
7691514|NCT01209689|26750412|P1|Overall Study|Adverse Event|4
7691515|NCT01209689|26750411|P2|Overall Study|Refused Treatment|3
7691516|NCT01209689|26750412|P1|Overall Study|Refused Treatment|8
7691517|NCT01209689|26750411|P2|Overall Study|Insufficient Therapeutic Response|2
7691518|NCT01209689|26750412|P1|Overall Study|Insufficient Therapeutic Response|7
7691519|NCT01209624|26750418|P1|Overall Study|Other|4
7691520|NCT01209624|26750418|P1|Overall Study|Lost to Follow-up|290
7691521|NCT01209624|26750418|P1|Overall Study|Lack of Efficacy|17
7691522|NCT01209624|26750418|P1|Overall Study|Adverse Event|13
7691523|NCT01209624|26750418|P1|Overall Study|Death|2
7691524|NCT01209598|26750451|P2|Overall Study|Withdrawal by Subject|0
7691525|NCT01209598|26750452|P1|Overall Study|Withdrawal by Subject|1
7691526|NCT01209520|26750460|P1|Overall Study|Withdrawal by Subject|3
7691527|NCT01209325|26750470|P1|Overall Study|Incarceration|2
7691528|NCT01209325|26750470|P1|Overall Study|Refusal prior to therapy|1
7691529|NCT01209325|26750470|P1|Overall Study|Protocol Violation|4
7691530|NCT01209325|26750470|P1|Overall Study|Refusal after starting therapy|8
7691531|NCT01209325|26750470|P1|Overall Study|Relocated|3
7691532|NCT01209325|26750470|P1|Overall Study|Adverse Event|1
7691533|NCT01209325|26750470|P1|Overall Study|Lost to Follow-up|24
7691534|NCT01209286|26750525|P3|Overall Study|Other|0
7691535|NCT01209286|26750526|P2|Overall Study|Other|1
7691536|NCT01209286|26750527|P1|Overall Study|Other|0
7691537|NCT01209286|26750525|P3|Overall Study|Physician Decision|0
7691538|NCT01209286|26750526|P2|Overall Study|Physician Decision|2
7691539|NCT01209286|26750527|P1|Overall Study|Physician Decision|0
7691540|NCT01209286|26750525|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
7691541|NCT01209286|26750526|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
7691542|NCT01209286|26750527|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
7691543|NCT01209286|26750525|P3|Overall Study|Hematological Relapse After Remission|1
7691544|NCT01209286|26750526|P2|Overall Study|Hematological Relapse After Remission|1
7691545|NCT01209286|26750527|P1|Overall Study|Hematological Relapse After Remission|0
7691546|NCT01209286|26750525|P3|Overall Study|Adverse Event|1
7691547|NCT01209286|26750526|P2|Overall Study|Adverse Event|3
7691548|NCT01209286|26750527|P1|Overall Study|Adverse Event|4
7691549|NCT01209143|26750647|P2|Overall Study|Disease progression|16
7691550|NCT01209143|26750648|P1|Overall Study|Disease progression|11
7691551|NCT01209143|26750647|P2|Overall Study|Withdrawal by Subject|1
7691552|NCT01209143|26750648|P1|Overall Study|Withdrawal by Subject|2
7691553|NCT01209143|26750647|P2|Overall Study|Lost to Follow-up|0
7691554|NCT01209143|26750648|P1|Overall Study|Lost to Follow-up|1
7691555|NCT01209143|26750647|P2|Overall Study|Physician Decision|1
7691556|NCT01209143|26750648|P1|Overall Study|Physician Decision|3
7691557|NCT01209143|26750647|P2|Overall Study|Death|1
7691558|NCT01209143|26750648|P1|Overall Study|Death|0
7691559|NCT01209143|26750647|P2|Overall Study|Adverse Event|1
7691560|NCT01209143|26750648|P1|Overall Study|Adverse Event|2
7691561|NCT01209078|26750658|P2|Overall Study|Withdrawal by Subject|1
7691562|NCT01209078|26750659|P1|Overall Study|Withdrawal by Subject|2
7691563|NCT01209078|26750658|P2|Overall Study|Physician Decision|2
7691564|NCT01209078|26750659|P1|Overall Study|Physician Decision|5
7691565|NCT01209078|26750658|P2|Overall Study|Lost to Follow-up|0
7691566|NCT01209078|26750659|P1|Overall Study|Lost to Follow-up|4
7691567|NCT01209078|26750658|P2|Overall Study|Adverse Event|0
7691568|NCT01209078|26750659|P1|Overall Study|Adverse Event|5
7691569|NCT01208961|26750734|P2|High-Fat Period III|Protocol Violation|0
7691570|NCT01208961|26750735|P1|High-Fat Period III|Protocol Violation|1
7691571|NCT01208870|26750757|P2|Overall Study|Lost to Follow-up|8
7691572|NCT01208870|26750758|P1|Overall Study|Lost to Follow-up|2
7691573|NCT01208415|26750774|P1|Overall Study|Still be eligible for follow-up|33
7691574|NCT01208415|26750774|P1|Overall Study|Device not placed|1
7691575|NCT01208415|26750774|P1|Overall Study|Withdrawal by Subject|3
7691576|NCT01208415|26750774|P1|Overall Study|Lost to Follow-up|2
7691577|NCT01208415|26750774|P1|Overall Study|Death|1
7691578|NCT01208402|26750780|P2|Overall Study|Withdrawal by Subject|0
7691579|NCT01208402|26750781|P1|Overall Study|Withdrawal by Subject|1
7691580|NCT01208337|26750797|P1|Overall Study|Death|3
7691581|NCT01208324|26750809|P4|Post-randomization of Patch|Withdrawal by Subject|0
7691582|NCT01208324|26750810|P3|Post-randomization of Patch|Withdrawal by Subject|0
7691583|NCT01208324|26750811|P2|Post-randomization of Patch|Withdrawal by Subject|0
7691584|NCT01208324|26750812|P1|Post-randomization of Patch|Withdrawal by Subject|1
7691585|NCT01208233|26750828|P6|Overall Study|Withdrawal by Subject|2
7691586|NCT01208233|26750829|P5|Overall Study|Withdrawal by Subject|4
7691587|NCT01208233|26750830|P4|Overall Study|Withdrawal by Subject|1
7691588|NCT01208233|26750831|P3|Overall Study|Withdrawal by Subject|1
7691589|NCT01208233|26750832|P2|Overall Study|Withdrawal by Subject|0
7691590|NCT01208233|26750833|P1|Overall Study|Withdrawal by Subject|1
7691591|NCT01208233|26750828|P6|Overall Study|Other|1
7691592|NCT01208233|26750829|P5|Overall Study|Other|0
7691593|NCT01208233|26750830|P4|Overall Study|Other|0
7691594|NCT01208233|26750831|P3|Overall Study|Other|0
7691595|NCT01208233|26750832|P2|Overall Study|Other|1
7691596|NCT01208233|26750833|P1|Overall Study|Other|2
7691597|NCT01208233|26750828|P6|Overall Study|Protocol Violation|0
7691598|NCT01208233|26750829|P5|Overall Study|Protocol Violation|3
7691599|NCT01208233|26750830|P4|Overall Study|Protocol Violation|0
7691600|NCT01208233|26750831|P3|Overall Study|Protocol Violation|0
7691601|NCT01208233|26750832|P2|Overall Study|Protocol Violation|0
7691602|NCT01208233|26750833|P1|Overall Study|Protocol Violation|0
7691603|NCT01208233|26750828|P6|Overall Study|Study terminated by sponsor|7
7691604|NCT01208233|26750829|P5|Overall Study|Study terminated by sponsor|10
7691605|NCT01208233|26750830|P4|Overall Study|Study terminated by sponsor|0
7691606|NCT01208233|26750831|P3|Overall Study|Study terminated by sponsor|0
7691607|NCT01208233|26750832|P2|Overall Study|Study terminated by sponsor|0
7691608|NCT01208233|26750833|P1|Overall Study|Study terminated by sponsor|0
7691609|NCT01208233|26750828|P6|Overall Study|Medication error without adverse event|1
7691610|NCT01208233|26750829|P5|Overall Study|Medication error without adverse event|0
7691611|NCT01208233|26750830|P4|Overall Study|Medication error without adverse event|0
7691612|NCT01208233|26750831|P3|Overall Study|Medication error without adverse event|0
7691613|NCT01208233|26750832|P2|Overall Study|Medication error without adverse event|0
7691614|NCT01208233|26750833|P1|Overall Study|Medication error without adverse event|0
7691615|NCT01208233|26750828|P6|Overall Study|Did not meet entrance criteria|0
7691616|NCT01208233|26750829|P5|Overall Study|Did not meet entrance criteria|1
7691617|NCT01208233|26750830|P4|Overall Study|Did not meet entrance criteria|0
7691618|NCT01208233|26750831|P3|Overall Study|Did not meet entrance criteria|1
7691619|NCT01208233|26750832|P2|Overall Study|Did not meet entrance criteria|1
7691620|NCT01208233|26750833|P1|Overall Study|Did not meet entrance criteria|2
7691621|NCT01208233|26750828|P6|Overall Study|Death|5
7691622|NCT01208233|26750829|P5|Overall Study|Death|3
7691623|NCT01208233|26750830|P4|Overall Study|Death|0
7691624|NCT01208233|26750831|P3|Overall Study|Death|0
7691625|NCT01208233|26750832|P2|Overall Study|Death|0
7691626|NCT01208233|26750833|P1|Overall Study|Death|0
7691627|NCT01208233|26750828|P6|Overall Study|Adverse Event|5
7691628|NCT01208233|26750829|P5|Overall Study|Adverse Event|3
7691629|NCT01208233|26750830|P4|Overall Study|Adverse Event|0
7691630|NCT01208233|26750831|P3|Overall Study|Adverse Event|2
7691631|NCT01208233|26750832|P2|Overall Study|Adverse Event|1
7691632|NCT01208233|26750833|P1|Overall Study|Adverse Event|0
7691633|NCT01208207|26750958|P7|Part II|Technical Problems|0
7691634|NCT01208207|26750959|P6|Part II|Technical Problems|1
7691635|NCT01208207|26750960|P5|Part II|Technical Problems|0
7691636|NCT01208207|26750961|P4|Part II|Technical Problems|1
7691637|NCT01208207|26750962|P3|Part II|Technical Problems|0
7691638|NCT01208207|26750963|P2|Part II|Technical Problems|0
7691639|NCT01208207|26750964|P1|Part II|Technical Problems|0
7691640|NCT01208207|26750958|P7|Part II|Protocol Violation|0
7691641|NCT01208207|26750959|P6|Part II|Protocol Violation|0
7691642|NCT01208207|26750960|P5|Part II|Protocol Violation|0
7691643|NCT01208207|26750961|P4|Part II|Protocol Violation|1
7691644|NCT01208207|26750962|P3|Part II|Protocol Violation|0
7691645|NCT01208207|26750963|P2|Part II|Protocol Violation|0
7691646|NCT01208207|26750964|P1|Part II|Protocol Violation|0
7691647|NCT01208207|26750958|P7|Part II|Physician Decision|0
7691648|NCT01208207|26750959|P6|Part II|Physician Decision|2
7691649|NCT01208207|26750960|P5|Part II|Physician Decision|0
7691650|NCT01208207|26750961|P4|Part II|Physician Decision|1
7691651|NCT01208207|26750962|P3|Part II|Physician Decision|0
7691652|NCT01208207|26750963|P2|Part II|Physician Decision|0
7691653|NCT01208207|26750964|P1|Part II|Physician Decision|0
7691654|NCT01208207|26750958|P7|Part II|Non-Compliance With Study Drug|0
7691655|NCT01208207|26750959|P6|Part II|Non-Compliance With Study Drug|1
7691656|NCT01208207|26750960|P5|Part II|Non-Compliance With Study Drug|1
7691657|NCT01208207|26750961|P4|Part II|Non-Compliance With Study Drug|4
7691658|NCT01208207|26750962|P3|Part II|Non-Compliance With Study Drug|0
7691659|NCT01208207|26750963|P2|Part II|Non-Compliance With Study Drug|0
7691660|NCT01208207|26750964|P1|Part II|Non-Compliance With Study Drug|0
7691661|NCT01208207|26750958|P7|Part II|Lost to Follow-up|1
7691662|NCT01208207|26750959|P6|Part II|Lost to Follow-up|2
7691663|NCT01208207|26750960|P5|Part II|Lost to Follow-up|0
7691664|NCT01208207|26750961|P4|Part II|Lost to Follow-up|4
7691665|NCT01208207|26750962|P3|Part II|Lost to Follow-up|0
7691666|NCT01208207|26750963|P2|Part II|Lost to Follow-up|0
7691667|NCT01208207|26750964|P1|Part II|Lost to Follow-up|0
7691668|NCT01208207|26750958|P7|Part II|Lack of Efficacy|3
7691669|NCT01208207|26750959|P6|Part II|Lack of Efficacy|3
7691670|NCT01208207|26750960|P5|Part II|Lack of Efficacy|4
7691671|NCT01208207|26750961|P4|Part II|Lack of Efficacy|6
7691672|NCT01208207|26750962|P3|Part II|Lack of Efficacy|0
7691673|NCT01208207|26750963|P2|Part II|Lack of Efficacy|0
7691674|NCT01208207|26750964|P1|Part II|Lack of Efficacy|0
7691675|NCT01208207|26750958|P7|Part II|Adverse Event|2
7691676|NCT01208207|26750959|P6|Part II|Adverse Event|4
7691677|NCT01208207|26750960|P5|Part II|Adverse Event|9
7691678|NCT01208207|26750961|P4|Part II|Adverse Event|5
7691679|NCT01208207|26750962|P3|Part II|Adverse Event|0
7691680|NCT01208207|26750963|P2|Part II|Adverse Event|0
7691681|NCT01208207|26750964|P1|Part II|Adverse Event|0
7691682|NCT01208207|26750958|P7|Part II|Withdrawal by Subject|5
7691683|NCT01208207|26750959|P6|Part II|Withdrawal by Subject|3
7691684|NCT01208207|26750960|P5|Part II|Withdrawal by Subject|9
7691685|NCT01208207|26750961|P4|Part II|Withdrawal by Subject|10
7691686|NCT01208207|26750962|P3|Part II|Withdrawal by Subject|0
7691687|NCT01208207|26750963|P2|Part II|Withdrawal by Subject|0
7691688|NCT01208207|26750964|P1|Part II|Withdrawal by Subject|0
7691689|NCT01208207|26750958|P7|Part I|Withdrawal by Subject|0
7691690|NCT01208207|26750959|P6|Part I|Withdrawal by Subject|0
7691691|NCT01208207|26750960|P5|Part I|Withdrawal by Subject|0
7691692|NCT01208207|26750961|P4|Part I|Withdrawal by Subject|0
7691693|NCT01208207|26750962|P3|Part I|Withdrawal by Subject|4
7691694|NCT01208207|26750963|P2|Part I|Withdrawal by Subject|4
7691695|NCT01208207|26750964|P1|Part I|Withdrawal by Subject|14
7691696|NCT01208207|26750958|P7|Part I|Protocol Violation|0
7691697|NCT01208207|26750959|P6|Part I|Protocol Violation|0
7691698|NCT01208207|26750960|P5|Part I|Protocol Violation|0
7691699|NCT01208207|26750961|P4|Part I|Protocol Violation|0
7691700|NCT01208207|26750962|P3|Part I|Protocol Violation|2
7691701|NCT01208207|26750963|P2|Part I|Protocol Violation|0
7691702|NCT01208207|26750964|P1|Part I|Protocol Violation|8
7691703|NCT01208207|26750958|P7|Part I|Progressive Disease|0
7691704|NCT01208207|26750959|P6|Part I|Progressive Disease|0
7691705|NCT01208207|26750960|P5|Part I|Progressive Disease|0
7691706|NCT01208207|26750961|P4|Part I|Progressive Disease|0
7691707|NCT01208207|26750962|P3|Part I|Progressive Disease|0
7691708|NCT01208207|26750963|P2|Part I|Progressive Disease|0
7691709|NCT01208207|26750964|P1|Part I|Progressive Disease|1
7691710|NCT01208207|26750958|P7|Part I|Physician Decision|0
7691711|NCT01208207|26750959|P6|Part I|Physician Decision|0
7691712|NCT01208207|26750960|P5|Part I|Physician Decision|0
7691713|NCT01208207|26750961|P4|Part I|Physician Decision|0
7691714|NCT01208207|26750962|P3|Part I|Physician Decision|0
7691715|NCT01208207|26750963|P2|Part I|Physician Decision|1
7691716|NCT01208207|26750964|P1|Part I|Physician Decision|0
7691717|NCT01208207|26750958|P7|Part I|Non-Compliance With Study Drug|0
7691718|NCT01208207|26750959|P6|Part I|Non-Compliance With Study Drug|0
7691719|NCT01208207|26750960|P5|Part I|Non-Compliance With Study Drug|0
7691720|NCT01208207|26750961|P4|Part I|Non-Compliance With Study Drug|0
7691721|NCT01208207|26750962|P3|Part I|Non-Compliance With Study Drug|1
7691722|NCT01208207|26750963|P2|Part I|Non-Compliance With Study Drug|0
7691723|NCT01208207|26750964|P1|Part I|Non-Compliance With Study Drug|1
7691724|NCT01208207|26750958|P7|Part I|Lost to Follow-up|0
7691725|NCT01208207|26750959|P6|Part I|Lost to Follow-up|0
7691726|NCT01208207|26750960|P5|Part I|Lost to Follow-up|0
7691727|NCT01208207|26750961|P4|Part I|Lost to Follow-up|0
7691728|NCT01208207|26750962|P3|Part I|Lost to Follow-up|0
7691729|NCT01208207|26750963|P2|Part I|Lost to Follow-up|1
7691730|NCT01208207|26750964|P1|Part I|Lost to Follow-up|6
7691731|NCT01208207|26750958|P7|Part I|Lack of Efficacy|0
7691732|NCT01208207|26750959|P6|Part I|Lack of Efficacy|0
7691733|NCT01208207|26750960|P5|Part I|Lack of Efficacy|0
7691734|NCT01208207|26750961|P4|Part I|Lack of Efficacy|0
7691735|NCT01208207|26750962|P3|Part I|Lack of Efficacy|2
7691736|NCT01208207|26750963|P2|Part I|Lack of Efficacy|3
7691737|NCT01208207|26750964|P1|Part I|Lack of Efficacy|21
7691738|NCT01208207|26750958|P7|Part I|Adverse Event|0
7691739|NCT01208207|26750959|P6|Part I|Adverse Event|0
7691740|NCT01208207|26750960|P5|Part I|Adverse Event|0
7691741|NCT01208207|26750961|P4|Part I|Adverse Event|0
7691742|NCT01208207|26750962|P3|Part I|Adverse Event|6
7691743|NCT01208207|26750963|P2|Part I|Adverse Event|2
7691744|NCT01208207|26750964|P1|Part I|Adverse Event|19
7691745|NCT01208181|26750991|P5|Part 2|Lack of Efficacy|0
7691746|NCT01208181|26750992|P4|Part 2|Lack of Efficacy|7
7691747|NCT01208181|26750993|P3|Part 2|Lack of Efficacy|5
7691748|NCT01208181|26750994|P2|Part 2|Lack of Efficacy|0
7691749|NCT01208181|26750995|P1|Part 2|Lack of Efficacy|0
7691750|NCT01208181|26750991|P5|Part 2|Lost to Follow-up|0
7691751|NCT01208181|26750992|P4|Part 2|Lost to Follow-up|2
7691752|NCT01208181|26750993|P3|Part 2|Lost to Follow-up|1
7691753|NCT01208181|26750994|P2|Part 2|Lost to Follow-up|0
7691754|NCT01208181|26750995|P1|Part 2|Lost to Follow-up|0
7691755|NCT01208181|26750991|P5|Part 2|Non-compliance with study drug|0
7691756|NCT01208181|26750992|P4|Part 2|Non-compliance with study drug|1
7691757|NCT01208181|26750993|P3|Part 2|Non-compliance with study drug|1
7691758|NCT01208181|26750994|P2|Part 2|Non-compliance with study drug|0
7691759|NCT01208181|26750995|P1|Part 2|Non-compliance with study drug|0
7691760|NCT01208181|26750991|P5|Part 2|Physician Decision|0
7691761|NCT01208181|26750992|P4|Part 2|Physician Decision|2
7691762|NCT01208181|26750993|P3|Part 2|Physician Decision|1
7691763|NCT01208181|26750994|P2|Part 2|Physician Decision|0
7691764|NCT01208181|26750995|P1|Part 2|Physician Decision|0
7691765|NCT01208181|26750991|P5|Part 2|Protocol Violation|0
7691766|NCT01208181|26750992|P4|Part 2|Protocol Violation|0
7691767|NCT01208181|26750993|P3|Part 2|Protocol Violation|1
7691768|NCT01208181|26750994|P2|Part 2|Protocol Violation|0
7691769|NCT01208181|26750995|P1|Part 2|Protocol Violation|0
7691770|NCT01208181|26750991|P5|Part 2|Withdrawal by Subject|0
7691771|NCT01208181|26750992|P4|Part 2|Withdrawal by Subject|1
7691772|NCT01208181|26750993|P3|Part 2|Withdrawal by Subject|1
7691773|NCT01208181|26750994|P2|Part 2|Withdrawal by Subject|0
7691774|NCT01208181|26750995|P1|Part 2|Withdrawal by Subject|0
7691775|NCT01208181|26750991|P5|Part 2|Adverse Event|0
7691776|NCT01208181|26750992|P4|Part 2|Adverse Event|7
7691777|NCT01208181|26750993|P3|Part 2|Adverse Event|6
7691778|NCT01208181|26750994|P2|Part 2|Adverse Event|0
7691779|NCT01208181|26750995|P1|Part 2|Adverse Event|0
7691780|NCT01208181|26750991|P5|Part 1|Adverse Event|4
7691781|NCT01208181|26750992|P4|Part 1|Adverse Event|0
7691782|NCT01208181|26750993|P3|Part 1|Adverse Event|0
7691783|NCT01208181|26750994|P2|Part 1|Adverse Event|24
7691784|NCT01208181|26750995|P1|Part 1|Adverse Event|26
7691785|NCT01208181|26750991|P5|Part 1|Lack of Efficacy|17
7691786|NCT01208181|26750992|P4|Part 1|Lack of Efficacy|0
7691787|NCT01208181|26750993|P3|Part 1|Lack of Efficacy|0
7691788|NCT01208181|26750994|P2|Part 1|Lack of Efficacy|12
7691789|NCT01208181|26750995|P1|Part 1|Lack of Efficacy|37
7691790|NCT01208181|26750991|P5|Part 1|Lost to Follow-up|1
7691791|NCT01208181|26750992|P4|Part 1|Lost to Follow-up|0
7691792|NCT01208181|26750993|P3|Part 1|Lost to Follow-up|0
7691793|NCT01208181|26750994|P2|Part 1|Lost to Follow-up|3
7691794|NCT01208181|26750995|P1|Part 1|Lost to Follow-up|5
7691795|NCT01208181|26750991|P5|Part 1|Non-compliance with study drug|0
7691796|NCT01208181|26750992|P4|Part 1|Non-compliance with study drug|0
7691797|NCT01208181|26750993|P3|Part 1|Non-compliance with study drug|0
7691798|NCT01208181|26750994|P2|Part 1|Non-compliance with study drug|1
7691799|NCT01208181|26750995|P1|Part 1|Non-compliance with study drug|1
7691800|NCT01208181|26750991|P5|Part 1|Physician Decision|0
7691801|NCT01208181|26750992|P4|Part 1|Physician Decision|0
7691802|NCT01208181|26750993|P3|Part 1|Physician Decision|0
7691803|NCT01208181|26750994|P2|Part 1|Physician Decision|0
7691804|NCT01208181|26750995|P1|Part 1|Physician Decision|4
7691805|NCT01208181|26750991|P5|Part 1|Protocol Violation|0
7691806|NCT01208181|26750992|P4|Part 1|Protocol Violation|0
7691807|NCT01208181|26750993|P3|Part 1|Protocol Violation|0
7691808|NCT01208181|26750994|P2|Part 1|Protocol Violation|5
7691809|NCT01208181|26750995|P1|Part 1|Protocol Violation|10
7691810|NCT01208181|26750991|P5|Part 1|Technical problem|0
7691811|NCT01208181|26750992|P4|Part 1|Technical problem|0
7691812|NCT01208181|26750993|P3|Part 1|Technical problem|0
7691813|NCT01208181|26750994|P2|Part 1|Technical problem|0
7691814|NCT01208181|26750995|P1|Part 1|Technical problem|5
7691815|NCT01208181|26750991|P5|Part 1|Withdrawal by Subject|0
7691816|NCT01208181|26750992|P4|Part 1|Withdrawal by Subject|0
7691817|NCT01208181|26750993|P3|Part 1|Withdrawal by Subject|0
7691818|NCT01208181|26750994|P2|Part 1|Withdrawal by Subject|10
7691819|NCT01208181|26750995|P1|Part 1|Withdrawal by Subject|11
7691820|NCT01208103|26751024|P1|Overall Study|Withdrawal by Subject|1
7691821|NCT01208103|26751024|P1|Overall Study|Adverse Event|1
7691822|NCT01208051|26751037|P5|Total Enrollment|Brain metastases|0
7691823|NCT01208051|26751038|P4|Total Enrollment|Brain metastases|0
7691824|NCT01208051|26751039|P3|Total Enrollment|Brain metastases|1
7691825|NCT01208051|26751040|P2|Total Enrollment|Brain metastases|0
7691826|NCT01208051|26751041|P1|Total Enrollment|Brain metastases|0
7691827|NCT01208051|26751037|P5|Total Enrollment|Withdrawal by Subject|2
7691828|NCT01208051|26751038|P4|Total Enrollment|Withdrawal by Subject|0
7691829|NCT01208051|26751039|P3|Total Enrollment|Withdrawal by Subject|0
7691830|NCT01208051|26751040|P2|Total Enrollment|Withdrawal by Subject|1
7691831|NCT01208051|26751041|P1|Total Enrollment|Withdrawal by Subject|0
7691832|NCT01208038|26751088|P1|Overall Study|Withdrawal by Subject|1
7691833|NCT01207687|26751166|P1|Overall Study|Withdrawal by Subject|1
7691834|NCT01207687|26751166|P1|Overall Study|Adverse Event|1
7691835|NCT01207596|26751204|P1|Overall Study|Withdrawal by Subject|1
7691836|NCT01207596|26751204|P1|Overall Study|Adverse Event|3
7691837|NCT01207596|26751204|P1|Overall Study|Lack of Efficacy|1
7691838|NCT01207596|26751204|P1|Overall Study|Physician Decision|4
7691839|NCT01207583|26751217|P3|Overall Study|Lost to Follow-up|0
7691840|NCT01207583|26751218|P2|Overall Study|Lost to Follow-up|2
7691841|NCT01207583|26751219|P1|Overall Study|Lost to Follow-up|0
7691842|NCT01207583|26751217|P3|Overall Study|Participant failed to return|0
7691843|NCT01207583|26751218|P2|Overall Study|Participant failed to return|0
7691844|NCT01207583|26751219|P1|Overall Study|Participant failed to return|1
7691845|NCT01207583|26751217|P3|Overall Study|Withdrawal by Subject|1
7691846|NCT01207583|26751218|P2|Overall Study|Withdrawal by Subject|3
7691847|NCT01207583|26751219|P1|Overall Study|Withdrawal by Subject|0
7691848|NCT01207492|26751272|P1|Overall Study|Toxicity|1
7691849|NCT01207492|26751272|P1|Overall Study|Progressive disease|3
7691850|NCT01207492|26751272|P1|Overall Study|Physician Decision|1
7691851|NCT01207492|26751272|P1|Overall Study|Withdrawal by Subject|9
7691852|NCT01207492|26751272|P1|Overall Study|Still on study|1
7691853|NCT01207453|26751287|P2|2nd Intervention|Lost to Follow-up|0
7691854|NCT01207453|26751288|P1|2nd Intervention|Lost to Follow-up|1
7691855|NCT01207453|26751287|P2|2nd Intervention|Adverse Event|2
7691856|NCT01207453|26751288|P1|2nd Intervention|Adverse Event|1
7691857|NCT01207453|26751287|P2|Washout|Lost to Follow-up|0
7691858|NCT01207453|26751288|P1|Washout|Lost to Follow-up|1
7691859|NCT01207453|26751287|P2|Washout|Adverse Event|0
7691860|NCT01207453|26751288|P1|Washout|Adverse Event|1
7691861|NCT01207453|26751287|P2|First Intervention|Adverse Event|1
7691862|NCT01207453|26751288|P1|First Intervention|Adverse Event|2
7691863|NCT01207440|26751314|P7|Overall Study|Reason Not Specified|0
7691864|NCT01207440|26751315|P6|Overall Study|Reason Not Specified|3
7691865|NCT01207440|26751316|P5|Overall Study|Reason Not Specified|4
7691866|NCT01207440|26751317|P4|Overall Study|Reason Not Specified|0
7691867|NCT01207440|26751318|P3|Overall Study|Reason Not Specified|7
7691868|NCT01207440|26751319|P2|Overall Study|Reason Not Specified|10
7691869|NCT01207440|26751320|P1|Overall Study|Reason Not Specified|10
7691870|NCT01207440|26751314|P7|Overall Study|Withdrawal by Subject|0
7691871|NCT01207440|26751315|P6|Overall Study|Withdrawal by Subject|2
7691872|NCT01207440|26751316|P5|Overall Study|Withdrawal by Subject|2
7691873|NCT01207440|26751317|P4|Overall Study|Withdrawal by Subject|3
7691874|NCT01207440|26751318|P3|Overall Study|Withdrawal by Subject|5
7691875|NCT01207440|26751319|P2|Overall Study|Withdrawal by Subject|4
7691876|NCT01207440|26751320|P1|Overall Study|Withdrawal by Subject|29
7691877|NCT01207440|26751314|P7|Overall Study|Site Terminated by Sponsor|2
7691878|NCT01207440|26751315|P6|Overall Study|Site Terminated by Sponsor|0
7691879|NCT01207440|26751316|P5|Overall Study|Site Terminated by Sponsor|3
7691880|NCT01207440|26751317|P4|Overall Study|Site Terminated by Sponsor|2
7691881|NCT01207440|26751318|P3|Overall Study|Site Terminated by Sponsor|12
7691882|NCT01207440|26751319|P2|Overall Study|Site Terminated by Sponsor|19
7691883|NCT01207440|26751320|P1|Overall Study|Site Terminated by Sponsor|69
7691884|NCT01207440|26751314|P7|Overall Study|Protocol Violation|0
7691885|NCT01207440|26751315|P6|Overall Study|Protocol Violation|0
7691886|NCT01207440|26751316|P5|Overall Study|Protocol Violation|0
7691887|NCT01207440|26751317|P4|Overall Study|Protocol Violation|0
7691888|NCT01207440|26751318|P3|Overall Study|Protocol Violation|0
7691889|NCT01207440|26751319|P2|Overall Study|Protocol Violation|0
7691890|NCT01207440|26751320|P1|Overall Study|Protocol Violation|2
7691891|NCT01207440|26751314|P7|Overall Study|Progressive Disease|0
7691892|NCT01207440|26751315|P6|Overall Study|Progressive Disease|27
7691893|NCT01207440|26751316|P5|Overall Study|Progressive Disease|23
7691894|NCT01207440|26751317|P4|Overall Study|Progressive Disease|7
7691895|NCT01207440|26751318|P3|Overall Study|Progressive Disease|19
7691896|NCT01207440|26751319|P2|Overall Study|Progressive Disease|10
7691897|NCT01207440|26751320|P1|Overall Study|Progressive Disease|19
7691898|NCT01207440|26751314|P7|Overall Study|Physician Decision|0
7691899|NCT01207440|26751315|P6|Overall Study|Physician Decision|0
7691900|NCT01207440|26751316|P5|Overall Study|Physician Decision|1
7691901|NCT01207440|26751317|P4|Overall Study|Physician Decision|0
7691902|NCT01207440|26751318|P3|Overall Study|Physician Decision|5
7691903|NCT01207440|26751319|P2|Overall Study|Physician Decision|5
7691904|NCT01207440|26751320|P1|Overall Study|Physician Decision|6
7691905|NCT01207440|26751314|P7|Overall Study|Non-compliance with Study Drug|0
7691906|NCT01207440|26751315|P6|Overall Study|Non-compliance with Study Drug|0
7691907|NCT01207440|26751316|P5|Overall Study|Non-compliance with Study Drug|0
7691908|NCT01207440|26751317|P4|Overall Study|Non-compliance with Study Drug|0
7691909|NCT01207440|26751318|P3|Overall Study|Non-compliance with Study Drug|1
7691910|NCT01207440|26751319|P2|Overall Study|Non-compliance with Study Drug|0
7691911|NCT01207440|26751320|P1|Overall Study|Non-compliance with Study Drug|3
7691912|NCT01207440|26751314|P7|Overall Study|Lost to Follow-up|0
7691913|NCT01207440|26751315|P6|Overall Study|Lost to Follow-up|0
7691914|NCT01207440|26751316|P5|Overall Study|Lost to Follow-up|0
7691915|NCT01207440|26751317|P4|Overall Study|Lost to Follow-up|1
7691916|NCT01207440|26751318|P3|Overall Study|Lost to Follow-up|2
7691917|NCT01207440|26751319|P2|Overall Study|Lost to Follow-up|0
7691918|NCT01207440|26751320|P1|Overall Study|Lost to Follow-up|0
7691919|NCT01207440|26751314|P7|Overall Study|Lack of Efficacy|0
7691920|NCT01207440|26751315|P6|Overall Study|Lack of Efficacy|3
7691921|NCT01207440|26751316|P5|Overall Study|Lack of Efficacy|2
7691922|NCT01207440|26751317|P4|Overall Study|Lack of Efficacy|1
7691923|NCT01207440|26751318|P3|Overall Study|Lack of Efficacy|5
7691924|NCT01207440|26751319|P2|Overall Study|Lack of Efficacy|2
7691925|NCT01207440|26751320|P1|Overall Study|Lack of Efficacy|13
7691926|NCT01207440|26751314|P7|Overall Study|Death|1
7691927|NCT01207440|26751315|P6|Overall Study|Death|5
7691928|NCT01207440|26751316|P5|Overall Study|Death|7
7691929|NCT01207440|26751317|P4|Overall Study|Death|2
7691930|NCT01207440|26751318|P3|Overall Study|Death|2
7691931|NCT01207440|26751319|P2|Overall Study|Death|3
7691932|NCT01207440|26751320|P1|Overall Study|Death|6
7691933|NCT01207440|26751314|P7|Overall Study|Adverse Event|2
7691934|NCT01207440|26751315|P6|Overall Study|Adverse Event|6
7691935|NCT01207440|26751316|P5|Overall Study|Adverse Event|6
7691936|NCT01207440|26751317|P4|Overall Study|Adverse Event|2
7691937|NCT01207440|26751318|P3|Overall Study|Adverse Event|7
7691938|NCT01207440|26751319|P2|Overall Study|Adverse Event|11
7691939|NCT01207440|26751320|P1|Overall Study|Adverse Event|46
7691940|NCT01207427|26751387|P3|Double-blind Treatment Period|Withdrawal by Subject|0
7691941|NCT01207427|26751388|P2|Double-blind Treatment Period|Withdrawal by Subject|0
7691942|NCT01207427|26751389|P1|Double-blind Treatment Period|Withdrawal by Subject|1
7691943|NCT01207427|26751387|P3|Double-blind Treatment Period|Protocol Violation|1
7691944|NCT01207427|26751388|P2|Double-blind Treatment Period|Protocol Violation|1
7691945|NCT01207427|26751389|P1|Double-blind Treatment Period|Protocol Violation|2
7691946|NCT01207427|26751387|P3|Double-blind Treatment Period|Lost to Follow-up|1
7691947|NCT01207427|26751388|P2|Double-blind Treatment Period|Lost to Follow-up|0
7691948|NCT01207427|26751389|P1|Double-blind Treatment Period|Lost to Follow-up|0
7691949|NCT01207427|26751387|P3|Double-blind Treatment Period|Adverse Event|0
7691950|NCT01207427|26751388|P2|Double-blind Treatment Period|Adverse Event|1
7691951|NCT01207427|26751389|P1|Double-blind Treatment Period|Adverse Event|0
7691952|NCT01207414|26751399|P2|Overall Study|Randomized in error|0
7691953|NCT01207414|26751400|P1|Overall Study|Randomized in error|1
7691954|NCT01207414|26751399|P2|Overall Study|Protocol deviation|9
7691955|NCT01207414|26751400|P1|Overall Study|Protocol deviation|12
7691956|NCT01207414|26751399|P2|Overall Study|Administrative problems|1
7691957|NCT01207414|26751400|P1|Overall Study|Administrative problems|1
7691958|NCT01207414|26751399|P2|Overall Study|Lost to Follow-up|17
7691959|NCT01207414|26751400|P1|Overall Study|Lost to Follow-up|15
7691960|NCT01207414|26751399|P2|Overall Study|Patient withdrew consent|11
7691961|NCT01207414|26751400|P1|Overall Study|Patient withdrew consent|14
7691962|NCT01207414|26751399|P2|Overall Study|Unsatisfactory therapeutic effect|4
7691963|NCT01207414|26751400|P1|Overall Study|Unsatisfactory therapeutic effect|5
7691964|NCT01207414|26751399|P2|Overall Study|Abnormal test procedure results|1
7691965|NCT01207414|26751400|P1|Overall Study|Abnormal test procedure results|0
7691966|NCT01207414|26751399|P2|Overall Study|Adverse Event|39
7691967|NCT01207414|26751400|P1|Overall Study|Adverse Event|25
7691968|NCT01207388|26751425|P1|Overall Study|Withdrawal by Subject|1
7691969|NCT01207388|26751425|P1|Overall Study|Death|67
7691970|NCT01207219|26751450|P3|Overall Study|Lost to Follow-up|6
7691971|NCT01207219|26751451|P2|Overall Study|Lost to Follow-up|8
7691972|NCT01207219|26751452|P1|Overall Study|Lost to Follow-up|6
7691973|NCT01207219|26751450|P3|Overall Study|changed diagnosis during study period|1
7691974|NCT01207219|26751451|P2|Overall Study|changed diagnosis during study period|3
7691975|NCT01207219|26751452|P1|Overall Study|changed diagnosis during study period|5
7691976|NCT01207102|26751472|P1|Overall Study|Withdrawal by Treating Physician|1
7691977|NCT01207102|26751472|P1|Overall Study|progression|2
7691978|NCT01207102|26751472|P1|Overall Study|Adverse Event|2
7691979|NCT01207102|26751472|P1|Overall Study|Withdrawal by Subject|5
7691980|NCT01206816|26751484|P7|Overall Study|other than stated above|1
7691981|NCT01206816|26751485|P6|Overall Study|other than stated above|0
7691982|NCT01206816|26751486|P5|Overall Study|other than stated above|0
7691983|NCT01206816|26751487|P4|Overall Study|other than stated above|0
7691984|NCT01206816|26751488|P3|Overall Study|other than stated above|1
7691985|NCT01206816|26751489|P2|Overall Study|other than stated above|0
7691986|NCT01206816|26751490|P1|Overall Study|other than stated above|0
7691987|NCT01206816|26751484|P7|Overall Study|Other AE|2
7691988|NCT01206816|26751485|P6|Overall Study|Other AE|3
7691989|NCT01206816|26751486|P5|Overall Study|Other AE|0
7691990|NCT01206816|26751487|P4|Overall Study|Other AE|0
7691991|NCT01206816|26751488|P3|Overall Study|Other AE|4
7691992|NCT01206816|26751489|P2|Overall Study|Other AE|0
7691993|NCT01206816|26751490|P1|Overall Study|Other AE|0
7691994|NCT01206816|26751484|P7|Overall Study|Progressive disease|3
7691995|NCT01206816|26751485|P6|Overall Study|Progressive disease|16
7691996|NCT01206816|26751486|P5|Overall Study|Progressive disease|3
7691997|NCT01206816|26751487|P4|Overall Study|Progressive disease|3
7691998|NCT01206816|26751488|P3|Overall Study|Progressive disease|13
7691999|NCT01206816|26751489|P2|Overall Study|Progressive disease|3
7692000|NCT01206816|26751490|P1|Overall Study|Progressive disease|3
7692001|NCT01206816|26751484|P7|Overall Study|Withdrawal by Subject|0
7692002|NCT01206816|26751485|P6|Overall Study|Withdrawal by Subject|0
7692003|NCT01206816|26751486|P5|Overall Study|Withdrawal by Subject|0
7692004|NCT01206816|26751487|P4|Overall Study|Withdrawal by Subject|0
7692005|NCT01206816|26751488|P3|Overall Study|Withdrawal by Subject|1
7692006|NCT01206816|26751489|P2|Overall Study|Withdrawal by Subject|0
7692007|NCT01206816|26751490|P1|Overall Study|Withdrawal by Subject|0
7692008|NCT01206816|26751484|P7|Overall Study|Protocol Violation|0
7692009|NCT01206816|26751485|P6|Overall Study|Protocol Violation|0
7692010|NCT01206816|26751486|P5|Overall Study|Protocol Violation|0
7692011|NCT01206816|26751487|P4|Overall Study|Protocol Violation|0
7692012|NCT01206816|26751488|P3|Overall Study|Protocol Violation|1
7692013|NCT01206816|26751489|P2|Overall Study|Protocol Violation|0
7692014|NCT01206816|26751490|P1|Overall Study|Protocol Violation|0
7692015|NCT01206777|26751536|P1|Overall Study|Adverse Event|1
7692016|NCT01206777|26751536|P1|Overall Study|Death|1
7692017|NCT01206764|26751542|P1|Overall Study|Protocol deviation|3
7692018|NCT01206764|26751542|P1|Overall Study|Disease progression|88
7692019|NCT01206764|26751542|P1|Overall Study|New cancer therapy|2
7692020|NCT01206764|26751542|P1|Overall Study|Death|11
7692021|NCT01206764|26751542|P1|Overall Study|Lost to Follow-up|6
7692022|NCT01206764|26751542|P1|Overall Study|Patient withdrew consent|5
7692023|NCT01206764|26751542|P1|Overall Study|Abnormal test procedure result|1
7692024|NCT01206764|26751542|P1|Overall Study|Abnormal laboratory value|2
7692025|NCT01206764|26751542|P1|Overall Study|Adverse Event|20
7692026|NCT01206582|26751600|P2|Overall Study|Discontinued intervention before week 8|2
7692027|NCT01206582|26751601|P1|Overall Study|Discontinued intervention before week 8|1
7692028|NCT01206582|26751600|P2|Overall Study|Withdrew prior to study|0
7692029|NCT01206582|26751601|P1|Overall Study|Withdrew prior to study|1
7692030|NCT01206517|26751633|P6|Overall Study|Withdrawal by Subject|0
7692031|NCT01206517|26751634|P5|Overall Study|Withdrawal by Subject|1
7692032|NCT01206517|26751635|P4|Overall Study|Withdrawal by Subject|0
7692033|NCT01206517|26751636|P3|Overall Study|Withdrawal by Subject|2
7692034|NCT01206517|26751637|P2|Overall Study|Withdrawal by Subject|0
7692035|NCT01206517|26751638|P1|Overall Study|Withdrawal by Subject|0
7692036|NCT01206439|26751718|P1|Overall Study|subject did not meet inclusion criteria|1
7692037|NCT01206322|26751741|P4|Overall Study|Adverse Event|1
7692038|NCT01206322|26751742|P3|Overall Study|Adverse Event|0
7692039|NCT01206322|26751743|P2|Overall Study|Adverse Event|0
7692040|NCT01206322|26751744|P1|Overall Study|Adverse Event|0
7692041|NCT01206166|26751764|P2|Overall Study|No evaluable data|3
7692042|NCT01206166|26751765|P1|Overall Study|No evaluable data|2
7692043|NCT01206140|26751831|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
7692044|NCT01206140|26751832|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
7692045|NCT01206101|26751844|P2|Overall Study|Unclassified|0
7692046|NCT01206101|26751845|P1|Overall Study|Unclassified|1
7692047|NCT01206101|26751844|P2|Overall Study|Physician Decision|1
7692048|NCT01206101|26751845|P1|Overall Study|Physician Decision|0
7692049|NCT01206101|26751844|P2|Overall Study|Adverse Event|0
7692050|NCT01206101|26751845|P1|Overall Study|Adverse Event|1
7692051|NCT01205776|26751890|P2|Overall Study|Withdrawal by Subject|34
7692052|NCT01205776|26751891|P1|Overall Study|Withdrawal by Subject|11
7692053|NCT01205776|26751890|P2|Overall Study|Lost to Follow-up|61
7692054|NCT01205776|26751891|P1|Overall Study|Lost to Follow-up|53
7692055|NCT01205685|26752079|P1|Overall Study|Withdrawal by Subject|1
7692056|NCT01205685|26752079|P1|Overall Study|Disease Progression|10
7692057|NCT01205581|26752099|P6|Overall Study|Withdrawal by Subject|0
7692058|NCT01205581|26752100|P5|Overall Study|Withdrawal by Subject|0
7692059|NCT01205581|26752101|P4|Overall Study|Withdrawal by Subject|0
7692060|NCT01205581|26752102|P3|Overall Study|Withdrawal by Subject|0
7692061|NCT01205581|26752103|P2|Overall Study|Withdrawal by Subject|0
7692062|NCT01205581|26752104|P1|Overall Study|Withdrawal by Subject|1
7692063|NCT01205529|26752174|P1|Overall Study|No longer met criteria|30
7692064|NCT01205529|26752174|P1|Overall Study|Unstable post op|15
7692065|NCT01205529|26752174|P1|Overall Study|Physician Decision|4
7692066|NCT01205529|26752174|P1|Overall Study|Withdrawal by Subject|2
7692067|NCT01205529|26752174|P1|Overall Study|Procedure Cancelled|4
7692068|NCT01205451|26752197|P2|Overall Study|Withdrawal by Subject|9
7692069|NCT01205451|26752198|P1|Overall Study|Withdrawal by Subject|5
7692070|NCT01205451|26752197|P2|Overall Study|Lost to Follow-up|1
7692071|NCT01205451|26752198|P1|Overall Study|Lost to Follow-up|1
7692072|NCT01205438|26752243|P3|Overall Study|Sponsor Decision|1
7692073|NCT01205438|26752244|P2|Overall Study|Sponsor Decision|1
7692074|NCT01205438|26752245|P1|Overall Study|Sponsor Decision|0
7692075|NCT01205438|26752243|P3|Overall Study|Protocol Violation|4
7692076|NCT01205438|26752244|P2|Overall Study|Protocol Violation|7
7692077|NCT01205438|26752245|P1|Overall Study|Protocol Violation|2
7692078|NCT01205438|26752243|P3|Overall Study|Physician Decision|2
7692079|NCT01205438|26752244|P2|Overall Study|Physician Decision|3
7692080|NCT01205438|26752245|P1|Overall Study|Physician Decision|0
7692081|NCT01205438|26752243|P3|Overall Study|Withdrawal by Subject|19
7692082|NCT01205438|26752244|P2|Overall Study|Withdrawal by Subject|25
7692083|NCT01205438|26752245|P1|Overall Study|Withdrawal by Subject|19
7692084|NCT01205438|26752243|P3|Overall Study|Lost to Follow-up|8
7692085|NCT01205438|26752244|P2|Overall Study|Lost to Follow-up|7
7692086|NCT01205438|26752245|P1|Overall Study|Lost to Follow-up|6
7692087|NCT01205438|26752243|P3|Overall Study|Lack of Efficacy|14
7692088|NCT01205438|26752244|P2|Overall Study|Lack of Efficacy|11
7692089|NCT01205438|26752245|P1|Overall Study|Lack of Efficacy|14
7692090|NCT01205438|26752243|P3|Overall Study|Entry Criteria Not Met|13
7692091|NCT01205438|26752244|P2|Overall Study|Entry Criteria Not Met|15
7692092|NCT01205438|26752245|P1|Overall Study|Entry Criteria Not Met|16
7692093|NCT01205438|26752243|P3|Overall Study|Death|3
7692094|NCT01205438|26752244|P2|Overall Study|Death|1
7692095|NCT01205438|26752245|P1|Overall Study|Death|1
7692096|NCT01205438|26752243|P3|Overall Study|Adverse Event|24
7692097|NCT01205438|26752244|P2|Overall Study|Adverse Event|17
7692098|NCT01205438|26752245|P1|Overall Study|Adverse Event|19
7692099|NCT01205269|26752301|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
7692100|NCT01205269|26752302|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
7692101|NCT01205269|26752303|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
7692102|NCT01205269|26752304|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
7692103|NCT01205269|26752305|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
7692104|NCT01205269|26752306|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
7692105|NCT01205230|26752346|P2|Overall Study|Physician Decision|0
7692106|NCT01205230|26752347|P1|Overall Study|Physician Decision|1
7692107|NCT01205230|26752346|P2|Overall Study|Adverse Event|0
7692108|NCT01205230|26752347|P1|Overall Study|Adverse Event|4
7692109|NCT01205165|26752390|P1|Overall Study|Lost to Follow-up|2
7692110|NCT01205152|26752403|P1|Overall Study|Death|1
7692111|NCT01205126|26752416|P2|Maintenance Phase|Withdrawal by Subject|11
7692112|NCT01205126|26752417|P1|Maintenance Phase|Withdrawal by Subject|8
7692113|NCT01205126|26752416|P2|Maintenance Phase|Lost to Follow-up|5
7692114|NCT01205126|26752417|P1|Maintenance Phase|Lost to Follow-up|5
7692115|NCT01205126|26752416|P2|Maintenance Phase|Other|8
7692116|NCT01205126|26752417|P1|Maintenance Phase|Other|11
7692117|NCT01205126|26752416|P2|Maintenance Phase|Prohibited drugs used|0
7692118|NCT01205126|26752417|P1|Maintenance Phase|Prohibited drugs used|1
7692119|NCT01205126|26752416|P2|Maintenance Phase|More than the maximum dosage required|5
7692120|NCT01205126|26752417|P1|Maintenance Phase|More than the maximum dosage required|5
7692121|NCT01205126|26752416|P2|Maintenance Phase|Death|4
7692122|NCT01205126|26752417|P1|Maintenance Phase|Death|4
7692123|NCT01205126|26752416|P2|Maintenance Phase|Adverse Event|7
7692124|NCT01205126|26752417|P1|Maintenance Phase|Adverse Event|3
7692125|NCT01205126|26752416|P2|Between Titration & Maintenance Phase|Other|4
7692126|NCT01205126|26752417|P1|Between Titration & Maintenance Phase|Other|0
7692127|NCT01205126|26752416|P2|Titration Phase|Other|6
7692128|NCT01205126|26752417|P1|Titration Phase|Other|8
7692129|NCT01205126|26752416|P2|Titration Phase|More than maximum dosage required|3
7692130|NCT01205126|26752417|P1|Titration Phase|More than maximum dosage required|2
7692131|NCT01205126|26752416|P2|Titration Phase|No stable titration dose|0
7692132|NCT01205126|26752417|P1|Titration Phase|No stable titration dose|1
7692133|NCT01205126|26752416|P2|Titration Phase|Lost to Follow-up|2
7692134|NCT01205126|26752417|P1|Titration Phase|Lost to Follow-up|2
7692135|NCT01205126|26752416|P2|Titration Phase|Withdrawal by Subject|5
7692136|NCT01205126|26752417|P1|Titration Phase|Withdrawal by Subject|5
7692137|NCT01205126|26752416|P2|Titration Phase|Adverse Event|3
7692138|NCT01205126|26752417|P1|Titration Phase|Adverse Event|5
7692139|NCT01205035|26752435|P2|Overall Study|Physician Decision|0
7692140|NCT01205035|26752436|P1|Overall Study|Physician Decision|1
7692141|NCT01205035|26752435|P2|Overall Study|Withdrawal by Subject|0
7692142|NCT01205035|26752436|P1|Overall Study|Withdrawal by Subject|1
7692143|NCT01204918|26752453|P3|Overall Study|Withdrawal by Subject|5
7692144|NCT01204918|26752454|P2|Overall Study|Withdrawal by Subject|10
7692145|NCT01204918|26752455|P1|Overall Study|Withdrawal by Subject|4
7692146|NCT01204775|26752498|P2|Overall Study|Withdrawal by Subject|0
7692147|NCT01204775|26752499|P1|Overall Study|Withdrawal by Subject|1
7692148|NCT01204775|26752498|P2|Overall Study|Poor/non-compliance|1
7692149|NCT01204775|26752499|P1|Overall Study|Poor/non-compliance|0
7692150|NCT01204710|26752524|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
7692151|NCT01204710|26752525|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
7692152|NCT01204710|26752524|P2|Optional Olaratumab Monotherapy|Physician Decision|1
7692153|NCT01204710|26752525|P1|Optional Olaratumab Monotherapy|Physician Decision|0
7692154|NCT01204710|26752524|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
7692155|NCT01204710|26752525|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
7692156|NCT01204710|26752524|P2|Randomization Treatment|Moved and Followed for Survival|1
7692157|NCT01204710|26752525|P1|Randomization Treatment|Moved and Followed for Survival|0
7692158|NCT01204710|26752524|P2|Randomization Treatment|Worsening of General condition|1
7692159|NCT01204710|26752525|P1|Randomization Treatment|Worsening of General condition|0
7692160|NCT01204710|26752524|P2|Randomization Treatment|Sponsor Decision|1
7692161|NCT01204710|26752525|P1|Randomization Treatment|Sponsor Decision|0
7692162|NCT01204710|26752524|P2|Randomization Treatment|Adverse Event|2
7692163|NCT01204710|26752525|P1|Randomization Treatment|Adverse Event|4
7692164|NCT01204710|26752524|P2|Randomization Treatment|Entry criteria not met|1
7692165|NCT01204710|26752525|P1|Randomization Treatment|Entry criteria not met|0
7692166|NCT01204710|26752524|P2|Randomization Treatment|Physician Decision|2
7692167|NCT01204710|26752525|P1|Randomization Treatment|Physician Decision|3
7692168|NCT01204710|26752524|P2|Randomization Treatment|Withdrawal by Subject|5
7692169|NCT01204710|26752525|P1|Randomization Treatment|Withdrawal by Subject|6
7692170|NCT01204710|26752524|P2|Randomization Treatment|Lost to Follow-up|0
7692171|NCT01204710|26752525|P1|Randomization Treatment|Lost to Follow-up|1
7692172|NCT01204697|26752561|P2|Overall Study|Randomized, but not treated|1
7692173|NCT01204697|26752562|P1|Overall Study|Randomized, but not treated|0
7692174|NCT01204697|26752561|P2|Overall Study|Withdrawal by Subject|4
7692175|NCT01204697|26752562|P1|Overall Study|Withdrawal by Subject|2
7692176|NCT01204697|26752561|P2|Overall Study|Lost to Follow-up|4
7692177|NCT01204697|26752562|P1|Overall Study|Lost to Follow-up|3
7692178|NCT01204697|26752561|P2|Overall Study|Death|27
7692179|NCT01204697|26752562|P1|Overall Study|Death|26
7692180|NCT01204671|26752583|P5|Overall Study|Physician Decision|0
7692181|NCT01204671|26752584|P4|Overall Study|Physician Decision|1
7692182|NCT01204671|26752585|P3|Overall Study|Physician Decision|0
7692183|NCT01204671|26752586|P2|Overall Study|Physician Decision|0
7692184|NCT01204671|26752587|P1|Overall Study|Physician Decision|0
7692185|NCT01204671|26752583|P5|Overall Study|Unknown Completion Status|0
7692186|NCT01204671|26752584|P4|Overall Study|Unknown Completion Status|0
7692187|NCT01204671|26752585|P3|Overall Study|Unknown Completion Status|0
7692188|NCT01204671|26752586|P2|Overall Study|Unknown Completion Status|1
7692189|NCT01204671|26752587|P1|Overall Study|Unknown Completion Status|1
7692190|NCT01204671|26752583|P5|Overall Study|Lost to Follow-up|0
7692191|NCT01204671|26752584|P4|Overall Study|Lost to Follow-up|4
7692192|NCT01204671|26752585|P3|Overall Study|Lost to Follow-up|6
7692193|NCT01204671|26752586|P2|Overall Study|Lost to Follow-up|8
7692194|NCT01204671|26752587|P1|Overall Study|Lost to Follow-up|7
7692195|NCT01204671|26752583|P5|Overall Study|Withdrawal by Subject|3
7692196|NCT01204671|26752584|P4|Overall Study|Withdrawal by Subject|5
7692197|NCT01204671|26752585|P3|Overall Study|Withdrawal by Subject|4
7692198|NCT01204671|26752586|P2|Overall Study|Withdrawal by Subject|3
7692199|NCT01204671|26752587|P1|Overall Study|Withdrawal by Subject|2
7692200|NCT01204671|26752583|P5|Overall Study|Adverse Event|1
7692201|NCT01204671|26752584|P4|Overall Study|Adverse Event|3
7692202|NCT01204671|26752585|P3|Overall Study|Adverse Event|3
7692203|NCT01204671|26752586|P2|Overall Study|Adverse Event|3
7692204|NCT01204671|26752587|P1|Overall Study|Adverse Event|4
7692205|NCT01204658|26752649|P4|Primary Phase|Adverse Event|0
7692206|NCT01204658|26752650|P3|Primary Phase|Adverse Event|1
7692207|NCT01204658|26752651|P2|Primary Phase|Adverse Event|0
7692208|NCT01204658|26752652|P1|Primary Phase|Adverse Event|0
7692209|NCT01204398|26752770|P1|Overall Study|Adverse Event|1
7692210|NCT01204294|26752787|P7|Overall Study|Other (house moving)|0
7692211|NCT01204294|26752788|P6|Overall Study|Other (house moving)|0
7692212|NCT01204294|26752789|P5|Overall Study|Other (house moving)|0
7692213|NCT01204294|26752790|P4|Overall Study|Other (house moving)|0
7692214|NCT01204294|26752791|P3|Overall Study|Other (house moving)|1
7692215|NCT01204294|26752792|P2|Overall Study|Other (house moving)|0
7692216|NCT01204294|26752793|P1|Overall Study|Other (house moving)|0
7692217|NCT01204294|26752787|P7|Overall Study|Lack of Efficacy|0
7692218|NCT01204294|26752788|P6|Overall Study|Lack of Efficacy|0
7692219|NCT01204294|26752789|P5|Overall Study|Lack of Efficacy|0
7692220|NCT01204294|26752790|P4|Overall Study|Lack of Efficacy|2
7692221|NCT01204294|26752791|P3|Overall Study|Lack of Efficacy|0
7692222|NCT01204294|26752792|P2|Overall Study|Lack of Efficacy|0
7692223|NCT01204294|26752793|P1|Overall Study|Lack of Efficacy|0
7692224|NCT01204294|26752787|P7|Overall Study|Withdrawal by Subject|2
7692225|NCT01204294|26752788|P6|Overall Study|Withdrawal by Subject|1
7692226|NCT01204294|26752789|P5|Overall Study|Withdrawal by Subject|1
7692227|NCT01204294|26752790|P4|Overall Study|Withdrawal by Subject|1
7692228|NCT01204294|26752791|P3|Overall Study|Withdrawal by Subject|2
7692229|NCT01204294|26752792|P2|Overall Study|Withdrawal by Subject|2
7692230|NCT01204294|26752793|P1|Overall Study|Withdrawal by Subject|0
7692231|NCT01204294|26752787|P7|Overall Study|Protocol Violation|0
7692232|NCT01204294|26752788|P6|Overall Study|Protocol Violation|0
7692233|NCT01204294|26752789|P5|Overall Study|Protocol Violation|0
7692234|NCT01204294|26752790|P4|Overall Study|Protocol Violation|1
7692235|NCT01204294|26752791|P3|Overall Study|Protocol Violation|2
7692236|NCT01204294|26752792|P2|Overall Study|Protocol Violation|0
7692237|NCT01204294|26752793|P1|Overall Study|Protocol Violation|1
7692238|NCT01204294|26752787|P7|Overall Study|Adverse Event|0
7692239|NCT01204294|26752788|P6|Overall Study|Adverse Event|4
7692240|NCT01204294|26752789|P5|Overall Study|Adverse Event|1
7692241|NCT01204294|26752790|P4|Overall Study|Adverse Event|7
7692242|NCT01204294|26752791|P3|Overall Study|Adverse Event|0
7692243|NCT01204294|26752792|P2|Overall Study|Adverse Event|6
7692244|NCT01204294|26752793|P1|Overall Study|Adverse Event|2
7692245|NCT01203956|26752827|P2|Second Two-week Period|Non-compliant: no evaluable results|6
7692246|NCT01203956|26752828|P1|Second Two-week Period|Non-compliant: no evaluable results|5
7692247|NCT01203930|26752837|P2|Overall Study|Adverse Event|5
7692248|NCT01203930|26752838|P1|Overall Study|Adverse Event|17
7692249|NCT01203930|26752837|P2|Overall Study|Poor tolerance of study drug|1
7692250|NCT01203930|26752838|P1|Overall Study|Poor tolerance of study drug|0
7692251|NCT01203930|26752837|P2|Overall Study|Study Terminated by Sponsor|12
7692252|NCT01203930|26752838|P1|Overall Study|Study Terminated by Sponsor|0
7692253|NCT01203930|26752837|P2|Overall Study|Investigator Request|8
7692254|NCT01203930|26752838|P1|Overall Study|Investigator Request|0
7692255|NCT01203930|26752837|P2|Overall Study|Withdrew Consent|10
7692256|NCT01203930|26752838|P1|Overall Study|Withdrew Consent|1
7692257|NCT01203930|26752837|P2|Overall Study|Death|1
7692258|NCT01203930|26752838|P1|Overall Study|Death|3
7692259|NCT01203930|26752837|P2|Overall Study|Disease Progression|4
7692260|NCT01203930|26752838|P1|Overall Study|Disease Progression|0
7692261|NCT01203917|26752860|P1|Overall Study|Due to EGFR M+I patient|1
7692262|NCT01203917|26752860|P1|Overall Study|Due to objective disease progression|1
7692263|NCT01203917|26752860|P1|Overall Study|Withdrawal by Subject|3
7692264|NCT01203917|26752860|P1|Overall Study|Lost to Follow-up|2
7692265|NCT01203917|26752860|P1|Overall Study|Death|29
7692266|NCT01203878|26752873|P3|Overall Study|Adverse Event|2
7692267|NCT01203878|26752874|P2|Overall Study|Adverse Event|0
7692268|NCT01203878|26752875|P1|Overall Study|Adverse Event|0
7692269|NCT01203878|26752873|P3|Overall Study|Withdrawal by Subject|1
7692270|NCT01203878|26752874|P2|Overall Study|Withdrawal by Subject|0
7692271|NCT01203878|26752875|P1|Overall Study|Withdrawal by Subject|0
7692272|NCT01203852|26752886|P1|Washout 2 Weeks|Physician Decision|46
7692273|NCT01203852|26752886|P1|Metoprolol 8 Weeks|Physician Decision|470
7692274|NCT01203787|26752904|P2|Overall Study|Adverse Event|15
7692275|NCT01203787|26752905|P1|Overall Study|Adverse Event|11
7692276|NCT01203787|26752904|P2|Overall Study|Lost to Follow-up|0
7692277|NCT01203787|26752905|P1|Overall Study|Lost to Follow-up|2
7692278|NCT01203787|26752904|P2|Overall Study|Withdrawal by Subject|2
7692279|NCT01203787|26752905|P1|Overall Study|Withdrawal by Subject|6
7692280|NCT01203787|26752904|P2|Overall Study|Death|10
7692281|NCT01203787|26752905|P1|Overall Study|Death|12
7692282|NCT01203098|26752985|P3|Overall Study|Withdrawal by Subject|3
7692283|NCT01203098|26752986|P2|Overall Study|Withdrawal by Subject|1
7692284|NCT01203098|26752987|P1|Overall Study|Withdrawal by Subject|1
7692285|NCT01203098|26752985|P3|Overall Study|Physician Decision|0
7692286|NCT01203098|26752986|P2|Overall Study|Physician Decision|2
7692287|NCT01203098|26752987|P1|Overall Study|Physician Decision|2
7692288|NCT01203098|26752985|P3|Overall Study|Lost to Follow-up|1
7692289|NCT01203098|26752986|P2|Overall Study|Lost to Follow-up|0
7692290|NCT01203098|26752987|P1|Overall Study|Lost to Follow-up|0
7692291|NCT01203098|26752985|P3|Overall Study|Adverse Event|7
7692292|NCT01203098|26752986|P2|Overall Study|Adverse Event|1
7692293|NCT01203098|26752987|P1|Overall Study|Adverse Event|3
7692294|NCT01203072|26753003|P5|Overall Study|Withdrawal by Subject|3
7692295|NCT01203072|26753004|P4|Overall Study|Withdrawal by Subject|2
7692296|NCT01203072|26753005|P3|Overall Study|Withdrawal by Subject|1
7692297|NCT01203072|26753006|P2|Overall Study|Withdrawal by Subject|2
7692298|NCT01203072|26753007|P1|Overall Study|Withdrawal by Subject|2
7692299|NCT01203072|26753003|P5|Overall Study|Protocol Violation|1
7692300|NCT01203072|26753004|P4|Overall Study|Protocol Violation|0
7692301|NCT01203072|26753005|P3|Overall Study|Protocol Violation|0
7692302|NCT01203072|26753006|P2|Overall Study|Protocol Violation|0
7692303|NCT01203072|26753007|P1|Overall Study|Protocol Violation|2
7692304|NCT01203072|26753003|P5|Overall Study|Lost to Follow-up|0
7692305|NCT01203072|26753004|P4|Overall Study|Lost to Follow-up|0
7692306|NCT01203072|26753005|P3|Overall Study|Lost to Follow-up|0
7692307|NCT01203072|26753006|P2|Overall Study|Lost to Follow-up|1
7692308|NCT01203072|26753007|P1|Overall Study|Lost to Follow-up|0
7692309|NCT01203072|26753003|P5|Overall Study|Lack of Efficacy|0
7692310|NCT01203072|26753004|P4|Overall Study|Lack of Efficacy|0
7692311|NCT01203072|26753005|P3|Overall Study|Lack of Efficacy|0
7692312|NCT01203072|26753006|P2|Overall Study|Lack of Efficacy|0
7692313|NCT01203072|26753007|P1|Overall Study|Lack of Efficacy|1
7692314|NCT01203072|26753003|P5|Overall Study|Adverse Event|2
7692315|NCT01203072|26753004|P4|Overall Study|Adverse Event|4
7692316|NCT01203072|26753005|P3|Overall Study|Adverse Event|2
7692317|NCT01203072|26753006|P2|Overall Study|Adverse Event|3
7692318|NCT01203072|26753007|P1|Overall Study|Adverse Event|5
7692319|NCT01202955|26753042|P2|Period 1: 10 Days|Withdrawal by Subject|2
7692320|NCT01202955|26753043|P1|Period 1: 10 Days|Withdrawal by Subject|0
7692321|NCT01202903|26753055|P2|Overall Study|Withdrawal by Subject|4
7692322|NCT01202903|26753056|P1|Overall Study|Withdrawal by Subject|4
7692323|NCT01202903|26753055|P2|Overall Study|Adverse Event|3
7692324|NCT01202903|26753056|P1|Overall Study|Adverse Event|3
7692325|NCT01202903|26753055|P2|Overall Study|Lack of Efficacy|3
7692326|NCT01202903|26753056|P1|Overall Study|Lack of Efficacy|1
7692327|NCT01202903|26753055|P2|Overall Study|Lost to Follow-up|1
7692328|NCT01202903|26753056|P1|Overall Study|Lost to Follow-up|1
7692329|NCT01202903|26753055|P2|Overall Study|Death|0
7692330|NCT01202903|26753056|P1|Overall Study|Death|1
7692331|NCT01202903|26753055|P2|Overall Study|Protocol Violation|1
7692332|NCT01202903|26753056|P1|Overall Study|Protocol Violation|0
7692333|NCT01202903|26753055|P2|Overall Study|Administrative Probelms|4
7692334|NCT01202903|26753056|P1|Overall Study|Administrative Probelms|1
7692335|NCT01202877|26753083|P3|Overall Study|Death|1
7692336|NCT01202877|26753084|P2|Overall Study|Death|0
7692337|NCT01202877|26753085|P1|Overall Study|Death|0
7692338|NCT01202877|26753083|P3|Overall Study|Withdrawal by Subject|1
7692339|NCT01202877|26753084|P2|Overall Study|Withdrawal by Subject|0
7692340|NCT01202877|26753085|P1|Overall Study|Withdrawal by Subject|0
7692341|NCT01202877|26753083|P3|Overall Study|Adverse Event|2
7692342|NCT01202877|26753084|P2|Overall Study|Adverse Event|0
7692343|NCT01202877|26753085|P1|Overall Study|Adverse Event|0
7692344|NCT01202877|26753083|P3|Overall Study|Disease Progression|2
7692345|NCT01202877|26753084|P2|Overall Study|Disease Progression|1
7692346|NCT01202877|26753085|P1|Overall Study|Disease Progression|0
7692347|NCT01202773|26753099|P3|Overall Study|Sponsor Decision|23
7692348|NCT01202773|26753100|P2|Overall Study|Sponsor Decision|20
7692349|NCT01202773|26753101|P1|Overall Study|Sponsor Decision|19
7692350|NCT01202773|26753099|P3|Overall Study|Protocol Violation|10
7692351|NCT01202773|26753100|P2|Overall Study|Protocol Violation|6
7692352|NCT01202773|26753101|P1|Overall Study|Protocol Violation|11
7692353|NCT01202773|26753099|P3|Overall Study|Physician Decision|0
7692354|NCT01202773|26753100|P2|Overall Study|Physician Decision|0
7692355|NCT01202773|26753101|P1|Overall Study|Physician Decision|2
7692356|NCT01202773|26753099|P3|Overall Study|Withdrawal by Subject|5
7692357|NCT01202773|26753100|P2|Overall Study|Withdrawal by Subject|6
7692358|NCT01202773|26753101|P1|Overall Study|Withdrawal by Subject|13
7692359|NCT01202773|26753099|P3|Overall Study|Lost to Follow-up|2
7692360|NCT01202773|26753100|P2|Overall Study|Lost to Follow-up|2
7692361|NCT01202773|26753101|P1|Overall Study|Lost to Follow-up|1
7692362|NCT01202773|26753099|P3|Overall Study|Entry Criteria Not Met|1
7692363|NCT01202773|26753100|P2|Overall Study|Entry Criteria Not Met|0
7692364|NCT01202773|26753101|P1|Overall Study|Entry Criteria Not Met|2
7692365|NCT01202773|26753099|P3|Overall Study|Lack of Efficacy|9
7692366|NCT01202773|26753100|P2|Overall Study|Lack of Efficacy|4
7692367|NCT01202773|26753101|P1|Overall Study|Lack of Efficacy|5
7692368|NCT01202773|26753099|P3|Overall Study|Adverse Event|5
7692369|NCT01202773|26753100|P2|Overall Study|Adverse Event|5
7692370|NCT01202773|26753101|P1|Overall Study|Adverse Event|4
7692371|NCT01202760|26753178|P3|Overall Study|Sponsor Decision|0
7692372|NCT01202760|26753179|P2|Overall Study|Sponsor Decision|4
7692373|NCT01202760|26753180|P1|Overall Study|Sponsor Decision|4
7692374|NCT01202760|26753178|P3|Overall Study|Protocol Violation|2
7692375|NCT01202760|26753179|P2|Overall Study|Protocol Violation|5
7692376|NCT01202760|26753180|P1|Overall Study|Protocol Violation|7
7692377|NCT01202760|26753178|P3|Overall Study|Physician Decision|0
7692378|NCT01202760|26753179|P2|Overall Study|Physician Decision|1
7692379|NCT01202760|26753180|P1|Overall Study|Physician Decision|0
7692380|NCT01202760|26753178|P3|Overall Study|Withdrawal by Subject|14
7692381|NCT01202760|26753179|P2|Overall Study|Withdrawal by Subject|18
7692382|NCT01202760|26753180|P1|Overall Study|Withdrawal by Subject|17
7692383|NCT01202760|26753178|P3|Overall Study|Parent / Caregiver Decision|0
7692384|NCT01202760|26753179|P2|Overall Study|Parent / Caregiver Decision|1
7692385|NCT01202760|26753180|P1|Overall Study|Parent / Caregiver Decision|0
7692386|NCT01202760|26753178|P3|Overall Study|Lost to Follow-up|1
7692387|NCT01202760|26753179|P2|Overall Study|Lost to Follow-up|2
7692388|NCT01202760|26753180|P1|Overall Study|Lost to Follow-up|0
7692389|NCT01202760|26753178|P3|Overall Study|Lack of Efficacy|7
7692390|NCT01202760|26753179|P2|Overall Study|Lack of Efficacy|8
7692391|NCT01202760|26753180|P1|Overall Study|Lack of Efficacy|6
7692392|NCT01202760|26753178|P3|Overall Study|Death|0
7692393|NCT01202760|26753179|P2|Overall Study|Death|1
7692394|NCT01202760|26753180|P1|Overall Study|Death|2
7692395|NCT01202760|26753178|P3|Overall Study|Adverse Event|10
7692396|NCT01202760|26753179|P2|Overall Study|Adverse Event|9
7692397|NCT01202760|26753180|P1|Overall Study|Adverse Event|11
7692398|NCT01202760|26753178|P3|Overall Study|Entry Criteria Not Met|1
7692399|NCT01202760|26753179|P2|Overall Study|Entry Criteria Not Met|3
7692400|NCT01202760|26753180|P1|Overall Study|Entry Criteria Not Met|0
7692401|NCT01202747|26753248|P1|Overall Study|Withdrawal by Subject|1
7692402|NCT01202591|26753301|P6|Overall Study|Objective Disease Progression|0
7692403|NCT01202591|26753302|P5|Overall Study|Objective Disease Progression|2
7692404|NCT01202591|26753303|P4|Overall Study|Objective Disease Progression|0
7692405|NCT01202591|26753304|P3|Overall Study|Objective Disease Progression|0
7692406|NCT01202591|26753305|P2|Overall Study|Objective Disease Progression|0
7692407|NCT01202591|26753306|P1|Overall Study|Objective Disease Progression|0
7692408|NCT01202591|26753301|P6|Overall Study|Withdrawal by Subject|1
7692409|NCT01202591|26753302|P5|Overall Study|Withdrawal by Subject|2
7692410|NCT01202591|26753303|P4|Overall Study|Withdrawal by Subject|0
7692411|NCT01202591|26753304|P3|Overall Study|Withdrawal by Subject|0
7692412|NCT01202591|26753305|P2|Overall Study|Withdrawal by Subject|0
7692413|NCT01202591|26753306|P1|Overall Study|Withdrawal by Subject|0
7692414|NCT01202591|26753301|P6|Overall Study|Other reason as per investigator|3
7692415|NCT01202591|26753302|P5|Overall Study|Other reason as per investigator|1
7692416|NCT01202591|26753303|P4|Overall Study|Other reason as per investigator|3
7692417|NCT01202591|26753304|P3|Overall Study|Other reason as per investigator|7
7692418|NCT01202591|26753305|P2|Overall Study|Other reason as per investigator|4
7692419|NCT01202591|26753306|P1|Overall Study|Other reason as per investigator|3
7692420|NCT01202591|26753301|P6|Overall Study|Adverse Event|0
7692421|NCT01202591|26753302|P5|Overall Study|Adverse Event|0
7692422|NCT01202591|26753303|P4|Overall Study|Adverse Event|4
7692423|NCT01202591|26753304|P3|Overall Study|Adverse Event|4
7692424|NCT01202591|26753305|P2|Overall Study|Adverse Event|1
7692425|NCT01202591|26753306|P1|Overall Study|Adverse Event|2
7692426|NCT01202409|26753350|P1|Overall Study|Ineligible - KRAS mutants|7
7692427|NCT01202409|26753350|P1|Overall Study|Adverse Event|1
7692428|NCT01202279|26753357|P2|Overall Study|study compliance|2
7692429|NCT01202279|26753358|P1|Overall Study|study compliance|5
7692430|NCT01202279|26753357|P2|Overall Study|Protocol Violation|1
7692431|NCT01202279|26753358|P1|Overall Study|Protocol Violation|1
7692432|NCT01202279|26753357|P2|Overall Study|Lost to Follow-up|7
7692433|NCT01202279|26753358|P1|Overall Study|Lost to Follow-up|10
7692434|NCT01202279|26753357|P2|Overall Study|Physician Decision|1
7692435|NCT01202279|26753358|P1|Overall Study|Physician Decision|0
7692436|NCT01202279|26753357|P2|Overall Study|Withdrawal by Subject|10
7692437|NCT01202279|26753358|P1|Overall Study|Withdrawal by Subject|13
7692438|NCT01202279|26753357|P2|Overall Study|Adverse Event|6
7692439|NCT01202279|26753358|P1|Overall Study|Adverse Event|8
7692440|NCT01202227|26753410|P1|Overall Study|Lack of Efficacy|1
7692441|NCT01202227|26753410|P1|Overall Study|Withdrawal by Subject|2
7692442|NCT01202227|26753410|P1|Overall Study|Adverse Event|16
7692443|NCT01202188|26753434|P5|Overall Study|Abnormal test procedure result (s)|0
7692444|NCT01202188|26753435|P4|Overall Study|Abnormal test procedure result (s)|0
7692445|NCT01202188|26753436|P3|Overall Study|Abnormal test procedure result (s)|2
7692446|NCT01202188|26753437|P2|Overall Study|Abnormal test procedure result (s)|0
7692447|NCT01202188|26753438|P1|Overall Study|Abnormal test procedure result (s)|0
7692448|NCT01202188|26753434|P5|Overall Study|Death|0
7692449|NCT01202188|26753435|P4|Overall Study|Death|1
7692450|NCT01202188|26753436|P3|Overall Study|Death|1
7692451|NCT01202188|26753437|P2|Overall Study|Death|1
7692452|NCT01202188|26753438|P1|Overall Study|Death|1
7692453|NCT01202188|26753434|P5|Overall Study|Lost to Follow-up|1
7692454|NCT01202188|26753435|P4|Overall Study|Lost to Follow-up|4
7692455|NCT01202188|26753436|P3|Overall Study|Lost to Follow-up|0
7692456|NCT01202188|26753437|P2|Overall Study|Lost to Follow-up|1
7692457|NCT01202188|26753438|P1|Overall Study|Lost to Follow-up|1
7692458|NCT01202188|26753434|P5|Overall Study|Unsatisfactory therapeutic effect|8
7692459|NCT01202188|26753435|P4|Overall Study|Unsatisfactory therapeutic effect|5
7692460|NCT01202188|26753436|P3|Overall Study|Unsatisfactory therapeutic effect|2
7692461|NCT01202188|26753437|P2|Overall Study|Unsatisfactory therapeutic effect|8
7692462|NCT01202188|26753438|P1|Overall Study|Unsatisfactory therapeutic effect|2
7692463|NCT01202188|26753434|P5|Overall Study|Administrative problems|2
7692464|NCT01202188|26753435|P4|Overall Study|Administrative problems|1
7692465|NCT01202188|26753436|P3|Overall Study|Administrative problems|1
7692466|NCT01202188|26753437|P2|Overall Study|Administrative problems|2
7692467|NCT01202188|26753438|P1|Overall Study|Administrative problems|3
7692468|NCT01202188|26753434|P5|Overall Study|Adverse Event|10
7692469|NCT01202188|26753435|P4|Overall Study|Adverse Event|10
7692470|NCT01202188|26753436|P3|Overall Study|Adverse Event|13
7692471|NCT01202188|26753437|P2|Overall Study|Adverse Event|23
7692472|NCT01202188|26753438|P1|Overall Study|Adverse Event|5
7692473|NCT01202188|26753434|P5|Overall Study|Subject withdrew consent|13
7692474|NCT01202188|26753435|P4|Overall Study|Subject withdrew consent|11
7692475|NCT01202188|26753436|P3|Overall Study|Subject withdrew consent|22
7692476|NCT01202188|26753437|P2|Overall Study|Subject withdrew consent|13
7692477|NCT01202188|26753438|P1|Overall Study|Subject withdrew consent|12
7692478|NCT01202188|26753434|P5|Overall Study|Protocol deviation|11
7692479|NCT01202188|26753435|P4|Overall Study|Protocol deviation|10
7692480|NCT01202188|26753436|P3|Overall Study|Protocol deviation|12
7692481|NCT01202188|26753437|P2|Overall Study|Protocol deviation|8
7692482|NCT01202188|26753438|P1|Overall Study|Protocol deviation|14
7692483|NCT01202175|26753546|P1|Overall Study|Adverse Event|2
7692484|NCT01202175|26753546|P1|Overall Study|Withdrawal by Subject|1
7692485|NCT01202175|26753546|P1|Overall Study|Lost to Follow-up|2
7692486|NCT01201967|26753614|P2|Overall Study|Lost to Follow-up|5
7692487|NCT01201967|26753615|P1|Overall Study|Lost to Follow-up|6
7692488|NCT01201915|26753640|P3|Overall Study|Target Lesion Progression|0
7692489|NCT01201915|26753641|P2|Overall Study|Target Lesion Progression|3
7692490|NCT01201915|26753642|P1|Overall Study|Target Lesion Progression|0
7692491|NCT01201915|26753640|P3|Overall Study|Subject Decision|5
7692492|NCT01201915|26753641|P2|Overall Study|Subject Decision|3
7692493|NCT01201915|26753642|P1|Overall Study|Subject Decision|3
7692494|NCT01201915|26753640|P3|Overall Study|Physician Decision|0
7692495|NCT01201915|26753641|P2|Overall Study|Physician Decision|0
7692496|NCT01201915|26753642|P1|Overall Study|Physician Decision|3
7692497|NCT01201915|26753640|P3|Overall Study|Lost to Follow-up|0
7692498|NCT01201915|26753641|P2|Overall Study|Lost to Follow-up|4
7692499|NCT01201915|26753642|P1|Overall Study|Lost to Follow-up|0
7692500|NCT01201915|26753640|P3|Overall Study|Adverse Event|1
7692501|NCT01201915|26753641|P2|Overall Study|Adverse Event|1
7692502|NCT01201915|26753642|P1|Overall Study|Adverse Event|2
7692503|NCT01201850|26753666|P1|Overall Study|Tumor progression|4
7692504|NCT01201811|26753674|P1|Overall Study|Physician Decision|1
7692505|NCT01201811|26753674|P1|Overall Study|Treatment Failure|2
7692506|NCT01201811|26753674|P1|Overall Study|Death|4
7692507|NCT01201811|26753674|P1|Overall Study|Withdrawal by Subject|3
7692508|NCT01201811|26753674|P1|Overall Study|Disease progression|3
7692509|NCT01201811|26753674|P1|Overall Study|Adverse Event|6
7692510|NCT01201798|26753696|P2|Overall Study|Treatment Failure|8
7692511|NCT01201798|26753697|P1|Overall Study|Treatment Failure|1
7692512|NCT01201798|26753696|P2|Overall Study|Protocol Violation|1
7692513|NCT01201798|26753697|P1|Overall Study|Protocol Violation|1
7692514|NCT01201798|26753696|P2|Overall Study|Noncompliance|0
7692515|NCT01201798|26753697|P1|Overall Study|Noncompliance|1
7692516|NCT01201798|26753696|P2|Overall Study|Decision Unrelated to an Adverse Event|1
7692517|NCT01201798|26753697|P1|Overall Study|Decision Unrelated to an Adverse Event|1
7692518|NCT01201798|26753696|P2|Overall Study|Lost to Follow-up|5
7692519|NCT01201798|26753697|P1|Overall Study|Lost to Follow-up|3
7692520|NCT01201798|26753696|P2|Overall Study|Adverse Event|0
7692521|NCT01201798|26753697|P1|Overall Study|Adverse Event|2
7692522|NCT01201785|26753721|P1|Overall Study|Lost to Follow-up|16
7692523|NCT01201759|26753738|P2|Visit 4 Crossover|Lost to Follow-up|1
7692524|NCT01201759|26753739|P1|Visit 4 Crossover|Lost to Follow-up|0
7692525|NCT01201759|26753738|P2|Visit 3 - Washout|Lost to Follow-up|0
7692526|NCT01201759|26753739|P1|Visit 3 - Washout|Lost to Follow-up|1
7692527|NCT01201759|26753738|P2|Visit 3 - Washout|Adverse Event|3
7692528|NCT01201759|26753739|P1|Visit 3 - Washout|Adverse Event|0
7692529|NCT01201759|26753738|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
7692530|NCT01201759|26753739|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
7692531|NCT01201356|26753768|P1|Overall Study|Protocol Violation|12
7692532|NCT01201356|26753768|P1|Overall Study|Death|16
7692533|NCT01201356|26753768|P1|Overall Study|administrative problems|74
7692534|NCT01201356|26753768|P1|Overall Study|Lost to Follow-up|50
7692535|NCT01201356|26753768|P1|Overall Study|Withdrawal by Subject|144
7692536|NCT01201356|26753768|P1|Overall Study|Condition no longer requires study drug|12
7692537|NCT01201356|26753768|P1|Overall Study|Unsatisfactory therapeutic effect|112
7692538|NCT01201356|26753768|P1|Overall Study|Abnormal test procedure result(s)|3
7692539|NCT01201356|26753768|P1|Overall Study|Abnormal laboratory value(s)|51
7692540|NCT01201356|26753768|P1|Overall Study|Adverse Event|170
7692541|NCT01201343|26753782|P1|Overall Study|Randomized, not treated|3
7692542|NCT01201343|26753782|P1|Overall Study|Participant wrongly included in trial|1
7692543|NCT01201343|26753782|P1|Overall Study|Lack of Efficacy|2
7692544|NCT01201343|26753782|P1|Overall Study|Lost to Follow-up|2
7692545|NCT01201343|26753782|P1|Overall Study|Withdrawal by Subject|5
7692546|NCT01201343|26753782|P1|Overall Study|Adverse Event|6
7692547|NCT01201317|26753796|P3|Overall Study|Safety, possible history of tuberculosis|1
7692548|NCT01201317|26753797|P2|Overall Study|Safety, possible history of tuberculosis|0
7692549|NCT01201317|26753798|P1|Overall Study|Safety, possible history of tuberculosis|0
7692550|NCT01201317|26753796|P3|Overall Study|Lack of Efficacy|0
7692551|NCT01201317|26753797|P2|Overall Study|Lack of Efficacy|0
7692552|NCT01201317|26753798|P1|Overall Study|Lack of Efficacy|1
7692553|NCT01201317|26753796|P3|Overall Study|Decrease in renal function|0
7692554|NCT01201317|26753797|P2|Overall Study|Decrease in renal function|1
7692555|NCT01201317|26753798|P1|Overall Study|Decrease in renal function|0
7692556|NCT01201317|26753796|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
7692557|NCT01201317|26753797|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
7692558|NCT01201317|26753798|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
7692559|NCT01201317|26753796|P3|Overall Study|Study-specific withdrawal criteria|1
7692560|NCT01201317|26753797|P2|Overall Study|Study-specific withdrawal criteria|0
7692561|NCT01201317|26753798|P1|Overall Study|Study-specific withdrawal criteria|0
7692562|NCT01201317|26753796|P3|Overall Study|Death|0
7692563|NCT01201317|26753797|P2|Overall Study|Death|1
7692564|NCT01201317|26753798|P1|Overall Study|Death|0
7692565|NCT01201317|26753796|P3|Overall Study|Protocol Violation|1
7692566|NCT01201317|26753797|P2|Overall Study|Protocol Violation|1
7692567|NCT01201317|26753798|P1|Overall Study|Protocol Violation|0
7692568|NCT01201317|26753796|P3|Overall Study|Screen failure|0
7692569|NCT01201317|26753797|P2|Overall Study|Screen failure|1
7692570|NCT01201317|26753798|P1|Overall Study|Screen failure|1
7692571|NCT01201317|26753796|P3|Overall Study|Adverse Event|2
7692572|NCT01201317|26753797|P2|Overall Study|Adverse Event|2
7692573|NCT01201317|26753798|P1|Overall Study|Adverse Event|2
7692574|NCT01201317|26753796|P3|Overall Study|Withdrawal by Subject|3
7692575|NCT01201317|26753797|P2|Overall Study|Withdrawal by Subject|0
7692576|NCT01201317|26753798|P1|Overall Study|Withdrawal by Subject|5
7692577|NCT01201265|26753818|P1|Overall Study|Disease Progression|4
7692578|NCT01201265|26753818|P1|Overall Study|Withdrawal by Subject|7
7692579|NCT01201265|26753818|P1|Overall Study|Lost to Follow-up|10
7692580|NCT01201265|26753818|P1|Overall Study|Insufficient Therapeutic Response|3
7692581|NCT01201265|26753818|P1|Overall Study|Death|14
7692582|NCT01200992|26753865|P2|Overall Study|Randomized but not treated|0
7692583|NCT01200992|26753866|P1|Overall Study|Randomized but not treated|2
7692584|NCT01200992|26753865|P2|Overall Study|Study terminated early|41
7692585|NCT01200992|26753866|P1|Overall Study|Study terminated early|35
7692586|NCT01200810|26753897|P2|Overall Study|Sponsor stopped making study drug|3
7692587|NCT01200810|26753898|P1|Overall Study|Sponsor stopped making study drug|3
7692588|NCT01200810|26753897|P2|Overall Study|Withdrawal by Subject|2
7692589|NCT01200810|26753898|P1|Overall Study|Withdrawal by Subject|1
7692590|NCT01200810|26753897|P2|Overall Study|Physician Decision|0
7692591|NCT01200810|26753898|P1|Overall Study|Physician Decision|1
7692592|NCT01200797|26753918|P1|Overall Study|Disease Progression|13
7692593|NCT01200797|26753918|P1|Overall Study|Adverse Event|4
7692594|NCT01200797|26753918|P1|Overall Study|symptomatic deterioration|2
7692595|NCT01200758|26753928|P4|Stage 2|Death|5
7692596|NCT01200758|26753929|P3|Stage 2|Death|3
7692597|NCT01200758|26753930|P2|Stage 2|Death|0
7692598|NCT01200758|26753931|P1|Stage 2|Death|0
7692599|NCT01200758|26753928|P4|Stage 2|Protocol Violation|4
7692600|NCT01200758|26753929|P3|Stage 2|Protocol Violation|1
7692601|NCT01200758|26753930|P2|Stage 2|Protocol Violation|0
7692602|NCT01200758|26753931|P1|Stage 2|Protocol Violation|0
7692603|NCT01200758|26753928|P4|Stage 2|Lost to Follow-up|1
7692604|NCT01200758|26753929|P3|Stage 2|Lost to Follow-up|3
7692605|NCT01200758|26753930|P2|Stage 2|Lost to Follow-up|0
7692606|NCT01200758|26753931|P1|Stage 2|Lost to Follow-up|0
7692607|NCT01200758|26753928|P4|Stage 2|Withdrawal by Subject|1
7692608|NCT01200758|26753929|P3|Stage 2|Withdrawal by Subject|4
7692609|NCT01200758|26753930|P2|Stage 2|Withdrawal by Subject|0
7692610|NCT01200758|26753931|P1|Stage 2|Withdrawal by Subject|0
7692611|NCT01200758|26753928|P4|Stage 2|Adverse Event|9
7692612|NCT01200758|26753929|P3|Stage 2|Adverse Event|5
7692613|NCT01200758|26753930|P2|Stage 2|Adverse Event|0
7692614|NCT01200758|26753931|P1|Stage 2|Adverse Event|0
7692615|NCT01200758|26753928|P4|Stage 2|Physician Decision|7
7692616|NCT01200758|26753929|P3|Stage 2|Physician Decision|5
7692617|NCT01200758|26753930|P2|Stage 2|Physician Decision|0
7692618|NCT01200758|26753931|P1|Stage 2|Physician Decision|0
7692619|NCT01200758|26753928|P4|Stage 2|Lack of Efficacy|2
7692620|NCT01200758|26753929|P3|Stage 2|Lack of Efficacy|4
7692621|NCT01200758|26753930|P2|Stage 2|Lack of Efficacy|0
7692622|NCT01200758|26753931|P1|Stage 2|Lack of Efficacy|0
7692623|NCT01200758|26753928|P4|Stage 2|Disease Progression|21
7692624|NCT01200758|26753929|P3|Stage 2|Disease Progression|16
7692625|NCT01200758|26753930|P2|Stage 2|Disease Progression|0
7692626|NCT01200758|26753931|P1|Stage 2|Disease Progression|0
7692627|NCT01200758|26753928|P4|Stage I|Disease Progression|0
7692628|NCT01200758|26753929|P3|Stage I|Disease Progression|0
7692629|NCT01200758|26753930|P2|Stage I|Disease Progression|7
7692630|NCT01200758|26753931|P1|Stage I|Disease Progression|9
7692631|NCT01200758|26753928|P4|Stage I|Withdrawal by Subject|0
7692632|NCT01200758|26753929|P3|Stage I|Withdrawal by Subject|0
7692633|NCT01200758|26753930|P2|Stage I|Withdrawal by Subject|2
7692634|NCT01200758|26753931|P1|Stage I|Withdrawal by Subject|1
7692635|NCT01200758|26753928|P4|Stage I|Adverse Event|0
7692636|NCT01200758|26753929|P3|Stage I|Adverse Event|0
7692637|NCT01200758|26753930|P2|Stage I|Adverse Event|5
7692638|NCT01200758|26753931|P1|Stage I|Adverse Event|5
7692639|NCT01200758|26753928|P4|Stage I|Lack of Efficacy|0
7692640|NCT01200758|26753929|P3|Stage I|Lack of Efficacy|0
7692641|NCT01200758|26753930|P2|Stage I|Lack of Efficacy|1
7692642|NCT01200758|26753931|P1|Stage I|Lack of Efficacy|2
7692643|NCT01200758|26753928|P4|Stage I|Physician Decision|0
7692644|NCT01200758|26753929|P3|Stage I|Physician Decision|0
7692645|NCT01200758|26753930|P2|Stage I|Physician Decision|1
7692646|NCT01200758|26753931|P1|Stage I|Physician Decision|1
7692647|NCT01200758|26753928|P4|Stage I|Death|0
7692648|NCT01200758|26753929|P3|Stage I|Death|0
7692649|NCT01200758|26753930|P2|Stage I|Death|1
7692650|NCT01200758|26753931|P1|Stage I|Death|0
7692651|NCT01200589|26754004|P2|Overall Study|Study terminated|172
7692652|NCT01200589|26754005|P1|Overall Study|Study terminated|170
7692653|NCT01200589|26754004|P2|Overall Study|Lost to Follow-up|4
7692654|NCT01200589|26754005|P1|Overall Study|Lost to Follow-up|5
7692655|NCT01200589|26754004|P2|Overall Study|Physician Decision|2
7692656|NCT01200589|26754005|P1|Overall Study|Physician Decision|2
7692657|NCT01200589|26754004|P2|Overall Study|Withdrawal by Subject|11
7692658|NCT01200589|26754005|P1|Overall Study|Withdrawal by Subject|13
7692659|NCT01200524|26754032|P3|Overall Study|Non availability of study nurse|1
7692660|NCT01200524|26754033|P2|Overall Study|Non availability of study nurse|0
7692661|NCT01200524|26754034|P1|Overall Study|Non availability of study nurse|0
7692662|NCT01200524|26754032|P3|Overall Study|Adverse Event|0
7692663|NCT01200524|26754033|P2|Overall Study|Adverse Event|0
7692664|NCT01200524|26754034|P1|Overall Study|Adverse Event|1
7692665|NCT01200524|26754032|P3|Overall Study|Withdrawal by Subject|3
7692666|NCT01200524|26754033|P2|Overall Study|Withdrawal by Subject|1
7692667|NCT01200524|26754034|P1|Overall Study|Withdrawal by Subject|1
7692668|NCT01200511|26754054|P1|Overall Study|Adverse Event|1
7692669|NCT01200511|26754054|P1|Overall Study|Withdrawal by Subject|1
7692670|NCT01200511|26754054|P1|Overall Study|Lost to Follow-up|3
7692671|NCT01200485|26754066|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
7692672|NCT01200485|26754067|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
7692673|NCT01200485|26754068|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
7692674|NCT01200485|26754066|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
7692675|NCT01200485|26754067|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
7692676|NCT01200485|26754068|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
7692677|NCT01200407|26754100|P1|Overall Study|Other|19
7692678|NCT01200407|26754100|P1|Overall Study|Withdrawal by Subject|4
7692679|NCT01200407|26754100|P1|Overall Study|Adverse Event|3
7692680|NCT01200407|26754100|P1|Overall Study|Lost to Follow-up|56
7692681|NCT01200394|26754109|P2|Overall Study|Other|1
7692682|NCT01200394|26754110|P1|Overall Study|Other|0
7692683|NCT01200394|26754109|P2|Overall Study|Withdrawal by Subject|5
7692684|NCT01200394|26754110|P1|Overall Study|Withdrawal by Subject|0
7692685|NCT01200394|26754109|P2|Overall Study|Protocol Violation|3
7692686|NCT01200394|26754110|P1|Overall Study|Protocol Violation|0
7692687|NCT01200394|26754109|P2|Overall Study|Did Not Meet Entrance Criteria|4
7692688|NCT01200394|26754110|P1|Overall Study|Did Not Meet Entrance Criteria|1
7692689|NCT01200394|26754109|P2|Overall Study|Lost to Follow-up|1
7692690|NCT01200394|26754110|P1|Overall Study|Lost to Follow-up|0
7692691|NCT01200394|26754109|P2|Overall Study|Death|0
7692692|NCT01200394|26754110|P1|Overall Study|Death|1
7692693|NCT01200394|26754109|P2|Overall Study|Adverse Event|14
7692694|NCT01200394|26754110|P1|Overall Study|Adverse Event|0
7692695|NCT01200368|26754148|P3|Toddler Dose|Adverse Event|1
7692696|NCT01200368|26754149|P2|Toddler Dose|Adverse Event|3
7692697|NCT01200368|26754150|P1|Toddler Dose|Adverse Event|0
7692698|NCT01200368|26754148|P3|After Infant Series|Other|2
7692699|NCT01200368|26754149|P2|After Infant Series|Other|2
7692700|NCT01200368|26754150|P1|After Infant Series|Other|1
7692701|NCT01200368|26754148|P3|After Infant Series|Lost to Follow-up|0
7692702|NCT01200368|26754149|P2|After Infant Series|Lost to Follow-up|0
7692703|NCT01200368|26754150|P1|After Infant Series|Lost to Follow-up|1
7692704|NCT01200368|26754148|P3|After Infant Series|Withdrawal by Subject|4
7692705|NCT01200368|26754149|P2|After Infant Series|Withdrawal by Subject|8
7692706|NCT01200368|26754150|P1|After Infant Series|Withdrawal by Subject|10
7692707|NCT01200368|26754148|P3|After Infant Series|Adverse Event|3
7692708|NCT01200368|26754149|P2|After Infant Series|Adverse Event|6
7692709|NCT01200368|26754150|P1|After Infant Series|Adverse Event|6
7692710|NCT01200368|26754148|P3|Infant Series|Other|0
7692711|NCT01200368|26754149|P2|Infant Series|Other|0
7692712|NCT01200368|26754150|P1|Infant Series|Other|1
7692713|NCT01200368|26754148|P3|Infant Series|Randomized, not vaccinated|1
7692714|NCT01200368|26754149|P2|Infant Series|Randomized, not vaccinated|1
7692715|NCT01200368|26754150|P1|Infant Series|Randomized, not vaccinated|0
7692716|NCT01200368|26754148|P3|Infant Series|Did not meet entrance criteria|0
7692717|NCT01200368|26754149|P2|Infant Series|Did not meet entrance criteria|1
7692718|NCT01200368|26754150|P1|Infant Series|Did not meet entrance criteria|0
7692719|NCT01200368|26754148|P3|Infant Series|Withdrawal by Subject|2
7692720|NCT01200368|26754149|P2|Infant Series|Withdrawal by Subject|2
7692721|NCT01200368|26754150|P1|Infant Series|Withdrawal by Subject|0
7692722|NCT01200368|26754148|P3|Infant Series|Adverse Event|3
7692723|NCT01200368|26754149|P2|Infant Series|Adverse Event|2
7692724|NCT01200368|26754150|P1|Infant Series|Adverse Event|2
7692725|NCT01200355|26754216|P2|Overall Study|Death|2
7692726|NCT01200355|26754217|P1|Overall Study|Death|7
7692727|NCT01200342|26754231|P1|Overall Study|Disease Progression|1
7692728|NCT01200329|26754236|P1|Overall Study|Progressive disease|1
7692729|NCT01200329|26754236|P1|Overall Study|Lack of financial coverage|2
7692730|NCT01200290|26754241|P1|Post-Treatment Follow-Up Period|Death|2
7692731|NCT01200290|26754241|P1|Treatment Period|Adverse Event|1
7692732|NCT01200238|26754254|P2|Overall Study|Withdrawal by Subject|1
7692733|NCT01200238|26754255|P1|Overall Study|Withdrawal by Subject|0
7692734|NCT01200238|26754254|P2|Overall Study|Progressive Disease|8
7692735|NCT01200238|26754255|P1|Overall Study|Progressive Disease|5
7692736|NCT01200238|26754254|P2|Overall Study|Adverse Event|1
7692737|NCT01200238|26754255|P1|Overall Study|Adverse Event|2
7692738|NCT01200069|26754279|P2|Overall Study|Withdrawal by Subject|1
7692739|NCT01200069|26754280|P1|Overall Study|Withdrawal by Subject|0
7692740|NCT01199939|26754376|P1|Overall Study|Reached a virologic endpoint|4
7692741|NCT01199939|26754376|P1|Overall Study|Lost to Follow-up|2
7692742|NCT01199939|26754376|P1|Overall Study|Protocol Violation|3
7692743|NCT01199939|26754376|P1|Overall Study|Adverse Event|4
7692744|NCT01199861|26754408|P2|Overall Study|Adverse Event|0
7692745|NCT01199861|26754409|P1|Overall Study|Adverse Event|1
7692746|NCT01199861|26754408|P2|Overall Study|Administrative problems|0
7692747|NCT01199861|26754409|P1|Overall Study|Administrative problems|1
7692748|NCT01199822|26754444|P3|Overall Study|Investigator discontinued therapy|0
7692749|NCT01199822|26754445|P2|Overall Study|Investigator discontinued therapy|1
7692750|NCT01199822|26754446|P1|Overall Study|Investigator discontinued therapy|0
7692751|NCT01199731|26754495|P3|Overall Study|Withdrawal by Subject|0
7692752|NCT01199731|26754496|P2|Overall Study|Withdrawal by Subject|0
7692753|NCT01199731|26754497|P1|Overall Study|Withdrawal by Subject|2
7692754|NCT01199731|26754495|P3|Overall Study|Physician Decision|1
7692755|NCT01199731|26754496|P2|Overall Study|Physician Decision|1
7692756|NCT01199731|26754497|P1|Overall Study|Physician Decision|0
7692757|NCT01199731|26754495|P3|Overall Study|Lost to Follow-up|2
7692758|NCT01199731|26754496|P2|Overall Study|Lost to Follow-up|0
7692759|NCT01199731|26754497|P1|Overall Study|Lost to Follow-up|0
7692760|NCT01199731|26754495|P3|Overall Study|Study closed/terminated|7
7692761|NCT01199731|26754496|P2|Overall Study|Study closed/terminated|9
7692762|NCT01199731|26754497|P1|Overall Study|Study closed/terminated|7
7692763|NCT01199731|26754495|P3|Overall Study|Adverse Event|0
7692764|NCT01199731|26754496|P2|Overall Study|Adverse Event|1
7692765|NCT01199731|26754497|P1|Overall Study|Adverse Event|0
7692766|NCT01199705|26754535|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
7692767|NCT01199601|26754567|P2|Overall Study|Insecurity prevented staff interviewing.|9
7692768|NCT01199601|26754568|P1|Overall Study|Insecurity prevented staff interviewing.|7
7692769|NCT01199601|26754567|P2|Overall Study|Withdrawal by Subject|3
7692770|NCT01199601|26754568|P1|Overall Study|Withdrawal by Subject|15
7692771|NCT01199601|26754567|P2|Overall Study|Lost to Follow-up|66
7692772|NCT01199601|26754568|P1|Overall Study|Lost to Follow-up|47
7692773|NCT01199575|26754578|P1|Overall Study|Withdrawal by Subject|5
7692774|NCT01199471|26754583|P1|Overall Study|Physician Decision|1
7692775|NCT01199471|26754583|P1|Overall Study|Withdrawal by Subject|1
7692776|NCT01199471|26754583|P1|Overall Study|Protocol Violation|4
7692777|NCT01199263|26754603|P2|Overall Study|Never Treated|0
7692778|NCT01199263|26754604|P1|Overall Study|Never Treated|6
7692779|NCT01199263|26754603|P2|Overall Study|Ineligible|2
7692780|NCT01199263|26754604|P1|Overall Study|Ineligible|0
7692781|NCT01199198|26754637|P2|Overall Study|Hospice-care transfer|2
7692782|NCT01199198|26754638|P1|Overall Study|Hospice-care transfer|1
7692783|NCT01199198|26754637|P2|Overall Study|ICU Transfer|2
7692784|NCT01199198|26754638|P1|Overall Study|ICU Transfer|1
7692785|NCT01199198|26754637|P2|Overall Study|Withdrawal by Subject|2
7692786|NCT01199198|26754638|P1|Overall Study|Withdrawal by Subject|1
7692787|NCT01199198|26754637|P2|Overall Study|Lost to Follow-up|5
7692788|NCT01199198|26754638|P1|Overall Study|Lost to Follow-up|1
7692789|NCT01199198|26754637|P2|Overall Study|Adverse Event|0
7692790|NCT01199198|26754638|P1|Overall Study|Adverse Event|3
7692791|NCT01199068|26754655|P3|Overall Study|Withdrawal by Subject|1
7692792|NCT01199068|26754656|P2|Overall Study|Withdrawal by Subject|0
7692793|NCT01199068|26754657|P1|Overall Study|Withdrawal by Subject|0
7692794|NCT01199068|26754655|P3|Overall Study|Progressive disease|6
7692795|NCT01199068|26754656|P2|Overall Study|Progressive disease|3
7692796|NCT01199068|26754657|P1|Overall Study|Progressive disease|3
7692797|NCT01199068|26754655|P3|Overall Study|Unacceptable toxicity|2
7692798|NCT01199068|26754656|P2|Overall Study|Unacceptable toxicity|0
7692799|NCT01199068|26754657|P1|Overall Study|Unacceptable toxicity|0
7692800|NCT01199055|26754691|P3|Overall Study|Withdrawal by Subject|1
7692801|NCT01199055|26754692|P2|Overall Study|Withdrawal by Subject|0
7692802|NCT01199055|26754693|P1|Overall Study|Withdrawal by Subject|0
7692803|NCT01199055|26754691|P3|Overall Study|Progressive disease|2
7692804|NCT01199055|26754692|P2|Overall Study|Progressive disease|1
7692805|NCT01199055|26754693|P1|Overall Study|Progressive disease|2
7692806|NCT01199055|26754691|P3|Overall Study|Physician Decision|1
7692807|NCT01199055|26754692|P2|Overall Study|Physician Decision|1
7692808|NCT01199055|26754693|P1|Overall Study|Physician Decision|0
7692809|NCT01199055|26754691|P3|Overall Study|Death|0
7692810|NCT01199055|26754692|P2|Overall Study|Death|1
7692811|NCT01199055|26754693|P1|Overall Study|Death|0
7692812|NCT01199042|26754718|P1|At Home (3 Months)|Lost to Follow-up|1
7692813|NCT01199042|26754718|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
7692814|NCT01199016|26754727|P1|Overall Study|Lost to Follow-up|25
7692815|NCT01199016|26754727|P1|Overall Study|Withdrawal by Subject|21
7692816|NCT01199016|26754727|P1|Overall Study|Other|13
7692817|NCT01199016|26754727|P1|Overall Study|Protocol Violation|9
7692818|NCT01199016|26754727|P1|Overall Study|Entrance criteria|5
7692819|NCT01199016|26754727|P1|Overall Study|No longer meets eligibility criteria|4
7692820|NCT01198977|26754736|P2|Overall Study|Lost to Follow-up|0
7692821|NCT01198977|26754737|P1|Overall Study|Lost to Follow-up|1
7692822|NCT01198873|26754749|P2|Overall Study|Other than above|2
7692823|NCT01198873|26754750|P1|Overall Study|Other than above|4
7692824|NCT01198873|26754749|P2|Overall Study|Study closure|23
7692825|NCT01198873|26754750|P1|Overall Study|Study closure|29
7692826|NCT01198873|26754749|P2|Overall Study|Adverse Event|7
7692827|NCT01198873|26754750|P1|Overall Study|Adverse Event|4
7692828|NCT01198795|26754764|P1|Overall Study|Other Reason|4
7692829|NCT01198795|26754764|P1|Overall Study|Protocol Violation|2
7692830|NCT01198795|26754764|P1|Overall Study|Lack of Efficacy|5
7692831|NCT01198795|26754764|P1|Overall Study|Adverse Event|9
7692832|NCT01198795|26754764|P1|Overall Study|Lost to Follow-up|15
7692833|NCT01198795|26754764|P1|Overall Study|Withdrawal by Subject|17
7692834|NCT01198795|26754764|P1|Overall Study|Did not meet InclusionExclusion criteria|30
7692835|NCT01198756|26754781|P4|Overall Study|Lost to Follow-up|18
7692836|NCT01198756|26754782|P3|Overall Study|Lost to Follow-up|23
7692837|NCT01198756|26754783|P2|Overall Study|Lost to Follow-up|36
7692838|NCT01198756|26754784|P1|Overall Study|Lost to Follow-up|29
7692839|NCT01198756|26754781|P4|Overall Study|Withdrawal by Subject|5
7692840|NCT01198756|26754782|P3|Overall Study|Withdrawal by Subject|7
7692841|NCT01198756|26754783|P2|Overall Study|Withdrawal by Subject|4
7692842|NCT01198756|26754784|P1|Overall Study|Withdrawal by Subject|9
7692843|NCT01198756|26754781|P4|Overall Study|Protocol Violation|2
7692844|NCT01198756|26754782|P3|Overall Study|Protocol Violation|0
7692845|NCT01198756|26754783|P2|Overall Study|Protocol Violation|0
7692846|NCT01198756|26754784|P1|Overall Study|Protocol Violation|0
7692847|NCT01198756|26754781|P4|Overall Study|Adverse Event|1
7692848|NCT01198756|26754782|P3|Overall Study|Adverse Event|0
7692849|NCT01198756|26754783|P2|Overall Study|Adverse Event|0
7692850|NCT01198756|26754784|P1|Overall Study|Adverse Event|0
7692851|NCT01198600|26754895|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7693013|NCT01197794|26755393|P5|Overall Study|Adverse Event|4
7692852|NCT01198600|26754896|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
7692853|NCT01198600|26754897|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7692854|NCT01198600|26754898|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7692855|NCT01198600|26754895|P4|Phase 2: 56 Days of Wear|Relocation|0
7692856|NCT01198600|26754896|P3|Phase 2: 56 Days of Wear|Relocation|2
7692857|NCT01198600|26754897|P2|Phase 2: 56 Days of Wear|Relocation|0
7692858|NCT01198600|26754898|P1|Phase 2: 56 Days of Wear|Relocation|0
7692859|NCT01198600|26754895|P4|Phase 2: 56 Days of Wear|Inconvenience|0
7692860|NCT01198600|26754896|P3|Phase 2: 56 Days of Wear|Inconvenience|2
7692861|NCT01198600|26754897|P2|Phase 2: 56 Days of Wear|Inconvenience|0
7692862|NCT01198600|26754898|P1|Phase 2: 56 Days of Wear|Inconvenience|0
7692863|NCT01198600|26754895|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7692864|NCT01198600|26754896|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7692865|NCT01198600|26754897|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
7692866|NCT01198600|26754898|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7692867|NCT01198600|26754895|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7692868|NCT01198600|26754896|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7692869|NCT01198600|26754897|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
7692870|NCT01198600|26754898|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7692871|NCT01198600|26754895|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7692872|NCT01198600|26754896|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7692873|NCT01198600|26754897|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7692874|NCT01198600|26754898|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
7692875|NCT01198600|26754895|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7692876|NCT01198600|26754896|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7692877|NCT01198600|26754897|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7692878|NCT01198600|26754898|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
7692879|NCT01198587|26754924|P4|Overall Study|Lost to Follow-up|0
7692880|NCT01198587|26754925|P3|Overall Study|Lost to Follow-up|9
7692881|NCT01198587|26754926|P2|Overall Study|Lost to Follow-up|0
7692882|NCT01198587|26754927|P1|Overall Study|Lost to Follow-up|8
7692883|NCT01198574|26754949|P4|Overall Study|Resigned from schools|4
7692884|NCT01198574|26754950|P3|Overall Study|Resigned from schools|1
7692885|NCT01198574|26754951|P2|Overall Study|Resigned from schools|1
7692886|NCT01198574|26754952|P1|Overall Study|Resigned from schools|4
7692887|NCT01198548|26754970|P1|Overall Study|Administrative Decision|1
7692888|NCT01198548|26754970|P1|Overall Study|Disease Progression|9
7692889|NCT01198509|26754985|P6|Overall Study|Withdrawal by Subject|0
7692890|NCT01198509|26754986|P5|Overall Study|Withdrawal by Subject|0
7692891|NCT01198509|26754987|P4|Overall Study|Withdrawal by Subject|0
7692892|NCT01198509|26754988|P3|Overall Study|Withdrawal by Subject|0
7692893|NCT01198509|26754989|P2|Overall Study|Withdrawal by Subject|0
7692894|NCT01198509|26754990|P1|Overall Study|Withdrawal by Subject|1
7692895|NCT01198470|26755007|P1|Overall Study|Adverse Event|2
7692896|NCT01198275|26755073|P2|Overall Study|spontaneous return to sinus rhythm|2
7692897|NCT01198275|26755074|P1|Overall Study|spontaneous return to sinus rhythm|4
7692898|NCT01198275|26755073|P2|Overall Study|Adverse Event|3
7692899|NCT01198275|26755074|P1|Overall Study|Adverse Event|2
7692900|NCT01198145|26755097|P2|Overall Study|Withdrawal by Subject|1
7692901|NCT01198145|26755098|P1|Overall Study|Withdrawal by Subject|1
7692902|NCT01198132|26755120|P2|Overall Study|Protocol Violation|0
7692903|NCT01198132|26755121|P1|Overall Study|Protocol Violation|1
7692904|NCT01198132|26755120|P2|Overall Study|Adverse Event|1
7692905|NCT01198132|26755121|P1|Overall Study|Adverse Event|0
7692906|NCT01198132|26755120|P2|Overall Study|Abnormal/clinically significant biologic|1
7692907|NCT01198132|26755121|P1|Overall Study|Abnormal/clinically significant biologic|1
7692908|NCT01198132|26755120|P2|Overall Study|Sign/symptoms of underlying disease|1
7692909|NCT01198132|26755121|P1|Overall Study|Sign/symptoms of underlying disease|2
7692910|NCT01198132|26755120|P2|Overall Study|Lack of Efficacy|3
7692911|NCT01198132|26755121|P1|Overall Study|Lack of Efficacy|2
7692912|NCT01198132|26755120|P2|Overall Study|Other Unspecified|6
7692913|NCT01198132|26755121|P1|Overall Study|Other Unspecified|3
7692914|NCT01198132|26755120|P2|Overall Study|Physician Decision|4
7692915|NCT01198132|26755121|P1|Overall Study|Physician Decision|5
7692916|NCT01198132|26755120|P2|Overall Study|Withdrawal by Subject|5
7692917|NCT01198132|26755121|P1|Overall Study|Withdrawal by Subject|4
7692918|NCT01198028|26755145|P1|Overall Study|Physician Decision|2
7692919|NCT01198028|26755145|P1|Overall Study|Death|3
7692920|NCT01198028|26755145|P1|Overall Study|Adverse Event|5
7692921|NCT01198002|26755157|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
7692922|NCT01198002|26755158|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
7692923|NCT01198002|26755159|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
7692924|NCT01198002|26755157|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7692925|NCT01198002|26755158|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
7692926|NCT01198002|26755159|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7692927|NCT01198002|26755157|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
7692928|NCT01198002|26755158|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
7692929|NCT01198002|26755159|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
7692930|NCT01198002|26755157|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
7692931|NCT01198002|26755158|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
7692932|NCT01198002|26755159|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
7692933|NCT01198002|26755157|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
7692934|NCT01198002|26755158|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
7692935|NCT01198002|26755159|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
7692936|NCT01198002|26755157|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
7692937|NCT01198002|26755158|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
7692938|NCT01198002|26755159|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
7692939|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
7692940|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
7692941|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
7692942|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
7692943|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
7692944|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
7692945|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
7692946|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
7692947|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
7692948|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
7692949|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
7692950|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
7692951|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
7692952|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
7692953|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
7692954|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
7692955|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
7692956|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
7692957|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
7692958|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
7692959|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
7692960|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Death|1
7692961|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Death|0
7692962|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Death|2
7692963|NCT01198002|26755157|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
7692964|NCT01198002|26755158|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
7692965|NCT01198002|26755159|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
7692966|NCT01197911|26755274|P3|Overall Study|Adverse Event|1
7692967|NCT01197911|26755275|P2|Overall Study|Adverse Event|0
7692968|NCT01197911|26755276|P1|Overall Study|Adverse Event|0
7692969|NCT01197794|26755391|P7|Overall Study|Other|4
7692970|NCT01197794|26755392|P6|Overall Study|Other|2
7692971|NCT01197794|26755393|P5|Overall Study|Other|2
7692972|NCT01197794|26755394|P4|Overall Study|Other|0
7692973|NCT01197794|26755395|P3|Overall Study|Other|3
7692974|NCT01197794|26755396|P2|Overall Study|Other|1
7692975|NCT01197794|26755397|P1|Overall Study|Other|1
7692976|NCT01197794|26755391|P7|Overall Study|Lost to Follow-up|0
7692977|NCT01197794|26755392|P6|Overall Study|Lost to Follow-up|1
7692978|NCT01197794|26755393|P5|Overall Study|Lost to Follow-up|0
7692979|NCT01197794|26755394|P4|Overall Study|Lost to Follow-up|1
7692980|NCT01197794|26755395|P3|Overall Study|Lost to Follow-up|0
7692981|NCT01197794|26755396|P2|Overall Study|Lost to Follow-up|1
7692982|NCT01197794|26755397|P1|Overall Study|Lost to Follow-up|1
7692983|NCT01197794|26755391|P7|Overall Study|Withdrawal by Subject|6
7692984|NCT01197794|26755392|P6|Overall Study|Withdrawal by Subject|5
7692985|NCT01197794|26755393|P5|Overall Study|Withdrawal by Subject|1
7692986|NCT01197794|26755394|P4|Overall Study|Withdrawal by Subject|1
7692987|NCT01197794|26755395|P3|Overall Study|Withdrawal by Subject|4
7692988|NCT01197794|26755396|P2|Overall Study|Withdrawal by Subject|3
7692989|NCT01197794|26755397|P1|Overall Study|Withdrawal by Subject|3
7692990|NCT01197794|26755391|P7|Overall Study|Eligibility criteria not fulfilled|6
7692991|NCT01197794|26755392|P6|Overall Study|Eligibility criteria not fulfilled|9
7692992|NCT01197794|26755393|P5|Overall Study|Eligibility criteria not fulfilled|5
7692993|NCT01197794|26755394|P4|Overall Study|Eligibility criteria not fulfilled|5
7692994|NCT01197794|26755395|P3|Overall Study|Eligibility criteria not fulfilled|2
7692995|NCT01197794|26755396|P2|Overall Study|Eligibility criteria not fulfilled|8
7692996|NCT01197794|26755397|P1|Overall Study|Eligibility criteria not fulfilled|5
7692997|NCT01197794|26755391|P7|Overall Study|Development of study withdrawal criteria|1
7692998|NCT01197794|26755392|P6|Overall Study|Development of study withdrawal criteria|0
7692999|NCT01197794|26755393|P5|Overall Study|Development of study withdrawal criteria|0
7693000|NCT01197794|26755394|P4|Overall Study|Development of study withdrawal criteria|1
7693001|NCT01197794|26755395|P3|Overall Study|Development of study withdrawal criteria|0
7693002|NCT01197794|26755396|P2|Overall Study|Development of study withdrawal criteria|0
7693003|NCT01197794|26755397|P1|Overall Study|Development of study withdrawal criteria|3
7693004|NCT01197794|26755391|P7|Overall Study|Protocol Violation|1
7693005|NCT01197794|26755392|P6|Overall Study|Protocol Violation|0
7693006|NCT01197794|26755393|P5|Overall Study|Protocol Violation|2
7693007|NCT01197794|26755394|P4|Overall Study|Protocol Violation|0
7693008|NCT01197794|26755395|P3|Overall Study|Protocol Violation|0
7693009|NCT01197794|26755396|P2|Overall Study|Protocol Violation|0
7693010|NCT01197794|26755397|P1|Overall Study|Protocol Violation|0
7693011|NCT01197794|26755391|P7|Overall Study|Adverse Event|3
7693012|NCT01197794|26755392|P6|Overall Study|Adverse Event|2
7693014|NCT01197794|26755394|P4|Overall Study|Adverse Event|4
7693015|NCT01197794|26755395|P3|Overall Study|Adverse Event|4
7693016|NCT01197794|26755396|P2|Overall Study|Adverse Event|2
7693017|NCT01197794|26755397|P1|Overall Study|Adverse Event|3
7693018|NCT01197755|26755479|P3|Overall Study|eg, change in circumstances|2
7693019|NCT01197755|26755480|P2|Overall Study|eg, change in circumstances|3
7693020|NCT01197755|26755481|P1|Overall Study|eg, change in circumstances|7
7693021|NCT01197755|26755479|P3|Overall Study|Lost to Follow-up|1
7693022|NCT01197755|26755480|P2|Overall Study|Lost to Follow-up|0
7693023|NCT01197755|26755481|P1|Overall Study|Lost to Follow-up|0
7693024|NCT01197755|26755479|P3|Overall Study|Withdrawal by Subject|0
7693025|NCT01197755|26755480|P2|Overall Study|Withdrawal by Subject|0
7693026|NCT01197755|26755481|P1|Overall Study|Withdrawal by Subject|1
7693027|NCT01197755|26755479|P3|Overall Study|Severe non-compliance to the protocol|2
7693028|NCT01197755|26755480|P2|Overall Study|Severe non-compliance to the protocol|1
7693029|NCT01197755|26755481|P1|Overall Study|Severe non-compliance to the protocol|2
7693030|NCT01197755|26755479|P3|Overall Study|Lack of therapeutic response|4
7693031|NCT01197755|26755480|P2|Overall Study|Lack of therapeutic response|7
7693032|NCT01197755|26755481|P1|Overall Study|Lack of therapeutic response|0
7693033|NCT01197755|26755479|P3|Overall Study|Entered the long-term extension study|35
7693034|NCT01197755|26755480|P2|Overall Study|Entered the long-term extension study|21
7693035|NCT01197755|26755481|P1|Overall Study|Entered the long-term extension study|18
7693036|NCT01197755|26755479|P3|Overall Study|Study-specific discontinuation criteria|0
7693037|NCT01197755|26755480|P2|Overall Study|Study-specific discontinuation criteria|1
7693038|NCT01197755|26755481|P1|Overall Study|Study-specific discontinuation criteria|2
7693039|NCT01197755|26755479|P3|Overall Study|Adverse Event|10
7693040|NCT01197755|26755480|P2|Overall Study|Adverse Event|10
7693041|NCT01197755|26755481|P1|Overall Study|Adverse Event|8
7693042|NCT01197560|26755553|P2|Overall Study|Missing|1
7693043|NCT01197560|26755554|P1|Overall Study|Missing|0
7693044|NCT01197560|26755553|P2|Overall Study|Miscellaneous|3
7693045|NCT01197560|26755554|P1|Overall Study|Miscellaneous|4
7693046|NCT01197560|26755553|P2|Overall Study|Disease progression|35
7693047|NCT01197560|26755554|P1|Overall Study|Disease progression|40
7693048|NCT01197560|26755553|P2|Overall Study|Withdrawal by Subject|1
7693049|NCT01197560|26755554|P1|Overall Study|Withdrawal by Subject|1
7693050|NCT01197560|26755553|P2|Overall Study|Death|5
7693051|NCT01197560|26755554|P1|Overall Study|Death|3
7693052|NCT01197560|26755553|P2|Overall Study|Adverse Event|8
7693053|NCT01197560|26755554|P1|Overall Study|Adverse Event|6
7693054|NCT01197534|26755601|P3|Overall Study|Adverse Event|24
7693055|NCT01197534|26755602|P2|Overall Study|Adverse Event|36
7693056|NCT01197534|26755603|P1|Overall Study|Adverse Event|35
7693057|NCT01197534|26755601|P3|Overall Study|Lost to Follow-up|2
7693058|NCT01197534|26755602|P2|Overall Study|Lost to Follow-up|4
7693059|NCT01197534|26755603|P1|Overall Study|Lost to Follow-up|1
7693060|NCT01197534|26755601|P3|Overall Study|Dev. of study specific discont. criteria|2
7693061|NCT01197534|26755602|P2|Overall Study|Dev. of study specific discont. criteria|6
7693062|NCT01197534|26755603|P1|Overall Study|Dev. of study specific discont. criteria|13
7693063|NCT01197534|26755601|P3|Overall Study|Lack of therapeutic response|9
7693064|NCT01197534|26755602|P2|Overall Study|Lack of therapeutic response|4
7693065|NCT01197534|26755603|P1|Overall Study|Lack of therapeutic response|9
7693066|NCT01197534|26755601|P3|Overall Study|Severe non-compliance to protocol|1
7693067|NCT01197534|26755602|P2|Overall Study|Severe non-compliance to protocol|4
7693068|NCT01197534|26755603|P1|Overall Study|Severe non-compliance to protocol|3
7693069|NCT01197534|26755601|P3|Overall Study|Enrolment in long term extension|119
7693070|NCT01197534|26755602|P2|Overall Study|Enrolment in long term extension|66
7693071|NCT01197534|26755603|P1|Overall Study|Enrolment in long term extension|57
7693072|NCT01197534|26755601|P3|Overall Study|Not reported|16
7693073|NCT01197534|26755602|P2|Overall Study|Not reported|10
7693074|NCT01197534|26755603|P1|Overall Study|Not reported|16
7693075|NCT01197521|26755647|P3|Overall Study|Adverse Event|24
7693076|NCT01197521|26755648|P2|Overall Study|Adverse Event|28
7693077|NCT01197521|26755649|P1|Overall Study|Adverse Event|25
7693078|NCT01197521|26755647|P3|Overall Study|Lost to Follow-up|2
7693079|NCT01197521|26755648|P2|Overall Study|Lost to Follow-up|2
7693080|NCT01197521|26755649|P1|Overall Study|Lost to Follow-up|3
7693081|NCT01197521|26755647|P3|Overall Study|Dev. of study specific discont. criteria|2
7693082|NCT01197521|26755648|P2|Overall Study|Dev. of study specific discont. criteria|16
7693083|NCT01197521|26755649|P1|Overall Study|Dev. of study specific discont. criteria|6
7693084|NCT01197521|26755647|P3|Overall Study|Lack of therapeutic response|4
7693085|NCT01197521|26755648|P2|Overall Study|Lack of therapeutic response|3
7693086|NCT01197521|26755649|P1|Overall Study|Lack of therapeutic response|2
7693087|NCT01197521|26755647|P3|Overall Study|Severe non-compliance to protocol|3
7693088|NCT01197521|26755648|P2|Overall Study|Severe non-compliance to protocol|3
7693089|NCT01197521|26755649|P1|Overall Study|Severe non-compliance to protocol|1
7693090|NCT01197521|26755647|P3|Overall Study|Enrolment in long term extension|87
7693091|NCT01197521|26755648|P2|Overall Study|Enrolment in long term extension|36
7693092|NCT01197521|26755649|P1|Overall Study|Enrolment in long term extension|42
7693093|NCT01197521|26755647|P3|Overall Study|Not reported|21
7693094|NCT01197521|26755648|P2|Overall Study|Not reported|25
7693095|NCT01197521|26755649|P1|Overall Study|Not reported|24
7693096|NCT01197508|26755694|P4|Overall Study|Other|2
7693097|NCT01197508|26755695|P3|Overall Study|Other|2
7693098|NCT01197508|26755696|P2|Overall Study|Other|3
7693099|NCT01197508|26755697|P1|Overall Study|Other|2
7693100|NCT01197508|26755694|P4|Overall Study|Lost to Follow-up|0
7693101|NCT01197508|26755695|P3|Overall Study|Lost to Follow-up|2
7693102|NCT01197508|26755696|P2|Overall Study|Lost to Follow-up|1
7693103|NCT01197508|26755697|P1|Overall Study|Lost to Follow-up|1
7693104|NCT01197508|26755694|P4|Overall Study|Study-specific withdrawal criteria|2
7693105|NCT01197508|26755695|P3|Overall Study|Study-specific withdrawal criteria|1
7693106|NCT01197508|26755696|P2|Overall Study|Study-specific withdrawal criteria|0
7693107|NCT01197508|26755697|P1|Overall Study|Study-specific withdrawal criteria|0
7693108|NCT01197508|26755694|P4|Overall Study|Lack of Efficacy|1
7693109|NCT01197508|26755695|P3|Overall Study|Lack of Efficacy|2
7693110|NCT01197508|26755696|P2|Overall Study|Lack of Efficacy|2
7693111|NCT01197508|26755697|P1|Overall Study|Lack of Efficacy|1
7693112|NCT01197508|26755694|P4|Overall Study|Condition under investigation worsened|1
7693113|NCT01197508|26755695|P3|Overall Study|Condition under investigation worsened|1
7693114|NCT01197508|26755696|P2|Overall Study|Condition under investigation worsened|1
7693115|NCT01197508|26755697|P1|Overall Study|Condition under investigation worsened|1
7693116|NCT01197508|26755694|P4|Overall Study|Severe non-compliance to protocol|3
7693117|NCT01197508|26755695|P3|Overall Study|Severe non-compliance to protocol|1
7693118|NCT01197508|26755696|P2|Overall Study|Severe non-compliance to protocol|3
7693119|NCT01197508|26755697|P1|Overall Study|Severe non-compliance to protocol|0
7693120|NCT01197508|26755694|P4|Overall Study|Adverse Event|3
7693121|NCT01197508|26755695|P3|Overall Study|Adverse Event|23
7693122|NCT01197508|26755696|P2|Overall Study|Adverse Event|13
7693123|NCT01197508|26755697|P1|Overall Study|Adverse Event|10
7693124|NCT01197508|26755694|P4|Overall Study|Eligiblity criteria not fulfilled|0
7693125|NCT01197508|26755695|P3|Overall Study|Eligiblity criteria not fulfilled|2
7693126|NCT01197508|26755696|P2|Overall Study|Eligiblity criteria not fulfilled|0
7693127|NCT01197508|26755697|P1|Overall Study|Eligiblity criteria not fulfilled|0
7693128|NCT01197508|26755694|P4|Overall Study|Withdrawal by Subject|4
7693129|NCT01197508|26755695|P3|Overall Study|Withdrawal by Subject|15
7693130|NCT01197508|26755696|P2|Overall Study|Withdrawal by Subject|7
7693131|NCT01197508|26755697|P1|Overall Study|Withdrawal by Subject|8
7693132|NCT01197417|26755818|P2|Overall Study|No 25-hour magnesium level|2
7693133|NCT01197417|26755819|P1|Overall Study|No 25-hour magnesium level|0
7693134|NCT01197417|26755818|P2|Overall Study|Found to be ineligible|5
7693135|NCT01197417|26755819|P1|Overall Study|Found to be ineligible|2
7693136|NCT01197417|26755818|P2|Overall Study|Hypotension|2
7693137|NCT01197417|26755819|P1|Overall Study|Hypotension|1
7693138|NCT01197417|26755818|P2|Overall Study|Not consented in time to receive drug|1
7693139|NCT01197417|26755819|P1|Overall Study|Not consented in time to receive drug|0
7693140|NCT01197417|26755818|P2|Overall Study|Subject transferred to intensive care|1
7693141|NCT01197417|26755819|P1|Overall Study|Subject transferred to intensive care|0
7693142|NCT01197417|26755818|P2|Overall Study|Site miscommunication|1
7693143|NCT01197417|26755819|P1|Overall Study|Site miscommunication|0
7693144|NCT01197417|26755818|P2|Overall Study|Withdrawal by Subject|4
7693145|NCT01197417|26755819|P1|Overall Study|Withdrawal by Subject|2
7693146|NCT01197417|26755818|P2|Overall Study|Physician Decision|2
7693147|NCT01197417|26755819|P1|Overall Study|Physician Decision|3
7693148|NCT01197378|26755837|P1|Overall Study|Other|2
7693149|NCT01197378|26755837|P1|Overall Study|Physician Decision|1
7693150|NCT01197378|26755837|P1|Overall Study|Withdrawal by Subject|1
7693151|NCT01197378|26755837|P1|Overall Study|Adverse Event|3
7693152|NCT01197300|26755856|P2|Overall Study|Protocol Violation|1
7693153|NCT01197300|26755857|P1|Overall Study|Protocol Violation|0
7693154|NCT01197300|26755856|P2|Overall Study|Lost to Follow-up|1
7693155|NCT01197300|26755857|P1|Overall Study|Lost to Follow-up|0
7693156|NCT01196988|26755889|P4|Overall Study|Other|0
7693157|NCT01196988|26755890|P3|Overall Study|Other|0
7693158|NCT01196988|26755891|P2|Overall Study|Other|0
7693159|NCT01196988|26755892|P1|Overall Study|Other|2
7693160|NCT01196988|26755889|P4|Overall Study|Lost to Follow-up|1
7693161|NCT01196988|26755890|P3|Overall Study|Lost to Follow-up|21
7693162|NCT01196988|26755891|P2|Overall Study|Lost to Follow-up|29
7693163|NCT01196988|26755892|P1|Overall Study|Lost to Follow-up|16
7693164|NCT01196988|26755889|P4|Overall Study|Withdrawal by Subject|0
7693165|NCT01196988|26755890|P3|Overall Study|Withdrawal by Subject|4
7693166|NCT01196988|26755891|P2|Overall Study|Withdrawal by Subject|1
7693167|NCT01196988|26755892|P1|Overall Study|Withdrawal by Subject|5
7693168|NCT01196988|26755889|P4|Overall Study|Adverse Event|0
7693169|NCT01196988|26755890|P3|Overall Study|Adverse Event|0
7693170|NCT01196988|26755891|P2|Overall Study|Adverse Event|2
7693171|NCT01196988|26755892|P1|Overall Study|Adverse Event|1
7693172|NCT01196975|26755986|P5|Overall Study|Lost to Follow-up|11
7693173|NCT01196975|26755987|P4|Overall Study|Lost to Follow-up|5
7693174|NCT01196975|26755988|P3|Overall Study|Lost to Follow-up|5
7693175|NCT01196975|26755989|P2|Overall Study|Lost to Follow-up|6
7693176|NCT01196975|26755990|P1|Overall Study|Lost to Follow-up|11
7693177|NCT01196975|26755986|P5|Overall Study|Withdrawal by Subject|0
7693178|NCT01196975|26755987|P4|Overall Study|Withdrawal by Subject|1
7693179|NCT01196975|26755988|P3|Overall Study|Withdrawal by Subject|0
7693180|NCT01196975|26755989|P2|Overall Study|Withdrawal by Subject|1
7693181|NCT01196975|26755990|P1|Overall Study|Withdrawal by Subject|2
7693182|NCT01196975|26755986|P5|Overall Study|Adverse Event|2
7693183|NCT01196975|26755987|P4|Overall Study|Adverse Event|0
7693184|NCT01196975|26755988|P3|Overall Study|Adverse Event|0
7693185|NCT01196975|26755989|P2|Overall Study|Adverse Event|2
7693186|NCT01196975|26755990|P1|Overall Study|Adverse Event|2
7693187|NCT01196741|26756274|P2|Overall Study|Protocol Violation|1
7693188|NCT01196741|26756275|P1|Overall Study|Protocol Violation|2
7693189|NCT01196741|26756274|P2|Overall Study|Other|2
7693190|NCT01196741|26756275|P1|Overall Study|Other|3
7693191|NCT01196741|26756274|P2|Overall Study|Other reason|3
7693192|NCT01196741|26756275|P1|Overall Study|Other reason|3
7693193|NCT01196741|26756274|P2|Overall Study|Withdrawal by Subject|0
7693194|NCT01196741|26756275|P1|Overall Study|Withdrawal by Subject|3
7693195|NCT01196741|26756274|P2|Overall Study|Dose limiting Adverse Event|1
7693196|NCT01196741|26756275|P1|Overall Study|Dose limiting Adverse Event|2
7693197|NCT01196741|26756274|P2|Overall Study|Serious Adverse Event|1
7693198|NCT01196741|26756275|P1|Overall Study|Serious Adverse Event|3
7693199|NCT01196741|26756274|P2|Overall Study|Adverse Event|6
7693200|NCT01196741|26756275|P1|Overall Study|Adverse Event|10
7693201|NCT01196741|26756274|P2|Overall Study|Disease progression|14
7693202|NCT01196741|26756275|P1|Overall Study|Disease progression|34
7693203|NCT01196429|26756305|P2|Overall Study|Refused - Never Treated|0
7693204|NCT01196429|26756306|P1|Overall Study|Refused - Never Treated|1
7693205|NCT01196429|26756305|P2|Overall Study|Ineligible - wrong cell type|0
7693206|NCT01196429|26756306|P1|Overall Study|Ineligible - wrong cell type|1
7693207|NCT01196429|26756305|P2|Overall Study|Ineligible - inadequate pathology|0
7693208|NCT01196429|26756306|P1|Overall Study|Ineligible - inadequate pathology|1
7693209|NCT01196416|26756322|P1|Overall Study|Withdrawal by Subject|2
7693210|NCT01196390|26756338|P2|Overall Study|Protocol Violation|5
7693211|NCT01196390|26756339|P1|Overall Study|Protocol Violation|4
7693212|NCT01196104|26756399|P2|Overall Study|Various|1
7693213|NCT01196104|26756400|P1|Overall Study|Various|0
7693214|NCT01196104|26756399|P2|Overall Study|Withdrawal by Subject|3
7693215|NCT01196104|26756400|P1|Overall Study|Withdrawal by Subject|3
7693216|NCT01196104|26756399|P2|Overall Study|Physician Decision|1
7693217|NCT01196104|26756400|P1|Overall Study|Physician Decision|0
7693218|NCT01196104|26756399|P2|Overall Study|Lost to Follow-up|0
7693219|NCT01196104|26756400|P1|Overall Study|Lost to Follow-up|1
7693220|NCT01196091|26756443|P3|Overall Study|Randomized, No Study Drug Received|1
7693221|NCT01196091|26756444|P2|Overall Study|Randomized, No Study Drug Received|0
7693222|NCT01196091|26756445|P1|Overall Study|Randomized, No Study Drug Received|1
7693223|NCT01196091|26756443|P3|Overall Study|Excluded Site|8
7693224|NCT01196091|26756444|P2|Overall Study|Excluded Site|11
7693225|NCT01196091|26756445|P1|Overall Study|Excluded Site|5
7693226|NCT01196091|26756443|P3|Overall Study|Sponsor Decision|4
7693227|NCT01196091|26756444|P2|Overall Study|Sponsor Decision|5
7693228|NCT01196091|26756445|P1|Overall Study|Sponsor Decision|6
7693229|NCT01196091|26756443|P3|Overall Study|Protocol Violation|3
7693230|NCT01196091|26756444|P2|Overall Study|Protocol Violation|3
7693231|NCT01196091|26756445|P1|Overall Study|Protocol Violation|1
7693232|NCT01196091|26756443|P3|Overall Study|Physician Decision|4
7693233|NCT01196091|26756444|P2|Overall Study|Physician Decision|3
7693234|NCT01196091|26756445|P1|Overall Study|Physician Decision|3
7693235|NCT01196091|26756443|P3|Overall Study|Withdrawal by Subject|22
7693236|NCT01196091|26756444|P2|Overall Study|Withdrawal by Subject|19
7693237|NCT01196091|26756445|P1|Overall Study|Withdrawal by Subject|16
7693238|NCT01196091|26756443|P3|Overall Study|Parent/Caregiver Decision|1
7693239|NCT01196091|26756444|P2|Overall Study|Parent/Caregiver Decision|0
7693240|NCT01196091|26756445|P1|Overall Study|Parent/Caregiver Decision|0
7693241|NCT01196091|26756443|P3|Overall Study|Lost to Follow-up|6
7693242|NCT01196091|26756444|P2|Overall Study|Lost to Follow-up|5
7693243|NCT01196091|26756445|P1|Overall Study|Lost to Follow-up|5
7693244|NCT01196091|26756443|P3|Overall Study|Lack of Efficacy|17
7693245|NCT01196091|26756444|P2|Overall Study|Lack of Efficacy|12
7693246|NCT01196091|26756445|P1|Overall Study|Lack of Efficacy|15
7693247|NCT01196091|26756443|P3|Overall Study|Entry Criteria Not Met|10
7693248|NCT01196091|26756444|P2|Overall Study|Entry Criteria Not Met|11
7693249|NCT01196091|26756445|P1|Overall Study|Entry Criteria Not Met|11
7693250|NCT01196091|26756443|P3|Overall Study|Death|2
7693251|NCT01196091|26756444|P2|Overall Study|Death|2
7693252|NCT01196091|26756445|P1|Overall Study|Death|3
7693253|NCT01196091|26756443|P3|Overall Study|Adverse Event|26
7693254|NCT01196091|26756444|P2|Overall Study|Adverse Event|27
7693255|NCT01196091|26756445|P1|Overall Study|Adverse Event|22
7693256|NCT01196078|26756497|P2|Overall Study|Death|4
7693257|NCT01196078|26756498|P1|Overall Study|Death|6
7693258|NCT01196078|26756497|P2|Overall Study|Lost to Follow-up|0
7693259|NCT01196078|26756498|P1|Overall Study|Lost to Follow-up|1
7693260|NCT01196078|26756497|P2|Overall Study|Lack of Efficacy|23
7693261|NCT01196078|26756498|P1|Overall Study|Lack of Efficacy|17
7693262|NCT01196078|26756497|P2|Overall Study|Protocol Violation|1
7693263|NCT01196078|26756498|P1|Overall Study|Protocol Violation|2
7693264|NCT01196078|26756497|P2|Overall Study|Adverse Event|4
7693265|NCT01196078|26756498|P1|Overall Study|Adverse Event|4
7693266|NCT01196078|26756497|P2|Overall Study|Withdrawal by Subject|5
7693267|NCT01196078|26756498|P1|Overall Study|Withdrawal by Subject|3
7693268|NCT01196052|26756526|P1|Overall Study|Withdrawal by Subject|6
7693269|NCT01196052|26756526|P1|Overall Study|Reason not Specified|5
7693270|NCT01196052|26756526|P1|Overall Study|Noncompliance to Protocol Requirements|2
7693271|NCT01196052|26756526|P1|Overall Study|Lost to Follow-up|1
7693272|NCT01196052|26756526|P1|Overall Study|Adverse Event|9
7693273|NCT01196026|26756543|P6|Overall Study|Other|0
7693274|NCT01196026|26756544|P5|Overall Study|Other|0
7693275|NCT01196026|26756545|P4|Overall Study|Other|0
7693276|NCT01196026|26756546|P3|Overall Study|Other|0
7693277|NCT01196026|26756547|P2|Overall Study|Other|1
7693278|NCT01196026|26756548|P1|Overall Study|Other|0
7693279|NCT01196026|26756543|P6|Overall Study|Lost to Follow-up|0
7693280|NCT01196026|26756544|P5|Overall Study|Lost to Follow-up|1
7693281|NCT01196026|26756545|P4|Overall Study|Lost to Follow-up|0
7693282|NCT01196026|26756546|P3|Overall Study|Lost to Follow-up|0
7693283|NCT01196026|26756547|P2|Overall Study|Lost to Follow-up|3
7693284|NCT01196026|26756548|P1|Overall Study|Lost to Follow-up|0
7693285|NCT01196026|26756543|P6|Overall Study|Withdrawal by Subject|0
7693286|NCT01196026|26756544|P5|Overall Study|Withdrawal by Subject|0
7693287|NCT01196026|26756545|P4|Overall Study|Withdrawal by Subject|0
7693288|NCT01196026|26756546|P3|Overall Study|Withdrawal by Subject|0
7693289|NCT01196026|26756547|P2|Overall Study|Withdrawal by Subject|4
7693290|NCT01196026|26756548|P1|Overall Study|Withdrawal by Subject|1
7693291|NCT01195948|26756782|P3|Overall Study|Lost to Follow-up|2
7693292|NCT01195948|26756783|P2|Overall Study|Lost to Follow-up|1
7693293|NCT01195948|26756784|P1|Overall Study|Lost to Follow-up|0
7693294|NCT01195844|26756837|P1|Overall Study|Fecal sample not collected|40
7693295|NCT01195831|26756854|P2|Overall Study|Protocol Violation|2
7693296|NCT01195831|26756855|P1|Overall Study|Protocol Violation|0
7693297|NCT01195831|26756854|P2|Overall Study|Adverse Event|2
7693298|NCT01195831|26756855|P1|Overall Study|Adverse Event|4
7693299|NCT01195831|26756854|P2|Overall Study|Withdrawal by Subject|2
7693300|NCT01195831|26756855|P1|Overall Study|Withdrawal by Subject|2
7693301|NCT01195831|26756854|P2|Overall Study|Lost to Follow-up|4
7693302|NCT01195831|26756855|P1|Overall Study|Lost to Follow-up|2
7693303|NCT01195675|26757095|P1|Overall Study|Withdrawal by Subject|2
7693304|NCT01195675|26757095|P1|Overall Study|Adverse Event|1
7693305|NCT01195662|26757128|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
7693306|NCT01195662|26757129|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
7693307|NCT01195662|26757130|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
7693308|NCT01195662|26757128|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
7693309|NCT01195662|26757129|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
7693310|NCT01195662|26757130|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
7693311|NCT01195662|26757128|P3|Double Blind Treatment Period|Missing disposition information|1
7693312|NCT01195662|26757129|P2|Double Blind Treatment Period|Missing disposition information|1
7693313|NCT01195662|26757130|P1|Double Blind Treatment Period|Missing disposition information|0
7693314|NCT01195662|26757128|P3|Double Blind Treatment Period|Non-specified|0
7693315|NCT01195662|26757129|P2|Double Blind Treatment Period|Non-specified|0
7693316|NCT01195662|26757130|P1|Double Blind Treatment Period|Non-specified|3
7693317|NCT01195662|26757128|P3|Double Blind Treatment Period|Lack of Efficacy|0
7693318|NCT01195662|26757129|P2|Double Blind Treatment Period|Lack of Efficacy|0
7693319|NCT01195662|26757130|P1|Double Blind Treatment Period|Lack of Efficacy|2
7693320|NCT01195662|26757128|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
7693321|NCT01195662|26757129|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
7693322|NCT01195662|26757130|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
7693323|NCT01195662|26757128|P3|Double Blind Treatment Period|Requested discontinue treatment|1
7693324|NCT01195662|26757129|P2|Double Blind Treatment Period|Requested discontinue treatment|0
7693325|NCT01195662|26757130|P1|Double Blind Treatment Period|Requested discontinue treatment|1
7693326|NCT01195662|26757128|P3|Double Blind Treatment Period|Administrative reason|1
7693327|NCT01195662|26757129|P2|Double Blind Treatment Period|Administrative reason|1
7693328|NCT01195662|26757130|P1|Double Blind Treatment Period|Administrative reason|2
7693329|NCT01195662|26757128|P3|Double Blind Treatment Period|Lost to Follow-up|3
7693330|NCT01195662|26757129|P2|Double Blind Treatment Period|Lost to Follow-up|2
7693331|NCT01195662|26757130|P1|Double Blind Treatment Period|Lost to Follow-up|3
7693332|NCT01195662|26757128|P3|Double Blind Treatment Period|Withdrawal by Subject|4
7693333|NCT01195662|26757129|P2|Double Blind Treatment Period|Withdrawal by Subject|4
7693334|NCT01195662|26757130|P1|Double Blind Treatment Period|Withdrawal by Subject|6
7693335|NCT01195662|26757128|P3|Double Blind Treatment Period|Adverse Event|2
7693336|NCT01195662|26757129|P2|Double Blind Treatment Period|Adverse Event|1
7693337|NCT01195662|26757130|P1|Double Blind Treatment Period|Adverse Event|4
7693338|NCT01195636|26757160|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7693339|NCT01195636|26757161|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7693340|NCT01195636|26757160|P2|Second Intervention (3 Weeks)|Adverse Event|1
7693341|NCT01195636|26757161|P1|Second Intervention (3 Weeks)|Adverse Event|1
7693342|NCT01195636|26757160|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
7693343|NCT01195636|26757161|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
7693344|NCT01195636|26757160|P2|Washout Period (2 Weeks)|Adverse Event|1
7693345|NCT01195636|26757161|P1|Washout Period (2 Weeks)|Adverse Event|1
7693346|NCT01195636|26757160|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
7693347|NCT01195636|26757161|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
7693348|NCT01195636|26757160|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
7693349|NCT01195636|26757161|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
7693350|NCT01195636|26757160|P2|First Intervention (3 Weeks)|Protocol Violation|0
7693351|NCT01195636|26757161|P1|First Intervention (3 Weeks)|Protocol Violation|1
7693352|NCT01195636|26757160|P2|First Intervention (3 Weeks)|Adverse Event|3
7693353|NCT01195636|26757161|P1|First Intervention (3 Weeks)|Adverse Event|2
7693354|NCT01195623|26757187|P2|Overall Study|Lost to Follow-up|37
7693355|NCT01195623|26757188|P1|Overall Study|Lost to Follow-up|35
7693356|NCT01195545|26757217|P1|Overall Study|Protocol Violation|4
7693357|NCT01195415|26757229|P1|Overall Study|No repeat biopsy due to progression|2
7693358|NCT01195363|26757238|P2|Overall Study|incarceration|0
7693359|NCT01195363|26757239|P1|Overall Study|incarceration|1
7693360|NCT01195363|26757238|P2|Overall Study|Lack of Efficacy|4
7693361|NCT01195363|26757239|P1|Overall Study|Lack of Efficacy|0
7693362|NCT01195363|26757238|P2|Overall Study|Adverse Event|1
7693363|NCT01195363|26757239|P1|Overall Study|Adverse Event|3
7693364|NCT01195363|26757238|P2|Overall Study|Lost to Follow-up|4
7693365|NCT01195363|26757239|P1|Overall Study|Lost to Follow-up|7
7693366|NCT01195272|26757245|P1|Overall Study|Lack of Efficacy|3
7693367|NCT01195272|26757245|P1|Overall Study|Adverse Event|1
7693368|NCT01195103|26757274|P3|Overall Study|Withdrawal by Subject|0
7693369|NCT01195103|26757275|P2|Overall Study|Withdrawal by Subject|0
7693370|NCT01195103|26757276|P1|Overall Study|Withdrawal by Subject|1
7693371|NCT01195090|26757286|P2|Overall Study|Protocol Violation|4
7693372|NCT01195090|26757287|P1|Overall Study|Protocol Violation|3
7693373|NCT01195090|26757286|P2|Overall Study|Lost to Follow-up|2
7693374|NCT01195090|26757287|P1|Overall Study|Lost to Follow-up|2
7693375|NCT01195090|26757286|P2|Overall Study|Adverse Event|2
7693376|NCT01195090|26757287|P1|Overall Study|Adverse Event|1
7693377|NCT01194999|26757356|P1|Overall Study|Lost to Follow-up|17
7693378|NCT01194973|26757360|P1|26 Week Treatment Period|Pregnancy|1
7693379|NCT01194973|26757360|P1|26 Week Treatment Period|Lack of Efficacy|1
7693380|NCT01194973|26757360|P1|26 Week Treatment Period|Adverse Event|1
7693381|NCT01194973|26757360|P1|Screening Period|Screen Failure|3
7693382|NCT01194869|26757380|P1|Overall Study|Toxicity|2
7693383|NCT01194869|26757380|P1|Overall Study|Disease Progression|2
7693384|NCT01194830|26757411|P2|Overall Study|Other Reason|8
7693385|NCT01194830|26757412|P1|Overall Study|Other Reason|12
7693386|NCT01194830|26757411|P2|Overall Study|Non-compliance issues|4
7693387|NCT01194830|26757412|P1|Overall Study|Non-compliance issues|4
7693388|NCT01194830|26757411|P2|Overall Study|Lack of Efficacy|1
7693389|NCT01194830|26757412|P1|Overall Study|Lack of Efficacy|1
7693390|NCT01194830|26757411|P2|Overall Study|Withdrawal by Subject|1
7693391|NCT01194830|26757412|P1|Overall Study|Withdrawal by Subject|2
7693392|NCT01194830|26757411|P2|Overall Study|Lost to Follow-up|7
7693393|NCT01194830|26757412|P1|Overall Study|Lost to Follow-up|9
7693394|NCT01194830|26757411|P2|Overall Study|Protocol Violation|4
7693395|NCT01194830|26757412|P1|Overall Study|Protocol Violation|5
7693396|NCT01194830|26757411|P2|Overall Study|Adverse Event|2
7693397|NCT01194830|26757412|P1|Overall Study|Adverse Event|3
7693398|NCT01194804|26757434|P1|Overall Study|Withdrawal by Subject|1
7693399|NCT01194570|26757456|P2|Overall Study|Lost to Follow-up|4
7693400|NCT01194570|26757457|P1|Overall Study|Lost to Follow-up|1
7693401|NCT01194570|26757456|P2|Overall Study|Pregnancy|1
7693402|NCT01194570|26757457|P1|Overall Study|Pregnancy|1
7693403|NCT01194570|26757456|P2|Overall Study|Withdrawal by Subject|22
7693404|NCT01194570|26757457|P1|Overall Study|Withdrawal by Subject|21
7693405|NCT01194570|26757456|P2|Overall Study|Lack of Efficacy|21
7693406|NCT01194570|26757457|P1|Overall Study|Lack of Efficacy|27
7693407|NCT01194570|26757456|P2|Overall Study|Non-compliance|2
7693408|NCT01194570|26757457|P1|Overall Study|Non-compliance|2
7693409|NCT01194570|26757456|P2|Overall Study|Adverse Event|18
7693410|NCT01194570|26757457|P1|Overall Study|Adverse Event|12
7693411|NCT01194570|26757456|P2|Overall Study|Non-compliance with study drug|2
7693412|NCT01194570|26757457|P1|Overall Study|Non-compliance with study drug|2
7693413|NCT01194570|26757456|P2|Overall Study|Protocol Violation|2
7693414|NCT01194570|26757457|P1|Overall Study|Protocol Violation|0
7693415|NCT01194570|26757456|P2|Overall Study|Reason not specified|20
7693416|NCT01194570|26757457|P1|Overall Study|Reason not specified|13
7693417|NCT01194570|26757456|P2|Overall Study|Physician Decision|6
7693418|NCT01194570|26757457|P1|Overall Study|Physician Decision|2
7693419|NCT01194570|26757456|P2|Overall Study|Ongoing at CCOD|387
7693420|NCT01194570|26757457|P1|Overall Study|Ongoing at CCOD|162
7693421|NCT01194570|26757456|P2|Overall Study|Death|3
7693422|NCT01194570|26757457|P1|Overall Study|Death|1
7693423|NCT01194531|26757477|P2|Overall Study|Physician Decision|2
7693424|NCT01194531|26757478|P1|Overall Study|Physician Decision|0
7693425|NCT01194531|26757477|P2|Overall Study|Protocol Violation|1
7693426|NCT01194531|26757478|P1|Overall Study|Protocol Violation|4
7693427|NCT01194531|26757477|P2|Overall Study|Withdrawal by Subject|0
7693428|NCT01194531|26757478|P1|Overall Study|Withdrawal by Subject|1
7693429|NCT01194440|26757532|P1|6-months (2nd Dose)|Change in therapy|4
7693430|NCT01194440|26757532|P1|Baseline (First Dose)|Adverse Event|1
7693431|NCT01194440|26757532|P1|Baseline (First Dose)|Change in therapy|1
7693432|NCT01194440|26757532|P1|Baseline (First Dose)|Lack of Efficacy|1
7693433|NCT01194440|26757532|P1|Baseline (First Dose)|Reason not specified|4
7693434|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Death|2
7693435|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Death|0
7693436|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Death|2
7693437|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Death|1
7693438|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
7693439|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
7693440|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
7693441|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
7693442|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Adverse Event|12
7693443|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Adverse Event|2
7693444|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Adverse Event|21
7693445|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Adverse Event|35
7693446|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Protocol Violation|1
7693447|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Protocol Violation|0
7693448|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Protocol Violation|0
7693449|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Protocol Violation|0
7693450|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Other|0
7693451|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Other|0
7693452|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Other|1
7693453|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Other|2
7693454|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Pregnancy|1
7693455|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Pregnancy|1
7693456|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Pregnancy|3
7693457|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Pregnancy|1
7693458|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7693459|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7693460|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
7693461|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
7693462|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
7693463|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
7693464|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
7693465|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
7693466|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
7693467|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
7693468|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
7693469|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
7693470|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
7693471|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
7693472|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
7693473|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
7693474|NCT01194414|26757545|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
7693475|NCT01194414|26757546|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
7693476|NCT01194414|26757547|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
7693477|NCT01194414|26757548|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
7693478|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Death|0
7693479|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Death|0
7693480|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Death|1
7693481|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Death|0
7693482|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
7693483|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
7693484|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
7693485|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
7693486|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Adverse Event|0
7693487|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Adverse Event|0
7693488|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Adverse Event|40
7693489|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Adverse Event|28
7693490|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Other|0
7693491|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Other|0
7693492|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Other|1
7693493|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Other|0
7693494|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
7693495|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
7693496|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
7693497|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
7693498|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Pregnancy|0
7693499|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Pregnancy|0
7693500|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Pregnancy|2
7693501|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Pregnancy|2
7693502|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7693503|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7693504|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
7693505|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7693506|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Protocol Violation|0
7693507|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Protocol Violation|0
7693508|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Protocol Violation|3
7693509|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Protocol Violation|5
7693510|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
7693511|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
7693512|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
7693513|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
7693514|NCT01194414|26757545|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
7693515|NCT01194414|26757546|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
7693516|NCT01194414|26757547|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
7693517|NCT01194414|26757548|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
7693518|NCT01194271|26757619|P1|Overall Study|Death|1
7693519|NCT01194271|26757619|P1|Overall Study|Ineligible, Screen Failure|1
7693520|NCT01194271|26757619|P1|Overall Study|Withdrawal by Subject|1
7693521|NCT01194258|26757623|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
7693522|NCT01194258|26757624|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
7693523|NCT01194258|26757625|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
7693524|NCT01194258|26757626|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
7693525|NCT01194258|26757627|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
7693526|NCT01194258|26757623|P5|Period 2 (12 Weeks)|Adverse Event|0
7693527|NCT01194258|26757624|P4|Period 2 (12 Weeks)|Adverse Event|0
7693528|NCT01194258|26757625|P3|Period 2 (12 Weeks)|Adverse Event|0
7693529|NCT01194258|26757626|P2|Period 2 (12 Weeks)|Adverse Event|1
7693530|NCT01194258|26757627|P1|Period 2 (12 Weeks)|Adverse Event|0
7693531|NCT01194258|26757623|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
7693532|NCT01194258|26757624|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
7693533|NCT01194258|26757625|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
7693534|NCT01194258|26757626|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
7693535|NCT01194258|26757627|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
7693536|NCT01194258|26757623|P5|Period 1 (12 Weeks)|Death|1
7693537|NCT01194258|26757624|P4|Period 1 (12 Weeks)|Death|0
7693538|NCT01194258|26757625|P3|Period 1 (12 Weeks)|Death|0
7693539|NCT01194258|26757626|P2|Period 1 (12 Weeks)|Death|0
7693540|NCT01194258|26757627|P1|Period 1 (12 Weeks)|Death|0
7693541|NCT01194258|26757623|P5|Titration Period|Titration failure|0
7693542|NCT01194258|26757624|P4|Titration Period|Titration failure|0
7693543|NCT01194258|26757625|P3|Titration Period|Titration failure|0
7693544|NCT01194258|26757626|P2|Titration Period|Titration failure|0
7693545|NCT01194258|26757627|P1|Titration Period|Titration failure|3
7693546|NCT01194258|26757623|P5|Titration Period|Lost to Follow-up|0
7693547|NCT01194258|26757624|P4|Titration Period|Lost to Follow-up|0
7693548|NCT01194258|26757625|P3|Titration Period|Lost to Follow-up|0
7693549|NCT01194258|26757626|P2|Titration Period|Lost to Follow-up|0
7693550|NCT01194258|26757627|P1|Titration Period|Lost to Follow-up|2
7693551|NCT01194258|26757623|P5|Titration Period|Withdrawal by Subject|0
7693552|NCT01194258|26757624|P4|Titration Period|Withdrawal by Subject|0
7693553|NCT01194258|26757625|P3|Titration Period|Withdrawal by Subject|0
7693554|NCT01194258|26757626|P2|Titration Period|Withdrawal by Subject|0
7693555|NCT01194258|26757627|P1|Titration Period|Withdrawal by Subject|6
7693556|NCT01194245|26757651|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7693557|NCT01194245|26757652|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7693558|NCT01194245|26757653|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7693559|NCT01194245|26757654|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7693560|NCT01194245|26757655|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7693561|NCT01194245|26757651|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7693562|NCT01194245|26757652|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7693563|NCT01194245|26757653|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7693564|NCT01194245|26757654|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7693565|NCT01194245|26757655|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7693566|NCT01194245|26757651|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7693567|NCT01194245|26757652|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7693568|NCT01194245|26757653|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7693569|NCT01194245|26757654|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7693570|NCT01194245|26757655|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
7693571|NCT01194245|26757651|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
7693572|NCT01194245|26757652|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
7693573|NCT01194245|26757653|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
7693574|NCT01194245|26757654|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
7693575|NCT01194245|26757655|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
7693576|NCT01194245|26757651|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
7693577|NCT01194245|26757652|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
7693578|NCT01194245|26757653|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
7693579|NCT01194245|26757654|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
7693580|NCT01194245|26757655|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
7693581|NCT01194245|26757651|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7693582|NCT01194245|26757652|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7693583|NCT01194245|26757653|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7693584|NCT01194245|26757654|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7693585|NCT01194245|26757655|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
7693586|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
7693587|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
7693588|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693589|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693590|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693591|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693592|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693593|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693594|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693737|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Other|0
7693595|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7693596|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693597|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
7693598|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693599|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693600|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693601|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693602|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693603|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693604|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693605|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7693606|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
7693607|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
7693608|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693609|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693610|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693611|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693612|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693613|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693614|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693615|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7693616|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Death|1
7693617|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Death|1
7693618|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Death|0
7693619|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Death|0
7693620|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Death|0
7693621|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Death|0
7693622|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Death|0
7693623|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Death|0
7693624|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Death|0
7693625|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Death|0
7693626|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
7693627|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
7693628|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693629|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693630|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693631|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693632|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693633|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693634|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693635|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7693636|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
7693637|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
7693638|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693639|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693640|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693641|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693642|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693643|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693644|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693645|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7693646|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
7693647|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
7693648|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693649|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693650|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693651|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693652|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693653|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693654|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693655|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7693656|NCT01194219|26757676|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
7693657|NCT01194219|26757677|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
7693658|NCT01194219|26757678|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693659|NCT01194219|26757679|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693660|NCT01194219|26757680|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693661|NCT01194219|26757681|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693662|NCT01194219|26757682|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693663|NCT01194219|26757683|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693664|NCT01194219|26757684|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693665|NCT01194219|26757685|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7693666|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693667|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693668|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693669|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
7693670|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693671|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693672|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693673|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693674|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693675|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7693676|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693677|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693678|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
7693679|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693680|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693681|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693682|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693683|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693684|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693685|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7693686|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693687|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693688|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693689|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
7693690|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
7693691|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
7693692|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693693|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693694|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693695|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7693696|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693697|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693698|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
7693699|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
7693700|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693701|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
7693702|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693703|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693704|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693705|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7693706|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693707|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693708|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693709|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
7693710|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693711|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
7693712|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693713|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693714|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693715|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7693716|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7693717|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7693718|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
7693719|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
7693720|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
7693721|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
7693722|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7693723|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7693724|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7693725|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7693726|NCT01194219|26757676|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693727|NCT01194219|26757677|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693728|NCT01194219|26757678|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
7693729|NCT01194219|26757679|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
7693730|NCT01194219|26757680|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
7693731|NCT01194219|26757681|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693732|NCT01194219|26757682|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693733|NCT01194219|26757683|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693734|NCT01194219|26757684|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693735|NCT01194219|26757685|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7693736|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Other|0
7693738|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Other|0
7693739|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Other|0
7693740|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Other|0
7693741|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Other|0
7693742|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Other|1
7693743|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Other|2
7693744|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Other|0
7693745|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Other|0
7693746|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
7693747|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
7693748|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
7693749|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
7693750|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
7693751|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
7693752|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
7693753|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
7693754|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
7693755|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
7693756|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693757|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693758|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693759|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693760|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693761|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693762|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693763|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
7693764|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693765|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7693766|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693767|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693768|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693769|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693770|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693771|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693772|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
7693773|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
7693774|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693775|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7693776|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693777|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693778|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693779|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693780|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693781|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693782|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
7693783|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
7693784|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693785|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7693786|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693787|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693788|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693789|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693790|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693791|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693792|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
7693793|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
7693794|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693795|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7693796|NCT01194219|26757676|P10|Maintenance Phase Weeks16-32|Adverse Event|0
7693797|NCT01194219|26757677|P9|Maintenance Phase Weeks16-32|Adverse Event|0
7693798|NCT01194219|26757678|P8|Maintenance Phase Weeks16-32|Adverse Event|0
7693799|NCT01194219|26757679|P7|Maintenance Phase Weeks16-32|Adverse Event|0
7693800|NCT01194219|26757680|P6|Maintenance Phase Weeks16-32|Adverse Event|0
7693801|NCT01194219|26757681|P5|Maintenance Phase Weeks16-32|Adverse Event|0
7693802|NCT01194219|26757682|P4|Maintenance Phase Weeks16-32|Adverse Event|9
7693803|NCT01194219|26757683|P3|Maintenance Phase Weeks16-32|Adverse Event|8
7693804|NCT01194219|26757684|P2|Maintenance Phase Weeks16-32|Adverse Event|0
7693805|NCT01194219|26757685|P1|Maintenance Phase Weeks16-32|Adverse Event|0
7693806|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693807|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693808|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693809|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693810|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693811|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693812|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693813|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7693814|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
7693815|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
7693816|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693817|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693818|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693819|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693820|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693821|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693822|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693823|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7693824|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
7693825|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
7693826|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693827|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693828|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693829|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693830|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693831|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693832|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693833|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7693834|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
7693835|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
7693836|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
7693837|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
7693838|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
7693839|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
7693840|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
7693841|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
7693842|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
7693843|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
7693844|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
7693845|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
7693846|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693847|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693848|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693849|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693850|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693851|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693852|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693853|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7693854|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
7693855|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
7693856|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693857|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693858|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693859|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693860|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693861|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693862|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693863|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693864|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7693865|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
7693866|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693867|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693868|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693869|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693870|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693871|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693872|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693873|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7693874|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
7693875|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
7693876|NCT01194219|26757676|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693877|NCT01194219|26757677|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693878|NCT01194219|26757678|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693879|NCT01194219|26757679|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693880|NCT01194219|26757680|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693881|NCT01194219|26757681|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693882|NCT01194219|26757682|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693883|NCT01194219|26757683|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7693884|NCT01194219|26757684|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
7693885|NCT01194219|26757685|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
7693886|NCT01194154|26757719|P2|Overall Study|Did not receive study medication|4
7693887|NCT01194154|26757720|P1|Overall Study|Did not receive study medication|2
7693888|NCT01194154|26757719|P2|Overall Study|Other|0
7693889|NCT01194154|26757720|P1|Overall Study|Other|4
7693890|NCT01194154|26757719|P2|Overall Study|Treatment with prohibited medication|5
7693891|NCT01194154|26757720|P1|Overall Study|Treatment with prohibited medication|4
7693892|NCT01194154|26757719|P2|Overall Study|Skipping of CERA treatment at two visits|0
7693893|NCT01194154|26757720|P1|Overall Study|Skipping of CERA treatment at two visits|3
7693894|NCT01194154|26757719|P2|Overall Study|Hemoglobin increase|3
7693895|NCT01194154|26757720|P1|Overall Study|Hemoglobin increase|12
7693896|NCT01194154|26757719|P2|Overall Study|Hemoglobin decrease|1
7693897|NCT01194154|26757720|P1|Overall Study|Hemoglobin decrease|0
7693898|NCT01194154|26757719|P2|Overall Study|Blood pressure increase|3
7693899|NCT01194154|26757720|P1|Overall Study|Blood pressure increase|5
7693900|NCT01194154|26757719|P2|Overall Study|Withdrawal by Subject|6
7693901|NCT01194154|26757720|P1|Overall Study|Withdrawal by Subject|5
7693902|NCT01194154|26757719|P2|Overall Study|Protocol Violation|1
7693903|NCT01194154|26757720|P1|Overall Study|Protocol Violation|0
7693904|NCT01194154|26757719|P2|Overall Study|Lost to Follow-up|3
7693905|NCT01194154|26757720|P1|Overall Study|Lost to Follow-up|2
7693906|NCT01194154|26757719|P2|Overall Study|Adverse Event|7
7693907|NCT01194154|26757720|P1|Overall Study|Adverse Event|12
7693908|NCT01193920|26757761|P10|Overall Study|Unable to classify|0
7693909|NCT01193920|26757762|P9|Overall Study|Unable to classify|0
7693910|NCT01193920|26757763|P8|Overall Study|Unable to classify|1
7693911|NCT01193920|26757764|P7|Overall Study|Unable to classify|0
7693912|NCT01193920|26757765|P6|Overall Study|Unable to classify|0
7693913|NCT01193920|26757766|P5|Overall Study|Unable to classify|0
7693914|NCT01193920|26757767|P4|Overall Study|Unable to classify|1
7693915|NCT01193920|26757768|P3|Overall Study|Unable to classify|0
7693916|NCT01193920|26757769|P2|Overall Study|Unable to classify|0
7693917|NCT01193920|26757770|P1|Overall Study|Unable to classify|0
7693918|NCT01193920|26757761|P10|Overall Study|Death|4
7693919|NCT01193920|26757762|P9|Overall Study|Death|2
7693920|NCT01193920|26757763|P8|Overall Study|Death|3
7693921|NCT01193920|26757764|P7|Overall Study|Death|2
7693922|NCT01193920|26757765|P6|Overall Study|Death|0
7693923|NCT01193920|26757766|P5|Overall Study|Death|0
7693924|NCT01193920|26757767|P4|Overall Study|Death|1
7693925|NCT01193920|26757768|P3|Overall Study|Death|0
7693926|NCT01193920|26757769|P2|Overall Study|Death|0
7693927|NCT01193920|26757770|P1|Overall Study|Death|0
7693928|NCT01193920|26757761|P10|Overall Study|Protocol Violation|0
7693929|NCT01193920|26757762|P9|Overall Study|Protocol Violation|0
7693930|NCT01193920|26757763|P8|Overall Study|Protocol Violation|0
7693931|NCT01193920|26757764|P7|Overall Study|Protocol Violation|0
7693932|NCT01193920|26757765|P6|Overall Study|Protocol Violation|0
7693933|NCT01193920|26757766|P5|Overall Study|Protocol Violation|0
7693934|NCT01193920|26757767|P4|Overall Study|Protocol Violation|0
7693935|NCT01193920|26757768|P3|Overall Study|Protocol Violation|0
7693936|NCT01193920|26757769|P2|Overall Study|Protocol Violation|0
7693937|NCT01193920|26757770|P1|Overall Study|Protocol Violation|1
7693938|NCT01193920|26757761|P10|Overall Study|Lost to Follow-up|3
7693939|NCT01193920|26757762|P9|Overall Study|Lost to Follow-up|2
7693940|NCT01193920|26757763|P8|Overall Study|Lost to Follow-up|0
7693941|NCT01193920|26757764|P7|Overall Study|Lost to Follow-up|1
7693942|NCT01193920|26757765|P6|Overall Study|Lost to Follow-up|3
7693943|NCT01193920|26757766|P5|Overall Study|Lost to Follow-up|3
7693944|NCT01193920|26757767|P4|Overall Study|Lost to Follow-up|1
7693945|NCT01193920|26757768|P3|Overall Study|Lost to Follow-up|1
7693946|NCT01193920|26757769|P2|Overall Study|Lost to Follow-up|0
7693947|NCT01193920|26757770|P1|Overall Study|Lost to Follow-up|1
7693948|NCT01193920|26757761|P10|Overall Study|Withdrawal by Subject|0
7693949|NCT01193920|26757762|P9|Overall Study|Withdrawal by Subject|1
7693950|NCT01193920|26757763|P8|Overall Study|Withdrawal by Subject|0
7693951|NCT01193920|26757764|P7|Overall Study|Withdrawal by Subject|3
7693952|NCT01193920|26757765|P6|Overall Study|Withdrawal by Subject|1
7693953|NCT01193920|26757766|P5|Overall Study|Withdrawal by Subject|3
7693954|NCT01193920|26757767|P4|Overall Study|Withdrawal by Subject|1
7693955|NCT01193920|26757768|P3|Overall Study|Withdrawal by Subject|5
7693956|NCT01193920|26757769|P2|Overall Study|Withdrawal by Subject|0
7693957|NCT01193920|26757770|P1|Overall Study|Withdrawal by Subject|1
7693958|NCT01193842|26757866|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
7693959|NCT01193842|26757867|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
7693960|NCT01193842|26757868|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7693961|NCT01193842|26757869|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7693962|NCT01193842|26757870|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7693963|NCT01193842|26757866|P5|Phase II: Randomized Groups|Ineligible|1
7693964|NCT01193842|26757867|P4|Phase II: Randomized Groups|Ineligible|0
7693965|NCT01193842|26757868|P3|Phase II: Randomized Groups|Ineligible|0
7693966|NCT01193842|26757869|P2|Phase II: Randomized Groups|Ineligible|0
7693967|NCT01193842|26757870|P1|Phase II: Randomized Groups|Ineligible|0
7693968|NCT01193842|26757866|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
7693969|NCT01193842|26757867|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
7693970|NCT01193842|26757868|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
7693971|NCT01193842|26757869|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
7693972|NCT01193842|26757870|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
7693973|NCT01193842|26757866|P5|Phase II: Randomized Groups|Adverse Event|3
7693974|NCT01193842|26757867|P4|Phase II: Randomized Groups|Adverse Event|5
7693975|NCT01193842|26757868|P3|Phase II: Randomized Groups|Adverse Event|0
7693976|NCT01193842|26757869|P2|Phase II: Randomized Groups|Adverse Event|0
7693977|NCT01193842|26757870|P1|Phase II: Randomized Groups|Adverse Event|0
7693978|NCT01193842|26757866|P5|Phase II: Randomized Groups|Death|1
7693979|NCT01193842|26757867|P4|Phase II: Randomized Groups|Death|1
7693980|NCT01193842|26757868|P3|Phase II: Randomized Groups|Death|0
7693981|NCT01193842|26757869|P2|Phase II: Randomized Groups|Death|0
7693982|NCT01193842|26757870|P1|Phase II: Randomized Groups|Death|0
7693983|NCT01193842|26757866|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7693984|NCT01193842|26757867|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7693985|NCT01193842|26757868|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
7693986|NCT01193842|26757869|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7693987|NCT01193842|26757870|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7693988|NCT01193842|26757866|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7693989|NCT01193842|26757867|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7693990|NCT01193842|26757868|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7693991|NCT01193842|26757869|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7693992|NCT01193842|26757870|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
7693993|NCT01193842|26757866|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7693994|NCT01193842|26757867|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7693995|NCT01193842|26757868|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7693996|NCT01193842|26757869|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
7693997|NCT01193842|26757870|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7693998|NCT01193686|26757905|P2|Overall Study|Removed by Investigators; unable to matc|0
7693999|NCT01193686|26757906|P1|Overall Study|Removed by Investigators; unable to matc|3
7694000|NCT01193686|26757905|P2|Overall Study|Withdrawal by Subject|1
7694001|NCT01193686|26757906|P1|Overall Study|Withdrawal by Subject|4
7694002|NCT01193660|26757923|P3|Overall Study|Physician Decision|1
7694003|NCT01193660|26757924|P2|Overall Study|Physician Decision|0
7694004|NCT01193660|26757925|P1|Overall Study|Physician Decision|1
7694005|NCT01193660|26757923|P3|Overall Study|Death|0
7694006|NCT01193660|26757924|P2|Overall Study|Death|0
7694007|NCT01193660|26757925|P1|Overall Study|Death|1
7694008|NCT01193660|26757923|P3|Overall Study|Withdrawal by Subject|1
7694009|NCT01193660|26757924|P2|Overall Study|Withdrawal by Subject|3
7694010|NCT01193660|26757925|P1|Overall Study|Withdrawal by Subject|2
7694011|NCT01193608|26757969|P6|Overall Study|Adverse Event|0
7694012|NCT01193608|26757970|P5|Overall Study|Adverse Event|1
7694013|NCT01193608|26757971|P4|Overall Study|Adverse Event|0
7694014|NCT01193608|26757972|P3|Overall Study|Adverse Event|0
7694015|NCT01193608|26757973|P2|Overall Study|Adverse Event|0
7694016|NCT01193608|26757974|P1|Overall Study|Adverse Event|0
7694017|NCT01193608|26757969|P6|Overall Study|Lost to Follow-up|2
7694018|NCT01193608|26757970|P5|Overall Study|Lost to Follow-up|1
7694019|NCT01193608|26757971|P4|Overall Study|Lost to Follow-up|0
7694020|NCT01193608|26757972|P3|Overall Study|Lost to Follow-up|0
7694021|NCT01193608|26757973|P2|Overall Study|Lost to Follow-up|0
7694022|NCT01193608|26757974|P1|Overall Study|Lost to Follow-up|0
7694023|NCT01193608|26757969|P6|Overall Study|Withdrawal by Subject|0
7694024|NCT01193608|26757970|P5|Overall Study|Withdrawal by Subject|3
7694025|NCT01193608|26757971|P4|Overall Study|Withdrawal by Subject|3
7694026|NCT01193608|26757972|P3|Overall Study|Withdrawal by Subject|2
7694027|NCT01193608|26757973|P2|Overall Study|Withdrawal by Subject|1
7694028|NCT01193608|26757974|P1|Overall Study|Withdrawal by Subject|0
7694029|NCT01193608|26757969|P6|Overall Study|Other|0
7694030|NCT01193608|26757970|P5|Overall Study|Other|0
7694031|NCT01193608|26757971|P4|Overall Study|Other|0
7694032|NCT01193608|26757972|P3|Overall Study|Other|0
7694033|NCT01193608|26757973|P2|Overall Study|Other|1
7694034|NCT01193608|26757974|P1|Overall Study|Other|0
7694035|NCT01193582|26758211|P4|12 Month Follow-up|Withdrawal by Subject|11
7694036|NCT01193582|26758212|P3|12 Month Follow-up|Withdrawal by Subject|3
7694037|NCT01193582|26758213|P2|12 Month Follow-up|Withdrawal by Subject|0
7694038|NCT01193582|26758214|P1|12 Month Follow-up|Withdrawal by Subject|6
7694039|NCT01193582|26758211|P4|12 Month Follow-up|Death|0
7694040|NCT01193582|26758212|P3|12 Month Follow-up|Death|1
7694041|NCT01193582|26758213|P2|12 Month Follow-up|Death|0
7694042|NCT01193582|26758214|P1|12 Month Follow-up|Death|0
7694043|NCT01193582|26758211|P4|Vaccination Series|Withdrawal by Subject|3
7694044|NCT01193582|26758212|P3|Vaccination Series|Withdrawal by Subject|8
7694045|NCT01193582|26758213|P2|Vaccination Series|Withdrawal by Subject|13
7694046|NCT01193582|26758214|P1|Vaccination Series|Withdrawal by Subject|11
7694047|NCT01193556|26758244|P2|Overall Study|Study termination|25
7694048|NCT01193556|26758245|P1|Overall Study|Study termination|26
7694049|NCT01193530|26758255|P2|Overall Study|Non-Compliance|1
7694050|NCT01193530|26758256|P1|Overall Study|Non-Compliance|0
7694051|NCT01193530|26758255|P2|Overall Study|Returned home - out of state|1
7694052|NCT01193530|26758256|P1|Overall Study|Returned home - out of state|0
7694053|NCT01193530|26758255|P2|Overall Study|Lost Light Box|1
7694054|NCT01193530|26758256|P1|Overall Study|Lost Light Box|0
7694055|NCT01193530|26758255|P2|Overall Study|Began Contraindicated Therapy|0
7694056|NCT01193530|26758256|P1|Overall Study|Began Contraindicated Therapy|1
7694057|NCT01193530|26758255|P2|Overall Study|Withdrawal by Subject|2
7694058|NCT01193530|26758256|P1|Overall Study|Withdrawal by Subject|2
7694059|NCT01193517|26758265|P3|Overall Study|Early Progression|0
7694060|NCT01193517|26758266|P2|Overall Study|Early Progression|0
7694061|NCT01193517|26758267|P1|Overall Study|Early Progression|1
7694062|NCT01193348|26758276|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
7694063|NCT01193348|26758276|P1|Extension Treatment Period|Physician Decision|1
7694064|NCT01193348|26758276|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
7694065|NCT01193348|26758276|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
7694066|NCT01193348|26758276|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
7694067|NCT01193348|26758276|P1|Screening Period|Screen Failure|5
7694068|NCT01193335|26758296|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
7694069|NCT01193335|26758297|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
7694070|NCT01193335|26758296|P2|2-Year Follow-up|No Longer Willing to Participate|6
7694071|NCT01193335|26758297|P1|2-Year Follow-up|No Longer Willing to Participate|5
7694072|NCT01193335|26758296|P2|1-Year Follow-up|Lost to Follow-up|0
7694073|NCT01193335|26758297|P1|1-Year Follow-up|Lost to Follow-up|4
7694074|NCT01193335|26758296|P2|1-Year Follow-up|No Longer Willing to Participate|9
7694075|NCT01193335|26758297|P1|1-Year Follow-up|No Longer Willing to Participate|7
7694076|NCT01193335|26758296|P2|After Infant Series|No Longer Met Eligibility Criteria|1
7694077|NCT01193335|26758297|P1|After Infant Series|No Longer Met Eligibility Criteria|0
7694078|NCT01193335|26758296|P2|After Infant Series|Lost to Follow-up|2
7694079|NCT01193335|26758297|P1|After Infant Series|Lost to Follow-up|1
7694080|NCT01193283|26758392|P1|Overall Study|Death|1
7694081|NCT01193257|26758398|P2|Overall Study|Unblinded due to futility|251
7694082|NCT01193257|26758399|P1|Overall Study|Unblinded due to futility|135
7694083|NCT01193257|26758398|P2|Overall Study|Lost to Follow-up|3
7694084|NCT01193257|26758399|P1|Overall Study|Lost to Follow-up|2
7694085|NCT01193257|26758398|P2|Overall Study|Withdrawal by Subject|86
7694086|NCT01193257|26758399|P1|Overall Study|Withdrawal by Subject|26
7694087|NCT01193257|26758398|P2|Overall Study|Study termination by sponsor|3
7694088|NCT01193257|26758399|P1|Overall Study|Study termination by sponsor|0
7694089|NCT01193257|26758398|P2|Overall Study|Death|391
7694090|NCT01193257|26758399|P1|Overall Study|Death|202
7694091|NCT01193244|26758449|P2|Overall Study|Lost to Follow-up|15
7694092|NCT01193244|26758450|P1|Overall Study|Lost to Follow-up|6
7694093|NCT01193244|26758449|P2|Overall Study|Other|278
7694094|NCT01193244|26758450|P1|Overall Study|Other|303
7694095|NCT01193244|26758449|P2|Overall Study|Withdrawal by Subject|97
7694096|NCT01193244|26758450|P1|Overall Study|Withdrawal by Subject|79
7694097|NCT01193218|26758505|P8|12-52 Weeks|Other reason than above|0
7694098|NCT01193218|26758506|P7|12-52 Weeks|Other reason than above|0
7694099|NCT01193218|26758507|P6|12-52 Weeks|Other reason than above|0
7694100|NCT01193218|26758508|P5|12-52 Weeks|Other reason than above|1
7694101|NCT01193218|26758509|P4|12-52 Weeks|Other reason than above|1
7694102|NCT01193218|26758510|P3|12-52 Weeks|Other reason than above|0
7694103|NCT01193218|26758511|P2|12-52 Weeks|Other reason than above|0
7694104|NCT01193218|26758512|P1|12-52 Weeks|Other reason than above|1
7694105|NCT01193218|26758505|P8|12-52 Weeks|Withdrawal by Subject|2
7694106|NCT01193218|26758506|P7|12-52 Weeks|Withdrawal by Subject|1
7694107|NCT01193218|26758507|P6|12-52 Weeks|Withdrawal by Subject|2
7694108|NCT01193218|26758508|P5|12-52 Weeks|Withdrawal by Subject|0
7694109|NCT01193218|26758509|P4|12-52 Weeks|Withdrawal by Subject|0
7694110|NCT01193218|26758510|P3|12-52 Weeks|Withdrawal by Subject|3
7694111|NCT01193218|26758511|P2|12-52 Weeks|Withdrawal by Subject|0
7694112|NCT01193218|26758512|P1|12-52 Weeks|Withdrawal by Subject|3
7694113|NCT01193218|26758505|P8|12-52 Weeks|Lack of Efficacy|0
7694114|NCT01193218|26758506|P7|12-52 Weeks|Lack of Efficacy|1
7694115|NCT01193218|26758507|P6|12-52 Weeks|Lack of Efficacy|0
7694116|NCT01193218|26758508|P5|12-52 Weeks|Lack of Efficacy|0
7694117|NCT01193218|26758509|P4|12-52 Weeks|Lack of Efficacy|0
7694118|NCT01193218|26758510|P3|12-52 Weeks|Lack of Efficacy|0
7694119|NCT01193218|26758511|P2|12-52 Weeks|Lack of Efficacy|0
7694120|NCT01193218|26758512|P1|12-52 Weeks|Lack of Efficacy|0
7694121|NCT01193218|26758505|P8|12-52 Weeks|Adverse Event|2
7694122|NCT01193218|26758506|P7|12-52 Weeks|Adverse Event|1
7694123|NCT01193218|26758507|P6|12-52 Weeks|Adverse Event|3
7694124|NCT01193218|26758508|P5|12-52 Weeks|Adverse Event|3
7694125|NCT01193218|26758509|P4|12-52 Weeks|Adverse Event|2
7694126|NCT01193218|26758510|P3|12-52 Weeks|Adverse Event|1
7694127|NCT01193218|26758511|P2|12-52 Weeks|Adverse Event|0
7694128|NCT01193218|26758512|P1|12-52 Weeks|Adverse Event|1
7694129|NCT01193218|26758505|P8|0-12 Weeks|Withdrawal by Subject|0
7694130|NCT01193218|26758506|P7|0-12 Weeks|Withdrawal by Subject|1
7694131|NCT01193218|26758507|P6|0-12 Weeks|Withdrawal by Subject|0
7694132|NCT01193218|26758508|P5|0-12 Weeks|Withdrawal by Subject|0
7694133|NCT01193218|26758509|P4|0-12 Weeks|Withdrawal by Subject|0
7694134|NCT01193218|26758510|P3|0-12 Weeks|Withdrawal by Subject|2
7694135|NCT01193218|26758511|P2|0-12 Weeks|Withdrawal by Subject|0
7694136|NCT01193218|26758512|P1|0-12 Weeks|Withdrawal by Subject|3
7694137|NCT01193218|26758505|P8|0-12 Weeks|Protocol Violation|0
7694138|NCT01193218|26758506|P7|0-12 Weeks|Protocol Violation|0
7694139|NCT01193218|26758507|P6|0-12 Weeks|Protocol Violation|1
7694140|NCT01193218|26758508|P5|0-12 Weeks|Protocol Violation|1
7694141|NCT01193218|26758509|P4|0-12 Weeks|Protocol Violation|0
7694142|NCT01193218|26758510|P3|0-12 Weeks|Protocol Violation|0
7694143|NCT01193218|26758511|P2|0-12 Weeks|Protocol Violation|0
7694144|NCT01193218|26758512|P1|0-12 Weeks|Protocol Violation|0
7694145|NCT01193218|26758505|P8|0-12 Weeks|Adverse Event|0
7694146|NCT01193218|26758506|P7|0-12 Weeks|Adverse Event|2
7694147|NCT01193218|26758507|P6|0-12 Weeks|Adverse Event|2
7694148|NCT01193218|26758508|P5|0-12 Weeks|Adverse Event|0
7694149|NCT01193218|26758509|P4|0-12 Weeks|Adverse Event|0
7694150|NCT01193218|26758510|P3|0-12 Weeks|Adverse Event|1
7694151|NCT01193218|26758511|P2|0-12 Weeks|Adverse Event|0
7694152|NCT01193218|26758512|P1|0-12 Weeks|Adverse Event|6
7694153|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
7694154|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
7694155|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
7694156|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
7694157|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
7694158|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
7694159|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Pregnancy|0
7694160|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Pregnancy|1
7694161|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
7694162|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
7694163|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Death|0
7694164|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Death|2
7694165|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Adverse Event|3
7694166|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Adverse Event|12
7694167|NCT01193153|26758543|P2|Double Blind Relapse Prevention Period|Other|3
7694168|NCT01193153|26758544|P1|Double Blind Relapse Prevention Period|Other|2
7694169|NCT01193153|26758543|P2|Open-label Stabilization Period|Other|0
7694170|NCT01193153|26758544|P1|Open-label Stabilization Period|Other|8
7694171|NCT01193153|26758543|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
7694172|NCT01193153|26758544|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
7694173|NCT01193153|26758543|P2|Open-label Stabilization Period|Withdrawal by Subject|0
7694174|NCT01193153|26758544|P1|Open-label Stabilization Period|Withdrawal by Subject|29
7694175|NCT01193153|26758543|P2|Open-label Stabilization Period|Lack of Efficacy|0
7694176|NCT01193153|26758544|P1|Open-label Stabilization Period|Lack of Efficacy|5
7694177|NCT01193153|26758543|P2|Open-label Stabilization Period|Lost to Follow-up|0
7694178|NCT01193153|26758544|P1|Open-label Stabilization Period|Lost to Follow-up|10
7694179|NCT01193153|26758543|P2|Open-label Stabilization Period|Death|0
7694180|NCT01193153|26758544|P1|Open-label Stabilization Period|Death|2
7694181|NCT01193153|26758543|P2|Open-label Stabilization Period|Adverse Event|0
7694182|NCT01193153|26758544|P1|Open-label Stabilization Period|Adverse Event|9
7694183|NCT01193153|26758543|P2|Open-label Lead in Period|Lack of Efficacy|0
7694184|NCT01193153|26758544|P1|Open-label Lead in Period|Lack of Efficacy|26
7694185|NCT01193153|26758543|P2|Open-label Lead in Period|Death|0
7694186|NCT01193153|26758544|P1|Open-label Lead in Period|Death|1
7694187|NCT01193153|26758543|P2|Open-label Lead in Period|Adverse Event|0
7694188|NCT01193153|26758544|P1|Open-label Lead in Period|Adverse Event|41
7694189|NCT01193153|26758543|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
7694190|NCT01193153|26758544|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
7694191|NCT01193153|26758543|P2|Open-label Lead in Period|Other|0
7694192|NCT01193153|26758544|P1|Open-label Lead in Period|Other|14
7694193|NCT01193153|26758543|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
7694194|NCT01193153|26758544|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
7694195|NCT01193153|26758543|P2|Open-label Lead in Period|Withdrawal by Subject|0
7694196|NCT01193153|26758544|P1|Open-label Lead in Period|Withdrawal by Subject|69
7694197|NCT01193153|26758543|P2|Open-label Lead in Period|Pregnancy|0
7694198|NCT01193153|26758544|P1|Open-label Lead in Period|Pregnancy|1
7694199|NCT01193153|26758543|P2|Open-label Lead in Period|Lost to Follow-up|0
7694200|NCT01193153|26758544|P1|Open-label Lead in Period|Lost to Follow-up|32
7694201|NCT01193127|26758579|P4|Treated|Withdrawal by Subject|1
7694202|NCT01193127|26758580|P3|Treated|Withdrawal by Subject|0
7694203|NCT01193127|26758581|P2|Treated|Withdrawal by Subject|0
7694204|NCT01193127|26758582|P1|Treated|Withdrawal by Subject|0
7694205|NCT01193127|26758579|P4|Randomized|Surgery Cancelled|1
7694206|NCT01193127|26758580|P3|Randomized|Surgery Cancelled|0
7694207|NCT01193127|26758581|P2|Randomized|Surgery Cancelled|0
7694208|NCT01193127|26758582|P1|Randomized|Surgery Cancelled|0
7694209|NCT01193101|26758907|P4|Overall Study|Abnormal test procedure results|0
7694210|NCT01193101|26758908|P3|Overall Study|Abnormal test procedure results|0
7694211|NCT01193101|26758909|P2|Overall Study|Abnormal test procedure results|1
7694212|NCT01193101|26758910|P1|Overall Study|Abnormal test procedure results|0
7694213|NCT01193101|26758907|P4|Overall Study|Administrative problems|0
7694214|NCT01193101|26758908|P3|Overall Study|Administrative problems|1
7694215|NCT01193101|26758909|P2|Overall Study|Administrative problems|0
7694216|NCT01193101|26758910|P1|Overall Study|Administrative problems|0
7694217|NCT01193101|26758907|P4|Overall Study|Withdrawal by Subject|1
7694218|NCT01193101|26758908|P3|Overall Study|Withdrawal by Subject|1
7694219|NCT01193101|26758909|P2|Overall Study|Withdrawal by Subject|4
7694220|NCT01193101|26758910|P1|Overall Study|Withdrawal by Subject|2
7694221|NCT01193101|26758907|P4|Overall Study|Lack of Efficacy|8
7694222|NCT01193101|26758908|P3|Overall Study|Lack of Efficacy|0
7694223|NCT01193101|26758909|P2|Overall Study|Lack of Efficacy|1
7694224|NCT01193101|26758910|P1|Overall Study|Lack of Efficacy|3
7694225|NCT01193101|26758907|P4|Overall Study|Adverse Event|3
7694226|NCT01193101|26758908|P3|Overall Study|Adverse Event|1
7694227|NCT01193101|26758909|P2|Overall Study|Adverse Event|1
7694228|NCT01193101|26758910|P1|Overall Study|Adverse Event|0
7694229|NCT01192815|26759027|P1|Overall Study|Lack of Efficacy|1
7694230|NCT01192815|26759027|P1|Overall Study|Withdrawal by Subject|1
7694231|NCT01192776|26759042|P4|Overall Study|Lost to Follow-up|5
7694232|NCT01192776|26759043|P3|Overall Study|Lost to Follow-up|3
7694233|NCT01192776|26759044|P2|Overall Study|Lost to Follow-up|6
7694234|NCT01192776|26759045|P1|Overall Study|Lost to Follow-up|3
7694235|NCT01192776|26759042|P4|Overall Study|Death|15
7694236|NCT01192776|26759043|P3|Overall Study|Death|18
7694237|NCT01192776|26759044|P2|Overall Study|Death|15
7694238|NCT01192776|26759045|P1|Overall Study|Death|8
7694239|NCT01192516|26759123|P3|Overall Study|Unable to follow Actiwatch instructions|0
7694240|NCT01192516|26759124|P2|Overall Study|Unable to follow Actiwatch instructions|2
7694241|NCT01192516|26759125|P1|Overall Study|Unable to follow Actiwatch instructions|4
7694242|NCT01192516|26759123|P3|Overall Study|started new treatment|0
7694243|NCT01192516|26759124|P2|Overall Study|started new treatment|1
7694244|NCT01192516|26759125|P1|Overall Study|started new treatment|5
7694245|NCT01192516|26759123|P3|Overall Study|Withdrawal by Subject|1
7694246|NCT01192516|26759124|P2|Overall Study|Withdrawal by Subject|4
7694247|NCT01192516|26759125|P1|Overall Study|Withdrawal by Subject|4
7694248|NCT01192516|26759123|P3|Overall Study|Lost to Follow-up|7
7694249|NCT01192516|26759124|P2|Overall Study|Lost to Follow-up|10
7694250|NCT01192516|26759125|P1|Overall Study|Lost to Follow-up|7
7694251|NCT01192412|26759159|P2|Overall Study|Withdrawal by Subject|1
7694252|NCT01192412|26759160|P1|Overall Study|Withdrawal by Subject|2
7694253|NCT01192412|26759159|P2|Overall Study|Lost to Follow-up|1
7694254|NCT01192412|26759160|P1|Overall Study|Lost to Follow-up|2
7694255|NCT01192399|26759168|P1|Overall Study|Lack of Efficacy|2
7694256|NCT01192347|26759178|P1|Overall Study|Patient did not show up for visits|1
7694257|NCT01192347|26759178|P1|Overall Study|Patient not visiting hospital regularly|1
7694258|NCT01192347|26759178|P1|Overall Study|Patient seen in different hospital|1
7694259|NCT01192347|26759178|P1|Overall Study|Suspected serious adverse drug reaction|1
7694260|NCT01192347|26759178|P1|Overall Study|Adverse Event|1
7694261|NCT01192347|26759178|P1|Overall Study|Withdrawal by Subject|1
7694262|NCT01192347|26759178|P1|Overall Study|Lost to Follow-up|3
7694263|NCT01192347|26759178|P1|Overall Study|Death|3
7694264|NCT01192295|26759201|P2|Overall Study|Administrative|6
7694265|NCT01192295|26759202|P1|Overall Study|Administrative|4
7694266|NCT01192295|26759201|P2|Overall Study|Lack of Efficacy|5
7694267|NCT01192295|26759202|P1|Overall Study|Lack of Efficacy|0
7694268|NCT01192295|26759201|P2|Overall Study|Lost to Follow-up|1
7694269|NCT01192295|26759202|P1|Overall Study|Lost to Follow-up|0
7694270|NCT01192295|26759201|P2|Overall Study|Withdrawal by Subject|4
7694271|NCT01192295|26759202|P1|Overall Study|Withdrawal by Subject|3
7694272|NCT01192295|26759201|P2|Overall Study|Adverse Event|7
7694273|NCT01192295|26759202|P1|Overall Study|Adverse Event|3
7694274|NCT01192204|26759240|P2|Overall Study|could not keep recall appointments|0
7694275|NCT01192204|26759241|P1|Overall Study|could not keep recall appointments|1
7694276|NCT01192191|26759253|P2|Overall Study|Withdrawal by Subject|6
7694277|NCT01192191|26759254|P1|Overall Study|Withdrawal by Subject|1
7694278|NCT01192191|26759253|P2|Overall Study|Lost to Follow-up|1
7694279|NCT01192191|26759254|P1|Overall Study|Lost to Follow-up|0
7694280|NCT01192191|26759253|P2|Overall Study|Participants Reached Stopping Criteria|2
7694281|NCT01192191|26759254|P1|Overall Study|Participants Reached Stopping Criteria|3
7694282|NCT01192191|26759253|P2|Overall Study|Adverse Event|12
7694283|NCT01192191|26759254|P1|Overall Study|Adverse Event|7
7694284|NCT01192178|26759280|P2|Overall Study|Lack of Efficacy|2
7694285|NCT01192178|26759281|P1|Overall Study|Lack of Efficacy|1
7694286|NCT01192178|26759280|P2|Overall Study|Adverse Event|1
7694287|NCT01192178|26759281|P1|Overall Study|Adverse Event|2
7694288|NCT01192178|26759280|P2|Overall Study|Lost to Follow-up|3
7694289|NCT01192178|26759281|P1|Overall Study|Lost to Follow-up|3
7694290|NCT01192178|26759280|P2|Overall Study|Physician Decision|4
7694291|NCT01192178|26759281|P1|Overall Study|Physician Decision|2
7694292|NCT01192178|26759280|P2|Overall Study|Protocol Violation|3
7694293|NCT01192178|26759281|P1|Overall Study|Protocol Violation|10
7694294|NCT01192178|26759280|P2|Overall Study|Withdrawal by Subject|10
7694295|NCT01192178|26759281|P1|Overall Study|Withdrawal by Subject|6
7694296|NCT01192152|26759301|P2|Period 3|family emergency|0
7694297|NCT01192152|26759302|P1|Period 3|family emergency|1
7694298|NCT01192152|26759301|P2|Period 1|left prematurely (while on treatment B)|1
7694299|NCT01192152|26759302|P1|Period 1|left prematurely (while on treatment B)|0
7694300|NCT01192126|26759473|P2|First Intervention (1 Week)|Lost to Follow-up|1
7694301|NCT01192126|26759474|P1|First Intervention (1 Week)|Lost to Follow-up|1
7694302|NCT01192126|26759473|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
7694303|NCT01192126|26759474|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
7694304|NCT01192100|26759482|P6|Overall Study|Protocol Violation|0
7694305|NCT01192100|26759483|P5|Overall Study|Protocol Violation|0
7694306|NCT01192100|26759484|P4|Overall Study|Protocol Violation|1
7694307|NCT01192100|26759485|P3|Overall Study|Protocol Violation|0
7694308|NCT01192100|26759486|P2|Overall Study|Protocol Violation|0
7694309|NCT01192100|26759487|P1|Overall Study|Protocol Violation|0
7694310|NCT01192100|26759482|P6|Overall Study|Withdrawal by Subject|0
7694311|NCT01192100|26759483|P5|Overall Study|Withdrawal by Subject|1
7694312|NCT01192100|26759484|P4|Overall Study|Withdrawal by Subject|0
7694313|NCT01192100|26759485|P3|Overall Study|Withdrawal by Subject|0
7694314|NCT01192100|26759486|P2|Overall Study|Withdrawal by Subject|0
7694315|NCT01192100|26759487|P1|Overall Study|Withdrawal by Subject|0
7694316|NCT01192022|26759507|P5|Overall Study|Parents did not allow all follow up|0
7694317|NCT01192022|26759508|P4|Overall Study|Parents did not allow all follow up|1
7694318|NCT01192022|26759509|P3|Overall Study|Parents did not allow all follow up|0
7694319|NCT01192022|26759510|P2|Overall Study|Parents did not allow all follow up|0
7694320|NCT01192022|26759511|P1|Overall Study|Parents did not allow all follow up|0
7694321|NCT01192022|26759507|P5|Overall Study|Patient needed surgery|0
7694322|NCT01192022|26759508|P4|Overall Study|Patient needed surgery|0
7694323|NCT01192022|26759509|P3|Overall Study|Patient needed surgery|0
7694324|NCT01192022|26759510|P2|Overall Study|Patient needed surgery|1
7694325|NCT01192022|26759511|P1|Overall Study|Patient needed surgery|0
7694326|NCT01192022|26759507|P5|Overall Study|Patient too sick from chemotherapy|0
7694327|NCT01192022|26759508|P4|Overall Study|Patient too sick from chemotherapy|0
7694328|NCT01192022|26759509|P3|Overall Study|Patient too sick from chemotherapy|0
7694329|NCT01192022|26759510|P2|Overall Study|Patient too sick from chemotherapy|1
7694330|NCT01192022|26759511|P1|Overall Study|Patient too sick from chemotherapy|0
7694331|NCT01192022|26759507|P5|Overall Study|Physician withdrew-patient hardship|0
7694332|NCT01192022|26759508|P4|Overall Study|Physician withdrew-patient hardship|0
7694333|NCT01192022|26759509|P3|Overall Study|Physician withdrew-patient hardship|0
7694334|NCT01192022|26759510|P2|Overall Study|Physician withdrew-patient hardship|0
7694335|NCT01192022|26759511|P1|Overall Study|Physician withdrew-patient hardship|1
7694336|NCT01192022|26759507|P5|Overall Study|Fatal Adverse Event|1
7694337|NCT01192022|26759508|P4|Overall Study|Fatal Adverse Event|0
7694338|NCT01192022|26759509|P3|Overall Study|Fatal Adverse Event|0
7694339|NCT01192022|26759510|P2|Overall Study|Fatal Adverse Event|6
7694340|NCT01192022|26759511|P1|Overall Study|Fatal Adverse Event|4
7694341|NCT01192022|26759507|P5|Overall Study|Adverse Event|0
7694342|NCT01192022|26759508|P4|Overall Study|Adverse Event|0
7694343|NCT01192022|26759509|P3|Overall Study|Adverse Event|0
7694344|NCT01192022|26759510|P2|Overall Study|Adverse Event|0
7694345|NCT01192022|26759511|P1|Overall Study|Adverse Event|1
7694346|NCT01192022|26759507|P5|Overall Study|Lost to Follow-up|0
7694347|NCT01192022|26759508|P4|Overall Study|Lost to Follow-up|1
7694348|NCT01192022|26759509|P3|Overall Study|Lost to Follow-up|1
7694349|NCT01192022|26759510|P2|Overall Study|Lost to Follow-up|2
7694350|NCT01192022|26759511|P1|Overall Study|Lost to Follow-up|4
7694351|NCT01192022|26759507|P5|Overall Study|Withdrawal of Consent|0
7694352|NCT01192022|26759508|P4|Overall Study|Withdrawal of Consent|0
7694353|NCT01192022|26759509|P3|Overall Study|Withdrawal of Consent|0
7694354|NCT01192022|26759510|P2|Overall Study|Withdrawal of Consent|1
7694355|NCT01192022|26759511|P1|Overall Study|Withdrawal of Consent|3
7694356|NCT01191944|26759534|P2|Overall Study|Other|3
7694357|NCT01191944|26759535|P1|Overall Study|Other|1
7694358|NCT01191944|26759534|P2|Overall Study|Withdrawal by Subject|2
7694359|NCT01191944|26759535|P1|Overall Study|Withdrawal by Subject|4
7694360|NCT01191944|26759534|P2|Overall Study|Protocol Violation|2
7694361|NCT01191944|26759535|P1|Overall Study|Protocol Violation|1
7694362|NCT01191944|26759534|P2|Overall Study|Adverse Event|12
7694363|NCT01191944|26759535|P1|Overall Study|Adverse Event|11
7694364|NCT01191840|26759581|P2|Overall Study|Withdrawal by Subject|0
7694365|NCT01191840|26759582|P1|Overall Study|Withdrawal by Subject|2
7694366|NCT01191840|26759581|P2|Overall Study|lab error speciation - non Staph infecti|1
7694367|NCT01191840|26759582|P1|Overall Study|lab error speciation - non Staph infecti|0
7694368|NCT01191840|26759581|P2|Overall Study|IRB approval lapse|2
7694369|NCT01191840|26759582|P1|Overall Study|IRB approval lapse|0
7694370|NCT01191840|26759581|P2|Overall Study|ineligible at enrollment|0
7694371|NCT01191840|26759582|P1|Overall Study|ineligible at enrollment|1
7694372|NCT01191840|26759581|P2|Overall Study|Non Staph Infection|3
7694373|NCT01191840|26759582|P1|Overall Study|Non Staph Infection|4
7694374|NCT01191840|26759581|P2|Overall Study|Lost to Follow-up|6
7694375|NCT01191840|26759582|P1|Overall Study|Lost to Follow-up|4
7694376|NCT01191840|26759581|P2|Overall Study|Subject discontinued treatment|2
7694377|NCT01191840|26759582|P1|Overall Study|Subject discontinued treatment|1
7694378|NCT01191840|26759581|P2|Overall Study|withdrew consent|1
7694379|NCT01191840|26759582|P1|Overall Study|withdrew consent|2
7694380|NCT01191801|26759607|P2|Overall Study|Not Provided|27
7694381|NCT01191801|26759608|P1|Overall Study|Not Provided|45
7694382|NCT01191801|26759607|P2|Overall Study|Withdrawal by Subject|4
7694383|NCT01191801|26759608|P1|Overall Study|Withdrawal by Subject|1
7694384|NCT01191801|26759607|P2|Overall Study|Physician Decision|24
7694385|NCT01191801|26759608|P1|Overall Study|Physician Decision|47
7694386|NCT01191801|26759607|P2|Overall Study|Protocol Violation|4
7694387|NCT01191801|26759608|P1|Overall Study|Protocol Violation|2
7694388|NCT01191801|26759607|P2|Overall Study|Adverse Event|8
7694389|NCT01191801|26759608|P1|Overall Study|Adverse Event|9
7694390|NCT01191801|26759607|P2|Overall Study|Lack of Efficacy|258
7694391|NCT01191801|26759608|P1|Overall Study|Lack of Efficacy|176
7694392|NCT01191801|26759607|P2|Overall Study|Death|12
7694393|NCT01191801|26759608|P1|Overall Study|Death|36
7694394|NCT01191788|26759628|P2|Overall Study|Lost to Follow-up|22
7694395|NCT01191788|26759629|P1|Overall Study|Lost to Follow-up|21
7694396|NCT01191762|26759639|P2|Overall Study|Adverse Event|0
7694397|NCT01191762|26759640|P1|Overall Study|Adverse Event|1
7694398|NCT01191268|26759817|P3|Overall Study|Sponsor Decision|0
7694399|NCT01191268|26759818|P2|Overall Study|Sponsor Decision|2
7694400|NCT01191268|26759819|P1|Overall Study|Sponsor Decision|0
7694401|NCT01191268|26759817|P3|Overall Study|Protocol Violation|1
7694402|NCT01191268|26759818|P2|Overall Study|Protocol Violation|0
7694403|NCT01191268|26759819|P1|Overall Study|Protocol Violation|1
7694404|NCT01191268|26759817|P3|Overall Study|Death|3
7694405|NCT01191268|26759818|P2|Overall Study|Death|1
7694406|NCT01191268|26759819|P1|Overall Study|Death|0
7694407|NCT01191268|26759817|P3|Overall Study|Entry Criteria Not Met|1
7694408|NCT01191268|26759818|P2|Overall Study|Entry Criteria Not Met|1
7694409|NCT01191268|26759819|P1|Overall Study|Entry Criteria Not Met|3
7694410|NCT01191268|26759817|P3|Overall Study|Lost to Follow-up|9
7694411|NCT01191268|26759818|P2|Overall Study|Lost to Follow-up|5
7694412|NCT01191268|26759819|P1|Overall Study|Lost to Follow-up|8
7694413|NCT01191268|26759817|P3|Overall Study|Physician Decision|9
7694414|NCT01191268|26759818|P2|Overall Study|Physician Decision|8
7694415|NCT01191268|26759819|P1|Overall Study|Physician Decision|6
7694416|NCT01191268|26759817|P3|Overall Study|Adverse Event|8
7694417|NCT01191268|26759818|P2|Overall Study|Adverse Event|13
7694418|NCT01191268|26759819|P1|Overall Study|Adverse Event|21
7694419|NCT01191268|26759817|P3|Overall Study|Withdrawal by Subject|21
7694420|NCT01191268|26759818|P2|Overall Study|Withdrawal by Subject|25
7694421|NCT01191268|26759819|P1|Overall Study|Withdrawal by Subject|19
7694422|NCT01191190|26759960|P1|Overall Study|Withdrawal by Subject|1
7694423|NCT01191086|26759973|P1|Overall Study|Other|1
7694424|NCT01191086|26759973|P1|Overall Study|Discontinuation criterion met|1
7694425|NCT01191086|26759973|P1|Overall Study|Withdrawal by Subject|24
7694426|NCT01191086|26759973|P1|Overall Study|Physician Decision|2
7694427|NCT01191086|26759973|P1|Overall Study|Lost to Follow-up|4
7694428|NCT01191086|26759973|P1|Overall Study|Lack of Efficacy|10
7694429|NCT01191086|26759973|P1|Overall Study|Adverse Event|20
7694430|NCT01191008|26759977|P1|Overall Study|Lost to Follow-up|8
7694431|NCT01191008|26759977|P1|Overall Study|Protocol Violation|7
7694432|NCT01190930|26759985|P10|Maintenance|Still on therapy|0
7694433|NCT01190930|26759986|P9|Maintenance|Still on therapy|0
7694434|NCT01190930|26759987|P8|Maintenance|Still on therapy|0
7694435|NCT01190930|26759988|P7|Maintenance|Still on therapy|0
7694436|NCT01190930|26759989|P6|Maintenance|Still on therapy|0
7694437|NCT01190930|26759990|P5|Maintenance|Still on therapy|0
7694438|NCT01190930|26759991|P4|Maintenance|Still on therapy|29
7694439|NCT01190930|26759992|P3|Maintenance|Still on therapy|0
7694440|NCT01190930|26759993|P2|Maintenance|Still on therapy|8
7694441|NCT01190930|26759994|P1|Maintenance|Still on therapy|0
7694442|NCT01190930|26759985|P10|Maintenance|Relapse|11
7694443|NCT01190930|26759986|P9|Maintenance|Relapse|11
7694444|NCT01190930|26759987|P8|Maintenance|Relapse|13
7694445|NCT01190930|26759988|P7|Maintenance|Relapse|6
7694446|NCT01190930|26759989|P6|Maintenance|Relapse|1
7694447|NCT01190930|26759990|P5|Maintenance|Relapse|0
7694448|NCT01190930|26759991|P4|Maintenance|Relapse|2
7694449|NCT01190930|26759992|P3|Maintenance|Relapse|0
7694450|NCT01190930|26759993|P2|Maintenance|Relapse|0
7694451|NCT01190930|26759994|P1|Maintenance|Relapse|0
7694452|NCT01190930|26759985|P10|Maintenance|Enrollment onto another COG Protocol|0
7694453|NCT01190930|26759986|P9|Maintenance|Enrollment onto another COG Protocol|1
7694454|NCT01190930|26759987|P8|Maintenance|Enrollment onto another COG Protocol|0
7694455|NCT01190930|26759988|P7|Maintenance|Enrollment onto another COG Protocol|0
7694456|NCT01190930|26759989|P6|Maintenance|Enrollment onto another COG Protocol|0
7694457|NCT01190930|26759990|P5|Maintenance|Enrollment onto another COG Protocol|0
7694458|NCT01190930|26759991|P4|Maintenance|Enrollment onto another COG Protocol|0
7694459|NCT01190930|26759992|P3|Maintenance|Enrollment onto another COG Protocol|0
7694460|NCT01190930|26759993|P2|Maintenance|Enrollment onto another COG Protocol|0
7694461|NCT01190930|26759994|P1|Maintenance|Enrollment onto another COG Protocol|0
7694462|NCT01190930|26759985|P10|Maintenance|Inevaluable|0
7694463|NCT01190930|26759986|P9|Maintenance|Inevaluable|0
7694464|NCT01190930|26759987|P8|Maintenance|Inevaluable|1
7694465|NCT01190930|26759988|P7|Maintenance|Inevaluable|1
7694466|NCT01190930|26759989|P6|Maintenance|Inevaluable|1
7694467|NCT01190930|26759990|P5|Maintenance|Inevaluable|0
7694468|NCT01190930|26759991|P4|Maintenance|Inevaluable|0
7694469|NCT01190930|26759992|P3|Maintenance|Inevaluable|0
7694470|NCT01190930|26759993|P2|Maintenance|Inevaluable|0
7694471|NCT01190930|26759994|P1|Maintenance|Inevaluable|0
7694472|NCT01190930|26759985|P10|Maintenance|second malignant neoplasm|0
7694473|NCT01190930|26759986|P9|Maintenance|second malignant neoplasm|1
7694474|NCT01190930|26759987|P8|Maintenance|second malignant neoplasm|0
7694475|NCT01190930|26759988|P7|Maintenance|second malignant neoplasm|0
7694476|NCT01190930|26759989|P6|Maintenance|second malignant neoplasm|1
7694477|NCT01190930|26759990|P5|Maintenance|second malignant neoplasm|0
7694478|NCT01190930|26759991|P4|Maintenance|second malignant neoplasm|1
7694479|NCT01190930|26759992|P3|Maintenance|second malignant neoplasm|0
7694480|NCT01190930|26759993|P2|Maintenance|second malignant neoplasm|0
7694481|NCT01190930|26759994|P1|Maintenance|second malignant neoplasm|0
7694482|NCT01190930|26759985|P10|Maintenance|Refusal|6
7694483|NCT01190930|26759986|P9|Maintenance|Refusal|13
7694484|NCT01190930|26759987|P8|Maintenance|Refusal|17
7694485|NCT01190930|26759988|P7|Maintenance|Refusal|5
7694486|NCT01190930|26759989|P6|Maintenance|Refusal|4
7694487|NCT01190930|26759990|P5|Maintenance|Refusal|0
7694488|NCT01190930|26759991|P4|Maintenance|Refusal|2
7694489|NCT01190930|26759992|P3|Maintenance|Refusal|0
7694490|NCT01190930|26759993|P2|Maintenance|Refusal|1
7694491|NCT01190930|26759994|P1|Maintenance|Refusal|0
7694492|NCT01190930|26759985|P10|Maintenance|Withdrawal by Subject|1
7694493|NCT01190930|26759986|P9|Maintenance|Withdrawal by Subject|4
7694494|NCT01190930|26759987|P8|Maintenance|Withdrawal by Subject|1
7694495|NCT01190930|26759988|P7|Maintenance|Withdrawal by Subject|2
7694496|NCT01190930|26759989|P6|Maintenance|Withdrawal by Subject|0
7694497|NCT01190930|26759990|P5|Maintenance|Withdrawal by Subject|0
7694498|NCT01190930|26759991|P4|Maintenance|Withdrawal by Subject|0
7694499|NCT01190930|26759992|P3|Maintenance|Withdrawal by Subject|0
7694500|NCT01190930|26759993|P2|Maintenance|Withdrawal by Subject|0
7694501|NCT01190930|26759994|P1|Maintenance|Withdrawal by Subject|0
7694502|NCT01190930|26759985|P10|Maintenance|Physician Decision|17
7694503|NCT01190930|26759986|P9|Maintenance|Physician Decision|10
7694504|NCT01190930|26759987|P8|Maintenance|Physician Decision|8
7694505|NCT01190930|26759988|P7|Maintenance|Physician Decision|8
7694506|NCT01190930|26759989|P6|Maintenance|Physician Decision|4
7694507|NCT01190930|26759990|P5|Maintenance|Physician Decision|9
7694508|NCT01190930|26759991|P4|Maintenance|Physician Decision|5
7694509|NCT01190930|26759992|P3|Maintenance|Physician Decision|0
7694510|NCT01190930|26759993|P2|Maintenance|Physician Decision|1
7694511|NCT01190930|26759994|P1|Maintenance|Physician Decision|0
7694512|NCT01190930|26759985|P10|Maintenance|Lost to Follow-up|0
7694513|NCT01190930|26759986|P9|Maintenance|Lost to Follow-up|1
7694514|NCT01190930|26759987|P8|Maintenance|Lost to Follow-up|1
7694515|NCT01190930|26759988|P7|Maintenance|Lost to Follow-up|1
7694516|NCT01190930|26759989|P6|Maintenance|Lost to Follow-up|0
7694517|NCT01190930|26759990|P5|Maintenance|Lost to Follow-up|0
7694518|NCT01190930|26759991|P4|Maintenance|Lost to Follow-up|0
7694519|NCT01190930|26759992|P3|Maintenance|Lost to Follow-up|0
7694520|NCT01190930|26759993|P2|Maintenance|Lost to Follow-up|0
7694521|NCT01190930|26759994|P1|Maintenance|Lost to Follow-up|0
7694522|NCT01190930|26759985|P10|Maintenance|Death|2
7694523|NCT01190930|26759986|P9|Maintenance|Death|2
7694524|NCT01190930|26759987|P8|Maintenance|Death|2
7694525|NCT01190930|26759988|P7|Maintenance|Death|2
7694526|NCT01190930|26759989|P6|Maintenance|Death|0
7694527|NCT01190930|26759990|P5|Maintenance|Death|0
7694528|NCT01190930|26759991|P4|Maintenance|Death|1
7694529|NCT01190930|26759992|P3|Maintenance|Death|0
7694530|NCT01190930|26759993|P2|Maintenance|Death|0
7694531|NCT01190930|26759994|P1|Maintenance|Death|0
7694532|NCT01190930|26759985|P10|Maintenance|Adverse Event|0
7694533|NCT01190930|26759986|P9|Maintenance|Adverse Event|3
7694534|NCT01190930|26759987|P8|Maintenance|Adverse Event|3
7694535|NCT01190930|26759988|P7|Maintenance|Adverse Event|1
7694536|NCT01190930|26759989|P6|Maintenance|Adverse Event|1
7694537|NCT01190930|26759990|P5|Maintenance|Adverse Event|0
7694538|NCT01190930|26759991|P4|Maintenance|Adverse Event|0
7694539|NCT01190930|26759992|P3|Maintenance|Adverse Event|0
7694540|NCT01190930|26759993|P2|Maintenance|Adverse Event|0
7694541|NCT01190930|26759994|P1|Maintenance|Adverse Event|0
7694542|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Relapse|0
7694543|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Relapse|0
7694544|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Relapse|0
7694545|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Relapse|0
7694546|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Relapse|0
7694547|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Relapse|0
7694548|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Relapse|0
7694549|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Relapse|1
7694550|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Relapse|0
7694551|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Relapse|0
7694552|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Progressive disease|0
7694553|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Progressive disease|0
7694554|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Progressive disease|0
7694555|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Progressive disease|0
7694556|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Progressive disease|0
7694557|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Progressive disease|0
7694558|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Progressive disease|0
7694559|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Progressive disease|1
7694560|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Progressive disease|0
7694561|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Progressive disease|0
7694562|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694563|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694564|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694565|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694566|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694567|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694568|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694569|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694570|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
7694571|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7694572|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Inevaluable|0
7694573|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Inevaluable|0
7694574|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Inevaluable|0
7694575|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Inevaluable|0
7694576|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Inevaluable|0
7694577|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Inevaluable|0
7694578|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Inevaluable|0
7694579|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Inevaluable|6
7694580|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Inevaluable|0
7694581|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Inevaluable|0
7694582|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Refusal|0
7694583|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Refusal|0
7694584|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Refusal|0
7694585|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Refusal|0
7694586|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Refusal|3
7694587|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Refusal|0
7694588|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Refusal|4
7694589|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Refusal|694
7694590|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Refusal|2
7694591|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Refusal|0
7694592|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694593|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694594|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694595|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694596|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694597|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694598|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Withdrawal by Subject|2
7694599|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Withdrawal by Subject|5
7694600|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Withdrawal by Subject|1
7694601|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7694602|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Physician Decision|0
7694603|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Physician Decision|0
7694604|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Physician Decision|0
7694605|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Physician Decision|0
7694606|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Physician Decision|3
7694607|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Physician Decision|5
7694608|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Physician Decision|7
7694609|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Physician Decision|35
7694610|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Physician Decision|2
7694611|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Physician Decision|0
7694612|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Death|0
7694613|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Death|0
7694614|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Death|0
7694615|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Death|0
7694616|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Death|0
7694617|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Death|0
7694618|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Death|4
7694619|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Death|8
7694620|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Death|0
7694621|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Death|0
7694622|NCT01190930|26759985|P10|Post Induction Pre-Maintenance|Adverse Event|0
7694623|NCT01190930|26759986|P9|Post Induction Pre-Maintenance|Adverse Event|0
7694624|NCT01190930|26759987|P8|Post Induction Pre-Maintenance|Adverse Event|0
7694625|NCT01190930|26759988|P7|Post Induction Pre-Maintenance|Adverse Event|0
7694626|NCT01190930|26759989|P6|Post Induction Pre-Maintenance|Adverse Event|0
7694627|NCT01190930|26759990|P5|Post Induction Pre-Maintenance|Adverse Event|0
7694628|NCT01190930|26759991|P4|Post Induction Pre-Maintenance|Adverse Event|0
7694629|NCT01190930|26759992|P3|Post Induction Pre-Maintenance|Adverse Event|8
7694630|NCT01190930|26759993|P2|Post Induction Pre-Maintenance|Adverse Event|0
7694631|NCT01190930|26759994|P1|Post Induction Pre-Maintenance|Adverse Event|0
7694632|NCT01190930|26759985|P10|Induction|Ineligible|0
7694633|NCT01190930|26759986|P9|Induction|Ineligible|0
7694634|NCT01190930|26759987|P8|Induction|Ineligible|0
7694635|NCT01190930|26759988|P7|Induction|Ineligible|0
7694636|NCT01190930|26759989|P6|Induction|Ineligible|0
7694637|NCT01190930|26759990|P5|Induction|Ineligible|0
7694638|NCT01190930|26759991|P4|Induction|Ineligible|0
7694639|NCT01190930|26759992|P3|Induction|Ineligible|0
7694640|NCT01190930|26759993|P2|Induction|Ineligible|4
7694641|NCT01190930|26759994|P1|Induction|Ineligible|69
7694642|NCT01190930|26759985|P10|Induction|No treatment|0
7694643|NCT01190930|26759986|P9|Induction|No treatment|0
7694644|NCT01190930|26759987|P8|Induction|No treatment|0
7694645|NCT01190930|26759988|P7|Induction|No treatment|0
7694646|NCT01190930|26759989|P6|Induction|No treatment|0
7694647|NCT01190930|26759990|P5|Induction|No treatment|0
7694648|NCT01190930|26759991|P4|Induction|No treatment|0
7694649|NCT01190930|26759992|P3|Induction|No treatment|0
7694650|NCT01190930|26759993|P2|Induction|No treatment|0
7694651|NCT01190930|26759994|P1|Induction|No treatment|3
7694652|NCT01190930|26759985|P10|Induction|Progressive disease|0
7694653|NCT01190930|26759986|P9|Induction|Progressive disease|0
7694654|NCT01190930|26759987|P8|Induction|Progressive disease|0
7694655|NCT01190930|26759988|P7|Induction|Progressive disease|0
7694656|NCT01190930|26759989|P6|Induction|Progressive disease|0
7694657|NCT01190930|26759990|P5|Induction|Progressive disease|0
7694658|NCT01190930|26759991|P4|Induction|Progressive disease|0
7694659|NCT01190930|26759992|P3|Induction|Progressive disease|0
7694660|NCT01190930|26759993|P2|Induction|Progressive disease|1
7694661|NCT01190930|26759994|P1|Induction|Progressive disease|0
7694662|NCT01190930|26759985|P10|Induction|Incomplete Induction data|0
7694663|NCT01190930|26759986|P9|Induction|Incomplete Induction data|0
7694664|NCT01190930|26759987|P8|Induction|Incomplete Induction data|0
7694665|NCT01190930|26759988|P7|Induction|Incomplete Induction data|0
7694666|NCT01190930|26759989|P6|Induction|Incomplete Induction data|0
7694667|NCT01190930|26759990|P5|Induction|Incomplete Induction data|0
7694668|NCT01190930|26759991|P4|Induction|Incomplete Induction data|0
7694669|NCT01190930|26759992|P3|Induction|Incomplete Induction data|0
7694670|NCT01190930|26759993|P2|Induction|Incomplete Induction data|0
7694671|NCT01190930|26759994|P1|Induction|Incomplete Induction data|63
7694672|NCT01190930|26759985|P10|Induction|Philadelphia chromosome-positive|0
7694673|NCT01190930|26759986|P9|Induction|Philadelphia chromosome-positive|0
7694674|NCT01190930|26759987|P8|Induction|Philadelphia chromosome-positive|0
7694675|NCT01190930|26759988|P7|Induction|Philadelphia chromosome-positive|0
7694676|NCT01190930|26759989|P6|Induction|Philadelphia chromosome-positive|0
7694677|NCT01190930|26759990|P5|Induction|Philadelphia chromosome-positive|0
7694678|NCT01190930|26759991|P4|Induction|Philadelphia chromosome-positive|0
7694679|NCT01190930|26759992|P3|Induction|Philadelphia chromosome-positive|0
7694680|NCT01190930|26759993|P2|Induction|Philadelphia chromosome-positive|0
7694681|NCT01190930|26759994|P1|Induction|Philadelphia chromosome-positive|99
7694682|NCT01190930|26759985|P10|Induction|Very High Risk|0
7694683|NCT01190930|26759986|P9|Induction|Very High Risk|0
7694684|NCT01190930|26759987|P8|Induction|Very High Risk|0
7694685|NCT01190930|26759988|P7|Induction|Very High Risk|0
7694686|NCT01190930|26759989|P6|Induction|Very High Risk|0
7694687|NCT01190930|26759990|P5|Induction|Very High Risk|0
7694688|NCT01190930|26759991|P4|Induction|Very High Risk|0
7694689|NCT01190930|26759992|P3|Induction|Very High Risk|0
7694690|NCT01190930|26759993|P2|Induction|Very High Risk|0
7694691|NCT01190930|26759994|P1|Induction|Very High Risk|1012
7694692|NCT01190930|26759985|P10|Induction|Low Risk|0
7694693|NCT01190930|26759986|P9|Induction|Low Risk|0
7694694|NCT01190930|26759987|P8|Induction|Low Risk|0
7694695|NCT01190930|26759988|P7|Induction|Low Risk|0
7694696|NCT01190930|26759989|P6|Induction|Low Risk|0
7694697|NCT01190930|26759990|P5|Induction|Low Risk|0
7694698|NCT01190930|26759991|P4|Induction|Low Risk|0
7694699|NCT01190930|26759992|P3|Induction|Low Risk|0
7694700|NCT01190930|26759993|P2|Induction|Low Risk|0
7694701|NCT01190930|26759994|P1|Induction|Low Risk|443
7694702|NCT01190930|26759985|P10|Induction|High Risk|0
7694703|NCT01190930|26759986|P9|Induction|High Risk|0
7694704|NCT01190930|26759987|P8|Induction|High Risk|0
7694705|NCT01190930|26759988|P7|Induction|High Risk|0
7694706|NCT01190930|26759989|P6|Induction|High Risk|0
7694707|NCT01190930|26759990|P5|Induction|High Risk|0
7694708|NCT01190930|26759991|P4|Induction|High Risk|0
7694709|NCT01190930|26759992|P3|Induction|High Risk|0
7694710|NCT01190930|26759993|P2|Induction|High Risk|0
7694711|NCT01190930|26759994|P1|Induction|High Risk|1227
7694712|NCT01190930|26759985|P10|Induction|Average Risk|0
7694713|NCT01190930|26759986|P9|Induction|Average Risk|0
7694714|NCT01190930|26759987|P8|Induction|Average Risk|0
7694715|NCT01190930|26759988|P7|Induction|Average Risk|0
7694716|NCT01190930|26759989|P6|Induction|Average Risk|0
7694717|NCT01190930|26759990|P5|Induction|Average Risk|0
7694718|NCT01190930|26759991|P4|Induction|Average Risk|0
7694719|NCT01190930|26759992|P3|Induction|Average Risk|0
7694720|NCT01190930|26759993|P2|Induction|Average Risk|0
7694721|NCT01190930|26759994|P1|Induction|Average Risk|1847
7694722|NCT01190930|26759985|P10|Induction|Enrollment onto another COG Protocol|0
7694723|NCT01190930|26759986|P9|Induction|Enrollment onto another COG Protocol|0
7694724|NCT01190930|26759987|P8|Induction|Enrollment onto another COG Protocol|0
7694725|NCT01190930|26759988|P7|Induction|Enrollment onto another COG Protocol|0
7694726|NCT01190930|26759989|P6|Induction|Enrollment onto another COG Protocol|0
7694727|NCT01190930|26759990|P5|Induction|Enrollment onto another COG Protocol|0
7694728|NCT01190930|26759991|P4|Induction|Enrollment onto another COG Protocol|0
7694729|NCT01190930|26759992|P3|Induction|Enrollment onto another COG Protocol|0
7694730|NCT01190930|26759993|P2|Induction|Enrollment onto another COG Protocol|0
7694731|NCT01190930|26759994|P1|Induction|Enrollment onto another COG Protocol|1
7694732|NCT01190930|26759985|P10|Induction|High Risk Downs|0
7694733|NCT01190930|26759986|P9|Induction|High Risk Downs|0
7694734|NCT01190930|26759987|P8|Induction|High Risk Downs|0
7694735|NCT01190930|26759988|P7|Induction|High Risk Downs|0
7694736|NCT01190930|26759989|P6|Induction|High Risk Downs|0
7694737|NCT01190930|26759990|P5|Induction|High Risk Downs|0
7694738|NCT01190930|26759991|P4|Induction|High Risk Downs|0
7694739|NCT01190930|26759992|P3|Induction|High Risk Downs|0
7694740|NCT01190930|26759993|P2|Induction|High Risk Downs|0
7694741|NCT01190930|26759994|P1|Induction|High Risk Downs|80
7694742|NCT01190930|26759985|P10|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694743|NCT01190930|26759986|P9|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694744|NCT01190930|26759987|P8|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694745|NCT01190930|26759988|P7|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694746|NCT01190930|26759989|P6|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694747|NCT01190930|26759990|P5|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694748|NCT01190930|26759991|P4|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694749|NCT01190930|26759992|P3|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694750|NCT01190930|26759993|P2|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7694751|NCT01190930|26759994|P1|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
7694752|NCT01190930|26759985|P10|Induction|Inevaluable|0
7694753|NCT01190930|26759986|P9|Induction|Inevaluable|0
7694754|NCT01190930|26759987|P8|Induction|Inevaluable|0
7694755|NCT01190930|26759988|P7|Induction|Inevaluable|0
7694756|NCT01190930|26759989|P6|Induction|Inevaluable|0
7694757|NCT01190930|26759990|P5|Induction|Inevaluable|0
7694758|NCT01190930|26759991|P4|Induction|Inevaluable|0
7694759|NCT01190930|26759992|P3|Induction|Inevaluable|0
7694760|NCT01190930|26759993|P2|Induction|Inevaluable|1
7694761|NCT01190930|26759994|P1|Induction|Inevaluable|23
7694762|NCT01190930|26759985|P10|Induction|Refusal|0
7694763|NCT01190930|26759986|P9|Induction|Refusal|0
7694764|NCT01190930|26759987|P8|Induction|Refusal|0
7694765|NCT01190930|26759988|P7|Induction|Refusal|0
7694766|NCT01190930|26759989|P6|Induction|Refusal|0
7694767|NCT01190930|26759990|P5|Induction|Refusal|0
7694768|NCT01190930|26759991|P4|Induction|Refusal|0
7694769|NCT01190930|26759992|P3|Induction|Refusal|0
7694770|NCT01190930|26759993|P2|Induction|Refusal|0
7694771|NCT01190930|26759994|P1|Induction|Refusal|235
7694772|NCT01190930|26759985|P10|Induction|Withdrawal by Subject|0
7694773|NCT01190930|26759986|P9|Induction|Withdrawal by Subject|0
7694774|NCT01190930|26759987|P8|Induction|Withdrawal by Subject|0
7694775|NCT01190930|26759988|P7|Induction|Withdrawal by Subject|0
7694776|NCT01190930|26759989|P6|Induction|Withdrawal by Subject|0
7694777|NCT01190930|26759990|P5|Induction|Withdrawal by Subject|0
7694778|NCT01190930|26759991|P4|Induction|Withdrawal by Subject|0
7694779|NCT01190930|26759992|P3|Induction|Withdrawal by Subject|0
7694780|NCT01190930|26759993|P2|Induction|Withdrawal by Subject|0
7694781|NCT01190930|26759994|P1|Induction|Withdrawal by Subject|9
7694782|NCT01190930|26759985|P10|Induction|Physician Decision|0
7694783|NCT01190930|26759986|P9|Induction|Physician Decision|0
7694784|NCT01190930|26759987|P8|Induction|Physician Decision|0
7694785|NCT01190930|26759988|P7|Induction|Physician Decision|0
7694786|NCT01190930|26759989|P6|Induction|Physician Decision|0
7694787|NCT01190930|26759990|P5|Induction|Physician Decision|0
7694788|NCT01190930|26759991|P4|Induction|Physician Decision|0
7694789|NCT01190930|26759992|P3|Induction|Physician Decision|0
7694790|NCT01190930|26759993|P2|Induction|Physician Decision|3
7694791|NCT01190930|26759994|P1|Induction|Physician Decision|125
7694792|NCT01190930|26759985|P10|Induction|Lost to Follow-up|0
7694793|NCT01190930|26759986|P9|Induction|Lost to Follow-up|0
7694794|NCT01190930|26759987|P8|Induction|Lost to Follow-up|0
7694795|NCT01190930|26759988|P7|Induction|Lost to Follow-up|0
7694796|NCT01190930|26759989|P6|Induction|Lost to Follow-up|0
7694797|NCT01190930|26759990|P5|Induction|Lost to Follow-up|0
7694798|NCT01190930|26759991|P4|Induction|Lost to Follow-up|0
7694799|NCT01190930|26759992|P3|Induction|Lost to Follow-up|0
7694800|NCT01190930|26759993|P2|Induction|Lost to Follow-up|0
7694801|NCT01190930|26759994|P1|Induction|Lost to Follow-up|1
7694802|NCT01190930|26759985|P10|Induction|Death|0
7694803|NCT01190930|26759986|P9|Induction|Death|0
7694804|NCT01190930|26759987|P8|Induction|Death|0
7694805|NCT01190930|26759988|P7|Induction|Death|0
7694806|NCT01190930|26759989|P6|Induction|Death|0
7694807|NCT01190930|26759990|P5|Induction|Death|0
7694808|NCT01190930|26759991|P4|Induction|Death|0
7694809|NCT01190930|26759992|P3|Induction|Death|0
7694810|NCT01190930|26759993|P2|Induction|Death|0
7694811|NCT01190930|26759994|P1|Induction|Death|34
7694812|NCT01190930|26759985|P10|Induction|Adverse Event|0
7694813|NCT01190930|26759986|P9|Induction|Adverse Event|0
7694814|NCT01190930|26759987|P8|Induction|Adverse Event|0
7694815|NCT01190930|26759988|P7|Induction|Adverse Event|0
7694816|NCT01190930|26759989|P6|Induction|Adverse Event|0
7694817|NCT01190930|26759990|P5|Induction|Adverse Event|0
7694818|NCT01190930|26759991|P4|Induction|Adverse Event|0
7694819|NCT01190930|26759992|P3|Induction|Adverse Event|0
7694820|NCT01190930|26759993|P2|Induction|Adverse Event|0
7694821|NCT01190930|26759994|P1|Induction|Adverse Event|17
7694822|NCT01190891|26760074|P2|Overall Study|Withdrawal by Subject|0
7694823|NCT01190891|26760075|P1|Overall Study|Withdrawal by Subject|5
7694824|NCT01190891|26760074|P2|Overall Study|Protocol Violation|0
7694825|NCT01190891|26760075|P1|Overall Study|Protocol Violation|1
7694826|NCT01190865|26760100|P1|Overall Study|Non-compliance|2
7694827|NCT01190865|26760100|P1|Overall Study|Withdrawal by Subject|1
7694828|NCT01190839|26760107|P2|Overall Study|Randomized but not treated|4
7694829|NCT01190839|26760108|P1|Overall Study|Randomized but not treated|2
7694830|NCT01190839|26760107|P2|Overall Study|Undefined|31
7694831|NCT01190839|26760108|P1|Overall Study|Undefined|35
7694832|NCT01190839|26760107|P2|Overall Study|Trial stopped by Sponsor|68
7694833|NCT01190839|26760108|P1|Overall Study|Trial stopped by Sponsor|71
7694834|NCT01190839|26760107|P2|Overall Study|Death|0
7694835|NCT01190839|26760108|P1|Overall Study|Death|1
7694836|NCT01190839|26760107|P2|Overall Study|Lost to Follow-up|1
7694837|NCT01190839|26760108|P1|Overall Study|Lost to Follow-up|7
7694838|NCT01190839|26760107|P2|Overall Study|Protocol Violation|2
7694839|NCT01190839|26760108|P1|Overall Study|Protocol Violation|2
7694840|NCT01190839|26760107|P2|Overall Study|Adverse Event|41
7694841|NCT01190839|26760108|P1|Overall Study|Adverse Event|32
7694842|NCT01190813|26760122|P2|Overall Study|Adverse Event|1
7694843|NCT01190813|26760123|P1|Overall Study|Adverse Event|0
7694844|NCT01190813|26760122|P2|Overall Study|Refused study treatment after randomized|0
7694845|NCT01190813|26760123|P1|Overall Study|Refused study treatment after randomized|1
7694846|NCT01190813|26760122|P2|Overall Study|Withdrawal by Subject|1
7694847|NCT01190813|26760123|P1|Overall Study|Withdrawal by Subject|2
7694848|NCT01190813|26760122|P2|Overall Study|Lost to Follow-up|2
7694849|NCT01190813|26760123|P1|Overall Study|Lost to Follow-up|1
7694850|NCT01190514|26760244|P4|Third Intervention (Period 3)|Adverse Event|0
7694851|NCT01190514|26760245|P3|Third Intervention (Period 3)|Adverse Event|0
7694852|NCT01190514|26760246|P2|Third Intervention (Period 3)|Adverse Event|0
7694853|NCT01190514|26760247|P1|Third Intervention (Period 3)|Adverse Event|1
7694854|NCT01190514|26760244|P4|First Intervention (Period 1)|Adverse Event|0
7694855|NCT01190514|26760245|P3|First Intervention (Period 1)|Adverse Event|0
7694856|NCT01190514|26760246|P2|First Intervention (Period 1)|Adverse Event|0
7694857|NCT01190514|26760247|P1|First Intervention (Period 1)|Adverse Event|1
7694858|NCT01190475|26760280|P3|Overall Study|Withdrawal by Subject|1
7694859|NCT01190475|26760281|P2|Overall Study|Withdrawal by Subject|0
7694860|NCT01190475|26760282|P1|Overall Study|Withdrawal by Subject|0
7694861|NCT01190449|26760298|P2|Overall Study|Ineligible|4
7694862|NCT01190449|26760299|P1|Overall Study|Ineligible|0
7694863|NCT01190436|26760307|P1|Overall Study|Other|4
7694864|NCT01190436|26760307|P1|Overall Study|Lost to Follow-up|35
7694865|NCT01190410|26760323|P2|Overall Study|PI discretion|2
7694866|NCT01190410|26760324|P1|Overall Study|PI discretion|0
7694867|NCT01190410|26760323|P2|Overall Study|Administrative decision|0
7694868|NCT01190410|26760324|P1|Overall Study|Administrative decision|1
7694869|NCT01190410|26760323|P2|Overall Study|Withdrawal by Subject|2
7694870|NCT01190410|26760324|P1|Overall Study|Withdrawal by Subject|0
7694871|NCT01190410|26760323|P2|Overall Study|Lack of Efficacy|2
7694872|NCT01190410|26760324|P1|Overall Study|Lack of Efficacy|0
7694873|NCT01190410|26760323|P2|Overall Study|Adverse Event|3
7694874|NCT01190410|26760324|P1|Overall Study|Adverse Event|0
7694875|NCT01190267|26760352|P2|Overall Study|Protocol Violation|1
7694876|NCT01190267|26760353|P1|Overall Study|Protocol Violation|8
7694877|NCT01190267|26760352|P2|Overall Study|Withdrawal by Subject|1
7694878|NCT01190267|26760353|P1|Overall Study|Withdrawal by Subject|13
7694879|NCT01190267|26760352|P2|Overall Study|Lost to Follow-up|0
7694880|NCT01190267|26760353|P1|Overall Study|Lost to Follow-up|2
7694881|NCT01190267|26760352|P2|Overall Study|Treatment Failure|2
7694882|NCT01190267|26760353|P1|Overall Study|Treatment Failure|8
7694883|NCT01190267|26760352|P2|Overall Study|Adverse Event|0
7694884|NCT01190267|26760353|P1|Overall Study|Adverse Event|10
7694885|NCT01190254|26760364|P3|Overall Study|Did not meet protocol eligibility|0
7694886|NCT01190254|26760365|P2|Overall Study|Did not meet protocol eligibility|0
7694887|NCT01190254|26760366|P1|Overall Study|Did not meet protocol eligibility|1
7694888|NCT01190254|26760364|P3|Overall Study|Protocol Violation|2
7694889|NCT01190254|26760365|P2|Overall Study|Protocol Violation|0
7694890|NCT01190254|26760366|P1|Overall Study|Protocol Violation|2
7694891|NCT01190254|26760364|P3|Overall Study|Withdrawal by Subject|7
7694892|NCT01190254|26760365|P2|Overall Study|Withdrawal by Subject|5
7694893|NCT01190254|26760366|P1|Overall Study|Withdrawal by Subject|4
7694894|NCT01190254|26760364|P3|Overall Study|Lost to Follow-up|0
7694895|NCT01190254|26760365|P2|Overall Study|Lost to Follow-up|2
7694896|NCT01190254|26760366|P1|Overall Study|Lost to Follow-up|4
7694897|NCT01190254|26760364|P3|Overall Study|Lack of Efficacy|5
7694898|NCT01190254|26760365|P2|Overall Study|Lack of Efficacy|4
7694899|NCT01190254|26760366|P1|Overall Study|Lack of Efficacy|7
7694900|NCT01190254|26760364|P3|Overall Study|Adverse Event|8
7694901|NCT01190254|26760365|P2|Overall Study|Adverse Event|6
7694902|NCT01190254|26760366|P1|Overall Study|Adverse Event|3
7694903|NCT01190228|26760431|P3|Overall Study|Withdrawal by Subject|0
7694904|NCT01190228|26760432|P2|Overall Study|Withdrawal by Subject|0
7694905|NCT01190228|26760433|P1|Overall Study|Withdrawal by Subject|1
7694906|NCT01190228|26760431|P3|Overall Study|Protocol Violation|0
7694907|NCT01190228|26760432|P2|Overall Study|Protocol Violation|0
7694908|NCT01190228|26760433|P1|Overall Study|Protocol Violation|4
7694909|NCT01190215|26760456|P2|Up to Month 6|Lost to Follow-up|0
7694910|NCT01190215|26760457|P1|Up to Month 6|Lost to Follow-up|2
7694911|NCT01190189|26760790|P1|Overall Study|Migrated/moved from study area|1
7694912|NCT01190189|26760790|P1|Overall Study|Withdrawal by Subject|1
7694913|NCT01190189|26760790|P1|Overall Study|Lost to Follow-up|4
7694914|NCT01190176|26760797|P1|Overall Study|Lost to Follow-up|1
7694915|NCT01190176|26760797|P1|Overall Study|Withdrawal by Subject|1
7694916|NCT01190150|26760818|P2|Washout|Difficulty in adherence|1
7694917|NCT01190150|26760819|P1|Washout|Difficulty in adherence|0
7694918|NCT01190150|26760818|P2|Washout|Withdrawal by Subject|1
7694919|NCT01190150|26760819|P1|Washout|Withdrawal by Subject|0
7694920|NCT01190150|26760818|P2|First Treatment|Withdrawal by Subject|0
7694921|NCT01190150|26760819|P1|First Treatment|Withdrawal by Subject|1
7694922|NCT01190124|26760846|P3|Overall Study|Lost to Follow-up|0
7694923|NCT01190124|26760847|P2|Overall Study|Lost to Follow-up|0
7694924|NCT01190124|26760848|P1|Overall Study|Lost to Follow-up|2
7694925|NCT01190124|26760846|P3|Overall Study|Therapeutic Failure|1
7694926|NCT01190124|26760847|P2|Overall Study|Therapeutic Failure|0
7694927|NCT01190124|26760848|P1|Overall Study|Therapeutic Failure|12
7694928|NCT01190124|26760846|P3|Overall Study|Death|0
7694929|NCT01190124|26760847|P2|Overall Study|Death|0
7694930|NCT01190124|26760848|P1|Overall Study|Death|3
7694931|NCT01190098|26760886|P2|Overall Study|Other|1
7694932|NCT01190098|26760887|P1|Overall Study|Other|0
7694933|NCT01190098|26760886|P2|Overall Study|Lack of transportation|0
7694934|NCT01190098|26760887|P1|Overall Study|Lack of transportation|1
7694935|NCT01190098|26760886|P2|Overall Study|Patient coomorbidity|1
7694936|NCT01190098|26760887|P1|Overall Study|Patient coomorbidity|0
7694937|NCT01190098|26760886|P2|Overall Study|Adverse Event|0
7694938|NCT01190098|26760887|P1|Overall Study|Adverse Event|2
7694939|NCT01190020|26760928|P2|Overall Study|Withdrawal by Subject|0
7694940|NCT01190020|26760929|P1|Overall Study|Withdrawal by Subject|3
7694941|NCT01190020|26760928|P2|Overall Study|Lost to Follow-up|0
7694942|NCT01190020|26760929|P1|Overall Study|Lost to Follow-up|2
7694943|NCT01190020|26760928|P2|Overall Study|Adverse Event|0
7694944|NCT01190020|26760929|P1|Overall Study|Adverse Event|2
7694945|NCT01190007|26760941|P1|Overall Study|Participant was arrested|1
7694946|NCT01190007|26760941|P1|Overall Study|Difficulty of visit for complications|1
7694947|NCT01190007|26760941|P1|Overall Study|Adverse Event|8
7694948|NCT01190007|26760941|P1|Overall Study|Withdrawal by Subject|4
7694949|NCT01189890|26760958|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
7694950|NCT01189890|26760959|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
7694951|NCT01189890|26760958|P2|Overall Study|Physician Decision|4
7694952|NCT01189890|26760959|P1|Overall Study|Physician Decision|5
7694953|NCT01189890|26760958|P2|Overall Study|Non Compliance|1
7694954|NCT01189890|26760959|P1|Overall Study|Non Compliance|0
7694955|NCT01189890|26760958|P2|Overall Study|Withdrawal by Subject|11
7694956|NCT01189890|26760959|P1|Overall Study|Withdrawal by Subject|15
7694957|NCT01189890|26760958|P2|Overall Study|Protocol Violation|5
7694958|NCT01189890|26760959|P1|Overall Study|Protocol Violation|1
7694959|NCT01189890|26760958|P2|Overall Study|Lost to Follow-up|7
7694960|NCT01189890|26760959|P1|Overall Study|Lost to Follow-up|1
7694961|NCT01189890|26760958|P2|Overall Study|Lack of Efficacy|2
7694962|NCT01189890|26760959|P1|Overall Study|Lack of Efficacy|7
7694963|NCT01189890|26760958|P2|Overall Study|Adverse Event|4
7694964|NCT01189890|26760959|P1|Overall Study|Adverse Event|3
7694965|NCT01189812|26760981|P2|Overall Study|Moved out of State|2
7694966|NCT01189812|26760982|P1|Overall Study|Moved out of State|1
7694967|NCT01189812|26760981|P2|Overall Study|Out of Window|3
7694968|NCT01189812|26760982|P1|Overall Study|Out of Window|4
7694969|NCT01189812|26760981|P2|Overall Study|Adverse Event|0
7694970|NCT01189812|26760982|P1|Overall Study|Adverse Event|1
7694971|NCT01189812|26760981|P2|Overall Study|Withdrawal by Subject|3
7694972|NCT01189812|26760982|P1|Overall Study|Withdrawal by Subject|2
7694973|NCT01189604|26761066|P7|Overall Study|Withdrawal by Subject|0
7694974|NCT01189604|26761067|P6|Overall Study|Withdrawal by Subject|0
7694975|NCT01189604|26761068|P5|Overall Study|Withdrawal by Subject|0
7694976|NCT01189604|26761069|P4|Overall Study|Withdrawal by Subject|0
7694977|NCT01189604|26761070|P3|Overall Study|Withdrawal by Subject|0
7694978|NCT01189604|26761071|P2|Overall Study|Withdrawal by Subject|0
7694979|NCT01189604|26761072|P1|Overall Study|Withdrawal by Subject|1
7694980|NCT01189604|26761066|P7|Overall Study|Adverse Event|1
7694981|NCT01189604|26761067|P6|Overall Study|Adverse Event|0
7694982|NCT01189604|26761068|P5|Overall Study|Adverse Event|2
7694983|NCT01189604|26761069|P4|Overall Study|Adverse Event|0
7694984|NCT01189604|26761070|P3|Overall Study|Adverse Event|0
7694985|NCT01189604|26761071|P2|Overall Study|Adverse Event|1
7694986|NCT01189604|26761072|P1|Overall Study|Adverse Event|0
7694987|NCT01189604|26761066|P7|Overall Study|Impossible to visit|0
7694988|NCT01189604|26761067|P6|Overall Study|Impossible to visit|1
7694989|NCT01189604|26761068|P5|Overall Study|Impossible to visit|0
7694990|NCT01189604|26761069|P4|Overall Study|Impossible to visit|0
7694991|NCT01189604|26761070|P3|Overall Study|Impossible to visit|0
7694992|NCT01189604|26761071|P2|Overall Study|Impossible to visit|0
7694993|NCT01189604|26761072|P1|Overall Study|Impossible to visit|0
7694994|NCT01189500|26761116|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
7694995|NCT01189500|26761116|P1|Period 1: TAMOX Alone|Adverse Event|1
7694996|NCT01189487|26761177|P1|Overall Study|Adverse Event|1
7694997|NCT01189487|26761177|P1|Overall Study|Lack of Efficacy|2
7694998|NCT01189461|26761185|P1|Overall Study|Other|8
7694999|NCT01189461|26761185|P1|Overall Study|Did not meet entrance criteria|3
7695000|NCT01189461|26761185|P1|Overall Study|Adverse Event|2
7695001|NCT01189461|26761185|P1|Overall Study|Protocol Violation|1
7695002|NCT01189461|26761185|P1|Overall Study|Withdrawal by Subject|6
7695003|NCT01189461|26761185|P1|Overall Study|Lost to Follow-up|1
7695004|NCT01189461|26761185|P1|Overall Study|Lack of Efficacy|13
7695005|NCT01189435|26761192|P1|Overall Study|Physician Decision|1
7695006|NCT01189435|26761192|P1|Overall Study|Withdrawal by Subject|1
7695031|NCT01189227|26761324|P2|Overall Study|Study terminated due to low accrual|3
7695032|NCT01189227|26761325|P1|Overall Study|Study terminated due to low accrual|6
7695033|NCT01189201|26761331|P1|Overall Study|Adverse Event|1
7695034|NCT01189032|26761434|P3|Overall Study|Protocol Violation|1
7695035|NCT01189032|26761435|P2|Overall Study|Protocol Violation|1
7695036|NCT01189032|26761436|P1|Overall Study|Protocol Violation|1
7695037|NCT01189032|26761434|P3|Overall Study|Withdrawal by Subject|1
7695038|NCT01189032|26761435|P2|Overall Study|Withdrawal by Subject|0
7695039|NCT01189032|26761436|P1|Overall Study|Withdrawal by Subject|1
7695040|NCT01189032|26761434|P3|Overall Study|Lack of Efficacy|0
7695041|NCT01189032|26761435|P2|Overall Study|Lack of Efficacy|3
7695042|NCT01189032|26761436|P1|Overall Study|Lack of Efficacy|2
7695043|NCT01189032|26761434|P3|Overall Study|Adverse Event|4
7695044|NCT01189032|26761435|P2|Overall Study|Adverse Event|3
7695045|NCT01189032|26761436|P1|Overall Study|Adverse Event|1
7695046|NCT01188967|26761446|P2|Overall Study|Lost to Follow-up|2
7695047|NCT01188967|26761447|P1|Overall Study|Lost to Follow-up|3
7695048|NCT01188967|26761446|P2|Overall Study|Physician Decision|1
7695049|NCT01188967|26761447|P1|Overall Study|Physician Decision|1
7695050|NCT01188967|26761446|P2|Overall Study|Withdrawal by Subject|1
7695051|NCT01188967|26761447|P1|Overall Study|Withdrawal by Subject|1
7695052|NCT01188811|26761500|P2|Overall Study|Adverse Event|0
7695053|NCT01188811|26761501|P1|Overall Study|Adverse Event|6
7695054|NCT01188811|26761500|P2|Overall Study|Withdrawal by Subject|2
7695055|NCT01188811|26761501|P1|Overall Study|Withdrawal by Subject|0
7695056|NCT01188798|26761513|P2|Overall Study|Protocol closure|1
7695057|NCT01188798|26761514|P1|Overall Study|Protocol closure|1
7695058|NCT01188798|26761513|P2|Overall Study|Required additional transplant|1
7695059|NCT01188798|26761514|P1|Overall Study|Required additional transplant|1
7695060|NCT01188798|26761513|P2|Overall Study|Death|1
7695061|NCT01188798|26761514|P1|Overall Study|Death|0
7695062|NCT01188772|26761526|P4|Overall Study|Withdrawal by Subject|0
7695063|NCT01188772|26761527|P3|Overall Study|Withdrawal by Subject|2
7695064|NCT01188772|26761528|P2|Overall Study|Withdrawal by Subject|0
7695065|NCT01188772|26761529|P1|Overall Study|Withdrawal by Subject|0
7695066|NCT01188772|26761526|P4|Overall Study|Virologic Failure|0
7695067|NCT01188772|26761527|P3|Overall Study|Virologic Failure|0
7695068|NCT01188772|26761528|P2|Overall Study|Virologic Failure|0
7695069|NCT01188772|26761529|P1|Overall Study|Virologic Failure|1
7695070|NCT01188772|26761526|P4|Overall Study|Treatment Failure|0
7695071|NCT01188772|26761527|P3|Overall Study|Treatment Failure|1
7695072|NCT01188772|26761528|P2|Overall Study|Treatment Failure|0
7695073|NCT01188772|26761529|P1|Overall Study|Treatment Failure|0
7695074|NCT01188772|26761526|P4|Overall Study|Terminated by Sponsor|0
7695075|NCT01188772|26761527|P3|Overall Study|Terminated by Sponsor|1
7695076|NCT01188772|26761528|P2|Overall Study|Terminated by Sponsor|0
7695077|NCT01188772|26761529|P1|Overall Study|Terminated by Sponsor|0
7695078|NCT01188772|26761526|P4|Overall Study|Physician Decision|0
7695079|NCT01188772|26761527|P3|Overall Study|Physician Decision|1
7695080|NCT01188772|26761528|P2|Overall Study|Physician Decision|0
7695081|NCT01188772|26761529|P1|Overall Study|Physician Decision|0
7695082|NCT01188772|26761526|P4|Overall Study|Non-responder|0
7695083|NCT01188772|26761527|P3|Overall Study|Non-responder|3
7695084|NCT01188772|26761528|P2|Overall Study|Non-responder|0
7695085|NCT01188772|26761529|P1|Overall Study|Non-responder|0
7695086|NCT01188772|26761526|P4|Overall Study|Lost to Follow-up|1
7695087|NCT01188772|26761527|P3|Overall Study|Lost to Follow-up|1
7695088|NCT01188772|26761528|P2|Overall Study|Lost to Follow-up|1
7695089|NCT01188772|26761529|P1|Overall Study|Lost to Follow-up|4
7695090|NCT01188772|26761526|P4|Overall Study|Adverse Event|0
7695091|NCT01188772|26761527|P3|Overall Study|Adverse Event|2
7695092|NCT01188772|26761528|P2|Overall Study|Adverse Event|1
7695093|NCT01188772|26761529|P1|Overall Study|Adverse Event|0
7695094|NCT01188772|26761526|P4|Overall Study|Randomized but Not Treated|0
7695095|NCT01188772|26761527|P3|Overall Study|Randomized but Not Treated|0
7695096|NCT01188772|26761528|P2|Overall Study|Randomized but Not Treated|1
7695097|NCT01188772|26761529|P1|Overall Study|Randomized but Not Treated|0
7695098|NCT01188681|26761601|P4|Overall Study|Withdrawal by Subject|1
7695099|NCT01188681|26761602|P3|Overall Study|Withdrawal by Subject|0
7695100|NCT01188681|26761603|P2|Overall Study|Withdrawal by Subject|0
7695101|NCT01188681|26761604|P1|Overall Study|Withdrawal by Subject|0
7695102|NCT01188681|26761601|P4|Overall Study|bladder cancer|0
7695103|NCT01188681|26761602|P3|Overall Study|bladder cancer|1
7695104|NCT01188681|26761603|P2|Overall Study|bladder cancer|0
7695105|NCT01188681|26761604|P1|Overall Study|bladder cancer|0
7695106|NCT01188668|26761618|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
7695107|NCT01188668|26761618|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
7695108|NCT01188668|26761618|P1|Period 1: ARIP Alone|Protocol Violation|2
7695109|NCT01188655|26761651|P1|Overall Study|Other|11
7695110|NCT01188655|26761651|P1|Overall Study|Lost to Follow-up|1
7695111|NCT01188655|26761651|P1|Overall Study|Lack of Efficacy|1
7695112|NCT01188564|26761695|P2|Double-blind Phase|randomized not treated|0
7695113|NCT01188564|26761696|P1|Double-blind Phase|randomized not treated|1
7695114|NCT01188551|26761708|P4|Overall Study|Pharmacy issues|0
7695115|NCT01188551|26761709|P3|Overall Study|Pharmacy issues|0
7695116|NCT01188551|26761710|P2|Overall Study|Pharmacy issues|0
7695117|NCT01188551|26761711|P1|Overall Study|Pharmacy issues|1
7695118|NCT01188538|26761727|P2|Overall Study|Lost to Follow-up|1
7695119|NCT01188538|26761728|P1|Overall Study|Lost to Follow-up|0
7695120|NCT01188343|26761824|P3|Overall Study|Withdrawal by Subject|0
7695121|NCT01188343|26761825|P2|Overall Study|Withdrawal by Subject|24
7695122|NCT01188343|26761826|P1|Overall Study|Withdrawal by Subject|1
7695123|NCT01188343|26761824|P3|Overall Study|Not vaccinated|1
7695124|NCT01188343|26761825|P2|Overall Study|Not vaccinated|2
7695125|NCT01188343|26761826|P1|Overall Study|Not vaccinated|0
7695126|NCT01188226|26761852|P1|Overall Study|Withdrawal by Subject|4
7695127|NCT01187953|26761898|P2|Overall Study|Withdrawal by Subject|3
7695128|NCT01187953|26761899|P1|Overall Study|Withdrawal by Subject|3
7695129|NCT01187953|26761898|P2|Overall Study|Lost to Follow-up|3
7695130|NCT01187953|26761899|P1|Overall Study|Lost to Follow-up|0
7695131|NCT01187953|26761898|P2|Overall Study|Adverse Event|2
7695132|NCT01187953|26761899|P1|Overall Study|Adverse Event|1
7695133|NCT01187953|26761898|P2|Overall Study|Death|13
7695134|NCT01187953|26761899|P1|Overall Study|Death|11
7695135|NCT01187901|26761913|P2|Overall Study|Pregnancy|2
7695136|NCT01187901|26761914|P1|Overall Study|Pregnancy|0
7695137|NCT01187901|26761913|P2|Overall Study|No Endpoint due to Early Study Halt|3
7695138|NCT01187901|26761914|P1|Overall Study|No Endpoint due to Early Study Halt|2
7695139|NCT01187901|26761913|P2|Overall Study|Adverse Event|0
7695140|NCT01187901|26761914|P1|Overall Study|Adverse Event|3
7695141|NCT01187901|26761913|P2|Overall Study|Suspected Allergic Reaction|1
7695142|NCT01187901|26761914|P1|Overall Study|Suspected Allergic Reaction|1
7695143|NCT01187901|26761913|P2|Overall Study|Unrelated Health Reasons|2
7695144|NCT01187901|26761914|P1|Overall Study|Unrelated Health Reasons|1
7695145|NCT01187901|26761913|P2|Overall Study|Lost to Follow-up|2
7695146|NCT01187901|26761914|P1|Overall Study|Lost to Follow-up|1
7695147|NCT01187901|26761913|P2|Overall Study|Protocol Violation|0
7695148|NCT01187901|26761914|P1|Overall Study|Protocol Violation|1
7695149|NCT01187550|26761955|P2|Overall Study|Randomized but not treated|0
7695150|NCT01187550|26761956|P1|Overall Study|Randomized but not treated|8
7695151|NCT01187550|26761955|P2|Overall Study|Other|0
7695152|NCT01187550|26761956|P1|Overall Study|Other|3
7695153|NCT01187550|26761955|P2|Overall Study|Protocol Violation|1
7695154|NCT01187550|26761956|P1|Overall Study|Protocol Violation|3
7695155|NCT01187446|26762112|P2|Overall Study|Patient started non-protocol therapy|1
7695156|NCT01187446|26762113|P1|Overall Study|Patient started non-protocol therapy|0
7695157|NCT01187433|26762129|P2|Overall Study|Withdrawal by Subject|2
7695158|NCT01187433|26762130|P1|Overall Study|Withdrawal by Subject|5
7695159|NCT01187433|26762129|P2|Overall Study|Protocol Violation|2
7695160|NCT01187433|26762130|P1|Overall Study|Protocol Violation|6
7695161|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
7695162|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7695163|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7695164|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7695165|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7695166|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
7695167|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
7695168|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7695169|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7695170|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7695171|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
7695172|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
7695173|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7695174|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
7695175|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7695176|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7695177|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7695178|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7695179|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7695180|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7695181|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
7695182|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
7695183|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
7695184|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
7695185|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7695186|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
7695187|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
7695188|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
7695189|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
7695190|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7695191|NCT01187407|26762160|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
7695192|NCT01187407|26762161|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
7695193|NCT01187407|26762162|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
7695194|NCT01187407|26762163|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7695195|NCT01187407|26762164|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7695196|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695197|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695198|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695199|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695200|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
7695201|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695202|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695203|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695204|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695205|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
7695206|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695207|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695208|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695209|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695210|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
7695211|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695212|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695213|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695214|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695215|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
7695216|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695217|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695218|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695219|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695220|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
7695221|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695222|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695223|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695224|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695225|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
7695226|NCT01187407|26762160|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695227|NCT01187407|26762161|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695228|NCT01187407|26762162|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695229|NCT01187407|26762163|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695230|NCT01187407|26762164|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
7695231|NCT01187043|26762288|P5|Overall Study|Unable to make scheduled visits|1
7695232|NCT01187043|26762289|P4|Overall Study|Unable to make scheduled visits|0
7695233|NCT01187043|26762290|P3|Overall Study|Unable to make scheduled visits|4
7695234|NCT01187043|26762291|P2|Overall Study|Unable to make scheduled visits|0
7695235|NCT01187043|26762292|P1|Overall Study|Unable to make scheduled visits|1
7695236|NCT01187043|26762288|P5|Overall Study|Adverse Event|1
7695237|NCT01187043|26762289|P4|Overall Study|Adverse Event|0
7695238|NCT01187043|26762290|P3|Overall Study|Adverse Event|0
7695239|NCT01187043|26762291|P2|Overall Study|Adverse Event|0
7695240|NCT01187043|26762292|P1|Overall Study|Adverse Event|0
7695241|NCT01186978|26762322|P1|Overall Study|Withdrawal by Subject|1
7695242|NCT01186939|26762329|P1|Overall Study|Transformation to AML|1
7695243|NCT01186939|26762329|P1|Overall Study|Bone marrow transplant|1
7695244|NCT01186939|26762329|P1|Overall Study|Myocardial infarction|1
7695245|NCT01186939|26762329|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
7695246|NCT01186939|26762329|P1|Overall Study|Started additional treatment|1
7695247|NCT01186939|26762329|P1|Overall Study|Sponsor decision|4
7695248|NCT01186939|26762329|P1|Overall Study|Program closed|5
7695249|NCT01186939|26762329|P1|Overall Study|No longer receiving clinical benefit|17
7695250|NCT01186939|26762329|P1|Overall Study|Withdrawal by Subject|2
7695251|NCT01186939|26762329|P1|Overall Study|Death|7
7695252|NCT01186848|26762333|P1|Overall Study|Adverse Event|2
7695253|NCT01186848|26762333|P1|Overall Study|Withdrawal by Subject|2
7695254|NCT01186848|26762333|P1|Overall Study|Lost to Follow-up|4
7695255|NCT01186809|26762339|P1|Overall Study|Death|30
7695256|NCT01186796|26762345|P2|Overall Study|Protocol Violation|1
7695257|NCT01186796|26762346|P1|Overall Study|Protocol Violation|0
7695258|NCT01186796|26762345|P2|Overall Study|Withdrawal by Subject|1
7695259|NCT01186796|26762346|P1|Overall Study|Withdrawal by Subject|1
7695260|NCT01186796|26762345|P2|Overall Study|Adverse Event|0
7695261|NCT01186796|26762346|P1|Overall Study|Adverse Event|3
7695262|NCT01186770|26762364|P4|Overall Study|Other than specified|2
7695263|NCT01186770|26762365|P3|Overall Study|Other than specified|1
7695264|NCT01186770|26762366|P2|Overall Study|Other than specified|1
7695265|NCT01186770|26762367|P1|Overall Study|Other than specified|0
7695266|NCT01186770|26762364|P4|Overall Study|Insufficient response to treatment|7
7695267|NCT01186770|26762365|P3|Overall Study|Insufficient response to treatment|5
7695268|NCT01186770|26762366|P2|Overall Study|Insufficient response to treatment|8
7695269|NCT01186770|26762367|P1|Overall Study|Insufficient response to treatment|7
7695270|NCT01186770|26762364|P4|Overall Study|Lost to Follow-up|9
7695271|NCT01186770|26762365|P3|Overall Study|Lost to Follow-up|14
7695272|NCT01186770|26762366|P2|Overall Study|Lost to Follow-up|6
7695273|NCT01186770|26762367|P1|Overall Study|Lost to Follow-up|10
7695274|NCT01186770|26762364|P4|Overall Study|Withdrawal by Subject|17
7695275|NCT01186770|26762365|P3|Overall Study|Withdrawal by Subject|11
7695276|NCT01186770|26762366|P2|Overall Study|Withdrawal by Subject|13
7695277|NCT01186770|26762367|P1|Overall Study|Withdrawal by Subject|15
7695278|NCT01186770|26762364|P4|Overall Study|Adverse Event|9
7695279|NCT01186770|26762365|P3|Overall Study|Adverse Event|7
7695280|NCT01186770|26762366|P2|Overall Study|Adverse Event|9
7695281|NCT01186770|26762367|P1|Overall Study|Adverse Event|2
7695282|NCT01186770|26762364|P4|Overall Study|Protocol Violation|14
7695283|NCT01186770|26762365|P3|Overall Study|Protocol Violation|12
7695284|NCT01186770|26762366|P2|Overall Study|Protocol Violation|9
7695285|NCT01186770|26762367|P1|Overall Study|Protocol Violation|7
7695286|NCT01186770|26762364|P4|Overall Study|Ineligibility|0
7695287|NCT01186770|26762365|P3|Overall Study|Ineligibility|2
7695288|NCT01186770|26762366|P2|Overall Study|Ineligibility|0
7695289|NCT01186770|26762367|P1|Overall Study|Ineligibility|0
7695290|NCT01186744|26762391|P6|Overall Study|Death|0
7695291|NCT01186744|26762392|P5|Overall Study|Death|0
7695292|NCT01186744|26762393|P4|Overall Study|Death|0
7695293|NCT01186744|26762394|P3|Overall Study|Death|0
7695294|NCT01186744|26762395|P2|Overall Study|Death|0
7695295|NCT01186744|26762396|P1|Overall Study|Death|1
7695296|NCT01186744|26762391|P6|Overall Study|Adverse Event|4
7695297|NCT01186744|26762392|P5|Overall Study|Adverse Event|1
7695298|NCT01186744|26762393|P4|Overall Study|Adverse Event|0
7695299|NCT01186744|26762394|P3|Overall Study|Adverse Event|1
7695300|NCT01186744|26762395|P2|Overall Study|Adverse Event|14
7695301|NCT01186744|26762396|P1|Overall Study|Adverse Event|10
7695302|NCT01186744|26762391|P6|Overall Study|Other|5
7695303|NCT01186744|26762392|P5|Overall Study|Other|1
7695304|NCT01186744|26762393|P4|Overall Study|Other|2
7695305|NCT01186744|26762394|P3|Overall Study|Other|1
7695306|NCT01186744|26762395|P2|Overall Study|Other|10
7695307|NCT01186744|26762396|P1|Overall Study|Other|9
7695308|NCT01186744|26762391|P6|Overall Study|Study terminated by Sponsor|0
7695309|NCT01186744|26762392|P5|Overall Study|Study terminated by Sponsor|0
7695310|NCT01186744|26762393|P4|Overall Study|Study terminated by Sponsor|0
7695311|NCT01186744|26762394|P3|Overall Study|Study terminated by Sponsor|0
7695312|NCT01186744|26762395|P2|Overall Study|Study terminated by Sponsor|0
7695313|NCT01186744|26762396|P1|Overall Study|Study terminated by Sponsor|1
7695314|NCT01186744|26762391|P6|Overall Study|Withdrawal by Subject|6
7695315|NCT01186744|26762392|P5|Overall Study|Withdrawal by Subject|0
7695316|NCT01186744|26762393|P4|Overall Study|Withdrawal by Subject|5
7695317|NCT01186744|26762394|P3|Overall Study|Withdrawal by Subject|2
7695318|NCT01186744|26762395|P2|Overall Study|Withdrawal by Subject|10
7695319|NCT01186744|26762396|P1|Overall Study|Withdrawal by Subject|14
7695320|NCT01186744|26762391|P6|Overall Study|Screen failure|0
7695321|NCT01186744|26762392|P5|Overall Study|Screen failure|0
7695322|NCT01186744|26762393|P4|Overall Study|Screen failure|1
7695323|NCT01186744|26762394|P3|Overall Study|Screen failure|0
7695324|NCT01186744|26762395|P2|Overall Study|Screen failure|1
7695325|NCT01186744|26762396|P1|Overall Study|Screen failure|1
7695326|NCT01186744|26762391|P6|Overall Study|Lost to Follow-up|4
7695327|NCT01186744|26762392|P5|Overall Study|Lost to Follow-up|1
7695328|NCT01186744|26762393|P4|Overall Study|Lost to Follow-up|1
7695329|NCT01186744|26762394|P3|Overall Study|Lost to Follow-up|2
7695330|NCT01186744|26762395|P2|Overall Study|Lost to Follow-up|16
7695331|NCT01186744|26762396|P1|Overall Study|Lost to Follow-up|15
7695332|NCT01186744|26762391|P6|Overall Study|Protocol Violation|2
7695333|NCT01186744|26762392|P5|Overall Study|Protocol Violation|1
7695334|NCT01186744|26762393|P4|Overall Study|Protocol Violation|1
7695335|NCT01186744|26762394|P3|Overall Study|Protocol Violation|0
7695336|NCT01186744|26762395|P2|Overall Study|Protocol Violation|2
7695337|NCT01186744|26762396|P1|Overall Study|Protocol Violation|1
7695338|NCT01186744|26762391|P6|Overall Study|Lack of Efficacy|5
7695339|NCT01186744|26762392|P5|Overall Study|Lack of Efficacy|2
7695340|NCT01186744|26762393|P4|Overall Study|Lack of Efficacy|2
7695341|NCT01186744|26762394|P3|Overall Study|Lack of Efficacy|0
7695342|NCT01186744|26762395|P2|Overall Study|Lack of Efficacy|99
7695343|NCT01186744|26762396|P1|Overall Study|Lack of Efficacy|156
7695344|NCT01186692|26762816|P1|Overall Study|Adverse Event|2
7695345|NCT01186692|26762816|P1|Overall Study|Futher testing contraindicated implant|19
7695346|NCT01186692|26762816|P1|Overall Study|Not Catheterized|11
7695347|NCT01186458|26762843|P1|Overall Study|Adverse Event|1
7695348|NCT01186419|26762852|P2|Overall Study|Other|1
7695349|NCT01186419|26762853|P1|Overall Study|Other|1
7695350|NCT01186419|26762852|P2|Overall Study|Physician Decision|3
7695351|NCT01186419|26762853|P1|Overall Study|Physician Decision|0
7695352|NCT01186419|26762852|P2|Overall Study|Adverse Event|2
7695353|NCT01186419|26762853|P1|Overall Study|Adverse Event|1
7695354|NCT01186419|26762852|P2|Overall Study|Withdrawal by Subject|3
7695355|NCT01186419|26762853|P1|Overall Study|Withdrawal by Subject|5
7695356|NCT01186328|26762867|P3|Overall Study|Death|0
7695357|NCT01186328|26762868|P2|Overall Study|Death|0
7695358|NCT01186328|26762869|P1|Overall Study|Death|1
7695359|NCT01185964|26762899|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
7695360|NCT01185964|26762900|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7695361|NCT01185964|26762901|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7695362|NCT01185964|26762902|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7695446|NCT01185782|26762993|P2|Overall Study|Randomized but not treated|4
7695363|NCT01185964|26762899|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
7695364|NCT01185964|26762900|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7695365|NCT01185964|26762901|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7695366|NCT01185964|26762902|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7695367|NCT01185964|26762899|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
7695368|NCT01185964|26762900|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7695369|NCT01185964|26762901|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7695370|NCT01185964|26762902|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7695371|NCT01185964|26762899|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
7695372|NCT01185964|26762900|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
7695373|NCT01185964|26762901|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
7695374|NCT01185964|26762902|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
7695375|NCT01185964|26762899|P4|Phase 1b and Phase 2|Adverse Event|0
7695376|NCT01185964|26762900|P3|Phase 1b and Phase 2|Adverse Event|2
7695377|NCT01185964|26762901|P2|Phase 1b and Phase 2|Adverse Event|0
7695378|NCT01185964|26762902|P1|Phase 1b and Phase 2|Adverse Event|1
7695379|NCT01185964|26762899|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7695380|NCT01185964|26762900|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
7695381|NCT01185964|26762901|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7695382|NCT01185964|26762902|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7695383|NCT01185964|26762899|P4|Phase 1b and Phase 2|Other Therapy Started|0
7695384|NCT01185964|26762900|P3|Phase 1b and Phase 2|Other Therapy Started|3
7695385|NCT01185964|26762901|P2|Phase 1b and Phase 2|Other Therapy Started|3
7695386|NCT01185964|26762902|P1|Phase 1b and Phase 2|Other Therapy Started|0
7695387|NCT01185964|26762899|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
7695388|NCT01185964|26762900|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
7695389|NCT01185964|26762901|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
7695390|NCT01185964|26762902|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
7695391|NCT01185834|26762928|P1|Overall Study|Early exit - Site error|2
7695392|NCT01185834|26762928|P1|Overall Study|Time/Job Conflict|2
7695393|NCT01185834|26762928|P1|Overall Study|Biomicroscopy|4
7695394|NCT01185834|26762928|P1|Overall Study|Discomfort|4
7695395|NCT01185834|26762928|P1|Overall Study|Lost to Follow-up|2
7695396|NCT01185821|26762938|P5|Overall Study|Administrative problems|2
7695397|NCT01185821|26762939|P4|Overall Study|Administrative problems|1
7695398|NCT01185821|26762940|P3|Overall Study|Administrative problems|1
7695399|NCT01185821|26762941|P2|Overall Study|Administrative problems|0
7695400|NCT01185821|26762942|P1|Overall Study|Administrative problems|0
7695401|NCT01185821|26762938|P5|Overall Study|Lost to Follow-up|2
7695402|NCT01185821|26762939|P4|Overall Study|Lost to Follow-up|1
7695403|NCT01185821|26762940|P3|Overall Study|Lost to Follow-up|2
7695404|NCT01185821|26762941|P2|Overall Study|Lost to Follow-up|1
7695405|NCT01185821|26762942|P1|Overall Study|Lost to Follow-up|1
7695406|NCT01185821|26762938|P5|Overall Study|Withdrawal by Subject|3
7695407|NCT01185821|26762939|P4|Overall Study|Withdrawal by Subject|1
7695408|NCT01185821|26762940|P3|Overall Study|Withdrawal by Subject|2
7695409|NCT01185821|26762941|P2|Overall Study|Withdrawal by Subject|2
7695410|NCT01185821|26762942|P1|Overall Study|Withdrawal by Subject|3
7695411|NCT01185821|26762938|P5|Overall Study|Lack of Efficacy|9
7695412|NCT01185821|26762939|P4|Overall Study|Lack of Efficacy|0
7695413|NCT01185821|26762940|P3|Overall Study|Lack of Efficacy|3
7695414|NCT01185821|26762941|P2|Overall Study|Lack of Efficacy|0
7695415|NCT01185821|26762942|P1|Overall Study|Lack of Efficacy|0
7695416|NCT01185821|26762938|P5|Overall Study|Adverse Event|5
7695417|NCT01185821|26762939|P4|Overall Study|Adverse Event|2
7695418|NCT01185821|26762940|P3|Overall Study|Adverse Event|1
7695419|NCT01185821|26762941|P2|Overall Study|Adverse Event|3
7695420|NCT01185821|26762942|P1|Overall Study|Adverse Event|2
7695421|NCT01185821|26762938|P5|Overall Study|Condition no longer required study drug|1
7695422|NCT01185821|26762939|P4|Overall Study|Condition no longer required study drug|0
7695423|NCT01185821|26762940|P3|Overall Study|Condition no longer required study drug|0
7695424|NCT01185821|26762941|P2|Overall Study|Condition no longer required study drug|0
7695425|NCT01185821|26762942|P1|Overall Study|Condition no longer required study drug|0
7695426|NCT01185821|26762938|P5|Overall Study|Death|0
7695427|NCT01185821|26762939|P4|Overall Study|Death|0
7695428|NCT01185821|26762940|P3|Overall Study|Death|0
7695429|NCT01185821|26762941|P2|Overall Study|Death|1
7695430|NCT01185821|26762942|P1|Overall Study|Death|0
7695431|NCT01185821|26762938|P5|Overall Study|Abnormal test procedure result|1
7695432|NCT01185821|26762939|P4|Overall Study|Abnormal test procedure result|0
7695433|NCT01185821|26762940|P3|Overall Study|Abnormal test procedure result|0
7695434|NCT01185821|26762941|P2|Overall Study|Abnormal test procedure result|0
7695435|NCT01185821|26762942|P1|Overall Study|Abnormal test procedure result|0
7695436|NCT01185821|26762938|P5|Overall Study|Protocol Violation|1
7695437|NCT01185821|26762939|P4|Overall Study|Protocol Violation|1
7695438|NCT01185821|26762940|P3|Overall Study|Protocol Violation|0
7695439|NCT01185821|26762941|P2|Overall Study|Protocol Violation|0
7695440|NCT01185821|26762942|P1|Overall Study|Protocol Violation|0
7695441|NCT01185821|26762938|P5|Overall Study|Abnormal laboratory value(s)|0
7695442|NCT01185821|26762939|P4|Overall Study|Abnormal laboratory value(s)|0
7695443|NCT01185821|26762940|P3|Overall Study|Abnormal laboratory value(s)|1
7695444|NCT01185821|26762941|P2|Overall Study|Abnormal laboratory value(s)|2
7695445|NCT01185821|26762942|P1|Overall Study|Abnormal laboratory value(s)|1
7695447|NCT01185782|26762994|P1|Overall Study|Randomized but not treated|0
7695448|NCT01185782|26762993|P2|Overall Study|Other|5
7695449|NCT01185782|26762994|P1|Overall Study|Other|2
7695450|NCT01185782|26762993|P2|Overall Study|Poor Response to Treatment|1
7695451|NCT01185782|26762994|P1|Overall Study|Poor Response to Treatment|3
7695452|NCT01185782|26762993|P2|Overall Study|Protocol Violation|0
7695453|NCT01185782|26762994|P1|Overall Study|Protocol Violation|1
7695454|NCT01185782|26762993|P2|Overall Study|Adverse Event|1
7695455|NCT01185782|26762994|P1|Overall Study|Adverse Event|0
7695456|NCT01185704|26763022|P2|Overall Study|Ectopic pregnancy|1
7695457|NCT01185704|26763023|P1|Overall Study|Ectopic pregnancy|0
7695458|NCT01185704|26763022|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
7695459|NCT01185704|26763023|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
7695460|NCT01185704|26763022|P2|Overall Study|Lack of ovarian response|1
7695461|NCT01185704|26763023|P1|Overall Study|Lack of ovarian response|5
7695462|NCT01185704|26763022|P2|Overall Study|Randomized but not treated|3
7695463|NCT01185704|26763023|P1|Overall Study|Randomized but not treated|3
7695464|NCT01185639|26763057|P1|Overall Study|Progressed and didn't receive therapy|2
7695465|NCT01185600|26763067|P2|Overall Study|Hold by DSMB|2
7695466|NCT01185600|26763068|P1|Overall Study|Hold by DSMB|1
7695467|NCT01185600|26763067|P2|Overall Study|Withdrawal by Subject|1
7695468|NCT01185600|26763068|P1|Overall Study|Withdrawal by Subject|1
7695469|NCT01185600|26763067|P2|Overall Study|Physician Decision|35
7695470|NCT01185600|26763068|P1|Overall Study|Physician Decision|29
7695471|NCT01185600|26763067|P2|Overall Study|Lost to Follow-up|5
7695472|NCT01185600|26763068|P1|Overall Study|Lost to Follow-up|0
7695473|NCT01185600|26763067|P2|Overall Study|Death|1
7695474|NCT01185600|26763068|P1|Overall Study|Death|0
7695475|NCT01185600|26763067|P2|Overall Study|Adverse Event|1
7695476|NCT01185600|26763068|P1|Overall Study|Adverse Event|1
7695477|NCT01185561|26763090|P2|Overall Study|Withdrawal by Subject|8
7695478|NCT01185561|26763091|P1|Overall Study|Withdrawal by Subject|2
7695479|NCT01185561|26763090|P2|Overall Study|Lost to Follow-up|4
7695480|NCT01185561|26763091|P1|Overall Study|Lost to Follow-up|0
7695481|NCT01185548|26763103|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
7695482|NCT01185522|26763116|P1|Overall Study|Other reasons|12
7695483|NCT01185522|26763116|P1|Overall Study|Poor tolerance|39
7695484|NCT01185522|26763116|P1|Overall Study|Withdrawal by Subject|10
7695485|NCT01185522|26763116|P1|Overall Study|Lost to Follow-up|19
7695486|NCT01185522|26763116|P1|Overall Study|Lack of Efficacy|28
7695487|NCT01185509|26763142|P2|Overall Study|Intercurrent Illness|1
7695488|NCT01185509|26763143|P1|Overall Study|Intercurrent Illness|0
7695489|NCT01185509|26763142|P2|Overall Study|Death|1
7695490|NCT01185509|26763143|P1|Overall Study|Death|0
7695491|NCT01185509|26763142|P2|Overall Study|Withdrawal by Subject|1
7695492|NCT01185509|26763143|P1|Overall Study|Withdrawal by Subject|0
7695493|NCT01185509|26763142|P2|Overall Study|Physician Decision|2
7695494|NCT01185509|26763143|P1|Overall Study|Physician Decision|2
7695495|NCT01185509|26763142|P2|Overall Study|Progression/Relapse|15
7695496|NCT01185509|26763143|P1|Overall Study|Progression/Relapse|9
7695497|NCT01185366|26763156|P2|Crossover to Second Line Therapy|Continued with 1st drug|3
7695498|NCT01185366|26763157|P1|Crossover to Second Line Therapy|Continued with 1st drug|5
7695499|NCT01185366|26763156|P2|Crossover to Second Line Therapy|Withdrawal by Subject|0
7695500|NCT01185366|26763157|P1|Crossover to Second Line Therapy|Withdrawal by Subject|1
7695501|NCT01185366|26763156|P2|Crossover to Second Line Therapy|Physician Decision|1
7695502|NCT01185366|26763157|P1|Crossover to Second Line Therapy|Physician Decision|5
7695503|NCT01185366|26763156|P2|Crossover to Second Line Therapy|Adverse Event|6
7695504|NCT01185366|26763157|P1|Crossover to Second Line Therapy|Adverse Event|3
7695505|NCT01185366|26763156|P2|First Line Therapy|Lack of Metastatic Site|0
7695506|NCT01185366|26763157|P1|First Line Therapy|Lack of Metastatic Site|1
7695507|NCT01185366|26763156|P2|First Line Therapy|Withdrawal by Subject|0
7695508|NCT01185366|26763157|P1|First Line Therapy|Withdrawal by Subject|1
7695509|NCT01185366|26763156|P2|First Line Therapy|Insurance Coverage Denied|1
7695510|NCT01185366|26763157|P1|First Line Therapy|Insurance Coverage Denied|1
7695511|NCT01185353|26763176|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
7695512|NCT01185353|26763177|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
7695513|NCT01185353|26763178|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
7695514|NCT01185353|26763179|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
7695515|NCT01185353|26763180|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
7695516|NCT01185353|26763181|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
7695517|NCT01185353|26763182|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
7695518|NCT01185353|26763183|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
7695519|NCT01185353|26763184|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
7695520|NCT01185353|26763185|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
7695521|NCT01185353|26763176|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
7695522|NCT01185353|26763177|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
7695523|NCT01185353|26763178|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
7695524|NCT01185353|26763179|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695525|NCT01185353|26763180|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695526|NCT01185353|26763181|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695527|NCT01185353|26763182|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695528|NCT01185353|26763183|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695529|NCT01185353|26763184|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695530|NCT01185353|26763185|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7695531|NCT01185353|26763176|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695532|NCT01185353|26763177|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
7695533|NCT01185353|26763178|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
7695534|NCT01185353|26763179|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695535|NCT01185353|26763180|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695536|NCT01185353|26763181|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695537|NCT01185353|26763182|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695538|NCT01185353|26763183|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695539|NCT01185353|26763184|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695540|NCT01185353|26763185|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7695541|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Reason missing|0
7695542|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Reason missing|1
7695543|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Reason missing|0
7695544|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Reason missing|0
7695545|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Reason missing|0
7695546|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Reason missing|0
7695547|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Reason missing|0
7695548|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Reason missing|0
7695549|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Reason missing|0
7695550|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Reason missing|0
7695551|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
7695552|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
7695553|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
7695554|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
7695555|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
7695556|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
7695557|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
7695558|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
7695559|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
7695560|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
7695561|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
7695562|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695563|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695564|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695565|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695566|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695567|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695568|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695569|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695570|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7695571|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Death|1
7695572|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Death|0
7695573|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Death|0
7695574|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Death|0
7695575|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Death|0
7695576|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Death|0
7695577|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Death|0
7695578|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Death|0
7695579|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Death|0
7695580|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Death|0
7695581|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695582|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
7695583|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695584|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695585|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695586|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695587|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695588|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695589|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695590|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7695591|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
7695592|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
7695593|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
7695594|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695595|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695596|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695597|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695598|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695599|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695600|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7695601|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
7695602|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
7695603|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
7695604|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695605|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695606|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695607|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695608|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695609|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695610|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7695611|NCT01185353|26763176|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
7695612|NCT01185353|26763177|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
7695613|NCT01185353|26763178|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
7695614|NCT01185353|26763179|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
7695615|NCT01185353|26763180|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
7695616|NCT01185353|26763181|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
7695617|NCT01185353|26763182|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
7695618|NCT01185353|26763183|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
7695619|NCT01185353|26763184|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
7695620|NCT01185353|26763185|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
7695621|NCT01185353|26763176|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695622|NCT01185353|26763177|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695623|NCT01185353|26763178|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695624|NCT01185353|26763179|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
7695625|NCT01185353|26763180|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695626|NCT01185353|26763181|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695627|NCT01185353|26763182|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695628|NCT01185353|26763183|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695629|NCT01185353|26763184|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695630|NCT01185353|26763185|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7695631|NCT01185353|26763176|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7695632|NCT01185353|26763177|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7695633|NCT01185353|26763178|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7695634|NCT01185353|26763179|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
7695635|NCT01185353|26763180|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
7695636|NCT01185353|26763181|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7695637|NCT01185353|26763182|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
7695638|NCT01185353|26763183|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
7695639|NCT01185353|26763184|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7695640|NCT01185353|26763185|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7695641|NCT01185353|26763176|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695642|NCT01185353|26763177|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695643|NCT01185353|26763178|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695644|NCT01185353|26763179|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
7695645|NCT01185353|26763180|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695646|NCT01185353|26763181|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695647|NCT01185353|26763182|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
7695648|NCT01185353|26763183|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695649|NCT01185353|26763184|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695650|NCT01185353|26763185|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7695651|NCT01185353|26763176|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695652|NCT01185353|26763177|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695653|NCT01185353|26763178|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695654|NCT01185353|26763179|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695655|NCT01185353|26763180|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695656|NCT01185353|26763181|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695657|NCT01185353|26763182|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
7695658|NCT01185353|26763183|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695659|NCT01185353|26763184|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
7695660|NCT01185353|26763185|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7695661|NCT01185353|26763176|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
7695662|NCT01185353|26763177|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
7695663|NCT01185353|26763178|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
7695664|NCT01185353|26763179|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
7695665|NCT01185353|26763180|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
7695666|NCT01185353|26763181|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
7695667|NCT01185353|26763182|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
7695668|NCT01185353|26763183|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
7695669|NCT01185353|26763184|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
7695670|NCT01185353|26763185|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
7695671|NCT01185353|26763176|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695672|NCT01185353|26763177|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695673|NCT01185353|26763178|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695674|NCT01185353|26763179|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695675|NCT01185353|26763180|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695676|NCT01185353|26763181|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
7695677|NCT01185353|26763182|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695678|NCT01185353|26763183|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695679|NCT01185353|26763184|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7695680|NCT01185353|26763185|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
7695681|NCT01185353|26763176|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695682|NCT01185353|26763177|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695683|NCT01185353|26763178|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695684|NCT01185353|26763179|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695685|NCT01185353|26763180|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695686|NCT01185353|26763181|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
7695687|NCT01185353|26763182|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695688|NCT01185353|26763183|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695689|NCT01185353|26763184|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695690|NCT01185353|26763185|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
7695691|NCT01185353|26763176|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
7695692|NCT01185353|26763177|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
7695693|NCT01185353|26763178|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
7695694|NCT01185353|26763179|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
7695695|NCT01185353|26763180|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
7695696|NCT01185353|26763181|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
7695697|NCT01185353|26763182|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
7695698|NCT01185353|26763183|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
7695699|NCT01185353|26763184|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
7695700|NCT01185353|26763185|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
7695701|NCT01185353|26763176|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695702|NCT01185353|26763177|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695703|NCT01185353|26763178|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695704|NCT01185353|26763179|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695705|NCT01185353|26763180|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695706|NCT01185353|26763181|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
7695707|NCT01185353|26763182|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695708|NCT01185353|26763183|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695709|NCT01185353|26763184|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7695710|NCT01185353|26763185|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
7695711|NCT01185353|26763176|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695712|NCT01185353|26763177|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695713|NCT01185353|26763178|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695714|NCT01185353|26763179|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695715|NCT01185353|26763180|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695716|NCT01185353|26763181|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
7695717|NCT01185353|26763182|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695718|NCT01185353|26763183|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695719|NCT01185353|26763184|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695720|NCT01185353|26763185|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7695721|NCT01185353|26763176|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
7695722|NCT01185353|26763177|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
7695723|NCT01185353|26763178|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
7695724|NCT01185353|26763179|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
7695725|NCT01185353|26763180|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
7695726|NCT01185353|26763181|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
7695727|NCT01185353|26763182|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
7695728|NCT01185353|26763183|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
7695729|NCT01185353|26763184|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
7695730|NCT01185353|26763185|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
7695731|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
7695732|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
7695733|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7695734|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7695735|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
7695736|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
7695737|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
7695738|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7695739|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7695740|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
7695741|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7695742|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7695743|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7695744|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7695745|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7695746|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7695747|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
7695748|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
7695749|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
7695750|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7695751|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
7695752|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
7695753|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
7695754|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7695755|NCT01185340|26763346|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7695756|NCT01185340|26763347|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
7695757|NCT01185340|26763348|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7695758|NCT01185340|26763349|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7695759|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695760|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695761|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7695762|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
7695763|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695764|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695765|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7695766|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
7695767|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695768|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695769|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7695770|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
7695771|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695772|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695773|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7695774|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
7695775|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695776|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695777|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7695778|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
7695779|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695780|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695781|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7695782|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
7695783|NCT01185340|26763346|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695784|NCT01185340|26763347|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695785|NCT01185340|26763348|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7695786|NCT01185340|26763349|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
7695787|NCT01185301|26763401|P4|Overall Study|Other Reason|2
7695788|NCT01185301|26763402|P3|Overall Study|Other Reason|2
7695789|NCT01185301|26763403|P2|Overall Study|Other Reason|2
7695790|NCT01185301|26763404|P1|Overall Study|Other Reason|3
7695791|NCT01185301|26763401|P4|Overall Study|Lost to Follow-up|1
7695792|NCT01185301|26763402|P3|Overall Study|Lost to Follow-up|0
7695793|NCT01185301|26763403|P2|Overall Study|Lost to Follow-up|0
7695794|NCT01185301|26763404|P1|Overall Study|Lost to Follow-up|2
7695795|NCT01185301|26763401|P4|Overall Study|Withdrawal by Subject|3
7695796|NCT01185301|26763402|P3|Overall Study|Withdrawal by Subject|2
7695797|NCT01185301|26763403|P2|Overall Study|Withdrawal by Subject|5
7695798|NCT01185301|26763404|P1|Overall Study|Withdrawal by Subject|7
7695799|NCT01185301|26763401|P4|Overall Study|Adverse Event|3
7695800|NCT01185301|26763402|P3|Overall Study|Adverse Event|2
7695801|NCT01185301|26763403|P2|Overall Study|Adverse Event|0
7695802|NCT01185301|26763404|P1|Overall Study|Adverse Event|3
7695803|NCT01185288|26763464|P2|Overall Study|Noncompliance|1
7695804|NCT01185288|26763465|P1|Overall Study|Noncompliance|0
7695805|NCT01185288|26763464|P2|Overall Study|Did not meet inclusion criteria|0
7695806|NCT01185288|26763465|P1|Overall Study|Did not meet inclusion criteria|1
7695807|NCT01185288|26763464|P2|Overall Study|Investigator discretion|0
7695808|NCT01185288|26763465|P1|Overall Study|Investigator discretion|1
7695809|NCT01185288|26763464|P2|Overall Study|Lack of Efficacy|0
7695810|NCT01185288|26763465|P1|Overall Study|Lack of Efficacy|2
7695811|NCT01185288|26763464|P2|Overall Study|Lost to Follow-up|5
7695812|NCT01185288|26763465|P1|Overall Study|Lost to Follow-up|2
7695813|NCT01185288|26763464|P2|Overall Study|Withdrawal by Subject|4
7695814|NCT01185288|26763465|P1|Overall Study|Withdrawal by Subject|6
7695815|NCT01185288|26763464|P2|Overall Study|Adverse Event|6
7695816|NCT01185288|26763465|P1|Overall Study|Adverse Event|7
7695817|NCT01185249|26763483|P1|Overall Study|Patients discharged or change in status|42
7695818|NCT01185171|26763488|P1|Maintenance|Disease Recurrence|1
7695819|NCT01185171|26763488|P1|Maintenance|Withdrawal by Subject|1
7695820|NCT01185171|26763488|P1|Maintenance|Comorbid Illness|2
7695821|NCT01185171|26763488|P1|Maintenance|Nausea|1
7695822|NCT01185171|26763488|P1|Maintenance|Xerostomia|1
7695823|NCT01185171|26763488|P1|Maintenance|Diarrhea|1
7695824|NCT01185171|26763488|P1|Maintenance|Rush|2
7695825|NCT01185171|26763488|P1|Maintenance|Elevated liver transaminases|3
7695826|NCT01185171|26763488|P1|Concurrent Chemo and Radiation Treatment|Death|3
7695827|NCT01185171|26763488|P1|Induction Chemotherapy|Duodenal Ulcer|1
7695828|NCT01185171|26763488|P1|Induction Chemotherapy|Withdrawal by Subject|1
7695829|NCT01185080|26763498|P3|Overall Study|Personal reasons|1
7695830|NCT01185080|26763499|P2|Overall Study|Personal reasons|0
7695831|NCT01185080|26763500|P1|Overall Study|Personal reasons|0
7695832|NCT01185080|26763498|P3|Overall Study|Adverse Event|0
7695833|NCT01185080|26763499|P2|Overall Study|Adverse Event|1
7695834|NCT01185080|26763500|P1|Overall Study|Adverse Event|1
7695835|NCT01184989|26763553|P1|Overall Study|Withdrawal by Subject|1
7695836|NCT01184989|26763553|P1|Overall Study|Adverse Event|11
7695837|NCT01184872|26763573|P2|Overall Study|Protocol deviation|0
7695838|NCT01184872|26763574|P1|Overall Study|Protocol deviation|1
7695839|NCT01184872|26763573|P2|Overall Study|Administrative problems|1
7695840|NCT01184872|26763574|P1|Overall Study|Administrative problems|1
7695841|NCT01184872|26763573|P2|Overall Study|Lost to Follow-up|1
7695842|NCT01184872|26763574|P1|Overall Study|Lost to Follow-up|0
7695843|NCT01184872|26763573|P2|Overall Study|Withdrawal by Subject|0
7695844|NCT01184872|26763574|P1|Overall Study|Withdrawal by Subject|2
7695845|NCT01184872|26763573|P2|Overall Study|Unsatisfactory therapeutic effect|2
7695846|NCT01184872|26763574|P1|Overall Study|Unsatisfactory therapeutic effect|3
7695847|NCT01184872|26763573|P2|Overall Study|Adverse Event|4
7695848|NCT01184872|26763574|P1|Overall Study|Adverse Event|3
7695849|NCT01184859|26763593|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
7695850|NCT01184859|26763594|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
7695851|NCT01184859|26763595|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
7695852|NCT01184859|26763596|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
7695853|NCT01184859|26763597|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
7695854|NCT01184859|26763593|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
7695855|NCT01184859|26763594|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7695856|NCT01184859|26763595|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7695857|NCT01184859|26763596|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7695858|NCT01184859|26763597|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7695859|NCT01184859|26763593|P5|Period 1: Single Dose|Adverse Event|1
7695860|NCT01184859|26763594|P4|Period 1: Single Dose|Adverse Event|0
7695861|NCT01184859|26763595|P3|Period 1: Single Dose|Adverse Event|0
7695862|NCT01184859|26763596|P2|Period 1: Single Dose|Adverse Event|0
7695863|NCT01184859|26763597|P1|Period 1: Single Dose|Adverse Event|0
7695864|NCT01184859|26763593|P5|Period 1: Single Dose|Protocol Violation|0
7695865|NCT01184859|26763594|P4|Period 1: Single Dose|Protocol Violation|0
7695866|NCT01184859|26763595|P3|Period 1: Single Dose|Protocol Violation|0
7695867|NCT01184859|26763596|P2|Period 1: Single Dose|Protocol Violation|1
7695868|NCT01184859|26763597|P1|Period 1: Single Dose|Protocol Violation|0
7695869|NCT01184859|26763593|P5|Period 1: Single Dose|Insufficient urine production|0
7695870|NCT01184859|26763594|P4|Period 1: Single Dose|Insufficient urine production|0
7695871|NCT01184859|26763595|P3|Period 1: Single Dose|Insufficient urine production|0
7695872|NCT01184859|26763596|P2|Period 1: Single Dose|Insufficient urine production|1
7695873|NCT01184859|26763597|P1|Period 1: Single Dose|Insufficient urine production|0
7695874|NCT01184846|26763689|P1|Overall Study|Insufficient response|1
7695875|NCT01184846|26763689|P1|Overall Study|Adverse Event|2
7695876|NCT01184508|26763722|P2|Overall Study|Randomized, Not Treated|1
7695877|NCT01184508|26763723|P1|Overall Study|Randomized, Not Treated|0
7695878|NCT01184508|26763722|P2|Overall Study|Withdrawal by Subject|3
7695879|NCT01184508|26763723|P1|Overall Study|Withdrawal by Subject|1
7695880|NCT01184508|26763722|P2|Overall Study|Sponsor Decision|2
7695881|NCT01184508|26763723|P1|Overall Study|Sponsor Decision|5
7695882|NCT01184508|26763722|P2|Overall Study|Protocol Violation|1
7695883|NCT01184508|26763723|P1|Overall Study|Protocol Violation|3
7695884|NCT01184508|26763722|P2|Overall Study|Physician Decision|0
7695885|NCT01184508|26763723|P1|Overall Study|Physician Decision|1
7695886|NCT01184508|26763722|P2|Overall Study|Lost to Follow-up|1
7695887|NCT01184508|26763723|P1|Overall Study|Lost to Follow-up|1
7695888|NCT01184508|26763722|P2|Overall Study|Lack of Efficacy|1
7695889|NCT01184508|26763723|P1|Overall Study|Lack of Efficacy|1
7695890|NCT01184508|26763722|P2|Overall Study|Adverse Event|6
7695891|NCT01184508|26763723|P1|Overall Study|Adverse Event|4
7695892|NCT01184326|26763783|P3|Overall Study|Disease Progression|12
7695893|NCT01184326|26763784|P2|Overall Study|Disease Progression|3
7695894|NCT01184326|26763785|P1|Overall Study|Disease Progression|1
7695895|NCT01184326|26763783|P3|Overall Study|Physician Decision|0
7695896|NCT01184326|26763784|P2|Overall Study|Physician Decision|1
7695897|NCT01184326|26763785|P1|Overall Study|Physician Decision|1
7695898|NCT01184326|26763783|P3|Overall Study|Withdrawal by Subject|1
7695899|NCT01184326|26763784|P2|Overall Study|Withdrawal by Subject|0
7695900|NCT01184326|26763785|P1|Overall Study|Withdrawal by Subject|0
7695901|NCT01184326|26763783|P3|Overall Study|Death|1
7695902|NCT01184326|26763784|P2|Overall Study|Death|0
7695903|NCT01184326|26763785|P1|Overall Study|Death|0
7695904|NCT01184326|26763783|P3|Overall Study|Adverse Event|0
7695905|NCT01184326|26763784|P2|Overall Study|Adverse Event|2
7695906|NCT01184326|26763785|P1|Overall Study|Adverse Event|1
7695907|NCT01184118|26763799|P1|Overall Study|Withdrawal by Subject|5
7695908|NCT01184118|26763799|P1|Overall Study|Exclusionary medical condition|2
7695909|NCT01184118|26763799|P1|Overall Study|FEV1 <60% predicted|2
7695910|NCT01184118|26763799|P1|Overall Study|No physiologic confirmation of asthma|8
7695911|NCT01184118|26763799|P1|Overall Study|Only asthma step 1 - screen fail|1
7695912|NCT01184079|26763807|P2|Overall Study|Lost to Follow-up|2
7695913|NCT01184079|26763808|P1|Overall Study|Lost to Follow-up|14
7695914|NCT01184053|26763818|P1|Overall Study|progression while on treatment|3
7695915|NCT01183975|26763834|P1|Overall Study|Lost to Follow-up|73
7695916|NCT01183884|26763851|P1|Overall Study|Other|4
7695917|NCT01183884|26763851|P1|Overall Study|Not Treated|1
7695918|NCT01183884|26763851|P1|Overall Study|Other Complicating Disease|3
7695919|NCT01183884|26763851|P1|Overall Study|Withdrawal by Subject|1
7695920|NCT01183884|26763851|P1|Overall Study|Adverse Event|3
7695921|NCT01183884|26763851|P1|Overall Study|Progressive Disease|26
7695922|NCT01183858|26763859|P2|Overall Study|Lost to Follow-up|1
7695923|NCT01183858|26763860|P1|Overall Study|Lost to Follow-up|1
7695924|NCT01183858|26763859|P2|Overall Study|Death related to Progressive Disease|5
7695925|NCT01183858|26763860|P1|Overall Study|Death related to Progressive Disease|4
7695926|NCT01183858|26763859|P2|Overall Study|Progressive Disease|115
7695927|NCT01183858|26763860|P1|Overall Study|Progressive Disease|112
7695928|NCT01183858|26763859|P2|Overall Study|Administrative/Other|6
7695929|NCT01183858|26763860|P1|Overall Study|Administrative/Other|6
7695930|NCT01183858|26763859|P2|Overall Study|Protocol Violation|0
7695931|NCT01183858|26763860|P1|Overall Study|Protocol Violation|1
7695932|NCT01183858|26763859|P2|Overall Study|Discontinued Smoking|1
7695933|NCT01183858|26763860|P1|Overall Study|Discontinued Smoking|3
7695934|NCT01183858|26763859|P2|Overall Study|Withdrew Consent|4
7695935|NCT01183858|26763860|P1|Overall Study|Withdrew Consent|4
7695936|NCT01183858|26763859|P2|Overall Study|Refused Treatment|4
7695937|NCT01183858|26763860|P1|Overall Study|Refused Treatment|1
7695938|NCT01183858|26763859|P2|Overall Study|Insufficient Therapeutic Response|0
7695939|NCT01183858|26763860|P1|Overall Study|Insufficient Therapeutic Response|2
7695940|NCT01183858|26763859|P2|Overall Study|Investigator's Decision|3
7695941|NCT01183858|26763860|P1|Overall Study|Investigator's Decision|0
7695942|NCT01183858|26763859|P2|Overall Study|Adverse Event|11
7695943|NCT01183858|26763860|P1|Overall Study|Adverse Event|14
7695944|NCT01183858|26763859|P2|Overall Study|Death not related to Progressive Disease|6
7695945|NCT01183858|26763860|P1|Overall Study|Death not related to Progressive Disease|5
7695946|NCT01183780|26763882|P2|Overall Study|Lost to Follow-up|11
7695947|NCT01183780|26763883|P1|Overall Study|Lost to Follow-up|6
7695948|NCT01183780|26763882|P2|Overall Study|Withdrawal by Subject|14
7695949|NCT01183780|26763883|P1|Overall Study|Withdrawal by Subject|25
7695950|NCT01183468|26764021|P4|Overall Study|Withdrawal by Subject|0
7695951|NCT01183468|26764022|P3|Overall Study|Withdrawal by Subject|0
7695952|NCT01183468|26764023|P2|Overall Study|Withdrawal by Subject|1
7695953|NCT01183468|26764024|P1|Overall Study|Withdrawal by Subject|0
7695954|NCT01183468|26764021|P4|Overall Study|Physician Decision|0
7695955|NCT01183468|26764022|P3|Overall Study|Physician Decision|0
7695956|NCT01183468|26764023|P2|Overall Study|Physician Decision|0
7695957|NCT01183468|26764024|P1|Overall Study|Physician Decision|1
7695958|NCT01183468|26764021|P4|Overall Study|Lost to Follow-up|0
7695959|NCT01183468|26764022|P3|Overall Study|Lost to Follow-up|0
7695960|NCT01183468|26764023|P2|Overall Study|Lost to Follow-up|1
7695961|NCT01183468|26764024|P1|Overall Study|Lost to Follow-up|2
7695962|NCT01183390|26764046|P2|First Intervention|Adverse Event|1
7695963|NCT01183390|26764047|P1|First Intervention|Adverse Event|0
7695964|NCT01183260|26764080|P2|Overall Study|Death|0
7695965|NCT01183260|26764081|P1|Overall Study|Death|1
7695966|NCT01183260|26764080|P2|Overall Study|Revised within 30 days|1
7695967|NCT01183260|26764081|P1|Overall Study|Revised within 30 days|0
7695968|NCT01183260|26764080|P2|Overall Study|Withdrawal by Subject|1
7695969|NCT01183260|26764081|P1|Overall Study|Withdrawal by Subject|1
7695970|NCT01183260|26764080|P2|Overall Study|Intraop screen failure|0
7695971|NCT01183260|26764081|P1|Overall Study|Intraop screen failure|2
7695972|NCT01183234|26764091|P2|First Intervention|Adverse Event|0
7695973|NCT01183234|26764092|P1|First Intervention|Adverse Event|1
7695974|NCT01183221|26764104|P2|3 Weeks Wash Out|Lost to Follow-up|1
7695975|NCT01183221|26764105|P1|3 Weeks Wash Out|Lost to Follow-up|1
7695976|NCT01183143|26764195|P1|Overall Study|Subjects enrolled, but not treated|11
7695977|NCT01183143|26764195|P1|Overall Study|Subject Questionnaires not returned|5
7695978|NCT01183143|26764195|P1|Overall Study|Withdrawal by Subject|19
7695979|NCT01183143|26764195|P1|Overall Study|Protocol Violation|115
7695980|NCT01183104|26764211|P2|Overall Study|Did not receive study drug|9
7695981|NCT01183104|26764212|P1|Overall Study|Did not receive study drug|5
7695982|NCT01183104|26764211|P2|Overall Study|Nonparticipation in Extension Study|50
7695983|NCT01183104|26764212|P1|Overall Study|Nonparticipation in Extension Study|39
7695984|NCT01183104|26764211|P2|Overall Study|Withdrawal by Subject|11
7695985|NCT01183104|26764212|P1|Overall Study|Withdrawal by Subject|6
7695986|NCT01183104|26764211|P2|Overall Study|Physician Decision|8
7695987|NCT01183104|26764212|P1|Overall Study|Physician Decision|5
7695988|NCT01183104|26764211|P2|Overall Study|Lost to Follow-up|7
7695989|NCT01183104|26764212|P1|Overall Study|Lost to Follow-up|14
7695990|NCT01183104|26764211|P2|Overall Study|Death|1
7695991|NCT01183104|26764212|P1|Overall Study|Death|0
7695992|NCT01183104|26764211|P2|Overall Study|Adverse Event|6
7695993|NCT01183104|26764212|P1|Overall Study|Adverse Event|8
7695994|NCT01183065|26764228|P1|Overall Study|Patient no longer fits eligibility crite|1
7695995|NCT01183013|26764239|P7|Overall Study|Reasons other than stated above|13
7695996|NCT01183013|26764240|P6|Overall Study|Reasons other than stated above|15
7695997|NCT01183013|26764241|P5|Overall Study|Reasons other than stated above|12
7695998|NCT01183013|26764242|P4|Overall Study|Reasons other than stated above|12
7695999|NCT01183013|26764243|P3|Overall Study|Reasons other than stated above|17
7696000|NCT01183013|26764244|P2|Overall Study|Reasons other than stated above|11
7696001|NCT01183013|26764245|P1|Overall Study|Reasons other than stated above|15
7696002|NCT01183013|26764239|P7|Overall Study|Withdrawal by Subject|10
7696003|NCT01183013|26764240|P6|Overall Study|Withdrawal by Subject|9
7696004|NCT01183013|26764241|P5|Overall Study|Withdrawal by Subject|7
7696005|NCT01183013|26764242|P4|Overall Study|Withdrawal by Subject|8
7696006|NCT01183013|26764243|P3|Overall Study|Withdrawal by Subject|10
7696007|NCT01183013|26764244|P2|Overall Study|Withdrawal by Subject|13
7696008|NCT01183013|26764245|P1|Overall Study|Withdrawal by Subject|9
7696009|NCT01183013|26764239|P7|Overall Study|Lost to Follow-up|5
7696010|NCT01183013|26764240|P6|Overall Study|Lost to Follow-up|6
7696011|NCT01183013|26764241|P5|Overall Study|Lost to Follow-up|2
7696012|NCT01183013|26764242|P4|Overall Study|Lost to Follow-up|3
7696013|NCT01183013|26764243|P3|Overall Study|Lost to Follow-up|4
7696014|NCT01183013|26764244|P2|Overall Study|Lost to Follow-up|3
7696015|NCT01183013|26764245|P1|Overall Study|Lost to Follow-up|7
7696016|NCT01183013|26764239|P7|Overall Study|Protocol Violation|3
7696017|NCT01183013|26764240|P6|Overall Study|Protocol Violation|3
7696018|NCT01183013|26764241|P5|Overall Study|Protocol Violation|4
7696019|NCT01183013|26764242|P4|Overall Study|Protocol Violation|0
7696020|NCT01183013|26764243|P3|Overall Study|Protocol Violation|4
7696021|NCT01183013|26764244|P2|Overall Study|Protocol Violation|2
7696022|NCT01183013|26764245|P1|Overall Study|Protocol Violation|5
7696023|NCT01183013|26764239|P7|Overall Study|Lack of Efficacy|0
7696024|NCT01183013|26764240|P6|Overall Study|Lack of Efficacy|2
7696025|NCT01183013|26764241|P5|Overall Study|Lack of Efficacy|1
7696026|NCT01183013|26764242|P4|Overall Study|Lack of Efficacy|2
7696027|NCT01183013|26764243|P3|Overall Study|Lack of Efficacy|1
7696028|NCT01183013|26764244|P2|Overall Study|Lack of Efficacy|2
7696029|NCT01183013|26764245|P1|Overall Study|Lack of Efficacy|3
7696030|NCT01183013|26764239|P7|Overall Study|Adverse Event|6
7696031|NCT01183013|26764240|P6|Overall Study|Adverse Event|10
7696032|NCT01183013|26764241|P5|Overall Study|Adverse Event|10
7696033|NCT01183013|26764242|P4|Overall Study|Adverse Event|5
7696034|NCT01183013|26764243|P3|Overall Study|Adverse Event|5
7696035|NCT01183013|26764244|P2|Overall Study|Adverse Event|8
7696036|NCT01183013|26764245|P1|Overall Study|Adverse Event|6
7696037|NCT01182844|26764326|P2|Overall Study|Withdrawal by Subject|2
7696038|NCT01182844|26764327|P1|Overall Study|Withdrawal by Subject|0
7696039|NCT01182441|26764412|P2|Overall Study|Physician Decision|1
7696040|NCT01182441|26764413|P1|Overall Study|Physician Decision|1
7696041|NCT01182441|26764412|P2|Overall Study|Adverse Event|0
7696042|NCT01182441|26764413|P1|Overall Study|Adverse Event|2
7696043|NCT01182441|26764412|P2|Overall Study|Implant Not Attempted|0
7696044|NCT01182441|26764413|P1|Overall Study|Implant Not Attempted|4
7696045|NCT01182441|26764412|P2|Overall Study|Withdrawal by Subject|13
7696046|NCT01182441|26764413|P1|Overall Study|Withdrawal by Subject|6
7696047|NCT01182441|26764412|P2|Overall Study|Lost to Follow-up|8
7696048|NCT01182441|26764413|P1|Overall Study|Lost to Follow-up|5
7696049|NCT01182441|26764412|P2|Overall Study|Implant Attempt Unsuccessful|0
7696050|NCT01182441|26764413|P1|Overall Study|Implant Attempt Unsuccessful|13
7696051|NCT01182441|26764412|P2|Overall Study|Death|25
7696052|NCT01182441|26764413|P1|Overall Study|Death|37
7696053|NCT01182441|26764412|P2|Overall Study|Patient Still in Follow-up|72
7696054|NCT01182441|26764413|P1|Overall Study|Patient Still in Follow-up|152
7696055|NCT01182428|26764424|P2|Overall Study|Withdrawal by Subject|0
7696056|NCT01182428|26764425|P1|Overall Study|Withdrawal by Subject|1
7696057|NCT01182428|26764424|P2|Overall Study|Lost to Follow-up|1
7696058|NCT01182428|26764425|P1|Overall Study|Lost to Follow-up|9
7696059|NCT01182428|26764424|P2|Overall Study|Physician Decision|0
7696060|NCT01182428|26764425|P1|Overall Study|Physician Decision|1
7696061|NCT01182415|26764489|P1|Overall Study|Lost to Follow-up|1
7696062|NCT01182350|26764505|P5|Overall Study|Unevaluable for Biopsy|3
7696063|NCT01182350|26764506|P4|Overall Study|Unevaluable for Biopsy|0
7696064|NCT01182350|26764507|P3|Overall Study|Unevaluable for Biopsy|0
7696065|NCT01182350|26764508|P2|Overall Study|Unevaluable for Biopsy|0
7696066|NCT01182350|26764509|P1|Overall Study|Unevaluable for Biopsy|0
7696067|NCT01182350|26764505|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
7696068|NCT01182350|26764506|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
7696069|NCT01182350|26764507|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
7696070|NCT01182350|26764508|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
7696071|NCT01182350|26764509|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
7696072|NCT01182350|26764505|P5|Overall Study|Alternative Therapy|0
7696073|NCT01182350|26764506|P4|Overall Study|Alternative Therapy|0
7696074|NCT01182350|26764507|P3|Overall Study|Alternative Therapy|1
7696075|NCT01182350|26764508|P2|Overall Study|Alternative Therapy|0
7696076|NCT01182350|26764509|P1|Overall Study|Alternative Therapy|2
7696077|NCT01182350|26764505|P5|Overall Study|Withdrawal by Subject|0
7696078|NCT01182350|26764506|P4|Overall Study|Withdrawal by Subject|1
7696079|NCT01182350|26764507|P3|Overall Study|Withdrawal by Subject|0
7696080|NCT01182350|26764508|P2|Overall Study|Withdrawal by Subject|1
7696081|NCT01182350|26764509|P1|Overall Study|Withdrawal by Subject|3
7696082|NCT01182350|26764505|P5|Overall Study|Death|0
7696083|NCT01182350|26764506|P4|Overall Study|Death|0
7696084|NCT01182350|26764507|P3|Overall Study|Death|1
7696085|NCT01182350|26764508|P2|Overall Study|Death|1
7696086|NCT01182350|26764509|P1|Overall Study|Death|0
7696087|NCT01182350|26764505|P5|Overall Study|Disease Progression|0
7696088|NCT01182350|26764506|P4|Overall Study|Disease Progression|1
7696089|NCT01182350|26764507|P3|Overall Study|Disease Progression|0
7696090|NCT01182350|26764508|P2|Overall Study|Disease Progression|12
7696091|NCT01182350|26764509|P1|Overall Study|Disease Progression|15
7696092|NCT01182350|26764505|P5|Overall Study|Adverse Event|0
7696093|NCT01182350|26764506|P4|Overall Study|Adverse Event|0
7696094|NCT01182350|26764507|P3|Overall Study|Adverse Event|0
7696095|NCT01182350|26764508|P2|Overall Study|Adverse Event|0
7696096|NCT01182350|26764509|P1|Overall Study|Adverse Event|5
7696097|NCT01182337|26764531|P2|Overall Study|Lost to Follow-up|1
7696098|NCT01182337|26764532|P1|Overall Study|Lost to Follow-up|0
7696099|NCT01182337|26764531|P2|Overall Study|Withdrawal by Subject|1
7696100|NCT01182337|26764532|P1|Overall Study|Withdrawal by Subject|3
7696101|NCT01182298|26764550|P1|Overall Study|Withdrawal by Subject|2
7696102|NCT01182298|26764550|P1|Overall Study|Lack of Efficacy|4
7696103|NCT01182285|26764554|P3|Third Intervention Week 11-52|Other|2
7696104|NCT01182285|26764555|P2|Third Intervention Week 11-52|Other|0
7696105|NCT01182285|26764556|P1|Third Intervention Week 11-52|Other|0
7696106|NCT01182285|26764554|P3|Third Intervention Week 11-52|Disease Progression|6
7696107|NCT01182285|26764555|P2|Third Intervention Week 11-52|Disease Progression|0
7696108|NCT01182285|26764556|P1|Third Intervention Week 11-52|Disease Progression|0
7696109|NCT01182285|26764554|P3|First Intervention Week 1-10|Non-compliance|0
7696110|NCT01182285|26764555|P2|First Intervention Week 1-10|Non-compliance|0
7696111|NCT01182285|26764556|P1|First Intervention Week 1-10|Non-compliance|1
7696112|NCT01182285|26764554|P3|First Intervention Week 1-10|Adverse Event|0
7696113|NCT01182285|26764555|P2|First Intervention Week 1-10|Adverse Event|0
7696114|NCT01182285|26764556|P1|First Intervention Week 1-10|Adverse Event|1
7696115|NCT01182285|26764554|P3|First Intervention Week 1-10|Disease progression|0
7696116|NCT01182285|26764555|P2|First Intervention Week 1-10|Disease progression|0
7696117|NCT01182285|26764556|P1|First Intervention Week 1-10|Disease progression|1
7696118|NCT01182207|26764566|P2|Second Intervention|Emeses within 1 hour of dosing|0
7696119|NCT01182207|26764567|P1|Second Intervention|Emeses within 1 hour of dosing|1
7696120|NCT01182207|26764566|P2|First Intervention|Positive Hepatitis Results|1
7696121|NCT01182207|26764567|P1|First Intervention|Positive Hepatitis Results|0
7696122|NCT01182194|26764585|P2|Washout of 28 Days|Withdrawal by Subject|0
7696123|NCT01182194|26764586|P1|Washout of 28 Days|Withdrawal by Subject|1
7696124|NCT01182181|26764604|P2|Washout of 21 Days|Withdrawal by Subject|1
7696125|NCT01182181|26764605|P1|Washout of 21 Days|Withdrawal by Subject|0
7696126|NCT01182181|26764604|P2|First Intervention|Adverse Event|0
7696127|NCT01182181|26764605|P1|First Intervention|Adverse Event|1
7696128|NCT01181986|26764630|P3|Phase 2|Medical condition|0
7696129|NCT01181986|26764631|P2|Phase 2|Medical condition|1
7696130|NCT01181986|26764632|P1|Phase 2|Medical condition|0
7696131|NCT01181986|26764630|P3|Phase 2|Adverse Event|0
7696132|NCT01181986|26764631|P2|Phase 2|Adverse Event|3
7696133|NCT01181986|26764632|P1|Phase 2|Adverse Event|0
7696134|NCT01181986|26764630|P3|Phase 1|Protocol Violation|0
7696135|NCT01181986|26764631|P2|Phase 1|Protocol Violation|0
7696136|NCT01181986|26764632|P1|Phase 1|Protocol Violation|1
7696137|NCT01181986|26764630|P3|Phase 1|Adverse Event|1
7696138|NCT01181986|26764631|P2|Phase 1|Adverse Event|0
7696139|NCT01181986|26764632|P1|Phase 1|Adverse Event|0
7696140|NCT01181986|26764630|P3|Phase 1|Lost to Follow-up|1
7696141|NCT01181986|26764631|P2|Phase 1|Lost to Follow-up|1
7696142|NCT01181986|26764632|P1|Phase 1|Lost to Follow-up|0
7696143|NCT01181921|26764653|P1|Overall Study|Lost to Follow-up|1
7696144|NCT01181895|26764660|P3|Overall Study|Withdrawal by Subject|5
7696145|NCT01181895|26764661|P2|Overall Study|Withdrawal by Subject|0
7696146|NCT01181895|26764662|P1|Overall Study|Withdrawal by Subject|3
7696147|NCT01181895|26764660|P3|Overall Study|Investigator Discretion|1
7696148|NCT01181895|26764661|P2|Overall Study|Investigator Discretion|2
7696149|NCT01181895|26764662|P1|Overall Study|Investigator Discretion|1
7696150|NCT01181895|26764660|P3|Overall Study|Lost to Follow-up|2
7696151|NCT01181895|26764661|P2|Overall Study|Lost to Follow-up|1
7696152|NCT01181895|26764662|P1|Overall Study|Lost to Follow-up|0
7696153|NCT01181895|26764660|P3|Overall Study|Protocol Violation|0
7696154|NCT01181895|26764661|P2|Overall Study|Protocol Violation|1
7696155|NCT01181895|26764662|P1|Overall Study|Protocol Violation|2
7696156|NCT01181895|26764660|P3|Overall Study|Lack of Efficacy|9
7696157|NCT01181895|26764661|P2|Overall Study|Lack of Efficacy|9
7696158|NCT01181895|26764662|P1|Overall Study|Lack of Efficacy|8
7696159|NCT01181895|26764660|P3|Overall Study|Adverse Event|1
7696160|NCT01181895|26764661|P2|Overall Study|Adverse Event|1
7696161|NCT01181895|26764662|P1|Overall Study|Adverse Event|3
7696162|NCT01181778|26764720|P1|Overall Study|Physician Decision|48
7696163|NCT01181726|26764728|P2|First Intervention|Adverse Event|0
7696164|NCT01181726|26764729|P1|First Intervention|Adverse Event|1
7696165|NCT01181609|26764809|P1|Overall Study|Death|50
7696166|NCT01181609|26764809|P1|Overall Study|Lost to Follow-up|1
7696167|NCT01181609|26764809|P1|Overall Study|Withdrawal by Subject|1
7696168|NCT01181609|26764809|P1|Overall Study|Adverse Event|1
7696169|NCT01181531|26764827|P2|Overall Study|Adverse Event|1
7696170|NCT01181531|26764828|P1|Overall Study|Adverse Event|0
7696171|NCT01181531|26764827|P2|Overall Study|Death|12
7696172|NCT01181531|26764828|P1|Overall Study|Death|9
7696173|NCT01181531|26764827|P2|Overall Study|Protocol Violation|6
7696174|NCT01181531|26764828|P1|Overall Study|Protocol Violation|6
7696175|NCT01181531|26764827|P2|Overall Study|Withdrawal by Subject|7
7696176|NCT01181531|26764828|P1|Overall Study|Withdrawal by Subject|8
7696177|NCT01181531|26764827|P2|Overall Study|Pregnancy|1
7696178|NCT01181531|26764828|P1|Overall Study|Pregnancy|0
7696179|NCT01181531|26764827|P2|Overall Study|Protocol Specified Criteria|8
7696180|NCT01181531|26764828|P1|Overall Study|Protocol Specified Criteria|15
7696181|NCT01181531|26764827|P2|Overall Study|Ineligibility determined|2
7696182|NCT01181531|26764828|P1|Overall Study|Ineligibility determined|1
7696183|NCT01181531|26764827|P2|Overall Study|Noncompliance|2
7696184|NCT01181531|26764828|P1|Overall Study|Noncompliance|2
7696185|NCT01181531|26764827|P2|Overall Study|Physician Decision|1
7696186|NCT01181531|26764828|P1|Overall Study|Physician Decision|3
7696187|NCT01181531|26764827|P2|Overall Study|Partial consent by subject withdrawn|1
7696188|NCT01181531|26764828|P1|Overall Study|Partial consent by subject withdrawn|0
7696189|NCT01181531|26764827|P2|Overall Study|Other|12
7696190|NCT01181531|26764828|P1|Overall Study|Other|17
7696279|NCT01180790|26765262|P1|Overall Study|compliance|0
7696191|NCT01181271|26764970|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
7696192|NCT01181271|26764970|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
7696193|NCT01181271|26764970|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
7696194|NCT01181271|26764970|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
7696195|NCT01181167|26764994|P2|Overall Study|Withdrawal by Subject|8
7696196|NCT01181167|26764995|P1|Overall Study|Withdrawal by Subject|6
7696197|NCT01181167|26764994|P2|Overall Study|Protocol Violation|0
7696198|NCT01181167|26764995|P1|Overall Study|Protocol Violation|3
7696199|NCT01181167|26764994|P2|Overall Study|Physician Decision|3
7696200|NCT01181167|26764995|P1|Overall Study|Physician Decision|2
7696201|NCT01181167|26764994|P2|Overall Study|Lost to Follow-up|0
7696202|NCT01181167|26764995|P1|Overall Study|Lost to Follow-up|1
7696203|NCT01181167|26764994|P2|Overall Study|Adverse Event|21
7696204|NCT01181167|26764995|P1|Overall Study|Adverse Event|11
7696205|NCT01181141|26765005|P2|Overall Study|Withdrawal by Subject|1
7696206|NCT01181141|26765006|P1|Overall Study|Withdrawal by Subject|3
7696207|NCT01181141|26765005|P2|Overall Study|Protocol Violation|1
7696208|NCT01181141|26765006|P1|Overall Study|Protocol Violation|3
7696209|NCT01181141|26765005|P2|Overall Study|Physician Decision|0
7696210|NCT01181141|26765006|P1|Overall Study|Physician Decision|2
7696211|NCT01181141|26765005|P2|Overall Study|Lost to Follow-up|1
7696212|NCT01181141|26765006|P1|Overall Study|Lost to Follow-up|1
7696213|NCT01181141|26765005|P2|Overall Study|Lack of Efficacy|0
7696214|NCT01181141|26765006|P1|Overall Study|Lack of Efficacy|1
7696215|NCT01181141|26765005|P2|Overall Study|Adverse Event|1
7696216|NCT01181141|26765006|P1|Overall Study|Adverse Event|2
7696217|NCT01181128|26765015|P3|Overall Study|Other|1
7696218|NCT01181128|26765016|P2|Overall Study|Other|1
7696219|NCT01181128|26765017|P1|Overall Study|Other|1
7696220|NCT01181128|26765015|P3|Overall Study|Adverse Event|0
7696221|NCT01181128|26765016|P2|Overall Study|Adverse Event|2
7696222|NCT01181128|26765017|P1|Overall Study|Adverse Event|0
7696223|NCT01181128|26765015|P3|Overall Study|Physician Decision|0
7696224|NCT01181128|26765016|P2|Overall Study|Physician Decision|0
7696225|NCT01181128|26765017|P1|Overall Study|Physician Decision|2
7696226|NCT01181128|26765015|P3|Overall Study|Death|0
7696227|NCT01181128|26765016|P2|Overall Study|Death|0
7696228|NCT01181128|26765017|P1|Overall Study|Death|1
7696229|NCT01181128|26765015|P3|Overall Study|Withdrawal by Subject|0
7696230|NCT01181128|26765016|P2|Overall Study|Withdrawal by Subject|2
7696231|NCT01181128|26765017|P1|Overall Study|Withdrawal by Subject|2
7696232|NCT01181102|26765105|P2|Overall Study|Withdrawal by Subject|12
7696233|NCT01181102|26765106|P1|Overall Study|Withdrawal by Subject|10
7696234|NCT01181102|26765105|P2|Overall Study|Protocol Violation|6
7696235|NCT01181102|26765106|P1|Overall Study|Protocol Violation|5
7696236|NCT01181102|26765105|P2|Overall Study|Physician Decision|1
7696237|NCT01181102|26765106|P1|Overall Study|Physician Decision|3
7696238|NCT01181102|26765105|P2|Overall Study|Lost to Follow-up|0
7696239|NCT01181102|26765106|P1|Overall Study|Lost to Follow-up|2
7696240|NCT01181102|26765105|P2|Overall Study|Lack of Efficacy|1
7696241|NCT01181102|26765106|P1|Overall Study|Lack of Efficacy|3
7696242|NCT01181102|26765105|P2|Overall Study|Adverse Event|26
7696243|NCT01181102|26765106|P1|Overall Study|Adverse Event|28
7696244|NCT01181011|26765150|P1|Overall Study|Lost to Follow-up|1
7696245|NCT01181011|26765150|P1|Overall Study|Adverse Event|2
7696246|NCT01180998|26765200|P3|Overall Study|Poor lens handling|2
7696247|NCT01180998|26765201|P2|Overall Study|Poor lens handling|0
7696248|NCT01180998|26765202|P1|Overall Study|Poor lens handling|0
7696249|NCT01180998|26765200|P3|Overall Study|Poor comfort|4
7696250|NCT01180998|26765201|P2|Overall Study|Poor comfort|0
7696251|NCT01180998|26765202|P1|Overall Study|Poor comfort|3
7696252|NCT01180998|26765200|P3|Overall Study|Withdrawal by Subject|1
7696253|NCT01180998|26765201|P2|Overall Study|Withdrawal by Subject|0
7696254|NCT01180998|26765202|P1|Overall Study|Withdrawal by Subject|0
7696255|NCT01180998|26765200|P3|Overall Study|Protocol Violation|0
7696256|NCT01180998|26765201|P2|Overall Study|Protocol Violation|2
7696257|NCT01180998|26765202|P1|Overall Study|Protocol Violation|1
7696258|NCT01180998|26765200|P3|Overall Study|Lost to Follow-up|1
7696259|NCT01180998|26765201|P2|Overall Study|Lost to Follow-up|0
7696260|NCT01180998|26765202|P1|Overall Study|Lost to Follow-up|0
7696261|NCT01180998|26765200|P3|Overall Study|Poor Vision|2
7696262|NCT01180998|26765201|P2|Overall Study|Poor Vision|2
7696263|NCT01180998|26765202|P1|Overall Study|Poor Vision|0
7696264|NCT01180985|26765216|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
7696265|NCT01180985|26765217|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
7696266|NCT01180790|26765256|P7|Overall Study|Severe coronary atherosclerosis (death)|0
7696267|NCT01180790|26765257|P6|Overall Study|Severe coronary atherosclerosis (death)|0
7696268|NCT01180790|26765258|P5|Overall Study|Severe coronary atherosclerosis (death)|0
7696269|NCT01180790|26765259|P4|Overall Study|Severe coronary atherosclerosis (death)|0
7696270|NCT01180790|26765260|P3|Overall Study|Severe coronary atherosclerosis (death)|1
7696271|NCT01180790|26765261|P2|Overall Study|Severe coronary atherosclerosis (death)|0
7696272|NCT01180790|26765262|P1|Overall Study|Severe coronary atherosclerosis (death)|0
7696273|NCT01180790|26765256|P7|Overall Study|compliance|0
7696274|NCT01180790|26765257|P6|Overall Study|compliance|0
7696275|NCT01180790|26765258|P5|Overall Study|compliance|0
7696276|NCT01180790|26765259|P4|Overall Study|compliance|0
7696277|NCT01180790|26765260|P3|Overall Study|compliance|0
7696278|NCT01180790|26765261|P2|Overall Study|compliance|1
7696280|NCT01180790|26765256|P7|Overall Study|Lack of Efficacy|0
7696281|NCT01180790|26765257|P6|Overall Study|Lack of Efficacy|3
7696282|NCT01180790|26765258|P5|Overall Study|Lack of Efficacy|1
7696283|NCT01180790|26765259|P4|Overall Study|Lack of Efficacy|6
7696284|NCT01180790|26765260|P3|Overall Study|Lack of Efficacy|5
7696285|NCT01180790|26765261|P2|Overall Study|Lack of Efficacy|2
7696286|NCT01180790|26765262|P1|Overall Study|Lack of Efficacy|1
7696287|NCT01180790|26765256|P7|Overall Study|Physician Decision|0
7696288|NCT01180790|26765257|P6|Overall Study|Physician Decision|0
7696289|NCT01180790|26765258|P5|Overall Study|Physician Decision|0
7696290|NCT01180790|26765259|P4|Overall Study|Physician Decision|1
7696291|NCT01180790|26765260|P3|Overall Study|Physician Decision|0
7696292|NCT01180790|26765261|P2|Overall Study|Physician Decision|0
7696293|NCT01180790|26765262|P1|Overall Study|Physician Decision|1
7696294|NCT01180790|26765256|P7|Overall Study|Lost to Follow-up|1
7696295|NCT01180790|26765257|P6|Overall Study|Lost to Follow-up|0
7696296|NCT01180790|26765258|P5|Overall Study|Lost to Follow-up|1
7696297|NCT01180790|26765259|P4|Overall Study|Lost to Follow-up|2
7696298|NCT01180790|26765260|P3|Overall Study|Lost to Follow-up|0
7696299|NCT01180790|26765261|P2|Overall Study|Lost to Follow-up|1
7696300|NCT01180790|26765262|P1|Overall Study|Lost to Follow-up|3
7696301|NCT01180790|26765256|P7|Overall Study|Withdrawal by Subject|0
7696302|NCT01180790|26765257|P6|Overall Study|Withdrawal by Subject|1
7696303|NCT01180790|26765258|P5|Overall Study|Withdrawal by Subject|2
7696304|NCT01180790|26765259|P4|Overall Study|Withdrawal by Subject|0
7696305|NCT01180790|26765260|P3|Overall Study|Withdrawal by Subject|5
7696306|NCT01180790|26765261|P2|Overall Study|Withdrawal by Subject|0
7696307|NCT01180790|26765262|P1|Overall Study|Withdrawal by Subject|3
7696308|NCT01180790|26765256|P7|Overall Study|Adverse Event|0
7696309|NCT01180790|26765257|P6|Overall Study|Adverse Event|3
7696310|NCT01180790|26765258|P5|Overall Study|Adverse Event|1
7696311|NCT01180790|26765259|P4|Overall Study|Adverse Event|0
7696312|NCT01180790|26765260|P3|Overall Study|Adverse Event|2
7696313|NCT01180790|26765261|P2|Overall Study|Adverse Event|1
7696314|NCT01180790|26765262|P1|Overall Study|Adverse Event|1
7696315|NCT01180777|26765327|P1|Overall Study|Adverse Event|1
7696316|NCT01180777|26765327|P1|Overall Study|Lost to Follow-up|1
7696317|NCT01180777|26765327|P1|Overall Study|Poor lens fit|4
7696318|NCT01180777|26765327|P1|Overall Study|Protocol Violation|6
7696319|NCT01180660|26765341|P2|Overall Study|Changed to open surgery|0
7696320|NCT01180660|26765342|P1|Overall Study|Changed to open surgery|1
7696321|NCT01180647|26765352|P2|Overall Study|Lost to Follow-up|6
7696322|NCT01180647|26765353|P1|Overall Study|Lost to Follow-up|5
7696323|NCT01180400|26765388|P2|Overall Study|Other|1
7696324|NCT01180400|26765389|P1|Overall Study|Other|0
7696325|NCT01180400|26765388|P2|Overall Study|Lost to Follow-up|3
7696326|NCT01180400|26765389|P1|Overall Study|Lost to Follow-up|2
7696327|NCT01180400|26765388|P2|Overall Study|Study-specific withdrawal criteria|2
7696328|NCT01180400|26765389|P1|Overall Study|Study-specific withdrawal criteria|1
7696329|NCT01180400|26765388|P2|Overall Study|Lack of Efficacy|0
7696330|NCT01180400|26765389|P1|Overall Study|Lack of Efficacy|2
7696331|NCT01180400|26765388|P2|Overall Study|Condition under investigation worsened|1
7696332|NCT01180400|26765389|P1|Overall Study|Condition under investigation worsened|2
7696333|NCT01180400|26765388|P2|Overall Study|Severe non-compliance to protocol|2
7696334|NCT01180400|26765389|P1|Overall Study|Severe non-compliance to protocol|1
7696335|NCT01180400|26765388|P2|Overall Study|Adverse Event|10
7696336|NCT01180400|26765389|P1|Overall Study|Adverse Event|12
7696337|NCT01180400|26765388|P2|Overall Study|Eligibility criteria not fulfilled|2
7696338|NCT01180400|26765389|P1|Overall Study|Eligibility criteria not fulfilled|0
7696339|NCT01180400|26765388|P2|Overall Study|Withdrawal by Subject|6
7696340|NCT01180400|26765389|P1|Overall Study|Withdrawal by Subject|5
7696341|NCT01180296|26765437|P2|Overall Study|Protocol Violation|2
7696342|NCT01180296|26765438|P1|Overall Study|Protocol Violation|1
7696343|NCT01180244|26765448|P2|Overall Study|Lost to Follow-up|0
7696344|NCT01180244|26765449|P1|Overall Study|Lost to Follow-up|1
7696345|NCT01180244|26765448|P2|Overall Study|Protocol Violation|0
7696346|NCT01180244|26765449|P1|Overall Study|Protocol Violation|1
7696347|NCT01180244|26765448|P2|Overall Study|Withdrawal by Subject|1
7696348|NCT01180244|26765449|P1|Overall Study|Withdrawal by Subject|0
7696349|NCT01180244|26765448|P2|Overall Study|Adverse Event|0
7696350|NCT01180244|26765449|P1|Overall Study|Adverse Event|1
7696351|NCT01180244|26765448|P2|Overall Study|Physician Decision|0
7696352|NCT01180244|26765449|P1|Overall Study|Physician Decision|3
7696353|NCT01180244|26765448|P2|Overall Study|Lack of Efficacy|7
7696354|NCT01180244|26765449|P1|Overall Study|Lack of Efficacy|0
7696355|NCT01180049|26765494|P2|Overall Study|Death|35
7696356|NCT01180049|26765495|P1|Overall Study|Death|36
7696357|NCT01180049|26765494|P2|Overall Study|Lost to Follow-up|6
7696358|NCT01180049|26765495|P1|Overall Study|Lost to Follow-up|8
7696359|NCT01180049|26765494|P2|Overall Study|Other|7
7696360|NCT01180049|26765495|P1|Overall Study|Other|9
7696361|NCT01179919|26765532|P1|Overall Study|Adverse Event|1
7696362|NCT01179919|26765532|P1|Overall Study|Protocol Violation|1
7696363|NCT01179737|26765541|P4|Extension|The study was terminated|0
7696364|NCT01179737|26765542|P3|Extension|The study was terminated|0
7696365|NCT01179737|26765543|P2|Extension|The study was terminated|0
7696366|NCT01179737|26765544|P1|Extension|The study was terminated|3
7696367|NCT01179737|26765541|P4|Cohort 1 & Cohort 2 Expansion|Death|0
7696368|NCT01179737|26765542|P3|Cohort 1 & Cohort 2 Expansion|Death|0
7696369|NCT01179737|26765543|P2|Cohort 1 & Cohort 2 Expansion|Death|0
7696370|NCT01179737|26765544|P1|Cohort 1 & Cohort 2 Expansion|Death|1
7696371|NCT01179737|26765541|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7696372|NCT01179737|26765542|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7696373|NCT01179737|26765543|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
7696374|NCT01179737|26765544|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7696375|NCT01179737|26765541|P4|Cohort 1 & Cohort 2|Death|0
7696376|NCT01179737|26765542|P3|Cohort 1 & Cohort 2|Death|1
7696377|NCT01179737|26765543|P2|Cohort 1 & Cohort 2|Death|0
7696378|NCT01179737|26765544|P1|Cohort 1 & Cohort 2|Death|0
7696379|NCT01179737|26765541|P4|Cohort 1 & Cohort 2|Administrative problems|4
7696380|NCT01179737|26765542|P3|Cohort 1 & Cohort 2|Administrative problems|2
7696381|NCT01179737|26765543|P2|Cohort 1 & Cohort 2|Administrative problems|0
7696382|NCT01179737|26765544|P1|Cohort 1 & Cohort 2|Administrative problems|0
7696383|NCT01179737|26765541|P4|Cohort 1 & Cohort 2|Withdrew consent|0
7696384|NCT01179737|26765542|P3|Cohort 1 & Cohort 2|Withdrew consent|0
7696385|NCT01179737|26765543|P2|Cohort 1 & Cohort 2|Withdrew consent|0
7696386|NCT01179737|26765544|P1|Cohort 1 & Cohort 2|Withdrew consent|2
7696387|NCT01179737|26765541|P4|Cohort 1 & Cohort 2|Adverse Event|0
7696388|NCT01179737|26765542|P3|Cohort 1 & Cohort 2|Adverse Event|1
7696389|NCT01179737|26765543|P2|Cohort 1 & Cohort 2|Adverse Event|1
7696390|NCT01179737|26765544|P1|Cohort 1 & Cohort 2|Adverse Event|3
7696391|NCT01179672|26765555|P2|Overall Study|Physician Decision|1
7696392|NCT01179672|26765556|P1|Overall Study|Physician Decision|1
7696393|NCT01179672|26765555|P2|Overall Study|Protocol Violation|2
7696394|NCT01179672|26765556|P1|Overall Study|Protocol Violation|2
7696395|NCT01179672|26765555|P2|Overall Study|Lost to Follow-up|1
7696396|NCT01179672|26765556|P1|Overall Study|Lost to Follow-up|0
7696397|NCT01179672|26765555|P2|Overall Study|Entry Criteria Not Met|2
7696398|NCT01179672|26765556|P1|Overall Study|Entry Criteria Not Met|0
7696399|NCT01179672|26765555|P2|Overall Study|Withdrawal by Subject|12
7696400|NCT01179672|26765556|P1|Overall Study|Withdrawal by Subject|10
7696401|NCT01179672|26765555|P2|Overall Study|Adverse Event|8
7696402|NCT01179672|26765556|P1|Overall Study|Adverse Event|17
7696403|NCT01179516|26765612|P3|Overall Study|Other|2
7696404|NCT01179516|26765613|P2|Overall Study|Other|0
7696405|NCT01179516|26765614|P1|Overall Study|Other|2
7696406|NCT01179516|26765612|P3|Overall Study|Lost to Follow-up|3
7696407|NCT01179516|26765613|P2|Overall Study|Lost to Follow-up|7
7696408|NCT01179516|26765614|P1|Overall Study|Lost to Follow-up|7
7696409|NCT01179516|26765612|P3|Overall Study|Withdrawal of Consent|10
7696410|NCT01179516|26765613|P2|Overall Study|Withdrawal of Consent|6
7696411|NCT01179516|26765614|P1|Overall Study|Withdrawal of Consent|2
7696412|NCT01179516|26765612|P3|Overall Study|Protocol Deviations|3
7696413|NCT01179516|26765613|P2|Overall Study|Protocol Deviations|3
7696414|NCT01179516|26765614|P1|Overall Study|Protocol Deviations|4
7696415|NCT01179516|26765612|P3|Overall Study|Noncompliance with Study Drug|1
7696416|NCT01179516|26765613|P2|Overall Study|Noncompliance with Study Drug|0
7696417|NCT01179516|26765614|P1|Overall Study|Noncompliance with Study Drug|2
7696418|NCT01179516|26765612|P3|Overall Study|Lack of Efficacy|0
7696419|NCT01179516|26765613|P2|Overall Study|Lack of Efficacy|2
7696420|NCT01179516|26765614|P1|Overall Study|Lack of Efficacy|4
7696421|NCT01179516|26765612|P3|Overall Study|Pretreatment Event or Adverse Event|12
7696422|NCT01179516|26765613|P2|Overall Study|Pretreatment Event or Adverse Event|8
7696423|NCT01179516|26765614|P1|Overall Study|Pretreatment Event or Adverse Event|6
7696424|NCT01179477|26765658|P1|Overall Study|Did not complete final visit|27
7696425|NCT01179477|26765658|P1|Overall Study|Non-death withdrawal|438
7696426|NCT01179477|26765658|P1|Overall Study|Unsuccessful implant|80
7696427|NCT01179477|26765658|P1|Overall Study|Death|542
7696428|NCT01179399|26765663|P1|Overall Study|Withdrawal by Subject|1
7696429|NCT01179399|26765663|P1|Overall Study|Lack of Efficacy|30
7696430|NCT01179399|26765663|P1|Overall Study|Adverse Event|1
7696431|NCT01179347|26765669|P2|Open-label Period (12 Weeks)|Other|4
7696432|NCT01179347|26765670|P1|Open-label Period (12 Weeks)|Other|7
7696433|NCT01179347|26765669|P2|Open-label Period (12 Weeks)|Protocol Violation|0
7696434|NCT01179347|26765670|P1|Open-label Period (12 Weeks)|Protocol Violation|1
7696435|NCT01179347|26765669|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
7696436|NCT01179347|26765670|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
7696437|NCT01179347|26765669|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
7696438|NCT01179347|26765670|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
7696439|NCT01179347|26765669|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
7696440|NCT01179347|26765670|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
7696441|NCT01179347|26765669|P2|Open-label Period (12 Weeks)|Adverse Event|9
7696442|NCT01179347|26765670|P1|Open-label Period (12 Weeks)|Adverse Event|5
7696443|NCT01179347|26765669|P2|Double-blind Period (12 Weeks)|Other|4
7696444|NCT01179347|26765670|P1|Double-blind Period (12 Weeks)|Other|2
7696445|NCT01179347|26765669|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
7696446|NCT01179347|26765670|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
7696447|NCT01179347|26765669|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7696448|NCT01179347|26765670|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
7696449|NCT01179347|26765669|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
7696450|NCT01179347|26765670|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
7696451|NCT01179347|26765669|P2|Double-blind Period (12 Weeks)|Adverse Event|6
7696452|NCT01179347|26765670|P1|Double-blind Period (12 Weeks)|Adverse Event|2
7696453|NCT01179334|26765692|P2|Long-term Extension (LTE) Period|Adverse Event|4
7696454|NCT01179334|26765693|P1|Long-term Extension (LTE) Period|Adverse Event|2
7696455|NCT01179334|26765692|P2|Long-term Extension (LTE) Period|Death|0
7696456|NCT01179334|26765693|P1|Long-term Extension (LTE) Period|Death|3
7696457|NCT01179334|26765692|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
7696458|NCT01179334|26765693|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
7696459|NCT01179334|26765692|P2|Treatment Period|Adverse Event|0
7696460|NCT01179334|26765693|P1|Treatment Period|Adverse Event|1
7696461|NCT01179191|26765748|P1|Maintenance Phase (8 Weeks)|Other|66
7696462|NCT01179191|26765748|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
7696463|NCT01179191|26765748|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
7696464|NCT01179191|26765748|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
7696465|NCT01179191|26765748|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
7696466|NCT01179191|26765748|P1|Titration Phase (up to 6 Weeks)|Other|62
7696467|NCT01179191|26765748|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
7696468|NCT01179191|26765748|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
7696469|NCT01179191|26765748|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
7696470|NCT01179191|26765748|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
7696471|NCT01179191|26765748|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
7696472|NCT01179048|26765780|P2|Overall Study|Alive|142
7696473|NCT01179048|26765781|P1|Overall Study|Alive|127
7696474|NCT01179048|26765780|P2|Overall Study|Lost to Follow-up|9
7696475|NCT01179048|26765781|P1|Overall Study|Lost to Follow-up|8
7696476|NCT01179048|26765780|P2|Overall Study|Withdrawn - does not allow contact|8
7696477|NCT01179048|26765781|P1|Overall Study|Withdrawn - does not allow contact|4
7696478|NCT01178853|26765808|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
7696479|NCT01178853|26765809|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
7696480|NCT01178853|26765808|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
7696481|NCT01178853|26765809|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
7696482|NCT01178853|26765808|P2|Period 3 (Warfarin Titration)|Adverse Event|0
7696483|NCT01178853|26765809|P1|Period 3 (Warfarin Titration)|Adverse Event|1
7696484|NCT01178853|26765808|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
7696485|NCT01178853|26765809|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
7696486|NCT01178853|26765808|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
7696487|NCT01178853|26765809|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
7696488|NCT01178762|26765853|P1|Overall Study|Lost to Follow-up|15
7696489|NCT01178671|26765859|P2|Overall Study|Physician Decision|6
7696490|NCT01178671|26765860|P1|Overall Study|Physician Decision|4
7696491|NCT01178671|26765859|P2|Overall Study|Lost to Follow-up|1
7696492|NCT01178671|26765860|P1|Overall Study|Lost to Follow-up|3
7696493|NCT01178671|26765859|P2|Overall Study|Lack of Efficacy|1
7696494|NCT01178671|26765860|P1|Overall Study|Lack of Efficacy|0
7696495|NCT01178671|26765859|P2|Overall Study|Protocol Violation|1
7696496|NCT01178671|26765860|P1|Overall Study|Protocol Violation|1
7696497|NCT01178671|26765859|P2|Overall Study|Adverse Event|6
7696498|NCT01178671|26765860|P1|Overall Study|Adverse Event|4
7696499|NCT01178411|26765906|P1|Overall Study|Drug manufacturing ended|1
7696500|NCT01178411|26765906|P1|Overall Study|No reason provided|1
7696501|NCT01178411|26765906|P1|Overall Study|Death|1
7696502|NCT01178411|26765906|P1|Overall Study|Physician Decision|6
7696503|NCT01178411|26765906|P1|Overall Study|Progressive disease per clinician|9
7696504|NCT01178411|26765906|P1|Overall Study|Progressive disease per RECIST|32
7696505|NCT01178411|26765906|P1|Overall Study|Protocol Violation|1
7696506|NCT01178411|26765906|P1|Overall Study|Withdrawal by Subject|4
7696507|NCT01178411|26765906|P1|Overall Study|Adverse Event|5
7696508|NCT01178385|26765914|P2|Overall Study|Withdrawal by Subject|0
7696509|NCT01178385|26765915|P1|Overall Study|Withdrawal by Subject|2
7696510|NCT01178294|26765984|P1|Overall Study|Completion status could not be verified|1
7696511|NCT01178294|26765984|P1|Overall Study|Subject status is terminal|1
7696512|NCT01178294|26765984|P1|Overall Study|Development of inhibitors to OBI-1|1
7696513|NCT01178294|26765984|P1|Overall Study|Death|1
7696514|NCT01178294|26765984|P1|Overall Study|Lack of Efficacy|1
7696515|NCT01178294|26765984|P1|Overall Study|Lost to Follow-up|2
7696516|NCT01178294|26765984|P1|Overall Study|Adverse Event|4
7696517|NCT01178138|26766264|P1|Overall Study|Physician Decision|8
7696518|NCT01178138|26766264|P1|Overall Study|Withdrawal by Subject|7
7696519|NCT01178138|26766264|P1|Overall Study|Lost to Follow-up|8
7696520|NCT01178125|26766285|P1|Overall Study|Investigator Decision|5
7696521|NCT01178125|26766285|P1|Overall Study|Protocol Violation|17
7696522|NCT01178125|26766285|P1|Overall Study|Sponsor Decision|28
7696523|NCT01178125|26766285|P1|Overall Study|Other Reason|39
7696524|NCT01178125|26766285|P1|Overall Study|Pregnancy|55
7696525|NCT01178125|26766285|P1|Overall Study|Noncompliance|184
7696526|NCT01178125|26766285|P1|Overall Study|Withdrawal by Subject|209
7696527|NCT01178125|26766285|P1|Overall Study|Adverse Event|244
7696528|NCT01178125|26766285|P1|Overall Study|Lost to Follow-up|397
7696529|NCT01178099|26766316|P2|Overall Study|Physician Decision|1
7696530|NCT01178099|26766317|P1|Overall Study|Physician Decision|0
7696531|NCT01178086|26766357|P1|Overall Study|Excluded from EAS|20
7696532|NCT01178086|26766357|P1|Overall Study|Other unspecified|89
7696533|NCT01178086|26766357|P1|Overall Study|Death|59
7696534|NCT01178086|26766357|P1|Overall Study|Switch to other CLL therapy|113
7696535|NCT01178086|26766357|P1|Overall Study|Physician Decision|44
7696536|NCT01178086|26766357|P1|Overall Study|Participant refusal|7
7696537|NCT01178073|26766384|P3|Overall Study|Missing Completion Status|0
7696538|NCT01178073|26766385|P2|Overall Study|Missing Completion Status|0
7696539|NCT01178073|26766386|P1|Overall Study|Missing Completion Status|1
7696540|NCT01178073|26766384|P3|Overall Study|Withdrawal by Subject|8
7696541|NCT01178073|26766385|P2|Overall Study|Withdrawal by Subject|6
7696542|NCT01178073|26766386|P1|Overall Study|Withdrawal by Subject|10
7696543|NCT01178073|26766384|P3|Overall Study|Physician Decision|10
7696544|NCT01178073|26766385|P2|Overall Study|Physician Decision|10
7696545|NCT01178073|26766386|P1|Overall Study|Physician Decision|14
7696546|NCT01178073|26766384|P3|Overall Study|Lost to Follow-up|3
7696547|NCT01178073|26766385|P2|Overall Study|Lost to Follow-up|0
7696548|NCT01178073|26766386|P1|Overall Study|Lost to Follow-up|2
7696549|NCT01178073|26766384|P3|Overall Study|Protocol Violation|1
7696550|NCT01178073|26766385|P2|Overall Study|Protocol Violation|1
7696551|NCT01178073|26766386|P1|Overall Study|Protocol Violation|1
7696552|NCT01178073|26766384|P3|Overall Study|Adverse Event|24
7696553|NCT01178073|26766385|P2|Overall Study|Adverse Event|27
7696554|NCT01178073|26766386|P1|Overall Study|Adverse Event|34
7696555|NCT01177969|26766417|P2|Overall Study|Withdrawal by Subject|2
7696556|NCT01177969|26766418|P1|Overall Study|Withdrawal by Subject|1
7696557|NCT01177969|26766417|P2|Overall Study|Protocol Violation|1
7696558|NCT01177969|26766418|P1|Overall Study|Protocol Violation|2
7696559|NCT01177943|26766441|P2|First Intervention|Withdrawal by Subject|0
7696560|NCT01177943|26766442|P1|First Intervention|Withdrawal by Subject|2
7696561|NCT01177813|26766455|P5|Overall Study|Other reason not defined above|2
7696562|NCT01177813|26766456|P4|Overall Study|Other reason not defined above|3
7696563|NCT01177813|26766457|P3|Overall Study|Other reason not defined above|2
7696564|NCT01177813|26766458|P2|Overall Study|Other reason not defined above|2
7696565|NCT01177813|26766459|P1|Overall Study|Other reason not defined above|5
7696566|NCT01177813|26766455|P5|Overall Study|Withdrawal by Subject|3
7696567|NCT01177813|26766456|P4|Overall Study|Withdrawal by Subject|5
7696568|NCT01177813|26766457|P3|Overall Study|Withdrawal by Subject|6
7696569|NCT01177813|26766458|P2|Overall Study|Withdrawal by Subject|7
7696570|NCT01177813|26766459|P1|Overall Study|Withdrawal by Subject|12
7696571|NCT01177813|26766455|P5|Overall Study|Lost to Follow-up|0
7696572|NCT01177813|26766456|P4|Overall Study|Lost to Follow-up|3
7696573|NCT01177813|26766457|P3|Overall Study|Lost to Follow-up|6
7696574|NCT01177813|26766458|P2|Overall Study|Lost to Follow-up|5
7696575|NCT01177813|26766459|P1|Overall Study|Lost to Follow-up|12
7696576|NCT01177813|26766455|P5|Overall Study|Protocol Violation|1
7696577|NCT01177813|26766456|P4|Overall Study|Protocol Violation|0
7696578|NCT01177813|26766457|P3|Overall Study|Protocol Violation|2
7696579|NCT01177813|26766458|P2|Overall Study|Protocol Violation|2
7696580|NCT01177813|26766459|P1|Overall Study|Protocol Violation|3
7696581|NCT01177813|26766455|P5|Overall Study|Lack of Efficacy|0
7696582|NCT01177813|26766456|P4|Overall Study|Lack of Efficacy|0
7696583|NCT01177813|26766457|P3|Overall Study|Lack of Efficacy|0
7696584|NCT01177813|26766458|P2|Overall Study|Lack of Efficacy|0
7696585|NCT01177813|26766459|P1|Overall Study|Lack of Efficacy|1
7696586|NCT01177813|26766455|P5|Overall Study|Adverse Event|3
7696587|NCT01177813|26766456|P4|Overall Study|Adverse Event|6
7696588|NCT01177813|26766457|P3|Overall Study|Adverse Event|4
7696589|NCT01177813|26766458|P2|Overall Study|Adverse Event|2
7696590|NCT01177813|26766459|P1|Overall Study|Adverse Event|8
7696591|NCT01177800|26766488|P2|Overall Study|Withdrawal of informed consent|1
7696592|NCT01177800|26766489|P1|Overall Study|Withdrawal of informed consent|0
7696593|NCT01177800|26766488|P2|Overall Study|Physician Decision|0
7696594|NCT01177800|26766489|P1|Overall Study|Physician Decision|1
7696595|NCT01177800|26766488|P2|Overall Study|Protocol Violation|1
7696596|NCT01177800|26766489|P1|Overall Study|Protocol Violation|0
7696597|NCT01177800|26766488|P2|Overall Study|Adverse Event|3
7696598|NCT01177800|26766489|P1|Overall Study|Adverse Event|9
7696599|NCT01177787|26766503|P1|Cryolipolysis on Thigh|Lost to Follow-up|1
7696600|NCT01177787|26766503|P1|Cryolipolysis on Thigh|Lack of Efficacy|9
7696601|NCT01177787|26766503|P1|Cryolipolysis on Thigh|Protocol Violation|4
7696602|NCT01177722|26766525|P4|Overall Study|Withdrawal by Subject|6
7696603|NCT01177722|26766526|P3|Overall Study|Withdrawal by Subject|4
7696604|NCT01177722|26766527|P2|Overall Study|Withdrawal by Subject|6
7696605|NCT01177722|26766528|P1|Overall Study|Withdrawal by Subject|10
7696606|NCT01177722|26766525|P4|Overall Study|Lost to Follow-up|1
7696607|NCT01177722|26766526|P3|Overall Study|Lost to Follow-up|3
7696608|NCT01177722|26766527|P2|Overall Study|Lost to Follow-up|4
7696609|NCT01177722|26766528|P1|Overall Study|Lost to Follow-up|3
7696610|NCT01177722|26766525|P4|Overall Study|Protocol Violation|0
7696611|NCT01177722|26766526|P3|Overall Study|Protocol Violation|1
7696612|NCT01177722|26766527|P2|Overall Study|Protocol Violation|0
7696613|NCT01177722|26766528|P1|Overall Study|Protocol Violation|0
7696614|NCT01177722|26766525|P4|Overall Study|Serious Adverse Event|0
7696615|NCT01177722|26766526|P3|Overall Study|Serious Adverse Event|1
7696616|NCT01177722|26766527|P2|Overall Study|Serious Adverse Event|0
7696617|NCT01177722|26766528|P1|Overall Study|Serious Adverse Event|0
7696618|NCT01177670|26766560|P1|Overall Study|Withdrawal by Subject|4
7696619|NCT01177670|26766560|P1|Overall Study|Physician Decision|50
7696620|NCT01177670|26766560|P1|Overall Study|Study Terminated|115
7696621|NCT01177553|26766567|P2|Overall Study|babies not yet 6 months of age|0
7696622|NCT01177553|26766568|P1|Overall Study|babies not yet 6 months of age|1
7696623|NCT01177410|26766577|P3|Overall Study|Lost to Follow-up|0
7696624|NCT01177410|26766578|P2|Overall Study|Lost to Follow-up|1
7696625|NCT01177410|26766579|P1|Overall Study|Lost to Follow-up|0
7696626|NCT01177410|26766577|P3|Overall Study|Withdrawal by Subject|3
7696627|NCT01177410|26766578|P2|Overall Study|Withdrawal by Subject|4
7696628|NCT01177410|26766579|P1|Overall Study|Withdrawal by Subject|1
7696629|NCT01177410|26766577|P3|Overall Study|Adverse Event|2
7696630|NCT01177410|26766578|P2|Overall Study|Adverse Event|2
7696631|NCT01177410|26766579|P1|Overall Study|Adverse Event|0
7696632|NCT01177384|26766592|P2|Overall Study|Withdrawal by Subject|12
7696633|NCT01177384|26766593|P1|Overall Study|Withdrawal by Subject|5
7696634|NCT01177384|26766592|P2|Overall Study|Protocol Violation|2
7696635|NCT01177384|26766593|P1|Overall Study|Protocol Violation|0
7696636|NCT01177384|26766592|P2|Overall Study|Physician Decision|3
7696637|NCT01177384|26766593|P1|Overall Study|Physician Decision|0
7696638|NCT01177384|26766592|P2|Overall Study|Lost to Follow-up|4
7696639|NCT01177384|26766593|P1|Overall Study|Lost to Follow-up|3
7696640|NCT01177384|26766592|P2|Overall Study|Lack of Efficacy|1
7696641|NCT01177384|26766593|P1|Overall Study|Lack of Efficacy|0
7696642|NCT01177384|26766592|P2|Overall Study|Adverse Event|4
7696643|NCT01177384|26766593|P1|Overall Study|Adverse Event|6
7696644|NCT01177293|26766605|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
7696645|NCT01177293|26766606|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
7696646|NCT01177228|26766624|P4|Overall Study|Withdrawal by Subject|0
7696647|NCT01177228|26766625|P3|Overall Study|Withdrawal by Subject|0
7696648|NCT01177228|26766626|P2|Overall Study|Withdrawal by Subject|1
7696649|NCT01177228|26766627|P1|Overall Study|Withdrawal by Subject|0
7696650|NCT01177228|26766624|P4|Overall Study|Worsening disease activity|0
7696651|NCT01177228|26766625|P3|Overall Study|Worsening disease activity|0
7696652|NCT01177228|26766626|P2|Overall Study|Worsening disease activity|0
7696653|NCT01177228|26766627|P1|Overall Study|Worsening disease activity|1
7696654|NCT01177228|26766624|P4|Overall Study|Positive tuberculosis test|0
7696655|NCT01177228|26766625|P3|Overall Study|Positive tuberculosis test|0
7696656|NCT01177228|26766626|P2|Overall Study|Positive tuberculosis test|1
7696657|NCT01177228|26766627|P1|Overall Study|Positive tuberculosis test|0
7696658|NCT01177137|26766681|P3|Overall Study|Withdrawal by Subject|2
7696659|NCT01177137|26766682|P2|Overall Study|Withdrawal by Subject|10
7696660|NCT01177137|26766683|P1|Overall Study|Withdrawal by Subject|10
7696661|NCT01177059|26766767|P1|Overall Study|Lost to Follow-up|18
7696662|NCT01177059|26766767|P1|Overall Study|Withdrew consent|2
7696663|NCT01177059|26766767|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
7696664|NCT01177007|26766773|P1|Overall Study|Change in treatment modality|21
7696665|NCT01177007|26766773|P1|Overall Study|Required additional Y90 treatment|6
7696666|NCT01177007|26766773|P1|Overall Study|Entered hospice care|5
7696667|NCT01177007|26766773|P1|Overall Study|Death|4
7696668|NCT01177007|26766773|P1|Overall Study|Lost to Follow-up|2
7696669|NCT01176968|26766787|P2|Overall Study|Reason not defined|3
7696670|NCT01176968|26766788|P1|Overall Study|Reason not defined|5
7696671|NCT01176968|26766787|P2|Overall Study|Study terminated by sponsor|1
7696672|NCT01176968|26766788|P1|Overall Study|Study terminated by sponsor|0
7696673|NCT01176968|26766787|P2|Overall Study|Did Not Meet Entrance Criteria|0
7696674|NCT01176968|26766788|P1|Overall Study|Did Not Meet Entrance Criteria|1
7696675|NCT01176968|26766787|P2|Overall Study|Protocol Violation|1
7696676|NCT01176968|26766788|P1|Overall Study|Protocol Violation|2
7696677|NCT01176968|26766787|P2|Overall Study|Withdrawal by Subject|48
7696678|NCT01176968|26766788|P1|Overall Study|Withdrawal by Subject|48
7696679|NCT01176968|26766787|P2|Overall Study|Lost to Follow-up|14
7696680|NCT01176968|26766788|P1|Overall Study|Lost to Follow-up|16
7696681|NCT01176968|26766787|P2|Overall Study|Lack of Efficacy|1
7696682|NCT01176968|26766788|P1|Overall Study|Lack of Efficacy|0
7696683|NCT01176968|26766787|P2|Overall Study|Death|3
7696684|NCT01176968|26766788|P1|Overall Study|Death|2
7696685|NCT01176968|26766787|P2|Overall Study|Adverse Event|11
7696686|NCT01176968|26766788|P1|Overall Study|Adverse Event|10
7696695|NCT01176773|26766849|P1|Overall Study|Withdrew consent|1
7696696|NCT01176773|26766849|P1|Overall Study|Screen Failure|2
7696697|NCT01176565|26766892|P2|Overall Study|Not Analyzed (any other reason)|2
7696698|NCT01176565|26766893|P1|Overall Study|Not Analyzed (any other reason)|1
7696699|NCT01176565|26766892|P2|Overall Study|Withdrawal by Subject|1
7696700|NCT01176565|26766893|P1|Overall Study|Withdrawal by Subject|7
7696701|NCT01176565|26766892|P2|Overall Study|Lost to Follow-up|16
7696702|NCT01176565|26766893|P1|Overall Study|Lost to Follow-up|12
7696703|NCT01176513|26766911|P1|Overall Study|Withdrew subjects prior to dosing|3
7696704|NCT01176292|26766939|P2|Overall Study|Has not scheduled one-year visit yet|2
7696705|NCT01176292|26766940|P1|Overall Study|Has not scheduled one-year visit yet|2
7696706|NCT01176292|26766939|P2|Overall Study|Physician Decision|2
7696707|NCT01176292|26766940|P1|Overall Study|Physician Decision|0
7696708|NCT01176292|26766939|P2|Overall Study|Adverse Event|1
7696709|NCT01176292|26766940|P1|Overall Study|Adverse Event|1
7696710|NCT01176292|26766939|P2|Overall Study|Lost to Follow-up|4
7696711|NCT01176292|26766940|P1|Overall Study|Lost to Follow-up|2
7696712|NCT01176266|26766958|P1|Overall Study|Withdrawal by Subject|3
7696713|NCT01176266|26766958|P1|Overall Study|Death|6
7696714|NCT01176240|26766982|P2|Study 306B|withdrew prior to dosing|1
7696715|NCT01176240|26766983|P1|Study 306B|withdrew prior to dosing|2
7696716|NCT01176240|26766982|P2|Study 306B|Lost to Follow-up|1
7696717|NCT01176240|26766983|P1|Study 306B|Lost to Follow-up|0
7696718|NCT01176240|26766982|P2|Study 306B|Supine Hypertension|2
7696719|NCT01176240|26766983|P1|Study 306B|Supine Hypertension|1
7696720|NCT01176240|26766982|P2|Study 306B|Physician Decision|1
7696721|NCT01176240|26766983|P1|Study 306B|Physician Decision|2
7696722|NCT01176240|26766982|P2|Study 306B|Withdrawal by Subject|1
7696723|NCT01176240|26766983|P1|Study 306B|Withdrawal by Subject|4
7696724|NCT01176240|26766982|P2|Study 306B|Protocol Violation|3
7696725|NCT01176240|26766983|P1|Study 306B|Protocol Violation|2
7696726|NCT01176240|26766982|P2|Study 306B|Adverse Event|5
7696727|NCT01176240|26766983|P1|Study 306B|Adverse Event|10
7696728|NCT01176240|26766982|P2|Study 306B|Lack of Efficacy|3
7696729|NCT01176240|26766983|P1|Study 306B|Lack of Efficacy|5
7696730|NCT01176240|26766982|P2|Study 306A|Stop due to diverse problems|0
7696731|NCT01176240|26766983|P1|Study 306A|Stop due to diverse problems|1
7696732|NCT01176240|26766982|P2|Study 306A|Withdrawal by Subject|1
7696733|NCT01176240|26766983|P1|Study 306A|Withdrawal by Subject|0
7696734|NCT01176240|26766982|P2|Study 306A|Protocol Violation|1
7696735|NCT01176240|26766983|P1|Study 306A|Protocol Violation|0
7696736|NCT01176240|26766982|P2|Study 306A|Lack of Efficacy|1
7696737|NCT01176240|26766983|P1|Study 306A|Lack of Efficacy|2
7696738|NCT01176058|26767009|P2|Overall Study|Withdrawal by Subject|0
7696739|NCT01176058|26767010|P1|Overall Study|Withdrawal by Subject|1
7696740|NCT01176058|26767009|P2|Overall Study|Insufficient mycological response|1
7696741|NCT01176058|26767010|P1|Overall Study|Insufficient mycological response|0
7696742|NCT01176058|26767009|P2|Overall Study|Insufficient clinical response|2
7696743|NCT01176058|26767010|P1|Overall Study|Insufficient clinical response|2
7696744|NCT01176058|26767009|P2|Overall Study|Adverse Event|0
7696745|NCT01176058|26767010|P1|Overall Study|Adverse Event|1
7696746|NCT01176032|26767034|P2|Overall Study|Other|0
7696747|NCT01176032|26767035|P1|Overall Study|Other|1
7696748|NCT01176032|26767034|P2|Overall Study|Informed consent withdrawn|0
7696749|NCT01176032|26767035|P1|Overall Study|Informed consent withdrawn|3
7696750|NCT01176032|26767034|P2|Overall Study|Protocol Violation|0
7696751|NCT01176032|26767035|P1|Overall Study|Protocol Violation|1
7696752|NCT01176032|26767034|P2|Overall Study|Unsatisfactory therapeutic effect|1
7696753|NCT01176032|26767035|P1|Overall Study|Unsatisfactory therapeutic effect|0
7696754|NCT01176032|26767034|P2|Overall Study|Adverse Event|0
7696755|NCT01176032|26767035|P1|Overall Study|Adverse Event|1
7696756|NCT01175824|26767176|P2|Overall Study|Entry Criteria Not Met|4
7696757|NCT01175824|26767177|P1|Overall Study|Entry Criteria Not Met|6
7696758|NCT01175824|26767176|P2|Overall Study|Sponsor Decision|0
7696759|NCT01175824|26767177|P1|Overall Study|Sponsor Decision|1
7696760|NCT01175824|26767176|P2|Overall Study|Withdrawal by Subject|7
7696761|NCT01175824|26767177|P1|Overall Study|Withdrawal by Subject|3
7696762|NCT01175824|26767176|P2|Overall Study|Protocol Violation|5
7696763|NCT01175824|26767177|P1|Overall Study|Protocol Violation|2
7696764|NCT01175824|26767176|P2|Overall Study|Physician Decision|4
7696765|NCT01175824|26767177|P1|Overall Study|Physician Decision|0
7696766|NCT01175824|26767176|P2|Overall Study|Lost to Follow-up|1
7696767|NCT01175824|26767177|P1|Overall Study|Lost to Follow-up|0
7696768|NCT01175824|26767176|P2|Overall Study|Lack of Efficacy|0
7696769|NCT01175824|26767177|P1|Overall Study|Lack of Efficacy|2
7696770|NCT01175824|26767176|P2|Overall Study|Adverse Event|1
7696771|NCT01175824|26767177|P1|Overall Study|Adverse Event|2
7696772|NCT01175811|26767211|P2|Overall Study|Withdrawal by Subject|7
7696773|NCT01175811|26767212|P1|Overall Study|Withdrawal by Subject|6
7696774|NCT01175811|26767211|P2|Overall Study|Protocol Violation|2
7696775|NCT01175811|26767212|P1|Overall Study|Protocol Violation|1
7696776|NCT01175811|26767211|P2|Overall Study|Physician Decision|1
7696777|NCT01175811|26767212|P1|Overall Study|Physician Decision|1
7696778|NCT01175811|26767211|P2|Overall Study|Lost to Follow-up|2
7696779|NCT01175811|26767212|P1|Overall Study|Lost to Follow-up|3
7696780|NCT01175811|26767211|P2|Overall Study|Lack of Efficacy|0
7696781|NCT01175811|26767212|P1|Overall Study|Lack of Efficacy|1
7696782|NCT01175811|26767211|P2|Overall Study|Entry criteria not met|1
7696783|NCT01175811|26767212|P1|Overall Study|Entry criteria not met|3
7696784|NCT01175811|26767211|P2|Overall Study|Adverse Event|1
7696785|NCT01175811|26767212|P1|Overall Study|Adverse Event|1
7696786|NCT01175707|26767247|P2|Overall Study|Adverse Event|6
7696787|NCT01175707|26767248|P1|Overall Study|Adverse Event|4
7696788|NCT01175668|26767284|P2|Overall Study|Withdrawal by Subject|0
7696789|NCT01175668|26767285|P1|Overall Study|Withdrawal by Subject|2
7696790|NCT01175590|26767295|P2|Overall Study|Protocol Violation|1
7696791|NCT01175590|26767296|P1|Overall Study|Protocol Violation|0
7696792|NCT01175590|26767295|P2|Overall Study|Herpes Simplex Dermatitis|0
7696793|NCT01175590|26767296|P1|Overall Study|Herpes Simplex Dermatitis|1
7696794|NCT01175590|26767295|P2|Overall Study|Treated not as randomized|2
7696795|NCT01175590|26767296|P1|Overall Study|Treated not as randomized|3
7696796|NCT01175590|26767295|P2|Overall Study|Residual Bacterial Conjunctivitis|0
7696797|NCT01175590|26767296|P1|Overall Study|Residual Bacterial Conjunctivitis|1
7696798|NCT01175590|26767295|P2|Overall Study|Lack of Efficacy|1
7696799|NCT01175590|26767296|P1|Overall Study|Lack of Efficacy|1
7696800|NCT01175590|26767295|P2|Overall Study|Physician Decision|4
7696801|NCT01175590|26767296|P1|Overall Study|Physician Decision|1
7696802|NCT01175590|26767295|P2|Overall Study|Adverse Event|0
7696803|NCT01175590|26767296|P1|Overall Study|Adverse Event|4
7696804|NCT01175590|26767295|P2|Overall Study|Withdrawal by Subject|2
7696805|NCT01175590|26767296|P1|Overall Study|Withdrawal by Subject|0
7696806|NCT01175590|26767295|P2|Overall Study|Lost to Follow-up|0
7696807|NCT01175590|26767296|P1|Overall Study|Lost to Follow-up|1
7696808|NCT01175473|26767330|P2|Overall Study|Adverse Event|2
7696809|NCT01175473|26767331|P1|Overall Study|Adverse Event|2
7696810|NCT01175382|26767372|P3|Overall Study|Unable to tolerate study meds|1
7696811|NCT01175382|26767373|P2|Overall Study|Unable to tolerate study meds|1
7696812|NCT01175382|26767374|P1|Overall Study|Unable to tolerate study meds|0
7696813|NCT01175382|26767372|P3|Overall Study|Unwilling to follow protocol|0
7696814|NCT01175382|26767373|P2|Overall Study|Unwilling to follow protocol|1
7696815|NCT01175382|26767374|P1|Overall Study|Unwilling to follow protocol|0
7696816|NCT01175382|26767372|P3|Overall Study|Unable/unwilling to attend visits|2
7696817|NCT01175382|26767373|P2|Overall Study|Unable/unwilling to attend visits|1
7696818|NCT01175382|26767374|P1|Overall Study|Unable/unwilling to attend visits|3
7696819|NCT01175382|26767372|P3|Overall Study|No longer having problem|1
7696820|NCT01175382|26767373|P2|Overall Study|No longer having problem|0
7696821|NCT01175382|26767374|P1|Overall Study|No longer having problem|1
7696822|NCT01175382|26767372|P3|Overall Study|Withdrawal by Subject|1
7696823|NCT01175382|26767373|P2|Overall Study|Withdrawal by Subject|0
7696824|NCT01175382|26767374|P1|Overall Study|Withdrawal by Subject|0
7696825|NCT01175382|26767372|P3|Overall Study|Physician Decision|0
7696826|NCT01175382|26767373|P2|Overall Study|Physician Decision|1
7696827|NCT01175382|26767374|P1|Overall Study|Physician Decision|0
7696828|NCT01175382|26767372|P3|Overall Study|Lost to Follow-up|1
7696829|NCT01175382|26767373|P2|Overall Study|Lost to Follow-up|3
7696830|NCT01175382|26767374|P1|Overall Study|Lost to Follow-up|4
7696831|NCT01175356|26767460|P1|Overall Study|Initiation other tx prior to completion|9
7696832|NCT01175356|26767460|P1|Overall Study|Inadequate stem cell for transplant|1
7696833|NCT01175356|26767460|P1|Overall Study|On other COG study w/tumor tx intent|7
7696834|NCT01175356|26767460|P1|Overall Study|Pts MIBG non-avid after enrollment|2
7696835|NCT01175356|26767460|P1|Overall Study|Refusal by patient/parent/guardian|6
7696836|NCT01175356|26767460|P1|Overall Study|Treatment Slot Not Available|18
7696837|NCT01175356|26767460|P1|Overall Study|Ineligible|1
7696838|NCT01175356|26767460|P1|Overall Study|Physician Decision|23
7696839|NCT01175356|26767460|P1|Overall Study|Lost to Follow-up|1
7696840|NCT01175356|26767460|P1|Overall Study|Lack of Efficacy|12
7696841|NCT01175356|26767460|P1|Overall Study|Death|1
7696842|NCT01175213|26767500|P2|Safety Follow-up|Adverse Event|0
7696843|NCT01175213|26767501|P1|Safety Follow-up|Adverse Event|1
7696844|NCT01175213|26767500|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
7696845|NCT01175213|26767501|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
7696846|NCT01175213|26767500|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
7696847|NCT01175213|26767501|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
7696848|NCT01175213|26767500|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
7696849|NCT01175213|26767501|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
7696850|NCT01175213|26767500|P2|IGSC, 10%/rHuPH20|Death|0
7696851|NCT01175213|26767501|P1|IGSC, 10%/rHuPH20|Death|1
7696852|NCT01175213|26767500|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
7696853|NCT01175213|26767501|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
7696854|NCT01175135|26767558|P4|Overall Study|Randomized But Not Treated|0
7696855|NCT01175135|26767559|P3|Overall Study|Randomized But Not Treated|1
7696856|NCT01175135|26767560|P2|Overall Study|Randomized But Not Treated|0
7696857|NCT01175135|26767561|P1|Overall Study|Randomized But Not Treated|0
7696858|NCT01175135|26767558|P4|Overall Study|Other|0
7696859|NCT01175135|26767559|P3|Overall Study|Other|3
7696860|NCT01175135|26767560|P2|Overall Study|Other|1
7696861|NCT01175135|26767561|P1|Overall Study|Other|3
7696862|NCT01175135|26767558|P4|Overall Study|Withdrawal by Subject|5
7696863|NCT01175135|26767559|P3|Overall Study|Withdrawal by Subject|5
7696864|NCT01175135|26767560|P2|Overall Study|Withdrawal by Subject|8
7696865|NCT01175135|26767561|P1|Overall Study|Withdrawal by Subject|4
7696866|NCT01175135|26767558|P4|Overall Study|Protocol Violation|0
7696867|NCT01175135|26767559|P3|Overall Study|Protocol Violation|0
7696868|NCT01175135|26767560|P2|Overall Study|Protocol Violation|1
7696869|NCT01175135|26767561|P1|Overall Study|Protocol Violation|1
7696870|NCT01175135|26767558|P4|Overall Study|Lost to Follow-up|0
7696871|NCT01175135|26767559|P3|Overall Study|Lost to Follow-up|0
7696872|NCT01175135|26767560|P2|Overall Study|Lost to Follow-up|2
7696873|NCT01175135|26767561|P1|Overall Study|Lost to Follow-up|1
7696874|NCT01175135|26767558|P4|Overall Study|Lack of Efficacy|5
7696875|NCT01175135|26767559|P3|Overall Study|Lack of Efficacy|0
7696876|NCT01175135|26767560|P2|Overall Study|Lack of Efficacy|5
7696877|NCT01175135|26767561|P1|Overall Study|Lack of Efficacy|4
7696878|NCT01175135|26767558|P4|Overall Study|Death|0
7696879|NCT01175135|26767559|P3|Overall Study|Death|0
7696880|NCT01175135|26767560|P2|Overall Study|Death|0
7696881|NCT01175135|26767561|P1|Overall Study|Death|1
7696882|NCT01175135|26767558|P4|Overall Study|Adverse Event|4
7696883|NCT01175135|26767559|P3|Overall Study|Adverse Event|3
7696884|NCT01175135|26767560|P2|Overall Study|Adverse Event|5
7696885|NCT01175135|26767561|P1|Overall Study|Adverse Event|2
7696886|NCT01175083|26767649|P6|Booster Epoch|Withdrawal by Subject|0
7696887|NCT01175083|26767650|P5|Booster Epoch|Withdrawal by Subject|0
7696888|NCT01175083|26767651|P4|Booster Epoch|Withdrawal by Subject|1
7696889|NCT01175083|26767652|P3|Booster Epoch|Withdrawal by Subject|0
7696890|NCT01175083|26767653|P2|Booster Epoch|Withdrawal by Subject|0
7696891|NCT01175083|26767654|P1|Booster Epoch|Withdrawal by Subject|0
7696892|NCT01175083|26767649|P6|Booster Epoch|Death|0
7696893|NCT01175083|26767650|P5|Booster Epoch|Death|0
7696894|NCT01175083|26767651|P4|Booster Epoch|Death|0
7696895|NCT01175083|26767652|P3|Booster Epoch|Death|1
7696896|NCT01175083|26767653|P2|Booster Epoch|Death|0
7696897|NCT01175083|26767654|P1|Booster Epoch|Death|0
7696898|NCT01175083|26767649|P6|Primary Epoch|Lost to Follow-up|1
7696899|NCT01175083|26767650|P5|Primary Epoch|Lost to Follow-up|0
7696900|NCT01175083|26767651|P4|Primary Epoch|Lost to Follow-up|0
7696901|NCT01175083|26767652|P3|Primary Epoch|Lost to Follow-up|0
7696902|NCT01175083|26767653|P2|Primary Epoch|Lost to Follow-up|0
7696903|NCT01175083|26767654|P1|Primary Epoch|Lost to Follow-up|0
7696904|NCT01175083|26767649|P6|Primary Epoch|Withdrawal by Subject|2
7696905|NCT01175083|26767650|P5|Primary Epoch|Withdrawal by Subject|0
7696906|NCT01175083|26767651|P4|Primary Epoch|Withdrawal by Subject|0
7696907|NCT01175083|26767652|P3|Primary Epoch|Withdrawal by Subject|0
7696908|NCT01175083|26767653|P2|Primary Epoch|Withdrawal by Subject|0
7696909|NCT01175083|26767654|P1|Primary Epoch|Withdrawal by Subject|0
7696910|NCT01175018|26767746|P2|Overall Study|Adverse Event|1
7696911|NCT01175018|26767747|P1|Overall Study|Adverse Event|3
7696912|NCT01174784|26767809|P1|Overall Study|Screen fails|4
7696913|NCT01174563|26767855|P1|Overall Study|Sponsor's decision|1
7696914|NCT01174563|26767855|P1|Overall Study|Rash Adverse Event|1
7696915|NCT01174563|26767855|P1|Overall Study|Participant Withdrew Consent|3
7696916|NCT01174563|26767855|P1|Overall Study|Investigator's Discretion|5
7696917|NCT01174563|26767855|P1|Overall Study|Death|5
7696918|NCT01174563|26767855|P1|Overall Study|Progressive Disease|45
7696919|NCT01174550|26767863|P2|Overall Study|Withdrawal by Subject|289
7696920|NCT01174550|26767864|P1|Overall Study|Withdrawal by Subject|543
7696921|NCT01174550|26767863|P2|Overall Study|Lost to Follow-up|510
7696922|NCT01174550|26767864|P1|Overall Study|Lost to Follow-up|652
7696923|NCT01174550|26767863|P2|Overall Study|Death|74
7696924|NCT01174550|26767864|P1|Overall Study|Death|75
7696925|NCT01174459|26767892|P1|Overall Study|case report form (CRF) not collected|5
7696926|NCT01174446|26767897|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7696927|NCT01174446|26767898|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7696928|NCT01174446|26767899|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
7696929|NCT01174446|26767900|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7696930|NCT01174446|26767897|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7696931|NCT01174446|26767898|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7696932|NCT01174446|26767899|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7696933|NCT01174446|26767900|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
7696934|NCT01174446|26767897|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7696935|NCT01174446|26767898|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
7696936|NCT01174446|26767899|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7696937|NCT01174446|26767900|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7696938|NCT01174446|26767897|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7696939|NCT01174446|26767898|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
7696940|NCT01174446|26767899|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7696941|NCT01174446|26767900|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7696942|NCT01174368|26768087|P1|Overall Study|Withdrawal by Subject|1
7696943|NCT01174342|26768093|P1|Overall Study|Conversion to cesarean section|4
7696944|NCT01174264|26768100|P3|Steady-state Pharmacokinetics|Not evaluable|2
7696945|NCT01174264|26768101|P2|Steady-state Pharmacokinetics|Not evaluable|0
7696946|NCT01174264|26768102|P1|Steady-state Pharmacokinetics|Not evaluable|6
7696947|NCT01174264|26768100|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
7696948|NCT01174264|26768101|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
7696949|NCT01174264|26768102|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
7696950|NCT01174264|26768100|P3|Single Dose Pharmacokinetics|Early progressive disease|1
7696951|NCT01174264|26768101|P2|Single Dose Pharmacokinetics|Early progressive disease|0
7696952|NCT01174264|26768102|P1|Single Dose Pharmacokinetics|Early progressive disease|1
7696953|NCT01174238|26768134|P1|Overall Study|Lost to Follow-up|2
7696954|NCT01174186|26768145|P2|Overall Study|Withdrawal by Subject|2
7696955|NCT01174186|26768146|P1|Overall Study|Withdrawal by Subject|0
7696956|NCT01174186|26768145|P2|Overall Study|Lost to Follow-up|1
7696957|NCT01174186|26768146|P1|Overall Study|Lost to Follow-up|0
7696958|NCT01174173|26768153|P1|Overall Study|drug-drug interaction|1
7696959|NCT01174160|26768164|P2|Overall Study|Withdrawal by Subject|0
7696960|NCT01174160|26768165|P1|Overall Study|Withdrawal by Subject|1
7696961|NCT01174160|26768164|P2|Overall Study|Protocol Violation|6
7696962|NCT01174160|26768165|P1|Overall Study|Protocol Violation|4
7696963|NCT01174160|26768164|P2|Overall Study|Physician Decision|0
7696964|NCT01174160|26768165|P1|Overall Study|Physician Decision|1
7696965|NCT01174160|26768164|P2|Overall Study|Lost to Follow-up|0
7696966|NCT01174160|26768165|P1|Overall Study|Lost to Follow-up|1
7696967|NCT01174160|26768164|P2|Overall Study|Adverse Event|0
7696968|NCT01174160|26768165|P1|Overall Study|Adverse Event|1
7696969|NCT01174043|26768180|P1|Overall Study|Withdrawal by Subject|2
7696970|NCT01174043|26768180|P1|Overall Study|Death|1
7696971|NCT01174043|26768180|P1|Overall Study|Adverse Event|3
7696972|NCT01174043|26768180|P1|Overall Study|Disease progression|5
7696973|NCT01174004|26768219|P2|Overall Study|Physician Decision|0
7696974|NCT01174004|26768220|P1|Overall Study|Physician Decision|1
7696975|NCT01174004|26768219|P2|Overall Study|Protocol Violation|1
7696976|NCT01174004|26768220|P1|Overall Study|Protocol Violation|0
7696977|NCT01174004|26768219|P2|Overall Study|At Discretion of Sponsor|2
7696978|NCT01174004|26768220|P1|Overall Study|At Discretion of Sponsor|2
7696979|NCT01174004|26768219|P2|Overall Study|Withdrawal by Subject|3
7696980|NCT01174004|26768220|P1|Overall Study|Withdrawal by Subject|2
7696981|NCT01174004|26768219|P2|Overall Study|Adverse Event|10
7696982|NCT01174004|26768220|P1|Overall Study|Adverse Event|2
7696983|NCT01173718|26768251|P1|Overall Study|Abandonment of study graft|27
7696984|NCT01173718|26768251|P1|Overall Study|Death|17
7696985|NCT01173692|26768262|P2|Overall Study|Withdrawal by Subject|3
7696986|NCT01173692|26768263|P1|Overall Study|Withdrawal by Subject|1
7696987|NCT01173692|26768262|P2|Overall Study|Adverse Event|2
7696988|NCT01173692|26768263|P1|Overall Study|Adverse Event|1
7696989|NCT01173679|26768269|P1|Overall Study|Death|1
7696990|NCT01173653|26768277|P2|Overall Study|Pts unwilling to provide follow-up|41
7696991|NCT01173653|26768278|P1|Overall Study|Pts unwilling to provide follow-up|53
7696992|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
7696993|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7696994|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7696995|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7696996|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7696997|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
7696998|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
7696999|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
7697000|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7697001|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7697002|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7697003|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
7697004|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7697005|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
7697006|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7697007|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7697008|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7697009|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7697010|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7697011|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7697012|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
7697013|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
7697014|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7697015|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
7697016|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7697017|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
7697018|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
7697019|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
7697020|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
7697021|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7697022|NCT01173601|26768288|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
7697023|NCT01173601|26768289|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
7697024|NCT01173601|26768290|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
7697025|NCT01173601|26768291|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
7697026|NCT01173601|26768292|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7697027|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7697028|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7697029|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7697030|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7697031|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
7697032|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7697033|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7697034|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7697035|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7697036|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
7697037|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7697038|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7697039|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7697040|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7697041|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
7697042|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7697043|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7697044|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7697045|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7697046|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
7697047|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7697048|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7697049|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7697050|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7697051|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
7697052|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7697053|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7697054|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7697055|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7697056|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
7697057|NCT01173601|26768288|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7697058|NCT01173601|26768289|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7697059|NCT01173601|26768290|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7697060|NCT01173601|26768291|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7697061|NCT01173601|26768292|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
7697062|NCT01173523|26768369|P2|Overall Study|Other|3
7697063|NCT01173523|26768370|P1|Overall Study|Other|2
7697064|NCT01173523|26768369|P2|Overall Study|Progressive Disease|8
7697065|NCT01173523|26768370|P1|Overall Study|Progressive Disease|10
7697066|NCT01173523|26768369|P2|Overall Study|Clinical Progression|1
7697067|NCT01173523|26768370|P1|Overall Study|Clinical Progression|1
7697068|NCT01173471|26768386|P4|Overall Study|Reason given as Other|0
7697069|NCT01173471|26768387|P3|Overall Study|Reason given as Other|1
7697070|NCT01173471|26768388|P2|Overall Study|Reason given as Other|0
7697071|NCT01173471|26768389|P1|Overall Study|Reason given as Other|0
7697072|NCT01173471|26768386|P4|Overall Study|Lost to Follow-up|0
7697073|NCT01173471|26768387|P3|Overall Study|Lost to Follow-up|1
7697074|NCT01173471|26768388|P2|Overall Study|Lost to Follow-up|0
7697075|NCT01173471|26768389|P1|Overall Study|Lost to Follow-up|0
7697076|NCT01173471|26768386|P4|Overall Study|Condition under investigation worsened|0
7697077|NCT01173471|26768387|P3|Overall Study|Condition under investigation worsened|0
7697078|NCT01173471|26768388|P2|Overall Study|Condition under investigation worsened|0
7697079|NCT01173471|26768389|P1|Overall Study|Condition under investigation worsened|2
7697080|NCT01173471|26768386|P4|Overall Study|Eligibility criteria not fulfilled|1
7697081|NCT01173471|26768387|P3|Overall Study|Eligibility criteria not fulfilled|1
7697082|NCT01173471|26768388|P2|Overall Study|Eligibility criteria not fulfilled|0
7697083|NCT01173471|26768389|P1|Overall Study|Eligibility criteria not fulfilled|0
7697084|NCT01173120|26768529|P1|Overall Study|Switch-Difficulty With Device|12
7697085|NCT01173120|26768529|P1|Overall Study|Switch-Participant Decision|12
7697086|NCT01173120|26768529|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
7697087|NCT01173120|26768529|P1|Overall Study|Participant Decision|2
7697088|NCT01173120|26768529|P1|Overall Study|Lost to Follow-up|1
7697089|NCT01173120|26768529|P1|Overall Study|Lack of Efficacy|2
7697090|NCT01173055|26768547|P2|Period 2 - Day 64 to 112|Adverse Event|1
7697091|NCT01173055|26768548|P1|Period 2 - Day 64 to 112|Adverse Event|0
7697092|NCT01173055|26768547|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
7697093|NCT01173055|26768548|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
7697094|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
7697095|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697096|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697097|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697098|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697099|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697100|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697101|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697102|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7697103|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697104|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697105|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697106|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697107|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697108|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697109|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
7697110|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697111|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7697112|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
7697113|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
7697114|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
7697115|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
7697116|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
7697117|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
7697118|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
7697119|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
7697120|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
7697121|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7697122|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
7697123|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7697124|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7697125|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7697126|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7697127|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
7697128|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
7697129|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7697130|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697131|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
7697132|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697133|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697134|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697135|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697136|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697137|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
7697138|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7697139|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697140|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697141|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697142|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697143|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697144|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697145|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
7697146|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697147|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7697148|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7697149|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7697150|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7697151|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7697152|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7697153|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7697154|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7697155|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7697156|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7697157|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697158|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
7697159|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697160|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697161|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697162|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697163|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697164|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697165|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7697166|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
7697167|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697168|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697169|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697170|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697171|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697172|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
7697173|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697174|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7697175|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
7697176|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
7697177|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7697178|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7697179|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7697180|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7697181|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
7697182|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
7697183|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7697184|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
7697185|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
7697186|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7697187|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7697188|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7697189|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7697190|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
7697191|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
7697192|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7697193|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7697194|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
7697195|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7697196|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7697197|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7697198|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7697199|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
7697200|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
7697201|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7697202|NCT01172938|26768599|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697203|NCT01172938|26768600|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697204|NCT01172938|26768601|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697205|NCT01172938|26768602|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697206|NCT01172938|26768603|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697207|NCT01172938|26768604|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697208|NCT01172938|26768605|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
7697209|NCT01172938|26768606|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697210|NCT01172938|26768607|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7697211|NCT01172938|26768599|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697212|NCT01172938|26768600|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697213|NCT01172938|26768601|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697214|NCT01172938|26768602|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697215|NCT01172938|26768603|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697216|NCT01172938|26768604|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697217|NCT01172938|26768605|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697218|NCT01172938|26768606|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
7697219|NCT01172938|26768607|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7697220|NCT01172938|26768599|P9|Active-Treatment Phase Weeks (104-156)|Death|0
7697221|NCT01172938|26768600|P8|Active-Treatment Phase Weeks (104-156)|Death|1
7697222|NCT01172938|26768601|P7|Active-Treatment Phase Weeks (104-156)|Death|0
7697223|NCT01172938|26768602|P6|Active-Treatment Phase Weeks (104-156)|Death|0
7697224|NCT01172938|26768603|P5|Active-Treatment Phase Weeks (104-156)|Death|0
7697225|NCT01172938|26768604|P4|Active-Treatment Phase Weeks (104-156)|Death|0
7697226|NCT01172938|26768605|P3|Active-Treatment Phase Weeks (104-156)|Death|0
7697227|NCT01172938|26768606|P2|Active-Treatment Phase Weeks (104-156)|Death|0
7697228|NCT01172938|26768607|P1|Active-Treatment Phase Weeks (104-156)|Death|0
7697229|NCT01172938|26768599|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
7697230|NCT01172938|26768600|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
7697231|NCT01172938|26768601|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7697232|NCT01172938|26768602|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7697233|NCT01172938|26768603|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7697234|NCT01172938|26768604|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7697235|NCT01172938|26768605|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
7697236|NCT01172938|26768606|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
7697237|NCT01172938|26768607|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7697238|NCT01172938|26768599|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7697239|NCT01172938|26768600|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7697240|NCT01172938|26768601|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7697241|NCT01172938|26768602|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7697242|NCT01172938|26768603|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7697243|NCT01172938|26768604|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7697244|NCT01172938|26768605|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7697245|NCT01172938|26768606|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
7697246|NCT01172938|26768607|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7697247|NCT01172938|26768599|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
7697248|NCT01172938|26768600|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697249|NCT01172938|26768601|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697250|NCT01172938|26768602|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697251|NCT01172938|26768603|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697252|NCT01172938|26768604|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697253|NCT01172938|26768605|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697254|NCT01172938|26768606|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697255|NCT01172938|26768607|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7697256|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697257|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697258|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697259|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697260|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697261|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697262|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697263|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
7697264|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
7697265|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
7697266|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697267|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697268|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697269|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697270|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697271|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697272|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
7697273|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7697274|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7697275|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
7697276|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7697277|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7697278|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7697279|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7697280|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
7697281|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
7697282|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7697283|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
7697284|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
7697285|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
7697286|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
7697287|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
7697288|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
7697289|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
7697290|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
7697291|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
7697292|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
7697293|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
7697294|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7697295|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7697296|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7697297|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7697298|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
7697299|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
7697300|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7697301|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697302|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697303|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697304|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697305|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697306|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697307|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
7697308|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697309|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7697310|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7697311|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
7697312|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7697313|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7697314|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7697315|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7697316|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
7697317|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
7697318|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7697319|NCT01172938|26768599|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
7697320|NCT01172938|26768600|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
7697321|NCT01172938|26768601|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7697322|NCT01172938|26768602|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7697323|NCT01172938|26768603|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7697324|NCT01172938|26768604|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7697325|NCT01172938|26768605|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
7697326|NCT01172938|26768606|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
7697327|NCT01172938|26768607|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7697328|NCT01172938|26768599|P9|Active Treatment Phase (Weeks 25-52)|Other|0
7697329|NCT01172938|26768600|P8|Active Treatment Phase (Weeks 25-52)|Other|0
7697330|NCT01172938|26768601|P7|Active Treatment Phase (Weeks 25-52)|Other|1
7697331|NCT01172938|26768602|P6|Active Treatment Phase (Weeks 25-52)|Other|1
7697332|NCT01172938|26768603|P5|Active Treatment Phase (Weeks 25-52)|Other|0
7697333|NCT01172938|26768604|P4|Active Treatment Phase (Weeks 25-52)|Other|0
7697334|NCT01172938|26768605|P3|Active Treatment Phase (Weeks 25-52)|Other|0
7697335|NCT01172938|26768606|P2|Active Treatment Phase (Weeks 25-52)|Other|0
7697336|NCT01172938|26768607|P1|Active Treatment Phase (Weeks 25-52)|Other|0
7697337|NCT01172938|26768599|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7697338|NCT01172938|26768600|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7697339|NCT01172938|26768601|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7697340|NCT01172938|26768602|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7697341|NCT01172938|26768603|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7697342|NCT01172938|26768604|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7697343|NCT01172938|26768605|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7697344|NCT01172938|26768606|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7697345|NCT01172938|26768607|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7697346|NCT01172938|26768599|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7697347|NCT01172938|26768600|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7697348|NCT01172938|26768601|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
7697349|NCT01172938|26768602|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
7697350|NCT01172938|26768603|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
7697351|NCT01172938|26768604|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
7697352|NCT01172938|26768605|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
7697353|NCT01172938|26768606|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
7697354|NCT01172938|26768607|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7697355|NCT01172938|26768599|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697356|NCT01172938|26768600|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697357|NCT01172938|26768601|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697358|NCT01172938|26768602|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697359|NCT01172938|26768603|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697360|NCT01172938|26768604|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697361|NCT01172938|26768605|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
7697362|NCT01172938|26768606|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697363|NCT01172938|26768607|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7697364|NCT01172938|26768599|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7697365|NCT01172938|26768600|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7697366|NCT01172938|26768601|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7697367|NCT01172938|26768602|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
7697368|NCT01172938|26768603|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
7697369|NCT01172938|26768604|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
7697370|NCT01172938|26768605|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
7697371|NCT01172938|26768606|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
7697372|NCT01172938|26768607|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7697373|NCT01172938|26768599|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7697374|NCT01172938|26768600|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7697375|NCT01172938|26768601|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7697376|NCT01172938|26768602|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
7697377|NCT01172938|26768603|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
7697378|NCT01172938|26768604|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
7697379|NCT01172938|26768605|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
7697380|NCT01172938|26768606|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
7697381|NCT01172938|26768607|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7697382|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Other|0
7697383|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Other|0
7697384|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Other|0
7697385|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Other|0
7697386|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Other|0
7697387|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Other|0
7697388|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Other|1
7697389|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Other|2
7697390|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Other|0
7697391|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697392|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697393|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697394|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697395|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697396|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697397|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697398|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7697399|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
7697400|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Death|0
7697401|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Death|0
7697402|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Death|0
7697403|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Death|0
7697404|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Death|0
7697405|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Death|0
7697406|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Death|0
7697407|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Death|1
7697408|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Death|0
7697409|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7697410|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7697493|NCT01172639|26769021|P4|Overall Study|Withdrawal by Subject|5
7697411|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7697412|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7697413|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7697414|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7697415|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7697416|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7697417|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
7697418|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697419|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697420|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697421|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697422|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697423|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697424|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
7697425|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7697426|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7697427|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7697428|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7697429|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7697430|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7697431|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7697432|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7697433|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
7697434|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7697435|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
7697436|NCT01172938|26768599|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7697437|NCT01172938|26768600|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7697438|NCT01172938|26768601|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7697439|NCT01172938|26768602|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7697440|NCT01172938|26768603|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7697441|NCT01172938|26768604|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7697442|NCT01172938|26768605|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
7697443|NCT01172938|26768606|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
7697444|NCT01172938|26768607|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
7697445|NCT01172873|26768793|P2|Overall Study|Withdrawal by Subject|2
7697446|NCT01172873|26768794|P1|Overall Study|Withdrawal by Subject|3
7697447|NCT01172847|26768804|P1|Overall Study|Withdrawal by Subject|3
7697448|NCT01172821|26768833|P4|Overall Study|Other|3
7697449|NCT01172821|26768834|P3|Overall Study|Other|5
7697450|NCT01172821|26768835|P2|Overall Study|Other|4
7697451|NCT01172821|26768836|P1|Overall Study|Other|3
7697452|NCT01172821|26768833|P4|Overall Study|Withdrawal by Subject|3
7697453|NCT01172821|26768834|P3|Overall Study|Withdrawal by Subject|3
7697454|NCT01172821|26768835|P2|Overall Study|Withdrawal by Subject|3
7697455|NCT01172821|26768836|P1|Overall Study|Withdrawal by Subject|2
7697456|NCT01172821|26768833|P4|Overall Study|Lost to Follow-up|2
7697457|NCT01172821|26768834|P3|Overall Study|Lost to Follow-up|2
7697458|NCT01172821|26768835|P2|Overall Study|Lost to Follow-up|1
7697459|NCT01172821|26768836|P1|Overall Study|Lost to Follow-up|4
7697460|NCT01172821|26768833|P4|Overall Study|Protocol Violation|2
7697461|NCT01172821|26768834|P3|Overall Study|Protocol Violation|1
7697462|NCT01172821|26768835|P2|Overall Study|Protocol Violation|2
7697463|NCT01172821|26768836|P1|Overall Study|Protocol Violation|0
7697464|NCT01172821|26768833|P4|Overall Study|Adverse Event|7
7697465|NCT01172821|26768834|P3|Overall Study|Adverse Event|2
7697466|NCT01172821|26768835|P2|Overall Study|Adverse Event|2
7697467|NCT01172821|26768836|P1|Overall Study|Adverse Event|5
7697468|NCT01172808|26768926|P4|Overall Study|Other|7
7697469|NCT01172808|26768927|P3|Overall Study|Other|9
7697470|NCT01172808|26768928|P2|Overall Study|Other|5
7697471|NCT01172808|26768929|P1|Overall Study|Other|6
7697472|NCT01172808|26768926|P4|Overall Study|Withdrawal by Subject|2
7697473|NCT01172808|26768927|P3|Overall Study|Withdrawal by Subject|3
7697474|NCT01172808|26768928|P2|Overall Study|Withdrawal by Subject|1
7697475|NCT01172808|26768929|P1|Overall Study|Withdrawal by Subject|4
7697476|NCT01172808|26768926|P4|Overall Study|Lost to Follow-up|3
7697477|NCT01172808|26768927|P3|Overall Study|Lost to Follow-up|1
7697478|NCT01172808|26768928|P2|Overall Study|Lost to Follow-up|1
7697479|NCT01172808|26768929|P1|Overall Study|Lost to Follow-up|0
7697480|NCT01172808|26768926|P4|Overall Study|Protocol Violation|0
7697481|NCT01172808|26768927|P3|Overall Study|Protocol Violation|2
7697482|NCT01172808|26768928|P2|Overall Study|Protocol Violation|2
7697483|NCT01172808|26768929|P1|Overall Study|Protocol Violation|2
7697484|NCT01172808|26768926|P4|Overall Study|Lack of Efficacy|0
7697485|NCT01172808|26768927|P3|Overall Study|Lack of Efficacy|0
7697486|NCT01172808|26768928|P2|Overall Study|Lack of Efficacy|0
7697487|NCT01172808|26768929|P1|Overall Study|Lack of Efficacy|1
7697488|NCT01172808|26768926|P4|Overall Study|Adverse Event|3
7697489|NCT01172808|26768927|P3|Overall Study|Adverse Event|8
7697490|NCT01172808|26768928|P2|Overall Study|Adverse Event|4
7697491|NCT01172808|26768929|P1|Overall Study|Adverse Event|8
7697492|NCT01172639|26769020|P5|Overall Study|Withdrawal by Subject|0
7697494|NCT01172639|26769022|P3|Overall Study|Withdrawal by Subject|5
7697495|NCT01172639|26769023|P2|Overall Study|Withdrawal by Subject|3
7697496|NCT01172639|26769024|P1|Overall Study|Withdrawal by Subject|3
7697497|NCT01172639|26769020|P5|Overall Study|Lost to Follow-up|6
7697498|NCT01172639|26769021|P4|Overall Study|Lost to Follow-up|6
7697499|NCT01172639|26769022|P3|Overall Study|Lost to Follow-up|11
7697500|NCT01172639|26769023|P2|Overall Study|Lost to Follow-up|7
7697501|NCT01172639|26769024|P1|Overall Study|Lost to Follow-up|9
7697502|NCT01172639|26769020|P5|Overall Study|Death|0
7697503|NCT01172639|26769021|P4|Overall Study|Death|0
7697504|NCT01172639|26769022|P3|Overall Study|Death|0
7697505|NCT01172639|26769023|P2|Overall Study|Death|1
7697506|NCT01172639|26769024|P1|Overall Study|Death|1
7697507|NCT01172535|26769099|P1|Overall Study|Unwilling to adhere to study requirement|1
7697508|NCT01172535|26769099|P1|Overall Study|Ineligible at study entry|1
7697509|NCT01172535|26769099|P1|Overall Study|Lost to Follow-up|1
7697510|NCT01172535|26769099|P1|Overall Study|Withdrawal by Subject|2
7697511|NCT01172535|26769099|P1|Overall Study|Death|3
7697512|NCT01172288|26769152|P2|Overall Study|Protocol Violation|1
7697513|NCT01172288|26769153|P1|Overall Study|Protocol Violation|0
7697514|NCT01172288|26769152|P2|Overall Study|Adverse Event|0
7697515|NCT01172288|26769153|P1|Overall Study|Adverse Event|1
7697516|NCT01172275|26769169|P2|Overall Study|Protocol Violation|0
7697517|NCT01172275|26769170|P1|Overall Study|Protocol Violation|1
7697518|NCT01172275|26769169|P2|Overall Study|Lost to Follow-up|0
7697519|NCT01172275|26769170|P1|Overall Study|Lost to Follow-up|1
7697520|NCT01171989|26769228|P3|Overall Study|Lost to Follow-up|1
7697521|NCT01171989|26769229|P2|Overall Study|Lost to Follow-up|0
7697522|NCT01171989|26769230|P1|Overall Study|Lost to Follow-up|0
7697523|NCT01171976|26769304|P3|Overall Study|Adverse Event|5
7697524|NCT01171976|26769305|P2|Overall Study|Adverse Event|2
7697525|NCT01171976|26769306|P1|Overall Study|Adverse Event|6
7697526|NCT01171976|26769304|P3|Overall Study|Abnormal test result|0
7697527|NCT01171976|26769305|P2|Overall Study|Abnormal test result|0
7697528|NCT01171976|26769306|P1|Overall Study|Abnormal test result|1
7697529|NCT01171976|26769304|P3|Overall Study|Withdrawal by Subject|6
7697530|NCT01171976|26769305|P2|Overall Study|Withdrawal by Subject|5
7697531|NCT01171976|26769306|P1|Overall Study|Withdrawal by Subject|1
7697532|NCT01171976|26769304|P3|Overall Study|Lost to Follow-up|2
7697533|NCT01171976|26769305|P2|Overall Study|Lost to Follow-up|0
7697534|NCT01171976|26769306|P1|Overall Study|Lost to Follow-up|4
7697535|NCT01171976|26769304|P3|Overall Study|Death|1
7697536|NCT01171976|26769305|P2|Overall Study|Death|4
7697537|NCT01171976|26769306|P1|Overall Study|Death|2
7697538|NCT01171976|26769304|P3|Overall Study|Protocol Violation|1
7697539|NCT01171976|26769305|P2|Overall Study|Protocol Violation|0
7697540|NCT01171976|26769306|P1|Overall Study|Protocol Violation|0
7697541|NCT01171963|26769343|P2|Overall Study|Withdrawal by Subject|129
7697542|NCT01171963|26769344|P1|Overall Study|Withdrawal by Subject|114
7697543|NCT01171963|26769343|P2|Overall Study|Other - diarrhoea|0
7697544|NCT01171963|26769344|P1|Overall Study|Other - diarrhoea|1
7697545|NCT01171963|26769343|P2|Overall Study|Lost to Follow-up|24
7697546|NCT01171963|26769344|P1|Overall Study|Lost to Follow-up|23
7697547|NCT01171963|26769343|P2|Overall Study|Adverse Event|15
7697548|NCT01171963|26769344|P1|Overall Study|Adverse Event|10
7697549|NCT01171898|26769413|P4|Overall Study|Other|2
7697550|NCT01171898|26769414|P3|Overall Study|Other|0
7697551|NCT01171898|26769415|P2|Overall Study|Other|5
7697552|NCT01171898|26769416|P1|Overall Study|Other|1
7697553|NCT01171898|26769413|P4|Overall Study|Ongoing|0
7697554|NCT01171898|26769414|P3|Overall Study|Ongoing|3
7697555|NCT01171898|26769415|P2|Overall Study|Ongoing|9
7697556|NCT01171898|26769416|P1|Overall Study|Ongoing|1
7697557|NCT01171898|26769413|P4|Overall Study|Terminated by Sponsor|0
7697558|NCT01171898|26769414|P3|Overall Study|Terminated by Sponsor|0
7697559|NCT01171898|26769415|P2|Overall Study|Terminated by Sponsor|0
7697560|NCT01171898|26769416|P1|Overall Study|Terminated by Sponsor|1
7697561|NCT01171898|26769413|P4|Overall Study|Withdrawal by Subject|3
7697562|NCT01171898|26769414|P3|Overall Study|Withdrawal by Subject|6
7697563|NCT01171898|26769415|P2|Overall Study|Withdrawal by Subject|4
7697564|NCT01171898|26769416|P1|Overall Study|Withdrawal by Subject|1
7697565|NCT01171898|26769413|P4|Overall Study|Lost to Follow-up|1
7697566|NCT01171898|26769414|P3|Overall Study|Lost to Follow-up|1
7697567|NCT01171898|26769415|P2|Overall Study|Lost to Follow-up|1
7697568|NCT01171898|26769416|P1|Overall Study|Lost to Follow-up|0
7697569|NCT01171898|26769413|P4|Overall Study|Death|0
7697570|NCT01171898|26769414|P3|Overall Study|Death|2
7697571|NCT01171898|26769415|P2|Overall Study|Death|0
7697572|NCT01171898|26769416|P1|Overall Study|Death|0
7697573|NCT01171820|26769440|P2|Overall Study|1-Year Missed Visit|1
7697574|NCT01171820|26769441|P1|Overall Study|1-Year Missed Visit|1
7697575|NCT01171820|26769440|P2|Overall Study|Physician Decision|1
7697576|NCT01171820|26769441|P1|Overall Study|Physician Decision|0
7697577|NCT01171820|26769440|P2|Overall Study|Withdrawal by Subject|0
7697578|NCT01171820|26769441|P1|Overall Study|Withdrawal by Subject|2
7697579|NCT01171820|26769440|P2|Overall Study|Lost to Follow-up|1
7697580|NCT01171820|26769441|P1|Overall Study|Lost to Follow-up|0
7697581|NCT01171820|26769440|P2|Overall Study|Death|3
7697582|NCT01171820|26769441|P1|Overall Study|Death|3
7697583|NCT01171677|26769519|P2|Overall Study|completed <70% IntenSati classes|0
7697584|NCT01171677|26769520|P1|Overall Study|completed <70% IntenSati classes|5
7697585|NCT01171677|26769519|P2|Overall Study|Adverse Event|0
7697586|NCT01171677|26769520|P1|Overall Study|Adverse Event|1
7697587|NCT01171677|26769519|P2|Overall Study|Withdrawal by Subject|3
7697588|NCT01171677|26769520|P1|Overall Study|Withdrawal by Subject|0
7697589|NCT01171625|26769552|P1|Overall Study|Consented but did not receive device|25
7697590|NCT01171625|26769552|P1|Overall Study|Other|1
7697591|NCT01171625|26769552|P1|Overall Study|Patient received valve-in-valve|3
7697592|NCT01171625|26769552|P1|Overall Study|Lost to Follow-up|5
7697593|NCT01171625|26769552|P1|Overall Study|Explanted|10
7697594|NCT01171625|26769552|P1|Overall Study|Withdrawal by Subject|31
7697595|NCT01171625|26769552|P1|Overall Study|Death|38
7697596|NCT01171625|26769552|P1|Overall Study|On-Protocol|67
7697597|NCT01171612|26769585|P1|Overall Study|Lost to Follow-up|51
7697598|NCT01171534|26769595|P2|Overall Study|screen failure|1
7697599|NCT01171534|26769596|P1|Overall Study|screen failure|0
7697600|NCT01171534|26769595|P2|Overall Study|Lost to Follow-up|2
7697601|NCT01171534|26769596|P1|Overall Study|Lost to Follow-up|0
7697602|NCT01171521|26769608|P1|Overall Study|screen failure|1
7697603|NCT01171521|26769608|P1|Overall Study|Lost to Follow-up|5
7697604|NCT01171183|26769615|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
7697605|NCT01171183|26769616|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
7697606|NCT01171183|26769615|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
7697607|NCT01171183|26769616|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
7697608|NCT01171183|26769615|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
7697609|NCT01171183|26769616|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
7697610|NCT01171183|26769615|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
7697611|NCT01171183|26769616|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
7697612|NCT01171183|26769615|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
7697613|NCT01171183|26769616|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
7697614|NCT01171183|26769615|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
7697615|NCT01171183|26769616|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
7697616|NCT01170962|26769637|P3|Follow up Period|Others|3
7697617|NCT01170962|26769638|P2|Follow up Period|Others|7
7697618|NCT01170962|26769639|P1|Follow up Period|Others|10
7697619|NCT01170962|26769637|P3|Follow up Period|Death|0
7697620|NCT01170962|26769638|P2|Follow up Period|Death|2
7697621|NCT01170962|26769639|P1|Follow up Period|Death|2
7697622|NCT01170962|26769637|P3|Follow up Period|Lost to Follow-up|1
7697623|NCT01170962|26769638|P2|Follow up Period|Lost to Follow-up|8
7697624|NCT01170962|26769639|P1|Follow up Period|Lost to Follow-up|13
7697625|NCT01170962|26769637|P3|Follow up Period|Withdrawal by Subject|2
7697626|NCT01170962|26769638|P2|Follow up Period|Withdrawal by Subject|10
7697627|NCT01170962|26769639|P1|Follow up Period|Withdrawal by Subject|14
7697628|NCT01170962|26769637|P3|Treatment Period|Completed 24 Week treatment period only|0
7697629|NCT01170962|26769638|P2|Treatment Period|Completed 24 Week treatment period only|2
7697630|NCT01170962|26769639|P1|Treatment Period|Completed 24 Week treatment period only|10
7697631|NCT01170962|26769637|P3|Treatment Period|Request to discontinue treatment|1
7697632|NCT01170962|26769638|P2|Treatment Period|Request to discontinue treatment|3
7697633|NCT01170962|26769639|P1|Treatment Period|Request to discontinue treatment|7
7697634|NCT01170962|26769637|P3|Treatment Period|Participant no longer meets criteria|0
7697635|NCT01170962|26769638|P2|Treatment Period|Participant no longer meets criteria|1
7697636|NCT01170962|26769639|P1|Treatment Period|Participant no longer meets criteria|0
7697637|NCT01170962|26769637|P3|Treatment Period|Lost to Follow-up|1
7697638|NCT01170962|26769638|P2|Treatment Period|Lost to Follow-up|1
7697639|NCT01170962|26769639|P1|Treatment Period|Lost to Follow-up|1
7697640|NCT01170962|26769637|P3|Treatment Period|Withdrawal by Subject|0
7697641|NCT01170962|26769638|P2|Treatment Period|Withdrawal by Subject|1
7697642|NCT01170962|26769639|P1|Treatment Period|Withdrawal by Subject|2
7697643|NCT01170962|26769637|P3|Treatment Period|Adverse Event|3
7697644|NCT01170962|26769638|P2|Treatment Period|Adverse Event|12
7697645|NCT01170962|26769639|P1|Treatment Period|Adverse Event|11
7697646|NCT01170962|26769637|P3|Treatment Period|Lack of Efficacy|7
7697647|NCT01170962|26769638|P2|Treatment Period|Lack of Efficacy|91
7697648|NCT01170962|26769639|P1|Treatment Period|Lack of Efficacy|96
7697649|NCT01170663|26769740|P2|Overall Study|Withdrawal of consent without follow-up|11
7697650|NCT01170663|26769741|P1|Overall Study|Withdrawal of consent without follow-up|11
7697651|NCT01170663|26769740|P2|Overall Study|Lost to Follow-up|9
7697652|NCT01170663|26769741|P1|Overall Study|Lost to Follow-up|3
7697653|NCT01170598|26769769|P1|Overall Study|Refused|1
7697654|NCT01170598|26769769|P1|Overall Study|Lost to Follow-up|1
7697655|NCT01170598|26769769|P1|Overall Study|Death|3
7697656|NCT01170598|26769769|P1|Overall Study|Withdrawal by Subject|1
7697657|NCT01170364|26769832|P2|Overall Study|Protocol Violation|1
7697658|NCT01170364|26769833|P1|Overall Study|Protocol Violation|4
7697659|NCT01170273|26769841|P2|Overall Study|Adverse Event|1
7697660|NCT01170273|26769842|P1|Overall Study|Adverse Event|0
7697661|NCT01170273|26769841|P2|Overall Study|Death|0
7697662|NCT01170273|26769842|P1|Overall Study|Death|1
7697663|NCT01170273|26769841|P2|Overall Study|Protocol Violation|0
7697664|NCT01170273|26769842|P1|Overall Study|Protocol Violation|1
7697665|NCT01170273|26769841|P2|Overall Study|Lost to Follow-up|8
7697666|NCT01170273|26769842|P1|Overall Study|Lost to Follow-up|6
7697667|NCT01170221|26769859|P2|Overall Study|Randomized but not treated|0
7697668|NCT01170221|26769860|P1|Overall Study|Randomized but not treated|1
7697669|NCT01170221|26769859|P2|Overall Study|Subject completed only screening and LFU|0
7697670|NCT01170221|26769860|P1|Overall Study|Subject completed only screening and LFU|1
7697671|NCT01170221|26769859|P2|Overall Study|Withdrawal by Subject|7
7697672|NCT01170221|26769860|P1|Overall Study|Withdrawal by Subject|9
7697673|NCT01170221|26769859|P2|Overall Study|Lost to Follow-up|21
7697674|NCT01170221|26769860|P1|Overall Study|Lost to Follow-up|22
7697675|NCT01170208|26769883|P3|Overall Study|Protocol Violation|1
7697676|NCT01170208|26769884|P2|Overall Study|Protocol Violation|0
7697677|NCT01170208|26769885|P1|Overall Study|Protocol Violation|1
7697678|NCT01170208|26769883|P3|Overall Study|Withdrawal by Subject|1
7697679|NCT01170208|26769884|P2|Overall Study|Withdrawal by Subject|0
7697680|NCT01170208|26769885|P1|Overall Study|Withdrawal by Subject|5
7697681|NCT01170091|26769913|P1|Overall Study|Treatment duration is less than 4 weeks|21
7697682|NCT01170091|26769913|P1|Overall Study|Missing efficacy evaluation|3
7697683|NCT01170065|26769923|P3|Overall Study|Ongoing after planned observation time|10
7697684|NCT01170065|26769924|P2|Overall Study|Ongoing after planned observation time|26
7697685|NCT01170065|26769925|P1|Overall Study|Ongoing after planned observation time|5
7697686|NCT01170065|26769923|P3|Overall Study|Reason other than specified|3
7697687|NCT01170065|26769924|P2|Overall Study|Reason other than specified|8
7697688|NCT01170065|26769925|P1|Overall Study|Reason other than specified|3
7697689|NCT01170065|26769923|P3|Overall Study|Consent withdrawn, not due to AE|2
7697690|NCT01170065|26769924|P2|Overall Study|Consent withdrawn, not due to AE|4
7697691|NCT01170065|26769925|P1|Overall Study|Consent withdrawn, not due to AE|2
7697692|NCT01170065|26769923|P3|Overall Study|Lost to Follow-up|1
7697693|NCT01170065|26769924|P2|Overall Study|Lost to Follow-up|4
7697694|NCT01170065|26769925|P1|Overall Study|Lost to Follow-up|1
7697695|NCT01170065|26769923|P3|Overall Study|Adverse Event|10
7697696|NCT01170065|26769924|P2|Overall Study|Adverse Event|50
7697697|NCT01170065|26769925|P1|Overall Study|Adverse Event|17
7697698|NCT01170039|26769956|P2|Overall Study|Lack of funding, drug not available|3
7697699|NCT01170039|26769957|P1|Overall Study|Lack of funding, drug not available|3
7697700|NCT01170039|26769956|P2|Overall Study|Withdrawal by Subject|3
7697701|NCT01170039|26769957|P1|Overall Study|Withdrawal by Subject|5
7697702|NCT01169987|26769969|P1|Overall Study|Other|4
7697703|NCT01169987|26769969|P1|Overall Study|Lost to Follow-up|24
7697704|NCT01169987|26769969|P1|Overall Study|Withdrawal by Subject|3
7697705|NCT01169844|26770035|P2|Overall Study|Unsatisfactory therapeutic effect|0
7697706|NCT01169844|26770036|P1|Overall Study|Unsatisfactory therapeutic effect|1
7697707|NCT01169844|26770035|P2|Overall Study|Patient withdrew consent|0
7697708|NCT01169844|26770036|P1|Overall Study|Patient withdrew consent|4
7697709|NCT01169844|26770035|P2|Overall Study|Adverse Event|1
7697710|NCT01169844|26770036|P1|Overall Study|Adverse Event|0
7697711|NCT01169779|26770048|P2|Overall Study|Familial and personal reasons|3
7697712|NCT01169779|26770049|P1|Overall Study|Familial and personal reasons|3
7697713|NCT01169779|26770048|P2|Overall Study|Withdrawal by Subject|2
7697714|NCT01169779|26770049|P1|Overall Study|Withdrawal by Subject|3
7697715|NCT01169779|26770048|P2|Overall Study|Protocol Violation|1
7697716|NCT01169779|26770049|P1|Overall Study|Protocol Violation|1
7697717|NCT01169779|26770048|P2|Overall Study|Lack of Efficacy|0
7697718|NCT01169779|26770049|P1|Overall Study|Lack of Efficacy|1
7697719|NCT01169779|26770048|P2|Overall Study|Adverse Event|11
7697720|NCT01169779|26770049|P1|Overall Study|Adverse Event|3
7697721|NCT01169701|26770084|P2|Overall Study|Sponsor decision|1
7697722|NCT01169701|26770085|P1|Overall Study|Sponsor decision|0
7697723|NCT01169701|26770084|P2|Overall Study|Serious adverse event|1
7697724|NCT01169701|26770085|P1|Overall Study|Serious adverse event|0
7697725|NCT01169701|26770084|P2|Overall Study|Administrative problems|1
7697726|NCT01169701|26770085|P1|Overall Study|Administrative problems|0
7697727|NCT01169701|26770084|P2|Overall Study|Death|1
7697728|NCT01169701|26770085|P1|Overall Study|Death|0
7697729|NCT01169701|26770084|P2|Overall Study|Exclusion criteria|0
7697730|NCT01169701|26770085|P1|Overall Study|Exclusion criteria|2
7697731|NCT01169701|26770084|P2|Overall Study|Adverse Event|2
7697732|NCT01169701|26770085|P1|Overall Study|Adverse Event|1
7697733|NCT01169701|26770084|P2|Overall Study|Withdrawal by Subject|3
7697734|NCT01169701|26770085|P1|Overall Study|Withdrawal by Subject|1
7697735|NCT01169701|26770084|P2|Overall Study|Lost to Follow-up|1
7697736|NCT01169701|26770085|P1|Overall Study|Lost to Follow-up|1
7697737|NCT01169675|26770122|P5|Overall Study|Other Reason Not Defined Above|1
7697738|NCT01169675|26770123|P4|Overall Study|Other Reason Not Defined Above|1
7697739|NCT01169675|26770124|P3|Overall Study|Other Reason Not Defined Above|0
7697740|NCT01169675|26770125|P2|Overall Study|Other Reason Not Defined Above|0
7697741|NCT01169675|26770126|P1|Overall Study|Other Reason Not Defined Above|0
7697742|NCT01169675|26770122|P5|Overall Study|Withdrawal by Subject|2
7697743|NCT01169675|26770123|P4|Overall Study|Withdrawal by Subject|1
7697744|NCT01169675|26770124|P3|Overall Study|Withdrawal by Subject|0
7697745|NCT01169675|26770125|P2|Overall Study|Withdrawal by Subject|0
7697746|NCT01169675|26770126|P1|Overall Study|Withdrawal by Subject|1
7697747|NCT01169675|26770122|P5|Overall Study|Adverse Event|0
7697748|NCT01169675|26770123|P4|Overall Study|Adverse Event|0
7697749|NCT01169675|26770124|P3|Overall Study|Adverse Event|2
7697750|NCT01169675|26770125|P2|Overall Study|Adverse Event|1
7697751|NCT01169675|26770126|P1|Overall Study|Adverse Event|5
7697752|NCT01169675|26770122|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
7697753|NCT01169675|26770123|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
7697754|NCT01169675|26770124|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
7697755|NCT01169675|26770125|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
7697756|NCT01169675|26770126|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
7697757|NCT01169675|26770122|P5|Overall Study|Progressive disease|1
7697758|NCT01169675|26770123|P4|Overall Study|Progressive disease|15
7697759|NCT01169675|26770124|P3|Overall Study|Progressive disease|5
7697760|NCT01169675|26770125|P2|Overall Study|Progressive disease|2
7697761|NCT01169675|26770126|P1|Overall Study|Progressive disease|13
7697762|NCT01169649|26770163|P1|Overall Study|Patient Not Treated|3
7697763|NCT01169636|26770172|P5|Overall Study|Withdrawal by Subject|3
7697764|NCT01169636|26770173|P4|Overall Study|Withdrawal by Subject|0
7697765|NCT01169636|26770174|P3|Overall Study|Withdrawal by Subject|0
7697766|NCT01169636|26770175|P2|Overall Study|Withdrawal by Subject|0
7697767|NCT01169636|26770176|P1|Overall Study|Withdrawal by Subject|0
7697768|NCT01169636|26770172|P5|Overall Study|Screen failure|0
7697769|NCT01169636|26770173|P4|Overall Study|Screen failure|0
7697770|NCT01169636|26770174|P3|Overall Study|Screen failure|2
7697771|NCT01169636|26770175|P2|Overall Study|Screen failure|0
7697772|NCT01169636|26770176|P1|Overall Study|Screen failure|0
7697773|NCT01169636|26770172|P5|Overall Study|Adverse Event|0
7697774|NCT01169636|26770173|P4|Overall Study|Adverse Event|1
7697775|NCT01169636|26770174|P3|Overall Study|Adverse Event|1
7697776|NCT01169636|26770175|P2|Overall Study|Adverse Event|0
7697777|NCT01169636|26770176|P1|Overall Study|Adverse Event|0
7697778|NCT01169558|26770198|P1|Overall Study|Partial response|2
7697779|NCT01169558|26770198|P1|Overall Study|Protocol Violation|2
7697780|NCT01169558|26770198|P1|Overall Study|Non-compliance|2
7697781|NCT01169558|26770198|P1|Overall Study|Need for Surgery|4
7697782|NCT01169558|26770198|P1|Overall Study|Lost to Follow-up|4
7697783|NCT01169558|26770198|P1|Overall Study|Stable Disease|4
7697784|NCT01169558|26770198|P1|Overall Study|Medical Decision|7
7697785|NCT01169558|26770198|P1|Overall Study|Withdrawal of Consent|8
7697786|NCT01169558|26770198|P1|Overall Study|Adverse Event|25
7697787|NCT01169558|26770198|P1|Overall Study|Disease progression|98
7697788|NCT01169532|26770205|P1|Overall Study|Withdrawal by Subject|1
7697789|NCT01169493|26770229|P6|Period 3 (6 Months)|Physician Decision|0
7697790|NCT01169493|26770230|P5|Period 3 (6 Months)|Physician Decision|0
7697791|NCT01169493|26770231|P4|Period 3 (6 Months)|Physician Decision|0
7697792|NCT01169493|26770232|P3|Period 3 (6 Months)|Physician Decision|1
7697793|NCT01169493|26770233|P2|Period 3 (6 Months)|Physician Decision|1
7697794|NCT01169493|26770234|P1|Period 3 (6 Months)|Physician Decision|0
7697795|NCT01169493|26770229|P6|Period 3 (6 Months)|Adverse Event|0
7697796|NCT01169493|26770230|P5|Period 3 (6 Months)|Adverse Event|0
7697797|NCT01169493|26770231|P4|Period 3 (6 Months)|Adverse Event|0
7697798|NCT01169493|26770232|P3|Period 3 (6 Months)|Adverse Event|0
7697799|NCT01169493|26770233|P2|Period 3 (6 Months)|Adverse Event|1
7697800|NCT01169493|26770234|P1|Period 3 (6 Months)|Adverse Event|0
7697801|NCT01169493|26770229|P6|Period 1 (6 Months)|Withdrawal by Subject|3
7697802|NCT01169493|26770230|P5|Period 1 (6 Months)|Withdrawal by Subject|0
7697803|NCT01169493|26770231|P4|Period 1 (6 Months)|Withdrawal by Subject|0
7697804|NCT01169493|26770232|P3|Period 1 (6 Months)|Withdrawal by Subject|2
7697805|NCT01169493|26770233|P2|Period 1 (6 Months)|Withdrawal by Subject|1
7697806|NCT01169493|26770234|P1|Period 1 (6 Months)|Withdrawal by Subject|0
7697807|NCT01169350|26770280|P1|Overall Study|Lost to Follow-up|2
7697808|NCT01169350|26770280|P1|Overall Study|Physician Decision|3
7697809|NCT01169337|26770290|P3|Overall Study|Continuing lenalidomide|0
7697810|NCT01169337|26770291|P2|Overall Study|Continuing lenalidomide|43
7697811|NCT01169337|26770292|P1|Overall Study|Continuing lenalidomide|9
7697812|NCT01169337|26770290|P3|Overall Study|Reason not reported|0
7697813|NCT01169337|26770291|P2|Overall Study|Reason not reported|0
7697814|NCT01169337|26770292|P1|Overall Study|Reason not reported|1
7697815|NCT01169337|26770290|P3|Overall Study|Never started treatment|0
7697816|NCT01169337|26770291|P2|Overall Study|Never started treatment|2
7697817|NCT01169337|26770292|P1|Overall Study|Never started treatment|0
7697818|NCT01169337|26770290|P3|Overall Study|Changed hospital|0
7697819|NCT01169337|26770291|P2|Overall Study|Changed hospital|1
7697820|NCT01169337|26770292|P1|Overall Study|Changed hospital|0
7697821|NCT01169337|26770290|P3|Overall Study|Alternative therapy|0
7697822|NCT01169337|26770291|P2|Overall Study|Alternative therapy|2
7697823|NCT01169337|26770292|P1|Overall Study|Alternative therapy|0
7697824|NCT01169337|26770290|P3|Overall Study|Physician Decision|0
7697825|NCT01169337|26770291|P2|Overall Study|Physician Decision|5
7697826|NCT01169337|26770292|P1|Overall Study|Physician Decision|1
7697827|NCT01169337|26770290|P3|Overall Study|Other complicating disease|0
7697828|NCT01169337|26770291|P2|Overall Study|Other complicating disease|1
7697829|NCT01169337|26770292|P1|Overall Study|Other complicating disease|1
7697830|NCT01169337|26770290|P3|Overall Study|Noncompliance|0
7697831|NCT01169337|26770291|P2|Overall Study|Noncompliance|0
7697832|NCT01169337|26770292|P1|Overall Study|Noncompliance|2
7697833|NCT01169337|26770290|P3|Overall Study|Withdrawal by Subject|6
7697834|NCT01169337|26770291|P2|Overall Study|Withdrawal by Subject|11
7697835|NCT01169337|26770292|P1|Overall Study|Withdrawal by Subject|11
7697836|NCT01169337|26770290|P3|Overall Study|Death|0
7697837|NCT01169337|26770291|P2|Overall Study|Death|0
7697838|NCT01169337|26770292|P1|Overall Study|Death|2
7697839|NCT01169337|26770290|P3|Overall Study|Adverse Event|0
7697840|NCT01169337|26770291|P2|Overall Study|Adverse Event|18
7697841|NCT01169337|26770292|P1|Overall Study|Adverse Event|12
7697842|NCT01169337|26770290|P3|Overall Study|Lack of Efficacy|0
7697843|NCT01169337|26770291|P2|Overall Study|Lack of Efficacy|7
7697844|NCT01169337|26770292|P1|Overall Study|Lack of Efficacy|5
7697845|NCT01169103|26770440|P2|Overall Study|Withdrawal by Subject|1
7697846|NCT01169103|26770441|P1|Overall Study|Withdrawal by Subject|3
7697847|NCT01169103|26770440|P2|Overall Study|Lost to Follow-up|3
7697848|NCT01169103|26770441|P1|Overall Study|Lost to Follow-up|3
7697849|NCT01169038|26770468|P1|Overall Study|Required antibiotic administration|1
7697850|NCT01169038|26770468|P1|Overall Study|Adverse Event|5
7697851|NCT01169038|26770468|P1|Overall Study|Death|1
7697852|NCT01168999|26770476|P4|Overall Study|Lost to Follow-up|0
7697853|NCT01168999|26770477|P3|Overall Study|Lost to Follow-up|0
7697854|NCT01168999|26770478|P2|Overall Study|Lost to Follow-up|1
7697855|NCT01168999|26770479|P1|Overall Study|Lost to Follow-up|2
7697856|NCT01168973|26770545|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
7697857|NCT01168973|26770546|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
7697858|NCT01168973|26770545|P2|Overall Study|Sponsor Decision|1
7697859|NCT01168973|26770546|P1|Overall Study|Sponsor Decision|2
7697860|NCT01168973|26770545|P2|Overall Study|Physician Decision|19
7697861|NCT01168973|26770546|P1|Overall Study|Physician Decision|37
7697862|NCT01168973|26770545|P2|Overall Study|Death|45
7697863|NCT01168973|26770546|P1|Overall Study|Death|42
7697864|NCT01168973|26770545|P2|Overall Study|Withdrawal by Subject|53
7697865|NCT01168973|26770546|P1|Overall Study|Withdrawal by Subject|90
7697866|NCT01168973|26770545|P2|Overall Study|Adverse Event|55
7697867|NCT01168973|26770546|P1|Overall Study|Adverse Event|94
7697868|NCT01168973|26770545|P2|Overall Study|Progressive Disease|429
7697869|NCT01168973|26770546|P1|Overall Study|Progressive Disease|341
7697870|NCT01168856|26770621|P2|Overall Study|Protocol Violation|6
7697871|NCT01168856|26770622|P1|Overall Study|Protocol Violation|4
7697872|NCT01168856|26770621|P2|Overall Study|Other|291
7697873|NCT01168856|26770622|P1|Overall Study|Other|1
7697874|NCT01168856|26770621|P2|Overall Study|Death|2
7697875|NCT01168856|26770622|P1|Overall Study|Death|0
7697876|NCT01168856|26770621|P2|Overall Study|Participant received anti-HCV treatment|0
7697877|NCT01168856|26770622|P1|Overall Study|Participant received anti-HCV treatment|1
7697878|NCT01168856|26770621|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
7697879|NCT01168856|26770622|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
7697880|NCT01168856|26770621|P2|Overall Study|Physician Decision|1
7697881|NCT01168856|26770622|P1|Overall Study|Physician Decision|2
7697882|NCT01168856|26770621|P2|Overall Study|Withdrawal by Subject|8
7697883|NCT01168856|26770622|P1|Overall Study|Withdrawal by Subject|6
7697884|NCT01168856|26770621|P2|Overall Study|Lost to Follow-up|34
7697885|NCT01168856|26770622|P1|Overall Study|Lost to Follow-up|4
7697886|NCT01168596|26770720|P2|Overall Study|Withdrawal by Subject|1
7697887|NCT01168596|26770721|P1|Overall Study|Withdrawal by Subject|3
7697888|NCT01168427|26770765|P1|Overall Study|Patient exited prior to implant|1
7697889|NCT01168401|26770781|P11|Overall Study|Withdrawal by Subject|0
7697890|NCT01168401|26770782|P10|Overall Study|Withdrawal by Subject|0
7697891|NCT01168401|26770783|P9|Overall Study|Withdrawal by Subject|0
7697892|NCT01168401|26770784|P8|Overall Study|Withdrawal by Subject|0
7697893|NCT01168401|26770785|P7|Overall Study|Withdrawal by Subject|0
7697894|NCT01168401|26770786|P6|Overall Study|Withdrawal by Subject|0
7697895|NCT01168401|26770787|P5|Overall Study|Withdrawal by Subject|0
7697896|NCT01168401|26770788|P4|Overall Study|Withdrawal by Subject|1
7697897|NCT01168401|26770789|P3|Overall Study|Withdrawal by Subject|0
7697898|NCT01168401|26770790|P2|Overall Study|Withdrawal by Subject|0
7697899|NCT01168401|26770791|P1|Overall Study|Withdrawal by Subject|0
7697900|NCT01168401|26770781|P11|Overall Study|Lost to Follow-up|0
7697901|NCT01168401|26770782|P10|Overall Study|Lost to Follow-up|0
7697902|NCT01168401|26770783|P9|Overall Study|Lost to Follow-up|0
7697903|NCT01168401|26770784|P8|Overall Study|Lost to Follow-up|0
7697904|NCT01168401|26770785|P7|Overall Study|Lost to Follow-up|0
7697905|NCT01168401|26770786|P6|Overall Study|Lost to Follow-up|0
7697906|NCT01168401|26770787|P5|Overall Study|Lost to Follow-up|0
7697907|NCT01168401|26770788|P4|Overall Study|Lost to Follow-up|1
7697908|NCT01168401|26770789|P3|Overall Study|Lost to Follow-up|2
7697909|NCT01168401|26770790|P2|Overall Study|Lost to Follow-up|1
7697910|NCT01168401|26770791|P1|Overall Study|Lost to Follow-up|1
7697911|NCT01168349|26771024|P1|Overall Study|Protocol Violation|76
7697912|NCT01168349|26771024|P1|Overall Study|Other|22
7697913|NCT01168349|26771024|P1|Overall Study|Kidney transplantation|3
7697914|NCT01168349|26771024|P1|Overall Study|Withdrawal by Subject|9
7697915|NCT01168349|26771024|P1|Overall Study|Lost to Follow-up|34
7697916|NCT01168349|26771024|P1|Overall Study|Death|157
7697917|NCT01168232|26771130|P1|Overall Study|Ineligible-Inadequate pathology|1
7697918|NCT01168232|26771130|P1|Overall Study|Ineligible- Wrong cell type|6
7697919|NCT01168232|26771130|P1|Overall Study|Ineligible-Second primary cancer site|1
7697920|NCT01168219|26771137|P1|Overall Study|ineligible due to CML|2
7697921|NCT01168219|26771137|P1|Overall Study|withdrew before transplant|1
7697922|NCT01168219|26771137|P1|Overall Study|off study before starting treatment|2
7697923|NCT01167907|26771160|P2|Overall Study|saphenous catheter dislodged before comp|1
7697924|NCT01167907|26771161|P1|Overall Study|saphenous catheter dislodged before comp|1
7697925|NCT01167907|26771160|P2|Overall Study|Protocol Violation|0
7697926|NCT01167907|26771161|P1|Overall Study|Protocol Violation|1
7697927|NCT01167881|26771179|P2|Overall Study|Other not defined above|55
7697928|NCT01167881|26771180|P1|Overall Study|Other not defined above|31
7697929|NCT01167881|26771179|P2|Overall Study|Not treated|0
7697930|NCT01167881|26771180|P1|Overall Study|Not treated|4
7697931|NCT01167881|26771179|P2|Overall Study|Patient refusal to cont., not due to AE|40
7697932|NCT01167881|26771180|P1|Overall Study|Patient refusal to cont., not due to AE|45
7697933|NCT01167881|26771179|P2|Overall Study|Lost to Follow-up|20
7697934|NCT01167881|26771180|P1|Overall Study|Lost to Follow-up|19
7697935|NCT01167881|26771179|P2|Overall Study|Non compliant with protocol|18
7697936|NCT01167881|26771180|P1|Overall Study|Non compliant with protocol|9
7697937|NCT01167881|26771179|P2|Overall Study|Lack of Efficacy|7
7697938|NCT01167881|26771180|P1|Overall Study|Lack of Efficacy|4
7697939|NCT01167881|26771179|P2|Overall Study|Adverse Event|51
7697940|NCT01167881|26771180|P1|Overall Study|Adverse Event|47
7697941|NCT01167634|26771234|P4|Overall Study|Withdrawal by Subject|0
7697942|NCT01167634|26771235|P3|Overall Study|Withdrawal by Subject|0
7697943|NCT01167634|26771236|P2|Overall Study|Withdrawal by Subject|1
7697944|NCT01167634|26771237|P1|Overall Study|Withdrawal by Subject|1
7697945|NCT01167634|26771234|P4|Overall Study|Lost to Follow-up|4
7697946|NCT01167634|26771235|P3|Overall Study|Lost to Follow-up|3
7697947|NCT01167634|26771236|P2|Overall Study|Lost to Follow-up|3
7697948|NCT01167634|26771237|P1|Overall Study|Lost to Follow-up|1
7697949|NCT01167582|26771275|P2|Overall Study|Lost to Follow-up|1
7697950|NCT01167582|26771276|P1|Overall Study|Lost to Follow-up|0
7697951|NCT01167426|26771327|P1|Overall Study|Sponsor Decision|1
7697952|NCT01167426|26771327|P1|Overall Study|Withdrawal by Subject|2
7697953|NCT01167426|26771327|P1|Overall Study|Protocol Violation|1
7697954|NCT01167426|26771327|P1|Overall Study|Lost to Follow-up|6
7697955|NCT01167257|26771335|P2|Overall Study|Withdrew consent|1
7697956|NCT01167257|26771336|P1|Overall Study|Withdrew consent|1
7697957|NCT01167257|26771335|P2|Overall Study|Lost to Follow-up|2
7697958|NCT01167257|26771336|P1|Overall Study|Lost to Follow-up|2
7697959|NCT01167192|26771358|P1|Overall Study|Insurance denial|1
7697960|NCT01167192|26771358|P1|Overall Study|Withdrawal by Subject|1
7697961|NCT01167192|26771358|P1|Overall Study|Death|1
7697962|NCT01167192|26771358|P1|Overall Study|Adverse Event|1
7697963|NCT01167179|26771375|P2|Overall Study|diverse|5
7697964|NCT01167179|26771376|P1|Overall Study|diverse|6
7697965|NCT01167179|26771375|P2|Overall Study|Withdrawal by Subject|2
7697966|NCT01167179|26771376|P1|Overall Study|Withdrawal by Subject|1
7697967|NCT01167179|26771375|P2|Overall Study|Death|10
7697968|NCT01167179|26771376|P1|Overall Study|Death|4
7697969|NCT01167179|26771375|P2|Overall Study|disease recurrence|4
7697970|NCT01167179|26771376|P1|Overall Study|disease recurrence|4
7697971|NCT01167153|26771386|P2|Overall Study|Subject initiation withdrawal, Other|8
7697972|NCT01167153|26771387|P1|Overall Study|Subject initiation withdrawal, Other|5
7697973|NCT01167153|26771386|P2|Overall Study|Withdrawal consent|1
7697974|NCT01167153|26771387|P1|Overall Study|Withdrawal consent|1
7697975|NCT01167153|26771386|P2|Overall Study|Investigator initiation withdrawal,Other|1
7697976|NCT01167153|26771387|P1|Overall Study|Investigator initiation withdrawal,Other|1
7697977|NCT01167153|26771386|P2|Overall Study|Non-compliance to concomitant medication|2
7697978|NCT01167153|26771387|P1|Overall Study|Non-compliance to concomitant medication|0
7697979|NCT01167153|26771386|P2|Overall Study|Lost to Follow-up|9
7697980|NCT01167153|26771387|P1|Overall Study|Lost to Follow-up|7
7697981|NCT01167153|26771386|P2|Overall Study|Hypotension|0
7697982|NCT01167153|26771387|P1|Overall Study|Hypotension|1
7697983|NCT01167153|26771386|P2|Overall Study|AE including clinical laboratory AE|8
7697984|NCT01167153|26771387|P1|Overall Study|AE including clinical laboratory AE|2
7697985|NCT01167153|26771386|P2|Overall Study|Non-effective therapy|4
7697986|NCT01167153|26771387|P1|Overall Study|Non-effective therapy|1
7697987|NCT01167140|26771405|P1|Overall Study|Withdrawal by Subject|1
7697988|NCT01167023|26771413|P3|Overall Study|Withdrawal by Subject|1
7697989|NCT01167023|26771414|P2|Overall Study|Withdrawal by Subject|0
7697990|NCT01167023|26771415|P1|Overall Study|Withdrawal by Subject|0
7697991|NCT01167023|26771413|P3|Overall Study|Sponsor Decision|0
7697992|NCT01167023|26771414|P2|Overall Study|Sponsor Decision|1
7697993|NCT01167023|26771415|P1|Overall Study|Sponsor Decision|0
7697994|NCT01167023|26771413|P3|Overall Study|Screen Failure|0
7697995|NCT01167023|26771414|P2|Overall Study|Screen Failure|1
7697996|NCT01167023|26771415|P1|Overall Study|Screen Failure|0
7697997|NCT01167023|26771413|P3|Overall Study|Lost to Follow-up|1
7697998|NCT01167023|26771414|P2|Overall Study|Lost to Follow-up|1
7697999|NCT01167023|26771415|P1|Overall Study|Lost to Follow-up|0
7698000|NCT01166958|26771499|P2|Overall Study|Withdrawal by Subject|0
7698001|NCT01166958|26771500|P1|Overall Study|Withdrawal by Subject|1
7698002|NCT01166945|26771516|P2|Day 30|Lost to Follow-up|3
7698003|NCT01166945|26771517|P1|Day 30|Lost to Follow-up|4
7698004|NCT01166945|26771516|P2|Day 15|NonCompliance/Lost to Follow Up|1
7698005|NCT01166945|26771517|P1|Day 15|NonCompliance/Lost to Follow Up|2
7698006|NCT01166945|26771516|P2|Day 10|NonCompliance/Lost to Follow Up|2
7698007|NCT01166945|26771517|P1|Day 10|NonCompliance/Lost to Follow Up|3
7698008|NCT01166945|26771516|P2|Randomized|diagnosed with Group A strep|4
7698009|NCT01166945|26771517|P1|Randomized|diagnosed with Group A strep|4
7698010|NCT01166763|26771525|P1|Overall Study|Withdrawal by Subject|3
7698011|NCT01166750|26771533|P2|Overall Study|Lost to Follow-up|0
7698012|NCT01166750|26771534|P1|Overall Study|Lost to Follow-up|1
7698013|NCT01166659|26771551|P1|Overall Study|Study Closed at Site|1
7698014|NCT01166659|26771551|P1|Overall Study|Lost to Follow-up|1
7698015|NCT01166659|26771551|P1|Overall Study|Death|1
7698016|NCT01166659|26771551|P1|Overall Study|Investigator Decision|2
7698017|NCT01166659|26771551|P1|Overall Study|Subject Decision|8
7698018|NCT01166646|26771560|P2|Overall Study|Adverse Event|0
7698019|NCT01166646|26771561|P1|Overall Study|Adverse Event|1
7698020|NCT01166646|26771560|P2|Overall Study|Protocol Violation|1
7698021|NCT01166646|26771561|P1|Overall Study|Protocol Violation|0
7698022|NCT01166568|26771580|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7698023|NCT01166568|26771581|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7698024|NCT01166568|26771582|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
7698025|NCT01166568|26771580|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
7698026|NCT01166568|26771581|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7698027|NCT01166568|26771582|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
7698028|NCT01166568|26771580|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
7698029|NCT01166568|26771581|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
7698030|NCT01166568|26771582|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
7698031|NCT01166438|26771595|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
7698032|NCT01166438|26771596|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
7698033|NCT01166438|26771595|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
7698034|NCT01166438|26771596|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
7698035|NCT01166438|26771595|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
7698036|NCT01166438|26771596|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
7698037|NCT01166438|26771595|P2|Double-blind Phase: 1st 6 Months|Not treated|1
7698038|NCT01166438|26771596|P1|Double-blind Phase: 1st 6 Months|Not treated|1
7698039|NCT01166438|26771595|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
7698040|NCT01166438|26771596|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
7698041|NCT01166438|26771595|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
7698042|NCT01166438|26771596|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
7698043|NCT01166386|26771612|P2|Overall Study|Withdrawal by Subject|5
7698044|NCT01166386|26771613|P1|Overall Study|Withdrawal by Subject|3
7698045|NCT01166373|26771625|P4|Overall Study|Physician Decision|0
7698046|NCT01166373|26771626|P3|Overall Study|Physician Decision|0
7698047|NCT01166373|26771627|P2|Overall Study|Physician Decision|0
7698048|NCT01166373|26771628|P1|Overall Study|Physician Decision|1
7698049|NCT01166373|26771625|P4|Overall Study|Withdrawal by Subject|3
7698050|NCT01166373|26771626|P3|Overall Study|Withdrawal by Subject|2
7698051|NCT01166373|26771627|P2|Overall Study|Withdrawal by Subject|2
7698052|NCT01166373|26771628|P1|Overall Study|Withdrawal by Subject|1
7698053|NCT01166373|26771625|P4|Overall Study|Lost to Follow-up|2
7698054|NCT01166373|26771626|P3|Overall Study|Lost to Follow-up|2
7698055|NCT01166373|26771627|P2|Overall Study|Lost to Follow-up|2
7698056|NCT01166373|26771628|P1|Overall Study|Lost to Follow-up|3
7698057|NCT01166282|26771761|P3|Open-label Period|Irregular Compliance|1
7698058|NCT01166282|26771762|P2|Open-label Period|Irregular Compliance|0
7698059|NCT01166282|26771763|P1|Open-label Period|Irregular Compliance|0
7698060|NCT01166282|26771761|P3|Open-label Period|Remission|4
7698061|NCT01166282|26771762|P2|Open-label Period|Remission|0
7698062|NCT01166282|26771763|P1|Open-label Period|Remission|0
7698063|NCT01166282|26771761|P3|Open-label Period|Lack of Efficacy|2
7698064|NCT01166282|26771762|P2|Open-label Period|Lack of Efficacy|0
7698065|NCT01166282|26771763|P1|Open-label Period|Lack of Efficacy|0
7698066|NCT01166282|26771761|P3|Open-label Period|Withdrawal by Subject|4
7698067|NCT01166282|26771762|P2|Open-label Period|Withdrawal by Subject|0
7698068|NCT01166282|26771763|P1|Open-label Period|Withdrawal by Subject|0
7698069|NCT01166282|26771761|P3|Open-label Period|Adverse Event|6
7698070|NCT01166282|26771762|P2|Open-label Period|Adverse Event|0
7698071|NCT01166282|26771763|P1|Open-label Period|Adverse Event|0
7698072|NCT01166178|26771802|P2|Overall Study|Study was terminated|8
7698073|NCT01166178|26771803|P1|Overall Study|Study was terminated|20
7698074|NCT01166178|26771802|P2|Overall Study|Withdrawal by Subject|0
7698075|NCT01166178|26771803|P1|Overall Study|Withdrawal by Subject|1
7698076|NCT01165996|26771842|P1|Overall Study|Physician Decision|1
7698077|NCT01165996|26771842|P1|Overall Study|Death|1
7698078|NCT01165684|26771913|P2|Overall Study|Unclassified|22
7698079|NCT01165684|26771914|P1|Overall Study|Unclassified|16
7698080|NCT01165684|26771913|P2|Overall Study|Withdrawal Criteria|13
7698081|NCT01165684|26771914|P1|Overall Study|Withdrawal Criteria|2
7698082|NCT01165684|26771913|P2|Overall Study|Protocol Violation|15
7698083|NCT01165684|26771914|P1|Overall Study|Protocol Violation|7
7698084|NCT01165684|26771913|P2|Overall Study|Lack of Efficacy|1
7698085|NCT01165684|26771914|P1|Overall Study|Lack of Efficacy|2
7698086|NCT01165684|26771913|P2|Overall Study|Adverse Event|1
7698087|NCT01165684|26771914|P1|Overall Study|Adverse Event|1
7698088|NCT01165554|26771948|P1|Overall Study|Withdrawal by Subject|23
7698089|NCT01165424|26771971|P1|Overall Study|Participant moved (relocated)|1
7698090|NCT01165424|26771971|P1|Overall Study|Did not meet entry criteria|1
7698091|NCT01165424|26771971|P1|Overall Study|Laboratory adverse experiences|1
7698092|NCT01165424|26771971|P1|Overall Study|Clinical adverse experiences|1
7698093|NCT01165320|26771978|P3|Overall Study|Reason unknown|0
7698094|NCT01165320|26771979|P2|Overall Study|Reason unknown|1
7698095|NCT01165320|26771980|P1|Overall Study|Reason unknown|0
7698096|NCT01165320|26771978|P3|Overall Study|Lack of Efficacy|0
7698097|NCT01165320|26771979|P2|Overall Study|Lack of Efficacy|2
7698098|NCT01165320|26771980|P1|Overall Study|Lack of Efficacy|0
7698099|NCT01165320|26771978|P3|Overall Study|Laboratory adverse experience|0
7698100|NCT01165320|26771979|P2|Overall Study|Laboratory adverse experience|0
7698101|NCT01165320|26771980|P1|Overall Study|Laboratory adverse experience|1
7698102|NCT01165320|26771978|P3|Overall Study|Clinical adverse experience|0
7698103|NCT01165320|26771979|P2|Overall Study|Clinical adverse experience|1
7698104|NCT01165320|26771980|P1|Overall Study|Clinical adverse experience|2
7698105|NCT01165307|26771990|P2|Overall Study|Subject not available for contact|0
7698106|NCT01165307|26771991|P1|Overall Study|Subject not available for contact|1
7698107|NCT01165307|26771990|P2|Overall Study|Withdrawal by Subject|0
7698108|NCT01165307|26771991|P1|Overall Study|Withdrawal by Subject|2
7698109|NCT01165307|26771990|P2|Overall Study|Lost to Follow-up|3
7698110|NCT01165307|26771991|P1|Overall Study|Lost to Follow-up|11
7698111|NCT01165281|26772021|P2|Overall Study|Other|0
7698112|NCT01165281|26772022|P1|Overall Study|Other|6
7698113|NCT01165281|26772021|P2|Overall Study|Progressive Disease|14
7698114|NCT01165281|26772022|P1|Overall Study|Progressive Disease|10
7698115|NCT01165281|26772021|P2|Overall Study|Noncompliance with Study Drug|4
7698116|NCT01165281|26772022|P1|Overall Study|Noncompliance with Study Drug|1
7698117|NCT01165281|26772021|P2|Overall Study|Withdrawal by Subject|7
7698118|NCT01165281|26772022|P1|Overall Study|Withdrawal by Subject|8
7698119|NCT01165281|26772021|P2|Overall Study|Protocol Violation|5
7698120|NCT01165281|26772022|P1|Overall Study|Protocol Violation|6
7698121|NCT01165281|26772021|P2|Overall Study|Physician Decision|1
7698122|NCT01165281|26772022|P1|Overall Study|Physician Decision|8
7698123|NCT01165281|26772021|P2|Overall Study|Lost to Follow-up|1
7698124|NCT01165281|26772022|P1|Overall Study|Lost to Follow-up|0
7698125|NCT01165281|26772021|P2|Overall Study|Lack of Efficacy|1
7698126|NCT01165281|26772022|P1|Overall Study|Lack of Efficacy|4
7698127|NCT01165281|26772021|P2|Overall Study|Death|4
7698128|NCT01165281|26772022|P1|Overall Study|Death|3
7698129|NCT01165281|26772021|P2|Overall Study|Adverse Event|14
7698130|NCT01165281|26772022|P1|Overall Study|Adverse Event|12
7698131|NCT01165242|26772043|P3|Overall Study|Lost to Follow-up|10
7698132|NCT01165242|26772044|P2|Overall Study|Lost to Follow-up|7
7698133|NCT01165242|26772045|P1|Overall Study|Lost to Follow-up|9
7698134|NCT01165242|26772043|P3|Overall Study|Extended Holiday|1
7698135|NCT01165242|26772044|P2|Overall Study|Extended Holiday|0
7698136|NCT01165242|26772045|P1|Overall Study|Extended Holiday|0
7698137|NCT01165242|26772043|P3|Overall Study|Withdrawal by Subject|2
7698138|NCT01165242|26772044|P2|Overall Study|Withdrawal by Subject|2
7698139|NCT01165242|26772045|P1|Overall Study|Withdrawal by Subject|0
7698140|NCT01165242|26772043|P3|Overall Study|Visit 2 Declined by Subject|1
7698141|NCT01165242|26772044|P2|Overall Study|Visit 2 Declined by Subject|0
7698142|NCT01165242|26772045|P1|Overall Study|Visit 2 Declined by Subject|0
7698143|NCT01165242|26772043|P3|Overall Study|Incarcerated Subjects|0
7698144|NCT01165242|26772044|P2|Overall Study|Incarcerated Subjects|1
7698145|NCT01165242|26772045|P1|Overall Study|Incarcerated Subjects|0
7698146|NCT01165242|26772043|P3|Overall Study|Unreachable Subjects|0
7698147|NCT01165242|26772044|P2|Overall Study|Unreachable Subjects|0
7698148|NCT01165242|26772045|P1|Overall Study|Unreachable Subjects|1
7698149|NCT01165229|26772079|P2|Overall Study|Unknown completion status|1
7698150|NCT01165229|26772080|P1|Overall Study|Unknown completion status|0
7698151|NCT01165229|26772079|P2|Overall Study|No reason from the subject|102
7698152|NCT01165229|26772080|P1|Overall Study|No reason from the subject|108
7698153|NCT01165229|26772079|P2|Overall Study|Suspected HZ Episode|2
7698154|NCT01165229|26772080|P1|Overall Study|Suspected HZ Episode|2
7698155|NCT01165229|26772079|P2|Overall Study|Lost to Follow-up|133
7698156|NCT01165229|26772080|P1|Overall Study|Lost to Follow-up|123
7698157|NCT01165229|26772079|P2|Overall Study|Migrated/moved from study area|46
7698158|NCT01165229|26772080|P1|Overall Study|Migrated/moved from study area|51
7698159|NCT01165229|26772079|P2|Overall Study|Withdrawal by Subject|396
7698160|NCT01165229|26772080|P1|Overall Study|Withdrawal by Subject|387
7698161|NCT01165229|26772079|P2|Overall Study|Protocol Violation|8
7698162|NCT01165229|26772080|P1|Overall Study|Protocol Violation|6
7698163|NCT01165229|26772079|P2|Overall Study|Non-Serious Adverse Event|15
7698164|NCT01165229|26772080|P1|Overall Study|Non-Serious Adverse Event|47
7698165|NCT01165229|26772079|P2|Overall Study|Serious Adverse Event|487
7698166|NCT01165229|26772080|P1|Overall Study|Serious Adverse Event|456
7698167|NCT01165216|26772214|P2|Overall Study|Disease progression|3
7698168|NCT01165216|26772215|P1|Overall Study|Disease progression|1
7698169|NCT01165216|26772214|P2|Overall Study|Withdrawal by Subject|1
7698170|NCT01165216|26772215|P1|Overall Study|Withdrawal by Subject|1
7698171|NCT01165216|26772214|P2|Overall Study|Adverse Event|3
7698172|NCT01165216|26772215|P1|Overall Study|Adverse Event|6
7698173|NCT01165203|26772237|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
7698174|NCT01165203|26772238|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
7698175|NCT01165203|26772237|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
7698176|NCT01165203|26772238|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
7698177|NCT01165203|26772237|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
7698178|NCT01165203|26772238|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
7698179|NCT01165203|26772237|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
7698180|NCT01165203|26772238|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
7698181|NCT01165203|26772237|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
7698182|NCT01165203|26772238|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
7698183|NCT01165203|26772237|P2|Active Phase|Lost to Follow-up|0
7698184|NCT01165203|26772238|P1|Active Phase|Lost to Follow-up|2
7698185|NCT01165203|26772237|P2|Active Phase|Migrated/moved from study area|1
7698186|NCT01165203|26772238|P1|Active Phase|Migrated/moved from study area|0
7698187|NCT01165203|26772237|P2|Active Phase|Withdrawal by Subject|1
7698188|NCT01165203|26772238|P1|Active Phase|Withdrawal by Subject|2
7698189|NCT01165203|26772237|P2|Active Phase|Serious Adverse Event|0
7698190|NCT01165203|26772238|P1|Active Phase|Serious Adverse Event|1
7698191|NCT01165177|26772328|P2|Overall Study|Migrated/ moved from study area|43
7698192|NCT01165177|26772329|P1|Overall Study|Migrated/ moved from study area|48
7698193|NCT01165177|26772328|P2|Overall Study|Lost to Follow-up|194
7698194|NCT01165177|26772329|P1|Overall Study|Lost to Follow-up|183
7698195|NCT01165177|26772328|P2|Overall Study|Suspected HZ episode|2
7698196|NCT01165177|26772329|P1|Overall Study|Suspected HZ episode|0
7698197|NCT01165177|26772328|P2|Overall Study|Other unspecified reasons|35
7698198|NCT01165177|26772329|P1|Overall Study|Other unspecified reasons|47
7698199|NCT01165177|26772328|P2|Overall Study|Non-serious adverse event|18
7698200|NCT01165177|26772329|P1|Overall Study|Non-serious adverse event|30
7698201|NCT01165177|26772328|P2|Overall Study|Protocol Violation|21
7698202|NCT01165177|26772329|P1|Overall Study|Protocol Violation|19
7698203|NCT01165177|26772328|P2|Overall Study|Withdrawal by Subject|354
7698204|NCT01165177|26772329|P1|Overall Study|Withdrawal by Subject|368
7698205|NCT01165177|26772328|P2|Overall Study|Serious Adverse Event|235
7698206|NCT01165177|26772329|P1|Overall Study|Serious Adverse Event|227
7698207|NCT01165138|26772458|P4|Overall Study|Withdrawal by Subject|3
7698208|NCT01165138|26772459|P3|Overall Study|Withdrawal by Subject|6
7698209|NCT01165138|26772460|P2|Overall Study|Withdrawal by Subject|6
7698210|NCT01165138|26772461|P1|Overall Study|Withdrawal by Subject|0
7698211|NCT01165138|26772458|P4|Overall Study|Physician Decision|6
7698212|NCT01165138|26772459|P3|Overall Study|Physician Decision|7
7698213|NCT01165138|26772460|P2|Overall Study|Physician Decision|6
7698214|NCT01165138|26772461|P1|Overall Study|Physician Decision|0
7698215|NCT01165138|26772458|P4|Overall Study|Lost to Follow-up|2
7698216|NCT01165138|26772459|P3|Overall Study|Lost to Follow-up|1
7698217|NCT01165138|26772460|P2|Overall Study|Lost to Follow-up|0
7698218|NCT01165138|26772461|P1|Overall Study|Lost to Follow-up|0
7698219|NCT01165138|26772458|P4|Overall Study|Protocol Violation|2
7698220|NCT01165138|26772459|P3|Overall Study|Protocol Violation|0
7698221|NCT01165138|26772460|P2|Overall Study|Protocol Violation|7
7698222|NCT01165138|26772461|P1|Overall Study|Protocol Violation|0
7698223|NCT01165138|26772458|P4|Overall Study|Lack of Efficacy|7
7698224|NCT01165138|26772459|P3|Overall Study|Lack of Efficacy|6
7698225|NCT01165138|26772460|P2|Overall Study|Lack of Efficacy|32
7698226|NCT01165138|26772461|P1|Overall Study|Lack of Efficacy|0
7698227|NCT01165138|26772458|P4|Overall Study|Adverse Event|2
7698228|NCT01165138|26772459|P3|Overall Study|Adverse Event|0
7698229|NCT01165138|26772460|P2|Overall Study|Adverse Event|1
7698230|NCT01165138|26772461|P1|Overall Study|Adverse Event|0
7698231|NCT01165021|26772531|P1|Overall Study|Death|1
7698232|NCT01164956|26772539|P3|Overall Study|Side Effects|1
7698233|NCT01164956|26772540|P2|Overall Study|Side Effects|0
7698234|NCT01164956|26772541|P1|Overall Study|Side Effects|1
7698235|NCT01164891|26772549|P1|Overall Study|Adverse Event|1
7698236|NCT01164891|26772549|P1|Overall Study|Disease Progression|5
7698237|NCT01164865|26772569|P2|Overall Study|Lost to Follow-up|1
7698238|NCT01164865|26772570|P1|Overall Study|Lost to Follow-up|2
7698239|NCT01164722|26772580|P2|Overall Study|enrolled on other study, concomitant med|3
7698240|NCT01164722|26772581|P1|Overall Study|enrolled on other study, concomitant med|1
7698241|NCT01164722|26772580|P2|Overall Study|met protocol criteria for non-treatment|1
7698242|NCT01164722|26772581|P1|Overall Study|met protocol criteria for non-treatment|11
7698243|NCT01164722|26772580|P2|Overall Study|Lost to Follow-up|6
7698244|NCT01164722|26772581|P1|Overall Study|Lost to Follow-up|3
7698245|NCT01164722|26772580|P2|Overall Study|Withdrawal by Subject|4
7698246|NCT01164722|26772581|P1|Overall Study|Withdrawal by Subject|3
7698247|NCT01164722|26772580|P2|Overall Study|Adverse Event|1
7698248|NCT01164722|26772581|P1|Overall Study|Adverse Event|0
7698249|NCT01164579|26772611|P3|Overall Study|Reason not specified|0
7698250|NCT01164579|26772612|P2|Overall Study|Reason not specified|0
7698251|NCT01164579|26772613|P1|Overall Study|Reason not specified|1
7698252|NCT01164579|26772611|P3|Overall Study|Adverse Event|5
7698253|NCT01164579|26772612|P2|Overall Study|Adverse Event|2
7698254|NCT01164579|26772613|P1|Overall Study|Adverse Event|4
7698255|NCT01164579|26772611|P3|Overall Study|Protocol Violation|2
7698256|NCT01164579|26772612|P2|Overall Study|Protocol Violation|1
7698257|NCT01164579|26772613|P1|Overall Study|Protocol Violation|0
7698258|NCT01164579|26772611|P3|Overall Study|Withdrawal by Subject|3
7698259|NCT01164579|26772612|P2|Overall Study|Withdrawal by Subject|5
7698260|NCT01164579|26772613|P1|Overall Study|Withdrawal by Subject|2
7698261|NCT01164579|26772611|P3|Overall Study|Lost to Follow-up|0
7698262|NCT01164579|26772612|P2|Overall Study|Lost to Follow-up|1
7698263|NCT01164579|26772613|P1|Overall Study|Lost to Follow-up|1
7698264|NCT01164579|26772611|P3|Overall Study|Lack of Efficacy|6
7698265|NCT01164579|26772612|P2|Overall Study|Lack of Efficacy|0
7698266|NCT01164579|26772613|P1|Overall Study|Lack of Efficacy|0
7698267|NCT01164501|26772693|P3|Overall Study|Other reason not defined above|4
7698268|NCT01164501|26772694|P2|Overall Study|Other reason not defined above|1
7698269|NCT01164501|26772695|P1|Overall Study|Other reason not defined above|9
7698270|NCT01164501|26772693|P3|Overall Study|Patient refusal to continue,not due toAE|8
7698271|NCT01164501|26772694|P2|Overall Study|Patient refusal to continue,not due toAE|4
7698272|NCT01164501|26772695|P1|Overall Study|Patient refusal to continue,not due toAE|10
7698273|NCT01164501|26772693|P3|Overall Study|Lost to Follow-up|3
7698274|NCT01164501|26772694|P2|Overall Study|Lost to Follow-up|0
7698275|NCT01164501|26772695|P1|Overall Study|Lost to Follow-up|3
7698276|NCT01164501|26772693|P3|Overall Study|Non compliant with protocol|4
7698277|NCT01164501|26772694|P2|Overall Study|Non compliant with protocol|1
7698278|NCT01164501|26772695|P1|Overall Study|Non compliant with protocol|1
7698279|NCT01164501|26772693|P3|Overall Study|Lack of Efficacy|1
7698280|NCT01164501|26772694|P2|Overall Study|Lack of Efficacy|0
7698281|NCT01164501|26772695|P1|Overall Study|Lack of Efficacy|0
7698282|NCT01164501|26772693|P3|Overall Study|Adverse Event|21
7698283|NCT01164501|26772694|P2|Overall Study|Adverse Event|4
7698284|NCT01164501|26772695|P1|Overall Study|Adverse Event|18
7698285|NCT01164501|26772693|P3|Overall Study|Not treated|1
7698286|NCT01164501|26772694|P2|Overall Study|Not treated|0
7698287|NCT01164501|26772695|P1|Overall Study|Not treated|2
7698288|NCT01164475|26772712|P2|Overall Study|Protocol Violation|0
7698289|NCT01164475|26772713|P1|Overall Study|Protocol Violation|1
7698290|NCT01164475|26772712|P2|Overall Study|Progressive disease|1
7698291|NCT01164475|26772713|P1|Overall Study|Progressive disease|0
7698292|NCT01164475|26772712|P2|Overall Study|Other|1
7698293|NCT01164475|26772713|P1|Overall Study|Other|0
7698294|NCT01164475|26772712|P2|Overall Study|Lack of Efficacy|0
7698295|NCT01164475|26772713|P1|Overall Study|Lack of Efficacy|1
7698296|NCT01164228|26772739|P2|Overall Study|Ineligible|0
7698297|NCT01164228|26772740|P1|Overall Study|Ineligible|1
7698298|NCT01164228|26772739|P2|Overall Study|Never started treatment|3
7698299|NCT01164228|26772740|P1|Overall Study|Never started treatment|1
7698300|NCT01164228|26772739|P2|Overall Study|Symptomatic deterioration|0
7698301|NCT01164228|26772740|P1|Overall Study|Symptomatic deterioration|1
7698302|NCT01164228|26772739|P2|Overall Study|Physician Decision|2
7698303|NCT01164228|26772740|P1|Overall Study|Physician Decision|1
7698304|NCT01164228|26772739|P2|Overall Study|Withdrawal by Subject|0
7698305|NCT01164228|26772740|P1|Overall Study|Withdrawal by Subject|2
7698306|NCT01164228|26772739|P2|Overall Study|Death|1
7698307|NCT01164228|26772740|P1|Overall Study|Death|1
7698308|NCT01164228|26772739|P2|Overall Study|Adverse Event|7
7698309|NCT01164228|26772740|P1|Overall Study|Adverse Event|13
7698310|NCT01164228|26772739|P2|Overall Study|Progression|25
7698311|NCT01164228|26772740|P1|Overall Study|Progression|24
7698312|NCT01164007|26772780|P1|Overall Study|Medical Decision|3
7698313|NCT01164007|26772780|P1|Overall Study|Withdrawal by Subject|1
7698314|NCT01164007|26772780|P1|Overall Study|Protocol Violation|1
7698315|NCT01164007|26772780|P1|Overall Study|Progression of Disease|30
7698316|NCT01164007|26772780|P1|Overall Study|Adverse Event|5
7698317|NCT01163916|26772806|P3|Overall Study|Other|16
7698318|NCT01163916|26772807|P2|Overall Study|Other|4
7698319|NCT01163916|26772808|P1|Overall Study|Other|24
7698320|NCT01163916|26772806|P3|Overall Study|Lack of Efficacy|1
7698321|NCT01163916|26772807|P2|Overall Study|Lack of Efficacy|0
7698322|NCT01163916|26772808|P1|Overall Study|Lack of Efficacy|2
7698323|NCT01163916|26772806|P3|Overall Study|Adverse Event|1
7698324|NCT01163916|26772807|P2|Overall Study|Adverse Event|0
7698325|NCT01163916|26772808|P1|Overall Study|Adverse Event|2
7698326|NCT01163916|26772806|P3|Overall Study|Withdrawal by Subject|2
7698327|NCT01163916|26772807|P2|Overall Study|Withdrawal by Subject|0
7698328|NCT01163916|26772808|P1|Overall Study|Withdrawal by Subject|2
7698329|NCT01163851|26772846|P2|Overall Study|Enrolled but not treated|0
7698330|NCT01163851|26772847|P1|Overall Study|Enrolled but not treated|1
7698331|NCT01163851|26772846|P2|Overall Study|Site Closure|1
7698332|NCT01163851|26772847|P1|Overall Study|Site Closure|0
7698333|NCT01163786|26772925|P1|Completed Follow up (Visit 9 and 10)|Other|1
7698334|NCT01163786|26772925|P1|Treatment With Bortezomib|Adverse Event|2
7698335|NCT01163786|26772925|P1|Treatment With Bortezomib|Withdrawal by Subject|1
7698336|NCT01163747|26772948|P2|Overall Study|Refused Treatment|4
7698337|NCT01163747|26772949|P1|Overall Study|Refused Treatment|6
7698338|NCT01163747|26772948|P2|Overall Study|Protocol Violation|1
7698339|NCT01163747|26772949|P1|Overall Study|Protocol Violation|0
7698340|NCT01163747|26772948|P2|Overall Study|Insufficient Therapeutic Response|1
7698341|NCT01163747|26772949|P1|Overall Study|Insufficient Therapeutic Response|0
7698342|NCT01163747|26772948|P2|Overall Study|Adverse Event|5
7698343|NCT01163747|26772949|P1|Overall Study|Adverse Event|0
7698344|NCT01163721|26772969|P2|Overall Study|Physician Decision|1
7698345|NCT01163721|26772970|P1|Overall Study|Physician Decision|0
7698346|NCT01163721|26772969|P2|Overall Study|Lost to Follow-up|1
7698347|NCT01163721|26772970|P1|Overall Study|Lost to Follow-up|0
7698348|NCT01163721|26772969|P2|Overall Study|Withdrawal by Subject|4
7698349|NCT01163721|26772970|P1|Overall Study|Withdrawal by Subject|3
7698350|NCT01163721|26772969|P2|Overall Study|Adverse Event|6
7698351|NCT01163721|26772970|P1|Overall Study|Adverse Event|5
7698352|NCT01163617|26773020|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698353|NCT01163617|26773021|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698354|NCT01163617|26773022|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698355|NCT01163617|26773023|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698356|NCT01163617|26773024|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698357|NCT01163617|26773025|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
7698358|NCT01163617|26773026|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698359|NCT01163617|26773027|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7698360|NCT01163617|26773020|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698361|NCT01163617|26773021|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698362|NCT01163617|26773022|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698363|NCT01163617|26773023|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698364|NCT01163617|26773024|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698365|NCT01163617|26773025|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698366|NCT01163617|26773026|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
7698367|NCT01163617|26773027|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7698368|NCT01163617|26773020|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698369|NCT01163617|26773021|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698370|NCT01163617|26773022|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698371|NCT01163617|26773023|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698372|NCT01163617|26773024|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698373|NCT01163617|26773025|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698374|NCT01163617|26773026|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
7698375|NCT01163617|26773027|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7698376|NCT01163474|26773056|P1|Overall Study|Lost to Follow-up|3
7698377|NCT01163474|26773056|P1|Overall Study|Tech barriers to videoteleconference vis|12
7698378|NCT01163474|26773056|P1|Overall Study|Withdrawal by Subject|1
7698379|NCT01163318|26773068|P1|Overall Study|Multiple Reasons Per Participant|224
7698380|NCT01163318|26773068|P1|Overall Study|Participants Without Case Report Form|7
7698381|NCT01163318|26773068|P1|Overall Study|History/comorbidity of malignant tumor|3
7698382|NCT01163318|26773068|P1|Overall Study|Did Not Continue Use of Adalimumab|26
7698383|NCT01163318|26773068|P1|Overall Study|Off-Label Use of Adalimumab|8
7698384|NCT01163292|26773077|P2|Overall Study|No further visits|7
7698385|NCT01163292|26773078|P1|Overall Study|No further visits|5
7698386|NCT01163292|26773077|P2|Overall Study|Economic reasons|0
7698387|NCT01163292|26773078|P1|Overall Study|Economic reasons|6
7698388|NCT01163292|26773077|P2|Overall Study|Refusal to receive adalimumab|0
7698389|NCT01163292|26773078|P1|Overall Study|Refusal to receive adalimumab|7
7698390|NCT01163292|26773077|P2|Overall Study|Sufficient response to adalimumab|0
7698391|NCT01163292|26773078|P1|Overall Study|Sufficient response to adalimumab|8
7698392|NCT01163292|26773077|P2|Overall Study|Initiation of biological therapy|15
7698393|NCT01163292|26773078|P1|Overall Study|Initiation of biological therapy|0
7698394|NCT01163292|26773077|P2|Overall Study|Adverse Event|0
7698395|NCT01163292|26773078|P1|Overall Study|Adverse Event|6
7698396|NCT01163292|26773077|P2|Overall Study|Lack of Efficacy|0
7698397|NCT01163292|26773078|P1|Overall Study|Lack of Efficacy|9
7698398|NCT01163279|26773094|P2|Overall Study|Withdrawal by Subject|0
7698399|NCT01163279|26773095|P1|Overall Study|Withdrawal by Subject|2
7698400|NCT01163266|26773124|P3|Overall Study|Other|2
7698401|NCT01163266|26773125|P2|Overall Study|Other|1
7698402|NCT01163266|26773126|P1|Overall Study|Other|1
7698403|NCT01163266|26773124|P3|Overall Study|Lost to Follow-up|10
7698404|NCT01163266|26773125|P2|Overall Study|Lost to Follow-up|7
7698405|NCT01163266|26773126|P1|Overall Study|Lost to Follow-up|7
7698406|NCT01163266|26773124|P3|Overall Study|Withdrawal of Consent|3
7698407|NCT01163266|26773125|P2|Overall Study|Withdrawal of Consent|7
7698408|NCT01163266|26773126|P1|Overall Study|Withdrawal of Consent|5
7698409|NCT01163266|26773124|P3|Overall Study|Protocol Deviations|5
7698410|NCT01163266|26773125|P2|Overall Study|Protocol Deviations|2
7698411|NCT01163266|26773126|P1|Overall Study|Protocol Deviations|2
7698412|NCT01163266|26773124|P3|Overall Study|Noncompliance with Study Drug|0
7698413|NCT01163266|26773125|P2|Overall Study|Noncompliance with Study Drug|2
7698414|NCT01163266|26773126|P1|Overall Study|Noncompliance with Study Drug|0
7698415|NCT01163266|26773124|P3|Overall Study|Lack of Efficacy|1
7698416|NCT01163266|26773125|P2|Overall Study|Lack of Efficacy|3
7698417|NCT01163266|26773126|P1|Overall Study|Lack of Efficacy|1
7698418|NCT01163266|26773124|P3|Overall Study|Pretreatment Event or Adverse Event|7
7698419|NCT01163266|26773125|P2|Overall Study|Pretreatment Event or Adverse Event|9
7698420|NCT01163266|26773126|P1|Overall Study|Pretreatment Event or Adverse Event|2
7698421|NCT01163253|26773151|P2|Overall Study|Other Unspecified|34
7698422|NCT01163253|26773152|P1|Overall Study|Other Unspecified|170
7698423|NCT01163253|26773151|P2|Overall Study|Ongoing|4
7698424|NCT01163253|26773152|P1|Overall Study|Ongoing|13
7698425|NCT01163253|26773151|P2|Overall Study|Death|5
7698426|NCT01163253|26773152|P1|Overall Study|Death|17
7698427|NCT01163253|26773151|P2|Overall Study|Adverse Event|78
7698428|NCT01163253|26773152|P1|Overall Study|Adverse Event|300
7698429|NCT01163253|26773151|P2|Overall Study|Insufficient Clinical Response|29
7698430|NCT01163253|26773152|P1|Overall Study|Insufficient Clinical Response|423
7698431|NCT01163253|26773151|P2|Overall Study|Lost to Follow-up|23
7698432|NCT01163253|26773152|P1|Overall Study|Lost to Follow-up|125
7698433|NCT01163253|26773151|P2|Overall Study|Medication Error|0
7698434|NCT01163253|26773152|P1|Overall Study|Medication Error|1
7698435|NCT01163253|26773151|P2|Overall Study|Withdrawal by Subject|50
7698436|NCT01163253|26773152|P1|Overall Study|Withdrawal by Subject|199
7698437|NCT01163253|26773151|P2|Overall Study|Protocol Violation|12
7698438|NCT01163253|26773152|P1|Overall Study|Protocol Violation|43
7698439|NCT01163253|26773151|P2|Overall Study|Study Terminated by Sponsor|349
7698440|NCT01163253|26773152|P1|Overall Study|Study Terminated by Sponsor|978
7698441|NCT01163253|26773151|P2|Overall Study|Withdrawn Due to Pregnancy|2
7698442|NCT01163253|26773152|P1|Overall Study|Withdrawn Due to Pregnancy|12
7698443|NCT01163149|26773340|P3|Extension Treatment Period|Noncompliance|1
7698444|NCT01163149|26773341|P2|Extension Treatment Period|Noncompliance|0
7698445|NCT01163149|26773342|P1|Extension Treatment Period|Noncompliance|0
7698446|NCT01163149|26773340|P3|Extension Treatment Period|Adverse Event|0
7698447|NCT01163149|26773341|P2|Extension Treatment Period|Adverse Event|1
7698448|NCT01163149|26773342|P1|Extension Treatment Period|Adverse Event|0
7698449|NCT01163149|26773340|P3|Extension Treatment Period|Withdrawal by Subject|1
7698450|NCT01163149|26773341|P2|Extension Treatment Period|Withdrawal by Subject|0
7698451|NCT01163149|26773342|P1|Extension Treatment Period|Withdrawal by Subject|2
7698452|NCT01163032|26773451|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
7698453|NCT01163032|26773452|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
7698454|NCT01163032|26773453|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
7698455|NCT01163032|26773451|P3|Open Label Extension Phase|Study Termination|7
7698456|NCT01163032|26773452|P2|Open Label Extension Phase|Study Termination|0
7698457|NCT01163032|26773453|P1|Open Label Extension Phase|Study Termination|0
7698458|NCT01163032|26773451|P3|Open Label Extension Phase|Protocol Violation|1
7698459|NCT01163032|26773452|P2|Open Label Extension Phase|Protocol Violation|0
7698460|NCT01163032|26773453|P1|Open Label Extension Phase|Protocol Violation|0
7698461|NCT01163032|26773451|P3|Open Label Extension Phase|Withdrawal by Subject|3
7698462|NCT01163032|26773452|P2|Open Label Extension Phase|Withdrawal by Subject|0
7698463|NCT01163032|26773453|P1|Open Label Extension Phase|Withdrawal by Subject|0
7698464|NCT01163032|26773451|P3|Open Label Extension Phase|Adverse Event|3
7698465|NCT01163032|26773452|P2|Open Label Extension Phase|Adverse Event|0
7698466|NCT01163032|26773453|P1|Open Label Extension Phase|Adverse Event|0
7698467|NCT01163032|26773451|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
7698468|NCT01163032|26773452|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
7698469|NCT01163032|26773453|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
7698470|NCT01163032|26773451|P3|Randomization Phase|Various*|0
7698471|NCT01163032|26773452|P2|Randomization Phase|Various*|4
7698472|NCT01163032|26773453|P1|Randomization Phase|Various*|5
7698473|NCT01163032|26773451|P3|Randomization Phase|Protocol Violation|0
7698474|NCT01163032|26773452|P2|Randomization Phase|Protocol Violation|1
7698475|NCT01163032|26773453|P1|Randomization Phase|Protocol Violation|0
7698476|NCT01163032|26773451|P3|Randomization Phase|Adverse Event|0
7698477|NCT01163032|26773452|P2|Randomization Phase|Adverse Event|3
7698478|NCT01163032|26773453|P1|Randomization Phase|Adverse Event|3
7698479|NCT01163032|26773451|P3|Randomization Phase|Withdrawal by Subject|0
7698480|NCT01163032|26773452|P2|Randomization Phase|Withdrawal by Subject|3
7698481|NCT01163032|26773453|P1|Randomization Phase|Withdrawal by Subject|2
7698482|NCT01162863|26773486|P3|Overall Study|Adverse Event|0
7698483|NCT01162863|26773487|P2|Overall Study|Adverse Event|1
7698484|NCT01162863|26773488|P1|Overall Study|Adverse Event|0
7698485|NCT01162863|26773486|P3|Overall Study|Lack of Efficacy|0
7698486|NCT01162863|26773487|P2|Overall Study|Lack of Efficacy|0
7698487|NCT01162863|26773488|P1|Overall Study|Lack of Efficacy|1
7698488|NCT01162499|26773518|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
7698489|NCT01162499|26773519|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
7698490|NCT01162486|26773544|P5|Overall Study|Pregnancy|0
7698491|NCT01162486|26773545|P4|Overall Study|Pregnancy|1
7698492|NCT01162486|26773546|P3|Overall Study|Pregnancy|0
7698493|NCT01162486|26773547|P2|Overall Study|Pregnancy|0
7698494|NCT01162486|26773548|P1|Overall Study|Pregnancy|0
7698495|NCT01162486|26773544|P5|Overall Study|elevated LFTs|0
7698496|NCT01162486|26773545|P4|Overall Study|elevated LFTs|0
7698497|NCT01162486|26773546|P3|Overall Study|elevated LFTs|1
7698498|NCT01162486|26773547|P2|Overall Study|elevated LFTs|0
7698499|NCT01162486|26773548|P1|Overall Study|elevated LFTs|0
7698500|NCT01162486|26773544|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
7698501|NCT01162486|26773545|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
7698502|NCT01162486|26773546|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
7698503|NCT01162486|26773547|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
7698504|NCT01162486|26773548|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
7698505|NCT01162486|26773544|P5|Overall Study|low ANC|0
7698506|NCT01162486|26773545|P4|Overall Study|low ANC|0
7698507|NCT01162486|26773546|P3|Overall Study|low ANC|0
7698508|NCT01162486|26773547|P2|Overall Study|low ANC|0
7698509|NCT01162486|26773548|P1|Overall Study|low ANC|1
7698510|NCT01162473|26773581|P2|Overall Study|Withdrawal by Subject|4
7698511|NCT01162473|26773582|P1|Overall Study|Withdrawal by Subject|0
7698512|NCT01162473|26773581|P2|Overall Study|Adverse Event|1
7698513|NCT01162473|26773582|P1|Overall Study|Adverse Event|2
7698514|NCT01162421|26773590|P2|Overall Study|Other|3
7698515|NCT01162421|26773591|P1|Overall Study|Other|2
7698516|NCT01162421|26773590|P2|Overall Study|Lack of Efficacy|2
7698517|NCT01162421|26773591|P1|Overall Study|Lack of Efficacy|2
7698518|NCT01162421|26773590|P2|Overall Study|Lost to Follow-up|2
7698519|NCT01162421|26773591|P1|Overall Study|Lost to Follow-up|0
7698520|NCT01162421|26773590|P2|Overall Study|Adverse Event|5
7698521|NCT01162421|26773591|P1|Overall Study|Adverse Event|2
7698522|NCT01162421|26773590|P2|Overall Study|Did not receive study drug|1
7698523|NCT01162421|26773591|P1|Overall Study|Did not receive study drug|2
7698524|NCT01162343|26773674|P1|Overall Study|Refused psychiatrist assessment|12
7698525|NCT01162343|26773674|P1|Overall Study|Left ED prior to psychiatrist assessment|80
7698526|NCT01162304|26773689|P1|Overall Study|Beck scale to high|11
7698527|NCT01162239|26773707|P4|Extended Follow-up|Lost to Follow-up|6
7698528|NCT01162239|26773708|P3|Extended Follow-up|Lost to Follow-up|8
7698529|NCT01162239|26773709|P2|Extended Follow-up|Lost to Follow-up|13
7698530|NCT01162239|26773710|P1|Extended Follow-up|Lost to Follow-up|8
7698531|NCT01162239|26773707|P4|Treatment Phase|Lost to Follow-up|1
7698532|NCT01162239|26773708|P3|Treatment Phase|Lost to Follow-up|2
7698533|NCT01162239|26773709|P2|Treatment Phase|Lost to Follow-up|4
7698534|NCT01162239|26773710|P1|Treatment Phase|Lost to Follow-up|5
7698535|NCT01162239|26773707|P4|Treatment Phase|Death|1
7698536|NCT01162239|26773708|P3|Treatment Phase|Death|0
7698537|NCT01162239|26773709|P2|Treatment Phase|Death|0
7698538|NCT01162239|26773710|P1|Treatment Phase|Death|0
7698539|NCT01162239|26773707|P4|Treatment Phase|Withdrawal by Subject|3
7698540|NCT01162239|26773708|P3|Treatment Phase|Withdrawal by Subject|2
7698541|NCT01162239|26773709|P2|Treatment Phase|Withdrawal by Subject|3
7698542|NCT01162239|26773710|P1|Treatment Phase|Withdrawal by Subject|1
7698543|NCT01162135|26773740|P1|Overall Study|Ineligible|1
7698544|NCT01162135|26773740|P1|Overall Study|Severe back pain|1
7698545|NCT01162135|26773740|P1|Overall Study|Withdrawal by Subject|1
7698546|NCT01162122|26773746|P2|Overall Study|Missing primary reason|0
7698547|NCT01162122|26773747|P1|Overall Study|Missing primary reason|1
7698548|NCT01162122|26773746|P2|Overall Study|Unable to classify|7
7698549|NCT01162122|26773747|P1|Overall Study|Unable to classify|3
7698550|NCT01162122|26773746|P2|Overall Study|Administrative reason|1
7698551|NCT01162122|26773747|P1|Overall Study|Administrative reason|1
7698552|NCT01162122|26773746|P2|Overall Study|Inappropriate enrollment|4
7698553|NCT01162122|26773747|P1|Overall Study|Inappropriate enrollment|5
7698554|NCT01162122|26773746|P2|Overall Study|Protocol Violation|2
7698555|NCT01162122|26773747|P1|Overall Study|Protocol Violation|2
7698556|NCT01162122|26773746|P2|Overall Study|Death|46
7698557|NCT01162122|26773747|P1|Overall Study|Death|51
7698558|NCT01162122|26773746|P2|Overall Study|Adverse Event|2
7698559|NCT01162122|26773747|P1|Overall Study|Adverse Event|3
7698560|NCT01162122|26773746|P2|Overall Study|Lost to Follow-up|91
7698561|NCT01162122|26773747|P1|Overall Study|Lost to Follow-up|73
7698562|NCT01162122|26773746|P2|Overall Study|Withdrawal by Subject|43
7698563|NCT01162122|26773747|P1|Overall Study|Withdrawal by Subject|52
7698564|NCT01161628|26773853|P1|Overall Study|Lack of Efficacy|2
7698565|NCT01161628|26773853|P1|Overall Study|Death|6
7698566|NCT01161537|26773876|P1|Part B|Withdrawal by Subject|2
7698567|NCT01161524|26773894|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
7698568|NCT01161524|26773895|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
7698569|NCT01161524|26773896|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
7698570|NCT01161524|26773894|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
7698571|NCT01161524|26773895|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
7698572|NCT01161524|26773896|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
7698573|NCT01161524|26773894|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
7698574|NCT01161524|26773895|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
7698575|NCT01161524|26773896|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
7698576|NCT01161524|26773894|P3|Extension Phase (Approximately 83 Weeks)|Other|6
7698577|NCT01161524|26773895|P2|Extension Phase (Approximately 83 Weeks)|Other|0
7698578|NCT01161524|26773896|P1|Extension Phase (Approximately 83 Weeks)|Other|0
7698579|NCT01161524|26773894|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
7698580|NCT01161524|26773895|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
7698581|NCT01161524|26773896|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
7698582|NCT01161524|26773894|P3|Core Study (23 Weeks)|Subject Choice|0
7698583|NCT01161524|26773895|P2|Core Study (23 Weeks)|Subject Choice|2
7698584|NCT01161524|26773896|P1|Core Study (23 Weeks)|Subject Choice|3
7698585|NCT01161524|26773894|P3|Core Study (23 Weeks)|Lost to Follow-up|0
7698586|NCT01161524|26773895|P2|Core Study (23 Weeks)|Lost to Follow-up|2
7698587|NCT01161524|26773896|P1|Core Study (23 Weeks)|Lost to Follow-up|1
7698588|NCT01161524|26773894|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
7698589|NCT01161524|26773895|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
7698590|NCT01161524|26773896|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
7698591|NCT01161524|26773894|P3|Core Study (23 Weeks)|Other|0
7698592|NCT01161524|26773895|P2|Core Study (23 Weeks)|Other|0
7698593|NCT01161524|26773896|P1|Core Study (23 Weeks)|Other|1
7698594|NCT01161524|26773894|P3|Core Study (23 Weeks)|Adverse Event|0
7698595|NCT01161524|26773895|P2|Core Study (23 Weeks)|Adverse Event|0
7698596|NCT01161524|26773896|P1|Core Study (23 Weeks)|Adverse Event|3
7698597|NCT01161498|26773935|P2|Overall Study|Disease Progression|1
7698598|NCT01161498|26773936|P1|Overall Study|Disease Progression|0
7698599|NCT01161472|26773960|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7698600|NCT01161472|26773961|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7698601|NCT01161472|26773962|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7698602|NCT01161472|26773963|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
7698603|NCT01161446|26774019|P2|Overall Study|Withdrawal by Subject|1
7698604|NCT01161446|26774020|P1|Overall Study|Withdrawal by Subject|0
7698605|NCT01161446|26774019|P2|Overall Study|Lost to Follow-up|14
7698606|NCT01161446|26774020|P1|Overall Study|Lost to Follow-up|18
7698607|NCT01161407|26774046|P2|Overall Study|Protocol Violation|1
7698608|NCT01161407|26774047|P1|Overall Study|Protocol Violation|3
7698609|NCT01161173|26774102|P1|Overall Study|Reasons Not Specified|23
7698610|NCT01161173|26774102|P1|Overall Study|End of Study|2
7698611|NCT01161173|26774102|P1|Overall Study|Death|194
7698612|NCT01161173|26774102|P1|Overall Study|Unacceptable Toxicity|21
7698613|NCT01161173|26774102|P1|Overall Study|Withdrawal of Consent|5
7698614|NCT01161173|26774102|P1|Overall Study|Progressive Disease|82
7698615|NCT01161173|26774102|P1|Overall Study|Lost to Follow-up|7
7698616|NCT01161173|26774102|P1|Overall Study|Protocol Violation|13
7698617|NCT01161043|26774197|P1|Overall Study|Withdrawal by Subject|3
7698618|NCT01160822|26774234|P7|Overall Study|Protocol deviation|0
7698619|NCT01160822|26774235|P6|Overall Study|Protocol deviation|0
7698620|NCT01160822|26774236|P5|Overall Study|Protocol deviation|2
7698621|NCT01160822|26774237|P4|Overall Study|Protocol deviation|0
7698622|NCT01160822|26774238|P3|Overall Study|Protocol deviation|0
7698623|NCT01160822|26774239|P2|Overall Study|Protocol deviation|0
7698624|NCT01160822|26774240|P1|Overall Study|Protocol deviation|0
7698625|NCT01160822|26774234|P7|Overall Study|Administrative problems|0
7698626|NCT01160822|26774235|P6|Overall Study|Administrative problems|0
7698627|NCT01160822|26774236|P5|Overall Study|Administrative problems|1
7698628|NCT01160822|26774237|P4|Overall Study|Administrative problems|0
7698629|NCT01160822|26774238|P3|Overall Study|Administrative problems|0
7698630|NCT01160822|26774239|P2|Overall Study|Administrative problems|0
7698631|NCT01160822|26774240|P1|Overall Study|Administrative problems|0
7698632|NCT01160822|26774234|P7|Overall Study|Lost to Follow-up|0
7698633|NCT01160822|26774235|P6|Overall Study|Lost to Follow-up|0
7698634|NCT01160822|26774236|P5|Overall Study|Lost to Follow-up|1
7698635|NCT01160822|26774237|P4|Overall Study|Lost to Follow-up|0
7698636|NCT01160822|26774238|P3|Overall Study|Lost to Follow-up|0
7698637|NCT01160822|26774239|P2|Overall Study|Lost to Follow-up|0
7698638|NCT01160822|26774240|P1|Overall Study|Lost to Follow-up|0
7698639|NCT01160822|26774234|P7|Overall Study|Withdrawal by Subject|1
7698640|NCT01160822|26774235|P6|Overall Study|Withdrawal by Subject|0
7698641|NCT01160822|26774236|P5|Overall Study|Withdrawal by Subject|0
7698642|NCT01160822|26774237|P4|Overall Study|Withdrawal by Subject|0
7698643|NCT01160822|26774238|P3|Overall Study|Withdrawal by Subject|0
7698644|NCT01160822|26774239|P2|Overall Study|Withdrawal by Subject|0
7698645|NCT01160822|26774240|P1|Overall Study|Withdrawal by Subject|0
7698646|NCT01160822|26774234|P7|Overall Study|Unsatisfactory therapeutic effect|3
7698647|NCT01160822|26774235|P6|Overall Study|Unsatisfactory therapeutic effect|5
7698648|NCT01160822|26774236|P5|Overall Study|Unsatisfactory therapeutic effect|4
7698649|NCT01160822|26774237|P4|Overall Study|Unsatisfactory therapeutic effect|0
7698650|NCT01160822|26774238|P3|Overall Study|Unsatisfactory therapeutic effect|0
7698651|NCT01160822|26774239|P2|Overall Study|Unsatisfactory therapeutic effect|0
7698652|NCT01160822|26774240|P1|Overall Study|Unsatisfactory therapeutic effect|0
7698653|NCT01160822|26774234|P7|Overall Study|Adverse Event|5
7698654|NCT01160822|26774235|P6|Overall Study|Adverse Event|2
7698655|NCT01160822|26774236|P5|Overall Study|Adverse Event|1
7698656|NCT01160822|26774237|P4|Overall Study|Adverse Event|0
7698657|NCT01160822|26774238|P3|Overall Study|Adverse Event|0
7698658|NCT01160822|26774239|P2|Overall Study|Adverse Event|0
7698659|NCT01160822|26774240|P1|Overall Study|Adverse Event|0
7698660|NCT01160770|26774329|P1|Overall Study|Other Reasons|1
7698661|NCT01160770|26774329|P1|Overall Study|Lack of Efficacy|15
7698662|NCT01160770|26774329|P1|Overall Study|Death|9
7698663|NCT01160770|26774329|P1|Overall Study|Study termination or sponsor request|1
7698664|NCT01160770|26774329|P1|Overall Study|Lost to Follow-up|7
7698665|NCT01160770|26774329|P1|Overall Study|Physician Decision|1
7698666|NCT01160770|26774329|P1|Overall Study|Subject/parent/caregiver request|33
7698667|NCT01160770|26774329|P1|Overall Study|Protocol Violation|2
7698668|NCT01160770|26774329|P1|Overall Study|Adverse Event|10
7698669|NCT01160744|26774342|P4|Overall Study|Not meet inclusion/exclusion criteria|0
7698670|NCT01160744|26774343|P3|Overall Study|Not meet inclusion/exclusion criteria|1
7698671|NCT01160744|26774344|P2|Overall Study|Not meet inclusion/exclusion criteria|0
7698672|NCT01160744|26774345|P1|Overall Study|Not meet inclusion/exclusion criteria|0
7698673|NCT01160744|26774342|P4|Overall Study|Withdrawal by Subject|4
7698674|NCT01160744|26774343|P3|Overall Study|Withdrawal by Subject|6
7698675|NCT01160744|26774344|P2|Overall Study|Withdrawal by Subject|5
7698676|NCT01160744|26774345|P1|Overall Study|Withdrawal by Subject|11
7698677|NCT01160640|26774381|P2|Overall Study|Withdrawal by Subject|3
7698678|NCT01160640|26774382|P1|Overall Study|Withdrawal by Subject|0
7698679|NCT01160640|26774381|P2|Overall Study|Incarceration|0
7698680|NCT01160640|26774382|P1|Overall Study|Incarceration|1
7698681|NCT01160640|26774381|P2|Overall Study|Physician Decision|3
7698682|NCT01160640|26774382|P1|Overall Study|Physician Decision|3
7698683|NCT01160614|26774398|P2|Overall Study|Withdrawal by Subject|2
7698684|NCT01160614|26774399|P1|Overall Study|Withdrawal by Subject|0
7698685|NCT01160484|26774447|P1|Overall Study|inclusion/exclusion criteria failure|1
7698686|NCT01160484|26774447|P1|Overall Study|Withdrawal by Subject|2
7698687|NCT01160484|26774447|P1|Overall Study|Adverse Event|6
7698688|NCT01160484|26774447|P1|Overall Study|Lack of Efficacy|9
7698689|NCT01160354|26774500|P3|Overall Study|Death|1
7698690|NCT01160354|26774501|P2|Overall Study|Death|1
7698691|NCT01160354|26774502|P1|Overall Study|Death|0
7698692|NCT01160289|26774521|P6|Post-Randomization Period|Sponsor Decision|0
7698693|NCT01160289|26774522|P5|Post-Randomization Period|Sponsor Decision|0
7698694|NCT01160289|26774523|P4|Post-Randomization Period|Sponsor Decision|0
7698695|NCT01160289|26774524|P3|Post-Randomization Period|Sponsor Decision|0
7698696|NCT01160289|26774525|P2|Post-Randomization Period|Sponsor Decision|1
7698697|NCT01160289|26774526|P1|Post-Randomization Period|Sponsor Decision|0
7698698|NCT01160289|26774521|P6|Post-Randomization Period|Entry Criteria Not Met|0
7698699|NCT01160289|26774522|P5|Post-Randomization Period|Entry Criteria Not Met|0
7698700|NCT01160289|26774523|P4|Post-Randomization Period|Entry Criteria Not Met|2
7698701|NCT01160289|26774524|P3|Post-Randomization Period|Entry Criteria Not Met|2
7698702|NCT01160289|26774525|P2|Post-Randomization Period|Entry Criteria Not Met|2
7698703|NCT01160289|26774526|P1|Post-Randomization Period|Entry Criteria Not Met|0
7698704|NCT01160289|26774521|P6|Post-Randomization Period|Withdrawal by Subject|7
7698705|NCT01160289|26774522|P5|Post-Randomization Period|Withdrawal by Subject|5
7698706|NCT01160289|26774523|P4|Post-Randomization Period|Withdrawal by Subject|8
7698707|NCT01160289|26774524|P3|Post-Randomization Period|Withdrawal by Subject|13
7698708|NCT01160289|26774525|P2|Post-Randomization Period|Withdrawal by Subject|5
7698709|NCT01160289|26774526|P1|Post-Randomization Period|Withdrawal by Subject|0
7698710|NCT01160289|26774521|P6|Post-Randomization Period|Protocol Violation|3
7698711|NCT01160289|26774522|P5|Post-Randomization Period|Protocol Violation|1
7698712|NCT01160289|26774523|P4|Post-Randomization Period|Protocol Violation|0
7698713|NCT01160289|26774524|P3|Post-Randomization Period|Protocol Violation|2
7698714|NCT01160289|26774525|P2|Post-Randomization Period|Protocol Violation|4
7698715|NCT01160289|26774526|P1|Post-Randomization Period|Protocol Violation|0
7698716|NCT01160289|26774521|P6|Post-Randomization Period|Physician Decision|0
7698717|NCT01160289|26774522|P5|Post-Randomization Period|Physician Decision|0
7698718|NCT01160289|26774523|P4|Post-Randomization Period|Physician Decision|0
7698719|NCT01160289|26774524|P3|Post-Randomization Period|Physician Decision|1
7698720|NCT01160289|26774525|P2|Post-Randomization Period|Physician Decision|0
7698721|NCT01160289|26774526|P1|Post-Randomization Period|Physician Decision|0
7698722|NCT01160289|26774521|P6|Post-Randomization Period|Lost to Follow-up|4
7698723|NCT01160289|26774522|P5|Post-Randomization Period|Lost to Follow-up|3
7698724|NCT01160289|26774523|P4|Post-Randomization Period|Lost to Follow-up|5
7698725|NCT01160289|26774524|P3|Post-Randomization Period|Lost to Follow-up|2
7698726|NCT01160289|26774525|P2|Post-Randomization Period|Lost to Follow-up|3
7698727|NCT01160289|26774526|P1|Post-Randomization Period|Lost to Follow-up|0
7698728|NCT01160289|26774521|P6|Post-Randomization Period|Lack of Efficacy|0
7698729|NCT01160289|26774522|P5|Post-Randomization Period|Lack of Efficacy|0
7698730|NCT01160289|26774523|P4|Post-Randomization Period|Lack of Efficacy|3
7698731|NCT01160289|26774524|P3|Post-Randomization Period|Lack of Efficacy|0
7698732|NCT01160289|26774525|P2|Post-Randomization Period|Lack of Efficacy|1
7698733|NCT01160289|26774526|P1|Post-Randomization Period|Lack of Efficacy|0
7698734|NCT01160289|26774521|P6|Post-Randomization Period|Death|0
7698735|NCT01160289|26774522|P5|Post-Randomization Period|Death|0
7698736|NCT01160289|26774523|P4|Post-Randomization Period|Death|1
7698737|NCT01160289|26774524|P3|Post-Randomization Period|Death|0
7698738|NCT01160289|26774525|P2|Post-Randomization Period|Death|0
7698739|NCT01160289|26774526|P1|Post-Randomization Period|Death|0
7698740|NCT01160289|26774521|P6|Post-Randomization Period|Adverse Event|0
7698741|NCT01160289|26774522|P5|Post-Randomization Period|Adverse Event|0
7698742|NCT01160289|26774523|P4|Post-Randomization Period|Adverse Event|2
7698743|NCT01160289|26774524|P3|Post-Randomization Period|Adverse Event|4
7698744|NCT01160289|26774525|P2|Post-Randomization Period|Adverse Event|4
7698745|NCT01160289|26774526|P1|Post-Randomization Period|Adverse Event|0
7698746|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7698747|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7698748|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7698749|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7698750|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7698751|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
7698752|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7698753|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7698754|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7698755|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7698756|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7698757|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
7698758|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
7698759|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
7698760|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
7698761|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
7698762|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
7698763|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
7698764|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
7698765|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
7698766|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
7698767|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
7698768|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
7698769|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
7698770|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7698771|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7698772|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7698773|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7698774|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7698775|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
7698776|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7698777|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7698778|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7698779|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7698780|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7698781|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
7698782|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7698783|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7698784|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7698785|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7698786|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7698787|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
7698788|NCT01160289|26774521|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
7698789|NCT01160289|26774522|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
7698790|NCT01160289|26774523|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
7698791|NCT01160289|26774524|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
7698792|NCT01160289|26774525|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
7698793|NCT01160289|26774526|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
7698794|NCT01160211|26774615|P3|Overall Study|Lost to Follow-up|5
7698795|NCT01160211|26774616|P2|Overall Study|Lost to Follow-up|7
7698796|NCT01160211|26774617|P1|Overall Study|Lost to Follow-up|4
7698797|NCT01160211|26774615|P3|Overall Study|Physician Decision|0
7698798|NCT01160211|26774616|P2|Overall Study|Physician Decision|0
7698799|NCT01160211|26774617|P1|Overall Study|Physician Decision|2
7698800|NCT01160211|26774615|P3|Overall Study|Withdrawal by Subject|3
7698801|NCT01160211|26774616|P2|Overall Study|Withdrawal by Subject|5
7698802|NCT01160211|26774617|P1|Overall Study|Withdrawal by Subject|3
7698803|NCT01160211|26774615|P3|Overall Study|ongoing|79
7698804|NCT01160211|26774616|P2|Overall Study|ongoing|75
7698805|NCT01160211|26774617|P1|Overall Study|ongoing|90
7698806|NCT01160198|26774650|P3|Overall Study|Participant lost drug; withdrew consent|1
7698807|NCT01160198|26774651|P2|Overall Study|Participant lost drug; withdrew consent|0
7698808|NCT01160198|26774652|P1|Overall Study|Participant lost drug; withdrew consent|0
7698809|NCT01160198|26774650|P3|Overall Study|Lost to Follow-up|0
7698810|NCT01160198|26774651|P2|Overall Study|Lost to Follow-up|1
7698811|NCT01160198|26774652|P1|Overall Study|Lost to Follow-up|0
7698812|NCT01160198|26774650|P3|Overall Study|Adverse Event|0
7698813|NCT01160198|26774651|P2|Overall Study|Adverse Event|1
7698814|NCT01160198|26774652|P1|Overall Study|Adverse Event|0
7698815|NCT01160198|26774650|P3|Overall Study|Withdrawal by Subject|0
7698816|NCT01160198|26774651|P2|Overall Study|Withdrawal by Subject|1
7698817|NCT01160198|26774652|P1|Overall Study|Withdrawal by Subject|2
7698818|NCT01159938|26774674|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
7698819|NCT01159938|26774675|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
7698820|NCT01159938|26774676|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
7698821|NCT01159938|26774677|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
7698822|NCT01159938|26774678|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
7698823|NCT01159912|26774741|P3|Overall Study|Withdrawal by Subject|3
7698824|NCT01159912|26774742|P2|Overall Study|Withdrawal by Subject|3
7698825|NCT01159912|26774743|P1|Overall Study|Withdrawal by Subject|10
7698826|NCT01159912|26774741|P3|Overall Study|Physician Decision|3
7698827|NCT01159912|26774742|P2|Overall Study|Physician Decision|0
7698828|NCT01159912|26774743|P1|Overall Study|Physician Decision|0
7698829|NCT01159912|26774741|P3|Overall Study|Lost to Follow-up|0
7698830|NCT01159912|26774742|P2|Overall Study|Lost to Follow-up|0
7698831|NCT01159912|26774743|P1|Overall Study|Lost to Follow-up|4
7698832|NCT01159912|26774741|P3|Overall Study|Protocol Violation|3
7698833|NCT01159912|26774742|P2|Overall Study|Protocol Violation|2
7698834|NCT01159912|26774743|P1|Overall Study|Protocol Violation|1
7698835|NCT01159912|26774741|P3|Overall Study|Lack of Efficacy|14
7698836|NCT01159912|26774742|P2|Overall Study|Lack of Efficacy|15
7698837|NCT01159912|26774743|P1|Overall Study|Lack of Efficacy|23
7698838|NCT01159912|26774741|P3|Overall Study|Adverse Event|3
7698839|NCT01159912|26774742|P2|Overall Study|Adverse Event|2
7698840|NCT01159912|26774743|P1|Overall Study|Adverse Event|2
7698841|NCT01159769|26774766|P1|Overall Study|Adverse Event|1
7698842|NCT01159691|26774786|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
7698843|NCT01159691|26774786|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
7698844|NCT01159691|26774786|P1|Overall Study|Disc. Neupro other & unknown reasons|7
7698845|NCT01159691|26774786|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
7698846|NCT01159691|26774786|P1|Overall Study|Discontinued Neupro due to other reasons|1
7698847|NCT01159691|26774786|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
7698848|NCT01159691|26774786|P1|Overall Study|Unknown reasons|1
7698849|NCT01159691|26774786|P1|Overall Study|Lost to Follow-up|2
7698850|NCT01159665|26774799|P6|Overall Study|Withdrawal by Subject|0
7698851|NCT01159665|26774800|P5|Overall Study|Withdrawal by Subject|0
7698852|NCT01159665|26774801|P4|Overall Study|Withdrawal by Subject|0
7698853|NCT01159665|26774802|P3|Overall Study|Withdrawal by Subject|0
7698854|NCT01159665|26774803|P2|Overall Study|Withdrawal by Subject|1
7698855|NCT01159665|26774804|P1|Overall Study|Withdrawal by Subject|0
7698856|NCT01159600|26774832|P8|Overall Study|Other reason not defined above|3
7698857|NCT01159600|26774833|P7|Overall Study|Other reason not defined above|3
7698858|NCT01159600|26774834|P6|Overall Study|Other reason not defined above|7
7698859|NCT01159600|26774835|P5|Overall Study|Other reason not defined above|5
7698860|NCT01159600|26774836|P4|Overall Study|Other reason not defined above|2
7698861|NCT01159600|26774837|P3|Overall Study|Other reason not defined above|4
7698862|NCT01159600|26774838|P2|Overall Study|Other reason not defined above|0
7698863|NCT01159600|26774839|P1|Overall Study|Other reason not defined above|3
7698864|NCT01159600|26774832|P8|Overall Study|Patient refusal to continue,not due toAE|5
7698865|NCT01159600|26774833|P7|Overall Study|Patient refusal to continue,not due toAE|2
7698866|NCT01159600|26774834|P6|Overall Study|Patient refusal to continue,not due toAE|4
7698867|NCT01159600|26774835|P5|Overall Study|Patient refusal to continue,not due toAE|4
7698868|NCT01159600|26774836|P4|Overall Study|Patient refusal to continue,not due toAE|5
7698869|NCT01159600|26774837|P3|Overall Study|Patient refusal to continue,not due toAE|4
7698870|NCT01159600|26774838|P2|Overall Study|Patient refusal to continue,not due toAE|2
7698871|NCT01159600|26774839|P1|Overall Study|Patient refusal to continue,not due toAE|7
7698872|NCT01159600|26774832|P8|Overall Study|Lost to Follow-up|2
7698873|NCT01159600|26774833|P7|Overall Study|Lost to Follow-up|3
7698874|NCT01159600|26774834|P6|Overall Study|Lost to Follow-up|0
7698875|NCT01159600|26774835|P5|Overall Study|Lost to Follow-up|3
7698876|NCT01159600|26774836|P4|Overall Study|Lost to Follow-up|3
7698877|NCT01159600|26774837|P3|Overall Study|Lost to Follow-up|4
7698878|NCT01159600|26774838|P2|Overall Study|Lost to Follow-up|3
7698879|NCT01159600|26774839|P1|Overall Study|Lost to Follow-up|2
7698880|NCT01159600|26774832|P8|Overall Study|Non compliant with protocol|0
7698881|NCT01159600|26774833|P7|Overall Study|Non compliant with protocol|2
7698882|NCT01159600|26774834|P6|Overall Study|Non compliant with protocol|0
7698883|NCT01159600|26774835|P5|Overall Study|Non compliant with protocol|2
7698884|NCT01159600|26774836|P4|Overall Study|Non compliant with protocol|0
7698885|NCT01159600|26774837|P3|Overall Study|Non compliant with protocol|0
7698886|NCT01159600|26774838|P2|Overall Study|Non compliant with protocol|1
7698887|NCT01159600|26774839|P1|Overall Study|Non compliant with protocol|2
7698888|NCT01159600|26774832|P8|Overall Study|Lack of Efficacy|1
7698889|NCT01159600|26774833|P7|Overall Study|Lack of Efficacy|0
7698890|NCT01159600|26774834|P6|Overall Study|Lack of Efficacy|0
7698891|NCT01159600|26774835|P5|Overall Study|Lack of Efficacy|2
7698892|NCT01159600|26774836|P4|Overall Study|Lack of Efficacy|0
7698893|NCT01159600|26774837|P3|Overall Study|Lack of Efficacy|0
7698894|NCT01159600|26774838|P2|Overall Study|Lack of Efficacy|0
7698895|NCT01159600|26774839|P1|Overall Study|Lack of Efficacy|0
7698896|NCT01159600|26774832|P8|Overall Study|Adverse Event|5
7698897|NCT01159600|26774833|P7|Overall Study|Adverse Event|7
7698898|NCT01159600|26774834|P6|Overall Study|Adverse Event|6
7698899|NCT01159600|26774835|P5|Overall Study|Adverse Event|8
7698900|NCT01159600|26774836|P4|Overall Study|Adverse Event|1
7698901|NCT01159600|26774837|P3|Overall Study|Adverse Event|5
7698902|NCT01159600|26774838|P2|Overall Study|Adverse Event|2
7698903|NCT01159600|26774839|P1|Overall Study|Adverse Event|7
7698904|NCT01159600|26774832|P8|Overall Study|Not treated|2
7698905|NCT01159600|26774833|P7|Overall Study|Not treated|2
7698906|NCT01159600|26774834|P6|Overall Study|Not treated|1
7698907|NCT01159600|26774835|P5|Overall Study|Not treated|0
7698908|NCT01159600|26774836|P4|Overall Study|Not treated|0
7698909|NCT01159600|26774837|P3|Overall Study|Not treated|1
7698910|NCT01159600|26774838|P2|Overall Study|Not treated|0
7698911|NCT01159600|26774839|P1|Overall Study|Not treated|0
7698912|NCT01159574|26774881|P1|Follow Up Phase|still being followed for overall surviva|18
7698913|NCT01159574|26774881|P1|Follow Up Phase|Lost to Follow-up|2
7698914|NCT01159574|26774881|P1|Treatment Phase|still on treatment|2
7698915|NCT01159574|26774881|P1|Treatment Phase|Withdrawal by Subject|7
7698916|NCT01159574|26774881|P1|Treatment Phase|Physician Decision|2
7698917|NCT01159574|26774881|P1|Treatment Phase|Death|6
7698918|NCT01159574|26774881|P1|Treatment Phase|Adverse Event|3
7698919|NCT01159574|26774881|P1|Treatment Phase|non-evaluable/not included in analysis|1
7698920|NCT01159431|26774902|P2|Overall Study|Lack of Efficacy|3
7698921|NCT01159431|26774903|P1|Overall Study|Lack of Efficacy|0
7698922|NCT01159431|26774902|P2|Overall Study|non-compliance|1
7698923|NCT01159431|26774903|P1|Overall Study|non-compliance|1
7698924|NCT01159431|26774902|P2|Overall Study|Adverse Event|2
7698925|NCT01159431|26774903|P1|Overall Study|Adverse Event|1
7698926|NCT01159171|26774956|P1|Overall Study|Death|1
7698927|NCT01159171|26774956|P1|Overall Study|Medical Decision|4
7698928|NCT01159171|26774956|P1|Overall Study|Need for Surgery|5
7698929|NCT01159171|26774956|P1|Overall Study|Protocol Violation|1
7698930|NCT01159171|26774956|P1|Overall Study|Progression of Disease|28
7698931|NCT01159171|26774956|P1|Overall Study|Adverse Event|11
7698932|NCT01158950|26775044|P2|1st Intervention (1 Day)|Physician Decision|2
7698933|NCT01158950|26775045|P1|1st Intervention (1 Day)|Physician Decision|1
7698934|NCT01158924|26775053|P2|Overall Study|Lost to Follow-up|1
7698935|NCT01158924|26775054|P1|Overall Study|Lost to Follow-up|0
7698936|NCT01158924|26775053|P2|Overall Study|Withdrawal by Subject|2
7698937|NCT01158924|26775054|P1|Overall Study|Withdrawal by Subject|1
7698938|NCT01158534|26775159|P1|Overall Study|Other|1
7698939|NCT01158534|26775159|P1|Overall Study|Death|1
7698940|NCT01158534|26775159|P1|Overall Study|Withdrawal by Subject|1
7698941|NCT01158404|26775184|P8|Overall Study|Progressive Disease|0
7698942|NCT01158404|26775185|P7|Overall Study|Progressive Disease|1
7698943|NCT01158404|26775186|P6|Overall Study|Progressive Disease|0
7698944|NCT01158404|26775187|P5|Overall Study|Progressive Disease|0
7698945|NCT01158404|26775188|P4|Overall Study|Progressive Disease|0
7698946|NCT01158404|26775189|P3|Overall Study|Progressive Disease|0
7698947|NCT01158404|26775190|P2|Overall Study|Progressive Disease|0
7698948|NCT01158404|26775191|P1|Overall Study|Progressive Disease|0
7698949|NCT01158404|26775184|P8|Overall Study|Physician Decision|1
7698950|NCT01158404|26775185|P7|Overall Study|Physician Decision|0
7698951|NCT01158404|26775186|P6|Overall Study|Physician Decision|0
7698952|NCT01158404|26775187|P5|Overall Study|Physician Decision|0
7698953|NCT01158404|26775188|P4|Overall Study|Physician Decision|0
7698954|NCT01158404|26775189|P3|Overall Study|Physician Decision|0
7698955|NCT01158404|26775190|P2|Overall Study|Physician Decision|0
7698956|NCT01158404|26775191|P1|Overall Study|Physician Decision|0
7698957|NCT01158404|26775184|P8|Overall Study|Withdrawal by Subject|1
7698958|NCT01158404|26775185|P7|Overall Study|Withdrawal by Subject|0
7698959|NCT01158404|26775186|P6|Overall Study|Withdrawal by Subject|1
7698960|NCT01158404|26775187|P5|Overall Study|Withdrawal by Subject|3
7698961|NCT01158404|26775188|P4|Overall Study|Withdrawal by Subject|0
7698962|NCT01158404|26775189|P3|Overall Study|Withdrawal by Subject|0
7698963|NCT01158404|26775190|P2|Overall Study|Withdrawal by Subject|1
7698964|NCT01158404|26775191|P1|Overall Study|Withdrawal by Subject|0
7698965|NCT01158378|26775233|P2|Overall Study|Withdrawal by Subject|0
7698966|NCT01158378|26775234|P1|Overall Study|Withdrawal by Subject|4
7698967|NCT01158378|26775233|P2|Overall Study|Lost to Follow-up|4
7698968|NCT01158378|26775234|P1|Overall Study|Lost to Follow-up|2
7698969|NCT01158378|26775233|P2|Overall Study|Death|5
7698970|NCT01158378|26775234|P1|Overall Study|Death|4
7698971|NCT01158261|26775246|P1|Overall Study|Withdrawal by Subject|1
7698972|NCT01158261|26775246|P1|Overall Study|Death|7
7698973|NCT01158261|26775246|P1|Overall Study|Lost to Follow-up|9
7698974|NCT01158222|26775250|P1|Overall Study|Not eligible for intermediate phase|17
7698975|NCT01158118|26775262|P2|Overall Study|Death|1
7698976|NCT01158118|26775263|P1|Overall Study|Death|0
7698977|NCT01158118|26775262|P2|Overall Study|Suffered stroke prior to transplant|1
7698978|NCT01158118|26775263|P1|Overall Study|Suffered stroke prior to transplant|0
7698979|NCT01158118|26775262|P2|Overall Study|Donor match was a screen failure|1
7698980|NCT01158118|26775263|P1|Overall Study|Donor match was a screen failure|0
7698981|NCT01158118|26775262|P2|Overall Study|Screen failure|0
7698982|NCT01158118|26775263|P1|Overall Study|Screen failure|1
7698983|NCT01157897|26775283|P4|Overall Study|Relocated|0
7698984|NCT01157897|26775284|P3|Overall Study|Relocated|0
7698985|NCT01157897|26775285|P2|Overall Study|Relocated|2
7698986|NCT01157897|26775286|P1|Overall Study|Relocated|0
7698987|NCT01157897|26775283|P4|Overall Study|Lost to Follow-up|1
7698988|NCT01157897|26775284|P3|Overall Study|Lost to Follow-up|0
7698989|NCT01157897|26775285|P2|Overall Study|Lost to Follow-up|0
7698990|NCT01157897|26775286|P1|Overall Study|Lost to Follow-up|2
7698991|NCT01157845|26775311|P1|Overall Study|Device malfunction|1
7698992|NCT01157845|26775311|P1|Overall Study|Study was ended|1
7698993|NCT01157845|26775311|P1|Overall Study|Protocol Violation|13
7698994|NCT01157845|26775311|P1|Overall Study|Physician Decision|3
7698995|NCT01157845|26775311|P1|Overall Study|Withdrawal by Subject|12
7698996|NCT01157845|26775311|P1|Overall Study|Lost to Follow-up|5
7698997|NCT01157676|26775318|P2|Surgery|underwent robotic cystectomy|0
7698998|NCT01157676|26775319|P1|Surgery|underwent robotic cystectomy|1
7698999|NCT01157676|26775318|P2|Surgery|converted to open procedure|5
7699000|NCT01157676|26775319|P1|Surgery|converted to open procedure|0
7699001|NCT01157676|26775318|P2|Surgery|underwent open cystectomy|4
7699002|NCT01157676|26775319|P1|Surgery|underwent open cystectomy|0
7699003|NCT01157676|26775318|P2|Randomization|Physician Decision|0
7699004|NCT01157676|26775319|P1|Randomization|Physician Decision|1
7699005|NCT01157676|26775318|P2|Randomization|Withdrawal by Subject|13
7699006|NCT01157676|26775319|P1|Randomization|Withdrawal by Subject|17
7699007|NCT01157676|26775318|P2|Randomization|unresectable|3
7699008|NCT01157676|26775319|P1|Randomization|unresectable|2
7699009|NCT01157676|26775318|P2|Randomization|Death|1
7699010|NCT01157676|26775319|P1|Randomization|Death|1
7699011|NCT01157377|26775394|P7|Overall Study|Other Miscellaneous Reasons|1
7699012|NCT01157377|26775395|P6|Overall Study|Other Miscellaneous Reasons|1
7699013|NCT01157377|26775396|P5|Overall Study|Other Miscellaneous Reasons|1
7699014|NCT01157377|26775397|P4|Overall Study|Other Miscellaneous Reasons|0
7699015|NCT01157377|26775398|P3|Overall Study|Other Miscellaneous Reasons|0
7699016|NCT01157377|26775399|P2|Overall Study|Other Miscellaneous Reasons|2
7699017|NCT01157377|26775400|P1|Overall Study|Other Miscellaneous Reasons|0
7699018|NCT01157377|26775394|P7|Overall Study|Lack of Efficacy|1
7699019|NCT01157377|26775395|P6|Overall Study|Lack of Efficacy|0
7699020|NCT01157377|26775396|P5|Overall Study|Lack of Efficacy|0
7699021|NCT01157377|26775397|P4|Overall Study|Lack of Efficacy|0
7699022|NCT01157377|26775398|P3|Overall Study|Lack of Efficacy|0
7699023|NCT01157377|26775399|P2|Overall Study|Lack of Efficacy|0
7699024|NCT01157377|26775400|P1|Overall Study|Lack of Efficacy|0
7699025|NCT01157377|26775394|P7|Overall Study|Protocol Violation|0
7699026|NCT01157377|26775395|P6|Overall Study|Protocol Violation|1
7699027|NCT01157377|26775396|P5|Overall Study|Protocol Violation|0
7699028|NCT01157377|26775397|P4|Overall Study|Protocol Violation|0
7699029|NCT01157377|26775398|P3|Overall Study|Protocol Violation|0
7699030|NCT01157377|26775399|P2|Overall Study|Protocol Violation|0
7699031|NCT01157377|26775400|P1|Overall Study|Protocol Violation|0
7699032|NCT01157377|26775394|P7|Overall Study|Personal Reasons|0
7699033|NCT01157377|26775395|P6|Overall Study|Personal Reasons|0
7699034|NCT01157377|26775396|P5|Overall Study|Personal Reasons|0
7699035|NCT01157377|26775397|P4|Overall Study|Personal Reasons|1
7699036|NCT01157377|26775398|P3|Overall Study|Personal Reasons|0
7699037|NCT01157377|26775399|P2|Overall Study|Personal Reasons|1
7699038|NCT01157377|26775400|P1|Overall Study|Personal Reasons|2
7699039|NCT01157377|26775394|P7|Overall Study|Lost to Follow-up|0
7699040|NCT01157377|26775395|P6|Overall Study|Lost to Follow-up|1
7699041|NCT01157377|26775396|P5|Overall Study|Lost to Follow-up|1
7699042|NCT01157377|26775397|P4|Overall Study|Lost to Follow-up|0
7699043|NCT01157377|26775398|P3|Overall Study|Lost to Follow-up|1
7699044|NCT01157377|26775399|P2|Overall Study|Lost to Follow-up|0
7699045|NCT01157377|26775400|P1|Overall Study|Lost to Follow-up|0
7699046|NCT01157364|26775422|P6|Overall Study|Adverse Event|0
7699047|NCT01157364|26775423|P5|Overall Study|Adverse Event|1
7699048|NCT01157364|26775424|P4|Overall Study|Adverse Event|0
7699049|NCT01157364|26775425|P3|Overall Study|Adverse Event|1
7699050|NCT01157364|26775426|P2|Overall Study|Adverse Event|1
7699051|NCT01157364|26775427|P1|Overall Study|Adverse Event|0
7699052|NCT01157364|26775422|P6|Overall Study|Lack of Efficacy|0
7699053|NCT01157364|26775423|P5|Overall Study|Lack of Efficacy|0
7699054|NCT01157364|26775424|P4|Overall Study|Lack of Efficacy|1
7699055|NCT01157364|26775425|P3|Overall Study|Lack of Efficacy|0
7699056|NCT01157364|26775426|P2|Overall Study|Lack of Efficacy|0
7699057|NCT01157364|26775427|P1|Overall Study|Lack of Efficacy|0
7699058|NCT01157364|26775422|P6|Overall Study|Lost to Follow-up|0
7699059|NCT01157364|26775423|P5|Overall Study|Lost to Follow-up|0
7699060|NCT01157364|26775424|P4|Overall Study|Lost to Follow-up|0
7699061|NCT01157364|26775425|P3|Overall Study|Lost to Follow-up|1
7699062|NCT01157364|26775426|P2|Overall Study|Lost to Follow-up|0
7699063|NCT01157364|26775427|P1|Overall Study|Lost to Follow-up|1
7699064|NCT01157364|26775422|P6|Overall Study|Personal Reasons|1
7699065|NCT01157364|26775423|P5|Overall Study|Personal Reasons|1
7699066|NCT01157364|26775424|P4|Overall Study|Personal Reasons|0
7699067|NCT01157364|26775425|P3|Overall Study|Personal Reasons|0
7699068|NCT01157364|26775426|P2|Overall Study|Personal Reasons|2
7699069|NCT01157364|26775427|P1|Overall Study|Personal Reasons|0
7699070|NCT01157364|26775422|P6|Overall Study|Other Reasons|0
7699071|NCT01157364|26775423|P5|Overall Study|Other Reasons|0
7699072|NCT01157364|26775424|P4|Overall Study|Other Reasons|1
7699073|NCT01157364|26775425|P3|Overall Study|Other Reasons|2
7699074|NCT01157364|26775426|P2|Overall Study|Other Reasons|1
7699075|NCT01157364|26775427|P1|Overall Study|Other Reasons|1
7699076|NCT01157351|26775461|P2|Overall Study|Randomized but not Treated|2
7699077|NCT01157351|26775462|P1|Overall Study|Randomized but not Treated|4
7699078|NCT01157351|26775461|P2|Overall Study|Noncompliance with Study Drug|3
7699079|NCT01157351|26775462|P1|Overall Study|Noncompliance with Study Drug|0
7699080|NCT01157351|26775461|P2|Overall Study|Other|36
7699081|NCT01157351|26775462|P1|Overall Study|Other|32
7699082|NCT01157351|26775461|P2|Overall Study|Protocol Violation|1
7699083|NCT01157351|26775462|P1|Overall Study|Protocol Violation|0
7699084|NCT01157351|26775461|P2|Overall Study|Physician Decision|4
7699085|NCT01157351|26775462|P1|Overall Study|Physician Decision|5
7699086|NCT01157351|26775461|P2|Overall Study|Withdrawal by Subject|27
7699087|NCT01157351|26775462|P1|Overall Study|Withdrawal by Subject|37
7699088|NCT01157351|26775461|P2|Overall Study|Lost to Follow-up|55
7699089|NCT01157351|26775462|P1|Overall Study|Lost to Follow-up|53
7699090|NCT01157351|26775461|P2|Overall Study|Death|0
7699091|NCT01157351|26775462|P1|Overall Study|Death|1
7699092|NCT01157351|26775461|P2|Overall Study|Adverse Event|4
7699093|NCT01157351|26775462|P1|Overall Study|Adverse Event|5
7699094|NCT01157234|26775480|P2|Overall Study|Withdrawal by Subject|0
7699095|NCT01157234|26775481|P1|Overall Study|Withdrawal by Subject|1
7699096|NCT01157182|26775513|P2|Washout of 28 Days|Adverse Event|0
7699097|NCT01157182|26775514|P1|Washout of 28 Days|Adverse Event|2
7699098|NCT01157169|26775562|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
7699099|NCT01157169|26775563|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
7699100|NCT01157169|26775562|P2|First Intervention|Emesis Within 4 hrs of Administration|2
7699101|NCT01157169|26775563|P1|First Intervention|Emesis Within 4 hrs of Administration|4
7699102|NCT01157117|26775582|P3|Overall Study|Unknown (Pending Final Form Submission)|13
7699103|NCT01157117|26775583|P2|Overall Study|Unknown (Pending Final Form Submission)|5
7699104|NCT01157117|26775584|P1|Overall Study|Unknown (Pending Final Form Submission)|4
7699105|NCT01157117|26775582|P3|Overall Study|Lost to Follow-up|1
7699106|NCT01157117|26775583|P2|Overall Study|Lost to Follow-up|0
7699107|NCT01157117|26775584|P1|Overall Study|Lost to Follow-up|0
7699108|NCT01157117|26775582|P3|Overall Study|Lack of Efficacy|0
7699109|NCT01157117|26775583|P2|Overall Study|Lack of Efficacy|1
7699110|NCT01157117|26775584|P1|Overall Study|Lack of Efficacy|1
7699111|NCT01157117|26775582|P3|Overall Study|Withdrawal by Subject|1
7699112|NCT01157117|26775583|P2|Overall Study|Withdrawal by Subject|1
7699113|NCT01157117|26775584|P1|Overall Study|Withdrawal by Subject|4
7699114|NCT01157117|26775582|P3|Overall Study|Dosing Symptoms|0
7699115|NCT01157117|26775583|P2|Overall Study|Dosing Symptoms|4
7699116|NCT01157117|26775584|P1|Overall Study|Dosing Symptoms|0
7699117|NCT01157078|26775625|P2|Overall Study|Other|4
7699118|NCT01157078|26775626|P1|Overall Study|Other|2
7699119|NCT01157078|26775625|P2|Overall Study|Lost to Follow-up|5
7699120|NCT01157078|26775626|P1|Overall Study|Lost to Follow-up|7
7699121|NCT01157078|26775625|P2|Overall Study|Study-specific withdrawal criteria|2
7699122|NCT01157078|26775626|P1|Overall Study|Study-specific withdrawal criteria|2
7699123|NCT01157078|26775625|P2|Overall Study|Lack of Efficacy|0
7699124|NCT01157078|26775626|P1|Overall Study|Lack of Efficacy|2
7699125|NCT01157078|26775625|P2|Overall Study|Condition under investigation worsened|1
7699126|NCT01157078|26775626|P1|Overall Study|Condition under investigation worsened|0
7699127|NCT01157078|26775625|P2|Overall Study|Severe non-compliance to protocol|4
7699128|NCT01157078|26775626|P1|Overall Study|Severe non-compliance to protocol|2
7699129|NCT01157078|26775625|P2|Overall Study|Adverse Event|6
7699130|NCT01157078|26775626|P1|Overall Study|Adverse Event|6
7699131|NCT01157078|26775625|P2|Overall Study|Eligibility criteria not fulfilled|0
7699132|NCT01157078|26775626|P1|Overall Study|Eligibility criteria not fulfilled|2
7699133|NCT01157078|26775625|P2|Overall Study|Withdrawal by Subject|14
7699134|NCT01157078|26775626|P1|Overall Study|Withdrawal by Subject|12
7699135|NCT01157065|26775676|P2|Overall Study|Death|1
7699136|NCT01157065|26775677|P1|Overall Study|Death|0
7699137|NCT01156844|26775698|P4|Overall Study|Protocol deviation|0
7699138|NCT01156844|26775699|P3|Overall Study|Protocol deviation|0
7699139|NCT01156844|26775700|P2|Overall Study|Protocol deviation|0
7699140|NCT01156844|26775701|P1|Overall Study|Protocol deviation|2
7699141|NCT01156844|26775698|P4|Overall Study|Administrative problems|1
7699142|NCT01156844|26775699|P3|Overall Study|Administrative problems|0
7699143|NCT01156844|26775700|P2|Overall Study|Administrative problems|1
7699144|NCT01156844|26775701|P1|Overall Study|Administrative problems|0
7699145|NCT01156844|26775698|P4|Overall Study|Lost to Follow-up|0
7699146|NCT01156844|26775699|P3|Overall Study|Lost to Follow-up|1
7699147|NCT01156844|26775700|P2|Overall Study|Lost to Follow-up|0
7699148|NCT01156844|26775701|P1|Overall Study|Lost to Follow-up|0
7699149|NCT01156844|26775698|P4|Overall Study|Withdrawal by Subject|2
7699150|NCT01156844|26775699|P3|Overall Study|Withdrawal by Subject|2
7699151|NCT01156844|26775700|P2|Overall Study|Withdrawal by Subject|0
7699152|NCT01156844|26775701|P1|Overall Study|Withdrawal by Subject|0
7699153|NCT01156844|26775698|P4|Overall Study|Abnormal test procedure result(s)|2
7699154|NCT01156844|26775699|P3|Overall Study|Abnormal test procedure result(s)|2
7699155|NCT01156844|26775700|P2|Overall Study|Abnormal test procedure result(s)|1
7699156|NCT01156844|26775701|P1|Overall Study|Abnormal test procedure result(s)|0
7699157|NCT01156844|26775698|P4|Overall Study|Adverse Event|1
7699158|NCT01156844|26775699|P3|Overall Study|Adverse Event|1
7699159|NCT01156844|26775700|P2|Overall Study|Adverse Event|0
7699160|NCT01156844|26775701|P1|Overall Study|Adverse Event|0
7699161|NCT01156792|26775735|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
7699162|NCT01156792|26775735|P1|Overall Study|Withdrawal by Subject|9
7699163|NCT01156792|26775735|P1|Overall Study|Physician Decision|3
7699164|NCT01156792|26775735|P1|Overall Study|Lost to Follow-up|3
7699165|NCT01156792|26775735|P1|Overall Study|Protocol Violation|6
7699166|NCT01156792|26775735|P1|Overall Study|Lack of Efficacy|36
7699167|NCT01156792|26775735|P1|Overall Study|Adverse Event|1
7699168|NCT01156714|26775803|P3|Overall Study|Withdrawal by Subject|3
7699169|NCT01156714|26775804|P2|Overall Study|Withdrawal by Subject|4
7699170|NCT01156714|26775805|P1|Overall Study|Withdrawal by Subject|9
7699171|NCT01156675|26775868|P3|Overall Study|No data|2
7699172|NCT01156675|26775869|P2|Overall Study|No data|22
7699173|NCT01156675|26775870|P1|Overall Study|No data|29
7699174|NCT01156675|26775868|P3|Overall Study|Death|0
7699175|NCT01156675|26775869|P2|Overall Study|Death|3
7699176|NCT01156675|26775870|P1|Overall Study|Death|5
7699177|NCT01156532|26775928|P1|Overall Study|Lost to Follow-up|1
7699178|NCT01156532|26775928|P1|Overall Study|Family Reasons|1
7699179|NCT01156480|26775940|P2|Overall Study|change in diagnosis|1
7699180|NCT01156480|26775941|P1|Overall Study|change in diagnosis|0
7699181|NCT01156376|26775970|P3|Overall Study|Withdrawal by Subject|3
7699182|NCT01156376|26775971|P2|Overall Study|Withdrawal by Subject|0
7699183|NCT01156376|26775972|P1|Overall Study|Withdrawal by Subject|0
7699184|NCT01156376|26775970|P3|Overall Study|Adverse Event|1
7699185|NCT01156376|26775971|P2|Overall Study|Adverse Event|0
7699186|NCT01156376|26775972|P1|Overall Study|Adverse Event|1
7699187|NCT01156363|26776193|P1|Overall Study|Other|6
7699188|NCT01156363|26776193|P1|Overall Study|Refused Treatment|4
7699189|NCT01156363|26776193|P1|Overall Study|Failure to Return|1
7699190|NCT01156363|26776193|P1|Overall Study|Insufficient Therapeutic Response|5
7699191|NCT01156363|26776193|P1|Overall Study|Adverse Event|6
7699192|NCT01156311|26776215|P4|6-month Add-on Therapy Period|Other|2
7699193|NCT01156311|26776216|P3|6-month Add-on Therapy Period|Other|1
7699194|NCT01156311|26776217|P2|6-month Add-on Therapy Period|Other|0
7699195|NCT01156311|26776218|P1|6-month Add-on Therapy Period|Other|0
7699196|NCT01156311|26776215|P4|6-month Add-on Therapy Period|Physician Decision|0
7699197|NCT01156311|26776216|P3|6-month Add-on Therapy Period|Physician Decision|1
7699198|NCT01156311|26776217|P2|6-month Add-on Therapy Period|Physician Decision|0
7699373|NCT01155466|26776647|P5|Overall Study|Administrative|0
7699199|NCT01156311|26776218|P1|6-month Add-on Therapy Period|Physician Decision|0
7699200|NCT01156311|26776215|P4|6-month Add-on Therapy Period|Disease Activity|2
7699201|NCT01156311|26776216|P3|6-month Add-on Therapy Period|Disease Activity|1
7699202|NCT01156311|26776217|P2|6-month Add-on Therapy Period|Disease Activity|0
7699203|NCT01156311|26776218|P1|6-month Add-on Therapy Period|Disease Activity|0
7699204|NCT01156311|26776215|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
7699205|NCT01156311|26776216|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
7699206|NCT01156311|26776217|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
7699207|NCT01156311|26776218|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
7699208|NCT01156311|26776215|P4|6-month Add-on Therapy Period|Adverse Event|6
7699209|NCT01156311|26776216|P3|6-month Add-on Therapy Period|Adverse Event|7
7699210|NCT01156311|26776217|P2|6-month Add-on Therapy Period|Adverse Event|0
7699211|NCT01156311|26776218|P1|6-month Add-on Therapy Period|Adverse Event|0
7699212|NCT01156311|26776215|P4|2-Month Monotherapy Period|Other|0
7699213|NCT01156311|26776216|P3|2-Month Monotherapy Period|Other|0
7699214|NCT01156311|26776217|P2|2-Month Monotherapy Period|Other|0
7699215|NCT01156311|26776218|P1|2-Month Monotherapy Period|Other|1
7699216|NCT01156311|26776215|P4|2-Month Monotherapy Period|Physician Decision|0
7699217|NCT01156311|26776216|P3|2-Month Monotherapy Period|Physician Decision|0
7699218|NCT01156311|26776217|P2|2-Month Monotherapy Period|Physician Decision|1
7699219|NCT01156311|26776218|P1|2-Month Monotherapy Period|Physician Decision|0
7699220|NCT01156311|26776215|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
7699221|NCT01156311|26776216|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
7699222|NCT01156311|26776217|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
7699223|NCT01156311|26776218|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
7699224|NCT01156142|26776242|P2|Overall Study|Ineligible|1
7699225|NCT01156142|26776243|P1|Overall Study|Ineligible|0
7699226|NCT01156142|26776242|P2|Overall Study|Withdrawal by Subject|6
7699227|NCT01156142|26776243|P1|Overall Study|Withdrawal by Subject|8
7699228|NCT01156116|26776261|P2|Overall Study|CPAP intolerance|0
7699229|NCT01156116|26776262|P1|Overall Study|CPAP intolerance|2
7699230|NCT01156116|26776261|P2|Overall Study|Withdrawal by Subject|1
7699231|NCT01156116|26776262|P1|Overall Study|Withdrawal by Subject|3
7699232|NCT01156051|26776276|P2|Overall Study|patient not compliant with protocol|1
7699233|NCT01156051|26776277|P1|Overall Study|patient not compliant with protocol|0
7699234|NCT01156051|26776276|P2|Overall Study|Lost to Follow-up|0
7699235|NCT01156051|26776277|P1|Overall Study|Lost to Follow-up|1
7699236|NCT01156012|26776291|P2|Overall Study|Non respect of one of inclusion criteria|1
7699237|NCT01156012|26776292|P1|Overall Study|Non respect of one of inclusion criteria|2
7699238|NCT01156012|26776291|P2|Overall Study|use of commercial drug instead of study|1
7699239|NCT01156012|26776292|P1|Overall Study|use of commercial drug instead of study|0
7699240|NCT01156012|26776291|P2|Overall Study|Withdrawal by Subject|0
7699241|NCT01156012|26776292|P1|Overall Study|Withdrawal by Subject|1
7699242|NCT01156012|26776291|P2|Overall Study|Lost to Follow-up|0
7699243|NCT01156012|26776292|P1|Overall Study|Lost to Follow-up|1
7699244|NCT01156012|26776291|P2|Overall Study|Adverse Event|1
7699245|NCT01156012|26776292|P1|Overall Study|Adverse Event|3
7699246|NCT01155869|26776309|P2|Overall Study|Lost to Follow-up|1
7699247|NCT01155869|26776310|P1|Overall Study|Lost to Follow-up|3
7699248|NCT01155726|26776419|P4|Period 1, 3 Days (Masked)|Inconvenience|0
7699249|NCT01155726|26776420|P3|Period 1, 3 Days (Masked)|Inconvenience|2
7699250|NCT01155726|26776421|P2|Period 1, 3 Days (Masked)|Inconvenience|0
7699251|NCT01155726|26776422|P1|Period 1, 3 Days (Masked)|Inconvenience|1
7699252|NCT01155661|26776444|P1|Overall Study|Sponsor Decision|13
7699253|NCT01155661|26776444|P1|Overall Study|Withdrawal by Subject|73
7699254|NCT01155661|26776444|P1|Overall Study|Protocol Violation|35
7699255|NCT01155661|26776444|P1|Overall Study|Physician Decision|3
7699256|NCT01155661|26776444|P1|Overall Study|Lost to Follow-up|22
7699257|NCT01155661|26776444|P1|Overall Study|Lack of Efficacy|32
7699258|NCT01155661|26776444|P1|Overall Study|Death|1
7699259|NCT01155661|26776444|P1|Overall Study|Adverse Event|101
7699260|NCT01155583|26776479|P9|Phase I|Withdrawal by Subject|0
7699261|NCT01155583|26776480|P8|Phase I|Withdrawal by Subject|1
7699262|NCT01155583|26776481|P7|Phase I|Withdrawal by Subject|0
7699263|NCT01155583|26776482|P6|Phase I|Withdrawal by Subject|0
7699264|NCT01155583|26776483|P5|Phase I|Withdrawal by Subject|0
7699265|NCT01155583|26776484|P4|Phase I|Withdrawal by Subject|0
7699266|NCT01155583|26776485|P3|Phase I|Withdrawal by Subject|0
7699267|NCT01155583|26776486|P2|Phase I|Withdrawal by Subject|0
7699268|NCT01155583|26776487|P1|Phase I|Withdrawal by Subject|0
7699269|NCT01155583|26776479|P9|Phase I|Screen failure - did not start treatment|0
7699270|NCT01155583|26776480|P8|Phase I|Screen failure - did not start treatment|2
7699271|NCT01155583|26776481|P7|Phase I|Screen failure - did not start treatment|0
7699272|NCT01155583|26776482|P6|Phase I|Screen failure - did not start treatment|0
7699273|NCT01155583|26776483|P5|Phase I|Screen failure - did not start treatment|1
7699274|NCT01155583|26776484|P4|Phase I|Screen failure - did not start treatment|0
7699275|NCT01155583|26776485|P3|Phase I|Screen failure - did not start treatment|0
7699276|NCT01155583|26776486|P2|Phase I|Screen failure - did not start treatment|0
7699277|NCT01155583|26776487|P1|Phase I|Screen failure - did not start treatment|0
7699278|NCT01155570|26776506|P1|Overall Study|Other Reasons|23
7699279|NCT01155570|26776506|P1|Overall Study|Participant's Economic Reasons + Other|1
7699280|NCT01155570|26776506|P1|Overall Study|Adverse Event + Other Reasons|7
7699281|NCT01155570|26776506|P1|Overall Study|Adverse Event + Lack of Efficacy|2
7699282|NCT01155570|26776506|P1|Overall Study|No Hospital Visits|7
7699283|NCT01155570|26776506|P1|Overall Study|Participant's Economic Reasons|17
7699284|NCT01155570|26776506|P1|Overall Study|Lack of Efficacy|46
7699285|NCT01155570|26776506|P1|Overall Study|Adverse Event|39
7699286|NCT01155531|26776540|P4|Overall Study|Withdrawal by Subject|0
7699287|NCT01155531|26776541|P3|Overall Study|Withdrawal by Subject|1
7699288|NCT01155531|26776542|P2|Overall Study|Withdrawal by Subject|0
7699289|NCT01155531|26776543|P1|Overall Study|Withdrawal by Subject|1
7699290|NCT01155531|26776540|P4|Overall Study|Lost to Follow-up|1
7699291|NCT01155531|26776541|P3|Overall Study|Lost to Follow-up|0
7699292|NCT01155531|26776542|P2|Overall Study|Lost to Follow-up|0
7699293|NCT01155531|26776543|P1|Overall Study|Lost to Follow-up|0
7699294|NCT01155531|26776540|P4|Overall Study|Adverse Event|0
7699295|NCT01155531|26776541|P3|Overall Study|Adverse Event|1
7699296|NCT01155531|26776542|P2|Overall Study|Adverse Event|0
7699297|NCT01155531|26776543|P1|Overall Study|Adverse Event|0
7699298|NCT01155479|26776591|P5|Part II|Non-Compliance with Protocol|0
7699299|NCT01155479|26776592|P4|Part II|Non-Compliance with Protocol|2
7699300|NCT01155479|26776593|P3|Part II|Non-Compliance with Protocol|0
7699301|NCT01155479|26776594|P2|Part II|Non-Compliance with Protocol|1
7699302|NCT01155479|26776595|P1|Part II|Non-Compliance with Protocol|0
7699303|NCT01155479|26776591|P5|Part II|Treatment Failure|1
7699304|NCT01155479|26776592|P4|Part II|Treatment Failure|0
7699305|NCT01155479|26776593|P3|Part II|Treatment Failure|2
7699306|NCT01155479|26776594|P2|Part II|Treatment Failure|1
7699307|NCT01155479|26776595|P1|Part II|Treatment Failure|0
7699308|NCT01155479|26776591|P5|Part II|Lost to Follow-up|1
7699309|NCT01155479|26776592|P4|Part II|Lost to Follow-up|0
7699310|NCT01155479|26776593|P3|Part II|Lost to Follow-up|0
7699311|NCT01155479|26776594|P2|Part II|Lost to Follow-up|0
7699312|NCT01155479|26776595|P1|Part II|Lost to Follow-up|1
7699313|NCT01155479|26776591|P5|Part II|Withdrawal by Subject|3
7699314|NCT01155479|26776592|P4|Part II|Withdrawal by Subject|7
7699315|NCT01155479|26776593|P3|Part II|Withdrawal by Subject|12
7699316|NCT01155479|26776594|P2|Part II|Withdrawal by Subject|4
7699317|NCT01155479|26776595|P1|Part II|Withdrawal by Subject|8
7699318|NCT01155479|26776591|P5|Part II|Administrative|46
7699319|NCT01155479|26776592|P4|Part II|Administrative|38
7699320|NCT01155479|26776593|P3|Part II|Administrative|36
7699321|NCT01155479|26776594|P2|Part II|Administrative|49
7699322|NCT01155479|26776595|P1|Part II|Administrative|43
7699323|NCT01155479|26776591|P5|Part II|Adverse Event|4
7699324|NCT01155479|26776592|P4|Part II|Adverse Event|3
7699325|NCT01155479|26776593|P3|Part II|Adverse Event|8
7699326|NCT01155479|26776594|P2|Part II|Adverse Event|6
7699327|NCT01155479|26776595|P1|Part II|Adverse Event|7
7699328|NCT01155479|26776591|P5|Part I|Non-Compliance with Protocol|2
7699329|NCT01155479|26776592|P4|Part I|Non-Compliance with Protocol|3
7699330|NCT01155479|26776593|P3|Part I|Non-Compliance with Protocol|3
7699331|NCT01155479|26776594|P2|Part I|Non-Compliance with Protocol|1
7699332|NCT01155479|26776595|P1|Part I|Non-Compliance with Protocol|2
7699333|NCT01155479|26776591|P5|Part I|Did Not Receive Treatment|1
7699334|NCT01155479|26776592|P4|Part I|Did Not Receive Treatment|6
7699335|NCT01155479|26776593|P3|Part I|Did Not Receive Treatment|2
7699336|NCT01155479|26776594|P2|Part I|Did Not Receive Treatment|2
7699337|NCT01155479|26776595|P1|Part I|Did Not Receive Treatment|4
7699338|NCT01155479|26776591|P5|Part I|Treatment Failure|2
7699339|NCT01155479|26776592|P4|Part I|Treatment Failure|1
7699340|NCT01155479|26776593|P3|Part I|Treatment Failure|3
7699341|NCT01155479|26776594|P2|Part I|Treatment Failure|0
7699342|NCT01155479|26776595|P1|Part I|Treatment Failure|3
7699343|NCT01155479|26776591|P5|Part I|Lost to Follow-up|0
7699344|NCT01155479|26776592|P4|Part I|Lost to Follow-up|1
7699345|NCT01155479|26776593|P3|Part I|Lost to Follow-up|1
7699346|NCT01155479|26776594|P2|Part I|Lost to Follow-up|0
7699347|NCT01155479|26776595|P1|Part I|Lost to Follow-up|0
7699348|NCT01155479|26776591|P5|Part I|Withdrawal by Subject|9
7699349|NCT01155479|26776592|P4|Part I|Withdrawal by Subject|8
7699350|NCT01155479|26776593|P3|Part I|Withdrawal by Subject|8
7699351|NCT01155479|26776594|P2|Part I|Withdrawal by Subject|13
7699352|NCT01155479|26776595|P1|Part I|Withdrawal by Subject|11
7699353|NCT01155479|26776591|P5|Part I|Did Not Meet Protocol Eligibility|3
7699354|NCT01155479|26776592|P4|Part I|Did Not Meet Protocol Eligibility|1
7699355|NCT01155479|26776593|P3|Part I|Did Not Meet Protocol Eligibility|2
7699356|NCT01155479|26776594|P2|Part I|Did Not Meet Protocol Eligibility|1
7699357|NCT01155479|26776595|P1|Part I|Did Not Meet Protocol Eligibility|3
7699358|NCT01155479|26776591|P5|Part I|Administrative|0
7699359|NCT01155479|26776592|P4|Part I|Administrative|0
7699360|NCT01155479|26776593|P3|Part I|Administrative|2
7699361|NCT01155479|26776594|P2|Part I|Administrative|2
7699362|NCT01155479|26776595|P1|Part I|Administrative|2
7699363|NCT01155479|26776591|P5|Part I|Adverse Event|6
7699364|NCT01155479|26776592|P4|Part I|Adverse Event|7
7699365|NCT01155479|26776593|P3|Part I|Adverse Event|18
7699366|NCT01155479|26776594|P2|Part I|Adverse Event|8
7699367|NCT01155479|26776595|P1|Part I|Adverse Event|13
7699368|NCT01155466|26776647|P5|Overall Study|Randomized not treated|2
7699369|NCT01155466|26776648|P4|Overall Study|Randomized not treated|0
7699370|NCT01155466|26776649|P3|Overall Study|Randomized not treated|3
7699371|NCT01155466|26776650|P2|Overall Study|Randomized not treated|2
7699372|NCT01155466|26776651|P1|Overall Study|Randomized not treated|2
7699374|NCT01155466|26776648|P4|Overall Study|Administrative|0
7699375|NCT01155466|26776649|P3|Overall Study|Administrative|0
7699376|NCT01155466|26776650|P2|Overall Study|Administrative|3
7699377|NCT01155466|26776651|P1|Overall Study|Administrative|0
7699378|NCT01155466|26776647|P5|Overall Study|Protocol Violation|1
7699379|NCT01155466|26776648|P4|Overall Study|Protocol Violation|0
7699380|NCT01155466|26776649|P3|Overall Study|Protocol Violation|2
7699381|NCT01155466|26776650|P2|Overall Study|Protocol Violation|0
7699382|NCT01155466|26776651|P1|Overall Study|Protocol Violation|0
7699383|NCT01155466|26776647|P5|Overall Study|Withdrawal by Subject|4
7699384|NCT01155466|26776648|P4|Overall Study|Withdrawal by Subject|4
7699385|NCT01155466|26776649|P3|Overall Study|Withdrawal by Subject|9
7699386|NCT01155466|26776650|P2|Overall Study|Withdrawal by Subject|5
7699387|NCT01155466|26776651|P1|Overall Study|Withdrawal by Subject|7
7699388|NCT01155466|26776647|P5|Overall Study|Lost to Follow-up|2
7699389|NCT01155466|26776648|P4|Overall Study|Lost to Follow-up|0
7699390|NCT01155466|26776649|P3|Overall Study|Lost to Follow-up|0
7699391|NCT01155466|26776650|P2|Overall Study|Lost to Follow-up|0
7699392|NCT01155466|26776651|P1|Overall Study|Lost to Follow-up|0
7699393|NCT01155466|26776647|P5|Overall Study|Adverse Event|18
7699394|NCT01155466|26776648|P4|Overall Study|Adverse Event|17
7699395|NCT01155466|26776649|P3|Overall Study|Adverse Event|6
7699396|NCT01155466|26776650|P2|Overall Study|Adverse Event|15
7699397|NCT01155466|26776651|P1|Overall Study|Adverse Event|13
7699398|NCT01155388|26776705|P2|Overall Study|Adverse Event|0
7699399|NCT01155388|26776706|P1|Overall Study|Adverse Event|1
7699400|NCT01155375|26776716|P2|Overall Study|Adverse Event|0
7699401|NCT01155375|26776717|P1|Overall Study|Adverse Event|1
7699402|NCT01155323|26776736|P2|Second Intervention|Lost to Follow-up|1
7699403|NCT01155323|26776737|P1|Second Intervention|Lost to Follow-up|1
7699404|NCT01155323|26776736|P2|First Intervention|exclusion criteria|1
7699405|NCT01155323|26776737|P1|First Intervention|exclusion criteria|1
7699406|NCT01155284|26776755|P2|Overall Study|Adverse Event|0
7699407|NCT01155284|26776756|P1|Overall Study|Adverse Event|1
7699408|NCT01155284|26776755|P2|Overall Study|Physician Decision|0
7699409|NCT01155284|26776756|P1|Overall Study|Physician Decision|1
7699410|NCT01155284|26776755|P2|Overall Study|Lost to Follow-up|2
7699411|NCT01155284|26776756|P1|Overall Study|Lost to Follow-up|1
7699412|NCT01155284|26776755|P2|Overall Study|Withdrawal by Subject|3
7699413|NCT01155284|26776756|P1|Overall Study|Withdrawal by Subject|4
7699414|NCT01155219|26776766|P2|Overall Study|non-medical reason|2
7699415|NCT01155219|26776767|P1|Overall Study|non-medical reason|1
7699416|NCT01155219|26776766|P2|Overall Study|Adverse Event|1
7699417|NCT01155219|26776767|P1|Overall Study|Adverse Event|3
7699418|NCT01155167|26776816|P2|Overall Study|Access site changed to femoral artery|0
7699419|NCT01155167|26776817|P1|Overall Study|Access site changed to femoral artery|1
7699420|NCT01155167|26776816|P2|Overall Study|Insufficient ultrasound data|0
7699421|NCT01155167|26776817|P1|Overall Study|Insufficient ultrasound data|2
7699422|NCT01155141|26776840|P1|Overall Study|Screen Failure|1
7699423|NCT01155141|26776840|P1|Overall Study|Withdrawal by Subject|1
7699424|NCT01155063|26776852|P1|Overall Study|Study terminated by sponsor|87
7699425|NCT01155063|26776852|P1|Overall Study|Withdrawal by Subject|1
7699426|NCT01155063|26776852|P1|Overall Study|Adverse Event|1
7699427|NCT01155050|26776866|P4|Overall Study|Lost to Follow-up|22
7699428|NCT01155050|26776867|P3|Overall Study|Lost to Follow-up|19
7699429|NCT01155050|26776868|P2|Overall Study|Lost to Follow-up|20
7699430|NCT01155050|26776869|P1|Overall Study|Lost to Follow-up|15
7699431|NCT01155024|26776907|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
7699432|NCT01155024|26776908|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
7699433|NCT01155024|26776907|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
7699434|NCT01155024|26776908|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
7699435|NCT01155024|26776907|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
7699436|NCT01155024|26776908|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
7699437|NCT01155011|26776918|P2|6 to 12 Months|Death|5
7699438|NCT01155011|26776919|P1|6 to 12 Months|Death|1
7699439|NCT01155011|26776918|P2|6 to 12 Months|Withdrawal by Subject|5
7699440|NCT01155011|26776919|P1|6 to 12 Months|Withdrawal by Subject|8
7699441|NCT01155011|26776918|P2|Baseline to 6 Months|Death|1
7699442|NCT01155011|26776919|P1|Baseline to 6 Months|Death|0
7699443|NCT01155011|26776918|P2|Baseline to 6 Months|investigator decision, moved|5
7699444|NCT01155011|26776919|P1|Baseline to 6 Months|investigator decision, moved|4
7699445|NCT01155011|26776918|P2|Baseline to 6 Months|Withdrawal by Subject|19
7699446|NCT01155011|26776919|P1|Baseline to 6 Months|Withdrawal by Subject|18
7699447|NCT01154816|26776960|P12|Overall Study|Adverse Event|0
7699448|NCT01154816|26776961|P11|Overall Study|Adverse Event|0
7699449|NCT01154816|26776962|P10|Overall Study|Adverse Event|0
7699450|NCT01154816|26776963|P9|Overall Study|Adverse Event|0
7699451|NCT01154816|26776964|P8|Overall Study|Adverse Event|1
7699452|NCT01154816|26776965|P7|Overall Study|Adverse Event|1
7699453|NCT01154816|26776966|P6|Overall Study|Adverse Event|0
7699454|NCT01154816|26776967|P5|Overall Study|Adverse Event|0
7699455|NCT01154816|26776968|P4|Overall Study|Adverse Event|0
7699456|NCT01154816|26776969|P3|Overall Study|Adverse Event|0
7699457|NCT01154816|26776970|P2|Overall Study|Adverse Event|2
7699458|NCT01154816|26776971|P1|Overall Study|Adverse Event|5
7699459|NCT01154816|26776960|P12|Overall Study|Physician Decision|1
7699460|NCT01154816|26776961|P11|Overall Study|Physician Decision|1
7699461|NCT01154816|26776962|P10|Overall Study|Physician Decision|1
7699462|NCT01154816|26776963|P9|Overall Study|Physician Decision|0
7699463|NCT01154816|26776964|P8|Overall Study|Physician Decision|0
7699464|NCT01154816|26776965|P7|Overall Study|Physician Decision|0
7699465|NCT01154816|26776966|P6|Overall Study|Physician Decision|0
7699466|NCT01154816|26776967|P5|Overall Study|Physician Decision|2
7699467|NCT01154816|26776968|P4|Overall Study|Physician Decision|0
7699468|NCT01154816|26776969|P3|Overall Study|Physician Decision|1
7699469|NCT01154816|26776970|P2|Overall Study|Physician Decision|0
7699470|NCT01154816|26776971|P1|Overall Study|Physician Decision|1
7699471|NCT01154816|26776960|P12|Overall Study|Progressive Disease|3
7699472|NCT01154816|26776961|P11|Overall Study|Progressive Disease|10
7699473|NCT01154816|26776962|P10|Overall Study|Progressive Disease|6
7699474|NCT01154816|26776963|P9|Overall Study|Progressive Disease|8
7699475|NCT01154816|26776964|P8|Overall Study|Progressive Disease|6
7699476|NCT01154816|26776965|P7|Overall Study|Progressive Disease|5
7699477|NCT01154816|26776966|P6|Overall Study|Progressive Disease|8
7699478|NCT01154816|26776967|P5|Overall Study|Progressive Disease|8
7699479|NCT01154816|26776968|P4|Overall Study|Progressive Disease|9
7699480|NCT01154816|26776969|P3|Overall Study|Progressive Disease|9
7699481|NCT01154816|26776970|P2|Overall Study|Progressive Disease|8
7699482|NCT01154816|26776971|P1|Overall Study|Progressive Disease|13
7699483|NCT01154816|26776960|P12|Overall Study|Withdrawal by Subject|0
7699484|NCT01154816|26776961|P11|Overall Study|Withdrawal by Subject|0
7699485|NCT01154816|26776962|P10|Overall Study|Withdrawal by Subject|3
7699486|NCT01154816|26776963|P9|Overall Study|Withdrawal by Subject|1
7699487|NCT01154816|26776964|P8|Overall Study|Withdrawal by Subject|0
7699488|NCT01154816|26776965|P7|Overall Study|Withdrawal by Subject|0
7699489|NCT01154816|26776966|P6|Overall Study|Withdrawal by Subject|0
7699490|NCT01154816|26776967|P5|Overall Study|Withdrawal by Subject|0
7699491|NCT01154816|26776968|P4|Overall Study|Withdrawal by Subject|1
7699492|NCT01154816|26776969|P3|Overall Study|Withdrawal by Subject|0
7699493|NCT01154816|26776970|P2|Overall Study|Withdrawal by Subject|0
7699494|NCT01154816|26776971|P1|Overall Study|Withdrawal by Subject|1
7699495|NCT01154673|26777048|P2|Overall Study|moved out of province|0
7699496|NCT01154673|26777049|P1|Overall Study|moved out of province|1
7699497|NCT01154673|26777048|P2|Overall Study|Lost to Follow-up|0
7699498|NCT01154673|26777049|P1|Overall Study|Lost to Follow-up|1
7699499|NCT01154452|26777104|P4|Phase II|Adverse Event|4
7699500|NCT01154452|26777105|P3|Phase II|Adverse Event|4
7699501|NCT01154452|26777106|P2|Phase II|Adverse Event|0
7699502|NCT01154452|26777107|P1|Phase II|Adverse Event|0
7699503|NCT01154452|26777104|P4|Phase II|Withdrawal by Subject|2
7699504|NCT01154452|26777105|P3|Phase II|Withdrawal by Subject|1
7699505|NCT01154452|26777106|P2|Phase II|Withdrawal by Subject|0
7699506|NCT01154452|26777107|P1|Phase II|Withdrawal by Subject|0
7699507|NCT01154452|26777104|P4|Phase Ib|Adverse Event|0
7699508|NCT01154452|26777105|P3|Phase Ib|Adverse Event|0
7699509|NCT01154452|26777106|P2|Phase Ib|Adverse Event|1
7699510|NCT01154452|26777107|P1|Phase Ib|Adverse Event|2
7699511|NCT01154452|26777104|P4|Phase Ib|Not Treated|0
7699512|NCT01154452|26777105|P3|Phase Ib|Not Treated|0
7699513|NCT01154452|26777106|P2|Phase Ib|Not Treated|0
7699514|NCT01154452|26777107|P1|Phase Ib|Not Treated|1
7699515|NCT01154296|26777139|P2|6-month Follow-up|Declined by Study Coordinator|4
7699516|NCT01154296|26777140|P1|6-month Follow-up|Declined by Study Coordinator|5
7699517|NCT01154296|26777139|P2|6-month Follow-up|Death|2
7699518|NCT01154296|26777140|P1|6-month Follow-up|Death|3
7699519|NCT01154296|26777139|P2|6-month Follow-up|Withdrew consent|15
7699520|NCT01154296|26777140|P1|6-month Follow-up|Withdrew consent|14
7699521|NCT01154296|26777139|P2|6-month Follow-up|Incarcerated|32
7699522|NCT01154296|26777140|P1|6-month Follow-up|Incarcerated|37
7699523|NCT01154296|26777139|P2|6-month Follow-up|Lost contact|275
7699524|NCT01154296|26777140|P1|6-month Follow-up|Lost contact|269
7699525|NCT01154296|26777139|P2|Randomization and Intervention|Left clinic early|0
7699526|NCT01154296|26777140|P1|Randomization and Intervention|Left clinic early|2
7699527|NCT01154296|26777139|P2|Randomization and Intervention|Left before test|1
7699528|NCT01154296|26777140|P1|Randomization and Intervention|Left before test|0
7699529|NCT01154296|26777139|P2|Randomization and Intervention|Did not return|0
7699530|NCT01154296|26777140|P1|Randomization and Intervention|Did not return|1
7699531|NCT01154296|26777139|P2|Randomization and Intervention|Declined by staff|0
7699532|NCT01154296|26777140|P1|Randomization and Intervention|Declined by staff|1
7699533|NCT01154296|26777139|P2|Randomization and Intervention|Decided to decline|1
7699534|NCT01154296|26777140|P1|Randomization and Intervention|Decided to decline|1
7699535|NCT01154283|26777158|P2|7-12 Weeks|Withdrawal by Subject|1
7699536|NCT01154283|26777159|P1|7-12 Weeks|Withdrawal by Subject|0
7699537|NCT01154283|26777158|P2|7-12 Weeks|Death|0
7699538|NCT01154283|26777159|P1|7-12 Weeks|Death|1
7699539|NCT01154283|26777158|P2|0-6 Weeks|Death|1
7699540|NCT01154283|26777159|P1|0-6 Weeks|Death|0
7699541|NCT01154283|26777158|P2|0-6 Weeks|Withdrawal by Subject|2
7699542|NCT01154283|26777159|P1|0-6 Weeks|Withdrawal by Subject|7
7699543|NCT01154231|26777171|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
7699544|NCT01154231|26777171|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
7699545|NCT01154218|26777177|P4|Fourth Intervention Period|Withdrawal by Subject|0
7699546|NCT01154218|26777178|P3|Fourth Intervention Period|Withdrawal by Subject|0
7699547|NCT01154218|26777179|P2|Fourth Intervention Period|Withdrawal by Subject|0
7699548|NCT01154218|26777180|P1|Fourth Intervention Period|Withdrawal by Subject|1
7699549|NCT01154218|26777177|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7699550|NCT01154218|26777178|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7699551|NCT01154218|26777179|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7699552|NCT01154218|26777180|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7699553|NCT01154218|26777177|P4|Third Intervention Period|Adverse Event|0
7699554|NCT01154218|26777178|P3|Third Intervention Period|Adverse Event|0
7699555|NCT01154218|26777179|P2|Third Intervention Period|Adverse Event|1
7699556|NCT01154218|26777180|P1|Third Intervention Period|Adverse Event|0
7699557|NCT01154166|26777254|P2|Overall Study|Poor Compliance|0
7699558|NCT01154166|26777255|P1|Overall Study|Poor Compliance|1
7699559|NCT01154166|26777254|P2|Overall Study|Disease Progression|0
7699560|NCT01154166|26777255|P1|Overall Study|Disease Progression|1
7699561|NCT01154166|26777254|P2|Overall Study|Lack of Efficacy|0
7699562|NCT01154166|26777255|P1|Overall Study|Lack of Efficacy|3
7699563|NCT01154166|26777254|P2|Overall Study|Withdrawal by Subject|1
7699564|NCT01154166|26777255|P1|Overall Study|Withdrawal by Subject|10
7699565|NCT01154166|26777254|P2|Overall Study|Protocol Violation|1
7699566|NCT01154166|26777255|P1|Overall Study|Protocol Violation|4
7699567|NCT01154166|26777254|P2|Overall Study|Lost to Follow-up|1
7699568|NCT01154166|26777255|P1|Overall Study|Lost to Follow-up|1
7699569|NCT01154166|26777254|P2|Overall Study|Adverse Event|9
7699570|NCT01154166|26777255|P1|Overall Study|Adverse Event|14
7699571|NCT01154153|26777287|P2|Overall Study|Withdrew consent|0
7699572|NCT01154153|26777288|P1|Overall Study|Withdrew consent|1
7699573|NCT01154153|26777287|P2|Overall Study|Unable to use labs|3
7699574|NCT01154153|26777288|P1|Overall Study|Unable to use labs|2
7699575|NCT01154153|26777287|P2|Overall Study|Poor compliance to protocol|0
7699576|NCT01154153|26777288|P1|Overall Study|Poor compliance to protocol|2
7699577|NCT01154140|26777306|P2|Overall Study|Randomized but not treated|2
7699578|NCT01154140|26777307|P1|Overall Study|Randomized but not treated|1
7699579|NCT01154140|26777306|P2|Overall Study|Other|1
7699580|NCT01154140|26777307|P1|Overall Study|Other|3
7699581|NCT01154140|26777306|P2|Overall Study|Withdrawal by Subject|13
7699582|NCT01154140|26777307|P1|Overall Study|Withdrawal by Subject|12
7699583|NCT01154140|26777306|P2|Overall Study|Lost to Follow-up|5
7699584|NCT01154140|26777307|P1|Overall Study|Lost to Follow-up|4
7699585|NCT01154140|26777306|P2|Overall Study|Death|81
7699586|NCT01154140|26777307|P1|Overall Study|Death|71
7699587|NCT01154127|26777360|P2|Period 2 (21 Days)|Protocol Deviation|1
7699588|NCT01154127|26777361|P1|Period 2 (21 Days)|Protocol Deviation|0
7699589|NCT01154127|26777360|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
7699590|NCT01154127|26777361|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
7699591|NCT01154127|26777360|P2|Washout (14 - 28 Days)|Adverse Event|0
7699592|NCT01154127|26777361|P1|Washout (14 - 28 Days)|Adverse Event|2
7699593|NCT01154127|26777360|P2|Period 1 (21 Days)|Withdrawal by Subject|2
7699594|NCT01154127|26777361|P1|Period 1 (21 Days)|Withdrawal by Subject|0
7699595|NCT01154127|26777360|P2|Period 1 (21 Days)|Adverse Event|4
7699596|NCT01154127|26777361|P1|Period 1 (21 Days)|Adverse Event|3
7699597|NCT01154101|26777388|P5|Overall Study|Withdrawal by Subject|1
7699598|NCT01154101|26777389|P4|Overall Study|Withdrawal by Subject|0
7699599|NCT01154101|26777390|P3|Overall Study|Withdrawal by Subject|2
7699600|NCT01154101|26777391|P2|Overall Study|Withdrawal by Subject|1
7699601|NCT01154101|26777392|P1|Overall Study|Withdrawal by Subject|0
7699602|NCT01154101|26777388|P5|Overall Study|Lost to Follow-up|0
7699603|NCT01154101|26777389|P4|Overall Study|Lost to Follow-up|1
7699604|NCT01154101|26777390|P3|Overall Study|Lost to Follow-up|0
7699605|NCT01154101|26777391|P2|Overall Study|Lost to Follow-up|1
7699606|NCT01154101|26777392|P1|Overall Study|Lost to Follow-up|0
7699607|NCT01154101|26777388|P5|Overall Study|Adverse Event|0
7699608|NCT01154101|26777389|P4|Overall Study|Adverse Event|1
7699609|NCT01154101|26777390|P3|Overall Study|Adverse Event|1
7699610|NCT01154101|26777391|P2|Overall Study|Adverse Event|2
7699611|NCT01154101|26777392|P1|Overall Study|Adverse Event|0
7699612|NCT01154088|26777447|P3|Overall Study|Lost to Follow-up|7
7699613|NCT01154088|26777448|P2|Overall Study|Lost to Follow-up|6
7699614|NCT01154088|26777449|P1|Overall Study|Lost to Follow-up|4
7699615|NCT01154036|26777489|P8|Phase II|Withdrawal by Subject|4
7699616|NCT01154036|26777490|P7|Phase II|Withdrawal by Subject|5
7699617|NCT01154036|26777491|P6|Phase II|Withdrawal by Subject|2
7699618|NCT01154036|26777492|P5|Phase II|Withdrawal by Subject|4
7699619|NCT01154036|26777493|P4|Phase II|Withdrawal by Subject|0
7699620|NCT01154036|26777494|P3|Phase II|Withdrawal by Subject|0
7699621|NCT01154036|26777495|P2|Phase II|Withdrawal by Subject|0
7699622|NCT01154036|26777496|P1|Phase II|Withdrawal by Subject|0
7699623|NCT01154036|26777489|P8|Phase II|Protocol Violation|0
7699624|NCT01154036|26777490|P7|Phase II|Protocol Violation|0
7699625|NCT01154036|26777491|P6|Phase II|Protocol Violation|2
7699626|NCT01154036|26777492|P5|Phase II|Protocol Violation|1
7699627|NCT01154036|26777493|P4|Phase II|Protocol Violation|0
7699628|NCT01154036|26777494|P3|Phase II|Protocol Violation|0
7699629|NCT01154036|26777495|P2|Phase II|Protocol Violation|0
7699630|NCT01154036|26777496|P1|Phase II|Protocol Violation|0
7699631|NCT01154036|26777489|P8|Phase II|Lost to Follow-up|1
7699632|NCT01154036|26777490|P7|Phase II|Lost to Follow-up|2
7699633|NCT01154036|26777491|P6|Phase II|Lost to Follow-up|0
7699634|NCT01154036|26777492|P5|Phase II|Lost to Follow-up|2
7699635|NCT01154036|26777493|P4|Phase II|Lost to Follow-up|1
7699636|NCT01154036|26777494|P3|Phase II|Lost to Follow-up|0
7699637|NCT01154036|26777495|P2|Phase II|Lost to Follow-up|0
7699638|NCT01154036|26777496|P1|Phase II|Lost to Follow-up|0
7699639|NCT01154036|26777489|P8|Phase II|Physician Decision|0
7699640|NCT01154036|26777490|P7|Phase II|Physician Decision|1
7699641|NCT01154036|26777491|P6|Phase II|Physician Decision|0
7699642|NCT01154036|26777492|P5|Phase II|Physician Decision|0
7699643|NCT01154036|26777493|P4|Phase II|Physician Decision|0
7699644|NCT01154036|26777494|P3|Phase II|Physician Decision|0
7699645|NCT01154036|26777495|P2|Phase II|Physician Decision|0
7699646|NCT01154036|26777496|P1|Phase II|Physician Decision|0
7699647|NCT01154036|26777489|P8|Phase II|Adverse Event|1
7699648|NCT01154036|26777490|P7|Phase II|Adverse Event|1
7699649|NCT01154036|26777491|P6|Phase II|Adverse Event|1
7699650|NCT01154036|26777492|P5|Phase II|Adverse Event|1
7699651|NCT01154036|26777493|P4|Phase II|Adverse Event|0
7699652|NCT01154036|26777494|P3|Phase II|Adverse Event|0
7699653|NCT01154036|26777495|P2|Phase II|Adverse Event|0
7699654|NCT01154036|26777496|P1|Phase II|Adverse Event|0
7699655|NCT01154036|26777489|P8|Phase I|Adverse Event|0
7699656|NCT01154036|26777490|P7|Phase I|Adverse Event|0
7699657|NCT01154036|26777491|P6|Phase I|Adverse Event|0
7699658|NCT01154036|26777492|P5|Phase I|Adverse Event|0
7699659|NCT01154036|26777493|P4|Phase I|Adverse Event|0
7699660|NCT01154036|26777494|P3|Phase I|Adverse Event|12
7699661|NCT01154036|26777495|P2|Phase I|Adverse Event|11
7699662|NCT01154036|26777496|P1|Phase I|Adverse Event|1
7699663|NCT01154036|26777489|P8|Phase I|Withdrawal by Subject|0
7699664|NCT01154036|26777490|P7|Phase I|Withdrawal by Subject|0
7699665|NCT01154036|26777491|P6|Phase I|Withdrawal by Subject|0
7699666|NCT01154036|26777492|P5|Phase I|Withdrawal by Subject|0
7699667|NCT01154036|26777493|P4|Phase I|Withdrawal by Subject|0
7699668|NCT01154036|26777494|P3|Phase I|Withdrawal by Subject|29
7699669|NCT01154036|26777495|P2|Phase I|Withdrawal by Subject|10
7699670|NCT01154036|26777496|P1|Phase I|Withdrawal by Subject|2
7699671|NCT01154036|26777489|P8|Phase I|Protocol Violation|0
7699672|NCT01154036|26777490|P7|Phase I|Protocol Violation|0
7699673|NCT01154036|26777491|P6|Phase I|Protocol Violation|0
7699674|NCT01154036|26777492|P5|Phase I|Protocol Violation|0
7699675|NCT01154036|26777493|P4|Phase I|Protocol Violation|0
7699676|NCT01154036|26777494|P3|Phase I|Protocol Violation|9
7699677|NCT01154036|26777495|P2|Phase I|Protocol Violation|3
7699678|NCT01154036|26777496|P1|Phase I|Protocol Violation|0
7699679|NCT01154036|26777489|P8|Phase I|Lost to Follow-up|0
7699680|NCT01154036|26777490|P7|Phase I|Lost to Follow-up|0
7699681|NCT01154036|26777491|P6|Phase I|Lost to Follow-up|0
7699682|NCT01154036|26777492|P5|Phase I|Lost to Follow-up|0
7699683|NCT01154036|26777493|P4|Phase I|Lost to Follow-up|0
7699684|NCT01154036|26777494|P3|Phase I|Lost to Follow-up|6
7699685|NCT01154036|26777495|P2|Phase I|Lost to Follow-up|3
7699686|NCT01154036|26777496|P1|Phase I|Lost to Follow-up|0
7699687|NCT01154036|26777489|P8|Phase I|Physician Decision|0
7699688|NCT01154036|26777490|P7|Phase I|Physician Decision|0
7699689|NCT01154036|26777491|P6|Phase I|Physician Decision|0
7699690|NCT01154036|26777492|P5|Phase I|Physician Decision|0
7699691|NCT01154036|26777493|P4|Phase I|Physician Decision|0
7699692|NCT01154036|26777494|P3|Phase I|Physician Decision|0
7699693|NCT01154036|26777495|P2|Phase I|Physician Decision|1
7699694|NCT01154036|26777496|P1|Phase I|Physician Decision|0
7699695|NCT01154010|26777620|P2|Overall Study|Lost to Follow-up|1
7699696|NCT01154010|26777621|P1|Overall Study|Lost to Follow-up|0
7699697|NCT01153984|26777627|P1|Overall Study|Adverse Event|1
7699698|NCT01153984|26777627|P1|Overall Study|Withdrawal by Subject|1
7699699|NCT01153971|26777638|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
7699700|NCT01153971|26777638|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
7699701|NCT01153971|26777638|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
7699702|NCT01153971|26777638|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
7699703|NCT01153971|26777638|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
7699704|NCT01153971|26777638|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
7699705|NCT01153971|26777638|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
7699706|NCT01153958|26777661|P2|Overall Study|Study Terminated|32
7699707|NCT01153958|26777662|P1|Overall Study|Study Terminated|36
7699708|NCT01153893|26777680|P2|Overall Study|Adverse Event|0
7699709|NCT01153893|26777681|P1|Overall Study|Adverse Event|1
7699710|NCT01153841|26777707|P2|Overall Study|Lost to Follow-up|0
7699711|NCT01153841|26777708|P1|Overall Study|Lost to Follow-up|2
7699712|NCT01153841|26777707|P2|Overall Study|Protocol Violation|0
7699713|NCT01153841|26777708|P1|Overall Study|Protocol Violation|2
7699714|NCT01153841|26777707|P2|Overall Study|Withdrawal by Subject|0
7699715|NCT01153841|26777708|P1|Overall Study|Withdrawal by Subject|1
7699716|NCT01153841|26777707|P2|Overall Study|Adverse Event|0
7699717|NCT01153841|26777708|P1|Overall Study|Adverse Event|1
7699718|NCT01153815|26777724|P2|Overall Study|Withdrawal by Subject|4
7699719|NCT01153815|26777725|P1|Overall Study|Withdrawal by Subject|6
7699720|NCT01153815|26777724|P2|Overall Study|Adverse Event|1
7699721|NCT01153815|26777725|P1|Overall Study|Adverse Event|3
7699722|NCT01153763|26777747|P1|Overall Study|Withdrawal by Subject|2
7699723|NCT01153763|26777747|P1|Overall Study|Physician Decision|2
7699724|NCT01153763|26777747|P1|Overall Study|Lost to Follow-up|1
7699725|NCT01153763|26777747|P1|Overall Study|Study Closed|16
7699726|NCT01153724|26777763|P1|Treatment Period 2|Other reason not defined above|1
7699727|NCT01153724|26777763|P1|Treatment Period 2|Adverse Event|1
7699728|NCT01153724|26777763|P1|Treatment Period 1|Withdrawal by Subject|1
7699729|NCT01153698|26777803|P1|Overall Study|Not treated with Pradaxa|5
7699730|NCT01153698|26777803|P1|Overall Study|Other|2
7699731|NCT01153698|26777803|P1|Overall Study|Switch to other anticoagulants|4
7699732|NCT01153698|26777803|P1|Overall Study|Withdrawal by Subject|2
7699733|NCT01153698|26777803|P1|Overall Study|Lost to Follow-up|4
7699734|NCT01153698|26777803|P1|Overall Study|Adverse Event|12
7699735|NCT01153633|26777854|P2|Overall Study|Therapeutic failure|3
7699736|NCT01153633|26777855|P1|Overall Study|Therapeutic failure|3
7699737|NCT01153633|26777854|P2|Overall Study|Protocol Violation|1
7699738|NCT01153633|26777855|P1|Overall Study|Protocol Violation|1
7699739|NCT01153516|26777892|P2|Overall Study|Both subjects refused surgery|0
7699740|NCT01153516|26777893|P1|Overall Study|Both subjects refused surgery|2
7699741|NCT01153425|26777918|P2|Overall Study|Withdrawal by Subject|3
7699742|NCT01153425|26777919|P1|Overall Study|Withdrawal by Subject|3
7699743|NCT01153347|26777931|P4|Overall Study|Death|0
7699744|NCT01153347|26777932|P3|Overall Study|Death|0
7699745|NCT01153347|26777933|P2|Overall Study|Death|0
7699746|NCT01153347|26777934|P1|Overall Study|Death|1
7699747|NCT01153347|26777931|P4|Overall Study|Other|0
7699748|NCT01153347|26777932|P3|Overall Study|Other|4
7699749|NCT01153347|26777933|P2|Overall Study|Other|5
7699750|NCT01153347|26777934|P1|Overall Study|Other|5
7699751|NCT01153347|26777931|P4|Overall Study|Lost to Follow-up|8
7699752|NCT01153347|26777932|P3|Overall Study|Lost to Follow-up|11
7699753|NCT01153347|26777933|P2|Overall Study|Lost to Follow-up|9
7699754|NCT01153347|26777934|P1|Overall Study|Lost to Follow-up|4
7699755|NCT01153347|26777931|P4|Overall Study|Study-specific withdrawal criteria|2
7699756|NCT01153347|26777932|P3|Overall Study|Study-specific withdrawal criteria|1
7699757|NCT01153347|26777933|P2|Overall Study|Study-specific withdrawal criteria|3
7699758|NCT01153347|26777934|P1|Overall Study|Study-specific withdrawal criteria|4
7699759|NCT01153347|26777931|P4|Overall Study|Lack of Efficacy|4
7699760|NCT01153347|26777932|P3|Overall Study|Lack of Efficacy|0
7699761|NCT01153347|26777933|P2|Overall Study|Lack of Efficacy|2
7699762|NCT01153347|26777934|P1|Overall Study|Lack of Efficacy|2
7699763|NCT01153347|26777931|P4|Overall Study|Condition under investigation worsened|0
7699764|NCT01153347|26777932|P3|Overall Study|Condition under investigation worsened|0
7699765|NCT01153347|26777933|P2|Overall Study|Condition under investigation worsened|1
7699766|NCT01153347|26777934|P1|Overall Study|Condition under investigation worsened|1
7699767|NCT01153347|26777931|P4|Overall Study|Severe non-compliance to protocol|3
7699768|NCT01153347|26777932|P3|Overall Study|Severe non-compliance to protocol|4
7699769|NCT01153347|26777933|P2|Overall Study|Severe non-compliance to protocol|7
7699770|NCT01153347|26777934|P1|Overall Study|Severe non-compliance to protocol|6
7699771|NCT01153347|26777931|P4|Overall Study|Adverse Event|7
7699772|NCT01153347|26777932|P3|Overall Study|Adverse Event|21
7699773|NCT01153347|26777933|P2|Overall Study|Adverse Event|9
7699774|NCT01153347|26777934|P1|Overall Study|Adverse Event|3
7699775|NCT01153347|26777931|P4|Overall Study|Eligibility criteria not fulfilled|1
7699776|NCT01153347|26777932|P3|Overall Study|Eligibility criteria not fulfilled|2
7699777|NCT01153347|26777933|P2|Overall Study|Eligibility criteria not fulfilled|1
7699778|NCT01153347|26777934|P1|Overall Study|Eligibility criteria not fulfilled|0
7699779|NCT01153347|26777931|P4|Overall Study|Withdrawal by Subject|7
7699780|NCT01153347|26777932|P3|Overall Study|Withdrawal by Subject|7
7699781|NCT01153347|26777933|P2|Overall Study|Withdrawal by Subject|7
7699782|NCT01153347|26777934|P1|Overall Study|Withdrawal by Subject|7
7699783|NCT01153321|26778034|P2|Overall Study|Adverse Event|1
7699784|NCT01153321|26778035|P1|Overall Study|Adverse Event|1
7699785|NCT01153321|26778034|P2|Overall Study|Withdrawal by Subject|1
7699786|NCT01153321|26778035|P1|Overall Study|Withdrawal by Subject|0
7699787|NCT01153321|26778034|P2|Overall Study|Development of study withdrawal criteria|1
7699788|NCT01153321|26778035|P1|Overall Study|Development of study withdrawal criteria|0
7699789|NCT01153269|26778147|P1|Overall Study|Antiretroviral therapy break|1
7699790|NCT01153269|26778147|P1|Overall Study|Withdrawal by Subject|1
7699791|NCT01153009|26778210|P4|Overall Study|Other|2
7699792|NCT01153009|26778211|P3|Overall Study|Other|3
7699793|NCT01153009|26778212|P2|Overall Study|Other|1
7699794|NCT01153009|26778213|P1|Overall Study|Other|1
7699795|NCT01153009|26778210|P4|Overall Study|Lost to Follow-up|15
7699796|NCT01153009|26778211|P3|Overall Study|Lost to Follow-up|11
7699797|NCT01153009|26778212|P2|Overall Study|Lost to Follow-up|8
7699798|NCT01153009|26778213|P1|Overall Study|Lost to Follow-up|8
7699799|NCT01153009|26778210|P4|Overall Study|Withdrawal of Consent|6
7699800|NCT01153009|26778211|P3|Overall Study|Withdrawal of Consent|4
7699801|NCT01153009|26778212|P2|Overall Study|Withdrawal of Consent|5
7699802|NCT01153009|26778213|P1|Overall Study|Withdrawal of Consent|5
7699803|NCT01153009|26778210|P4|Overall Study|Protocol Deviations|2
7699804|NCT01153009|26778211|P3|Overall Study|Protocol Deviations|3
7699805|NCT01153009|26778212|P2|Overall Study|Protocol Deviations|3
7699806|NCT01153009|26778213|P1|Overall Study|Protocol Deviations|4
7699807|NCT01153009|26778210|P4|Overall Study|Noncompliance with Study Medication|1
7699808|NCT01153009|26778211|P3|Overall Study|Noncompliance with Study Medication|4
7699809|NCT01153009|26778212|P2|Overall Study|Noncompliance with Study Medication|3
7699810|NCT01153009|26778213|P1|Overall Study|Noncompliance with Study Medication|1
7699811|NCT01153009|26778210|P4|Overall Study|Lack of Efficacy|1
7699812|NCT01153009|26778211|P3|Overall Study|Lack of Efficacy|2
7699813|NCT01153009|26778212|P2|Overall Study|Lack of Efficacy|0
7699814|NCT01153009|26778213|P1|Overall Study|Lack of Efficacy|9
7699815|NCT01153009|26778210|P4|Overall Study|Adverse Event|10
7699816|NCT01153009|26778211|P3|Overall Study|Adverse Event|14
7699817|NCT01153009|26778212|P2|Overall Study|Adverse Event|14
7699818|NCT01153009|26778213|P1|Overall Study|Adverse Event|4
7699819|NCT01152996|26778243|P1|Overall Study|Elevated liver enzymes|1
7699820|NCT01152996|26778243|P1|Overall Study|Protocol Violation|22
7699821|NCT01152996|26778243|P1|Overall Study|Other|36
7699822|NCT01152996|26778243|P1|Overall Study|Noncompliance|41
7699823|NCT01152996|26778243|P1|Overall Study|Lack of Efficacy|68
7699824|NCT01152996|26778243|P1|Overall Study|Lost to Follow-up|112
7699825|NCT01152996|26778243|P1|Overall Study|Adverse Event|115
7699826|NCT01152996|26778243|P1|Overall Study|Withdrawal by Subject|142
7699827|NCT01152814|26778256|P1|Overall Study|Lost to Follow-up|2
7699828|NCT01152788|26778265|P2|Overall Study|No treatment|1
7699829|NCT01152788|26778266|P1|Overall Study|No treatment|0
7699830|NCT01152788|26778265|P2|Overall Study|Withdrawal by Subject|3
7699831|NCT01152788|26778266|P1|Overall Study|Withdrawal by Subject|0
7699832|NCT01152580|26778303|P2|Overall Study|Withdrawal by Subject|1
7699833|NCT01152580|26778304|P1|Overall Study|Withdrawal by Subject|0
7699834|NCT01152554|26778326|P2|Overall Study|Death|1
7699835|NCT01152554|26778327|P1|Overall Study|Death|1
7699836|NCT01152554|26778326|P2|Overall Study|Other|8
7699837|NCT01152554|26778327|P1|Overall Study|Other|28
7699838|NCT01152554|26778326|P2|Overall Study|Lost to Follow-up|32
7699839|NCT01152554|26778327|P1|Overall Study|Lost to Follow-up|87
7699840|NCT01152554|26778326|P2|Overall Study|Study-specific withdrawal criteria|8
7699841|NCT01152554|26778327|P1|Overall Study|Study-specific withdrawal criteria|17
7699842|NCT01152554|26778326|P2|Overall Study|Lack of Efficacy|3
7699843|NCT01152554|26778327|P1|Overall Study|Lack of Efficacy|20
7699844|NCT01152554|26778326|P2|Overall Study|Condition under investigation worsened|2
7699845|NCT01152554|26778327|P1|Overall Study|Condition under investigation worsened|5
7699846|NCT01152554|26778326|P2|Overall Study|Severe non-compliance to protocol|14
7699847|NCT01152554|26778327|P1|Overall Study|Severe non-compliance to protocol|36
7699848|NCT01152554|26778326|P2|Overall Study|Adverse Event|14
7699849|NCT01152554|26778327|P1|Overall Study|Adverse Event|67
7699850|NCT01152554|26778326|P2|Overall Study|Eligiblity criteria not fulfilled|1
7699851|NCT01152554|26778327|P1|Overall Study|Eligiblity criteria not fulfilled|0
7699852|NCT01152554|26778326|P2|Overall Study|Withdrawal by Subject|28
7699853|NCT01152554|26778327|P1|Overall Study|Withdrawal by Subject|73
7699854|NCT01152450|26778366|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
7699855|NCT01152450|26778367|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
7699856|NCT01152450|26778368|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
7699857|NCT01152450|26778369|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
7699858|NCT01152450|26778370|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
7699859|NCT01152450|26778371|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
7699860|NCT01152450|26778366|P6|Period 1 (4 Weeks)|Protocol Violation|0
7699861|NCT01152450|26778367|P5|Period 1 (4 Weeks)|Protocol Violation|1
7699862|NCT01152450|26778368|P4|Period 1 (4 Weeks)|Protocol Violation|0
7699863|NCT01152450|26778369|P3|Period 1 (4 Weeks)|Protocol Violation|0
7699864|NCT01152450|26778370|P2|Period 1 (4 Weeks)|Protocol Violation|0
7699865|NCT01152450|26778371|P1|Period 1 (4 Weeks)|Protocol Violation|0
7699866|NCT01152450|26778366|P6|Period 1 (4 Weeks)|Adverse Event|1
7699867|NCT01152450|26778367|P5|Period 1 (4 Weeks)|Adverse Event|1
7699868|NCT01152450|26778368|P4|Period 1 (4 Weeks)|Adverse Event|0
7699869|NCT01152450|26778369|P3|Period 1 (4 Weeks)|Adverse Event|0
7699870|NCT01152450|26778370|P2|Period 1 (4 Weeks)|Adverse Event|0
7699871|NCT01152450|26778371|P1|Period 1 (4 Weeks)|Adverse Event|0
7699872|NCT01152437|26778442|P3|Overall Study|Refusal to continue taking trial medicat|2
7699873|NCT01152437|26778443|P2|Overall Study|Refusal to continue taking trial medicat|0
7699874|NCT01152437|26778444|P1|Overall Study|Refusal to continue taking trial medicat|1
7699875|NCT01152437|26778442|P3|Overall Study|Progressive disease|32
7699876|NCT01152437|26778443|P2|Overall Study|Progressive disease|13
7699877|NCT01152437|26778444|P1|Overall Study|Progressive disease|27
7699878|NCT01152437|26778442|P3|Overall Study|Not treated|2
7699879|NCT01152437|26778443|P2|Overall Study|Not treated|1
7699880|NCT01152437|26778444|P1|Overall Study|Not treated|0
7699881|NCT01152437|26778442|P3|Overall Study|Other Adverse Event|7
7699882|NCT01152437|26778443|P2|Overall Study|Other Adverse Event|1
7699883|NCT01152437|26778444|P1|Overall Study|Other Adverse Event|8
7699884|NCT01152385|26778464|P4|Overall Study|Other|3
7699885|NCT01152385|26778465|P3|Overall Study|Other|2
7699886|NCT01152385|26778466|P2|Overall Study|Other|3
7699887|NCT01152385|26778467|P1|Overall Study|Other|4
7699888|NCT01152385|26778464|P4|Overall Study|Study-specific withdrawal criteria|0
7699889|NCT01152385|26778465|P3|Overall Study|Study-specific withdrawal criteria|2
7699890|NCT01152385|26778466|P2|Overall Study|Study-specific withdrawal criteria|1
7699891|NCT01152385|26778467|P1|Overall Study|Study-specific withdrawal criteria|1
7699892|NCT01152385|26778464|P4|Overall Study|Adverse Event|0
7699893|NCT01152385|26778465|P3|Overall Study|Adverse Event|0
7699894|NCT01152385|26778466|P2|Overall Study|Adverse Event|1
7699895|NCT01152385|26778467|P1|Overall Study|Adverse Event|1
7699896|NCT01152385|26778464|P4|Overall Study|Protocol Violation|1
7699897|NCT01152385|26778465|P3|Overall Study|Protocol Violation|0
7699898|NCT01152385|26778466|P2|Overall Study|Protocol Violation|0
7699899|NCT01152385|26778467|P1|Overall Study|Protocol Violation|0
7699900|NCT01152385|26778464|P4|Overall Study|Withdrawal by Subject|1
7699901|NCT01152385|26778465|P3|Overall Study|Withdrawal by Subject|1
7699902|NCT01152385|26778466|P2|Overall Study|Withdrawal by Subject|1
7699903|NCT01152385|26778467|P1|Overall Study|Withdrawal by Subject|3
7699904|NCT01152190|26778538|P2|Overall Study|Withdrawal by Subject|3
7699905|NCT01152190|26778539|P1|Overall Study|Withdrawal by Subject|1
7699906|NCT01152190|26778538|P2|Overall Study|Protocol Violation|1
7699907|NCT01152190|26778539|P1|Overall Study|Protocol Violation|1
7699908|NCT01152190|26778538|P2|Overall Study|Death|0
7699909|NCT01152190|26778539|P1|Overall Study|Death|1
7699910|NCT01152190|26778538|P2|Overall Study|Adverse Event|4
7699911|NCT01152190|26778539|P1|Overall Study|Adverse Event|2
7699912|NCT01152021|26778562|P2|Overall Study|No access to study drug in Pharmacy|1
7699913|NCT01152021|26778563|P1|Overall Study|No access to study drug in Pharmacy|0
7699914|NCT01152021|26778562|P2|Overall Study|Physician Decision|1
7699915|NCT01152021|26778563|P1|Overall Study|Physician Decision|1
7699916|NCT01152021|26778562|P2|Overall Study|Study drug had expired|0
7699917|NCT01152021|26778563|P1|Overall Study|Study drug had expired|1
7699918|NCT01152021|26778562|P2|Overall Study|Adverse Event|4
7699919|NCT01152021|26778563|P1|Overall Study|Adverse Event|4
7699920|NCT01151618|26778620|P1|Overall Study|Withdrawal by Subject|7
7699921|NCT01151618|26778620|P1|Overall Study|Adverse Event|2
7699922|NCT01151579|26778628|P2|Overall Study|Not meet inclusion criteria|4
7699923|NCT01151579|26778629|P1|Overall Study|Not meet inclusion criteria|6
7699924|NCT01151579|26778628|P2|Overall Study|Withdrawal by Subject|2
7699925|NCT01151579|26778629|P1|Overall Study|Withdrawal by Subject|3
7699926|NCT01151579|26778628|P2|Overall Study|Physician Decision|1
7699927|NCT01151579|26778629|P1|Overall Study|Physician Decision|3
7699928|NCT01151540|26778643|P1|Overall Study|Withdrawal by Subject|7
7699929|NCT01151540|26778643|P1|Overall Study|Adverse event, non-fatal|4
7699930|NCT01151540|26778643|P1|Overall Study|Other|2
7699931|NCT01151423|26778692|P2|Overall Study|Participated in other clinical trial|0
7699932|NCT01151423|26778693|P1|Overall Study|Participated in other clinical trial|1
7699933|NCT01151423|26778692|P2|Overall Study|Diagnosed as non-TTP patient|1
7699934|NCT01151423|26778693|P1|Overall Study|Diagnosed as non-TTP patient|0
7699935|NCT01151423|26778692|P2|Overall Study|Lost to Follow-up|0
7699936|NCT01151423|26778693|P1|Overall Study|Lost to Follow-up|1
7699937|NCT01151423|26778692|P2|Overall Study|Withdrawal by Subject|3
7699938|NCT01151423|26778693|P1|Overall Study|Withdrawal by Subject|1
7699939|NCT01151423|26778692|P2|Overall Study|Adverse Event|0
7699940|NCT01151423|26778693|P1|Overall Study|Adverse Event|3
7699941|NCT01151423|26778692|P2|Overall Study|Death|1
7699942|NCT01151423|26778693|P1|Overall Study|Death|0
7699943|NCT01151423|26778692|P2|Overall Study|Pregnancy|1
7699944|NCT01151423|26778693|P1|Overall Study|Pregnancy|0
7699945|NCT01151423|26778692|P2|Overall Study|Physician Decision|1
7699946|NCT01151423|26778693|P1|Overall Study|Physician Decision|1
7699947|NCT01151423|26778692|P2|Overall Study|Protocol Violation|1
7699948|NCT01151423|26778693|P1|Overall Study|Protocol Violation|0
7699949|NCT01151423|26778692|P2|Overall Study|Study terminated by Sponsor|10
7699950|NCT01151423|26778693|P1|Overall Study|Study terminated by Sponsor|9
7699951|NCT01151410|26778741|P2|Overall Study|Abnormal laboratory value(s)|1
7699952|NCT01151410|26778742|P1|Overall Study|Abnormal laboratory value(s)|0
7699953|NCT01151410|26778741|P2|Overall Study|Unsatisfactory therapeutic effect|1
7699954|NCT01151410|26778742|P1|Overall Study|Unsatisfactory therapeutic effect|1
7699955|NCT01151410|26778741|P2|Overall Study|Administrative problems|1
7699956|NCT01151410|26778742|P1|Overall Study|Administrative problems|1
7699957|NCT01151410|26778741|P2|Overall Study|Protocol deviation|1
7699958|NCT01151410|26778742|P1|Overall Study|Protocol deviation|2
7699959|NCT01151410|26778741|P2|Overall Study|Adverse Event|2
7699960|NCT01151410|26778742|P1|Overall Study|Adverse Event|1
7699961|NCT01151410|26778741|P2|Overall Study|Lost to Follow-up|4
7699962|NCT01151410|26778742|P1|Overall Study|Lost to Follow-up|3
7699963|NCT01151410|26778741|P2|Overall Study|Withdrawal by Subject|5
7699964|NCT01151410|26778742|P1|Overall Study|Withdrawal by Subject|3
7699965|NCT01151345|26778786|P2|First Intervention Period|Protocol Violation|1
7699966|NCT01151345|26778787|P1|First Intervention Period|Protocol Violation|0
7699967|NCT01151280|26778801|P1|Overall Study|Lack of Efficacy|3
7699968|NCT01151280|26778801|P1|Overall Study|Adverse Event|1
7699969|NCT01151215|26778814|P3|Overall Study|Safety as judged by the investigator|1
7699970|NCT01151215|26778815|P2|Overall Study|Safety as judged by the investigator|0
7699971|NCT01151215|26778816|P1|Overall Study|Safety as judged by the investigator|0
7699972|NCT01151215|26778814|P3|Overall Study|Disease progression|1
7699973|NCT01151215|26778815|P2|Overall Study|Disease progression|1
7699974|NCT01151215|26778816|P1|Overall Study|Disease progression|0
7699975|NCT01151215|26778814|P3|Overall Study|Withdrawal by Subject|2
7699976|NCT01151215|26778815|P2|Overall Study|Withdrawal by Subject|1
7699977|NCT01151215|26778816|P1|Overall Study|Withdrawal by Subject|3
7699978|NCT01151215|26778814|P3|Overall Study|Lost to Follow-up|3
7699979|NCT01151215|26778815|P2|Overall Study|Lost to Follow-up|0
7699980|NCT01151215|26778816|P1|Overall Study|Lost to Follow-up|0
7699981|NCT01151215|26778814|P3|Overall Study|Death|11
7699982|NCT01151215|26778815|P2|Overall Study|Death|20
7699983|NCT01151215|26778816|P1|Overall Study|Death|16
7699984|NCT01151215|26778814|P3|Overall Study|Worsening of condition under study|1
7699985|NCT01151215|26778815|P2|Overall Study|Worsening of condition under study|1
7699986|NCT01151215|26778816|P1|Overall Study|Worsening of condition under study|1
7699987|NCT01151137|26778872|P2|Overall Study|Lost to Follow-up|1
7699988|NCT01151137|26778873|P1|Overall Study|Lost to Follow-up|1
7699989|NCT01151137|26778872|P2|Overall Study|Death|27
7699990|NCT01151137|26778873|P1|Overall Study|Death|15
7699991|NCT01151098|26778891|P1|Overall Study|Miscellaneous|13
7699992|NCT01151098|26778891|P1|Overall Study|Protocol Violation|1
7699993|NCT01151098|26778891|P1|Overall Study|Lack of Efficacy|15
7699994|NCT01151098|26778891|P1|Overall Study|Lost to Follow-up|6
7699995|NCT01151098|26778891|P1|Overall Study|Adverse Event|82
7699996|NCT01151085|26778895|P1|Overall Study|Protocol Violation|25
7699997|NCT01151085|26778895|P1|Overall Study|Lost to Follow-up|31
7699998|NCT01151020|26778926|P1|Overall Study|Patients did not receive the device|2
7699999|NCT01151020|26778926|P1|Overall Study|Withdrawal by Subject|22
7700000|NCT01151020|26778926|P1|Overall Study|Lost to Follow-up|4
7700001|NCT01151020|26778926|P1|Overall Study|Conversion to open repair|1
7700002|NCT01151020|26778926|P1|Overall Study|Death|25
7700003|NCT01150474|26779005|P2|Overall Study|Surgery Changed|0
7700004|NCT01150474|26779006|P1|Overall Study|Surgery Changed|1
7700005|NCT01150474|26779005|P2|Overall Study|Drug not administered|0
7700006|NCT01150474|26779006|P1|Overall Study|Drug not administered|1
7700007|NCT01150474|26779005|P2|Overall Study|Drug did not arrive in time|0
7700008|NCT01150474|26779006|P1|Overall Study|Drug did not arrive in time|1
7700009|NCT01150474|26779005|P2|Overall Study|Rectotomy|0
7700010|NCT01150474|26779006|P1|Overall Study|Rectotomy|1
7700011|NCT01150474|26779005|P2|Overall Study|Multiple Studies|1
7700012|NCT01150474|26779006|P1|Overall Study|Multiple Studies|0
7700013|NCT01150474|26779005|P2|Overall Study|Cancer found|0
7700014|NCT01150474|26779006|P1|Overall Study|Cancer found|1
7700015|NCT01150474|26779005|P2|Overall Study|Withdrawal by Subject|2
7700016|NCT01150474|26779006|P1|Overall Study|Withdrawal by Subject|5
7700017|NCT01150357|26779051|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
7700018|NCT01150357|26779052|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
7700019|NCT01150357|26779053|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
7700020|NCT01150357|26779051|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
7700021|NCT01150357|26779052|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
7700022|NCT01150357|26779053|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
7700023|NCT01150357|26779051|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
7700024|NCT01150357|26779052|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
7700025|NCT01150357|26779053|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
7700026|NCT01150357|26779051|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
7700027|NCT01150357|26779052|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
7700028|NCT01150357|26779053|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
7700029|NCT01150357|26779051|P3|Dose Response Phase (Phase 1)|Adverse Event|1
7700030|NCT01150357|26779052|P2|Dose Response Phase (Phase 1)|Adverse Event|0
7700031|NCT01150357|26779053|P1|Dose Response Phase (Phase 1)|Adverse Event|0
7700032|NCT01150357|26779051|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
7700033|NCT01150357|26779052|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
7700034|NCT01150357|26779053|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
7700035|NCT01150357|26779051|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
7700036|NCT01150357|26779052|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
7700037|NCT01150357|26779053|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
7700038|NCT01150123|26779133|P18|Overall Study|Lost to Follow-up|0
7700039|NCT01150123|26779134|P17|Overall Study|Lost to Follow-up|0
7700040|NCT01150123|26779135|P16|Overall Study|Lost to Follow-up|0
7700041|NCT01150123|26779136|P15|Overall Study|Lost to Follow-up|0
7700042|NCT01150123|26779137|P14|Overall Study|Lost to Follow-up|0
7700043|NCT01150123|26779138|P13|Overall Study|Lost to Follow-up|2
7700044|NCT01150123|26779139|P12|Overall Study|Lost to Follow-up|1
7700045|NCT01150123|26779140|P11|Overall Study|Lost to Follow-up|1
7700046|NCT01150123|26779141|P10|Overall Study|Lost to Follow-up|1
7700047|NCT01150123|26779142|P9|Overall Study|Lost to Follow-up|3
7700048|NCT01150123|26779143|P8|Overall Study|Lost to Follow-up|0
7700049|NCT01150123|26779144|P7|Overall Study|Lost to Follow-up|0
7700050|NCT01150123|26779145|P6|Overall Study|Lost to Follow-up|5
7700051|NCT01150123|26779146|P5|Overall Study|Lost to Follow-up|2
7700052|NCT01150123|26779147|P4|Overall Study|Lost to Follow-up|2
7700053|NCT01150123|26779148|P3|Overall Study|Lost to Follow-up|2
7700054|NCT01150123|26779149|P2|Overall Study|Lost to Follow-up|1
7700055|NCT01150123|26779150|P1|Overall Study|Lost to Follow-up|2
7700056|NCT01150123|26779133|P18|Overall Study|Withdrawal by Subject|1
7700057|NCT01150123|26779134|P17|Overall Study|Withdrawal by Subject|0
7700058|NCT01150123|26779135|P16|Overall Study|Withdrawal by Subject|1
7700059|NCT01150123|26779136|P15|Overall Study|Withdrawal by Subject|0
7700060|NCT01150123|26779137|P14|Overall Study|Withdrawal by Subject|0
7700061|NCT01150123|26779138|P13|Overall Study|Withdrawal by Subject|1
7700062|NCT01150123|26779139|P12|Overall Study|Withdrawal by Subject|0
7700063|NCT01150123|26779140|P11|Overall Study|Withdrawal by Subject|1
7700064|NCT01150123|26779141|P10|Overall Study|Withdrawal by Subject|0
7700065|NCT01150123|26779142|P9|Overall Study|Withdrawal by Subject|2
7700066|NCT01150123|26779143|P8|Overall Study|Withdrawal by Subject|3
7700067|NCT01150123|26779144|P7|Overall Study|Withdrawal by Subject|0
7700068|NCT01150123|26779145|P6|Overall Study|Withdrawal by Subject|1
7700069|NCT01150123|26779146|P5|Overall Study|Withdrawal by Subject|1
7700070|NCT01150123|26779147|P4|Overall Study|Withdrawal by Subject|1
7700071|NCT01150123|26779148|P3|Overall Study|Withdrawal by Subject|2
7700072|NCT01150123|26779149|P2|Overall Study|Withdrawal by Subject|1
7700073|NCT01150123|26779150|P1|Overall Study|Withdrawal by Subject|1
7700074|NCT01150097|26779326|P3|Months 24 to 48 Post-transplantation|Death|0
7700075|NCT01150097|26779327|P2|Months 24 to 48 Post-transplantation|Death|0
7700076|NCT01150097|26779328|P1|Months 24 to 48 Post-transplantation|Death|2
7700077|NCT01150097|26779326|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
7700078|NCT01150097|26779327|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
7700079|NCT01150097|26779328|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
7700080|NCT01150097|26779326|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
7700081|NCT01150097|26779327|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
7700082|NCT01150097|26779328|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
7700083|NCT01150097|26779326|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
7700084|NCT01150097|26779327|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
7700085|NCT01150097|26779328|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
7700086|NCT01150097|26779326|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
7700087|NCT01150097|26779327|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
7700088|NCT01150097|26779328|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
7700089|NCT01150097|26779326|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
7700090|NCT01150097|26779327|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
7700091|NCT01150097|26779328|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
7700092|NCT01150097|26779326|P3|Months 24 to 36 Post-transplantation|Death|0
7700093|NCT01150097|26779327|P2|Months 24 to 36 Post-transplantation|Death|0
7700094|NCT01150097|26779328|P1|Months 24 to 36 Post-transplantation|Death|2
7700095|NCT01150045|26779355|P4|Overall Study|Protocol Violation|1
7700096|NCT01150045|26779356|P3|Overall Study|Protocol Violation|0
7700097|NCT01150045|26779357|P2|Overall Study|Protocol Violation|1
7700098|NCT01150045|26779358|P1|Overall Study|Protocol Violation|0
7700099|NCT01149863|26779389|P1|Overall Study|Missing data or Not receiveing studydrug|3
7700100|NCT01149681|26779464|P1|Overall Study|adverse events nonrelated study drug|2
7700101|NCT01149681|26779464|P1|Overall Study|Physician Decision|2
7700102|NCT01149681|26779464|P1|Overall Study|Progressive disease|1
7700103|NCT01149681|26779464|P1|Overall Study|Withdrawal by Subject|7
7700104|NCT01149655|26779472|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
7700105|NCT01149655|26779473|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
7700106|NCT01149655|26779474|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
7700107|NCT01149655|26779475|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
7700108|NCT01149655|26779472|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
7700109|NCT01149655|26779473|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
7700110|NCT01149655|26779474|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
7700111|NCT01149655|26779475|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
7700112|NCT01149655|26779472|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
7700113|NCT01149655|26779473|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
7700114|NCT01149655|26779474|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
7700115|NCT01149655|26779475|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
7700116|NCT01149655|26779472|P4|Period 3-DB Maintenance Phase|Physician Decision|0
7700117|NCT01149655|26779473|P3|Period 3-DB Maintenance Phase|Physician Decision|1
7700118|NCT01149655|26779474|P2|Period 3-DB Maintenance Phase|Physician Decision|0
7700119|NCT01149655|26779475|P1|Period 3-DB Maintenance Phase|Physician Decision|0
7700120|NCT01149655|26779472|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
7700121|NCT01149655|26779473|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
7700122|NCT01149655|26779474|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
7700123|NCT01149655|26779475|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
7700124|NCT01149655|26779472|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7700125|NCT01149655|26779473|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7700126|NCT01149655|26779474|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
7700127|NCT01149655|26779475|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7700128|NCT01149655|26779472|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
7700129|NCT01149655|26779473|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
7700130|NCT01149655|26779474|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
7700131|NCT01149655|26779475|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
7700132|NCT01149655|26779472|P4|Period 2-Stabilization Phase|Physician Decision|0
7700133|NCT01149655|26779473|P3|Period 2-Stabilization Phase|Physician Decision|0
7700134|NCT01149655|26779474|P2|Period 2-Stabilization Phase|Physician Decision|3
7700135|NCT01149655|26779475|P1|Period 2-Stabilization Phase|Physician Decision|0
7700136|NCT01149655|26779472|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7700137|NCT01149655|26779473|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7700138|NCT01149655|26779474|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
7700139|NCT01149655|26779475|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7700140|NCT01149655|26779472|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7700141|NCT01149655|26779473|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7700142|NCT01149655|26779474|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
7700143|NCT01149655|26779475|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7700144|NCT01149655|26779472|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7700145|NCT01149655|26779473|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7700146|NCT01149655|26779474|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7700147|NCT01149655|26779475|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
7700148|NCT01149655|26779472|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
7700149|NCT01149655|26779473|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
7700150|NCT01149655|26779474|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
7700151|NCT01149655|26779475|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
7700152|NCT01149655|26779472|P4|Period 1 - Conversion Phase|Physician Decision|0
7700153|NCT01149655|26779473|P3|Period 1 - Conversion Phase|Physician Decision|0
7700154|NCT01149655|26779474|P2|Period 1 - Conversion Phase|Physician Decision|0
7700155|NCT01149655|26779475|P1|Period 1 - Conversion Phase|Physician Decision|2
7700156|NCT01149655|26779472|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7700157|NCT01149655|26779473|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7700158|NCT01149655|26779474|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7700159|NCT01149655|26779475|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
7700160|NCT01149655|26779472|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7700161|NCT01149655|26779473|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7700162|NCT01149655|26779474|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7700163|NCT01149655|26779475|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
7700164|NCT01149655|26779472|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
7700165|NCT01149655|26779473|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
7700166|NCT01149655|26779474|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
7700167|NCT01149655|26779475|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
7700168|NCT01149538|26779518|P2|Overall Study|Withdrawal by Subject|3
7700169|NCT01149538|26779519|P1|Overall Study|Withdrawal by Subject|5
7700170|NCT01149538|26779518|P2|Overall Study|Lost to Follow-up|1
7700171|NCT01149538|26779519|P1|Overall Study|Lost to Follow-up|0
7700172|NCT01149486|26779540|P2|First Intervention|Adverse Event|1
7700173|NCT01149486|26779541|P1|First Intervention|Adverse Event|0
7700174|NCT01149473|26779565|P2|Washout of 7 Days|Withdrawal by Subject|1
7700175|NCT01149473|26779566|P1|Washout of 7 Days|Withdrawal by Subject|1
7700176|NCT01149473|26779565|P2|First Intervention|Adverse Event|1
7700177|NCT01149473|26779566|P1|First Intervention|Adverse Event|1
7700178|NCT01149460|26779584|P2|Overall Study|Withdrawal by Subject|2
7700179|NCT01149460|26779585|P1|Overall Study|Withdrawal by Subject|0
7700180|NCT01149421|26779618|P3|Overall Study|Protocol Violation|6
7700181|NCT01149421|26779619|P2|Overall Study|Protocol Violation|2
7700182|NCT01149421|26779620|P1|Overall Study|Protocol Violation|2
7700183|NCT01149421|26779618|P3|Overall Study|Entry Criteria Not Met|2
7700184|NCT01149421|26779619|P2|Overall Study|Entry Criteria Not Met|1
7700185|NCT01149421|26779620|P1|Overall Study|Entry Criteria Not Met|1
7700186|NCT01149421|26779618|P3|Overall Study|Physician Decision|6
7700187|NCT01149421|26779619|P2|Overall Study|Physician Decision|3
7700188|NCT01149421|26779620|P1|Overall Study|Physician Decision|5
7700189|NCT01149421|26779618|P3|Overall Study|Lost to Follow-up|5
7700190|NCT01149421|26779619|P2|Overall Study|Lost to Follow-up|4
7700191|NCT01149421|26779620|P1|Overall Study|Lost to Follow-up|2
7700192|NCT01149421|26779618|P3|Overall Study|Sponsor Decision|1
7700193|NCT01149421|26779619|P2|Overall Study|Sponsor Decision|1
7700194|NCT01149421|26779620|P1|Overall Study|Sponsor Decision|0
7700195|NCT01149421|26779618|P3|Overall Study|Withdrawal by Subject|13
7700196|NCT01149421|26779619|P2|Overall Study|Withdrawal by Subject|12
7700197|NCT01149421|26779620|P1|Overall Study|Withdrawal by Subject|20
7700198|NCT01149421|26779618|P3|Overall Study|Adverse Event|11
7700199|NCT01149421|26779619|P2|Overall Study|Adverse Event|6
7700200|NCT01149421|26779620|P1|Overall Study|Adverse Event|22
7700201|NCT01149369|26779701|P2|Overall Study|Adverse Event|3
7700202|NCT01149369|26779702|P1|Overall Study|Adverse Event|6
7700203|NCT01149343|26779870|P4|Overall Study|Recurrence / Progressive disease|0
7700204|NCT01149343|26779871|P3|Overall Study|Recurrence / Progressive disease|1
7700205|NCT01149343|26779872|P2|Overall Study|Recurrence / Progressive disease|0
7700206|NCT01149343|26779873|P1|Overall Study|Recurrence / Progressive disease|0
7700207|NCT01149343|26779870|P4|Overall Study|Sponsor study termination|2
7700208|NCT01149343|26779871|P3|Overall Study|Sponsor study termination|0
7700209|NCT01149343|26779872|P2|Overall Study|Sponsor study termination|0
7700210|NCT01149343|26779873|P1|Overall Study|Sponsor study termination|0
7700211|NCT01149343|26779870|P4|Overall Study|Other|14
7700212|NCT01149343|26779871|P3|Overall Study|Other|2
7700213|NCT01149343|26779872|P2|Overall Study|Other|10
7700214|NCT01149343|26779873|P1|Overall Study|Other|8
7700215|NCT01149343|26779870|P4|Overall Study|Lost to Follow-up|1
7700216|NCT01149343|26779871|P3|Overall Study|Lost to Follow-up|0
7700217|NCT01149343|26779872|P2|Overall Study|Lost to Follow-up|0
7700218|NCT01149343|26779873|P1|Overall Study|Lost to Follow-up|1
7700219|NCT01149343|26779870|P4|Overall Study|Death|18
7700220|NCT01149343|26779871|P3|Overall Study|Death|18
7700221|NCT01149343|26779872|P2|Overall Study|Death|13
7700222|NCT01149343|26779873|P1|Overall Study|Death|10
7700223|NCT01149343|26779870|P4|Overall Study|Withdrawal by Subject|5
7700224|NCT01149343|26779871|P3|Overall Study|Withdrawal by Subject|1
7700225|NCT01149343|26779872|P2|Overall Study|Withdrawal by Subject|1
7700226|NCT01149343|26779873|P1|Overall Study|Withdrawal by Subject|1
7700227|NCT01149148|26779958|P2|Overall Study|Death|0
7700228|NCT01149148|26779959|P1|Overall Study|Death|1
7700229|NCT01149148|26779958|P2|Overall Study|Lost to Follow-up|2
7700230|NCT01149148|26779959|P1|Overall Study|Lost to Follow-up|1
7700231|NCT01149096|26779969|P2|Overall Study|Lost to Follow-up|1
7700232|NCT01149096|26779970|P1|Overall Study|Lost to Follow-up|0
7700233|NCT01149057|26779994|P1|Overall Study|Other|6
7700234|NCT01149057|26779994|P1|Overall Study|High Parathyroid Hormone Value|1
7700235|NCT01149057|26779994|P1|Overall Study|Lost to Follow-up|1
7700236|NCT01149057|26779994|P1|Overall Study|Participant Non-Compliance|2
7700237|NCT01149057|26779994|P1|Overall Study|B Cell Depletion|4
7700238|NCT01149057|26779994|P1|Overall Study|Positive Hepatitis B Core Antibody|5
7700239|NCT01149057|26779994|P1|Overall Study|Withdrawal by Subject|9
7700240|NCT01149057|26779994|P1|Overall Study|Adverse Event|13
7700241|NCT01149057|26779994|P1|Overall Study|Lack of Efficacy|16
7700242|NCT01148979|26780021|P2|Overall Study|Lost to Follow-up|1
7700243|NCT01148979|26780022|P1|Overall Study|Lost to Follow-up|0
7700244|NCT01148862|26780040|P2|Second Intervention|Withdrawal by Subject|2
7700245|NCT01148862|26780041|P1|Second Intervention|Withdrawal by Subject|0
7700246|NCT01148810|26780073|P2|Overall Study|Protocol Violation|0
7700247|NCT01148810|26780074|P1|Overall Study|Protocol Violation|1
7700248|NCT01148810|26780073|P2|Overall Study|Withdrawal by Subject|2
7700249|NCT01148810|26780074|P1|Overall Study|Withdrawal by Subject|0
7700250|NCT01148810|26780073|P2|Overall Study|Lack of Efficacy|1
7700251|NCT01148810|26780074|P1|Overall Study|Lack of Efficacy|0
7700252|NCT01148810|26780073|P2|Overall Study|Adverse Event|2
7700253|NCT01148810|26780074|P1|Overall Study|Adverse Event|0
7700254|NCT01148771|26780101|P2|Washout Period|Withdrawal by Subject|1
7700255|NCT01148771|26780102|P1|Washout Period|Withdrawal by Subject|0
7700256|NCT01148693|26780122|P2|Overall Study|Attempts for cannulation were failed|10
7700257|NCT01148693|26780123|P1|Overall Study|Attempts for cannulation were failed|13
7700258|NCT01148537|26780143|P3|Overall Study|Adverse Event|1
7700259|NCT01148537|26780144|P2|Overall Study|Adverse Event|0
7700260|NCT01148537|26780145|P1|Overall Study|Adverse Event|2
7700261|NCT01148537|26780143|P3|Overall Study|Withdrawal by Subject|2
7700262|NCT01148537|26780144|P2|Overall Study|Withdrawal by Subject|0
7700263|NCT01148537|26780145|P1|Overall Study|Withdrawal by Subject|1
7700264|NCT01148511|26780231|P3|Randomized|Other|1
7700265|NCT01148511|26780232|P2|Randomized|Other|1
7700266|NCT01148511|26780233|P1|Randomized|Other|0
7700267|NCT01148511|26780231|P3|Randomized|Consent withdrawal|3
7700268|NCT01148511|26780232|P2|Randomized|Consent withdrawal|5
7700269|NCT01148511|26780233|P1|Randomized|Consent withdrawal|0
7700270|NCT01148511|26780231|P3|Randomized|Lost to Follow-up|1
7700271|NCT01148511|26780232|P2|Randomized|Lost to Follow-up|1
7700272|NCT01148511|26780233|P1|Randomized|Lost to Follow-up|0
7700273|NCT01148511|26780231|P3|Randomized|Protocol Violation|1
7700274|NCT01148511|26780232|P2|Randomized|Protocol Violation|2
7700275|NCT01148511|26780233|P1|Randomized|Protocol Violation|0
7700276|NCT01148511|26780231|P3|Randomized|Adverse Event|0
7700277|NCT01148511|26780232|P2|Randomized|Adverse Event|1
7700278|NCT01148511|26780233|P1|Randomized|Adverse Event|0
7700279|NCT01148511|26780231|P3|Exposed to Study Drug|Lost to Follow-up|0
7700280|NCT01148511|26780232|P2|Exposed to Study Drug|Lost to Follow-up|0
7700281|NCT01148511|26780233|P1|Exposed to Study Drug|Lost to Follow-up|4
7700282|NCT01148511|26780231|P3|Exposed to Study Drug|Protocol Violation|0
7700283|NCT01148511|26780232|P2|Exposed to Study Drug|Protocol Violation|0
7700284|NCT01148511|26780233|P1|Exposed to Study Drug|Protocol Violation|2
7700285|NCT01148459|26780254|P2|Overall Study|Failure to comply with study procedures|1
7700286|NCT01148459|26780255|P1|Overall Study|Failure to comply with study procedures|0
7700287|NCT01148459|26780254|P2|Overall Study|Refusal|0
7700288|NCT01148459|26780255|P1|Overall Study|Refusal|1
7700289|NCT01148459|26780254|P2|Overall Study|Lost to Follow-up|0
7700290|NCT01148459|26780255|P1|Overall Study|Lost to Follow-up|2
7700291|NCT01148459|26780254|P2|Overall Study|Migrated/moved from study area|6
7700292|NCT01148459|26780255|P1|Overall Study|Migrated/moved from study area|3
7700293|NCT01148459|26780254|P2|Overall Study|Withdrawal by Subject|0
7700294|NCT01148459|26780255|P1|Overall Study|Withdrawal by Subject|1
7700295|NCT01148459|26780254|P2|Overall Study|Serious Adverse Event|4
7700296|NCT01148459|26780255|P1|Overall Study|Serious Adverse Event|5
7700297|NCT01148225|26780303|P1|Overall Study|Other|185
7700298|NCT01148017|26780354|P4|Overall Study|Unable to classify|0
7700299|NCT01148017|26780355|P3|Overall Study|Unable to classify|0
7700300|NCT01148017|26780356|P2|Overall Study|Unable to classify|1
7700301|NCT01148017|26780357|P1|Overall Study|Unable to classify|3
7700302|NCT01148017|26780354|P4|Overall Study|Administrative reason|0
7700303|NCT01148017|26780355|P3|Overall Study|Administrative reason|0
7700304|NCT01148017|26780356|P2|Overall Study|Administrative reason|9
7700305|NCT01148017|26780357|P1|Overall Study|Administrative reason|22
7700306|NCT01148017|26780354|P4|Overall Study|Inappropriate enrollment|0
7700307|NCT01148017|26780355|P3|Overall Study|Inappropriate enrollment|0
7700308|NCT01148017|26780356|P2|Overall Study|Inappropriate enrollment|0
7700309|NCT01148017|26780357|P1|Overall Study|Inappropriate enrollment|1
7700310|NCT01148017|26780354|P4|Overall Study|Lost to Follow-up|0
7700311|NCT01148017|26780355|P3|Overall Study|Lost to Follow-up|0
7700312|NCT01148017|26780356|P2|Overall Study|Lost to Follow-up|10
7700313|NCT01148017|26780357|P1|Overall Study|Lost to Follow-up|23
7700314|NCT01148017|26780354|P4|Overall Study|Withdrawal by Subject|0
7700315|NCT01148017|26780355|P3|Overall Study|Withdrawal by Subject|0
7700316|NCT01148017|26780356|P2|Overall Study|Withdrawal by Subject|14
7700317|NCT01148017|26780357|P1|Overall Study|Withdrawal by Subject|31
7700318|NCT01147926|26780396|P2|Overall Study|Colonoscopy result|1
7700319|NCT01147926|26780397|P1|Overall Study|Colonoscopy result|0
7700320|NCT01147926|26780396|P2|Overall Study|Went on holiday|1
7700321|NCT01147926|26780397|P1|Overall Study|Went on holiday|0
7700322|NCT01147926|26780396|P2|Overall Study|Too busy, no time for study|0
7700323|NCT01147926|26780397|P1|Overall Study|Too busy, no time for study|1
7700324|NCT01147926|26780396|P2|Overall Study|Lack of Efficacy|0
7700325|NCT01147926|26780397|P1|Overall Study|Lack of Efficacy|1
7700326|NCT01147926|26780396|P2|Overall Study|Sponsor's Decision|1
7700327|NCT01147926|26780397|P1|Overall Study|Sponsor's Decision|0
7700328|NCT01147926|26780396|P2|Overall Study|Lost to Follow-up|2
7700329|NCT01147926|26780397|P1|Overall Study|Lost to Follow-up|0
7700330|NCT01147926|26780396|P2|Overall Study|Selection criteria not met|1
7700331|NCT01147926|26780397|P1|Overall Study|Selection criteria not met|3
7700332|NCT01147926|26780396|P2|Overall Study|Principal investigator left hospital|3
7700333|NCT01147926|26780397|P1|Overall Study|Principal investigator left hospital|1
7700334|NCT01147926|26780396|P2|Overall Study|Subject Non-Compliant|4
7700335|NCT01147926|26780397|P1|Overall Study|Subject Non-Compliant|5
7700336|NCT01147926|26780396|P2|Overall Study|Adverse Event|6
7700337|NCT01147926|26780397|P1|Overall Study|Adverse Event|7
7700338|NCT01147926|26780396|P2|Overall Study|Subject Withdrew Consent|10
7700339|NCT01147926|26780397|P1|Overall Study|Subject Withdrew Consent|9
7700340|NCT01147900|26780432|P3|At Year 10|Lost to Follow-up|0
7700341|NCT01147900|26780433|P2|At Year 10|Lost to Follow-up|1
7700342|NCT01147900|26780434|P1|At Year 10|Lost to Follow-up|0
7700343|NCT01147874|26780493|P1|Overall Study|Withdrawal by Subject|24
7700344|NCT01147874|26780493|P1|Overall Study|Sponsor's Decision|2
7700345|NCT01147874|26780493|P1|Overall Study|Protocol Violation|5
7700346|NCT01147874|26780493|P1|Overall Study|Other|5
7700347|NCT01147874|26780493|P1|Overall Study|Lost to Follow-up|25
7700348|NCT01147874|26780493|P1|Overall Study|Investigator's Request|1
7700349|NCT01147874|26780493|P1|Overall Study|Adverse Event|5
7700350|NCT01147848|26780501|P3|Randomized Phase|Withdrawal by Subject|9
7700351|NCT01147848|26780502|P2|Randomized Phase|Withdrawal by Subject|7
7700352|NCT01147848|26780503|P1|Randomized Phase|Withdrawal by Subject|0
7700353|NCT01147848|26780501|P3|Randomized Phase|Physician Decision|1
7700354|NCT01147848|26780502|P2|Randomized Phase|Physician Decision|0
7700355|NCT01147848|26780503|P1|Randomized Phase|Physician Decision|0
7700356|NCT01147848|26780501|P3|Randomized Phase|Lost to Follow-up|7
7700357|NCT01147848|26780502|P2|Randomized Phase|Lost to Follow-up|5
7700358|NCT01147848|26780503|P1|Randomized Phase|Lost to Follow-up|0
7700359|NCT01147848|26780501|P3|Randomized Phase|Protocol Violation|10
7700360|NCT01147848|26780502|P2|Randomized Phase|Protocol Violation|7
7700361|NCT01147848|26780503|P1|Randomized Phase|Protocol Violation|0
7700362|NCT01147848|26780501|P3|Randomized Phase|Lack of Efficacy|11
7700363|NCT01147848|26780502|P2|Randomized Phase|Lack of Efficacy|20
7700364|NCT01147848|26780503|P1|Randomized Phase|Lack of Efficacy|0
7700365|NCT01147848|26780501|P3|Randomized Phase|Adverse Event|8
7700366|NCT01147848|26780502|P2|Randomized Phase|Adverse Event|6
7700367|NCT01147848|26780503|P1|Randomized Phase|Adverse Event|0
7700368|NCT01147848|26780501|P3|Run-in Period|Run-in Failure|0
7700369|NCT01147848|26780502|P2|Run-in Period|Run-in Failure|0
7700370|NCT01147848|26780503|P1|Run-in Period|Run-in Failure|135
7700371|NCT01147848|26780501|P3|Run-in Period|Screen Failure|0
7700372|NCT01147848|26780502|P2|Run-in Period|Screen Failure|0
7700373|NCT01147848|26780503|P1|Run-in Period|Screen Failure|623
7700374|NCT01147822|26780535|P2|Overall Study|Not Completed/Ongoing|102
7700375|NCT01147822|26780536|P1|Overall Study|Not Completed/Ongoing|111
7700376|NCT01147822|26780535|P2|Overall Study|Withdrawal by Subject|13
7700377|NCT01147822|26780536|P1|Overall Study|Withdrawal by Subject|8
7700378|NCT01147822|26780535|P2|Overall Study|Physician Decision|2
7700379|NCT01147822|26780536|P1|Overall Study|Physician Decision|0
7700380|NCT01147822|26780535|P2|Overall Study|Lost to Follow-up|2
7700381|NCT01147822|26780536|P1|Overall Study|Lost to Follow-up|3
7700382|NCT01147822|26780535|P2|Overall Study|Protocol Violation|1
7700383|NCT01147822|26780536|P1|Overall Study|Protocol Violation|0
7700384|NCT01147822|26780535|P2|Overall Study|Death|59
7700385|NCT01147822|26780536|P1|Overall Study|Death|66
7700386|NCT01147809|26780556|P6|Phase II (168 Days)|Ongoing|0
7700387|NCT01147809|26780557|P5|Phase II (168 Days)|Ongoing|1
7700388|NCT01147809|26780558|P4|Phase II (168 Days)|Ongoing|0
7700389|NCT01147809|26780559|P3|Phase II (168 Days)|Ongoing|0
7700390|NCT01147809|26780560|P2|Phase II (168 Days)|Ongoing|0
7700391|NCT01147809|26780561|P1|Phase II (168 Days)|Ongoing|0
7700392|NCT01147809|26780556|P6|Phase II (168 Days)|Withdrawal by Subject|15
7700393|NCT01147809|26780557|P5|Phase II (168 Days)|Withdrawal by Subject|7
7700394|NCT01147809|26780558|P4|Phase II (168 Days)|Withdrawal by Subject|0
7700395|NCT01147809|26780559|P3|Phase II (168 Days)|Withdrawal by Subject|0
7700396|NCT01147809|26780560|P2|Phase II (168 Days)|Withdrawal by Subject|0
7700397|NCT01147809|26780561|P1|Phase II (168 Days)|Withdrawal by Subject|0
7700398|NCT01147809|26780556|P6|Phase II (168 Days)|Physician Decision|11
7700399|NCT01147809|26780557|P5|Phase II (168 Days)|Physician Decision|5
7700400|NCT01147809|26780558|P4|Phase II (168 Days)|Physician Decision|0
7700401|NCT01147809|26780559|P3|Phase II (168 Days)|Physician Decision|0
7700402|NCT01147809|26780560|P2|Phase II (168 Days)|Physician Decision|0
7700403|NCT01147809|26780561|P1|Phase II (168 Days)|Physician Decision|0
7700404|NCT01147809|26780556|P6|Phase II (168 Days)|Protocol Violation|1
7700405|NCT01147809|26780557|P5|Phase II (168 Days)|Protocol Violation|0
7700406|NCT01147809|26780558|P4|Phase II (168 Days)|Protocol Violation|0
7700407|NCT01147809|26780559|P3|Phase II (168 Days)|Protocol Violation|0
7700408|NCT01147809|26780560|P2|Phase II (168 Days)|Protocol Violation|0
7700409|NCT01147809|26780561|P1|Phase II (168 Days)|Protocol Violation|0
7700410|NCT01147809|26780556|P6|Phase II (168 Days)|Adverse Event|6
7700411|NCT01147809|26780557|P5|Phase II (168 Days)|Adverse Event|3
7700412|NCT01147809|26780558|P4|Phase II (168 Days)|Adverse Event|0
7700413|NCT01147809|26780559|P3|Phase II (168 Days)|Adverse Event|0
7700414|NCT01147809|26780560|P2|Phase II (168 Days)|Adverse Event|0
7700415|NCT01147809|26780561|P1|Phase II (168 Days)|Adverse Event|0
7700416|NCT01147809|26780556|P6|Phase I (168 Days)|Withdrawal by Subject|0
7700417|NCT01147809|26780557|P5|Phase I (168 Days)|Withdrawal by Subject|0
7700418|NCT01147809|26780558|P4|Phase I (168 Days)|Withdrawal by Subject|3
7700419|NCT01147809|26780559|P3|Phase I (168 Days)|Withdrawal by Subject|0
7700420|NCT01147809|26780560|P2|Phase I (168 Days)|Withdrawal by Subject|0
7700421|NCT01147809|26780561|P1|Phase I (168 Days)|Withdrawal by Subject|0
7700422|NCT01147809|26780556|P6|Phase I (168 Days)|Physician Decision|0
7700423|NCT01147809|26780557|P5|Phase I (168 Days)|Physician Decision|0
7700424|NCT01147809|26780558|P4|Phase I (168 Days)|Physician Decision|0
7700425|NCT01147809|26780559|P3|Phase I (168 Days)|Physician Decision|2
7700426|NCT01147809|26780560|P2|Phase I (168 Days)|Physician Decision|1
7700427|NCT01147809|26780561|P1|Phase I (168 Days)|Physician Decision|0
7700428|NCT01147809|26780556|P6|Phase I (168 Days)|Lost to Follow-up|0
7700429|NCT01147809|26780557|P5|Phase I (168 Days)|Lost to Follow-up|0
7700430|NCT01147809|26780558|P4|Phase I (168 Days)|Lost to Follow-up|1
7700431|NCT01147809|26780559|P3|Phase I (168 Days)|Lost to Follow-up|0
7700432|NCT01147809|26780560|P2|Phase I (168 Days)|Lost to Follow-up|0
7700433|NCT01147809|26780561|P1|Phase I (168 Days)|Lost to Follow-up|1
7700434|NCT01147809|26780556|P6|Phase I (168 Days)|Adverse Event|0
7700435|NCT01147809|26780557|P5|Phase I (168 Days)|Adverse Event|0
7700436|NCT01147809|26780558|P4|Phase I (168 Days)|Adverse Event|1
7700437|NCT01147809|26780559|P3|Phase I (168 Days)|Adverse Event|0
7700438|NCT01147809|26780560|P2|Phase I (168 Days)|Adverse Event|0
7700439|NCT01147809|26780561|P1|Phase I (168 Days)|Adverse Event|0
7700440|NCT01147744|26780682|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
7700441|NCT01147744|26780683|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
7700442|NCT01147744|26780684|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
7700443|NCT01147744|26780685|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
7700444|NCT01147744|26780686|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
7700445|NCT01147744|26780687|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
7700446|NCT01147744|26780688|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
7700447|NCT01147744|26780682|P7|Overall Study|Sponsor decision to amend protocol|6
7700448|NCT01147744|26780683|P6|Overall Study|Sponsor decision to amend protocol|2
7700449|NCT01147744|26780684|P5|Overall Study|Sponsor decision to amend protocol|7
7700450|NCT01147744|26780685|P4|Overall Study|Sponsor decision to amend protocol|5
7700451|NCT01147744|26780686|P3|Overall Study|Sponsor decision to amend protocol|2
7700452|NCT01147744|26780687|P2|Overall Study|Sponsor decision to amend protocol|4
7700453|NCT01147744|26780688|P1|Overall Study|Sponsor decision to amend protocol|7
7700454|NCT01147744|26780682|P7|Overall Study|Lost to Follow-up|0
7700455|NCT01147744|26780683|P6|Overall Study|Lost to Follow-up|0
7700456|NCT01147744|26780684|P5|Overall Study|Lost to Follow-up|0
7700457|NCT01147744|26780685|P4|Overall Study|Lost to Follow-up|0
7700458|NCT01147744|26780686|P3|Overall Study|Lost to Follow-up|0
7700459|NCT01147744|26780687|P2|Overall Study|Lost to Follow-up|1
7700460|NCT01147744|26780688|P1|Overall Study|Lost to Follow-up|0
7700461|NCT01147744|26780682|P7|Overall Study|Withdrawal by Subject|2
7700462|NCT01147744|26780683|P6|Overall Study|Withdrawal by Subject|5
7700463|NCT01147744|26780684|P5|Overall Study|Withdrawal by Subject|2
7700464|NCT01147744|26780685|P4|Overall Study|Withdrawal by Subject|2
7700465|NCT01147744|26780686|P3|Overall Study|Withdrawal by Subject|2
7700466|NCT01147744|26780687|P2|Overall Study|Withdrawal by Subject|4
7700467|NCT01147744|26780688|P1|Overall Study|Withdrawal by Subject|8
7700468|NCT01147744|26780682|P7|Overall Study|Adverse Event|2
7700469|NCT01147744|26780683|P6|Overall Study|Adverse Event|1
7700470|NCT01147744|26780684|P5|Overall Study|Adverse Event|2
7700471|NCT01147744|26780685|P4|Overall Study|Adverse Event|0
7700472|NCT01147744|26780686|P3|Overall Study|Adverse Event|3
7700473|NCT01147744|26780687|P2|Overall Study|Adverse Event|2
7700474|NCT01147744|26780688|P1|Overall Study|Adverse Event|1
7700475|NCT01147744|26780682|P7|Overall Study|Lack of Efficacy|7
7700476|NCT01147744|26780683|P6|Overall Study|Lack of Efficacy|8
7700477|NCT01147744|26780684|P5|Overall Study|Lack of Efficacy|13
7700478|NCT01147744|26780685|P4|Overall Study|Lack of Efficacy|11
7700479|NCT01147744|26780686|P3|Overall Study|Lack of Efficacy|9
7700480|NCT01147744|26780687|P2|Overall Study|Lack of Efficacy|11
7700481|NCT01147744|26780688|P1|Overall Study|Lack of Efficacy|11
7700482|NCT01147744|26780682|P7|Overall Study|Physician Decision|1
7700483|NCT01147744|26780683|P6|Overall Study|Physician Decision|0
7700484|NCT01147744|26780684|P5|Overall Study|Physician Decision|0
7700485|NCT01147744|26780685|P4|Overall Study|Physician Decision|0
7700486|NCT01147744|26780686|P3|Overall Study|Physician Decision|1
7700487|NCT01147744|26780687|P2|Overall Study|Physician Decision|1
7700488|NCT01147744|26780688|P1|Overall Study|Physician Decision|0
7700489|NCT01147744|26780682|P7|Overall Study|Protocol Violation|1
7700490|NCT01147744|26780683|P6|Overall Study|Protocol Violation|3
7700491|NCT01147744|26780684|P5|Overall Study|Protocol Violation|1
7700492|NCT01147744|26780685|P4|Overall Study|Protocol Violation|0
7700493|NCT01147744|26780686|P3|Overall Study|Protocol Violation|1
7700494|NCT01147744|26780687|P2|Overall Study|Protocol Violation|0
7700495|NCT01147744|26780688|P1|Overall Study|Protocol Violation|1
7700496|NCT01147653|26780783|P2|Year 2|Withdrawal by Subject|3
7700497|NCT01147653|26780784|P1|Year 2|Withdrawal by Subject|2
7700498|NCT01147640|26780845|P2|Overall Study|Didn't meet eligibility criteria|0
7700499|NCT01147640|26780846|P1|Overall Study|Didn't meet eligibility criteria|1
7700500|NCT01147640|26780845|P2|Overall Study|Lost to Follow-up|1
7700501|NCT01147640|26780846|P1|Overall Study|Lost to Follow-up|0
7700502|NCT01147640|26780845|P2|Overall Study|Withdrawal by Subject|0
7700503|NCT01147640|26780846|P1|Overall Study|Withdrawal by Subject|1
7700504|NCT01147640|26780845|P2|Overall Study|Physician Decision|0
7700505|NCT01147640|26780846|P1|Overall Study|Physician Decision|1
7700506|NCT01147640|26780845|P2|Overall Study|Adverse Event|0
7700507|NCT01147640|26780846|P1|Overall Study|Adverse Event|2
7700508|NCT01147536|26780876|P1|Overall Study|Death|1
7700509|NCT01147536|26780876|P1|Overall Study|Administrative study close|2
7700510|NCT01147497|26780882|P2|Overall Study|failed insertion|0
7700511|NCT01147497|26780883|P1|Overall Study|failed insertion|2
7700512|NCT01147471|26780903|P2|6 Month Follow Up|Lost to Follow-up|2
7700513|NCT01147471|26780904|P1|6 Month Follow Up|Lost to Follow-up|4
7700514|NCT01147471|26780903|P2|3 Month Follow Up|Physician Decision|1
7700515|NCT01147471|26780904|P1|3 Month Follow Up|Physician Decision|0
7700516|NCT01147471|26780903|P2|3 Month Follow Up|Lost to Follow-up|1
7700517|NCT01147471|26780904|P1|3 Month Follow Up|Lost to Follow-up|1
7700518|NCT01147471|26780903|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
7700519|NCT01147471|26780904|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
7700520|NCT01147471|26780903|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
7700521|NCT01147471|26780904|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
7700522|NCT01147471|26780903|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
7700523|NCT01147471|26780904|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
7700524|NCT01147458|26780918|P4|Second Intervention|Other|0
7700525|NCT01147458|26780919|P3|Second Intervention|Other|1
7700526|NCT01147458|26780920|P2|Second Intervention|Other|0
7700527|NCT01147458|26780921|P1|Second Intervention|Other|0
7700528|NCT01147458|26780918|P4|Second Intervention|Adverse Event|1
7700529|NCT01147458|26780919|P3|Second Intervention|Adverse Event|1
7700530|NCT01147458|26780920|P2|Second Intervention|Adverse Event|0
7700531|NCT01147458|26780921|P1|Second Intervention|Adverse Event|2
7700532|NCT01147458|26780918|P4|Second Intervention|Withdrawal by Subject|0
7700533|NCT01147458|26780919|P3|Second Intervention|Withdrawal by Subject|0
7700534|NCT01147458|26780920|P2|Second Intervention|Withdrawal by Subject|1
7700535|NCT01147458|26780921|P1|Second Intervention|Withdrawal by Subject|0
7700536|NCT01147458|26780918|P4|Second Intervention|Protocol Violation|0
7700537|NCT01147458|26780919|P3|Second Intervention|Protocol Violation|1
7700538|NCT01147458|26780920|P2|Second Intervention|Protocol Violation|1
7700539|NCT01147458|26780921|P1|Second Intervention|Protocol Violation|0
7700540|NCT01147458|26780918|P4|Second Intervention|Study terminated by sponsor|3
7700541|NCT01147458|26780919|P3|Second Intervention|Study terminated by sponsor|5
7700542|NCT01147458|26780920|P2|Second Intervention|Study terminated by sponsor|5
7700543|NCT01147458|26780921|P1|Second Intervention|Study terminated by sponsor|7
7700544|NCT01147458|26780918|P4|First Intervention|Other|0
7700545|NCT01147458|26780919|P3|First Intervention|Other|0
7700546|NCT01147458|26780920|P2|First Intervention|Other|2
7700547|NCT01147458|26780921|P1|First Intervention|Other|1
7700548|NCT01147458|26780918|P4|First Intervention|Adverse Event|3
7700549|NCT01147458|26780919|P3|First Intervention|Adverse Event|2
7700550|NCT01147458|26780920|P2|First Intervention|Adverse Event|3
7700551|NCT01147458|26780921|P1|First Intervention|Adverse Event|0
7700552|NCT01147458|26780918|P4|First Intervention|Withdrawal by Subject|0
7700553|NCT01147458|26780919|P3|First Intervention|Withdrawal by Subject|1
7700554|NCT01147458|26780920|P2|First Intervention|Withdrawal by Subject|0
7700555|NCT01147458|26780921|P1|First Intervention|Withdrawal by Subject|3
7700556|NCT01147458|26780918|P4|First Intervention|Protocol Violation|3
7700557|NCT01147458|26780919|P3|First Intervention|Protocol Violation|2
7700558|NCT01147458|26780920|P2|First Intervention|Protocol Violation|3
7700559|NCT01147458|26780921|P1|First Intervention|Protocol Violation|2
7700560|NCT01147458|26780918|P4|First Intervention|Study terminated by sponsor|8
7700561|NCT01147458|26780919|P3|First Intervention|Study terminated by sponsor|7
7700562|NCT01147458|26780920|P2|First Intervention|Study terminated by sponsor|8
7700563|NCT01147458|26780921|P1|First Intervention|Study terminated by sponsor|8
7700564|NCT01147393|26781000|P1|Dose Level -1|Dose Limited Toxicity|1
7700565|NCT01147393|26781000|P1|Dose Level 1|Dose limiting Toxicity|2
7700566|NCT01147341|26781021|P2|Open Label Period|Subject moved|0
7700567|NCT01147341|26781022|P1|Open Label Period|Subject moved|1
7700568|NCT01147341|26781021|P2|Open Label Period|Lack of Efficacy|0
7700569|NCT01147341|26781022|P1|Open Label Period|Lack of Efficacy|3
7700570|NCT01147341|26781021|P2|Double Blind Period|Withdrawal by Subject|1
7700571|NCT01147341|26781022|P1|Double Blind Period|Withdrawal by Subject|0
7700572|NCT01147341|26781021|P2|Double Blind Period|Lack of Efficacy|1
7700573|NCT01147341|26781022|P1|Double Blind Period|Lack of Efficacy|1
7700574|NCT01147250|26781085|P2|Overall Study|Other than specified|1
7700575|NCT01147250|26781086|P1|Overall Study|Other than specified|0
7700576|NCT01147250|26781085|P2|Overall Study|Site termination by sponsor|5
7700577|NCT01147250|26781086|P1|Overall Study|Site termination by sponsor|13
7700578|NCT01147250|26781085|P2|Overall Study|Withdrawal by Subject|88
7700579|NCT01147250|26781086|P1|Overall Study|Withdrawal by Subject|83
7700580|NCT01147250|26781085|P2|Overall Study|Lost to Follow-up|11
7700581|NCT01147250|26781086|P1|Overall Study|Lost to Follow-up|14
7700582|NCT01147172|26781098|P1|Overall Study|Lost to Follow-up|2
7700583|NCT01147172|26781098|P1|Overall Study|Withdrawal by Subject|2
7700584|NCT01147107|26781111|P2|Overall Study|Withdrawal by Subject|1
7700585|NCT01147107|26781112|P1|Overall Study|Withdrawal by Subject|1
7700586|NCT01147107|26781111|P2|Overall Study|Lack of Efficacy|0
7700587|NCT01147107|26781112|P1|Overall Study|Lack of Efficacy|5
7700588|NCT01147068|26781125|P7|Subjects That Completed Safety Follow-up|Ineligible|0
7700589|NCT01147068|26781126|P6|Subjects That Completed Safety Follow-up|Ineligible|0
7700590|NCT01147068|26781127|P5|Subjects That Completed Safety Follow-up|Ineligible|0
7700591|NCT01147068|26781128|P4|Subjects That Completed Safety Follow-up|Ineligible|0
7700592|NCT01147068|26781129|P3|Subjects That Completed Safety Follow-up|Ineligible|0
7700593|NCT01147068|26781130|P2|Subjects That Completed Safety Follow-up|Ineligible|1
7700594|NCT01147068|26781131|P1|Subjects That Completed Safety Follow-up|Ineligible|0
7700595|NCT01147068|26781125|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7700596|NCT01147068|26781126|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7700597|NCT01147068|26781127|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7700598|NCT01147068|26781128|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
7700599|NCT01147068|26781129|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7700600|NCT01147068|26781130|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7700601|NCT01147068|26781131|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7700602|NCT01147068|26781125|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7700603|NCT01147068|26781126|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7700604|NCT01147068|26781127|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7700605|NCT01147068|26781128|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7700606|NCT01147068|26781129|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7700607|NCT01147068|26781130|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7700608|NCT01147068|26781131|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7700609|NCT01147068|26781125|P7|Subjects That Received 2nd Dose|Other|0
7700610|NCT01147068|26781126|P6|Subjects That Received 2nd Dose|Other|0
7700611|NCT01147068|26781127|P5|Subjects That Received 2nd Dose|Other|1
7700612|NCT01147068|26781128|P4|Subjects That Received 2nd Dose|Other|0
7700613|NCT01147068|26781129|P3|Subjects That Received 2nd Dose|Other|3
7700614|NCT01147068|26781130|P2|Subjects That Received 2nd Dose|Other|3
7700615|NCT01147068|26781131|P1|Subjects That Received 2nd Dose|Other|0
7700616|NCT01147068|26781125|P7|Subjects That Received 2nd Dose|Did not complete the study|0
7700617|NCT01147068|26781126|P6|Subjects That Received 2nd Dose|Did not complete the study|1
7700618|NCT01147068|26781127|P5|Subjects That Received 2nd Dose|Did not complete the study|0
7700619|NCT01147068|26781128|P4|Subjects That Received 2nd Dose|Did not complete the study|0
7700620|NCT01147068|26781129|P3|Subjects That Received 2nd Dose|Did not complete the study|0
7700621|NCT01147068|26781130|P2|Subjects That Received 2nd Dose|Did not complete the study|1
7700622|NCT01147068|26781131|P1|Subjects That Received 2nd Dose|Did not complete the study|0
7700623|NCT01147068|26781125|P7|Subjects That Received 2nd Dose|Ineligible|0
7700624|NCT01147068|26781126|P6|Subjects That Received 2nd Dose|Ineligible|0
7700625|NCT01147068|26781127|P5|Subjects That Received 2nd Dose|Ineligible|0
7700626|NCT01147068|26781128|P4|Subjects That Received 2nd Dose|Ineligible|0
7700627|NCT01147068|26781129|P3|Subjects That Received 2nd Dose|Ineligible|0
7700628|NCT01147068|26781130|P2|Subjects That Received 2nd Dose|Ineligible|1
7700629|NCT01147068|26781131|P1|Subjects That Received 2nd Dose|Ineligible|0
7700630|NCT01147068|26781125|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
7700631|NCT01147068|26781126|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
7700632|NCT01147068|26781127|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
7700633|NCT01147068|26781128|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
7700634|NCT01147068|26781129|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
7700635|NCT01147068|26781130|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
7700636|NCT01147068|26781131|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
7700637|NCT01147055|26781161|P2|First Intervention Period|Lost to Follow-up|0
7700638|NCT01147055|26781162|P1|First Intervention Period|Lost to Follow-up|1
7700639|NCT01146951|26781204|P2|Overall Study|Adverse Event|1
7700640|NCT01146951|26781205|P1|Overall Study|Adverse Event|4
7700641|NCT01146912|26781226|P8|Overall Study|Duplicate patient|0
7700642|NCT01146912|26781227|P7|Overall Study|Duplicate patient|0
7700643|NCT01146912|26781228|P6|Overall Study|Duplicate patient|0
7700644|NCT01146912|26781229|P5|Overall Study|Duplicate patient|0
7700645|NCT01146912|26781230|P4|Overall Study|Duplicate patient|0
7700646|NCT01146912|26781231|P3|Overall Study|Duplicate patient|1
7700647|NCT01146912|26781232|P2|Overall Study|Duplicate patient|0
7700648|NCT01146912|26781233|P1|Overall Study|Duplicate patient|0
7700649|NCT01146912|26781226|P8|Overall Study|< 14 weeks gestational age|0
7700650|NCT01146912|26781227|P7|Overall Study|< 14 weeks gestational age|0
7700651|NCT01146912|26781228|P6|Overall Study|< 14 weeks gestational age|0
7700652|NCT01146912|26781229|P5|Overall Study|< 14 weeks gestational age|0
7700653|NCT01146912|26781230|P4|Overall Study|< 14 weeks gestational age|2
7700654|NCT01146912|26781231|P3|Overall Study|< 14 weeks gestational age|3
7700655|NCT01146912|26781232|P2|Overall Study|< 14 weeks gestational age|0
7700656|NCT01146912|26781233|P1|Overall Study|< 14 weeks gestational age|0
7700657|NCT01146912|26781226|P8|Overall Study|Already received influenza vaccination|0
7700658|NCT01146912|26781227|P7|Overall Study|Already received influenza vaccination|56
7700659|NCT01146912|26781228|P6|Overall Study|Already received influenza vaccination|61
7700660|NCT01146912|26781229|P5|Overall Study|Already received influenza vaccination|41
7700661|NCT01146912|26781230|P4|Overall Study|Already received influenza vaccination|15
7700662|NCT01146912|26781231|P3|Overall Study|Already received influenza vaccination|13
7700663|NCT01146912|26781232|P2|Overall Study|Already received influenza vaccination|822
7700664|NCT01146912|26781233|P1|Overall Study|Already received influenza vaccination|817
7700665|NCT01146873|26781255|P2|Overall Study|Transfer out|6
7700666|NCT01146873|26781256|P1|Overall Study|Transfer out|0
7700667|NCT01146860|26781272|P2|Overall Study|Withdrawal by Subject|1
7700668|NCT01146860|26781273|P1|Overall Study|Withdrawal by Subject|0
7700669|NCT01146795|26781324|P1|Overall Study|Still in treatment at study closure|10
7700670|NCT01146795|26781324|P1|Overall Study|Adverse Event|6
7700671|NCT01146795|26781324|P1|Overall Study|Withdrawal by Subject|4
7700672|NCT01146782|26781331|P1|Primary Endpoint Cohort|Physician Decision|1
7700673|NCT01146782|26781331|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
7700674|NCT01146782|26781331|P1|Safety Cohort|TST <4 hrs|14
7700675|NCT01146782|26781331|P1|Safety Cohort|Control AHI <5|4
7700676|NCT01146782|26781331|P1|Safety Cohort|Withdrawal by Subject|4
7700677|NCT01146782|26781331|P1|Safety Cohort|Screen Failure|61
7700678|NCT01146782|26781331|P1|Screening Cohort|Withdrawal by Subject|29
7700679|NCT01146782|26781331|P1|Screening Cohort|Physician Decision|1
7700680|NCT01146782|26781331|P1|Screening Cohort|Lost to Follow-up|4
7700681|NCT01146782|26781331|P1|Screening Cohort|Screen Failure|187
7700682|NCT01146665|26781349|P2|Overall Study|Withdrawal by Subject|16
7700683|NCT01146665|26781350|P1|Overall Study|Withdrawal by Subject|10
7700684|NCT01146613|26781382|P2|Overall Study|Outpatient detox|0
7700685|NCT01146613|26781383|P1|Overall Study|Outpatient detox|1
7700686|NCT01146613|26781382|P2|Overall Study|schedule conflict|0
7700687|NCT01146613|26781383|P1|Overall Study|schedule conflict|1
7700688|NCT01146613|26781382|P2|Overall Study|Withdrawal by Subject|3
7700689|NCT01146613|26781383|P1|Overall Study|Withdrawal by Subject|0
7700690|NCT01146613|26781382|P2|Overall Study|Physician Decision|0
7700691|NCT01146613|26781383|P1|Overall Study|Physician Decision|1
7700692|NCT01146613|26781382|P2|Overall Study|Death|0
7700693|NCT01146613|26781383|P1|Overall Study|Death|1
7700694|NCT01146613|26781382|P2|Overall Study|Lack of Efficacy|1
7700695|NCT01146613|26781383|P1|Overall Study|Lack of Efficacy|0
7700696|NCT01146613|26781382|P2|Overall Study|Lost to Follow-up|8
7700697|NCT01146613|26781383|P1|Overall Study|Lost to Follow-up|3
7700698|NCT01146561|26781417|P1|Overall Study|Lost to Follow-up|1
7700699|NCT01146561|26781417|P1|Overall Study|Withdrawal by Subject|1
7700700|NCT01146288|26781514|P2|First Intervention(1 Day)|Adverse Event|1
7700701|NCT01146288|26781515|P1|First Intervention(1 Day)|Adverse Event|0
7700702|NCT01146054|26781529|P1|Overall Study|Lost to Follow-up|1
7700703|NCT01146054|26781529|P1|Overall Study|Other illness precluded treatment|2
7700704|NCT01146054|26781529|P1|Overall Study|Rapid tumor progression|2
7700705|NCT01146054|26781529|P1|Overall Study|Did not meet dose constraints for SBRT|5
7700706|NCT01145898|26781539|P2|3-year Treatment|medication change by treating physician|16
7700707|NCT01145898|26781540|P1|3-year Treatment|medication change by treating physician|3
7700708|NCT01145885|26781571|P1|Overall Study|Progressive Disease|7
7700709|NCT01145755|26781617|P3|Overall Study|Positive urine ethanol|0
7700710|NCT01145755|26781618|P2|Overall Study|Positive urine ethanol|1
7700711|NCT01145755|26781619|P1|Overall Study|Positive urine ethanol|0
7700712|NCT01145755|26781617|P3|Overall Study|Withdrawal by Subject|1
7700713|NCT01145755|26781618|P2|Overall Study|Withdrawal by Subject|0
7700714|NCT01145755|26781619|P1|Overall Study|Withdrawal by Subject|0
7700715|NCT01145755|26781617|P3|Overall Study|Patient could not swollow medication|1
7700716|NCT01145755|26781618|P2|Overall Study|Patient could not swollow medication|0
7700717|NCT01145755|26781619|P1|Overall Study|Patient could not swollow medication|0
7700718|NCT01145755|26781617|P3|Overall Study|Lack of Efficacy|0
7700719|NCT01145755|26781618|P2|Overall Study|Lack of Efficacy|1
7700720|NCT01145755|26781619|P1|Overall Study|Lack of Efficacy|0
7700721|NCT01145755|26781617|P3|Overall Study|Study Closure|17
7700722|NCT01145755|26781618|P2|Overall Study|Study Closure|14
7700723|NCT01145755|26781619|P1|Overall Study|Study Closure|14
7700724|NCT01145755|26781617|P3|Overall Study|Protocol Violation|1
7700725|NCT01145755|26781618|P2|Overall Study|Protocol Violation|3
7700726|NCT01145755|26781619|P1|Overall Study|Protocol Violation|0
7700727|NCT01145755|26781617|P3|Overall Study|Lost to Follow-up|1
7700728|NCT01145755|26781618|P2|Overall Study|Lost to Follow-up|3
7700729|NCT01145755|26781619|P1|Overall Study|Lost to Follow-up|2
7700730|NCT01145755|26781617|P3|Overall Study|Withdrawal by Subject|2
7700731|NCT01145755|26781618|P2|Overall Study|Withdrawal by Subject|2
7700732|NCT01145755|26781619|P1|Overall Study|Withdrawal by Subject|2
7700733|NCT01145755|26781617|P3|Overall Study|Adverse Event|2
7700734|NCT01145755|26781618|P2|Overall Study|Adverse Event|4
7700735|NCT01145755|26781619|P1|Overall Study|Adverse Event|2
7700736|NCT01145625|26781646|P2|Overall Study|Pregnancy|1
7700737|NCT01145625|26781647|P1|Overall Study|Pregnancy|0
7700738|NCT01145625|26781646|P2|Overall Study|Withdrawal by Subject|16
7700739|NCT01145625|26781647|P1|Overall Study|Withdrawal by Subject|7
7700740|NCT01145625|26781646|P2|Overall Study|Protocol Violation|1
7700741|NCT01145625|26781647|P1|Overall Study|Protocol Violation|3
7700742|NCT01145625|26781646|P2|Overall Study|Adverse Event|4
7700743|NCT01145625|26781647|P1|Overall Study|Adverse Event|6
7700744|NCT01145625|26781646|P2|Overall Study|Lost to Follow-up|9
7700745|NCT01145625|26781647|P1|Overall Study|Lost to Follow-up|8
7700746|NCT01145560|26781660|P3|Overall Study|Withdrawal of therapy|1
7700747|NCT01145560|26781661|P2|Overall Study|Withdrawal of therapy|0
7700748|NCT01145560|26781662|P1|Overall Study|Withdrawal of therapy|0
7700749|NCT01145560|26781660|P3|Overall Study|False insurance information|0
7700750|NCT01145560|26781661|P2|Overall Study|False insurance information|1
7700751|NCT01145560|26781662|P1|Overall Study|False insurance information|0
7700752|NCT01145560|26781660|P3|Overall Study|Accidental unblinding of study treatment|0
7700753|NCT01145560|26781661|P2|Overall Study|Accidental unblinding of study treatment|1
7700754|NCT01145560|26781662|P1|Overall Study|Accidental unblinding of study treatment|0
7700755|NCT01145560|26781660|P3|Overall Study|No study drug by 24h after organ failure|0
7700756|NCT01145560|26781661|P2|Overall Study|No study drug by 24h after organ failure|0
7700757|NCT01145560|26781662|P1|Overall Study|No study drug by 24h after organ failure|1
7700758|NCT01145560|26781660|P3|Overall Study|Lost to Follow-up|1
7700759|NCT01145560|26781661|P2|Overall Study|Lost to Follow-up|1
7700760|NCT01145560|26781662|P1|Overall Study|Lost to Follow-up|1
7700761|NCT01145560|26781660|P3|Overall Study|Withdrawal by Subject|0
7700762|NCT01145560|26781661|P2|Overall Study|Withdrawal by Subject|1
7700763|NCT01145560|26781662|P1|Overall Study|Withdrawal by Subject|2
7700764|NCT01145508|26781688|P2|Overall Study|Never started treatment|1
7700765|NCT01145508|26781689|P1|Overall Study|Never started treatment|1
7700766|NCT01145508|26781688|P2|Overall Study|Physician Decision|1
7700767|NCT01145508|26781689|P1|Overall Study|Physician Decision|2
7700768|NCT01145508|26781688|P2|Overall Study|Death|0
7700769|NCT01145508|26781689|P1|Overall Study|Death|1
7700770|NCT01145508|26781688|P2|Overall Study|Adverse Event|0
7700771|NCT01145508|26781689|P1|Overall Study|Adverse Event|1
7700772|NCT01145495|26781695|P1|Overall Study|Disease progression after respone|1
7700773|NCT01145495|26781695|P1|Overall Study|Withdrawal by Subject|5
7700774|NCT01145495|26781695|P1|Overall Study|Adverse Event|6
7700775|NCT01145482|26781701|P2|First Intervention (1 Day)|Withdrawal by Subject|1
7700776|NCT01145482|26781702|P1|First Intervention (1 Day)|Withdrawal by Subject|0
7700777|NCT01145417|26781712|P2|Overall Study|Other|0
7700778|NCT01145417|26781713|P1|Overall Study|Other|1
7700779|NCT01145417|26781712|P2|Overall Study|Study terminated by sponsor|43
7700780|NCT01145417|26781713|P1|Overall Study|Study terminated by sponsor|35
7700781|NCT01145417|26781712|P2|Overall Study|Adverse Event|1
7700782|NCT01145417|26781713|P1|Overall Study|Adverse Event|0
7700783|NCT01145417|26781712|P2|Overall Study|Pregnancy|0
7700784|NCT01145417|26781713|P1|Overall Study|Pregnancy|1
7700785|NCT01145417|26781712|P2|Overall Study|Withdrawal by Subject|2
7700786|NCT01145417|26781713|P1|Overall Study|Withdrawal by Subject|1
7700787|NCT01145417|26781712|P2|Overall Study|Lost to Follow-up|1
7700788|NCT01145417|26781713|P1|Overall Study|Lost to Follow-up|2
7700789|NCT01145417|26781712|P2|Overall Study|Death|0
7700790|NCT01145417|26781713|P1|Overall Study|Death|1
7700791|NCT01145352|26781746|P1|Overall Study|Syringe formulation was used|1
7700792|NCT01145352|26781746|P1|Overall Study|Treated before marketing approval|4
7700793|NCT01145352|26781746|P1|Overall Study|Found to have been registered twice|6
7700794|NCT01145222|26781758|P4|Overall Study|Poor bowel preparation|1
7700795|NCT01145222|26781759|P3|Overall Study|Poor bowel preparation|0
7700796|NCT01145222|26781760|P2|Overall Study|Poor bowel preparation|0
7700797|NCT01145222|26781761|P1|Overall Study|Poor bowel preparation|0
7700798|NCT01145222|26781758|P4|Overall Study|Procedure not done (no anesthesiologist)|0
7700799|NCT01145222|26781759|P3|Overall Study|Procedure not done (no anesthesiologist)|1
7700800|NCT01145222|26781760|P2|Overall Study|Procedure not done (no anesthesiologist)|0
7700801|NCT01145222|26781761|P1|Overall Study|Procedure not done (no anesthesiologist)|0
7700802|NCT01145066|26781808|P3|Overall Study|Low platelet count|0
7700803|NCT01145066|26781809|P2|Overall Study|Low platelet count|1
7700804|NCT01145066|26781810|P1|Overall Study|Low platelet count|0
7700805|NCT01145066|26781808|P3|Overall Study|Abdominal discomfort|0
7700806|NCT01145066|26781809|P2|Overall Study|Abdominal discomfort|1
7700807|NCT01145066|26781810|P1|Overall Study|Abdominal discomfort|0
7700808|NCT01145066|26781808|P3|Overall Study|problems swallowing capsule|0
7700809|NCT01145066|26781809|P2|Overall Study|problems swallowing capsule|0
7700810|NCT01145066|26781810|P1|Overall Study|problems swallowing capsule|1
7700811|NCT01145066|26781808|P3|Overall Study|To start new med|0
7700812|NCT01145066|26781809|P2|Overall Study|To start new med|0
7700813|NCT01145066|26781810|P1|Overall Study|To start new med|1
7700814|NCT01145066|26781808|P3|Overall Study|Withdrawal by Subject|2
7700815|NCT01145066|26781809|P2|Overall Study|Withdrawal by Subject|0
7700816|NCT01145066|26781810|P1|Overall Study|Withdrawal by Subject|0
7700817|NCT01145066|26781808|P3|Overall Study|Non-related surgery|1
7700818|NCT01145066|26781809|P2|Overall Study|Non-related surgery|0
7700819|NCT01145066|26781810|P1|Overall Study|Non-related surgery|0
7700820|NCT01145066|26781808|P3|Overall Study|To resume NSAIDs|1
7700821|NCT01145066|26781809|P2|Overall Study|To resume NSAIDs|2
7700822|NCT01145066|26781810|P1|Overall Study|To resume NSAIDs|2
7700823|NCT01145053|26781878|P1|Overall Study|Other|18
7700824|NCT01145053|26781878|P1|Overall Study|Withdrawal by Subject|25
7700825|NCT01145053|26781878|P1|Overall Study|Lost to Follow-up|28
7700826|NCT01145053|26781878|P1|Overall Study|Adverse Event|22
7700827|NCT01144715|26781930|P2|Overall Study|Adverse Event|1
7700828|NCT01144715|26781931|P1|Overall Study|Adverse Event|0
7700829|NCT01144715|26781930|P2|Overall Study|Withdrawal by Subject|1
7700830|NCT01144715|26781931|P1|Overall Study|Withdrawal by Subject|2
7700831|NCT01144715|26781930|P2|Overall Study|Lost to Follow-up|1
7700832|NCT01144715|26781931|P1|Overall Study|Lost to Follow-up|2
7700833|NCT01144663|26781947|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
7700834|NCT01144663|26781948|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
7700835|NCT01144663|26781949|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
7700836|NCT01144663|26781950|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
7700837|NCT01144663|26781947|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
7700838|NCT01144663|26781948|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
7700839|NCT01144663|26781949|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
7700840|NCT01144663|26781950|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
7700841|NCT01144663|26781947|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
7700842|NCT01144663|26781948|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
7700843|NCT01144663|26781949|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
7700844|NCT01144663|26781950|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
7700845|NCT01144663|26781947|P4|Booster Vaccination Phase|Lost to Follow-up|0
7700846|NCT01144663|26781948|P3|Booster Vaccination Phase|Lost to Follow-up|3
7700847|NCT01144663|26781949|P2|Booster Vaccination Phase|Lost to Follow-up|1
7700848|NCT01144663|26781950|P1|Booster Vaccination Phase|Lost to Follow-up|2
7700849|NCT01144663|26781947|P4|Booster Vaccination Phase|Migrated/moved from study area|0
7700850|NCT01144663|26781948|P3|Booster Vaccination Phase|Migrated/moved from study area|1
7700851|NCT01144663|26781949|P2|Booster Vaccination Phase|Migrated/moved from study area|1
7700852|NCT01144663|26781950|P1|Booster Vaccination Phase|Migrated/moved from study area|1
7700853|NCT01144663|26781947|P4|Booster Vaccination Phase|Withdrawal by Subject|1
7700854|NCT01144663|26781948|P3|Booster Vaccination Phase|Withdrawal by Subject|1
7700855|NCT01144663|26781949|P2|Booster Vaccination Phase|Withdrawal by Subject|0
7700856|NCT01144663|26781950|P1|Booster Vaccination Phase|Withdrawal by Subject|0
7700857|NCT01144663|26781947|P4|Primary Vaccination Phase|Other|2
7700858|NCT01144663|26781948|P3|Primary Vaccination Phase|Other|0
7700859|NCT01144663|26781949|P2|Primary Vaccination Phase|Other|1
7700860|NCT01144663|26781950|P1|Primary Vaccination Phase|Other|0
7700861|NCT01144663|26781947|P4|Primary Vaccination Phase|Lost to Follow-up|2
7700862|NCT01144663|26781948|P3|Primary Vaccination Phase|Lost to Follow-up|1
7700863|NCT01144663|26781949|P2|Primary Vaccination Phase|Lost to Follow-up|0
7700864|NCT01144663|26781950|P1|Primary Vaccination Phase|Lost to Follow-up|2
7700865|NCT01144663|26781947|P4|Primary Vaccination Phase|Migrated/moved from study area|3
7700866|NCT01144663|26781948|P3|Primary Vaccination Phase|Migrated/moved from study area|2
7700867|NCT01144663|26781949|P2|Primary Vaccination Phase|Migrated/moved from study area|1
7700868|NCT01144663|26781950|P1|Primary Vaccination Phase|Migrated/moved from study area|4
7700869|NCT01144663|26781947|P4|Primary Vaccination Phase|Withdrawal by Subject|10
7700870|NCT01144663|26781948|P3|Primary Vaccination Phase|Withdrawal by Subject|3
7700871|NCT01144663|26781949|P2|Primary Vaccination Phase|Withdrawal by Subject|5
7700872|NCT01144663|26781950|P1|Primary Vaccination Phase|Withdrawal by Subject|9
7700873|NCT01144663|26781947|P4|Primary Vaccination Phase|Protocol Violation|0
7700874|NCT01144663|26781948|P3|Primary Vaccination Phase|Protocol Violation|1
7700875|NCT01144663|26781949|P2|Primary Vaccination Phase|Protocol Violation|0
7700876|NCT01144663|26781950|P1|Primary Vaccination Phase|Protocol Violation|2
7700877|NCT01144663|26781947|P4|Primary Vaccination Phase|Adverse Event|1
7700878|NCT01144663|26781948|P3|Primary Vaccination Phase|Adverse Event|0
7700879|NCT01144663|26781949|P2|Primary Vaccination Phase|Adverse Event|0
7700880|NCT01144663|26781950|P1|Primary Vaccination Phase|Adverse Event|1
7700881|NCT01144663|26781947|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
7700882|NCT01144663|26781948|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
7700883|NCT01144663|26781949|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
7700884|NCT01144663|26781950|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
7700885|NCT01144416|26782288|P2|Intervention Period|Other|5
7700886|NCT01144416|26782289|P1|Intervention Period|Other|7
7700887|NCT01144416|26782288|P2|Intervention Period|No/too few/bad quality embryos|3
7700888|NCT01144416|26782289|P1|Intervention Period|No/too few/bad quality embryos|3
7700889|NCT01144416|26782288|P2|Intervention Period|No or abnormal fertilization|10
7700890|NCT01144416|26782289|P1|Intervention Period|No or abnormal fertilization|25
7700891|NCT01144416|26782288|P2|Intervention Period|No/too few/bad oocytes|5
7700892|NCT01144416|26782289|P1|Intervention Period|No/too few/bad oocytes|7
7700893|NCT01144416|26782288|P2|Intervention Period|Too high ovarian response|2
7700894|NCT01144416|26782289|P1|Intervention Period|Too high ovarian response|4
7700895|NCT01144416|26782288|P2|Intervention Period|Risk of OHSS|1
7700896|NCT01144416|26782289|P1|Intervention Period|Risk of OHSS|0
7700897|NCT01144416|26782288|P2|Intervention Period|Insufficient ovarian response|17
7700898|NCT01144416|26782289|P1|Intervention Period|Insufficient ovarian response|11
7700899|NCT01144416|26782288|P2|Intervention Period|Adverse Event|6
7700900|NCT01144416|26782289|P1|Intervention Period|Adverse Event|5
7700901|NCT01144403|26782305|P1|Overall Study|Adverse Event|1
7700902|NCT01144403|26782305|P1|Overall Study|Death|1
7700903|NCT01144403|26782305|P1|Overall Study|Lost to Follow-up|3
7700904|NCT01144377|26782317|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7700905|NCT01144377|26782318|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7700985|NCT01144364|26782370|P3|Induction Phase|Withdrawal by Subject|0
7700906|NCT01144377|26782319|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7700907|NCT01144377|26782320|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7700908|NCT01144377|26782321|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
7700909|NCT01144377|26782317|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
7700910|NCT01144377|26782318|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7700911|NCT01144377|26782319|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7700912|NCT01144377|26782320|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7700913|NCT01144377|26782321|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7700914|NCT01144377|26782317|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
7700915|NCT01144377|26782318|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7700916|NCT01144377|26782319|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7700917|NCT01144377|26782320|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
7700918|NCT01144377|26782321|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7700919|NCT01144377|26782317|P5|52 Week Treatment Period|Sponsor Decision|1
7700920|NCT01144377|26782318|P4|52 Week Treatment Period|Sponsor Decision|0
7700921|NCT01144377|26782319|P3|52 Week Treatment Period|Sponsor Decision|0
7700922|NCT01144377|26782320|P2|52 Week Treatment Period|Sponsor Decision|0
7700923|NCT01144377|26782321|P1|52 Week Treatment Period|Sponsor Decision|0
7700924|NCT01144377|26782317|P5|52 Week Treatment Period|Withdrawal by Subject|0
7700925|NCT01144377|26782318|P4|52 Week Treatment Period|Withdrawal by Subject|1
7700926|NCT01144377|26782319|P3|52 Week Treatment Period|Withdrawal by Subject|1
7700927|NCT01144377|26782320|P2|52 Week Treatment Period|Withdrawal by Subject|1
7700928|NCT01144377|26782321|P1|52 Week Treatment Period|Withdrawal by Subject|4
7700929|NCT01144377|26782317|P5|52 Week Treatment Period|Lost to Follow-up|0
7700930|NCT01144377|26782318|P4|52 Week Treatment Period|Lost to Follow-up|0
7700931|NCT01144377|26782319|P3|52 Week Treatment Period|Lost to Follow-up|0
7700932|NCT01144377|26782320|P2|52 Week Treatment Period|Lost to Follow-up|0
7700933|NCT01144377|26782321|P1|52 Week Treatment Period|Lost to Follow-up|1
7700934|NCT01144377|26782317|P5|52 Week Treatment Period|Protocol Violation|1
7700935|NCT01144377|26782318|P4|52 Week Treatment Period|Protocol Violation|0
7700936|NCT01144377|26782319|P3|52 Week Treatment Period|Protocol Violation|0
7700937|NCT01144377|26782320|P2|52 Week Treatment Period|Protocol Violation|0
7700938|NCT01144377|26782321|P1|52 Week Treatment Period|Protocol Violation|0
7700939|NCT01144377|26782317|P5|52 Week Treatment Period|Entry Criteria Not Met|0
7700940|NCT01144377|26782318|P4|52 Week Treatment Period|Entry Criteria Not Met|1
7700941|NCT01144377|26782319|P3|52 Week Treatment Period|Entry Criteria Not Met|1
7700942|NCT01144377|26782320|P2|52 Week Treatment Period|Entry Criteria Not Met|0
7700943|NCT01144377|26782321|P1|52 Week Treatment Period|Entry Criteria Not Met|0
7700944|NCT01144377|26782317|P5|52 Week Treatment Period|Adverse Event|1
7700945|NCT01144377|26782318|P4|52 Week Treatment Period|Adverse Event|2
7700946|NCT01144377|26782319|P3|52 Week Treatment Period|Adverse Event|3
7700947|NCT01144377|26782320|P2|52 Week Treatment Period|Adverse Event|0
7700948|NCT01144377|26782321|P1|52 Week Treatment Period|Adverse Event|0
7700949|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Physician Decision|1
7700950|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Physician Decision|0
7700951|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Physician Decision|0
7700952|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Relapse|5
7700953|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Relapse|5
7700954|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Relapse|0
7700955|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
7700956|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
7700957|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
7700958|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
7700959|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
7700960|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
7700961|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Death|0
7700962|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Death|2
7700963|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Death|0
7700964|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Adverse Event|1
7700965|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Adverse Event|3
7700966|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Adverse Event|0
7700967|NCT01144364|26782370|P3|Follow-Up/Maintenance Phase|Disease progression|29
7700968|NCT01144364|26782371|P2|Follow-Up/Maintenance Phase|Disease progression|23
7700969|NCT01144364|26782372|P1|Follow-Up/Maintenance Phase|Disease progression|0
7700970|NCT01144364|26782370|P3|Induction Phase|Protocol Violation|0
7700971|NCT01144364|26782371|P2|Induction Phase|Protocol Violation|0
7700972|NCT01144364|26782372|P1|Induction Phase|Protocol Violation|1
7700973|NCT01144364|26782370|P3|Induction Phase|Secondary neoplasia|0
7700974|NCT01144364|26782371|P2|Induction Phase|Secondary neoplasia|0
7700975|NCT01144364|26782372|P1|Induction Phase|Secondary neoplasia|1
7700976|NCT01144364|26782370|P3|Induction Phase|Stable disease|0
7700977|NCT01144364|26782371|P2|Induction Phase|Stable disease|0
7700978|NCT01144364|26782372|P1|Induction Phase|Stable disease|2
7700979|NCT01144364|26782370|P3|Induction Phase|Physician Decision|0
7700980|NCT01144364|26782371|P2|Induction Phase|Physician Decision|0
7700981|NCT01144364|26782372|P1|Induction Phase|Physician Decision|1
7700982|NCT01144364|26782370|P3|Induction Phase|Lost to Follow-up|0
7700983|NCT01144364|26782371|P2|Induction Phase|Lost to Follow-up|0
7700984|NCT01144364|26782372|P1|Induction Phase|Lost to Follow-up|2
7700986|NCT01144364|26782371|P2|Induction Phase|Withdrawal by Subject|0
7700987|NCT01144364|26782372|P1|Induction Phase|Withdrawal by Subject|1
7700988|NCT01144364|26782370|P3|Induction Phase|Death|0
7700989|NCT01144364|26782371|P2|Induction Phase|Death|0
7700990|NCT01144364|26782372|P1|Induction Phase|Death|1
7700991|NCT01144364|26782370|P3|Induction Phase|Adverse Event|0
7700992|NCT01144364|26782371|P2|Induction Phase|Adverse Event|0
7700993|NCT01144364|26782372|P1|Induction Phase|Adverse Event|9
7700994|NCT01144364|26782370|P3|Induction Phase|Disease progression|0
7700995|NCT01144364|26782371|P2|Induction Phase|Disease progression|0
7700996|NCT01144364|26782372|P1|Induction Phase|Disease progression|14
7700997|NCT01144299|26782421|P2|Overall Study|Withdrawal by Subject|0
7700998|NCT01144299|26782422|P1|Overall Study|Withdrawal by Subject|1
7700999|NCT01144299|26782421|P2|Overall Study|Lost to Follow-up|0
7701000|NCT01144299|26782422|P1|Overall Study|Lost to Follow-up|1
7701001|NCT01144182|26782467|P2|Overall Study|Lost to Follow-up|9
7701002|NCT01144182|26782468|P1|Overall Study|Lost to Follow-up|9
7701003|NCT01144182|26782467|P2|Overall Study|Withdrawal by Subject|6
7701004|NCT01144182|26782468|P1|Overall Study|Withdrawal by Subject|3
7701005|NCT01144182|26782467|P2|Overall Study|Death|6
7701006|NCT01144182|26782468|P1|Overall Study|Death|5
7701007|NCT01144052|26782528|P2|Overall Study|Withdrawal by Subject|1
7701008|NCT01144052|26782529|P1|Overall Study|Withdrawal by Subject|1
7701009|NCT01143896|26782560|P2|Overall Study|Death|3
7701010|NCT01143896|26782561|P1|Overall Study|Death|6
7701011|NCT01143896|26782560|P2|Overall Study|Withdrawal by Subject|5
7701012|NCT01143896|26782561|P1|Overall Study|Withdrawal by Subject|13
7701013|NCT01143896|26782560|P2|Overall Study|Lost to Follow-up|13
7701014|NCT01143896|26782561|P1|Overall Study|Lost to Follow-up|18
7701015|NCT01143896|26782560|P2|Overall Study|Did not complete Baseline Interview|4
7701016|NCT01143896|26782561|P1|Overall Study|Did not complete Baseline Interview|5
7701017|NCT01143714|26782673|P2|Overall Study|wound size increased|0
7701018|NCT01143714|26782674|P1|Overall Study|wound size increased|1
7701019|NCT01143714|26782673|P2|Overall Study|wound closed = deemed healed|0
7701020|NCT01143714|26782674|P1|Overall Study|wound closed = deemed healed|1
7701021|NCT01143714|26782673|P2|Overall Study|Subject non-compliance|1
7701022|NCT01143714|26782674|P1|Overall Study|Subject non-compliance|0
7701023|NCT01143714|26782673|P2|Overall Study|Withdrawal by Subject|0
7701024|NCT01143714|26782674|P1|Overall Study|Withdrawal by Subject|1
7701025|NCT01143714|26782673|P2|Overall Study|Adverse Event|2
7701026|NCT01143714|26782674|P1|Overall Study|Adverse Event|4
7701027|NCT01143402|26782779|P3|Overall Study|Not Treated|1
7701028|NCT01143402|26782780|P2|Overall Study|Not Treated|0
7701029|NCT01143402|26782781|P1|Overall Study|Not Treated|0
7701030|NCT01143402|26782779|P3|Overall Study|Rapid clinical decline|0
7701031|NCT01143402|26782780|P2|Overall Study|Rapid clinical decline|1
7701032|NCT01143402|26782781|P1|Overall Study|Rapid clinical decline|1
7701033|NCT01143389|26782792|P2|Overall Study|Lost to Follow-up|25
7701034|NCT01143389|26782793|P1|Overall Study|Lost to Follow-up|26
7701035|NCT01143337|26782807|P3|Overall Study|Other reason|5
7701036|NCT01143337|26782808|P2|Overall Study|Other reason|0
7701037|NCT01143337|26782809|P1|Overall Study|Other reason|0
7701038|NCT01143337|26782807|P3|Overall Study|Withdrawal by Subject|1
7701039|NCT01143337|26782808|P2|Overall Study|Withdrawal by Subject|0
7701040|NCT01143337|26782809|P1|Overall Study|Withdrawal by Subject|0
7701041|NCT01143337|26782807|P3|Overall Study|Protocol Violation|0
7701042|NCT01143337|26782808|P2|Overall Study|Protocol Violation|0
7701043|NCT01143337|26782809|P1|Overall Study|Protocol Violation|1
7701044|NCT01143337|26782807|P3|Overall Study|Lack of Efficacy|1
7701045|NCT01143337|26782808|P2|Overall Study|Lack of Efficacy|2
7701046|NCT01143337|26782809|P1|Overall Study|Lack of Efficacy|6
7701047|NCT01143337|26782807|P3|Overall Study|Adverse Event|5
7701048|NCT01143337|26782808|P2|Overall Study|Adverse Event|9
7701049|NCT01143337|26782809|P1|Overall Study|Adverse Event|3
7701050|NCT01143324|26782823|P1|Overall Study|Explant of the device|4
7701051|NCT01143324|26782823|P1|Overall Study|Withdrawal by Subject|4
7701052|NCT01143324|26782823|P1|Overall Study|Lost to Follow-up|11
7701053|NCT01143259|26782862|P2|Overall Study|Screen Failure|9
7701054|NCT01143259|26782863|P1|Overall Study|Screen Failure|7
7701055|NCT01143259|26782862|P2|Overall Study|Protocol Violation|9
7701056|NCT01143259|26782863|P1|Overall Study|Protocol Violation|13
7701057|NCT01143259|26782862|P2|Overall Study|Withdrawal by Subject|2
7701058|NCT01143259|26782863|P1|Overall Study|Withdrawal by Subject|3
7701059|NCT01143207|26782871|P1|Overall Study|Lost to Follow-up|2
7701060|NCT01143090|26782908|P1|Overall Study|Administrative|1
7701061|NCT01143090|26782908|P1|Overall Study|Failure to meet eligibility criteria|1
7701062|NCT01143090|26782908|P1|Overall Study|Non-compliance with study drug|1
7701063|NCT01143090|26782908|P1|Overall Study|Withdrawal by Subject|18
7701064|NCT01143090|26782908|P1|Overall Study|Protocol Violation|2
7701065|NCT01143090|26782908|P1|Overall Study|Lost to Follow-up|9
7701066|NCT01143090|26782908|P1|Overall Study|Adverse Event|17
7701067|NCT01143090|26782908|P1|Overall Study|Lack of Efficacy|2
7701068|NCT01143077|26782915|P3|Overall Study|Principal Investigator Decision|1
7701069|NCT01143077|26782916|P2|Overall Study|Principal Investigator Decision|0
7701070|NCT01143077|26782917|P1|Overall Study|Principal Investigator Decision|2
7701071|NCT01143077|26782915|P3|Overall Study|Administrative|0
7701072|NCT01143077|26782916|P2|Overall Study|Administrative|0
7701073|NCT01143077|26782917|P1|Overall Study|Administrative|1
7701074|NCT01143077|26782915|P3|Overall Study|Non-compliance with study drug|1
7701075|NCT01143077|26782916|P2|Overall Study|Non-compliance with study drug|1
7701076|NCT01143077|26782917|P1|Overall Study|Non-compliance with study drug|0
7701077|NCT01143077|26782915|P3|Overall Study|Withdrawal by Subject|3
7701078|NCT01143077|26782916|P2|Overall Study|Withdrawal by Subject|3
7701079|NCT01143077|26782917|P1|Overall Study|Withdrawal by Subject|4
7701080|NCT01143077|26782915|P3|Overall Study|Protocol Violation|0
7701081|NCT01143077|26782916|P2|Overall Study|Protocol Violation|0
7701082|NCT01143077|26782917|P1|Overall Study|Protocol Violation|2
7701083|NCT01143077|26782915|P3|Overall Study|Lost to Follow-up|4
7701084|NCT01143077|26782916|P2|Overall Study|Lost to Follow-up|3
7701085|NCT01143077|26782917|P1|Overall Study|Lost to Follow-up|2
7701086|NCT01143077|26782915|P3|Overall Study|Adverse Event|5
7701087|NCT01143077|26782916|P2|Overall Study|Adverse Event|6
7701088|NCT01143077|26782917|P1|Overall Study|Adverse Event|5
7701089|NCT01143077|26782915|P3|Overall Study|Lack of Efficacy|1
7701090|NCT01143077|26782916|P2|Overall Study|Lack of Efficacy|2
7701091|NCT01143077|26782917|P1|Overall Study|Lack of Efficacy|0
7701092|NCT01143051|26782934|P6|3-14 Day Washout|Withdrawal by Subject|1
7701093|NCT01143051|26782935|P5|3-14 Day Washout|Withdrawal by Subject|0
7701094|NCT01143051|26782936|P4|3-14 Day Washout|Withdrawal by Subject|0
7701095|NCT01143051|26782937|P3|3-14 Day Washout|Withdrawal by Subject|0
7701096|NCT01143051|26782938|P2|3-14 Day Washout|Withdrawal by Subject|0
7701097|NCT01143051|26782939|P1|3-14 Day Washout|Withdrawal by Subject|0
7701098|NCT01143051|26782934|P6|3-14 Day Washout|Withdrawal by Subject|0
7701099|NCT01143051|26782935|P5|3-14 Day Washout|Withdrawal by Subject|0
7701100|NCT01143051|26782936|P4|3-14 Day Washout|Withdrawal by Subject|0
7701101|NCT01143051|26782937|P3|3-14 Day Washout|Withdrawal by Subject|1
7701102|NCT01143051|26782938|P2|3-14 Day Washout|Withdrawal by Subject|0
7701103|NCT01143051|26782939|P1|3-14 Day Washout|Withdrawal by Subject|0
7701104|NCT01143038|26782988|P1|Overall Study|Death|1
7701105|NCT01143038|26782988|P1|Overall Study|Protocol Deviation|1
7701106|NCT01143038|26782988|P1|Overall Study|Lost to Follow-up|2
7701107|NCT01143038|26782988|P1|Overall Study|Adverse Event|3
7701108|NCT01143038|26782988|P1|Overall Study|Requirement for alternative therapy|5
7701109|NCT01143038|26782988|P1|Overall Study|Withdrawal by Subject|4
7701110|NCT01142908|26783002|P2|Overall Study|Withdrawal by Subject|0
7701111|NCT01142908|26783003|P1|Overall Study|Withdrawal by Subject|3
7701112|NCT01142908|26783002|P2|Overall Study|Excluded - did not meet criteria|5
7701113|NCT01142908|26783003|P1|Overall Study|Excluded - did not meet criteria|9
7701114|NCT01142908|26783002|P2|Overall Study|Death|4
7701115|NCT01142908|26783003|P1|Overall Study|Death|1
7701116|NCT01142908|26783002|P2|Overall Study|Lost to Follow-up|13
7701117|NCT01142908|26783003|P1|Overall Study|Lost to Follow-up|19
7701118|NCT01142791|26783049|P2|Overall Study|Received only 1 sonication|6
7701119|NCT01142791|26783050|P1|Overall Study|Received only 1 sonication|0
7701120|NCT01142791|26783049|P2|Overall Study|Withdrawal by Subject|0
7701121|NCT01142791|26783050|P1|Overall Study|Withdrawal by Subject|5
7701122|NCT01142791|26783049|P2|Overall Study|Lost to Follow-up|0
7701123|NCT01142791|26783050|P1|Overall Study|Lost to Follow-up|1
7701124|NCT01142791|26783049|P2|Overall Study|Alternative Treatment|0
7701125|NCT01142791|26783050|P1|Overall Study|Alternative Treatment|1
7701126|NCT01142726|26783057|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
7701127|NCT01142726|26783058|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
7701128|NCT01142726|26783059|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
7701129|NCT01142726|26783057|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
7701130|NCT01142726|26783058|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
7701131|NCT01142726|26783059|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
7701132|NCT01142726|26783057|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7701133|NCT01142726|26783058|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7701134|NCT01142726|26783059|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7701135|NCT01142726|26783057|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
7701136|NCT01142726|26783058|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
7701137|NCT01142726|26783059|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
7701138|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
7701139|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
7701140|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
7701141|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
7701142|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
7701143|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
7701144|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
7701145|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
7701146|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
7701147|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
7701148|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
7701149|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
7701150|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
7701151|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
7701152|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
7701153|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
7701154|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
7701155|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
7701156|NCT01142726|26783057|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
7701157|NCT01142726|26783058|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
7701158|NCT01142726|26783059|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
7701159|NCT01142726|26783057|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
7701160|NCT01142726|26783058|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
7701161|NCT01142726|26783059|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
7701162|NCT01142726|26783057|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
7701163|NCT01142726|26783058|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
7701164|NCT01142726|26783059|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
7701165|NCT01142726|26783057|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
7701166|NCT01142726|26783058|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
7701167|NCT01142726|26783059|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
7701168|NCT01142726|26783057|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
7701169|NCT01142726|26783058|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
7701170|NCT01142726|26783059|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
7701171|NCT01142726|26783057|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
7701172|NCT01142726|26783058|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
7701173|NCT01142726|26783059|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
7701174|NCT01142661|26783122|P1|Overall Study|Physician Decision|1
7701175|NCT01142661|26783122|P1|Overall Study|Withdrawal by Subject|1
7701176|NCT01142661|26783122|P1|Overall Study|Adverse Event|2
7701177|NCT01142596|26783129|P2|Overall Study|Other reason (not specified)|4
7701178|NCT01142596|26783130|P1|Overall Study|Other reason (not specified)|5
7701179|NCT01142596|26783129|P2|Overall Study|Lost to Follow-up|3
7701180|NCT01142596|26783130|P1|Overall Study|Lost to Follow-up|2
7701181|NCT01142596|26783129|P2|Overall Study|Lack of Efficacy|9
7701182|NCT01142596|26783130|P1|Overall Study|Lack of Efficacy|5
7701183|NCT01142596|26783129|P2|Overall Study|Adverse Event|35
7701184|NCT01142596|26783130|P1|Overall Study|Adverse Event|8
7701185|NCT01142596|26783129|P2|Overall Study|Withdrawal by Subject|35
7701186|NCT01142596|26783130|P1|Overall Study|Withdrawal by Subject|9
7701187|NCT01142466|26783182|P2|Overall Study|Withdrawal by Subject|1
7701188|NCT01142466|26783183|P1|Overall Study|Withdrawal by Subject|1
7701189|NCT01142466|26783182|P2|Overall Study|Adverse Event|1
7701190|NCT01142466|26783183|P1|Overall Study|Adverse Event|2
7701207|NCT01142336|26783216|P2|Overall Study|Lost to Follow-up|1
7701208|NCT01142336|26783217|P1|Overall Study|Lost to Follow-up|0
7701209|NCT01142336|26783216|P2|Overall Study|Adverse Event|1
7701210|NCT01142336|26783217|P1|Overall Study|Adverse Event|1
7701211|NCT01142232|26783254|P5|Overall Study|Noncompliance|2
7701212|NCT01142232|26783255|P4|Overall Study|Noncompliance|0
7701213|NCT01142232|26783256|P3|Overall Study|Noncompliance|0
7701214|NCT01142232|26783257|P2|Overall Study|Noncompliance|0
7701215|NCT01142232|26783258|P1|Overall Study|Noncompliance|0
7701216|NCT01142232|26783254|P5|Overall Study|Off Trt for other complicating disease|1
7701217|NCT01142232|26783255|P4|Overall Study|Off Trt for other complicating disease|0
7701218|NCT01142232|26783256|P3|Overall Study|Off Trt for other complicating disease|0
7701219|NCT01142232|26783257|P2|Overall Study|Off Trt for other complicating disease|0
7701220|NCT01142232|26783258|P1|Overall Study|Off Trt for other complicating disease|0
7701221|NCT01142232|26783254|P5|Overall Study|Alternative Therapy|1
7701222|NCT01142232|26783255|P4|Overall Study|Alternative Therapy|0
7701223|NCT01142232|26783256|P3|Overall Study|Alternative Therapy|1
7701224|NCT01142232|26783257|P2|Overall Study|Alternative Therapy|1
7701225|NCT01142232|26783258|P1|Overall Study|Alternative Therapy|0
7701226|NCT01142232|26783254|P5|Overall Study|Physician Decision|10
7701227|NCT01142232|26783255|P4|Overall Study|Physician Decision|2
7701228|NCT01142232|26783256|P3|Overall Study|Physician Decision|0
7701229|NCT01142232|26783257|P2|Overall Study|Physician Decision|1
7701230|NCT01142232|26783258|P1|Overall Study|Physician Decision|0
7701231|NCT01142232|26783254|P5|Overall Study|Withdrawal by Subject|3
7701232|NCT01142232|26783255|P4|Overall Study|Withdrawal by Subject|1
7701233|NCT01142232|26783256|P3|Overall Study|Withdrawal by Subject|0
7701234|NCT01142232|26783257|P2|Overall Study|Withdrawal by Subject|0
7701235|NCT01142232|26783258|P1|Overall Study|Withdrawal by Subject|0
7701236|NCT01142232|26783254|P5|Overall Study|Disease Progression|12
7701237|NCT01142232|26783255|P4|Overall Study|Disease Progression|2
7701238|NCT01142232|26783256|P3|Overall Study|Disease Progression|1
7701239|NCT01142232|26783257|P2|Overall Study|Disease Progression|0
7701240|NCT01142232|26783258|P1|Overall Study|Disease Progression|2
7701241|NCT01142232|26783254|P5|Overall Study|Death|1
7701242|NCT01142232|26783255|P4|Overall Study|Death|0
7701243|NCT01142232|26783256|P3|Overall Study|Death|0
7701244|NCT01142232|26783257|P2|Overall Study|Death|0
7701245|NCT01142232|26783258|P1|Overall Study|Death|0
7701246|NCT01142232|26783254|P5|Overall Study|Adverse Event|4
7701247|NCT01142232|26783255|P4|Overall Study|Adverse Event|0
7701248|NCT01142232|26783256|P3|Overall Study|Adverse Event|1
7701249|NCT01142232|26783257|P2|Overall Study|Adverse Event|2
7701250|NCT01142232|26783258|P1|Overall Study|Adverse Event|1
7701251|NCT01142193|26783273|P2|Overall Study|Other|2
7701252|NCT01142193|26783274|P1|Overall Study|Other|1
7701253|NCT01142193|26783273|P2|Overall Study|Protocol Discontinuation Criterion Met|0
7701254|NCT01142193|26783274|P1|Overall Study|Protocol Discontinuation Criterion Met|1
7701255|NCT01142193|26783273|P2|Overall Study|Withdrawal by Subject|3
7701256|NCT01142193|26783274|P1|Overall Study|Withdrawal by Subject|4
7701257|NCT01142193|26783273|P2|Overall Study|Physician Decision|1
7701258|NCT01142193|26783274|P1|Overall Study|Physician Decision|1
7701259|NCT01142193|26783273|P2|Overall Study|Lack of Efficacy|1
7701260|NCT01142193|26783274|P1|Overall Study|Lack of Efficacy|2
7701261|NCT01142193|26783273|P2|Overall Study|Adverse Event|4
7701262|NCT01142193|26783274|P1|Overall Study|Adverse Event|12
7701263|NCT01142128|26783302|P1|Overall Study|Withdrawal by Subject|2
7701264|NCT01142128|26783302|P1|Overall Study|Lost to Follow-up|1
7701265|NCT01142128|26783302|P1|Overall Study|Physician Decision|1
7701266|NCT01142115|26783312|P2|First Intervention|Adverse Event|0
7701267|NCT01142115|26783313|P1|First Intervention|Adverse Event|1
7701268|NCT01142115|26783312|P2|First Intervention|Lack of Efficacy|1
7701269|NCT01142115|26783313|P1|First Intervention|Lack of Efficacy|1
7701270|NCT01142089|26783330|P2|Overall Study|Patient required rescue medication|17
7701271|NCT01142089|26783331|P1|Overall Study|Patient required rescue medication|8
7701272|NCT01142089|26783330|P2|Overall Study|Noncompliance with study procedures|1
7701273|NCT01142089|26783331|P1|Overall Study|Noncompliance with study procedures|2
7701274|NCT01142089|26783330|P2|Overall Study|Use of prohibited medications|1
7701275|NCT01142089|26783331|P1|Overall Study|Use of prohibited medications|0
7701276|NCT01142089|26783330|P2|Overall Study|Withdrawal by Subject|2
7701277|NCT01142089|26783331|P1|Overall Study|Withdrawal by Subject|1
7701278|NCT01142089|26783330|P2|Overall Study|Physician Decision|0
7701279|NCT01142089|26783331|P1|Overall Study|Physician Decision|1
7701280|NCT01141712|26783362|P1|Overall Study|Disease progression|3
7701281|NCT01141660|26783383|P2|Overall Study|Physician Decision|12
7701282|NCT01141660|26783384|P1|Overall Study|Physician Decision|0
7701283|NCT01141478|26783438|P2|Overall Study|Withdrawal by Subject|1
7701284|NCT01141478|26783439|P1|Overall Study|Withdrawal by Subject|1
7701285|NCT01141283|26783461|P1|Overall Study|Lack of Efficacy|10
7701286|NCT01141283|26783461|P1|Overall Study|Administrative|4
7701287|NCT01141283|26783461|P1|Overall Study|Withdrawal by Subject|14
7701288|NCT01141283|26783461|P1|Overall Study|Lost to Follow-up|4
7701289|NCT01141283|26783461|P1|Overall Study|Adverse Event|56
7701290|NCT01141205|26783467|P2|Overall Study|Withdrawal by Subject|1
7701291|NCT01141205|26783468|P1|Overall Study|Withdrawal by Subject|1
7701292|NCT01141205|26783467|P2|Overall Study|Lost to Follow-up|0
7701293|NCT01141205|26783468|P1|Overall Study|Lost to Follow-up|1
7701294|NCT01141205|26783467|P2|Overall Study|Physician Decision|1
7701295|NCT01141205|26783468|P1|Overall Study|Physician Decision|1
7701296|NCT01140906|26783507|P4|Overall Study|Administrative or other reason|2
7701297|NCT01140906|26783508|P3|Overall Study|Administrative or other reason|3
7701298|NCT01140906|26783509|P2|Overall Study|Administrative or other reason|5
7701299|NCT01140906|26783510|P1|Overall Study|Administrative or other reason|0
7701300|NCT01140906|26783507|P4|Overall Study|Lost to Follow-up|2
7701301|NCT01140906|26783508|P3|Overall Study|Lost to Follow-up|0
7701302|NCT01140906|26783509|P2|Overall Study|Lost to Follow-up|1
7701303|NCT01140906|26783510|P1|Overall Study|Lost to Follow-up|1
7701304|NCT01140906|26783507|P4|Overall Study|Withdrawal of consent|2
7701305|NCT01140906|26783508|P3|Overall Study|Withdrawal of consent|2
7701306|NCT01140906|26783509|P2|Overall Study|Withdrawal of consent|6
7701307|NCT01140906|26783510|P1|Overall Study|Withdrawal of consent|6
7701308|NCT01140906|26783507|P4|Overall Study|Protocol Violation|1
7701309|NCT01140906|26783508|P3|Overall Study|Protocol Violation|2
7701310|NCT01140906|26783509|P2|Overall Study|Protocol Violation|3
7701311|NCT01140906|26783510|P1|Overall Study|Protocol Violation|5
7701312|NCT01140906|26783507|P4|Overall Study|Non-compliance|1
7701313|NCT01140906|26783508|P3|Overall Study|Non-compliance|0
7701314|NCT01140906|26783509|P2|Overall Study|Non-compliance|1
7701315|NCT01140906|26783510|P1|Overall Study|Non-compliance|0
7701316|NCT01140906|26783507|P4|Overall Study|Lack of Efficacy|1
7701317|NCT01140906|26783508|P3|Overall Study|Lack of Efficacy|2
7701318|NCT01140906|26783509|P2|Overall Study|Lack of Efficacy|8
7701319|NCT01140906|26783510|P1|Overall Study|Lack of Efficacy|6
7701320|NCT01140906|26783507|P4|Overall Study|Adverse Event|7
7701321|NCT01140906|26783508|P3|Overall Study|Adverse Event|17
7701322|NCT01140906|26783509|P2|Overall Study|Adverse Event|10
7701323|NCT01140906|26783510|P1|Overall Study|Adverse Event|7
7701324|NCT01140880|26783550|P2|Overall Study|Protocol Violation|30
7701325|NCT01140880|26783551|P1|Overall Study|Protocol Violation|0
7701326|NCT01140880|26783550|P2|Overall Study|Lost to Follow-up|10
7701327|NCT01140880|26783551|P1|Overall Study|Lost to Follow-up|8
7701328|NCT01140880|26783550|P2|Overall Study|Withdrawal by Subject|3
7701329|NCT01140880|26783551|P1|Overall Study|Withdrawal by Subject|6
7701330|NCT01140880|26783550|P2|Overall Study|Death|1
7701331|NCT01140880|26783551|P1|Overall Study|Death|0
7701332|NCT01140867|26783563|P1|Overall Study|Medication Noncompliance|2
7701333|NCT01140867|26783563|P1|Overall Study|Uncooperative patient|2
7701334|NCT01140867|26783563|P1|Overall Study|Protocol Violation|1
7701335|NCT01140867|26783563|P1|Overall Study|Withdrawal by Subject|1
7701336|NCT01140867|26783563|P1|Overall Study|Lost to Follow-up|2
7701337|NCT01140867|26783563|P1|Overall Study|Lack of Efficacy|3
7701338|NCT01140867|26783563|P1|Overall Study|Adverse Event|22
7701339|NCT01140646|26783603|P1|Overall Study|Refused Further Treatment|5
7701340|NCT01140646|26783603|P1|Overall Study|Adverse Event|4
7701341|NCT01140568|26783611|P1|Overall Study|Screen Fail|4
7701342|NCT01140568|26783611|P1|Overall Study|Withdrawal by Subject|1
7701343|NCT01140568|26783611|P1|Overall Study|disease progression|31
7701344|NCT01140503|26783616|P1|Overall Study|Withdrawal by Subject|1
7701345|NCT01140477|26783624|P2|Overall Study|Subject explanted|1
7701346|NCT01140477|26783625|P1|Overall Study|Subject explanted|0
7701347|NCT01140477|26783624|P2|Overall Study|Death|1
7701348|NCT01140477|26783625|P1|Overall Study|Death|1
7701349|NCT01140477|26783624|P2|Overall Study|Surgical complication preventing implant|0
7701350|NCT01140477|26783625|P1|Overall Study|Surgical complication preventing implant|2
7701351|NCT01140477|26783624|P2|Overall Study|Withdrawal by Subject|4
7701352|NCT01140477|26783625|P1|Overall Study|Withdrawal by Subject|1
7701353|NCT01140477|26783624|P2|Overall Study|Lost to Follow-up|0
7701354|NCT01140477|26783625|P1|Overall Study|Lost to Follow-up|4
7701355|NCT01140451|26783636|P2|Overall Study|Participants Planning Pregnancy|0
7701356|NCT01140451|26783637|P1|Overall Study|Participants Planning Pregnancy|3
7701357|NCT01140451|26783636|P2|Overall Study|Lost to Follow-up|0
7701358|NCT01140451|26783637|P1|Overall Study|Lost to Follow-up|2
7701359|NCT01140451|26783636|P2|Overall Study|Physician Decision|3
7701360|NCT01140451|26783637|P1|Overall Study|Physician Decision|5
7701361|NCT01140451|26783636|P2|Overall Study|Adverse Event|6
7701362|NCT01140451|26783637|P1|Overall Study|Adverse Event|2
7701363|NCT01140451|26783636|P2|Overall Study|Withdrawal by Subject|33
7701364|NCT01140451|26783637|P1|Overall Study|Withdrawal by Subject|26
7701365|NCT01140347|26783702|P2|Overall Study|Withdrawal by Subject|8
7701366|NCT01140347|26783703|P1|Overall Study|Withdrawal by Subject|13
7701367|NCT01140347|26783702|P2|Overall Study|Lost to Follow-up|6
7701368|NCT01140347|26783703|P1|Overall Study|Lost to Follow-up|5
7701369|NCT01140061|26783756|P10|Extension|Laboratory Adverse Event|1
7701370|NCT01140061|26783757|P9|Extension|Laboratory Adverse Event|0
7701371|NCT01140061|26783758|P8|Extension|Laboratory Adverse Event|0
7701372|NCT01140061|26783759|P7|Extension|Laboratory Adverse Event|0
7701373|NCT01140061|26783760|P6|Extension|Laboratory Adverse Event|0
7701374|NCT01140061|26783761|P5|Extension|Laboratory Adverse Event|0
7701375|NCT01140061|26783762|P4|Extension|Laboratory Adverse Event|0
7701376|NCT01140061|26783763|P3|Extension|Laboratory Adverse Event|0
7701377|NCT01140061|26783764|P2|Extension|Laboratory Adverse Event|0
7701378|NCT01140061|26783765|P1|Extension|Laboratory Adverse Event|0
7701379|NCT01140061|26783756|P10|Part I|Adverse Event|0
7701380|NCT01140061|26783757|P9|Part I|Adverse Event|0
7701381|NCT01140061|26783758|P8|Part I|Adverse Event|0
7701382|NCT01140061|26783759|P7|Part I|Adverse Event|0
7701383|NCT01140061|26783760|P6|Part I|Adverse Event|0
7701384|NCT01140061|26783761|P5|Part I|Adverse Event|0
7701385|NCT01140061|26783762|P4|Part I|Adverse Event|0
7701386|NCT01140061|26783763|P3|Part I|Adverse Event|0
7701387|NCT01140061|26783764|P2|Part I|Adverse Event|0
7701388|NCT01140061|26783765|P1|Part I|Adverse Event|1
7701389|NCT01140048|26783792|P1|Overall Study|Lost to Follow-up|31
7701390|NCT01140048|26783792|P1|Overall Study|Withdrawal by Subject|13
7701391|NCT01140048|26783792|P1|Overall Study|Physician Decision|1
7701392|NCT01139775|26783832|P3|Overall Study|Physician Decision|2
7701393|NCT01139775|26783833|P2|Overall Study|Physician Decision|2
7701394|NCT01139775|26783834|P1|Overall Study|Physician Decision|0
7701395|NCT01139775|26783832|P3|Overall Study|Withdrawal by Subject|2
7701396|NCT01139775|26783833|P2|Overall Study|Withdrawal by Subject|0
7701397|NCT01139775|26783834|P1|Overall Study|Withdrawal by Subject|1
7701398|NCT01139775|26783832|P3|Overall Study|Protocol Violation|0
7701399|NCT01139775|26783833|P2|Overall Study|Protocol Violation|5
7701400|NCT01139775|26783834|P1|Overall Study|Protocol Violation|0
7701401|NCT01139775|26783832|P3|Overall Study|Adverse Event|2
7701402|NCT01139775|26783833|P2|Overall Study|Adverse Event|6
7701403|NCT01139775|26783834|P1|Overall Study|Adverse Event|0
7701404|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
7701405|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
7701406|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
7701407|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
7701408|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
7701409|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
7701410|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
7701411|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
7701412|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
7701413|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
7701414|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
7701415|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
7701416|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
7701417|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
7701418|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
7701419|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
7701420|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
7701421|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
7701422|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
7701423|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
7701424|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
7701425|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Death|1
7701426|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Death|1
7701427|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Death|0
7701428|NCT01139762|26783866|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
7701429|NCT01139762|26783867|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
7701430|NCT01139762|26783868|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
7701431|NCT01139762|26783866|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
7701432|NCT01139762|26783867|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
7701433|NCT01139762|26783868|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
7701434|NCT01139762|26783866|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
7701435|NCT01139762|26783867|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
7701436|NCT01139762|26783868|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
7701437|NCT01139762|26783866|P3|Washout and Placebo Lead-In Period|Physician Decision|0
7701438|NCT01139762|26783867|P2|Washout and Placebo Lead-In Period|Physician Decision|0
7701439|NCT01139762|26783868|P1|Washout and Placebo Lead-In Period|Physician Decision|12
7701440|NCT01139762|26783866|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
7701441|NCT01139762|26783867|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
7701442|NCT01139762|26783868|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
7701443|NCT01139762|26783866|P3|Washout and Placebo Lead-In Period|Adverse Event|0
7701444|NCT01139762|26783867|P2|Washout and Placebo Lead-In Period|Adverse Event|0
7701445|NCT01139762|26783868|P1|Washout and Placebo Lead-In Period|Adverse Event|1
7701446|NCT01139762|26783866|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
7701447|NCT01139762|26783867|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
7701448|NCT01139762|26783868|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
7701449|NCT01139658|26783903|P2|Overall Study|Other|75
7701450|NCT01139658|26783904|P1|Overall Study|Other|28
7701451|NCT01139658|26783903|P2|Overall Study|No documentation of treatment|0
7701452|NCT01139658|26783904|P1|Overall Study|No documentation of treatment|1
7701453|NCT01139658|26783903|P2|Overall Study|Withdrawal by Subject|4
7701454|NCT01139658|26783904|P1|Overall Study|Withdrawal by Subject|2
7701455|NCT01139658|26783903|P2|Overall Study|Lack of Efficacy|7
7701456|NCT01139658|26783904|P1|Overall Study|Lack of Efficacy|15
7701457|NCT01139658|26783903|P2|Overall Study|Adverse Event|27
7701458|NCT01139658|26783904|P1|Overall Study|Adverse Event|10
7701459|NCT01139580|26783942|P2|Overall Study|Participant Randomization in Error|1
7701460|NCT01139580|26783943|P1|Overall Study|Participant Randomization in Error|0
7701461|NCT01139580|26783942|P2|Overall Study|Beginning Study Exclusion Treatment|1
7701462|NCT01139580|26783943|P1|Overall Study|Beginning Study Exclusion Treatment|0
7701463|NCT01139580|26783942|P2|Overall Study|Misrandomized|0
7701464|NCT01139580|26783943|P1|Overall Study|Misrandomized|1
7701465|NCT01139580|26783942|P2|Overall Study|Did Not Meet Exclusion Criteria|0
7701466|NCT01139580|26783943|P1|Overall Study|Did Not Meet Exclusion Criteria|1
7701467|NCT01139580|26783942|P2|Overall Study|Used Excluded Medicine After Enrollment|0
7701468|NCT01139580|26783943|P1|Overall Study|Used Excluded Medicine After Enrollment|1
7701469|NCT01139580|26783942|P2|Overall Study|Withdrawal by Subject|9
7701470|NCT01139580|26783943|P1|Overall Study|Withdrawal by Subject|6
7701471|NCT01139580|26783942|P2|Overall Study|Lack of Efficacy|2
7701472|NCT01139580|26783943|P1|Overall Study|Lack of Efficacy|0
7701473|NCT01139580|26783942|P2|Overall Study|Lost to Follow-up|1
7701474|NCT01139580|26783943|P1|Overall Study|Lost to Follow-up|9
7701475|NCT01139580|26783942|P2|Overall Study|Adverse Event|4
7701476|NCT01139580|26783943|P1|Overall Study|Adverse Event|5
7701477|NCT01139450|26783991|P3|Overall Study|Adverse Event|3
7701478|NCT01139450|26783992|P2|Overall Study|Adverse Event|2
7701479|NCT01139450|26783993|P1|Overall Study|Adverse Event|2
7701480|NCT01139450|26783991|P3|Overall Study|Administrative|1
7701481|NCT01139450|26783992|P2|Overall Study|Administrative|0
7701482|NCT01139450|26783993|P1|Overall Study|Administrative|0
7701483|NCT01139450|26783991|P3|Overall Study|Lost to Follow-up|11
7701484|NCT01139450|26783992|P2|Overall Study|Lost to Follow-up|7
7701485|NCT01139450|26783993|P1|Overall Study|Lost to Follow-up|9
7701486|NCT01139450|26783991|P3|Overall Study|Protocol Violation|2
7701487|NCT01139450|26783992|P2|Overall Study|Protocol Violation|5
7701488|NCT01139450|26783993|P1|Overall Study|Protocol Violation|6
7701489|NCT01139450|26783991|P3|Overall Study|Lack of Efficacy|8
7701490|NCT01139450|26783992|P2|Overall Study|Lack of Efficacy|1
7701491|NCT01139450|26783993|P1|Overall Study|Lack of Efficacy|3
7701492|NCT01139450|26783991|P3|Overall Study|Withdrawal by Subject|13
7701493|NCT01139450|26783992|P2|Overall Study|Withdrawal by Subject|10
7701494|NCT01139450|26783993|P1|Overall Study|Withdrawal by Subject|7
7701495|NCT01139164|26784045|P3|Overall Study|Withdrawn prior to study start|0
7701496|NCT01139164|26784046|P2|Overall Study|Withdrawn prior to study start|2
7701497|NCT01139164|26784047|P1|Overall Study|Withdrawn prior to study start|0
7701498|NCT01139125|26784061|P1|Overall Study|Withdrawal by Subject|1
7701499|NCT01139047|26784065|P1|Overall Study|Withdrawal by Subject|1
7701500|NCT01139021|26784080|P6|Overall Study|Withdrawal by Subject|0
7701501|NCT01139021|26784081|P5|Overall Study|Withdrawal by Subject|4
7701502|NCT01139021|26784082|P4|Overall Study|Withdrawal by Subject|1
7701503|NCT01139021|26784083|P3|Overall Study|Withdrawal by Subject|0
7701504|NCT01139021|26784084|P2|Overall Study|Withdrawal by Subject|0
7701505|NCT01139021|26784085|P1|Overall Study|Withdrawal by Subject|0
7701506|NCT01139021|26784080|P6|Overall Study|Protocol Violation|0
7701507|NCT01139021|26784081|P5|Overall Study|Protocol Violation|2
7701508|NCT01139021|26784082|P4|Overall Study|Protocol Violation|0
7701509|NCT01139021|26784083|P3|Overall Study|Protocol Violation|0
7701510|NCT01139021|26784084|P2|Overall Study|Protocol Violation|0
7701511|NCT01139021|26784085|P1|Overall Study|Protocol Violation|1
7701512|NCT01139021|26784080|P6|Overall Study|Lost to Follow-up|0
7701513|NCT01139021|26784081|P5|Overall Study|Lost to Follow-up|2
7701514|NCT01139021|26784082|P4|Overall Study|Lost to Follow-up|0
7701515|NCT01139021|26784083|P3|Overall Study|Lost to Follow-up|0
7701516|NCT01139021|26784084|P2|Overall Study|Lost to Follow-up|0
7701517|NCT01139021|26784085|P1|Overall Study|Lost to Follow-up|0
7701518|NCT01139021|26784080|P6|Overall Study|Adverse Event|0
7701519|NCT01139021|26784081|P5|Overall Study|Adverse Event|1
7701520|NCT01139021|26784082|P4|Overall Study|Adverse Event|0
7701521|NCT01139021|26784083|P3|Overall Study|Adverse Event|0
7701522|NCT01139021|26784084|P2|Overall Study|Adverse Event|0
7701523|NCT01139021|26784085|P1|Overall Study|Adverse Event|0
7701524|NCT01139008|26784121|P1|Overall Study|Non-compliant, lost product|1
7701525|NCT01139008|26784121|P1|Overall Study|Withdrawal by Subject|5
7701526|NCT01138826|26784168|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
7701527|NCT01138826|26784169|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
7701528|NCT01138826|26784170|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
7701529|NCT01138826|26784171|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
7701530|NCT01138826|26784172|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
7701531|NCT01138826|26784173|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
7701532|NCT01138657|26784210|P2|Overall Study|Miscellaneous Reasons|4
7701533|NCT01138657|26784211|P1|Overall Study|Miscellaneous Reasons|3
7701534|NCT01138657|26784210|P2|Overall Study|Lost to Follow-up|3
7701535|NCT01138657|26784211|P1|Overall Study|Lost to Follow-up|0
7701536|NCT01138657|26784210|P2|Overall Study|Lack of Efficacy|1
7701537|NCT01138657|26784211|P1|Overall Study|Lack of Efficacy|2
7701538|NCT01138657|26784210|P2|Overall Study|Adverse Event|10
7701539|NCT01138657|26784211|P1|Overall Study|Adverse Event|3
7701540|NCT01138501|26784274|P1|Overall Study|Withdrawal by Subject|3
7701541|NCT01138501|26784274|P1|Overall Study|Protocol Violation|2
7701542|NCT01138150|26784318|P2|Overall Study|Physician Decision|0
7701543|NCT01138150|26784319|P1|Overall Study|Physician Decision|1
7701544|NCT01138150|26784318|P2|Overall Study|blood unable to be processed|1
7701545|NCT01138150|26784319|P1|Overall Study|blood unable to be processed|0
7701546|NCT01138111|26784400|P1|Overall Study|Lost to Follow-up|2
7701547|NCT01138111|26784400|P1|Overall Study|Death|1
7701548|NCT01138111|26784400|P1|Overall Study|Adverse Event|1
7701549|NCT01138111|26784400|P1|Overall Study|Withdrawal by Subject|5
7701550|NCT01138046|26784454|P1|Overall Study|Withdrawal due to death|6
7701551|NCT01138007|26784474|P3|Overall Study|Withdrawal by Subject|15
7701552|NCT01138007|26784475|P2|Overall Study|Withdrawal by Subject|6
7701553|NCT01138007|26784476|P1|Overall Study|Withdrawal by Subject|5
7701554|NCT01138007|26784474|P3|Overall Study|Physician Decision|3
7701555|NCT01138007|26784475|P2|Overall Study|Physician Decision|5
7701556|NCT01138007|26784476|P1|Overall Study|Physician Decision|0
7701557|NCT01138007|26784474|P3|Overall Study|Lost to Follow-up|5
7701558|NCT01138007|26784475|P2|Overall Study|Lost to Follow-up|3
7701559|NCT01138007|26784476|P1|Overall Study|Lost to Follow-up|3
7701560|NCT01138007|26784474|P3|Overall Study|Protocol-Defined Stopping Criteria|8
7701561|NCT01138007|26784475|P2|Overall Study|Protocol-Defined Stopping Criteria|1
7701562|NCT01138007|26784476|P1|Overall Study|Protocol-Defined Stopping Criteria|6
7701563|NCT01138007|26784474|P3|Overall Study|Protocol Violation|2
7701564|NCT01138007|26784475|P2|Overall Study|Protocol Violation|3
7701565|NCT01138007|26784476|P1|Overall Study|Protocol Violation|2
7701566|NCT01138007|26784474|P3|Overall Study|Lack of Efficacy|6
7701567|NCT01138007|26784475|P2|Overall Study|Lack of Efficacy|0
7701568|NCT01138007|26784476|P1|Overall Study|Lack of Efficacy|2
7701569|NCT01138007|26784474|P3|Overall Study|Adverse Event|9
7701570|NCT01138007|26784475|P2|Overall Study|Adverse Event|12
7701571|NCT01138007|26784476|P1|Overall Study|Adverse Event|4
7701572|NCT01137812|26784583|P2|Overall Study|Other|27
7701573|NCT01137812|26784584|P1|Overall Study|Other|19
7701574|NCT01137812|26784583|P2|Overall Study|Patient met glycemic withdrawal criteria|85
7701575|NCT01137812|26784584|P1|Overall Study|Patient met glycemic withdrawal criteria|40
7701576|NCT01137812|26784583|P2|Overall Study|Death|0
7701577|NCT01137812|26784584|P1|Overall Study|Death|2
7701578|NCT01137812|26784583|P2|Overall Study|Withdrawal by Subject|13
7701579|NCT01137812|26784584|P1|Overall Study|Withdrawal by Subject|5
7701580|NCT01137812|26784583|P2|Overall Study|Protocol Violation|4
7701581|NCT01137812|26784584|P1|Overall Study|Protocol Violation|5
7701582|NCT01137812|26784583|P2|Overall Study|Physician Decision|17
7701583|NCT01137812|26784584|P1|Overall Study|Physician Decision|25
7701584|NCT01137812|26784583|P2|Overall Study|Lost to Follow-up|8
7701585|NCT01137812|26784584|P1|Overall Study|Lost to Follow-up|6
7701586|NCT01137812|26784583|P2|Overall Study|Adverse Event|14
7701587|NCT01137812|26784584|P1|Overall Study|Adverse Event|21
7701588|NCT01137786|26784604|P2|Overall Study|Withdrawal by Subject|1
7701589|NCT01137786|26784605|P1|Overall Study|Withdrawal by Subject|1
7701590|NCT01137786|26784604|P2|Overall Study|Lost to Follow-up|2
7701591|NCT01137786|26784605|P1|Overall Study|Lost to Follow-up|0
7701592|NCT01137773|26784615|P2|Overall Study|Lost to Follow-up|0
7701593|NCT01137773|26784616|P1|Overall Study|Lost to Follow-up|6
7701594|NCT01137773|26784615|P2|Overall Study|Death|3
7701595|NCT01137773|26784616|P1|Overall Study|Death|3
7701596|NCT01137682|26784627|P3|Overall Study|Did not receive treatment in extension|1
7701597|NCT01137682|26784628|P2|Overall Study|Did not receive treatment in extension|0
7701598|NCT01137682|26784629|P1|Overall Study|Did not receive treatment in extension|0
7701599|NCT01137682|26784627|P3|Overall Study|Did not enter extension|2
7701600|NCT01137682|26784628|P2|Overall Study|Did not enter extension|3
7701601|NCT01137682|26784629|P1|Overall Study|Did not enter extension|2
7701602|NCT01137682|26784627|P3|Overall Study|Protocol Violation-Extension|0
7701603|NCT01137682|26784628|P2|Overall Study|Protocol Violation-Extension|1
7701604|NCT01137682|26784629|P1|Overall Study|Protocol Violation-Extension|2
7701605|NCT01137682|26784627|P3|Overall Study|Death-Extension|0
7701606|NCT01137682|26784628|P2|Overall Study|Death-Extension|0
7701607|NCT01137682|26784629|P1|Overall Study|Death-Extension|2
7701608|NCT01137682|26784627|P3|Overall Study|Administrative problems-Extension|0
7701609|NCT01137682|26784628|P2|Overall Study|Administrative problems-Extension|2
7701610|NCT01137682|26784629|P1|Overall Study|Administrative problems-Extension|0
7701611|NCT01137682|26784627|P3|Overall Study|Lost to Follow Up-Extension|0
7701612|NCT01137682|26784628|P2|Overall Study|Lost to Follow Up-Extension|1
7701613|NCT01137682|26784629|P1|Overall Study|Lost to Follow Up-Extension|0
7701614|NCT01137682|26784627|P3|Overall Study|Withdrawal by Subject-Extension|8
7701615|NCT01137682|26784628|P2|Overall Study|Withdrawal by Subject-Extension|8
7701616|NCT01137682|26784629|P1|Overall Study|Withdrawal by Subject-Extension|6
7701617|NCT01137682|26784627|P3|Overall Study|Lack of Efficacy-Extension|13
7701618|NCT01137682|26784628|P2|Overall Study|Lack of Efficacy-Extension|9
7701619|NCT01137682|26784629|P1|Overall Study|Lack of Efficacy-Extension|15
7701620|NCT01137682|26784627|P3|Overall Study|Adverse Event-Extension|7
7701621|NCT01137682|26784628|P2|Overall Study|Adverse Event-Extension|8
7701622|NCT01137682|26784629|P1|Overall Study|Adverse Event-Extension|4
7701623|NCT01137682|26784627|P3|Overall Study|Protocol Violation-CORE|1
7701624|NCT01137682|26784628|P2|Overall Study|Protocol Violation-CORE|1
7701625|NCT01137682|26784629|P1|Overall Study|Protocol Violation-CORE|0
7701626|NCT01137682|26784627|P3|Overall Study|Administrative problems-CORE|0
7701627|NCT01137682|26784628|P2|Overall Study|Administrative problems-CORE|1
7701628|NCT01137682|26784629|P1|Overall Study|Administrative problems-CORE|2
7701629|NCT01137682|26784627|P3|Overall Study|Withdrawal by Subject-CORE|2
7701630|NCT01137682|26784628|P2|Overall Study|Withdrawal by Subject-CORE|2
7701631|NCT01137682|26784629|P1|Overall Study|Withdrawal by Subject-CORE|2
7701632|NCT01137682|26784627|P3|Overall Study|Adverse Event-CORE|0
7701633|NCT01137682|26784628|P2|Overall Study|Adverse Event-CORE|4
7701634|NCT01137682|26784629|P1|Overall Study|Adverse Event-CORE|2
7701635|NCT01137604|26784679|P4|Overall Study|Clinical Decline|1
7701636|NCT01137604|26784680|P3|Overall Study|Clinical Decline|1
7701637|NCT01137604|26784681|P2|Overall Study|Clinical Decline|0
7701638|NCT01137604|26784682|P1|Overall Study|Clinical Decline|0
7701639|NCT01137604|26784679|P4|Overall Study|Participant's Decision|0
7701640|NCT01137604|26784680|P3|Overall Study|Participant's Decision|0
7701641|NCT01137604|26784681|P2|Overall Study|Participant's Decision|0
7701642|NCT01137604|26784682|P1|Overall Study|Participant's Decision|1
7701643|NCT01137604|26784679|P4|Overall Study|Clinical Progression|0
7701644|NCT01137604|26784680|P3|Overall Study|Clinical Progression|1
7701645|NCT01137604|26784681|P2|Overall Study|Clinical Progression|2
7701646|NCT01137604|26784682|P1|Overall Study|Clinical Progression|0
7701647|NCT01137604|26784679|P4|Overall Study|Withdrawal by Subject|1
7701648|NCT01137604|26784680|P3|Overall Study|Withdrawal by Subject|2
7701649|NCT01137604|26784681|P2|Overall Study|Withdrawal by Subject|2
7701650|NCT01137604|26784682|P1|Overall Study|Withdrawal by Subject|0
7701651|NCT01137604|26784679|P4|Overall Study|Adverse Event|9
7701652|NCT01137604|26784680|P3|Overall Study|Adverse Event|9
7701653|NCT01137604|26784681|P2|Overall Study|Adverse Event|6
7701654|NCT01137604|26784682|P1|Overall Study|Adverse Event|1
7701655|NCT01137578|26784716|P3|Overall Study|Other|6
7701656|NCT01137578|26784717|P2|Overall Study|Other|2
7701657|NCT01137578|26784718|P1|Overall Study|Other|12
7701658|NCT01137578|26784716|P3|Overall Study|Withdrawal by Subject|0
7701659|NCT01137578|26784717|P2|Overall Study|Withdrawal by Subject|0
7701660|NCT01137578|26784718|P1|Overall Study|Withdrawal by Subject|1
7701661|NCT01137578|26784716|P3|Overall Study|Participant requested to Discontinue|0
7701662|NCT01137578|26784717|P2|Overall Study|Participant requested to Discontinue|0
7701663|NCT01137578|26784718|P1|Overall Study|Participant requested to Discontinue|3
7701664|NCT01137474|26784767|P4|Overall Study|Administrative reason by sponsor|0
7701665|NCT01137474|26784768|P3|Overall Study|Administrative reason by sponsor|0
7701666|NCT01137474|26784769|P2|Overall Study|Administrative reason by sponsor|1
7701667|NCT01137474|26784770|P1|Overall Study|Administrative reason by sponsor|0
7701668|NCT01137474|26784767|P4|Overall Study|Pregnancy|0
7701669|NCT01137474|26784768|P3|Overall Study|Pregnancy|0
7701670|NCT01137474|26784769|P2|Overall Study|Pregnancy|1
7701671|NCT01137474|26784770|P1|Overall Study|Pregnancy|0
7701672|NCT01137474|26784767|P4|Overall Study|Other|0
7701673|NCT01137474|26784768|P3|Overall Study|Other|0
7701674|NCT01137474|26784769|P2|Overall Study|Other|1
7701675|NCT01137474|26784770|P1|Overall Study|Other|3
7701676|NCT01137474|26784767|P4|Overall Study|Lack of Efficacy|2
7701677|NCT01137474|26784768|P3|Overall Study|Lack of Efficacy|0
7701678|NCT01137474|26784769|P2|Overall Study|Lack of Efficacy|0
7701679|NCT01137474|26784770|P1|Overall Study|Lack of Efficacy|0
7701680|NCT01137474|26784767|P4|Overall Study|Lost to Follow-up|2
7701681|NCT01137474|26784768|P3|Overall Study|Lost to Follow-up|0
7701682|NCT01137474|26784769|P2|Overall Study|Lost to Follow-up|1
7701683|NCT01137474|26784770|P1|Overall Study|Lost to Follow-up|5
7701684|NCT01137474|26784767|P4|Overall Study|No longer met study criteria|5
7701685|NCT01137474|26784768|P3|Overall Study|No longer met study criteria|0
7701686|NCT01137474|26784769|P2|Overall Study|No longer met study criteria|1
7701687|NCT01137474|26784770|P1|Overall Study|No longer met study criteria|6
7701688|NCT01137474|26784767|P4|Overall Study|Withdrawal by Subject|9
7701689|NCT01137474|26784768|P3|Overall Study|Withdrawal by Subject|6
7701690|NCT01137474|26784769|P2|Overall Study|Withdrawal by Subject|2
7701691|NCT01137474|26784770|P1|Overall Study|Withdrawal by Subject|7
7701692|NCT01137474|26784767|P4|Overall Study|Adverse Event|3
7701693|NCT01137474|26784768|P3|Overall Study|Adverse Event|1
7701694|NCT01137474|26784769|P2|Overall Study|Adverse Event|5
7701695|NCT01137474|26784770|P1|Overall Study|Adverse Event|3
7701696|NCT01137435|26784788|P1|Overall Study|Off label usage|4
7701697|NCT01137435|26784788|P1|Overall Study|Lost to Follow-up|24
7701698|NCT01137292|26784815|P1|Overall Study|Other|7
7701699|NCT01137292|26784815|P1|Overall Study|Lost to Follow-up|1
7701700|NCT01137292|26784815|P1|Overall Study|Lack of Efficacy|13
7701701|NCT01137292|26784815|P1|Overall Study|Adverse Event|3
7701702|NCT01137292|26784815|P1|Overall Study|Death|30
7701703|NCT01137110|26784824|P2|Overall Study|Protocol Violation|0
7701704|NCT01137110|26784825|P1|Overall Study|Protocol Violation|1
7701705|NCT01137071|26784831|P1|Overall Study|Wrongly Included|1
7701706|NCT01137071|26784831|P1|Overall Study|Withdrawal by Subject|2
7701707|NCT01137071|26784831|P1|Overall Study|Disease Progression|11
7701708|NCT01136967|26784987|P2|Overall Study|Diagnosis of Second Primary Cancer|1
7701709|NCT01136967|26784988|P1|Overall Study|Diagnosis of Second Primary Cancer|0
7701710|NCT01136967|26784987|P2|Overall Study|Increase in Lesion Size|2
7701711|NCT01136967|26784988|P1|Overall Study|Increase in Lesion Size|0
7701712|NCT01136967|26784987|P2|Overall Study|Investigator's Choice|1
7701713|NCT01136967|26784988|P1|Overall Study|Investigator's Choice|1
7701714|NCT01136967|26784987|P2|Overall Study|Non-compliance|0
7701715|NCT01136967|26784988|P1|Overall Study|Non-compliance|1
7701716|NCT01136967|26784987|P2|Overall Study|Radiation|0
7701717|NCT01136967|26784988|P1|Overall Study|Radiation|1
7701718|NCT01136967|26784987|P2|Overall Study|Clinical Progression|5
7701719|NCT01136967|26784988|P1|Overall Study|Clinical Progression|3
7701720|NCT01136967|26784987|P2|Overall Study|Withdrawal by Subject|2
7701721|NCT01136967|26784988|P1|Overall Study|Withdrawal by Subject|1
7701722|NCT01136967|26784987|P2|Overall Study|Lost to Follow-up|1
7701723|NCT01136967|26784988|P1|Overall Study|Lost to Follow-up|0
7701724|NCT01136967|26784987|P2|Overall Study|Participant Choice|3
7701725|NCT01136967|26784988|P1|Overall Study|Participant Choice|8
7701726|NCT01136967|26784987|P2|Overall Study|Adverse Event|12
7701727|NCT01136967|26784988|P1|Overall Study|Adverse Event|9
7701728|NCT01136954|26785010|P2|Overall Study|Other|3
7701729|NCT01136954|26785011|P1|Overall Study|Other|1
7701730|NCT01136954|26785010|P2|Overall Study|Physician Decision|1
7701731|NCT01136954|26785011|P1|Overall Study|Physician Decision|0
7701732|NCT01136954|26785010|P2|Overall Study|Lack of Efficacy|13
7701733|NCT01136954|26785011|P1|Overall Study|Lack of Efficacy|14
7701734|NCT01136954|26785010|P2|Overall Study|Withdrawal by Subject|2
7701735|NCT01136954|26785011|P1|Overall Study|Withdrawal by Subject|6
7701736|NCT01136954|26785010|P2|Overall Study|Adverse Event|2
7701737|NCT01136954|26785011|P1|Overall Study|Adverse Event|3
7701738|NCT01136915|26785025|P2|Overall Study|Exclusion criterion met|1
7701739|NCT01136915|26785026|P1|Overall Study|Exclusion criterion met|0
7701740|NCT01136915|26785025|P2|Overall Study|Lost to Follow-up|0
7701741|NCT01136915|26785026|P1|Overall Study|Lost to Follow-up|2
7701742|NCT01136876|26785036|P2|Overall Study|Missing NGAL measurement|5
7701743|NCT01136876|26785037|P1|Overall Study|Missing NGAL measurement|2
7701744|NCT01136876|26785036|P2|Overall Study|Physician Decision|5
7701745|NCT01136876|26785037|P1|Overall Study|Physician Decision|3
7701746|NCT01136876|26785036|P2|Overall Study|Lost to Follow-up|1
7701747|NCT01136876|26785037|P1|Overall Study|Lost to Follow-up|0
7701748|NCT01136811|26785045|P1|Overall Study|Physician Decision|11
7701749|NCT01136785|26785073|P2|Overall Study|Protocol Violation|1
7701750|NCT01136785|26785074|P1|Overall Study|Protocol Violation|2
7701751|NCT01136772|26785089|P2|Overall Study|Did not follow up after first injection|2
7701752|NCT01136772|26785090|P1|Overall Study|Did not follow up after first injection|2
7701753|NCT01136772|26785089|P2|Overall Study|Did not receive injection|7
7701754|NCT01136772|26785090|P1|Overall Study|Did not receive injection|10
7701755|NCT01136772|26785089|P2|Overall Study|Withdrawal by Subject|36
7701756|NCT01136772|26785090|P1|Overall Study|Withdrawal by Subject|33
7701757|NCT01136772|26785089|P2|Overall Study|Administrative|12
7701758|NCT01136772|26785090|P1|Overall Study|Administrative|14
7701759|NCT01136772|26785089|P2|Overall Study|Lack of Efficacy|39
7701760|NCT01136772|26785090|P1|Overall Study|Lack of Efficacy|42
7701761|NCT01136772|26785089|P2|Overall Study|Adverse Event|14
7701762|NCT01136772|26785090|P1|Overall Study|Adverse Event|15
7701763|NCT01136746|26785100|P2|Overall Study|Death|0
7701764|NCT01136746|26785101|P1|Overall Study|Death|1
7701765|NCT01136746|26785100|P2|Overall Study|Protocol Violation|1
7701766|NCT01136746|26785101|P1|Overall Study|Protocol Violation|2
7701767|NCT01136746|26785100|P2|Overall Study|Lost to Follow-up|2
7701768|NCT01136746|26785101|P1|Overall Study|Lost to Follow-up|0
7701769|NCT01136733|26785168|P7|Phase 2|Other|6
7701770|NCT01136733|26785169|P6|Phase 2|Other|7
7701771|NCT01136733|26785170|P5|Phase 2|Other|6
7701772|NCT01136733|26785171|P4|Phase 2|Other|0
7701773|NCT01136733|26785172|P3|Phase 2|Other|0
7701774|NCT01136733|26785173|P2|Phase 2|Other|0
7701775|NCT01136733|26785174|P1|Phase 2|Other|0
7701776|NCT01136733|26785168|P7|Phase 2|Administrative-Withdrew Consent|0
7701777|NCT01136733|26785169|P6|Phase 2|Administrative-Withdrew Consent|0
7701778|NCT01136733|26785170|P5|Phase 2|Administrative-Withdrew Consent|1
7701779|NCT01136733|26785171|P4|Phase 2|Administrative-Withdrew Consent|0
7701780|NCT01136733|26785172|P3|Phase 2|Administrative-Withdrew Consent|0
7701781|NCT01136733|26785173|P2|Phase 2|Administrative-Withdrew Consent|0
7701782|NCT01136733|26785174|P1|Phase 2|Administrative-Withdrew Consent|0
7701783|NCT01136733|26785168|P7|Phase 2|Participant Choice|1
7701784|NCT01136733|26785169|P6|Phase 2|Participant Choice|0
7701785|NCT01136733|26785170|P5|Phase 2|Participant Choice|3
7701786|NCT01136733|26785171|P4|Phase 2|Participant Choice|0
7701787|NCT01136733|26785172|P3|Phase 2|Participant Choice|0
7701788|NCT01136733|26785173|P2|Phase 2|Participant Choice|0
7701789|NCT01136733|26785174|P1|Phase 2|Participant Choice|0
7701790|NCT01136733|26785168|P7|Phase 2|Adverse Event|5
7701791|NCT01136733|26785169|P6|Phase 2|Adverse Event|13
7701792|NCT01136733|26785170|P5|Phase 2|Adverse Event|11
7701793|NCT01136733|26785171|P4|Phase 2|Adverse Event|0
7701794|NCT01136733|26785172|P3|Phase 2|Adverse Event|0
7701795|NCT01136733|26785173|P2|Phase 2|Adverse Event|0
7701796|NCT01136733|26785174|P1|Phase 2|Adverse Event|0
7701797|NCT01136733|26785168|P7|Phase 2|Disease Progression|38
7701798|NCT01136733|26785169|P6|Phase 2|Disease Progression|32
7701799|NCT01136733|26785170|P5|Phase 2|Disease Progression|30
7701800|NCT01136733|26785171|P4|Phase 2|Disease Progression|0
7701801|NCT01136733|26785172|P3|Phase 2|Disease Progression|0
7701802|NCT01136733|26785173|P2|Phase 2|Disease Progression|0
7701803|NCT01136733|26785174|P1|Phase 2|Disease Progression|0
7701804|NCT01136733|26785168|P7|Phase 1b|Clinical Progression|0
7701805|NCT01136733|26785169|P6|Phase 1b|Clinical Progression|0
7701806|NCT01136733|26785170|P5|Phase 1b|Clinical Progression|0
7701807|NCT01136733|26785171|P4|Phase 1b|Clinical Progression|0
7701808|NCT01136733|26785172|P3|Phase 1b|Clinical Progression|0
7701809|NCT01136733|26785173|P2|Phase 1b|Clinical Progression|1
7701810|NCT01136733|26785174|P1|Phase 1b|Clinical Progression|1
7701811|NCT01136733|26785168|P7|Phase 1b|Administrative-Withdrew Consent|0
7701812|NCT01136733|26785169|P6|Phase 1b|Administrative-Withdrew Consent|0
7701813|NCT01136733|26785170|P5|Phase 1b|Administrative-Withdrew Consent|0
7701814|NCT01136733|26785171|P4|Phase 1b|Administrative-Withdrew Consent|0
7701815|NCT01136733|26785172|P3|Phase 1b|Administrative-Withdrew Consent|0
7701816|NCT01136733|26785173|P2|Phase 1b|Administrative-Withdrew Consent|1
7701817|NCT01136733|26785174|P1|Phase 1b|Administrative-Withdrew Consent|0
7701818|NCT01136733|26785168|P7|Phase 1b|Participant Choice|0
7701819|NCT01136733|26785169|P6|Phase 1b|Participant Choice|0
7701820|NCT01136733|26785170|P5|Phase 1b|Participant Choice|0
7701821|NCT01136733|26785171|P4|Phase 1b|Participant Choice|0
7701822|NCT01136733|26785172|P3|Phase 1b|Participant Choice|1
7701823|NCT01136733|26785173|P2|Phase 1b|Participant Choice|0
7701824|NCT01136733|26785174|P1|Phase 1b|Participant Choice|0
7701825|NCT01136733|26785168|P7|Phase 1b|Adverse Event|0
7701826|NCT01136733|26785169|P6|Phase 1b|Adverse Event|0
7701827|NCT01136733|26785170|P5|Phase 1b|Adverse Event|0
7701828|NCT01136733|26785171|P4|Phase 1b|Adverse Event|0
7701829|NCT01136733|26785172|P3|Phase 1b|Adverse Event|1
7701830|NCT01136733|26785173|P2|Phase 1b|Adverse Event|3
7701831|NCT01136733|26785174|P1|Phase 1b|Adverse Event|0
7701832|NCT01136655|26785266|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
7701833|NCT01136655|26785266|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
7701834|NCT01136655|26785266|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
7701835|NCT01136655|26785266|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
7701836|NCT01136408|26785299|P3|Overall Study|Protocol Violation|1
7701837|NCT01136408|26785300|P2|Overall Study|Protocol Violation|1
7701838|NCT01136408|26785301|P1|Overall Study|Protocol Violation|1
7701839|NCT01136408|26785299|P3|Overall Study|Adverse Event|4
7701840|NCT01136408|26785300|P2|Overall Study|Adverse Event|8
7701841|NCT01136408|26785301|P1|Overall Study|Adverse Event|4
7701842|NCT01136382|26785358|P2|Overall Study|Withdrawal by Subject|1
7701843|NCT01136382|26785359|P1|Overall Study|Withdrawal by Subject|4
7701844|NCT01136382|26785358|P2|Overall Study|Severe Non-Compliance to Protocol|2
7701845|NCT01136382|26785359|P1|Overall Study|Severe Non-Compliance to Protocol|0
7701846|NCT01136382|26785358|P2|Overall Study|Study-Specific Withdrawal Criteria|25
7701847|NCT01136382|26785359|P1|Overall Study|Study-Specific Withdrawal Criteria|48
7701848|NCT01136382|26785358|P2|Overall Study|Other|3
7701849|NCT01136382|26785359|P1|Overall Study|Other|8
7701850|NCT01136356|26785385|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
7701851|NCT01136356|26785386|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
7701852|NCT01136356|26785385|P2|First 18-day Withdrawal|Physician Decision|0
7701853|NCT01136356|26785386|P1|First 18-day Withdrawal|Physician Decision|1
7701854|NCT01136356|26785385|P2|First 18-day Withdrawal|Withdrawal by Subject|0
7701855|NCT01136356|26785386|P1|First 18-day Withdrawal|Withdrawal by Subject|3
7701856|NCT01136291|26785397|P2|Overall Study|Lost to Follow-up|1
7701857|NCT01136291|26785398|P1|Overall Study|Lost to Follow-up|1
7701858|NCT01136174|26785417|P4|Overall Study|Adverse Event|4
7701859|NCT01136174|26785418|P3|Overall Study|Adverse Event|0
7701860|NCT01136174|26785419|P2|Overall Study|Adverse Event|0
7701861|NCT01136174|26785420|P1|Overall Study|Adverse Event|0
7701862|NCT01135992|26785500|P1|Overall Study|Unclassified|7
7701863|NCT01135992|26785500|P1|Overall Study|Withdrawal criteria|10
7701864|NCT01135992|26785500|P1|Overall Study|Protocol Violation|2
7701865|NCT01135992|26785500|P1|Overall Study|Lack of Efficacy|1
7701866|NCT01135992|26785500|P1|Overall Study|Adverse Event|1
7701867|NCT01135914|26785512|P3|Overall Study|Adverse Event|2
7701868|NCT01135914|26785513|P2|Overall Study|Adverse Event|1
7701869|NCT01135914|26785514|P1|Overall Study|Adverse Event|0
7701870|NCT01135914|26785512|P3|Overall Study|Lack of Efficacy|10
7701871|NCT01135914|26785513|P2|Overall Study|Lack of Efficacy|1
7701872|NCT01135914|26785514|P1|Overall Study|Lack of Efficacy|2
7701873|NCT01135914|26785512|P3|Overall Study|Protocol Violation|3
7701874|NCT01135914|26785513|P2|Overall Study|Protocol Violation|0
7701875|NCT01135914|26785514|P1|Overall Study|Protocol Violation|0
7701876|NCT01135914|26785512|P3|Overall Study|Lost to Follow-up|1
7701877|NCT01135914|26785513|P2|Overall Study|Lost to Follow-up|0
7701878|NCT01135914|26785514|P1|Overall Study|Lost to Follow-up|1
7701879|NCT01135914|26785512|P3|Overall Study|Withdrawal by Subject|6
7701880|NCT01135914|26785513|P2|Overall Study|Withdrawal by Subject|3
7701881|NCT01135914|26785514|P1|Overall Study|Withdrawal by Subject|1
7701882|NCT01135524|26785547|P1|Overall Study|Lack of Efficacy|8
7701883|NCT01135524|26785547|P1|Overall Study|Administrative|151
7701884|NCT01135524|26785547|P1|Overall Study|Lost to Follow-up|3
7701885|NCT01135524|26785547|P1|Overall Study|Adverse Event|20
7701886|NCT01135524|26785547|P1|Overall Study|Withdrawal by Subject|14
7701887|NCT01135511|26785560|P9|Overall Study|Withdrawal by Subject|1
7701888|NCT01135511|26785561|P8|Overall Study|Withdrawal by Subject|0
7701889|NCT01135511|26785562|P7|Overall Study|Withdrawal by Subject|1
7701890|NCT01135511|26785563|P6|Overall Study|Withdrawal by Subject|0
7701891|NCT01135511|26785564|P5|Overall Study|Withdrawal by Subject|0
7701892|NCT01135511|26785565|P4|Overall Study|Withdrawal by Subject|0
7701893|NCT01135511|26785566|P3|Overall Study|Withdrawal by Subject|0
7701894|NCT01135511|26785567|P2|Overall Study|Withdrawal by Subject|0
7701895|NCT01135511|26785568|P1|Overall Study|Withdrawal by Subject|0
7701896|NCT01135511|26785560|P9|Overall Study|noncompliance with study drug taken|0
7701897|NCT01135511|26785561|P8|Overall Study|noncompliance with study drug taken|0
7701898|NCT01135511|26785562|P7|Overall Study|noncompliance with study drug taken|0
7701899|NCT01135511|26785563|P6|Overall Study|noncompliance with study drug taken|0
7701900|NCT01135511|26785564|P5|Overall Study|noncompliance with study drug taken|1
7701901|NCT01135511|26785565|P4|Overall Study|noncompliance with study drug taken|0
7701902|NCT01135511|26785566|P3|Overall Study|noncompliance with study drug taken|0
7701903|NCT01135511|26785567|P2|Overall Study|noncompliance with study drug taken|0
7701904|NCT01135511|26785568|P1|Overall Study|noncompliance with study drug taken|0
7701905|NCT01135511|26785560|P9|Overall Study|could not visit the clinic|0
7701906|NCT01135511|26785561|P8|Overall Study|could not visit the clinic|0
7701907|NCT01135511|26785562|P7|Overall Study|could not visit the clinic|0
7701908|NCT01135511|26785563|P6|Overall Study|could not visit the clinic|0
7701909|NCT01135511|26785564|P5|Overall Study|could not visit the clinic|0
7701910|NCT01135511|26785565|P4|Overall Study|could not visit the clinic|0
7701911|NCT01135511|26785566|P3|Overall Study|could not visit the clinic|2
7701912|NCT01135511|26785567|P2|Overall Study|could not visit the clinic|1
7701913|NCT01135511|26785568|P1|Overall Study|could not visit the clinic|0
7701914|NCT01135511|26785560|P9|Overall Study|Pregnancy|0
7701915|NCT01135511|26785561|P8|Overall Study|Pregnancy|0
7701916|NCT01135511|26785562|P7|Overall Study|Pregnancy|0
7701917|NCT01135511|26785563|P6|Overall Study|Pregnancy|0
7701918|NCT01135511|26785564|P5|Overall Study|Pregnancy|0
7701919|NCT01135511|26785565|P4|Overall Study|Pregnancy|1
7701920|NCT01135511|26785566|P3|Overall Study|Pregnancy|0
7701921|NCT01135511|26785567|P2|Overall Study|Pregnancy|0
7701922|NCT01135511|26785568|P1|Overall Study|Pregnancy|0
7701923|NCT01135511|26785560|P9|Overall Study|Protocol Violation|0
7701924|NCT01135511|26785561|P8|Overall Study|Protocol Violation|0
7701925|NCT01135511|26785562|P7|Overall Study|Protocol Violation|0
7701926|NCT01135511|26785563|P6|Overall Study|Protocol Violation|0
7701927|NCT01135511|26785564|P5|Overall Study|Protocol Violation|0
7701928|NCT01135511|26785565|P4|Overall Study|Protocol Violation|0
7701929|NCT01135511|26785566|P3|Overall Study|Protocol Violation|3
7701930|NCT01135511|26785567|P2|Overall Study|Protocol Violation|0
7701931|NCT01135511|26785568|P1|Overall Study|Protocol Violation|0
7701932|NCT01135511|26785560|P9|Overall Study|Lack of Efficacy|0
7701933|NCT01135511|26785561|P8|Overall Study|Lack of Efficacy|0
7701934|NCT01135511|26785562|P7|Overall Study|Lack of Efficacy|0
7701935|NCT01135511|26785563|P6|Overall Study|Lack of Efficacy|0
7701936|NCT01135511|26785564|P5|Overall Study|Lack of Efficacy|0
7701937|NCT01135511|26785565|P4|Overall Study|Lack of Efficacy|2
7701938|NCT01135511|26785566|P3|Overall Study|Lack of Efficacy|1
7701939|NCT01135511|26785567|P2|Overall Study|Lack of Efficacy|1
7701940|NCT01135511|26785568|P1|Overall Study|Lack of Efficacy|0
7701941|NCT01135511|26785560|P9|Overall Study|Adverse Event|0
7701942|NCT01135511|26785561|P8|Overall Study|Adverse Event|1
7701943|NCT01135511|26785562|P7|Overall Study|Adverse Event|0
7701944|NCT01135511|26785563|P6|Overall Study|Adverse Event|1
7701945|NCT01135511|26785564|P5|Overall Study|Adverse Event|0
7701946|NCT01135511|26785565|P4|Overall Study|Adverse Event|0
7701947|NCT01135511|26785566|P3|Overall Study|Adverse Event|2
7701948|NCT01135511|26785567|P2|Overall Study|Adverse Event|1
7701949|NCT01135511|26785568|P1|Overall Study|Adverse Event|0
7701950|NCT01135498|26785850|P1|Overall Study|Ongoing at time of analysis|2
7701951|NCT01135498|26785850|P1|Overall Study|Death|1
7701952|NCT01135498|26785850|P1|Overall Study|Withdrawal by Subject|4
7701953|NCT01135498|26785850|P1|Overall Study|Investigator judgement|25
7701954|NCT01135498|26785850|P1|Overall Study|Progressive disease|38
7701955|NCT01135498|26785850|P1|Overall Study|Adverse Event|20
7701956|NCT01135394|26785868|P1|Study Treatment|Adverse Event|2
7701957|NCT01135394|26785868|P1|Study Treatment|Physician Decision|1
7701958|NCT01135394|26785868|P1|Study Treatment|Withdrawal by Subject|1
7701959|NCT01135394|26785868|P1|Baseline Assessment|Adverse Event|1
7701960|NCT01135394|26785868|P1|Baseline Assessment|Lost to Follow-up|2
7701961|NCT01135394|26785868|P1|Baseline Assessment|Physician Decision|3
7701962|NCT01135394|26785868|P1|Baseline Assessment|Withdrawal by Subject|9
7701963|NCT01135394|26785868|P1|Screening|Physician Decision|5
7701964|NCT01135394|26785868|P1|Screening|Screening failure|16
7701965|NCT01135394|26785868|P1|Screening|Withdrawal by Subject|10
7701966|NCT01135394|26785868|P1|Screening|Lost to Follow-up|2
7701967|NCT01135134|26786033|P2|Overall Study|Did not meet protocol eligibility|0
7701968|NCT01135134|26786034|P1|Overall Study|Did not meet protocol eligibility|1
7701969|NCT01135134|26786033|P2|Overall Study|Adverse Event|1
7701970|NCT01135134|26786034|P1|Overall Study|Adverse Event|1
7701971|NCT01135017|26786061|P2|Overall Study|Other than above|4
7701972|NCT01135017|26786062|P1|Overall Study|Other than above|3
7701973|NCT01135017|26786061|P2|Overall Study|Adverse Event|8
7701974|NCT01135017|26786062|P1|Overall Study|Adverse Event|3
7701975|NCT01134939|26786100|P8|Overall Study|Termination page not available|0
7701976|NCT01134939|26786101|P7|Overall Study|Termination page not available|7
7701977|NCT01134939|26786102|P6|Overall Study|Termination page not available|3
7701978|NCT01134939|26786103|P5|Overall Study|Termination page not available|0
7701979|NCT01134939|26786104|P4|Overall Study|Termination page not available|8
7701980|NCT01134939|26786105|P3|Overall Study|Termination page not available|5
7701981|NCT01134939|26786106|P2|Overall Study|Termination page not available|6
7701982|NCT01134939|26786107|P1|Overall Study|Termination page not available|4
7701983|NCT01134939|26786100|P8|Overall Study|Death|0
7701984|NCT01134939|26786101|P7|Overall Study|Death|0
7701985|NCT01134939|26786102|P6|Overall Study|Death|0
7701986|NCT01134939|26786103|P5|Overall Study|Death|0
7701987|NCT01134939|26786104|P4|Overall Study|Death|0
7701988|NCT01134939|26786105|P3|Overall Study|Death|0
7701989|NCT01134939|26786106|P2|Overall Study|Death|1
7701990|NCT01134939|26786107|P1|Overall Study|Death|0
7701991|NCT01134939|26786100|P8|Overall Study|Lost to Follow-up|0
7701992|NCT01134939|26786101|P7|Overall Study|Lost to Follow-up|0
7701993|NCT01134939|26786102|P6|Overall Study|Lost to Follow-up|1
7701994|NCT01134939|26786103|P5|Overall Study|Lost to Follow-up|2
7701995|NCT01134939|26786104|P4|Overall Study|Lost to Follow-up|1
7701996|NCT01134939|26786105|P3|Overall Study|Lost to Follow-up|0
7701997|NCT01134939|26786106|P2|Overall Study|Lost to Follow-up|3
7701998|NCT01134939|26786107|P1|Overall Study|Lost to Follow-up|2
7701999|NCT01134939|26786100|P8|Overall Study|Lack of Efficacy|0
7702000|NCT01134939|26786101|P7|Overall Study|Lack of Efficacy|1
7702001|NCT01134939|26786102|P6|Overall Study|Lack of Efficacy|0
7702002|NCT01134939|26786103|P5|Overall Study|Lack of Efficacy|3
7702003|NCT01134939|26786104|P4|Overall Study|Lack of Efficacy|0
7702004|NCT01134939|26786105|P3|Overall Study|Lack of Efficacy|1
7702005|NCT01134939|26786106|P2|Overall Study|Lack of Efficacy|5
7702006|NCT01134939|26786107|P1|Overall Study|Lack of Efficacy|2
7702007|NCT01134939|26786100|P8|Overall Study|Adverse Event|0
7702008|NCT01134939|26786101|P7|Overall Study|Adverse Event|1
7702009|NCT01134939|26786102|P6|Overall Study|Adverse Event|5
7702010|NCT01134939|26786103|P5|Overall Study|Adverse Event|5
7702011|NCT01134939|26786104|P4|Overall Study|Adverse Event|5
7702012|NCT01134939|26786105|P3|Overall Study|Adverse Event|4
7702013|NCT01134939|26786106|P2|Overall Study|Adverse Event|3
7702014|NCT01134939|26786107|P1|Overall Study|Adverse Event|9
7702015|NCT01134783|26786245|P2|Overall Study|Lost to Follow-up|20
7702016|NCT01134783|26786246|P1|Overall Study|Lost to Follow-up|5
7702017|NCT01134783|26786245|P2|Overall Study|Withdrawal by Subject|9
7702018|NCT01134783|26786246|P1|Overall Study|Withdrawal by Subject|15
7702019|NCT01134783|26786245|P2|Overall Study|Pregnancy|8
7702020|NCT01134783|26786246|P1|Overall Study|Pregnancy|16
7702021|NCT01134731|26786265|P3|Overall Study|Lost to Follow-up|3
7702022|NCT01134731|26786266|P2|Overall Study|Lost to Follow-up|4
7702023|NCT01134731|26786267|P1|Overall Study|Lost to Follow-up|5
7702024|NCT01134731|26786265|P3|Overall Study|Withdrawal by Subject|1
7702025|NCT01134731|26786266|P2|Overall Study|Withdrawal by Subject|3
7702026|NCT01134731|26786267|P1|Overall Study|Withdrawal by Subject|3
7702027|NCT01134731|26786265|P3|Overall Study|Lack of Efficacy|1
7702028|NCT01134731|26786266|P2|Overall Study|Lack of Efficacy|0
7702029|NCT01134731|26786267|P1|Overall Study|Lack of Efficacy|0
7702030|NCT01134731|26786265|P3|Overall Study|Physician Decision|2
7702031|NCT01134731|26786266|P2|Overall Study|Physician Decision|2
7702032|NCT01134731|26786267|P1|Overall Study|Physician Decision|2
7702033|NCT01134731|26786265|P3|Overall Study|Adverse Event|1
7702034|NCT01134731|26786266|P2|Overall Study|Adverse Event|2
7702035|NCT01134731|26786267|P1|Overall Study|Adverse Event|3
7702036|NCT01134705|26786280|P2|Overall Study|Other|6
7702037|NCT01134705|26786281|P1|Overall Study|Other|1
7702038|NCT01134705|26786280|P2|Overall Study|Protocol Violation|1
7702039|NCT01134705|26786281|P1|Overall Study|Protocol Violation|1
7702040|NCT01134705|26786280|P2|Overall Study|Lost to Follow-up|2
7702041|NCT01134705|26786281|P1|Overall Study|Lost to Follow-up|5
7702042|NCT01134705|26786280|P2|Overall Study|Pregnancy|0
7702043|NCT01134705|26786281|P1|Overall Study|Pregnancy|1
7702044|NCT01134705|26786280|P2|Overall Study|Withdrawal by Subject|6
7702045|NCT01134705|26786281|P1|Overall Study|Withdrawal by Subject|6
7702046|NCT01134705|26786280|P2|Overall Study|Adverse Event|7
7702047|NCT01134705|26786281|P1|Overall Study|Adverse Event|1
7702048|NCT01134627|26786293|P2|Overall Study|Other|14
7702049|NCT01134627|26786294|P1|Overall Study|Other|11
7702050|NCT01134627|26786293|P2|Overall Study|Planning to become pregnant/pregnancy|0
7702051|NCT01134627|26786294|P1|Overall Study|Planning to become pregnant/pregnancy|1
7702052|NCT01134627|26786293|P2|Overall Study|Withdrawal by Subject|3
7702053|NCT01134627|26786294|P1|Overall Study|Withdrawal by Subject|4
7702054|NCT01134627|26786293|P2|Overall Study|Lack of Efficacy|12
7702055|NCT01134627|26786294|P1|Overall Study|Lack of Efficacy|2
7702056|NCT01134627|26786293|P2|Overall Study|Protocol Violation|5
7702057|NCT01134627|26786294|P1|Overall Study|Protocol Violation|3
7702058|NCT01134627|26786293|P2|Overall Study|Lost to Follow-up|2
7702059|NCT01134627|26786294|P1|Overall Study|Lost to Follow-up|1
7702060|NCT01134627|26786293|P2|Overall Study|Adverse Event|31
7702061|NCT01134627|26786294|P1|Overall Study|Adverse Event|47
7702062|NCT01134614|26786324|P2|Overall Study|Patient in hospice care|1
7702063|NCT01134614|26786325|P1|Overall Study|Patient in hospice care|0
7702064|NCT01134614|26786324|P2|Overall Study|Symptomatic deterioration|1
7702065|NCT01134614|26786325|P1|Overall Study|Symptomatic deterioration|0
7702066|NCT01134614|26786324|P2|Overall Study|Pt received tx not allowed on study|1
7702067|NCT01134614|26786325|P1|Overall Study|Pt received tx not allowed on study|0
7702068|NCT01134614|26786324|P2|Overall Study|Never started treatment|1
7702069|NCT01134614|26786325|P1|Overall Study|Never started treatment|4
7702070|NCT01134614|26786324|P2|Overall Study|Physician's decision|1
7702071|NCT01134614|26786325|P1|Overall Study|Physician's decision|0
7702072|NCT01134614|26786324|P2|Overall Study|Complicating disease|1
7702073|NCT01134614|26786325|P1|Overall Study|Complicating disease|2
7702074|NCT01134614|26786324|P2|Overall Study|Alternative therapy|0
7702075|NCT01134614|26786325|P1|Overall Study|Alternative therapy|2
7702076|NCT01134614|26786324|P2|Overall Study|Withdrawal by Subject|2
7702077|NCT01134614|26786325|P1|Overall Study|Withdrawal by Subject|3
7702078|NCT01134614|26786324|P2|Overall Study|Death|8
7702079|NCT01134614|26786325|P1|Overall Study|Death|5
7702080|NCT01134614|26786324|P2|Overall Study|Adverse Event|39
7702081|NCT01134614|26786325|P1|Overall Study|Adverse Event|26
7702082|NCT01134614|26786324|P2|Overall Study|Progressive disease|54
7702083|NCT01134614|26786325|P1|Overall Study|Progressive disease|60
7702084|NCT01134614|26786324|P2|Overall Study|Still on treatment as of March 2013|13
7702085|NCT01134614|26786325|P1|Overall Study|Still on treatment as of March 2013|21
7702086|NCT01134562|26786353|P5|Overall Study|Adverse Event|0
7702087|NCT01134562|26786354|P4|Overall Study|Adverse Event|0
7702088|NCT01134562|26786355|P3|Overall Study|Adverse Event|0
7702089|NCT01134562|26786356|P2|Overall Study|Adverse Event|1
7702090|NCT01134562|26786357|P1|Overall Study|Adverse Event|0
7702091|NCT01134393|26786529|P1|Overall Study|Other|6
7702092|NCT01134393|26786529|P1|Overall Study|Withdrawal by Subject|11
7702093|NCT01134393|26786529|P1|Overall Study|Lost to Follow-up|3
7702094|NCT01134393|26786529|P1|Overall Study|Protocol Violation|12
7702095|NCT01134393|26786529|P1|Overall Study|Lack of Efficacy|2
7702096|NCT01134393|26786529|P1|Overall Study|Adverse Event|18
7702097|NCT01134315|26786650|P2|Overall Study|Other Reason|17
7702098|NCT01134315|26786651|P1|Overall Study|Other Reason|8
7702099|NCT01134315|26786650|P2|Overall Study|Adverse Event|2
7702100|NCT01134315|26786651|P1|Overall Study|Adverse Event|1
7702101|NCT01134263|26786689|P5|Overall Study|Enrolled, but not treated|0
7702102|NCT01134263|26786690|P4|Overall Study|Enrolled, but not treated|1
7702103|NCT01134263|26786691|P3|Overall Study|Enrolled, but not treated|0
7702104|NCT01134263|26786692|P2|Overall Study|Enrolled, but not treated|1
7702105|NCT01134263|26786693|P1|Overall Study|Enrolled, but not treated|1
7702106|NCT01134263|26786689|P5|Overall Study|Withdrawal by Subject|5
7702107|NCT01134263|26786690|P4|Overall Study|Withdrawal by Subject|7
7702108|NCT01134263|26786691|P3|Overall Study|Withdrawal by Subject|16
7702109|NCT01134263|26786692|P2|Overall Study|Withdrawal by Subject|6
7702110|NCT01134263|26786693|P1|Overall Study|Withdrawal by Subject|8
7702111|NCT01134263|26786689|P5|Overall Study|Lost to Follow-up|1
7702112|NCT01134263|26786690|P4|Overall Study|Lost to Follow-up|3
7702113|NCT01134263|26786691|P3|Overall Study|Lost to Follow-up|5
7702114|NCT01134263|26786692|P2|Overall Study|Lost to Follow-up|3
7702115|NCT01134263|26786693|P1|Overall Study|Lost to Follow-up|4
7702116|NCT01134263|26786689|P5|Overall Study|Protocol Violation|2
7702117|NCT01134263|26786690|P4|Overall Study|Protocol Violation|4
7702118|NCT01134263|26786691|P3|Overall Study|Protocol Violation|2
7702119|NCT01134263|26786692|P2|Overall Study|Protocol Violation|7
7702120|NCT01134263|26786693|P1|Overall Study|Protocol Violation|8
7702121|NCT01134263|26786689|P5|Overall Study|Other adverse event|0
7702122|NCT01134263|26786690|P4|Overall Study|Other adverse event|3
7702123|NCT01134263|26786691|P3|Overall Study|Other adverse event|5
7702124|NCT01134263|26786692|P2|Overall Study|Other adverse event|2
7702125|NCT01134263|26786693|P1|Overall Study|Other adverse event|1
7702126|NCT01134263|26786689|P5|Overall Study|Serious adverse event|1
7702127|NCT01134263|26786690|P4|Overall Study|Serious adverse event|1
7702128|NCT01134263|26786691|P3|Overall Study|Serious adverse event|1
7702129|NCT01134263|26786692|P2|Overall Study|Serious adverse event|1
7702130|NCT01134263|26786693|P1|Overall Study|Serious adverse event|2
7702131|NCT01134107|26786726|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
7702132|NCT01134107|26786727|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
7702133|NCT01134107|26786726|P2|Period 2-Second Treatment Intervention|Physician Decision|0
7702134|NCT01134107|26786727|P1|Period 2-Second Treatment Intervention|Physician Decision|1
7702135|NCT01134107|26786726|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
7702136|NCT01134107|26786727|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
7702137|NCT01134107|26786726|P2|Period 1-First Treatment Intervention|Physician Decision|0
7702138|NCT01134107|26786727|P1|Period 1-First Treatment Intervention|Physician Decision|1
7702139|NCT01134107|26786726|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
7702140|NCT01134107|26786727|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
7702141|NCT01134107|26786726|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
7702142|NCT01134107|26786727|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
7702143|NCT01134107|26786726|P2|Period 1-First Treatment Intervention|Adverse Event|0
7702144|NCT01134107|26786727|P1|Period 1-First Treatment Intervention|Adverse Event|1
7702145|NCT01134055|26786774|P7|Overall Study|Physician Decision|1
7702146|NCT01134055|26786775|P6|Overall Study|Physician Decision|0
7702147|NCT01134055|26786776|P5|Overall Study|Physician Decision|0
7702148|NCT01134055|26786777|P4|Overall Study|Physician Decision|0
7702149|NCT01134055|26786778|P3|Overall Study|Physician Decision|0
7702150|NCT01134055|26786779|P2|Overall Study|Physician Decision|0
7702151|NCT01134055|26786780|P1|Overall Study|Physician Decision|0
7702152|NCT01134055|26786774|P7|Overall Study|Protocol Violation|0
7702153|NCT01134055|26786775|P6|Overall Study|Protocol Violation|0
7702154|NCT01134055|26786776|P5|Overall Study|Protocol Violation|1
7702155|NCT01134055|26786777|P4|Overall Study|Protocol Violation|1
7702156|NCT01134055|26786778|P3|Overall Study|Protocol Violation|0
7702157|NCT01134055|26786779|P2|Overall Study|Protocol Violation|0
7702158|NCT01134055|26786780|P1|Overall Study|Protocol Violation|0
7702159|NCT01134055|26786774|P7|Overall Study|Withdrawal by Subject|8
7702160|NCT01134055|26786775|P6|Overall Study|Withdrawal by Subject|0
7702161|NCT01134055|26786776|P5|Overall Study|Withdrawal by Subject|0
7702162|NCT01134055|26786777|P4|Overall Study|Withdrawal by Subject|2
7702163|NCT01134055|26786778|P3|Overall Study|Withdrawal by Subject|1
7702164|NCT01134055|26786779|P2|Overall Study|Withdrawal by Subject|3
7702165|NCT01134055|26786780|P1|Overall Study|Withdrawal by Subject|3
7702166|NCT01134055|26786774|P7|Overall Study|Lost to Follow-up|0
7702167|NCT01134055|26786775|P6|Overall Study|Lost to Follow-up|0
7702168|NCT01134055|26786776|P5|Overall Study|Lost to Follow-up|0
7702169|NCT01134055|26786777|P4|Overall Study|Lost to Follow-up|1
7702170|NCT01134055|26786778|P3|Overall Study|Lost to Follow-up|0
7702171|NCT01134055|26786779|P2|Overall Study|Lost to Follow-up|1
7702172|NCT01134055|26786780|P1|Overall Study|Lost to Follow-up|0
7702173|NCT01134055|26786774|P7|Overall Study|Adverse Event|2
7702174|NCT01134055|26786775|P6|Overall Study|Adverse Event|7
7702175|NCT01134055|26786776|P5|Overall Study|Adverse Event|5
7702176|NCT01134055|26786777|P4|Overall Study|Adverse Event|2
7702177|NCT01134055|26786778|P3|Overall Study|Adverse Event|2
7702178|NCT01134055|26786779|P2|Overall Study|Adverse Event|2
7702179|NCT01134055|26786780|P1|Overall Study|Adverse Event|5
7702180|NCT01134042|26786914|P3|Overall Study|Withdrawal by Subject|7
7702181|NCT01134042|26786915|P2|Overall Study|Withdrawal by Subject|4
7702182|NCT01134042|26786916|P1|Overall Study|Withdrawal by Subject|13
7702183|NCT01134042|26786914|P3|Overall Study|Physician Decision|1
7702184|NCT01134042|26786915|P2|Overall Study|Physician Decision|8
7702185|NCT01134042|26786916|P1|Overall Study|Physician Decision|4
7702186|NCT01134042|26786914|P3|Overall Study|Lost to Follow-up|1
7702187|NCT01134042|26786915|P2|Overall Study|Lost to Follow-up|0
7702188|NCT01134042|26786916|P1|Overall Study|Lost to Follow-up|2
7702189|NCT01134042|26786914|P3|Overall Study|Protocol Violation|5
7702190|NCT01134042|26786915|P2|Overall Study|Protocol Violation|3
7702191|NCT01134042|26786916|P1|Overall Study|Protocol Violation|5
7702192|NCT01134042|26786914|P3|Overall Study|Lack of Efficacy|18
7702193|NCT01134042|26786915|P2|Overall Study|Lack of Efficacy|6
7702194|NCT01134042|26786916|P1|Overall Study|Lack of Efficacy|21
7702195|NCT01134042|26786914|P3|Overall Study|Adverse Event|2
7702196|NCT01134042|26786915|P2|Overall Study|Adverse Event|7
7702197|NCT01134042|26786916|P1|Overall Study|Adverse Event|3
7702198|NCT01133977|26786992|P5|Overall Study|Withdrawal by Subject|1
7702199|NCT01133977|26786993|P4|Overall Study|Withdrawal by Subject|5
7702200|NCT01133977|26786994|P3|Overall Study|Withdrawal by Subject|0
7702201|NCT01133977|26786995|P2|Overall Study|Withdrawal by Subject|0
7702202|NCT01133977|26786996|P1|Overall Study|Withdrawal by Subject|0
7702203|NCT01133977|26786992|P5|Overall Study|Lost to Follow-up|1
7702204|NCT01133977|26786993|P4|Overall Study|Lost to Follow-up|2
7702205|NCT01133977|26786994|P3|Overall Study|Lost to Follow-up|0
7702206|NCT01133977|26786995|P2|Overall Study|Lost to Follow-up|0
7702207|NCT01133977|26786996|P1|Overall Study|Lost to Follow-up|0
7702208|NCT01133977|26786992|P5|Overall Study|Started a New Line of Therapy|33
7702209|NCT01133977|26786993|P4|Overall Study|Started a New Line of Therapy|25
7702210|NCT01133977|26786994|P3|Overall Study|Started a New Line of Therapy|4
7702211|NCT01133977|26786995|P2|Overall Study|Started a New Line of Therapy|6
7702212|NCT01133977|26786996|P1|Overall Study|Started a New Line of Therapy|2
7702213|NCT01133977|26786992|P5|Overall Study|Death|3
7702214|NCT01133977|26786993|P4|Overall Study|Death|7
7702215|NCT01133977|26786994|P3|Overall Study|Death|1
7702216|NCT01133977|26786995|P2|Overall Study|Death|1
7702217|NCT01133977|26786996|P1|Overall Study|Death|1
7702218|NCT01133977|26786992|P5|Overall Study|Adverse Event|0
7702219|NCT01133977|26786993|P4|Overall Study|Adverse Event|0
7702220|NCT01133977|26786994|P3|Overall Study|Adverse Event|1
7702221|NCT01133977|26786995|P2|Overall Study|Adverse Event|0
7702222|NCT01133977|26786996|P1|Overall Study|Adverse Event|0
7702223|NCT01133847|26787023|P3|Follow-Up Phase|Lost to Follow-up|7
7702224|NCT01133847|26787024|P2|Follow-Up Phase|Lost to Follow-up|3
7702225|NCT01133847|26787025|P1|Follow-Up Phase|Lost to Follow-up|1
7702226|NCT01133847|26787023|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
7702227|NCT01133847|26787024|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
7702228|NCT01133847|26787025|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
7702229|NCT01133821|26787065|P2|Overall Study|Refused participation|3
7702230|NCT01133821|26787066|P1|Overall Study|Refused participation|1
7702231|NCT01133821|26787065|P2|Overall Study|Protocol Violation|1
7702232|NCT01133821|26787066|P1|Overall Study|Protocol Violation|0
7702233|NCT01133821|26787065|P2|Overall Study|preferred other treatment|1
7702234|NCT01133821|26787066|P1|Overall Study|preferred other treatment|1
7702235|NCT01133821|26787065|P2|Overall Study|Withdrawal by Subject|3
7702236|NCT01133821|26787066|P1|Overall Study|Withdrawal by Subject|8
7702237|NCT01133821|26787065|P2|Overall Study|Lost to Follow-up|11
7702238|NCT01133821|26787066|P1|Overall Study|Lost to Follow-up|8
7702239|NCT01133756|26787077|P3|Overall Study|Progression of Disease|1
7702240|NCT01133756|26787078|P2|Overall Study|Progression of Disease|0
7702241|NCT01133756|26787079|P1|Overall Study|Progression of Disease|0
7702242|NCT01133756|26787077|P3|Overall Study|Withdrawal by Subject|0
7702243|NCT01133756|26787078|P2|Overall Study|Withdrawal by Subject|1
7702244|NCT01133756|26787079|P1|Overall Study|Withdrawal by Subject|0
7702245|NCT01133756|26787077|P3|Overall Study|Investigator Decision|0
7702246|NCT01133756|26787078|P2|Overall Study|Investigator Decision|0
7702247|NCT01133756|26787079|P1|Overall Study|Investigator Decision|1
7702248|NCT01133756|26787077|P3|Overall Study|Adverse Event|1
7702249|NCT01133756|26787078|P2|Overall Study|Adverse Event|2
7702250|NCT01133756|26787079|P1|Overall Study|Adverse Event|1
7702251|NCT01133704|26787095|P2|Overall Study|Study Closure|0
7702252|NCT01133704|26787096|P1|Overall Study|Study Closure|1
7702253|NCT01133704|26787095|P2|Overall Study|Patient refused to continue|0
7702254|NCT01133704|26787096|P1|Overall Study|Patient refused to continue|4
7702255|NCT01133704|26787095|P2|Overall Study|Death|26
7702256|NCT01133704|26787096|P1|Overall Study|Death|44
7702257|NCT01133678|26787106|P2|Overall Study|Death|1
7702258|NCT01133678|26787107|P1|Overall Study|Death|1
7702259|NCT01133665|26787113|P1|Overall Study|Physician Decision|2
7702260|NCT01133626|26787173|P3|Overall Study|Other|0
7702261|NCT01133626|26787174|P2|Overall Study|Other|2
7702262|NCT01133626|26787175|P1|Overall Study|Other|0
7702263|NCT01133626|26787173|P3|Overall Study|Withdrawal by Subject|2
7702264|NCT01133626|26787174|P2|Overall Study|Withdrawal by Subject|2
7702265|NCT01133626|26787175|P1|Overall Study|Withdrawal by Subject|1
7702266|NCT01133626|26787173|P3|Overall Study|Adverse Event|0
7702267|NCT01133626|26787174|P2|Overall Study|Adverse Event|1
7702268|NCT01133626|26787175|P1|Overall Study|Adverse Event|0
7702269|NCT01133522|26787193|P10|Overall Study|Physician Decision|0
7702270|NCT01133522|26787194|P9|Overall Study|Physician Decision|0
7702271|NCT01133522|26787195|P8|Overall Study|Physician Decision|0
7702272|NCT01133522|26787196|P7|Overall Study|Physician Decision|0
7702273|NCT01133522|26787197|P6|Overall Study|Physician Decision|0
7702274|NCT01133522|26787198|P5|Overall Study|Physician Decision|1
7702275|NCT01133522|26787199|P4|Overall Study|Physician Decision|0
7702276|NCT01133522|26787200|P3|Overall Study|Physician Decision|0
7702277|NCT01133522|26787201|P2|Overall Study|Physician Decision|0
7702278|NCT01133522|26787202|P1|Overall Study|Physician Decision|0
7702279|NCT01133522|26787193|P10|Overall Study|Withdrawal by Subject|0
7702280|NCT01133522|26787194|P9|Overall Study|Withdrawal by Subject|0
7702281|NCT01133522|26787195|P8|Overall Study|Withdrawal by Subject|0
7702282|NCT01133522|26787196|P7|Overall Study|Withdrawal by Subject|0
7702283|NCT01133522|26787197|P6|Overall Study|Withdrawal by Subject|0
7702284|NCT01133522|26787198|P5|Overall Study|Withdrawal by Subject|0
7702285|NCT01133522|26787199|P4|Overall Study|Withdrawal by Subject|1
7702286|NCT01133522|26787200|P3|Overall Study|Withdrawal by Subject|0
7702287|NCT01133522|26787201|P2|Overall Study|Withdrawal by Subject|1
7702288|NCT01133522|26787202|P1|Overall Study|Withdrawal by Subject|0
7702289|NCT01133418|26787270|P2|Overall Study|Lost to Follow-up|6
7702290|NCT01133418|26787271|P1|Overall Study|Lost to Follow-up|5
7702291|NCT01133405|26787293|P10|Period 2|Physician Decision|0
7702292|NCT01133405|26787294|P9|Period 2|Physician Decision|0
7702293|NCT01133405|26787295|P8|Period 2|Physician Decision|0
7702294|NCT01133405|26787296|P7|Period 2|Physician Decision|0
7702295|NCT01133405|26787297|P6|Period 2|Physician Decision|1
7702296|NCT01133405|26787298|P5|Period 2|Physician Decision|0
7702297|NCT01133405|26787299|P4|Period 2|Physician Decision|0
7702298|NCT01133405|26787300|P3|Period 2|Physician Decision|0
7702299|NCT01133405|26787301|P2|Period 2|Physician Decision|0
7702300|NCT01133405|26787302|P1|Period 2|Physician Decision|0
7702301|NCT01133405|26787293|P10|Period 2|Entry Criteria Not Met|0
7702302|NCT01133405|26787294|P9|Period 2|Entry Criteria Not Met|0
7702303|NCT01133405|26787295|P8|Period 2|Entry Criteria Not Met|0
7702304|NCT01133405|26787296|P7|Period 2|Entry Criteria Not Met|0
7702305|NCT01133405|26787297|P6|Period 2|Entry Criteria Not Met|0
7702306|NCT01133405|26787298|P5|Period 2|Entry Criteria Not Met|0
7702307|NCT01133405|26787299|P4|Period 2|Entry Criteria Not Met|0
7702308|NCT01133405|26787300|P3|Period 2|Entry Criteria Not Met|0
7702309|NCT01133405|26787301|P2|Period 2|Entry Criteria Not Met|1
7702310|NCT01133405|26787302|P1|Period 2|Entry Criteria Not Met|0
7702311|NCT01133405|26787293|P10|Period 2|Withdrawal by Subject|0
7702312|NCT01133405|26787294|P9|Period 2|Withdrawal by Subject|0
7702313|NCT01133405|26787295|P8|Period 2|Withdrawal by Subject|0
7702314|NCT01133405|26787296|P7|Period 2|Withdrawal by Subject|0
7702315|NCT01133405|26787297|P6|Period 2|Withdrawal by Subject|1
7702316|NCT01133405|26787298|P5|Period 2|Withdrawal by Subject|0
7702317|NCT01133405|26787299|P4|Period 2|Withdrawal by Subject|1
7702318|NCT01133405|26787300|P3|Period 2|Withdrawal by Subject|0
7702319|NCT01133405|26787301|P2|Period 2|Withdrawal by Subject|0
7702320|NCT01133405|26787302|P1|Period 2|Withdrawal by Subject|0
7702321|NCT01133405|26787293|P10|Period 2|Adverse Event|0
7702322|NCT01133405|26787294|P9|Period 2|Adverse Event|0
7702323|NCT01133405|26787295|P8|Period 2|Adverse Event|0
7702324|NCT01133405|26787296|P7|Period 2|Adverse Event|0
7702325|NCT01133405|26787297|P6|Period 2|Adverse Event|0
7702326|NCT01133405|26787298|P5|Period 2|Adverse Event|0
7702327|NCT01133405|26787299|P4|Period 2|Adverse Event|0
7702328|NCT01133405|26787300|P3|Period 2|Adverse Event|1
7702329|NCT01133405|26787301|P2|Period 2|Adverse Event|0
7702330|NCT01133405|26787302|P1|Period 2|Adverse Event|0
7702331|NCT01133405|26787293|P10|Period 1|Received drug only in period 3|0
7702332|NCT01133405|26787294|P9|Period 1|Received drug only in period 3|0
7702333|NCT01133405|26787295|P8|Period 1|Received drug only in period 3|0
7702334|NCT01133405|26787296|P7|Period 1|Received drug only in period 3|0
7702335|NCT01133405|26787297|P6|Period 1|Received drug only in period 3|0
7702336|NCT01133405|26787298|P5|Period 1|Received drug only in period 3|0
7702337|NCT01133405|26787299|P4|Period 1|Received drug only in period 3|0
7702338|NCT01133405|26787300|P3|Period 1|Received drug only in period 3|1
7702339|NCT01133405|26787301|P2|Period 1|Received drug only in period 3|1
7702340|NCT01133405|26787302|P1|Period 1|Received drug only in period 3|0
7702341|NCT01133405|26787293|P10|Period 1|Received drug only in period 2|0
7702342|NCT01133405|26787294|P9|Period 1|Received drug only in period 2|0
7702343|NCT01133405|26787295|P8|Period 1|Received drug only in period 2|0
7702344|NCT01133405|26787296|P7|Period 1|Received drug only in period 2|0
7702345|NCT01133405|26787297|P6|Period 1|Received drug only in period 2|1
7702346|NCT01133405|26787298|P5|Period 1|Received drug only in period 2|0
7702347|NCT01133405|26787299|P4|Period 1|Received drug only in period 2|2
7702348|NCT01133405|26787300|P3|Period 1|Received drug only in period 2|0
7702349|NCT01133405|26787301|P2|Period 1|Received drug only in period 2|1
7702350|NCT01133405|26787302|P1|Period 1|Received drug only in period 2|0
7702351|NCT01133405|26787293|P10|Period 1|Discontinued after randomization|0
7702352|NCT01133405|26787294|P9|Period 1|Discontinued after randomization|0
7702353|NCT01133405|26787295|P8|Period 1|Discontinued after randomization|0
7702354|NCT01133405|26787296|P7|Period 1|Discontinued after randomization|1
7702355|NCT01133405|26787297|P6|Period 1|Discontinued after randomization|0
7702356|NCT01133405|26787298|P5|Period 1|Discontinued after randomization|0
7702357|NCT01133405|26787299|P4|Period 1|Discontinued after randomization|0
7702358|NCT01133405|26787300|P3|Period 1|Discontinued after randomization|0
7702359|NCT01133405|26787301|P2|Period 1|Discontinued after randomization|0
7702360|NCT01133405|26787302|P1|Period 1|Discontinued after randomization|1
7702361|NCT01133405|26787293|P10|Period 1|Physician Decision|0
7702362|NCT01133405|26787294|P9|Period 1|Physician Decision|0
7702363|NCT01133405|26787295|P8|Period 1|Physician Decision|0
7702364|NCT01133405|26787296|P7|Period 1|Physician Decision|0
7702365|NCT01133405|26787297|P6|Period 1|Physician Decision|0
7702366|NCT01133405|26787298|P5|Period 1|Physician Decision|0
7702367|NCT01133405|26787299|P4|Period 1|Physician Decision|1
7702368|NCT01133405|26787300|P3|Period 1|Physician Decision|0
7702369|NCT01133405|26787301|P2|Period 1|Physician Decision|0
7702370|NCT01133405|26787302|P1|Period 1|Physician Decision|0
7702371|NCT01133405|26787293|P10|Period 1|Withdrawal by Subject|0
7702372|NCT01133405|26787294|P9|Period 1|Withdrawal by Subject|0
7702373|NCT01133405|26787295|P8|Period 1|Withdrawal by Subject|0
7702374|NCT01133405|26787296|P7|Period 1|Withdrawal by Subject|0
7702375|NCT01133405|26787297|P6|Period 1|Withdrawal by Subject|1
7702376|NCT01133405|26787298|P5|Period 1|Withdrawal by Subject|0
7702377|NCT01133405|26787299|P4|Period 1|Withdrawal by Subject|1
7702378|NCT01133405|26787300|P3|Period 1|Withdrawal by Subject|0
7702379|NCT01133405|26787301|P2|Period 1|Withdrawal by Subject|1
7702380|NCT01133405|26787302|P1|Period 1|Withdrawal by Subject|0
7702381|NCT01133392|26787353|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
7702382|NCT01133392|26787354|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
7702383|NCT01133392|26787353|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
7702384|NCT01133392|26787354|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
7702385|NCT01133379|26787371|P3|Overall Study|Lost to Follow-up|1
7702386|NCT01133379|26787372|P2|Overall Study|Lost to Follow-up|1
7702387|NCT01133379|26787373|P1|Overall Study|Lost to Follow-up|1
7702388|NCT01133379|26787371|P3|Overall Study|Withdrawal by Subject|1
7702389|NCT01133379|26787372|P2|Overall Study|Withdrawal by Subject|1
7702390|NCT01133379|26787373|P1|Overall Study|Withdrawal by Subject|0
7702391|NCT01133288|26787426|P1|Intervention Allocation|study terminated|2
7702392|NCT01133288|26787426|P1|Eligibility Assessment|met exclusion criteria|5
7702393|NCT01133275|26787431|P1|Overall Study|Cerebrovascular accident (CVA)|1
7702394|NCT01133275|26787431|P1|Overall Study|Withdrawal by Subject|1
7702395|NCT01133171|26787439|P3|Overall Study|Withdrawal by Subject|0
7702396|NCT01133171|26787440|P2|Overall Study|Withdrawal by Subject|2
7702397|NCT01133171|26787441|P1|Overall Study|Withdrawal by Subject|1
7702398|NCT01133067|26787457|P1|Overall Study|Lost to Follow-up|3
7702399|NCT01133067|26787457|P1|Overall Study|Death|136
7702400|NCT01132820|26787517|P1|Overall Study|Inadequate data|1
7702401|NCT01132820|26787517|P1|Overall Study|Never treated|1
7702402|NCT01132820|26787517|P1|Overall Study|Ineligible:Inadequate pathology|1
7702403|NCT01132820|26787517|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
7702404|NCT01132820|26787517|P1|Overall Study|Ineligible: wrong cell type|1
7702405|NCT01132807|26787526|P3|Initial ABVD Treatment (2 Cycles)|Ineligible|0
7702406|NCT01132807|26787527|P2|Initial ABVD Treatment (2 Cycles)|Ineligible|0
7702407|NCT01132807|26787528|P1|Initial ABVD Treatment (2 Cycles)|Ineligible|6
7702408|NCT01132807|26787526|P3|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
7702409|NCT01132807|26787527|P2|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
7702410|NCT01132807|26787528|P1|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
7702411|NCT01132755|26787538|P1|Overall Study|Withdrawal by Subject|4
7702412|NCT01132755|26787538|P1|Overall Study|Protocol Violation|15
7702413|NCT01132755|26787538|P1|Overall Study|Procedure not done due to medical reason|23
7702414|NCT01132664|26787567|P5|BM Cohort|Withdrawal by Subject|1
7702415|NCT01132664|26787568|P4|BM Cohort|Withdrawal by Subject|0
7702416|NCT01132664|26787569|P3|BM Cohort|Withdrawal by Subject|0
7702417|NCT01132664|26787570|P2|BM Cohort|Withdrawal by Subject|0
7702418|NCT01132664|26787571|P1|BM Cohort|Withdrawal by Subject|0
7702419|NCT01132664|26787567|P5|BM Cohort|Adverse Event|1
7702420|NCT01132664|26787568|P4|BM Cohort|Adverse Event|0
7702421|NCT01132664|26787569|P3|BM Cohort|Adverse Event|0
7702422|NCT01132664|26787570|P2|BM Cohort|Adverse Event|0
7702423|NCT01132664|26787571|P1|BM Cohort|Adverse Event|0
7702424|NCT01132664|26787567|P5|BM Cohort|Disease progression|4
7702425|NCT01132664|26787568|P4|BM Cohort|Disease progression|3
7702426|NCT01132664|26787569|P3|BM Cohort|Disease progression|0
7702427|NCT01132664|26787570|P2|BM Cohort|Disease progression|0
7702428|NCT01132664|26787571|P1|BM Cohort|Disease progression|0
7702429|NCT01132664|26787567|P5|Phase ll|Disease progression|0
7702430|NCT01132664|26787568|P4|Phase ll|Disease progression|0
7702431|NCT01132664|26787569|P3|Phase ll|Disease progression|35
7702432|NCT01132664|26787570|P2|Phase ll|Disease progression|0
7702433|NCT01132664|26787571|P1|Phase ll|Disease progression|0
7702434|NCT01132664|26787567|P5|Phase ll|Withdrawal by Subject|0
7702435|NCT01132664|26787568|P4|Phase ll|Withdrawal by Subject|0
7702436|NCT01132664|26787569|P3|Phase ll|Withdrawal by Subject|3
7702437|NCT01132664|26787570|P2|Phase ll|Withdrawal by Subject|0
7702438|NCT01132664|26787571|P1|Phase ll|Withdrawal by Subject|0
7702439|NCT01132664|26787567|P5|Phase ll|Adverse Event|0
7702440|NCT01132664|26787568|P4|Phase ll|Adverse Event|0
7702441|NCT01132664|26787569|P3|Phase ll|Adverse Event|10
7702442|NCT01132664|26787570|P2|Phase ll|Adverse Event|0
7702443|NCT01132664|26787571|P1|Phase ll|Adverse Event|0
7702444|NCT01132664|26787567|P5|Phase ll|Death|0
7702445|NCT01132664|26787568|P4|Phase ll|Death|0
7702446|NCT01132664|26787569|P3|Phase ll|Death|2
7702447|NCT01132664|26787570|P2|Phase ll|Death|0
7702448|NCT01132664|26787571|P1|Phase ll|Death|0
7702449|NCT01132664|26787567|P5|Phase lb|Disease Progression|0
7702450|NCT01132664|26787568|P4|Phase lb|Disease Progression|0
7702451|NCT01132664|26787569|P3|Phase lb|Disease Progression|0
7702452|NCT01132664|26787570|P2|Phase lb|Disease Progression|9
7702453|NCT01132664|26787571|P1|Phase lb|Disease Progression|4
7702454|NCT01132664|26787567|P5|Phase lb|Withdrawal by Subject|0
7702455|NCT01132664|26787568|P4|Phase lb|Withdrawal by Subject|0
7702456|NCT01132664|26787569|P3|Phase lb|Withdrawal by Subject|0
7702457|NCT01132664|26787570|P2|Phase lb|Withdrawal by Subject|2
7702458|NCT01132664|26787571|P1|Phase lb|Withdrawal by Subject|1
7702459|NCT01132664|26787567|P5|Phase lb|Adverse Event|0
7702460|NCT01132664|26787568|P4|Phase lb|Adverse Event|0
7702461|NCT01132664|26787569|P3|Phase lb|Adverse Event|0
7702462|NCT01132664|26787570|P2|Phase lb|Adverse Event|1
7702463|NCT01132664|26787571|P1|Phase lb|Adverse Event|0
7702464|NCT01132651|26787605|P2|Overall Study|Lost to Follow-up|1
7702465|NCT01132651|26787606|P1|Overall Study|Lost to Follow-up|1
7702466|NCT01132612|26787617|P3|Overall Study|Lack of Efficacy|73
7702467|NCT01132612|26787618|P2|Overall Study|Lack of Efficacy|22
7702468|NCT01132612|26787619|P1|Overall Study|Lack of Efficacy|23
7702469|NCT01132612|26787617|P3|Overall Study|Administrative problems|52
7702470|NCT01132612|26787618|P2|Overall Study|Administrative problems|1
7702471|NCT01132612|26787619|P1|Overall Study|Administrative problems|5
7702472|NCT01132612|26787617|P3|Overall Study|Withdrawal by Subject|19
7702473|NCT01132612|26787618|P2|Overall Study|Withdrawal by Subject|8
7702474|NCT01132612|26787619|P1|Overall Study|Withdrawal by Subject|5
7702475|NCT01132612|26787617|P3|Overall Study|Adverse Event|15
7702476|NCT01132612|26787618|P2|Overall Study|Adverse Event|2
7702477|NCT01132612|26787619|P1|Overall Study|Adverse Event|5
7702478|NCT01132612|26787617|P3|Overall Study|Lost to Follow-up|7
7702479|NCT01132612|26787618|P2|Overall Study|Lost to Follow-up|2
7702480|NCT01132612|26787619|P1|Overall Study|Lost to Follow-up|2
7702481|NCT01132612|26787617|P3|Overall Study|Protocol deviation|3
7702482|NCT01132612|26787618|P2|Overall Study|Protocol deviation|0
7702483|NCT01132612|26787619|P1|Overall Study|Protocol deviation|0
7702484|NCT01132612|26787617|P3|Overall Study|Death|1
7702485|NCT01132612|26787618|P2|Overall Study|Death|0
7702486|NCT01132612|26787619|P1|Overall Study|Death|0
7702487|NCT01132547|26787635|P2|Overall Study|Death|0
7702488|NCT01132547|26787636|P1|Overall Study|Death|1
7702489|NCT01132547|26787635|P2|Overall Study|Withdrawal by Subject|1
7702490|NCT01132547|26787636|P1|Overall Study|Withdrawal by Subject|3
7702491|NCT01132495|26787706|P4|Overall Study|Various reasons|12
7702492|NCT01132495|26787707|P3|Overall Study|Various reasons|20
7702493|NCT01132495|26787708|P2|Overall Study|Various reasons|38
7702494|NCT01132495|26787709|P1|Overall Study|Various reasons|40
7702495|NCT01132482|26787722|P2|Overall Study|Adverse Event|0
7702496|NCT01132482|26787723|P1|Overall Study|Adverse Event|1
7702497|NCT01132326|26787746|P1|Overall Study|Subject Unable to Come To Visits|1
7702498|NCT01132326|26787746|P1|Overall Study|Death|5
7702499|NCT01132326|26787746|P1|Overall Study|Caregiver Withdrew Consent|1
7702500|NCT01132326|26787746|P1|Overall Study|Pregnancy|1
7702501|NCT01132326|26787746|P1|Overall Study|Declining Health|1
7702502|NCT01132326|26787746|P1|Overall Study|Study Termination|80
7702503|NCT01132326|26787746|P1|Overall Study|Physician Decision|10
7702504|NCT01132326|26787746|P1|Overall Study|Withdrawal by Subject|40
7702505|NCT01132326|26787746|P1|Overall Study|Lost to Follow-up|16
7702506|NCT01132326|26787746|P1|Overall Study|Protocol Violation|1
7702507|NCT01132326|26787746|P1|Overall Study|Adverse Event|37
7702508|NCT01132326|26787746|P1|Overall Study|Lack of Efficacy|25
7702509|NCT01132313|26787762|P12|Overall Study|Other reason not defined above|0
7702510|NCT01132313|26787763|P11|Overall Study|Other reason not defined above|0
7702511|NCT01132313|26787764|P10|Overall Study|Other reason not defined above|0
7702512|NCT01132313|26787765|P9|Overall Study|Other reason not defined above|0
7702513|NCT01132313|26787766|P8|Overall Study|Other reason not defined above|1
7702514|NCT01132313|26787767|P7|Overall Study|Other reason not defined above|0
7702515|NCT01132313|26787768|P6|Overall Study|Other reason not defined above|0
7702516|NCT01132313|26787769|P5|Overall Study|Other reason not defined above|0
7702517|NCT01132313|26787770|P4|Overall Study|Other reason not defined above|0
7702518|NCT01132313|26787771|P3|Overall Study|Other reason not defined above|0
7702519|NCT01132313|26787772|P2|Overall Study|Other reason not defined above|0
7702520|NCT01132313|26787773|P1|Overall Study|Other reason not defined above|0
7702521|NCT01132313|26787762|P12|Overall Study|Lack of antiviral response|0
7702522|NCT01132313|26787763|P11|Overall Study|Lack of antiviral response|1
7702523|NCT01132313|26787764|P10|Overall Study|Lack of antiviral response|0
7702524|NCT01132313|26787765|P9|Overall Study|Lack of antiviral response|0
7702525|NCT01132313|26787766|P8|Overall Study|Lack of antiviral response|0
7702526|NCT01132313|26787767|P7|Overall Study|Lack of antiviral response|21
7702527|NCT01132313|26787768|P6|Overall Study|Lack of antiviral response|18
7702528|NCT01132313|26787769|P5|Overall Study|Lack of antiviral response|18
7702529|NCT01132313|26787770|P4|Overall Study|Lack of antiviral response|18
7702530|NCT01132313|26787771|P3|Overall Study|Lack of antiviral response|12
7702531|NCT01132313|26787772|P2|Overall Study|Lack of antiviral response|0
7702532|NCT01132313|26787773|P1|Overall Study|Lack of antiviral response|0
7702533|NCT01132313|26787762|P12|Overall Study|Withdrawal by Subject|0
7702534|NCT01132313|26787763|P11|Overall Study|Withdrawal by Subject|0
7702535|NCT01132313|26787764|P10|Overall Study|Withdrawal by Subject|2
7702536|NCT01132313|26787765|P9|Overall Study|Withdrawal by Subject|0
7702537|NCT01132313|26787766|P8|Overall Study|Withdrawal by Subject|0
7702538|NCT01132313|26787767|P7|Overall Study|Withdrawal by Subject|1
7702539|NCT01132313|26787768|P6|Overall Study|Withdrawal by Subject|0
7702540|NCT01132313|26787769|P5|Overall Study|Withdrawal by Subject|6
7702541|NCT01132313|26787770|P4|Overall Study|Withdrawal by Subject|3
7702542|NCT01132313|26787771|P3|Overall Study|Withdrawal by Subject|3
7702543|NCT01132313|26787772|P2|Overall Study|Withdrawal by Subject|0
7702544|NCT01132313|26787773|P1|Overall Study|Withdrawal by Subject|0
7702545|NCT01132313|26787762|P12|Overall Study|Lost to Follow-up|0
7702546|NCT01132313|26787763|P11|Overall Study|Lost to Follow-up|0
7702547|NCT01132313|26787764|P10|Overall Study|Lost to Follow-up|0
7702548|NCT01132313|26787765|P9|Overall Study|Lost to Follow-up|0
7702549|NCT01132313|26787766|P8|Overall Study|Lost to Follow-up|1
7702550|NCT01132313|26787767|P7|Overall Study|Lost to Follow-up|0
7702551|NCT01132313|26787768|P6|Overall Study|Lost to Follow-up|0
7702552|NCT01132313|26787769|P5|Overall Study|Lost to Follow-up|0
7702553|NCT01132313|26787770|P4|Overall Study|Lost to Follow-up|0
7702554|NCT01132313|26787771|P3|Overall Study|Lost to Follow-up|1
7702555|NCT01132313|26787772|P2|Overall Study|Lost to Follow-up|0
7702556|NCT01132313|26787773|P1|Overall Study|Lost to Follow-up|0
7702557|NCT01132313|26787762|P12|Overall Study|Protocol Violation|0
7702558|NCT01132313|26787763|P11|Overall Study|Protocol Violation|0
7702559|NCT01132313|26787764|P10|Overall Study|Protocol Violation|0
7702560|NCT01132313|26787765|P9|Overall Study|Protocol Violation|0
7702561|NCT01132313|26787766|P8|Overall Study|Protocol Violation|0
7702562|NCT01132313|26787767|P7|Overall Study|Protocol Violation|0
7702563|NCT01132313|26787768|P6|Overall Study|Protocol Violation|0
7702564|NCT01132313|26787769|P5|Overall Study|Protocol Violation|0
7702565|NCT01132313|26787770|P4|Overall Study|Protocol Violation|1
7702566|NCT01132313|26787771|P3|Overall Study|Protocol Violation|0
7702567|NCT01132313|26787772|P2|Overall Study|Protocol Violation|0
7702568|NCT01132313|26787773|P1|Overall Study|Protocol Violation|0
7702569|NCT01132313|26787762|P12|Overall Study|Adverse Event|0
7702570|NCT01132313|26787763|P11|Overall Study|Adverse Event|0
7702571|NCT01132313|26787764|P10|Overall Study|Adverse Event|2
7702572|NCT01132313|26787765|P9|Overall Study|Adverse Event|7
7702573|NCT01132313|26787766|P8|Overall Study|Adverse Event|3
7702574|NCT01132313|26787767|P7|Overall Study|Adverse Event|5
7702575|NCT01132313|26787768|P6|Overall Study|Adverse Event|6
7702576|NCT01132313|26787769|P5|Overall Study|Adverse Event|19
7702577|NCT01132313|26787770|P4|Overall Study|Adverse Event|10
7702578|NCT01132313|26787771|P3|Overall Study|Adverse Event|4
7702579|NCT01132313|26787772|P2|Overall Study|Adverse Event|0
7702580|NCT01132313|26787773|P1|Overall Study|Adverse Event|0
7702581|NCT01132313|26787762|P12|Overall Study|Not treated|0
7702582|NCT01132313|26787763|P11|Overall Study|Not treated|0
7702583|NCT01132313|26787764|P10|Overall Study|Not treated|0
7702584|NCT01132313|26787765|P9|Overall Study|Not treated|0
7702585|NCT01132313|26787766|P8|Overall Study|Not treated|0
7702586|NCT01132313|26787767|P7|Overall Study|Not treated|3
7702587|NCT01132313|26787768|P6|Overall Study|Not treated|1
7702588|NCT01132313|26787769|P5|Overall Study|Not treated|2
7702589|NCT01132313|26787770|P4|Overall Study|Not treated|0
7702590|NCT01132313|26787771|P3|Overall Study|Not treated|0
7702591|NCT01132313|26787772|P2|Overall Study|Not treated|0
7702592|NCT01132313|26787773|P1|Overall Study|Not treated|2
7702593|NCT01132313|26787762|P12|Overall Study|Lack of Efficacy|0
7702594|NCT01132313|26787763|P11|Overall Study|Lack of Efficacy|0
7702595|NCT01132313|26787764|P10|Overall Study|Lack of Efficacy|16
7702596|NCT01132313|26787765|P9|Overall Study|Lack of Efficacy|14
7702597|NCT01132313|26787766|P8|Overall Study|Lack of Efficacy|3
7702598|NCT01132313|26787767|P7|Overall Study|Lack of Efficacy|0
7702599|NCT01132313|26787768|P6|Overall Study|Lack of Efficacy|0
7702600|NCT01132313|26787769|P5|Overall Study|Lack of Efficacy|0
7702601|NCT01132313|26787770|P4|Overall Study|Lack of Efficacy|0
7702602|NCT01132313|26787771|P3|Overall Study|Lack of Efficacy|0
7702603|NCT01132313|26787772|P2|Overall Study|Lack of Efficacy|0
7702604|NCT01132313|26787773|P1|Overall Study|Lack of Efficacy|1
7702605|NCT01132118|26787853|P2|Second Intervention (8 Weeks)|Adverse Event|1
7702606|NCT01132118|26787854|P1|Second Intervention (8 Weeks)|Adverse Event|0
7702607|NCT01132118|26787853|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
7702608|NCT01132118|26787854|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
7702609|NCT01132118|26787853|P2|First Intervention (8 Weeks)|Adverse Event|0
7702610|NCT01132118|26787854|P1|First Intervention (8 Weeks)|Adverse Event|1
7702611|NCT01131676|26787884|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
7702612|NCT01131676|26787885|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
7702613|NCT01131676|26787886|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
7702614|NCT01131676|26787884|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
7702615|NCT01131676|26787885|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
7702616|NCT01131676|26787886|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
7702617|NCT01131676|26787884|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
7702618|NCT01131676|26787885|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
7702619|NCT01131676|26787886|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
7702620|NCT01131676|26787884|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
7702621|NCT01131676|26787885|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
7702622|NCT01131676|26787886|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
7702623|NCT01131676|26787884|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
7702624|NCT01131676|26787885|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
7702625|NCT01131676|26787886|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
7702626|NCT01131676|26787884|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
7702627|NCT01131676|26787885|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
7702628|NCT01131676|26787886|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
7702629|NCT01131676|26787884|P3|Discontinuation From Treatment|Adverse Event|273
7702630|NCT01131676|26787885|P2|Discontinuation From Treatment|Adverse Event|267
7702631|NCT01131676|26787886|P1|Discontinuation From Treatment|Adverse Event|303
7702632|NCT01131676|26787884|P3|Discontinuation From Treatment|Other than those specified|125
7702633|NCT01131676|26787885|P2|Discontinuation From Treatment|Other than those specified|142
7702634|NCT01131676|26787886|P1|Discontinuation From Treatment|Other than those specified|162
7702635|NCT01131676|26787884|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
7702636|NCT01131676|26787885|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
7702637|NCT01131676|26787886|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
7702638|NCT01131676|26787884|P3|Discontinuation From Treatment|Lost to Follow-up|6
7702639|NCT01131676|26787885|P2|Discontinuation From Treatment|Lost to Follow-up|9
7702640|NCT01131676|26787886|P1|Discontinuation From Treatment|Lost to Follow-up|15
7702641|NCT01131676|26787884|P3|Discontinuation From Treatment|Non compliant with protocol|12
7702642|NCT01131676|26787885|P2|Discontinuation From Treatment|Non compliant with protocol|15
7702643|NCT01131676|26787886|P1|Discontinuation From Treatment|Non compliant with protocol|15
7702644|NCT01131676|26787884|P3|Discontinuation From Treatment|Lack of Efficacy|0
7702645|NCT01131676|26787885|P2|Discontinuation From Treatment|Lack of Efficacy|1
7702646|NCT01131676|26787886|P1|Discontinuation From Treatment|Lack of Efficacy|11
7702647|NCT01131676|26787884|P3|Discontinuation From Treatment|Not treated|2
7702648|NCT01131676|26787885|P2|Discontinuation From Treatment|Not treated|2
7702649|NCT01131676|26787886|P1|Discontinuation From Treatment|Not treated|4
7702650|NCT01131676|26787884|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
7702651|NCT01131676|26787885|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
7702652|NCT01131676|26787886|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
7702653|NCT01131585|26787921|P2|Overall Study|Study termination|32
7702654|NCT01131585|26787922|P1|Overall Study|Study termination|78
7702655|NCT01131585|26787921|P2|Overall Study|Administrative problems|1
7702656|NCT01131585|26787922|P1|Overall Study|Administrative problems|1
7702657|NCT01131585|26787921|P2|Overall Study|Lost to Follow-up|1
7702658|NCT01131585|26787922|P1|Overall Study|Lost to Follow-up|0
7702659|NCT01131585|26787921|P2|Overall Study|Withdrawal by Subject|3
7702660|NCT01131585|26787922|P1|Overall Study|Withdrawal by Subject|3
7702661|NCT01131585|26787921|P2|Overall Study|Protocol Violation|1
7702662|NCT01131585|26787922|P1|Overall Study|Protocol Violation|2
7702663|NCT01131585|26787921|P2|Overall Study|Unsatisfactory therapeutic effect|3
7702664|NCT01131585|26787922|P1|Overall Study|Unsatisfactory therapeutic effect|0
7702665|NCT01131585|26787921|P2|Overall Study|Abnormal laboratory value|0
7702666|NCT01131585|26787922|P1|Overall Study|Abnormal laboratory value|1
7702667|NCT01131585|26787921|P2|Overall Study|Adverse Event|2
7702668|NCT01131585|26787922|P1|Overall Study|Adverse Event|0
7702669|NCT01131520|26787930|P2|Overall Study|Subject changed history after enrollment|1
7702670|NCT01131520|26787931|P1|Overall Study|Subject changed history after enrollment|0
7702671|NCT01131520|26787930|P2|Overall Study|Counselor not available|3
7702672|NCT01131520|26787931|P1|Overall Study|Counselor not available|0
7702673|NCT01131520|26787930|P2|Overall Study|Computer problem|0
7702674|NCT01131520|26787931|P1|Overall Study|Computer problem|1
7702675|NCT01131507|26787953|P1|Overall Study|Withdrawal by Subject|1
7702676|NCT01131507|26787953|P1|Overall Study|Lost to Follow-up|1
7702677|NCT01131507|26787953|P1|Overall Study|Adverse Event|1
7702678|NCT01131494|26787958|P1|Overall Study|Withdrawal by Subject|2
7702679|NCT01131455|26787968|P3|Overall Study|Death of PI|0
7702680|NCT01131455|26787969|P2|Overall Study|Death of PI|4
7702681|NCT01131455|26787970|P1|Overall Study|Death of PI|6
7702682|NCT01131325|26787978|P1|Overall Study|The participants discontinued the study as the study got terminated|2
7702683|NCT01131325|26787978|P1|Overall Study|Adverse Event|1
7702684|NCT01131312|26787991|P3|Overall Study|Lost to Follow-up|351
7702685|NCT01131312|26787992|P2|Overall Study|Lost to Follow-up|229
7702686|NCT01131312|26787993|P1|Overall Study|Lost to Follow-up|425
7702687|NCT01131299|26788004|P2|Overall Study|Withdrawal by Subject|7
7702688|NCT01131299|26788005|P1|Overall Study|Withdrawal by Subject|4
7702689|NCT01131260|26788018|P2|Overall Study|Ineligible|2
7702690|NCT01131260|26788019|P1|Overall Study|Ineligible|0
7702691|NCT01131260|26788018|P2|Overall Study|Staff error|1
7702692|NCT01131260|26788019|P1|Overall Study|Staff error|2
7702693|NCT01131260|26788018|P2|Overall Study|Technical problems|6
7702694|NCT01131260|26788019|P1|Overall Study|Technical problems|7
7702695|NCT01131260|26788018|P2|Overall Study|Physician Decision|24
7702696|NCT01131260|26788019|P1|Overall Study|Physician Decision|22
7702697|NCT01131260|26788018|P2|Overall Study|Declined to continue participation|13
7702698|NCT01131260|26788019|P1|Overall Study|Declined to continue participation|8
7702699|NCT01131260|26788018|P2|Overall Study|Randomization error|1
7702700|NCT01131260|26788019|P1|Overall Study|Randomization error|5
7702701|NCT01131182|26788067|P2|Overall Study|Other Reason|0
7702702|NCT01131182|26788068|P1|Overall Study|Other Reason|1
7702703|NCT01131182|26788067|P2|Overall Study|Lost to Follow-up|15
7702704|NCT01131182|26788068|P1|Overall Study|Lost to Follow-up|14
7702705|NCT01131182|26788067|P2|Overall Study|Withdrawal by Subject|1
7702706|NCT01131182|26788068|P1|Overall Study|Withdrawal by Subject|1
7702707|NCT01131130|26788076|P1|Period 3- Crossover|+ Slit lamp finding|1
7702708|NCT01131130|26788076|P1|Period 1 - Baseline|Pregnancy|1
7702709|NCT01131104|26788089|P1|Overall Study|No Information on Index Date of Onset|1
7702710|NCT01131104|26788089|P1|Overall Study|Information Not Available|5
7702711|NCT01131104|26788089|P1|Overall Study|Physician Decision|4
7702712|NCT01131104|26788089|P1|Overall Study|Withdrawal by Subject|3
7702713|NCT01131078|26788096|P3|Overall Study|Other|0
7702714|NCT01131078|26788097|P2|Overall Study|Other|1
7702715|NCT01131078|26788098|P1|Overall Study|Other|0
7702716|NCT01131078|26788096|P3|Overall Study|Death|2
7702717|NCT01131078|26788097|P2|Overall Study|Death|0
7702718|NCT01131078|26788098|P1|Overall Study|Death|4
7702719|NCT01131078|26788096|P3|Overall Study|Physician Decision|8
7702720|NCT01131078|26788097|P2|Overall Study|Physician Decision|6
7702721|NCT01131078|26788098|P1|Overall Study|Physician Decision|10
7702722|NCT01131078|26788096|P3|Overall Study|Non-compliance|0
7702723|NCT01131078|26788097|P2|Overall Study|Non-compliance|0
7702724|NCT01131078|26788098|P1|Overall Study|Non-compliance|3
7702725|NCT01131078|26788096|P3|Overall Study|Withdrawal by Subject|3
7702726|NCT01131078|26788097|P2|Overall Study|Withdrawal by Subject|4
7702727|NCT01131078|26788098|P1|Overall Study|Withdrawal by Subject|2
7702728|NCT01131078|26788096|P3|Overall Study|Lost to Follow-up|1
7702729|NCT01131078|26788097|P2|Overall Study|Lost to Follow-up|1
7702730|NCT01131078|26788098|P1|Overall Study|Lost to Follow-up|1
7702731|NCT01131078|26788096|P3|Overall Study|Protocol Violation|0
7702732|NCT01131078|26788097|P2|Overall Study|Protocol Violation|0
7702733|NCT01131078|26788098|P1|Overall Study|Protocol Violation|1
7702734|NCT01131078|26788096|P3|Overall Study|Progressive Disease|71
7702735|NCT01131078|26788097|P2|Overall Study|Progressive Disease|77
7702736|NCT01131078|26788098|P1|Overall Study|Progressive Disease|58
7702737|NCT01131078|26788096|P3|Overall Study|Adverse Event|17
7702738|NCT01131078|26788097|P2|Overall Study|Adverse Event|12
7702739|NCT01131078|26788098|P1|Overall Study|Adverse Event|22
7702740|NCT01130974|26788185|P2|Overall Study|Ineligibility criteria|2
7702741|NCT01130974|26788186|P1|Overall Study|Ineligibility criteria|5
7702742|NCT01130974|26788185|P2|Overall Study|Withdrawal by Subject|1
7702743|NCT01130974|26788186|P1|Overall Study|Withdrawal by Subject|0
7702744|NCT01130974|26788185|P2|Overall Study|Protocol Violation|10
7702745|NCT01130974|26788186|P1|Overall Study|Protocol Violation|10
7702746|NCT01130883|26788212|P1|Overall Study|Adverse Event|3
7702747|NCT01130883|26788212|P1|Overall Study|Reason Unknown|1
7702748|NCT01130883|26788212|P1|Overall Study|Patient Noncompliance|6
7702749|NCT01130831|26788269|P1|Overall Study|Information was missing|3
7702750|NCT01130831|26788269|P1|Overall Study|Death|4
7702751|NCT01130831|26788269|P1|Overall Study|Withdrawal by Subject|7
7702752|NCT01130597|26788308|P1|Overall Study|Protocol Violation|1
7702753|NCT01130597|26788308|P1|Overall Study|Death|1
7702754|NCT01130597|26788308|P1|Overall Study|Adverse Event|4
7702755|NCT01130597|26788308|P1|Overall Study|Protocol-specified (High K+)|1
7702756|NCT01130532|26788333|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
7702757|NCT01130532|26788334|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7702758|NCT01130532|26788335|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7702759|NCT01130532|26788336|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7702760|NCT01130532|26788333|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
7702761|NCT01130532|26788334|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
7702762|NCT01130532|26788335|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
7702763|NCT01130532|26788336|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
7702764|NCT01130532|26788333|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
7702765|NCT01130532|26788334|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7702766|NCT01130532|26788335|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7702767|NCT01130532|26788336|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7702768|NCT01130532|26788333|P4|Period IV (Weeks 13-16)|Adverse Event|1
7702769|NCT01130532|26788334|P3|Period IV (Weeks 13-16)|Adverse Event|0
7702770|NCT01130532|26788335|P2|Period IV (Weeks 13-16)|Adverse Event|0
7702771|NCT01130532|26788336|P1|Period IV (Weeks 13-16)|Adverse Event|0
7702772|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
7702773|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
7702774|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
7702775|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
7702776|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Sponsor Decision|0
7702777|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Sponsor Decision|2
7702778|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Sponsor Decision|4
7702779|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Sponsor Decision|3
7702780|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Protocol Violation|0
7702781|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Protocol Violation|1
7702782|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Protocol Violation|0
7702783|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Protocol Violation|0
7702784|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
7702785|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
7702786|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
7702787|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
7702788|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
7702789|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
7702790|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
7702791|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
7702792|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
7702793|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
7702794|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
7702795|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
7702796|NCT01130532|26788333|P4|Period III (Weeks 0-12)|Adverse Event|0
7702797|NCT01130532|26788334|P3|Period III (Weeks 0-12)|Adverse Event|2
7702798|NCT01130532|26788335|P2|Period III (Weeks 0-12)|Adverse Event|3
7702799|NCT01130532|26788336|P1|Period III (Weeks 0-12)|Adverse Event|3
7702800|NCT01130493|26788381|P3|Part 2: OLE|Withdrawal by Subject|4
7702801|NCT01130493|26788382|P2|Part 2: OLE|Withdrawal by Subject|1
7702802|NCT01130493|26788383|P1|Part 2: OLE|Withdrawal by Subject|0
7702803|NCT01130493|26788381|P3|Part 2: OLE|Adverse Event|1
7702804|NCT01130493|26788382|P2|Part 2: OLE|Adverse Event|2
7702805|NCT01130493|26788383|P1|Part 2: OLE|Adverse Event|0
7702806|NCT01130493|26788381|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
7702807|NCT01130493|26788382|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
7702808|NCT01130493|26788383|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
7702809|NCT01130493|26788381|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
7702810|NCT01130493|26788382|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
7702811|NCT01130493|26788383|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
7702812|NCT01130493|26788381|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
7702813|NCT01130493|26788382|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
7702814|NCT01130493|26788383|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
7702815|NCT01130493|26788381|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
7702816|NCT01130493|26788382|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
7702817|NCT01130493|26788383|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
7702818|NCT01130493|26788381|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
7702819|NCT01130493|26788382|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
7702820|NCT01130493|26788383|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
7702821|NCT01130493|26788381|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
7702822|NCT01130493|26788382|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
7702823|NCT01130493|26788383|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
7702824|NCT01130493|26788381|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
7702825|NCT01130493|26788382|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
7702826|NCT01130493|26788383|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
7702827|NCT01130493|26788381|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
7702828|NCT01130493|26788382|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
7702829|NCT01130493|26788383|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
7702830|NCT01130493|26788381|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
7702831|NCT01130493|26788382|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
7702832|NCT01130493|26788383|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
7702833|NCT01130493|26788381|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
7702834|NCT01130493|26788382|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
7702835|NCT01130493|26788383|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
7702836|NCT01130493|26788381|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
7702837|NCT01130493|26788382|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
7702838|NCT01130493|26788383|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
7702839|NCT01130493|26788381|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
7702840|NCT01130493|26788382|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
7702841|NCT01130493|26788383|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
7702842|NCT01130337|26788400|P1|Overall Study|Surgical resection (R2)|1
7702843|NCT01130337|26788400|P1|Overall Study|Toxicity, AE/intercurrent disease|7
7702844|NCT01130337|26788400|P1|Overall Study|Disease progression|1
7702845|NCT01130337|26788400|P1|Overall Study|Death|1
7702846|NCT01130337|26788400|P1|Overall Study|Principal investigator decision|1
7702847|NCT01130337|26788400|P1|Overall Study|Withdrawal by Subject|3
7702848|NCT01130272|26788412|P5|Overall Study|Study arm discontinued|0
7702849|NCT01130272|26788413|P4|Overall Study|Study arm discontinued|0
7702850|NCT01130272|26788414|P3|Overall Study|Study arm discontinued|0
7702851|NCT01130272|26788415|P2|Overall Study|Study arm discontinued|0
7702852|NCT01130272|26788416|P1|Overall Study|Study arm discontinued|38
7702853|NCT01130272|26788412|P5|Overall Study|Sponsor decision|16
7702854|NCT01130272|26788413|P4|Overall Study|Sponsor decision|13
7702855|NCT01130272|26788414|P3|Overall Study|Sponsor decision|16
7702856|NCT01130272|26788415|P2|Overall Study|Sponsor decision|15
7702857|NCT01130272|26788416|P1|Overall Study|Sponsor decision|6
7702858|NCT01130272|26788412|P5|Overall Study|Physician Decision|2
7702859|NCT01130272|26788413|P4|Overall Study|Physician Decision|1
7702860|NCT01130272|26788414|P3|Overall Study|Physician Decision|0
7702861|NCT01130272|26788415|P2|Overall Study|Physician Decision|1
7702862|NCT01130272|26788416|P1|Overall Study|Physician Decision|1
7702863|NCT01130272|26788412|P5|Overall Study|Withdrawal by Subject|8
7702864|NCT01130272|26788413|P4|Overall Study|Withdrawal by Subject|9
7702865|NCT01130272|26788414|P3|Overall Study|Withdrawal by Subject|10
7702866|NCT01130272|26788415|P2|Overall Study|Withdrawal by Subject|11
7702867|NCT01130272|26788416|P1|Overall Study|Withdrawal by Subject|4
7702868|NCT01130272|26788412|P5|Overall Study|Lost to Follow-up|6
7702869|NCT01130272|26788413|P4|Overall Study|Lost to Follow-up|7
7702870|NCT01130272|26788414|P3|Overall Study|Lost to Follow-up|4
7702871|NCT01130272|26788415|P2|Overall Study|Lost to Follow-up|3
7702872|NCT01130272|26788416|P1|Overall Study|Lost to Follow-up|4
7702873|NCT01130272|26788412|P5|Overall Study|Protocol Violation|5
7702874|NCT01130272|26788413|P4|Overall Study|Protocol Violation|5
7702875|NCT01130272|26788414|P3|Overall Study|Protocol Violation|3
7702876|NCT01130272|26788415|P2|Overall Study|Protocol Violation|0
7702877|NCT01130272|26788416|P1|Overall Study|Protocol Violation|0
7702878|NCT01130272|26788412|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7702879|NCT01130272|26788413|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
7702880|NCT01130272|26788414|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7702881|NCT01130272|26788415|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7702882|NCT01130272|26788416|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7702883|NCT01130272|26788412|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
7702884|NCT01130272|26788413|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
7702885|NCT01130272|26788414|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
7702886|NCT01130272|26788415|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7702887|NCT01130272|26788416|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7702888|NCT01130272|26788412|P5|Overall Study|Rescue medications due to diarrhea|6
7702889|NCT01130272|26788413|P4|Overall Study|Rescue medications due to diarrhea|8
7702890|NCT01130272|26788414|P3|Overall Study|Rescue medications due to diarrhea|8
7702891|NCT01130272|26788415|P2|Overall Study|Rescue medications due to diarrhea|5
7702892|NCT01130272|26788416|P1|Overall Study|Rescue medications due to diarrhea|3
7702893|NCT01130272|26788412|P5|Overall Study|IVRS-confirmed constipation|0
7702894|NCT01130272|26788413|P4|Overall Study|IVRS-confirmed constipation|2
7702895|NCT01130272|26788414|P3|Overall Study|IVRS-confirmed constipation|1
7702896|NCT01130272|26788415|P2|Overall Study|IVRS-confirmed constipation|1
7702897|NCT01130272|26788416|P1|Overall Study|IVRS-confirmed constipation|0
7702898|NCT01130272|26788412|P5|Overall Study|Adverse Event|7
7702899|NCT01130272|26788413|P4|Overall Study|Adverse Event|22
7702900|NCT01130272|26788414|P3|Overall Study|Adverse Event|6
7702901|NCT01130272|26788415|P2|Overall Study|Adverse Event|5
7702902|NCT01130272|26788416|P1|Overall Study|Adverse Event|2
7702903|NCT01130168|26788453|P6|Period 1|Adverse Event|0
7702904|NCT01130168|26788454|P5|Period 1|Adverse Event|0
7702905|NCT01130168|26788455|P4|Period 1|Adverse Event|1
7702906|NCT01130168|26788456|P3|Period 1|Adverse Event|0
7702907|NCT01130168|26788457|P2|Period 1|Adverse Event|0
7702908|NCT01130168|26788458|P1|Period 1|Adverse Event|0
7702909|NCT01130168|26788453|P6|Period 1|Discontinued For Other Reason|0
7702910|NCT01130168|26788454|P5|Period 1|Discontinued For Other Reason|0
7702911|NCT01130168|26788455|P4|Period 1|Discontinued For Other Reason|1
7702912|NCT01130168|26788456|P3|Period 1|Discontinued For Other Reason|1
7702913|NCT01130168|26788457|P2|Period 1|Discontinued For Other Reason|0
7702914|NCT01130168|26788458|P1|Period 1|Discontinued For Other Reason|0
7702915|NCT01130168|26788453|P6|Period 1|Withdrawal by Subject|0
7702916|NCT01130168|26788454|P5|Period 1|Withdrawal by Subject|0
7702917|NCT01130168|26788455|P4|Period 1|Withdrawal by Subject|1
7702918|NCT01130168|26788456|P3|Period 1|Withdrawal by Subject|0
7702919|NCT01130168|26788457|P2|Period 1|Withdrawal by Subject|1
7702920|NCT01130168|26788458|P1|Period 1|Withdrawal by Subject|0
7702921|NCT01130103|26788495|P2|Maintenance Treatment|Withdrawal by Subject|0
7702922|NCT01130103|26788496|P1|Maintenance Treatment|Withdrawal by Subject|1
7702923|NCT01130103|26788495|P2|Maintenance Treatment|Lost to Follow-up|1
7702924|NCT01130103|26788496|P1|Maintenance Treatment|Lost to Follow-up|1
7702925|NCT01130103|26788495|P2|Maintenance Treatment|Lack of Efficacy|1
7702926|NCT01130103|26788496|P1|Maintenance Treatment|Lack of Efficacy|0
7702927|NCT01130103|26788495|P2|Randomized Treatment|Withdrawal by Subject|2
7702928|NCT01130103|26788496|P1|Randomized Treatment|Withdrawal by Subject|1
7702929|NCT01130103|26788495|P2|Randomized Treatment|Protocol Violation|2
7702930|NCT01130103|26788496|P1|Randomized Treatment|Protocol Violation|3
7702931|NCT01130103|26788495|P2|Randomized Treatment|Lost to Follow-up|0
7702932|NCT01130103|26788496|P1|Randomized Treatment|Lost to Follow-up|1
7702933|NCT01130103|26788495|P2|Randomized Treatment|Adverse Event|1
7702934|NCT01130103|26788496|P1|Randomized Treatment|Adverse Event|1
7702935|NCT01130051|26788510|P2|Washout Period of 14 Days|Protocol Violation|1
7702936|NCT01130051|26788511|P1|Washout Period of 14 Days|Protocol Violation|1
7702937|NCT01130051|26788510|P2|Washout Period of 14 Days|Withdrawal by Subject|1
7702938|NCT01130051|26788511|P1|Washout Period of 14 Days|Withdrawal by Subject|0
7702939|NCT01129960|26788525|P4|Overall Study|Pregnancy|0
7702940|NCT01129960|26788526|P3|Overall Study|Pregnancy|0
7702941|NCT01129960|26788527|P2|Overall Study|Pregnancy|0
7702942|NCT01129960|26788528|P1|Overall Study|Pregnancy|1
7702943|NCT01129960|26788525|P4|Overall Study|Physician Decision|0
7702944|NCT01129960|26788526|P3|Overall Study|Physician Decision|0
7702945|NCT01129960|26788527|P2|Overall Study|Physician Decision|0
7702946|NCT01129960|26788528|P1|Overall Study|Physician Decision|1
7702947|NCT01129960|26788525|P4|Overall Study|Discontinuation of the study by Sponsor|0
7702948|NCT01129960|26788526|P3|Overall Study|Discontinuation of the study by Sponsor|0
7702949|NCT01129960|26788527|P2|Overall Study|Discontinuation of the study by Sponsor|1
7702950|NCT01129960|26788528|P1|Overall Study|Discontinuation of the study by Sponsor|0
7702951|NCT01129960|26788525|P4|Overall Study|Lost to Follow-up|3
7702952|NCT01129960|26788526|P3|Overall Study|Lost to Follow-up|3
7702953|NCT01129960|26788527|P2|Overall Study|Lost to Follow-up|2
7702954|NCT01129960|26788528|P1|Overall Study|Lost to Follow-up|0
7702955|NCT01129960|26788525|P4|Overall Study|Protocol Violation|0
7702956|NCT01129960|26788526|P3|Overall Study|Protocol Violation|3
7702957|NCT01129960|26788527|P2|Overall Study|Protocol Violation|2
7702958|NCT01129960|26788528|P1|Overall Study|Protocol Violation|1
7702959|NCT01129960|26788525|P4|Overall Study|Adverse Event|7
7702960|NCT01129960|26788526|P3|Overall Study|Adverse Event|16
7702961|NCT01129960|26788527|P2|Overall Study|Adverse Event|16
7702962|NCT01129960|26788528|P1|Overall Study|Adverse Event|23
7702963|NCT01129960|26788525|P4|Overall Study|Lack of Efficacy|1
7702964|NCT01129960|26788526|P3|Overall Study|Lack of Efficacy|1
7702965|NCT01129960|26788527|P2|Overall Study|Lack of Efficacy|1
7702966|NCT01129960|26788528|P1|Overall Study|Lack of Efficacy|1
7702967|NCT01129960|26788525|P4|Overall Study|Withdrawal by Subject|2
7702968|NCT01129960|26788526|P3|Overall Study|Withdrawal by Subject|3
7702969|NCT01129960|26788527|P2|Overall Study|Withdrawal by Subject|0
7702970|NCT01129960|26788528|P1|Overall Study|Withdrawal by Subject|3
7702971|NCT01129921|26788540|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
7702972|NCT01129921|26788541|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
7702973|NCT01129921|26788540|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
7702974|NCT01129921|26788541|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
7702975|NCT01129921|26788540|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
7702976|NCT01129921|26788541|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
7702977|NCT01129921|26788540|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
7702978|NCT01129921|26788541|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
7702979|NCT01129882|26788551|P1|Overall Study|Withdrawal by Subject|160
7702980|NCT01129882|26788551|P1|Overall Study|Trial Termination by Sponsor|6
7702981|NCT01129882|26788551|P1|Overall Study|Withdrawal Criteria Met|19
7702982|NCT01129882|26788551|P1|Overall Study|Protocol Deviation|3
7702983|NCT01129882|26788551|P1|Overall Study|Physician Decision|27
7702984|NCT01129882|26788551|P1|Overall Study|Lost to Follow-up|13
7702985|NCT01129882|26788551|P1|Overall Study|Lack of Efficacy|5
7702986|NCT01129882|26788551|P1|Overall Study|Death|6
7702987|NCT01129882|26788551|P1|Overall Study|Adverse Event|39
7702988|NCT01129622|26788570|P1|Overall Study|Withdrawal by Subject|2
7702989|NCT01129583|26788581|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
7702990|NCT01129583|26788582|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
7702991|NCT01129583|26788581|P2|Overall Study|Lost to Follow-up|1
7702992|NCT01129583|26788582|P1|Overall Study|Lost to Follow-up|1
7702993|NCT01129583|26788581|P2|Overall Study|Death|0
7702994|NCT01129583|26788582|P1|Overall Study|Death|1
7702995|NCT01129557|26788595|P3|Overall Study|Novartis terminated study early|2
7702996|NCT01129557|26788596|P2|Overall Study|Novartis terminated study early|3
7702997|NCT01129557|26788597|P1|Overall Study|Novartis terminated study early|3
7702998|NCT01129557|26788595|P3|Overall Study|Adverse Event|2
7702999|NCT01129557|26788596|P2|Overall Study|Adverse Event|2
7703000|NCT01129557|26788597|P1|Overall Study|Adverse Event|1
7703001|NCT01129336|26788710|P2|Overall Study|Death|4
7703002|NCT01129336|26788711|P1|Overall Study|Death|0
7703003|NCT01129336|26788710|P2|Overall Study|Missing Study Completion Status|3
7703004|NCT01129336|26788711|P1|Overall Study|Missing Study Completion Status|2
7703005|NCT01129336|26788710|P2|Overall Study|Adverse Event|1
7703006|NCT01129336|26788711|P1|Overall Study|Adverse Event|0
7703007|NCT01129336|26788710|P2|Overall Study|Withdrawal by Subject|4
7703008|NCT01129336|26788711|P1|Overall Study|Withdrawal by Subject|7
7703009|NCT01129336|26788710|P2|Overall Study|Lost to Follow-up|0
7703010|NCT01129336|26788711|P1|Overall Study|Lost to Follow-up|1
7703011|NCT01129336|26788710|P2|Overall Study|Disease Progression|4
7703012|NCT01129336|26788711|P1|Overall Study|Disease Progression|1
7703013|NCT01129336|26788710|P2|Overall Study|Protocol Violation|0
7703014|NCT01129336|26788711|P1|Overall Study|Protocol Violation|1
7703015|NCT01129284|26788726|P3|Overall Study|Adverse Event|1
7703016|NCT01129284|26788727|P2|Overall Study|Adverse Event|0
7703017|NCT01129284|26788728|P1|Overall Study|Adverse Event|2
7703018|NCT01129128|26788776|P3|Overall Study|Physician Decision|0
7703019|NCT01129128|26788777|P2|Overall Study|Physician Decision|0
7703020|NCT01129128|26788778|P1|Overall Study|Physician Decision|1
7703021|NCT01129128|26788776|P3|Overall Study|Withdrawal by Subject|3
7703022|NCT01129128|26788777|P2|Overall Study|Withdrawal by Subject|1
7703023|NCT01129128|26788778|P1|Overall Study|Withdrawal by Subject|0
7703024|NCT01129128|26788776|P3|Overall Study|Protocol Violation|0
7703025|NCT01129128|26788777|P2|Overall Study|Protocol Violation|1
7703026|NCT01129128|26788778|P1|Overall Study|Protocol Violation|0
7703027|NCT01129128|26788776|P3|Overall Study|Lost to Follow-up|1
7703028|NCT01129128|26788777|P2|Overall Study|Lost to Follow-up|2
7703029|NCT01129128|26788778|P1|Overall Study|Lost to Follow-up|2
7703030|NCT01129115|26788802|P4|Overall Study|Protocol Violation|2
7703031|NCT01129115|26788803|P3|Overall Study|Protocol Violation|2
7703032|NCT01129115|26788804|P2|Overall Study|Protocol Violation|2
7703033|NCT01129115|26788805|P1|Overall Study|Protocol Violation|0
7703034|NCT01129115|26788802|P4|Overall Study|Withdrawal by Subject|4
7703035|NCT01129115|26788803|P3|Overall Study|Withdrawal by Subject|1
7703036|NCT01129115|26788804|P2|Overall Study|Withdrawal by Subject|3
7703037|NCT01129115|26788805|P1|Overall Study|Withdrawal by Subject|1
7703038|NCT01129115|26788802|P4|Overall Study|Adverse Event|3
7703039|NCT01129115|26788803|P3|Overall Study|Adverse Event|3
7703040|NCT01129115|26788804|P2|Overall Study|Adverse Event|2
7703041|NCT01129115|26788805|P1|Overall Study|Adverse Event|1
7703042|NCT01129102|26788842|P3|Overall Study|Lost to Follow-up|0
7703043|NCT01129102|26788843|P2|Overall Study|Lost to Follow-up|0
7703044|NCT01129102|26788844|P1|Overall Study|Lost to Follow-up|2
7703045|NCT01129102|26788842|P3|Overall Study|Adverse Event|1
7703046|NCT01129102|26788843|P2|Overall Study|Adverse Event|2
7703047|NCT01129102|26788844|P1|Overall Study|Adverse Event|2
7703048|NCT01129102|26788842|P3|Overall Study|Pregnancy|1
7703049|NCT01129102|26788843|P2|Overall Study|Pregnancy|0
7703050|NCT01129102|26788844|P1|Overall Study|Pregnancy|0
7703051|NCT01129102|26788842|P3|Overall Study|Protocol Violation|1
7703052|NCT01129102|26788843|P2|Overall Study|Protocol Violation|1
7703053|NCT01129102|26788844|P1|Overall Study|Protocol Violation|0
7703054|NCT01129102|26788842|P3|Overall Study|Withdrawal by Subject|3
7703055|NCT01129102|26788843|P2|Overall Study|Withdrawal by Subject|0
7703056|NCT01129102|26788844|P1|Overall Study|Withdrawal by Subject|2
7703057|NCT01129102|26788842|P3|Overall Study|No study drug treatment|1
7703058|NCT01129102|26788843|P2|Overall Study|No study drug treatment|3
7703059|NCT01129102|26788844|P1|Overall Study|No study drug treatment|2
7703060|NCT01129024|26788853|P1|Overall Study|Needed a Platelet Transfusion|1
7703061|NCT01129024|26788853|P1|Overall Study|Lack of Efficacy|3
7703062|NCT01129024|26788853|P1|Overall Study|Withdrawal by Subject|2
7703063|NCT01129024|26788853|P1|Overall Study|Study Terminated by Sponsor|8
7703064|NCT01129024|26788853|P1|Overall Study|Physician Decision|5
7703065|NCT01129011|26788864|P2|Overall Study|misc|4
7703066|NCT01129011|26788865|P1|Overall Study|misc|7
7703067|NCT01129011|26788864|P2|Overall Study|Duodenal Ulcer|8
7703068|NCT01129011|26788865|P1|Overall Study|Duodenal Ulcer|2
7703069|NCT01129011|26788864|P2|Overall Study|Lost to Follow-up|7
7703070|NCT01129011|26788865|P1|Overall Study|Lost to Follow-up|6
7703071|NCT01129011|26788864|P2|Overall Study|Withdrawal by Subject|8
7703072|NCT01129011|26788865|P1|Overall Study|Withdrawal by Subject|24
7703073|NCT01129011|26788864|P2|Overall Study|Adverse Event|30
7703074|NCT01129011|26788865|P1|Overall Study|Adverse Event|20
7703075|NCT01128959|26788920|P1|Treatment Period|Withdrawal by Subject|1
7703076|NCT01128959|26788920|P1|Treatment Period|Adverse Event|3
7703077|NCT01128959|26788920|P1|Lead in Period|Adverse Event|3
7703078|NCT01128946|26788926|P4|Period III|Protocol Violation|0
7703079|NCT01128946|26788927|P3|Period III|Protocol Violation|0
7703080|NCT01128946|26788928|P2|Period III|Protocol Violation|0
7703081|NCT01128946|26788929|P1|Period III|Protocol Violation|1
7703082|NCT01128946|26788926|P4|Period II|Withdrawal by Subject|1
7703083|NCT01128946|26788927|P3|Period II|Withdrawal by Subject|0
7703084|NCT01128946|26788928|P2|Period II|Withdrawal by Subject|0
7703085|NCT01128946|26788929|P1|Period II|Withdrawal by Subject|0
7703086|NCT01128946|26788926|P4|Period II|Protocol Violation|0
7703087|NCT01128946|26788927|P3|Period II|Protocol Violation|0
7703088|NCT01128946|26788928|P2|Period II|Protocol Violation|1
7703089|NCT01128946|26788929|P1|Period II|Protocol Violation|0
7703090|NCT01128946|26788926|P4|Period I|Withdrawal by Subject|1
7703091|NCT01128946|26788927|P3|Period I|Withdrawal by Subject|1
7703092|NCT01128946|26788928|P2|Period I|Withdrawal by Subject|0
7703093|NCT01128946|26788929|P1|Period I|Withdrawal by Subject|0
7703094|NCT01128946|26788926|P4|Period I|Protocol Violation|0
7703095|NCT01128946|26788927|P3|Period I|Protocol Violation|0
7703096|NCT01128946|26788928|P2|Period I|Protocol Violation|1
7703097|NCT01128946|26788929|P1|Period I|Protocol Violation|0
7703098|NCT01128894|26788947|P2|Overall Study|Conflicting HbA1c Results at Screening|0
7703099|NCT01128894|26788948|P1|Overall Study|Conflicting HbA1c Results at Screening|1
7703100|NCT01128894|26788947|P2|Overall Study|Physician Decision|1
7703101|NCT01128894|26788948|P1|Overall Study|Physician Decision|2
7703102|NCT01128894|26788947|P2|Overall Study|Withdrawal by Subject|12
7703103|NCT01128894|26788948|P1|Overall Study|Withdrawal by Subject|10
7703104|NCT01128894|26788947|P2|Overall Study|Lost to Follow-up|8
7703105|NCT01128894|26788948|P1|Overall Study|Lost to Follow-up|8
7703106|NCT01128894|26788947|P2|Overall Study|Noncompliance|5
7703107|NCT01128894|26788948|P1|Overall Study|Noncompliance|4
7703108|NCT01128894|26788947|P2|Overall Study|Protocol Violation|1
7703109|NCT01128894|26788948|P1|Overall Study|Protocol Violation|2
7703110|NCT01128894|26788947|P2|Overall Study|Adverse Event|41
7703111|NCT01128894|26788948|P1|Overall Study|Adverse Event|31
7703112|NCT01128842|26788966|P1|Overall Study|Disease Progression|6
7703113|NCT01128842|26788966|P1|Overall Study|Adverse Event|1
7703114|NCT01128738|26788983|P2|Second TP|Withdrawal by Subject|2
7703115|NCT01128738|26788984|P1|Second TP|Withdrawal by Subject|0
7703116|NCT01128738|26788983|P2|Second TP|Lost to Follow-up|1
7703117|NCT01128738|26788984|P1|Second TP|Lost to Follow-up|0
7703118|NCT01128738|26788983|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
7703119|NCT01128738|26788984|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
7703120|NCT01128738|26788983|P2|First Treatment Phase (TP)|Lost to Follow-up|0
7703121|NCT01128738|26788984|P1|First Treatment Phase (TP)|Lost to Follow-up|1
7703122|NCT01128621|26789109|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
7703123|NCT01128621|26789110|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
7703124|NCT01128595|26789231|P4|Treatment Period 3|Withdrawal by Subject|0
7703125|NCT01128595|26789232|P3|Treatment Period 3|Withdrawal by Subject|0
7703126|NCT01128595|26789233|P2|Treatment Period 3|Withdrawal by Subject|1
7703127|NCT01128595|26789234|P1|Treatment Period 3|Withdrawal by Subject|0
7703128|NCT01128569|26789264|P6|Treatment Period 2|Withdrawal by Subject|0
7703129|NCT01128569|26789265|P5|Treatment Period 2|Withdrawal by Subject|0
7703130|NCT01128569|26789266|P4|Treatment Period 2|Withdrawal by Subject|0
7703131|NCT01128569|26789267|P3|Treatment Period 2|Withdrawal by Subject|0
7703132|NCT01128569|26789268|P2|Treatment Period 2|Withdrawal by Subject|1
7703133|NCT01128569|26789269|P1|Treatment Period 2|Withdrawal by Subject|0
7703134|NCT01128569|26789264|P6|Washout Period 1|Adverse Event|0
7703135|NCT01128569|26789265|P5|Washout Period 1|Adverse Event|0
7703136|NCT01128569|26789266|P4|Washout Period 1|Adverse Event|0
7703137|NCT01128569|26789267|P3|Washout Period 1|Adverse Event|1
7703138|NCT01128569|26789268|P2|Washout Period 1|Adverse Event|0
7703139|NCT01128569|26789269|P1|Washout Period 1|Adverse Event|0
7703140|NCT01128543|26789286|P1|Overall Study|Protocol Violation|1
7703141|NCT01128543|26789286|P1|Overall Study|Withdrawal by Subject|3
7703142|NCT01128413|26789312|P2|Overall Study|Pt made DNR|0
7703143|NCT01128413|26789313|P1|Overall Study|Pt made DNR|1
7703144|NCT01128413|26789312|P2|Overall Study|NICOM Monitor Problems|1
7703145|NCT01128413|26789313|P1|Overall Study|NICOM Monitor Problems|2
7703146|NCT01128413|26789312|P2|Overall Study|Withdrawal by Subject|0
7703147|NCT01128413|26789313|P1|Overall Study|Withdrawal by Subject|1
7703148|NCT01128400|26789322|P3|Overall Study|Excluded due to sinus problems|0
7703149|NCT01128400|26789323|P2|Overall Study|Excluded due to sinus problems|1
7703150|NCT01128400|26789324|P1|Overall Study|Excluded due to sinus problems|0
7703151|NCT01128400|26789322|P3|Overall Study|were not invited to participate on taste|15
7703152|NCT01128400|26789323|P2|Overall Study|were not invited to participate on taste|0
7703153|NCT01128400|26789324|P1|Overall Study|were not invited to participate on taste|0
7703154|NCT01128400|26789322|P3|Overall Study|Screening failure|0
7703155|NCT01128400|26789323|P2|Overall Study|Screening failure|0
7703156|NCT01128400|26789324|P1|Overall Study|Screening failure|1
7703157|NCT01128400|26789322|P3|Overall Study|Lost to Follow-up|1
7703158|NCT01128400|26789323|P2|Overall Study|Lost to Follow-up|0
7703159|NCT01128400|26789324|P1|Overall Study|Lost to Follow-up|1
7703160|NCT01128387|26789337|P2|Overall Study|Physician Decision|1
7703161|NCT01128387|26789338|P1|Overall Study|Physician Decision|0
7703162|NCT01128361|26789348|P2|Overall Study|Withdrawal by Subject|2
7703163|NCT01128361|26789349|P1|Overall Study|Withdrawal by Subject|5
7703164|NCT01128361|26789348|P2|Overall Study|Lost to Follow-up|1
7703165|NCT01128361|26789349|P1|Overall Study|Lost to Follow-up|0
7703166|NCT01128296|26789361|P6|Overall Study|Withdrawal by Subject|2
7703167|NCT01128296|26789362|P5|Overall Study|Withdrawal by Subject|0
7703168|NCT01128296|26789363|P4|Overall Study|Withdrawal by Subject|0
7703169|NCT01128296|26789364|P3|Overall Study|Withdrawal by Subject|0
7703170|NCT01128296|26789365|P2|Overall Study|Withdrawal by Subject|0
7703171|NCT01128296|26789366|P1|Overall Study|Withdrawal by Subject|0
7703172|NCT01128296|26789361|P6|Overall Study|Physician Decision|3
7703173|NCT01128296|26789362|P5|Overall Study|Physician Decision|0
7703174|NCT01128296|26789363|P4|Overall Study|Physician Decision|0
7703175|NCT01128296|26789364|P3|Overall Study|Physician Decision|0
7703176|NCT01128296|26789365|P2|Overall Study|Physician Decision|0
7703177|NCT01128296|26789366|P1|Overall Study|Physician Decision|0
7703178|NCT01128244|26789397|P1|Overall Study|Scheduling conflict|2
7703179|NCT01128244|26789397|P1|Overall Study|Adverse Event|1
7703180|NCT01128179|26789438|P2|Overall Study|Protocol Violation|0
7703181|NCT01128179|26789439|P1|Overall Study|Protocol Violation|1
7703182|NCT01128179|26789438|P2|Overall Study|Death|0
7703183|NCT01128179|26789439|P1|Overall Study|Death|1
7703184|NCT01128153|26789459|P2|Overall Study|Developed discontinuation criteria|1
7703185|NCT01128153|26789460|P1|Overall Study|Developed discontinuation criteria|1
7703186|NCT01128153|26789459|P2|Overall Study|Protocol Violation|0
7703187|NCT01128153|26789460|P1|Overall Study|Protocol Violation|2
7703188|NCT01128153|26789459|P2|Overall Study|Incorrect enrolment to study|1
7703189|NCT01128153|26789460|P1|Overall Study|Incorrect enrolment to study|2
7703190|NCT01128153|26789459|P2|Overall Study|Withdrawal by Subject|3
7703191|NCT01128153|26789460|P1|Overall Study|Withdrawal by Subject|2
7703192|NCT01128153|26789459|P2|Overall Study|Condition under investigation worsened|7
7703193|NCT01128153|26789460|P1|Overall Study|Condition under investigation worsened|8
7703194|NCT01128153|26789459|P2|Overall Study|Adverse Event|3
7703195|NCT01128153|26789460|P1|Overall Study|Adverse Event|1
7703196|NCT01128114|26789476|P1|Overall Study|Screening Failed|2
7703197|NCT01128114|26789476|P1|Overall Study|Treatment Withdrawn|6
7703198|NCT01127893|26789493|P1|Overall Study|Study Termination by the Sponsor|1
7703199|NCT01127763|26789518|P1|Overall Study|Physician Decision|2
7703200|NCT01127763|26789518|P1|Overall Study|Withdrawal by Subject|1
7703201|NCT01127763|26789518|P1|Overall Study|Adverse Event|2
7703202|NCT01127646|26789563|P2|Overall Study|Protocol Violation|1
7703203|NCT01127646|26789564|P1|Overall Study|Protocol Violation|0
7703204|NCT01127646|26789563|P2|Overall Study|Entry Criteria Not Met|0
7703205|NCT01127646|26789564|P1|Overall Study|Entry Criteria Not Met|1
7703206|NCT01127633|26789598|P2|Overall Study|Not treated|0
7703207|NCT01127633|26789599|P1|Overall Study|Not treated|1
7703208|NCT01127633|26789598|P2|Overall Study|Abnormal Lab/ECG Result|1
7703209|NCT01127633|26789599|P1|Overall Study|Abnormal Lab/ECG Result|0
7703210|NCT01127633|26789598|P2|Overall Study|Protocol Violation|16
7703211|NCT01127633|26789599|P1|Overall Study|Protocol Violation|8
7703212|NCT01127633|26789598|P2|Overall Study|Sponsor Decision|195
7703213|NCT01127633|26789599|P1|Overall Study|Sponsor Decision|163
7703214|NCT01127633|26789598|P2|Overall Study|Withdrawal by Subject|72
7703215|NCT01127633|26789599|P1|Overall Study|Withdrawal by Subject|57
7703216|NCT01127633|26789598|P2|Overall Study|Physician Decision|45
7703217|NCT01127633|26789599|P1|Overall Study|Physician Decision|60
7703218|NCT01127633|26789598|P2|Overall Study|Parent/Caregiver Decision|228
7703219|NCT01127633|26789599|P1|Overall Study|Parent/Caregiver Decision|246
7703220|NCT01127633|26789598|P2|Overall Study|Lost to Follow-up|0
7703221|NCT01127633|26789599|P1|Overall Study|Lost to Follow-up|4
7703222|NCT01127633|26789598|P2|Overall Study|Death|43
7703223|NCT01127633|26789599|P1|Overall Study|Death|40
7703224|NCT01127633|26789598|P2|Overall Study|Adverse Event|73
7703225|NCT01127633|26789599|P1|Overall Study|Adverse Event|74
7703226|NCT01127607|26789631|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
7703227|NCT01127607|26789632|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
7703228|NCT01127607|26789631|P2|Phase II (Between Subjects)|Lost to Follow-up|2
7703229|NCT01127607|26789632|P1|Phase II (Between Subjects)|Lost to Follow-up|0
7703230|NCT01127373|26789776|P1|Overall Study|Disease progression|1
7703231|NCT01127373|26789776|P1|Overall Study|Withdrawal by Subject|1
7703232|NCT01127373|26789776|P1|Overall Study|Lost to Follow-up|7
7703233|NCT01127373|26789776|P1|Overall Study|Not Treated|3
7703234|NCT01127256|26789824|P2|Overall Study|Protocol Violation|0
7703235|NCT01127256|26789825|P1|Overall Study|Protocol Violation|1
7703236|NCT01127256|26789824|P2|Overall Study|Withdrawal by Subject|9
7703237|NCT01127256|26789825|P1|Overall Study|Withdrawal by Subject|5
7703238|NCT01127256|26789824|P2|Overall Study|Lost to Follow-up|17
7703239|NCT01127256|26789825|P1|Overall Study|Lost to Follow-up|16
7703240|NCT01127256|26789824|P2|Overall Study|Lack of Efficacy|0
7703241|NCT01127256|26789825|P1|Overall Study|Lack of Efficacy|4
7703242|NCT01127256|26789824|P2|Overall Study|Adverse Event|13
7703243|NCT01127256|26789825|P1|Overall Study|Adverse Event|13
7703244|NCT01127165|26789837|P2|Overall Study|Protocol Violation|1
7703245|NCT01127165|26789838|P1|Overall Study|Protocol Violation|0
7703246|NCT01127165|26789837|P2|Overall Study|Withdrawal by Subject|3
7703247|NCT01127165|26789838|P1|Overall Study|Withdrawal by Subject|1
7703248|NCT01127165|26789837|P2|Overall Study|Lost to Follow-up|5
7703249|NCT01127165|26789838|P1|Overall Study|Lost to Follow-up|3
7703250|NCT01127165|26789837|P2|Overall Study|Lack of Efficacy|8
7703251|NCT01127165|26789838|P1|Overall Study|Lack of Efficacy|10
7703252|NCT01127165|26789837|P2|Overall Study|Adverse Event|2
7703253|NCT01127165|26789838|P1|Overall Study|Adverse Event|2
7703254|NCT01127139|26789850|P1|Overall Study|Reason not specified|1
7703255|NCT01127139|26789850|P1|Overall Study|Lack of Efficacy|4
7703256|NCT01127139|26789850|P1|Overall Study|Incompliance|12
7703257|NCT01127139|26789850|P1|Overall Study|Adverse Event|40
7703258|NCT01127061|26789878|P2|Overall Study|Physician Decision|3
7703259|NCT01127061|26789879|P1|Overall Study|Physician Decision|3
7703260|NCT01127061|26789878|P2|Overall Study|Lost to Follow-up|10
7703261|NCT01127061|26789879|P1|Overall Study|Lost to Follow-up|7
7703262|NCT01126879|26789916|P2|Overall Study|Physician Decision|0
7703263|NCT01126879|26789917|P1|Overall Study|Physician Decision|1
7703264|NCT01126879|26789916|P2|Overall Study|Adverse Event|1
7703265|NCT01126879|26789917|P1|Overall Study|Adverse Event|0
7703266|NCT01126879|26789916|P2|Overall Study|Withdrawal by Subject|0
7703267|NCT01126879|26789917|P1|Overall Study|Withdrawal by Subject|1
7703268|NCT01126879|26789916|P2|Overall Study|Progressive Disease|1
7703269|NCT01126879|26789917|P1|Overall Study|Progressive Disease|3
7703270|NCT01126619|26789964|P1|Overall Study|Non-compliance|1
7703271|NCT01126619|26789964|P1|Overall Study|Withdrawal by Subject|9
7703272|NCT01126619|26789964|P1|Overall Study|Serious adverse event|1
7703273|NCT01126619|26789964|P1|Overall Study|Investigator decision|4
7703274|NCT01126619|26789964|P1|Overall Study|Not eligible for the study|2
7703275|NCT01126580|26789992|P3|Overall Study|Treatment Non-compliance|3
7703276|NCT01126580|26789993|P2|Overall Study|Treatment Non-compliance|2
7703277|NCT01126580|26789994|P1|Overall Study|Treatment Non-compliance|0
7703278|NCT01126580|26789992|P3|Overall Study|Lost to Follow-up|9
7703279|NCT01126580|26789993|P2|Overall Study|Lost to Follow-up|13
7703280|NCT01126580|26789994|P1|Overall Study|Lost to Follow-up|15
7703281|NCT01126580|26789992|P3|Overall Study|Protocol Violation|2
7703282|NCT01126580|26789993|P2|Overall Study|Protocol Violation|1
7703283|NCT01126580|26789994|P1|Overall Study|Protocol Violation|0
7703284|NCT01126580|26789992|P3|Overall Study|Lack of Efficacy|4
7703285|NCT01126580|26789993|P2|Overall Study|Lack of Efficacy|3
7703286|NCT01126580|26789994|P1|Overall Study|Lack of Efficacy|2
7703287|NCT01126580|26789992|P3|Overall Study|Entry Criteria Not Met|2
7703288|NCT01126580|26789993|P2|Overall Study|Entry Criteria Not Met|1
7703289|NCT01126580|26789994|P1|Overall Study|Entry Criteria Not Met|1
7703290|NCT01126580|26789992|P3|Overall Study|Physician Decision|2
7703291|NCT01126580|26789993|P2|Overall Study|Physician Decision|1
7703292|NCT01126580|26789994|P1|Overall Study|Physician Decision|1
7703293|NCT01126580|26789992|P3|Overall Study|Sponsor Decision|7
7703294|NCT01126580|26789993|P2|Overall Study|Sponsor Decision|4
7703295|NCT01126580|26789994|P1|Overall Study|Sponsor Decision|5
7703296|NCT01126580|26789992|P3|Overall Study|Withdrawal by Subject|14
7703297|NCT01126580|26789993|P2|Overall Study|Withdrawal by Subject|19
7703298|NCT01126580|26789994|P1|Overall Study|Withdrawal by Subject|11
7703299|NCT01126580|26789992|P3|Overall Study|Adverse Event|12
7703300|NCT01126580|26789993|P2|Overall Study|Adverse Event|8
7703301|NCT01126580|26789994|P1|Overall Study|Adverse Event|14
7703302|NCT01126541|26790089|P3|Overall Study|Administrative reason or other|2
7703303|NCT01126541|26790090|P2|Overall Study|Administrative reason or other|1
7703304|NCT01126541|26790091|P1|Overall Study|Administrative reason or other|1
7703305|NCT01126541|26790089|P3|Overall Study|Protocol Violation|1
7703306|NCT01126541|26790090|P2|Overall Study|Protocol Violation|0
7703307|NCT01126541|26790091|P1|Overall Study|Protocol Violation|0
7703308|NCT01126541|26790089|P3|Overall Study|Withdrawal by Subject|6
7703309|NCT01126541|26790090|P2|Overall Study|Withdrawal by Subject|5
7703310|NCT01126541|26790091|P1|Overall Study|Withdrawal by Subject|2
7703311|NCT01126541|26790089|P3|Overall Study|Lost to Follow-up|2
7703312|NCT01126541|26790090|P2|Overall Study|Lost to Follow-up|2
7703313|NCT01126541|26790091|P1|Overall Study|Lost to Follow-up|1
7703314|NCT01126541|26790089|P3|Overall Study|Lack of Efficacy|11
7703315|NCT01126541|26790090|P2|Overall Study|Lack of Efficacy|1
7703316|NCT01126541|26790091|P1|Overall Study|Lack of Efficacy|6
7703317|NCT01126541|26790089|P3|Overall Study|Death|0
7703318|NCT01126541|26790090|P2|Overall Study|Death|1
7703319|NCT01126541|26790091|P1|Overall Study|Death|0
7703320|NCT01126541|26790089|P3|Overall Study|Adverse Event|4
7703321|NCT01126541|26790090|P2|Overall Study|Adverse Event|2
7703322|NCT01126541|26790091|P1|Overall Study|Adverse Event|0
7703323|NCT01126437|26790175|P3|Overall Study|Other reason not specified|178
7703324|NCT01126437|26790176|P2|Overall Study|Other reason not specified|176
7703325|NCT01126437|26790177|P1|Overall Study|Other reason not specified|210
7703326|NCT01126437|26790175|P3|Overall Study|Withdrawal by Subject|319
7703327|NCT01126437|26790176|P2|Overall Study|Withdrawal by Subject|335
7703328|NCT01126437|26790177|P1|Overall Study|Withdrawal by Subject|331
7703329|NCT01126437|26790175|P3|Overall Study|Lost to Follow-up|55
7703330|NCT01126437|26790176|P2|Overall Study|Lost to Follow-up|63
7703331|NCT01126437|26790177|P1|Overall Study|Lost to Follow-up|52
7703332|NCT01126437|26790175|P3|Overall Study|Protocol Violation|41
7703333|NCT01126437|26790176|P2|Overall Study|Protocol Violation|66
7703334|NCT01126437|26790177|P1|Overall Study|Protocol Violation|64
7703335|NCT01126437|26790175|P3|Overall Study|Lack of Efficacy|59
7703336|NCT01126437|26790176|P2|Overall Study|Lack of Efficacy|60
7703337|NCT01126437|26790177|P1|Overall Study|Lack of Efficacy|65
7703338|NCT01126437|26790175|P3|Overall Study|Adverse Event|635
7703339|NCT01126437|26790176|P2|Overall Study|Adverse Event|606
7703340|NCT01126437|26790177|P1|Overall Study|Adverse Event|602
7703341|NCT01126437|26790175|P3|Overall Study|Sites with data irregularities/fraud|7
7703342|NCT01126437|26790176|P2|Overall Study|Sites with data irregularities/fraud|6
7703343|NCT01126437|26790177|P1|Overall Study|Sites with data irregularities/fraud|6
7703344|NCT01126437|26790175|P3|Overall Study|Not treated|19
7703345|NCT01126437|26790176|P2|Overall Study|Not treated|18
7703346|NCT01126437|26790177|P1|Overall Study|Not treated|11
7703347|NCT01126424|26790215|P6|Overall Study|Withdrawal by Subject|0
7703348|NCT01126424|26790216|P5|Overall Study|Withdrawal by Subject|1
7703349|NCT01126424|26790217|P4|Overall Study|Withdrawal by Subject|3
7703350|NCT01126424|26790218|P3|Overall Study|Withdrawal by Subject|1
7703351|NCT01126424|26790219|P2|Overall Study|Withdrawal by Subject|0
7703352|NCT01126424|26790220|P1|Overall Study|Withdrawal by Subject|0
7703353|NCT01126424|26790215|P6|Overall Study|Adverse Event|0
7703354|NCT01126424|26790216|P5|Overall Study|Adverse Event|1
7703355|NCT01126424|26790217|P4|Overall Study|Adverse Event|0
7703356|NCT01126424|26790218|P3|Overall Study|Adverse Event|0
7703357|NCT01126424|26790219|P2|Overall Study|Adverse Event|0
7703358|NCT01126424|26790220|P1|Overall Study|Adverse Event|0
7703359|NCT01126359|26790243|P2|First Intervention (20-minutes)|Physician Decision|1
7703360|NCT01126359|26790244|P1|First Intervention (20-minutes)|Physician Decision|0
7703361|NCT01126268|26790256|P1|Overall Study|Adverse Event|1
7703362|NCT01126060|26790295|P2|Overall Study|Protocol Violation|2
7703363|NCT01126060|26790296|P1|Overall Study|Protocol Violation|0
7703364|NCT01125930|26790304|P2|Overall Study|Lost to Follow-up|2
7703365|NCT01125930|26790305|P1|Overall Study|Lost to Follow-up|0
7703366|NCT01125930|26790304|P2|Overall Study|Protocol Violation|1
7703367|NCT01125930|26790305|P1|Overall Study|Protocol Violation|0
7703368|NCT01125930|26790304|P2|Overall Study|Withdrawal by Subject|6
7703369|NCT01125930|26790305|P1|Overall Study|Withdrawal by Subject|1
7703370|NCT01125930|26790304|P2|Overall Study|Adverse Event|1
7703371|NCT01125930|26790305|P1|Overall Study|Adverse Event|0
7703372|NCT01125917|26790459|P1|Overall Study|Lack of Efficacy|19
7703373|NCT01125917|26790459|P1|Overall Study|Administrative|223
7703374|NCT01125917|26790459|P1|Overall Study|Withdrawal by Subject|31
7703375|NCT01125917|26790459|P1|Overall Study|Lost to Follow-up|23
7703376|NCT01125917|26790459|P1|Overall Study|Adverse Event|43
7703377|NCT01125813|26790463|P1|Overall Study|Screen Failures|4
7703378|NCT01125813|26790463|P1|Overall Study|Withdrawal by Subject|1
7703379|NCT01125813|26790463|P1|Overall Study|Death|1
7703380|NCT01125800|26790473|P5|Phase II|Disease progression|8
7703381|NCT01125800|26790474|P4|Phase II|Disease progression|1
7703382|NCT01125800|26790475|P3|Phase II|Disease progression|0
7703383|NCT01125800|26790476|P2|Phase II|Disease progression|0
7703384|NCT01125800|26790477|P1|Phase II|Disease progression|0
7703385|NCT01125800|26790473|P5|Phase II|Adverse Event|2
7703386|NCT01125800|26790474|P4|Phase II|Adverse Event|0
7703387|NCT01125800|26790475|P3|Phase II|Adverse Event|0
7703388|NCT01125800|26790476|P2|Phase II|Adverse Event|0
7703389|NCT01125800|26790477|P1|Phase II|Adverse Event|0
7703390|NCT01125800|26790473|P5|Phase II|Protocol Violation|1
7703391|NCT01125800|26790474|P4|Phase II|Protocol Violation|0
7703392|NCT01125800|26790475|P3|Phase II|Protocol Violation|0
7703393|NCT01125800|26790476|P2|Phase II|Protocol Violation|0
7703394|NCT01125800|26790477|P1|Phase II|Protocol Violation|0
7703395|NCT01125800|26790473|P5|Phase I|Disease progression|0
7703396|NCT01125800|26790474|P4|Phase I|Disease progression|3
7703397|NCT01125800|26790475|P3|Phase I|Disease progression|1
7703398|NCT01125800|26790476|P2|Phase I|Disease progression|4
7703399|NCT01125800|26790477|P1|Phase I|Disease progression|5
7703400|NCT01125800|26790473|P5|Phase I|Withdrawal by Subject|0
7703401|NCT01125800|26790474|P4|Phase I|Withdrawal by Subject|0
7703402|NCT01125800|26790475|P3|Phase I|Withdrawal by Subject|1
7703403|NCT01125800|26790476|P2|Phase I|Withdrawal by Subject|0
7703404|NCT01125800|26790477|P1|Phase I|Withdrawal by Subject|0
7703405|NCT01125800|26790473|P5|Phase I|Administrative problems|0
7703406|NCT01125800|26790474|P4|Phase I|Administrative problems|0
7703407|NCT01125800|26790475|P3|Phase I|Administrative problems|0
7703408|NCT01125800|26790476|P2|Phase I|Administrative problems|0
7703409|NCT01125800|26790477|P1|Phase I|Administrative problems|1
7703410|NCT01125800|26790473|P5|Phase I|Adverse Event|0
7703411|NCT01125800|26790474|P4|Phase I|Adverse Event|7
7703412|NCT01125800|26790475|P3|Phase I|Adverse Event|1
7703413|NCT01125800|26790476|P2|Phase I|Adverse Event|2
7703414|NCT01125800|26790477|P1|Phase I|Adverse Event|2
7703415|NCT01125800|26790473|P5|Phase I|Protocol Violation|0
7703416|NCT01125800|26790474|P4|Phase I|Protocol Violation|1
7703417|NCT01125800|26790475|P3|Phase I|Protocol Violation|1
7703418|NCT01125800|26790476|P2|Phase I|Protocol Violation|3
7703419|NCT01125800|26790477|P1|Phase I|Protocol Violation|0
7703420|NCT01125748|26790543|P2|Overall Study|Patient Decision to Withdraw|4
7703421|NCT01125748|26790544|P1|Overall Study|Patient Decision to Withdraw|2
7703422|NCT01125748|26790543|P2|Overall Study|Physician Decision|7
7703423|NCT01125748|26790544|P1|Overall Study|Physician Decision|8
7703424|NCT01125748|26790543|P2|Overall Study|Lost to Follow-up|1
7703425|NCT01125748|26790544|P1|Overall Study|Lost to Follow-up|0
7703426|NCT01125748|26790543|P2|Overall Study|Adverse Event|2
7703427|NCT01125748|26790544|P1|Overall Study|Adverse Event|0
7703428|NCT01125722|26790554|P2|Overall Study|Lost to Follow-up|0
7703429|NCT01125722|26790555|P1|Overall Study|Lost to Follow-up|1
7703430|NCT01125722|26790554|P2|Overall Study|Withdrawal by Subject|1
7703431|NCT01125722|26790555|P1|Overall Study|Withdrawal by Subject|2
7703432|NCT01125566|26790602|P3|Patients Who Switched From AV to TV|Other than listed above|4
7703433|NCT01125566|26790603|P2|Patients Who Switched From AV to TV|Other than listed above|0
7703434|NCT01125566|26790604|P1|Patients Who Switched From AV to TV|Other than listed above|0
7703435|NCT01125566|26790602|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
7703436|NCT01125566|26790603|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
7703437|NCT01125566|26790604|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
7703438|NCT01125566|26790602|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
7703439|NCT01125566|26790603|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
7703440|NCT01125566|26790604|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
7703441|NCT01125566|26790602|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
7703442|NCT01125566|26790603|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
7703443|NCT01125566|26790604|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
7703444|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
7703445|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
7703446|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
7703447|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
7703448|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
7703449|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
7703450|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Not treated|0
7703451|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Not treated|0
7703452|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Not treated|2
7703453|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
7703454|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
7703455|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
7703456|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
7703457|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
7703458|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
7703459|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
7703460|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
7703461|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
7703462|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
7703463|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
7703464|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
7703465|NCT01125566|26790602|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
7703466|NCT01125566|26790603|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
7703467|NCT01125566|26790604|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
7703468|NCT01125514|26790617|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
7703469|NCT01125514|26790617|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
7703470|NCT01125514|26790617|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
7703471|NCT01125514|26790617|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
7703472|NCT01125514|26790617|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
7703473|NCT01125514|26790617|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
7703474|NCT01125358|26790693|P4|Overall Study|Withdrawal by Subject|1
7703475|NCT01125358|26790694|P3|Overall Study|Withdrawal by Subject|1
7703476|NCT01125358|26790695|P2|Overall Study|Withdrawal by Subject|1
7703477|NCT01125358|26790696|P1|Overall Study|Withdrawal by Subject|2
7703478|NCT01125358|26790693|P4|Overall Study|Sponsor Decision|1
7703479|NCT01125358|26790694|P3|Overall Study|Sponsor Decision|1
7703480|NCT01125358|26790695|P2|Overall Study|Sponsor Decision|0
7703481|NCT01125358|26790696|P1|Overall Study|Sponsor Decision|0
7703482|NCT01125358|26790693|P4|Overall Study|Protocol Violation|0
7703483|NCT01125358|26790694|P3|Overall Study|Protocol Violation|0
7703484|NCT01125358|26790695|P2|Overall Study|Protocol Violation|0
7703485|NCT01125358|26790696|P1|Overall Study|Protocol Violation|1
7703486|NCT01125358|26790693|P4|Overall Study|Perceived Lack of Efficacy|4
7703487|NCT01125358|26790694|P3|Overall Study|Perceived Lack of Efficacy|7
7703488|NCT01125358|26790695|P2|Overall Study|Perceived Lack of Efficacy|3
7703489|NCT01125358|26790696|P1|Overall Study|Perceived Lack of Efficacy|6
7703490|NCT01125358|26790693|P4|Overall Study|Adverse Event|2
7703491|NCT01125358|26790694|P3|Overall Study|Adverse Event|0
7703492|NCT01125358|26790695|P2|Overall Study|Adverse Event|0
7703493|NCT01125358|26790696|P1|Overall Study|Adverse Event|3
7703494|NCT01125293|26790731|P6|Overall Study|Physician Decision|2
7703495|NCT01125293|26790732|P5|Overall Study|Physician Decision|0
7703496|NCT01125293|26790733|P4|Overall Study|Physician Decision|0
7703497|NCT01125293|26790734|P3|Overall Study|Physician Decision|0
7703498|NCT01125293|26790735|P2|Overall Study|Physician Decision|0
7703499|NCT01125293|26790736|P1|Overall Study|Physician Decision|0
7703500|NCT01125293|26790731|P6|Overall Study|Withdrawal by Subject|1
7703501|NCT01125293|26790732|P5|Overall Study|Withdrawal by Subject|2
7703502|NCT01125293|26790733|P4|Overall Study|Withdrawal by Subject|0
7703503|NCT01125293|26790734|P3|Overall Study|Withdrawal by Subject|0
7703504|NCT01125293|26790735|P2|Overall Study|Withdrawal by Subject|0
7703505|NCT01125293|26790736|P1|Overall Study|Withdrawal by Subject|0
7703506|NCT01125293|26790731|P6|Overall Study|Death|0
7703507|NCT01125293|26790732|P5|Overall Study|Death|1
7703508|NCT01125293|26790733|P4|Overall Study|Death|0
7703509|NCT01125293|26790734|P3|Overall Study|Death|0
7703510|NCT01125293|26790735|P2|Overall Study|Death|0
7703511|NCT01125293|26790736|P1|Overall Study|Death|0
7703512|NCT01125293|26790731|P6|Overall Study|Symptomatic Deterioration|0
7703513|NCT01125293|26790732|P5|Overall Study|Symptomatic Deterioration|0
7703514|NCT01125293|26790733|P4|Overall Study|Symptomatic Deterioration|0
7703515|NCT01125293|26790734|P3|Overall Study|Symptomatic Deterioration|0
7703516|NCT01125293|26790735|P2|Overall Study|Symptomatic Deterioration|0
7703517|NCT01125293|26790736|P1|Overall Study|Symptomatic Deterioration|1
7703518|NCT01125293|26790731|P6|Overall Study|Adverse Event|8
7703519|NCT01125293|26790732|P5|Overall Study|Adverse Event|2
7703520|NCT01125293|26790733|P4|Overall Study|Adverse Event|0
7703521|NCT01125293|26790734|P3|Overall Study|Adverse Event|0
7703522|NCT01125293|26790735|P2|Overall Study|Adverse Event|0
7703523|NCT01125293|26790736|P1|Overall Study|Adverse Event|1
7703524|NCT01125293|26790731|P6|Overall Study|Disease Progression|12
7703525|NCT01125293|26790732|P5|Overall Study|Disease Progression|5
7703526|NCT01125293|26790733|P4|Overall Study|Disease Progression|3
7703527|NCT01125293|26790734|P3|Overall Study|Disease Progression|4
7703528|NCT01125293|26790735|P2|Overall Study|Disease Progression|3
7703529|NCT01125293|26790736|P1|Overall Study|Disease Progression|1
7703530|NCT01125189|26790790|P3|Follow up Period|Other reasons|5
7703531|NCT01125189|26790791|P2|Follow up Period|Other reasons|4
7703532|NCT01125189|26790792|P1|Follow up Period|Other reasons|4
7703533|NCT01125189|26790790|P3|Follow up Period|Lost to Follow-up|6
7703534|NCT01125189|26790791|P2|Follow up Period|Lost to Follow-up|9
7703535|NCT01125189|26790792|P1|Follow up Period|Lost to Follow-up|12
7703536|NCT01125189|26790790|P3|Follow up Period|Death|0
7703537|NCT01125189|26790791|P2|Follow up Period|Death|0
7703538|NCT01125189|26790792|P1|Follow up Period|Death|1
7703539|NCT01125189|26790790|P3|Follow up Period|Withdrawal by Subject|5
7703540|NCT01125189|26790791|P2|Follow up Period|Withdrawal by Subject|2
7703541|NCT01125189|26790792|P1|Follow up Period|Withdrawal by Subject|3
7703542|NCT01125189|26790790|P3|Treatment Period|Completed 24 week treatment period only|2
7703543|NCT01125189|26790791|P2|Treatment Period|Completed 24 week treatment period only|1
7703544|NCT01125189|26790792|P1|Treatment Period|Completed 24 week treatment period only|2
7703545|NCT01125189|26790790|P3|Treatment Period|Other reasons|0
7703546|NCT01125189|26790791|P2|Treatment Period|Other reasons|1
7703547|NCT01125189|26790792|P1|Treatment Period|Other reasons|1
7703548|NCT01125189|26790790|P3|Treatment Period|Participants requested to discontinue|4
7703549|NCT01125189|26790791|P2|Treatment Period|Participants requested to discontinue|3
7703550|NCT01125189|26790792|P1|Treatment Period|Participants requested to discontinue|1
7703551|NCT01125189|26790790|P3|Treatment Period|Poor compliance/noncompliance|0
7703552|NCT01125189|26790791|P2|Treatment Period|Poor compliance/noncompliance|1
7703553|NCT01125189|26790792|P1|Treatment Period|Poor compliance/noncompliance|0
7703554|NCT01125189|26790790|P3|Treatment Period|Lost to Follow-up|1
7703555|NCT01125189|26790791|P2|Treatment Period|Lost to Follow-up|2
7703556|NCT01125189|26790792|P1|Treatment Period|Lost to Follow-up|1
7703557|NCT01125189|26790790|P3|Treatment Period|Death|0
7703558|NCT01125189|26790791|P2|Treatment Period|Death|0
7703559|NCT01125189|26790792|P1|Treatment Period|Death|1
7703560|NCT01125189|26790790|P3|Treatment Period|Withdrawal by Subject|1
7703561|NCT01125189|26790791|P2|Treatment Period|Withdrawal by Subject|1
7703562|NCT01125189|26790792|P1|Treatment Period|Withdrawal by Subject|3
7703563|NCT01125189|26790790|P3|Treatment Period|Adverse Event|8
7703564|NCT01125189|26790791|P2|Treatment Period|Adverse Event|8
7703565|NCT01125189|26790792|P1|Treatment Period|Adverse Event|7
7703566|NCT01125189|26790790|P3|Treatment Period|Lack of Efficacy|25
7703567|NCT01125189|26790791|P2|Treatment Period|Lack of Efficacy|18
7703568|NCT01125189|26790792|P1|Treatment Period|Lack of Efficacy|15
7703569|NCT01125046|26790842|P1|Follow-up/Data Cut Off Point|Lost to Follow-up|4
7703570|NCT01125046|26790842|P1|Follow-up/Data Cut Off Point|Death|29
7703571|NCT01125046|26790842|P1|Continued Treatment After 6 Months|Adverse Event|1
7703572|NCT01125046|26790842|P1|Continued Treatment After 6 Months|Progressive Disease|2
7703573|NCT01125046|26790842|P1|First 6 Months of Treatment|Adverse Event|2
7703574|NCT01125046|26790842|P1|First 6 Months of Treatment|Progressive Disease|7
7703575|NCT01125046|26790842|P1|First 6 Months of Treatment|Surgery|1
7703576|NCT01125046|26790842|P1|First 6 Months of Treatment|Non-compliance|1
7703577|NCT01125046|26790842|P1|First 6 Months of Treatment|Withdrawal by Subject|2
7703578|NCT01125046|26790842|P1|First 6 Months of Treatment|Death|1
7703579|NCT01124916|26790869|P2|Overall Study|Lost to Follow-up|2
7703580|NCT01124916|26790870|P1|Overall Study|Lost to Follow-up|3
7703581|NCT01124864|26790884|P6|Overall Study|Protocol Violation|0
7703582|NCT01124864|26790885|P5|Overall Study|Protocol Violation|1
7703583|NCT01124864|26790886|P4|Overall Study|Protocol Violation|0
7703584|NCT01124864|26790887|P3|Overall Study|Protocol Violation|0
7703585|NCT01124864|26790888|P2|Overall Study|Protocol Violation|0
7703586|NCT01124864|26790889|P1|Overall Study|Protocol Violation|1
7703587|NCT01124864|26790884|P6|Overall Study|Lost to Follow-up|0
7703588|NCT01124864|26790885|P5|Overall Study|Lost to Follow-up|0
7703589|NCT01124864|26790886|P4|Overall Study|Lost to Follow-up|1
7703590|NCT01124864|26790887|P3|Overall Study|Lost to Follow-up|0
7703591|NCT01124864|26790888|P2|Overall Study|Lost to Follow-up|1
7703592|NCT01124864|26790889|P1|Overall Study|Lost to Follow-up|1
7703593|NCT01124864|26790884|P6|Overall Study|Withdrawal by Subject|1
7703594|NCT01124864|26790885|P5|Overall Study|Withdrawal by Subject|2
7703595|NCT01124864|26790886|P4|Overall Study|Withdrawal by Subject|0
7703596|NCT01124864|26790887|P3|Overall Study|Withdrawal by Subject|4
7703597|NCT01124864|26790888|P2|Overall Study|Withdrawal by Subject|3
7703598|NCT01124864|26790889|P1|Overall Study|Withdrawal by Subject|2
7703599|NCT01124864|26790884|P6|Overall Study|Death|0
7703600|NCT01124864|26790885|P5|Overall Study|Death|1
7703601|NCT01124864|26790886|P4|Overall Study|Death|2
7703602|NCT01124864|26790887|P3|Overall Study|Death|6
7703603|NCT01124864|26790888|P2|Overall Study|Death|9
7703604|NCT01124864|26790889|P1|Overall Study|Death|6
7703605|NCT01124864|26790884|P6|Overall Study|Follow up phase competed as per protocol|2
7703606|NCT01124864|26790885|P5|Overall Study|Follow up phase competed as per protocol|26
7703607|NCT01124864|26790886|P4|Overall Study|Follow up phase competed as per protocol|18
7703608|NCT01124864|26790887|P3|Overall Study|Follow up phase competed as per protocol|24
7703609|NCT01124864|26790888|P2|Overall Study|Follow up phase competed as per protocol|22
7703610|NCT01124864|26790889|P1|Overall Study|Follow up phase competed as per protocol|18
7703611|NCT01124838|26790923|P2|Overall Study|Lost to Follow-up|0
7703612|NCT01124838|26790924|P1|Overall Study|Lost to Follow-up|2
7703613|NCT01124838|26790923|P2|Overall Study|Withdrawal by Subject|2
7703614|NCT01124838|26790924|P1|Overall Study|Withdrawal by Subject|3
7703615|NCT01124838|26790923|P2|Overall Study|Lack of Efficacy|0
7703616|NCT01124838|26790924|P1|Overall Study|Lack of Efficacy|2
7703617|NCT01124838|26790923|P2|Overall Study|Adverse Event|11
7703618|NCT01124838|26790924|P1|Overall Study|Adverse Event|7
7703619|NCT01124838|26790923|P2|Overall Study|Miscellaneous|2
7703620|NCT01124838|26790924|P1|Overall Study|Miscellaneous|4
7703621|NCT01124734|26790991|P1|Overall Study|Elected for alternative treatment|2
7703622|NCT01124734|26790991|P1|Overall Study|Withdrawal by Subject|1
7703623|NCT01124734|26790991|P1|Overall Study|Adverse Event|1
7703624|NCT01124734|26790991|P1|Overall Study|Disease progression|13
7703625|NCT01124643|26791002|P1|Overall Study|Death|1
7703626|NCT01124617|26791016|P2|Overall Study|Other|1
7703627|NCT01124617|26791017|P1|Overall Study|Other|2
7703628|NCT01124617|26791016|P2|Overall Study|Withdrawal by Subject|1
7703629|NCT01124617|26791017|P1|Overall Study|Withdrawal by Subject|9
7703630|NCT01124617|26791016|P2|Overall Study|Protocol Violation|1
7703631|NCT01124617|26791017|P1|Overall Study|Protocol Violation|1
7703632|NCT01124617|26791016|P2|Overall Study|Lack of Efficacy|1
7703633|NCT01124617|26791017|P1|Overall Study|Lack of Efficacy|2
7703634|NCT01124617|26791016|P2|Overall Study|Adverse Event|2
7703635|NCT01124617|26791017|P1|Overall Study|Adverse Event|5
7703636|NCT01124604|26791049|P2|Overall Study|Disease Progression|1
7703637|NCT01124604|26791050|P1|Overall Study|Disease Progression|0
7703638|NCT01124604|26791049|P2|Overall Study|Withdrawal by Subject|0
7703639|NCT01124604|26791050|P1|Overall Study|Withdrawal by Subject|4
7703640|NCT01124604|26791049|P2|Overall Study|Lack of Efficacy|0
7703641|NCT01124604|26791050|P1|Overall Study|Lack of Efficacy|1
7703642|NCT01124604|26791049|P2|Overall Study|Adverse Event|1
7703643|NCT01124604|26791050|P1|Overall Study|Adverse Event|10
7703644|NCT01124448|26791089|P2|Overall Study|Protocol Violation|0
7703645|NCT01124448|26791090|P1|Overall Study|Protocol Violation|2
7703646|NCT01124448|26791089|P2|Overall Study|Lost to Follow-up|3
7703647|NCT01124448|26791090|P1|Overall Study|Lost to Follow-up|0
7703648|NCT01124422|26791098|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
7703649|NCT01124422|26791099|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
7703650|NCT01124422|26791100|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
7703651|NCT01124422|26791098|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
7703652|NCT01124422|26791099|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
7703653|NCT01124422|26791100|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
7703654|NCT01124422|26791098|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
7703655|NCT01124422|26791099|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
7703656|NCT01124422|26791100|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
7703657|NCT01124422|26791098|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
7703658|NCT01124422|26791099|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
7703659|NCT01124422|26791100|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
7703660|NCT01124422|26791098|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
7703661|NCT01124422|26791099|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
7703662|NCT01124422|26791100|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
7703663|NCT01124422|26791098|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
7703664|NCT01124422|26791099|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
7703665|NCT01124422|26791100|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
7703666|NCT01124422|26791098|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
7703667|NCT01124422|26791099|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
7703668|NCT01124422|26791100|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
7703669|NCT01124422|26791098|P3|4-Week Open-label Run-in Phase|Physician Decision|0
7703670|NCT01124422|26791099|P2|4-Week Open-label Run-in Phase|Physician Decision|0
7703671|NCT01124422|26791100|P1|4-Week Open-label Run-in Phase|Physician Decision|4
7703672|NCT01124422|26791098|P3|4-Week Open-label Run-in Phase|Adverse Event|0
7703673|NCT01124422|26791099|P2|4-Week Open-label Run-in Phase|Adverse Event|0
7703674|NCT01124422|26791100|P1|4-Week Open-label Run-in Phase|Adverse Event|7
7703675|NCT01124422|26791098|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
7703676|NCT01124422|26791099|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
7703677|NCT01124422|26791100|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
7703678|NCT01124292|26791170|P3|Overall Study|piercing track closed|1
7703679|NCT01124292|26791171|P2|Overall Study|piercing track closed|2
7703680|NCT01124292|26791172|P1|Overall Study|piercing track closed|0
7703681|NCT01124292|26791170|P3|Overall Study|medical issue unrelated to the study|2
7703682|NCT01124292|26791171|P2|Overall Study|medical issue unrelated to the study|0
7703683|NCT01124292|26791172|P1|Overall Study|medical issue unrelated to the study|0
7703684|NCT01124292|26791170|P3|Overall Study|Withdrawal by Subject|2
7703685|NCT01124292|26791171|P2|Overall Study|Withdrawal by Subject|6
7703686|NCT01124292|26791172|P1|Overall Study|Withdrawal by Subject|0
7703687|NCT01124292|26791170|P3|Overall Study|Physician Decision|2
7703688|NCT01124292|26791171|P2|Overall Study|Physician Decision|3
7703689|NCT01124292|26791172|P1|Overall Study|Physician Decision|0
7703690|NCT01124292|26791170|P3|Overall Study|Lost to Follow-up|3
7703691|NCT01124292|26791171|P2|Overall Study|Lost to Follow-up|4
7703692|NCT01124292|26791172|P1|Overall Study|Lost to Follow-up|2
7703693|NCT01124175|26791243|P2|Washout of 7 Days|Withdrawal by Subject|2
7703694|NCT01124175|26791244|P1|Washout of 7 Days|Withdrawal by Subject|0
7703695|NCT01124162|26791262|P2|Washout of 7 Days|Withdrawal by Subject|0
7703696|NCT01124162|26791263|P1|Washout of 7 Days|Withdrawal by Subject|1
7703697|NCT01124162|26791262|P2|First Intervention|Adverse Event|0
7703698|NCT01124162|26791263|P1|First Intervention|Adverse Event|2
7703699|NCT01124149|26791279|P1|Maintenance Phase|Non-compliance|1
7703700|NCT01124149|26791279|P1|Maintenance Phase|Coordinator error|1
7703701|NCT01124149|26791279|P1|Maintenance Phase|Protocol Violation|5
7703702|NCT01124149|26791279|P1|Maintenance Phase|Withdrawal by Subject|10
7703703|NCT01124149|26791279|P1|Maintenance Phase|Lost to Follow-up|15
7703704|NCT01124149|26791279|P1|Maintenance Phase|Adverse Event|24
7703705|NCT01124149|26791279|P1|Maintenance Phase|Lack of Efficacy|40
7703706|NCT01124149|26791279|P1|Acute Phase|Sponsor decision|1
7703707|NCT01124149|26791279|P1|Acute Phase|Travelling to another country|1
7703708|NCT01124149|26791279|P1|Acute Phase|Low hemoglobin|1
7703709|NCT01124149|26791279|P1|Acute Phase|Non-compliance|1
7703710|NCT01124149|26791279|P1|Acute Phase|UC symptoms not ameliorated|1
7703711|NCT01124149|26791279|P1|Acute Phase|Sponsor request|1
7703712|NCT01124149|26791279|P1|Acute Phase|Prolonged antibiotic therapy|1
7703713|NCT01124149|26791279|P1|Acute Phase|Lost to Follow-up|2
7703714|NCT01124149|26791279|P1|Acute Phase|Protocol Violation|14
7703715|NCT01124149|26791279|P1|Acute Phase|Lack of Efficacy|17
7703716|NCT01124149|26791279|P1|Acute Phase|Adverse Event|21
7703717|NCT01124149|26791279|P1|Acute Phase|Withdrawal by Subject|22
7703718|NCT01124097|26791299|P4|Overall Study|Physician Decision|0
7703719|NCT01124097|26791300|P3|Overall Study|Physician Decision|0
7703720|NCT01124097|26791301|P2|Overall Study|Physician Decision|1
7703721|NCT01124097|26791302|P1|Overall Study|Physician Decision|2
7703722|NCT01124097|26791299|P4|Overall Study|Protocol Violation|1
7703723|NCT01124097|26791300|P3|Overall Study|Protocol Violation|2
7703724|NCT01124097|26791301|P2|Overall Study|Protocol Violation|0
7703725|NCT01124097|26791302|P1|Overall Study|Protocol Violation|2
7703726|NCT01124097|26791299|P4|Overall Study|Adverse Event|7
7703727|NCT01124097|26791300|P3|Overall Study|Adverse Event|15
7703728|NCT01124097|26791301|P2|Overall Study|Adverse Event|15
7703729|NCT01124097|26791302|P1|Overall Study|Adverse Event|24
7703730|NCT01124097|26791299|P4|Overall Study|Lack of Efficacy|3
7703731|NCT01124097|26791300|P3|Overall Study|Lack of Efficacy|1
7703732|NCT01124097|26791301|P2|Overall Study|Lack of Efficacy|3
7703733|NCT01124097|26791302|P1|Overall Study|Lack of Efficacy|2
7703734|NCT01124097|26791299|P4|Overall Study|Withdrawal by Subject|3
7703735|NCT01124097|26791300|P3|Overall Study|Withdrawal by Subject|2
7703736|NCT01124097|26791301|P2|Overall Study|Withdrawal by Subject|3
7703737|NCT01124097|26791302|P1|Overall Study|Withdrawal by Subject|4
7703738|NCT01124045|26791314|P2|Overall Study|Physician Decision|2
7703739|NCT01124045|26791315|P1|Overall Study|Physician Decision|0
7703740|NCT01124045|26791314|P2|Overall Study|Lost to Follow-up|1
7703741|NCT01124045|26791315|P1|Overall Study|Lost to Follow-up|0
7703742|NCT01124006|26791348|P3|Overall Study|Other|1
7703743|NCT01124006|26791349|P2|Overall Study|Other|0
7703744|NCT01124006|26791350|P1|Overall Study|Other|0
7703745|NCT01124006|26791348|P3|Overall Study|Lost to Follow-up|1
7703746|NCT01124006|26791349|P2|Overall Study|Lost to Follow-up|0
7703747|NCT01124006|26791350|P1|Overall Study|Lost to Follow-up|1
7703748|NCT01124006|26791348|P3|Overall Study|Withdrawal by Subject|0
7703749|NCT01124006|26791349|P2|Overall Study|Withdrawal by Subject|2
7703750|NCT01124006|26791350|P1|Overall Study|Withdrawal by Subject|2
7703751|NCT01123980|26791378|P2|Overall Study|Unclassified|7
7703752|NCT01123980|26791379|P1|Overall Study|Unclassified|6
7703753|NCT01123980|26791378|P2|Overall Study|Withdrawal by Subject|3
7703754|NCT01123980|26791379|P1|Overall Study|Withdrawal by Subject|5
7703755|NCT01123980|26791378|P2|Overall Study|Protocol Violation|6
7703756|NCT01123980|26791379|P1|Overall Study|Protocol Violation|6
7703757|NCT01123980|26791378|P2|Overall Study|Lost to Follow-up|6
7703758|NCT01123980|26791379|P1|Overall Study|Lost to Follow-up|0
7703759|NCT01123980|26791378|P2|Overall Study|Physician Decision|1
7703760|NCT01123980|26791379|P1|Overall Study|Physician Decision|0
7703761|NCT01123980|26791378|P2|Overall Study|Lack of Efficacy|0
7703762|NCT01123980|26791379|P1|Overall Study|Lack of Efficacy|1
7703763|NCT01123980|26791378|P2|Overall Study|Adverse Event|1
7703764|NCT01123980|26791379|P1|Overall Study|Adverse Event|1
7703765|NCT01123941|26791399|P2|Overall Study|Lost to Follow-up|1
7703766|NCT01123941|26791400|P1|Overall Study|Lost to Follow-up|2
7703767|NCT01123889|26791435|P2|Overall Study|Lost to Follow-up|1
7703768|NCT01123889|26791436|P1|Overall Study|Lost to Follow-up|3
7703769|NCT01123850|26791446|P1|Overall Study|Slow enrollment|45
7703770|NCT01123655|26791453|P3|Overall Study|began prohibitive drug|1
7703771|NCT01123655|26791454|P2|Overall Study|began prohibitive drug|0
7703772|NCT01123655|26791455|P1|Overall Study|began prohibitive drug|0
7703773|NCT01123655|26791453|P3|Overall Study|new illness|0
7703774|NCT01123655|26791454|P2|Overall Study|new illness|1
7703775|NCT01123655|26791455|P1|Overall Study|new illness|0
7703776|NCT01123655|26791453|P3|Overall Study|Medication for RA had to be changed|0
7703777|NCT01123655|26791454|P2|Overall Study|Medication for RA had to be changed|0
7703778|NCT01123655|26791455|P1|Overall Study|Medication for RA had to be changed|1
7703779|NCT01123642|26791527|P1|Overall Study|ineligible at baseline assessment|36
7703780|NCT01123642|26791527|P1|Overall Study|Withdrawal by Subject|9
7703781|NCT01123642|26791527|P1|Overall Study|Lost to Follow-up|23
7703782|NCT01123395|26791543|P2|Washout Period of 14 Days|Withdrawal by Subject|1
7703783|NCT01123395|26791544|P1|Washout Period of 14 Days|Withdrawal by Subject|0
7703784|NCT01123382|26791556|P2|Overall Study|Lost to Follow-up|2
7703785|NCT01123382|26791557|P1|Overall Study|Lost to Follow-up|1
7703786|NCT01123382|26791556|P2|Overall Study|Withdrawal by Subject|4
7703787|NCT01123382|26791557|P1|Overall Study|Withdrawal by Subject|1
7703788|NCT01123356|26791579|P1|Overall Study|Withdrawal by Subject|1
7703789|NCT01123356|26791579|P1|Overall Study|Lack of Efficacy|4
7703790|NCT01123356|26791579|P1|Overall Study|Adverse Event|2
7703791|NCT01123200|26791587|P1|Overall Study|Withdrawal by Subject|1
7703792|NCT01123161|26791594|P2|Overall Study|Withdrawal by Subject|0
7703793|NCT01123161|26791595|P1|Overall Study|Withdrawal by Subject|1
7703794|NCT01123161|26791594|P2|Overall Study|Lost to Follow-up|0
7703795|NCT01123161|26791595|P1|Overall Study|Lost to Follow-up|1
7703796|NCT01123148|26791613|P1|Overall Study|Didn't meet milestone criteria|1
7703797|NCT01123148|26791613|P1|Overall Study|Coughing caused unacceptable EEG quality|1
7703798|NCT01123083|26791619|P2|Overall Study|Participant/legal representative request|3
7703799|NCT01123083|26791620|P1|Overall Study|Participant/legal representative request|7
7703800|NCT01123083|26791619|P2|Overall Study|Withdrew for another reason not covered|1
7703801|NCT01123083|26791620|P1|Overall Study|Withdrew for another reason not covered|0
7703802|NCT01123083|26791619|P2|Overall Study|Adverse Event|0
7703803|NCT01123083|26791620|P1|Overall Study|Adverse Event|1
7703804|NCT01123083|26791619|P2|Overall Study|Lost to Follow-up|6
7703805|NCT01123083|26791620|P1|Overall Study|Lost to Follow-up|2
7703806|NCT01123083|26791619|P2|Overall Study|Administrative reasons|4
7703807|NCT01123083|26791620|P1|Overall Study|Administrative reasons|0
7703808|NCT01123083|26791619|P2|Overall Study|Investigator recommendation|1
7703809|NCT01123083|26791620|P1|Overall Study|Investigator recommendation|1
7703810|NCT01123070|26791648|P4|Part B Double Blind Period|Sponsor's Decision|2
7703811|NCT01123070|26791649|P3|Part B Double Blind Period|Sponsor's Decision|2
7703812|NCT01123070|26791650|P2|Part B Double Blind Period|Sponsor's Decision|0
7703813|NCT01123070|26791651|P1|Part B Double Blind Period|Sponsor's Decision|0
7703814|NCT01123070|26791648|P4|Part B Double Blind Period|Adverse Event|0
7703815|NCT01123070|26791649|P3|Part B Double Blind Period|Adverse Event|2
7703816|NCT01123070|26791650|P2|Part B Double Blind Period|Adverse Event|0
7703817|NCT01123070|26791651|P1|Part B Double Blind Period|Adverse Event|0
7703818|NCT01123070|26791648|P4|Part B Double Blind Period|Protocol Violation|1
7703819|NCT01123070|26791649|P3|Part B Double Blind Period|Protocol Violation|0
7703820|NCT01123070|26791650|P2|Part B Double Blind Period|Protocol Violation|0
7703821|NCT01123070|26791651|P1|Part B Double Blind Period|Protocol Violation|0
7703822|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
7703823|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
7703824|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
7703825|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
7703826|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
7703827|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
7703828|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
7703829|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
7703830|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
7703831|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
7703832|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
7703833|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
7703834|NCT01122927|26791674|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
7703835|NCT01122927|26791675|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
7703836|NCT01122927|26791674|P2|Period 1 - Conversion Phase|Protocol Deviation|0
7703837|NCT01122927|26791675|P1|Period 1 - Conversion Phase|Protocol Deviation|1
7703838|NCT01122927|26791674|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
7703839|NCT01122927|26791675|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
7703840|NCT01122927|26791674|P2|Period 1 - Conversion Phase|Physician Decision|0
7703841|NCT01122927|26791675|P1|Period 1 - Conversion Phase|Physician Decision|2
7703842|NCT01122927|26791674|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7703843|NCT01122927|26791675|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
7703844|NCT01122927|26791674|P2|Period 1 - Conversion Phase|Adverse Event|0
7703845|NCT01122927|26791675|P1|Period 1 - Conversion Phase|Adverse Event|3
7703846|NCT01122862|26791727|P3|Period 2|Adverse Event|1
7703847|NCT01122862|26791728|P2|Period 2|Adverse Event|0
7703848|NCT01122862|26791729|P1|Period 2|Adverse Event|0
7703849|NCT01122862|26791727|P3|Period 1|Protocol Violation|0
7703850|NCT01122862|26791728|P2|Period 1|Protocol Violation|1
7703851|NCT01122862|26791729|P1|Period 1|Protocol Violation|0
7703852|NCT01122680|26791835|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
7703853|NCT01122680|26791836|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
7703854|NCT01122680|26791837|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
7703855|NCT01122680|26791838|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
7703856|NCT01122680|26791835|P4|Period 3 (4 Weeks)|Adverse Event|0
7703857|NCT01122680|26791836|P3|Period 3 (4 Weeks)|Adverse Event|0
7703858|NCT01122680|26791837|P2|Period 3 (4 Weeks)|Adverse Event|0
7703859|NCT01122680|26791838|P1|Period 3 (4 Weeks)|Adverse Event|1
7703860|NCT01122680|26791835|P4|Period 2 (4 Weeks)|Other|0
7703861|NCT01122680|26791836|P3|Period 2 (4 Weeks)|Other|0
7703862|NCT01122680|26791837|P2|Period 2 (4 Weeks)|Other|0
7703863|NCT01122680|26791838|P1|Period 2 (4 Weeks)|Other|1
7703864|NCT01122680|26791835|P4|Period 2 (4 Weeks)|Protocol Violation|1
7703865|NCT01122680|26791836|P3|Period 2 (4 Weeks)|Protocol Violation|0
7703866|NCT01122680|26791837|P2|Period 2 (4 Weeks)|Protocol Violation|0
7703867|NCT01122680|26791838|P1|Period 2 (4 Weeks)|Protocol Violation|0
7703868|NCT01122680|26791835|P4|Period 1 (4 Weeks)|Other|0
7703869|NCT01122680|26791836|P3|Period 1 (4 Weeks)|Other|0
7703870|NCT01122680|26791837|P2|Period 1 (4 Weeks)|Other|1
7703871|NCT01122680|26791838|P1|Period 1 (4 Weeks)|Other|1
7703872|NCT01122680|26791835|P4|Period 1 (4 Weeks)|Protocol Violation|0
7703873|NCT01122680|26791836|P3|Period 1 (4 Weeks)|Protocol Violation|0
7703874|NCT01122680|26791837|P2|Period 1 (4 Weeks)|Protocol Violation|0
7703875|NCT01122680|26791838|P1|Period 1 (4 Weeks)|Protocol Violation|1
7703876|NCT01122680|26791835|P4|Period 1 (4 Weeks)|Adverse Event|0
7703877|NCT01122680|26791836|P3|Period 1 (4 Weeks)|Adverse Event|0
7703878|NCT01122680|26791837|P2|Period 1 (4 Weeks)|Adverse Event|0
7703879|NCT01122680|26791838|P1|Period 1 (4 Weeks)|Adverse Event|1
7703880|NCT01122576|26791903|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
7703881|NCT01122576|26791904|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
7703882|NCT01122576|26791905|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
7703883|NCT01122576|26791903|P3|Post-Cataract Surgery|Central Macular Edema|1
7703884|NCT01122576|26791904|P2|Post-Cataract Surgery|Central Macular Edema|0
7703885|NCT01122576|26791905|P1|Post-Cataract Surgery|Central Macular Edema|0
7703886|NCT01122576|26791903|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
7703887|NCT01122576|26791904|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
7703888|NCT01122576|26791905|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
7703889|NCT01122394|26792086|P2|Overall Study|Adverse Event|1
7703890|NCT01122394|26792087|P1|Overall Study|Adverse Event|0
7703891|NCT01122394|26792086|P2|Overall Study|Lost to Follow-up|2
7703892|NCT01122394|26792087|P1|Overall Study|Lost to Follow-up|2
7703893|NCT01122394|26792086|P2|Overall Study|Withdrawal by Subject|1
7703894|NCT01122394|26792087|P1|Overall Study|Withdrawal by Subject|1
7703895|NCT01122381|26792103|P2|Overall Study|study terminated early|1
7703896|NCT01122381|26792104|P1|Overall Study|study terminated early|0
7703897|NCT01122264|26792120|P3|Overall Study|Lack of Efficacy|1
7703898|NCT01122264|26792121|P2|Overall Study|Lack of Efficacy|1
7703899|NCT01122264|26792122|P1|Overall Study|Lack of Efficacy|3
7703900|NCT01122264|26792120|P3|Overall Study|Physician Decision|1
7703901|NCT01122264|26792121|P2|Overall Study|Physician Decision|1
7703902|NCT01122264|26792122|P1|Overall Study|Physician Decision|3
7703903|NCT01122264|26792120|P3|Overall Study|Withdrawal by Subject|16
7703904|NCT01122264|26792121|P2|Overall Study|Withdrawal by Subject|6
7703905|NCT01122264|26792122|P1|Overall Study|Withdrawal by Subject|6
7703906|NCT01122264|26792120|P3|Overall Study|Protocol Violation|9
7703907|NCT01122264|26792121|P2|Overall Study|Protocol Violation|7
7703908|NCT01122264|26792122|P1|Overall Study|Protocol Violation|7
7703909|NCT01122264|26792120|P3|Overall Study|Entry Criteria Not Met|0
7703910|NCT01122264|26792121|P2|Overall Study|Entry Criteria Not Met|0
7703911|NCT01122264|26792122|P1|Overall Study|Entry Criteria Not Met|1
7703912|NCT01122264|26792120|P3|Overall Study|Lost to Follow-up|13
7703913|NCT01122264|26792121|P2|Overall Study|Lost to Follow-up|9
7703914|NCT01122264|26792122|P1|Overall Study|Lost to Follow-up|5
7703915|NCT01122264|26792120|P3|Overall Study|Death|0
7703916|NCT01122264|26792121|P2|Overall Study|Death|0
7703917|NCT01122264|26792122|P1|Overall Study|Death|1
7703918|NCT01122264|26792120|P3|Overall Study|Adverse Event|7
7703919|NCT01122264|26792121|P2|Overall Study|Adverse Event|5
7703920|NCT01122264|26792122|P1|Overall Study|Adverse Event|6
7703921|NCT01122173|26792232|P1|Overall Study|Left study for other reasons|3
7703922|NCT01122173|26792232|P1|Overall Study|Withdrawal by Subject|3
7703923|NCT01122173|26792232|P1|Overall Study|Lost to Follow-up|3
7703924|NCT01121991|26792455|P1|Overall Study|No Fertilization|1
7703925|NCT01121991|26792455|P1|Overall Study|No Oocytes Retrieved|3
7703926|NCT01121991|26792455|P1|Overall Study|Lack of Ovarian Response|2
7703927|NCT01121926|26792480|P2|Washout Period|Positive pregnancy test|1
7703928|NCT01121926|26792481|P1|Washout Period|Positive pregnancy test|0
7703929|NCT01121926|26792480|P2|Washout Period|Adverse Event|1
7703930|NCT01121926|26792481|P1|Washout Period|Adverse Event|0
7703931|NCT01121926|26792480|P2|First Intervention Period|Adverse Event|0
7703932|NCT01121926|26792481|P1|First Intervention Period|Adverse Event|1
7703933|NCT01121913|26792499|P4|Third Washout Period|Adverse Event|0
7703934|NCT01121913|26792500|P3|Third Washout Period|Adverse Event|0
7703935|NCT01121913|26792501|P2|Third Washout Period|Adverse Event|0
7703936|NCT01121913|26792502|P1|Third Washout Period|Adverse Event|1
7703937|NCT01121913|26792499|P4|Second Washout Period|Withdrawal by Subject|0
7703938|NCT01121913|26792500|P3|Second Washout Period|Withdrawal by Subject|1
7703939|NCT01121913|26792501|P2|Second Washout Period|Withdrawal by Subject|0
7703940|NCT01121913|26792502|P1|Second Washout Period|Withdrawal by Subject|0
7703941|NCT01121913|26792499|P4|Second Intervention Period|Adverse Event|0
7703942|NCT01121913|26792500|P3|Second Intervention Period|Adverse Event|1
7703943|NCT01121913|26792501|P2|Second Intervention Period|Adverse Event|0
7703944|NCT01121913|26792502|P1|Second Intervention Period|Adverse Event|0
7703945|NCT01121913|26792499|P4|First Washout Period|Withdrawal by Subject|0
7703946|NCT01121913|26792500|P3|First Washout Period|Withdrawal by Subject|0
7703947|NCT01121913|26792501|P2|First Washout Period|Withdrawal by Subject|0
7703948|NCT01121913|26792502|P1|First Washout Period|Withdrawal by Subject|1
7703949|NCT01121913|26792499|P4|First Intervention Period|Adverse Event|0
7703950|NCT01121913|26792500|P3|First Intervention Period|Adverse Event|1
7703951|NCT01121913|26792501|P2|First Intervention Period|Adverse Event|0
7703952|NCT01121913|26792502|P1|First Intervention Period|Adverse Event|0
7703953|NCT01121900|26792532|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7703954|NCT01121900|26792533|P1|Washout Period of 7 Days|Withdrawal by Subject|0
7703955|NCT01121900|26792532|P2|First Intervention Period|Adverse Event|1
7703956|NCT01121900|26792533|P1|First Intervention Period|Adverse Event|1
7703957|NCT01121757|26792553|P2|Combination|Disease Progression|0
7703958|NCT01121757|26792554|P1|Combination|Disease Progression|2
7703959|NCT01121757|26792553|P2|Combination|Physician Decision|1
7703960|NCT01121757|26792554|P1|Combination|Physician Decision|0
7703961|NCT01121757|26792553|P2|First Drug|Disease Progression|2
7703962|NCT01121757|26792554|P1|First Drug|Disease Progression|0
7703963|NCT01121757|26792553|P2|First Drug|Death|0
7703964|NCT01121757|26792554|P1|First Drug|Death|1
7703965|NCT01121666|26792570|P2|Overall Study|Protocol Violation|10
7703966|NCT01121666|26792571|P1|Overall Study|Protocol Violation|29
7703967|NCT01121575|26792627|P6|Overall Study|Death|1
7703968|NCT01121575|26792628|P5|Overall Study|Death|7
7703969|NCT01121575|26792629|P4|Overall Study|Death|1
7703970|NCT01121575|26792630|P3|Overall Study|Death|0
7703971|NCT01121575|26792631|P2|Overall Study|Death|0
7703972|NCT01121575|26792632|P1|Overall Study|Death|6
7703973|NCT01121575|26792627|P6|Overall Study|Unspecified Reasons|10
7703974|NCT01121575|26792628|P5|Overall Study|Unspecified Reasons|13
7703975|NCT01121575|26792629|P4|Overall Study|Unspecified Reasons|5
7703976|NCT01121575|26792630|P3|Overall Study|Unspecified Reasons|7
7703977|NCT01121575|26792631|P2|Overall Study|Unspecified Reasons|6
7703978|NCT01121575|26792632|P1|Overall Study|Unspecified Reasons|8
7703979|NCT01121575|26792627|P6|Overall Study|Participant Refused Further Follow-Up|1
7703980|NCT01121575|26792628|P5|Overall Study|Participant Refused Further Follow-Up|5
7703981|NCT01121575|26792629|P4|Overall Study|Participant Refused Further Follow-Up|0
7703982|NCT01121575|26792630|P3|Overall Study|Participant Refused Further Follow-Up|0
7703983|NCT01121575|26792631|P2|Overall Study|Participant Refused Further Follow-Up|0
7703984|NCT01121575|26792632|P1|Overall Study|Participant Refused Further Follow-Up|0
7703985|NCT01121562|26792756|P1|Overall Study|Met study discontinuation criteria|1
7703986|NCT01121562|26792756|P1|Overall Study|Sponsor Decision|1
7703987|NCT01121562|26792756|P1|Overall Study|Adverse Event|1
7703988|NCT01121562|26792756|P1|Overall Study|Withdrawal by Subject|1
7703989|NCT01121562|26792756|P1|Overall Study|Objective progression or relapse|8
7703990|NCT01121549|26792765|P1|Overall Study|Other|58
7703991|NCT01121549|26792765|P1|Overall Study|Withdrawal by Subject|16
7703992|NCT01121549|26792765|P1|Overall Study|Protocol Violation|33
7703993|NCT01121549|26792765|P1|Overall Study|Pregnancy|1
7703994|NCT01121549|26792765|P1|Overall Study|Study terminated by sponsor|197
7703995|NCT01121549|26792765|P1|Overall Study|Did not meet entrance criteria|9
7703996|NCT01121549|26792765|P1|Overall Study|Lost to Follow-up|12
7703997|NCT01121549|26792765|P1|Overall Study|Lack of Efficacy|11
7703998|NCT01121549|26792765|P1|Overall Study|Adverse Event|10
7703999|NCT01121536|26792776|P1|Overall Study|Other|118
7704000|NCT01121536|26792776|P1|Overall Study|Lost to Follow-up|39
7704001|NCT01121536|26792776|P1|Overall Study|Noncompliance with study procedures|9
7704002|NCT01121536|26792776|P1|Overall Study|Noncompliance with study medication|12
7704003|NCT01121536|26792776|P1|Overall Study|Protocol Violation|20
7704004|NCT01121536|26792776|P1|Overall Study|Withdrawal by Subject|65
7704005|NCT01121536|26792776|P1|Overall Study|Lack of Efficacy|35
7704006|NCT01121536|26792776|P1|Overall Study|Adverse Event|63
7704007|NCT01121484|26792797|P2|Overall Study|Randomized, not treated|4
7704008|NCT01121484|26792798|P1|Overall Study|Randomized, not treated|1
7704009|NCT01121484|26792797|P2|Overall Study|Other|3
7704010|NCT01121484|26792798|P1|Overall Study|Other|3
7704011|NCT01121484|26792797|P2|Overall Study|Discontinuation of study by sponsor|1
7704012|NCT01121484|26792798|P1|Overall Study|Discontinuation of study by sponsor|0
7704013|NCT01121484|26792797|P2|Overall Study|Withdrawal by Subject|7
7704014|NCT01121484|26792798|P1|Overall Study|Withdrawal by Subject|8
7704015|NCT01121484|26792797|P2|Overall Study|Protocol Violation|0
7704016|NCT01121484|26792798|P1|Overall Study|Protocol Violation|1
7704017|NCT01121484|26792797|P2|Overall Study|Physician Decision|3
7704018|NCT01121484|26792798|P1|Overall Study|Physician Decision|0
7704019|NCT01121484|26792797|P2|Overall Study|Lost to Follow-up|9
7704020|NCT01121484|26792798|P1|Overall Study|Lost to Follow-up|5
7704021|NCT01121484|26792797|P2|Overall Study|Lack of Efficacy|11
7704022|NCT01121484|26792798|P1|Overall Study|Lack of Efficacy|3
7704023|NCT01121484|26792797|P2|Overall Study|Adverse Event|5
7704024|NCT01121484|26792798|P1|Overall Study|Adverse Event|12
7704025|NCT01121406|26792816|P2|Overall Study|Not treated|0
7704026|NCT01121406|26792817|P1|Overall Study|Not treated|1
7704027|NCT01121406|26792816|P2|Overall Study|Reason other than specified above|6
7704028|NCT01121406|26792817|P1|Overall Study|Reason other than specified above|2
7704029|NCT01121406|26792816|P2|Overall Study|Refused continuation of study med.|2
7704030|NCT01121406|26792817|P1|Overall Study|Refused continuation of study med.|1
7704031|NCT01121406|26792816|P2|Overall Study|Lost to Follow-up|1
7704032|NCT01121406|26792817|P1|Overall Study|Lost to Follow-up|0
7704033|NCT01121406|26792816|P2|Overall Study|Non-compliant with protocol|2
7704034|NCT01121406|26792817|P1|Overall Study|Non-compliant with protocol|0
7704035|NCT01121406|26792816|P2|Overall Study|Other AE|10
7704036|NCT01121406|26792817|P1|Overall Study|Other AE|3
7704037|NCT01121406|26792816|P2|Overall Study|Wors. or AE of underlying cancer disease|6
7704038|NCT01121406|26792817|P1|Overall Study|Wors. or AE of underlying cancer disease|4
7704039|NCT01121406|26792816|P2|Overall Study|Progressive disease RECIST|28
7704040|NCT01121406|26792817|P1|Overall Study|Progressive disease RECIST|44
7704041|NCT01121393|26792867|P2|Overall Study|Other than listed|0
7704042|NCT01121393|26792868|P1|Overall Study|Other than listed|6
7704043|NCT01121393|26792867|P2|Overall Study|Not treated|9
7704044|NCT01121393|26792868|P1|Overall Study|Not treated|3
7704045|NCT01121393|26792867|P2|Overall Study|Refused cont. medication|7
7704046|NCT01121393|26792868|P1|Overall Study|Refused cont. medication|7
7704047|NCT01121393|26792867|P2|Overall Study|Lost to Follow-up|0
7704048|NCT01121393|26792868|P1|Overall Study|Lost to Follow-up|1
7704049|NCT01121393|26792867|P2|Overall Study|Non-compliant with protocol|3
7704050|NCT01121393|26792868|P1|Overall Study|Non-compliant with protocol|0
7704051|NCT01121393|26792867|P2|Overall Study|Other Adverse events|45
7704052|NCT01121393|26792868|P1|Overall Study|Other Adverse events|24
7704053|NCT01121393|26792867|P2|Overall Study|Progressive disease|20
7704054|NCT01121393|26792868|P1|Overall Study|Progressive disease|201
7704055|NCT01121263|26792913|P2|Overall Study|Withdrawal by Subject|1
7704056|NCT01121263|26792914|P1|Overall Study|Withdrawal by Subject|0
7704057|NCT01121263|26792913|P2|Overall Study|Lost to Follow-up|12
7704058|NCT01121263|26792914|P1|Overall Study|Lost to Follow-up|22
7704059|NCT01121263|26792913|P2|Overall Study|Death|2
7704060|NCT01121263|26792914|P1|Overall Study|Death|3
7704061|NCT01121185|26793005|P2|Overall Study|Not transplanted|0
7704062|NCT01121185|26793006|P1|Overall Study|Not transplanted|1
7704063|NCT01121185|26793005|P2|Overall Study|Not infused|1
7704064|NCT01121185|26793006|P1|Overall Study|Not infused|0
7704065|NCT01121146|26793040|P2|Overall Study|Lost to Follow-up|16
7704066|NCT01121146|26793041|P1|Overall Study|Lost to Follow-up|7
7704067|NCT01121146|26793040|P2|Overall Study|Adverse Event|11
7704068|NCT01121146|26793041|P1|Overall Study|Adverse Event|2
7704069|NCT01121146|26793040|P2|Overall Study|Death|15
7704070|NCT01121146|26793041|P1|Overall Study|Death|17
7704071|NCT01120899|26793062|P1|Overall Study|Withdrawal by Subject|3
7704072|NCT01120782|26793090|P1|Overall Study|Test article shipping error|11
7704073|NCT01120756|26793096|P2|Overall Study|Withdrawal by Subject|1
7704074|NCT01120756|26793097|P1|Overall Study|Withdrawal by Subject|1
7704075|NCT01120717|26793107|P2|Overall Study|Abnormal Test Procedure Result(s)|0
7704076|NCT01120717|26793108|P1|Overall Study|Abnormal Test Procedure Result(s)|1
7704077|NCT01120717|26793107|P2|Overall Study|Death|1
7704078|NCT01120717|26793108|P1|Overall Study|Death|3
7704079|NCT01120717|26793107|P2|Overall Study|Lost to Follow-up|3
7704080|NCT01120717|26793108|P1|Overall Study|Lost to Follow-up|2
7704081|NCT01120717|26793107|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
7704082|NCT01120717|26793108|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
7704083|NCT01120717|26793107|P2|Overall Study|Protocol Deviation|5
7704084|NCT01120717|26793108|P1|Overall Study|Protocol Deviation|2
7704085|NCT01120717|26793107|P2|Overall Study|Adverse Event|6
7704086|NCT01120717|26793108|P1|Overall Study|Adverse Event|10
7704087|NCT01120717|26793107|P2|Overall Study|Withdrawal by Subject|6
7704088|NCT01120717|26793108|P1|Overall Study|Withdrawal by Subject|11
7704089|NCT01120691|26793214|P3|Overall Study|Abnormal laboratory value(s)|4
7704090|NCT01120691|26793215|P2|Overall Study|Abnormal laboratory value(s)|3
7704091|NCT01120691|26793216|P1|Overall Study|Abnormal laboratory value(s)|1
7704092|NCT01120691|26793214|P3|Overall Study|Patient's inability to use the device|0
7704093|NCT01120691|26793215|P2|Overall Study|Patient's inability to use the device|1
7704094|NCT01120691|26793216|P1|Overall Study|Patient's inability to use the device|3
7704095|NCT01120691|26793214|P3|Overall Study|Abnormal test procedure result(s)|1
7704096|NCT01120691|26793215|P2|Overall Study|Abnormal test procedure result(s)|2
7704097|NCT01120691|26793216|P1|Overall Study|Abnormal test procedure result(s)|3
7704098|NCT01120691|26793214|P3|Overall Study|Lost to Follow-up|4
7704099|NCT01120691|26793215|P2|Overall Study|Lost to Follow-up|6
7704100|NCT01120691|26793216|P1|Overall Study|Lost to Follow-up|5
7704101|NCT01120691|26793214|P3|Overall Study|Protocol deviation|12
7704102|NCT01120691|26793215|P2|Overall Study|Protocol deviation|12
7704103|NCT01120691|26793216|P1|Overall Study|Protocol deviation|13
7704104|NCT01120691|26793214|P3|Overall Study|Administrative problems|9
7704105|NCT01120691|26793215|P2|Overall Study|Administrative problems|8
7704106|NCT01120691|26793216|P1|Overall Study|Administrative problems|15
7704107|NCT01120691|26793214|P3|Overall Study|Unsatisfactory therapeutic effect|38
7704108|NCT01120691|26793215|P2|Overall Study|Unsatisfactory therapeutic effect|32
7704109|NCT01120691|26793216|P1|Overall Study|Unsatisfactory therapeutic effect|18
7704110|NCT01120691|26793214|P3|Overall Study|Death|24
7704111|NCT01120691|26793215|P2|Overall Study|Death|22
7704112|NCT01120691|26793216|P1|Overall Study|Death|21
7704113|NCT01120691|26793214|P3|Overall Study|Subject withdrew consent|44
7704114|NCT01120691|26793215|P2|Overall Study|Subject withdrew consent|50
7704115|NCT01120691|26793216|P1|Overall Study|Subject withdrew consent|33
7704116|NCT01120691|26793214|P3|Overall Study|Adverse Event|47
7704117|NCT01120691|26793215|P2|Overall Study|Adverse Event|67
7704118|NCT01120691|26793216|P1|Overall Study|Adverse Event|59
7704119|NCT01120626|26793313|P2|Overall Study|Withdrawal by Subject|0
7704120|NCT01120626|26793314|P1|Overall Study|Withdrawal by Subject|1
7704121|NCT01120600|26793324|P2|Overall Study|Withdrawal by Subject|11
7704122|NCT01120600|26793325|P1|Overall Study|Withdrawal by Subject|10
7704123|NCT01120600|26793324|P2|Overall Study|Protocol Violation|4
7704124|NCT01120600|26793325|P1|Overall Study|Protocol Violation|0
7704125|NCT01120600|26793324|P2|Overall Study|Physician Decision|3
7704126|NCT01120600|26793325|P1|Overall Study|Physician Decision|1
7704127|NCT01120600|26793324|P2|Overall Study|Lost to Follow-up|3
7704128|NCT01120600|26793325|P1|Overall Study|Lost to Follow-up|1
7704129|NCT01120600|26793324|P2|Overall Study|Excessive Bone Loss|4
7704130|NCT01120600|26793325|P1|Overall Study|Excessive Bone Loss|0
7704131|NCT01120600|26793324|P2|Overall Study|Adverse Event|7
7704132|NCT01120600|26793325|P1|Overall Study|Adverse Event|7
7704133|NCT01120379|26793380|P1|Four Year Timepoint|Any other reason for early termination|217
7704134|NCT01120379|26793380|P1|Four Year Timepoint|Physician Decision|5
7704135|NCT01120379|26793380|P1|Four Year Timepoint|Death|131
7704136|NCT01120379|26793380|P1|Four Year Timepoint|Lost to Follow-up|10
7704137|NCT01120379|26793380|P1|Four Year Timepoint|Withdrawal by Subject|5
7704138|NCT01120379|26793380|P1|Three Year Timepoint|Any other reason for early termination|17
7704139|NCT01120379|26793380|P1|Three Year Timepoint|Physician Decision|9
7704140|NCT01120379|26793380|P1|Three Year Timepoint|Death|120
7704141|NCT01120379|26793380|P1|Three Year Timepoint|Lost to Follow-up|43
7704142|NCT01120379|26793380|P1|Three Year Timepoint|Withdrawal by Subject|25
7704143|NCT01120379|26793380|P1|Two Year Timepoint|Any other reason for early termination|4
7704144|NCT01120379|26793380|P1|Two Year Timepoint|Physician Decision|12
7704145|NCT01120379|26793380|P1|Two Year Timepoint|Death|123
7704146|NCT01120379|26793380|P1|Two Year Timepoint|Lost to Follow-up|87
7704147|NCT01120379|26793380|P1|Two Year Timepoint|Withdrawal by Subject|11
7704148|NCT01120379|26793380|P1|One Year Timepoint|Any other reason for early termination|5
7704149|NCT01120379|26793380|P1|One Year Timepoint|Physician Decision|9
7704150|NCT01120379|26793380|P1|One Year Timepoint|Death|108
7704151|NCT01120379|26793380|P1|One Year Timepoint|Lost to Follow-up|115
7704152|NCT01120379|26793380|P1|One Year Timepoint|Withdrawal by Subject|41
7704153|NCT01120275|26793416|P1|Overall Study|Not specific|1
7704154|NCT01120275|26793416|P1|Overall Study|Refusal|1
7704155|NCT01120275|26793416|P1|Overall Study|Withdrawal by Subject|1
7704156|NCT01120275|26793416|P1|Overall Study|Ineligible|3
7704157|NCT01120275|26793416|P1|Overall Study|Progression|27
7704158|NCT01120275|26793416|P1|Overall Study|Adverse Event|3
7704159|NCT01120210|26793483|P2|MAIN INFUSION|Withdrawal by Subject|1
7704160|NCT01120210|26793484|P1|MAIN INFUSION|Withdrawal by Subject|0
7704161|NCT01120210|26793483|P2|MAIN INFUSION|Adverse Event|0
7704162|NCT01120210|26793484|P1|MAIN INFUSION|Adverse Event|1
7704163|NCT01120184|26793534|P3|Overall Study|Death|169
7704164|NCT01120184|26793535|P2|Overall Study|Death|176
7704165|NCT01120184|26793536|P1|Overall Study|Death|170
7704166|NCT01120184|26793534|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
7704167|NCT01120184|26793535|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
7704168|NCT01120184|26793536|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
7704169|NCT01120184|26793534|P3|Overall Study|Sponsor Decision to Terminate Study|143
7704170|NCT01120184|26793535|P2|Overall Study|Sponsor Decision to Terminate Study|144
7704171|NCT01120184|26793536|P1|Overall Study|Sponsor Decision to Terminate Study|133
7704172|NCT01120184|26793534|P3|Overall Study|Reason not Specified|12
7704173|NCT01120184|26793535|P2|Overall Study|Reason not Specified|3
7704174|NCT01120184|26793536|P1|Overall Study|Reason not Specified|8
7704175|NCT01120184|26793534|P3|Overall Study|Physician Decision|3
7704176|NCT01120184|26793535|P2|Overall Study|Physician Decision|1
7704177|NCT01120184|26793536|P1|Overall Study|Physician Decision|9
7704178|NCT01120184|26793534|P3|Overall Study|Lost to Follow-up|11
7704179|NCT01120184|26793535|P2|Overall Study|Lost to Follow-up|13
7704180|NCT01120184|26793536|P1|Overall Study|Lost to Follow-up|13
7704181|NCT01120184|26793534|P3|Overall Study|Adverse Event|0
7704182|NCT01120184|26793535|P2|Overall Study|Adverse Event|1
7704183|NCT01120184|26793536|P1|Overall Study|Adverse Event|0
7704184|NCT01120093|26793658|P5|Treatment Period 5|Adverse Event|0
7704185|NCT01120093|26793659|P4|Treatment Period 5|Adverse Event|1
7704186|NCT01120093|26793660|P3|Treatment Period 5|Adverse Event|0
7704187|NCT01120093|26793661|P2|Treatment Period 5|Adverse Event|1
7704188|NCT01120093|26793662|P1|Treatment Period 5|Adverse Event|0
7704189|NCT01120093|26793658|P5|Treatment Period 4|Adverse Event|0
7704190|NCT01120093|26793659|P4|Treatment Period 4|Adverse Event|0
7704191|NCT01120093|26793660|P3|Treatment Period 4|Adverse Event|0
7704192|NCT01120093|26793661|P2|Treatment Period 4|Adverse Event|0
7704193|NCT01120093|26793662|P1|Treatment Period 4|Adverse Event|1
7704194|NCT01120093|26793658|P5|Treatment Period 3|Withdrawal by Subject|0
7704195|NCT01120093|26793659|P4|Treatment Period 3|Withdrawal by Subject|0
7704196|NCT01120093|26793660|P3|Treatment Period 3|Withdrawal by Subject|1
7704197|NCT01120093|26793661|P2|Treatment Period 3|Withdrawal by Subject|0
7704198|NCT01120093|26793662|P1|Treatment Period 3|Withdrawal by Subject|0
7704199|NCT01120093|26793658|P5|Treatment Period 3|Adverse Event|1
7704200|NCT01120093|26793659|P4|Treatment Period 3|Adverse Event|0
7704201|NCT01120093|26793660|P3|Treatment Period 3|Adverse Event|0
7704202|NCT01120093|26793661|P2|Treatment Period 3|Adverse Event|0
7704203|NCT01120093|26793662|P1|Treatment Period 3|Adverse Event|0
7704204|NCT01120093|26793658|P5|Treatment Period 3|Lack of Efficacy|0
7704205|NCT01120093|26793659|P4|Treatment Period 3|Lack of Efficacy|1
7704206|NCT01120093|26793660|P3|Treatment Period 3|Lack of Efficacy|0
7704207|NCT01120093|26793661|P2|Treatment Period 3|Lack of Efficacy|0
7704208|NCT01120093|26793662|P1|Treatment Period 3|Lack of Efficacy|0
7704209|NCT01120093|26793658|P5|Treatment Period 2|Withdrawal by Subject|1
7704210|NCT01120093|26793659|P4|Treatment Period 2|Withdrawal by Subject|0
7704211|NCT01120093|26793660|P3|Treatment Period 2|Withdrawal by Subject|0
7704212|NCT01120093|26793661|P2|Treatment Period 2|Withdrawal by Subject|0
7704213|NCT01120093|26793662|P1|Treatment Period 2|Withdrawal by Subject|0
7704214|NCT01120093|26793658|P5|Treatment Period 2|Adverse Event|0
7704215|NCT01120093|26793659|P4|Treatment Period 2|Adverse Event|1
7704216|NCT01120093|26793660|P3|Treatment Period 2|Adverse Event|0
7704217|NCT01120093|26793661|P2|Treatment Period 2|Adverse Event|0
7704218|NCT01120093|26793662|P1|Treatment Period 2|Adverse Event|0
7704219|NCT01120093|26793658|P5|Treatment Period 1|Withdrawal by Subject|0
7704220|NCT01120093|26793659|P4|Treatment Period 1|Withdrawal by Subject|0
7704221|NCT01120093|26793660|P3|Treatment Period 1|Withdrawal by Subject|0
7704222|NCT01120093|26793661|P2|Treatment Period 1|Withdrawal by Subject|1
7704223|NCT01120093|26793662|P1|Treatment Period 1|Withdrawal by Subject|0
7704224|NCT01120093|26793658|P5|Treatment Period 1|Adverse Event|1
7704225|NCT01120093|26793659|P4|Treatment Period 1|Adverse Event|0
7704226|NCT01120093|26793660|P3|Treatment Period 1|Adverse Event|1
7704227|NCT01120093|26793661|P2|Treatment Period 1|Adverse Event|0
7704228|NCT01120093|26793662|P1|Treatment Period 1|Adverse Event|0
7704229|NCT01120067|26793691|P2|Overall Study|fail to engage >3 sessions|0
7704230|NCT01120067|26793692|P1|Overall Study|fail to engage >3 sessions|2
7704231|NCT01120067|26793691|P2|Overall Study|Lost to Follow-up|1
7704232|NCT01120067|26793692|P1|Overall Study|Lost to Follow-up|3
7704233|NCT01120028|26793702|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
7704234|NCT01120028|26793703|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
7704235|NCT01120028|26793704|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
7704236|NCT01120028|26793705|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
7704237|NCT01120028|26793702|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7704238|NCT01120028|26793703|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7704239|NCT01120028|26793704|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
7704240|NCT01120028|26793705|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7704241|NCT01119963|26793729|P2|Overall Study|Lost to Follow-up|1
7704242|NCT01119963|26793730|P1|Overall Study|Lost to Follow-up|1
7704243|NCT01119950|26793740|P1|Overall Study|Death|1
7704244|NCT01119950|26793740|P1|Overall Study|Abnormal lab value|1
7704245|NCT01119950|26793740|P1|Overall Study|Administrative|2
7704246|NCT01119950|26793740|P1|Overall Study|Lost to Follow-up|4
7704247|NCT01119950|26793740|P1|Overall Study|Protocol Violation|5
7704248|NCT01119950|26793740|P1|Overall Study|Withdrawal by Subject|9
7704249|NCT01119950|26793740|P1|Overall Study|Adverse Event|25
7704250|NCT01119937|26793987|P2|Overall Study|Withdrawal by Subject|1
7704251|NCT01119937|26793988|P1|Overall Study|Withdrawal by Subject|2
7704252|NCT01119937|26793987|P2|Overall Study|Unsatisfactory therapeutic effect|0
7704253|NCT01119937|26793988|P1|Overall Study|Unsatisfactory therapeutic effect|3
7704254|NCT01119937|26793987|P2|Overall Study|Protocol deviation|1
7704255|NCT01119937|26793988|P1|Overall Study|Protocol deviation|3
7704256|NCT01119937|26793987|P2|Overall Study|Adverse Event|5
7704257|NCT01119937|26793988|P1|Overall Study|Adverse Event|11
7704258|NCT01119898|26794016|P2|Overall Study|Randomized in error did not participate|0
7704259|NCT01119898|26794017|P1|Overall Study|Randomized in error did not participate|1
7704260|NCT01119898|26794016|P2|Overall Study|Medical procedure|0
7704261|NCT01119898|26794017|P1|Overall Study|Medical procedure|1
7704262|NCT01119898|26794016|P2|Overall Study|Protocol Violation|1
7704263|NCT01119898|26794017|P1|Overall Study|Protocol Violation|1
7704264|NCT01119898|26794016|P2|Overall Study|Lack of Efficacy|2
7704265|NCT01119898|26794017|P1|Overall Study|Lack of Efficacy|0
7704266|NCT01119898|26794016|P2|Overall Study|Withdrawal by Subject|4
7704267|NCT01119898|26794017|P1|Overall Study|Withdrawal by Subject|1
7704268|NCT01119898|26794016|P2|Overall Study|Adverse Event|5
7704269|NCT01119898|26794017|P1|Overall Study|Adverse Event|4
7704270|NCT01119859|26794043|P2|Overall Study|Failure to return|0
7704271|NCT01119859|26794044|P1|Overall Study|Failure to return|3
7704272|NCT01119859|26794043|P2|Overall Study|Refused treatment|6
7704273|NCT01119859|26794044|P1|Overall Study|Refused treatment|3
7704274|NCT01119859|26794043|P2|Overall Study|Insufficient therapeutic response|14
7704275|NCT01119859|26794044|P1|Overall Study|Insufficient therapeutic response|7
7704276|NCT01119859|26794043|P2|Overall Study|Death|0
7704277|NCT01119859|26794044|P1|Overall Study|Death|2
7704278|NCT01119859|26794043|P2|Overall Study|Adverse Event|10
7704279|NCT01119859|26794044|P1|Overall Study|Adverse Event|9
7704280|NCT01119846|26794063|P3|Overall Study|Withdrawal by Subject|4
7704281|NCT01119846|26794064|P2|Overall Study|Withdrawal by Subject|0
7704282|NCT01119846|26794065|P1|Overall Study|Withdrawal by Subject|0
7704283|NCT01119846|26794063|P3|Overall Study|Protocol Violation|1
7704284|NCT01119846|26794064|P2|Overall Study|Protocol Violation|0
7704285|NCT01119846|26794065|P1|Overall Study|Protocol Violation|0
7704286|NCT01119846|26794063|P3|Overall Study|Physician Decision|0
7704287|NCT01119846|26794064|P2|Overall Study|Physician Decision|0
7704288|NCT01119846|26794065|P1|Overall Study|Physician Decision|1
7704289|NCT01119846|26794063|P3|Overall Study|Adverse Event|6
7704290|NCT01119846|26794064|P2|Overall Study|Adverse Event|0
7704291|NCT01119846|26794065|P1|Overall Study|Adverse Event|1
7704292|NCT01119768|26794279|P2|Treatment Period|Lack of Efficacy|25
7704293|NCT01119768|26794280|P1|Treatment Period|Lack of Efficacy|18
7704294|NCT01119703|26794336|P2|Overall Study|Adverse Event|1
7704295|NCT01119703|26794337|P1|Overall Study|Adverse Event|0
7704296|NCT01119625|26794351|P2|Overall Study|Other|1
7704297|NCT01119625|26794352|P1|Overall Study|Other|0
7704298|NCT01119625|26794351|P2|Overall Study|Withdrawal by Subject|1
7704299|NCT01119625|26794352|P1|Overall Study|Withdrawal by Subject|2
7704300|NCT01119625|26794351|P2|Overall Study|Lost to Follow-up|2
7704301|NCT01119625|26794352|P1|Overall Study|Lost to Follow-up|1
7704302|NCT01119508|26794392|P1|Overall Study|Died before tumor response evaluation|1
7704303|NCT01119508|26794392|P1|Overall Study|Withdrawal by Subject|2
7704304|NCT01119508|26794392|P1|Overall Study|Adverse Event|56
7704305|NCT01119443|26794472|P2|Crossover Period 1 (5 Days)|Adverse Event|1
7704306|NCT01119443|26794473|P1|Crossover Period 1 (5 Days)|Adverse Event|0
7704307|NCT01119287|26794516|P6|Overall Study|Patient Decision, not related to AE|0
7704308|NCT01119287|26794517|P5|Overall Study|Patient Decision, not related to AE|1
7704309|NCT01119287|26794518|P4|Overall Study|Patient Decision, not related to AE|2
7704310|NCT01119287|26794519|P3|Overall Study|Patient Decision, not related to AE|2
7704311|NCT01119287|26794520|P2|Overall Study|Patient Decision, not related to AE|0
7704312|NCT01119287|26794521|P1|Overall Study|Patient Decision, not related to AE|0
7704313|NCT01119248|26794534|P1|Overall Study|Physician Decision|5
7704314|NCT01119131|26794584|P3|Overall Study|Physician Decision|1
7704315|NCT01119131|26794585|P2|Overall Study|Physician Decision|0
7704316|NCT01119131|26794586|P1|Overall Study|Physician Decision|0
7704317|NCT01119131|26794584|P3|Overall Study|Non-Compliance|4
7704318|NCT01119131|26794585|P2|Overall Study|Non-Compliance|0
7704319|NCT01119131|26794586|P1|Overall Study|Non-Compliance|1
7704320|NCT01119131|26794584|P3|Overall Study|Adverse Event|1
7704321|NCT01119131|26794585|P2|Overall Study|Adverse Event|1
7704322|NCT01119131|26794586|P1|Overall Study|Adverse Event|1
7704323|NCT01119118|26794615|P1|Overall Study|Adverse Event|1
7704324|NCT01119105|26794626|P3|Overall Study|Other|0
7704325|NCT01119105|26794627|P2|Overall Study|Other|1
7704326|NCT01119105|26794628|P1|Overall Study|Other|1
7704327|NCT01119105|26794626|P3|Overall Study|study drug missed on 2 consecutive days|1
7704328|NCT01119105|26794627|P2|Overall Study|study drug missed on 2 consecutive days|2
7704329|NCT01119105|26794628|P1|Overall Study|study drug missed on 2 consecutive days|1
7704330|NCT01119105|26794626|P3|Overall Study|Adverse Event|1
7704331|NCT01119105|26794627|P2|Overall Study|Adverse Event|0
7704332|NCT01119105|26794628|P1|Overall Study|Adverse Event|1
7704333|NCT01119105|26794626|P3|Overall Study|Lost to Follow-up|5
7704334|NCT01119105|26794627|P2|Overall Study|Lost to Follow-up|2
7704335|NCT01119105|26794628|P1|Overall Study|Lost to Follow-up|0
7704336|NCT01119105|26794626|P3|Overall Study|Withdrawal by Subject|1
7704337|NCT01119105|26794627|P2|Overall Study|Withdrawal by Subject|1
7704338|NCT01119105|26794628|P1|Overall Study|Withdrawal by Subject|1
7704339|NCT01119001|26794643|P1|Overall Study|Withdrawal by Subject|2
7704340|NCT01118975|26794687|P2|Overall Study|Adverse Event|1
7704341|NCT01118975|26794688|P1|Overall Study|Adverse Event|0
7704342|NCT01118962|26794694|P1|Overall Study|Non-compliance with Medicinal Product|1
7704343|NCT01118962|26794694|P1|Overall Study|Pregnancy|1
7704344|NCT01118962|26794694|P1|Overall Study|Withdrawal by Subject|4
7704345|NCT01118962|26794694|P1|Overall Study|Protocol Violation|1
7704346|NCT01118962|26794694|P1|Overall Study|Lack of Efficacy|1
7704347|NCT01118962|26794694|P1|Overall Study|Adverse Event|2
7704348|NCT01118949|26794699|P1|Overall Study|Withdrawal by Subject|4
7704349|NCT01118949|26794699|P1|Overall Study|Adverse Event|5
7704350|NCT01118780|26794729|P2|Overall Study|Withdrawal by Subject|8
7704351|NCT01118780|26794730|P1|Overall Study|Withdrawal by Subject|13
7704352|NCT01118780|26794729|P2|Overall Study|Protocol Violation|6
7704353|NCT01118780|26794730|P1|Overall Study|Protocol Violation|3
7704354|NCT01118780|26794729|P2|Overall Study|Physician Decision|0
7704355|NCT01118780|26794730|P1|Overall Study|Physician Decision|2
7704356|NCT01118780|26794729|P2|Overall Study|Lack of Efficacy|6
7704357|NCT01118780|26794730|P1|Overall Study|Lack of Efficacy|2
7704358|NCT01118780|26794729|P2|Overall Study|Death|0
7704359|NCT01118780|26794730|P1|Overall Study|Death|1
7704360|NCT01118780|26794729|P2|Overall Study|Adverse Event|15
7704361|NCT01118780|26794730|P1|Overall Study|Adverse Event|15
7704362|NCT01118728|26794788|P1|Overall Study|Lost to Follow-up|4
7704363|NCT01118728|26794788|P1|Overall Study|Withdrawal by Subject|3
7704364|NCT01118728|26794788|P1|Overall Study|Sponsor's decision to discontinue study|172
7704365|NCT01118728|26794788|P1|Overall Study|Lack of Efficacy|27
7704366|NCT01118728|26794788|P1|Overall Study|Adverse Event|17
7704367|NCT01118663|26794825|P2|Overall Study|Withdrawal by Subject|1
7704368|NCT01118663|26794826|P1|Overall Study|Withdrawal by Subject|0
7704369|NCT01118663|26794825|P2|Overall Study|Adverse Event|1
7704370|NCT01118663|26794826|P1|Overall Study|Adverse Event|2
7704371|NCT01118520|26794850|P3|Overall Study|Withdrawal by Subject|8
7704372|NCT01118520|26794851|P2|Overall Study|Withdrawal by Subject|13
7704373|NCT01118520|26794852|P1|Overall Study|Withdrawal by Subject|8
7704374|NCT01118520|26794850|P3|Overall Study|Adverse Event|3
7704375|NCT01118520|26794851|P2|Overall Study|Adverse Event|3
7704376|NCT01118520|26794852|P1|Overall Study|Adverse Event|3
7704377|NCT01118520|26794850|P3|Overall Study|AAA repair|9
7704378|NCT01118520|26794851|P2|Overall Study|AAA repair|7
7704379|NCT01118520|26794852|P1|Overall Study|AAA repair|9
7704380|NCT01118455|26794865|P2|Baseline [Visits 1 & 2]|Adverse Event|0
7704381|NCT01118455|26794866|P1|Baseline [Visits 1 & 2]|Adverse Event|1
7704382|NCT01118377|26794894|P1|Overall Study|Failure to Return|3
7704383|NCT01118377|26794894|P1|Overall Study|Death|38
7704384|NCT01118377|26794894|P1|Overall Study|Did Not Receive Study Medication|1
7704385|NCT01118351|26794900|P1|Overall Study|Withdrawal by Subject|1
7704386|NCT01118351|26794900|P1|Overall Study|Adverse Event|3
7704387|NCT01118325|26794924|P3|Overall Study|Adverse Event|1
7704388|NCT01118325|26794925|P2|Overall Study|Adverse Event|0
7704389|NCT01118325|26794926|P1|Overall Study|Adverse Event|1
7704390|NCT01118312|26794972|P2|Overall Study|Withdrawal by Subject|3
7704391|NCT01118312|26794973|P1|Overall Study|Withdrawal by Subject|1
7704392|NCT01118312|26794972|P2|Overall Study|Lost to Follow-up|32
7704393|NCT01118312|26794973|P1|Overall Study|Lost to Follow-up|33
7704394|NCT01118299|26794983|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
7704395|NCT01118299|26794984|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
7704396|NCT01118299|26794983|P2|Overall Study|Lost to Follow-up|1
7704397|NCT01118299|26794984|P1|Overall Study|Lost to Follow-up|2
7704398|NCT01118299|26794983|P2|Overall Study|Withdrawal by Subject|8
7704399|NCT01118299|26794984|P1|Overall Study|Withdrawal by Subject|8
7704400|NCT01118299|26794983|P2|Overall Study|Death|5
7704401|NCT01118299|26794984|P1|Overall Study|Death|7
7704402|NCT01118143|26795181|P2|Overall Study|Withdrawal by Subject|5
7704403|NCT01118143|26795182|P1|Overall Study|Withdrawal by Subject|2
7704404|NCT01118117|26795192|P2|Overall Study|Missed 12 Month Visit|0
7704405|NCT01118117|26795193|P1|Overall Study|Missed 12 Month Visit|7
7704406|NCT01118117|26795192|P2|Overall Study|Lost to Follow-up|0
7704407|NCT01118117|26795193|P1|Overall Study|Lost to Follow-up|6
7704408|NCT01118117|26795192|P2|Overall Study|Death|0
7704409|NCT01118117|26795193|P1|Overall Study|Death|8
7704410|NCT01118052|26795225|P1|Overall Study|Never treated|2
7704411|NCT01117987|26795248|P2|Overall Study|Administrative problems|22
7704412|NCT01117987|26795249|P1|Overall Study|Administrative problems|25
7704413|NCT01117987|26795248|P2|Overall Study|Adverse Event|26
7704414|NCT01117987|26795249|P1|Overall Study|Adverse Event|19
7704415|NCT01117987|26795248|P2|Overall Study|Withdrawal by Subject|10
7704416|NCT01117987|26795249|P1|Overall Study|Withdrawal by Subject|5
7704417|NCT01117987|26795248|P2|Overall Study|Death|10
7704418|NCT01117987|26795249|P1|Overall Study|Death|5
7704419|NCT01117987|26795248|P2|Overall Study|Lack of Efficacy|4
7704420|NCT01117987|26795249|P1|Overall Study|Lack of Efficacy|3
7704421|NCT01117987|26795248|P2|Overall Study|Abnormal test procedure result|0
7704422|NCT01117987|26795249|P1|Overall Study|Abnormal test procedure result|2
7704423|NCT01117987|26795248|P2|Overall Study|Lost to Follow-up|1
7704424|NCT01117987|26795249|P1|Overall Study|Lost to Follow-up|1
7704425|NCT01117987|26795248|P2|Overall Study|Subject no longer requires study drug|0
7704426|NCT01117987|26795249|P1|Overall Study|Subject no longer requires study drug|1
7704427|NCT01117987|26795248|P2|Overall Study|Protocol deviation|1
7704428|NCT01117987|26795249|P1|Overall Study|Protocol deviation|0
7704429|NCT01117870|26795270|P2|Overall Study|Inability to place needle|0
7704430|NCT01117870|26795271|P1|Overall Study|Inability to place needle|1
7704431|NCT01117857|26795285|P1|Overall Study|Physician Decision|1
7704432|NCT01117857|26795285|P1|Overall Study|Withdrawal by Subject|4
7704433|NCT01117857|26795285|P1|Overall Study|Lost to Follow-up|4
7704434|NCT01117792|26795293|P1|Overall Study|Adverse Event|3
7704435|NCT01117792|26795293|P1|Overall Study|Death|1
7704436|NCT01117766|26795297|P2|Second Intervention|Withdrawal by Subject|1
7704437|NCT01117766|26795298|P1|Second Intervention|Withdrawal by Subject|0
7704438|NCT01117766|26795297|P2|Second Intervention|Adverse Event|2
7704439|NCT01117766|26795298|P1|Second Intervention|Adverse Event|0
7704440|NCT01117766|26795297|P2|Second Intervention|Other|2
7704441|NCT01117766|26795298|P1|Second Intervention|Other|1
7704442|NCT01117766|26795297|P2|Second Intervention|Lost to Follow-up|0
7704443|NCT01117766|26795298|P1|Second Intervention|Lost to Follow-up|1
7704444|NCT01117766|26795297|P2|Washout Period|Protocol Violation|2
7704445|NCT01117766|26795298|P1|Washout Period|Protocol Violation|0
7704446|NCT01117766|26795297|P2|First Intervention|Protocol Violation|0
7704447|NCT01117766|26795298|P1|First Intervention|Protocol Violation|1
7704448|NCT01117766|26795297|P2|First Intervention|Adverse Event|1
7704449|NCT01117766|26795298|P1|First Intervention|Adverse Event|0
7704450|NCT01117623|26795335|P8|Overall Study|Invest. text: completed all planned txs|0
7704451|NCT01117623|26795336|P7|Overall Study|Invest. text: completed all planned txs|0
7704452|NCT01117623|26795337|P6|Overall Study|Invest. text: completed all planned txs|1
7704453|NCT01117623|26795338|P5|Overall Study|Invest. text: completed all planned txs|0
7704454|NCT01117623|26795339|P4|Overall Study|Invest. text: completed all planned txs|0
7704455|NCT01117623|26795340|P3|Overall Study|Invest. text: completed all planned txs|0
7704456|NCT01117623|26795341|P2|Overall Study|Invest. text: completed all planned txs|0
7704457|NCT01117623|26795342|P1|Overall Study|Invest. text: completed all planned txs|0
7704458|NCT01117623|26795335|P8|Overall Study|Non-compliance with study medication|1
7704459|NCT01117623|26795336|P7|Overall Study|Non-compliance with study medication|0
7704460|NCT01117623|26795337|P6|Overall Study|Non-compliance with study medication|0
7704461|NCT01117623|26795338|P5|Overall Study|Non-compliance with study medication|0
7704462|NCT01117623|26795339|P4|Overall Study|Non-compliance with study medication|0
7704463|NCT01117623|26795340|P3|Overall Study|Non-compliance with study medication|0
7704464|NCT01117623|26795341|P2|Overall Study|Non-compliance with study medication|0
7704465|NCT01117623|26795342|P1|Overall Study|Non-compliance with study medication|0
7704466|NCT01117623|26795335|P8|Overall Study|Withdrawal by Subject|1
7704467|NCT01117623|26795336|P7|Overall Study|Withdrawal by Subject|1
7704468|NCT01117623|26795337|P6|Overall Study|Withdrawal by Subject|1
7704469|NCT01117623|26795338|P5|Overall Study|Withdrawal by Subject|0
7704470|NCT01117623|26795339|P4|Overall Study|Withdrawal by Subject|0
7704471|NCT01117623|26795340|P3|Overall Study|Withdrawal by Subject|2
7704472|NCT01117623|26795341|P2|Overall Study|Withdrawal by Subject|0
7704473|NCT01117623|26795342|P1|Overall Study|Withdrawal by Subject|0
7704474|NCT01117623|26795335|P8|Overall Study|Disease progression, recurrence, relapse|22
7704475|NCT01117623|26795336|P7|Overall Study|Disease progression, recurrence, relapse|5
7704476|NCT01117623|26795337|P6|Overall Study|Disease progression, recurrence, relapse|14
7704477|NCT01117623|26795338|P5|Overall Study|Disease progression, recurrence, relapse|8
7704478|NCT01117623|26795339|P4|Overall Study|Disease progression, recurrence, relapse|6
7704479|NCT01117623|26795340|P3|Overall Study|Disease progression, recurrence, relapse|5
7704480|NCT01117623|26795341|P2|Overall Study|Disease progression, recurrence, relapse|6
7704481|NCT01117623|26795342|P1|Overall Study|Disease progression, recurrence, relapse|3
7704482|NCT01117623|26795335|P8|Overall Study|Adverse Event|2
7704483|NCT01117623|26795336|P7|Overall Study|Adverse Event|0
7704484|NCT01117623|26795337|P6|Overall Study|Adverse Event|0
7704485|NCT01117623|26795338|P5|Overall Study|Adverse Event|2
7704486|NCT01117623|26795339|P4|Overall Study|Adverse Event|0
7704487|NCT01117623|26795340|P3|Overall Study|Adverse Event|4
7704488|NCT01117623|26795341|P2|Overall Study|Adverse Event|2
7704489|NCT01117623|26795342|P1|Overall Study|Adverse Event|0
7704490|NCT01117480|26795494|P1|Overall Study|Did Not Start Adalimumab Therapy|20
7704491|NCT01117480|26795494|P1|Overall Study|Protocol Violation|8
7704492|NCT01117454|26795502|P2|Overall Study|Pregnancy|1
7704493|NCT01117454|26795503|P1|Overall Study|Pregnancy|0
7704494|NCT01117428|26795515|P6|Overall Study|Progressive disease|17
7704495|NCT01117428|26795516|P5|Overall Study|Progressive disease|16
7704496|NCT01117428|26795517|P4|Overall Study|Progressive disease|12
7704497|NCT01117428|26795518|P3|Overall Study|Progressive disease|10
7704498|NCT01117428|26795519|P2|Overall Study|Progressive disease|27
7704499|NCT01117428|26795520|P1|Overall Study|Progressive disease|15
7704500|NCT01117428|26795515|P6|Overall Study|Withdrawal by Subject|0
7704501|NCT01117428|26795516|P5|Overall Study|Withdrawal by Subject|0
7704502|NCT01117428|26795517|P4|Overall Study|Withdrawal by Subject|0
7704503|NCT01117428|26795518|P3|Overall Study|Withdrawal by Subject|1
7704504|NCT01117428|26795519|P2|Overall Study|Withdrawal by Subject|0
7704505|NCT01117428|26795520|P1|Overall Study|Withdrawal by Subject|0
7704506|NCT01117428|26795515|P6|Overall Study|Physician Decision|0
7704507|NCT01117428|26795516|P5|Overall Study|Physician Decision|0
7704508|NCT01117428|26795517|P4|Overall Study|Physician Decision|0
7704509|NCT01117428|26795518|P3|Overall Study|Physician Decision|0
7704510|NCT01117428|26795519|P2|Overall Study|Physician Decision|1
7704511|NCT01117428|26795520|P1|Overall Study|Physician Decision|0
7704512|NCT01117428|26795515|P6|Overall Study|Death|1
7704513|NCT01117428|26795516|P5|Overall Study|Death|0
7704514|NCT01117428|26795517|P4|Overall Study|Death|0
7704515|NCT01117428|26795518|P3|Overall Study|Death|2
7704516|NCT01117428|26795519|P2|Overall Study|Death|1
7704517|NCT01117428|26795520|P1|Overall Study|Death|0
7704518|NCT01117428|26795515|P6|Overall Study|Adverse Event|2
7704519|NCT01117428|26795516|P5|Overall Study|Adverse Event|1
7704520|NCT01117428|26795517|P4|Overall Study|Adverse Event|0
7704521|NCT01117428|26795518|P3|Overall Study|Adverse Event|0
7704522|NCT01117428|26795519|P2|Overall Study|Adverse Event|0
7704523|NCT01117428|26795520|P1|Overall Study|Adverse Event|4
7704524|NCT01117428|26795515|P6|Overall Study|Lack of Efficacy|0
7704525|NCT01117428|26795516|P5|Overall Study|Lack of Efficacy|0
7704526|NCT01117428|26795517|P4|Overall Study|Lack of Efficacy|0
7704527|NCT01117428|26795518|P3|Overall Study|Lack of Efficacy|0
7704528|NCT01117428|26795519|P2|Overall Study|Lack of Efficacy|0
7704529|NCT01117428|26795520|P1|Overall Study|Lack of Efficacy|1
7704530|NCT01117350|26795554|P2|Extension Period|Prohibited medication|1
7704531|NCT01117350|26795555|P1|Extension Period|Prohibited medication|0
7704532|NCT01117350|26795554|P2|Extension Period|Inclusion criteria not respected|1
7704533|NCT01117350|26795555|P1|Extension Period|Inclusion criteria not respected|0
7704534|NCT01117350|26795554|P2|Extension Period|Lack of Efficacy|2
7704535|NCT01117350|26795555|P1|Extension Period|Lack of Efficacy|0
7704536|NCT01117350|26795554|P2|Extension Period|Withdrawal by Subject|3
7704537|NCT01117350|26795555|P1|Extension Period|Withdrawal by Subject|0
7704538|NCT01117350|26795554|P2|Extension Period|Lost to Follow-up|2
7704539|NCT01117350|26795555|P1|Extension Period|Lost to Follow-up|0
7704540|NCT01117350|26795554|P2|Extension Period|Protocol Violation|2
7704541|NCT01117350|26795555|P1|Extension Period|Protocol Violation|0
7704542|NCT01117350|26795554|P2|Extension Period|Adverse Event|2
7704543|NCT01117350|26795555|P1|Extension Period|Adverse Event|0
7704544|NCT01117350|26795554|P2|Extension Period|Not included in extension, not treated|50
7704545|NCT01117350|26795555|P1|Extension Period|Not included in extension, not treated|0
7704546|NCT01117350|26795554|P2|Comparative Period|Move to another city/country|1
7704547|NCT01117350|26795555|P1|Comparative Period|Move to another city/country|2
7704548|NCT01117350|26795554|P2|Comparative Period|Physician Decision|1
7704549|NCT01117350|26795555|P1|Comparative Period|Physician Decision|0
7704550|NCT01117350|26795554|P2|Comparative Period|Lack of Efficacy|0
7704551|NCT01117350|26795555|P1|Comparative Period|Lack of Efficacy|1
7704552|NCT01117350|26795554|P2|Comparative Period|Protocol Violation|12
7704553|NCT01117350|26795555|P1|Comparative Period|Protocol Violation|8
7704554|NCT01117350|26795554|P2|Comparative Period|Withdrawal by Subject|13
7704555|NCT01117350|26795555|P1|Comparative Period|Withdrawal by Subject|9
7704556|NCT01117350|26795554|P2|Comparative Period|Lost to Follow-up|7
7704557|NCT01117350|26795555|P1|Comparative Period|Lost to Follow-up|11
7704558|NCT01117350|26795554|P2|Comparative Period|Adverse Event|33
7704559|NCT01117350|26795555|P1|Comparative Period|Adverse Event|6
7704560|NCT01117350|26795554|P2|Comparative Period|Not Treated|8
7704561|NCT01117350|26795555|P1|Comparative Period|Not Treated|5
7704562|NCT01117337|26795587|P2|Overall Study|Lost to Follow-up|0
7704563|NCT01117337|26795588|P1|Overall Study|Lost to Follow-up|4
7704564|NCT01117181|26795609|P2|Overall Study|Withdrawal by Subject|2
7704565|NCT01117181|26795610|P1|Overall Study|Withdrawal by Subject|0
7704566|NCT01117181|26795609|P2|Overall Study|Lost to Follow-up|0
7704567|NCT01117181|26795610|P1|Overall Study|Lost to Follow-up|1
7704568|NCT01117051|26795643|P2|Overall Study|Convenience issue|0
7704569|NCT01117051|26795644|P1|Overall Study|Convenience issue|1
7704570|NCT01117051|26795643|P2|Overall Study|Randomized by mistake|1
7704571|NCT01117051|26795644|P1|Overall Study|Randomized by mistake|0
7704572|NCT01117051|26795643|P2|Overall Study|Surgical procedure|1
7704573|NCT01117051|26795644|P1|Overall Study|Surgical procedure|0
7704574|NCT01117051|26795643|P2|Overall Study|Sponsor's decision|1
7704575|NCT01117051|26795644|P1|Overall Study|Sponsor's decision|3
7704576|NCT01117051|26795643|P2|Overall Study|Did not meet in-/exclusion criteria|1
7704577|NCT01117051|26795644|P1|Overall Study|Did not meet in-/exclusion criteria|0
7704578|NCT01117051|26795643|P2|Overall Study|Lost to Follow-up|1
7704579|NCT01117051|26795644|P1|Overall Study|Lost to Follow-up|0
7704580|NCT01117051|26795643|P2|Overall Study|Adverse Event|3
7704581|NCT01117051|26795644|P1|Overall Study|Adverse Event|4
7704582|NCT01117051|26795643|P2|Overall Study|Withdrawal by Subject|3
7704583|NCT01117051|26795644|P1|Overall Study|Withdrawal by Subject|5
7704584|NCT01117012|26795654|P2|Overall Study|Undefined|3
7704585|NCT01117012|26795655|P1|Overall Study|Undefined|4
7704586|NCT01117012|26795654|P2|Overall Study|Withdrawal by Subject|0
7704587|NCT01117012|26795655|P1|Overall Study|Withdrawal by Subject|3
7704588|NCT01117012|26795654|P2|Overall Study|Death|1
7704589|NCT01117012|26795655|P1|Overall Study|Death|1
7704590|NCT01117012|26795654|P2|Overall Study|Adverse Event|1
7704591|NCT01117012|26795655|P1|Overall Study|Adverse Event|0
7704592|NCT01116882|26795829|P2|12-month|Withdrawal by Subject|8
7704593|NCT01116882|26795830|P1|12-month|Withdrawal by Subject|5
7704594|NCT01116882|26795829|P2|12-month|Other Reasons|49
7704595|NCT01116882|26795830|P1|12-month|Other Reasons|151
7704596|NCT01116882|26795829|P2|12-month|Lost to Follow-up|42
7704597|NCT01116882|26795830|P1|12-month|Lost to Follow-up|111
7704598|NCT01116882|26795829|P2|30-day|Other Reasons|6
7704599|NCT01116882|26795830|P1|30-day|Other Reasons|16
7704600|NCT01116882|26795829|P2|30-day|Withdrawal by Subject|4
7704601|NCT01116882|26795830|P1|30-day|Withdrawal by Subject|2
7704602|NCT01116882|26795829|P2|30-day|Lost to Follow-up|21
7704603|NCT01116882|26795830|P1|30-day|Lost to Follow-up|50
7704604|NCT01116739|26795870|P2|Overall Study|enrolled caregiver not legal guardian|0
7704605|NCT01116739|26795871|P1|Overall Study|enrolled caregiver not legal guardian|2
7704606|NCT01116739|26795870|P2|Overall Study|child not enrolled in head start|2
7704607|NCT01116739|26795871|P1|Overall Study|child not enrolled in head start|10
7704608|NCT01116739|26795870|P2|Overall Study|child too young|6
7704609|NCT01116739|26795871|P1|Overall Study|child too young|2
7704610|NCT01116739|26795870|P2|Overall Study|Withdrawal by Subject|0
7704611|NCT01116739|26795871|P1|Overall Study|Withdrawal by Subject|6
7704612|NCT01116739|26795870|P2|Overall Study|Child had 2 years of HS|128
7704613|NCT01116739|26795871|P1|Overall Study|Child had 2 years of HS|110
7704614|NCT01116687|26795891|P1|Overall Study|Withdrawal by Subject|4
7704615|NCT01116648|26795918|P15|Phase 1 Dose Level 3|Adverse Event|0
7704616|NCT01116648|26795919|P14|Phase 1 Dose Level 3|Adverse Event|0
7704617|NCT01116648|26795920|P13|Phase 1 Dose Level 3|Adverse Event|0
7704618|NCT01116648|26795921|P12|Phase 1 Dose Level 3|Adverse Event|0
7704619|NCT01116648|26795922|P11|Phase 1 Dose Level 3|Adverse Event|0
7704620|NCT01116648|26795923|P10|Phase 1 Dose Level 3|Adverse Event|0
7704621|NCT01116648|26795924|P9|Phase 1 Dose Level 3|Adverse Event|0
7704622|NCT01116648|26795925|P8|Phase 1 Dose Level 3|Adverse Event|0
7704623|NCT01116648|26795926|P7|Phase 1 Dose Level 3|Adverse Event|0
7704624|NCT01116648|26795927|P6|Phase 1 Dose Level 3|Adverse Event|0
7704625|NCT01116648|26795928|P5|Phase 1 Dose Level 3|Adverse Event|0
7704626|NCT01116648|26795929|P4|Phase 1 Dose Level 3|Adverse Event|2
7704627|NCT01116648|26795930|P3|Phase 1 Dose Level 3|Adverse Event|0
7704628|NCT01116648|26795931|P2|Phase 1 Dose Level 3|Adverse Event|0
7704629|NCT01116648|26795932|P1|Phase 1 Dose Level 3|Adverse Event|0
7704630|NCT01116544|26795959|P2|Overall Study|Withdrawal by Subject|1
7704631|NCT01116544|26795960|P1|Overall Study|Withdrawal by Subject|1
7704632|NCT01116544|26795959|P2|Overall Study|Protocol Violation|0
7704633|NCT01116544|26795960|P1|Overall Study|Protocol Violation|1
7704634|NCT01116440|26795987|P2|Follow-up|Withdrawal by Subject|1
7704635|NCT01116440|26795988|P1|Follow-up|Withdrawal by Subject|0
7704636|NCT01116440|26795987|P2|Follow-up|Lost to Follow-up|1
7704637|NCT01116440|26795988|P1|Follow-up|Lost to Follow-up|0
7704638|NCT01116440|26795987|P2|Withdrawal|Lost to Follow-up|1
7704639|NCT01116440|26795988|P1|Withdrawal|Lost to Follow-up|0
7704640|NCT01116440|26795987|P2|Withdrawal|Withdrawal by Subject|1
7704641|NCT01116440|26795988|P1|Withdrawal|Withdrawal by Subject|0
7704642|NCT01116440|26795987|P2|Treatment|Adverse Event|1
7704643|NCT01116440|26795988|P1|Treatment|Adverse Event|0
7704644|NCT01116440|26795987|P2|Treatment|Lack of Efficacy|1
7704645|NCT01116440|26795988|P1|Treatment|Lack of Efficacy|0
7704646|NCT01116440|26795987|P2|Treatment|Protocol Violation|2
7704647|NCT01116440|26795988|P1|Treatment|Protocol Violation|0
7704648|NCT01116440|26795987|P2|Treatment|Lost to Follow-up|1
7704649|NCT01116440|26795988|P1|Treatment|Lost to Follow-up|1
7704650|NCT01116440|26795987|P2|Treatment|Withdrawal by Subject|2
7704651|NCT01116440|26795988|P1|Treatment|Withdrawal by Subject|2
7704652|NCT01116427|26796004|P2|Extension Phase|Not using appropriate birth control|0
7704653|NCT01116427|26796005|P1|Extension Phase|Not using appropriate birth control|1
7704654|NCT01116427|26796004|P2|Extension Phase|Withdrawal by Subject|1
7704655|NCT01116427|26796005|P1|Extension Phase|Withdrawal by Subject|5
7704656|NCT01116427|26796004|P2|Extension Phase|Lost to Follow-up|0
7704657|NCT01116427|26796005|P1|Extension Phase|Lost to Follow-up|2
7704658|NCT01116427|26796004|P2|Extension Phase|Adverse Event|1
7704659|NCT01116427|26796005|P1|Extension Phase|Adverse Event|1
7704660|NCT01116427|26796004|P2|Core Phase|Worsening Multiple Sclerosis|0
7704661|NCT01116427|26796005|P1|Core Phase|Worsening Multiple Sclerosis|1
7704662|NCT01116427|26796004|P2|Core Phase|Withdrawal by Subject|0
7704663|NCT01116427|26796005|P1|Core Phase|Withdrawal by Subject|3
7704664|NCT01116427|26796004|P2|Core Phase|Lost to Follow-up|0
7704665|NCT01116427|26796005|P1|Core Phase|Lost to Follow-up|1
7704666|NCT01116427|26796004|P2|Core Phase|Adverse Event|1
7704667|NCT01116427|26796005|P1|Core Phase|Adverse Event|0
7704668|NCT01116232|26796046|P1|Overall Study|Progressive diease|4
7704669|NCT01115998|26796160|P2|Overall Study|Lost to Follow-up|6
7704670|NCT01115998|26796161|P1|Overall Study|Lost to Follow-up|6
7704671|NCT01115933|26796171|P1|Overall Study|Did not receive XIENCE PRIME SV|1
7704672|NCT01115855|26796268|P2|Overall Study|Other|6
7704673|NCT01115855|26796269|P1|Overall Study|Other|8
7704674|NCT01115855|26796268|P2|Overall Study|Withdrawal by Subject|5
7704675|NCT01115855|26796269|P1|Overall Study|Withdrawal by Subject|5
7704676|NCT01115855|26796268|P2|Overall Study|Protocol Violation|1
7704677|NCT01115855|26796269|P1|Overall Study|Protocol Violation|0
7704678|NCT01115855|26796268|P2|Overall Study|Lab Abnormality|1
7704679|NCT01115855|26796269|P1|Overall Study|Lab Abnormality|1
7704680|NCT01115855|26796268|P2|Overall Study|Death|5
7704681|NCT01115855|26796269|P1|Overall Study|Death|6
7704682|NCT01115855|26796268|P2|Overall Study|Adverse Event|18
7704683|NCT01115855|26796269|P1|Overall Study|Adverse Event|16
7704684|NCT01115803|26796324|P7|Overall Study|Progressive Disease during Cycle1|1
7704685|NCT01115803|26796325|P6|Overall Study|Progressive Disease during Cycle1|0
7704686|NCT01115803|26796326|P5|Overall Study|Progressive Disease during Cycle1|0
7704687|NCT01115803|26796327|P4|Overall Study|Progressive Disease during Cycle1|0
7704688|NCT01115803|26796328|P3|Overall Study|Progressive Disease during Cycle1|0
7704689|NCT01115803|26796329|P2|Overall Study|Progressive Disease during Cycle1|0
7704690|NCT01115803|26796330|P1|Overall Study|Progressive Disease during Cycle1|0
7704691|NCT01115803|26796324|P7|Overall Study|Lost to Follow-up|0
7704692|NCT01115803|26796325|P6|Overall Study|Lost to Follow-up|0
7704693|NCT01115803|26796326|P5|Overall Study|Lost to Follow-up|0
7704694|NCT01115803|26796327|P4|Overall Study|Lost to Follow-up|0
7704695|NCT01115803|26796328|P3|Overall Study|Lost to Follow-up|1
7704696|NCT01115803|26796329|P2|Overall Study|Lost to Follow-up|0
7704697|NCT01115803|26796330|P1|Overall Study|Lost to Follow-up|0
7704698|NCT01115803|26796324|P7|Overall Study|Withdrawal by Subject|1
7704699|NCT01115803|26796325|P6|Overall Study|Withdrawal by Subject|0
7704700|NCT01115803|26796326|P5|Overall Study|Withdrawal by Subject|0
7704701|NCT01115803|26796327|P4|Overall Study|Withdrawal by Subject|0
7704702|NCT01115803|26796328|P3|Overall Study|Withdrawal by Subject|0
7704703|NCT01115803|26796329|P2|Overall Study|Withdrawal by Subject|0
7704704|NCT01115803|26796330|P1|Overall Study|Withdrawal by Subject|0
7704705|NCT01115738|26796393|P3|Overall Study|Withdrawal by Subject|9
7704706|NCT01115738|26796394|P2|Overall Study|Withdrawal by Subject|6
7704707|NCT01115738|26796395|P1|Overall Study|Withdrawal by Subject|6
7704708|NCT01115738|26796393|P3|Overall Study|Physician Decision|17
7704709|NCT01115738|26796394|P2|Overall Study|Physician Decision|15
7704710|NCT01115738|26796395|P1|Overall Study|Physician Decision|18
7704711|NCT01115738|26796393|P3|Overall Study|Lost to Follow-up|1
7704712|NCT01115738|26796394|P2|Overall Study|Lost to Follow-up|0
7704713|NCT01115738|26796395|P1|Overall Study|Lost to Follow-up|0
7704714|NCT01115738|26796393|P3|Overall Study|Death|0
7704715|NCT01115738|26796394|P2|Overall Study|Death|0
7704716|NCT01115738|26796395|P1|Overall Study|Death|1
7704717|NCT01115569|26796593|P2|Maintenance Phase|Administrative|1
7704718|NCT01115569|26796594|P1|Maintenance Phase|Administrative|0
7704719|NCT01115569|26796593|P2|Maintenance Phase|Non-Compliance with Study Drug|48
7704720|NCT01115569|26796594|P1|Maintenance Phase|Non-Compliance with Study Drug|0
7704721|NCT01115569|26796593|P2|Maintenance Phase|Withdrawal by Subject|27
7704722|NCT01115569|26796594|P1|Maintenance Phase|Withdrawal by Subject|0
7704723|NCT01115569|26796593|P2|Maintenance Phase|Protocol Violation|9
7704724|NCT01115569|26796594|P1|Maintenance Phase|Protocol Violation|0
7704725|NCT01115569|26796593|P2|Maintenance Phase|Physician Decision|3
7704726|NCT01115569|26796594|P1|Maintenance Phase|Physician Decision|0
7704727|NCT01115569|26796593|P2|Maintenance Phase|Lost to Follow-up|8
7704728|NCT01115569|26796594|P1|Maintenance Phase|Lost to Follow-up|0
7704729|NCT01115569|26796593|P2|Maintenance Phase|Adverse Event|43
7704730|NCT01115569|26796594|P1|Maintenance Phase|Adverse Event|0
7704731|NCT01115569|26796593|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
7704732|NCT01115569|26796594|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
7704733|NCT01115569|26796593|P2|Conversion/Titration Phase|Withdrawal by Subject|0
7704734|NCT01115569|26796594|P1|Conversion/Titration Phase|Withdrawal by Subject|26
7704735|NCT01115569|26796593|P2|Conversion/Titration Phase|Protocol Violation|0
7704736|NCT01115569|26796594|P1|Conversion/Titration Phase|Protocol Violation|68
7704737|NCT01115569|26796593|P2|Conversion/Titration Phase|Physician Decision|0
7704738|NCT01115569|26796594|P1|Conversion/Titration Phase|Physician Decision|5
7704739|NCT01115569|26796593|P2|Conversion/Titration Phase|Lost to Follow-up|0
7704740|NCT01115569|26796594|P1|Conversion/Titration Phase|Lost to Follow-up|3
7704741|NCT01115569|26796593|P2|Conversion/Titration Phase|Adverse Event|0
7704742|NCT01115569|26796594|P1|Conversion/Titration Phase|Adverse Event|59
7704743|NCT01115491|26796623|P1|Overall Study|Physician Decision|1
7704744|NCT01115491|26796623|P1|Overall Study|Withdrawal by Subject|1
7704745|NCT01115491|26796623|P1|Overall Study|Lost to Follow-up|3
7704746|NCT01115491|26796623|P1|Overall Study|Adverse Event|3
7704747|NCT01115491|26796623|P1|Overall Study|Death|22
7704748|NCT01115309|26796682|P1|Long-term Follow-up|Lost to Follow-up|6
7704749|NCT01115309|26796682|P1|Procedure Safety (1-Month)|Withdrawal by Subject|1
7704750|NCT01115309|26796682|P1|Procedure Safety (1-Month)|Lost to Follow-up|2
7704751|NCT01114880|26796849|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
7704752|NCT01114880|26796850|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
7704753|NCT01114880|26796849|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
7704754|NCT01114880|26796850|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
7704755|NCT01114880|26796849|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
7704756|NCT01114880|26796850|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
7704757|NCT01114880|26796849|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
7704758|NCT01114880|26796850|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
7704759|NCT01114880|26796849|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
7704760|NCT01114880|26796850|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
7704761|NCT01114880|26796849|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
7704762|NCT01114880|26796850|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
7704763|NCT01114828|26796902|P2|Overall Study|Withdrawal by Subject|1
7704764|NCT01114828|26796903|P1|Overall Study|Withdrawal by Subject|0
7704765|NCT01114828|26796902|P2|Overall Study|Protocol Violation|0
7704766|NCT01114828|26796903|P1|Overall Study|Protocol Violation|2
7704767|NCT01114828|26796902|P2|Overall Study|Lack of Efficacy|2
7704768|NCT01114828|26796903|P1|Overall Study|Lack of Efficacy|0
7704769|NCT01114828|26796902|P2|Overall Study|Adverse Event|1
7704770|NCT01114828|26796903|P1|Overall Study|Adverse Event|1
7704771|NCT01114737|26796913|P2|Open-Label Treatment Period|Difficult Personal Events|0
7704772|NCT01114737|26796914|P1|Open-Label Treatment Period|Difficult Personal Events|1
7704773|NCT01114737|26796913|P2|Open-Label Treatment Period|Lost to Follow-up|1
7704774|NCT01114737|26796914|P1|Open-Label Treatment Period|Lost to Follow-up|3
7704775|NCT01114737|26796913|P2|Open-Label Treatment Period|Withdrawal by Subject|1
7704776|NCT01114737|26796914|P1|Open-Label Treatment Period|Withdrawal by Subject|1
7704777|NCT01114737|26796913|P2|Randomized Treatment Period|Pregnancy|0
7704778|NCT01114737|26796914|P1|Randomized Treatment Period|Pregnancy|1
7704779|NCT01114737|26796913|P2|Randomized Treatment Period|Lost to Follow-up|1
7704780|NCT01114737|26796914|P1|Randomized Treatment Period|Lost to Follow-up|1
7704781|NCT01114737|26796913|P2|Randomized Treatment Period|Withdrawal by Subject|0
7704782|NCT01114737|26796914|P1|Randomized Treatment Period|Withdrawal by Subject|1
7704786|NCT01114672|26796982|P2|Overall Study|transplanted|0
7704787|NCT01114672|26796983|P1|Overall Study|transplanted|1
7704788|NCT01114672|26796982|P2|Overall Study|Lost to Follow-up|0
7704789|NCT01114672|26796983|P1|Overall Study|Lost to Follow-up|1
7704790|NCT01114672|26796982|P2|Overall Study|Withdrawal by Subject|1
7704791|NCT01114672|26796983|P1|Overall Study|Withdrawal by Subject|2
7704792|NCT01114672|26796982|P2|Overall Study|Death|1
7704793|NCT01114672|26796983|P1|Overall Study|Death|0
7704794|NCT01114646|26796991|P2|Overall Study|Withdrawal by Subject|2
7704795|NCT01114646|26796992|P1|Overall Study|Withdrawal by Subject|3
7704796|NCT01114529|26797052|P3|Completed Study Phase at Month 24|Missing|0
7704797|NCT01114529|26797053|P2|Completed Study Phase at Month 24|Missing|0
7704798|NCT01114529|26797054|P1|Completed Study Phase at Month 24|Missing|2
7704799|NCT01114529|26797052|P3|Completed Study Phase at Month 24|Other|0
7704800|NCT01114529|26797053|P2|Completed Study Phase at Month 24|Other|0
7704801|NCT01114529|26797054|P1|Completed Study Phase at Month 24|Other|2
7704802|NCT01114529|26797052|P3|Completed Study Phase at Month 24|Death|4
7704803|NCT01114529|26797053|P2|Completed Study Phase at Month 24|Death|5
7704804|NCT01114529|26797054|P1|Completed Study Phase at Month 24|Death|8
7704805|NCT01114529|26797052|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
7704806|NCT01114529|26797053|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
7704807|NCT01114529|26797054|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
7704808|NCT01114529|26797052|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
7704809|NCT01114529|26797053|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
7704810|NCT01114529|26797054|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
7704811|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Missing|0
7704812|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Missing|0
7704813|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Missing|2
7704814|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Protocol Violation|2
7704815|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Protocol Violation|5
7704816|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Protocol Violation|0
7704817|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Graft loss|0
7704818|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Graft loss|2
7704819|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Graft loss|0
7704820|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Death|2
7704821|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Death|1
7704822|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Death|2
7704823|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Administrative problems|2
7704824|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Administrative problems|1
7704825|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Administrative problems|2
7704826|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
7704827|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
7704828|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
7704829|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
7704830|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
7704831|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
7704832|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
7704833|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
7704834|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
7704835|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
7704836|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
7704837|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
7704838|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
7704839|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
7704840|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
7704841|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
7704842|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
7704843|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
7704844|NCT01114529|26797052|P3|Completed Study Medication at Month 24|Adverse Event|17
7704845|NCT01114529|26797053|P2|Completed Study Medication at Month 24|Adverse Event|18
7704846|NCT01114529|26797054|P1|Completed Study Medication at Month 24|Adverse Event|87
7704847|NCT01114516|26797073|P2|Overall Study|Lost to Follow-up|1
7704848|NCT01114516|26797074|P1|Overall Study|Lost to Follow-up|2
7704849|NCT01114438|26797109|P1|Overall Study|Withdrawal by Subject|2
7704850|NCT01114438|26797109|P1|Overall Study|Physician Decision|1
7704851|NCT01114438|26797109|P1|Overall Study|concomitant medication|1
7704852|NCT01114438|26797109|P1|Overall Study|Adverse Event|10
7704853|NCT01114373|26797119|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
7704854|NCT01114373|26797120|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
7704855|NCT01114373|26797119|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
7704856|NCT01114373|26797120|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
7704857|NCT01114373|26797119|P2|Intervention 1 (4 Weeks)|Incarceration|0
7704858|NCT01114373|26797120|P1|Intervention 1 (4 Weeks)|Incarceration|1
7704859|NCT01114373|26797119|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
7704860|NCT01114373|26797120|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
7704861|NCT01114360|26797152|P2|Intervention 1 (4 Weeks)|Physician Decision|1
7704862|NCT01114360|26797153|P1|Intervention 1 (4 Weeks)|Physician Decision|0
7704863|NCT01114217|26797204|P2|Overall Study|Other-Withdrawal by Subject|1
7704864|NCT01114217|26797205|P1|Overall Study|Other-Withdrawal by Subject|1
7704865|NCT01114217|26797204|P2|Overall Study|Other-Lost to Follow-up|0
7704866|NCT01114217|26797205|P1|Overall Study|Other-Lost to Follow-up|1
7704867|NCT01114217|26797204|P2|Overall Study|Other-Site Stopped Communicating|0
7704868|NCT01114217|26797205|P1|Overall Study|Other-Site Stopped Communicating|2
7704869|NCT01114217|26797204|P2|Overall Study|Other-Study Withdrawn|1
7704870|NCT01114217|26797205|P1|Overall Study|Other-Study Withdrawn|1
7704871|NCT01114217|26797204|P2|Overall Study|Other-Study Termination|1
7704872|NCT01114217|26797205|P1|Overall Study|Other-Study Termination|0
7704873|NCT01114217|26797204|P2|Overall Study|Other-Sponsor Decision|12
7704874|NCT01114217|26797205|P1|Overall Study|Other-Sponsor Decision|10
7704875|NCT01114217|26797204|P2|Overall Study|Other-Physician Decision|1
7704876|NCT01114217|26797205|P1|Overall Study|Other-Physician Decision|1
7704877|NCT01114217|26797204|P2|Overall Study|Other-Non Compliance|0
7704878|NCT01114217|26797205|P1|Overall Study|Other-Non Compliance|2
7704879|NCT01114217|26797204|P2|Overall Study|Other-Lack of Efficacy|0
7704880|NCT01114217|26797205|P1|Overall Study|Other-Lack of Efficacy|1
7704881|NCT01114217|26797204|P2|Overall Study|Other-Protocol Violation|3
7704882|NCT01114217|26797205|P1|Overall Study|Other-Protocol Violation|1
7704883|NCT01114217|26797204|P2|Overall Study|Other-Pregnancy|4
7704884|NCT01114217|26797205|P1|Overall Study|Other-Pregnancy|2
7704885|NCT01114217|26797204|P2|Overall Study|Other-Procedure|1
7704886|NCT01114217|26797205|P1|Overall Study|Other-Procedure|1
7704887|NCT01114217|26797204|P2|Overall Study|Other-Early termination|10
7704888|NCT01114217|26797205|P1|Overall Study|Other-Early termination|6
7704889|NCT01114217|26797204|P2|Overall Study|Other-Clerical Error|0
7704890|NCT01114217|26797205|P1|Overall Study|Other-Clerical Error|3
7704891|NCT01114217|26797204|P2|Overall Study|Withdrawal by Subject|28
7704892|NCT01114217|26797205|P1|Overall Study|Withdrawal by Subject|21
7704893|NCT01114217|26797204|P2|Overall Study|Lost to Follow-up|33
7704894|NCT01114217|26797205|P1|Overall Study|Lost to Follow-up|17
7704895|NCT01114217|26797204|P2|Overall Study|Adverse Event|3
7704896|NCT01114217|26797205|P1|Overall Study|Adverse Event|5
7704897|NCT01114204|26797217|P2|Overall Study|Other-Protocol Violation|0
7704898|NCT01114204|26797218|P1|Overall Study|Other-Protocol Violation|1
7704899|NCT01114204|26797217|P2|Overall Study|Other-Participant request|0
7704900|NCT01114204|26797218|P1|Overall Study|Other-Participant request|2
7704901|NCT01114204|26797217|P2|Overall Study|Other-Medical monitor request|0
7704902|NCT01114204|26797218|P1|Overall Study|Other-Medical monitor request|1
7704903|NCT01114204|26797217|P2|Overall Study|Other-Personal reasons|0
7704904|NCT01114204|26797218|P1|Overall Study|Other-Personal reasons|2
7704905|NCT01114204|26797217|P2|Overall Study|Death|0
7704906|NCT01114204|26797218|P1|Overall Study|Death|1
7704907|NCT01114204|26797217|P2|Overall Study|Withdrawal by Subject|6
7704908|NCT01114204|26797218|P1|Overall Study|Withdrawal by Subject|10
7704909|NCT01114204|26797217|P2|Overall Study|Lost to Follow-up|0
7704910|NCT01114204|26797218|P1|Overall Study|Lost to Follow-up|1
7704911|NCT01114204|26797217|P2|Overall Study|Adverse Event|2
7704912|NCT01114204|26797218|P1|Overall Study|Adverse Event|3
7704913|NCT01114139|26797236|P2|Overall Study|Other-Withdrew prior to receiving dose|3
7704914|NCT01114139|26797237|P1|Overall Study|Other-Withdrew prior to receiving dose|1
7704915|NCT01114139|26797236|P2|Overall Study|Other-Physician changed treatment|0
7704916|NCT01114139|26797237|P1|Overall Study|Other-Physician changed treatment|1
7704917|NCT01114139|26797236|P2|Overall Study|Other-Participant went on hospice|1
7704918|NCT01114139|26797237|P1|Overall Study|Other-Participant went on hospice|0
7704919|NCT01114139|26797236|P2|Overall Study|Other-Participant falsified records|1
7704920|NCT01114139|26797237|P1|Overall Study|Other-Participant falsified records|0
7704921|NCT01114139|26797236|P2|Overall Study|Other-Out of window for study drug dose|0
7704922|NCT01114139|26797237|P1|Overall Study|Other-Out of window for study drug dose|1
7704923|NCT01114139|26797236|P2|Overall Study|Other-Protocol Violation|0
7704924|NCT01114139|26797237|P1|Overall Study|Other-Protocol Violation|1
7704925|NCT01114139|26797236|P2|Overall Study|Other-Missed 1 visit|0
7704926|NCT01114139|26797237|P1|Overall Study|Other-Missed 1 visit|1
7704927|NCT01114139|26797236|P2|Overall Study|Withdrawal by Subject|6
7704928|NCT01114139|26797237|P1|Overall Study|Withdrawal by Subject|17
7704929|NCT01114139|26797236|P2|Overall Study|Lost to Follow-up|3
7704930|NCT01114139|26797237|P1|Overall Study|Lost to Follow-up|15
7704931|NCT01114139|26797236|P2|Overall Study|Adverse Event|2
7704932|NCT01114139|26797237|P1|Overall Study|Adverse Event|3
7704933|NCT01113931|26797266|P2|Overall Study|Withdrawal by Subject|0
7704934|NCT01113931|26797267|P1|Overall Study|Withdrawal by Subject|3
7704935|NCT01113931|26797266|P2|Overall Study|Various|4
7704936|NCT01113931|26797267|P1|Overall Study|Various|2
7704937|NCT01113931|26797266|P2|Overall Study|Lost to Follow-up|9
7704938|NCT01113931|26797267|P1|Overall Study|Lost to Follow-up|12
7704939|NCT01113931|26797266|P2|Overall Study|Physician Decision|2
7704940|NCT01113931|26797267|P1|Overall Study|Physician Decision|0
7704941|NCT01113931|26797266|P2|Overall Study|Adverse Event|2
7704942|NCT01113931|26797267|P1|Overall Study|Adverse Event|2
7704943|NCT01113892|26797281|P2|Overall Study|Graft no longer evaluable|9
7704944|NCT01113892|26797282|P1|Overall Study|Graft no longer evaluable|9
7704945|NCT01113892|26797281|P2|Overall Study|Death|4
7704946|NCT01113892|26797282|P1|Overall Study|Death|2
7704947|NCT01113892|26797281|P2|Overall Study|Withdrawal by Subject|1
7704948|NCT01113892|26797282|P1|Overall Study|Withdrawal by Subject|1
7704949|NCT01113892|26797281|P2|Overall Study|Lost to Follow-up|2
7704950|NCT01113892|26797282|P1|Overall Study|Lost to Follow-up|2
7704951|NCT01113879|26797310|P2|Period 1: Block 1|Withdrawal by Subject|0
7704952|NCT01113879|26797311|P1|Period 1: Block 1|Withdrawal by Subject|2
7704953|NCT01113801|26797323|P4|Overall Study|Clinical Endpoint (ESRD)|5
7704954|NCT01113801|26797324|P3|Overall Study|Clinical Endpoint (ESRD)|2
7704955|NCT01113801|26797325|P2|Overall Study|Clinical Endpoint (ESRD)|4
7704956|NCT01113801|26797326|P1|Overall Study|Clinical Endpoint (ESRD)|7
7704957|NCT01113801|26797323|P4|Overall Study|Sponsor Decision|15
7704958|NCT01113801|26797324|P3|Overall Study|Sponsor Decision|20
7704959|NCT01113801|26797325|P2|Overall Study|Sponsor Decision|21
7704960|NCT01113801|26797326|P1|Overall Study|Sponsor Decision|15
7704961|NCT01113801|26797323|P4|Overall Study|Physician Decision|3
7704962|NCT01113801|26797324|P3|Overall Study|Physician Decision|3
7704963|NCT01113801|26797325|P2|Overall Study|Physician Decision|2
7704964|NCT01113801|26797326|P1|Overall Study|Physician Decision|2
7704965|NCT01113801|26797323|P4|Overall Study|Withdrawal by Subject|8
7704966|NCT01113801|26797324|P3|Overall Study|Withdrawal by Subject|7
7704967|NCT01113801|26797325|P2|Overall Study|Withdrawal by Subject|7
7704968|NCT01113801|26797326|P1|Overall Study|Withdrawal by Subject|9
7704969|NCT01113801|26797323|P4|Overall Study|Protocol Violation|0
7704970|NCT01113801|26797324|P3|Overall Study|Protocol Violation|0
7704971|NCT01113801|26797325|P2|Overall Study|Protocol Violation|1
7704972|NCT01113801|26797326|P1|Overall Study|Protocol Violation|0
7704973|NCT01113801|26797323|P4|Overall Study|Death|4
7704974|NCT01113801|26797324|P3|Overall Study|Death|3
7704975|NCT01113801|26797325|P2|Overall Study|Death|5
7704976|NCT01113801|26797326|P1|Overall Study|Death|4
7704977|NCT01113801|26797323|P4|Overall Study|Adverse Event|6
7704978|NCT01113801|26797324|P3|Overall Study|Adverse Event|2
7704979|NCT01113801|26797325|P2|Overall Study|Adverse Event|0
7704980|NCT01113801|26797326|P1|Overall Study|Adverse Event|4
7704981|NCT01113749|26797354|P2|Overall Study|Lost to Follow-up|2
7704982|NCT01113749|26797355|P1|Overall Study|Lost to Follow-up|1
7704983|NCT01113710|26797378|P1|Overall Study|Subject Did Not Receive Neupro|3
7704984|NCT01113710|26797378|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
7704985|NCT01113710|26797378|P1|Overall Study|Lack of Patient's Compliance/Other|1
7704986|NCT01113710|26797378|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
7704987|NCT01113710|26797378|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
7704988|NCT01113710|26797378|P1|Overall Study|Compliance/Efficacy/AE/Other|1
7704989|NCT01113710|26797378|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
7704990|NCT01113710|26797378|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
7704991|NCT01113710|26797378|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
7704992|NCT01113710|26797378|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
7704993|NCT01113710|26797378|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
7704994|NCT01113710|26797378|P1|Overall Study|Lack of Efficacy/Adverse Event|3
7704995|NCT01113710|26797378|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
7704996|NCT01113710|26797378|P1|Overall Study|Lack of Efficacy/Other|4
7704997|NCT01113710|26797378|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
7704998|NCT01113710|26797378|P1|Overall Study|Adverse Event/Other|5
7704999|NCT01113710|26797378|P1|Overall Study|Other|7
7705000|NCT01113710|26797378|P1|Overall Study|Lack of Patient's Compliance|8
7705001|NCT01113710|26797378|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
7705002|NCT01113710|26797378|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
7705003|NCT01113710|26797378|P1|Overall Study|Lost to Follow-up|20
7705004|NCT01113710|26797378|P1|Overall Study|Withdrawal by Subject|28
7705005|NCT01113710|26797378|P1|Overall Study|No Information Available|40
7705006|NCT01113710|26797378|P1|Overall Study|Lack of Efficacy|41
7705007|NCT01113710|26797378|P1|Overall Study|Adverse Event|64
7705008|NCT01113580|26797406|P2|Overall Study|Protocol Violation|0
7705009|NCT01113580|26797407|P1|Overall Study|Protocol Violation|1
7705010|NCT01113541|26797421|P1|Overall Study|Adverse Event|4
7705011|NCT01113541|26797421|P1|Overall Study|Study Terminated by Sponsor|7
7705012|NCT01113541|26797421|P1|Overall Study|Protocol Violation|1
7705013|NCT01113541|26797421|P1|Overall Study|Withdrawal by Subject|1
7705014|NCT01113502|26797459|P5|Overall Study|Adverse Event|0
7705015|NCT01113502|26797460|P4|Overall Study|Adverse Event|2
7705016|NCT01113502|26797461|P3|Overall Study|Adverse Event|3
7705017|NCT01113502|26797462|P2|Overall Study|Adverse Event|0
7705018|NCT01113502|26797463|P1|Overall Study|Adverse Event|0
7705019|NCT01113502|26797459|P5|Overall Study|Withdrawal by Subject|0
7705020|NCT01113502|26797460|P4|Overall Study|Withdrawal by Subject|1
7705021|NCT01113502|26797461|P3|Overall Study|Withdrawal by Subject|1
7705022|NCT01113502|26797462|P2|Overall Study|Withdrawal by Subject|0
7705023|NCT01113502|26797463|P1|Overall Study|Withdrawal by Subject|1
7705024|NCT01113463|26797489|P1|Overall Study|Physician Decision|5
7705025|NCT01112982|26797519|P1|Overall Study|exceeded weight limit to complete MRI|1
7705026|NCT01112982|26797519|P1|Overall Study|Withdrawal by Subject|1
7705027|NCT01112917|26797531|P2|Overall Study|Unable to Convert Filter|0
7705028|NCT01112917|26797532|P1|Overall Study|Unable to Convert Filter|3
7705029|NCT01112917|26797531|P2|Overall Study|Withdrawal by Subject|3
7705030|NCT01112917|26797532|P1|Overall Study|Withdrawal by Subject|1
7705031|NCT01112917|26797531|P2|Overall Study|Lost to Follow-up|1
7705032|NCT01112917|26797532|P1|Overall Study|Lost to Follow-up|1
7705033|NCT01112917|26797531|P2|Overall Study|Death|11
7705034|NCT01112917|26797532|P1|Overall Study|Death|2
7705035|NCT01112579|26797636|P2|Overall Study|Death|2
7705036|NCT01112579|26797637|P1|Overall Study|Death|0
7705037|NCT01112579|26797636|P2|Overall Study|Missed Visit|1
7705038|NCT01112579|26797637|P1|Overall Study|Missed Visit|1
7705039|NCT01112514|26797647|P1|Overall Study|Lost to Follow-up|1
7705040|NCT01112267|26797703|P2|Overall Study|Participants not receive any study drug|2
7705041|NCT01112267|26797704|P1|Overall Study|Participants not receive any study drug|1
7705042|NCT01112267|26797703|P2|Overall Study|Participants not compliant|2
7705043|NCT01112267|26797704|P1|Overall Study|Participants not compliant|1
7705044|NCT01112267|26797703|P2|Overall Study|Protocol Violation|3
7705045|NCT01112267|26797704|P1|Overall Study|Protocol Violation|5
7705046|NCT01112267|26797703|P2|Overall Study|Withdrawal by Subject|5
7705047|NCT01112267|26797704|P1|Overall Study|Withdrawal by Subject|3
7705048|NCT01112267|26797703|P2|Overall Study|Adverse Event|6
7705049|NCT01112267|26797704|P1|Overall Study|Adverse Event|24
7705050|NCT01112059|26797743|P2|Overall Study|Withdrawal by Subject|0
7705051|NCT01112059|26797744|P1|Overall Study|Withdrawal by Subject|1
7705052|NCT01111851|26797758|P2|Overall Study|All planned PET scans were not obtained.|0
7705053|NCT01111851|26797759|P1|Overall Study|All planned PET scans were not obtained.|2
7705054|NCT01111838|26797771|P1|Overall Study|Other Complicating Disease|1
7705055|NCT01111838|26797771|P1|Overall Study|Clinical deterioration|1
7705056|NCT01111838|26797771|P1|Overall Study|Not Treated|3
7705057|NCT01111838|26797771|P1|Overall Study|Patient Ineligible|2
7705058|NCT01111825|26797779|P4|Overall Study|Discontinuation by Sponsor|20
7705059|NCT01111825|26797780|P3|Overall Study|Discontinuation by Sponsor|0
7705060|NCT01111825|26797781|P2|Overall Study|Discontinuation by Sponsor|0
7705061|NCT01111825|26797782|P1|Overall Study|Discontinuation by Sponsor|0
7705062|NCT01111825|26797779|P4|Overall Study|Disease Progression|0
7705063|NCT01111825|26797780|P3|Overall Study|Disease Progression|0
7705064|NCT01111825|26797781|P2|Overall Study|Disease Progression|0
7705065|NCT01111825|26797782|P1|Overall Study|Disease Progression|1
7705066|NCT01111825|26797779|P4|Overall Study|Adverse Event|0
7705067|NCT01111825|26797780|P3|Overall Study|Adverse Event|4
7705068|NCT01111825|26797781|P2|Overall Study|Adverse Event|1
7705069|NCT01111825|26797782|P1|Overall Study|Adverse Event|2
7705070|NCT01111825|26797779|P4|Overall Study|Lost to Follow-up|1
7705071|NCT01111825|26797780|P3|Overall Study|Lost to Follow-up|3
7705072|NCT01111825|26797781|P2|Overall Study|Lost to Follow-up|0
7705073|NCT01111825|26797782|P1|Overall Study|Lost to Follow-up|0
7705074|NCT01111825|26797779|P4|Overall Study|Withdrawal by Subject|0
7705075|NCT01111825|26797780|P3|Overall Study|Withdrawal by Subject|1
7705076|NCT01111825|26797781|P2|Overall Study|Withdrawal by Subject|0
7705077|NCT01111825|26797782|P1|Overall Study|Withdrawal by Subject|0
7705078|NCT01111604|26797804|P3|Overall Study|Met Exclusion Criteria|0
7705079|NCT01111604|26797805|P2|Overall Study|Met Exclusion Criteria|0
7705080|NCT01111604|26797806|P1|Overall Study|Met Exclusion Criteria|2
7705081|NCT01111604|26797804|P3|Overall Study|Death|0
7705082|NCT01111604|26797805|P2|Overall Study|Death|0
7705083|NCT01111604|26797806|P1|Overall Study|Death|1
7705084|NCT01111604|26797804|P3|Overall Study|Withdrawal by Subject|0
7705085|NCT01111604|26797805|P2|Overall Study|Withdrawal by Subject|0
7705086|NCT01111604|26797806|P1|Overall Study|Withdrawal by Subject|2
7705087|NCT01111604|26797804|P3|Overall Study|Withdrew Consent|2
7705088|NCT01111604|26797805|P2|Overall Study|Withdrew Consent|0
7705089|NCT01111604|26797806|P1|Overall Study|Withdrew Consent|3
7705090|NCT01111604|26797804|P3|Overall Study|Lost to Follow-up|1
7705091|NCT01111604|26797805|P2|Overall Study|Lost to Follow-up|0
7705092|NCT01111604|26797806|P1|Overall Study|Lost to Follow-up|0
7705093|NCT01111526|26797844|P3|Overall Study|GVHD Disease Progression|2
7705094|NCT01111526|26797845|P2|Overall Study|GVHD Disease Progression|1
7705095|NCT01111526|26797846|P1|Overall Study|GVHD Disease Progression|0
7705096|NCT01111474|26797858|P1|Overall Study|Lost to Follow-up|12
7705097|NCT01111461|26797866|P1|Overall Study|Other|6
7705098|NCT01111461|26797866|P1|Overall Study|Withdrawal by Subject|1
7705099|NCT01111461|26797866|P1|Overall Study|Lost to Follow-up|1
7705100|NCT01111461|26797866|P1|Overall Study|Participant choice|11
7705101|NCT01111461|26797866|P1|Overall Study|Adverse Event|32
7705102|NCT01111292|26798048|P2|Treatment|Physician Decision|1
7705103|NCT01111292|26798049|P1|Treatment|Physician Decision|1
7705104|NCT01111240|26798055|P1|Overall Study|Other|312
7705105|NCT01111240|26798055|P1|Overall Study|Lack of Efficacy and Adverse Event|19
7705106|NCT01111240|26798055|P1|Overall Study|Lack of Efficacy|545
7705107|NCT01111240|26798055|P1|Overall Study|Adverse Event|190
7705108|NCT01111149|26798085|P3|Overall Study|Withdrawal by Subject|2
7705109|NCT01111149|26798086|P2|Overall Study|Withdrawal by Subject|0
7705110|NCT01111149|26798087|P1|Overall Study|Withdrawal by Subject|1
7705111|NCT01111149|26798085|P3|Overall Study|Protocol Violation|2
7705112|NCT01111149|26798086|P2|Overall Study|Protocol Violation|1
7705113|NCT01111149|26798087|P1|Overall Study|Protocol Violation|1
7705114|NCT01111123|26798163|P2|Maintenance Phase|Lost to Follow-up|2
7705115|NCT01111123|26798164|P1|Maintenance Phase|Lost to Follow-up|0
7705116|NCT01111123|26798163|P2|Open- Label Phase|Failed to be clear or almost cleared|0
7705117|NCT01111123|26798164|P1|Open- Label Phase|Failed to be clear or almost cleared|14
7705118|NCT01111019|26798210|P1|Overall Study|Other|1
7705119|NCT01111019|26798210|P1|Overall Study|Withdrew Prematurely|2
7705120|NCT01110915|26798242|P2|Overall Study|Withdrawal by Subject|1
7705121|NCT01110915|26798243|P1|Overall Study|Withdrawal by Subject|7
7705122|NCT01110915|26798242|P2|Overall Study|Lost to Follow-up|0
7705123|NCT01110915|26798243|P1|Overall Study|Lost to Follow-up|1
7705124|NCT01110915|26798242|P2|Overall Study|Death|1
7705125|NCT01110915|26798243|P1|Overall Study|Death|2
7705126|NCT01110707|26798271|P2|Overall Study|Protocol Violation|3
7705127|NCT01110707|26798272|P1|Overall Study|Protocol Violation|0
7705128|NCT01110408|26798373|P2|Overall Study|Protocol Violation|0
7705129|NCT01110408|26798374|P1|Overall Study|Protocol Violation|1
7705130|NCT01110382|26798398|P2|Overall Study|Protocol Violation|1
7705131|NCT01110382|26798399|P1|Overall Study|Protocol Violation|0
7705132|NCT01110382|26798398|P2|Overall Study|Withdrawal by Subject|1
7705133|NCT01110382|26798399|P1|Overall Study|Withdrawal by Subject|0
7705134|NCT01110330|26798420|P3|Overall Study|Other|1
7705135|NCT01110330|26798421|P2|Overall Study|Other|1
7705136|NCT01110330|26798422|P1|Overall Study|Other|1
7705137|NCT01110330|26798420|P3|Overall Study|Withdrawal by Subject|2
7705138|NCT01110330|26798421|P2|Overall Study|Withdrawal by Subject|6
7705139|NCT01110330|26798422|P1|Overall Study|Withdrawal by Subject|0
7705140|NCT01110330|26798420|P3|Overall Study|Protocol Violation|4
7705141|NCT01110330|26798421|P2|Overall Study|Protocol Violation|0
7705142|NCT01110330|26798422|P1|Overall Study|Protocol Violation|2
7705143|NCT01110330|26798420|P3|Overall Study|Physician Decision|0
7705144|NCT01110330|26798421|P2|Overall Study|Physician Decision|1
7705145|NCT01110330|26798422|P1|Overall Study|Physician Decision|0
7705146|NCT01110330|26798420|P3|Overall Study|Lost to Follow-up|15
7705147|NCT01110330|26798421|P2|Overall Study|Lost to Follow-up|10
7705148|NCT01110330|26798422|P1|Overall Study|Lost to Follow-up|9
7705149|NCT01110330|26798420|P3|Overall Study|Lack of Efficacy|1
7705150|NCT01110330|26798421|P2|Overall Study|Lack of Efficacy|1
7705151|NCT01110330|26798422|P1|Overall Study|Lack of Efficacy|3
7705152|NCT01110330|26798420|P3|Overall Study|Adverse Event|3
7705153|NCT01110330|26798421|P2|Overall Study|Adverse Event|4
7705154|NCT01110330|26798422|P1|Overall Study|Adverse Event|0
7705155|NCT01110239|26798450|P4|7.5 Min Ischemia|Withdrawal by Subject|0
7705156|NCT01110239|26798451|P3|7.5 Min Ischemia|Withdrawal by Subject|1
7705157|NCT01110239|26798452|P2|7.5 Min Ischemia|Withdrawal by Subject|0
7705158|NCT01110239|26798453|P1|7.5 Min Ischemia|Withdrawal by Subject|0
7705159|NCT01110239|26798450|P4|Sham Preconditioning|Withdrawal by Subject|0
7705160|NCT01110239|26798451|P3|Sham Preconditioning|Withdrawal by Subject|1
7705161|NCT01110239|26798452|P2|Sham Preconditioning|Withdrawal by Subject|0
7705162|NCT01110239|26798453|P1|Sham Preconditioning|Withdrawal by Subject|0
7705163|NCT01110200|26798469|P2|Overall Study|Lost to Follow-up|7
7705164|NCT01110200|26798470|P1|Overall Study|Lost to Follow-up|10
7705165|NCT01110200|26798469|P2|Overall Study|Physician Decision|17
7705166|NCT01110200|26798470|P1|Overall Study|Physician Decision|13
7705167|NCT01110200|26798469|P2|Overall Study|Protocol Violation|12
7705168|NCT01110200|26798470|P1|Overall Study|Protocol Violation|14
7705169|NCT01110200|26798469|P2|Overall Study|Lack of Efficacy|25
7705170|NCT01110200|26798470|P1|Overall Study|Lack of Efficacy|16
7705171|NCT01110200|26798469|P2|Overall Study|Withdrawal by Subject|32
7705172|NCT01110200|26798470|P1|Overall Study|Withdrawal by Subject|25
7705173|NCT01110200|26798469|P2|Overall Study|Adverse Event|28
7705174|NCT01110200|26798470|P1|Overall Study|Adverse Event|28
7705175|NCT01110005|26798506|P2|Overall Study|Withdrawal by Subject|1
7705176|NCT01110005|26798507|P1|Overall Study|Withdrawal by Subject|0
7705177|NCT01110005|26798506|P2|Overall Study|missing consent|2
7705178|NCT01110005|26798507|P1|Overall Study|missing consent|3
7705179|NCT01110005|26798506|P2|Overall Study|ineligible|2
7705180|NCT01110005|26798507|P1|Overall Study|ineligible|1
7705181|NCT01109992|26798519|P2|Overall Study|Movement during rest scan.|1
7705182|NCT01109992|26798520|P1|Overall Study|Movement during rest scan.|0
7705183|NCT01109992|26798519|P2|Overall Study|Withdrawal by Subject|1
7705184|NCT01109992|26798520|P1|Overall Study|Withdrawal by Subject|0
7705185|NCT01109979|26798534|P2|Overall Study|Withdrawal by Subject|1
7705186|NCT01109979|26798535|P1|Overall Study|Withdrawal by Subject|0
7705187|NCT01109979|26798534|P2|Overall Study|Physician Decision|0
7705188|NCT01109979|26798535|P1|Overall Study|Physician Decision|2
7705189|NCT01109940|26798545|P4|Overall Study|Unsatisfactory therapeutic effect|0
7705190|NCT01109940|26798546|P3|Overall Study|Unsatisfactory therapeutic effect|1
7705191|NCT01109940|26798547|P2|Overall Study|Unsatisfactory therapeutic effect|0
7705192|NCT01109940|26798548|P1|Overall Study|Unsatisfactory therapeutic effect|2
7705193|NCT01109940|26798545|P4|Overall Study|Patient withdrew consent|0
7705194|NCT01109940|26798546|P3|Overall Study|Patient withdrew consent|0
7705195|NCT01109940|26798547|P2|Overall Study|Patient withdrew consent|1
7705196|NCT01109940|26798548|P1|Overall Study|Patient withdrew consent|1
7705197|NCT01109940|26798545|P4|Overall Study|Lost to Follow-up|0
7705198|NCT01109940|26798546|P3|Overall Study|Lost to Follow-up|0
7705199|NCT01109940|26798547|P2|Overall Study|Lost to Follow-up|0
7705200|NCT01109940|26798548|P1|Overall Study|Lost to Follow-up|1
7705201|NCT01109940|26798545|P4|Overall Study|Serious Adverse Event|0
7705202|NCT01109940|26798546|P3|Overall Study|Serious Adverse Event|0
7705203|NCT01109940|26798547|P2|Overall Study|Serious Adverse Event|1
7705204|NCT01109940|26798548|P1|Overall Study|Serious Adverse Event|2
7705205|NCT01109940|26798545|P4|Overall Study|Administrative problems|0
7705206|NCT01109940|26798546|P3|Overall Study|Administrative problems|0
7705207|NCT01109940|26798547|P2|Overall Study|Administrative problems|0
7705208|NCT01109940|26798548|P1|Overall Study|Administrative problems|2
7705209|NCT01109849|26798576|P5|Adaptive Randomization: Weight Recovery|moved away|0
7705210|NCT01109849|26798577|P4|Adaptive Randomization: Weight Recovery|moved away|2
7705211|NCT01109849|26798578|P3|Adaptive Randomization: Weight Recovery|moved away|0
7705212|NCT01109849|26798579|P2|Adaptive Randomization: Weight Recovery|moved away|0
7705213|NCT01109849|26798580|P1|Adaptive Randomization: Weight Recovery|moved away|0
7705214|NCT01109849|26798576|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7705215|NCT01109849|26798577|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7705216|NCT01109849|26798578|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7705217|NCT01109849|26798579|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
7705218|NCT01109849|26798580|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
7705219|NCT01109849|26798576|P5|Initial Randomization: ADHD Treatment|move away|0
7705220|NCT01109849|26798577|P4|Initial Randomization: ADHD Treatment|move away|0
7705221|NCT01109849|26798578|P3|Initial Randomization: ADHD Treatment|move away|0
7705222|NCT01109849|26798579|P2|Initial Randomization: ADHD Treatment|move away|7
7705223|NCT01109849|26798580|P1|Initial Randomization: ADHD Treatment|move away|2
7705224|NCT01109849|26798576|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7705225|NCT01109849|26798577|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7705226|NCT01109849|26798578|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7705227|NCT01109849|26798579|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
7705228|NCT01109849|26798580|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
7705229|NCT01109849|26798576|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
7705230|NCT01109849|26798577|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
7705231|NCT01109849|26798578|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
7705232|NCT01109849|26798579|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
7705233|NCT01109849|26798580|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
7705234|NCT01109849|26798576|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7705235|NCT01109849|26798577|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7705236|NCT01109849|26798578|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7705237|NCT01109849|26798579|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
7705238|NCT01109849|26798580|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
7705239|NCT01109524|26798649|P1|Overall Study|Other|5
7705240|NCT01109524|26798649|P1|Overall Study|Participant requested to end treatment|4
7705241|NCT01109524|26798649|P1|Overall Study|No longer meets criteria|2
7705242|NCT01109524|26798649|P1|Overall Study|Death|2
7705243|NCT01109524|26798649|P1|Overall Study|Maximum clinical benefit|3
7705244|NCT01109524|26798649|P1|Overall Study|Withdrawal by Subject|2
7705245|NCT01109524|26798649|P1|Overall Study|Adverse Event|4
7705246|NCT01109524|26798649|P1|Overall Study|Study Drug toxicity|6
7705247|NCT01109524|26798649|P1|Overall Study|Disease Progression|29
7705248|NCT01109316|26798671|P6|Study Period 3|Withdrawal by Subject|0
7705249|NCT01109316|26798672|P5|Study Period 3|Withdrawal by Subject|1
7705250|NCT01109316|26798673|P4|Study Period 3|Withdrawal by Subject|0
7705251|NCT01109316|26798674|P3|Study Period 3|Withdrawal by Subject|0
7705252|NCT01109316|26798675|P2|Study Period 3|Withdrawal by Subject|0
7705253|NCT01109316|26798676|P1|Study Period 3|Withdrawal by Subject|1
7705254|NCT01109316|26798671|P6|Study Period 3|Lost to Follow-up|0
7705255|NCT01109316|26798672|P5|Study Period 3|Lost to Follow-up|1
7705256|NCT01109316|26798673|P4|Study Period 3|Lost to Follow-up|0
7705257|NCT01109316|26798674|P3|Study Period 3|Lost to Follow-up|0
7705258|NCT01109316|26798675|P2|Study Period 3|Lost to Follow-up|0
7705259|NCT01109316|26798676|P1|Study Period 3|Lost to Follow-up|0
7705260|NCT01109316|26798671|P6|Study Period 2|Withdrawal by Subject|1
7705261|NCT01109316|26798672|P5|Study Period 2|Withdrawal by Subject|0
7705262|NCT01109316|26798673|P4|Study Period 2|Withdrawal by Subject|0
7705263|NCT01109316|26798674|P3|Study Period 2|Withdrawal by Subject|1
7705264|NCT01109316|26798675|P2|Study Period 2|Withdrawal by Subject|0
7705265|NCT01109316|26798676|P1|Study Period 2|Withdrawal by Subject|0
7705266|NCT01109316|26798671|P6|Study Period 2|Protocol Violation|0
7705267|NCT01109316|26798672|P5|Study Period 2|Protocol Violation|0
7705268|NCT01109316|26798673|P4|Study Period 2|Protocol Violation|0
7705269|NCT01109316|26798674|P3|Study Period 2|Protocol Violation|0
7705270|NCT01109316|26798675|P2|Study Period 2|Protocol Violation|0
7705271|NCT01109316|26798676|P1|Study Period 2|Protocol Violation|1
7705272|NCT01109316|26798671|P6|Study Period 2|Physician Decision|0
7705273|NCT01109316|26798672|P5|Study Period 2|Physician Decision|0
7705274|NCT01109316|26798673|P4|Study Period 2|Physician Decision|1
7705275|NCT01109316|26798674|P3|Study Period 2|Physician Decision|0
7705276|NCT01109316|26798675|P2|Study Period 2|Physician Decision|0
7705277|NCT01109316|26798676|P1|Study Period 2|Physician Decision|0
7705278|NCT01109316|26798671|P6|Study Period 2|Entry Criteria Not Met|0
7705279|NCT01109316|26798672|P5|Study Period 2|Entry Criteria Not Met|0
7705280|NCT01109316|26798673|P4|Study Period 2|Entry Criteria Not Met|0
7705281|NCT01109316|26798674|P3|Study Period 2|Entry Criteria Not Met|0
7705282|NCT01109316|26798675|P2|Study Period 2|Entry Criteria Not Met|1
7705283|NCT01109316|26798676|P1|Study Period 2|Entry Criteria Not Met|0
7705284|NCT01109316|26798671|P6|Study Period 1|Sponsor Decision|2
7705285|NCT01109316|26798672|P5|Study Period 1|Sponsor Decision|0
7705286|NCT01109316|26798673|P4|Study Period 1|Sponsor Decision|0
7705287|NCT01109316|26798674|P3|Study Period 1|Sponsor Decision|0
7705288|NCT01109316|26798675|P2|Study Period 1|Sponsor Decision|0
7705289|NCT01109316|26798676|P1|Study Period 1|Sponsor Decision|0
7705290|NCT01109316|26798671|P6|Study Period 1|Withdrawal by Subject|0
7705291|NCT01109316|26798672|P5|Study Period 1|Withdrawal by Subject|2
7705292|NCT01109316|26798673|P4|Study Period 1|Withdrawal by Subject|0
7705293|NCT01109316|26798674|P3|Study Period 1|Withdrawal by Subject|1
7705294|NCT01109316|26798675|P2|Study Period 1|Withdrawal by Subject|0
7705295|NCT01109316|26798676|P1|Study Period 1|Withdrawal by Subject|0
7705296|NCT01109316|26798671|P6|Study Period 1|Lost to Follow-up|0
7705297|NCT01109316|26798672|P5|Study Period 1|Lost to Follow-up|0
7705298|NCT01109316|26798673|P4|Study Period 1|Lost to Follow-up|1
7705299|NCT01109316|26798674|P3|Study Period 1|Lost to Follow-up|1
7705300|NCT01109316|26798675|P2|Study Period 1|Lost to Follow-up|0
7705301|NCT01109316|26798676|P1|Study Period 1|Lost to Follow-up|0
7705302|NCT01109316|26798671|P6|Study Period 1|Adverse Event|0
7705303|NCT01109316|26798672|P5|Study Period 1|Adverse Event|0
7705304|NCT01109316|26798673|P4|Study Period 1|Adverse Event|0
7705305|NCT01109316|26798674|P3|Study Period 1|Adverse Event|1
7705306|NCT01109316|26798675|P2|Study Period 1|Adverse Event|0
7705307|NCT01109316|26798676|P1|Study Period 1|Adverse Event|0
7705308|NCT01109173|26798724|P4|Overall Study|Not Specifiied|14
7705309|NCT01109173|26798725|P3|Overall Study|Not Specifiied|9
7705310|NCT01109173|26798726|P2|Overall Study|Not Specifiied|4
7705311|NCT01109173|26798727|P1|Overall Study|Not Specifiied|5
7705312|NCT01109173|26798724|P4|Overall Study|Patient Did Not Use Study Medication|7
7705313|NCT01109173|26798725|P3|Overall Study|Patient Did Not Use Study Medication|11
7705314|NCT01109173|26798726|P2|Overall Study|Patient Did Not Use Study Medication|26
7705315|NCT01109173|26798727|P1|Overall Study|Patient Did Not Use Study Medication|34
7705316|NCT01109173|26798724|P4|Overall Study|Protocol Violation|2
7705317|NCT01109173|26798725|P3|Overall Study|Protocol Violation|1
7705318|NCT01109173|26798726|P2|Overall Study|Protocol Violation|5
7705319|NCT01109173|26798727|P1|Overall Study|Protocol Violation|4
7705320|NCT01109173|26798724|P4|Overall Study|Treatment Failure|64
7705321|NCT01109173|26798725|P3|Overall Study|Treatment Failure|69
7705322|NCT01109173|26798726|P2|Overall Study|Treatment Failure|32
7705323|NCT01109173|26798727|P1|Overall Study|Treatment Failure|25
7705324|NCT01109173|26798724|P4|Overall Study|Noncompliance|0
7705325|NCT01109173|26798725|P3|Overall Study|Noncompliance|0
7705326|NCT01109173|26798726|P2|Overall Study|Noncompliance|1
7705327|NCT01109173|26798727|P1|Overall Study|Noncompliance|0
7705328|NCT01109173|26798724|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
7705329|NCT01109173|26798725|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
7705330|NCT01109173|26798726|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
7705331|NCT01109173|26798727|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
7705332|NCT01109173|26798724|P4|Overall Study|Lost to Follow-up|0
7705333|NCT01109173|26798725|P3|Overall Study|Lost to Follow-up|0
7705334|NCT01109173|26798726|P2|Overall Study|Lost to Follow-up|1
7705335|NCT01109173|26798727|P1|Overall Study|Lost to Follow-up|0
7705336|NCT01109173|26798724|P4|Overall Study|Adverse Event|6
7705337|NCT01109173|26798725|P3|Overall Study|Adverse Event|9
7705338|NCT01109173|26798726|P2|Overall Study|Adverse Event|17
7705339|NCT01109173|26798727|P1|Overall Study|Adverse Event|15
7705340|NCT01108809|26798840|P1|Overall Study|Lost to Follow-up|1
7705341|NCT01108809|26798840|P1|Overall Study|Adverse Event|3
7705342|NCT01108796|26798857|P2|Overall Study|Lost to Follow-up|6
7705343|NCT01108796|26798858|P1|Overall Study|Lost to Follow-up|7
7705344|NCT01108796|26798857|P2|Overall Study|Adverse Event|1
7705345|NCT01108796|26798858|P1|Overall Study|Adverse Event|0
7705346|NCT01108731|26798901|P2|Overall Study|Adverse Event|3
7705347|NCT01108731|26798902|P1|Overall Study|Adverse Event|3
7705348|NCT01108731|26798901|P2|Overall Study|Withdrawal by Subject|1
7705349|NCT01108731|26798902|P1|Overall Study|Withdrawal by Subject|1
7705350|NCT01108718|26798914|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
7705351|NCT01108718|26798915|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
7705352|NCT01108523|26798927|P1|Overall Study|Protocol Violation|4
7705353|NCT01108510|26798934|P2|Overall Study|Death|1
7705354|NCT01108510|26798935|P1|Overall Study|Death|1
7705355|NCT01108510|26798934|P2|Overall Study|Pregnancy|3
7705356|NCT01108510|26798935|P1|Overall Study|Pregnancy|0
7705357|NCT01108510|26798934|P2|Overall Study|Lack of Efficacy|0
7705358|NCT01108510|26798935|P1|Overall Study|Lack of Efficacy|3
7705359|NCT01108510|26798934|P2|Overall Study|Participant Noncompliance|7
7705360|NCT01108510|26798935|P1|Overall Study|Participant Noncompliance|5
7705361|NCT01108510|26798934|P2|Overall Study|Investigator's Discretion|10
7705362|NCT01108510|26798935|P1|Overall Study|Investigator's Discretion|12
7705363|NCT01108510|26798934|P2|Overall Study|Withdrew Consent|15
7705364|NCT01108510|26798935|P1|Overall Study|Withdrew Consent|21
7705365|NCT01108510|26798934|P2|Overall Study|Lost to Follow-up|17
7705366|NCT01108510|26798935|P1|Overall Study|Lost to Follow-up|20
7705367|NCT01108510|26798934|P2|Overall Study|Adverse Event|19
7705368|NCT01108510|26798935|P1|Overall Study|Adverse Event|26
7705369|NCT01108510|26798934|P2|Overall Study|Joined Another Gilead-sponsored Study|195
7705370|NCT01108510|26798935|P1|Overall Study|Joined Another Gilead-sponsored Study|186
7705371|NCT01108510|26798934|P2|Overall Study|Randomized but Not Treated|1
7705372|NCT01108510|26798935|P1|Overall Study|Randomized but Not Treated|5
7705373|NCT01108458|26798955|P1|Overall Study|Withdrawal by Subject|1
7705374|NCT01108341|26799007|P1|Overall Study|Other|1
7705375|NCT01108341|26799007|P1|Overall Study|Lost to Follow-up|1
7705376|NCT01108341|26799007|P1|Overall Study|Withdrawal by Subject|1
7705377|NCT01108341|26799007|P1|Overall Study|Death|2
7705378|NCT01108263|26799014|P2|Overall Study|Adverse Event|1
7705379|NCT01108263|26799015|P1|Overall Study|Adverse Event|0
7705380|NCT01108237|26799025|P2|Overall Study|Did not meet criteria for analysis|0
7705381|NCT01108237|26799026|P1|Overall Study|Did not meet criteria for analysis|7
7705382|NCT01108237|26799025|P2|Overall Study|No alignment data|17
7705383|NCT01108237|26799026|P1|Overall Study|No alignment data|2
7705384|NCT01108185|26799032|P1|Overall Study|Lost to Follow-up|12
7705385|NCT01108185|26799032|P1|Overall Study|Non-compliance|15
7705386|NCT01108094|26799049|P4|Overall Study|Withdrawal by Subject|0
7705387|NCT01108094|26799050|P3|Overall Study|Withdrawal by Subject|0
7705388|NCT01108094|26799051|P2|Overall Study|Withdrawal by Subject|0
7705389|NCT01108094|26799052|P1|Overall Study|Withdrawal by Subject|1
7705390|NCT01108094|26799049|P4|Overall Study|Adverse Event|0
7705391|NCT01108094|26799050|P3|Overall Study|Adverse Event|0
7705392|NCT01108094|26799051|P2|Overall Study|Adverse Event|0
7705393|NCT01108094|26799052|P1|Overall Study|Adverse Event|2
7705394|NCT01108068|26799096|P2|Overall Study|5 not started, 1 stop due to side effect|0
7705395|NCT01108068|26799097|P1|Overall Study|5 not started, 1 stop due to side effect|6
7705396|NCT01108055|26799104|P1|Overall Study|Not evaluable- didn't complete treatment|4
7705397|NCT01108055|26799104|P1|Overall Study|Ineligible|11
7705398|NCT01107925|26799142|P6|Period 2|Withdrawal by Subject|1
7705399|NCT01107925|26799143|P5|Period 2|Withdrawal by Subject|0
7705400|NCT01107925|26799144|P4|Period 2|Withdrawal by Subject|0
7705401|NCT01107925|26799145|P3|Period 2|Withdrawal by Subject|0
7705402|NCT01107925|26799146|P2|Period 2|Withdrawal by Subject|1
7705403|NCT01107925|26799147|P1|Period 2|Withdrawal by Subject|0
7705404|NCT01107925|26799142|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7705405|NCT01107925|26799143|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
7705406|NCT01107925|26799144|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7705407|NCT01107925|26799145|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7705408|NCT01107925|26799146|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7705409|NCT01107925|26799147|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
7705410|NCT01107912|26799185|P6|Period 3|Withdrawal by Subject|0
7705411|NCT01107912|26799186|P5|Period 3|Withdrawal by Subject|0
7705412|NCT01107912|26799187|P4|Period 3|Withdrawal by Subject|1
7705413|NCT01107912|26799188|P3|Period 3|Withdrawal by Subject|0
7705414|NCT01107912|26799189|P2|Period 3|Withdrawal by Subject|0
7705415|NCT01107912|26799190|P1|Period 3|Withdrawal by Subject|0
7705416|NCT01107912|26799185|P6|Period 3|Adverse Event|0
7705417|NCT01107912|26799186|P5|Period 3|Adverse Event|0
7705418|NCT01107912|26799187|P4|Period 3|Adverse Event|0
7705419|NCT01107912|26799188|P3|Period 3|Adverse Event|1
7705420|NCT01107912|26799189|P2|Period 3|Adverse Event|1
7705421|NCT01107912|26799190|P1|Period 3|Adverse Event|0
7705422|NCT01107912|26799185|P6|Period 2|Physician Decision|0
7705423|NCT01107912|26799186|P5|Period 2|Physician Decision|0
7705424|NCT01107912|26799187|P4|Period 2|Physician Decision|0
7705425|NCT01107912|26799188|P3|Period 2|Physician Decision|1
7705426|NCT01107912|26799189|P2|Period 2|Physician Decision|0
7705427|NCT01107912|26799190|P1|Period 2|Physician Decision|0
7705428|NCT01107912|26799185|P6|Period 1|Withdrawal by Subject|0
7705429|NCT01107912|26799186|P5|Period 1|Withdrawal by Subject|0
7705430|NCT01107912|26799187|P4|Period 1|Withdrawal by Subject|0
7705431|NCT01107912|26799188|P3|Period 1|Withdrawal by Subject|0
7705432|NCT01107912|26799189|P2|Period 1|Withdrawal by Subject|0
7705433|NCT01107912|26799190|P1|Period 1|Withdrawal by Subject|1
7705434|NCT01107912|26799185|P6|Period 1|Physician Decision|0
7705435|NCT01107912|26799186|P5|Period 1|Physician Decision|1
7705436|NCT01107912|26799187|P4|Period 1|Physician Decision|0
7705437|NCT01107912|26799188|P3|Period 1|Physician Decision|0
7705438|NCT01107912|26799189|P2|Period 1|Physician Decision|0
7705439|NCT01107912|26799190|P1|Period 1|Physician Decision|0
7705440|NCT01107912|26799185|P6|Period 1|Adverse Event|0
7705441|NCT01107912|26799186|P5|Period 1|Adverse Event|2
7705442|NCT01107912|26799187|P4|Period 1|Adverse Event|0
7705443|NCT01107912|26799188|P3|Period 1|Adverse Event|0
7705444|NCT01107912|26799189|P2|Period 1|Adverse Event|0
7705445|NCT01107912|26799190|P1|Period 1|Adverse Event|0
7705446|NCT01107899|26799227|P3|Overall Study|Withdrawal by Subject|1
7705447|NCT01107899|26799228|P2|Overall Study|Withdrawal by Subject|0
7705448|NCT01107899|26799229|P1|Overall Study|Withdrawal by Subject|0
7705449|NCT01107899|26799227|P3|Overall Study|Physician Decision|3
7705450|NCT01107899|26799228|P2|Overall Study|Physician Decision|0
7705451|NCT01107899|26799229|P1|Overall Study|Physician Decision|5
7705452|NCT01107886|26799275|P2|Overall Study|Administrative withdrawal of consent|5
7705453|NCT01107886|26799276|P1|Overall Study|Administrative withdrawal of consent|7
7705454|NCT01107886|26799275|P2|Overall Study|Withdrawal by Subject|196
7705455|NCT01107886|26799276|P1|Overall Study|Withdrawal by Subject|180
7705456|NCT01107886|26799275|P2|Overall Study|Lost to Follow-up|13
7705457|NCT01107886|26799276|P1|Overall Study|Lost to Follow-up|15
7705458|NCT01107743|26799309|P1|Overall Study|Protocol Violation|46
7705459|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Off treatment reason not reported|10
7705460|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Off treatment reason not reported|4
7705461|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Off treatment reason not reported|4
7705462|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Off treatment reason not reported|0
7705463|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Pain|1
7705464|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Pain|0
7705465|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Pain|0
7705466|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Pain|0
7705467|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Non-compliance|2
7705468|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Non-compliance|0
7705469|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Non-compliance|0
7705470|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Non-compliance|0
7705471|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Hospice care|0
7705472|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Hospice care|2
7705473|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Hospice care|1
7705474|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Hospice care|0
7705475|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Physician Decision|3
7705476|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Physician Decision|3
7705477|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Physician Decision|2
7705478|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Physician Decision|0
7705479|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Financial reason|0
7705480|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Financial reason|0
7705481|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Financial reason|2
7705482|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Financial reason|0
7705483|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
7705484|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
7705485|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
7705486|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
7705487|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
7705488|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
7705489|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
7705490|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
7705491|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Symptomatic deterioration|3
7705492|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Symptomatic deterioration|4
7705493|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Symptomatic deterioration|2
7705494|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Symptomatic deterioration|0
7705495|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Other complicating disease|9
7705496|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Other complicating disease|5
7705497|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Other complicating disease|2
7705498|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Other complicating disease|0
7705499|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Alternative therapy|5
7705500|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Alternative therapy|4
7705501|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Alternative therapy|2
7705502|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Alternative therapy|0
7705503|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Withdrawal by Subject|27
7705504|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Withdrawal by Subject|21
7705505|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Withdrawal by Subject|11
7705506|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Withdrawal by Subject|0
7705507|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Death|13
7705508|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Death|2
7705509|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Death|8
7705510|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Death|0
7705511|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Adverse Event|46
7705512|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Adverse Event|29
7705513|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Adverse Event|32
7705514|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Adverse Event|0
7705515|NCT01107626|26799427|P4|Step 2: Maintenance Therapy|Lack of Efficacy|170
7705516|NCT01107626|26799428|P3|Step 2: Maintenance Therapy|Lack of Efficacy|217
7705517|NCT01107626|26799429|P2|Step 2: Maintenance Therapy|Lack of Efficacy|217
7705518|NCT01107626|26799430|P1|Step 2: Maintenance Therapy|Lack of Efficacy|0
7705519|NCT01107626|26799427|P4|Step 1: Induction Therapy|Off treatment reason not reported|0
7705520|NCT01107626|26799428|P3|Step 1: Induction Therapy|Off treatment reason not reported|0
7705521|NCT01107626|26799429|P2|Step 1: Induction Therapy|Off treatment reason not reported|0
7705522|NCT01107626|26799430|P1|Step 1: Induction Therapy|Off treatment reason not reported|50
7705523|NCT01107626|26799427|P4|Step 1: Induction Therapy|Physician Decision|0
7705524|NCT01107626|26799428|P3|Step 1: Induction Therapy|Physician Decision|0
7705525|NCT01107626|26799429|P2|Step 1: Induction Therapy|Physician Decision|0
7705526|NCT01107626|26799430|P1|Step 1: Induction Therapy|Physician Decision|1
7705527|NCT01107626|26799427|P4|Step 1: Induction Therapy|Hospice care|0
7705528|NCT01107626|26799428|P3|Step 1: Induction Therapy|Hospice care|0
7705529|NCT01107626|26799429|P2|Step 1: Induction Therapy|Hospice care|0
7705530|NCT01107626|26799430|P1|Step 1: Induction Therapy|Hospice care|1
7705531|NCT01107626|26799427|P4|Step 1: Induction Therapy|Protocol Violation|0
7705532|NCT01107626|26799428|P3|Step 1: Induction Therapy|Protocol Violation|0
7705533|NCT01107626|26799429|P2|Step 1: Induction Therapy|Protocol Violation|0
7705534|NCT01107626|26799430|P1|Step 1: Induction Therapy|Protocol Violation|1
7705535|NCT01107626|26799427|P4|Step 1: Induction Therapy|Pain|0
7705536|NCT01107626|26799428|P3|Step 1: Induction Therapy|Pain|0
7705537|NCT01107626|26799429|P2|Step 1: Induction Therapy|Pain|0
7705538|NCT01107626|26799430|P1|Step 1: Induction Therapy|Pain|4
7705539|NCT01107626|26799427|P4|Step 1: Induction Therapy|Non-compliance|0
7705540|NCT01107626|26799428|P3|Step 1: Induction Therapy|Non-compliance|0
7705541|NCT01107626|26799429|P2|Step 1: Induction Therapy|Non-compliance|0
7705542|NCT01107626|26799430|P1|Step 1: Induction Therapy|Non-compliance|4
7705543|NCT01107626|26799427|P4|Step 1: Induction Therapy|Symptomatic deterioration|0
7705544|NCT01107626|26799428|P3|Step 1: Induction Therapy|Symptomatic deterioration|0
7705545|NCT01107626|26799429|P2|Step 1: Induction Therapy|Symptomatic deterioration|0
7705546|NCT01107626|26799430|P1|Step 1: Induction Therapy|Symptomatic deterioration|10
7705547|NCT01107626|26799427|P4|Step 1: Induction Therapy|Alternative therapy|0
7705548|NCT01107626|26799428|P3|Step 1: Induction Therapy|Alternative therapy|0
7705549|NCT01107626|26799429|P2|Step 1: Induction Therapy|Alternative therapy|0
7705550|NCT01107626|26799430|P1|Step 1: Induction Therapy|Alternative therapy|12
7705551|NCT01107626|26799427|P4|Step 1: Induction Therapy|Complicating disease|0
7705552|NCT01107626|26799428|P3|Step 1: Induction Therapy|Complicating disease|0
7705553|NCT01107626|26799429|P2|Step 1: Induction Therapy|Complicating disease|0
7705554|NCT01107626|26799430|P1|Step 1: Induction Therapy|Complicating disease|13
7705555|NCT01107626|26799427|P4|Step 1: Induction Therapy|Withdrawal by Subject|0
7705556|NCT01107626|26799428|P3|Step 1: Induction Therapy|Withdrawal by Subject|0
7705557|NCT01107626|26799429|P2|Step 1: Induction Therapy|Withdrawal by Subject|0
7705558|NCT01107626|26799430|P1|Step 1: Induction Therapy|Withdrawal by Subject|54
7705559|NCT01107626|26799427|P4|Step 1: Induction Therapy|Death|0
7705560|NCT01107626|26799428|P3|Step 1: Induction Therapy|Death|0
7705561|NCT01107626|26799429|P2|Step 1: Induction Therapy|Death|0
7705562|NCT01107626|26799430|P1|Step 1: Induction Therapy|Death|62
7705563|NCT01107626|26799427|P4|Step 1: Induction Therapy|Adverse Event|0
7705564|NCT01107626|26799428|P3|Step 1: Induction Therapy|Adverse Event|0
7705565|NCT01107626|26799429|P2|Step 1: Induction Therapy|Adverse Event|0
7705566|NCT01107626|26799430|P1|Step 1: Induction Therapy|Adverse Event|198
7705567|NCT01107626|26799427|P4|Step 1: Induction Therapy|Lack of Efficacy|0
7705568|NCT01107626|26799428|P3|Step 1: Induction Therapy|Lack of Efficacy|0
7705569|NCT01107626|26799429|P2|Step 1: Induction Therapy|Lack of Efficacy|0
7705570|NCT01107626|26799430|P1|Step 1: Induction Therapy|Lack of Efficacy|167
7705571|NCT01107535|26799445|P1|Overall Study|Death|5
7705572|NCT01107457|26799458|P6|Part B and C|Clinical Relapse|4
7705573|NCT01107457|26799459|P5|Part B and C|Clinical Relapse|0
7705574|NCT01107457|26799460|P4|Part B and C|Clinical Relapse|0
7705575|NCT01107457|26799461|P3|Part B and C|Clinical Relapse|0
7705576|NCT01107457|26799462|P2|Part B and C|Clinical Relapse|0
7705577|NCT01107457|26799463|P1|Part B and C|Clinical Relapse|0
7705578|NCT01107457|26799458|P6|Part B and C|Withdrawal by Subject|16
7705579|NCT01107457|26799459|P5|Part B and C|Withdrawal by Subject|0
7705580|NCT01107457|26799460|P4|Part B and C|Withdrawal by Subject|0
7705581|NCT01107457|26799461|P3|Part B and C|Withdrawal by Subject|0
7705582|NCT01107457|26799462|P2|Part B and C|Withdrawal by Subject|0
7705583|NCT01107457|26799463|P1|Part B and C|Withdrawal by Subject|0
7705584|NCT01107457|26799458|P6|Part B and C|Sponsor Decision|66
7705585|NCT01107457|26799459|P5|Part B and C|Sponsor Decision|0
7705586|NCT01107457|26799460|P4|Part B and C|Sponsor Decision|0
7705587|NCT01107457|26799461|P3|Part B and C|Sponsor Decision|0
7705588|NCT01107457|26799462|P2|Part B and C|Sponsor Decision|0
7705589|NCT01107457|26799463|P1|Part B and C|Sponsor Decision|0
7705590|NCT01107457|26799458|P6|Part B and C|Protocol Violation|1
7705591|NCT01107457|26799459|P5|Part B and C|Protocol Violation|0
7705592|NCT01107457|26799460|P4|Part B and C|Protocol Violation|0
7705593|NCT01107457|26799461|P3|Part B and C|Protocol Violation|0
7705594|NCT01107457|26799462|P2|Part B and C|Protocol Violation|0
7705595|NCT01107457|26799463|P1|Part B and C|Protocol Violation|0
7705596|NCT01107457|26799458|P6|Part B and C|Lost to Follow-up|10
7705597|NCT01107457|26799459|P5|Part B and C|Lost to Follow-up|0
7705598|NCT01107457|26799460|P4|Part B and C|Lost to Follow-up|0
7705599|NCT01107457|26799461|P3|Part B and C|Lost to Follow-up|0
7705600|NCT01107457|26799462|P2|Part B and C|Lost to Follow-up|0
7705601|NCT01107457|26799463|P1|Part B and C|Lost to Follow-up|0
7705602|NCT01107457|26799458|P6|Part B and C|Lack of Efficacy|7
7705603|NCT01107457|26799459|P5|Part B and C|Lack of Efficacy|0
7705604|NCT01107457|26799460|P4|Part B and C|Lack of Efficacy|0
7705605|NCT01107457|26799461|P3|Part B and C|Lack of Efficacy|0
7705606|NCT01107457|26799462|P2|Part B and C|Lack of Efficacy|0
7705607|NCT01107457|26799463|P1|Part B and C|Lack of Efficacy|0
7705608|NCT01107457|26799458|P6|Part B and C|Physician Decision|3
7705609|NCT01107457|26799459|P5|Part B and C|Physician Decision|0
7705610|NCT01107457|26799460|P4|Part B and C|Physician Decision|0
7705611|NCT01107457|26799461|P3|Part B and C|Physician Decision|0
7705612|NCT01107457|26799462|P2|Part B and C|Physician Decision|0
7705613|NCT01107457|26799463|P1|Part B and C|Physician Decision|0
7705614|NCT01107457|26799458|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
7705615|NCT01107457|26799459|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7705616|NCT01107457|26799460|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7705617|NCT01107457|26799461|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7705618|NCT01107457|26799462|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7705619|NCT01107457|26799463|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7705620|NCT01107457|26799458|P6|Part B and C|Adverse Event|12
7705621|NCT01107457|26799459|P5|Part B and C|Adverse Event|0
7705622|NCT01107457|26799460|P4|Part B and C|Adverse Event|0
7705623|NCT01107457|26799461|P3|Part B and C|Adverse Event|0
7705624|NCT01107457|26799462|P2|Part B and C|Adverse Event|0
7705625|NCT01107457|26799463|P1|Part B and C|Adverse Event|0
7705626|NCT01107457|26799458|P6|Part A|Protocol Violation|0
7705627|NCT01107457|26799459|P5|Part A|Protocol Violation|0
7705628|NCT01107457|26799460|P4|Part A|Protocol Violation|0
7705629|NCT01107457|26799461|P3|Part A|Protocol Violation|0
7705630|NCT01107457|26799462|P2|Part A|Protocol Violation|1
7705631|NCT01107457|26799463|P1|Part A|Protocol Violation|0
7705632|NCT01107457|26799458|P6|Part A|Lack of Efficacy|0
7705633|NCT01107457|26799459|P5|Part A|Lack of Efficacy|0
7705634|NCT01107457|26799460|P4|Part A|Lack of Efficacy|0
7705635|NCT01107457|26799461|P3|Part A|Lack of Efficacy|0
7705636|NCT01107457|26799462|P2|Part A|Lack of Efficacy|0
7705637|NCT01107457|26799463|P1|Part A|Lack of Efficacy|1
7705638|NCT01107457|26799458|P6|Part A|Lost to Follow-up|0
7705639|NCT01107457|26799459|P5|Part A|Lost to Follow-up|0
7705640|NCT01107457|26799460|P4|Part A|Lost to Follow-up|0
7705641|NCT01107457|26799461|P3|Part A|Lost to Follow-up|0
7705642|NCT01107457|26799462|P2|Part A|Lost to Follow-up|1
7705643|NCT01107457|26799463|P1|Part A|Lost to Follow-up|0
7705644|NCT01107457|26799458|P6|Part A|Withdrawal by Subject|0
7705645|NCT01107457|26799459|P5|Part A|Withdrawal by Subject|1
7705646|NCT01107457|26799460|P4|Part A|Withdrawal by Subject|3
7705647|NCT01107457|26799461|P3|Part A|Withdrawal by Subject|0
7705648|NCT01107457|26799462|P2|Part A|Withdrawal by Subject|3
7705649|NCT01107457|26799463|P1|Part A|Withdrawal by Subject|3
7705650|NCT01107457|26799458|P6|Part A|Adverse Event|0
7705651|NCT01107457|26799459|P5|Part A|Adverse Event|0
7705652|NCT01107457|26799460|P4|Part A|Adverse Event|0
7705653|NCT01107457|26799461|P3|Part A|Adverse Event|1
7705654|NCT01107457|26799462|P2|Part A|Adverse Event|2
7705655|NCT01107457|26799463|P1|Part A|Adverse Event|1
7705656|NCT01107444|26799591|P2|Overall Study|Protocol Entry Criteria Not Met|1
7705657|NCT01107444|26799592|P1|Overall Study|Protocol Entry Criteria Not Met|0
7705658|NCT01107444|26799591|P2|Overall Study|Withdrawal by Subject|12
7705659|NCT01107444|26799592|P1|Overall Study|Withdrawal by Subject|8
7705660|NCT01107418|26799626|P1|Overall Study|Entered Extension Study|1
7705661|NCT01107418|26799626|P1|Overall Study|Started Other Therapy|1
7705662|NCT01107418|26799626|P1|Overall Study|Study Closing|1
7705663|NCT01107418|26799626|P1|Overall Study|Withdrawal by Subject|1
7705664|NCT01107418|26799626|P1|Overall Study|Adverse Event|3
7705665|NCT01107418|26799626|P1|Overall Study|Disease Progression|45
7705666|NCT01107405|26799699|P5|Overall Study|Protocol Violation|0
7705667|NCT01107405|26799700|P4|Overall Study|Protocol Violation|1
7705668|NCT01107405|26799701|P3|Overall Study|Protocol Violation|1
7705669|NCT01107405|26799702|P2|Overall Study|Protocol Violation|0
7705670|NCT01107405|26799703|P1|Overall Study|Protocol Violation|0
7705671|NCT01107405|26799699|P5|Overall Study|Withdrawal by Subject|1
7705672|NCT01107405|26799700|P4|Overall Study|Withdrawal by Subject|2
7705673|NCT01107405|26799701|P3|Overall Study|Withdrawal by Subject|1
7705674|NCT01107405|26799702|P2|Overall Study|Withdrawal by Subject|0
7705675|NCT01107405|26799703|P1|Overall Study|Withdrawal by Subject|1
7705676|NCT01107405|26799699|P5|Overall Study|Adverse Event|2
7705677|NCT01107405|26799700|P4|Overall Study|Adverse Event|0
7705678|NCT01107405|26799701|P3|Overall Study|Adverse Event|0
7705679|NCT01107405|26799702|P2|Overall Study|Adverse Event|1
7705680|NCT01107405|26799703|P1|Overall Study|Adverse Event|1
7705681|NCT01107392|26799742|P2|Overall Study|Administrative decision|0
7705682|NCT01107392|26799743|P1|Overall Study|Administrative decision|1
7705683|NCT01107392|26799742|P2|Overall Study|Personal Reasons|3
7705684|NCT01107392|26799743|P1|Overall Study|Personal Reasons|2
7705685|NCT01107392|26799742|P2|Overall Study|Adverse Event|0
7705686|NCT01107392|26799743|P1|Overall Study|Adverse Event|2
7705687|NCT01107379|26799755|P1|Overall Study|Lost to Follow-up|3
7705688|NCT01107379|26799755|P1|Overall Study|Withdrawal by Subject|18
7705689|NCT01107353|26799766|P2|Overall Study|Positive Drug Screen|0
7705690|NCT01107353|26799767|P1|Overall Study|Positive Drug Screen|1
7705691|NCT01107197|26799775|P2|Overall Study|Withdrawal by Subject|5
7705692|NCT01107197|26799776|P1|Overall Study|Withdrawal by Subject|3
7705693|NCT01107197|26799775|P2|Overall Study|Lost to Follow-up|8
7705694|NCT01107197|26799776|P1|Overall Study|Lost to Follow-up|5
7705695|NCT01107197|26799775|P2|Overall Study|Death|10
7705696|NCT01107197|26799776|P1|Overall Study|Death|12
7705697|NCT01106976|26799811|P1|Overall Study|Lost to Follow-up|8
7705698|NCT01106911|26799825|P1|Overall Study|deemed ineligible after screening|3
7705699|NCT01106911|26799825|P1|Overall Study|Physician Decision|2
7705700|NCT01106898|26799829|P1|Overall Study|Adverse Event|6
7705701|NCT01106846|26799874|P2|Overall Study|Change in surgical procedure|1
7705702|NCT01106846|26799875|P1|Overall Study|Change in surgical procedure|0
7705703|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7705704|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7705705|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7705706|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Other|4
7705707|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Other|3
7705708|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Other|8
7705709|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7705710|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7705711|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7705712|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
7705713|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7705714|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7705715|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
7705716|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
7705717|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
7705718|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7705719|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7705720|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7705721|NCT01106690|26799925|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
7705722|NCT01106690|26799926|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
7705723|NCT01106690|26799927|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
7705724|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Other|6
7705725|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Other|2
7705726|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Other|10
7705727|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7705728|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7705729|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
7705730|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7705731|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7705732|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7705733|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7705734|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7705735|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7705736|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
7705737|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
7705738|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
7705739|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
7705740|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
7705741|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
7705742|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Protocol Violation|0
7705743|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Protocol Violation|0
7705744|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Protocol Violation|1
7705745|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
7705746|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
7705747|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
7705748|NCT01106690|26799925|P3|Core Period: Baseline to Week 26|Adverse Event|4
7705749|NCT01106690|26799926|P2|Core Period: Baseline to Week 26|Adverse Event|1
7705750|NCT01106690|26799927|P1|Core Period: Baseline to Week 26|Adverse Event|6
7705751|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Other|5
7705752|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Other|8
7705753|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Other|5
7705754|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Other|6
7705755|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7705756|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7705757|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7705758|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7705759|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7705760|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
7705761|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
7705762|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7705763|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7705764|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
7705765|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
7705766|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7705767|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
7705768|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
7705769|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
7705770|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
7705771|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
7705772|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
7705773|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
7705774|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
7705775|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7705776|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7705777|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7705778|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7705779|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
7705780|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
7705781|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
7705782|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
7705783|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Death|1
7705784|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Death|0
7705785|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Death|0
7705786|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Death|0
7705787|NCT01106677|26799963|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
7705788|NCT01106677|26799964|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
7705789|NCT01106677|26799965|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
7705790|NCT01106677|26799966|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
7705791|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Pregnancy|0
7705792|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Pregnancy|0
7705793|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Pregnancy|1
7705794|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Pregnancy|0
7705795|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Other|23
7705796|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Other|8
7705797|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Other|14
7705798|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Other|8
7705799|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Product quality complaint|0
7705800|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Product quality complaint|1
7705801|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Product quality complaint|1
7705802|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Product quality complaint|0
7705803|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
7705804|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
7705805|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
7705806|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
7705807|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7705808|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7705809|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
7705810|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7705811|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
7705812|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
7705813|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
7705814|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
7705815|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
7705816|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
7705817|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7705818|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
7705819|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Protocol Violation|3
7705820|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Protocol Violation|0
7705821|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Protocol Violation|1
7705822|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Protocol Violation|0
7705823|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Physician Decision|1
7705824|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Physician Decision|3
7705825|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Physician Decision|1
7705826|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Physician Decision|2
7705827|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
7705828|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
7705829|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
7705830|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
7705831|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
7705832|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
7705833|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
7705834|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
7705835|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Death|0
7705836|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Death|1
7705837|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Death|0
7705838|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Death|0
7705839|NCT01106677|26799963|P4|Core Period: Baseline to Week 26|Adverse Event|8
7705840|NCT01106677|26799964|P3|Core Period: Baseline to Week 26|Adverse Event|6
7705841|NCT01106677|26799965|P2|Core Period: Baseline to Week 26|Adverse Event|18
7705842|NCT01106677|26799966|P1|Core Period: Baseline to Week 26|Adverse Event|7
7705843|NCT01106651|26800029|P3|Overall Study|Death|0
7705844|NCT01106651|26800030|P2|Overall Study|Death|3
7705845|NCT01106651|26800031|P1|Overall Study|Death|0
7705846|NCT01106651|26800029|P3|Overall Study|Other|21
7705847|NCT01106651|26800030|P2|Overall Study|Other|31
7705848|NCT01106651|26800031|P1|Overall Study|Other|34
7705849|NCT01106651|26800029|P3|Overall Study|Noncompliance with study drug|2
7705850|NCT01106651|26800030|P2|Overall Study|Noncompliance with study drug|0
7705851|NCT01106651|26800031|P1|Overall Study|Noncompliance with study drug|1
7705852|NCT01106651|26800029|P3|Overall Study|Withdrawal by Subject|4
7705853|NCT01106651|26800030|P2|Overall Study|Withdrawal by Subject|7
7705854|NCT01106651|26800031|P1|Overall Study|Withdrawal by Subject|14
7705855|NCT01106651|26800029|P3|Overall Study|Protocol Violation|1
7705856|NCT01106651|26800030|P2|Overall Study|Protocol Violation|2
7705857|NCT01106651|26800031|P1|Overall Study|Protocol Violation|1
7705858|NCT01106651|26800029|P3|Overall Study|Physician Decision|1
7705859|NCT01106651|26800030|P2|Overall Study|Physician Decision|3
7705860|NCT01106651|26800031|P1|Overall Study|Physician Decision|4
7705861|NCT01106651|26800029|P3|Overall Study|Lost to Follow-up|6
7705862|NCT01106651|26800030|P2|Overall Study|Lost to Follow-up|2
7705863|NCT01106651|26800031|P1|Overall Study|Lost to Follow-up|8
7705864|NCT01106651|26800029|P3|Overall Study|Adverse Event|23
7705865|NCT01106651|26800030|P2|Overall Study|Adverse Event|9
7705866|NCT01106651|26800031|P1|Overall Study|Adverse Event|17
7705867|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Other|4
7705868|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Other|5
7705869|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Other|5
7705870|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7705871|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7705872|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7705873|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
7705874|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
7705875|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
7705876|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7705877|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7705878|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
7705879|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
7705880|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
7705881|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
7705882|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
7705883|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
7705884|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
7705885|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7705886|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
7705887|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7705888|NCT01106625|26800084|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
7705889|NCT01106625|26800085|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
7705890|NCT01106625|26800086|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
7705891|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Other|4
7705892|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Other|7
7705893|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Other|8
7705894|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7705895|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7705896|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7705897|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
7705898|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
7705899|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
7705900|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7705901|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7705902|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
7705903|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
7705904|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
7705905|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
7705906|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Protocol Violation|3
7705907|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Protocol Violation|1
7705908|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Protocol Violation|2
7705909|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Physician Decision|0
7705910|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Physician Decision|0
7705911|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Physician Decision|1
7705912|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
7705913|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
7705914|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
7705915|NCT01106625|26800084|P3|Core Period: Baseline to Week 26|Adverse Event|8
7705916|NCT01106625|26800085|P2|Core Period: Baseline to Week 26|Adverse Event|8
7705917|NCT01106625|26800086|P1|Core Period: Baseline to Week 26|Adverse Event|6
7705918|NCT01106586|26800117|P2|Overall Study|Participant Transferred to Another Study|197
7705919|NCT01106586|26800118|P1|Overall Study|Participant Transferred to Another Study|212
7705920|NCT01106586|26800117|P2|Overall Study|Protocol Violation|0
7705921|NCT01106586|26800118|P1|Overall Study|Protocol Violation|1
7705922|NCT01106586|26800117|P2|Overall Study|Participant Noncompliance|10
7705923|NCT01106586|26800118|P1|Overall Study|Participant Noncompliance|12
7705924|NCT01106586|26800117|P2|Overall Study|Lost to Follow-up|20
7705925|NCT01106586|26800118|P1|Overall Study|Lost to Follow-up|24
7705926|NCT01106586|26800117|P2|Overall Study|Withdrew Consent|30
7705927|NCT01106586|26800118|P1|Overall Study|Withdrew Consent|18
7705928|NCT01106586|26800117|P2|Overall Study|Investigator's Discretion|8
7705929|NCT01106586|26800118|P1|Overall Study|Investigator's Discretion|5
7705930|NCT01106586|26800117|P2|Overall Study|Lack of Efficacy|0
7705931|NCT01106586|26800118|P1|Overall Study|Lack of Efficacy|1
7705932|NCT01106586|26800117|P2|Overall Study|Pregnancy|2
7705933|NCT01106586|26800118|P1|Overall Study|Pregnancy|2
7705934|NCT01106586|26800117|P2|Overall Study|Death|3
7705935|NCT01106586|26800118|P1|Overall Study|Death|1
7705936|NCT01106586|26800117|P2|Overall Study|Adverse Event|15
7705937|NCT01106586|26800118|P1|Overall Study|Adverse Event|9
7705938|NCT01106534|26800136|P1|Overall Study|Physician Decision|1
7705939|NCT01106534|26800136|P1|Overall Study|Death|16
7705940|NCT01106534|26800136|P1|Overall Study|Lost to Follow-up|2
7705941|NCT01106534|26800136|P1|Overall Study|Withdrawal by Subject|18
7705942|NCT01106430|26800168|P2|Overall Study|Withdrawal by Subject|4
7705943|NCT01106430|26800169|P1|Overall Study|Withdrawal by Subject|8
7705944|NCT01106430|26800168|P2|Overall Study|Protocol Violation|2
7705945|NCT01106430|26800169|P1|Overall Study|Protocol Violation|7
7705946|NCT01106430|26800168|P2|Overall Study|Previous Use Of Marijuana|0
7705947|NCT01106430|26800169|P1|Overall Study|Previous Use Of Marijuana|1
7705948|NCT01106430|26800168|P2|Overall Study|Hard Time Swallowing The Pills|0
7705949|NCT01106430|26800169|P1|Overall Study|Hard Time Swallowing The Pills|1
7705950|NCT01106430|26800168|P2|Overall Study|Noncompliance|1
7705951|NCT01106430|26800169|P1|Overall Study|Noncompliance|0
7705952|NCT01106430|26800168|P2|Overall Study|Refused To Take Medication|1
7705953|NCT01106430|26800169|P1|Overall Study|Refused To Take Medication|0
7705954|NCT01106430|26800168|P2|Overall Study|Moved Out Of State|1
7705955|NCT01106430|26800169|P1|Overall Study|Moved Out Of State|0
7705956|NCT01106430|26800168|P2|Overall Study|Early Termination Requested By Sponsor|0
7705957|NCT01106430|26800169|P1|Overall Study|Early Termination Requested By Sponsor|1
7705958|NCT01106430|26800168|P2|Overall Study|Lost to Follow-up|1
7705959|NCT01106430|26800169|P1|Overall Study|Lost to Follow-up|5
7705960|NCT01106430|26800168|P2|Overall Study|Lack of Efficacy|13
7705961|NCT01106430|26800169|P1|Overall Study|Lack of Efficacy|2
7705962|NCT01106430|26800168|P2|Overall Study|Adverse Event|10
7705963|NCT01106430|26800169|P1|Overall Study|Adverse Event|8
7705964|NCT01106404|26800191|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
7705965|NCT01106404|26800192|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
7705966|NCT01106404|26800191|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
7705967|NCT01106404|26800192|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
7705968|NCT01106404|26800191|P2|Period I (First 6 Weeks)|Physician Decision|0
7705969|NCT01106404|26800192|P1|Period I (First 6 Weeks)|Physician Decision|1
7705970|NCT01106404|26800191|P2|Period I (First 6 Weeks)|Adverse Event|0
7705971|NCT01106404|26800192|P1|Period I (First 6 Weeks)|Adverse Event|2
7705972|NCT01106352|26800215|P5|Overall Study|Home hospice since July 2013|0
7705973|NCT01106352|26800216|P4|Overall Study|Home hospice since July 2013|1
7705974|NCT01106352|26800217|P3|Overall Study|Home hospice since July 2013|0
7705975|NCT01106352|26800218|P2|Overall Study|Home hospice since July 2013|0
7705976|NCT01106352|26800219|P1|Overall Study|Home hospice since July 2013|0
7705977|NCT01106352|26800215|P5|Overall Study|Subject entered hospice|0
7705978|NCT01106352|26800216|P4|Overall Study|Subject entered hospice|1
7705979|NCT01106352|26800217|P3|Overall Study|Subject entered hospice|0
7705980|NCT01106352|26800218|P2|Overall Study|Subject entered hospice|0
7705981|NCT01106352|26800219|P1|Overall Study|Subject entered hospice|0
7705982|NCT01106352|26800215|P5|Overall Study|Went on hospice|0
7705983|NCT01106352|26800216|P4|Overall Study|Went on hospice|1
7705984|NCT01106352|26800217|P3|Overall Study|Went on hospice|0
7705985|NCT01106352|26800218|P2|Overall Study|Went on hospice|0
7705986|NCT01106352|26800219|P1|Overall Study|Went on hospice|0
7705987|NCT01106352|26800215|P5|Overall Study|Withdrawal by Subject|2
7705988|NCT01106352|26800216|P4|Overall Study|Withdrawal by Subject|3
7705989|NCT01106352|26800217|P3|Overall Study|Withdrawal by Subject|0
7705990|NCT01106352|26800218|P2|Overall Study|Withdrawal by Subject|0
7705991|NCT01106352|26800219|P1|Overall Study|Withdrawal by Subject|0
7705992|NCT01106352|26800215|P5|Overall Study|Disease progression|0
7705993|NCT01106352|26800216|P4|Overall Study|Disease progression|1
7705994|NCT01106352|26800217|P3|Overall Study|Disease progression|0
7705995|NCT01106352|26800218|P2|Overall Study|Disease progression|0
7705996|NCT01106352|26800219|P1|Overall Study|Disease progression|0
7705997|NCT01106352|26800215|P5|Overall Study|Death|1
7705998|NCT01106352|26800216|P4|Overall Study|Death|3
7705999|NCT01106352|26800217|P3|Overall Study|Death|1
7706000|NCT01106352|26800218|P2|Overall Study|Death|0
7706001|NCT01106352|26800219|P1|Overall Study|Death|0
7706002|NCT01106352|26800215|P5|Overall Study|Lost to Follow-up|1
7706003|NCT01106352|26800216|P4|Overall Study|Lost to Follow-up|0
7706004|NCT01106352|26800217|P3|Overall Study|Lost to Follow-up|0
7706005|NCT01106352|26800218|P2|Overall Study|Lost to Follow-up|0
7706006|NCT01106352|26800219|P1|Overall Study|Lost to Follow-up|0
7706007|NCT01106352|26800215|P5|Overall Study|Too ill to come in for the visit|0
7706008|NCT01106352|26800216|P4|Overall Study|Too ill to come in for the visit|0
7706009|NCT01106352|26800217|P3|Overall Study|Too ill to come in for the visit|1
7706010|NCT01106352|26800218|P2|Overall Study|Too ill to come in for the visit|0
7706011|NCT01106352|26800219|P1|Overall Study|Too ill to come in for the visit|0
7706012|NCT01106352|26800215|P5|Overall Study|Sponsor Decision|0
7706013|NCT01106352|26800216|P4|Overall Study|Sponsor Decision|0
7706014|NCT01106352|26800217|P3|Overall Study|Sponsor Decision|0
7706015|NCT01106352|26800218|P2|Overall Study|Sponsor Decision|0
7706016|NCT01106352|26800219|P1|Overall Study|Sponsor Decision|1
7706017|NCT01106352|26800215|P5|Overall Study|Subjects untreated|4
7706018|NCT01106352|26800216|P4|Overall Study|Subjects untreated|3
7706019|NCT01106352|26800217|P3|Overall Study|Subjects untreated|0
7706020|NCT01106352|26800218|P2|Overall Study|Subjects untreated|0
7706021|NCT01106352|26800219|P1|Overall Study|Subjects untreated|0
7706022|NCT01106287|26800315|P4|Overall Study|Adverse Event|0
7706023|NCT01106287|26800316|P3|Overall Study|Adverse Event|0
7706024|NCT01106287|26800317|P2|Overall Study|Adverse Event|0
7706025|NCT01106287|26800318|P1|Overall Study|Adverse Event|1
7706026|NCT01106248|26800338|P1|Overall Study|Administrative|2
7706027|NCT01106248|26800338|P1|Overall Study|Adverse Event|1
7706028|NCT01106157|26800346|P2|Overall Study|Withdrawal by Subject|0
7706029|NCT01106157|26800347|P1|Overall Study|Withdrawal by Subject|1
7706030|NCT01106092|26800375|P4|Overall Study|Withdrawal by Subject|1
7706031|NCT01106092|26800376|P3|Overall Study|Withdrawal by Subject|0
7706032|NCT01106092|26800377|P2|Overall Study|Withdrawal by Subject|0
7706033|NCT01106092|26800378|P1|Overall Study|Withdrawal by Subject|0
7706034|NCT01106027|26800461|P1|Overall Study|Lost graft early, discontinued|1
7706035|NCT01106014|26800467|P2|Overall Study|Lost to Follow-up|3
7706036|NCT01106014|26800468|P1|Overall Study|Lost to Follow-up|2
7706037|NCT01106014|26800467|P2|Overall Study|Administrative reason|6
7706038|NCT01106014|26800468|P1|Overall Study|Administrative reason|7
7706039|NCT01106014|26800467|P2|Overall Study|Withdrawal by Subject|37
7706040|NCT01106014|26800468|P1|Overall Study|Withdrawal by Subject|43
7706041|NCT01106014|26800467|P2|Overall Study|Adverse Event|42
7706042|NCT01106014|26800468|P1|Overall Study|Adverse Event|78
7706043|NCT01106014|26800467|P2|Overall Study|Morbidity or Mortality primary endpoint|242
7706044|NCT01106014|26800468|P1|Overall Study|Morbidity or Mortality primary endpoint|155
7706045|NCT01105975|26800488|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7706046|NCT01105975|26800489|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
7706047|NCT01105975|26800490|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7706048|NCT01105975|26800491|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7706049|NCT01105975|26800492|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
7706050|NCT01105975|26800493|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7706051|NCT01105975|26800494|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7706052|NCT01105975|26800495|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7706053|NCT01105975|26800496|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7706054|NCT01105975|26800497|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7706055|NCT01105975|26800488|P10|Overall Study|Protocol Violation|2
7706056|NCT01105975|26800489|P9|Overall Study|Protocol Violation|2
7706057|NCT01105975|26800490|P8|Overall Study|Protocol Violation|1
7706058|NCT01105975|26800491|P7|Overall Study|Protocol Violation|1
7706059|NCT01105975|26800492|P6|Overall Study|Protocol Violation|1
7706060|NCT01105975|26800493|P5|Overall Study|Protocol Violation|1
7706061|NCT01105975|26800494|P4|Overall Study|Protocol Violation|0
7706062|NCT01105975|26800495|P3|Overall Study|Protocol Violation|2
7706063|NCT01105975|26800496|P2|Overall Study|Protocol Violation|2
7706064|NCT01105975|26800497|P1|Overall Study|Protocol Violation|0
7706065|NCT01105975|26800488|P10|Overall Study|Physician Decision|0
7706066|NCT01105975|26800489|P9|Overall Study|Physician Decision|0
7706067|NCT01105975|26800490|P8|Overall Study|Physician Decision|0
7706068|NCT01105975|26800491|P7|Overall Study|Physician Decision|2
7706069|NCT01105975|26800492|P6|Overall Study|Physician Decision|0
7706070|NCT01105975|26800493|P5|Overall Study|Physician Decision|0
7706071|NCT01105975|26800494|P4|Overall Study|Physician Decision|0
7706072|NCT01105975|26800495|P3|Overall Study|Physician Decision|0
7706073|NCT01105975|26800496|P2|Overall Study|Physician Decision|0
7706074|NCT01105975|26800497|P1|Overall Study|Physician Decision|0
7706075|NCT01105975|26800488|P10|Overall Study|Lost to Follow-up|0
7706076|NCT01105975|26800489|P9|Overall Study|Lost to Follow-up|1
7706077|NCT01105975|26800490|P8|Overall Study|Lost to Follow-up|0
7706078|NCT01105975|26800491|P7|Overall Study|Lost to Follow-up|0
7706079|NCT01105975|26800492|P6|Overall Study|Lost to Follow-up|0
7706080|NCT01105975|26800493|P5|Overall Study|Lost to Follow-up|1
7706081|NCT01105975|26800494|P4|Overall Study|Lost to Follow-up|1
7706082|NCT01105975|26800495|P3|Overall Study|Lost to Follow-up|0
7706083|NCT01105975|26800496|P2|Overall Study|Lost to Follow-up|0
7706084|NCT01105975|26800497|P1|Overall Study|Lost to Follow-up|1
7706085|NCT01105975|26800488|P10|Overall Study|Withdrawal by Subject|3
7706086|NCT01105975|26800489|P9|Overall Study|Withdrawal by Subject|0
7706087|NCT01105975|26800490|P8|Overall Study|Withdrawal by Subject|1
7706088|NCT01105975|26800491|P7|Overall Study|Withdrawal by Subject|2
7706089|NCT01105975|26800492|P6|Overall Study|Withdrawal by Subject|1
7706090|NCT01105975|26800493|P5|Overall Study|Withdrawal by Subject|4
7706091|NCT01105975|26800494|P4|Overall Study|Withdrawal by Subject|0
7706092|NCT01105975|26800495|P3|Overall Study|Withdrawal by Subject|2
7706093|NCT01105975|26800496|P2|Overall Study|Withdrawal by Subject|2
7706094|NCT01105975|26800497|P1|Overall Study|Withdrawal by Subject|2
7706095|NCT01105975|26800488|P10|Overall Study|Adverse Event|4
7706096|NCT01105975|26800489|P9|Overall Study|Adverse Event|1
7706097|NCT01105975|26800490|P8|Overall Study|Adverse Event|4
7706098|NCT01105975|26800491|P7|Overall Study|Adverse Event|2
7706099|NCT01105975|26800492|P6|Overall Study|Adverse Event|1
7706100|NCT01105975|26800493|P5|Overall Study|Adverse Event|0
7706101|NCT01105975|26800494|P4|Overall Study|Adverse Event|1
7706102|NCT01105975|26800495|P3|Overall Study|Adverse Event|5
7706103|NCT01105975|26800496|P2|Overall Study|Adverse Event|1
7706104|NCT01105975|26800497|P1|Overall Study|Adverse Event|2
7706105|NCT01105936|26800645|P4|Period 3|Protocol Violation|0
7706106|NCT01105936|26800646|P3|Period 3|Protocol Violation|0
7706107|NCT01105936|26800647|P2|Period 3|Protocol Violation|2
7706108|NCT01105936|26800648|P1|Period 3|Protocol Violation|0
7706109|NCT01105936|26800645|P4|Period 2|Adverse Event|0
7706110|NCT01105936|26800646|P3|Period 2|Adverse Event|0
7706111|NCT01105936|26800647|P2|Period 2|Adverse Event|0
7706112|NCT01105936|26800648|P1|Period 2|Adverse Event|1
7706113|NCT01105936|26800645|P4|Period 1|Adverse Event|1
7706114|NCT01105936|26800646|P3|Period 1|Adverse Event|0
7706115|NCT01105936|26800647|P2|Period 1|Adverse Event|0
7706116|NCT01105936|26800648|P1|Period 1|Adverse Event|0
7706117|NCT01105767|26800677|P3|Overall Study|Lost to Follow-up|1184
7706118|NCT01105767|26800678|P2|Overall Study|Lost to Follow-up|1614
7706119|NCT01105767|26800679|P1|Overall Study|Lost to Follow-up|1160
7706120|NCT01105533|26800731|P9|Overall Study|Physician Decision|0
7706121|NCT01105533|26800732|P8|Overall Study|Physician Decision|1
7706122|NCT01105533|26800733|P7|Overall Study|Physician Decision|0
7706123|NCT01105533|26800734|P6|Overall Study|Physician Decision|0
7706124|NCT01105533|26800735|P5|Overall Study|Physician Decision|0
7706125|NCT01105533|26800736|P4|Overall Study|Physician Decision|0
7706126|NCT01105533|26800737|P3|Overall Study|Physician Decision|0
7706127|NCT01105533|26800738|P2|Overall Study|Physician Decision|0
7706128|NCT01105533|26800739|P1|Overall Study|Physician Decision|0
7706129|NCT01105533|26800731|P9|Overall Study|Other|2
7706130|NCT01105533|26800732|P8|Overall Study|Other|1
7706131|NCT01105533|26800733|P7|Overall Study|Other|3
7706132|NCT01105533|26800734|P6|Overall Study|Other|0
7706133|NCT01105533|26800735|P5|Overall Study|Other|1
7706134|NCT01105533|26800736|P4|Overall Study|Other|0
7706135|NCT01105533|26800737|P3|Overall Study|Other|0
7706136|NCT01105533|26800738|P2|Overall Study|Other|0
7706137|NCT01105533|26800739|P1|Overall Study|Other|0
7706138|NCT01105533|26800731|P9|Overall Study|Adverse Event|1
7706139|NCT01105533|26800732|P8|Overall Study|Adverse Event|0
7706140|NCT01105533|26800733|P7|Overall Study|Adverse Event|2
7706141|NCT01105533|26800734|P6|Overall Study|Adverse Event|2
7706142|NCT01105533|26800735|P5|Overall Study|Adverse Event|1
7706143|NCT01105533|26800736|P4|Overall Study|Adverse Event|0
7706144|NCT01105533|26800737|P3|Overall Study|Adverse Event|0
7706145|NCT01105533|26800738|P2|Overall Study|Adverse Event|0
7706146|NCT01105533|26800739|P1|Overall Study|Adverse Event|0
7706147|NCT01105533|26800731|P9|Overall Study|Lack of Efficacy|9
7706148|NCT01105533|26800732|P8|Overall Study|Lack of Efficacy|2
7706149|NCT01105533|26800733|P7|Overall Study|Lack of Efficacy|3
7706150|NCT01105533|26800734|P6|Overall Study|Lack of Efficacy|5
7706151|NCT01105533|26800735|P5|Overall Study|Lack of Efficacy|4
7706152|NCT01105533|26800736|P4|Overall Study|Lack of Efficacy|3
7706153|NCT01105533|26800737|P3|Overall Study|Lack of Efficacy|3
7706154|NCT01105533|26800738|P2|Overall Study|Lack of Efficacy|1
7706155|NCT01105533|26800739|P1|Overall Study|Lack of Efficacy|1
7706156|NCT01105533|26800731|P9|Overall Study|Death|0
7706157|NCT01105533|26800732|P8|Overall Study|Death|0
7706158|NCT01105533|26800733|P7|Overall Study|Death|0
7706159|NCT01105533|26800734|P6|Overall Study|Death|0
7706160|NCT01105533|26800735|P5|Overall Study|Death|1
7706161|NCT01105533|26800736|P4|Overall Study|Death|0
7706162|NCT01105533|26800737|P3|Overall Study|Death|0
7706163|NCT01105533|26800738|P2|Overall Study|Death|0
7706164|NCT01105533|26800739|P1|Overall Study|Death|0
7706165|NCT01105377|26800829|P2|Overall Study|Withdrawal by Subject|1
7706166|NCT01105377|26800830|P1|Overall Study|Withdrawal by Subject|0
7706167|NCT01105130|26800878|P3|Overall Study|Multiple Reasons|2
7706168|NCT01105130|26800879|P2|Overall Study|Multiple Reasons|0
7706169|NCT01105130|26800880|P1|Overall Study|Multiple Reasons|3
7706170|NCT01105130|26800878|P3|Overall Study|Toxicity|2
7706171|NCT01105130|26800879|P2|Overall Study|Toxicity|3
7706172|NCT01105130|26800880|P1|Overall Study|Toxicity|1
7706173|NCT01105130|26800878|P3|Overall Study|Never Started|4
7706174|NCT01105130|26800879|P2|Overall Study|Never Started|2
7706175|NCT01105130|26800880|P1|Overall Study|Never Started|2
7706176|NCT01105130|26800878|P3|Overall Study|Withdrawal by Subject|2
7706177|NCT01105130|26800879|P2|Overall Study|Withdrawal by Subject|6
7706178|NCT01105130|26800880|P1|Overall Study|Withdrawal by Subject|4
7706179|NCT01105091|26800910|P2|Overall Study|Death|0
7706180|NCT01105091|26800911|P1|Overall Study|Death|2
7706181|NCT01105065|26800935|P1|Overall Study|Technical Problems|1
7706182|NCT01105065|26800935|P1|Overall Study|Adverse Event|5
7706183|NCT01104870|26800944|P3|Overall Study|Withdrawal by Subject|1
7706184|NCT01104870|26800945|P2|Overall Study|Withdrawal by Subject|0
7706185|NCT01104870|26800946|P1|Overall Study|Withdrawal by Subject|0
7706186|NCT01104870|26800944|P3|Overall Study|Death|1
7706187|NCT01104870|26800945|P2|Overall Study|Death|0
7706188|NCT01104870|26800946|P1|Overall Study|Death|0
7706189|NCT01104870|26800944|P3|Overall Study|Adverse Event|0
7706190|NCT01104870|26800945|P2|Overall Study|Adverse Event|1
7706191|NCT01104870|26800946|P1|Overall Study|Adverse Event|1
7706192|NCT01104792|26800975|P1|Overall Study|Did Not Meet Eligibility Criteria|133
7706193|NCT01104792|26800975|P1|Overall Study|Reasons Not Specified|27
7706194|NCT01104792|26800975|P1|Overall Study|Lost to Follow-up|43
7706195|NCT01104792|26800975|P1|Overall Study|Withdrawal of Consent|179
7706196|NCT01104792|26800975|P1|Overall Study|Protocol Violation|45
7706197|NCT01104792|26800975|P1|Overall Study|Insufficient Therapeutic Response|22
7706198|NCT01104792|26800975|P1|Overall Study|Adverse Event|77
7706199|NCT01104779|26800983|P3|Overall Study|Withdrawal by Subject|32
7706200|NCT01104779|26800984|P2|Overall Study|Withdrawal by Subject|25
7706201|NCT01104779|26800985|P1|Overall Study|Withdrawal by Subject|16
7706202|NCT01104779|26800983|P3|Overall Study|Lost to Follow-up|1
7706203|NCT01104779|26800984|P2|Overall Study|Lost to Follow-up|0
7706204|NCT01104779|26800985|P1|Overall Study|Lost to Follow-up|2
7706205|NCT01104779|26800983|P3|Overall Study|Other reasons|0
7706206|NCT01104779|26800984|P2|Overall Study|Other reasons|1
7706207|NCT01104779|26800985|P1|Overall Study|Other reasons|0
7706208|NCT01104779|26800983|P3|Overall Study|Did not meet inc/exc criteria|1
7706209|NCT01104779|26800984|P2|Overall Study|Did not meet inc/exc criteria|1
7706210|NCT01104779|26800985|P1|Overall Study|Did not meet inc/exc criteria|1
7706211|NCT01104779|26800983|P3|Overall Study|Adverse Event|13
7706212|NCT01104779|26800984|P2|Overall Study|Adverse Event|14
7706213|NCT01104779|26800985|P1|Overall Study|Adverse Event|13
7706214|NCT01104779|26800983|P3|Overall Study|Lack of Efficacy|13
7706215|NCT01104779|26800984|P2|Overall Study|Lack of Efficacy|12
7706216|NCT01104779|26800985|P1|Overall Study|Lack of Efficacy|26
7706217|NCT01104779|26800983|P3|Overall Study|Protocol Violation|2
7706218|NCT01104779|26800984|P2|Overall Study|Protocol Violation|2
7706219|NCT01104779|26800985|P1|Overall Study|Protocol Violation|1
7706220|NCT01104766|26801000|P4|Overall Study|Lost to Follow-up|1
7706221|NCT01104766|26801001|P3|Overall Study|Lost to Follow-up|1
7706222|NCT01104766|26801002|P2|Overall Study|Lost to Follow-up|2
7706223|NCT01104766|26801003|P1|Overall Study|Lost to Follow-up|1
7706224|NCT01104766|26801000|P4|Overall Study|Withdrawal by Subject|15
7706225|NCT01104766|26801001|P3|Overall Study|Withdrawal by Subject|25
7706226|NCT01104766|26801002|P2|Overall Study|Withdrawal by Subject|19
7706227|NCT01104766|26801003|P1|Overall Study|Withdrawal by Subject|17
7706228|NCT01104766|26801000|P4|Overall Study|Protocol Violation|0
7706229|NCT01104766|26801001|P3|Overall Study|Protocol Violation|0
7706230|NCT01104766|26801002|P2|Overall Study|Protocol Violation|0
7706231|NCT01104766|26801003|P1|Overall Study|Protocol Violation|2
7706232|NCT01104766|26801000|P4|Overall Study|Lack of Efficacy|8
7706233|NCT01104766|26801001|P3|Overall Study|Lack of Efficacy|14
7706234|NCT01104766|26801002|P2|Overall Study|Lack of Efficacy|15
7706235|NCT01104766|26801003|P1|Overall Study|Lack of Efficacy|20
7706236|NCT01104766|26801000|P4|Overall Study|Adverse Event|14
7706237|NCT01104766|26801001|P3|Overall Study|Adverse Event|20
7706238|NCT01104766|26801002|P2|Overall Study|Adverse Event|15
7706239|NCT01104766|26801003|P1|Overall Study|Adverse Event|17
7706240|NCT01104766|26801000|P4|Overall Study|Did not meet inc/exc criteria|0
7706241|NCT01104766|26801001|P3|Overall Study|Did not meet inc/exc criteria|0
7706242|NCT01104766|26801002|P2|Overall Study|Did not meet inc/exc criteria|0
7706243|NCT01104766|26801003|P1|Overall Study|Did not meet inc/exc criteria|1
7706244|NCT01104701|26801021|P4|Overall Study|Physician Decision|0
7706245|NCT01104701|26801022|P3|Overall Study|Physician Decision|0
7706246|NCT01104701|26801023|P2|Overall Study|Physician Decision|2
7706247|NCT01104701|26801024|P1|Overall Study|Physician Decision|0
7706248|NCT01104701|26801021|P4|Overall Study|Adverse Event|1
7706249|NCT01104701|26801022|P3|Overall Study|Adverse Event|0
7706250|NCT01104701|26801023|P2|Overall Study|Adverse Event|0
7706251|NCT01104701|26801024|P1|Overall Study|Adverse Event|0
7706252|NCT01104701|26801021|P4|Overall Study|Withdrawal by Subject|1
7706253|NCT01104701|26801022|P3|Overall Study|Withdrawal by Subject|2
7706254|NCT01104701|26801023|P2|Overall Study|Withdrawal by Subject|1
7706255|NCT01104701|26801024|P1|Overall Study|Withdrawal by Subject|0
7706256|NCT01104662|26801086|P8|Overall Study|Randomized but not treated|0
7706257|NCT01104662|26801087|P7|Overall Study|Randomized but not treated|0
7706258|NCT01104662|26801088|P6|Overall Study|Randomized but not treated|1
7706259|NCT01104662|26801089|P5|Overall Study|Randomized but not treated|0
7706260|NCT01104662|26801090|P4|Overall Study|Randomized but not treated|0
7706261|NCT01104662|26801091|P3|Overall Study|Randomized but not treated|1
7706262|NCT01104662|26801092|P2|Overall Study|Randomized but not treated|4
7706263|NCT01104662|26801093|P1|Overall Study|Randomized but not treated|3
7706264|NCT01104662|26801086|P8|Overall Study|Reason not specified|0
7706265|NCT01104662|26801087|P7|Overall Study|Reason not specified|0
7706266|NCT01104662|26801088|P6|Overall Study|Reason not specified|1
7706267|NCT01104662|26801089|P5|Overall Study|Reason not specified|0
7706268|NCT01104662|26801090|P4|Overall Study|Reason not specified|0
7706269|NCT01104662|26801091|P3|Overall Study|Reason not specified|0
7706270|NCT01104662|26801092|P2|Overall Study|Reason not specified|3
7706271|NCT01104662|26801093|P1|Overall Study|Reason not specified|3
7706272|NCT01104662|26801086|P8|Overall Study|Participant left investigator's care|0
7706273|NCT01104662|26801087|P7|Overall Study|Participant left investigator's care|0
7706274|NCT01104662|26801088|P6|Overall Study|Participant left investigator's care|0
7706275|NCT01104662|26801089|P5|Overall Study|Participant left investigator's care|0
7706276|NCT01104662|26801090|P4|Overall Study|Participant left investigator's care|0
7706277|NCT01104662|26801091|P3|Overall Study|Participant left investigator's care|0
7706278|NCT01104662|26801092|P2|Overall Study|Participant left investigator's care|1
7706279|NCT01104662|26801093|P1|Overall Study|Participant left investigator's care|1
7706280|NCT01104662|26801086|P8|Overall Study|Clinical Failure|0
7706281|NCT01104662|26801087|P7|Overall Study|Clinical Failure|0
7706282|NCT01104662|26801088|P6|Overall Study|Clinical Failure|1
7706283|NCT01104662|26801089|P5|Overall Study|Clinical Failure|0
7706284|NCT01104662|26801090|P4|Overall Study|Clinical Failure|0
7706285|NCT01104662|26801091|P3|Overall Study|Clinical Failure|0
7706286|NCT01104662|26801092|P2|Overall Study|Clinical Failure|0
7706287|NCT01104662|26801093|P1|Overall Study|Clinical Failure|1
7706288|NCT01104662|26801086|P8|Overall Study|Adverse Event|0
7706289|NCT01104662|26801087|P7|Overall Study|Adverse Event|0
7706290|NCT01104662|26801088|P6|Overall Study|Adverse Event|1
7706291|NCT01104662|26801089|P5|Overall Study|Adverse Event|1
7706292|NCT01104662|26801090|P4|Overall Study|Adverse Event|1
7706293|NCT01104662|26801091|P3|Overall Study|Adverse Event|0
7706294|NCT01104662|26801092|P2|Overall Study|Adverse Event|2
7706295|NCT01104662|26801093|P1|Overall Study|Adverse Event|2
7706296|NCT01104636|26801119|P1|Overall Study|Ongoing|21
7706297|NCT01104636|26801119|P1|Overall Study|Adverse Event|40
7706298|NCT01104636|26801119|P1|Overall Study|Pregnancy|2
7706299|NCT01104636|26801119|P1|Overall Study|Study terminated by sponsor|1
7706300|NCT01104636|26801119|P1|Overall Study|Other|43
7706301|NCT01104636|26801119|P1|Overall Study|Withdrawal by Subject|4
7706302|NCT01104636|26801119|P1|Overall Study|Lost to Follow-up|24
7706303|NCT01104636|26801119|P1|Overall Study|Lack of Efficacy|43
7706304|NCT01104584|26801124|P1|Overall Study|Study prematurely discontinued|2
7706305|NCT01104584|26801124|P1|Overall Study|Study drug never administered|21
7706306|NCT01104558|26801194|P1|Overall Study|Missing of genetic analysis results|1
7706307|NCT01104558|26801194|P1|Overall Study|Missing of primary efficacy assessment|10
7706308|NCT01104558|26801194|P1|Overall Study|Protocol Violation|6
7706309|NCT01104545|26801238|P3|Overall Study|Adverse Event|2
7706310|NCT01104545|26801239|P2|Overall Study|Adverse Event|1
7706311|NCT01104545|26801240|P1|Overall Study|Adverse Event|0
7706312|NCT01104493|26801397|P2|Overall Study|Lost to Follow-up|2
7706313|NCT01104493|26801398|P1|Overall Study|Lost to Follow-up|0
7706314|NCT01104415|26801416|P2|Extension Period|Heart surgery/feeling miserable|1
7706315|NCT01104415|26801417|P1|Extension Period|Heart surgery/feeling miserable|0
7706316|NCT01104415|26801416|P2|Extension Period|Transition to Study LX1606.302|4
7706317|NCT01104415|26801417|P1|Extension Period|Transition to Study LX1606.302|0
7706318|NCT01104415|26801416|P2|Extension Period|Physician Decision|1
7706319|NCT01104415|26801417|P1|Extension Period|Physician Decision|0
7706320|NCT01104415|26801416|P2|Extension Period|Death|1
7706321|NCT01104415|26801417|P1|Extension Period|Death|0
7706322|NCT01104415|26801416|P2|Extension Period|Progressive disease|4
7706323|NCT01104415|26801417|P1|Extension Period|Progressive disease|0
7706324|NCT01104415|26801416|P2|Core Phase|Consent withdrawn by subjects|0
7706325|NCT01104415|26801417|P1|Core Phase|Consent withdrawn by subjects|1
7706326|NCT01104376|26801461|P1|Overall Study|Consented but excluded after labs|13
7706327|NCT01104376|26801461|P1|Overall Study|Withdrawal by Subject|15
7706328|NCT01104311|26801467|P2|Overall Study|Adverse Event|2
7706329|NCT01104311|26801468|P1|Overall Study|Adverse Event|1
7706330|NCT01104311|26801467|P2|Overall Study|low compliance|1
7706331|NCT01104311|26801468|P1|Overall Study|low compliance|1
7706332|NCT01104311|26801467|P2|Overall Study|Physician Decision|2
7706333|NCT01104311|26801468|P1|Overall Study|Physician Decision|2
7706334|NCT01104311|26801467|P2|Overall Study|Protocol Violation|1
7706335|NCT01104311|26801468|P1|Overall Study|Protocol Violation|0
7706336|NCT01104311|26801467|P2|Overall Study|Withdrawal by Subject|6
7706337|NCT01104311|26801468|P1|Overall Study|Withdrawal by Subject|6
7706338|NCT01104246|26801495|P1|Overall Study|did not meet inclusion criteria|4
7706339|NCT01104246|26801495|P1|Overall Study|Withdrawal by Subject|1
7706340|NCT01104155|26801510|P2|Overall Study|Other|4
7706341|NCT01104155|26801511|P1|Overall Study|Other|3
7706342|NCT01104155|26801510|P2|Overall Study|Withdrawal of consent|1
7706343|NCT01104155|26801511|P1|Overall Study|Withdrawal of consent|1
7706344|NCT01104155|26801510|P2|Overall Study|Participant choice|5
7706345|NCT01104155|26801511|P1|Overall Study|Participant choice|6
7706346|NCT01104155|26801510|P2|Overall Study|Adverse Event|8
7706347|NCT01104155|26801511|P1|Overall Study|Adverse Event|15
7706348|NCT01103960|26801563|P2|Overall Study|Other|0
7706349|NCT01103960|26801564|P1|Overall Study|Other|1
7706350|NCT01103960|26801563|P2|Overall Study|Withdrawal by Subject|1
7706351|NCT01103960|26801564|P1|Overall Study|Withdrawal by Subject|2
7706352|NCT01103960|26801563|P2|Overall Study|Adverse Event|1
7706353|NCT01103960|26801564|P1|Overall Study|Adverse Event|2
7706354|NCT01103778|26801599|P1|Overall Study|Screen failure|1
7706355|NCT01103778|26801599|P1|Overall Study|Proteinuria improved prior to enrollment|1
7706356|NCT01103778|26801599|P1|Overall Study|Lost to Follow-up|1
7706357|NCT01103713|26801606|P1|Overall Study|Other|1
7706358|NCT01103713|26801606|P1|Overall Study|Study terminated by sponsor|2
7706359|NCT01103713|26801606|P1|Overall Study|Withdrawal by Subject|8
7706360|NCT01103713|26801606|P1|Overall Study|Lost to Follow-up|2
7706361|NCT01103479|26801656|P3|Overall Study|Saw non-study physician|0
7706362|NCT01103479|26801657|P2|Overall Study|Saw non-study physician|0
7706363|NCT01103479|26801658|P1|Overall Study|Saw non-study physician|2
7706364|NCT01103479|26801656|P3|Overall Study|Active cancer|0
7706365|NCT01103479|26801657|P2|Overall Study|Active cancer|0
7706366|NCT01103479|26801658|P1|Overall Study|Active cancer|1
7706367|NCT01103479|26801656|P3|Overall Study|Family history of CRC|2
7706368|NCT01103479|26801657|P2|Overall Study|Family history of CRC|0
7706369|NCT01103479|26801658|P1|Overall Study|Family history of CRC|1
7706370|NCT01103479|26801656|P3|Overall Study|Up to date with CRC screening|12
7706371|NCT01103479|26801657|P2|Overall Study|Up to date with CRC screening|9
7706372|NCT01103479|26801658|P1|Overall Study|Up to date with CRC screening|1
7706373|NCT01103466|26801671|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
7706374|NCT01103466|26801672|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
7706375|NCT01103466|26801673|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
7706376|NCT01103466|26801671|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
7706377|NCT01103466|26801672|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
7706378|NCT01103466|26801673|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
7706379|NCT01103466|26801671|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
7706380|NCT01103466|26801672|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
7706381|NCT01103466|26801673|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
7706382|NCT01103466|26801671|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
7706383|NCT01103466|26801672|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
7706384|NCT01103466|26801673|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
7706385|NCT01103466|26801671|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
7706386|NCT01103466|26801672|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
7706387|NCT01103466|26801673|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
7706388|NCT01103466|26801671|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
7706389|NCT01103466|26801672|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
7706390|NCT01103466|26801673|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
7706391|NCT01103362|26801763|P1|Overall Study|study terminated|596
7706392|NCT01103323|26801769|P2|Switched From Placebo to Regorafenib|Adverse Event|1
7706393|NCT01103323|26801770|P1|Switched From Placebo to Regorafenib|Adverse Event|0
7706394|NCT01103323|26801769|P2|Without/Before Drug Switch|Switch to Regorafenib|4
7706395|NCT01103323|26801770|P1|Without/Before Drug Switch|Switch to Regorafenib|0
7706396|NCT01103323|26801769|P2|Without/Before Drug Switch|did not receive study treatment|2
7706397|NCT01103323|26801770|P1|Without/Before Drug Switch|did not receive study treatment|5
7706398|NCT01103323|26801769|P2|Without/Before Drug Switch|Physician Decision|0
7706399|NCT01103323|26801770|P1|Without/Before Drug Switch|Physician Decision|2
7706400|NCT01103323|26801769|P2|Without/Before Drug Switch|Protocol Violation|0
7706401|NCT01103323|26801770|P1|Without/Before Drug Switch|Protocol Violation|2
7706402|NCT01103323|26801769|P2|Without/Before Drug Switch|Withdrawal by Subject|5
7706403|NCT01103323|26801770|P1|Without/Before Drug Switch|Withdrawal by Subject|17
7706404|NCT01103323|26801769|P2|Without/Before Drug Switch|Adverse Event|7
7706405|NCT01103323|26801770|P1|Without/Before Drug Switch|Adverse Event|50
7706406|NCT01103284|26801787|P2|Overall Study|Missing CRF entries for study completion|2
7706407|NCT01103284|26801788|P1|Overall Study|Missing CRF entries for study completion|0
7706408|NCT01103284|26801787|P2|Overall Study|Not described|1
7706409|NCT01103284|26801788|P1|Overall Study|Not described|2
7706410|NCT01103284|26801787|P2|Overall Study|Termination by the Sponsor|1
7706411|NCT01103284|26801788|P1|Overall Study|Termination by the Sponsor|0
7706412|NCT01103284|26801787|P2|Overall Study|Dermal Hypersensitivity|1
7706413|NCT01103284|26801788|P1|Overall Study|Dermal Hypersensitivity|0
7706414|NCT01103284|26801787|P2|Overall Study|Withdrawal by Subject|18
7706415|NCT01103284|26801788|P1|Overall Study|Withdrawal by Subject|14
7706416|NCT01103284|26801787|P2|Overall Study|Adverse Event|5
7706417|NCT01103284|26801788|P1|Overall Study|Adverse Event|0
7706418|NCT01103284|26801787|P2|Overall Study|Protocol Violation|5
7706419|NCT01103284|26801788|P1|Overall Study|Protocol Violation|12
7706420|NCT01103284|26801787|P2|Overall Study|Pregnancy|1
7706421|NCT01103284|26801788|P1|Overall Study|Pregnancy|3
7706422|NCT01103284|26801787|P2|Overall Study|Lost to Follow-up|10
7706423|NCT01103284|26801788|P1|Overall Study|Lost to Follow-up|9
7706424|NCT01103284|26801787|P2|Overall Study|Death|0
7706425|NCT01103284|26801788|P1|Overall Study|Death|2
7706426|NCT01103245|26801816|P4|Overall Study|Physician Decision|0
7706427|NCT01103245|26801817|P3|Overall Study|Physician Decision|0
7706428|NCT01103245|26801818|P2|Overall Study|Physician Decision|0
7706429|NCT01103245|26801819|P1|Overall Study|Physician Decision|1
7706430|NCT01103245|26801816|P4|Overall Study|Adverse Event|0
7706431|NCT01103245|26801817|P3|Overall Study|Adverse Event|1
7706432|NCT01103245|26801818|P2|Overall Study|Adverse Event|2
7706433|NCT01103245|26801819|P1|Overall Study|Adverse Event|0
7706434|NCT01103245|26801816|P4|Overall Study|Inadequate IV access|0
7706435|NCT01103245|26801817|P3|Overall Study|Inadequate IV access|0
7706436|NCT01103245|26801818|P2|Overall Study|Inadequate IV access|0
7706437|NCT01103245|26801819|P1|Overall Study|Inadequate IV access|1
7706438|NCT01103245|26801816|P4|Overall Study|Withdrawal by Subject|0
7706439|NCT01103245|26801817|P3|Overall Study|Withdrawal by Subject|3
7706440|NCT01103245|26801818|P2|Overall Study|Withdrawal by Subject|0
7706441|NCT01103245|26801819|P1|Overall Study|Withdrawal by Subject|1
7706442|NCT01103232|26801835|P2|Overall Study|Protocol Violation|1
7706443|NCT01103232|26801836|P1|Overall Study|Protocol Violation|0
7706444|NCT01103232|26801835|P2|Overall Study|Withdrawal by Subject|1
7706445|NCT01103232|26801836|P1|Overall Study|Withdrawal by Subject|1
7706446|NCT01103180|26801844|P2|Overall Study|Protocol Violation|1
7706447|NCT01103180|26801845|P1|Overall Study|Protocol Violation|0
7706448|NCT01103180|26801844|P2|Overall Study|Physician Decision|0
7706449|NCT01103180|26801845|P1|Overall Study|Physician Decision|1
7706450|NCT01103180|26801844|P2|Overall Study|Lost to Follow-up|7
7706451|NCT01103180|26801845|P1|Overall Study|Lost to Follow-up|13
7706452|NCT01103180|26801844|P2|Overall Study|Withdrawal by Subject|13
7706453|NCT01103180|26801845|P1|Overall Study|Withdrawal by Subject|8
7706454|NCT01103141|26801855|P2|Overall Study|Lost to Follow-up|1
7706455|NCT01103141|26801856|P1|Overall Study|Lost to Follow-up|2
7706456|NCT01103141|26801855|P2|Overall Study|Death|1
7706457|NCT01103141|26801856|P1|Overall Study|Death|0
7706458|NCT01103063|26801864|P2|Overall Study|Death|1
7706459|NCT01103063|26801865|P1|Overall Study|Death|3
7706460|NCT01103063|26801864|P2|Overall Study|Study terminated by Sponsor|342
7706461|NCT01103063|26801865|P1|Overall Study|Study terminated by Sponsor|326
7706462|NCT01103063|26801864|P2|Overall Study|Protocol Violation|0
7706463|NCT01103063|26801865|P1|Overall Study|Protocol Violation|1
7706464|NCT01103063|26801864|P2|Overall Study|Other|11
7706465|NCT01103063|26801865|P1|Overall Study|Other|16
7706466|NCT01103063|26801864|P2|Overall Study|Withdrawal by Subject|15
7706467|NCT01103063|26801865|P1|Overall Study|Withdrawal by Subject|60
7706468|NCT01103063|26801864|P2|Overall Study|Lost to Follow-up|51
7706469|NCT01103063|26801865|P1|Overall Study|Lost to Follow-up|68
7706470|NCT01103063|26801864|P2|Overall Study|Adverse Event|1
7706471|NCT01103063|26801865|P1|Overall Study|Adverse Event|3
7706472|NCT01102972|26801933|P2|Overall Study|Withdrawal by Subject|6
7706473|NCT01102972|26801934|P1|Overall Study|Withdrawal by Subject|6
7706474|NCT01102972|26801933|P2|Overall Study|Investigator Discretion|0
7706475|NCT01102972|26801934|P1|Overall Study|Investigator Discretion|2
7706476|NCT01102972|26801933|P2|Overall Study|Lost to Follow-up|5
7706477|NCT01102972|26801934|P1|Overall Study|Lost to Follow-up|10
7706478|NCT01102972|26801933|P2|Overall Study|Protocol Violation|0
7706479|NCT01102972|26801934|P1|Overall Study|Protocol Violation|1
7706480|NCT01102972|26801933|P2|Overall Study|Lack of Efficacy|1
7706481|NCT01102972|26801934|P1|Overall Study|Lack of Efficacy|2
7706482|NCT01102972|26801933|P2|Overall Study|Adverse Event|2
7706483|NCT01102972|26801934|P1|Overall Study|Adverse Event|8
7706484|NCT01102803|26801998|P2|Post to Follow-Up|Lost to Follow-up|3
7706485|NCT01102803|26801999|P1|Post to Follow-Up|Lost to Follow-up|1
7706486|NCT01102803|26801998|P2|Baseline to Post-Treatment|Lost to Follow-up|0
7706487|NCT01102803|26801999|P1|Baseline to Post-Treatment|Lost to Follow-up|3
7706488|NCT01102777|26802013|P2|Overall Study|Lost to Follow-up|10
7706489|NCT01102777|26802014|P1|Overall Study|Lost to Follow-up|7
7706490|NCT01102777|26802013|P2|Overall Study|Death|6
7706491|NCT01102777|26802014|P1|Overall Study|Death|2
7706492|NCT01102491|26802073|P2|Overall Study|Protocol Violation|12
7706493|NCT01102491|26802074|P1|Overall Study|Protocol Violation|11
7706494|NCT01102426|26802082|P2|Overall Study|Death (non-related to the study|8
7706495|NCT01102426|26802083|P1|Overall Study|Death (non-related to the study|19
7706496|NCT01102426|26802082|P2|Overall Study|Death (due to adverse events|1
7706497|NCT01102426|26802083|P1|Overall Study|Death (due to adverse events|0
7706498|NCT01102426|26802082|P2|Overall Study|Patient Refusal|12
7706499|NCT01102426|26802083|P1|Overall Study|Patient Refusal|24
7706500|NCT01102426|26802082|P2|Overall Study|Adverse Events (unrelated to|1
7706501|NCT01102426|26802083|P1|Overall Study|Adverse Events (unrelated to|9
7706502|NCT01102426|26802082|P2|Overall Study|Progressive Disease|44
7706503|NCT01102426|26802083|P1|Overall Study|Progressive Disease|85
7706504|NCT01102426|26802082|P2|Overall Study|Physician Decision|6
7706505|NCT01102426|26802083|P1|Overall Study|Physician Decision|9
7706506|NCT01102426|26802082|P2|Overall Study|Adverse Events (treatment-related)|8
7706507|NCT01102426|26802083|P1|Overall Study|Adverse Events (treatment-related)|15
7706508|NCT01102426|26802082|P2|Overall Study|Randomized but not treated|1
7706509|NCT01102426|26802083|P1|Overall Study|Randomized but not treated|4
7706510|NCT01102374|26802134|P2|Overall Study|Lost to Follow-up|6
7706511|NCT01102374|26802135|P1|Overall Study|Lost to Follow-up|7
7706512|NCT01102374|26802134|P2|Overall Study|Death|13
7706513|NCT01102374|26802135|P1|Overall Study|Death|9
7706514|NCT01102257|26802184|P2|Overall Study|Adverse Event|0
7706515|NCT01102257|26802185|P1|Overall Study|Adverse Event|1
7706516|NCT01102257|26802184|P2|Overall Study|Adverse Event|0
7706517|NCT01102257|26802185|P1|Overall Study|Adverse Event|1
7706518|NCT01102231|26802191|P1|Overall Study|Did not received the treatment|4
7706519|NCT01102231|26802191|P1|Overall Study|Withdrawal by Subject|1
7706520|NCT01102231|26802191|P1|Overall Study|Adverse Event|3
7706521|NCT01102231|26802191|P1|Overall Study|Death|2
7706522|NCT01102231|26802191|P1|Overall Study|Lack of Efficacy|2
7706523|NCT01102231|26802191|P1|Overall Study|Protocol Violation|3
7706524|NCT01102140|26802208|P2|Overall Study|Investigator terminated study|2
7706525|NCT01102140|26802209|P1|Overall Study|Investigator terminated study|2
7706526|NCT01102140|26802208|P2|Overall Study|Lost to Follow-up|0
7706527|NCT01102140|26802209|P1|Overall Study|Lost to Follow-up|1
7706528|NCT01101997|26802221|P1|Overall Study|Withdrawal by Subject|2
7706529|NCT01101841|26802270|P2|Overall Study|Eligibility Criteria|2
7706530|NCT01101841|26802271|P1|Overall Study|Eligibility Criteria|1
7706531|NCT01101841|26802270|P2|Overall Study|Suicidality Tracking Scale|1
7706532|NCT01101841|26802271|P1|Overall Study|Suicidality Tracking Scale|3
7706533|NCT01101841|26802270|P2|Overall Study|Other|1
7706534|NCT01101841|26802271|P1|Overall Study|Other|0
7706535|NCT01101841|26802270|P2|Overall Study|Lack of Efficacy|2
7706536|NCT01101841|26802271|P1|Overall Study|Lack of Efficacy|0
7706537|NCT01101841|26802270|P2|Overall Study|Physician Decision|2
7706538|NCT01101841|26802271|P1|Overall Study|Physician Decision|0
7706539|NCT01101841|26802270|P2|Overall Study|Protocol Violation|1
7706540|NCT01101841|26802271|P1|Overall Study|Protocol Violation|1
7706541|NCT01101841|26802270|P2|Overall Study|Withdrawal by Subject|40
7706542|NCT01101841|26802271|P1|Overall Study|Withdrawal by Subject|21
7706543|NCT01101841|26802270|P2|Overall Study|Lost to Follow-up|3
7706544|NCT01101841|26802271|P1|Overall Study|Lost to Follow-up|9
7706545|NCT01101841|26802270|P2|Overall Study|Adverse Event|15
7706546|NCT01101841|26802271|P1|Overall Study|Adverse Event|15
7706547|NCT01101542|26802313|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
7706548|NCT01101542|26802313|P1|Year 6 Surveillance Period|Pregnancy|1
7706549|NCT01101542|26802313|P1|Year 6 Surveillance Period|Lost to Follow-up|986
7706550|NCT01101542|26802313|P1|Year 5 Surveillance Period|Pregnancy|1
7706551|NCT01101542|26802313|P1|Year 5 Surveillance Period|Lost to Follow-up|140
7706552|NCT01101542|26802313|P1|Year 4 Surveillance Period|Other|287
7706553|NCT01101542|26802313|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
7706554|NCT01101542|26802313|P1|Year 3 Surveillance Period|Lost to Follow-up|7
7706555|NCT01101477|26802329|P3|Overall Study|Protocol Violation|1
7706556|NCT01101477|26802330|P2|Overall Study|Protocol Violation|3
7706557|NCT01101477|26802331|P1|Overall Study|Protocol Violation|5
7706558|NCT01101334|26802354|P2|Overall Study|Other|1
7706559|NCT01101334|26802355|P1|Overall Study|Other|2
7706560|NCT01101334|26802354|P2|Overall Study|Progressive Disease|35
7706561|NCT01101334|26802355|P1|Overall Study|Progressive Disease|22
7706562|NCT01101334|26802354|P2|Overall Study|Withdrawal by Sponsor|1
7706563|NCT01101334|26802355|P1|Overall Study|Withdrawal by Sponsor|1
7706564|NCT01101334|26802354|P2|Overall Study|Withdrawal by Subject|3
7706565|NCT01101334|26802355|P1|Overall Study|Withdrawal by Subject|4
7706566|NCT01101334|26802354|P2|Overall Study|Death|1
7706567|NCT01101334|26802355|P1|Overall Study|Death|7
7706568|NCT01101334|26802354|P2|Overall Study|Adverse Event|4
7706569|NCT01101334|26802355|P1|Overall Study|Adverse Event|9
7706570|NCT01101321|26802367|P2|Period 1|Adverse Event|3
7706571|NCT01101321|26802368|P1|Period 1|Adverse Event|3
7706572|NCT01101321|26802367|P2|Period 1|Withdrawal by Subject|1
7706573|NCT01101321|26802368|P1|Period 1|Withdrawal by Subject|1
7706574|NCT01101308|26802378|P2|Period 1|Positive for cotinine|0
7706575|NCT01101308|26802379|P1|Period 1|Positive for cotinine|1
7706576|NCT01101308|26802378|P2|Period 1|Adverse Event|1
7706577|NCT01101308|26802379|P1|Period 1|Adverse Event|2
7706578|NCT01101191|26802390|P2|Period 1|Adverse Event|2
7706579|NCT01101191|26802391|P1|Period 1|Adverse Event|1
7706580|NCT01101191|26802390|P2|Period 1|Withdrawal by Subject|0
7706581|NCT01101191|26802391|P1|Period 1|Withdrawal by Subject|1
7706582|NCT01101178|26802402|P2|Period 2|Withdrawal by Subject|1
7706583|NCT01101178|26802403|P1|Period 2|Withdrawal by Subject|0
7706584|NCT01101178|26802402|P2|Period 1|Adverse Event|1
7706585|NCT01101178|26802403|P1|Period 1|Adverse Event|2
7706586|NCT01101178|26802402|P2|Period 1|Positive drug screen|1
7706587|NCT01101178|26802403|P1|Period 1|Positive drug screen|1
7706588|NCT01101178|26802402|P2|Period 1|Withdrawal by Subject|2
7706589|NCT01101178|26802403|P1|Period 1|Withdrawal by Subject|1
7706590|NCT01101165|26802414|P2|Period 2|Adverse Event|0
7706591|NCT01101165|26802415|P1|Period 2|Adverse Event|1
7706592|NCT01101165|26802414|P2|Period 2|Withdrawal by Subject|1
7706593|NCT01101165|26802415|P1|Period 2|Withdrawal by Subject|3
7706594|NCT01101165|26802414|P2|Period 1|Lost to Follow-up|0
7706595|NCT01101165|26802415|P1|Period 1|Lost to Follow-up|1
7706596|NCT01101165|26802414|P2|Period 1|Positive Drug Screen|1
7706597|NCT01101165|26802415|P1|Period 1|Positive Drug Screen|0
7706598|NCT01101165|26802414|P2|Period 1|Withdrawal by Subject|2
7706599|NCT01101165|26802415|P1|Period 1|Withdrawal by Subject|0
7706600|NCT01101165|26802414|P2|Period 1|Adverse Event|2
7706601|NCT01101165|26802415|P1|Period 1|Adverse Event|1
7706602|NCT01101061|26802436|P6|Overall Study|Adverse Event|0
7706603|NCT01101061|26802437|P5|Overall Study|Adverse Event|0
7706604|NCT01101061|26802438|P4|Overall Study|Adverse Event|0
7706605|NCT01101061|26802439|P3|Overall Study|Adverse Event|1
7706606|NCT01101061|26802440|P2|Overall Study|Adverse Event|0
7706607|NCT01101061|26802441|P1|Overall Study|Adverse Event|0
7706608|NCT01101035|26802521|P2|Overall Study|Reason not Specified|363
7706609|NCT01101035|26802522|P1|Overall Study|Reason not Specified|333
7706610|NCT01101035|26802521|P2|Overall Study|Voluntary Withdrawal|587
7706611|NCT01101035|26802522|P1|Overall Study|Voluntary Withdrawal|595
7706612|NCT01101035|26802521|P2|Overall Study|Lost to Follow-up|223
7706613|NCT01101035|26802522|P1|Overall Study|Lost to Follow-up|226
7706614|NCT01101035|26802521|P2|Overall Study|Major Protocol Deviation|46
7706615|NCT01101035|26802522|P1|Overall Study|Major Protocol Deviation|52
7706616|NCT01101035|26802521|P2|Overall Study|Adverse Event|172
7706617|NCT01101035|26802522|P1|Overall Study|Adverse Event|191
7706618|NCT01101022|26802542|P2|Overall Study|Vacation|1
7706619|NCT01101022|26802543|P1|Overall Study|Vacation|0
7706620|NCT01101022|26802542|P2|Overall Study|Work schedule|1
7706621|NCT01101022|26802543|P1|Overall Study|Work schedule|1
7706622|NCT01101022|26802542|P2|Overall Study|Non-compliance|0
7706623|NCT01101022|26802543|P1|Overall Study|Non-compliance|1
7706624|NCT01101022|26802542|P2|Overall Study|Sponsor decision|1
7706625|NCT01101022|26802543|P1|Overall Study|Sponsor decision|1
7706626|NCT01101022|26802542|P2|Overall Study|Lack of Efficacy|7
7706627|NCT01101022|26802543|P1|Overall Study|Lack of Efficacy|0
7706628|NCT01101022|26802542|P2|Overall Study|Lost to Follow-up|4
7706629|NCT01101022|26802543|P1|Overall Study|Lost to Follow-up|1
7706630|NCT01101022|26802542|P2|Overall Study|Withdrawal by Subject|8
7706631|NCT01101022|26802543|P1|Overall Study|Withdrawal by Subject|3
7706632|NCT01101022|26802542|P2|Overall Study|Protocol Violation|3
7706633|NCT01101022|26802543|P1|Overall Study|Protocol Violation|4
7706634|NCT01101022|26802542|P2|Overall Study|Adverse Event|2
7706635|NCT01101022|26802543|P1|Overall Study|Adverse Event|6
7706636|NCT01100944|26802577|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
7706637|NCT01100944|26802578|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
7706638|NCT01100944|26802579|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
7706639|NCT01100944|26802577|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
7706640|NCT01100944|26802578|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
7706641|NCT01100944|26802579|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
7706642|NCT01100944|26802577|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
7706643|NCT01100944|26802578|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
7706644|NCT01100944|26802579|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
7706645|NCT01100944|26802577|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
7706646|NCT01100944|26802578|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
7706647|NCT01100944|26802579|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
7706648|NCT01100853|26802637|P2|Overall Study|Withdrawal by Subject|4
7706649|NCT01100853|26802638|P1|Overall Study|Withdrawal by Subject|6
7706650|NCT01100853|26802637|P2|Overall Study|Received <4 study injections|13
7706651|NCT01100853|26802638|P1|Overall Study|Received <4 study injections|10
7706652|NCT01100853|26802637|P2|Overall Study|Lost to Follow-up|6
7706653|NCT01100853|26802638|P1|Overall Study|Lost to Follow-up|11
7706654|NCT01100658|26802684|P1|Overall Study|Withdrawal by Subject|1
7706655|NCT01100567|26802716|P2|Overall Study|Deemed ineligible after consent|1
7706656|NCT01100567|26802717|P1|Overall Study|Deemed ineligible after consent|0
7706657|NCT01100567|26802716|P2|Overall Study|Physician Decision|1
7706658|NCT01100567|26802717|P1|Overall Study|Physician Decision|0
7706659|NCT01100567|26802716|P2|Overall Study|Lost to Follow-up|2
7706660|NCT01100567|26802717|P1|Overall Study|Lost to Follow-up|1
7706661|NCT01100567|26802716|P2|Overall Study|Early Hospital Discharge|4
7706662|NCT01100567|26802717|P1|Overall Study|Early Hospital Discharge|6
7706663|NCT01100567|26802716|P2|Overall Study|Withdrawal by Subject|8
7706664|NCT01100567|26802717|P1|Overall Study|Withdrawal by Subject|5
7706665|NCT01100528|26802725|P1|Overall Study|Withdrawal by Subject|2
7706666|NCT01100528|26802725|P1|Overall Study|Death|1
7706667|NCT01100502|26802733|P2|Overall Study|Death|40
7706668|NCT01100502|26802734|P1|Overall Study|Death|45
7706669|NCT01100502|26802733|P2|Overall Study|Site request to end participation in study|1
7706670|NCT01100502|26802734|P1|Overall Study|Site request to end participation in study|0
7706671|NCT01100502|26802733|P2|Overall Study|Lost to Follow-up|28
7706672|NCT01100502|26802734|P1|Overall Study|Lost to Follow-up|13
7706673|NCT01100502|26802733|P2|Overall Study|Withdrawal by Subject|25
7706674|NCT01100502|26802734|P1|Overall Study|Withdrawal by Subject|18
7706675|NCT01100437|26802746|P3|Maintenance|Sponsor termination of study|1
7706676|NCT01100437|26802747|P2|Maintenance|Sponsor termination of study|0
7706677|NCT01100437|26802748|P1|Maintenance|Sponsor termination of study|0
7706678|NCT01100437|26802746|P3|Maintenance|Withdrawal by Subject|1
7706679|NCT01100437|26802747|P2|Maintenance|Withdrawal by Subject|0
7706680|NCT01100437|26802748|P1|Maintenance|Withdrawal by Subject|0
7706681|NCT01100437|26802746|P3|Titration/Stabilization|Sponsor canceled study|1
7706682|NCT01100437|26802747|P2|Titration/Stabilization|Sponsor canceled study|0
7706683|NCT01100437|26802748|P1|Titration/Stabilization|Sponsor canceled study|0
7706684|NCT01100437|26802746|P3|Titration/Stabilization|Non-compliance|1
7706685|NCT01100437|26802747|P2|Titration/Stabilization|Non-compliance|0
7706686|NCT01100437|26802748|P1|Titration/Stabilization|Non-compliance|0
7706687|NCT01100437|26802746|P3|Titration/Stabilization|Adverse Event|4
7706688|NCT01100437|26802747|P2|Titration/Stabilization|Adverse Event|0
7706689|NCT01100437|26802748|P1|Titration/Stabilization|Adverse Event|0
7706690|NCT01100320|26802785|P2|Period 2|Withdrawal by Subject|1
7706691|NCT01100320|26802786|P1|Period 2|Withdrawal by Subject|1
7706692|NCT01100320|26802785|P2|Period 1|Adverse Event|2
7706693|NCT01100320|26802786|P1|Period 1|Adverse Event|2
7706694|NCT01100320|26802785|P2|Period 1|Positive Drug Screen|1
7706695|NCT01100320|26802786|P1|Period 1|Positive Drug Screen|1
7706696|NCT01100320|26802785|P2|Period 1|Withdrawal by Subject|4
7706697|NCT01100320|26802786|P1|Period 1|Withdrawal by Subject|2
7706698|NCT01100307|26802798|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
7706699|NCT01100307|26802799|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
7706700|NCT01100307|26802798|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
7706701|NCT01100307|26802799|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
7706702|NCT01100307|26802798|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
7706703|NCT01100307|26802799|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
7706704|NCT01100307|26802798|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
7706705|NCT01100307|26802799|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
7706706|NCT01100307|26802798|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
7706707|NCT01100307|26802799|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
7706708|NCT01100307|26802798|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
7706709|NCT01100307|26802799|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
7706710|NCT01100086|26802868|P2|Period 1|Withdrawal by Subject|0
7706711|NCT01100086|26802869|P1|Period 1|Withdrawal by Subject|1
7706712|NCT01100073|26802879|P1|Overall Study|Missing|5
7706713|NCT01100073|26802879|P1|Overall Study|Other|8
7706714|NCT01100073|26802879|P1|Overall Study|Insufficient tolerability +patients wish|8
7706715|NCT01100073|26802879|P1|Overall Study|Lack of effect + patient's wish|2
7706716|NCT01100073|26802879|P1|Overall Study|Lost to Follow-up|39
7706717|NCT01100073|26802879|P1|Overall Study|Withdrawal by Subject|13
7706718|NCT01100073|26802879|P1|Overall Study|Insufficient Tolerability|21
7706719|NCT01100073|26802879|P1|Overall Study|Lack of Efficacy|4
7706720|NCT01100034|26802894|P1|Overall Study|Site closed due to non-responsiveness|1
7706721|NCT01100034|26802894|P1|Overall Study|Participants moved to another hospital|4
7706722|NCT01100034|26802894|P1|Overall Study|Participated in another clinical trial|1
7706723|NCT01100034|26802894|P1|Overall Study|Sponsor decision|21
7706724|NCT01100034|26802894|P1|Overall Study|Withdrawal by Subject|4
7706725|NCT01100034|26802894|P1|Overall Study|Withdrawal of parent/guardian consent|1
7706726|NCT01100034|26802894|P1|Overall Study|Lost to Follow-up|11
7706727|NCT01099917|26802932|P1|Overall Study|Not Treated|24
7706728|NCT01099917|26802932|P1|Overall Study|Adverse Event|3
7706729|NCT01099709|26802994|P2|Period 1|Adverse Event|0
7706730|NCT01099709|26802995|P1|Period 1|Adverse Event|1
7706731|NCT01099709|26802994|P2|Period 1|Positive cotinine test|1
7706732|NCT01099709|26802995|P1|Period 1|Positive cotinine test|0
7706733|NCT01099709|26802994|P2|Period 1|Withdrawal by Subject|1
7706734|NCT01099709|26802995|P1|Period 1|Withdrawal by Subject|0
7706735|NCT01099579|26803064|P3|Stage 2 (ATV Capsule)|Adverse Event|0
7706736|NCT01099579|26803065|P2|Stage 2 (ATV Capsule)|Adverse Event|1
7706737|NCT01099579|26803066|P1|Stage 2 (ATV Capsule)|Adverse Event|0
7706738|NCT01099579|26803064|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
7706739|NCT01099579|26803065|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
7706740|NCT01099579|26803066|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
7706741|NCT01099579|26803064|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7706742|NCT01099579|26803065|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7706743|NCT01099579|26803066|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7706744|NCT01099579|26803064|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
7706745|NCT01099579|26803065|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
7706746|NCT01099579|26803066|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
7706747|NCT01099579|26803064|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7706748|NCT01099579|26803065|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7706749|NCT01099579|26803066|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7706750|NCT01099579|26803064|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
7706751|NCT01099579|26803065|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
7706752|NCT01099579|26803066|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
7706753|NCT01099579|26803064|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
7706754|NCT01099579|26803065|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
7706755|NCT01099579|26803066|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
7706756|NCT01099579|26803064|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
7706757|NCT01099579|26803065|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
7706758|NCT01099579|26803066|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
7706759|NCT01099579|26803064|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
7706760|NCT01099579|26803065|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
7706761|NCT01099579|26803066|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
7706762|NCT01099579|26803064|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
7706763|NCT01099579|26803065|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
7706764|NCT01099579|26803066|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
7706765|NCT01099397|26803175|P1|Overall Study|Withdrawal by Subject|5
7706766|NCT01099397|26803175|P1|Overall Study|Protocol Violation|4
7706767|NCT01099397|26803175|P1|Overall Study|Lost to Follow-up|4
7706768|NCT01099267|26803202|P1|MDS-003 Study|Secondary Malign Disease|1
7706769|NCT01099267|26803202|P1|MDS-003 Study|Loss of Response|1
7706770|NCT01099267|26803202|P1|MDS-003 Study|Non-Compliance|2
7706771|NCT01099267|26803202|P1|MDS-003 Study|Investigator Decision|2
7706772|NCT01099267|26803202|P1|MDS-003 Study|Disease Progression|7
7706773|NCT01099267|26803202|P1|MDS-003 Study|Study Closed by Sponsor|2
7706774|NCT01099267|26803202|P1|MDS-003 Study|Death|11
7706775|NCT01099267|26803202|P1|MDS-003 Study|Lost to Follow-up|1
7706776|NCT01099267|26803202|P1|MDS-003 Study|Withdrawal by Subject|8
7706777|NCT01099267|26803202|P1|MDS-003 Study|Lack of Efficacy|52
7706778|NCT01099267|26803202|P1|MDS-003 Study|Adverse Event|37
7706779|NCT01099215|26803212|P2|Overall Study|Adverse Event|1
7706780|NCT01099215|26803213|P1|Overall Study|Adverse Event|0
7706781|NCT01099215|26803212|P2|Overall Study|Withdrawal by Subject|0
7706782|NCT01099215|26803213|P1|Overall Study|Withdrawal by Subject|1
7706783|NCT01098851|26803283|P2|Overall Study|Equipment failure|0
7706784|NCT01098851|26803284|P1|Overall Study|Equipment failure|1
7706785|NCT01098812|26803295|P3|Overall Study|Lost to Follow-up|0
7706786|NCT01098812|26803296|P2|Overall Study|Lost to Follow-up|1
7706787|NCT01098812|26803297|P1|Overall Study|Lost to Follow-up|0
7706788|NCT01098812|26803295|P3|Overall Study|Death|1
7706789|NCT01098812|26803296|P2|Overall Study|Death|0
7706790|NCT01098812|26803297|P1|Overall Study|Death|2
7706791|NCT01098539|26803373|P2|Overall Study|Physician Decision|3
7706792|NCT01098539|26803374|P1|Overall Study|Physician Decision|5
7706793|NCT01098539|26803373|P2|Overall Study|Withdrawal by Subject|26
7706794|NCT01098539|26803374|P1|Overall Study|Withdrawal by Subject|12
7706795|NCT01098539|26803373|P2|Overall Study|Lost to Follow-up|4
7706796|NCT01098539|26803374|P1|Overall Study|Lost to Follow-up|4
7706797|NCT01098539|26803373|P2|Overall Study|Noncompliance|5
7706798|NCT01098539|26803374|P1|Overall Study|Noncompliance|3
7706799|NCT01098539|26803373|P2|Overall Study|Protocol Violation|4
7706800|NCT01098539|26803374|P1|Overall Study|Protocol Violation|1
7706801|NCT01098539|26803373|P2|Overall Study|Adverse Event|26
7706802|NCT01098539|26803374|P1|Overall Study|Adverse Event|26
7706803|NCT01098487|26803425|P1|Overall Study|Physician Decision|1
7706804|NCT01098487|26803425|P1|Overall Study|Lost to Follow-up|3
7706805|NCT01098487|26803425|P1|Overall Study|Withdrawal by Subject|7
7706806|NCT01098487|26803425|P1|Overall Study|Lack of Efficacy|11
7706807|NCT01098487|26803425|P1|Overall Study|Adverse Event|22
7706808|NCT01098474|26803443|P6|Follow Up Phase|Lost to Follow-up|0
7706809|NCT01098474|26803444|P5|Follow Up Phase|Lost to Follow-up|1
7706810|NCT01098474|26803445|P4|Follow Up Phase|Lost to Follow-up|0
7706811|NCT01098474|26803446|P3|Follow Up Phase|Lost to Follow-up|0
7706812|NCT01098474|26803447|P2|Follow Up Phase|Lost to Follow-up|0
7706813|NCT01098474|26803448|P1|Follow Up Phase|Lost to Follow-up|0
7706814|NCT01098474|26803443|P6|Follow Up Phase|Withdrawal by Subject|1
7706815|NCT01098474|26803444|P5|Follow Up Phase|Withdrawal by Subject|0
7706816|NCT01098474|26803445|P4|Follow Up Phase|Withdrawal by Subject|2
7706817|NCT01098474|26803446|P3|Follow Up Phase|Withdrawal by Subject|0
7706818|NCT01098474|26803447|P2|Follow Up Phase|Withdrawal by Subject|0
7706819|NCT01098474|26803448|P1|Follow Up Phase|Withdrawal by Subject|0
7706820|NCT01098474|26803443|P6|Follow Up Phase|Other|4
7706821|NCT01098474|26803444|P5|Follow Up Phase|Other|0
7706822|NCT01098474|26803445|P4|Follow Up Phase|Other|0
7706823|NCT01098474|26803446|P3|Follow Up Phase|Other|0
7706824|NCT01098474|26803447|P2|Follow Up Phase|Other|0
7706825|NCT01098474|26803448|P1|Follow Up Phase|Other|0
7706826|NCT01098474|26803443|P6|Follow Up Phase|Travelled out of study area|0
7706827|NCT01098474|26803444|P5|Follow Up Phase|Travelled out of study area|1
7706828|NCT01098474|26803445|P4|Follow Up Phase|Travelled out of study area|0
7706829|NCT01098474|26803446|P3|Follow Up Phase|Travelled out of study area|0
7706830|NCT01098474|26803447|P2|Follow Up Phase|Travelled out of study area|0
7706831|NCT01098474|26803448|P1|Follow Up Phase|Travelled out of study area|0
7706832|NCT01098474|26803443|P6|Active Phase|Lost to Follow-up|0
7706833|NCT01098474|26803444|P5|Active Phase|Lost to Follow-up|0
7706834|NCT01098474|26803445|P4|Active Phase|Lost to Follow-up|0
7706835|NCT01098474|26803446|P3|Active Phase|Lost to Follow-up|0
7706836|NCT01098474|26803447|P2|Active Phase|Lost to Follow-up|0
7706837|NCT01098474|26803448|P1|Active Phase|Lost to Follow-up|1
7706838|NCT01098474|26803443|P6|Active Phase|Withdrawal by Subject|0
7706839|NCT01098474|26803444|P5|Active Phase|Withdrawal by Subject|0
7706840|NCT01098474|26803445|P4|Active Phase|Withdrawal by Subject|0
7706841|NCT01098474|26803446|P3|Active Phase|Withdrawal by Subject|2
7706842|NCT01098474|26803447|P2|Active Phase|Withdrawal by Subject|1
7706843|NCT01098474|26803448|P1|Active Phase|Withdrawal by Subject|1
7706844|NCT01098474|26803443|P6|Active Phase|Other|0
7706845|NCT01098474|26803444|P5|Active Phase|Other|0
7706846|NCT01098474|26803445|P4|Active Phase|Other|0
7706847|NCT01098474|26803446|P3|Active Phase|Other|3
7706848|NCT01098474|26803447|P2|Active Phase|Other|0
7706849|NCT01098474|26803448|P1|Active Phase|Other|0
7706850|NCT01098461|26803682|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
7706851|NCT01098461|26803683|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
7706852|NCT01098461|26803684|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
7706853|NCT01098461|26803685|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
7706854|NCT01098461|26803682|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7706855|NCT01098461|26803683|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7706856|NCT01098461|26803684|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
7706857|NCT01098461|26803685|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7706858|NCT01098461|26803682|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7706859|NCT01098461|26803683|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7706860|NCT01098461|26803684|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
7706861|NCT01098461|26803685|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7706862|NCT01098461|26803682|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7706863|NCT01098461|26803683|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7706864|NCT01098461|26803684|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
7706865|NCT01098461|26803685|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7706866|NCT01098461|26803682|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
7706867|NCT01098461|26803683|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
7706868|NCT01098461|26803684|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
7706869|NCT01098461|26803685|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
7706870|NCT01098461|26803682|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
7706871|NCT01098461|26803683|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
7706872|NCT01098461|26803684|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
7706873|NCT01098461|26803685|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
7706874|NCT01098461|26803682|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
7706875|NCT01098461|26803683|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
7706876|NCT01098461|26803684|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
7706877|NCT01098461|26803685|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
7706878|NCT01098305|26803753|P2|Overall Study|Lost to Follow-up|33
7706879|NCT01098305|26803754|P1|Overall Study|Lost to Follow-up|31
7706880|NCT01098266|26803764|P2|Overall Study|Withdrawal by Subject|5
7706881|NCT01098266|26803765|P1|Overall Study|Withdrawal by Subject|3
7706882|NCT01098266|26803764|P2|Overall Study|Death|2
7706883|NCT01098266|26803765|P1|Overall Study|Death|3
7706884|NCT01098266|26803764|P2|Overall Study|Physician Decision|0
7706885|NCT01098266|26803765|P1|Overall Study|Physician Decision|1
7706886|NCT01098240|26803794|P3|Double-Blind Phase|Adverse Event|3
7706887|NCT01098240|26803795|P2|Double-Blind Phase|Adverse Event|3
7706888|NCT01098240|26803796|P1|Double-Blind Phase|Adverse Event|0
7706889|NCT01098240|26803794|P3|Double-Blind Phase|Withdrawal by Subject|3
7706890|NCT01098240|26803795|P2|Double-Blind Phase|Withdrawal by Subject|1
7706891|NCT01098240|26803796|P1|Double-Blind Phase|Withdrawal by Subject|0
7706892|NCT01098240|26803794|P3|Double-Blind Phase|Insufficient Clinical Response|2
7706893|NCT01098240|26803795|P2|Double-Blind Phase|Insufficient Clinical Response|1
7706894|NCT01098240|26803796|P1|Double-Blind Phase|Insufficient Clinical Response|0
7706895|NCT01098240|26803794|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
7706896|NCT01098240|26803795|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
7706897|NCT01098240|26803796|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
7706898|NCT01098240|26803794|P3|Double-Blind Phase|Other|2
7706899|NCT01098240|26803795|P2|Double-Blind Phase|Other|2
7706900|NCT01098240|26803796|P1|Double-Blind Phase|Other|0
7706901|NCT01098240|26803794|P3|Double-Blind Phase|Lost to Follow-up|0
7706902|NCT01098240|26803795|P2|Double-Blind Phase|Lost to Follow-up|2
7706903|NCT01098240|26803796|P1|Double-Blind Phase|Lost to Follow-up|0
7706904|NCT01098240|26803794|P3|Double-Blind Phase|Protocol Violation|4
7706905|NCT01098240|26803795|P2|Double-Blind Phase|Protocol Violation|2
7706906|NCT01098240|26803796|P1|Double-Blind Phase|Protocol Violation|0
7706907|NCT01098240|26803794|P3|Double-Blind Phase|Study Terminated by Sponsor|8
7706908|NCT01098240|26803795|P2|Double-Blind Phase|Study Terminated by Sponsor|5
7706909|NCT01098240|26803796|P1|Double-Blind Phase|Study Terminated by Sponsor|0
7706910|NCT01098240|26803794|P3|Open-Label Phase|Adverse Event|0
7706911|NCT01098240|26803795|P2|Open-Label Phase|Adverse Event|0
7706912|NCT01098240|26803796|P1|Open-Label Phase|Adverse Event|12
7706913|NCT01098240|26803794|P3|Open-Label Phase|Withdrawal by Subject|0
7706914|NCT01098240|26803795|P2|Open-Label Phase|Withdrawal by Subject|0
7706915|NCT01098240|26803796|P1|Open-Label Phase|Withdrawal by Subject|9
7706916|NCT01098240|26803794|P3|Open-Label Phase|Pregnancy|0
7706917|NCT01098240|26803795|P2|Open-Label Phase|Pregnancy|0
7706918|NCT01098240|26803796|P1|Open-Label Phase|Pregnancy|1
7706919|NCT01098240|26803794|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
7706920|NCT01098240|26803795|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
7706921|NCT01098240|26803796|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
7706922|NCT01098240|26803794|P3|Open-Label Phase|Other|0
7706923|NCT01098240|26803795|P2|Open-Label Phase|Other|0
7706924|NCT01098240|26803796|P1|Open-Label Phase|Other|19
7706925|NCT01098240|26803794|P3|Open-Label Phase|Lost to Follow-up|0
7706926|NCT01098240|26803795|P2|Open-Label Phase|Lost to Follow-up|0
7706927|NCT01098240|26803796|P1|Open-Label Phase|Lost to Follow-up|13
7706928|NCT01098240|26803794|P3|Open-Label Phase|Protocol Violation|0
7706929|NCT01098240|26803795|P2|Open-Label Phase|Protocol Violation|0
7706930|NCT01098240|26803796|P1|Open-Label Phase|Protocol Violation|4
7706931|NCT01098240|26803794|P3|Open-Label Phase|Study Terminated by Sponsor|0
7706932|NCT01098240|26803795|P2|Open-Label Phase|Study Terminated by Sponsor|0
7706933|NCT01098240|26803796|P1|Open-Label Phase|Study Terminated by Sponsor|27
7706934|NCT01098162|26803826|P1|Overall Study|Reason Unknown|26
7706935|NCT01098162|26803826|P1|Overall Study|Other Reason|1
7706936|NCT01098162|26803826|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
7706937|NCT01098162|26803826|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
7706938|NCT01098162|26803826|P1|Overall Study|Adverse Event & Lost to Follow-up|2
7706939|NCT01098162|26803826|P1|Overall Study|Adverse Event & Wish of Patient|13
7706940|NCT01098162|26803826|P1|Overall Study|Adverse Event & Lack of Efficacy|6
7706941|NCT01098162|26803826|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
7706942|NCT01098162|26803826|P1|Overall Study|Lost to Follow-up|9
7706943|NCT01098162|26803826|P1|Overall Study|Wish of Patient|7
7706944|NCT01098162|26803826|P1|Overall Study|Lack of Efficacy|4
7706945|NCT01098162|26803826|P1|Overall Study|Adverse Event|37
7706946|NCT01098110|26803838|P3|Overall Study|Untreated|0
7706947|NCT01098110|26803839|P2|Overall Study|Untreated|1
7706948|NCT01098110|26803840|P1|Overall Study|Untreated|1
7706949|NCT01098110|26803838|P3|Overall Study|Other|5
7706950|NCT01098110|26803839|P2|Overall Study|Other|7
7706951|NCT01098110|26803840|P1|Overall Study|Other|4
7706952|NCT01098110|26803838|P3|Overall Study|Lack of Efficacy|27
7706953|NCT01098110|26803839|P2|Overall Study|Lack of Efficacy|9
7706954|NCT01098110|26803840|P1|Overall Study|Lack of Efficacy|13
7706955|NCT01098110|26803838|P3|Overall Study|Adverse Event|43
7706956|NCT01098110|26803839|P2|Overall Study|Adverse Event|32
7706957|NCT01098110|26803840|P1|Overall Study|Adverse Event|30
7706958|NCT01098110|26803838|P3|Overall Study|Withdrawal by Subject|19
7706959|NCT01098110|26803839|P2|Overall Study|Withdrawal by Subject|24
7706960|NCT01098110|26803840|P1|Overall Study|Withdrawal by Subject|14
7706961|NCT01098097|26803881|P1|Overall Study|No reason reported|31
7706962|NCT01098097|26803881|P1|Overall Study|Status unknown|16
7706963|NCT01098097|26803881|P1|Overall Study|Lost to Follow-up|18
7706964|NCT01098097|26803881|P1|Overall Study|Adverse Event|17
7706965|NCT01098071|26803890|P1|Overall Study|Lost to Follow-up|13
7706966|NCT01098071|26803890|P1|Overall Study|Surgery (adenoidectomy)|2
7706967|NCT01098032|26803903|P2|Overall Study|Withdrawal by Subject|1
7706968|NCT01098032|26803904|P1|Overall Study|Withdrawal by Subject|1
7706969|NCT01097863|26804021|P3|Overall Study|Did not return for final visit|1
7706970|NCT01097863|26804022|P2|Overall Study|Did not return for final visit|0
7706971|NCT01097863|26804023|P1|Overall Study|Did not return for final visit|0
7706972|NCT01097863|26804021|P3|Overall Study|Discomfort|1
7706973|NCT01097863|26804022|P2|Overall Study|Discomfort|0
7706974|NCT01097863|26804023|P1|Overall Study|Discomfort|1
7706975|NCT01097707|26804047|P5|Overall Study|Reason unknown|1
7706976|NCT01097707|26804048|P4|Overall Study|Reason unknown|0
7706977|NCT01097707|26804049|P3|Overall Study|Reason unknown|0
7706978|NCT01097707|26804050|P2|Overall Study|Reason unknown|0
7706979|NCT01097707|26804051|P1|Overall Study|Reason unknown|0
7706980|NCT01097707|26804047|P5|Overall Study|Withdrawal by Subject|3
7706981|NCT01097707|26804048|P4|Overall Study|Withdrawal by Subject|4
7706982|NCT01097707|26804049|P3|Overall Study|Withdrawal by Subject|1
7706983|NCT01097707|26804050|P2|Overall Study|Withdrawal by Subject|6
7706984|NCT01097707|26804051|P1|Overall Study|Withdrawal by Subject|3
7706985|NCT01097707|26804047|P5|Overall Study|Sponsor Decision|36
7706986|NCT01097707|26804048|P4|Overall Study|Sponsor Decision|35
7706987|NCT01097707|26804049|P3|Overall Study|Sponsor Decision|34
7706988|NCT01097707|26804050|P2|Overall Study|Sponsor Decision|31
7706989|NCT01097707|26804051|P1|Overall Study|Sponsor Decision|31
7706990|NCT01097707|26804047|P5|Overall Study|Protocol Violation|2
7706991|NCT01097707|26804048|P4|Overall Study|Protocol Violation|2
7706992|NCT01097707|26804049|P3|Overall Study|Protocol Violation|3
7706993|NCT01097707|26804050|P2|Overall Study|Protocol Violation|2
7706994|NCT01097707|26804051|P1|Overall Study|Protocol Violation|2
7706995|NCT01097707|26804047|P5|Overall Study|Lost to Follow-up|3
7706996|NCT01097707|26804048|P4|Overall Study|Lost to Follow-up|0
7706997|NCT01097707|26804049|P3|Overall Study|Lost to Follow-up|2
7706998|NCT01097707|26804050|P2|Overall Study|Lost to Follow-up|1
7706999|NCT01097707|26804051|P1|Overall Study|Lost to Follow-up|1
7707000|NCT01097707|26804047|P5|Overall Study|Lack of Efficacy|0
7707001|NCT01097707|26804048|P4|Overall Study|Lack of Efficacy|1
7707002|NCT01097707|26804049|P3|Overall Study|Lack of Efficacy|0
7707003|NCT01097707|26804050|P2|Overall Study|Lack of Efficacy|0
7707004|NCT01097707|26804051|P1|Overall Study|Lack of Efficacy|1
7707005|NCT01097707|26804047|P5|Overall Study|Entry Criteria Not Met|1
7707006|NCT01097707|26804048|P4|Overall Study|Entry Criteria Not Met|0
7707007|NCT01097707|26804049|P3|Overall Study|Entry Criteria Not Met|1
7707008|NCT01097707|26804050|P2|Overall Study|Entry Criteria Not Met|1
7707009|NCT01097707|26804051|P1|Overall Study|Entry Criteria Not Met|2
7707010|NCT01097707|26804047|P5|Overall Study|Adverse Event|3
7707011|NCT01097707|26804048|P4|Overall Study|Adverse Event|1
7707012|NCT01097707|26804049|P3|Overall Study|Adverse Event|3
7707013|NCT01097707|26804050|P2|Overall Study|Adverse Event|2
7707014|NCT01097707|26804051|P1|Overall Study|Adverse Event|4
7707015|NCT01097707|26804047|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7707016|NCT01097707|26804048|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7707017|NCT01097707|26804049|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7707018|NCT01097707|26804050|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7707019|NCT01097707|26804051|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7707020|NCT01097694|26804100|P2|Overall Study|Withdrawal by Subject|1
7707021|NCT01097694|26804101|P1|Overall Study|Withdrawal by Subject|3
7707022|NCT01097694|26804100|P2|Overall Study|Lost to Follow-up|3
7707023|NCT01097694|26804101|P1|Overall Study|Lost to Follow-up|0
7707024|NCT01097694|26804100|P2|Overall Study|Adverse Event|0
7707025|NCT01097694|26804101|P1|Overall Study|Adverse Event|5
7707026|NCT01097668|26804163|P2|Overall Study|Lost to Follow-up|0
7707027|NCT01097668|26804164|P1|Overall Study|Lost to Follow-up|1
7707028|NCT01097668|26804163|P2|Overall Study|Withdrawal by Subject|2
7707029|NCT01097668|26804164|P1|Overall Study|Withdrawal by Subject|1
7707030|NCT01097655|26804174|P1|Overall Study|Did Not Meet Inclusion Criteria|8
7707031|NCT01097655|26804174|P1|Overall Study|Subject Documented Twice|1
7707032|NCT01097655|26804174|P1|Overall Study|Withdrawal by Subject|1
7707033|NCT01097629|26804197|P8|DB RO Phase|Lost to Follow-up|0
7707034|NCT01097629|26804198|P7|DB RO Phase|Lost to Follow-up|2
7707035|NCT01097629|26804199|P6|DB RO Phase|Lost to Follow-up|0
7707036|NCT01097629|26804200|P5|DB RO Phase|Lost to Follow-up|0
7707037|NCT01097629|26804201|P4|DB RO Phase|Lost to Follow-up|0
7707038|NCT01097629|26804202|P3|DB RO Phase|Lost to Follow-up|0
7707039|NCT01097629|26804203|P2|DB RO Phase|Lost to Follow-up|0
7707040|NCT01097629|26804204|P1|DB RO Phase|Lost to Follow-up|0
7707041|NCT01097629|26804197|P8|DB RO Phase|Protocol Violation|0
7707042|NCT01097629|26804198|P7|DB RO Phase|Protocol Violation|1
7707043|NCT01097629|26804199|P6|DB RO Phase|Protocol Violation|1
7707044|NCT01097629|26804200|P5|DB RO Phase|Protocol Violation|0
7707045|NCT01097629|26804201|P4|DB RO Phase|Protocol Violation|1
7707046|NCT01097629|26804202|P3|DB RO Phase|Protocol Violation|0
7707047|NCT01097629|26804203|P2|DB RO Phase|Protocol Violation|0
7707048|NCT01097629|26804204|P1|DB RO Phase|Protocol Violation|0
7707049|NCT01097629|26804197|P8|DB RO Phase|Withdrawal by Subject|1
7707050|NCT01097629|26804198|P7|DB RO Phase|Withdrawal by Subject|0
7707051|NCT01097629|26804199|P6|DB RO Phase|Withdrawal by Subject|0
7707052|NCT01097629|26804200|P5|DB RO Phase|Withdrawal by Subject|0
7707053|NCT01097629|26804201|P4|DB RO Phase|Withdrawal by Subject|0
7707054|NCT01097629|26804202|P3|DB RO Phase|Withdrawal by Subject|0
7707055|NCT01097629|26804203|P2|DB RO Phase|Withdrawal by Subject|0
7707056|NCT01097629|26804204|P1|DB RO Phase|Withdrawal by Subject|0
7707057|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707058|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707059|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707060|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707061|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707062|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
7707063|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
7707064|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
7707065|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707066|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707067|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707068|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707069|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707070|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707071|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
7707072|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
7707073|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707074|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707075|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707076|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707077|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707078|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
7707079|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
7707080|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
7707081|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707082|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707083|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707084|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707085|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707086|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7707087|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
7707088|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
7707089|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707090|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707091|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707092|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707093|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707094|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
7707095|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
7707096|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
7707097|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707098|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707099|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707100|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707101|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707102|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
7707103|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
7707104|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7707105|NCT01097629|26804197|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707106|NCT01097629|26804198|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707107|NCT01097629|26804199|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707108|NCT01097629|26804200|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707109|NCT01097629|26804201|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707110|NCT01097629|26804202|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
7707111|NCT01097629|26804203|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
7707112|NCT01097629|26804204|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
7707113|NCT01097616|26804255|P8|DB RO Phase|Not Treated in RO|0
7707114|NCT01097616|26804256|P7|DB RO Phase|Not Treated in RO|0
7707115|NCT01097616|26804257|P6|DB RO Phase|Not Treated in RO|1
7707116|NCT01097616|26804258|P5|DB RO Phase|Not Treated in RO|0
7707117|NCT01097616|26804259|P4|DB RO Phase|Not Treated in RO|0
7707118|NCT01097616|26804260|P3|DB RO Phase|Not Treated in RO|0
7707119|NCT01097616|26804261|P2|DB RO Phase|Not Treated in RO|0
7707120|NCT01097616|26804262|P1|DB RO Phase|Not Treated in RO|0
7707121|NCT01097616|26804255|P8|DB RO Phase|Lost to Follow-up|1
7707122|NCT01097616|26804256|P7|DB RO Phase|Lost to Follow-up|0
7707123|NCT01097616|26804257|P6|DB RO Phase|Lost to Follow-up|0
7707124|NCT01097616|26804258|P5|DB RO Phase|Lost to Follow-up|1
7707125|NCT01097616|26804259|P4|DB RO Phase|Lost to Follow-up|1
7707126|NCT01097616|26804260|P3|DB RO Phase|Lost to Follow-up|0
7707127|NCT01097616|26804261|P2|DB RO Phase|Lost to Follow-up|0
7707128|NCT01097616|26804262|P1|DB RO Phase|Lost to Follow-up|0
7707129|NCT01097616|26804255|P8|DB RO Phase|Withdrawal by Subject|0
7707130|NCT01097616|26804256|P7|DB RO Phase|Withdrawal by Subject|0
7707131|NCT01097616|26804257|P6|DB RO Phase|Withdrawal by Subject|1
7707132|NCT01097616|26804258|P5|DB RO Phase|Withdrawal by Subject|0
7707133|NCT01097616|26804259|P4|DB RO Phase|Withdrawal by Subject|0
7707134|NCT01097616|26804260|P3|DB RO Phase|Withdrawal by Subject|0
7707135|NCT01097616|26804261|P2|DB RO Phase|Withdrawal by Subject|0
7707136|NCT01097616|26804262|P1|DB RO Phase|Withdrawal by Subject|0
7707137|NCT01097616|26804255|P8|DB RO Phase|Adverse Event|0
7707138|NCT01097616|26804256|P7|DB RO Phase|Adverse Event|1
7707139|NCT01097616|26804257|P6|DB RO Phase|Adverse Event|0
7707140|NCT01097616|26804258|P5|DB RO Phase|Adverse Event|0
7707141|NCT01097616|26804259|P4|DB RO Phase|Adverse Event|0
7707142|NCT01097616|26804260|P3|DB RO Phase|Adverse Event|0
7707143|NCT01097616|26804261|P2|DB RO Phase|Adverse Event|0
7707144|NCT01097616|26804262|P1|DB RO Phase|Adverse Event|0
7707145|NCT01097616|26804255|P8|Optional DB EXT Phase|Physician Decision|0
7707146|NCT01097616|26804256|P7|Optional DB EXT Phase|Physician Decision|0
7707147|NCT01097616|26804257|P6|Optional DB EXT Phase|Physician Decision|0
7707148|NCT01097616|26804258|P5|Optional DB EXT Phase|Physician Decision|0
7707149|NCT01097616|26804259|P4|Optional DB EXT Phase|Physician Decision|0
7707150|NCT01097616|26804260|P3|Optional DB EXT Phase|Physician Decision|0
7707151|NCT01097616|26804261|P2|Optional DB EXT Phase|Physician Decision|0
7707152|NCT01097616|26804262|P1|Optional DB EXT Phase|Physician Decision|1
7707153|NCT01097616|26804255|P8|Optional DB EXT Phase|Lack of Efficacy|0
7707154|NCT01097616|26804256|P7|Optional DB EXT Phase|Lack of Efficacy|0
7707155|NCT01097616|26804257|P6|Optional DB EXT Phase|Lack of Efficacy|0
7707156|NCT01097616|26804258|P5|Optional DB EXT Phase|Lack of Efficacy|0
7707157|NCT01097616|26804259|P4|Optional DB EXT Phase|Lack of Efficacy|0
7707158|NCT01097616|26804260|P3|Optional DB EXT Phase|Lack of Efficacy|1
7707159|NCT01097616|26804261|P2|Optional DB EXT Phase|Lack of Efficacy|1
7707160|NCT01097616|26804262|P1|Optional DB EXT Phase|Lack of Efficacy|1
7707161|NCT01097616|26804255|P8|Optional DB EXT Phase|Lost to Follow-up|0
7707162|NCT01097616|26804256|P7|Optional DB EXT Phase|Lost to Follow-up|0
7707163|NCT01097616|26804257|P6|Optional DB EXT Phase|Lost to Follow-up|0
7707164|NCT01097616|26804258|P5|Optional DB EXT Phase|Lost to Follow-up|0
7707165|NCT01097616|26804259|P4|Optional DB EXT Phase|Lost to Follow-up|0
7707166|NCT01097616|26804260|P3|Optional DB EXT Phase|Lost to Follow-up|1
7707167|NCT01097616|26804261|P2|Optional DB EXT Phase|Lost to Follow-up|5
7707168|NCT01097616|26804262|P1|Optional DB EXT Phase|Lost to Follow-up|1
7707169|NCT01097616|26804255|P8|Optional DB EXT Phase|Protocol Violation|0
7707170|NCT01097616|26804256|P7|Optional DB EXT Phase|Protocol Violation|0
7707171|NCT01097616|26804257|P6|Optional DB EXT Phase|Protocol Violation|0
7707172|NCT01097616|26804258|P5|Optional DB EXT Phase|Protocol Violation|0
7707173|NCT01097616|26804259|P4|Optional DB EXT Phase|Protocol Violation|0
7707174|NCT01097616|26804260|P3|Optional DB EXT Phase|Protocol Violation|3
7707175|NCT01097616|26804261|P2|Optional DB EXT Phase|Protocol Violation|2
7707176|NCT01097616|26804262|P1|Optional DB EXT Phase|Protocol Violation|0
7707177|NCT01097616|26804255|P8|Optional DB EXT Phase|Withdrawal by Subject|0
7707178|NCT01097616|26804256|P7|Optional DB EXT Phase|Withdrawal by Subject|0
7707179|NCT01097616|26804257|P6|Optional DB EXT Phase|Withdrawal by Subject|0
7707180|NCT01097616|26804258|P5|Optional DB EXT Phase|Withdrawal by Subject|0
7707181|NCT01097616|26804259|P4|Optional DB EXT Phase|Withdrawal by Subject|0
7707182|NCT01097616|26804260|P3|Optional DB EXT Phase|Withdrawal by Subject|3
7707183|NCT01097616|26804261|P2|Optional DB EXT Phase|Withdrawal by Subject|6
7707184|NCT01097616|26804262|P1|Optional DB EXT Phase|Withdrawal by Subject|12
7707185|NCT01097616|26804255|P8|Optional DB EXT Phase|Adverse Event|0
7707186|NCT01097616|26804256|P7|Optional DB EXT Phase|Adverse Event|0
7707187|NCT01097616|26804257|P6|Optional DB EXT Phase|Adverse Event|0
7707188|NCT01097616|26804258|P5|Optional DB EXT Phase|Adverse Event|0
7707189|NCT01097616|26804259|P4|Optional DB EXT Phase|Adverse Event|0
7707190|NCT01097616|26804260|P3|Optional DB EXT Phase|Adverse Event|2
7707191|NCT01097616|26804261|P2|Optional DB EXT Phase|Adverse Event|7
7707192|NCT01097616|26804262|P1|Optional DB EXT Phase|Adverse Event|0
7707193|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707194|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707195|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707196|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707197|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707198|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
7707199|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707200|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7707201|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707202|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707203|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707204|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707205|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707206|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7707207|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
7707208|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
7707209|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7707210|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7707211|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7707212|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7707213|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7707214|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7707215|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
7707216|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
7707217|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707218|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707219|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707220|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707221|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7707222|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
7707223|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
7707224|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
7707225|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707226|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707227|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707228|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707229|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707230|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7707231|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7707232|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7707233|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707234|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707235|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707236|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707237|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7707238|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
7707239|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
7707240|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
7707241|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707242|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707243|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707244|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707245|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7707246|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
7707247|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7707248|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
7707249|NCT01097616|26804255|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707250|NCT01097616|26804256|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707251|NCT01097616|26804257|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707252|NCT01097616|26804258|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707253|NCT01097616|26804259|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7707254|NCT01097616|26804260|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
7707255|NCT01097616|26804261|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
7707256|NCT01097616|26804262|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
7707257|NCT01097577|26804335|P2|Overall Study|Adverse Event|1
7707258|NCT01097577|26804336|P1|Overall Study|Adverse Event|0
7707259|NCT01097421|26804356|P1|Overall Study|Withdrawal by Subject|3
7707260|NCT01097421|26804356|P1|Overall Study|Lost to Follow-up|1
7707261|NCT01097421|26804356|P1|Overall Study|Protocol Violation|2
7707262|NCT01097421|26804356|P1|Overall Study|Adverse Event|8
7707263|NCT01097330|26804388|P2|Overall Study|Study terminated early|5
7707264|NCT01097330|26804389|P1|Overall Study|Study terminated early|7
7707265|NCT01097057|26804406|P1|Overall Study|Physician Decision|3
7707266|NCT01097044|26804415|P2|Overall Study|Withdrawal by Sponsor|1
7707267|NCT01097044|26804416|P1|Overall Study|Withdrawal by Sponsor|0
7707268|NCT01097044|26804415|P2|Overall Study|Lost to Follow-up|0
7707269|NCT01097044|26804416|P1|Overall Study|Lost to Follow-up|1
7707270|NCT01097044|26804415|P2|Overall Study|Withdrawal by Subject|4
7707271|NCT01097044|26804416|P1|Overall Study|Withdrawal by Subject|4
7707272|NCT01097005|26804434|P1|Overall Study|Discontinuance by complication|50
7707273|NCT01097005|26804434|P1|Overall Study|Adverse Event|14
7707274|NCT01097005|26804434|P1|Overall Study|Deviation from exclusion criteria|37
7707275|NCT01097005|26804434|P1|Overall Study|No examination data available|244
7707276|NCT01097005|26804434|P1|Overall Study|Poor medication compliance|1
7707277|NCT01097005|26804434|P1|Overall Study|Subjects cannot visit the hospital|1
7707278|NCT01097005|26804434|P1|Overall Study|Case Report Form not collected|18
7707279|NCT01096849|26804480|P3|Overall Study|Lost to Follow-up|1
7707280|NCT01096849|26804481|P2|Overall Study|Lost to Follow-up|3
7707281|NCT01096849|26804482|P1|Overall Study|Lost to Follow-up|1
7707282|NCT01096849|26804480|P3|Overall Study|Administrative Reasons|2
7707283|NCT01096849|26804481|P2|Overall Study|Administrative Reasons|1
7707284|NCT01096849|26804482|P1|Overall Study|Administrative Reasons|0
7707285|NCT01096849|26804480|P3|Overall Study|Investigator or Medical Monitor Decision|0
7707286|NCT01096849|26804481|P2|Overall Study|Investigator or Medical Monitor Decision|1
7707287|NCT01096849|26804482|P1|Overall Study|Investigator or Medical Monitor Decision|0
7707288|NCT01096849|26804480|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
7707289|NCT01096849|26804481|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
7707290|NCT01096849|26804482|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
7707291|NCT01096849|26804480|P3|Overall Study|Lack of Efficacy|0
7707292|NCT01096849|26804481|P2|Overall Study|Lack of Efficacy|2
7707293|NCT01096849|26804482|P1|Overall Study|Lack of Efficacy|0
7707294|NCT01096849|26804480|P3|Overall Study|Consent Withdrawn|2
7707295|NCT01096849|26804481|P2|Overall Study|Consent Withdrawn|4
7707296|NCT01096849|26804482|P1|Overall Study|Consent Withdrawn|1
7707297|NCT01096784|26804558|P2|Overall Study|Other Unspecified|1
7707298|NCT01096784|26804559|P1|Overall Study|Other Unspecified|0
7707299|NCT01096784|26804558|P2|Overall Study|Administrative Decision|1
7707300|NCT01096784|26804559|P1|Overall Study|Administrative Decision|0
7707301|NCT01096784|26804558|P2|Overall Study|Protocol Deviation|2
7707302|NCT01096784|26804559|P1|Overall Study|Protocol Deviation|2
7707303|NCT01096784|26804558|P2|Overall Study|Adverse Event|9
7707304|NCT01096784|26804559|P1|Overall Study|Adverse Event|11
7707305|NCT01096784|26804558|P2|Overall Study|Withdrawal by Subject|1
7707306|NCT01096784|26804559|P1|Overall Study|Withdrawal by Subject|2
7707307|NCT01096667|26804664|P5|Overall Study|Not treated|0
7707308|NCT01096667|26804665|P4|Overall Study|Not treated|0
7707309|NCT01096667|26804666|P3|Overall Study|Not treated|0
7707310|NCT01096667|26804667|P2|Overall Study|Not treated|0
7707311|NCT01096667|26804668|P1|Overall Study|Not treated|1
7707312|NCT01096667|26804664|P5|Overall Study|Protocol Violation|0
7707313|NCT01096667|26804665|P4|Overall Study|Protocol Violation|1
7707314|NCT01096667|26804666|P3|Overall Study|Protocol Violation|0
7707315|NCT01096667|26804667|P2|Overall Study|Protocol Violation|0
7707316|NCT01096667|26804668|P1|Overall Study|Protocol Violation|0
7707317|NCT01096667|26804664|P5|Overall Study|Reason not available|0
7707318|NCT01096667|26804665|P4|Overall Study|Reason not available|1
7707319|NCT01096667|26804666|P3|Overall Study|Reason not available|1
7707320|NCT01096667|26804667|P2|Overall Study|Reason not available|1
7707321|NCT01096667|26804668|P1|Overall Study|Reason not available|0
7707322|NCT01096667|26804664|P5|Overall Study|Withdrawal by Subject|0
7707323|NCT01096667|26804665|P4|Overall Study|Withdrawal by Subject|1
7707324|NCT01096667|26804666|P3|Overall Study|Withdrawal by Subject|0
7707325|NCT01096667|26804667|P2|Overall Study|Withdrawal by Subject|0
7707326|NCT01096667|26804668|P1|Overall Study|Withdrawal by Subject|1
7707327|NCT01096667|26804664|P5|Overall Study|Lost to Follow-up|0
7707328|NCT01096667|26804665|P4|Overall Study|Lost to Follow-up|0
7707329|NCT01096667|26804666|P3|Overall Study|Lost to Follow-up|1
7707330|NCT01096667|26804667|P2|Overall Study|Lost to Follow-up|1
7707331|NCT01096667|26804668|P1|Overall Study|Lost to Follow-up|1
7707332|NCT01096589|26804810|P4|Overall Study|found treatment exhausting|1
7707333|NCT01096589|26804811|P3|Overall Study|found treatment exhausting|0
7707334|NCT01096589|26804812|P2|Overall Study|found treatment exhausting|0
7707335|NCT01096589|26804813|P1|Overall Study|found treatment exhausting|0
7707336|NCT01096589|26804810|P4|Overall Study|Compliance with protocol|0
7707337|NCT01096589|26804811|P3|Overall Study|Compliance with protocol|1
7707338|NCT01096589|26804812|P2|Overall Study|Compliance with protocol|0
7707339|NCT01096589|26804813|P1|Overall Study|Compliance with protocol|0
7707340|NCT01096589|26804810|P4|Overall Study|Withdrawal by Subject|1
7707341|NCT01096589|26804811|P3|Overall Study|Withdrawal by Subject|1
7707342|NCT01096589|26804812|P2|Overall Study|Withdrawal by Subject|1
7707343|NCT01096589|26804813|P1|Overall Study|Withdrawal by Subject|2
7707344|NCT01096589|26804810|P4|Overall Study|Adverse Event|1
7707345|NCT01096589|26804811|P3|Overall Study|Adverse Event|2
7707346|NCT01096589|26804812|P2|Overall Study|Adverse Event|1
7707347|NCT01096589|26804813|P1|Overall Study|Adverse Event|2
7707348|NCT01096550|26804829|P2|Overall Study|Lost to Follow-up|9
7707349|NCT01096550|26804830|P1|Overall Study|Lost to Follow-up|12
7707350|NCT01096550|26804829|P2|Overall Study|non-African American participant|6
7707351|NCT01096550|26804830|P1|Overall Study|non-African American participant|13
7707352|NCT01096550|26804829|P2|Overall Study|Withdrawal by Subject|1
7707353|NCT01096550|26804830|P1|Overall Study|Withdrawal by Subject|0
7707354|NCT01096550|26804829|P2|Overall Study|clinic readmission|1
7707355|NCT01096550|26804830|P1|Overall Study|clinic readmission|1
7707356|NCT01096550|26804829|P2|Overall Study|non-regular treatment track at clinic|1
7707357|NCT01096550|26804830|P1|Overall Study|non-regular treatment track at clinic|1
7707358|NCT01096550|26804829|P2|Overall Study|discontinued site|11
7707359|NCT01096550|26804830|P1|Overall Study|discontinued site|10
7707360|NCT01096446|26804838|P2|Overall Study|Protocol Violation|0
7707361|NCT01096446|26804839|P1|Overall Study|Protocol Violation|2
7707362|NCT01096446|26804838|P2|Overall Study|Death|0
7707363|NCT01096446|26804839|P1|Overall Study|Death|1
7707364|NCT01096342|26804844|P1|Overall Study|Protocol Violation|1
7707365|NCT01096316|26804852|P2|Overall Study|Lost to Follow-up|9
7707366|NCT01096316|26804853|P1|Overall Study|Lost to Follow-up|15
7707367|NCT01096186|26804874|P1|Overall Study|Noncompliance with study drug|1
7707368|NCT01096186|26804874|P1|Overall Study|Physician Decision|1
7707369|NCT01096186|26804874|P1|Overall Study|Withdrawal by Subject|22
7707370|NCT01096186|26804874|P1|Overall Study|Lost to Follow-up|2
7707371|NCT01096186|26804874|P1|Overall Study|Lack of Efficacy|4
7707372|NCT01096186|26804874|P1|Overall Study|Death|4
7707373|NCT01096186|26804874|P1|Overall Study|Adverse Event|16
7707374|NCT01096160|26804890|P10|Overall Study|Met stopping criteria per protocol|0
7707375|NCT01096160|26804891|P9|Overall Study|Met stopping criteria per protocol|2
7707376|NCT01096160|26804892|P8|Overall Study|Met stopping criteria per protocol|0
7707377|NCT01096160|26804893|P7|Overall Study|Met stopping criteria per protocol|2
7707378|NCT01096160|26804894|P6|Overall Study|Met stopping criteria per protocol|0
7707379|NCT01096160|26804895|P5|Overall Study|Met stopping criteria per protocol|1
7707380|NCT01096160|26804896|P4|Overall Study|Met stopping criteria per protocol|0
7707381|NCT01096160|26804897|P3|Overall Study|Met stopping criteria per protocol|0
7707382|NCT01096160|26804898|P2|Overall Study|Met stopping criteria per protocol|0
7707383|NCT01096160|26804899|P1|Overall Study|Met stopping criteria per protocol|0
7707384|NCT01096160|26804890|P10|Overall Study|Adverse Event|1
7707385|NCT01096160|26804891|P9|Overall Study|Adverse Event|0
7707386|NCT01096160|26804892|P8|Overall Study|Adverse Event|0
7707387|NCT01096160|26804893|P7|Overall Study|Adverse Event|0
7707388|NCT01096160|26804894|P6|Overall Study|Adverse Event|0
7707389|NCT01096160|26804895|P5|Overall Study|Adverse Event|0
7707390|NCT01096160|26804896|P4|Overall Study|Adverse Event|0
7707391|NCT01096160|26804897|P3|Overall Study|Adverse Event|1
7707392|NCT01096160|26804898|P2|Overall Study|Adverse Event|0
7707393|NCT01096160|26804899|P1|Overall Study|Adverse Event|0
7707394|NCT01096056|26804957|P2|Overall Study|Lost to Follow-up|1
7707395|NCT01096056|26804958|P1|Overall Study|Lost to Follow-up|0
7707396|NCT01096017|26804990|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
7707397|NCT01096017|26804991|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
7707398|NCT01095978|26805019|P1|Overall Study|Adverse Event|1
7707399|NCT01095978|26805019|P1|Overall Study|Did not take Klacid SR|2
7707400|NCT01095835|26805053|P3|Overall Study|Protocol Violation|0
7707401|NCT01095835|26805054|P2|Overall Study|Protocol Violation|2
7707402|NCT01095835|26805055|P1|Overall Study|Protocol Violation|1
7707403|NCT01095835|26805053|P3|Overall Study|Non study compliance|1
7707404|NCT01095835|26805054|P2|Overall Study|Non study compliance|0
7707405|NCT01095835|26805055|P1|Overall Study|Non study compliance|0
7707406|NCT01095835|26805053|P3|Overall Study|Withdrawal by Subject|0
7707407|NCT01095835|26805054|P2|Overall Study|Withdrawal by Subject|3
7707408|NCT01095835|26805055|P1|Overall Study|Withdrawal by Subject|1
7707409|NCT01095835|26805053|P3|Overall Study|Physician Decision|1
7707410|NCT01095835|26805054|P2|Overall Study|Physician Decision|0
7707411|NCT01095835|26805055|P1|Overall Study|Physician Decision|0
7707412|NCT01095835|26805053|P3|Overall Study|Lack of Efficacy|0
7707413|NCT01095835|26805054|P2|Overall Study|Lack of Efficacy|1
7707414|NCT01095835|26805055|P1|Overall Study|Lack of Efficacy|0
7707415|NCT01095835|26805053|P3|Overall Study|Adverse Event|6
7707416|NCT01095835|26805054|P2|Overall Study|Adverse Event|6
7707417|NCT01095835|26805055|P1|Overall Study|Adverse Event|8
7707418|NCT01095796|26805093|P2|Overall Study|Participant Transferred to Another Study|200
7707419|NCT01095796|26805094|P1|Overall Study|Participant Transferred to Another Study|215
7707420|NCT01095796|26805093|P2|Overall Study|Protocol Violation|0
7707421|NCT01095796|26805094|P1|Overall Study|Protocol Violation|1
7707422|NCT01095796|26805093|P2|Overall Study|Participant Noncompliance|10
7707423|NCT01095796|26805094|P1|Overall Study|Participant Noncompliance|5
7707424|NCT01095796|26805093|P2|Overall Study|Lost to Follow-up|29
7707425|NCT01095796|26805094|P1|Overall Study|Lost to Follow-up|27
7707426|NCT01095796|26805093|P2|Overall Study|Withdrew Consent|22
7707427|NCT01095796|26805094|P1|Overall Study|Withdrew Consent|16
7707428|NCT01095796|26805093|P2|Overall Study|Investigator's Discretion|2
7707429|NCT01095796|26805094|P1|Overall Study|Investigator's Discretion|7
7707430|NCT01095796|26805093|P2|Overall Study|Lack of Efficacy|3
7707431|NCT01095796|26805094|P1|Overall Study|Lack of Efficacy|5
7707432|NCT01095796|26805093|P2|Overall Study|Pregnancy|0
7707433|NCT01095796|26805094|P1|Overall Study|Pregnancy|2
7707434|NCT01095796|26805093|P2|Overall Study|Death|2
7707435|NCT01095796|26805094|P1|Overall Study|Death|3
7707436|NCT01095796|26805093|P2|Overall Study|Adverse Event|19
7707437|NCT01095796|26805094|P1|Overall Study|Adverse Event|9
7707438|NCT01095796|26805093|P2|Overall Study|Randomized but Not Treated|2
7707439|NCT01095796|26805094|P1|Overall Study|Randomized but Not Treated|5
7707440|NCT01095666|26805124|P3|Overall Study|Non-compliance, not met criteria etc.|2
7707441|NCT01095666|26805125|P2|Overall Study|Non-compliance, not met criteria etc.|2
7707442|NCT01095666|26805126|P1|Overall Study|Non-compliance, not met criteria etc.|7
7707443|NCT01095666|26805124|P3|Overall Study|Withdrawal by Subject|1
7707444|NCT01095666|26805125|P2|Overall Study|Withdrawal by Subject|6
7707445|NCT01095666|26805126|P1|Overall Study|Withdrawal by Subject|6
7707446|NCT01095666|26805124|P3|Overall Study|Lost to Follow-up|0
7707447|NCT01095666|26805125|P2|Overall Study|Lost to Follow-up|2
7707448|NCT01095666|26805126|P1|Overall Study|Lost to Follow-up|2
7707449|NCT01095666|26805124|P3|Overall Study|Adverse Event|3
7707450|NCT01095666|26805125|P2|Overall Study|Adverse Event|1
7707451|NCT01095666|26805126|P1|Overall Study|Adverse Event|2
7707452|NCT01095666|26805124|P3|Overall Study|Lack of Efficacy|1
7707453|NCT01095666|26805125|P2|Overall Study|Lack of Efficacy|0
7707454|NCT01095666|26805126|P1|Overall Study|Lack of Efficacy|0
7707455|NCT01095653|26805149|P3|Overall Study|non-compliance, not met criteria, etc.|5
7707456|NCT01095653|26805150|P2|Overall Study|non-compliance, not met criteria, etc.|6
7707457|NCT01095653|26805151|P1|Overall Study|non-compliance, not met criteria, etc.|10
7707458|NCT01095653|26805149|P3|Overall Study|Withdrawal by Subject|3
7707459|NCT01095653|26805150|P2|Overall Study|Withdrawal by Subject|5
7707460|NCT01095653|26805151|P1|Overall Study|Withdrawal by Subject|4
7707461|NCT01095653|26805149|P3|Overall Study|Lost to Follow-up|4
7707462|NCT01095653|26805150|P2|Overall Study|Lost to Follow-up|0
7707463|NCT01095653|26805151|P1|Overall Study|Lost to Follow-up|1
7707464|NCT01095653|26805149|P3|Overall Study|Adverse Event|4
7707465|NCT01095653|26805150|P2|Overall Study|Adverse Event|4
7707466|NCT01095653|26805151|P1|Overall Study|Adverse Event|1
7707467|NCT01095653|26805149|P3|Overall Study|Lack of Efficacy|0
7707468|NCT01095653|26805150|P2|Overall Study|Lack of Efficacy|0
7707469|NCT01095653|26805151|P1|Overall Study|Lack of Efficacy|3
7707470|NCT01095250|26805218|P4|Overall Study|Withdrawal by Subject|0
7707471|NCT01095250|26805219|P3|Overall Study|Withdrawal by Subject|1
7707472|NCT01095250|26805220|P2|Overall Study|Withdrawal by Subject|0
7707473|NCT01095250|26805221|P1|Overall Study|Withdrawal by Subject|0
7707474|NCT01095250|26805218|P4|Overall Study|administrative reasons|5
7707475|NCT01095250|26805219|P3|Overall Study|administrative reasons|7
7707476|NCT01095250|26805220|P2|Overall Study|administrative reasons|10
7707477|NCT01095250|26805221|P1|Overall Study|administrative reasons|8
7707478|NCT01095094|26805251|P1|Overall Study|Physician Decision|1
7707479|NCT01095094|26805251|P1|Overall Study|Death|1
7707480|NCT01095094|26805251|P1|Overall Study|Withdrawal by Subject|1
7707481|NCT01094886|26805273|P1|Overall Study|Withdrawal by Subject|5
7707482|NCT01094886|26805273|P1|Overall Study|Adverse Event|2
7707483|NCT01094808|26805283|P3|Overall Study|Withdrawal by Subject|0
7707484|NCT01094808|26805284|P2|Overall Study|Withdrawal by Subject|1
7707485|NCT01094808|26805285|P1|Overall Study|Withdrawal by Subject|1
7707486|NCT01094782|26805326|P6|Overall Study|Noncompliance With Study Schedule|0
7707487|NCT01094782|26805327|P5|Overall Study|Noncompliance With Study Schedule|0
7707488|NCT01094782|26805328|P4|Overall Study|Noncompliance With Study Schedule|1
7707489|NCT01094782|26805329|P3|Overall Study|Noncompliance With Study Schedule|0
7707490|NCT01094782|26805330|P2|Overall Study|Noncompliance With Study Schedule|0
7707491|NCT01094782|26805331|P1|Overall Study|Noncompliance With Study Schedule|0
7707492|NCT01094782|26805326|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
7707493|NCT01094782|26805327|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
7707494|NCT01094782|26805328|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
7707495|NCT01094782|26805329|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
7707496|NCT01094782|26805330|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
7707497|NCT01094782|26805331|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
7707498|NCT01094782|26805326|P6|Overall Study|Recent Interventional Injection|1
7707499|NCT01094782|26805327|P5|Overall Study|Recent Interventional Injection|0
7707500|NCT01094782|26805328|P4|Overall Study|Recent Interventional Injection|0
7707501|NCT01094782|26805329|P3|Overall Study|Recent Interventional Injection|0
7707502|NCT01094782|26805330|P2|Overall Study|Recent Interventional Injection|0
7707503|NCT01094782|26805331|P1|Overall Study|Recent Interventional Injection|0
7707504|NCT01094782|26805326|P6|Overall Study|Wrong Pain Condition|1
7707505|NCT01094782|26805327|P5|Overall Study|Wrong Pain Condition|1
7707506|NCT01094782|26805328|P4|Overall Study|Wrong Pain Condition|2
7707507|NCT01094782|26805329|P3|Overall Study|Wrong Pain Condition|0
7707508|NCT01094782|26805330|P2|Overall Study|Wrong Pain Condition|0
7707509|NCT01094782|26805331|P1|Overall Study|Wrong Pain Condition|0
7707510|NCT01094782|26805326|P6|Overall Study|Hypertension|0
7707511|NCT01094782|26805327|P5|Overall Study|Hypertension|0
7707512|NCT01094782|26805328|P4|Overall Study|Hypertension|0
7707513|NCT01094782|26805329|P3|Overall Study|Hypertension|1
7707514|NCT01094782|26805330|P2|Overall Study|Hypertension|0
7707515|NCT01094782|26805331|P1|Overall Study|Hypertension|0
7707516|NCT01094782|26805326|P6|Overall Study|Healthy Subject Had Pain|0
7707517|NCT01094782|26805327|P5|Overall Study|Healthy Subject Had Pain|0
7707518|NCT01094782|26805328|P4|Overall Study|Healthy Subject Had Pain|0
7707519|NCT01094782|26805329|P3|Overall Study|Healthy Subject Had Pain|0
7707520|NCT01094782|26805330|P2|Overall Study|Healthy Subject Had Pain|1
7707521|NCT01094782|26805331|P1|Overall Study|Healthy Subject Had Pain|0
7707522|NCT01094782|26805326|P6|Overall Study|Unable to Complete Questionnaires|0
7707523|NCT01094782|26805327|P5|Overall Study|Unable to Complete Questionnaires|0
7707524|NCT01094782|26805328|P4|Overall Study|Unable to Complete Questionnaires|0
7707525|NCT01094782|26805329|P3|Overall Study|Unable to Complete Questionnaires|0
7707526|NCT01094782|26805330|P2|Overall Study|Unable to Complete Questionnaires|1
7707527|NCT01094782|26805331|P1|Overall Study|Unable to Complete Questionnaires|0
7707528|NCT01094782|26805326|P6|Overall Study|Sensory Deficit at Site of QST|0
7707529|NCT01094782|26805327|P5|Overall Study|Sensory Deficit at Site of QST|0
7707530|NCT01094782|26805328|P4|Overall Study|Sensory Deficit at Site of QST|0
7707531|NCT01094782|26805329|P3|Overall Study|Sensory Deficit at Site of QST|0
7707532|NCT01094782|26805330|P2|Overall Study|Sensory Deficit at Site of QST|1
7707533|NCT01094782|26805331|P1|Overall Study|Sensory Deficit at Site of QST|0
7707534|NCT01094782|26805326|P6|Overall Study|Positive Drug Screen|2
7707535|NCT01094782|26805327|P5|Overall Study|Positive Drug Screen|3
7707536|NCT01094782|26805328|P4|Overall Study|Positive Drug Screen|1
7707537|NCT01094782|26805329|P3|Overall Study|Positive Drug Screen|1
7707538|NCT01094782|26805330|P2|Overall Study|Positive Drug Screen|2
7707539|NCT01094782|26805331|P1|Overall Study|Positive Drug Screen|2
7707540|NCT01094782|26805326|P6|Overall Study|Lost to Follow-up|4
7707541|NCT01094782|26805327|P5|Overall Study|Lost to Follow-up|1
7707542|NCT01094782|26805328|P4|Overall Study|Lost to Follow-up|2
7707543|NCT01094782|26805329|P3|Overall Study|Lost to Follow-up|0
7707544|NCT01094782|26805330|P2|Overall Study|Lost to Follow-up|0
7707545|NCT01094782|26805331|P1|Overall Study|Lost to Follow-up|1
7707546|NCT01094782|26805326|P6|Overall Study|Withdrawal by Subject|0
7707547|NCT01094782|26805327|P5|Overall Study|Withdrawal by Subject|5
7707548|NCT01094782|26805328|P4|Overall Study|Withdrawal by Subject|5
7707549|NCT01094782|26805329|P3|Overall Study|Withdrawal by Subject|1
7707550|NCT01094782|26805330|P2|Overall Study|Withdrawal by Subject|5
7707551|NCT01094782|26805331|P1|Overall Study|Withdrawal by Subject|5
7707552|NCT01094743|26805375|P1|Period 1|Unsatisfactory comfort at lens fitting|2
7707553|NCT01094730|26805392|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
7707554|NCT01094730|26805393|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
7707555|NCT01094730|26805392|P2|Period 2 (14 Days)|Adverse Event|1
7707556|NCT01094730|26805393|P1|Period 2 (14 Days)|Adverse Event|0
7707557|NCT01094730|26805392|P2|Period 2 (14 Days)|No time for the follow-up visit|0
7707558|NCT01094730|26805393|P1|Period 2 (14 Days)|No time for the follow-up visit|1
7707559|NCT01094730|26805392|P2|Period 2 (14 Days)|Protocol Violation|0
7707560|NCT01094730|26805393|P1|Period 2 (14 Days)|Protocol Violation|2
7707561|NCT01094730|26805392|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
7707562|NCT01094730|26805393|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
7707563|NCT01094730|26805392|P2|Period 1 (14 Days)|No time for the follow-up visit|0
7707564|NCT01094730|26805393|P1|Period 1 (14 Days)|No time for the follow-up visit|1
7707565|NCT01094730|26805392|P2|Period 1 (14 Days)|Withdrawal by Subject|1
7707566|NCT01094730|26805393|P1|Period 1 (14 Days)|Withdrawal by Subject|0
7707567|NCT01094730|26805392|P2|Period 1 (14 Days)|Lost to Follow-up|1
7707568|NCT01094730|26805393|P1|Period 1 (14 Days)|Lost to Follow-up|0
7707569|NCT01094301|26805529|P1|Implant Stage|No return of pain|4
7707570|NCT01094301|26805529|P1|Implant Stage|Withdrawal by Subject|2
7707571|NCT01094301|26805529|P1|Implant Stage|Protocol Violation|1
7707572|NCT01094301|26805529|P1|Implant Stage|Adverse Event|1
7707573|NCT01094301|26805529|P1|Trial Stage|Withdrawal by Subject|1
7707574|NCT01094288|26805559|P8|Overall Study|Ongoing Participants|0
7707575|NCT01094288|26805560|P7|Overall Study|Ongoing Participants|0
7707576|NCT01094288|26805561|P6|Overall Study|Ongoing Participants|0
7707577|NCT01094288|26805562|P5|Overall Study|Ongoing Participants|0
7707578|NCT01094288|26805563|P4|Overall Study|Ongoing Participants|0
7707579|NCT01094288|26805564|P3|Overall Study|Ongoing Participants|0
7707580|NCT01094288|26805565|P2|Overall Study|Ongoing Participants|3
7707581|NCT01094288|26805566|P1|Overall Study|Ongoing Participants|0
7707582|NCT01094288|26805559|P8|Overall Study|Reason not Specified|0
7707583|NCT01094288|26805560|P7|Overall Study|Reason not Specified|0
7707584|NCT01094288|26805561|P6|Overall Study|Reason not Specified|0
7707585|NCT01094288|26805562|P5|Overall Study|Reason not Specified|0
7707586|NCT01094288|26805563|P4|Overall Study|Reason not Specified|1
7707587|NCT01094288|26805564|P3|Overall Study|Reason not Specified|0
7707588|NCT01094288|26805565|P2|Overall Study|Reason not Specified|3
7707589|NCT01094288|26805566|P1|Overall Study|Reason not Specified|2
7707590|NCT01094288|26805559|P8|Overall Study|Initiation of Alternative Therapy|0
7707591|NCT01094288|26805560|P7|Overall Study|Initiation of Alternative Therapy|0
7707592|NCT01094288|26805561|P6|Overall Study|Initiation of Alternative Therapy|0
7707593|NCT01094288|26805562|P5|Overall Study|Initiation of Alternative Therapy|0
7707594|NCT01094288|26805563|P4|Overall Study|Initiation of Alternative Therapy|0
7707595|NCT01094288|26805564|P3|Overall Study|Initiation of Alternative Therapy|1
7707596|NCT01094288|26805565|P2|Overall Study|Initiation of Alternative Therapy|0
7707597|NCT01094288|26805566|P1|Overall Study|Initiation of Alternative Therapy|0
7707598|NCT01094288|26805559|P8|Overall Study|Withdrawal by Subject|2
7707599|NCT01094288|26805560|P7|Overall Study|Withdrawal by Subject|0
7707600|NCT01094288|26805561|P6|Overall Study|Withdrawal by Subject|0
7707601|NCT01094288|26805562|P5|Overall Study|Withdrawal by Subject|0
7707602|NCT01094288|26805563|P4|Overall Study|Withdrawal by Subject|0
7707603|NCT01094288|26805564|P3|Overall Study|Withdrawal by Subject|2
7707604|NCT01094288|26805565|P2|Overall Study|Withdrawal by Subject|1
7707605|NCT01094288|26805566|P1|Overall Study|Withdrawal by Subject|0
7707606|NCT01094288|26805559|P8|Overall Study|Adverse Event|0
7707607|NCT01094288|26805560|P7|Overall Study|Adverse Event|0
7707608|NCT01094288|26805561|P6|Overall Study|Adverse Event|0
7707609|NCT01094288|26805562|P5|Overall Study|Adverse Event|0
7707610|NCT01094288|26805563|P4|Overall Study|Adverse Event|1
7707611|NCT01094288|26805564|P3|Overall Study|Adverse Event|1
7707612|NCT01094288|26805565|P2|Overall Study|Adverse Event|3
7707613|NCT01094288|26805566|P1|Overall Study|Adverse Event|0
7707614|NCT01094184|26805678|P2|Overall Study|Death|11
7707615|NCT01094184|26805679|P1|Overall Study|Death|35
7707616|NCT01094171|26805913|P1|Overall Study|Other|1
7707617|NCT01094171|26805913|P1|Overall Study|Migration from the study area|3
7707618|NCT01094171|26805913|P1|Overall Study|Informed consent withdrawal|4
7707619|NCT01094171|26805913|P1|Overall Study|Lost to Follow-up|2
7707620|NCT01094119|26805922|P2|Overall Study|Lack of Efficacy|4
7707621|NCT01094119|26805923|P1|Overall Study|Lack of Efficacy|2
7707622|NCT01093885|26805948|P1|Overall Study|Lost to Follow-up|1
7707623|NCT01093885|26805948|P1|Overall Study|Adverse Event|4
7707624|NCT01093846|26805956|P3|Overall Study|Administrative Problems|15
7707625|NCT01093846|26805957|P2|Overall Study|Administrative Problems|17
7707626|NCT01093846|26805958|P1|Overall Study|Administrative Problems|18
7707627|NCT01093846|26805956|P3|Overall Study|Condition no longer required study drug|1
7707628|NCT01093846|26805957|P2|Overall Study|Condition no longer required study drug|1
7707629|NCT01093846|26805958|P1|Overall Study|Condition no longer required study drug|1
7707630|NCT01093846|26805956|P3|Overall Study|Lack of Efficacy|4
7707631|NCT01093846|26805957|P2|Overall Study|Lack of Efficacy|0
7707632|NCT01093846|26805958|P1|Overall Study|Lack of Efficacy|0
7707633|NCT01093846|26805956|P3|Overall Study|Adverse Event|1
7707634|NCT01093846|26805957|P2|Overall Study|Adverse Event|0
7707635|NCT01093846|26805958|P1|Overall Study|Adverse Event|0
7707636|NCT01093755|26805983|P2|Overall Study|Withdrawal by Subject|4
7707637|NCT01093755|26805984|P1|Overall Study|Withdrawal by Subject|3
7707638|NCT01093625|26806024|P2|1-Year Visit|Lost to Follow-up|3
7707639|NCT01093625|26806025|P1|1-Year Visit|Lost to Follow-up|5
7707640|NCT01093625|26806024|P2|6-Month Visit|Lost to Follow-up|2
7707641|NCT01093625|26806025|P1|6-Month Visit|Lost to Follow-up|2
7707642|NCT01093625|26806024|P2|6-Month Visit|Withdrawal by Subject|7
7707643|NCT01093625|26806025|P1|6-Month Visit|Withdrawal by Subject|6
7707644|NCT01093625|26806024|P2|3-Month Visit|Lost to Follow-up|0
7707645|NCT01093625|26806025|P1|3-Month Visit|Lost to Follow-up|2
7707646|NCT01093625|26806024|P2|1-Month Visit|Lost to Follow-up|0
7707647|NCT01093625|26806025|P1|1-Month Visit|Lost to Follow-up|2
7707648|NCT01093625|26806024|P2|2-Week Visit|Withdrawal by Subject|0
7707649|NCT01093625|26806025|P1|2-Week Visit|Withdrawal by Subject|1
7707650|NCT01093625|26806024|P2|Baseline and Dispensed|Withdrawal by Subject|0
7707651|NCT01093625|26806025|P1|Baseline and Dispensed|Withdrawal by Subject|2
7707652|NCT01093599|26806045|P2|Overall Study|Lost to Follow-up|46
7707653|NCT01093599|26806046|P1|Overall Study|Lost to Follow-up|32
7707654|NCT01093586|26806052|P1|Overall Study|Failed to engraft|3
7707655|NCT01093573|26806073|P3|Overall Study|Insurance Denied|1
7707656|NCT01093573|26806074|P2|Overall Study|Insurance Denied|0
7707657|NCT01093573|26806075|P1|Overall Study|Insurance Denied|0
7707658|NCT01093573|26806073|P3|Overall Study|Physician Decision|1
7707659|NCT01093573|26806074|P2|Overall Study|Physician Decision|0
7707660|NCT01093573|26806075|P1|Overall Study|Physician Decision|0
7707661|NCT01093534|26806092|P3|Overall Study|Other|4
7707662|NCT01093534|26806093|P2|Overall Study|Other|3
7707663|NCT01093534|26806094|P1|Overall Study|Other|1
7707664|NCT01093534|26806092|P3|Overall Study|Withdrawal by Subject|2
7707665|NCT01093534|26806093|P2|Overall Study|Withdrawal by Subject|7
7707666|NCT01093534|26806094|P1|Overall Study|Withdrawal by Subject|5
7707667|NCT01093534|26806092|P3|Overall Study|Lack of Efficacy|1
7707668|NCT01093534|26806093|P2|Overall Study|Lack of Efficacy|1
7707669|NCT01093534|26806094|P1|Overall Study|Lack of Efficacy|2
7707670|NCT01093534|26806092|P3|Overall Study|Adverse Event|2
7707671|NCT01093534|26806093|P2|Overall Study|Adverse Event|5
7707672|NCT01093534|26806094|P1|Overall Study|Adverse Event|2
7707673|NCT01093222|26806242|P1|Overall Study|Not protocol specified|1
7707674|NCT01093222|26806242|P1|Overall Study|Death|2
7707675|NCT01093222|26806242|P1|Overall Study|Progression/relapse|24
7707676|NCT01093222|26806242|P1|Overall Study|Adverse Event|7
7707677|NCT01093222|26806242|P1|Overall Study|Ineligible|6
7707678|NCT01092832|26806318|P2|Overall Study|Other|0
7707679|NCT01092832|26806319|P1|Overall Study|Other|1
7707680|NCT01092780|26806331|P4|Washout Period 2|Adverse Event|0
7707681|NCT01092780|26806332|P3|Washout Period 2|Adverse Event|1
7707682|NCT01092780|26806333|P2|Washout Period 2|Adverse Event|1
7707683|NCT01092780|26806334|P1|Washout Period 2|Adverse Event|0
7707684|NCT01092780|26806331|P4|Washout Period 1|Noncompliance with nCPAP|0
7707685|NCT01092780|26806332|P3|Washout Period 1|Noncompliance with nCPAP|0
7707686|NCT01092780|26806333|P2|Washout Period 1|Noncompliance with nCPAP|0
7707687|NCT01092780|26806334|P1|Washout Period 1|Noncompliance with nCPAP|1
7707688|NCT01092780|26806331|P4|Washout Period 1|Adverse Event|0
7707689|NCT01092780|26806332|P3|Washout Period 1|Adverse Event|0
7707690|NCT01092780|26806333|P2|Washout Period 1|Adverse Event|1
7707691|NCT01092780|26806334|P1|Washout Period 1|Adverse Event|0
7707692|NCT01092728|26806370|P2|Overall Study|Prohibited Concomitant Medications|0
7707693|NCT01092728|26806371|P1|Overall Study|Prohibited Concomitant Medications|1
7707694|NCT01092728|26806370|P2|Overall Study|Disease Progression|13
7707695|NCT01092728|26806371|P1|Overall Study|Disease Progression|1
7707696|NCT01092728|26806370|P2|Overall Study|Adverse Event|1
7707697|NCT01092728|26806371|P1|Overall Study|Adverse Event|0
7707698|NCT01092728|26806370|P2|Overall Study|Withdrawal by Subject|0
7707699|NCT01092728|26806371|P1|Overall Study|Withdrawal by Subject|2
7707700|NCT01092702|26806379|P1|Overall Study|Lost to Follow-up|2
7707701|NCT01092702|26806379|P1|Overall Study|Withdrawal by Subject|7
7707702|NCT01092663|26806396|P2|Overall Study|Protocol Violation|1
7707703|NCT01092663|26806397|P1|Overall Study|Protocol Violation|0
7707704|NCT01092663|26806396|P2|Overall Study|Adverse Event|1
7707705|NCT01092663|26806397|P1|Overall Study|Adverse Event|1
7707706|NCT01092663|26806396|P2|Overall Study|High fasting triglyceride|0
7707707|NCT01092663|26806397|P1|Overall Study|High fasting triglyceride|2
7707708|NCT01092663|26806396|P2|Overall Study|Glucose >300mg/dL|0
7707709|NCT01092663|26806397|P1|Overall Study|Glucose >300mg/dL|1
7707710|NCT01092663|26806396|P2|Overall Study|Withdrawal by Subject|2
7707711|NCT01092663|26806397|P1|Overall Study|Withdrawal by Subject|3
7707712|NCT01092637|26806445|P2|Overall Study|Death|49
7707713|NCT01092637|26806446|P1|Overall Study|Death|47
7707714|NCT01092546|26806461|P1|Overall Study|Subjects withdrawn prior to dosing|4
7707715|NCT01092507|26806468|P2|Overall Study|Withdrawal by Subject|0
7707716|NCT01092507|26806469|P1|Overall Study|Withdrawal by Subject|2
7707717|NCT01092416|26806504|P1|12-Month Follow-up|Data collected after close of 1Y window|2
7707718|NCT01092416|26806504|P1|12-Month Follow-up|Missed 1-year follow-up|1
7707719|NCT01092416|26806504|P1|12-Month Follow-up|Withdrawal by Subject|2
7707720|NCT01092416|26806504|P1|12-Month Follow-up|Lost to Follow-up|4
7707721|NCT01092416|26806504|P1|12-Month Follow-up|Death|16
7707722|NCT01092416|26806504|P1|30-Day Follow-up|Data collected after close of 30D window|5
7707723|NCT01092416|26806504|P1|30-Day Follow-up|Missed 30-day follow-up|3
7707724|NCT01092416|26806504|P1|30-Day Follow-up|Death|2
7707725|NCT01092416|26806504|P1|Enrollment|Atherectomy device not inserted|3
7707726|NCT01091974|26806554|P4|Overall Study|side-effects|2
7707727|NCT01091974|26806555|P3|Overall Study|side-effects|0
7707728|NCT01091974|26806556|P2|Overall Study|side-effects|1
7707729|NCT01091974|26806557|P1|Overall Study|side-effects|1
7707730|NCT01091974|26806554|P4|Overall Study|Withdrawal by Subject|2
7707731|NCT01091974|26806555|P3|Overall Study|Withdrawal by Subject|2
7707732|NCT01091974|26806556|P2|Overall Study|Withdrawal by Subject|3
7707733|NCT01091974|26806557|P1|Overall Study|Withdrawal by Subject|1
7707734|NCT01091974|26806554|P4|Overall Study|resumed sleep medication|2
7707735|NCT01091974|26806555|P3|Overall Study|resumed sleep medication|1
7707736|NCT01091974|26806556|P2|Overall Study|resumed sleep medication|0
7707737|NCT01091974|26806557|P1|Overall Study|resumed sleep medication|0
7707738|NCT01091974|26806554|P4|Overall Study|Did not start intervention|1
7707739|NCT01091974|26806555|P3|Overall Study|Did not start intervention|3
7707740|NCT01091974|26806556|P2|Overall Study|Did not start intervention|1
7707741|NCT01091974|26806557|P1|Overall Study|Did not start intervention|3
7707742|NCT01091675|26806592|P1|Overall Study|Lack of Efficacy|27
7707743|NCT01091675|26806592|P1|Overall Study|Adverse Event|7
7707744|NCT01091662|26806598|P2|Overall Study|unable to swallow capsule|1
7707745|NCT01091662|26806599|P1|Overall Study|unable to swallow capsule|0
7707746|NCT01091662|26806598|P2|Overall Study|Protocol Violation|2
7707747|NCT01091662|26806599|P1|Overall Study|Protocol Violation|0
7707748|NCT01091662|26806598|P2|Overall Study|Pregnancy|1
7707749|NCT01091662|26806599|P1|Overall Study|Pregnancy|0
7707750|NCT01091662|26806598|P2|Overall Study|Lost to Follow-up|1
7707751|NCT01091662|26806599|P1|Overall Study|Lost to Follow-up|0
7707752|NCT01091662|26806598|P2|Overall Study|met exclusion criteria|0
7707753|NCT01091662|26806599|P1|Overall Study|met exclusion criteria|1
7707754|NCT01091662|26806598|P2|Overall Study|met exit criteria|13
7707755|NCT01091662|26806599|P1|Overall Study|met exit criteria|7
7707756|NCT01091662|26806598|P2|Overall Study|Withdrawal by Subject|6
7707757|NCT01091662|26806599|P1|Overall Study|Withdrawal by Subject|7
7707758|NCT01091662|26806598|P2|Overall Study|Physician Decision|1
7707759|NCT01091662|26806599|P1|Overall Study|Physician Decision|1
7707760|NCT01091662|26806598|P2|Overall Study|Adverse Event|9
7707761|NCT01091662|26806599|P1|Overall Study|Adverse Event|1
7707762|NCT01091519|26806637|P2|Overall Study|Randomized not treated|4
7707763|NCT01091519|26806638|P1|Overall Study|Randomized not treated|4
7707764|NCT01091519|26806637|P2|Overall Study|Other|8
7707765|NCT01091519|26806638|P1|Overall Study|Other|6
7707766|NCT01091519|26806637|P2|Overall Study|Withdrawal by Subject|2
7707767|NCT01091519|26806638|P1|Overall Study|Withdrawal by Subject|2
7707768|NCT01091519|26806637|P2|Overall Study|Lost to Follow-up|24
7707769|NCT01091519|26806638|P1|Overall Study|Lost to Follow-up|14
7707770|NCT01091519|26806637|P2|Overall Study|Lack of Efficacy|19
7707771|NCT01091519|26806638|P1|Overall Study|Lack of Efficacy|16
7707772|NCT01091519|26806637|P2|Overall Study|Death|0
7707773|NCT01091519|26806638|P1|Overall Study|Death|1
7707774|NCT01091519|26806637|P2|Overall Study|Adverse Event|16
7707775|NCT01091519|26806638|P1|Overall Study|Adverse Event|12
7707776|NCT01091454|26806650|P1|Overall Study|Ineligible|1
7707777|NCT01091428|26806663|P4|Phase 2|Physician Decision|0
7707778|NCT01091428|26806664|P3|Phase 2|Physician Decision|2
7707779|NCT01091428|26806665|P2|Phase 2|Physician Decision|0
7707780|NCT01091428|26806666|P1|Phase 2|Physician Decision|0
7707781|NCT01091428|26806663|P4|Phase 2|Reason not specified|3
7707782|NCT01091428|26806664|P3|Phase 2|Reason not specified|4
7707783|NCT01091428|26806665|P2|Phase 2|Reason not specified|0
7707784|NCT01091428|26806666|P1|Phase 2|Reason not specified|0
7707785|NCT01091428|26806663|P4|Phase 2|Unsatisfactory Therapeutic Response|1
7707786|NCT01091428|26806664|P3|Phase 2|Unsatisfactory Therapeutic Response|1
7707787|NCT01091428|26806665|P2|Phase 2|Unsatisfactory Therapeutic Response|0
7707788|NCT01091428|26806666|P1|Phase 2|Unsatisfactory Therapeutic Response|0
7707789|NCT01091428|26806663|P4|Phase 2|Withdrawal by Subject|8
7707790|NCT01091428|26806664|P3|Phase 2|Withdrawal by Subject|9
7707791|NCT01091428|26806665|P2|Phase 2|Withdrawal by Subject|0
7707792|NCT01091428|26806666|P1|Phase 2|Withdrawal by Subject|0
7707793|NCT01091428|26806663|P4|Phase 2|Adverse Event|5
7707794|NCT01091428|26806664|P3|Phase 2|Adverse Event|12
7707795|NCT01091428|26806665|P2|Phase 2|Adverse Event|0
7707796|NCT01091428|26806666|P1|Phase 2|Adverse Event|0
7707797|NCT01091428|26806663|P4|Phase 2|Symptomatic Deterioration|6
7707798|NCT01091428|26806664|P3|Phase 2|Symptomatic Deterioration|1
7707799|NCT01091428|26806665|P2|Phase 2|Symptomatic Deterioration|0
7707800|NCT01091428|26806666|P1|Phase 2|Symptomatic Deterioration|0
7707801|NCT01091428|26806663|P4|Phase 2|Progressive Disease|46
7707802|NCT01091428|26806664|P3|Phase 2|Progressive Disease|44
7707803|NCT01091428|26806665|P2|Phase 2|Progressive Disease|0
7707804|NCT01091428|26806666|P1|Phase 2|Progressive Disease|0
7707805|NCT01091428|26806663|P4|Phase 1|Single-Patient IND|0
7707806|NCT01091428|26806664|P3|Phase 1|Single-Patient IND|0
7707807|NCT01091428|26806665|P2|Phase 1|Single-Patient IND|0
7707808|NCT01091428|26806666|P1|Phase 1|Single-Patient IND|2
7707809|NCT01091428|26806663|P4|Phase 1|Reason not specified|0
7707810|NCT01091428|26806664|P3|Phase 1|Reason not specified|0
7707811|NCT01091428|26806665|P2|Phase 1|Reason not specified|1
7707812|NCT01091428|26806666|P1|Phase 1|Reason not specified|0
7707813|NCT01091428|26806663|P4|Phase 1|Withdrawal by Subject|0
7707814|NCT01091428|26806664|P3|Phase 1|Withdrawal by Subject|0
7707815|NCT01091428|26806665|P2|Phase 1|Withdrawal by Subject|0
7707816|NCT01091428|26806666|P1|Phase 1|Withdrawal by Subject|7
7707817|NCT01091428|26806663|P4|Phase 1|Adverse Event|0
7707818|NCT01091428|26806664|P3|Phase 1|Adverse Event|0
7707819|NCT01091428|26806665|P2|Phase 1|Adverse Event|0
7707820|NCT01091428|26806666|P1|Phase 1|Adverse Event|2
7707821|NCT01091428|26806663|P4|Phase 1|Symptomatic Deterioration|0
7707822|NCT01091428|26806664|P3|Phase 1|Symptomatic Deterioration|0
7707823|NCT01091428|26806665|P2|Phase 1|Symptomatic Deterioration|2
7707824|NCT01091428|26806666|P1|Phase 1|Symptomatic Deterioration|3
7707825|NCT01091428|26806663|P4|Phase 1|Progressive Disease|0
7707826|NCT01091428|26806664|P3|Phase 1|Progressive Disease|0
7707827|NCT01091428|26806665|P2|Phase 1|Progressive Disease|8
7707828|NCT01091428|26806666|P1|Phase 1|Progressive Disease|24
7707829|NCT01091363|26806769|P2|Overall Study|Lost to Follow-up|2
7707830|NCT01091363|26806770|P1|Overall Study|Lost to Follow-up|2
7707831|NCT01091363|26806769|P2|Overall Study|Withdrawal by Subject|15
7707832|NCT01091363|26806770|P1|Overall Study|Withdrawal by Subject|11
7707833|NCT01091259|26806780|P1|Overall Study|Lack of Efficacy|2
7707834|NCT01091259|26806780|P1|Overall Study|Adverse Event|3
7707835|NCT01091246|26806791|P3|Overall Study|Subject not dosed|1
7707836|NCT01091246|26806792|P2|Overall Study|Subject not dosed|0
7707837|NCT01091246|26806793|P1|Overall Study|Subject not dosed|2
7707838|NCT01091246|26806791|P3|Overall Study|Withdrawal by Subject|4
7707839|NCT01091246|26806792|P2|Overall Study|Withdrawal by Subject|5
7707840|NCT01091246|26806793|P1|Overall Study|Withdrawal by Subject|9
7707841|NCT01091246|26806791|P3|Overall Study|Adverse Event|1
7707842|NCT01091246|26806792|P2|Overall Study|Adverse Event|0
7707843|NCT01091246|26806793|P1|Overall Study|Adverse Event|1
7707844|NCT01091246|26806791|P3|Overall Study|Lost to Follow-up|7
7707845|NCT01091246|26806792|P2|Overall Study|Lost to Follow-up|11
7707846|NCT01091246|26806793|P1|Overall Study|Lost to Follow-up|23
7707847|NCT01091168|26806869|P2|Overall Study|Physician, patient's decision, other|37
7707848|NCT01091168|26806870|P1|Overall Study|Physician, patient's decision, other|27
7707849|NCT01091168|26806869|P2|Overall Study|Lost to Follow-up|1
7707850|NCT01091168|26806870|P1|Overall Study|Lost to Follow-up|0
7707851|NCT01091168|26806869|P2|Overall Study|Adverse Event|24
7707852|NCT01091168|26806870|P1|Overall Study|Adverse Event|21
7707853|NCT01091168|26806869|P2|Overall Study|Progressive disease|234
7707854|NCT01091168|26806870|P1|Overall Study|Progressive disease|250
7707855|NCT01091103|26806945|P1|Overall Study|Progressive Disease|3
7707856|NCT01091103|26806945|P1|Overall Study|Adverse Event|1
7707857|NCT01090973|26806965|P1|Overall Study|Disease progression|1
7707858|NCT01090765|26806986|P6|Overall Study|Vasovagal reaction with first infusion|0
7707859|NCT01090765|26806987|P5|Overall Study|Vasovagal reaction with first infusion|1
7707860|NCT01090765|26806988|P4|Overall Study|Vasovagal reaction with first infusion|0
7707861|NCT01090765|26806989|P3|Overall Study|Vasovagal reaction with first infusion|0
7707862|NCT01090765|26806990|P2|Overall Study|Vasovagal reaction with first infusion|0
7707863|NCT01090765|26806991|P1|Overall Study|Vasovagal reaction with first infusion|0
7707864|NCT01090765|26806986|P6|Overall Study|Developed a DVT, needed anticoagulation|0
7707865|NCT01090765|26806987|P5|Overall Study|Developed a DVT, needed anticoagulation|0
7707866|NCT01090765|26806988|P4|Overall Study|Developed a DVT, needed anticoagulation|1
7707867|NCT01090765|26806989|P3|Overall Study|Developed a DVT, needed anticoagulation|0
7707868|NCT01090765|26806990|P2|Overall Study|Developed a DVT, needed anticoagulation|0
7707869|NCT01090765|26806991|P1|Overall Study|Developed a DVT, needed anticoagulation|0
7707870|NCT01090765|26806986|P6|Overall Study|Patient withdrew consent|1
7707871|NCT01090765|26806987|P5|Overall Study|Patient withdrew consent|1
7707872|NCT01090765|26806988|P4|Overall Study|Patient withdrew consent|0
7707873|NCT01090765|26806989|P3|Overall Study|Patient withdrew consent|0
7707874|NCT01090765|26806990|P2|Overall Study|Patient withdrew consent|0
7707875|NCT01090765|26806991|P1|Overall Study|Patient withdrew consent|0
7707876|NCT01090739|26807037|P1|36 Month Follow-up|Visit still pending|17
7707877|NCT01090739|26807037|P1|36 Month Follow-up|Withdrawal by Subject|6
7707878|NCT01090739|26807037|P1|24 Month Follow-up|Death|1
7707879|NCT01090739|26807037|P1|24 Month Follow-up|Lost to Follow-up|1
7707880|NCT01090739|26807037|P1|24 Month Follow-up|Withdrawal by Subject|7
7707881|NCT01090739|26807037|P1|12 Month Follow-up|Death|1
7707882|NCT01090739|26807037|P1|12 Month Follow-up|Physician Decision|1
7707883|NCT01090739|26807037|P1|12 Month Follow-up|Lost to Follow-up|1
7707884|NCT01090739|26807037|P1|12 Month Follow-up|Withdrawal by Subject|2
7707885|NCT01090739|26807037|P1|Enrollment|Adverse Event|1
7707886|NCT01090739|26807037|P1|Enrollment|Study implant limit reached|2
7707887|NCT01090739|26807037|P1|Enrollment|Sponsor termination of site|4
7707888|NCT01090739|26807037|P1|Enrollment|Physician Decision|5
7707889|NCT01090739|26807037|P1|Enrollment|Lost to Follow-up|5
7707890|NCT01090739|26807037|P1|Enrollment|Protocol Violation|14
7707891|NCT01090739|26807037|P1|Enrollment|Withdrawal by Subject|24
7707892|NCT01090492|26807062|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707893|NCT01090492|26807063|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
7707894|NCT01090492|26807064|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707895|NCT01090492|26807065|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707896|NCT01090492|26807066|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707897|NCT01090492|26807067|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707898|NCT01090492|26807068|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707899|NCT01090492|26807069|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7707900|NCT01090492|26807062|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
7707901|NCT01090492|26807063|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
7707902|NCT01090492|26807064|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
7707903|NCT01090492|26807065|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
7707904|NCT01090492|26807066|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
7707905|NCT01090492|26807067|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
7707906|NCT01090492|26807068|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
7707907|NCT01090492|26807069|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
7707908|NCT01090492|26807062|P8|Second Intervention Period (4 Weeks)|Other|0
7707909|NCT01090492|26807063|P7|Second Intervention Period (4 Weeks)|Other|0
7707910|NCT01090492|26807064|P6|Second Intervention Period (4 Weeks)|Other|0
7707911|NCT01090492|26807065|P5|Second Intervention Period (4 Weeks)|Other|0
7707912|NCT01090492|26807066|P4|Second Intervention Period (4 Weeks)|Other|0
7707913|NCT01090492|26807067|P3|Second Intervention Period (4 Weeks)|Other|1
7707914|NCT01090492|26807068|P2|Second Intervention Period (4 Weeks)|Other|1
7707915|NCT01090492|26807069|P1|Second Intervention Period (4 Weeks)|Other|0
7707916|NCT01090492|26807062|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
7707917|NCT01090492|26807063|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
7707918|NCT01090492|26807064|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
7707919|NCT01090492|26807065|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
7707920|NCT01090492|26807066|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
7707921|NCT01090492|26807067|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
7707922|NCT01090492|26807068|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
7707923|NCT01090492|26807069|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
7707924|NCT01090492|26807062|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
7707925|NCT01090492|26807063|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
7707926|NCT01090492|26807064|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
7707927|NCT01090492|26807065|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
7707928|NCT01090492|26807066|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
7707929|NCT01090492|26807067|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
7707930|NCT01090492|26807068|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
7707931|NCT01090492|26807069|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
7707932|NCT01090492|26807062|P8|First Intervention Period (4 Weeks)|Adverse Event|5
7707933|NCT01090492|26807063|P7|First Intervention Period (4 Weeks)|Adverse Event|0
7707934|NCT01090492|26807064|P6|First Intervention Period (4 Weeks)|Adverse Event|2
7707935|NCT01090492|26807065|P5|First Intervention Period (4 Weeks)|Adverse Event|1
7707936|NCT01090492|26807066|P4|First Intervention Period (4 Weeks)|Adverse Event|3
7707937|NCT01090492|26807067|P3|First Intervention Period (4 Weeks)|Adverse Event|0
7707938|NCT01090492|26807068|P2|First Intervention Period (4 Weeks)|Adverse Event|2
7707939|NCT01090492|26807069|P1|First Intervention Period (4 Weeks)|Adverse Event|0
7707940|NCT01090492|26807062|P8|First Intervention Period (4 Weeks)|Pregnancy|0
7707941|NCT01090492|26807063|P7|First Intervention Period (4 Weeks)|Pregnancy|0
7707942|NCT01090492|26807064|P6|First Intervention Period (4 Weeks)|Pregnancy|0
7707943|NCT01090492|26807065|P5|First Intervention Period (4 Weeks)|Pregnancy|1
7707944|NCT01090492|26807066|P4|First Intervention Period (4 Weeks)|Pregnancy|0
7707945|NCT01090492|26807067|P3|First Intervention Period (4 Weeks)|Pregnancy|0
7707946|NCT01090492|26807068|P2|First Intervention Period (4 Weeks)|Pregnancy|0
7707947|NCT01090492|26807069|P1|First Intervention Period (4 Weeks)|Pregnancy|0
7707948|NCT01090492|26807062|P8|First Intervention Period (4 Weeks)|Other|0
7707949|NCT01090492|26807063|P7|First Intervention Period (4 Weeks)|Other|0
7707950|NCT01090492|26807064|P6|First Intervention Period (4 Weeks)|Other|0
7707951|NCT01090492|26807065|P5|First Intervention Period (4 Weeks)|Other|2
7707952|NCT01090492|26807066|P4|First Intervention Period (4 Weeks)|Other|1
7707953|NCT01090492|26807067|P3|First Intervention Period (4 Weeks)|Other|1
7707954|NCT01090492|26807068|P2|First Intervention Period (4 Weeks)|Other|0
7707955|NCT01090492|26807069|P1|First Intervention Period (4 Weeks)|Other|0
7707956|NCT01090492|26807062|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707957|NCT01090492|26807063|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707958|NCT01090492|26807064|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707959|NCT01090492|26807065|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707960|NCT01090492|26807066|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707961|NCT01090492|26807067|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
7707962|NCT01090492|26807068|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707963|NCT01090492|26807069|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7707964|NCT01090492|26807062|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
7707965|NCT01090492|26807063|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7707966|NCT01090492|26807064|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7707967|NCT01090492|26807065|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7707968|NCT01090492|26807066|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7707969|NCT01090492|26807067|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7707970|NCT01090492|26807068|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
7707971|NCT01090492|26807069|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7707972|NCT01090492|26807062|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
7707973|NCT01090492|26807063|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
7707974|NCT01090492|26807064|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
7707975|NCT01090492|26807065|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
7707976|NCT01090492|26807066|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
7707977|NCT01090492|26807067|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
7707978|NCT01090492|26807068|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
7707979|NCT01090492|26807069|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
7707980|NCT01090453|26807137|P2|Overall Study|Eligibility Criteria|1
7707981|NCT01090453|26807138|P1|Overall Study|Eligibility Criteria|0
7707982|NCT01090453|26807137|P2|Overall Study|Other|4
7707983|NCT01090453|26807138|P1|Overall Study|Other|2
7707984|NCT01090453|26807137|P2|Overall Study|Protocol Violation|0
7707985|NCT01090453|26807138|P1|Overall Study|Protocol Violation|2
7707986|NCT01090453|26807137|P2|Overall Study|Non serious AEs|0
7707987|NCT01090453|26807138|P1|Overall Study|Non serious AEs|1
7707988|NCT01090453|26807137|P2|Overall Study|Lost to Follow-up|7
7707989|NCT01090453|26807138|P1|Overall Study|Lost to Follow-up|7
7707990|NCT01090453|26807137|P2|Overall Study|Withdrawal by Subject|2
7707991|NCT01090453|26807138|P1|Overall Study|Withdrawal by Subject|1
7707992|NCT01090427|26807189|P7|After Controlled Period|Adverse Event|0
7707993|NCT01090427|26807190|P6|After Controlled Period|Adverse Event|1
7707994|NCT01090427|26807191|P5|After Controlled Period|Adverse Event|0
7707995|NCT01090427|26807192|P4|After Controlled Period|Adverse Event|2
7707996|NCT01090427|26807193|P3|After Controlled Period|Adverse Event|0
7707997|NCT01090427|26807194|P2|After Controlled Period|Adverse Event|0
7707998|NCT01090427|26807195|P1|After Controlled Period|Adverse Event|0
7707999|NCT01090427|26807189|P7|After Controlled Period|Lack of Efficacy|2
7708000|NCT01090427|26807190|P6|After Controlled Period|Lack of Efficacy|3
7708001|NCT01090427|26807191|P5|After Controlled Period|Lack of Efficacy|0
7708002|NCT01090427|26807192|P4|After Controlled Period|Lack of Efficacy|0
7708003|NCT01090427|26807193|P3|After Controlled Period|Lack of Efficacy|0
7708004|NCT01090427|26807194|P2|After Controlled Period|Lack of Efficacy|0
7708005|NCT01090427|26807195|P1|After Controlled Period|Lack of Efficacy|0
7708006|NCT01090427|26807189|P7|After Controlled Period|Death|0
7708007|NCT01090427|26807190|P6|After Controlled Period|Death|1
7708008|NCT01090427|26807191|P5|After Controlled Period|Death|0
7708009|NCT01090427|26807192|P4|After Controlled Period|Death|0
7708010|NCT01090427|26807193|P3|After Controlled Period|Death|0
7708011|NCT01090427|26807194|P2|After Controlled Period|Death|0
7708012|NCT01090427|26807195|P1|After Controlled Period|Death|0
7708013|NCT01090414|26807232|P4|Study 101-99|Participant Request|0
7708014|NCT01090414|26807233|P3|Study 101-99|Participant Request|0
7708015|NCT01090414|26807234|P2|Study 101-99|Participant Request|1
7708016|NCT01090414|26807235|P1|Study 101-99|Participant Request|3
7708017|NCT01090414|26807232|P4|Study 101-99|Withdrew Consent|1
7708018|NCT01090414|26807233|P3|Study 101-99|Withdrew Consent|3
7708019|NCT01090414|26807234|P2|Study 101-99|Withdrew Consent|2
7708020|NCT01090414|26807235|P1|Study 101-99|Withdrew Consent|0
7708021|NCT01090414|26807232|P4|Study 101-99|Other (Unknown Reasons)|0
7708022|NCT01090414|26807233|P3|Study 101-99|Other (Unknown Reasons)|0
7708023|NCT01090414|26807234|P2|Study 101-99|Other (Unknown Reasons)|3
7708024|NCT01090414|26807235|P1|Study 101-99|Other (Unknown Reasons)|3
7708025|NCT01090414|26807232|P4|Study 101-99|Sponsor Discontinued Study|0
7708026|NCT01090414|26807233|P3|Study 101-99|Sponsor Discontinued Study|5
7708027|NCT01090414|26807234|P2|Study 101-99|Sponsor Discontinued Study|7
7708028|NCT01090414|26807235|P1|Study 101-99|Sponsor Discontinued Study|0
7708029|NCT01090414|26807232|P4|Study 101-99|Death|0
7708030|NCT01090414|26807233|P3|Study 101-99|Death|1
7708031|NCT01090414|26807234|P2|Study 101-99|Death|8
7708032|NCT01090414|26807235|P1|Study 101-99|Death|3
7708033|NCT01090414|26807232|P4|Study 101-99|Investigator Request|0
7708034|NCT01090414|26807233|P3|Study 101-99|Investigator Request|4
7708035|NCT01090414|26807234|P2|Study 101-99|Investigator Request|11
7708036|NCT01090414|26807235|P1|Study 101-99|Investigator Request|1
7708037|NCT01090414|26807232|P4|Study 101-99|Adverse Event|0
7708038|NCT01090414|26807233|P3|Study 101-99|Adverse Event|18
7708039|NCT01090414|26807234|P2|Study 101-99|Adverse Event|28
7708040|NCT01090414|26807235|P1|Study 101-99|Adverse Event|10
7708041|NCT01090414|26807232|P4|Study 101-99|Progressive Disease|4
7708042|NCT01090414|26807233|P3|Study 101-99|Progressive Disease|10
7708043|NCT01090414|26807234|P2|Study 101-99|Progressive Disease|48
7708044|NCT01090414|26807235|P1|Study 101-99|Progressive Disease|28
7708045|NCT01090323|26807302|P2|Overall Study|Stopped end of extension 1#|1
7708046|NCT01090323|26807303|P1|Overall Study|Stopped end of extension 1#|3
7708047|NCT01090323|26807302|P2|Overall Study|Stopped end of core|0
7708048|NCT01090323|26807303|P1|Overall Study|Stopped end of core|7
7708049|NCT01090323|26807302|P2|Overall Study|Death|2
7708050|NCT01090323|26807303|P1|Overall Study|Death|1
7708051|NCT01090323|26807302|P2|Overall Study|Administrative problems|4
7708052|NCT01090323|26807303|P1|Overall Study|Administrative problems|6
7708053|NCT01090323|26807302|P2|Overall Study|Lost to Follow-up|6
7708054|NCT01090323|26807303|P1|Overall Study|Lost to Follow-up|11
7708055|NCT01090323|26807302|P2|Overall Study|Withdrew consent|11
7708056|NCT01090323|26807303|P1|Overall Study|Withdrew consent|33
7708057|NCT01090323|26807302|P2|Overall Study|Protocol Violation|1
7708058|NCT01090323|26807303|P1|Overall Study|Protocol Violation|2
7708059|NCT01090323|26807302|P2|Overall Study|Condition no longer requires drug|4
7708060|NCT01090323|26807303|P1|Overall Study|Condition no longer requires drug|5
7708061|NCT01090323|26807302|P2|Overall Study|Unsatisfactory therapeutic effect|2
7708062|NCT01090323|26807303|P1|Overall Study|Unsatisfactory therapeutic effect|4
7708063|NCT01090323|26807302|P2|Overall Study|Abnormal Test Procedure Results|0
7708064|NCT01090323|26807303|P1|Overall Study|Abnormal Test Procedure Results|2
7708065|NCT01090323|26807302|P2|Overall Study|Abnormal Lab Values|1
7708066|NCT01090323|26807303|P1|Overall Study|Abnormal Lab Values|3
7708067|NCT01090323|26807302|P2|Overall Study|Adverse Event|2
7708068|NCT01090323|26807303|P1|Overall Study|Adverse Event|12
7708069|NCT01090310|26807315|P4|Extension Study|Subject withdrew consent|0
7708070|NCT01090310|26807316|P3|Extension Study|Subject withdrew consent|0
7708071|NCT01090310|26807317|P2|Extension Study|Subject withdrew consent|1
7708072|NCT01090310|26807318|P1|Extension Study|Subject withdrew consent|0
7708073|NCT01090310|26807315|P4|Extension Study|Unsatisfactory therapeutic effect|1
7708074|NCT01090310|26807316|P3|Extension Study|Unsatisfactory therapeutic effect|1
7708075|NCT01090310|26807317|P2|Extension Study|Unsatisfactory therapeutic effect|0
7708076|NCT01090310|26807318|P1|Extension Study|Unsatisfactory therapeutic effect|1
7708077|NCT01090310|26807315|P4|Extension Study|Adverse Event|1
7708078|NCT01090310|26807316|P3|Extension Study|Adverse Event|0
7708079|NCT01090310|26807317|P2|Extension Study|Adverse Event|0
7708080|NCT01090310|26807318|P1|Extension Study|Adverse Event|0
7708081|NCT01090310|26807315|P4|Extension Study|Aministrative problems|18
7708082|NCT01090310|26807316|P3|Extension Study|Aministrative problems|14
7708083|NCT01090310|26807317|P2|Extension Study|Aministrative problems|15
7708084|NCT01090310|26807318|P1|Extension Study|Aministrative problems|13
7708085|NCT01090310|26807315|P4|Core Study|Protocol deviation|1
7708086|NCT01090310|26807316|P3|Core Study|Protocol deviation|0
7708087|NCT01090310|26807317|P2|Core Study|Protocol deviation|0
7708088|NCT01090310|26807318|P1|Core Study|Protocol deviation|1
7708089|NCT01090310|26807315|P4|Core Study|Administrative reasons|4
7708090|NCT01090310|26807316|P3|Core Study|Administrative reasons|4
7708091|NCT01090310|26807317|P2|Core Study|Administrative reasons|6
7708092|NCT01090310|26807318|P1|Core Study|Administrative reasons|5
7708093|NCT01090310|26807315|P4|Core Study|Abnormal test procedure result|0
7708094|NCT01090310|26807316|P3|Core Study|Abnormal test procedure result|1
7708095|NCT01090310|26807317|P2|Core Study|Abnormal test procedure result|0
7708096|NCT01090310|26807318|P1|Core Study|Abnormal test procedure result|0
7708097|NCT01090310|26807315|P4|Core Study|Subject withdrew consent|1
7708098|NCT01090310|26807316|P3|Core Study|Subject withdrew consent|1
7708099|NCT01090310|26807317|P2|Core Study|Subject withdrew consent|3
7708100|NCT01090310|26807318|P1|Core Study|Subject withdrew consent|0
7708101|NCT01090310|26807315|P4|Core Study|Adverse Event|1
7708102|NCT01090310|26807316|P3|Core Study|Adverse Event|1
7708103|NCT01090310|26807317|P2|Core Study|Adverse Event|2
7708104|NCT01090310|26807318|P1|Core Study|Adverse Event|2
7708105|NCT01090102|26807366|P2|Second 12 Weeks|Withdrawal by Subject|1
7708106|NCT01090102|26807367|P1|Second 12 Weeks|Withdrawal by Subject|0
7708107|NCT01090102|26807366|P2|First 12 Weeks|Death|1
7708108|NCT01090102|26807367|P1|First 12 Weeks|Death|1
7708109|NCT01090102|26807366|P2|First 12 Weeks|Adverse Event|0
7708110|NCT01090102|26807367|P1|First 12 Weeks|Adverse Event|2
7708111|NCT01090102|26807366|P2|First 12 Weeks|Withdrawal by Subject|1
7708112|NCT01090102|26807367|P1|First 12 Weeks|Withdrawal by Subject|1
7708113|NCT01090076|26807377|P2|Overall Study|Withdrawal by Subject|1
7708114|NCT01090076|26807378|P1|Overall Study|Withdrawal by Subject|0
7708115|NCT01090076|26807377|P2|Overall Study|Death|1
7708116|NCT01090076|26807378|P1|Overall Study|Death|1
7708117|NCT01090063|26807388|P1|Treatment|Withdrawal by Subject|4
7708118|NCT01090063|26807388|P1|Screen|Screen Failed|4
7708119|NCT01090050|26807404|P2|Overall Study|Physician Decision|1
7708120|NCT01090050|26807405|P1|Overall Study|Physician Decision|0
7708121|NCT01090050|26807404|P2|Overall Study|Lack of Efficacy|5
7708122|NCT01090050|26807405|P1|Overall Study|Lack of Efficacy|1
7708123|NCT01090050|26807404|P2|Overall Study|Lost to Follow-up|1
7708124|NCT01090050|26807405|P1|Overall Study|Lost to Follow-up|0
7708125|NCT01090011|26807425|P1|Overall Study|Other reason not defined above|5
7708126|NCT01090011|26807425|P1|Overall Study|Refusal to start/continue medication|5
7708127|NCT01090011|26807425|P1|Overall Study|Protocol Violation|1
7708128|NCT01090011|26807425|P1|Overall Study|Adverse Event|32
7708129|NCT01090011|26807425|P1|Overall Study|Progressive disease|128
7708130|NCT01089725|26807521|P5|Overall Study|Other|0
7708131|NCT01089725|26807522|P4|Overall Study|Other|1
7708132|NCT01089725|26807523|P3|Overall Study|Other|0
7708133|NCT01089725|26807524|P2|Overall Study|Other|0
7708134|NCT01089725|26807525|P1|Overall Study|Other|3
7708135|NCT01089725|26807521|P5|Overall Study|Randomized, but not treated|2
7708136|NCT01089725|26807522|P4|Overall Study|Randomized, but not treated|1
7708137|NCT01089725|26807523|P3|Overall Study|Randomized, but not treated|2
7708138|NCT01089725|26807524|P2|Overall Study|Randomized, but not treated|1
7708139|NCT01089725|26807525|P1|Overall Study|Randomized, but not treated|0
7708140|NCT01089725|26807521|P5|Overall Study|Study Terminated by Sponsor|68
7708141|NCT01089725|26807522|P4|Overall Study|Study Terminated by Sponsor|68
7708142|NCT01089725|26807523|P3|Overall Study|Study Terminated by Sponsor|53
7708143|NCT01089725|26807524|P2|Overall Study|Study Terminated by Sponsor|56
7708144|NCT01089725|26807525|P1|Overall Study|Study Terminated by Sponsor|51
7708145|NCT01089725|26807521|P5|Overall Study|Withdrawal by Subject|4
7708146|NCT01089725|26807522|P4|Overall Study|Withdrawal by Subject|5
7708147|NCT01089725|26807523|P3|Overall Study|Withdrawal by Subject|4
7708148|NCT01089725|26807524|P2|Overall Study|Withdrawal by Subject|5
7708149|NCT01089725|26807525|P1|Overall Study|Withdrawal by Subject|5
7708150|NCT01089725|26807521|P5|Overall Study|Protocol Violation|0
7708151|NCT01089725|26807522|P4|Overall Study|Protocol Violation|1
7708152|NCT01089725|26807523|P3|Overall Study|Protocol Violation|1
7708153|NCT01089725|26807524|P2|Overall Study|Protocol Violation|0
7708154|NCT01089725|26807525|P1|Overall Study|Protocol Violation|0
7708155|NCT01089725|26807521|P5|Overall Study|Lost to Follow-up|0
7708156|NCT01089725|26807522|P4|Overall Study|Lost to Follow-up|3
7708157|NCT01089725|26807523|P3|Overall Study|Lost to Follow-up|0
7708158|NCT01089725|26807524|P2|Overall Study|Lost to Follow-up|2
7708159|NCT01089725|26807525|P1|Overall Study|Lost to Follow-up|2
7708160|NCT01089725|26807521|P5|Overall Study|Lack of Efficacy|4
7708161|NCT01089725|26807522|P4|Overall Study|Lack of Efficacy|0
7708162|NCT01089725|26807523|P3|Overall Study|Lack of Efficacy|1
7708163|NCT01089725|26807524|P2|Overall Study|Lack of Efficacy|3
7708164|NCT01089725|26807525|P1|Overall Study|Lack of Efficacy|4
7708165|NCT01089725|26807521|P5|Overall Study|Adverse Event|2
7708166|NCT01089725|26807522|P4|Overall Study|Adverse Event|0
7708167|NCT01089725|26807523|P3|Overall Study|Adverse Event|0
7708168|NCT01089725|26807524|P2|Overall Study|Adverse Event|1
7708169|NCT01089725|26807525|P1|Overall Study|Adverse Event|1
7708170|NCT01089647|26807692|P2|Overall Study|Adverse Event|1
7708171|NCT01089647|26807693|P1|Overall Study|Adverse Event|0
7708172|NCT01089647|26807692|P2|Overall Study|Withdrawal by Subject|1
7708173|NCT01089647|26807693|P1|Overall Study|Withdrawal by Subject|2
7708174|NCT01089647|26807692|P2|Overall Study|Lost to Follow-up|2
7708175|NCT01089647|26807693|P1|Overall Study|Lost to Follow-up|2
7708176|NCT01089608|26807701|P2|Overall Study|Lost to Follow-up|2
7708177|NCT01089608|26807702|P1|Overall Study|Lost to Follow-up|0
7708178|NCT01089608|26807701|P2|Overall Study|Adverse Event|4
7708179|NCT01089608|26807702|P1|Overall Study|Adverse Event|0
7708180|NCT01089582|26807719|P1|Overall Study|Withdrawal by Subject|1
7708181|NCT01089582|26807719|P1|Overall Study|Other|4
7708182|NCT01089582|26807719|P1|Overall Study|Lost to Follow-up|8
7708183|NCT01089582|26807719|P1|Overall Study|Adverse Event|15
7708184|NCT01089582|26807719|P1|Overall Study|Death|2
7708185|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
7708186|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
7708187|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7708188|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
7708189|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7708190|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7708191|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
7708192|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
7708193|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
7708194|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
7708195|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
7708196|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
7708197|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
7708198|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
7708199|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
7708200|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
7708201|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
7708202|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
7708203|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7708204|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7708205|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7708206|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
7708207|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7708208|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7708209|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7708210|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
7708211|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
7708212|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7708213|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7708214|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7708215|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7708216|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7708217|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7708218|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7708219|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7708220|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7708221|NCT01089556|26807762|P6|Study Period III (Weeks 9-16)|Adverse Event|3
7708222|NCT01089556|26807763|P5|Study Period III (Weeks 9-16)|Adverse Event|4
7708223|NCT01089556|26807764|P4|Study Period III (Weeks 9-16)|Adverse Event|2
7708224|NCT01089556|26807765|P3|Study Period III (Weeks 9-16)|Adverse Event|4
7708225|NCT01089556|26807766|P2|Study Period III (Weeks 9-16)|Adverse Event|0
7708226|NCT01089556|26807767|P1|Study Period III (Weeks 9-16)|Adverse Event|0
7708227|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
7708228|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
7708229|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
7708230|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
7708231|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
7708232|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
7708233|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7708234|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7708235|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7708236|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7708237|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
7708238|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
7708239|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
7708240|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
7708241|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
7708242|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
7708243|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
7708244|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
7708245|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Physician Decision|0
7708246|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Physician Decision|0
7708247|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Physician Decision|0
7708248|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Physician Decision|0
7708249|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Physician Decision|0
7708250|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Physician Decision|4
7708251|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7708252|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7708253|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7708254|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7708255|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
7708256|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7708257|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7708258|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7708259|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7708260|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7708261|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
7708262|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
7708263|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7708264|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7708265|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7708266|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7708267|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
7708268|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
7708269|NCT01089556|26807762|P6|Study Period II (Weeks 1-8)|Adverse Event|0
7708270|NCT01089556|26807763|P5|Study Period II (Weeks 1-8)|Adverse Event|0
7708271|NCT01089556|26807764|P4|Study Period II (Weeks 1-8)|Adverse Event|0
7708272|NCT01089556|26807765|P3|Study Period II (Weeks 1-8)|Adverse Event|0
7708273|NCT01089556|26807766|P2|Study Period II (Weeks 1-8)|Adverse Event|39
7708274|NCT01089556|26807767|P1|Study Period II (Weeks 1-8)|Adverse Event|35
7708275|NCT01089543|26807841|P4|Overall Study|Adverse Event|0
7708276|NCT01089543|26807842|P3|Overall Study|Adverse Event|0
7708277|NCT01089543|26807843|P2|Overall Study|Adverse Event|1
7708278|NCT01089543|26807844|P1|Overall Study|Adverse Event|0
7708279|NCT01089543|26807841|P4|Overall Study|Physician Decision|1
7708280|NCT01089543|26807842|P3|Overall Study|Physician Decision|0
7708281|NCT01089543|26807843|P2|Overall Study|Physician Decision|0
7708282|NCT01089543|26807844|P1|Overall Study|Physician Decision|1
7708283|NCT01089543|26807841|P4|Overall Study|Withdrawal by Subject|1
7708284|NCT01089543|26807842|P3|Overall Study|Withdrawal by Subject|3
7708285|NCT01089543|26807843|P2|Overall Study|Withdrawal by Subject|3
7708286|NCT01089543|26807844|P1|Overall Study|Withdrawal by Subject|2
7708287|NCT01089504|26807879|P2|Overall Study|Withdrawal by Subject|0
7708288|NCT01089504|26807880|P1|Overall Study|Withdrawal by Subject|2
7708289|NCT01089504|26807879|P2|Overall Study|Lost to Follow-up|1
7708290|NCT01089504|26807880|P1|Overall Study|Lost to Follow-up|1
7708291|NCT01089413|26807893|P1|Overall Study|Other|71
7708292|NCT01089413|26807893|P1|Overall Study|Metastasectomy|13
7708293|NCT01089413|26807893|P1|Overall Study|Death|10
7708294|NCT01089413|26807893|P1|Overall Study|Unacceptable Toxicity|12
7708295|NCT01089413|26807893|P1|Overall Study|Participant Withdrew Consent|1
7708296|NCT01089413|26807893|P1|Overall Study|Progressive Disease|93
7708297|NCT01089413|26807893|P1|Overall Study|Lost to Follow-up|1
7708298|NCT01089361|26807912|P2|Overall Study|Death|0
7708299|NCT01089361|26807913|P1|Overall Study|Death|1
7708300|NCT01089127|26807962|P6|Overall Study|Protocol deviation|0
7708301|NCT01089127|26807963|P5|Overall Study|Protocol deviation|1
7708302|NCT01089127|26807964|P4|Overall Study|Protocol deviation|0
7708303|NCT01089127|26807965|P3|Overall Study|Protocol deviation|0
7708304|NCT01089127|26807966|P2|Overall Study|Protocol deviation|1
7708305|NCT01089127|26807967|P1|Overall Study|Protocol deviation|0
7708306|NCT01089127|26807962|P6|Overall Study|Lost to Follow-up|0
7708307|NCT01089127|26807963|P5|Overall Study|Lost to Follow-up|1
7708308|NCT01089127|26807964|P4|Overall Study|Lost to Follow-up|0
7708309|NCT01089127|26807965|P3|Overall Study|Lost to Follow-up|0
7708310|NCT01089127|26807966|P2|Overall Study|Lost to Follow-up|1
7708311|NCT01089127|26807967|P1|Overall Study|Lost to Follow-up|1
7708312|NCT01089127|26807962|P6|Overall Study|Abnormal test procedure result(s)|0
7708313|NCT01089127|26807963|P5|Overall Study|Abnormal test procedure result(s)|0
7708314|NCT01089127|26807964|P4|Overall Study|Abnormal test procedure result(s)|0
7708315|NCT01089127|26807965|P3|Overall Study|Abnormal test procedure result(s)|0
7708316|NCT01089127|26807966|P2|Overall Study|Abnormal test procedure result(s)|1
7708317|NCT01089127|26807967|P1|Overall Study|Abnormal test procedure result(s)|2
7708318|NCT01089127|26807962|P6|Overall Study|Subject withdrew consent|2
7708319|NCT01089127|26807963|P5|Overall Study|Subject withdrew consent|0
7708320|NCT01089127|26807964|P4|Overall Study|Subject withdrew consent|1
7708321|NCT01089127|26807965|P3|Overall Study|Subject withdrew consent|1
7708322|NCT01089127|26807966|P2|Overall Study|Subject withdrew consent|1
7708323|NCT01089127|26807967|P1|Overall Study|Subject withdrew consent|0
7708324|NCT01089127|26807962|P6|Overall Study|Adverse Event|1
7708325|NCT01089127|26807963|P5|Overall Study|Adverse Event|0
7708326|NCT01089127|26807964|P4|Overall Study|Adverse Event|0
7708327|NCT01089127|26807965|P3|Overall Study|Adverse Event|1
7708328|NCT01089127|26807966|P2|Overall Study|Adverse Event|1
7708329|NCT01089127|26807967|P1|Overall Study|Adverse Event|5
7708330|NCT01089023|26808021|P1|Overall Study|Lack of Efficacy|1
7708331|NCT01089023|26808021|P1|Overall Study|Protocol Violation|1
7708332|NCT01089023|26808021|P1|Overall Study|Withdrawal by Subject|1
7708333|NCT01089023|26808021|P1|Overall Study|Adverse Event|1
7708334|NCT01089023|26808021|P1|Overall Study|Lost to Follow-up|3
7708335|NCT01088997|26808035|P2|Overall Study|Excluded prior to receiving drug|1
7708336|NCT01088997|26808036|P1|Overall Study|Excluded prior to receiving drug|1
7708337|NCT01088997|26808035|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
7708338|NCT01088997|26808036|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
7708339|NCT01088997|26808035|P2|Overall Study|Physician Decision|1
7708340|NCT01088997|26808036|P1|Overall Study|Physician Decision|1
7708341|NCT01088984|26808047|P2|Phase 2|Other|1
7708342|NCT01088984|26808048|P1|Phase 2|Other|0
7708343|NCT01088984|26808047|P2|Phase 2|DIsease Progression|25
7708344|NCT01088984|26808048|P1|Phase 2|DIsease Progression|0
7708345|NCT01088984|26808047|P2|Phase 2|Withdrawal by Subject|1
7708346|NCT01088984|26808048|P1|Phase 2|Withdrawal by Subject|0
7708347|NCT01088984|26808047|P2|Phase 2|Death|5
7708348|NCT01088984|26808048|P1|Phase 2|Death|0
7708349|NCT01088984|26808047|P2|Phase 1|Other|1
7708350|NCT01088984|26808048|P1|Phase 1|Other|1
7708351|NCT01088984|26808047|P2|Phase 1|Disease Progression|4
7708352|NCT01088984|26808048|P1|Phase 1|Disease Progression|2
7708353|NCT01088984|26808047|P2|Phase 1|Death|1
7708354|NCT01088984|26808048|P1|Phase 1|Death|2
7708355|NCT01088529|26808119|P2|Overall Study|Did not receive study treatment|1
7708356|NCT01088529|26808120|P1|Overall Study|Did not receive study treatment|0
7708357|NCT01088503|26808133|P3|Overall Study|Death|7
7708358|NCT01088503|26808134|P2|Overall Study|Death|358
7708359|NCT01088503|26808135|P1|Overall Study|Death|64
7708360|NCT01088503|26808133|P3|Overall Study|Withdrawal by Subject|10
7708361|NCT01088503|26808134|P2|Overall Study|Withdrawal by Subject|327
7708362|NCT01088503|26808135|P1|Overall Study|Withdrawal by Subject|118
7708363|NCT01088438|26808213|P2|Overall Study|Lost to Follow-up|30
7708364|NCT01088438|26808214|P1|Overall Study|Lost to Follow-up|18
7708365|NCT01088438|26808213|P2|Overall Study|Withdrawal by Subject|6
7708366|NCT01088438|26808214|P1|Overall Study|Withdrawal by Subject|11
7708367|NCT01088412|26808227|P3|Overall Study|Study Summary Not Completed|22
7708368|NCT01088412|26808228|P2|Overall Study|Study Summary Not Completed|64
7708369|NCT01088412|26808229|P1|Overall Study|Study Summary Not Completed|4360
7708370|NCT01088412|26808227|P3|Overall Study|Lost to Follow-up|11
7708371|NCT01088412|26808228|P2|Overall Study|Lost to Follow-up|130
7708372|NCT01088412|26808229|P1|Overall Study|Lost to Follow-up|3052
7708373|NCT01088412|26808227|P3|Overall Study|Third Party Required to Change Brand|0
7708374|NCT01088412|26808228|P2|Overall Study|Third Party Required to Change Brand|0
7708375|NCT01088412|26808229|P1|Overall Study|Third Party Required to Change Brand|487
7708376|NCT01088412|26808227|P3|Overall Study|Sponsor Decision|23
7708377|NCT01088412|26808228|P2|Overall Study|Sponsor Decision|79
7708378|NCT01088412|26808229|P1|Overall Study|Sponsor Decision|4467
7708379|NCT01088412|26808227|P3|Overall Study|Physician Decision|4
7708380|NCT01088412|26808228|P2|Overall Study|Physician Decision|8
7708381|NCT01088412|26808229|P1|Overall Study|Physician Decision|1041
7708382|NCT01088412|26808227|P3|Overall Study|Participant Moved|2
7708383|NCT01088412|26808228|P2|Overall Study|Participant Moved|21
7708384|NCT01088412|26808229|P1|Overall Study|Participant Moved|601
7708385|NCT01088412|26808227|P3|Overall Study|Received Another GH Product|0
7708386|NCT01088412|26808228|P2|Overall Study|Received Another GH Product|0
7708387|NCT01088412|26808229|P1|Overall Study|Received Another GH Product|79
7708388|NCT01088412|26808227|P3|Overall Study|Withdrawal by Subject|1
7708389|NCT01088412|26808228|P2|Overall Study|Withdrawal by Subject|25
7708390|NCT01088412|26808229|P1|Overall Study|Withdrawal by Subject|1761
7708391|NCT01088412|26808227|P3|Overall Study|Other Reason per Case Report Form|9
7708392|NCT01088412|26808228|P2|Overall Study|Other Reason per Case Report Form|103
7708393|NCT01088412|26808229|P1|Overall Study|Other Reason per Case Report Form|2089
7708394|NCT01088412|26808227|P3|Overall Study|Death|0
7708395|NCT01088412|26808228|P2|Overall Study|Death|6
7708396|NCT01088412|26808229|P1|Overall Study|Death|42
7708397|NCT01088412|26808227|P3|Overall Study|Adverse Event|0
7708398|NCT01088412|26808228|P2|Overall Study|Adverse Event|0
7708399|NCT01088412|26808229|P1|Overall Study|Adverse Event|38
7708400|NCT01088399|26808248|P3|Overall Study|Study summary visit not completed|80
7708401|NCT01088399|26808249|P2|Overall Study|Study summary visit not completed|283
7708402|NCT01088399|26808250|P1|Overall Study|Study summary visit not completed|2398
7708403|NCT01088399|26808248|P3|Overall Study|Enrollment criteria not met|70
7708404|NCT01088399|26808249|P2|Overall Study|Enrollment criteria not met|119
7708405|NCT01088399|26808250|P1|Overall Study|Enrollment criteria not met|48
7708406|NCT01088399|26808248|P3|Overall Study|Protocol Violation|0
7708407|NCT01088399|26808249|P2|Overall Study|Protocol Violation|1
7708408|NCT01088399|26808250|P1|Overall Study|Protocol Violation|10
7708409|NCT01088399|26808248|P3|Overall Study|Sponsor decision|7
7708410|NCT01088399|26808249|P2|Overall Study|Sponsor decision|298
7708411|NCT01088399|26808250|P1|Overall Study|Sponsor decision|1573
7708412|NCT01088399|26808248|P3|Overall Study|Change to or start of somatropin therapy|12
7708413|NCT01088399|26808249|P2|Overall Study|Change to or start of somatropin therapy|17
7708414|NCT01088399|26808250|P1|Overall Study|Change to or start of somatropin therapy|234
7708415|NCT01088399|26808248|P3|Overall Study|Withdrawal by Subject|33
7708416|NCT01088399|26808249|P2|Overall Study|Withdrawal by Subject|195
7708417|NCT01088399|26808250|P1|Overall Study|Withdrawal by Subject|544
7708418|NCT01088399|26808248|P3|Overall Study|Physician Decision|16
7708419|NCT01088399|26808249|P2|Overall Study|Physician Decision|88
7708420|NCT01088399|26808250|P1|Overall Study|Physician Decision|531
7708421|NCT01088399|26808248|P3|Overall Study|Lost to Follow-up|58
7708422|NCT01088399|26808249|P2|Overall Study|Lost to Follow-up|278
7708423|NCT01088399|26808250|P1|Overall Study|Lost to Follow-up|1070
7708424|NCT01088399|26808248|P3|Overall Study|Lack of Efficacy|5
7708425|NCT01088399|26808249|P2|Overall Study|Lack of Efficacy|7
7708426|NCT01088399|26808250|P1|Overall Study|Lack of Efficacy|298
7708427|NCT01088399|26808248|P3|Overall Study|Death|0
7708428|NCT01088399|26808249|P2|Overall Study|Death|45
7708429|NCT01088399|26808250|P1|Overall Study|Death|204
7708430|NCT01088399|26808248|P3|Overall Study|Adverse Event|0
7708431|NCT01088399|26808249|P2|Overall Study|Adverse Event|16
7708432|NCT01088399|26808250|P1|Overall Study|Adverse Event|211
7708433|NCT01088243|26808279|P2|Overall Study|Adverse Event|0
7708434|NCT01088243|26808280|P1|Overall Study|Adverse Event|1
7708435|NCT01088048|26808306|P10|Overall Study|Other|0
7708436|NCT01088048|26808307|P9|Overall Study|Other|0
7708437|NCT01088048|26808308|P8|Overall Study|Other|2
7708438|NCT01088048|26808309|P7|Overall Study|Other|0
7708439|NCT01088048|26808310|P6|Overall Study|Other|0
7708440|NCT01088048|26808311|P5|Overall Study|Other|2
7708441|NCT01088048|26808312|P4|Overall Study|Other|0
7708442|NCT01088048|26808313|P3|Overall Study|Other|0
7708443|NCT01088048|26808314|P2|Overall Study|Other|5
7708444|NCT01088048|26808315|P1|Overall Study|Other|3
7708445|NCT01088048|26808306|P10|Overall Study|Death|1
7708446|NCT01088048|26808307|P9|Overall Study|Death|3
7708447|NCT01088048|26808308|P8|Overall Study|Death|0
7708448|NCT01088048|26808309|P7|Overall Study|Death|0
7708449|NCT01088048|26808310|P6|Overall Study|Death|3
7708450|NCT01088048|26808311|P5|Overall Study|Death|1
7708451|NCT01088048|26808312|P4|Overall Study|Death|3
7708452|NCT01088048|26808313|P3|Overall Study|Death|3
7708453|NCT01088048|26808314|P2|Overall Study|Death|5
7708454|NCT01088048|26808315|P1|Overall Study|Death|1
7708455|NCT01088048|26808306|P10|Overall Study|Disease Progression|0
7708456|NCT01088048|26808307|P9|Overall Study|Disease Progression|0
7708457|NCT01088048|26808308|P8|Overall Study|Disease Progression|1
7708458|NCT01088048|26808309|P7|Overall Study|Disease Progression|2
7708459|NCT01088048|26808310|P6|Overall Study|Disease Progression|3
7708460|NCT01088048|26808311|P5|Overall Study|Disease Progression|3
7708461|NCT01088048|26808312|P4|Overall Study|Disease Progression|5
7708462|NCT01088048|26808313|P3|Overall Study|Disease Progression|3
7708463|NCT01088048|26808314|P2|Overall Study|Disease Progression|4
7708464|NCT01088048|26808315|P1|Overall Study|Disease Progression|7
7708465|NCT01088048|26808306|P10|Overall Study|Patient Non-compliance|0
7708466|NCT01088048|26808307|P9|Overall Study|Patient Non-compliance|0
7708467|NCT01088048|26808308|P8|Overall Study|Patient Non-compliance|0
7708468|NCT01088048|26808309|P7|Overall Study|Patient Non-compliance|0
7708469|NCT01088048|26808310|P6|Overall Study|Patient Non-compliance|0
7708470|NCT01088048|26808311|P5|Overall Study|Patient Non-compliance|0
7708471|NCT01088048|26808312|P4|Overall Study|Patient Non-compliance|0
7708472|NCT01088048|26808313|P3|Overall Study|Patient Non-compliance|0
7708473|NCT01088048|26808314|P2|Overall Study|Patient Non-compliance|1
7708474|NCT01088048|26808315|P1|Overall Study|Patient Non-compliance|0
7708475|NCT01088048|26808306|P10|Overall Study|Investigator Request|0
7708476|NCT01088048|26808307|P9|Overall Study|Investigator Request|0
7708477|NCT01088048|26808308|P8|Overall Study|Investigator Request|0
7708478|NCT01088048|26808309|P7|Overall Study|Investigator Request|1
7708479|NCT01088048|26808310|P6|Overall Study|Investigator Request|1
7708480|NCT01088048|26808311|P5|Overall Study|Investigator Request|3
7708481|NCT01088048|26808312|P4|Overall Study|Investigator Request|0
7708482|NCT01088048|26808313|P3|Overall Study|Investigator Request|0
7708483|NCT01088048|26808314|P2|Overall Study|Investigator Request|2
7708484|NCT01088048|26808315|P1|Overall Study|Investigator Request|2
7708485|NCT01088048|26808306|P10|Overall Study|Concomitant Medication Prohibited|0
7708486|NCT01088048|26808307|P9|Overall Study|Concomitant Medication Prohibited|0
7708487|NCT01088048|26808308|P8|Overall Study|Concomitant Medication Prohibited|0
7708488|NCT01088048|26808309|P7|Overall Study|Concomitant Medication Prohibited|0
7708489|NCT01088048|26808310|P6|Overall Study|Concomitant Medication Prohibited|0
7708490|NCT01088048|26808311|P5|Overall Study|Concomitant Medication Prohibited|0
7708491|NCT01088048|26808312|P4|Overall Study|Concomitant Medication Prohibited|0
7708492|NCT01088048|26808313|P3|Overall Study|Concomitant Medication Prohibited|0
7708493|NCT01088048|26808314|P2|Overall Study|Concomitant Medication Prohibited|0
7708494|NCT01088048|26808315|P1|Overall Study|Concomitant Medication Prohibited|1
7708495|NCT01088048|26808306|P10|Overall Study|Withdrew Consent|1
7708496|NCT01088048|26808307|P9|Overall Study|Withdrew Consent|2
7708497|NCT01088048|26808308|P8|Overall Study|Withdrew Consent|2
7708498|NCT01088048|26808309|P7|Overall Study|Withdrew Consent|0
7708499|NCT01088048|26808310|P6|Overall Study|Withdrew Consent|1
7708500|NCT01088048|26808311|P5|Overall Study|Withdrew Consent|2
7708501|NCT01088048|26808312|P4|Overall Study|Withdrew Consent|1
7708502|NCT01088048|26808313|P3|Overall Study|Withdrew Consent|1
7708503|NCT01088048|26808314|P2|Overall Study|Withdrew Consent|1
7708504|NCT01088048|26808315|P1|Overall Study|Withdrew Consent|1
7708505|NCT01088048|26808306|P10|Overall Study|Adverse Event|2
7708506|NCT01088048|26808307|P9|Overall Study|Adverse Event|2
7708507|NCT01088048|26808308|P8|Overall Study|Adverse Event|0
7708508|NCT01088048|26808309|P7|Overall Study|Adverse Event|3
7708509|NCT01088048|26808310|P6|Overall Study|Adverse Event|3
7708510|NCT01088048|26808311|P5|Overall Study|Adverse Event|6
7708511|NCT01088048|26808312|P4|Overall Study|Adverse Event|5
7708512|NCT01088048|26808313|P3|Overall Study|Adverse Event|7
7708513|NCT01088048|26808314|P2|Overall Study|Adverse Event|9
7708514|NCT01088048|26808315|P1|Overall Study|Adverse Event|7
7708515|NCT01087970|26808433|P1|Overall Study|Protocol Violation|2
7708516|NCT01087957|26808445|P2|Overall Study|Physician Decision|9
7708517|NCT01087957|26808446|P1|Overall Study|Physician Decision|5
7708518|NCT01087957|26808445|P2|Overall Study|Withdrawal by Subject|15
7708519|NCT01087957|26808446|P1|Overall Study|Withdrawal by Subject|18
7708520|NCT01087957|26808445|P2|Overall Study|Protocol Violation|25
7708521|NCT01087957|26808446|P1|Overall Study|Protocol Violation|13
7708522|NCT01087957|26808445|P2|Overall Study|Lost to Follow-up|4
7708523|NCT01087957|26808446|P1|Overall Study|Lost to Follow-up|3
7708524|NCT01087957|26808445|P2|Overall Study|Death|2
7708525|NCT01087957|26808446|P1|Overall Study|Death|2
7708526|NCT01087944|26808472|P2|Period 2 (Week 4-6)|Adverse Event|2
7708527|NCT01087944|26808473|P1|Period 2 (Week 4-6)|Adverse Event|0
7708528|NCT01087944|26808472|P2|Period 1 (Week 1-3)|Adverse Event|0
7708529|NCT01087944|26808473|P1|Period 1 (Week 1-3)|Adverse Event|1
7708530|NCT01087905|26808553|P8|Overall Study|Withdrawal by Subject|5
7708531|NCT01087905|26808554|P7|Overall Study|Withdrawal by Subject|3
7708532|NCT01087905|26808555|P6|Overall Study|Withdrawal by Subject|3
7708533|NCT01087905|26808556|P5|Overall Study|Withdrawal by Subject|4
7708534|NCT01087905|26808557|P4|Overall Study|Withdrawal by Subject|5
7708535|NCT01087905|26808558|P3|Overall Study|Withdrawal by Subject|4
7708536|NCT01087905|26808559|P2|Overall Study|Withdrawal by Subject|4
7708537|NCT01087905|26808560|P1|Overall Study|Withdrawal by Subject|5
7708538|NCT01087905|26808553|P8|Overall Study|Lost to Follow-up|24
7708539|NCT01087905|26808554|P7|Overall Study|Lost to Follow-up|20
7708540|NCT01087905|26808555|P6|Overall Study|Lost to Follow-up|25
7708541|NCT01087905|26808556|P5|Overall Study|Lost to Follow-up|27
7708542|NCT01087905|26808557|P4|Overall Study|Lost to Follow-up|31
7708543|NCT01087905|26808558|P3|Overall Study|Lost to Follow-up|18
7708544|NCT01087905|26808559|P2|Overall Study|Lost to Follow-up|28
7708545|NCT01087905|26808560|P1|Overall Study|Lost to Follow-up|24
7708546|NCT01087814|26808582|P2|Second Intervention (5 Days)|Physician Decision|0
7708547|NCT01087814|26808583|P1|Second Intervention (5 Days)|Physician Decision|1
7708548|NCT01087814|26808582|P2|First Intervention (5 Days)|Withdrawal by Subject|1
7708549|NCT01087814|26808583|P1|First Intervention (5 Days)|Withdrawal by Subject|3
7708550|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Personal reasons|1
7708551|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Personal reasons|0
7708552|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Personal reasons|0
7708553|NCT01087788|26808601|P3|Open-Label Period (OL-P)|No participation in study extension|1
7708554|NCT01087788|26808602|P2|Open-Label Period (OL-P)|No participation in study extension|0
7708555|NCT01087788|26808603|P1|Open-Label Period (OL-P)|No participation in study extension|0
7708556|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Principal investigator decision|2
7708557|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Principal investigator decision|1
7708558|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Principal investigator decision|0
7708559|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Sponsor request|0
7708560|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Sponsor request|0
7708561|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Sponsor request|1
7708562|NCT01087788|26808601|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
7708563|NCT01087788|26808602|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
7708564|NCT01087788|26808603|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
7708565|NCT01087788|26808601|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
7708566|NCT01087788|26808602|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
7708567|NCT01087788|26808603|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
7708568|NCT01087788|26808601|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
7708569|NCT01087788|26808602|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
7708570|NCT01087788|26808603|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
7708571|NCT01087788|26808601|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
7708572|NCT01087788|26808602|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
7708573|NCT01087788|26808603|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
7708574|NCT01087788|26808601|P3|Open-Label Period (OL-P)|AE, serious fatal|1
7708575|NCT01087788|26808602|P2|Open-Label Period (OL-P)|AE, serious fatal|0
7708576|NCT01087788|26808603|P1|Open-Label Period (OL-P)|AE, serious fatal|2
7708577|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
7708578|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
7708579|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
7708580|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
7708581|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
7708582|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
7708583|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Protocol Violation|0
7708584|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Protocol Violation|1
7708585|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Protocol Violation|2
7708586|NCT01087788|26808601|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
7708587|NCT01087788|26808602|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
7708588|NCT01087788|26808603|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
7708589|NCT01087788|26808601|P3|24-weeks Dose-blind Period|Patient moved|1
7708590|NCT01087788|26808602|P2|24-weeks Dose-blind Period|Patient moved|0
7708591|NCT01087788|26808603|P1|24-weeks Dose-blind Period|Patient moved|0
7708592|NCT01087788|26808601|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
7708593|NCT01087788|26808602|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
7708594|NCT01087788|26808603|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
7708595|NCT01087788|26808601|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
7708596|NCT01087788|26808602|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
7708597|NCT01087788|26808603|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
7708598|NCT01087788|26808601|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
7708599|NCT01087788|26808602|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
7708600|NCT01087788|26808603|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
7708601|NCT01087788|26808601|P3|24-weeks Dose-blind Period|AE, serious fatal|0
7708602|NCT01087788|26808602|P2|24-weeks Dose-blind Period|AE, serious fatal|1
7708603|NCT01087788|26808603|P1|24-weeks Dose-blind Period|AE, serious fatal|0
7708604|NCT01087788|26808601|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
7708605|NCT01087788|26808602|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
7708606|NCT01087788|26808603|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
7708607|NCT01087788|26808601|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
7708608|NCT01087788|26808602|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
7708609|NCT01087788|26808603|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
7708610|NCT01087788|26808601|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
7708611|NCT01087788|26808602|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
7708612|NCT01087788|26808603|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
7708613|NCT01087788|26808601|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
7708614|NCT01087788|26808602|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
7708615|NCT01087788|26808603|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
7708616|NCT01087788|26808601|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
7708617|NCT01087788|26808602|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
7708618|NCT01087788|26808603|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
7708619|NCT01087788|26808601|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
7708620|NCT01087788|26808602|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
7708621|NCT01087788|26808603|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
7708622|NCT01087788|26808601|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
7708623|NCT01087788|26808602|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
7708624|NCT01087788|26808603|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
7708625|NCT01087788|26808601|P3|24-weeks Double-blind Period|AE, unknown type|1
7708626|NCT01087788|26808602|P2|24-weeks Double-blind Period|AE, unknown type|0
7708627|NCT01087788|26808603|P1|24-weeks Double-blind Period|AE, unknown type|0
7708628|NCT01087788|26808601|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
7708629|NCT01087788|26808602|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
7708630|NCT01087788|26808603|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
7708631|NCT01087788|26808601|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
7708632|NCT01087788|26808602|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
7708633|NCT01087788|26808603|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
7708634|NCT01087788|26808601|P3|24-weeks Double-blind Period|AE, serious fatal|1
7708635|NCT01087788|26808602|P2|24-weeks Double-blind Period|AE, serious fatal|1
7708636|NCT01087788|26808603|P1|24-weeks Double-blind Period|AE, serious fatal|0
7708637|NCT01087788|26808601|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
7708638|NCT01087788|26808602|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
7708639|NCT01087788|26808603|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
7708640|NCT01087788|26808601|P3|24-weeks Double-blind Period|Lost to Follow-up|1
7708641|NCT01087788|26808602|P2|24-weeks Double-blind Period|Lost to Follow-up|1
7708642|NCT01087788|26808603|P1|24-weeks Double-blind Period|Lost to Follow-up|4
7708643|NCT01087788|26808601|P3|24-weeks Double-blind Period|Protocol Violation|0
7708644|NCT01087788|26808602|P2|24-weeks Double-blind Period|Protocol Violation|1
7708645|NCT01087788|26808603|P1|24-weeks Double-blind Period|Protocol Violation|0
7708646|NCT01087788|26808601|P3|24-weeks Double-blind Period|Lack of Efficacy|1
7708647|NCT01087788|26808602|P2|24-weeks Double-blind Period|Lack of Efficacy|0
7708648|NCT01087788|26808603|P1|24-weeks Double-blind Period|Lack of Efficacy|2
7708649|NCT01087775|26808630|P1|Overall Study|failed inclusion criteria|2
7708650|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
7708651|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
7708652|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7708653|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7708654|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7708655|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
7708656|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
7708657|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7708658|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7708659|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7708660|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
7708661|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
7708662|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7708663|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7708664|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7708665|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|Other|4
7708666|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|Other|2
7708667|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|Other|0
7708668|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|Other|0
7708669|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|Other|0
7708670|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
7708671|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
7708672|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7708673|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7708674|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7708675|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
7708676|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
7708677|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7708678|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7708679|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7708680|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
7708681|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
7708682|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7708683|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7708684|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7708685|NCT01087762|26808638|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
7708686|NCT01087762|26808639|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
7708687|NCT01087762|26808640|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7708688|NCT01087762|26808641|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7708689|NCT01087762|26808642|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7708690|NCT01087762|26808638|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
7708691|NCT01087762|26808639|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
7708692|NCT01087762|26808640|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
7708693|NCT01087762|26808641|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
7708694|NCT01087762|26808642|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
7708695|NCT01087762|26808638|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
7708696|NCT01087762|26808639|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
7708697|NCT01087762|26808640|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
7708698|NCT01087762|26808641|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
7708699|NCT01087762|26808642|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
7708700|NCT01087762|26808638|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
7708701|NCT01087762|26808639|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
7708702|NCT01087762|26808640|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
7708703|NCT01087762|26808641|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
7708704|NCT01087762|26808642|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
7708705|NCT01087762|26808638|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7708706|NCT01087762|26808639|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7708707|NCT01087762|26808640|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
7708708|NCT01087762|26808641|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7708709|NCT01087762|26808642|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
7708710|NCT01087762|26808638|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7708711|NCT01087762|26808639|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7708712|NCT01087762|26808640|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
7708713|NCT01087762|26808641|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7708714|NCT01087762|26808642|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
7708715|NCT01087736|26808690|P2|Overall Study|Withdrawal by Subject|1
7708716|NCT01087736|26808691|P1|Overall Study|Withdrawal by Subject|0
7708717|NCT01087736|26808690|P2|Overall Study|Death|1
7708718|NCT01087736|26808691|P1|Overall Study|Death|0
7708719|NCT01087736|26808690|P2|Overall Study|Lost to Follow-up|0
7708720|NCT01087736|26808691|P1|Overall Study|Lost to Follow-up|1
7708721|NCT01087723|26808701|P2|Overall Study|Reason Not Specified|2
7708722|NCT01087723|26808702|P1|Overall Study|Reason Not Specified|1
7708723|NCT01087723|26808701|P2|Overall Study|Lost to Follow-up|4
7708724|NCT01087723|26808702|P1|Overall Study|Lost to Follow-up|1
7708725|NCT01087723|26808701|P2|Overall Study|Physician Decision|0
7708726|NCT01087723|26808702|P1|Overall Study|Physician Decision|2
7708727|NCT01087723|26808701|P2|Overall Study|Withdrawal by Subject|13
7708728|NCT01087723|26808702|P1|Overall Study|Withdrawal by Subject|10
7708729|NCT01087723|26808701|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
7708730|NCT01087723|26808702|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
7708731|NCT01087528|26808743|P1|Overall Study|Incomplete CE procedure|6
7708732|NCT01087528|26808743|P1|Overall Study|Withdrawal by Subject|1
7708733|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
7708734|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
7708735|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
7708736|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
7708737|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
7708738|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
7708739|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
7708740|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
7708741|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
7708742|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
7708743|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
7708744|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
7708745|NCT01087502|26808755|P2|Up to Final Analysis (Week 52)|Adverse Event|10
7708746|NCT01087502|26808756|P1|Up to Final Analysis (Week 52)|Adverse Event|17
7708747|NCT01087502|26808755|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
7708748|NCT01087502|26808756|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
7708749|NCT01087502|26808755|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
7708750|NCT01087502|26808756|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
7708751|NCT01087502|26808755|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
7708752|NCT01087502|26808756|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
7708753|NCT01087502|26808755|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
7708754|NCT01087502|26808756|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
7708755|NCT01087502|26808755|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
7708756|NCT01087502|26808756|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
7708757|NCT01087489|26808775|P2|Overall Study|unable to survey by telephone|1
7708758|NCT01087489|26808776|P1|Overall Study|unable to survey by telephone|0
7708759|NCT01087489|26808775|P2|Overall Study|Death|1
7708760|NCT01087489|26808776|P1|Overall Study|Death|0
7708761|NCT01087489|26808775|P2|Overall Study|enrolled in another VA study|1
7708762|NCT01087489|26808776|P1|Overall Study|enrolled in another VA study|0
7708763|NCT01087203|26808788|P2|Overall Study|Study terminated by sponsor|27
7708764|NCT01087203|26808789|P1|Overall Study|Study terminated by sponsor|27
7708765|NCT01087203|26808788|P2|Overall Study|Lack of Efficacy|2
7708766|NCT01087203|26808789|P1|Overall Study|Lack of Efficacy|1
7708767|NCT01087203|26808788|P2|Overall Study|Withdrawal by Subject|6
7708768|NCT01087203|26808789|P1|Overall Study|Withdrawal by Subject|2
7708769|NCT01087203|26808788|P2|Overall Study|Lost to Follow-up|0
7708770|NCT01087203|26808789|P1|Overall Study|Lost to Follow-up|2
7708771|NCT01086969|26808848|P3|Overall Study|Withdrawal by Subject|0
7708772|NCT01086969|26808849|P2|Overall Study|Withdrawal by Subject|2
7708773|NCT01086969|26808850|P1|Overall Study|Withdrawal by Subject|1
7708774|NCT01086540|26808946|P2|Overall Study|Addition of new therapy for PAH|0
7708775|NCT01086540|26808947|P1|Overall Study|Addition of new therapy for PAH|1
7708776|NCT01086540|26808946|P2|Overall Study|Physician Decision|1
7708777|NCT01086540|26808947|P1|Overall Study|Physician Decision|2
7708778|NCT01086540|26808946|P2|Overall Study|Death|1
7708779|NCT01086540|26808947|P1|Overall Study|Death|3
7708780|NCT01086423|26809005|P3|Overall Study|Lost to Follow-up|1
7708781|NCT01086423|26809006|P2|Overall Study|Lost to Follow-up|0
7708782|NCT01086423|26809007|P1|Overall Study|Lost to Follow-up|0
7708783|NCT01086423|26809005|P3|Overall Study|Withdrawal by Subject|3
7708784|NCT01086423|26809006|P2|Overall Study|Withdrawal by Subject|1
7708785|NCT01086423|26809007|P1|Overall Study|Withdrawal by Subject|5
7708786|NCT01086423|26809005|P3|Overall Study|Adverse event, non-fatal|0
7708787|NCT01086423|26809006|P2|Overall Study|Adverse event, non-fatal|1
7708788|NCT01086423|26809007|P1|Overall Study|Adverse event, non-fatal|2
7708789|NCT01086423|26809005|P3|Overall Study|Adverse event, fatal|0
7708790|NCT01086423|26809006|P2|Overall Study|Adverse event, fatal|1
7708791|NCT01086423|26809007|P1|Overall Study|Adverse event, fatal|1
7708792|NCT01086423|26809005|P3|Overall Study|Migrated/moved from study area|4
7708793|NCT01086423|26809006|P2|Overall Study|Migrated/moved from study area|0
7708794|NCT01086423|26809007|P1|Overall Study|Migrated/moved from study area|2
7708795|NCT01086423|26809005|P3|Overall Study|Protocol Violation|1
7708796|NCT01086423|26809006|P2|Overall Study|Protocol Violation|0
7708797|NCT01086423|26809007|P1|Overall Study|Protocol Violation|0
7708798|NCT01086410|26809052|P4|Overall Study|Lost to Follow-up|0
7708799|NCT01086410|26809053|P3|Overall Study|Lost to Follow-up|1
7708800|NCT01086410|26809054|P2|Overall Study|Lost to Follow-up|0
7708801|NCT01086410|26809055|P1|Overall Study|Lost to Follow-up|0
7708802|NCT01086410|26809052|P4|Overall Study|Protocol Violation|0
7708803|NCT01086410|26809053|P3|Overall Study|Protocol Violation|0
7708804|NCT01086410|26809054|P2|Overall Study|Protocol Violation|1
7708805|NCT01086410|26809055|P1|Overall Study|Protocol Violation|1
7708806|NCT01086410|26809052|P4|Overall Study|Lack of Efficacy|0
7708807|NCT01086410|26809053|P3|Overall Study|Lack of Efficacy|0
7708808|NCT01086410|26809054|P2|Overall Study|Lack of Efficacy|1
7708809|NCT01086410|26809055|P1|Overall Study|Lack of Efficacy|1
7708810|NCT01086410|26809052|P4|Overall Study|Adverse Event|2
7708811|NCT01086410|26809053|P3|Overall Study|Adverse Event|0
7708812|NCT01086410|26809054|P2|Overall Study|Adverse Event|0
7708813|NCT01086410|26809055|P1|Overall Study|Adverse Event|1
7708814|NCT01086384|26809151|P3|Treatment Period|Received Treatment in Error|0
7708815|NCT01086384|26809152|P2|Treatment Period|Received Treatment in Error|1
7708816|NCT01086384|26809153|P1|Treatment Period|Received Treatment in Error|0
7708817|NCT01086384|26809151|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
7708818|NCT01086384|26809152|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
7708819|NCT01086384|26809153|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
7708820|NCT01086384|26809151|P3|Treatment Period|Study Closed/Terminated|8
7708821|NCT01086384|26809152|P2|Treatment Period|Study Closed/Terminated|7
7708822|NCT01086384|26809153|P1|Treatment Period|Study Closed/Terminated|0
7708823|NCT01086384|26809151|P3|Treatment Period|Physician Decision|6
7708824|NCT01086384|26809152|P2|Treatment Period|Physician Decision|9
7708825|NCT01086384|26809153|P1|Treatment Period|Physician Decision|0
7708826|NCT01086384|26809151|P3|Treatment Period|Lost to Follow-up|9
7708827|NCT01086384|26809152|P2|Treatment Period|Lost to Follow-up|11
7708828|NCT01086384|26809153|P1|Treatment Period|Lost to Follow-up|0
7708829|NCT01086384|26809151|P3|Treatment Period|Adverse Event|15
7708830|NCT01086384|26809152|P2|Treatment Period|Adverse Event|19
7708831|NCT01086384|26809153|P1|Treatment Period|Adverse Event|0
7708832|NCT01086384|26809151|P3|Treatment Period|Lack of Efficacy|13
7708833|NCT01086384|26809152|P2|Treatment Period|Lack of Efficacy|22
7708834|NCT01086384|26809153|P1|Treatment Period|Lack of Efficacy|0
7708835|NCT01086384|26809151|P3|Treatment Period|Protocol Violation|17
7708836|NCT01086384|26809152|P2|Treatment Period|Protocol Violation|26
7708837|NCT01086384|26809153|P1|Treatment Period|Protocol Violation|0
7708838|NCT01086384|26809151|P3|Treatment Period|Withdrawal by Subject|55
7708839|NCT01086384|26809152|P2|Treatment Period|Withdrawal by Subject|53
7708840|NCT01086384|26809153|P1|Treatment Period|Withdrawal by Subject|0
7708841|NCT01086384|26809151|P3|2-week Run-in Period|Randomized in Error|0
7708842|NCT01086384|26809152|P2|2-week Run-in Period|Randomized in Error|0
7708843|NCT01086384|26809153|P1|2-week Run-in Period|Randomized in Error|1
7708844|NCT01086384|26809151|P3|2-week Run-in Period|Continuation Criteria Not Met|0
7708845|NCT01086384|26809152|P2|2-week Run-in Period|Continuation Criteria Not Met|0
7708846|NCT01086384|26809153|P1|2-week Run-in Period|Continuation Criteria Not Met|92
7708847|NCT01086384|26809151|P3|2-week Run-in Period|Study Closed/Terminated|0
7708848|NCT01086384|26809152|P2|2-week Run-in Period|Study Closed/Terminated|0
7708849|NCT01086384|26809153|P1|2-week Run-in Period|Study Closed/Terminated|42
7708850|NCT01086384|26809151|P3|2-week Run-in Period|Withdrawal by Subject|0
7708851|NCT01086384|26809152|P2|2-week Run-in Period|Withdrawal by Subject|0
7708852|NCT01086384|26809153|P1|2-week Run-in Period|Withdrawal by Subject|19
7708853|NCT01086384|26809151|P3|2-week Run-in Period|Physician Decision|0
7708854|NCT01086384|26809152|P2|2-week Run-in Period|Physician Decision|0
7708855|NCT01086384|26809153|P1|2-week Run-in Period|Physician Decision|6
7708856|NCT01086384|26809151|P3|2-week Run-in Period|Lost to Follow-up|0
7708857|NCT01086384|26809152|P2|2-week Run-in Period|Lost to Follow-up|0
7708858|NCT01086384|26809153|P1|2-week Run-in Period|Lost to Follow-up|1
7708859|NCT01086384|26809151|P3|2-week Run-in Period|Protocol Violation|0
7708860|NCT01086384|26809152|P2|2-week Run-in Period|Protocol Violation|0
7708861|NCT01086384|26809153|P1|2-week Run-in Period|Protocol Violation|1
7708862|NCT01086384|26809151|P3|2-week Run-in Period|Adverse Event|0
7708863|NCT01086384|26809152|P2|2-week Run-in Period|Adverse Event|0
7708864|NCT01086384|26809153|P1|2-week Run-in Period|Adverse Event|1
7708865|NCT01086358|26809163|P2|Second Intervention|Lost to Follow-up|4
7708866|NCT01086358|26809164|P1|Second Intervention|Lost to Follow-up|4
7708867|NCT01086358|26809163|P2|First Intervention|Withdrawal by Subject|1
7708868|NCT01086358|26809164|P1|First Intervention|Withdrawal by Subject|0
7708869|NCT01086358|26809163|P2|First Intervention|Lost to Follow-up|4
7708870|NCT01086358|26809164|P1|First Intervention|Lost to Follow-up|9
7708871|NCT01086215|26809234|P4|Overall Study|Lost to Follow-up|2
7708872|NCT01086215|26809235|P3|Overall Study|Lost to Follow-up|18
7708873|NCT01086215|26809236|P2|Overall Study|Lost to Follow-up|39
7708874|NCT01086215|26809237|P1|Overall Study|Lost to Follow-up|22
7708875|NCT01086215|26809234|P4|Overall Study|Death|1
7708876|NCT01086215|26809235|P3|Overall Study|Death|8
7708877|NCT01086215|26809236|P2|Overall Study|Death|8
7708878|NCT01086215|26809237|P1|Overall Study|Death|14
7708879|NCT01086150|26809258|P3|Overall Study|Screen Failure|0
7708880|NCT01086150|26809259|P2|Overall Study|Screen Failure|1
7708881|NCT01086150|26809260|P1|Overall Study|Screen Failure|0
7708882|NCT01086150|26809258|P3|Overall Study|Lost to Follow-up|0
7708883|NCT01086150|26809259|P2|Overall Study|Lost to Follow-up|1
7708884|NCT01086150|26809260|P1|Overall Study|Lost to Follow-up|0
7708885|NCT01086150|26809258|P3|Overall Study|Withdrawal by Subject|1
7708886|NCT01086150|26809259|P2|Overall Study|Withdrawal by Subject|4
7708887|NCT01086150|26809260|P1|Overall Study|Withdrawal by Subject|0
7708888|NCT01086033|26809271|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
7708889|NCT01086033|26809271|P1|Overall Study|AE and Other Reason|1
7708890|NCT01086033|26809271|P1|Overall Study|AE and Lost to Follow-up|1
7708891|NCT01086033|26809271|P1|Overall Study|Death|1
7708892|NCT01086033|26809271|P1|Overall Study|AE and Lack of Efficacy|4
7708893|NCT01086033|26809271|P1|Overall Study|Withdrew consent and Other Reason|4
7708894|NCT01086033|26809271|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
7708895|NCT01086033|26809271|P1|Overall Study|AE and Withdrew Consent|5
7708896|NCT01086033|26809271|P1|Overall Study|Other|13
7708897|NCT01086033|26809271|P1|Overall Study|Other|14
7708898|NCT01086033|26809271|P1|Overall Study|Withdrawal by Subject|41
7708899|NCT01086033|26809271|P1|Overall Study|Adverse Event|42
7708900|NCT01086033|26809271|P1|Overall Study|Lost to Follow-up|86
7708901|NCT01086033|26809271|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
7708902|NCT01085812|26809337|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
7708903|NCT01085812|26809338|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
7708904|NCT01085812|26809337|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
7708905|NCT01085812|26809338|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
7708906|NCT01085812|26809337|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
7708907|NCT01085812|26809338|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
7708908|NCT01085812|26809337|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
7708909|NCT01085812|26809338|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
7708910|NCT01085812|26809337|P2|Double-blind Intent-to-treat Population|Adverse Event|8
7708911|NCT01085812|26809338|P1|Double-blind Intent-to-treat Population|Adverse Event|3
7708912|NCT01085812|26809337|P2|Double-Blind Period|Other Reasons|2
7708913|NCT01085812|26809338|P1|Double-Blind Period|Other Reasons|0
7708914|NCT01085812|26809337|P2|Double-Blind Period|Lost to Follow-up|17
7708915|NCT01085812|26809338|P1|Double-Blind Period|Lost to Follow-up|5
7708916|NCT01085812|26809337|P2|Double-Blind Period|Withdrawal by Subject|24
7708917|NCT01085812|26809338|P1|Double-Blind Period|Withdrawal by Subject|11
7708918|NCT01085812|26809337|P2|Double-Blind Period|Protocol Violation|7
7708919|NCT01085812|26809338|P1|Double-Blind Period|Protocol Violation|2
7708920|NCT01085812|26809337|P2|Double-Blind Period|Adverse Event|8
7708921|NCT01085812|26809338|P1|Double-Blind Period|Adverse Event|3
7708922|NCT01085812|26809337|P2|Open-Label Period|Lost to Follow-up|42
7708923|NCT01085812|26809338|P1|Open-Label Period|Lost to Follow-up|0
7708924|NCT01085812|26809337|P2|Open-Label Period|Withdrawal by Subject|53
7708925|NCT01085812|26809338|P1|Open-Label Period|Withdrawal by Subject|0
7708926|NCT01085812|26809337|P2|Open-Label Period|Protocol Violation|39
7708927|NCT01085812|26809338|P1|Open-Label Period|Protocol Violation|0
7708928|NCT01085812|26809337|P2|Open-Label Period|Lack of Efficacy|26
7708929|NCT01085812|26809338|P1|Open-Label Period|Lack of Efficacy|0
7708930|NCT01085812|26809337|P2|Open-Label Period|Adverse Event|80
7708931|NCT01085812|26809338|P1|Open-Label Period|Adverse Event|0
7708932|NCT01085734|26809385|P2|Overall Study|Withdrawal by Subject|1
7708933|NCT01085734|26809386|P1|Overall Study|Withdrawal by Subject|0
7708934|NCT01085734|26809385|P2|Overall Study|Lost to Follow-up|1
7708935|NCT01085734|26809386|P1|Overall Study|Lost to Follow-up|0
7708936|NCT01085734|26809385|P2|Overall Study|Death|0
7708937|NCT01085734|26809386|P1|Overall Study|Death|1
7708938|NCT01085734|26809385|P2|Overall Study|Adverse Event|2
7708939|NCT01085734|26809386|P1|Overall Study|Adverse Event|0
7708940|NCT01085682|26809398|P2|Overall Study|Withdrawal by Subject|25
7708941|NCT01085682|26809399|P1|Overall Study|Withdrawal by Subject|25
7708942|NCT01085630|26809416|P2|Overall Study|Ineligible|0
7708943|NCT01085630|26809417|P1|Overall Study|Ineligible|3
7708944|NCT01085630|26809416|P2|Overall Study|Insufficient data|0
7708945|NCT01085630|26809417|P1|Overall Study|Insufficient data|1
7708946|NCT01085591|26809430|P3|Overall Study|Not Properly Consented|0
7708947|NCT01085591|26809431|P2|Overall Study|Not Properly Consented|0
7708948|NCT01085591|26809432|P1|Overall Study|Not Properly Consented|1
7708949|NCT01085591|26809430|P3|Overall Study|Other|0
7708950|NCT01085591|26809431|P2|Overall Study|Other|1
7708951|NCT01085591|26809432|P1|Overall Study|Other|0
7708952|NCT01085591|26809430|P3|Overall Study|Protocol Violation|1
7708953|NCT01085591|26809431|P2|Overall Study|Protocol Violation|1
7708954|NCT01085591|26809432|P1|Overall Study|Protocol Violation|1
7708955|NCT01085591|26809430|P3|Overall Study|Lost to Follow-up|1
7708956|NCT01085591|26809431|P2|Overall Study|Lost to Follow-up|1
7708957|NCT01085591|26809432|P1|Overall Study|Lost to Follow-up|0
7708958|NCT01085591|26809430|P3|Overall Study|Withdrawal by Subject|1
7708959|NCT01085591|26809431|P2|Overall Study|Withdrawal by Subject|2
7708960|NCT01085591|26809432|P1|Overall Study|Withdrawal by Subject|0
7708961|NCT01085591|26809430|P3|Overall Study|Physician Decision|1
7708962|NCT01085591|26809431|P2|Overall Study|Physician Decision|0
7708963|NCT01085591|26809432|P1|Overall Study|Physician Decision|1
7708964|NCT01085591|26809430|P3|Overall Study|Adverse Event|3
7708965|NCT01085591|26809431|P2|Overall Study|Adverse Event|1
7708966|NCT01085591|26809432|P1|Overall Study|Adverse Event|0
7708967|NCT01085357|26809485|P2|Overall Study|Lost to Follow-up|0
7708968|NCT01085357|26809486|P1|Overall Study|Lost to Follow-up|2
7708969|NCT01085357|26809485|P2|Overall Study|Death|1
7708970|NCT01085357|26809486|P1|Overall Study|Death|11
7708971|NCT01085357|26809485|P2|Overall Study|Investigator Decision|1
7708972|NCT01085357|26809486|P1|Overall Study|Investigator Decision|1
7708973|NCT01085357|26809485|P2|Overall Study|Subject Decision|3
7708974|NCT01085357|26809486|P1|Overall Study|Subject Decision|4
7708975|NCT01085357|26809485|P2|Overall Study|Adverse Event|1
7708976|NCT01085357|26809486|P1|Overall Study|Adverse Event|1
7708977|NCT01085214|26809559|P1|Overall Study|Alternate treatment required|1
7708978|NCT01085201|26809571|P5|Overall Study|Fond ineligible after consent|0
7708979|NCT01085201|26809572|P4|Overall Study|Fond ineligible after consent|0
7708980|NCT01085201|26809573|P3|Overall Study|Fond ineligible after consent|1
7708981|NCT01085201|26809574|P2|Overall Study|Fond ineligible after consent|1
7708982|NCT01085201|26809575|P1|Overall Study|Fond ineligible after consent|0
7708983|NCT01085201|26809571|P5|Overall Study|Unknown- no study drug|0
7708984|NCT01085201|26809572|P4|Overall Study|Unknown- no study drug|0
7708985|NCT01085201|26809573|P3|Overall Study|Unknown- no study drug|0
7708986|NCT01085201|26809574|P2|Overall Study|Unknown- no study drug|0
7708987|NCT01085201|26809575|P1|Overall Study|Unknown- no study drug|2
7708988|NCT01085201|26809571|P5|Overall Study|Scheduling conflict|0
7708989|NCT01085201|26809572|P4|Overall Study|Scheduling conflict|0
7708990|NCT01085201|26809573|P3|Overall Study|Scheduling conflict|1
7708991|NCT01085201|26809574|P2|Overall Study|Scheduling conflict|0
7708992|NCT01085201|26809575|P1|Overall Study|Scheduling conflict|1
7708993|NCT01085136|26809597|P3|Part B|Other reason not defined above|3
7708994|NCT01085136|26809598|P2|Part B|Other reason not defined above|6
7708995|NCT01085136|26809599|P1|Part B|Other reason not defined above|0
7708996|NCT01085136|26809597|P3|Part B|Not treated|8
7708997|NCT01085136|26809598|P2|Part B|Not treated|4
7708998|NCT01085136|26809599|P1|Part B|Not treated|0
7708999|NCT01085136|26809597|P3|Part B|Refusal to continue trial medication|7
7709000|NCT01085136|26809598|P2|Part B|Refusal to continue trial medication|12
7709001|NCT01085136|26809599|P1|Part B|Refusal to continue trial medication|0
7709002|NCT01085136|26809597|P3|Part B|Other AE|8
7709003|NCT01085136|26809598|P2|Part B|Other AE|29
7709004|NCT01085136|26809599|P1|Part B|Other AE|0
7709005|NCT01085136|26809597|P3|Part A|Other reason not defined above|0
7709006|NCT01085136|26809598|P2|Part A|Other reason not defined above|0
7709007|NCT01085136|26809599|P1|Part A|Other reason not defined above|30
7709008|NCT01085136|26809597|P3|Part A|Refusal to continue trial medication|0
7709009|NCT01085136|26809598|P2|Part A|Refusal to continue trial medication|0
7709010|NCT01085136|26809599|P1|Part A|Refusal to continue trial medication|64
7709011|NCT01085136|26809597|P3|Part A|Lost to Follow-up|0
7709012|NCT01085136|26809598|P2|Part A|Lost to Follow-up|0
7709013|NCT01085136|26809599|P1|Part A|Lost to Follow-up|3
7709014|NCT01085136|26809597|P3|Part A|Protocol Violation|0
7709015|NCT01085136|26809598|P2|Part A|Protocol Violation|0
7709016|NCT01085136|26809599|P1|Part A|Protocol Violation|3
7709017|NCT01085136|26809597|P3|Part A|Other Adverse event|0
7709018|NCT01085136|26809598|P2|Part A|Other Adverse event|0
7709019|NCT01085136|26809599|P1|Part A|Other Adverse event|223
7709020|NCT01085045|26809615|P1|Part B|Adverse Event|6
7709021|NCT01085045|26809615|P1|Part B|Lost to Follow-up|1
7709022|NCT01085045|26809615|P1|Part B|Protocol Specified Criteria|6
7709023|NCT01085045|26809615|P1|Part B|Withdrawal by Subject|2
7709024|NCT01085045|26809615|P1|Part A|Protocol Specified Criteria|7
7709025|NCT01085045|26809615|P1|Part A|Protocol Violation|1
7709026|NCT01085045|26809615|P1|Part A|Adverse Event|6
7709027|NCT01085045|26809615|P1|Part A|Withdrawal by Subject|4
7709028|NCT01084772|26809726|P2|2 Years|Study Termination|2
7709029|NCT01084772|26809727|P1|2 Years|Study Termination|3
7709030|NCT01084772|26809726|P2|2 Years|Lost to Follow-up|2
7709031|NCT01084772|26809727|P1|2 Years|Lost to Follow-up|5
7709032|NCT01084772|26809726|P2|2 Years|Withdrawal by Subject|0
7709033|NCT01084772|26809727|P1|2 Years|Withdrawal by Subject|1
7709034|NCT01084772|26809726|P2|1 Year|Study Termination|7
7709035|NCT01084772|26809727|P1|1 Year|Study Termination|0
7709036|NCT01084772|26809726|P2|1 Year|Lost to Follow-up|0
7709037|NCT01084772|26809727|P1|1 Year|Lost to Follow-up|3
7709038|NCT01084772|26809726|P2|1 Year|Withdrawal by Subject|1
7709039|NCT01084772|26809727|P1|1 Year|Withdrawal by Subject|0
7709040|NCT01084772|26809726|P2|3 Months|Study Termination|2
7709041|NCT01084772|26809727|P1|3 Months|Study Termination|2
7709042|NCT01084772|26809726|P2|3 Months|Death|0
7709043|NCT01084772|26809727|P1|3 Months|Death|1
7709044|NCT01084772|26809726|P2|Baseline|Withdrawal by Subject|6
7709045|NCT01084772|26809727|P1|Baseline|Withdrawal by Subject|7
7709046|NCT01084707|26809763|P1|Overall Study|Withdrawal by Subject|6
7709047|NCT01084694|26809799|P2|Overall Study|eligibility not maintained|7
7709048|NCT01084694|26809800|P1|Overall Study|eligibility not maintained|2
7709049|NCT01084694|26809799|P2|Overall Study|Death|12
7709050|NCT01084694|26809800|P1|Overall Study|Death|2
7709051|NCT01084694|26809799|P2|Overall Study|Withdrawal by Subject|1
7709052|NCT01084694|26809800|P1|Overall Study|Withdrawal by Subject|2
7709053|NCT01084668|26809816|P1|Overall Study|Non-compliance|1
7709054|NCT01084668|26809816|P1|Overall Study|Pregnancy|1
7709055|NCT01084668|26809816|P1|Overall Study|Withdrawal by Subject|2
7709056|NCT01084668|26809816|P1|Overall Study|Lack of Efficacy|5
7709057|NCT01084655|26809828|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
7709058|NCT01084655|26809829|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
7709059|NCT01084655|26809830|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
7709060|NCT01084655|26809828|P3|Overall Study|Symptomatic deterioration|2
7709061|NCT01084655|26809829|P2|Overall Study|Symptomatic deterioration|0
7709062|NCT01084655|26809830|P1|Overall Study|Symptomatic deterioration|0
7709063|NCT01084655|26809828|P3|Overall Study|Other|2
7709064|NCT01084655|26809829|P2|Overall Study|Other|3
7709065|NCT01084655|26809830|P1|Overall Study|Other|0
7709066|NCT01084655|26809828|P3|Overall Study|Adverse Event|2
7709067|NCT01084655|26809829|P2|Overall Study|Adverse Event|1
7709068|NCT01084655|26809830|P1|Overall Study|Adverse Event|2
7709069|NCT01084655|26809828|P3|Overall Study|Withdrawal by Subject|4
7709070|NCT01084655|26809829|P2|Overall Study|Withdrawal by Subject|0
7709071|NCT01084655|26809830|P1|Overall Study|Withdrawal by Subject|1
7709072|NCT01084655|26809828|P3|Overall Study|Radiographic disease progression|8
7709073|NCT01084655|26809829|P2|Overall Study|Radiographic disease progression|2
7709074|NCT01084655|26809830|P1|Overall Study|Radiographic disease progression|3
7709075|NCT01084603|26809865|P1|Washout Period 4|Adverse Event|1
7709076|NCT01084603|26809865|P1|Oral Nicotine 1|Withdrawal by Subject|1
7709077|NCT01084603|26809865|P1|Nicorette® Gum|Withdrawal by Subject|1
7709078|NCT01084603|26809865|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
7709079|NCT01084603|26809865|P1|Baseline|Withdrawal by Subject|2
7709080|NCT01084551|26809901|P3|Overall Study|Physician Decision|0
7709081|NCT01084551|26809902|P2|Overall Study|Physician Decision|0
7709082|NCT01084551|26809903|P1|Overall Study|Physician Decision|1
7709083|NCT01084551|26809901|P3|Overall Study|Lost to Follow-up|3
7709084|NCT01084551|26809902|P2|Overall Study|Lost to Follow-up|0
7709085|NCT01084551|26809903|P1|Overall Study|Lost to Follow-up|0
7709086|NCT01084551|26809901|P3|Overall Study|Protocol Violation|0
7709087|NCT01084551|26809902|P2|Overall Study|Protocol Violation|4
7709088|NCT01084551|26809903|P1|Overall Study|Protocol Violation|2
7709089|NCT01084551|26809901|P3|Overall Study|Withdrawal by Subject|0
7709090|NCT01084551|26809902|P2|Overall Study|Withdrawal by Subject|1
7709091|NCT01084551|26809903|P1|Overall Study|Withdrawal by Subject|2
7709092|NCT01084551|26809901|P3|Overall Study|Lack of Efficacy|1
7709093|NCT01084551|26809902|P2|Overall Study|Lack of Efficacy|0
7709094|NCT01084551|26809903|P1|Overall Study|Lack of Efficacy|2
7709095|NCT01084551|26809901|P3|Overall Study|Adverse Event|4
7709096|NCT01084551|26809902|P2|Overall Study|Adverse Event|9
7709097|NCT01084551|26809903|P1|Overall Study|Adverse Event|2
7709098|NCT01084538|26809941|P1|Overall Study|Reason unknown|8
7709099|NCT01084538|26809941|P1|Overall Study|Over-suppression of parathyroid gland|2
7709100|NCT01084538|26809941|P1|Overall Study|Change of residence|2
7709101|NCT01084538|26809941|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
7709102|NCT01084538|26809941|P1|Overall Study|Hyperphosphatemia|2
7709103|NCT01084538|26809941|P1|Overall Study|Patient noncompliance|2
7709104|NCT01084538|26809941|P1|Overall Study|Lack of effectiveness|2
7709105|NCT01084538|26809941|P1|Overall Study|Serious Adverse Event|3
7709106|NCT01084538|26809941|P1|Overall Study|Kidney transplant|6
7709107|NCT01084538|26809941|P1|Overall Study|Adverse Event|9
7709108|NCT01084538|26809941|P1|Overall Study|Drug not available|30
7709109|NCT01084252|26810075|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709110|NCT01084252|26810076|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
7709111|NCT01084252|26810077|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709112|NCT01084252|26810078|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709113|NCT01084252|26810079|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709114|NCT01084252|26810080|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709115|NCT01084252|26810081|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709116|NCT01084252|26810082|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709117|NCT01084252|26810083|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709118|NCT01084252|26810084|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709119|NCT01084252|26810085|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709120|NCT01084252|26810086|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709121|NCT01084252|26810087|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709122|NCT01084252|26810088|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7709123|NCT01084252|26810075|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
7709124|NCT01084252|26810076|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
7709125|NCT01084252|26810077|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709126|NCT01084252|26810078|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709127|NCT01084252|26810079|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709128|NCT01084252|26810080|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709129|NCT01084252|26810081|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709130|NCT01084252|26810082|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709131|NCT01084252|26810083|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709132|NCT01084252|26810084|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709133|NCT01084252|26810085|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709134|NCT01084252|26810086|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709135|NCT01084252|26810087|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709136|NCT01084252|26810088|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7709137|NCT01084252|26810075|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
7709138|NCT01084252|26810076|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
7709139|NCT01084252|26810077|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709140|NCT01084252|26810078|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709141|NCT01084252|26810079|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709142|NCT01084252|26810080|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709143|NCT01084252|26810081|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709144|NCT01084252|26810082|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709145|NCT01084252|26810083|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709146|NCT01084252|26810084|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709147|NCT01084252|26810085|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709148|NCT01084252|26810086|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709149|NCT01084252|26810087|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709150|NCT01084252|26810088|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7709151|NCT01084252|26810075|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709152|NCT01084252|26810076|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
7709153|NCT01084252|26810077|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709154|NCT01084252|26810078|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709155|NCT01084252|26810079|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709156|NCT01084252|26810080|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709157|NCT01084252|26810081|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709158|NCT01084252|26810082|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709159|NCT01084252|26810083|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709160|NCT01084252|26810084|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709161|NCT01084252|26810085|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709162|NCT01084252|26810086|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709163|NCT01084252|26810087|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709164|NCT01084252|26810088|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7709165|NCT01084252|26810075|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
7709166|NCT01084252|26810076|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
7709167|NCT01084252|26810077|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709168|NCT01084252|26810078|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709169|NCT01084252|26810079|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709170|NCT01084252|26810080|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709171|NCT01084252|26810081|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709172|NCT01084252|26810082|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709173|NCT01084252|26810083|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709174|NCT01084252|26810084|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709175|NCT01084252|26810085|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709176|NCT01084252|26810086|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709177|NCT01084252|26810087|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709178|NCT01084252|26810088|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7709179|NCT01084252|26810075|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
7709180|NCT01084252|26810076|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
7709181|NCT01084252|26810077|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709182|NCT01084252|26810078|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709183|NCT01084252|26810079|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709184|NCT01084252|26810080|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709185|NCT01084252|26810081|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709186|NCT01084252|26810082|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709187|NCT01084252|26810083|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709188|NCT01084252|26810084|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709189|NCT01084252|26810085|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709190|NCT01084252|26810086|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709191|NCT01084252|26810087|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709192|NCT01084252|26810088|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7709193|NCT01084252|26810075|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709194|NCT01084252|26810076|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709195|NCT01084252|26810077|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7709196|NCT01084252|26810078|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7709197|NCT01084252|26810079|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
7709198|NCT01084252|26810080|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
7709199|NCT01084252|26810081|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709200|NCT01084252|26810082|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709201|NCT01084252|26810083|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709202|NCT01084252|26810084|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709203|NCT01084252|26810085|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709204|NCT01084252|26810086|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709205|NCT01084252|26810087|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709206|NCT01084252|26810088|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7709207|NCT01084252|26810075|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709208|NCT01084252|26810076|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709209|NCT01084252|26810077|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
7709210|NCT01084252|26810078|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
7709211|NCT01084252|26810079|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709212|NCT01084252|26810080|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
7709213|NCT01084252|26810081|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709214|NCT01084252|26810082|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709215|NCT01084252|26810083|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709216|NCT01084252|26810084|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709217|NCT01084252|26810085|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709218|NCT01084252|26810086|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709219|NCT01084252|26810087|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709220|NCT01084252|26810088|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7709221|NCT01084252|26810075|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709222|NCT01084252|26810076|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709223|NCT01084252|26810077|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
7709224|NCT01084252|26810078|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
7709225|NCT01084252|26810079|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
7709226|NCT01084252|26810080|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
7709227|NCT01084252|26810081|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709228|NCT01084252|26810082|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709229|NCT01084252|26810083|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709230|NCT01084252|26810084|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709231|NCT01084252|26810085|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709232|NCT01084252|26810086|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709233|NCT01084252|26810087|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709234|NCT01084252|26810088|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7709235|NCT01084252|26810075|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709236|NCT01084252|26810076|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709237|NCT01084252|26810077|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
7709238|NCT01084252|26810078|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7709239|NCT01084252|26810079|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7709240|NCT01084252|26810080|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709241|NCT01084252|26810081|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709242|NCT01084252|26810082|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709243|NCT01084252|26810083|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709244|NCT01084252|26810084|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709245|NCT01084252|26810085|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709246|NCT01084252|26810086|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709247|NCT01084252|26810087|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709248|NCT01084252|26810088|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7709249|NCT01084252|26810075|P14|Phase 1 (120 Weeks)|Other than specified above|0
7709250|NCT01084252|26810076|P13|Phase 1 (120 Weeks)|Other than specified above|0
7709251|NCT01084252|26810077|P12|Phase 1 (120 Weeks)|Other than specified above|0
7709252|NCT01084252|26810078|P11|Phase 1 (120 Weeks)|Other than specified above|0
7709253|NCT01084252|26810079|P10|Phase 1 (120 Weeks)|Other than specified above|0
7709254|NCT01084252|26810080|P9|Phase 1 (120 Weeks)|Other than specified above|0
7709255|NCT01084252|26810081|P8|Phase 1 (120 Weeks)|Other than specified above|1
7709256|NCT01084252|26810082|P7|Phase 1 (120 Weeks)|Other than specified above|1
7709257|NCT01084252|26810083|P6|Phase 1 (120 Weeks)|Other than specified above|0
7709258|NCT01084252|26810084|P5|Phase 1 (120 Weeks)|Other than specified above|1
7709259|NCT01084252|26810085|P4|Phase 1 (120 Weeks)|Other than specified above|3
7709260|NCT01084252|26810086|P3|Phase 1 (120 Weeks)|Other than specified above|0
7709261|NCT01084252|26810087|P2|Phase 1 (120 Weeks)|Other than specified above|1
7709262|NCT01084252|26810088|P1|Phase 1 (120 Weeks)|Other than specified above|1
7709263|NCT01084252|26810075|P14|Phase 1 (120 Weeks)|Progressive disease|0
7709264|NCT01084252|26810076|P13|Phase 1 (120 Weeks)|Progressive disease|0
7709265|NCT01084252|26810077|P12|Phase 1 (120 Weeks)|Progressive disease|0
7709266|NCT01084252|26810078|P11|Phase 1 (120 Weeks)|Progressive disease|0
7709267|NCT01084252|26810079|P10|Phase 1 (120 Weeks)|Progressive disease|0
7709268|NCT01084252|26810080|P9|Phase 1 (120 Weeks)|Progressive disease|0
7709269|NCT01084252|26810081|P8|Phase 1 (120 Weeks)|Progressive disease|6
7709270|NCT01084252|26810082|P7|Phase 1 (120 Weeks)|Progressive disease|5
7709271|NCT01084252|26810083|P6|Phase 1 (120 Weeks)|Progressive disease|6
7709272|NCT01084252|26810084|P5|Phase 1 (120 Weeks)|Progressive disease|16
7709273|NCT01084252|26810085|P4|Phase 1 (120 Weeks)|Progressive disease|22
7709274|NCT01084252|26810086|P3|Phase 1 (120 Weeks)|Progressive disease|2
7709275|NCT01084252|26810087|P2|Phase 1 (120 Weeks)|Progressive disease|5
7709276|NCT01084252|26810088|P1|Phase 1 (120 Weeks)|Progressive disease|15
7709277|NCT01084252|26810075|P14|Phase 1 (120 Weeks)|Adverse Event|0
7709278|NCT01084252|26810076|P13|Phase 1 (120 Weeks)|Adverse Event|0
7709279|NCT01084252|26810077|P12|Phase 1 (120 Weeks)|Adverse Event|0
7709280|NCT01084252|26810078|P11|Phase 1 (120 Weeks)|Adverse Event|0
7709281|NCT01084252|26810079|P10|Phase 1 (120 Weeks)|Adverse Event|0
7709282|NCT01084252|26810080|P9|Phase 1 (120 Weeks)|Adverse Event|0
7709283|NCT01084252|26810081|P8|Phase 1 (120 Weeks)|Adverse Event|0
7709284|NCT01084252|26810082|P7|Phase 1 (120 Weeks)|Adverse Event|1
7709285|NCT01084252|26810083|P6|Phase 1 (120 Weeks)|Adverse Event|0
7709286|NCT01084252|26810084|P5|Phase 1 (120 Weeks)|Adverse Event|1
7709287|NCT01084252|26810085|P4|Phase 1 (120 Weeks)|Adverse Event|1
7709288|NCT01084252|26810086|P3|Phase 1 (120 Weeks)|Adverse Event|1
7709289|NCT01084252|26810087|P2|Phase 1 (120 Weeks)|Adverse Event|0
7709290|NCT01084252|26810088|P1|Phase 1 (120 Weeks)|Adverse Event|0
7709291|NCT01084239|26810272|P2|28-Day Follow-up|Lost to Follow-up|9
7709292|NCT01084239|26810273|P1|28-Day Follow-up|Lost to Follow-up|4
7709293|NCT01084174|26810291|P2|Overall Study|Participant noncompliance|1
7709294|NCT01084174|26810292|P1|Overall Study|Participant noncompliance|0
7709295|NCT01084174|26810291|P2|Overall Study|Anaphylaxis|1
7709296|NCT01084174|26810292|P1|Overall Study|Anaphylaxis|0
7709297|NCT01084174|26810291|P2|Overall Study|Eosinophilic esophagitis|1
7709298|NCT01084174|26810292|P1|Overall Study|Eosinophilic esophagitis|0
7709299|NCT01084174|26810291|P2|Overall Study|gastrointestinal symptoms|1
7709300|NCT01084174|26810292|P1|Overall Study|gastrointestinal symptoms|1
7709301|NCT01084135|26810325|P2|20 Week|Physician Decision|1
7709302|NCT01084135|26810326|P1|20 Week|Physician Decision|0
7709303|NCT01084083|26810336|P1|Overall Study|Never started assigned therapy|1
7709304|NCT01084083|26810336|P1|Overall Study|Other|2
7709305|NCT01084083|26810336|P1|Overall Study|Complicating disease|1
7709306|NCT01084083|26810336|P1|Overall Study|Withdrawal by Subject|2
7709307|NCT01084083|26810336|P1|Overall Study|Death|1
7709308|NCT01084083|26810336|P1|Overall Study|Adverse Event|5
7709309|NCT01084005|26810344|P2|Overall Study|Withdrawal by Subject|1
7709310|NCT01084005|26810345|P1|Overall Study|Withdrawal by Subject|1
7709311|NCT01084005|26810344|P2|Overall Study|Protocol Violation|7
7709312|NCT01084005|26810345|P1|Overall Study|Protocol Violation|3
7709313|NCT01084005|26810344|P2|Overall Study|Adverse Event|8
7709314|NCT01084005|26810345|P1|Overall Study|Adverse Event|1
7709315|NCT01083810|26810426|P3|Overall Study|Virologic failure|0
7709316|NCT01083810|26810427|P2|Overall Study|Virologic failure|8
7709317|NCT01083810|26810428|P1|Overall Study|Virologic failure|1
7709318|NCT01083810|26810426|P3|Overall Study|Therapy break|2
7709319|NCT01083810|26810427|P2|Overall Study|Therapy break|2
7709320|NCT01083810|26810428|P1|Overall Study|Therapy break|1
7709321|NCT01083810|26810426|P3|Overall Study|Participation in study|0
7709322|NCT01083810|26810427|P2|Overall Study|Participation in study|0
7709323|NCT01083810|26810428|P1|Overall Study|Participation in study|1
7709324|NCT01083810|26810426|P3|Overall Study|Co-morbidities|0
7709325|NCT01083810|26810427|P2|Overall Study|Co-morbidities|0
7709326|NCT01083810|26810428|P1|Overall Study|Co-morbidities|1
7709327|NCT01083810|26810426|P3|Overall Study|Death|3
7709328|NCT01083810|26810427|P2|Overall Study|Death|2
7709329|NCT01083810|26810428|P1|Overall Study|Death|2
7709330|NCT01083810|26810426|P3|Overall Study|Simplification|0
7709331|NCT01083810|26810427|P2|Overall Study|Simplification|1
7709332|NCT01083810|26810428|P1|Overall Study|Simplification|4
7709333|NCT01083810|26810426|P3|Overall Study|Non-compliance|2
7709334|NCT01083810|26810427|P2|Overall Study|Non-compliance|7
7709335|NCT01083810|26810428|P1|Overall Study|Non-compliance|4
7709336|NCT01083810|26810426|P3|Overall Study|Reason not reported|1
7709337|NCT01083810|26810427|P2|Overall Study|Reason not reported|1
7709338|NCT01083810|26810428|P1|Overall Study|Reason not reported|6
7709339|NCT01083810|26810426|P3|Overall Study|Withdrawal by Subject|4
7709340|NCT01083810|26810427|P2|Overall Study|Withdrawal by Subject|2
7709341|NCT01083810|26810428|P1|Overall Study|Withdrawal by Subject|7
7709342|NCT01083810|26810426|P3|Overall Study|Adverse Event|4
7709343|NCT01083810|26810427|P2|Overall Study|Adverse Event|11
7709344|NCT01083810|26810428|P1|Overall Study|Adverse Event|15
7709345|NCT01083810|26810426|P3|Overall Study|Lost to Follow-up|4
7709346|NCT01083810|26810427|P2|Overall Study|Lost to Follow-up|11
7709347|NCT01083810|26810428|P1|Overall Study|Lost to Follow-up|23
7709348|NCT01083771|26810449|P1|Overall Study|Withdrawal by Subject|3
7709349|NCT01083771|26810449|P1|Overall Study|non-compliant|2
7709350|NCT01083693|26810550|P3|Overall Study|Reason unknown|1
7709351|NCT01083693|26810551|P2|Overall Study|Reason unknown|0
7709352|NCT01083693|26810552|P1|Overall Study|Reason unknown|0
7709353|NCT01083693|26810550|P3|Overall Study|Withdrawal by Subject|2
7709354|NCT01083693|26810551|P2|Overall Study|Withdrawal by Subject|0
7709355|NCT01083693|26810552|P1|Overall Study|Withdrawal by Subject|3
7709356|NCT01083693|26810550|P3|Overall Study|Other medical condition/surgery|0
7709357|NCT01083693|26810551|P2|Overall Study|Other medical condition/surgery|1
7709358|NCT01083693|26810552|P1|Overall Study|Other medical condition/surgery|1
7709359|NCT01083693|26810550|P3|Overall Study|Complete remission|0
7709360|NCT01083693|26810551|P2|Overall Study|Complete remission|1
7709361|NCT01083693|26810552|P1|Overall Study|Complete remission|0
7709362|NCT01083693|26810550|P3|Overall Study|Patient Moved|0
7709363|NCT01083693|26810551|P2|Overall Study|Patient Moved|1
7709364|NCT01083693|26810552|P1|Overall Study|Patient Moved|0
7709365|NCT01083693|26810550|P3|Overall Study|Lack of effectiveness|2
7709366|NCT01083693|26810551|P2|Overall Study|Lack of effectiveness|2
7709367|NCT01083693|26810552|P1|Overall Study|Lack of effectiveness|13
7709368|NCT01083693|26810550|P3|Overall Study|Lost to Follow-up|2
7709369|NCT01083693|26810551|P2|Overall Study|Lost to Follow-up|0
7709370|NCT01083693|26810552|P1|Overall Study|Lost to Follow-up|2
7709371|NCT01083693|26810550|P3|Overall Study|Adverse Event|0
7709372|NCT01083693|26810551|P2|Overall Study|Adverse Event|1
7709373|NCT01083693|26810552|P1|Overall Study|Adverse Event|1
7709374|NCT01083680|26810587|P1|Overall Study|Withdrawal by Subject|1086
7709375|NCT01083680|26810587|P1|Overall Study|Lost to Follow-up|2758
7709376|NCT01083641|26810610|P1|Overall Study|Withdrawal by Subject|2
7709377|NCT01083602|26810630|P1|Overall Study|Lack of Efficacy|36
7709378|NCT01083602|26810630|P1|Overall Study|Withdrawal by Subject|5
7709379|NCT01083602|26810630|P1|Overall Study|Death|1
7709380|NCT01083602|26810630|P1|Overall Study|New Cancer Therapy|2
7709381|NCT01083602|26810630|P1|Overall Study|Adverse Event|11
7709382|NCT01083576|26810641|P2|Overall Study|Treatment Failure|1
7709383|NCT01083576|26810642|P1|Overall Study|Treatment Failure|6
7709384|NCT01083485|26810672|P2|Overall Study|Other|0
7709385|NCT01083485|26810673|P1|Overall Study|Other|1
7709386|NCT01083485|26810672|P2|Overall Study|Withdrawal by Subject|2
7709387|NCT01083485|26810673|P1|Overall Study|Withdrawal by Subject|5
7709388|NCT01083485|26810672|P2|Overall Study|Protocol Violation|0
7709389|NCT01083485|26810673|P1|Overall Study|Protocol Violation|1
7709390|NCT01083485|26810672|P2|Overall Study|Adverse Event|1
7709391|NCT01083485|26810673|P1|Overall Study|Adverse Event|0
7709392|NCT01083316|26810705|P1|Overall Study|Withdrawal by Subject|1
7709393|NCT01083316|26810705|P1|Overall Study|Adverse Event|2
7709394|NCT01083186|26810717|P1|Overall Study|Non-compliance to Study Treatment|1
7709395|NCT01083186|26810717|P1|Overall Study|Administrative Reasons|2
7709396|NCT01083186|26810717|P1|Overall Study|Hemodialysis Initiation|28
7709397|NCT01083186|26810717|P1|Overall Study|Lack of Efficacy|2
7709398|NCT01083186|26810717|P1|Overall Study|Adverse Event|3
7709399|NCT01083186|26810717|P1|Overall Study|Death|3
7709400|NCT01083186|26810717|P1|Overall Study|Consent Withdrawal|7
7709401|NCT01083186|26810717|P1|Overall Study|Lost to Follow-up|48
7709402|NCT01083173|26810758|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
7709403|NCT01083173|26810759|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
7709404|NCT01083173|26810758|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
7709405|NCT01083173|26810759|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
7709406|NCT01083173|26810758|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
7709407|NCT01083173|26810759|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
7709408|NCT01083173|26810758|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
7709409|NCT01083173|26810759|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
7709410|NCT01083173|26810758|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
7709411|NCT01083173|26810759|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
7709412|NCT01083173|26810758|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
7709413|NCT01083173|26810759|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
7709414|NCT01083173|26810758|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
7709415|NCT01083173|26810759|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
7709416|NCT01083173|26810758|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
7709417|NCT01083173|26810759|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
7709418|NCT01083173|26810758|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
7709419|NCT01083173|26810759|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
7709420|NCT01083173|26810758|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
7709421|NCT01083173|26810759|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
7709422|NCT01083173|26810758|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
7709423|NCT01083173|26810759|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
7709424|NCT01083160|26810777|P1|Overall Study|Adverse Event|1
7709425|NCT01083121|26810784|P1|Overall Study|Use of Humira outside the approved label|81
7709426|NCT01082965|26810794|P2|Overall Study|Other|1
7709427|NCT01082965|26810795|P1|Overall Study|Other|1
7709428|NCT01082965|26810794|P2|Overall Study|Protocol Violation|1
7709429|NCT01082965|26810795|P1|Overall Study|Protocol Violation|0
7709430|NCT01082874|26810832|P4|Overall Study|Withdrawal by Subject|3
7709431|NCT01082874|26810833|P3|Overall Study|Withdrawal by Subject|5
7709432|NCT01082874|26810834|P2|Overall Study|Withdrawal by Subject|2
7709433|NCT01082874|26810835|P1|Overall Study|Withdrawal by Subject|1
7709434|NCT01082874|26810832|P4|Overall Study|Lost to Follow-up|10
7709435|NCT01082874|26810833|P3|Overall Study|Lost to Follow-up|6
7709436|NCT01082874|26810834|P2|Overall Study|Lost to Follow-up|10
7709437|NCT01082874|26810835|P1|Overall Study|Lost to Follow-up|10
7709438|NCT01082640|26810848|P3|Overall Study|Other|3
7709439|NCT01082640|26810849|P2|Overall Study|Other|1
7709440|NCT01082640|26810850|P1|Overall Study|Other|2
7709441|NCT01082640|26810848|P3|Overall Study|Lost to Follow-up|0
7709442|NCT01082640|26810849|P2|Overall Study|Lost to Follow-up|3
7709443|NCT01082640|26810850|P1|Overall Study|Lost to Follow-up|0
7709444|NCT01082640|26810848|P3|Overall Study|Major protocol deviation|0
7709445|NCT01082640|26810849|P2|Overall Study|Major protocol deviation|3
7709446|NCT01082640|26810850|P1|Overall Study|Major protocol deviation|3
7709447|NCT01082640|26810848|P3|Overall Study|Withdrawal by Subject|2
7709448|NCT01082640|26810849|P2|Overall Study|Withdrawal by Subject|3
7709449|NCT01082640|26810850|P1|Overall Study|Withdrawal by Subject|3
7709450|NCT01082640|26810848|P3|Overall Study|Adverse Event|3
7709451|NCT01082640|26810849|P2|Overall Study|Adverse Event|5
7709452|NCT01082640|26810850|P1|Overall Study|Adverse Event|9
7709453|NCT01082614|26810872|P2|Overall Study|Physician Decision|0
7709454|NCT01082614|26810873|P1|Overall Study|Physician Decision|2
7709455|NCT01082614|26810872|P2|Overall Study|Equipment Malfunction|1
7709456|NCT01082614|26810873|P1|Overall Study|Equipment Malfunction|0
7709457|NCT01082614|26810872|P2|Overall Study|Adverse Event|4
7709458|NCT01082614|26810873|P1|Overall Study|Adverse Event|1
7709459|NCT01082367|26810944|P2|Follow-up (F-U) Period|Adverse Event|1
7709460|NCT01082367|26810945|P1|Follow-up (F-U) Period|Adverse Event|0
7709461|NCT01082367|26810944|P2|Follow-up (F-U) Period|Abnormal lab values|0
7709462|NCT01082367|26810945|P1|Follow-up (F-U) Period|Abnormal lab values|1
7709463|NCT01082367|26810944|P2|Follow-up (F-U) Period|Administrative problems|0
7709464|NCT01082367|26810945|P1|Follow-up (F-U) Period|Administrative problems|1
7709465|NCT01082367|26810944|P2|Double-blind Period|Adverse Event|1
7709466|NCT01082367|26810945|P1|Double-blind Period|Adverse Event|0
7709467|NCT01082367|26810944|P2|Double-blind Period|Lack of Efficacy|11
7709468|NCT01082367|26810945|P1|Double-blind Period|Lack of Efficacy|5
7709469|NCT01082367|26810944|P2|Double-blind Period|Administrative problems|1
7709470|NCT01082367|26810945|P1|Double-blind Period|Administrative problems|0
7709471|NCT01082328|26810959|P1|Overall Study|Adverse Event|1
7709472|NCT01082211|26810968|P1|Overall Study|No protocol treatment received|3
7709473|NCT01082211|26810968|P1|Overall Study|Protocol Violation|4
7709474|NCT01082081|26810995|P3|Overall Study|Other Reason|0
7709475|NCT01082081|26810996|P2|Overall Study|Other Reason|1
7709476|NCT01082081|26810997|P1|Overall Study|Other Reason|0
7709477|NCT01082081|26810995|P3|Overall Study|Withdrawal by Subject|1
7709478|NCT01082081|26810996|P2|Overall Study|Withdrawal by Subject|0
7709479|NCT01082081|26810997|P1|Overall Study|Withdrawal by Subject|0
7709480|NCT01082081|26810995|P3|Overall Study|Lost to Follow-up|1
7709481|NCT01082081|26810996|P2|Overall Study|Lost to Follow-up|0
7709482|NCT01082081|26810997|P1|Overall Study|Lost to Follow-up|0
7709483|NCT01081951|26811049|P2|Overall Study|Lost to Follow-up|1
7709484|NCT01081951|26811050|P1|Overall Study|Lost to Follow-up|0
7709485|NCT01081951|26811049|P2|Overall Study|Allocated treatment but did not take it|1
7709486|NCT01081951|26811050|P1|Overall Study|Allocated treatment but did not take it|0
7709487|NCT01081951|26811049|P2|Overall Study|Withdrawal by Subject|6
7709488|NCT01081951|26811050|P1|Overall Study|Withdrawal by Subject|2
7709489|NCT01081951|26811049|P2|Overall Study|Death|47
7709490|NCT01081951|26811050|P1|Overall Study|Death|54
7709491|NCT01081912|26811060|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
7709492|NCT01081912|26811061|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
7709493|NCT01081912|26811062|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
7709494|NCT01081912|26811060|P3|Maintenance Treatment|Non-Compliance|7
7709495|NCT01081912|26811061|P2|Maintenance Treatment|Non-Compliance|4
7709496|NCT01081912|26811062|P1|Maintenance Treatment|Non-Compliance|0
7709497|NCT01081912|26811060|P3|Maintenance Treatment|Withdrawal by Subject|5
7709498|NCT01081912|26811061|P2|Maintenance Treatment|Withdrawal by Subject|5
7709499|NCT01081912|26811062|P1|Maintenance Treatment|Withdrawal by Subject|0
7709500|NCT01081912|26811060|P3|Maintenance Treatment|Protocol Violation|2
7709501|NCT01081912|26811061|P2|Maintenance Treatment|Protocol Violation|1
7709502|NCT01081912|26811062|P1|Maintenance Treatment|Protocol Violation|0
7709503|NCT01081912|26811060|P3|Maintenance Treatment|Physician Decision|1
7709504|NCT01081912|26811061|P2|Maintenance Treatment|Physician Decision|0
7709505|NCT01081912|26811062|P1|Maintenance Treatment|Physician Decision|0
7709506|NCT01081912|26811060|P3|Maintenance Treatment|Lost to Follow-up|0
7709507|NCT01081912|26811061|P2|Maintenance Treatment|Lost to Follow-up|1
7709508|NCT01081912|26811062|P1|Maintenance Treatment|Lost to Follow-up|0
7709509|NCT01081912|26811060|P3|Maintenance Treatment|Lack of Efficacy|64
7709510|NCT01081912|26811061|P2|Maintenance Treatment|Lack of Efficacy|14
7709511|NCT01081912|26811062|P1|Maintenance Treatment|Lack of Efficacy|0
7709512|NCT01081912|26811060|P3|Maintenance Treatment|Adverse Event|12
7709513|NCT01081912|26811061|P2|Maintenance Treatment|Adverse Event|2
7709514|NCT01081912|26811062|P1|Maintenance Treatment|Adverse Event|0
7709515|NCT01081912|26811060|P3|Conversion/Titration|Non-Compliance|0
7709516|NCT01081912|26811061|P2|Conversion/Titration|Non-Compliance|0
7709517|NCT01081912|26811062|P1|Conversion/Titration|Non-Compliance|47
7709518|NCT01081912|26811060|P3|Conversion/Titration|Withdrawal by Subject|0
7709519|NCT01081912|26811061|P2|Conversion/Titration|Withdrawal by Subject|0
7709520|NCT01081912|26811062|P1|Conversion/Titration|Withdrawal by Subject|23
7709521|NCT01081912|26811060|P3|Conversion/Titration|Protocol Violation|0
7709522|NCT01081912|26811061|P2|Conversion/Titration|Protocol Violation|0
7709523|NCT01081912|26811062|P1|Conversion/Titration|Protocol Violation|67
7709524|NCT01081912|26811060|P3|Conversion/Titration|Physician Decision|0
7709525|NCT01081912|26811061|P2|Conversion/Titration|Physician Decision|0
7709526|NCT01081912|26811062|P1|Conversion/Titration|Physician Decision|2
7709527|NCT01081912|26811060|P3|Conversion/Titration|Lost to Follow-up|0
7709528|NCT01081912|26811061|P2|Conversion/Titration|Lost to Follow-up|0
7709529|NCT01081912|26811062|P1|Conversion/Titration|Lost to Follow-up|5
7709530|NCT01081912|26811060|P3|Conversion/Titration|Lack of Efficacy|0
7709531|NCT01081912|26811061|P2|Conversion/Titration|Lack of Efficacy|0
7709532|NCT01081912|26811062|P1|Conversion/Titration|Lack of Efficacy|17
7709533|NCT01081912|26811060|P3|Conversion/Titration|Adverse Event|0
7709534|NCT01081912|26811061|P2|Conversion/Titration|Adverse Event|0
7709535|NCT01081912|26811062|P1|Conversion/Titration|Adverse Event|47
7709536|NCT01081886|26811071|P2|Overall Study|Study termination|13
7709537|NCT01081886|26811072|P1|Overall Study|Study termination|11
7709538|NCT01081873|26811080|P1|Overall Study|Other|47
7709539|NCT01081873|26811080|P1|Overall Study|Progression of prostate cancer|13
7709540|NCT01081873|26811080|P1|Overall Study|Lost to Follow-up|142
7709541|NCT01081873|26811080|P1|Overall Study|Withdrawal by Subject|10
7709542|NCT01081873|26811080|P1|Overall Study|Death|86
7709543|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
7709544|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
7709545|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
7709546|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
7709547|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
7709548|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7709549|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7709550|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7709551|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
7709552|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
7709553|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Other|0
7709554|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Other|0
7709555|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Other|4
7709556|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Other|5
7709557|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Other|4
7709558|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7709559|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7709560|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7709561|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
7709562|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7709563|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7709564|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7709565|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7709566|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7709567|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7709568|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7709569|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7709570|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7709571|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
7709572|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7709573|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
7709574|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
7709575|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
7709576|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
7709577|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
7709578|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7709579|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7709580|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7709581|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
7709582|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
7709583|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Death|0
7709584|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Death|0
7709585|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Death|0
7709586|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Death|0
7709587|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Death|1
7709588|NCT01081834|26811152|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
7709589|NCT01081834|26811153|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
7709590|NCT01081834|26811154|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
7709591|NCT01081834|26811155|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
7709592|NCT01081834|26811156|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
7709593|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7709594|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7709595|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7709596|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
7709597|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
7709598|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Other|0
7709599|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Other|1
7709600|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Other|3
7709601|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Other|4
7709602|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Other|4
7709603|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7709604|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7709605|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7709606|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7709607|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7709608|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7709609|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
7709610|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
7709611|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
7709612|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
7709613|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
7709614|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7709615|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
7709616|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7709617|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
7709618|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Protocol Violation|2
7709619|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Protocol Violation|0
7709620|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Protocol Violation|0
7709621|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Protocol Violation|4
7709622|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Protocol Violation|0
7709623|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
7709624|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
7709625|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
7709626|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
7709627|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
7709628|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Death|0
7709629|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Death|0
7709630|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Death|0
7709631|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Death|0
7709632|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Death|1
7709633|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Adverse Event|1
7709634|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Adverse Event|1
7709635|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Adverse Event|3
7709636|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Adverse Event|5
7709637|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Adverse Event|2
7709638|NCT01081834|26811152|P5|Core Period: Baseline to Week 26|Pregnancy|0
7709639|NCT01081834|26811153|P4|Core Period: Baseline to Week 26|Pregnancy|0
7709640|NCT01081834|26811154|P3|Core Period: Baseline to Week 26|Pregnancy|0
7709641|NCT01081834|26811155|P2|Core Period: Baseline to Week 26|Pregnancy|0
7709642|NCT01081834|26811156|P1|Core Period: Baseline to Week 26|Pregnancy|1
7709643|NCT01081795|26811217|P3|Overall Study|Other|0
7709644|NCT01081795|26811218|P2|Overall Study|Other|2
7709645|NCT01081795|26811219|P1|Overall Study|Other|1
7709646|NCT01081795|26811217|P3|Overall Study|Using drug with restricted days of use|2
7709647|NCT01081795|26811218|P2|Overall Study|Using drug with restricted days of use|3
7709648|NCT01081795|26811219|P1|Overall Study|Using drug with restricted days of use|2
7709649|NCT01081795|26811217|P3|Overall Study|Use of a prohibited concomitant drug|1
7709650|NCT01081795|26811218|P2|Overall Study|Use of a prohibited concomitant drug|1
7709651|NCT01081795|26811219|P1|Overall Study|Use of a prohibited concomitant drug|1
7709652|NCT01081795|26811217|P3|Overall Study|Ineligible for participation|0
7709653|NCT01081795|26811218|P2|Overall Study|Ineligible for participation|0
7709654|NCT01081795|26811219|P1|Overall Study|Ineligible for participation|1
7709655|NCT01081795|26811217|P3|Overall Study|Revocation of informed consent|0
7709656|NCT01081795|26811218|P2|Overall Study|Revocation of informed consent|0
7709657|NCT01081795|26811219|P1|Overall Study|Revocation of informed consent|2
7709658|NCT01081795|26811217|P3|Overall Study|Subject's schedule|2
7709659|NCT01081795|26811218|P2|Overall Study|Subject's schedule|1
7709660|NCT01081795|26811219|P1|Overall Study|Subject's schedule|1
7709661|NCT01081795|26811217|P3|Overall Study|Lack of Efficacy|19
7709662|NCT01081795|26811218|P2|Overall Study|Lack of Efficacy|5
7709663|NCT01081795|26811219|P1|Overall Study|Lack of Efficacy|7
7709664|NCT01081795|26811217|P3|Overall Study|Adverse Event|6
7709665|NCT01081795|26811218|P2|Overall Study|Adverse Event|23
7709666|NCT01081795|26811219|P1|Overall Study|Adverse Event|18
7709667|NCT01081769|26811256|P2|CORE Intent-To-Treat|Patient Moved|2
7709668|NCT01081769|26811257|P1|CORE Intent-To-Treat|Patient Moved|2
7709669|NCT01081769|26811256|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
7709670|NCT01081769|26811257|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
7709671|NCT01081769|26811256|P2|CORE Intent-To-Treat|Ineligibility|4
7709672|NCT01081769|26811257|P1|CORE Intent-To-Treat|Ineligibility|3
7709673|NCT01081769|26811256|P2|CORE Intent-To-Treat|Other|1
7709674|NCT01081769|26811257|P1|CORE Intent-To-Treat|Other|0
7709675|NCT01081769|26811256|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
7709676|NCT01081769|26811257|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
7709677|NCT01081769|26811256|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
7709678|NCT01081769|26811257|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
7709679|NCT01081769|26811256|P2|CORE Intent-To-Treat|Pregnancy|0
7709680|NCT01081769|26811257|P1|CORE Intent-To-Treat|Pregnancy|1
7709681|NCT01081769|26811256|P2|CORE Intent-To-Treat|Lost to Follow-up|5
7709682|NCT01081769|26811257|P1|CORE Intent-To-Treat|Lost to Follow-up|4
7709683|NCT01081769|26811256|P2|CORE Intent-To-Treat|Lack of Efficacy|6
7709684|NCT01081769|26811257|P1|CORE Intent-To-Treat|Lack of Efficacy|2
7709685|NCT01081769|26811256|P2|CORE Intent-To-Treat|Death|1
7709686|NCT01081769|26811257|P1|CORE Intent-To-Treat|Death|1
7709687|NCT01081769|26811256|P2|CORE Intent-To-Treat|Adverse Event|11
7709688|NCT01081769|26811257|P1|CORE Intent-To-Treat|Adverse Event|14
7709689|NCT01081769|26811256|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
7709690|NCT01081769|26811257|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
7709691|NCT01081769|26811256|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
7709692|NCT01081769|26811257|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
7709693|NCT01081769|26811256|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
7709694|NCT01081769|26811257|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
7709695|NCT01081769|26811256|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
7709696|NCT01081769|26811257|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
7709697|NCT01081678|26811295|P4|Overall Study|Other|0
7709698|NCT01081678|26811296|P3|Overall Study|Other|0
7709699|NCT01081678|26811297|P2|Overall Study|Other|1
7709700|NCT01081678|26811298|P1|Overall Study|Other|0
7709701|NCT01081678|26811295|P4|Overall Study|Death|6
7709702|NCT01081678|26811296|P3|Overall Study|Death|2
7709703|NCT01081678|26811297|P2|Overall Study|Death|2
7709704|NCT01081678|26811298|P1|Overall Study|Death|2
7709705|NCT01081678|26811295|P4|Overall Study|Lost to Follow-up|3
7709706|NCT01081678|26811296|P3|Overall Study|Lost to Follow-up|4
7709707|NCT01081678|26811297|P2|Overall Study|Lost to Follow-up|1
7709708|NCT01081678|26811298|P1|Overall Study|Lost to Follow-up|4
7709709|NCT01081678|26811295|P4|Overall Study|Administrative Decision|1
7709710|NCT01081678|26811296|P3|Overall Study|Administrative Decision|0
7709711|NCT01081678|26811297|P2|Overall Study|Administrative Decision|0
7709712|NCT01081678|26811298|P1|Overall Study|Administrative Decision|1
7709713|NCT01081678|26811295|P4|Overall Study|Withdrawal by Subject|14
7709714|NCT01081678|26811296|P3|Overall Study|Withdrawal by Subject|17
7709715|NCT01081678|26811297|P2|Overall Study|Withdrawal by Subject|7
7709716|NCT01081678|26811298|P1|Overall Study|Withdrawal by Subject|15
7709717|NCT01081678|26811295|P4|Overall Study|Adverse Event|2
7709718|NCT01081678|26811296|P3|Overall Study|Adverse Event|2
7709719|NCT01081678|26811297|P2|Overall Study|Adverse Event|1
7709720|NCT01081678|26811298|P1|Overall Study|Adverse Event|2
7709721|NCT01081678|26811295|P4|Overall Study|Noncompliance|2
7709722|NCT01081678|26811296|P3|Overall Study|Noncompliance|5
7709723|NCT01081678|26811297|P2|Overall Study|Noncompliance|4
7709724|NCT01081678|26811298|P1|Overall Study|Noncompliance|3
7709725|NCT01081678|26811295|P4|Overall Study|Ineligibility Determined|1
7709726|NCT01081678|26811296|P3|Overall Study|Ineligibility Determined|1
7709727|NCT01081678|26811297|P2|Overall Study|Ineligibility Determined|0
7709728|NCT01081678|26811298|P1|Overall Study|Ineligibility Determined|0
7709729|NCT01081665|26811328|P1|Overall Study|Lack of Efficacy|1
7709730|NCT01081665|26811328|P1|Overall Study|Adverse Event|1
7709731|NCT01081665|26811328|P1|Overall Study|Change in renal replacement therapy|2
7709732|NCT01081665|26811328|P1|Overall Study|Regulation of iPTH|5
7709733|NCT01081665|26811328|P1|Overall Study|Change of dialysis unit|10
7709734|NCT01081665|26811328|P1|Overall Study|Withdrawal by Subject|17
7709735|NCT01081665|26811328|P1|Overall Study|Lost to Follow-up|18
7709736|NCT01081665|26811328|P1|Overall Study|Death|41
7709737|NCT01081626|26811340|P2|Overall Study|Other|30
7709738|NCT01081626|26811341|P1|Overall Study|Other|33
7709739|NCT01081626|26811340|P2|Overall Study|Lost to Follow-up|1
7709740|NCT01081626|26811341|P1|Overall Study|Lost to Follow-up|0
7709741|NCT01081626|26811340|P2|Overall Study|Overstimulation|1
7709742|NCT01081626|26811341|P1|Overall Study|Overstimulation|0
7709743|NCT01081626|26811340|P2|Overall Study|Low antral follicle count|0
7709744|NCT01081626|26811341|P1|Overall Study|Low antral follicle count|1
7709745|NCT01081626|26811340|P2|Overall Study|Missing Estradiol|28
7709746|NCT01081626|26811341|P1|Overall Study|Missing Estradiol|25
7709747|NCT01081626|26811340|P2|Overall Study|Dosing error|1
7709748|NCT01081626|26811341|P1|Overall Study|Dosing error|1
7709749|NCT01081301|26811367|P1|Overall Study|Lost to Follow-up|4
7709750|NCT01081301|26811367|P1|Overall Study|Patient too ill|2
7709751|NCT01081301|26811367|P1|Overall Study|Too busy|5
7709752|NCT01081301|26811367|P1|Overall Study|Bereaved|3
7709753|NCT01081249|26811442|P2|Overall Study|Diagnosed with Bipolar Disorder|1
7709754|NCT01081249|26811443|P1|Overall Study|Diagnosed with Bipolar Disorder|0
7709755|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
7709756|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
7709757|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
7709758|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
7709759|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
7709760|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
7709761|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
7709762|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
7709763|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
7709764|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
7709765|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
7709766|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
7709767|NCT01081145|26811449|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
7709768|NCT01081145|26811450|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
7709769|NCT01081145|26811449|P2|Open-Label Phase|Protocol Violation|0
7709770|NCT01081145|26811450|P1|Open-Label Phase|Protocol Violation|4
7709771|NCT01081145|26811449|P2|Open-Label Phase|Lost to Follow-up|0
7709772|NCT01081145|26811450|P1|Open-Label Phase|Lost to Follow-up|11
7709773|NCT01081145|26811449|P2|Open-Label Phase|Other|0
7709774|NCT01081145|26811450|P1|Open-Label Phase|Other|12
7709775|NCT01081145|26811449|P2|Open-Label Phase|Withdrawal by Subject|0
7709776|NCT01081145|26811450|P1|Open-Label Phase|Withdrawal by Subject|41
7709777|NCT01081145|26811449|P2|Open-Label Phase|Adverse Event|0
7709778|NCT01081145|26811450|P1|Open-Label Phase|Adverse Event|42
7709779|NCT01081145|26811449|P2|Open-Label Phase|Response criteria not met|0
7709780|NCT01081145|26811450|P1|Open-Label Phase|Response criteria not met|46
7709781|NCT01081145|26811449|P2|Open-Label Phase|Lack of Efficacy|0
7709782|NCT01081145|26811450|P1|Open-Label Phase|Lack of Efficacy|56
7709783|NCT01081132|26811478|P2|Overall Study|Protocol Violation|1
7709784|NCT01081132|26811479|P1|Overall Study|Protocol Violation|3
7709785|NCT01081132|26811478|P2|Overall Study|Declined Taper Phase|1
7709786|NCT01081132|26811479|P1|Overall Study|Declined Taper Phase|0
7709787|NCT01081132|26811478|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
7709788|NCT01081132|26811479|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
7709789|NCT01081132|26811478|P2|Overall Study|Stopped Taking Meds|0
7709790|NCT01081132|26811479|P1|Overall Study|Stopped Taking Meds|2
7709791|NCT01081132|26811478|P2|Overall Study|Missed Visits|1
7709792|NCT01081132|26811479|P1|Overall Study|Missed Visits|1
7709793|NCT01081132|26811478|P2|Overall Study|Lack Of Compliance|1
7709794|NCT01081132|26811479|P1|Overall Study|Lack Of Compliance|0
7709795|NCT01081132|26811478|P2|Overall Study|Non Compliance|2
7709796|NCT01081132|26811479|P1|Overall Study|Non Compliance|4
7709797|NCT01081132|26811478|P2|Overall Study|Adverse Event|9
7709798|NCT01081132|26811479|P1|Overall Study|Adverse Event|3
7709799|NCT01081132|26811478|P2|Overall Study|Lost to Follow-up|11
7709800|NCT01081132|26811479|P1|Overall Study|Lost to Follow-up|4
7709801|NCT01081132|26811478|P2|Overall Study|Withdrawal by Subject|16
7709802|NCT01081132|26811479|P1|Overall Study|Withdrawal by Subject|13
7709803|NCT01081132|26811478|P2|Overall Study|Lack of Efficacy|9
7709804|NCT01081132|26811479|P1|Overall Study|Lack of Efficacy|25
7709805|NCT01080807|26811563|P2|Overall Study|Moved away without notifying center|0
7709806|NCT01080807|26811564|P1|Overall Study|Moved away without notifying center|1
7709807|NCT01080807|26811563|P2|Overall Study|Switched to first shift|0
7709808|NCT01080807|26811564|P1|Overall Study|Switched to first shift|1
7709809|NCT01080807|26811563|P2|Overall Study|Work schedule and travel|1
7709810|NCT01080807|26811564|P1|Overall Study|Work schedule and travel|0
7709811|NCT01080807|26811563|P2|Overall Study|Work schedule changing|1
7709812|NCT01080807|26811564|P1|Overall Study|Work schedule changing|1
7709813|NCT01080807|26811563|P2|Overall Study|Stopped working consistent night shifts|1
7709814|NCT01080807|26811564|P1|Overall Study|Stopped working consistent night shifts|0
7709815|NCT01080807|26811563|P2|Overall Study|Laid off or terminated from job|2
7709816|NCT01080807|26811564|P1|Overall Study|Laid off or terminated from job|1
7709817|NCT01080807|26811563|P2|Overall Study|Began working day shift|2
7709818|NCT01080807|26811564|P1|Overall Study|Began working day shift|0
7709819|NCT01080807|26811563|P2|Overall Study|Noncompliance to study procedures|1
7709820|NCT01080807|26811564|P1|Overall Study|Noncompliance to study procedures|1
7709821|NCT01080807|26811563|P2|Overall Study|Noncompliance with drug administration|1
7709822|NCT01080807|26811564|P1|Overall Study|Noncompliance with drug administration|1
7709823|NCT01080807|26811563|P2|Overall Study|Lost to Follow-up|4
7709824|NCT01080807|26811564|P1|Overall Study|Lost to Follow-up|6
7709825|NCT01080807|26811563|P2|Overall Study|Protocol Violation|6
7709826|NCT01080807|26811564|P1|Overall Study|Protocol Violation|7
7709827|NCT01080807|26811563|P2|Overall Study|Withdrawal by Subject|2
7709828|NCT01080807|26811564|P1|Overall Study|Withdrawal by Subject|7
7709829|NCT01080807|26811563|P2|Overall Study|Lack of Efficacy|1
7709830|NCT01080807|26811564|P1|Overall Study|Lack of Efficacy|0
7709831|NCT01080807|26811563|P2|Overall Study|Adverse Event|1
7709832|NCT01080807|26811564|P1|Overall Study|Adverse Event|9
7709833|NCT01080768|26811673|P2|Overall Study|Protocol Deviation|1
7709834|NCT01080768|26811674|P1|Overall Study|Protocol Deviation|2
7709835|NCT01080716|26811684|P4|Part 1|Physician Decision|0
7709836|NCT01080716|26811685|P3|Part 1|Physician Decision|0
7709837|NCT01080716|26811686|P2|Part 1|Physician Decision|0
7709838|NCT01080716|26811687|P1|Part 1|Physician Decision|1
7709839|NCT01080625|26811726|P3|Overall Study|Physician Decision|1
7709840|NCT01080625|26811727|P2|Overall Study|Physician Decision|2
7709841|NCT01080625|26811728|P1|Overall Study|Physician Decision|0
7709842|NCT01080391|26811738|P2|Overall Study|Randomized but not treated|4
7709843|NCT01080391|26811739|P1|Overall Study|Randomized but not treated|7
7709844|NCT01080326|26811757|P1|Overall Study|Surgeon decision|1
7709845|NCT01080326|26811757|P1|Overall Study|Patient deterioration prior to procedure|3
7709846|NCT01080300|26811763|P2|Overall Study|Reasons not specified|6
7709847|NCT01080300|26811764|P1|Overall Study|Reasons not specified|4
7709848|NCT01080300|26811763|P2|Overall Study|Withdrawal by Subject|28
7709849|NCT01080300|26811764|P1|Overall Study|Withdrawal by Subject|12
7709850|NCT01080300|26811763|P2|Overall Study|Death|1
7709851|NCT01080300|26811764|P1|Overall Study|Death|0
7709852|NCT01080300|26811763|P2|Overall Study|Lost to Follow-up|6
7709853|NCT01080300|26811764|P1|Overall Study|Lost to Follow-up|10
7709854|NCT01080300|26811763|P2|Overall Study|Protocol Violation|13
7709855|NCT01080300|26811764|P1|Overall Study|Protocol Violation|7
7709856|NCT01080300|26811763|P2|Overall Study|Lack of Efficacy|15
7709857|NCT01080300|26811764|P1|Overall Study|Lack of Efficacy|12
7709858|NCT01080300|26811763|P2|Overall Study|Adverse Event|35
7709859|NCT01080300|26811764|P1|Overall Study|Adverse Event|49
7709860|NCT01080131|26811869|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
7709861|NCT01080131|26811870|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
7709862|NCT01080131|26811869|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
7709863|NCT01080131|26811870|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
7709864|NCT01080131|26811869|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
7709865|NCT01080131|26811870|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
7709866|NCT01080131|26811869|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
7709867|NCT01080131|26811870|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
7709868|NCT01080131|26811869|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
7709869|NCT01080131|26811870|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
7709870|NCT01080131|26811869|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
7709871|NCT01080131|26811870|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
7709872|NCT01080131|26811869|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
7709873|NCT01080131|26811870|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
7709874|NCT01080131|26811869|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
7709875|NCT01080131|26811870|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
7709876|NCT01080131|26811869|P2|Core Study (0- 12 Weeks)|Death|0
7709877|NCT01080131|26811870|P1|Core Study (0- 12 Weeks)|Death|1
7709878|NCT01080131|26811869|P2|Core Study (0- 12 Weeks)|Administrative problems|1
7709879|NCT01080131|26811870|P1|Core Study (0- 12 Weeks)|Administrative problems|0
7709880|NCT01080131|26811869|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
7709881|NCT01080131|26811870|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
7709882|NCT01080131|26811869|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
7709883|NCT01080131|26811870|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
7709884|NCT01080131|26811869|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
7709885|NCT01080131|26811870|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
7709886|NCT01079988|26811965|P5|Overall Study|Other|1
7709887|NCT01079988|26811966|P4|Overall Study|Other|2
7709888|NCT01079988|26811967|P3|Overall Study|Other|0
7709889|NCT01079988|26811968|P2|Overall Study|Other|0
7709890|NCT01079988|26811969|P1|Overall Study|Other|0
7709891|NCT01079988|26811965|P5|Overall Study|Lack of Efficacy|0
7709892|NCT01079988|26811966|P4|Overall Study|Lack of Efficacy|0
7709893|NCT01079988|26811967|P3|Overall Study|Lack of Efficacy|0
7709894|NCT01079988|26811968|P2|Overall Study|Lack of Efficacy|0
7709895|NCT01079988|26811969|P1|Overall Study|Lack of Efficacy|1
7709896|NCT01079988|26811965|P5|Overall Study|Lost to Follow-up|0
7709897|NCT01079988|26811966|P4|Overall Study|Lost to Follow-up|1
7709898|NCT01079988|26811967|P3|Overall Study|Lost to Follow-up|0
7709899|NCT01079988|26811968|P2|Overall Study|Lost to Follow-up|0
7709900|NCT01079988|26811969|P1|Overall Study|Lost to Follow-up|0
7709901|NCT01079962|26811988|P2|Overall Study|Due to arrhythmia/bradycardia|1
7709902|NCT01079962|26811989|P1|Overall Study|Due to arrhythmia/bradycardia|1
7709903|NCT01079962|26811988|P2|Overall Study|Participant not returning for next visit|0
7709904|NCT01079962|26811989|P1|Overall Study|Participant not returning for next visit|1
7709905|NCT01079962|26811988|P2|Overall Study|Inclusion/exclusion criteria|3
7709906|NCT01079962|26811989|P1|Overall Study|Inclusion/exclusion criteria|1
7709907|NCT01079962|26811988|P2|Overall Study|No blood pressure (BP) control|0
7709908|NCT01079962|26811989|P1|Overall Study|No blood pressure (BP) control|3
7709909|NCT01079962|26811988|P2|Overall Study|Protocol Violation|2
7709910|NCT01079962|26811989|P1|Overall Study|Protocol Violation|2
7709911|NCT01079962|26811988|P2|Overall Study|Withdrawal by Subject|7
7709912|NCT01079962|26811989|P1|Overall Study|Withdrawal by Subject|5
7709913|NCT01079962|26811988|P2|Overall Study|Adverse Event|2
7709914|NCT01079962|26811989|P1|Overall Study|Adverse Event|2
7709915|NCT01079949|26812017|P2|Overall Study|Randomized but not treated|0
7709916|NCT01079949|26812018|P1|Overall Study|Randomized but not treated|1
7709917|NCT01079949|26812017|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
7709918|NCT01079949|26812018|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
7709919|NCT01079949|26812017|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
7709920|NCT01079949|26812018|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
7709921|NCT01079949|26812017|P2|Overall Study|Withdrawal before r-hCG administration|3
7709922|NCT01079949|26812018|P1|Overall Study|Withdrawal before r-hCG administration|2
7709923|NCT01079936|26812064|P5|Phase II|Insurance Issue|1
7709924|NCT01079936|26812065|P4|Phase II|Insurance Issue|0
7709925|NCT01079936|26812066|P3|Phase II|Insurance Issue|0
7709926|NCT01079936|26812067|P2|Phase II|Insurance Issue|0
7709927|NCT01079936|26812068|P1|Phase II|Insurance Issue|0
7709928|NCT01079936|26812064|P5|Phase II|Adverse Event|0
7709929|NCT01079936|26812065|P4|Phase II|Adverse Event|0
7709930|NCT01079936|26812066|P3|Phase II|Adverse Event|1
7709931|NCT01079936|26812067|P2|Phase II|Adverse Event|0
7709932|NCT01079936|26812068|P1|Phase II|Adverse Event|0
7709933|NCT01079936|26812064|P5|Phase I: MTD|No Stem Cell Transplantation|0
7709934|NCT01079936|26812065|P4|Phase I: MTD|No Stem Cell Transplantation|0
7709935|NCT01079936|26812066|P3|Phase I: MTD|No Stem Cell Transplantation|0
7709936|NCT01079936|26812067|P2|Phase I: MTD|No Stem Cell Transplantation|0
7709937|NCT01079936|26812068|P1|Phase I: MTD|No Stem Cell Transplantation|2
7709938|NCT01079936|26812064|P5|Phase I: MTD|First Remission Status|0
7709939|NCT01079936|26812065|P4|Phase I: MTD|First Remission Status|0
7709940|NCT01079936|26812066|P3|Phase I: MTD|First Remission Status|0
7709941|NCT01079936|26812067|P2|Phase I: MTD|First Remission Status|0
7709942|NCT01079936|26812068|P1|Phase I: MTD|First Remission Status|2
7709943|NCT01079832|26812087|P1|Overall Study|Withdrawal by Subject|1
7709944|NCT01079806|26812097|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7709945|NCT01079806|26812098|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7709946|NCT01079806|26812097|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
7709947|NCT01079806|26812098|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
7709948|NCT01079806|26812097|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
7709949|NCT01079806|26812098|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
7709950|NCT01079806|26812097|P2|Day 1 to Week 96|Removal by Medical Monitor|1
7709951|NCT01079806|26812098|P1|Day 1 to Week 96|Removal by Medical Monitor|0
7709952|NCT01079806|26812097|P2|Day 1 to Week 96|Subject request to stop study treatment|0
7709953|NCT01079806|26812098|P1|Day 1 to Week 96|Subject request to stop study treatment|1
7709954|NCT01079806|26812097|P2|Day 1 to Week 96|Lost to Follow-up|0
7709955|NCT01079806|26812098|P1|Day 1 to Week 96|Lost to Follow-up|1
7709956|NCT01079806|26812097|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
7709957|NCT01079806|26812098|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
7709958|NCT01079806|26812097|P2|Day 1 to Week 96|Pregnancy|1
7709959|NCT01079806|26812098|P1|Day 1 to Week 96|Pregnancy|0
7709960|NCT01079806|26812097|P2|Day 1 to Week 96|Withdrawal by Subject|2
7709961|NCT01079806|26812098|P1|Day 1 to Week 96|Withdrawal by Subject|3
7709962|NCT01079806|26812097|P2|Day 1 to Week 96|Adverse Event|3
7709963|NCT01079806|26812098|P1|Day 1 to Week 96|Adverse Event|0
7709964|NCT01079741|26812133|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
7709965|NCT01079741|26812134|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7709966|NCT01079741|26812135|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7709967|NCT01079741|26812136|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7709968|NCT01079741|26812137|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7709969|NCT01079741|26812133|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7709970|NCT01079741|26812134|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7709971|NCT01079741|26812135|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7709972|NCT01079741|26812136|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
7709973|NCT01079741|26812137|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7709974|NCT01079663|26812153|P2|Overall Study|Protocol Violation|2
7709975|NCT01079663|26812154|P1|Overall Study|Protocol Violation|0
7709976|NCT01079663|26812153|P2|Overall Study|Adverse Event|2
7709977|NCT01079663|26812154|P1|Overall Study|Adverse Event|0
7709978|NCT01079234|26812198|P4|Extension: Week 27 to 52|Unclassified|7
7709979|NCT01079234|26812199|P3|Extension: Week 27 to 52|Unclassified|4
7709980|NCT01079234|26812200|P2|Extension: Week 27 to 52|Unclassified|0
7709981|NCT01079234|26812201|P1|Extension: Week 27 to 52|Unclassified|0
7709982|NCT01079234|26812198|P4|Extension: Week 27 to 52|Withdrawal criteria|2
7709983|NCT01079234|26812199|P3|Extension: Week 27 to 52|Withdrawal criteria|4
7709984|NCT01079234|26812200|P2|Extension: Week 27 to 52|Withdrawal criteria|0
7709985|NCT01079234|26812201|P1|Extension: Week 27 to 52|Withdrawal criteria|0
7709986|NCT01079234|26812198|P4|Extension: Week 27 to 52|Protocol Violation|5
7709987|NCT01079234|26812199|P3|Extension: Week 27 to 52|Protocol Violation|2
7709988|NCT01079234|26812200|P2|Extension: Week 27 to 52|Protocol Violation|0
7709989|NCT01079234|26812201|P1|Extension: Week 27 to 52|Protocol Violation|0
7709990|NCT01079234|26812198|P4|Extension: Week 27 to 52|Lack of Efficacy|2
7709991|NCT01079234|26812199|P3|Extension: Week 27 to 52|Lack of Efficacy|0
7709992|NCT01079234|26812200|P2|Extension: Week 27 to 52|Lack of Efficacy|0
7709993|NCT01079234|26812201|P1|Extension: Week 27 to 52|Lack of Efficacy|0
7709994|NCT01079234|26812198|P4|Extension: Week 27 to 52|Adverse Event|0
7709995|NCT01079234|26812199|P3|Extension: Week 27 to 52|Adverse Event|1
7709996|NCT01079234|26812200|P2|Extension: Week 27 to 52|Adverse Event|0
7709997|NCT01079234|26812201|P1|Extension: Week 27 to 52|Adverse Event|0
7709998|NCT01079234|26812198|P4|Main: Week 0 to 26|Unclassified|0
7709999|NCT01079234|26812199|P3|Main: Week 0 to 26|Unclassified|4
7710000|NCT01079234|26812200|P2|Main: Week 0 to 26|Unclassified|13
7710001|NCT01079234|26812201|P1|Main: Week 0 to 26|Unclassified|7
7710002|NCT01079234|26812198|P4|Main: Week 0 to 26|Withdrawal criteria|0
7710003|NCT01079234|26812199|P3|Main: Week 0 to 26|Withdrawal criteria|2
7710004|NCT01079234|26812200|P2|Main: Week 0 to 26|Withdrawal criteria|6
7710005|NCT01079234|26812201|P1|Main: Week 0 to 26|Withdrawal criteria|6
7710006|NCT01079234|26812198|P4|Main: Week 0 to 26|Protocol Violation|0
7710007|NCT01079234|26812199|P3|Main: Week 0 to 26|Protocol Violation|4
7710008|NCT01079234|26812200|P2|Main: Week 0 to 26|Protocol Violation|2
7710009|NCT01079234|26812201|P1|Main: Week 0 to 26|Protocol Violation|6
7710010|NCT01079234|26812198|P4|Main: Week 0 to 26|Lack of Efficacy|0
7710011|NCT01079234|26812199|P3|Main: Week 0 to 26|Lack of Efficacy|1
7710012|NCT01079234|26812200|P2|Main: Week 0 to 26|Lack of Efficacy|1
7710013|NCT01079234|26812201|P1|Main: Week 0 to 26|Lack of Efficacy|2
7710014|NCT01079234|26812198|P4|Main: Week 0 to 26|Adverse Event|0
7710015|NCT01079234|26812199|P3|Main: Week 0 to 26|Adverse Event|1
7710016|NCT01079234|26812200|P2|Main: Week 0 to 26|Adverse Event|4
7710017|NCT01079234|26812201|P1|Main: Week 0 to 26|Adverse Event|5
7710018|NCT01079195|26812219|P1|Overall Study|Non-compliance|2
7710019|NCT01079195|26812219|P1|Overall Study|No Follow-up Documentation Available|4
7710020|NCT01079195|26812219|P1|Overall Study|Improved Status of Participant|4
7710021|NCT01079195|26812219|P1|Overall Study|Physician Decision|4
7710022|NCT01079195|26812219|P1|Overall Study|Lack of Effectiveness|12
7710023|NCT01079195|26812219|P1|Overall Study|Financial Reasons|15
7710024|NCT01079195|26812219|P1|Overall Study|Withdrawal by Subject|18
7710025|NCT01079195|26812219|P1|Overall Study|Reason Unknown|39
7710026|NCT01079195|26812219|P1|Overall Study|Adverse Event|157
7710027|NCT01079195|26812219|P1|Overall Study|No Documentation Available|437
7710028|NCT01079195|26812219|P1|Overall Study|No Documentation of Tarka Therapy|739
7710029|NCT01079182|26812225|P1|Overall Study|Reasons not Evaluated|271
7710030|NCT01079182|26812225|P1|Overall Study|ADR and Lack of Effectiveness|39
7710031|NCT01079182|26812225|P1|Overall Study|Lack of Efficacy|514
7710032|NCT01079182|26812225|P1|Overall Study|Adverse Drug Reaction (ADR)|261
7710033|NCT01079182|26812225|P1|Overall Study|Lost to Follow-up|1634
7710034|NCT01079130|26812333|P6|Overall Study|Lost to Follow-up|0
7710035|NCT01079130|26812334|P5|Overall Study|Lost to Follow-up|1
7710036|NCT01079130|26812335|P4|Overall Study|Lost to Follow-up|0
7710037|NCT01079130|26812336|P3|Overall Study|Lost to Follow-up|0
7710038|NCT01079130|26812337|P2|Overall Study|Lost to Follow-up|0
7710039|NCT01079130|26812338|P1|Overall Study|Lost to Follow-up|0
7710040|NCT01079130|26812333|P6|Overall Study|Unsatisfactory therapeutic effect|0
7710041|NCT01079130|26812334|P5|Overall Study|Unsatisfactory therapeutic effect|0
7710042|NCT01079130|26812335|P4|Overall Study|Unsatisfactory therapeutic effect|2
7710043|NCT01079130|26812336|P3|Overall Study|Unsatisfactory therapeutic effect|0
7710044|NCT01079130|26812337|P2|Overall Study|Unsatisfactory therapeutic effect|0
7710045|NCT01079130|26812338|P1|Overall Study|Unsatisfactory therapeutic effect|0
7710046|NCT01079130|26812333|P6|Overall Study|Abnormal test procedure result(s)|0
7710047|NCT01079130|26812334|P5|Overall Study|Abnormal test procedure result(s)|1
7710048|NCT01079130|26812335|P4|Overall Study|Abnormal test procedure result(s)|0
7710049|NCT01079130|26812336|P3|Overall Study|Abnormal test procedure result(s)|0
7710050|NCT01079130|26812337|P2|Overall Study|Abnormal test procedure result(s)|0
7710051|NCT01079130|26812338|P1|Overall Study|Abnormal test procedure result(s)|0
7710052|NCT01079130|26812333|P6|Overall Study|Protocol deviation|0
7710053|NCT01079130|26812334|P5|Overall Study|Protocol deviation|0
7710054|NCT01079130|26812335|P4|Overall Study|Protocol deviation|2
7710055|NCT01079130|26812336|P3|Overall Study|Protocol deviation|1
7710056|NCT01079130|26812337|P2|Overall Study|Protocol deviation|2
7710057|NCT01079130|26812338|P1|Overall Study|Protocol deviation|0
7710058|NCT01079130|26812333|P6|Overall Study|Withdrawal by Subject|3
7710059|NCT01079130|26812334|P5|Overall Study|Withdrawal by Subject|1
7710060|NCT01079130|26812335|P4|Overall Study|Withdrawal by Subject|0
7710061|NCT01079130|26812336|P3|Overall Study|Withdrawal by Subject|0
7710062|NCT01079130|26812337|P2|Overall Study|Withdrawal by Subject|1
7710063|NCT01079130|26812338|P1|Overall Study|Withdrawal by Subject|0
7710064|NCT01079130|26812333|P6|Overall Study|Administrative problems|1
7710065|NCT01079130|26812334|P5|Overall Study|Administrative problems|0
7710066|NCT01079130|26812335|P4|Overall Study|Administrative problems|0
7710067|NCT01079130|26812336|P3|Overall Study|Administrative problems|0
7710068|NCT01079130|26812337|P2|Overall Study|Administrative problems|3
7710069|NCT01079130|26812338|P1|Overall Study|Administrative problems|1
7710070|NCT01079130|26812333|P6|Overall Study|Adverse Event|1
7710071|NCT01079130|26812334|P5|Overall Study|Adverse Event|5
7710072|NCT01079130|26812335|P4|Overall Study|Adverse Event|1
7710073|NCT01079130|26812336|P3|Overall Study|Adverse Event|0
7710074|NCT01079130|26812337|P2|Overall Study|Adverse Event|1
7710075|NCT01079130|26812338|P1|Overall Study|Adverse Event|1
7710076|NCT01078974|26812358|P1|Overall Study|Adverse Event|3
7710077|NCT01078922|26812363|P1|Overall Study|Adverse Event|1
7710078|NCT01078805|26812404|P1|Overall Study|Didn't take study drug|82
7710079|NCT01078805|26812404|P1|Overall Study|Other|173
7710080|NCT01078805|26812404|P1|Overall Study|Withdrawal by Subject|739
7710081|NCT01078805|26812404|P1|Overall Study|Sponsor decision|46
7710082|NCT01078805|26812404|P1|Overall Study|Serious adverse event|26
7710083|NCT01078805|26812404|P1|Overall Study|Physician Decision|169
7710084|NCT01078805|26812404|P1|Overall Study|Lost to Follow-up|676
7710085|NCT01078805|26812404|P1|Overall Study|Death|134
7710086|NCT01078805|26812404|P1|Overall Study|Clinically significant abnormal lab|5
7710087|NCT01078675|26812431|P2|Overall Study|Adverse Event|0
7710088|NCT01078675|26812432|P1|Overall Study|Adverse Event|3
7710089|NCT01078675|26812431|P2|Overall Study|Provided in CRF for specific reasons|3
7710090|NCT01078675|26812432|P1|Overall Study|Provided in CRF for specific reasons|2
7710091|NCT01078675|26812431|P2|Overall Study|Protocol Violation|0
7710092|NCT01078675|26812432|P1|Overall Study|Protocol Violation|56
7710093|NCT01078675|26812431|P2|Overall Study|Withdrawal by Subject|3
7710094|NCT01078675|26812432|P1|Overall Study|Withdrawal by Subject|7
7710095|NCT01078662|26812454|P5|Overall Study|Lost to Follow-up|0
7710096|NCT01078662|26812455|P4|Overall Study|Lost to Follow-up|0
7710097|NCT01078662|26812456|P3|Overall Study|Lost to Follow-up|0
7710098|NCT01078662|26812457|P2|Overall Study|Lost to Follow-up|0
7710099|NCT01078662|26812458|P1|Overall Study|Lost to Follow-up|1
7710100|NCT01078662|26812454|P5|Overall Study|Protocol Violation|0
7710101|NCT01078662|26812455|P4|Overall Study|Protocol Violation|0
7710102|NCT01078662|26812456|P3|Overall Study|Protocol Violation|0
7710103|NCT01078662|26812457|P2|Overall Study|Protocol Violation|1
7710104|NCT01078662|26812458|P1|Overall Study|Protocol Violation|0
7710105|NCT01078662|26812454|P5|Overall Study|Withdrawal by Subject|0
7710106|NCT01078662|26812455|P4|Overall Study|Withdrawal by Subject|0
7710107|NCT01078662|26812456|P3|Overall Study|Withdrawal by Subject|1
7710108|NCT01078662|26812457|P2|Overall Study|Withdrawal by Subject|11
7710109|NCT01078662|26812458|P1|Overall Study|Withdrawal by Subject|4
7710110|NCT01078662|26812454|P5|Overall Study|Patients reached data cut-off|3
7710111|NCT01078662|26812455|P4|Overall Study|Patients reached data cut-off|2
7710112|NCT01078662|26812456|P3|Overall Study|Patients reached data cut-off|2
7710113|NCT01078662|26812457|P2|Overall Study|Patients reached data cut-off|53
7710114|NCT01078662|26812458|P1|Overall Study|Patients reached data cut-off|12
7710115|NCT01078662|26812454|P5|Overall Study|Death|8
7710116|NCT01078662|26812455|P4|Overall Study|Death|5
7710117|NCT01078662|26812456|P3|Overall Study|Death|18
7710118|NCT01078662|26812457|P2|Overall Study|Death|103
7710119|NCT01078662|26812458|P1|Overall Study|Death|41
7710120|NCT01078623|26812497|P20|Treatment Period 4|Withdrawal by Subject|0
7710121|NCT01078623|26812498|P19|Treatment Period 4|Withdrawal by Subject|0
7710122|NCT01078623|26812499|P18|Treatment Period 4|Withdrawal by Subject|0
7710123|NCT01078623|26812500|P17|Treatment Period 4|Withdrawal by Subject|0
7710124|NCT01078623|26812501|P16|Treatment Period 4|Withdrawal by Subject|1
7710125|NCT01078623|26812502|P15|Treatment Period 4|Withdrawal by Subject|0
7710126|NCT01078623|26812503|P14|Treatment Period 4|Withdrawal by Subject|0
7710127|NCT01078623|26812504|P13|Treatment Period 4|Withdrawal by Subject|0
7710128|NCT01078623|26812505|P12|Treatment Period 4|Withdrawal by Subject|0
7710129|NCT01078623|26812506|P11|Treatment Period 4|Withdrawal by Subject|0
7710130|NCT01078623|26812507|P10|Treatment Period 4|Withdrawal by Subject|0
7710131|NCT01078623|26812508|P9|Treatment Period 4|Withdrawal by Subject|0
7710132|NCT01078623|26812509|P8|Treatment Period 4|Withdrawal by Subject|0
7710133|NCT01078623|26812510|P7|Treatment Period 4|Withdrawal by Subject|0
7710134|NCT01078623|26812511|P6|Treatment Period 4|Withdrawal by Subject|0
7710135|NCT01078623|26812512|P5|Treatment Period 4|Withdrawal by Subject|0
7710136|NCT01078623|26812513|P4|Treatment Period 4|Withdrawal by Subject|0
7710137|NCT01078623|26812514|P3|Treatment Period 4|Withdrawal by Subject|0
7710138|NCT01078623|26812515|P2|Treatment Period 4|Withdrawal by Subject|0
7710139|NCT01078623|26812516|P1|Treatment Period 4|Withdrawal by Subject|0
7710140|NCT01078623|26812497|P20|Treatment Period 4|Adverse Event|0
7710141|NCT01078623|26812498|P19|Treatment Period 4|Adverse Event|0
7710142|NCT01078623|26812499|P18|Treatment Period 4|Adverse Event|0
7710143|NCT01078623|26812500|P17|Treatment Period 4|Adverse Event|0
7710144|NCT01078623|26812501|P16|Treatment Period 4|Adverse Event|0
7710145|NCT01078623|26812502|P15|Treatment Period 4|Adverse Event|0
7710146|NCT01078623|26812503|P14|Treatment Period 4|Adverse Event|0
7710147|NCT01078623|26812504|P13|Treatment Period 4|Adverse Event|0
7710148|NCT01078623|26812505|P12|Treatment Period 4|Adverse Event|0
7710149|NCT01078623|26812506|P11|Treatment Period 4|Adverse Event|0
7710150|NCT01078623|26812507|P10|Treatment Period 4|Adverse Event|0
7710151|NCT01078623|26812508|P9|Treatment Period 4|Adverse Event|0
7710152|NCT01078623|26812509|P8|Treatment Period 4|Adverse Event|0
7710153|NCT01078623|26812510|P7|Treatment Period 4|Adverse Event|0
7710154|NCT01078623|26812511|P6|Treatment Period 4|Adverse Event|0
7710155|NCT01078623|26812512|P5|Treatment Period 4|Adverse Event|0
7710156|NCT01078623|26812513|P4|Treatment Period 4|Adverse Event|0
7710157|NCT01078623|26812514|P3|Treatment Period 4|Adverse Event|1
7710158|NCT01078623|26812515|P2|Treatment Period 4|Adverse Event|0
7710159|NCT01078623|26812516|P1|Treatment Period 4|Adverse Event|0
7710160|NCT01078623|26812497|P20|Treatment Period 3|Adverse Event|0
7710161|NCT01078623|26812498|P19|Treatment Period 3|Adverse Event|0
7710162|NCT01078623|26812499|P18|Treatment Period 3|Adverse Event|0
7710163|NCT01078623|26812500|P17|Treatment Period 3|Adverse Event|0
7710164|NCT01078623|26812501|P16|Treatment Period 3|Adverse Event|0
7710165|NCT01078623|26812502|P15|Treatment Period 3|Adverse Event|0
7710166|NCT01078623|26812503|P14|Treatment Period 3|Adverse Event|1
7710167|NCT01078623|26812504|P13|Treatment Period 3|Adverse Event|0
7710168|NCT01078623|26812505|P12|Treatment Period 3|Adverse Event|0
7710169|NCT01078623|26812506|P11|Treatment Period 3|Adverse Event|0
7710170|NCT01078623|26812507|P10|Treatment Period 3|Adverse Event|0
7710171|NCT01078623|26812508|P9|Treatment Period 3|Adverse Event|0
7710172|NCT01078623|26812509|P8|Treatment Period 3|Adverse Event|0
7710173|NCT01078623|26812510|P7|Treatment Period 3|Adverse Event|0
7710174|NCT01078623|26812511|P6|Treatment Period 3|Adverse Event|0
7710175|NCT01078623|26812512|P5|Treatment Period 3|Adverse Event|1
7710176|NCT01078623|26812513|P4|Treatment Period 3|Adverse Event|0
7710177|NCT01078623|26812514|P3|Treatment Period 3|Adverse Event|0
7710178|NCT01078623|26812515|P2|Treatment Period 3|Adverse Event|0
7710179|NCT01078623|26812516|P1|Treatment Period 3|Adverse Event|0
7710180|NCT01078623|26812497|P20|Treatment Period 2|Withdrawal by Subject|0
7710181|NCT01078623|26812498|P19|Treatment Period 2|Withdrawal by Subject|0
7710182|NCT01078623|26812499|P18|Treatment Period 2|Withdrawal by Subject|0
7710183|NCT01078623|26812500|P17|Treatment Period 2|Withdrawal by Subject|0
7710184|NCT01078623|26812501|P16|Treatment Period 2|Withdrawal by Subject|0
7710185|NCT01078623|26812502|P15|Treatment Period 2|Withdrawal by Subject|0
7710186|NCT01078623|26812503|P14|Treatment Period 2|Withdrawal by Subject|0
7710187|NCT01078623|26812504|P13|Treatment Period 2|Withdrawal by Subject|0
7710188|NCT01078623|26812505|P12|Treatment Period 2|Withdrawal by Subject|0
7710189|NCT01078623|26812506|P11|Treatment Period 2|Withdrawal by Subject|0
7710190|NCT01078623|26812507|P10|Treatment Period 2|Withdrawal by Subject|0
7710191|NCT01078623|26812508|P9|Treatment Period 2|Withdrawal by Subject|0
7710192|NCT01078623|26812509|P8|Treatment Period 2|Withdrawal by Subject|0
7710193|NCT01078623|26812510|P7|Treatment Period 2|Withdrawal by Subject|0
7710194|NCT01078623|26812511|P6|Treatment Period 2|Withdrawal by Subject|1
7710195|NCT01078623|26812512|P5|Treatment Period 2|Withdrawal by Subject|0
7710196|NCT01078623|26812513|P4|Treatment Period 2|Withdrawal by Subject|0
7710197|NCT01078623|26812514|P3|Treatment Period 2|Withdrawal by Subject|0
7710198|NCT01078623|26812515|P2|Treatment Period 2|Withdrawal by Subject|0
7710199|NCT01078623|26812516|P1|Treatment Period 2|Withdrawal by Subject|0
7710200|NCT01078623|26812497|P20|Treatment Period 2|Adverse Event|0
7710201|NCT01078623|26812498|P19|Treatment Period 2|Adverse Event|1
7710202|NCT01078623|26812499|P18|Treatment Period 2|Adverse Event|0
7710203|NCT01078623|26812500|P17|Treatment Period 2|Adverse Event|0
7710204|NCT01078623|26812501|P16|Treatment Period 2|Adverse Event|0
7710205|NCT01078623|26812502|P15|Treatment Period 2|Adverse Event|0
7710206|NCT01078623|26812503|P14|Treatment Period 2|Adverse Event|0
7710207|NCT01078623|26812504|P13|Treatment Period 2|Adverse Event|0
7710208|NCT01078623|26812505|P12|Treatment Period 2|Adverse Event|0
7710209|NCT01078623|26812506|P11|Treatment Period 2|Adverse Event|0
7710210|NCT01078623|26812507|P10|Treatment Period 2|Adverse Event|0
7710211|NCT01078623|26812508|P9|Treatment Period 2|Adverse Event|0
7710212|NCT01078623|26812509|P8|Treatment Period 2|Adverse Event|0
7710213|NCT01078623|26812510|P7|Treatment Period 2|Adverse Event|1
7710214|NCT01078623|26812511|P6|Treatment Period 2|Adverse Event|0
7710215|NCT01078623|26812512|P5|Treatment Period 2|Adverse Event|0
7710216|NCT01078623|26812513|P4|Treatment Period 2|Adverse Event|0
7710217|NCT01078623|26812514|P3|Treatment Period 2|Adverse Event|0
7710218|NCT01078623|26812515|P2|Treatment Period 2|Adverse Event|0
7710219|NCT01078623|26812516|P1|Treatment Period 2|Adverse Event|0
7710220|NCT01078623|26812497|P20|Treatment Period 1|Protocol Violation|0
7710221|NCT01078623|26812498|P19|Treatment Period 1|Protocol Violation|0
7710222|NCT01078623|26812499|P18|Treatment Period 1|Protocol Violation|0
7710223|NCT01078623|26812500|P17|Treatment Period 1|Protocol Violation|0
7710224|NCT01078623|26812501|P16|Treatment Period 1|Protocol Violation|0
7710225|NCT01078623|26812502|P15|Treatment Period 1|Protocol Violation|0
7710226|NCT01078623|26812503|P14|Treatment Period 1|Protocol Violation|0
7710227|NCT01078623|26812504|P13|Treatment Period 1|Protocol Violation|0
7710228|NCT01078623|26812505|P12|Treatment Period 1|Protocol Violation|0
7710229|NCT01078623|26812506|P11|Treatment Period 1|Protocol Violation|0
7710230|NCT01078623|26812507|P10|Treatment Period 1|Protocol Violation|0
7710231|NCT01078623|26812508|P9|Treatment Period 1|Protocol Violation|0
7710232|NCT01078623|26812509|P8|Treatment Period 1|Protocol Violation|0
7710233|NCT01078623|26812510|P7|Treatment Period 1|Protocol Violation|0
7710234|NCT01078623|26812511|P6|Treatment Period 1|Protocol Violation|1
7710235|NCT01078623|26812512|P5|Treatment Period 1|Protocol Violation|0
7710236|NCT01078623|26812513|P4|Treatment Period 1|Protocol Violation|0
7710237|NCT01078623|26812514|P3|Treatment Period 1|Protocol Violation|0
7710238|NCT01078623|26812515|P2|Treatment Period 1|Protocol Violation|0
7710239|NCT01078623|26812516|P1|Treatment Period 1|Protocol Violation|0
7710240|NCT01078623|26812497|P20|Treatment Period 1|Withdrawal by Subject|0
7710241|NCT01078623|26812498|P19|Treatment Period 1|Withdrawal by Subject|0
7710242|NCT01078623|26812499|P18|Treatment Period 1|Withdrawal by Subject|0
7710243|NCT01078623|26812500|P17|Treatment Period 1|Withdrawal by Subject|0
7710244|NCT01078623|26812501|P16|Treatment Period 1|Withdrawal by Subject|0
7710245|NCT01078623|26812502|P15|Treatment Period 1|Withdrawal by Subject|0
7710246|NCT01078623|26812503|P14|Treatment Period 1|Withdrawal by Subject|0
7710247|NCT01078623|26812504|P13|Treatment Period 1|Withdrawal by Subject|0
7710248|NCT01078623|26812505|P12|Treatment Period 1|Withdrawal by Subject|0
7710249|NCT01078623|26812506|P11|Treatment Period 1|Withdrawal by Subject|1
7710250|NCT01078623|26812507|P10|Treatment Period 1|Withdrawal by Subject|0
7710251|NCT01078623|26812508|P9|Treatment Period 1|Withdrawal by Subject|0
7710252|NCT01078623|26812509|P8|Treatment Period 1|Withdrawal by Subject|1
7710253|NCT01078623|26812510|P7|Treatment Period 1|Withdrawal by Subject|0
7710254|NCT01078623|26812511|P6|Treatment Period 1|Withdrawal by Subject|0
7710255|NCT01078623|26812512|P5|Treatment Period 1|Withdrawal by Subject|0
7710256|NCT01078623|26812513|P4|Treatment Period 1|Withdrawal by Subject|0
7710257|NCT01078623|26812514|P3|Treatment Period 1|Withdrawal by Subject|0
7710258|NCT01078623|26812515|P2|Treatment Period 1|Withdrawal by Subject|0
7710259|NCT01078623|26812516|P1|Treatment Period 1|Withdrawal by Subject|0
7710260|NCT01078623|26812497|P20|Treatment Period 1|Adverse Event|0
7710261|NCT01078623|26812498|P19|Treatment Period 1|Adverse Event|0
7710262|NCT01078623|26812499|P18|Treatment Period 1|Adverse Event|0
7710263|NCT01078623|26812500|P17|Treatment Period 1|Adverse Event|0
7710264|NCT01078623|26812501|P16|Treatment Period 1|Adverse Event|0
7710265|NCT01078623|26812502|P15|Treatment Period 1|Adverse Event|0
7710266|NCT01078623|26812503|P14|Treatment Period 1|Adverse Event|0
7710267|NCT01078623|26812504|P13|Treatment Period 1|Adverse Event|0
7710268|NCT01078623|26812505|P12|Treatment Period 1|Adverse Event|0
7710269|NCT01078623|26812506|P11|Treatment Period 1|Adverse Event|0
7710270|NCT01078623|26812507|P10|Treatment Period 1|Adverse Event|1
7710271|NCT01078623|26812508|P9|Treatment Period 1|Adverse Event|1
7710272|NCT01078623|26812509|P8|Treatment Period 1|Adverse Event|0
7710273|NCT01078623|26812510|P7|Treatment Period 1|Adverse Event|1
7710274|NCT01078623|26812511|P6|Treatment Period 1|Adverse Event|0
7710275|NCT01078623|26812512|P5|Treatment Period 1|Adverse Event|0
7710276|NCT01078623|26812513|P4|Treatment Period 1|Adverse Event|0
7710277|NCT01078623|26812514|P3|Treatment Period 1|Adverse Event|1
7710278|NCT01078623|26812515|P2|Treatment Period 1|Adverse Event|1
7710279|NCT01078623|26812516|P1|Treatment Period 1|Adverse Event|1
7710280|NCT01078584|26812538|P1|Overall Study|Multiple Reasons|2
7710281|NCT01078584|26812538|P1|Overall Study|Serious Adverse Event|27
7710282|NCT01078584|26812538|P1|Overall Study|Protocol Violation|75
7710283|NCT01078584|26812538|P1|Overall Study|Lack of Efficacy|98
7710284|NCT01078584|26812538|P1|Overall Study|Physician Discontinued Patient|12
7710285|NCT01078584|26812538|P1|Overall Study|Physician Switched Medication|26
7710286|NCT01078584|26812538|P1|Overall Study|Blood Pressure Controlled|49
7710287|NCT01078584|26812538|P1|Overall Study|Non-compliance|67
7710288|NCT01078584|26812538|P1|Overall Study|Physician Withdrew from Study|90
7710289|NCT01078584|26812538|P1|Overall Study|Withdrawal of Consent|244
7710290|NCT01078584|26812538|P1|Overall Study|Non-serious Adverse Event|577
7710291|NCT01078584|26812538|P1|Overall Study|Lost to Follow-up|670
7710292|NCT01078584|26812538|P1|Overall Study|Final Status Unknown|1073
7710293|NCT01078571|26812619|P1|Overall Study|Protocol Violation|2
7710294|NCT01078571|26812619|P1|Overall Study|Lost to Follow-up|8
7710295|NCT01078571|26812619|P1|Overall Study|Withdrawal by Subject|12
7710296|NCT01078571|26812619|P1|Overall Study|Reason not reported|21
7710297|NCT01078571|26812619|P1|Overall Study|Lack of effectiveness|36
7710298|NCT01078571|26812619|P1|Overall Study|Adverse Event|36
7710299|NCT01078545|26812670|P1|Overall Study|Participant moved to another physician|1
7710300|NCT01078545|26812670|P1|Overall Study|Death|3
7710301|NCT01078545|26812670|P1|Overall Study|Withdrawal by Subject|3
7710302|NCT01078545|26812670|P1|Overall Study|Physician Decision|6
7710303|NCT01078545|26812670|P1|Overall Study|Lost to Follow-up|13
7710304|NCT01078454|26812680|P2|Overall Study|Death|1
7710305|NCT01078454|26812681|P1|Overall Study|Death|0
7710306|NCT01078454|26812680|P2|Overall Study|Adverse Event|1
7710307|NCT01078454|26812681|P1|Overall Study|Adverse Event|1
7710308|NCT01078441|26812687|P1|Overall Study|Withdrawal by Subject|1
7710309|NCT01078389|26812727|P2|Overall Study|Other|2
7710310|NCT01078389|26812728|P1|Overall Study|Other|9
7710311|NCT01078389|26812727|P2|Overall Study|Voluntary Withdrawal|36
7710312|NCT01078389|26812728|P1|Overall Study|Voluntary Withdrawal|20
7710313|NCT01078389|26812727|P2|Overall Study|Lost to Follow-up|23
7710314|NCT01078389|26812728|P1|Overall Study|Lost to Follow-up|23
7710315|NCT01078389|26812727|P2|Overall Study|Major Protocol Deviation|0
7710316|NCT01078389|26812728|P1|Overall Study|Major Protocol Deviation|2
7710317|NCT01078389|26812727|P2|Overall Study|Adverse Event|6
7710318|NCT01078389|26812728|P1|Overall Study|Adverse Event|10
7710319|NCT01078298|26812889|P2|Overall Study|Other|32
7710320|NCT01078298|26812890|P1|Overall Study|Other|24
7710321|NCT01078298|26812889|P2|Overall Study|Did not meet entrance criteria|1
7710322|NCT01078298|26812890|P1|Overall Study|Did not meet entrance criteria|0
7710323|NCT01078298|26812889|P2|Overall Study|Death|0
7710324|NCT01078298|26812890|P1|Overall Study|Death|2
7710325|NCT01078298|26812889|P2|Overall Study|Adverse Event|5
7710326|NCT01078298|26812890|P1|Overall Study|Adverse Event|6
7710327|NCT01078298|26812889|P2|Overall Study|Protocol Violation|6
7710328|NCT01078298|26812890|P1|Overall Study|Protocol Violation|6
7710329|NCT01078298|26812889|P2|Overall Study|Withdrawal by Subject|33
7710330|NCT01078298|26812890|P1|Overall Study|Withdrawal by Subject|31
7710331|NCT01078298|26812889|P2|Overall Study|Lost to Follow-up|13
7710332|NCT01078298|26812890|P1|Overall Study|Lost to Follow-up|12
7710333|NCT01078168|26813000|P2|Overall Study|Physician Decision|1
7710334|NCT01078168|26813001|P1|Overall Study|Physician Decision|0
7710335|NCT01078155|26813007|P1|Overall Study|Lost to Follow-up|15
7710336|NCT01078155|26813007|P1|Overall Study|Participant's Decision|6
7710337|NCT01078155|26813007|P1|Overall Study|Lack of Efficacy|16
7710338|NCT01078155|26813007|P1|Overall Study|Adverse Event|7
7710339|NCT01078116|26813023|P1|Overall Study|Case report form not completed|3
7710340|NCT01078116|26813023|P1|Overall Study|Lack of effectiveness|15
7710341|NCT01078116|26813023|P1|Overall Study|Withdrawal by Subject|8
7710342|NCT01078116|26813023|P1|Overall Study|Adverse Event|5
7710343|NCT01078116|26813023|P1|Overall Study|Lost to Follow-up|17
7710344|NCT01078090|26813031|P1|Overall Study|Other|523
7710345|NCT01078090|26813031|P1|Overall Study|ADR and lack of efficacy|61
7710346|NCT01078090|26813031|P1|Overall Study|Lack of Efficacy|1193
7710347|NCT01078090|26813031|P1|Overall Study|Adverse drug reaction (ADR)|453
7710348|NCT01078090|26813031|P1|Overall Study|Lost to Follow-up|2363
7710349|NCT01077960|26813125|P1|Overall Study|Reason unspecified|1
7710350|NCT01077960|26813125|P1|Overall Study|Subject decision|1
7710351|NCT01077960|26813125|P1|Overall Study|Lost to Follow-up|5
7710352|NCT01077960|26813125|P1|Overall Study|Protocol Violation|3
7710353|NCT01077960|26813125|P1|Overall Study|Adverse Event|6
7710354|NCT01077804|26813375|P1|Overall Study|Other|18
7710355|NCT01077804|26813375|P1|Overall Study|Refused to continue|79
7710356|NCT01077804|26813375|P1|Overall Study|Unreachable|102
7710357|NCT01077739|26813384|P2|Overall Study|Other|2
7710358|NCT01077739|26813385|P1|Overall Study|Other|2
7710359|NCT01077739|26813384|P2|Overall Study|Unacceptable toxicity|2
7710360|NCT01077739|26813385|P1|Overall Study|Unacceptable toxicity|1
7710361|NCT01077739|26813384|P2|Overall Study|Death|3
7710362|NCT01077739|26813385|P1|Overall Study|Death|0
7710363|NCT01077739|26813384|P2|Overall Study|Withdrawal by Subject|0
7710364|NCT01077739|26813385|P1|Overall Study|Withdrawal by Subject|1
7710365|NCT01077739|26813384|P2|Overall Study|Premature withdrawal|3
7710366|NCT01077739|26813385|P1|Overall Study|Premature withdrawal|1
7710367|NCT01077713|26813399|P2|Overall Study|Other|2
7710368|NCT01077713|26813400|P1|Overall Study|Other|4
7710369|NCT01077713|26813399|P2|Overall Study|Adverse Event|1
7710370|NCT01077713|26813400|P1|Overall Study|Adverse Event|2
7710371|NCT01077713|26813399|P2|Overall Study|Lost to Follow-up|1
7710372|NCT01077713|26813400|P1|Overall Study|Lost to Follow-up|1
7710373|NCT01077713|26813399|P2|Overall Study|Death|29
7710374|NCT01077713|26813400|P1|Overall Study|Death|28
7710375|NCT01077713|26813399|P2|Overall Study|Progressive Disease (PD)|1
7710376|NCT01077713|26813400|P1|Overall Study|Progressive Disease (PD)|0
7710377|NCT01077713|26813399|P2|Overall Study|Withdrawal by Subject|2
7710378|NCT01077713|26813400|P1|Overall Study|Withdrawal by Subject|1
7710379|NCT01077622|26813424|P1|Overall Study|Withdrawal by Subject|1
7710380|NCT01077622|26813424|P1|Overall Study|Physician Decision|2
7710381|NCT01077544|26813544|P2|Overall Study|Disease Progression|1
7710382|NCT01077544|26813545|P1|Overall Study|Disease Progression|0
7710383|NCT01077544|26813544|P2|Overall Study|Adverse Event|1
7710384|NCT01077544|26813545|P1|Overall Study|Adverse Event|0
7710385|NCT01077544|26813544|P2|Overall Study|New Cancer Therapy|3
7710386|NCT01077544|26813545|P1|Overall Study|New Cancer Therapy|3
7710387|NCT01077518|26813573|P3|Optional Ofa Phase|Withdrawal by Subject|3
7710388|NCT01077518|26813574|P2|Optional Ofa Phase|Withdrawal by Subject|0
7710389|NCT01077518|26813575|P1|Optional Ofa Phase|Withdrawal by Subject|0
7710390|NCT01077518|26813573|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
7710391|NCT01077518|26813574|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
7710392|NCT01077518|26813575|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
7710393|NCT01077518|26813573|P3|Optional Ofa Phase|Physician Decision|1
7710394|NCT01077518|26813574|P2|Optional Ofa Phase|Physician Decision|0
7710395|NCT01077518|26813575|P1|Optional Ofa Phase|Physician Decision|0
7710396|NCT01077518|26813573|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
7710397|NCT01077518|26813574|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
7710398|NCT01077518|26813575|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
7710399|NCT01077518|26813573|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
7710400|NCT01077518|26813574|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
7710401|NCT01077518|26813575|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
7710402|NCT01077518|26813573|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
7710403|NCT01077518|26813574|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
7710404|NCT01077518|26813575|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
7710405|NCT01077518|26813573|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
7710406|NCT01077518|26813574|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
7710407|NCT01077518|26813575|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
7710408|NCT01077375|26813648|P2|Overall Study|Other Reason|1
7710409|NCT01077375|26813649|P1|Overall Study|Other Reason|0
7710410|NCT01077375|26813648|P2|Overall Study|Lost to Follow-up|5
7710411|NCT01077375|26813649|P1|Overall Study|Lost to Follow-up|2
7710412|NCT01077375|26813648|P2|Overall Study|Withdrawal by Subject|6
7710413|NCT01077375|26813649|P1|Overall Study|Withdrawal by Subject|0
7710414|NCT01077375|26813648|P2|Overall Study|Lack of Efficacy|8
7710415|NCT01077375|26813649|P1|Overall Study|Lack of Efficacy|6
7710416|NCT01077375|26813648|P2|Overall Study|Adverse Event|15
7710417|NCT01077375|26813649|P1|Overall Study|Adverse Event|2
7710418|NCT01077362|26813660|P3|Overall Study|Other|2
7710419|NCT01077362|26813661|P2|Overall Study|Other|1
7710420|NCT01077362|26813662|P1|Overall Study|Other|0
7710421|NCT01077362|26813660|P3|Overall Study|Withdrawal by Subject|5
7710422|NCT01077362|26813661|P2|Overall Study|Withdrawal by Subject|3
7710423|NCT01077362|26813662|P1|Overall Study|Withdrawal by Subject|5
7710424|NCT01077362|26813660|P3|Overall Study|Adverse Event|4
7710425|NCT01077362|26813661|P2|Overall Study|Adverse Event|7
7710426|NCT01077362|26813662|P1|Overall Study|Adverse Event|12
7710427|NCT01077362|26813660|P3|Overall Study|Lost to Follow-up|3
7710428|NCT01077362|26813661|P2|Overall Study|Lost to Follow-up|0
7710429|NCT01077362|26813662|P1|Overall Study|Lost to Follow-up|1
7710430|NCT01077362|26813660|P3|Overall Study|Lack of Efficacy|10
7710431|NCT01077362|26813661|P2|Overall Study|Lack of Efficacy|8
7710432|NCT01077362|26813662|P1|Overall Study|Lack of Efficacy|13
7710433|NCT01077323|26813698|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
7710434|NCT01077323|26813699|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
7710435|NCT01077323|26813700|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
7710436|NCT01077323|26813698|P3|Overall Study|Dispensing of drug in baseline period|256446
7710437|NCT01077323|26813699|P2|Overall Study|Dispensing of drug in baseline period|120229
7710438|NCT01077323|26813700|P1|Overall Study|Dispensing of drug in baseline period|0
7710439|NCT01077323|26813698|P3|Overall Study|<9 months enroll before drug dispensed|11655523
7710440|NCT01077323|26813699|P2|Overall Study|<9 months enroll before drug dispensed|263954
7710441|NCT01077323|26813700|P1|Overall Study|<9 months enroll before drug dispensed|11226
7710442|NCT01077284|26813743|P3|Overall Study|Other|1
7710443|NCT01077284|26813744|P2|Overall Study|Other|0
7710444|NCT01077284|26813745|P1|Overall Study|Other|0
7710445|NCT01077284|26813743|P3|Overall Study|Withdrawal by Subject|1
7710446|NCT01077284|26813744|P2|Overall Study|Withdrawal by Subject|3
7710447|NCT01077284|26813745|P1|Overall Study|Withdrawal by Subject|2
7710448|NCT01077284|26813743|P3|Overall Study|Lost to Follow-up|0
7710449|NCT01077284|26813744|P2|Overall Study|Lost to Follow-up|2
7710450|NCT01077284|26813745|P1|Overall Study|Lost to Follow-up|1
7710451|NCT01077284|26813743|P3|Overall Study|Adverse Event|1
7710452|NCT01077284|26813744|P2|Overall Study|Adverse Event|0
7710453|NCT01077284|26813745|P1|Overall Study|Adverse Event|2
7710454|NCT01077271|26813766|P1|Overall Study|Mother unconvinced of the necessity|1
7710455|NCT01077271|26813766|P1|Overall Study|End of RSV season nearly reached|1
7710456|NCT01077271|26813766|P1|Overall Study|Parents thought too many injections|2
7710457|NCT01077271|26813766|P1|Overall Study|Changed doctors|2
7710458|NCT01077271|26813766|P1|Overall Study|Quota used up (insurance reimb issue)|2
7710459|NCT01077271|26813766|P1|Overall Study|Noncompliance|2
7710460|NCT01077271|26813766|P1|Overall Study|Screen failure, did not take palivizumab|4
7710461|NCT01077271|26813766|P1|Overall Study|Parental desire|8
7710462|NCT01077258|26813804|P1|Overall Study|Other reasons|260
7710463|NCT01077258|26813804|P1|Overall Study|Clinical remission|37
7710464|NCT01077258|26813804|P1|Overall Study|Lack of Efficacy|663
7710465|NCT01077258|26813804|P1|Overall Study|Adverse drug reaction|218
7710466|NCT01077258|26813804|P1|Overall Study|Lost to Follow-up|1390
7710467|NCT01077193|26813840|P1|Overall Study|Study Terminated by Sponsor|40
7710468|NCT01077193|26813840|P1|Overall Study|Lack of Efficacy|1
7710469|NCT01077193|26813840|P1|Overall Study|Withdrawal by Subject|2
7710470|NCT01077193|26813840|P1|Overall Study|Lost to Follow-up|1
7710471|NCT01077154|26813846|P2|Overall Study|Protocol Deviation|0
7710472|NCT01077154|26813847|P1|Overall Study|Protocol Deviation|1
7710473|NCT01077154|26813846|P2|Overall Study|Administrative Decision|6
7710474|NCT01077154|26813847|P1|Overall Study|Administrative Decision|1
7710475|NCT01077154|26813846|P2|Overall Study|Adverse Event|9
7710476|NCT01077154|26813847|P1|Overall Study|Adverse Event|9
7710477|NCT01077154|26813846|P2|Overall Study|Other|11
7710478|NCT01077154|26813847|P1|Overall Study|Other|14
7710479|NCT01077154|26813846|P2|Overall Study|Ineligibility Determined|14
7710480|NCT01077154|26813847|P1|Overall Study|Ineligibility Determined|10
7710481|NCT01077154|26813846|P2|Overall Study|Disease Progression|20
7710482|NCT01077154|26813847|P1|Overall Study|Disease Progression|18
7710483|NCT01077154|26813846|P2|Overall Study|Noncompliance|20
7710484|NCT01077154|26813847|P1|Overall Study|Noncompliance|22
7710485|NCT01077154|26813846|P2|Overall Study|Lost to Follow-up|35
7710486|NCT01077154|26813847|P1|Overall Study|Lost to Follow-up|43
7710487|NCT01077154|26813846|P2|Overall Study|Death|214
7710488|NCT01077154|26813847|P1|Overall Study|Death|215
7710489|NCT01077154|26813846|P2|Overall Study|Withdrawal by Subject|385
7710490|NCT01077154|26813847|P1|Overall Study|Withdrawal by Subject|369
7710491|NCT01077154|26813846|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
7710492|NCT01077154|26813847|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
7710493|NCT01077128|26813861|P1|Overall Study|Other|54
7710494|NCT01077128|26813861|P1|Overall Study|Lack of efficacy/disease exacerbation|1
7710495|NCT01077128|26813861|P1|Overall Study|Adverse event and disease exacerbation|1
7710496|NCT01077128|26813861|P1|Overall Study|Adverse event and consent withdrawal|1
7710497|NCT01077128|26813861|P1|Overall Study|Disease exacerbation|1
7710498|NCT01077128|26813861|P1|Overall Study|Lack of Efficacy|1
7710499|NCT01077128|26813861|P1|Overall Study|Adverse Event|8
7710500|NCT01077076|26813919|P6|Third Intervention|Death in the participant's family|1
7710501|NCT01077076|26813920|P5|Third Intervention|Death in the participant's family|0
7710502|NCT01077076|26813921|P4|Third Intervention|Death in the participant's family|0
7710503|NCT01077076|26813922|P3|Third Intervention|Death in the participant's family|0
7710504|NCT01077076|26813923|P2|Third Intervention|Death in the participant's family|0
7710505|NCT01077076|26813924|P1|Third Intervention|Death in the participant's family|0
7710506|NCT01077076|26813919|P6|First Intervention|Withdrawal by Subject|0
7710507|NCT01077076|26813920|P5|First Intervention|Withdrawal by Subject|0
7710508|NCT01077076|26813921|P4|First Intervention|Withdrawal by Subject|0
7710509|NCT01077076|26813922|P3|First Intervention|Withdrawal by Subject|0
7710510|NCT01077076|26813923|P2|First Intervention|Withdrawal by Subject|0
7710511|NCT01077076|26813924|P1|First Intervention|Withdrawal by Subject|1
7710512|NCT01077063|26813934|P2|Overall Study|Withdrawal by Subject|2
7710513|NCT01077063|26813935|P1|Overall Study|Withdrawal by Subject|0
7710514|NCT01077063|26813934|P2|Overall Study|Death|1
7710515|NCT01077063|26813935|P1|Overall Study|Death|1
7710516|NCT01077063|26813934|P2|Overall Study|Adverse Event|0
7710517|NCT01077063|26813935|P1|Overall Study|Adverse Event|3
7710518|NCT01077050|26813941|P1|Overall Study|Screen failure|8
7710519|NCT01077050|26813941|P1|Overall Study|Subjects signed ICF could not be located|1
7710520|NCT01077024|26813947|P2|Overall Study|Other|4
7710521|NCT01077024|26813948|P1|Overall Study|Other|4
7710522|NCT01077024|26813947|P2|Overall Study|Incarcerated|8
7710523|NCT01077024|26813948|P1|Overall Study|Incarcerated|7
7710524|NCT01077024|26813947|P2|Overall Study|Withdrawal by Subject|2
7710525|NCT01077024|26813948|P1|Overall Study|Withdrawal by Subject|0
7710526|NCT01077024|26813947|P2|Overall Study|Lost to Follow-up|14
7710527|NCT01077024|26813948|P1|Overall Study|Lost to Follow-up|20
7710528|NCT01076959|26813987|P1|Overall Study|Other|119
7710529|NCT01076959|26813987|P1|Overall Study|Lost to Follow-up|241
7710530|NCT01076959|26813987|P1|Overall Study|Non-compliance|274
7710531|NCT01076959|26813987|P1|Overall Study|Lack of Efficacy|849
7710532|NCT01076959|26813987|P1|Overall Study|Adverse Event|767
7710533|NCT01076647|26814023|P2|Overall Study|Unclassified|12
7710534|NCT01076647|26814024|P1|Overall Study|Unclassified|12
7710535|NCT01076647|26814023|P2|Overall Study|Withdrawal criteria|2
7710536|NCT01076647|26814024|P1|Overall Study|Withdrawal criteria|2
7710537|NCT01076647|26814023|P2|Overall Study|Protocol Violation|9
7710538|NCT01076647|26814024|P1|Overall Study|Protocol Violation|7
7710539|NCT01076647|26814023|P2|Overall Study|Lack of Efficacy|1
7710540|NCT01076647|26814024|P1|Overall Study|Lack of Efficacy|0
7710541|NCT01076647|26814023|P2|Overall Study|Adverse Event|1
7710542|NCT01076647|26814024|P1|Overall Study|Adverse Event|4
7710543|NCT01076543|26814038|P6|Overall Study|Withdrawal by Subject|0
7710544|NCT01076543|26814039|P5|Overall Study|Withdrawal by Subject|0
7710545|NCT01076543|26814040|P4|Overall Study|Withdrawal by Subject|0
7710546|NCT01076543|26814041|P3|Overall Study|Withdrawal by Subject|0
7710547|NCT01076543|26814042|P2|Overall Study|Withdrawal by Subject|0
7710548|NCT01076543|26814043|P1|Overall Study|Withdrawal by Subject|2
7710549|NCT01076400|26814104|P3|Overall Study|Progressive Disease|0
7710550|NCT01076400|26814105|P2|Overall Study|Progressive Disease|0
7710551|NCT01076400|26814106|P1|Overall Study|Progressive Disease|5
7710552|NCT01076400|26814104|P3|Overall Study|Adverse Event|0
7710553|NCT01076400|26814105|P2|Overall Study|Adverse Event|0
7710554|NCT01076400|26814106|P1|Overall Study|Adverse Event|2
7710555|NCT01076361|26814112|P1|Overall Study|22 leads were excluded from analysis|21
7710556|NCT01076335|26814120|P1|Overall Study|Withdrawal without treatment|1
7710557|NCT01076335|26814120|P1|Overall Study|Withdrawal by Subject|3
7710558|NCT01076205|26814179|P1|Overall Study|Lost to Follow-up|3151
7710559|NCT01076205|26814179|P1|Overall Study|Unknown Reason|71
7710560|NCT01076205|26814179|P1|Overall Study|Other Reason|1075
7710561|NCT01076205|26814179|P1|Overall Study|Lack of Effectiveness|1423
7710562|NCT01076205|26814179|P1|Overall Study|Adverse Drug Reaction|299
7710563|NCT01076192|26814232|P1|Overall Study|Other|197
7710564|NCT01076179|26814247|P1|Overall Study|Withdrawal by Subject|1
7710565|NCT01076166|26814270|P1|Overall Study|Symptoms improved/resolved|6
7710566|NCT01076166|26814270|P1|Overall Study|Adverse Event|3
7710567|NCT01076153|26814277|P1|Overall Study|Adverse Event|1
7710568|NCT01076153|26814277|P1|Overall Study|Symptoms improved/resolved|10
7710569|NCT01076088|26814291|P6|Overall Study|Other protocol specified criteria|1
7710570|NCT01076088|26814292|P5|Overall Study|Other protocol specified criteria|0
7710571|NCT01076088|26814293|P4|Overall Study|Other protocol specified criteria|0
7710572|NCT01076088|26814294|P3|Overall Study|Other protocol specified criteria|0
7710573|NCT01076088|26814295|P2|Overall Study|Other protocol specified criteria|0
7710574|NCT01076088|26814296|P1|Overall Study|Other protocol specified criteria|0
7710575|NCT01076088|26814291|P6|Overall Study|Withdrawal by Subject|17
7710576|NCT01076088|26814292|P5|Overall Study|Withdrawal by Subject|11
7710577|NCT01076088|26814293|P4|Overall Study|Withdrawal by Subject|10
7710578|NCT01076088|26814294|P3|Overall Study|Withdrawal by Subject|14
7710579|NCT01076088|26814295|P2|Overall Study|Withdrawal by Subject|8
7710580|NCT01076088|26814296|P1|Overall Study|Withdrawal by Subject|8
7710581|NCT01076088|26814291|P6|Overall Study|Physician Decision|0
7710582|NCT01076088|26814292|P5|Overall Study|Physician Decision|1
7710583|NCT01076088|26814293|P4|Overall Study|Physician Decision|1
7710584|NCT01076088|26814294|P3|Overall Study|Physician Decision|0
7710585|NCT01076088|26814295|P2|Overall Study|Physician Decision|3
7710586|NCT01076088|26814296|P1|Overall Study|Physician Decision|1
7710587|NCT01076088|26814291|P6|Overall Study|Non-compliance with study drug|0
7710588|NCT01076088|26814292|P5|Overall Study|Non-compliance with study drug|0
7710589|NCT01076088|26814293|P4|Overall Study|Non-compliance with study drug|1
7710590|NCT01076088|26814294|P3|Overall Study|Non-compliance with study drug|0
7710591|NCT01076088|26814295|P2|Overall Study|Non-compliance with study drug|0
7710592|NCT01076088|26814296|P1|Overall Study|Non-compliance with study drug|0
7710593|NCT01076088|26814291|P6|Overall Study|Lost to Follow-up|2
7710594|NCT01076088|26814292|P5|Overall Study|Lost to Follow-up|1
7710595|NCT01076088|26814293|P4|Overall Study|Lost to Follow-up|1
7710596|NCT01076088|26814294|P3|Overall Study|Lost to Follow-up|0
7710597|NCT01076088|26814295|P2|Overall Study|Lost to Follow-up|1
7710598|NCT01076088|26814296|P1|Overall Study|Lost to Follow-up|1
7710599|NCT01076088|26814291|P6|Overall Study|Adverse Event|3
7710600|NCT01076088|26814292|P5|Overall Study|Adverse Event|3
7710601|NCT01076088|26814293|P4|Overall Study|Adverse Event|2
7710602|NCT01076088|26814294|P3|Overall Study|Adverse Event|3
7710603|NCT01076088|26814295|P2|Overall Study|Adverse Event|6
7710604|NCT01076088|26814296|P1|Overall Study|Adverse Event|1
7710605|NCT01076075|26814324|P2|Overall Study|Withdrawal by Subject|19
7710606|NCT01076075|26814325|P1|Overall Study|Withdrawal by Subject|8
7710607|NCT01076075|26814324|P2|Overall Study|Protocol Violation|1
7710608|NCT01076075|26814325|P1|Overall Study|Protocol Violation|0
7710609|NCT01076075|26814324|P2|Overall Study|other|9
7710610|NCT01076075|26814325|P1|Overall Study|other|19
7710611|NCT01076075|26814324|P2|Overall Study|Lost to Follow-up|5
7710612|NCT01076075|26814325|P1|Overall Study|Lost to Follow-up|6
7710613|NCT01076075|26814324|P2|Overall Study|Lack of Efficacy|4
7710614|NCT01076075|26814325|P1|Overall Study|Lack of Efficacy|5
7710615|NCT01076075|26814324|P2|Overall Study|Adverse Event|9
7710616|NCT01076075|26814325|P1|Overall Study|Adverse Event|3
7710617|NCT01076036|26814358|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
7710618|NCT01076010|26814366|P3|Overall Study|Other|0
7710619|NCT01076010|26814367|P2|Overall Study|Other|2
7710620|NCT01076010|26814368|P1|Overall Study|Other|5
7710621|NCT01076010|26814366|P3|Overall Study|Withdrawal by Subject|1
7710622|NCT01076010|26814367|P2|Overall Study|Withdrawal by Subject|0
7710623|NCT01076010|26814368|P1|Overall Study|Withdrawal by Subject|3
7710624|NCT01076010|26814366|P3|Overall Study|Noncompliance|0
7710625|NCT01076010|26814367|P2|Overall Study|Noncompliance|1
7710626|NCT01076010|26814368|P1|Overall Study|Noncompliance|1
7710627|NCT01076010|26814366|P3|Overall Study|Protocol Violation|0
7710628|NCT01076010|26814367|P2|Overall Study|Protocol Violation|1
7710629|NCT01076010|26814368|P1|Overall Study|Protocol Violation|0
7710630|NCT01076010|26814366|P3|Overall Study|Significant Surgical Procedure|0
7710631|NCT01076010|26814367|P2|Overall Study|Significant Surgical Procedure|1
7710632|NCT01076010|26814368|P1|Overall Study|Significant Surgical Procedure|0
7710633|NCT01076010|26814366|P3|Overall Study|Treatment Interruption for > 2 Weeks|0
7710634|NCT01076010|26814367|P2|Overall Study|Treatment Interruption for > 2 Weeks|1
7710635|NCT01076010|26814368|P1|Overall Study|Treatment Interruption for > 2 Weeks|0
7710636|NCT01076010|26814366|P3|Overall Study|Lack of Efficacy|0
7710637|NCT01076010|26814367|P2|Overall Study|Lack of Efficacy|0
7710638|NCT01076010|26814368|P1|Overall Study|Lack of Efficacy|4
7710639|NCT01076010|26814366|P3|Overall Study|Progressive disease|1
7710640|NCT01076010|26814367|P2|Overall Study|Progressive disease|30
7710641|NCT01076010|26814368|P1|Overall Study|Progressive disease|90
7710642|NCT01076010|26814366|P3|Overall Study|Adverse Event|0
7710643|NCT01076010|26814367|P2|Overall Study|Adverse Event|2
7710644|NCT01076010|26814368|P1|Overall Study|Adverse Event|7
7710645|NCT01076010|26814366|P3|Overall Study|Death|0
7710646|NCT01076010|26814367|P2|Overall Study|Death|1
7710647|NCT01076010|26814368|P1|Overall Study|Death|15
7710648|NCT01075984|26814408|P5|Follow-up Phase|Treatment failure|4
7710649|NCT01075984|26814409|P4|Follow-up Phase|Treatment failure|0
7710650|NCT01075984|26814410|P3|Follow-up Phase|Treatment failure|0
7710651|NCT01075984|26814411|P2|Follow-up Phase|Treatment failure|0
7710652|NCT01075984|26814412|P1|Follow-up Phase|Treatment failure|0
7710653|NCT01075984|26814408|P5|Follow-up Phase|Progression of disease|2
7710654|NCT01075984|26814409|P4|Follow-up Phase|Progression of disease|0
7710655|NCT01075984|26814410|P3|Follow-up Phase|Progression of disease|0
7710656|NCT01075984|26814411|P2|Follow-up Phase|Progression of disease|0
7710657|NCT01075984|26814412|P1|Follow-up Phase|Progression of disease|0
7710658|NCT01075984|26814408|P5|Follow-up Phase|Withdrawal by Subject|10
7710659|NCT01075984|26814409|P4|Follow-up Phase|Withdrawal by Subject|0
7710660|NCT01075984|26814410|P3|Follow-up Phase|Withdrawal by Subject|0
7710661|NCT01075984|26814411|P2|Follow-up Phase|Withdrawal by Subject|0
7710662|NCT01075984|26814412|P1|Follow-up Phase|Withdrawal by Subject|0
7710663|NCT01075984|26814408|P5|Follow-up Phase|Administrative|1
7710664|NCT01075984|26814409|P4|Follow-up Phase|Administrative|0
7710665|NCT01075984|26814410|P3|Follow-up Phase|Administrative|0
7710666|NCT01075984|26814411|P2|Follow-up Phase|Administrative|0
7710667|NCT01075984|26814412|P1|Follow-up Phase|Administrative|0
7710668|NCT01075984|26814408|P5|Follow-up Phase|Adverse Event|27
7710669|NCT01075984|26814409|P4|Follow-up Phase|Adverse Event|2
7710670|NCT01075984|26814410|P3|Follow-up Phase|Adverse Event|0
7710671|NCT01075984|26814411|P2|Follow-up Phase|Adverse Event|0
7710672|NCT01075984|26814412|P1|Follow-up Phase|Adverse Event|0
7710673|NCT01075984|26814408|P5|Follow-up Phase|Protocol Violation|3
7710674|NCT01075984|26814409|P4|Follow-up Phase|Protocol Violation|0
7710675|NCT01075984|26814410|P3|Follow-up Phase|Protocol Violation|1
7710676|NCT01075984|26814411|P2|Follow-up Phase|Protocol Violation|0
7710677|NCT01075984|26814412|P1|Follow-up Phase|Protocol Violation|0
7710678|NCT01075984|26814408|P5|Treatment Phase|Progression of disease|2
7710679|NCT01075984|26814409|P4|Treatment Phase|Progression of disease|0
7710680|NCT01075984|26814410|P3|Treatment Phase|Progression of disease|0
7710681|NCT01075984|26814411|P2|Treatment Phase|Progression of disease|0
7710682|NCT01075984|26814412|P1|Treatment Phase|Progression of disease|0
7710683|NCT01075984|26814408|P5|Treatment Phase|Treatment Failure|5
7710684|NCT01075984|26814409|P4|Treatment Phase|Treatment Failure|0
7710685|NCT01075984|26814410|P3|Treatment Phase|Treatment Failure|1
7710686|NCT01075984|26814411|P2|Treatment Phase|Treatment Failure|0
7710687|NCT01075984|26814412|P1|Treatment Phase|Treatment Failure|0
7710688|NCT01075984|26814408|P5|Treatment Phase|Withdrawal by Subject|15
7710689|NCT01075984|26814409|P4|Treatment Phase|Withdrawal by Subject|0
7710690|NCT01075984|26814410|P3|Treatment Phase|Withdrawal by Subject|2
7710691|NCT01075984|26814411|P2|Treatment Phase|Withdrawal by Subject|0
7710692|NCT01075984|26814412|P1|Treatment Phase|Withdrawal by Subject|0
7710693|NCT01075984|26814408|P5|Treatment Phase|Protocol Violation|3
7710694|NCT01075984|26814409|P4|Treatment Phase|Protocol Violation|0
7710695|NCT01075984|26814410|P3|Treatment Phase|Protocol Violation|1
7710696|NCT01075984|26814411|P2|Treatment Phase|Protocol Violation|0
7710697|NCT01075984|26814412|P1|Treatment Phase|Protocol Violation|0
7710698|NCT01075984|26814408|P5|Treatment Phase|Adverse Event|35
7710699|NCT01075984|26814409|P4|Treatment Phase|Adverse Event|7
7710700|NCT01075984|26814410|P3|Treatment Phase|Adverse Event|3
7710701|NCT01075984|26814411|P2|Treatment Phase|Adverse Event|1
7710702|NCT01075984|26814412|P1|Treatment Phase|Adverse Event|0
7710703|NCT01075958|26814470|P1|Overall Study|Blood sample could not be obtained|44
7710704|NCT01075815|26814486|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
7710705|NCT01075815|26814487|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
7710706|NCT01075815|26814486|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
7710707|NCT01075815|26814487|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
7710708|NCT01075815|26814486|P2|Overall Study|Withdrawal before r-hCG administration|1
7710709|NCT01075815|26814487|P1|Overall Study|Withdrawal before r-hCG administration|6
7710710|NCT01075763|26814525|P2|Overall Study|Withdrawal by Subject|2
7710711|NCT01075763|26814526|P1|Overall Study|Withdrawal by Subject|2
7710712|NCT01075763|26814525|P2|Overall Study|Lack of Efficacy|1
7710713|NCT01075763|26814526|P1|Overall Study|Lack of Efficacy|0
7710714|NCT01075763|26814525|P2|Overall Study|Lost to Follow-up|1
7710715|NCT01075763|26814526|P1|Overall Study|Lost to Follow-up|2
7710716|NCT01075685|26814550|P2|Overall Study|Lost to Follow-up|220
7710717|NCT01075685|26814551|P1|Overall Study|Lost to Follow-up|563
7710718|NCT01075685|26814550|P2|Overall Study|Withdrawal by Subject|5
7710719|NCT01075685|26814551|P1|Overall Study|Withdrawal by Subject|20
7710720|NCT01075685|26814550|P2|Overall Study|Protocol Violation|1
7710721|NCT01075685|26814551|P1|Overall Study|Protocol Violation|9
7710722|NCT01075646|26814567|P4|Overall Study|Lost to Follow-up|2
7710723|NCT01075646|26814568|P3|Overall Study|Lost to Follow-up|1
7710724|NCT01075646|26814569|P2|Overall Study|Lost to Follow-up|3
7710725|NCT01075646|26814570|P1|Overall Study|Lost to Follow-up|4
7710726|NCT01075516|26814602|P2|Overall Study|Withdrawal by Subject|5
7710727|NCT01075516|26814603|P1|Overall Study|Withdrawal by Subject|3
7710728|NCT01075516|26814602|P2|Overall Study|Lost to Follow-up|2
7710729|NCT01075516|26814603|P1|Overall Study|Lost to Follow-up|10
7710730|NCT01075516|26814602|P2|Overall Study|Death|9
7710731|NCT01075516|26814603|P1|Overall Study|Death|5
7710732|NCT01075412|26814615|P2|Overall Study|Withdrawal by Subject|1
7710733|NCT01075412|26814616|P1|Overall Study|Withdrawal by Subject|0
7710734|NCT01075321|26814641|P4|Overall Study|Ineligible (miscalculated lab value)|1
7710735|NCT01075321|26814642|P3|Overall Study|Ineligible (miscalculated lab value)|0
7710736|NCT01075321|26814643|P2|Overall Study|Ineligible (miscalculated lab value)|0
7710737|NCT01075321|26814644|P1|Overall Study|Ineligible (miscalculated lab value)|0
7710738|NCT01075321|26814641|P4|Overall Study|Treatment Incomplete due to progression|0
7710739|NCT01075321|26814642|P3|Overall Study|Treatment Incomplete due to progression|0
7710740|NCT01075321|26814643|P2|Overall Study|Treatment Incomplete due to progression|0
7710741|NCT01075321|26814644|P1|Overall Study|Treatment Incomplete due to progression|1
7710742|NCT01075321|26814641|P4|Overall Study|Protocol Violation|0
7710743|NCT01075321|26814642|P3|Overall Study|Protocol Violation|1
7710744|NCT01075321|26814643|P2|Overall Study|Protocol Violation|0
7710745|NCT01075321|26814644|P1|Overall Study|Protocol Violation|0
7710746|NCT01075321|26814641|P4|Overall Study|Withdrawal by Subject|1
7710747|NCT01075321|26814642|P3|Overall Study|Withdrawal by Subject|1
7710748|NCT01075321|26814643|P2|Overall Study|Withdrawal by Subject|0
7710749|NCT01075321|26814644|P1|Overall Study|Withdrawal by Subject|0
7710750|NCT01075282|26814662|P3|Overall Study|Death|2
7710751|NCT01075282|26814663|P2|Overall Study|Death|1
7710752|NCT01075282|26814664|P1|Overall Study|Death|0
7710753|NCT01075282|26814662|P3|Overall Study|Protocol Violation|1
7710754|NCT01075282|26814663|P2|Overall Study|Protocol Violation|2
7710755|NCT01075282|26814664|P1|Overall Study|Protocol Violation|0
7710756|NCT01075282|26814662|P3|Overall Study|Treatment Non-compliance|2
7710757|NCT01075282|26814663|P2|Overall Study|Treatment Non-compliance|2
7710758|NCT01075282|26814664|P1|Overall Study|Treatment Non-compliance|1
7710759|NCT01075282|26814662|P3|Overall Study|Lack of Efficacy|0
7710760|NCT01075282|26814663|P2|Overall Study|Lack of Efficacy|1
7710761|NCT01075282|26814664|P1|Overall Study|Lack of Efficacy|1
7710762|NCT01075282|26814662|P3|Overall Study|Physician Decision|3
7710763|NCT01075282|26814663|P2|Overall Study|Physician Decision|3
7710764|NCT01075282|26814664|P1|Overall Study|Physician Decision|3
7710765|NCT01075282|26814662|P3|Overall Study|Lost to Follow-up|3
7710766|NCT01075282|26814663|P2|Overall Study|Lost to Follow-up|3
7710767|NCT01075282|26814664|P1|Overall Study|Lost to Follow-up|3
7710768|NCT01075282|26814662|P3|Overall Study|Entry Criteria Not Met|0
7710769|NCT01075282|26814663|P2|Overall Study|Entry Criteria Not Met|2
7710770|NCT01075282|26814664|P1|Overall Study|Entry Criteria Not Met|3
7710771|NCT01075282|26814662|P3|Overall Study|Adverse Event|5
7710772|NCT01075282|26814663|P2|Overall Study|Adverse Event|8
7710773|NCT01075282|26814664|P1|Overall Study|Adverse Event|9
7710774|NCT01075282|26814662|P3|Overall Study|Withdrawal by Subject|11
7710775|NCT01075282|26814663|P2|Overall Study|Withdrawal by Subject|7
7710776|NCT01075282|26814664|P1|Overall Study|Withdrawal by Subject|11
7710777|NCT01075256|26814747|P3|Overall Study|Withdrawal by Subject|0
7710778|NCT01075256|26814748|P2|Overall Study|Withdrawal by Subject|0
7710779|NCT01075256|26814749|P1|Overall Study|Withdrawal by Subject|1
7710780|NCT01075243|26814781|P3|Overall Study|Withdrawal by Subject|0
7710781|NCT01075243|26814782|P2|Overall Study|Withdrawal by Subject|1
7710782|NCT01075243|26814783|P1|Overall Study|Withdrawal by Subject|1
7710783|NCT01075243|26814781|P3|Overall Study|Lost to Follow-up|0
7710784|NCT01075243|26814782|P2|Overall Study|Lost to Follow-up|2
7710785|NCT01075243|26814783|P1|Overall Study|Lost to Follow-up|5
7710786|NCT01075217|26814835|P2|Overall Study|Physician Decision|0
7710787|NCT01075217|26814836|P1|Overall Study|Physician Decision|1
7710788|NCT01075217|26814835|P2|Overall Study|Adverse Event|1
7710789|NCT01075217|26814836|P1|Overall Study|Adverse Event|1
7710790|NCT01075191|26814869|P1|Overall Study|Unknown Reasons|1
7710791|NCT01075191|26814869|P1|Overall Study|Patient's Wish|2
7710792|NCT01075191|26814869|P1|Overall Study|Therapy Break|3
7710793|NCT01075191|26814869|P1|Overall Study|Noncompliance|3
7710794|NCT01075191|26814869|P1|Overall Study|Adverse Event|4
7710795|NCT01075191|26814869|P1|Overall Study|Co-morbidities|1
7710796|NCT01075191|26814869|P1|Overall Study|Intensification|3
7710797|NCT01075191|26814869|P1|Overall Study|Death|1
7710798|NCT01075178|26814880|P2|Subject Chart Review|matched partner excluded (reasons above)|3
7710799|NCT01075178|26814881|P1|Subject Chart Review|matched partner excluded (reasons above)|6
7710800|NCT01075178|26814880|P2|Subject Chart Review|no data collected due to site closure|4
7710801|NCT01075178|26814881|P1|Subject Chart Review|no data collected due to site closure|3
7710802|NCT01075178|26814880|P2|Subject Chart Review|died before chart review period|2
7710803|NCT01075178|26814881|P1|Subject Chart Review|died before chart review period|0
7710804|NCT01075178|26814880|P2|Subject Matching|eligible but not matched|403
7710805|NCT01075178|26814881|P1|Subject Matching|eligible but not matched|130
7710806|NCT01075152|26814895|P2|Overall Study|Withdrawal by Subject|0
7710807|NCT01075152|26814896|P1|Overall Study|Withdrawal by Subject|1
7710808|NCT01075100|26814922|P2|Overall Study|Other|1
7710809|NCT01075100|26814923|P1|Overall Study|Other|3
7710810|NCT01075100|26814922|P2|Overall Study|Disease Progression|29
7710811|NCT01075100|26814923|P1|Overall Study|Disease Progression|25
7710812|NCT01075100|26814922|P2|Overall Study|Investigator Request|1
7710813|NCT01075100|26814923|P1|Overall Study|Investigator Request|2
7710814|NCT01075100|26814922|P2|Overall Study|Patient Request|4
7710815|NCT01075100|26814923|P1|Overall Study|Patient Request|4
7710816|NCT01075100|26814922|P2|Overall Study|Adverse Event|18
7710817|NCT01075100|26814923|P1|Overall Study|Adverse Event|15
7710818|NCT01075074|26814953|P3|Overall Study|Surgeon changed to open incisional case|2
7710819|NCT01075074|26814954|P2|Overall Study|Surgeon changed to open incisional case|2
7710820|NCT01075074|26814955|P1|Overall Study|Surgeon changed to open incisional case|1
7710821|NCT01075048|26814975|P3|Overall Study|Lost to Follow-up|1
7710822|NCT01075048|26814976|P2|Overall Study|Lost to Follow-up|1
7710823|NCT01075048|26814977|P1|Overall Study|Lost to Follow-up|0
7710824|NCT01075048|26814975|P3|Overall Study|Withdrawal by Subject|3
7710825|NCT01075048|26814976|P2|Overall Study|Withdrawal by Subject|6
7710826|NCT01075048|26814977|P1|Overall Study|Withdrawal by Subject|1
7710827|NCT01075048|26814975|P3|Overall Study|Start of other or new therapy|46
7710828|NCT01075048|26814976|P2|Overall Study|Start of other or new therapy|36
7710829|NCT01075048|26814977|P1|Overall Study|Start of other or new therapy|4
7710830|NCT01075048|26814975|P3|Overall Study|Death|12
7710831|NCT01075048|26814976|P2|Overall Study|Death|17
7710832|NCT01075048|26814977|P1|Overall Study|Death|4
7710833|NCT01074944|26815000|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
7710834|NCT01074944|26815001|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7710835|NCT01074944|26815002|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7710836|NCT01074944|26815003|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7710837|NCT01074944|26815004|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7710838|NCT01074944|26815000|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
7710839|NCT01074944|26815001|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
7710840|NCT01074944|26815002|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
7710841|NCT01074944|26815003|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
7710842|NCT01074944|26815004|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
7710843|NCT01074944|26815000|P5|Long Term Treatment|Withdrawal by Subject|0
7710844|NCT01074944|26815001|P4|Long Term Treatment|Withdrawal by Subject|2
7710845|NCT01074944|26815002|P3|Long Term Treatment|Withdrawal by Subject|0
7710846|NCT01074944|26815003|P2|Long Term Treatment|Withdrawal by Subject|0
7710847|NCT01074944|26815004|P1|Long Term Treatment|Withdrawal by Subject|0
7710848|NCT01074944|26815000|P5|Long Term Treatment|Entered in Period, But Not Treated|0
7710849|NCT01074944|26815001|P4|Long Term Treatment|Entered in Period, But Not Treated|1
7710850|NCT01074944|26815002|P3|Long Term Treatment|Entered in Period, But Not Treated|0
7710851|NCT01074944|26815003|P2|Long Term Treatment|Entered in Period, But Not Treated|0
7710852|NCT01074944|26815004|P1|Long Term Treatment|Entered in Period, But Not Treated|0
7710853|NCT01074944|26815000|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7710854|NCT01074944|26815001|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
7710855|NCT01074944|26815002|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7710856|NCT01074944|26815003|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7710857|NCT01074944|26815004|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7710858|NCT01074944|26815000|P5|Long Term Treatment|Lost to Follow-up|0
7710859|NCT01074944|26815001|P4|Long Term Treatment|Lost to Follow-up|2
7710860|NCT01074944|26815002|P3|Long Term Treatment|Lost to Follow-up|0
7710861|NCT01074944|26815003|P2|Long Term Treatment|Lost to Follow-up|0
7710862|NCT01074944|26815004|P1|Long Term Treatment|Lost to Follow-up|0
7710863|NCT01074944|26815000|P5|Long Term Treatment|Adverse Event|0
7710864|NCT01074944|26815001|P4|Long Term Treatment|Adverse Event|3
7710865|NCT01074944|26815002|P3|Long Term Treatment|Adverse Event|0
7710866|NCT01074944|26815003|P2|Long Term Treatment|Adverse Event|0
7710867|NCT01074944|26815004|P1|Long Term Treatment|Adverse Event|0
7710868|NCT01074944|26815000|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7710869|NCT01074944|26815001|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7710870|NCT01074944|26815002|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
7710871|NCT01074944|26815003|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
7710872|NCT01074944|26815004|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7710873|NCT01074944|26815000|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7710874|NCT01074944|26815001|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7710875|NCT01074944|26815002|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7710876|NCT01074944|26815003|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
7710877|NCT01074944|26815004|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7710878|NCT01074944|26815000|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7710879|NCT01074944|26815001|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7710880|NCT01074944|26815002|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
7710881|NCT01074944|26815003|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
7710882|NCT01074944|26815004|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7710883|NCT01074944|26815000|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7710884|NCT01074944|26815001|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7710885|NCT01074944|26815002|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
7710886|NCT01074944|26815003|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
7710887|NCT01074944|26815004|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7710888|NCT01074944|26815000|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7710889|NCT01074944|26815001|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7710890|NCT01074944|26815002|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
7710891|NCT01074944|26815003|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
7710892|NCT01074944|26815004|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7710893|NCT01074944|26815000|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7710894|NCT01074944|26815001|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7710895|NCT01074944|26815002|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7710896|NCT01074944|26815003|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7710897|NCT01074944|26815004|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
7710898|NCT01074944|26815000|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7710899|NCT01074944|26815001|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7710900|NCT01074944|26815002|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7710901|NCT01074944|26815003|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7710902|NCT01074944|26815004|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
7710903|NCT01074944|26815000|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7710904|NCT01074944|26815001|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7710905|NCT01074944|26815002|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7710906|NCT01074944|26815003|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7710907|NCT01074944|26815004|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
7710908|NCT01074944|26815000|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7710909|NCT01074944|26815001|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7710910|NCT01074944|26815002|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7710911|NCT01074944|26815003|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7710912|NCT01074944|26815004|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
7710913|NCT01074931|26815058|P1|Overall Study|Death|5
7710914|NCT01074931|26815058|P1|Overall Study|Economic reasons|1
7710915|NCT01074658|26815070|P1|Overall Study|No implant attempted|19
7710916|NCT01074554|26815078|P2|Overall Study|Lost to Follow-up|1
7710917|NCT01074554|26815079|P1|Overall Study|Lost to Follow-up|0
7710918|NCT01074554|26815078|P2|Overall Study|Adverse Event|3
7710919|NCT01074554|26815079|P1|Overall Study|Adverse Event|3
7710920|NCT01074502|26815089|P1|Overall Study|Withdrawal by Subject|1
7710921|NCT01074450|26815113|P2|Second Intervention|Physician Decision|1
7710922|NCT01074450|26815114|P1|Second Intervention|Physician Decision|0
7710923|NCT01074450|26815113|P2|Second Intervention|Protocol Violation|0
7710924|NCT01074450|26815114|P1|Second Intervention|Protocol Violation|1
7710925|NCT01074450|26815113|P2|First Intervention|Emesis in Dosing Interval|2
7710926|NCT01074450|26815114|P1|First Intervention|Emesis in Dosing Interval|0
7710927|NCT01074307|26815143|P2|Overall Study|Protocol Violation|5
7710928|NCT01074307|26815144|P1|Overall Study|Protocol Violation|8
7710929|NCT01074307|26815143|P2|Overall Study|Exclusion criterion|1
7710930|NCT01074307|26815144|P1|Overall Study|Exclusion criterion|0
7710931|NCT01074307|26815143|P2|Overall Study|No primary endpoint evaluation|6
7710932|NCT01074307|26815144|P1|Overall Study|No primary endpoint evaluation|14
7710933|NCT01074268|26815166|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
7710934|NCT01074268|26815167|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
7710935|NCT01074268|26815166|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
7710936|NCT01074268|26815167|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
7710937|NCT01074268|26815166|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
7710938|NCT01074268|26815167|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
7710939|NCT01074268|26815166|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
7710940|NCT01074268|26815167|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
7710941|NCT01074268|26815166|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
7710942|NCT01074268|26815167|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
7710943|NCT01074268|26815166|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
7710944|NCT01074268|26815167|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
7710945|NCT01074268|26815166|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
7710946|NCT01074268|26815167|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
7710947|NCT01074268|26815166|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
7710948|NCT01074268|26815167|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
7710949|NCT01074268|26815166|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
7710950|NCT01074268|26815167|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
7710951|NCT01074255|26815193|P1|Overall Study|Did not receive EMEND|2
7710952|NCT01074242|26815197|P1|Overall Study|Duplicate Case Report Form|5
7710953|NCT01074242|26815197|P1|Overall Study|Violation of vaccine dose or dosage|351
7710954|NCT01074242|26815197|P1|Overall Study|Case report unclear|6
7710955|NCT01074242|26815197|P1|Overall Study|Lost to Follow-up|1
7710956|NCT01074242|26815197|P1|Overall Study|Case report before date of contract|40
7710957|NCT01074229|26815205|P3|Overall Study|Change to open surgical procedure|4
7710958|NCT01074229|26815206|P2|Overall Study|Change to open surgical procedure|3
7710959|NCT01074229|26815207|P1|Overall Study|Change to open surgical procedure|1
7710960|NCT01074229|26815205|P3|Overall Study|Lost to Follow-up|0
7710961|NCT01074229|26815206|P2|Overall Study|Lost to Follow-up|0
7710962|NCT01074229|26815207|P1|Overall Study|Lost to Follow-up|1
7710963|NCT01074216|26815218|P1|Overall Study|Not Treated|12
7710964|NCT01074216|26815218|P1|Overall Study|Physician Decision|1
7710965|NCT01074047|26815282|P2|Extension Phase|Death|0
7710966|NCT01074047|26815283|P1|Extension Phase|Death|5
7710967|NCT01074047|26815282|P2|Extension Phase|Withdrawal by Subject|0
7710968|NCT01074047|26815283|P1|Extension Phase|Withdrawal by Subject|2
7710969|NCT01074047|26815282|P2|Extension Phase|Disease Progression|0
7710970|NCT01074047|26815283|P1|Extension Phase|Disease Progression|9
7710971|NCT01074047|26815282|P2|Extension Phase|Adverse Event|0
7710972|NCT01074047|26815283|P1|Extension Phase|Adverse Event|5
7710973|NCT01074047|26815282|P2|Extension Phase|Physician Decision|0
7710974|NCT01074047|26815283|P1|Extension Phase|Physician Decision|1
7710975|NCT01074047|26815282|P2|Survival Follow-Up Phase|Alive at study closure|3
7710976|NCT01074047|26815283|P1|Survival Follow-Up Phase|Alive at study closure|1
7710977|NCT01074047|26815282|P2|Survival Follow-Up Phase|Death|124
7710978|NCT01074047|26815283|P1|Survival Follow-Up Phase|Death|116
7710979|NCT01074047|26815282|P2|Survival Follow-Up Phase|Lost to Follow-up|1
7710980|NCT01074047|26815283|P1|Survival Follow-Up Phase|Lost to Follow-up|2
7710981|NCT01074047|26815282|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
7710982|NCT01074047|26815283|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
7710983|NCT01074047|26815282|P2|Treatment Phase|Miscellaneous|39
7710984|NCT01074047|26815283|P1|Treatment Phase|Miscellaneous|32
7710985|NCT01074047|26815282|P2|Treatment Phase|Protocol Violation|1
7710986|NCT01074047|26815283|P1|Treatment Phase|Protocol Violation|0
7710987|NCT01074047|26815282|P2|Treatment Phase|Lost to Follow-up|1
7710988|NCT01074047|26815283|P1|Treatment Phase|Lost to Follow-up|0
7710989|NCT01074047|26815282|P2|Treatment Phase|Death|58
7710990|NCT01074047|26815283|P1|Treatment Phase|Death|53
7710991|NCT01074047|26815282|P2|Treatment Phase|Withdrawal by Subject|48
7710992|NCT01074047|26815283|P1|Treatment Phase|Withdrawal by Subject|27
7710993|NCT01074047|26815282|P2|Treatment Phase|Disease Progression|21
7710994|NCT01074047|26815283|P1|Treatment Phase|Disease Progression|16
7710995|NCT01074047|26815282|P2|Treatment Phase|Adverse Event|66
7710996|NCT01074047|26815283|P1|Treatment Phase|Adverse Event|89
7710997|NCT01074008|26815371|P9|Overall Study|Lost to Follow-up|4
7710998|NCT01074008|26815372|P8|Overall Study|Lost to Follow-up|0
7710999|NCT01074008|26815373|P7|Overall Study|Lost to Follow-up|1
7711000|NCT01074008|26815374|P6|Overall Study|Lost to Follow-up|0
7711001|NCT01074008|26815375|P5|Overall Study|Lost to Follow-up|1
7711002|NCT01074008|26815376|P4|Overall Study|Lost to Follow-up|1
7711003|NCT01074008|26815377|P3|Overall Study|Lost to Follow-up|1
7711004|NCT01074008|26815378|P2|Overall Study|Lost to Follow-up|1
7711005|NCT01074008|26815379|P1|Overall Study|Lost to Follow-up|0
7711006|NCT01074008|26815371|P9|Overall Study|Withdrawal by Subject|0
7711007|NCT01074008|26815372|P8|Overall Study|Withdrawal by Subject|0
7711008|NCT01074008|26815373|P7|Overall Study|Withdrawal by Subject|0
7711009|NCT01074008|26815374|P6|Overall Study|Withdrawal by Subject|0
7711010|NCT01074008|26815375|P5|Overall Study|Withdrawal by Subject|1
7711011|NCT01074008|26815376|P4|Overall Study|Withdrawal by Subject|0
7711012|NCT01074008|26815377|P3|Overall Study|Withdrawal by Subject|1
7711013|NCT01074008|26815378|P2|Overall Study|Withdrawal by Subject|1
7711014|NCT01074008|26815379|P1|Overall Study|Withdrawal by Subject|1
7711015|NCT01074008|26815371|P9|Overall Study|Adverse Event|0
7711016|NCT01074008|26815372|P8|Overall Study|Adverse Event|0
7711017|NCT01074008|26815373|P7|Overall Study|Adverse Event|0
7711018|NCT01074008|26815374|P6|Overall Study|Adverse Event|0
7711019|NCT01074008|26815375|P5|Overall Study|Adverse Event|0
7711020|NCT01074008|26815376|P4|Overall Study|Adverse Event|0
7711021|NCT01074008|26815377|P3|Overall Study|Adverse Event|0
7711022|NCT01074008|26815378|P2|Overall Study|Adverse Event|1
7711023|NCT01074008|26815379|P1|Overall Study|Adverse Event|0
7711024|NCT01073943|26815489|P2|Overall Study|Could not tolerate prep|0
7711025|NCT01073943|26815490|P1|Overall Study|Could not tolerate prep|1
7711026|NCT01073943|26815489|P2|Overall Study|Unable to return for follow-up|1
7711027|NCT01073943|26815490|P1|Overall Study|Unable to return for follow-up|0
7711028|NCT01073943|26815489|P2|Overall Study|Subject forgot|1
7711029|NCT01073943|26815490|P1|Overall Study|Subject forgot|0
7711030|NCT01073943|26815489|P2|Overall Study|Power outage; colonoscopy not done|0
7711031|NCT01073943|26815490|P1|Overall Study|Power outage; colonoscopy not done|1
7711032|NCT01073943|26815489|P2|Overall Study|Lost to Follow-up|2
7711033|NCT01073943|26815490|P1|Overall Study|Lost to Follow-up|0
7711034|NCT01073943|26815489|P2|Overall Study|Adverse Event|1
7711035|NCT01073943|26815490|P1|Overall Study|Adverse Event|1
7711036|NCT01073943|26815489|P2|Overall Study|Protocol Violation|1
7711037|NCT01073943|26815490|P1|Overall Study|Protocol Violation|2
7711038|NCT01073943|26815489|P2|Overall Study|Withdrawal by Subject|2
7711039|NCT01073943|26815490|P1|Overall Study|Withdrawal by Subject|8
7711040|NCT01073930|26815516|P2|Overall Study|Inadequate prep; unable to do procedure|1
7711041|NCT01073930|26815517|P1|Overall Study|Inadequate prep; unable to do procedure|0
7711042|NCT01073930|26815516|P2|Overall Study|Noncompliance with study drug|1
7711043|NCT01073930|26815517|P1|Overall Study|Noncompliance with study drug|0
7711044|NCT01073930|26815516|P2|Overall Study|Adverse Event|1
7711045|NCT01073930|26815517|P1|Overall Study|Adverse Event|0
7711046|NCT01073930|26815516|P2|Overall Study|Lost to Follow-up|1
7711047|NCT01073930|26815517|P1|Overall Study|Lost to Follow-up|0
7711048|NCT01073930|26815516|P2|Overall Study|Withdrawal by Subject|2
7711049|NCT01073930|26815517|P1|Overall Study|Withdrawal by Subject|3
7711050|NCT01073865|26815541|P2|Overall Study|Withdrawal by Subject|5
7711051|NCT01073865|26815542|P1|Overall Study|Withdrawal by Subject|5
7711052|NCT01073865|26815541|P2|Overall Study|Death|2
7711053|NCT01073865|26815542|P1|Overall Study|Death|3
7711054|NCT01073865|26815541|P2|Overall Study|Lost to Follow-up|1
7711055|NCT01073865|26815542|P1|Overall Study|Lost to Follow-up|1
7711056|NCT01073865|26815541|P2|Overall Study|Reasons other than below|31
7711057|NCT01073865|26815542|P1|Overall Study|Reasons other than below|19
7711058|NCT01073631|26815561|P1|Overall Study|Other|63
7711059|NCT01073631|26815561|P1|Overall Study|Adverse Event|24
7711060|NCT01073631|26815561|P1|Overall Study|Death|82
7711061|NCT01073618|26815566|P1|Overall Study|Other|80
7711062|NCT01073618|26815566|P1|Overall Study|Adverse Event|19
7711063|NCT01073618|26815566|P1|Overall Study|Death|208
7711064|NCT01073605|26815574|P3|Overall Study|Randomized But Not Treated|1
7711065|NCT01073605|26815575|P2|Overall Study|Randomized But Not Treated|1
7711066|NCT01073605|26815576|P1|Overall Study|Randomized But Not Treated|0
7711067|NCT01073605|26815574|P3|Overall Study|Withdrawal by Subject|22
7711068|NCT01073605|26815575|P2|Overall Study|Withdrawal by Subject|39
7711069|NCT01073605|26815576|P1|Overall Study|Withdrawal by Subject|31
7711070|NCT01073605|26815574|P3|Overall Study|Other|29
7711071|NCT01073605|26815575|P2|Overall Study|Other|21
7711072|NCT01073605|26815576|P1|Overall Study|Other|25
7711073|NCT01073605|26815574|P3|Overall Study|Lost to Follow-up|9
7711074|NCT01073605|26815575|P2|Overall Study|Lost to Follow-up|4
7711075|NCT01073605|26815576|P1|Overall Study|Lost to Follow-up|3
7711076|NCT01073605|26815574|P3|Overall Study|Adverse Event|0
7711077|NCT01073605|26815575|P2|Overall Study|Adverse Event|1
7711078|NCT01073605|26815576|P1|Overall Study|Adverse Event|2
7711079|NCT01073605|26815574|P3|Overall Study|Ongoing at Cutoff Date|0
7711080|NCT01073605|26815575|P2|Overall Study|Ongoing at Cutoff Date|1
7711081|NCT01073605|26815576|P1|Overall Study|Ongoing at Cutoff Date|1
7711082|NCT01073566|26815622|P2|Period 2 (6 Weeks)|Adverse Event|0
7711083|NCT01073566|26815623|P1|Period 2 (6 Weeks)|Adverse Event|1
7711084|NCT01073462|26815635|P1|Overall Study|Lost to Follow-up|7
7711085|NCT01073462|26815635|P1|Overall Study|Serious adverse event|2
7711086|NCT01073462|26815635|P1|Overall Study|Low parathyroid hormone levels|8
7711087|NCT01073462|26815635|P1|Overall Study|Kidney transplant|10
7711088|NCT01073462|26815635|P1|Overall Study|Death|14
7711089|NCT01073293|26815654|P2|Overall Study|Withdrawal by Subject|10
7711090|NCT01073293|26815655|P1|Overall Study|Withdrawal by Subject|5
7711091|NCT01073293|26815654|P2|Overall Study|Lost to Follow-up|1
7711092|NCT01073293|26815655|P1|Overall Study|Lost to Follow-up|0
7711093|NCT01073267|26815677|P1|Overall Study|Disease Progression|3
7711094|NCT01073163|26815681|P1|Overall Study|Early termination|1
7711095|NCT01073163|26815681|P1|Overall Study|Disease Progression|1
7711096|NCT01073163|26815681|P1|Overall Study|Adverse Event|1
7711097|NCT01073020|26815705|P4|Overall Study|Death|0
7711098|NCT01073020|26815706|P3|Overall Study|Death|0
7711099|NCT01073020|26815707|P2|Overall Study|Death|1
7711100|NCT01073020|26815708|P1|Overall Study|Death|0
7711101|NCT01073020|26815705|P4|Overall Study|Physician Decision|0
7711102|NCT01073020|26815706|P3|Overall Study|Physician Decision|2
7711103|NCT01073020|26815707|P2|Overall Study|Physician Decision|0
7711104|NCT01073020|26815708|P1|Overall Study|Physician Decision|1
7711105|NCT01073020|26815705|P4|Overall Study|Withdrawal by Subject|2
7711106|NCT01073020|26815706|P3|Overall Study|Withdrawal by Subject|1
7711107|NCT01073020|26815707|P2|Overall Study|Withdrawal by Subject|4
7711108|NCT01073020|26815708|P1|Overall Study|Withdrawal by Subject|6
7711109|NCT01072929|26815733|P3|Overall Study|Other|0
7711110|NCT01072929|26815734|P2|Overall Study|Other|3
7711111|NCT01072929|26815735|P1|Overall Study|Other|0
7711112|NCT01072929|26815733|P3|Overall Study|Noncompliance with study procedures|1
7711113|NCT01072929|26815734|P2|Overall Study|Noncompliance with study procedures|0
7711114|NCT01072929|26815735|P1|Overall Study|Noncompliance with study procedures|1
7711115|NCT01072929|26815733|P3|Overall Study|Noncompliance with study medication|0
7711116|NCT01072929|26815734|P2|Overall Study|Noncompliance with study medication|3
7711117|NCT01072929|26815735|P1|Overall Study|Noncompliance with study medication|0
7711118|NCT01072929|26815733|P3|Overall Study|Lost to Follow-up|1
7711119|NCT01072929|26815734|P2|Overall Study|Lost to Follow-up|4
7711120|NCT01072929|26815735|P1|Overall Study|Lost to Follow-up|8
7711121|NCT01072929|26815733|P3|Overall Study|Protocol Violation|2
7711122|NCT01072929|26815734|P2|Overall Study|Protocol Violation|11
7711123|NCT01072929|26815735|P1|Overall Study|Protocol Violation|13
7711124|NCT01072929|26815733|P3|Overall Study|Withdrawal by Subject|3
7711125|NCT01072929|26815734|P2|Overall Study|Withdrawal by Subject|15
7711126|NCT01072929|26815735|P1|Overall Study|Withdrawal by Subject|7
7711127|NCT01072929|26815733|P3|Overall Study|Lack of Efficacy|0
7711128|NCT01072929|26815734|P2|Overall Study|Lack of Efficacy|4
7711129|NCT01072929|26815735|P1|Overall Study|Lack of Efficacy|7
7711130|NCT01072929|26815733|P3|Overall Study|Adverse Event|2
7711131|NCT01072929|26815734|P2|Overall Study|Adverse Event|11
7711132|NCT01072929|26815735|P1|Overall Study|Adverse Event|8
7711133|NCT01072877|26815814|P5|Overall Study|Lost to Follow-up|0
7711134|NCT01072877|26815815|P4|Overall Study|Lost to Follow-up|2
7711135|NCT01072877|26815816|P3|Overall Study|Lost to Follow-up|0
7711136|NCT01072877|26815817|P2|Overall Study|Lost to Follow-up|1
7711137|NCT01072877|26815818|P1|Overall Study|Lost to Follow-up|1
7711138|NCT01072630|26815897|P3|Overall Study|Other|1
7711139|NCT01072630|26815898|P2|Overall Study|Other|2
7711140|NCT01072630|26815899|P1|Overall Study|Other|3
7711141|NCT01072630|26815897|P3|Overall Study|Noncompliance with study procedures|1
7711142|NCT01072630|26815898|P2|Overall Study|Noncompliance with study procedures|2
7711143|NCT01072630|26815899|P1|Overall Study|Noncompliance with study procedures|1
7711144|NCT01072630|26815897|P3|Overall Study|Noncompliance with study medication|1
7711145|NCT01072630|26815898|P2|Overall Study|Noncompliance with study medication|1
7711146|NCT01072630|26815899|P1|Overall Study|Noncompliance with study medication|1
7711147|NCT01072630|26815897|P3|Overall Study|Lost to Follow-up|1
7711148|NCT01072630|26815898|P2|Overall Study|Lost to Follow-up|11
7711149|NCT01072630|26815899|P1|Overall Study|Lost to Follow-up|11
7711150|NCT01072630|26815897|P3|Overall Study|Protocol Violation|4
7711151|NCT01072630|26815898|P2|Overall Study|Protocol Violation|8
7711152|NCT01072630|26815899|P1|Overall Study|Protocol Violation|10
7711153|NCT01072630|26815897|P3|Overall Study|Withdrawal by Subject|2
7711154|NCT01072630|26815898|P2|Overall Study|Withdrawal by Subject|7
7711155|NCT01072630|26815899|P1|Overall Study|Withdrawal by Subject|8
7711156|NCT01072630|26815897|P3|Overall Study|Lack of Efficacy|1
7711157|NCT01072630|26815898|P2|Overall Study|Lack of Efficacy|10
7711158|NCT01072630|26815899|P1|Overall Study|Lack of Efficacy|10
7711159|NCT01072630|26815897|P3|Overall Study|Adverse Event|2
7711160|NCT01072630|26815898|P2|Overall Study|Adverse Event|19
7711161|NCT01072630|26815899|P1|Overall Study|Adverse Event|11
7711162|NCT01072539|26815980|P1|Overall Study|Protocol Violation|2
7711163|NCT01072539|26815980|P1|Overall Study|Treated prior to the Site Initiation|1
7711164|NCT01072500|26816004|P2|Overall Study|Withdrawal by Subject|10
7711165|NCT01072500|26816005|P1|Overall Study|Withdrawal by Subject|17
7711166|NCT01072500|26816004|P2|Overall Study|Lost to Follow-up|2
7711167|NCT01072500|26816005|P1|Overall Study|Lost to Follow-up|5
7711168|NCT01072500|26816004|P2|Overall Study|Death|2
7711169|NCT01072500|26816005|P1|Overall Study|Death|2
7711170|NCT01072448|26816015|P2|Overall Study|Death|2
7711171|NCT01072448|26816016|P1|Overall Study|Death|0
7711172|NCT01072448|26816015|P2|Overall Study|Abnormal laboratory value(s)|1
7711173|NCT01072448|26816016|P1|Overall Study|Abnormal laboratory value(s)|0
7711174|NCT01072448|26816015|P2|Overall Study|Lost to Follow-up|1
7711175|NCT01072448|26816016|P1|Overall Study|Lost to Follow-up|1
7711176|NCT01072448|26816015|P2|Overall Study|Unsatisfactory therapeutic effect|3
7711177|NCT01072448|26816016|P1|Overall Study|Unsatisfactory therapeutic effect|1
7711178|NCT01072448|26816015|P2|Overall Study|Abnormal test procedure result(s)|0
7711179|NCT01072448|26816016|P1|Overall Study|Abnormal test procedure result(s)|1
7711180|NCT01072448|26816015|P2|Overall Study|Protocol deviation|4
7711181|NCT01072448|26816016|P1|Overall Study|Protocol deviation|3
7711182|NCT01072448|26816015|P2|Overall Study|Subject withdrew consent|9
7711183|NCT01072448|26816016|P1|Overall Study|Subject withdrew consent|4
7711184|NCT01072448|26816015|P2|Overall Study|Adverse Event|10
7711185|NCT01072448|26816016|P1|Overall Study|Adverse Event|9
7711186|NCT01072396|26816030|P2|Period Two|Lost to Follow-up|0
7711187|NCT01072396|26816031|P1|Period Two|Lost to Follow-up|1
7711188|NCT01072396|26816030|P2|Period Two|Adverse Event|3
7711189|NCT01072396|26816031|P1|Period Two|Adverse Event|0
7711190|NCT01072396|26816030|P2|Washout Period|Missing termination information|1
7711191|NCT01072396|26816031|P1|Washout Period|Missing termination information|0
7711192|NCT01072396|26816030|P2|Period One|Withdrawal by Subject|0
7711193|NCT01072396|26816031|P1|Period One|Withdrawal by Subject|2
7711194|NCT01072396|26816030|P2|Period One|Protocol Violation|1
7711195|NCT01072396|26816031|P1|Period One|Protocol Violation|2
7711196|NCT01072396|26816030|P2|Period One|Adverse Event|1
7711197|NCT01072396|26816031|P1|Period One|Adverse Event|1
7711198|NCT01072357|26816043|P2|Overall Study|Lost to Follow-up|1
7711199|NCT01072357|26816044|P1|Overall Study|Lost to Follow-up|0
7711200|NCT01072344|26816054|P2|Overall Study|Lost to Follow-up|4
7711201|NCT01072344|26816055|P1|Overall Study|Lost to Follow-up|3
7711202|NCT01072344|26816054|P2|Overall Study|Protocol Violation|2
7711203|NCT01072344|26816055|P1|Overall Study|Protocol Violation|1
7711204|NCT01072344|26816054|P2|Overall Study|Relasped-reached end point|12
7711205|NCT01072344|26816055|P1|Overall Study|Relasped-reached end point|7
7711206|NCT01072201|26816093|P2|Overall Study|Lost to Follow-up|1
7711207|NCT01072201|26816094|P1|Overall Study|Lost to Follow-up|0
7711208|NCT01072175|26816127|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711209|NCT01072175|26816128|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
7711210|NCT01072175|26816129|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
7711211|NCT01072175|26816130|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711212|NCT01072175|26816131|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711213|NCT01072175|26816132|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711214|NCT01072175|26816133|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711215|NCT01072175|26816134|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711216|NCT01072175|26816135|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711217|NCT01072175|26816136|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711218|NCT01072175|26816137|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711219|NCT01072175|26816138|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711220|NCT01072175|26816139|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
7711221|NCT01072175|26816127|P13|Part D (HPMC Capsules)|Study closed/terminated|9
7711222|NCT01072175|26816128|P12|Part D (HPMC Capsules)|Study closed/terminated|10
7711223|NCT01072175|26816129|P11|Part D (HPMC Capsules)|Study closed/terminated|1
7711224|NCT01072175|26816130|P10|Part D (HPMC Capsules)|Study closed/terminated|2
7711225|NCT01072175|26816131|P9|Part D (HPMC Capsules)|Study closed/terminated|0
7711226|NCT01072175|26816132|P8|Part D (HPMC Capsules)|Study closed/terminated|0
7711227|NCT01072175|26816133|P7|Part D (HPMC Capsules)|Study closed/terminated|0
7711228|NCT01072175|26816134|P6|Part D (HPMC Capsules)|Study closed/terminated|0
7711229|NCT01072175|26816135|P5|Part D (HPMC Capsules)|Study closed/terminated|0
7711230|NCT01072175|26816136|P4|Part D (HPMC Capsules)|Study closed/terminated|0
7711231|NCT01072175|26816137|P3|Part D (HPMC Capsules)|Study closed/terminated|0
7711232|NCT01072175|26816138|P2|Part D (HPMC Capsules)|Study closed/terminated|0
7711233|NCT01072175|26816139|P1|Part D (HPMC Capsules)|Study closed/terminated|0
7711234|NCT01072175|26816127|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
7711235|NCT01072175|26816128|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
7711236|NCT01072175|26816129|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
7711237|NCT01072175|26816130|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
7711238|NCT01072175|26816131|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
7711239|NCT01072175|26816132|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
7711240|NCT01072175|26816133|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
7711241|NCT01072175|26816134|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
7711242|NCT01072175|26816135|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
7711243|NCT01072175|26816136|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
7711244|NCT01072175|26816137|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
7711245|NCT01072175|26816138|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
7711246|NCT01072175|26816139|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
7711247|NCT01072175|26816127|P13|Part D (HPMC Capsules)|Physician Decision|1
7711248|NCT01072175|26816128|P12|Part D (HPMC Capsules)|Physician Decision|1
7711249|NCT01072175|26816129|P11|Part D (HPMC Capsules)|Physician Decision|1
7711250|NCT01072175|26816130|P10|Part D (HPMC Capsules)|Physician Decision|0
7711251|NCT01072175|26816131|P9|Part D (HPMC Capsules)|Physician Decision|0
7711252|NCT01072175|26816132|P8|Part D (HPMC Capsules)|Physician Decision|0
7711253|NCT01072175|26816133|P7|Part D (HPMC Capsules)|Physician Decision|0
7711254|NCT01072175|26816134|P6|Part D (HPMC Capsules)|Physician Decision|0
7711255|NCT01072175|26816135|P5|Part D (HPMC Capsules)|Physician Decision|0
7711256|NCT01072175|26816136|P4|Part D (HPMC Capsules)|Physician Decision|0
7711257|NCT01072175|26816137|P3|Part D (HPMC Capsules)|Physician Decision|0
7711258|NCT01072175|26816138|P2|Part D (HPMC Capsules)|Physician Decision|0
7711259|NCT01072175|26816139|P1|Part D (HPMC Capsules)|Physician Decision|0
7711260|NCT01072175|26816127|P13|Part D (HPMC Capsules)|Death|26
7711261|NCT01072175|26816128|P12|Part D (HPMC Capsules)|Death|28
7711262|NCT01072175|26816129|P11|Part D (HPMC Capsules)|Death|12
7711263|NCT01072175|26816130|P10|Part D (HPMC Capsules)|Death|10
7711264|NCT01072175|26816131|P9|Part D (HPMC Capsules)|Death|0
7711265|NCT01072175|26816132|P8|Part D (HPMC Capsules)|Death|0
7711266|NCT01072175|26816133|P7|Part D (HPMC Capsules)|Death|0
7711267|NCT01072175|26816134|P6|Part D (HPMC Capsules)|Death|0
7711268|NCT01072175|26816135|P5|Part D (HPMC Capsules)|Death|0
7711269|NCT01072175|26816136|P4|Part D (HPMC Capsules)|Death|0
7711270|NCT01072175|26816137|P3|Part D (HPMC Capsules)|Death|0
7711271|NCT01072175|26816138|P2|Part D (HPMC Capsules)|Death|0
7711272|NCT01072175|26816139|P1|Part D (HPMC Capsules)|Death|0
7711273|NCT01072175|26816127|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711274|NCT01072175|26816128|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711275|NCT01072175|26816129|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711276|NCT01072175|26816130|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711277|NCT01072175|26816131|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
7711278|NCT01072175|26816132|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711279|NCT01072175|26816133|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711280|NCT01072175|26816134|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711281|NCT01072175|26816135|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711282|NCT01072175|26816136|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711283|NCT01072175|26816137|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711284|NCT01072175|26816138|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711285|NCT01072175|26816139|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7711286|NCT01072175|26816127|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711287|NCT01072175|26816128|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711288|NCT01072175|26816129|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711289|NCT01072175|26816130|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711290|NCT01072175|26816131|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
7711291|NCT01072175|26816132|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711292|NCT01072175|26816133|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711293|NCT01072175|26816134|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711294|NCT01072175|26816135|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711295|NCT01072175|26816136|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711296|NCT01072175|26816137|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711297|NCT01072175|26816138|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711298|NCT01072175|26816139|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7711299|NCT01072175|26816127|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711300|NCT01072175|26816128|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711301|NCT01072175|26816129|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711302|NCT01072175|26816130|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711303|NCT01072175|26816131|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
7711304|NCT01072175|26816132|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711305|NCT01072175|26816133|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711306|NCT01072175|26816134|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711307|NCT01072175|26816135|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711308|NCT01072175|26816136|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711309|NCT01072175|26816137|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711310|NCT01072175|26816138|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711311|NCT01072175|26816139|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7711312|NCT01072175|26816127|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
7711313|NCT01072175|26816128|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
7711314|NCT01072175|26816129|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
7711315|NCT01072175|26816130|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
7711316|NCT01072175|26816131|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
7711317|NCT01072175|26816132|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
7711318|NCT01072175|26816133|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
7711319|NCT01072175|26816134|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
7711320|NCT01072175|26816135|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
7711321|NCT01072175|26816136|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
7711322|NCT01072175|26816137|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
7711323|NCT01072175|26816138|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
7711324|NCT01072175|26816139|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
7711325|NCT01072175|26816127|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711326|NCT01072175|26816128|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711327|NCT01072175|26816129|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711328|NCT01072175|26816130|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711329|NCT01072175|26816131|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711330|NCT01072175|26816132|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711331|NCT01072175|26816133|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
7711332|NCT01072175|26816134|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
7711333|NCT01072175|26816135|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711334|NCT01072175|26816136|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711335|NCT01072175|26816137|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711336|NCT01072175|26816138|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711337|NCT01072175|26816139|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7711338|NCT01072175|26816127|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711339|NCT01072175|26816128|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711340|NCT01072175|26816129|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711341|NCT01072175|26816130|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711342|NCT01072175|26816131|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711343|NCT01072175|26816132|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
7711344|NCT01072175|26816133|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
7711345|NCT01072175|26816134|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
7711346|NCT01072175|26816135|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711347|NCT01072175|26816136|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711348|NCT01072175|26816137|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711349|NCT01072175|26816138|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711350|NCT01072175|26816139|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7711351|NCT01072175|26816127|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711352|NCT01072175|26816128|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711353|NCT01072175|26816129|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711354|NCT01072175|26816130|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711355|NCT01072175|26816131|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711356|NCT01072175|26816132|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7711357|NCT01072175|26816133|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7711358|NCT01072175|26816134|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711359|NCT01072175|26816135|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711360|NCT01072175|26816136|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711361|NCT01072175|26816137|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711362|NCT01072175|26816138|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711363|NCT01072175|26816139|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7711364|NCT01072175|26816127|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711365|NCT01072175|26816128|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711366|NCT01072175|26816129|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711367|NCT01072175|26816130|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711368|NCT01072175|26816131|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711369|NCT01072175|26816132|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
7711370|NCT01072175|26816133|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
7711371|NCT01072175|26816134|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
7711372|NCT01072175|26816135|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711373|NCT01072175|26816136|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711374|NCT01072175|26816137|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711375|NCT01072175|26816138|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711376|NCT01072175|26816139|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
7711377|NCT01072175|26816127|P13|Part C (Phase II: Randomized Phase)|Death|0
7711378|NCT01072175|26816128|P12|Part C (Phase II: Randomized Phase)|Death|0
7711379|NCT01072175|26816129|P11|Part C (Phase II: Randomized Phase)|Death|0
7711380|NCT01072175|26816130|P10|Part C (Phase II: Randomized Phase)|Death|0
7711381|NCT01072175|26816131|P9|Part C (Phase II: Randomized Phase)|Death|0
7711382|NCT01072175|26816132|P8|Part C (Phase II: Randomized Phase)|Death|39
7711383|NCT01072175|26816133|P7|Part C (Phase II: Randomized Phase)|Death|34
7711384|NCT01072175|26816134|P6|Part C (Phase II: Randomized Phase)|Death|44
7711385|NCT01072175|26816135|P5|Part C (Phase II: Randomized Phase)|Death|0
7711386|NCT01072175|26816136|P4|Part C (Phase II: Randomized Phase)|Death|0
7711387|NCT01072175|26816137|P3|Part C (Phase II: Randomized Phase)|Death|0
7711388|NCT01072175|26816138|P2|Part C (Phase II: Randomized Phase)|Death|0
7711389|NCT01072175|26816139|P1|Part C (Phase II: Randomized Phase)|Death|0
7711390|NCT01072175|26816127|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711391|NCT01072175|26816128|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711392|NCT01072175|26816129|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711393|NCT01072175|26816130|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711394|NCT01072175|26816131|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711395|NCT01072175|26816132|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711396|NCT01072175|26816133|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711397|NCT01072175|26816134|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711398|NCT01072175|26816135|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
7711399|NCT01072175|26816136|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
7711400|NCT01072175|26816137|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711401|NCT01072175|26816138|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
7711402|NCT01072175|26816139|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7711403|NCT01072175|26816127|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711404|NCT01072175|26816128|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711405|NCT01072175|26816129|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711406|NCT01072175|26816130|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711407|NCT01072175|26816131|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711408|NCT01072175|26816132|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711409|NCT01072175|26816133|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711410|NCT01072175|26816134|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711411|NCT01072175|26816135|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
7711412|NCT01072175|26816136|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
7711413|NCT01072175|26816137|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
7711414|NCT01072175|26816138|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711415|NCT01072175|26816139|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7711416|NCT01072175|26816127|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711417|NCT01072175|26816128|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711418|NCT01072175|26816129|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711419|NCT01072175|26816130|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711420|NCT01072175|26816131|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711421|NCT01072175|26816132|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711422|NCT01072175|26816133|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711423|NCT01072175|26816134|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711424|NCT01072175|26816135|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
7711425|NCT01072175|26816136|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7711426|NCT01072175|26816137|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711427|NCT01072175|26816138|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7711428|NCT01072175|26816139|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7711429|NCT01072175|26816127|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711430|NCT01072175|26816128|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711431|NCT01072175|26816129|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711432|NCT01072175|26816130|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711433|NCT01072175|26816131|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711434|NCT01072175|26816132|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711435|NCT01072175|26816133|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711436|NCT01072175|26816134|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711437|NCT01072175|26816135|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
7711438|NCT01072175|26816136|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711439|NCT01072175|26816137|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
7711440|NCT01072175|26816138|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711441|NCT01072175|26816139|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
7711442|NCT01072175|26816127|P13|Part B (Dose Escalation and Expansion)|Death|0
7711443|NCT01072175|26816128|P12|Part B (Dose Escalation and Expansion)|Death|0
7711444|NCT01072175|26816129|P11|Part B (Dose Escalation and Expansion)|Death|0
7711445|NCT01072175|26816130|P10|Part B (Dose Escalation and Expansion)|Death|0
7711446|NCT01072175|26816131|P9|Part B (Dose Escalation and Expansion)|Death|0
7711447|NCT01072175|26816132|P8|Part B (Dose Escalation and Expansion)|Death|0
7711448|NCT01072175|26816133|P7|Part B (Dose Escalation and Expansion)|Death|0
7711449|NCT01072175|26816134|P6|Part B (Dose Escalation and Expansion)|Death|0
7711450|NCT01072175|26816135|P5|Part B (Dose Escalation and Expansion)|Death|68
7711451|NCT01072175|26816136|P4|Part B (Dose Escalation and Expansion)|Death|21
7711452|NCT01072175|26816137|P3|Part B (Dose Escalation and Expansion)|Death|18
7711453|NCT01072175|26816138|P2|Part B (Dose Escalation and Expansion)|Death|4
7711454|NCT01072175|26816139|P1|Part B (Dose Escalation and Expansion)|Death|0
7711455|NCT01072175|26816127|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711456|NCT01072175|26816128|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711457|NCT01072175|26816129|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711458|NCT01072175|26816130|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711459|NCT01072175|26816131|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711460|NCT01072175|26816132|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711461|NCT01072175|26816133|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711462|NCT01072175|26816134|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711463|NCT01072175|26816135|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711464|NCT01072175|26816136|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711465|NCT01072175|26816137|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711466|NCT01072175|26816138|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7711467|NCT01072175|26816139|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
7711468|NCT01072175|26816127|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
7711469|NCT01072175|26816128|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
7711470|NCT01072175|26816129|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
7711471|NCT01072175|26816130|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
7711472|NCT01072175|26816131|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
7711473|NCT01072175|26816132|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
7711474|NCT01072175|26816133|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
7711475|NCT01072175|26816134|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
7711476|NCT01072175|26816135|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
7711477|NCT01072175|26816136|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
7711478|NCT01072175|26816137|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
7711479|NCT01072175|26816138|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
7711480|NCT01072175|26816139|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
7711481|NCT01072175|26816127|P13|Part A (Drug-Drug Interaction)|Death|0
7711482|NCT01072175|26816128|P12|Part A (Drug-Drug Interaction)|Death|0
7711483|NCT01072175|26816129|P11|Part A (Drug-Drug Interaction)|Death|0
7711484|NCT01072175|26816130|P10|Part A (Drug-Drug Interaction)|Death|0
7711485|NCT01072175|26816131|P9|Part A (Drug-Drug Interaction)|Death|0
7711486|NCT01072175|26816132|P8|Part A (Drug-Drug Interaction)|Death|0
7711487|NCT01072175|26816133|P7|Part A (Drug-Drug Interaction)|Death|0
7711488|NCT01072175|26816134|P6|Part A (Drug-Drug Interaction)|Death|0
7711489|NCT01072175|26816135|P5|Part A (Drug-Drug Interaction)|Death|0
7711490|NCT01072175|26816136|P4|Part A (Drug-Drug Interaction)|Death|0
7711491|NCT01072175|26816137|P3|Part A (Drug-Drug Interaction)|Death|0
7711492|NCT01072175|26816138|P2|Part A (Drug-Drug Interaction)|Death|0
7711493|NCT01072175|26816139|P1|Part A (Drug-Drug Interaction)|Death|1
7711494|NCT01072149|26816348|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711495|NCT01072149|26816349|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711496|NCT01072149|26816350|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711497|NCT01072149|26816351|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711498|NCT01072149|26816352|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
7711499|NCT01072149|26816353|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711500|NCT01072149|26816354|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711501|NCT01072149|26816355|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711502|NCT01072149|26816356|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711503|NCT01072149|26816357|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711504|NCT01072149|26816358|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711505|NCT01072149|26816359|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711506|NCT01072149|26816360|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711507|NCT01072149|26816361|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711508|NCT01072149|26816362|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711509|NCT01072149|26816363|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
7711510|NCT01072149|26816364|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711511|NCT01072149|26816365|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7711512|NCT01072149|26816348|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711513|NCT01072149|26816349|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711514|NCT01072149|26816350|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711515|NCT01072149|26816351|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711516|NCT01072149|26816352|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711517|NCT01072149|26816353|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
7711518|NCT01072149|26816354|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711519|NCT01072149|26816355|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711520|NCT01072149|26816356|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711521|NCT01072149|26816357|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711522|NCT01072149|26816358|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711523|NCT01072149|26816359|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711524|NCT01072149|26816360|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711525|NCT01072149|26816361|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711526|NCT01072149|26816362|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711527|NCT01072149|26816363|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711528|NCT01072149|26816364|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711529|NCT01072149|26816365|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
7711530|NCT01072149|26816348|P18|Washout Period 2 (14 Days)|Adverse Event|0
7711531|NCT01072149|26816349|P17|Washout Period 2 (14 Days)|Adverse Event|0
7711532|NCT01072149|26816350|P16|Washout Period 2 (14 Days)|Adverse Event|1
7711533|NCT01072149|26816351|P15|Washout Period 2 (14 Days)|Adverse Event|0
7711534|NCT01072149|26816352|P14|Washout Period 2 (14 Days)|Adverse Event|0
7711535|NCT01072149|26816353|P13|Washout Period 2 (14 Days)|Adverse Event|0
7711536|NCT01072149|26816354|P12|Washout Period 2 (14 Days)|Adverse Event|0
7711537|NCT01072149|26816355|P11|Washout Period 2 (14 Days)|Adverse Event|0
7711538|NCT01072149|26816356|P10|Washout Period 2 (14 Days)|Adverse Event|0
7711539|NCT01072149|26816357|P9|Washout Period 2 (14 Days)|Adverse Event|0
7711540|NCT01072149|26816358|P8|Washout Period 2 (14 Days)|Adverse Event|0
7711541|NCT01072149|26816359|P7|Washout Period 2 (14 Days)|Adverse Event|0
7711542|NCT01072149|26816360|P6|Washout Period 2 (14 Days)|Adverse Event|0
7711543|NCT01072149|26816361|P5|Washout Period 2 (14 Days)|Adverse Event|0
7711544|NCT01072149|26816362|P4|Washout Period 2 (14 Days)|Adverse Event|0
7711545|NCT01072149|26816363|P3|Washout Period 2 (14 Days)|Adverse Event|0
7711546|NCT01072149|26816364|P2|Washout Period 2 (14 Days)|Adverse Event|0
7711547|NCT01072149|26816365|P1|Washout Period 2 (14 Days)|Adverse Event|0
7711548|NCT01072149|26816348|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711549|NCT01072149|26816349|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711550|NCT01072149|26816350|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
7711551|NCT01072149|26816351|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711552|NCT01072149|26816352|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711553|NCT01072149|26816353|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711554|NCT01072149|26816354|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711555|NCT01072149|26816355|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711556|NCT01072149|26816356|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711557|NCT01072149|26816357|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711558|NCT01072149|26816358|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711559|NCT01072149|26816359|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711560|NCT01072149|26816360|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711561|NCT01072149|26816361|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711562|NCT01072149|26816362|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711563|NCT01072149|26816363|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711564|NCT01072149|26816364|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711565|NCT01072149|26816365|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7711566|NCT01072149|26816348|P18|Washout Period 2 (14 Days)|Physician Decision|0
7711567|NCT01072149|26816349|P17|Washout Period 2 (14 Days)|Physician Decision|0
7711568|NCT01072149|26816350|P16|Washout Period 2 (14 Days)|Physician Decision|0
7711569|NCT01072149|26816351|P15|Washout Period 2 (14 Days)|Physician Decision|0
7711570|NCT01072149|26816352|P14|Washout Period 2 (14 Days)|Physician Decision|0
7711571|NCT01072149|26816353|P13|Washout Period 2 (14 Days)|Physician Decision|0
7711572|NCT01072149|26816354|P12|Washout Period 2 (14 Days)|Physician Decision|0
7711573|NCT01072149|26816355|P11|Washout Period 2 (14 Days)|Physician Decision|0
7711574|NCT01072149|26816356|P10|Washout Period 2 (14 Days)|Physician Decision|0
7711575|NCT01072149|26816357|P9|Washout Period 2 (14 Days)|Physician Decision|0
7711576|NCT01072149|26816358|P8|Washout Period 2 (14 Days)|Physician Decision|0
7711577|NCT01072149|26816359|P7|Washout Period 2 (14 Days)|Physician Decision|0
7711578|NCT01072149|26816360|P6|Washout Period 2 (14 Days)|Physician Decision|0
7711579|NCT01072149|26816361|P5|Washout Period 2 (14 Days)|Physician Decision|0
7711580|NCT01072149|26816362|P4|Washout Period 2 (14 Days)|Physician Decision|0
7711581|NCT01072149|26816363|P3|Washout Period 2 (14 Days)|Physician Decision|0
7711582|NCT01072149|26816364|P2|Washout Period 2 (14 Days)|Physician Decision|0
7711583|NCT01072149|26816365|P1|Washout Period 2 (14 Days)|Physician Decision|1
7711584|NCT01072149|26816348|P18|Treatment Period 2 (28 Days)|Physician Decision|0
7711585|NCT01072149|26816349|P17|Treatment Period 2 (28 Days)|Physician Decision|0
7711586|NCT01072149|26816350|P16|Treatment Period 2 (28 Days)|Physician Decision|0
7711587|NCT01072149|26816351|P15|Treatment Period 2 (28 Days)|Physician Decision|0
7711588|NCT01072149|26816352|P14|Treatment Period 2 (28 Days)|Physician Decision|0
7711589|NCT01072149|26816353|P13|Treatment Period 2 (28 Days)|Physician Decision|0
7711590|NCT01072149|26816354|P12|Treatment Period 2 (28 Days)|Physician Decision|0
7711591|NCT01072149|26816355|P11|Treatment Period 2 (28 Days)|Physician Decision|0
7711592|NCT01072149|26816356|P10|Treatment Period 2 (28 Days)|Physician Decision|0
7711593|NCT01072149|26816357|P9|Treatment Period 2 (28 Days)|Physician Decision|0
7711594|NCT01072149|26816358|P8|Treatment Period 2 (28 Days)|Physician Decision|1
7711595|NCT01072149|26816359|P7|Treatment Period 2 (28 Days)|Physician Decision|0
7711596|NCT01072149|26816360|P6|Treatment Period 2 (28 Days)|Physician Decision|0
7711597|NCT01072149|26816361|P5|Treatment Period 2 (28 Days)|Physician Decision|0
7711598|NCT01072149|26816362|P4|Treatment Period 2 (28 Days)|Physician Decision|0
7711599|NCT01072149|26816363|P3|Treatment Period 2 (28 Days)|Physician Decision|0
7711600|NCT01072149|26816364|P2|Treatment Period 2 (28 Days)|Physician Decision|0
7711601|NCT01072149|26816365|P1|Treatment Period 2 (28 Days)|Physician Decision|0
7711602|NCT01072149|26816348|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711603|NCT01072149|26816349|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711604|NCT01072149|26816350|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711605|NCT01072149|26816351|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711606|NCT01072149|26816352|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711607|NCT01072149|26816353|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711608|NCT01072149|26816354|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711609|NCT01072149|26816355|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711610|NCT01072149|26816356|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711611|NCT01072149|26816357|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711612|NCT01072149|26816358|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711613|NCT01072149|26816359|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711614|NCT01072149|26816360|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711615|NCT01072149|26816361|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711616|NCT01072149|26816362|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711617|NCT01072149|26816363|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7711618|NCT01072149|26816364|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711619|NCT01072149|26816365|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7711620|NCT01072149|26816348|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711621|NCT01072149|26816349|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711622|NCT01072149|26816350|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711623|NCT01072149|26816351|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711624|NCT01072149|26816352|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711625|NCT01072149|26816353|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711626|NCT01072149|26816354|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711627|NCT01072149|26816355|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711628|NCT01072149|26816356|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711629|NCT01072149|26816357|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711630|NCT01072149|26816358|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711631|NCT01072149|26816359|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711632|NCT01072149|26816360|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711633|NCT01072149|26816361|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711634|NCT01072149|26816362|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711635|NCT01072149|26816363|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711636|NCT01072149|26816364|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
7711637|NCT01072149|26816365|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7711638|NCT01072149|26816348|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711639|NCT01072149|26816349|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711640|NCT01072149|26816350|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711641|NCT01072149|26816351|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711642|NCT01072149|26816352|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711643|NCT01072149|26816353|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711644|NCT01072149|26816354|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711645|NCT01072149|26816355|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
7711646|NCT01072149|26816356|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711647|NCT01072149|26816357|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711648|NCT01072149|26816358|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711649|NCT01072149|26816359|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711650|NCT01072149|26816360|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711651|NCT01072149|26816361|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711652|NCT01072149|26816362|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711653|NCT01072149|26816363|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711654|NCT01072149|26816364|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711655|NCT01072149|26816365|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7711656|NCT01072149|26816348|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
7711657|NCT01072149|26816349|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
7711658|NCT01072149|26816350|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
7711659|NCT01072149|26816351|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
7711660|NCT01072149|26816352|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
7711661|NCT01072149|26816353|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
7711662|NCT01072149|26816354|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
7711663|NCT01072149|26816355|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
7711664|NCT01072149|26816356|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
7711665|NCT01072149|26816357|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
7711666|NCT01072149|26816358|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
7711667|NCT01072149|26816359|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
7711668|NCT01072149|26816360|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
7711669|NCT01072149|26816361|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
7711670|NCT01072149|26816362|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
7711671|NCT01072149|26816363|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
7711672|NCT01072149|26816364|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
7711673|NCT01072149|26816365|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
7711674|NCT01072149|26816348|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711675|NCT01072149|26816349|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711676|NCT01072149|26816350|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711677|NCT01072149|26816351|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711678|NCT01072149|26816352|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711679|NCT01072149|26816353|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711680|NCT01072149|26816354|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711681|NCT01072149|26816355|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711682|NCT01072149|26816356|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711683|NCT01072149|26816357|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711684|NCT01072149|26816358|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711685|NCT01072149|26816359|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711686|NCT01072149|26816360|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711687|NCT01072149|26816361|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711688|NCT01072149|26816362|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711689|NCT01072149|26816363|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7711690|NCT01072149|26816364|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711691|NCT01072149|26816365|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7711692|NCT01071954|26816454|P1|Overall Study|Protocol Specified Criteria|1
7711693|NCT01071954|26816454|P1|Overall Study|Administrative Decision|5
7711694|NCT01071954|26816454|P1|Overall Study|Requirement for Alternative Therapy|5
7711695|NCT01071954|26816454|P1|Overall Study|Withdrawal by Subject|11
7711696|NCT01071954|26816454|P1|Overall Study|Adverse Event|1
7711697|NCT01071954|26816454|P1|Overall Study|Noncompliance|4
7711698|NCT01071915|26816463|P1|Overall Study|Miscellaneous Reasons|2
7711699|NCT01071915|26816463|P1|Overall Study|Withdrawal by Subject|2
7711700|NCT01071915|26816463|P1|Overall Study|Physician Decision|2
7711701|NCT01071915|26816463|P1|Overall Study|Adverse Event|3
7711702|NCT01071798|26816473|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
7711703|NCT01071798|26816473|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
7711704|NCT01071798|26816473|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
7711705|NCT01071798|26816473|P1|Subpopulation Who Received Two Cycles|Remission|1
7711706|NCT01071798|26816473|P1|Participants Who Received One Cycle|Severe concomitant disease|2
7711707|NCT01071798|26816473|P1|Participants Who Received One Cycle|Change of therapy|6
7711708|NCT01071798|26816473|P1|Participants Who Received One Cycle|Death|5
7711709|NCT01071798|26816473|P1|Participants Who Received One Cycle|Patient requirement|20
7711710|NCT01071798|26816473|P1|Participants Who Received One Cycle|Lack of tolerability|14
7711711|NCT01071798|26816473|P1|Participants Who Received One Cycle|Lack of Efficacy|18
7711712|NCT01071512|26816503|P1|Overall Study|positive anti-JC virus antibody test|2
7711713|NCT01071512|26816503|P1|Overall Study|Development of antibodies to drug|2
7711714|NCT01071512|26816503|P1|Overall Study|Adverse Event|1
7711715|NCT01071395|26816513|P2|Overall Study|Adverse Event|1
7711716|NCT01071395|26816514|P1|Overall Study|Adverse Event|3
7711717|NCT01071395|26816513|P2|Overall Study|Withdrawal by Subject|1
7711718|NCT01071395|26816514|P1|Overall Study|Withdrawal by Subject|2
7711719|NCT01071317|26816533|P2|Overall Study|Lost to Follow-up|2
7711720|NCT01071317|26816534|P1|Overall Study|Lost to Follow-up|2
7711721|NCT01071278|26816546|P1|Overall Study|Completion Status Unknown|459
7711722|NCT01071278|26816546|P1|Overall Study|Premature Discontinuation|254
7711723|NCT01071252|26816557|P5|Overall Study|Death|1
7711724|NCT01071252|26816558|P4|Overall Study|Death|0
7711725|NCT01071252|26816559|P3|Overall Study|Death|0
7711726|NCT01071252|26816560|P2|Overall Study|Death|0
7711727|NCT01071252|26816561|P1|Overall Study|Death|0
7711728|NCT01071252|26816557|P5|Overall Study|Adverse Event|0
7711729|NCT01071252|26816558|P4|Overall Study|Adverse Event|1
7711730|NCT01071252|26816559|P3|Overall Study|Adverse Event|0
7711731|NCT01071252|26816560|P2|Overall Study|Adverse Event|1
7711732|NCT01071252|26816561|P1|Overall Study|Adverse Event|1
7711733|NCT01071252|26816557|P5|Overall Study|Lost to Follow-up|0
7711734|NCT01071252|26816558|P4|Overall Study|Lost to Follow-up|2
7711735|NCT01071252|26816559|P3|Overall Study|Lost to Follow-up|1
7711736|NCT01071252|26816560|P2|Overall Study|Lost to Follow-up|0
7711737|NCT01071252|26816561|P1|Overall Study|Lost to Follow-up|1
7711738|NCT01071252|26816557|P5|Overall Study|administrative problems|1
7711739|NCT01071252|26816558|P4|Overall Study|administrative problems|2
7711740|NCT01071252|26816559|P3|Overall Study|administrative problems|0
7711741|NCT01071252|26816560|P2|Overall Study|administrative problems|1
7711742|NCT01071252|26816561|P1|Overall Study|administrative problems|1
7711743|NCT01071252|26816557|P5|Overall Study|Withdrawal by Subject|3
7711744|NCT01071252|26816558|P4|Overall Study|Withdrawal by Subject|2
7711745|NCT01071252|26816559|P3|Overall Study|Withdrawal by Subject|1
7711746|NCT01071252|26816560|P2|Overall Study|Withdrawal by Subject|2
7711747|NCT01071252|26816561|P1|Overall Study|Withdrawal by Subject|8
7711748|NCT01071252|26816557|P5|Overall Study|unsatisfactory therapeutic effect|6
7711749|NCT01071252|26816558|P4|Overall Study|unsatisfactory therapeutic effect|0
7711750|NCT01071252|26816559|P3|Overall Study|unsatisfactory therapeutic effect|2
7711751|NCT01071252|26816560|P2|Overall Study|unsatisfactory therapeutic effect|6
7711752|NCT01071252|26816561|P1|Overall Study|unsatisfactory therapeutic effect|4
7711753|NCT01071200|26816589|P2|Overall Study|No viable embryos|1
7711754|NCT01071200|26816590|P1|Overall Study|No viable embryos|0
7711755|NCT01071200|26816589|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
7711756|NCT01071200|26816590|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
7711757|NCT01071200|26816589|P2|Overall Study|No oocytes retrieved|1
7711758|NCT01071200|26816590|P1|Overall Study|No oocytes retrieved|1
7711759|NCT01071200|26816589|P2|Overall Study|No fertilization|0
7711760|NCT01071200|26816590|P1|Overall Study|No fertilization|4
7711761|NCT01071200|26816589|P2|Overall Study|Lack of ovarian response|1
7711762|NCT01071200|26816590|P1|Overall Study|Lack of ovarian response|1
7711763|NCT01071096|26816622|P2|First Intervention (90 Days)|Lost to Follow-up|0
7711764|NCT01071096|26816623|P1|First Intervention (90 Days)|Lost to Follow-up|1
7711765|NCT01071083|26816647|P5|Overall Study|Subject Refused to Continue|0
7711766|NCT01071083|26816648|P4|Overall Study|Subject Refused to Continue|0
7711767|NCT01071083|26816649|P3|Overall Study|Subject Refused to Continue|0
7711768|NCT01071083|26816650|P2|Overall Study|Subject Refused to Continue|0
7711769|NCT01071083|26816651|P1|Overall Study|Subject Refused to Continue|1
7711770|NCT01071083|26816647|P5|Overall Study|Did Not Want Per Protocol Treatment|1
7711771|NCT01071083|26816648|P4|Overall Study|Did Not Want Per Protocol Treatment|0
7711772|NCT01071083|26816649|P3|Overall Study|Did Not Want Per Protocol Treatment|1
7711773|NCT01071083|26816650|P2|Overall Study|Did Not Want Per Protocol Treatment|0
7711774|NCT01071083|26816651|P1|Overall Study|Did Not Want Per Protocol Treatment|0
7711775|NCT01071083|26816647|P5|Overall Study|Did Not Meet Eligibility Criteria|1
7711776|NCT01071083|26816648|P4|Overall Study|Did Not Meet Eligibility Criteria|1
7711777|NCT01071083|26816649|P3|Overall Study|Did Not Meet Eligibility Criteria|1
7711778|NCT01071083|26816650|P2|Overall Study|Did Not Meet Eligibility Criteria|0
7711779|NCT01071083|26816651|P1|Overall Study|Did Not Meet Eligibility Criteria|0
7711780|NCT01071083|26816647|P5|Overall Study|Images Not Usable (Motion)|0
7711781|NCT01071083|26816648|P4|Overall Study|Images Not Usable (Motion)|0
7711782|NCT01071083|26816649|P3|Overall Study|Images Not Usable (Motion)|0
7711783|NCT01071083|26816650|P2|Overall Study|Images Not Usable (Motion)|1
7711784|NCT01071083|26816651|P1|Overall Study|Images Not Usable (Motion)|0
7711785|NCT01071083|26816647|P5|Overall Study|Subject Moved|0
7711786|NCT01071083|26816648|P4|Overall Study|Subject Moved|0
7711787|NCT01071083|26816649|P3|Overall Study|Subject Moved|0
7711788|NCT01071083|26816650|P2|Overall Study|Subject Moved|1
7711789|NCT01071083|26816651|P1|Overall Study|Subject Moved|0
7711790|NCT01071083|26816647|P5|Overall Study|Early Rescue|1
7711791|NCT01071083|26816648|P4|Overall Study|Early Rescue|0
7711792|NCT01071083|26816649|P3|Overall Study|Early Rescue|0
7711793|NCT01071083|26816650|P2|Overall Study|Early Rescue|0
7711794|NCT01071083|26816651|P1|Overall Study|Early Rescue|1
7711795|NCT01071083|26816647|P5|Overall Study|Physician Decision|1
7711796|NCT01071083|26816648|P4|Overall Study|Physician Decision|1
7711797|NCT01071083|26816649|P3|Overall Study|Physician Decision|0
7711798|NCT01071083|26816650|P2|Overall Study|Physician Decision|0
7711799|NCT01071083|26816651|P1|Overall Study|Physician Decision|1
7711800|NCT01071083|26816647|P5|Overall Study|Withdrawal by Subject|3
7711801|NCT01071083|26816648|P4|Overall Study|Withdrawal by Subject|0
7711802|NCT01071083|26816649|P3|Overall Study|Withdrawal by Subject|2
7711803|NCT01071083|26816650|P2|Overall Study|Withdrawal by Subject|0
7711804|NCT01071083|26816651|P1|Overall Study|Withdrawal by Subject|3
7711805|NCT01071083|26816647|P5|Overall Study|Adverse Event|1
7711806|NCT01071083|26816648|P4|Overall Study|Adverse Event|0
7711807|NCT01071083|26816649|P3|Overall Study|Adverse Event|1
7711808|NCT01071083|26816650|P2|Overall Study|Adverse Event|0
7711809|NCT01071083|26816651|P1|Overall Study|Adverse Event|1
7711810|NCT01071070|26816670|P2|Overall Study|Hypercalcemia|0
7711811|NCT01071070|26816671|P1|Overall Study|Hypercalcemia|1
7711812|NCT01071070|26816670|P2|Overall Study|Missed 3 consecutive doses of study drug|0
7711813|NCT01071070|26816671|P1|Overall Study|Missed 3 consecutive doses of study drug|2
7711814|NCT01071070|26816670|P2|Overall Study|Withdrawal by Subject|0
7711815|NCT01071070|26816671|P1|Overall Study|Withdrawal by Subject|1
7711816|NCT01071070|26816670|P2|Overall Study|Adverse Event|3
7711817|NCT01071070|26816671|P1|Overall Study|Adverse Event|0
7711818|NCT01070979|26816717|P3|Overall Study|No study drug taken|0
7711819|NCT01070979|26816718|P2|Overall Study|No study drug taken|1
7711820|NCT01070979|26816719|P1|Overall Study|No study drug taken|0
7711821|NCT01070979|26816717|P3|Overall Study|Withdrawal by Subject|1
7711822|NCT01070979|26816718|P2|Overall Study|Withdrawal by Subject|1
7711823|NCT01070979|26816719|P1|Overall Study|Withdrawal by Subject|3
7711824|NCT01070979|26816717|P3|Overall Study|Surgery, moving, personal, abn. labs|2
7711825|NCT01070979|26816718|P2|Overall Study|Surgery, moving, personal, abn. labs|4
7711826|NCT01070979|26816719|P1|Overall Study|Surgery, moving, personal, abn. labs|4
7711827|NCT01070979|26816717|P3|Overall Study|Protocol Violation|6
7711828|NCT01070979|26816718|P2|Overall Study|Protocol Violation|2
7711829|NCT01070979|26816719|P1|Overall Study|Protocol Violation|0
7711830|NCT01070979|26816717|P3|Overall Study|Lost to Follow-up|1
7711831|NCT01070979|26816718|P2|Overall Study|Lost to Follow-up|1
7711832|NCT01070979|26816719|P1|Overall Study|Lost to Follow-up|2
7711833|NCT01070979|26816717|P3|Overall Study|Adverse Event|3
7711834|NCT01070979|26816718|P2|Overall Study|Adverse Event|3
7711835|NCT01070979|26816719|P1|Overall Study|Adverse Event|2
7711836|NCT01070966|26816745|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
7711837|NCT01070966|26816745|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
7711838|NCT01070966|26816745|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
7711839|NCT01070966|26816745|P1|Participants for Safety Evaluation|TMT given before date of contract|3
7711840|NCT01070966|26816745|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
7711841|NCT01070966|26816745|P1|Participants for Safety Evaluation|Duplicate Participants|4
7711842|NCT01070966|26816745|P1|Participants for Safety Evaluation|Off-label use|9
7711843|NCT01070966|26816745|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
7711844|NCT01070953|26816756|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
7711845|NCT01070953|26816756|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
7711846|NCT01070953|26816756|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
7711847|NCT01070953|26816756|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
7711848|NCT01070953|26816756|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
7711849|NCT01070953|26816756|P1|Participants for Safety Evaluation|Uncontracted participants|4
7711850|NCT01070953|26816756|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
7711851|NCT01070953|26816756|P1|Participants for Safety Evaluation|Duplicated participants|22
7711852|NCT01070953|26816756|P1|Participants for Safety Evaluation|Off-label use|283
7711853|NCT01070953|26816756|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
7711854|NCT01070888|26816769|P2|Washout (14 Days)|Physician Decision|0
7711855|NCT01070888|26816770|P1|Washout (14 Days)|Physician Decision|1
7711856|NCT01070888|26816769|P2|First Intervention (14 Days)|Lost to Follow-up|1
7711857|NCT01070888|26816770|P1|First Intervention (14 Days)|Lost to Follow-up|0
7711858|NCT01070888|26816769|P2|First Intervention (14 Days)|Adverse Event|1
7711859|NCT01070888|26816770|P1|First Intervention (14 Days)|Adverse Event|0
7711860|NCT01070784|26816795|P2|Overall Study|Adverse Event|9
7711861|NCT01070784|26816796|P1|Overall Study|Adverse Event|14
7711862|NCT01070784|26816795|P2|Overall Study|Withdrawal by Subject|9
7711863|NCT01070784|26816796|P1|Overall Study|Withdrawal by Subject|6
7711864|NCT01070771|26816884|P1|Overall Study|Protocol Violation|1
7711865|NCT01070771|26816884|P1|Overall Study|Adverse Event|2
7711866|NCT01070550|26816904|P6|Overall Study|Withdrawal by Subject|0
7711867|NCT01070550|26816905|P5|Overall Study|Withdrawal by Subject|0
7711868|NCT01070550|26816906|P4|Overall Study|Withdrawal by Subject|0
7711869|NCT01070550|26816907|P3|Overall Study|Withdrawal by Subject|3
7711870|NCT01070550|26816908|P2|Overall Study|Withdrawal by Subject|0
7711871|NCT01070550|26816909|P1|Overall Study|Withdrawal by Subject|35
7711872|NCT01070550|26816904|P6|Overall Study|Other|0
7711873|NCT01070550|26816905|P5|Overall Study|Other|0
7711874|NCT01070550|26816906|P4|Overall Study|Other|1
7711875|NCT01070550|26816907|P3|Overall Study|Other|0
7711876|NCT01070550|26816908|P2|Overall Study|Other|0
7711877|NCT01070550|26816909|P1|Overall Study|Other|5
7711878|NCT01070550|26816904|P6|Overall Study|Treatment was stopped early|0
7711879|NCT01070550|26816905|P5|Overall Study|Treatment was stopped early|0
7711880|NCT01070550|26816906|P4|Overall Study|Treatment was stopped early|0
7711881|NCT01070550|26816907|P3|Overall Study|Treatment was stopped early|0
7711882|NCT01070550|26816908|P2|Overall Study|Treatment was stopped early|0
7711883|NCT01070550|26816909|P1|Overall Study|Treatment was stopped early|7
7711884|NCT01070550|26816904|P6|Overall Study|Treatment unavailable|0
7711885|NCT01070550|26816905|P5|Overall Study|Treatment unavailable|0
7711886|NCT01070550|26816906|P4|Overall Study|Treatment unavailable|0
7711887|NCT01070550|26816907|P3|Overall Study|Treatment unavailable|0
7711888|NCT01070550|26816908|P2|Overall Study|Treatment unavailable|0
7711889|NCT01070550|26816909|P1|Overall Study|Treatment unavailable|1
7711890|NCT01070550|26816904|P6|Overall Study|Treatment stopped|0
7711891|NCT01070550|26816905|P5|Overall Study|Treatment stopped|0
7711892|NCT01070550|26816906|P4|Overall Study|Treatment stopped|0
7711893|NCT01070550|26816907|P3|Overall Study|Treatment stopped|0
7711894|NCT01070550|26816908|P2|Overall Study|Treatment stopped|0
7711895|NCT01070550|26816909|P1|Overall Study|Treatment stopped|3
7711896|NCT01070550|26816904|P6|Overall Study|Treatment restarted|0
7711897|NCT01070550|26816905|P5|Overall Study|Treatment restarted|0
7711898|NCT01070550|26816906|P4|Overall Study|Treatment restarted|0
7711899|NCT01070550|26816907|P3|Overall Study|Treatment restarted|0
7711900|NCT01070550|26816908|P2|Overall Study|Treatment restarted|1
7711901|NCT01070550|26816909|P1|Overall Study|Treatment restarted|0
7711902|NCT01070550|26816904|P6|Overall Study|Treatment not started|0
7711903|NCT01070550|26816905|P5|Overall Study|Treatment not started|0
7711904|NCT01070550|26816906|P4|Overall Study|Treatment not started|0
7711905|NCT01070550|26816907|P3|Overall Study|Treatment not started|4
7711906|NCT01070550|26816908|P2|Overall Study|Treatment not started|2
7711907|NCT01070550|26816909|P1|Overall Study|Treatment not started|14
7711908|NCT01070550|26816904|P6|Overall Study|Treatment interrupted|0
7711909|NCT01070550|26816905|P5|Overall Study|Treatment interrupted|0
7711910|NCT01070550|26816906|P4|Overall Study|Treatment interrupted|1
7711911|NCT01070550|26816907|P3|Overall Study|Treatment interrupted|1
7711912|NCT01070550|26816908|P2|Overall Study|Treatment interrupted|0
7711913|NCT01070550|26816909|P1|Overall Study|Treatment interrupted|7
7711914|NCT01070550|26816904|P6|Overall Study|Treatment duration shortened|0
7711915|NCT01070550|26816905|P5|Overall Study|Treatment duration shortened|0
7711916|NCT01070550|26816906|P4|Overall Study|Treatment duration shortened|0
7711917|NCT01070550|26816907|P3|Overall Study|Treatment duration shortened|0
7711918|NCT01070550|26816908|P2|Overall Study|Treatment duration shortened|0
7711919|NCT01070550|26816909|P1|Overall Study|Treatment duration shortened|1
7711920|NCT01070550|26816904|P6|Overall Study|Sponsor decision|0
7711921|NCT01070550|26816905|P5|Overall Study|Sponsor decision|0
7711922|NCT01070550|26816906|P4|Overall Study|Sponsor decision|0
7711923|NCT01070550|26816907|P3|Overall Study|Sponsor decision|0
7711924|NCT01070550|26816908|P2|Overall Study|Sponsor decision|0
7711925|NCT01070550|26816909|P1|Overall Study|Sponsor decision|1
7711926|NCT01070550|26816904|P6|Overall Study|Screen failure|0
7711927|NCT01070550|26816905|P5|Overall Study|Screen failure|0
7711928|NCT01070550|26816906|P4|Overall Study|Screen failure|0
7711929|NCT01070550|26816907|P3|Overall Study|Screen failure|0
7711930|NCT01070550|26816908|P2|Overall Study|Screen failure|0
7711931|NCT01070550|26816909|P1|Overall Study|Screen failure|1
7711932|NCT01070550|26816904|P6|Overall Study|Result not available|0
7711933|NCT01070550|26816905|P5|Overall Study|Result not available|0
7711934|NCT01070550|26816906|P4|Overall Study|Result not available|0
7711935|NCT01070550|26816907|P3|Overall Study|Result not available|3
7711936|NCT01070550|26816908|P2|Overall Study|Result not available|1
7711937|NCT01070550|26816909|P1|Overall Study|Result not available|3
7711938|NCT01070550|26816904|P6|Overall Study|Relapse|0
7711939|NCT01070550|26816905|P5|Overall Study|Relapse|0
7711940|NCT01070550|26816906|P4|Overall Study|Relapse|4
7711941|NCT01070550|26816907|P3|Overall Study|Relapse|14
7711942|NCT01070550|26816908|P2|Overall Study|Relapse|5
7711943|NCT01070550|26816909|P1|Overall Study|Relapse|44
7711944|NCT01070550|26816904|P6|Overall Study|Protocol Violation|0
7711945|NCT01070550|26816905|P5|Overall Study|Protocol Violation|0
7711946|NCT01070550|26816906|P4|Overall Study|Protocol Violation|1
7711947|NCT01070550|26816907|P3|Overall Study|Protocol Violation|1
7711948|NCT01070550|26816908|P2|Overall Study|Protocol Violation|1
7711949|NCT01070550|26816909|P1|Overall Study|Protocol Violation|15
7711950|NCT01070550|26816904|P6|Overall Study|Not categorized|1
7711951|NCT01070550|26816905|P5|Overall Study|Not categorized|0
7711952|NCT01070550|26816906|P4|Overall Study|Not categorized|1
7711953|NCT01070550|26816907|P3|Overall Study|Not categorized|6
7711954|NCT01070550|26816908|P2|Overall Study|Not categorized|2
7711955|NCT01070550|26816909|P1|Overall Study|Not categorized|33
7711956|NCT01070550|26816904|P6|Overall Study|Non-responders|2
7711957|NCT01070550|26816905|P5|Overall Study|Non-responders|0
7711958|NCT01070550|26816906|P4|Overall Study|Non-responders|20
7711959|NCT01070550|26816907|P3|Overall Study|Non-responders|21
7711960|NCT01070550|26816908|P2|Overall Study|Non-responders|4
7711961|NCT01070550|26816909|P1|Overall Study|Non-responders|493
7711962|NCT01070550|26816904|P6|Overall Study|New treatment started|0
7711963|NCT01070550|26816905|P5|Overall Study|New treatment started|0
7711964|NCT01070550|26816906|P4|Overall Study|New treatment started|2
7711965|NCT01070550|26816907|P3|Overall Study|New treatment started|0
7711966|NCT01070550|26816908|P2|Overall Study|New treatment started|1
7711967|NCT01070550|26816909|P1|Overall Study|New treatment started|3
7711968|NCT01070550|26816904|P6|Overall Study|Miscellaneous|0
7711969|NCT01070550|26816905|P5|Overall Study|Miscellaneous|0
7711970|NCT01070550|26816906|P4|Overall Study|Miscellaneous|1
7711971|NCT01070550|26816907|P3|Overall Study|Miscellaneous|3
7711972|NCT01070550|26816908|P2|Overall Study|Miscellaneous|2
7711973|NCT01070550|26816909|P1|Overall Study|Miscellaneous|12
7711974|NCT01070550|26816904|P6|Overall Study|Lack of Efficacy|1
7711975|NCT01070550|26816905|P5|Overall Study|Lack of Efficacy|0
7711976|NCT01070550|26816906|P4|Overall Study|Lack of Efficacy|5
7711977|NCT01070550|26816907|P3|Overall Study|Lack of Efficacy|5
7711978|NCT01070550|26816908|P2|Overall Study|Lack of Efficacy|1
7711979|NCT01070550|26816909|P1|Overall Study|Lack of Efficacy|65
7711980|NCT01070550|26816904|P6|Overall Study|Lab test not done|1
7711981|NCT01070550|26816905|P5|Overall Study|Lab test not done|0
7711982|NCT01070550|26816906|P4|Overall Study|Lab test not done|1
7711983|NCT01070550|26816907|P3|Overall Study|Lab test not done|4
7711984|NCT01070550|26816908|P2|Overall Study|Lab test not done|3
7711985|NCT01070550|26816909|P1|Overall Study|Lab test not done|22
7711986|NCT01070550|26816904|P6|Overall Study|Incomplete treatment|0
7711987|NCT01070550|26816905|P5|Overall Study|Incomplete treatment|0
7711988|NCT01070550|26816906|P4|Overall Study|Incomplete treatment|0
7711989|NCT01070550|26816907|P3|Overall Study|Incomplete treatment|0
7711990|NCT01070550|26816908|P2|Overall Study|Incomplete treatment|0
7711991|NCT01070550|26816909|P1|Overall Study|Incomplete treatment|2
7711992|NCT01070550|26816904|P6|Overall Study|Failed to return|2
7711993|NCT01070550|26816905|P5|Overall Study|Failed to return|1
7711994|NCT01070550|26816906|P4|Overall Study|Failed to return|40
7711995|NCT01070550|26816907|P3|Overall Study|Failed to return|144
7711996|NCT01070550|26816908|P2|Overall Study|Failed to return|33
7711997|NCT01070550|26816909|P1|Overall Study|Failed to return|450
7711998|NCT01070550|26816904|P6|Overall Study|Early termination|0
7711999|NCT01070550|26816905|P5|Overall Study|Early termination|0
7712000|NCT01070550|26816906|P4|Overall Study|Early termination|0
7712001|NCT01070550|26816907|P3|Overall Study|Early termination|0
7712002|NCT01070550|26816908|P2|Overall Study|Early termination|0
7712003|NCT01070550|26816909|P1|Overall Study|Early termination|3
7712004|NCT01070550|26816904|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
7712005|NCT01070550|26816905|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
7712006|NCT01070550|26816906|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
7712007|NCT01070550|26816907|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
7712008|NCT01070550|26816908|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
7712009|NCT01070550|26816909|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
7712010|NCT01070550|26816904|P6|Overall Study|Death|0
7712011|NCT01070550|26816905|P5|Overall Study|Death|0
7712012|NCT01070550|26816906|P4|Overall Study|Death|0
7712013|NCT01070550|26816907|P3|Overall Study|Death|3
7712014|NCT01070550|26816908|P2|Overall Study|Death|4
7712015|NCT01070550|26816909|P1|Overall Study|Death|20
7712016|NCT01070550|26816904|P6|Overall Study|Adverse Event|0
7712017|NCT01070550|26816905|P5|Overall Study|Adverse Event|0
7712018|NCT01070550|26816906|P4|Overall Study|Adverse Event|0
7712019|NCT01070550|26816907|P3|Overall Study|Adverse Event|3
7712020|NCT01070550|26816908|P2|Overall Study|Adverse Event|1
7712021|NCT01070550|26816909|P1|Overall Study|Adverse Event|43
7712022|NCT01070394|26817049|P1|Overall Study|Withdrawal by Subject|1
7712023|NCT01070394|26817049|P1|Overall Study|Adverse Event|6
7712024|NCT01070381|26817060|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
7712025|NCT01070381|26817061|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
7712026|NCT01070381|26817060|P2|Period 2, 1 Week of Wear|Handling|1
7712027|NCT01070381|26817061|P1|Period 2, 1 Week of Wear|Handling|0
7712028|NCT01070329|26817069|P2|Overall Study|Sponsor Decision|1
7712029|NCT01070329|26817070|P1|Overall Study|Sponsor Decision|0
7712030|NCT01070329|26817069|P2|Overall Study|Entry Criteria Not Met|0
7712031|NCT01070329|26817070|P1|Overall Study|Entry Criteria Not Met|1
7712032|NCT01070329|26817069|P2|Overall Study|Physician Decision|1
7712033|NCT01070329|26817070|P1|Overall Study|Physician Decision|2
7712034|NCT01070329|26817069|P2|Overall Study|Lack of Efficacy|6
7712035|NCT01070329|26817070|P1|Overall Study|Lack of Efficacy|2
7712036|NCT01070329|26817069|P2|Overall Study|Protocol Violation|8
7712037|NCT01070329|26817070|P1|Overall Study|Protocol Violation|3
7712038|NCT01070329|26817069|P2|Overall Study|Withdrawal by Subject|11
7712039|NCT01070329|26817070|P1|Overall Study|Withdrawal by Subject|9
7712040|NCT01070329|26817069|P2|Overall Study|Lost to Follow-up|12
7712041|NCT01070329|26817070|P1|Overall Study|Lost to Follow-up|22
7712042|NCT01070329|26817069|P2|Overall Study|Adverse Event|10
7712043|NCT01070329|26817070|P1|Overall Study|Adverse Event|13
7712044|NCT01070316|26817102|P1|Extension Phase|Withdrawal by Subject|1
7712045|NCT01070316|26817102|P1|Extension Phase|Lack of Efficacy|3
7712046|NCT01070303|26817109|P1|Overall Study|Other|18
7712047|NCT01070303|26817109|P1|Overall Study|Administrative Reason|1
7712048|NCT01070303|26817109|P1|Overall Study|Lack of Efficacy|2
7712049|NCT01070303|26817109|P1|Overall Study|Protocol Violation|0
7712050|NCT01070303|26817109|P1|Overall Study|Lost to Follow-up|9
7712051|NCT01070303|26817109|P1|Overall Study|Withdrawal by Subject|20
7712052|NCT01070303|26817109|P1|Overall Study|Adverse Event|39
7712053|NCT01070043|26817204|P3|Double-Blind Treatment|Adverse Event|2
7712054|NCT01070043|26817205|P2|Double-Blind Treatment|Adverse Event|0
7712055|NCT01070043|26817206|P1|Double-Blind Treatment|Adverse Event|0
7712056|NCT01070043|26817204|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
7712057|NCT01070043|26817205|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
7712058|NCT01070043|26817206|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
7712059|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Removal|0
7712060|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Removal|1
7712061|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Physician Decision|2
7712062|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Physician Decision|0
7712063|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
7712064|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
7712065|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
7712066|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
7712067|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
7712068|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
7712069|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
7712070|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
7712071|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Protocol Violation|1
7712072|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Protocol Violation|0
7712073|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
7712074|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
7712075|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
7712076|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
7712077|NCT01069939|26817222|P2|Randomised and Included in the Analyses|Adverse Event|22
7712078|NCT01069939|26817223|P1|Randomised and Included in the Analyses|Adverse Event|17
7712079|NCT01069900|26817249|P2|Overall Study|Insufficient Therapeutic effect|0
7712080|NCT01069900|26817250|P1|Overall Study|Insufficient Therapeutic effect|1
7712081|NCT01069900|26817249|P2|Overall Study|Protocol Violation|1
7712082|NCT01069900|26817250|P1|Overall Study|Protocol Violation|4
7712083|NCT01069900|26817249|P2|Overall Study|Withdrawal by Subject|1
7712084|NCT01069900|26817250|P1|Overall Study|Withdrawal by Subject|6
7712085|NCT01069900|26817249|P2|Overall Study|Lost to Follow-up|1
7712086|NCT01069900|26817250|P1|Overall Study|Lost to Follow-up|7
7712087|NCT01069900|26817249|P2|Overall Study|Technical problems|1
7712088|NCT01069900|26817250|P1|Overall Study|Technical problems|0
7712089|NCT01069861|26817294|P1|Overall Study|Did not meet entrance criteria|1
7712090|NCT01069861|26817294|P1|Overall Study|Adverse Event|1
7712091|NCT01069861|26817294|P1|Overall Study|Death|1
7712092|NCT01069705|26817307|P1|Overall Study|Withdrawal by Subject|2
7712093|NCT01069705|26817307|P1|Overall Study|Adverse Event|1
7712094|NCT01069627|26817322|P1|Overall Study|Protocol Violation|1
7712095|NCT01069627|26817322|P1|Overall Study|Adverse Event|12
7712096|NCT01069627|26817322|P1|Overall Study|Disease progression|7
7712097|NCT01069523|26817372|P2|Overall Study|Withdrawal by Subject|7
7712098|NCT01069523|26817373|P1|Overall Study|Withdrawal by Subject|4
7712099|NCT01069484|26817396|P2|Overall Study|Illness mother or child|1
7712100|NCT01069484|26817397|P1|Overall Study|Illness mother or child|3
7712101|NCT01069484|26817396|P2|Overall Study|No specific reason|2
7712102|NCT01069484|26817397|P1|Overall Study|No specific reason|8
7712103|NCT01069484|26817396|P2|Overall Study|Death-in-near-family|0
7712104|NCT01069484|26817397|P1|Overall Study|Death-in-near-family|1
7712105|NCT01069419|26817405|P1|Overall Study|Missing termination information|13
7712106|NCT01069419|26817405|P1|Overall Study|Other Reason|43
7712107|NCT01069419|26817405|P1|Overall Study|Withdrawal by Subject|34
7712108|NCT01069419|26817405|P1|Overall Study|Remission of disease|11
7712109|NCT01069419|26817405|P1|Overall Study|Lost to Follow-up|49
7712110|NCT01069419|26817405|P1|Overall Study|Lack of Efficacy|332
7712111|NCT01069419|26817405|P1|Overall Study|Adverse Event|233
7712112|NCT01069341|26817434|P1|Overall Study|Lost to Follow-up|1
7712113|NCT01069289|26817476|P2|Overall Study|Due to deteriorating health condition|0
7712114|NCT01069289|26817477|P1|Overall Study|Due to deteriorating health condition|1
7712115|NCT01069289|26817476|P2|Overall Study|Severe non-compliance to protocol|2
7712116|NCT01069289|26817477|P1|Overall Study|Severe non-compliance to protocol|3
7712117|NCT01069289|26817476|P2|Overall Study|Eligibility criteria not fulfilled|0
7712118|NCT01069289|26817477|P1|Overall Study|Eligibility criteria not fulfilled|2
7712119|NCT01069289|26817476|P2|Overall Study|Adverse Event|28
7712120|NCT01069289|26817477|P1|Overall Study|Adverse Event|21
7712121|NCT01069289|26817476|P2|Overall Study|Withdrawal by Subject|26
7712122|NCT01069289|26817477|P1|Overall Study|Withdrawal by Subject|15
7712123|NCT01069172|26817526|P2|Overall Study|Withdrawal by Subject|0
7712124|NCT01069172|26817527|P1|Overall Study|Withdrawal by Subject|1
7712125|NCT01069120|26817537|P1|Overall Study|Study prematurely terminated|27
7712126|NCT01068912|26817574|P3|Overall Study|other underlying illness|3
7712127|NCT01068912|26817575|P2|Overall Study|other underlying illness|3
7712128|NCT01068912|26817576|P1|Overall Study|other underlying illness|0
7712129|NCT01068912|26817574|P3|Overall Study|aggravation influenza|1
7712130|NCT01068912|26817575|P2|Overall Study|aggravation influenza|1
7712131|NCT01068912|26817576|P1|Overall Study|aggravation influenza|1
7712132|NCT01068912|26817574|P3|Overall Study|Protocol Violation|0
7712133|NCT01068912|26817575|P2|Overall Study|Protocol Violation|2
7712134|NCT01068912|26817576|P1|Overall Study|Protocol Violation|0
7712135|NCT01068912|26817574|P3|Overall Study|Lost to Follow-up|3
7712136|NCT01068912|26817575|P2|Overall Study|Lost to Follow-up|7
7712137|NCT01068912|26817576|P1|Overall Study|Lost to Follow-up|3
7712138|NCT01068912|26817574|P3|Overall Study|Withdrawal by Subject|6
7712139|NCT01068912|26817575|P2|Overall Study|Withdrawal by Subject|6
7712140|NCT01068912|26817576|P1|Overall Study|Withdrawal by Subject|5
7712141|NCT01068912|26817574|P3|Overall Study|Adverse Event|2
7712142|NCT01068912|26817575|P2|Overall Study|Adverse Event|3
7712143|NCT01068912|26817576|P1|Overall Study|Adverse Event|2
7712144|NCT01068860|26817604|P10|Overall Study|Lost to Follow-up|0
7712145|NCT01068860|26817605|P9|Overall Study|Lost to Follow-up|0
7712146|NCT01068860|26817606|P8|Overall Study|Lost to Follow-up|0
7712147|NCT01068860|26817607|P7|Overall Study|Lost to Follow-up|0
7712148|NCT01068860|26817608|P6|Overall Study|Lost to Follow-up|0
7712149|NCT01068860|26817609|P5|Overall Study|Lost to Follow-up|0
7712150|NCT01068860|26817610|P4|Overall Study|Lost to Follow-up|0
7712151|NCT01068860|26817611|P3|Overall Study|Lost to Follow-up|0
7712152|NCT01068860|26817612|P2|Overall Study|Lost to Follow-up|1
7712153|NCT01068860|26817613|P1|Overall Study|Lost to Follow-up|0
7712154|NCT01068860|26817604|P10|Overall Study|Administrative problems; misrandomized|1
7712155|NCT01068860|26817605|P9|Overall Study|Administrative problems; misrandomized|0
7712156|NCT01068860|26817606|P8|Overall Study|Administrative problems; misrandomized|0
7712157|NCT01068860|26817607|P7|Overall Study|Administrative problems; misrandomized|0
7712158|NCT01068860|26817608|P6|Overall Study|Administrative problems; misrandomized|0
7712159|NCT01068860|26817609|P5|Overall Study|Administrative problems; misrandomized|0
7712160|NCT01068860|26817610|P4|Overall Study|Administrative problems; misrandomized|1
7712161|NCT01068860|26817611|P3|Overall Study|Administrative problems; misrandomized|0
7712162|NCT01068860|26817612|P2|Overall Study|Administrative problems; misrandomized|0
7712163|NCT01068860|26817613|P1|Overall Study|Administrative problems; misrandomized|0
7712164|NCT01068860|26817604|P10|Overall Study|Withdrawal by Subject|3
7712165|NCT01068860|26817605|P9|Overall Study|Withdrawal by Subject|0
7712166|NCT01068860|26817606|P8|Overall Study|Withdrawal by Subject|0
7712167|NCT01068860|26817607|P7|Overall Study|Withdrawal by Subject|0
7712168|NCT01068860|26817608|P6|Overall Study|Withdrawal by Subject|2
7712169|NCT01068860|26817609|P5|Overall Study|Withdrawal by Subject|0
7712170|NCT01068860|26817610|P4|Overall Study|Withdrawal by Subject|0
7712171|NCT01068860|26817611|P3|Overall Study|Withdrawal by Subject|0
7712172|NCT01068860|26817612|P2|Overall Study|Withdrawal by Subject|0
7712173|NCT01068860|26817613|P1|Overall Study|Withdrawal by Subject|0
7712174|NCT01068769|26817796|P1|Overall Study|Ineligible|1
7712175|NCT01068743|26817801|P4|Period 3|Adverse Event|0
7712176|NCT01068743|26817802|P3|Period 3|Adverse Event|0
7712177|NCT01068743|26817803|P2|Period 3|Adverse Event|1
7712178|NCT01068743|26817804|P1|Period 3|Adverse Event|0
7712179|NCT01068730|26817878|P4|Period 4|Family emergency|0
7712180|NCT01068730|26817879|P3|Period 4|Family emergency|0
7712181|NCT01068730|26817880|P2|Period 4|Family emergency|1
7712182|NCT01068730|26817881|P1|Period 4|Family emergency|0
7712183|NCT01068730|26817878|P4|Period 3|Personal reason|0
7712184|NCT01068730|26817879|P3|Period 3|Personal reason|0
7712185|NCT01068730|26817880|P2|Period 3|Personal reason|0
7712186|NCT01068730|26817881|P1|Period 3|Personal reason|1
7712187|NCT01068717|26817935|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7712188|NCT01068717|26817936|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7712189|NCT01068717|26817937|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7712190|NCT01068717|26817938|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
7712191|NCT01068678|26817994|P2|Overall Study|Unclassified|15
7712192|NCT01068678|26817995|P1|Overall Study|Unclassified|18
7712193|NCT01068678|26817994|P2|Overall Study|Withdrawal criteria|6
7712194|NCT01068678|26817995|P1|Overall Study|Withdrawal criteria|12
7712195|NCT01068678|26817994|P2|Overall Study|Protocol Violation|1
7712196|NCT01068678|26817995|P1|Overall Study|Protocol Violation|5
7712197|NCT01068678|26817994|P2|Overall Study|Lack of Efficacy|2
7712198|NCT01068678|26817995|P1|Overall Study|Lack of Efficacy|3
7712199|NCT01068665|26818005|P2|Overall Study|Other|12
7712200|NCT01068665|26818006|P1|Overall Study|Other|17
7712201|NCT01068665|26818005|P2|Overall Study|Withdrawal Criteria|9
7712202|NCT01068665|26818006|P1|Overall Study|Withdrawal Criteria|3
7712203|NCT01068665|26818005|P2|Overall Study|Protocol Violation|2
7712204|NCT01068665|26818006|P1|Overall Study|Protocol Violation|5
7712205|NCT01068665|26818005|P2|Overall Study|Lack of Efficacy|2
7712206|NCT01068665|26818006|P1|Overall Study|Lack of Efficacy|0
7712207|NCT01068665|26818005|P2|Overall Study|Adverse Event|4
7712208|NCT01068665|26818006|P1|Overall Study|Adverse Event|5
7712209|NCT01068652|26818016|P2|Overall Study|Unclassified|4
7712210|NCT01068652|26818017|P1|Overall Study|Unclassified|7
7712211|NCT01068652|26818016|P2|Overall Study|Patient was not eligible|0
7712212|NCT01068652|26818017|P1|Overall Study|Patient was not eligible|1
7712213|NCT01068652|26818016|P2|Overall Study|Withdrawal criteria|2
7712214|NCT01068652|26818017|P1|Overall Study|Withdrawal criteria|1
7712215|NCT01068652|26818016|P2|Overall Study|Protocol Violation|6
7712216|NCT01068652|26818017|P1|Overall Study|Protocol Violation|3
7712217|NCT01068652|26818016|P2|Overall Study|Lost to Follow-up|1
7712218|NCT01068652|26818017|P1|Overall Study|Lost to Follow-up|2
7712219|NCT01068652|26818016|P2|Overall Study|Lack of Efficacy|2
7712220|NCT01068652|26818017|P1|Overall Study|Lack of Efficacy|0
7712221|NCT01068652|26818016|P2|Overall Study|Adverse Event|0
7712222|NCT01068652|26818017|P1|Overall Study|Adverse Event|4
7712223|NCT01068626|26818057|P2|Overall Study|Withdrawal by Subject|2
7712224|NCT01068626|26818058|P1|Overall Study|Withdrawal by Subject|0
7712225|NCT01068626|26818057|P2|Overall Study|Adverse Event|0
7712226|NCT01068626|26818058|P1|Overall Study|Adverse Event|3
7712227|NCT01068600|26818076|P2|Overall Study|Administrative problems|1
7712228|NCT01068600|26818077|P1|Overall Study|Administrative problems|0
7712229|NCT01068600|26818076|P2|Overall Study|Unsatisfactory therapeutic effect|4
7712230|NCT01068600|26818077|P1|Overall Study|Unsatisfactory therapeutic effect|0
7712231|NCT01068600|26818076|P2|Overall Study|Protocol deviation|1
7712232|NCT01068600|26818077|P1|Overall Study|Protocol deviation|1
7712233|NCT01068600|26818076|P2|Overall Study|Lost to Follow-up|2
7712234|NCT01068600|26818077|P1|Overall Study|Lost to Follow-up|1
7712235|NCT01068600|26818076|P2|Overall Study|Abnormal laboratory value(s)|0
7712236|NCT01068600|26818077|P1|Overall Study|Abnormal laboratory value(s)|1
7712237|NCT01068600|26818076|P2|Overall Study|Adverse Event|3
7712238|NCT01068600|26818077|P1|Overall Study|Adverse Event|3
7712239|NCT01068600|26818076|P2|Overall Study|Withdrawal by Subject|6
7712240|NCT01068600|26818077|P1|Overall Study|Withdrawal by Subject|5
7712241|NCT01068509|26818099|P3|Overall Study|Reason Not Specified|0
7712242|NCT01068509|26818100|P2|Overall Study|Reason Not Specified|1
7712243|NCT01068509|26818101|P1|Overall Study|Reason Not Specified|0
7712244|NCT01068509|26818099|P3|Overall Study|Withdrew Consent|2
7712245|NCT01068509|26818100|P2|Overall Study|Withdrew Consent|1
7712246|NCT01068509|26818101|P1|Overall Study|Withdrew Consent|0
7712247|NCT01068509|26818099|P3|Overall Study|Lost to Follow-up|0
7712248|NCT01068509|26818100|P2|Overall Study|Lost to Follow-up|0
7712249|NCT01068509|26818101|P1|Overall Study|Lost to Follow-up|1
7712250|NCT01068509|26818099|P3|Overall Study|Disease Progression|18
7712251|NCT01068509|26818100|P2|Overall Study|Disease Progression|20
7712252|NCT01068509|26818101|P1|Overall Study|Disease Progression|5
7712253|NCT01068509|26818099|P3|Overall Study|Death|1
7712254|NCT01068509|26818100|P2|Overall Study|Death|0
7712255|NCT01068509|26818101|P1|Overall Study|Death|0
7712256|NCT01068418|26818114|P1|Overall Study|Physician Decision|12
7712257|NCT01068262|26818123|P4|Overall Study|Withdrawal by Subject|0
7712258|NCT01068262|26818124|P3|Overall Study|Withdrawal by Subject|0
7712259|NCT01068262|26818125|P2|Overall Study|Withdrawal by Subject|1
7712260|NCT01068262|26818126|P1|Overall Study|Withdrawal by Subject|0
7712261|NCT01068262|26818123|P4|Overall Study|Protocol Violation|0
7712262|NCT01068262|26818124|P3|Overall Study|Protocol Violation|0
7712263|NCT01068262|26818125|P2|Overall Study|Protocol Violation|0
7712264|NCT01068262|26818126|P1|Overall Study|Protocol Violation|1
7712265|NCT01068262|26818123|P4|Overall Study|Adverse Event|0
7712266|NCT01068262|26818124|P3|Overall Study|Adverse Event|1
7712267|NCT01068262|26818125|P2|Overall Study|Adverse Event|0
7712268|NCT01068262|26818126|P1|Overall Study|Adverse Event|2
7712269|NCT01068158|26818156|P2|Overall Study|Protocol Violation|2
7712270|NCT01068158|26818157|P1|Overall Study|Protocol Violation|0
7712271|NCT01068158|26818156|P2|Overall Study|Lost to Follow-up|0
7712272|NCT01068158|26818157|P1|Overall Study|Lost to Follow-up|7
7712273|NCT01068158|26818156|P2|Overall Study|Withdrawal by Subject|2
7712274|NCT01068158|26818157|P1|Overall Study|Withdrawal by Subject|1
7712275|NCT01067976|26818169|P1|Overall Study|Study prematurely discontinued|2
7712276|NCT01067976|26818169|P1|Overall Study|Study drug never administered|20
7712277|NCT01067846|26818230|P2|Overall Study|participation in other tx study|0
7712278|NCT01067846|26818231|P1|Overall Study|participation in other tx study|1
7712279|NCT01067846|26818230|P2|Overall Study|Withdrawal by Subject|0
7712280|NCT01067846|26818231|P1|Overall Study|Withdrawal by Subject|1
7712281|NCT01067846|26818230|P2|Overall Study|Lost to Follow-up|19
7712282|NCT01067846|26818231|P1|Overall Study|Lost to Follow-up|17
7712283|NCT01067521|26818301|P2|Open-Label Period|Lost to Follow-up|20
7712284|NCT01067521|26818302|P1|Open-Label Period|Lost to Follow-up|21
7712285|NCT01067521|26818301|P2|Open-Label Period|Teva requested subject to be withdrawn|2
7712286|NCT01067521|26818302|P1|Open-Label Period|Teva requested subject to be withdrawn|5
7712287|NCT01067521|26818301|P2|Open-Label Period|Pregnancy|8
7712288|NCT01067521|26818302|P1|Open-Label Period|Pregnancy|14
7712289|NCT01067521|26818301|P2|Open-Label Period|Protocol Violation|0
7712290|NCT01067521|26818302|P1|Open-Label Period|Protocol Violation|3
7712291|NCT01067521|26818301|P2|Open-Label Period|Non-compliance with study drug|0
7712292|NCT01067521|26818302|P1|Open-Label Period|Non-compliance with study drug|5
7712293|NCT01067521|26818301|P2|Open-Label Period|Physician Decision|11
7712294|NCT01067521|26818302|P1|Open-Label Period|Physician Decision|13
7712295|NCT01067521|26818301|P2|Open-Label Period|Withdrawal by Subject|88
7712296|NCT01067521|26818302|P1|Open-Label Period|Withdrawal by Subject|160
7712297|NCT01067521|26818301|P2|Open-Label Period|Adverse Event|28
7712298|NCT01067521|26818302|P1|Open-Label Period|Adverse Event|30
7712299|NCT01067521|26818301|P2|Open-Label Period|Death|1
7712300|NCT01067521|26818302|P1|Open-Label Period|Death|3
7712301|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
7712302|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
7712303|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
7712304|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
7712305|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7712306|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
7712307|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
7712308|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
7712309|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
7712310|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
7712311|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
7712312|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
7712313|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
7712314|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
7712315|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
7712316|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
7712317|NCT01067521|26818301|P2|Double-Blind Placebo-Controlled Period|Death|1
7712318|NCT01067521|26818302|P1|Double-Blind Placebo-Controlled Period|Death|0
7712319|NCT01067508|26818328|P2|Overall Study|Withdrawal by Subject|1
7712320|NCT01067508|26818329|P1|Overall Study|Withdrawal by Subject|0
7712321|NCT01067508|26818328|P2|Overall Study|Physician Decision|1
7712322|NCT01067508|26818329|P1|Overall Study|Physician Decision|0
7712323|NCT01067469|26818337|P2|Overall Study|Disease Progression|1
7712324|NCT01067469|26818338|P1|Overall Study|Disease Progression|0
7712325|NCT01067469|26818337|P2|Overall Study|Withdrawal by Subject|1
7712326|NCT01067469|26818338|P1|Overall Study|Withdrawal by Subject|0
7712327|NCT01067352|26818370|P3|Overall Study|Physician Decision|0
7712328|NCT01067352|26818371|P2|Overall Study|Physician Decision|1
7712329|NCT01067352|26818372|P1|Overall Study|Physician Decision|0
7712330|NCT01067352|26818370|P3|Overall Study|Withdrawal by Subject|1
7712331|NCT01067352|26818371|P2|Overall Study|Withdrawal by Subject|2
7712332|NCT01067352|26818372|P1|Overall Study|Withdrawal by Subject|1
7712333|NCT01067339|26818388|P2|Overall Study|Withdrawal by Subject|5
7712334|NCT01067339|26818389|P1|Overall Study|Withdrawal by Subject|6
7712335|NCT01067326|26818399|P2|Overall Study|Early Study Termination|1
7712336|NCT01067326|26818400|P1|Overall Study|Early Study Termination|1
7712337|NCT01067326|26818399|P2|Overall Study|Withdrawal by Subject|0
7712338|NCT01067326|26818400|P1|Overall Study|Withdrawal by Subject|1
7712339|NCT01067326|26818399|P2|Overall Study|Adverse Event|2
7712340|NCT01067326|26818400|P1|Overall Study|Adverse Event|0
7712341|NCT01067144|26818414|P2|Follow-up|Death|1
7712342|NCT01067144|26818415|P1|Follow-up|Death|0
7712343|NCT01067144|26818414|P2|Follow-up|Surgery cancelled|1
7712344|NCT01067144|26818415|P1|Follow-up|Surgery cancelled|0
7712345|NCT01067144|26818414|P2|Follow-up|Withdrawal by Subject|14
7712346|NCT01067144|26818415|P1|Follow-up|Withdrawal by Subject|18
7712347|NCT01067144|26818414|P2|Follow-up|Censored owing to second surgery|28
7712348|NCT01067144|26818415|P1|Follow-up|Censored owing to second surgery|19
7712349|NCT01067144|26818414|P2|Follow-up|Lost to Follow-up|12
7712350|NCT01067144|26818415|P1|Follow-up|Lost to Follow-up|22
7712351|NCT01067144|26818414|P2|Treatment|Did not receive allocated intervention|7
7712352|NCT01067144|26818415|P1|Treatment|Did not receive allocated intervention|4
7712353|NCT01067105|26818431|P1|Overall Study|Other|31
7712354|NCT01067105|26818431|P1|Overall Study|Physician Decision|6
7712355|NCT01067105|26818431|P1|Overall Study|Lost to Follow-up|6
7712356|NCT01067105|26818431|P1|Overall Study|Withdrawal by Subject|36
7712357|NCT01067105|26818431|P1|Overall Study|Protocol Violation|48
7712358|NCT01067105|26818431|P1|Overall Study|Adverse Event|14
7712359|NCT01066936|26818448|P1|Overall Study|Withdrawal by Subject|4
7712360|NCT01066936|26818448|P1|Overall Study|Lost to Follow-up|3
7712361|NCT01066936|26818448|P1|Overall Study|Device revised/removed|1
7712362|NCT01066936|26818448|P1|Overall Study|Death|2
7712363|NCT01066923|26818484|P4|Overall Study|Withdrawal by Subject|8
7712364|NCT01066923|26818485|P3|Overall Study|Withdrawal by Subject|8
7712365|NCT01066923|26818486|P2|Overall Study|Withdrawal by Subject|3
7712366|NCT01066923|26818487|P1|Overall Study|Withdrawal by Subject|3
7712367|NCT01066897|26818511|P2|Overall Study|stopped study after developing the flu.|0
7712368|NCT01066897|26818512|P1|Overall Study|stopped study after developing the flu.|1
7712369|NCT01066897|26818511|P2|Overall Study|Withdrawal by Subject|0
7712370|NCT01066897|26818512|P1|Overall Study|Withdrawal by Subject|1
7712371|NCT01066871|26818526|P4|Overall Study|Other|2
7712372|NCT01066871|26818527|P3|Overall Study|Other|1
7712373|NCT01066871|26818528|P2|Overall Study|Other|2
7712374|NCT01066871|26818529|P1|Overall Study|Other|0
7712375|NCT01066871|26818526|P4|Overall Study|Withdrawal by Subject|0
7712376|NCT01066871|26818527|P3|Overall Study|Withdrawal by Subject|0
7712377|NCT01066871|26818528|P2|Overall Study|Withdrawal by Subject|1
7712378|NCT01066871|26818529|P1|Overall Study|Withdrawal by Subject|3
7712379|NCT01066871|26818526|P4|Overall Study|Lack of Efficacy|1
7712380|NCT01066871|26818527|P3|Overall Study|Lack of Efficacy|0
7712381|NCT01066871|26818528|P2|Overall Study|Lack of Efficacy|0
7712382|NCT01066871|26818529|P1|Overall Study|Lack of Efficacy|0
7712383|NCT01066871|26818526|P4|Overall Study|Protocol Violation|2
7712384|NCT01066871|26818527|P3|Overall Study|Protocol Violation|3
7712385|NCT01066871|26818528|P2|Overall Study|Protocol Violation|0
7712386|NCT01066871|26818529|P1|Overall Study|Protocol Violation|1
7712387|NCT01066871|26818526|P4|Overall Study|Lost to Follow-up|0
7712388|NCT01066871|26818527|P3|Overall Study|Lost to Follow-up|2
7712389|NCT01066871|26818528|P2|Overall Study|Lost to Follow-up|2
7712390|NCT01066871|26818529|P1|Overall Study|Lost to Follow-up|0
7712391|NCT01066819|26818593|P6|Overall Study|Other|0
7712392|NCT01066819|26818594|P5|Overall Study|Other|0
7712393|NCT01066819|26818595|P4|Overall Study|Other|0
7712394|NCT01066819|26818596|P3|Overall Study|Other|1
7712395|NCT01066819|26818597|P2|Overall Study|Other|1
7712396|NCT01066819|26818598|P1|Overall Study|Other|5
7712397|NCT01066819|26818593|P6|Overall Study|Treatment stopped|0
7712398|NCT01066819|26818594|P5|Overall Study|Treatment stopped|0
7712399|NCT01066819|26818595|P4|Overall Study|Treatment stopped|1
7712400|NCT01066819|26818596|P3|Overall Study|Treatment stopped|2
7712401|NCT01066819|26818597|P2|Overall Study|Treatment stopped|1
7712402|NCT01066819|26818598|P1|Overall Study|Treatment stopped|12
7712403|NCT01066819|26818593|P6|Overall Study|Treatment never started|2
7712404|NCT01066819|26818594|P5|Overall Study|Treatment never started|2
7712405|NCT01066819|26818595|P4|Overall Study|Treatment never started|3
7712406|NCT01066819|26818596|P3|Overall Study|Treatment never started|19
7712407|NCT01066819|26818597|P2|Overall Study|Treatment never started|19
7712408|NCT01066819|26818598|P1|Overall Study|Treatment never started|85
7712409|NCT01066819|26818593|P6|Overall Study|Spontaneous cure|0
7712410|NCT01066819|26818594|P5|Overall Study|Spontaneous cure|0
7712411|NCT01066819|26818595|P4|Overall Study|Spontaneous cure|0
7712412|NCT01066819|26818596|P3|Overall Study|Spontaneous cure|0
7712413|NCT01066819|26818597|P2|Overall Study|Spontaneous cure|0
7712414|NCT01066819|26818598|P1|Overall Study|Spontaneous cure|1
7712415|NCT01066819|26818593|P6|Overall Study|Screen failure|0
7712416|NCT01066819|26818594|P5|Overall Study|Screen failure|0
7712417|NCT01066819|26818595|P4|Overall Study|Screen failure|0
7712418|NCT01066819|26818596|P3|Overall Study|Screen failure|0
7712419|NCT01066819|26818597|P2|Overall Study|Screen failure|0
7712420|NCT01066819|26818598|P1|Overall Study|Screen failure|1
7712421|NCT01066819|26818593|P6|Overall Study|Results not available|0
7712422|NCT01066819|26818594|P5|Overall Study|Results not available|0
7712423|NCT01066819|26818595|P4|Overall Study|Results not available|0
7712424|NCT01066819|26818596|P3|Overall Study|Results not available|0
7712425|NCT01066819|26818597|P2|Overall Study|Results not available|0
7712426|NCT01066819|26818598|P1|Overall Study|Results not available|1
7712427|NCT01066819|26818593|P6|Overall Study|Relapse|0
7712428|NCT01066819|26818594|P5|Overall Study|Relapse|0
7712429|NCT01066819|26818595|P4|Overall Study|Relapse|0
7712430|NCT01066819|26818596|P3|Overall Study|Relapse|3
7712431|NCT01066819|26818597|P2|Overall Study|Relapse|4
7712432|NCT01066819|26818598|P1|Overall Study|Relapse|16
7712433|NCT01066819|26818593|P6|Overall Study|Not categorised|0
7712434|NCT01066819|26818594|P5|Overall Study|Not categorised|0
7712435|NCT01066819|26818595|P4|Overall Study|Not categorised|1
7712436|NCT01066819|26818596|P3|Overall Study|Not categorised|6
7712437|NCT01066819|26818597|P2|Overall Study|Not categorised|2
7712438|NCT01066819|26818598|P1|Overall Study|Not categorised|9
7712439|NCT01066819|26818593|P6|Overall Study|Non responders|1
7712440|NCT01066819|26818594|P5|Overall Study|Non responders|0
7712441|NCT01066819|26818595|P4|Overall Study|Non responders|2
7712442|NCT01066819|26818596|P3|Overall Study|Non responders|7
7712443|NCT01066819|26818597|P2|Overall Study|Non responders|2
7712444|NCT01066819|26818598|P1|Overall Study|Non responders|123
7712445|NCT01066819|26818593|P6|Overall Study|Miscellaneous|0
7712446|NCT01066819|26818594|P5|Overall Study|Miscellaneous|0
7712447|NCT01066819|26818595|P4|Overall Study|Miscellaneous|1
7712448|NCT01066819|26818596|P3|Overall Study|Miscellaneous|18
7712449|NCT01066819|26818597|P2|Overall Study|Miscellaneous|10
7712450|NCT01066819|26818598|P1|Overall Study|Miscellaneous|28
7712451|NCT01066819|26818593|P6|Overall Study|Lab test not done|0
7712452|NCT01066819|26818594|P5|Overall Study|Lab test not done|0
7712453|NCT01066819|26818595|P4|Overall Study|Lab test not done|1
7712454|NCT01066819|26818596|P3|Overall Study|Lab test not done|2
7712455|NCT01066819|26818597|P2|Overall Study|Lab test not done|0
7712456|NCT01066819|26818598|P1|Overall Study|Lab test not done|9
7712457|NCT01066819|26818593|P6|Overall Study|Failed to return|3
7712458|NCT01066819|26818594|P5|Overall Study|Failed to return|2
7712459|NCT01066819|26818595|P4|Overall Study|Failed to return|7
7712460|NCT01066819|26818596|P3|Overall Study|Failed to return|68
7712461|NCT01066819|26818597|P2|Overall Study|Failed to return|107
7712462|NCT01066819|26818598|P1|Overall Study|Failed to return|298
7712463|NCT01066819|26818593|P6|Overall Study|Early termination|0
7712464|NCT01066819|26818594|P5|Overall Study|Early termination|0
7712465|NCT01066819|26818595|P4|Overall Study|Early termination|0
7712466|NCT01066819|26818596|P3|Overall Study|Early termination|0
7712467|NCT01066819|26818597|P2|Overall Study|Early termination|0
7712468|NCT01066819|26818598|P1|Overall Study|Early termination|2
7712469|NCT01066819|26818593|P6|Overall Study|Not met inclusion/exclusion criteria|0
7712470|NCT01066819|26818594|P5|Overall Study|Not met inclusion/exclusion criteria|0
7712471|NCT01066819|26818595|P4|Overall Study|Not met inclusion/exclusion criteria|0
7712472|NCT01066819|26818596|P3|Overall Study|Not met inclusion/exclusion criteria|0
7712473|NCT01066819|26818597|P2|Overall Study|Not met inclusion/exclusion criteria|0
7712474|NCT01066819|26818598|P1|Overall Study|Not met inclusion/exclusion criteria|1
7712475|NCT01066819|26818593|P6|Overall Study|Administrative|0
7712476|NCT01066819|26818594|P5|Overall Study|Administrative|0
7712477|NCT01066819|26818595|P4|Overall Study|Administrative|0
7712478|NCT01066819|26818596|P3|Overall Study|Administrative|2
7712479|NCT01066819|26818597|P2|Overall Study|Administrative|4
7712480|NCT01066819|26818598|P1|Overall Study|Administrative|6
7712481|NCT01066819|26818593|P6|Overall Study|Withdrawal by Subject|0
7712482|NCT01066819|26818594|P5|Overall Study|Withdrawal by Subject|0
7712483|NCT01066819|26818595|P4|Overall Study|Withdrawal by Subject|0
7712484|NCT01066819|26818596|P3|Overall Study|Withdrawal by Subject|6
7712485|NCT01066819|26818597|P2|Overall Study|Withdrawal by Subject|11
7712486|NCT01066819|26818598|P1|Overall Study|Withdrawal by Subject|29
7712487|NCT01066819|26818593|P6|Overall Study|Protocol Violation|0
7712488|NCT01066819|26818594|P5|Overall Study|Protocol Violation|0
7712489|NCT01066819|26818595|P4|Overall Study|Protocol Violation|0
7712490|NCT01066819|26818596|P3|Overall Study|Protocol Violation|0
7712491|NCT01066819|26818597|P2|Overall Study|Protocol Violation|6
7712492|NCT01066819|26818598|P1|Overall Study|Protocol Violation|12
7712493|NCT01066819|26818593|P6|Overall Study|Physician Decision|0
7712494|NCT01066819|26818594|P5|Overall Study|Physician Decision|0
7712495|NCT01066819|26818595|P4|Overall Study|Physician Decision|0
7712496|NCT01066819|26818596|P3|Overall Study|Physician Decision|3
7712497|NCT01066819|26818597|P2|Overall Study|Physician Decision|2
7712498|NCT01066819|26818598|P1|Overall Study|Physician Decision|6
7712499|NCT01066819|26818593|P6|Overall Study|Lack of Efficacy|0
7712500|NCT01066819|26818594|P5|Overall Study|Lack of Efficacy|0
7712501|NCT01066819|26818595|P4|Overall Study|Lack of Efficacy|1
7712502|NCT01066819|26818596|P3|Overall Study|Lack of Efficacy|2
7712503|NCT01066819|26818597|P2|Overall Study|Lack of Efficacy|1
7712504|NCT01066819|26818598|P1|Overall Study|Lack of Efficacy|22
7712505|NCT01066819|26818593|P6|Overall Study|Death|0
7712506|NCT01066819|26818594|P5|Overall Study|Death|0
7712507|NCT01066819|26818595|P4|Overall Study|Death|0
7712508|NCT01066819|26818596|P3|Overall Study|Death|1
7712509|NCT01066819|26818597|P2|Overall Study|Death|0
7712510|NCT01066819|26818598|P1|Overall Study|Death|5
7712511|NCT01066819|26818593|P6|Overall Study|Adverse Event|0
7712512|NCT01066819|26818594|P5|Overall Study|Adverse Event|0
7712513|NCT01066819|26818595|P4|Overall Study|Adverse Event|0
7712514|NCT01066819|26818596|P3|Overall Study|Adverse Event|6
7712515|NCT01066819|26818597|P2|Overall Study|Adverse Event|1
7712516|NCT01066819|26818598|P1|Overall Study|Adverse Event|18
7712517|NCT01066793|26818739|P6|Overall Study|Treatment Stopped|0
7712518|NCT01066793|26818740|P5|Overall Study|Treatment Stopped|0
7712519|NCT01066793|26818741|P4|Overall Study|Treatment Stopped|1
7712520|NCT01066793|26818742|P3|Overall Study|Treatment Stopped|0
7712521|NCT01066793|26818743|P2|Overall Study|Treatment Stopped|1
7712522|NCT01066793|26818744|P1|Overall Study|Treatment Stopped|2
7712523|NCT01066793|26818739|P6|Overall Study|Treatment Never Started|0
7712524|NCT01066793|26818740|P5|Overall Study|Treatment Never Started|0
7712525|NCT01066793|26818741|P4|Overall Study|Treatment Never Started|1
7712526|NCT01066793|26818742|P3|Overall Study|Treatment Never Started|4
7712527|NCT01066793|26818743|P2|Overall Study|Treatment Never Started|5
7712528|NCT01066793|26818744|P1|Overall Study|Treatment Never Started|18
7712529|NCT01066793|26818739|P6|Overall Study|Treatment Interrupted|0
7712530|NCT01066793|26818740|P5|Overall Study|Treatment Interrupted|0
7712531|NCT01066793|26818741|P4|Overall Study|Treatment Interrupted|0
7712532|NCT01066793|26818742|P3|Overall Study|Treatment Interrupted|0
7712533|NCT01066793|26818743|P2|Overall Study|Treatment Interrupted|1
7712534|NCT01066793|26818744|P1|Overall Study|Treatment Interrupted|1
7712535|NCT01066793|26818739|P6|Overall Study|Result Not Available|0
7712536|NCT01066793|26818740|P5|Overall Study|Result Not Available|0
7712537|NCT01066793|26818741|P4|Overall Study|Result Not Available|0
7712538|NCT01066793|26818742|P3|Overall Study|Result Not Available|0
7712539|NCT01066793|26818743|P2|Overall Study|Result Not Available|0
7712540|NCT01066793|26818744|P1|Overall Study|Result Not Available|1
7712541|NCT01066793|26818739|P6|Overall Study|Relapse|0
7712542|NCT01066793|26818740|P5|Overall Study|Relapse|0
7712543|NCT01066793|26818741|P4|Overall Study|Relapse|3
7712544|NCT01066793|26818742|P3|Overall Study|Relapse|2
7712545|NCT01066793|26818743|P2|Overall Study|Relapse|8
7712546|NCT01066793|26818744|P1|Overall Study|Relapse|20
7712547|NCT01066793|26818739|P6|Overall Study|Other|0
7712548|NCT01066793|26818740|P5|Overall Study|Other|0
7712549|NCT01066793|26818741|P4|Overall Study|Other|2
7712550|NCT01066793|26818742|P3|Overall Study|Other|6
7712551|NCT01066793|26818743|P2|Overall Study|Other|5
7712552|NCT01066793|26818744|P1|Overall Study|Other|15
7712553|NCT01066793|26818739|P6|Overall Study|Non-responders|0
7712554|NCT01066793|26818740|P5|Overall Study|Non-responders|0
7712555|NCT01066793|26818741|P4|Overall Study|Non-responders|25
7712556|NCT01066793|26818742|P3|Overall Study|Non-responders|11
7712557|NCT01066793|26818743|P2|Overall Study|Non-responders|5
7712558|NCT01066793|26818744|P1|Overall Study|Non-responders|104
7712559|NCT01066793|26818739|P6|Overall Study|Miscellaneous|0
7712560|NCT01066793|26818740|P5|Overall Study|Miscellaneous|0
7712561|NCT01066793|26818741|P4|Overall Study|Miscellaneous|0
7712562|NCT01066793|26818742|P3|Overall Study|Miscellaneous|6
7712563|NCT01066793|26818743|P2|Overall Study|Miscellaneous|5
7712564|NCT01066793|26818744|P1|Overall Study|Miscellaneous|4
7712565|NCT01066793|26818739|P6|Overall Study|Lab test not done|0
7712566|NCT01066793|26818740|P5|Overall Study|Lab test not done|0
7712567|NCT01066793|26818741|P4|Overall Study|Lab test not done|1
7712568|NCT01066793|26818742|P3|Overall Study|Lab test not done|0
7712569|NCT01066793|26818743|P2|Overall Study|Lab test not done|0
7712570|NCT01066793|26818744|P1|Overall Study|Lab test not done|7
7712571|NCT01066793|26818739|P6|Overall Study|Early Termination|0
7712572|NCT01066793|26818740|P5|Overall Study|Early Termination|0
7712573|NCT01066793|26818741|P4|Overall Study|Early Termination|0
7712574|NCT01066793|26818742|P3|Overall Study|Early Termination|0
7712575|NCT01066793|26818743|P2|Overall Study|Early Termination|0
7712576|NCT01066793|26818744|P1|Overall Study|Early Termination|3
7712577|NCT01066793|26818739|P6|Overall Study|Withdrawal by Subject|0
7712578|NCT01066793|26818740|P5|Overall Study|Withdrawal by Subject|0
7712579|NCT01066793|26818741|P4|Overall Study|Withdrawal by Subject|0
7712580|NCT01066793|26818742|P3|Overall Study|Withdrawal by Subject|1
7712581|NCT01066793|26818743|P2|Overall Study|Withdrawal by Subject|4
7712582|NCT01066793|26818744|P1|Overall Study|Withdrawal by Subject|7
7712583|NCT01066793|26818739|P6|Overall Study|Protocol Violation|0
7712584|NCT01066793|26818740|P5|Overall Study|Protocol Violation|0
7712585|NCT01066793|26818741|P4|Overall Study|Protocol Violation|0
7712586|NCT01066793|26818742|P3|Overall Study|Protocol Violation|2
7712587|NCT01066793|26818743|P2|Overall Study|Protocol Violation|2
7712588|NCT01066793|26818744|P1|Overall Study|Protocol Violation|3
7712589|NCT01066793|26818739|P6|Overall Study|Physician Decision|0
7712590|NCT01066793|26818740|P5|Overall Study|Physician Decision|0
7712591|NCT01066793|26818741|P4|Overall Study|Physician Decision|0
7712592|NCT01066793|26818742|P3|Overall Study|Physician Decision|0
7712593|NCT01066793|26818743|P2|Overall Study|Physician Decision|0
7712594|NCT01066793|26818744|P1|Overall Study|Physician Decision|3
7712595|NCT01066793|26818739|P6|Overall Study|Lost to Follow-up|1
7712596|NCT01066793|26818740|P5|Overall Study|Lost to Follow-up|0
7712597|NCT01066793|26818741|P4|Overall Study|Lost to Follow-up|16
7712598|NCT01066793|26818742|P3|Overall Study|Lost to Follow-up|82
7712599|NCT01066793|26818743|P2|Overall Study|Lost to Follow-up|39
7712600|NCT01066793|26818744|P1|Overall Study|Lost to Follow-up|180
7712601|NCT01066793|26818739|P6|Overall Study|Lack of Efficacy|0
7712602|NCT01066793|26818740|P5|Overall Study|Lack of Efficacy|0
7712603|NCT01066793|26818741|P4|Overall Study|Lack of Efficacy|0
7712604|NCT01066793|26818742|P3|Overall Study|Lack of Efficacy|0
7712605|NCT01066793|26818743|P2|Overall Study|Lack of Efficacy|1
7712606|NCT01066793|26818744|P1|Overall Study|Lack of Efficacy|2
7712607|NCT01066793|26818739|P6|Overall Study|Death|0
7712608|NCT01066793|26818740|P5|Overall Study|Death|0
7712609|NCT01066793|26818741|P4|Overall Study|Death|0
7712610|NCT01066793|26818742|P3|Overall Study|Death|1
7712611|NCT01066793|26818743|P2|Overall Study|Death|1
7712612|NCT01066793|26818744|P1|Overall Study|Death|4
7712613|NCT01066780|26818884|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
7712614|NCT01066780|26818885|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
7712615|NCT01066585|26818915|P2|Overall Study|Withdrawal by Subject|3
7712616|NCT01066585|26818916|P1|Overall Study|Withdrawal by Subject|0
7712617|NCT01066585|26818915|P2|Overall Study|Protocol Violation|0
7712618|NCT01066585|26818916|P1|Overall Study|Protocol Violation|1
7712619|NCT01066546|26818928|P1|Overall Study|Study terminated by sponsor|5
7712620|NCT01066156|26818973|P1|Overall Study|Withdrawal by Subject|1
7712621|NCT01066156|26818973|P1|Overall Study|Lost to Follow-up|7
7712622|NCT01066156|26818973|P1|Overall Study|ineligible|2
7712623|NCT01066143|26818977|P1|Overall Study|ineligible for the study|8
7712624|NCT01066104|26818983|P2|Overall Study|Protocol Violation|0
7712625|NCT01066104|26818984|P1|Overall Study|Protocol Violation|1
7712626|NCT01066104|26818983|P2|Overall Study|Adverse Event|1
7712627|NCT01066104|26818984|P1|Overall Study|Adverse Event|1
7712628|NCT01066052|26818994|P2|Overall Study|Enrolled But Not Treated|0
7712629|NCT01066052|26818995|P1|Overall Study|Enrolled But Not Treated|3
7712630|NCT01066039|26819006|P1|Overall Study|Drug/Dose Adjustment Required|1
7712631|NCT01066039|26819006|P1|Overall Study|Failure to Control Blood Pressure|1
7712632|NCT01066039|26819006|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
7712633|NCT01066039|26819006|P1|Overall Study|Additional Antihypertensive Required|4
7712634|NCT01066039|26819006|P1|Overall Study|Dropout due to Insulin Administration|1
7712635|NCT01066039|26819006|P1|Overall Study|Investigator's Request|1
7712636|NCT01066039|26819006|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
7712637|NCT01066039|26819006|P1|Overall Study|Protocol Violation|2
7712638|NCT01066039|26819006|P1|Overall Study|Withdrawal by Subject|17
7712639|NCT01066039|26819006|P1|Overall Study|Adverse Event|6
7712640|NCT01066000|26819031|P1|Overall Study|Adverse Event|1
7712641|NCT01066000|26819031|P1|Overall Study|Withdrawal by Subject|1
7712642|NCT01066000|26819031|P1|Overall Study|Death|3
7712643|NCT01066000|26819031|P1|Overall Study|Protocol Violation|4
7712644|NCT01065844|26819042|P1|Overall Study|Adverse Event|5
7712645|NCT01065818|26819046|P1|Overall Study|Not a candidate for surgery|1
7712646|NCT01065818|26819046|P1|Overall Study|Withdrawal by Subject|1
7712647|NCT01065779|26819050|P1|Overall Study|Inclusion Criteria Violation|7
7712648|NCT01065779|26819050|P1|Overall Study|Failed to Follow-up|10
7712649|NCT01065779|26819050|P1|Overall Study|Not Administered With Study Drug|17
7712650|NCT01065779|26819050|P1|Overall Study|Non-enrollment Period Administration|10
7712651|NCT01065779|26819050|P1|Overall Study|Investigation Before Contract Date|37
7712652|NCT01065779|26819050|P1|Overall Study|Duplicate Investigation|1
7712653|NCT01065766|26819061|P1|Overall Study|Violated dosage/administration|25
7712654|NCT01065766|26819061|P1|Overall Study|Contraindication to administration|6
7712655|NCT01065766|26819061|P1|Overall Study|Assessed before the contracted date|1
7712656|NCT01065597|26819080|P1|Overall Study|Adverse Event|1
7712705|NCT01065350|26819253|P2|Overall Study|Received incorrect drug allocation|1
7712706|NCT01065350|26819254|P1|Overall Study|Received incorrect drug allocation|0
7712707|NCT01064947|26819315|P1|Overall Study|negative culture|41
7712708|NCT01064856|26819356|P4|Open-label (OL) Period|Other|7
7712709|NCT01064856|26819357|P3|Open-label (OL) Period|Other|7
7712710|NCT01064856|26819358|P2|Open-label (OL) Period|Other|0
7712711|NCT01064856|26819359|P1|Open-label (OL) Period|Other|0
7712712|NCT01064856|26819356|P4|Open-label (OL) Period|Lost to Follow-up|1
7712713|NCT01064856|26819357|P3|Open-label (OL) Period|Lost to Follow-up|2
7712714|NCT01064856|26819358|P2|Open-label (OL) Period|Lost to Follow-up|0
7712715|NCT01064856|26819359|P1|Open-label (OL) Period|Lost to Follow-up|0
7712716|NCT01064856|26819356|P4|Open-label (OL) Period|Consent withdrawn by participant|6
7712717|NCT01064856|26819357|P3|Open-label (OL) Period|Consent withdrawn by participant|5
7712718|NCT01064856|26819358|P2|Open-label (OL) Period|Consent withdrawn by participant|0
7712719|NCT01064856|26819359|P1|Open-label (OL) Period|Consent withdrawn by participant|0
7712720|NCT01064856|26819356|P4|Open-label (OL) Period|Adverse Event|6
7712721|NCT01064856|26819357|P3|Open-label (OL) Period|Adverse Event|12
7712722|NCT01064856|26819358|P2|Open-label (OL) Period|Adverse Event|0
7712723|NCT01064856|26819359|P1|Open-label (OL) Period|Adverse Event|0
7712724|NCT01064856|26819356|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
7712725|NCT01064856|26819357|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
7712726|NCT01064856|26819358|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
7712727|NCT01064856|26819359|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
7712728|NCT01064856|26819356|P4|Double-blind (DB) Period|Adverse Event|0
7712729|NCT01064856|26819357|P3|Double-blind (DB) Period|Adverse Event|0
7712730|NCT01064856|26819358|P2|Double-blind (DB) Period|Adverse Event|0
7712731|NCT01064856|26819359|P1|Double-blind (DB) Period|Adverse Event|1
7712732|NCT01064817|26819403|P2|Study Completion|Withdrawal by Subject|0
7712733|NCT01064817|26819404|P1|Study Completion|Withdrawal by Subject|1
7712734|NCT01064817|26819403|P2|Study Completion|Physician Decision|0
7712735|NCT01064817|26819404|P1|Study Completion|Physician Decision|1
7712736|NCT01064739|26819416|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
7712737|NCT01064687|26819487|P4|Overall Study|Treatment Noncompliance|0
7712738|NCT01064687|26819488|P3|Overall Study|Treatment Noncompliance|1
7712739|NCT01064687|26819489|P2|Overall Study|Treatment Noncompliance|1
7712740|NCT01064687|26819490|P1|Overall Study|Treatment Noncompliance|1
7712741|NCT01064687|26819487|P4|Overall Study|Withdrawal by Subject|5
7712742|NCT01064687|26819488|P3|Overall Study|Withdrawal by Subject|12
7712743|NCT01064687|26819489|P2|Overall Study|Withdrawal by Subject|7
7712744|NCT01064687|26819490|P1|Overall Study|Withdrawal by Subject|9
7712745|NCT01064687|26819487|P4|Overall Study|Sponsor Decision|0
7712746|NCT01064687|26819488|P3|Overall Study|Sponsor Decision|3
7712747|NCT01064687|26819489|P2|Overall Study|Sponsor Decision|0
7712748|NCT01064687|26819490|P1|Overall Study|Sponsor Decision|0
7712749|NCT01064687|26819487|P4|Overall Study|Protocol Violation|1
7712750|NCT01064687|26819488|P3|Overall Study|Protocol Violation|0
7712751|NCT01064687|26819489|P2|Overall Study|Protocol Violation|1
7712752|NCT01064687|26819490|P1|Overall Study|Protocol Violation|1
7712753|NCT01064687|26819487|P4|Overall Study|Physician Decision|0
7712754|NCT01064687|26819488|P3|Overall Study|Physician Decision|0
7712755|NCT01064687|26819489|P2|Overall Study|Physician Decision|2
7712756|NCT01064687|26819490|P1|Overall Study|Physician Decision|2
7712757|NCT01064687|26819487|P4|Overall Study|Lost to Follow-up|5
7712758|NCT01064687|26819488|P3|Overall Study|Lost to Follow-up|13
7712759|NCT01064687|26819489|P2|Overall Study|Lost to Follow-up|10
7712760|NCT01064687|26819490|P1|Overall Study|Lost to Follow-up|7
7712761|NCT01064687|26819487|P4|Overall Study|Lack of Efficacy|3
7712762|NCT01064687|26819488|P3|Overall Study|Lack of Efficacy|2
7712763|NCT01064687|26819489|P2|Overall Study|Lack of Efficacy|0
7712764|NCT01064687|26819490|P1|Overall Study|Lack of Efficacy|1
7712765|NCT01064687|26819487|P4|Overall Study|Entry Criteria Not Met|0
7712766|NCT01064687|26819488|P3|Overall Study|Entry Criteria Not Met|0
7712767|NCT01064687|26819489|P2|Overall Study|Entry Criteria Not Met|0
7712768|NCT01064687|26819490|P1|Overall Study|Entry Criteria Not Met|3
7712769|NCT01064687|26819487|P4|Overall Study|Death|0
7712770|NCT01064687|26819488|P3|Overall Study|Death|0
7712771|NCT01064687|26819489|P2|Overall Study|Death|1
7712772|NCT01064687|26819490|P1|Overall Study|Death|1
7712773|NCT01064687|26819487|P4|Overall Study|Adverse Event|3
7712774|NCT01064687|26819488|P3|Overall Study|Adverse Event|10
7712775|NCT01064687|26819489|P2|Overall Study|Adverse Event|4
7712776|NCT01064687|26819490|P1|Overall Study|Adverse Event|9
7712777|NCT01064648|26819670|P4|Phase II|Under Review|0
7712778|NCT01064648|26819671|P3|Phase II|Under Review|2
7712779|NCT01064648|26819672|P2|Phase II|Under Review|0
7712780|NCT01064648|26819673|P1|Phase II|Under Review|0
7712781|NCT01064648|26819670|P4|Phase II|Non-protocol specified|3
7712782|NCT01064648|26819671|P3|Phase II|Non-protocol specified|5
7712783|NCT01064648|26819672|P2|Phase II|Non-protocol specified|0
7712784|NCT01064648|26819673|P1|Phase II|Non-protocol specified|0
7712785|NCT01064648|26819670|P4|Phase II|Progression|27
7712786|NCT01064648|26819671|P3|Phase II|Progression|21
7712787|NCT01064648|26819672|P2|Phase II|Progression|0
7712788|NCT01064648|26819673|P1|Phase II|Progression|0
7712789|NCT01064648|26819670|P4|Phase II|Withdrawal by Subject|5
7712790|NCT01064648|26819671|P3|Phase II|Withdrawal by Subject|2
7712791|NCT01064648|26819672|P2|Phase II|Withdrawal by Subject|0
7712792|NCT01064648|26819673|P1|Phase II|Withdrawal by Subject|0
7712793|NCT01064648|26819670|P4|Phase II|Death|5
7712794|NCT01064648|26819671|P3|Phase II|Death|4
7712795|NCT01064648|26819672|P2|Phase II|Death|0
7712796|NCT01064648|26819673|P1|Phase II|Death|0
7712797|NCT01064648|26819670|P4|Phase II|Adverse Event|8
7712798|NCT01064648|26819671|P3|Phase II|Adverse Event|15
7712799|NCT01064648|26819672|P2|Phase II|Adverse Event|0
7712800|NCT01064648|26819673|P1|Phase II|Adverse Event|0
7712801|NCT01064648|26819670|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7712802|NCT01064648|26819671|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7712803|NCT01064648|26819672|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
7712804|NCT01064648|26819673|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7712805|NCT01064648|26819670|P4|Phase I Cohort 2: Dose Level 2|Progression|0
7712806|NCT01064648|26819671|P3|Phase I Cohort 2: Dose Level 2|Progression|0
7712807|NCT01064648|26819672|P2|Phase I Cohort 2: Dose Level 2|Progression|5
7712808|NCT01064648|26819673|P1|Phase I Cohort 2: Dose Level 2|Progression|0
7712809|NCT01064648|26819670|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7712810|NCT01064648|26819671|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7712811|NCT01064648|26819672|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
7712812|NCT01064648|26819673|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7712813|NCT01064648|26819670|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7712814|NCT01064648|26819671|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7712815|NCT01064648|26819672|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
7712816|NCT01064648|26819673|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7712817|NCT01064648|26819670|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7712818|NCT01064648|26819671|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7712819|NCT01064648|26819672|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7712820|NCT01064648|26819673|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
7712821|NCT01064648|26819670|P4|Phase I Cohort1: Dose Level 1|Progression|0
7712822|NCT01064648|26819671|P3|Phase I Cohort1: Dose Level 1|Progression|0
7712823|NCT01064648|26819672|P2|Phase I Cohort1: Dose Level 1|Progression|0
7712824|NCT01064648|26819673|P1|Phase I Cohort1: Dose Level 1|Progression|5
7712825|NCT01064622|26819699|P2|Randomized Phase II|Protocol Violation|1
7712826|NCT01064622|26819700|P1|Randomized Phase II|Protocol Violation|0
7712827|NCT01064622|26819699|P2|Randomized Phase II|Withdrawal by Subject|2
7712828|NCT01064622|26819700|P1|Randomized Phase II|Withdrawal by Subject|2
7712829|NCT01064531|26819723|P2|Overall Study|Death|1
7712830|NCT01064531|26819724|P1|Overall Study|Death|0
7712831|NCT01064531|26819723|P2|Overall Study|Revision due to dislocation|1
7712832|NCT01064531|26819724|P1|Overall Study|Revision due to dislocation|0
7712833|NCT01064531|26819723|P2|Overall Study|Revision due to femoral stem loosening|0
7712834|NCT01064531|26819724|P1|Overall Study|Revision due to femoral stem loosening|1
7712835|NCT01064531|26819723|P2|Overall Study|Withdrawal by Subject|2
7712836|NCT01064531|26819724|P1|Overall Study|Withdrawal by Subject|2
7712837|NCT01064531|26819723|P2|Overall Study|Physician Decision|1
7712838|NCT01064531|26819724|P1|Overall Study|Physician Decision|0
7712839|NCT01064531|26819723|P2|Overall Study|Lost to Follow-up|2
7712840|NCT01064531|26819724|P1|Overall Study|Lost to Follow-up|0
7712841|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Other|1
7712842|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Other|2
7712843|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Other|5
7712844|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
7712845|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
7712846|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
7712847|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7712848|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7712849|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
7712850|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7712851|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7712852|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7712853|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
7712854|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
7712855|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
7712856|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7712857|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7712858|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7712859|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Death|0
7712860|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Death|1
7712861|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Death|0
7712862|NCT01064414|26819771|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
7712863|NCT01064414|26819772|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
7712864|NCT01064414|26819773|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
7712865|NCT01064414|26819771|P3|Core Period: Baseline to Week 26|Other|2
7712866|NCT01064414|26819772|P2|Core Period: Baseline to Week 26|Other|7
7712867|NCT01064414|26819773|P1|Core Period: Baseline to Week 26|Other|4
7712868|NCT01064414|26819771|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7712869|NCT01064414|26819772|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7712870|NCT01064414|26819773|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7712871|NCT01064414|26819771|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
7712872|NCT01064414|26819772|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
7712873|NCT01064414|26819773|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
7712874|NCT01064414|26819771|P3|Core Period: Baseline to Week 26|Protocol Violation|1
7712875|NCT01064414|26819772|P2|Core Period: Baseline to Week 26|Protocol Violation|0
7712876|NCT01064414|26819773|P1|Core Period: Baseline to Week 26|Protocol Violation|1
7712877|NCT01064414|26819771|P3|Core Period: Baseline to Week 26|Death|0
7712878|NCT01064414|26819772|P2|Core Period: Baseline to Week 26|Death|1
7712879|NCT01064414|26819773|P1|Core Period: Baseline to Week 26|Death|0
7712880|NCT01064414|26819771|P3|Core Period: Baseline to Week 26|Adverse Event|2
7712881|NCT01064414|26819772|P2|Core Period: Baseline to Week 26|Adverse Event|4
7712882|NCT01064414|26819773|P1|Core Period: Baseline to Week 26|Adverse Event|4
7712883|NCT01064401|26819792|P2|Overall Study|Other|1
7712884|NCT01064401|26819793|P1|Overall Study|Other|2
7712885|NCT01064401|26819792|P2|Overall Study|Site Closure|5
7712886|NCT01064401|26819793|P1|Overall Study|Site Closure|4
7712887|NCT01064401|26819792|P2|Overall Study|Noncompliance|8
7712888|NCT01064401|26819793|P1|Overall Study|Noncompliance|7
7712889|NCT01064401|26819792|P2|Overall Study|Pregnancy|7
7712890|NCT01064401|26819793|P1|Overall Study|Pregnancy|4
7712891|NCT01064401|26819792|P2|Overall Study|Death|0
7712892|NCT01064401|26819793|P1|Overall Study|Death|4
7712893|NCT01064401|26819792|P2|Overall Study|Investigator Decision|6
7712894|NCT01064401|26819793|P1|Overall Study|Investigator Decision|4
7712895|NCT01064401|26819792|P2|Overall Study|Consent Withdrawn|80
7712896|NCT01064401|26819793|P1|Overall Study|Consent Withdrawn|98
7712897|NCT01064401|26819792|P2|Overall Study|Lost to Follow-up|9
7712898|NCT01064401|26819793|P1|Overall Study|Lost to Follow-up|12
7712899|NCT01064401|26819792|P2|Overall Study|Lack of Efficacy|23
7712900|NCT01064401|26819793|P1|Overall Study|Lack of Efficacy|46
7712901|NCT01064401|26819792|P2|Overall Study|Adverse Event|56
7712902|NCT01064401|26819793|P1|Overall Study|Adverse Event|47
7712903|NCT01064310|26819842|P3|Open Label Pazopinib|Physician Decision|20
7712904|NCT01064310|26819843|P2|Open Label Pazopinib|Physician Decision|0
7712905|NCT01064310|26819844|P1|Open Label Pazopinib|Physician Decision|0
7712906|NCT01064310|26819842|P3|Open Label Pazopinib|Lack of Efficacy|51
7712907|NCT01064310|26819843|P2|Open Label Pazopinib|Lack of Efficacy|0
7712908|NCT01064310|26819844|P1|Open Label Pazopinib|Lack of Efficacy|0
7712909|NCT01064310|26819842|P3|Open Label Pazopinib|Adverse Event|12
7712910|NCT01064310|26819843|P2|Open Label Pazopinib|Adverse Event|0
7712911|NCT01064310|26819844|P1|Open Label Pazopinib|Adverse Event|0
7712912|NCT01064310|26819842|P3|Open Label Pazopinib|Withdrawal by Subject|1
7712913|NCT01064310|26819843|P2|Open Label Pazopinib|Withdrawal by Subject|0
7712914|NCT01064310|26819844|P1|Open Label Pazopinib|Withdrawal by Subject|0
7712915|NCT01064310|26819842|P3|Period 2|Lack of Efficacy|0
7712916|NCT01064310|26819843|P2|Period 2|Lack of Efficacy|4
7712917|NCT01064310|26819844|P1|Period 2|Lack of Efficacy|1
7712918|NCT01064310|26819842|P3|Period 2|Entered Open-label Period|0
7712919|NCT01064310|26819843|P2|Period 2|Entered Open-label Period|0
7712920|NCT01064310|26819844|P1|Period 2|Entered Open-label Period|1
7712921|NCT01064310|26819842|P3|Period 2|Physician Decision|0
7712922|NCT01064310|26819843|P2|Period 2|Physician Decision|1
7712923|NCT01064310|26819844|P1|Period 2|Physician Decision|0
7712924|NCT01064310|26819842|P3|Period 2|Adverse Event|0
7712925|NCT01064310|26819843|P2|Period 2|Adverse Event|1
7712926|NCT01064310|26819844|P1|Period 2|Adverse Event|2
7712927|NCT01064310|26819842|P3|Period 1|Entered Open-label Period|0
7712928|NCT01064310|26819843|P2|Period 1|Entered Open-label Period|1
7712929|NCT01064310|26819844|P1|Period 1|Entered Open-label Period|1
7712930|NCT01064310|26819842|P3|Period 1|Lack of Efficacy|0
7712931|NCT01064310|26819843|P2|Period 1|Lack of Efficacy|5
7712932|NCT01064310|26819844|P1|Period 1|Lack of Efficacy|3
7712933|NCT01064310|26819842|P3|Period 1|Withdrawal by Subject|0
7712934|NCT01064310|26819843|P2|Period 1|Withdrawal by Subject|2
7712935|NCT01064310|26819844|P1|Period 1|Withdrawal by Subject|2
7712936|NCT01064310|26819842|P3|Period 1|Physician Decision|0
7712937|NCT01064310|26819843|P2|Period 1|Physician Decision|0
7712938|NCT01064310|26819844|P1|Period 1|Physician Decision|1
7712939|NCT01064310|26819842|P3|Period 1|Adverse Event|0
7712940|NCT01064310|26819843|P2|Period 1|Adverse Event|10
7712941|NCT01064310|26819844|P1|Period 1|Adverse Event|7
7712942|NCT01064297|26819874|P3|Overall Study|Lost to Follow-up|133
7712943|NCT01064297|26819875|P2|Overall Study|Lost to Follow-up|48
7712944|NCT01064297|26819876|P1|Overall Study|Lost to Follow-up|791
7712945|NCT01064167|26819945|P2|Overall Study|Protocol Violation|15
7712946|NCT01064167|26819946|P1|Overall Study|Protocol Violation|14
7712947|NCT01063972|26819961|P2|Overall Study|Incarcerated|1
7712948|NCT01063972|26819962|P1|Overall Study|Incarcerated|2
7712949|NCT01063972|26819961|P2|Overall Study|Death|11
7712950|NCT01063972|26819962|P1|Overall Study|Death|12
7712951|NCT01063881|26820012|P3|Overall Study|Reason for not completed not specified|0
7712952|NCT01063881|26820013|P2|Overall Study|Reason for not completed not specified|1
7712953|NCT01063881|26820014|P1|Overall Study|Reason for not completed not specified|5
7712954|NCT01063881|26820012|P3|Overall Study|Withdrawal by Subject|0
7712955|NCT01063881|26820013|P2|Overall Study|Withdrawal by Subject|1
7712956|NCT01063881|26820014|P1|Overall Study|Withdrawal by Subject|25
7712957|NCT01063881|26820012|P3|Overall Study|Lost to Follow-up|1
7712958|NCT01063881|26820013|P2|Overall Study|Lost to Follow-up|7
7712959|NCT01063881|26820014|P1|Overall Study|Lost to Follow-up|13
7712960|NCT01063881|26820012|P3|Overall Study|Adverse Event|0
7712961|NCT01063881|26820013|P2|Overall Study|Adverse Event|2
7712962|NCT01063881|26820014|P1|Overall Study|Adverse Event|12
7712963|NCT01063868|26820038|P2|Overall Study|Study Terminated By Sponsor|4
7712964|NCT01063868|26820039|P1|Overall Study|Study Terminated By Sponsor|23
7712965|NCT01063868|26820038|P2|Overall Study|Withdrawal by Subject|1
7712966|NCT01063868|26820039|P1|Overall Study|Withdrawal by Subject|3
7712967|NCT01063868|26820038|P2|Overall Study|Adverse Event|7
7712968|NCT01063868|26820039|P1|Overall Study|Adverse Event|9
7712969|NCT01063855|26820047|P2|Overall Study|Reason not specified|11
7712970|NCT01063855|26820048|P1|Overall Study|Reason not specified|13
7712971|NCT01063855|26820047|P2|Overall Study|Withdrawal by Subject|8
7712972|NCT01063855|26820048|P1|Overall Study|Withdrawal by Subject|11
7712973|NCT01063855|26820047|P2|Overall Study|Lack of Efficacy|1
7712974|NCT01063855|26820048|P1|Overall Study|Lack of Efficacy|0
7712975|NCT01063855|26820047|P2|Overall Study|Pregnancy|0
7712976|NCT01063855|26820048|P1|Overall Study|Pregnancy|1
7712977|NCT01063855|26820047|P2|Overall Study|Lost to Follow-up|4
7712978|NCT01063855|26820048|P1|Overall Study|Lost to Follow-up|8
7712979|NCT01063855|26820047|P2|Overall Study|Death|1
7712980|NCT01063855|26820048|P1|Overall Study|Death|0
7712981|NCT01063855|26820047|P2|Overall Study|Adverse Event|4
7712982|NCT01063855|26820048|P1|Overall Study|Adverse Event|4
7712983|NCT01063764|26820095|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
7712984|NCT01063764|26820095|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
7712985|NCT01063764|26820095|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
7712986|NCT01063764|26820095|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
7712987|NCT01063764|26820095|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
7712988|NCT01063764|26820095|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
7712989|NCT01063764|26820095|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
7712990|NCT01063595|26820114|P2|First Intervention|Reason not Specified|1
7712991|NCT01063595|26820115|P1|First Intervention|Reason not Specified|0
7712992|NCT01063595|26820114|P2|First Intervention|Withdrawal by Subject|0
7712993|NCT01063595|26820115|P1|First Intervention|Withdrawal by Subject|1
7712994|NCT01063595|26820114|P2|First Intervention|Adverse Event|4
7712995|NCT01063595|26820115|P1|First Intervention|Adverse Event|1
7712996|NCT01063595|26820114|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
7712997|NCT01063595|26820115|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
7712998|NCT01063595|26820114|P2|Enrolled in Study and Randomized|Adverse Event|1
7712999|NCT01063595|26820115|P1|Enrolled in Study and Randomized|Adverse Event|0
7713000|NCT01063595|26820114|P2|Enrolled in Study and Randomized|Reason not Specified|0
7713001|NCT01063595|26820115|P1|Enrolled in Study and Randomized|Reason not Specified|1
7713012|NCT01063348|26820168|P2|Overall Study|Lost to Follow-up|10
7713013|NCT01063348|26820169|P1|Overall Study|Lost to Follow-up|3
7713014|NCT01063283|26820179|P3|Cycle 1|Technical failure in data collection|0
7713015|NCT01063283|26820180|P2|Cycle 1|Technical failure in data collection|0
7713016|NCT01063283|26820181|P1|Cycle 1|Technical failure in data collection|1
7713017|NCT01063283|26820179|P3|Cycle 1|Adverse Event|0
7713018|NCT01063283|26820180|P2|Cycle 1|Adverse Event|0
7713019|NCT01063283|26820181|P1|Cycle 1|Adverse Event|2
7713020|NCT01063153|26820195|P2|Overall Study|Physician Decision|4
7713021|NCT01063153|26820196|P1|Overall Study|Physician Decision|0
7713022|NCT01063153|26820195|P2|Overall Study|Withdrawal by Subject|1
7713023|NCT01063153|26820196|P1|Overall Study|Withdrawal by Subject|0
7713024|NCT01063153|26820195|P2|Overall Study|Lost to Follow-up|7
7713025|NCT01063153|26820196|P1|Overall Study|Lost to Follow-up|0
7713026|NCT01063153|26820195|P2|Overall Study|Found Ineligible During Screening|0
7713027|NCT01063153|26820196|P1|Overall Study|Found Ineligible During Screening|2
7713028|NCT01063062|26820227|P2|Overall Study|Miscellaneous reason|1
7713029|NCT01063062|26820228|P1|Overall Study|Miscellaneous reason|0
7713030|NCT01063062|26820227|P2|Overall Study|Lost to Follow-up|2
7713031|NCT01063062|26820228|P1|Overall Study|Lost to Follow-up|0
7713032|NCT01063062|26820227|P2|Overall Study|Investigator's request|0
7713033|NCT01063062|26820228|P1|Overall Study|Investigator's request|1
7713034|NCT01063062|26820227|P2|Overall Study|Protocol Violation|4
7713035|NCT01063062|26820228|P1|Overall Study|Protocol Violation|5
7713036|NCT01063062|26820227|P2|Overall Study|Adverse Event|4
7713037|NCT01063062|26820228|P1|Overall Study|Adverse Event|2
7713038|NCT01063062|26820227|P2|Overall Study|Patient withdrew consent|1
7713039|NCT01063062|26820228|P1|Overall Study|Patient withdrew consent|0
7713040|NCT01063036|26820282|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
7713041|NCT01063036|26820282|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
7713042|NCT01063036|26820282|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
7713043|NCT01063036|26820282|P1|Participants Treated With Study Drug|Pregnancy|1
7713044|NCT01063036|26820282|P1|Participants Treated With Study Drug|Lost to Follow-up|1
7713045|NCT01063036|26820282|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
7713046|NCT01063036|26820282|P1|Participants Treated With Study Drug|Protocol Violation|1
7713047|NCT01063036|26820282|P1|Participants Treated With Study Drug|Adverse Event|1
7713048|NCT01062971|26820298|P2|Overall Study|Lost to Follow-up|4
7713049|NCT01062971|26820299|P1|Overall Study|Lost to Follow-up|3
7713050|NCT01062971|26820298|P2|Overall Study|Protocol Violation|3
7713051|NCT01062971|26820299|P1|Overall Study|Protocol Violation|1
7713052|NCT01062841|26820338|P2|Overall Study|Withdrawal by Study|0
7713053|NCT01062841|26820339|P1|Overall Study|Withdrawal by Study|3
7713054|NCT01062841|26820338|P2|Overall Study|Withdrawal by Subject|0
7713055|NCT01062841|26820339|P1|Overall Study|Withdrawal by Subject|2
7713056|NCT01062841|26820338|P2|Overall Study|Death|5
7713057|NCT01062841|26820339|P1|Overall Study|Death|3
7713058|NCT01062841|26820338|P2|Overall Study|Indwelling Device Removed|48
7713059|NCT01062841|26820339|P1|Overall Study|Indwelling Device Removed|41
7713060|NCT01062763|26820369|P2|Overall Study|Adverse Event|4
7713061|NCT01062763|26820370|P1|Overall Study|Adverse Event|3
7713062|NCT01062555|26820396|P4|Phase 2|Physician Decision|17
7713063|NCT01062555|26820397|P3|Phase 2|Physician Decision|0
7713064|NCT01062555|26820398|P2|Phase 2|Physician Decision|0
7713065|NCT01062555|26820399|P1|Phase 2|Physician Decision|0
7713066|NCT01062555|26820396|P4|Phase 2|Protocol Violation|3
7713067|NCT01062555|26820397|P3|Phase 2|Protocol Violation|0
7713068|NCT01062555|26820398|P2|Phase 2|Protocol Violation|0
7713069|NCT01062555|26820399|P1|Phase 2|Protocol Violation|0
7713070|NCT01062555|26820396|P4|Phase 2|Withdrawal by Subject|7
7713071|NCT01062555|26820397|P3|Phase 2|Withdrawal by Subject|0
7713072|NCT01062555|26820398|P2|Phase 2|Withdrawal by Subject|0
7713073|NCT01062555|26820399|P1|Phase 2|Withdrawal by Subject|0
7713074|NCT01062555|26820396|P4|Phase 2|Graft failure|4
7713075|NCT01062555|26820397|P3|Phase 2|Graft failure|7
7713076|NCT01062555|26820398|P2|Phase 2|Graft failure|0
7713077|NCT01062555|26820399|P1|Phase 2|Graft failure|0
7713078|NCT01062555|26820396|P4|Phase 2|Death|3
7713079|NCT01062555|26820397|P3|Phase 2|Death|8
7713080|NCT01062555|26820398|P2|Phase 2|Death|0
7713081|NCT01062555|26820399|P1|Phase 2|Death|0
7713082|NCT01062555|26820396|P4|Phase 1|Withdrawal by Subject|0
7713083|NCT01062555|26820397|P3|Phase 1|Withdrawal by Subject|0
7713084|NCT01062555|26820398|P2|Phase 1|Withdrawal by Subject|1
7713085|NCT01062555|26820399|P1|Phase 1|Withdrawal by Subject|1
7713086|NCT01062555|26820396|P4|Phase 1|Graft Failure|0
7713087|NCT01062555|26820397|P3|Phase 1|Graft Failure|0
7713088|NCT01062555|26820398|P2|Phase 1|Graft Failure|8
7713089|NCT01062555|26820399|P1|Phase 1|Graft Failure|12
7713090|NCT01062555|26820396|P4|Phase 1|Death|0
7713091|NCT01062555|26820397|P3|Phase 1|Death|0
7713092|NCT01062555|26820398|P2|Phase 1|Death|17
7713093|NCT01062555|26820399|P1|Phase 1|Death|10
7713094|NCT01062425|26820419|P2|Overall Study|Protocol Violation|6
7713095|NCT01062425|26820420|P1|Overall Study|Protocol Violation|3
7713096|NCT01062399|26820437|P5|Overall Study|Protocol Violation|4
7713097|NCT01062399|26820438|P4|Overall Study|Protocol Violation|6
7713098|NCT01062399|26820439|P3|Overall Study|Protocol Violation|0
7713099|NCT01062399|26820440|P2|Overall Study|Protocol Violation|1
7713100|NCT01062399|26820441|P1|Overall Study|Protocol Violation|0
7713101|NCT01062256|26820485|P3|Overall Study|Administrative|0
7713102|NCT01062256|26820486|P2|Overall Study|Administrative|2
7713103|NCT01062256|26820487|P1|Overall Study|Administrative|0
7713104|NCT01062256|26820485|P3|Overall Study|Ineligible|3
7713105|NCT01062256|26820486|P2|Overall Study|Ineligible|4
7713106|NCT01062256|26820487|P1|Overall Study|Ineligible|1
7713107|NCT01062256|26820485|P3|Overall Study|Withdrawal by Subject|1
7713108|NCT01062256|26820486|P2|Overall Study|Withdrawal by Subject|1
7713109|NCT01062256|26820487|P1|Overall Study|Withdrawal by Subject|1
7713110|NCT01062256|26820485|P3|Overall Study|Adverse Event|0
7713111|NCT01062256|26820486|P2|Overall Study|Adverse Event|0
7713112|NCT01062256|26820487|P1|Overall Study|Adverse Event|1
7713113|NCT01062126|26820518|P1|Overall Study|All Withdrawals|324
7713114|NCT01062126|26820518|P1|Overall Study|Death|209
7713115|NCT01062113|26820525|P3|Overall Study|Withdrawal by Subject|0
7713116|NCT01062113|26820526|P2|Overall Study|Withdrawal by Subject|0
7713117|NCT01062113|26820527|P1|Overall Study|Withdrawal by Subject|1
7713118|NCT01062113|26820525|P3|Overall Study|Lack of Efficacy|31
7713119|NCT01062113|26820526|P2|Overall Study|Lack of Efficacy|22
7713120|NCT01062113|26820527|P1|Overall Study|Lack of Efficacy|38
7713121|NCT01062113|26820525|P3|Overall Study|Adverse Event|0
7713122|NCT01062113|26820526|P2|Overall Study|Adverse Event|0
7713123|NCT01062113|26820527|P1|Overall Study|Adverse Event|1
7713124|NCT01062061|26820545|P1|Overall Study|Failed to meet inclusion criteria|2
7713125|NCT01062061|26820545|P1|Overall Study|Outside chief indications|10
7713126|NCT01062061|26820545|P1|Overall Study|Investigated before study start|13
7713127|NCT01062061|26820545|P1|Overall Study|Enrolled more than once|2
7713128|NCT01061866|26820584|P1|Overall Study|Adverse Event|2
7713129|NCT01061775|26820588|P1|Overall Study|Lost to Follow-up|1
7713130|NCT01061775|26820588|P1|Overall Study|Physician Decision|2
7713131|NCT01061736|26820605|P10|Overall Study|Other than specified above|21
7713132|NCT01061736|26820606|P9|Overall Study|Other than specified above|15
7713133|NCT01061736|26820607|P8|Overall Study|Other than specified above|18
7713134|NCT01061736|26820608|P7|Overall Study|Other than specified above|0
7713135|NCT01061736|26820609|P6|Overall Study|Other than specified above|0
7713136|NCT01061736|26820610|P5|Overall Study|Other than specified above|1
7713137|NCT01061736|26820611|P4|Overall Study|Other than specified above|0
7713138|NCT01061736|26820612|P3|Overall Study|Other than specified above|2
7713139|NCT01061736|26820613|P2|Overall Study|Other than specified above|1
7713140|NCT01061736|26820614|P1|Overall Study|Other than specified above|0
7713141|NCT01061736|26820605|P10|Overall Study|Not treated|0
7713142|NCT01061736|26820606|P9|Overall Study|Not treated|1
7713143|NCT01061736|26820607|P8|Overall Study|Not treated|2
7713144|NCT01061736|26820608|P7|Overall Study|Not treated|0
7713145|NCT01061736|26820609|P6|Overall Study|Not treated|0
7713146|NCT01061736|26820610|P5|Overall Study|Not treated|1
7713147|NCT01061736|26820611|P4|Overall Study|Not treated|0
7713148|NCT01061736|26820612|P3|Overall Study|Not treated|0
7713149|NCT01061736|26820613|P2|Overall Study|Not treated|0
7713150|NCT01061736|26820614|P1|Overall Study|Not treated|0
7713151|NCT01061736|26820605|P10|Overall Study|Poor compliance to protocol|9
7713152|NCT01061736|26820606|P9|Overall Study|Poor compliance to protocol|5
7713153|NCT01061736|26820607|P8|Overall Study|Poor compliance to protocol|2
7713154|NCT01061736|26820608|P7|Overall Study|Poor compliance to protocol|0
7713155|NCT01061736|26820609|P6|Overall Study|Poor compliance to protocol|0
7713156|NCT01061736|26820610|P5|Overall Study|Poor compliance to protocol|0
7713157|NCT01061736|26820611|P4|Overall Study|Poor compliance to protocol|0
7713158|NCT01061736|26820612|P3|Overall Study|Poor compliance to protocol|0
7713159|NCT01061736|26820613|P2|Overall Study|Poor compliance to protocol|0
7713160|NCT01061736|26820614|P1|Overall Study|Poor compliance to protocol|0
7713161|NCT01061736|26820605|P10|Overall Study|Lack of Efficacy|10
7713162|NCT01061736|26820606|P9|Overall Study|Lack of Efficacy|9
7713163|NCT01061736|26820607|P8|Overall Study|Lack of Efficacy|9
7713164|NCT01061736|26820608|P7|Overall Study|Lack of Efficacy|1
7713165|NCT01061736|26820609|P6|Overall Study|Lack of Efficacy|2
7713166|NCT01061736|26820610|P5|Overall Study|Lack of Efficacy|1
7713167|NCT01061736|26820611|P4|Overall Study|Lack of Efficacy|1
7713168|NCT01061736|26820612|P3|Overall Study|Lack of Efficacy|1
7713169|NCT01061736|26820613|P2|Overall Study|Lack of Efficacy|2
7713170|NCT01061736|26820614|P1|Overall Study|Lack of Efficacy|0
7713171|NCT01061736|26820605|P10|Overall Study|Adverse Event|34
7713172|NCT01061736|26820606|P9|Overall Study|Adverse Event|67
7713173|NCT01061736|26820607|P8|Overall Study|Adverse Event|63
7713174|NCT01061736|26820608|P7|Overall Study|Adverse Event|4
7713175|NCT01061736|26820609|P6|Overall Study|Adverse Event|1
7713176|NCT01061736|26820610|P5|Overall Study|Adverse Event|4
7713177|NCT01061736|26820611|P4|Overall Study|Adverse Event|2
7713178|NCT01061736|26820612|P3|Overall Study|Adverse Event|3
7713179|NCT01061736|26820613|P2|Overall Study|Adverse Event|1
7713180|NCT01061736|26820614|P1|Overall Study|Adverse Event|13
7713181|NCT01061736|26820605|P10|Overall Study|Dose regimen not selected|0
7713182|NCT01061736|26820606|P9|Overall Study|Dose regimen not selected|0
7713183|NCT01061736|26820607|P8|Overall Study|Dose regimen not selected|0
7713184|NCT01061736|26820608|P7|Overall Study|Dose regimen not selected|79
7713185|NCT01061736|26820609|P6|Overall Study|Dose regimen not selected|0
7713186|NCT01061736|26820610|P5|Overall Study|Dose regimen not selected|0
7713187|NCT01061736|26820611|P4|Overall Study|Dose regimen not selected|0
7713188|NCT01061736|26820612|P3|Overall Study|Dose regimen not selected|0
7713189|NCT01061736|26820613|P2|Overall Study|Dose regimen not selected|0
7713190|NCT01061736|26820614|P1|Overall Study|Dose regimen not selected|0
7713191|NCT01061723|26820653|P6|Overall Study|Other than specified above|1
7713192|NCT01061723|26820654|P5|Overall Study|Other than specified above|0
7713193|NCT01061723|26820655|P4|Overall Study|Other than specified above|1
7713194|NCT01061723|26820656|P3|Overall Study|Other than specified above|1
7713195|NCT01061723|26820657|P2|Overall Study|Other than specified above|1
7713196|NCT01061723|26820658|P1|Overall Study|Other than specified above|2
7713197|NCT01061723|26820653|P6|Overall Study|Randomized but not treated|1
7713198|NCT01061723|26820654|P5|Overall Study|Randomized but not treated|0
7713199|NCT01061723|26820655|P4|Overall Study|Randomized but not treated|0
7713200|NCT01061723|26820656|P3|Overall Study|Randomized but not treated|0
7713201|NCT01061723|26820657|P2|Overall Study|Randomized but not treated|0
7713202|NCT01061723|26820658|P1|Overall Study|Randomized but not treated|0
7713203|NCT01061723|26820653|P6|Overall Study|Lack of Efficacy|1
7713204|NCT01061723|26820654|P5|Overall Study|Lack of Efficacy|1
7713205|NCT01061723|26820655|P4|Overall Study|Lack of Efficacy|2
7713206|NCT01061723|26820656|P3|Overall Study|Lack of Efficacy|4
7713207|NCT01061723|26820657|P2|Overall Study|Lack of Efficacy|3
7713208|NCT01061723|26820658|P1|Overall Study|Lack of Efficacy|2
7713209|NCT01061723|26820653|P6|Overall Study|Adverse Event|6
7713210|NCT01061723|26820654|P5|Overall Study|Adverse Event|2
7713211|NCT01061723|26820655|P4|Overall Study|Adverse Event|5
7713212|NCT01061723|26820656|P3|Overall Study|Adverse Event|5
7713213|NCT01061723|26820657|P2|Overall Study|Adverse Event|2
7713214|NCT01061723|26820658|P1|Overall Study|Adverse Event|0
7713215|NCT01061710|26820738|P1|Overall Study|Protocol Violation|14
7713216|NCT01061671|26820748|P2|Overall Study|Death|30
7713217|NCT01061671|26820749|P1|Overall Study|Death|28
7713218|NCT01061671|26820748|P2|Overall Study|Lost to Follow-up|5
7713219|NCT01061671|26820749|P1|Overall Study|Lost to Follow-up|3
7713220|NCT01061671|26820748|P2|Overall Study|Withdrawal by Subject|20
7713221|NCT01061671|26820749|P1|Overall Study|Withdrawal by Subject|16
7713222|NCT01061606|26820761|P1|Overall Study|alternative therapy|2
7713223|NCT01061606|26820761|P1|Overall Study|Disease Progression|4
7713224|NCT01061606|26820761|P1|Overall Study|Death|1
7713225|NCT01061606|26820761|P1|Overall Study|Adverse Event|1
7713226|NCT01061567|26820770|P1|Overall Study|Other reason than stated above|3
7713227|NCT01061567|26820770|P1|Overall Study|Withdrawal by Subject|11
7713228|NCT01061567|26820770|P1|Overall Study|Protocol Violation|1
7713229|NCT01061567|26820770|P1|Overall Study|Lost to Follow-up|24
7713230|NCT01061567|26820770|P1|Overall Study|Lack of Efficacy|3
7713231|NCT01061567|26820770|P1|Overall Study|Death|2
7713232|NCT01061567|26820770|P1|Overall Study|Adverse Event|32
7713233|NCT01061385|26820794|P2|Overall Study|subject decision not related to AE|1
7713234|NCT01061385|26820795|P1|Overall Study|subject decision not related to AE|0
7713235|NCT01061385|26820794|P2|Overall Study|Lost to Follow-up|0
7713236|NCT01061385|26820795|P1|Overall Study|Lost to Follow-up|1
7713237|NCT01061359|26820803|P1|Overall Study|Secondary neoplasm|11
7713238|NCT01061359|26820803|P1|Overall Study|Relapse|187
7713239|NCT01061359|26820803|P1|Overall Study|Lost to Follow-up|1072
7713240|NCT01061359|26820803|P1|Overall Study|Death|32
7713241|NCT01061333|26820809|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
7713242|NCT01061333|26820810|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
7713243|NCT01061177|26820848|P1|Overall Study|Death|4
7713244|NCT01061177|26820848|P1|Overall Study|Administratie problems|4
7713245|NCT01061177|26820848|P1|Overall Study|Abnormal test procedure results|4
7713246|NCT01061177|26820848|P1|Overall Study|Abnormal laboratory values|6
7713247|NCT01061177|26820848|P1|Overall Study|New cancer therapy|9
7713248|NCT01061177|26820848|P1|Overall Study|Lost to Follow-up|9
7713249|NCT01061177|26820848|P1|Overall Study|Protocol Violation|11
7713250|NCT01061177|26820848|P1|Overall Study|Disease progression|17
7713251|NCT01061177|26820848|P1|Overall Study|Withdrawal by Subject|27
7713252|NCT01061177|26820848|P1|Overall Study|Adverse Event|117
7713253|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
7713254|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
7713255|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
7713256|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
7713257|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
7713258|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
7713259|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
7713260|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
7713261|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
7713262|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
7713263|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
7713264|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
7713265|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
7713266|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
7713267|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
7713268|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
7713269|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
7713270|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
7713271|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
7713272|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
7713273|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
7713274|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
7713275|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
7713276|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
7713277|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7713278|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7713279|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7713280|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
7713281|NCT01061151|26820871|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
7713282|NCT01061151|26820872|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
7713283|NCT01061151|26820873|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7713284|NCT01061151|26820874|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7713285|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
7713286|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
7713287|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
7713288|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
7713289|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
7713290|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
7713291|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
7713292|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
7713293|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
7713294|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
7713295|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
7713296|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
7713297|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
7713298|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
7713299|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
7713300|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
7713301|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
7713302|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
7713303|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
7713304|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
7713305|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
7713306|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
7713307|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
7713308|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
7713309|NCT01061151|26820871|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
7713310|NCT01061151|26820872|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
7713311|NCT01061151|26820873|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
7713312|NCT01061151|26820874|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
7713313|NCT01061008|26820933|P2|Overall Study|Adverse Event|1
7713314|NCT01061008|26820934|P1|Overall Study|Adverse Event|0
7713315|NCT01061008|26820933|P2|Overall Study|Unable to exercise following surgery|0
7713316|NCT01061008|26820934|P1|Overall Study|Unable to exercise following surgery|1
7713317|NCT01061008|26820933|P2|Overall Study|Withdrawal by Subject|3
7713318|NCT01061008|26820934|P1|Overall Study|Withdrawal by Subject|1
7713319|NCT01061008|26820933|P2|Overall Study|Death|0
7713320|NCT01061008|26820934|P1|Overall Study|Death|1
7713321|NCT01061008|26820933|P2|Overall Study|Badiocephalic fistula failed|2
7713322|NCT01061008|26820934|P1|Overall Study|Badiocephalic fistula failed|3
7713323|NCT01060670|26820942|P2|Run In|screen failure|238
7713324|NCT01060670|26820943|P1|Run In|screen failure|0
7713325|NCT01060553|26820978|P2|Overall Study|Lack of Efficacy|0
7713326|NCT01060553|26820979|P1|Overall Study|Lack of Efficacy|1
7713327|NCT01060553|26820978|P2|Overall Study|Withdrawal by Subject|5
7713328|NCT01060553|26820979|P1|Overall Study|Withdrawal by Subject|5
7713329|NCT01060553|26820978|P2|Overall Study|Lost to Follow-up|5
7713330|NCT01060553|26820979|P1|Overall Study|Lost to Follow-up|3
7713331|NCT01060540|26820986|P2|Overall Study|Physician Decision|1
7713332|NCT01060540|26820987|P1|Overall Study|Physician Decision|0
7713333|NCT01060540|26820986|P2|Overall Study|Death|1
7713334|NCT01060540|26820987|P1|Overall Study|Death|2
7713335|NCT01060540|26820986|P2|Overall Study|Lost to Follow-up|43
7713336|NCT01060540|26820987|P1|Overall Study|Lost to Follow-up|52
7713337|NCT01060540|26820986|P2|Overall Study|Withdrawal by Subject|20
7713338|NCT01060540|26820987|P1|Overall Study|Withdrawal by Subject|10
7713339|NCT01060384|26821001|P5|Overall Study|Intercurrent illness|1
7713340|NCT01060384|26821002|P4|Overall Study|Intercurrent illness|0
7713341|NCT01060384|26821003|P3|Overall Study|Intercurrent illness|0
7713342|NCT01060384|26821004|P2|Overall Study|Intercurrent illness|0
7713343|NCT01060384|26821005|P1|Overall Study|Intercurrent illness|0
7713344|NCT01060384|26821001|P5|Overall Study|Death|1
7713345|NCT01060384|26821002|P4|Overall Study|Death|0
7713346|NCT01060384|26821003|P3|Overall Study|Death|0
7713347|NCT01060384|26821004|P2|Overall Study|Death|0
7713348|NCT01060384|26821005|P1|Overall Study|Death|0
7713349|NCT01060384|26821001|P5|Overall Study|Withdrawal by Subject|0
7713350|NCT01060384|26821002|P4|Overall Study|Withdrawal by Subject|0
7713351|NCT01060384|26821003|P3|Overall Study|Withdrawal by Subject|0
7713352|NCT01060384|26821004|P2|Overall Study|Withdrawal by Subject|1
7713353|NCT01060384|26821005|P1|Overall Study|Withdrawal by Subject|0
7713354|NCT01060150|26821024|P1|Overall Study|Enrolled, but not treated|2
7713355|NCT01060150|26821024|P1|Overall Study|Withdrawal by Subject|8
7713356|NCT01060150|26821024|P1|Overall Study|Protocol Violation|6
7713357|NCT01060150|26821024|P1|Overall Study|Lost to Follow-up|1
7713358|NCT01060150|26821024|P1|Overall Study|Adverse Event|6
7713359|NCT01060124|26821039|P1|Overall Study|Withdrawal by Subject|7
7713360|NCT01060124|26821039|P1|Overall Study|Adverse Event|14
7713361|NCT01060124|26821039|P1|Overall Study|Other|16
7713362|NCT01060111|26821050|P3|Overall Study|Other|4
7713363|NCT01060111|26821051|P2|Overall Study|Other|3
7713364|NCT01060111|26821052|P1|Overall Study|Other|2
7713365|NCT01060111|26821050|P3|Overall Study|Participants' non-cooperation|0
7713366|NCT01060111|26821051|P2|Overall Study|Participants' non-cooperation|0
7713367|NCT01060111|26821052|P1|Overall Study|Participants' non-cooperation|1
7713368|NCT01060111|26821050|P3|Overall Study|Adverse event and insufficient effect|0
7713369|NCT01060111|26821051|P2|Overall Study|Adverse event and insufficient effect|1
7713370|NCT01060111|26821052|P1|Overall Study|Adverse event and insufficient effect|0
7713371|NCT01060111|26821050|P3|Overall Study|Participants' non-cooperation|6
7713372|NCT01060111|26821051|P2|Overall Study|Participants' non-cooperation|6
7713373|NCT01060111|26821052|P1|Overall Study|Participants' non-cooperation|8
7713374|NCT01060111|26821050|P3|Overall Study|Participants' evasion for hospital visit|2
7713375|NCT01060111|26821051|P2|Overall Study|Participants' evasion for hospital visit|3
7713376|NCT01060111|26821052|P1|Overall Study|Participants' evasion for hospital visit|0
7713377|NCT01060111|26821050|P3|Overall Study|Inappropriate participant|5
7713378|NCT01060111|26821051|P2|Overall Study|Inappropriate participant|4
7713379|NCT01060111|26821052|P1|Overall Study|Inappropriate participant|5
7713380|NCT01060111|26821050|P3|Overall Study|Lack of Efficacy|0
7713381|NCT01060111|26821051|P2|Overall Study|Lack of Efficacy|1
7713382|NCT01060111|26821052|P1|Overall Study|Lack of Efficacy|2
7713383|NCT01060111|26821050|P3|Overall Study|Adverse Event|18
7713384|NCT01060111|26821051|P2|Overall Study|Adverse Event|5
7713385|NCT01060111|26821052|P1|Overall Study|Adverse Event|9
7713386|NCT01060072|26821084|P2|Overall Study|Excluded Medications|1
7713387|NCT01060072|26821085|P1|Overall Study|Excluded Medications|0
7713388|NCT01060072|26821084|P2|Overall Study|Acute cholecystitis|0
7713389|NCT01060072|26821085|P1|Overall Study|Acute cholecystitis|1
7713390|NCT01060072|26821084|P2|Overall Study|Protocol Violation|1
7713391|NCT01060072|26821085|P1|Overall Study|Protocol Violation|0
7713392|NCT01060072|26821084|P2|Overall Study|Physician Decision|2
7713393|NCT01060072|26821085|P1|Overall Study|Physician Decision|0
7713394|NCT01060072|26821084|P2|Overall Study|Adverse Event|1
7713395|NCT01060072|26821085|P1|Overall Study|Adverse Event|1
7713396|NCT01060059|26821101|P2|Overall Study|lack of compliance|2
7713397|NCT01060059|26821102|P1|Overall Study|lack of compliance|5
7713398|NCT01060059|26821101|P2|Overall Study|lack of glycemic control|1
7713399|NCT01060059|26821102|P1|Overall Study|lack of glycemic control|2
7713400|NCT01060059|26821101|P2|Overall Study|Withdrawal by Subject|23
7713401|NCT01060059|26821102|P1|Overall Study|Withdrawal by Subject|35
7713402|NCT01060059|26821101|P2|Overall Study|entry criteria not met|3
7713403|NCT01060059|26821102|P1|Overall Study|entry criteria not met|4
7713404|NCT01060059|26821101|P2|Overall Study|Lost to Follow-up|34
7713405|NCT01060059|26821102|P1|Overall Study|Lost to Follow-up|18
7713406|NCT01060059|26821101|P2|Overall Study|Death|3
7713407|NCT01060059|26821102|P1|Overall Study|Death|2
7713408|NCT01060059|26821101|P2|Overall Study|Adverse Event|1
7713409|NCT01060059|26821102|P1|Overall Study|Adverse Event|1
7713410|NCT01060007|26821160|P1|Overall Study|Inevaluable for response at surgery|3
7713411|NCT01060007|26821160|P1|Overall Study|Withdrawal by Subject|1
7713412|NCT01059903|26821228|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
7713413|NCT01059903|26821229|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
7713414|NCT01059864|26821272|P3|Double-Blind Treatment Phase|Adverse Event|3
7713415|NCT01059864|26821273|P2|Double-Blind Treatment Phase|Adverse Event|3
7713416|NCT01059864|26821274|P1|Double-Blind Treatment Phase|Adverse Event|0
7713417|NCT01059864|26821272|P3|Open-Label Run-In Phase|Protocol Violation|0
7713418|NCT01059864|26821273|P2|Open-Label Run-In Phase|Protocol Violation|0
7713419|NCT01059864|26821274|P1|Open-Label Run-In Phase|Protocol Violation|2
7713420|NCT01059864|26821272|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
7713421|NCT01059864|26821273|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
7713422|NCT01059864|26821274|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
7713423|NCT01059864|26821272|P3|Open-Label Run-In Phase|Lost to Follow-up|0
7713424|NCT01059864|26821273|P2|Open-Label Run-In Phase|Lost to Follow-up|0
7713425|NCT01059864|26821274|P1|Open-Label Run-In Phase|Lost to Follow-up|2
7713426|NCT01059864|26821272|P3|Open-Label Run-In Phase|Lack of Efficacy|0
7713427|NCT01059864|26821273|P2|Open-Label Run-In Phase|Lack of Efficacy|0
7713428|NCT01059864|26821274|P1|Open-Label Run-In Phase|Lack of Efficacy|1
7713429|NCT01059864|26821272|P3|Open-Label Run-In Phase|Adverse Event|0
7713430|NCT01059864|26821273|P2|Open-Label Run-In Phase|Adverse Event|0
7713431|NCT01059864|26821274|P1|Open-Label Run-In Phase|Adverse Event|7
7713432|NCT01059825|26821348|P7|Treatment Period|Adverse event not related to study drug|0
7713433|NCT01059825|26821349|P6|Treatment Period|Adverse event not related to study drug|1
7713434|NCT01059825|26821350|P5|Treatment Period|Adverse event not related to study drug|1
7713435|NCT01059825|26821351|P4|Treatment Period|Adverse event not related to study drug|1
7713436|NCT01059825|26821352|P3|Treatment Period|Adverse event not related to study drug|2
7713437|NCT01059825|26821353|P2|Treatment Period|Adverse event not related to study drug|1
7713438|NCT01059825|26821354|P1|Treatment Period|Adverse event not related to study drug|0
7713439|NCT01059825|26821348|P7|Treatment Period|Insufficient clinical response|0
7713440|NCT01059825|26821349|P6|Treatment Period|Insufficient clinical response|0
7713441|NCT01059825|26821350|P5|Treatment Period|Insufficient clinical response|0
7713442|NCT01059825|26821351|P4|Treatment Period|Insufficient clinical response|0
7713443|NCT01059825|26821352|P3|Treatment Period|Insufficient clinical response|0
7713444|NCT01059825|26821353|P2|Treatment Period|Insufficient clinical response|0
7713445|NCT01059825|26821354|P1|Treatment Period|Insufficient clinical response|3
7713446|NCT01059825|26821348|P7|Treatment Period|Adverse event related to study drug|0
7713447|NCT01059825|26821349|P6|Treatment Period|Adverse event related to study drug|0
7713448|NCT01059825|26821350|P5|Treatment Period|Adverse event related to study drug|0
7713449|NCT01059825|26821351|P4|Treatment Period|Adverse event related to study drug|1
7713450|NCT01059825|26821352|P3|Treatment Period|Adverse event related to study drug|1
7713451|NCT01059825|26821353|P2|Treatment Period|Adverse event related to study drug|0
7713452|NCT01059825|26821354|P1|Treatment Period|Adverse event related to study drug|1
7713453|NCT01059825|26821348|P7|Treatment Period|Protocol Violation|0
7713454|NCT01059825|26821349|P6|Treatment Period|Protocol Violation|1
7713455|NCT01059825|26821350|P5|Treatment Period|Protocol Violation|1
7713456|NCT01059825|26821351|P4|Treatment Period|Protocol Violation|1
7713457|NCT01059825|26821352|P3|Treatment Period|Protocol Violation|1
7713458|NCT01059825|26821353|P2|Treatment Period|Protocol Violation|0
7713459|NCT01059825|26821354|P1|Treatment Period|Protocol Violation|0
7713460|NCT01059825|26821348|P7|Treatment Period|Other reason not specified|0
7713461|NCT01059825|26821349|P6|Treatment Period|Other reason not specified|0
7713462|NCT01059825|26821350|P5|Treatment Period|Other reason not specified|0
7713463|NCT01059825|26821351|P4|Treatment Period|Other reason not specified|2
7713464|NCT01059825|26821352|P3|Treatment Period|Other reason not specified|1
7713465|NCT01059825|26821353|P2|Treatment Period|Other reason not specified|2
7713466|NCT01059825|26821354|P1|Treatment Period|Other reason not specified|1
7713467|NCT01059825|26821348|P7|Treatment Period|Withdrawal by Subject|0
7713468|NCT01059825|26821349|P6|Treatment Period|Withdrawal by Subject|1
7713469|NCT01059825|26821350|P5|Treatment Period|Withdrawal by Subject|4
7713470|NCT01059825|26821351|P4|Treatment Period|Withdrawal by Subject|5
7713471|NCT01059825|26821352|P3|Treatment Period|Withdrawal by Subject|1
7713472|NCT01059825|26821353|P2|Treatment Period|Withdrawal by Subject|0
7713473|NCT01059825|26821354|P1|Treatment Period|Withdrawal by Subject|3
7713474|NCT01059825|26821348|P7|Treatment Period|Lost to Follow-up|0
7713475|NCT01059825|26821349|P6|Treatment Period|Lost to Follow-up|0
7713476|NCT01059825|26821350|P5|Treatment Period|Lost to Follow-up|2
7713477|NCT01059825|26821351|P4|Treatment Period|Lost to Follow-up|1
7713478|NCT01059825|26821352|P3|Treatment Period|Lost to Follow-up|0
7713479|NCT01059825|26821353|P2|Treatment Period|Lost to Follow-up|1
7713480|NCT01059825|26821354|P1|Treatment Period|Lost to Follow-up|2
7713481|NCT01059825|26821348|P7|Enrolled, Run-in Period|Protocol Violation|5
7713482|NCT01059825|26821349|P6|Enrolled, Run-in Period|Protocol Violation|0
7713483|NCT01059825|26821350|P5|Enrolled, Run-in Period|Protocol Violation|0
7713484|NCT01059825|26821351|P4|Enrolled, Run-in Period|Protocol Violation|0
7713485|NCT01059825|26821352|P3|Enrolled, Run-in Period|Protocol Violation|0
7713486|NCT01059825|26821353|P2|Enrolled, Run-in Period|Protocol Violation|0
7713487|NCT01059825|26821354|P1|Enrolled, Run-in Period|Protocol Violation|0
7713488|NCT01059825|26821348|P7|Enrolled, Run-in Period|Other reason not specified|7
7713489|NCT01059825|26821349|P6|Enrolled, Run-in Period|Other reason not specified|0
7713490|NCT01059825|26821350|P5|Enrolled, Run-in Period|Other reason not specified|0
7713491|NCT01059825|26821351|P4|Enrolled, Run-in Period|Other reason not specified|0
7713492|NCT01059825|26821352|P3|Enrolled, Run-in Period|Other reason not specified|0
7713493|NCT01059825|26821353|P2|Enrolled, Run-in Period|Other reason not specified|0
7713494|NCT01059825|26821354|P1|Enrolled, Run-in Period|Other reason not specified|0
7713495|NCT01059825|26821348|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
7713496|NCT01059825|26821349|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
7713497|NCT01059825|26821350|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
7713498|NCT01059825|26821351|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
7713499|NCT01059825|26821352|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
7713500|NCT01059825|26821353|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
7713501|NCT01059825|26821354|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
7713502|NCT01059825|26821348|P7|Enrolled, Run-in Period|Lost to Follow-up|5
7713503|NCT01059825|26821349|P6|Enrolled, Run-in Period|Lost to Follow-up|0
7713504|NCT01059825|26821350|P5|Enrolled, Run-in Period|Lost to Follow-up|0
7713505|NCT01059825|26821351|P4|Enrolled, Run-in Period|Lost to Follow-up|0
7713506|NCT01059825|26821352|P3|Enrolled, Run-in Period|Lost to Follow-up|0
7713507|NCT01059825|26821353|P2|Enrolled, Run-in Period|Lost to Follow-up|0
7713508|NCT01059825|26821354|P1|Enrolled, Run-in Period|Lost to Follow-up|0
7713509|NCT01059825|26821348|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
7713510|NCT01059825|26821349|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
7713511|NCT01059825|26821350|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
7713512|NCT01059825|26821351|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
7713513|NCT01059825|26821352|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
7713514|NCT01059825|26821353|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
7713515|NCT01059825|26821354|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
7713516|NCT01059825|26821348|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
7713517|NCT01059825|26821349|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
7713518|NCT01059825|26821350|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
7713519|NCT01059825|26821351|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
7713520|NCT01059825|26821352|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
7713521|NCT01059825|26821353|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
7713522|NCT01059825|26821354|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
7713523|NCT01059812|26821541|P2|Overall Study|Unclassified|4
7713524|NCT01059812|26821542|P1|Overall Study|Unclassified|14
7713525|NCT01059812|26821541|P2|Overall Study|Withdrawal Criteria|4
7713526|NCT01059812|26821542|P1|Overall Study|Withdrawal Criteria|9
7713527|NCT01059812|26821541|P2|Overall Study|Protocol Violation|1
7713528|NCT01059812|26821542|P1|Overall Study|Protocol Violation|3
7713529|NCT01059812|26821541|P2|Overall Study|Lack of Efficacy|2
7713530|NCT01059812|26821542|P1|Overall Study|Lack of Efficacy|2
7713531|NCT01059812|26821541|P2|Overall Study|Adverse Event|5
7713532|NCT01059812|26821542|P1|Overall Study|Adverse Event|9
7713533|NCT01059799|26821558|P2|Overall Study|Other|3
7713534|NCT01059799|26821559|P1|Overall Study|Other|12
7713535|NCT01059799|26821558|P2|Overall Study|Withdrawal criteria|2
7713536|NCT01059799|26821559|P1|Overall Study|Withdrawal criteria|13
7713537|NCT01059799|26821558|P2|Overall Study|Protocol Violation|2
7713538|NCT01059799|26821559|P1|Overall Study|Protocol Violation|3
7713539|NCT01059799|26821558|P2|Overall Study|Lack of Efficacy|0
7713540|NCT01059799|26821559|P1|Overall Study|Lack of Efficacy|1
7713541|NCT01059799|26821558|P2|Overall Study|Adverse Event|3
7713542|NCT01059799|26821559|P1|Overall Study|Adverse Event|2
7713543|NCT01059773|26821573|P2|Overall Study|Other|3
7713544|NCT01059773|26821574|P1|Overall Study|Other|1
7713545|NCT01059773|26821573|P2|Overall Study|Ineligible follow TB screening criteria|1
7713546|NCT01059773|26821574|P1|Overall Study|Ineligible follow TB screening criteria|0
7713547|NCT01059773|26821573|P2|Overall Study|Malignancy including squamous cell skin|1
7713548|NCT01059773|26821574|P1|Overall Study|Malignancy including squamous cell skin|0
7713549|NCT01059773|26821573|P2|Overall Study|Death|1
7713550|NCT01059773|26821574|P1|Overall Study|Death|0
7713551|NCT01059773|26821573|P2|Overall Study|Lack of Efficacy|3
7713552|NCT01059773|26821574|P1|Overall Study|Lack of Efficacy|3
7713553|NCT01059773|26821573|P2|Overall Study|Physician Decision|4
7713554|NCT01059773|26821574|P1|Overall Study|Physician Decision|5
7713555|NCT01059773|26821573|P2|Overall Study|Protocol Violation|2
7713556|NCT01059773|26821574|P1|Overall Study|Protocol Violation|6
7713557|NCT01059773|26821573|P2|Overall Study|Pregnancy|1
7713558|NCT01059773|26821574|P1|Overall Study|Pregnancy|1
7713559|NCT01059773|26821573|P2|Overall Study|Lost to Follow-up|1
7713560|NCT01059773|26821574|P1|Overall Study|Lost to Follow-up|1
7713561|NCT01059773|26821573|P2|Overall Study|Withdrawal by Subject|5
7713562|NCT01059773|26821574|P1|Overall Study|Withdrawal by Subject|1
7713563|NCT01059773|26821573|P2|Overall Study|Adverse Event|2
7713564|NCT01059773|26821574|P1|Overall Study|Adverse Event|2
7713565|NCT01059643|26821730|P1|Overall Study|Physician Decision|1
7713566|NCT01059643|26821730|P1|Overall Study|Withdrawal by Subject|2
7713567|NCT01059643|26821730|P1|Overall Study|Adverse Event|3
7713568|NCT01059630|26821745|P2|Overall Study|Withdrawal by Subject|14
7713569|NCT01059630|26821746|P1|Overall Study|Withdrawal by Subject|21
7713570|NCT01059630|26821745|P2|Overall Study|Physician Decision|4
7713571|NCT01059630|26821746|P1|Overall Study|Physician Decision|2
7713572|NCT01059630|26821745|P2|Overall Study|Lost to Follow-up|1
7713573|NCT01059630|26821746|P1|Overall Study|Lost to Follow-up|4
7713574|NCT01059630|26821745|P2|Overall Study|Death|84
7713575|NCT01059630|26821746|P1|Overall Study|Death|100
7713576|NCT01059617|26821820|P4|Overall Study|Other|6
7713577|NCT01059617|26821821|P3|Overall Study|Other|8
7713578|NCT01059617|26821822|P2|Overall Study|Other|1
7713579|NCT01059617|26821823|P1|Overall Study|Other|7
7713580|NCT01059565|26821993|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
7713581|NCT01059565|26821994|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
7713582|NCT01059565|26821993|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
7713583|NCT01059565|26821994|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
7713584|NCT01059565|26821993|P2|24-Week Open-Label Phase|Subject noncompliance|0
7713585|NCT01059565|26821994|P1|24-Week Open-Label Phase|Subject noncompliance|1
7713586|NCT01059565|26821993|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
7713587|NCT01059565|26821994|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
7713588|NCT01059565|26821993|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
7713589|NCT01059565|26821994|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
7713590|NCT01059565|26821993|P2|24-Week Open-Label Phase|Adverse Event|0
7713591|NCT01059565|26821994|P1|24-Week Open-Label Phase|Adverse Event|2
7713592|NCT01059565|26821993|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
7713593|NCT01059565|26821994|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
7713594|NCT01059565|26821993|P2|24-Week Randomized Phase|Lost to Follow-up|1
7713595|NCT01059565|26821994|P1|24-Week Randomized Phase|Lost to Follow-up|0
7713596|NCT01059565|26821993|P2|24-Week Randomized Phase|Withdrawal by Subject|1
7713597|NCT01059565|26821994|P1|24-Week Randomized Phase|Withdrawal by Subject|3
7713598|NCT01059565|26821993|P2|24-Week Randomized Phase|Adverse Event|0
7713599|NCT01059565|26821994|P1|24-Week Randomized Phase|Adverse Event|5
7713600|NCT01059565|26821993|P2|24-Week Randomized Phase|Randomized but not treated|0
7713601|NCT01059565|26821994|P1|24-Week Randomized Phase|Randomized but not treated|1
7713602|NCT01059539|26822028|P1|Overall Study|Reason Not Specified|2
7713603|NCT01059539|26822028|P1|Overall Study|Lost to Follow-up|42
7713604|NCT01059539|26822028|P1|Overall Study|Withdrawal of Consent|80
7713605|NCT01059539|26822028|P1|Overall Study|Protocol Violation|55
7713606|NCT01059539|26822028|P1|Overall Study|Insufficient Therapeutic Response|26
7713607|NCT01059539|26822028|P1|Overall Study|Adverse Event|66
7713608|NCT01059526|26822035|P2|Overall Study|Patient found to be dermatographic|0
7713609|NCT01059526|26822036|P1|Overall Study|Patient found to be dermatographic|1
7713610|NCT01059526|26822035|P2|Overall Study|Lost to Follow-up|1
7713611|NCT01059526|26822036|P1|Overall Study|Lost to Follow-up|4
7713612|NCT01059526|26822035|P2|Overall Study|Withdrawal by Subject|1
7713613|NCT01059526|26822036|P1|Overall Study|Withdrawal by Subject|3
7713614|NCT01059526|26822035|P2|Overall Study|Protocol Violation|1
7713615|NCT01059526|26822036|P1|Overall Study|Protocol Violation|0
7713616|NCT01059526|26822035|P2|Overall Study|Adverse Event|2
7713617|NCT01059526|26822036|P1|Overall Study|Adverse Event|2
7713618|NCT01059526|26822035|P2|Overall Study|Patient enrolled but not treated|17
7713619|NCT01059526|26822036|P1|Overall Study|Patient enrolled but not treated|20
7713620|NCT01059344|26822382|P2|Overall Study|Other|6
7713621|NCT01059344|26822383|P1|Overall Study|Other|3
7713622|NCT01059344|26822382|P2|Overall Study|Lost to Follow-up|1
7713623|NCT01059344|26822383|P1|Overall Study|Lost to Follow-up|1
7713624|NCT01059344|26822382|P2|Overall Study|Withdrawal by Subject|9
7713625|NCT01059344|26822383|P1|Overall Study|Withdrawal by Subject|6
7713626|NCT01059344|26822382|P2|Overall Study|Adverse Event|30
7713627|NCT01059344|26822383|P1|Overall Study|Adverse Event|12
7713628|NCT01059318|26822401|P1|Extension (36 Week)|Adverse Event|3
7713629|NCT01059318|26822401|P1|Core Study (26 Week)|Withdrawal by Subject|1
7713630|NCT01059318|26822401|P1|Core Study (26 Week)|Adverse Event|3
7713631|NCT01059175|26822422|P2|Overall Study|Lost to Follow-up|1
7713632|NCT01059175|26822423|P1|Overall Study|Lost to Follow-up|0
7713633|NCT01059175|26822422|P2|Overall Study|Adverse Event|2
7713634|NCT01059175|26822423|P1|Overall Study|Adverse Event|4
7713635|NCT01059175|26822422|P2|Overall Study|Death|17
7713636|NCT01059175|26822423|P1|Overall Study|Death|17
7713637|NCT01059071|26822445|P4|Overall Study|Physician Decision|1
7713638|NCT01059071|26822446|P3|Overall Study|Physician Decision|0
7713639|NCT01059071|26822447|P2|Overall Study|Physician Decision|0
7713640|NCT01059071|26822448|P1|Overall Study|Physician Decision|0
7713641|NCT01059071|26822445|P4|Overall Study|Withdrawal by Subject|2
7713642|NCT01059071|26822446|P3|Overall Study|Withdrawal by Subject|0
7713643|NCT01059071|26822447|P2|Overall Study|Withdrawal by Subject|0
7713644|NCT01059071|26822448|P1|Overall Study|Withdrawal by Subject|1
7713645|NCT01059071|26822445|P4|Overall Study|Lack of Efficacy|3
7713646|NCT01059071|26822446|P3|Overall Study|Lack of Efficacy|2
7713647|NCT01059071|26822447|P2|Overall Study|Lack of Efficacy|4
7713648|NCT01059071|26822448|P1|Overall Study|Lack of Efficacy|1
7713649|NCT01058863|26822475|P1|Overall Study|Randomized in error|1
7713650|NCT01058863|26822475|P1|Overall Study|Sponsor requested withdrawal|1
7713651|NCT01058863|26822475|P1|Overall Study|Withdrawal by Subject|1
7713652|NCT01058863|26822475|P1|Overall Study|Lost to Follow-up|1
7713653|NCT01058707|26822500|P7|Overall Study|Reason Not Specified|7
7713654|NCT01058707|26822501|P6|Overall Study|Reason Not Specified|1
7713655|NCT01058707|26822502|P5|Overall Study|Reason Not Specified|7
7713656|NCT01058707|26822503|P4|Overall Study|Reason Not Specified|0
7713657|NCT01058707|26822504|P3|Overall Study|Reason Not Specified|2
7713658|NCT01058707|26822505|P2|Overall Study|Reason Not Specified|3
7713659|NCT01058707|26822506|P1|Overall Study|Reason Not Specified|0
7713660|NCT01058707|26822500|P7|Overall Study|Lost to Follow-up|0
7713661|NCT01058707|26822501|P6|Overall Study|Lost to Follow-up|0
7713662|NCT01058707|26822502|P5|Overall Study|Lost to Follow-up|0
7713663|NCT01058707|26822503|P4|Overall Study|Lost to Follow-up|0
7713664|NCT01058707|26822504|P3|Overall Study|Lost to Follow-up|1
7713665|NCT01058707|26822505|P2|Overall Study|Lost to Follow-up|0
7713666|NCT01058707|26822506|P1|Overall Study|Lost to Follow-up|0
7713667|NCT01058707|26822500|P7|Overall Study|Subject Decision|6
7713668|NCT01058707|26822501|P6|Overall Study|Subject Decision|3
7713669|NCT01058707|26822502|P5|Overall Study|Subject Decision|2
7713670|NCT01058707|26822503|P4|Overall Study|Subject Decision|1
7713671|NCT01058707|26822504|P3|Overall Study|Subject Decision|3
7713672|NCT01058707|26822505|P2|Overall Study|Subject Decision|3
7713673|NCT01058707|26822506|P1|Overall Study|Subject Decision|5
7713674|NCT01058707|26822500|P7|Overall Study|Adverse Event|1
7713675|NCT01058707|26822501|P6|Overall Study|Adverse Event|3
7713676|NCT01058707|26822502|P5|Overall Study|Adverse Event|7
7713677|NCT01058707|26822503|P4|Overall Study|Adverse Event|6
7713678|NCT01058707|26822504|P3|Overall Study|Adverse Event|7
7713679|NCT01058707|26822505|P2|Overall Study|Adverse Event|4
7713680|NCT01058707|26822506|P1|Overall Study|Adverse Event|11
7713681|NCT01058707|26822500|P7|Overall Study|Disease Progression|12
7713682|NCT01058707|26822501|P6|Overall Study|Disease Progression|10
7713683|NCT01058707|26822502|P5|Overall Study|Disease Progression|23
7713684|NCT01058707|26822503|P4|Overall Study|Disease Progression|15
7713685|NCT01058707|26822504|P3|Overall Study|Disease Progression|20
7713686|NCT01058707|26822505|P2|Overall Study|Disease Progression|20
7713687|NCT01058707|26822506|P1|Overall Study|Disease Progression|15
7713688|NCT01058668|26822672|P3|Double-blind Treatment Phase|Other Unspecified|0
7713689|NCT01058668|26822673|P2|Double-blind Treatment Phase|Other Unspecified|1
7713690|NCT01058668|26822674|P1|Double-blind Treatment Phase|Other Unspecified|1
7713691|NCT01058668|26822672|P3|Double-blind Treatment Phase|Lost to Follow-up|1
7713692|NCT01058668|26822673|P2|Double-blind Treatment Phase|Lost to Follow-up|1
7713693|NCT01058668|26822674|P1|Double-blind Treatment Phase|Lost to Follow-up|0
7713694|NCT01058668|26822672|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
7713695|NCT01058668|26822673|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
7713696|NCT01058668|26822674|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
7713697|NCT01058668|26822672|P3|Double-blind Treatment Phase|Protocol Violation|2
7713698|NCT01058668|26822673|P2|Double-blind Treatment Phase|Protocol Violation|1
7713699|NCT01058668|26822674|P1|Double-blind Treatment Phase|Protocol Violation|1
7713700|NCT01058668|26822672|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
7713701|NCT01058668|26822673|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
7713702|NCT01058668|26822674|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
7713703|NCT01058668|26822672|P3|Double-blind Treatment Phase|Adverse Event|25
7713704|NCT01058668|26822673|P2|Double-blind Treatment Phase|Adverse Event|15
7713705|NCT01058668|26822674|P1|Double-blind Treatment Phase|Adverse Event|8
7713706|NCT01058655|26822689|P4|Overall Study|Other|4
7713707|NCT01058655|26822690|P3|Overall Study|Other|0
7713708|NCT01058655|26822691|P2|Overall Study|Other|0
7713709|NCT01058655|26822692|P1|Overall Study|Other|0
7713710|NCT01058655|26822689|P4|Overall Study|Disease Progression|24
7713711|NCT01058655|26822690|P3|Overall Study|Disease Progression|4
7713712|NCT01058655|26822691|P2|Overall Study|Disease Progression|2
7713713|NCT01058655|26822692|P1|Overall Study|Disease Progression|1
7713714|NCT01058655|26822689|P4|Overall Study|Death|0
7713715|NCT01058655|26822690|P3|Overall Study|Death|1
7713716|NCT01058655|26822691|P2|Overall Study|Death|1
7713717|NCT01058655|26822692|P1|Overall Study|Death|0
7713718|NCT01058655|26822689|P4|Overall Study|Clinical Progression (non-RECIST)|7
7713719|NCT01058655|26822690|P3|Overall Study|Clinical Progression (non-RECIST)|0
7713720|NCT01058655|26822691|P2|Overall Study|Clinical Progression (non-RECIST)|0
7713721|NCT01058655|26822692|P1|Overall Study|Clinical Progression (non-RECIST)|1
7713722|NCT01058655|26822689|P4|Overall Study|Symptomatic Deterioration|1
7713723|NCT01058655|26822690|P3|Overall Study|Symptomatic Deterioration|0
7713724|NCT01058655|26822691|P2|Overall Study|Symptomatic Deterioration|0
7713725|NCT01058655|26822692|P1|Overall Study|Symptomatic Deterioration|0
7713726|NCT01058655|26822689|P4|Overall Study|Prolonged Treatment Delay|2
7713727|NCT01058655|26822690|P3|Overall Study|Prolonged Treatment Delay|0
7713728|NCT01058655|26822691|P2|Overall Study|Prolonged Treatment Delay|0
7713729|NCT01058655|26822692|P1|Overall Study|Prolonged Treatment Delay|0
7713730|NCT01058655|26822689|P4|Overall Study|Withdrawal by Subject|4
7713731|NCT01058655|26822690|P3|Overall Study|Withdrawal by Subject|3
7713732|NCT01058655|26822691|P2|Overall Study|Withdrawal by Subject|0
7713733|NCT01058655|26822692|P1|Overall Study|Withdrawal by Subject|1
7713734|NCT01058642|26822710|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
7713735|NCT01058642|26822711|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
7713736|NCT01058642|26822712|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
7713737|NCT01058642|26822713|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
7713738|NCT01058642|26822710|P4|Treatment Period 1|Protocol Violation|1
7713739|NCT01058642|26822711|P3|Treatment Period 1|Protocol Violation|0
7713740|NCT01058642|26822712|P2|Treatment Period 1|Protocol Violation|0
7713741|NCT01058642|26822713|P1|Treatment Period 1|Protocol Violation|0
7713742|NCT01058642|26822710|P4|Treatment Period 1|Lack of Efficacy|1
7713743|NCT01058642|26822711|P3|Treatment Period 1|Lack of Efficacy|0
7713744|NCT01058642|26822712|P2|Treatment Period 1|Lack of Efficacy|0
7713745|NCT01058642|26822713|P1|Treatment Period 1|Lack of Efficacy|0
7713746|NCT01058642|26822710|P4|Treatment Period 1|Withdrawal by Subject|0
7713747|NCT01058642|26822711|P3|Treatment Period 1|Withdrawal by Subject|0
7713748|NCT01058642|26822712|P2|Treatment Period 1|Withdrawal by Subject|0
7713749|NCT01058642|26822713|P1|Treatment Period 1|Withdrawal by Subject|1
7713750|NCT01058642|26822710|P4|Treatment Period 1|Physician Decision|0
7713751|NCT01058642|26822711|P3|Treatment Period 1|Physician Decision|1
7713752|NCT01058642|26822712|P2|Treatment Period 1|Physician Decision|0
7713753|NCT01058642|26822713|P1|Treatment Period 1|Physician Decision|0
7713754|NCT01058642|26822710|P4|Treatment Period 1|Adverse Event|0
7713755|NCT01058642|26822711|P3|Treatment Period 1|Adverse Event|1
7713756|NCT01058642|26822712|P2|Treatment Period 1|Adverse Event|1
7713757|NCT01058642|26822713|P1|Treatment Period 1|Adverse Event|0
7713758|NCT01058421|26822723|P2|6 Month Outcomes|Remained in Other Facility|3
7713759|NCT01058421|26822724|P1|6 Month Outcomes|Remained in Other Facility|1
7713760|NCT01058421|26822723|P2|6 Month Outcomes|Lost to Follow-up|21
7713761|NCT01058421|26822724|P1|6 Month Outcomes|Lost to Follow-up|16
7713762|NCT01058421|26822723|P2|6 Month Outcomes|Death|2
7713763|NCT01058421|26822724|P1|6 Month Outcomes|Death|2
7713764|NCT01058421|26822723|P2|3 Month Outcomes|Remained in Other Facility|8
7713765|NCT01058421|26822724|P1|3 Month Outcomes|Remained in Other Facility|5
7713766|NCT01058421|26822723|P2|3 Month Outcomes|Remained in Hospital|2
7713767|NCT01058421|26822724|P1|3 Month Outcomes|Remained in Hospital|0
7713768|NCT01058421|26822723|P2|3 Month Outcomes|Lost to Follow-up|11
7713769|NCT01058421|26822724|P1|3 Month Outcomes|Lost to Follow-up|12
7713770|NCT01058421|26822723|P2|3 Month Outcomes|Death|5
7713771|NCT01058421|26822724|P1|3 Month Outcomes|Death|3
7713772|NCT01058421|26822723|P2|1 Month Outcomes|Remained in Other Facility|17
7713773|NCT01058421|26822724|P1|1 Month Outcomes|Remained in Other Facility|16
7713774|NCT01058421|26822723|P2|1 Month Outcomes|Remained in Hospital|12
7713775|NCT01058421|26822724|P1|1 Month Outcomes|Remained in Hospital|5
7713776|NCT01058421|26822723|P2|1 Month Outcomes|Lost to Follow-up|7
7713777|NCT01058421|26822724|P1|1 Month Outcomes|Lost to Follow-up|8
7713778|NCT01058421|26822723|P2|1 Month Outcomes|Death|6
7713779|NCT01058421|26822724|P1|1 Month Outcomes|Death|10
7713780|NCT01058395|26822748|P2|Overall Study|Lost to Follow-up|0
7713781|NCT01058395|26822749|P1|Overall Study|Lost to Follow-up|1
7713782|NCT01058395|26822748|P2|Overall Study|Death|1
7713783|NCT01058395|26822749|P1|Overall Study|Death|2
7713784|NCT01058369|26822758|P1|Overall Study|Early termination study|1
7713785|NCT01058369|26822758|P1|Overall Study|Adverse Event|1
7713786|NCT01058356|26822762|P1|Overall Study|Lost to Follow-up|4
7713787|NCT01058356|26822762|P1|Overall Study|Withdrawal by Subject|21
7713788|NCT01058356|26822762|P1|Overall Study|Administration of contraindicated drugs|12
7713789|NCT01058356|26822762|P1|Overall Study|Adverse Event|5
7713790|NCT01058304|26822769|P2|Overall Study|Developed exclusion criterion|12
7713791|NCT01058304|26822770|P1|Overall Study|Developed exclusion criterion|6
7713792|NCT01058304|26822769|P2|Overall Study|Lost to Follow-up|16
7713793|NCT01058304|26822770|P1|Overall Study|Lost to Follow-up|13
7713794|NCT01058304|26822769|P2|Overall Study|Withdrawal by Subject|5
7713795|NCT01058304|26822770|P1|Overall Study|Withdrawal by Subject|8
7713796|NCT01058265|26822780|P2|Overall Study|Lost to Follow-up|12
7713797|NCT01058265|26822781|P1|Overall Study|Lost to Follow-up|11
7713798|NCT01058096|26822800|P2|Double-blind Treatment Phase|Other Unspecified|0
7713799|NCT01058096|26822801|P1|Double-blind Treatment Phase|Other Unspecified|2
7713800|NCT01058096|26822800|P2|Double-blind Treatment Phase|Lost to Follow-up|1
7713801|NCT01058096|26822801|P1|Double-blind Treatment Phase|Lost to Follow-up|0
7713802|NCT01058096|26822800|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
7713803|NCT01058096|26822801|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
7713804|NCT01058096|26822800|P2|Double-blind Treatment Phase|Protocol Violation|1
7713805|NCT01058096|26822801|P1|Double-blind Treatment Phase|Protocol Violation|2
7713806|NCT01058096|26822800|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
7713807|NCT01058096|26822801|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
7713808|NCT01058096|26822800|P2|Double-blind Treatment Phase|Adverse Event|15
7713809|NCT01058096|26822801|P1|Double-blind Treatment Phase|Adverse Event|11
7713810|NCT01058005|26822817|P3|Overall Study|Reason Missing|1
7713811|NCT01058005|26822818|P2|Overall Study|Reason Missing|3
7713812|NCT01058005|26822819|P1|Overall Study|Reason Missing|5
7713813|NCT01058005|26822817|P3|Overall Study|Withdrawn Due to Study Termination|7
7713814|NCT01058005|26822818|P2|Overall Study|Withdrawn Due to Study Termination|13
7713815|NCT01058005|26822819|P1|Overall Study|Withdrawn Due to Study Termination|27
7713816|NCT01058005|26822817|P3|Overall Study|Withdrawal by Subject|11
7713817|NCT01058005|26822818|P2|Overall Study|Withdrawal by Subject|5
7713818|NCT01058005|26822819|P1|Overall Study|Withdrawal by Subject|4
7713819|NCT01058005|26822817|P3|Overall Study|Physician Decision|0
7713820|NCT01058005|26822818|P2|Overall Study|Physician Decision|2
7713821|NCT01058005|26822819|P1|Overall Study|Physician Decision|2
7713822|NCT01058005|26822817|P3|Overall Study|Adverse Event|1
7713823|NCT01058005|26822818|P2|Overall Study|Adverse Event|2
7713824|NCT01058005|26822819|P1|Overall Study|Adverse Event|0
7713825|NCT01057862|26822854|P2|Overall Study|Withdrawal by Subject|2
7713826|NCT01057862|26822855|P1|Overall Study|Withdrawal by Subject|1
7713827|NCT01057810|26822865|P2|Overall Study|Other|14
7713828|NCT01057810|26822866|P1|Overall Study|Other|7
7713829|NCT01057810|26822865|P2|Overall Study|No longer met study criteria|1
7713830|NCT01057810|26822866|P1|Overall Study|No longer met study criteria|0
7713831|NCT01057810|26822865|P2|Overall Study|Poor/non-compliance|1
7713832|NCT01057810|26822866|P1|Overall Study|Poor/non-compliance|0
7713833|NCT01057810|26822865|P2|Overall Study|Maximum clinical benefit|5
7713834|NCT01057810|26822866|P1|Overall Study|Maximum clinical benefit|5
7713835|NCT01057810|26822865|P2|Overall Study|Death|12
7713836|NCT01057810|26822866|P1|Overall Study|Death|2
7713837|NCT01057810|26822865|P2|Overall Study|Withdrawal by Subject|25
7713838|NCT01057810|26822866|P1|Overall Study|Withdrawal by Subject|10
7713839|NCT01057810|26822865|P2|Overall Study|Adverse event unrelated to study drug|29
7713840|NCT01057810|26822866|P1|Overall Study|Adverse event unrelated to study drug|13
7713841|NCT01057810|26822865|P2|Overall Study|Study drug toxicity|114
7713842|NCT01057810|26822866|P1|Overall Study|Study drug toxicity|5
7713843|NCT01057810|26822865|P2|Overall Study|Disease progression|197
7713844|NCT01057810|26822866|P1|Overall Study|Disease progression|156
7713845|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
7713846|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
7713847|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
7713848|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
7713849|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
7713850|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
7713851|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
7713852|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
7713853|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
7713854|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
7713855|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
7713856|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
7713857|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
7713858|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
7713859|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
7713860|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
7713861|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
7713862|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
7713863|NCT01057693|26822882|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
7713864|NCT01057693|26822883|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
7713865|NCT01057693|26822884|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
7713866|NCT01057693|26822882|P3|Between Single-Blind and Double-Blind|Other|0
7713867|NCT01057693|26822883|P2|Between Single-Blind and Double-Blind|Other|0
7713868|NCT01057693|26822884|P1|Between Single-Blind and Double-Blind|Other|6
7713869|NCT01057693|26822882|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
7713870|NCT01057693|26822883|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
7713871|NCT01057693|26822884|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
7713872|NCT01057693|26822882|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
7713873|NCT01057693|26822883|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
7713874|NCT01057693|26822884|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
7713875|NCT01057693|26822882|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
7713876|NCT01057693|26822883|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
7713877|NCT01057693|26822884|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
7713878|NCT01057693|26822882|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
7713879|NCT01057693|26822883|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
7713880|NCT01057693|26822884|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
7713881|NCT01057693|26822882|P3|Between Single-Blind and Double-Blind|Adverse Event|0
7713882|NCT01057693|26822883|P2|Between Single-Blind and Double-Blind|Adverse Event|0
7713883|NCT01057693|26822884|P1|Between Single-Blind and Double-Blind|Adverse Event|5
7713884|NCT01057693|26822882|P3|Single-Blind Phase (Up to Week 6)|Other|0
7713885|NCT01057693|26822883|P2|Single-Blind Phase (Up to Week 6)|Other|0
7713886|NCT01057693|26822884|P1|Single-Blind Phase (Up to Week 6)|Other|2
7713887|NCT01057693|26822882|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
7713888|NCT01057693|26822883|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
7713889|NCT01057693|26822884|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
7713890|NCT01057693|26822882|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
7713891|NCT01057693|26822883|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
7713892|NCT01057693|26822884|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
7713893|NCT01057693|26822882|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
7713894|NCT01057693|26822883|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
7713895|NCT01057693|26822884|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
7713896|NCT01057693|26822882|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
7713897|NCT01057693|26822883|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
7713898|NCT01057693|26822884|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
7713899|NCT01057693|26822882|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7713900|NCT01057693|26822883|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7713901|NCT01057693|26822884|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
7713902|NCT01057589|26822930|P1|Overall Study|Lost to Follow-up|1
7713903|NCT01057589|26822930|P1|Overall Study|Death|8
7713904|NCT01057589|26822930|P1|Overall Study|Sponsor Decision|1
7713905|NCT01057589|26822930|P1|Overall Study|Withdrawal by Subject|3
7713906|NCT01057589|26822930|P1|Overall Study|Physician Decision|8
7713907|NCT01057589|26822930|P1|Overall Study|Adverse Event|10
7713908|NCT01057589|26822930|P1|Overall Study|Disease Progression|35
7713909|NCT01057433|26822939|P1|Overall Study|Adverse Event|1
7713910|NCT01057394|26822943|P2|Overall Study|Not eligible|2
7713911|NCT01057394|26822944|P1|Overall Study|Not eligible|0
7713912|NCT01057251|26822991|P2|Overall Study|Other Reason|1
7713913|NCT01057251|26822992|P1|Overall Study|Other Reason|1
7713914|NCT01057251|26822991|P2|Overall Study|Lost to Follow-up|6
7713915|NCT01057251|26822992|P1|Overall Study|Lost to Follow-up|7
7713916|NCT01057251|26822991|P2|Overall Study|Withdrawal by Subject|5
7713917|NCT01057251|26822992|P1|Overall Study|Withdrawal by Subject|4
7713918|NCT01057251|26822991|P2|Overall Study|Protocol Violation|2
7713919|NCT01057251|26822992|P1|Overall Study|Protocol Violation|6
7713920|NCT01057251|26822991|P2|Overall Study|Lack of Efficacy|11
7713921|NCT01057251|26822992|P1|Overall Study|Lack of Efficacy|2
7713922|NCT01057251|26822991|P2|Overall Study|Adverse Event|2
7713923|NCT01057251|26822992|P1|Overall Study|Adverse Event|4
7713924|NCT01057251|26822991|P2|Overall Study|Did not meet InclusionExclusion criteria|2
7713925|NCT01057251|26822992|P1|Overall Study|Did not meet InclusionExclusion criteria|4
7713926|NCT01056822|26823070|P2|Overall Study|Lost to Follow-up|0
7713927|NCT01056822|26823071|P1|Overall Study|Lost to Follow-up|1
7713928|NCT01056822|26823070|P2|Overall Study|Withdrawal by Subject|1
7713929|NCT01056822|26823071|P1|Overall Study|Withdrawal by Subject|1
7713930|NCT01056822|26823070|P2|Overall Study|Protocol Violation|5
7713931|NCT01056822|26823071|P1|Overall Study|Protocol Violation|6
7713932|NCT01056822|26823070|P2|Overall Study|Adverse Event|1
7713933|NCT01056822|26823071|P1|Overall Study|Adverse Event|0
7713934|NCT01056718|26823120|P1|Overall Study|Ischemia on baseline stress test|1
7713935|NCT01056718|26823120|P1|Overall Study|Withdrawal by Subject|2
7713936|NCT01056653|26823153|P3|Overall Study|Lost to Follow-up|2
7713937|NCT01056653|26823154|P2|Overall Study|Lost to Follow-up|0
7713938|NCT01056653|26823155|P1|Overall Study|Lost to Follow-up|0
7713939|NCT01056640|26823171|P2|Overall Study|Death|4
7713940|NCT01056640|26823172|P1|Overall Study|Death|15
7713941|NCT01056640|26823171|P2|Overall Study|Withdrawal by Subject|8
7713942|NCT01056640|26823172|P1|Overall Study|Withdrawal by Subject|11
7713943|NCT01056536|26823187|P3|Overall Study|Lost to Follow-up|248
7713944|NCT01056536|26823188|P2|Overall Study|Lost to Follow-up|116
7713945|NCT01056536|26823189|P1|Overall Study|Lost to Follow-up|202
7713946|NCT01056523|26823200|P7|Overall Study|Death|1
7713947|NCT01056523|26823201|P6|Overall Study|Death|0
7713948|NCT01056523|26823202|P5|Overall Study|Death|0
7713949|NCT01056523|26823203|P4|Overall Study|Death|3
7713950|NCT01056523|26823204|P3|Overall Study|Death|2
7713951|NCT01056523|26823205|P2|Overall Study|Death|0
7713952|NCT01056523|26823206|P1|Overall Study|Death|1
7713953|NCT01056510|26823216|P2|Overall Study|Missing|1
7713954|NCT01056510|26823217|P1|Overall Study|Missing|0
7713955|NCT01056510|26823216|P2|Overall Study|Other|12
7713956|NCT01056510|26823217|P1|Overall Study|Other|10
7713957|NCT01056510|26823216|P2|Overall Study|Lost to Follow-up|6
7713958|NCT01056510|26823217|P1|Overall Study|Lost to Follow-up|5
7713959|NCT01056510|26823216|P2|Overall Study|Physician Decision|5
7713960|NCT01056510|26823217|P1|Overall Study|Physician Decision|4
7713961|NCT01056510|26823216|P2|Overall Study|Noncompliance|3
7713962|NCT01056510|26823217|P1|Overall Study|Noncompliance|1
7713963|NCT01056510|26823216|P2|Overall Study|Death|34
7713964|NCT01056510|26823217|P1|Overall Study|Death|29
7713965|NCT01056510|26823216|P2|Overall Study|Withdrawal by Subject|2
7713966|NCT01056510|26823217|P1|Overall Study|Withdrawal by Subject|4
7713967|NCT01056510|26823216|P2|Overall Study|Dropout Before Start of Treatment|1
7713968|NCT01056510|26823217|P1|Overall Study|Dropout Before Start of Treatment|1
7713969|NCT01056484|26823263|P2|Follow up - Non-randomized|Withdrawal by Subject|2
7713970|NCT01056484|26823264|P1|Follow up - Non-randomized|Withdrawal by Subject|0
7713971|NCT01056484|26823263|P2|Randomized Controlled Trial|Physician Decision|0
7713972|NCT01056484|26823264|P1|Randomized Controlled Trial|Physician Decision|1
7713973|NCT01056484|26823263|P2|Randomized Controlled Trial|Withdrawal by Subject|1
7713974|NCT01056484|26823264|P1|Randomized Controlled Trial|Withdrawal by Subject|6
7713975|NCT01056380|26823280|P2|Overall Study|Lost to Follow-up|3
7713976|NCT01056380|26823281|P1|Overall Study|Lost to Follow-up|2
7713977|NCT01056341|26823308|P5|Overall Study|Other reasons|5
7713978|NCT01056341|26823309|P4|Overall Study|Other reasons|9
7713979|NCT01056341|26823310|P3|Overall Study|Other reasons|8
7713980|NCT01056341|26823311|P2|Overall Study|Other reasons|4
7713981|NCT01056341|26823312|P1|Overall Study|Other reasons|4
7713982|NCT01056341|26823308|P5|Overall Study|Lack of Efficacy|9
7713983|NCT01056341|26823309|P4|Overall Study|Lack of Efficacy|25
7713984|NCT01056341|26823310|P3|Overall Study|Lack of Efficacy|7
7713985|NCT01056341|26823311|P2|Overall Study|Lack of Efficacy|30
7713986|NCT01056341|26823312|P1|Overall Study|Lack of Efficacy|32
7713987|NCT01056341|26823308|P5|Overall Study|Treatment Intolerance|0
7713988|NCT01056341|26823309|P4|Overall Study|Treatment Intolerance|2
7713989|NCT01056341|26823310|P3|Overall Study|Treatment Intolerance|0
7713990|NCT01056341|26823311|P2|Overall Study|Treatment Intolerance|2
7713991|NCT01056341|26823312|P1|Overall Study|Treatment Intolerance|0
7713992|NCT01056289|26823391|P4|Double-blind Phase|Physician Decision|0
7713993|NCT01056289|26823392|P3|Double-blind Phase|Physician Decision|1
7713994|NCT01056289|26823393|P2|Double-blind Phase|Physician Decision|0
7713995|NCT01056289|26823394|P1|Double-blind Phase|Physician Decision|0
7713996|NCT01056289|26823391|P4|Double-blind Phase|Discontinuation symptom|2
7713997|NCT01056289|26823392|P3|Double-blind Phase|Discontinuation symptom|2
7713998|NCT01056289|26823393|P2|Double-blind Phase|Discontinuation symptom|1
7713999|NCT01056289|26823394|P1|Double-blind Phase|Discontinuation symptom|0
7714000|NCT01056289|26823391|P4|Double-blind Phase|Withdrawal by Subject|2
7714001|NCT01056289|26823392|P3|Double-blind Phase|Withdrawal by Subject|4
7714002|NCT01056289|26823393|P2|Double-blind Phase|Withdrawal by Subject|0
7714003|NCT01056289|26823394|P1|Double-blind Phase|Withdrawal by Subject|0
7714004|NCT01056289|26823391|P4|Double-blind Phase|Protocol Violation|1
7714005|NCT01056289|26823392|P3|Double-blind Phase|Protocol Violation|1
7714006|NCT01056289|26823393|P2|Double-blind Phase|Protocol Violation|0
7714007|NCT01056289|26823394|P1|Double-blind Phase|Protocol Violation|0
7714008|NCT01056289|26823391|P4|Double-blind Phase|Other|2
7714009|NCT01056289|26823392|P3|Double-blind Phase|Other|1
7714010|NCT01056289|26823393|P2|Double-blind Phase|Other|0
7714011|NCT01056289|26823394|P1|Double-blind Phase|Other|0
7714012|NCT01056289|26823391|P4|Double-blind Phase|Lost to Follow-up|2
7714013|NCT01056289|26823392|P3|Double-blind Phase|Lost to Follow-up|2
7714014|NCT01056289|26823393|P2|Double-blind Phase|Lost to Follow-up|2
7714015|NCT01056289|26823394|P1|Double-blind Phase|Lost to Follow-up|0
7714016|NCT01056289|26823391|P4|Double-blind Phase|Adverse Event|1
7714017|NCT01056289|26823392|P3|Double-blind Phase|Adverse Event|2
7714018|NCT01056289|26823393|P2|Double-blind Phase|Adverse Event|1
7714019|NCT01056289|26823394|P1|Double-blind Phase|Adverse Event|0
7714020|NCT01056289|26823391|P4|Open-label Phase|Not randomized to Double-blind phase|0
7714021|NCT01056289|26823392|P3|Open-label Phase|Not randomized to Double-blind phase|0
7714022|NCT01056289|26823393|P2|Open-label Phase|Not randomized to Double-blind phase|0
7714023|NCT01056289|26823394|P1|Open-label Phase|Not randomized to Double-blind phase|1
7714024|NCT01056289|26823391|P4|Open-label Phase|Lack of Efficacy|0
7714025|NCT01056289|26823392|P3|Open-label Phase|Lack of Efficacy|0
7714026|NCT01056289|26823393|P2|Open-label Phase|Lack of Efficacy|0
7714027|NCT01056289|26823394|P1|Open-label Phase|Lack of Efficacy|18
7714028|NCT01056289|26823391|P4|Open-label Phase|Withdrawal by Subject|0
7714029|NCT01056289|26823392|P3|Open-label Phase|Withdrawal by Subject|0
7714030|NCT01056289|26823393|P2|Open-label Phase|Withdrawal by Subject|0
7714031|NCT01056289|26823394|P1|Open-label Phase|Withdrawal by Subject|26
7714032|NCT01056289|26823391|P4|Open-label Phase|Protocol Violation|0
7714033|NCT01056289|26823392|P3|Open-label Phase|Protocol Violation|0
7714034|NCT01056289|26823393|P2|Open-label Phase|Protocol Violation|0
7714035|NCT01056289|26823394|P1|Open-label Phase|Protocol Violation|6
7714036|NCT01056289|26823391|P4|Open-label Phase|Other|0
7714037|NCT01056289|26823392|P3|Open-label Phase|Other|0
7714038|NCT01056289|26823393|P2|Open-label Phase|Other|0
7714039|NCT01056289|26823394|P1|Open-label Phase|Other|9
7714040|NCT01056289|26823391|P4|Open-label Phase|Lost to Follow-up|0
7714041|NCT01056289|26823392|P3|Open-label Phase|Lost to Follow-up|0
7714042|NCT01056289|26823393|P2|Open-label Phase|Lost to Follow-up|0
7714043|NCT01056289|26823394|P1|Open-label Phase|Lost to Follow-up|30
7714044|NCT01056289|26823391|P4|Open-label Phase|Adverse Event|0
7714045|NCT01056289|26823392|P3|Open-label Phase|Adverse Event|0
7714046|NCT01056289|26823393|P2|Open-label Phase|Adverse Event|0
7714047|NCT01056289|26823394|P1|Open-label Phase|Adverse Event|29
7714048|NCT01056276|26823411|P2|Maintenance Therapy|Continuing maintenance therapy|14
7714049|NCT01056276|26823412|P1|Maintenance Therapy|Continuing maintenance therapy|0
7714050|NCT01056276|26823411|P2|Maintenance Therapy|Intercurrent Illness|1
7714051|NCT01056276|26823412|P1|Maintenance Therapy|Intercurrent Illness|0
7714052|NCT01056276|26823411|P2|Maintenance Therapy|Withdrawal by Subject|1
7714053|NCT01056276|26823412|P1|Maintenance Therapy|Withdrawal by Subject|0
7714054|NCT01056276|26823411|P2|Maintenance Therapy|Physician Decision|1
7714055|NCT01056276|26823412|P1|Maintenance Therapy|Physician Decision|0
7714056|NCT01056276|26823411|P2|Maintenance Therapy|Progressive Disease|9
7714057|NCT01056276|26823412|P1|Maintenance Therapy|Progressive Disease|0
7714058|NCT01056276|26823411|P2|Maintenance Therapy|Toxicity|2
7714059|NCT01056276|26823412|P1|Maintenance Therapy|Toxicity|0
7714060|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
7714061|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
7714062|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Death|1
7714063|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Death|3
7714064|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Physician Decision|0
7714065|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Physician Decision|3
7714066|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
7714067|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
7714068|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Disease Progression|2
7714069|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Disease Progression|2
7714070|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
7714071|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
7714072|NCT01056276|26823411|P2|Treatment Period-Cycles 1-8|Toxicity|1
7714073|NCT01056276|26823412|P1|Treatment Period-Cycles 1-8|Toxicity|2
7714074|NCT01056263|26823426|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
7714075|NCT01056263|26823426|P1|Overall Study|Objective progression or relapse|1
7714076|NCT01056263|26823426|P1|Overall Study|Neoplasm progression|1
7714077|NCT01056263|26823426|P1|Overall Study|Progressive disease|2
7714078|NCT01056263|26823426|P1|Overall Study|Lack of Efficacy|29
7714079|NCT01056263|26823426|P1|Overall Study|Withdrawal by Subject|1
7714080|NCT01056263|26823426|P1|Overall Study|Death|1
7714081|NCT01056263|26823426|P1|Overall Study|Adverse Event|12
7714082|NCT01056107|26823449|P4|Overall Study|Withdrawal by Subject|0
7714083|NCT01056107|26823450|P3|Overall Study|Withdrawal by Subject|3
7714084|NCT01056107|26823451|P2|Overall Study|Withdrawal by Subject|1
7714085|NCT01056107|26823452|P1|Overall Study|Withdrawal by Subject|0
7714086|NCT01055886|26823509|P2|Overall Study|Withdrawal by PI|1
7714087|NCT01055886|26823510|P1|Overall Study|Withdrawal by PI|0
7714088|NCT01055886|26823509|P2|Overall Study|Lost to Follow-up|1
7714089|NCT01055886|26823510|P1|Overall Study|Lost to Follow-up|1
7714090|NCT01055886|26823509|P2|Overall Study|Withdrawal by Subject|9
7714091|NCT01055886|26823510|P1|Overall Study|Withdrawal by Subject|4
7714092|NCT01055834|26823522|P2|Treatment Period I|Adverse Event|0
7714093|NCT01055834|26823523|P1|Treatment Period I|Adverse Event|1
7714094|NCT01055639|26823608|P2|Overall Study|Withdrawal by Subject|11
7714095|NCT01055639|26823609|P1|Overall Study|Withdrawal by Subject|8
7714096|NCT01055639|26823608|P2|Overall Study|Protocol Violation|5
7714097|NCT01055639|26823609|P1|Overall Study|Protocol Violation|5
7714098|NCT01055639|26823608|P2|Overall Study|Lost to Follow-up|11
7714099|NCT01055639|26823609|P1|Overall Study|Lost to Follow-up|8
7714100|NCT01055639|26823608|P2|Overall Study|Lack of Efficacy|1
7714101|NCT01055639|26823609|P1|Overall Study|Lack of Efficacy|0
7714102|NCT01055639|26823608|P2|Overall Study|Adverse Event|1
7714103|NCT01055639|26823609|P1|Overall Study|Adverse Event|0
7714104|NCT01055613|26823633|P2|Overall Study|Subject Disinterest|1
7714105|NCT01055613|26823634|P1|Overall Study|Subject Disinterest|1
7714106|NCT01055613|26823633|P2|Overall Study|Protocol Violation|1
7714107|NCT01055613|26823634|P1|Overall Study|Protocol Violation|1
7714108|NCT01055613|26823633|P2|Overall Study|Lost to Follow-up|1
7714109|NCT01055613|26823634|P1|Overall Study|Lost to Follow-up|1
7714110|NCT01055613|26823633|P2|Overall Study|Discomfort|1
7714111|NCT01055613|26823634|P1|Overall Study|Discomfort|2
7714112|NCT01055613|26823633|P2|Overall Study|Unacceptable lens fit|0
7714113|NCT01055613|26823634|P1|Overall Study|Unacceptable lens fit|1
7714114|NCT01055613|26823633|P2|Overall Study|No Longer Meets Eligibility Criteria|0
7714115|NCT01055613|26823634|P1|Overall Study|No Longer Meets Eligibility Criteria|3
7714116|NCT01055496|26823644|P2|Overall Study|Other - Unspecified|1
7714117|NCT01055496|26823645|P1|Overall Study|Other - Unspecified|0
7714118|NCT01055496|26823644|P2|Overall Study|Lost to Follow-up|2
7714119|NCT01055496|26823645|P1|Overall Study|Lost to Follow-up|0
7714120|NCT01055496|26823644|P2|Overall Study|Death|23
7714121|NCT01055496|26823645|P1|Overall Study|Death|13
7714122|NCT01055496|26823644|P2|Overall Study|Withdrawal by Subject|4
7714123|NCT01055496|26823645|P1|Overall Study|Withdrawal by Subject|2
7714124|NCT01055457|26823702|P10|Overall Study|Adverse Event|0
7714125|NCT01055457|26823703|P9|Overall Study|Adverse Event|0
7714126|NCT01055457|26823704|P8|Overall Study|Adverse Event|0
7714127|NCT01055457|26823705|P7|Overall Study|Adverse Event|0
7714128|NCT01055457|26823706|P6|Overall Study|Adverse Event|0
7714129|NCT01055457|26823707|P5|Overall Study|Adverse Event|0
7714130|NCT01055457|26823708|P4|Overall Study|Adverse Event|1
7714131|NCT01055457|26823709|P3|Overall Study|Adverse Event|0
7714132|NCT01055457|26823710|P2|Overall Study|Adverse Event|0
7714133|NCT01055457|26823711|P1|Overall Study|Adverse Event|0
7714134|NCT01055457|26823702|P10|Overall Study|Pregnancy|0
7714135|NCT01055457|26823703|P9|Overall Study|Pregnancy|0
7714136|NCT01055457|26823704|P8|Overall Study|Pregnancy|0
7714137|NCT01055457|26823705|P7|Overall Study|Pregnancy|0
7714138|NCT01055457|26823706|P6|Overall Study|Pregnancy|0
7714139|NCT01055457|26823707|P5|Overall Study|Pregnancy|0
7714140|NCT01055457|26823708|P4|Overall Study|Pregnancy|1
7714141|NCT01055457|26823709|P3|Overall Study|Pregnancy|0
7714142|NCT01055457|26823710|P2|Overall Study|Pregnancy|0
7714143|NCT01055457|26823711|P1|Overall Study|Pregnancy|0
7714144|NCT01055457|26823702|P10|Overall Study|Discomfort|0
7714145|NCT01055457|26823703|P9|Overall Study|Discomfort|0
7714146|NCT01055457|26823704|P8|Overall Study|Discomfort|0
7714147|NCT01055457|26823705|P7|Overall Study|Discomfort|0
7714148|NCT01055457|26823706|P6|Overall Study|Discomfort|0
7714149|NCT01055457|26823707|P5|Overall Study|Discomfort|1
7714150|NCT01055457|26823708|P4|Overall Study|Discomfort|0
7714151|NCT01055457|26823709|P3|Overall Study|Discomfort|0
7714152|NCT01055457|26823710|P2|Overall Study|Discomfort|0
7714153|NCT01055457|26823711|P1|Overall Study|Discomfort|0
7714154|NCT01055457|26823702|P10|Overall Study|Subject Ineligible|0
7714155|NCT01055457|26823703|P9|Overall Study|Subject Ineligible|0
7714156|NCT01055457|26823704|P8|Overall Study|Subject Ineligible|0
7714157|NCT01055457|26823705|P7|Overall Study|Subject Ineligible|0
7714158|NCT01055457|26823706|P6|Overall Study|Subject Ineligible|0
7714159|NCT01055457|26823707|P5|Overall Study|Subject Ineligible|1
7714160|NCT01055457|26823708|P4|Overall Study|Subject Ineligible|0
7714161|NCT01055457|26823709|P3|Overall Study|Subject Ineligible|1
7714162|NCT01055457|26823710|P2|Overall Study|Subject Ineligible|0
7714163|NCT01055457|26823711|P1|Overall Study|Subject Ineligible|1
7714164|NCT01055457|26823702|P10|Overall Study|Subject Disinterest|0
7714165|NCT01055457|26823703|P9|Overall Study|Subject Disinterest|0
7714166|NCT01055457|26823704|P8|Overall Study|Subject Disinterest|1
7714167|NCT01055457|26823705|P7|Overall Study|Subject Disinterest|0
7714168|NCT01055457|26823706|P6|Overall Study|Subject Disinterest|0
7714169|NCT01055457|26823707|P5|Overall Study|Subject Disinterest|0
7714170|NCT01055457|26823708|P4|Overall Study|Subject Disinterest|0
7714171|NCT01055457|26823709|P3|Overall Study|Subject Disinterest|0
7714172|NCT01055457|26823710|P2|Overall Study|Subject Disinterest|0
7714173|NCT01055457|26823711|P1|Overall Study|Subject Disinterest|0
7714174|NCT01055457|26823702|P10|Overall Study|Protocol Violation|1
7714175|NCT01055457|26823703|P9|Overall Study|Protocol Violation|0
7714176|NCT01055457|26823704|P8|Overall Study|Protocol Violation|0
7714177|NCT01055457|26823705|P7|Overall Study|Protocol Violation|1
7714178|NCT01055457|26823706|P6|Overall Study|Protocol Violation|2
7714179|NCT01055457|26823707|P5|Overall Study|Protocol Violation|1
7714180|NCT01055457|26823708|P4|Overall Study|Protocol Violation|1
7714181|NCT01055457|26823709|P3|Overall Study|Protocol Violation|1
7714182|NCT01055457|26823710|P2|Overall Study|Protocol Violation|0
7714183|NCT01055457|26823711|P1|Overall Study|Protocol Violation|0
7714184|NCT01055457|26823702|P10|Overall Study|Lost to Follow-up|0
7714185|NCT01055457|26823703|P9|Overall Study|Lost to Follow-up|0
7714186|NCT01055457|26823704|P8|Overall Study|Lost to Follow-up|0
7714187|NCT01055457|26823705|P7|Overall Study|Lost to Follow-up|0
7714188|NCT01055457|26823706|P6|Overall Study|Lost to Follow-up|1
7714189|NCT01055457|26823707|P5|Overall Study|Lost to Follow-up|0
7714190|NCT01055457|26823708|P4|Overall Study|Lost to Follow-up|0
7714191|NCT01055457|26823709|P3|Overall Study|Lost to Follow-up|0
7714192|NCT01055457|26823710|P2|Overall Study|Lost to Follow-up|1
7714193|NCT01055457|26823711|P1|Overall Study|Lost to Follow-up|0
7714194|NCT01055314|26823745|P2|Overall Study|No treatment|0
7714195|NCT01055314|26823746|P1|Overall Study|No treatment|1
7714196|NCT01055314|26823745|P2|Overall Study|Refusal of further protocol therapy|4
7714197|NCT01055314|26823746|P1|Overall Study|Refusal of further protocol therapy|10
7714198|NCT01055314|26823745|P2|Overall Study|Ineligible|5
7714199|NCT01055314|26823746|P1|Overall Study|Ineligible|3
7714200|NCT01055314|26823745|P2|Overall Study|Withdrawal by Subject|0
7714201|NCT01055314|26823746|P1|Overall Study|Withdrawal by Subject|1
7714202|NCT01055314|26823745|P2|Overall Study|Physician Decision|5
7714203|NCT01055314|26823746|P1|Overall Study|Physician Decision|10
7714204|NCT01055314|26823745|P2|Overall Study|Lack of Efficacy|19
7714205|NCT01055314|26823746|P1|Overall Study|Lack of Efficacy|11
7714206|NCT01055314|26823745|P2|Overall Study|Death|1
7714207|NCT01055314|26823746|P1|Overall Study|Death|2
7714208|NCT01055314|26823745|P2|Overall Study|Adverse Event|4
7714209|NCT01055314|26823746|P1|Overall Study|Adverse Event|7
7714210|NCT01055262|26823758|P1|Overall Study|Uncooperativeness|1
7714211|NCT01055262|26823758|P1|Overall Study|Protocol Violation|3
7714212|NCT01055262|26823758|P1|Overall Study|Adverse Event|5
7714213|NCT01055197|26823799|P2|Overall Study|Withdrawal by Subject|0
7714214|NCT01055197|26823800|P1|Overall Study|Withdrawal by Subject|2
7714215|NCT01055197|26823799|P2|Overall Study|Protocol Violation|2
7714216|NCT01055197|26823800|P1|Overall Study|Protocol Violation|7
7714217|NCT01055132|26823835|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
7714218|NCT01055132|26823836|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
7714219|NCT01055132|26823835|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
7714220|NCT01055132|26823836|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
7714221|NCT01055028|26823861|P2|Inter-treatment Period|Did not start Cycle 4|3
7714222|NCT01055028|26823862|P1|Inter-treatment Period|Did not start Cycle 4|0
7714223|NCT01055028|26823861|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
7714224|NCT01055028|26823862|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
7714225|NCT01055028|26823861|P2|Treatment Cycles 1 to 3|Adverse Event|1
7714226|NCT01055028|26823862|P1|Treatment Cycles 1 to 3|Adverse Event|0
7714227|NCT01055028|26823861|P2|Screening|Screen Failure|1
7714228|NCT01055028|26823862|P1|Screening|Screen Failure|1
7714229|NCT01054976|26823876|P1|Overall Study|Other|8
7714230|NCT01054976|26823876|P1|Overall Study|Withdrawal by Subject|4
7714231|NCT01054976|26823876|P1|Overall Study|Uncooperative participations to study|7
7714232|NCT01054976|26823876|P1|Overall Study|Adverse Event|16
7714233|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
7714234|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7714235|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
7714236|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7714237|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7714238|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
7714386|NCT01054599|26824084|P1|Overall Study|Lost to Follow-up|0
7714239|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7714240|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Physician Decision|1
7714241|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Physician Decision|1
7714242|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Physician Decision|3
7714243|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Physician Decision|6
7714244|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Physician Decision|1
7714245|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Physician Decision|4
7714246|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Physician Decision|0
7714247|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7714248|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7714249|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7714250|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7714251|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7714252|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7714253|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7714254|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
7714255|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7714256|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7714257|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7714258|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
7714259|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7714260|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7714261|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
7714262|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
7714263|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7714264|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7714265|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
7714266|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7714267|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
7714268|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
7714269|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
7714270|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
7714271|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
7714272|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
7714273|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
7714274|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
7714275|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
7714276|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
7714277|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
7714278|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
7714279|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
7714280|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
7714281|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7714282|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7714283|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
7714284|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7714285|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
7714286|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7714287|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7714288|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7714289|NCT01054885|26823897|P7|24-week, Double-blind Treatment Period|Adverse Event|19
7714290|NCT01054885|26823898|P6|24-week, Double-blind Treatment Period|Adverse Event|17
7714291|NCT01054885|26823899|P5|24-week, Double-blind Treatment Period|Adverse Event|15
7714292|NCT01054885|26823900|P4|24-week, Double-blind Treatment Period|Adverse Event|15
7714293|NCT01054885|26823901|P3|24-week, Double-blind Treatment Period|Adverse Event|12
7714294|NCT01054885|26823902|P2|24-week, Double-blind Treatment Period|Adverse Event|18
7714295|NCT01054885|26823903|P1|24-week, Double-blind Treatment Period|Adverse Event|0
7714296|NCT01054885|26823897|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714297|NCT01054885|26823898|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714298|NCT01054885|26823899|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714299|NCT01054885|26823900|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714300|NCT01054885|26823901|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714301|NCT01054885|26823902|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714302|NCT01054885|26823903|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
7714303|NCT01054885|26823897|P7|2-week, Single-blind Run-In Period|Adverse Event|0
7714304|NCT01054885|26823898|P6|2-week, Single-blind Run-In Period|Adverse Event|0
7714305|NCT01054885|26823899|P5|2-week, Single-blind Run-In Period|Adverse Event|0
7714306|NCT01054885|26823900|P4|2-week, Single-blind Run-In Period|Adverse Event|0
7714307|NCT01054885|26823901|P3|2-week, Single-blind Run-In Period|Adverse Event|0
7714308|NCT01054885|26823902|P2|2-week, Single-blind Run-In Period|Adverse Event|0
7714309|NCT01054885|26823903|P1|2-week, Single-blind Run-In Period|Adverse Event|7
7714310|NCT01054885|26823897|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714311|NCT01054885|26823898|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714312|NCT01054885|26823899|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714313|NCT01054885|26823900|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714314|NCT01054885|26823901|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714315|NCT01054885|26823902|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714316|NCT01054885|26823903|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
7714317|NCT01054885|26823897|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714318|NCT01054885|26823898|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714319|NCT01054885|26823899|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714320|NCT01054885|26823900|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714321|NCT01054885|26823901|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714322|NCT01054885|26823902|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714323|NCT01054885|26823903|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
7714324|NCT01054885|26823897|P7|2-week, Single-blind Run-In Period|Physician Decision|0
7714325|NCT01054885|26823898|P6|2-week, Single-blind Run-In Period|Physician Decision|0
7714326|NCT01054885|26823899|P5|2-week, Single-blind Run-In Period|Physician Decision|0
7714327|NCT01054885|26823900|P4|2-week, Single-blind Run-In Period|Physician Decision|0
7714328|NCT01054885|26823901|P3|2-week, Single-blind Run-In Period|Physician Decision|0
7714329|NCT01054885|26823902|P2|2-week, Single-blind Run-In Period|Physician Decision|0
7714330|NCT01054885|26823903|P1|2-week, Single-blind Run-In Period|Physician Decision|6
7714331|NCT01054885|26823897|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714332|NCT01054885|26823898|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714333|NCT01054885|26823899|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714334|NCT01054885|26823900|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714335|NCT01054885|26823901|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714336|NCT01054885|26823902|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714337|NCT01054885|26823903|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
7714338|NCT01054846|26823943|P2|Overall Study|Lost to Follow-up|17
7714339|NCT01054846|26823944|P1|Overall Study|Lost to Follow-up|76
7714340|NCT01054820|26823951|P1|Overall Study|Withdrawal by Subject|2
7714341|NCT01054729|26823982|P4|Overall Study|Lack of Efficacy|1
7714342|NCT01054729|26823983|P3|Overall Study|Lack of Efficacy|0
7714343|NCT01054729|26823984|P2|Overall Study|Lack of Efficacy|0
7714344|NCT01054729|26823985|P1|Overall Study|Lack of Efficacy|0
7714345|NCT01054729|26823982|P4|Overall Study|Subject moved|0
7714346|NCT01054729|26823983|P3|Overall Study|Subject moved|1
7714347|NCT01054729|26823984|P2|Overall Study|Subject moved|0
7714348|NCT01054729|26823985|P1|Overall Study|Subject moved|0
7714349|NCT01054729|26823982|P4|Overall Study|Personal/Obligations|0
7714350|NCT01054729|26823983|P3|Overall Study|Personal/Obligations|0
7714351|NCT01054729|26823984|P2|Overall Study|Personal/Obligations|1
7714352|NCT01054729|26823985|P1|Overall Study|Personal/Obligations|0
7714353|NCT01054729|26823982|P4|Overall Study|PEG/RBV Non-responder|0
7714354|NCT01054729|26823983|P3|Overall Study|PEG/RBV Non-responder|1
7714355|NCT01054729|26823984|P2|Overall Study|PEG/RBV Non-responder|0
7714356|NCT01054729|26823985|P1|Overall Study|PEG/RBV Non-responder|1
7714357|NCT01054729|26823982|P4|Overall Study|Non-responder|1
7714358|NCT01054729|26823983|P3|Overall Study|Non-responder|1
7714359|NCT01054729|26823984|P2|Overall Study|Non-responder|0
7714360|NCT01054729|26823985|P1|Overall Study|Non-responder|1
7714361|NCT01054729|26823982|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
7714362|NCT01054729|26823983|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
7714363|NCT01054729|26823984|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
7714364|NCT01054729|26823985|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
7714365|NCT01054729|26823982|P4|Overall Study|Lost to Follow-up|0
7714366|NCT01054729|26823983|P3|Overall Study|Lost to Follow-up|0
7714367|NCT01054729|26823984|P2|Overall Study|Lost to Follow-up|1
7714368|NCT01054729|26823985|P1|Overall Study|Lost to Follow-up|0
7714369|NCT01054729|26823982|P4|Overall Study|Withdrawal by Subject|0
7714370|NCT01054729|26823983|P3|Overall Study|Withdrawal by Subject|1
7714371|NCT01054729|26823984|P2|Overall Study|Withdrawal by Subject|0
7714372|NCT01054729|26823985|P1|Overall Study|Withdrawal by Subject|1
7714373|NCT01054729|26823982|P4|Overall Study|Adverse Event|1
7714374|NCT01054729|26823983|P3|Overall Study|Adverse Event|2
7714375|NCT01054729|26823984|P2|Overall Study|Adverse Event|1
7714376|NCT01054729|26823985|P1|Overall Study|Adverse Event|1
7714377|NCT01054729|26823982|P4|Overall Study|Randomized but Not Treated|0
7714378|NCT01054729|26823983|P3|Overall Study|Randomized but Not Treated|0
7714379|NCT01054729|26823984|P2|Overall Study|Randomized but Not Treated|1
7714380|NCT01054729|26823985|P1|Overall Study|Randomized but Not Treated|0
7714381|NCT01054599|26824083|P2|Overall Study|Withdrawal by Subject|1
7714382|NCT01054599|26824084|P1|Overall Study|Withdrawal by Subject|0
7714383|NCT01054599|26824083|P2|Overall Study|Adverse Event|1
7714384|NCT01054599|26824084|P1|Overall Study|Adverse Event|0
7714385|NCT01054599|26824083|P2|Overall Study|Lost to Follow-up|2
7714387|NCT01054599|26824083|P2|Overall Study|Visual impairment, WTAR <80|1
7714388|NCT01054599|26824084|P1|Overall Study|Visual impairment, WTAR <80|0
7714389|NCT01054599|26824083|P2|Overall Study|Timing/scheduling difficulties|1
7714390|NCT01054599|26824084|P1|Overall Study|Timing/scheduling difficulties|1
7714391|NCT01054599|26824083|P2|Overall Study|Spells/seizure-like episodes|1
7714392|NCT01054599|26824084|P1|Overall Study|Spells/seizure-like episodes|1
7714393|NCT01054599|26824083|P2|Overall Study|Protocol Violation|0
7714394|NCT01054599|26824084|P1|Overall Study|Protocol Violation|1
7714395|NCT01054599|26824083|P2|Overall Study|Dizziness due to phenytoin toxicity|0
7714396|NCT01054599|26824084|P1|Overall Study|Dizziness due to phenytoin toxicity|1
7714397|NCT01054573|26824191|P4|Overall Study|Withdrawal by Subject|1
7714398|NCT01054573|26824192|P3|Overall Study|Withdrawal by Subject|2
7714399|NCT01054573|26824193|P2|Overall Study|Withdrawal by Subject|2
7714400|NCT01054573|26824194|P1|Overall Study|Withdrawal by Subject|0
7714401|NCT01054573|26824191|P4|Overall Study|Lost to Follow-up|0
7714402|NCT01054573|26824192|P3|Overall Study|Lost to Follow-up|0
7714403|NCT01054573|26824193|P2|Overall Study|Lost to Follow-up|2
7714404|NCT01054573|26824194|P1|Overall Study|Lost to Follow-up|0
7714405|NCT01054573|26824191|P4|Overall Study|Adverse Event|1
7714406|NCT01054573|26824192|P3|Overall Study|Adverse Event|1
7714407|NCT01054573|26824193|P2|Overall Study|Adverse Event|0
7714408|NCT01054573|26824194|P1|Overall Study|Adverse Event|1
7714409|NCT01054560|26824240|P2|Overall Study|Physician Decision|0
7714410|NCT01054560|26824241|P1|Overall Study|Physician Decision|1
7714411|NCT01054560|26824240|P2|Overall Study|Withdrawal by Subject|2
7714412|NCT01054560|26824241|P1|Overall Study|Withdrawal by Subject|0
7714413|NCT01054560|26824240|P2|Overall Study|Lost to Follow-up|5
7714414|NCT01054560|26824241|P1|Overall Study|Lost to Follow-up|2
7714415|NCT01054560|26824240|P2|Overall Study|Death|21
7714416|NCT01054560|26824241|P1|Overall Study|Death|10
7714417|NCT01054456|26824263|P1|Overall Study|Other|1
7714418|NCT01054443|26824285|P4|Overall Study|Withdrawal by Subject|1
7714419|NCT01054443|26824286|P3|Overall Study|Withdrawal by Subject|0
7714420|NCT01054443|26824287|P2|Overall Study|Withdrawal by Subject|0
7714421|NCT01054443|26824288|P1|Overall Study|Withdrawal by Subject|0
7714422|NCT01054300|26824362|P4|Period 2|Withdrawal by Subject|0
7714423|NCT01054300|26824363|P3|Period 2|Withdrawal by Subject|1
7714424|NCT01054300|26824364|P2|Period 2|Withdrawal by Subject|0
7714425|NCT01054300|26824365|P1|Period 2|Withdrawal by Subject|0
7714426|NCT01054300|26824362|P4|Period 1|Adverse Event|0
7714427|NCT01054300|26824363|P3|Period 1|Adverse Event|0
7714428|NCT01054300|26824364|P2|Period 1|Adverse Event|0
7714429|NCT01054300|26824365|P1|Period 1|Adverse Event|1
7714430|NCT01054222|26824415|P1|Overall Study|Withdrawal by Subject|6
7714431|NCT01054222|26824415|P1|Overall Study|Lost to Follow-up|4
7714432|NCT01054222|26824415|P1|Overall Study|Lack of Efficacy|1
7714433|NCT01054170|26824456|P2|Overall Study|Adverse Event|4
7714434|NCT01054170|26824457|P1|Overall Study|Adverse Event|0
7714435|NCT01054170|26824456|P2|Overall Study|Withdrawal by Subject|2
7714436|NCT01054170|26824457|P1|Overall Study|Withdrawal by Subject|3
7714437|NCT01054170|26824456|P2|Overall Study|Protocol Violation|0
7714438|NCT01054170|26824457|P1|Overall Study|Protocol Violation|1
7714439|NCT01054144|26824509|P1|Overall Study|Death|2
7714440|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7714441|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
7714442|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7714443|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7714444|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
7714445|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7714446|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Physician Decision|4
7714447|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Physician Decision|5
7714448|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Physician Decision|5
7714449|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Physician Decision|2
7714450|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Physician Decision|5
7714451|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Physician Decision|0
7714452|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7714453|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7714454|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7714455|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7714456|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
7714457|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7714458|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
7714459|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7714460|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
7714461|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
7714462|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
7714463|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7714464|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
7714465|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
7714466|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
7714467|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
7714468|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
7714469|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
7714470|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
7714471|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
7714472|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7714473|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
7714474|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
7714475|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7714476|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7714477|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7714478|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7714479|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7714480|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7714481|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7714482|NCT01053988|26824531|P6|24-week, Double-blind Treatment Period|Adverse Event|14
7714483|NCT01053988|26824532|P5|24-week, Double-blind Treatment Period|Adverse Event|17
7714484|NCT01053988|26824533|P4|24-week, Double-blind Treatment Period|Adverse Event|24
7714485|NCT01053988|26824534|P3|24-week, Double-blind Treatment Period|Adverse Event|23
7714486|NCT01053988|26824535|P2|24-week, Double-blind Treatment Period|Adverse Event|15
7714487|NCT01053988|26824536|P1|24-week, Double-blind Treatment Period|Adverse Event|0
7714488|NCT01053988|26824531|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714489|NCT01053988|26824532|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714490|NCT01053988|26824533|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714491|NCT01053988|26824534|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714492|NCT01053988|26824535|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7714493|NCT01053988|26824536|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
7714494|NCT01053988|26824531|P6|2-week, Single-blind Run-In Period|Physician Decision|0
7714495|NCT01053988|26824532|P5|2-week, Single-blind Run-In Period|Physician Decision|0
7714496|NCT01053988|26824533|P4|2-week, Single-blind Run-In Period|Physician Decision|0
7714497|NCT01053988|26824534|P3|2-week, Single-blind Run-In Period|Physician Decision|0
7714498|NCT01053988|26824535|P2|2-week, Single-blind Run-In Period|Physician Decision|0
7714499|NCT01053988|26824536|P1|2-week, Single-blind Run-In Period|Physician Decision|5
7714500|NCT01053988|26824531|P6|2-week, Single-blind Run-In Period|Adverse Event|0
7714501|NCT01053988|26824532|P5|2-week, Single-blind Run-In Period|Adverse Event|0
7714502|NCT01053988|26824533|P4|2-week, Single-blind Run-In Period|Adverse Event|0
7714503|NCT01053988|26824534|P3|2-week, Single-blind Run-In Period|Adverse Event|0
7714504|NCT01053988|26824535|P2|2-week, Single-blind Run-In Period|Adverse Event|0
7714505|NCT01053988|26824536|P1|2-week, Single-blind Run-In Period|Adverse Event|6
7714506|NCT01053988|26824531|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714507|NCT01053988|26824532|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714508|NCT01053988|26824533|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714509|NCT01053988|26824534|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714510|NCT01053988|26824535|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7714511|NCT01053988|26824536|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
7714512|NCT01053988|26824531|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714513|NCT01053988|26824532|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714514|NCT01053988|26824533|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714515|NCT01053988|26824534|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714516|NCT01053988|26824535|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7714517|NCT01053988|26824536|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
7714518|NCT01053988|26824531|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714519|NCT01053988|26824532|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714520|NCT01053988|26824533|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714521|NCT01053988|26824534|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714522|NCT01053988|26824535|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7714523|NCT01053988|26824536|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
7714524|NCT01053962|26824573|P5|Treatment Period|Noncompliance with protocol|0
7714525|NCT01053962|26824574|P4|Treatment Period|Noncompliance with protocol|0
7714526|NCT01053962|26824575|P3|Treatment Period|Noncompliance with protocol|0
7714527|NCT01053962|26824576|P2|Treatment Period|Noncompliance with protocol|0
7714528|NCT01053962|26824577|P1|Treatment Period|Noncompliance with protocol|1
7714529|NCT01053962|26824573|P5|Treatment Period|Withdrawal by Subject|1
7714530|NCT01053962|26824574|P4|Treatment Period|Withdrawal by Subject|0
7714531|NCT01053962|26824575|P3|Treatment Period|Withdrawal by Subject|0
7714532|NCT01053962|26824576|P2|Treatment Period|Withdrawal by Subject|0
7714533|NCT01053962|26824577|P1|Treatment Period|Withdrawal by Subject|0
7714534|NCT01053962|26824573|P5|Treatment Period|Adverse Event|1
7714535|NCT01053962|26824574|P4|Treatment Period|Adverse Event|0
7714536|NCT01053962|26824575|P3|Treatment Period|Adverse Event|0
7714537|NCT01053962|26824576|P2|Treatment Period|Adverse Event|0
7714538|NCT01053962|26824577|P1|Treatment Period|Adverse Event|0
7714539|NCT01053962|26824573|P5|Treatment Period|Lack of Efficacy|1
7714540|NCT01053962|26824574|P4|Treatment Period|Lack of Efficacy|0
7714541|NCT01053962|26824575|P3|Treatment Period|Lack of Efficacy|0
7714542|NCT01053962|26824576|P2|Treatment Period|Lack of Efficacy|0
7714543|NCT01053962|26824577|P1|Treatment Period|Lack of Efficacy|0
7714544|NCT01053962|26824573|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
7714545|NCT01053962|26824574|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
7714546|NCT01053962|26824575|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
7714547|NCT01053962|26824576|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
7714548|NCT01053962|26824577|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
7714549|NCT01053962|26824573|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
7714550|NCT01053962|26824574|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
7714551|NCT01053962|26824575|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
7714552|NCT01053962|26824576|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
7714553|NCT01053962|26824577|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
7714554|NCT01053962|26824573|P5|Pretreatment Period|Venipuncture Failure|0
7714555|NCT01053962|26824574|P4|Pretreatment Period|Venipuncture Failure|0
7714556|NCT01053962|26824575|P3|Pretreatment Period|Venipuncture Failure|1
7714557|NCT01053962|26824576|P2|Pretreatment Period|Venipuncture Failure|0
7714558|NCT01053962|26824577|P1|Pretreatment Period|Venipuncture Failure|0
7714559|NCT01053962|26824573|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
7714560|NCT01053962|26824574|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
7714561|NCT01053962|26824575|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7714562|NCT01053962|26824576|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7714563|NCT01053962|26824577|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7714564|NCT01053741|26824628|P2|2nd Study Intervention|Physician Decision|1
7714565|NCT01053741|26824629|P1|2nd Study Intervention|Physician Decision|0
7714566|NCT01053663|26824638|P1|Overall Study|Negative Influenza Diagnosis|1
7714567|NCT01053663|26824638|P1|Overall Study|Transferred to Another Hospital|1
7714568|NCT01053663|26824638|P1|Overall Study|Poor IV Access|1
7714569|NCT01053663|26824638|P1|Overall Study|Lost to Follow-up|1
7714570|NCT01053663|26824638|P1|Overall Study|Death|2
7714571|NCT01053429|26824709|P1|Overall Study|Other|309
7714572|NCT01053429|26824709|P1|Overall Study|Adverse Event|64
7714573|NCT01053247|26824739|P3|Overall Study|Adverse Event|3
7714574|NCT01053247|26824740|P2|Overall Study|Adverse Event|9
7714575|NCT01053247|26824741|P1|Overall Study|Adverse Event|0
7714576|NCT01053247|26824739|P3|Overall Study|Lost to Follow-up|7
7714577|NCT01053247|26824740|P2|Overall Study|Lost to Follow-up|5
7714578|NCT01053247|26824741|P1|Overall Study|Lost to Follow-up|8
7714579|NCT01053247|26824739|P3|Overall Study|Protocol Violation|2
7714580|NCT01053247|26824740|P2|Overall Study|Protocol Violation|1
7714581|NCT01053247|26824741|P1|Overall Study|Protocol Violation|2
7714582|NCT01053247|26824739|P3|Overall Study|Lack of Efficacy|1
7714583|NCT01053247|26824740|P2|Overall Study|Lack of Efficacy|0
7714584|NCT01053247|26824741|P1|Overall Study|Lack of Efficacy|1
7714585|NCT01053247|26824739|P3|Overall Study|Withdrawal by Subject|15
7714586|NCT01053247|26824740|P2|Overall Study|Withdrawal by Subject|4
7714587|NCT01053247|26824741|P1|Overall Study|Withdrawal by Subject|9
7714588|NCT01053221|26824751|P2|Overall Study|The study was closed prematurely|9
7714589|NCT01053221|26824752|P1|Overall Study|The study was closed prematurely|5
7714590|NCT01052844|26825050|P2|Overall Study|Adverse Event|1
7714591|NCT01052844|26825051|P1|Overall Study|Adverse Event|0
7714592|NCT01052779|26825072|P2|Overall Study|Other-Missed Week 5 Visit|0
7714593|NCT01052779|26825073|P1|Overall Study|Other-Missed Week 5 Visit|2
7714594|NCT01052779|26825072|P2|Overall Study|Other-Surgery|2
7714595|NCT01052779|26825073|P1|Overall Study|Other-Surgery|0
7714596|NCT01052779|26825072|P2|Overall Study|Other-Protocol Violation|1
7714597|NCT01052779|26825073|P1|Overall Study|Other-Protocol Violation|1
7714598|NCT01052779|26825072|P2|Overall Study|Withdrawal by Subject|2
7714599|NCT01052779|26825073|P1|Overall Study|Withdrawal by Subject|1
7714600|NCT01052779|26825072|P2|Overall Study|Adverse Event|4
7714601|NCT01052779|26825073|P1|Overall Study|Adverse Event|1
7714602|NCT01052714|26825083|P3|Overall Study|Withdrawal by Subject|1
7714603|NCT01052714|26825084|P2|Overall Study|Withdrawal by Subject|12
7714604|NCT01052714|26825085|P1|Overall Study|Withdrawal by Subject|7
7714605|NCT01052714|26825083|P3|Overall Study|Physician Decision|1
7714606|NCT01052714|26825084|P2|Overall Study|Physician Decision|9
7714607|NCT01052714|26825085|P1|Overall Study|Physician Decision|9
7714608|NCT01052714|26825083|P3|Overall Study|Lost to Follow-up|0
7714609|NCT01052714|26825084|P2|Overall Study|Lost to Follow-up|3
7714610|NCT01052714|26825085|P1|Overall Study|Lost to Follow-up|2
7714611|NCT01052714|26825083|P3|Overall Study|Death|0
7714612|NCT01052714|26825084|P2|Overall Study|Death|2
7714613|NCT01052714|26825085|P1|Overall Study|Death|1
7714614|NCT01052714|26825083|P3|Overall Study|Adverse Event|0
7714615|NCT01052714|26825084|P2|Overall Study|Adverse Event|3
7714616|NCT01052714|26825085|P1|Overall Study|Adverse Event|6
7714617|NCT01052662|26825139|P3|Overall Study|Administrative|0
7714618|NCT01052662|26825140|P2|Overall Study|Administrative|3
7714619|NCT01052662|26825141|P1|Overall Study|Administrative|0
7714620|NCT01052662|26825139|P3|Overall Study|Legal Problem|0
7714621|NCT01052662|26825140|P2|Overall Study|Legal Problem|0
7714622|NCT01052662|26825141|P1|Overall Study|Legal Problem|2
7714623|NCT01052662|26825139|P3|Overall Study|Adverse Event|0
7714624|NCT01052662|26825140|P2|Overall Study|Adverse Event|1
7714625|NCT01052662|26825141|P1|Overall Study|Adverse Event|1
7714626|NCT01052662|26825139|P3|Overall Study|Pharmacy issue|3
7714627|NCT01052662|26825140|P2|Overall Study|Pharmacy issue|3
7714628|NCT01052662|26825141|P1|Overall Study|Pharmacy issue|1
7714629|NCT01052662|26825139|P3|Overall Study|Withdrawal by Subject|1
7714630|NCT01052662|26825140|P2|Overall Study|Withdrawal by Subject|2
7714631|NCT01052662|26825141|P1|Overall Study|Withdrawal by Subject|3
7714632|NCT01052662|26825139|P3|Overall Study|Lost to Follow-up|18
7714633|NCT01052662|26825140|P2|Overall Study|Lost to Follow-up|13
7714634|NCT01052662|26825141|P1|Overall Study|Lost to Follow-up|15
7714635|NCT01052493|26825180|P3|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7714636|NCT01052493|26825181|P2|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7714637|NCT01052493|26825182|P1|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
7714638|NCT01052480|26825209|P2|Overall Study|Death|5
7714639|NCT01052480|26825210|P1|Overall Study|Death|1
7714640|NCT01052480|26825209|P2|Overall Study|Physician Decision|2
7714641|NCT01052480|26825210|P1|Overall Study|Physician Decision|0
7714642|NCT01052480|26825209|P2|Overall Study|Withdrawal by Subject|7
7714643|NCT01052480|26825210|P1|Overall Study|Withdrawal by Subject|3
7714644|NCT01052480|26825209|P2|Overall Study|Protocol Violation|0
7714645|NCT01052480|26825210|P1|Overall Study|Protocol Violation|1
7714646|NCT01052480|26825209|P2|Overall Study|Lost to Follow-up|3
7714647|NCT01052480|26825210|P1|Overall Study|Lost to Follow-up|3
7714648|NCT01052428|26825260|P2|Overall Study|Withdrawal by Subject|1
7714649|NCT01052428|26825261|P1|Overall Study|Withdrawal by Subject|0
7714650|NCT01052428|26825260|P2|Overall Study|Death|0
7714651|NCT01052428|26825261|P1|Overall Study|Death|1
7714652|NCT01052272|26825283|P4|Overall Study|decline in health|0
7714653|NCT01052272|26825284|P3|Overall Study|decline in health|1
7714654|NCT01052272|26825285|P2|Overall Study|decline in health|0
7714655|NCT01052272|26825286|P1|Overall Study|decline in health|0
7714656|NCT01052272|26825283|P4|Overall Study|placed in long-term care|0
7714657|NCT01052272|26825284|P3|Overall Study|placed in long-term care|1
7714658|NCT01052272|26825285|P2|Overall Study|placed in long-term care|0
7714659|NCT01052272|26825286|P1|Overall Study|placed in long-term care|0
7714660|NCT01052272|26825283|P4|Overall Study|Withdrawal by Subject|2
7714661|NCT01052272|26825284|P3|Overall Study|Withdrawal by Subject|3
7714662|NCT01052272|26825285|P2|Overall Study|Withdrawal by Subject|2
7714663|NCT01052272|26825286|P1|Overall Study|Withdrawal by Subject|0
7714664|NCT01052272|26825283|P4|Overall Study|patient refuses follow-up|4
7714665|NCT01052272|26825284|P3|Overall Study|patient refuses follow-up|2
7714666|NCT01052272|26825285|P2|Overall Study|patient refuses follow-up|4
7714667|NCT01052272|26825286|P1|Overall Study|patient refuses follow-up|5
7714668|NCT01052272|26825283|P4|Overall Study|Physician Decision|0
7714669|NCT01052272|26825284|P3|Overall Study|Physician Decision|0
7714670|NCT01052272|26825285|P2|Overall Study|Physician Decision|1
7714671|NCT01052272|26825286|P1|Overall Study|Physician Decision|0
7714672|NCT01052272|26825283|P4|Overall Study|Death|1
7714673|NCT01052272|26825284|P3|Overall Study|Death|1
7714674|NCT01052272|26825285|P2|Overall Study|Death|0
7714675|NCT01052272|26825286|P1|Overall Study|Death|0
7714676|NCT01052116|26825331|P2|Overall Study|Spirometry not performed|4
7714677|NCT01052116|26825332|P1|Overall Study|Spirometry not performed|0
7714678|NCT01052116|26825331|P2|Overall Study|Withdrawal by Subject|6
7714679|NCT01052116|26825332|P1|Overall Study|Withdrawal by Subject|3
7714680|NCT01052116|26825331|P2|Overall Study|Lost to Follow-up|17
7714681|NCT01052116|26825332|P1|Overall Study|Lost to Follow-up|11
7714682|NCT01052103|26825340|P2|Overall Study|Perceived Lack of Efficacy|0
7714683|NCT01052103|26825341|P1|Overall Study|Perceived Lack of Efficacy|1
7714684|NCT01052103|26825340|P2|Overall Study|Withdrawal by Subject|6
7714685|NCT01052103|26825341|P1|Overall Study|Withdrawal by Subject|3
7714686|NCT01052103|26825340|P2|Overall Study|Sponsor Decision|0
7714687|NCT01052103|26825341|P1|Overall Study|Sponsor Decision|2
7714688|NCT01052103|26825340|P2|Overall Study|Scheduling conflict|1
7714689|NCT01052103|26825341|P1|Overall Study|Scheduling conflict|2
7714690|NCT01052103|26825340|P2|Overall Study|Protocol Violation|4
7714691|NCT01052103|26825341|P1|Overall Study|Protocol Violation|10
7714692|NCT01052103|26825340|P2|Overall Study|Lost to Follow-up|5
7714693|NCT01052103|26825341|P1|Overall Study|Lost to Follow-up|3
7714694|NCT01052103|26825340|P2|Overall Study|Entry Criteria Not Met|1
7714695|NCT01052103|26825341|P1|Overall Study|Entry Criteria Not Met|3
7714696|NCT01052103|26825340|P2|Overall Study|Adverse Event|6
7714697|NCT01052103|26825341|P1|Overall Study|Adverse Event|10
7714698|NCT01052077|26825397|P4|Phase A+|Withdrawal by Subject|7
7714699|NCT01052077|26825398|P3|Phase A+|Withdrawal by Subject|0
7714700|NCT01052077|26825399|P2|Phase A+|Withdrawal by Subject|0
7714701|NCT01052077|26825400|P1|Phase A+|Withdrawal by Subject|0
7714702|NCT01052077|26825397|P4|Phase A+|Met Withdrawal Criteria|2
7714703|NCT01052077|26825398|P3|Phase A+|Met Withdrawal Criteria|0
7714704|NCT01052077|26825399|P2|Phase A+|Met Withdrawal Criteria|0
7714705|NCT01052077|26825400|P1|Phase A+|Met Withdrawal Criteria|0
7714706|NCT01052077|26825397|P4|Phase A+|Adverse Event|4
7714707|NCT01052077|26825398|P3|Phase A+|Adverse Event|0
7714708|NCT01052077|26825399|P2|Phase A+|Adverse Event|0
7714709|NCT01052077|26825400|P1|Phase A+|Adverse Event|0
7714710|NCT01052077|26825397|P4|Phase A+|Lost to Follow-up|8
7714711|NCT01052077|26825398|P3|Phase A+|Lost to Follow-up|0
7714712|NCT01052077|26825399|P2|Phase A+|Lost to Follow-up|0
7714713|NCT01052077|26825400|P1|Phase A+|Lost to Follow-up|0
7714714|NCT01052077|26825397|P4|Phase B|Lack of Efficacy|0
7714715|NCT01052077|26825398|P3|Phase B|Lack of Efficacy|0
7714716|NCT01052077|26825399|P2|Phase B|Lack of Efficacy|1
7714717|NCT01052077|26825400|P1|Phase B|Lack of Efficacy|0
7714718|NCT01052077|26825397|P4|Phase B|Protocol Deviation|0
7714719|NCT01052077|26825398|P3|Phase B|Protocol Deviation|4
7714720|NCT01052077|26825399|P2|Phase B|Protocol Deviation|3
7714721|NCT01052077|26825400|P1|Phase B|Protocol Deviation|0
7714722|NCT01052077|26825397|P4|Phase B|Withdrawal by Subject|0
7714723|NCT01052077|26825398|P3|Phase B|Withdrawal by Subject|5
7714724|NCT01052077|26825399|P2|Phase B|Withdrawal by Subject|0
7714725|NCT01052077|26825400|P1|Phase B|Withdrawal by Subject|0
7714726|NCT01052077|26825397|P4|Phase B|Physician Decision|0
7714727|NCT01052077|26825398|P3|Phase B|Physician Decision|1
7714728|NCT01052077|26825399|P2|Phase B|Physician Decision|1
7714729|NCT01052077|26825400|P1|Phase B|Physician Decision|0
7714730|NCT01052077|26825397|P4|Phase B|Met Withdrawal Criteria|0
7714731|NCT01052077|26825398|P3|Phase B|Met Withdrawal Criteria|1
7714732|NCT01052077|26825399|P2|Phase B|Met Withdrawal Criteria|2
7714733|NCT01052077|26825400|P1|Phase B|Met Withdrawal Criteria|0
7714734|NCT01052077|26825397|P4|Phase B|Adverse Event|0
7714735|NCT01052077|26825398|P3|Phase B|Adverse Event|2
7714736|NCT01052077|26825399|P2|Phase B|Adverse Event|9
7714737|NCT01052077|26825400|P1|Phase B|Adverse Event|0
7714738|NCT01052077|26825397|P4|Phase B|Lost to Follow-up|0
7714739|NCT01052077|26825398|P3|Phase B|Lost to Follow-up|3
7714740|NCT01052077|26825399|P2|Phase B|Lost to Follow-up|2
7714741|NCT01052077|26825400|P1|Phase B|Lost to Follow-up|0
7714742|NCT01052077|26825397|P4|Phase A|Protocol Deviation|0
7714743|NCT01052077|26825398|P3|Phase A|Protocol Deviation|0
7714744|NCT01052077|26825399|P2|Phase A|Protocol Deviation|0
7714745|NCT01052077|26825400|P1|Phase A|Protocol Deviation|27
7714746|NCT01052077|26825397|P4|Phase A|Withdrawal by Subject|0
7714747|NCT01052077|26825398|P3|Phase A|Withdrawal by Subject|0
7714748|NCT01052077|26825399|P2|Phase A|Withdrawal by Subject|0
7714749|NCT01052077|26825400|P1|Phase A|Withdrawal by Subject|29
7714750|NCT01052077|26825397|P4|Phase A|Physician Decision|0
7714751|NCT01052077|26825398|P3|Phase A|Physician Decision|0
7714752|NCT01052077|26825399|P2|Phase A|Physician Decision|0
7714753|NCT01052077|26825400|P1|Phase A|Physician Decision|10
7714754|NCT01052077|26825397|P4|Phase A|Met Withdrawal Criteria|0
7714755|NCT01052077|26825398|P3|Phase A|Met Withdrawal Criteria|0
7714756|NCT01052077|26825399|P2|Phase A|Met Withdrawal Criteria|0
7714757|NCT01052077|26825400|P1|Phase A|Met Withdrawal Criteria|26
7714758|NCT01052077|26825397|P4|Phase A|Adverse Event|0
7714759|NCT01052077|26825398|P3|Phase A|Adverse Event|0
7714760|NCT01052077|26825399|P2|Phase A|Adverse Event|0
7714761|NCT01052077|26825400|P1|Phase A|Adverse Event|32
7714762|NCT01052077|26825397|P4|Phase A|Lost to Follow-up|0
7714763|NCT01052077|26825398|P3|Phase A|Lost to Follow-up|0
7714764|NCT01052077|26825399|P2|Phase A|Lost to Follow-up|0
7714765|NCT01052077|26825400|P1|Phase A|Lost to Follow-up|22
7714766|NCT01052038|26825427|P3|Overall Study|Protocol Violation|3
7714767|NCT01052038|26825428|P2|Overall Study|Protocol Violation|3
7714768|NCT01052038|26825429|P1|Overall Study|Protocol Violation|2
7714769|NCT01052038|26825427|P3|Overall Study|Lost to Follow-up|1
7714770|NCT01052038|26825428|P2|Overall Study|Lost to Follow-up|3
7714771|NCT01052038|26825429|P1|Overall Study|Lost to Follow-up|2
7714772|NCT01052012|26825455|P6|Overall Study|Other|0
7714773|NCT01052012|26825456|P5|Overall Study|Other|1
7714774|NCT01052012|26825457|P4|Overall Study|Other|0
7714775|NCT01052012|26825458|P3|Overall Study|Other|0
7714776|NCT01052012|26825459|P2|Overall Study|Other|0
7714777|NCT01052012|26825460|P1|Overall Study|Other|0
7714778|NCT01052012|26825455|P6|Overall Study|Physician Decision|1
7714779|NCT01052012|26825456|P5|Overall Study|Physician Decision|0
7714780|NCT01052012|26825457|P4|Overall Study|Physician Decision|0
7714781|NCT01052012|26825458|P3|Overall Study|Physician Decision|0
7714782|NCT01052012|26825459|P2|Overall Study|Physician Decision|0
7714783|NCT01052012|26825460|P1|Overall Study|Physician Decision|0
7714784|NCT01052012|26825455|P6|Overall Study|Withdrawal by Subject|1
7714785|NCT01052012|26825456|P5|Overall Study|Withdrawal by Subject|3
7714786|NCT01052012|26825457|P4|Overall Study|Withdrawal by Subject|0
7714787|NCT01052012|26825458|P3|Overall Study|Withdrawal by Subject|0
7714788|NCT01052012|26825459|P2|Overall Study|Withdrawal by Subject|1
7714789|NCT01052012|26825460|P1|Overall Study|Withdrawal by Subject|1
7714790|NCT01052012|26825455|P6|Overall Study|Lost to Follow-up|0
7714791|NCT01052012|26825456|P5|Overall Study|Lost to Follow-up|1
7714792|NCT01052012|26825457|P4|Overall Study|Lost to Follow-up|0
7714793|NCT01052012|26825458|P3|Overall Study|Lost to Follow-up|0
7714794|NCT01052012|26825459|P2|Overall Study|Lost to Follow-up|0
7714795|NCT01052012|26825460|P1|Overall Study|Lost to Follow-up|0
7714796|NCT01052012|26825455|P6|Overall Study|Adverse Event|0
7714797|NCT01052012|26825456|P5|Overall Study|Adverse Event|0
7714798|NCT01052012|26825457|P4|Overall Study|Adverse Event|1
7714799|NCT01052012|26825458|P3|Overall Study|Adverse Event|0
7714800|NCT01052012|26825459|P2|Overall Study|Adverse Event|0
7714801|NCT01052012|26825460|P1|Overall Study|Adverse Event|1
7714802|NCT01052012|26825455|P6|Overall Study|Not treated|8
7714803|NCT01052012|26825456|P5|Overall Study|Not treated|11
7714804|NCT01052012|26825457|P4|Overall Study|Not treated|0
7714805|NCT01052012|26825458|P3|Overall Study|Not treated|0
7714806|NCT01052012|26825459|P2|Overall Study|Not treated|5
7714807|NCT01052012|26825460|P1|Overall Study|Not treated|2
7714808|NCT01051986|26825524|P2|Overall Study|Protocol Violation|3
7714809|NCT01051986|26825525|P1|Overall Study|Protocol Violation|2
7714810|NCT01051986|26825524|P2|Overall Study|Withdrawal by Subject|1
7714811|NCT01051986|26825525|P1|Overall Study|Withdrawal by Subject|2
7714812|NCT01051986|26825524|P2|Overall Study|Death|0
7714813|NCT01051986|26825525|P1|Overall Study|Death|1
7714814|NCT01051960|26825539|P1|Overall Study|Adverse Event|1
7714815|NCT01051921|26825547|P1|Overall Study|patient moved|1
7714816|NCT01051921|26825547|P1|Overall Study|virological failure|1
7714817|NCT01051921|26825547|P1|Overall Study|Lost to Follow-up|4
7714818|NCT01051921|26825547|P1|Overall Study|Withdrawal by Subject|7
7714819|NCT01051921|26825547|P1|Overall Study|Adverse Event|8
7714820|NCT01051921|26825547|P1|Overall Study|Physician Decision|9
7714821|NCT01051856|26825554|P2|Overall Study|Withdrawal by Subject|0
7714822|NCT01051856|26825555|P1|Overall Study|Withdrawal by Subject|1
7714823|NCT01051817|26825565|P2|Overall Study|Protocol Violation|1
7714824|NCT01051817|26825566|P1|Overall Study|Protocol Violation|0
7714825|NCT01051817|26825565|P2|Overall Study|Withdrawal by Subject|5
7714826|NCT01051817|26825566|P1|Overall Study|Withdrawal by Subject|3
7714827|NCT01051817|26825565|P2|Overall Study|Abnormal Test Proceedure reults|1
7714828|NCT01051817|26825566|P1|Overall Study|Abnormal Test Proceedure reults|0
7714829|NCT01051817|26825565|P2|Overall Study|Adverse Event|2
7714830|NCT01051817|26825566|P1|Overall Study|Adverse Event|0
7714831|NCT01051791|26825576|P1|Overall Study|Withdrawal by Subject|1
7714832|NCT01051791|26825576|P1|Overall Study|Failed screening|3
7714833|NCT01051739|26825594|P2|Overall Study|Withdrawal by Subject|10
7714834|NCT01051739|26825595|P1|Overall Study|Withdrawal by Subject|25
7714835|NCT01051739|26825594|P2|Overall Study|Death|3
7714836|NCT01051739|26825595|P1|Overall Study|Death|3
7714837|NCT01051661|26825607|P6|Overall Study|Withdrawal by Subject|34
7714838|NCT01051661|26825608|P5|Overall Study|Withdrawal by Subject|12
7714839|NCT01051661|26825609|P4|Overall Study|Withdrawal by Subject|28
7714840|NCT01051661|26825610|P3|Overall Study|Withdrawal by Subject|13
7714841|NCT01051661|26825611|P2|Overall Study|Withdrawal by Subject|30
7714842|NCT01051661|26825612|P1|Overall Study|Withdrawal by Subject|16
7714843|NCT01051661|26825607|P6|Overall Study|Protocol Violation|1
7714844|NCT01051661|26825608|P5|Overall Study|Protocol Violation|2
7714845|NCT01051661|26825609|P4|Overall Study|Protocol Violation|1
7714846|NCT01051661|26825610|P3|Overall Study|Protocol Violation|0
7714847|NCT01051661|26825611|P2|Overall Study|Protocol Violation|0
7714848|NCT01051661|26825612|P1|Overall Study|Protocol Violation|0
7714849|NCT01051661|26825607|P6|Overall Study|Subject lost legal representation|0
7714850|NCT01051661|26825608|P5|Overall Study|Subject lost legal representation|1
7714851|NCT01051661|26825609|P4|Overall Study|Subject lost legal representation|0
7714852|NCT01051661|26825610|P3|Overall Study|Subject lost legal representation|0
7714853|NCT01051661|26825611|P2|Overall Study|Subject lost legal representation|0
7714854|NCT01051661|26825612|P1|Overall Study|Subject lost legal representation|0
7714855|NCT01051661|26825607|P6|Overall Study|Failure to comply with protocol|0
7714856|NCT01051661|26825608|P5|Overall Study|Failure to comply with protocol|0
7714857|NCT01051661|26825609|P4|Overall Study|Failure to comply with protocol|0
7714858|NCT01051661|26825610|P3|Overall Study|Failure to comply with protocol|2
7714859|NCT01051661|26825611|P2|Overall Study|Failure to comply with protocol|0
7714860|NCT01051661|26825612|P1|Overall Study|Failure to comply with protocol|0
7714861|NCT01051661|26825607|P6|Overall Study|Consent not received from both parents|1
7714862|NCT01051661|26825608|P5|Overall Study|Consent not received from both parents|0
7714863|NCT01051661|26825609|P4|Overall Study|Consent not received from both parents|0
7714864|NCT01051661|26825610|P3|Overall Study|Consent not received from both parents|0
7714865|NCT01051661|26825611|P2|Overall Study|Consent not received from both parents|0
7714866|NCT01051661|26825612|P1|Overall Study|Consent not received from both parents|0
7714867|NCT01051661|26825607|P6|Overall Study|Unable to attend visit(s)|2
7714868|NCT01051661|26825608|P5|Overall Study|Unable to attend visit(s)|3
7714869|NCT01051661|26825609|P4|Overall Study|Unable to attend visit(s)|1
7714870|NCT01051661|26825610|P3|Overall Study|Unable to attend visit(s)|2
7714871|NCT01051661|26825611|P2|Overall Study|Unable to attend visit(s)|4
7714872|NCT01051661|26825612|P1|Overall Study|Unable to attend visit(s)|2
7714873|NCT01051661|26825607|P6|Overall Study|Data not reliable|1
7714874|NCT01051661|26825608|P5|Overall Study|Data not reliable|0
7714875|NCT01051661|26825609|P4|Overall Study|Data not reliable|0
7714876|NCT01051661|26825610|P3|Overall Study|Data not reliable|0
7714877|NCT01051661|26825611|P2|Overall Study|Data not reliable|0
7714878|NCT01051661|26825612|P1|Overall Study|Data not reliable|1
7714879|NCT01051661|26825607|P6|Overall Study|Refused blood sampling|1
7714880|NCT01051661|26825608|P5|Overall Study|Refused blood sampling|0
7714881|NCT01051661|26825609|P4|Overall Study|Refused blood sampling|0
7714882|NCT01051661|26825610|P3|Overall Study|Refused blood sampling|0
7714883|NCT01051661|26825611|P2|Overall Study|Refused blood sampling|0
7714884|NCT01051661|26825612|P1|Overall Study|Refused blood sampling|0
7714885|NCT01051661|26825607|P6|Overall Study|Migrated/moved from study area|3
7714886|NCT01051661|26825608|P5|Overall Study|Migrated/moved from study area|7
7714887|NCT01051661|26825609|P4|Overall Study|Migrated/moved from study area|8
7714888|NCT01051661|26825610|P3|Overall Study|Migrated/moved from study area|6
7714889|NCT01051661|26825611|P2|Overall Study|Migrated/moved from study area|6
7714890|NCT01051661|26825612|P1|Overall Study|Migrated/moved from study area|1
7714891|NCT01051661|26825607|P6|Overall Study|Lost to Follow-up|24
7714892|NCT01051661|26825608|P5|Overall Study|Lost to Follow-up|10
7714893|NCT01051661|26825609|P4|Overall Study|Lost to Follow-up|17
7714894|NCT01051661|26825610|P3|Overall Study|Lost to Follow-up|15
7714895|NCT01051661|26825611|P2|Overall Study|Lost to Follow-up|22
7714896|NCT01051661|26825612|P1|Overall Study|Lost to Follow-up|13
7714897|NCT01051661|26825607|P6|Overall Study|Adverse Event|0
7714898|NCT01051661|26825608|P5|Overall Study|Adverse Event|0
7714899|NCT01051661|26825609|P4|Overall Study|Adverse Event|1
7714900|NCT01051661|26825610|P3|Overall Study|Adverse Event|1
7714901|NCT01051661|26825611|P2|Overall Study|Adverse Event|1
7714902|NCT01051661|26825612|P1|Overall Study|Adverse Event|1
7714903|NCT01051557|26825814|P7|Overall Study|Adverse Event|4
7714904|NCT01051557|26825815|P6|Overall Study|Adverse Event|3
7714905|NCT01051557|26825816|P5|Overall Study|Adverse Event|1
7714906|NCT01051557|26825817|P4|Overall Study|Adverse Event|1
7714907|NCT01051557|26825818|P3|Overall Study|Adverse Event|0
7714908|NCT01051557|26825819|P2|Overall Study|Adverse Event|0
7714909|NCT01051557|26825820|P1|Overall Study|Adverse Event|0
7714910|NCT01051557|26825814|P7|Overall Study|Withdrawal by Subject|1
7714911|NCT01051557|26825815|P6|Overall Study|Withdrawal by Subject|0
7714912|NCT01051557|26825816|P5|Overall Study|Withdrawal by Subject|2
7714913|NCT01051557|26825817|P4|Overall Study|Withdrawal by Subject|0
7714914|NCT01051557|26825818|P3|Overall Study|Withdrawal by Subject|1
7714915|NCT01051557|26825819|P2|Overall Study|Withdrawal by Subject|0
7714916|NCT01051557|26825820|P1|Overall Study|Withdrawal by Subject|0
7714917|NCT01051557|26825814|P7|Overall Study|disease progression|1
7714918|NCT01051557|26825815|P6|Overall Study|disease progression|3
7714919|NCT01051557|26825816|P5|Overall Study|disease progression|4
7714920|NCT01051557|26825817|P4|Overall Study|disease progression|2
7714921|NCT01051557|26825818|P3|Overall Study|disease progression|5
7714922|NCT01051557|26825819|P2|Overall Study|disease progression|3
7714923|NCT01051557|26825820|P1|Overall Study|disease progression|3
7714924|NCT01051557|26825814|P7|Overall Study|Physician Decision|0
7714925|NCT01051557|26825815|P6|Overall Study|Physician Decision|0
7714926|NCT01051557|26825816|P5|Overall Study|Physician Decision|0
7714927|NCT01051557|26825817|P4|Overall Study|Physician Decision|0
7714928|NCT01051557|26825818|P3|Overall Study|Physician Decision|0
7714929|NCT01051557|26825819|P2|Overall Study|Physician Decision|0
7714930|NCT01051557|26825820|P1|Overall Study|Physician Decision|1
7714931|NCT01051466|26825851|P2|Overall Study|Physician Decision|0
7714932|NCT01051466|26825852|P1|Overall Study|Physician Decision|1
7714933|NCT01051466|26825851|P2|Overall Study|Entry Criteria Not Met|3
7714934|NCT01051466|26825852|P1|Overall Study|Entry Criteria Not Met|0
7714935|NCT01051466|26825851|P2|Overall Study|Withdrawal by Subject|1
7714936|NCT01051466|26825852|P1|Overall Study|Withdrawal by Subject|5
7714937|NCT01051466|26825851|P2|Overall Study|Lost to Follow-up|1
7714938|NCT01051466|26825852|P1|Overall Study|Lost to Follow-up|1
7714939|NCT01051466|26825851|P2|Overall Study|Adverse Event|0
7714940|NCT01051466|26825852|P1|Overall Study|Adverse Event|1
7714941|NCT01051349|26825897|P1|Overall Study|Reason not Specified|12
7714942|NCT01051349|26825897|P1|Overall Study|Subject non-compliance|7
7714943|NCT01051349|26825897|P1|Overall Study|Lost to Follow-up|6
7714944|NCT01051349|26825897|P1|Overall Study|Investigator Decision|6
7714945|NCT01051349|26825897|P1|Overall Study|Consent Withdrawn|54
7714946|NCT01051349|26825897|P1|Overall Study|Adverse Event|88
7714947|NCT01051323|26825926|P1|Overall Study|Missing|37
7714948|NCT01051323|26825926|P1|Overall Study|Other|148
7714949|NCT01051323|26825926|P1|Overall Study|Hospitalization|28
7714950|NCT01051323|26825926|P1|Overall Study|Death|129
7714951|NCT01051323|26825926|P1|Overall Study|Lost to Follow-up|31
7714952|NCT01051323|26825926|P1|Overall Study|Withdrawal by Subject|13
7714953|NCT01051323|26825926|P1|Overall Study|Dialysis dependency|22
7714954|NCT01051323|26825926|P1|Overall Study|Transplantation|28
7714955|NCT01051323|26825926|P1|Overall Study|Discontinuation of treatment|103
7714956|NCT01051063|26825955|P2|Overall Study|Lost to Follow-up|1
7714957|NCT01051063|26825956|P1|Overall Study|Lost to Follow-up|0
7714958|NCT01051063|26825955|P2|Overall Study|Other|0
7714959|NCT01051063|26825956|P1|Overall Study|Other|1
7714960|NCT01051063|26825955|P2|Overall Study|Moved from the study site area|0
7714961|NCT01051063|26825956|P1|Overall Study|Moved from the study site area|1
7714962|NCT01051063|26825955|P2|Overall Study|Termination of the study|0
7714963|NCT01051063|26825956|P1|Overall Study|Termination of the study|5
7714964|NCT01051063|26825955|P2|Overall Study|Withdrawal by Subject|1
7714965|NCT01051063|26825956|P1|Overall Study|Withdrawal by Subject|1
7714966|NCT01051063|26825955|P2|Overall Study|Death|2
7714967|NCT01051063|26825956|P1|Overall Study|Death|2
7714968|NCT01050998|26825976|P5|Overall Study|Data integrity issues|4
7714969|NCT01050998|26825977|P4|Overall Study|Data integrity issues|1
7714970|NCT01050998|26825978|P3|Overall Study|Data integrity issues|1
7714971|NCT01050998|26825979|P2|Overall Study|Data integrity issues|0
7714972|NCT01050998|26825980|P1|Overall Study|Data integrity issues|0
7714973|NCT01050998|26825976|P5|Overall Study|Other|5
7714974|NCT01050998|26825977|P4|Overall Study|Other|1
7714975|NCT01050998|26825978|P3|Overall Study|Other|1
7714976|NCT01050998|26825979|P2|Overall Study|Other|2
7714977|NCT01050998|26825980|P1|Overall Study|Other|3
7714978|NCT01050998|26825976|P5|Overall Study|Withdrawal by Subject|3
7714979|NCT01050998|26825977|P4|Overall Study|Withdrawal by Subject|1
7714980|NCT01050998|26825978|P3|Overall Study|Withdrawal by Subject|0
7714981|NCT01050998|26825979|P2|Overall Study|Withdrawal by Subject|0
7714982|NCT01050998|26825980|P1|Overall Study|Withdrawal by Subject|0
7714983|NCT01050998|26825976|P5|Overall Study|Adverse Event|2
7714984|NCT01050998|26825977|P4|Overall Study|Adverse Event|0
7714985|NCT01050998|26825978|P3|Overall Study|Adverse Event|1
7714986|NCT01050998|26825979|P2|Overall Study|Adverse Event|0
7714987|NCT01050998|26825980|P1|Overall Study|Adverse Event|1
7714988|NCT01050816|26826319|P1|Overall Study|patient's refusal|2
7714989|NCT01050816|26826319|P1|Overall Study|Lost to Follow-up|2
7714990|NCT01050790|26826325|P1|Overall Study|Adverse Event|1
7714991|NCT01050764|26826335|P1|Overall Study|Death after HSCT, before T-cell infusion|1
7714992|NCT01050764|26826335|P1|Overall Study|Donor mobilization failure, death|1
7714993|NCT01050764|26826335|P1|Overall Study|Death, before HSCT|1
7714994|NCT01050673|26826346|P2|Overall Study|Physician Decision|5
7714995|NCT01050673|26826347|P1|Overall Study|Physician Decision|4
7714996|NCT01050634|26826415|P1|Overall Study|Ongoing at Date of Cut-Off|5
7714997|NCT01050634|26826415|P1|Overall Study|Other|21
7714998|NCT01050634|26826415|P1|Overall Study|Lost to Follow-up|2
7714999|NCT01050634|26826415|P1|Overall Study|Adverse Event|42
7715000|NCT01050634|26826415|P1|Overall Study|Death|2
7715001|NCT01050634|26826415|P1|Overall Study|Enrolled, but Not Treated|56
7715002|NCT01050569|26826439|P3|Overall Study|Physician Decision|3
7715003|NCT01050569|26826440|P2|Overall Study|Physician Decision|3
7715004|NCT01050569|26826441|P1|Overall Study|Physician Decision|3
7715005|NCT01050569|26826439|P3|Overall Study|Adverse Event|0
7715006|NCT01050569|26826440|P2|Overall Study|Adverse Event|0
7715007|NCT01050569|26826441|P1|Overall Study|Adverse Event|1
7715008|NCT01050569|26826439|P3|Overall Study|Lack of Efficacy|3
7715009|NCT01050569|26826440|P2|Overall Study|Lack of Efficacy|4
7715010|NCT01050569|26826441|P1|Overall Study|Lack of Efficacy|5
7715011|NCT01050569|26826439|P3|Overall Study|Withdrawal by Subject|11
7715012|NCT01050569|26826440|P2|Overall Study|Withdrawal by Subject|3
7715013|NCT01050569|26826441|P1|Overall Study|Withdrawal by Subject|9
7715014|NCT01050569|26826439|P3|Overall Study|Lost to Follow-up|16
7715015|NCT01050569|26826440|P2|Overall Study|Lost to Follow-up|14
7715016|NCT01050569|26826441|P1|Overall Study|Lost to Follow-up|20
7715017|NCT01050543|26826460|P2|Overall Study|Administrative|1
7715018|NCT01050543|26826461|P1|Overall Study|Administrative|4
7715019|NCT01050543|26826460|P2|Overall Study|Protocol Violation|1
7715020|NCT01050543|26826461|P1|Overall Study|Protocol Violation|0
7715021|NCT01050543|26826460|P2|Overall Study|Withdrawal by Subject|2
7715022|NCT01050543|26826461|P1|Overall Study|Withdrawal by Subject|0
7715023|NCT01050530|26826469|P2|Overall Study|Protocol Violation|0
7715024|NCT01050530|26826470|P1|Overall Study|Protocol Violation|1
7715025|NCT01050530|26826469|P2|Overall Study|Withdrawal by Subject|3
7715026|NCT01050530|26826470|P1|Overall Study|Withdrawal by Subject|0
7715027|NCT01050530|26826469|P2|Overall Study|Lack of Efficacy|4
7715028|NCT01050530|26826470|P1|Overall Study|Lack of Efficacy|1
7715029|NCT01050530|26826469|P2|Overall Study|Adverse Event|3
7715030|NCT01050530|26826470|P1|Overall Study|Adverse Event|6
7715031|NCT01050257|26826481|P3|Overall Study|Death|1
7715032|NCT01050257|26826482|P2|Overall Study|Death|0
7715033|NCT01050257|26826483|P1|Overall Study|Death|0
7715034|NCT01050257|26826481|P3|Overall Study|Failure to return|0
7715035|NCT01050257|26826482|P2|Overall Study|Failure to return|2
7715036|NCT01050257|26826483|P1|Overall Study|Failure to return|0
7715037|NCT01050257|26826481|P3|Overall Study|Violation criteria|0
7715038|NCT01050257|26826482|P2|Overall Study|Violation criteria|1
7715039|NCT01050257|26826483|P1|Overall Study|Violation criteria|0
7715040|NCT01050257|26826481|P3|Overall Study|Refused treatment/ Did not Cooperate|0
7715041|NCT01050257|26826482|P2|Overall Study|Refused treatment/ Did not Cooperate|1
7715042|NCT01050257|26826483|P1|Overall Study|Refused treatment/ Did not Cooperate|1
7715043|NCT01050257|26826481|P3|Overall Study|No reason specified|2
7715044|NCT01050257|26826482|P2|Overall Study|No reason specified|0
7715045|NCT01050257|26826483|P1|Overall Study|No reason specified|0
7715046|NCT01050257|26826481|P3|Overall Study|Withdrawal by Subject|0
7715047|NCT01050257|26826482|P2|Overall Study|Withdrawal by Subject|3
7715048|NCT01050257|26826483|P1|Overall Study|Withdrawal by Subject|0
7715049|NCT01050257|26826481|P3|Overall Study|Admin/Other (did not switch to oral)|2
7715050|NCT01050257|26826482|P2|Overall Study|Admin/Other (did not switch to oral)|2
7715051|NCT01050257|26826483|P1|Overall Study|Admin/Other (did not switch to oral)|6
7715052|NCT01050257|26826481|P3|Overall Study|Adverse Event|2
7715053|NCT01050257|26826482|P2|Overall Study|Adverse Event|4
7715054|NCT01050257|26826483|P1|Overall Study|Adverse Event|4
7715055|NCT01050218|26826527|P1|Overall Study|Family emergency|1
7715056|NCT01050218|26826527|P1|Overall Study|Serious Adverse Event|1
7715057|NCT01050218|26826527|P1|Overall Study|Failed to return|7
7715058|NCT01050218|26826527|P1|Overall Study|Compliance|2
7715059|NCT01050218|26826527|P1|Overall Study|Discontinued by sponsor|18
7715060|NCT01050218|26826527|P1|Overall Study|Withdrawal by Subject|18
7715061|NCT01050218|26826527|P1|Overall Study|Protocol Violation|3
7715062|NCT01050218|26826527|P1|Overall Study|Lack of Efficacy|8
7715063|NCT01050218|26826527|P1|Overall Study|Adverse Event|37
7715064|NCT01050205|26826533|P2|Overall Study|Discontinued Intervention|0
7715065|NCT01050205|26826534|P1|Overall Study|Discontinued Intervention|2
7715066|NCT01050205|26826533|P2|Overall Study|Relocated from area|2
7715067|NCT01050205|26826534|P1|Overall Study|Relocated from area|1
7715068|NCT01050205|26826533|P2|Overall Study|Withdrawal by Subject|1
7715069|NCT01050205|26826534|P1|Overall Study|Withdrawal by Subject|1
7715070|NCT01050205|26826533|P2|Overall Study|Lost to Follow-up|1
7715071|NCT01050205|26826534|P1|Overall Study|Lost to Follow-up|7
7715072|NCT01050062|26826591|P2|Overall Study|Others|11
7715073|NCT01050062|26826592|P1|Overall Study|Others|17
7715074|NCT01050062|26826591|P2|Overall Study|Physician Decision|9
7715075|NCT01050062|26826592|P1|Overall Study|Physician Decision|74
7715076|NCT01050062|26826591|P2|Overall Study|Lack of Efficacy|35
7715077|NCT01050062|26826592|P1|Overall Study|Lack of Efficacy|22
7715078|NCT01050062|26826591|P2|Overall Study|Lost to Follow-up|35
7715079|NCT01050062|26826592|P1|Overall Study|Lost to Follow-up|83
7715080|NCT01050062|26826591|P2|Overall Study|Adverse Event|22
7715081|NCT01050062|26826592|P1|Overall Study|Adverse Event|75
7715082|NCT01049984|26826614|P2|Overall Study|Treatment failure|2
7715083|NCT01049984|26826615|P1|Overall Study|Treatment failure|0
7715084|NCT01049984|26826614|P2|Overall Study|Adverse Event|7
7715085|NCT01049984|26826615|P1|Overall Study|Adverse Event|13
7715086|NCT01049984|26826614|P2|Overall Study|Lost to Follow-up|1
7715087|NCT01049984|26826615|P1|Overall Study|Lost to Follow-up|2
7715088|NCT01049984|26826614|P2|Overall Study|Protocol Violation|4
7715089|NCT01049984|26826615|P1|Overall Study|Protocol Violation|3
7715090|NCT01049984|26826614|P2|Overall Study|Withdrawal by Subject|5
7715091|NCT01049984|26826615|P1|Overall Study|Withdrawal by Subject|1
7715092|NCT01049919|26826658|P2|Overall Study|Early study termination by sponsor.|0
7715093|NCT01049919|26826659|P1|Overall Study|Early study termination by sponsor.|2
7715094|NCT01049919|26826658|P2|Overall Study|Received 2nd treatment via compassionate use|0
7715095|NCT01049919|26826659|P1|Overall Study|Received 2nd treatment via compassionate use|1
7715096|NCT01049919|26826658|P2|Overall Study|Physician Decision|0
7715097|NCT01049919|26826659|P1|Overall Study|Physician Decision|2
7715098|NCT01049919|26826658|P2|Overall Study|Lost to Follow-up|1
7715099|NCT01049919|26826659|P1|Overall Study|Lost to Follow-up|6
7715100|NCT01049919|26826658|P2|Overall Study|Withdrawal by Subject|0
7715101|NCT01049919|26826659|P1|Overall Study|Withdrawal by Subject|5
7715102|NCT01049919|26826658|P2|Overall Study|Met study endpoint (major amputation, death)|16
7715103|NCT01049919|26826659|P1|Overall Study|Met study endpoint (major amputation, death)|36
7715104|NCT01049581|26826696|P2|Overall Study|Lost to Follow-up|1
7715105|NCT01049581|26826697|P1|Overall Study|Lost to Follow-up|2
7715106|NCT01049503|26826712|P6|Overall Study|Lost to Follow-up|8
7715107|NCT01049503|26826713|P5|Overall Study|Lost to Follow-up|27
7715108|NCT01049503|26826714|P4|Overall Study|Lost to Follow-up|26
7715109|NCT01049503|26826715|P3|Overall Study|Lost to Follow-up|24
7715110|NCT01049503|26826716|P2|Overall Study|Lost to Follow-up|12
7715111|NCT01049503|26826717|P1|Overall Study|Lost to Follow-up|11
7715112|NCT01049412|26826748|P2|Period II|Lost to Follow-up|0
7715113|NCT01049412|26826749|P1|Period II|Lost to Follow-up|1
7715114|NCT01049412|26826748|P2|Period II|Adverse Event|0
7715115|NCT01049412|26826749|P1|Period II|Adverse Event|1
7715116|NCT01049412|26826748|P2|Period II|Withdrawal by Subject|3
7715117|NCT01049412|26826749|P1|Period II|Withdrawal by Subject|2
7715118|NCT01049412|26826748|P2|Period I|Adverse Event|0
7715119|NCT01049412|26826749|P1|Period I|Adverse Event|1
7715120|NCT01049412|26826748|P2|Period I|Protocol Violation|2
7715121|NCT01049412|26826749|P1|Period I|Protocol Violation|1
7715122|NCT01049412|26826748|P2|Period I|Physician Decision|3
7715123|NCT01049412|26826749|P1|Period I|Physician Decision|0
7715124|NCT01049412|26826748|P2|Period I|Lost to Follow-up|2
7715125|NCT01049412|26826749|P1|Period I|Lost to Follow-up|2
7715126|NCT01049412|26826748|P2|Period I|Withdrawal by Subject|6
7715127|NCT01049412|26826749|P1|Period I|Withdrawal by Subject|4
7715128|NCT01049373|26826778|P2|Overall Study|Non-cooperation|1
7715129|NCT01049373|26826779|P1|Overall Study|Non-cooperation|0
7715130|NCT01049373|26826778|P2|Overall Study|Other|1
7715131|NCT01049373|26826779|P1|Overall Study|Other|1
7715132|NCT01049373|26826778|P2|Overall Study|no evaluable study values|21
7715133|NCT01049373|26826779|P1|Overall Study|no evaluable study values|9
7715134|NCT01049373|26826778|P2|Overall Study|Lost to Follow-up|4
7715135|NCT01049373|26826779|P1|Overall Study|Lost to Follow-up|9
7715136|NCT01049373|26826778|P2|Overall Study|Adverse Event|3
7715137|NCT01049373|26826779|P1|Overall Study|Adverse Event|3
7715138|NCT01049373|26826778|P2|Overall Study|Withdrawal by Subject|5
7715139|NCT01049373|26826779|P1|Overall Study|Withdrawal by Subject|8
7715140|NCT01049373|26826778|P2|Overall Study|Protocol Violation|9
7715141|NCT01049373|26826779|P1|Overall Study|Protocol Violation|9
7715142|NCT01049360|26826793|P20|Period 4|Withdrawal by Subject|0
7715143|NCT01049360|26826794|P19|Period 4|Withdrawal by Subject|0
7715144|NCT01049360|26826795|P18|Period 4|Withdrawal by Subject|0
7715145|NCT01049360|26826796|P17|Period 4|Withdrawal by Subject|0
7715146|NCT01049360|26826797|P16|Period 4|Withdrawal by Subject|0
7715147|NCT01049360|26826798|P15|Period 4|Withdrawal by Subject|0
7715148|NCT01049360|26826799|P14|Period 4|Withdrawal by Subject|0
7715149|NCT01049360|26826800|P13|Period 4|Withdrawal by Subject|0
7715150|NCT01049360|26826801|P12|Period 4|Withdrawal by Subject|0
7715151|NCT01049360|26826802|P11|Period 4|Withdrawal by Subject|0
7715152|NCT01049360|26826803|P10|Period 4|Withdrawal by Subject|0
7715153|NCT01049360|26826804|P9|Period 4|Withdrawal by Subject|0
7715154|NCT01049360|26826805|P8|Period 4|Withdrawal by Subject|0
7715155|NCT01049360|26826806|P7|Period 4|Withdrawal by Subject|0
7715156|NCT01049360|26826807|P6|Period 4|Withdrawal by Subject|0
7715157|NCT01049360|26826808|P5|Period 4|Withdrawal by Subject|0
7715158|NCT01049360|26826809|P4|Period 4|Withdrawal by Subject|1
7715159|NCT01049360|26826810|P3|Period 4|Withdrawal by Subject|0
7715160|NCT01049360|26826811|P2|Period 4|Withdrawal by Subject|0
7715161|NCT01049360|26826812|P1|Period 4|Withdrawal by Subject|0
7715162|NCT01049360|26826793|P20|Period 4|Protocol Violation|0
7715163|NCT01049360|26826794|P19|Period 4|Protocol Violation|0
7715164|NCT01049360|26826795|P18|Period 4|Protocol Violation|1
7715165|NCT01049360|26826796|P17|Period 4|Protocol Violation|0
7715166|NCT01049360|26826797|P16|Period 4|Protocol Violation|0
7715167|NCT01049360|26826798|P15|Period 4|Protocol Violation|0
7715168|NCT01049360|26826799|P14|Period 4|Protocol Violation|0
7715169|NCT01049360|26826800|P13|Period 4|Protocol Violation|0
7715170|NCT01049360|26826801|P12|Period 4|Protocol Violation|0
7715171|NCT01049360|26826802|P11|Period 4|Protocol Violation|0
7715172|NCT01049360|26826803|P10|Period 4|Protocol Violation|0
7715173|NCT01049360|26826804|P9|Period 4|Protocol Violation|0
7715174|NCT01049360|26826805|P8|Period 4|Protocol Violation|0
7715175|NCT01049360|26826806|P7|Period 4|Protocol Violation|0
7715176|NCT01049360|26826807|P6|Period 4|Protocol Violation|0
7715177|NCT01049360|26826808|P5|Period 4|Protocol Violation|0
7715178|NCT01049360|26826809|P4|Period 4|Protocol Violation|0
7715179|NCT01049360|26826810|P3|Period 4|Protocol Violation|0
7715180|NCT01049360|26826811|P2|Period 4|Protocol Violation|0
7715181|NCT01049360|26826812|P1|Period 4|Protocol Violation|0
7715182|NCT01049360|26826793|P20|Period 2|Lack of Efficacy|0
7715183|NCT01049360|26826794|P19|Period 2|Lack of Efficacy|0
7715184|NCT01049360|26826795|P18|Period 2|Lack of Efficacy|0
7715185|NCT01049360|26826796|P17|Period 2|Lack of Efficacy|0
7715186|NCT01049360|26826797|P16|Period 2|Lack of Efficacy|0
7715187|NCT01049360|26826798|P15|Period 2|Lack of Efficacy|0
7715188|NCT01049360|26826799|P14|Period 2|Lack of Efficacy|0
7715189|NCT01049360|26826800|P13|Period 2|Lack of Efficacy|0
7715190|NCT01049360|26826801|P12|Period 2|Lack of Efficacy|0
7715191|NCT01049360|26826802|P11|Period 2|Lack of Efficacy|0
7715192|NCT01049360|26826803|P10|Period 2|Lack of Efficacy|0
7715193|NCT01049360|26826804|P9|Period 2|Lack of Efficacy|0
7715194|NCT01049360|26826805|P8|Period 2|Lack of Efficacy|0
7715195|NCT01049360|26826806|P7|Period 2|Lack of Efficacy|0
7715196|NCT01049360|26826807|P6|Period 2|Lack of Efficacy|1
7715197|NCT01049360|26826808|P5|Period 2|Lack of Efficacy|0
7715198|NCT01049360|26826809|P4|Period 2|Lack of Efficacy|0
7715199|NCT01049360|26826810|P3|Period 2|Lack of Efficacy|0
7715200|NCT01049360|26826811|P2|Period 2|Lack of Efficacy|0
7715201|NCT01049360|26826812|P1|Period 2|Lack of Efficacy|0
7715202|NCT01049360|26826793|P20|Period 2|Withdrawal by Subject|1
7715203|NCT01049360|26826794|P19|Period 2|Withdrawal by Subject|0
7715204|NCT01049360|26826795|P18|Period 2|Withdrawal by Subject|0
7715205|NCT01049360|26826796|P17|Period 2|Withdrawal by Subject|0
7715206|NCT01049360|26826797|P16|Period 2|Withdrawal by Subject|0
7715207|NCT01049360|26826798|P15|Period 2|Withdrawal by Subject|1
7715208|NCT01049360|26826799|P14|Period 2|Withdrawal by Subject|0
7715209|NCT01049360|26826800|P13|Period 2|Withdrawal by Subject|0
7715210|NCT01049360|26826801|P12|Period 2|Withdrawal by Subject|0
7715211|NCT01049360|26826802|P11|Period 2|Withdrawal by Subject|0
7715212|NCT01049360|26826803|P10|Period 2|Withdrawal by Subject|0
7715213|NCT01049360|26826804|P9|Period 2|Withdrawal by Subject|0
7715214|NCT01049360|26826805|P8|Period 2|Withdrawal by Subject|0
7715215|NCT01049360|26826806|P7|Period 2|Withdrawal by Subject|0
7715216|NCT01049360|26826807|P6|Period 2|Withdrawal by Subject|0
7715217|NCT01049360|26826808|P5|Period 2|Withdrawal by Subject|0
7715218|NCT01049360|26826809|P4|Period 2|Withdrawal by Subject|1
7715219|NCT01049360|26826810|P3|Period 2|Withdrawal by Subject|0
7715220|NCT01049360|26826811|P2|Period 2|Withdrawal by Subject|0
7715221|NCT01049360|26826812|P1|Period 2|Withdrawal by Subject|0
7715222|NCT01049360|26826793|P20|Period 2|Adverse Event|1
7715223|NCT01049360|26826794|P19|Period 2|Adverse Event|0
7715224|NCT01049360|26826795|P18|Period 2|Adverse Event|0
7715225|NCT01049360|26826796|P17|Period 2|Adverse Event|0
7715226|NCT01049360|26826797|P16|Period 2|Adverse Event|0
7715227|NCT01049360|26826798|P15|Period 2|Adverse Event|0
7715228|NCT01049360|26826799|P14|Period 2|Adverse Event|0
7715229|NCT01049360|26826800|P13|Period 2|Adverse Event|0
7715230|NCT01049360|26826801|P12|Period 2|Adverse Event|0
7715231|NCT01049360|26826802|P11|Period 2|Adverse Event|0
7715232|NCT01049360|26826803|P10|Period 2|Adverse Event|0
7715233|NCT01049360|26826804|P9|Period 2|Adverse Event|1
7715234|NCT01049360|26826805|P8|Period 2|Adverse Event|0
7715235|NCT01049360|26826806|P7|Period 2|Adverse Event|0
7715236|NCT01049360|26826807|P6|Period 2|Adverse Event|0
7715237|NCT01049360|26826808|P5|Period 2|Adverse Event|0
7715238|NCT01049360|26826809|P4|Period 2|Adverse Event|0
7715239|NCT01049360|26826810|P3|Period 2|Adverse Event|0
7715240|NCT01049360|26826811|P2|Period 2|Adverse Event|1
7715241|NCT01049360|26826812|P1|Period 2|Adverse Event|0
7715242|NCT01049360|26826793|P20|Period 2|Protocol Violation|0
7715243|NCT01049360|26826794|P19|Period 2|Protocol Violation|0
7715244|NCT01049360|26826795|P18|Period 2|Protocol Violation|0
7715245|NCT01049360|26826796|P17|Period 2|Protocol Violation|0
7715246|NCT01049360|26826797|P16|Period 2|Protocol Violation|1
7715247|NCT01049360|26826798|P15|Period 2|Protocol Violation|1
7715248|NCT01049360|26826799|P14|Period 2|Protocol Violation|0
7715249|NCT01049360|26826800|P13|Period 2|Protocol Violation|0
7715250|NCT01049360|26826801|P12|Period 2|Protocol Violation|0
7715251|NCT01049360|26826802|P11|Period 2|Protocol Violation|0
7715252|NCT01049360|26826803|P10|Period 2|Protocol Violation|0
7715253|NCT01049360|26826804|P9|Period 2|Protocol Violation|0
7715254|NCT01049360|26826805|P8|Period 2|Protocol Violation|0
7715255|NCT01049360|26826806|P7|Period 2|Protocol Violation|0
7715256|NCT01049360|26826807|P6|Period 2|Protocol Violation|0
7715257|NCT01049360|26826808|P5|Period 2|Protocol Violation|0
7715258|NCT01049360|26826809|P4|Period 2|Protocol Violation|1
7715259|NCT01049360|26826810|P3|Period 2|Protocol Violation|0
7715260|NCT01049360|26826811|P2|Period 2|Protocol Violation|0
7715261|NCT01049360|26826812|P1|Period 2|Protocol Violation|0
7715262|NCT01049360|26826793|P20|Period 1|Withdrawal by Subject|0
7715263|NCT01049360|26826794|P19|Period 1|Withdrawal by Subject|0
7715264|NCT01049360|26826795|P18|Period 1|Withdrawal by Subject|0
7715265|NCT01049360|26826796|P17|Period 1|Withdrawal by Subject|0
7715266|NCT01049360|26826797|P16|Period 1|Withdrawal by Subject|0
7715267|NCT01049360|26826798|P15|Period 1|Withdrawal by Subject|0
7715268|NCT01049360|26826799|P14|Period 1|Withdrawal by Subject|0
7715269|NCT01049360|26826800|P13|Period 1|Withdrawal by Subject|1
7715270|NCT01049360|26826801|P12|Period 1|Withdrawal by Subject|0
7715271|NCT01049360|26826802|P11|Period 1|Withdrawal by Subject|1
7715272|NCT01049360|26826803|P10|Period 1|Withdrawal by Subject|0
7715273|NCT01049360|26826804|P9|Period 1|Withdrawal by Subject|1
7715274|NCT01049360|26826805|P8|Period 1|Withdrawal by Subject|0
7715275|NCT01049360|26826806|P7|Period 1|Withdrawal by Subject|0
7715276|NCT01049360|26826807|P6|Period 1|Withdrawal by Subject|0
7715277|NCT01049360|26826808|P5|Period 1|Withdrawal by Subject|0
7715278|NCT01049360|26826809|P4|Period 1|Withdrawal by Subject|0
7715279|NCT01049360|26826810|P3|Period 1|Withdrawal by Subject|0
7715280|NCT01049360|26826811|P2|Period 1|Withdrawal by Subject|0
7715281|NCT01049360|26826812|P1|Period 1|Withdrawal by Subject|0
7715282|NCT01049360|26826793|P20|Period 1|Did not meet inc/exc criteria|0
7715283|NCT01049360|26826794|P19|Period 1|Did not meet inc/exc criteria|0
7715284|NCT01049360|26826795|P18|Period 1|Did not meet inc/exc criteria|0
7715285|NCT01049360|26826796|P17|Period 1|Did not meet inc/exc criteria|0
7715286|NCT01049360|26826797|P16|Period 1|Did not meet inc/exc criteria|0
7715287|NCT01049360|26826798|P15|Period 1|Did not meet inc/exc criteria|0
7715288|NCT01049360|26826799|P14|Period 1|Did not meet inc/exc criteria|0
7715289|NCT01049360|26826800|P13|Period 1|Did not meet inc/exc criteria|0
7715290|NCT01049360|26826801|P12|Period 1|Did not meet inc/exc criteria|0
7715291|NCT01049360|26826802|P11|Period 1|Did not meet inc/exc criteria|0
7715292|NCT01049360|26826803|P10|Period 1|Did not meet inc/exc criteria|0
7715293|NCT01049360|26826804|P9|Period 1|Did not meet inc/exc criteria|1
7715294|NCT01049360|26826805|P8|Period 1|Did not meet inc/exc criteria|1
7715295|NCT01049360|26826806|P7|Period 1|Did not meet inc/exc criteria|0
7715296|NCT01049360|26826807|P6|Period 1|Did not meet inc/exc criteria|0
7715297|NCT01049360|26826808|P5|Period 1|Did not meet inc/exc criteria|0
7715298|NCT01049360|26826809|P4|Period 1|Did not meet inc/exc criteria|0
7715299|NCT01049360|26826810|P3|Period 1|Did not meet inc/exc criteria|0
7715300|NCT01049360|26826811|P2|Period 1|Did not meet inc/exc criteria|0
7715301|NCT01049360|26826812|P1|Period 1|Did not meet inc/exc criteria|0
7715302|NCT01049360|26826793|P20|Period 1|Adverse Event|0
7715303|NCT01049360|26826794|P19|Period 1|Adverse Event|1
7715304|NCT01049360|26826795|P18|Period 1|Adverse Event|0
7715305|NCT01049360|26826796|P17|Period 1|Adverse Event|1
7715306|NCT01049360|26826797|P16|Period 1|Adverse Event|0
7715307|NCT01049360|26826798|P15|Period 1|Adverse Event|0
7715308|NCT01049360|26826799|P14|Period 1|Adverse Event|1
7715309|NCT01049360|26826800|P13|Period 1|Adverse Event|1
7715310|NCT01049360|26826801|P12|Period 1|Adverse Event|0
7715311|NCT01049360|26826802|P11|Period 1|Adverse Event|0
7715312|NCT01049360|26826803|P10|Period 1|Adverse Event|0
7715313|NCT01049360|26826804|P9|Period 1|Adverse Event|0
7715314|NCT01049360|26826805|P8|Period 1|Adverse Event|1
7715315|NCT01049360|26826806|P7|Period 1|Adverse Event|0
7715316|NCT01049360|26826807|P6|Period 1|Adverse Event|0
7715317|NCT01049360|26826808|P5|Period 1|Adverse Event|0
7715318|NCT01049360|26826809|P4|Period 1|Adverse Event|1
7715319|NCT01049360|26826810|P3|Period 1|Adverse Event|0
7715320|NCT01049360|26826811|P2|Period 1|Adverse Event|1
7715321|NCT01049360|26826812|P1|Period 1|Adverse Event|0
7715322|NCT01049334|26826836|P2|Overall Study|Protocol Violation|1
7715323|NCT01049334|26826837|P1|Overall Study|Protocol Violation|0
7715324|NCT01049334|26826836|P2|Overall Study|Physician Decision|0
7715325|NCT01049334|26826837|P1|Overall Study|Physician Decision|2
7715326|NCT01049334|26826836|P2|Overall Study|Adverse Event|3
7715327|NCT01049334|26826837|P1|Overall Study|Adverse Event|2
7715328|NCT01049334|26826836|P2|Overall Study|Withdrawal by Subject|3
7715329|NCT01049334|26826837|P1|Overall Study|Withdrawal by Subject|5
7715330|NCT01049308|26826873|P1|Pill Counts|Withdrawal by Subject|83
7715331|NCT01049217|26826887|P2|Overall Study|Randomized but not Treated|2
7715332|NCT01049217|26826888|P1|Overall Study|Randomized but not Treated|0
7715333|NCT01049217|26826887|P2|Overall Study|Other|2
7715334|NCT01049217|26826888|P1|Overall Study|Other|1
7715335|NCT01049217|26826887|P2|Overall Study|Study Terminated by Sponsor|43
7715336|NCT01049217|26826888|P1|Overall Study|Study Terminated by Sponsor|43
7715337|NCT01049217|26826887|P2|Overall Study|Pregnancy|0
7715338|NCT01049217|26826888|P1|Overall Study|Pregnancy|1
7715339|NCT01049217|26826887|P2|Overall Study|Protocol Violation|3
7715340|NCT01049217|26826888|P1|Overall Study|Protocol Violation|1
7715341|NCT01049217|26826887|P2|Overall Study|Withdrawal by Subject|3
7715342|NCT01049217|26826888|P1|Overall Study|Withdrawal by Subject|4
7715343|NCT01049217|26826887|P2|Overall Study|Lost to Follow-up|8
7715344|NCT01049217|26826888|P1|Overall Study|Lost to Follow-up|3
7715345|NCT01049217|26826887|P2|Overall Study|Lack of Efficacy|1
7715346|NCT01049217|26826888|P1|Overall Study|Lack of Efficacy|1
7715347|NCT01049217|26826887|P2|Overall Study|Adverse Event|1
7715348|NCT01049217|26826888|P1|Overall Study|Adverse Event|2
7715349|NCT01049035|26826965|P7|Overall Study|Voluntary withdrawal not due to an AE|2
7715350|NCT01049035|26826966|P6|Overall Study|Voluntary withdrawal not due to an AE|5
7715351|NCT01049035|26826967|P5|Overall Study|Voluntary withdrawal not due to an AE|1
7715352|NCT01049035|26826968|P4|Overall Study|Voluntary withdrawal not due to an AE|2
7715353|NCT01049035|26826969|P3|Overall Study|Voluntary withdrawal not due to an AE|8
7715354|NCT01049035|26826970|P2|Overall Study|Voluntary withdrawal not due to an AE|10
7715355|NCT01049035|26826971|P1|Overall Study|Voluntary withdrawal not due to an AE|16
7715356|NCT01049035|26826965|P7|Overall Study|Lost to Follow-up|3
7715357|NCT01049035|26826966|P6|Overall Study|Lost to Follow-up|3
7715358|NCT01049035|26826967|P5|Overall Study|Lost to Follow-up|0
7715359|NCT01049035|26826968|P4|Overall Study|Lost to Follow-up|1
7715360|NCT01049035|26826969|P3|Overall Study|Lost to Follow-up|4
7715361|NCT01049035|26826970|P2|Overall Study|Lost to Follow-up|4
7715362|NCT01049035|26826971|P1|Overall Study|Lost to Follow-up|5
7715363|NCT01049035|26826965|P7|Overall Study|Non-compliance with the protocol|10
7715364|NCT01049035|26826966|P6|Overall Study|Non-compliance with the protocol|4
7715365|NCT01049035|26826967|P5|Overall Study|Non-compliance with the protocol|3
7715366|NCT01049035|26826968|P4|Overall Study|Non-compliance with the protocol|5
7715367|NCT01049035|26826969|P3|Overall Study|Non-compliance with the protocol|14
7715368|NCT01049035|26826970|P2|Overall Study|Non-compliance with the protocol|6
7715369|NCT01049035|26826971|P1|Overall Study|Non-compliance with the protocol|12
7715370|NCT01049035|26826965|P7|Overall Study|Other adverse event (AE)|0
7715371|NCT01049035|26826966|P6|Overall Study|Other adverse event (AE)|0
7715372|NCT01049035|26826967|P5|Overall Study|Other adverse event (AE)|0
7715373|NCT01049035|26826968|P4|Overall Study|Other adverse event (AE)|1
7715374|NCT01049035|26826969|P3|Overall Study|Other adverse event (AE)|0
7715375|NCT01049035|26826970|P2|Overall Study|Other adverse event (AE)|0
7715376|NCT01049035|26826971|P1|Overall Study|Other adverse event (AE)|0
7715377|NCT01049035|26826965|P7|Overall Study|Serious adverse event|0
7715378|NCT01049035|26826966|P6|Overall Study|Serious adverse event|0
7715379|NCT01049035|26826967|P5|Overall Study|Serious adverse event|0
7715380|NCT01049035|26826968|P4|Overall Study|Serious adverse event|2
7715381|NCT01049035|26826969|P3|Overall Study|Serious adverse event|1
7715382|NCT01049035|26826970|P2|Overall Study|Serious adverse event|1
7715383|NCT01049035|26826971|P1|Overall Study|Serious adverse event|0
7715384|NCT01049009|26827130|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
7715385|NCT01049009|26827131|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
7715386|NCT01049009|26827130|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
7715387|NCT01049009|26827131|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
7715388|NCT01049009|26827130|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7715389|NCT01049009|26827131|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7715390|NCT01049009|26827130|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7715391|NCT01049009|26827131|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7715392|NCT01048944|26827143|P4|Overall Study|Protocol Violation|2
7715393|NCT01048944|26827144|P3|Overall Study|Protocol Violation|10
7715394|NCT01048944|26827145|P2|Overall Study|Protocol Violation|10
7715395|NCT01048944|26827146|P1|Overall Study|Protocol Violation|8
7715396|NCT01048866|26827187|P2|Overall Study|Other|1
7715397|NCT01048866|26827188|P1|Overall Study|Other|1
7715398|NCT01048866|26827187|P2|Overall Study|Lost to Follow-up|2
7715399|NCT01048866|26827188|P1|Overall Study|Lost to Follow-up|0
7715400|NCT01048866|26827187|P2|Overall Study|Withdrawal by Subject|2
7715401|NCT01048866|26827188|P1|Overall Study|Withdrawal by Subject|0
7715402|NCT01048866|26827187|P2|Overall Study|Physician Decision|0
7715403|NCT01048866|26827188|P1|Overall Study|Physician Decision|1
7715404|NCT01048866|26827187|P2|Overall Study|Protocol Violation|0
7715405|NCT01048866|26827188|P1|Overall Study|Protocol Violation|1
7715406|NCT01048866|26827187|P2|Overall Study|Adverse Event|0
7715407|NCT01048866|26827188|P1|Overall Study|Adverse Event|1
7715408|NCT01048788|26827233|P3|Overall Study|Withdrawal by Subject|0
7715409|NCT01048788|26827234|P2|Overall Study|Withdrawal by Subject|1
7715410|NCT01048788|26827235|P1|Overall Study|Withdrawal by Subject|0
7715411|NCT01048788|26827233|P3|Overall Study|Lack of Efficacy|1
7715412|NCT01048788|26827234|P2|Overall Study|Lack of Efficacy|0
7715413|NCT01048788|26827235|P1|Overall Study|Lack of Efficacy|0
7715414|NCT01048788|26827233|P3|Overall Study|Adverse Event|1
7715415|NCT01048788|26827234|P2|Overall Study|Adverse Event|1
7715416|NCT01048788|26827235|P1|Overall Study|Adverse Event|5
7715417|NCT01048671|26827257|P3|Overall Study|Protocol Violation|1
7715418|NCT01048671|26827258|P2|Overall Study|Protocol Violation|1
7715419|NCT01048671|26827259|P1|Overall Study|Protocol Violation|0
7715420|NCT01048541|26827339|P2|Overall Study|Withdrawal by Subject|0
7715421|NCT01048541|26827340|P1|Overall Study|Withdrawal by Subject|1
7715422|NCT01048502|26827350|P4|Overall Study|Physician Decision|1
7715423|NCT01048502|26827351|P3|Overall Study|Physician Decision|0
7715424|NCT01048502|26827352|P2|Overall Study|Physician Decision|3
7715425|NCT01048502|26827353|P1|Overall Study|Physician Decision|0
7715426|NCT01048502|26827350|P4|Overall Study|Withdrawal by Subject|3
7715427|NCT01048502|26827351|P3|Overall Study|Withdrawal by Subject|5
7715428|NCT01048502|26827352|P2|Overall Study|Withdrawal by Subject|4
7715429|NCT01048502|26827353|P1|Overall Study|Withdrawal by Subject|1
7715430|NCT01048502|26827350|P4|Overall Study|Adverse Event|0
7715431|NCT01048502|26827351|P3|Overall Study|Adverse Event|0
7715432|NCT01048502|26827352|P2|Overall Study|Adverse Event|0
7715433|NCT01048502|26827353|P1|Overall Study|Adverse Event|1
7715434|NCT01048502|26827350|P4|Overall Study|Lost to Follow-up|0
7715435|NCT01048502|26827351|P3|Overall Study|Lost to Follow-up|0
7715436|NCT01048502|26827352|P2|Overall Study|Lost to Follow-up|0
7715437|NCT01048502|26827353|P1|Overall Study|Lost to Follow-up|2
7715438|NCT01048333|26827389|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7715439|NCT01048333|26827390|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7715440|NCT01048333|26827391|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7715441|NCT01048333|26827392|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7715442|NCT01048333|26827393|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
7715443|NCT01048333|26827394|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7715444|NCT01048242|26827416|P2|Overall Study|See study flow chart|2
7715445|NCT01048242|26827417|P1|Overall Study|See study flow chart|4
7715446|NCT01048099|26827432|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
7715447|NCT01048099|26827432|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
7715448|NCT01047553|26827480|P2|Overall Study|PI's decision|1
7715449|NCT01047553|26827481|P1|Overall Study|PI's decision|0
7715450|NCT01047553|26827480|P2|Overall Study|Sever Non-Compliance to Protocol|0
7715451|NCT01047553|26827481|P1|Overall Study|Sever Non-Compliance to Protocol|1
7715452|NCT01047553|26827480|P2|Overall Study|Lost to Follow-up|0
7715453|NCT01047553|26827481|P1|Overall Study|Lost to Follow-up|1
7715454|NCT01047553|26827480|P2|Overall Study|Development of Study-Specific Withdrawal|1
7715455|NCT01047553|26827481|P1|Overall Study|Development of Study-Specific Withdrawal|1
7715456|NCT01047553|26827480|P2|Overall Study|Withdrawal by Subject|2
7715457|NCT01047553|26827481|P1|Overall Study|Withdrawal by Subject|4
7715458|NCT01047553|26827480|P2|Overall Study|Adverse Event|5
7715459|NCT01047553|26827481|P1|Overall Study|Adverse Event|10
7715460|NCT01047436|26827588|P2|Overall Study|Protocol Violation|0
7715461|NCT01047436|26827589|P1|Overall Study|Protocol Violation|1
7715462|NCT01047345|26827614|P3|Extension|Lost to Follow-up|5
7715463|NCT01047345|26827615|P2|Extension|Lost to Follow-up|0
7715464|NCT01047345|26827616|P1|Extension|Lost to Follow-up|0
7715465|NCT01047345|26827614|P3|Extension|Withdrawal by Subject|1
7715466|NCT01047345|26827615|P2|Extension|Withdrawal by Subject|0
7715467|NCT01047345|26827616|P1|Extension|Withdrawal by Subject|0
7715468|NCT01047345|26827614|P3|Base Study|Withdrawal by Subject|0
7715469|NCT01047345|26827615|P2|Base Study|Withdrawal by Subject|4
7715470|NCT01047345|26827616|P1|Base Study|Withdrawal by Subject|12
7715471|NCT01047345|26827614|P3|Base Study|Protocol Violation|0
7715472|NCT01047345|26827615|P2|Base Study|Protocol Violation|1
7715473|NCT01047345|26827616|P1|Base Study|Protocol Violation|3
7715474|NCT01047345|26827614|P3|Base Study|Lost to Follow-up|0
7715475|NCT01047345|26827615|P2|Base Study|Lost to Follow-up|1
7715476|NCT01047345|26827616|P1|Base Study|Lost to Follow-up|4
7715477|NCT01047345|26827614|P3|Base Study|Adverse Event|0
7715478|NCT01047345|26827615|P2|Base Study|Adverse Event|0
7715479|NCT01047345|26827616|P1|Base Study|Adverse Event|3
7715480|NCT01047332|26827638|P2|Overall Study|Lost to Follow-up|3
7715481|NCT01047332|26827639|P1|Overall Study|Lost to Follow-up|8
7715482|NCT01047332|26827638|P2|Overall Study|Died Unobstructed|41
7715483|NCT01047332|26827639|P1|Overall Study|Died Unobstructed|38
7715484|NCT01047332|26827638|P2|Overall Study|SEMS Obstruction|20
7715485|NCT01047332|26827639|P1|Overall Study|SEMS Obstruction|11
7715486|NCT01047319|26827654|P3|Overall Study|Study terminated by Sponsor|203
7715487|NCT01047319|26827655|P2|Overall Study|Study terminated by Sponsor|215
7715488|NCT01047319|26827656|P1|Overall Study|Study terminated by Sponsor|198
7715489|NCT01047319|26827654|P3|Overall Study|Withdrawal by Subject|87
7715490|NCT01047319|26827655|P2|Overall Study|Withdrawal by Subject|75
7715491|NCT01047319|26827656|P1|Overall Study|Withdrawal by Subject|77
7715492|NCT01047319|26827654|P3|Overall Study|Adverse Event|21
7715493|NCT01047319|26827655|P2|Overall Study|Adverse Event|27
7715494|NCT01047319|26827656|P1|Overall Study|Adverse Event|16
7715495|NCT01047319|26827654|P3|Overall Study|Lost to Follow-up|10
7715496|NCT01047319|26827655|P2|Overall Study|Lost to Follow-up|10
7715497|NCT01047319|26827656|P1|Overall Study|Lost to Follow-up|14
7715498|NCT01047319|26827654|P3|Overall Study|Physician Decision|10
7715499|NCT01047319|26827655|P2|Overall Study|Physician Decision|9
7715500|NCT01047319|26827656|P1|Overall Study|Physician Decision|12
7715501|NCT01047319|26827654|P3|Overall Study|Pregnancy|8
7715502|NCT01047319|26827655|P2|Overall Study|Pregnancy|8
7715503|NCT01047319|26827656|P1|Overall Study|Pregnancy|13
7715504|NCT01047319|26827654|P3|Overall Study|Death|5
7715505|NCT01047319|26827655|P2|Overall Study|Death|1
7715506|NCT01047319|26827656|P1|Overall Study|Death|5
7715507|NCT01047319|26827654|P3|Overall Study|Lack of Efficacy|3
7715508|NCT01047319|26827655|P2|Overall Study|Lack of Efficacy|3
7715509|NCT01047319|26827656|P1|Overall Study|Lack of Efficacy|4
7715510|NCT01047319|26827654|P3|Overall Study|Protocol Violation|4
7715511|NCT01047319|26827655|P2|Overall Study|Protocol Violation|2
7715512|NCT01047319|26827656|P1|Overall Study|Protocol Violation|3
7715513|NCT01047319|26827654|P3|Overall Study|Teva requested participant withdrawal|1
7715514|NCT01047319|26827655|P2|Overall Study|Teva requested participant withdrawal|0
7715515|NCT01047319|26827656|P1|Overall Study|Teva requested participant withdrawal|3
7715516|NCT01047306|26827678|P2|Overall Study|Lost to Follow-up|0
7715517|NCT01047306|26827679|P1|Overall Study|Lost to Follow-up|1
7715518|NCT01047306|26827678|P2|Overall Study|Withdrawal by Subject|0
7715519|NCT01047306|26827679|P1|Overall Study|Withdrawal by Subject|2
7715520|NCT01047293|26827753|P4|Overall Study|DLT criteria not fulfilled|0
7715521|NCT01047293|26827754|P3|Overall Study|DLT criteria not fulfilled|0
7715522|NCT01047293|26827755|P2|Overall Study|DLT criteria not fulfilled|1
7715523|NCT01047293|26827756|P1|Overall Study|DLT criteria not fulfilled|1
7715524|NCT01047007|26827787|P4|Overall Study|Progressive Disease|0
7715525|NCT01047007|26827788|P3|Overall Study|Progressive Disease|1
7715526|NCT01047007|26827789|P2|Overall Study|Progressive Disease|4
7715527|NCT01047007|26827790|P1|Overall Study|Progressive Disease|2
7715528|NCT01047007|26827787|P4|Overall Study|Adverse Event|0
7715529|NCT01047007|26827788|P3|Overall Study|Adverse Event|1
7715530|NCT01047007|26827789|P2|Overall Study|Adverse Event|2
7715531|NCT01047007|26827790|P1|Overall Study|Adverse Event|0
7715532|NCT01046903|26827801|P1|Overall Study|Other|5
7715533|NCT01046903|26827801|P1|Overall Study|Withdrawal by Subject|3
7715534|NCT01046903|26827801|P1|Overall Study|Adverse Event|4
7715535|NCT01046903|26827801|P1|Overall Study|Lost to Follow-up|16
7715536|NCT01046877|26827814|P1|Overall Study|Exited voluntarily after tube extrusion|11
7715537|NCT01046877|26827814|P1|Overall Study|Exited voluntarily before tube extrusion|7
7715538|NCT01046695|26827830|P2|Overall Study|TENS interfered with the cardiac monitor|1
7715539|NCT01046695|26827831|P1|Overall Study|TENS interfered with the cardiac monitor|0
7715540|NCT01046695|26827830|P2|Overall Study|Subject had a pacemaker|1
7715541|NCT01046695|26827831|P1|Overall Study|Subject had a pacemaker|0
7715542|NCT01046682|26827843|P2|Overall Study|Adverse Event|0
7715543|NCT01046682|26827844|P1|Overall Study|Adverse Event|2
7715544|NCT01046643|26827861|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
7715545|NCT01046643|26827862|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
7715546|NCT01046643|26827863|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
7715547|NCT01046643|26827864|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
7715548|NCT01046565|26827886|P1|Overall Study|Withdrawal by Subject|7
7715549|NCT01046565|26827886|P1|Overall Study|Adverse Event|2
7715550|NCT01046396|26827895|P1|Overall Study|Withdrawal by Subject|5
7715551|NCT01046253|26827906|P2|Second Intervention|Protocol Violation|1
7715552|NCT01046253|26827907|P1|Second Intervention|Protocol Violation|0
7715553|NCT01046253|26827906|P2|Second Intervention|Adverse Event|1
7715554|NCT01046253|26827907|P1|Second Intervention|Adverse Event|0
7715555|NCT01046136|26827919|P2|Overall Study|Lost to Follow-up|3
7715556|NCT01046136|26827920|P1|Overall Study|Lost to Follow-up|3
7715557|NCT01046136|26827919|P2|Overall Study|Physician Decision|1
7715558|NCT01046136|26827920|P1|Overall Study|Physician Decision|1
7715559|NCT01046136|26827919|P2|Overall Study|Withdrawal by Subject|4
7715560|NCT01046136|26827920|P1|Overall Study|Withdrawal by Subject|0
7715561|NCT01046110|26827932|P2|Overall Study|Unclassified|35
7715562|NCT01046110|26827933|P1|Overall Study|Unclassified|36
7715563|NCT01046110|26827932|P2|Overall Study|Withdrawal Criteria|5
7715564|NCT01046110|26827933|P1|Overall Study|Withdrawal Criteria|3
7715565|NCT01046110|26827932|P2|Overall Study|Protocol Violation|12
7715566|NCT01046110|26827933|P1|Overall Study|Protocol Violation|7
7715567|NCT01046110|26827932|P2|Overall Study|Lack of Efficacy|1
7715568|NCT01046110|26827933|P1|Overall Study|Lack of Efficacy|0
7715569|NCT01046110|26827932|P2|Overall Study|Adverse Event|2
7715570|NCT01046110|26827933|P1|Overall Study|Adverse Event|9
7715571|NCT01046084|26827943|P2|Third Washout of 7 Days|Withdrawal by Subject|0
7715572|NCT01046084|26827944|P1|Third Washout of 7 Days|Withdrawal by Subject|2
7715573|NCT01045993|26827958|P4|Overall Study|Treated-later found eligibility not met|0
7715574|NCT01045993|26827959|P3|Overall Study|Treated-later found eligibility not met|0
7715575|NCT01045993|26827960|P2|Overall Study|Treated-later found eligibility not met|1
7715576|NCT01045993|26827961|P1|Overall Study|Treated-later found eligibility not met|0
7715577|NCT01045967|26828037|P2|Second Intervention|Protocol Violation|1
7715578|NCT01045967|26828038|P1|Second Intervention|Protocol Violation|0
7715579|NCT01045798|26828050|P2|Overall Study|Received Systemic Antifungal Prestudy|1
7715580|NCT01045798|26828051|P1|Overall Study|Received Systemic Antifungal Prestudy|0
7715581|NCT01045798|26828050|P2|Overall Study|Changed to Other Antifungal Therapy|2
7715582|NCT01045798|26828051|P1|Overall Study|Changed to Other Antifungal Therapy|1
7715583|NCT01045798|26828050|P2|Overall Study|Invasive Fungal Infection at Baseline|1
7715584|NCT01045798|26828051|P1|Overall Study|Invasive Fungal Infection at Baseline|0
7715585|NCT01045798|26828050|P2|Overall Study|Changed to Open-Label Caspofungin|0
7715586|NCT01045798|26828051|P1|Overall Study|Changed to Open-Label Caspofungin|1
7715587|NCT01045707|26828059|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
7715588|NCT01045707|26828060|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
7715589|NCT01045707|26828059|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
7715590|NCT01045707|26828060|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
7715591|NCT01045707|26828059|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
7715592|NCT01045707|26828060|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
7715593|NCT01045707|26828059|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
7715594|NCT01045707|26828060|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
7715595|NCT01045707|26828059|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
7715596|NCT01045707|26828060|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
7715597|NCT01045707|26828059|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
7715598|NCT01045707|26828060|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
7715599|NCT01045707|26828059|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
7715600|NCT01045707|26828060|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
7715601|NCT01045707|26828059|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
7715602|NCT01045707|26828060|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
7715603|NCT01045707|26828059|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
7715604|NCT01045707|26828060|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
7715605|NCT01045694|26828076|P1|Overall Study|Withdrawal by Subject|2
7715606|NCT01045460|26828097|P2|Overall Study|Lack of Efficacy|0
7715607|NCT01045460|26828098|P1|Overall Study|Lack of Efficacy|3
7715608|NCT01045460|26828097|P2|Overall Study|Lost to Follow-up|1
7715609|NCT01045460|26828098|P1|Overall Study|Lost to Follow-up|0
7715610|NCT01045460|26828097|P2|Overall Study|Physician Decision|2
7715611|NCT01045460|26828098|P1|Overall Study|Physician Decision|3
7715612|NCT01045447|26828126|P2|Overall Study|Unclassified|13
7715613|NCT01045447|26828127|P1|Overall Study|Unclassified|17
7715614|NCT01045447|26828126|P2|Overall Study|Withdrawal Criteria|10
7715615|NCT01045447|26828127|P1|Overall Study|Withdrawal Criteria|10
7715616|NCT01045447|26828126|P2|Overall Study|Protocol Violation|3
7715617|NCT01045447|26828127|P1|Overall Study|Protocol Violation|6
7715618|NCT01045447|26828126|P2|Overall Study|Lack of Efficacy|1
7715619|NCT01045447|26828127|P1|Overall Study|Lack of Efficacy|3
7715620|NCT01045447|26828126|P2|Overall Study|Adverse Event|1
7715621|NCT01045447|26828127|P1|Overall Study|Adverse Event|0
7715622|NCT01045421|26828141|P11|Phase 2|Other|1
7715623|NCT01045421|26828142|P10|Phase 2|Other|0
7715624|NCT01045421|26828143|P9|Phase 2|Other|0
7715625|NCT01045421|26828144|P8|Phase 2|Other|3
7715626|NCT01045421|26828145|P7|Phase 2|Other|0
7715627|NCT01045421|26828146|P6|Phase 2|Other|0
7715628|NCT01045421|26828147|P5|Phase 2|Other|0
7715629|NCT01045421|26828148|P4|Phase 2|Other|0
7715630|NCT01045421|26828149|P3|Phase 2|Other|0
7715631|NCT01045421|26828150|P2|Phase 2|Other|0
7715632|NCT01045421|26828151|P1|Phase 2|Other|0
7715633|NCT01045421|26828141|P11|Phase 2|Death|0
7715634|NCT01045421|26828142|P10|Phase 2|Death|2
7715635|NCT01045421|26828143|P9|Phase 2|Death|1
7715636|NCT01045421|26828144|P8|Phase 2|Death|1
7715637|NCT01045421|26828145|P7|Phase 2|Death|0
7715638|NCT01045421|26828146|P6|Phase 2|Death|0
7715639|NCT01045421|26828147|P5|Phase 2|Death|0
7715640|NCT01045421|26828148|P4|Phase 2|Death|0
7715641|NCT01045421|26828149|P3|Phase 2|Death|0
7715642|NCT01045421|26828150|P2|Phase 2|Death|0
7715643|NCT01045421|26828151|P1|Phase 2|Death|0
7715644|NCT01045421|26828141|P11|Phase 2|Progressive Disease|1
7715645|NCT01045421|26828142|P10|Phase 2|Progressive Disease|1
7715646|NCT01045421|26828143|P9|Phase 2|Progressive Disease|1
7715647|NCT01045421|26828144|P8|Phase 2|Progressive Disease|1
7715648|NCT01045421|26828145|P7|Phase 2|Progressive Disease|0
7715649|NCT01045421|26828146|P6|Phase 2|Progressive Disease|0
7715650|NCT01045421|26828147|P5|Phase 2|Progressive Disease|0
7715651|NCT01045421|26828148|P4|Phase 2|Progressive Disease|0
7715652|NCT01045421|26828149|P3|Phase 2|Progressive Disease|0
7715653|NCT01045421|26828150|P2|Phase 2|Progressive Disease|0
7715654|NCT01045421|26828151|P1|Phase 2|Progressive Disease|0
7715655|NCT01045421|26828141|P11|Phase 1|Withdrawal by Subject|0
7715656|NCT01045421|26828142|P10|Phase 1|Withdrawal by Subject|0
7715657|NCT01045421|26828143|P9|Phase 1|Withdrawal by Subject|0
7715658|NCT01045421|26828144|P8|Phase 1|Withdrawal by Subject|0
7715659|NCT01045421|26828145|P7|Phase 1|Withdrawal by Subject|0
7715660|NCT01045421|26828146|P6|Phase 1|Withdrawal by Subject|0
7715661|NCT01045421|26828147|P5|Phase 1|Withdrawal by Subject|0
7715662|NCT01045421|26828148|P4|Phase 1|Withdrawal by Subject|1
7715663|NCT01045421|26828149|P3|Phase 1|Withdrawal by Subject|0
7715664|NCT01045421|26828150|P2|Phase 1|Withdrawal by Subject|0
7715665|NCT01045421|26828151|P1|Phase 1|Withdrawal by Subject|0
7715666|NCT01045421|26828141|P11|Phase 1|Progressive Disease|0
7715667|NCT01045421|26828142|P10|Phase 1|Progressive Disease|0
7715668|NCT01045421|26828143|P9|Phase 1|Progressive Disease|0
7715669|NCT01045421|26828144|P8|Phase 1|Progressive Disease|0
7715670|NCT01045421|26828145|P7|Phase 1|Progressive Disease|0
7715671|NCT01045421|26828146|P6|Phase 1|Progressive Disease|0
7715672|NCT01045421|26828147|P5|Phase 1|Progressive Disease|1
7715673|NCT01045421|26828148|P4|Phase 1|Progressive Disease|0
7715674|NCT01045421|26828149|P3|Phase 1|Progressive Disease|0
7715675|NCT01045421|26828150|P2|Phase 1|Progressive Disease|0
7715676|NCT01045421|26828151|P1|Phase 1|Progressive Disease|0
7715677|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
7715678|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
7715679|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
7715680|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
7715681|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
7715682|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
7715683|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
7715684|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
7715685|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
7715686|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
7715687|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
7715688|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
7715689|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
7715690|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
7715691|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
7715692|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
7715693|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
7715694|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
7715695|NCT01045161|26828260|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
7715696|NCT01045161|26828261|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
7715697|NCT01045161|26828262|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
7715698|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
7715699|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
7715700|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
7715701|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
7715702|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
7715703|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
7715704|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7715705|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7715706|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7715707|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
7715708|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
7715709|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
7715710|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
7715711|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
7715712|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
7715713|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
7715714|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
7715715|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
7715716|NCT01045161|26828260|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
7715717|NCT01045161|26828261|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
7715718|NCT01045161|26828262|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
7715719|NCT01045096|26828299|P3|Overall Study|Other|0
7715720|NCT01045096|26828300|P2|Overall Study|Other|0
7715721|NCT01045096|26828301|P1|Overall Study|Other|1
7715722|NCT01045096|26828299|P3|Overall Study|Withdrawal by Subject|0
7715723|NCT01045096|26828300|P2|Overall Study|Withdrawal by Subject|0
7715724|NCT01045096|26828301|P1|Overall Study|Withdrawal by Subject|2
7715725|NCT01044745|26828465|P1|Overall Study|Ineiligible|2
7715726|NCT01044732|26828474|P2|Overall Study|Technical error or malfunction|14
7715727|NCT01044732|26828475|P1|Overall Study|Technical error or malfunction|15
7715728|NCT01044732|26828474|P2|Overall Study|Inability to reach cecum|2
7715729|NCT01044732|26828475|P1|Overall Study|Inability to reach cecum|5
7715730|NCT01044732|26828474|P2|Overall Study|Inadequate bowel preparation|17
7715731|NCT01044732|26828475|P1|Overall Study|Inadequate bowel preparation|11
7715732|NCT01044732|26828474|P2|Overall Study|Withdrawal by Subject|1
7715733|NCT01044732|26828475|P1|Overall Study|Withdrawal by Subject|0
7715734|NCT01044732|26828474|P2|Overall Study|Protocol Violation|12
7715735|NCT01044732|26828475|P1|Overall Study|Protocol Violation|11
7715736|NCT01044732|26828474|P2|Overall Study|Physician Decision|3
7715737|NCT01044732|26828475|P1|Overall Study|Physician Decision|5
7715738|NCT01044732|26828474|P2|Overall Study|Lost to Follow-up|1
7715739|NCT01044732|26828475|P1|Overall Study|Lost to Follow-up|2
7715740|NCT01044498|26828671|P2|Overall Study|Other|0
7715741|NCT01044498|26828672|P1|Overall Study|Other|1
7715742|NCT01044498|26828671|P2|Overall Study|Adverse Event|1
7715743|NCT01044498|26828672|P1|Overall Study|Adverse Event|1
7715744|NCT01044498|26828671|P2|Overall Study|Withdrew consent|1
7715745|NCT01044498|26828672|P1|Overall Study|Withdrew consent|1
7715746|NCT01044459|26828698|P2|Overall Study|Lost to Follow-up|12
7715747|NCT01044459|26828699|P1|Overall Study|Lost to Follow-up|18
7715748|NCT01044459|26828698|P2|Overall Study|COPD exacerbation|8
7715749|NCT01044459|26828699|P1|Overall Study|COPD exacerbation|9
7715750|NCT01044459|26828698|P2|Overall Study|Other Reason|14
7715751|NCT01044459|26828699|P1|Overall Study|Other Reason|7
7715752|NCT01044459|26828698|P2|Overall Study|Protocol Violation|16
7715753|NCT01044459|26828699|P1|Overall Study|Protocol Violation|11
7715754|NCT01044459|26828698|P2|Overall Study|Lack of Efficacy|12
7715755|NCT01044459|26828699|P1|Overall Study|Lack of Efficacy|23
7715756|NCT01044459|26828698|P2|Overall Study|Adverse Event|20
7715757|NCT01044459|26828699|P1|Overall Study|Adverse Event|22
7715758|NCT01044459|26828698|P2|Overall Study|Terminated by Sponsor|21
7715759|NCT01044459|26828699|P1|Overall Study|Terminated by Sponsor|22
7715760|NCT01044459|26828698|P2|Overall Study|Withdrawal by Subject|28
7715761|NCT01044459|26828699|P1|Overall Study|Withdrawal by Subject|21
7715762|NCT01044433|26828707|P1|Overall Study|Withdrawal by Subject|3
7715763|NCT01044433|26828707|P1|Overall Study|Lost to Follow-up|3
7715764|NCT01044303|26828715|P1|Overall Study|Lost to Follow-up|2
7715765|NCT01044290|26828725|P3|Follow-Up 2|Withdrawal by Subject|1
7715766|NCT01044290|26828726|P2|Follow-Up 2|Withdrawal by Subject|1
7715767|NCT01044290|26828727|P1|Follow-Up 2|Withdrawal by Subject|0
7715768|NCT01044290|26828725|P3|Follow-Up 2|Death|1
7715769|NCT01044290|26828726|P2|Follow-Up 2|Death|1
7715770|NCT01044290|26828727|P1|Follow-Up 2|Death|0
7715771|NCT01044290|26828725|P3|Follow-up 1|Withdrawal by Subject|0
7715772|NCT01044290|26828726|P2|Follow-up 1|Withdrawal by Subject|2
7715773|NCT01044290|26828727|P1|Follow-up 1|Withdrawal by Subject|2
7715774|NCT01044290|26828725|P3|Follow-up 1|Death|1
7715775|NCT01044290|26828726|P2|Follow-up 1|Death|3
7715776|NCT01044290|26828727|P1|Follow-up 1|Death|3
7715777|NCT01043874|26828847|P1|Overall Study|Administrative Problems|1
7715778|NCT01043874|26828847|P1|Overall Study|Lack of Efficacy|1
7715779|NCT01043874|26828847|P1|Overall Study|Withdrawal by Subject|1
7715780|NCT01043874|26828847|P1|Overall Study|Adverse Event|3
7715781|NCT01043705|26828857|P3|Overall Study|Other|25
7715782|NCT01043705|26828858|P2|Overall Study|Other|19
7715783|NCT01043705|26828859|P1|Overall Study|Other|0
7715784|NCT01043705|26828857|P3|Overall Study|Screen Fail|0
7715785|NCT01043705|26828858|P2|Overall Study|Screen Fail|0
7715786|NCT01043705|26828859|P1|Overall Study|Screen Fail|21
7715787|NCT01043705|26828857|P3|Overall Study|Adverse Event|0
7715788|NCT01043705|26828858|P2|Overall Study|Adverse Event|2
7715789|NCT01043705|26828859|P1|Overall Study|Adverse Event|0
7715790|NCT01043705|26828857|P3|Overall Study|Subsequent Procedure|29
7715791|NCT01043705|26828858|P2|Overall Study|Subsequent Procedure|24
7715792|NCT01043705|26828859|P1|Overall Study|Subsequent Procedure|9
7715793|NCT01043705|26828857|P3|Overall Study|Site Closure|0
7715794|NCT01043705|26828858|P2|Overall Study|Site Closure|0
7715795|NCT01043705|26828859|P1|Overall Study|Site Closure|8
7715796|NCT01043705|26828857|P3|Overall Study|Withdrawal by Subject|0
7715797|NCT01043705|26828858|P2|Overall Study|Withdrawal by Subject|6
7715798|NCT01043705|26828859|P1|Overall Study|Withdrawal by Subject|8
7715799|NCT01043705|26828857|P3|Overall Study|Protocol Violation|0
7715800|NCT01043705|26828858|P2|Overall Study|Protocol Violation|1
7715801|NCT01043705|26828859|P1|Overall Study|Protocol Violation|2
7715802|NCT01043705|26828857|P3|Overall Study|Multiple Reasons|0
7715803|NCT01043705|26828858|P2|Overall Study|Multiple Reasons|7
7715804|NCT01043705|26828859|P1|Overall Study|Multiple Reasons|4
7715805|NCT01043705|26828857|P3|Overall Study|Lost to Follow-up|0
7715806|NCT01043705|26828858|P2|Overall Study|Lost to Follow-up|12
7715807|NCT01043705|26828859|P1|Overall Study|Lost to Follow-up|27
7715808|NCT01043705|26828857|P3|Overall Study|Death|26
7715809|NCT01043705|26828858|P2|Overall Study|Death|60
7715810|NCT01043705|26828859|P1|Overall Study|Death|28
7715811|NCT01043185|26828948|P10|Period 6 - Third Washout Period|Protocol Violation|0
7715812|NCT01043185|26828949|P9|Period 6 - Third Washout Period|Protocol Violation|1
7715813|NCT01043185|26828950|P8|Period 6 - Third Washout Period|Protocol Violation|0
7715814|NCT01043185|26828951|P7|Period 6 - Third Washout Period|Protocol Violation|0
7715815|NCT01043185|26828952|P6|Period 6 - Third Washout Period|Protocol Violation|0
7715816|NCT01043185|26828953|P5|Period 6 - Third Washout Period|Protocol Violation|0
7715817|NCT01043185|26828954|P4|Period 6 - Third Washout Period|Protocol Violation|0
7715818|NCT01043185|26828955|P3|Period 6 - Third Washout Period|Protocol Violation|0
7715819|NCT01043185|26828956|P2|Period 6 - Third Washout Period|Protocol Violation|0
7715820|NCT01043185|26828957|P1|Period 6 - Third Washout Period|Protocol Violation|0
7715821|NCT01042977|26829033|P2|Overall Study|Various|0
7715822|NCT01042977|26829034|P1|Overall Study|Various|3
7715823|NCT01042977|26829033|P2|Overall Study|Administrative reason by sponsor|1
7715824|NCT01042977|26829034|P1|Overall Study|Administrative reason by sponsor|0
7715825|NCT01042977|26829033|P2|Overall Study|Safety|2
7715826|NCT01042977|26829034|P1|Overall Study|Safety|0
7715827|NCT01042977|26829033|P2|Overall Study|Incorrect enrollment|4
7715828|NCT01042977|26829034|P1|Overall Study|Incorrect enrollment|6
7715829|NCT01042977|26829033|P2|Overall Study|Subject no longer meets study criteria|13
7715830|NCT01042977|26829034|P1|Overall Study|Subject no longer meets study criteria|15
7715831|NCT01042977|26829033|P2|Overall Study|Poor/non-compliance|4
7715832|NCT01042977|26829034|P1|Overall Study|Poor/non-compliance|3
7715833|NCT01042977|26829033|P2|Overall Study|Lost to Follow-up|2
7715834|NCT01042977|26829034|P1|Overall Study|Lost to Follow-up|0
7715835|NCT01042977|26829033|P2|Overall Study|Withdrawal by Subject|16
7715836|NCT01042977|26829034|P1|Overall Study|Withdrawal by Subject|8
7715837|NCT01042977|26829033|P2|Overall Study|Death|1
7715838|NCT01042977|26829034|P1|Overall Study|Death|2
7715839|NCT01042977|26829033|P2|Overall Study|Adverse Event|12
7715840|NCT01042977|26829034|P1|Overall Study|Adverse Event|4
7715841|NCT01042938|26829054|P2|Overall Study|Ineligible: RTOG study conflict|0
7715842|NCT01042938|26829055|P1|Overall Study|Ineligible: RTOG study conflict|1
7715843|NCT01042938|26829054|P2|Overall Study|Protocol Violation|1
7715844|NCT01042938|26829055|P1|Overall Study|Protocol Violation|1
7715845|NCT01042938|26829054|P2|Overall Study|Withdrawal by Subject|1
7715846|NCT01042938|26829055|P1|Overall Study|Withdrawal by Subject|1
7715847|NCT01042678|26829074|P6|Overall Study|Physician Decision|0
7715848|NCT01042678|26829075|P5|Overall Study|Physician Decision|0
7715849|NCT01042678|26829076|P4|Overall Study|Physician Decision|0
7715850|NCT01042678|26829077|P3|Overall Study|Physician Decision|0
7715851|NCT01042678|26829078|P2|Overall Study|Physician Decision|0
7715852|NCT01042678|26829079|P1|Overall Study|Physician Decision|1
7715853|NCT01042600|26829117|P2|Overall Study|Ineligible|0
7715854|NCT01042600|26829118|P1|Overall Study|Ineligible|1
7715855|NCT01042535|26829138|P1|Overall Study|complications from other disease|2
7715856|NCT01042535|26829138|P1|Overall Study|disease progression during treatment|3
7715857|NCT01042535|26829138|P1|Overall Study|disease progression prior to treatment|3
7715858|NCT01042392|26829172|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7715859|NCT01042392|26829173|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7715860|NCT01042392|26829174|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7715861|NCT01042392|26829175|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
7715862|NCT01042392|26829172|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7715863|NCT01042392|26829173|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
7715864|NCT01042392|26829174|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7715865|NCT01042392|26829175|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7715866|NCT01042392|26829172|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7715867|NCT01042392|26829173|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7715868|NCT01042392|26829174|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7715869|NCT01042392|26829175|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
7715870|NCT01042392|26829172|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7715871|NCT01042392|26829173|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
7715872|NCT01042392|26829174|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7715873|NCT01042392|26829175|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7715874|NCT01042392|26829172|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7715875|NCT01042392|26829173|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7715876|NCT01042392|26829174|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7715877|NCT01042392|26829175|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
7715878|NCT01042392|26829172|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7715879|NCT01042392|26829173|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
7715880|NCT01042392|26829174|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7715881|NCT01042392|26829175|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7715882|NCT01042392|26829172|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
7715883|NCT01042392|26829173|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
7715884|NCT01042392|26829174|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
7715885|NCT01042392|26829175|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
7715886|NCT01042392|26829172|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7715887|NCT01042392|26829173|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7715888|NCT01042392|26829174|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7715889|NCT01042392|26829175|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
7715890|NCT01042392|26829172|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
7715891|NCT01042392|26829173|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
7715892|NCT01042392|26829174|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
7715893|NCT01042392|26829175|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
7715894|NCT01042236|26829223|P6|Treatment Period 3|Protocol Violation|0
7715895|NCT01042236|26829224|P5|Treatment Period 3|Protocol Violation|0
7715896|NCT01042236|26829225|P4|Treatment Period 3|Protocol Violation|1
7715897|NCT01042236|26829226|P3|Treatment Period 3|Protocol Violation|0
7715898|NCT01042236|26829227|P2|Treatment Period 3|Protocol Violation|0
7715899|NCT01042236|26829228|P1|Treatment Period 3|Protocol Violation|0
7715900|NCT01042236|26829223|P6|Treatment Period 3|Adverse Event|0
7715901|NCT01042236|26829224|P5|Treatment Period 3|Adverse Event|0
7715902|NCT01042236|26829225|P4|Treatment Period 3|Adverse Event|1
7715903|NCT01042236|26829226|P3|Treatment Period 3|Adverse Event|0
7715904|NCT01042236|26829227|P2|Treatment Period 3|Adverse Event|0
7715905|NCT01042236|26829228|P1|Treatment Period 3|Adverse Event|0
7715906|NCT01042236|26829223|P6|Treatment Period 1|Adverse Event|0
7715907|NCT01042236|26829224|P5|Treatment Period 1|Adverse Event|1
7715908|NCT01042236|26829225|P4|Treatment Period 1|Adverse Event|0
7715909|NCT01042236|26829226|P3|Treatment Period 1|Adverse Event|0
7715910|NCT01042236|26829227|P2|Treatment Period 1|Adverse Event|1
7715911|NCT01042236|26829228|P1|Treatment Period 1|Adverse Event|0
7715912|NCT01042158|26829265|P1|Overall Study|Physician Decision|1
7715913|NCT01042093|26829295|P4|Overall Study|Withdrawal by Subject|1
7715914|NCT01042093|26829296|P3|Overall Study|Withdrawal by Subject|0
7715915|NCT01042093|26829297|P2|Overall Study|Withdrawal by Subject|0
7715916|NCT01042093|26829298|P1|Overall Study|Withdrawal by Subject|0
7715917|NCT01042093|26829295|P4|Overall Study|Protocol Violation|3
7715918|NCT01042093|26829296|P3|Overall Study|Protocol Violation|2
7715919|NCT01042093|26829297|P2|Overall Study|Protocol Violation|2
7715920|NCT01042093|26829298|P1|Overall Study|Protocol Violation|2
7715921|NCT01041976|26829318|P2|Overall Study|Death|4
7715922|NCT01041976|26829319|P1|Overall Study|Death|0
7715923|NCT01041976|26829318|P2|Overall Study|Incarceration|0
7715924|NCT01041976|26829319|P1|Overall Study|Incarceration|2
7715925|NCT01041976|26829318|P2|Overall Study|Withdrawal by Subject|0
7715926|NCT01041976|26829319|P1|Overall Study|Withdrawal by Subject|3
7715927|NCT01041859|26829329|P3|Double-Blind Maintenance|Withdrawal by Subject|9
7715928|NCT01041859|26829330|P2|Double-Blind Maintenance|Withdrawal by Subject|8
7715929|NCT01041859|26829331|P1|Double-Blind Maintenance|Withdrawal by Subject|0
7715930|NCT01041859|26829329|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
7715931|NCT01041859|26829330|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
7715932|NCT01041859|26829331|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
7715933|NCT01041859|26829329|P3|Double-Blind Maintenance|Other|2
7715934|NCT01041859|26829330|P2|Double-Blind Maintenance|Other|6
7715935|NCT01041859|26829331|P1|Double-Blind Maintenance|Other|0
7715936|NCT01041859|26829329|P3|Double-Blind Maintenance|Protocol Violation|3
7715937|NCT01041859|26829330|P2|Double-Blind Maintenance|Protocol Violation|1
7715938|NCT01041859|26829331|P1|Double-Blind Maintenance|Protocol Violation|0
7715939|NCT01041859|26829329|P3|Double-Blind Maintenance|Physician Decision|1
7715940|NCT01041859|26829330|P2|Double-Blind Maintenance|Physician Decision|2
7715941|NCT01041859|26829331|P1|Double-Blind Maintenance|Physician Decision|0
7715942|NCT01041859|26829329|P3|Double-Blind Maintenance|Lost to Follow-up|0
7715943|NCT01041859|26829330|P2|Double-Blind Maintenance|Lost to Follow-up|1
7715944|NCT01041859|26829331|P1|Double-Blind Maintenance|Lost to Follow-up|0
7715945|NCT01041859|26829329|P3|Double-Blind Maintenance|Lack of Efficacy|11
7715946|NCT01041859|26829330|P2|Double-Blind Maintenance|Lack of Efficacy|3
7715947|NCT01041859|26829331|P1|Double-Blind Maintenance|Lack of Efficacy|0
7715948|NCT01041859|26829329|P3|Double-Blind Maintenance|Adverse Event|13
7715949|NCT01041859|26829330|P2|Double-Blind Maintenance|Adverse Event|23
7715950|NCT01041859|26829331|P1|Double-Blind Maintenance|Adverse Event|0
7715951|NCT01041859|26829329|P3|Open-Label Titration|Withdrawal by Subject|0
7715952|NCT01041859|26829330|P2|Open-Label Titration|Withdrawal by Subject|0
7715953|NCT01041859|26829331|P1|Open-Label Titration|Withdrawal by Subject|11
7715954|NCT01041859|26829329|P3|Open-Label Titration|Noncompliance With Study Drug|0
7715955|NCT01041859|26829330|P2|Open-Label Titration|Noncompliance With Study Drug|0
7715956|NCT01041859|26829331|P1|Open-Label Titration|Noncompliance With Study Drug|8
7715957|NCT01041859|26829329|P3|Open-Label Titration|Other|0
7715958|NCT01041859|26829330|P2|Open-Label Titration|Other|0
7715959|NCT01041859|26829331|P1|Open-Label Titration|Other|7
7715960|NCT01041859|26829329|P3|Open-Label Titration|Protocol Violation|0
7715961|NCT01041859|26829330|P2|Open-Label Titration|Protocol Violation|0
7715962|NCT01041859|26829331|P1|Open-Label Titration|Protocol Violation|1
7715963|NCT01041859|26829329|P3|Open-Label Titration|Physician Decision|0
7715964|NCT01041859|26829330|P2|Open-Label Titration|Physician Decision|0
7715965|NCT01041859|26829331|P1|Open-Label Titration|Physician Decision|1
7715966|NCT01041859|26829329|P3|Open-Label Titration|Lost to Follow-up|0
7715967|NCT01041859|26829330|P2|Open-Label Titration|Lost to Follow-up|0
7715968|NCT01041859|26829331|P1|Open-Label Titration|Lost to Follow-up|1
7715969|NCT01041859|26829329|P3|Open-Label Titration|Lack of Efficacy|0
7715970|NCT01041859|26829330|P2|Open-Label Titration|Lack of Efficacy|0
7715971|NCT01041859|26829331|P1|Open-Label Titration|Lack of Efficacy|3
7715972|NCT01041859|26829329|P3|Open-Label Titration|Adverse Event|0
7715973|NCT01041859|26829330|P2|Open-Label Titration|Adverse Event|0
7715974|NCT01041859|26829331|P1|Open-Label Titration|Adverse Event|69
7715975|NCT01041638|26829367|P1|Overall Study|Withdrawal by Subject|11
7715976|NCT01041638|26829367|P1|Overall Study|Physician Decision|4
7715977|NCT01041638|26829367|P1|Overall Study|Lack of Efficacy|7
7715978|NCT01041638|26829367|P1|Overall Study|Death|1
7715979|NCT01041638|26829367|P1|Overall Study|Adverse Event|4
7715980|NCT01041573|26829377|P4|Overall Study|positive to anti-HCV|0
7715981|NCT01041573|26829378|P3|Overall Study|positive to anti-HCV|0
7715982|NCT01041573|26829379|P2|Overall Study|positive to anti-HCV|0
7715983|NCT01041573|26829380|P1|Overall Study|positive to anti-HCV|1
7715984|NCT01041573|26829377|P4|Overall Study|further blood extraction|0
7715985|NCT01041573|26829378|P3|Overall Study|further blood extraction|0
7715986|NCT01041573|26829379|P2|Overall Study|further blood extraction|1
7715987|NCT01041573|26829380|P1|Overall Study|further blood extraction|0
7715988|NCT01041573|26829377|P4|Overall Study|relocation|1
7715989|NCT01041573|26829378|P3|Overall Study|relocation|3
7715990|NCT01041573|26829379|P2|Overall Study|relocation|4
7715991|NCT01041573|26829380|P1|Overall Study|relocation|1
7715992|NCT01041573|26829377|P4|Overall Study|Adverse Event|0
7715993|NCT01041573|26829378|P3|Overall Study|Adverse Event|0
7715994|NCT01041573|26829379|P2|Overall Study|Adverse Event|2
7715995|NCT01041573|26829380|P1|Overall Study|Adverse Event|0
7715996|NCT01041573|26829377|P4|Overall Study|Lost to Follow-up|1
7715997|NCT01041573|26829378|P3|Overall Study|Lost to Follow-up|2
7715998|NCT01041573|26829379|P2|Overall Study|Lost to Follow-up|1
7715999|NCT01041573|26829380|P1|Overall Study|Lost to Follow-up|0
7716000|NCT01041573|26829377|P4|Overall Study|Death|0
7716001|NCT01041573|26829378|P3|Overall Study|Death|0
7716002|NCT01041573|26829379|P2|Overall Study|Death|0
7716003|NCT01041573|26829380|P1|Overall Study|Death|1
7716004|NCT01041573|26829377|P4|Overall Study|Withdrawal by Subject|0
7716005|NCT01041573|26829378|P3|Overall Study|Withdrawal by Subject|2
7716006|NCT01041573|26829379|P2|Overall Study|Withdrawal by Subject|5
7716007|NCT01041573|26829380|P1|Overall Study|Withdrawal by Subject|2
7716008|NCT01041495|26829423|P2|Overall Study|Lost to Follow-up|1
7716009|NCT01041495|26829424|P1|Overall Study|Lost to Follow-up|0
7716010|NCT01041495|26829423|P2|Overall Study|Adverse Event|1
7716011|NCT01041495|26829424|P1|Overall Study|Adverse Event|2
7716012|NCT01041495|26829423|P2|Overall Study|Withdrawal by Subject|5
7716013|NCT01041495|26829424|P1|Overall Study|Withdrawal by Subject|2
7716014|NCT01041417|26829436|P2|Overall Study|Death|0
7716015|NCT01041417|26829437|P1|Overall Study|Death|1
7716016|NCT01041417|26829436|P2|Overall Study|Lost to Follow-up|1
7716017|NCT01041417|26829437|P1|Overall Study|Lost to Follow-up|1
7716018|NCT01041417|26829436|P2|Overall Study|Adverse Event|2
7716019|NCT01041417|26829437|P1|Overall Study|Adverse Event|5
7716020|NCT01041404|26829475|P2|Overall Study|Other|23
7716021|NCT01041404|26829476|P1|Overall Study|Other|11
7716022|NCT01041404|26829475|P2|Overall Study|Failure to Return|2
7716023|NCT01041404|26829476|P1|Overall Study|Failure to Return|1
7716024|NCT01041404|26829475|P2|Overall Study|Withdrawal by Subject|23
7716025|NCT01041404|26829476|P1|Overall Study|Withdrawal by Subject|29
7716026|NCT01041404|26829475|P2|Overall Study|Protocol Violation|0
7716027|NCT01041404|26829476|P1|Overall Study|Protocol Violation|4
7716028|NCT01041404|26829475|P2|Overall Study|Violation of Selection Criteria|1
7716029|NCT01041404|26829476|P1|Overall Study|Violation of Selection Criteria|0
7716030|NCT01041404|26829475|P2|Overall Study|Lack of Efficacy|210
7716031|NCT01041404|26829476|P1|Overall Study|Lack of Efficacy|200
7716032|NCT01041404|26829475|P2|Overall Study|Adverse Event|35
7716033|NCT01041404|26829476|P1|Overall Study|Adverse Event|45
7716034|NCT01041287|26829517|P2|Treatment Period 2 (3 Months)|Adverse Event|2
7716035|NCT01041287|26829518|P1|Treatment Period 2 (3 Months)|Adverse Event|0
7716036|NCT01041287|26829517|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
7716037|NCT01041287|26829518|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
7716038|NCT01040871|26829564|P2|Overall Study|Randomized and Not Treated|1
7716039|NCT01040871|26829565|P1|Overall Study|Randomized and Not Treated|2
7716040|NCT01040871|26829564|P2|Overall Study|drug supply issue|0
7716041|NCT01040871|26829565|P1|Overall Study|drug supply issue|1
7716042|NCT01040871|26829564|P2|Overall Study|Lack of Efficacy|1
7716043|NCT01040871|26829565|P1|Overall Study|Lack of Efficacy|1
7716044|NCT01040871|26829564|P2|Overall Study|Death|3
7716045|NCT01040871|26829565|P1|Overall Study|Death|1
7716046|NCT01040871|26829564|P2|Overall Study|Withdrawal by Subject|0
7716047|NCT01040871|26829565|P1|Overall Study|Withdrawal by Subject|2
7716048|NCT01040871|26829564|P2|Overall Study|Adverse Event|2
7716049|NCT01040871|26829565|P1|Overall Study|Adverse Event|6
7716050|NCT01040845|26829616|P2|Overall Study|Physician Decision|0
7716051|NCT01040845|26829617|P1|Overall Study|Physician Decision|1
7716052|NCT01040845|26829616|P2|Overall Study|Withdrawal by Subject|1
7716053|NCT01040845|26829617|P1|Overall Study|Withdrawal by Subject|1
7716054|NCT01040832|26829632|P2|Overall Study|Other|1
7716055|NCT01040832|26829633|P1|Overall Study|Other|2
7716056|NCT01040832|26829632|P2|Overall Study|Symptomatic deterioration|5
7716057|NCT01040832|26829633|P1|Overall Study|Symptomatic deterioration|2
7716058|NCT01040832|26829632|P2|Overall Study|Progressive disease|17
7716059|NCT01040832|26829633|P1|Overall Study|Progressive disease|32
7716060|NCT01040832|26829632|P2|Overall Study|Withdrawal by Subject|3
7716061|NCT01040832|26829633|P1|Overall Study|Withdrawal by Subject|2
7716062|NCT01040832|26829632|P2|Overall Study|Death|6
7716063|NCT01040832|26829633|P1|Overall Study|Death|4
7716064|NCT01040832|26829632|P2|Overall Study|Adverse Event|5
7716065|NCT01040832|26829633|P1|Overall Study|Adverse Event|4
7716066|NCT01040793|26829656|P6|Overall Study|Other reasons not listed above|0
7716067|NCT01040793|26829657|P5|Overall Study|Other reasons not listed above|1
7716068|NCT01040793|26829658|P4|Overall Study|Other reasons not listed above|0
7716069|NCT01040793|26829659|P3|Overall Study|Other reasons not listed above|1
7716070|NCT01040793|26829660|P2|Overall Study|Other reasons not listed above|0
7716071|NCT01040793|26829661|P1|Overall Study|Other reasons not listed above|0
7716072|NCT01040793|26829656|P6|Overall Study|Withdrawal by Subject|0
7716073|NCT01040793|26829657|P5|Overall Study|Withdrawal by Subject|0
7716074|NCT01040793|26829658|P4|Overall Study|Withdrawal by Subject|2
7716075|NCT01040793|26829659|P3|Overall Study|Withdrawal by Subject|0
7716076|NCT01040793|26829660|P2|Overall Study|Withdrawal by Subject|0
7716077|NCT01040793|26829661|P1|Overall Study|Withdrawal by Subject|0
7716078|NCT01040793|26829656|P6|Overall Study|Lost to Follow-up|0
7716079|NCT01040793|26829657|P5|Overall Study|Lost to Follow-up|0
7716080|NCT01040793|26829658|P4|Overall Study|Lost to Follow-up|0
7716081|NCT01040793|26829659|P3|Overall Study|Lost to Follow-up|1
7716082|NCT01040793|26829660|P2|Overall Study|Lost to Follow-up|1
7716083|NCT01040793|26829661|P1|Overall Study|Lost to Follow-up|0
7716084|NCT01040793|26829656|P6|Overall Study|Protocol Violation|0
7716085|NCT01040793|26829657|P5|Overall Study|Protocol Violation|1
7716086|NCT01040793|26829658|P4|Overall Study|Protocol Violation|0
7716087|NCT01040793|26829659|P3|Overall Study|Protocol Violation|1
7716088|NCT01040793|26829660|P2|Overall Study|Protocol Violation|1
7716089|NCT01040793|26829661|P1|Overall Study|Protocol Violation|1
7716090|NCT01040793|26829656|P6|Overall Study|Adverse Event|1
7716091|NCT01040793|26829657|P5|Overall Study|Adverse Event|2
7716092|NCT01040793|26829658|P4|Overall Study|Adverse Event|2
7716093|NCT01040793|26829659|P3|Overall Study|Adverse Event|0
7716094|NCT01040793|26829660|P2|Overall Study|Adverse Event|3
7716095|NCT01040793|26829661|P1|Overall Study|Adverse Event|5
7716096|NCT01040780|26829740|P2|Overall Study|Protocol Violation|3
7716097|NCT01040780|26829741|P1|Overall Study|Protocol Violation|1
7716098|NCT01040728|26829755|P4|Overall Study|Other reasons not listed above|0
7716099|NCT01040728|26829756|P3|Overall Study|Other reasons not listed above|0
7716100|NCT01040728|26829757|P2|Overall Study|Other reasons not listed above|1
7716101|NCT01040728|26829758|P1|Overall Study|Other reasons not listed above|0
7716102|NCT01040728|26829755|P4|Overall Study|Lack of Efficacy|1
7716103|NCT01040728|26829756|P3|Overall Study|Lack of Efficacy|0
7716104|NCT01040728|26829757|P2|Overall Study|Lack of Efficacy|1
7716105|NCT01040728|26829758|P1|Overall Study|Lack of Efficacy|0
7716106|NCT01040728|26829755|P4|Overall Study|Protocol Violation|1
7716107|NCT01040728|26829756|P3|Overall Study|Protocol Violation|0
7716108|NCT01040728|26829757|P2|Overall Study|Protocol Violation|0
7716109|NCT01040728|26829758|P1|Overall Study|Protocol Violation|0
7716110|NCT01040728|26829755|P4|Overall Study|Withdrawal by Subject|0
7716111|NCT01040728|26829756|P3|Overall Study|Withdrawal by Subject|1
7716112|NCT01040728|26829757|P2|Overall Study|Withdrawal by Subject|1
7716113|NCT01040728|26829758|P1|Overall Study|Withdrawal by Subject|0
7716114|NCT01040728|26829755|P4|Overall Study|Adverse Event|4
7716115|NCT01040728|26829756|P3|Overall Study|Adverse Event|0
7716116|NCT01040728|26829757|P2|Overall Study|Adverse Event|8
7716117|NCT01040728|26829758|P1|Overall Study|Adverse Event|4
7716118|NCT01040689|26829828|P4|Overall Study|Other reasons not listed above|0
7716119|NCT01040689|26829829|P3|Overall Study|Other reasons not listed above|0
7716120|NCT01040689|26829830|P2|Overall Study|Other reasons not listed above|1
7716121|NCT01040689|26829831|P1|Overall Study|Other reasons not listed above|0
7716122|NCT01040689|26829828|P4|Overall Study|Withdrawal by Subject|0
7716123|NCT01040689|26829829|P3|Overall Study|Withdrawal by Subject|1
7716124|NCT01040689|26829830|P2|Overall Study|Withdrawal by Subject|1
7716125|NCT01040689|26829831|P1|Overall Study|Withdrawal by Subject|2
7716126|NCT01040689|26829828|P4|Overall Study|Lost to Follow-up|0
7716127|NCT01040689|26829829|P3|Overall Study|Lost to Follow-up|0
7716128|NCT01040689|26829830|P2|Overall Study|Lost to Follow-up|0
7716129|NCT01040689|26829831|P1|Overall Study|Lost to Follow-up|1
7716130|NCT01040689|26829828|P4|Overall Study|Lack of Efficacy|0
7716131|NCT01040689|26829829|P3|Overall Study|Lack of Efficacy|1
7716132|NCT01040689|26829830|P2|Overall Study|Lack of Efficacy|0
7716133|NCT01040689|26829831|P1|Overall Study|Lack of Efficacy|0
7716134|NCT01040689|26829828|P4|Overall Study|Adverse Event|4
7716135|NCT01040689|26829829|P3|Overall Study|Adverse Event|2
7716136|NCT01040689|26829830|P2|Overall Study|Adverse Event|0
7716137|NCT01040689|26829831|P1|Overall Study|Adverse Event|0
7716138|NCT01040403|26829910|P1|Overall Study|Other reason not defined above|6
7716139|NCT01040403|26829910|P1|Overall Study|Not treated|1
7716140|NCT01040403|26829910|P1|Overall Study|Lost to Follow-up|1
7716141|NCT01040403|26829910|P1|Overall Study|Protocol Violation|2
7716142|NCT01040403|26829910|P1|Overall Study|Adverse Event|10
7716143|NCT01040351|26830098|P2|Overall Study|poor ovarian response|2
7716144|NCT01040351|26830099|P1|Overall Study|poor ovarian response|1
7716145|NCT01040260|26830109|P2|Overall Study|Lost to Follow-up|5
7716146|NCT01040260|26830110|P1|Overall Study|Lost to Follow-up|3
7716147|NCT01040260|26830109|P2|Overall Study|Withdrawal by Subject|6
7716148|NCT01040260|26830110|P1|Overall Study|Withdrawal by Subject|12
7716149|NCT01040169|26830137|P2|Overall Study|Lost to Follow-up|8
7716150|NCT01040169|26830138|P1|Overall Study|Lost to Follow-up|3
7716151|NCT01040130|26830146|P6|Overall Study|Other reasons not listed above|0
7716152|NCT01040130|26830147|P5|Overall Study|Other reasons not listed above|0
7716153|NCT01040130|26830148|P4|Overall Study|Other reasons not listed above|0
7716154|NCT01040130|26830149|P3|Overall Study|Other reasons not listed above|0
7716155|NCT01040130|26830150|P2|Overall Study|Other reasons not listed above|0
7716156|NCT01040130|26830151|P1|Overall Study|Other reasons not listed above|2
7716157|NCT01040130|26830146|P6|Overall Study|Withdrawal by Subject|1
7716158|NCT01040130|26830147|P5|Overall Study|Withdrawal by Subject|0
7716159|NCT01040130|26830148|P4|Overall Study|Withdrawal by Subject|0
7716160|NCT01040130|26830149|P3|Overall Study|Withdrawal by Subject|0
7716161|NCT01040130|26830150|P2|Overall Study|Withdrawal by Subject|2
7716162|NCT01040130|26830151|P1|Overall Study|Withdrawal by Subject|0
7716163|NCT01040130|26830146|P6|Overall Study|Protocol Violation|0
7716164|NCT01040130|26830147|P5|Overall Study|Protocol Violation|0
7716165|NCT01040130|26830148|P4|Overall Study|Protocol Violation|0
7716166|NCT01040130|26830149|P3|Overall Study|Protocol Violation|2
7716167|NCT01040130|26830150|P2|Overall Study|Protocol Violation|0
7716168|NCT01040130|26830151|P1|Overall Study|Protocol Violation|0
7716169|NCT01040130|26830146|P6|Overall Study|Adverse Event|3
7716170|NCT01040130|26830147|P5|Overall Study|Adverse Event|0
7716171|NCT01040130|26830148|P4|Overall Study|Adverse Event|5
7716172|NCT01040130|26830149|P3|Overall Study|Adverse Event|0
7716173|NCT01040130|26830150|P2|Overall Study|Adverse Event|1
7716174|NCT01040130|26830151|P1|Overall Study|Adverse Event|1
7716175|NCT01039688|26830244|P3|Overall Study|Death|0
7716176|NCT01039688|26830245|P2|Overall Study|Death|0
7716177|NCT01039688|26830246|P1|Overall Study|Death|2
7716178|NCT01039688|26830244|P3|Overall Study|Withdrawal by Subject|13
7716179|NCT01039688|26830245|P2|Overall Study|Withdrawal by Subject|27
7716180|NCT01039688|26830246|P1|Overall Study|Withdrawal by Subject|23
7716181|NCT01039688|26830244|P3|Overall Study|Other|12
7716182|NCT01039688|26830245|P2|Overall Study|Other|25
7716183|NCT01039688|26830246|P1|Overall Study|Other|13
7716184|NCT01039688|26830244|P3|Overall Study|Lost to Follow-up|5
7716185|NCT01039688|26830245|P2|Overall Study|Lost to Follow-up|9
7716186|NCT01039688|26830246|P1|Overall Study|Lost to Follow-up|11
7716187|NCT01039688|26830244|P3|Overall Study|Lack of Efficacy|26
7716188|NCT01039688|26830245|P2|Overall Study|Lack of Efficacy|11
7716189|NCT01039688|26830246|P1|Overall Study|Lack of Efficacy|20
7716190|NCT01039688|26830244|P3|Overall Study|Adverse Event|24
7716191|NCT01039688|26830245|P2|Overall Study|Adverse Event|39
7716192|NCT01039688|26830246|P1|Overall Study|Adverse Event|38
7716193|NCT01039675|26830517|P2|Overall Study|Physician Decision|1
7716194|NCT01039675|26830518|P1|Overall Study|Physician Decision|0
7716195|NCT01039675|26830517|P2|Overall Study|Lost to Follow-up|1
7716196|NCT01039675|26830518|P1|Overall Study|Lost to Follow-up|0
7716197|NCT01039675|26830517|P2|Overall Study|Withdrawal by Subject|1
7716198|NCT01039675|26830518|P1|Overall Study|Withdrawal by Subject|0
7716199|NCT01039675|26830517|P2|Overall Study|Lack of Efficacy|2
7716200|NCT01039675|26830518|P1|Overall Study|Lack of Efficacy|0
7716201|NCT01039675|26830517|P2|Overall Study|Adverse Event|2
7716202|NCT01039675|26830518|P1|Overall Study|Adverse Event|0
7716203|NCT01039584|26830531|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
7716204|NCT01039584|26830532|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
7716205|NCT01039584|26830533|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
7716206|NCT01039584|26830531|P3|Overall Study|Pap smear with significant pathology|3
7716207|NCT01039584|26830532|P2|Overall Study|Pap smear with significant pathology|10
7716208|NCT01039584|26830533|P1|Overall Study|Pap smear with significant pathology|10
7716209|NCT01039584|26830531|P3|Overall Study|other|1
7716210|NCT01039584|26830532|P2|Overall Study|other|3
7716211|NCT01039584|26830533|P1|Overall Study|other|1
7716212|NCT01039584|26830531|P3|Overall Study|Lack of Efficacy|10
7716213|NCT01039584|26830532|P2|Overall Study|Lack of Efficacy|6
7716214|NCT01039584|26830533|P1|Overall Study|Lack of Efficacy|7
7716215|NCT01039584|26830531|P3|Overall Study|Negative Baseline culture for Candida|24
7716216|NCT01039584|26830532|P2|Overall Study|Negative Baseline culture for Candida|59
7716217|NCT01039584|26830533|P1|Overall Study|Negative Baseline culture for Candida|59
7716218|NCT01039584|26830531|P3|Overall Study|Lost to Follow-up|4
7716219|NCT01039584|26830532|P2|Overall Study|Lost to Follow-up|3
7716220|NCT01039584|26830533|P1|Overall Study|Lost to Follow-up|5
7716221|NCT01039584|26830531|P3|Overall Study|Protocol Violation|6
7716222|NCT01039584|26830532|P2|Overall Study|Protocol Violation|4
7716223|NCT01039584|26830533|P1|Overall Study|Protocol Violation|10
7716224|NCT01039584|26830531|P3|Overall Study|Withdrawal by Subject|1
7716225|NCT01039584|26830532|P2|Overall Study|Withdrawal by Subject|2
7716226|NCT01039584|26830533|P1|Overall Study|Withdrawal by Subject|4
7716227|NCT01039519|26830547|P1|Survival Follow-up|Sponsor decision|4
7716228|NCT01039519|26830547|P1|Survival Follow-up|Death|23
7716229|NCT01039519|26830547|P1|Treatment|Physician Decision|2
7716230|NCT01039519|26830547|P1|Treatment|Adverse Event|3
7716231|NCT01039519|26830547|P1|Treatment|Treatment failure|2
7716232|NCT01039519|26830547|P1|Treatment|Progressive disease|20
7716233|NCT01039428|26830583|P2|Overall Study|Withdrawal by Subject|0
7716234|NCT01039428|26830584|P1|Overall Study|Withdrawal by Subject|1
7716235|NCT01039428|26830583|P2|Overall Study|Protocol Violation|0
7716236|NCT01039428|26830584|P1|Overall Study|Protocol Violation|1
7716237|NCT01039376|26830608|P2|Overall Study|Study terminated by Sponsor|72
7716238|NCT01039376|26830609|P1|Overall Study|Study terminated by Sponsor|90
7716239|NCT01039376|26830608|P2|Overall Study|Withdrawal by Subject|32
7716240|NCT01039376|26830609|P1|Overall Study|Withdrawal by Subject|20
7716241|NCT01039376|26830608|P2|Overall Study|Physician Decision|10
7716242|NCT01039376|26830609|P1|Overall Study|Physician Decision|15
7716243|NCT01039376|26830608|P2|Overall Study|Lost to Follow-up|12
7716244|NCT01039376|26830609|P1|Overall Study|Lost to Follow-up|5
7716245|NCT01038921|26830678|P2|Overall Study|Physician Decision|0
7716246|NCT01038921|26830679|P1|Overall Study|Physician Decision|1
7716247|NCT01038921|26830678|P2|Overall Study|Withdrawal by Subject|0
7716248|NCT01038921|26830679|P1|Overall Study|Withdrawal by Subject|1
7716249|NCT01038869|26830685|P1|Overall Study|Lost to Follow-up|6
7716250|NCT01038869|26830685|P1|Overall Study|Withdrawal by Subject|1
7716251|NCT01038856|26830693|P1|Overall Study|Adverse Event|2
7716252|NCT01038778|26830702|P3|Overall Study|Withdrawal by Subject|3
7716253|NCT01038778|26830703|P2|Overall Study|Withdrawal by Subject|2
7716254|NCT01038778|26830704|P1|Overall Study|Withdrawal by Subject|0
7716255|NCT01038752|26830722|P2|Overall Study|Lost to Follow-up|3
7716256|NCT01038752|26830723|P1|Overall Study|Lost to Follow-up|3
7716257|NCT01038752|26830722|P2|Overall Study|Tumor Progression|2
7716258|NCT01038752|26830723|P1|Overall Study|Tumor Progression|2
7716259|NCT01038713|26830746|P3|Overall Study|Autoimmune Pancreatitis|0
7716260|NCT01038713|26830747|P2|Overall Study|Autoimmune Pancreatitis|0
7716261|NCT01038713|26830748|P1|Overall Study|Autoimmune Pancreatitis|1
7716262|NCT01038713|26830746|P3|Overall Study|died from PEP|0
7716263|NCT01038713|26830747|P2|Overall Study|died from PEP|1
7716264|NCT01038713|26830748|P1|Overall Study|died from PEP|0
7716265|NCT01038713|26830746|P3|Overall Study|Neuroendocrine Tumor|0
7716266|NCT01038713|26830747|P2|Overall Study|Neuroendocrine Tumor|1
7716267|NCT01038713|26830748|P1|Overall Study|Neuroendocrine Tumor|0
7716268|NCT01038713|26830746|P3|Overall Study|Lost to Follow-up|0
7716269|NCT01038713|26830747|P2|Overall Study|Lost to Follow-up|0
7716270|NCT01038713|26830748|P1|Overall Study|Lost to Follow-up|3
7716271|NCT01038713|26830746|P3|Overall Study|Patient to hospice|1
7716272|NCT01038713|26830747|P2|Overall Study|Patient to hospice|1
7716273|NCT01038713|26830748|P1|Overall Study|Patient to hospice|1
7716274|NCT01038687|26830771|P3|Overall Study|Adverse Event|1
7716275|NCT01038687|26830772|P2|Overall Study|Adverse Event|2
7716276|NCT01038687|26830773|P1|Overall Study|Adverse Event|0
7716277|NCT01038635|26830814|P9|Overall Study|Death|2
7716278|NCT01038635|26830815|P8|Overall Study|Death|1
7716279|NCT01038635|26830816|P7|Overall Study|Death|1
7716280|NCT01038635|26830817|P6|Overall Study|Death|0
7716281|NCT01038635|26830818|P5|Overall Study|Death|1
7716282|NCT01038635|26830819|P4|Overall Study|Death|0
7716283|NCT01038635|26830820|P3|Overall Study|Death|0
7716284|NCT01038635|26830821|P2|Overall Study|Death|0
7716285|NCT01038635|26830822|P1|Overall Study|Death|0
7716286|NCT01038635|26830814|P9|Overall Study|Disease Progression|0
7716287|NCT01038635|26830815|P8|Overall Study|Disease Progression|4
7716288|NCT01038635|26830816|P7|Overall Study|Disease Progression|1
7716289|NCT01038635|26830817|P6|Overall Study|Disease Progression|0
7716290|NCT01038635|26830818|P5|Overall Study|Disease Progression|0
7716291|NCT01038635|26830819|P4|Overall Study|Disease Progression|0
7716292|NCT01038635|26830820|P3|Overall Study|Disease Progression|0
7716293|NCT01038635|26830821|P2|Overall Study|Disease Progression|0
7716294|NCT01038635|26830822|P1|Overall Study|Disease Progression|2
7716295|NCT01038609|26830848|P5|Overall Study|Refusal of Blood Draws|0
7716296|NCT01038609|26830849|P4|Overall Study|Refusal of Blood Draws|0
7716297|NCT01038609|26830850|P3|Overall Study|Refusal of Blood Draws|0
7716298|NCT01038609|26830851|P2|Overall Study|Refusal of Blood Draws|1
7716299|NCT01038609|26830852|P1|Overall Study|Refusal of Blood Draws|0
7716300|NCT01038609|26830848|P5|Overall Study|Death in the Family|0
7716301|NCT01038609|26830849|P4|Overall Study|Death in the Family|0
7716302|NCT01038609|26830850|P3|Overall Study|Death in the Family|0
7716303|NCT01038609|26830851|P2|Overall Study|Death in the Family|0
7716304|NCT01038609|26830852|P1|Overall Study|Death in the Family|1
7716305|NCT01038609|26830848|P5|Overall Study|Dosing Error|1
7716306|NCT01038609|26830849|P4|Overall Study|Dosing Error|1
7716307|NCT01038609|26830850|P3|Overall Study|Dosing Error|0
7716308|NCT01038609|26830851|P2|Overall Study|Dosing Error|0
7716309|NCT01038609|26830852|P1|Overall Study|Dosing Error|0
7716310|NCT01038609|26830848|P5|Overall Study|Adverse Event|0
7716311|NCT01038609|26830849|P4|Overall Study|Adverse Event|0
7716312|NCT01038609|26830850|P3|Overall Study|Adverse Event|1
7716313|NCT01038609|26830851|P2|Overall Study|Adverse Event|0
7716314|NCT01038609|26830852|P1|Overall Study|Adverse Event|0
7716315|NCT01038427|26830937|P3|Overall Study|Other|0
7716316|NCT01038427|26830938|P2|Overall Study|Other|2
7716317|NCT01038427|26830939|P1|Overall Study|Other|0
7716318|NCT01038427|26830937|P3|Overall Study|Enrolled in error|1
7716319|NCT01038427|26830938|P2|Overall Study|Enrolled in error|1
7716320|NCT01038427|26830939|P1|Overall Study|Enrolled in error|0
7716321|NCT01038427|26830937|P3|Overall Study|Adverse Event|1
7716322|NCT01038427|26830938|P2|Overall Study|Adverse Event|2
7716323|NCT01038427|26830939|P1|Overall Study|Adverse Event|2
7716324|NCT01038427|26830937|P3|Overall Study|Withdrew consent|1
7716325|NCT01038427|26830938|P2|Overall Study|Withdrew consent|0
7716326|NCT01038427|26830939|P1|Overall Study|Withdrew consent|0
7716327|NCT01038427|26830937|P3|Overall Study|Restricted medication for seasonal allergic rhinitis|1
7716328|NCT01038427|26830938|P2|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7716329|NCT01038427|26830939|P1|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7716330|NCT01038427|26830937|P3|Overall Study|Lost to follow up|0
7716331|NCT01038427|26830938|P2|Overall Study|Lost to follow up|1
7716332|NCT01038427|26830939|P1|Overall Study|Lost to follow up|1
7716333|NCT01038323|26830997|P3|Overall Study|Withdrawal by Subject|4
7716334|NCT01038323|26830998|P2|Overall Study|Withdrawal by Subject|2
7716335|NCT01038323|26830999|P1|Overall Study|Withdrawal by Subject|3
7716336|NCT01038297|26831016|P3|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
7716337|NCT01038297|26831017|P2|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
7716338|NCT01038297|26831018|P1|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
7716339|NCT01038128|26831053|P1|Overall Study|Withdrawal by Subject|2
7716340|NCT01038128|26831053|P1|Overall Study|Lost to Follow-up|1
7716341|NCT01038128|26831053|P1|Overall Study|Lack of Efficacy|1
7716342|NCT01037985|26831061|P2|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
7716343|NCT01037985|26831062|P1|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
7716344|NCT01037985|26831061|P2|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
7716345|NCT01037985|26831062|P1|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
7716346|NCT01037985|26831061|P2|Part A: Skin Testing (50 Days)|Physician Decision|0
7716347|NCT01037985|26831062|P1|Part A: Skin Testing (50 Days)|Physician Decision|1
7716348|NCT01037985|26831061|P2|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
7716349|NCT01037985|26831062|P1|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
7716350|NCT01037413|26831208|P2|Part B: Scar Revision|Assigned But Not Treated|1
7716351|NCT01037413|26831209|P1|Part B: Scar Revision|Assigned But Not Treated|0
7716352|NCT01037413|26831208|P2|Part B: Scar Revision|Withdrawal by Subject|1
7716353|NCT01037413|26831209|P1|Part B: Scar Revision|Withdrawal by Subject|0
7716354|NCT01037413|26831208|P2|Part A: Skin Testing|Protocol Violation|0
7716355|NCT01037413|26831209|P1|Part A: Skin Testing|Protocol Violation|1
7716356|NCT01037413|26831208|P2|Part A: Skin Testing|Adverse Event|0
7716357|NCT01037413|26831209|P1|Part A: Skin Testing|Adverse Event|1
7716358|NCT01037244|26831287|P4|Overall Study|Various|1
7716359|NCT01037244|26831288|P3|Overall Study|Various|1
7716360|NCT01037244|26831289|P2|Overall Study|Various|2
7716361|NCT01037244|26831290|P1|Overall Study|Various|3
7716362|NCT01037244|26831287|P4|Overall Study|Partner Withdrew Consent|0
7716363|NCT01037244|26831288|P3|Overall Study|Partner Withdrew Consent|0
7716364|NCT01037244|26831289|P2|Overall Study|Partner Withdrew Consent|1
7716365|NCT01037244|26831290|P1|Overall Study|Partner Withdrew Consent|2
7716366|NCT01037244|26831287|P4|Overall Study|Withdrawal by Subject|5
7716367|NCT01037244|26831288|P3|Overall Study|Withdrawal by Subject|3
7716368|NCT01037244|26831289|P2|Overall Study|Withdrawal by Subject|5
7716369|NCT01037244|26831290|P1|Overall Study|Withdrawal by Subject|1
7716370|NCT01037244|26831287|P4|Overall Study|Lost to Follow-up|4
7716371|NCT01037244|26831288|P3|Overall Study|Lost to Follow-up|4
7716372|NCT01037244|26831289|P2|Overall Study|Lost to Follow-up|3
7716373|NCT01037244|26831290|P1|Overall Study|Lost to Follow-up|3
7716374|NCT01037244|26831287|P4|Overall Study|Lack of Efficacy|1
7716375|NCT01037244|26831288|P3|Overall Study|Lack of Efficacy|0
7716376|NCT01037244|26831289|P2|Overall Study|Lack of Efficacy|1
7716377|NCT01037244|26831290|P1|Overall Study|Lack of Efficacy|1
7716378|NCT01037244|26831287|P4|Overall Study|Adverse Event|3
7716379|NCT01037244|26831288|P3|Overall Study|Adverse Event|6
7716380|NCT01037244|26831289|P2|Overall Study|Adverse Event|2
7716381|NCT01037244|26831290|P1|Overall Study|Adverse Event|3
7716382|NCT01037218|26831352|P4|Overall Study|Various|1
7716383|NCT01037218|26831353|P3|Overall Study|Various|3
7716384|NCT01037218|26831354|P2|Overall Study|Various|2
7716385|NCT01037218|26831355|P1|Overall Study|Various|3
7716386|NCT01037218|26831352|P4|Overall Study|Protocol Violation|2
7716387|NCT01037218|26831353|P3|Overall Study|Protocol Violation|2
7716388|NCT01037218|26831354|P2|Overall Study|Protocol Violation|0
7716389|NCT01037218|26831355|P1|Overall Study|Protocol Violation|0
7716390|NCT01037218|26831352|P4|Overall Study|Partner Withdrew Consent|1
7716391|NCT01037218|26831353|P3|Overall Study|Partner Withdrew Consent|2
7716392|NCT01037218|26831354|P2|Overall Study|Partner Withdrew Consent|3
7716393|NCT01037218|26831355|P1|Overall Study|Partner Withdrew Consent|0
7716394|NCT01037218|26831352|P4|Overall Study|Withdrawal by Subject|4
7716395|NCT01037218|26831353|P3|Overall Study|Withdrawal by Subject|7
7716396|NCT01037218|26831354|P2|Overall Study|Withdrawal by Subject|7
7716397|NCT01037218|26831355|P1|Overall Study|Withdrawal by Subject|6
7716398|NCT01037218|26831352|P4|Overall Study|Lost to Follow-up|2
7716399|NCT01037218|26831353|P3|Overall Study|Lost to Follow-up|4
7716400|NCT01037218|26831354|P2|Overall Study|Lost to Follow-up|5
7716401|NCT01037218|26831355|P1|Overall Study|Lost to Follow-up|3
7716402|NCT01037218|26831352|P4|Overall Study|Lack of Efficacy|5
7716403|NCT01037218|26831353|P3|Overall Study|Lack of Efficacy|1
7716404|NCT01037218|26831354|P2|Overall Study|Lack of Efficacy|2
7716405|NCT01037218|26831355|P1|Overall Study|Lack of Efficacy|0
7716406|NCT01037218|26831352|P4|Overall Study|Adverse Event|1
7716407|NCT01037218|26831353|P3|Overall Study|Adverse Event|2
7716408|NCT01037218|26831354|P2|Overall Study|Adverse Event|2
7716409|NCT01037218|26831355|P1|Overall Study|Adverse Event|4
7716410|NCT01037127|26831426|P2|Overall Study|Study Closed Terminated|17
7716411|NCT01037127|26831427|P1|Overall Study|Study Closed Terminated|2
7716412|NCT01037127|26831426|P2|Overall Study|Physician Decision|0
7716413|NCT01037127|26831427|P1|Overall Study|Physician Decision|1
7716414|NCT01037127|26831426|P2|Overall Study|Lost to Follow-up|4
7716415|NCT01037127|26831427|P1|Overall Study|Lost to Follow-up|2
7716416|NCT01037114|26831459|P1|Year 20|Others|1
7716417|NCT01037088|26831472|P1|Overall Study|Withdrawal by Subject|3
7716418|NCT01036763|26831504|P1|Overall Study|Other reason (not specified)|40
7716419|NCT01036763|26831504|P1|Overall Study|Lost to Follow-up|28
7716420|NCT01036763|26831504|P1|Overall Study|Adverse Event|25
7716421|NCT01036724|26831516|P2|Overall Study|Protocol Violation|5
7716422|NCT01036724|26831517|P1|Overall Study|Protocol Violation|4
7716423|NCT01036724|26831516|P2|Overall Study|Lack of Efficacy|1
7716424|NCT01036724|26831517|P1|Overall Study|Lack of Efficacy|1
7716425|NCT01036724|26831516|P2|Overall Study|Adverse Event|2
7716426|NCT01036724|26831517|P1|Overall Study|Adverse Event|1
7716427|NCT01036594|26831525|P2|Treatment Regiments Post Week 12|Lack of Efficacy|1
7716428|NCT01036594|26831526|P1|Treatment Regiments Post Week 12|Lack of Efficacy|0
7716429|NCT01036594|26831525|P2|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
7716430|NCT01036594|26831526|P1|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
7716431|NCT01036594|26831525|P2|Treatment Regiments Post Week 12|Adverse Event|1
7716432|NCT01036594|26831526|P1|Treatment Regiments Post Week 12|Adverse Event|0
7716433|NCT01036594|26831525|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7716434|NCT01036594|26831526|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|1
7716435|NCT01036594|26831525|P2|Treatment Regiments Post Week 12|Physician Decision|1
7716436|NCT01036594|26831526|P1|Treatment Regiments Post Week 12|Physician Decision|1
7716437|NCT01036594|26831525|P2|Week 12 Evaluation|Physician Decision|0
7716438|NCT01036594|26831526|P1|Week 12 Evaluation|Physician Decision|1
7716439|NCT01036594|26831525|P2|Week 12 Evaluation|Adverse Event|0
7716440|NCT01036594|26831526|P1|Week 12 Evaluation|Adverse Event|5
7716441|NCT01036594|26831525|P2|First Treatment Regimen|Withdrawal by Subject|0
7716442|NCT01036594|26831526|P1|First Treatment Regimen|Withdrawal by Subject|1
7716443|NCT01036594|26831525|P2|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
7716444|NCT01036594|26831526|P1|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
7716445|NCT01036529|26831550|P2|Overall Study|Sponsor study termination|12
7716446|NCT01036529|26831551|P1|Overall Study|Sponsor study termination|11
7716447|NCT01036529|26831550|P2|Overall Study|Withdrawal by Subject|1
7716448|NCT01036529|26831551|P1|Overall Study|Withdrawal by Subject|1
7716449|NCT01036529|26831550|P2|Overall Study|Physician Decision|0
7716450|NCT01036529|26831551|P1|Overall Study|Physician Decision|1
7716451|NCT01036529|26831550|P2|Overall Study|Lost to Follow-up|1
7716452|NCT01036529|26831551|P1|Overall Study|Lost to Follow-up|0
7716453|NCT01036529|26831550|P2|Overall Study|Adverse Event|1
7716454|NCT01036529|26831551|P1|Overall Study|Adverse Event|0
7716455|NCT01036438|26831578|P2|Overall Study|No effect of study treatment|1
7716456|NCT01036438|26831579|P1|Overall Study|No effect of study treatment|3
7716457|NCT01036438|26831578|P2|Overall Study|Death|1
7716458|NCT01036438|26831579|P1|Overall Study|Death|0
7716459|NCT01036438|26831578|P2|Overall Study|Adverse Event|8
7716460|NCT01036438|26831579|P1|Overall Study|Adverse Event|7
7716461|NCT01036321|26831587|P2|Overall Study|Adverse Event|1
7716462|NCT01036321|26831588|P1|Overall Study|Adverse Event|2
7716463|NCT01036321|26831587|P2|Overall Study|Withdrawal by Subject|2
7716464|NCT01036321|26831588|P1|Overall Study|Withdrawal by Subject|3
7716465|NCT01036321|26831587|P2|Overall Study|Ineligible after randomization|1
7716466|NCT01036321|26831588|P1|Overall Study|Ineligible after randomization|0
7716467|NCT01036165|26831612|P1|Overall Study|Problems finding proper area to inject|1
7716468|NCT01036165|26831612|P1|Overall Study|Device Related Issues|3
7716469|NCT01036165|26831612|P1|Overall Study|Withdrawal by Subject|3
7716470|NCT01036165|26831612|P1|Overall Study|Lost to Follow-up|2
7716471|NCT01036165|26831612|P1|Overall Study|Adverse Event|6
7716472|NCT01036022|26831623|P6|Overall Study|Withdrawal by Subject|0
7716473|NCT01036022|26831624|P5|Overall Study|Withdrawal by Subject|2
7716474|NCT01036022|26831625|P4|Overall Study|Withdrawal by Subject|1
7716475|NCT01036022|26831626|P3|Overall Study|Withdrawal by Subject|0
7716476|NCT01036022|26831627|P2|Overall Study|Withdrawal by Subject|0
7716477|NCT01036022|26831628|P1|Overall Study|Withdrawal by Subject|0
7716478|NCT01036022|26831623|P6|Overall Study|Physician Decision|0
7716479|NCT01036022|26831624|P5|Overall Study|Physician Decision|0
7716480|NCT01036022|26831625|P4|Overall Study|Physician Decision|0
7716481|NCT01036022|26831626|P3|Overall Study|Physician Decision|1
7716482|NCT01036022|26831627|P2|Overall Study|Physician Decision|0
7716483|NCT01036022|26831628|P1|Overall Study|Physician Decision|0
7716484|NCT01036022|26831623|P6|Overall Study|Lack of Efficacy|1
7716485|NCT01036022|26831624|P5|Overall Study|Lack of Efficacy|1
7716486|NCT01036022|26831625|P4|Overall Study|Lack of Efficacy|0
7716487|NCT01036022|26831626|P3|Overall Study|Lack of Efficacy|1
7716488|NCT01036022|26831627|P2|Overall Study|Lack of Efficacy|1
7716489|NCT01036022|26831628|P1|Overall Study|Lack of Efficacy|1
7716490|NCT01036022|26831623|P6|Overall Study|Adverse Event|2
7716491|NCT01036022|26831624|P5|Overall Study|Adverse Event|0
7716492|NCT01036022|26831625|P4|Overall Study|Adverse Event|1
7716493|NCT01036022|26831626|P3|Overall Study|Adverse Event|2
7716494|NCT01036022|26831627|P2|Overall Study|Adverse Event|3
7716495|NCT01036022|26831628|P1|Overall Study|Adverse Event|1
7716496|NCT01035905|26831764|P2|Overall Study|Lack of Efficacy|1
7716497|NCT01035905|26831765|P1|Overall Study|Lack of Efficacy|1
7716498|NCT01035606|26831938|P3|Overall Study|change in health, job demands,family|4
7716499|NCT01035606|26831939|P2|Overall Study|change in health, job demands,family|3
7716500|NCT01035606|26831940|P1|Overall Study|change in health, job demands,family|3
7716501|NCT01035463|26831956|P6|Overall Study|Other|2
7716502|NCT01035463|26831957|P5|Overall Study|Other|0
7716503|NCT01035463|26831958|P4|Overall Study|Other|1
7716504|NCT01035463|26831959|P3|Overall Study|Other|0
7716505|NCT01035463|26831960|P2|Overall Study|Other|0
7716506|NCT01035463|26831961|P1|Overall Study|Other|0
7716507|NCT01035463|26831956|P6|Overall Study|Other Malignancy|2
7716508|NCT01035463|26831957|P5|Overall Study|Other Malignancy|0
7716509|NCT01035463|26831958|P4|Overall Study|Other Malignancy|0
7716510|NCT01035463|26831959|P3|Overall Study|Other Malignancy|0
7716511|NCT01035463|26831960|P2|Overall Study|Other Malignancy|0
7716512|NCT01035463|26831961|P1|Overall Study|Other Malignancy|0
7716513|NCT01035463|26831956|P6|Overall Study|Disease progression|3
7716514|NCT01035463|26831957|P5|Overall Study|Disease progression|0
7716515|NCT01035463|26831958|P4|Overall Study|Disease progression|0
7716516|NCT01035463|26831959|P3|Overall Study|Disease progression|0
7716517|NCT01035463|26831960|P2|Overall Study|Disease progression|0
7716518|NCT01035463|26831961|P1|Overall Study|Disease progression|0
7716519|NCT01035463|26831956|P6|Overall Study|Withdrawal by Subject|4
7716520|NCT01035463|26831957|P5|Overall Study|Withdrawal by Subject|1
7716521|NCT01035463|26831958|P4|Overall Study|Withdrawal by Subject|0
7716522|NCT01035463|26831959|P3|Overall Study|Withdrawal by Subject|1
7716523|NCT01035463|26831960|P2|Overall Study|Withdrawal by Subject|2
7716524|NCT01035463|26831961|P1|Overall Study|Withdrawal by Subject|0
7716525|NCT01035463|26831956|P6|Overall Study|Adverse Event|7
7716526|NCT01035463|26831957|P5|Overall Study|Adverse Event|5
7716527|NCT01035463|26831958|P4|Overall Study|Adverse Event|1
7716528|NCT01035463|26831959|P3|Overall Study|Adverse Event|4
7716529|NCT01035463|26831960|P2|Overall Study|Adverse Event|0
7716530|NCT01035463|26831961|P1|Overall Study|Adverse Event|0
7716531|NCT01035255|26831998|P2|Overall Study|patient's request|13
7716532|NCT01035255|26831999|P1|Overall Study|patient's request|15
7716533|NCT01035255|26831998|P2|Overall Study|Lost to Follow-up|5
7716534|NCT01035255|26831999|P1|Overall Study|Lost to Follow-up|2
7716535|NCT01035255|26831998|P2|Overall Study|Death|844
7716536|NCT01035255|26831999|P1|Overall Study|Death|724
7716537|NCT01035229|26832017|P2|Overall Study|Disease Progression|152
7716538|NCT01035229|26832018|P1|Overall Study|Disease Progression|261
7716539|NCT01035229|26832017|P2|Overall Study|Sponsor's decision to end study|3
7716540|NCT01035229|26832018|P1|Overall Study|Sponsor's decision to end study|3
7716541|NCT01035229|26832017|P2|Overall Study|Protocol Violation|2
7716542|NCT01035229|26832018|P1|Overall Study|Protocol Violation|0
7716543|NCT01035229|26832017|P2|Overall Study|New cancer therapy|0
7716544|NCT01035229|26832018|P1|Overall Study|New cancer therapy|2
7716545|NCT01035229|26832017|P2|Overall Study|Death|5
7716546|NCT01035229|26832018|P1|Overall Study|Death|13
7716547|NCT01035229|26832017|P2|Overall Study|Administrative problems|1
7716548|NCT01035229|26832018|P1|Overall Study|Administrative problems|1
7716549|NCT01035229|26832017|P2|Overall Study|Lost to Follow-up|0
7716550|NCT01035229|26832018|P1|Overall Study|Lost to Follow-up|1
7716551|NCT01035229|26832017|P2|Overall Study|Withdrawal by Subject|7
7716552|NCT01035229|26832018|P1|Overall Study|Withdrawal by Subject|20
7716553|NCT01035229|26832017|P2|Overall Study|Adverse Event|14
7716554|NCT01035229|26832018|P1|Overall Study|Adverse Event|61
7716555|NCT01035138|26832048|P3|Overall Study|Lost to Follow-up|1
7716556|NCT01035138|26832049|P2|Overall Study|Lost to Follow-up|0
7716557|NCT01035138|26832050|P1|Overall Study|Lost to Follow-up|0
7716558|NCT01035138|26832048|P3|Overall Study|Sponsor Decision|42
7716559|NCT01035138|26832049|P2|Overall Study|Sponsor Decision|60
7716560|NCT01035138|26832050|P1|Overall Study|Sponsor Decision|66
7716561|NCT01035138|26832048|P3|Overall Study|Physician Decision|1
7716562|NCT01035138|26832049|P2|Overall Study|Physician Decision|0
7716563|NCT01035138|26832050|P1|Overall Study|Physician Decision|0
7716564|NCT01035138|26832048|P3|Overall Study|Withdrawal by Subject|0
7716565|NCT01035138|26832049|P2|Overall Study|Withdrawal by Subject|0
7716566|NCT01035138|26832050|P1|Overall Study|Withdrawal by Subject|1
7716567|NCT01035138|26832048|P3|Overall Study|Caregiver Decision|1
7716568|NCT01035138|26832049|P2|Overall Study|Caregiver Decision|0
7716569|NCT01035138|26832050|P1|Overall Study|Caregiver Decision|2
7716570|NCT01035138|26832048|P3|Overall Study|Adverse Event|2
7716571|NCT01035138|26832049|P2|Overall Study|Adverse Event|0
7716572|NCT01035138|26832050|P1|Overall Study|Adverse Event|4
7716573|NCT01035060|26832150|P2|Overall Study|Physician Decision|0
7716574|NCT01035060|26832151|P1|Overall Study|Physician Decision|2
7716575|NCT01035060|26832150|P2|Overall Study|Withdrawal by Subject|6
7716576|NCT01035060|26832151|P1|Overall Study|Withdrawal by Subject|8
7716577|NCT01035060|26832150|P2|Overall Study|Did not quality after 2nd screening|1
7716578|NCT01035060|26832151|P1|Overall Study|Did not quality after 2nd screening|14
7716579|NCT01035060|26832150|P2|Overall Study|Lost to Follow-up|7
7716580|NCT01035060|26832151|P1|Overall Study|Lost to Follow-up|0
7716581|NCT01034709|26832176|P2|Overall Study|Protocol Violation|16
7716582|NCT01034709|26832177|P1|Overall Study|Protocol Violation|9
7716583|NCT01034657|26832183|P3|Randomized Phase|Adverse Event|1
7716584|NCT01034657|26832184|P2|Randomized Phase|Adverse Event|2
7716585|NCT01034657|26832185|P1|Randomized Phase|Adverse Event|0
7716586|NCT01034657|26832183|P3|Randomized Phase|Abnormal laboratory value|0
7716587|NCT01034657|26832184|P2|Randomized Phase|Abnormal laboratory value|1
7716588|NCT01034657|26832185|P1|Randomized Phase|Abnormal laboratory value|0
7716589|NCT01034657|26832183|P3|Randomized Phase|Lack of Efficacy|0
7716590|NCT01034657|26832184|P2|Randomized Phase|Lack of Efficacy|1
7716591|NCT01034657|26832185|P1|Randomized Phase|Lack of Efficacy|5
7716592|NCT01034657|26832183|P3|Randomized Phase|Withdrawal by Subject|0
7716593|NCT01034657|26832184|P2|Randomized Phase|Withdrawal by Subject|2
7716594|NCT01034657|26832185|P1|Randomized Phase|Withdrawal by Subject|0
7716595|NCT01034657|26832183|P3|Core Phase|Protocol Violation|0
7716596|NCT01034657|26832184|P2|Core Phase|Protocol Violation|0
7716597|NCT01034657|26832185|P1|Core Phase|Protocol Violation|2
7716598|NCT01034657|26832183|P3|Core Phase|Adverse Event|0
7716599|NCT01034657|26832184|P2|Core Phase|Adverse Event|0
7716600|NCT01034657|26832185|P1|Core Phase|Adverse Event|8
7716601|NCT01034657|26832183|P3|Core Phase|Abnormal laboratory value|0
7716602|NCT01034657|26832184|P2|Core Phase|Abnormal laboratory value|0
7716603|NCT01034657|26832185|P1|Core Phase|Abnormal laboratory value|1
7716604|NCT01034657|26832183|P3|Core Phase|Lack of Efficacy|0
7716605|NCT01034657|26832184|P2|Core Phase|Lack of Efficacy|0
7716606|NCT01034657|26832185|P1|Core Phase|Lack of Efficacy|2
7716607|NCT01034657|26832183|P3|Core Phase|Withdrawal by Subject|0
7716608|NCT01034657|26832184|P2|Core Phase|Withdrawal by Subject|0
7716609|NCT01034657|26832185|P1|Core Phase|Withdrawal by Subject|1
7716610|NCT01034631|26832226|P3|Phase II|Determined Ineligible per protocol|0
7716611|NCT01034631|26832227|P2|Phase II|Determined Ineligible per protocol|1
7716612|NCT01034631|26832228|P1|Phase II|Determined Ineligible per protocol|0
7716613|NCT01034631|26832226|P3|Phase II|Not Evaluable per protocol|2
7716614|NCT01034631|26832227|P2|Phase II|Not Evaluable per protocol|0
7716615|NCT01034631|26832228|P1|Phase II|Not Evaluable per protocol|0
7716616|NCT01034631|26832226|P3|Phase I|Symptomatic Deterioration before Treatme|0
7716617|NCT01034631|26832227|P2|Phase I|Symptomatic Deterioration before Treatme|0
7716618|NCT01034631|26832228|P1|Phase I|Symptomatic Deterioration before Treatme|3
7716619|NCT01034540|26832295|P2|Overall Study|Adverse Event|1
7716620|NCT01034540|26832296|P1|Overall Study|Adverse Event|0
7716621|NCT01034462|26832315|P2|Overall Study|Other reasons|2
7716622|NCT01034462|26832316|P1|Overall Study|Other reasons|1
7716623|NCT01034462|26832315|P2|Overall Study|Lost to Follow-up|16
7716624|NCT01034462|26832316|P1|Overall Study|Lost to Follow-up|14
7716625|NCT01034462|26832315|P2|Overall Study|Withdrawal by Subject|8
7716626|NCT01034462|26832316|P1|Overall Study|Withdrawal by Subject|9
7716627|NCT01034462|26832315|P2|Overall Study|Protocol Violation|7
7716628|NCT01034462|26832316|P1|Overall Study|Protocol Violation|10
7716629|NCT01034462|26832315|P2|Overall Study|Lack of Efficacy|4
7716630|NCT01034462|26832316|P1|Overall Study|Lack of Efficacy|4
7716631|NCT01034462|26832315|P2|Overall Study|Adverse Event|17
7716632|NCT01034462|26832316|P1|Overall Study|Adverse Event|7
7716633|NCT01034397|26832326|P2|Overall Study|Other|1
7716634|NCT01034397|26832327|P1|Overall Study|Other|0
7716635|NCT01034397|26832326|P2|Overall Study|Adverse Event|0
7716636|NCT01034397|26832327|P1|Overall Study|Adverse Event|4
7716637|NCT01034397|26832326|P2|Overall Study|Lack of Efficacy|0
7716638|NCT01034397|26832327|P1|Overall Study|Lack of Efficacy|3
7716639|NCT01034397|26832326|P2|Overall Study|Lack of compliance|1
7716640|NCT01034397|26832327|P1|Overall Study|Lack of compliance|0
7716641|NCT01034358|26832476|P1|Overall Study|Protocol Violation|1
7716642|NCT01034358|26832476|P1|Overall Study|Withdrawal by Subject|1
7716643|NCT01034306|26832482|P2|Overall Study|Noncomplience|0
7716644|NCT01034306|26832483|P1|Overall Study|Noncomplience|1
7716645|NCT01034306|26832482|P2|Overall Study|hospitalized and decided to stop|0
7716646|NCT01034306|26832483|P1|Overall Study|hospitalized and decided to stop|1
7716647|NCT01034306|26832482|P2|Overall Study|Withdrawal by Subject|2
7716648|NCT01034306|26832483|P1|Overall Study|Withdrawal by Subject|2
7716649|NCT01034306|26832482|P2|Overall Study|Lost to Follow-up|1
7716650|NCT01034306|26832483|P1|Overall Study|Lost to Follow-up|0
7716651|NCT01034306|26832482|P2|Overall Study|Adverse Event|0
7716652|NCT01034306|26832483|P1|Overall Study|Adverse Event|1
7716653|NCT01034176|26832491|P2|Overall Study|Lost to Follow-up|1
7716654|NCT01034176|26832492|P1|Overall Study|Lost to Follow-up|0
7716655|NCT01034176|26832491|P2|Overall Study|Withdrawal by Subject|1
7716656|NCT01034176|26832492|P1|Overall Study|Withdrawal by Subject|0
7716657|NCT01034176|26832491|P2|Overall Study|Physician Decision|0
7716658|NCT01034176|26832492|P1|Overall Study|Physician Decision|2
7716659|NCT01034163|26832502|P2|Overall Study|Abnormal laboratory value|0
7716660|NCT01034163|26832503|P1|Overall Study|Abnormal laboratory value|1
7716661|NCT01034163|26832502|P2|Overall Study|Administrative problems|1
7716662|NCT01034163|26832503|P1|Overall Study|Administrative problems|0
7716663|NCT01034163|26832502|P2|Overall Study|Adverse Event|0
7716664|NCT01034163|26832503|P1|Overall Study|Adverse Event|6
7716665|NCT01034163|26832502|P2|Overall Study|Disease progression|4
7716666|NCT01034163|26832503|P1|Overall Study|Disease progression|3
7716667|NCT01034163|26832502|P2|Overall Study|Protocol deviation|0
7716668|NCT01034163|26832503|P1|Overall Study|Protocol deviation|1
7716669|NCT01034163|26832502|P2|Overall Study|Withdrawal by Subject|2
7716670|NCT01034163|26832503|P1|Overall Study|Withdrawal by Subject|8
7716671|NCT01034163|26832502|P2|Overall Study|Treatment completed as per protocol|7
7716672|NCT01034163|26832503|P1|Overall Study|Treatment completed as per protocol|8
7716673|NCT01034137|26832512|P3|Overall Study|Administrative or other|4
7716674|NCT01034137|26832513|P2|Overall Study|Administrative or other|3
7716675|NCT01034137|26832514|P1|Overall Study|Administrative or other|2
7716676|NCT01034137|26832512|P3|Overall Study|Refused treatment or did not cooperate|1
7716677|NCT01034137|26832513|P2|Overall Study|Refused treatment or did not cooperate|0
7716678|NCT01034137|26832514|P1|Overall Study|Refused treatment or did not cooperate|2
7716679|NCT01034137|26832512|P3|Overall Study|Protocol Violation|1
7716680|NCT01034137|26832513|P2|Overall Study|Protocol Violation|2
7716681|NCT01034137|26832514|P1|Overall Study|Protocol Violation|2
7716682|NCT01034137|26832512|P3|Overall Study|Lack of Efficacy|13
7716683|NCT01034137|26832513|P2|Overall Study|Lack of Efficacy|4
7716684|NCT01034137|26832514|P1|Overall Study|Lack of Efficacy|9
7716685|NCT01034137|26832512|P3|Overall Study|Withdrawal by Subject|3
7716686|NCT01034137|26832513|P2|Overall Study|Withdrawal by Subject|3
7716687|NCT01034137|26832514|P1|Overall Study|Withdrawal by Subject|4
7716688|NCT01034137|26832512|P3|Overall Study|Adverse Event|8
7716689|NCT01034137|26832513|P2|Overall Study|Adverse Event|10
7716690|NCT01034137|26832514|P1|Overall Study|Adverse Event|9
7716691|NCT01033942|26832653|P3|Overall Study|Enrolled in Extension Study|0
7716692|NCT01033942|26832654|P2|Overall Study|Enrolled in Extension Study|3
7716693|NCT01033942|26832655|P1|Overall Study|Enrolled in Extension Study|0
7716694|NCT01033942|26832653|P3|Overall Study|Lost to Follow-up|0
7716695|NCT01033942|26832654|P2|Overall Study|Lost to Follow-up|0
7716696|NCT01033942|26832655|P1|Overall Study|Lost to Follow-up|1
7716697|NCT01033942|26832653|P3|Overall Study|Withdrawal by Subject|1
7716698|NCT01033942|26832654|P2|Overall Study|Withdrawal by Subject|1
7716699|NCT01033942|26832655|P1|Overall Study|Withdrawal by Subject|1
7716700|NCT01033851|26832953|P2|Overall Study|Withdrawal by Subject|7
7716701|NCT01033851|26832954|P1|Overall Study|Withdrawal by Subject|3
7716702|NCT01033825|26832969|P7|Overall Study|Other|0
7716703|NCT01033825|26832970|P6|Overall Study|Other|0
7716704|NCT01033825|26832971|P5|Overall Study|Other|1
7716705|NCT01033825|26832972|P4|Overall Study|Other|0
7716706|NCT01033825|26832973|P3|Overall Study|Other|0
7716707|NCT01033825|26832974|P2|Overall Study|Other|0
7716708|NCT01033825|26832975|P1|Overall Study|Other|0
7716709|NCT01033825|26832969|P7|Overall Study|Protocol Violation|0
7716710|NCT01033825|26832970|P6|Overall Study|Protocol Violation|0
7716711|NCT01033825|26832971|P5|Overall Study|Protocol Violation|0
7716712|NCT01033825|26832972|P4|Overall Study|Protocol Violation|0
7716713|NCT01033825|26832973|P3|Overall Study|Protocol Violation|0
7716714|NCT01033825|26832974|P2|Overall Study|Protocol Violation|0
7716715|NCT01033825|26832975|P1|Overall Study|Protocol Violation|1
7716716|NCT01033825|26832969|P7|Overall Study|Adverse Event|0
7716717|NCT01033825|26832970|P6|Overall Study|Adverse Event|0
7716718|NCT01033825|26832971|P5|Overall Study|Adverse Event|0
7716719|NCT01033825|26832972|P4|Overall Study|Adverse Event|1
7716720|NCT01033825|26832973|P3|Overall Study|Adverse Event|0
7716721|NCT01033825|26832974|P2|Overall Study|Adverse Event|0
7716722|NCT01033825|26832975|P1|Overall Study|Adverse Event|0
7716723|NCT01033825|26832969|P7|Overall Study|Withdrawal by Subject|0
7716724|NCT01033825|26832970|P6|Overall Study|Withdrawal by Subject|0
7716725|NCT01033825|26832971|P5|Overall Study|Withdrawal by Subject|1
7716726|NCT01033825|26832972|P4|Overall Study|Withdrawal by Subject|1
7716727|NCT01033825|26832973|P3|Overall Study|Withdrawal by Subject|2
7716728|NCT01033825|26832974|P2|Overall Study|Withdrawal by Subject|3
7716729|NCT01033825|26832975|P1|Overall Study|Withdrawal by Subject|2
7716730|NCT01033747|26833202|P2|Overall Study|Stopped at end of Extension 1|0
7716731|NCT01033747|26833203|P1|Overall Study|Stopped at end of Extension 1|2
7716732|NCT01033747|26833202|P2|Overall Study|Stopped at end of prolongation visit 1|0
7716733|NCT01033747|26833203|P1|Overall Study|Stopped at end of prolongation visit 1|1
7716734|NCT01033747|26833202|P2|Overall Study|Withdrawal by Subject|6
7716735|NCT01033747|26833203|P1|Overall Study|Withdrawal by Subject|9
7716736|NCT01033747|26833202|P2|Overall Study|Protocol Violation|0
7716737|NCT01033747|26833203|P1|Overall Study|Protocol Violation|1
7716738|NCT01033747|26833202|P2|Overall Study|Unsatisfactory therapeutic effect|4
7716739|NCT01033747|26833203|P1|Overall Study|Unsatisfactory therapeutic effect|14
7716740|NCT01033747|26833202|P2|Overall Study|Abnormal test procedure|1
7716741|NCT01033747|26833203|P1|Overall Study|Abnormal test procedure|0
7716742|NCT01033747|26833202|P2|Overall Study|Abnormal Laboratory Value|0
7716743|NCT01033747|26833203|P1|Overall Study|Abnormal Laboratory Value|1
7716744|NCT01033747|26833202|P2|Overall Study|Adverse Event|4
7716745|NCT01033747|26833203|P1|Overall Study|Adverse Event|9
7716746|NCT01033734|26833211|P1|Overall Study|Withdrawal by Subject|1
7716747|NCT01033643|26833268|P6|Overall Study|Withdrew Consent|1
7716748|NCT01033643|26833269|P5|Overall Study|Withdrew Consent|0
7716749|NCT01033643|26833270|P4|Overall Study|Withdrew Consent|0
7716750|NCT01033643|26833271|P3|Overall Study|Withdrew Consent|0
7716751|NCT01033643|26833272|P2|Overall Study|Withdrew Consent|3
7716752|NCT01033643|26833273|P1|Overall Study|Withdrew Consent|0
7716753|NCT01033487|26833409|P10|Fourth Intervention Period|Adverse Event|0
7716754|NCT01033487|26833410|P9|Fourth Intervention Period|Adverse Event|1
7716755|NCT01033487|26833411|P8|Fourth Intervention Period|Adverse Event|0
7716756|NCT01033487|26833412|P7|Fourth Intervention Period|Adverse Event|0
7716757|NCT01033487|26833413|P6|Fourth Intervention Period|Adverse Event|0
7716758|NCT01033487|26833414|P5|Fourth Intervention Period|Adverse Event|0
7716759|NCT01033487|26833415|P4|Fourth Intervention Period|Adverse Event|0
7716760|NCT01033487|26833416|P3|Fourth Intervention Period|Adverse Event|0
7716761|NCT01033487|26833417|P2|Fourth Intervention Period|Adverse Event|0
7716762|NCT01033487|26833418|P1|Fourth Intervention Period|Adverse Event|0
7716763|NCT01033448|26833472|P1|Overall Study|Unknown disposition|1
7716764|NCT01033448|26833472|P1|Overall Study|Withdrew due to other reasons|3
7716765|NCT01033448|26833472|P1|Overall Study|Lost to Follow-up|3
7716766|NCT01033448|26833472|P1|Overall Study|Positive HCV-RNA at week 48|1
7716767|NCT01033448|26833472|P1|Overall Study|Withdrawal by Subject|4
7716768|NCT01033240|26833521|P3|Overall Study|Other|2
7716769|NCT01033240|26833522|P2|Overall Study|Other|1
7716770|NCT01033240|26833523|P1|Overall Study|Other|0
7716771|NCT01033240|26833521|P3|Overall Study|Investigator Discretion|2
7716772|NCT01033240|26833522|P2|Overall Study|Investigator Discretion|0
7716773|NCT01033240|26833523|P1|Overall Study|Investigator Discretion|0
7716774|NCT01033240|26833521|P3|Overall Study|Disease Progression|41
7716775|NCT01033240|26833522|P2|Overall Study|Disease Progression|32
7716776|NCT01033240|26833523|P1|Overall Study|Disease Progression|35
7716777|NCT01033240|26833521|P3|Overall Study|Withdrew Consent|2
7716778|NCT01033240|26833522|P2|Overall Study|Withdrew Consent|9
7716779|NCT01033240|26833523|P1|Overall Study|Withdrew Consent|2
7716780|NCT01033240|26833521|P3|Overall Study|Death|0
7716781|NCT01033240|26833522|P2|Overall Study|Death|0
7716782|NCT01033240|26833523|P1|Overall Study|Death|2
7716783|NCT01033240|26833521|P3|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
7716784|NCT01033240|26833522|P2|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
7716785|NCT01033240|26833523|P1|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
7716786|NCT01033136|26833553|P2|Follow-Up (3 Month)|Lost to Follow-up|2
7716787|NCT01033136|26833554|P1|Follow-Up (3 Month)|Lost to Follow-up|2
7716788|NCT01033071|26833565|P3|Overall Study|Other|3
7716789|NCT01033071|26833566|P2|Overall Study|Other|4
7716790|NCT01033071|26833567|P1|Overall Study|Other|6
7716791|NCT01033071|26833565|P3|Overall Study|Lack of Efficacy|1
7716792|NCT01033071|26833566|P2|Overall Study|Lack of Efficacy|1
7716793|NCT01033071|26833567|P1|Overall Study|Lack of Efficacy|0
7716794|NCT01033071|26833565|P3|Overall Study|Withdrawal by Subject|11
7716795|NCT01033071|26833566|P2|Overall Study|Withdrawal by Subject|14
7716796|NCT01033071|26833567|P1|Overall Study|Withdrawal by Subject|17
7716797|NCT01033071|26833565|P3|Overall Study|Lost to Follow-up|5
7716798|NCT01033071|26833566|P2|Overall Study|Lost to Follow-up|5
7716799|NCT01033071|26833567|P1|Overall Study|Lost to Follow-up|4
7716800|NCT01033071|26833565|P3|Overall Study|Protocol Violation|1
7716801|NCT01033071|26833566|P2|Overall Study|Protocol Violation|2
7716802|NCT01033071|26833567|P1|Overall Study|Protocol Violation|0
7716803|NCT01033071|26833565|P3|Overall Study|Adverse Event|26
7716804|NCT01033071|26833566|P2|Overall Study|Adverse Event|51
7716805|NCT01033071|26833567|P1|Overall Study|Adverse Event|28
7716806|NCT01033019|26833638|P2|Overall Study|Withdrawal by Subject|0
7716807|NCT01033019|26833639|P1|Overall Study|Withdrawal by Subject|1
7716808|NCT01032915|26833696|P4|Overall Study|Protocol Violation|1
7716809|NCT01032915|26833697|P3|Overall Study|Protocol Violation|0
7716810|NCT01032915|26833698|P2|Overall Study|Protocol Violation|0
7716811|NCT01032915|26833699|P1|Overall Study|Protocol Violation|1
7716812|NCT01032915|26833696|P4|Overall Study|Administrative reasons|4
7716813|NCT01032915|26833697|P3|Overall Study|Administrative reasons|4
7716814|NCT01032915|26833698|P2|Overall Study|Administrative reasons|6
7716815|NCT01032915|26833699|P1|Overall Study|Administrative reasons|5
7716816|NCT01032915|26833696|P4|Overall Study|Withdrawal by Subject|1
7716817|NCT01032915|26833697|P3|Overall Study|Withdrawal by Subject|1
7716818|NCT01032915|26833698|P2|Overall Study|Withdrawal by Subject|3
7716819|NCT01032915|26833699|P1|Overall Study|Withdrawal by Subject|0
7716820|NCT01032915|26833696|P4|Overall Study|Abnormal test procedure result|0
7716821|NCT01032915|26833697|P3|Overall Study|Abnormal test procedure result|1
7716822|NCT01032915|26833698|P2|Overall Study|Abnormal test procedure result|0
7716823|NCT01032915|26833699|P1|Overall Study|Abnormal test procedure result|0
7716824|NCT01032915|26833696|P4|Overall Study|Adverse Event|1
7716825|NCT01032915|26833697|P3|Overall Study|Adverse Event|1
7716826|NCT01032915|26833698|P2|Overall Study|Adverse Event|2
7716827|NCT01032915|26833699|P1|Overall Study|Adverse Event|2
7716828|NCT01032889|26833724|P3|Overall Study|Miscellaneous Reasons|1
7716829|NCT01032889|26833725|P2|Overall Study|Miscellaneous Reasons|1
7716830|NCT01032889|26833726|P1|Overall Study|Miscellaneous Reasons|2
7716831|NCT01032889|26833724|P3|Overall Study|Lack of Submental Fat|1
7716832|NCT01032889|26833725|P2|Overall Study|Lack of Submental Fat|8
7716833|NCT01032889|26833726|P1|Overall Study|Lack of Submental Fat|2
7716834|NCT01032889|26833724|P3|Overall Study|Lost to Follow-up|0
7716835|NCT01032889|26833725|P2|Overall Study|Lost to Follow-up|1
7716836|NCT01032889|26833726|P1|Overall Study|Lost to Follow-up|1
7716837|NCT01032889|26833724|P3|Overall Study|Patient Request|0
7716838|NCT01032889|26833725|P2|Overall Study|Patient Request|1
7716839|NCT01032889|26833726|P1|Overall Study|Patient Request|0
7716840|NCT01032889|26833724|P3|Overall Study|Withdrawal of Consent|1
7716841|NCT01032889|26833725|P2|Overall Study|Withdrawal of Consent|2
7716842|NCT01032889|26833726|P1|Overall Study|Withdrawal of Consent|1
7716843|NCT01032889|26833724|P3|Overall Study|Adverse Event|0
7716844|NCT01032889|26833725|P2|Overall Study|Adverse Event|2
7716845|NCT01032889|26833726|P1|Overall Study|Adverse Event|2
7716846|NCT01032837|26833757|P4|Overall Study|Refused treatment|1
7716847|NCT01032837|26833758|P3|Overall Study|Refused treatment|0
7716848|NCT01032837|26833759|P2|Overall Study|Refused treatment|0
7716849|NCT01032837|26833760|P1|Overall Study|Refused treatment|0
7716850|NCT01032837|26833757|P4|Overall Study|Failed to return|0
7716851|NCT01032837|26833758|P3|Overall Study|Failed to return|1
7716852|NCT01032837|26833759|P2|Overall Study|Failed to return|0
7716853|NCT01032837|26833760|P1|Overall Study|Failed to return|0
7716854|NCT01032837|26833757|P4|Overall Study|Withdrew consent|1
7716855|NCT01032837|26833758|P3|Overall Study|Withdrew consent|0
7716856|NCT01032837|26833759|P2|Overall Study|Withdrew consent|2
7716857|NCT01032837|26833760|P1|Overall Study|Withdrew consent|0
7716858|NCT01032837|26833757|P4|Overall Study|Adverse event/internal illness|1
7716859|NCT01032837|26833758|P3|Overall Study|Adverse event/internal illness|0
7716860|NCT01032837|26833759|P2|Overall Study|Adverse event/internal illness|1
7716861|NCT01032837|26833760|P1|Overall Study|Adverse event/internal illness|0
7716862|NCT01032629|26833860|P3|Overall Study|Lost to Follow-up|37
7716863|NCT01032629|26833861|P2|Overall Study|Lost to Follow-up|47
7716864|NCT01032629|26833862|P1|Overall Study|Lost to Follow-up|74
7716865|NCT01032629|26833860|P3|Overall Study|Withdrawal by Subject|35
7716866|NCT01032629|26833861|P2|Overall Study|Withdrawal by Subject|36
7716867|NCT01032629|26833862|P1|Overall Study|Withdrawal by Subject|50
7716868|NCT01032629|26833860|P3|Overall Study|Closed Site|16
7716869|NCT01032629|26833861|P2|Overall Study|Closed Site|18
7716870|NCT01032629|26833862|P1|Overall Study|Closed Site|21
7716871|NCT01032382|26833974|P2|Overall Study|Index lesion relapse|3
7716872|NCT01032382|26833975|P1|Overall Study|Index lesion relapse|1
7716873|NCT01032382|26833974|P2|Overall Study|Treatment failure|1
7716874|NCT01032382|26833975|P1|Overall Study|Treatment failure|3
7716875|NCT01032382|26833974|P2|Overall Study|Disease dissemination|1
7716876|NCT01032382|26833975|P1|Overall Study|Disease dissemination|1
7716877|NCT01032291|26834063|P3|Proof of Concept|Never Received Study Drug|0
7716878|NCT01032291|26834064|P2|Proof of Concept|Never Received Study Drug|1
7716879|NCT01032291|26834065|P1|Proof of Concept|Never Received Study Drug|0
7716880|NCT01032291|26834063|P3|Proof of Concept|Lack of Efficacy|0
7716881|NCT01032291|26834064|P2|Proof of Concept|Lack of Efficacy|1
7716882|NCT01032291|26834065|P1|Proof of Concept|Lack of Efficacy|0
7716883|NCT01032291|26834063|P3|Proof of Concept|Death|2
7716884|NCT01032291|26834064|P2|Proof of Concept|Death|1
7716885|NCT01032291|26834065|P1|Proof of Concept|Death|0
7716886|NCT01032291|26834063|P3|Proof of Concept|Adverse Event|1
7716887|NCT01032291|26834064|P2|Proof of Concept|Adverse Event|5
7716888|NCT01032291|26834065|P1|Proof of Concept|Adverse Event|0
7716889|NCT01032291|26834063|P3|Safety Lead-in|Death|0
7716890|NCT01032291|26834064|P2|Safety Lead-in|Death|0
7716891|NCT01032291|26834065|P1|Safety Lead-in|Death|1
7716892|NCT01032291|26834063|P3|Safety Lead-in|Adverse Event|0
7716893|NCT01032291|26834064|P2|Safety Lead-in|Adverse Event|0
7716894|NCT01032291|26834065|P1|Safety Lead-in|Adverse Event|1
7716895|NCT01032239|26834112|P2|Overall Study|Protocol Violation|0
7716896|NCT01032239|26834113|P1|Overall Study|Protocol Violation|1
7716897|NCT01032239|26834112|P2|Overall Study|Death|0
7716898|NCT01032239|26834113|P1|Overall Study|Death|1
7716899|NCT01032239|26834112|P2|Overall Study|Withdrawal by Subject|3
7716900|NCT01032239|26834113|P1|Overall Study|Withdrawal by Subject|2
7716901|NCT01032239|26834112|P2|Overall Study|Lost to Follow-up|2
7716902|NCT01032239|26834113|P1|Overall Study|Lost to Follow-up|3
7716903|NCT01032200|26834143|P2|Overall Study|Multiple|1
7716904|NCT01032200|26834144|P1|Overall Study|Multiple|1
7716905|NCT01032200|26834143|P2|Overall Study|Progression|0
7716906|NCT01032200|26834144|P1|Overall Study|Progression|1
7716907|NCT01032200|26834143|P2|Overall Study|Toxicity|2
7716908|NCT01032200|26834144|P1|Overall Study|Toxicity|0
7716909|NCT01032200|26834143|P2|Overall Study|Withdrawal by Subject|3
7716910|NCT01032200|26834144|P1|Overall Study|Withdrawal by Subject|1
7716911|NCT01032200|26834143|P2|Overall Study|Death|1
7716912|NCT01032200|26834144|P1|Overall Study|Death|1
7716913|NCT01032174|26834160|P2|Overall Study|Adverse Event|1
7716914|NCT01032174|26834161|P1|Overall Study|Adverse Event|0
7716915|NCT01032070|26834401|P2|Overall Study|Withdrawal by Subject|2
7716916|NCT01032070|26834402|P1|Overall Study|Withdrawal by Subject|0
7716917|NCT01032070|26834401|P2|Overall Study|Medical or ethical reasons|2
7716918|NCT01032070|26834402|P1|Overall Study|Medical or ethical reasons|0
7716919|NCT01032070|26834401|P2|Overall Study|Disease progression|8
7716920|NCT01032070|26834402|P1|Overall Study|Disease progression|13
7716921|NCT01032044|26834431|P2|Overall Study|Lost to Follow-up|11
7716922|NCT01032044|26834432|P1|Overall Study|Lost to Follow-up|11
7716923|NCT01032044|26834431|P2|Overall Study|Adverse Event|1
7716924|NCT01032044|26834432|P1|Overall Study|Adverse Event|0
7716925|NCT01032044|26834431|P2|Overall Study|Protocol Violation|8
7716926|NCT01032044|26834432|P1|Overall Study|Protocol Violation|14
7716927|NCT01032018|26834440|P2|Overall Study|Death|1
7716928|NCT01032018|26834441|P1|Overall Study|Death|0
7716929|NCT01032018|26834440|P2|Overall Study|Lost to Follow-up|5
7716930|NCT01032018|26834441|P1|Overall Study|Lost to Follow-up|6
7716931|NCT01031979|26834451|P2|Overall Study|Lost to Follow-up|4
7716932|NCT01031979|26834452|P1|Overall Study|Lost to Follow-up|5
7716933|NCT01031836|26834485|P6|Stage II|Other|0
7716934|NCT01031836|26834486|P5|Stage II|Other|1
7716935|NCT01031836|26834487|P4|Stage II|Other|1
7716936|NCT01031836|26834488|P3|Stage II|Other|0
7716937|NCT01031836|26834489|P2|Stage II|Other|0
7716938|NCT01031836|26834490|P1|Stage II|Other|2
7716939|NCT01031836|26834485|P6|Stage II|Adverse Event|1
7716940|NCT01031836|26834486|P5|Stage II|Adverse Event|1
7716941|NCT01031836|26834487|P4|Stage II|Adverse Event|2
7716942|NCT01031836|26834488|P3|Stage II|Adverse Event|2
7716943|NCT01031836|26834489|P2|Stage II|Adverse Event|0
7716944|NCT01031836|26834490|P1|Stage II|Adverse Event|0
7716945|NCT01031836|26834485|P6|Stage I|Other|1
7716946|NCT01031836|26834486|P5|Stage I|Other|0
7716947|NCT01031836|26834487|P4|Stage I|Other|0
7716948|NCT01031836|26834488|P3|Stage I|Other|0
7716949|NCT01031836|26834489|P2|Stage I|Other|1
7716950|NCT01031836|26834490|P1|Stage I|Other|0
7716951|NCT01031836|26834485|P6|Stage I|Adverse Event|0
7716952|NCT01031836|26834486|P5|Stage I|Adverse Event|0
7716953|NCT01031836|26834487|P4|Stage I|Adverse Event|0
7716954|NCT01031836|26834488|P3|Stage I|Adverse Event|0
7716955|NCT01031836|26834489|P2|Stage I|Adverse Event|1
7716956|NCT01031836|26834490|P1|Stage I|Adverse Event|1
7716957|NCT01031706|26834551|P2|Overall Study|Withdrawal by Subject|1
7716958|NCT01031706|26834552|P1|Overall Study|Withdrawal by Subject|1
7716959|NCT01031706|26834551|P2|Overall Study|Adverse Event|0
7716960|NCT01031706|26834552|P1|Overall Study|Adverse Event|1
7716961|NCT01031680|26834562|P2|Overall Study|Various|2
7716962|NCT01031680|26834563|P1|Overall Study|Various|0
7716963|NCT01031680|26834562|P2|Overall Study|Administrative Reason by Sponsor|1
7716964|NCT01031680|26834563|P1|Overall Study|Administrative Reason by Sponsor|0
7716965|NCT01031680|26834562|P2|Overall Study|Incorrect Enrolment|2
7716966|NCT01031680|26834563|P1|Overall Study|Incorrect Enrolment|1
7716967|NCT01031680|26834562|P2|Overall Study|Safety|0
7716968|NCT01031680|26834563|P1|Overall Study|Safety|1
7716969|NCT01031680|26834562|P2|Overall Study|Poor/Non-compliance|6
7716970|NCT01031680|26834563|P1|Overall Study|Poor/Non-compliance|5
7716971|NCT01031680|26834562|P2|Overall Study|Subject No Longer Meets Study Criteria|17
7716972|NCT01031680|26834563|P1|Overall Study|Subject No Longer Meets Study Criteria|26
7716973|NCT01031680|26834562|P2|Overall Study|Death|1
7716974|NCT01031680|26834563|P1|Overall Study|Death|2
7716975|NCT01031680|26834562|P2|Overall Study|Withdrawal by Subject|16
7716976|NCT01031680|26834563|P1|Overall Study|Withdrawal by Subject|12
7716977|NCT01031680|26834562|P2|Overall Study|Lost to Follow-up|10
7716978|NCT01031680|26834563|P1|Overall Study|Lost to Follow-up|2
7716979|NCT01031680|26834562|P2|Overall Study|Adverse Event|3
7716980|NCT01031680|26834563|P1|Overall Study|Adverse Event|8
7716981|NCT01031628|26834583|P4|Overall Study|Study terminated early|0
7716982|NCT01031628|26834584|P3|Overall Study|Study terminated early|3
7716983|NCT01031628|26834585|P2|Overall Study|Study terminated early|1
7716984|NCT01031628|26834586|P1|Overall Study|Study terminated early|0
7716985|NCT01031537|26834611|P1|Overall Study|PI removal, no longer met eligibility|12
7716986|NCT01031537|26834611|P1|Overall Study|Withdrawal by Subject|5
7716987|NCT01031537|26834611|P1|Overall Study|moved, met exclusion criteria|10
7716988|NCT01031537|26834611|P1|Overall Study|retired from NIH, met exclusion criteria|1
7716989|NCT01031537|26834611|P1|Overall Study|Lack of Efficacy|1
7716990|NCT01031537|26834611|P1|Overall Study|medical reasons not related to study|3
7716991|NCT01031446|26834629|P1|Overall Study|Still on treatment|1
7716992|NCT01031446|26834629|P1|Overall Study|Withdrawal by Subject|3
7716993|NCT01031446|26834629|P1|Overall Study|Physician Decision|4
7716994|NCT01031446|26834629|P1|Overall Study|Adverse Event|9
7716995|NCT01031446|26834629|P1|Overall Study|Disease Progression|38
7716996|NCT01031381|26834643|P1|Overall Study|Withdrawal by Subject|6
7716997|NCT01031381|26834643|P1|Overall Study|Physician Decision|3
7716998|NCT01031069|26834672|P4|Overall Study|Other|0
7716999|NCT01031069|26834673|P3|Overall Study|Other|1
7717000|NCT01031069|26834674|P2|Overall Study|Other|0
7717001|NCT01031069|26834675|P1|Overall Study|Other|0
7717002|NCT01031069|26834672|P4|Overall Study|Lost to Follow-up|15
7717003|NCT01031069|26834673|P3|Overall Study|Lost to Follow-up|21
7717004|NCT01031069|26834674|P2|Overall Study|Lost to Follow-up|5
7717005|NCT01031069|26834675|P1|Overall Study|Lost to Follow-up|9
7717006|NCT01031069|26834672|P4|Overall Study|Migrated/moved from study area|1
7717007|NCT01031069|26834673|P3|Overall Study|Migrated/moved from study area|1
7717008|NCT01031069|26834674|P2|Overall Study|Migrated/moved from study area|2
7717009|NCT01031069|26834675|P1|Overall Study|Migrated/moved from study area|1
7717010|NCT01031069|26834672|P4|Overall Study|Withdrawal by Subject|18
7717011|NCT01031069|26834673|P3|Overall Study|Withdrawal by Subject|18
7717012|NCT01031069|26834674|P2|Overall Study|Withdrawal by Subject|3
7717013|NCT01031069|26834675|P1|Overall Study|Withdrawal by Subject|2
7717014|NCT01031069|26834672|P4|Overall Study|Serious Adverse Event|0
7717015|NCT01031069|26834673|P3|Overall Study|Serious Adverse Event|0
7717016|NCT01031069|26834674|P2|Overall Study|Serious Adverse Event|1
7717017|NCT01031069|26834675|P1|Overall Study|Serious Adverse Event|0
7717018|NCT01031004|26834777|P2|Overall Study|Lost to Follow-up|0
7717019|NCT01031004|26834778|P1|Overall Study|Lost to Follow-up|1
7717020|NCT01031004|26834777|P2|Overall Study|Protocol Violation|1
7717021|NCT01031004|26834778|P1|Overall Study|Protocol Violation|0
7717022|NCT01030965|26834822|P4|Overall Study|Withdrawal by Subject|2
7717023|NCT01030965|26834823|P3|Overall Study|Withdrawal by Subject|0
7717024|NCT01030965|26834824|P2|Overall Study|Withdrawal by Subject|1
7717025|NCT01030965|26834825|P1|Overall Study|Withdrawal by Subject|0
7717026|NCT01030965|26834822|P4|Overall Study|Protocol-defined Stopping Criteria|0
7717027|NCT01030965|26834823|P3|Overall Study|Protocol-defined Stopping Criteria|1
7717028|NCT01030965|26834824|P2|Overall Study|Protocol-defined Stopping Criteria|1
7717029|NCT01030965|26834825|P1|Overall Study|Protocol-defined Stopping Criteria|0
7717030|NCT01030965|26834822|P4|Overall Study|Adverse Event|1
7717031|NCT01030965|26834823|P3|Overall Study|Adverse Event|2
7717032|NCT01030965|26834824|P2|Overall Study|Adverse Event|1
7717033|NCT01030965|26834825|P1|Overall Study|Adverse Event|0
7717034|NCT01030965|26834822|P4|Overall Study|Protocol Violation|1
7717035|NCT01030965|26834823|P3|Overall Study|Protocol Violation|1
7717036|NCT01030965|26834824|P2|Overall Study|Protocol Violation|1
7717037|NCT01030965|26834825|P1|Overall Study|Protocol Violation|1
7717038|NCT01030965|26834822|P4|Overall Study|Lack of Efficacy|3
7717039|NCT01030965|26834823|P3|Overall Study|Lack of Efficacy|0
7717040|NCT01030965|26834824|P2|Overall Study|Lack of Efficacy|2
7717041|NCT01030965|26834825|P1|Overall Study|Lack of Efficacy|3
7717042|NCT01030952|26834845|P2|Overall Study|Unexplained|1
7717043|NCT01030952|26834846|P1|Overall Study|Unexplained|1
7717044|NCT01030952|26834845|P2|Overall Study|Lost to Follow-up|1
7717045|NCT01030952|26834846|P1|Overall Study|Lost to Follow-up|0
7717046|NCT01030952|26834845|P2|Overall Study|Informed consent withdrawal|0
7717047|NCT01030952|26834846|P1|Overall Study|Informed consent withdrawal|1
7717048|NCT01030952|26834845|P2|Overall Study|Protocol Violation|1
7717049|NCT01030952|26834846|P1|Overall Study|Protocol Violation|0
7717050|NCT01030874|26834882|P2|Overall Study|Discharged in first 2 weeks|16
7717051|NCT01030874|26834883|P1|Overall Study|Discharged in first 2 weeks|17
7717052|NCT01030874|26834882|P2|Overall Study|Withdrawal by Subject|0
7717053|NCT01030874|26834883|P1|Overall Study|Withdrawal by Subject|1
7717054|NCT01030822|26834905|P3|Overall Study|Lost to Follow-up|7
7717055|NCT01030822|26834906|P2|Overall Study|Lost to Follow-up|4
7717056|NCT01030822|26834907|P1|Overall Study|Lost to Follow-up|9
7717057|NCT01030822|26834905|P3|Overall Study|Withdrawal by Subject|16
7717058|NCT01030822|26834906|P2|Overall Study|Withdrawal by Subject|13
7717059|NCT01030822|26834907|P1|Overall Study|Withdrawal by Subject|16
7717060|NCT01030822|26834905|P3|Overall Study|Moved/migrated from study area|3
7717061|NCT01030822|26834906|P2|Overall Study|Moved/migrated from study area|7
7717062|NCT01030822|26834907|P1|Overall Study|Moved/migrated from study area|6
7717063|NCT01030718|26834982|P3|Study CA180-036 Only|Other Reasons|0
7717064|NCT01030718|26834983|P2|Study CA180-036 Only|Other Reasons|2
7717065|NCT01030718|26834984|P1|Study CA180-036 Only|Other Reasons|0
7717066|NCT01030718|26834982|P3|Study CA180-036 Only|Death|0
7717067|NCT01030718|26834983|P2|Study CA180-036 Only|Death|1
7717068|NCT01030718|26834984|P1|Study CA180-036 Only|Death|0
7717069|NCT01030718|26834982|P3|Study CA180-036 Only|Adverse Event|0
7717070|NCT01030718|26834983|P2|Study CA180-036 Only|Adverse Event|3
7717071|NCT01030718|26834984|P1|Study CA180-036 Only|Adverse Event|2
7717072|NCT01030718|26834982|P3|Study CA180-036 Only|insufficient effect|5
7717073|NCT01030718|26834983|P2|Study CA180-036 Only|insufficient effect|1
7717074|NCT01030718|26834984|P1|Study CA180-036 Only|insufficient effect|1
7717075|NCT01030718|26834982|P3|Studies CA180-031 and -036 Combined|other reasons|0
7717076|NCT01030718|26834983|P2|Studies CA180-031 and -036 Combined|other reasons|2
7717077|NCT01030718|26834984|P1|Studies CA180-031 and -036 Combined|other reasons|0
7717078|NCT01030718|26834982|P3|Studies CA180-031 and -036 Combined|Death|0
7717079|NCT01030718|26834983|P2|Studies CA180-031 and -036 Combined|Death|1
7717080|NCT01030718|26834984|P1|Studies CA180-031 and -036 Combined|Death|0
7717081|NCT01030718|26834982|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
7717082|NCT01030718|26834983|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
7717083|NCT01030718|26834984|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
7717084|NCT01030718|26834982|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
7717085|NCT01030718|26834983|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
7717086|NCT01030718|26834984|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
7717087|NCT01030666|26835045|P2|Overall Study|Lost to Follow-up|2
7717088|NCT01030666|26835046|P1|Overall Study|Lost to Follow-up|3
7717089|NCT01030536|26835091|P5|Overall Study|Death|0
7717090|NCT01030536|26835092|P4|Overall Study|Death|0
7717091|NCT01030536|26835093|P3|Overall Study|Death|0
7717092|NCT01030536|26835094|P2|Overall Study|Death|1
7717093|NCT01030536|26835095|P1|Overall Study|Death|0
7717094|NCT01030536|26835091|P5|Overall Study|Progressive disease|0
7717095|NCT01030536|26835092|P4|Overall Study|Progressive disease|2
7717096|NCT01030536|26835093|P3|Overall Study|Progressive disease|3
7717097|NCT01030536|26835094|P2|Overall Study|Progressive disease|2
7717098|NCT01030536|26835095|P1|Overall Study|Progressive disease|6
7717099|NCT01030536|26835091|P5|Overall Study|Adverse Event|1
7717100|NCT01030536|26835092|P4|Overall Study|Adverse Event|0
7717101|NCT01030536|26835093|P3|Overall Study|Adverse Event|1
7717102|NCT01030536|26835094|P2|Overall Study|Adverse Event|3
7717103|NCT01030536|26835095|P1|Overall Study|Adverse Event|0
7717104|NCT01030536|26835091|P5|Overall Study|undefined|0
7717105|NCT01030536|26835092|P4|Overall Study|undefined|1
7717106|NCT01030536|26835093|P3|Overall Study|undefined|1
7717107|NCT01030536|26835094|P2|Overall Study|undefined|0
7717108|NCT01030536|26835095|P1|Overall Study|undefined|1
7717109|NCT01030536|26835091|P5|Overall Study|Withdrawal by Subject|0
7717110|NCT01030536|26835092|P4|Overall Study|Withdrawal by Subject|0
7717111|NCT01030536|26835093|P3|Overall Study|Withdrawal by Subject|1
7717112|NCT01030536|26835094|P2|Overall Study|Withdrawal by Subject|0
7717113|NCT01030536|26835095|P1|Overall Study|Withdrawal by Subject|0
7717114|NCT01030523|26835200|P2|Overall Study|Withdrawal by Subject|1
7717115|NCT01030523|26835201|P1|Overall Study|Withdrawal by Subject|0
7717116|NCT01030523|26835200|P2|Overall Study|Implant failure|0
7717117|NCT01030523|26835201|P1|Overall Study|Implant failure|1
7717118|NCT01030523|26835200|P2|Overall Study|Lost to Follow-up|4
7717119|NCT01030523|26835201|P1|Overall Study|Lost to Follow-up|4
7717120|NCT01030523|26835200|P2|Overall Study|Death|0
7717121|NCT01030523|26835201|P1|Overall Study|Death|1
7717122|NCT01030458|26835215|P2|Overall Study|Side effect of medication|1
7717123|NCT01030458|26835216|P1|Overall Study|Side effect of medication|1
7717124|NCT01030458|26835215|P2|Overall Study|Moved or changed job|13
7717125|NCT01030458|26835216|P1|Overall Study|Moved or changed job|6
7717126|NCT01030458|26835215|P2|Overall Study|Logistical reasons|5
7717127|NCT01030458|26835216|P1|Overall Study|Logistical reasons|9
7717128|NCT01030458|26835215|P2|Overall Study|Withdrawal by Subject|3
7717129|NCT01030458|26835216|P1|Overall Study|Withdrawal by Subject|2
7717130|NCT01030458|26835215|P2|Overall Study|Lost to Follow-up|10
7717131|NCT01030458|26835216|P1|Overall Study|Lost to Follow-up|9
7717132|NCT01030341|26835249|P1|Overall Study|Lost to Follow-up|2
7717133|NCT01030341|26835249|P1|Overall Study|Withdrawal by Subject|1
7717134|NCT01030198|26835272|P2|Overall Study|Could not measure efficacy accurately|7
7717135|NCT01030198|26835273|P1|Overall Study|Could not measure efficacy accurately|0
7717136|NCT01030133|26835281|P2|Overall Study|failed to experience pain at level 7/10|2
7717137|NCT01030133|26835282|P1|Overall Study|failed to experience pain at level 7/10|2
7717138|NCT01029925|26835294|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
7717139|NCT01029925|26835294|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
7717140|NCT01029925|26835294|P1|Completion of Cycle 1 (28 Days)|Death|2
7717141|NCT01029886|26835313|P2|Overall Study|Loss Glucose Control|1
7717142|NCT01029886|26835314|P1|Overall Study|Loss Glucose Control|7
7717143|NCT01029886|26835313|P2|Overall Study|Sponsor Decision|0
7717144|NCT01029886|26835314|P1|Overall Study|Sponsor Decision|1
7717145|NCT01029886|26835313|P2|Overall Study|Entry Criteria Not Met|5
7717146|NCT01029886|26835314|P1|Overall Study|Entry Criteria Not Met|13
7717147|NCT01029886|26835313|P2|Overall Study|Withdrawal by Subject|18
7717148|NCT01029886|26835314|P1|Overall Study|Withdrawal by Subject|8
7717149|NCT01029886|26835313|P2|Overall Study|Protocol Violation|5
7717150|NCT01029886|26835314|P1|Overall Study|Protocol Violation|17
7717151|NCT01029886|26835313|P2|Overall Study|Physician Decision|6
7717152|NCT01029886|26835314|P1|Overall Study|Physician Decision|2
7717153|NCT01029886|26835313|P2|Overall Study|Lost to Follow-up|0
7717154|NCT01029886|26835314|P1|Overall Study|Lost to Follow-up|1
7717155|NCT01029886|26835313|P2|Overall Study|Adverse Event|25
7717156|NCT01029886|26835314|P1|Overall Study|Adverse Event|12
7717157|NCT01029795|26835342|P2|Overall Study|Withdrawal by Subject|3
7717158|NCT01029795|26835343|P1|Overall Study|Withdrawal by Subject|1
7717159|NCT01029795|26835342|P2|Overall Study|Sponsor Decision|17
7717160|NCT01029795|26835343|P1|Overall Study|Sponsor Decision|11
7717161|NCT01029795|26835342|P2|Overall Study|Physician Decision|1
7717162|NCT01029795|26835343|P1|Overall Study|Physician Decision|2
7717163|NCT01029795|26835342|P2|Overall Study|Entry Criteria Not Met|1
7717164|NCT01029795|26835343|P1|Overall Study|Entry Criteria Not Met|2
7717165|NCT01029782|26835397|P2|Overall Study|Withdrawal by Subject|1
7717166|NCT01029782|26835398|P1|Overall Study|Withdrawal by Subject|0
7717167|NCT01029782|26835397|P2|Overall Study|Protocol Violation|2
7717168|NCT01029782|26835398|P1|Overall Study|Protocol Violation|0
7717169|NCT01029782|26835397|P2|Overall Study|Physician Decision|1
7717170|NCT01029782|26835398|P1|Overall Study|Physician Decision|0
7717171|NCT01029782|26835397|P2|Overall Study|Adverse Event|1
7717172|NCT01029782|26835398|P1|Overall Study|Adverse Event|0
7717173|NCT01029782|26835397|P2|Overall Study|Diagnosis changed|1
7717174|NCT01029782|26835398|P1|Overall Study|Diagnosis changed|1
7717175|NCT01029782|26835397|P2|Overall Study|Lost to Follow-up|2
7717176|NCT01029782|26835398|P1|Overall Study|Lost to Follow-up|2
7717177|NCT01029704|26835420|P9|Overall Study|Withdrawn due to major protocol violation|0
7717178|NCT01029704|26835421|P8|Overall Study|Withdrawn due to major protocol violation|1
7717179|NCT01029704|26835422|P7|Overall Study|Withdrawn due to major protocol violation|0
7717180|NCT01029704|26835423|P6|Overall Study|Withdrawn due to major protocol violation|0
7717181|NCT01029704|26835424|P5|Overall Study|Withdrawn due to major protocol violation|1
7717182|NCT01029704|26835425|P4|Overall Study|Withdrawn due to major protocol violation|0
7717183|NCT01029704|26835426|P3|Overall Study|Withdrawn due to major protocol violation|0
7717184|NCT01029704|26835427|P2|Overall Study|Withdrawn due to major protocol violation|0
7717185|NCT01029704|26835428|P1|Overall Study|Withdrawn due to major protocol violation|0
7717186|NCT01029704|26835420|P9|Overall Study|Lack of Efficacy|0
7717187|NCT01029704|26835421|P8|Overall Study|Lack of Efficacy|2
7717188|NCT01029704|26835422|P7|Overall Study|Lack of Efficacy|1
7717189|NCT01029704|26835423|P6|Overall Study|Lack of Efficacy|3
7717190|NCT01029704|26835424|P5|Overall Study|Lack of Efficacy|2
7717191|NCT01029704|26835425|P4|Overall Study|Lack of Efficacy|0
7717192|NCT01029704|26835426|P3|Overall Study|Lack of Efficacy|0
7717193|NCT01029704|26835427|P2|Overall Study|Lack of Efficacy|0
7717194|NCT01029704|26835428|P1|Overall Study|Lack of Efficacy|0
7717195|NCT01029704|26835420|P9|Overall Study|Lost to Follow-up|1
7717196|NCT01029704|26835421|P8|Overall Study|Lost to Follow-up|1
7717197|NCT01029704|26835422|P7|Overall Study|Lost to Follow-up|1
7717198|NCT01029704|26835423|P6|Overall Study|Lost to Follow-up|0
7717199|NCT01029704|26835424|P5|Overall Study|Lost to Follow-up|0
7717200|NCT01029704|26835425|P4|Overall Study|Lost to Follow-up|0
7717201|NCT01029704|26835426|P3|Overall Study|Lost to Follow-up|0
7717202|NCT01029704|26835427|P2|Overall Study|Lost to Follow-up|0
7717203|NCT01029704|26835428|P1|Overall Study|Lost to Follow-up|0
7717204|NCT01029704|26835420|P9|Overall Study|Withdrawal by Subject|0
7717205|NCT01029704|26835421|P8|Overall Study|Withdrawal by Subject|1
7717206|NCT01029704|26835422|P7|Overall Study|Withdrawal by Subject|1
7717207|NCT01029704|26835423|P6|Overall Study|Withdrawal by Subject|1
7717208|NCT01029704|26835424|P5|Overall Study|Withdrawal by Subject|2
7717209|NCT01029704|26835425|P4|Overall Study|Withdrawal by Subject|0
7717210|NCT01029704|26835426|P3|Overall Study|Withdrawal by Subject|0
7717211|NCT01029704|26835427|P2|Overall Study|Withdrawal by Subject|0
7717212|NCT01029704|26835428|P1|Overall Study|Withdrawal by Subject|0
7717213|NCT01029704|26835420|P9|Overall Study|Adverse Event|0
7717214|NCT01029704|26835421|P8|Overall Study|Adverse Event|1
7717215|NCT01029704|26835422|P7|Overall Study|Adverse Event|1
7717216|NCT01029704|26835423|P6|Overall Study|Adverse Event|0
7717217|NCT01029704|26835424|P5|Overall Study|Adverse Event|0
7717218|NCT01029704|26835425|P4|Overall Study|Adverse Event|0
7717219|NCT01029704|26835426|P3|Overall Study|Adverse Event|0
7717220|NCT01029704|26835427|P2|Overall Study|Adverse Event|0
7717221|NCT01029704|26835428|P1|Overall Study|Adverse Event|0
7717222|NCT01029691|26835475|P3|Continued APAP to Delivery|Death|1
7717223|NCT01029691|26835476|P2|Continued APAP to Delivery|Death|0
7717224|NCT01029691|26835477|P1|Continued APAP to Delivery|Death|0
7717225|NCT01029652|26835502|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
7717226|NCT01029652|26835503|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
7717227|NCT01029652|26835502|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
7717228|NCT01029652|26835503|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
7717229|NCT01029652|26835502|P2|Extension Study 2 (25-72 Weeks)|Death|1
7717230|NCT01029652|26835503|P1|Extension Study 2 (25-72 Weeks)|Death|1
7717231|NCT01029652|26835502|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
7717232|NCT01029652|26835503|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
7717233|NCT01029652|26835502|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
7717234|NCT01029652|26835503|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
7717235|NCT01029652|26835502|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
7717236|NCT01029652|26835503|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
7717237|NCT01029652|26835502|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
7717238|NCT01029652|26835503|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
7717239|NCT01029652|26835502|P2|Core Study (0-12 Weeks)|Death|1
7717240|NCT01029652|26835503|P1|Core Study (0-12 Weeks)|Death|0
7717241|NCT01029652|26835502|P2|Core Study (0-12 Weeks)|Administrative problems|1
7717242|NCT01029652|26835503|P1|Core Study (0-12 Weeks)|Administrative problems|2
7717243|NCT01029652|26835502|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
7717244|NCT01029652|26835503|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
7717245|NCT01029652|26835502|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
7717246|NCT01029652|26835503|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
7717247|NCT01029652|26835502|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
7717248|NCT01029652|26835503|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
7717249|NCT01029535|26835587|P1|Overall Study|Death|1
7717250|NCT01029535|26835587|P1|Overall Study|Use of Another Treatment|1
7717251|NCT01029535|26835587|P1|Overall Study|Adverse Event|1
7717252|NCT01029535|26835587|P1|Overall Study|Participant Withdrew Consent|2
7717253|NCT01029535|26835587|P1|Overall Study|Protocol Violation|2
7717254|NCT01029535|26835587|P1|Overall Study|Lost to Follow-up|24
7717255|NCT01029405|26835616|P4|Overall Study|Other|1
7717256|NCT01029405|26835617|P3|Overall Study|Other|0
7717257|NCT01029405|26835618|P2|Overall Study|Other|1
7717258|NCT01029405|26835619|P1|Overall Study|Other|0
7717259|NCT01029405|26835616|P4|Overall Study|Lost to Follow-up|2
7717260|NCT01029405|26835617|P3|Overall Study|Lost to Follow-up|1
7717261|NCT01029405|26835618|P2|Overall Study|Lost to Follow-up|1
7717262|NCT01029405|26835619|P1|Overall Study|Lost to Follow-up|2
7717263|NCT01029405|26835616|P4|Overall Study|Adverse Event|1
7717264|NCT01029405|26835617|P3|Overall Study|Adverse Event|1
7717265|NCT01029405|26835618|P2|Overall Study|Adverse Event|0
7717266|NCT01029405|26835619|P1|Overall Study|Adverse Event|0
7717267|NCT01029405|26835616|P4|Overall Study|Protocol Violation|1
7717268|NCT01029405|26835617|P3|Overall Study|Protocol Violation|0
7717269|NCT01029405|26835618|P2|Overall Study|Protocol Violation|0
7717270|NCT01029405|26835619|P1|Overall Study|Protocol Violation|0
7717271|NCT01029405|26835616|P4|Overall Study|Withdrawal by Subject|0
7717272|NCT01029405|26835617|P3|Overall Study|Withdrawal by Subject|2
7717273|NCT01029405|26835618|P2|Overall Study|Withdrawal by Subject|1
7717274|NCT01029405|26835619|P1|Overall Study|Withdrawal by Subject|0
7717275|NCT01029392|26835631|P2|Overall Study|Physician Decision|0
7717276|NCT01029392|26835632|P1|Overall Study|Physician Decision|2
7717277|NCT01029392|26835631|P2|Overall Study|Withdrawal by Subject|11
7717278|NCT01029392|26835632|P1|Overall Study|Withdrawal by Subject|18
7717279|NCT01029366|26835642|P2|Overall Study|manufacturing failure|1
7717280|NCT01029366|26835643|P1|Overall Study|manufacturing failure|0
7717281|NCT01029366|26835642|P2|Overall Study|disease progression|0
7717282|NCT01029366|26835643|P1|Overall Study|disease progression|2
7717283|NCT01029366|26835642|P2|Overall Study|Death|1
7717284|NCT01029366|26835643|P1|Overall Study|Death|1
7717285|NCT01029366|26835642|P2|Overall Study|Withdrawal by Subject|0
7717286|NCT01029366|26835643|P1|Overall Study|Withdrawal by Subject|1
7717287|NCT01029340|26835655|P6|Extension Period|Physician Decision|1
7717288|NCT01029340|26835656|P5|Extension Period|Physician Decision|0
7717289|NCT01029340|26835657|P4|Extension Period|Physician Decision|0
7717290|NCT01029340|26835658|P3|Extension Period|Physician Decision|0
7717291|NCT01029340|26835659|P2|Extension Period|Physician Decision|0
7717292|NCT01029340|26835660|P1|Extension Period|Physician Decision|0
7717293|NCT01029340|26835655|P6|Extension Period|Withdrawal by Subject|1
7717294|NCT01029340|26835656|P5|Extension Period|Withdrawal by Subject|0
7717295|NCT01029340|26835657|P4|Extension Period|Withdrawal by Subject|0
7717296|NCT01029340|26835658|P3|Extension Period|Withdrawal by Subject|0
7717297|NCT01029340|26835659|P2|Extension Period|Withdrawal by Subject|0
7717298|NCT01029340|26835660|P1|Extension Period|Withdrawal by Subject|0
7717299|NCT01029340|26835655|P6|Extension Period|non-compliance|1
7717300|NCT01029340|26835656|P5|Extension Period|non-compliance|0
7717301|NCT01029340|26835657|P4|Extension Period|non-compliance|0
7717302|NCT01029340|26835658|P3|Extension Period|non-compliance|0
7717303|NCT01029340|26835659|P2|Extension Period|non-compliance|0
7717304|NCT01029340|26835660|P1|Extension Period|non-compliance|0
7717305|NCT01029340|26835655|P6|Extension Period|starting another study|8
7717306|NCT01029340|26835656|P5|Extension Period|starting another study|0
7717307|NCT01029340|26835657|P4|Extension Period|starting another study|0
7717308|NCT01029340|26835658|P3|Extension Period|starting another study|0
7717309|NCT01029340|26835659|P2|Extension Period|starting another study|0
7717310|NCT01029340|26835660|P1|Extension Period|starting another study|0
7717311|NCT01029340|26835655|P6|Extension Period|Adverse Event|1
7717312|NCT01029340|26835656|P5|Extension Period|Adverse Event|0
7717313|NCT01029340|26835657|P4|Extension Period|Adverse Event|0
7717314|NCT01029340|26835658|P3|Extension Period|Adverse Event|0
7717315|NCT01029340|26835659|P2|Extension Period|Adverse Event|0
7717316|NCT01029340|26835660|P1|Extension Period|Adverse Event|0
7717317|NCT01029340|26835655|P6|Part B Treatment Period|Protocol Violation|0
7717318|NCT01029340|26835656|P5|Part B Treatment Period|Protocol Violation|0
7717319|NCT01029340|26835657|P4|Part B Treatment Period|Protocol Violation|0
7717320|NCT01029340|26835658|P3|Part B Treatment Period|Protocol Violation|1
7717321|NCT01029340|26835659|P2|Part B Treatment Period|Protocol Violation|0
7717322|NCT01029340|26835660|P1|Part B Treatment Period|Protocol Violation|0
7717323|NCT01029340|26835655|P6|Part B Treatment Period|Withdrawal by Subject|0
7717324|NCT01029340|26835656|P5|Part B Treatment Period|Withdrawal by Subject|0
7717325|NCT01029340|26835657|P4|Part B Treatment Period|Withdrawal by Subject|0
7717326|NCT01029340|26835658|P3|Part B Treatment Period|Withdrawal by Subject|1
7717327|NCT01029340|26835659|P2|Part B Treatment Period|Withdrawal by Subject|0
7717328|NCT01029340|26835660|P1|Part B Treatment Period|Withdrawal by Subject|0
7717329|NCT01029262|26835691|P2|Overall Study|Death|3
7717330|NCT01029262|26835692|P1|Overall Study|Death|0
7717331|NCT01029262|26835691|P2|Overall Study|Miscellaneous|9
7717332|NCT01029262|26835692|P1|Overall Study|Miscellaneous|1
7717333|NCT01029262|26835691|P2|Overall Study|Protocol Violation|3
7717334|NCT01029262|26835692|P1|Overall Study|Protocol Violation|2
7717335|NCT01029262|26835691|P2|Overall Study|Withdrawal by Subject|17
7717336|NCT01029262|26835692|P1|Overall Study|Withdrawal by Subject|10
7717337|NCT01029262|26835691|P2|Overall Study|Lack of therapeutic effect|76
7717338|NCT01029262|26835692|P1|Overall Study|Lack of therapeutic effect|57
7717339|NCT01029262|26835691|P2|Overall Study|Adverse Event|52
7717340|NCT01029262|26835692|P1|Overall Study|Adverse Event|9
7717341|NCT01028651|26835861|P1|Overall Study|Adverse Event|1
7717342|NCT01028651|26835861|P1|Overall Study|Death|2
7717343|NCT01028560|26835884|P2|Overall Study|Withdrawal by Subject|12
7717344|NCT01028560|26835885|P1|Overall Study|Withdrawal by Subject|7
7717345|NCT01028560|26835884|P2|Overall Study|Lack of Efficacy|6
7717346|NCT01028560|26835885|P1|Overall Study|Lack of Efficacy|3
7717347|NCT01028391|26835899|P2|Overall Study|Needed excluded medication|1
7717348|NCT01028391|26835900|P1|Overall Study|Needed excluded medication|1
7717349|NCT01028391|26835899|P2|Overall Study|Withdrawal by Subject|3
7717350|NCT01028391|26835900|P1|Overall Study|Withdrawal by Subject|6
7717351|NCT01028391|26835899|P2|Overall Study|Physician Decision|1
7717352|NCT01028391|26835900|P1|Overall Study|Physician Decision|0
7717353|NCT01028391|26835899|P2|Overall Study|Lost to Follow-up|4
7717354|NCT01028391|26835900|P1|Overall Study|Lost to Follow-up|3
7717355|NCT01028391|26835899|P2|Overall Study|Lack of Efficacy|2
7717356|NCT01028391|26835900|P1|Overall Study|Lack of Efficacy|0
7717357|NCT01028391|26835899|P2|Overall Study|Adverse Event|0
7717358|NCT01028391|26835900|P1|Overall Study|Adverse Event|4
7717359|NCT01028378|26835908|P1|Overall Study|Adminstrative Reasons|4
7717360|NCT01028378|26835908|P1|Overall Study|Withdrawal by Subject|1
7717361|NCT01028378|26835908|P1|Overall Study|Lost to Follow-up|12
7717362|NCT01028352|26835920|P1|Overall Study|Withdrawal by Subject|1
7717363|NCT01028352|26835920|P1|Overall Study|Ineligible due to baseline average pain|5
7717364|NCT01028300|26835925|P1|Overall Study|Study Terminated|4
7717365|NCT01028222|26835934|P2|Overall Study|Adverse Event|0
7717366|NCT01028222|26835935|P1|Overall Study|Adverse Event|2
7717367|NCT01028222|26835934|P2|Overall Study|Crossover to nilotinib w/out progression|2
7717368|NCT01028222|26835935|P1|Overall Study|Crossover to nilotinib w/out progression|0
7717369|NCT01028222|26835934|P2|Overall Study|Withdrawal by Subject|0
7717370|NCT01028222|26835935|P1|Overall Study|Withdrawal by Subject|1
7717371|NCT01028222|26835934|P2|Overall Study|Lost to Follow-up|1
7717372|NCT01028222|26835935|P1|Overall Study|Lost to Follow-up|0
7717373|NCT01028222|26835934|P2|Overall Study|Administrative problems|1
7717374|NCT01028222|26835935|P1|Overall Study|Administrative problems|1
7717375|NCT01028222|26835934|P2|Overall Study|Disease progression|9
7717376|NCT01028222|26835935|P1|Overall Study|Disease progression|33
7717377|NCT01028222|26835934|P2|Overall Study|Protocol deviation|0
7717378|NCT01028222|26835935|P1|Overall Study|Protocol deviation|1
7717379|NCT01028053|26835977|P1|Overall Study|Various reasons|4
7717380|NCT01028053|26835977|P1|Overall Study|Terminated by Sponsor|1
7717381|NCT01028053|26835977|P1|Overall Study|Technical Problem|1
7717382|NCT01028053|26835977|P1|Overall Study|Physician Decision|2
7717383|NCT01028053|26835977|P1|Overall Study|Protocol Violation|1
7717384|NCT01028053|26835977|P1|Overall Study|Patient Request|11
7717385|NCT01028053|26835977|P1|Overall Study|Screen Failure|113
7717386|NCT01028027|26835985|P2|Overall Study|Lack of Efficacy|1
7717387|NCT01028027|26835986|P1|Overall Study|Lack of Efficacy|0
7717388|NCT01028027|26835985|P2|Overall Study|Protocol Violation|1
7717389|NCT01028027|26835986|P1|Overall Study|Protocol Violation|3
7717390|NCT01028027|26835985|P2|Overall Study|Adverse Event|7
7717391|NCT01028027|26835986|P1|Overall Study|Adverse Event|4
7717392|NCT01028027|26835985|P2|Overall Study|Withdrawal by Subject|3
7717393|NCT01028027|26835986|P1|Overall Study|Withdrawal by Subject|5
7717394|NCT01028027|26835985|P2|Overall Study|Lost to Follow-up|1
7717395|NCT01028027|26835986|P1|Overall Study|Lost to Follow-up|4
7717396|NCT01028014|26836008|P6|Overall Study|Lost to Follow-up|2
7717397|NCT01028014|26836009|P5|Overall Study|Lost to Follow-up|1
7717398|NCT01028014|26836010|P4|Overall Study|Lost to Follow-up|1
7717399|NCT01028014|26836011|P3|Overall Study|Lost to Follow-up|0
7717400|NCT01028014|26836012|P2|Overall Study|Lost to Follow-up|2
7717401|NCT01028014|26836013|P1|Overall Study|Lost to Follow-up|1
7717402|NCT01027949|26836039|P1|Overall Study|Surgery|1
7717403|NCT01027949|26836039|P1|Overall Study|Pregnancy|1
7717404|NCT01027949|26836039|P1|Overall Study|Patient Self-discontinuation|1
7717405|NCT01027949|26836039|P1|Overall Study|Use of Excluded Medication|2
7717406|NCT01027949|26836039|P1|Overall Study|Unable to Tolerate Study Drug|2
7717407|NCT01027949|26836039|P1|Overall Study|Lung Transplant|5
7717408|NCT01027949|26836039|P1|Overall Study|Non-compliance with Study Procedures|7
7717409|NCT01027949|26836039|P1|Overall Study|Limited Study Drug Effectiveness|7
7717410|NCT01027949|26836039|P1|Overall Study|PI Decision|8
7717411|NCT01027949|26836039|P1|Overall Study|Protocol Violation|13
7717412|NCT01027949|26836039|P1|Overall Study|Lost to Follow-up|17
7717413|NCT01027949|26836039|P1|Overall Study|Withdrawal by Subject|113
7717414|NCT01027949|26836039|P1|Overall Study|Adverse Event|172
7717415|NCT01027949|26836039|P1|Overall Study|Progressive Disease|163
7717416|NCT01027949|26836039|P1|Overall Study|Death|174
7717417|NCT01027897|26836058|P1|Overall Study|Withdrawal by Subject|1
7717418|NCT01027897|26836058|P1|Overall Study|Protocol Violation|1
7717419|NCT01027884|26836066|P2|Overall Study|Spinal fixation surgery|3
7717420|NCT01027884|26836067|P1|Overall Study|Spinal fixation surgery|0
7717421|NCT01027884|26836066|P2|Overall Study|Lost to Follow-up|1
7717422|NCT01027884|26836067|P1|Overall Study|Lost to Follow-up|0
7717423|NCT01027884|26836066|P2|Overall Study|Withdrawal by Subject|1
7717424|NCT01027884|26836067|P1|Overall Study|Withdrawal by Subject|0
7717425|NCT01027884|26836066|P2|Overall Study|Non-compliance|1
7717426|NCT01027884|26836067|P1|Overall Study|Non-compliance|1
7717427|NCT01027884|26836066|P2|Overall Study|Protocol Violation|0
7717428|NCT01027884|26836067|P1|Overall Study|Protocol Violation|1
7717429|NCT01027884|26836066|P2|Overall Study|Adverse Event|1
7717430|NCT01027884|26836067|P1|Overall Study|Adverse Event|2
7717431|NCT01027871|26836084|P3|Overall Study|Discontinued Prior to Treatment|1
7717432|NCT01027871|26836085|P2|Overall Study|Discontinued Prior to Treatment|0
7717433|NCT01027871|26836086|P1|Overall Study|Discontinued Prior to Treatment|0
7717434|NCT01027871|26836084|P3|Overall Study|Sponsor Decision|0
7717435|NCT01027871|26836085|P2|Overall Study|Sponsor Decision|2
7717436|NCT01027871|26836086|P1|Overall Study|Sponsor Decision|0
7717437|NCT01027871|26836084|P3|Overall Study|Adverse Event|2
7717438|NCT01027871|26836085|P2|Overall Study|Adverse Event|2
7717439|NCT01027871|26836086|P1|Overall Study|Adverse Event|0
7717440|NCT01027871|26836084|P3|Overall Study|Withdrawal by Subject|2
7717441|NCT01027871|26836085|P2|Overall Study|Withdrawal by Subject|2
7717442|NCT01027871|26836086|P1|Overall Study|Withdrawal by Subject|1
7717443|NCT01027871|26836084|P3|Overall Study|Protocol Violation|2
7717444|NCT01027871|26836085|P2|Overall Study|Protocol Violation|2
7717445|NCT01027871|26836086|P1|Overall Study|Protocol Violation|0
7717446|NCT01027871|26836084|P3|Overall Study|Physician Decision|0
7717447|NCT01027871|26836085|P2|Overall Study|Physician Decision|5
7717448|NCT01027871|26836086|P1|Overall Study|Physician Decision|1
7717449|NCT01027845|26836145|P4|Booster Vaccination Phase|Migrated/moved from study area|0
7717450|NCT01027845|26836146|P3|Booster Vaccination Phase|Migrated/moved from study area|0
7717451|NCT01027845|26836147|P2|Booster Vaccination Phase|Migrated/moved from study area|0
7717452|NCT01027845|26836148|P1|Booster Vaccination Phase|Migrated/moved from study area|1
7717453|NCT01027845|26836145|P4|Booster Vaccination Phase|Withdrawal by Subject|0
7717454|NCT01027845|26836146|P3|Booster Vaccination Phase|Withdrawal by Subject|0
7717455|NCT01027845|26836147|P2|Booster Vaccination Phase|Withdrawal by Subject|0
7717456|NCT01027845|26836148|P1|Booster Vaccination Phase|Withdrawal by Subject|1
7717457|NCT01027845|26836145|P4|Primary Vaccination Phase|Migrated/moved from study area|0
7717458|NCT01027845|26836146|P3|Primary Vaccination Phase|Migrated/moved from study area|0
7717459|NCT01027845|26836147|P2|Primary Vaccination Phase|Migrated/moved from study area|1
7717460|NCT01027845|26836148|P1|Primary Vaccination Phase|Migrated/moved from study area|0
7717461|NCT01027845|26836145|P4|Primary Vaccination Phase|Protocol Violation|0
7717462|NCT01027845|26836146|P3|Primary Vaccination Phase|Protocol Violation|0
7717463|NCT01027845|26836147|P2|Primary Vaccination Phase|Protocol Violation|0
7717464|NCT01027845|26836148|P1|Primary Vaccination Phase|Protocol Violation|1
7717465|NCT01027845|26836145|P4|Primary Vaccination Phase|Adverse Event|0
7717466|NCT01027845|26836146|P3|Primary Vaccination Phase|Adverse Event|0
7717467|NCT01027845|26836147|P2|Primary Vaccination Phase|Adverse Event|0
7717468|NCT01027845|26836148|P1|Primary Vaccination Phase|Adverse Event|1
7717469|NCT01027845|26836145|P4|Primary Vaccination Phase|Serious Adverse Event|0
7717470|NCT01027845|26836146|P3|Primary Vaccination Phase|Serious Adverse Event|0
7717471|NCT01027845|26836147|P2|Primary Vaccination Phase|Serious Adverse Event|0
7717472|NCT01027845|26836148|P1|Primary Vaccination Phase|Serious Adverse Event|2
7717473|NCT01027754|26836246|P2|Overall Study|Withdrawal by Subject|5
7717474|NCT01027754|26836247|P1|Overall Study|Withdrawal by Subject|0
7717475|NCT01027754|26836246|P2|Overall Study|withdrew/lost to follow-up after interve|3
7717476|NCT01027754|26836247|P1|Overall Study|withdrew/lost to follow-up after interve|2
7717477|NCT01027702|26836281|P7|Overall Study|Death|0
7717478|NCT01027702|26836282|P6|Overall Study|Death|0
7717479|NCT01027702|26836283|P5|Overall Study|Death|0
7717480|NCT01027702|26836284|P4|Overall Study|Death|0
7717481|NCT01027702|26836285|P3|Overall Study|Death|1
7717482|NCT01027702|26836286|P2|Overall Study|Death|0
7717483|NCT01027702|26836287|P1|Overall Study|Death|0
7717484|NCT01027702|26836281|P7|Overall Study|Received subsequent therapy|1
7717485|NCT01027702|26836282|P6|Overall Study|Received subsequent therapy|0
7717486|NCT01027702|26836283|P5|Overall Study|Received subsequent therapy|1
7717487|NCT01027702|26836284|P4|Overall Study|Received subsequent therapy|4
7717488|NCT01027702|26836285|P3|Overall Study|Received subsequent therapy|0
7717489|NCT01027702|26836286|P2|Overall Study|Received subsequent therapy|2
7717490|NCT01027702|26836287|P1|Overall Study|Received subsequent therapy|1
7717491|NCT01027650|26836313|P8|Overall Study|Lack of Efficacy|0
7717492|NCT01027650|26836314|P7|Overall Study|Lack of Efficacy|0
7717493|NCT01027650|26836315|P6|Overall Study|Lack of Efficacy|1
7717494|NCT01027650|26836316|P5|Overall Study|Lack of Efficacy|0
7717495|NCT01027650|26836317|P4|Overall Study|Lack of Efficacy|0
7717496|NCT01027650|26836318|P3|Overall Study|Lack of Efficacy|0
7717497|NCT01027650|26836319|P2|Overall Study|Lack of Efficacy|0
7717498|NCT01027650|26836320|P1|Overall Study|Lack of Efficacy|0
7717499|NCT01027650|26836313|P8|Overall Study|Lost to Follow-up|0
7717500|NCT01027650|26836314|P7|Overall Study|Lost to Follow-up|1
7717501|NCT01027650|26836315|P6|Overall Study|Lost to Follow-up|0
7717502|NCT01027650|26836316|P5|Overall Study|Lost to Follow-up|0
7717503|NCT01027650|26836317|P4|Overall Study|Lost to Follow-up|0
7717504|NCT01027650|26836318|P3|Overall Study|Lost to Follow-up|0
7717505|NCT01027650|26836319|P2|Overall Study|Lost to Follow-up|0
7717506|NCT01027650|26836320|P1|Overall Study|Lost to Follow-up|0
7717507|NCT01027650|26836313|P8|Overall Study|Personal Reasons|0
7717508|NCT01027650|26836314|P7|Overall Study|Personal Reasons|0
7717509|NCT01027650|26836315|P6|Overall Study|Personal Reasons|1
7717510|NCT01027650|26836316|P5|Overall Study|Personal Reasons|2
7717511|NCT01027650|26836317|P4|Overall Study|Personal Reasons|0
7717512|NCT01027650|26836318|P3|Overall Study|Personal Reasons|0
7717513|NCT01027650|26836319|P2|Overall Study|Personal Reasons|0
7717514|NCT01027650|26836320|P1|Overall Study|Personal Reasons|0
7717515|NCT01027416|26836398|P2|Overall Study|Physician Decision|4
7717516|NCT01027416|26836399|P1|Overall Study|Physician Decision|1
7717517|NCT01027416|26836398|P2|Overall Study|Withdrawal by Subject|1
7717518|NCT01027416|26836399|P1|Overall Study|Withdrawal by Subject|0
7717519|NCT01027364|26836411|P4|Overall Study|Withdrawal by Subject|0
7717520|NCT01027364|26836412|P3|Overall Study|Withdrawal by Subject|0
7717521|NCT01027364|26836413|P2|Overall Study|Withdrawal by Subject|2
7717522|NCT01027364|26836414|P1|Overall Study|Withdrawal by Subject|1
7717523|NCT01027364|26836411|P4|Overall Study|Protocol Violation|1
7717524|NCT01027364|26836412|P3|Overall Study|Protocol Violation|0
7717525|NCT01027364|26836413|P2|Overall Study|Protocol Violation|0
7717526|NCT01027364|26836414|P1|Overall Study|Protocol Violation|1
7717527|NCT01027364|26836411|P4|Overall Study|Lost to Follow-up|0
7717528|NCT01027364|26836412|P3|Overall Study|Lost to Follow-up|0
7717529|NCT01027364|26836413|P2|Overall Study|Lost to Follow-up|0
7717530|NCT01027364|26836414|P1|Overall Study|Lost to Follow-up|1
7717531|NCT01027364|26836411|P4|Overall Study|Adverse Event|0
7717532|NCT01027364|26836412|P3|Overall Study|Adverse Event|1
7717533|NCT01027364|26836413|P2|Overall Study|Adverse Event|0
7717534|NCT01027364|26836414|P1|Overall Study|Adverse Event|1
7717535|NCT01027351|26836509|P6|Overall Study|Protocol Violation|0
7717536|NCT01027351|26836510|P5|Overall Study|Protocol Violation|1
7717537|NCT01027351|26836511|P4|Overall Study|Protocol Violation|1
7717538|NCT01027351|26836512|P3|Overall Study|Protocol Violation|0
7717539|NCT01027351|26836513|P2|Overall Study|Protocol Violation|0
7717540|NCT01027351|26836514|P1|Overall Study|Protocol Violation|1
7717541|NCT01027351|26836509|P6|Overall Study|Inappropriate enrollment|0
7717542|NCT01027351|26836510|P5|Overall Study|Inappropriate enrollment|1
7717543|NCT01027351|26836511|P4|Overall Study|Inappropriate enrollment|0
7717544|NCT01027351|26836512|P3|Overall Study|Inappropriate enrollment|0
7717545|NCT01027351|26836513|P2|Overall Study|Inappropriate enrollment|0
7717546|NCT01027351|26836514|P1|Overall Study|Inappropriate enrollment|0
7717547|NCT01027351|26836509|P6|Overall Study|Lost to Follow-up|0
7717548|NCT01027351|26836510|P5|Overall Study|Lost to Follow-up|6
7717549|NCT01027351|26836511|P4|Overall Study|Lost to Follow-up|1
7717550|NCT01027351|26836512|P3|Overall Study|Lost to Follow-up|0
7717551|NCT01027351|26836513|P2|Overall Study|Lost to Follow-up|1
7717552|NCT01027351|26836514|P1|Overall Study|Lost to Follow-up|1
7717553|NCT01027351|26836509|P6|Overall Study|Withdrawal by Subject|5
7717554|NCT01027351|26836510|P5|Overall Study|Withdrawal by Subject|3
7717555|NCT01027351|26836511|P4|Overall Study|Withdrawal by Subject|0
7717556|NCT01027351|26836512|P3|Overall Study|Withdrawal by Subject|1
7717557|NCT01027351|26836513|P2|Overall Study|Withdrawal by Subject|0
7717558|NCT01027351|26836514|P1|Overall Study|Withdrawal by Subject|1
7717559|NCT01027286|26836598|P2|Overall Study|Lost to Follow-up|1
7717560|NCT01027286|26836599|P1|Overall Study|Lost to Follow-up|0
7717561|NCT01027286|26836598|P2|Overall Study|Unable to Obtain Required Blood Volume|0
7717562|NCT01027286|26836599|P1|Overall Study|Unable to Obtain Required Blood Volume|1
7717563|NCT01027273|26836619|P2|Overall Study|Death|2
7717564|NCT01027273|26836620|P1|Overall Study|Death|2
7717565|NCT01027273|26836619|P2|Overall Study|Lost to Follow-up|31
7717566|NCT01027273|26836620|P1|Overall Study|Lost to Follow-up|57
7717567|NCT01026974|26836667|P4|Overall Study|Inappropriate enrollment|0
7717568|NCT01026974|26836668|P3|Overall Study|Inappropriate enrollment|1
7717569|NCT01026974|26836669|P2|Overall Study|Inappropriate enrollment|0
7717570|NCT01026974|26836670|P1|Overall Study|Inappropriate enrollment|0
7717571|NCT01026974|26836667|P4|Overall Study|Adverse Event|1
7717572|NCT01026974|26836668|P3|Overall Study|Adverse Event|0
7717573|NCT01026974|26836669|P2|Overall Study|Adverse Event|0
7717574|NCT01026974|26836670|P1|Overall Study|Adverse Event|0
7717575|NCT01026974|26836667|P4|Overall Study|Lost to Follow-up|0
7717576|NCT01026974|26836668|P3|Overall Study|Lost to Follow-up|4
7717577|NCT01026974|26836669|P2|Overall Study|Lost to Follow-up|1
7717578|NCT01026974|26836670|P1|Overall Study|Lost to Follow-up|1
7717579|NCT01026974|26836667|P4|Overall Study|Withdrawal by Subject|2
7717580|NCT01026974|26836668|P3|Overall Study|Withdrawal by Subject|7
7717581|NCT01026974|26836669|P2|Overall Study|Withdrawal by Subject|1
7717582|NCT01026974|26836670|P1|Overall Study|Withdrawal by Subject|0
7717583|NCT01026948|26836727|P1|Overall Study|Physician Decision|8
7717584|NCT01026831|26836760|P2|Overall Study|Withdrawal by Subject|5
7717585|NCT01026831|26836761|P1|Overall Study|Withdrawal by Subject|7
7717586|NCT01026831|26836760|P2|Overall Study|Protocol Violation|2
7717587|NCT01026831|26836761|P1|Overall Study|Protocol Violation|0
7717588|NCT01026831|26836760|P2|Overall Study|Physician Decision|1
7717589|NCT01026831|26836761|P1|Overall Study|Physician Decision|1
7717590|NCT01026831|26836760|P2|Overall Study|Lost to Follow-up|0
7717591|NCT01026831|26836761|P1|Overall Study|Lost to Follow-up|2
7717592|NCT01026831|26836760|P2|Overall Study|Adverse Event|3
7717593|NCT01026831|26836761|P1|Overall Study|Adverse Event|4
7717594|NCT01026818|26836772|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
7717595|NCT01026818|26836773|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
7717596|NCT01026818|26836774|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
7717597|NCT01026818|26836775|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
7717598|NCT01026818|26836772|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
7717599|NCT01026818|26836773|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
7717600|NCT01026818|26836774|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
7717601|NCT01026818|26836775|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
7717602|NCT01026818|26836772|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
7717603|NCT01026818|26836773|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
7717604|NCT01026818|26836774|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
7717605|NCT01026818|26836775|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
7717606|NCT01026818|26836772|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7717607|NCT01026818|26836773|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7717608|NCT01026818|26836774|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
7717609|NCT01026818|26836775|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7717610|NCT01026818|26836772|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7717611|NCT01026818|26836773|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7717612|NCT01026818|26836774|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
7717613|NCT01026818|26836775|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7717614|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
7717615|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
7717616|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
7717617|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
7717618|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
7717619|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
7717620|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
7717621|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
7717622|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7717623|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7717624|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
7717625|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7717626|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
7717627|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
7717628|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
7717629|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
7717630|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
7717631|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
7717632|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
7717633|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
7717634|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7717635|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7717636|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
7717637|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7717638|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
7717639|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
7717640|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
7717641|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
7717642|NCT01026818|26836772|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
7717643|NCT01026818|26836773|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
7717644|NCT01026818|26836774|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
7717645|NCT01026818|26836775|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
7717646|NCT01026818|26836772|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
7717647|NCT01026818|26836773|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
7717648|NCT01026818|26836774|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
7717649|NCT01026818|26836775|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
7717650|NCT01026818|26836772|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
7717651|NCT01026818|26836773|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
7717652|NCT01026818|26836774|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
7717653|NCT01026818|26836775|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
7717654|NCT01026818|26836772|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
7717655|NCT01026818|26836773|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
7717656|NCT01026818|26836774|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
7717657|NCT01026818|26836775|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
7717658|NCT01026818|26836772|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
7717659|NCT01026818|26836773|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
7717660|NCT01026818|26836774|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
7717661|NCT01026818|26836775|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
7717662|NCT01026818|26836772|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
7717663|NCT01026818|26836773|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
7717664|NCT01026818|26836774|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
7717665|NCT01026818|26836775|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
7717666|NCT01026818|26836772|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
7717667|NCT01026818|26836773|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
7717668|NCT01026818|26836774|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
7717669|NCT01026818|26836775|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
7717670|NCT01026818|26836772|P4|Screening Period|Physician Decision|0
7717671|NCT01026818|26836773|P3|Screening Period|Physician Decision|0
7717672|NCT01026818|26836774|P2|Screening Period|Physician Decision|0
7717673|NCT01026818|26836775|P1|Screening Period|Physician Decision|1
7717674|NCT01026818|26836772|P4|Screening Period|Adverse Event|0
7717675|NCT01026818|26836773|P3|Screening Period|Adverse Event|0
7717676|NCT01026818|26836774|P2|Screening Period|Adverse Event|0
7717677|NCT01026818|26836775|P1|Screening Period|Adverse Event|2
7717678|NCT01026818|26836772|P4|Screening Period|Protocol Deviation|0
7717679|NCT01026818|26836773|P3|Screening Period|Protocol Deviation|0
7717680|NCT01026818|26836774|P2|Screening Period|Protocol Deviation|0
7717681|NCT01026818|26836775|P1|Screening Period|Protocol Deviation|3
7717682|NCT01026818|26836772|P4|Screening Period|Withdrawal by Subject|0
7717683|NCT01026818|26836773|P3|Screening Period|Withdrawal by Subject|0
7717684|NCT01026818|26836774|P2|Screening Period|Withdrawal by Subject|0
7717685|NCT01026818|26836775|P1|Screening Period|Withdrawal by Subject|49
7717686|NCT01026818|26836772|P4|Screening Period|Entry Criteria Not Met|0
7717687|NCT01026818|26836773|P3|Screening Period|Entry Criteria Not Met|0
7717688|NCT01026818|26836774|P2|Screening Period|Entry Criteria Not Met|0
7717689|NCT01026818|26836775|P1|Screening Period|Entry Criteria Not Met|105
7717690|NCT01026792|26836863|P1|Overall Study|Protocol Violation|1
7717691|NCT01026493|26836906|P8|Overall Study|Protocol Violation|1
7717692|NCT01026493|26836907|P7|Overall Study|Protocol Violation|4
7717693|NCT01026493|26836908|P6|Overall Study|Protocol Violation|3
7717694|NCT01026493|26836909|P5|Overall Study|Protocol Violation|2
7717695|NCT01026493|26836910|P4|Overall Study|Protocol Violation|0
7717696|NCT01026493|26836911|P3|Overall Study|Protocol Violation|0
7717697|NCT01026493|26836912|P2|Overall Study|Protocol Violation|1
7717698|NCT01026493|26836913|P1|Overall Study|Protocol Violation|0
7717699|NCT01026454|26836941|P2|Second Intervention|Pregnancy|1
7717700|NCT01026454|26836942|P1|Second Intervention|Pregnancy|1
7717701|NCT01026389|26837291|P2|Overall Study|change of treatment, patient moved|2
7717702|NCT01026389|26837292|P1|Overall Study|change of treatment, patient moved|4
7717703|NCT01026389|26837291|P2|Overall Study|Withdrawal by Subject|3
7717704|NCT01026389|26837292|P1|Overall Study|Withdrawal by Subject|1
7717705|NCT01026324|26837307|P3|Follow up/Survival|Withdrawal by Subject|0
7717706|NCT01026324|26837308|P2|Follow up/Survival|Withdrawal by Subject|0
7717707|NCT01026324|26837309|P1|Follow up/Survival|Withdrawal by Subject|1
7717708|NCT01026220|26837319|P3|Consolidation Maintenance|Withdrawal by Subject|6
7717709|NCT01026220|26837320|P2|Consolidation Maintenance|Withdrawal by Subject|2
7717710|NCT01026220|26837321|P1|Consolidation Maintenance|Withdrawal by Subject|0
7717711|NCT01026220|26837319|P3|Consolidation Maintenance|Physician Decision|7
7717712|NCT01026220|26837320|P2|Consolidation Maintenance|Physician Decision|2
7717713|NCT01026220|26837321|P1|Consolidation Maintenance|Physician Decision|0
7717714|NCT01026220|26837319|P3|Consolidation Maintenance|Lack of Efficacy|1
7717715|NCT01026220|26837320|P2|Consolidation Maintenance|Lack of Efficacy|1
7717716|NCT01026220|26837321|P1|Consolidation Maintenance|Lack of Efficacy|0
7717717|NCT01026220|26837319|P3|Consolidation Maintenance|Death|0
7717718|NCT01026220|26837320|P2|Consolidation Maintenance|Death|1
7717719|NCT01026220|26837321|P1|Consolidation Maintenance|Death|0
7717720|NCT01026220|26837319|P3|Induction|Ineligible|0
7717721|NCT01026220|26837320|P2|Induction|Ineligible|0
7717722|NCT01026220|26837321|P1|Induction|Ineligible|1
7717723|NCT01026220|26837319|P3|Induction|Withdrawal by Subject|0
7717724|NCT01026220|26837320|P2|Induction|Withdrawal by Subject|0
7717725|NCT01026220|26837321|P1|Induction|Withdrawal by Subject|9
7717726|NCT01026220|26837319|P3|Induction|Physician Decision|0
7717727|NCT01026220|26837320|P2|Induction|Physician Decision|0
7717728|NCT01026220|26837321|P1|Induction|Physician Decision|12
7717729|NCT01026220|26837319|P3|Induction|Lack of Efficacy|0
7717730|NCT01026220|26837320|P2|Induction|Lack of Efficacy|0
7717731|NCT01026220|26837321|P1|Induction|Lack of Efficacy|2
7717732|NCT01026220|26837319|P3|Induction|Death|0
7717733|NCT01026220|26837320|P2|Induction|Death|0
7717734|NCT01026220|26837321|P1|Induction|Death|1
7717735|NCT01026194|26837345|P2|Period 2：Open-label Period|Withdrawal by Subject|4
7717736|NCT01026194|26837346|P1|Period 2：Open-label Period|Withdrawal by Subject|0
7717737|NCT01026194|26837345|P2|Period 2：Open-label Period|Physician Decision|1
7717738|NCT01026194|26837346|P1|Period 2：Open-label Period|Physician Decision|3
7717739|NCT01026194|26837345|P2|Period 2：Open-label Period|Adverse Event|5
7717740|NCT01026194|26837346|P1|Period 2：Open-label Period|Adverse Event|4
7717741|NCT01026194|26837345|P2|Period 1：Double Blind Period|Physician Decision|4
7717742|NCT01026194|26837346|P1|Period 1：Double Blind Period|Physician Decision|0
7717743|NCT01026194|26837345|P2|Period 1：Double Blind Period|Lack of Efficacy|0
7717744|NCT01026194|26837346|P1|Period 1：Double Blind Period|Lack of Efficacy|1
7717745|NCT01026194|26837345|P2|Period 1：Double Blind Period|Adverse Event|1
7717746|NCT01026194|26837346|P1|Period 1：Double Blind Period|Adverse Event|2
7717747|NCT01026142|26837378|P2|Overall Study|Withdrew consent or lost to follow-up|29
7717748|NCT01026142|26837379|P1|Overall Study|Withdrew consent or lost to follow-up|36
7717749|NCT01026142|26837378|P2|Overall Study|Death|134
7717750|NCT01026142|26837379|P1|Overall Study|Death|136
7717751|NCT01026103|26837401|P1|Overall Study|did not receive study device bc of error|1
7717752|NCT01026103|26837401|P1|Overall Study|Physician Decision|1
7717753|NCT01026038|26837411|P3|Overall Study|Lost to Follow-up|0
7717754|NCT01026038|26837412|P2|Overall Study|Lost to Follow-up|1
7717755|NCT01026038|26837413|P1|Overall Study|Lost to Follow-up|1
7717756|NCT01025843|26837462|P10|Washout 4|Withdrawal by Subject|0
7717757|NCT01025843|26837463|P9|Washout 4|Withdrawal by Subject|0
7717758|NCT01025843|26837464|P8|Washout 4|Withdrawal by Subject|0
7717759|NCT01025843|26837465|P7|Washout 4|Withdrawal by Subject|0
7717760|NCT01025843|26837466|P6|Washout 4|Withdrawal by Subject|0
7717761|NCT01025843|26837467|P5|Washout 4|Withdrawal by Subject|0
7717762|NCT01025843|26837468|P4|Washout 4|Withdrawal by Subject|1
7717763|NCT01025843|26837469|P3|Washout 4|Withdrawal by Subject|1
7717764|NCT01025843|26837470|P2|Washout 4|Withdrawal by Subject|0
7717765|NCT01025843|26837471|P1|Washout 4|Withdrawal by Subject|0
7717766|NCT01025817|26837565|P2|Completed Study|Lost to Follow-up|1
7717767|NCT01025817|26837566|P1|Completed Study|Lost to Follow-up|0
7717768|NCT01025817|26837565|P2|Completed Study|Missing|0
7717769|NCT01025817|26837566|P1|Completed Study|Missing|2
7717770|NCT01025817|26837565|P2|Completed Study|Death|5
7717771|NCT01025817|26837566|P1|Completed Study|Death|6
7717772|NCT01025817|26837565|P2|Completed Study|Withdrawal by Subject|16
7717773|NCT01025817|26837566|P1|Completed Study|Withdrawal by Subject|8
7717774|NCT01025817|26837565|P2|Completed Study Medication|Lost to Follow-up|1
7717775|NCT01025817|26837566|P1|Completed Study Medication|Lost to Follow-up|0
7717776|NCT01025817|26837565|P2|Completed Study Medication|Subject no longer required study drug|1
7717777|NCT01025817|26837566|P1|Completed Study Medication|Subject no longer required study drug|0
7717778|NCT01025817|26837565|P2|Completed Study Medication|Abnormal lab values|2
7717779|NCT01025817|26837566|P1|Completed Study Medication|Abnormal lab values|0
7717780|NCT01025817|26837565|P2|Completed Study Medication|Death|2
7717781|NCT01025817|26837566|P1|Completed Study Medication|Death|2
7717782|NCT01025817|26837565|P2|Completed Study Medication|Graft loss|5
7717783|NCT01025817|26837566|P1|Completed Study Medication|Graft loss|2
7717784|NCT01025817|26837565|P2|Completed Study Medication|Abnormal test procedure|0
7717785|NCT01025817|26837566|P1|Completed Study Medication|Abnormal test procedure|4
7717786|NCT01025817|26837565|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
7717787|NCT01025817|26837566|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
7717788|NCT01025817|26837565|P2|Completed Study Medication|Administrative problems|5
7717789|NCT01025817|26837566|P1|Completed Study Medication|Administrative problems|7
7717790|NCT01025817|26837565|P2|Completed Study Medication|Withdrawal by Subject|9
7717791|NCT01025817|26837566|P1|Completed Study Medication|Withdrawal by Subject|8
7717792|NCT01025817|26837565|P2|Completed Study Medication|Protocol Deviation|8
7717793|NCT01025817|26837566|P1|Completed Study Medication|Protocol Deviation|9
7717794|NCT01025817|26837565|P2|Completed Study Medication|Adverse Event|39
7717795|NCT01025817|26837566|P1|Completed Study Medication|Adverse Event|66
7717796|NCT01025752|26837732|P2|Overall Study|Physician Decision|3
7717797|NCT01025752|26837733|P1|Overall Study|Physician Decision|1
7717798|NCT01025752|26837732|P2|Overall Study|Lost to Follow-up|10
7717799|NCT01025752|26837733|P1|Overall Study|Lost to Follow-up|7
7717800|NCT01025635|26837753|P2|Overall Study|Reason not known|2
7717801|NCT01025635|26837754|P1|Overall Study|Reason not known|4
7717802|NCT01025635|26837753|P2|Overall Study|Lost to Follow-up|13
7717803|NCT01025635|26837754|P1|Overall Study|Lost to Follow-up|9
7717804|NCT01025635|26837753|P2|Overall Study|Lack of Efficacy|1
7717805|NCT01025635|26837754|P1|Overall Study|Lack of Efficacy|0
7717806|NCT01025635|26837753|P2|Overall Study|Protocol Violation|2
7717807|NCT01025635|26837754|P1|Overall Study|Protocol Violation|4
7717808|NCT01025635|26837753|P2|Overall Study|Withdrawal by Subject|7
7717809|NCT01025635|26837754|P1|Overall Study|Withdrawal by Subject|6
7717810|NCT01025336|26837786|P5|Overall Study|Protocol Violation|0
7717811|NCT01025336|26837787|P4|Overall Study|Protocol Violation|2
7717812|NCT01025336|26837788|P3|Overall Study|Protocol Violation|0
7717813|NCT01025336|26837789|P2|Overall Study|Protocol Violation|0
7717814|NCT01025336|26837790|P1|Overall Study|Protocol Violation|0
7717815|NCT01025284|26837845|P3|Overall Study|Withdrawal by Subject|0
7717816|NCT01025284|26837846|P2|Overall Study|Withdrawal by Subject|1
7717817|NCT01025284|26837847|P1|Overall Study|Withdrawal by Subject|0
7717818|NCT01025284|26837845|P3|Overall Study|Investigator Decision|0
7717819|NCT01025284|26837846|P2|Overall Study|Investigator Decision|1
7717820|NCT01025284|26837847|P1|Overall Study|Investigator Decision|0
7717821|NCT01025232|26837872|P2|Overall Study|Study drug no longer available|6
7717822|NCT01025232|26837873|P1|Overall Study|Study drug no longer available|3
7717823|NCT01025193|26837891|P1|Overall Study|Adverse Event|3
7717824|NCT01025193|26837891|P1|Overall Study|Protocol Violation|1
7717825|NCT01025154|26837901|P1|Overall Study|Withdrawal by Subject|1
7717826|NCT01025154|26837901|P1|Overall Study|Lost to Follow-up|1
7717827|NCT01025037|26837910|P1|Overall Study|Withdrawal by Subject|1
7717828|NCT01025037|26837910|P1|Overall Study|Lost to Follow-up|7
7717829|NCT01025037|26837910|P1|Overall Study|Adverse Event|3
7717830|NCT01024959|26837932|P1|Overall Study|missing results required for analysis|17
7717831|NCT01024959|26837932|P1|Overall Study|results not evaluable|12
7717832|NCT01024959|26837932|P1|Overall Study|ineligible|12
7717833|NCT01024946|26837941|P1|Overall Study|Adverse Event|1
7717834|NCT01024946|26837941|P1|Overall Study|Withdrawal by Subject|1
7717835|NCT01024946|26837941|P1|Overall Study|Screen Failure|3
7717836|NCT01024920|26837947|P2|Overall Study|Protocol Violation|1
7717837|NCT01024920|26837948|P1|Overall Study|Protocol Violation|0
7717838|NCT01024920|26837947|P2|Overall Study|Not treated|0
7717839|NCT01024920|26837948|P1|Overall Study|Not treated|3
7717840|NCT01024920|26837947|P2|Overall Study|Other than listed|1
7717841|NCT01024920|26837948|P1|Overall Study|Other than listed|5
7717842|NCT01024920|26837947|P2|Overall Study|Patient refusal to continue|0
7717843|NCT01024920|26837948|P1|Overall Study|Patient refusal to continue|4
7717844|NCT01024920|26837947|P2|Overall Study|Lost to Follow-up|1
7717845|NCT01024920|26837948|P1|Overall Study|Lost to Follow-up|0
7717846|NCT01024920|26837947|P2|Overall Study|Adverse Event|4
7717847|NCT01024920|26837948|P1|Overall Study|Adverse Event|8
7717848|NCT01024920|26837947|P2|Overall Study|Progressive disease|25
7717849|NCT01024920|26837948|P1|Overall Study|Progressive disease|47
7717850|NCT01024855|26838008|P1|Overall Study|Inclusion/exclusion criteria|1
7717851|NCT01024751|26838015|P2|Eligible Participants|Ineligible|1
7717852|NCT01024751|26838016|P1|Eligible Participants|Ineligible|0
7717853|NCT01024751|26838015|P2|Eligible Participants|Lost to Follow-up|1
7717854|NCT01024751|26838016|P1|Eligible Participants|Lost to Follow-up|0
7717855|NCT01024751|26838015|P2|Eligible Participants|Withdrawal by Subject|1
7717856|NCT01024751|26838016|P1|Eligible Participants|Withdrawal by Subject|0
7717857|NCT01024751|26838015|P2|Enrolled Participants|Ineligible at baseline|4
7717858|NCT01024751|26838016|P1|Enrolled Participants|Ineligible at baseline|3
7717859|NCT01024608|26838073|P2|Overall Study|Never received study treatment|0
7717860|NCT01024608|26838074|P1|Overall Study|Never received study treatment|2
7717861|NCT01024608|26838073|P2|Overall Study|Protocol Violation|3
7717862|NCT01024608|26838074|P1|Overall Study|Protocol Violation|0
7717863|NCT01024608|26838073|P2|Overall Study|Lost to Follow-up|1
7717864|NCT01024608|26838074|P1|Overall Study|Lost to Follow-up|0
7717865|NCT01024608|26838073|P2|Overall Study|Withdrawal by Subject|0
7717866|NCT01024608|26838074|P1|Overall Study|Withdrawal by Subject|1
7717867|NCT01024608|26838073|P2|Overall Study|Adverse Event|0
7717868|NCT01024608|26838074|P1|Overall Study|Adverse Event|1
7717869|NCT01024465|26838103|P1|Overall Study|Physician Decision|1
7717870|NCT01024465|26838103|P1|Overall Study|Adverse Event|2
7717871|NCT01024387|26838107|P1|Overall Study|Other|5
7717872|NCT01024387|26838107|P1|Overall Study|Adverse Event|3
7717873|NCT01024387|26838107|P1|Overall Study|Prolonged Treatment Delay|1
7717874|NCT01024387|26838107|P1|Overall Study|Death|2
7717875|NCT01024387|26838107|P1|Overall Study|Withdrawal by Subject|5
7717876|NCT01024387|26838107|P1|Overall Study|Physician Decision|5
7717877|NCT01024387|26838107|P1|Overall Study|Symptomatic Progression|10
7717878|NCT01024387|26838107|P1|Overall Study|Radiographic Progression|29
7717879|NCT01024309|26838128|P2|Overall Study|Withdrawal by Subject|4
7717880|NCT01024309|26838129|P1|Overall Study|Withdrawal by Subject|4
7717881|NCT01024309|26838128|P2|Overall Study|Physician Decision|0
7717882|NCT01024309|26838129|P1|Overall Study|Physician Decision|4
7717883|NCT01024244|26838161|P5|Overall Study|Withdrawal by Subject|0
7717884|NCT01024244|26838162|P4|Overall Study|Withdrawal by Subject|0
7717885|NCT01024244|26838163|P3|Overall Study|Withdrawal by Subject|0
7717886|NCT01024244|26838164|P2|Overall Study|Withdrawal by Subject|1
7717887|NCT01024244|26838165|P1|Overall Study|Withdrawal by Subject|0
7717888|NCT01024244|26838161|P5|Overall Study|Sponsor Decision|10
7717889|NCT01024244|26838162|P4|Overall Study|Sponsor Decision|12
7717890|NCT01024244|26838163|P3|Overall Study|Sponsor Decision|14
7717891|NCT01024244|26838164|P2|Overall Study|Sponsor Decision|7
7717892|NCT01024244|26838165|P1|Overall Study|Sponsor Decision|14
7717893|NCT01024244|26838161|P5|Overall Study|Protocol Violation|2
7717894|NCT01024244|26838162|P4|Overall Study|Protocol Violation|0
7717895|NCT01024244|26838163|P3|Overall Study|Protocol Violation|0
7717896|NCT01024244|26838164|P2|Overall Study|Protocol Violation|0
7717897|NCT01024244|26838165|P1|Overall Study|Protocol Violation|1
7717898|NCT01024244|26838161|P5|Overall Study|Lack of Efficacy|0
7717899|NCT01024244|26838162|P4|Overall Study|Lack of Efficacy|0
7717900|NCT01024244|26838163|P3|Overall Study|Lack of Efficacy|0
7717901|NCT01024244|26838164|P2|Overall Study|Lack of Efficacy|0
7717902|NCT01024244|26838165|P1|Overall Study|Lack of Efficacy|1
7717903|NCT01024244|26838161|P5|Overall Study|Entry Criteria Not Met|0
7717904|NCT01024244|26838162|P4|Overall Study|Entry Criteria Not Met|0
7717905|NCT01024244|26838163|P3|Overall Study|Entry Criteria Not Met|0
7717906|NCT01024244|26838164|P2|Overall Study|Entry Criteria Not Met|1
7717907|NCT01024244|26838165|P1|Overall Study|Entry Criteria Not Met|0
7717908|NCT01024244|26838161|P5|Overall Study|Adverse Event|2
7717909|NCT01024244|26838162|P4|Overall Study|Adverse Event|1
7717910|NCT01024244|26838163|P3|Overall Study|Adverse Event|0
7717911|NCT01024244|26838164|P2|Overall Study|Adverse Event|2
7717912|NCT01024244|26838165|P1|Overall Study|Adverse Event|1
7717913|NCT01024231|26838284|P7|Overall Study|Continuing on Treatment|0
7717914|NCT01024231|26838285|P6|Overall Study|Continuing on Treatment|2
7717915|NCT01024231|26838286|P5|Overall Study|Continuing on Treatment|3
7717916|NCT01024231|26838287|P4|Overall Study|Continuing on Treatment|0
7717917|NCT01024231|26838288|P3|Overall Study|Continuing on Treatment|0
7717918|NCT01024231|26838289|P2|Overall Study|Continuing on Treatment|0
7717919|NCT01024231|26838290|P1|Overall Study|Continuing on Treatment|0
7717920|NCT01024231|26838284|P7|Overall Study|Withdrew Consent|0
7717921|NCT01024231|26838285|P6|Overall Study|Withdrew Consent|0
7717922|NCT01024231|26838286|P5|Overall Study|Withdrew Consent|0
7717923|NCT01024231|26838287|P4|Overall Study|Withdrew Consent|0
7717924|NCT01024231|26838288|P3|Overall Study|Withdrew Consent|0
7717925|NCT01024231|26838289|P2|Overall Study|Withdrew Consent|1
7717926|NCT01024231|26838290|P1|Overall Study|Withdrew Consent|0
7717927|NCT01024231|26838284|P7|Overall Study|Lost to Follow-up|1
7717928|NCT01024231|26838285|P6|Overall Study|Lost to Follow-up|0
7717929|NCT01024231|26838286|P5|Overall Study|Lost to Follow-up|0
7717930|NCT01024231|26838287|P4|Overall Study|Lost to Follow-up|0
7717931|NCT01024231|26838288|P3|Overall Study|Lost to Follow-up|0
7717932|NCT01024231|26838289|P2|Overall Study|Lost to Follow-up|0
7717933|NCT01024231|26838290|P1|Overall Study|Lost to Follow-up|0
7717934|NCT01024231|26838284|P7|Overall Study|Death|5
7717935|NCT01024231|26838285|P6|Overall Study|Death|3
7717936|NCT01024231|26838286|P5|Overall Study|Death|4
7717937|NCT01024231|26838287|P4|Overall Study|Death|0
7717938|NCT01024231|26838288|P3|Overall Study|Death|1
7717939|NCT01024231|26838289|P2|Overall Study|Death|2
7717940|NCT01024231|26838290|P1|Overall Study|Death|6
7717941|NCT01024231|26838284|P7|Overall Study|Study Drug Toxicity|7
7717942|NCT01024231|26838285|P6|Overall Study|Study Drug Toxicity|0
7717943|NCT01024231|26838286|P5|Overall Study|Study Drug Toxicity|2
7717944|NCT01024231|26838287|P4|Overall Study|Study Drug Toxicity|4
7717945|NCT01024231|26838288|P3|Overall Study|Study Drug Toxicity|6
7717946|NCT01024231|26838289|P2|Overall Study|Study Drug Toxicity|6
7717947|NCT01024231|26838290|P1|Overall Study|Study Drug Toxicity|1
7717948|NCT01024231|26838284|P7|Overall Study|No longer meets criteria|1
7717949|NCT01024231|26838285|P6|Overall Study|No longer meets criteria|0
7717950|NCT01024231|26838286|P5|Overall Study|No longer meets criteria|1
7717951|NCT01024231|26838287|P4|Overall Study|No longer meets criteria|0
7717952|NCT01024231|26838288|P3|Overall Study|No longer meets criteria|0
7717953|NCT01024231|26838289|P2|Overall Study|No longer meets criteria|0
7717954|NCT01024231|26838290|P1|Overall Study|No longer meets criteria|0
7717955|NCT01024231|26838284|P7|Overall Study|AE unrelated to Study Drug|0
7717956|NCT01024231|26838285|P6|Overall Study|AE unrelated to Study Drug|0
7717957|NCT01024231|26838286|P5|Overall Study|AE unrelated to Study Drug|0
7717958|NCT01024231|26838287|P4|Overall Study|AE unrelated to Study Drug|0
7717959|NCT01024231|26838288|P3|Overall Study|AE unrelated to Study Drug|0
7717960|NCT01024231|26838289|P2|Overall Study|AE unrelated to Study Drug|1
7717961|NCT01024231|26838290|P1|Overall Study|AE unrelated to Study Drug|0
7717962|NCT01024231|26838284|P7|Overall Study|Disease Progression|6
7717963|NCT01024231|26838285|P6|Overall Study|Disease Progression|11
7717964|NCT01024231|26838286|P5|Overall Study|Disease Progression|4
7717965|NCT01024231|26838287|P4|Overall Study|Disease Progression|0
7717966|NCT01024231|26838288|P3|Overall Study|Disease Progression|3
7717967|NCT01024231|26838289|P2|Overall Study|Disease Progression|1
7717968|NCT01024231|26838290|P1|Overall Study|Disease Progression|3
7717969|NCT01024231|26838284|P7|Overall Study|Maximum Clinical Benefit|0
7717970|NCT01024231|26838285|P6|Overall Study|Maximum Clinical Benefit|0
7717971|NCT01024231|26838286|P5|Overall Study|Maximum Clinical Benefit|1
7717972|NCT01024231|26838287|P4|Overall Study|Maximum Clinical Benefit|1
7717973|NCT01024231|26838288|P3|Overall Study|Maximum Clinical Benefit|0
7717974|NCT01024231|26838289|P2|Overall Study|Maximum Clinical Benefit|2
7717975|NCT01024231|26838290|P1|Overall Study|Maximum Clinical Benefit|1
7717976|NCT01024231|26838284|P7|Overall Study|Other Reasons|1
7717977|NCT01024231|26838285|P6|Overall Study|Other Reasons|0
7717978|NCT01024231|26838286|P5|Overall Study|Other Reasons|2
7717979|NCT01024231|26838287|P4|Overall Study|Other Reasons|0
7717980|NCT01024231|26838288|P3|Overall Study|Other Reasons|0
7717981|NCT01024231|26838289|P2|Overall Study|Other Reasons|2
7717982|NCT01024231|26838290|P1|Overall Study|Other Reasons|1
7717983|NCT01024036|26838443|P2|Follow-Up Period|Adverse Event|1
7717984|NCT01024036|26838444|P1|Follow-Up Period|Adverse Event|4
7717985|NCT01024036|26838443|P2|Follow-Up Period|Withdrawal by Subject|1
7717986|NCT01024036|26838444|P1|Follow-Up Period|Withdrawal by Subject|0
7717987|NCT01024036|26838443|P2|Follow-Up Period|Lost to Follow-up|1
7717988|NCT01024036|26838444|P1|Follow-Up Period|Lost to Follow-up|1
7717989|NCT01024036|26838443|P2|Unblinded Treatment|Lack of Efficacy|2
7717990|NCT01024036|26838444|P1|Unblinded Treatment|Lack of Efficacy|0
7717991|NCT01024036|26838443|P2|Unblinded Treatment|Adverse Event|1
7717992|NCT01024036|26838444|P1|Unblinded Treatment|Adverse Event|0
7717993|NCT01024036|26838443|P2|Blinded Treatment|Withdrawal by Subject|3
7717994|NCT01024036|26838444|P1|Blinded Treatment|Withdrawal by Subject|4
7717995|NCT01024036|26838443|P2|Blinded Treatment|Death|2
7717996|NCT01024036|26838444|P1|Blinded Treatment|Death|0
7717997|NCT01024036|26838443|P2|Blinded Treatment|Physician Decision|0
7717998|NCT01024036|26838444|P1|Blinded Treatment|Physician Decision|1
7717999|NCT01024036|26838443|P2|Blinded Treatment|Lack of Efficacy|14
7718000|NCT01024036|26838444|P1|Blinded Treatment|Lack of Efficacy|16
7718001|NCT01024036|26838443|P2|Blinded Treatment|Adverse Event|1
7718002|NCT01024036|26838444|P1|Blinded Treatment|Adverse Event|1
7718003|NCT01023958|26838491|P1|Overall Study|Refused to continue medication|1
7718004|NCT01023958|26838491|P1|Overall Study|Other adverse event|1
7718005|NCT01023958|26838491|P1|Overall Study|Progressive disease|48
7718006|NCT01023815|26838539|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7718007|NCT01023815|26838540|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7718008|NCT01023815|26838541|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
7718009|NCT01023815|26838542|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7718010|NCT01023815|26838539|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
7718011|NCT01023815|26838540|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
7718012|NCT01023815|26838541|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
7718013|NCT01023815|26838542|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
7718014|NCT01023815|26838539|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
7718015|NCT01023815|26838540|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
7718016|NCT01023815|26838541|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
7718017|NCT01023815|26838542|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
7718018|NCT01023815|26838539|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
7718019|NCT01023815|26838540|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
7718020|NCT01023815|26838541|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
7718021|NCT01023815|26838542|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
7718022|NCT01023815|26838539|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7718023|NCT01023815|26838540|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7718024|NCT01023815|26838541|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7718025|NCT01023815|26838542|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
7718026|NCT01023789|26838561|P1|3 - Year Visit|Lost to Follow-up|13
7718027|NCT01023789|26838561|P1|3 - Year Visit|Withdrawal of consent|1
7718028|NCT01023789|26838561|P1|3 - Year Visit|Death|29
7718029|NCT01023672|26838647|P1|Overall Study|Death|1
7718030|NCT01023672|26838647|P1|Overall Study|Worsening disease|2
7718031|NCT01023659|26838654|P3|Overall Study|Lost to Follow-up|99
7718032|NCT01023659|26838655|P2|Overall Study|Lost to Follow-up|228
7718033|NCT01023659|26838656|P1|Overall Study|Lost to Follow-up|73
7718034|NCT01023581|26838683|P7|Overall Study|Other|0
7718035|NCT01023581|26838684|P6|Overall Study|Other|0
7718036|NCT01023581|26838685|P5|Overall Study|Other|1
7718037|NCT01023581|26838686|P4|Overall Study|Other|0
7718038|NCT01023581|26838687|P3|Overall Study|Other|1
7718039|NCT01023581|26838688|P2|Overall Study|Other|0
7718040|NCT01023581|26838689|P1|Overall Study|Other|1
7718041|NCT01023581|26838683|P7|Overall Study|Physician Decision|1
7718042|NCT01023581|26838684|P6|Overall Study|Physician Decision|1
7718043|NCT01023581|26838685|P5|Overall Study|Physician Decision|1
7718044|NCT01023581|26838686|P4|Overall Study|Physician Decision|1
7718045|NCT01023581|26838687|P3|Overall Study|Physician Decision|2
7718046|NCT01023581|26838688|P2|Overall Study|Physician Decision|0
7718047|NCT01023581|26838689|P1|Overall Study|Physician Decision|2
7718048|NCT01023581|26838683|P7|Overall Study|Lack of Efficacy|1
7718049|NCT01023581|26838684|P6|Overall Study|Lack of Efficacy|2
7718050|NCT01023581|26838685|P5|Overall Study|Lack of Efficacy|1
7718051|NCT01023581|26838686|P4|Overall Study|Lack of Efficacy|2
7718052|NCT01023581|26838687|P3|Overall Study|Lack of Efficacy|6
7718053|NCT01023581|26838688|P2|Overall Study|Lack of Efficacy|3
7718054|NCT01023581|26838689|P1|Overall Study|Lack of Efficacy|9
7718055|NCT01023581|26838683|P7|Overall Study|Pregnancy|0
7718056|NCT01023581|26838684|P6|Overall Study|Pregnancy|1
7718057|NCT01023581|26838685|P5|Overall Study|Pregnancy|0
7718058|NCT01023581|26838686|P4|Overall Study|Pregnancy|2
7718059|NCT01023581|26838687|P3|Overall Study|Pregnancy|0
7718060|NCT01023581|26838688|P2|Overall Study|Pregnancy|0
7718061|NCT01023581|26838689|P1|Overall Study|Pregnancy|0
7718062|NCT01023581|26838683|P7|Overall Study|Withdrawal by Subject|5
7718063|NCT01023581|26838684|P6|Overall Study|Withdrawal by Subject|8
7718064|NCT01023581|26838685|P5|Overall Study|Withdrawal by Subject|6
7718065|NCT01023581|26838686|P4|Overall Study|Withdrawal by Subject|10
7718066|NCT01023581|26838687|P3|Overall Study|Withdrawal by Subject|16
7718067|NCT01023581|26838688|P2|Overall Study|Withdrawal by Subject|8
7718068|NCT01023581|26838689|P1|Overall Study|Withdrawal by Subject|13
7718069|NCT01023581|26838683|P7|Overall Study|Lost to Follow-up|2
7718070|NCT01023581|26838684|P6|Overall Study|Lost to Follow-up|2
7718071|NCT01023581|26838685|P5|Overall Study|Lost to Follow-up|5
7718072|NCT01023581|26838686|P4|Overall Study|Lost to Follow-up|2
7718073|NCT01023581|26838687|P3|Overall Study|Lost to Follow-up|7
7718074|NCT01023581|26838688|P2|Overall Study|Lost to Follow-up|8
7718075|NCT01023581|26838689|P1|Overall Study|Lost to Follow-up|4
7718076|NCT01023581|26838683|P7|Overall Study|Major protocol deviation|0
7718077|NCT01023581|26838684|P6|Overall Study|Major protocol deviation|0
7718078|NCT01023581|26838685|P5|Overall Study|Major protocol deviation|0
7718079|NCT01023581|26838686|P4|Overall Study|Major protocol deviation|0
7718080|NCT01023581|26838687|P3|Overall Study|Major protocol deviation|3
7718081|NCT01023581|26838688|P2|Overall Study|Major protocol deviation|0
7718082|NCT01023581|26838689|P1|Overall Study|Major protocol deviation|2
7718083|NCT01023581|26838683|P7|Overall Study|Adverse Event|11
7718084|NCT01023581|26838684|P6|Overall Study|Adverse Event|5
7718085|NCT01023581|26838685|P5|Overall Study|Adverse Event|2
7718086|NCT01023581|26838686|P4|Overall Study|Adverse Event|3
7718087|NCT01023581|26838687|P3|Overall Study|Adverse Event|7
7718088|NCT01023581|26838688|P2|Overall Study|Adverse Event|4
7718089|NCT01023581|26838689|P1|Overall Study|Adverse Event|4
7718090|NCT01023516|26838746|P2|Overall Study|Incorrect enrolment|2
7718091|NCT01023516|26838747|P1|Overall Study|Incorrect enrolment|4
7718092|NCT01023516|26838746|P2|Overall Study|Study-specific criteria|2
7718093|NCT01023516|26838747|P1|Overall Study|Study-specific criteria|4
7718094|NCT01023516|26838746|P2|Overall Study|Safety reason|3
7718095|NCT01023516|26838747|P1|Overall Study|Safety reason|0
7718096|NCT01023516|26838746|P2|Overall Study|Adverse Event|6
7718097|NCT01023516|26838747|P1|Overall Study|Adverse Event|9
7718098|NCT01023516|26838746|P2|Overall Study|Voluntary discontinuation|5
7718099|NCT01023516|26838747|P1|Overall Study|Voluntary discontinuation|7
7718100|NCT01023308|26838844|P2|Overall Study|Withdrawal by Subject|18
7718101|NCT01023308|26838845|P1|Overall Study|Withdrawal by Subject|34
7718102|NCT01023308|26838844|P2|Overall Study|Lost to Follow-up|0
7718103|NCT01023308|26838845|P1|Overall Study|Lost to Follow-up|1
7718104|NCT01023308|26838844|P2|Overall Study|Untreated|5
7718105|NCT01023308|26838845|P1|Overall Study|Untreated|5
7718106|NCT01023308|26838844|P2|Overall Study|Protocol Violation|4
7718107|NCT01023308|26838845|P1|Overall Study|Protocol Violation|3
7718108|NCT01023308|26838844|P2|Overall Study|New Cancer therapy|7
7718109|NCT01023308|26838845|P1|Overall Study|New Cancer therapy|4
7718110|NCT01023308|26838844|P2|Overall Study|Disease progression|153
7718111|NCT01023308|26838845|P1|Overall Study|Disease progression|82
7718112|NCT01023308|26838844|P2|Overall Study|Death|17
7718113|NCT01023308|26838845|P1|Overall Study|Death|21
7718114|NCT01023308|26838844|P2|Overall Study|Adverse Event|66
7718115|NCT01023308|26838845|P1|Overall Study|Adverse Event|130
7718116|NCT01023308|26838844|P2|Overall Study|Administrative problems|1
7718117|NCT01023308|26838845|P1|Overall Study|Administrative problems|2
7718118|NCT01023308|26838844|P2|Overall Study|Abnormal test proceedure results|8
7718119|NCT01023308|26838845|P1|Overall Study|Abnormal test proceedure results|3
7718120|NCT01023269|26838871|P2|Overall Study|early termination of the study|0
7718121|NCT01023269|26838872|P1|Overall Study|early termination of the study|2
7718122|NCT01023256|26838880|P4|Overall Study|Withdrawal by Subject|2
7718123|NCT01023256|26838881|P3|Overall Study|Withdrawal by Subject|0
7718124|NCT01023256|26838882|P2|Overall Study|Withdrawal by Subject|0
7718125|NCT01023256|26838883|P1|Overall Study|Withdrawal by Subject|0
7718126|NCT01023256|26838880|P4|Overall Study|Adverse Event|1
7718127|NCT01023256|26838881|P3|Overall Study|Adverse Event|0
7718128|NCT01023256|26838882|P2|Overall Study|Adverse Event|0
7718129|NCT01023256|26838883|P1|Overall Study|Adverse Event|0
7718130|NCT01023256|26838880|P4|Overall Study|Other|2
7718131|NCT01023256|26838881|P3|Overall Study|Other|0
7718132|NCT01023256|26838882|P2|Overall Study|Other|0
7718133|NCT01023256|26838883|P1|Overall Study|Other|1
7718134|NCT01023256|26838880|P4|Overall Study|Randomized but not treated|0
7718135|NCT01023256|26838881|P3|Overall Study|Randomized but not treated|1
7718136|NCT01023256|26838882|P2|Overall Study|Randomized but not treated|0
7718137|NCT01023256|26838883|P1|Overall Study|Randomized but not treated|1
7718138|NCT01023256|26838880|P4|Overall Study|Protocol Violation|0
7718139|NCT01023256|26838881|P3|Overall Study|Protocol Violation|0
7718140|NCT01023256|26838882|P2|Overall Study|Protocol Violation|3
7718141|NCT01023256|26838883|P1|Overall Study|Protocol Violation|2
7718142|NCT01023217|26838925|P2|Overall Study|Withdrawal by Subject|0
7718143|NCT01023217|26838926|P1|Overall Study|Withdrawal by Subject|1
7718144|NCT01023061|26838964|P1|Overall Study|Withdrawal prior to treatment|2
7718145|NCT01023035|26838973|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
7718146|NCT01023035|26838974|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
7718147|NCT01023035|26838975|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
7718148|NCT01023035|26838973|P3|Follow-up Period (up to Week 72)|Adverse Event|1
7718149|NCT01023035|26838974|P2|Follow-up Period (up to Week 72)|Adverse Event|0
7718150|NCT01023035|26838975|P1|Follow-up Period (up to Week 72)|Adverse Event|2
7718151|NCT01023035|26838973|P3|Treatment Period|Treatment Failure|24
7718152|NCT01023035|26838974|P2|Treatment Period|Treatment Failure|31
7718153|NCT01023035|26838975|P1|Treatment Period|Treatment Failure|26
7718154|NCT01023035|26838973|P3|Treatment Period|Non-Medical Reasons|44
7718155|NCT01023035|26838974|P2|Treatment Period|Non-Medical Reasons|22
7718156|NCT01023035|26838975|P1|Treatment Period|Non-Medical Reasons|19
7718157|NCT01023035|26838973|P3|Treatment Period|Adverse Event|50
7718158|NCT01023035|26838974|P2|Treatment Period|Adverse Event|32
7718159|NCT01023035|26838975|P1|Treatment Period|Adverse Event|27
7718160|NCT01023022|26838985|P1|Overall Study|due to technical issues|2
7718161|NCT01023022|26838985|P1|Overall Study|Lost to Follow-up|7
7718162|NCT01023022|26838985|P1|Overall Study|Death|5
7718163|NCT01022996|26838991|P1|Overall Study|Protocol Violation|1
7718164|NCT01022996|26838991|P1|Overall Study|Disease Progression|32
7718165|NCT01022996|26838991|P1|Overall Study|Administrative problems|6
7718166|NCT01022996|26838991|P1|Overall Study|Lost to Follow-up|1
7718167|NCT01022996|26838991|P1|Overall Study|Withdrawal by Subject|3
7718168|NCT01022996|26838991|P1|Overall Study|Adverse Event|14
7718169|NCT01022853|26839005|P5|Overall Study|Other not stated above|0
7718170|NCT01022853|26839006|P4|Overall Study|Other not stated above|0
7718171|NCT01022853|26839007|P3|Overall Study|Other not stated above|1
7718172|NCT01022853|26839008|P2|Overall Study|Other not stated above|0
7718173|NCT01022853|26839009|P1|Overall Study|Other not stated above|1
7718174|NCT01022853|26839005|P5|Overall Study|Withdrawal by Subject|0
7718175|NCT01022853|26839006|P4|Overall Study|Withdrawal by Subject|1
7718176|NCT01022853|26839007|P3|Overall Study|Withdrawal by Subject|1
7718177|NCT01022853|26839008|P2|Overall Study|Withdrawal by Subject|1
7718178|NCT01022853|26839009|P1|Overall Study|Withdrawal by Subject|0
7718179|NCT01022853|26839005|P5|Overall Study|Dose-limiting toxicity|1
7718180|NCT01022853|26839006|P4|Overall Study|Dose-limiting toxicity|0
7718181|NCT01022853|26839007|P3|Overall Study|Dose-limiting toxicity|0
7718182|NCT01022853|26839008|P2|Overall Study|Dose-limiting toxicity|0
7718183|NCT01022853|26839009|P1|Overall Study|Dose-limiting toxicity|0
7718184|NCT01022853|26839005|P5|Overall Study|Progressive disease|1
7718185|NCT01022853|26839006|P4|Overall Study|Progressive disease|7
7718186|NCT01022853|26839007|P3|Overall Study|Progressive disease|11
7718187|NCT01022853|26839008|P2|Overall Study|Progressive disease|3
7718188|NCT01022853|26839009|P1|Overall Study|Progressive disease|2
7718189|NCT01022762|26839088|P2|Overall Study|Unclassified|20
7718190|NCT01022762|26839089|P1|Overall Study|Unclassified|12
7718191|NCT01022762|26839088|P2|Overall Study|Protocol Violation|6
7718192|NCT01022762|26839089|P1|Overall Study|Protocol Violation|7
7718193|NCT01022762|26839088|P2|Overall Study|Lack of Efficacy|1
7718194|NCT01022762|26839089|P1|Overall Study|Lack of Efficacy|0
7718195|NCT01022762|26839088|P2|Overall Study|Adverse Event|1
7718196|NCT01022762|26839089|P1|Overall Study|Adverse Event|3
7718197|NCT01022580|26839117|P2|Overall Study|Death|22
7718198|NCT01022580|26839118|P1|Overall Study|Death|18
7718199|NCT01022502|26839141|P1|Overall Study|Withdrawal by Subject|1
7718200|NCT01022502|26839141|P1|Overall Study|employment related reasons|1
7718201|NCT01022502|26839141|P1|Overall Study|Adverse Event|1
7718202|NCT01022424|26839155|P1|Overall Study|eGFR under the withdrawal criteria|2
7718203|NCT01022424|26839155|P1|Overall Study|Physician Decision|1
7718204|NCT01022424|26839155|P1|Overall Study|Adverse Event|1
7718205|NCT01022398|26839170|P2|Overall Study|Study terminated|2
7718206|NCT01022398|26839171|P1|Overall Study|Study terminated|2
7718207|NCT01022203|26839217|P2|Follow-Up Assessment|Lost to Follow-up|2
7718208|NCT01022203|26839218|P1|Follow-Up Assessment|Lost to Follow-up|2
7718209|NCT01022203|26839217|P2|Post Treatment Assessment|Adverse Event|2
7718210|NCT01022203|26839218|P1|Post Treatment Assessment|Adverse Event|0
7718211|NCT01022203|26839217|P2|Post Treatment Assessment|Physician Decision|0
7718212|NCT01022203|26839218|P1|Post Treatment Assessment|Physician Decision|2
7718213|NCT01022203|26839217|P2|Post Treatment Assessment|Withdrawal by Subject|12
7718214|NCT01022203|26839218|P1|Post Treatment Assessment|Withdrawal by Subject|12
7718215|NCT01022112|26839237|P5|Overall Study|Fasting plasma glucose level increased|7
7718216|NCT01022112|26839238|P4|Overall Study|Fasting plasma glucose level increased|0
7718217|NCT01022112|26839239|P3|Overall Study|Fasting plasma glucose level increased|0
7718218|NCT01022112|26839240|P2|Overall Study|Fasting plasma glucose level increased|0
7718219|NCT01022112|26839241|P1|Overall Study|Fasting plasma glucose level increased|1
7718220|NCT01022112|26839237|P5|Overall Study|Withdrawal by Subject|1
7718221|NCT01022112|26839238|P4|Overall Study|Withdrawal by Subject|2
7718222|NCT01022112|26839239|P3|Overall Study|Withdrawal by Subject|2
7718223|NCT01022112|26839240|P2|Overall Study|Withdrawal by Subject|1
7718224|NCT01022112|26839241|P1|Overall Study|Withdrawal by Subject|0
7718225|NCT01022112|26839237|P5|Overall Study|Physician Decision|1
7718226|NCT01022112|26839238|P4|Overall Study|Physician Decision|0
7718227|NCT01022112|26839239|P3|Overall Study|Physician Decision|1
7718228|NCT01022112|26839240|P2|Overall Study|Physician Decision|0
7718229|NCT01022112|26839241|P1|Overall Study|Physician Decision|0
7718230|NCT01022112|26839237|P5|Overall Study|Lack of Efficacy|1
7718231|NCT01022112|26839238|P4|Overall Study|Lack of Efficacy|0
7718232|NCT01022112|26839239|P3|Overall Study|Lack of Efficacy|0
7718233|NCT01022112|26839240|P2|Overall Study|Lack of Efficacy|0
7718234|NCT01022112|26839241|P1|Overall Study|Lack of Efficacy|1
7718235|NCT01022112|26839237|P5|Overall Study|Adverse Event|0
7718236|NCT01022112|26839238|P4|Overall Study|Adverse Event|1
7718237|NCT01022112|26839239|P3|Overall Study|Adverse Event|0
7718238|NCT01022112|26839240|P2|Overall Study|Adverse Event|2
7718239|NCT01022112|26839241|P1|Overall Study|Adverse Event|1
7718240|NCT01021878|26839290|P2|Overall Study|Transplantation|1
7718241|NCT01021878|26839291|P1|Overall Study|Transplantation|6
7718242|NCT01021878|26839290|P2|Overall Study|Adverse Event|5
7718243|NCT01021878|26839291|P1|Overall Study|Adverse Event|6
7718244|NCT01021878|26839290|P2|Overall Study|Death|1
7718245|NCT01021878|26839291|P1|Overall Study|Death|0
7718246|NCT01021878|26839290|P2|Overall Study|Lost to Follow-up|3
7718247|NCT01021878|26839291|P1|Overall Study|Lost to Follow-up|4
7718248|NCT01021852|26839313|P8|Treatment Period 2|Withdrawal by Subject|2
7718249|NCT01021852|26839314|P7|Treatment Period 2|Withdrawal by Subject|1
7718250|NCT01021852|26839315|P6|Treatment Period 2|Withdrawal by Subject|0
7718251|NCT01021852|26839316|P5|Treatment Period 2|Withdrawal by Subject|0
7718252|NCT01021852|26839317|P4|Treatment Period 2|Withdrawal by Subject|0
7718253|NCT01021852|26839318|P3|Treatment Period 2|Withdrawal by Subject|0
7718254|NCT01021852|26839319|P2|Treatment Period 2|Withdrawal by Subject|0
7718255|NCT01021852|26839320|P1|Treatment Period 2|Withdrawal by Subject|0
7718256|NCT01021852|26839313|P8|Treatment Period 2|Protocol Violation|0
7718257|NCT01021852|26839314|P7|Treatment Period 2|Protocol Violation|1
7718258|NCT01021852|26839315|P6|Treatment Period 2|Protocol Violation|0
7718259|NCT01021852|26839316|P5|Treatment Period 2|Protocol Violation|1
7718260|NCT01021852|26839317|P4|Treatment Period 2|Protocol Violation|0
7718261|NCT01021852|26839318|P3|Treatment Period 2|Protocol Violation|0
7718262|NCT01021852|26839319|P2|Treatment Period 2|Protocol Violation|0
7718263|NCT01021852|26839320|P1|Treatment Period 2|Protocol Violation|0
7718264|NCT01021852|26839313|P8|Treatment Period 2|Physician Decision|0
7718265|NCT01021852|26839314|P7|Treatment Period 2|Physician Decision|0
7718266|NCT01021852|26839315|P6|Treatment Period 2|Physician Decision|0
7718267|NCT01021852|26839316|P5|Treatment Period 2|Physician Decision|0
7718268|NCT01021852|26839317|P4|Treatment Period 2|Physician Decision|0
7718269|NCT01021852|26839318|P3|Treatment Period 2|Physician Decision|1
7718270|NCT01021852|26839319|P2|Treatment Period 2|Physician Decision|0
7718271|NCT01021852|26839320|P1|Treatment Period 2|Physician Decision|0
7718272|NCT01021852|26839313|P8|Treatment Period 2|Lack of Efficacy|0
7718273|NCT01021852|26839314|P7|Treatment Period 2|Lack of Efficacy|0
7718274|NCT01021852|26839315|P6|Treatment Period 2|Lack of Efficacy|1
7718275|NCT01021852|26839316|P5|Treatment Period 2|Lack of Efficacy|0
7718276|NCT01021852|26839317|P4|Treatment Period 2|Lack of Efficacy|0
7718277|NCT01021852|26839318|P3|Treatment Period 2|Lack of Efficacy|0
7718278|NCT01021852|26839319|P2|Treatment Period 2|Lack of Efficacy|0
7718279|NCT01021852|26839320|P1|Treatment Period 2|Lack of Efficacy|0
7718280|NCT01021852|26839313|P8|Treatment Period 2|Adverse Event|0
7718281|NCT01021852|26839314|P7|Treatment Period 2|Adverse Event|1
7718282|NCT01021852|26839315|P6|Treatment Period 2|Adverse Event|0
7718283|NCT01021852|26839316|P5|Treatment Period 2|Adverse Event|1
7718284|NCT01021852|26839317|P4|Treatment Period 2|Adverse Event|0
7718285|NCT01021852|26839318|P3|Treatment Period 2|Adverse Event|0
7718286|NCT01021852|26839319|P2|Treatment Period 2|Adverse Event|1
7718287|NCT01021852|26839320|P1|Treatment Period 2|Adverse Event|0
7718288|NCT01021852|26839313|P8|Washout Period-No Drug|Adverse Event|0
7718289|NCT01021852|26839314|P7|Washout Period-No Drug|Adverse Event|0
7718290|NCT01021852|26839315|P6|Washout Period-No Drug|Adverse Event|1
7718291|NCT01021852|26839316|P5|Washout Period-No Drug|Adverse Event|0
7718292|NCT01021852|26839317|P4|Washout Period-No Drug|Adverse Event|0
7718293|NCT01021852|26839318|P3|Washout Period-No Drug|Adverse Event|0
7718294|NCT01021852|26839319|P2|Washout Period-No Drug|Adverse Event|0
7718295|NCT01021852|26839320|P1|Washout Period-No Drug|Adverse Event|1
7718296|NCT01021852|26839313|P8|Washout Period-Placebo|Protocol Violation|0
7718297|NCT01021852|26839314|P7|Washout Period-Placebo|Protocol Violation|1
7718298|NCT01021852|26839315|P6|Washout Period-Placebo|Protocol Violation|0
7718299|NCT01021852|26839316|P5|Washout Period-Placebo|Protocol Violation|0
7718300|NCT01021852|26839317|P4|Washout Period-Placebo|Protocol Violation|0
7718301|NCT01021852|26839318|P3|Washout Period-Placebo|Protocol Violation|0
7718302|NCT01021852|26839319|P2|Washout Period-Placebo|Protocol Violation|0
7718303|NCT01021852|26839320|P1|Washout Period-Placebo|Protocol Violation|0
7718304|NCT01021852|26839313|P8|Washout Period-Placebo|Lost to Follow-up|0
7718305|NCT01021852|26839314|P7|Washout Period-Placebo|Lost to Follow-up|0
7718306|NCT01021852|26839315|P6|Washout Period-Placebo|Lost to Follow-up|0
7718307|NCT01021852|26839316|P5|Washout Period-Placebo|Lost to Follow-up|1
7718308|NCT01021852|26839317|P4|Washout Period-Placebo|Lost to Follow-up|0
7718309|NCT01021852|26839318|P3|Washout Period-Placebo|Lost to Follow-up|0
7718310|NCT01021852|26839319|P2|Washout Period-Placebo|Lost to Follow-up|0
7718311|NCT01021852|26839320|P1|Washout Period-Placebo|Lost to Follow-up|0
7718312|NCT01021852|26839313|P8|Washout Period-Placebo|Adverse Event|0
7718313|NCT01021852|26839314|P7|Washout Period-Placebo|Adverse Event|0
7718314|NCT01021852|26839315|P6|Washout Period-Placebo|Adverse Event|1
7718315|NCT01021852|26839316|P5|Washout Period-Placebo|Adverse Event|0
7718316|NCT01021852|26839317|P4|Washout Period-Placebo|Adverse Event|1
7718317|NCT01021852|26839318|P3|Washout Period-Placebo|Adverse Event|0
7718318|NCT01021852|26839319|P2|Washout Period-Placebo|Adverse Event|0
7718319|NCT01021852|26839320|P1|Washout Period-Placebo|Adverse Event|0
7718320|NCT01021852|26839313|P8|Treatment Period 1|Not Treated|0
7718321|NCT01021852|26839314|P7|Treatment Period 1|Not Treated|0
7718322|NCT01021852|26839315|P6|Treatment Period 1|Not Treated|0
7718323|NCT01021852|26839316|P5|Treatment Period 1|Not Treated|0
7718324|NCT01021852|26839317|P4|Treatment Period 1|Not Treated|2
7718325|NCT01021852|26839318|P3|Treatment Period 1|Not Treated|0
7718326|NCT01021852|26839319|P2|Treatment Period 1|Not Treated|0
7718327|NCT01021852|26839320|P1|Treatment Period 1|Not Treated|0
7718328|NCT01021852|26839313|P8|Treatment Period 1|Withdrawal by Subject|1
7718329|NCT01021852|26839314|P7|Treatment Period 1|Withdrawal by Subject|0
7718330|NCT01021852|26839315|P6|Treatment Period 1|Withdrawal by Subject|0
7718331|NCT01021852|26839316|P5|Treatment Period 1|Withdrawal by Subject|1
7718332|NCT01021852|26839317|P4|Treatment Period 1|Withdrawal by Subject|0
7718333|NCT01021852|26839318|P3|Treatment Period 1|Withdrawal by Subject|0
7718334|NCT01021852|26839319|P2|Treatment Period 1|Withdrawal by Subject|0
7718335|NCT01021852|26839320|P1|Treatment Period 1|Withdrawal by Subject|0
7718336|NCT01021852|26839313|P8|Treatment Period 1|Pregnancy|0
7718337|NCT01021852|26839314|P7|Treatment Period 1|Pregnancy|0
7718338|NCT01021852|26839315|P6|Treatment Period 1|Pregnancy|0
7718339|NCT01021852|26839316|P5|Treatment Period 1|Pregnancy|0
7718340|NCT01021852|26839317|P4|Treatment Period 1|Pregnancy|0
7718341|NCT01021852|26839318|P3|Treatment Period 1|Pregnancy|1
7718342|NCT01021852|26839319|P2|Treatment Period 1|Pregnancy|0
7718343|NCT01021852|26839320|P1|Treatment Period 1|Pregnancy|0
7718344|NCT01021852|26839313|P8|Treatment Period 1|Adverse Event|0
7718345|NCT01021852|26839314|P7|Treatment Period 1|Adverse Event|0
7718346|NCT01021852|26839315|P6|Treatment Period 1|Adverse Event|2
7718347|NCT01021852|26839316|P5|Treatment Period 1|Adverse Event|2
7718348|NCT01021852|26839317|P4|Treatment Period 1|Adverse Event|0
7718349|NCT01021852|26839318|P3|Treatment Period 1|Adverse Event|1
7718350|NCT01021852|26839319|P2|Treatment Period 1|Adverse Event|1
7718351|NCT01021852|26839320|P1|Treatment Period 1|Adverse Event|3
7718352|NCT01021813|26839356|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
7718353|NCT01021813|26839357|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
7718354|NCT01021813|26839358|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
7718355|NCT01021813|26839359|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
7718356|NCT01021813|26839360|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
7718357|NCT01021813|26839356|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
7718358|NCT01021813|26839357|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
7718359|NCT01021813|26839358|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
7718360|NCT01021813|26839359|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
7718361|NCT01021813|26839360|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
7718362|NCT01021813|26839356|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
7718363|NCT01021813|26839357|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7718364|NCT01021813|26839358|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7718365|NCT01021813|26839359|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7718366|NCT01021813|26839360|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7718367|NCT01021813|26839356|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7718368|NCT01021813|26839357|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
7718369|NCT01021813|26839358|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7718370|NCT01021813|26839359|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7718371|NCT01021813|26839360|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7718372|NCT01021813|26839356|P5|DB Randomized Discontinuation Phase|Adverse Event|1
7718373|NCT01021813|26839357|P4|DB Randomized Discontinuation Phase|Adverse Event|3
7718374|NCT01021813|26839358|P3|DB Randomized Discontinuation Phase|Adverse Event|0
7718375|NCT01021813|26839359|P2|DB Randomized Discontinuation Phase|Adverse Event|0
7718376|NCT01021813|26839360|P1|DB Randomized Discontinuation Phase|Adverse Event|0
7718377|NCT01021813|26839356|P5|DB Treatment Phase|Withdrawal by Subject|0
7718378|NCT01021813|26839357|P4|DB Treatment Phase|Withdrawal by Subject|0
7718379|NCT01021813|26839358|P3|DB Treatment Phase|Withdrawal by Subject|0
7718380|NCT01021813|26839359|P2|DB Treatment Phase|Withdrawal by Subject|24
7718381|NCT01021813|26839360|P1|DB Treatment Phase|Withdrawal by Subject|60
7718382|NCT01021813|26839356|P5|DB Treatment Phase|Protocol Violation|0
7718383|NCT01021813|26839357|P4|DB Treatment Phase|Protocol Violation|0
7718384|NCT01021813|26839358|P3|DB Treatment Phase|Protocol Violation|0
7718385|NCT01021813|26839359|P2|DB Treatment Phase|Protocol Violation|3
7718386|NCT01021813|26839360|P1|DB Treatment Phase|Protocol Violation|4
7718387|NCT01021813|26839356|P5|DB Treatment Phase|Pregnancy|0
7718388|NCT01021813|26839357|P4|DB Treatment Phase|Pregnancy|0
7718389|NCT01021813|26839358|P3|DB Treatment Phase|Pregnancy|0
7718390|NCT01021813|26839359|P2|DB Treatment Phase|Pregnancy|0
7718391|NCT01021813|26839360|P1|DB Treatment Phase|Pregnancy|1
7718392|NCT01021813|26839356|P5|DB Treatment Phase|Physician Decision|0
7718393|NCT01021813|26839357|P4|DB Treatment Phase|Physician Decision|0
7718394|NCT01021813|26839358|P3|DB Treatment Phase|Physician Decision|0
7718395|NCT01021813|26839359|P2|DB Treatment Phase|Physician Decision|8
7718396|NCT01021813|26839360|P1|DB Treatment Phase|Physician Decision|17
7718397|NCT01021813|26839356|P5|DB Treatment Phase|Lost to Follow-up|0
7718398|NCT01021813|26839357|P4|DB Treatment Phase|Lost to Follow-up|0
7718399|NCT01021813|26839358|P3|DB Treatment Phase|Lost to Follow-up|0
7718400|NCT01021813|26839359|P2|DB Treatment Phase|Lost to Follow-up|12
7718401|NCT01021813|26839360|P1|DB Treatment Phase|Lost to Follow-up|14
7718402|NCT01021813|26839356|P5|DB Treatment Phase|Lack of Efficacy|0
7718403|NCT01021813|26839357|P4|DB Treatment Phase|Lack of Efficacy|0
7718404|NCT01021813|26839358|P3|DB Treatment Phase|Lack of Efficacy|0
7718405|NCT01021813|26839359|P2|DB Treatment Phase|Lack of Efficacy|28
7718406|NCT01021813|26839360|P1|DB Treatment Phase|Lack of Efficacy|44
7718407|NCT01021813|26839356|P5|DB Treatment Phase|Adverse Event|0
7718408|NCT01021813|26839357|P4|DB Treatment Phase|Adverse Event|0
7718409|NCT01021813|26839358|P3|DB Treatment Phase|Adverse Event|0
7718410|NCT01021813|26839359|P2|DB Treatment Phase|Adverse Event|22
7718411|NCT01021813|26839360|P1|DB Treatment Phase|Adverse Event|60
7718412|NCT01021748|26839421|P9|Overall Study|Not Treated|0
7718413|NCT01021748|26839422|P8|Overall Study|Not Treated|0
7718414|NCT01021748|26839423|P7|Overall Study|Not Treated|0
7718415|NCT01021748|26839424|P6|Overall Study|Not Treated|0
7718416|NCT01021748|26839425|P5|Overall Study|Not Treated|0
7718417|NCT01021748|26839426|P4|Overall Study|Not Treated|0
7718418|NCT01021748|26839427|P3|Overall Study|Not Treated|0
7718419|NCT01021748|26839428|P2|Overall Study|Not Treated|1
7718420|NCT01021748|26839429|P1|Overall Study|Not Treated|0
7718421|NCT01021748|26839421|P9|Overall Study|Withdrawal by Subject|1
7718422|NCT01021748|26839422|P8|Overall Study|Withdrawal by Subject|0
7718423|NCT01021748|26839423|P7|Overall Study|Withdrawal by Subject|1
7718424|NCT01021748|26839424|P6|Overall Study|Withdrawal by Subject|0
7718425|NCT01021748|26839425|P5|Overall Study|Withdrawal by Subject|0
7718426|NCT01021748|26839426|P4|Overall Study|Withdrawal by Subject|0
7718427|NCT01021748|26839427|P3|Overall Study|Withdrawal by Subject|0
7718428|NCT01021748|26839428|P2|Overall Study|Withdrawal by Subject|0
7718429|NCT01021748|26839429|P1|Overall Study|Withdrawal by Subject|0
7718430|NCT01021748|26839421|P9|Overall Study|Progressive Disease|6
7718431|NCT01021748|26839422|P8|Overall Study|Progressive Disease|5
7718432|NCT01021748|26839423|P7|Overall Study|Progressive Disease|0
7718433|NCT01021748|26839424|P6|Overall Study|Progressive Disease|3
7718434|NCT01021748|26839425|P5|Overall Study|Progressive Disease|7
7718435|NCT01021748|26839426|P4|Overall Study|Progressive Disease|6
7718436|NCT01021748|26839427|P3|Overall Study|Progressive Disease|4
7718437|NCT01021748|26839428|P2|Overall Study|Progressive Disease|3
7718438|NCT01021748|26839429|P1|Overall Study|Progressive Disease|3
7718439|NCT01021748|26839421|P9|Overall Study|Physician Decision|2
7718440|NCT01021748|26839422|P8|Overall Study|Physician Decision|1
7718441|NCT01021748|26839423|P7|Overall Study|Physician Decision|1
7718442|NCT01021748|26839424|P6|Overall Study|Physician Decision|0
7718443|NCT01021748|26839425|P5|Overall Study|Physician Decision|0
7718444|NCT01021748|26839426|P4|Overall Study|Physician Decision|1
7718445|NCT01021748|26839427|P3|Overall Study|Physician Decision|1
7718446|NCT01021748|26839428|P2|Overall Study|Physician Decision|0
7718447|NCT01021748|26839429|P1|Overall Study|Physician Decision|1
7718448|NCT01021748|26839421|P9|Overall Study|Adverse Event|7
7718449|NCT01021748|26839422|P8|Overall Study|Adverse Event|0
7718450|NCT01021748|26839423|P7|Overall Study|Adverse Event|1
7718451|NCT01021748|26839424|P6|Overall Study|Adverse Event|0
7718452|NCT01021748|26839425|P5|Overall Study|Adverse Event|2
7718453|NCT01021748|26839426|P4|Overall Study|Adverse Event|0
7718454|NCT01021748|26839427|P3|Overall Study|Adverse Event|2
7718455|NCT01021748|26839428|P2|Overall Study|Adverse Event|1
7718456|NCT01021748|26839429|P1|Overall Study|Adverse Event|2
7718457|NCT01021683|26839476|P1|Overall Study|Other|8
7718458|NCT01021683|26839476|P1|Overall Study|Recovery of neutrophil count|51
7718459|NCT01021683|26839476|P1|Overall Study|Lack of Efficacy|12
7718460|NCT01021553|26839502|P3|Overall Study|Withdrawal by Subject|0
7718461|NCT01021553|26839503|P2|Overall Study|Withdrawal by Subject|1
7718462|NCT01021553|26839504|P1|Overall Study|Withdrawal by Subject|1
7718463|NCT01021553|26839502|P3|Overall Study|Lost to Follow-up|1
7718464|NCT01021553|26839503|P2|Overall Study|Lost to Follow-up|0
7718465|NCT01021553|26839504|P1|Overall Study|Lost to Follow-up|0
7718466|NCT01021553|26839502|P3|Overall Study|Protocol Violation|2
7718467|NCT01021553|26839503|P2|Overall Study|Protocol Violation|2
7718468|NCT01021553|26839504|P1|Overall Study|Protocol Violation|0
7718469|NCT01021553|26839502|P3|Overall Study|Lack of Efficacy|0
7718470|NCT01021553|26839503|P2|Overall Study|Lack of Efficacy|2
7718471|NCT01021553|26839504|P1|Overall Study|Lack of Efficacy|2
7718472|NCT01021553|26839502|P3|Overall Study|Adverse Event|0
7718473|NCT01021553|26839503|P2|Overall Study|Adverse Event|0
7718474|NCT01021553|26839504|P1|Overall Study|Adverse Event|1
7718475|NCT01021423|26839558|P2|Overall Study|Study terminated|5
7718476|NCT01021423|26839559|P1|Overall Study|Study terminated|4
7718477|NCT01021332|26839575|P1|Overall Study|Miscellaneous|3
7718478|NCT01021332|26839575|P1|Overall Study|Protocol Violation|9
7718479|NCT01021332|26839575|P1|Overall Study|Lost to Follow-up|4
7718480|NCT01021332|26839575|P1|Overall Study|Withdrawal of Consent|23
7718481|NCT01021332|26839575|P1|Overall Study|Lack of Efficacy|19
7718482|NCT01021332|26839575|P1|Overall Study|Adverse Event|43
7718483|NCT01021332|26839575|P1|Overall Study|Not fulfilling incl./excl.criteria|5
7718484|NCT01021293|26839636|P2|Overall Study|Lost to Follow-up|1
7718485|NCT01021293|26839637|P1|Overall Study|Lost to Follow-up|1
7718486|NCT01021293|26839636|P2|Overall Study|Migrated/moved from study area|18
7718487|NCT01021293|26839637|P1|Overall Study|Migrated/moved from study area|6
7718488|NCT01021293|26839636|P2|Overall Study|Withdrawal by Subject|3
7718489|NCT01021293|26839637|P1|Overall Study|Withdrawal by Subject|1
7718490|NCT01021293|26839636|P2|Overall Study|Adverse Event|1
7718491|NCT01021293|26839637|P1|Overall Study|Adverse Event|2
7718492|NCT01021293|26839636|P2|Overall Study|Serious Adverse Event|1
7718493|NCT01021293|26839637|P1|Overall Study|Serious Adverse Event|2
7718494|NCT01021215|26839656|P2|Overall Study|Lost to Follow-up|0
7718495|NCT01021215|26839657|P1|Overall Study|Lost to Follow-up|3
7718496|NCT01021137|26839671|P4|Overall Study|Withdrawal by Subject|3
7718497|NCT01021137|26839672|P3|Overall Study|Withdrawal by Subject|0
7718498|NCT01021137|26839673|P2|Overall Study|Withdrawal by Subject|0
7718499|NCT01021137|26839674|P1|Overall Study|Withdrawal by Subject|1
7718500|NCT01021137|26839671|P4|Overall Study|Lost to Follow-up|6
7718501|NCT01021137|26839672|P3|Overall Study|Lost to Follow-up|2
7718502|NCT01021137|26839673|P2|Overall Study|Lost to Follow-up|4
7718503|NCT01021137|26839674|P1|Overall Study|Lost to Follow-up|9
7718504|NCT01021020|26839717|P1|14 Day Washout Period A|Physician Decision|1
7718505|NCT01021020|26839717|P1|Period I|Withdrawal by Subject|1
7718506|NCT01021020|26839717|P1|Period I|Protocol Violation|1
7718507|NCT01021007|26839733|P2|Overall Study|Adverse Event|3
7718508|NCT01021007|26839734|P1|Overall Study|Adverse Event|1
7718509|NCT01021007|26839733|P2|Overall Study|Lost to Follow-up|1
7718510|NCT01021007|26839734|P1|Overall Study|Lost to Follow-up|1
7718511|NCT01020981|26839746|P2|Overall Study|Participant declined to complete survey|0
7718512|NCT01020981|26839747|P1|Overall Study|Participant declined to complete survey|2
7718513|NCT01020981|26839746|P2|Overall Study|Survey returned undeliverable|32
7718514|NCT01020981|26839747|P1|Overall Study|Survey returned undeliverable|8
7718515|NCT01020981|26839746|P2|Overall Study|Did not return mailed survey|58
7718516|NCT01020981|26839747|P1|Overall Study|Did not return mailed survey|74
7718517|NCT01020877|26839768|P2|Second Intervention|Withdrawal by Subject|0
7718518|NCT01020877|26839769|P1|Second Intervention|Withdrawal by Subject|1
7718519|NCT01020838|26839779|P1|Overall Study|Most common: Study ended by sponsor|77
7718520|NCT01020838|26839779|P1|Overall Study|Lost to Follow-up|6
7718521|NCT01020838|26839779|P1|Overall Study|Withdrawal by Subject|9
7718522|NCT01020838|26839779|P1|Overall Study|Adverse Event|1
7718523|NCT01020838|26839779|P1|Overall Study|Death|90
7718524|NCT01020812|26839794|P1|Overall Study|Protocol Violation|1
7718525|NCT01020812|26839794|P1|Overall Study|Withdrawal by Subject|1
7718526|NCT01020812|26839794|P1|Overall Study|Physician Decision|1
7718527|NCT01020799|26839804|P3|Overall Study|Lost to Follow-up|2
7718528|NCT01020799|26839805|P2|Overall Study|Lost to Follow-up|4
7718529|NCT01020799|26839806|P1|Overall Study|Lost to Follow-up|6
7718530|NCT01020799|26839804|P3|Overall Study|Withdrawal by Subject|3
7718531|NCT01020799|26839805|P2|Overall Study|Withdrawal by Subject|2
7718532|NCT01020799|26839806|P1|Overall Study|Withdrawal by Subject|2
7718533|NCT01020799|26839804|P3|Overall Study|Protocol Violation|0
7718534|NCT01020799|26839805|P2|Overall Study|Protocol Violation|2
7718535|NCT01020799|26839806|P1|Overall Study|Protocol Violation|3
7718536|NCT01020799|26839804|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
7718537|NCT01020799|26839805|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
7718538|NCT01020799|26839806|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
7718539|NCT01020799|26839804|P3|Overall Study|Adverse Event|2
7718540|NCT01020799|26839805|P2|Overall Study|Adverse Event|3
7718541|NCT01020799|26839806|P1|Overall Study|Adverse Event|4
7718542|NCT01020786|26839829|P1|Maintenance Period|Sponsor Decision|1
7718543|NCT01020786|26839829|P1|Maintenance Period|Withdrawal by Subject|8
7718544|NCT01020786|26839829|P1|Maintenance Period|Progressive Disease|43
7718545|NCT01020786|26839829|P1|Maintenance Period|Adverse Event|8
7718546|NCT01020786|26839829|P1|Induction Period|Withdrawal by Subject|3
7718547|NCT01020786|26839829|P1|Induction Period|Investigator Decision|3
7718548|NCT01020786|26839829|P1|Induction Period|Progressive Disease|31
7718549|NCT01020786|26839829|P1|Induction Period|Adverse Event|10
7718550|NCT01020786|26839829|P1|Induction Period|Entry Criteria Not Met|2
7718551|NCT01020773|26839843|P2|Overall Study|Withdrawal by Subject|3
7718552|NCT01020773|26839844|P1|Overall Study|Withdrawal by Subject|4
7718553|NCT01020747|26839850|P1|Overall Study|Withdrawal by Subject|1
7718554|NCT01020526|26839866|P1|Overall Study|Adverse Event|2
7718555|NCT01020526|26839866|P1|Overall Study|Lost to Follow-up|1
7718556|NCT01020526|26839866|P1|Overall Study|Insufficient clinical response|3
7718557|NCT01020526|26839866|P1|Overall Study|Other reasons|3
7718558|NCT01020526|26839866|P1|Overall Study|Withdrawal by Subject|5
7718559|NCT01020474|26839872|P2|Overall Study|Insufficient Clinical Response|3
7718560|NCT01020474|26839873|P1|Overall Study|Insufficient Clinical Response|0
7718561|NCT01020474|26839872|P2|Overall Study|Other Reasons|1
7718562|NCT01020474|26839873|P1|Overall Study|Other Reasons|1
7718563|NCT01020474|26839872|P2|Overall Study|Withdrawal by Subject|7
7718564|NCT01020474|26839873|P1|Overall Study|Withdrawal by Subject|5
7718565|NCT01020474|26839872|P2|Overall Study|Protocol Violation|2
7718566|NCT01020474|26839873|P1|Overall Study|Protocol Violation|0
7718567|NCT01020474|26839872|P2|Overall Study|Adverse Event|4
7718568|NCT01020474|26839873|P1|Overall Study|Adverse Event|4
7718569|NCT01020448|26839893|P1|Treatment|Lost to Follow-up|2
7718570|NCT01020448|26839893|P1|Treatment|Lack of Efficacy|8
7718571|NCT01020448|26839893|P1|Treatment|Disease Progression|2
7718572|NCT01020448|26839893|P1|Treatment|Consent Withdrawn|3
7718573|NCT01020448|26839893|P1|Treatment|Adverse Event|11
7718574|NCT01020448|26839893|P1|Pre-assignment|Does Not Meet Entry Criteria|2
7718575|NCT01020448|26839893|P1|Pre-assignment|Withdrawal by Subject|5
7718576|NCT01020448|26839893|P1|Pre-assignment|Adverse Event|6
7718577|NCT01020435|26839904|P2|Overall Study|Lost to Follow-up|1
7718578|NCT01020435|26839905|P1|Overall Study|Lost to Follow-up|0
7718579|NCT01020305|26839913|P1|Overall Study|Adverse Event|2
7718580|NCT01020123|26839924|P7|Extention Period|Lost to Follow-up|0
7718581|NCT01020123|26839925|P6|Extention Period|Lost to Follow-up|2
7718582|NCT01020123|26839926|P5|Extention Period|Lost to Follow-up|0
7718583|NCT01020123|26839927|P4|Extention Period|Lost to Follow-up|0
7718584|NCT01020123|26839928|P3|Extention Period|Lost to Follow-up|0
7718585|NCT01020123|26839929|P2|Extention Period|Lost to Follow-up|0
7718586|NCT01020123|26839930|P1|Extention Period|Lost to Follow-up|0
7718587|NCT01020123|26839924|P7|Extention Period|Protocol Violation|1
7718588|NCT01020123|26839925|P6|Extention Period|Protocol Violation|0
7718589|NCT01020123|26839926|P5|Extention Period|Protocol Violation|0
7718590|NCT01020123|26839927|P4|Extention Period|Protocol Violation|0
7718591|NCT01020123|26839928|P3|Extention Period|Protocol Violation|1
7718592|NCT01020123|26839929|P2|Extention Period|Protocol Violation|1
7718593|NCT01020123|26839930|P1|Extention Period|Protocol Violation|1
7718594|NCT01020123|26839924|P7|Extention Period|Adverse Event|0
7718595|NCT01020123|26839925|P6|Extention Period|Adverse Event|0
7718596|NCT01020123|26839926|P5|Extention Period|Adverse Event|0
7718597|NCT01020123|26839927|P4|Extention Period|Adverse Event|1
7718598|NCT01020123|26839928|P3|Extention Period|Adverse Event|0
7718599|NCT01020123|26839929|P2|Extention Period|Adverse Event|0
7718600|NCT01020123|26839930|P1|Extention Period|Adverse Event|0
7718601|NCT01020123|26839924|P7|Extention Period|Withdrawal by Subject|0
7718602|NCT01020123|26839925|P6|Extention Period|Withdrawal by Subject|0
7718603|NCT01020123|26839926|P5|Extention Period|Withdrawal by Subject|0
7718604|NCT01020123|26839927|P4|Extention Period|Withdrawal by Subject|0
7718605|NCT01020123|26839928|P3|Extention Period|Withdrawal by Subject|1
7718606|NCT01020123|26839929|P2|Extention Period|Withdrawal by Subject|1
7718607|NCT01020123|26839930|P1|Extention Period|Withdrawal by Subject|2
7718608|NCT01020123|26839924|P7|Main Period|Unclasified|6
7718609|NCT01020123|26839925|P6|Main Period|Unclasified|3
7718610|NCT01020123|26839926|P5|Main Period|Unclasified|1
7718611|NCT01020123|26839927|P4|Main Period|Unclasified|0
7718612|NCT01020123|26839928|P3|Main Period|Unclasified|1
7718613|NCT01020123|26839929|P2|Main Period|Unclasified|0
7718614|NCT01020123|26839930|P1|Main Period|Unclasified|2
7718615|NCT01020123|26839924|P7|Main Period|Lost to Follow-up|0
7718616|NCT01020123|26839925|P6|Main Period|Lost to Follow-up|0
7718617|NCT01020123|26839926|P5|Main Period|Lost to Follow-up|0
7718618|NCT01020123|26839927|P4|Main Period|Lost to Follow-up|0
7718619|NCT01020123|26839928|P3|Main Period|Lost to Follow-up|0
7718620|NCT01020123|26839929|P2|Main Period|Lost to Follow-up|2
7718621|NCT01020123|26839930|P1|Main Period|Lost to Follow-up|0
7718622|NCT01020123|26839924|P7|Main Period|Protocol Violation|2
7718623|NCT01020123|26839925|P6|Main Period|Protocol Violation|3
7718624|NCT01020123|26839926|P5|Main Period|Protocol Violation|2
7718625|NCT01020123|26839927|P4|Main Period|Protocol Violation|5
7718626|NCT01020123|26839928|P3|Main Period|Protocol Violation|2
7718627|NCT01020123|26839929|P2|Main Period|Protocol Violation|4
7718628|NCT01020123|26839930|P1|Main Period|Protocol Violation|4
7718629|NCT01020123|26839924|P7|Main Period|Adverse Event|1
7718630|NCT01020123|26839925|P6|Main Period|Adverse Event|2
7718631|NCT01020123|26839926|P5|Main Period|Adverse Event|1
7718632|NCT01020123|26839927|P4|Main Period|Adverse Event|1
7718633|NCT01020123|26839928|P3|Main Period|Adverse Event|2
7718634|NCT01020123|26839929|P2|Main Period|Adverse Event|2
7718635|NCT01020123|26839930|P1|Main Period|Adverse Event|5
7718636|NCT01020123|26839924|P7|Main Period|Eligibility Criteria not fullfilled|0
7718637|NCT01020123|26839925|P6|Main Period|Eligibility Criteria not fullfilled|0
7718638|NCT01020123|26839926|P5|Main Period|Eligibility Criteria not fullfilled|1
7718639|NCT01020123|26839927|P4|Main Period|Eligibility Criteria not fullfilled|0
7718640|NCT01020123|26839928|P3|Main Period|Eligibility Criteria not fullfilled|0
7718641|NCT01020123|26839929|P2|Main Period|Eligibility Criteria not fullfilled|1
7718642|NCT01020123|26839930|P1|Main Period|Eligibility Criteria not fullfilled|0
7718643|NCT01020123|26839924|P7|Main Period|Withdrawal by Subject|2
7718644|NCT01020123|26839925|P6|Main Period|Withdrawal by Subject|3
7718645|NCT01020123|26839926|P5|Main Period|Withdrawal by Subject|6
7718646|NCT01020123|26839927|P4|Main Period|Withdrawal by Subject|1
7718647|NCT01020123|26839928|P3|Main Period|Withdrawal by Subject|3
7718648|NCT01020123|26839929|P2|Main Period|Withdrawal by Subject|5
7718649|NCT01020123|26839930|P1|Main Period|Withdrawal by Subject|6
7718650|NCT01020019|26840125|P2|Overall Study|moving|2
7718651|NCT01020019|26840126|P1|Overall Study|moving|0
7718652|NCT01020019|26840125|P2|Overall Study|not interested in treatment|4
7718653|NCT01020019|26840126|P1|Overall Study|not interested in treatment|4
7718654|NCT01020019|26840125|P2|Overall Study|Adverse Event|5
7718655|NCT01020019|26840126|P1|Overall Study|Adverse Event|1
7718656|NCT01020019|26840125|P2|Overall Study|Lost to Follow-up|18
7718657|NCT01020019|26840126|P1|Overall Study|Lost to Follow-up|21
7718658|NCT01019980|26840147|P2|Overall Study|Drug not available.|0
7718659|NCT01019980|26840148|P1|Overall Study|Drug not available.|2
7718660|NCT01019694|26840211|P3|Overall Study|Other reason (not specified)|6
7718661|NCT01019694|26840212|P2|Overall Study|Other reason (not specified)|5
7718662|NCT01019694|26840213|P1|Overall Study|Other reason (not specified)|1
7718663|NCT01019694|26840211|P3|Overall Study|Not treated|3
7718664|NCT01019694|26840212|P2|Overall Study|Not treated|2
7718665|NCT01019694|26840213|P1|Overall Study|Not treated|0
7718666|NCT01019694|26840211|P3|Overall Study|Withdrawal by Subject|12
7718667|NCT01019694|26840212|P2|Overall Study|Withdrawal by Subject|6
7718668|NCT01019694|26840213|P1|Overall Study|Withdrawal by Subject|4
7718669|NCT01019694|26840211|P3|Overall Study|Lost to Follow-up|3
7718670|NCT01019694|26840212|P2|Overall Study|Lost to Follow-up|3
7718671|NCT01019694|26840213|P1|Overall Study|Lost to Follow-up|5
7718672|NCT01019694|26840211|P3|Overall Study|Protocol Violation|4
7718673|NCT01019694|26840212|P2|Overall Study|Protocol Violation|6
7718674|NCT01019694|26840213|P1|Overall Study|Protocol Violation|2
7718675|NCT01019694|26840211|P3|Overall Study|Adverse Event|19
7718676|NCT01019694|26840212|P2|Overall Study|Adverse Event|16
7718677|NCT01019694|26840213|P1|Overall Study|Adverse Event|12
7718678|NCT01019486|26840338|P3|Overall Study|Withdrawal by Subject|1
7718679|NCT01019486|26840339|P2|Overall Study|Withdrawal by Subject|1
7718680|NCT01019486|26840340|P1|Overall Study|Withdrawal by Subject|1
7718681|NCT01019369|26840354|P2|Overall Study|Withdrawal by Subject|1
7718682|NCT01019369|26840355|P1|Overall Study|Withdrawal by Subject|0
7718683|NCT01019369|26840354|P2|Overall Study|Lost to Follow-up|6
7718684|NCT01019369|26840355|P1|Overall Study|Lost to Follow-up|10
7718685|NCT01019317|26840371|P1|Overall Study|Not Eligible|4
7718686|NCT01019252|26840377|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
7718687|NCT01019252|26840378|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
7718688|NCT01019252|26840377|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
7718689|NCT01019252|26840378|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
7718690|NCT01019252|26840377|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
7718691|NCT01019252|26840378|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
7718692|NCT01019252|26840377|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
7718693|NCT01019252|26840378|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
7718694|NCT01019135|26840391|P3|Overall Study|Did not attend CR|6
7718695|NCT01019135|26840392|P2|Overall Study|Did not attend CR|13
7718696|NCT01019135|26840393|P1|Overall Study|Did not attend CR|8
7718697|NCT01019135|26840391|P3|Overall Study|Did not receive allocated intervention|25
7718698|NCT01019135|26840392|P2|Overall Study|Did not receive allocated intervention|6
7718699|NCT01019135|26840393|P1|Overall Study|Did not receive allocated intervention|12
7718700|NCT01018992|26840421|P2|Overall Study|Lost to Follow-up|1
7718701|NCT01018992|26840422|P1|Overall Study|Lost to Follow-up|5
7718702|NCT01018992|26840421|P2|Overall Study|Protocol Violation|4
7718703|NCT01018992|26840422|P1|Overall Study|Protocol Violation|0
7718704|NCT01018992|26840421|P2|Overall Study|Withdrawal by Subject|8
7718705|NCT01018992|26840422|P1|Overall Study|Withdrawal by Subject|3
7718706|NCT01018992|26840421|P2|Overall Study|Adverse Event|3
7718707|NCT01018992|26840422|P1|Overall Study|Adverse Event|8
7718708|NCT01018979|26840436|P2|Overall Study|Not received at least one dose|1
7718709|NCT01018979|26840437|P1|Overall Study|Not received at least one dose|0
7718710|NCT01018979|26840436|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
7718711|NCT01018979|26840437|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
7718712|NCT01018953|26840467|P1|Overall Study|Study termination by sponsor|5
7718713|NCT01018953|26840467|P1|Overall Study|Withdrawal by Subject|1
7718714|NCT01018953|26840467|P1|Overall Study|Adverse Event|2
7718715|NCT01018862|26840480|P3|Overall Study|administrative problems|4
7718716|NCT01018862|26840481|P2|Overall Study|administrative problems|4
7718717|NCT01018862|26840482|P1|Overall Study|administrative problems|5
7718718|NCT01018862|26840480|P3|Overall Study|Withdrawal by Subject|1
7718719|NCT01018862|26840481|P2|Overall Study|Withdrawal by Subject|2
7718720|NCT01018862|26840482|P1|Overall Study|Withdrawal by Subject|1
7718721|NCT01018862|26840480|P3|Overall Study|Protocol Violation|3
7718722|NCT01018862|26840481|P2|Overall Study|Protocol Violation|3
7718723|NCT01018862|26840482|P1|Overall Study|Protocol Violation|1
7718724|NCT01018862|26840480|P3|Overall Study|Lost to Follow-up|0
7718725|NCT01018862|26840481|P2|Overall Study|Lost to Follow-up|1
7718726|NCT01018862|26840482|P1|Overall Study|Lost to Follow-up|3
7718727|NCT01018862|26840480|P3|Overall Study|Lack of Efficacy|2
7718728|NCT01018862|26840481|P2|Overall Study|Lack of Efficacy|0
7718729|NCT01018862|26840482|P1|Overall Study|Lack of Efficacy|1
7718730|NCT01018862|26840480|P3|Overall Study|Adverse Event|6
7718731|NCT01018862|26840481|P2|Overall Study|Adverse Event|0
7718732|NCT01018862|26840482|P1|Overall Study|Adverse Event|2
7718733|NCT01018810|26840504|P5|Overall Study|Sponsor Decision|1
7718734|NCT01018810|26840505|P4|Overall Study|Sponsor Decision|1
7718735|NCT01018810|26840506|P3|Overall Study|Sponsor Decision|1
7718736|NCT01018810|26840507|P2|Overall Study|Sponsor Decision|0
7718737|NCT01018810|26840508|P1|Overall Study|Sponsor Decision|2
7718738|NCT01018810|26840504|P5|Overall Study|Withdrawal by Subject|0
7718739|NCT01018810|26840505|P4|Overall Study|Withdrawal by Subject|0
7718740|NCT01018810|26840506|P3|Overall Study|Withdrawal by Subject|0
7718741|NCT01018810|26840507|P2|Overall Study|Withdrawal by Subject|1
7718742|NCT01018810|26840508|P1|Overall Study|Withdrawal by Subject|0
7718743|NCT01018732|26840568|P3|Overall Study|Unable to Classify|1
7718744|NCT01018732|26840569|P2|Overall Study|Unable to Classify|0
7718745|NCT01018732|26840570|P1|Overall Study|Unable to Classify|0
7718746|NCT01018732|26840568|P3|Overall Study|Inappropriate Enrollment|0
7718747|NCT01018732|26840569|P2|Overall Study|Inappropriate Enrollment|1
7718748|NCT01018732|26840570|P1|Overall Study|Inappropriate Enrollment|0
7718749|NCT01018732|26840568|P3|Overall Study|Protocol Violation|0
7718750|NCT01018732|26840569|P2|Overall Study|Protocol Violation|1
7718751|NCT01018732|26840570|P1|Overall Study|Protocol Violation|1
7718752|NCT01018732|26840568|P3|Overall Study|Lost to Follow-up|3
7718753|NCT01018732|26840569|P2|Overall Study|Lost to Follow-up|0
7718754|NCT01018732|26840570|P1|Overall Study|Lost to Follow-up|0
7718755|NCT01018680|26840604|P2|Overall Study|Physician Decision|1
7718756|NCT01018680|26840605|P1|Overall Study|Physician Decision|3
7718757|NCT01018680|26840604|P2|Overall Study|Entry Criteria Not Met|4
7718758|NCT01018680|26840605|P1|Overall Study|Entry Criteria Not Met|1
7718759|NCT01018680|26840604|P2|Overall Study|Lost to Follow-up|3
7718760|NCT01018680|26840605|P1|Overall Study|Lost to Follow-up|5
7718761|NCT01018680|26840604|P2|Overall Study|Lack of Efficacy|2
7718762|NCT01018680|26840605|P1|Overall Study|Lack of Efficacy|8
7718763|NCT01018680|26840604|P2|Overall Study|Sponsor Decision|7
7718764|NCT01018680|26840605|P1|Overall Study|Sponsor Decision|6
7718765|NCT01018680|26840604|P2|Overall Study|Protocol Violation|8
7718766|NCT01018680|26840605|P1|Overall Study|Protocol Violation|5
7718767|NCT01018680|26840604|P2|Overall Study|Withdrawal by Subject|10
7718768|NCT01018680|26840605|P1|Overall Study|Withdrawal by Subject|10
7718769|NCT01018680|26840604|P2|Overall Study|Adverse Event|40
7718770|NCT01018680|26840605|P1|Overall Study|Adverse Event|23
7718771|NCT01020487|26840648|P3|Part 2 Open-label Period|Adverse Event|1
7718772|NCT01020487|26840649|P2|Part 2 Open-label Period|Adverse Event|4
7718773|NCT01020487|26840650|P1|Part 2 Open-label Period|Adverse Event|0
7718774|NCT01020487|26840648|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
7718775|NCT01020487|26840649|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
7718776|NCT01020487|26840650|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
7718777|NCT01020487|26840648|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
7718778|NCT01020487|26840649|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
7718779|NCT01020487|26840650|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
7718780|NCT01020487|26840648|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
7718781|NCT01020487|26840649|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
7718782|NCT01020487|26840650|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
7718783|NCT01020487|26840648|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
7718784|NCT01020487|26840649|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
7718785|NCT01020487|26840650|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
7718786|NCT01018511|26840675|P4|Overall Study|Miscellaneous|0
7718787|NCT01018511|26840676|P3|Overall Study|Miscellaneous|0
7718788|NCT01018511|26840677|P2|Overall Study|Miscellaneous|2
7718789|NCT01018511|26840678|P1|Overall Study|Miscellaneous|0
7718790|NCT01018511|26840675|P4|Overall Study|Protocol Violation|9
7718791|NCT01018511|26840676|P3|Overall Study|Protocol Violation|7
7718792|NCT01018511|26840677|P2|Overall Study|Protocol Violation|8
7718793|NCT01018511|26840678|P1|Overall Study|Protocol Violation|5
7718794|NCT01018511|26840675|P4|Overall Study|Lost to Follow-up|0
7718795|NCT01018511|26840676|P3|Overall Study|Lost to Follow-up|1
7718796|NCT01018511|26840677|P2|Overall Study|Lost to Follow-up|0
7718797|NCT01018511|26840678|P1|Overall Study|Lost to Follow-up|0
7718798|NCT01018511|26840675|P4|Overall Study|Withdrawal by Subject|9
7718799|NCT01018511|26840676|P3|Overall Study|Withdrawal by Subject|11
7718800|NCT01018511|26840677|P2|Overall Study|Withdrawal by Subject|5
7718801|NCT01018511|26840678|P1|Overall Study|Withdrawal by Subject|6
7718802|NCT01018511|26840675|P4|Overall Study|Lack of Efficacy|2
7718803|NCT01018511|26840676|P3|Overall Study|Lack of Efficacy|1
7718804|NCT01018511|26840677|P2|Overall Study|Lack of Efficacy|1
7718805|NCT01018511|26840678|P1|Overall Study|Lack of Efficacy|4
7718806|NCT01018511|26840675|P4|Overall Study|Adverse Event|10
7718807|NCT01018511|26840676|P3|Overall Study|Adverse Event|13
7718808|NCT01018511|26840677|P2|Overall Study|Adverse Event|9
7718809|NCT01018511|26840678|P1|Overall Study|Adverse Event|5
7718810|NCT01018511|26840675|P4|Overall Study|Not fulfilling eligibility criteria|3
7718811|NCT01018511|26840676|P3|Overall Study|Not fulfilling eligibility criteria|7
7718812|NCT01018511|26840677|P2|Overall Study|Not fulfilling eligibility criteria|7
7718813|NCT01018511|26840678|P1|Overall Study|Not fulfilling eligibility criteria|6
7718814|NCT01018394|26840875|P2|Overall Study|Lost to Follow-up|3
7718815|NCT01018394|26840876|P1|Overall Study|Lost to Follow-up|4
7718816|NCT01018394|26840875|P2|Overall Study|Withdrawal by Subject|5
7718817|NCT01018394|26840876|P1|Overall Study|Withdrawal by Subject|5
7718818|NCT01018264|26840886|P2|Overall Study|Lost to Follow-up|1
7718819|NCT01018264|26840887|P1|Overall Study|Lost to Follow-up|0
7718820|NCT01018264|26840886|P2|Overall Study|Withdrawal by Subject|0
7718821|NCT01018264|26840887|P1|Overall Study|Withdrawal by Subject|1
7718822|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
7718823|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
7718824|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
7718825|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
7718826|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Physician Decision|3
7718827|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Physician Decision|0
7718828|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Physician Decision|1
7718829|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Physician Decision|0
7718830|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
7718831|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
7718832|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
7718833|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
7718834|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
7718835|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
7718836|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
7718837|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
7718838|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Protocol Violation|2
7718839|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Protocol Violation|8
7718840|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Protocol Violation|8
7718841|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Protocol Violation|0
7718842|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
7718843|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
7718844|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
7718845|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
7718846|NCT01018186|26840904|P4|52-week Double-blind Treatment Period|Adverse Event|6
7718847|NCT01018186|26840905|P3|52-week Double-blind Treatment Period|Adverse Event|3
7718848|NCT01018186|26840906|P2|52-week Double-blind Treatment Period|Adverse Event|5
7718849|NCT01018186|26840907|P1|52-week Double-blind Treatment Period|Adverse Event|0
7718850|NCT01018186|26840904|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7718851|NCT01018186|26840905|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7718852|NCT01018186|26840906|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7718853|NCT01018186|26840907|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
7718854|NCT01018186|26840904|P4|2-week Run-in Period|Withdrawal by Subject|0
7718855|NCT01018186|26840905|P3|2-week Run-in Period|Withdrawal by Subject|0
7718856|NCT01018186|26840906|P2|2-week Run-in Period|Withdrawal by Subject|0
7718857|NCT01018186|26840907|P1|2-week Run-in Period|Withdrawal by Subject|11
7718858|NCT01018186|26840904|P4|2-week Run-in Period|Physician Decision|0
7718859|NCT01018186|26840905|P3|2-week Run-in Period|Physician Decision|0
7718860|NCT01018186|26840906|P2|2-week Run-in Period|Physician Decision|0
7718861|NCT01018186|26840907|P1|2-week Run-in Period|Physician Decision|3
7718862|NCT01018186|26840904|P4|2-week Run-in Period|Lost to Follow-up|0
7718863|NCT01018186|26840905|P3|2-week Run-in Period|Lost to Follow-up|0
7718864|NCT01018186|26840906|P2|2-week Run-in Period|Lost to Follow-up|0
7718865|NCT01018186|26840907|P1|2-week Run-in Period|Lost to Follow-up|2
7718866|NCT01018186|26840904|P4|2-week Run-in Period|Protocol Violation|0
7718867|NCT01018186|26840905|P3|2-week Run-in Period|Protocol Violation|0
7718868|NCT01018186|26840906|P2|2-week Run-in Period|Protocol Violation|0
7718869|NCT01018186|26840907|P1|2-week Run-in Period|Protocol Violation|1
7718870|NCT01018030|26841108|P3|Overall Study|Did Not Receive Study Drug|0
7718871|NCT01018030|26841109|P2|Overall Study|Did Not Receive Study Drug|3
7718872|NCT01018030|26841110|P1|Overall Study|Did Not Receive Study Drug|1
7718873|NCT01018030|26841108|P3|Overall Study|Lack of Efficacy|0
7718874|NCT01018030|26841109|P2|Overall Study|Lack of Efficacy|0
7718875|NCT01018030|26841110|P1|Overall Study|Lack of Efficacy|1
7718876|NCT01018030|26841108|P3|Overall Study|Physician Decision|1
7718877|NCT01018030|26841109|P2|Overall Study|Physician Decision|0
7718878|NCT01018030|26841110|P1|Overall Study|Physician Decision|1
7718879|NCT01018030|26841108|P3|Overall Study|Protocol Violation|0
7718880|NCT01018030|26841109|P2|Overall Study|Protocol Violation|1
7718881|NCT01018030|26841110|P1|Overall Study|Protocol Violation|2
7718882|NCT01018030|26841108|P3|Overall Study|Lost to Follow-up|3
7718883|NCT01018030|26841109|P2|Overall Study|Lost to Follow-up|0
7718884|NCT01018030|26841110|P1|Overall Study|Lost to Follow-up|2
7718885|NCT01018030|26841108|P3|Overall Study|Withdrawal by Subject|4
7718886|NCT01018030|26841109|P2|Overall Study|Withdrawal by Subject|2
7718887|NCT01018030|26841110|P1|Overall Study|Withdrawal by Subject|2
7718888|NCT01018030|26841108|P3|Overall Study|Adverse Event|5
7718889|NCT01018030|26841109|P2|Overall Study|Adverse Event|5
7718890|NCT01018030|26841110|P1|Overall Study|Adverse Event|10
7718891|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Physician Decision|7
7718892|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Physician Decision|9
7718893|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Physician Decision|8
7718894|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Physician Decision|10
7718895|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Physician Decision|0
7718896|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
7718897|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7718898|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
7718899|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7718900|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
7718901|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7718902|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7718903|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7718904|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7718905|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7718906|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
7718907|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
7718908|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7718909|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
7718910|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7718911|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
7718912|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
7718913|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
7718914|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
7718915|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
7718916|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
7718917|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
7718918|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
7718919|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
7718920|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
7718921|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
7718922|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
7718923|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
7718924|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
7718925|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
7718926|NCT01017952|26841161|P5|52-week, Double-blind Treatment Period|Adverse Event|30
7718927|NCT01017952|26841162|P4|52-week, Double-blind Treatment Period|Adverse Event|35
7718928|NCT01017952|26841163|P3|52-week, Double-blind Treatment Period|Adverse Event|32
7718929|NCT01017952|26841164|P2|52-week, Double-blind Treatment Period|Adverse Event|25
7718930|NCT01017952|26841165|P1|52-week, Double-blind Treatment Period|Adverse Event|0
7718931|NCT01017952|26841161|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7718932|NCT01017952|26841162|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7718933|NCT01017952|26841163|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7718934|NCT01017952|26841164|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7718935|NCT01017952|26841165|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
7718936|NCT01017952|26841161|P5|4-week, Open-label Run-In Period|Physician Decision|0
7718937|NCT01017952|26841162|P4|4-week, Open-label Run-In Period|Physician Decision|0
7718938|NCT01017952|26841163|P3|4-week, Open-label Run-In Period|Physician Decision|0
7718939|NCT01017952|26841164|P2|4-week, Open-label Run-In Period|Physician Decision|0
7718940|NCT01017952|26841165|P1|4-week, Open-label Run-In Period|Physician Decision|10
7718941|NCT01017952|26841161|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
7718942|NCT01017952|26841162|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
7718943|NCT01017952|26841163|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
7718944|NCT01017952|26841164|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
7718945|NCT01017952|26841165|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
7718946|NCT01017952|26841161|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7718947|NCT01017952|26841162|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7718948|NCT01017952|26841163|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7718949|NCT01017952|26841164|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7718950|NCT01017952|26841165|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
7718951|NCT01017952|26841161|P5|4-week, Open-label Run-In Period|Adverse Event|0
7718952|NCT01017952|26841162|P4|4-week, Open-label Run-In Period|Adverse Event|0
7718953|NCT01017952|26841163|P3|4-week, Open-label Run-In Period|Adverse Event|0
7718954|NCT01017952|26841164|P2|4-week, Open-label Run-In Period|Adverse Event|0
7718955|NCT01017952|26841165|P1|4-week, Open-label Run-In Period|Adverse Event|23
7718956|NCT01017952|26841161|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7718957|NCT01017952|26841162|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7718958|NCT01017952|26841163|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7718959|NCT01017952|26841164|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7718960|NCT01017952|26841165|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
7718961|NCT01017874|26841189|P2|Overall Study|Physician Decision|3
7718962|NCT01017874|26841190|P1|Overall Study|Physician Decision|1
7718963|NCT01017874|26841189|P2|Overall Study|Lost to Follow-up|2
7718964|NCT01017874|26841190|P1|Overall Study|Lost to Follow-up|3
7718965|NCT01017874|26841189|P2|Overall Study|Sponsor decision|1
7718966|NCT01017874|26841190|P1|Overall Study|Sponsor decision|3
7718967|NCT01017874|26841189|P2|Overall Study|Withdrawal by Subject|20
7718968|NCT01017874|26841190|P1|Overall Study|Withdrawal by Subject|23
7718969|NCT01017731|26841208|P1|Overall Study|Adverse Event|1
7718970|NCT01017731|26841208|P1|Overall Study|Physician Decision|2
7718971|NCT01017731|26841208|P1|Overall Study|Withdrawal by Subject|3
7718972|NCT01017731|26841208|P1|Overall Study|Lost to Follow-up|2
7718973|NCT01017601|26841237|P2|Overall Study|Withdrawal by Subject|1
7718974|NCT01017601|26841238|P1|Overall Study|Withdrawal by Subject|0
7718975|NCT01017601|26841237|P2|Overall Study|Disease Progression|12
7718976|NCT01017601|26841238|P1|Overall Study|Disease Progression|12
7718977|NCT01017575|26841265|P5|Overall Study|Withdrawal by Subject|0
7718978|NCT01017575|26841266|P4|Overall Study|Withdrawal by Subject|0
7718979|NCT01017575|26841267|P3|Overall Study|Withdrawal by Subject|0
7718980|NCT01017575|26841268|P2|Overall Study|Withdrawal by Subject|0
7718981|NCT01017575|26841269|P1|Overall Study|Withdrawal by Subject|1
7718982|NCT01017575|26841265|P5|Overall Study|Adverse Event|2
7718983|NCT01017575|26841266|P4|Overall Study|Adverse Event|0
7718984|NCT01017575|26841267|P3|Overall Study|Adverse Event|0
7718985|NCT01017575|26841268|P2|Overall Study|Adverse Event|1
7718986|NCT01017575|26841269|P1|Overall Study|Adverse Event|0
7718987|NCT01017575|26841265|P5|Overall Study|Lack of Efficacy|1
7718988|NCT01017575|26841266|P4|Overall Study|Lack of Efficacy|1
7718989|NCT01017575|26841267|P3|Overall Study|Lack of Efficacy|0
7718990|NCT01017575|26841268|P2|Overall Study|Lack of Efficacy|1
7718991|NCT01017575|26841269|P1|Overall Study|Lack of Efficacy|0
7718992|NCT01017549|26841306|P1|5 Year Follow-up|Mastectomy|3
7718993|NCT01017549|26841306|P1|5 Year Follow-up|Lost to Follow-up|9
7718994|NCT01017549|26841306|P1|One-year Follow-up|Withdrawal by Subject|5
7718995|NCT01017549|26841306|P1|One-year Follow-up|Lost to Follow-up|2
7718996|NCT01017549|26841306|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
7718997|NCT01017263|26841337|P1|Overall Study|not eligible|12
7718998|NCT01017146|26841418|P2|Overall Study|Change in Work Situation|0
7718999|NCT01017146|26841419|P1|Overall Study|Change in Work Situation|1
7719000|NCT01017146|26841418|P2|Overall Study|Did Not Meet Eligibility Criteria|2
7719001|NCT01017146|26841419|P1|Overall Study|Did Not Meet Eligibility Criteria|1
7719002|NCT01017146|26841418|P2|Overall Study|Took Excluded Medication|0
7719003|NCT01017146|26841419|P1|Overall Study|Took Excluded Medication|2
7719004|NCT01017146|26841418|P2|Overall Study|Protocol Violation|0
7719005|NCT01017146|26841419|P1|Overall Study|Protocol Violation|2
7719006|NCT01017146|26841418|P2|Overall Study|Pregnancy|1
7719007|NCT01017146|26841419|P1|Overall Study|Pregnancy|2
7719008|NCT01017146|26841418|P2|Overall Study|Relocation|4
7719009|NCT01017146|26841419|P1|Overall Study|Relocation|0
7719010|NCT01017146|26841418|P2|Overall Study|Withdrawal by Subject|16
7719011|NCT01017146|26841419|P1|Overall Study|Withdrawal by Subject|32
7719012|NCT01017146|26841418|P2|Overall Study|Noncompliance with Study Product|1
7719013|NCT01017146|26841419|P1|Overall Study|Noncompliance with Study Product|1
7719014|NCT01017146|26841418|P2|Overall Study|Lost to Follow-up|14
7719015|NCT01017146|26841419|P1|Overall Study|Lost to Follow-up|14
7719016|NCT01017146|26841418|P2|Overall Study|Adverse Event|1
7719017|NCT01017146|26841419|P1|Overall Study|Adverse Event|11
7719018|NCT01017120|26841457|P2|Overall Study|Parent Unable to Provide Transportation|0
7719019|NCT01017120|26841458|P1|Overall Study|Parent Unable to Provide Transportation|1
7719020|NCT01017120|26841457|P2|Overall Study|Protocol Violation|0
7719021|NCT01017120|26841458|P1|Overall Study|Protocol Violation|1
7719022|NCT01017120|26841457|P2|Overall Study|Relocated Out of Town|2
7719023|NCT01017120|26841458|P1|Overall Study|Relocated Out of Town|0
7719024|NCT01017120|26841457|P2|Overall Study|Did Not Meet Eligibility Criteria|0
7719025|NCT01017120|26841458|P1|Overall Study|Did Not Meet Eligibility Criteria|1
7719026|NCT01017120|26841457|P2|Overall Study|Pregnancy|1
7719027|NCT01017120|26841458|P1|Overall Study|Pregnancy|1
7719028|NCT01017120|26841457|P2|Overall Study|Withdrawal by Subject|21
7719029|NCT01017120|26841458|P1|Overall Study|Withdrawal by Subject|39
7719030|NCT01017120|26841457|P2|Overall Study|Lack of Efficacy|0
7719031|NCT01017120|26841458|P1|Overall Study|Lack of Efficacy|1
7719032|NCT01017120|26841457|P2|Overall Study|Lost to Follow-up|11
7719033|NCT01017120|26841458|P1|Overall Study|Lost to Follow-up|13
7719034|NCT01017120|26841457|P2|Overall Study|Adverse Event|0
7719035|NCT01017120|26841458|P1|Overall Study|Adverse Event|9
7719036|NCT01017029|26841519|P2|Overall Study|Death|1
7719037|NCT01017029|26841520|P1|Overall Study|Death|3
7719038|NCT01017029|26841519|P2|Overall Study|Administrative problem|1
7719039|NCT01017029|26841520|P1|Overall Study|Administrative problem|0
7719040|NCT01017029|26841519|P2|Overall Study|Lost to Follow-up|0
7719041|NCT01017029|26841520|P1|Overall Study|Lost to Follow-up|1
7719042|NCT01016977|26841548|P2|Overall Study|Withdrawal by Subject|2
7719043|NCT01016977|26841549|P1|Overall Study|Withdrawal by Subject|2
7719044|NCT01016977|26841548|P2|Overall Study|Lost to Follow-up|0
7719045|NCT01016977|26841549|P1|Overall Study|Lost to Follow-up|1
7719046|NCT01016964|26841585|P2|Overall Study|Lost to Follow-up|3
7719047|NCT01016964|26841586|P1|Overall Study|Lost to Follow-up|3
7719048|NCT01016912|26841602|P5|Follow-up Period|Other reason|0
7719049|NCT01016912|26841603|P4|Follow-up Period|Other reason|1
7719050|NCT01016912|26841604|P3|Follow-up Period|Other reason|1
7719051|NCT01016912|26841605|P2|Follow-up Period|Other reason|0
7719052|NCT01016912|26841606|P1|Follow-up Period|Other reason|0
7719053|NCT01016912|26841602|P5|End of Treatment Period|Completed double-blind period only|0
7719054|NCT01016912|26841603|P4|End of Treatment Period|Completed double-blind period only|0
7719055|NCT01016912|26841604|P3|End of Treatment Period|Completed double-blind period only|0
7719056|NCT01016912|26841605|P2|End of Treatment Period|Completed double-blind period only|1
7719057|NCT01016912|26841606|P1|End of Treatment Period|Completed double-blind period only|0
7719058|NCT01016912|26841602|P5|End of Treatment Period|Adverse Event|0
7719059|NCT01016912|26841603|P4|End of Treatment Period|Adverse Event|0
7719060|NCT01016912|26841604|P3|End of Treatment Period|Adverse Event|1
7719061|NCT01016912|26841605|P2|End of Treatment Period|Adverse Event|1
7719062|NCT01016912|26841606|P1|End of Treatment Period|Adverse Event|0
7719063|NCT01016912|26841602|P5|End of Treatment Period|Lack of Efficacy|4
7719064|NCT01016912|26841603|P4|End of Treatment Period|Lack of Efficacy|4
7719065|NCT01016912|26841604|P3|End of Treatment Period|Lack of Efficacy|0
7719066|NCT01016912|26841605|P2|End of Treatment Period|Lack of Efficacy|1
7719067|NCT01016912|26841606|P1|End of Treatment Period|Lack of Efficacy|0
7719068|NCT01016600|26841785|P4|Overall Study|Did not start treatment|0
7719069|NCT01016600|26841786|P3|Overall Study|Did not start treatment|0
7719070|NCT01016600|26841787|P2|Overall Study|Did not start treatment|0
7719071|NCT01016600|26841788|P1|Overall Study|Did not start treatment|1
7719072|NCT01016262|26841985|P6|Open-Label Phase|Withdrawal of Informed Consent|0
7719073|NCT01016262|26841986|P5|Open-Label Phase|Withdrawal of Informed Consent|1
7719074|NCT01016262|26841987|P4|Open-Label Phase|Withdrawal of Informed Consent|0
7719075|NCT01016262|26841988|P3|Open-Label Phase|Withdrawal of Informed Consent|0
7719076|NCT01016262|26841989|P2|Open-Label Phase|Withdrawal of Informed Consent|0
7719077|NCT01016262|26841990|P1|Open-Label Phase|Withdrawal of Informed Consent|0
7719078|NCT01016262|26841985|P6|Open-Label Phase|Lack of Efficacy|0
7719079|NCT01016262|26841986|P5|Open-Label Phase|Lack of Efficacy|0
7719080|NCT01016262|26841987|P4|Open-Label Phase|Lack of Efficacy|1
7719081|NCT01016262|26841988|P3|Open-Label Phase|Lack of Efficacy|0
7719082|NCT01016262|26841989|P2|Open-Label Phase|Lack of Efficacy|0
7719083|NCT01016262|26841990|P1|Open-Label Phase|Lack of Efficacy|0
7719084|NCT01016262|26841985|P6|Open-Label Phase|Lost to Follow-up|0
7719085|NCT01016262|26841986|P5|Open-Label Phase|Lost to Follow-up|1
7719086|NCT01016262|26841987|P4|Open-Label Phase|Lost to Follow-up|0
7719087|NCT01016262|26841988|P3|Open-Label Phase|Lost to Follow-up|0
7719088|NCT01016262|26841989|P2|Open-Label Phase|Lost to Follow-up|0
7719089|NCT01016262|26841990|P1|Open-Label Phase|Lost to Follow-up|0
7719090|NCT01016262|26841985|P6|Open-Label Phase|Adverse Event|0
7719091|NCT01016262|26841986|P5|Open-Label Phase|Adverse Event|0
7719092|NCT01016262|26841987|P4|Open-Label Phase|Adverse Event|1
7719093|NCT01016262|26841988|P3|Open-Label Phase|Adverse Event|0
7719094|NCT01016262|26841989|P2|Open-Label Phase|Adverse Event|0
7719095|NCT01016262|26841990|P1|Open-Label Phase|Adverse Event|0
7719096|NCT01016262|26841985|P6|Double-blind Phase|Withdrawal of Informed Consent|0
7719097|NCT01016262|26841986|P5|Double-blind Phase|Withdrawal of Informed Consent|0
7719098|NCT01016262|26841987|P4|Double-blind Phase|Withdrawal of Informed Consent|0
7719099|NCT01016262|26841988|P3|Double-blind Phase|Withdrawal of Informed Consent|1
7719100|NCT01016262|26841989|P2|Double-blind Phase|Withdrawal of Informed Consent|0
7719101|NCT01016262|26841990|P1|Double-blind Phase|Withdrawal of Informed Consent|0
7719102|NCT01016262|26841985|P6|Double-blind Phase|Disease Progression|0
7719103|NCT01016262|26841986|P5|Double-blind Phase|Disease Progression|0
7719104|NCT01016262|26841987|P4|Double-blind Phase|Disease Progression|0
7719105|NCT01016262|26841988|P3|Double-blind Phase|Disease Progression|2
7719106|NCT01016262|26841989|P2|Double-blind Phase|Disease Progression|1
7719107|NCT01016262|26841990|P1|Double-blind Phase|Disease Progression|0
7719108|NCT01016262|26841985|P6|Double-blind Phase|Lack of Efficacy|0
7719109|NCT01016262|26841986|P5|Double-blind Phase|Lack of Efficacy|0
7719110|NCT01016262|26841987|P4|Double-blind Phase|Lack of Efficacy|0
7719111|NCT01016262|26841988|P3|Double-blind Phase|Lack of Efficacy|5
7719112|NCT01016262|26841989|P2|Double-blind Phase|Lack of Efficacy|0
7719113|NCT01016262|26841990|P1|Double-blind Phase|Lack of Efficacy|1
7719114|NCT01016262|26841985|P6|Double-blind Phase|Adverse Event|0
7719115|NCT01016262|26841986|P5|Double-blind Phase|Adverse Event|0
7719116|NCT01016262|26841987|P4|Double-blind Phase|Adverse Event|0
7719117|NCT01016262|26841988|P3|Double-blind Phase|Adverse Event|1
7719118|NCT01016262|26841989|P2|Double-blind Phase|Adverse Event|0
7719119|NCT01016262|26841990|P1|Double-blind Phase|Adverse Event|0
7719120|NCT01016132|26842013|P1|Overall Study|Discomfort|1
7719121|NCT01016067|26842028|P2|Overall Study|Withdrew due to Relocation|1
7719122|NCT01016067|26842029|P1|Overall Study|Withdrew due to Relocation|0
7719123|NCT01016067|26842028|P2|Overall Study|Physician Decision|1
7719124|NCT01016067|26842029|P1|Overall Study|Physician Decision|1
7719125|NCT01016067|26842028|P2|Overall Study|Lost to Follow-up|2
7719126|NCT01016067|26842029|P1|Overall Study|Lost to Follow-up|1
7719127|NCT01016015|26842047|P1|Overall Study|Adverse Event|15
7719128|NCT01016015|26842047|P1|Overall Study|Withdrawal by Subject|1
7719129|NCT01016015|26842047|P1|Overall Study|Not Treated|3
7719130|NCT01015833|26842058|P2|Overall Study|Did not start treatment|0
7719131|NCT01015833|26842059|P1|Overall Study|Did not start treatment|1
7719132|NCT01015833|26842058|P2|Overall Study|Motor Vehicle Accidents|0
7719133|NCT01015833|26842059|P1|Overall Study|Motor Vehicle Accidents|1
7719134|NCT01015833|26842058|P2|Overall Study|Other|1
7719135|NCT01015833|26842059|P1|Overall Study|Other|5
7719136|NCT01015833|26842058|P2|Overall Study|Symptomatic deterioration|1
7719137|NCT01015833|26842059|P1|Overall Study|Symptomatic deterioration|0
7719138|NCT01015833|26842058|P2|Overall Study|Physician Decision|0
7719139|NCT01015833|26842059|P1|Overall Study|Physician Decision|2
7719140|NCT01015833|26842058|P2|Overall Study|Adverse Event|1
7719141|NCT01015833|26842059|P1|Overall Study|Adverse Event|0
7719142|NCT01015833|26842058|P2|Overall Study|Withdrawal by Subject|2
7719143|NCT01015833|26842059|P1|Overall Study|Withdrawal by Subject|3
7719144|NCT01015833|26842058|P2|Overall Study|Death|0
7719145|NCT01015833|26842059|P1|Overall Study|Death|1
7719146|NCT01015820|26842075|P2|Overall Study|Suboptimal measurements|0
7719147|NCT01015820|26842076|P1|Overall Study|Suboptimal measurements|1
7719148|NCT01015768|26842106|P2|Overall Study|Some subject data unuseable|4
7719149|NCT01015768|26842107|P1|Overall Study|Some subject data unuseable|4
7719150|NCT01015703|26842122|P5|Overall Study|Protocol Violation|0
7719151|NCT01015703|26842123|P4|Overall Study|Protocol Violation|0
7719152|NCT01015703|26842124|P3|Overall Study|Protocol Violation|0
7719153|NCT01015703|26842125|P2|Overall Study|Protocol Violation|0
7719154|NCT01015703|26842126|P1|Overall Study|Protocol Violation|1
7719155|NCT01015703|26842122|P5|Overall Study|Adverse Event|0
7719156|NCT01015703|26842123|P4|Overall Study|Adverse Event|0
7719157|NCT01015703|26842124|P3|Overall Study|Adverse Event|0
7719158|NCT01015703|26842125|P2|Overall Study|Adverse Event|0
7719159|NCT01015703|26842126|P1|Overall Study|Adverse Event|1
7719160|NCT01015703|26842122|P5|Overall Study|Withdrawal by Subject|0
7719161|NCT01015703|26842123|P4|Overall Study|Withdrawal by Subject|0
7719162|NCT01015703|26842124|P3|Overall Study|Withdrawal by Subject|0
7719163|NCT01015703|26842125|P2|Overall Study|Withdrawal by Subject|1
7719164|NCT01015703|26842126|P1|Overall Study|Withdrawal by Subject|0
7719165|NCT01015677|26842141|P3|Overall Study|Withdrawal by Subject|0
7719166|NCT01015677|26842142|P2|Overall Study|Withdrawal by Subject|1
7719167|NCT01015677|26842143|P1|Overall Study|Withdrawal by Subject|1
7719168|NCT01015677|26842141|P3|Overall Study|Protocol Violation|0
7719169|NCT01015677|26842142|P2|Overall Study|Protocol Violation|1
7719170|NCT01015677|26842143|P1|Overall Study|Protocol Violation|0
7719171|NCT01015677|26842141|P3|Overall Study|Lack of Efficacy|0
7719172|NCT01015677|26842142|P2|Overall Study|Lack of Efficacy|1
7719173|NCT01015677|26842143|P1|Overall Study|Lack of Efficacy|0
7719174|NCT01015677|26842141|P3|Overall Study|Adverse Event|0
7719175|NCT01015677|26842142|P2|Overall Study|Adverse Event|1
7719176|NCT01015677|26842143|P1|Overall Study|Adverse Event|0
7719177|NCT01015638|26842165|P2|Overall Study|Withdrawal by Subject|0
7719178|NCT01015638|26842166|P1|Overall Study|Withdrawal by Subject|1
7719179|NCT01015612|26842194|P1|Overall Study|Withdrawal by Subject|40
7719180|NCT01015612|26842194|P1|Overall Study|Death|113
7719181|NCT01015560|26842225|P1|Overall Study|Withdrawal by Subject|1
7719182|NCT01015560|26842225|P1|Overall Study|Not protocol specified|1
7719183|NCT01015560|26842225|P1|Overall Study|Adverse Event|1
7719184|NCT01015287|26842274|P2|Overall Study|Protocol Violation|1
7719185|NCT01015287|26842275|P1|Overall Study|Protocol Violation|1
7719186|NCT01015287|26842274|P2|Overall Study|Lost to Follow-up|1
7719187|NCT01015287|26842275|P1|Overall Study|Lost to Follow-up|2
7719188|NCT01015287|26842274|P2|Overall Study|Entry Criteria not Met|14
7719189|NCT01015287|26842275|P1|Overall Study|Entry Criteria not Met|11
7719190|NCT01015287|26842274|P2|Overall Study|Withdrawal by Subject|19
7719191|NCT01015287|26842275|P1|Overall Study|Withdrawal by Subject|14
7719192|NCT01015287|26842274|P2|Overall Study|Physician Decision|21
7719193|NCT01015287|26842275|P1|Overall Study|Physician Decision|19
7719194|NCT01015287|26842274|P2|Overall Study|Sponsor Decision|7
7719195|NCT01015287|26842275|P1|Overall Study|Sponsor Decision|3
7719196|NCT01015287|26842274|P2|Overall Study|Adverse Event|0
7719197|NCT01015287|26842275|P1|Overall Study|Adverse Event|1
7719198|NCT01015287|26842274|P2|Overall Study|Death|16
7719199|NCT01015287|26842275|P1|Overall Study|Death|21
7719200|NCT01015131|26842307|P1|Overall Study|Other Protocol Specified Criteria|4
7719201|NCT01015131|26842307|P1|Overall Study|Withdrawal by Subject|2
7719202|NCT01015131|26842307|P1|Overall Study|Protocol Violation|1
7719203|NCT01015131|26842307|P1|Overall Study|Physician Decision|1
7719204|NCT01015118|26842323|P2|Overall Study|Other than stated above|23
7719205|NCT01015118|26842324|P1|Overall Study|Other than stated above|42
7719206|NCT01015118|26842323|P2|Overall Study|Not treated|5
7719207|NCT01015118|26842324|P1|Overall Study|Not treated|9
7719208|NCT01015118|26842323|P2|Overall Study|Progressive disease|229
7719209|NCT01015118|26842324|P1|Overall Study|Progressive disease|364
7719210|NCT01015118|26842323|P2|Overall Study|Worsening or AE of underlying disease|4
7719211|NCT01015118|26842324|P1|Overall Study|Worsening or AE of underlying disease|5
7719212|NCT01015118|26842323|P2|Overall Study|Other Adverse Event (AE)|33
7719213|NCT01015118|26842324|P1|Overall Study|Other Adverse Event (AE)|141
7719214|NCT01015118|26842323|P2|Overall Study|Withdrawal by Subject|27
7719215|NCT01015118|26842324|P1|Overall Study|Withdrawal by Subject|103
7719216|NCT01015118|26842323|P2|Overall Study|Protocol Violation|6
7719217|NCT01015118|26842324|P1|Overall Study|Protocol Violation|5
7719218|NCT01014988|26842352|P6|Overall Study|Withdrawal by Subject|0
7719219|NCT01014988|26842353|P5|Overall Study|Withdrawal by Subject|0
7719220|NCT01014988|26842354|P4|Overall Study|Withdrawal by Subject|0
7719221|NCT01014988|26842355|P3|Overall Study|Withdrawal by Subject|0
7719222|NCT01014988|26842356|P2|Overall Study|Withdrawal by Subject|0
7719223|NCT01014988|26842357|P1|Overall Study|Withdrawal by Subject|1
7719224|NCT01014988|26842352|P6|Overall Study|Physician Decision|0
7719225|NCT01014988|26842353|P5|Overall Study|Physician Decision|0
7719226|NCT01014988|26842354|P4|Overall Study|Physician Decision|0
7719227|NCT01014988|26842355|P3|Overall Study|Physician Decision|0
7719228|NCT01014988|26842356|P2|Overall Study|Physician Decision|0
7719229|NCT01014988|26842357|P1|Overall Study|Physician Decision|1
7719230|NCT01014988|26842352|P6|Overall Study|Lost to Follow-up|0
7719231|NCT01014988|26842353|P5|Overall Study|Lost to Follow-up|0
7719232|NCT01014988|26842354|P4|Overall Study|Lost to Follow-up|0
7719233|NCT01014988|26842355|P3|Overall Study|Lost to Follow-up|1
7719234|NCT01014988|26842356|P2|Overall Study|Lost to Follow-up|0
7719235|NCT01014988|26842357|P1|Overall Study|Lost to Follow-up|1
7719236|NCT01014988|26842352|P6|Overall Study|Adverse Event|3
7719237|NCT01014988|26842353|P5|Overall Study|Adverse Event|1
7719238|NCT01014988|26842354|P4|Overall Study|Adverse Event|0
7719239|NCT01014988|26842355|P3|Overall Study|Adverse Event|1
7719240|NCT01014988|26842356|P2|Overall Study|Adverse Event|0
7719241|NCT01014988|26842357|P1|Overall Study|Adverse Event|20
7719242|NCT01014975|26842529|P3|Overall Study|Lost to Follow-up|1
7719243|NCT01014975|26842530|P2|Overall Study|Lost to Follow-up|0
7719244|NCT01014975|26842531|P1|Overall Study|Lost to Follow-up|0
7719245|NCT01014975|26842529|P3|Overall Study|Death|4
7719246|NCT01014975|26842530|P2|Overall Study|Death|3
7719247|NCT01014975|26842531|P1|Overall Study|Death|3
7719248|NCT01014975|26842529|P3|Overall Study|Withdrawal by Subject|1
7719249|NCT01014975|26842530|P2|Overall Study|Withdrawal by Subject|0
7719250|NCT01014975|26842531|P1|Overall Study|Withdrawal by Subject|1
7719251|NCT01014910|26843036|P2|Overall Study|Withdrawal by Subject|2
7719252|NCT01014910|26843037|P1|Overall Study|Withdrawal by Subject|0
7719253|NCT01014767|26843055|P4|Overall Study|PI left institution, data unavailable|1
7719254|NCT01014767|26843056|P3|Overall Study|PI left institution, data unavailable|4
7719255|NCT01014767|26843057|P2|Overall Study|PI left institution, data unavailable|1
7719256|NCT01014767|26843058|P1|Overall Study|PI left institution, data unavailable|12
7719257|NCT01014689|26843102|P2|Overall Study|Pregnancy|0
7719258|NCT01014689|26843103|P1|Overall Study|Pregnancy|1
7719259|NCT01014689|26843102|P2|Overall Study|Lost to Follow-up|7
7719260|NCT01014689|26843103|P1|Overall Study|Lost to Follow-up|3
7719261|NCT01014689|26843102|P2|Overall Study|Protocol Violation|1
7719262|NCT01014689|26843103|P1|Overall Study|Protocol Violation|1
7719263|NCT01014689|26843102|P2|Overall Study|Withdrawal by Subject|4
7719264|NCT01014689|26843103|P1|Overall Study|Withdrawal by Subject|5
7719265|NCT01014689|26843102|P2|Overall Study|Adverse Event|0
7719266|NCT01014689|26843103|P1|Overall Study|Adverse Event|3
7719267|NCT01014689|26843102|P2|Overall Study|Lack of Efficacy|1
7719268|NCT01014689|26843103|P1|Overall Study|Lack of Efficacy|0
7719269|NCT01014624|26843113|P2|Overall Study|Withdrawal by Subject|0
7719270|NCT01014624|26843114|P1|Overall Study|Withdrawal by Subject|1
7719271|NCT01014624|26843113|P2|Overall Study|Protocol Violation|0
7719272|NCT01014624|26843114|P1|Overall Study|Protocol Violation|1
7719273|NCT01014624|26843113|P2|Overall Study|Adverse Event|1
7719274|NCT01014624|26843114|P1|Overall Study|Adverse Event|0
7719275|NCT01014585|26843138|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
7719276|NCT01014585|26843139|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
7719277|NCT01014585|26843140|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
7719278|NCT01014585|26843141|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
7719279|NCT01014585|26843138|P4|Overall Study|Lost to Follow-up|2
7719280|NCT01014585|26843139|P3|Overall Study|Lost to Follow-up|0
7719281|NCT01014585|26843140|P2|Overall Study|Lost to Follow-up|0
7719282|NCT01014585|26843141|P1|Overall Study|Lost to Follow-up|0
7719283|NCT01014585|26843138|P4|Overall Study|Withdrawal by Subject|3
7719284|NCT01014585|26843139|P3|Overall Study|Withdrawal by Subject|1
7719285|NCT01014585|26843140|P2|Overall Study|Withdrawal by Subject|0
7719286|NCT01014585|26843141|P1|Overall Study|Withdrawal by Subject|2
7719287|NCT01014585|26843138|P4|Overall Study|Adverse Event|3
7719288|NCT01014585|26843139|P3|Overall Study|Adverse Event|0
7719289|NCT01014585|26843140|P2|Overall Study|Adverse Event|2
7719290|NCT01014585|26843141|P1|Overall Study|Adverse Event|0
7719291|NCT01014533|26843161|P2|Overall Study|unable to come to appointment|3
7719292|NCT01014533|26843162|P1|Overall Study|unable to come to appointment|0
7719293|NCT01014533|26843161|P2|Overall Study|Withdrawal by Subject|0
7719294|NCT01014533|26843162|P1|Overall Study|Withdrawal by Subject|2
7719295|NCT01014533|26843161|P2|Overall Study|Protocol Violation|2
7719296|NCT01014533|26843162|P1|Overall Study|Protocol Violation|3
7719297|NCT01014442|26843183|P2|Overall Study|Unspecified Reason|1
7719298|NCT01014442|26843184|P1|Overall Study|Unspecified Reason|1
7719299|NCT01014442|26843183|P2|Overall Study|Lack of Compliance|1
7719300|NCT01014442|26843184|P1|Overall Study|Lack of Compliance|0
7719301|NCT01014442|26843183|P2|Overall Study|Protocol Violation|5
7719302|NCT01014442|26843184|P1|Overall Study|Protocol Violation|2
7719303|NCT01014442|26843183|P2|Overall Study|Withdrawal by Subject|4
7719304|NCT01014442|26843184|P1|Overall Study|Withdrawal by Subject|4
7719305|NCT01014442|26843183|P2|Overall Study|Adverse Event|8
7719306|NCT01014442|26843184|P1|Overall Study|Adverse Event|0
7719307|NCT01014208|26843321|P2|Overall Study|Study Closed/terminated|83
7719308|NCT01014208|26843322|P1|Overall Study|Study Closed/terminated|78
7719309|NCT01014208|26843321|P2|Overall Study|Did Not Receive Study Drug|0
7719310|NCT01014208|26843322|P1|Overall Study|Did Not Receive Study Drug|2
7719311|NCT01014208|26843321|P2|Overall Study|Participant Withdrew Consent|12
7719312|NCT01014208|26843322|P1|Overall Study|Participant Withdrew Consent|12
7719313|NCT01014208|26843321|P2|Overall Study|Lost to Follow-up|5
7719314|NCT01014208|26843322|P1|Overall Study|Lost to Follow-up|2
7719315|NCT01014143|26843364|P3|Second Intervention|Lost to Follow-up|0
7719316|NCT01014143|26843365|P2|Second Intervention|Lost to Follow-up|0
7719317|NCT01014143|26843366|P1|Second Intervention|Lost to Follow-up|2
7719318|NCT01014013|26843461|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
7719319|NCT01014013|26843462|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
7719320|NCT01014013|26843461|P2|Overall Study|Appendectomy|0
7719321|NCT01014013|26843462|P1|Overall Study|Appendectomy|1
7719322|NCT01014013|26843461|P2|Overall Study|Another antibiotic therapy required|1
7719323|NCT01014013|26843462|P1|Overall Study|Another antibiotic therapy required|0
7719324|NCT01014013|26843461|P2|Overall Study|Physician Decision|1
7719325|NCT01014013|26843462|P1|Overall Study|Physician Decision|0
7719326|NCT01014013|26843461|P2|Overall Study|Pathogen resistant|4
7719327|NCT01014013|26843462|P1|Overall Study|Pathogen resistant|7
7719328|NCT01014013|26843461|P2|Overall Study|Negative urine culture|0
7719329|NCT01014013|26843462|P1|Overall Study|Negative urine culture|2
7719330|NCT01014013|26843461|P2|Overall Study|Pathogen culture = no growth|34
7719331|NCT01014013|26843462|P1|Overall Study|Pathogen culture = no growth|26
7719332|NCT01014013|26843461|P2|Overall Study|Clinical/microbiologic failure|2
7719333|NCT01014013|26843462|P1|Overall Study|Clinical/microbiologic failure|1
7719334|NCT01014013|26843461|P2|Overall Study|Withdrawal by Subject|4
7719335|NCT01014013|26843462|P1|Overall Study|Withdrawal by Subject|7
7719336|NCT01014013|26843461|P2|Overall Study|Protocol Violation|3
7719337|NCT01014013|26843462|P1|Overall Study|Protocol Violation|1
7719338|NCT01014013|26843461|P2|Overall Study|Laboratory adverse experience|1
7719339|NCT01014013|26843462|P1|Overall Study|Laboratory adverse experience|1
7719340|NCT01014013|26843461|P2|Overall Study|Clinical adverse experience|2
7719341|NCT01014013|26843462|P1|Overall Study|Clinical adverse experience|4
7719342|NCT01014013|26843461|P2|Overall Study|Inclusion/Exclusion criteria not met|3
7719343|NCT01014013|26843462|P1|Overall Study|Inclusion/Exclusion criteria not met|1
7719344|NCT01013961|26843474|P2|Overall Study|Physician Decision|1
7719345|NCT01013961|26843475|P1|Overall Study|Physician Decision|0
7719346|NCT01013961|26843474|P2|Overall Study|Withdrawal by Subject|0
7719347|NCT01013961|26843475|P1|Overall Study|Withdrawal by Subject|1
7719348|NCT01013961|26843474|P2|Overall Study|Adverse Event|2
7719349|NCT01013961|26843475|P1|Overall Study|Adverse Event|2
7719350|NCT01013883|26843493|P2|Overall Study|Lost to Follow-up|2
7719351|NCT01013883|26843494|P1|Overall Study|Lost to Follow-up|2
7719352|NCT01013870|26843506|P2|Overall Study|Lost to Follow-up|3
7719353|NCT01013870|26843507|P1|Overall Study|Lost to Follow-up|1
7719354|NCT01013792|26843556|P2|Overall Study|Lost to Follow-up|1
7719355|NCT01013792|26843557|P1|Overall Study|Lost to Follow-up|0
7719356|NCT01013792|26843556|P2|Overall Study|Adverse Event|3
7719357|NCT01013792|26843557|P1|Overall Study|Adverse Event|0
7719358|NCT01013792|26843556|P2|Overall Study|Study suspended|1
7719359|NCT01013792|26843557|P1|Overall Study|Study suspended|2
7719360|NCT01013753|26843563|P1|Overall Study|Other|2
7719361|NCT01013753|26843563|P1|Overall Study|Withdrawal by Subject|2
7719362|NCT01013753|26843563|P1|Overall Study|Lost to Follow-up|1
7719363|NCT01013753|26843563|P1|Overall Study|Protocol Violation|3
7719364|NCT01013753|26843563|P1|Overall Study|Adverse Event|8
7719365|NCT01013740|26843759|P2|Overall Study|Ongoing: Study records not completed|2
7719366|NCT01013740|26843760|P1|Overall Study|Ongoing: Study records not completed|0
7719367|NCT01013740|26843759|P2|Overall Study|Missing|1
7719368|NCT01013740|26843760|P1|Overall Study|Missing|2
7719369|NCT01013740|26843759|P2|Overall Study|study close / terminated : done in error|1
7719370|NCT01013740|26843760|P1|Overall Study|study close / terminated : done in error|2
7719371|NCT01013740|26843759|P2|Overall Study|Withdrawal by Subject|10
7719372|NCT01013740|26843760|P1|Overall Study|Withdrawal by Subject|2
7719373|NCT01013740|26843759|P2|Overall Study|Physician Decision|0
7719374|NCT01013740|26843760|P1|Overall Study|Physician Decision|2
7719375|NCT01013740|26843759|P2|Overall Study|Lost to Follow-up|5
7719376|NCT01013740|26843760|P1|Overall Study|Lost to Follow-up|3
7719377|NCT01013701|26843784|P1|Overall Study|study prematurely terminated|7
7719378|NCT01013597|26843791|P1|Overall Study|Withdrawal by Subject|1
7719379|NCT01013350|26843803|P2|Overall Study|Other|25
7719380|NCT01013350|26843804|P1|Overall Study|Other|1
7719381|NCT01013350|26843803|P2|Overall Study|Participant entered interventional study|8
7719382|NCT01013350|26843804|P1|Overall Study|Participant entered interventional study|0
7719383|NCT01013350|26843803|P2|Overall Study|Death|5
7719384|NCT01013350|26843804|P1|Overall Study|Death|3
7719385|NCT01013350|26843803|P2|Overall Study|Withdrawal by Subject|38
7719386|NCT01013350|26843804|P1|Overall Study|Withdrawal by Subject|15
7719387|NCT01013350|26843803|P2|Overall Study|Physician Decision|20
7719388|NCT01013350|26843804|P1|Overall Study|Physician Decision|4
7719389|NCT01013350|26843803|P2|Overall Study|Adverse Event|1
7719390|NCT01013350|26843804|P1|Overall Study|Adverse Event|0
7719391|NCT01013350|26843803|P2|Overall Study|Lost to Follow-up|95
7719392|NCT01013350|26843804|P1|Overall Study|Lost to Follow-up|15
7719393|NCT01013285|26843817|P2|Overall Study|Death|89
7719394|NCT01013285|26843818|P1|Overall Study|Death|48
7719395|NCT01013207|26843831|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
7719396|NCT01012999|26843849|P1|Overall Study|Protocol Violation|1
7719397|NCT01012973|26843855|P2|Overall Study|Withdrawal by Subject|6
7719398|NCT01012973|26843856|P1|Overall Study|Withdrawal by Subject|4
7719399|NCT01012973|26843855|P2|Overall Study|Protocol Violation|2
7719400|NCT01012973|26843856|P1|Overall Study|Protocol Violation|5
7719401|NCT01012973|26843855|P2|Overall Study|Increase in vis. acuity, never injected|1
7719402|NCT01012973|26843856|P1|Overall Study|Increase in vis. acuity, never injected|0
7719403|NCT01012973|26843855|P2|Overall Study|(Overseas travel - indefinite period)|0
7719404|NCT01012973|26843856|P1|Overall Study|(Overseas travel - indefinite period)|1
7719405|NCT01012973|26843855|P2|Overall Study|Lost to Follow-up|0
7719406|NCT01012973|26843856|P1|Overall Study|Lost to Follow-up|1
7719407|NCT01012973|26843855|P2|Overall Study|Lack of Efficacy|5
7719408|NCT01012973|26843856|P1|Overall Study|Lack of Efficacy|0
7719409|NCT01012973|26843855|P2|Overall Study|Adverse Event|5
7719410|NCT01012973|26843856|P1|Overall Study|Adverse Event|5
7719411|NCT01012947|26843881|P5|Overall Study|Lost to Follow-up|142
7719412|NCT01012947|26843882|P4|Overall Study|Lost to Follow-up|118
7719413|NCT01012947|26843883|P3|Overall Study|Lost to Follow-up|130
7719414|NCT01012947|26843884|P2|Overall Study|Lost to Follow-up|135
7719415|NCT01012947|26843885|P1|Overall Study|Lost to Follow-up|131
7719416|NCT01012765|26843906|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
7719417|NCT01012765|26843907|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
7719418|NCT01012765|26843908|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
7719419|NCT01012765|26843909|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
7719420|NCT01012765|26843910|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
7719421|NCT01012765|26843911|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
7719422|NCT01012765|26843906|P6|Treatment Period 2|Adverse Event|0
7719423|NCT01012765|26843907|P5|Treatment Period 2|Adverse Event|0
7719424|NCT01012765|26843908|P4|Treatment Period 2|Adverse Event|0
7719425|NCT01012765|26843909|P3|Treatment Period 2|Adverse Event|1
7719426|NCT01012765|26843910|P2|Treatment Period 2|Adverse Event|1
7719427|NCT01012765|26843911|P1|Treatment Period 2|Adverse Event|0
7719428|NCT01012765|26843906|P6|Treatment Period 2|Abnormal laboratory value(s)|1
7719429|NCT01012765|26843907|P5|Treatment Period 2|Abnormal laboratory value(s)|0
7719430|NCT01012765|26843908|P4|Treatment Period 2|Abnormal laboratory value(s)|0
7719431|NCT01012765|26843909|P3|Treatment Period 2|Abnormal laboratory value(s)|0
7719432|NCT01012765|26843910|P2|Treatment Period 2|Abnormal laboratory value(s)|0
7719433|NCT01012765|26843911|P1|Treatment Period 2|Abnormal laboratory value(s)|0
7719434|NCT01012765|26843906|P6|Treatment Period 2|Withdrawal by Subject|0
7719435|NCT01012765|26843907|P5|Treatment Period 2|Withdrawal by Subject|1
7719436|NCT01012765|26843908|P4|Treatment Period 2|Withdrawal by Subject|0
7719437|NCT01012765|26843909|P3|Treatment Period 2|Withdrawal by Subject|1
7719438|NCT01012765|26843910|P2|Treatment Period 2|Withdrawal by Subject|0
7719439|NCT01012765|26843911|P1|Treatment Period 2|Withdrawal by Subject|1
7719440|NCT01012765|26843906|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
7719441|NCT01012765|26843907|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
7719442|NCT01012765|26843908|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
7719443|NCT01012765|26843909|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
7719444|NCT01012765|26843910|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
7719445|NCT01012765|26843911|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
7719446|NCT01012765|26843906|P6|Treatment Period 1|Protocol Violation|0
7719447|NCT01012765|26843907|P5|Treatment Period 1|Protocol Violation|1
7719448|NCT01012765|26843908|P4|Treatment Period 1|Protocol Violation|2
7719449|NCT01012765|26843909|P3|Treatment Period 1|Protocol Violation|0
7719450|NCT01012765|26843910|P2|Treatment Period 1|Protocol Violation|0
7719451|NCT01012765|26843911|P1|Treatment Period 1|Protocol Violation|0
7719452|NCT01012765|26843906|P6|Treatment Period 1|Administrative problems|0
7719453|NCT01012765|26843907|P5|Treatment Period 1|Administrative problems|1
7719454|NCT01012765|26843908|P4|Treatment Period 1|Administrative problems|1
7719455|NCT01012765|26843909|P3|Treatment Period 1|Administrative problems|1
7719456|NCT01012765|26843910|P2|Treatment Period 1|Administrative problems|0
7719457|NCT01012765|26843911|P1|Treatment Period 1|Administrative problems|0
7719458|NCT01012765|26843906|P6|Treatment Period 1|Withdrawal by Subject|0
7719459|NCT01012765|26843907|P5|Treatment Period 1|Withdrawal by Subject|0
7719460|NCT01012765|26843908|P4|Treatment Period 1|Withdrawal by Subject|0
7719461|NCT01012765|26843909|P3|Treatment Period 1|Withdrawal by Subject|0
7719462|NCT01012765|26843910|P2|Treatment Period 1|Withdrawal by Subject|0
7719463|NCT01012765|26843911|P1|Treatment Period 1|Withdrawal by Subject|2
7719464|NCT01012765|26843906|P6|Treatment Period 1|Adverse Event|0
7719465|NCT01012765|26843907|P5|Treatment Period 1|Adverse Event|0
7719466|NCT01012765|26843908|P4|Treatment Period 1|Adverse Event|0
7719467|NCT01012765|26843909|P3|Treatment Period 1|Adverse Event|1
7719468|NCT01012765|26843910|P2|Treatment Period 1|Adverse Event|0
7719469|NCT01012765|26843911|P1|Treatment Period 1|Adverse Event|1
7719470|NCT01012739|26843940|P4|Treatment Period 2|Abnormal test procedure results|1
7719471|NCT01012739|26843941|P3|Treatment Period 2|Abnormal test procedure results|0
7719472|NCT01012739|26843942|P2|Treatment Period 2|Abnormal test procedure results|0
7719473|NCT01012739|26843943|P1|Treatment Period 2|Abnormal test procedure results|0
7719474|NCT01012739|26843940|P4|Treatment Period 1|Adverse Event|1
7719475|NCT01012739|26843941|P3|Treatment Period 1|Adverse Event|0
7719476|NCT01012739|26843942|P2|Treatment Period 1|Adverse Event|0
7719477|NCT01012739|26843943|P1|Treatment Period 1|Adverse Event|0
7719478|NCT01012713|26843971|P1|Overall Study|Lack of Efficacy|3
7719479|NCT01012622|26843997|P1|Overall Study|withdrawal of consent by a parent|2
7719480|NCT01012622|26843997|P1|Overall Study|screening failure|1
7719481|NCT01012622|26843997|P1|Overall Study|Other|1
7719482|NCT01012622|26843997|P1|Overall Study|non-compliance with the drug|9
7719483|NCT01012622|26843997|P1|Overall Study|Adverse Event|7
7719484|NCT01012622|26843997|P1|Overall Study|Lost to Follow-up|5
7719485|NCT01012622|26843997|P1|Overall Study|Withdrawal by Subject|6
7719486|NCT01012609|26844018|P2|Overall Study|Withdrawal by Subject|1
7719487|NCT01012609|26844019|P1|Overall Study|Withdrawal by Subject|1
7719488|NCT01012440|26844047|P1|Overall Study|Withdrawal by Subject|2
7719489|NCT01012414|26844051|P1|Overall Study|Trial was stopped before completed|7
7719490|NCT01012414|26844051|P1|Overall Study|Lost to Follow-up|1
7719491|NCT01012414|26844051|P1|Overall Study|Withdrawal by Subject|2
7719492|NCT01012323|26844092|P1|Overall Study|Investigator Judgment|1
7719493|NCT01012258|26844129|P1|Overall Study|Ongoing|29
7719494|NCT01012258|26844129|P1|Overall Study|Another Tumor Discovered|1
7719495|NCT01012258|26844129|P1|Overall Study|Another Anti-cancer Drug Received|1
7719496|NCT01012258|26844129|P1|Overall Study|Symptomatic Deterioration|1
7719497|NCT01012258|26844129|P1|Overall Study|Progressive Disease (PD)|18
7719498|NCT01012258|26844129|P1|Overall Study|Adverse Event|1
7719499|NCT01012258|26844129|P1|Overall Study|Lost to Follow-up|1
7719500|NCT01012258|26844129|P1|Overall Study|Death|14
7719501|NCT01012219|26844176|P1|Period 2|Withdrawal by Subject|1
7719502|NCT01012219|26844176|P1|Period 1|Withdrawal by Subject|1
7719503|NCT01012037|26844467|P3|Overall Study|Other reason (not specified)|1
7719504|NCT01012037|26844468|P2|Overall Study|Other reason (not specified)|1
7719505|NCT01012037|26844469|P1|Overall Study|Other reason (not specified)|1
7719506|NCT01012037|26844467|P3|Overall Study|Withdrawal by Subject|1
7719507|NCT01012037|26844468|P2|Overall Study|Withdrawal by Subject|4
7719508|NCT01012037|26844469|P1|Overall Study|Withdrawal by Subject|0
7719509|NCT01012037|26844467|P3|Overall Study|Protocol Violation|5
7719510|NCT01012037|26844468|P2|Overall Study|Protocol Violation|3
7719511|NCT01012037|26844469|P1|Overall Study|Protocol Violation|0
7719512|NCT01012037|26844467|P3|Overall Study|Adverse Event|3
7719513|NCT01012037|26844468|P2|Overall Study|Adverse Event|8
7719514|NCT01012037|26844469|P1|Overall Study|Adverse Event|0
7719515|NCT01011946|26844504|P1|Overall Study|No pathological lab value|1
7719516|NCT01011946|26844504|P1|Overall Study|Transferred to another hospital|2
7719517|NCT01011933|26844508|P1|Overall Study|Never treated|1
7719518|NCT01011933|26844508|P1|Overall Study|Inadequate pathology|1
7719519|NCT01011933|26844508|P1|Overall Study|Improper pre-protocol Rx|1
7719520|NCT01011933|26844508|P1|Overall Study|Wrong cell type|1
7719521|NCT01011907|26844525|P2|Overall Study|Adverse Event|4
7719522|NCT01011907|26844526|P1|Overall Study|Adverse Event|1
7719523|NCT01011907|26844525|P2|Overall Study|Withdrawal by Subject|11
7719524|NCT01011907|26844526|P1|Overall Study|Withdrawal by Subject|13
7719525|NCT01011868|26844543|P3|After Week 78 Follow-up|Other reason not defined above|16
7719526|NCT01011868|26844544|P2|After Week 78 Follow-up|Other reason not defined above|5
7719527|NCT01011868|26844545|P1|After Week 78 Follow-up|Other reason not defined above|5
7719528|NCT01011868|26844543|P3|After Week 78 Follow-up|Withdrawal by Subject|1
7719529|NCT01011868|26844544|P2|After Week 78 Follow-up|Withdrawal by Subject|8
7719530|NCT01011868|26844545|P1|After Week 78 Follow-up|Withdrawal by Subject|9
7719531|NCT01011868|26844543|P3|After Week 78 Follow-up|Lost to Follow-up|4
7719532|NCT01011868|26844544|P2|After Week 78 Follow-up|Lost to Follow-up|6
7719533|NCT01011868|26844545|P1|After Week 78 Follow-up|Lost to Follow-up|11
7719534|NCT01011868|26844543|P3|After Week 78 Follow-up|Protocol Violation|2
7719535|NCT01011868|26844544|P2|After Week 78 Follow-up|Protocol Violation|1
7719536|NCT01011868|26844545|P1|After Week 78 Follow-up|Protocol Violation|9
7719537|NCT01011868|26844543|P3|After Week 78 Follow-up|Lack of Efficacy|0
7719538|NCT01011868|26844544|P2|After Week 78 Follow-up|Lack of Efficacy|0
7719539|NCT01011868|26844545|P1|After Week 78 Follow-up|Lack of Efficacy|4
7719540|NCT01011868|26844543|P3|After Week 78 Follow-up|Adverse Event|21
7719541|NCT01011868|26844544|P2|After Week 78 Follow-up|Adverse Event|18
7719542|NCT01011868|26844545|P1|After Week 78 Follow-up|Adverse Event|14
7719543|NCT01011868|26844543|P3|After Week 18 Follow-up|Other reason not defined above|12
7719544|NCT01011868|26844544|P2|After Week 18 Follow-up|Other reason not defined above|3
7719545|NCT01011868|26844545|P1|After Week 18 Follow-up|Other reason not defined above|2
7719546|NCT01011868|26844543|P3|After Week 18 Follow-up|Withdrawal by Subject|0
7719547|NCT01011868|26844544|P2|After Week 18 Follow-up|Withdrawal by Subject|3
7719548|NCT01011868|26844545|P1|After Week 18 Follow-up|Withdrawal by Subject|6
7719549|NCT01011868|26844543|P3|After Week 18 Follow-up|Lost to Follow-up|0
7719550|NCT01011868|26844544|P2|After Week 18 Follow-up|Lost to Follow-up|3
7719551|NCT01011868|26844545|P1|After Week 18 Follow-up|Lost to Follow-up|5
7719552|NCT01011868|26844543|P3|After Week 18 Follow-up|Protocol Violation|1
7719553|NCT01011868|26844544|P2|After Week 18 Follow-up|Protocol Violation|1
7719554|NCT01011868|26844545|P1|After Week 18 Follow-up|Protocol Violation|1
7719555|NCT01011868|26844543|P3|After Week 18 Follow-up|Lack of Efficacy|0
7719556|NCT01011868|26844544|P2|After Week 18 Follow-up|Lack of Efficacy|0
7719557|NCT01011868|26844545|P1|After Week 18 Follow-up|Lack of Efficacy|1
7719558|NCT01011868|26844543|P3|After Week 18 Follow-up|Adverse Event|13
7719559|NCT01011868|26844544|P2|After Week 18 Follow-up|Adverse Event|6
7719560|NCT01011868|26844545|P1|After Week 18 Follow-up|Adverse Event|8
7719561|NCT01011738|26844607|P3|Overall Study|Unknown reasons|17
7719562|NCT01011738|26844608|P2|Overall Study|Unknown reasons|291
7719563|NCT01011738|26844609|P1|Overall Study|Unknown reasons|312
7719564|NCT01011738|26844607|P3|Overall Study|Death|0
7719565|NCT01011738|26844608|P2|Overall Study|Death|3
7719566|NCT01011738|26844609|P1|Overall Study|Death|12
7719567|NCT01011673|26844649|P2|24 Hour Follow-up|Lost to Follow-up|3
7719568|NCT01011673|26844650|P1|24 Hour Follow-up|Lost to Follow-up|3
7719569|NCT01011673|26844649|P2|Randomized|Secondary headache|1
7719570|NCT01011673|26844650|P1|Randomized|Secondary headache|2
7719571|NCT01011556|26844673|P4|Overall Study|Inclusion/exclusion criteria not met|5
7719572|NCT01011556|26844674|P3|Overall Study|Inclusion/exclusion criteria not met|3
7719573|NCT01011556|26844675|P2|Overall Study|Inclusion/exclusion criteria not met|1
7719574|NCT01011556|26844676|P1|Overall Study|Inclusion/exclusion criteria not met|2
7719575|NCT01011556|26844673|P4|Overall Study|Sponsor decision|2
7719576|NCT01011556|26844674|P3|Overall Study|Sponsor decision|1
7719577|NCT01011556|26844675|P2|Overall Study|Sponsor decision|1
7719578|NCT01011556|26844676|P1|Overall Study|Sponsor decision|0
7719579|NCT01011556|26844673|P4|Overall Study|Withdrawal by Subject|4
7719580|NCT01011556|26844674|P3|Overall Study|Withdrawal by Subject|4
7719581|NCT01011556|26844675|P2|Overall Study|Withdrawal by Subject|2
7719582|NCT01011556|26844676|P1|Overall Study|Withdrawal by Subject|1
7719583|NCT01011556|26844673|P4|Overall Study|Protocol Violation|0
7719584|NCT01011556|26844674|P3|Overall Study|Protocol Violation|0
7719585|NCT01011556|26844675|P2|Overall Study|Protocol Violation|1
7719586|NCT01011556|26844676|P1|Overall Study|Protocol Violation|0
7719587|NCT01011556|26844673|P4|Overall Study|Physician Decision|1
7719588|NCT01011556|26844674|P3|Overall Study|Physician Decision|0
7719589|NCT01011556|26844675|P2|Overall Study|Physician Decision|0
7719590|NCT01011556|26844676|P1|Overall Study|Physician Decision|1
7719591|NCT01011556|26844673|P4|Overall Study|Lost to Follow-up|0
7719592|NCT01011556|26844674|P3|Overall Study|Lost to Follow-up|0
7719593|NCT01011556|26844675|P2|Overall Study|Lost to Follow-up|0
7719594|NCT01011556|26844676|P1|Overall Study|Lost to Follow-up|1
7719595|NCT01011556|26844673|P4|Overall Study|Adverse Event|1
7719596|NCT01011556|26844674|P3|Overall Study|Adverse Event|2
7719597|NCT01011556|26844675|P2|Overall Study|Adverse Event|3
7719598|NCT01011556|26844676|P1|Overall Study|Adverse Event|1
7719599|NCT01011465|26844754|P8|Overall Study|Withdrawal by Subject|0
7719600|NCT01011465|26844755|P7|Overall Study|Withdrawal by Subject|1
7719601|NCT01011465|26844756|P6|Overall Study|Withdrawal by Subject|0
7719602|NCT01011465|26844757|P5|Overall Study|Withdrawal by Subject|1
7719603|NCT01011465|26844758|P4|Overall Study|Withdrawal by Subject|0
7719604|NCT01011465|26844759|P3|Overall Study|Withdrawal by Subject|0
7719605|NCT01011465|26844760|P2|Overall Study|Withdrawal by Subject|1
7719606|NCT01011465|26844761|P1|Overall Study|Withdrawal by Subject|2
7719607|NCT01011439|26844789|P1|Overall Study|Sponsor's decision|15
7719608|NCT01011439|26844789|P1|Overall Study|Withdrawal by Subject|1
7719609|NCT01011439|26844789|P1|Overall Study|Lost to Follow-up|4
7719610|NCT01011439|26844789|P1|Overall Study|Death|37
7719611|NCT01011387|26844826|P1|Overall Study|Protocol Violation|1
7719612|NCT01011387|26844826|P1|Overall Study|Adverse Event|2
7719613|NCT01011387|26844826|P1|Overall Study|Withdrawal by Subject|3
7719614|NCT01011335|26844834|P13|Overall Study|Adverse Event|1
7719615|NCT01011335|26844835|P12|Overall Study|Adverse Event|0
7719616|NCT01011335|26844836|P11|Overall Study|Adverse Event|4
7719617|NCT01011335|26844837|P10|Overall Study|Adverse Event|0
7719618|NCT01011335|26844838|P9|Overall Study|Adverse Event|0
7719619|NCT01011335|26844839|P8|Overall Study|Adverse Event|0
7719620|NCT01011335|26844840|P7|Overall Study|Adverse Event|0
7719621|NCT01011335|26844841|P6|Overall Study|Adverse Event|0
7719622|NCT01011335|26844842|P5|Overall Study|Adverse Event|0
7719623|NCT01011335|26844843|P4|Overall Study|Adverse Event|0
7719624|NCT01011335|26844844|P3|Overall Study|Adverse Event|0
7719625|NCT01011335|26844845|P2|Overall Study|Adverse Event|0
7719626|NCT01011335|26844846|P1|Overall Study|Adverse Event|0
7719627|NCT01011335|26844834|P13|Overall Study|Moved/deployed or no booster|0
7719628|NCT01011335|26844835|P12|Overall Study|Moved/deployed or no booster|0
7719629|NCT01011335|26844836|P11|Overall Study|Moved/deployed or no booster|2
7719630|NCT01011335|26844837|P10|Overall Study|Moved/deployed or no booster|0
7719631|NCT01011335|26844838|P9|Overall Study|Moved/deployed or no booster|1
7719632|NCT01011335|26844839|P8|Overall Study|Moved/deployed or no booster|0
7719633|NCT01011335|26844840|P7|Overall Study|Moved/deployed or no booster|1
7719634|NCT01011335|26844841|P6|Overall Study|Moved/deployed or no booster|0
7719635|NCT01011335|26844842|P5|Overall Study|Moved/deployed or no booster|0
7719636|NCT01011335|26844843|P4|Overall Study|Moved/deployed or no booster|1
7719637|NCT01011335|26844844|P3|Overall Study|Moved/deployed or no booster|0
7719638|NCT01011335|26844845|P2|Overall Study|Moved/deployed or no booster|0
7719639|NCT01011335|26844846|P1|Overall Study|Moved/deployed or no booster|1
7719640|NCT01011335|26844834|P13|Overall Study|Protocol Violation|0
7719641|NCT01011335|26844835|P12|Overall Study|Protocol Violation|0
7719642|NCT01011335|26844836|P11|Overall Study|Protocol Violation|0
7719643|NCT01011335|26844837|P10|Overall Study|Protocol Violation|0
7719644|NCT01011335|26844838|P9|Overall Study|Protocol Violation|0
7719645|NCT01011335|26844839|P8|Overall Study|Protocol Violation|0
7719646|NCT01011335|26844840|P7|Overall Study|Protocol Violation|0
7719647|NCT01011335|26844841|P6|Overall Study|Protocol Violation|0
7719648|NCT01011335|26844842|P5|Overall Study|Protocol Violation|0
7719649|NCT01011335|26844843|P4|Overall Study|Protocol Violation|0
7719650|NCT01011335|26844844|P3|Overall Study|Protocol Violation|0
7719651|NCT01011335|26844845|P2|Overall Study|Protocol Violation|1
7719652|NCT01011335|26844846|P1|Overall Study|Protocol Violation|0
7719653|NCT01011335|26844834|P13|Overall Study|Lost to Follow-up|2
7719654|NCT01011335|26844835|P12|Overall Study|Lost to Follow-up|1
7719655|NCT01011335|26844836|P11|Overall Study|Lost to Follow-up|0
7719656|NCT01011335|26844837|P10|Overall Study|Lost to Follow-up|0
7719657|NCT01011335|26844838|P9|Overall Study|Lost to Follow-up|1
7719658|NCT01011335|26844839|P8|Overall Study|Lost to Follow-up|2
7719659|NCT01011335|26844840|P7|Overall Study|Lost to Follow-up|2
7719660|NCT01011335|26844841|P6|Overall Study|Lost to Follow-up|1
7719661|NCT01011335|26844842|P5|Overall Study|Lost to Follow-up|1
7719662|NCT01011335|26844843|P4|Overall Study|Lost to Follow-up|1
7719663|NCT01011335|26844844|P3|Overall Study|Lost to Follow-up|1
7719664|NCT01011335|26844845|P2|Overall Study|Lost to Follow-up|0
7719665|NCT01011335|26844846|P1|Overall Study|Lost to Follow-up|0
7719666|NCT01011309|26844886|P3|Overall Study|Protocol Violation|3
7719667|NCT01011309|26844887|P2|Overall Study|Protocol Violation|1
7719668|NCT01011309|26844888|P1|Overall Study|Protocol Violation|0
7719669|NCT01011309|26844886|P3|Overall Study|Lack of Efficacy|0
7719670|NCT01011309|26844887|P2|Overall Study|Lack of Efficacy|1
7719671|NCT01011309|26844888|P1|Overall Study|Lack of Efficacy|0
7719672|NCT01011309|26844886|P3|Overall Study|Adverse Event|2
7719673|NCT01011309|26844887|P2|Overall Study|Adverse Event|1
7719674|NCT01011309|26844888|P1|Overall Study|Adverse Event|2
7719675|NCT01011283|26844904|P2|Overall Study|Other|2
7719676|NCT01011283|26844905|P1|Overall Study|Other|2
7719677|NCT01011283|26844904|P2|Overall Study|Terminated by Sponsor|5
7719678|NCT01011283|26844905|P1|Overall Study|Terminated by Sponsor|5
7719679|NCT01011283|26844904|P2|Overall Study|Progressive Disease|2
7719680|NCT01011283|26844905|P1|Overall Study|Progressive Disease|0
7719681|NCT01011283|26844904|P2|Overall Study|Adverse Event|2
7719682|NCT01011283|26844905|P1|Overall Study|Adverse Event|4
7719683|NCT01011153|26844964|P3|Overall Study|Less than 78 cases completed|9
7719684|NCT01011153|26844965|P2|Overall Study|Less than 78 cases completed|11
7719685|NCT01011153|26844966|P1|Overall Study|Less than 78 cases completed|8
7719686|NCT01011049|26844995|P4|Overall Study|Withdrawal by Subject|0
7719687|NCT01011049|26844996|P3|Overall Study|Withdrawal by Subject|1
7719688|NCT01011049|26844997|P2|Overall Study|Withdrawal by Subject|0
7719689|NCT01011049|26844998|P1|Overall Study|Withdrawal by Subject|0
7719690|NCT01011049|26844995|P4|Overall Study|Lost to Follow-up|0
7719691|NCT01011049|26844996|P3|Overall Study|Lost to Follow-up|1
7719692|NCT01011049|26844997|P2|Overall Study|Lost to Follow-up|2
7719693|NCT01011049|26844998|P1|Overall Study|Lost to Follow-up|1
7719694|NCT01011049|26844995|P4|Overall Study|Protocol Violation|0
7719695|NCT01011049|26844996|P3|Overall Study|Protocol Violation|2
7719696|NCT01011049|26844997|P2|Overall Study|Protocol Violation|0
7719697|NCT01011049|26844998|P1|Overall Study|Protocol Violation|0
7719698|NCT01010971|26845028|P3|Overall Study|Other|2
7719699|NCT01010971|26845029|P2|Overall Study|Other|0
7719700|NCT01010971|26845030|P1|Overall Study|Other|1
7719701|NCT01010971|26845028|P3|Overall Study|Lost to Follow-up|3
7719702|NCT01010971|26845029|P2|Overall Study|Lost to Follow-up|2
7719703|NCT01010971|26845030|P1|Overall Study|Lost to Follow-up|0
7719704|NCT01010971|26845028|P3|Overall Study|Withdrawal by Subject|5
7719705|NCT01010971|26845029|P2|Overall Study|Withdrawal by Subject|2
7719706|NCT01010971|26845030|P1|Overall Study|Withdrawal by Subject|0
7719707|NCT01010971|26845028|P3|Overall Study|Adverse Event|3
7719708|NCT01010971|26845029|P2|Overall Study|Adverse Event|4
7719709|NCT01010971|26845030|P1|Overall Study|Adverse Event|2
7719710|NCT01010867|26845158|P1|Overall Study|< 50% adherence to probiotic|1
7719711|NCT01010776|26845170|P1|Extension Phase|Other|3
7719712|NCT01010776|26845170|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
7719713|NCT01010776|26845170|P1|Main Phase|Did not received study medication|5
7719714|NCT01010776|26845170|P1|Main Phase|Other|1
7719715|NCT01010776|26845170|P1|Main Phase|Inform consent withdrawal|1
7719716|NCT01010776|26845170|P1|Main Phase|Selection failure|2
7719717|NCT01010776|26845170|P1|Main Phase|Non-compliance to study medication|5
7719718|NCT01010776|26845170|P1|Main Phase|Lost to Follow-up|6
7719719|NCT01010776|26845170|P1|Main Phase|Adverse Event|7
7719720|NCT01010776|26845170|P1|Main Phase|Lack of Efficacy|8
7719721|NCT01010776|26845170|P1|Main Phase|Withdrawal by Subject|14
7719722|NCT01010750|26845227|P6|Second Intervention|Adverse Event|0
7719723|NCT01010750|26845228|P5|Second Intervention|Adverse Event|0
7719724|NCT01010750|26845229|P4|Second Intervention|Adverse Event|0
7719725|NCT01010750|26845230|P3|Second Intervention|Adverse Event|0
7719726|NCT01010750|26845231|P2|Second Intervention|Adverse Event|1
7719727|NCT01010750|26845232|P1|Second Intervention|Adverse Event|0
7719728|NCT01010633|26845257|P2|Overall Study|Investigator decision|1
7719729|NCT01010633|26845258|P1|Overall Study|Investigator decision|0
7719730|NCT01010633|26845257|P2|Overall Study|Withdrawal by Subject|1
7719731|NCT01010633|26845258|P1|Overall Study|Withdrawal by Subject|2
7719732|NCT01010633|26845257|P2|Overall Study|Protocol Violation|2
7719733|NCT01010633|26845258|P1|Overall Study|Protocol Violation|1
7719734|NCT01010633|26845257|P2|Overall Study|Adverse Event|1
7719735|NCT01010633|26845258|P1|Overall Study|Adverse Event|1
7719736|NCT01010503|26845285|P1|Overall Study|Death|1
7719737|NCT01010503|26845285|P1|Overall Study|Adverse Event|1
7719738|NCT01010230|26845344|P2|Overall Study|Lost to Follow-up|2
7719739|NCT01010230|26845345|P1|Overall Study|Lost to Follow-up|4
7719740|NCT01010230|26845344|P2|Overall Study|Withdrawal by Subject|5
7719741|NCT01010230|26845345|P1|Overall Study|Withdrawal by Subject|6
7719742|NCT01010217|26845380|P5|Overall Study|Physician Decision|3
7719743|NCT01010217|26845381|P4|Overall Study|Physician Decision|6
7719744|NCT01010217|26845382|P3|Overall Study|Physician Decision|0
7719745|NCT01010217|26845383|P2|Overall Study|Physician Decision|0
7719746|NCT01010217|26845384|P1|Overall Study|Physician Decision|0
7719747|NCT01010217|26845380|P5|Overall Study|Withdrawal by Subject|0
7719748|NCT01010217|26845381|P4|Overall Study|Withdrawal by Subject|0
7719749|NCT01010217|26845382|P3|Overall Study|Withdrawal by Subject|0
7719750|NCT01010217|26845383|P2|Overall Study|Withdrawal by Subject|0
7719751|NCT01010217|26845384|P1|Overall Study|Withdrawal by Subject|1
7719752|NCT01010217|26845380|P5|Overall Study|Lost to Follow-up|0
7719753|NCT01010217|26845381|P4|Overall Study|Lost to Follow-up|0
7719754|NCT01010217|26845382|P3|Overall Study|Lost to Follow-up|1
7719755|NCT01010217|26845383|P2|Overall Study|Lost to Follow-up|5
7719756|NCT01010217|26845384|P1|Overall Study|Lost to Follow-up|4
7719757|NCT01010204|26845423|P2|Overall Study|psychiatric hospitalization|1
7719758|NCT01010204|26845424|P1|Overall Study|psychiatric hospitalization|2
7719759|NCT01010204|26845423|P2|Overall Study|Withdrawal by Subject|3
7719760|NCT01010204|26845424|P1|Overall Study|Withdrawal by Subject|2
7719761|NCT01010204|26845423|P2|Overall Study|Adverse Event|3
7719762|NCT01010204|26845424|P1|Overall Study|Adverse Event|1
7719763|NCT01010204|26845423|P2|Overall Study|Lost to Follow-up|2
7719764|NCT01010204|26845424|P1|Overall Study|Lost to Follow-up|2
7719765|NCT01010126|26845440|P6|Overall Study|Withdrawal by Subject|0
7719766|NCT01010126|26845441|P5|Overall Study|Withdrawal by Subject|3
7719767|NCT01010126|26845442|P4|Overall Study|Withdrawal by Subject|0
7719768|NCT01010126|26845443|P3|Overall Study|Withdrawal by Subject|1
7719769|NCT01010126|26845444|P2|Overall Study|Withdrawal by Subject|0
7719770|NCT01010126|26845445|P1|Overall Study|Withdrawal by Subject|1
7719771|NCT01010061|26845497|P2|Overall Study|Did Not Receive Treatment|2
7719772|NCT01010061|26845498|P1|Overall Study|Did Not Receive Treatment|2
7719773|NCT01010061|26845497|P2|Overall Study|Violation of Selection Criteria|1
7719774|NCT01010061|26845498|P1|Overall Study|Violation of Selection Criteria|0
7719775|NCT01010061|26845497|P2|Overall Study|Insufficient Therapeutic Response|5
7719776|NCT01010061|26845498|P1|Overall Study|Insufficient Therapeutic Response|1
7719777|NCT01010061|26845497|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
7719778|NCT01010061|26845498|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
7719779|NCT01010061|26845497|P2|Overall Study|Administrative/Other|1
7719780|NCT01010061|26845498|P1|Overall Study|Administrative/Other|0
7719781|NCT01010061|26845497|P2|Overall Study|Death|6
7719782|NCT01010061|26845498|P1|Overall Study|Death|3
7719783|NCT01010061|26845497|P2|Overall Study|Withdrew Consent|1
7719784|NCT01010061|26845498|P1|Overall Study|Withdrew Consent|5
7719785|NCT01010061|26845497|P2|Overall Study|Disease Progression|8
7719786|NCT01010061|26845498|P1|Overall Study|Disease Progression|2
7719787|NCT01010061|26845497|P2|Overall Study|Adverse Events or Intercurrent Illness|16
7719788|NCT01010061|26845498|P1|Overall Study|Adverse Events or Intercurrent Illness|33
7719789|NCT01009983|26845549|P1|Overall Study|necessary scans not completed|1
7719790|NCT01009840|26845587|P1|Overall Study|Subject Withdrew Consent to Participate|1
7719791|NCT01009840|26845587|P1|Overall Study|Subject was Withdrawn by Investigator|1
7719792|NCT01009840|26845587|P1|Overall Study|Subject Met Withdrawal Criteria|7
7719793|NCT01009840|26845587|P1|Overall Study|Adverse Event|4
7719794|NCT01009840|26845587|P1|Overall Study|Lost to Follow-up|1
7719795|NCT01009814|26845605|P5|Overall Study|No longer met study criteria|0
7719796|NCT01009814|26845606|P4|Overall Study|No longer met study criteria|0
7719797|NCT01009814|26845607|P3|Overall Study|No longer met study criteria|0
7719798|NCT01009814|26845608|P2|Overall Study|No longer met study criteria|1
7719799|NCT01009814|26845609|P1|Overall Study|No longer met study criteria|1
7719800|NCT01009645|26845733|P4|Overall Study|Lost to Follow-up|5
7719801|NCT01009645|26845734|P3|Overall Study|Lost to Follow-up|4
7719802|NCT01009645|26845735|P2|Overall Study|Lost to Follow-up|8
7719803|NCT01009645|26845736|P1|Overall Study|Lost to Follow-up|2
7719804|NCT01009580|26845773|P2|Overall Study|Unclassified|21
7719805|NCT01009580|26845774|P1|Overall Study|Unclassified|17
7719806|NCT01009580|26845773|P2|Overall Study|Withdrawal Criteria|6
7719807|NCT01009580|26845774|P1|Overall Study|Withdrawal Criteria|4
7719808|NCT01009580|26845773|P2|Overall Study|Protocol Violation|3
7719809|NCT01009580|26845774|P1|Overall Study|Protocol Violation|2
7719810|NCT01009580|26845773|P2|Overall Study|Lack of Efficacy|1
7719811|NCT01009580|26845774|P1|Overall Study|Lack of Efficacy|0
7719812|NCT01009580|26845773|P2|Overall Study|Adverse Event|4
7719813|NCT01009580|26845774|P1|Overall Study|Adverse Event|4
7719814|NCT01009554|26845788|P2|Overall Study|Noncompliant with Study Product|3
7719815|NCT01009554|26845789|P1|Overall Study|Noncompliant with Study Product|0
7719816|NCT01009554|26845788|P2|Overall Study|Withdrawal by Subject|3
7719817|NCT01009554|26845789|P1|Overall Study|Withdrawal by Subject|1
7719818|NCT01009554|26845788|P2|Overall Study|Adverse Event|1
7719819|NCT01009554|26845789|P1|Overall Study|Adverse Event|1
7719820|NCT01009515|26845921|P1|Overall Study|Withdrawal by Subject|3
7719821|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Physician Decision|8
7719822|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Physician Decision|6
7719823|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Physician Decision|6
7719824|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Physician Decision|4
7719825|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Physician Decision|0
7719826|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
7719827|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7719828|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
7719829|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
7719830|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
7719831|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7719832|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7719833|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7719834|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
7719835|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7719836|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
7719837|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7719838|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
7719839|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
7719840|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7719841|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
7719842|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
7719843|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
7719844|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
7719845|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
7719846|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
7719847|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
7719848|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
7719849|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
7719850|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
7719851|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
7719852|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
7719853|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
7719854|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
7719855|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
7719856|NCT01009463|26845932|P5|52-week, Double-blind Treatment Period|Adverse Event|31
7719857|NCT01009463|26845933|P4|52-week, Double-blind Treatment Period|Adverse Event|29
7719858|NCT01009463|26845934|P3|52-week, Double-blind Treatment Period|Adverse Event|25
7719859|NCT01009463|26845935|P2|52-week, Double-blind Treatment Period|Adverse Event|22
7719860|NCT01009463|26845936|P1|52-week, Double-blind Treatment Period|Adverse Event|0
7719861|NCT01009463|26845932|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7719862|NCT01009463|26845933|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7719863|NCT01009463|26845934|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7719864|NCT01009463|26845935|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7719865|NCT01009463|26845936|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
7719866|NCT01009463|26845932|P5|4-week, Open-label Run-In Period|Physician Decision|0
7719867|NCT01009463|26845933|P4|4-week, Open-label Run-In Period|Physician Decision|0
7719868|NCT01009463|26845934|P3|4-week, Open-label Run-In Period|Physician Decision|0
7719869|NCT01009463|26845935|P2|4-week, Open-label Run-In Period|Physician Decision|0
7719870|NCT01009463|26845936|P1|4-week, Open-label Run-In Period|Physician Decision|10
7719871|NCT01009463|26845932|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
7719872|NCT01009463|26845933|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
7719873|NCT01009463|26845934|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
7719874|NCT01009463|26845935|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
7719875|NCT01009463|26845936|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
7719876|NCT01009463|26845932|P5|4-week, Open-label Run-In Period|Adverse Event|0
7719877|NCT01009463|26845933|P4|4-week, Open-label Run-In Period|Adverse Event|0
7719878|NCT01009463|26845934|P3|4-week, Open-label Run-In Period|Adverse Event|0
7719879|NCT01009463|26845935|P2|4-week, Open-label Run-In Period|Adverse Event|0
7719880|NCT01009463|26845936|P1|4-week, Open-label Run-In Period|Adverse Event|10
7719881|NCT01009463|26845932|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7719882|NCT01009463|26845933|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7719883|NCT01009463|26845934|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7719884|NCT01009463|26845935|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7719885|NCT01009463|26845936|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
7719886|NCT01009346|26845958|P1|Overall Study|Adverse Event|4
7719887|NCT01009294|26845982|P1|Overall Study|Study discontinued by Sponsor|6
7719888|NCT01009281|26846003|P1|Overall Study|Administrative problems|7
7719889|NCT01009203|26846013|P1|Overall Study|Treatment-unrelated death|1
7719890|NCT01009203|26846013|P1|Overall Study|Adverse Event|5
7719891|NCT01009203|26846013|P1|Overall Study|Withdrawal by Subject|1
7719892|NCT01009099|26846053|P2|Overall Study|Death|1
7719893|NCT01009099|26846054|P1|Overall Study|Death|0
7719894|NCT01009099|26846053|P2|Overall Study|Withdrawal by Subject|1
7719895|NCT01009099|26846054|P1|Overall Study|Withdrawal by Subject|1
7719896|NCT01009099|26846053|P2|Overall Study|Physician Decision|2
7719897|NCT01009099|26846054|P1|Overall Study|Physician Decision|3
7719898|NCT01009099|26846053|P2|Overall Study|Lost to Follow-up|0
7719899|NCT01009099|26846054|P1|Overall Study|Lost to Follow-up|1
7719900|NCT01009086|26846063|P3|Overall Study|Other|1
7719901|NCT01009086|26846064|P2|Overall Study|Other|5
7719902|NCT01009086|26846065|P1|Overall Study|Other|3
7719903|NCT01009086|26846063|P3|Overall Study|Withdrawal by Subject|13
7719904|NCT01009086|26846064|P2|Overall Study|Withdrawal by Subject|11
7719905|NCT01009086|26846065|P1|Overall Study|Withdrawal by Subject|9
7719906|NCT01009086|26846063|P3|Overall Study|Adverse Event|8
7719907|NCT01009086|26846064|P2|Overall Study|Adverse Event|11
7719908|NCT01009086|26846065|P1|Overall Study|Adverse Event|12
7719909|NCT01009086|26846063|P3|Overall Study|Lost to Follow-up|3
7719910|NCT01009086|26846064|P2|Overall Study|Lost to Follow-up|5
7719911|NCT01009086|26846065|P1|Overall Study|Lost to Follow-up|4
7719912|NCT01009086|26846063|P3|Overall Study|Lack of Efficacy|9
7719913|NCT01009086|26846064|P2|Overall Study|Lack of Efficacy|15
7719914|NCT01009086|26846065|P1|Overall Study|Lack of Efficacy|16
7719915|NCT01009060|26846100|P2|Overall Study|Withdrawal by Subject|1
7719916|NCT01009060|26846101|P1|Overall Study|Withdrawal by Subject|1
7719917|NCT01009060|26846100|P2|Overall Study|Physician Decision|1
7719918|NCT01009060|26846101|P1|Overall Study|Physician Decision|1
7719919|NCT01009060|26846100|P2|Overall Study|Lost to Follow-up|0
7719920|NCT01009060|26846101|P1|Overall Study|Lost to Follow-up|1
7719921|NCT01009060|26846100|P2|Overall Study|Protocol Violation|1
7719922|NCT01009060|26846101|P1|Overall Study|Protocol Violation|0
7719923|NCT01009060|26846100|P2|Overall Study|Adverse Event|2
7719924|NCT01009060|26846101|P1|Overall Study|Adverse Event|1
7719925|NCT01009047|26846139|P2|Overall Study|Other|2
7719926|NCT01009047|26846140|P1|Overall Study|Other|3
7719927|NCT01009047|26846139|P2|Overall Study|Withdrawal by consent|11
7719928|NCT01009047|26846140|P1|Overall Study|Withdrawal by consent|16
7719929|NCT01009047|26846139|P2|Overall Study|Lack of Efficacy|11
7719930|NCT01009047|26846140|P1|Overall Study|Lack of Efficacy|4
7719931|NCT01009047|26846139|P2|Overall Study|Lost to Follow-up|2
7719932|NCT01009047|26846140|P1|Overall Study|Lost to Follow-up|0
7719933|NCT01009047|26846139|P2|Overall Study|Adverse Event|0
7719934|NCT01009047|26846140|P1|Overall Study|Adverse Event|5
7719935|NCT01009034|26846162|P1|Overall Study|Withdrawal by Subject|2
7719936|NCT01009034|26846162|P1|Overall Study|Lost to Follow-up|2
7719937|NCT01008995|26846170|P4|After Controlled Period|Other|0
7719938|NCT01008995|26846171|P3|After Controlled Period|Other|1
7719939|NCT01008995|26846172|P2|After Controlled Period|Other|0
7719940|NCT01008995|26846173|P1|After Controlled Period|Other|0
7719941|NCT01008995|26846170|P4|After Controlled Period|Adverse Event|1
7719942|NCT01008995|26846171|P3|After Controlled Period|Adverse Event|1
7719943|NCT01008995|26846172|P2|After Controlled Period|Adverse Event|0
7719944|NCT01008995|26846173|P1|After Controlled Period|Adverse Event|0
7719945|NCT01008995|26846170|P4|Controlled Period|Other|0
7719946|NCT01008995|26846171|P3|Controlled Period|Other|0
7719947|NCT01008995|26846172|P2|Controlled Period|Other|1
7719948|NCT01008995|26846173|P1|Controlled Period|Other|2
7719949|NCT01008995|26846170|P4|Controlled Period|Adverse Event|0
7719950|NCT01008995|26846171|P3|Controlled Period|Adverse Event|0
7719951|NCT01008995|26846172|P2|Controlled Period|Adverse Event|2
7719952|NCT01008995|26846173|P1|Controlled Period|Adverse Event|1
7719953|NCT01008943|26846190|P1|Overall Study|Withdrawal by Subject|1
7719954|NCT01008904|26846197|P1|Overall Study|unexpected unrelated surgery|1
7719955|NCT01008904|26846197|P1|Overall Study|Adverse Event|2
7719956|NCT01008904|26846197|P1|Overall Study|Lost to Follow-up|1
7719957|NCT01008748|26846202|P1|Overall Study|Other|1
7719958|NCT01008748|26846202|P1|Overall Study|Lost to Follow-up|80
7719959|NCT01008696|26846227|P2|Overall Study|Other|2
7719960|NCT01008696|26846228|P1|Overall Study|Other|0
7719961|NCT01008696|26846227|P2|Overall Study|Other|3
7719962|NCT01008696|26846228|P1|Overall Study|Other|2
7719963|NCT01008696|26846227|P2|Overall Study|Participants' non-cooperation|3
7719964|NCT01008696|26846228|P1|Overall Study|Participants' non-cooperation|2
7719965|NCT01008696|26846227|P2|Overall Study|Adverse Event|0
7719966|NCT01008696|26846228|P1|Overall Study|Adverse Event|1
7719967|NCT01008696|26846227|P2|Overall Study|Physician Decision|1
7719968|NCT01008696|26846228|P1|Overall Study|Physician Decision|5
7719969|NCT01008696|26846227|P2|Overall Study|Withdrawal by Subject|4
7719970|NCT01008696|26846228|P1|Overall Study|Withdrawal by Subject|2
7719971|NCT01008696|26846227|P2|Overall Study|Participant's evasion of hospital visit|4
7719972|NCT01008696|26846228|P1|Overall Study|Participant's evasion of hospital visit|5
7720129|NCT01007838|26846573|P1|Overall Study|Withdrawal by Subject|1
7719973|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
7719974|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
7719975|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
7719976|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
7719977|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
7719978|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
7719979|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
7719980|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7719981|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7719982|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
7719983|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7719984|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7719985|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|Physician Decision|0
7719986|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|Physician Decision|1
7719987|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|Physician Decision|0
7719988|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7719989|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
7719990|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
7719991|NCT01008618|26846238|P3|Period 2 (Double-Blind Period)|Adverse Event|2
7719992|NCT01008618|26846239|P2|Period 2 (Double-Blind Period)|Adverse Event|11
7719993|NCT01008618|26846240|P1|Period 2 (Double-Blind Period)|Adverse Event|0
7719994|NCT01008618|26846238|P3|Period 1 (Titration Period)|Aggravated symptom|0
7719995|NCT01008618|26846239|P2|Period 1 (Titration Period)|Aggravated symptom|0
7719996|NCT01008618|26846240|P1|Period 1 (Titration Period)|Aggravated symptom|2
7719997|NCT01008618|26846238|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7719998|NCT01008618|26846239|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7719999|NCT01008618|26846240|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
7720000|NCT01008618|26846238|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
7720001|NCT01008618|26846239|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
7720002|NCT01008618|26846240|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
7720003|NCT01008618|26846238|P3|Period 1 (Titration Period)|Adverse Event|0
7720004|NCT01008618|26846239|P2|Period 1 (Titration Period)|Adverse Event|0
7720005|NCT01008618|26846240|P1|Period 1 (Titration Period)|Adverse Event|33
7720006|NCT01008618|26846238|P3|Period 1 (Titration Period)|Physician Decision|0
7720007|NCT01008618|26846239|P2|Period 1 (Titration Period)|Physician Decision|0
7720008|NCT01008618|26846240|P1|Period 1 (Titration Period)|Physician Decision|2
7720009|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
7720010|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
7720011|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
7720012|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
7720013|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7720014|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7720015|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
7720016|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
7720017|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
7720018|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
7720019|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
7720020|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7720021|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
7720022|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
7720023|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
7720024|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7720025|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7720026|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
7720027|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|Adverse Event|4
7720028|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|Adverse Event|14
7720029|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|Adverse Event|0
7720030|NCT01008553|26846289|P3|Period 2 (Double-Blind Period)|Physician Decision|2
7720031|NCT01008553|26846290|P2|Period 2 (Double-Blind Period)|Physician Decision|1
7720032|NCT01008553|26846291|P1|Period 2 (Double-Blind Period)|Physician Decision|0
7720033|NCT01008553|26846289|P3|Period 1 (Titration Period)|Not appropriate for this study|0
7720034|NCT01008553|26846290|P2|Period 1 (Titration Period)|Not appropriate for this study|0
7720035|NCT01008553|26846291|P1|Period 1 (Titration Period)|Not appropriate for this study|1
7720036|NCT01008553|26846289|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7720037|NCT01008553|26846290|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7720038|NCT01008553|26846291|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
7720039|NCT01008553|26846289|P3|Period 1 (Titration Period)|Determined to increase dosage|0
7720040|NCT01008553|26846290|P2|Period 1 (Titration Period)|Determined to increase dosage|0
7720041|NCT01008553|26846291|P1|Period 1 (Titration Period)|Determined to increase dosage|3
7720042|NCT01008553|26846289|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
7720043|NCT01008553|26846290|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
7720044|NCT01008553|26846291|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
7720045|NCT01008553|26846289|P3|Period 1 (Titration Period)|Adverse Event|0
7720046|NCT01008553|26846290|P2|Period 1 (Titration Period)|Adverse Event|0
7720047|NCT01008553|26846291|P1|Period 1 (Titration Period)|Adverse Event|33
7720048|NCT01008553|26846289|P3|Period 1 (Titration Period)|Physician Decision|0
7720049|NCT01008553|26846290|P2|Period 1 (Titration Period)|Physician Decision|0
7720050|NCT01008553|26846291|P1|Period 1 (Titration Period)|Physician Decision|2
7720051|NCT01008475|26846323|P7|Overall Study|Ongoing treatment at data cut-off date|4
7720052|NCT01008475|26846324|P6|Overall Study|Ongoing treatment at data cut-off date|6
7720053|NCT01008475|26846325|P5|Overall Study|Ongoing treatment at data cut-off date|5
7720054|NCT01008475|26846326|P4|Overall Study|Ongoing treatment at data cut-off date|0
7720055|NCT01008475|26846327|P3|Overall Study|Ongoing treatment at data cut-off date|0
7720056|NCT01008475|26846328|P2|Overall Study|Ongoing treatment at data cut-off date|0
7720057|NCT01008475|26846329|P1|Overall Study|Ongoing treatment at data cut-off date|0
7720058|NCT01008449|26846369|P2|Overall Study|Lost to Follow-up|19
7720059|NCT01008449|26846370|P1|Overall Study|Lost to Follow-up|29
7720060|NCT01008423|26846392|P2|Overall Study|Other|1
7720061|NCT01008423|26846393|P1|Overall Study|Other|0
7720062|NCT01008423|26846392|P2|Overall Study|Personal Conflict|0
7720063|NCT01008423|26846393|P1|Overall Study|Personal Conflict|1
7720064|NCT01008423|26846392|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
7720065|NCT01008423|26846393|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
7720066|NCT01008423|26846392|P2|Overall Study|Lack of Efficacy|5
7720067|NCT01008423|26846393|P1|Overall Study|Lack of Efficacy|0
7720068|NCT01008423|26846392|P2|Overall Study|Low Cortisol|1
7720069|NCT01008423|26846393|P1|Overall Study|Low Cortisol|0
7720070|NCT01008423|26846392|P2|Overall Study|Lost to Follow-up|2
7720071|NCT01008423|26846393|P1|Overall Study|Lost to Follow-up|0
7720072|NCT01008423|26846392|P2|Overall Study|Withdrawal by Subject|7
7720073|NCT01008423|26846393|P1|Overall Study|Withdrawal by Subject|4
7720074|NCT01008423|26846392|P2|Overall Study|Adverse Event|6
7720075|NCT01008423|26846393|P1|Overall Study|Adverse Event|13
7720076|NCT01008410|26846419|P2|Overall Study|Met Exclusion Criterion|1
7720077|NCT01008410|26846420|P1|Overall Study|Met Exclusion Criterion|0
7720078|NCT01008410|26846419|P2|Overall Study|Lack of Efficacy|6
7720079|NCT01008410|26846420|P1|Overall Study|Lack of Efficacy|2
7720080|NCT01008410|26846419|P2|Overall Study|Low Cortisol|0
7720081|NCT01008410|26846420|P1|Overall Study|Low Cortisol|2
7720082|NCT01008410|26846419|P2|Overall Study|Noncompliance|0
7720083|NCT01008410|26846420|P1|Overall Study|Noncompliance|1
7720084|NCT01008410|26846419|P2|Overall Study|Lost to Follow-up|0
7720085|NCT01008410|26846420|P1|Overall Study|Lost to Follow-up|1
7720086|NCT01008410|26846419|P2|Overall Study|Withdrawal by Subject|2
7720087|NCT01008410|26846420|P1|Overall Study|Withdrawal by Subject|6
7720088|NCT01008410|26846419|P2|Overall Study|Adverse Event|7
7720089|NCT01008410|26846420|P1|Overall Study|Adverse Event|13
7720094|NCT01007916|26846534|P2|Period 2, 4 Weeks of Wear|Relocation|0
7720095|NCT01007916|26846535|P1|Period 2, 4 Weeks of Wear|Relocation|1
7720096|NCT01007916|26846534|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
7720097|NCT01007916|26846535|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
7720098|NCT01007942|26846543|P2|Overall Study|Patients untreated|3
7720099|NCT01007942|26846544|P1|Overall Study|Patients untreated|4
7720100|NCT01007942|26846543|P2|Overall Study|Death|2
7720101|NCT01007942|26846544|P1|Overall Study|Death|3
7720102|NCT01007942|26846543|P2|Overall Study|Administrative problems|0
7720103|NCT01007942|26846544|P1|Overall Study|Administrative problems|2
7720104|NCT01007942|26846543|P2|Overall Study|Lost to Follow-up|0
7720105|NCT01007942|26846544|P1|Overall Study|Lost to Follow-up|1
7720106|NCT01007942|26846543|P2|Overall Study|Withdrawal by Subject|14
7720107|NCT01007942|26846544|P1|Overall Study|Withdrawal by Subject|19
7720108|NCT01007942|26846543|P2|Overall Study|Protocol Violation|1
7720109|NCT01007942|26846544|P1|Overall Study|Protocol Violation|1
7720110|NCT01007942|26846543|P2|Overall Study|New cancer therapy|1
7720111|NCT01007942|26846544|P1|Overall Study|New cancer therapy|5
7720112|NCT01007942|26846543|P2|Overall Study|Disease progression|242
7720113|NCT01007942|26846544|P1|Overall Study|Disease progression|217
7720114|NCT01007942|26846543|P2|Overall Study|Abnormal test procedure|1
7720115|NCT01007942|26846544|P1|Overall Study|Abnormal test procedure|0
7720116|NCT01007942|26846543|P2|Overall Study|Adverse Event|14
7720117|NCT01007942|26846544|P1|Overall Study|Adverse Event|29
7720118|NCT01007838|26846570|P4|Overall Study|Started home haemodialysis|0
7720119|NCT01007838|26846571|P3|Overall Study|Started home haemodialysis|0
7720120|NCT01007838|26846572|P2|Overall Study|Started home haemodialysis|0
7720121|NCT01007838|26846573|P1|Overall Study|Started home haemodialysis|1
7720122|NCT01007838|26846570|P4|Overall Study|Physician Decision|0
7720123|NCT01007838|26846571|P3|Overall Study|Physician Decision|0
7720124|NCT01007838|26846572|P2|Overall Study|Physician Decision|0
7720125|NCT01007838|26846573|P1|Overall Study|Physician Decision|1
7720126|NCT01007838|26846570|P4|Overall Study|Withdrawal by Subject|0
7720127|NCT01007838|26846571|P3|Overall Study|Withdrawal by Subject|0
7720128|NCT01007838|26846572|P2|Overall Study|Withdrawal by Subject|0
7720130|NCT01007812|26846583|P2|Period 1, One Week|Discomfort|0
7720131|NCT01007812|26846584|P1|Period 1, One Week|Discomfort|1
7720132|NCT01007812|26846583|P2|Period 1, One Week|Lost to Follow-up|1
7720133|NCT01007812|26846584|P1|Period 1, One Week|Lost to Follow-up|0
7720134|NCT01007552|26846634|P1|Overall Study|Withdrawal by Subject|1
7720135|NCT01007448|26846650|P2|Overall Study|Adverse Event|4
7720136|NCT01007448|26846651|P1|Overall Study|Adverse Event|1
7720137|NCT01007448|26846650|P2|Overall Study|Withdrawal by Subject|3
7720138|NCT01007448|26846651|P1|Overall Study|Withdrawal by Subject|2
7720139|NCT01007448|26846650|P2|Overall Study|Lack of Efficacy|0
7720140|NCT01007448|26846651|P1|Overall Study|Lack of Efficacy|2
7720141|NCT01007448|26846650|P2|Overall Study|Progressive Disease|2
7720142|NCT01007448|26846651|P1|Overall Study|Progressive Disease|1
7720143|NCT01007448|26846650|P2|Overall Study|Participant Given Prohibited Medication|0
7720144|NCT01007448|26846651|P1|Overall Study|Participant Given Prohibited Medication|1
7720145|NCT01007448|26846650|P2|Overall Study|Participant Leaving the Country|0
7720146|NCT01007448|26846651|P1|Overall Study|Participant Leaving the Country|1
7720147|NCT01007448|26846650|P2|Overall Study|Staph Skin Infection Flare|0
7720148|NCT01007448|26846651|P1|Overall Study|Staph Skin Infection Flare|1
7720149|NCT01007448|26846650|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
7720150|NCT01007448|26846651|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
7720151|NCT01007435|26846683|P4|Overall Study|Reason not Specified|1
7720152|NCT01007435|26846684|P3|Overall Study|Reason not Specified|2
7720153|NCT01007435|26846685|P2|Overall Study|Reason not Specified|1
7720154|NCT01007435|26846686|P1|Overall Study|Reason not Specified|1
7720155|NCT01007435|26846683|P4|Overall Study|Failure to Return|6
7720156|NCT01007435|26846684|P3|Overall Study|Failure to Return|3
7720157|NCT01007435|26846685|P2|Overall Study|Failure to Return|4
7720158|NCT01007435|26846686|P1|Overall Study|Failure to Return|5
7720159|NCT01007435|26846683|P4|Overall Study|Refused Treatment|8
7720160|NCT01007435|26846684|P3|Overall Study|Refused Treatment|5
7720161|NCT01007435|26846685|P2|Overall Study|Refused Treatment|13
7720162|NCT01007435|26846686|P1|Overall Study|Refused Treatment|13
7720163|NCT01007435|26846683|P4|Overall Study|Other Protocol Violation|0
7720164|NCT01007435|26846684|P3|Overall Study|Other Protocol Violation|1
7720165|NCT01007435|26846685|P2|Overall Study|Other Protocol Violation|0
7720166|NCT01007435|26846686|P1|Overall Study|Other Protocol Violation|2
7720167|NCT01007435|26846683|P4|Overall Study|Violation of Selection Criteria at Entry|0
7720168|NCT01007435|26846684|P3|Overall Study|Violation of Selection Criteria at Entry|2
7720169|NCT01007435|26846685|P2|Overall Study|Violation of Selection Criteria at Entry|5
7720170|NCT01007435|26846686|P1|Overall Study|Violation of Selection Criteria at Entry|3
7720171|NCT01007435|26846683|P4|Overall Study|Insufficient Therapeutic Response|9
7720172|NCT01007435|26846684|P3|Overall Study|Insufficient Therapeutic Response|2
7720173|NCT01007435|26846685|P2|Overall Study|Insufficient Therapeutic Response|7
7720174|NCT01007435|26846686|P1|Overall Study|Insufficient Therapeutic Response|21
7720175|NCT01007435|26846683|P4|Overall Study|Death|1
7720176|NCT01007435|26846684|P3|Overall Study|Death|2
7720177|NCT01007435|26846685|P2|Overall Study|Death|4
7720178|NCT01007435|26846686|P1|Overall Study|Death|2
7720179|NCT01007435|26846683|P4|Overall Study|Adverse Event|31
7720180|NCT01007435|26846684|P3|Overall Study|Adverse Event|47
7720181|NCT01007435|26846685|P2|Overall Study|Adverse Event|25
7720182|NCT01007435|26846686|P1|Overall Study|Adverse Event|16
7720183|NCT01007396|26846728|P1|Overall Study|Lost to Follow-up|47
7720184|NCT01007253|26846733|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
7720185|NCT01007253|26846734|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
7720186|NCT01007253|26846735|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
7720187|NCT01007253|26846736|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
7720188|NCT01007149|26846768|P2|Overall Study|Administrative problems|1
7720189|NCT01007149|26846769|P1|Overall Study|Administrative problems|0
7720190|NCT01007123|26846843|P4|Overall Study|Lost to Follow-up|0
7720191|NCT01007123|26846844|P3|Overall Study|Lost to Follow-up|0
7720192|NCT01007123|26846845|P2|Overall Study|Lost to Follow-up|1
7720193|NCT01007123|26846846|P1|Overall Study|Lost to Follow-up|0
7720194|NCT01007123|26846843|P4|Overall Study|Withdrawal by Subject|0
7720195|NCT01007123|26846844|P3|Overall Study|Withdrawal by Subject|1
7720196|NCT01007123|26846845|P2|Overall Study|Withdrawal by Subject|0
7720197|NCT01007123|26846846|P1|Overall Study|Withdrawal by Subject|1
7720198|NCT01007123|26846843|P4|Overall Study|Protocol Violation|1
7720199|NCT01007123|26846844|P3|Overall Study|Protocol Violation|2
7720200|NCT01007123|26846845|P2|Overall Study|Protocol Violation|1
7720201|NCT01007123|26846846|P1|Overall Study|Protocol Violation|1
7720202|NCT01007123|26846843|P4|Overall Study|Lack of Efficacy|4
7720203|NCT01007123|26846844|P3|Overall Study|Lack of Efficacy|1
7720204|NCT01007123|26846845|P2|Overall Study|Lack of Efficacy|0
7720205|NCT01007123|26846846|P1|Overall Study|Lack of Efficacy|1
7720206|NCT01007123|26846843|P4|Overall Study|Adverse Event|1
7720207|NCT01007123|26846844|P3|Overall Study|Adverse Event|7
7720208|NCT01007123|26846845|P2|Overall Study|Adverse Event|4
7720209|NCT01007123|26846846|P1|Overall Study|Adverse Event|3
7720210|NCT01007032|26846907|P4|Overall Study|Withdrawal by Subject|1
7720211|NCT01007032|26846908|P3|Overall Study|Withdrawal by Subject|0
7720212|NCT01007032|26846909|P2|Overall Study|Withdrawal by Subject|0
7720213|NCT01007032|26846910|P1|Overall Study|Withdrawal by Subject|0
7720214|NCT01007032|26846907|P4|Overall Study|On Study Treatment at Cut-off Date|0
7720215|NCT01007032|26846908|P3|Overall Study|On Study Treatment at Cut-off Date|1
7720216|NCT01007032|26846909|P2|Overall Study|On Study Treatment at Cut-off Date|1
7720217|NCT01007032|26846910|P1|Overall Study|On Study Treatment at Cut-off Date|0
7720218|NCT01006980|26846954|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
7720219|NCT01006980|26846955|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
7720220|NCT01006980|26846954|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
7720221|NCT01006980|26846955|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
7720222|NCT01006980|26846954|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
7720223|NCT01006980|26846955|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
7720224|NCT01006980|26846954|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
7720225|NCT01006980|26846955|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
7720226|NCT01006980|26846954|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
7720227|NCT01006980|26846955|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
7720228|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
7720229|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
7720230|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
7720231|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
7720232|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
7720233|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
7720234|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
7720235|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
7720236|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Progression|218
7720237|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Progression|257
7720238|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Death|12
7720239|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Death|13
7720240|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Adverse Event|5
7720241|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Adverse Event|25
7720242|NCT01006980|26846954|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
7720243|NCT01006980|26846955|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
7720244|NCT01006889|26846994|P1|Overall Study|Withdrawal by Subject|3
7720245|NCT01006707|26847005|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
7720246|NCT01006707|26847006|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
7720247|NCT01006707|26847007|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
7720248|NCT01006707|26847005|P3|Study Session 1|Lost to Follow-up|0
7720249|NCT01006707|26847006|P2|Study Session 1|Lost to Follow-up|0
7720250|NCT01006707|26847007|P1|Study Session 1|Lost to Follow-up|2
7720251|NCT01006629|26847027|P1|Overall Study|Parent unable to perform site visit|4
7720252|NCT01006629|26847027|P1|Overall Study|Parent refused to continue participation|1
7720253|NCT01006629|26847027|P1|Overall Study|Adverse Event|1
7720254|NCT01006616|26847042|P4|Period 2 (18 Months)|Study Terminated|70
7720255|NCT01006616|26847043|P3|Period 2 (18 Months)|Study Terminated|44
7720256|NCT01006616|26847044|P2|Period 2 (18 Months)|Study Terminated|46
7720257|NCT01006616|26847045|P1|Period 2 (18 Months)|Study Terminated|63
7720258|NCT01006616|26847042|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
7720259|NCT01006616|26847043|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
7720260|NCT01006616|26847044|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
7720261|NCT01006616|26847045|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
7720262|NCT01006616|26847042|P4|Period 2 (18 Months)|Withdrawal by Subject|1
7720263|NCT01006616|26847043|P3|Period 2 (18 Months)|Withdrawal by Subject|0
7720264|NCT01006616|26847044|P2|Period 2 (18 Months)|Withdrawal by Subject|4
7720265|NCT01006616|26847045|P1|Period 2 (18 Months)|Withdrawal by Subject|1
7720266|NCT01006616|26847042|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
7720267|NCT01006616|26847043|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
7720268|NCT01006616|26847044|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
7720269|NCT01006616|26847045|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
7720270|NCT01006616|26847042|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
7720271|NCT01006616|26847043|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
7720272|NCT01006616|26847044|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
7720273|NCT01006616|26847045|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
7720274|NCT01006616|26847042|P4|Period 2 (18 Months)|Lost to Follow-up|0
7720275|NCT01006616|26847043|P3|Period 2 (18 Months)|Lost to Follow-up|0
7720276|NCT01006616|26847044|P2|Period 2 (18 Months)|Lost to Follow-up|0
7720277|NCT01006616|26847045|P1|Period 2 (18 Months)|Lost to Follow-up|2
7720278|NCT01006616|26847042|P4|Period 2 (18 Months)|Lack of Efficacy|2
7720279|NCT01006616|26847043|P3|Period 2 (18 Months)|Lack of Efficacy|1
7720280|NCT01006616|26847044|P2|Period 2 (18 Months)|Lack of Efficacy|0
7720281|NCT01006616|26847045|P1|Period 2 (18 Months)|Lack of Efficacy|0
7720282|NCT01006616|26847042|P4|Period 2 (18 Months)|Adverse Event|4
7720283|NCT01006616|26847043|P3|Period 2 (18 Months)|Adverse Event|6
7720284|NCT01006616|26847044|P2|Period 2 (18 Months)|Adverse Event|6
7720285|NCT01006616|26847045|P1|Period 2 (18 Months)|Adverse Event|6
7720286|NCT01006616|26847042|P4|Period 1 (6 Months)|Not Treated|1
7720287|NCT01006616|26847043|P3|Period 1 (6 Months)|Not Treated|1
7720288|NCT01006616|26847044|P2|Period 1 (6 Months)|Not Treated|0
7720289|NCT01006616|26847045|P1|Period 1 (6 Months)|Not Treated|0
7720290|NCT01006616|26847042|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
7720291|NCT01006616|26847043|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
7720292|NCT01006616|26847044|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
7720293|NCT01006616|26847045|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
7720294|NCT01006616|26847042|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7720295|NCT01006616|26847043|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7720296|NCT01006616|26847044|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
7720297|NCT01006616|26847045|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7720298|NCT01006616|26847042|P4|Period 1 (6 Months)|Withdrawal by Subject|0
7720299|NCT01006616|26847043|P3|Period 1 (6 Months)|Withdrawal by Subject|2
7720300|NCT01006616|26847044|P2|Period 1 (6 Months)|Withdrawal by Subject|2
7720301|NCT01006616|26847045|P1|Period 1 (6 Months)|Withdrawal by Subject|2
7720302|NCT01006616|26847042|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
7720303|NCT01006616|26847043|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
7720304|NCT01006616|26847044|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
7720305|NCT01006616|26847045|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
7720306|NCT01006616|26847042|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
7720307|NCT01006616|26847043|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
7720308|NCT01006616|26847044|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
7720309|NCT01006616|26847045|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
7720310|NCT01006616|26847042|P4|Period 1 (6 Months)|Lost to Follow-up|0
7720311|NCT01006616|26847043|P3|Period 1 (6 Months)|Lost to Follow-up|1
7720312|NCT01006616|26847044|P2|Period 1 (6 Months)|Lost to Follow-up|0
7720313|NCT01006616|26847045|P1|Period 1 (6 Months)|Lost to Follow-up|0
7720314|NCT01006616|26847042|P4|Period 1 (6 Months)|Lack of Efficacy|4
7720315|NCT01006616|26847043|P3|Period 1 (6 Months)|Lack of Efficacy|0
7720316|NCT01006616|26847044|P2|Period 1 (6 Months)|Lack of Efficacy|4
7720317|NCT01006616|26847045|P1|Period 1 (6 Months)|Lack of Efficacy|3
7720318|NCT01006616|26847042|P4|Period 1 (6 Months)|Adverse Event|9
7720319|NCT01006616|26847043|P3|Period 1 (6 Months)|Adverse Event|37
7720320|NCT01006616|26847044|P2|Period 1 (6 Months)|Adverse Event|31
7720321|NCT01006616|26847045|P1|Period 1 (6 Months)|Adverse Event|10
7720322|NCT01006603|26847181|P2|Overall Study|Other|7
7720323|NCT01006603|26847182|P1|Overall Study|Other|3
7720324|NCT01006603|26847181|P2|Overall Study|Study specific discontinuation criteria|34
7720325|NCT01006603|26847182|P1|Overall Study|Study specific discontinuation criteria|33
7720326|NCT01006603|26847181|P2|Overall Study|Death|1
7720327|NCT01006603|26847182|P1|Overall Study|Death|1
7720328|NCT01006603|26847181|P2|Overall Study|Adverse Event|7
7720329|NCT01006603|26847182|P1|Overall Study|Adverse Event|15
7720330|NCT01006603|26847181|P2|Overall Study|Incorrect enrolment|2
7720331|NCT01006603|26847182|P1|Overall Study|Incorrect enrolment|0
7720332|NCT01006603|26847181|P2|Overall Study|Protocol Violation|3
7720333|NCT01006603|26847182|P1|Overall Study|Protocol Violation|1
7720334|NCT01006603|26847181|P2|Overall Study|Safety reason|1
7720335|NCT01006603|26847182|P1|Overall Study|Safety reason|1
7720336|NCT01006603|26847181|P2|Overall Study|Lost to Follow-up|1
7720337|NCT01006603|26847182|P1|Overall Study|Lost to Follow-up|0
7720338|NCT01006603|26847181|P2|Overall Study|Withdrawal by Subject|19
7720339|NCT01006603|26847182|P1|Overall Study|Withdrawal by Subject|17
7720340|NCT01006590|26847202|P2|Overall Study|Other|2
7720341|NCT01006590|26847203|P1|Overall Study|Other|3
7720342|NCT01006590|26847202|P2|Overall Study|Study specific discontinuation criteria|23
7720343|NCT01006590|26847203|P1|Overall Study|Study specific discontinuation criteria|16
7720344|NCT01006590|26847202|P2|Overall Study|Withdrawal by Subject|2
7720345|NCT01006590|26847203|P1|Overall Study|Withdrawal by Subject|4
7720346|NCT01006590|26847202|P2|Overall Study|Protocol Violation|0
7720347|NCT01006590|26847203|P1|Overall Study|Protocol Violation|1
7720348|NCT01006590|26847202|P2|Overall Study|Lost to Follow-up|1
7720349|NCT01006590|26847203|P1|Overall Study|Lost to Follow-up|1
7720350|NCT01006590|26847202|P2|Overall Study|Death|1
7720351|NCT01006590|26847203|P1|Overall Study|Death|1
7720352|NCT01006590|26847202|P2|Overall Study|Adverse Event|3
7720353|NCT01006590|26847203|P1|Overall Study|Adverse Event|2
7720354|NCT01006356|26847252|P1|Overall Study|Other|23
7720355|NCT01006356|26847252|P1|Overall Study|Protocol Violation|3
7720356|NCT01006356|26847252|P1|Overall Study|Choice by participants|2
7720357|NCT01006356|26847252|P1|Overall Study|Withdrawal by Subject|1
7720358|NCT01006356|26847252|P1|Overall Study|Paticipants did not cooperate|6
7720359|NCT01006356|26847252|P1|Overall Study|Physician Decision|1
7720360|NCT01006356|26847252|P1|Overall Study|Adverse Event|6
7720361|NCT01006291|26847267|P3|Overall Study|Other|17
7720362|NCT01006291|26847268|P2|Overall Study|Other|14
7720363|NCT01006291|26847269|P1|Overall Study|Other|14
7720364|NCT01006291|26847267|P3|Overall Study|Withdrawal criteria|4
7720365|NCT01006291|26847268|P2|Overall Study|Withdrawal criteria|4
7720366|NCT01006291|26847269|P1|Overall Study|Withdrawal criteria|5
7720367|NCT01006291|26847267|P3|Overall Study|Protocol Violation|3
7720368|NCT01006291|26847268|P2|Overall Study|Protocol Violation|3
7720369|NCT01006291|26847269|P1|Overall Study|Protocol Violation|3
7720370|NCT01006291|26847267|P3|Overall Study|Lack of Efficacy|1
7720371|NCT01006291|26847268|P2|Overall Study|Lack of Efficacy|2
7720372|NCT01006291|26847269|P1|Overall Study|Lack of Efficacy|2
7720373|NCT01006291|26847267|P3|Overall Study|Adverse Event|2
7720374|NCT01006291|26847268|P2|Overall Study|Adverse Event|1
7720375|NCT01006291|26847269|P1|Overall Study|Adverse Event|2
7720376|NCT01006265|26847290|P4|Overall Study|Administrative reason|0
7720377|NCT01006265|26847291|P3|Overall Study|Administrative reason|3
7720378|NCT01006265|26847292|P2|Overall Study|Administrative reason|2
7720379|NCT01006265|26847293|P1|Overall Study|Administrative reason|1
7720380|NCT01006265|26847290|P4|Overall Study|Withdrawal by Subject|5
7720381|NCT01006265|26847291|P3|Overall Study|Withdrawal by Subject|5
7720382|NCT01006265|26847292|P2|Overall Study|Withdrawal by Subject|7
7720383|NCT01006265|26847293|P1|Overall Study|Withdrawal by Subject|4
7720384|NCT01006265|26847290|P4|Overall Study|Lost to Follow-up|0
7720385|NCT01006265|26847291|P3|Overall Study|Lost to Follow-up|1
7720386|NCT01006265|26847292|P2|Overall Study|Lost to Follow-up|0
7720387|NCT01006265|26847293|P1|Overall Study|Lost to Follow-up|1
7720388|NCT01006135|26847344|P1|Overall Study|Other|72
7720389|NCT01006135|26847344|P1|Overall Study|Lost to Follow-up|32
7720390|NCT01006135|26847344|P1|Overall Study|Protocol Violation|14
7720391|NCT01006135|26847344|P1|Overall Study|Adverse Event|22
7720392|NCT01006122|26847351|P2|Second Double-blind Intervention Period|Death|1
7720393|NCT01006122|26847352|P1|Second Double-blind Intervention Period|Death|0
7720394|NCT01006122|26847351|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
7720395|NCT01006122|26847352|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
7720396|NCT01006122|26847351|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
7720397|NCT01006122|26847352|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
7720398|NCT01006122|26847351|P2|Second Double-blind Intervention Period|Protocol Violation|0
7720399|NCT01006122|26847352|P1|Second Double-blind Intervention Period|Protocol Violation|1
7720400|NCT01006122|26847351|P2|Second Double-blind Intervention Period|Adverse Event|1
7720401|NCT01006122|26847352|P1|Second Double-blind Intervention Period|Adverse Event|1
7720402|NCT01006122|26847351|P2|First Double-blind Intervention Period|Adverse Event|4
7720403|NCT01006122|26847352|P1|First Double-blind Intervention Period|Adverse Event|0
7720404|NCT01006122|26847351|P2|First Double-blind Intervention Period|Other|0
7720405|NCT01006122|26847352|P1|First Double-blind Intervention Period|Other|3
7720406|NCT01006122|26847351|P2|First Double-blind Intervention Period|Lack of Efficacy|1
7720407|NCT01006122|26847352|P1|First Double-blind Intervention Period|Lack of Efficacy|2
7720408|NCT01006122|26847351|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
7720409|NCT01006122|26847352|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
7720410|NCT01006122|26847351|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
7720411|NCT01006122|26847352|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
7720412|NCT01006122|26847351|P2|First Double-blind Intervention Period|Pregnancy|1
7720413|NCT01006122|26847352|P1|First Double-blind Intervention Period|Pregnancy|0
7720414|NCT01006122|26847351|P2|First Double-blind Intervention Period|Protocol Violation|1
7720415|NCT01006122|26847352|P1|First Double-blind Intervention Period|Protocol Violation|1
7720416|NCT01006122|26847351|P2|First Double-blind Intervention Period|Lost to Follow-up|2
7720417|NCT01006122|26847352|P1|First Double-blind Intervention Period|Lost to Follow-up|0
7720418|NCT01005966|26847403|P5|Treatment Period 4 (14 Days)|Other Reason|1
7720419|NCT01005966|26847404|P4|Treatment Period 4 (14 Days)|Other Reason|0
7720420|NCT01005966|26847405|P3|Treatment Period 4 (14 Days)|Other Reason|0
7720421|NCT01005966|26847406|P2|Treatment Period 4 (14 Days)|Other Reason|0
7720422|NCT01005966|26847407|P1|Treatment Period 4 (14 Days)|Other Reason|0
7720423|NCT01005966|26847403|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
7720424|NCT01005966|26847404|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
7720425|NCT01005966|26847405|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
7720426|NCT01005966|26847406|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
7720427|NCT01005966|26847407|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
7720428|NCT01005966|26847403|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
7720429|NCT01005966|26847404|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
7720430|NCT01005966|26847405|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
7720431|NCT01005966|26847406|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
7720432|NCT01005966|26847407|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
7720433|NCT01005966|26847403|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7720434|NCT01005966|26847404|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7720435|NCT01005966|26847405|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7720436|NCT01005966|26847406|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7720437|NCT01005966|26847407|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7720438|NCT01005966|26847403|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
7720439|NCT01005966|26847404|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
7720440|NCT01005966|26847405|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
7720441|NCT01005966|26847406|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
7720442|NCT01005966|26847407|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
7720443|NCT01005966|26847403|P5|Treatment Period 2 (14 Days)|Adverse Event|0
7720444|NCT01005966|26847404|P4|Treatment Period 2 (14 Days)|Adverse Event|0
7720445|NCT01005966|26847405|P3|Treatment Period 2 (14 Days)|Adverse Event|1
7720446|NCT01005966|26847406|P2|Treatment Period 2 (14 Days)|Adverse Event|1
7720447|NCT01005966|26847407|P1|Treatment Period 2 (14 Days)|Adverse Event|0
7720448|NCT01005966|26847403|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7720449|NCT01005966|26847404|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
7720450|NCT01005966|26847405|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7720451|NCT01005966|26847406|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7720452|NCT01005966|26847407|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7720453|NCT01005966|26847403|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
7720454|NCT01005966|26847404|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
7720455|NCT01005966|26847405|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
7720456|NCT01005966|26847406|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
7720457|NCT01005966|26847407|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
7720458|NCT01005966|26847403|P5|Treatment Period 1 (14 Days)|Adverse Event|0
7720459|NCT01005966|26847404|P4|Treatment Period 1 (14 Days)|Adverse Event|0
7720460|NCT01005966|26847405|P3|Treatment Period 1 (14 Days)|Adverse Event|0
7720461|NCT01005966|26847406|P2|Treatment Period 1 (14 Days)|Adverse Event|0
7720462|NCT01005966|26847407|P1|Treatment Period 1 (14 Days)|Adverse Event|1
7720463|NCT01005914|26847427|P1|Overall Study|Withdrawal by Subject|1
7720464|NCT01005914|26847427|P1|Overall Study|Lack of Efficacy|1
7720465|NCT01005914|26847427|P1|Overall Study|Death|4
7720466|NCT01005914|26847427|P1|Overall Study|Adverse Event|4
7720467|NCT01005901|26847433|P2|Overall Study|No longer requires study drug|1
7720468|NCT01005901|26847434|P1|Overall Study|No longer requires study drug|0
7720469|NCT01005901|26847433|P2|Overall Study|Patient's inability to use the device|1
7720470|NCT01005901|26847434|P1|Overall Study|Patient's inability to use the device|1
7720471|NCT01005901|26847433|P2|Overall Study|Lost to Follow-up|2
7720472|NCT01005901|26847434|P1|Overall Study|Lost to Follow-up|1
7720473|NCT01005901|26847433|P2|Overall Study|Death|3
7720474|NCT01005901|26847434|P1|Overall Study|Death|2
7720475|NCT01005901|26847433|P2|Overall Study|Protocol Violation|3
7720476|NCT01005901|26847434|P1|Overall Study|Protocol Violation|4
7720477|NCT01005901|26847433|P2|Overall Study|Unsatisfactory therapeutic effect|5
7720478|NCT01005901|26847434|P1|Overall Study|Unsatisfactory therapeutic effect|5
7720479|NCT01005901|26847433|P2|Overall Study|Administrative problems|13
7720480|NCT01005901|26847434|P1|Overall Study|Administrative problems|21
7720481|NCT01005901|26847433|P2|Overall Study|Adverse Event|16
7720482|NCT01005901|26847434|P1|Overall Study|Adverse Event|30
7720483|NCT01005901|26847433|P2|Overall Study|Withdrawal by Subject|14
7720484|NCT01005901|26847434|P1|Overall Study|Withdrawal by Subject|38
7720485|NCT01005875|26847497|P1|Overall Study|Death|3
7720486|NCT01005745|26847514|P1|Overall Study|Inappropriate antidiuretic hormone|1
7720487|NCT01005745|26847514|P1|Overall Study|Death prior to treatment|1
7720488|NCT01005745|26847514|P1|Overall Study|Disease progressed during TIL growth|3
7720489|NCT01005745|26847514|P1|Overall Study|No TIL growth|1
7720490|NCT01005732|26847519|P1|Overall Study|Death|1
7720491|NCT01005732|26847519|P1|Overall Study|Lost to Follow-up|10
7720492|NCT01005719|26847535|P6|Period 2|Adverse Event|1
7720493|NCT01005719|26847536|P5|Period 2|Adverse Event|1
7720494|NCT01005719|26847537|P4|Period 2|Adverse Event|0
7720495|NCT01005719|26847538|P3|Period 2|Adverse Event|0
7720496|NCT01005719|26847539|P2|Period 2|Adverse Event|0
7720497|NCT01005719|26847540|P1|Period 2|Adverse Event|0
7720498|NCT01005719|26847535|P6|Period 1|Delay in completing study procedures|1
7720499|NCT01005719|26847536|P5|Period 1|Delay in completing study procedures|0
7720500|NCT01005719|26847537|P4|Period 1|Delay in completing study procedures|0
7720501|NCT01005719|26847538|P3|Period 1|Delay in completing study procedures|0
7720502|NCT01005719|26847539|P2|Period 1|Delay in completing study procedures|0
7720503|NCT01005719|26847540|P1|Period 1|Delay in completing study procedures|0
7720504|NCT01005719|26847535|P6|Period 1|Adverse Event|0
7720505|NCT01005719|26847536|P5|Period 1|Adverse Event|0
7720506|NCT01005719|26847537|P4|Period 1|Adverse Event|1
7720507|NCT01005719|26847538|P3|Period 1|Adverse Event|0
7720508|NCT01005719|26847539|P2|Period 1|Adverse Event|0
7720509|NCT01005719|26847540|P1|Period 1|Adverse Event|0
7720510|NCT01005680|26847607|P2|Overall Study|Physician Decision|1
7720511|NCT01005680|26847608|P1|Overall Study|Physician Decision|1
7720512|NCT01005680|26847607|P2|Overall Study|Withdrawal by Subject|4
7720513|NCT01005680|26847608|P1|Overall Study|Withdrawal by Subject|1
7720514|NCT01005680|26847607|P2|Overall Study|Lost to Follow-up|6
7720515|NCT01005680|26847608|P1|Overall Study|Lost to Follow-up|4
7720516|NCT01005602|26847632|P2|Overall Study|Excluded due to unreliable clinical data|0
7720517|NCT01005602|26847633|P1|Overall Study|Excluded due to unreliable clinical data|1
7720518|NCT01005329|26847721|P1|Overall Study|Ineligible or received no protocol trt.|4
7720519|NCT01005316|26847734|P4|Overall Study|Retransplanted|0
7720520|NCT01005316|26847735|P3|Overall Study|Retransplanted|0
7720521|NCT01005316|26847736|P2|Overall Study|Retransplanted|1
7720522|NCT01005316|26847737|P1|Overall Study|Retransplanted|0
7720523|NCT01005316|26847734|P4|Overall Study|Transferred Care|3
7720524|NCT01005316|26847735|P3|Overall Study|Transferred Care|1
7720525|NCT01005316|26847736|P2|Overall Study|Transferred Care|0
7720526|NCT01005316|26847737|P1|Overall Study|Transferred Care|1
7720527|NCT01005316|26847734|P4|Overall Study|Delisted|0
7720528|NCT01005316|26847735|P3|Overall Study|Delisted|0
7720529|NCT01005316|26847736|P2|Overall Study|Delisted|0
7720530|NCT01005316|26847737|P1|Overall Study|Delisted|8
7720531|NCT01005316|26847734|P4|Overall Study|Consented to Another Study|0
7720532|NCT01005316|26847735|P3|Overall Study|Consented to Another Study|0
7720533|NCT01005316|26847736|P2|Overall Study|Consented to Another Study|0
7720534|NCT01005316|26847737|P1|Overall Study|Consented to Another Study|2
7720535|NCT01005316|26847734|P4|Overall Study|Withdrawal by Subject|2
7720536|NCT01005316|26847735|P3|Overall Study|Withdrawal by Subject|0
7720537|NCT01005316|26847736|P2|Overall Study|Withdrawal by Subject|1
7720538|NCT01005316|26847737|P1|Overall Study|Withdrawal by Subject|1
7720539|NCT01005316|26847734|P4|Overall Study|Sponsor Decision|0
7720540|NCT01005316|26847735|P3|Overall Study|Sponsor Decision|0
7720541|NCT01005316|26847736|P2|Overall Study|Sponsor Decision|3
7720542|NCT01005316|26847737|P1|Overall Study|Sponsor Decision|6
7720543|NCT01005316|26847734|P4|Overall Study|Physician Decision|0
7720544|NCT01005316|26847735|P3|Overall Study|Physician Decision|0
7720545|NCT01005316|26847736|P2|Overall Study|Physician Decision|0
7720546|NCT01005316|26847737|P1|Overall Study|Physician Decision|6
7720547|NCT01005316|26847734|P4|Overall Study|Lost to Follow-up|2
7720548|NCT01005316|26847735|P3|Overall Study|Lost to Follow-up|0
7720549|NCT01005316|26847736|P2|Overall Study|Lost to Follow-up|3
7720550|NCT01005316|26847737|P1|Overall Study|Lost to Follow-up|1
7720551|NCT01005316|26847734|P4|Overall Study|Study Termination|85
7720552|NCT01005316|26847735|P3|Overall Study|Study Termination|9
7720553|NCT01005316|26847736|P2|Overall Study|Study Termination|63
7720554|NCT01005316|26847737|P1|Overall Study|Study Termination|5
7720555|NCT01005316|26847734|P4|Overall Study|Death|15
7720556|NCT01005316|26847735|P3|Overall Study|Death|1
7720557|NCT01005316|26847736|P2|Overall Study|Death|5
7720558|NCT01005316|26847737|P1|Overall Study|Death|20
7720559|NCT01005316|26847734|P4|Overall Study|Adverse Event|1
7720560|NCT01005316|26847735|P3|Overall Study|Adverse Event|0
7720561|NCT01005316|26847736|P2|Overall Study|Adverse Event|0
7720562|NCT01005316|26847737|P1|Overall Study|Adverse Event|0
7720563|NCT01005251|26847804|P5|Overall Study|Lack of Efficacy|0
7720564|NCT01005251|26847805|P4|Overall Study|Lack of Efficacy|1
7720565|NCT01005251|26847806|P3|Overall Study|Lack of Efficacy|1
7720566|NCT01005251|26847807|P2|Overall Study|Lack of Efficacy|0
7720567|NCT01005251|26847808|P1|Overall Study|Lack of Efficacy|0
7720568|NCT01005251|26847804|P5|Overall Study|Randomized in error|0
7720569|NCT01005251|26847805|P4|Overall Study|Randomized in error|1
7720570|NCT01005251|26847806|P3|Overall Study|Randomized in error|1
7720571|NCT01005251|26847807|P2|Overall Study|Randomized in error|0
7720572|NCT01005251|26847808|P1|Overall Study|Randomized in error|0
7720573|NCT01005251|26847804|P5|Overall Study|Wrong drug dispensed|0
7720574|NCT01005251|26847805|P4|Overall Study|Wrong drug dispensed|0
7720575|NCT01005251|26847806|P3|Overall Study|Wrong drug dispensed|0
7720576|NCT01005251|26847807|P2|Overall Study|Wrong drug dispensed|1
7720577|NCT01005251|26847808|P1|Overall Study|Wrong drug dispensed|0
7720578|NCT01005251|26847804|P5|Overall Study|Patient moved|0
7720579|NCT01005251|26847805|P4|Overall Study|Patient moved|0
7720580|NCT01005251|26847806|P3|Overall Study|Patient moved|0
7720581|NCT01005251|26847807|P2|Overall Study|Patient moved|0
7720582|NCT01005251|26847808|P1|Overall Study|Patient moved|1
7720583|NCT01005251|26847804|P5|Overall Study|Physician Decision|2
7720584|NCT01005251|26847805|P4|Overall Study|Physician Decision|0
7720585|NCT01005251|26847806|P3|Overall Study|Physician Decision|0
7720586|NCT01005251|26847807|P2|Overall Study|Physician Decision|0
7720587|NCT01005251|26847808|P1|Overall Study|Physician Decision|0
7720588|NCT01005251|26847804|P5|Overall Study|Lost to Follow-up|0
7720589|NCT01005251|26847805|P4|Overall Study|Lost to Follow-up|0
7720590|NCT01005251|26847806|P3|Overall Study|Lost to Follow-up|2
7720591|NCT01005251|26847807|P2|Overall Study|Lost to Follow-up|4
7720592|NCT01005251|26847808|P1|Overall Study|Lost to Follow-up|1
7720593|NCT01005251|26847804|P5|Overall Study|Developed study-specific withdrawal crit|1
7720594|NCT01005251|26847805|P4|Overall Study|Developed study-specific withdrawal crit|0
7720595|NCT01005251|26847806|P3|Overall Study|Developed study-specific withdrawal crit|3
7720596|NCT01005251|26847807|P2|Overall Study|Developed study-specific withdrawal crit|0
7720597|NCT01005251|26847808|P1|Overall Study|Developed study-specific withdrawal crit|2
7720598|NCT01005251|26847804|P5|Overall Study|Protocol Violation|2
7720599|NCT01005251|26847805|P4|Overall Study|Protocol Violation|0
7720600|NCT01005251|26847806|P3|Overall Study|Protocol Violation|0
7720601|NCT01005251|26847807|P2|Overall Study|Protocol Violation|0
7720602|NCT01005251|26847808|P1|Overall Study|Protocol Violation|1
7720603|NCT01005251|26847804|P5|Overall Study|Adverse Event|4
7720604|NCT01005251|26847805|P4|Overall Study|Adverse Event|5
7720605|NCT01005251|26847806|P3|Overall Study|Adverse Event|8
7720606|NCT01005251|26847807|P2|Overall Study|Adverse Event|6
7720607|NCT01005251|26847808|P1|Overall Study|Adverse Event|2
7720608|NCT01005251|26847804|P5|Overall Study|Eligibility criteria not fulfilled|0
7720609|NCT01005251|26847805|P4|Overall Study|Eligibility criteria not fulfilled|1
7720610|NCT01005251|26847806|P3|Overall Study|Eligibility criteria not fulfilled|4
7720611|NCT01005251|26847807|P2|Overall Study|Eligibility criteria not fulfilled|0
7720612|NCT01005251|26847808|P1|Overall Study|Eligibility criteria not fulfilled|4
7720613|NCT01005251|26847804|P5|Overall Study|Withdrawal by Subject|9
7720614|NCT01005251|26847805|P4|Overall Study|Withdrawal by Subject|4
7720615|NCT01005251|26847806|P3|Overall Study|Withdrawal by Subject|3
7720616|NCT01005251|26847807|P2|Overall Study|Withdrawal by Subject|5
7720617|NCT01005251|26847808|P1|Overall Study|Withdrawal by Subject|2
7720618|NCT01004861|26847892|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720619|NCT01004861|26847893|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720620|NCT01004861|26847894|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720621|NCT01004861|26847895|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720622|NCT01004861|26847896|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
7720623|NCT01004861|26847897|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720624|NCT01004861|26847898|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720625|NCT01004861|26847899|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720626|NCT01004861|26847900|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720627|NCT01004861|26847901|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720628|NCT01004861|26847902|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720629|NCT01004861|26847903|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720630|NCT01004861|26847904|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
7720631|NCT01004861|26847892|P13|Overall Study|Other|3
7720632|NCT01004861|26847893|P12|Overall Study|Other|2
7720633|NCT01004861|26847894|P11|Overall Study|Other|1
7720634|NCT01004861|26847895|P10|Overall Study|Other|2
7720635|NCT01004861|26847896|P9|Overall Study|Other|1
7720636|NCT01004861|26847897|P8|Overall Study|Other|0
7720637|NCT01004861|26847898|P7|Overall Study|Other|0
7720638|NCT01004861|26847899|P6|Overall Study|Other|0
7720639|NCT01004861|26847900|P5|Overall Study|Other|0
7720640|NCT01004861|26847901|P4|Overall Study|Other|0
7720641|NCT01004861|26847902|P3|Overall Study|Other|0
7720642|NCT01004861|26847903|P2|Overall Study|Other|0
7720643|NCT01004861|26847904|P1|Overall Study|Other|0
7720644|NCT01004861|26847892|P13|Overall Study|Non-compliance|1
7720645|NCT01004861|26847893|P12|Overall Study|Non-compliance|0
7720646|NCT01004861|26847894|P11|Overall Study|Non-compliance|0
7720647|NCT01004861|26847895|P10|Overall Study|Non-compliance|0
7720648|NCT01004861|26847896|P9|Overall Study|Non-compliance|5
7720649|NCT01004861|26847897|P8|Overall Study|Non-compliance|0
7720650|NCT01004861|26847898|P7|Overall Study|Non-compliance|0
7720651|NCT01004861|26847899|P6|Overall Study|Non-compliance|0
7720652|NCT01004861|26847900|P5|Overall Study|Non-compliance|0
7720653|NCT01004861|26847901|P4|Overall Study|Non-compliance|0
7720654|NCT01004861|26847902|P3|Overall Study|Non-compliance|0
7720655|NCT01004861|26847903|P2|Overall Study|Non-compliance|0
7720656|NCT01004861|26847904|P1|Overall Study|Non-compliance|0
7720657|NCT01004861|26847892|P13|Overall Study|Lost to Follow-up|0
7720658|NCT01004861|26847893|P12|Overall Study|Lost to Follow-up|1
7720659|NCT01004861|26847894|P11|Overall Study|Lost to Follow-up|0
7720660|NCT01004861|26847895|P10|Overall Study|Lost to Follow-up|0
7720661|NCT01004861|26847896|P9|Overall Study|Lost to Follow-up|1
7720662|NCT01004861|26847897|P8|Overall Study|Lost to Follow-up|1
7720663|NCT01004861|26847898|P7|Overall Study|Lost to Follow-up|0
7720664|NCT01004861|26847899|P6|Overall Study|Lost to Follow-up|0
7720665|NCT01004861|26847900|P5|Overall Study|Lost to Follow-up|0
7720666|NCT01004861|26847901|P4|Overall Study|Lost to Follow-up|0
7720667|NCT01004861|26847902|P3|Overall Study|Lost to Follow-up|0
7720668|NCT01004861|26847903|P2|Overall Study|Lost to Follow-up|0
7720669|NCT01004861|26847904|P1|Overall Study|Lost to Follow-up|0
7720670|NCT01004861|26847892|P13|Overall Study|Withdrawal by Subject|3
7720671|NCT01004861|26847893|P12|Overall Study|Withdrawal by Subject|2
7720672|NCT01004861|26847894|P11|Overall Study|Withdrawal by Subject|1
7720673|NCT01004861|26847895|P10|Overall Study|Withdrawal by Subject|1
7720674|NCT01004861|26847896|P9|Overall Study|Withdrawal by Subject|2
7720675|NCT01004861|26847897|P8|Overall Study|Withdrawal by Subject|0
7720676|NCT01004861|26847898|P7|Overall Study|Withdrawal by Subject|1
7720677|NCT01004861|26847899|P6|Overall Study|Withdrawal by Subject|0
7720678|NCT01004861|26847900|P5|Overall Study|Withdrawal by Subject|1
7720679|NCT01004861|26847901|P4|Overall Study|Withdrawal by Subject|0
7720680|NCT01004861|26847902|P3|Overall Study|Withdrawal by Subject|0
7720681|NCT01004861|26847903|P2|Overall Study|Withdrawal by Subject|0
7720682|NCT01004861|26847904|P1|Overall Study|Withdrawal by Subject|0
7720683|NCT01004861|26847892|P13|Overall Study|Protocol Violation|0
7720684|NCT01004861|26847893|P12|Overall Study|Protocol Violation|0
7720685|NCT01004861|26847894|P11|Overall Study|Protocol Violation|0
7720686|NCT01004861|26847895|P10|Overall Study|Protocol Violation|0
7720687|NCT01004861|26847896|P9|Overall Study|Protocol Violation|0
7720688|NCT01004861|26847897|P8|Overall Study|Protocol Violation|0
7720689|NCT01004861|26847898|P7|Overall Study|Protocol Violation|0
7720690|NCT01004861|26847899|P6|Overall Study|Protocol Violation|0
7720691|NCT01004861|26847900|P5|Overall Study|Protocol Violation|1
7720692|NCT01004861|26847901|P4|Overall Study|Protocol Violation|0
7720693|NCT01004861|26847902|P3|Overall Study|Protocol Violation|0
7720694|NCT01004861|26847903|P2|Overall Study|Protocol Violation|0
7720695|NCT01004861|26847904|P1|Overall Study|Protocol Violation|0
7720696|NCT01004861|26847892|P13|Overall Study|Adverse Event|2
7720697|NCT01004861|26847893|P12|Overall Study|Adverse Event|0
7720698|NCT01004861|26847894|P11|Overall Study|Adverse Event|1
7720699|NCT01004861|26847895|P10|Overall Study|Adverse Event|1
7720700|NCT01004861|26847896|P9|Overall Study|Adverse Event|13
7720701|NCT01004861|26847897|P8|Overall Study|Adverse Event|1
7720702|NCT01004861|26847898|P7|Overall Study|Adverse Event|1
7720703|NCT01004861|26847899|P6|Overall Study|Adverse Event|2
7720704|NCT01004861|26847900|P5|Overall Study|Adverse Event|0
7720705|NCT01004861|26847901|P4|Overall Study|Adverse Event|1
7720706|NCT01004861|26847902|P3|Overall Study|Adverse Event|0
7720707|NCT01004861|26847903|P2|Overall Study|Adverse Event|0
7720708|NCT01004861|26847904|P1|Overall Study|Adverse Event|0
7720709|NCT01004861|26847892|P13|Overall Study|Physician Decision|3
7720710|NCT01004861|26847893|P12|Overall Study|Physician Decision|0
7720711|NCT01004861|26847894|P11|Overall Study|Physician Decision|0
7720712|NCT01004861|26847895|P10|Overall Study|Physician Decision|0
7720713|NCT01004861|26847896|P9|Overall Study|Physician Decision|0
7720714|NCT01004861|26847897|P8|Overall Study|Physician Decision|1
7720715|NCT01004861|26847898|P7|Overall Study|Physician Decision|0
7720716|NCT01004861|26847899|P6|Overall Study|Physician Decision|0
7720717|NCT01004861|26847900|P5|Overall Study|Physician Decision|1
7720718|NCT01004861|26847901|P4|Overall Study|Physician Decision|1
7720719|NCT01004861|26847902|P3|Overall Study|Physician Decision|1
7720720|NCT01004861|26847903|P2|Overall Study|Physician Decision|2
7720721|NCT01004861|26847904|P1|Overall Study|Physician Decision|0
7720722|NCT01004861|26847892|P13|Overall Study|Disease progression|8
7720723|NCT01004861|26847893|P12|Overall Study|Disease progression|3
7720724|NCT01004861|26847894|P11|Overall Study|Disease progression|6
7720725|NCT01004861|26847895|P10|Overall Study|Disease progression|7
7720726|NCT01004861|26847896|P9|Overall Study|Disease progression|4
7720727|NCT01004861|26847897|P8|Overall Study|Disease progression|1
7720728|NCT01004861|26847898|P7|Overall Study|Disease progression|5
7720729|NCT01004861|26847899|P6|Overall Study|Disease progression|4
7720730|NCT01004861|26847900|P5|Overall Study|Disease progression|4
7720731|NCT01004861|26847901|P4|Overall Study|Disease progression|4
7720732|NCT01004861|26847902|P3|Overall Study|Disease progression|5
7720733|NCT01004861|26847903|P2|Overall Study|Disease progression|4
7720734|NCT01004861|26847904|P1|Overall Study|Disease progression|3
7720735|NCT01004848|26847970|P2|Overall Study|Lost to Follow-up|45
7720736|NCT01004848|26847971|P1|Overall Study|Lost to Follow-up|55
7720737|NCT01004822|26848009|P8|Overall Study|Other|0
7720738|NCT01004822|26848010|P7|Overall Study|Other|0
7720739|NCT01004822|26848011|P6|Overall Study|Other|1
7720740|NCT01004822|26848012|P5|Overall Study|Other|0
7720741|NCT01004822|26848013|P4|Overall Study|Other|1
7720742|NCT01004822|26848014|P3|Overall Study|Other|4
7720743|NCT01004822|26848015|P2|Overall Study|Other|0
7720744|NCT01004822|26848016|P1|Overall Study|Other|0
7720745|NCT01004822|26848009|P8|Overall Study|Adverse Event|1
7720746|NCT01004822|26848010|P7|Overall Study|Adverse Event|1
7720747|NCT01004822|26848011|P6|Overall Study|Adverse Event|0
7720748|NCT01004822|26848012|P5|Overall Study|Adverse Event|0
7720749|NCT01004822|26848013|P4|Overall Study|Adverse Event|0
7720750|NCT01004822|26848014|P3|Overall Study|Adverse Event|0
7720751|NCT01004822|26848015|P2|Overall Study|Adverse Event|0
7720752|NCT01004822|26848016|P1|Overall Study|Adverse Event|0
7720753|NCT01004822|26848009|P8|Overall Study|No longer willing to continue|0
7720754|NCT01004822|26848010|P7|Overall Study|No longer willing to continue|1
7720755|NCT01004822|26848011|P6|Overall Study|No longer willing to continue|1
7720756|NCT01004822|26848012|P5|Overall Study|No longer willing to continue|2
7720757|NCT01004822|26848013|P4|Overall Study|No longer willing to continue|1
7720758|NCT01004822|26848014|P3|Overall Study|No longer willing to continue|0
7720759|NCT01004822|26848015|P2|Overall Study|No longer willing to continue|0
7720760|NCT01004822|26848016|P1|Overall Study|No longer willing to continue|0
7720761|NCT01004822|26848009|P8|Overall Study|Global deterioration of health status|0
7720762|NCT01004822|26848010|P7|Overall Study|Global deterioration of health status|1
7720763|NCT01004822|26848011|P6|Overall Study|Global deterioration of health status|0
7720764|NCT01004822|26848012|P5|Overall Study|Global deterioration of health status|0
7720765|NCT01004822|26848013|P4|Overall Study|Global deterioration of health status|1
7720766|NCT01004822|26848014|P3|Overall Study|Global deterioration of health status|0
7720767|NCT01004822|26848015|P2|Overall Study|Global deterioration of health status|0
7720768|NCT01004822|26848016|P1|Overall Study|Global deterioration of health status|0
7720769|NCT01004822|26848009|P8|Overall Study|Objective progression or relapse|4
7720770|NCT01004822|26848010|P7|Overall Study|Objective progression or relapse|1
7720771|NCT01004822|26848011|P6|Overall Study|Objective progression or relapse|2
7720772|NCT01004822|26848012|P5|Overall Study|Objective progression or relapse|2
7720773|NCT01004822|26848013|P4|Overall Study|Objective progression or relapse|1
7720774|NCT01004822|26848014|P3|Overall Study|Objective progression or relapse|0
7720775|NCT01004822|26848015|P2|Overall Study|Objective progression or relapse|3
7720776|NCT01004822|26848016|P1|Overall Study|Objective progression or relapse|3
7720777|NCT01004614|26848190|P4|Washout|Withdrawal by Subject|0
7720778|NCT01004614|26848191|P3|Washout|Withdrawal by Subject|0
7720779|NCT01004614|26848192|P2|Washout|Withdrawal by Subject|1
7720780|NCT01004614|26848193|P1|Washout|Withdrawal by Subject|0
7720781|NCT01004510|26848227|P1|Overall Study|Adverse Event|1
7720782|NCT01004432|26848231|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
7720783|NCT01004432|26848232|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7720784|NCT01004432|26848233|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7720785|NCT01004432|26848234|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7720786|NCT01004432|26848235|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7720787|NCT01004432|26848231|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
7720788|NCT01004432|26848232|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7720789|NCT01004432|26848233|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7720790|NCT01004432|26848234|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7720791|NCT01004432|26848235|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7720792|NCT01004432|26848231|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
7720793|NCT01004432|26848232|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7720794|NCT01004432|26848233|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7720795|NCT01004432|26848234|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7720796|NCT01004432|26848235|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7720797|NCT01004432|26848231|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
7720798|NCT01004432|26848232|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
7720799|NCT01004432|26848233|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
7720800|NCT01004432|26848234|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
7720801|NCT01004432|26848235|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
7720802|NCT01004432|26848231|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
7720803|NCT01004432|26848232|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
7720804|NCT01004432|26848233|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
7720805|NCT01004432|26848234|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
7720806|NCT01004432|26848235|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
7720807|NCT01004432|26848231|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
7720808|NCT01004432|26848232|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
7720809|NCT01004432|26848233|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
7720810|NCT01004432|26848234|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
7720811|NCT01004432|26848235|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
7720812|NCT01004432|26848231|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7720813|NCT01004432|26848232|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
7720814|NCT01004432|26848233|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7720815|NCT01004432|26848234|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7720816|NCT01004432|26848235|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7720817|NCT01004432|26848231|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
7720818|NCT01004432|26848232|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
7720819|NCT01004432|26848233|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
7720820|NCT01004432|26848234|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
7720821|NCT01004432|26848235|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
7720822|NCT01004432|26848231|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
7720823|NCT01004432|26848232|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
7720824|NCT01004432|26848233|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
7720825|NCT01004432|26848234|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
7720826|NCT01004432|26848235|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
7720827|NCT01004432|26848231|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
7720828|NCT01004432|26848232|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
7720829|NCT01004432|26848233|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
7720830|NCT01004432|26848234|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
7720831|NCT01004432|26848235|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
7720832|NCT01004432|26848231|P5|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7720833|NCT01004432|26848232|P4|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7720834|NCT01004432|26848233|P3|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7720835|NCT01004432|26848234|P2|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7720836|NCT01004432|26848235|P1|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
7720837|NCT01004432|26848231|P5|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7720838|NCT01004432|26848232|P4|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7720839|NCT01004432|26848233|P3|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7720840|NCT01004432|26848234|P2|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7720841|NCT01004432|26848235|P1|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
7720842|NCT01004432|26848231|P5|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7720843|NCT01004432|26848232|P4|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7720844|NCT01004432|26848233|P3|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7720845|NCT01004432|26848234|P2|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7720846|NCT01004432|26848235|P1|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
7720847|NCT01004432|26848231|P5|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7720848|NCT01004432|26848232|P4|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7720849|NCT01004432|26848233|P3|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7720850|NCT01004432|26848234|P2|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7720851|NCT01004432|26848235|P1|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
7720852|NCT01004432|26848231|P5|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7720853|NCT01004432|26848232|P4|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7720854|NCT01004432|26848233|P3|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7720855|NCT01004432|26848234|P2|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7720856|NCT01004432|26848235|P1|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
7720857|NCT01004406|26848257|P2|Overall Study|Lost to Follow-up|0
7720858|NCT01004406|26848258|P1|Overall Study|Lost to Follow-up|1
7720859|NCT01004406|26848257|P2|Overall Study|Withdrawal by Subject|0
7720860|NCT01004406|26848258|P1|Overall Study|Withdrawal by Subject|2
7720861|NCT01004263|26848293|P1|Overall Study|Lack of Qualifying Event|2
7720862|NCT01004263|26848293|P1|Overall Study|Physician Decision|15
7720863|NCT01004263|26848293|P1|Overall Study|Pregnancy|2
7720864|NCT01004263|26848293|P1|Overall Study|Lack of Efficacy|13
7720865|NCT01004263|26848293|P1|Overall Study|Lost to Follow-up|64
7720866|NCT01004263|26848293|P1|Overall Study|Protocol Violation|10
7720867|NCT01004263|26848293|P1|Overall Study|Withdrawal by Subject|58
7720868|NCT01004263|26848293|P1|Overall Study|Adverse Event|15
7720869|NCT01004250|26848301|P1|Follow-Up (FU) Period|Lost to Follow-up|1
7720870|NCT01004250|26848301|P1|Maintenance Therapy Period|Physician Decision|4
7720871|NCT01004250|26848301|P1|Maintenance Therapy Period|Withdrawal by Subject|5
7720872|NCT01004250|26848301|P1|Maintenance Therapy Period|Protocol Violation|1
7720873|NCT01004250|26848301|P1|Maintenance Therapy Period|Lost to Follow-up|1
7720874|NCT01004250|26848301|P1|Maintenance Therapy Period|Adverse Event|15
7720875|NCT01004250|26848301|P1|Induction Therapy Period|Physician Decision|2
7720876|NCT01004250|26848301|P1|Induction Therapy Period|Withdrawal by Subject|2
7720877|NCT01004250|26848301|P1|Induction Therapy Period|Entry Criteria Not Met|1
7720878|NCT01004250|26848301|P1|Induction Therapy Period|Adverse Event|10
7720879|NCT01004185|26848313|P2|Overall Study|Withdrawal by Subject|1
7720880|NCT01004185|26848314|P1|Overall Study|Withdrawal by Subject|2
7720881|NCT01004185|26848313|P2|Overall Study|Sponsor Terminated Study|5
7720882|NCT01004185|26848314|P1|Overall Study|Sponsor Terminated Study|4
7720883|NCT01004185|26848313|P2|Overall Study|Lack of Efficacy|1
7720884|NCT01004185|26848314|P1|Overall Study|Lack of Efficacy|2
7720885|NCT01004185|26848313|P2|Overall Study|Lost to Follow-up|1
7720886|NCT01004185|26848314|P1|Overall Study|Lost to Follow-up|0
7720887|NCT01004185|26848313|P2|Overall Study|Adverse Event|1
7720888|NCT01004185|26848314|P1|Overall Study|Adverse Event|1
7720889|NCT01004172|26848322|P1|Overall Study|Symptomatic Deterioration|2
7720890|NCT01004172|26848322|P1|Overall Study|Physician Decision|1
7720891|NCT01004172|26848322|P1|Overall Study|Adverse Event|1
7720892|NCT01004172|26848322|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
7720893|NCT01004172|26848322|P1|Overall Study|Progressive Disease in Non-CNS Only|16
7720894|NCT01004172|26848322|P1|Overall Study|Progressive Disease in CNS Only|16
7720895|NCT01004159|26848330|P1|Overall Study|Disease Progression|18
7720896|NCT01004159|26848330|P1|Overall Study|Adverse Event|2
7720897|NCT01004146|26848337|P2|Overall Study|Withdrawal by Subject|5
7720898|NCT01004146|26848338|P1|Overall Study|Withdrawal by Subject|4
7720899|NCT01004003|26848470|P9|Overall Study|Other|0
7720900|NCT01004003|26848471|P8|Overall Study|Other|0
7720901|NCT01004003|26848472|P7|Overall Study|Other|0
7720902|NCT01004003|26848473|P6|Overall Study|Other|1
7720903|NCT01004003|26848474|P5|Overall Study|Other|0
7720904|NCT01004003|26848475|P4|Overall Study|Other|0
7720905|NCT01004003|26848476|P3|Overall Study|Other|0
7720906|NCT01004003|26848477|P2|Overall Study|Other|0
7720907|NCT01004003|26848478|P1|Overall Study|Other|0
7720908|NCT01004003|26848470|P9|Overall Study|Refused to continue taking trial med.|2
7720909|NCT01004003|26848471|P8|Overall Study|Refused to continue taking trial med.|0
7720910|NCT01004003|26848472|P7|Overall Study|Refused to continue taking trial med.|0
7720911|NCT01004003|26848473|P6|Overall Study|Refused to continue taking trial med.|0
7720912|NCT01004003|26848474|P5|Overall Study|Refused to continue taking trial med.|0
7720913|NCT01004003|26848475|P4|Overall Study|Refused to continue taking trial med.|0
7720914|NCT01004003|26848476|P3|Overall Study|Refused to continue taking trial med.|0
7720915|NCT01004003|26848477|P2|Overall Study|Refused to continue taking trial med.|0
7720916|NCT01004003|26848478|P1|Overall Study|Refused to continue taking trial med.|0
7720917|NCT01004003|26848470|P9|Overall Study|Adverse Event|6
7720918|NCT01004003|26848471|P8|Overall Study|Adverse Event|21
7720919|NCT01004003|26848472|P7|Overall Study|Adverse Event|7
7720920|NCT01004003|26848473|P6|Overall Study|Adverse Event|2
7720921|NCT01004003|26848474|P5|Overall Study|Adverse Event|2
7720922|NCT01004003|26848475|P4|Overall Study|Adverse Event|3
7720923|NCT01004003|26848476|P3|Overall Study|Adverse Event|3
7720924|NCT01004003|26848477|P2|Overall Study|Adverse Event|2
7720925|NCT01004003|26848478|P1|Overall Study|Adverse Event|4
7720926|NCT01004003|26848470|P9|Overall Study|Progressive disease|22
7720927|NCT01004003|26848471|P8|Overall Study|Progressive disease|39
7720928|NCT01004003|26848472|P7|Overall Study|Progressive disease|1
7720929|NCT01004003|26848473|P6|Overall Study|Progressive disease|1
7720930|NCT01004003|26848474|P5|Overall Study|Progressive disease|2
7720931|NCT01004003|26848475|P4|Overall Study|Progressive disease|0
7720932|NCT01004003|26848476|P3|Overall Study|Progressive disease|1
7720933|NCT01004003|26848477|P2|Overall Study|Progressive disease|1
7720934|NCT01004003|26848478|P1|Overall Study|Progressive disease|2
7720935|NCT01003990|26848509|P3|Overall Study|Subject Withdrew Consent|7
7720936|NCT01003990|26848510|P2|Overall Study|Subject Withdrew Consent|5
7720937|NCT01003990|26848511|P1|Overall Study|Subject Withdrew Consent|12
7720938|NCT01003990|26848509|P3|Overall Study|No Longer Met Study Criteria|0
7720939|NCT01003990|26848510|P2|Overall Study|No Longer Met Study Criteria|1
7720940|NCT01003990|26848511|P1|Overall Study|No Longer Met Study Criteria|4
7720941|NCT01003990|26848509|P3|Overall Study|Pregnancy|4
7720942|NCT01003990|26848510|P2|Overall Study|Pregnancy|2
7720943|NCT01003990|26848511|P1|Overall Study|Pregnancy|10
7720944|NCT01003990|26848509|P3|Overall Study|Poor/Non-compliance|2
7720945|NCT01003990|26848510|P2|Overall Study|Poor/Non-compliance|3
7720946|NCT01003990|26848511|P1|Overall Study|Poor/Non-compliance|4
7720947|NCT01003990|26848509|P3|Overall Study|Reasons Not Identified|8
7720948|NCT01003990|26848510|P2|Overall Study|Reasons Not Identified|13
7720949|NCT01003990|26848511|P1|Overall Study|Reasons Not Identified|14
7720950|NCT01003990|26848509|P3|Overall Study|Lost to Follow-up|7
7720951|NCT01003990|26848510|P2|Overall Study|Lost to Follow-up|12
7720952|NCT01003990|26848511|P1|Overall Study|Lost to Follow-up|30
7720953|NCT01003990|26848509|P3|Overall Study|Lack of Efficacy|3
7720954|NCT01003990|26848510|P2|Overall Study|Lack of Efficacy|2
7720955|NCT01003990|26848511|P1|Overall Study|Lack of Efficacy|10
7720956|NCT01003990|26848509|P3|Overall Study|Death|1
7720957|NCT01003990|26848510|P2|Overall Study|Death|8
7720958|NCT01003990|26848511|P1|Overall Study|Death|0
7720959|NCT01003990|26848509|P3|Overall Study|Adverse Event|11
7720960|NCT01003990|26848510|P2|Overall Study|Adverse Event|5
7720961|NCT01003990|26848511|P1|Overall Study|Adverse Event|8
7720962|NCT01003899|26848528|P1|Overall Study|Progressive disease|34
7720963|NCT01003899|26848528|P1|Overall Study|Not treated|1
7720964|NCT01003899|26848528|P1|Overall Study|Not entered|4
7720965|NCT01003899|26848528|P1|Overall Study|Other Adverse Event|8
7720966|NCT01003886|26848537|P1|Overall Study|Adverse Event|3
7720967|NCT01003886|26848537|P1|Overall Study|Other|14
7720968|NCT01003886|26848537|P1|Overall Study|Withdrawal by Subject|39
7720969|NCT01003886|26848537|P1|Overall Study|Lost to Follow-up|169
7720970|NCT01003886|26848537|P1|Overall Study|Lack of Efficacy|5
7720971|NCT01003639|26848558|P2|Overall Study|Physician Decision|0
7720972|NCT01003639|26848559|P1|Overall Study|Physician Decision|1
7720973|NCT01003639|26848558|P2|Overall Study|Protocol Violation|1
7720974|NCT01003639|26848559|P1|Overall Study|Protocol Violation|0
7720975|NCT01003639|26848558|P2|Overall Study|Adverse Event|1
7720976|NCT01003639|26848559|P1|Overall Study|Adverse Event|0
7720977|NCT01003639|26848558|P2|Overall Study|Lack of Efficacy|6
7720978|NCT01003639|26848559|P1|Overall Study|Lack of Efficacy|1
7720979|NCT01003639|26848558|P2|Overall Study|Withdrawal by Subject|5
7720980|NCT01003639|26848559|P1|Overall Study|Withdrawal by Subject|9
7720981|NCT01003639|26848558|P2|Overall Study|Lost to Follow-up|9
7720982|NCT01003639|26848559|P1|Overall Study|Lost to Follow-up|6
7720983|NCT01003249|26848615|P2|Second Intervention (4 Weeks)|Adverse Event|0
7720984|NCT01003249|26848616|P1|Second Intervention (4 Weeks)|Adverse Event|1
7720985|NCT01003249|26848615|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7720986|NCT01003249|26848616|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7720987|NCT01003249|26848615|P2|First Intervention (4 Weeks)|Non-Serious Event|1
7720988|NCT01003249|26848616|P1|First Intervention (4 Weeks)|Non-Serious Event|1
7720989|NCT01003249|26848615|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
7720990|NCT01003249|26848616|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
7720991|NCT01003210|26848634|P2|Overall Study|Lost to Follow-up|3
7720992|NCT01003210|26848635|P1|Overall Study|Lost to Follow-up|1
7720993|NCT01003184|26848647|P2|Overall Study|Physician Decision|0
7720994|NCT01003184|26848648|P1|Overall Study|Physician Decision|1
7720995|NCT01003184|26848647|P2|Overall Study|Withdrawal by Subject|6
7720996|NCT01003184|26848648|P1|Overall Study|Withdrawal by Subject|1
7720997|NCT01003184|26848647|P2|Overall Study|Protocol Violation|0
7720998|NCT01003184|26848648|P1|Overall Study|Protocol Violation|3
7720999|NCT01003184|26848647|P2|Overall Study|Loss of glucose control|1
7721000|NCT01003184|26848648|P1|Overall Study|Loss of glucose control|1
7721001|NCT01003184|26848647|P2|Overall Study|Lost to Follow-up|0
7721002|NCT01003184|26848648|P1|Overall Study|Lost to Follow-up|1
7721003|NCT01003184|26848647|P2|Overall Study|Adverse Event|5
7721004|NCT01003184|26848648|P1|Overall Study|Adverse Event|12
7721005|NCT01002989|26848731|P1|Overall Study|exclusion criteria, no consent|5
7721006|NCT01002742|26848746|P2|Overall Study|Determined to be ineligible|1
7721007|NCT01002742|26848747|P1|Overall Study|Determined to be ineligible|0
7721008|NCT01002573|26848783|P2|Overall Study|Subject did not receive at least 1 dose|7
7721009|NCT01002573|26848784|P1|Overall Study|Subject did not receive at least 1 dose|11
7721010|NCT01002547|26848805|P3|Overall Study|Adverse Event|0
7721011|NCT01002547|26848806|P2|Overall Study|Adverse Event|0
7721012|NCT01002547|26848807|P1|Overall Study|Adverse Event|1
7721013|NCT01002547|26848805|P3|Overall Study|Death|2
7721014|NCT01002547|26848806|P2|Overall Study|Death|2
7721015|NCT01002547|26848807|P1|Overall Study|Death|0
7721016|NCT01002547|26848805|P3|Overall Study|Physician Decision|0
7721017|NCT01002547|26848806|P2|Overall Study|Physician Decision|0
7721018|NCT01002547|26848807|P1|Overall Study|Physician Decision|1
7721019|NCT01002547|26848805|P3|Overall Study|Lost to Follow-up|1
7721020|NCT01002547|26848806|P2|Overall Study|Lost to Follow-up|1
7721021|NCT01002547|26848807|P1|Overall Study|Lost to Follow-up|2
7721022|NCT01002547|26848805|P3|Overall Study|Withdrawal by Subject|5
7721023|NCT01002547|26848806|P2|Overall Study|Withdrawal by Subject|0
7721024|NCT01002547|26848807|P1|Overall Study|Withdrawal by Subject|4
7721025|NCT01002482|26848865|P2|Overall Study|Included twice|0
7721026|NCT01002482|26848866|P1|Overall Study|Included twice|1
7721027|NCT01002482|26848865|P2|Overall Study|Withdrawal by Subject|21
7721028|NCT01002482|26848866|P1|Overall Study|Withdrawal by Subject|14
7721029|NCT01002339|26848900|P3|Overall Study|Randomized. Not transplanted|1
7721030|NCT01002339|26848901|P2|Overall Study|Randomized. Not transplanted|0
7721031|NCT01002339|26848902|P1|Overall Study|Randomized. Not transplanted|0
7721032|NCT01002339|26848900|P3|Overall Study|Lung cancer detected before transplant|1
7721033|NCT01002339|26848901|P2|Overall Study|Lung cancer detected before transplant|0
7721034|NCT01002339|26848902|P1|Overall Study|Lung cancer detected before transplant|0
7721035|NCT01002339|26848900|P3|Overall Study|Protocol Violation|2
7721036|NCT01002339|26848901|P2|Overall Study|Protocol Violation|0
7721037|NCT01002339|26848902|P1|Overall Study|Protocol Violation|0
7721038|NCT01002339|26848900|P3|Overall Study|Incorrect treatment assignment|1
7721039|NCT01002339|26848901|P2|Overall Study|Incorrect treatment assignment|0
7721040|NCT01002339|26848902|P1|Overall Study|Incorrect treatment assignment|0
7721041|NCT01002339|26848900|P3|Overall Study|Withdrawal by Subject|0
7721042|NCT01002339|26848901|P2|Overall Study|Withdrawal by Subject|1
7721043|NCT01002339|26848902|P1|Overall Study|Withdrawal by Subject|0
7721044|NCT01002105|26848978|P2|Overall Study|condition worsened|2
7721045|NCT01002105|26848979|P1|Overall Study|condition worsened|4
7721046|NCT01002105|26848978|P2|Overall Study|non compliance|3
7721047|NCT01002105|26848979|P1|Overall Study|non compliance|5
7721048|NCT01002105|26848978|P2|Overall Study|Lost to Follow-up|16
7721049|NCT01002105|26848979|P1|Overall Study|Lost to Follow-up|10
7721050|NCT01001988|26848995|P1|Overall Study|Lost to Follow-up|15
7721051|NCT01001988|26848995|P1|Overall Study|Withdrawal by Subject|18
7721052|NCT01001988|26848995|P1|Overall Study|Protocol Violation|84
7721053|NCT01001832|26849013|P2|Follow-up Period|Other|1
7721054|NCT01001832|26849014|P1|Follow-up Period|Other|2
7721055|NCT01001832|26849013|P2|Follow-up Period|Follow-up no longer required /protocol|20
7721056|NCT01001832|26849014|P1|Follow-up Period|Follow-up no longer required /protocol|15
7721057|NCT01001832|26849013|P2|Follow-up Period|Withdrawal by Subject|0
7721058|NCT01001832|26849014|P1|Follow-up Period|Withdrawal by Subject|1
7721059|NCT01001832|26849013|P2|Long-term Period|Other|2
7721060|NCT01001832|26849014|P1|Long-term Period|Other|1
7721061|NCT01001832|26849013|P2|Long-term Period|Lack of Efficacy|2
7721062|NCT01001832|26849014|P1|Long-term Period|Lack of Efficacy|0
7721063|NCT01001832|26849013|P2|Long-term Period|Withdrawal by Subject|0
7721064|NCT01001832|26849014|P1|Long-term Period|Withdrawal by Subject|1
7721065|NCT01001832|26849013|P2|Long-term Period|Adverse Event|1
7721066|NCT01001832|26849014|P1|Long-term Period|Adverse Event|2
7721067|NCT01001832|26849013|P2|Short-term Period|Adverse Event|3
7721068|NCT01001832|26849014|P1|Short-term Period|Adverse Event|2
7721069|NCT01001767|26849072|P2|Overall Study|Physician Decision|0
7721070|NCT01001767|26849073|P1|Overall Study|Physician Decision|1
7721071|NCT01001767|26849072|P2|Overall Study|Lost to Follow-up|0
7721072|NCT01001767|26849073|P1|Overall Study|Lost to Follow-up|1
7721073|NCT01001767|26849072|P2|Overall Study|Protocol Violation|0
7721074|NCT01001767|26849073|P1|Overall Study|Protocol Violation|1
7721075|NCT01001767|26849072|P2|Overall Study|no baseline study performed|0
7721076|NCT01001767|26849073|P1|Overall Study|no baseline study performed|1
7721077|NCT01001702|26849079|P1|Overall Study|Lack of Efficacy per Investigator|3
7721078|NCT01001702|26849079|P1|Overall Study|Withdrawal by Subject|19
7721079|NCT01001702|26849079|P1|Overall Study|Investigator withdrew Subject|10
7721080|NCT01001702|26849079|P1|Overall Study|Subject met Withdrawal Criteria|22
7721081|NCT01001702|26849079|P1|Overall Study|Sponsor Discontinued Study|4
7721082|NCT01001702|26849079|P1|Overall Study|Adverse Event|7
7721083|NCT01001702|26849079|P1|Overall Study|Lost to Follow-up|7
7721084|NCT01001598|26849090|P1|Overall Study|Adverse Event|1
7721085|NCT01001598|26849090|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
7721086|NCT01001572|26849098|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
7721087|NCT01001572|26849099|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
7721088|NCT01001572|26849100|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
7721089|NCT01001572|26849098|P3|Double-Blind Treatment Phase|Protocol deviation|1
7721090|NCT01001572|26849099|P2|Double-Blind Treatment Phase|Protocol deviation|0
7721091|NCT01001572|26849100|P1|Double-Blind Treatment Phase|Protocol deviation|0
7721092|NCT01001572|26849098|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
7721093|NCT01001572|26849099|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7721094|NCT01001572|26849100|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7721095|NCT01001572|26849098|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
7721096|NCT01001572|26849099|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
7721097|NCT01001572|26849100|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
7721098|NCT01001572|26849098|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
7721099|NCT01001572|26849099|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
7721100|NCT01001572|26849100|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
7721101|NCT01001572|26849098|P3|Double-Blind Treatment Phase|Adverse Event|2
7721102|NCT01001572|26849099|P2|Double-Blind Treatment Phase|Adverse Event|2
7721103|NCT01001572|26849100|P1|Double-Blind Treatment Phase|Adverse Event|0
7721104|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
7721105|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
7721106|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
7721107|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
7721108|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
7721109|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
7721110|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
7721111|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
7721112|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
7721113|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
7721114|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
7721115|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
7721116|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
7721117|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
7721118|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
7721119|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
7721120|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
7721121|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
7721122|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
7721123|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
7721124|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
7721125|NCT01001572|26849098|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
7721126|NCT01001572|26849099|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
7721127|NCT01001572|26849100|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
7721128|NCT01001520|26849138|P2|Medication Period 2|Withdrawal by Subject|3
7721129|NCT01001520|26849139|P1|Medication Period 2|Withdrawal by Subject|0
7721130|NCT01001520|26849138|P2|Washout Period|Withdrawal by Subject|1
7721131|NCT01001520|26849139|P1|Washout Period|Withdrawal by Subject|2
7721132|NCT01001520|26849138|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
7721133|NCT01001520|26849139|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
7721134|NCT01001520|26849138|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
7721135|NCT01001520|26849139|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
7721136|NCT01001520|26849138|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
7721137|NCT01001520|26849139|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
7721138|NCT01001520|26849138|P2|Medication Period 1|Withdrawal by Subject|2
7721139|NCT01001520|26849139|P1|Medication Period 1|Withdrawal by Subject|2
7721140|NCT01001494|26849166|P3|Overall Study|Other|3
7721141|NCT01001494|26849167|P2|Overall Study|Other|1
7721142|NCT01001494|26849168|P1|Overall Study|Other|0
7721143|NCT01001494|26849166|P3|Overall Study|Lack of Efficacy|8
7721144|NCT01001494|26849167|P2|Overall Study|Lack of Efficacy|0
7721145|NCT01001494|26849168|P1|Overall Study|Lack of Efficacy|2
7721146|NCT01001494|26849166|P3|Overall Study|COPD exacerbation|5
7721147|NCT01001494|26849167|P2|Overall Study|COPD exacerbation|4
7721148|NCT01001494|26849168|P1|Overall Study|COPD exacerbation|3
7721149|NCT01001494|26849166|P3|Overall Study|Withdrawal by Subject|17
7721150|NCT01001494|26849167|P2|Overall Study|Withdrawal by Subject|7
7721151|NCT01001494|26849168|P1|Overall Study|Withdrawal by Subject|9
7721152|NCT01001494|26849166|P3|Overall Study|Lost to Follow-up|1
7721153|NCT01001494|26849167|P2|Overall Study|Lost to Follow-up|0
7721154|NCT01001494|26849168|P1|Overall Study|Lost to Follow-up|2
7721155|NCT01001494|26849166|P3|Overall Study|Protocol Violation|1
7721156|NCT01001494|26849167|P2|Overall Study|Protocol Violation|1
7721157|NCT01001494|26849168|P1|Overall Study|Protocol Violation|0
7721158|NCT01001494|26849166|P3|Overall Study|Adverse Event|6
7721159|NCT01001494|26849167|P2|Overall Study|Adverse Event|4
7721160|NCT01001494|26849168|P1|Overall Study|Adverse Event|8
7721161|NCT01001429|26849253|P2|Overall Study|surgery cancelled|1
7721162|NCT01001429|26849254|P1|Overall Study|surgery cancelled|0
7721163|NCT01001390|26849293|P2|Overall Study|Failure to wear AFO device|0
7721164|NCT01001390|26849294|P1|Overall Study|Failure to wear AFO device|2
7721165|NCT01001377|26849302|P2|Overall Study|Death|384
7721166|NCT01001377|26849303|P1|Overall Study|Death|391
7721167|NCT01001377|26849302|P2|Overall Study|Lost to Follow-up|17
7721168|NCT01001377|26849303|P1|Overall Study|Lost to Follow-up|14
7721169|NCT01001377|26849302|P2|Overall Study|Withdrawal by Subject|20
7721170|NCT01001377|26849303|P1|Overall Study|Withdrawal by Subject|19
7721171|NCT01001377|26849302|P2|Overall Study|Ineligibility determined|0
7721172|NCT01001377|26849303|P1|Overall Study|Ineligibility determined|2
7721173|NCT01001325|26849333|P2|Overall Study|Protocol Violation|0
7721174|NCT01001325|26849334|P1|Overall Study|Protocol Violation|2
7721175|NCT01001325|26849333|P2|Overall Study|Lost to Follow-up|10
7721176|NCT01001325|26849334|P1|Overall Study|Lost to Follow-up|16
7721177|NCT01001299|26849340|P1|Overall Study|Withdrew Consent|1
7721178|NCT01001299|26849340|P1|Overall Study|Began Taking Commercially Available Drug|2
7721179|NCT01001299|26849340|P1|Overall Study|Death|1
7721180|NCT01001299|26849340|P1|Overall Study|Adverse event or Intercurrent Illness|1
7721181|NCT01001299|26849340|P1|Overall Study|Insufficient Therapeutic Response|20
7721182|NCT01001234|26849369|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
7721183|NCT01001234|26849370|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
7721184|NCT01001234|26849371|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
7721185|NCT01001234|26849372|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
7721186|NCT01001234|26849373|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
7721187|NCT01001234|26849369|P5|Overall Study|Not Treated: Physician Decision|0
7721188|NCT01001234|26849370|P4|Overall Study|Not Treated: Physician Decision|0
7721189|NCT01001234|26849371|P3|Overall Study|Not Treated: Physician Decision|0
7721190|NCT01001234|26849372|P2|Overall Study|Not Treated: Physician Decision|4
7721191|NCT01001234|26849373|P1|Overall Study|Not Treated: Physician Decision|37
7721192|NCT01001234|26849369|P5|Overall Study|Not Treated: Pregnancy|0
7721193|NCT01001234|26849370|P4|Overall Study|Not Treated: Pregnancy|0
7721194|NCT01001234|26849371|P3|Overall Study|Not Treated: Pregnancy|0
7721195|NCT01001234|26849372|P2|Overall Study|Not Treated: Pregnancy|0
7721196|NCT01001234|26849373|P1|Overall Study|Not Treated: Pregnancy|3
7721197|NCT01001234|26849369|P5|Overall Study|Not Treated: Lost to Follow-up|0
7721198|NCT01001234|26849370|P4|Overall Study|Not Treated: Lost to Follow-up|5
7721199|NCT01001234|26849371|P3|Overall Study|Not Treated: Lost to Follow-up|7
7721200|NCT01001234|26849372|P2|Overall Study|Not Treated: Lost to Follow-up|4
7721201|NCT01001234|26849373|P1|Overall Study|Not Treated: Lost to Follow-up|53
7721202|NCT01001234|26849369|P5|Overall Study|Not Treated: Protocol Violation|0
7721203|NCT01001234|26849370|P4|Overall Study|Not Treated: Protocol Violation|0
7721204|NCT01001234|26849371|P3|Overall Study|Not Treated: Protocol Violation|0
7721205|NCT01001234|26849372|P2|Overall Study|Not Treated: Protocol Violation|0
7721206|NCT01001234|26849373|P1|Overall Study|Not Treated: Protocol Violation|3
7721207|NCT01001234|26849369|P5|Overall Study|Not Treated: Withdrawal by Subject|0
7721208|NCT01001234|26849370|P4|Overall Study|Not Treated: Withdrawal by Subject|0
7721209|NCT01001234|26849371|P3|Overall Study|Not Treated: Withdrawal by Subject|2
7721210|NCT01001234|26849372|P2|Overall Study|Not Treated: Withdrawal by Subject|2
7721211|NCT01001234|26849373|P1|Overall Study|Not Treated: Withdrawal by Subject|23
7721212|NCT01001234|26849369|P5|Overall Study|Not Treated: Adverse Event|0
7721213|NCT01001234|26849370|P4|Overall Study|Not Treated: Adverse Event|0
7721214|NCT01001234|26849371|P3|Overall Study|Not Treated: Adverse Event|0
7721215|NCT01001234|26849372|P2|Overall Study|Not Treated: Adverse Event|0
7721216|NCT01001234|26849373|P1|Overall Study|Not Treated: Adverse Event|1
7721217|NCT01001234|26849369|P5|Overall Study|Physician Decision|0
7721218|NCT01001234|26849370|P4|Overall Study|Physician Decision|0
7721219|NCT01001234|26849371|P3|Overall Study|Physician Decision|0
7721220|NCT01001234|26849372|P2|Overall Study|Physician Decision|0
7721221|NCT01001234|26849373|P1|Overall Study|Physician Decision|1
7721222|NCT01001234|26849369|P5|Overall Study|Lost to Follow-up|0
7721223|NCT01001234|26849370|P4|Overall Study|Lost to Follow-up|2
7721224|NCT01001234|26849371|P3|Overall Study|Lost to Follow-up|1
7721225|NCT01001234|26849372|P2|Overall Study|Lost to Follow-up|0
7721226|NCT01001234|26849373|P1|Overall Study|Lost to Follow-up|0
7721227|NCT01001234|26849369|P5|Overall Study|Protocol Violation|0
7721228|NCT01001234|26849370|P4|Overall Study|Protocol Violation|18
7721229|NCT01001234|26849371|P3|Overall Study|Protocol Violation|19
7721230|NCT01001234|26849372|P2|Overall Study|Protocol Violation|3
7721231|NCT01001234|26849373|P1|Overall Study|Protocol Violation|34
7721232|NCT01001234|26849369|P5|Overall Study|Withdrawal by Subject|0
7721233|NCT01001234|26849370|P4|Overall Study|Withdrawal by Subject|0
7721234|NCT01001234|26849371|P3|Overall Study|Withdrawal by Subject|3
7721235|NCT01001234|26849372|P2|Overall Study|Withdrawal by Subject|0
7721236|NCT01001234|26849373|P1|Overall Study|Withdrawal by Subject|2
7721237|NCT01001221|26849389|P5|Overall Study|Not treated; protocol exclusion|0
7721238|NCT01001221|26849390|P4|Overall Study|Not treated; protocol exclusion|0
7721239|NCT01001221|26849391|P3|Overall Study|Not treated; protocol exclusion|1
7721240|NCT01001221|26849392|P2|Overall Study|Not treated; protocol exclusion|0
7721241|NCT01001221|26849393|P1|Overall Study|Not treated; protocol exclusion|0
7721242|NCT01001221|26849389|P5|Overall Study|Other|0
7721243|NCT01001221|26849390|P4|Overall Study|Other|0
7721244|NCT01001221|26849391|P3|Overall Study|Other|0
7721245|NCT01001221|26849392|P2|Overall Study|Other|1
7721246|NCT01001221|26849393|P1|Overall Study|Other|1
7721247|NCT01001221|26849389|P5|Overall Study|Disease progression|0
7721248|NCT01001221|26849390|P4|Overall Study|Disease progression|4
7721249|NCT01001221|26849391|P3|Overall Study|Disease progression|2
7721250|NCT01001221|26849392|P2|Overall Study|Disease progression|2
7721251|NCT01001221|26849393|P1|Overall Study|Disease progression|3
7721252|NCT01001221|26849389|P5|Overall Study|Adverse Event|0
7721253|NCT01001221|26849390|P4|Overall Study|Adverse Event|2
7721254|NCT01001221|26849391|P3|Overall Study|Adverse Event|0
7721255|NCT01001221|26849392|P2|Overall Study|Adverse Event|2
7721256|NCT01001221|26849393|P1|Overall Study|Adverse Event|1
7721257|NCT01001208|26849568|P2|Overall Study|Other|2
7721258|NCT01001208|26849569|P1|Overall Study|Other|0
7721259|NCT01001208|26849568|P2|Overall Study|Disease Progression|3
7721260|NCT01001208|26849569|P1|Overall Study|Disease Progression|0
7721261|NCT01001208|26849568|P2|Overall Study|Noncompliance|7
7721262|NCT01001208|26849569|P1|Overall Study|Noncompliance|4
7721263|NCT01001208|26849568|P2|Overall Study|Ineligibility Determined|2
7721264|NCT01001208|26849569|P1|Overall Study|Ineligibility Determined|4
7721265|NCT01001208|26849568|P2|Overall Study|Withdrawal by Subject|5
7721266|NCT01001208|26849569|P1|Overall Study|Withdrawal by Subject|4
7721267|NCT01001208|26849568|P2|Overall Study|Physician Decision|0
7721268|NCT01001208|26849569|P1|Overall Study|Physician Decision|1
7721269|NCT01001208|26849568|P2|Overall Study|Lost to Follow-up|9
7721270|NCT01001208|26849569|P1|Overall Study|Lost to Follow-up|5
7721271|NCT01001208|26849568|P2|Overall Study|Adverse Event|5
7721272|NCT01001208|26849569|P1|Overall Study|Adverse Event|10
7721273|NCT01001169|26849612|P2|Overall Study|Withdrawal by Subject|1
7721274|NCT01001169|26849613|P1|Overall Study|Withdrawal by Subject|2
7721275|NCT01001104|26849721|P4|Overall Study|Withdrawal by Subject|2
7721276|NCT01001104|26849722|P3|Overall Study|Withdrawal by Subject|0
7721277|NCT01001104|26849723|P2|Overall Study|Withdrawal by Subject|0
7721278|NCT01001104|26849724|P1|Overall Study|Withdrawal by Subject|0
7721279|NCT01001104|26849721|P4|Overall Study|Entry Criteria Not Met|1
7721280|NCT01001104|26849722|P3|Overall Study|Entry Criteria Not Met|0
7721281|NCT01001104|26849723|P2|Overall Study|Entry Criteria Not Met|0
7721282|NCT01001104|26849724|P1|Overall Study|Entry Criteria Not Met|0
7721283|NCT01001104|26849721|P4|Overall Study|Lost to Follow-up|0
7721284|NCT01001104|26849722|P3|Overall Study|Lost to Follow-up|1
7721285|NCT01001104|26849723|P2|Overall Study|Lost to Follow-up|0
7721286|NCT01001104|26849724|P1|Overall Study|Lost to Follow-up|0
7721287|NCT01001104|26849721|P4|Overall Study|Adverse Event|0
7721288|NCT01001104|26849722|P3|Overall Study|Adverse Event|0
7721289|NCT01001104|26849723|P2|Overall Study|Adverse Event|1
7721290|NCT01001104|26849724|P1|Overall Study|Adverse Event|2
7721291|NCT01000974|26849815|P3|Booster Vaccination Phase|Other|4
7721292|NCT01000974|26849816|P2|Booster Vaccination Phase|Other|6
7721293|NCT01000974|26849817|P1|Booster Vaccination Phase|Other|24
7721294|NCT01000974|26849815|P3|Booster Vaccination Phase|Lost to Follow-up|7
7721295|NCT01000974|26849816|P2|Booster Vaccination Phase|Lost to Follow-up|5
7721296|NCT01000974|26849817|P1|Booster Vaccination Phase|Lost to Follow-up|40
7721297|NCT01000974|26849815|P3|Booster Vaccination Phase|Withdrawal by Subject|1
7721298|NCT01000974|26849816|P2|Booster Vaccination Phase|Withdrawal by Subject|1
7721299|NCT01000974|26849817|P1|Booster Vaccination Phase|Withdrawal by Subject|3
7721300|NCT01000974|26849815|P3|Booster Vaccination Phase|Protocol Violation|2
7721301|NCT01000974|26849816|P2|Booster Vaccination Phase|Protocol Violation|0
7721302|NCT01000974|26849817|P1|Booster Vaccination Phase|Protocol Violation|0
7721303|NCT01000974|26849815|P3|Primary Vaccination Phase|Other|12
7721304|NCT01000974|26849816|P2|Primary Vaccination Phase|Other|9
7721305|NCT01000974|26849817|P1|Primary Vaccination Phase|Other|4
7721306|NCT01000974|26849815|P3|Primary Vaccination Phase|Adverse Event|2
7721307|NCT01000974|26849816|P2|Primary Vaccination Phase|Adverse Event|2
7721308|NCT01000974|26849817|P1|Primary Vaccination Phase|Adverse Event|14
7721309|NCT01000974|26849815|P3|Primary Vaccination Phase|Protocol Violation|2
7721310|NCT01000974|26849816|P2|Primary Vaccination Phase|Protocol Violation|3
7721311|NCT01000974|26849817|P1|Primary Vaccination Phase|Protocol Violation|40
7721312|NCT01000974|26849815|P3|Primary Vaccination Phase|Lost to Follow-up|26
7721313|NCT01000974|26849816|P2|Primary Vaccination Phase|Lost to Follow-up|19
7721314|NCT01000974|26849817|P1|Primary Vaccination Phase|Lost to Follow-up|171
7721315|NCT01000974|26849815|P3|Primary Vaccination Phase|Withdrawal by Subject|21
7721316|NCT01000974|26849816|P2|Primary Vaccination Phase|Withdrawal by Subject|17
7721317|NCT01000974|26849817|P1|Primary Vaccination Phase|Withdrawal by Subject|109
7721318|NCT01000961|26849924|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
7721319|NCT01000961|26849925|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
7721320|NCT01000961|26849924|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
7721321|NCT01000961|26849925|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
7721322|NCT01000805|26849948|P2|Overall Study|Sponsor Decision|1
7721323|NCT01000805|26849949|P1|Overall Study|Sponsor Decision|0
7721324|NCT01000805|26849948|P2|Overall Study|Withdrawal by Subject|6
7721325|NCT01000805|26849949|P1|Overall Study|Withdrawal by Subject|16
7721326|NCT01000805|26849948|P2|Overall Study|Protocol Violation|8
7721327|NCT01000805|26849949|P1|Overall Study|Protocol Violation|12
7721328|NCT01000805|26849948|P2|Overall Study|Physician Decision|1
7721329|NCT01000805|26849949|P1|Overall Study|Physician Decision|0
7721330|NCT01000805|26849948|P2|Overall Study|Lost to Follow-up|21
7721331|NCT01000805|26849949|P1|Overall Study|Lost to Follow-up|16
7721332|NCT01000805|26849948|P2|Overall Study|Lack of Efficacy|16
7721333|NCT01000805|26849949|P1|Overall Study|Lack of Efficacy|5
7721334|NCT01000805|26849948|P2|Overall Study|Adverse Event|9
7721335|NCT01000805|26849949|P1|Overall Study|Adverse Event|21
7721336|NCT01000727|26849983|P2|Overall Study|Study closed/terminated|24
7721337|NCT01000727|26849984|P1|Overall Study|Study closed/terminated|23
7721338|NCT01000727|26849983|P2|Overall Study|Withdrawal by Subject|109
7721339|NCT01000727|26849984|P1|Overall Study|Withdrawal by Subject|111
7721340|NCT01000727|26849983|P2|Overall Study|Lost to Follow-up|43
7721341|NCT01000727|26849984|P1|Overall Study|Lost to Follow-up|41
7721342|NCT01000649|26850049|P4|Overall Study|Lost to Follow-up|2
7721343|NCT01000649|26850050|P3|Overall Study|Lost to Follow-up|0
7721344|NCT01000649|26850051|P2|Overall Study|Lost to Follow-up|2
7721345|NCT01000649|26850052|P1|Overall Study|Lost to Follow-up|0
7721346|NCT01000649|26850049|P4|Overall Study|Adverse Event|4
7721347|NCT01000649|26850050|P3|Overall Study|Adverse Event|2
7721348|NCT01000649|26850051|P2|Overall Study|Adverse Event|1
7721349|NCT01000649|26850052|P1|Overall Study|Adverse Event|5
7721350|NCT01000636|26850133|P1|Overall Study|Adverse Event|1
7721351|NCT01000636|26850133|P1|Overall Study|Withdrawal by Subject|1
7721352|NCT01000610|26850138|P1|Overall Study|Treatment failure|1
7721353|NCT01000610|26850138|P1|Overall Study|Lost to Follow-up|4
7721354|NCT01000610|26850138|P1|Overall Study|Adverse Event|1
7721355|NCT01000506|26850149|P4|Overall Study|Withdrawal by Subject|7
7721356|NCT01000506|26850150|P3|Overall Study|Withdrawal by Subject|2
7721357|NCT01000506|26850151|P2|Overall Study|Withdrawal by Subject|8
7721358|NCT01000506|26850152|P1|Overall Study|Withdrawal by Subject|11
7721359|NCT01000506|26850149|P4|Overall Study|Physician Decision|3
7721360|NCT01000506|26850150|P3|Overall Study|Physician Decision|3
7721361|NCT01000506|26850151|P2|Overall Study|Physician Decision|3
7721362|NCT01000506|26850152|P1|Overall Study|Physician Decision|1
7721363|NCT01000506|26850149|P4|Overall Study|Lost to Follow-up|0
7721364|NCT01000506|26850150|P3|Overall Study|Lost to Follow-up|4
7721365|NCT01000506|26850151|P2|Overall Study|Lost to Follow-up|1
7721366|NCT01000506|26850152|P1|Overall Study|Lost to Follow-up|1
7721367|NCT01000506|26850149|P4|Overall Study|Protocol Violation|0
7721368|NCT01000506|26850150|P3|Overall Study|Protocol Violation|0
7721369|NCT01000506|26850151|P2|Overall Study|Protocol Violation|1
7721370|NCT01000506|26850152|P1|Overall Study|Protocol Violation|1
7721371|NCT01000506|26850149|P4|Overall Study|Lack of Efficacy|4
7721372|NCT01000506|26850150|P3|Overall Study|Lack of Efficacy|4
7721373|NCT01000506|26850151|P2|Overall Study|Lack of Efficacy|6
7721374|NCT01000506|26850152|P1|Overall Study|Lack of Efficacy|8
7721375|NCT01000506|26850149|P4|Overall Study|Adverse Event|9
7721376|NCT01000506|26850150|P3|Overall Study|Adverse Event|8
7721377|NCT01000506|26850151|P2|Overall Study|Adverse Event|5
7721378|NCT01000506|26850152|P1|Overall Study|Adverse Event|6
7721379|NCT01000493|26850196|P2|Overall Study|Withdrawal by Subject|7
7721380|NCT01000493|26850197|P1|Overall Study|Withdrawal by Subject|3
7721381|NCT01000493|26850196|P2|Overall Study|Physician Decision|1
7721382|NCT01000493|26850197|P1|Overall Study|Physician Decision|1
7721383|NCT01000493|26850196|P2|Overall Study|Lost to Follow-up|9
7721384|NCT01000493|26850197|P1|Overall Study|Lost to Follow-up|5
7721385|NCT01000493|26850196|P2|Overall Study|Study closed/terminated|23
7721386|NCT01000493|26850197|P1|Overall Study|Study closed/terminated|25
7721387|NCT01000493|26850196|P2|Overall Study|Protocol Violation|8
7721388|NCT01000493|26850197|P1|Overall Study|Protocol Violation|1
7721389|NCT01000493|26850196|P2|Overall Study|Lack of Efficacy|1
7721390|NCT01000493|26850197|P1|Overall Study|Lack of Efficacy|1
7721391|NCT01000493|26850196|P2|Overall Study|Adverse Event|6
7721392|NCT01000493|26850197|P1|Overall Study|Adverse Event|3
7721393|NCT01000480|26850247|P1|Concurrent Therapy Phase|Physician Decision|1
7721394|NCT01000480|26850247|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
7721395|NCT01000480|26850247|P1|Concurrent Therapy Phase|Protocol Violation|2
7721396|NCT01000480|26850247|P1|Concurrent Therapy Phase|Adverse Event|4
7721397|NCT01000480|26850247|P1|Induction Phase|Entry Criteria Not Met|3
7721398|NCT01000480|26850247|P1|Induction Phase|Physician Decision|1
7721399|NCT01000480|26850247|P1|Induction Phase|Lost to Follow-up|1
7721400|NCT01000480|26850247|P1|Induction Phase|Adverse Event|2
7721401|NCT01000376|26850255|P2|Cycle 1 Day 1|Progressive Disease|0
7721402|NCT01000376|26850256|P1|Cycle 1 Day 1|Progressive Disease|1
7721403|NCT01000376|26850255|P2|Cycle 1 Day 1|Adverse Event|0
7721404|NCT01000376|26850256|P1|Cycle 1 Day 1|Adverse Event|1
7721405|NCT01000337|26850266|P2|Overall Study|Lost to Follow-up|3
7721406|NCT01000337|26850267|P1|Overall Study|Lost to Follow-up|4
7721407|NCT01000311|26850285|P2|Overall Study|Administrative reason|15
7721408|NCT01000311|26850286|P1|Overall Study|Administrative reason|9
7721409|NCT01000311|26850285|P2|Overall Study|Inappropriate enrollment|0
7721410|NCT01000311|26850286|P1|Overall Study|Inappropriate enrollment|2
7721411|NCT01000311|26850285|P2|Overall Study|Protocol Violation|2
7721412|NCT01000311|26850286|P1|Overall Study|Protocol Violation|1
7721413|NCT01000311|26850285|P2|Overall Study|Lost to Follow-up|24
7721414|NCT01000311|26850286|P1|Overall Study|Lost to Follow-up|15
7721415|NCT01000311|26850285|P2|Overall Study|Withdrawal by Subject|24
7721416|NCT01000311|26850286|P1|Overall Study|Withdrawal by Subject|16
7721417|NCT01000311|26850285|P2|Overall Study|Adverse Event|5
7721418|NCT01000311|26850286|P1|Overall Study|Adverse Event|2
7721419|NCT01000155|26850336|P1|Overall Study|Adverse Event|1
7721420|NCT01000155|26850336|P1|Overall Study|Withdrawal by Subject|1
7721421|NCT01000064|26850342|P2|Overall Study|Withdrawal by Subject|1
7721422|NCT01000064|26850343|P1|Overall Study|Withdrawal by Subject|1
7721423|NCT01000051|26850366|P2|Overall Study|Serious noncompliance|0
7721424|NCT01000051|26850367|P1|Overall Study|Serious noncompliance|1
7721425|NCT01000051|26850366|P2|Overall Study|Disease Progression|0
7721426|NCT01000051|26850367|P1|Overall Study|Disease Progression|1
7721427|NCT01000051|26850366|P2|Overall Study|Withdrawal by Subject|1
7721428|NCT01000051|26850367|P1|Overall Study|Withdrawal by Subject|1
7721429|NCT01000025|26850375|P2|Overall Study|Intercurrent Illness|7
7721430|NCT01000025|26850376|P1|Overall Study|Intercurrent Illness|26
7721431|NCT01000025|26850375|P2|Overall Study|Lack of Efficacy|208
7721432|NCT01000025|26850376|P1|Overall Study|Lack of Efficacy|363
7721433|NCT01000025|26850375|P2|Overall Study|Death|13
7721434|NCT01000025|26850376|P1|Overall Study|Death|23
7721435|NCT01000025|26850375|P2|Overall Study|Withdrawal by Subject|8
7721436|NCT01000025|26850376|P1|Overall Study|Withdrawal by Subject|13
7721437|NCT01000025|26850375|P2|Overall Study|Adverse Event|2
7721438|NCT01000025|26850376|P1|Overall Study|Adverse Event|43
7721439|NCT00999921|26850394|P2|Overall Study|Lost to Follow-up|19
7721440|NCT00999921|26850395|P1|Overall Study|Lost to Follow-up|10
7721441|NCT00999908|26850405|P3|Treatment Period 2|Protocol Violation|0
7721442|NCT00999908|26850406|P2|Treatment Period 2|Protocol Violation|0
7721443|NCT00999908|26850407|P1|Treatment Period 2|Protocol Violation|1
7721444|NCT00999908|26850405|P3|Treatment Period 1|Subject withdrew consent|0
7721445|NCT00999908|26850406|P2|Treatment Period 1|Subject withdrew consent|0
7721446|NCT00999908|26850407|P1|Treatment Period 1|Subject withdrew consent|2
7721447|NCT00999804|26850436|P2|Overall Study|Ineligible|0
7721448|NCT00999804|26850437|P1|Overall Study|Ineligible|3
7721449|NCT00999804|26850436|P2|Overall Study|Death|0
7721450|NCT00999804|26850437|P1|Overall Study|Death|1
7721451|NCT00999804|26850436|P2|Overall Study|Withdrawal by Subject|0
7721452|NCT00999804|26850437|P1|Overall Study|Withdrawal by Subject|4
7721453|NCT00999804|26850436|P2|Overall Study|Adverse Event|3
7721454|NCT00999804|26850437|P1|Overall Study|Adverse Event|4
7721455|NCT00999804|26850436|P2|Overall Study|Lack of Efficacy|2
7721456|NCT00999804|26850437|P1|Overall Study|Lack of Efficacy|9
7721457|NCT00999713|26850451|P2|Overall Study|Physician Decision|0
7721458|NCT00999713|26850452|P1|Overall Study|Physician Decision|2
7721459|NCT00999687|26850466|P1|Second Intervention|Lack of Efficacy|1
7721460|NCT00999687|26850466|P1|Second Intervention|Withdrawal by Subject|2
7721461|NCT00999687|26850466|P1|First Intervention|Withdrawal by Subject|1
7721462|NCT00999661|26850473|P1|Overall Study|Not meeting eligibility criteria|9
7721463|NCT00999661|26850473|P1|Overall Study|Withdrawal by Subject|1
7721464|NCT00999661|26850473|P1|Overall Study|Adverse Event|1
7721465|NCT00999661|26850473|P1|Overall Study|Lost to Follow-up|59
7721466|NCT00999596|26850494|P1|Overall Study|Statistical population not required|101
7721467|NCT00999544|26850499|P1|Overall Study|Withdrawal by Subject|1
7721468|NCT00999518|26850537|P5|Overall Study|Randomized but not Treated|1
7721469|NCT00999518|26850538|P4|Overall Study|Randomized but not Treated|0
7721470|NCT00999518|26850539|P3|Overall Study|Randomized but not Treated|2
7721471|NCT00999518|26850540|P2|Overall Study|Randomized but not Treated|1
7721472|NCT00999518|26850541|P1|Overall Study|Randomized but not Treated|1
7721473|NCT00999518|26850537|P5|Overall Study|Other|5
7721474|NCT00999518|26850538|P4|Overall Study|Other|4
7721475|NCT00999518|26850539|P3|Overall Study|Other|1
7721476|NCT00999518|26850540|P2|Overall Study|Other|7
7721477|NCT00999518|26850541|P1|Overall Study|Other|5
7721478|NCT00999518|26850537|P5|Overall Study|Withdrawal by Subject|1
7721479|NCT00999518|26850538|P4|Overall Study|Withdrawal by Subject|6
7721480|NCT00999518|26850539|P3|Overall Study|Withdrawal by Subject|10
7721481|NCT00999518|26850540|P2|Overall Study|Withdrawal by Subject|4
7721482|NCT00999518|26850541|P1|Overall Study|Withdrawal by Subject|5
7721483|NCT00999518|26850537|P5|Overall Study|Protocol Violation|2
7721484|NCT00999518|26850538|P4|Overall Study|Protocol Violation|0
7721485|NCT00999518|26850539|P3|Overall Study|Protocol Violation|0
7721486|NCT00999518|26850540|P2|Overall Study|Protocol Violation|1
7721487|NCT00999518|26850541|P1|Overall Study|Protocol Violation|0
7721488|NCT00999518|26850537|P5|Overall Study|Pregnancy|0
7721489|NCT00999518|26850538|P4|Overall Study|Pregnancy|0
7721490|NCT00999518|26850539|P3|Overall Study|Pregnancy|1
7721491|NCT00999518|26850540|P2|Overall Study|Pregnancy|0
7721492|NCT00999518|26850541|P1|Overall Study|Pregnancy|0
7721493|NCT00999518|26850537|P5|Overall Study|Study terminated by sponsor|9
7721494|NCT00999518|26850538|P4|Overall Study|Study terminated by sponsor|5
7721495|NCT00999518|26850539|P3|Overall Study|Study terminated by sponsor|5
7721496|NCT00999518|26850540|P2|Overall Study|Study terminated by sponsor|6
7721497|NCT00999518|26850541|P1|Overall Study|Study terminated by sponsor|10
7721498|NCT00999518|26850537|P5|Overall Study|Did not meet entrance criteria|1
7721499|NCT00999518|26850538|P4|Overall Study|Did not meet entrance criteria|0
7721500|NCT00999518|26850539|P3|Overall Study|Did not meet entrance criteria|0
7721501|NCT00999518|26850540|P2|Overall Study|Did not meet entrance criteria|0
7721502|NCT00999518|26850541|P1|Overall Study|Did not meet entrance criteria|0
7721503|NCT00999518|26850537|P5|Overall Study|Lost to Follow-up|1
7721504|NCT00999518|26850538|P4|Overall Study|Lost to Follow-up|4
7721505|NCT00999518|26850539|P3|Overall Study|Lost to Follow-up|0
7721506|NCT00999518|26850540|P2|Overall Study|Lost to Follow-up|0
7721507|NCT00999518|26850541|P1|Overall Study|Lost to Follow-up|0
7721508|NCT00999518|26850537|P5|Overall Study|Lack of Efficacy|2
7721509|NCT00999518|26850538|P4|Overall Study|Lack of Efficacy|2
7721510|NCT00999518|26850539|P3|Overall Study|Lack of Efficacy|0
7721511|NCT00999518|26850540|P2|Overall Study|Lack of Efficacy|0
7721512|NCT00999518|26850541|P1|Overall Study|Lack of Efficacy|2
7721513|NCT00999518|26850537|P5|Overall Study|Adverse Event|2
7721514|NCT00999518|26850538|P4|Overall Study|Adverse Event|1
7721515|NCT00999518|26850539|P3|Overall Study|Adverse Event|3
7721516|NCT00999518|26850540|P2|Overall Study|Adverse Event|6
7721517|NCT00999518|26850541|P1|Overall Study|Adverse Event|1
7721518|NCT00999466|26850730|P3|Main Part|Adverse Event|2
7721519|NCT00999466|26850731|P2|Main Part|Adverse Event|4
7721520|NCT00999466|26850732|P1|Main Part|Adverse Event|0
7721521|NCT00999466|26850730|P3|Main Part|Withdrawal by Subject|2
7721522|NCT00999466|26850731|P2|Main Part|Withdrawal by Subject|0
7721523|NCT00999466|26850732|P1|Main Part|Withdrawal by Subject|0
7721524|NCT00999167|26851009|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
7721525|NCT00999167|26851010|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
7721526|NCT00999167|26851011|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
7721527|NCT00999167|26851009|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
7721528|NCT00999167|26851010|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
7721529|NCT00999167|26851011|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
7721530|NCT00999167|26851009|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
7721531|NCT00999167|26851010|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
7721532|NCT00999167|26851011|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
7721533|NCT00999167|26851009|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
7721534|NCT00999167|26851010|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
7721535|NCT00999167|26851011|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
7721536|NCT00999167|26851009|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
7721537|NCT00999167|26851010|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
7721538|NCT00999167|26851011|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
7721539|NCT00999167|26851009|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
7721540|NCT00999167|26851010|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
7721541|NCT00999167|26851011|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
7721542|NCT00999167|26851009|P3|Part A: Open Label Safety run-in|Adverse Event|0
7721543|NCT00999167|26851010|P2|Part A: Open Label Safety run-in|Adverse Event|0
7721544|NCT00999167|26851011|P1|Part A: Open Label Safety run-in|Adverse Event|3
7721545|NCT00999167|26851009|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
7721546|NCT00999167|26851010|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
7721547|NCT00999167|26851011|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
7721548|NCT00998985|26851149|P14|Overall Study|Protocol Violation|0
7721549|NCT00998985|26851150|P13|Overall Study|Protocol Violation|0
7721550|NCT00998985|26851151|P12|Overall Study|Protocol Violation|0
7721551|NCT00998985|26851152|P11|Overall Study|Protocol Violation|0
7721552|NCT00998985|26851153|P10|Overall Study|Protocol Violation|0
7721553|NCT00998985|26851154|P9|Overall Study|Protocol Violation|0
7721554|NCT00998985|26851155|P8|Overall Study|Protocol Violation|0
7721555|NCT00998985|26851156|P7|Overall Study|Protocol Violation|0
7721556|NCT00998985|26851157|P6|Overall Study|Protocol Violation|1
7721557|NCT00998985|26851158|P5|Overall Study|Protocol Violation|0
7721558|NCT00998985|26851159|P4|Overall Study|Protocol Violation|0
7721559|NCT00998985|26851160|P3|Overall Study|Protocol Violation|0
7721560|NCT00998985|26851161|P2|Overall Study|Protocol Violation|0
7721561|NCT00998985|26851162|P1|Overall Study|Protocol Violation|0
7721562|NCT00998985|26851149|P14|Overall Study|Withdrawal by Subject|0
7721563|NCT00998985|26851150|P13|Overall Study|Withdrawal by Subject|0
7721564|NCT00998985|26851151|P12|Overall Study|Withdrawal by Subject|0
7721565|NCT00998985|26851152|P11|Overall Study|Withdrawal by Subject|0
7721566|NCT00998985|26851153|P10|Overall Study|Withdrawal by Subject|0
7721567|NCT00998985|26851154|P9|Overall Study|Withdrawal by Subject|1
7721568|NCT00998985|26851155|P8|Overall Study|Withdrawal by Subject|0
7721569|NCT00998985|26851156|P7|Overall Study|Withdrawal by Subject|0
7721570|NCT00998985|26851157|P6|Overall Study|Withdrawal by Subject|0
7721571|NCT00998985|26851158|P5|Overall Study|Withdrawal by Subject|0
7721572|NCT00998985|26851159|P4|Overall Study|Withdrawal by Subject|0
7721573|NCT00998985|26851160|P3|Overall Study|Withdrawal by Subject|0
7721574|NCT00998985|26851161|P2|Overall Study|Withdrawal by Subject|0
7721575|NCT00998985|26851162|P1|Overall Study|Withdrawal by Subject|0
7721576|NCT00998881|26851230|P2|Overall Study|Personal matter|0
7721577|NCT00998881|26851231|P1|Overall Study|Personal matter|1
7721578|NCT00998881|26851230|P2|Overall Study|Withdrawal by Subject|0
7721579|NCT00998881|26851231|P1|Overall Study|Withdrawal by Subject|1
7721580|NCT00998881|26851230|P2|Overall Study|Physician Decision|0
7721581|NCT00998881|26851231|P1|Overall Study|Physician Decision|3
7721582|NCT00998881|26851230|P2|Overall Study|Lack of Efficacy|0
7721583|NCT00998881|26851231|P1|Overall Study|Lack of Efficacy|1
7721584|NCT00998881|26851230|P2|Overall Study|Adverse Event|2
7721585|NCT00998881|26851231|P1|Overall Study|Adverse Event|2
7721586|NCT00998790|26851250|P1|Overall Study|Withdrawal by Subject|21
7721587|NCT00998764|26851260|P2|Overall Study|Recurrent Episode of vasogenic edema|0
7721588|NCT00998764|26851261|P1|Overall Study|Recurrent Episode of vasogenic edema|1
7721589|NCT00998764|26851260|P2|Overall Study|Other|4
7721590|NCT00998764|26851261|P1|Overall Study|Other|4
7721591|NCT00998764|26851260|P2|Overall Study|Loss of Caregiver|3
7721592|NCT00998764|26851261|P1|Overall Study|Loss of Caregiver|0
7721593|NCT00998764|26851260|P2|Overall Study|Lost to Follow-up|1
7721594|NCT00998764|26851261|P1|Overall Study|Lost to Follow-up|1
7721595|NCT00998764|26851260|P2|Overall Study|Failed to Return|1
7721596|NCT00998764|26851261|P1|Overall Study|Failed to Return|1
7721597|NCT00998764|26851260|P2|Overall Study|Protocol Violation|1
7721598|NCT00998764|26851261|P1|Overall Study|Protocol Violation|0
7721599|NCT00998764|26851260|P2|Overall Study|Discontinuation of Study by Sponsor|217
7721600|NCT00998764|26851261|P1|Overall Study|Discontinuation of Study by Sponsor|164
7721601|NCT00998764|26851260|P2|Overall Study|Death|1
7721602|NCT00998764|26851261|P1|Overall Study|Death|3
7721603|NCT00998764|26851260|P2|Overall Study|Physician Decision|3
7721604|NCT00998764|26851261|P1|Overall Study|Physician Decision|3
7721605|NCT00998764|26851260|P2|Overall Study|Withdrawal by Subject|25
7721606|NCT00998764|26851261|P1|Overall Study|Withdrawal by Subject|19
7721607|NCT00998764|26851260|P2|Overall Study|Adverse Event|12
7721608|NCT00998764|26851261|P1|Overall Study|Adverse Event|17
7721609|NCT00998764|26851260|P2|Overall Study|Lack of Efficacy|6
7721610|NCT00998764|26851261|P1|Overall Study|Lack of Efficacy|3
7721611|NCT00998738|26851283|P1|Overall Study|Uknown|1
7721612|NCT00998400|26851351|P2|Overall Study|Logistical problems|0
7721613|NCT00998400|26851352|P1|Overall Study|Logistical problems|1
7721614|NCT00998400|26851351|P2|Overall Study|Lack of interest/motivation|2
7721615|NCT00998400|26851352|P1|Overall Study|Lack of interest/motivation|1
7721616|NCT00998335|26851397|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
7721617|NCT00998335|26851398|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
7721618|NCT00998309|26851426|P1|Overall Study|Protocol Violation|4
7721619|NCT00998296|26851493|P11|Overall Study|Reason other than those specified above|0
7721620|NCT00998296|26851494|P10|Overall Study|Reason other than those specified above|1
7721621|NCT00998296|26851495|P9|Overall Study|Reason other than those specified above|0
7721622|NCT00998296|26851496|P8|Overall Study|Reason other than those specified above|0
7721623|NCT00998296|26851497|P7|Overall Study|Reason other than those specified above|0
7721624|NCT00998296|26851498|P6|Overall Study|Reason other than those specified above|0
7721625|NCT00998296|26851499|P5|Overall Study|Reason other than those specified above|0
7721626|NCT00998296|26851500|P4|Overall Study|Reason other than those specified above|0
7721627|NCT00998296|26851501|P3|Overall Study|Reason other than those specified above|0
7721628|NCT00998296|26851502|P2|Overall Study|Reason other than those specified above|0
7721629|NCT00998296|26851503|P1|Overall Study|Reason other than those specified above|0
7721630|NCT00998296|26851493|P11|Overall Study|Refused to continue taking trial med.|0
7721631|NCT00998296|26851494|P10|Overall Study|Refused to continue taking trial med.|2
7721632|NCT00998296|26851495|P9|Overall Study|Refused to continue taking trial med.|0
7721633|NCT00998296|26851496|P8|Overall Study|Refused to continue taking trial med.|0
7721634|NCT00998296|26851497|P7|Overall Study|Refused to continue taking trial med.|0
7721635|NCT00998296|26851498|P6|Overall Study|Refused to continue taking trial med.|0
7721636|NCT00998296|26851499|P5|Overall Study|Refused to continue taking trial med.|0
7721637|NCT00998296|26851500|P4|Overall Study|Refused to continue taking trial med.|0
7721638|NCT00998296|26851501|P3|Overall Study|Refused to continue taking trial med.|0
7721639|NCT00998296|26851502|P2|Overall Study|Refused to continue taking trial med.|0
7721640|NCT00998296|26851503|P1|Overall Study|Refused to continue taking trial med.|0
7721641|NCT00998296|26851493|P11|Overall Study|Other adverse event|2
7721642|NCT00998296|26851494|P10|Overall Study|Other adverse event|1
7721643|NCT00998296|26851495|P9|Overall Study|Other adverse event|0
7721644|NCT00998296|26851496|P8|Overall Study|Other adverse event|0
7721645|NCT00998296|26851497|P7|Overall Study|Other adverse event|0
7721646|NCT00998296|26851498|P6|Overall Study|Other adverse event|0
7721647|NCT00998296|26851499|P5|Overall Study|Other adverse event|1
7721648|NCT00998296|26851500|P4|Overall Study|Other adverse event|0
7721649|NCT00998296|26851501|P3|Overall Study|Other adverse event|0
7721650|NCT00998296|26851502|P2|Overall Study|Other adverse event|0
7721651|NCT00998296|26851503|P1|Overall Study|Other adverse event|0
7721652|NCT00998296|26851493|P11|Overall Study|Dose limiting or dose reducing toxicity|0
7721653|NCT00998296|26851494|P10|Overall Study|Dose limiting or dose reducing toxicity|0
7721654|NCT00998296|26851495|P9|Overall Study|Dose limiting or dose reducing toxicity|2
7721655|NCT00998296|26851496|P8|Overall Study|Dose limiting or dose reducing toxicity|2
7721656|NCT00998296|26851497|P7|Overall Study|Dose limiting or dose reducing toxicity|0
7721657|NCT00998296|26851498|P6|Overall Study|Dose limiting or dose reducing toxicity|0
7721658|NCT00998296|26851499|P5|Overall Study|Dose limiting or dose reducing toxicity|1
7721659|NCT00998296|26851500|P4|Overall Study|Dose limiting or dose reducing toxicity|0
7721660|NCT00998296|26851501|P3|Overall Study|Dose limiting or dose reducing toxicity|0
7721661|NCT00998296|26851502|P2|Overall Study|Dose limiting or dose reducing toxicity|0
7721662|NCT00998296|26851503|P1|Overall Study|Dose limiting or dose reducing toxicity|0
7721663|NCT00998296|26851493|P11|Overall Study|Progressive disease|5
7721664|NCT00998296|26851494|P10|Overall Study|Progressive disease|14
7721665|NCT00998296|26851495|P9|Overall Study|Progressive disease|0
7721666|NCT00998296|26851496|P8|Overall Study|Progressive disease|0
7721667|NCT00998296|26851497|P7|Overall Study|Progressive disease|1
7721668|NCT00998296|26851498|P6|Overall Study|Progressive disease|0
7721669|NCT00998296|26851499|P5|Overall Study|Progressive disease|0
7721670|NCT00998296|26851500|P4|Overall Study|Progressive disease|0
7721671|NCT00998296|26851501|P3|Overall Study|Progressive disease|0
7721672|NCT00998296|26851502|P2|Overall Study|Progressive disease|1
7721673|NCT00998296|26851503|P1|Overall Study|Progressive disease|0
7721674|NCT00997984|26851606|P3|Overall Study|Work schedule|2
7721675|NCT00997984|26851607|P2|Overall Study|Work schedule|0
7721676|NCT00997984|26851608|P1|Overall Study|Work schedule|0
7721677|NCT00997984|26851606|P3|Overall Study|Suicidal ideation|1
7721678|NCT00997984|26851607|P2|Overall Study|Suicidal ideation|0
7721679|NCT00997984|26851608|P1|Overall Study|Suicidal ideation|0
7721680|NCT00997984|26851606|P3|Overall Study|Wrong medication dispensed|0
7721681|NCT00997984|26851607|P2|Overall Study|Wrong medication dispensed|1
7721682|NCT00997984|26851608|P1|Overall Study|Wrong medication dispensed|0
7721683|NCT00997984|26851606|P3|Overall Study|non-compliance|3
7721684|NCT00997984|26851607|P2|Overall Study|non-compliance|2
7721685|NCT00997984|26851608|P1|Overall Study|non-compliance|0
7721686|NCT00997984|26851606|P3|Overall Study|Met exclusion criteria|0
7721687|NCT00997984|26851607|P2|Overall Study|Met exclusion criteria|0
7721688|NCT00997984|26851608|P1|Overall Study|Met exclusion criteria|1
7721689|NCT00997984|26851606|P3|Overall Study|Lack of Efficacy|3
7721690|NCT00997984|26851607|P2|Overall Study|Lack of Efficacy|6
7721691|NCT00997984|26851608|P1|Overall Study|Lack of Efficacy|20
7721692|NCT00997984|26851606|P3|Overall Study|Lost to Follow-up|4
7721693|NCT00997984|26851607|P2|Overall Study|Lost to Follow-up|5
7721694|NCT00997984|26851608|P1|Overall Study|Lost to Follow-up|8
7721695|NCT00997984|26851606|P3|Overall Study|Withdrawal by Subject|5
7721696|NCT00997984|26851607|P2|Overall Study|Withdrawal by Subject|9
7721697|NCT00997984|26851608|P1|Overall Study|Withdrawal by Subject|6
7721698|NCT00997984|26851606|P3|Overall Study|Protocol Violation|0
7721699|NCT00997984|26851607|P2|Overall Study|Protocol Violation|3
7721700|NCT00997984|26851608|P1|Overall Study|Protocol Violation|1
7721701|NCT00997984|26851606|P3|Overall Study|Adverse Event|8
7721702|NCT00997984|26851607|P2|Overall Study|Adverse Event|8
7721703|NCT00997984|26851608|P1|Overall Study|Adverse Event|1
7721704|NCT00997893|26851682|P3|Overall Study|Pain/pain meds during Visit 4|0
7721705|NCT00997893|26851683|P2|Overall Study|Pain/pain meds during Visit 4|1
7721706|NCT00997893|26851684|P1|Overall Study|Pain/pain meds during Visit 4|0
7721707|NCT00997893|26851682|P3|Overall Study|Unable to meet study timelines|0
7721708|NCT00997893|26851683|P2|Overall Study|Unable to meet study timelines|0
7721709|NCT00997893|26851684|P1|Overall Study|Unable to meet study timelines|1
7721710|NCT00997893|26851682|P3|Overall Study|Adverse Event|0
7721711|NCT00997893|26851683|P2|Overall Study|Adverse Event|0
7721712|NCT00997893|26851684|P1|Overall Study|Adverse Event|1
7721713|NCT00997503|26851791|P1|Overall Study|Other reason|13
7721714|NCT00997503|26851791|P1|Overall Study|Missed 12-month follow-up|85
7721715|NCT00997503|26851791|P1|Overall Study|Physician Decision|10
7721716|NCT00997503|26851791|P1|Overall Study|Adverse Event|3
7721717|NCT00997503|26851791|P1|Overall Study|Lost to Follow-up|33
7721718|NCT00997503|26851791|P1|Overall Study|Withdrawal by Subject|76
7721719|NCT00997503|26851791|P1|Overall Study|Death|53
7721720|NCT00997438|26851834|P3|Overall Study|Exclusion criteria at visit 1|3
7721721|NCT00997438|26851835|P2|Overall Study|Exclusion criteria at visit 1|2
7721722|NCT00997438|26851836|P1|Overall Study|Exclusion criteria at visit 1|2
7721723|NCT00997438|26851834|P3|Overall Study|Withdrawal by Subject|0
7721724|NCT00997438|26851835|P2|Overall Study|Withdrawal by Subject|1
7721725|NCT00997438|26851836|P1|Overall Study|Withdrawal by Subject|1
7721726|NCT00997438|26851834|P3|Overall Study|Blood draw difficulty|1
7721727|NCT00997438|26851835|P2|Overall Study|Blood draw difficulty|0
7721728|NCT00997438|26851836|P1|Overall Study|Blood draw difficulty|2
7721729|NCT00997386|26851876|P1|Overall Study|Death|7
7721730|NCT00997373|26851885|P2|Overall Study|could not have hysterectomy|0
7721731|NCT00997373|26851886|P1|Overall Study|could not have hysterectomy|6
7721732|NCT00997373|26851885|P2|Overall Study|wrong tumor type|0
7721733|NCT00997373|26851886|P1|Overall Study|wrong tumor type|4
7721734|NCT00997373|26851885|P2|Overall Study|Withdrawal by Subject|0
7721735|NCT00997373|26851886|P1|Overall Study|Withdrawal by Subject|5
7721736|NCT00997334|26851892|P1|Overall Study|Ineligible|1
7721737|NCT00997334|26851892|P1|Overall Study|No lesion amenable|1
7721738|NCT00997334|26851892|P1|Overall Study|Urgent Palliative Care|2
7721739|NCT00997334|26851892|P1|Overall Study|Death|2
7721740|NCT00997334|26851892|P1|Overall Study|Withdrawal by Subject|3
7721741|NCT00997334|26851892|P1|Overall Study|Patient non-compliance|1
7721742|NCT00997334|26851892|P1|Overall Study|Adverse Event|3
7721743|NCT00997334|26851892|P1|Overall Study|still on therapy|12
7721744|NCT00997321|26851901|P2|Overall Study|did not undergo sedation after enrollmen|3
7721745|NCT00997321|26851902|P1|Overall Study|did not undergo sedation after enrollmen|0
7721746|NCT00997243|26851914|P1|Overall Study|Early termination of study by sponsor|7
7721747|NCT00997126|26851946|P2|Overall Study|Physician Decision|11
7721748|NCT00997126|26851947|P1|Overall Study|Physician Decision|7
7721749|NCT00997035|26851976|P2|3-month Follow-up Visit|Lost to Follow-up|6
7721750|NCT00997035|26851977|P1|3-month Follow-up Visit|Lost to Follow-up|12
7721751|NCT00997035|26851976|P2|3-week Followup Visit|Lost to Follow-up|6
7721752|NCT00997035|26851977|P1|3-week Followup Visit|Lost to Follow-up|9
7721753|NCT00996996|26852001|P1|Overall Study|Did Not Receive Study Medications|1
7721754|NCT00996996|26852001|P1|Overall Study|Death|5
7721755|NCT00996996|26852001|P1|Overall Study|Lost to Follow-up|9
7721756|NCT00996996|26852001|P1|Overall Study|Non-compliance|8
7721757|NCT00996996|26852001|P1|Overall Study|Progressive Disease|10
7721758|NCT00996944|26852035|P2|Long-term Treatment Period|Study Closed/Terminated|5
7721759|NCT00996944|26852036|P1|Long-term Treatment Period|Study Closed/Terminated|12
7721760|NCT00996944|26852035|P2|Double-blind Treatment Period|Withdrawal by Subject|1
7721761|NCT00996944|26852036|P1|Double-blind Treatment Period|Withdrawal by Subject|1
7721762|NCT00996944|26852035|P2|Double-blind Treatment Period|Study Closed/Terminated|5
7721763|NCT00996944|26852036|P1|Double-blind Treatment Period|Study Closed/Terminated|6
7721764|NCT00996944|26852035|P2|Double-blind Treatment Period|Protocol Violation|0
7721765|NCT00996944|26852036|P1|Double-blind Treatment Period|Protocol Violation|1
7721766|NCT00996944|26852035|P2|Double-blind Treatment Period|Adverse Event|1
7721767|NCT00996944|26852036|P1|Double-blind Treatment Period|Adverse Event|2
7721768|NCT00996918|26852088|P5|Overall Study|Other|0
7721769|NCT00996918|26852089|P4|Overall Study|Other|0
7721770|NCT00996918|26852090|P3|Overall Study|Other|0
7721771|NCT00996918|26852091|P2|Overall Study|Other|1
7721772|NCT00996918|26852092|P1|Overall Study|Other|3
7721773|NCT00996918|26852088|P5|Overall Study|Loss of Caregiver|0
7721774|NCT00996918|26852089|P4|Overall Study|Loss of Caregiver|0
7721775|NCT00996918|26852090|P3|Overall Study|Loss of Caregiver|0
7721776|NCT00996918|26852091|P2|Overall Study|Loss of Caregiver|1
7721777|NCT00996918|26852092|P1|Overall Study|Loss of Caregiver|0
7721778|NCT00996918|26852088|P5|Overall Study|Discontinuation of Study by Sponsor|2
7721779|NCT00996918|26852089|P4|Overall Study|Discontinuation of Study by Sponsor|45
7721780|NCT00996918|26852090|P3|Overall Study|Discontinuation of Study by Sponsor|30
7721781|NCT00996918|26852091|P2|Overall Study|Discontinuation of Study by Sponsor|54
7721782|NCT00996918|26852092|P1|Overall Study|Discontinuation of Study by Sponsor|31
7721783|NCT00996918|26852088|P5|Overall Study|Physician Decision|0
7721784|NCT00996918|26852089|P4|Overall Study|Physician Decision|0
7721785|NCT00996918|26852090|P3|Overall Study|Physician Decision|0
7721786|NCT00996918|26852091|P2|Overall Study|Physician Decision|0
7721787|NCT00996918|26852092|P1|Overall Study|Physician Decision|1
7721788|NCT00996918|26852088|P5|Overall Study|Withdrawal by Subject|2
7721789|NCT00996918|26852089|P4|Overall Study|Withdrawal by Subject|3
7721790|NCT00996918|26852090|P3|Overall Study|Withdrawal by Subject|3
7721791|NCT00996918|26852091|P2|Overall Study|Withdrawal by Subject|4
7721792|NCT00996918|26852092|P1|Overall Study|Withdrawal by Subject|1
7721793|NCT00996918|26852088|P5|Overall Study|Adverse Event|0
7721794|NCT00996918|26852089|P4|Overall Study|Adverse Event|6
7721795|NCT00996918|26852090|P3|Overall Study|Adverse Event|2
7721796|NCT00996918|26852091|P2|Overall Study|Adverse Event|5
7721797|NCT00996918|26852092|P1|Overall Study|Adverse Event|2
7721798|NCT00996918|26852088|P5|Overall Study|Lack of Efficacy|0
7721799|NCT00996918|26852089|P4|Overall Study|Lack of Efficacy|2
7721800|NCT00996918|26852090|P3|Overall Study|Lack of Efficacy|2
7721801|NCT00996918|26852091|P2|Overall Study|Lack of Efficacy|1
7721802|NCT00996918|26852092|P1|Overall Study|Lack of Efficacy|1
7721803|NCT00996892|26852136|P20|Expansion Stage 2A|Disease Progression|31
7721804|NCT00996892|26852137|P19|Expansion Stage 2A|Disease Progression|0
7721805|NCT00996892|26852138|P18|Expansion Stage 2A|Disease Progression|0
7721806|NCT00996892|26852139|P17|Expansion Stage 2A|Disease Progression|0
7721807|NCT00996892|26852140|P16|Expansion Stage 2A|Disease Progression|0
7721808|NCT00996892|26852141|P15|Expansion Stage 2A|Disease Progression|0
7721809|NCT00996892|26852142|P14|Expansion Stage 2A|Disease Progression|0
7721810|NCT00996892|26852143|P13|Expansion Stage 2A|Disease Progression|0
7721811|NCT00996892|26852144|P12|Expansion Stage 2A|Disease Progression|0
7721812|NCT00996892|26852145|P11|Expansion Stage 2A|Disease Progression|0
7721813|NCT00996892|26852146|P10|Expansion Stage 2A|Disease Progression|0
7721814|NCT00996892|26852147|P9|Expansion Stage 2A|Disease Progression|0
7721815|NCT00996892|26852148|P8|Expansion Stage 2A|Disease Progression|0
7721816|NCT00996892|26852149|P7|Expansion Stage 2A|Disease Progression|0
7721817|NCT00996892|26852150|P6|Expansion Stage 2A|Disease Progression|0
7721818|NCT00996892|26852151|P5|Expansion Stage 2A|Disease Progression|0
7721819|NCT00996892|26852152|P4|Expansion Stage 2A|Disease Progression|0
7721820|NCT00996892|26852153|P3|Expansion Stage 2A|Disease Progression|0
7721821|NCT00996892|26852154|P2|Expansion Stage 2A|Disease Progression|0
7721822|NCT00996892|26852155|P1|Expansion Stage 2A|Disease Progression|0
7721823|NCT00996892|26852136|P20|Expansion Stage 2A|Withdrawal by Subject|4
7721824|NCT00996892|26852137|P19|Expansion Stage 2A|Withdrawal by Subject|0
7721825|NCT00996892|26852138|P18|Expansion Stage 2A|Withdrawal by Subject|0
7721826|NCT00996892|26852139|P17|Expansion Stage 2A|Withdrawal by Subject|0
7721827|NCT00996892|26852140|P16|Expansion Stage 2A|Withdrawal by Subject|0
7721828|NCT00996892|26852141|P15|Expansion Stage 2A|Withdrawal by Subject|0
7721829|NCT00996892|26852142|P14|Expansion Stage 2A|Withdrawal by Subject|0
7721830|NCT00996892|26852143|P13|Expansion Stage 2A|Withdrawal by Subject|0
7721831|NCT00996892|26852144|P12|Expansion Stage 2A|Withdrawal by Subject|0
7721832|NCT00996892|26852145|P11|Expansion Stage 2A|Withdrawal by Subject|0
7721833|NCT00996892|26852146|P10|Expansion Stage 2A|Withdrawal by Subject|0
7721834|NCT00996892|26852147|P9|Expansion Stage 2A|Withdrawal by Subject|0
7721835|NCT00996892|26852148|P8|Expansion Stage 2A|Withdrawal by Subject|0
7721836|NCT00996892|26852149|P7|Expansion Stage 2A|Withdrawal by Subject|0
7721837|NCT00996892|26852150|P6|Expansion Stage 2A|Withdrawal by Subject|0
7721838|NCT00996892|26852151|P5|Expansion Stage 2A|Withdrawal by Subject|0
7721839|NCT00996892|26852152|P4|Expansion Stage 2A|Withdrawal by Subject|0
7721840|NCT00996892|26852153|P3|Expansion Stage 2A|Withdrawal by Subject|0
7721841|NCT00996892|26852154|P2|Expansion Stage 2A|Withdrawal by Subject|0
7721842|NCT00996892|26852155|P1|Expansion Stage 2A|Withdrawal by Subject|0
7721843|NCT00996892|26852136|P20|Expansion Stage 2A|Physician Decision|2
7721844|NCT00996892|26852137|P19|Expansion Stage 2A|Physician Decision|0
7721845|NCT00996892|26852138|P18|Expansion Stage 2A|Physician Decision|0
7721846|NCT00996892|26852139|P17|Expansion Stage 2A|Physician Decision|0
7721847|NCT00996892|26852140|P16|Expansion Stage 2A|Physician Decision|0
7721848|NCT00996892|26852141|P15|Expansion Stage 2A|Physician Decision|0
7721849|NCT00996892|26852142|P14|Expansion Stage 2A|Physician Decision|0
7721850|NCT00996892|26852143|P13|Expansion Stage 2A|Physician Decision|0
7721851|NCT00996892|26852144|P12|Expansion Stage 2A|Physician Decision|0
7721852|NCT00996892|26852145|P11|Expansion Stage 2A|Physician Decision|0
7721853|NCT00996892|26852146|P10|Expansion Stage 2A|Physician Decision|0
7721854|NCT00996892|26852147|P9|Expansion Stage 2A|Physician Decision|0
7721855|NCT00996892|26852148|P8|Expansion Stage 2A|Physician Decision|0
7721856|NCT00996892|26852149|P7|Expansion Stage 2A|Physician Decision|0
7721857|NCT00996892|26852150|P6|Expansion Stage 2A|Physician Decision|0
7721858|NCT00996892|26852151|P5|Expansion Stage 2A|Physician Decision|0
7721859|NCT00996892|26852152|P4|Expansion Stage 2A|Physician Decision|0
7721860|NCT00996892|26852153|P3|Expansion Stage 2A|Physician Decision|0
7721861|NCT00996892|26852154|P2|Expansion Stage 2A|Physician Decision|0
7721862|NCT00996892|26852155|P1|Expansion Stage 2A|Physician Decision|0
7721863|NCT00996892|26852136|P20|Expansion Stage 2A|Adverse Event|8
7721864|NCT00996892|26852137|P19|Expansion Stage 2A|Adverse Event|0
7721865|NCT00996892|26852138|P18|Expansion Stage 2A|Adverse Event|0
7721866|NCT00996892|26852139|P17|Expansion Stage 2A|Adverse Event|0
7721867|NCT00996892|26852140|P16|Expansion Stage 2A|Adverse Event|0
7721868|NCT00996892|26852141|P15|Expansion Stage 2A|Adverse Event|0
7721869|NCT00996892|26852142|P14|Expansion Stage 2A|Adverse Event|0
7721870|NCT00996892|26852143|P13|Expansion Stage 2A|Adverse Event|0
7721871|NCT00996892|26852144|P12|Expansion Stage 2A|Adverse Event|0
7721872|NCT00996892|26852145|P11|Expansion Stage 2A|Adverse Event|0
7721873|NCT00996892|26852146|P10|Expansion Stage 2A|Adverse Event|0
7721874|NCT00996892|26852147|P9|Expansion Stage 2A|Adverse Event|0
7721875|NCT00996892|26852148|P8|Expansion Stage 2A|Adverse Event|0
7721876|NCT00996892|26852149|P7|Expansion Stage 2A|Adverse Event|0
7721877|NCT00996892|26852150|P6|Expansion Stage 2A|Adverse Event|0
7721878|NCT00996892|26852151|P5|Expansion Stage 2A|Adverse Event|0
7721879|NCT00996892|26852152|P4|Expansion Stage 2A|Adverse Event|0
7721880|NCT00996892|26852153|P3|Expansion Stage 2A|Adverse Event|0
7721881|NCT00996892|26852154|P2|Expansion Stage 2A|Adverse Event|0
7721882|NCT00996892|26852155|P1|Expansion Stage 2A|Adverse Event|0
7721883|NCT00996892|26852136|P20|Expansion Stage 2|Disease Progression|0
7721884|NCT00996892|26852137|P19|Expansion Stage 2|Disease Progression|28
7721885|NCT00996892|26852138|P18|Expansion Stage 2|Disease Progression|0
7721886|NCT00996892|26852139|P17|Expansion Stage 2|Disease Progression|0
7721887|NCT00996892|26852140|P16|Expansion Stage 2|Disease Progression|0
7721888|NCT00996892|26852141|P15|Expansion Stage 2|Disease Progression|0
7721889|NCT00996892|26852142|P14|Expansion Stage 2|Disease Progression|0
7721890|NCT00996892|26852143|P13|Expansion Stage 2|Disease Progression|0
7721891|NCT00996892|26852144|P12|Expansion Stage 2|Disease Progression|0
7721892|NCT00996892|26852145|P11|Expansion Stage 2|Disease Progression|0
7721893|NCT00996892|26852146|P10|Expansion Stage 2|Disease Progression|0
7721894|NCT00996892|26852147|P9|Expansion Stage 2|Disease Progression|0
7721895|NCT00996892|26852148|P8|Expansion Stage 2|Disease Progression|0
7721896|NCT00996892|26852149|P7|Expansion Stage 2|Disease Progression|0
7721897|NCT00996892|26852150|P6|Expansion Stage 2|Disease Progression|0
7721898|NCT00996892|26852151|P5|Expansion Stage 2|Disease Progression|0
7721899|NCT00996892|26852152|P4|Expansion Stage 2|Disease Progression|0
7721900|NCT00996892|26852153|P3|Expansion Stage 2|Disease Progression|0
7721901|NCT00996892|26852154|P2|Expansion Stage 2|Disease Progression|0
7721902|NCT00996892|26852155|P1|Expansion Stage 2|Disease Progression|0
7721903|NCT00996892|26852136|P20|Expansion Stage 2|Withdrawal by Subject|0
7721904|NCT00996892|26852137|P19|Expansion Stage 2|Withdrawal by Subject|1
7721905|NCT00996892|26852138|P18|Expansion Stage 2|Withdrawal by Subject|0
7721906|NCT00996892|26852139|P17|Expansion Stage 2|Withdrawal by Subject|0
7721907|NCT00996892|26852140|P16|Expansion Stage 2|Withdrawal by Subject|0
7721908|NCT00996892|26852141|P15|Expansion Stage 2|Withdrawal by Subject|0
7721909|NCT00996892|26852142|P14|Expansion Stage 2|Withdrawal by Subject|0
7721910|NCT00996892|26852143|P13|Expansion Stage 2|Withdrawal by Subject|0
7721911|NCT00996892|26852144|P12|Expansion Stage 2|Withdrawal by Subject|0
7721912|NCT00996892|26852145|P11|Expansion Stage 2|Withdrawal by Subject|0
7721913|NCT00996892|26852146|P10|Expansion Stage 2|Withdrawal by Subject|0
7721914|NCT00996892|26852147|P9|Expansion Stage 2|Withdrawal by Subject|0
7721915|NCT00996892|26852148|P8|Expansion Stage 2|Withdrawal by Subject|0
7721916|NCT00996892|26852149|P7|Expansion Stage 2|Withdrawal by Subject|0
7721917|NCT00996892|26852150|P6|Expansion Stage 2|Withdrawal by Subject|0
7721918|NCT00996892|26852151|P5|Expansion Stage 2|Withdrawal by Subject|0
7721919|NCT00996892|26852152|P4|Expansion Stage 2|Withdrawal by Subject|0
7721920|NCT00996892|26852153|P3|Expansion Stage 2|Withdrawal by Subject|0
7721921|NCT00996892|26852154|P2|Expansion Stage 2|Withdrawal by Subject|0
7721922|NCT00996892|26852155|P1|Expansion Stage 2|Withdrawal by Subject|0
7721923|NCT00996892|26852136|P20|Expansion Stage 2|Physician Decision|0
7721924|NCT00996892|26852137|P19|Expansion Stage 2|Physician Decision|1
7721925|NCT00996892|26852138|P18|Expansion Stage 2|Physician Decision|0
7721926|NCT00996892|26852139|P17|Expansion Stage 2|Physician Decision|0
7721927|NCT00996892|26852140|P16|Expansion Stage 2|Physician Decision|0
7721928|NCT00996892|26852141|P15|Expansion Stage 2|Physician Decision|0
7721929|NCT00996892|26852142|P14|Expansion Stage 2|Physician Decision|0
7721930|NCT00996892|26852143|P13|Expansion Stage 2|Physician Decision|0
7721931|NCT00996892|26852144|P12|Expansion Stage 2|Physician Decision|0
7721932|NCT00996892|26852145|P11|Expansion Stage 2|Physician Decision|0
7721933|NCT00996892|26852146|P10|Expansion Stage 2|Physician Decision|0
7721934|NCT00996892|26852147|P9|Expansion Stage 2|Physician Decision|0
7721935|NCT00996892|26852148|P8|Expansion Stage 2|Physician Decision|0
7721936|NCT00996892|26852149|P7|Expansion Stage 2|Physician Decision|0
7721937|NCT00996892|26852150|P6|Expansion Stage 2|Physician Decision|0
7721938|NCT00996892|26852151|P5|Expansion Stage 2|Physician Decision|0
7721939|NCT00996892|26852152|P4|Expansion Stage 2|Physician Decision|0
7721940|NCT00996892|26852153|P3|Expansion Stage 2|Physician Decision|0
7721941|NCT00996892|26852154|P2|Expansion Stage 2|Physician Decision|0
7721942|NCT00996892|26852155|P1|Expansion Stage 2|Physician Decision|0
7721943|NCT00996892|26852136|P20|Expansion Stage 2|Death|0
7721944|NCT00996892|26852137|P19|Expansion Stage 2|Death|2
7721945|NCT00996892|26852138|P18|Expansion Stage 2|Death|0
7721946|NCT00996892|26852139|P17|Expansion Stage 2|Death|0
7721947|NCT00996892|26852140|P16|Expansion Stage 2|Death|0
7721948|NCT00996892|26852141|P15|Expansion Stage 2|Death|0
7721949|NCT00996892|26852142|P14|Expansion Stage 2|Death|0
7721950|NCT00996892|26852143|P13|Expansion Stage 2|Death|0
7721951|NCT00996892|26852144|P12|Expansion Stage 2|Death|0
7721952|NCT00996892|26852145|P11|Expansion Stage 2|Death|0
7721953|NCT00996892|26852146|P10|Expansion Stage 2|Death|0
7721954|NCT00996892|26852147|P9|Expansion Stage 2|Death|0
7721955|NCT00996892|26852148|P8|Expansion Stage 2|Death|0
7721956|NCT00996892|26852149|P7|Expansion Stage 2|Death|0
7721957|NCT00996892|26852150|P6|Expansion Stage 2|Death|0
7721958|NCT00996892|26852151|P5|Expansion Stage 2|Death|0
7721959|NCT00996892|26852152|P4|Expansion Stage 2|Death|0
7721960|NCT00996892|26852153|P3|Expansion Stage 2|Death|0
7721961|NCT00996892|26852154|P2|Expansion Stage 2|Death|0
7721962|NCT00996892|26852155|P1|Expansion Stage 2|Death|0
7721963|NCT00996892|26852136|P20|Expansion Stage 2|Adverse Event|0
7721964|NCT00996892|26852137|P19|Expansion Stage 2|Adverse Event|3
7721965|NCT00996892|26852138|P18|Expansion Stage 2|Adverse Event|0
7721966|NCT00996892|26852139|P17|Expansion Stage 2|Adverse Event|0
7721967|NCT00996892|26852140|P16|Expansion Stage 2|Adverse Event|0
7721968|NCT00996892|26852141|P15|Expansion Stage 2|Adverse Event|0
7721969|NCT00996892|26852142|P14|Expansion Stage 2|Adverse Event|0
7721970|NCT00996892|26852143|P13|Expansion Stage 2|Adverse Event|0
7721971|NCT00996892|26852144|P12|Expansion Stage 2|Adverse Event|0
7721972|NCT00996892|26852145|P11|Expansion Stage 2|Adverse Event|0
7721973|NCT00996892|26852146|P10|Expansion Stage 2|Adverse Event|0
7721974|NCT00996892|26852147|P9|Expansion Stage 2|Adverse Event|0
7721975|NCT00996892|26852148|P8|Expansion Stage 2|Adverse Event|0
7721976|NCT00996892|26852149|P7|Expansion Stage 2|Adverse Event|0
7721977|NCT00996892|26852150|P6|Expansion Stage 2|Adverse Event|0
7721978|NCT00996892|26852151|P5|Expansion Stage 2|Adverse Event|0
7721979|NCT00996892|26852152|P4|Expansion Stage 2|Adverse Event|0
7721980|NCT00996892|26852153|P3|Expansion Stage 2|Adverse Event|0
7721981|NCT00996892|26852154|P2|Expansion Stage 2|Adverse Event|0
7721982|NCT00996892|26852155|P1|Expansion Stage 2|Adverse Event|0
7721983|NCT00996892|26852136|P20|Dose-Escalation Stage 1B|Disease Progression|0
7721984|NCT00996892|26852137|P19|Dose-Escalation Stage 1B|Disease Progression|0
7721985|NCT00996892|26852138|P18|Dose-Escalation Stage 1B|Disease Progression|3
7721986|NCT00996892|26852139|P17|Dose-Escalation Stage 1B|Disease Progression|3
7721987|NCT00996892|26852140|P16|Dose-Escalation Stage 1B|Disease Progression|3
7721988|NCT00996892|26852141|P15|Dose-Escalation Stage 1B|Disease Progression|4
7721989|NCT00996892|26852142|P14|Dose-Escalation Stage 1B|Disease Progression|0
7721990|NCT00996892|26852143|P13|Dose-Escalation Stage 1B|Disease Progression|0
7721991|NCT00996892|26852144|P12|Dose-Escalation Stage 1B|Disease Progression|0
7721992|NCT00996892|26852145|P11|Dose-Escalation Stage 1B|Disease Progression|0
7721993|NCT00996892|26852146|P10|Dose-Escalation Stage 1B|Disease Progression|0
7721994|NCT00996892|26852147|P9|Dose-Escalation Stage 1B|Disease Progression|0
7721995|NCT00996892|26852148|P8|Dose-Escalation Stage 1B|Disease Progression|0
7721996|NCT00996892|26852149|P7|Dose-Escalation Stage 1B|Disease Progression|0
7721997|NCT00996892|26852150|P6|Dose-Escalation Stage 1B|Disease Progression|0
7721998|NCT00996892|26852151|P5|Dose-Escalation Stage 1B|Disease Progression|0
7721999|NCT00996892|26852152|P4|Dose-Escalation Stage 1B|Disease Progression|0
7722000|NCT00996892|26852153|P3|Dose-Escalation Stage 1B|Disease Progression|0
7722001|NCT00996892|26852154|P2|Dose-Escalation Stage 1B|Disease Progression|0
7722002|NCT00996892|26852155|P1|Dose-Escalation Stage 1B|Disease Progression|0
7722003|NCT00996892|26852136|P20|Dose-Escalation Stage 1B|Physician Decision|0
7722004|NCT00996892|26852137|P19|Dose-Escalation Stage 1B|Physician Decision|0
7722005|NCT00996892|26852138|P18|Dose-Escalation Stage 1B|Physician Decision|2
7722006|NCT00996892|26852139|P17|Dose-Escalation Stage 1B|Physician Decision|0
7722007|NCT00996892|26852140|P16|Dose-Escalation Stage 1B|Physician Decision|0
7722008|NCT00996892|26852141|P15|Dose-Escalation Stage 1B|Physician Decision|0
7722009|NCT00996892|26852142|P14|Dose-Escalation Stage 1B|Physician Decision|0
7722010|NCT00996892|26852143|P13|Dose-Escalation Stage 1B|Physician Decision|0
7722011|NCT00996892|26852144|P12|Dose-Escalation Stage 1B|Physician Decision|0
7722012|NCT00996892|26852145|P11|Dose-Escalation Stage 1B|Physician Decision|0
7722013|NCT00996892|26852146|P10|Dose-Escalation Stage 1B|Physician Decision|0
7722014|NCT00996892|26852147|P9|Dose-Escalation Stage 1B|Physician Decision|0
7722015|NCT00996892|26852148|P8|Dose-Escalation Stage 1B|Physician Decision|0
7722016|NCT00996892|26852149|P7|Dose-Escalation Stage 1B|Physician Decision|0
7722017|NCT00996892|26852150|P6|Dose-Escalation Stage 1B|Physician Decision|0
7722018|NCT00996892|26852151|P5|Dose-Escalation Stage 1B|Physician Decision|0
7722019|NCT00996892|26852152|P4|Dose-Escalation Stage 1B|Physician Decision|0
7722020|NCT00996892|26852153|P3|Dose-Escalation Stage 1B|Physician Decision|0
7722021|NCT00996892|26852154|P2|Dose-Escalation Stage 1B|Physician Decision|0
7722022|NCT00996892|26852155|P1|Dose-Escalation Stage 1B|Physician Decision|0
7722023|NCT00996892|26852136|P20|Dose-Escalation Stage 1A|Disease Progression|0
7722024|NCT00996892|26852137|P19|Dose-Escalation Stage 1A|Disease Progression|0
7722025|NCT00996892|26852138|P18|Dose-Escalation Stage 1A|Disease Progression|0
7722026|NCT00996892|26852139|P17|Dose-Escalation Stage 1A|Disease Progression|0
7722027|NCT00996892|26852140|P16|Dose-Escalation Stage 1A|Disease Progression|0
7722028|NCT00996892|26852141|P15|Dose-Escalation Stage 1A|Disease Progression|0
7722029|NCT00996892|26852142|P14|Dose-Escalation Stage 1A|Disease Progression|4
7722030|NCT00996892|26852143|P13|Dose-Escalation Stage 1A|Disease Progression|6
7722031|NCT00996892|26852144|P12|Dose-Escalation Stage 1A|Disease Progression|7
7722032|NCT00996892|26852145|P11|Dose-Escalation Stage 1A|Disease Progression|5
7722033|NCT00996892|26852146|P10|Dose-Escalation Stage 1A|Disease Progression|1
7722034|NCT00996892|26852147|P9|Dose-Escalation Stage 1A|Disease Progression|3
7722035|NCT00996892|26852148|P8|Dose-Escalation Stage 1A|Disease Progression|2
7722036|NCT00996892|26852149|P7|Dose-Escalation Stage 1A|Disease Progression|0
7722037|NCT00996892|26852150|P6|Dose-Escalation Stage 1A|Disease Progression|0
7722038|NCT00996892|26852151|P5|Dose-Escalation Stage 1A|Disease Progression|0
7722039|NCT00996892|26852152|P4|Dose-Escalation Stage 1A|Disease Progression|0
7722040|NCT00996892|26852153|P3|Dose-Escalation Stage 1A|Disease Progression|0
7722041|NCT00996892|26852154|P2|Dose-Escalation Stage 1A|Disease Progression|0
7722042|NCT00996892|26852155|P1|Dose-Escalation Stage 1A|Disease Progression|0
7722043|NCT00996892|26852136|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722044|NCT00996892|26852137|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722045|NCT00996892|26852138|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722046|NCT00996892|26852139|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722047|NCT00996892|26852140|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722048|NCT00996892|26852141|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722049|NCT00996892|26852142|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722050|NCT00996892|26852143|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7722051|NCT00996892|26852144|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7722052|NCT00996892|26852145|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7722053|NCT00996892|26852146|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7722054|NCT00996892|26852147|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722055|NCT00996892|26852148|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722056|NCT00996892|26852149|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722057|NCT00996892|26852150|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722058|NCT00996892|26852151|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722059|NCT00996892|26852152|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722060|NCT00996892|26852153|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722061|NCT00996892|26852154|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722062|NCT00996892|26852155|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7722063|NCT00996892|26852136|P20|Dose-Escalation Stage 1A|Physician Decision|0
7722064|NCT00996892|26852137|P19|Dose-Escalation Stage 1A|Physician Decision|0
7722065|NCT00996892|26852138|P18|Dose-Escalation Stage 1A|Physician Decision|0
7722066|NCT00996892|26852139|P17|Dose-Escalation Stage 1A|Physician Decision|0
7722067|NCT00996892|26852140|P16|Dose-Escalation Stage 1A|Physician Decision|0
7722068|NCT00996892|26852141|P15|Dose-Escalation Stage 1A|Physician Decision|0
7722069|NCT00996892|26852142|P14|Dose-Escalation Stage 1A|Physician Decision|0
7722070|NCT00996892|26852143|P13|Dose-Escalation Stage 1A|Physician Decision|0
7722071|NCT00996892|26852144|P12|Dose-Escalation Stage 1A|Physician Decision|0
7722072|NCT00996892|26852145|P11|Dose-Escalation Stage 1A|Physician Decision|0
7722073|NCT00996892|26852146|P10|Dose-Escalation Stage 1A|Physician Decision|0
7722074|NCT00996892|26852147|P9|Dose-Escalation Stage 1A|Physician Decision|0
7722075|NCT00996892|26852148|P8|Dose-Escalation Stage 1A|Physician Decision|1
7722076|NCT00996892|26852149|P7|Dose-Escalation Stage 1A|Physician Decision|0
7722077|NCT00996892|26852150|P6|Dose-Escalation Stage 1A|Physician Decision|0
7722078|NCT00996892|26852151|P5|Dose-Escalation Stage 1A|Physician Decision|0
7722079|NCT00996892|26852152|P4|Dose-Escalation Stage 1A|Physician Decision|0
7722080|NCT00996892|26852153|P3|Dose-Escalation Stage 1A|Physician Decision|0
7722081|NCT00996892|26852154|P2|Dose-Escalation Stage 1A|Physician Decision|0
7722082|NCT00996892|26852155|P1|Dose-Escalation Stage 1A|Physician Decision|0
7722083|NCT00996892|26852136|P20|Dose-Escalation Stage 1A|Death|0
7722084|NCT00996892|26852137|P19|Dose-Escalation Stage 1A|Death|0
7722085|NCT00996892|26852138|P18|Dose-Escalation Stage 1A|Death|0
7722086|NCT00996892|26852139|P17|Dose-Escalation Stage 1A|Death|0
7722087|NCT00996892|26852140|P16|Dose-Escalation Stage 1A|Death|0
7722088|NCT00996892|26852141|P15|Dose-Escalation Stage 1A|Death|0
7722089|NCT00996892|26852142|P14|Dose-Escalation Stage 1A|Death|0
7722090|NCT00996892|26852143|P13|Dose-Escalation Stage 1A|Death|1
7722091|NCT00996892|26852144|P12|Dose-Escalation Stage 1A|Death|1
7722092|NCT00996892|26852145|P11|Dose-Escalation Stage 1A|Death|0
7722093|NCT00996892|26852146|P10|Dose-Escalation Stage 1A|Death|2
7722094|NCT00996892|26852147|P9|Dose-Escalation Stage 1A|Death|0
7722095|NCT00996892|26852148|P8|Dose-Escalation Stage 1A|Death|0
7722096|NCT00996892|26852149|P7|Dose-Escalation Stage 1A|Death|0
7722097|NCT00996892|26852150|P6|Dose-Escalation Stage 1A|Death|0
7722098|NCT00996892|26852151|P5|Dose-Escalation Stage 1A|Death|0
7722099|NCT00996892|26852152|P4|Dose-Escalation Stage 1A|Death|0
7722100|NCT00996892|26852153|P3|Dose-Escalation Stage 1A|Death|0
7722101|NCT00996892|26852154|P2|Dose-Escalation Stage 1A|Death|0
7722102|NCT00996892|26852155|P1|Dose-Escalation Stage 1A|Death|0
7722103|NCT00996892|26852136|P20|Dose-Escalation Stage 1A|Adverse Event|0
7722104|NCT00996892|26852137|P19|Dose-Escalation Stage 1A|Adverse Event|0
7722105|NCT00996892|26852138|P18|Dose-Escalation Stage 1A|Adverse Event|0
7722106|NCT00996892|26852139|P17|Dose-Escalation Stage 1A|Adverse Event|0
7722107|NCT00996892|26852140|P16|Dose-Escalation Stage 1A|Adverse Event|0
7722108|NCT00996892|26852141|P15|Dose-Escalation Stage 1A|Adverse Event|0
7722109|NCT00996892|26852142|P14|Dose-Escalation Stage 1A|Adverse Event|1
7722110|NCT00996892|26852143|P13|Dose-Escalation Stage 1A|Adverse Event|0
7722111|NCT00996892|26852144|P12|Dose-Escalation Stage 1A|Adverse Event|0
7722112|NCT00996892|26852145|P11|Dose-Escalation Stage 1A|Adverse Event|1
7722113|NCT00996892|26852146|P10|Dose-Escalation Stage 1A|Adverse Event|0
7722114|NCT00996892|26852147|P9|Dose-Escalation Stage 1A|Adverse Event|0
7722115|NCT00996892|26852148|P8|Dose-Escalation Stage 1A|Adverse Event|0
7722116|NCT00996892|26852149|P7|Dose-Escalation Stage 1A|Adverse Event|0
7722117|NCT00996892|26852150|P6|Dose-Escalation Stage 1A|Adverse Event|0
7722118|NCT00996892|26852151|P5|Dose-Escalation Stage 1A|Adverse Event|0
7722119|NCT00996892|26852152|P4|Dose-Escalation Stage 1A|Adverse Event|0
7722120|NCT00996892|26852153|P3|Dose-Escalation Stage 1A|Adverse Event|0
7722121|NCT00996892|26852154|P2|Dose-Escalation Stage 1A|Adverse Event|0
7722122|NCT00996892|26852155|P1|Dose-Escalation Stage 1A|Adverse Event|0
7722123|NCT00996892|26852136|P20|Dose-Escalation Stage 1|Disease Progression|0
7722124|NCT00996892|26852137|P19|Dose-Escalation Stage 1|Disease Progression|0
7722125|NCT00996892|26852138|P18|Dose-Escalation Stage 1|Disease Progression|0
7722126|NCT00996892|26852139|P17|Dose-Escalation Stage 1|Disease Progression|0
7722127|NCT00996892|26852140|P16|Dose-Escalation Stage 1|Disease Progression|0
7722128|NCT00996892|26852141|P15|Dose-Escalation Stage 1|Disease Progression|0
7722129|NCT00996892|26852142|P14|Dose-Escalation Stage 1|Disease Progression|0
7722130|NCT00996892|26852143|P13|Dose-Escalation Stage 1|Disease Progression|0
7722131|NCT00996892|26852144|P12|Dose-Escalation Stage 1|Disease Progression|0
7722132|NCT00996892|26852145|P11|Dose-Escalation Stage 1|Disease Progression|0
7722133|NCT00996892|26852146|P10|Dose-Escalation Stage 1|Disease Progression|0
7722134|NCT00996892|26852147|P9|Dose-Escalation Stage 1|Disease Progression|0
7722135|NCT00996892|26852148|P8|Dose-Escalation Stage 1|Disease Progression|0
7722136|NCT00996892|26852149|P7|Dose-Escalation Stage 1|Disease Progression|0
7722137|NCT00996892|26852150|P6|Dose-Escalation Stage 1|Disease Progression|7
7722138|NCT00996892|26852151|P5|Dose-Escalation Stage 1|Disease Progression|10
7722139|NCT00996892|26852152|P4|Dose-Escalation Stage 1|Disease Progression|4
7722140|NCT00996892|26852153|P3|Dose-Escalation Stage 1|Disease Progression|3
7722141|NCT00996892|26852154|P2|Dose-Escalation Stage 1|Disease Progression|2
7722142|NCT00996892|26852155|P1|Dose-Escalation Stage 1|Disease Progression|2
7722143|NCT00996892|26852136|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722144|NCT00996892|26852137|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722145|NCT00996892|26852138|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722146|NCT00996892|26852139|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722147|NCT00996892|26852140|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722148|NCT00996892|26852141|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722149|NCT00996892|26852142|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722150|NCT00996892|26852143|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722151|NCT00996892|26852144|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722152|NCT00996892|26852145|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722153|NCT00996892|26852146|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722154|NCT00996892|26852147|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722155|NCT00996892|26852148|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722156|NCT00996892|26852149|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
7722157|NCT00996892|26852150|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
7722158|NCT00996892|26852151|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
7722159|NCT00996892|26852152|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
7722160|NCT00996892|26852153|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722161|NCT00996892|26852154|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
7722162|NCT00996892|26852155|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
7722163|NCT00996892|26852136|P20|Dose-Escalation Stage 1|Physician Decision|0
7722164|NCT00996892|26852137|P19|Dose-Escalation Stage 1|Physician Decision|0
7722165|NCT00996892|26852138|P18|Dose-Escalation Stage 1|Physician Decision|0
7722166|NCT00996892|26852139|P17|Dose-Escalation Stage 1|Physician Decision|0
7722167|NCT00996892|26852140|P16|Dose-Escalation Stage 1|Physician Decision|0
7722168|NCT00996892|26852141|P15|Dose-Escalation Stage 1|Physician Decision|0
7722169|NCT00996892|26852142|P14|Dose-Escalation Stage 1|Physician Decision|0
7722170|NCT00996892|26852143|P13|Dose-Escalation Stage 1|Physician Decision|0
7722171|NCT00996892|26852144|P12|Dose-Escalation Stage 1|Physician Decision|0
7722172|NCT00996892|26852145|P11|Dose-Escalation Stage 1|Physician Decision|0
7722173|NCT00996892|26852146|P10|Dose-Escalation Stage 1|Physician Decision|0
7722174|NCT00996892|26852147|P9|Dose-Escalation Stage 1|Physician Decision|0
7722175|NCT00996892|26852148|P8|Dose-Escalation Stage 1|Physician Decision|0
7722176|NCT00996892|26852149|P7|Dose-Escalation Stage 1|Physician Decision|2
7722177|NCT00996892|26852150|P6|Dose-Escalation Stage 1|Physician Decision|1
7722178|NCT00996892|26852151|P5|Dose-Escalation Stage 1|Physician Decision|0
7722179|NCT00996892|26852152|P4|Dose-Escalation Stage 1|Physician Decision|1
7722180|NCT00996892|26852153|P3|Dose-Escalation Stage 1|Physician Decision|0
7722181|NCT00996892|26852154|P2|Dose-Escalation Stage 1|Physician Decision|0
7722182|NCT00996892|26852155|P1|Dose-Escalation Stage 1|Physician Decision|1
7722183|NCT00996892|26852136|P20|Dose-Escalation Stage 1|Death|0
7722184|NCT00996892|26852137|P19|Dose-Escalation Stage 1|Death|0
7722185|NCT00996892|26852138|P18|Dose-Escalation Stage 1|Death|0
7722186|NCT00996892|26852139|P17|Dose-Escalation Stage 1|Death|0
7722187|NCT00996892|26852140|P16|Dose-Escalation Stage 1|Death|0
7722188|NCT00996892|26852141|P15|Dose-Escalation Stage 1|Death|0
7722189|NCT00996892|26852142|P14|Dose-Escalation Stage 1|Death|0
7722190|NCT00996892|26852143|P13|Dose-Escalation Stage 1|Death|0
7722191|NCT00996892|26852144|P12|Dose-Escalation Stage 1|Death|0
7722192|NCT00996892|26852145|P11|Dose-Escalation Stage 1|Death|0
7722193|NCT00996892|26852146|P10|Dose-Escalation Stage 1|Death|0
7722194|NCT00996892|26852147|P9|Dose-Escalation Stage 1|Death|0
7722195|NCT00996892|26852148|P8|Dose-Escalation Stage 1|Death|0
7722196|NCT00996892|26852149|P7|Dose-Escalation Stage 1|Death|0
7722197|NCT00996892|26852150|P6|Dose-Escalation Stage 1|Death|1
7722198|NCT00996892|26852151|P5|Dose-Escalation Stage 1|Death|0
7722199|NCT00996892|26852152|P4|Dose-Escalation Stage 1|Death|0
7722200|NCT00996892|26852153|P3|Dose-Escalation Stage 1|Death|0
7722201|NCT00996892|26852154|P2|Dose-Escalation Stage 1|Death|0
7722202|NCT00996892|26852155|P1|Dose-Escalation Stage 1|Death|1
7722203|NCT00996892|26852136|P20|Dose-Escalation Stage 1|Adverse Event|0
7722204|NCT00996892|26852137|P19|Dose-Escalation Stage 1|Adverse Event|0
7722205|NCT00996892|26852138|P18|Dose-Escalation Stage 1|Adverse Event|0
7722206|NCT00996892|26852139|P17|Dose-Escalation Stage 1|Adverse Event|0
7722207|NCT00996892|26852140|P16|Dose-Escalation Stage 1|Adverse Event|0
7722208|NCT00996892|26852141|P15|Dose-Escalation Stage 1|Adverse Event|0
7722209|NCT00996892|26852142|P14|Dose-Escalation Stage 1|Adverse Event|0
7722210|NCT00996892|26852143|P13|Dose-Escalation Stage 1|Adverse Event|0
7722211|NCT00996892|26852144|P12|Dose-Escalation Stage 1|Adverse Event|0
7722212|NCT00996892|26852145|P11|Dose-Escalation Stage 1|Adverse Event|0
7722213|NCT00996892|26852146|P10|Dose-Escalation Stage 1|Adverse Event|0
7722214|NCT00996892|26852147|P9|Dose-Escalation Stage 1|Adverse Event|0
7722215|NCT00996892|26852148|P8|Dose-Escalation Stage 1|Adverse Event|0
7722216|NCT00996892|26852149|P7|Dose-Escalation Stage 1|Adverse Event|1
7722217|NCT00996892|26852150|P6|Dose-Escalation Stage 1|Adverse Event|0
7722218|NCT00996892|26852151|P5|Dose-Escalation Stage 1|Adverse Event|0
7722219|NCT00996892|26852152|P4|Dose-Escalation Stage 1|Adverse Event|2
7722220|NCT00996892|26852153|P3|Dose-Escalation Stage 1|Adverse Event|0
7722221|NCT00996892|26852154|P2|Dose-Escalation Stage 1|Adverse Event|0
7722222|NCT00996892|26852155|P1|Dose-Escalation Stage 1|Adverse Event|0
7722223|NCT00996840|26852749|P5|Overall Study|Withdrawal by Subject|0
7722224|NCT00996840|26852750|P4|Overall Study|Withdrawal by Subject|0
7722225|NCT00996840|26852751|P3|Overall Study|Withdrawal by Subject|0
7722226|NCT00996840|26852752|P2|Overall Study|Withdrawal by Subject|1
7722227|NCT00996840|26852753|P1|Overall Study|Withdrawal by Subject|1
7722228|NCT00996840|26852749|P5|Overall Study|Physician Decision|2
7722229|NCT00996840|26852750|P4|Overall Study|Physician Decision|1
7722230|NCT00996840|26852751|P3|Overall Study|Physician Decision|1
7722231|NCT00996840|26852752|P2|Overall Study|Physician Decision|0
7722232|NCT00996840|26852753|P1|Overall Study|Physician Decision|0
7722233|NCT00996840|26852749|P5|Overall Study|Adverse Event|0
7722234|NCT00996840|26852750|P4|Overall Study|Adverse Event|0
7722235|NCT00996840|26852751|P3|Overall Study|Adverse Event|0
7722236|NCT00996840|26852752|P2|Overall Study|Adverse Event|1
7722237|NCT00996840|26852753|P1|Overall Study|Adverse Event|0
7722238|NCT00996801|26852903|P6|Overall Study|Withdrawal by Subject|9
7722239|NCT00996801|26852904|P5|Overall Study|Withdrawal by Subject|5
7722240|NCT00996801|26852905|P4|Overall Study|Withdrawal by Subject|5
7722241|NCT00996801|26852906|P3|Overall Study|Withdrawal by Subject|9
7722242|NCT00996801|26852907|P2|Overall Study|Withdrawal by Subject|6
7722243|NCT00996801|26852908|P1|Overall Study|Withdrawal by Subject|8
7722244|NCT00996801|26852903|P6|Overall Study|Study Terminated by Sponsor|0
7722245|NCT00996801|26852904|P5|Overall Study|Study Terminated by Sponsor|46
7722246|NCT00996801|26852905|P4|Overall Study|Study Terminated by Sponsor|0
7722247|NCT00996801|26852906|P3|Overall Study|Study Terminated by Sponsor|0
7722248|NCT00996801|26852907|P2|Overall Study|Study Terminated by Sponsor|1
7722249|NCT00996801|26852908|P1|Overall Study|Study Terminated by Sponsor|0
7722250|NCT00996801|26852903|P6|Overall Study|Protocol Violation|4
7722251|NCT00996801|26852904|P5|Overall Study|Protocol Violation|3
7722252|NCT00996801|26852905|P4|Overall Study|Protocol Violation|2
7722253|NCT00996801|26852906|P3|Overall Study|Protocol Violation|1
7722254|NCT00996801|26852907|P2|Overall Study|Protocol Violation|4
7722255|NCT00996801|26852908|P1|Overall Study|Protocol Violation|3
7722256|NCT00996801|26852903|P6|Overall Study|Progressive Disease|0
7722257|NCT00996801|26852904|P5|Overall Study|Progressive Disease|0
7722258|NCT00996801|26852905|P4|Overall Study|Progressive Disease|0
7722259|NCT00996801|26852906|P3|Overall Study|Progressive Disease|0
7722260|NCT00996801|26852907|P2|Overall Study|Progressive Disease|1
7722261|NCT00996801|26852908|P1|Overall Study|Progressive Disease|0
7722262|NCT00996801|26852903|P6|Overall Study|Physician Decision|0
7722263|NCT00996801|26852904|P5|Overall Study|Physician Decision|0
7722264|NCT00996801|26852905|P4|Overall Study|Physician Decision|1
7722265|NCT00996801|26852906|P3|Overall Study|Physician Decision|0
7722266|NCT00996801|26852907|P2|Overall Study|Physician Decision|0
7722267|NCT00996801|26852908|P1|Overall Study|Physician Decision|0
7722268|NCT00996801|26852903|P6|Overall Study|Lost to Follow-up|2
7722269|NCT00996801|26852904|P5|Overall Study|Lost to Follow-up|3
7722270|NCT00996801|26852905|P4|Overall Study|Lost to Follow-up|3
7722271|NCT00996801|26852906|P3|Overall Study|Lost to Follow-up|0
7722272|NCT00996801|26852907|P2|Overall Study|Lost to Follow-up|0
7722273|NCT00996801|26852908|P1|Overall Study|Lost to Follow-up|0
7722274|NCT00996801|26852903|P6|Overall Study|Lack of Efficacy|1
7722275|NCT00996801|26852904|P5|Overall Study|Lack of Efficacy|0
7722276|NCT00996801|26852905|P4|Overall Study|Lack of Efficacy|3
7722277|NCT00996801|26852906|P3|Overall Study|Lack of Efficacy|1
7722278|NCT00996801|26852907|P2|Overall Study|Lack of Efficacy|0
7722279|NCT00996801|26852908|P1|Overall Study|Lack of Efficacy|3
7722280|NCT00996801|26852903|P6|Overall Study|Adverse Event|3
7722281|NCT00996801|26852904|P5|Overall Study|Adverse Event|31
7722282|NCT00996801|26852905|P4|Overall Study|Adverse Event|17
7722283|NCT00996801|26852906|P3|Overall Study|Adverse Event|12
7722284|NCT00996801|26852907|P2|Overall Study|Adverse Event|4
7722285|NCT00996801|26852908|P1|Overall Study|Adverse Event|6
7722286|NCT00996736|26853020|P2|Overall Study|Visit not within 3-month window|3
7722287|NCT00996736|26853021|P1|Overall Study|Visit not within 3-month window|5
7722288|NCT00996736|26853020|P2|Overall Study|Lost to Follow-up|14
7722289|NCT00996736|26853021|P1|Overall Study|Lost to Follow-up|15
7722290|NCT00996736|26853020|P2|Overall Study|Death|1
7722291|NCT00996736|26853021|P1|Overall Study|Death|1
7722292|NCT00996658|26853041|P2|Overall Study|Other|7
7722293|NCT00996658|26853042|P1|Overall Study|Other|9
7722294|NCT00996658|26853041|P2|Overall Study|Non-compliance issues|3
7722295|NCT00996658|26853042|P1|Overall Study|Non-compliance issues|3
7722296|NCT00996658|26853041|P2|Overall Study|Lost to Follow-up|5
7722297|NCT00996658|26853042|P1|Overall Study|Lost to Follow-up|2
7722298|NCT00996658|26853041|P2|Overall Study|Protocol Violation|1
7722299|NCT00996658|26853042|P1|Overall Study|Protocol Violation|0
7722300|NCT00996658|26853041|P2|Overall Study|Adverse Event|5
7722301|NCT00996658|26853042|P1|Overall Study|Adverse Event|2
7722302|NCT00996632|26853070|P2|Overall Study|Physician Decision|0
7722303|NCT00996632|26853071|P1|Overall Study|Physician Decision|0
7722304|NCT00996606|26853079|P1|Overall Study|Withdrawal by Subject|3
7722305|NCT00996606|26853079|P1|Overall Study|Protocol Violation|1
7722306|NCT00996606|26853079|P1|Overall Study|Insufficient Therapeutic Response|2
7722307|NCT00996606|26853079|P1|Overall Study|Adverse Event or Intercurrent Illness|2
7722308|NCT00996593|26853173|P1|Long-Term Follow-Up|Site Closed|1
7722309|NCT00996593|26853173|P1|Long-Term Follow-Up|Withdrawal by Subject|2
7722310|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
7722311|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
7722312|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
7722313|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Death|1
7722314|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
7722405|NCT00995930|26853531|P2|Overall Study|Death|1
7722315|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
7722316|NCT00996593|26853173|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
7722317|NCT00996580|26853201|P1|Overall Study|Other|29
7722318|NCT00996580|26853201|P1|Overall Study|Withdrawal by Subject|217
7722319|NCT00996580|26853201|P1|Overall Study|Sponsor requested participant withdrawal|35
7722320|NCT00996580|26853201|P1|Overall Study|Protocol Violation|16
7722321|NCT00996580|26853201|P1|Overall Study|Pregnancy|68
7722322|NCT00996580|26853201|P1|Overall Study|Physician Decision|5
7722323|NCT00996580|26853201|P1|Overall Study|Noncompliance with the protocol|137
7722324|NCT00996580|26853201|P1|Overall Study|Lost to Follow-up|480
7722325|NCT00996580|26853201|P1|Overall Study|Adverse Event|466
7722326|NCT00996489|26853236|P1|Overall Study|Discontinued|116
7722327|NCT00996489|26853236|P1|Overall Study|Device failure|45
7722328|NCT00996476|26853256|P5|Overall Study|Adverse Event|1
7722329|NCT00996476|26853257|P4|Overall Study|Adverse Event|0
7722330|NCT00996476|26853258|P3|Overall Study|Adverse Event|0
7722331|NCT00996476|26853259|P2|Overall Study|Adverse Event|1
7722332|NCT00996476|26853260|P1|Overall Study|Adverse Event|0
7722333|NCT00996476|26853256|P5|Overall Study|Withdrawal by Subject|1
7722334|NCT00996476|26853257|P4|Overall Study|Withdrawal by Subject|0
7722335|NCT00996476|26853258|P3|Overall Study|Withdrawal by Subject|1
7722336|NCT00996476|26853259|P2|Overall Study|Withdrawal by Subject|2
7722337|NCT00996476|26853260|P1|Overall Study|Withdrawal by Subject|1
7722338|NCT00996437|26853328|P2|Overall Study|Missed|5
7722339|NCT00996437|26853329|P1|Overall Study|Missed|2
7722340|NCT00996437|26853328|P2|Overall Study|Dropped|2
7722341|NCT00996437|26853329|P1|Overall Study|Dropped|2
7722342|NCT00996437|26853328|P2|Overall Study|Death|0
7722343|NCT00996437|26853329|P1|Overall Study|Death|1
7722344|NCT00996333|26853374|P1|Overall Study|Other|5
7722345|NCT00996333|26853374|P1|Overall Study|Physician Decision|1
7722346|NCT00996333|26853374|P1|Overall Study|Adverse Event|1
7722347|NCT00996333|26853374|P1|Overall Study|Death|4
7722348|NCT00996333|26853374|P1|Overall Study|Withdrawal by Subject|1
7722349|NCT00996333|26853374|P1|Overall Study|Screen failure|1
7722350|NCT00996307|26853384|P4|Overall Study|Unable to classify|1
7722351|NCT00996307|26853385|P3|Overall Study|Unable to classify|2
7722352|NCT00996307|26853386|P2|Overall Study|Unable to classify|0
7722353|NCT00996307|26853387|P1|Overall Study|Unable to classify|4
7722354|NCT00996307|26853384|P4|Overall Study|Administrative reason|0
7722355|NCT00996307|26853385|P3|Overall Study|Administrative reason|0
7722356|NCT00996307|26853386|P2|Overall Study|Administrative reason|1
7722357|NCT00996307|26853387|P1|Overall Study|Administrative reason|0
7722358|NCT00996307|26853384|P4|Overall Study|Lost to Follow-up|15
7722359|NCT00996307|26853385|P3|Overall Study|Lost to Follow-up|7
7722360|NCT00996307|26853386|P2|Overall Study|Lost to Follow-up|13
7722361|NCT00996307|26853387|P1|Overall Study|Lost to Follow-up|13
7722362|NCT00996307|26853384|P4|Overall Study|Withdrawal by Subject|5
7722363|NCT00996307|26853385|P3|Overall Study|Withdrawal by Subject|5
7722364|NCT00996307|26853386|P2|Overall Study|Withdrawal by Subject|2
7722365|NCT00996307|26853387|P1|Overall Study|Withdrawal by Subject|3
7722366|NCT00996307|26853384|P4|Overall Study|Adverse Event|0
7722367|NCT00996307|26853385|P3|Overall Study|Adverse Event|0
7722368|NCT00996307|26853386|P2|Overall Study|Adverse Event|1
7722369|NCT00996307|26853387|P1|Overall Study|Adverse Event|0
7722370|NCT00996281|26853447|P2|Overall Study|Other|7
7722371|NCT00996281|26853448|P1|Overall Study|Other|5
7722372|NCT00996281|26853447|P2|Overall Study|Lack of Efficacy|2
7722373|NCT00996281|26853448|P1|Overall Study|Lack of Efficacy|0
7722374|NCT00996281|26853447|P2|Overall Study|Withdrawal by Subject|20
7722375|NCT00996281|26853448|P1|Overall Study|Withdrawal by Subject|31
7722376|NCT00996281|26853447|P2|Overall Study|Lost to Follow-up|16
7722377|NCT00996281|26853448|P1|Overall Study|Lost to Follow-up|14
7722378|NCT00996281|26853447|P2|Overall Study|Major Protocol Deviation|7
7722379|NCT00996281|26853448|P1|Overall Study|Major Protocol Deviation|6
7722380|NCT00996281|26853447|P2|Overall Study|Adverse Event|37
7722381|NCT00996281|26853448|P1|Overall Study|Adverse Event|75
7722382|NCT00996216|26853456|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
7722383|NCT00996216|26853456|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
7722384|NCT00996216|26853456|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
7722385|NCT00996203|26853472|P1|Overall Study|Protocol Violation|2
7722386|NCT00996203|26853472|P1|Overall Study|Lack of Efficacy|1
7722387|NCT00996203|26853472|P1|Overall Study|Lost to Follow-up|1
7722388|NCT00996203|26853472|P1|Overall Study|Adverse Event|3
7722389|NCT00996125|26853504|P2|Overall Study|Withdrawal by Subject|3
7722390|NCT00996125|26853505|P1|Overall Study|Withdrawal by Subject|4
7722391|NCT00996125|26853504|P2|Overall Study|Lost to Follow-up|6
7722392|NCT00996125|26853505|P1|Overall Study|Lost to Follow-up|1
7722393|NCT00996125|26853504|P2|Overall Study|Adverse Event|2
7722394|NCT00996125|26853505|P1|Overall Study|Adverse Event|0
7722395|NCT00996034|26853525|P1|Overall Study|withdrawn by PI|1
7722396|NCT00996034|26853525|P1|Overall Study|Lost to Follow-up|2
7722397|NCT00995930|26853531|P2|Overall Study|Adverse Event|14
7722398|NCT00995930|26853532|P1|Overall Study|Adverse Event|11
7722399|NCT00995930|26853531|P2|Overall Study|Withdrawal by Subject|4
7722400|NCT00995930|26853532|P1|Overall Study|Withdrawal by Subject|3
7722401|NCT00995930|26853531|P2|Overall Study|Lost to Follow-up|2
7722402|NCT00995930|26853532|P1|Overall Study|Lost to Follow-up|1
7722403|NCT00995930|26853531|P2|Overall Study|Administrative problems|2
7722404|NCT00995930|26853532|P1|Overall Study|Administrative problems|4
7722406|NCT00995930|26853532|P1|Overall Study|Death|0
7722407|NCT00995930|26853531|P2|Overall Study|Protocol deviation|5
7722408|NCT00995930|26853532|P1|Overall Study|Protocol deviation|2
7722409|NCT00995865|26853583|P3|Overall Study|Lost to Follow-up|1
7722410|NCT00995865|26853584|P2|Overall Study|Lost to Follow-up|0
7722411|NCT00995865|26853585|P1|Overall Study|Lost to Follow-up|0
7722412|NCT00995865|26853583|P3|Overall Study|Protocol Violation|0
7722413|NCT00995865|26853584|P2|Overall Study|Protocol Violation|0
7722414|NCT00995865|26853585|P1|Overall Study|Protocol Violation|2
7722415|NCT00995774|26853607|P2|Training Period 2|Withdrawal by Subject|0
7722416|NCT00995774|26853608|P1|Training Period 2|Withdrawal by Subject|2
7722417|NCT00995709|26853642|P3|Overall Study|Protocol Violation|0
7722418|NCT00995709|26853643|P2|Overall Study|Protocol Violation|1
7722419|NCT00995709|26853644|P1|Overall Study|Protocol Violation|2
7722420|NCT00995709|26853642|P3|Overall Study|Death|0
7722421|NCT00995709|26853643|P2|Overall Study|Death|1
7722422|NCT00995709|26853644|P1|Overall Study|Death|0
7722423|NCT00995709|26853642|P3|Overall Study|Lost to Follow-up|0
7722424|NCT00995709|26853643|P2|Overall Study|Lost to Follow-up|0
7722425|NCT00995709|26853644|P1|Overall Study|Lost to Follow-up|1
7722426|NCT00995709|26853642|P3|Overall Study|Withdrawal by Subject|1
7722427|NCT00995709|26853643|P2|Overall Study|Withdrawal by Subject|4
7722428|NCT00995709|26853644|P1|Overall Study|Withdrawal by Subject|0
7722429|NCT00995709|26853642|P3|Overall Study|Lack of Efficacy|4
7722430|NCT00995709|26853643|P2|Overall Study|Lack of Efficacy|1
7722431|NCT00995709|26853644|P1|Overall Study|Lack of Efficacy|0
7722432|NCT00995709|26853642|P3|Overall Study|Adverse Event|0
7722433|NCT00995709|26853643|P2|Overall Study|Adverse Event|2
7722434|NCT00995709|26853644|P1|Overall Study|Adverse Event|4
7722435|NCT00995670|26853670|P3|Overall Study|Failed arterial cannulation|3
7722436|NCT00995670|26853671|P2|Overall Study|Failed arterial cannulation|0
7722437|NCT00995670|26853672|P1|Overall Study|Failed arterial cannulation|1
7722438|NCT00995566|26853680|P1|Overall Study|Early study termination|52
7722439|NCT00995566|26853680|P1|Overall Study|Adverse Event|2
7722440|NCT00995553|26853694|P2|Overall Study|Withdrawal by Subject|6
7722441|NCT00995553|26853695|P1|Overall Study|Withdrawal by Subject|2
7722442|NCT00995488|26853744|P1|Overall Study|Withdrawal by Subject|1
7722443|NCT00995436|26853778|P3|Overall Study|Withdrawal by Subject|0
7722444|NCT00995436|26853779|P2|Overall Study|Withdrawal by Subject|5
7722445|NCT00995436|26853780|P1|Overall Study|Withdrawal by Subject|2
7722446|NCT00995410|26853788|P1|Overall Study|Misc|28
7722447|NCT00995410|26853788|P1|Overall Study|Lost to Follow-up|2
7722448|NCT00995410|26853788|P1|Overall Study|Withdrawal by Subject|7
7722449|NCT00995410|26853788|P1|Overall Study|Adverse Event|51
7722450|NCT00995371|26853795|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
7722451|NCT00995371|26853796|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
7722452|NCT00995345|26853814|P5|Overall Study|all other reasons combined|3
7722453|NCT00995345|26853815|P4|Overall Study|all other reasons combined|1
7722454|NCT00995345|26853816|P3|Overall Study|all other reasons combined|2
7722455|NCT00995345|26853817|P2|Overall Study|all other reasons combined|2
7722456|NCT00995345|26853818|P1|Overall Study|all other reasons combined|2
7722457|NCT00995345|26853814|P5|Overall Study|Lost to Follow-up|0
7722458|NCT00995345|26853815|P4|Overall Study|Lost to Follow-up|1
7722459|NCT00995345|26853816|P3|Overall Study|Lost to Follow-up|2
7722460|NCT00995345|26853817|P2|Overall Study|Lost to Follow-up|2
7722461|NCT00995345|26853818|P1|Overall Study|Lost to Follow-up|2
7722462|NCT00995345|26853814|P5|Overall Study|Adverse Event|1
7722463|NCT00995345|26853815|P4|Overall Study|Adverse Event|0
7722464|NCT00995345|26853816|P3|Overall Study|Adverse Event|2
7722465|NCT00995345|26853817|P2|Overall Study|Adverse Event|1
7722466|NCT00995345|26853818|P1|Overall Study|Adverse Event|3
7722467|NCT00995345|26853814|P5|Overall Study|Withdrawal by Subject|1
7722468|NCT00995345|26853815|P4|Overall Study|Withdrawal by Subject|3
7722469|NCT00995345|26853816|P3|Overall Study|Withdrawal by Subject|1
7722470|NCT00995345|26853817|P2|Overall Study|Withdrawal by Subject|2
7722471|NCT00995345|26853818|P1|Overall Study|Withdrawal by Subject|4
7722472|NCT00995085|26853850|P1|Overall Study|Withdrawal by Subject|5
7722473|NCT00995020|26853867|P2|Overall Study|specimen fragmentation, thermal damage|2
7722474|NCT00995020|26853868|P1|Overall Study|specimen fragmentation, thermal damage|1
7722475|NCT00995020|26853867|P2|Overall Study|margin analysis not performed|5
7722476|NCT00995020|26853868|P1|Overall Study|margin analysis not performed|2
7722477|NCT00995007|26853878|P2|Overall Study|Toxicity|0
7722478|NCT00995007|26853879|P1|Overall Study|Toxicity|8
7722479|NCT00995007|26853878|P2|Overall Study|Refused further treatment|2
7722480|NCT00995007|26853879|P1|Overall Study|Refused further treatment|8
7722481|NCT00995007|26853878|P2|Overall Study|Withdrew consent|0
7722482|NCT00995007|26853879|P1|Overall Study|Withdrew consent|1
7722483|NCT00994890|26853904|P3|Overall Study|Other|1
7722484|NCT00994890|26853905|P2|Overall Study|Other|2
7722485|NCT00994890|26853906|P1|Overall Study|Other|2
7722486|NCT00994890|26853904|P3|Overall Study|Randomized, but not treated|0
7722487|NCT00994890|26853905|P2|Overall Study|Randomized, but not treated|0
7722488|NCT00994890|26853906|P1|Overall Study|Randomized, but not treated|1
7722489|NCT00994890|26853904|P3|Overall Study|Study terminated by sponsor|197
7722490|NCT00994890|26853905|P2|Overall Study|Study terminated by sponsor|201
7722491|NCT00994890|26853906|P1|Overall Study|Study terminated by sponsor|199
7722492|NCT00994890|26853904|P3|Overall Study|Protocol Violation|0
7722493|NCT00994890|26853905|P2|Overall Study|Protocol Violation|4
7722494|NCT00994890|26853906|P1|Overall Study|Protocol Violation|2
7722495|NCT00994890|26853904|P3|Overall Study|No longer willing to participate|13
7722496|NCT00994890|26853905|P2|Overall Study|No longer willing to participate|5
7722497|NCT00994890|26853906|P1|Overall Study|No longer willing to participate|8
7722498|NCT00994890|26853904|P3|Overall Study|Lost to Follow-up|3
7722499|NCT00994890|26853905|P2|Overall Study|Lost to Follow-up|1
7722500|NCT00994890|26853906|P1|Overall Study|Lost to Follow-up|6
7722501|NCT00994890|26853904|P3|Overall Study|Lack of Efficacy|1
7722502|NCT00994890|26853905|P2|Overall Study|Lack of Efficacy|0
7722503|NCT00994890|26853906|P1|Overall Study|Lack of Efficacy|0
7722504|NCT00994890|26853904|P3|Overall Study|Adverse Event|11
7722505|NCT00994890|26853905|P2|Overall Study|Adverse Event|9
7722506|NCT00994890|26853906|P1|Overall Study|Adverse Event|13
7722507|NCT00994682|26854075|P2|Pioglitazone Open Label|Physician Decision|1
7722508|NCT00994682|26854076|P1|Pioglitazone Open Label|Physician Decision|6
7722509|NCT00994682|26854075|P2|Pioglitazone Open Label|Lost to Follow-up|2
7722510|NCT00994682|26854076|P1|Pioglitazone Open Label|Lost to Follow-up|3
7722511|NCT00994682|26854075|P2|Pioglitazone Open Label|Withdrawal by Subject|4
7722512|NCT00994682|26854076|P1|Pioglitazone Open Label|Withdrawal by Subject|4
7722513|NCT00994682|26854075|P2|Double Bilnd|Adverse Event|0
7722514|NCT00994682|26854076|P1|Double Bilnd|Adverse Event|1
7722515|NCT00994682|26854075|P2|Double Bilnd|Lost to Follow-up|3
7722516|NCT00994682|26854076|P1|Double Bilnd|Lost to Follow-up|3
7722517|NCT00994682|26854075|P2|Double Bilnd|Withdrawal by Subject|6
7722518|NCT00994682|26854076|P1|Double Bilnd|Withdrawal by Subject|5
7722519|NCT00994643|26854120|P1|Overall Study|Withdrawal by Subject|1
7722520|NCT00994461|26854134|P3|Overall Study|Adverse Event|0
7722521|NCT00994461|26854135|P2|Overall Study|Adverse Event|1
7722522|NCT00994461|26854136|P1|Overall Study|Adverse Event|2
7722523|NCT00994448|26854164|P2|Overall Study|Physician Decision|0
7722524|NCT00994448|26854165|P1|Overall Study|Physician Decision|1
7722525|NCT00994448|26854164|P2|Overall Study|Withdrawal by Subject|1
7722526|NCT00994448|26854165|P1|Overall Study|Withdrawal by Subject|1
7722527|NCT00994448|26854164|P2|Overall Study|Lost to Follow-up|1
7722528|NCT00994448|26854165|P1|Overall Study|Lost to Follow-up|5
7722529|NCT00994448|26854164|P2|Overall Study|Adverse Event|0
7722530|NCT00994448|26854165|P1|Overall Study|Adverse Event|1
7722531|NCT00994422|26854173|P2|Overall Study|Lost to Follow-up|1
7722532|NCT00994422|26854174|P1|Overall Study|Lost to Follow-up|7
7722539|NCT00994240|26854210|P2|Overall Study|study termination|3
7722540|NCT00994240|26854211|P1|Overall Study|study termination|2
7722541|NCT00994240|26854210|P2|Overall Study|Withdrawal by Subject|0
7722542|NCT00994240|26854211|P1|Overall Study|Withdrawal by Subject|1
7722543|NCT00994240|26854210|P2|Overall Study|Lost to Follow-up|2
7722544|NCT00994240|26854211|P1|Overall Study|Lost to Follow-up|3
7722545|NCT00994214|26854221|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
7722546|NCT00994214|26854222|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
7722547|NCT00994214|26854223|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
7722548|NCT00994214|26854224|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
7722549|NCT00994214|26854221|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
7722550|NCT00994214|26854222|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7722551|NCT00994214|26854223|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7722552|NCT00994214|26854224|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7722553|NCT00994214|26854221|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
7722554|NCT00994214|26854222|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
7722555|NCT00994214|26854223|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
7722556|NCT00994214|26854224|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
7722557|NCT00994214|26854221|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7722558|NCT00994214|26854222|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7722559|NCT00994214|26854223|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7722560|NCT00994214|26854224|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
7722561|NCT00994214|26854221|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
7722562|NCT00994214|26854222|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7722563|NCT00994214|26854223|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7722564|NCT00994214|26854224|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7722565|NCT00994214|26854221|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7722566|NCT00994214|26854222|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7722567|NCT00994214|26854223|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
7722568|NCT00994214|26854224|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7722569|NCT00994110|26854303|P2|Overall Study|Pt not eligible|5
7722570|NCT00994110|26854304|P1|Overall Study|Pt not eligible|10
7722571|NCT00994110|26854303|P2|Overall Study|Patient not resected|52
7722572|NCT00994110|26854304|P1|Overall Study|Patient not resected|41
7722573|NCT00994110|26854303|P2|Overall Study|Adverse Event|0
7722574|NCT00994110|26854304|P1|Overall Study|Adverse Event|1
7722575|NCT00994110|26854303|P2|Overall Study|Not Treated|8
7722576|NCT00994110|26854304|P1|Overall Study|Not Treated|4
7722577|NCT00994110|26854303|P2|Overall Study|Withdrawal by Subject|9
7722578|NCT00994110|26854304|P1|Overall Study|Withdrawal by Subject|9
7722579|NCT00993967|26854310|P1|Overall Study|Protocol Violation|2
7722580|NCT00993967|26854310|P1|Overall Study|Withdrawal by Subject|36
7722581|NCT00993967|26854310|P1|Overall Study|Lost to Follow-up|14
7722582|NCT00993967|26854310|P1|Overall Study|Death|1
7722583|NCT00993967|26854310|P1|Overall Study|Adverse Event|8
7722584|NCT00993954|26854317|P2|Overall Study|Protocol Violation|2
7722585|NCT00993954|26854318|P1|Overall Study|Protocol Violation|21
7722586|NCT00993928|26854331|P2|Overall Study|ineligible|0
7722587|NCT00993928|26854332|P1|Overall Study|ineligible|1
7722588|NCT00993928|26854331|P2|Overall Study|Withdrawal by Subject|7
7722589|NCT00993928|26854332|P1|Overall Study|Withdrawal by Subject|4
7722590|NCT00993915|26854346|P1|Overall Study|Ongoing|3
7722591|NCT00993915|26854346|P1|Overall Study|Other|1
7722592|NCT00993915|26854346|P1|Overall Study|Withdrawal by Subject|2
7722593|NCT00993915|26854346|P1|Overall Study|Insufficient clinical response|3
7722594|NCT00993668|26854396|P2|Open-Label Period|Lost to Follow-up|1
7722595|NCT00993668|26854397|P1|Open-Label Period|Lost to Follow-up|6
7722596|NCT00993668|26854396|P2|Open-Label Period|Withdrawal by Subject|3
7722597|NCT00993668|26854397|P1|Open-Label Period|Withdrawal by Subject|4
7722598|NCT00993668|26854396|P2|Open-Label Period|Lack of Efficacy|3
7722599|NCT00993668|26854397|P1|Open-Label Period|Lack of Efficacy|4
7722600|NCT00993668|26854396|P2|Open-Label Period|Adverse Event|8
7722601|NCT00993668|26854397|P1|Open-Label Period|Adverse Event|9
7722602|NCT00993668|26854396|P2|Single-Blind Period|Lost to Follow-up|1
7722603|NCT00993668|26854397|P1|Single-Blind Period|Lost to Follow-up|3
7722604|NCT00993668|26854396|P2|Single-Blind Period|Lack of Efficacy|1
7722605|NCT00993668|26854397|P1|Single-Blind Period|Lack of Efficacy|0
7722606|NCT00993668|26854396|P2|Single-Blind Period|Adverse Event|1
7722607|NCT00993668|26854397|P1|Single-Blind Period|Adverse Event|1
7722608|NCT00993616|26854441|P1|Overall Study|Never treated|1
7722609|NCT00993616|26854441|P1|Overall Study|No tumor at entry|1
7722610|NCT00993499|26854459|P6|Discontinued After Starting Course 3|Other adverse event|0
7722611|NCT00993499|26854460|P5|Discontinued After Starting Course 3|Other adverse event|0
7722612|NCT00993499|26854461|P4|Discontinued After Starting Course 3|Other adverse event|0
7722613|NCT00993499|26854462|P3|Discontinued After Starting Course 3|Other adverse event|1
7722614|NCT00993499|26854463|P2|Discontinued After Starting Course 3|Other adverse event|0
7722615|NCT00993499|26854464|P1|Discontinued After Starting Course 3|Other adverse event|1
7722616|NCT00993499|26854459|P6|Discontinued After Starting Course 3|DLT|0
7722617|NCT00993499|26854460|P5|Discontinued After Starting Course 3|DLT|0
7722618|NCT00993499|26854461|P4|Discontinued After Starting Course 3|DLT|1
7722619|NCT00993499|26854462|P3|Discontinued After Starting Course 3|DLT|2
7722620|NCT00993499|26854463|P2|Discontinued After Starting Course 3|DLT|0
7722621|NCT00993499|26854464|P1|Discontinued After Starting Course 3|DLT|1
7722622|NCT00993499|26854459|P6|Discontinued After Starting Course 3|Progressive Disease|3
7722623|NCT00993499|26854460|P5|Discontinued After Starting Course 3|Progressive Disease|3
7722624|NCT00993499|26854461|P4|Discontinued After Starting Course 3|Progressive Disease|1
7722625|NCT00993499|26854462|P3|Discontinued After Starting Course 3|Progressive Disease|3
7722626|NCT00993499|26854463|P2|Discontinued After Starting Course 3|Progressive Disease|4
7722627|NCT00993499|26854464|P1|Discontinued After Starting Course 3|Progressive Disease|6
7722628|NCT00993499|26854459|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
7722629|NCT00993499|26854460|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
7722630|NCT00993499|26854461|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
7722631|NCT00993499|26854462|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
7722632|NCT00993499|26854463|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
7722633|NCT00993499|26854464|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
7722634|NCT00993499|26854459|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7722635|NCT00993499|26854460|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7722636|NCT00993499|26854461|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7722637|NCT00993499|26854462|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
7722638|NCT00993499|26854463|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7722639|NCT00993499|26854464|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7722640|NCT00993499|26854459|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7722641|NCT00993499|26854460|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7722642|NCT00993499|26854461|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
7722643|NCT00993499|26854462|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
7722644|NCT00993499|26854463|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7722645|NCT00993499|26854464|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7722646|NCT00993499|26854459|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7722647|NCT00993499|26854460|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7722648|NCT00993499|26854461|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7722649|NCT00993499|26854462|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7722650|NCT00993499|26854463|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
7722651|NCT00993499|26854464|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
7722652|NCT00993499|26854459|P6|Discontinued Before Starting Course 3|Progressive Disease|0
7722653|NCT00993499|26854460|P5|Discontinued Before Starting Course 3|Progressive Disease|0
7722654|NCT00993499|26854461|P4|Discontinued Before Starting Course 3|Progressive Disease|0
7722655|NCT00993499|26854462|P3|Discontinued Before Starting Course 3|Progressive Disease|0
7722656|NCT00993499|26854463|P2|Discontinued Before Starting Course 3|Progressive Disease|2
7722657|NCT00993499|26854464|P1|Discontinued Before Starting Course 3|Progressive Disease|2
7722658|NCT00993499|26854459|P6|Run-in Period (8 Days)|Progressive disease|0
7722659|NCT00993499|26854460|P5|Run-in Period (8 Days)|Progressive disease|0
7722660|NCT00993499|26854461|P4|Run-in Period (8 Days)|Progressive disease|0
7722661|NCT00993499|26854462|P3|Run-in Period (8 Days)|Progressive disease|1
7722662|NCT00993499|26854463|P2|Run-in Period (8 Days)|Progressive disease|1
7722663|NCT00993499|26854464|P1|Run-in Period (8 Days)|Progressive disease|0
7722664|NCT00993499|26854459|P6|Run-in Period (8 Days)|Consent withdrawn|0
7722665|NCT00993499|26854460|P5|Run-in Period (8 Days)|Consent withdrawn|0
7722666|NCT00993499|26854461|P4|Run-in Period (8 Days)|Consent withdrawn|0
7722667|NCT00993499|26854462|P3|Run-in Period (8 Days)|Consent withdrawn|0
7722668|NCT00993499|26854463|P2|Run-in Period (8 Days)|Consent withdrawn|1
7722669|NCT00993499|26854464|P1|Run-in Period (8 Days)|Consent withdrawn|0
7722670|NCT00993499|26854459|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7722671|NCT00993499|26854460|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7722672|NCT00993499|26854461|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7722673|NCT00993499|26854462|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7722674|NCT00993499|26854463|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7722675|NCT00993499|26854464|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
7722676|NCT00993499|26854459|P6|Run-in Period (8 Days)|Adverse Event|0
7722677|NCT00993499|26854460|P5|Run-in Period (8 Days)|Adverse Event|0
7722678|NCT00993499|26854461|P4|Run-in Period (8 Days)|Adverse Event|0
7722679|NCT00993499|26854462|P3|Run-in Period (8 Days)|Adverse Event|0
7722680|NCT00993499|26854463|P2|Run-in Period (8 Days)|Adverse Event|1
7722681|NCT00993499|26854464|P1|Run-in Period (8 Days)|Adverse Event|0
7722682|NCT00993473|26854546|P2|Overall Study|Family event|0
7722683|NCT00993473|26854547|P1|Overall Study|Family event|1
7722684|NCT00993473|26854546|P2|Overall Study|Technical problem with CGM device|1
7722685|NCT00993473|26854547|P1|Overall Study|Technical problem with CGM device|0
7722686|NCT00993473|26854546|P2|Overall Study|Withdrawal by Subject|5
7722687|NCT00993473|26854547|P1|Overall Study|Withdrawal by Subject|1
7722688|NCT00993473|26854546|P2|Overall Study|Lost to Follow-up|0
7722689|NCT00993473|26854547|P1|Overall Study|Lost to Follow-up|1
7722690|NCT00993473|26854546|P2|Overall Study|Protocol Violation|2
7722691|NCT00993473|26854547|P1|Overall Study|Protocol Violation|1
7722692|NCT00993473|26854546|P2|Overall Study|Adverse Event|2
7722693|NCT00993473|26854547|P1|Overall Study|Adverse Event|0
7722694|NCT00993447|26854585|P2|Overall Study|Adverse Event|0
7722695|NCT00993447|26854586|P1|Overall Study|Adverse Event|1
7722696|NCT00993447|26854585|P2|Overall Study|Lost to Follow-up|3
7722697|NCT00993447|26854586|P1|Overall Study|Lost to Follow-up|1
7722698|NCT00993447|26854585|P2|Overall Study|Protocol Violation|8
7722699|NCT00993447|26854586|P1|Overall Study|Protocol Violation|12
7722700|NCT00993447|26854585|P2|Overall Study|Withdrawal by Subject|8
7722701|NCT00993447|26854586|P1|Overall Study|Withdrawal by Subject|23
7722702|NCT00993421|26854623|P7|Overall Study|Protocol Violation|1
7722703|NCT00993421|26854624|P6|Overall Study|Protocol Violation|2
7722704|NCT00993421|26854625|P5|Overall Study|Protocol Violation|0
7722705|NCT00993421|26854626|P4|Overall Study|Protocol Violation|0
7722706|NCT00993421|26854627|P3|Overall Study|Protocol Violation|0
7722707|NCT00993421|26854628|P2|Overall Study|Protocol Violation|0
7722708|NCT00993421|26854629|P1|Overall Study|Protocol Violation|0
7722709|NCT00993421|26854623|P7|Overall Study|Physician Decision|1
7722710|NCT00993421|26854624|P6|Overall Study|Physician Decision|1
7722711|NCT00993421|26854625|P5|Overall Study|Physician Decision|0
7722712|NCT00993421|26854626|P4|Overall Study|Physician Decision|0
7722713|NCT00993421|26854627|P3|Overall Study|Physician Decision|0
7722714|NCT00993421|26854628|P2|Overall Study|Physician Decision|0
7722715|NCT00993421|26854629|P1|Overall Study|Physician Decision|0
7722716|NCT00993421|26854623|P7|Overall Study|Entry Criteria Exclusion|0
7722717|NCT00993421|26854624|P6|Overall Study|Entry Criteria Exclusion|1
7722718|NCT00993421|26854625|P5|Overall Study|Entry Criteria Exclusion|0
7722719|NCT00993421|26854626|P4|Overall Study|Entry Criteria Exclusion|3
7722720|NCT00993421|26854627|P3|Overall Study|Entry Criteria Exclusion|1
7722721|NCT00993421|26854628|P2|Overall Study|Entry Criteria Exclusion|0
7722722|NCT00993421|26854629|P1|Overall Study|Entry Criteria Exclusion|0
7722723|NCT00993421|26854623|P7|Overall Study|Death|1
7722724|NCT00993421|26854624|P6|Overall Study|Death|0
7722725|NCT00993421|26854625|P5|Overall Study|Death|0
7722726|NCT00993421|26854626|P4|Overall Study|Death|0
7722727|NCT00993421|26854627|P3|Overall Study|Death|0
7722728|NCT00993421|26854628|P2|Overall Study|Death|0
7722729|NCT00993421|26854629|P1|Overall Study|Death|0
7722730|NCT00993421|26854623|P7|Overall Study|Withdrawal by Subject|3
7722731|NCT00993421|26854624|P6|Overall Study|Withdrawal by Subject|5
7722732|NCT00993421|26854625|P5|Overall Study|Withdrawal by Subject|3
7722733|NCT00993421|26854626|P4|Overall Study|Withdrawal by Subject|3
7722734|NCT00993421|26854627|P3|Overall Study|Withdrawal by Subject|3
7722735|NCT00993421|26854628|P2|Overall Study|Withdrawal by Subject|2
7722736|NCT00993421|26854629|P1|Overall Study|Withdrawal by Subject|3
7722737|NCT00993421|26854623|P7|Overall Study|Lost to Follow-up|6
7722738|NCT00993421|26854624|P6|Overall Study|Lost to Follow-up|0
7722739|NCT00993421|26854625|P5|Overall Study|Lost to Follow-up|0
7722740|NCT00993421|26854626|P4|Overall Study|Lost to Follow-up|0
7722741|NCT00993421|26854627|P3|Overall Study|Lost to Follow-up|5
7722742|NCT00993421|26854628|P2|Overall Study|Lost to Follow-up|5
7722743|NCT00993421|26854629|P1|Overall Study|Lost to Follow-up|3
7722744|NCT00993421|26854623|P7|Overall Study|Sponsor Decision|29
7722745|NCT00993421|26854624|P6|Overall Study|Sponsor Decision|30
7722746|NCT00993421|26854625|P5|Overall Study|Sponsor Decision|38
7722747|NCT00993421|26854626|P4|Overall Study|Sponsor Decision|30
7722748|NCT00993421|26854627|P3|Overall Study|Sponsor Decision|28
7722749|NCT00993421|26854628|P2|Overall Study|Sponsor Decision|31
7722750|NCT00993421|26854629|P1|Overall Study|Sponsor Decision|36
7722751|NCT00993421|26854623|P7|Overall Study|Adverse Event|1
7722752|NCT00993421|26854624|P6|Overall Study|Adverse Event|7
7722753|NCT00993421|26854625|P5|Overall Study|Adverse Event|5
7722754|NCT00993421|26854626|P4|Overall Study|Adverse Event|9
7722755|NCT00993421|26854627|P3|Overall Study|Adverse Event|6
7722756|NCT00993421|26854628|P2|Overall Study|Adverse Event|7
7722757|NCT00993421|26854629|P1|Overall Study|Adverse Event|2
7722758|NCT00993317|26854780|P2|Overall Study|Early study termination at the site|0
7722759|NCT00993317|26854781|P1|Overall Study|Early study termination at the site|1
7722760|NCT00993317|26854780|P2|Overall Study|Investigator's opinion|1
7722761|NCT00993317|26854781|P1|Overall Study|Investigator's opinion|0
7722762|NCT00993317|26854780|P2|Overall Study|Withdrawal by Subject|2
7722763|NCT00993317|26854781|P1|Overall Study|Withdrawal by Subject|0
7722764|NCT00993317|26854780|P2|Overall Study|Lack of Efficacy|18
7722765|NCT00993317|26854781|P1|Overall Study|Lack of Efficacy|18
7722766|NCT00993317|26854780|P2|Overall Study|Adverse Event|4
7722767|NCT00993317|26854781|P1|Overall Study|Adverse Event|2
7722768|NCT00993291|26854799|P1|Overall Study|Withdrawal by Subject|1
7722769|NCT00993265|26854805|P2|Overall Study|Non-compliant with study medication|0
7722770|NCT00993265|26854806|P1|Overall Study|Non-compliant with study medication|1
7722771|NCT00993265|26854805|P2|Overall Study|Changed dose of concomitant drug|0
7722772|NCT00993265|26854806|P1|Overall Study|Changed dose of concomitant drug|2
7722773|NCT00993265|26854805|P2|Overall Study|Adverse Event|0
7722774|NCT00993265|26854806|P1|Overall Study|Adverse Event|1
7722775|NCT00993148|26854880|P1|Overall Study|never initiated treatment|1
7722776|NCT00993148|26854880|P1|Overall Study|Lost to Follow-up|2
7722777|NCT00993044|26854892|P1|Irinotecan 50 mg|Physician Decision|1
7722778|NCT00993031|26854899|P2|Overall Study|Lost to Follow-up|13
7722779|NCT00993031|26854900|P1|Overall Study|Lost to Follow-up|19
7722780|NCT00993031|26854899|P2|Overall Study|Withdrawal by Subject|3
7722781|NCT00993031|26854900|P1|Overall Study|Withdrawal by Subject|3
7722782|NCT00993031|26854899|P2|Overall Study|Physician Decision|2
7722783|NCT00993031|26854900|P1|Overall Study|Physician Decision|0
7722784|NCT00993031|26854899|P2|Overall Study|Death|1
7722785|NCT00993031|26854900|P1|Overall Study|Death|0
7722786|NCT00992992|26854932|P1|Overall Study|Sponsor Closed the Study|4
7722787|NCT00992992|26854932|P1|Overall Study|GlaxoSmithKline Closed the Study|2
7722788|NCT00992992|26854932|P1|Overall Study|Death|16
7722789|NCT00992992|26854932|P1|Overall Study|Lost to Follow-up|3
7722790|NCT00992836|26854963|P1|Overall Study|Protocol Violation|2
7722791|NCT00992836|26854963|P1|Overall Study|Withdrawal by Subject|2
7722792|NCT00992836|26854963|P1|Overall Study|Lost to Follow-up|1
7722793|NCT00992784|26854978|P3|Overall Study|Withdrawal by Subject|1
7722794|NCT00992784|26854979|P2|Overall Study|Withdrawal by Subject|1
7722795|NCT00992784|26854980|P1|Overall Study|Withdrawal by Subject|1
7722796|NCT00992784|26854978|P3|Overall Study|Adverse Event|0
7722797|NCT00992784|26854979|P2|Overall Study|Adverse Event|1
7722798|NCT00992784|26854980|P1|Overall Study|Adverse Event|2
7722799|NCT00992589|26855092|P4|Double-Blind Phase|Other|3
7722800|NCT00992589|26855093|P3|Double-Blind Phase|Other|6
7722801|NCT00992589|26855094|P2|Double-Blind Phase|Other|1
7722802|NCT00992589|26855095|P1|Double-Blind Phase|Other|0
7722803|NCT00992589|26855092|P4|Double-Blind Phase|Lost to Follow-up|2
7722804|NCT00992589|26855093|P3|Double-Blind Phase|Lost to Follow-up|0
7722805|NCT00992589|26855094|P2|Double-Blind Phase|Lost to Follow-up|0
7722806|NCT00992589|26855095|P1|Double-Blind Phase|Lost to Follow-up|0
7722807|NCT00992589|26855092|P4|Double-Blind Phase|Withdrawal by Subject|2
7722808|NCT00992589|26855093|P3|Double-Blind Phase|Withdrawal by Subject|5
7722809|NCT00992589|26855094|P2|Double-Blind Phase|Withdrawal by Subject|6
7722810|NCT00992589|26855095|P1|Double-Blind Phase|Withdrawal by Subject|0
7722811|NCT00992589|26855092|P4|Double-Blind Phase|Adverse Event|3
7722812|NCT00992589|26855093|P3|Double-Blind Phase|Adverse Event|2
7722813|NCT00992589|26855094|P2|Double-Blind Phase|Adverse Event|6
7722814|NCT00992589|26855095|P1|Double-Blind Phase|Adverse Event|0
7722815|NCT00992589|26855092|P4|Open-Label Phase|Other|0
7722816|NCT00992589|26855093|P3|Open-Label Phase|Other|0
7722817|NCT00992589|26855094|P2|Open-Label Phase|Other|0
7722818|NCT00992589|26855095|P1|Open-Label Phase|Other|45
7722819|NCT00992589|26855092|P4|Open-Label Phase|Physician Decision|0
7722820|NCT00992589|26855093|P3|Open-Label Phase|Physician Decision|0
7722821|NCT00992589|26855094|P2|Open-Label Phase|Physician Decision|0
7722822|NCT00992589|26855095|P1|Open-Label Phase|Physician Decision|4
7722823|NCT00992589|26855092|P4|Open-Label Phase|Protocol Violation|0
7722824|NCT00992589|26855093|P3|Open-Label Phase|Protocol Violation|0
7722825|NCT00992589|26855094|P2|Open-Label Phase|Protocol Violation|0
7722826|NCT00992589|26855095|P1|Open-Label Phase|Protocol Violation|3
7722827|NCT00992589|26855092|P4|Open-Label Phase|Lost to Follow-up|0
7722828|NCT00992589|26855093|P3|Open-Label Phase|Lost to Follow-up|0
7722829|NCT00992589|26855094|P2|Open-Label Phase|Lost to Follow-up|0
7722830|NCT00992589|26855095|P1|Open-Label Phase|Lost to Follow-up|1
7722831|NCT00992589|26855092|P4|Open-Label Phase|Withdrawal by Subject|0
7722832|NCT00992589|26855093|P3|Open-Label Phase|Withdrawal by Subject|0
7722833|NCT00992589|26855094|P2|Open-Label Phase|Withdrawal by Subject|0
7722834|NCT00992589|26855095|P1|Open-Label Phase|Withdrawal by Subject|20
7722835|NCT00992589|26855092|P4|Open-Label Phase|Adverse Event|0
7722836|NCT00992589|26855093|P3|Open-Label Phase|Adverse Event|0
7722837|NCT00992589|26855094|P2|Open-Label Phase|Adverse Event|0
7722838|NCT00992589|26855095|P1|Open-Label Phase|Adverse Event|4
7722839|NCT00992511|26855141|P4|Overall Study|Withdrawal by Subject|1
7722840|NCT00992511|26855142|P3|Overall Study|Withdrawal by Subject|1
7722841|NCT00992511|26855143|P2|Overall Study|Withdrawal by Subject|0
7722842|NCT00992511|26855144|P1|Overall Study|Withdrawal by Subject|0
7722843|NCT00992511|26855141|P4|Overall Study|Lost to Follow-up|2
7722844|NCT00992511|26855142|P3|Overall Study|Lost to Follow-up|0
7722845|NCT00992511|26855143|P2|Overall Study|Lost to Follow-up|0
7722846|NCT00992511|26855144|P1|Overall Study|Lost to Follow-up|1
7722847|NCT00992511|26855141|P4|Overall Study|Migrated/moved from study area|2
7722848|NCT00992511|26855142|P3|Overall Study|Migrated/moved from study area|1
7722849|NCT00992511|26855143|P2|Overall Study|Migrated/moved from study area|0
7722850|NCT00992511|26855144|P1|Overall Study|Migrated/moved from study area|1
7722851|NCT00992459|26855228|P2|Overall Study|Adverse Event|0
7722852|NCT00992459|26855229|P1|Overall Study|Adverse Event|1
7722853|NCT00992459|26855228|P2|Overall Study|Withdrawal by Subject|1
7722854|NCT00992459|26855229|P1|Overall Study|Withdrawal by Subject|0
7722855|NCT00992446|26855253|P1|Overall Study|Maintenance Therapy Screen Fail|5
7722856|NCT00992446|26855253|P1|Overall Study|Withdrawal by Subject|2
7722857|NCT00992446|26855253|P1|Overall Study|Disease Progression|1
7722858|NCT00992407|26855328|P2|Overall Study|Study medication not administered|13
7722859|NCT00992407|26855329|P1|Overall Study|Study medication not administered|17
7722860|NCT00992407|26855328|P2|Overall Study|Loss of follow-up & Adverse events|1
7722861|NCT00992407|26855329|P1|Overall Study|Loss of follow-up & Adverse events|2
7722862|NCT00992407|26855328|P2|Overall Study|Other|0
7722863|NCT00992407|26855329|P1|Overall Study|Other|2
7722864|NCT00992407|26855328|P2|Overall Study|protocol Violation & Adverse events|4
7722865|NCT00992407|26855329|P1|Overall Study|protocol Violation & Adverse events|2
7722866|NCT00992407|26855328|P2|Overall Study|Adverse Event|2
7722867|NCT00992407|26855329|P1|Overall Study|Adverse Event|3
7722868|NCT00992407|26855328|P2|Overall Study|Lost to Follow-up|3
7722869|NCT00992407|26855329|P1|Overall Study|Lost to Follow-up|3
7722870|NCT00992407|26855328|P2|Overall Study|Protocol Violation|1
7722871|NCT00992407|26855329|P1|Overall Study|Protocol Violation|2
7722872|NCT00992394|26855379|P2|Overall Study|Other event|0
7722873|NCT00992394|26855380|P1|Overall Study|Other event|1
7722874|NCT00992394|26855379|P2|Overall Study|Lost to Follow-up|0
7722875|NCT00992394|26855380|P1|Overall Study|Lost to Follow-up|2
7722876|NCT00992394|26855379|P2|Overall Study|Protocol Violation|4
7722877|NCT00992394|26855380|P1|Overall Study|Protocol Violation|2
7722878|NCT00992394|26855379|P2|Overall Study|Physician Decision|0
7722879|NCT00992394|26855380|P1|Overall Study|Physician Decision|1
7722880|NCT00992394|26855379|P2|Overall Study|Withdrawal by Subject|2
7722881|NCT00992394|26855380|P1|Overall Study|Withdrawal by Subject|8
7722882|NCT00992394|26855379|P2|Overall Study|Adverse Event|5
7722883|NCT00992394|26855380|P1|Overall Study|Adverse Event|4
7722884|NCT00992394|26855379|P2|Overall Study|Lack of Efficacy|3
7722885|NCT00992394|26855380|P1|Overall Study|Lack of Efficacy|6
7722886|NCT00992225|26855467|P1|Overall Study|Adverse Event|2
7722887|NCT00992225|26855467|P1|Overall Study|Entry Criteria Not Met|8
7722888|NCT00992186|26855477|P1|Overall Study|Refusal To Receive Study Agent|3
7722889|NCT00992186|26855477|P1|Overall Study|Progressive Disease|30
7722890|NCT00992186|26855477|P1|Overall Study|Adverse Event|9
7722891|NCT00992186|26855477|P1|Overall Study|Physician Decision|1
7722892|NCT00992186|26855477|P1|Overall Study|Protocol Violation|1
7722893|NCT00992186|26855477|P1|Overall Study|Withdrawal by Subject|2
7722894|NCT00992108|26855496|P2|Overall Study|Lost to Follow-up|1
7722895|NCT00992108|26855497|P1|Overall Study|Lost to Follow-up|0
7722896|NCT00992056|26855511|P2|Washout Period (2 Weeks)|Physician Decision|0
7722897|NCT00992056|26855512|P1|Washout Period (2 Weeks)|Physician Decision|1
7722898|NCT00992056|26855511|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
7722899|NCT00992056|26855512|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
7722900|NCT00992017|26855518|P1|Overall Study|Not adhere to study requirements|1
7722901|NCT00992017|26855518|P1|Overall Study|Unable to get to clinic|5
7722902|NCT00992017|26855518|P1|Overall Study|Withdrawal by Subject|2
7722903|NCT00992017|26855518|P1|Overall Study|Lost to Follow-up|2
7722904|NCT00991952|26855533|P2|Overall Study|Adverse Event|1
7722905|NCT00991952|26855534|P1|Overall Study|Adverse Event|0
7722906|NCT00991939|26855542|P2|Overall Study|Entire study terminated|1
7722907|NCT00991939|26855543|P1|Overall Study|Entire study terminated|4
7722908|NCT00991939|26855542|P2|Overall Study|Withdrawal by Subject|0
7722909|NCT00991939|26855543|P1|Overall Study|Withdrawal by Subject|1
7722910|NCT00991939|26855542|P2|Overall Study|Lost to Follow-up|1
7722911|NCT00991939|26855543|P1|Overall Study|Lost to Follow-up|0
7722912|NCT00991887|26855577|P2|Overall Study|Lost to Follow-up|1
7722913|NCT00991887|26855578|P1|Overall Study|Lost to Follow-up|2
7722914|NCT00991510|26855597|P2|Period III (Days 29-112)|Adverse Event|1
7722915|NCT00991510|26855598|P1|Period III (Days 29-112)|Adverse Event|1
7722916|NCT00991510|26855597|P2|Period I (Days 1-14)|Adverse Event|0
7722917|NCT00991510|26855598|P1|Period I (Days 1-14)|Adverse Event|1
7722918|NCT00991406|26855642|P1|Overall Study|One participant did not respond to FES.|1
7722919|NCT00991341|26855651|P2|Overall Study|Withdrawal by Subject|4
7722920|NCT00991341|26855652|P1|Overall Study|Withdrawal by Subject|3
7722921|NCT00991341|26855651|P2|Overall Study|Physician Decision|2
7722922|NCT00991341|26855652|P1|Overall Study|Physician Decision|1
7722923|NCT00991341|26855651|P2|Overall Study|no RBCs received 96hrs after randomized|155
7722924|NCT00991341|26855652|P1|Overall Study|no RBCs received 96hrs after randomized|186
7722925|NCT00991341|26855651|P2|Overall Study|Death|0
7722926|NCT00991341|26855652|P1|Overall Study|Death|3
7722927|NCT00991341|26855651|P2|Overall Study|no surgery w/in 30 days of randomization|18
7722928|NCT00991341|26855652|P1|Overall Study|no surgery w/in 30 days of randomization|11
7722929|NCT00991302|26855690|P2|Overall Study|Lost to Follow-up|12
7722930|NCT00991302|26855691|P1|Overall Study|Lost to Follow-up|14
7722931|NCT00991302|26855690|P2|Overall Study|Death|1
7722932|NCT00991302|26855691|P1|Overall Study|Death|0
7722933|NCT00991289|26855707|P1|Overall Study|Protocol Violation|2
7722934|NCT00991289|26855707|P1|Overall Study|Lost to Follow-up|4
7722935|NCT00991289|26855707|P1|Overall Study|Withdrawal by Subject|3
7722936|NCT00991289|26855707|P1|Overall Study|Physician Decision|2
7722937|NCT00991289|26855707|P1|Overall Study|Adverse Event|1
7722938|NCT00991276|26855727|P6|Third Intervention Period|Withdrawal by Subject|0
7722939|NCT00991276|26855728|P5|Third Intervention Period|Withdrawal by Subject|0
7722940|NCT00991276|26855729|P4|Third Intervention Period|Withdrawal by Subject|1
7722941|NCT00991276|26855730|P3|Third Intervention Period|Withdrawal by Subject|0
7722942|NCT00991276|26855731|P2|Third Intervention Period|Withdrawal by Subject|0
7722943|NCT00991276|26855732|P1|Third Intervention Period|Withdrawal by Subject|0
7722944|NCT00991276|26855727|P6|Third Intervention Period|Adverse Event|0
7722945|NCT00991276|26855728|P5|Third Intervention Period|Adverse Event|0
7722946|NCT00991276|26855729|P4|Third Intervention Period|Adverse Event|0
7722947|NCT00991276|26855730|P3|Third Intervention Period|Adverse Event|1
7722948|NCT00991276|26855731|P2|Third Intervention Period|Adverse Event|0
7722949|NCT00991276|26855732|P1|Third Intervention Period|Adverse Event|0
7722950|NCT00991276|26855727|P6|Third Intervention Period|Other|1
7722951|NCT00991276|26855728|P5|Third Intervention Period|Other|0
7722952|NCT00991276|26855729|P4|Third Intervention Period|Other|0
7722953|NCT00991276|26855730|P3|Third Intervention Period|Other|0
7722954|NCT00991276|26855731|P2|Third Intervention Period|Other|0
7722955|NCT00991276|26855732|P1|Third Intervention Period|Other|0
7722956|NCT00991276|26855727|P6|Third Intervention Period|Protocol Violation|0
7722957|NCT00991276|26855728|P5|Third Intervention Period|Protocol Violation|0
7722958|NCT00991276|26855729|P4|Third Intervention Period|Protocol Violation|0
7722959|NCT00991276|26855730|P3|Third Intervention Period|Protocol Violation|0
7722960|NCT00991276|26855731|P2|Third Intervention Period|Protocol Violation|0
7722961|NCT00991276|26855732|P1|Third Intervention Period|Protocol Violation|1
7722962|NCT00991276|26855727|P6|Second Intervention Period|Other|1
7722963|NCT00991276|26855728|P5|Second Intervention Period|Other|0
7722964|NCT00991276|26855729|P4|Second Intervention Period|Other|1
7722965|NCT00991276|26855730|P3|Second Intervention Period|Other|0
7722966|NCT00991276|26855731|P2|Second Intervention Period|Other|0
7722967|NCT00991276|26855732|P1|Second Intervention Period|Other|0
7722968|NCT00991276|26855727|P6|Second Intervention Period|Protocol Violation|0
7722969|NCT00991276|26855728|P5|Second Intervention Period|Protocol Violation|0
7722970|NCT00991276|26855729|P4|Second Intervention Period|Protocol Violation|0
7722971|NCT00991276|26855730|P3|Second Intervention Period|Protocol Violation|0
7722972|NCT00991276|26855731|P2|Second Intervention Period|Protocol Violation|0
7722973|NCT00991276|26855732|P1|Second Intervention Period|Protocol Violation|1
7722974|NCT00991276|26855727|P6|Second Intervention Period|Adverse Event|0
7722975|NCT00991276|26855728|P5|Second Intervention Period|Adverse Event|1
7722976|NCT00991276|26855729|P4|Second Intervention Period|Adverse Event|1
7722977|NCT00991276|26855730|P3|Second Intervention Period|Adverse Event|0
7722978|NCT00991276|26855731|P2|Second Intervention Period|Adverse Event|2
7722979|NCT00991276|26855732|P1|Second Intervention Period|Adverse Event|0
7722980|NCT00991276|26855727|P6|First Intervention Period|Lost to Follow-up|0
7722981|NCT00991276|26855728|P5|First Intervention Period|Lost to Follow-up|0
7722982|NCT00991276|26855729|P4|First Intervention Period|Lost to Follow-up|1
7722983|NCT00991276|26855730|P3|First Intervention Period|Lost to Follow-up|0
7722984|NCT00991276|26855731|P2|First Intervention Period|Lost to Follow-up|1
7722985|NCT00991276|26855732|P1|First Intervention Period|Lost to Follow-up|0
7722986|NCT00991276|26855727|P6|First Intervention Period|Withdrawal by Subject|1
7722987|NCT00991276|26855728|P5|First Intervention Period|Withdrawal by Subject|0
7722988|NCT00991276|26855729|P4|First Intervention Period|Withdrawal by Subject|1
7722989|NCT00991276|26855730|P3|First Intervention Period|Withdrawal by Subject|0
7722990|NCT00991276|26855731|P2|First Intervention Period|Withdrawal by Subject|1
7722991|NCT00991276|26855732|P1|First Intervention Period|Withdrawal by Subject|0
7722992|NCT00991276|26855727|P6|First Intervention Period|Other|0
7722993|NCT00991276|26855728|P5|First Intervention Period|Other|1
7722994|NCT00991276|26855729|P4|First Intervention Period|Other|1
7722995|NCT00991276|26855730|P3|First Intervention Period|Other|0
7722996|NCT00991276|26855731|P2|First Intervention Period|Other|0
7722997|NCT00991276|26855732|P1|First Intervention Period|Other|0
7722998|NCT00991276|26855727|P6|First Intervention Period|Insufficient clinical response|0
7722999|NCT00991276|26855728|P5|First Intervention Period|Insufficient clinical response|1
7723000|NCT00991276|26855729|P4|First Intervention Period|Insufficient clinical response|0
7723001|NCT00991276|26855730|P3|First Intervention Period|Insufficient clinical response|0
7723002|NCT00991276|26855731|P2|First Intervention Period|Insufficient clinical response|0
7723003|NCT00991276|26855732|P1|First Intervention Period|Insufficient clinical response|0
7723004|NCT00991276|26855727|P6|First Intervention Period|Protocol Violation|0
7723005|NCT00991276|26855728|P5|First Intervention Period|Protocol Violation|2
7723006|NCT00991276|26855729|P4|First Intervention Period|Protocol Violation|0
7723007|NCT00991276|26855730|P3|First Intervention Period|Protocol Violation|0
7723008|NCT00991276|26855731|P2|First Intervention Period|Protocol Violation|0
7723009|NCT00991276|26855732|P1|First Intervention Period|Protocol Violation|0
7723010|NCT00991276|26855727|P6|First Intervention Period|Adverse Event|0
7723011|NCT00991276|26855728|P5|First Intervention Period|Adverse Event|0
7723012|NCT00991276|26855729|P4|First Intervention Period|Adverse Event|1
7723013|NCT00991276|26855730|P3|First Intervention Period|Adverse Event|0
7723014|NCT00991276|26855731|P2|First Intervention Period|Adverse Event|1
7723015|NCT00991276|26855732|P1|First Intervention Period|Adverse Event|0
7723016|NCT00990821|26855947|P14|Overall Study|Withdrawal by Subject|1
7723017|NCT00990821|26855948|P13|Overall Study|Withdrawal by Subject|2
7723018|NCT00990821|26855949|P12|Overall Study|Withdrawal by Subject|5
7723019|NCT00990821|26855950|P11|Overall Study|Withdrawal by Subject|3
7723020|NCT00990821|26855951|P10|Overall Study|Withdrawal by Subject|1
7723021|NCT00990821|26855952|P9|Overall Study|Withdrawal by Subject|0
7723022|NCT00990821|26855953|P8|Overall Study|Withdrawal by Subject|0
7723023|NCT00990821|26855954|P7|Overall Study|Withdrawal by Subject|1
7723024|NCT00990821|26855955|P6|Overall Study|Withdrawal by Subject|3
7723025|NCT00990821|26855956|P5|Overall Study|Withdrawal by Subject|3
7723026|NCT00990821|26855957|P4|Overall Study|Withdrawal by Subject|0
7723027|NCT00990821|26855958|P3|Overall Study|Withdrawal by Subject|0
7723028|NCT00990821|26855959|P2|Overall Study|Withdrawal by Subject|2
7723029|NCT00990821|26855960|P1|Overall Study|Withdrawal by Subject|0
7723030|NCT00990704|26855997|P2|Overall Study|Physician Decision|1
7723031|NCT00990704|26855998|P1|Overall Study|Physician Decision|0
7723032|NCT00990704|26855997|P2|Overall Study|Adverse Event|1
7723033|NCT00990704|26855998|P1|Overall Study|Adverse Event|1
7723034|NCT00990665|26856018|P1|Overall Study|System Explant|3
7723035|NCT00990665|26856018|P1|Overall Study|Lost to Follow-up|1
7723036|NCT00990665|26856018|P1|Overall Study|Withdrawal by Subject|6
7723037|NCT00990665|26856018|P1|Overall Study|Heart Transplant|1
7723038|NCT00990665|26856018|P1|Overall Study|Death|29
7723039|NCT00990665|26856018|P1|Overall Study|Unsuccessful Implant|8
7723040|NCT00990652|26856025|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
7723041|NCT00990652|26856025|P1|Pre-surgical Bortezomib|Adverse Event|1
7723042|NCT00990340|26856059|P2|First 14-day Treatment|Protocol Violation|2
7723043|NCT00990340|26856060|P1|First 14-day Treatment|Protocol Violation|2
7723044|NCT00990340|26856059|P2|First 14-day Treatment|Lost to Follow-up|1
7723045|NCT00990340|26856060|P1|First 14-day Treatment|Lost to Follow-up|2
7723046|NCT00990340|26856059|P2|First 14-day Treatment|Not Compliant|1
7723047|NCT00990340|26856060|P1|First 14-day Treatment|Not Compliant|2
7723048|NCT00990314|26856074|P1|Overall Study|Lack of Efficacy|1
7723049|NCT00990314|26856074|P1|Overall Study|Physician Decision|3
7723050|NCT00990314|26856074|P1|Overall Study|Non-Compliance|1
7723051|NCT00990314|26856074|P1|Overall Study|Withdrawal by Subject|3
7723052|NCT00990314|26856074|P1|Overall Study|Adverse Event|2
7723053|NCT00990314|26856074|P1|Overall Study|Death|2
7723054|NCT00990249|26856116|P1|Overall Study|Not treated|2
7723055|NCT00990249|26856116|P1|Overall Study|Death|2
7723056|NCT00990249|26856116|P1|Overall Study|Non-Compliance|1
7723057|NCT00990249|26856116|P1|Overall Study|Disease Progression|8
7723058|NCT00990184|26856131|P1|Overall Study|Physician Decision|1
7723059|NCT00990106|26856139|P2|Overall Study|scheduling conflicts|2
7723060|NCT00990106|26856140|P1|Overall Study|scheduling conflicts|0
7723061|NCT00990106|26856139|P2|Overall Study|planned major surgery|1
7723062|NCT00990106|26856140|P1|Overall Study|planned major surgery|0
7723063|NCT00990106|26856139|P2|Overall Study|started exclusionary medication|1
7723064|NCT00990106|26856140|P1|Overall Study|started exclusionary medication|0
7723065|NCT00990106|26856139|P2|Overall Study|relocation/deployment|1
7723066|NCT00990106|26856140|P1|Overall Study|relocation/deployment|4
7723067|NCT00990106|26856139|P2|Overall Study|opted for open label prazosin|1
7723068|NCT00990106|26856140|P1|Overall Study|opted for open label prazosin|1
7723069|NCT00990106|26856139|P2|Overall Study|Withdrawal by Subject|1
7723070|NCT00990106|26856140|P1|Overall Study|Withdrawal by Subject|2
7723071|NCT00990106|26856139|P2|Overall Study|Lost to Follow-up|3
7723072|NCT00990106|26856140|P1|Overall Study|Lost to Follow-up|1
7723073|NCT00990106|26856139|P2|Overall Study|"too busy to continue"|2
7723074|NCT00990106|26856140|P1|Overall Study|"too busy to continue"|1
7723075|NCT00990093|26856150|P2|Test Period 2 (15-28 Days)|Other|1
7723076|NCT00990093|26856151|P1|Test Period 2 (15-28 Days)|Other|0
7723077|NCT00990093|26856150|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
7723078|NCT00990093|26856151|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
7723079|NCT00990093|26856150|P2|Test Period 2 (15-28 Days)|Adverse Event|0
7723080|NCT00990093|26856151|P1|Test Period 2 (15-28 Days)|Adverse Event|1
7723081|NCT00990093|26856150|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
7723082|NCT00990093|26856151|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
7723083|NCT00990093|26856150|P2|Test Period 1 (1-14 Days)|Other|0
7723084|NCT00990093|26856151|P1|Test Period 1 (1-14 Days)|Other|1
7723085|NCT00990093|26856150|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
7723086|NCT00990093|26856151|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
7723087|NCT00990093|26856150|P2|Test Period 1 (1-14 Days)|Adverse Event|0
7723088|NCT00990093|26856151|P1|Test Period 1 (1-14 Days)|Adverse Event|1
7723089|NCT00989963|26856203|P3|Overall Study|Adverse Event|1
7723090|NCT00989963|26856204|P2|Overall Study|Adverse Event|1
7723091|NCT00989963|26856205|P1|Overall Study|Adverse Event|1
7723092|NCT00989950|26856241|P4|Randomized Phase|Adverse Event|0
7723093|NCT00989950|26856242|P3|Randomized Phase|Adverse Event|0
7723094|NCT00989950|26856243|P2|Randomized Phase|Adverse Event|1
7723095|NCT00989950|26856244|P1|Randomized Phase|Adverse Event|0
7723096|NCT00989950|26856241|P4|Randomized Phase|Protocol Violation|0
7723097|NCT00989950|26856242|P3|Randomized Phase|Protocol Violation|0
7723098|NCT00989950|26856243|P2|Randomized Phase|Protocol Violation|0
7723099|NCT00989950|26856244|P1|Randomized Phase|Protocol Violation|1
7723100|NCT00989833|26856276|P3|Overall Study|Incorrectly randomized|0
7723101|NCT00989833|26856277|P2|Overall Study|Incorrectly randomized|0
7723102|NCT00989833|26856278|P1|Overall Study|Incorrectly randomized|1
7723103|NCT00989833|26856276|P3|Overall Study|Withdrawal by Subject|1
7723104|NCT00989833|26856277|P2|Overall Study|Withdrawal by Subject|0
7723105|NCT00989833|26856278|P1|Overall Study|Withdrawal by Subject|0
7723106|NCT00989833|26856276|P3|Overall Study|Protocol Violation|1
7723107|NCT00989833|26856277|P2|Overall Study|Protocol Violation|2
7723108|NCT00989833|26856278|P1|Overall Study|Protocol Violation|1
7723109|NCT00989833|26856276|P3|Overall Study|Lost to Follow-up|0
7723110|NCT00989833|26856277|P2|Overall Study|Lost to Follow-up|1
7723111|NCT00989833|26856278|P1|Overall Study|Lost to Follow-up|0
7723112|NCT00989781|26856309|P2|Ovarian Response to hCG|Lost to Follow-up|2
7723113|NCT00989781|26856310|P1|Ovarian Response to hCG|Lost to Follow-up|3
7723114|NCT00989664|26856340|P1|Long-Term Follow-Up|Death|3
7723115|NCT00989664|26856340|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
7723116|NCT00989664|26856340|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
7723117|NCT00989664|26856340|P1|Dosimetric and Therapeutic Treatment|Death|1
7723118|NCT00989664|26856340|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
7723119|NCT00989664|26856340|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
7723120|NCT00989664|26856340|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
7723121|NCT00989573|26856426|P3|Overall Study|Withdrawal by Subject|3
7723122|NCT00989573|26856427|P2|Overall Study|Withdrawal by Subject|7
7723123|NCT00989573|26856428|P1|Overall Study|Withdrawal by Subject|4
7723124|NCT00989573|26856426|P3|Overall Study|Protocol Violation|1
7723125|NCT00989573|26856427|P2|Overall Study|Protocol Violation|1
7723126|NCT00989573|26856428|P1|Overall Study|Protocol Violation|1
7723127|NCT00989573|26856426|P3|Overall Study|Physician Decision|0
7723128|NCT00989573|26856427|P2|Overall Study|Physician Decision|2
7723129|NCT00989573|26856428|P1|Overall Study|Physician Decision|0
7723130|NCT00989573|26856426|P3|Overall Study|Adverse Event|4
7723131|NCT00989573|26856427|P2|Overall Study|Adverse Event|12
7723132|NCT00989573|26856428|P1|Overall Study|Adverse Event|8
7723133|NCT00989287|26856447|P2|Overall Study|Lost to Follow-up|1
7723134|NCT00989287|26856448|P1|Overall Study|Lost to Follow-up|0
7723135|NCT00989287|26856447|P2|Overall Study|Adverse Event|0
7723136|NCT00989287|26856448|P1|Overall Study|Adverse Event|1
7723137|NCT00989261|26856550|P2|Overall Study|Lost to Follow-up|0
7723138|NCT00989261|26856551|P1|Overall Study|Lost to Follow-up|3
7723139|NCT00989261|26856550|P2|Overall Study|Withdrawal by Subject|1
7723140|NCT00989261|26856551|P1|Overall Study|Withdrawal by Subject|0
7723141|NCT00989261|26856550|P2|Overall Study|Still in follow up|21
7723142|NCT00989261|26856551|P1|Overall Study|Still in follow up|12
7723143|NCT00989235|26856581|P2|Overall Study|Lost to Follow-up|1
7723144|NCT00989235|26856582|P1|Overall Study|Lost to Follow-up|0
7723145|NCT00989235|26856581|P2|Overall Study|Randomized by Mistake|2
7723146|NCT00989235|26856582|P1|Overall Study|Randomized by Mistake|0
7723147|NCT00989235|26856581|P2|Overall Study|Desire to Become Pregnant|0
7723148|NCT00989235|26856582|P1|Overall Study|Desire to Become Pregnant|1
7723149|NCT00989235|26856581|P2|Overall Study|Withdrawal of Consent|1
7723150|NCT00989235|26856582|P1|Overall Study|Withdrawal of Consent|1
7723151|NCT00989235|26856581|P2|Overall Study|Lack of Efficacy|0
7723152|NCT00989235|26856582|P1|Overall Study|Lack of Efficacy|1
7723153|NCT00989235|26856581|P2|Overall Study|Adverse Event|1
7723154|NCT00989235|26856582|P1|Overall Study|Adverse Event|0
7723155|NCT00989235|26856581|P2|Overall Study|Death|1
7723156|NCT00989235|26856582|P1|Overall Study|Death|0
7723157|NCT00989196|26856627|P2|Treatment Period|Lost to Follow-up|0
7723158|NCT00989196|26856628|P1|Treatment Period|Lost to Follow-up|1
7723159|NCT00989092|26856666|P2|Overall Study|Did not receive study drug|0
7723160|NCT00989092|26856667|P1|Overall Study|Did not receive study drug|2
7723161|NCT00989092|26856666|P2|Overall Study|Erythropoietin therapy initiated|0
7723162|NCT00989092|26856667|P1|Overall Study|Erythropoietin therapy initiated|2
7723163|NCT00989092|26856666|P2|Overall Study|Protocol deviation|0
7723164|NCT00989092|26856667|P1|Overall Study|Protocol deviation|2
7723165|NCT00989092|26856666|P2|Overall Study|Other|1
7723166|NCT00989092|26856667|P1|Overall Study|Other|3
7723167|NCT00989092|26856666|P2|Overall Study|Lost to Follow-up|2
7723168|NCT00989092|26856667|P1|Overall Study|Lost to Follow-up|6
7723169|NCT00989092|26856666|P2|Overall Study|Ineligibility determined|3
7723170|NCT00989092|26856667|P1|Overall Study|Ineligibility determined|3
7723171|NCT00989092|26856666|P2|Overall Study|Death|2
7723172|NCT00989092|26856667|P1|Overall Study|Death|14
7723173|NCT00989092|26856666|P2|Overall Study|Withdrawal by Subject|9
7723174|NCT00989092|26856667|P1|Overall Study|Withdrawal by Subject|17
7723175|NCT00989092|26856666|P2|Overall Study|Chemotherapy initiated|4
7723176|NCT00989092|26856667|P1|Overall Study|Chemotherapy initiated|12
7723177|NCT00989092|26856666|P2|Overall Study|Adverse Event|1
7723178|NCT00989092|26856667|P1|Overall Study|Adverse Event|20
7723179|NCT00989092|26856666|P2|Overall Study|Physician Decision|6
7723180|NCT00989092|26856667|P1|Overall Study|Physician Decision|9
7723181|NCT00988884|26856719|P2|Overall Study|Withdrawal by Subject|18
7723182|NCT00988884|26856720|P1|Overall Study|Withdrawal by Subject|15
7723183|NCT00988884|26856719|P2|Overall Study|Protocol Violation|1
7723184|NCT00988884|26856720|P1|Overall Study|Protocol Violation|0
7723185|NCT00988884|26856719|P2|Overall Study|Lost to Follow-up|16
7723186|NCT00988884|26856720|P1|Overall Study|Lost to Follow-up|20
7723187|NCT00988884|26856719|P2|Overall Study|Adverse Event|1
7723188|NCT00988884|26856720|P1|Overall Study|Adverse Event|0
7723189|NCT00988858|26856742|P1|Overall Study|Sponsor Decision|1
7723190|NCT00988858|26856742|P1|Overall Study|Physician Decision|1
7723191|NCT00988858|26856742|P1|Overall Study|Death|1
7723192|NCT00988858|26856742|P1|Overall Study|Adverse Event|7
7723193|NCT00988637|26856791|P2|Overall Study|non-compliance with study drug|1
7723194|NCT00988637|26856792|P1|Overall Study|non-compliance with study drug|0
7723195|NCT00988637|26856791|P2|Overall Study|Withdrawal by Subject|1
7723196|NCT00988637|26856792|P1|Overall Study|Withdrawal by Subject|1
7723197|NCT00988637|26856791|P2|Overall Study|Lost to Follow-up|1
7723198|NCT00988637|26856792|P1|Overall Study|Lost to Follow-up|2
7723199|NCT00988598|26856824|P2|Overall Study|Withdrawal by Subject|0
7723200|NCT00988598|26856825|P1|Overall Study|Withdrawal by Subject|2
7723201|NCT00988559|26856853|P4|Overall Study|Lost to Follow-up|0
7723202|NCT00988559|26856854|P3|Overall Study|Lost to Follow-up|1
7723203|NCT00988559|26856855|P2|Overall Study|Lost to Follow-up|0
7723204|NCT00988559|26856856|P1|Overall Study|Lost to Follow-up|0
7723205|NCT00988559|26856853|P4|Overall Study|Pregnancy|0
7723206|NCT00988559|26856854|P3|Overall Study|Pregnancy|1
7723207|NCT00988559|26856855|P2|Overall Study|Pregnancy|1
7723208|NCT00988559|26856856|P1|Overall Study|Pregnancy|0
7723209|NCT00988559|26856853|P4|Overall Study|Withdrawal by Subject|1
7723210|NCT00988559|26856854|P3|Overall Study|Withdrawal by Subject|0
7723211|NCT00988559|26856855|P2|Overall Study|Withdrawal by Subject|1
7723212|NCT00988559|26856856|P1|Overall Study|Withdrawal by Subject|1
7723213|NCT00988533|26856870|P1|Overall Study|Lost to Follow-up|3
7723214|NCT00988442|26856884|P2|Overall Study|Early Study Closure|25
7723215|NCT00988442|26856885|P1|Overall Study|Early Study Closure|29
7723216|NCT00988442|26856884|P2|Overall Study|Lost to Follow-up|1
7723217|NCT00988442|26856885|P1|Overall Study|Lost to Follow-up|0
7723218|NCT00988442|26856884|P2|Overall Study|Death|2
7723219|NCT00988442|26856885|P1|Overall Study|Death|1
7723220|NCT00988429|26856948|P3|Overall Study|other reasons|1
7723221|NCT00988429|26856949|P2|Overall Study|other reasons|8
7723222|NCT00988429|26856950|P1|Overall Study|other reasons|8
7723223|NCT00988429|26856948|P3|Overall Study|Administrative Reasons|1
7723224|NCT00988429|26856949|P2|Overall Study|Administrative Reasons|2
7723225|NCT00988429|26856950|P1|Overall Study|Administrative Reasons|1
7723226|NCT00988429|26856948|P3|Overall Study|Withdrawal by Subject|12
7723227|NCT00988429|26856949|P2|Overall Study|Withdrawal by Subject|7
7723228|NCT00988429|26856950|P1|Overall Study|Withdrawal by Subject|7
7723229|NCT00988429|26856948|P3|Overall Study|Protocol Violation|3
7723230|NCT00988429|26856949|P2|Overall Study|Protocol Violation|3
7723231|NCT00988429|26856950|P1|Overall Study|Protocol Violation|4
7723232|NCT00988429|26856948|P3|Overall Study|Pregnancy|0
7723233|NCT00988429|26856949|P2|Overall Study|Pregnancy|1
7723234|NCT00988429|26856950|P1|Overall Study|Pregnancy|2
7723235|NCT00988429|26856948|P3|Overall Study|Physician Decision|3
7723236|NCT00988429|26856949|P2|Overall Study|Physician Decision|0
7723237|NCT00988429|26856950|P1|Overall Study|Physician Decision|1
7723238|NCT00988429|26856948|P3|Overall Study|Non-Compliance with Study Drug|3
7723239|NCT00988429|26856949|P2|Overall Study|Non-Compliance with Study Drug|1
7723240|NCT00988429|26856950|P1|Overall Study|Non-Compliance with Study Drug|5
7723241|NCT00988429|26856948|P3|Overall Study|Lack of Efficacy|1
7723242|NCT00988429|26856949|P2|Overall Study|Lack of Efficacy|0
7723243|NCT00988429|26856950|P1|Overall Study|Lack of Efficacy|0
7723244|NCT00988429|26856948|P3|Overall Study|Adverse Event|45
7723245|NCT00988429|26856949|P2|Overall Study|Adverse Event|21
7723246|NCT00988429|26856950|P1|Overall Study|Adverse Event|9
7723247|NCT00988351|26856963|P2|Overall Study|not using CPAP|3
7723248|NCT00988351|26856964|P1|Overall Study|not using CPAP|5
7723249|NCT00988351|26856963|P2|Overall Study|Lost to Follow-up|9
7723250|NCT00988351|26856964|P1|Overall Study|Lost to Follow-up|6
7723251|NCT00988351|26856963|P2|Overall Study|Withdrawal by Subject|0
7723252|NCT00988351|26856964|P1|Overall Study|Withdrawal by Subject|8
7723253|NCT00988247|26857041|P2|Overall Study|Other|0
7723254|NCT00988247|26857042|P1|Overall Study|Other|3
7723255|NCT00988247|26857041|P2|Overall Study|Sponsor requested withdrawal|1
7723256|NCT00988247|26857042|P1|Overall Study|Sponsor requested withdrawal|3
7723257|NCT00988247|26857041|P2|Overall Study|Protocol Violation|5
7723258|NCT00988247|26857042|P1|Overall Study|Protocol Violation|4
7723259|NCT00988247|26857041|P2|Overall Study|Lost to Follow-up|2
7723260|NCT00988247|26857042|P1|Overall Study|Lost to Follow-up|11
7723261|NCT00988247|26857041|P2|Overall Study|Pregnancy|2
7723262|NCT00988247|26857042|P1|Overall Study|Pregnancy|1
7723263|NCT00988247|26857041|P2|Overall Study|Withdrawal by Subject|13
7723264|NCT00988247|26857042|P1|Overall Study|Withdrawal by Subject|44
7723265|NCT00988247|26857041|P2|Overall Study|Adverse Event|3
7723266|NCT00988247|26857042|P1|Overall Study|Adverse Event|17
7723267|NCT00988221|26857061|P4|Part III|Refused Treatment|0
7723268|NCT00988221|26857062|P3|Part III|Refused Treatment|1
7723269|NCT00988221|26857063|P2|Part III|Refused Treatment|0
7723270|NCT00988221|26857064|P1|Part III|Refused Treatment|0
7723271|NCT00988221|26857061|P4|Part III|Insufficient Therapeutic Response|0
7723272|NCT00988221|26857062|P3|Part III|Insufficient Therapeutic Response|1
7723273|NCT00988221|26857063|P2|Part III|Insufficient Therapeutic Response|1
7723274|NCT00988221|26857064|P1|Part III|Insufficient Therapeutic Response|0
7723275|NCT00988221|26857061|P4|Part III|Adverse Event|0
7723276|NCT00988221|26857062|P3|Part III|Adverse Event|1
7723277|NCT00988221|26857063|P2|Part III|Adverse Event|0
7723278|NCT00988221|26857064|P1|Part III|Adverse Event|1
7723279|NCT00988221|26857061|P4|Part II|Reason not Specified|0
7723280|NCT00988221|26857062|P3|Part II|Reason not Specified|1
7723281|NCT00988221|26857063|P2|Part II|Reason not Specified|0
7723282|NCT00988221|26857064|P1|Part II|Reason not Specified|0
7723283|NCT00988221|26857061|P4|Part II|Withdrawal by Subject|2
7723284|NCT00988221|26857062|P3|Part II|Withdrawal by Subject|2
7723285|NCT00988221|26857063|P2|Part II|Withdrawal by Subject|0
7723286|NCT00988221|26857064|P1|Part II|Withdrawal by Subject|0
7723287|NCT00988221|26857061|P4|Part II|Adverse Event|1
7723288|NCT00988221|26857062|P3|Part II|Adverse Event|0
7723289|NCT00988221|26857063|P2|Part II|Adverse Event|0
7723290|NCT00988221|26857064|P1|Part II|Adverse Event|1
7723291|NCT00988221|26857061|P4|Part I|Lost to Follow-up|0
7723292|NCT00988221|26857062|P3|Part I|Lost to Follow-up|0
7723293|NCT00988221|26857063|P2|Part I|Lost to Follow-up|1
7723294|NCT00988221|26857064|P1|Part I|Lost to Follow-up|0
7723295|NCT00988221|26857061|P4|Part I|Refused Treatment|0
7723296|NCT00988221|26857062|P3|Part I|Refused Treatment|1
7723297|NCT00988221|26857063|P2|Part I|Refused Treatment|2
7723298|NCT00988221|26857064|P1|Part I|Refused Treatment|0
7723299|NCT00988221|26857061|P4|Part I|Insufficient Therapeutic Response|0
7723300|NCT00988221|26857062|P3|Part I|Insufficient Therapeutic Response|5
7723301|NCT00988221|26857063|P2|Part I|Insufficient Therapeutic Response|6
7723302|NCT00988221|26857064|P1|Part I|Insufficient Therapeutic Response|4
7723303|NCT00988221|26857061|P4|Part I|Adverse Event|0
7723304|NCT00988221|26857062|P3|Part I|Adverse Event|2
7723305|NCT00988221|26857063|P2|Part I|Adverse Event|1
7723306|NCT00988221|26857064|P1|Part I|Adverse Event|0
7723307|NCT00988208|26857237|P2|Overall Study|Other|3
7723308|NCT00988208|26857238|P1|Overall Study|Other|8
7723309|NCT00988208|26857237|P2|Overall Study|Subject Decision/Investigator Discretion|32
7723310|NCT00988208|26857238|P1|Overall Study|Subject Decision/Investigator Discretion|32
7723311|NCT00988208|26857237|P2|Overall Study|Clinical Deterioration|14
7723312|NCT00988208|26857238|P1|Overall Study|Clinical Deterioration|7
7723313|NCT00988208|26857237|P2|Overall Study|Biochemical Progression|7
7723314|NCT00988208|26857238|P1|Overall Study|Biochemical Progression|21
7723315|NCT00988208|26857237|P2|Overall Study|Clinical Progression|16
7723316|NCT00988208|26857238|P1|Overall Study|Clinical Progression|17
7723317|NCT00988208|26857237|P2|Overall Study|Sponsor Decision|78
7723318|NCT00988208|26857238|P1|Overall Study|Sponsor Decision|102
7723319|NCT00988208|26857237|P2|Overall Study|Protocol Violation|2
7723320|NCT00988208|26857238|P1|Overall Study|Protocol Violation|9
7723321|NCT00988208|26857237|P2|Overall Study|Lost to Follow-up|3
7723322|NCT00988208|26857238|P1|Overall Study|Lost to Follow-up|2
7723323|NCT00988208|26857237|P2|Overall Study|Death|15
7723324|NCT00988208|26857238|P1|Overall Study|Death|9
7723325|NCT00988208|26857237|P2|Overall Study|Withdrawal by Subject|57
7723326|NCT00988208|26857238|P1|Overall Study|Withdrawal by Subject|50
7723327|NCT00988208|26857237|P2|Overall Study|Disease Progression|89
7723328|NCT00988208|26857238|P1|Overall Study|Disease Progression|103
7723329|NCT00988208|26857237|P2|Overall Study|Adverse Event|122
7723330|NCT00988208|26857238|P1|Overall Study|Adverse Event|71
7723331|NCT00988169|26857256|P1|Overall Study|Withdrawal by Subject|1
7723332|NCT00988117|26857308|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
7723333|NCT00988117|26857308|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
7723334|NCT00988091|26857317|P2|Open-label Period|Other|3
7723335|NCT00988091|26857318|P1|Open-label Period|Other|2
7723336|NCT00988091|26857317|P2|Open-label Period|Lost to Follow-up|5
7723337|NCT00988091|26857318|P1|Open-label Period|Lost to Follow-up|3
7723338|NCT00988091|26857317|P2|Open-label Period|Withdrawal by Subject|16
7723339|NCT00988091|26857318|P1|Open-label Period|Withdrawal by Subject|10
7723340|NCT00988091|26857317|P2|Open-label Period|Protocol Violation|1
7723341|NCT00988091|26857318|P1|Open-label Period|Protocol Violation|1
7723342|NCT00988091|26857317|P2|Open-label Period|Use of exclusionary medication|1
7723343|NCT00988091|26857318|P1|Open-label Period|Use of exclusionary medication|1
7723344|NCT00988091|26857317|P2|Open-label Period|Adverse Event|7
7723345|NCT00988091|26857318|P1|Open-label Period|Adverse Event|4
7723346|NCT00988091|26857317|P2|Double-blind Period|Use of exclusionary medication|3
7723347|NCT00988091|26857318|P1|Double-blind Period|Use of exclusionary medication|2
7723348|NCT00988091|26857317|P2|Double-blind Period|Adverse Event|9
7723349|NCT00988091|26857318|P1|Double-blind Period|Adverse Event|6
7723350|NCT00988091|26857317|P2|Double-blind Period|Other|8
7723351|NCT00988091|26857318|P1|Double-blind Period|Other|8
7723352|NCT00988091|26857317|P2|Double-blind Period|Lost to Follow-up|14
7723353|NCT00988091|26857318|P1|Double-blind Period|Lost to Follow-up|12
7723354|NCT00988091|26857317|P2|Double-blind Period|Withdrawal by Subject|13
7723355|NCT00988091|26857318|P1|Double-blind Period|Withdrawal by Subject|15
7723356|NCT00988065|26857340|P3|Overall Study|Noncompliance with protocol|9
7723357|NCT00988065|26857341|P2|Overall Study|Noncompliance with protocol|6
7723358|NCT00988065|26857342|P1|Overall Study|Noncompliance with protocol|5
7723359|NCT00988065|26857340|P3|Overall Study|Subject withdrew consent|2
7723360|NCT00988065|26857341|P2|Overall Study|Subject withdrew consent|5
7723361|NCT00988065|26857342|P1|Overall Study|Subject withdrew consent|3
7723362|NCT00988065|26857340|P3|Overall Study|Lost to Follow-up|2
7723363|NCT00988065|26857341|P2|Overall Study|Lost to Follow-up|2
7723364|NCT00988065|26857342|P1|Overall Study|Lost to Follow-up|1
7723365|NCT00988065|26857340|P3|Overall Study|Adverse Event|2
7723366|NCT00988065|26857341|P2|Overall Study|Adverse Event|10
7723367|NCT00988065|26857342|P1|Overall Study|Adverse Event|4
7723368|NCT00988052|26857364|P2|Overall Study|Study terminated by sponsor|236
7723369|NCT00988052|26857365|P1|Overall Study|Study terminated by sponsor|240
7723370|NCT00988052|26857364|P2|Overall Study|Withdrawal by Subject|91
7723371|NCT00988052|26857365|P1|Overall Study|Withdrawal by Subject|90
7723372|NCT00988052|26857364|P2|Overall Study|Adverse Event|28
7723373|NCT00988052|26857365|P1|Overall Study|Adverse Event|35
7723374|NCT00988052|26857364|P2|Overall Study|Physician Decision|28
7723375|NCT00988052|26857365|P1|Overall Study|Physician Decision|27
7723376|NCT00988052|26857364|P2|Overall Study|Lost to Follow-up|11
7723377|NCT00988052|26857365|P1|Overall Study|Lost to Follow-up|6
7723378|NCT00988052|26857364|P2|Overall Study|Lack of Efficacy|7
7723379|NCT00988052|26857365|P1|Overall Study|Lack of Efficacy|8
7723380|NCT00988052|26857364|P2|Overall Study|Pregnancy|6
7723381|NCT00988052|26857365|P1|Overall Study|Pregnancy|6
7723382|NCT00988052|26857364|P2|Overall Study|Protocol Violation|5
7723383|NCT00988052|26857365|P1|Overall Study|Protocol Violation|6
7723384|NCT00988052|26857364|P2|Overall Study|Death|3
7723385|NCT00988052|26857365|P1|Overall Study|Death|1
7723386|NCT00988052|26857364|P2|Overall Study|Teva requested subject withdrawal|1
7723387|NCT00988052|26857365|P1|Overall Study|Teva requested subject withdrawal|3
7723388|NCT00988052|26857364|P2|Overall Study|Missing|0
7723389|NCT00988052|26857365|P1|Overall Study|Missing|1
7723390|NCT00987935|26857434|P9|Overall Study|Reason other than those specified above|1
7723391|NCT00987935|26857435|P8|Overall Study|Reason other than those specified above|0
7723392|NCT00987935|26857436|P7|Overall Study|Reason other than those specified above|0
7723393|NCT00987935|26857437|P6|Overall Study|Reason other than those specified above|0
7723394|NCT00987935|26857438|P5|Overall Study|Reason other than those specified above|0
7723395|NCT00987935|26857439|P4|Overall Study|Reason other than those specified above|0
7723396|NCT00987935|26857440|P3|Overall Study|Reason other than those specified above|0
7723397|NCT00987935|26857441|P2|Overall Study|Reason other than those specified above|0
7723398|NCT00987935|26857442|P1|Overall Study|Reason other than those specified above|0
7723399|NCT00987935|26857434|P9|Overall Study|Refused to continue taking trial med.|2
7723400|NCT00987935|26857435|P8|Overall Study|Refused to continue taking trial med.|4
7723401|NCT00987935|26857436|P7|Overall Study|Refused to continue taking trial med.|4
7723402|NCT00987935|26857437|P6|Overall Study|Refused to continue taking trial med.|0
7723403|NCT00987935|26857438|P5|Overall Study|Refused to continue taking trial med.|1
7723404|NCT00987935|26857439|P4|Overall Study|Refused to continue taking trial med.|0
7723405|NCT00987935|26857440|P3|Overall Study|Refused to continue taking trial med.|0
7723406|NCT00987935|26857441|P2|Overall Study|Refused to continue taking trial med.|0
7723407|NCT00987935|26857442|P1|Overall Study|Refused to continue taking trial med.|1
7723408|NCT00987935|26857434|P9|Overall Study|Adverse Event|6
7723409|NCT00987935|26857435|P8|Overall Study|Adverse Event|10
7723410|NCT00987935|26857436|P7|Overall Study|Adverse Event|2
7723411|NCT00987935|26857437|P6|Overall Study|Adverse Event|0
7723412|NCT00987935|26857438|P5|Overall Study|Adverse Event|1
7723413|NCT00987935|26857439|P4|Overall Study|Adverse Event|1
7723414|NCT00987935|26857440|P3|Overall Study|Adverse Event|0
7723415|NCT00987935|26857441|P2|Overall Study|Adverse Event|1
7723416|NCT00987935|26857442|P1|Overall Study|Adverse Event|0
7723417|NCT00987935|26857434|P9|Overall Study|Progressive disease|23
7723418|NCT00987935|26857435|P8|Overall Study|Progressive disease|48
7723419|NCT00987935|26857436|P7|Overall Study|Progressive disease|9
7723420|NCT00987935|26857437|P6|Overall Study|Progressive disease|3
7723421|NCT00987935|26857438|P5|Overall Study|Progressive disease|5
7723422|NCT00987935|26857439|P4|Overall Study|Progressive disease|2
7723423|NCT00987935|26857440|P3|Overall Study|Progressive disease|3
7723424|NCT00987935|26857441|P2|Overall Study|Progressive disease|2
7723425|NCT00987935|26857442|P1|Overall Study|Progressive disease|3
7723426|NCT00987831|26857498|P3|Overall Study|Lost to Follow-up|0
7723427|NCT00987831|26857499|P2|Overall Study|Lost to Follow-up|3
7723428|NCT00987831|26857500|P1|Overall Study|Lost to Follow-up|0
7723429|NCT00987831|26857498|P3|Overall Study|Never flared in 12 months|0
7723430|NCT00987831|26857499|P2|Overall Study|Never flared in 12 months|0
7723431|NCT00987831|26857500|P1|Overall Study|Never flared in 12 months|1
7723432|NCT00987623|26857522|P2|Overall Study|Influenza|1
7723433|NCT00987623|26857523|P1|Overall Study|Influenza|0
7723434|NCT00987623|26857522|P2|Overall Study|Biomicroscopy|1
7723435|NCT00987623|26857523|P1|Overall Study|Biomicroscopy|0
7723436|NCT00987623|26857522|P2|Overall Study|Discomfort|0
7723437|NCT00987623|26857523|P1|Overall Study|Discomfort|1
7723438|NCT00987623|26857522|P2|Overall Study|Time/job conflict|0
7723439|NCT00987623|26857523|P1|Overall Study|Time/job conflict|2
7723440|NCT00987623|26857522|P2|Overall Study|Lost to Follow-up|1
7723441|NCT00987623|26857523|P1|Overall Study|Lost to Follow-up|2
7723442|NCT00987467|26857552|P1|Overall Study|Lost to Follow-up|2
7723443|NCT00987402|26857576|P2|Overall Study|Insufficient data entry|98
7723444|NCT00987402|26857577|P1|Overall Study|Insufficient data entry|86
7723445|NCT00987389|26857585|P4|Overall Study|Multiple different reasons|1
7723446|NCT00987389|26857586|P3|Overall Study|Multiple different reasons|3
7723447|NCT00987389|26857587|P2|Overall Study|Multiple different reasons|0
7723448|NCT00987389|26857588|P1|Overall Study|Multiple different reasons|1
7723449|NCT00987389|26857585|P4|Overall Study|Withdrawn from Treatment|0
7723450|NCT00987389|26857586|P3|Overall Study|Withdrawn from Treatment|0
7723451|NCT00987389|26857587|P2|Overall Study|Withdrawn from Treatment|1
7723452|NCT00987389|26857588|P1|Overall Study|Withdrawn from Treatment|0
7723453|NCT00987389|26857585|P4|Overall Study|Withdrawal by Subject|1
7723454|NCT00987389|26857586|P3|Overall Study|Withdrawal by Subject|2
7723455|NCT00987389|26857587|P2|Overall Study|Withdrawal by Subject|3
7723456|NCT00987389|26857588|P1|Overall Study|Withdrawal by Subject|4
7723457|NCT00987389|26857585|P4|Overall Study|Lost to Follow-up|1
7723458|NCT00987389|26857586|P3|Overall Study|Lost to Follow-up|3
7723459|NCT00987389|26857587|P2|Overall Study|Lost to Follow-up|1
7723460|NCT00987389|26857588|P1|Overall Study|Lost to Follow-up|4
7723461|NCT00987389|26857585|P4|Overall Study|Ineligible|0
7723462|NCT00987389|26857586|P3|Overall Study|Ineligible|0
7723463|NCT00987389|26857587|P2|Overall Study|Ineligible|3
7723464|NCT00987389|26857588|P1|Overall Study|Ineligible|0
7723465|NCT00987337|26857607|P3|Overall Study|Participant Relapsed|5
7723466|NCT00987337|26857608|P2|Overall Study|Participant Relapsed|20
7723467|NCT00987337|26857609|P1|Overall Study|Participant Relapsed|18
7723468|NCT00987337|26857607|P3|Overall Study|Protocol Violation|2
7723469|NCT00987337|26857608|P2|Overall Study|Protocol Violation|0
7723470|NCT00987337|26857609|P1|Overall Study|Protocol Violation|1
7723471|NCT00987337|26857607|P3|Overall Study|Other|5
7723472|NCT00987337|26857608|P2|Overall Study|Other|2
7723473|NCT00987337|26857609|P1|Overall Study|Other|0
7723474|NCT00987337|26857607|P3|Overall Study|Withdrawal by Subject|9
7723475|NCT00987337|26857608|P2|Overall Study|Withdrawal by Subject|9
7723476|NCT00987337|26857609|P1|Overall Study|Withdrawal by Subject|6
7723477|NCT00987337|26857607|P3|Overall Study|Lost to Follow-up|2
7723478|NCT00987337|26857608|P2|Overall Study|Lost to Follow-up|6
7723479|NCT00987337|26857609|P1|Overall Study|Lost to Follow-up|10
7723480|NCT00987337|26857607|P3|Overall Study|Virologic Breakthrough|8
7723481|NCT00987337|26857608|P2|Overall Study|Virologic Breakthrough|2
7723482|NCT00987337|26857609|P1|Overall Study|Virologic Breakthrough|2
7723483|NCT00987337|26857607|P3|Overall Study|Insufficient Virologic Response|12
7723484|NCT00987337|26857608|P2|Overall Study|Insufficient Virologic Response|7
7723485|NCT00987337|26857609|P1|Overall Study|Insufficient Virologic Response|10
7723486|NCT00987337|26857607|P3|Overall Study|Adverse Event|8
7723487|NCT00987337|26857608|P2|Overall Study|Adverse Event|9
7723488|NCT00987337|26857609|P1|Overall Study|Adverse Event|10
7723489|NCT00986986|26857664|P2|Overall Study|Lost to Follow-up|1
7723490|NCT00986986|26857665|P1|Overall Study|Lost to Follow-up|0
7723491|NCT00986973|26857675|P1|Overall Study|Withdrawn by study team|1
7723492|NCT00986921|26857692|P2|Overall Study|Physician Decision|0
7723493|NCT00986921|26857693|P1|Overall Study|Physician Decision|1
7723494|NCT00986830|26857726|P1|Overall Study|Unable to access sinus with device|5
7723495|NCT00986830|26857726|P1|Overall Study|Lack of Efficacy|1
7723496|NCT00986830|26857726|P1|Overall Study|Lost to Follow-up|1
7723497|NCT00986830|26857726|P1|Overall Study|Death|1
7723498|NCT00986674|26857741|P3|Overall Study|unknown/not specify|9
7723499|NCT00986674|26857742|P2|Overall Study|unknown/not specify|7
7723500|NCT00986674|26857743|P1|Overall Study|unknown/not specify|0
7723501|NCT00986674|26857741|P3|Overall Study|not start protocol therapy|1
7723502|NCT00986674|26857742|P2|Overall Study|not start protocol therapy|3
7723503|NCT00986674|26857743|P1|Overall Study|not start protocol therapy|4
7723504|NCT00986674|26857741|P3|Overall Study|alternative therapy|1
7723505|NCT00986674|26857742|P2|Overall Study|alternative therapy|0
7723506|NCT00986674|26857743|P1|Overall Study|alternative therapy|0
7723507|NCT00986674|26857741|P3|Overall Study|Withdrawal by Subject|1
7723508|NCT00986674|26857742|P2|Overall Study|Withdrawal by Subject|2
7723509|NCT00986674|26857743|P1|Overall Study|Withdrawal by Subject|6
7723510|NCT00986674|26857741|P3|Overall Study|Death|4
7723511|NCT00986674|26857742|P2|Overall Study|Death|0
7723512|NCT00986674|26857743|P1|Overall Study|Death|5
7723513|NCT00986674|26857741|P3|Overall Study|Adverse Event|9
7723514|NCT00986674|26857742|P2|Overall Study|Adverse Event|8
7723515|NCT00986674|26857743|P1|Overall Study|Adverse Event|4
7723516|NCT00986674|26857741|P3|Overall Study|Lack of Efficacy|23
7723517|NCT00986674|26857742|P2|Overall Study|Lack of Efficacy|25
7723518|NCT00986674|26857743|P1|Overall Study|Lack of Efficacy|28
7723519|NCT00986570|26857776|P1|Overall Study|Potential bias for objective assessment|1
7723520|NCT00986570|26857776|P1|Overall Study|Lost to Follow-up|6
7723521|NCT00986479|26857793|P2|Period 1|Administrative reasons|0
7723522|NCT00986479|26857794|P1|Period 1|Administrative reasons|1
7723523|NCT00986479|26857793|P2|Period 1|Improved mood|0
7723524|NCT00986479|26857794|P1|Period 1|Improved mood|1
7723525|NCT00986440|26857840|P2|Overall Study|Screen failure (not dosed)|2
7723526|NCT00986440|26857841|P1|Overall Study|Screen failure (not dosed)|4
7723527|NCT00986440|26857840|P2|Overall Study|Withdrawal by Subject|2
7723528|NCT00986440|26857841|P1|Overall Study|Withdrawal by Subject|1
7723529|NCT00986440|26857840|P2|Overall Study|Serious adverse event or adverse event|2
7723530|NCT00986440|26857841|P1|Overall Study|Serious adverse event or adverse event|9
7723531|NCT00986440|26857840|P2|Overall Study|Progressive disease|37
7723532|NCT00986440|26857841|P1|Overall Study|Progressive disease|27
7723533|NCT00986427|26857859|P2|Overall Study|Withdrawal by Subject|0
7723534|NCT00986427|26857860|P1|Overall Study|Withdrawal by Subject|1
7723535|NCT00986427|26857859|P2|Overall Study|Lack of Efficacy|0
7723536|NCT00986427|26857860|P1|Overall Study|Lack of Efficacy|1
7723537|NCT00986427|26857859|P2|Overall Study|Lost to Follow-up|0
7723538|NCT00986427|26857860|P1|Overall Study|Lost to Follow-up|2
7723539|NCT00986362|26857888|P2|Overall Study|Lost to Follow-up|1
7723540|NCT00986362|26857889|P1|Overall Study|Lost to Follow-up|0
7723541|NCT00986362|26857888|P2|Overall Study|Death|0
7723542|NCT00986362|26857889|P1|Overall Study|Death|2
7723543|NCT00986349|26857895|P1|Overall Study|device migration|1
7723544|NCT00986349|26857895|P1|Overall Study|Physician Decision|1
7723545|NCT00986349|26857895|P1|Overall Study|Adverse Event|2
7723546|NCT00986349|26857895|P1|Overall Study|Unsuccessful implant procedure|3
7723547|NCT00986258|26857919|P1|Maintenance Period|Withdrawal by Subject|2
7723548|NCT00986258|26857919|P1|Maintenance Period|Lack of Efficacy|2
7723549|NCT00986258|26857919|P1|Maintenance Period|Adverse Event|5
7723550|NCT00986258|26857919|P1|Titration and Optimal Dose Period|Other|1
7723551|NCT00986258|26857919|P1|Titration and Optimal Dose Period|Non-Compliance|1
7723552|NCT00986258|26857919|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
7723553|NCT00986258|26857919|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
7723554|NCT00986258|26857919|P1|Titration and Optimal Dose Period|Adverse Event|15
7723555|NCT00986258|26857919|P1|Observation Period|Not eligible to be dosed|11
7723556|NCT00986245|26857947|P2|Second Intervention|Protocol Violation|1
7723557|NCT00986245|26857948|P1|Second Intervention|Protocol Violation|0
7723558|NCT00986245|26857947|P2|Second Intervention|Lost to Follow-up|0
7723559|NCT00986245|26857948|P1|Second Intervention|Lost to Follow-up|1
7723560|NCT00986245|26857947|P2|Second Intervention|Poor compliance|0
7723561|NCT00986245|26857948|P1|Second Intervention|Poor compliance|1
7723562|NCT00986245|26857947|P2|First Intervention|Out of indication|0
7723563|NCT00986245|26857948|P1|First Intervention|Out of indication|1
7723564|NCT00986245|26857947|P2|First Intervention|Protocol Violation|1
7723565|NCT00986245|26857948|P1|First Intervention|Protocol Violation|0
7723566|NCT00986245|26857947|P2|First Intervention|Withdrawal by Subject|1
7723567|NCT00986245|26857948|P1|First Intervention|Withdrawal by Subject|0
7723568|NCT00986245|26857947|P2|First Intervention|Lack of Efficacy|2
7723569|NCT00986245|26857948|P1|First Intervention|Lack of Efficacy|1
7723570|NCT00986245|26857947|P2|First Intervention|Poor compliance|4
7723571|NCT00986245|26857948|P1|First Intervention|Poor compliance|8
7723572|NCT00986232|26857985|P4|Overall Study|Incomplete safety follow-up|2
7723573|NCT00986232|26857986|P3|Overall Study|Incomplete safety follow-up|2
7723574|NCT00986232|26857987|P2|Overall Study|Incomplete safety follow-up|7
7723575|NCT00986232|26857988|P1|Overall Study|Incomplete safety follow-up|3
7723576|NCT00986232|26857985|P4|Overall Study|Missed one or more bleeds|7
7723577|NCT00986232|26857986|P3|Overall Study|Missed one or more bleeds|6
7723578|NCT00986232|26857987|P2|Overall Study|Missed one or more bleeds|10
7723579|NCT00986232|26857988|P1|Overall Study|Missed one or more bleeds|13
7723580|NCT00986232|26857985|P4|Overall Study|Withdrawal by Subject|3
7723581|NCT00986232|26857986|P3|Overall Study|Withdrawal by Subject|12
7723582|NCT00986232|26857987|P2|Overall Study|Withdrawal by Subject|16
7723583|NCT00986232|26857988|P1|Overall Study|Withdrawal by Subject|13
7723584|NCT00986232|26857985|P4|Overall Study|Protocol Violation|1
7723585|NCT00986232|26857986|P3|Overall Study|Protocol Violation|0
7723586|NCT00986232|26857987|P2|Overall Study|Protocol Violation|3
7723587|NCT00986232|26857988|P1|Overall Study|Protocol Violation|2
7723588|NCT00986232|26857985|P4|Overall Study|Lost to Follow-up|7
7723589|NCT00986232|26857986|P3|Overall Study|Lost to Follow-up|12
7723590|NCT00986232|26857987|P2|Overall Study|Lost to Follow-up|12
7723591|NCT00986232|26857988|P1|Overall Study|Lost to Follow-up|19
7723592|NCT00986232|26857985|P4|Overall Study|Adverse Event|0
7723593|NCT00986232|26857986|P3|Overall Study|Adverse Event|3
7723594|NCT00986232|26857987|P2|Overall Study|Adverse Event|2
7723595|NCT00986232|26857988|P1|Overall Study|Adverse Event|1
7723596|NCT00986180|26858062|P2|Overall Study|Miscellanies|11
7723597|NCT00986180|26858063|P1|Overall Study|Miscellanies|10
7723598|NCT00986180|26858062|P2|Overall Study|Withdrawal by Subject|9
7723599|NCT00986180|26858063|P1|Overall Study|Withdrawal by Subject|1
7723600|NCT00986180|26858062|P2|Overall Study|Protocol Violation|0
7723601|NCT00986180|26858063|P1|Overall Study|Protocol Violation|2
7723602|NCT00986180|26858062|P2|Overall Study|Physician Decision|3
7723603|NCT00986180|26858063|P1|Overall Study|Physician Decision|1
7723604|NCT00986180|26858062|P2|Overall Study|Lost to Follow-up|7
7723605|NCT00986180|26858063|P1|Overall Study|Lost to Follow-up|5
7723606|NCT00986180|26858062|P2|Overall Study|Lack of Efficacy|3
7723607|NCT00986180|26858063|P1|Overall Study|Lack of Efficacy|4
7723608|NCT00986180|26858062|P2|Overall Study|Adverse Event|23
7723609|NCT00986180|26858063|P1|Overall Study|Adverse Event|21
7723610|NCT00986154|26858141|P2|Overall Study|never received study drug|27
7723611|NCT00986154|26858142|P1|Overall Study|never received study drug|25
7723612|NCT00986154|26858141|P2|Overall Study|investigator/subject decide not continue|3
7723613|NCT00986154|26858142|P1|Overall Study|investigator/subject decide not continue|6
7723614|NCT00986154|26858141|P2|Overall Study|Withdrawal by Subject|33
7723615|NCT00986154|26858142|P1|Overall Study|Withdrawal by Subject|32
7723616|NCT00986154|26858141|P2|Overall Study|Lost to Follow-up|4
7723617|NCT00986154|26858142|P1|Overall Study|Lost to Follow-up|7
7723618|NCT00986154|26858141|P2|Overall Study|Death|127
7723619|NCT00986154|26858142|P1|Overall Study|Death|136
7723620|NCT00986102|26858156|P4|Overall Study|Withdrawal by Subject|0
7723621|NCT00986102|26858157|P3|Overall Study|Withdrawal by Subject|0
7723622|NCT00986102|26858158|P2|Overall Study|Withdrawal by Subject|1
7723623|NCT00986102|26858159|P1|Overall Study|Withdrawal by Subject|1
7723624|NCT00986102|26858156|P4|Overall Study|Lost to Follow-up|1
7723625|NCT00986102|26858157|P3|Overall Study|Lost to Follow-up|0
7723626|NCT00986102|26858158|P2|Overall Study|Lost to Follow-up|1
7723627|NCT00986102|26858159|P1|Overall Study|Lost to Follow-up|0
7723628|NCT00985985|26858209|P4|Overall Study|Other Reason|2
7723629|NCT00985985|26858210|P3|Overall Study|Other Reason|4
7723630|NCT00985985|26858211|P2|Overall Study|Other Reason|1
7723631|NCT00985985|26858212|P1|Overall Study|Other Reason|6
7723632|NCT00985985|26858209|P4|Overall Study|Withdrawal by Subject|2
7723633|NCT00985985|26858210|P3|Overall Study|Withdrawal by Subject|2
7723634|NCT00985985|26858211|P2|Overall Study|Withdrawal by Subject|2
7723635|NCT00985985|26858212|P1|Overall Study|Withdrawal by Subject|4
7723636|NCT00985985|26858209|P4|Overall Study|Lack of Efficacy|3
7723637|NCT00985985|26858210|P3|Overall Study|Lack of Efficacy|1
7723638|NCT00985985|26858211|P2|Overall Study|Lack of Efficacy|6
7723639|NCT00985985|26858212|P1|Overall Study|Lack of Efficacy|5
7723640|NCT00985985|26858209|P4|Overall Study|Protocol Violation|1
7723641|NCT00985985|26858210|P3|Overall Study|Protocol Violation|0
7723642|NCT00985985|26858211|P2|Overall Study|Protocol Violation|2
7723643|NCT00985985|26858212|P1|Overall Study|Protocol Violation|1
7723644|NCT00985985|26858209|P4|Overall Study|Lost to Follow-up|3
7723645|NCT00985985|26858210|P3|Overall Study|Lost to Follow-up|2
7723646|NCT00985985|26858211|P2|Overall Study|Lost to Follow-up|11
7723647|NCT00985985|26858212|P1|Overall Study|Lost to Follow-up|4
7723648|NCT00985985|26858209|P4|Overall Study|Adverse Event|2
7723649|NCT00985985|26858210|P3|Overall Study|Adverse Event|2
7723650|NCT00985985|26858211|P2|Overall Study|Adverse Event|2
7723651|NCT00985985|26858212|P1|Overall Study|Adverse Event|4
7723652|NCT00985959|26858253|P3|Overall Study|Other|11
7723653|NCT00985959|26858254|P2|Overall Study|Other|0
7723654|NCT00985959|26858255|P1|Overall Study|Other|0
7723655|NCT00985959|26858253|P3|Overall Study|Complete response observed over 2 cycles|4
7723656|NCT00985959|26858254|P2|Overall Study|Complete response observed over 2 cycles|1
7723657|NCT00985959|26858255|P1|Overall Study|Complete response observed over 2 cycles|0
7723658|NCT00985959|26858253|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
7723659|NCT00985959|26858254|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
7723660|NCT00985959|26858255|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
7723661|NCT00985959|26858253|P3|Overall Study|Unrecovered toxicity|7
7723662|NCT00985959|26858254|P2|Overall Study|Unrecovered toxicity|0
7723663|NCT00985959|26858255|P1|Overall Study|Unrecovered toxicity|0
7723664|NCT00985959|26858253|P3|Overall Study|Progressive disease|8
7723665|NCT00985959|26858254|P2|Overall Study|Progressive disease|2
7723666|NCT00985959|26858255|P1|Overall Study|Progressive disease|1
7723667|NCT00985959|26858253|P3|Overall Study|Withdrawal by Subject|8
7723668|NCT00985959|26858254|P2|Overall Study|Withdrawal by Subject|0
7723669|NCT00985959|26858255|P1|Overall Study|Withdrawal by Subject|0
7723670|NCT00985959|26858253|P3|Overall Study|Adverse Event|19
7723671|NCT00985959|26858254|P2|Overall Study|Adverse Event|0
7723672|NCT00985959|26858255|P1|Overall Study|Adverse Event|0
7723673|NCT00985946|26858278|P1|Overall Study|Withdrawal by Subject|1
7723674|NCT00985946|26858278|P1|Overall Study|Lost to Follow-up|6
7723675|NCT00985790|26858307|P2|Overall Study|Lost to Follow-up|7
7723676|NCT00985790|26858308|P1|Overall Study|Lost to Follow-up|6
7723677|NCT00985790|26858307|P2|Overall Study|Withdrawal by Subject|1
7723678|NCT00985790|26858308|P1|Overall Study|Withdrawal by Subject|1
7723679|NCT00985751|26858349|P5|Overall Study|Adverse Event|1
7723680|NCT00985751|26858350|P4|Overall Study|Adverse Event|0
7723681|NCT00985751|26858351|P3|Overall Study|Adverse Event|0
7723682|NCT00985751|26858352|P2|Overall Study|Adverse Event|0
7723683|NCT00985751|26858353|P1|Overall Study|Adverse Event|0
7723684|NCT00985738|26858416|P2|Overall Study|Study closed prematurely|8
7723685|NCT00985738|26858417|P1|Overall Study|Study closed prematurely|8
7723686|NCT00985725|26858425|P2|Overall Study|Out-of-window visits|1
7723687|NCT00985725|26858426|P1|Overall Study|Out-of-window visits|0
7723688|NCT00985725|26858425|P2|Overall Study|Non-compliance|2
7723689|NCT00985725|26858426|P1|Overall Study|Non-compliance|1
7723690|NCT00985725|26858425|P2|Overall Study|Lack of Efficacy|1
7723691|NCT00985725|26858426|P1|Overall Study|Lack of Efficacy|0
7723692|NCT00985725|26858425|P2|Overall Study|Lost to Follow-up|1
7723693|NCT00985725|26858426|P1|Overall Study|Lost to Follow-up|1
7723694|NCT00985725|26858425|P2|Overall Study|Withdrawal by Subject|4
7723695|NCT00985725|26858426|P1|Overall Study|Withdrawal by Subject|4
7723696|NCT00985725|26858425|P2|Overall Study|Protocol Violation|3
7723697|NCT00985725|26858426|P1|Overall Study|Protocol Violation|1
7723698|NCT00985725|26858425|P2|Overall Study|Adverse Event|1
7723699|NCT00985725|26858426|P1|Overall Study|Adverse Event|4
7723700|NCT00985712|26858462|P2|Overall Study|Sponsor decision|2
7723701|NCT00985712|26858463|P1|Overall Study|Sponsor decision|0
7723702|NCT00985712|26858462|P2|Overall Study|Withdrawal by Subject|1
7723703|NCT00985712|26858463|P1|Overall Study|Withdrawal by Subject|4
7723704|NCT00985712|26858462|P2|Overall Study|Protocol Violation|1
7723705|NCT00985712|26858463|P1|Overall Study|Protocol Violation|0
7723706|NCT00985712|26858462|P2|Overall Study|Lost to Follow-up|2
7723707|NCT00985712|26858463|P1|Overall Study|Lost to Follow-up|2
7723708|NCT00985712|26858462|P2|Overall Study|Adverse Event|1
7723709|NCT00985712|26858463|P1|Overall Study|Adverse Event|0
7723710|NCT00985686|26858481|P4|Overall Study|Lost to Follow-up|2
7723711|NCT00985686|26858482|P3|Overall Study|Lost to Follow-up|0
7723712|NCT00985686|26858483|P2|Overall Study|Lost to Follow-up|1
7723713|NCT00985686|26858484|P1|Overall Study|Lost to Follow-up|1
7723714|NCT00985673|26858498|P6|Overall Study|Other|0
7723715|NCT00985673|26858499|P5|Overall Study|Other|1
7723716|NCT00985673|26858500|P4|Overall Study|Other|0
7723717|NCT00985673|26858501|P3|Overall Study|Other|1
7723718|NCT00985673|26858502|P2|Overall Study|Other|0
7723719|NCT00985673|26858503|P1|Overall Study|Other|1
7723720|NCT00985673|26858498|P6|Overall Study|Withdrawal by Subject|3
7723721|NCT00985673|26858499|P5|Overall Study|Withdrawal by Subject|2
7723722|NCT00985673|26858500|P4|Overall Study|Withdrawal by Subject|2
7723723|NCT00985673|26858501|P3|Overall Study|Withdrawal by Subject|5
7723724|NCT00985673|26858502|P2|Overall Study|Withdrawal by Subject|4
7723725|NCT00985673|26858503|P1|Overall Study|Withdrawal by Subject|0
7723726|NCT00985673|26858498|P6|Overall Study|Lost to Follow-up|3
7723727|NCT00985673|26858499|P5|Overall Study|Lost to Follow-up|5
7723728|NCT00985673|26858500|P4|Overall Study|Lost to Follow-up|10
7723729|NCT00985673|26858501|P3|Overall Study|Lost to Follow-up|6
7723730|NCT00985673|26858502|P2|Overall Study|Lost to Follow-up|7
7723731|NCT00985673|26858503|P1|Overall Study|Lost to Follow-up|6
7723732|NCT00985621|26858758|P4|Overall Study|Randomized but not Treated|1
7723733|NCT00985621|26858759|P3|Overall Study|Randomized but not Treated|2
7723734|NCT00985621|26858760|P2|Overall Study|Randomized but not Treated|0
7723735|NCT00985621|26858761|P1|Overall Study|Randomized but not Treated|1
7723736|NCT00985621|26858758|P4|Overall Study|Other|0
7723737|NCT00985621|26858759|P3|Overall Study|Other|0
7723738|NCT00985621|26858760|P2|Overall Study|Other|0
7723739|NCT00985621|26858761|P1|Overall Study|Other|1
7723740|NCT00985621|26858758|P4|Overall Study|Withdrawal by Subject|12
7723741|NCT00985621|26858759|P3|Overall Study|Withdrawal by Subject|8
7723742|NCT00985621|26858760|P2|Overall Study|Withdrawal by Subject|10
7723743|NCT00985621|26858761|P1|Overall Study|Withdrawal by Subject|8
7723744|NCT00985621|26858758|P4|Overall Study|Protocol Violation|0
7723745|NCT00985621|26858759|P3|Overall Study|Protocol Violation|1
7723746|NCT00985621|26858760|P2|Overall Study|Protocol Violation|1
7723747|NCT00985621|26858761|P1|Overall Study|Protocol Violation|1
7723748|NCT00985621|26858758|P4|Overall Study|Study Terminated by Sponsor|92
7723749|NCT00985621|26858759|P3|Overall Study|Study Terminated by Sponsor|99
7723750|NCT00985621|26858760|P2|Overall Study|Study Terminated by Sponsor|108
7723751|NCT00985621|26858761|P1|Overall Study|Study Terminated by Sponsor|89
7723752|NCT00985621|26858758|P4|Overall Study|Lost to Follow-up|4
7723753|NCT00985621|26858759|P3|Overall Study|Lost to Follow-up|4
7723754|NCT00985621|26858760|P2|Overall Study|Lost to Follow-up|3
7723755|NCT00985621|26858761|P1|Overall Study|Lost to Follow-up|2
7723756|NCT00985621|26858758|P4|Overall Study|Lack of Efficacy|12
7723757|NCT00985621|26858759|P3|Overall Study|Lack of Efficacy|5
7723758|NCT00985621|26858760|P2|Overall Study|Lack of Efficacy|6
7723759|NCT00985621|26858761|P1|Overall Study|Lack of Efficacy|10
7723760|NCT00985621|26858758|P4|Overall Study|Adverse Event|16
7723761|NCT00985621|26858759|P3|Overall Study|Adverse Event|4
7723762|NCT00985621|26858760|P2|Overall Study|Adverse Event|3
7723763|NCT00985621|26858761|P1|Overall Study|Adverse Event|2
7723764|NCT00985504|26858983|P2|Optimization Period|Withdrawal by Subject|8
7723765|NCT00985504|26858984|P1|Optimization Period|Withdrawal by Subject|10
7723766|NCT00985504|26858983|P2|Optimization Period|Protocol Violation|1
7723767|NCT00985504|26858984|P1|Optimization Period|Protocol Violation|3
7723768|NCT00985504|26858983|P2|Optimization Period|Physician Decision|0
7723769|NCT00985504|26858984|P1|Optimization Period|Physician Decision|1
7723770|NCT00985504|26858983|P2|Optimization Period|Lost to Follow-up|1
7723771|NCT00985504|26858984|P1|Optimization Period|Lost to Follow-up|0
7723772|NCT00985504|26858983|P2|Optimization Period|Lack of Efficacy|3
7723773|NCT00985504|26858984|P1|Optimization Period|Lack of Efficacy|5
7723774|NCT00985504|26858983|P2|Optimization Period|Death|1
7723775|NCT00985504|26858984|P1|Optimization Period|Death|0
7723776|NCT00985504|26858983|P2|Optimization Period|Adverse Event|9
7723777|NCT00985504|26858984|P1|Optimization Period|Adverse Event|7
7723778|NCT00985504|26858983|P2|Acute Treatment Period|Withdrawal by Subject|5
7723779|NCT00985504|26858984|P1|Acute Treatment Period|Withdrawal by Subject|9
7723780|NCT00985504|26858983|P2|Acute Treatment Period|Sponsor Decision|1
7723781|NCT00985504|26858984|P1|Acute Treatment Period|Sponsor Decision|0
7723782|NCT00985504|26858983|P2|Acute Treatment Period|Protocol Violation|0
7723783|NCT00985504|26858984|P1|Acute Treatment Period|Protocol Violation|2
7723784|NCT00985504|26858983|P2|Acute Treatment Period|Entry Criteria Not Met|2
7723785|NCT00985504|26858984|P1|Acute Treatment Period|Entry Criteria Not Met|1
7723786|NCT00985504|26858983|P2|Acute Treatment Period|Adverse Event|4
7723787|NCT00985504|26858984|P1|Acute Treatment Period|Adverse Event|3
7723788|NCT00985491|26859010|P1|Overall Study|implant failure|3
7723789|NCT00985491|26859010|P1|Overall Study|Withdrawal by Subject|1
7723790|NCT00985491|26859010|P1|Overall Study|device migration|7
7723791|NCT00985491|26859010|P1|Overall Study|Adverse Event|8
7723792|NCT00985465|26859017|P2|Overall Study|Considered to be part of the other group|1
7723793|NCT00985465|26859018|P1|Overall Study|Considered to be part of the other group|0
7723794|NCT00985465|26859017|P2|Overall Study|Withdrawal by Subject|2
7723795|NCT00985465|26859018|P1|Overall Study|Withdrawal by Subject|1
7723796|NCT00985439|26859045|P4|Overall Study|Adverse Event|0
7723797|NCT00985439|26859046|P3|Overall Study|Adverse Event|1
7723798|NCT00985439|26859047|P2|Overall Study|Adverse Event|0
7723799|NCT00985439|26859048|P1|Overall Study|Adverse Event|0
7723800|NCT00985426|26859060|P2|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
7723801|NCT00985426|26859061|P1|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
7723802|NCT00985426|26859060|P2|Overall Study|Protocol Violation|0
7723803|NCT00985426|26859061|P1|Overall Study|Protocol Violation|2
7723804|NCT00985426|26859060|P2|Overall Study|Death|3
7723805|NCT00985426|26859061|P1|Overall Study|Death|7
7723806|NCT00985426|26859060|P2|Overall Study|Lost to Follow-up|10
7723807|NCT00985426|26859061|P1|Overall Study|Lost to Follow-up|8
7723808|NCT00985426|26859060|P2|Overall Study|Withdrawal by Subject|16
7723809|NCT00985426|26859061|P1|Overall Study|Withdrawal by Subject|12
7723810|NCT00985426|26859060|P2|Overall Study|Subject Non-Compliance|3
7723811|NCT00985426|26859061|P1|Overall Study|Subject Non-Compliance|3
7723812|NCT00985426|26859060|P2|Overall Study|Adverse Event|1
7723813|NCT00985426|26859061|P1|Overall Study|Adverse Event|0
7723814|NCT00985231|26859083|P2|Overall Study|Study related symptoms & complaints|2
7723815|NCT00985231|26859084|P1|Overall Study|Study related symptoms & complaints|0
7723816|NCT00985231|26859083|P2|Overall Study|Lost to Follow-up|1
7723817|NCT00985231|26859084|P1|Overall Study|Lost to Follow-up|0
7723818|NCT00985231|26859083|P2|Overall Study|Withdrawal by Subject|0
7723819|NCT00985231|26859084|P1|Overall Study|Withdrawal by Subject|1
7723820|NCT00985231|26859083|P2|Overall Study|Protocol Violation|0
7723821|NCT00985231|26859084|P1|Overall Study|Protocol Violation|1
7723822|NCT00985231|26859083|P2|Overall Study|ineligible|0
7723823|NCT00985231|26859084|P1|Overall Study|ineligible|1
7723824|NCT00985192|26859092|P1|Overall Study|Determined to be Ineligible During Trial|2
7723825|NCT00985192|26859092|P1|Overall Study|Disease Progression|1
7723826|NCT00985192|26859092|P1|Overall Study|Withdrawal by Subject|1
7723827|NCT00985166|26859104|P3|Overall Study|Other|1
7723828|NCT00985166|26859105|P2|Overall Study|Other|0
7723829|NCT00985166|26859106|P1|Overall Study|Other|1
7723830|NCT00985166|26859104|P3|Overall Study|Test not done|4
7723831|NCT00985166|26859105|P2|Overall Study|Test not done|0
7723832|NCT00985166|26859106|P1|Overall Study|Test not done|2
7723833|NCT00985166|26859104|P3|Overall Study|Withdrawal by Subject|0
7723834|NCT00985166|26859105|P2|Overall Study|Withdrawal by Subject|2
7723835|NCT00985166|26859106|P1|Overall Study|Withdrawal by Subject|3
7723836|NCT00985166|26859104|P3|Overall Study|Lost to Follow-up|2
7723837|NCT00985166|26859105|P2|Overall Study|Lost to Follow-up|2
7723838|NCT00985166|26859106|P1|Overall Study|Lost to Follow-up|3
7723839|NCT00985153|26859126|P4|Overall Study|Incomplete Safety Follow-up|4
7723840|NCT00985153|26859127|P3|Overall Study|Incomplete Safety Follow-up|4
7723841|NCT00985153|26859128|P2|Overall Study|Incomplete Safety Follow-up|5
7723842|NCT00985153|26859129|P1|Overall Study|Incomplete Safety Follow-up|3
7723843|NCT00985153|26859126|P4|Overall Study|Missed One or More Bleeds|10
7723844|NCT00985153|26859127|P3|Overall Study|Missed One or More Bleeds|8
7723845|NCT00985153|26859128|P2|Overall Study|Missed One or More Bleeds|7
7723846|NCT00985153|26859129|P1|Overall Study|Missed One or More Bleeds|7
7723847|NCT00985153|26859126|P4|Overall Study|Withdrawal by Subject|10
7723848|NCT00985153|26859127|P3|Overall Study|Withdrawal by Subject|11
7723849|NCT00985153|26859128|P2|Overall Study|Withdrawal by Subject|11
7723850|NCT00985153|26859129|P1|Overall Study|Withdrawal by Subject|6
7723851|NCT00985153|26859126|P4|Overall Study|Protocol Violation|3
7723852|NCT00985153|26859127|P3|Overall Study|Protocol Violation|4
7723853|NCT00985153|26859128|P2|Overall Study|Protocol Violation|2
7723854|NCT00985153|26859129|P1|Overall Study|Protocol Violation|3
7723855|NCT00985153|26859126|P4|Overall Study|Lost to Follow-up|20
7723856|NCT00985153|26859127|P3|Overall Study|Lost to Follow-up|17
7723857|NCT00985153|26859128|P2|Overall Study|Lost to Follow-up|19
7723858|NCT00985153|26859129|P1|Overall Study|Lost to Follow-up|16
7723859|NCT00985114|26859177|P2|Overall Study|Withdrawal by Subject|2
7723860|NCT00985114|26859178|P1|Overall Study|Withdrawal by Subject|0
7723861|NCT00985114|26859177|P2|Overall Study|Adverse Event|0
7723862|NCT00985114|26859178|P1|Overall Study|Adverse Event|1
7723863|NCT00985088|26859192|P8|Overall Study|Lost to Follow-up|2
7723864|NCT00985088|26859193|P7|Overall Study|Lost to Follow-up|3
7723865|NCT00985088|26859194|P6|Overall Study|Lost to Follow-up|5
7723866|NCT00985088|26859195|P5|Overall Study|Lost to Follow-up|6
7723867|NCT00985088|26859196|P4|Overall Study|Lost to Follow-up|6
7723868|NCT00985088|26859197|P3|Overall Study|Lost to Follow-up|2
7723869|NCT00985088|26859198|P2|Overall Study|Lost to Follow-up|1
7723870|NCT00985088|26859199|P1|Overall Study|Lost to Follow-up|6
7723871|NCT00985088|26859192|P8|Overall Study|Migrated/moved from study area|1
7723872|NCT00985088|26859193|P7|Overall Study|Migrated/moved from study area|0
7723873|NCT00985088|26859194|P6|Overall Study|Migrated/moved from study area|0
7723874|NCT00985088|26859195|P5|Overall Study|Migrated/moved from study area|0
7723875|NCT00985088|26859196|P4|Overall Study|Migrated/moved from study area|0
7723876|NCT00985088|26859197|P3|Overall Study|Migrated/moved from study area|1
7723877|NCT00985088|26859198|P2|Overall Study|Migrated/moved from study area|0
7723878|NCT00985088|26859199|P1|Overall Study|Migrated/moved from study area|0
7723879|NCT00985088|26859192|P8|Overall Study|Withdrawal by Subject|2
7723880|NCT00985088|26859193|P7|Overall Study|Withdrawal by Subject|1
7723881|NCT00985088|26859194|P6|Overall Study|Withdrawal by Subject|2
7723882|NCT00985088|26859195|P5|Overall Study|Withdrawal by Subject|3
7723883|NCT00985088|26859196|P4|Overall Study|Withdrawal by Subject|1
7723884|NCT00985088|26859197|P3|Overall Study|Withdrawal by Subject|0
7723885|NCT00985088|26859198|P2|Overall Study|Withdrawal by Subject|0
7723886|NCT00985088|26859199|P1|Overall Study|Withdrawal by Subject|4
7723887|NCT00985088|26859192|P8|Overall Study|Adverse Event|0
7723888|NCT00985088|26859193|P7|Overall Study|Adverse Event|0
7723889|NCT00985088|26859194|P6|Overall Study|Adverse Event|0
7723890|NCT00985088|26859195|P5|Overall Study|Adverse Event|0
7723891|NCT00985088|26859196|P4|Overall Study|Adverse Event|0
7723892|NCT00985088|26859197|P3|Overall Study|Adverse Event|1
7723893|NCT00985088|26859198|P2|Overall Study|Adverse Event|0
7723894|NCT00985088|26859199|P1|Overall Study|Adverse Event|0
7723895|NCT00985088|26859192|P8|Overall Study|Serious Adverse Event|1
7723896|NCT00985088|26859193|P7|Overall Study|Serious Adverse Event|0
7723897|NCT00985088|26859194|P6|Overall Study|Serious Adverse Event|0
7723898|NCT00985088|26859195|P5|Overall Study|Serious Adverse Event|0
7723899|NCT00985088|26859196|P4|Overall Study|Serious Adverse Event|0
7723900|NCT00985088|26859197|P3|Overall Study|Serious Adverse Event|0
7723901|NCT00985088|26859198|P2|Overall Study|Serious Adverse Event|1
7723902|NCT00985088|26859199|P1|Overall Study|Serious Adverse Event|1
7723903|NCT00984867|26859468|P2|Overall Study|lack of efficacy and subject compliance|0
7723904|NCT00984867|26859469|P1|Overall Study|lack of efficacy and subject compliance|1
7723905|NCT00984867|26859468|P2|Overall Study|site closing|0
7723906|NCT00984867|26859469|P1|Overall Study|site closing|1
7723907|NCT00984867|26859468|P2|Overall Study|Subject no longer meets study criteria|1
7723908|NCT00984867|26859469|P1|Overall Study|Subject no longer meets study criteria|1
7723909|NCT00984867|26859468|P2|Overall Study|Poor/non-compliance|1
7723910|NCT00984867|26859469|P1|Overall Study|Poor/non-compliance|0
7723911|NCT00984867|26859468|P2|Overall Study|Lost to Follow-up|4
7723912|NCT00984867|26859469|P1|Overall Study|Lost to Follow-up|3
7723913|NCT00984867|26859468|P2|Overall Study|Withdrawal by Subject|4
7723914|NCT00984867|26859469|P1|Overall Study|Withdrawal by Subject|13
7723915|NCT00984867|26859468|P2|Overall Study|Death|0
7723916|NCT00984867|26859469|P1|Overall Study|Death|1
7723917|NCT00984867|26859468|P2|Overall Study|Adverse Event|7
7723918|NCT00984867|26859469|P1|Overall Study|Adverse Event|3
7723919|NCT00984659|26859509|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
7723920|NCT00984659|26859510|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
7723921|NCT00984659|26859511|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
7723922|NCT00984659|26859512|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
7723923|NCT00984659|26859509|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7723924|NCT00984659|26859510|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
7723925|NCT00984659|26859511|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7723926|NCT00984659|26859512|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7723927|NCT00984659|26859509|P4|6-week Double-blind Treatment Period|Protocol Violation|4
7723928|NCT00984659|26859510|P3|6-week Double-blind Treatment Period|Protocol Violation|0
7723929|NCT00984659|26859511|P2|6-week Double-blind Treatment Period|Protocol Violation|0
7723930|NCT00984659|26859512|P1|6-week Double-blind Treatment Period|Protocol Violation|0
7723931|NCT00984659|26859509|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
7723932|NCT00984659|26859510|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
7723933|NCT00984659|26859511|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
7723934|NCT00984659|26859512|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
7723935|NCT00984659|26859509|P4|6-week Double-blind Treatment Period|Adverse Event|7
7723936|NCT00984659|26859510|P3|6-week Double-blind Treatment Period|Adverse Event|3
7723937|NCT00984659|26859511|P2|6-week Double-blind Treatment Period|Adverse Event|3
7723938|NCT00984659|26859512|P1|6-week Double-blind Treatment Period|Adverse Event|0
7723939|NCT00984659|26859509|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7723940|NCT00984659|26859510|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7723941|NCT00984659|26859511|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7723942|NCT00984659|26859512|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
7723943|NCT00984659|26859509|P4|2-week Run-in Period|Withdrawal by Subject|0
7723944|NCT00984659|26859510|P3|2-week Run-in Period|Withdrawal by Subject|0
7723945|NCT00984659|26859511|P2|2-week Run-in Period|Withdrawal by Subject|0
7723946|NCT00984659|26859512|P1|2-week Run-in Period|Withdrawal by Subject|10
7723947|NCT00984659|26859509|P4|2-week Run-in Period|Physician Decision|0
7723948|NCT00984659|26859510|P3|2-week Run-in Period|Physician Decision|0
7723949|NCT00984659|26859511|P2|2-week Run-in Period|Physician Decision|0
7723950|NCT00984659|26859512|P1|2-week Run-in Period|Physician Decision|10
7723951|NCT00984659|26859509|P4|2-week Run-in Period|Lost to Follow-up|0
7723952|NCT00984659|26859510|P3|2-week Run-in Period|Lost to Follow-up|0
7723953|NCT00984659|26859511|P2|2-week Run-in Period|Lost to Follow-up|0
7723954|NCT00984659|26859512|P1|2-week Run-in Period|Lost to Follow-up|3
7723955|NCT00984659|26859509|P4|2-week Run-in Period|Study Closed/Terminated|0
7723956|NCT00984659|26859510|P3|2-week Run-in Period|Study Closed/Terminated|0
7723957|NCT00984659|26859511|P2|2-week Run-in Period|Study Closed/Terminated|0
7723958|NCT00984659|26859512|P1|2-week Run-in Period|Study Closed/Terminated|2
7723959|NCT00984659|26859509|P4|2-week Run-in Period|Protocol Violation|0
7723960|NCT00984659|26859510|P3|2-week Run-in Period|Protocol Violation|0
7723961|NCT00984659|26859511|P2|2-week Run-in Period|Protocol Violation|0
7723962|NCT00984659|26859512|P1|2-week Run-in Period|Protocol Violation|5
7723963|NCT00984659|26859509|P4|2-week Run-in Period|Adverse Event|0
7723964|NCT00984659|26859510|P3|2-week Run-in Period|Adverse Event|0
7723965|NCT00984659|26859511|P2|2-week Run-in Period|Adverse Event|0
7723966|NCT00984659|26859512|P1|2-week Run-in Period|Adverse Event|8
7723967|NCT00984620|26859539|P2|Overall Study|reason other than listed above|4
7723968|NCT00984620|26859540|P1|Overall Study|reason other than listed above|0
7723969|NCT00984620|26859539|P2|Overall Study|Withdrawal by Subject|2
7723970|NCT00984620|26859540|P1|Overall Study|Withdrawal by Subject|0
7723971|NCT00984620|26859539|P2|Overall Study|Lost to Follow-up|1
7723972|NCT00984620|26859540|P1|Overall Study|Lost to Follow-up|1
7723973|NCT00984620|26859539|P2|Overall Study|Adverse Event|5
7723974|NCT00984620|26859540|P1|Overall Study|Adverse Event|5
7723975|NCT00984594|26859578|P2|Overall Study|Withdrawal by Subject|1
7723976|NCT00984594|26859579|P1|Overall Study|Withdrawal by Subject|0
7723977|NCT00984594|26859578|P2|Overall Study|Lost to Follow-up|0
7723978|NCT00984594|26859579|P1|Overall Study|Lost to Follow-up|1
7723979|NCT00984568|26859595|P2|Overall Study|Unknown Reason|3
7723980|NCT00984568|26859596|P1|Overall Study|Unknown Reason|1
7723981|NCT00984568|26859595|P2|Overall Study|Opportunistic Infection|0
7723982|NCT00984568|26859596|P1|Overall Study|Opportunistic Infection|1
7723983|NCT00984568|26859595|P2|Overall Study|Lost to Follow-up|1
7723984|NCT00984568|26859596|P1|Overall Study|Lost to Follow-up|0
7723985|NCT00984568|26859595|P2|Overall Study|Did Not Meet Randomization Criteria|0
7723986|NCT00984568|26859596|P1|Overall Study|Did Not Meet Randomization Criteria|1
7723987|NCT00984568|26859595|P2|Overall Study|Adverse Event|0
7723988|NCT00984568|26859596|P1|Overall Study|Adverse Event|2
7723989|NCT00984568|26859595|P2|Overall Study|Lack of Efficacy|0
7723990|NCT00984568|26859596|P1|Overall Study|Lack of Efficacy|2
7723991|NCT00984568|26859595|P2|Overall Study|Withdrawal by Subject|2
7723992|NCT00984568|26859596|P1|Overall Study|Withdrawal by Subject|1
7723993|NCT00984542|26859604|P1|Overall Study|clinical deterioration|2
7723994|NCT00984542|26859604|P1|Overall Study|Withdrawal by Subject|3
7723995|NCT00984542|26859604|P1|Overall Study|complicating disease|3
7723996|NCT00984542|26859604|P1|Overall Study|Death|7
7723997|NCT00984542|26859604|P1|Overall Study|toxicity|7
7723998|NCT00984542|26859604|P1|Overall Study|disease progression|19
7723999|NCT00984295|26859654|P3|Overall Study|Incomplete safety follow-up|3
7724000|NCT00984295|26859655|P2|Overall Study|Incomplete safety follow-up|2
7724001|NCT00984295|26859656|P1|Overall Study|Incomplete safety follow-up|11
7724002|NCT00984295|26859654|P3|Overall Study|Missed one or more blood samplings|2
7724003|NCT00984295|26859655|P2|Overall Study|Missed one or more blood samplings|7
7724004|NCT00984295|26859656|P1|Overall Study|Missed one or more blood samplings|3
7724005|NCT00984295|26859654|P3|Overall Study|CAE - discontinued test vaccine|3
7724006|NCT00984295|26859655|P2|Overall Study|CAE - discontinued test vaccine|1
7724007|NCT00984295|26859656|P1|Overall Study|CAE - discontinued test vaccine|0
7724008|NCT00984295|26859654|P3|Overall Study|Withdrawal by Subject|12
7724009|NCT00984295|26859655|P2|Overall Study|Withdrawal by Subject|9
7724010|NCT00984295|26859656|P1|Overall Study|Withdrawal by Subject|18
7724011|NCT00984295|26859654|P3|Overall Study|Protocol Violation|4
7724012|NCT00984295|26859655|P2|Overall Study|Protocol Violation|1
7724013|NCT00984295|26859656|P1|Overall Study|Protocol Violation|2
7724014|NCT00984295|26859654|P3|Overall Study|Lost to Follow-up|13
7724015|NCT00984295|26859655|P2|Overall Study|Lost to Follow-up|12
7724016|NCT00984295|26859656|P1|Overall Study|Lost to Follow-up|31
7724017|NCT00984282|26859723|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
7724018|NCT00984282|26859724|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
7724019|NCT00984282|26859723|P2|Long Term Follow-up|Switched to commercial drug|2
7724020|NCT00984282|26859724|P1|Long Term Follow-up|Switched to commercial drug|4
7724021|NCT00984282|26859723|P2|Long Term Follow-up|Transferred to treat. continuation study|3
7724022|NCT00984282|26859724|P1|Long Term Follow-up|Transferred to treat. continuation study|2
7724023|NCT00984282|26859723|P2|Long Term Follow-up|Protocol driven decision point|26
7724024|NCT00984282|26859724|P1|Long Term Follow-up|Protocol driven decision point|25
7724025|NCT00984282|26859723|P2|Long Term Follow-up|Lost to Follow-up|6
7724026|NCT00984282|26859724|P1|Long Term Follow-up|Lost to Follow-up|3
7724027|NCT00984282|26859723|P2|Long Term Follow-up|Death|68
7724028|NCT00984282|26859724|P1|Long Term Follow-up|Death|27
7724029|NCT00984282|26859723|P2|Long Term Follow-up|Withdrawal by Subject|14
7724030|NCT00984282|26859724|P1|Long Term Follow-up|Withdrawal by Subject|8
7724031|NCT00984282|26859723|P2|Open-label Treatment|Physician Decision|0
7724032|NCT00984282|26859724|P1|Open-label Treatment|Physician Decision|1
7724033|NCT00984282|26859723|P2|Open-label Treatment|Switched to commercial drug|7
7724034|NCT00984282|26859724|P1|Open-label Treatment|Switched to commercial drug|6
7724035|NCT00984282|26859723|P2|Open-label Treatment|Transferred to treat. continuation study|3
7724036|NCT00984282|26859724|P1|Open-label Treatment|Transferred to treat. continuation study|2
7724037|NCT00984282|26859723|P2|Open-label Treatment|Protocol driven decision point|1
7724038|NCT00984282|26859724|P1|Open-label Treatment|Protocol driven decision point|1
7724039|NCT00984282|26859723|P2|Open-label Treatment|Target lesion removed|1
7724040|NCT00984282|26859724|P1|Open-label Treatment|Target lesion removed|0
7724041|NCT00984282|26859723|P2|Open-label Treatment|Non-compliant with study medication|0
7724042|NCT00984282|26859724|P1|Open-label Treatment|Non-compliant with study medication|1
7724043|NCT00984282|26859723|P2|Open-label Treatment|Patient convenience|0
7724044|NCT00984282|26859724|P1|Open-label Treatment|Patient convenience|1
7724045|NCT00984282|26859723|P2|Open-label Treatment|Lost to Follow-up|1
7724046|NCT00984282|26859724|P1|Open-label Treatment|Lost to Follow-up|1
7724047|NCT00984282|26859723|P2|Open-label Treatment|Progression, recurrence or relapse|82
7724048|NCT00984282|26859724|P1|Open-label Treatment|Progression, recurrence or relapse|40
7724049|NCT00984282|26859723|P2|Open-label Treatment|Death|15
7724050|NCT00984282|26859724|P1|Open-label Treatment|Death|7
7724051|NCT00984282|26859723|P2|Open-label Treatment|Withdrawal by Subject|21
7724052|NCT00984282|26859724|P1|Open-label Treatment|Withdrawal by Subject|6
7724053|NCT00984282|26859723|P2|Open-label Treatment|Adverse Event|30
7724054|NCT00984282|26859724|P1|Open-label Treatment|Adverse Event|20
7724055|NCT00984282|26859723|P2|Double Blind Treatment|Transferred to treat. continuation study|1
7724056|NCT00984282|26859724|P1|Double Blind Treatment|Transferred to treat. continuation study|2
7724057|NCT00984282|26859723|P2|Double Blind Treatment|Radiological and clinical progression|1
7724058|NCT00984282|26859724|P1|Double Blind Treatment|Radiological and clinical progression|0
7724059|NCT00984282|26859723|P2|Double Blind Treatment|protocol driven decision point|1
7724060|NCT00984282|26859724|P1|Double Blind Treatment|protocol driven decision point|1
7724061|NCT00984282|26859723|P2|Double Blind Treatment|Switched to commercial drug|1
7724062|NCT00984282|26859724|P1|Double Blind Treatment|Switched to commercial drug|6
7724063|NCT00984282|26859723|P2|Double Blind Treatment|Not treated|1
7724064|NCT00984282|26859724|P1|Double Blind Treatment|Not treated|0
7724065|NCT00984282|26859723|P2|Double Blind Treatment|Death|4
7724066|NCT00984282|26859724|P1|Double Blind Treatment|Death|8
7724067|NCT00984282|26859723|P2|Double Blind Treatment|Lost to Follow-up|0
7724068|NCT00984282|26859724|P1|Double Blind Treatment|Lost to Follow-up|3
7724069|NCT00984282|26859723|P2|Double Blind Treatment|Withdrawal by Subject|18
7724070|NCT00984282|26859724|P1|Double Blind Treatment|Withdrawal by Subject|13
7724071|NCT00984282|26859723|P2|Double Blind Treatment|Progression by clinical judgment|0
7724072|NCT00984282|26859724|P1|Double Blind Treatment|Progression by clinical judgment|2
7724073|NCT00984282|26859723|P2|Double Blind Treatment|Noncompliance with study medication|0
7724074|NCT00984282|26859724|P1|Double Blind Treatment|Noncompliance with study medication|3
7724075|NCT00984282|26859723|P2|Double Blind Treatment|Physician Decision|2
7724076|NCT00984282|26859724|P1|Double Blind Treatment|Physician Decision|1
7724077|NCT00984282|26859723|P2|Double Blind Treatment|Progression, recurrence or relapse|3
7724078|NCT00984282|26859724|P1|Double Blind Treatment|Progression, recurrence or relapse|25
7724079|NCT00984282|26859723|P2|Double Blind Treatment|Adverse Event|6
7724080|NCT00984282|26859724|P1|Double Blind Treatment|Adverse Event|40
7724081|NCT00984256|26859747|P2|Overall Study|Withdrawal by Subject|1
7724082|NCT00984256|26859748|P1|Overall Study|Withdrawal by Subject|0
7724083|NCT00984204|26859768|P1|Overall Study|Lack of Efficacy|10
7724084|NCT00984204|26859768|P1|Overall Study|Lost to Follow-up|4
7724085|NCT00984204|26859768|P1|Overall Study|Death|1
7724086|NCT00984165|26859778|P4|Overall Study|removed with a pair recipient|1
7724087|NCT00984165|26859779|P3|Overall Study|removed with a pair recipient|0
7724088|NCT00984165|26859780|P2|Overall Study|removed with a pair recipient|0
7724089|NCT00984165|26859781|P1|Overall Study|removed with a pair recipient|0
7724090|NCT00984165|26859778|P4|Overall Study|P+/donor pair removed from protocol|1
7724091|NCT00984165|26859779|P3|Overall Study|P+/donor pair removed from protocol|0
7724092|NCT00984165|26859780|P2|Overall Study|P+/donor pair removed from protocol|0
7724093|NCT00984165|26859781|P1|Overall Study|P+/donor pair removed from protocol|0
7724094|NCT00984165|26859778|P4|Overall Study|New protocol|1
7724095|NCT00984165|26859779|P3|Overall Study|New protocol|0
7724096|NCT00984165|26859780|P2|Overall Study|New protocol|0
7724097|NCT00984165|26859781|P1|Overall Study|New protocol|0
7724098|NCT00984165|26859778|P4|Overall Study|Death of recipient|1
7724099|NCT00984165|26859779|P3|Overall Study|Death of recipient|0
7724100|NCT00984165|26859780|P2|Overall Study|Death of recipient|0
7724101|NCT00984165|26859781|P1|Overall Study|Death of recipient|0
7724102|NCT00984165|26859778|P4|Overall Study|Disease progression on study|0
7724103|NCT00984165|26859779|P3|Overall Study|Disease progression on study|0
7724104|NCT00984165|26859780|P2|Overall Study|Disease progression on study|1
7724105|NCT00984165|26859781|P1|Overall Study|Disease progression on study|5
7724106|NCT00984165|26859778|P4|Overall Study|Death on study|0
7724107|NCT00984165|26859779|P3|Overall Study|Death on study|0
7724108|NCT00984165|26859780|P2|Overall Study|Death on study|0
7724109|NCT00984165|26859781|P1|Overall Study|Death on study|2
7724110|NCT00984126|26859810|P4|Overall Study|Withdrawal criteria|9
7724111|NCT00984126|26859811|P3|Overall Study|Withdrawal criteria|3
7724112|NCT00984126|26859812|P2|Overall Study|Withdrawal criteria|1
7724113|NCT00984126|26859813|P1|Overall Study|Withdrawal criteria|0
7724114|NCT00984126|26859810|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
7724115|NCT00984126|26859811|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
7724116|NCT00984126|26859812|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
7724117|NCT00984126|26859813|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
7724118|NCT00984126|26859810|P4|Overall Study|Adverse Event|2
7724119|NCT00984126|26859811|P3|Overall Study|Adverse Event|0
7724120|NCT00984126|26859812|P2|Overall Study|Adverse Event|0
7724121|NCT00984126|26859813|P1|Overall Study|Adverse Event|0
7724122|NCT00984126|26859810|P4|Overall Study|Protocol Violation|2
7724123|NCT00984126|26859811|P3|Overall Study|Protocol Violation|1
7724124|NCT00984126|26859812|P2|Overall Study|Protocol Violation|0
7724125|NCT00984126|26859813|P1|Overall Study|Protocol Violation|0
7724126|NCT00984061|26859838|P1|Clarithromycin Alone|Protocol Violation|1
7724127|NCT00984022|26859851|P2|Overall Study|Lost to Follow-up|14
7724128|NCT00984022|26859852|P1|Overall Study|Lost to Follow-up|10
7724129|NCT00984009|26859862|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
7724130|NCT00983957|26859895|P1|Overall Study|Personal Reasons|1
7724131|NCT00983957|26859895|P1|Overall Study|Adverse Event|1
7724132|NCT00983931|26859929|P1|14 Day Washout Period|Physician Decision|1
7724133|NCT00983918|26859943|P4|Overall Study|conversion to open cholecystectomy|2
7724134|NCT00983918|26859944|P3|Overall Study|conversion to open cholecystectomy|2
7724135|NCT00983918|26859945|P2|Overall Study|conversion to open cholecystectomy|2
7724136|NCT00983918|26859946|P1|Overall Study|conversion to open cholecystectomy|0
7724137|NCT00983905|26859956|P1|Colchicine Alone|Adverse Event|2
7724138|NCT00983905|26859956|P1|Theophylline Alone|Adverse Event|1
7724139|NCT00983892|26859969|P2|Overall Study|Withdrawal by Subject|12
7724140|NCT00983892|26859970|P1|Overall Study|Withdrawal by Subject|10
7724141|NCT00983853|26859982|P6|Overall Study|Unable to come to study follow-up visits|0
7724142|NCT00983853|26859983|P5|Overall Study|Unable to come to study follow-up visits|0
7724143|NCT00983853|26859984|P4|Overall Study|Unable to come to study follow-up visits|0
7724144|NCT00983853|26859985|P3|Overall Study|Unable to come to study follow-up visits|0
7724145|NCT00983853|26859986|P2|Overall Study|Unable to come to study follow-up visits|1
7724146|NCT00983853|26859987|P1|Overall Study|Unable to come to study follow-up visits|0
7724147|NCT00983853|26859982|P6|Overall Study|Withdrawal by Subject|0
7724148|NCT00983853|26859983|P5|Overall Study|Withdrawal by Subject|1
7724149|NCT00983853|26859984|P4|Overall Study|Withdrawal by Subject|0
7724150|NCT00983853|26859985|P3|Overall Study|Withdrawal by Subject|1
7724151|NCT00983853|26859986|P2|Overall Study|Withdrawal by Subject|0
7724152|NCT00983853|26859987|P1|Overall Study|Withdrawal by Subject|0
7724153|NCT00983853|26859982|P6|Overall Study|Lost to Follow-up|1
7724154|NCT00983853|26859983|P5|Overall Study|Lost to Follow-up|2
7724155|NCT00983853|26859984|P4|Overall Study|Lost to Follow-up|2
7724156|NCT00983853|26859985|P3|Overall Study|Lost to Follow-up|2
7724157|NCT00983853|26859986|P2|Overall Study|Lost to Follow-up|1
7724158|NCT00983853|26859987|P1|Overall Study|Lost to Follow-up|1
7724159|NCT00983827|26860015|P1|Overall Study|Withdrawal by Subject|1
7724160|NCT00983749|26860033|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
7724161|NCT00983749|26860034|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
7724162|NCT00983619|26860069|P12|Overall Study|Other|0
7724163|NCT00983619|26860070|P11|Overall Study|Other|1
7724164|NCT00983619|26860071|P10|Overall Study|Other|1
7724165|NCT00983619|26860072|P9|Overall Study|Other|0
7724166|NCT00983619|26860073|P8|Overall Study|Other|2
7724167|NCT00983619|26860074|P7|Overall Study|Other|2
7724168|NCT00983619|26860075|P6|Overall Study|Other|12
7724169|NCT00983619|26860076|P5|Overall Study|Other|0
7724170|NCT00983619|26860077|P4|Overall Study|Other|1
7724171|NCT00983619|26860078|P3|Overall Study|Other|0
7724172|NCT00983619|26860079|P2|Overall Study|Other|0
7724173|NCT00983619|26860080|P1|Overall Study|Other|1
7724174|NCT00983619|26860069|P12|Overall Study|Death|8
7724175|NCT00983619|26860070|P11|Overall Study|Death|9
7724176|NCT00983619|26860071|P10|Overall Study|Death|2
7724177|NCT00983619|26860072|P9|Overall Study|Death|1
7724178|NCT00983619|26860073|P8|Overall Study|Death|0
7724179|NCT00983619|26860074|P7|Overall Study|Death|1
7724180|NCT00983619|26860075|P6|Overall Study|Death|30
7724181|NCT00983619|26860076|P5|Overall Study|Death|2
7724182|NCT00983619|26860077|P4|Overall Study|Death|1
7724183|NCT00983619|26860078|P3|Overall Study|Death|2
7724184|NCT00983619|26860079|P2|Overall Study|Death|2
7724185|NCT00983619|26860080|P1|Overall Study|Death|0
7724186|NCT00983619|26860069|P12|Overall Study|Withdrawal by Subject|1
7724187|NCT00983619|26860070|P11|Overall Study|Withdrawal by Subject|1
7724188|NCT00983619|26860071|P10|Overall Study|Withdrawal by Subject|0
7724189|NCT00983619|26860072|P9|Overall Study|Withdrawal by Subject|0
7724190|NCT00983619|26860073|P8|Overall Study|Withdrawal by Subject|0
7724191|NCT00983619|26860074|P7|Overall Study|Withdrawal by Subject|0
7724192|NCT00983619|26860075|P6|Overall Study|Withdrawal by Subject|23
7724193|NCT00983619|26860076|P5|Overall Study|Withdrawal by Subject|1
7724194|NCT00983619|26860077|P4|Overall Study|Withdrawal by Subject|3
7724195|NCT00983619|26860078|P3|Overall Study|Withdrawal by Subject|1
7724196|NCT00983619|26860079|P2|Overall Study|Withdrawal by Subject|1
7724197|NCT00983619|26860080|P1|Overall Study|Withdrawal by Subject|2
7724198|NCT00983619|26860069|P12|Overall Study|Lost to Follow-up|2
7724199|NCT00983619|26860070|P11|Overall Study|Lost to Follow-up|0
7724200|NCT00983619|26860071|P10|Overall Study|Lost to Follow-up|0
7724201|NCT00983619|26860072|P9|Overall Study|Lost to Follow-up|0
7724202|NCT00983619|26860073|P8|Overall Study|Lost to Follow-up|0
7724203|NCT00983619|26860074|P7|Overall Study|Lost to Follow-up|0
7724204|NCT00983619|26860075|P6|Overall Study|Lost to Follow-up|2
7724205|NCT00983619|26860076|P5|Overall Study|Lost to Follow-up|0
7724206|NCT00983619|26860077|P4|Overall Study|Lost to Follow-up|0
7724207|NCT00983619|26860078|P3|Overall Study|Lost to Follow-up|0
7724208|NCT00983619|26860079|P2|Overall Study|Lost to Follow-up|1
7724209|NCT00983619|26860080|P1|Overall Study|Lost to Follow-up|0
7724210|NCT00983580|26860385|P2|Overall Study|Ineligible|0
7724211|NCT00983580|26860386|P1|Overall Study|Ineligible|3
7724212|NCT00983580|26860385|P2|Overall Study|Protocol Violation|1
7724213|NCT00983580|26860386|P1|Overall Study|Protocol Violation|1
7724214|NCT00983580|26860385|P2|Overall Study|Cancel Prior to treatment|3
7724215|NCT00983580|26860386|P1|Overall Study|Cancel Prior to treatment|1
7724216|NCT00983528|26860412|P1|Overall Study|Study Terminated|1
7724217|NCT00983528|26860412|P1|Overall Study|Lost to Follow-up|1
7724218|NCT00983528|26860412|P1|Overall Study|Death|4
7724219|NCT00983515|26860417|P1|Colchicine With Ritonavir|Lost to Follow-up|1
7724220|NCT00983515|26860417|P1|Ritonavir Alone|liver panel out of range|6
7724221|NCT00983476|26860444|P3|Overall Study|Did not receive intervention|0
7724222|NCT00983476|26860445|P2|Overall Study|Did not receive intervention|22
7724223|NCT00983476|26860446|P1|Overall Study|Did not receive intervention|17
7724224|NCT00983437|26860478|P1|Overall Study|Other Reason|26
7724225|NCT00983437|26860478|P1|Overall Study|Lost to Follow-up|2
7724226|NCT00983437|26860478|P1|Overall Study|Noncompliance to Study Procedures|1
7724227|NCT00983437|26860478|P1|Overall Study|Withdrawal by Subject|8
7724228|NCT00983437|26860478|P1|Overall Study|Lack of Efficacy|1
7724229|NCT00983437|26860478|P1|Overall Study|Adverse Event|9
7724230|NCT00983385|26860497|P1|Observation Period|Not Evaluable due to Non Compliance|12
7724231|NCT00983385|26860497|P1|Observation Period|Not eligible to be dosed|20
7724232|NCT00983372|26860542|P1|Diltiazem ER Alone|Adverse Event|1
7724233|NCT00983372|26860542|P1|Diltiazem ER Alone|missed diltiazem dose|2
7724234|NCT00983372|26860542|P1|14 Day Washout Period|Withdrawal by Subject|1
7724235|NCT00983294|26860569|P1|Colchicine With Azithromycin|Adverse Event|1
7724236|NCT00983294|26860569|P1|14 Day Washout Period|Withdrawal by Subject|2
7724237|NCT00983073|26860611|P1|Maintenance Period|Other Reason|7
7724238|NCT00983073|26860611|P1|Maintenance Period|Lack of Efficacy|2
7724239|NCT00983073|26860611|P1|Maintenance Period|Withdrawal by Subject|2
7724240|NCT00983073|26860611|P1|Maintenance Period|Adverse Event|5
7724241|NCT00983073|26860611|P1|Titration and Optimal Dose Period|Other reason|4
7724242|NCT00983073|26860611|P1|Titration and Optimal Dose Period|Non-Compliance|1
7724243|NCT00983073|26860611|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
7724244|NCT00983073|26860611|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
7724245|NCT00983073|26860611|P1|Titration and Optimal Dose Period|Adverse Event|19
7724246|NCT00982930|26860637|P1|Overall Study|Administrative Problems|2
7724247|NCT00982930|26860637|P1|Overall Study|Withdrawal by Subject|1
7724248|NCT00982930|26860637|P1|Overall Study|Adverse Event|1
7724249|NCT00982878|26860655|P1|Overall Study|Physician Decision|1
7724250|NCT00982735|26860953|P1|Overall Study|Patient ineligible for trial|224
7724251|NCT00982735|26860953|P1|Overall Study|Lost to Follow-up|6
7724252|NCT00982657|26860963|P4|Overall Study|On going at date of cut-off|1
7724253|NCT00982657|26860964|P3|Overall Study|On going at date of cut-off|0
7724254|NCT00982657|26860965|P2|Overall Study|On going at date of cut-off|0
7724255|NCT00982657|26860966|P1|Overall Study|On going at date of cut-off|0
7724256|NCT00982657|26860963|P4|Overall Study|Other|4
7724257|NCT00982657|26860964|P3|Overall Study|Other|0
7724258|NCT00982657|26860965|P2|Overall Study|Other|0
7724259|NCT00982657|26860966|P1|Overall Study|Other|0
7724260|NCT00982657|26860963|P4|Overall Study|Withdrawal by Subject|3
7724261|NCT00982657|26860964|P3|Overall Study|Withdrawal by Subject|1
7724262|NCT00982657|26860965|P2|Overall Study|Withdrawal by Subject|0
7724263|NCT00982657|26860966|P1|Overall Study|Withdrawal by Subject|0
7724264|NCT00982657|26860963|P4|Overall Study|Death|1
7724265|NCT00982657|26860964|P3|Overall Study|Death|1
7724266|NCT00982657|26860965|P2|Overall Study|Death|0
7724267|NCT00982657|26860966|P1|Overall Study|Death|1
7724268|NCT00982644|26861007|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
7724269|NCT00982644|26861008|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
7724270|NCT00982644|26861007|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
7724271|NCT00982644|26861008|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
7724272|NCT00982644|26861007|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
7724273|NCT00982644|26861008|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
7724274|NCT00982644|26861007|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
7724275|NCT00982644|26861008|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
7724276|NCT00982644|26861007|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
7724277|NCT00982644|26861008|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
7724278|NCT00982644|26861007|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
7724279|NCT00982644|26861008|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
7724280|NCT00982644|26861007|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
7724281|NCT00982644|26861008|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
7724282|NCT00982644|26861007|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
7724283|NCT00982644|26861008|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
7724284|NCT00982644|26861007|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
7724285|NCT00982644|26861008|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
7724286|NCT00982644|26861007|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
7724287|NCT00982644|26861008|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
7724288|NCT00982488|26861063|P5|Overall Study|Withdrawal by Subject|0
7724289|NCT00982488|26861064|P4|Overall Study|Withdrawal by Subject|0
7724290|NCT00982488|26861065|P3|Overall Study|Withdrawal by Subject|1
7724291|NCT00982488|26861066|P2|Overall Study|Withdrawal by Subject|1
7724292|NCT00982488|26861067|P1|Overall Study|Withdrawal by Subject|5
7724293|NCT00982488|26861063|P5|Overall Study|Study drug toxicity|0
7724294|NCT00982488|26861064|P4|Overall Study|Study drug toxicity|0
7724295|NCT00982488|26861065|P3|Overall Study|Study drug toxicity|6
7724296|NCT00982488|26861066|P2|Overall Study|Study drug toxicity|1
7724297|NCT00982488|26861067|P1|Overall Study|Study drug toxicity|34
7724298|NCT00982488|26861063|P5|Overall Study|Stem cell transplant|0
7724299|NCT00982488|26861064|P4|Overall Study|Stem cell transplant|1
7724300|NCT00982488|26861065|P3|Overall Study|Stem cell transplant|0
7724301|NCT00982488|26861066|P2|Overall Study|Stem cell transplant|0
7724302|NCT00982488|26861067|P1|Overall Study|Stem cell transplant|2
7724303|NCT00982488|26861063|P5|Overall Study|Poor compliance/noncompliance|0
7724304|NCT00982488|26861064|P4|Overall Study|Poor compliance/noncompliance|0
7724305|NCT00982488|26861065|P3|Overall Study|Poor compliance/noncompliance|0
7724306|NCT00982488|26861066|P2|Overall Study|Poor compliance/noncompliance|1
7724307|NCT00982488|26861067|P1|Overall Study|Poor compliance/noncompliance|0
7724308|NCT00982488|26861063|P5|Overall Study|Other|0
7724309|NCT00982488|26861064|P4|Overall Study|Other|1
7724310|NCT00982488|26861065|P3|Overall Study|Other|3
7724311|NCT00982488|26861066|P2|Overall Study|Other|1
7724312|NCT00982488|26861067|P1|Overall Study|Other|15
7724313|NCT00982488|26861063|P5|Overall Study|Maximum clinical benefit|0
7724314|NCT00982488|26861064|P4|Overall Study|Maximum clinical benefit|0
7724315|NCT00982488|26861065|P3|Overall Study|Maximum clinical benefit|1
7724316|NCT00982488|26861066|P2|Overall Study|Maximum clinical benefit|1
7724317|NCT00982488|26861067|P1|Overall Study|Maximum clinical benefit|1
7724318|NCT00982488|26861063|P5|Overall Study|Lost to Follow-up|0
7724319|NCT00982488|26861064|P4|Overall Study|Lost to Follow-up|0
7724320|NCT00982488|26861065|P3|Overall Study|Lost to Follow-up|0
7724321|NCT00982488|26861066|P2|Overall Study|Lost to Follow-up|0
7724322|NCT00982488|26861067|P1|Overall Study|Lost to Follow-up|1
7724323|NCT00982488|26861063|P5|Overall Study|Disease progression|1
7724324|NCT00982488|26861064|P4|Overall Study|Disease progression|1
7724325|NCT00982488|26861065|P3|Overall Study|Disease progression|10
7724326|NCT00982488|26861066|P2|Overall Study|Disease progression|5
7724327|NCT00982488|26861067|P1|Overall Study|Disease progression|30
7724328|NCT00982488|26861063|P5|Overall Study|Death|0
7724329|NCT00982488|26861064|P4|Overall Study|Death|0
7724330|NCT00982488|26861065|P3|Overall Study|Death|2
7724331|NCT00982488|26861066|P2|Overall Study|Death|0
7724332|NCT00982488|26861067|P1|Overall Study|Death|11
7724333|NCT00982488|26861063|P5|Overall Study|Adverse event unrelated to study drug|0
7724334|NCT00982488|26861064|P4|Overall Study|Adverse event unrelated to study drug|0
7724335|NCT00982488|26861065|P3|Overall Study|Adverse event unrelated to study drug|0
7724336|NCT00982488|26861066|P2|Overall Study|Adverse event unrelated to study drug|1
7724337|NCT00982488|26861067|P1|Overall Study|Adverse event unrelated to study drug|5
7724338|NCT00982488|26861063|P5|Overall Study|Administrative reason by sponsor|0
7724339|NCT00982488|26861064|P4|Overall Study|Administrative reason by sponsor|0
7724340|NCT00982488|26861065|P3|Overall Study|Administrative reason by sponsor|11
7724341|NCT00982488|26861066|P2|Overall Study|Administrative reason by sponsor|3
7724342|NCT00982488|26861067|P1|Overall Study|Administrative reason by sponsor|81
7724343|NCT00982410|26861100|P2|12-month Follow-up Assessment|scheduled, no-show|0
7724344|NCT00982410|26861101|P1|12-month Follow-up Assessment|scheduled, no-show|1
7724345|NCT00982410|26861100|P2|12-month Follow-up Assessment|incarceration|1
7724346|NCT00982410|26861101|P1|12-month Follow-up Assessment|incarceration|2
7724347|NCT00982410|26861100|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
7724348|NCT00982410|26861101|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
7724349|NCT00982410|26861100|P2|12-month Follow-up Assessment|could not reach to schedule|5
7724350|NCT00982410|26861101|P1|12-month Follow-up Assessment|could not reach to schedule|6
7724351|NCT00982410|26861100|P2|12-month Follow-up Assessment|Death|2
7724352|NCT00982410|26861101|P1|12-month Follow-up Assessment|Death|0
7724353|NCT00982410|26861100|P2|6-month Follow-up Assessment|scheduled, no-show|1
7724354|NCT00982410|26861101|P1|6-month Follow-up Assessment|scheduled, no-show|0
7724355|NCT00982410|26861100|P2|6-month Follow-up Assessment|patent surgery|1
7724356|NCT00982410|26861101|P1|6-month Follow-up Assessment|patent surgery|0
7724357|NCT00982410|26861100|P2|6-month Follow-up Assessment|incarceration|2
7724358|NCT00982410|26861101|P1|6-month Follow-up Assessment|incarceration|0
7724359|NCT00982410|26861100|P2|6-month Follow-up Assessment|participant no transportation|0
7724360|NCT00982410|26861101|P1|6-month Follow-up Assessment|participant no transportation|1
7724361|NCT00982410|26861100|P2|6-month Follow-up Assessment|Could not reach to schedule|7
7724362|NCT00982410|26861101|P1|6-month Follow-up Assessment|Could not reach to schedule|5
7724363|NCT00982410|26861100|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
7724364|NCT00982410|26861101|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
7724365|NCT00982410|26861100|P2|3-month Follow-up Assessment|Scheduled, no-show|2
7724366|NCT00982410|26861101|P1|3-month Follow-up Assessment|Scheduled, no-show|1
7724367|NCT00982410|26861100|P2|3-month Follow-up Assessment|Could not reach to schedule|9
7724368|NCT00982410|26861101|P1|3-month Follow-up Assessment|Could not reach to schedule|8
7724369|NCT00982319|26861142|P2|Overall Study|Pregnancy|1
7724370|NCT00982319|26861143|P1|Overall Study|Pregnancy|0
7724371|NCT00982319|26861142|P2|Overall Study|Preop values out of acceptable range|1
7724372|NCT00982319|26861143|P1|Overall Study|Preop values out of acceptable range|1
7724373|NCT00982319|26861142|P2|Overall Study|Surgery date change|0
7724374|NCT00982319|26861143|P1|Overall Study|Surgery date change|1
7724375|NCT00982280|26861151|P1|Maintenance Period|Adverse Event|1
7724376|NCT00982280|26861151|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
7724377|NCT00982280|26861151|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
7724378|NCT00982280|26861151|P1|Titration and Optimal Dose Period|Adverse Event|5
7724379|NCT00982280|26861151|P1|Observation Period|Not eligible to be dosed|19
7724380|NCT00982228|26861176|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
7724381|NCT00982228|26861177|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
7724382|NCT00982228|26861176|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
7724383|NCT00982228|26861177|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
7724384|NCT00982228|26861176|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
7724385|NCT00982228|26861177|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
7724386|NCT00982228|26861176|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
7724387|NCT00982228|26861177|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
7724388|NCT00982228|26861176|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
7724389|NCT00982228|26861177|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
7724390|NCT00982228|26861176|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
7724391|NCT00982228|26861177|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
7724392|NCT00982228|26861176|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
7724393|NCT00982228|26861177|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
7724394|NCT00982228|26861176|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
7724395|NCT00982228|26861177|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
7724396|NCT00982228|26861176|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
7724397|NCT00982228|26861177|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
7724398|NCT00982228|26861176|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
7724399|NCT00982228|26861177|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
7724400|NCT00982137|26861236|P4|Overall Study|Withdrawal by Subject|0
7724401|NCT00982137|26861237|P3|Overall Study|Withdrawal by Subject|0
7724402|NCT00982137|26861238|P2|Overall Study|Withdrawal by Subject|1
7724403|NCT00982137|26861239|P1|Overall Study|Withdrawal by Subject|0
7724404|NCT00982137|26861236|P4|Overall Study|Lost to Follow-up|1
7724405|NCT00982137|26861237|P3|Overall Study|Lost to Follow-up|0
7724406|NCT00982137|26861238|P2|Overall Study|Lost to Follow-up|0
7724407|NCT00982137|26861239|P1|Overall Study|Lost to Follow-up|0
7724420|NCT00982020|26861322|P2|Overall Study|Clinical Relapse|1
7724421|NCT00982020|26861323|P1|Overall Study|Clinical Relapse|0
7724422|NCT00982020|26861322|P2|Overall Study|Protocol Violation|2
7724423|NCT00982020|26861323|P1|Overall Study|Protocol Violation|0
7724424|NCT00982020|26861322|P2|Overall Study|Entry Criteria Not Met|1
7724425|NCT00982020|26861323|P1|Overall Study|Entry Criteria Not Met|2
7724426|NCT00982020|26861322|P2|Overall Study|Physician Decision|5
7724427|NCT00982020|26861323|P1|Overall Study|Physician Decision|2
7724428|NCT00982020|26861322|P2|Overall Study|Treatment Non-compliance|6
7724429|NCT00982020|26861323|P1|Overall Study|Treatment Non-compliance|3
7724430|NCT00982020|26861322|P2|Overall Study|Parent/Caregiver Decision|5
7724431|NCT00982020|26861323|P1|Overall Study|Parent/Caregiver Decision|5
7724432|NCT00982020|26861322|P2|Overall Study|Lack of Efficacy|4
7724433|NCT00982020|26861323|P1|Overall Study|Lack of Efficacy|10
7724434|NCT00982020|26861322|P2|Overall Study|Lost to Follow-up|11
7724435|NCT00982020|26861323|P1|Overall Study|Lost to Follow-up|5
7724436|NCT00982020|26861322|P2|Overall Study|Withdrawal by Subject|14
7724437|NCT00982020|26861323|P1|Overall Study|Withdrawal by Subject|11
7724438|NCT00982020|26861322|P2|Overall Study|Adverse Event|15
7724439|NCT00982020|26861323|P1|Overall Study|Adverse Event|19
7724440|NCT00981799|26861377|P4|Overall Study|Adverse Event|0
7724441|NCT00981799|26861378|P3|Overall Study|Adverse Event|0
7724442|NCT00981799|26861379|P2|Overall Study|Adverse Event|1
7724443|NCT00981799|26861380|P1|Overall Study|Adverse Event|1
7724444|NCT00981747|26861394|P1|Placebo Oral Tablet|Withdrawal by Subject|1
7724445|NCT00981747|26861394|P1|Losartan|Death|1
7724446|NCT00981747|26861394|P1|Losartan|Withdrawal by Subject|1
7724447|NCT00981682|26861412|P1|Overall Study|administrative|9
7724448|NCT00981682|26861412|P1|Overall Study|Protocol Violation|6
7724449|NCT00981682|26861412|P1|Overall Study|Lack of Efficacy|13
7724450|NCT00981682|26861412|P1|Overall Study|Lost to Follow-up|14
7724451|NCT00981682|26861412|P1|Overall Study|Withdrawal by Subject|52
7724452|NCT00981682|26861412|P1|Overall Study|Adverse Event|48
7724453|NCT00981578|26861464|P1|Overall Study|Withdrawal by Subject|2
7724454|NCT00981578|26861464|P1|Overall Study|Death|1
7724455|NCT00981526|26861472|P2|Overall Study|Physician Decision|4
7724456|NCT00981526|26861473|P1|Overall Study|Physician Decision|4
7724457|NCT00981526|26861472|P2|Overall Study|Withdrawal by Subject|2
7724458|NCT00981526|26861473|P1|Overall Study|Withdrawal by Subject|0
7724459|NCT00981461|26861520|P2|Overall Study|Lost to Follow-up|2
7724460|NCT00981461|26861521|P1|Overall Study|Lost to Follow-up|5
7724461|NCT00981409|26861545|P2|Overall Study|Prostate Cancer Treatment before Trial|0
7724462|NCT00981409|26861546|P1|Overall Study|Prostate Cancer Treatment before Trial|2
7724463|NCT00981409|26861545|P2|Overall Study|Protocol Violation|1
7724464|NCT00981409|26861546|P1|Overall Study|Protocol Violation|0
7724465|NCT00981409|26861545|P2|Overall Study|Adverse Event|0
7724466|NCT00981409|26861546|P1|Overall Study|Adverse Event|4
7724467|NCT00981292|26861585|P6|Day 3|Protocol Violation|1
7724468|NCT00981292|26861586|P5|Day 3|Protocol Violation|0
7724469|NCT00981292|26861587|P4|Day 3|Protocol Violation|0
7724470|NCT00981292|26861588|P3|Day 3|Protocol Violation|0
7724471|NCT00981292|26861589|P2|Day 3|Protocol Violation|0
7724472|NCT00981292|26861590|P1|Day 3|Protocol Violation|0
7724473|NCT00981292|26861585|P6|Day 2|Protocol Violation|0
7724474|NCT00981292|26861586|P5|Day 2|Protocol Violation|0
7724475|NCT00981292|26861587|P4|Day 2|Protocol Violation|0
7724476|NCT00981292|26861588|P3|Day 2|Protocol Violation|0
7724477|NCT00981292|26861589|P2|Day 2|Protocol Violation|0
7724478|NCT00981292|26861590|P1|Day 2|Protocol Violation|2
7724479|NCT00981292|26861585|P6|Day 1|Protocol Violation|2
7724480|NCT00981292|26861586|P5|Day 1|Protocol Violation|0
7724481|NCT00981292|26861587|P4|Day 1|Protocol Violation|0
7724482|NCT00981292|26861588|P3|Day 1|Protocol Violation|0
7724483|NCT00981292|26861589|P2|Day 1|Protocol Violation|0
7724484|NCT00981292|26861590|P1|Day 1|Protocol Violation|1
7724485|NCT00981175|26861674|P2|Booster Dose Vaccination|Lost to Follow-up|3
7724486|NCT00981175|26861675|P1|Booster Dose Vaccination|Lost to Follow-up|2
7724487|NCT00981175|26861674|P2|Primary Dose Vaccination|Lost to Follow-up|1
7724488|NCT00981175|26861675|P1|Primary Dose Vaccination|Lost to Follow-up|2
7724489|NCT00981175|26861674|P2|Primary Dose Vaccination|Protocol Violation|1
7724490|NCT00981175|26861675|P1|Primary Dose Vaccination|Protocol Violation|0
7724491|NCT00981175|26861674|P2|Primary Dose Vaccination|Adverse Event|0
7724492|NCT00981175|26861675|P1|Primary Dose Vaccination|Adverse Event|1
7724493|NCT00981149|26861700|P2|Overall Study|Withdrawal by Subject|1
7724494|NCT00981149|26861701|P1|Overall Study|Withdrawal by Subject|1
7724495|NCT00981149|26861700|P2|Overall Study|Lost to Follow-up|2
7724496|NCT00981149|26861701|P1|Overall Study|Lost to Follow-up|1
7724497|NCT00981084|26861711|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
7724498|NCT00981084|26861712|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
7724499|NCT00981084|26861711|P2|Post Intervention (Data Analysis)|poor effort|1
7724500|NCT00981084|26861712|P1|Post Intervention (Data Analysis)|poor effort|1
7724501|NCT00981058|26861728|P2|Overall Study|On study treatment at conclusion|0
7724502|NCT00981058|26861729|P1|Overall Study|On study treatment at conclusion|9
7724503|NCT00981058|26861728|P2|Overall Study|Withdrawal by Subject|23
7724504|NCT00981058|26861729|P1|Overall Study|Withdrawal by Subject|25
7724505|NCT00981058|26861728|P2|Overall Study|Randomization Error|2
7724506|NCT00981058|26861729|P1|Overall Study|Randomization Error|1
7724507|NCT00981058|26861728|P2|Overall Study|Radiologist Error|1
7724508|NCT00981058|26861729|P1|Overall Study|Radiologist Error|0
7724509|NCT00981058|26861728|P2|Overall Study|Noncompliance|0
7724510|NCT00981058|26861729|P1|Overall Study|Noncompliance|1
7724511|NCT00981058|26861728|P2|Overall Study|New Anticancer Therapy|6
7724512|NCT00981058|26861729|P1|Overall Study|New Anticancer Therapy|6
7724513|NCT00981058|26861728|P2|Overall Study|Lost to Follow-up|15
7724514|NCT00981058|26861729|P1|Overall Study|Lost to Follow-up|16
7724515|NCT00981058|26861728|P2|Overall Study|Progressive Disease|49
7724516|NCT00981058|26861729|P1|Overall Study|Progressive Disease|61
7724517|NCT00981058|26861728|P2|Overall Study|Adverse Event|1
7724518|NCT00981058|26861729|P1|Overall Study|Adverse Event|1
7724519|NCT00981019|26861760|P1|Overall Study|Hit the survey after closure|79
7724520|NCT00981019|26861760|P1|Overall Study|Inadvertent exclusion|239
7724521|NCT00981019|26861760|P1|Overall Study|Did not match target population|94
7724522|NCT00981019|26861760|P1|Overall Study|Did not respond|65
7724523|NCT00980980|26861767|P3|Overall Study|Withdrawal by Hospital|0
7724524|NCT00980980|26861768|P2|Overall Study|Withdrawal by Hospital|1
7724525|NCT00980980|26861769|P1|Overall Study|Withdrawal by Hospital|0
7724526|NCT00980798|26861800|P2|Overall Study|Other|1
7724527|NCT00980798|26861801|P1|Overall Study|Other|0
7724528|NCT00980798|26861800|P2|Overall Study|Withdrawal by Subject|11
7724529|NCT00980798|26861801|P1|Overall Study|Withdrawal by Subject|8
7724530|NCT00980798|26861800|P2|Overall Study|Physician Decision|1
7724531|NCT00980798|26861801|P1|Overall Study|Physician Decision|2
7724532|NCT00980798|26861800|P2|Overall Study|Lost to Follow-up|1
7724533|NCT00980798|26861801|P1|Overall Study|Lost to Follow-up|0
7724534|NCT00980798|26861800|P2|Overall Study|Lack of Efficacy|5
7724535|NCT00980798|26861801|P1|Overall Study|Lack of Efficacy|16
7724536|NCT00980798|26861800|P2|Overall Study|Adverse Event|36
7724537|NCT00980798|26861801|P1|Overall Study|Adverse Event|7
7724538|NCT00980655|26861857|P2|Overall Study|Other|1
7724539|NCT00980655|26861858|P1|Overall Study|Other|0
7724540|NCT00980655|26861857|P2|Overall Study|Parent/legal guardian request|0
7724541|NCT00980655|26861858|P1|Overall Study|Parent/legal guardian request|1
7724542|NCT00980655|26861857|P2|Overall Study|Lost to Follow-up|1
7724543|NCT00980655|26861858|P1|Overall Study|Lost to Follow-up|0
7724544|NCT00980655|26861857|P2|Overall Study|Withdrawal by Subject|4
7724545|NCT00980655|26861858|P1|Overall Study|Withdrawal by Subject|0
7724546|NCT00980655|26861857|P2|Overall Study|Protocol Violation|7
7724547|NCT00980655|26861858|P1|Overall Study|Protocol Violation|2
7724548|NCT00980655|26861857|P2|Overall Study|Death|7
7724549|NCT00980655|26861858|P1|Overall Study|Death|0
7724550|NCT00980655|26861857|P2|Overall Study|Adverse Event|31
7724551|NCT00980655|26861858|P1|Overall Study|Adverse Event|13
7724552|NCT00980343|26861941|P2|Overall Study|no tumor at surgery - treatment effect|3
7724553|NCT00980343|26861942|P1|Overall Study|no tumor at surgery - treatment effect|1
7724554|NCT00980330|26861966|P7|Overall Study|(not specified)|0
7724555|NCT00980330|26861967|P6|Overall Study|(not specified)|1
7724556|NCT00980330|26861968|P5|Overall Study|(not specified)|1
7724557|NCT00980330|26861969|P4|Overall Study|(not specified)|1
7724558|NCT00980330|26861970|P3|Overall Study|(not specified)|0
7724559|NCT00980330|26861971|P2|Overall Study|(not specified)|0
7724560|NCT00980330|26861972|P1|Overall Study|(not specified)|2
7724561|NCT00980330|26861966|P7|Overall Study|Withdrawal by Subject|5
7724562|NCT00980330|26861967|P6|Overall Study|Withdrawal by Subject|2
7724563|NCT00980330|26861968|P5|Overall Study|Withdrawal by Subject|3
7724564|NCT00980330|26861969|P4|Overall Study|Withdrawal by Subject|1
7724565|NCT00980330|26861970|P3|Overall Study|Withdrawal by Subject|4
7724566|NCT00980330|26861971|P2|Overall Study|Withdrawal by Subject|4
7724567|NCT00980330|26861972|P1|Overall Study|Withdrawal by Subject|2
7724568|NCT00980330|26861966|P7|Overall Study|Lost to Follow-up|2
7724569|NCT00980330|26861967|P6|Overall Study|Lost to Follow-up|1
7724570|NCT00980330|26861968|P5|Overall Study|Lost to Follow-up|1
7724571|NCT00980330|26861969|P4|Overall Study|Lost to Follow-up|2
7724572|NCT00980330|26861970|P3|Overall Study|Lost to Follow-up|4
7724573|NCT00980330|26861971|P2|Overall Study|Lost to Follow-up|1
7724574|NCT00980330|26861972|P1|Overall Study|Lost to Follow-up|1
7724575|NCT00980330|26861966|P7|Overall Study|Adverse Event|0
7724576|NCT00980330|26861967|P6|Overall Study|Adverse Event|0
7724577|NCT00980330|26861968|P5|Overall Study|Adverse Event|0
7724578|NCT00980330|26861969|P4|Overall Study|Adverse Event|1
7724579|NCT00980330|26861970|P3|Overall Study|Adverse Event|0
7724580|NCT00980330|26861971|P2|Overall Study|Adverse Event|0
7724581|NCT00980330|26861972|P1|Overall Study|Adverse Event|0
7724582|NCT00980200|26862087|P5|7-day Treatment Period 3|Lack of Efficacy|1
7724583|NCT00980200|26862088|P4|7-day Treatment Period 3|Lack of Efficacy|0
7724584|NCT00980200|26862089|P3|7-day Treatment Period 3|Lack of Efficacy|0
7724585|NCT00980200|26862090|P2|7-day Treatment Period 3|Lack of Efficacy|1
7724586|NCT00980200|26862091|P1|7-day Treatment Period 3|Lack of Efficacy|0
7724587|NCT00980200|26862087|P5|7-day Treatment Period 1|Withdrawal by Subject|0
7724588|NCT00980200|26862088|P4|7-day Treatment Period 1|Withdrawal by Subject|0
7724589|NCT00980200|26862089|P3|7-day Treatment Period 1|Withdrawal by Subject|0
7724590|NCT00980200|26862090|P2|7-day Treatment Period 1|Withdrawal by Subject|1
7724591|NCT00980200|26862091|P1|7-day Treatment Period 1|Withdrawal by Subject|0
7724592|NCT00980174|26862110|P2|Overall Study|Other|1
7724593|NCT00980174|26862111|P1|Overall Study|Other|0
7724594|NCT00980174|26862110|P2|Overall Study|Death|1
7724595|NCT00980174|26862111|P1|Overall Study|Death|1
7724596|NCT00980174|26862110|P2|Overall Study|Ineligibility determined|1
7724597|NCT00980174|26862111|P1|Overall Study|Ineligibility determined|2
7724598|NCT00980174|26862110|P2|Overall Study|Adverse Event|3
7724599|NCT00980174|26862111|P1|Overall Study|Adverse Event|0
7724600|NCT00980174|26862110|P2|Overall Study|Withdrawal by Subject|4
7724601|NCT00980174|26862111|P1|Overall Study|Withdrawal by Subject|1
7724602|NCT00980148|26862129|P2|Overall Study|Various other reasons|9
7724603|NCT00980148|26862130|P1|Overall Study|Various other reasons|8
7724604|NCT00980148|26862129|P2|Overall Study|Negative for chlamydia at enrollment|9
7724605|NCT00980148|26862130|P1|Overall Study|Negative for chlamydia at enrollment|12
7724606|NCT00980148|26862129|P2|Overall Study|Received other antichlamydia treatment|14
7724607|NCT00980148|26862130|P1|Overall Study|Received other antichlamydia treatment|20
7724608|NCT00980148|26862129|P2|Overall Study|Discharged from facility|96
7724609|NCT00980148|26862130|P1|Overall Study|Discharged from facility|89
7724610|NCT00980057|26862138|P2|Overall Study|Withdrawal by Subject|1
7724611|NCT00980057|26862139|P1|Overall Study|Withdrawal by Subject|1
7724612|NCT00980057|26862138|P2|Overall Study|Lost to Follow-up|0
7724613|NCT00980057|26862139|P1|Overall Study|Lost to Follow-up|1
7724614|NCT00980057|26862138|P2|Overall Study|Physician Decision|0
7724615|NCT00980057|26862139|P1|Overall Study|Physician Decision|4
7724616|NCT00980057|26862138|P2|Overall Study|Adverse Event|1
7724617|NCT00980057|26862139|P1|Overall Study|Adverse Event|0
7724618|NCT00980057|26862138|P2|Overall Study|Death|3
7724619|NCT00980057|26862139|P1|Overall Study|Death|13
7724620|NCT00980044|26862162|P3|Overall Study|Protocol Violation|2
7724621|NCT00980044|26862163|P2|Overall Study|Protocol Violation|0
7724622|NCT00980044|26862164|P1|Overall Study|Protocol Violation|0
7724623|NCT00980044|26862162|P3|Overall Study|Withdrawal by Subject|3
7724624|NCT00980044|26862163|P2|Overall Study|Withdrawal by Subject|7
7724625|NCT00980044|26862164|P1|Overall Study|Withdrawal by Subject|5
7724626|NCT00980018|26862181|P1|Overall Study|Lost to Follow-up|1
7724627|NCT00980018|26862181|P1|Overall Study|Patient withdrew consent|3
7724628|NCT00980018|26862181|P1|Overall Study|Adverse Event|8
7724629|NCT00980005|26862195|P2|Overall Study|Other|3
7724630|NCT00980005|26862196|P1|Overall Study|Other|4
7724631|NCT00980005|26862195|P2|Overall Study|Lost to Follow-up|43
7724632|NCT00980005|26862196|P1|Overall Study|Lost to Follow-up|37
7724633|NCT00980005|26862195|P2|Overall Study|Withdrawal by Subject|17
7724634|NCT00980005|26862196|P1|Overall Study|Withdrawal by Subject|6
7724635|NCT00979992|26862236|P1|Overall Study|Refused - Never Treated|2
7724636|NCT00979992|26862236|P1|Overall Study|Ineligible - wrong cell type|2
7724637|NCT00979992|26862236|P1|Overall Study|Ineligible - inadequate pathology|1
7724638|NCT00979953|26862248|P4|Overall Study|Protocol Violation|2
7724639|NCT00979953|26862249|P3|Overall Study|Protocol Violation|2
7724640|NCT00979953|26862250|P2|Overall Study|Protocol Violation|0
7724641|NCT00979953|26862251|P1|Overall Study|Protocol Violation|1
7724642|NCT00979953|26862248|P4|Overall Study|Withdrawal by Subject|1
7724643|NCT00979953|26862249|P3|Overall Study|Withdrawal by Subject|2
7724644|NCT00979953|26862250|P2|Overall Study|Withdrawal by Subject|0
7724645|NCT00979953|26862251|P1|Overall Study|Withdrawal by Subject|0
7724646|NCT00979953|26862248|P4|Overall Study|Lost to Follow-up|0
7724647|NCT00979953|26862249|P3|Overall Study|Lost to Follow-up|1
7724648|NCT00979953|26862250|P2|Overall Study|Lost to Follow-up|1
7724649|NCT00979953|26862251|P1|Overall Study|Lost to Follow-up|1
7724650|NCT00979953|26862248|P4|Overall Study|Lack of Efficacy|0
7724651|NCT00979953|26862249|P3|Overall Study|Lack of Efficacy|0
7724652|NCT00979953|26862250|P2|Overall Study|Lack of Efficacy|2
7724653|NCT00979953|26862251|P1|Overall Study|Lack of Efficacy|1
7724654|NCT00979953|26862248|P4|Overall Study|Adverse Event|4
7724655|NCT00979953|26862249|P3|Overall Study|Adverse Event|17
7724656|NCT00979953|26862250|P2|Overall Study|Adverse Event|2
7724657|NCT00979953|26862251|P1|Overall Study|Adverse Event|5
7724658|NCT00979901|26862274|P4|Overall Study|Treatment Group Terminated by Sponsor|112
7724659|NCT00979901|26862275|P3|Overall Study|Treatment Group Terminated by Sponsor|0
7724660|NCT00979901|26862276|P2|Overall Study|Treatment Group Terminated by Sponsor|0
7724661|NCT00979901|26862277|P1|Overall Study|Treatment Group Terminated by Sponsor|0
7724662|NCT00979901|26862274|P4|Overall Study|Left Country|0
7724663|NCT00979901|26862275|P3|Overall Study|Left Country|1
7724664|NCT00979901|26862276|P2|Overall Study|Left Country|0
7724665|NCT00979901|26862277|P1|Overall Study|Left Country|0
7724666|NCT00979901|26862274|P4|Overall Study|Discontinued in Error|0
7724667|NCT00979901|26862275|P3|Overall Study|Discontinued in Error|0
7724668|NCT00979901|26862276|P2|Overall Study|Discontinued in Error|1
7724669|NCT00979901|26862277|P1|Overall Study|Discontinued in Error|0
7724670|NCT00979901|26862274|P4|Overall Study|elevated lab values pre-randomization|0
7724671|NCT00979901|26862275|P3|Overall Study|elevated lab values pre-randomization|0
7724672|NCT00979901|26862276|P2|Overall Study|elevated lab values pre-randomization|0
7724673|NCT00979901|26862277|P1|Overall Study|elevated lab values pre-randomization|1
7724674|NCT00979901|26862274|P4|Overall Study|vacation|0
7724675|NCT00979901|26862275|P3|Overall Study|vacation|0
7724676|NCT00979901|26862276|P2|Overall Study|vacation|0
7724677|NCT00979901|26862277|P1|Overall Study|vacation|1
7724678|NCT00979901|26862274|P4|Overall Study|out-of-state|0
7724679|NCT00979901|26862275|P3|Overall Study|out-of-state|0
7724680|NCT00979901|26862276|P2|Overall Study|out-of-state|0
7724681|NCT00979901|26862277|P1|Overall Study|out-of-state|1
7724682|NCT00979901|26862274|P4|Overall Study|Noncompliance|0
7724683|NCT00979901|26862275|P3|Overall Study|Noncompliance|0
7724684|NCT00979901|26862276|P2|Overall Study|Noncompliance|0
7724685|NCT00979901|26862277|P1|Overall Study|Noncompliance|1
7724686|NCT00979901|26862274|P4|Overall Study|Withdrawal by Subject|1
7724687|NCT00979901|26862275|P3|Overall Study|Withdrawal by Subject|1
7724688|NCT00979901|26862276|P2|Overall Study|Withdrawal by Subject|1
7724689|NCT00979901|26862277|P1|Overall Study|Withdrawal by Subject|2
7724690|NCT00979901|26862274|P4|Overall Study|Protocol Violation|1
7724691|NCT00979901|26862275|P3|Overall Study|Protocol Violation|7
7724692|NCT00979901|26862276|P2|Overall Study|Protocol Violation|2
7724693|NCT00979901|26862277|P1|Overall Study|Protocol Violation|2
7724694|NCT00979901|26862274|P4|Overall Study|Lost to Follow-up|0
7724695|NCT00979901|26862275|P3|Overall Study|Lost to Follow-up|2
7724696|NCT00979901|26862276|P2|Overall Study|Lost to Follow-up|1
7724697|NCT00979901|26862277|P1|Overall Study|Lost to Follow-up|1
7724698|NCT00979901|26862274|P4|Overall Study|Lack of Efficacy|0
7724699|NCT00979901|26862275|P3|Overall Study|Lack of Efficacy|9
7724700|NCT00979901|26862276|P2|Overall Study|Lack of Efficacy|4
7724701|NCT00979901|26862277|P1|Overall Study|Lack of Efficacy|8
7724702|NCT00979901|26862274|P4|Overall Study|Adverse Event|2
7724703|NCT00979901|26862275|P3|Overall Study|Adverse Event|9
7724704|NCT00979901|26862276|P2|Overall Study|Adverse Event|3
7724705|NCT00979901|26862277|P1|Overall Study|Adverse Event|1
7724706|NCT00979654|26862377|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
7724707|NCT00979654|26862377|P1|Overall Study|Serious Adverse Event|1
7724708|NCT00979654|26862377|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
7724709|NCT00979654|26862377|P1|Overall Study|Per Principal Investigator's Discretion|1
7724710|NCT00979654|26862377|P1|Overall Study|Adverse Event of Diverticulitis|1
7724711|NCT00979654|26862377|P1|Overall Study|Adverse Event|1
7724712|NCT00979654|26862377|P1|Overall Study|Lack of Efficacy|6
7724713|NCT00979654|26862377|P1|Overall Study|Death|1
7724714|NCT00979654|26862377|P1|Overall Study|Withdrawal by Subject|22
7724715|NCT00979654|26862377|P1|Overall Study|Lost to Follow-up|1
7724716|NCT00979628|26862392|P3|Overall Study|transferred to ICU|1
7724717|NCT00979628|26862393|P2|Overall Study|transferred to ICU|2
7724718|NCT00979628|26862394|P1|Overall Study|transferred to ICU|1
7724719|NCT00979628|26862392|P3|Overall Study|received steroids|0
7724720|NCT00979628|26862393|P2|Overall Study|received steroids|1
7724721|NCT00979628|26862394|P1|Overall Study|received steroids|1
7724722|NCT00979628|26862392|P3|Overall Study|received regimen < 24 hours|5
7724723|NCT00979628|26862393|P2|Overall Study|received regimen < 24 hours|6
7724724|NCT00979628|26862394|P1|Overall Study|received regimen < 24 hours|7
7724725|NCT00979602|26862424|P2|Overall Study|Others|3
7724726|NCT00979602|26862425|P1|Overall Study|Others|3
7724727|NCT00979602|26862424|P2|Overall Study|Migrated/moved from study area|6
7724728|NCT00979602|26862425|P1|Overall Study|Migrated/moved from study area|3
7724729|NCT00979602|26862424|P2|Overall Study|Lost to Follow-up|96
7724730|NCT00979602|26862425|P1|Overall Study|Lost to Follow-up|100
7724731|NCT00979602|26862424|P2|Overall Study|Withdrawal by Subject|25
7724732|NCT00979602|26862425|P1|Overall Study|Withdrawal by Subject|31
7724733|NCT00979602|26862424|P2|Overall Study|Protocol Violation|0
7724734|NCT00979602|26862425|P1|Overall Study|Protocol Violation|3
7724735|NCT00979602|26862424|P2|Overall Study|Serious Adverse Event|3
7724736|NCT00979602|26862425|P1|Overall Study|Serious Adverse Event|5
7724737|NCT00979576|26862596|P3|Combination Followed by Monotherapy|Progressive Disease|1
7724738|NCT00979576|26862597|P2|Combination Followed by Monotherapy|Progressive Disease|2
7724739|NCT00979576|26862598|P1|Combination Followed by Monotherapy|Progressive Disease|0
7724740|NCT00979576|26862596|P3|Combination Treatment Phase|Adverse Event|2
7724741|NCT00979576|26862597|P2|Combination Treatment Phase|Adverse Event|2
7724742|NCT00979576|26862598|P1|Combination Treatment Phase|Adverse Event|0
7724743|NCT00979576|26862596|P3|Combination Treatment Phase|Dose limiting toxicity|2
7724744|NCT00979576|26862597|P2|Combination Treatment Phase|Dose limiting toxicity|3
7724745|NCT00979576|26862598|P1|Combination Treatment Phase|Dose limiting toxicity|0
7724746|NCT00979576|26862596|P3|Combination Treatment Phase|Progressive disease|5
7724747|NCT00979576|26862597|P2|Combination Treatment Phase|Progressive disease|1
7724748|NCT00979576|26862598|P1|Combination Treatment Phase|Progressive disease|3
7724749|NCT00979420|26862655|P4|Overall Study|Other reasons not related to Viramune|1
7724750|NCT00979420|26862656|P3|Overall Study|Other reasons not related to Viramune|0
7724751|NCT00979420|26862657|P2|Overall Study|Other reasons not related to Viramune|0
7724752|NCT00979420|26862658|P1|Overall Study|Other reasons not related to Viramune|3
7724753|NCT00979420|26862655|P4|Overall Study|Lack of Efficacy|1
7724754|NCT00979420|26862656|P3|Overall Study|Lack of Efficacy|1
7724755|NCT00979420|26862657|P2|Overall Study|Lack of Efficacy|0
7724756|NCT00979420|26862658|P1|Overall Study|Lack of Efficacy|3
7724757|NCT00979420|26862655|P4|Overall Study|Adverse Event|0
7724758|NCT00979420|26862656|P3|Overall Study|Adverse Event|0
7724759|NCT00979420|26862657|P2|Overall Study|Adverse Event|0
7724760|NCT00979420|26862658|P1|Overall Study|Adverse Event|1
7724761|NCT00979407|26862728|P2|Overall Study|Lost to Follow-up|3
7724762|NCT00979407|26862729|P1|Overall Study|Lost to Follow-up|3
7724763|NCT00979407|26862728|P2|Overall Study|Withdrawal by Subject|4
7724764|NCT00979407|26862729|P1|Overall Study|Withdrawal by Subject|3
7724765|NCT00979212|26862782|P2|Overall Study|No protocol therapy received|0
7724766|NCT00979212|26862783|P1|Overall Study|No protocol therapy received|1
7724767|NCT00979212|26862782|P2|Overall Study|Protocol Violation|8
7724768|NCT00979212|26862783|P1|Overall Study|Protocol Violation|1
7724769|NCT00979134|26862820|P3|Overall Study|Other|5
7724770|NCT00979134|26862821|P2|Overall Study|Other|1
7724771|NCT00979134|26862822|P1|Overall Study|Other|8
7724772|NCT00979134|26862820|P3|Overall Study|Death|26
7724773|NCT00979134|26862821|P2|Overall Study|Death|0
7724774|NCT00979134|26862822|P1|Overall Study|Death|4
7724775|NCT00979134|26862820|P3|Overall Study|Lost to Follow-up|0
7724776|NCT00979134|26862821|P2|Overall Study|Lost to Follow-up|2
7724777|NCT00979134|26862822|P1|Overall Study|Lost to Follow-up|2
7724778|NCT00979134|26862820|P3|Overall Study|Withdrawal by Subject|2
7724779|NCT00979134|26862821|P2|Overall Study|Withdrawal by Subject|1
7724780|NCT00979134|26862822|P1|Overall Study|Withdrawal by Subject|1
7724781|NCT00979134|26862820|P3|Overall Study|Adverse Event|2
7724782|NCT00979134|26862821|P2|Overall Study|Adverse Event|0
7724783|NCT00979134|26862822|P1|Overall Study|Adverse Event|0
7724784|NCT00979134|26862820|P3|Overall Study|Disease progression|5
7724785|NCT00979134|26862821|P2|Overall Study|Disease progression|2
7724786|NCT00979134|26862822|P1|Overall Study|Disease progression|18
7724787|NCT00978757|26862914|P2|Overall Study|Physician Decision|3
7724788|NCT00978757|26862915|P1|Overall Study|Physician Decision|1
7724789|NCT00978731|26862925|P4|Overall Study|No response|0
7724790|NCT00978731|26862926|P3|Overall Study|No response|0
7724791|NCT00978731|26862927|P2|Overall Study|No response|0
7724792|NCT00978731|26862928|P1|Overall Study|No response|1
7724793|NCT00978731|26862925|P4|Overall Study|Study closure|1
7724794|NCT00978731|26862926|P3|Overall Study|Study closure|1
7724795|NCT00978731|26862927|P2|Overall Study|Study closure|4
7724796|NCT00978731|26862928|P1|Overall Study|Study closure|3
7724797|NCT00978731|26862925|P4|Overall Study|Disease progression/relapse|2
7724798|NCT00978731|26862926|P3|Overall Study|Disease progression/relapse|2
7724799|NCT00978731|26862927|P2|Overall Study|Disease progression/relapse|4
7724800|NCT00978731|26862928|P1|Overall Study|Disease progression/relapse|5
7724801|NCT00978731|26862925|P4|Overall Study|Deterioration without progression|0
7724802|NCT00978731|26862926|P3|Overall Study|Deterioration without progression|0
7724803|NCT00978731|26862927|P2|Overall Study|Deterioration without progression|1
7724804|NCT00978731|26862928|P1|Overall Study|Deterioration without progression|0
7724805|NCT00978731|26862925|P4|Overall Study|Administrative reason|0
7724806|NCT00978731|26862926|P3|Overall Study|Administrative reason|1
7724807|NCT00978731|26862927|P2|Overall Study|Administrative reason|3
7724808|NCT00978731|26862928|P1|Overall Study|Administrative reason|3
7724809|NCT00978731|26862925|P4|Overall Study|Participant's request|0
7724810|NCT00978731|26862926|P3|Overall Study|Participant's request|0
7724811|NCT00978731|26862927|P2|Overall Study|Participant's request|0
7724812|NCT00978731|26862928|P1|Overall Study|Participant's request|1
7724813|NCT00978731|26862925|P4|Overall Study|Adverse Event|0
7724814|NCT00978731|26862926|P3|Overall Study|Adverse Event|0
7724815|NCT00978731|26862927|P2|Overall Study|Adverse Event|2
7724816|NCT00978731|26862928|P1|Overall Study|Adverse Event|5
7724817|NCT00978731|26862925|P4|Overall Study|Lost to Follow-up|1
7724818|NCT00978731|26862926|P3|Overall Study|Lost to Follow-up|0
7724819|NCT00978731|26862927|P2|Overall Study|Lost to Follow-up|0
7724820|NCT00978731|26862928|P1|Overall Study|Lost to Follow-up|0
7724821|NCT00978731|26862925|P4|Overall Study|Death|0
7724822|NCT00978731|26862926|P3|Overall Study|Death|1
7724823|NCT00978731|26862927|P2|Overall Study|Death|1
7724824|NCT00978731|26862928|P1|Overall Study|Death|4
7724825|NCT00978627|26862968|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
7724826|NCT00978627|26862969|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
7724827|NCT00978627|26862968|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
7724828|NCT00978627|26862969|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
7724829|NCT00978627|26862968|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
7724830|NCT00978627|26862969|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
7724831|NCT00978627|26862968|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
7724832|NCT00978627|26862969|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
7724833|NCT00978627|26862968|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
7724834|NCT00978627|26862969|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
7724835|NCT00978627|26862968|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
7724836|NCT00978627|26862969|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
7724837|NCT00978627|26862968|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
7724838|NCT00978627|26862969|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
7724839|NCT00978627|26862968|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
7724840|NCT00978627|26862969|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
7724841|NCT00978627|26862968|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
7724842|NCT00978627|26862969|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
7724843|NCT00978432|26863007|P3|Overall Study|Adverse Event|1
7724844|NCT00978432|26863008|P2|Overall Study|Adverse Event|0
7724845|NCT00978432|26863009|P1|Overall Study|Adverse Event|2
7724846|NCT00978432|26863007|P3|Overall Study|Lack of Efficacy|3
7724847|NCT00978432|26863008|P2|Overall Study|Lack of Efficacy|1
7724848|NCT00978432|26863009|P1|Overall Study|Lack of Efficacy|1
7724849|NCT00978432|26863007|P3|Overall Study|Withdrawal by Subject|1
7724850|NCT00978432|26863008|P2|Overall Study|Withdrawal by Subject|0
7724851|NCT00978432|26863009|P1|Overall Study|Withdrawal by Subject|0
7724852|NCT00978380|26863060|P1|Overall Study|Unclassified|8
7724853|NCT00978380|26863060|P1|Overall Study|Withdrawal criteria|9
7724854|NCT00978380|26863060|P1|Overall Study|Protocol Violation|2
7724855|NCT00978341|26863066|P2|Washout Period of 2 Weeks|Adverse Event|0
7724856|NCT00978341|26863067|P1|Washout Period of 2 Weeks|Adverse Event|1
7724857|NCT00978250|26863089|P4|Overall Study|Late determination of ineligibility|1
7724858|NCT00978250|26863090|P3|Overall Study|Late determination of ineligibility|0
7724859|NCT00978250|26863091|P2|Overall Study|Late determination of ineligibility|1
7724860|NCT00978250|26863092|P1|Overall Study|Late determination of ineligibility|0
7724861|NCT00978120|26863108|P4|Overall Study|Moved out of state|1
7724862|NCT00978120|26863109|P3|Overall Study|Moved out of state|0
7724863|NCT00978120|26863110|P2|Overall Study|Moved out of state|0
7724864|NCT00978120|26863111|P1|Overall Study|Moved out of state|0
7724865|NCT00978120|26863108|P4|Overall Study|Withdrawal by Subject|0
7724866|NCT00978120|26863109|P3|Overall Study|Withdrawal by Subject|0
7724867|NCT00978120|26863110|P2|Overall Study|Withdrawal by Subject|0
7724868|NCT00978120|26863111|P1|Overall Study|Withdrawal by Subject|2
7724869|NCT00978120|26863108|P4|Overall Study|Lost to Follow-up|0
7724870|NCT00978120|26863109|P3|Overall Study|Lost to Follow-up|3
7724871|NCT00978120|26863110|P2|Overall Study|Lost to Follow-up|0
7724872|NCT00978120|26863111|P1|Overall Study|Lost to Follow-up|0
7724873|NCT00978120|26863108|P4|Overall Study|Death|1
7724874|NCT00978120|26863109|P3|Overall Study|Death|0
7724875|NCT00978120|26863110|P2|Overall Study|Death|0
7724876|NCT00978120|26863111|P1|Overall Study|Death|0
7724877|NCT00978068|26863163|P2|Overall Study|Unable to Comply with Study|2
7724878|NCT00978068|26863164|P1|Overall Study|Unable to Comply with Study|0
7724879|NCT00978068|26863163|P2|Overall Study|Physician Decision|1
7724880|NCT00978068|26863164|P1|Overall Study|Physician Decision|0
7724881|NCT00978068|26863163|P2|Overall Study|Lost to Follow-up|2
7724882|NCT00978068|26863164|P1|Overall Study|Lost to Follow-up|1
7724883|NCT00978068|26863163|P2|Overall Study|Death|2
7724884|NCT00978068|26863164|P1|Overall Study|Death|1
7724885|NCT00978068|26863163|P2|Overall Study|Were Awaiting Initiation of ART|2
7724886|NCT00978068|26863164|P1|Overall Study|Were Awaiting Initiation of ART|2
7724887|NCT00978042|26863182|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
7724888|NCT00978042|26863183|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
7724889|NCT00978042|26863182|P2|Initial Treatment Period|Consent withdrawn|9
7724890|NCT00978042|26863183|P1|Initial Treatment Period|Consent withdrawn|22
7724891|NCT00978042|26863182|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
7724892|NCT00978042|26863183|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
7724893|NCT00978042|26863182|P2|Initial Treatment Period|Adverse Event|0
7724894|NCT00978042|26863183|P1|Initial Treatment Period|Adverse Event|2
7724895|NCT00978042|26863182|P2|Initial Treatment Period|Lost to Follow-up|3
7724896|NCT00978042|26863183|P1|Initial Treatment Period|Lost to Follow-up|21
7724897|NCT00978042|26863182|P2|Initial Treatment Period|Ineligibility|0
7724898|NCT00978042|26863183|P1|Initial Treatment Period|Ineligibility|1
7724899|NCT00978042|26863182|P2|Initial Treatment Period|Treated in Error|3
7724900|NCT00978042|26863183|P1|Initial Treatment Period|Treated in Error|0
7724901|NCT00978029|26863196|P3|Overall Study|Protocol Violation|0
7724902|NCT00978029|26863197|P2|Overall Study|Protocol Violation|1
7724903|NCT00978029|26863198|P1|Overall Study|Protocol Violation|0
7724904|NCT00978029|26863196|P3|Overall Study|Withdrawal by Subject|1
7724905|NCT00978029|26863197|P2|Overall Study|Withdrawal by Subject|0
7724906|NCT00978029|26863198|P1|Overall Study|Withdrawal by Subject|0
7724907|NCT00978029|26863196|P3|Overall Study|Adverse Event|5
7724908|NCT00978029|26863197|P2|Overall Study|Adverse Event|2
7724909|NCT00978029|26863198|P1|Overall Study|Adverse Event|1
7724910|NCT00977938|26863225|P4|Observation (30-33 mo. Post Procedure)|Other|0
7724911|NCT00977938|26863226|P3|Observation (30-33 mo. Post Procedure)|Other|0
7724912|NCT00977938|26863227|P2|Observation (30-33 mo. Post Procedure)|Other|4
7724913|NCT00977938|26863228|P1|Observation (30-33 mo. Post Procedure)|Other|8
7724914|NCT00977938|26863225|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
7724915|NCT00977938|26863226|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
7724916|NCT00977938|26863227|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
7724917|NCT00977938|26863228|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
7724918|NCT00977938|26863225|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
7724919|NCT00977938|26863226|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
7724920|NCT00977938|26863227|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
7724921|NCT00977938|26863228|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
7724922|NCT00977938|26863225|P4|Treatment (12-30 mo. Post Procedure)|Other|4
7724923|NCT00977938|26863226|P3|Treatment (12-30 mo. Post Procedure)|Other|3
7724924|NCT00977938|26863227|P2|Treatment (12-30 mo. Post Procedure)|Other|18
7724925|NCT00977938|26863228|P1|Treatment (12-30 mo. Post Procedure)|Other|17
7724926|NCT00977938|26863225|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
7724927|NCT00977938|26863226|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
7724928|NCT00977938|26863227|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
7724929|NCT00977938|26863228|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
7724930|NCT00977938|26863225|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
7724931|NCT00977938|26863226|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
7724932|NCT00977938|26863227|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
7724933|NCT00977938|26863228|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
7724934|NCT00977665|26863305|P2|Overall Study|Treatment failure|1
7724935|NCT00977665|26863306|P1|Overall Study|Treatment failure|0
7724936|NCT00977665|26863305|P2|Overall Study|Adverse Event|7
7724937|NCT00977665|26863306|P1|Overall Study|Adverse Event|14
7724938|NCT00977665|26863305|P2|Overall Study|Death|2
7724939|NCT00977665|26863306|P1|Overall Study|Death|3
7724940|NCT00977665|26863305|P2|Overall Study|Lost to Follow-up|0
7724941|NCT00977665|26863306|P1|Overall Study|Lost to Follow-up|1
7724942|NCT00977665|26863305|P2|Overall Study|Sponsor requested withdrawal|1
7724943|NCT00977665|26863306|P1|Overall Study|Sponsor requested withdrawal|0
7724944|NCT00977665|26863305|P2|Overall Study|Physician Decision|1
7724945|NCT00977665|26863306|P1|Overall Study|Physician Decision|2
7724946|NCT00977665|26863305|P2|Overall Study|Withdrawal by Subject|3
7724947|NCT00977665|26863306|P1|Overall Study|Withdrawal by Subject|1
7724948|NCT00977613|26863338|P1|Overall Study|Lost to Follow-up|16
7724949|NCT00977574|26863345|P3|Overall Study|Never Treated|4
7724950|NCT00977574|26863346|P2|Overall Study|Never Treated|2
7724951|NCT00977574|26863347|P1|Overall Study|Never Treated|4
7724952|NCT00977561|26863366|P2|Overall Study|Other|0
7724953|NCT00977561|26863367|P1|Overall Study|Other|2
7724954|NCT00977561|26863366|P2|Overall Study|Study terminated|2
7724955|NCT00977561|26863367|P1|Overall Study|Study terminated|0
7724956|NCT00977561|26863366|P2|Overall Study|Death|2
7724957|NCT00977561|26863367|P1|Overall Study|Death|3
7724958|NCT00977548|26863394|P1|Overall Study|Withdrawal by Subject|1
7724959|NCT00977548|26863394|P1|Overall Study|Adverse Event|8
7724960|NCT00977548|26863394|P1|Overall Study|Ineligible|4
7724961|NCT00977470|26863403|P2|Overall Study|Still on-study|0
7724962|NCT00977470|26863404|P1|Overall Study|Still on-study|2
7724963|NCT00977470|26863403|P2|Overall Study|prolonged recovery post-surgery|1
7724964|NCT00977470|26863404|P1|Overall Study|prolonged recovery post-surgery|0
7724965|NCT00977470|26863403|P2|Overall Study|clinical decline|1
7724966|NCT00977470|26863404|P1|Overall Study|clinical decline|0
7724967|NCT00977470|26863403|P2|Overall Study|Death|2
7724968|NCT00977470|26863404|P1|Overall Study|Death|0
7724969|NCT00977470|26863403|P2|Overall Study|Withdrawal by Subject|2
7724970|NCT00977470|26863404|P1|Overall Study|Withdrawal by Subject|0
7724971|NCT00977470|26863403|P2|Overall Study|Protocol Violation|0
7724972|NCT00977470|26863404|P1|Overall Study|Protocol Violation|1
7724973|NCT00977470|26863403|P2|Overall Study|Adverse Event|2
7724974|NCT00977470|26863404|P1|Overall Study|Adverse Event|1
7724975|NCT00977470|26863403|P2|Overall Study|Physician Decision|0
7724976|NCT00977470|26863404|P1|Overall Study|Physician Decision|2
7724977|NCT00977470|26863403|P2|Overall Study|Lack of Efficacy|30
7724978|NCT00977470|26863404|P1|Overall Study|Lack of Efficacy|32
7724979|NCT00977431|26863427|P5|Overall Study|Progressive disease|5
7724980|NCT00977431|26863428|P4|Overall Study|Progressive disease|3
7724981|NCT00977431|26863429|P3|Overall Study|Progressive disease|1
7724982|NCT00977431|26863430|P2|Overall Study|Progressive disease|6
7724983|NCT00977431|26863431|P1|Overall Study|Progressive disease|2
7724984|NCT00977431|26863427|P5|Overall Study|Dose-limiting toxicity (DLT)|0
7724985|NCT00977431|26863428|P4|Overall Study|Dose-limiting toxicity (DLT)|0
7724986|NCT00977431|26863429|P3|Overall Study|Dose-limiting toxicity (DLT)|1
7724987|NCT00977431|26863430|P2|Overall Study|Dose-limiting toxicity (DLT)|0
7724988|NCT00977431|26863431|P1|Overall Study|Dose-limiting toxicity (DLT)|1
7724989|NCT00977431|26863427|P5|Overall Study|Adverse Event|6
7724990|NCT00977431|26863428|P4|Overall Study|Adverse Event|0
7724991|NCT00977431|26863429|P3|Overall Study|Adverse Event|4
7724992|NCT00977431|26863430|P2|Overall Study|Adverse Event|0
7724993|NCT00977431|26863431|P1|Overall Study|Adverse Event|3
7724994|NCT00977431|26863427|P5|Overall Study|Protocol Violation|0
7724995|NCT00977431|26863428|P4|Overall Study|Protocol Violation|0
7724996|NCT00977431|26863429|P3|Overall Study|Protocol Violation|1
7724997|NCT00977431|26863430|P2|Overall Study|Protocol Violation|0
7724998|NCT00977431|26863431|P1|Overall Study|Protocol Violation|0
7724999|NCT00977431|26863427|P5|Overall Study|Other than listed|2
7725000|NCT00977431|26863428|P4|Overall Study|Other than listed|0
7725001|NCT00977431|26863429|P3|Overall Study|Other than listed|0
7725002|NCT00977431|26863430|P2|Overall Study|Other than listed|0
7725003|NCT00977431|26863431|P1|Overall Study|Other than listed|1
7725004|NCT00977379|26863464|P2|Overall Study|Randomization Error|1
7725005|NCT00977379|26863465|P1|Overall Study|Randomization Error|0
7725006|NCT00977379|26863464|P2|Overall Study|Participant Moving House|1
7725007|NCT00977379|26863465|P1|Overall Study|Participant Moving House|0
7725008|NCT00977379|26863464|P2|Overall Study|Premature Study Termination|0
7725009|NCT00977379|26863465|P1|Overall Study|Premature Study Termination|4
7725010|NCT00977379|26863464|P2|Overall Study|Death|9
7725011|NCT00977379|26863465|P1|Overall Study|Death|7
7725012|NCT00977379|26863464|P2|Overall Study|Withdrawal by Subject|1
7725013|NCT00977379|26863465|P1|Overall Study|Withdrawal by Subject|1
7725014|NCT00977314|26863501|P2|Overall Study|Physician Decision|0
7725015|NCT00977314|26863502|P1|Overall Study|Physician Decision|1
7725016|NCT00977314|26863501|P2|Overall Study|Withdrawal by Subject|0
7725017|NCT00977314|26863502|P1|Overall Study|Withdrawal by Subject|1
7725018|NCT00977197|26863510|P2|Overall Study|Nonadherence|1
7725019|NCT00977197|26863511|P1|Overall Study|Nonadherence|1
7725020|NCT00977197|26863510|P2|Overall Study|Lost to Follow-up|3
7725021|NCT00977197|26863511|P1|Overall Study|Lost to Follow-up|1
7725022|NCT00977197|26863510|P2|Overall Study|Lack of Efficacy|0
7725023|NCT00977197|26863511|P1|Overall Study|Lack of Efficacy|1
7725024|NCT00977197|26863510|P2|Overall Study|Adverse Event|1
7725025|NCT00977197|26863511|P1|Overall Study|Adverse Event|3
7725026|NCT00977197|26863510|P2|Overall Study|Withdrawal by Subject|4
7725027|NCT00977197|26863511|P1|Overall Study|Withdrawal by Subject|3
7725028|NCT00977106|26863574|P2|Overall Study|Other|0
7725029|NCT00977106|26863575|P1|Overall Study|Other|1
7725030|NCT00977106|26863574|P2|Overall Study|Protocol Violation|1
7725031|NCT00977106|26863575|P1|Overall Study|Protocol Violation|0
7725032|NCT00977106|26863574|P2|Overall Study|Lack of Efficacy|2
7725033|NCT00977106|26863575|P1|Overall Study|Lack of Efficacy|2
7725034|NCT00977106|26863574|P2|Overall Study|Withdrawal by Subject|2
7725035|NCT00977106|26863575|P1|Overall Study|Withdrawal by Subject|2
7725036|NCT00977106|26863574|P2|Overall Study|Adverse Event|6
7725037|NCT00977106|26863575|P1|Overall Study|Adverse Event|5
7725038|NCT00977080|26863667|P4|Overall Study|Travel for family reasons|0
7725039|NCT00977080|26863668|P3|Overall Study|Travel for family reasons|0
7725040|NCT00977080|26863669|P2|Overall Study|Travel for family reasons|0
7725041|NCT00977080|26863670|P1|Overall Study|Travel for family reasons|1
7725042|NCT00977080|26863667|P4|Overall Study|Required kidney transplantation|1
7725043|NCT00977080|26863668|P3|Overall Study|Required kidney transplantation|3
7725044|NCT00977080|26863669|P2|Overall Study|Required kidney transplantation|3
7725045|NCT00977080|26863670|P1|Overall Study|Required kidney transplantation|1
7725046|NCT00977080|26863667|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
7725047|NCT00977080|26863668|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7725048|NCT00977080|26863669|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7725049|NCT00977080|26863670|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7725050|NCT00977080|26863667|P4|Overall Study|Noncompliance|0
7725051|NCT00977080|26863668|P3|Overall Study|Noncompliance|1
7725052|NCT00977080|26863669|P2|Overall Study|Noncompliance|2
7725053|NCT00977080|26863670|P1|Overall Study|Noncompliance|0
7725054|NCT00977080|26863667|P4|Overall Study|Protocol Violation|3
7725055|NCT00977080|26863668|P3|Overall Study|Protocol Violation|4
7725056|NCT00977080|26863669|P2|Overall Study|Protocol Violation|3
7725057|NCT00977080|26863670|P1|Overall Study|Protocol Violation|7
7725058|NCT00977080|26863667|P4|Overall Study|Withdrawal by Subject|5
7725059|NCT00977080|26863668|P3|Overall Study|Withdrawal by Subject|1
7725060|NCT00977080|26863669|P2|Overall Study|Withdrawal by Subject|5
7725061|NCT00977080|26863670|P1|Overall Study|Withdrawal by Subject|1
7725062|NCT00977080|26863667|P4|Overall Study|Adverse Event|7
7725063|NCT00977080|26863668|P3|Overall Study|Adverse Event|7
7725064|NCT00977080|26863669|P2|Overall Study|Adverse Event|7
7725065|NCT00977080|26863670|P1|Overall Study|Adverse Event|2
7725066|NCT00976989|26863703|P3|Overall Study|Other|1
7725067|NCT00976989|26863704|P2|Overall Study|Other|0
7725068|NCT00976989|26863705|P1|Overall Study|Other|1
7725069|NCT00976989|26863703|P3|Overall Study|Recurrence of Disease|0
7725070|NCT00976989|26863704|P2|Overall Study|Recurrence of Disease|1
7725071|NCT00976989|26863705|P1|Overall Study|Recurrence of Disease|0
7725072|NCT00976989|26863703|P3|Overall Study|Failure to Return|0
7725073|NCT00976989|26863704|P2|Overall Study|Failure to Return|1
7725074|NCT00976989|26863705|P1|Overall Study|Failure to Return|2
7725075|NCT00976989|26863703|P3|Overall Study|Refused Treatment|5
7725076|NCT00976989|26863704|P2|Overall Study|Refused Treatment|3
7725077|NCT00976989|26863705|P1|Overall Study|Refused Treatment|4
7725078|NCT00976989|26863703|P3|Overall Study|Death|10
7725079|NCT00976989|26863704|P2|Overall Study|Death|7
7725080|NCT00976989|26863705|P1|Overall Study|Death|5
7725081|NCT00976989|26863703|P3|Overall Study|Violation of Selection Criteria at Entry|1
7725082|NCT00976989|26863704|P2|Overall Study|Violation of Selection Criteria at Entry|0
7725083|NCT00976989|26863705|P1|Overall Study|Violation of Selection Criteria at Entry|1
7725084|NCT00976950|26863746|P1|Overall Study|Events with no relationship to Aptivus|3
7725085|NCT00976950|26863746|P1|Overall Study|Adverse Event|3
7725086|NCT00976937|26863754|P2|Overall Study|Personal and Familial Reason|2
7725087|NCT00976937|26863755|P1|Overall Study|Personal and Familial Reason|2
7725088|NCT00976937|26863754|P2|Overall Study|Poor compliance to protocol|0
7725089|NCT00976937|26863755|P1|Overall Study|Poor compliance to protocol|3
7725090|NCT00976937|26863754|P2|Overall Study|Withdrawal by Subject|3
7725091|NCT00976937|26863755|P1|Overall Study|Withdrawal by Subject|5
7725092|NCT00976937|26863754|P2|Overall Study|Lost to Follow-up|1
7725093|NCT00976937|26863755|P1|Overall Study|Lost to Follow-up|2
7725094|NCT00976937|26863754|P2|Overall Study|Adverse Event|5
7725095|NCT00976937|26863755|P1|Overall Study|Adverse Event|4
7725096|NCT00976911|26863797|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
7725097|NCT00976911|26863798|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
7725098|NCT00976911|26863797|P2|Overall Study|Other|9
7725099|NCT00976911|26863798|P1|Overall Study|Other|8
7725100|NCT00976911|26863797|P2|Overall Study|Protocol Violation|0
7725101|NCT00976911|26863798|P1|Overall Study|Protocol Violation|2
7725102|NCT00976911|26863797|P2|Overall Study|Adverse Event|1
7725103|NCT00976911|26863798|P1|Overall Study|Adverse Event|0
7725104|NCT00976911|26863797|P2|Overall Study|Death|126
7725105|NCT00976911|26863798|P1|Overall Study|Death|138
7725106|NCT00976911|26863797|P2|Overall Study|Withdrawal by Subject|6
7725107|NCT00976911|26863798|P1|Overall Study|Withdrawal by Subject|4
7725108|NCT00976898|26863816|P1|Overall Study|Progressive Disease|1
7725109|NCT00976898|26863816|P1|Overall Study|Liver Transplant|1
7725110|NCT00976898|26863816|P1|Overall Study|Physician Decision|1
7725111|NCT00976898|26863816|P1|Overall Study|Adverse Event|1
7725112|NCT00976898|26863816|P1|Overall Study|Protocol Violation|1
7725113|NCT00976820|26863827|P4|Overall Study|Withdrawal by Subject|4
7725114|NCT00976820|26863828|P3|Overall Study|Withdrawal by Subject|1
7725115|NCT00976820|26863829|P2|Overall Study|Withdrawal by Subject|4
7725116|NCT00976820|26863830|P1|Overall Study|Withdrawal by Subject|2
7725117|NCT00976820|26863827|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
7725118|NCT00976820|26863828|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
7725119|NCT00976820|26863829|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
7725120|NCT00976820|26863830|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
7725121|NCT00976820|26863827|P4|Overall Study|Lost to Follow-up|3
7725122|NCT00976820|26863828|P3|Overall Study|Lost to Follow-up|2
7725123|NCT00976820|26863829|P2|Overall Study|Lost to Follow-up|16
7725124|NCT00976820|26863830|P1|Overall Study|Lost to Follow-up|5
7725125|NCT00976716|26864166|P1|Overall Study|Adverse Event|1
7725126|NCT00976703|26864184|P2|Overall Study|ineligible for study|2
7725127|NCT00976703|26864185|P1|Overall Study|ineligible for study|2
7725128|NCT00976703|26864184|P2|Overall Study|Physician Decision|1
7725129|NCT00976703|26864185|P1|Overall Study|Physician Decision|1
7725130|NCT00976677|26864199|P2|Overall Study|Unknown/Missing|0
7725131|NCT00976677|26864200|P1|Overall Study|Unknown/Missing|1
7725132|NCT00976677|26864199|P2|Overall Study|Trial unblinded|2
7725133|NCT00976677|26864200|P1|Overall Study|Trial unblinded|2
7725134|NCT00976677|26864199|P2|Overall Study|Disease progression|1
7725135|NCT00976677|26864200|P1|Overall Study|Disease progression|1
7725136|NCT00976677|26864199|P2|Overall Study|Withdrawal by Subject|2
7725137|NCT00976677|26864200|P1|Overall Study|Withdrawal by Subject|0
7725138|NCT00976677|26864199|P2|Overall Study|Adverse Event|0
7725139|NCT00976677|26864200|P1|Overall Study|Adverse Event|1
7725140|NCT00976573|26864408|P2|Overall Study|Cancel prior to receiving treatment|2
7725141|NCT00976573|26864409|P1|Overall Study|Cancel prior to receiving treatment|4
7725142|NCT00976573|26864408|P2|Overall Study|Ineligible|1
7725143|NCT00976573|26864409|P1|Overall Study|Ineligible|0
7725144|NCT00976560|26864423|P2|Overall Study|Withdrawal by Subject|3
7725145|NCT00976560|26864424|P1|Overall Study|Withdrawal by Subject|2
7725146|NCT00976560|26864423|P2|Overall Study|Physician Decision|0
7725147|NCT00976560|26864424|P1|Overall Study|Physician Decision|2
7725148|NCT00976560|26864423|P2|Overall Study|Lost to Follow-up|0
7725149|NCT00976560|26864424|P1|Overall Study|Lost to Follow-up|1
7725150|NCT00976560|26864423|P2|Overall Study|Protocol Violation|0
7725151|NCT00976560|26864424|P1|Overall Study|Protocol Violation|1
7725152|NCT00976560|26864423|P2|Overall Study|Lack of Efficacy|5
7725153|NCT00976560|26864424|P1|Overall Study|Lack of Efficacy|3
7725154|NCT00976560|26864423|P2|Overall Study|Adverse Event|5
7725155|NCT00976560|26864424|P1|Overall Study|Adverse Event|5
7725156|NCT00976508|26864493|P2|Overall Study|Terminated by the Sponsor|1
7725157|NCT00976508|26864494|P1|Overall Study|Terminated by the Sponsor|0
7725158|NCT00976508|26864493|P2|Overall Study|Subject Enrolled in Hospice|0
7725159|NCT00976508|26864494|P1|Overall Study|Subject Enrolled in Hospice|1
7725160|NCT00976508|26864493|P2|Overall Study|Disease Progression|4
7725161|NCT00976508|26864494|P1|Overall Study|Disease Progression|4
7725162|NCT00976508|26864493|P2|Overall Study|Withdrawal by Subject|0
7725163|NCT00976508|26864494|P1|Overall Study|Withdrawal by Subject|1
7725164|NCT00976508|26864493|P2|Overall Study|Lost to Follow-up|0
7725165|NCT00976508|26864494|P1|Overall Study|Lost to Follow-up|1
7725166|NCT00976508|26864493|P2|Overall Study|Death|1
7725167|NCT00976508|26864494|P1|Overall Study|Death|7
7725168|NCT00976495|26864527|P3|Overall Study|Withdrawal by Subject|0
7725169|NCT00976495|26864528|P2|Overall Study|Withdrawal by Subject|1
7725170|NCT00976495|26864529|P1|Overall Study|Withdrawal by Subject|0
7725171|NCT00976482|26864546|P1|Overall Study|Protocol Violation|5
7725172|NCT00976482|26864546|P1|Overall Study|Center terminated|1
7725173|NCT00976482|26864546|P1|Overall Study|Withdrawal by Subject|45
7725174|NCT00976482|26864546|P1|Overall Study|Death|208
7725175|NCT00976456|26864552|P2|Overall Study|screening failure, unknown|4
7725176|NCT00976456|26864553|P1|Overall Study|screening failure, unknown|11
7725177|NCT00976456|26864552|P2|Overall Study|Withdrawal by Subject|1
7725178|NCT00976456|26864553|P1|Overall Study|Withdrawal by Subject|3
7725179|NCT00976456|26864552|P2|Overall Study|Lack of Efficacy|2
7725180|NCT00976456|26864553|P1|Overall Study|Lack of Efficacy|5
7725181|NCT00976456|26864552|P2|Overall Study|Death|9
7725182|NCT00976456|26864553|P1|Overall Study|Death|7
7725183|NCT00976456|26864552|P2|Overall Study|Adverse Event|22
7725184|NCT00976456|26864553|P1|Overall Study|Adverse Event|17
7725185|NCT00976391|26864580|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7725186|NCT00976391|26864581|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
7725187|NCT00976391|26864580|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
7725188|NCT00976391|26864581|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7725189|NCT00976391|26864580|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
7725190|NCT00976391|26864581|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
7725191|NCT00976391|26864580|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7725192|NCT00976391|26864581|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
7725193|NCT00976391|26864580|P2|Follow-up Period (8 Weeks)|Noncompliance|2
7725194|NCT00976391|26864581|P1|Follow-up Period (8 Weeks)|Noncompliance|2
7725195|NCT00976391|26864580|P2|Follow-up Period (8 Weeks)|Adverse Event|1
7725196|NCT00976391|26864581|P1|Follow-up Period (8 Weeks)|Adverse Event|3
7725197|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Pregnancy|0
7725198|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Pregnancy|1
7725199|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
7725200|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
7725201|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Physician Decision|1
7725202|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Physician Decision|1
7725203|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
7725204|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
7725205|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
7725206|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
7725207|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Noncompliance|4
7725208|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Noncompliance|4
7725209|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Protocol Violation|1
7725210|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Protocol Violation|1
7725211|NCT00976391|26864580|P2|Treatment Period (52 Weeks)|Adverse Event|2
7725212|NCT00976391|26864581|P1|Treatment Period (52 Weeks)|Adverse Event|16
7725213|NCT00976274|26864629|P2|Overall Study|Physician Decision|2
7725214|NCT00976274|26864630|P1|Overall Study|Physician Decision|1
7725215|NCT00976274|26864629|P2|Overall Study|Withdrawal by Subject|1
7725216|NCT00976274|26864630|P1|Overall Study|Withdrawal by Subject|1
7725217|NCT00976274|26864629|P2|Overall Study|Lost to Follow-up|5
7725218|NCT00976274|26864630|P1|Overall Study|Lost to Follow-up|5
7725219|NCT00976209|26864646|P2|Treatment Period 2|Lost to Follow-up|1
7725220|NCT00976209|26864647|P1|Treatment Period 2|Lost to Follow-up|0
7725221|NCT00976209|26864646|P2|Treatment Period 2|Withdrawal by Subject|1
7725222|NCT00976209|26864647|P1|Treatment Period 2|Withdrawal by Subject|0
7725223|NCT00976209|26864646|P2|Wash-out Period|Other|0
7725224|NCT00976209|26864647|P1|Wash-out Period|Other|1
7725225|NCT00976209|26864646|P2|Wash-out Period|Protocol Violation|0
7725226|NCT00976209|26864647|P1|Wash-out Period|Protocol Violation|1
7725227|NCT00976209|26864646|P2|Wash-out Period|Lost to Follow-up|0
7725228|NCT00976209|26864647|P1|Wash-out Period|Lost to Follow-up|1
7725229|NCT00976209|26864646|P2|Wash-out Period|Adverse Event|2
7725230|NCT00976209|26864647|P1|Wash-out Period|Adverse Event|1
7725231|NCT00976209|26864646|P2|Treatment Period 1|Other|1
7725232|NCT00976209|26864647|P1|Treatment Period 1|Other|0
7725233|NCT00976209|26864646|P2|Treatment Period 1|Lost to Follow-up|0
7725234|NCT00976209|26864647|P1|Treatment Period 1|Lost to Follow-up|2
7725235|NCT00976209|26864646|P2|Treatment Period 1|Protocol Violation|0
7725236|NCT00976209|26864647|P1|Treatment Period 1|Protocol Violation|1
7725237|NCT00976027|26864660|P2|Overall Study|Withdrawal by Subject|66
7725238|NCT00976027|26864661|P1|Overall Study|Withdrawal by Subject|107
7725239|NCT00976027|26864660|P2|Overall Study|Lost to Follow-up|103
7725240|NCT00976027|26864661|P1|Overall Study|Lost to Follow-up|208
7725241|NCT00976027|26864660|P2|Overall Study|Protocol Violation|27
7725242|NCT00976027|26864661|P1|Overall Study|Protocol Violation|60
7725243|NCT00976027|26864660|P2|Overall Study|Adverse Event|2
7725244|NCT00976027|26864661|P1|Overall Study|Adverse Event|0
7725245|NCT00976027|26864660|P2|Overall Study|Serious Adverse Event|17
7725246|NCT00976027|26864661|P1|Overall Study|Serious Adverse Event|36
7725247|NCT00975975|26864673|P1|Overall Study|Death|6
7725248|NCT00975923|26864681|P2|Overall Study|Withdrawal by Subject|1
7725249|NCT00975923|26864682|P1|Overall Study|Withdrawal by Subject|0
7725250|NCT00975884|26864692|P2|Overall Study|Other|3
7725251|NCT00975884|26864693|P1|Overall Study|Other|1
7725252|NCT00975884|26864692|P2|Overall Study|Withdrawal by Subject|9
7725253|NCT00975884|26864693|P1|Overall Study|Withdrawal by Subject|9
7725254|NCT00975884|26864692|P2|Overall Study|Lost to Follow-up|3
7725255|NCT00975884|26864693|P1|Overall Study|Lost to Follow-up|5
7725256|NCT00975884|26864692|P2|Overall Study|Adverse Event|0
7725257|NCT00975884|26864693|P1|Overall Study|Adverse Event|1
7725258|NCT00975806|26864850|P3|Overall Study|Physician decision and disease related|1
7725259|NCT00975806|26864851|P2|Overall Study|Physician decision and disease related|0
7725260|NCT00975806|26864852|P1|Overall Study|Physician decision and disease related|1
7725261|NCT00975806|26864850|P3|Overall Study|Death|0
7725262|NCT00975806|26864851|P2|Overall Study|Death|1
7725263|NCT00975806|26864852|P1|Overall Study|Death|0
7725264|NCT00975806|26864850|P3|Overall Study|Withdrawal by Subject|0
7725265|NCT00975806|26864851|P2|Overall Study|Withdrawal by Subject|0
7725266|NCT00975806|26864852|P1|Overall Study|Withdrawal by Subject|1
7725267|NCT00975806|26864850|P3|Overall Study|Disease Progression|1
7725268|NCT00975806|26864851|P2|Overall Study|Disease Progression|5
7725269|NCT00975806|26864852|P1|Overall Study|Disease Progression|1
7725270|NCT00975806|26864850|P3|Overall Study|Adverse Event|2
7725271|NCT00975806|26864851|P2|Overall Study|Adverse Event|1
7725272|NCT00975806|26864852|P1|Overall Study|Adverse Event|2
7725273|NCT00975780|26864876|P2|Follow Up|Discharged from Facility|12
7725274|NCT00975780|26864877|P1|Follow Up|Discharged from Facility|7
7725275|NCT00975780|26864876|P2|Follow Up|Facility Withdrawal|23
7725276|NCT00975780|26864877|P1|Follow Up|Facility Withdrawal|7
7725277|NCT00975780|26864876|P2|Follow Up|Death|122
7725278|NCT00975780|26864877|P1|Follow Up|Death|88
7725279|NCT00975715|26864887|P2|Maintenance Period|Adverse Event|1
7725280|NCT00975715|26864888|P1|Maintenance Period|Adverse Event|2
7725281|NCT00975715|26864887|P2|Titration Period|Protocol Violation|0
7725282|NCT00975715|26864888|P1|Titration Period|Protocol Violation|1
7725283|NCT00975715|26864887|P2|Titration Period|Adverse Event|0
7725284|NCT00975715|26864888|P1|Titration Period|Adverse Event|6
7725285|NCT00975689|26864904|P2|Overall Study|Physician Decision|0
7725286|NCT00975689|26864905|P1|Overall Study|Physician Decision|1
7725287|NCT00975689|26864904|P2|Overall Study|Withdrawal by Subject|0
7725288|NCT00975689|26864905|P1|Overall Study|Withdrawal by Subject|1
7725289|NCT00975689|26864904|P2|Overall Study|Adverse Event|3
7725290|NCT00975689|26864905|P1|Overall Study|Adverse Event|0
7725291|NCT00975611|26864974|P1|Overall Study|Physician Decision|1
7725292|NCT00975611|26864974|P1|Overall Study|Screen Fail|16
7725293|NCT00975585|26864980|P2|Overall Study|Lens issue|2
7725294|NCT00975585|26864981|P1|Overall Study|Lens issue|2
7725295|NCT00975585|26864980|P2|Overall Study|Withdrawal by Subject|1
7725296|NCT00975585|26864981|P1|Overall Study|Withdrawal by Subject|2
7725297|NCT00975585|26864980|P2|Overall Study|Lost to Follow-up|5
7725298|NCT00975585|26864981|P1|Overall Study|Lost to Follow-up|3
7725299|NCT00975585|26864980|P2|Overall Study|Adverse Event|4
7725300|NCT00975585|26864981|P1|Overall Study|Adverse Event|0
7725301|NCT00975507|26865001|P2|Overall Study|Withdrawal by Subject|3
7725302|NCT00975507|26865002|P1|Overall Study|Withdrawal by Subject|10
7725303|NCT00975507|26865001|P2|Overall Study|Protocol Violation|0
7725304|NCT00975507|26865002|P1|Overall Study|Protocol Violation|2
7725305|NCT00975507|26865001|P2|Overall Study|Lost to Follow-up|1
7725306|NCT00975507|26865002|P1|Overall Study|Lost to Follow-up|7
7725307|NCT00975507|26865001|P2|Overall Study|Adverse Event|0
7725308|NCT00975507|26865002|P1|Overall Study|Adverse Event|1
7725309|NCT00975481|26865022|P6|Fifth Intervention Period|Withdrawal by Subject|0
7725310|NCT00975481|26865023|P5|Fifth Intervention Period|Withdrawal by Subject|1
7725311|NCT00975481|26865024|P4|Fifth Intervention Period|Withdrawal by Subject|0
7725312|NCT00975481|26865025|P3|Fifth Intervention Period|Withdrawal by Subject|0
7725313|NCT00975481|26865026|P2|Fifth Intervention Period|Withdrawal by Subject|0
7725314|NCT00975481|26865027|P1|Fifth Intervention Period|Withdrawal by Subject|0
7725315|NCT00975481|26865022|P6|Fourth Intervention Period|Withdrawal by Subject|0
7725316|NCT00975481|26865023|P5|Fourth Intervention Period|Withdrawal by Subject|0
7725317|NCT00975481|26865024|P4|Fourth Intervention Period|Withdrawal by Subject|1
7725318|NCT00975481|26865025|P3|Fourth Intervention Period|Withdrawal by Subject|1
7725319|NCT00975481|26865026|P2|Fourth Intervention Period|Withdrawal by Subject|0
7725320|NCT00975481|26865027|P1|Fourth Intervention Period|Withdrawal by Subject|0
7725321|NCT00975481|26865022|P6|Second Intervention Period|Withdrawal by Subject|0
7725322|NCT00975481|26865023|P5|Second Intervention Period|Withdrawal by Subject|0
7725323|NCT00975481|26865024|P4|Second Intervention Period|Withdrawal by Subject|0
7725324|NCT00975481|26865025|P3|Second Intervention Period|Withdrawal by Subject|1
7725325|NCT00975481|26865026|P2|Second Intervention Period|Withdrawal by Subject|0
7725326|NCT00975481|26865027|P1|Second Intervention Period|Withdrawal by Subject|0
7725327|NCT00975481|26865022|P6|Second Intervention Period|Adverse Event|0
7725328|NCT00975481|26865023|P5|Second Intervention Period|Adverse Event|0
7725329|NCT00975481|26865024|P4|Second Intervention Period|Adverse Event|0
7725330|NCT00975481|26865025|P3|Second Intervention Period|Adverse Event|0
7725331|NCT00975481|26865026|P2|Second Intervention Period|Adverse Event|1
7725332|NCT00975481|26865027|P1|Second Intervention Period|Adverse Event|2
7725333|NCT00975416|26865127|P2|Overall Study|early discharge from tx|5
7725334|NCT00975416|26865128|P1|Overall Study|early discharge from tx|3
7725335|NCT00975286|26865137|P2|Overall Study|Sponsor Decision|2
7725336|NCT00975286|26865138|P1|Overall Study|Sponsor Decision|0
7725337|NCT00975286|26865137|P2|Overall Study|Poor Compliance to Protocol|2
7725338|NCT00975286|26865138|P1|Overall Study|Poor Compliance to Protocol|0
7725339|NCT00975286|26865137|P2|Overall Study|Familial and Personal Reasons|2
7725340|NCT00975286|26865138|P1|Overall Study|Familial and Personal Reasons|2
7725341|NCT00975286|26865137|P2|Overall Study|Withdrawal by Subject|2
7725342|NCT00975286|26865138|P1|Overall Study|Withdrawal by Subject|0
7725343|NCT00975286|26865137|P2|Overall Study|Protocol Violation|2
7725344|NCT00975286|26865138|P1|Overall Study|Protocol Violation|1
7725345|NCT00975286|26865137|P2|Overall Study|Adverse Event|19
7725346|NCT00975286|26865138|P1|Overall Study|Adverse Event|9
7725347|NCT00975221|26865170|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
7725348|NCT00975221|26865171|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
7725349|NCT00975221|26865170|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
7725350|NCT00975221|26865171|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
7725351|NCT00975221|26865170|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
7725352|NCT00975221|26865171|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
7725353|NCT00975221|26865170|P2|Titration Phase (Weeks 1-12)|Other|1
7725354|NCT00975221|26865171|P1|Titration Phase (Weeks 1-12)|Other|0
7725355|NCT00975221|26865170|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
7725356|NCT00975221|26865171|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
7725357|NCT00975221|26865170|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
7725358|NCT00975221|26865171|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
7725359|NCT00975195|26865187|P2|Overall Study|Not treated|2
7725360|NCT00975195|26865188|P1|Overall Study|Not treated|1
7725361|NCT00975195|26865187|P2|Overall Study|Other reason not defined above|33
7725362|NCT00975195|26865188|P1|Overall Study|Other reason not defined above|29
7725363|NCT00975195|26865187|P2|Overall Study|Withdrawal by Subject|61
7725364|NCT00975195|26865188|P1|Overall Study|Withdrawal by Subject|48
7725365|NCT00975195|26865187|P2|Overall Study|Lost to Follow-up|7
7725366|NCT00975195|26865188|P1|Overall Study|Lost to Follow-up|9
7725367|NCT00975195|26865187|P2|Overall Study|Protocol Violation|23
7725368|NCT00975195|26865188|P1|Overall Study|Protocol Violation|27
7725369|NCT00975195|26865187|P2|Overall Study|Lack of Efficacy|6
7725370|NCT00975195|26865188|P1|Overall Study|Lack of Efficacy|6
7725371|NCT00975195|26865187|P2|Overall Study|Adverse Event|101
7725372|NCT00975195|26865188|P1|Overall Study|Adverse Event|108
7725373|NCT00975156|26865248|P2|Overall Study|Protocol Violation|1
7725374|NCT00975156|26865249|P1|Overall Study|Protocol Violation|0
7725375|NCT00975143|26865261|P2|Overall Study|Details not available|4
7725376|NCT00975143|26865262|P1|Overall Study|Details not available|10
7725377|NCT00975143|26865261|P2|Overall Study|Physician Decision|2
7725378|NCT00975143|26865262|P1|Overall Study|Physician Decision|1
7725379|NCT00975143|26865261|P2|Overall Study|Non-compliance|8
7725380|NCT00975143|26865262|P1|Overall Study|Non-compliance|5
7725381|NCT00975143|26865261|P2|Overall Study|Lost to Follow-up|16
7725382|NCT00975143|26865262|P1|Overall Study|Lost to Follow-up|20
7725383|NCT00975143|26865261|P2|Overall Study|Withdrawal by Subject|15
7725384|NCT00975143|26865262|P1|Overall Study|Withdrawal by Subject|15
7725385|NCT00975143|26865261|P2|Overall Study|Adverse Event|15
7725386|NCT00975143|26865262|P1|Overall Study|Adverse Event|19
7725387|NCT00975130|26865272|P3|Study Part 2|Protocol Violation|1
7725388|NCT00975130|26865273|P2|Study Part 2|Protocol Violation|0
7725389|NCT00975130|26865274|P1|Study Part 2|Protocol Violation|0
7725390|NCT00975130|26865272|P3|Study Part 2|Administrative|0
7725391|NCT00975130|26865273|P2|Study Part 2|Administrative|1
7725392|NCT00975130|26865274|P1|Study Part 2|Administrative|0
7725393|NCT00975130|26865272|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
7725394|NCT00975130|26865273|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
7725395|NCT00975130|26865274|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
7725396|NCT00975130|26865272|P3|Study Part 2|Withdrew Consent|2
7725397|NCT00975130|26865273|P2|Study Part 2|Withdrew Consent|6
7725398|NCT00975130|26865274|P1|Study Part 2|Withdrew Consent|0
7725399|NCT00975130|26865272|P3|Study Part 2|Withdrawal by Subject|5
7725400|NCT00975130|26865273|P2|Study Part 2|Withdrawal by Subject|13
7725401|NCT00975130|26865274|P1|Study Part 2|Withdrawal by Subject|0
7725402|NCT00975130|26865272|P3|Study Part 2|Lost to Follow-up|1
7725403|NCT00975130|26865273|P2|Study Part 2|Lost to Follow-up|0
7725404|NCT00975130|26865274|P1|Study Part 2|Lost to Follow-up|0
7725405|NCT00975130|26865272|P3|Study Part 2|Adverse Event|7
7725406|NCT00975130|26865273|P2|Study Part 2|Adverse Event|14
7725407|NCT00975130|26865274|P1|Study Part 2|Adverse Event|0
7725408|NCT00975130|26865272|P3|Study Part 1|Withdrew Consent|0
7725409|NCT00975130|26865273|P2|Study Part 1|Withdrew Consent|0
7725410|NCT00975130|26865274|P1|Study Part 1|Withdrew Consent|24
7725411|NCT00975130|26865272|P3|Study Part 1|Administrative|0
7725412|NCT00975130|26865273|P2|Study Part 1|Administrative|0
7725413|NCT00975130|26865274|P1|Study Part 1|Administrative|4
7725414|NCT00975130|26865272|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
7725415|NCT00975130|26865273|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
7725416|NCT00975130|26865274|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
7725417|NCT00975130|26865272|P3|Study Part 1|Protocol Violation|0
7725418|NCT00975130|26865273|P2|Study Part 1|Protocol Violation|0
7725419|NCT00975130|26865274|P1|Study Part 1|Protocol Violation|13
7725420|NCT00975130|26865272|P3|Study Part 1|Withdrawal by Subject|0
7725421|NCT00975130|26865273|P2|Study Part 1|Withdrawal by Subject|0
7725422|NCT00975130|26865274|P1|Study Part 1|Withdrawal by Subject|61
7725423|NCT00975130|26865272|P3|Study Part 1|Lost to Follow-up|0
7725424|NCT00975130|26865273|P2|Study Part 1|Lost to Follow-up|0
7725425|NCT00975130|26865274|P1|Study Part 1|Lost to Follow-up|19
7725426|NCT00975130|26865272|P3|Study Part 1|Adverse Event|0
7725427|NCT00975130|26865273|P2|Study Part 1|Adverse Event|0
7725428|NCT00975130|26865274|P1|Study Part 1|Adverse Event|150
7725429|NCT00975000|26865458|P2|Overall Study|Non-compliance|1
7725430|NCT00975000|26865459|P1|Overall Study|Non-compliance|0
7725431|NCT00975000|26865458|P2|Overall Study|Protocol-specified Criteria|0
7725432|NCT00975000|26865459|P1|Overall Study|Protocol-specified Criteria|1
7725433|NCT00975000|26865458|P2|Overall Study|Lost to Follow-up|1
7725434|NCT00975000|26865459|P1|Overall Study|Lost to Follow-up|0
7725435|NCT00975000|26865458|P2|Overall Study|Withdrawal by Subject|2
7725436|NCT00975000|26865459|P1|Overall Study|Withdrawal by Subject|2
7725437|NCT00975000|26865458|P2|Overall Study|Adverse Event|1
7725438|NCT00975000|26865459|P1|Overall Study|Adverse Event|1
7725439|NCT00975000|26865458|P2|Overall Study|Other|0
7725440|NCT00975000|26865459|P1|Overall Study|Other|1
7725441|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Various|0
7725442|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Various|4
7725443|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
7725444|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
7725445|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
7725446|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
7725447|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7725448|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7725449|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
7725450|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
7725451|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
7725452|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
7725453|NCT00974974|26865483|P2|Maintenance - Double Blind Treatment|Adverse Event|3
7725454|NCT00974974|26865484|P1|Maintenance - Double Blind Treatment|Adverse Event|3
7725455|NCT00974974|26865483|P2|IPX066 Dose Conversion|Protocol Violation|0
7725456|NCT00974974|26865484|P1|IPX066 Dose Conversion|Protocol Violation|4
7725457|NCT00974974|26865483|P2|IPX066 Dose Conversion|Various|0
7725458|NCT00974974|26865484|P1|IPX066 Dose Conversion|Various|3
7725459|NCT00974974|26865483|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
7725460|NCT00974974|26865484|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
7725461|NCT00974974|26865483|P2|IPX066 Dose Conversion|Lack of Efficacy|0
7725462|NCT00974974|26865484|P1|IPX066 Dose Conversion|Lack of Efficacy|13
7725463|NCT00974974|26865483|P2|IPX066 Dose Conversion|Death|0
7725464|NCT00974974|26865484|P1|IPX066 Dose Conversion|Death|2
7725465|NCT00974974|26865483|P2|IPX066 Dose Conversion|Adverse Event|0
7725466|NCT00974974|26865484|P1|IPX066 Dose Conversion|Adverse Event|23
7725467|NCT00974974|26865483|P2|IR CD-LD Dose Adjustment|Various|9
7725468|NCT00974974|26865484|P1|IR CD-LD Dose Adjustment|Various|0
7725469|NCT00974974|26865483|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
7725470|NCT00974974|26865484|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
7725471|NCT00974974|26865483|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
7725472|NCT00974974|26865484|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
7725473|NCT00974974|26865483|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
7725474|NCT00974974|26865484|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
7725475|NCT00974974|26865483|P2|IR CD-LD Dose Adjustment|Adverse Event|3
7725476|NCT00974974|26865484|P1|IR CD-LD Dose Adjustment|Adverse Event|0
7725477|NCT00974922|26865494|P1|Overall Study|study terminated|24
7725478|NCT00974675|26865512|P4|Overall Study|Participant on holiday; unable to attend|1
7725479|NCT00974675|26865513|P3|Overall Study|Participant on holiday; unable to attend|0
7725480|NCT00974675|26865514|P2|Overall Study|Participant on holiday; unable to attend|0
7725481|NCT00974675|26865515|P1|Overall Study|Participant on holiday; unable to attend|0
7725482|NCT00974675|26865512|P4|Overall Study|Physician Decision|0
7725483|NCT00974675|26865513|P3|Overall Study|Physician Decision|1
7725484|NCT00974675|26865514|P2|Overall Study|Physician Decision|0
7725485|NCT00974675|26865515|P1|Overall Study|Physician Decision|0
7725486|NCT00974675|26865512|P4|Overall Study|Adverse Event|1
7725487|NCT00974675|26865513|P3|Overall Study|Adverse Event|1
7725488|NCT00974675|26865514|P2|Overall Study|Adverse Event|1
7725489|NCT00974675|26865515|P1|Overall Study|Adverse Event|2
7725490|NCT00974571|26865564|P3|Overall Study|Other|10
7725491|NCT00974571|26865565|P2|Overall Study|Other|0
7725492|NCT00974571|26865566|P1|Overall Study|Other|4
7725493|NCT00974571|26865564|P3|Overall Study|Patient Moved|1
7725494|NCT00974571|26865565|P2|Overall Study|Patient Moved|0
7725495|NCT00974571|26865566|P1|Overall Study|Patient Moved|1
7725496|NCT00974571|26865564|P3|Overall Study|Withdrawal by Subject|16
7725497|NCT00974571|26865565|P2|Overall Study|Withdrawal by Subject|5
7725498|NCT00974571|26865566|P1|Overall Study|Withdrawal by Subject|14
7725499|NCT00974571|26865564|P3|Overall Study|Protocol Violation|18
7725500|NCT00974571|26865565|P2|Overall Study|Protocol Violation|4
7725501|NCT00974571|26865566|P1|Overall Study|Protocol Violation|13
7725502|NCT00974571|26865564|P3|Overall Study|Lost to Follow-up|2
7725503|NCT00974571|26865565|P2|Overall Study|Lost to Follow-up|1
7725504|NCT00974571|26865566|P1|Overall Study|Lost to Follow-up|2
7725505|NCT00974571|26865564|P3|Overall Study|Lack of Efficacy|9
7725506|NCT00974571|26865565|P2|Overall Study|Lack of Efficacy|2
7725507|NCT00974571|26865566|P1|Overall Study|Lack of Efficacy|3
7725508|NCT00974571|26865564|P3|Overall Study|Adverse Event|27
7725509|NCT00974571|26865565|P2|Overall Study|Adverse Event|4
7725510|NCT00974571|26865566|P1|Overall Study|Adverse Event|31
7725511|NCT00974311|26865700|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
7725512|NCT00974311|26865701|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
7725513|NCT00974311|26865700|P2|OLE Phase (up to 77 Months)|Other|2
7725514|NCT00974311|26865701|P1|OLE Phase (up to 77 Months)|Other|15
7725515|NCT00974311|26865700|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
7725516|NCT00974311|26865701|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
7725517|NCT00974311|26865700|P2|OLE Phase (up to 77 Months)|Death|21
7725518|NCT00974311|26865701|P1|OLE Phase (up to 77 Months)|Death|14
7725519|NCT00974311|26865700|P2|DB Phase (up to 24 Months)|Other|0
7725520|NCT00974311|26865701|P1|DB Phase (up to 24 Months)|Other|1
7725521|NCT00974311|26865700|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
7725522|NCT00974311|26865701|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
7725523|NCT00974311|26865700|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
7725524|NCT00974311|26865701|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
7725525|NCT00974311|26865700|P2|DB Phase (up to 24 Months)|Death|298
7725526|NCT00974311|26865701|P1|DB Phase (up to 24 Months)|Death|561
7725527|NCT00974311|26865700|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
7725528|NCT00974311|26865701|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
7725529|NCT00974259|26865739|P2|Overall Study|Technically inadequate PbtO2 recordings|1
7725530|NCT00974259|26865740|P1|Overall Study|Technically inadequate PbtO2 recordings|2
7725531|NCT00974233|26865758|P1|Maintenance Lenalidomide|Adverse Event|8
7725532|NCT00974233|26865758|P1|Maintenance Lenalidomide|Lack of Efficacy|5
7725533|NCT00974233|26865758|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
7725534|NCT00974233|26865758|P1|Induction Chemoimmunotherapy|Adverse Event|7
7725535|NCT00974233|26865758|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
7725536|NCT00974233|26865758|P1|Induction Chemoimmunotherapy|Death|2
7725537|NCT00974220|26865773|P2|Treatment Period 1|noncompliant subjects|1
7725538|NCT00974220|26865774|P1|Treatment Period 1|noncompliant subjects|0
7725539|NCT00974220|26865773|P2|Treatment Period 1|Adverse Event|1
7725540|NCT00974220|26865774|P1|Treatment Period 1|Adverse Event|2
7725541|NCT00974090|26865819|P2|Period 2: Open-label Period|Withdrawal by Subject|0
7725542|NCT00974090|26865820|P1|Period 2: Open-label Period|Withdrawal by Subject|1
7725543|NCT00974090|26865819|P2|Period 2: Open-label Period|Physician Decision|3
7725544|NCT00974090|26865820|P1|Period 2: Open-label Period|Physician Decision|0
7725545|NCT00974090|26865819|P2|Period 2: Open-label Period|Lack of Efficacy|1
7725546|NCT00974090|26865820|P1|Period 2: Open-label Period|Lack of Efficacy|3
7725547|NCT00974090|26865819|P2|Period 2: Open-label Period|Adverse Event|6
7725548|NCT00974090|26865820|P1|Period 2: Open-label Period|Adverse Event|4
7725549|NCT00974090|26865819|P2|Period 1: Double Blind Period|Physician Decision|0
7725550|NCT00974090|26865820|P1|Period 1: Double Blind Period|Physician Decision|1
7725551|NCT00974090|26865819|P2|Period 1: Double Blind Period|Adverse Event|1
7725552|NCT00974090|26865820|P1|Period 1: Double Blind Period|Adverse Event|2
7725553|NCT00973973|26865856|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
7725554|NCT00973973|26865857|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
7725555|NCT00973973|26865856|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
7725556|NCT00973973|26865857|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
7725557|NCT00973973|26865856|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
7725558|NCT00973973|26865857|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
7725559|NCT00973973|26865856|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
7725560|NCT00973973|26865857|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
7725561|NCT00973973|26865856|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
7725562|NCT00973973|26865857|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
7725563|NCT00973973|26865856|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
7725564|NCT00973973|26865857|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
7725565|NCT00973973|26865856|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
7725566|NCT00973973|26865857|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
7725567|NCT00973973|26865856|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
7725568|NCT00973973|26865857|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
7725569|NCT00973973|26865856|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
7725570|NCT00973973|26865857|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
7725571|NCT00973973|26865856|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
7725572|NCT00973973|26865857|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
7725573|NCT00973973|26865856|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
7725574|NCT00973973|26865857|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
7725575|NCT00973973|26865856|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
7725576|NCT00973973|26865857|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
7725577|NCT00973921|26865917|P1|Overall Study|IVUS results were not available|9
7725578|NCT00973765|26865934|P2|Overall Study|Lost to Follow-up|14
7725579|NCT00973765|26865935|P1|Overall Study|Lost to Follow-up|8
7725580|NCT00973700|26865957|P5|Overall Study|Unable to Classify|1
7725581|NCT00973700|26865958|P4|Overall Study|Unable to Classify|2
7725582|NCT00973700|26865959|P3|Overall Study|Unable to Classify|1
7725583|NCT00973700|26865960|P2|Overall Study|Unable to Classify|0
7725584|NCT00973700|26865961|P1|Overall Study|Unable to Classify|0
7725585|NCT00973700|26865957|P5|Overall Study|Inappropriate enrolment|0
7725586|NCT00973700|26865958|P4|Overall Study|Inappropriate enrolment|4
7725587|NCT00973700|26865959|P3|Overall Study|Inappropriate enrolment|0
7725588|NCT00973700|26865960|P2|Overall Study|Inappropriate enrolment|0
7725589|NCT00973700|26865961|P1|Overall Study|Inappropriate enrolment|0
7725590|NCT00973700|26865957|P5|Overall Study|Lost to Follow-up|5
7725591|NCT00973700|26865958|P4|Overall Study|Lost to Follow-up|8
7725592|NCT00973700|26865959|P3|Overall Study|Lost to Follow-up|1
7725593|NCT00973700|26865960|P2|Overall Study|Lost to Follow-up|0
7725594|NCT00973700|26865961|P1|Overall Study|Lost to Follow-up|5
7725595|NCT00973700|26865957|P5|Overall Study|Withdrawal by Subject|4
7725596|NCT00973700|26865958|P4|Overall Study|Withdrawal by Subject|4
7725597|NCT00973700|26865959|P3|Overall Study|Withdrawal by Subject|8
7725598|NCT00973700|26865960|P2|Overall Study|Withdrawal by Subject|2
7725599|NCT00973700|26865961|P1|Overall Study|Withdrawal by Subject|2
7725600|NCT00973674|26866010|P2|Overall Study|Protocol Violation|0
7725601|NCT00973674|26866011|P1|Overall Study|Protocol Violation|2
7725602|NCT00973622|26866025|P2|Overall Study|did not complete rTMS sessions|2
7725603|NCT00973622|26866026|P1|Overall Study|did not complete rTMS sessions|11
7725604|NCT00973622|26866025|P2|Overall Study|did not pass MRI screen|0
7725605|NCT00973622|26866026|P1|Overall Study|did not pass MRI screen|6
7725606|NCT00973622|26866025|P2|Overall Study|did not attend MRI|3
7725607|NCT00973622|26866026|P1|Overall Study|did not attend MRI|14
7725608|NCT00973479|26866034|P2|Overall Study|Other|7
7725609|NCT00973479|26866035|P1|Overall Study|Other|1
7725610|NCT00973479|26866034|P2|Overall Study|Protocol Violation|2
7725611|NCT00973479|26866035|P1|Overall Study|Protocol Violation|2
7725612|NCT00973479|26866034|P2|Overall Study|Adverse Event|32
7725613|NCT00973479|26866035|P1|Overall Study|Adverse Event|12
7725614|NCT00973479|26866034|P2|Overall Study|Lack of Efficacy|7
7725615|NCT00973479|26866035|P1|Overall Study|Lack of Efficacy|5
7725616|NCT00973479|26866034|P2|Overall Study|Withdrawal by Subject|16
7725617|NCT00973479|26866035|P1|Overall Study|Withdrawal by Subject|15
7725618|NCT00973479|26866034|P2|Overall Study|Death|2
7725619|NCT00973479|26866035|P1|Overall Study|Death|2
7725620|NCT00973479|26866034|P2|Overall Study|Lost to Follow-up|3
7725621|NCT00973479|26866035|P1|Overall Study|Lost to Follow-up|0
7725622|NCT00973362|26866053|P2|3-Year Follow-up|Lost to Follow-up|0
7725623|NCT00973362|26866054|P1|3-Year Follow-up|Lost to Follow-up|17
7725624|NCT00973362|26866053|P2|Baseline Evaluation|Inevaluable|223
7725625|NCT00973362|26866054|P1|Baseline Evaluation|Inevaluable|686
7725626|NCT00973362|26866053|P2|Baseline Evaluation|No colposcopy visit|0
7725627|NCT00973362|26866054|P1|Baseline Evaluation|No colposcopy visit|62
7725628|NCT00973362|26866053|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
7725629|NCT00973362|26866054|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
7725630|NCT00973349|26866079|P16|Overall Study|Unable to classify|0
7725631|NCT00973349|26866080|P15|Overall Study|Unable to classify|0
7725632|NCT00973349|26866081|P14|Overall Study|Unable to classify|0
7725633|NCT00973349|26866082|P13|Overall Study|Unable to classify|0
7725634|NCT00973349|26866083|P12|Overall Study|Unable to classify|0
7725635|NCT00973349|26866084|P11|Overall Study|Unable to classify|0
7725636|NCT00973349|26866085|P10|Overall Study|Unable to classify|1
7725637|NCT00973349|26866086|P9|Overall Study|Unable to classify|0
7725638|NCT00973349|26866087|P8|Overall Study|Unable to classify|0
7725639|NCT00973349|26866088|P7|Overall Study|Unable to classify|0
7725640|NCT00973349|26866089|P6|Overall Study|Unable to classify|1
7725641|NCT00973349|26866090|P5|Overall Study|Unable to classify|1
7725642|NCT00973349|26866091|P4|Overall Study|Unable to classify|0
7725643|NCT00973349|26866092|P3|Overall Study|Unable to classify|0
7725644|NCT00973349|26866093|P2|Overall Study|Unable to classify|0
7725645|NCT00973349|26866094|P1|Overall Study|Unable to classify|0
7725646|NCT00973349|26866079|P16|Overall Study|Protocol Violation|0
7725647|NCT00973349|26866080|P15|Overall Study|Protocol Violation|0
7725648|NCT00973349|26866081|P14|Overall Study|Protocol Violation|0
7725649|NCT00973349|26866082|P13|Overall Study|Protocol Violation|0
7725650|NCT00973349|26866083|P12|Overall Study|Protocol Violation|0
7725651|NCT00973349|26866084|P11|Overall Study|Protocol Violation|0
7725652|NCT00973349|26866085|P10|Overall Study|Protocol Violation|0
7725653|NCT00973349|26866086|P9|Overall Study|Protocol Violation|1
7725654|NCT00973349|26866087|P8|Overall Study|Protocol Violation|0
7725655|NCT00973349|26866088|P7|Overall Study|Protocol Violation|0
7725656|NCT00973349|26866089|P6|Overall Study|Protocol Violation|0
7725657|NCT00973349|26866090|P5|Overall Study|Protocol Violation|0
7725658|NCT00973349|26866091|P4|Overall Study|Protocol Violation|0
7725659|NCT00973349|26866092|P3|Overall Study|Protocol Violation|0
7725660|NCT00973349|26866093|P2|Overall Study|Protocol Violation|0
7725661|NCT00973349|26866094|P1|Overall Study|Protocol Violation|0
7725662|NCT00973349|26866079|P16|Overall Study|Inappropriate enrolment|1
7725663|NCT00973349|26866080|P15|Overall Study|Inappropriate enrolment|1
7725664|NCT00973349|26866081|P14|Overall Study|Inappropriate enrolment|0
7725665|NCT00973349|26866082|P13|Overall Study|Inappropriate enrolment|1
7725666|NCT00973349|26866083|P12|Overall Study|Inappropriate enrolment|0
7725667|NCT00973349|26866084|P11|Overall Study|Inappropriate enrolment|0
7725668|NCT00973349|26866085|P10|Overall Study|Inappropriate enrolment|2
7725669|NCT00973349|26866086|P9|Overall Study|Inappropriate enrolment|0
7725670|NCT00973349|26866087|P8|Overall Study|Inappropriate enrolment|0
7725671|NCT00973349|26866088|P7|Overall Study|Inappropriate enrolment|0
7725672|NCT00973349|26866089|P6|Overall Study|Inappropriate enrolment|0
7725673|NCT00973349|26866090|P5|Overall Study|Inappropriate enrolment|0
7725674|NCT00973349|26866091|P4|Overall Study|Inappropriate enrolment|0
7725675|NCT00973349|26866092|P3|Overall Study|Inappropriate enrolment|1
7725676|NCT00973349|26866093|P2|Overall Study|Inappropriate enrolment|0
7725677|NCT00973349|26866094|P1|Overall Study|Inappropriate enrolment|0
7725678|NCT00973349|26866079|P16|Overall Study|Lost to Follow-up|1
7725679|NCT00973349|26866080|P15|Overall Study|Lost to Follow-up|0
7725680|NCT00973349|26866081|P14|Overall Study|Lost to Follow-up|0
7725681|NCT00973349|26866082|P13|Overall Study|Lost to Follow-up|0
7725682|NCT00973349|26866083|P12|Overall Study|Lost to Follow-up|1
7725683|NCT00973349|26866084|P11|Overall Study|Lost to Follow-up|0
7725684|NCT00973349|26866085|P10|Overall Study|Lost to Follow-up|1
7725685|NCT00973349|26866086|P9|Overall Study|Lost to Follow-up|2
7725686|NCT00973349|26866087|P8|Overall Study|Lost to Follow-up|1
7725687|NCT00973349|26866088|P7|Overall Study|Lost to Follow-up|0
7725688|NCT00973349|26866089|P6|Overall Study|Lost to Follow-up|3
7725689|NCT00973349|26866090|P5|Overall Study|Lost to Follow-up|1
7725690|NCT00973349|26866091|P4|Overall Study|Lost to Follow-up|2
7725691|NCT00973349|26866092|P3|Overall Study|Lost to Follow-up|2
7725692|NCT00973349|26866093|P2|Overall Study|Lost to Follow-up|1
7725693|NCT00973349|26866094|P1|Overall Study|Lost to Follow-up|3
7725694|NCT00973349|26866079|P16|Overall Study|Withdrawal by Subject|0
7725695|NCT00973349|26866080|P15|Overall Study|Withdrawal by Subject|0
7725696|NCT00973349|26866081|P14|Overall Study|Withdrawal by Subject|0
7725697|NCT00973349|26866082|P13|Overall Study|Withdrawal by Subject|0
7725698|NCT00973349|26866083|P12|Overall Study|Withdrawal by Subject|1
7725699|NCT00973349|26866084|P11|Overall Study|Withdrawal by Subject|0
7725700|NCT00973349|26866085|P10|Overall Study|Withdrawal by Subject|2
7725701|NCT00973349|26866086|P9|Overall Study|Withdrawal by Subject|0
7725702|NCT00973349|26866087|P8|Overall Study|Withdrawal by Subject|2
7725703|NCT00973349|26866088|P7|Overall Study|Withdrawal by Subject|2
7725704|NCT00973349|26866089|P6|Overall Study|Withdrawal by Subject|0
7725705|NCT00973349|26866090|P5|Overall Study|Withdrawal by Subject|2
7725706|NCT00973349|26866091|P4|Overall Study|Withdrawal by Subject|3
7725707|NCT00973349|26866092|P3|Overall Study|Withdrawal by Subject|2
7725708|NCT00973349|26866093|P2|Overall Study|Withdrawal by Subject|2
7725709|NCT00973349|26866094|P1|Overall Study|Withdrawal by Subject|1
7725710|NCT00973349|26866079|P16|Overall Study|Adverse Event|0
7725711|NCT00973349|26866080|P15|Overall Study|Adverse Event|1
7725712|NCT00973349|26866081|P14|Overall Study|Adverse Event|0
7725713|NCT00973349|26866082|P13|Overall Study|Adverse Event|0
7725714|NCT00973349|26866083|P12|Overall Study|Adverse Event|0
7725715|NCT00973349|26866084|P11|Overall Study|Adverse Event|0
7725716|NCT00973349|26866085|P10|Overall Study|Adverse Event|0
7725717|NCT00973349|26866086|P9|Overall Study|Adverse Event|1
7725718|NCT00973349|26866087|P8|Overall Study|Adverse Event|0
7725719|NCT00973349|26866088|P7|Overall Study|Adverse Event|0
7725720|NCT00973349|26866089|P6|Overall Study|Adverse Event|0
7725721|NCT00973349|26866090|P5|Overall Study|Adverse Event|1
7725722|NCT00973349|26866091|P4|Overall Study|Adverse Event|0
7725723|NCT00973349|26866092|P3|Overall Study|Adverse Event|0
7725724|NCT00973349|26866093|P2|Overall Study|Adverse Event|0
7725725|NCT00973349|26866094|P1|Overall Study|Adverse Event|0
7725726|NCT00973102|26866194|P2|Overall Study|Prisoner|1
7725727|NCT00973102|26866195|P1|Overall Study|Prisoner|0
7725728|NCT00973102|26866194|P2|Overall Study|Protocol Violation|0
7725729|NCT00973102|26866195|P1|Overall Study|Protocol Violation|1
7725730|NCT00972816|26866226|P8|Overall Study|Unable to classify|0
7725731|NCT00972816|26866227|P7|Overall Study|Unable to classify|0
7725732|NCT00972816|26866228|P6|Overall Study|Unable to classify|0
7725733|NCT00972816|26866229|P5|Overall Study|Unable to classify|1
7725734|NCT00972816|26866230|P4|Overall Study|Unable to classify|0
7725735|NCT00972816|26866231|P3|Overall Study|Unable to classify|0
7725736|NCT00972816|26866232|P2|Overall Study|Unable to classify|0
7725737|NCT00972816|26866233|P1|Overall Study|Unable to classify|2
7725738|NCT00972816|26866226|P8|Overall Study|Inappropriate enrolment|0
7725739|NCT00972816|26866227|P7|Overall Study|Inappropriate enrolment|2
7725740|NCT00972816|26866228|P6|Overall Study|Inappropriate enrolment|0
7725741|NCT00972816|26866229|P5|Overall Study|Inappropriate enrolment|0
7725742|NCT00972816|26866230|P4|Overall Study|Inappropriate enrolment|0
7725743|NCT00972816|26866231|P3|Overall Study|Inappropriate enrolment|0
7725744|NCT00972816|26866232|P2|Overall Study|Inappropriate enrolment|0
7725745|NCT00972816|26866233|P1|Overall Study|Inappropriate enrolment|0
7725746|NCT00972816|26866226|P8|Overall Study|Lost to Follow-up|7
7725747|NCT00972816|26866227|P7|Overall Study|Lost to Follow-up|7
7725748|NCT00972816|26866228|P6|Overall Study|Lost to Follow-up|10
7725749|NCT00972816|26866229|P5|Overall Study|Lost to Follow-up|11
7725750|NCT00972816|26866230|P4|Overall Study|Lost to Follow-up|5
7725751|NCT00972816|26866231|P3|Overall Study|Lost to Follow-up|7
7725752|NCT00972816|26866232|P2|Overall Study|Lost to Follow-up|9
7725753|NCT00972816|26866233|P1|Overall Study|Lost to Follow-up|11
7725754|NCT00972816|26866226|P8|Overall Study|Withdrawal by Subject|2
7725755|NCT00972816|26866227|P7|Overall Study|Withdrawal by Subject|1
7725756|NCT00972816|26866228|P6|Overall Study|Withdrawal by Subject|1
7725757|NCT00972816|26866229|P5|Overall Study|Withdrawal by Subject|0
7725758|NCT00972816|26866230|P4|Overall Study|Withdrawal by Subject|3
7725759|NCT00972816|26866231|P3|Overall Study|Withdrawal by Subject|1
7725760|NCT00972816|26866232|P2|Overall Study|Withdrawal by Subject|2
7725761|NCT00972816|26866233|P1|Overall Study|Withdrawal by Subject|4
7725762|NCT00972816|26866226|P8|Overall Study|Adverse Event|0
7725763|NCT00972816|26866227|P7|Overall Study|Adverse Event|0
7725764|NCT00972816|26866228|P6|Overall Study|Adverse Event|0
7725765|NCT00972816|26866229|P5|Overall Study|Adverse Event|0
7725766|NCT00972816|26866230|P4|Overall Study|Adverse Event|0
7725767|NCT00972816|26866231|P3|Overall Study|Adverse Event|1
7725768|NCT00972816|26866232|P2|Overall Study|Adverse Event|0
7725769|NCT00972816|26866233|P1|Overall Study|Adverse Event|0
7725770|NCT00972777|26866317|P2|Overall Study|Missed visit|0
7725771|NCT00972777|26866318|P1|Overall Study|Missed visit|1
7725772|NCT00972777|26866317|P2|Overall Study|Screening Failure|1
7725773|NCT00972777|26866318|P1|Overall Study|Screening Failure|2
7725774|NCT00972777|26866317|P2|Overall Study|Protocol Violation|2
7725775|NCT00972777|26866318|P1|Overall Study|Protocol Violation|0
7725776|NCT00972777|26866317|P2|Overall Study|Physician Decision|0
7725777|NCT00972777|26866318|P1|Overall Study|Physician Decision|4
7725778|NCT00972777|26866317|P2|Overall Study|Withdrawal by Subject|5
7725779|NCT00972777|26866318|P1|Overall Study|Withdrawal by Subject|4
7725780|NCT00972777|26866317|P2|Overall Study|Lost to Follow-up|4
7725781|NCT00972777|26866318|P1|Overall Study|Lost to Follow-up|0
7725782|NCT00972777|26866317|P2|Overall Study|Adverse Event|2
7725783|NCT00972777|26866318|P1|Overall Study|Adverse Event|3
7725784|NCT00972738|26866333|P3|Overall Study|Other|1
7725785|NCT00972738|26866334|P2|Overall Study|Other|2
7725786|NCT00972738|26866335|P1|Overall Study|Other|1
7725787|NCT00972738|26866333|P3|Overall Study|Moved|1
7725788|NCT00972738|26866334|P2|Overall Study|Moved|0
7725789|NCT00972738|26866335|P1|Overall Study|Moved|0
7725790|NCT00972738|26866333|P3|Overall Study|Withdrawal by Subject|4
7725791|NCT00972738|26866334|P2|Overall Study|Withdrawal by Subject|1
7725792|NCT00972738|26866335|P1|Overall Study|Withdrawal by Subject|5
7725793|NCT00972738|26866333|P3|Overall Study|Lack of Efficacy|11
7725794|NCT00972738|26866334|P2|Overall Study|Lack of Efficacy|1
7725795|NCT00972738|26866335|P1|Overall Study|Lack of Efficacy|5
7725796|NCT00972738|26866333|P3|Overall Study|Lost to Follow-up|1
7725797|NCT00972738|26866334|P2|Overall Study|Lost to Follow-up|0
7725798|NCT00972738|26866335|P1|Overall Study|Lost to Follow-up|1
7725799|NCT00972738|26866333|P3|Overall Study|Protocol Violation|3
7725800|NCT00972738|26866334|P2|Overall Study|Protocol Violation|1
7725801|NCT00972738|26866335|P1|Overall Study|Protocol Violation|2
7725802|NCT00972738|26866333|P3|Overall Study|Adverse Event|8
7725803|NCT00972738|26866334|P2|Overall Study|Adverse Event|1
7725804|NCT00972738|26866335|P1|Overall Study|Adverse Event|7
7725805|NCT00972595|26866452|P2|Period 1|Adverse Event|0
7725806|NCT00972595|26866453|P1|Period 1|Adverse Event|1
7725807|NCT00972543|26866463|P2|Overall Study|Early study termination by sponsor|1
7725808|NCT00972543|26866464|P1|Overall Study|Early study termination by sponsor|4
7725809|NCT00972543|26866463|P2|Overall Study|Adverse Event|0
7725810|NCT00972543|26866464|P1|Overall Study|Adverse Event|1
7725811|NCT00972517|26866547|P6|Overall Study|Withdrawal by Subject|0
7725812|NCT00972517|26866548|P5|Overall Study|Withdrawal by Subject|1
7725813|NCT00972517|26866549|P4|Overall Study|Withdrawal by Subject|2
7725814|NCT00972517|26866550|P3|Overall Study|Withdrawal by Subject|0
7725815|NCT00972517|26866551|P2|Overall Study|Withdrawal by Subject|1
7725816|NCT00972517|26866552|P1|Overall Study|Withdrawal by Subject|0
7725817|NCT00972517|26866547|P6|Overall Study|Adverse Event|0
7725818|NCT00972517|26866548|P5|Overall Study|Adverse Event|0
7725819|NCT00972517|26866549|P4|Overall Study|Adverse Event|1
7725820|NCT00972517|26866550|P3|Overall Study|Adverse Event|0
7725821|NCT00972517|26866551|P2|Overall Study|Adverse Event|0
7725822|NCT00972517|26866552|P1|Overall Study|Adverse Event|0
7725823|NCT00972504|26866647|P1|Overall Study|Investigator discretion|1
7725824|NCT00972504|26866647|P1|Overall Study|Adverse Event|2
7725839|NCT00972322|26866725|P2|Overall Study|Consistently high glucose values|0
7725840|NCT00972322|26866726|P1|Overall Study|Consistently high glucose values|1
7725841|NCT00972322|26866725|P2|Overall Study|Lost to Follow-up|1
7725842|NCT00972322|26866726|P1|Overall Study|Lost to Follow-up|0
7725843|NCT00972322|26866725|P2|Overall Study|Positive drug screen|1
7725844|NCT00972322|26866726|P1|Overall Study|Positive drug screen|0
7725845|NCT00972322|26866725|P2|Overall Study|Adverse Event|1
7725846|NCT00972322|26866726|P1|Overall Study|Adverse Event|2
7725847|NCT00972283|26866738|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
7725848|NCT00972283|26866739|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
7725849|NCT00972283|26866738|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
7725850|NCT00972283|26866739|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
7725851|NCT00972283|26866738|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
7725852|NCT00972283|26866739|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
7725853|NCT00972283|26866738|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
7725854|NCT00972283|26866739|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
7725855|NCT00972283|26866738|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
7725856|NCT00972283|26866739|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
7725857|NCT00972283|26866738|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
7725858|NCT00972283|26866739|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
7725859|NCT00972283|26866738|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
7725860|NCT00972283|26866739|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
7725861|NCT00972283|26866738|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
7725862|NCT00972283|26866739|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
7725863|NCT00972283|26866738|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
7725864|NCT00972283|26866739|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
7725865|NCT00972283|26866738|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
7725866|NCT00972283|26866739|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
7725867|NCT00972244|26866766|P5|Overall Study|Various|2
7725868|NCT00972244|26866767|P4|Overall Study|Various|0
7725869|NCT00972244|26866768|P3|Overall Study|Various|0
7725870|NCT00972244|26866769|P2|Overall Study|Various|0
7725871|NCT00972244|26866770|P1|Overall Study|Various|0
7725872|NCT00972244|26866766|P5|Overall Study|Death|0
7725873|NCT00972244|26866767|P4|Overall Study|Death|0
7725874|NCT00972244|26866768|P3|Overall Study|Death|0
7725875|NCT00972244|26866769|P2|Overall Study|Death|0
7725876|NCT00972244|26866770|P1|Overall Study|Death|1
7725877|NCT00972244|26866766|P5|Overall Study|Safety|1
7725878|NCT00972244|26866767|P4|Overall Study|Safety|0
7725879|NCT00972244|26866768|P3|Overall Study|Safety|0
7725880|NCT00972244|26866769|P2|Overall Study|Safety|0
7725881|NCT00972244|26866770|P1|Overall Study|Safety|0
7725882|NCT00972244|26866766|P5|Overall Study|Withdrawal by Subject|1
7725883|NCT00972244|26866767|P4|Overall Study|Withdrawal by Subject|0
7725884|NCT00972244|26866768|P3|Overall Study|Withdrawal by Subject|1
7725885|NCT00972244|26866769|P2|Overall Study|Withdrawal by Subject|2
7725886|NCT00972244|26866770|P1|Overall Study|Withdrawal by Subject|1
7725887|NCT00972244|26866766|P5|Overall Study|Subject No Longer Meets Study Criteria|5
7725888|NCT00972244|26866767|P4|Overall Study|Subject No Longer Meets Study Criteria|0
7725889|NCT00972244|26866768|P3|Overall Study|Subject No Longer Meets Study Criteria|0
7725890|NCT00972244|26866769|P2|Overall Study|Subject No Longer Meets Study Criteria|2
7725891|NCT00972244|26866770|P1|Overall Study|Subject No Longer Meets Study Criteria|2
7725892|NCT00972244|26866766|P5|Overall Study|Adverse Event|0
7725893|NCT00972244|26866767|P4|Overall Study|Adverse Event|0
7725894|NCT00972244|26866768|P3|Overall Study|Adverse Event|1
7725895|NCT00972244|26866769|P2|Overall Study|Adverse Event|1
7725896|NCT00972244|26866770|P1|Overall Study|Adverse Event|0
7725897|NCT00972244|26866766|P5|Overall Study|Incorrect Enrolment|0
7725898|NCT00972244|26866767|P4|Overall Study|Incorrect Enrolment|0
7725899|NCT00972244|26866768|P3|Overall Study|Incorrect Enrolment|0
7725900|NCT00972244|26866769|P2|Overall Study|Incorrect Enrolment|0
7725901|NCT00972244|26866770|P1|Overall Study|Incorrect Enrolment|1
7725902|NCT00972153|26866802|P3|Overall Study|Equipment malfunction during case|0
7725903|NCT00972153|26866803|P2|Overall Study|Equipment malfunction during case|1
7725904|NCT00972153|26866804|P1|Overall Study|Equipment malfunction during case|0
7725905|NCT00972023|26866819|P1|Overall Study|Withdrawal by Subject|1
7725906|NCT00971997|26866826|P1|Overall Study|Physician Decision|7
7725907|NCT00971997|26866826|P1|Overall Study|Withdrawal by Subject|5
7725908|NCT00971997|26866826|P1|Overall Study|Protocol Violation|4
7725909|NCT00971997|26866826|P1|Overall Study|Death|1
7725910|NCT00971997|26866826|P1|Overall Study|Adverse Event|2
7725911|NCT00971945|26866844|P1|Overall Study|Other reasons|2
7725912|NCT00971945|26866844|P1|Overall Study|Change in treatment policy|1
7725913|NCT00971945|26866844|P1|Overall Study|Progressive Disease|3
7725914|NCT00971932|26866851|P1|Overall Study|Ongoing|4
7725915|NCT00971932|26866851|P1|Overall Study|Investigator's decision|2
7725916|NCT00971932|26866851|P1|Overall Study|Withdrawal by Subject|1
7725917|NCT00971425|26866952|P2|Overall Study|Withdrawal by Subject|1
7725918|NCT00971425|26866953|P1|Overall Study|Withdrawal by Subject|0
7725919|NCT00971425|26866952|P2|Overall Study|Adverse Event|1
7725920|NCT00971425|26866953|P1|Overall Study|Adverse Event|1
7725921|NCT00971321|26866989|P2|Up to Month 11-12|Lost to Follow-up|0
7725922|NCT00971321|26866990|P1|Up to Month 11-12|Lost to Follow-up|1
7725923|NCT00971321|26866989|P2|Up to Month 11-12|Migrated/moved from study area|2
7725924|NCT00971321|26866990|P1|Up to Month 11-12|Migrated/moved from study area|2
7725925|NCT00971321|26866989|P2|Up to Month 11-12|Withdrawal by Subject|1
7725926|NCT00971321|26866990|P1|Up to Month 11-12|Withdrawal by Subject|2
7725927|NCT00971321|26866989|P2|Up to Month 7|Migrated/moved from study area|2
7725928|NCT00971321|26866990|P1|Up to Month 7|Migrated/moved from study area|3
7725929|NCT00971321|26866989|P2|Up to Month 7|Withdrawal by Subject|0
7725930|NCT00971321|26866990|P1|Up to Month 7|Withdrawal by Subject|1
7725931|NCT00971243|26867070|P5|Open-label Period|Other reason|2
7725932|NCT00971243|26867071|P4|Open-label Period|Other reason|0
7725933|NCT00971243|26867072|P3|Open-label Period|Other reason|0
7725934|NCT00971243|26867073|P2|Open-label Period|Other reason|0
7725935|NCT00971243|26867074|P1|Open-label Period|Other reason|0
7725936|NCT00971243|26867070|P5|Open-label Period|Withdrawal by Subject|1
7725937|NCT00971243|26867071|P4|Open-label Period|Withdrawal by Subject|2
7725938|NCT00971243|26867072|P3|Open-label Period|Withdrawal by Subject|0
7725939|NCT00971243|26867073|P2|Open-label Period|Withdrawal by Subject|0
7725940|NCT00971243|26867074|P1|Open-label Period|Withdrawal by Subject|1
7725941|NCT00971243|26867070|P5|Open-label Period|Protocol Violation|1
7725942|NCT00971243|26867071|P4|Open-label Period|Protocol Violation|0
7725943|NCT00971243|26867072|P3|Open-label Period|Protocol Violation|1
7725944|NCT00971243|26867073|P2|Open-label Period|Protocol Violation|1
7725945|NCT00971243|26867074|P1|Open-label Period|Protocol Violation|1
7725946|NCT00971243|26867070|P5|Open-label Period|Physician Decision|2
7725947|NCT00971243|26867071|P4|Open-label Period|Physician Decision|7
7725948|NCT00971243|26867072|P3|Open-label Period|Physician Decision|3
7725949|NCT00971243|26867073|P2|Open-label Period|Physician Decision|9
7725950|NCT00971243|26867074|P1|Open-label Period|Physician Decision|5
7725951|NCT00971243|26867070|P5|Open-label Period|Adverse Event|0
7725952|NCT00971243|26867071|P4|Open-label Period|Adverse Event|1
7725953|NCT00971243|26867072|P3|Open-label Period|Adverse Event|1
7725954|NCT00971243|26867073|P2|Open-label Period|Adverse Event|0
7725955|NCT00971243|26867074|P1|Open-label Period|Adverse Event|1
7725956|NCT00971243|26867070|P5|Double Blind Period|Other reasons|1
7725957|NCT00971243|26867071|P4|Double Blind Period|Other reasons|0
7725958|NCT00971243|26867072|P3|Double Blind Period|Other reasons|2
7725959|NCT00971243|26867073|P2|Double Blind Period|Other reasons|0
7725960|NCT00971243|26867074|P1|Double Blind Period|Other reasons|1
7725961|NCT00971243|26867070|P5|Double Blind Period|Withdrawal by Subject|4
7725962|NCT00971243|26867071|P4|Double Blind Period|Withdrawal by Subject|4
7725963|NCT00971243|26867072|P3|Double Blind Period|Withdrawal by Subject|4
7725964|NCT00971243|26867073|P2|Double Blind Period|Withdrawal by Subject|1
7725965|NCT00971243|26867074|P1|Double Blind Period|Withdrawal by Subject|4
7725966|NCT00971243|26867070|P5|Double Blind Period|Protocol Violation|2
7725967|NCT00971243|26867071|P4|Double Blind Period|Protocol Violation|2
7725968|NCT00971243|26867072|P3|Double Blind Period|Protocol Violation|3
7725969|NCT00971243|26867073|P2|Double Blind Period|Protocol Violation|0
7725970|NCT00971243|26867074|P1|Double Blind Period|Protocol Violation|2
7725971|NCT00971243|26867070|P5|Double Blind Period|Physician Decision|7
7725972|NCT00971243|26867071|P4|Double Blind Period|Physician Decision|6
7725973|NCT00971243|26867072|P3|Double Blind Period|Physician Decision|7
7725974|NCT00971243|26867073|P2|Double Blind Period|Physician Decision|6
7725975|NCT00971243|26867074|P1|Double Blind Period|Physician Decision|10
7725976|NCT00971243|26867070|P5|Double Blind Period|Lost to Follow-up|1
7725977|NCT00971243|26867071|P4|Double Blind Period|Lost to Follow-up|0
7725978|NCT00971243|26867072|P3|Double Blind Period|Lost to Follow-up|1
7725979|NCT00971243|26867073|P2|Double Blind Period|Lost to Follow-up|1
7725980|NCT00971243|26867074|P1|Double Blind Period|Lost to Follow-up|0
7725981|NCT00971243|26867070|P5|Double Blind Period|Adverse Event|3
7725982|NCT00971243|26867071|P4|Double Blind Period|Adverse Event|2
7725983|NCT00971243|26867072|P3|Double Blind Period|Adverse Event|2
7725984|NCT00971243|26867073|P2|Double Blind Period|Adverse Event|3
7725985|NCT00971243|26867074|P1|Double Blind Period|Adverse Event|2
7725986|NCT00971204|26867091|P1|Overall Study|Lost to Follow-up|10
7725987|NCT00971204|26867091|P1|Overall Study|Did not meet all criteria-not treated|14
7725988|NCT00971178|26867098|P3|Overall Study|Lost to Follow-up|2
7725989|NCT00971178|26867099|P2|Overall Study|Lost to Follow-up|2
7725990|NCT00971178|26867100|P1|Overall Study|Lost to Follow-up|2
7725991|NCT00971048|26867112|P4|Overall Study|Physician Decision|1
7725992|NCT00971048|26867113|P3|Overall Study|Physician Decision|0
7725993|NCT00971048|26867114|P2|Overall Study|Physician Decision|0
7725994|NCT00971048|26867115|P1|Overall Study|Physician Decision|0
7725995|NCT00971048|26867112|P4|Overall Study|Adverse Event|0
7725996|NCT00971048|26867113|P3|Overall Study|Adverse Event|1
7725997|NCT00971048|26867114|P2|Overall Study|Adverse Event|0
7725998|NCT00971048|26867115|P1|Overall Study|Adverse Event|0
7725999|NCT00971048|26867112|P4|Overall Study|Protocol Violation|1
7726000|NCT00971048|26867113|P3|Overall Study|Protocol Violation|0
7726001|NCT00971048|26867114|P2|Overall Study|Protocol Violation|2
7726002|NCT00971048|26867115|P1|Overall Study|Protocol Violation|1
7726003|NCT00970944|26867139|P2|Overall Study|Physician Decision|2
7726004|NCT00970944|26867140|P1|Overall Study|Physician Decision|0
7726005|NCT00970944|26867139|P2|Overall Study|Death|0
7726006|NCT00970944|26867140|P1|Overall Study|Death|1
7726007|NCT00970684|26867192|P1|Overall Study|Withdrawal by Subject|1
7726008|NCT00970684|26867192|P1|Overall Study|Adverse Event|4
7726009|NCT00970684|26867192|P1|Overall Study|Lack of Efficacy|5
7726010|NCT00970632|26867201|P3|Overall Study|Sponsor decision|1
7726011|NCT00970632|26867202|P2|Overall Study|Sponsor decision|0
7726012|NCT00970632|26867203|P1|Overall Study|Sponsor decision|1
7726013|NCT00970632|26867201|P3|Overall Study|Entry criteria not met|2
7726014|NCT00970632|26867202|P2|Overall Study|Entry criteria not met|2
7726015|NCT00970632|26867203|P1|Overall Study|Entry criteria not met|0
7726016|NCT00970632|26867201|P3|Overall Study|Withdrawal by Subject|4
7726017|NCT00970632|26867202|P2|Overall Study|Withdrawal by Subject|6
7726018|NCT00970632|26867203|P1|Overall Study|Withdrawal by Subject|7
7726019|NCT00970632|26867201|P3|Overall Study|Protocol Violation|8
7726020|NCT00970632|26867202|P2|Overall Study|Protocol Violation|5
7726021|NCT00970632|26867203|P1|Overall Study|Protocol Violation|8
7726022|NCT00970632|26867201|P3|Overall Study|Lost to Follow-up|2
7726023|NCT00970632|26867202|P2|Overall Study|Lost to Follow-up|0
7726024|NCT00970632|26867203|P1|Overall Study|Lost to Follow-up|3
7726025|NCT00970632|26867201|P3|Overall Study|Lack of Efficacy|0
7726026|NCT00970632|26867202|P2|Overall Study|Lack of Efficacy|0
7726027|NCT00970632|26867203|P1|Overall Study|Lack of Efficacy|3
7726028|NCT00970632|26867201|P3|Overall Study|Adverse Event|1
7726029|NCT00970632|26867202|P2|Overall Study|Adverse Event|2
7726030|NCT00970632|26867203|P1|Overall Study|Adverse Event|2
7726031|NCT00970593|26867275|P7|Overall Study|Withdrawal by Subject|0
7726032|NCT00970593|26867276|P6|Overall Study|Withdrawal by Subject|0
7726033|NCT00970593|26867277|P5|Overall Study|Withdrawal by Subject|0
7726034|NCT00970593|26867278|P4|Overall Study|Withdrawal by Subject|0
7726035|NCT00970593|26867279|P3|Overall Study|Withdrawal by Subject|1
7726036|NCT00970593|26867280|P2|Overall Study|Withdrawal by Subject|0
7726037|NCT00970593|26867281|P1|Overall Study|Withdrawal by Subject|0
7726038|NCT00970593|26867275|P7|Overall Study|Discontinuation of study by sponsor|2
7726039|NCT00970593|26867276|P6|Overall Study|Discontinuation of study by sponsor|0
7726040|NCT00970593|26867277|P5|Overall Study|Discontinuation of study by sponsor|0
7726041|NCT00970593|26867278|P4|Overall Study|Discontinuation of study by sponsor|0
7726042|NCT00970593|26867279|P3|Overall Study|Discontinuation of study by sponsor|5
7726043|NCT00970593|26867280|P2|Overall Study|Discontinuation of study by sponsor|0
7726044|NCT00970593|26867281|P1|Overall Study|Discontinuation of study by sponsor|0
7726045|NCT00970593|26867275|P7|Overall Study|Adverse Event|0
7726046|NCT00970593|26867276|P6|Overall Study|Adverse Event|0
7726047|NCT00970593|26867277|P5|Overall Study|Adverse Event|0
7726048|NCT00970593|26867278|P4|Overall Study|Adverse Event|0
7726049|NCT00970593|26867279|P3|Overall Study|Adverse Event|0
7726050|NCT00970593|26867280|P2|Overall Study|Adverse Event|1
7726051|NCT00970593|26867281|P1|Overall Study|Adverse Event|1
7726052|NCT00970502|26867363|P1|Overall Study|Withdrawal by Subject|1
7726053|NCT00970489|26867374|P2|Overall Study|Death/Withdrew/Criteria Violation|41
7726054|NCT00970489|26867375|P1|Overall Study|Death/Withdrew/Criteria Violation|54
7726055|NCT00970359|26867387|P1|Overall Study|Not Treated|4
7726056|NCT00970307|26867417|P3|Overall Study|Withdrawal by Subject|2
7726057|NCT00970307|26867418|P2|Overall Study|Withdrawal by Subject|3
7726058|NCT00970307|26867419|P1|Overall Study|Withdrawal by Subject|2
7726059|NCT00970307|26867417|P3|Overall Study|Serious Adverse Event|0
7726060|NCT00970307|26867418|P2|Overall Study|Serious Adverse Event|0
7726061|NCT00970307|26867419|P1|Overall Study|Serious Adverse Event|1
7726062|NCT00970294|26867493|P1|Overall Study|Withdrawal by Subject|1
7726063|NCT00970294|26867493|P1|Overall Study|Physician Decision|4
7726064|NCT00970281|26867501|P2|Overall Study|Physician Decision|1
7726065|NCT00970281|26867502|P1|Overall Study|Physician Decision|1
7726066|NCT00970281|26867501|P2|Overall Study|Withdrawal by Subject|1
7726067|NCT00970281|26867502|P1|Overall Study|Withdrawal by Subject|0
7726068|NCT00970281|26867501|P2|Overall Study|Lack of Efficacy|14
7726069|NCT00970281|26867502|P1|Overall Study|Lack of Efficacy|1
7726070|NCT00970268|26867520|P2|Overall Study|Inclusion/Exclusion Criteria|0
7726071|NCT00970268|26867521|P1|Overall Study|Inclusion/Exclusion Criteria|1
7726072|NCT00970268|26867520|P2|Overall Study|Lost to Follow-up|2
7726073|NCT00970268|26867521|P1|Overall Study|Lost to Follow-up|1
7726074|NCT00970268|26867520|P2|Overall Study|COPD Exacerbation|2
7726075|NCT00970268|26867521|P1|Overall Study|COPD Exacerbation|4
7726076|NCT00970268|26867520|P2|Overall Study|Other Reason|1
7726077|NCT00970268|26867521|P1|Overall Study|Other Reason|3
7726078|NCT00970268|26867520|P2|Overall Study|Protocol Violation|7
7726079|NCT00970268|26867521|P1|Overall Study|Protocol Violation|4
7726080|NCT00970268|26867520|P2|Overall Study|Lack of Efficacy|6
7726081|NCT00970268|26867521|P1|Overall Study|Lack of Efficacy|3
7726082|NCT00970268|26867520|P2|Overall Study|Adverse Event|12
7726083|NCT00970268|26867521|P1|Overall Study|Adverse Event|15
7726084|NCT00970268|26867520|P2|Overall Study|Withdrawal by Subject|19
7726085|NCT00970268|26867521|P1|Overall Study|Withdrawal by Subject|12
7726086|NCT00969761|26867607|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726087|NCT00969761|26867608|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726088|NCT00969761|26867609|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726089|NCT00969761|26867610|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
7726090|NCT00969761|26867611|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726091|NCT00969761|26867612|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726092|NCT00969761|26867613|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726093|NCT00969761|26867614|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
7726094|NCT00969761|26867615|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
7726095|NCT00969761|26867616|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726096|NCT00969761|26867617|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726097|NCT00969761|26867618|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7726098|NCT00969761|26867607|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7726099|NCT00969761|26867608|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7726100|NCT00969761|26867609|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7726101|NCT00969761|26867610|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
7726102|NCT00969761|26867611|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
7726103|NCT00969761|26867612|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7726104|NCT00969761|26867613|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7726105|NCT00969761|26867614|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7726106|NCT00969761|26867615|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7726107|NCT00969761|26867616|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
7726108|NCT00969761|26867617|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7726109|NCT00969761|26867618|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7726110|NCT00969761|26867607|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726111|NCT00969761|26867608|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726112|NCT00969761|26867609|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726113|NCT00969761|26867610|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
7726114|NCT00969761|26867611|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726115|NCT00969761|26867612|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726116|NCT00969761|26867613|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726117|NCT00969761|26867614|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726118|NCT00969761|26867615|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726119|NCT00969761|26867616|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726120|NCT00969761|26867617|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726121|NCT00969761|26867618|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7726122|NCT00969761|26867607|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726123|NCT00969761|26867608|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726124|NCT00969761|26867609|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726125|NCT00969761|26867610|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726126|NCT00969761|26867611|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726127|NCT00969761|26867612|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726128|NCT00969761|26867613|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726129|NCT00969761|26867614|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726130|NCT00969761|26867615|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726131|NCT00969761|26867616|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
7726132|NCT00969761|26867617|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726133|NCT00969761|26867618|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7726134|NCT00969761|26867607|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726135|NCT00969761|26867608|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726136|NCT00969761|26867609|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726137|NCT00969761|26867610|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726138|NCT00969761|26867611|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726139|NCT00969761|26867612|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726140|NCT00969761|26867613|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726141|NCT00969761|26867614|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726142|NCT00969761|26867615|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726143|NCT00969761|26867616|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
7726144|NCT00969761|26867617|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726145|NCT00969761|26867618|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7726146|NCT00969761|26867607|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726147|NCT00969761|26867608|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726148|NCT00969761|26867609|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7726149|NCT00969761|26867610|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7726150|NCT00969761|26867611|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726151|NCT00969761|26867612|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726152|NCT00969761|26867613|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726153|NCT00969761|26867614|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726154|NCT00969761|26867615|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7726155|NCT00969761|26867616|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726156|NCT00969761|26867617|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7726157|NCT00969761|26867618|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7726158|NCT00969709|26867924|P4|Overall Study|Other reasons|0
7726159|NCT00969709|26867925|P3|Overall Study|Other reasons|3
7726160|NCT00969709|26867926|P2|Overall Study|Other reasons|0
7726161|NCT00969709|26867927|P1|Overall Study|Other reasons|0
7726162|NCT00969709|26867924|P4|Overall Study|Lost to Follow-up|15
7726163|NCT00969709|26867925|P3|Overall Study|Lost to Follow-up|8
7726164|NCT00969709|26867926|P2|Overall Study|Lost to Follow-up|14
7726165|NCT00969709|26867927|P1|Overall Study|Lost to Follow-up|10
7726166|NCT00969709|26867924|P4|Overall Study|Withdrawal by Subject|23
7726167|NCT00969709|26867925|P3|Overall Study|Withdrawal by Subject|11
7726168|NCT00969709|26867926|P2|Overall Study|Withdrawal by Subject|12
7726169|NCT00969709|26867927|P1|Overall Study|Withdrawal by Subject|9
7726170|NCT00969709|26867924|P4|Overall Study|Protocol Violation|10
7726171|NCT00969709|26867925|P3|Overall Study|Protocol Violation|9
7726172|NCT00969709|26867926|P2|Overall Study|Protocol Violation|5
7726173|NCT00969709|26867927|P1|Overall Study|Protocol Violation|9
7726174|NCT00969709|26867924|P4|Overall Study|Lack of Efficacy|3
7726175|NCT00969709|26867925|P3|Overall Study|Lack of Efficacy|1
7726176|NCT00969709|26867926|P2|Overall Study|Lack of Efficacy|4
7726177|NCT00969709|26867927|P1|Overall Study|Lack of Efficacy|7
7726178|NCT00969709|26867924|P4|Overall Study|Adverse Event|12
7726179|NCT00969709|26867925|P3|Overall Study|Adverse Event|26
7726180|NCT00969709|26867926|P2|Overall Study|Adverse Event|13
7726181|NCT00969709|26867927|P1|Overall Study|Adverse Event|3
7726182|NCT00969618|26867941|P1|Overall Study|Withdrawal by Subject|27
7726183|NCT00969618|26867941|P1|Overall Study|Protocol Violation|9
7726184|NCT00969618|26867941|P1|Overall Study|Physician Decision|1
7726185|NCT00969618|26867941|P1|Overall Study|Lost to Follow-up|7
7726186|NCT00969618|26867941|P1|Overall Study|Lack of Efficacy|2
7726187|NCT00969618|26867941|P1|Overall Study|Entry Criteria Not Met|3
7726188|NCT00969618|26867941|P1|Overall Study|Adverse Event|29
7726189|NCT00969553|26867961|P9|Overall Study|Not specified above|0
7726190|NCT00969553|26867962|P8|Overall Study|Not specified above|1
7726191|NCT00969553|26867963|P7|Overall Study|Not specified above|1
7726192|NCT00969553|26867964|P6|Overall Study|Not specified above|0
7726193|NCT00969553|26867965|P5|Overall Study|Not specified above|0
7726194|NCT00969553|26867966|P4|Overall Study|Not specified above|4
7726195|NCT00969553|26867967|P3|Overall Study|Not specified above|0
7726196|NCT00969553|26867968|P2|Overall Study|Not specified above|0
7726197|NCT00969553|26867969|P1|Overall Study|Not specified above|0
7726198|NCT00969553|26867961|P9|Overall Study|Refused cont. medication|0
7726199|NCT00969553|26867962|P8|Overall Study|Refused cont. medication|1
7726200|NCT00969553|26867963|P7|Overall Study|Refused cont. medication|0
7726201|NCT00969553|26867964|P6|Overall Study|Refused cont. medication|0
7726202|NCT00969553|26867965|P5|Overall Study|Refused cont. medication|0
7726203|NCT00969553|26867966|P4|Overall Study|Refused cont. medication|2
7726204|NCT00969553|26867967|P3|Overall Study|Refused cont. medication|0
7726205|NCT00969553|26867968|P2|Overall Study|Refused cont. medication|1
7726206|NCT00969553|26867969|P1|Overall Study|Refused cont. medication|1
7726207|NCT00969553|26867961|P9|Overall Study|Other Adverse Event|0
7726208|NCT00969553|26867962|P8|Overall Study|Other Adverse Event|0
7726209|NCT00969553|26867963|P7|Overall Study|Other Adverse Event|1
7726210|NCT00969553|26867964|P6|Overall Study|Other Adverse Event|0
7726211|NCT00969553|26867965|P5|Overall Study|Other Adverse Event|0
7726212|NCT00969553|26867966|P4|Overall Study|Other Adverse Event|1
7726213|NCT00969553|26867967|P3|Overall Study|Other Adverse Event|0
7726214|NCT00969553|26867968|P2|Overall Study|Other Adverse Event|0
7726215|NCT00969553|26867969|P1|Overall Study|Other Adverse Event|0
7726216|NCT00969553|26867961|P9|Overall Study|Dose limiting Toxicity (DLT)|0
7726217|NCT00969553|26867962|P8|Overall Study|Dose limiting Toxicity (DLT)|0
7726218|NCT00969553|26867963|P7|Overall Study|Dose limiting Toxicity (DLT)|0
7726219|NCT00969553|26867964|P6|Overall Study|Dose limiting Toxicity (DLT)|0
7726220|NCT00969553|26867965|P5|Overall Study|Dose limiting Toxicity (DLT)|1
7726221|NCT00969553|26867966|P4|Overall Study|Dose limiting Toxicity (DLT)|0
7726222|NCT00969553|26867967|P3|Overall Study|Dose limiting Toxicity (DLT)|0
7726223|NCT00969553|26867968|P2|Overall Study|Dose limiting Toxicity (DLT)|0
7726224|NCT00969553|26867969|P1|Overall Study|Dose limiting Toxicity (DLT)|0
7726225|NCT00969553|26867961|P9|Overall Study|Progressive disease (PD)|3
7726226|NCT00969553|26867962|P8|Overall Study|Progressive disease (PD)|12
7726227|NCT00969553|26867963|P7|Overall Study|Progressive disease (PD)|2
7726228|NCT00969553|26867964|P6|Overall Study|Progressive disease (PD)|4
7726229|NCT00969553|26867965|P5|Overall Study|Progressive disease (PD)|2
7726230|NCT00969553|26867966|P4|Overall Study|Progressive disease (PD)|9
7726231|NCT00969553|26867967|P3|Overall Study|Progressive disease (PD)|6
7726232|NCT00969553|26867968|P2|Overall Study|Progressive disease (PD)|2
7726233|NCT00969553|26867969|P1|Overall Study|Progressive disease (PD)|2
7726234|NCT00969540|26868112|P2|Overall Study|Lost to Follow-up|1
7726235|NCT00969540|26868113|P1|Overall Study|Lost to Follow-up|1
7726236|NCT00969436|26868138|P3|Overall Study|Lost to Follow-up|5
7726237|NCT00969436|26868139|P2|Overall Study|Lost to Follow-up|8
7726238|NCT00969436|26868140|P1|Overall Study|Lost to Follow-up|8
7726239|NCT00969436|26868138|P3|Overall Study|Withdrawal by Subject|2
7726240|NCT00969436|26868139|P2|Overall Study|Withdrawal by Subject|0
7726241|NCT00969436|26868140|P1|Overall Study|Withdrawal by Subject|3
7726242|NCT00969436|26868138|P3|Overall Study|Subject eliminated (other vaccine)|0
7726243|NCT00969436|26868139|P2|Overall Study|Subject eliminated (other vaccine)|0
7726244|NCT00969436|26868140|P1|Overall Study|Subject eliminated (other vaccine)|1
7726245|NCT00969436|26868138|P3|Overall Study|Parents personal problem|1
7726246|NCT00969436|26868139|P2|Overall Study|Parents personal problem|0
7726247|NCT00969436|26868140|P1|Overall Study|Parents personal problem|0
7726248|NCT00969436|26868138|P3|Overall Study|Father - serious health problem|1
7726249|NCT00969436|26868139|P2|Overall Study|Father - serious health problem|0
7726250|NCT00969436|26868140|P1|Overall Study|Father - serious health problem|0
7726251|NCT00969436|26868138|P3|Overall Study|Migrated/moved from study area|2
7726252|NCT00969436|26868139|P2|Overall Study|Migrated/moved from study area|10
7726253|NCT00969436|26868140|P1|Overall Study|Migrated/moved from study area|12
7726254|NCT00969436|26868138|P3|Overall Study|Protocol Violation|0
7726255|NCT00969436|26868139|P2|Overall Study|Protocol Violation|3
7726256|NCT00969436|26868140|P1|Overall Study|Protocol Violation|1
7726257|NCT00969332|26868172|P1|Overall Study|Withdrawal by Subject|3
7726258|NCT00969332|26868172|P1|Overall Study|Physician Decision|8
7726259|NCT00969280|26868188|P2|Overall Study|infection of influenza A(H1N1)|1
7726260|NCT00969280|26868189|P1|Overall Study|infection of influenza A(H1N1)|0
7726261|NCT00969280|26868188|P2|Overall Study|Withdrawal by Subject|1
7726262|NCT00969280|26868189|P1|Overall Study|Withdrawal by Subject|0
7726263|NCT00969280|26868188|P2|Overall Study|Protocol Violation|1
7726264|NCT00969280|26868189|P1|Overall Study|Protocol Violation|2
7726265|NCT00969228|26868197|P2|Overall Study|Porcine circovirus detection in vaccine|14
7726266|NCT00969228|26868198|P1|Overall Study|Porcine circovirus detection in vaccine|38
7726267|NCT00969228|26868197|P2|Overall Study|Withdrawal by Subject|0
7726268|NCT00969228|26868198|P1|Overall Study|Withdrawal by Subject|4
7726269|NCT00969228|26868197|P2|Overall Study|Adverse Event|0
7726270|NCT00969228|26868198|P1|Overall Study|Adverse Event|1
7726271|NCT00969150|26868216|P2|Overall Study|Other reasons|0
7726272|NCT00969150|26868217|P1|Overall Study|Other reasons|1
7726273|NCT00969150|26868216|P2|Overall Study|Lost to Follow-up|4
7726274|NCT00969150|26868217|P1|Overall Study|Lost to Follow-up|5
7726275|NCT00969150|26868216|P2|Overall Study|Withdrawal by Subject|9
7726276|NCT00969150|26868217|P1|Overall Study|Withdrawal by Subject|13
7726277|NCT00969150|26868216|P2|Overall Study|Protocol Violation|12
7726278|NCT00969150|26868217|P1|Overall Study|Protocol Violation|9
7726279|NCT00969150|26868216|P2|Overall Study|Lack of Efficacy|1
7726280|NCT00969150|26868217|P1|Overall Study|Lack of Efficacy|1
7726281|NCT00969150|26868216|P2|Overall Study|Adverse Event|14
7726282|NCT00969150|26868217|P1|Overall Study|Adverse Event|4
7726283|NCT00969124|26868225|P1|Overall Study|Technical error|1
7726284|NCT00969124|26868225|P1|Overall Study|Previously unrecognized disease|3
7726285|NCT00969124|26868225|P1|Overall Study|Inability to reach cecum|9
7726286|NCT00969124|26868225|P1|Overall Study|Inadequate bowel preparation|15
7726287|NCT00969124|26868225|P1|Overall Study|Protocol Violation|2
7726288|NCT00968981|26868234|P3|Overall Study|Withdrawal by Subject|3
7726289|NCT00968981|26868235|P2|Overall Study|Withdrawal by Subject|3
7726290|NCT00968981|26868236|P1|Overall Study|Withdrawal by Subject|1
7726291|NCT00968981|26868234|P3|Overall Study|Physician Decision|5
7726292|NCT00968981|26868235|P2|Overall Study|Physician Decision|3
7726293|NCT00968981|26868236|P1|Overall Study|Physician Decision|5
7726294|NCT00968981|26868234|P3|Overall Study|Lost to Follow-up|1
7726295|NCT00968981|26868235|P2|Overall Study|Lost to Follow-up|0
7726296|NCT00968981|26868236|P1|Overall Study|Lost to Follow-up|0
7726297|NCT00968981|26868234|P3|Overall Study|Disease Progression|13
7726298|NCT00968981|26868235|P2|Overall Study|Disease Progression|16
7726299|NCT00968981|26868236|P1|Overall Study|Disease Progression|14
7726300|NCT00968981|26868234|P3|Overall Study|Adverse Event|0
7726301|NCT00968981|26868235|P2|Overall Study|Adverse Event|0
7726302|NCT00968981|26868236|P1|Overall Study|Adverse Event|2
7726303|NCT00968968|26868274|P2|Overall Study|Lost to Follow-up|1
7726304|NCT00968968|26868275|P1|Overall Study|Lost to Follow-up|0
7726305|NCT00968968|26868274|P2|Overall Study|Physician Decision|2
7726306|NCT00968968|26868275|P1|Overall Study|Physician Decision|1
7726307|NCT00968968|26868274|P2|Overall Study|Withdrawal by Subject|0
7726308|NCT00968968|26868275|P1|Overall Study|Withdrawal by Subject|2
7726309|NCT00968968|26868274|P2|Overall Study|Protocol defined stopping criteria|1
7726310|NCT00968968|26868275|P1|Overall Study|Protocol defined stopping criteria|3
7726311|NCT00968968|26868274|P2|Overall Study|Study closed/terminated|10
7726312|NCT00968968|26868275|P1|Overall Study|Study closed/terminated|10
7726313|NCT00968864|26868321|P1|Overall Study|Protocol exception/ not evaluable|1
7726314|NCT00968812|26868349|P3|Overall Study|Other|40
7726315|NCT00968812|26868350|P2|Overall Study|Other|37
7726316|NCT00968812|26868351|P1|Overall Study|Other|25
7726317|NCT00968812|26868349|P3|Overall Study|Unable to take rescue therapy|17
7726318|NCT00968812|26868350|P2|Overall Study|Unable to take rescue therapy|12
7726319|NCT00968812|26868351|P1|Overall Study|Unable to take rescue therapy|12
7726320|NCT00968812|26868349|P3|Overall Study|Noncompliance with study drug|6
7726321|NCT00968812|26868350|P2|Overall Study|Noncompliance with study drug|1
7726322|NCT00968812|26868351|P1|Overall Study|Noncompliance with study drug|4
7726323|NCT00968812|26868349|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
7726324|NCT00968812|26868350|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
7726325|NCT00968812|26868351|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
7726326|NCT00968812|26868349|P3|Overall Study|Withdrawal by Subject|25
7726327|NCT00968812|26868350|P2|Overall Study|Withdrawal by Subject|23
7726328|NCT00968812|26868351|P1|Overall Study|Withdrawal by Subject|17
7726329|NCT00968812|26868349|P3|Overall Study|Protocol Violation|3
7726330|NCT00968812|26868350|P2|Overall Study|Protocol Violation|4
7726331|NCT00968812|26868351|P1|Overall Study|Protocol Violation|7
7726332|NCT00968812|26868349|P3|Overall Study|Physician Decision|9
7726333|NCT00968812|26868350|P2|Overall Study|Physician Decision|5
7726334|NCT00968812|26868351|P1|Overall Study|Physician Decision|8
7726335|NCT00968812|26868349|P3|Overall Study|Lost to Follow-up|11
7726336|NCT00968812|26868350|P2|Overall Study|Lost to Follow-up|12
7726337|NCT00968812|26868351|P1|Overall Study|Lost to Follow-up|17
7726338|NCT00968812|26868349|P3|Overall Study|Lack of Efficacy|16
7726339|NCT00968812|26868350|P2|Overall Study|Lack of Efficacy|7
7726340|NCT00968812|26868351|P1|Overall Study|Lack of Efficacy|9
7726341|NCT00968812|26868349|P3|Overall Study|Death|1
7726342|NCT00968812|26868350|P2|Overall Study|Death|2
7726343|NCT00968812|26868351|P1|Overall Study|Death|2
7726344|NCT00968812|26868349|P3|Overall Study|Adverse Event|33
7726345|NCT00968812|26868350|P2|Overall Study|Adverse Event|46
7726346|NCT00968812|26868351|P1|Overall Study|Adverse Event|30
7726347|NCT00968799|26868371|P1|Overall Study|Advanced disease, HIPEC not applicable|2
7726348|NCT00968708|26868381|P2|Overall Study|Other|34
7726349|NCT00968708|26868382|P1|Overall Study|Other|26
7726350|NCT00968708|26868381|P2|Overall Study|Investigator Discretion|1
7726351|NCT00968708|26868382|P1|Overall Study|Investigator Discretion|0
7726352|NCT00968708|26868381|P2|Overall Study|Voluntary Withdrawal|101
7726353|NCT00968708|26868382|P1|Overall Study|Voluntary Withdrawal|104
7726354|NCT00968708|26868381|P2|Overall Study|Lost to Follow-up|11
7726355|NCT00968708|26868382|P1|Overall Study|Lost to Follow-up|19
7726356|NCT00968708|26868381|P2|Overall Study|Major Protocol Deviation|1
7726357|NCT00968708|26868382|P1|Overall Study|Major Protocol Deviation|0
7726358|NCT00968708|26868381|P2|Overall Study|Adverse Event|150
7726359|NCT00968708|26868382|P1|Overall Study|Adverse Event|169
7726360|NCT00968669|26868394|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
7726361|NCT00968669|26868395|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7726362|NCT00968669|26868396|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7726363|NCT00968669|26868397|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7726364|NCT00968669|26868394|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7726365|NCT00968669|26868395|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7726366|NCT00968669|26868396|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
7726367|NCT00968669|26868397|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7726368|NCT00968669|26868394|P4|Overall Study|SUBJECT INCARCERATED|0
7726369|NCT00968669|26868395|P3|Overall Study|SUBJECT INCARCERATED|0
7726370|NCT00968669|26868396|P2|Overall Study|SUBJECT INCARCERATED|1
7726371|NCT00968669|26868397|P1|Overall Study|SUBJECT INCARCERATED|0
7726372|NCT00968669|26868394|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7726373|NCT00968669|26868395|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7726374|NCT00968669|26868396|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
7726375|NCT00968669|26868397|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7726376|NCT00968669|26868394|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7726377|NCT00968669|26868395|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
7726378|NCT00968669|26868396|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7726379|NCT00968669|26868397|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7726380|NCT00968669|26868394|P4|Overall Study|SPONSOR DECISION|0
7726381|NCT00968669|26868395|P3|Overall Study|SPONSOR DECISION|0
7726382|NCT00968669|26868396|P2|Overall Study|SPONSOR DECISION|1
7726383|NCT00968669|26868397|P1|Overall Study|SPONSOR DECISION|0
7726384|NCT00968669|26868394|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7726385|NCT00968669|26868395|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7726386|NCT00968669|26868396|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
7726387|NCT00968669|26868397|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7726388|NCT00968669|26868394|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7726389|NCT00968669|26868395|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7726390|NCT00968669|26868396|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
7726391|NCT00968669|26868397|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7726392|NCT00968669|26868394|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7726393|NCT00968669|26868395|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7726394|NCT00968669|26868396|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
7726395|NCT00968669|26868397|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7726396|NCT00968669|26868394|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7726397|NCT00968669|26868395|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7726398|NCT00968669|26868396|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
7726399|NCT00968669|26868397|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7726400|NCT00968669|26868394|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7726401|NCT00968669|26868395|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7726402|NCT00968669|26868396|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7726403|NCT00968669|26868397|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
7726404|NCT00968669|26868394|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
7726405|NCT00968669|26868395|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
7726406|NCT00968669|26868396|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
7726407|NCT00968669|26868397|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
7726408|NCT00968669|26868394|P4|Overall Study|EARLY WITHDRAWAL|0
7726409|NCT00968669|26868395|P3|Overall Study|EARLY WITHDRAWAL|0
7726410|NCT00968669|26868396|P2|Overall Study|EARLY WITHDRAWAL|1
7726411|NCT00968669|26868397|P1|Overall Study|EARLY WITHDRAWAL|0
7726412|NCT00968669|26868394|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7726413|NCT00968669|26868395|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
7726414|NCT00968669|26868396|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7726415|NCT00968669|26868397|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7726416|NCT00968669|26868394|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7726417|NCT00968669|26868395|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7726418|NCT00968669|26868396|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7726419|NCT00968669|26868397|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
7726420|NCT00968669|26868394|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7726421|NCT00968669|26868395|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7726422|NCT00968669|26868396|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7726423|NCT00968669|26868397|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
7726424|NCT00968669|26868394|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
7726425|NCT00968669|26868395|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7726426|NCT00968669|26868396|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7726427|NCT00968669|26868397|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7726428|NCT00968669|26868394|P4|Overall Study|AE|0
7726429|NCT00968669|26868395|P3|Overall Study|AE|0
7726430|NCT00968669|26868396|P2|Overall Study|AE|0
7726431|NCT00968669|26868397|P1|Overall Study|AE|1
7726432|NCT00968669|26868394|P4|Overall Study|Pregnancy|0
7726433|NCT00968669|26868395|P3|Overall Study|Pregnancy|2
7726434|NCT00968669|26868396|P2|Overall Study|Pregnancy|0
7726435|NCT00968669|26868397|P1|Overall Study|Pregnancy|0
7726436|NCT00968669|26868394|P4|Overall Study|Withdrawal by Subject|3
7726437|NCT00968669|26868395|P3|Overall Study|Withdrawal by Subject|5
7726438|NCT00968669|26868396|P2|Overall Study|Withdrawal by Subject|7
7726439|NCT00968669|26868397|P1|Overall Study|Withdrawal by Subject|9
7726440|NCT00968669|26868394|P4|Overall Study|Lost to Follow-up|4
7726441|NCT00968669|26868395|P3|Overall Study|Lost to Follow-up|1
7726442|NCT00968669|26868396|P2|Overall Study|Lost to Follow-up|2
7726443|NCT00968669|26868397|P1|Overall Study|Lost to Follow-up|5
7726444|NCT00968617|26868487|P1|Overall Study|Study terminated by sponsor|6
7726445|NCT00968539|26868501|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
7726446|NCT00968539|26868502|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
7726447|NCT00968526|26868562|P2|Overall Study|Migrated/moved from study area|0
7726448|NCT00968526|26868563|P1|Overall Study|Migrated/moved from study area|1
7726449|NCT00968526|26868562|P2|Overall Study|Adverse Event|0
7726450|NCT00968526|26868563|P1|Overall Study|Adverse Event|2
7726451|NCT00968253|26868665|P3|Overall Study|Adverse Event|1
7726452|NCT00968253|26868666|P2|Overall Study|Adverse Event|0
7726453|NCT00968253|26868667|P1|Overall Study|Adverse Event|0
7726454|NCT00968253|26868665|P3|Overall Study|Disease Progression|3
7726455|NCT00968253|26868666|P2|Overall Study|Disease Progression|3
7726456|NCT00968253|26868667|P1|Overall Study|Disease Progression|0
7726457|NCT00968253|26868665|P3|Overall Study|Withdrawal by Subject|1
7726458|NCT00968253|26868666|P2|Overall Study|Withdrawal by Subject|0
7726459|NCT00968253|26868667|P1|Overall Study|Withdrawal by Subject|0
7726460|NCT00968253|26868665|P3|Overall Study|Death|2
7726461|NCT00968253|26868666|P2|Overall Study|Death|0
7726462|NCT00968253|26868667|P1|Overall Study|Death|0
7726463|NCT00968201|26868688|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
7726464|NCT00968201|26868689|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
7726465|NCT00968201|26868690|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
7726466|NCT00968201|26868688|P3|Extension Study - (Period III)|Other|2
7726467|NCT00968201|26868689|P2|Extension Study - (Period III)|Other|0
7726468|NCT00968201|26868690|P1|Extension Study - (Period III)|Other|0
7726469|NCT00968201|26868688|P3|Extension Study - (Period III)|Noncompliance|3
7726470|NCT00968201|26868689|P2|Extension Study - (Period III)|Noncompliance|0
7726471|NCT00968201|26868690|P1|Extension Study - (Period III)|Noncompliance|0
7726472|NCT00968201|26868688|P3|Extension Study - (Period III)|Patient Relocated|1
7726473|NCT00968201|26868689|P2|Extension Study - (Period III)|Patient Relocated|1
7726474|NCT00968201|26868690|P1|Extension Study - (Period III)|Patient Relocated|0
7726475|NCT00968201|26868688|P3|Extension Study - (Period III)|Withdrawal by Subject|40
7726476|NCT00968201|26868689|P2|Extension Study - (Period III)|Withdrawal by Subject|20
7726477|NCT00968201|26868690|P1|Extension Study - (Period III)|Withdrawal by Subject|0
7726478|NCT00968201|26868688|P3|Extension Study - (Period III)|Protocol Violation|14
7726479|NCT00968201|26868689|P2|Extension Study - (Period III)|Protocol Violation|17
7726480|NCT00968201|26868690|P1|Extension Study - (Period III)|Protocol Violation|0
7726481|NCT00968201|26868688|P3|Extension Study - (Period III)|Lost to Follow-up|13
7726482|NCT00968201|26868689|P2|Extension Study - (Period III)|Lost to Follow-up|7
7726483|NCT00968201|26868690|P1|Extension Study - (Period III)|Lost to Follow-up|0
7726484|NCT00968201|26868688|P3|Extension Study - (Period III)|Adverse Event|22
7726485|NCT00968201|26868689|P2|Extension Study - (Period III)|Adverse Event|5
7726486|NCT00968201|26868690|P1|Extension Study - (Period III)|Adverse Event|0
7726487|NCT00968201|26868688|P3|Base Study - (Period II)|Site Error|1
7726488|NCT00968201|26868689|P2|Base Study - (Period II)|Site Error|0
7726489|NCT00968201|26868690|P1|Base Study - (Period II)|Site Error|0
7726490|NCT00968201|26868688|P3|Base Study - (Period II)|Withdrawal by Subject|8
7726491|NCT00968201|26868689|P2|Base Study - (Period II)|Withdrawal by Subject|0
7726492|NCT00968201|26868690|P1|Base Study - (Period II)|Withdrawal by Subject|4
7726493|NCT00968201|26868688|P3|Base Study - (Period II)|Protocol Violation|12
7726494|NCT00968201|26868689|P2|Base Study - (Period II)|Protocol Violation|0
7726495|NCT00968201|26868690|P1|Base Study - (Period II)|Protocol Violation|12
7726496|NCT00968201|26868688|P3|Base Study - (Period II)|Lost to Follow-up|7
7726497|NCT00968201|26868689|P2|Base Study - (Period II)|Lost to Follow-up|0
7726498|NCT00968201|26868690|P1|Base Study - (Period II)|Lost to Follow-up|2
7726499|NCT00968201|26868688|P3|Base Study - (Period II)|Lack of Efficacy|1
7726500|NCT00968201|26868689|P2|Base Study - (Period II)|Lack of Efficacy|0
7726501|NCT00968201|26868690|P1|Base Study - (Period II)|Lack of Efficacy|0
7726502|NCT00968201|26868688|P3|Base Study - (Period II)|Adverse Event|16
7726503|NCT00968201|26868689|P2|Base Study - (Period II)|Adverse Event|0
7726504|NCT00968201|26868690|P1|Base Study - (Period II)|Adverse Event|8
7726505|NCT00968149|26868751|P2|Overall Study|Withdrawal by Subject|0
7726506|NCT00968149|26868752|P1|Overall Study|Withdrawal by Subject|2
7726507|NCT00968149|26868751|P2|Overall Study|Protocol Violation|0
7726508|NCT00968149|26868752|P1|Overall Study|Protocol Violation|4
7726509|NCT00968149|26868751|P2|Overall Study|Lost to Follow-up|1
7726510|NCT00968149|26868752|P1|Overall Study|Lost to Follow-up|0
7726511|NCT00968149|26868751|P2|Overall Study|Lack of Efficacy|4
7726512|NCT00968149|26868752|P1|Overall Study|Lack of Efficacy|0
7726513|NCT00968149|26868751|P2|Overall Study|Adverse Event|1
7726514|NCT00968149|26868752|P1|Overall Study|Adverse Event|5
7726515|NCT00967798|26868820|P2|Overall Study|Lost to Follow-up|1
7726516|NCT00967798|26868821|P1|Overall Study|Lost to Follow-up|4
7726517|NCT00967798|26868820|P2|Overall Study|Withdrawal by Subject|2
7726518|NCT00967798|26868821|P1|Overall Study|Withdrawal by Subject|5
7726519|NCT00967694|26868835|P1|Overall Study|Withdrawal by Subject|6
7726520|NCT00967668|26868842|P3|Overall Study|Pregnancy|0
7726521|NCT00967668|26868843|P2|Overall Study|Pregnancy|0
7726522|NCT00967668|26868844|P1|Overall Study|Pregnancy|1
7726523|NCT00967668|26868842|P3|Overall Study|Refused 12-mo assessment|9
7726524|NCT00967668|26868843|P2|Overall Study|Refused 12-mo assessment|1
7726525|NCT00967668|26868844|P1|Overall Study|Refused 12-mo assessment|3
7726526|NCT00967668|26868842|P3|Overall Study|Lost to Follow-up|16
7726527|NCT00967668|26868843|P2|Overall Study|Lost to Follow-up|9
7726528|NCT00967668|26868844|P1|Overall Study|Lost to Follow-up|15
7726529|NCT00967668|26868842|P3|Overall Study|Lost to follow-up at 12-mo|26
7726530|NCT00967668|26868843|P2|Overall Study|Lost to follow-up at 12-mo|29
7726531|NCT00967668|26868844|P1|Overall Study|Lost to follow-up at 12-mo|27
7726532|NCT00967668|26868842|P3|Overall Study|Refused Year 2|4
7726533|NCT00967668|26868843|P2|Overall Study|Refused Year 2|6
7726534|NCT00967668|26868844|P1|Overall Study|Refused Year 2|11
7726535|NCT00967668|26868842|P3|Overall Study|Removed due to behavior|2
7726536|NCT00967668|26868843|P2|Overall Study|Removed due to behavior|1
7726537|NCT00967668|26868844|P1|Overall Study|Removed due to behavior|1
7726538|NCT00967668|26868842|P3|Overall Study|Death|4
7726539|NCT00967668|26868843|P2|Overall Study|Death|2
7726540|NCT00967668|26868844|P1|Overall Study|Death|0
7726541|NCT00967668|26868842|P3|Overall Study|Withdrawal by Subject|8
7726542|NCT00967668|26868843|P2|Overall Study|Withdrawal by Subject|8
7726543|NCT00967668|26868844|P1|Overall Study|Withdrawal by Subject|13
7726544|NCT00967616|26868857|P2|Overall Study|Protocol Violation|0
7726545|NCT00967616|26868858|P1|Overall Study|Protocol Violation|1
7726546|NCT00967616|26868857|P2|Overall Study|Other|8
7726547|NCT00967616|26868858|P1|Overall Study|Other|8
7726548|NCT00967616|26868857|P2|Overall Study|Progressive Disease|18
7726549|NCT00967616|26868858|P1|Overall Study|Progressive Disease|31
7726550|NCT00967616|26868857|P2|Overall Study|Withdrawal by Subject|4
7726551|NCT00967616|26868858|P1|Overall Study|Withdrawal by Subject|8
7726552|NCT00967616|26868857|P2|Overall Study|Death|3
7726553|NCT00967616|26868858|P1|Overall Study|Death|0
7726554|NCT00967616|26868857|P2|Overall Study|Adverse Event or Serious Adverse Event|17
7726555|NCT00967616|26868858|P1|Overall Study|Adverse Event or Serious Adverse Event|2
7726556|NCT00967499|26868885|P2|Overall Study|Randomized but not treated|59
7726557|NCT00967499|26868886|P1|Overall Study|Randomized but not treated|63
7726558|NCT00967499|26868885|P2|Overall Study|Sponsor Decision|0
7726559|NCT00967499|26868886|P1|Overall Study|Sponsor Decision|1
7726560|NCT00967499|26868885|P2|Overall Study|Protocol Violation|0
7726561|NCT00967499|26868886|P1|Overall Study|Protocol Violation|1
7726562|NCT00967499|26868885|P2|Overall Study|Adverse Event|1
7726563|NCT00967499|26868886|P1|Overall Study|Adverse Event|0
7726564|NCT00967343|26868943|P1|Overall Study|Lost to Follow-up|1
7726565|NCT00967343|26868943|P1|Overall Study|Relapse|1
7726566|NCT00967343|26868943|P1|Overall Study|Death|24
7726567|NCT00967343|26868943|P1|Overall Study|Study termination by sponsor|12
7726568|NCT00967330|26868955|P2|Overall Study|Severe protocol deviation|1
7726569|NCT00967330|26868956|P1|Overall Study|Severe protocol deviation|0
7726570|NCT00967330|26868955|P2|Overall Study|Death|51
7726571|NCT00967330|26868956|P1|Overall Study|Death|102
7726572|NCT00967330|26868955|P2|Overall Study|Lost to Follow-up|1
7726573|NCT00967330|26868956|P1|Overall Study|Lost to Follow-up|1
7726574|NCT00967330|26868955|P2|Overall Study|Withdrawal by Subject|0
7726575|NCT00967330|26868956|P1|Overall Study|Withdrawal by Subject|6
7726576|NCT00967330|26868955|P2|Overall Study|Regular|3
7726577|NCT00967330|26868956|P1|Overall Study|Regular|10
7726578|NCT00967330|26868955|P2|Overall Study|Protocol Violation|4
7726579|NCT00967330|26868956|P1|Overall Study|Protocol Violation|3
7726580|NCT00967226|26868986|P2|Overall Study|Physician Decision|1
7726581|NCT00967226|26868987|P1|Overall Study|Physician Decision|0
7726582|NCT00967226|26868986|P2|Overall Study|Protocol Violation|0
7726583|NCT00967226|26868987|P1|Overall Study|Protocol Violation|2
7726584|NCT00967226|26868986|P2|Overall Study|Adverse Event|5
7726585|NCT00967226|26868987|P1|Overall Study|Adverse Event|0
7726586|NCT00967018|26869021|P1|Overall Study|Miscellaneous Reasons|9
7726587|NCT00967018|26869021|P1|Overall Study|Withdrawal by Subject|1
7726588|NCT00967018|26869021|P1|Overall Study|Lost to Follow-up|2
7726589|NCT00967018|26869021|P1|Overall Study|Physician Decision|7
7726590|NCT00967018|26869021|P1|Overall Study|Adverse Event|2
7726591|NCT00967005|26869030|P2|Overall Study|Lost to Follow-up|10
7726592|NCT00967005|26869031|P1|Overall Study|Lost to Follow-up|7
7726593|NCT00966940|26869117|P2|Period 1, First 6 Weeks|Protocol Violation|0
7726594|NCT00966940|26869118|P1|Period 1, First 6 Weeks|Protocol Violation|1
7726595|NCT00966940|26869117|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
7726596|NCT00966940|26869118|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
7726597|NCT00966875|26869145|P9|Part B|Entry Criteria|1
7726598|NCT00966875|26869146|P8|Part B|Entry Criteria|0
7726599|NCT00966875|26869147|P7|Part B|Entry Criteria|1
7726600|NCT00966875|26869148|P6|Part B|Entry Criteria|0
7726601|NCT00966875|26869149|P5|Part B|Entry Criteria|0
7726602|NCT00966875|26869150|P4|Part B|Entry Criteria|0
7726603|NCT00966875|26869151|P3|Part B|Entry Criteria|0
7726604|NCT00966875|26869152|P2|Part B|Entry Criteria|0
7726605|NCT00966875|26869153|P1|Part B|Entry Criteria|0
7726606|NCT00966875|26869145|P9|Part B|Withdrawal by Subject|5
7726607|NCT00966875|26869146|P8|Part B|Withdrawal by Subject|5
7726608|NCT00966875|26869147|P7|Part B|Withdrawal by Subject|4
7726609|NCT00966875|26869148|P6|Part B|Withdrawal by Subject|1
7726610|NCT00966875|26869149|P5|Part B|Withdrawal by Subject|2
7726611|NCT00966875|26869150|P4|Part B|Withdrawal by Subject|1
7726612|NCT00966875|26869151|P3|Part B|Withdrawal by Subject|2
7726613|NCT00966875|26869152|P2|Part B|Withdrawal by Subject|1
7726614|NCT00966875|26869153|P1|Part B|Withdrawal by Subject|2
7726615|NCT00966875|26869145|P9|Part B|Sponsor Decision|1
7726616|NCT00966875|26869146|P8|Part B|Sponsor Decision|2
7726617|NCT00966875|26869147|P7|Part B|Sponsor Decision|0
7726618|NCT00966875|26869148|P6|Part B|Sponsor Decision|1
7726619|NCT00966875|26869149|P5|Part B|Sponsor Decision|0
7726620|NCT00966875|26869150|P4|Part B|Sponsor Decision|0
7726621|NCT00966875|26869151|P3|Part B|Sponsor Decision|0
7726622|NCT00966875|26869152|P2|Part B|Sponsor Decision|0
7726623|NCT00966875|26869153|P1|Part B|Sponsor Decision|1
7726624|NCT00966875|26869145|P9|Part B|Physician Decision|2
7726625|NCT00966875|26869146|P8|Part B|Physician Decision|0
7726626|NCT00966875|26869147|P7|Part B|Physician Decision|0
7726627|NCT00966875|26869148|P6|Part B|Physician Decision|1
7726628|NCT00966875|26869149|P5|Part B|Physician Decision|2
7726629|NCT00966875|26869150|P4|Part B|Physician Decision|0
7726630|NCT00966875|26869151|P3|Part B|Physician Decision|1
7726631|NCT00966875|26869152|P2|Part B|Physician Decision|0
7726632|NCT00966875|26869153|P1|Part B|Physician Decision|0
7726633|NCT00966875|26869145|P9|Part B|Lost to Follow-up|1
7726634|NCT00966875|26869146|P8|Part B|Lost to Follow-up|0
7726635|NCT00966875|26869147|P7|Part B|Lost to Follow-up|0
7726636|NCT00966875|26869148|P6|Part B|Lost to Follow-up|0
7726637|NCT00966875|26869149|P5|Part B|Lost to Follow-up|0
7726638|NCT00966875|26869150|P4|Part B|Lost to Follow-up|1
7726639|NCT00966875|26869151|P3|Part B|Lost to Follow-up|0
7726640|NCT00966875|26869152|P2|Part B|Lost to Follow-up|0
7726641|NCT00966875|26869153|P1|Part B|Lost to Follow-up|0
7726642|NCT00966875|26869145|P9|Part B|Lack of Efficacy|6
7726643|NCT00966875|26869146|P8|Part B|Lack of Efficacy|9
7726644|NCT00966875|26869147|P7|Part B|Lack of Efficacy|12
7726645|NCT00966875|26869148|P6|Part B|Lack of Efficacy|3
7726646|NCT00966875|26869149|P5|Part B|Lack of Efficacy|2
7726647|NCT00966875|26869150|P4|Part B|Lack of Efficacy|1
7726648|NCT00966875|26869151|P3|Part B|Lack of Efficacy|1
7726649|NCT00966875|26869152|P2|Part B|Lack of Efficacy|1
7726650|NCT00966875|26869153|P1|Part B|Lack of Efficacy|2
7726651|NCT00966875|26869145|P9|Part B|Death|0
7726652|NCT00966875|26869146|P8|Part B|Death|1
7726653|NCT00966875|26869147|P7|Part B|Death|0
7726654|NCT00966875|26869148|P6|Part B|Death|0
7726655|NCT00966875|26869149|P5|Part B|Death|0
7726656|NCT00966875|26869150|P4|Part B|Death|0
7726657|NCT00966875|26869151|P3|Part B|Death|1
7726658|NCT00966875|26869152|P2|Part B|Death|0
7726659|NCT00966875|26869153|P1|Part B|Death|0
7726660|NCT00966875|26869145|P9|Part B|Adverse Event|2
7726661|NCT00966875|26869146|P8|Part B|Adverse Event|2
7726662|NCT00966875|26869147|P7|Part B|Adverse Event|5
7726663|NCT00966875|26869148|P6|Part B|Adverse Event|0
7726664|NCT00966875|26869149|P5|Part B|Adverse Event|1
7726665|NCT00966875|26869150|P4|Part B|Adverse Event|0
7726666|NCT00966875|26869151|P3|Part B|Adverse Event|1
7726667|NCT00966875|26869152|P2|Part B|Adverse Event|1
7726668|NCT00966875|26869153|P1|Part B|Adverse Event|0
7726669|NCT00966875|26869145|P9|Part A|Protocol Violation|1
7726670|NCT00966875|26869146|P8|Part A|Protocol Violation|1
7726671|NCT00966875|26869147|P7|Part A|Protocol Violation|2
7726672|NCT00966875|26869148|P6|Part A|Protocol Violation|0
7726673|NCT00966875|26869149|P5|Part A|Protocol Violation|0
7726674|NCT00966875|26869150|P4|Part A|Protocol Violation|0
7726675|NCT00966875|26869151|P3|Part A|Protocol Violation|0
7726676|NCT00966875|26869152|P2|Part A|Protocol Violation|0
7726677|NCT00966875|26869153|P1|Part A|Protocol Violation|0
7726678|NCT00966875|26869145|P9|Part A|Withdrawal by Subject|1
7726679|NCT00966875|26869146|P8|Part A|Withdrawal by Subject|1
7726680|NCT00966875|26869147|P7|Part A|Withdrawal by Subject|5
7726681|NCT00966875|26869148|P6|Part A|Withdrawal by Subject|0
7726682|NCT00966875|26869149|P5|Part A|Withdrawal by Subject|3
7726683|NCT00966875|26869150|P4|Part A|Withdrawal by Subject|1
7726684|NCT00966875|26869151|P3|Part A|Withdrawal by Subject|1
7726685|NCT00966875|26869152|P2|Part A|Withdrawal by Subject|2
7726686|NCT00966875|26869153|P1|Part A|Withdrawal by Subject|2
7726687|NCT00966875|26869145|P9|Part A|Sponsor Decision|1
7726688|NCT00966875|26869146|P8|Part A|Sponsor Decision|2
7726689|NCT00966875|26869147|P7|Part A|Sponsor Decision|0
7726690|NCT00966875|26869148|P6|Part A|Sponsor Decision|0
7726691|NCT00966875|26869149|P5|Part A|Sponsor Decision|1
7726692|NCT00966875|26869150|P4|Part A|Sponsor Decision|0
7726693|NCT00966875|26869151|P3|Part A|Sponsor Decision|1
7726694|NCT00966875|26869152|P2|Part A|Sponsor Decision|0
7726695|NCT00966875|26869153|P1|Part A|Sponsor Decision|0
7726696|NCT00966875|26869145|P9|Part A|Physician Decision|2
7726697|NCT00966875|26869146|P8|Part A|Physician Decision|0
7726698|NCT00966875|26869147|P7|Part A|Physician Decision|1
7726699|NCT00966875|26869148|P6|Part A|Physician Decision|0
7726700|NCT00966875|26869149|P5|Part A|Physician Decision|1
7726701|NCT00966875|26869150|P4|Part A|Physician Decision|0
7726702|NCT00966875|26869151|P3|Part A|Physician Decision|0
7726703|NCT00966875|26869152|P2|Part A|Physician Decision|0
7726704|NCT00966875|26869153|P1|Part A|Physician Decision|0
7726705|NCT00966875|26869145|P9|Part A|Parent/Caregiver Decision|0
7726706|NCT00966875|26869146|P8|Part A|Parent/Caregiver Decision|0
7726707|NCT00966875|26869147|P7|Part A|Parent/Caregiver Decision|0
7726708|NCT00966875|26869148|P6|Part A|Parent/Caregiver Decision|0
7726709|NCT00966875|26869149|P5|Part A|Parent/Caregiver Decision|0
7726710|NCT00966875|26869150|P4|Part A|Parent/Caregiver Decision|1
7726711|NCT00966875|26869151|P3|Part A|Parent/Caregiver Decision|0
7726712|NCT00966875|26869152|P2|Part A|Parent/Caregiver Decision|0
7726713|NCT00966875|26869153|P1|Part A|Parent/Caregiver Decision|0
7726714|NCT00966875|26869145|P9|Part A|Lost to Follow-up|0
7726715|NCT00966875|26869146|P8|Part A|Lost to Follow-up|0
7726716|NCT00966875|26869147|P7|Part A|Lost to Follow-up|0
7726717|NCT00966875|26869148|P6|Part A|Lost to Follow-up|1
7726718|NCT00966875|26869149|P5|Part A|Lost to Follow-up|0
7726719|NCT00966875|26869150|P4|Part A|Lost to Follow-up|0
7726720|NCT00966875|26869151|P3|Part A|Lost to Follow-up|0
7726721|NCT00966875|26869152|P2|Part A|Lost to Follow-up|0
7726722|NCT00966875|26869153|P1|Part A|Lost to Follow-up|2
7726723|NCT00966875|26869145|P9|Part A|Lack of Efficacy|0
7726724|NCT00966875|26869146|P8|Part A|Lack of Efficacy|0
7726725|NCT00966875|26869147|P7|Part A|Lack of Efficacy|4
7726726|NCT00966875|26869148|P6|Part A|Lack of Efficacy|0
7726727|NCT00966875|26869149|P5|Part A|Lack of Efficacy|0
7726728|NCT00966875|26869150|P4|Part A|Lack of Efficacy|0
7726729|NCT00966875|26869151|P3|Part A|Lack of Efficacy|0
7726730|NCT00966875|26869152|P2|Part A|Lack of Efficacy|1
7726731|NCT00966875|26869153|P1|Part A|Lack of Efficacy|0
7726732|NCT00966875|26869145|P9|Part A|Entry Criteria|0
7726733|NCT00966875|26869146|P8|Part A|Entry Criteria|0
7726734|NCT00966875|26869147|P7|Part A|Entry Criteria|0
7726735|NCT00966875|26869148|P6|Part A|Entry Criteria|2
7726736|NCT00966875|26869149|P5|Part A|Entry Criteria|0
7726737|NCT00966875|26869150|P4|Part A|Entry Criteria|0
7726738|NCT00966875|26869151|P3|Part A|Entry Criteria|0
7726739|NCT00966875|26869152|P2|Part A|Entry Criteria|0
7726740|NCT00966875|26869153|P1|Part A|Entry Criteria|0
7726741|NCT00966875|26869145|P9|Part A|Adverse Event|3
7726742|NCT00966875|26869146|P8|Part A|Adverse Event|3
7726743|NCT00966875|26869147|P7|Part A|Adverse Event|0
7726744|NCT00966875|26869148|P6|Part A|Adverse Event|1
7726745|NCT00966875|26869149|P5|Part A|Adverse Event|0
7726746|NCT00966875|26869150|P4|Part A|Adverse Event|1
7726747|NCT00966875|26869151|P3|Part A|Adverse Event|0
7726748|NCT00966875|26869152|P2|Part A|Adverse Event|1
7726749|NCT00966875|26869153|P1|Part A|Adverse Event|2
7726750|NCT00966719|26869504|P2|Overall Study|Lost to Follow-up|11
7726751|NCT00966719|26869505|P1|Overall Study|Lost to Follow-up|6
7726752|NCT00966693|26869529|P4|Overall Study|Disease Progression|16
7726753|NCT00966693|26869530|P3|Overall Study|Disease Progression|1
7726754|NCT00966693|26869531|P2|Overall Study|Disease Progression|0
7726755|NCT00966693|26869532|P1|Overall Study|Disease Progression|0
7726756|NCT00966693|26869529|P4|Overall Study|Withdrawal by Subject|5
7726757|NCT00966693|26869530|P3|Overall Study|Withdrawal by Subject|0
7726758|NCT00966693|26869531|P2|Overall Study|Withdrawal by Subject|0
7726759|NCT00966693|26869532|P1|Overall Study|Withdrawal by Subject|1
7726760|NCT00966693|26869529|P4|Overall Study|Death|0
7726761|NCT00966693|26869530|P3|Overall Study|Death|1
7726762|NCT00966693|26869531|P2|Overall Study|Death|0
7726763|NCT00966693|26869532|P1|Overall Study|Death|0
7726764|NCT00966693|26869529|P4|Overall Study|Adverse Event|2
7726765|NCT00966693|26869530|P3|Overall Study|Adverse Event|1
7726766|NCT00966693|26869531|P2|Overall Study|Adverse Event|0
7726767|NCT00966693|26869532|P1|Overall Study|Adverse Event|0
7726768|NCT00966654|26869566|P1|Overall Study|Study was terminated,PI left institution|12
7726769|NCT00966355|26869640|P3|Overall Study|Lost to Follow-up|3
7726770|NCT00966355|26869641|P2|Overall Study|Lost to Follow-up|4
7726771|NCT00966355|26869642|P1|Overall Study|Lost to Follow-up|5
7726772|NCT00966355|26869640|P3|Overall Study|newly diagnosed advanced HCC|10
7726773|NCT00966355|26869641|P2|Overall Study|newly diagnosed advanced HCC|12
7726774|NCT00966355|26869642|P1|Overall Study|newly diagnosed advanced HCC|11
7726775|NCT00966355|26869640|P3|Overall Study|non-variceal bleeding on endoscopy|71
7726776|NCT00966355|26869641|P2|Overall Study|non-variceal bleeding on endoscopy|70
7726777|NCT00966355|26869642|P1|Overall Study|non-variceal bleeding on endoscopy|68
7726778|NCT00966277|26869655|P2|Overall Study|Treatment Plan Changed|1
7726779|NCT00966277|26869656|P1|Overall Study|Treatment Plan Changed|0
7726780|NCT00966277|26869655|P2|Overall Study|Ineligible|3
7726781|NCT00966277|26869656|P1|Overall Study|Ineligible|1
7726782|NCT00966277|26869655|P2|Overall Study|Withdrawal by Subject|0
7726783|NCT00966277|26869656|P1|Overall Study|Withdrawal by Subject|3
7726784|NCT00966264|26869664|P2|Overall Study|Lost to Follow-up|3
7726785|NCT00966264|26869665|P1|Overall Study|Lost to Follow-up|4
7726786|NCT00965848|26869711|P3|Overall Study|Other|1
7726787|NCT00965848|26869712|P2|Overall Study|Other|0
7726788|NCT00965848|26869713|P1|Overall Study|Other|5
7726789|NCT00965848|26869711|P3|Overall Study|Not Clinically Evaluable|1
7726790|NCT00965848|26869712|P2|Overall Study|Not Clinically Evaluable|1
7726791|NCT00965848|26869713|P1|Overall Study|Not Clinically Evaluable|7
7726792|NCT00965848|26869711|P3|Overall Study|Indeterminate Clinical Outcome|1
7726793|NCT00965848|26869712|P2|Overall Study|Indeterminate Clinical Outcome|0
7726794|NCT00965848|26869713|P1|Overall Study|Indeterminate Clinical Outcome|2
7726795|NCT00965848|26869711|P3|Overall Study|Withdrawal by Subject|0
7726796|NCT00965848|26869712|P2|Overall Study|Withdrawal by Subject|0
7726797|NCT00965848|26869713|P1|Overall Study|Withdrawal by Subject|1
7726798|NCT00965848|26869711|P3|Overall Study|Lost to Follow-up|1
7726799|NCT00965848|26869712|P2|Overall Study|Lost to Follow-up|0
7726800|NCT00965848|26869713|P1|Overall Study|Lost to Follow-up|0
7726801|NCT00965848|26869711|P3|Overall Study|Death|5
7726802|NCT00965848|26869712|P2|Overall Study|Death|1
7726803|NCT00965848|26869713|P1|Overall Study|Death|11
7726804|NCT00965848|26869711|P3|Overall Study|Protocol Violation|1
7726805|NCT00965848|26869712|P2|Overall Study|Protocol Violation|0
7726806|NCT00965848|26869713|P1|Overall Study|Protocol Violation|3
7726807|NCT00965757|26869732|P4|Extension Phase|Other|1
7726808|NCT00965757|26869733|P3|Extension Phase|Other|2
7726809|NCT00965757|26869734|P2|Extension Phase|Other|0
7726810|NCT00965757|26869735|P1|Extension Phase|Other|0
7726811|NCT00965757|26869732|P4|Extension Phase|Protocol Violation|1
7726812|NCT00965757|26869733|P3|Extension Phase|Protocol Violation|0
7726813|NCT00965757|26869734|P2|Extension Phase|Protocol Violation|0
7726814|NCT00965757|26869735|P1|Extension Phase|Protocol Violation|0
7726815|NCT00965757|26869732|P4|Extension Phase|Ineligible after Taking Study Drug|3
7726816|NCT00965757|26869733|P3|Extension Phase|Ineligible after Taking Study Drug|3
7726817|NCT00965757|26869734|P2|Extension Phase|Ineligible after Taking Study Drug|0
7726818|NCT00965757|26869735|P1|Extension Phase|Ineligible after Taking Study Drug|0
7726819|NCT00965757|26869732|P4|Extension Phase|Lost to Follow-up|1
7726820|NCT00965757|26869733|P3|Extension Phase|Lost to Follow-up|0
7726821|NCT00965757|26869734|P2|Extension Phase|Lost to Follow-up|0
7726822|NCT00965757|26869735|P1|Extension Phase|Lost to Follow-up|0
7726823|NCT00965757|26869732|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
7726824|NCT00965757|26869733|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
7726825|NCT00965757|26869734|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
7726826|NCT00965757|26869735|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
7726827|NCT00965757|26869732|P4|Extension Phase|Lack of Efficacy|12
7726828|NCT00965757|26869733|P3|Extension Phase|Lack of Efficacy|8
7726829|NCT00965757|26869734|P2|Extension Phase|Lack of Efficacy|0
7726830|NCT00965757|26869735|P1|Extension Phase|Lack of Efficacy|0
7726831|NCT00965757|26869732|P4|Extension Phase|Abnormal Laboratory Value|1
7726832|NCT00965757|26869733|P3|Extension Phase|Abnormal Laboratory Value|6
7726833|NCT00965757|26869734|P2|Extension Phase|Abnormal Laboratory Value|0
7726834|NCT00965757|26869735|P1|Extension Phase|Abnormal Laboratory Value|0
7726835|NCT00965757|26869732|P4|Extension Phase|Adverse drug reaction|3
7726836|NCT00965757|26869733|P3|Extension Phase|Adverse drug reaction|6
7726837|NCT00965757|26869734|P2|Extension Phase|Adverse drug reaction|0
7726838|NCT00965757|26869735|P1|Extension Phase|Adverse drug reaction|0
7726839|NCT00965757|26869732|P4|Extension Phase|Progression of concomitant disease|2
7726840|NCT00965757|26869733|P3|Extension Phase|Progression of concomitant disease|4
7726841|NCT00965757|26869734|P2|Extension Phase|Progression of concomitant disease|0
7726842|NCT00965757|26869735|P1|Extension Phase|Progression of concomitant disease|0
7726843|NCT00965757|26869732|P4|Double-blind Phase|Other|0
7726844|NCT00965757|26869733|P3|Double-blind Phase|Other|0
7726845|NCT00965757|26869734|P2|Double-blind Phase|Other|0
7726846|NCT00965757|26869735|P1|Double-blind Phase|Other|1
7726847|NCT00965757|26869732|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
7726848|NCT00965757|26869733|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
7726849|NCT00965757|26869734|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
7726850|NCT00965757|26869735|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
7726851|NCT00965757|26869732|P4|Double-blind Phase|Lost to Follow-up|0
7726852|NCT00965757|26869733|P3|Double-blind Phase|Lost to Follow-up|0
7726853|NCT00965757|26869734|P2|Double-blind Phase|Lost to Follow-up|1
7726854|NCT00965757|26869735|P1|Double-blind Phase|Lost to Follow-up|0
7726855|NCT00965757|26869732|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7726856|NCT00965757|26869733|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7726857|NCT00965757|26869734|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7726858|NCT00965757|26869735|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
7726859|NCT00965757|26869732|P4|Double-blind Phase|Lack of Efficacy|0
7726860|NCT00965757|26869733|P3|Double-blind Phase|Lack of Efficacy|0
7726861|NCT00965757|26869734|P2|Double-blind Phase|Lack of Efficacy|11
7726862|NCT00965757|26869735|P1|Double-blind Phase|Lack of Efficacy|7
7726863|NCT00965757|26869732|P4|Double-blind Phase|Abnormal Laboratory Value|0
7726864|NCT00965757|26869733|P3|Double-blind Phase|Abnormal Laboratory Value|0
7726865|NCT00965757|26869734|P2|Double-blind Phase|Abnormal Laboratory Value|0
7726866|NCT00965757|26869735|P1|Double-blind Phase|Abnormal Laboratory Value|2
7726867|NCT00965757|26869732|P4|Double-blind Phase|Adverse drug reaction|0
7726868|NCT00965757|26869733|P3|Double-blind Phase|Adverse drug reaction|0
7726869|NCT00965757|26869734|P2|Double-blind Phase|Adverse drug reaction|1
7726870|NCT00965757|26869735|P1|Double-blind Phase|Adverse drug reaction|2
7726871|NCT00965757|26869732|P4|Double-blind Phase|Progression of concomitant disease|0
7726872|NCT00965757|26869733|P3|Double-blind Phase|Progression of concomitant disease|0
7726873|NCT00965757|26869734|P2|Double-blind Phase|Progression of concomitant disease|2
7726874|NCT00965757|26869735|P1|Double-blind Phase|Progression of concomitant disease|1
7726875|NCT00965731|26869769|P2|Overall Study|Other|15
7726876|NCT00965731|26869770|P1|Overall Study|Other|7
7726877|NCT00965731|26869769|P2|Overall Study|Withdrawal by Subject|1
7726878|NCT00965731|26869770|P1|Overall Study|Withdrawal by Subject|0
7726879|NCT00965731|26869769|P2|Overall Study|Death|4
7726880|NCT00965731|26869770|P1|Overall Study|Death|0
7726881|NCT00965718|26869834|P1|Overall Study|Withdrawal by Subject|4
7726882|NCT00965575|26869846|P2|Overall Study|subject unwillingness to swallow study c|0
7726883|NCT00965575|26869847|P1|Overall Study|subject unwillingness to swallow study c|1
7726884|NCT00965562|26869858|P3|Overall Study|Withdrawal by Subject|0
7726885|NCT00965562|26869859|P2|Overall Study|Withdrawal by Subject|2
7726886|NCT00965562|26869860|P1|Overall Study|Withdrawal by Subject|2
7726887|NCT00965562|26869858|P3|Overall Study|Lost to Follow-up|3
7726888|NCT00965562|26869859|P2|Overall Study|Lost to Follow-up|2
7726889|NCT00965562|26869860|P1|Overall Study|Lost to Follow-up|1
7726890|NCT00965523|26869898|P1|Study 224|Physician Decision|1
7726891|NCT00965523|26869898|P1|Study 224|Progressive Disease|5
7726892|NCT00965523|26869898|P1|Study 221|Physician Decision|3
7726893|NCT00965523|26869898|P1|Study 221|Progressive Disease|4
7726894|NCT00965497|26869903|P1|Overall Study|Physician Decision|1
7726895|NCT00965484|26869908|P1|Overall Study|Withdrawal by Subject|1
7726896|NCT00965484|26869908|P1|Overall Study|Protocol Violation|1
7726897|NCT00965458|26869917|P2|Overall Study|Withdrawal by Subject|1
7726898|NCT00965458|26869918|P1|Overall Study|Withdrawal by Subject|0
7726899|NCT00965458|26869917|P2|Overall Study|Lost to Follow-up|3
7726900|NCT00965458|26869918|P1|Overall Study|Lost to Follow-up|1
7726901|NCT00965458|26869917|P2|Overall Study|Adverse Event|0
7726902|NCT00965458|26869918|P1|Overall Study|Adverse Event|1
7726903|NCT00965419|26869934|P1|Follow-up Phase|Lack of Efficacy|28
7726904|NCT00965419|26869934|P1|Follow-up Phase|Parent/Caregiver Decision|9
7726905|NCT00965419|26869934|P1|Follow-up Phase|Physician Decision|4
7726906|NCT00965419|26869934|P1|Follow-up Phase|Withdrawal by Subject|8
7726907|NCT00965419|26869934|P1|Follow-up Phase|Protocol Violation|4
7726908|NCT00965419|26869934|P1|Follow-up Phase|Adverse Event|9
7726909|NCT00965419|26869934|P1|Open Label Treatment for Responders|Lost to Follow-up|46
7726910|NCT00965419|26869934|P1|Open Label Treatment for Responders|Lack of Efficacy|67
7726911|NCT00965419|26869934|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
7726912|NCT00965419|26869934|P1|Open Label Treatment for Responders|Sponsor Decision|5
7726913|NCT00965419|26869934|P1|Open Label Treatment for Responders|Physician Decision|6
7726914|NCT00965419|26869934|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
7726915|NCT00965419|26869934|P1|Open Label Treatment for Responders|Protocol Violation|21
7726916|NCT00965419|26869934|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
7726917|NCT00965419|26869934|P1|Open Label Treatment for Responders|Adverse Event|33
7726918|NCT00965341|26869980|P2|Overall Study|Transportation issues|3
7726919|NCT00965341|26869981|P1|Overall Study|Transportation issues|4
7726920|NCT00965341|26869980|P2|Overall Study|Lost to Follow-up|0
7726921|NCT00965341|26869981|P1|Overall Study|Lost to Follow-up|1
7726922|NCT00965341|26869980|P2|Overall Study|Withdrew consent|5
7726923|NCT00965341|26869981|P1|Overall Study|Withdrew consent|1
7726924|NCT00965263|26869991|P2|Overall Study|Protocol Violation|2
7726925|NCT00965263|26869992|P1|Overall Study|Protocol Violation|0
7726926|NCT00965263|26869991|P2|Overall Study|Family emergency|1
7726927|NCT00965263|26869992|P1|Overall Study|Family emergency|0
7726928|NCT00965263|26869991|P2|Overall Study|Physician Decision|0
7726929|NCT00965263|26869992|P1|Overall Study|Physician Decision|2
7726930|NCT00965185|26870052|P2|Overall Study|Withdrawal by Subject|1
7726931|NCT00965185|26870053|P1|Overall Study|Withdrawal by Subject|0
7726932|NCT00965185|26870052|P2|Overall Study|Lost to Follow-up|0
7726933|NCT00965185|26870053|P1|Overall Study|Lost to Follow-up|2
7726934|NCT00965146|26870073|P1|Overall Study|Overall Study Termination|145
7726935|NCT00965146|26870073|P1|Overall Study|Revision / Removal of Study Implant|6
7726936|NCT00965146|26870073|P1|Overall Study|Intercurrent illness|1
7726937|NCT00965146|26870073|P1|Overall Study|Unwilling to return|11
7726938|NCT00965146|26870073|P1|Overall Study|Unable to return|1
7726939|NCT00965146|26870073|P1|Overall Study|Withdrawal by Subject|17
7726940|NCT00965146|26870073|P1|Overall Study|Lost to Follow-up|22
7726941|NCT00965146|26870073|P1|Overall Study|Death|7
7726942|NCT00965094|26870080|P2|Overall Study|Lost to Follow-up|1
7726943|NCT00965094|26870081|P1|Overall Study|Lost to Follow-up|0
7726944|NCT00965094|26870080|P2|Overall Study|Adverse Event|0
7726945|NCT00965094|26870081|P1|Overall Study|Adverse Event|5
7726946|NCT00965081|26870097|P2|Overall Study|Switched to Rescue Arm|12
7726947|NCT00965081|26870098|P1|Overall Study|Switched to Rescue Arm|5
7726948|NCT00965081|26870097|P2|Overall Study|Withdrawal by Subject|7
7726949|NCT00965081|26870098|P1|Overall Study|Withdrawal by Subject|4
7726950|NCT00965081|26870097|P2|Overall Study|Sponsor Decision|0
7726951|NCT00965081|26870098|P1|Overall Study|Sponsor Decision|1
7726952|NCT00965081|26870097|P2|Overall Study|Protocol Violation|5
7726953|NCT00965081|26870098|P1|Overall Study|Protocol Violation|2
7726954|NCT00965081|26870097|P2|Overall Study|Physician Decision|0
7726955|NCT00965081|26870098|P1|Overall Study|Physician Decision|2
7726956|NCT00965081|26870097|P2|Overall Study|Lost to Follow-up|5
7726957|NCT00965081|26870098|P1|Overall Study|Lost to Follow-up|4
7726958|NCT00965081|26870097|P2|Overall Study|Lack of Efficacy|5
7726959|NCT00965081|26870098|P1|Overall Study|Lack of Efficacy|2
7726960|NCT00965081|26870097|P2|Overall Study|Adverse Event|9
7726961|NCT00965081|26870098|P1|Overall Study|Adverse Event|14
7726962|NCT00964886|26870130|P4|Overall Study|Protocol Violation|0
7726963|NCT00964886|26870131|P3|Overall Study|Protocol Violation|0
7726964|NCT00964886|26870132|P2|Overall Study|Protocol Violation|2
7726965|NCT00964886|26870133|P1|Overall Study|Protocol Violation|0
7726966|NCT00964886|26870130|P4|Overall Study|Adverse Event|2
7726967|NCT00964886|26870131|P3|Overall Study|Adverse Event|5
7726968|NCT00964886|26870132|P2|Overall Study|Adverse Event|1
7726969|NCT00964886|26870133|P1|Overall Study|Adverse Event|3
7726970|NCT00964886|26870130|P4|Overall Study|Withdrawal by Subject|3
7726971|NCT00964886|26870131|P3|Overall Study|Withdrawal by Subject|5
7726972|NCT00964886|26870132|P2|Overall Study|Withdrawal by Subject|2
7726973|NCT00964886|26870133|P1|Overall Study|Withdrawal by Subject|6
7726974|NCT00964886|26870130|P4|Overall Study|Lost to Follow-up|4
7726975|NCT00964886|26870131|P3|Overall Study|Lost to Follow-up|6
7726976|NCT00964886|26870132|P2|Overall Study|Lost to Follow-up|2
7726977|NCT00964886|26870133|P1|Overall Study|Lost to Follow-up|2
7726978|NCT00964860|26870149|P2|Overall Study|Withdrawal by Subject|1
7726979|NCT00964860|26870150|P1|Overall Study|Withdrawal by Subject|0
7726980|NCT00964795|26870158|P1|Overall Study|Other|23
7726981|NCT00964795|26870158|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
7726982|NCT00964795|26870158|P1|Overall Study|Termination of Study by Sponsor|169
7726983|NCT00964795|26870158|P1|Overall Study|Lost to Follow-up|7
7726984|NCT00964795|26870158|P1|Overall Study|Death|14
7726985|NCT00964795|26870158|P1|Overall Study|Adverse Event|12
7726986|NCT00964795|26870158|P1|Overall Study|Withdrawal by Subject|79
7726987|NCT00964782|26870167|P2|Overall Study|Lost to Follow-up|0
7726988|NCT00964782|26870168|P1|Overall Study|Lost to Follow-up|1
7726989|NCT00964743|26870182|P1|Overall Study|Neither patient completed 8 weeks of tre|2
7726990|NCT00964678|26870190|P1|Overall Study|Physician Decision|4
7726991|NCT00964392|26870254|P2|Overall Study|Not completed|168
7726992|NCT00964392|26870255|P1|Overall Study|Not completed|44
7726993|NCT00964392|26870254|P2|Overall Study|Early Termination, non-study arrhythmia|6
7726994|NCT00964392|26870255|P1|Overall Study|Early Termination, non-study arrhythmia|1
7726995|NCT00964392|26870254|P2|Overall Study|Lost to Follow-up|10
7726996|NCT00964392|26870255|P1|Overall Study|Lost to Follow-up|4
7726997|NCT00964392|26870254|P2|Overall Study|Withdrawal by Subject|6
7726998|NCT00964392|26870255|P1|Overall Study|Withdrawal by Subject|4
7726999|NCT00964366|26870265|P2|Overall Study|Withdrawal by Subject|1
7727000|NCT00964366|26870266|P1|Overall Study|Withdrawal by Subject|0
7727001|NCT00964366|26870265|P2|Overall Study|Did not qualify at Day 1|0
7727002|NCT00964366|26870266|P1|Overall Study|Did not qualify at Day 1|1
7727003|NCT00964223|26870291|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
7727004|NCT00964158|26870359|P3|Overall Study|Withdrawal by Subject|6
7727005|NCT00964158|26870360|P2|Overall Study|Withdrawal by Subject|0
7727006|NCT00964158|26870361|P1|Overall Study|Withdrawal by Subject|0
7727007|NCT00964158|26870359|P3|Overall Study|Lost to Follow-up|2
7727008|NCT00964158|26870360|P2|Overall Study|Lost to Follow-up|1
7727009|NCT00964158|26870361|P1|Overall Study|Lost to Follow-up|0
7727010|NCT00964028|26870436|P2|Overall Study|Withdrawal by Subject|1
7727011|NCT00964028|26870437|P1|Overall Study|Withdrawal by Subject|0
7727012|NCT00963937|26870452|P3|Overall Study|Physician Decision|4
7727013|NCT00963937|26870453|P2|Overall Study|Physician Decision|10
7727014|NCT00963937|26870454|P1|Overall Study|Physician Decision|18
7727015|NCT00963937|26870452|P3|Overall Study|Protocol Violation|0
7727016|NCT00963937|26870453|P2|Overall Study|Protocol Violation|1
7727017|NCT00963937|26870454|P1|Overall Study|Protocol Violation|1
7727018|NCT00963924|26870492|P2|Overall Study|Lost to Follow-up|1
7727019|NCT00963924|26870493|P1|Overall Study|Lost to Follow-up|0
7727020|NCT00963924|26870492|P2|Overall Study|Changed antipsychotic|1
7727021|NCT00963924|26870493|P1|Overall Study|Changed antipsychotic|0
7727022|NCT00963924|26870492|P2|Overall Study|Withdrawal by Subject|1
7727023|NCT00963924|26870493|P1|Overall Study|Withdrawal by Subject|0
7727024|NCT00963924|26870492|P2|Overall Study|Adverse Event|0
7727025|NCT00963924|26870493|P1|Overall Study|Adverse Event|1
7727026|NCT00963820|26870576|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
7727027|NCT00963820|26870577|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727028|NCT00963820|26870578|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727029|NCT00963820|26870579|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727030|NCT00963820|26870580|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727031|NCT00963820|26870581|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727032|NCT00963820|26870582|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727033|NCT00963820|26870583|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727034|NCT00963820|26870584|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727035|NCT00963820|26870585|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727036|NCT00963820|26870586|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727037|NCT00963820|26870587|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
7727038|NCT00963820|26870576|P12|Expansion Phase|Withdrawal by Subject|1
7727039|NCT00963820|26870577|P11|Expansion Phase|Withdrawal by Subject|1
7727040|NCT00963820|26870578|P10|Expansion Phase|Withdrawal by Subject|0
7727041|NCT00963820|26870579|P9|Expansion Phase|Withdrawal by Subject|1
7727042|NCT00963820|26870580|P8|Expansion Phase|Withdrawal by Subject|0
7727043|NCT00963820|26870581|P7|Expansion Phase|Withdrawal by Subject|0
7727044|NCT00963820|26870582|P6|Expansion Phase|Withdrawal by Subject|0
7727045|NCT00963820|26870583|P5|Expansion Phase|Withdrawal by Subject|0
7727046|NCT00963820|26870584|P4|Expansion Phase|Withdrawal by Subject|0
7727047|NCT00963820|26870585|P3|Expansion Phase|Withdrawal by Subject|0
7727048|NCT00963820|26870586|P2|Expansion Phase|Withdrawal by Subject|0
7727049|NCT00963820|26870587|P1|Expansion Phase|Withdrawal by Subject|0
7727050|NCT00963820|26870576|P12|Expansion Phase|Adverse Event|0
7727051|NCT00963820|26870577|P11|Expansion Phase|Adverse Event|0
7727052|NCT00963820|26870578|P10|Expansion Phase|Adverse Event|3
7727053|NCT00963820|26870579|P9|Expansion Phase|Adverse Event|1
7727054|NCT00963820|26870580|P8|Expansion Phase|Adverse Event|0
7727055|NCT00963820|26870581|P7|Expansion Phase|Adverse Event|0
7727056|NCT00963820|26870582|P6|Expansion Phase|Adverse Event|0
7727057|NCT00963820|26870583|P5|Expansion Phase|Adverse Event|0
7727058|NCT00963820|26870584|P4|Expansion Phase|Adverse Event|0
7727059|NCT00963820|26870585|P3|Expansion Phase|Adverse Event|0
7727060|NCT00963820|26870586|P2|Expansion Phase|Adverse Event|0
7727061|NCT00963820|26870587|P1|Expansion Phase|Adverse Event|0
7727062|NCT00963820|26870576|P12|Expansion Phase|Progressive Disease|2
7727063|NCT00963820|26870577|P11|Expansion Phase|Progressive Disease|4
7727064|NCT00963820|26870578|P10|Expansion Phase|Progressive Disease|6
7727065|NCT00963820|26870579|P9|Expansion Phase|Progressive Disease|8
7727066|NCT00963820|26870580|P8|Expansion Phase|Progressive Disease|0
7727067|NCT00963820|26870581|P7|Expansion Phase|Progressive Disease|0
7727068|NCT00963820|26870582|P6|Expansion Phase|Progressive Disease|0
7727069|NCT00963820|26870583|P5|Expansion Phase|Progressive Disease|0
7727070|NCT00963820|26870584|P4|Expansion Phase|Progressive Disease|0
7727071|NCT00963820|26870585|P3|Expansion Phase|Progressive Disease|0
7727072|NCT00963820|26870586|P2|Expansion Phase|Progressive Disease|0
7727073|NCT00963820|26870587|P1|Expansion Phase|Progressive Disease|0
7727074|NCT00963820|26870576|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727075|NCT00963820|26870577|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727076|NCT00963820|26870578|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727077|NCT00963820|26870579|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727078|NCT00963820|26870580|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727079|NCT00963820|26870581|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7727080|NCT00963820|26870582|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727081|NCT00963820|26870583|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727082|NCT00963820|26870584|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727083|NCT00963820|26870585|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727084|NCT00963820|26870586|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727085|NCT00963820|26870587|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7727086|NCT00963820|26870576|P12|Dose Escalation Phase|Withdrawal by Subject|0
7727087|NCT00963820|26870577|P11|Dose Escalation Phase|Withdrawal by Subject|0
7727088|NCT00963820|26870578|P10|Dose Escalation Phase|Withdrawal by Subject|0
7727089|NCT00963820|26870579|P9|Dose Escalation Phase|Withdrawal by Subject|0
7727090|NCT00963820|26870580|P8|Dose Escalation Phase|Withdrawal by Subject|2
7727091|NCT00963820|26870581|P7|Dose Escalation Phase|Withdrawal by Subject|1
7727092|NCT00963820|26870582|P6|Dose Escalation Phase|Withdrawal by Subject|0
7727093|NCT00963820|26870583|P5|Dose Escalation Phase|Withdrawal by Subject|0
7727094|NCT00963820|26870584|P4|Dose Escalation Phase|Withdrawal by Subject|0
7727095|NCT00963820|26870585|P3|Dose Escalation Phase|Withdrawal by Subject|0
7727096|NCT00963820|26870586|P2|Dose Escalation Phase|Withdrawal by Subject|0
7727097|NCT00963820|26870587|P1|Dose Escalation Phase|Withdrawal by Subject|0
7727098|NCT00963820|26870576|P12|Dose Escalation Phase|Adverse Event|0
7727099|NCT00963820|26870577|P11|Dose Escalation Phase|Adverse Event|0
7727100|NCT00963820|26870578|P10|Dose Escalation Phase|Adverse Event|0
7727101|NCT00963820|26870579|P9|Dose Escalation Phase|Adverse Event|0
7727102|NCT00963820|26870580|P8|Dose Escalation Phase|Adverse Event|1
7727103|NCT00963820|26870581|P7|Dose Escalation Phase|Adverse Event|3
7727104|NCT00963820|26870582|P6|Dose Escalation Phase|Adverse Event|0
7727105|NCT00963820|26870583|P5|Dose Escalation Phase|Adverse Event|0
7727106|NCT00963820|26870584|P4|Dose Escalation Phase|Adverse Event|0
7727107|NCT00963820|26870585|P3|Dose Escalation Phase|Adverse Event|0
7727108|NCT00963820|26870586|P2|Dose Escalation Phase|Adverse Event|0
7727109|NCT00963820|26870587|P1|Dose Escalation Phase|Adverse Event|0
7727110|NCT00963820|26870576|P12|Dose Escalation Phase|Progressive Disease|0
7727111|NCT00963820|26870577|P11|Dose Escalation Phase|Progressive Disease|0
7727112|NCT00963820|26870578|P10|Dose Escalation Phase|Progressive Disease|0
7727113|NCT00963820|26870579|P9|Dose Escalation Phase|Progressive Disease|0
7727114|NCT00963820|26870580|P8|Dose Escalation Phase|Progressive Disease|2
7727115|NCT00963820|26870581|P7|Dose Escalation Phase|Progressive Disease|3
7727116|NCT00963820|26870582|P6|Dose Escalation Phase|Progressive Disease|3
7727117|NCT00963820|26870583|P5|Dose Escalation Phase|Progressive Disease|4
7727118|NCT00963820|26870584|P4|Dose Escalation Phase|Progressive Disease|3
7727119|NCT00963820|26870585|P3|Dose Escalation Phase|Progressive Disease|3
7727120|NCT00963820|26870586|P2|Dose Escalation Phase|Progressive Disease|3
7727121|NCT00963820|26870587|P1|Dose Escalation Phase|Progressive Disease|3
7727122|NCT00963807|26870723|P1|Overall Study|Disease progression|15
7727123|NCT00963807|26870723|P1|Overall Study|Reaction to study chemotherapy regimen|1
7727124|NCT00963807|26870723|P1|Overall Study|Physician Decision|2
7727125|NCT00963599|26870756|P4|Overall Study|Withdrawal by Subject|3
7727126|NCT00963599|26870757|P3|Overall Study|Withdrawal by Subject|3
7727127|NCT00963599|26870758|P2|Overall Study|Withdrawal by Subject|1
7727128|NCT00963599|26870759|P1|Overall Study|Withdrawal by Subject|2
7727129|NCT00963599|26870756|P4|Overall Study|Protocol Violation|4
7727130|NCT00963599|26870757|P3|Overall Study|Protocol Violation|3
7727131|NCT00963599|26870758|P2|Overall Study|Protocol Violation|2
7727132|NCT00963599|26870759|P1|Overall Study|Protocol Violation|2
7727133|NCT00963599|26870756|P4|Overall Study|Lost to Follow-up|1
7727134|NCT00963599|26870757|P3|Overall Study|Lost to Follow-up|1
7727135|NCT00963599|26870758|P2|Overall Study|Lost to Follow-up|1
7727136|NCT00963599|26870759|P1|Overall Study|Lost to Follow-up|0
7727137|NCT00963599|26870756|P4|Overall Study|Lack of Efficacy|4
7727138|NCT00963599|26870757|P3|Overall Study|Lack of Efficacy|1
7727139|NCT00963599|26870758|P2|Overall Study|Lack of Efficacy|2
7727140|NCT00963599|26870759|P1|Overall Study|Lack of Efficacy|0
7727141|NCT00963599|26870756|P4|Overall Study|Adverse Event|2
7727142|NCT00963599|26870757|P3|Overall Study|Adverse Event|1
7727143|NCT00963599|26870758|P2|Overall Study|Adverse Event|0
7727144|NCT00963599|26870759|P1|Overall Study|Adverse Event|2
7727145|NCT00963547|26870830|P7|Overall Study|Reason Unknown|0
7727146|NCT00963547|26870831|P6|Overall Study|Reason Unknown|0
7727147|NCT00963547|26870832|P5|Overall Study|Reason Unknown|0
7727148|NCT00963547|26870833|P4|Overall Study|Reason Unknown|0
7727149|NCT00963547|26870834|P3|Overall Study|Reason Unknown|0
7727150|NCT00963547|26870835|P2|Overall Study|Reason Unknown|1
7727151|NCT00963547|26870836|P1|Overall Study|Reason Unknown|0
7727152|NCT00963547|26870830|P7|Overall Study|Withdrawal by Subject|0
7727153|NCT00963547|26870831|P6|Overall Study|Withdrawal by Subject|0
7727154|NCT00963547|26870832|P5|Overall Study|Withdrawal by Subject|0
7727155|NCT00963547|26870833|P4|Overall Study|Withdrawal by Subject|0
7727156|NCT00963547|26870834|P3|Overall Study|Withdrawal by Subject|3
7727157|NCT00963547|26870835|P2|Overall Study|Withdrawal by Subject|0
7727158|NCT00963547|26870836|P1|Overall Study|Withdrawal by Subject|0
7727159|NCT00963547|26870830|P7|Overall Study|Progressive Disease|0
7727160|NCT00963547|26870831|P6|Overall Study|Progressive Disease|0
7727161|NCT00963547|26870832|P5|Overall Study|Progressive Disease|0
7727162|NCT00963547|26870833|P4|Overall Study|Progressive Disease|5
7727163|NCT00963547|26870834|P3|Overall Study|Progressive Disease|9
7727164|NCT00963547|26870835|P2|Overall Study|Progressive Disease|8
7727165|NCT00963547|26870836|P1|Overall Study|Progressive Disease|3
7727166|NCT00963547|26870830|P7|Overall Study|Physician Decision|0
7727167|NCT00963547|26870831|P6|Overall Study|Physician Decision|0
7727168|NCT00963547|26870832|P5|Overall Study|Physician Decision|0
7727169|NCT00963547|26870833|P4|Overall Study|Physician Decision|0
7727170|NCT00963547|26870834|P3|Overall Study|Physician Decision|0
7727171|NCT00963547|26870835|P2|Overall Study|Physician Decision|1
7727172|NCT00963547|26870836|P1|Overall Study|Physician Decision|1
7727173|NCT00963547|26870830|P7|Overall Study|Adverse Event|0
7727174|NCT00963547|26870831|P6|Overall Study|Adverse Event|0
7727175|NCT00963547|26870832|P5|Overall Study|Adverse Event|0
7727176|NCT00963547|26870833|P4|Overall Study|Adverse Event|1
7727177|NCT00963547|26870834|P3|Overall Study|Adverse Event|0
7727178|NCT00963547|26870835|P2|Overall Study|Adverse Event|1
7727179|NCT00963547|26870836|P1|Overall Study|Adverse Event|0
7727180|NCT00963469|26870883|P3|Overall Study|Site closed (local pollen Season ended)|3
7727181|NCT00963469|26870884|P2|Overall Study|Site closed (local pollen Season ended)|1
7727182|NCT00963469|26870885|P1|Overall Study|Site closed (local pollen Season ended)|4
7727183|NCT00963469|26870883|P3|Overall Study|Moved|0
7727184|NCT00963469|26870884|P2|Overall Study|Moved|0
7727185|NCT00963469|26870885|P1|Overall Study|Moved|1
7727186|NCT00963469|26870883|P3|Overall Study|Pre-randomization Adverse Event|0
7727187|NCT00963469|26870884|P2|Overall Study|Pre-randomization Adverse Event|2
7727188|NCT00963469|26870885|P1|Overall Study|Pre-randomization Adverse Event|1
7727189|NCT00963469|26870883|P3|Overall Study|Withdrawal by Subject|1
7727190|NCT00963469|26870884|P2|Overall Study|Withdrawal by Subject|1
7727191|NCT00963469|26870885|P1|Overall Study|Withdrawal by Subject|4
7727192|NCT00963469|26870883|P3|Overall Study|Protocol Violation|3
7727193|NCT00963469|26870884|P2|Overall Study|Protocol Violation|5
7727194|NCT00963469|26870885|P1|Overall Study|Protocol Violation|5
7727195|NCT00963469|26870883|P3|Overall Study|Lost to Follow-up|0
7727196|NCT00963469|26870884|P2|Overall Study|Lost to Follow-up|1
7727197|NCT00963469|26870885|P1|Overall Study|Lost to Follow-up|1
7727198|NCT00963469|26870883|P3|Overall Study|Lack of Efficacy|2
7727199|NCT00963469|26870884|P2|Overall Study|Lack of Efficacy|7
7727200|NCT00963469|26870885|P1|Overall Study|Lack of Efficacy|10
7727201|NCT00963469|26870883|P3|Overall Study|Adverse Event|1
7727202|NCT00963469|26870884|P2|Overall Study|Adverse Event|11
7727203|NCT00963469|26870885|P1|Overall Study|Adverse Event|15
7727204|NCT00963235|26870952|P1|Overall Study|Other|1
7727205|NCT00963235|26870952|P1|Overall Study|Physician Decision|2
7727206|NCT00963235|26870952|P1|Overall Study|Adverse Event|5
7727207|NCT00963235|26870952|P1|Overall Study|Protocol Violation|7
7727208|NCT00963235|26870952|P1|Overall Study|Failed to return|9
7727209|NCT00963235|26870952|P1|Overall Study|Lost to Follow-up|14
7727210|NCT00963235|26870952|P1|Overall Study|Withdrawal by Subject|22
7727211|NCT00962780|26871244|P2|Overall Study|Other|1
7727212|NCT00962780|26871245|P1|Overall Study|Other|0
7727213|NCT00962780|26871244|P2|Overall Study|Withdrawal by Subject|8
7727214|NCT00962780|26871245|P1|Overall Study|Withdrawal by Subject|1
7727215|NCT00962780|26871244|P2|Overall Study|Protocol Violation|4
7727216|NCT00962780|26871245|P1|Overall Study|Protocol Violation|9
7727217|NCT00962780|26871244|P2|Overall Study|Death|1
7727218|NCT00962780|26871245|P1|Overall Study|Death|0
7727219|NCT00962741|26871320|P1|Overall Study|drug ineffective+prohibited drug taken|1
7727220|NCT00962741|26871320|P1|Overall Study|Lack of Efficacy|1
7727221|NCT00962741|26871320|P1|Overall Study|Withdrawal by Subject|1
7727222|NCT00962741|26871320|P1|Overall Study|Lost to Follow-up|2
7727223|NCT00962741|26871320|P1|Overall Study|Failed to return|3
7727224|NCT00962650|26871411|P1|Overall Study|Transgastric DP was not completed|2
7727225|NCT00962585|26871430|P4|Overall Study|Withdrew Consent|0
7727226|NCT00962585|26871431|P3|Overall Study|Withdrew Consent|0
7727227|NCT00962585|26871432|P2|Overall Study|Withdrew Consent|0
7727228|NCT00962585|26871433|P1|Overall Study|Withdrew Consent|2
7727229|NCT00962585|26871430|P4|Overall Study|Withdrawal by Subject|0
7727230|NCT00962585|26871431|P3|Overall Study|Withdrawal by Subject|0
7727231|NCT00962585|26871432|P2|Overall Study|Withdrawal by Subject|0
7727232|NCT00962585|26871433|P1|Overall Study|Withdrawal by Subject|1
7727233|NCT00962585|26871430|P4|Overall Study|Protocol Violation|0
7727234|NCT00962585|26871431|P3|Overall Study|Protocol Violation|1
7727235|NCT00962585|26871432|P2|Overall Study|Protocol Violation|0
7727236|NCT00962585|26871433|P1|Overall Study|Protocol Violation|0
7727237|NCT00962585|26871430|P4|Overall Study|Lost to Follow-up|0
7727238|NCT00962585|26871431|P3|Overall Study|Lost to Follow-up|1
7727239|NCT00962585|26871432|P2|Overall Study|Lost to Follow-up|0
7727240|NCT00962585|26871433|P1|Overall Study|Lost to Follow-up|3
7727241|NCT00962585|26871430|P4|Overall Study|Adverse Event|0
7727242|NCT00962585|26871431|P3|Overall Study|Adverse Event|1
7727243|NCT00962585|26871432|P2|Overall Study|Adverse Event|2
7727244|NCT00962585|26871433|P1|Overall Study|Adverse Event|0
7727245|NCT00962390|26871510|P4|Overall Study|Withdrawal by Subject|0
7727246|NCT00962390|26871511|P3|Overall Study|Withdrawal by Subject|1
7727247|NCT00962390|26871512|P2|Overall Study|Withdrawal by Subject|1
7727248|NCT00962390|26871513|P1|Overall Study|Withdrawal by Subject|1
7727249|NCT00962390|26871510|P4|Overall Study|Protocol Violation|0
7727250|NCT00962390|26871511|P3|Overall Study|Protocol Violation|0
7727251|NCT00962390|26871512|P2|Overall Study|Protocol Violation|0
7727252|NCT00962390|26871513|P1|Overall Study|Protocol Violation|1
7727253|NCT00962390|26871510|P4|Overall Study|Lost to Follow-up|0
7727254|NCT00962390|26871511|P3|Overall Study|Lost to Follow-up|0
7727255|NCT00962390|26871512|P2|Overall Study|Lost to Follow-up|2
7727256|NCT00962390|26871513|P1|Overall Study|Lost to Follow-up|2
7727257|NCT00962390|26871510|P4|Overall Study|Adverse Event|1
7727258|NCT00962390|26871511|P3|Overall Study|Adverse Event|3
7727259|NCT00962390|26871512|P2|Overall Study|Adverse Event|0
7727260|NCT00962390|26871513|P1|Overall Study|Adverse Event|0
7727261|NCT00962247|26871575|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
7727262|NCT00962247|26871575|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
7727263|NCT00962208|26871586|P2|Overall Study|Lost to Follow-up|9
7727264|NCT00962208|26871587|P1|Overall Study|Lost to Follow-up|0
7727265|NCT00962208|26871586|P2|Overall Study|Contraindicated to continue study|1
7727266|NCT00962208|26871587|P1|Overall Study|Contraindicated to continue study|5
7727267|NCT00962208|26871586|P2|Overall Study|Could not achieve good vision|0
7727268|NCT00962208|26871587|P1|Overall Study|Could not achieve good vision|9
7727269|NCT00962104|26871595|P2|Overall Study|Other|0
7727270|NCT00962104|26871596|P1|Overall Study|Other|2
7727271|NCT00962104|26871595|P2|Overall Study|Withdrawal by Subject|6
7727272|NCT00962104|26871596|P1|Overall Study|Withdrawal by Subject|10
7727273|NCT00962104|26871595|P2|Overall Study|Sponsor Decision|1
7727274|NCT00962104|26871596|P1|Overall Study|Sponsor Decision|0
7727275|NCT00962104|26871595|P2|Overall Study|Protocol Violation|8
7727276|NCT00962104|26871596|P1|Overall Study|Protocol Violation|6
7727277|NCT00962104|26871595|P2|Overall Study|Physician Decision|0
7727278|NCT00962104|26871596|P1|Overall Study|Physician Decision|1
7727279|NCT00962104|26871595|P2|Overall Study|Lost to Follow-up|4
7727280|NCT00962104|26871596|P1|Overall Study|Lost to Follow-up|10
7727281|NCT00962104|26871595|P2|Overall Study|Lack of Efficacy|1
7727282|NCT00962104|26871596|P1|Overall Study|Lack of Efficacy|0
7727283|NCT00962104|26871595|P2|Overall Study|Entry Criteria Not Met|2
7727284|NCT00962104|26871596|P1|Overall Study|Entry Criteria Not Met|1
7727285|NCT00962104|26871595|P2|Overall Study|Adverse Event|3
7727286|NCT00962104|26871596|P1|Overall Study|Adverse Event|10
7727287|NCT00962091|26871629|P7|Overall Study|Adverse Event|1
7727288|NCT00962091|26871630|P6|Overall Study|Adverse Event|0
7727289|NCT00962091|26871631|P5|Overall Study|Adverse Event|0
7727290|NCT00962091|26871632|P4|Overall Study|Adverse Event|0
7727291|NCT00962091|26871633|P3|Overall Study|Adverse Event|0
7727292|NCT00962091|26871634|P2|Overall Study|Adverse Event|0
7727293|NCT00962091|26871635|P1|Overall Study|Adverse Event|0
7727294|NCT00962091|26871629|P7|Overall Study|Withdrawal by Subject|0
7727295|NCT00962091|26871630|P6|Overall Study|Withdrawal by Subject|1
7727296|NCT00962091|26871631|P5|Overall Study|Withdrawal by Subject|0
7727297|NCT00962091|26871632|P4|Overall Study|Withdrawal by Subject|1
7727298|NCT00962091|26871633|P3|Overall Study|Withdrawal by Subject|1
7727299|NCT00962091|26871634|P2|Overall Study|Withdrawal by Subject|2
7727300|NCT00962091|26871635|P1|Overall Study|Withdrawal by Subject|1
7727301|NCT00962013|26871738|P1|Overall Study|No 5 year evaluation|6
7727302|NCT00962013|26871738|P1|Overall Study|Site Termination|24
7727303|NCT00962013|26871738|P1|Overall Study|Removal of study device|3
7727304|NCT00962013|26871738|P1|Overall Study|Withdrawal by Subject|8
7727305|NCT00962013|26871738|P1|Overall Study|Unable/Unwilling to return|6
7727306|NCT00962013|26871738|P1|Overall Study|Lost to Follow-up|12
7727307|NCT00962013|26871738|P1|Overall Study|Death|8
7727308|NCT00962013|26871738|P1|Overall Study|Did not have surgery|1
7727309|NCT00961961|26871762|P4|Phase II|Withdrawal by Subject|0
7727310|NCT00961961|26871763|P3|Phase II|Withdrawal by Subject|1
7727311|NCT00961961|26871764|P2|Phase II|Withdrawal by Subject|0
7727312|NCT00961961|26871765|P1|Phase II|Withdrawal by Subject|0
7727313|NCT00961961|26871762|P4|Phase II|Physician Decision|0
7727314|NCT00961961|26871763|P3|Phase II|Physician Decision|1
7727315|NCT00961961|26871764|P2|Phase II|Physician Decision|0
7727316|NCT00961961|26871765|P1|Phase II|Physician Decision|0
7727317|NCT00961961|26871762|P4|Phase II|Adverse Event|1
7727318|NCT00961961|26871763|P3|Phase II|Adverse Event|0
7727319|NCT00961961|26871764|P2|Phase II|Adverse Event|0
7727320|NCT00961961|26871765|P1|Phase II|Adverse Event|0
7727321|NCT00961961|26871762|P4|Phase II|Lost to Follow-up|7
7727322|NCT00961961|26871763|P3|Phase II|Lost to Follow-up|10
7727323|NCT00961961|26871764|P2|Phase II|Lost to Follow-up|0
7727324|NCT00961961|26871765|P1|Phase II|Lost to Follow-up|0
7727325|NCT00961961|26871762|P4|Phase I|Physician Decision|0
7727326|NCT00961961|26871763|P3|Phase I|Physician Decision|0
7727327|NCT00961961|26871764|P2|Phase I|Physician Decision|0
7727328|NCT00961961|26871765|P1|Phase I|Physician Decision|8
7727329|NCT00961961|26871762|P4|Phase I|Adverse Event|0
7727330|NCT00961961|26871763|P3|Phase I|Adverse Event|0
7727331|NCT00961961|26871764|P2|Phase I|Adverse Event|0
7727332|NCT00961961|26871765|P1|Phase I|Adverse Event|7
7727333|NCT00961961|26871762|P4|Phase I|Lack of Efficacy|0
7727334|NCT00961961|26871763|P3|Phase I|Lack of Efficacy|0
7727335|NCT00961961|26871764|P2|Phase I|Lack of Efficacy|0
7727336|NCT00961961|26871765|P1|Phase I|Lack of Efficacy|94
7727337|NCT00961961|26871762|P4|Phase I|Lost to Follow-up|0
7727338|NCT00961961|26871763|P3|Phase I|Lost to Follow-up|0
7727339|NCT00961961|26871764|P2|Phase I|Lost to Follow-up|0
7727340|NCT00961961|26871765|P1|Phase I|Lost to Follow-up|10
7727341|NCT00961961|26871762|P4|Phase I|Withdrawal by Subject|0
7727342|NCT00961961|26871763|P3|Phase I|Withdrawal by Subject|0
7727343|NCT00961961|26871764|P2|Phase I|Withdrawal by Subject|0
7727344|NCT00961961|26871765|P1|Phase I|Withdrawal by Subject|7
7727345|NCT00961896|26871790|P3|Overall Study|Abnormal laboratory value|1
7727346|NCT00961896|26871791|P2|Overall Study|Abnormal laboratory value|0
7727347|NCT00961896|26871792|P1|Overall Study|Abnormal laboratory value|0
7727348|NCT00961649|26871859|P4|Overall Study|Study terminated by sponsor|1
7727349|NCT00961649|26871860|P3|Overall Study|Study terminated by sponsor|4
7727350|NCT00961649|26871861|P2|Overall Study|Study terminated by sponsor|4
7727351|NCT00961649|26871862|P1|Overall Study|Study terminated by sponsor|4
7727352|NCT00961649|26871859|P4|Overall Study|Patient left to Mexico-family emergency|0
7727353|NCT00961649|26871860|P3|Overall Study|Patient left to Mexico-family emergency|0
7727354|NCT00961649|26871861|P2|Overall Study|Patient left to Mexico-family emergency|0
7727355|NCT00961649|26871862|P1|Overall Study|Patient left to Mexico-family emergency|1
7727356|NCT00961649|26871859|P4|Overall Study|Patient has travel plans during holidays|0
7727357|NCT00961649|26871860|P3|Overall Study|Patient has travel plans during holidays|1
7727358|NCT00961649|26871861|P2|Overall Study|Patient has travel plans during holidays|0
7727359|NCT00961649|26871862|P1|Overall Study|Patient has travel plans during holidays|0
7727360|NCT00961649|26871859|P4|Overall Study|Inadequate control of IOP|1
7727361|NCT00961649|26871860|P3|Overall Study|Inadequate control of IOP|0
7727362|NCT00961649|26871861|P2|Overall Study|Inadequate control of IOP|0
7727363|NCT00961649|26871862|P1|Overall Study|Inadequate control of IOP|0
7727364|NCT00961649|26871859|P4|Overall Study|Adverse Event|2
7727365|NCT00961649|26871860|P3|Overall Study|Adverse Event|0
7727366|NCT00961649|26871861|P2|Overall Study|Adverse Event|0
7727367|NCT00961649|26871862|P1|Overall Study|Adverse Event|4
7727368|NCT00961636|26871876|P3|Overall Study|Withdrawal by Subject|13
7727369|NCT00961636|26871877|P2|Overall Study|Withdrawal by Subject|22
7727370|NCT00961636|26871878|P1|Overall Study|Withdrawal by Subject|29
7727371|NCT00961636|26871876|P3|Overall Study|Protocol Violation|1
7727372|NCT00961636|26871877|P2|Overall Study|Protocol Violation|5
7727373|NCT00961636|26871878|P1|Overall Study|Protocol Violation|9
7727374|NCT00961636|26871876|P3|Overall Study|Physician Decision|1
7727375|NCT00961636|26871877|P2|Overall Study|Physician Decision|1
7727376|NCT00961636|26871878|P1|Overall Study|Physician Decision|3
7727377|NCT00961636|26871876|P3|Overall Study|Lost to Follow-up|1
7727378|NCT00961636|26871877|P2|Overall Study|Lost to Follow-up|3
7727379|NCT00961636|26871878|P1|Overall Study|Lost to Follow-up|2
7727380|NCT00961636|26871876|P3|Overall Study|Flushing Symptoms|3
7727381|NCT00961636|26871877|P2|Overall Study|Flushing Symptoms|46
7727382|NCT00961636|26871878|P1|Overall Study|Flushing Symptoms|29
7727383|NCT00961636|26871876|P3|Overall Study|Adverse Event|13
7727384|NCT00961636|26871877|P2|Overall Study|Adverse Event|54
7727385|NCT00961636|26871878|P1|Overall Study|Adverse Event|35
7727386|NCT00961571|26871889|P1|Overall Study|Physician Decision|39
7727387|NCT00961415|26871917|P3|Maintenance Treatment Phase|Other reason|3
7727388|NCT00961415|26871918|P2|Maintenance Treatment Phase|Other reason|1
7727389|NCT00961415|26871919|P1|Maintenance Treatment Phase|Other reason|0
7727390|NCT00961415|26871917|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
7727391|NCT00961415|26871918|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
7727392|NCT00961415|26871919|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
7727393|NCT00961415|26871917|P3|Maintenance Treatment Phase|Investigators decision|0
7727394|NCT00961415|26871918|P2|Maintenance Treatment Phase|Investigators decision|2
7727395|NCT00961415|26871919|P1|Maintenance Treatment Phase|Investigators decision|0
7727396|NCT00961415|26871917|P3|Maintenance Treatment Phase|Death|34
7727397|NCT00961415|26871918|P2|Maintenance Treatment Phase|Death|42
7727398|NCT00961415|26871919|P1|Maintenance Treatment Phase|Death|0
7727399|NCT00961415|26871917|P3|Induction Treatment Phase|Other Reason|0
7727400|NCT00961415|26871918|P2|Induction Treatment Phase|Other Reason|0
7727401|NCT00961415|26871919|P1|Induction Treatment Phase|Other Reason|5
7727402|NCT00961415|26871917|P3|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
7727403|NCT00961415|26871918|P2|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
7727404|NCT00961415|26871919|P1|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
7727405|NCT00961415|26871917|P3|Induction Treatment Phase|Physician Decision|0
7727406|NCT00961415|26871918|P2|Induction Treatment Phase|Physician Decision|0
7727407|NCT00961415|26871919|P1|Induction Treatment Phase|Physician Decision|2
7727408|NCT00961415|26871917|P3|Induction Treatment Phase|Protocol Violation|0
7727409|NCT00961415|26871918|P2|Induction Treatment Phase|Protocol Violation|0
7727410|NCT00961415|26871919|P1|Induction Treatment Phase|Protocol Violation|1
7727411|NCT00961415|26871917|P3|Induction Treatment Phase|Death|0
7727412|NCT00961415|26871918|P2|Induction Treatment Phase|Death|0
7727413|NCT00961415|26871919|P1|Induction Treatment Phase|Death|77
7727414|NCT00961415|26871917|P3|Induction Treatment Phase|Withdrawal by Subject|0
7727415|NCT00961415|26871918|P2|Induction Treatment Phase|Withdrawal by Subject|0
7727416|NCT00961415|26871919|P1|Induction Treatment Phase|Withdrawal by Subject|11
7727417|NCT00961350|26871959|P2|Overall Study|Misc|21
7727418|NCT00961350|26871960|P1|Overall Study|Misc|16
7727419|NCT00961350|26871959|P2|Overall Study|Lost to Follow-up|3
7727420|NCT00961350|26871960|P1|Overall Study|Lost to Follow-up|3
7727421|NCT00961350|26871959|P2|Overall Study|Withdrawal by Subject|10
7727422|NCT00961350|26871960|P1|Overall Study|Withdrawal by Subject|10
7727423|NCT00961350|26871959|P2|Overall Study|Adverse Event|33
7727424|NCT00961350|26871960|P1|Overall Study|Adverse Event|18
7727425|NCT00961298|26871981|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
7727426|NCT00961298|26871981|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
7727427|NCT00961298|26871981|P1|Two Week Placebo Run in|Withdrawal by Subject|1
7727428|NCT00961259|26871988|P3|Washout Period of 7 Days|due to concomitant medication used|0
7727429|NCT00961259|26871989|P2|Washout Period of 7 Days|due to concomitant medication used|1
7727430|NCT00961259|26871990|P1|Washout Period of 7 Days|due to concomitant medication used|0
7727431|NCT00961220|26872018|P1|Overall Study|Complete Response prior to 12 courses|1
7727432|NCT00961220|26872018|P1|Overall Study|O6BG no longer supplied|1
7727433|NCT00961220|26872018|P1|Overall Study|No IV access for O6BG|1
7727434|NCT00961220|26872018|P1|Overall Study|Lack of Efficacy|1
7727435|NCT00961220|26872018|P1|Overall Study|Adverse Event|3
7727436|NCT00961181|26872034|P1|Overall Study|Lost to Follow-up|1
7727437|NCT00961181|26872034|P1|Overall Study|Withdrawal by Subject|2
7727438|NCT00961181|26872034|P1|Overall Study|Death|2
7727439|NCT00961116|26872047|P2|Washout Period of 7 Days|Protocol Violation|1
7727440|NCT00961116|26872048|P1|Washout Period of 7 Days|Protocol Violation|0
7727441|NCT00961116|26872047|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7727442|NCT00961116|26872048|P1|Washout Period of 7 Days|Withdrawal by Subject|1
7727443|NCT00961116|26872047|P2|Washout Period of 7 Days|Adverse Event|1
7727444|NCT00961116|26872048|P1|Washout Period of 7 Days|Adverse Event|1
7727445|NCT00960999|26872075|P2|Overall Study|RT dose constraints not met|0
7727446|NCT00960999|26872076|P1|Overall Study|RT dose constraints not met|2
7727447|NCT00960999|26872075|P2|Overall Study|Protocol Violation|2
7727448|NCT00960999|26872076|P1|Overall Study|Protocol Violation|5
7727449|NCT00960999|26872075|P2|Overall Study|Withdrawal by Subject|0
7727450|NCT00960999|26872076|P1|Overall Study|Withdrawal by Subject|1
7727451|NCT00960986|26872108|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
7727452|NCT00960986|26872109|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
7727453|NCT00960986|26872110|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
7727454|NCT00960986|26872111|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
7727455|NCT00960986|26872108|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7727456|NCT00960986|26872109|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
7727457|NCT00960986|26872110|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7727458|NCT00960986|26872111|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7727459|NCT00960986|26872108|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
7727460|NCT00960986|26872109|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
7727461|NCT00960986|26872110|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
7727462|NCT00960986|26872111|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
7727463|NCT00960986|26872108|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7727464|NCT00960986|26872109|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
7727465|NCT00960986|26872110|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7727466|NCT00960986|26872111|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7727467|NCT00960986|26872108|P4|Period 3 (7-week Therapy Period)|Death|0
7727468|NCT00960986|26872109|P3|Period 3 (7-week Therapy Period)|Death|1
7727469|NCT00960986|26872110|P2|Period 3 (7-week Therapy Period)|Death|0
7727470|NCT00960986|26872111|P1|Period 3 (7-week Therapy Period)|Death|0
7727471|NCT00960986|26872108|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
7727472|NCT00960986|26872109|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
7727473|NCT00960986|26872110|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
7727474|NCT00960986|26872111|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
7727475|NCT00960986|26872108|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7727476|NCT00960986|26872109|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7727477|NCT00960986|26872110|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
7727478|NCT00960986|26872111|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7727479|NCT00960986|26872108|P4|Period 1 (Screening and Washout)|Protocol Violation|0
7727480|NCT00960986|26872109|P3|Period 1 (Screening and Washout)|Protocol Violation|0
7727481|NCT00960986|26872110|P2|Period 1 (Screening and Washout)|Protocol Violation|0
7727482|NCT00960986|26872111|P1|Period 1 (Screening and Washout)|Protocol Violation|1
7727483|NCT00960986|26872108|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
7727484|NCT00960986|26872109|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
7727485|NCT00960986|26872110|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
7727486|NCT00960986|26872111|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
7727487|NCT00960986|26872108|P4|Period 1 (Screening and Washout)|Adverse Event|1
7727488|NCT00960986|26872109|P3|Period 1 (Screening and Washout)|Adverse Event|1
7727489|NCT00960986|26872110|P2|Period 1 (Screening and Washout)|Adverse Event|2
7727490|NCT00960986|26872111|P1|Period 1 (Screening and Washout)|Adverse Event|1
7727491|NCT00960934|26872187|P6|Overall Study|Study Terminated by Sponsor|49
7727492|NCT00960934|26872188|P5|Overall Study|Study Terminated by Sponsor|49
7727493|NCT00960934|26872189|P4|Overall Study|Study Terminated by Sponsor|50
7727494|NCT00960934|26872190|P3|Overall Study|Study Terminated by Sponsor|52
7727495|NCT00960934|26872191|P2|Overall Study|Study Terminated by Sponsor|46
7727496|NCT00960934|26872192|P1|Overall Study|Study Terminated by Sponsor|50
7727497|NCT00960934|26872187|P6|Overall Study|Withdrawal by Subject|7
7727498|NCT00960934|26872188|P5|Overall Study|Withdrawal by Subject|5
7727499|NCT00960934|26872189|P4|Overall Study|Withdrawal by Subject|5
7727500|NCT00960934|26872190|P3|Overall Study|Withdrawal by Subject|4
7727501|NCT00960934|26872191|P2|Overall Study|Withdrawal by Subject|6
7727502|NCT00960934|26872192|P1|Overall Study|Withdrawal by Subject|5
7727503|NCT00960934|26872187|P6|Overall Study|Protocol Violation|2
7727504|NCT00960934|26872188|P5|Overall Study|Protocol Violation|3
7727505|NCT00960934|26872189|P4|Overall Study|Protocol Violation|3
7727506|NCT00960934|26872190|P3|Overall Study|Protocol Violation|0
7727507|NCT00960934|26872191|P2|Overall Study|Protocol Violation|4
7727508|NCT00960934|26872192|P1|Overall Study|Protocol Violation|3
7727509|NCT00960934|26872187|P6|Overall Study|Progressive Disease|1
7727510|NCT00960934|26872188|P5|Overall Study|Progressive Disease|1
7727511|NCT00960934|26872189|P4|Overall Study|Progressive Disease|0
7727512|NCT00960934|26872190|P3|Overall Study|Progressive Disease|0
7727513|NCT00960934|26872191|P2|Overall Study|Progressive Disease|1
7727514|NCT00960934|26872192|P1|Overall Study|Progressive Disease|1
7727515|NCT00960934|26872187|P6|Overall Study|Physician Decision|0
7727516|NCT00960934|26872188|P5|Overall Study|Physician Decision|0
7727517|NCT00960934|26872189|P4|Overall Study|Physician Decision|0
7727518|NCT00960934|26872190|P3|Overall Study|Physician Decision|0
7727519|NCT00960934|26872191|P2|Overall Study|Physician Decision|1
7727520|NCT00960934|26872192|P1|Overall Study|Physician Decision|0
7727521|NCT00960934|26872187|P6|Overall Study|Other|2
7727522|NCT00960934|26872188|P5|Overall Study|Other|2
7727523|NCT00960934|26872189|P4|Overall Study|Other|4
7727524|NCT00960934|26872190|P3|Overall Study|Other|5
7727525|NCT00960934|26872191|P2|Overall Study|Other|1
7727526|NCT00960934|26872192|P1|Overall Study|Other|2
7727527|NCT00960934|26872187|P6|Overall Study|Lost to Follow-up|0
7727528|NCT00960934|26872188|P5|Overall Study|Lost to Follow-up|0
7727529|NCT00960934|26872189|P4|Overall Study|Lost to Follow-up|0
7727530|NCT00960934|26872190|P3|Overall Study|Lost to Follow-up|0
7727531|NCT00960934|26872191|P2|Overall Study|Lost to Follow-up|1
7727532|NCT00960934|26872192|P1|Overall Study|Lost to Follow-up|0
7727533|NCT00960934|26872187|P6|Overall Study|Lack of Efficacy|0
7727534|NCT00960934|26872188|P5|Overall Study|Lack of Efficacy|0
7727535|NCT00960934|26872189|P4|Overall Study|Lack of Efficacy|0
7727536|NCT00960934|26872190|P3|Overall Study|Lack of Efficacy|0
7727537|NCT00960934|26872191|P2|Overall Study|Lack of Efficacy|0
7727538|NCT00960934|26872192|P1|Overall Study|Lack of Efficacy|1
7727539|NCT00960934|26872187|P6|Overall Study|Adverse Event|3
7727540|NCT00960934|26872188|P5|Overall Study|Adverse Event|4
7727541|NCT00960934|26872189|P4|Overall Study|Adverse Event|2
7727542|NCT00960934|26872190|P3|Overall Study|Adverse Event|3
7727543|NCT00960934|26872191|P2|Overall Study|Adverse Event|3
7727544|NCT00960934|26872192|P1|Overall Study|Adverse Event|2
7727545|NCT00960869|26872304|P2|Overall Study|Misc|18
7727546|NCT00960869|26872305|P1|Overall Study|Misc|19
7727547|NCT00960869|26872304|P2|Overall Study|Lost to Follow-up|4
7727548|NCT00960869|26872305|P1|Overall Study|Lost to Follow-up|1
7727549|NCT00960869|26872304|P2|Overall Study|Withdrawal by Subject|14
7727550|NCT00960869|26872305|P1|Overall Study|Withdrawal by Subject|16
7727551|NCT00960869|26872304|P2|Overall Study|Adverse Event|26
7727552|NCT00960869|26872305|P1|Overall Study|Adverse Event|17
7727553|NCT00960856|26872319|P4|Washout Period of 7 Days|Adverse Event|0
7727554|NCT00960856|26872320|P3|Washout Period of 7 Days|Adverse Event|1
7727555|NCT00960856|26872321|P2|Washout Period of 7 Days|Adverse Event|0
7727556|NCT00960856|26872322|P1|Washout Period of 7 Days|Adverse Event|0
7727557|NCT00960856|26872319|P4|Washout Period of 7 Days|Withdrawal by Subject|0
7727558|NCT00960856|26872320|P3|Washout Period of 7 Days|Withdrawal by Subject|0
7727559|NCT00960856|26872321|P2|Washout Period of 7 Days|Withdrawal by Subject|2
7727560|NCT00960856|26872322|P1|Washout Period of 7 Days|Withdrawal by Subject|0
7727561|NCT00960843|26872342|P2|Overall Study|Repeated needle dislodgment|1
7727562|NCT00960843|26872343|P1|Overall Study|Repeated needle dislodgment|0
7727563|NCT00960843|26872342|P2|Overall Study|Protocol Violation|4
7727564|NCT00960843|26872343|P1|Overall Study|Protocol Violation|0
7727565|NCT00960843|26872342|P2|Overall Study|Lost to Follow-up|0
7727566|NCT00960843|26872343|P1|Overall Study|Lost to Follow-up|2
7727567|NCT00960804|26872356|P3|Overall Study|Study terminated by the sponsor|10
7727568|NCT00960804|26872357|P2|Overall Study|Study terminated by the sponsor|4
7727569|NCT00960804|26872358|P1|Overall Study|Study terminated by the sponsor|5
7727570|NCT00960804|26872356|P3|Overall Study|Withdrawal by Subject|0
7727571|NCT00960804|26872357|P2|Overall Study|Withdrawal by Subject|0
7727572|NCT00960804|26872358|P1|Overall Study|Withdrawal by Subject|1
7727573|NCT00960804|26872356|P3|Overall Study|Adverse Event|0
7727574|NCT00960804|26872357|P2|Overall Study|Adverse Event|0
7727575|NCT00960804|26872358|P1|Overall Study|Adverse Event|1
7727576|NCT00960752|26872422|P3|Overall Study|Progression|1
7727577|NCT00960752|26872423|P2|Overall Study|Progression|0
7727578|NCT00960752|26872424|P1|Overall Study|Progression|0
7727579|NCT00960752|26872422|P3|Overall Study|Adverse Event|1
7727580|NCT00960752|26872423|P2|Overall Study|Adverse Event|0
7727581|NCT00960752|26872424|P1|Overall Study|Adverse Event|0
7727582|NCT00960687|26872435|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7727583|NCT00960687|26872436|P1|Washout Period of 7 Days|Withdrawal by Subject|1
7727584|NCT00960687|26872435|P2|Washout Period of 7 Days|Adverse Event|2
7727585|NCT00960687|26872436|P1|Washout Period of 7 Days|Adverse Event|3
7727586|NCT00960661|26872448|P3|Interventional Phase|Lack of Efficacy|0
7727587|NCT00960661|26872449|P2|Interventional Phase|Lack of Efficacy|2
7727588|NCT00960661|26872450|P1|Interventional Phase|Lack of Efficacy|0
7727589|NCT00960661|26872448|P3|Interventional Phase|sponsor decision|0
7727590|NCT00960661|26872449|P2|Interventional Phase|sponsor decision|1
7727591|NCT00960661|26872450|P1|Interventional Phase|sponsor decision|0
7727592|NCT00960661|26872448|P3|Interventional Phase|Physician Decision|5
7727593|NCT00960661|26872449|P2|Interventional Phase|Physician Decision|3
7727594|NCT00960661|26872450|P1|Interventional Phase|Physician Decision|0
7727595|NCT00960661|26872448|P3|Interventional Phase|Withdrawal by Subject|29
7727596|NCT00960661|26872449|P2|Interventional Phase|Withdrawal by Subject|18
7727597|NCT00960661|26872450|P1|Interventional Phase|Withdrawal by Subject|0
7727598|NCT00960661|26872448|P3|Interventional Phase|Protocol Violation|2
7727599|NCT00960661|26872449|P2|Interventional Phase|Protocol Violation|7
7727600|NCT00960661|26872450|P1|Interventional Phase|Protocol Violation|0
7727601|NCT00960661|26872448|P3|Interventional Phase|entry criteria not met|0
7727602|NCT00960661|26872449|P2|Interventional Phase|entry criteria not met|3
7727603|NCT00960661|26872450|P1|Interventional Phase|entry criteria not met|0
7727604|NCT00960661|26872448|P3|Interventional Phase|Lost to Follow-up|2
7727605|NCT00960661|26872449|P2|Interventional Phase|Lost to Follow-up|0
7727606|NCT00960661|26872450|P1|Interventional Phase|Lost to Follow-up|0
7727607|NCT00960661|26872448|P3|Interventional Phase|Death|0
7727608|NCT00960661|26872449|P2|Interventional Phase|Death|1
7727609|NCT00960661|26872450|P1|Interventional Phase|Death|0
7727610|NCT00960661|26872448|P3|Interventional Phase|Adverse Event|8
7727611|NCT00960661|26872449|P2|Interventional Phase|Adverse Event|17
7727612|NCT00960661|26872450|P1|Interventional Phase|Adverse Event|0
7727613|NCT00960661|26872448|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
7727614|NCT00960661|26872449|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
7727615|NCT00960661|26872450|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
7727616|NCT00960661|26872448|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
7727617|NCT00960661|26872449|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
7727618|NCT00960661|26872450|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
7727619|NCT00960661|26872448|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
7727620|NCT00960661|26872449|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
7727621|NCT00960661|26872450|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
7727622|NCT00960661|26872448|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
7727623|NCT00960661|26872449|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
7727624|NCT00960661|26872450|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
7727625|NCT00960661|26872448|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
7727626|NCT00960661|26872449|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
7727627|NCT00960661|26872450|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
7727628|NCT00960661|26872448|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
7727629|NCT00960661|26872449|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
7727630|NCT00960661|26872450|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
7727631|NCT00960570|26872489|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
7727632|NCT00960570|26872489|P1|1 Day Period Between Dosing|Adverse Event|2
7727633|NCT00960570|26872489|P1|21 Day Washout Period|Withdrawal by Subject|1
7727634|NCT00960570|26872489|P1|21 Day Washout Period|Adverse Event|1
7727635|NCT00960531|26872510|P10|Overall Study|Reason not Specified|1
7727636|NCT00960531|26872511|P9|Overall Study|Reason not Specified|8
7727637|NCT00960531|26872512|P8|Overall Study|Reason not Specified|0
7727638|NCT00960531|26872513|P7|Overall Study|Reason not Specified|16
7727639|NCT00960531|26872514|P6|Overall Study|Reason not Specified|0
7727640|NCT00960531|26872515|P5|Overall Study|Reason not Specified|2
7727641|NCT00960531|26872516|P4|Overall Study|Reason not Specified|1
7727642|NCT00960531|26872517|P3|Overall Study|Reason not Specified|13
7727643|NCT00960531|26872518|P2|Overall Study|Reason not Specified|1
7727644|NCT00960531|26872519|P1|Overall Study|Reason not Specified|2
7727645|NCT00960531|26872510|P10|Overall Study|Adverse Event (AE)|0
7727646|NCT00960531|26872511|P9|Overall Study|Adverse Event (AE)|2
7727647|NCT00960531|26872512|P8|Overall Study|Adverse Event (AE)|0
7727648|NCT00960531|26872513|P7|Overall Study|Adverse Event (AE)|2
7727649|NCT00960531|26872514|P6|Overall Study|Adverse Event (AE)|1
7727650|NCT00960531|26872515|P5|Overall Study|Adverse Event (AE)|0
7727651|NCT00960531|26872516|P4|Overall Study|Adverse Event (AE)|0
7727652|NCT00960531|26872517|P3|Overall Study|Adverse Event (AE)|0
7727653|NCT00960531|26872518|P2|Overall Study|Adverse Event (AE)|0
7727654|NCT00960531|26872519|P1|Overall Study|Adverse Event (AE)|2
7727655|NCT00960531|26872510|P10|Overall Study|Failed to Return|0
7727656|NCT00960531|26872511|P9|Overall Study|Failed to Return|0
7727657|NCT00960531|26872512|P8|Overall Study|Failed to Return|2
7727658|NCT00960531|26872513|P7|Overall Study|Failed to Return|0
7727659|NCT00960531|26872514|P6|Overall Study|Failed to Return|0
7727660|NCT00960531|26872515|P5|Overall Study|Failed to Return|0
7727661|NCT00960531|26872516|P4|Overall Study|Failed to Return|0
7727662|NCT00960531|26872517|P3|Overall Study|Failed to Return|0
7727663|NCT00960531|26872518|P2|Overall Study|Failed to Return|0
7727664|NCT00960531|26872519|P1|Overall Study|Failed to Return|2
7727665|NCT00960531|26872510|P10|Overall Study|Lost to Follow-up|0
7727666|NCT00960531|26872511|P9|Overall Study|Lost to Follow-up|0
7727667|NCT00960531|26872512|P8|Overall Study|Lost to Follow-up|0
7727668|NCT00960531|26872513|P7|Overall Study|Lost to Follow-up|1
7727669|NCT00960531|26872514|P6|Overall Study|Lost to Follow-up|0
7727670|NCT00960531|26872515|P5|Overall Study|Lost to Follow-up|0
7727671|NCT00960531|26872516|P4|Overall Study|Lost to Follow-up|0
7727672|NCT00960531|26872517|P3|Overall Study|Lost to Follow-up|1
7727673|NCT00960531|26872518|P2|Overall Study|Lost to Follow-up|0
7727674|NCT00960531|26872519|P1|Overall Study|Lost to Follow-up|0
7727675|NCT00960531|26872510|P10|Overall Study|Discontinuation of Study by Sponsor|0
7727676|NCT00960531|26872511|P9|Overall Study|Discontinuation of Study by Sponsor|0
7727677|NCT00960531|26872512|P8|Overall Study|Discontinuation of Study by Sponsor|1
7727678|NCT00960531|26872513|P7|Overall Study|Discontinuation of Study by Sponsor|0
7727679|NCT00960531|26872514|P6|Overall Study|Discontinuation of Study by Sponsor|0
7727680|NCT00960531|26872515|P5|Overall Study|Discontinuation of Study by Sponsor|0
7727681|NCT00960531|26872516|P4|Overall Study|Discontinuation of Study by Sponsor|0
7727682|NCT00960531|26872517|P3|Overall Study|Discontinuation of Study by Sponsor|0
7727683|NCT00960531|26872518|P2|Overall Study|Discontinuation of Study by Sponsor|0
7727684|NCT00960531|26872519|P1|Overall Study|Discontinuation of Study by Sponsor|0
7727685|NCT00960531|26872510|P10|Overall Study|Investigator Request|0
7727686|NCT00960531|26872511|P9|Overall Study|Investigator Request|0
7727687|NCT00960531|26872512|P8|Overall Study|Investigator Request|0
7727688|NCT00960531|26872513|P7|Overall Study|Investigator Request|0
7727689|NCT00960531|26872514|P6|Overall Study|Investigator Request|0
7727690|NCT00960531|26872515|P5|Overall Study|Investigator Request|0
7727691|NCT00960531|26872516|P4|Overall Study|Investigator Request|0
7727692|NCT00960531|26872517|P3|Overall Study|Investigator Request|1
7727693|NCT00960531|26872518|P2|Overall Study|Investigator Request|0
7727694|NCT00960531|26872519|P1|Overall Study|Investigator Request|0
7727695|NCT00960531|26872510|P10|Overall Study|Caregiver Request|0
7727696|NCT00960531|26872511|P9|Overall Study|Caregiver Request|3
7727697|NCT00960531|26872512|P8|Overall Study|Caregiver Request|1
7727698|NCT00960531|26872513|P7|Overall Study|Caregiver Request|3
7727699|NCT00960531|26872514|P6|Overall Study|Caregiver Request|2
7727700|NCT00960531|26872515|P5|Overall Study|Caregiver Request|0
7727701|NCT00960531|26872516|P4|Overall Study|Caregiver Request|5
7727702|NCT00960531|26872517|P3|Overall Study|Caregiver Request|6
7727703|NCT00960531|26872518|P2|Overall Study|Caregiver Request|0
7727704|NCT00960531|26872519|P1|Overall Study|Caregiver Request|2
7727705|NCT00960531|26872510|P10|Overall Study|Withdrawal by Subject|0
7727706|NCT00960531|26872511|P9|Overall Study|Withdrawal by Subject|1
7727707|NCT00960531|26872512|P8|Overall Study|Withdrawal by Subject|0
7727708|NCT00960531|26872513|P7|Overall Study|Withdrawal by Subject|2
7727709|NCT00960531|26872514|P6|Overall Study|Withdrawal by Subject|0
7727710|NCT00960531|26872515|P5|Overall Study|Withdrawal by Subject|0
7727711|NCT00960531|26872516|P4|Overall Study|Withdrawal by Subject|2
7727712|NCT00960531|26872517|P3|Overall Study|Withdrawal by Subject|5
7727713|NCT00960531|26872518|P2|Overall Study|Withdrawal by Subject|0
7727714|NCT00960531|26872519|P1|Overall Study|Withdrawal by Subject|1
7727715|NCT00960531|26872510|P10|Overall Study|Lack of Efficacy|0
7727716|NCT00960531|26872511|P9|Overall Study|Lack of Efficacy|0
7727717|NCT00960531|26872512|P8|Overall Study|Lack of Efficacy|0
7727718|NCT00960531|26872513|P7|Overall Study|Lack of Efficacy|0
7727719|NCT00960531|26872514|P6|Overall Study|Lack of Efficacy|0
7727720|NCT00960531|26872515|P5|Overall Study|Lack of Efficacy|0
7727721|NCT00960531|26872516|P4|Overall Study|Lack of Efficacy|0
7727722|NCT00960531|26872517|P3|Overall Study|Lack of Efficacy|0
7727723|NCT00960531|26872518|P2|Overall Study|Lack of Efficacy|0
7727724|NCT00960531|26872519|P1|Overall Study|Lack of Efficacy|1
7727725|NCT00960440|26872601|P4|Overall Study|Other|0
7727726|NCT00960440|26872602|P3|Overall Study|Other|1
7727727|NCT00960440|26872603|P2|Overall Study|Other|1
7727728|NCT00960440|26872604|P1|Overall Study|Other|1
7727729|NCT00960440|26872601|P4|Overall Study|Withdrawal by Subject|1
7727730|NCT00960440|26872602|P3|Overall Study|Withdrawal by Subject|2
7727731|NCT00960440|26872603|P2|Overall Study|Withdrawal by Subject|5
7727732|NCT00960440|26872604|P1|Overall Study|Withdrawal by Subject|9
7727733|NCT00960440|26872601|P4|Overall Study|Protocol Violation|4
7727734|NCT00960440|26872602|P3|Overall Study|Protocol Violation|3
7727735|NCT00960440|26872603|P2|Overall Study|Protocol Violation|8
7727736|NCT00960440|26872604|P1|Overall Study|Protocol Violation|2
7727737|NCT00960440|26872601|P4|Overall Study|Lack of Efficacy|8
7727738|NCT00960440|26872602|P3|Overall Study|Lack of Efficacy|3
7727739|NCT00960440|26872603|P2|Overall Study|Lack of Efficacy|5
7727740|NCT00960440|26872604|P1|Overall Study|Lack of Efficacy|2
7727741|NCT00960440|26872601|P4|Overall Study|Adverse Event|4
7727742|NCT00960440|26872602|P3|Overall Study|Adverse Event|4
7727743|NCT00960440|26872603|P2|Overall Study|Adverse Event|12
7727744|NCT00960440|26872604|P1|Overall Study|Adverse Event|12
7727745|NCT00960440|26872601|P4|Overall Study|Death|1
7727746|NCT00960440|26872602|P3|Overall Study|Death|0
7727747|NCT00960440|26872603|P2|Overall Study|Death|0
7727748|NCT00960440|26872604|P1|Overall Study|Death|0
7727749|NCT00960375|26872776|P2|Overall Study|Lost to Follow-up|22
7727750|NCT00960375|26872777|P1|Overall Study|Lost to Follow-up|20
7727751|NCT00960323|26872785|P1|Atorvastatin Alone|Withdrawal by Subject|1
7727752|NCT00960297|26872796|P1|Overall Study|Disease progression|1
7727753|NCT00960297|26872796|P1|Overall Study|Venous port infection|1
7727754|NCT00960297|26872796|P1|Overall Study|Physician Decision|1
7727755|NCT00960206|26872803|P3|Overall Study|Missing 10 year data|1
7727756|NCT00960206|26872804|P2|Overall Study|Missing 10 year data|1
7727757|NCT00960206|26872805|P1|Overall Study|Missing 10 year data|20
7727758|NCT00960206|26872803|P3|Overall Study|Revision of study component|2
7727759|NCT00960206|26872804|P2|Overall Study|Revision of study component|2
7727760|NCT00960206|26872805|P1|Overall Study|Revision of study component|2
7727761|NCT00960206|26872803|P3|Overall Study|Withdrawal by Subject|0
7727762|NCT00960206|26872804|P2|Overall Study|Withdrawal by Subject|4
7727763|NCT00960206|26872805|P1|Overall Study|Withdrawal by Subject|2
7727764|NCT00960206|26872803|P3|Overall Study|Lost to Follow-up|8
7727765|NCT00960206|26872804|P2|Overall Study|Lost to Follow-up|14
7727766|NCT00960206|26872805|P1|Overall Study|Lost to Follow-up|8
7727767|NCT00960206|26872803|P3|Overall Study|Unwilling/Unable to return|0
7727768|NCT00960206|26872804|P2|Overall Study|Unwilling/Unable to return|2
7727769|NCT00960206|26872805|P1|Overall Study|Unwilling/Unable to return|1
7727770|NCT00960206|26872803|P3|Overall Study|Death|1
7727771|NCT00960206|26872804|P2|Overall Study|Death|4
7727772|NCT00960206|26872805|P1|Overall Study|Death|7
7727773|NCT00960193|26872823|P1|14 Day Washout Period|Withdrawal by Subject|1
7727774|NCT00960154|26872836|P2|Overall Study|Study termination|25
7727775|NCT00960154|26872837|P1|Overall Study|Study termination|25
7727776|NCT00960141|26872848|P3|Overall Study|Withdrawal by Subject|1
7727777|NCT00960141|26872849|P2|Overall Study|Withdrawal by Subject|2
7727778|NCT00960141|26872850|P1|Overall Study|Withdrawal by Subject|1
7727779|NCT00960141|26872848|P3|Overall Study|Protocol Violation|2
7727780|NCT00960141|26872849|P2|Overall Study|Protocol Violation|3
7727781|NCT00960141|26872850|P1|Overall Study|Protocol Violation|1
7727782|NCT00960141|26872848|P3|Overall Study|Lost to Follow-up|0
7727783|NCT00960141|26872849|P2|Overall Study|Lost to Follow-up|0
7727784|NCT00960141|26872850|P1|Overall Study|Lost to Follow-up|1
7727785|NCT00960141|26872848|P3|Overall Study|Lack of Efficacy|2
7727786|NCT00960141|26872849|P2|Overall Study|Lack of Efficacy|4
7727787|NCT00960141|26872850|P1|Overall Study|Lack of Efficacy|3
7727788|NCT00960141|26872848|P3|Overall Study|Adverse Event|2
7727789|NCT00960141|26872849|P2|Overall Study|Adverse Event|8
7727790|NCT00960141|26872850|P1|Overall Study|Adverse Event|4
7727791|NCT00960115|26872875|P2|Overall Study|Ongoing treatment at data cut-off date|15
7727792|NCT00960115|26872876|P1|Overall Study|Ongoing treatment at data cut-off date|19
7727793|NCT00960076|26872890|P2|Overall Study|Did not attend the termination visit|1
7727794|NCT00960076|26872891|P1|Overall Study|Did not attend the termination visit|0
7727795|NCT00960076|26872890|P2|Overall Study|Hyperglycemia|5
7727796|NCT00960076|26872891|P1|Overall Study|Hyperglycemia|1
7727797|NCT00960076|26872890|P2|Overall Study|Severe non-compliance to protocol|2
7727798|NCT00960076|26872891|P1|Overall Study|Severe non-compliance to protocol|1
7727799|NCT00960076|26872890|P2|Overall Study|Lost to Follow-up|3
7727800|NCT00960076|26872891|P1|Overall Study|Lost to Follow-up|3
7727801|NCT00960076|26872890|P2|Overall Study|Withdrawal by Subject|2
7727802|NCT00960076|26872891|P1|Overall Study|Withdrawal by Subject|1
7727803|NCT00960076|26872890|P2|Overall Study|No longer met study criteria|5
7727804|NCT00960076|26872891|P1|Overall Study|No longer met study criteria|1
7727805|NCT00960076|26872890|P2|Overall Study|Adverse Event|7
7727806|NCT00960076|26872891|P1|Overall Study|Adverse Event|1
7727807|NCT00960063|26872906|P3|Overall Study|Progression of Disease|3
7727808|NCT00960063|26872907|P2|Overall Study|Progression of Disease|0
7727809|NCT00960063|26872908|P1|Overall Study|Progression of Disease|0
7727810|NCT00960063|26872906|P3|Overall Study|Adverse Event|0
7727811|NCT00960063|26872907|P2|Overall Study|Adverse Event|0
7727812|NCT00960063|26872908|P1|Overall Study|Adverse Event|1
7727813|NCT00960011|26872948|P2|Overall Study|Lost to Follow-up|2
7727814|NCT00960011|26872949|P1|Overall Study|Lost to Follow-up|6
7727815|NCT00960011|26872948|P2|Overall Study|Death|0
7727816|NCT00960011|26872949|P1|Overall Study|Death|5
7727817|NCT00959946|26873042|P8|Overall Study|Withdrawal by Subject|0
7727818|NCT00959946|26873043|P7|Overall Study|Withdrawal by Subject|0
7727819|NCT00959946|26873044|P6|Overall Study|Withdrawal by Subject|1
7727820|NCT00959946|26873045|P5|Overall Study|Withdrawal by Subject|0
7727821|NCT00959946|26873046|P4|Overall Study|Withdrawal by Subject|0
7727822|NCT00959946|26873047|P3|Overall Study|Withdrawal by Subject|0
7727823|NCT00959946|26873048|P2|Overall Study|Withdrawal by Subject|0
7727824|NCT00959946|26873049|P1|Overall Study|Withdrawal by Subject|0
7727825|NCT00959946|26873042|P8|Overall Study|Disease Progression|2
7727826|NCT00959946|26873043|P7|Overall Study|Disease Progression|2
7727827|NCT00959946|26873044|P6|Overall Study|Disease Progression|6
7727828|NCT00959946|26873045|P5|Overall Study|Disease Progression|4
7727829|NCT00959946|26873046|P4|Overall Study|Disease Progression|4
7727830|NCT00959946|26873047|P3|Overall Study|Disease Progression|2
7727831|NCT00959946|26873048|P2|Overall Study|Disease Progression|4
7727832|NCT00959946|26873049|P1|Overall Study|Disease Progression|2
7727833|NCT00959946|26873042|P8|Overall Study|Death|0
7727834|NCT00959946|26873043|P7|Overall Study|Death|0
7727835|NCT00959946|26873044|P6|Overall Study|Death|1
7727836|NCT00959946|26873045|P5|Overall Study|Death|0
7727837|NCT00959946|26873046|P4|Overall Study|Death|0
7727838|NCT00959946|26873047|P3|Overall Study|Death|0
7727839|NCT00959946|26873048|P2|Overall Study|Death|0
7727840|NCT00959946|26873049|P1|Overall Study|Death|0
7727841|NCT00959946|26873042|P8|Overall Study|Adverse Event|0
7727842|NCT00959946|26873043|P7|Overall Study|Adverse Event|0
7727843|NCT00959946|26873044|P6|Overall Study|Adverse Event|1
7727844|NCT00959946|26873045|P5|Overall Study|Adverse Event|0
7727845|NCT00959946|26873046|P4|Overall Study|Adverse Event|1
7727846|NCT00959946|26873047|P3|Overall Study|Adverse Event|2
7727847|NCT00959946|26873048|P2|Overall Study|Adverse Event|0
7727848|NCT00959946|26873049|P1|Overall Study|Adverse Event|0
7727849|NCT00959907|26873113|P2|Overall Study|Withdrawal by Subject|0
7727850|NCT00959907|26873114|P1|Overall Study|Withdrawal by Subject|2
7727851|NCT00959907|26873113|P2|Overall Study|Adverse Event|0
7727852|NCT00959907|26873114|P1|Overall Study|Adverse Event|1
7727853|NCT00959907|26873113|P2|Overall Study|Protocol Violation|1
7727854|NCT00959907|26873114|P1|Overall Study|Protocol Violation|0
7727855|NCT00959894|26873124|P1|Overall Study|Subject moved out of town|1
7727856|NCT00959894|26873124|P1|Overall Study|Need for contraindicated medication|1
7727857|NCT00959894|26873124|P1|Overall Study|Withdrawal by Subject|1
7727858|NCT00959894|26873124|P1|Overall Study|Adverse Event|3
7727859|NCT00959894|26873124|P1|Overall Study|Lost to Follow-up|10
7727860|NCT00959751|26873173|P2|Overall Study|No migraine headache without aura|7
7727861|NCT00959751|26873174|P1|Overall Study|No migraine headache without aura|7
7727862|NCT00959751|26873173|P2|Overall Study|Non-compliance to Study Procedures|1
7727863|NCT00959751|26873174|P1|Overall Study|Non-compliance to Study Procedures|0
7727864|NCT00959751|26873173|P2|Overall Study|Consent Withdrawn|1
7727865|NCT00959751|26873174|P1|Overall Study|Consent Withdrawn|0
7727866|NCT00959751|26873173|P2|Overall Study|Lost to Follow-up|3
7727867|NCT00959751|26873174|P1|Overall Study|Lost to Follow-up|2
7727868|NCT00959699|26873196|P2|Follow-up Period|Withdrawal by Subject|4
7727869|NCT00959699|26873197|P1|Follow-up Period|Withdrawal by Subject|3
7727870|NCT00959699|26873196|P2|Follow-up Period|Lost to Follow-up|2
7727871|NCT00959699|26873197|P1|Follow-up Period|Lost to Follow-up|3
7727872|NCT00959699|26873196|P2|Treatment Period|Futility/crossover to boceprevir|0
7727873|NCT00959699|26873197|P1|Treatment Period|Futility/crossover to boceprevir|4
7727874|NCT00959699|26873196|P2|Treatment Period|Did not receive treatment|1
7727875|NCT00959699|26873197|P1|Treatment Period|Did not receive treatment|0
7727876|NCT00959699|26873196|P2|Treatment Period|Non-Compliance with Protocol|1
7727877|NCT00959699|26873197|P1|Treatment Period|Non-Compliance with Protocol|0
7727878|NCT00959699|26873196|P2|Treatment Period|Withdrawal by Subject|3
7727879|NCT00959699|26873197|P1|Treatment Period|Withdrawal by Subject|1
7727880|NCT00959699|26873196|P2|Treatment Period|Lost to Follow-up|1
7727881|NCT00959699|26873197|P1|Treatment Period|Lost to Follow-up|0
7727882|NCT00959699|26873196|P2|Treatment Period|Lack of Efficacy|6
7727883|NCT00959699|26873197|P1|Treatment Period|Lack of Efficacy|15
7727884|NCT00959699|26873196|P2|Treatment Period|Adverse Event|13
7727885|NCT00959699|26873197|P1|Treatment Period|Adverse Event|3
7727886|NCT00959647|26873243|P1|Overall Study|Withdrawal by Subject|7
7727887|NCT00959647|26873243|P1|Overall Study|Study terminated by sponsor|4
7727888|NCT00959647|26873243|P1|Overall Study|Progressive disease|6
7727889|NCT00959647|26873243|P1|Overall Study|Adverse Event|2
7727890|NCT00959374|26873248|P1|Overall Study|Physician Decision|1
7727891|NCT00959374|26873248|P1|Overall Study|Implant Removed/Not Replaced|4
7727892|NCT00959374|26873248|P1|Overall Study|Protocol Violation|1
7727893|NCT00959374|26873248|P1|Overall Study|Death|1
7727894|NCT00959374|26873248|P1|Overall Study|Lost to Follow-up|14
7727895|NCT00959374|26873248|P1|Overall Study|Withdrawal by Subject|2
7727896|NCT00959192|26873262|P4|Overall Study|Caregiver Request|1
7727897|NCT00959192|26873263|P3|Overall Study|Caregiver Request|2
7727898|NCT00959192|26873264|P2|Overall Study|Caregiver Request|0
7727899|NCT00959192|26873265|P1|Overall Study|Caregiver Request|0
7727900|NCT00959192|26873262|P4|Overall Study|Investigator Request|0
7727901|NCT00959192|26873263|P3|Overall Study|Investigator Request|0
7727902|NCT00959192|26873264|P2|Overall Study|Investigator Request|0
7727903|NCT00959192|26873265|P1|Overall Study|Investigator Request|1
7727904|NCT00959192|26873262|P4|Overall Study|Adverse Event|0
7727905|NCT00959192|26873263|P3|Overall Study|Adverse Event|1
7727906|NCT00959192|26873264|P2|Overall Study|Adverse Event|1
7727907|NCT00959192|26873265|P1|Overall Study|Adverse Event|1
7727908|NCT00959049|26873324|P6|Overall Study|Withdrawal by Subject|0
7727909|NCT00959049|26873325|P5|Overall Study|Withdrawal by Subject|0
7727910|NCT00959049|26873326|P4|Overall Study|Withdrawal by Subject|0
7727911|NCT00959049|26873327|P3|Overall Study|Withdrawal by Subject|0
7727912|NCT00959049|26873328|P2|Overall Study|Withdrawal by Subject|2
7727913|NCT00959049|26873329|P1|Overall Study|Withdrawal by Subject|0
7727914|NCT00959049|26873324|P6|Overall Study|Contraindicated medication|0
7727915|NCT00959049|26873325|P5|Overall Study|Contraindicated medication|0
7727916|NCT00959049|26873326|P4|Overall Study|Contraindicated medication|1
7727917|NCT00959049|26873327|P3|Overall Study|Contraindicated medication|0
7727918|NCT00959049|26873328|P2|Overall Study|Contraindicated medication|0
7727919|NCT00959049|26873329|P1|Overall Study|Contraindicated medication|0
7727920|NCT00959049|26873324|P6|Overall Study|Lost to Follow-up|1
7727921|NCT00959049|26873325|P5|Overall Study|Lost to Follow-up|9
7727922|NCT00959049|26873326|P4|Overall Study|Lost to Follow-up|10
7727923|NCT00959049|26873327|P3|Overall Study|Lost to Follow-up|1
7727924|NCT00959049|26873328|P2|Overall Study|Lost to Follow-up|5
7727925|NCT00959049|26873329|P1|Overall Study|Lost to Follow-up|17
7727926|NCT00959049|26873324|P6|Overall Study|Adverse Event|0
7727927|NCT00959049|26873325|P5|Overall Study|Adverse Event|0
7727928|NCT00959049|26873326|P4|Overall Study|Adverse Event|0
7727929|NCT00959049|26873327|P3|Overall Study|Adverse Event|0
7727930|NCT00959049|26873328|P2|Overall Study|Adverse Event|0
7727931|NCT00959049|26873329|P1|Overall Study|Adverse Event|1
7727932|NCT00958893|26873394|P1|Overall Study|Study prematurely terminated|4
7727933|NCT00958880|26873400|P2|Overall Study|Lost to Follow-up|2
7727934|NCT00958880|26873401|P1|Overall Study|Lost to Follow-up|2
7727935|NCT00958841|26873409|P1|Overall Study|Discontinued prior to M*|28
7727936|NCT00958841|26873409|P1|Overall Study|Completed M6/did not enter extension|27
7727937|NCT00958841|26873409|P1|Overall Study|Unsatisfactory therapeutic effect|22
7727938|NCT00958841|26873409|P1|Overall Study|Withdrawal by Subject|1
7727939|NCT00958841|26873409|P1|Overall Study|New cancer therapy|5
7727940|NCT00958841|26873409|P1|Overall Study|Adverse Event|8
7727941|NCT00958841|26873409|P1|Overall Study|Administrative problems|1
7727942|NCT00958841|26873409|P1|Overall Study|Abnormal test procedure result(s)|3
7727943|NCT00958841|26873409|P1|Overall Study|Abnormal laboratory value(s)|1
7727944|NCT00958828|26873427|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
7727945|NCT00958828|26873428|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
7727946|NCT00958828|26873427|P2|Period 1, 1 Week of Wear|Randomization break|1
7727947|NCT00958828|26873428|P1|Period 1, 1 Week of Wear|Randomization break|0
7727955|NCT00958776|26873454|P2|Overall Study|Missing|1
7727956|NCT00958776|26873455|P1|Overall Study|Missing|1
7727957|NCT00958776|26873454|P2|Overall Study|Noncompliance; Protocol Deviations|3
7727958|NCT00958776|26873455|P1|Overall Study|Noncompliance; Protocol Deviations|2
7727959|NCT00958776|26873454|P2|Overall Study|Death|1
7727960|NCT00958776|26873455|P1|Overall Study|Death|2
7727961|NCT00958776|26873454|P2|Overall Study|Protocol Violation|1
7727962|NCT00958776|26873455|P1|Overall Study|Protocol Violation|1
7727963|NCT00958776|26873454|P2|Overall Study|Withdrawal by Subject|16
7727964|NCT00958776|26873455|P1|Overall Study|Withdrawal by Subject|7
7727965|NCT00958776|26873454|P2|Overall Study|Lost to Follow-up|6
7727966|NCT00958776|26873455|P1|Overall Study|Lost to Follow-up|2
7727967|NCT00958776|26873454|P2|Overall Study|Physician Decision|0
7727968|NCT00958776|26873455|P1|Overall Study|Physician Decision|1
7727969|NCT00958776|26873454|P2|Overall Study|Adverse Event|1
7727970|NCT00958776|26873455|P1|Overall Study|Adverse Event|0
7727971|NCT00958724|26873485|P1|Overall Study|Disease Progression|6
7727972|NCT00958711|26873497|P2|Overall Study|Adverse Event|2
7727973|NCT00958711|26873498|P1|Overall Study|Adverse Event|1
7727974|NCT00958711|26873497|P2|Overall Study|Death|2
7727975|NCT00958711|26873498|P1|Overall Study|Death|1
7727976|NCT00958711|26873497|P2|Overall Study|Other|5
7727977|NCT00958711|26873498|P1|Overall Study|Other|2
7727978|NCT00958711|26873497|P2|Overall Study|Lost to Follow-up|1
7727979|NCT00958711|26873498|P1|Overall Study|Lost to Follow-up|4
7727980|NCT00958711|26873497|P2|Overall Study|Physician Decision|7
7727981|NCT00958711|26873498|P1|Overall Study|Physician Decision|5
7727982|NCT00958711|26873497|P2|Overall Study|Withdrawal by Subject|4
7727983|NCT00958711|26873498|P1|Overall Study|Withdrawal by Subject|0
7727984|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7727985|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
7727986|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7727987|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7727988|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7727989|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
7727990|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7727991|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7727992|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
7727993|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
7727994|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
7727995|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
7727996|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
7727997|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
7727998|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
7727999|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
7728000|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
7728001|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
7728002|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
7728003|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
7728004|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
7728005|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
7728006|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
7728007|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
7728008|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
7728009|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
7728010|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
7728011|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
7728012|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
7728013|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
7728014|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
7728015|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
7728016|NCT00958568|26873543|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
7728017|NCT00958568|26873544|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
7728018|NCT00958568|26873545|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
7728019|NCT00958568|26873546|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
7728020|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7728021|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7728022|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
7728023|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7728024|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7728025|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7728026|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
7728027|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7728028|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7728029|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7728030|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
7728031|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7728032|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7728033|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7728034|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
7728035|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7728036|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7728037|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7728038|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
7728039|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7728040|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7728041|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7728042|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
7728043|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7728044|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7728045|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7728046|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
7728047|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7728048|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7728049|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7728050|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
7728051|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7728052|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7728053|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7728054|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
7728055|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7728056|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7728057|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7728058|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
7728059|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7728060|NCT00958568|26873543|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7728061|NCT00958568|26873544|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7728062|NCT00958568|26873545|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
7728063|NCT00958568|26873546|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7728064|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7728065|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7728066|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7728067|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
7728068|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7728069|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7728070|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7728071|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
7728072|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7728073|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7728074|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7728075|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
7728076|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7728077|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7728078|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7728079|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
7728080|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7728081|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7728082|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7728083|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
7728084|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7728085|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7728086|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7728087|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
7728088|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7728089|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7728090|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7728091|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
7728092|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7728093|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7728094|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7728095|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
7728096|NCT00958568|26873543|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7728097|NCT00958568|26873544|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7728098|NCT00958568|26873545|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7728099|NCT00958568|26873546|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
7728100|NCT00958438|26873783|P3|Overall Study|Other than specified above|2
7728101|NCT00958438|26873784|P2|Overall Study|Other than specified above|3
7728102|NCT00958438|26873785|P1|Overall Study|Other than specified above|2
7728103|NCT00958438|26873783|P3|Overall Study|Physician Decision|1
7728104|NCT00958438|26873784|P2|Overall Study|Physician Decision|0
7728105|NCT00958438|26873785|P1|Overall Study|Physician Decision|1
7728106|NCT00958438|26873783|P3|Overall Study|Adverse Event|0
7728107|NCT00958438|26873784|P2|Overall Study|Adverse Event|3
7728108|NCT00958438|26873785|P1|Overall Study|Adverse Event|0
7728109|NCT00958438|26873783|P3|Overall Study|Withdrawal by Subject|1
7728110|NCT00958438|26873784|P2|Overall Study|Withdrawal by Subject|2
7728111|NCT00958438|26873785|P1|Overall Study|Withdrawal by Subject|4
7728112|NCT00958438|26873783|P3|Overall Study|Protocol Violation|2
7728113|NCT00958438|26873784|P2|Overall Study|Protocol Violation|2
7728114|NCT00958438|26873785|P1|Overall Study|Protocol Violation|3
7728115|NCT00958412|26873808|P1|Overall Study|Study prematurely terminated|18
7728116|NCT00958360|26873814|P2|Overall Study|Lost to Follow-up|1
7728117|NCT00958360|26873815|P1|Overall Study|Lost to Follow-up|0
7728118|NCT00958360|26873814|P2|Overall Study|Physician Decision|1
7728119|NCT00958360|26873815|P1|Overall Study|Physician Decision|2
7728120|NCT00958360|26873814|P2|Overall Study|Death|7
7728121|NCT00958360|26873815|P1|Overall Study|Death|6
7728122|NCT00958360|26873814|P2|Overall Study|Withdrawal by Subject|1
7728123|NCT00958360|26873815|P1|Overall Study|Withdrawal by Subject|3
7728124|NCT00958347|26873829|P1|Overall Study|study termination|135
7728125|NCT00958347|26873829|P1|Overall Study|revision/removal|10
7728126|NCT00958347|26873829|P1|Overall Study|Lost to Follow-up|15
7728127|NCT00958347|26873829|P1|Overall Study|Withdrawal by Subject|23
7728128|NCT00958347|26873829|P1|Overall Study|Death|43
7728129|NCT00958256|26873873|P1|Overall Study|Adverse Event|3
7728130|NCT00958243|26873883|P6|Overall Study|Lost to Follow-up|5
7728131|NCT00958243|26873884|P5|Overall Study|Lost to Follow-up|8
7728132|NCT00958243|26873885|P4|Overall Study|Lost to Follow-up|2
7728133|NCT00958243|26873886|P3|Overall Study|Lost to Follow-up|11
7728134|NCT00958243|26873887|P2|Overall Study|Lost to Follow-up|5
7728135|NCT00958243|26873888|P1|Overall Study|Lost to Follow-up|2
7728136|NCT00958243|26873883|P6|Overall Study|Withdrawal by Subject|5
7728137|NCT00958243|26873884|P5|Overall Study|Withdrawal by Subject|1
7728138|NCT00958243|26873885|P4|Overall Study|Withdrawal by Subject|1
7728139|NCT00958243|26873886|P3|Overall Study|Withdrawal by Subject|3
7728140|NCT00958243|26873887|P2|Overall Study|Withdrawal by Subject|1
7728141|NCT00958243|26873888|P1|Overall Study|Withdrawal by Subject|0
7728142|NCT00958217|26873946|P2|Overall Study|Inpatient hospitalization|1
7728143|NCT00958217|26873947|P1|Overall Study|Inpatient hospitalization|0
7728144|NCT00958217|26873946|P2|Overall Study|Moved out of area|1
7728145|NCT00958217|26873947|P1|Overall Study|Moved out of area|1
7728146|NCT00958217|26873946|P2|Overall Study|Lost to Follow-up|19
7728147|NCT00958217|26873947|P1|Overall Study|Lost to Follow-up|17
7728148|NCT00958217|26873946|P2|Overall Study|Withdrawal by Subject|3
7728149|NCT00958217|26873947|P1|Overall Study|Withdrawal by Subject|4
7728150|NCT00958217|26873946|P2|Overall Study|Death|1
7728151|NCT00958217|26873947|P1|Overall Study|Death|2
7728152|NCT00958191|26873958|P1|Overall Study|No 5 yr x-rays|56
7728153|NCT00958191|26873958|P1|Overall Study|Site termination|11
7728154|NCT00958191|26873958|P1|Overall Study|Revision of study device|4
7728155|NCT00958191|26873958|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
7728156|NCT00958191|26873958|P1|Overall Study|Inadequate 5 yr x-ray quality|10
7728157|NCT00958191|26873958|P1|Overall Study|Lost to Follow-up|5
7728158|NCT00958191|26873958|P1|Overall Study|Death|4
7728159|NCT00958165|26873973|P1|Overall Study|Not eligible|9
7728160|NCT00958165|26873973|P1|Overall Study|Lost to Follow-up|5
7728161|NCT00958126|26873985|P8|Overall Study|Other Reason|0
7728162|NCT00958126|26873986|P7|Overall Study|Other Reason|0
7728163|NCT00958126|26873987|P6|Overall Study|Other Reason|1
7728164|NCT00958126|26873988|P5|Overall Study|Other Reason|0
7728165|NCT00958126|26873989|P4|Overall Study|Other Reason|1
7728166|NCT00958126|26873990|P3|Overall Study|Other Reason|0
7728167|NCT00958126|26873991|P2|Overall Study|Other Reason|0
7728168|NCT00958126|26873992|P1|Overall Study|Other Reason|0
7728169|NCT00958126|26873985|P8|Overall Study|Sponsor/Investigator decision|0
7728170|NCT00958126|26873986|P7|Overall Study|Sponsor/Investigator decision|0
7728171|NCT00958126|26873987|P6|Overall Study|Sponsor/Investigator decision|0
7728172|NCT00958126|26873988|P5|Overall Study|Sponsor/Investigator decision|0
7728173|NCT00958126|26873989|P4|Overall Study|Sponsor/Investigator decision|1
7728174|NCT00958126|26873990|P3|Overall Study|Sponsor/Investigator decision|0
7728175|NCT00958126|26873991|P2|Overall Study|Sponsor/Investigator decision|0
7728176|NCT00958126|26873992|P1|Overall Study|Sponsor/Investigator decision|0
7728177|NCT00958126|26873985|P8|Overall Study|Lost to Follow-up|0
7728178|NCT00958126|26873986|P7|Overall Study|Lost to Follow-up|0
7728179|NCT00958126|26873987|P6|Overall Study|Lost to Follow-up|0
7728180|NCT00958126|26873988|P5|Overall Study|Lost to Follow-up|0
7728181|NCT00958126|26873989|P4|Overall Study|Lost to Follow-up|8
7728182|NCT00958126|26873990|P3|Overall Study|Lost to Follow-up|9
7728183|NCT00958126|26873991|P2|Overall Study|Lost to Follow-up|5
7728184|NCT00958126|26873992|P1|Overall Study|Lost to Follow-up|1
7728185|NCT00958126|26873985|P8|Overall Study|Moved away from study area|0
7728186|NCT00958126|26873986|P7|Overall Study|Moved away from study area|0
7728187|NCT00958126|26873987|P6|Overall Study|Moved away from study area|0
7728188|NCT00958126|26873988|P5|Overall Study|Moved away from study area|0
7728189|NCT00958126|26873989|P4|Overall Study|Moved away from study area|1
7728190|NCT00958126|26873990|P3|Overall Study|Moved away from study area|1
7728191|NCT00958126|26873991|P2|Overall Study|Moved away from study area|0
7728192|NCT00958126|26873992|P1|Overall Study|Moved away from study area|0
7728193|NCT00958126|26873985|P8|Overall Study|Withdrawal by Subject|0
7728194|NCT00958126|26873986|P7|Overall Study|Withdrawal by Subject|0
7728195|NCT00958126|26873987|P6|Overall Study|Withdrawal by Subject|0
7728196|NCT00958126|26873988|P5|Overall Study|Withdrawal by Subject|0
7728197|NCT00958126|26873989|P4|Overall Study|Withdrawal by Subject|0
7728198|NCT00958126|26873990|P3|Overall Study|Withdrawal by Subject|0
7728199|NCT00958126|26873991|P2|Overall Study|Withdrawal by Subject|2
7728200|NCT00958126|26873992|P1|Overall Study|Withdrawal by Subject|0
7728201|NCT00958126|26873985|P8|Overall Study|Serious Adverse Event|0
7728202|NCT00958126|26873986|P7|Overall Study|Serious Adverse Event|1
7728203|NCT00958126|26873987|P6|Overall Study|Serious Adverse Event|0
7728204|NCT00958126|26873988|P5|Overall Study|Serious Adverse Event|0
7728205|NCT00958126|26873989|P4|Overall Study|Serious Adverse Event|0
7728206|NCT00958126|26873990|P3|Overall Study|Serious Adverse Event|0
7728207|NCT00958126|26873991|P2|Overall Study|Serious Adverse Event|2
7728208|NCT00958126|26873992|P1|Overall Study|Serious Adverse Event|0
7728209|NCT00958074|26874064|P2|Overall Study|Withdrawal by Subject|1
7728210|NCT00958074|26874065|P1|Overall Study|Withdrawal by Subject|0
7728211|NCT00958009|26874088|P1|Overall Study|Subject found device difficult to use|1
7728212|NCT00958009|26874088|P1|Overall Study|Adverse Event|1
7728213|NCT00957996|26874095|P2|Overall Study|Noncompliance; Protocol Deviations|6
7728214|NCT00957996|26874096|P1|Overall Study|Noncompliance; Protocol Deviations|5
7728215|NCT00957996|26874095|P2|Overall Study|Missing|0
7728216|NCT00957996|26874096|P1|Overall Study|Missing|1
7728217|NCT00957996|26874095|P2|Overall Study|Influenza-related complication|1
7728218|NCT00957996|26874096|P1|Overall Study|Influenza-related complication|0
7728219|NCT00957996|26874095|P2|Overall Study|Physician Decision|1
7728220|NCT00957996|26874096|P1|Overall Study|Physician Decision|1
7728221|NCT00957996|26874095|P2|Overall Study|Adverse Event|1
7728222|NCT00957996|26874096|P1|Overall Study|Adverse Event|2
7728223|NCT00957996|26874095|P2|Overall Study|Withdrawal by Subject|2
7728224|NCT00957996|26874096|P1|Overall Study|Withdrawal by Subject|9
7728225|NCT00957996|26874095|P2|Overall Study|Lost to Follow-up|7
7728226|NCT00957996|26874096|P1|Overall Study|Lost to Follow-up|4
7728227|NCT00957996|26874095|P2|Overall Study|Death|10
7728228|NCT00957996|26874096|P1|Overall Study|Death|4
7728229|NCT00957944|26874128|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
7728230|NCT00957944|26874129|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
7728231|NCT00957931|26874163|P1|Overall Study|Death|4
7728232|NCT00957905|26874173|P2|Part B|Protocol Violation|1
7728233|NCT00957905|26874174|P1|Part B|Protocol Violation|0
7728234|NCT00957905|26874173|P2|Part B|Death|1
7728235|NCT00957905|26874174|P1|Part B|Death|0
7728236|NCT00957905|26874173|P2|Part B|Physician Decision|1
7728237|NCT00957905|26874174|P1|Part B|Physician Decision|0
7728238|NCT00957905|26874173|P2|Part B|Not Treated|1
7728239|NCT00957905|26874174|P1|Part B|Not Treated|0
7728240|NCT00957853|26874183|P3|Overall Study|Withdrawal by Subject|0
7728241|NCT00957853|26874184|P2|Overall Study|Withdrawal by Subject|0
7728242|NCT00957853|26874185|P1|Overall Study|Withdrawal by Subject|1
7728243|NCT00957801|26874209|P4|Overall Study|Withdrawal by Subject|1
7728244|NCT00957801|26874210|P3|Overall Study|Withdrawal by Subject|0
7728245|NCT00957801|26874211|P2|Overall Study|Withdrawal by Subject|0
7728246|NCT00957801|26874212|P1|Overall Study|Withdrawal by Subject|0
7728247|NCT00957723|26874378|P1|Overall Study|2yr ROM Data Not Evaluable|12
7728248|NCT00957723|26874378|P1|Overall Study|Intercurrent Illness|2
7728249|NCT00957723|26874378|P1|Overall Study|Investigative Site Terminated|61
7728250|NCT00957723|26874378|P1|Overall Study|Withdrawal by Subject|24
7728251|NCT00957723|26874378|P1|Overall Study|Lost to Follow-up|8
7728252|NCT00957723|26874378|P1|Overall Study|Revision/ Removal of Study Implant|3
7728253|NCT00957723|26874378|P1|Overall Study|Death|3
7728254|NCT00957658|26874467|P1|Overall Study|Protocol Violation|5
7728255|NCT00957658|26874467|P1|Overall Study|surgery cancelled|2
7728256|NCT00957658|26874467|P1|Overall Study|unwilling/unable to return|2
7728257|NCT00957658|26874467|P1|Overall Study|Site termination|10
7728258|NCT00957658|26874467|P1|Overall Study|Incomplete 2 yr data|28
7728259|NCT00957658|26874467|P1|Overall Study|Revision|1
7728260|NCT00957658|26874467|P1|Overall Study|Withdrawal by Subject|12
7728261|NCT00957658|26874467|P1|Overall Study|Lost to Follow-up|4
7728262|NCT00957658|26874467|P1|Overall Study|Death|1
7728263|NCT00957580|26874494|P3|Overall Study|Enrolled but not treated|0
7728264|NCT00957580|26874495|P2|Overall Study|Enrolled but not treated|1
7728265|NCT00957580|26874496|P1|Overall Study|Enrolled but not treated|0
7728266|NCT00957580|26874494|P3|Overall Study|Ongoing at data cut-off|0
7728267|NCT00957580|26874495|P2|Overall Study|Ongoing at data cut-off|1
7728268|NCT00957580|26874496|P1|Overall Study|Ongoing at data cut-off|0
7728269|NCT00957528|26874643|P3|Overall Study|Withdrawal by Subject|1
7728270|NCT00957528|26874644|P2|Overall Study|Withdrawal by Subject|0
7728271|NCT00957528|26874645|P1|Overall Study|Withdrawal by Subject|0
7728272|NCT00957528|26874643|P3|Overall Study|Protocol Violation|0
7728273|NCT00957528|26874644|P2|Overall Study|Protocol Violation|1
7728274|NCT00957528|26874645|P1|Overall Study|Protocol Violation|0
7728275|NCT00957424|26874668|P1|Overall Study|Withdrawal by Subject|1
7728276|NCT00957424|26874668|P1|Overall Study|Protocol Violation|3
7728277|NCT00957424|26874668|P1|Overall Study|Lost to Follow-up|19
7728278|NCT00957372|26874678|P4|PART II|Patient non-compliance|4
7728279|NCT00957372|26874679|P3|PART II|Patient non-compliance|0
7728280|NCT00957372|26874680|P2|PART II|Patient non-compliance|0
7728281|NCT00957372|26874681|P1|PART II|Patient non-compliance|0
7728282|NCT00957372|26874678|P4|PART II|Adverse Event|10
7728283|NCT00957372|26874679|P3|PART II|Adverse Event|0
7728284|NCT00957372|26874680|P2|PART II|Adverse Event|0
7728285|NCT00957372|26874681|P1|PART II|Adverse Event|0
7728286|NCT00957372|26874678|P4|PART II|Not Know|20
7728287|NCT00957372|26874679|P3|PART II|Not Know|0
7728288|NCT00957372|26874680|P2|PART II|Not Know|0
7728289|NCT00957372|26874681|P1|PART II|Not Know|0
7728290|NCT00957372|26874678|P4|PART II|Pregnancy|1
7728291|NCT00957372|26874679|P3|PART II|Pregnancy|0
7728292|NCT00957372|26874680|P2|PART II|Pregnancy|0
7728293|NCT00957372|26874681|P1|PART II|Pregnancy|0
7728294|NCT00957372|26874678|P4|PART II|Physician Decision|1
7728295|NCT00957372|26874679|P3|PART II|Physician Decision|0
7728296|NCT00957372|26874680|P2|PART II|Physician Decision|0
7728297|NCT00957372|26874681|P1|PART II|Physician Decision|0
7728298|NCT00957372|26874678|P4|PART II|Withdrawal by Subject|8
7728299|NCT00957372|26874679|P3|PART II|Withdrawal by Subject|0
7728300|NCT00957372|26874680|P2|PART II|Withdrawal by Subject|0
7728301|NCT00957372|26874681|P1|PART II|Withdrawal by Subject|0
7728302|NCT00957372|26874678|P4|PART I|Lost to Follow-up|0
7728303|NCT00957372|26874679|P3|PART I|Lost to Follow-up|1
7728304|NCT00957372|26874680|P2|PART I|Lost to Follow-up|0
7728305|NCT00957372|26874681|P1|PART I|Lost to Follow-up|0
7728306|NCT00957268|26874821|P5|Overall Study|Voluntary Withdrawal|0
7728307|NCT00957268|26874822|P4|Overall Study|Voluntary Withdrawal|0
7728308|NCT00957268|26874823|P3|Overall Study|Voluntary Withdrawal|1
7728309|NCT00957268|26874824|P2|Overall Study|Voluntary Withdrawal|0
7728310|NCT00957268|26874825|P1|Overall Study|Voluntary Withdrawal|0
7728311|NCT00957229|26874920|P2|Reallocated to or Continued Vismodegib|Adverse Event|1
7728312|NCT00957229|26874921|P1|Reallocated to or Continued Vismodegib|Adverse Event|2
7728313|NCT00957229|26874920|P2|Reallocated to or Continued Vismodegib|Death|1
7728314|NCT00957229|26874921|P1|Reallocated to or Continued Vismodegib|Death|1
7728315|NCT00957229|26874920|P2|Study Start|Disease Progression|0
7728316|NCT00957229|26874921|P1|Study Start|Disease Progression|1
7728317|NCT00957229|26874920|P2|Study Start|Adverse Event|3
7728318|NCT00957229|26874921|P1|Study Start|Adverse Event|0
7728319|NCT00957034|26874960|P3|Overall Study|Withdrawal by Subject|0
7728320|NCT00957034|26874961|P2|Overall Study|Withdrawal by Subject|2
7728321|NCT00957034|26874962|P1|Overall Study|Withdrawal by Subject|0
7728322|NCT00957034|26874960|P3|Overall Study|Sponsor Terminated Study|5
7728323|NCT00957034|26874961|P2|Overall Study|Sponsor Terminated Study|1
7728324|NCT00957034|26874962|P1|Overall Study|Sponsor Terminated Study|6
7728325|NCT00957034|26874960|P3|Overall Study|Adverse Event|1
7728326|NCT00957034|26874961|P2|Overall Study|Adverse Event|1
7728327|NCT00957034|26874962|P1|Overall Study|Adverse Event|0
7728328|NCT00957021|26874985|P1|Overall Study|Termination due to language issue|2
7728329|NCT00957021|26874985|P1|Overall Study|Surgery Cancelled|9
7728330|NCT00957021|26874985|P1|Overall Study|Site Termination by the 2 yr visit|16
7728331|NCT00957021|26874985|P1|Overall Study|Revised study component by 2 yr visit|8
7728332|NCT00957021|26874985|P1|Overall Study|No 2 yr ROM data|35
7728333|NCT00957021|26874985|P1|Overall Study|Withdrawal by Subject|34
7728334|NCT00957021|26874985|P1|Overall Study|Lost to Follow-up|8
7728335|NCT00957021|26874985|P1|Overall Study|Death|5
7728336|NCT00957008|26874998|P4|Overall Study|Relocated; Family conflict|3
7728337|NCT00957008|26874999|P3|Overall Study|Relocated; Family conflict|1
7728338|NCT00957008|26875000|P2|Overall Study|Relocated; Family conflict|1
7728339|NCT00957008|26875001|P1|Overall Study|Relocated; Family conflict|4
7728340|NCT00957008|26874998|P4|Overall Study|Physician Decision|1
7728341|NCT00957008|26874999|P3|Overall Study|Physician Decision|1
7728342|NCT00957008|26875000|P2|Overall Study|Physician Decision|0
7728343|NCT00957008|26875001|P1|Overall Study|Physician Decision|1
7728344|NCT00957008|26874998|P4|Overall Study|Lost to Follow-up|4
7728345|NCT00957008|26874999|P3|Overall Study|Lost to Follow-up|3
7728346|NCT00957008|26875000|P2|Overall Study|Lost to Follow-up|1
7728347|NCT00957008|26875001|P1|Overall Study|Lost to Follow-up|3
7728348|NCT00957008|26874998|P4|Overall Study|Withdrawal by Subject|16
7728349|NCT00957008|26874999|P3|Overall Study|Withdrawal by Subject|12
7728350|NCT00957008|26875000|P2|Overall Study|Withdrawal by Subject|10
7728351|NCT00957008|26875001|P1|Overall Study|Withdrawal by Subject|13
7728352|NCT00956943|26875029|P2|Overall Study|Lost to Follow-up|10
7728353|NCT00956943|26875030|P1|Overall Study|Lost to Follow-up|9
7728354|NCT00956839|26875054|P3|Overall Study|Lost to Follow-up|3
7728355|NCT00956839|26875055|P2|Overall Study|Lost to Follow-up|0
7728356|NCT00956839|26875056|P1|Overall Study|Lost to Follow-up|3
7728357|NCT00956813|26875069|P2|Flaxseed and Placebo|Ineligible|1
7728358|NCT00956813|26875070|P1|Flaxseed and Placebo|Ineligible|3
7728359|NCT00956813|26875069|P2|Flaxseed and Placebo|Withdrawal by Subject|4
7728360|NCT00956813|26875070|P1|Flaxseed and Placebo|Withdrawal by Subject|5
7728361|NCT00956592|26875122|P2|Overall Study|Protocol Violation|3
7728362|NCT00956592|26875123|P1|Overall Study|Protocol Violation|1
7728363|NCT00956293|26875158|P3|Follow-up Period|Follow-up period was terminated.|0
7728364|NCT00956293|26875159|P2|Follow-up Period|Follow-up period was terminated.|32
7728365|NCT00956293|26875160|P1|Follow-up Period|Follow-up period was terminated.|20
7728366|NCT00956293|26875158|P3|Main Period (Randomization)|Adverse Event|0
7728367|NCT00956293|26875159|P2|Main Period (Randomization)|Adverse Event|15
7728368|NCT00956293|26875160|P1|Main Period (Randomization)|Adverse Event|0
7728369|NCT00956293|26875158|P3|Main Period (Randomization)|Lack of Efficacy|0
7728370|NCT00956293|26875159|P2|Main Period (Randomization)|Lack of Efficacy|10
7728371|NCT00956293|26875160|P1|Main Period (Randomization)|Lack of Efficacy|1
7728372|NCT00956293|26875158|P3|Main Period (Randomization)|Abnormal laboratory value|0
7728373|NCT00956293|26875159|P2|Main Period (Randomization)|Abnormal laboratory value|2
7728374|NCT00956293|26875160|P1|Main Period (Randomization)|Abnormal laboratory value|0
7728375|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
7728376|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
7728377|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
7728378|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Adverse Event|36
7728379|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Adverse Event|0
7728380|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Adverse Event|0
7728381|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
7728382|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
7728383|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
7728384|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
7728385|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
7728386|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
7728387|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Graft loss|7
7728388|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Graft loss|0
7728389|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Graft loss|0
7728390|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Administrative problems|6
7728391|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Administrative problems|0
7728392|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Administrative problems|0
7728393|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
7728394|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
7728395|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
7728396|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Protocol Violation|1
7728397|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Protocol Violation|0
7728398|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Protocol Violation|0
7728399|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Death|1
7728400|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Death|0
7728401|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Death|0
7728402|NCT00956293|26875158|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
7728403|NCT00956293|26875159|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
7728404|NCT00956293|26875160|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
7728405|NCT00955968|26875215|P2|Overall Study|Site closed|52
7728406|NCT00955968|26875216|P1|Overall Study|Site closed|55
7728407|NCT00955968|26875215|P2|Overall Study|Lost to Follow-up|39
7728408|NCT00955968|26875216|P1|Overall Study|Lost to Follow-up|45
7728409|NCT00955968|26875215|P2|Overall Study|Withdrawal by Subject|31
7728410|NCT00955968|26875216|P1|Overall Study|Withdrawal by Subject|35
7728411|NCT00955968|26875215|P2|Overall Study|Death|4
7728412|NCT00955968|26875216|P1|Overall Study|Death|2
7728413|NCT00955955|26875258|P3|Overall Study|Lost to Follow-up|0
7728414|NCT00955955|26875259|P2|Overall Study|Lost to Follow-up|0
7728415|NCT00955955|26875260|P1|Overall Study|Lost to Follow-up|2
7728416|NCT00955825|26875344|P2|Overall Study|Any other reason not above-mentioned|9
7728417|NCT00955825|26875345|P1|Overall Study|Any other reason not above-mentioned|7
7728418|NCT00955825|26875344|P2|Overall Study|Withdrawal by Subject|6
7728419|NCT00955825|26875345|P1|Overall Study|Withdrawal by Subject|4
7728420|NCT00955825|26875344|P2|Overall Study|Adverse Event|2
7728421|NCT00955825|26875345|P1|Overall Study|Adverse Event|15
7728422|NCT00955721|26875362|P2|Overall Study|Withdrawal by Subject|0
7728423|NCT00955721|26875363|P1|Overall Study|Withdrawal by Subject|1
7728424|NCT00955721|26875362|P2|Overall Study|Death|0
7728425|NCT00955721|26875363|P1|Overall Study|Death|1
7728426|NCT00955721|26875362|P2|Overall Study|Physician Decision|0
7728427|NCT00955721|26875363|P1|Overall Study|Physician Decision|1
7728428|NCT00955708|26875373|P1|Overall Study|Patient changed care provider/moved|91
7728429|NCT00955708|26875373|P1|Overall Study|Closure of study location|60
7728430|NCT00955708|26875373|P1|Overall Study|Patient Refused to participate further|116
7728431|NCT00955708|26875373|P1|Overall Study|Product removed from service|94
7728432|NCT00955708|26875373|P1|Overall Study|Registry Conclusion|186
7728433|NCT00955708|26875373|P1|Overall Study|Protocol Violation|134
7728434|NCT00955708|26875373|P1|Overall Study|Physician Decision|36
7728435|NCT00955708|26875373|P1|Overall Study|Lost to Follow-up|72
7728436|NCT00955708|26875373|P1|Overall Study|Death|269
7728437|NCT00955682|26875379|P2|Booster Period (Month 48- 49)|Lost to Follow-up|1
7728438|NCT00955682|26875380|P1|Booster Period (Month 48- 49)|Lost to Follow-up|1
7728439|NCT00955617|26875486|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
7728440|NCT00955617|26875487|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
7728441|NCT00955617|26875486|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
7728442|NCT00955617|26875487|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
7728443|NCT00955617|26875486|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
7728444|NCT00955617|26875487|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
7728445|NCT00955617|26875486|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
7728446|NCT00955617|26875487|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
7728447|NCT00955474|26875551|P2|Overall Study|Physician Decision|5
7728448|NCT00955474|26875552|P1|Overall Study|Physician Decision|7
7728449|NCT00955409|26875596|P10|Overall Study|Reason not Specified|1
7728450|NCT00955409|26875597|P9|Overall Study|Reason not Specified|8
7728451|NCT00955409|26875598|P8|Overall Study|Reason not Specified|0
7728452|NCT00955409|26875599|P7|Overall Study|Reason not Specified|16
7728453|NCT00955409|26875600|P6|Overall Study|Reason not Specified|0
7728454|NCT00955409|26875601|P5|Overall Study|Reason not Specified|2
7728455|NCT00955409|26875602|P4|Overall Study|Reason not Specified|1
7728456|NCT00955409|26875603|P3|Overall Study|Reason not Specified|13
7728457|NCT00955409|26875604|P2|Overall Study|Reason not Specified|1
7728458|NCT00955409|26875605|P1|Overall Study|Reason not Specified|2
7728459|NCT00955409|26875596|P10|Overall Study|Adverse Event (AE)|0
7728460|NCT00955409|26875597|P9|Overall Study|Adverse Event (AE)|2
7728461|NCT00955409|26875598|P8|Overall Study|Adverse Event (AE)|0
7728462|NCT00955409|26875599|P7|Overall Study|Adverse Event (AE)|2
7728463|NCT00955409|26875600|P6|Overall Study|Adverse Event (AE)|1
7728464|NCT00955409|26875601|P5|Overall Study|Adverse Event (AE)|0
7728465|NCT00955409|26875602|P4|Overall Study|Adverse Event (AE)|0
7728466|NCT00955409|26875603|P3|Overall Study|Adverse Event (AE)|0
7728467|NCT00955409|26875604|P2|Overall Study|Adverse Event (AE)|0
7728468|NCT00955409|26875605|P1|Overall Study|Adverse Event (AE)|2
7728469|NCT00955409|26875596|P10|Overall Study|Failed to Return|0
7728470|NCT00955409|26875597|P9|Overall Study|Failed to Return|0
7728471|NCT00955409|26875598|P8|Overall Study|Failed to Return|2
7728472|NCT00955409|26875599|P7|Overall Study|Failed to Return|0
7728473|NCT00955409|26875600|P6|Overall Study|Failed to Return|0
7728474|NCT00955409|26875601|P5|Overall Study|Failed to Return|0
7728475|NCT00955409|26875602|P4|Overall Study|Failed to Return|0
7728476|NCT00955409|26875603|P3|Overall Study|Failed to Return|0
7728477|NCT00955409|26875604|P2|Overall Study|Failed to Return|0
7728478|NCT00955409|26875605|P1|Overall Study|Failed to Return|2
7728479|NCT00955409|26875596|P10|Overall Study|Lost to Follow-up|0
7728480|NCT00955409|26875597|P9|Overall Study|Lost to Follow-up|0
7728481|NCT00955409|26875598|P8|Overall Study|Lost to Follow-up|0
7728482|NCT00955409|26875599|P7|Overall Study|Lost to Follow-up|1
7728483|NCT00955409|26875600|P6|Overall Study|Lost to Follow-up|0
7728484|NCT00955409|26875601|P5|Overall Study|Lost to Follow-up|0
7728485|NCT00955409|26875602|P4|Overall Study|Lost to Follow-up|0
7728486|NCT00955409|26875603|P3|Overall Study|Lost to Follow-up|1
7728487|NCT00955409|26875604|P2|Overall Study|Lost to Follow-up|0
7728488|NCT00955409|26875605|P1|Overall Study|Lost to Follow-up|0
7728489|NCT00955409|26875596|P10|Overall Study|Discontinuation of Study by Sponsor|0
7728490|NCT00955409|26875597|P9|Overall Study|Discontinuation of Study by Sponsor|0
7728491|NCT00955409|26875598|P8|Overall Study|Discontinuation of Study by Sponsor|1
7728492|NCT00955409|26875599|P7|Overall Study|Discontinuation of Study by Sponsor|0
7728493|NCT00955409|26875600|P6|Overall Study|Discontinuation of Study by Sponsor|0
7728494|NCT00955409|26875601|P5|Overall Study|Discontinuation of Study by Sponsor|0
7728495|NCT00955409|26875602|P4|Overall Study|Discontinuation of Study by Sponsor|0
7728496|NCT00955409|26875603|P3|Overall Study|Discontinuation of Study by Sponsor|0
7728497|NCT00955409|26875604|P2|Overall Study|Discontinuation of Study by Sponsor|0
7728498|NCT00955409|26875605|P1|Overall Study|Discontinuation of Study by Sponsor|0
7728499|NCT00955409|26875596|P10|Overall Study|Investigator Request|0
7728500|NCT00955409|26875597|P9|Overall Study|Investigator Request|0
7728501|NCT00955409|26875598|P8|Overall Study|Investigator Request|0
7728502|NCT00955409|26875599|P7|Overall Study|Investigator Request|0
7728503|NCT00955409|26875600|P6|Overall Study|Investigator Request|0
7728504|NCT00955409|26875601|P5|Overall Study|Investigator Request|0
7728505|NCT00955409|26875602|P4|Overall Study|Investigator Request|0
7728506|NCT00955409|26875603|P3|Overall Study|Investigator Request|1
7728507|NCT00955409|26875604|P2|Overall Study|Investigator Request|0
7728508|NCT00955409|26875605|P1|Overall Study|Investigator Request|0
7728509|NCT00955409|26875596|P10|Overall Study|Caregiver Request|0
7728510|NCT00955409|26875597|P9|Overall Study|Caregiver Request|3
7728511|NCT00955409|26875598|P8|Overall Study|Caregiver Request|1
7728512|NCT00955409|26875599|P7|Overall Study|Caregiver Request|3
7728513|NCT00955409|26875600|P6|Overall Study|Caregiver Request|2
7728514|NCT00955409|26875601|P5|Overall Study|Caregiver Request|0
7728515|NCT00955409|26875602|P4|Overall Study|Caregiver Request|5
7728516|NCT00955409|26875603|P3|Overall Study|Caregiver Request|6
7728517|NCT00955409|26875604|P2|Overall Study|Caregiver Request|0
7728518|NCT00955409|26875605|P1|Overall Study|Caregiver Request|2
7728519|NCT00955409|26875596|P10|Overall Study|Withdrawal by Subject|0
7728520|NCT00955409|26875597|P9|Overall Study|Withdrawal by Subject|1
7728521|NCT00955409|26875598|P8|Overall Study|Withdrawal by Subject|0
7728522|NCT00955409|26875599|P7|Overall Study|Withdrawal by Subject|2
7728523|NCT00955409|26875600|P6|Overall Study|Withdrawal by Subject|0
7728524|NCT00955409|26875601|P5|Overall Study|Withdrawal by Subject|0
7728525|NCT00955409|26875602|P4|Overall Study|Withdrawal by Subject|2
7728526|NCT00955409|26875603|P3|Overall Study|Withdrawal by Subject|5
7728527|NCT00955409|26875604|P2|Overall Study|Withdrawal by Subject|0
7728528|NCT00955409|26875605|P1|Overall Study|Withdrawal by Subject|1
7728529|NCT00955409|26875596|P10|Overall Study|Lack of Efficacy|0
7728530|NCT00955409|26875597|P9|Overall Study|Lack of Efficacy|0
7728531|NCT00955409|26875598|P8|Overall Study|Lack of Efficacy|0
7728532|NCT00955409|26875599|P7|Overall Study|Lack of Efficacy|0
7728533|NCT00955409|26875600|P6|Overall Study|Lack of Efficacy|0
7728534|NCT00955409|26875601|P5|Overall Study|Lack of Efficacy|0
7728535|NCT00955409|26875602|P4|Overall Study|Lack of Efficacy|0
7728536|NCT00955409|26875603|P3|Overall Study|Lack of Efficacy|0
7728537|NCT00955409|26875604|P2|Overall Study|Lack of Efficacy|0
7728538|NCT00955409|26875605|P1|Overall Study|Lack of Efficacy|1
7728539|NCT00955357|26875651|P2|Maintenance Phase|Non compliance to study procedures|0
7728540|NCT00955357|26875652|P1|Maintenance Phase|Non compliance to study procedures|1
7728541|NCT00955357|26875651|P2|Maintenance Phase|Patient moving out of area|1
7728542|NCT00955357|26875652|P1|Maintenance Phase|Patient moving out of area|0
7728543|NCT00955357|26875651|P2|Maintenance Phase|Withdrawal by Subject|4
7728544|NCT00955357|26875652|P1|Maintenance Phase|Withdrawal by Subject|4
7728545|NCT00955357|26875651|P2|Maintenance Phase|Lost to Follow-up|7
7728546|NCT00955357|26875652|P1|Maintenance Phase|Lost to Follow-up|2
7728547|NCT00955357|26875651|P2|Maintenance Phase|Protocol Violation|6
7728548|NCT00955357|26875652|P1|Maintenance Phase|Protocol Violation|2
7728549|NCT00955357|26875651|P2|Maintenance Phase|Lack of Efficacy|4
7728550|NCT00955357|26875652|P1|Maintenance Phase|Lack of Efficacy|0
7728551|NCT00955357|26875651|P2|Maintenance Phase|Adverse Event|23
7728552|NCT00955357|26875652|P1|Maintenance Phase|Adverse Event|3
7728553|NCT00955357|26875651|P2|Titration Phase|Non compliance to study procedures|1
7728554|NCT00955357|26875652|P1|Titration Phase|Non compliance to study procedures|0
7728555|NCT00955357|26875651|P2|Titration Phase|Study medication not tolerated|1
7728556|NCT00955357|26875652|P1|Titration Phase|Study medication not tolerated|0
7728557|NCT00955357|26875651|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
7728558|NCT00955357|26875652|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
7728559|NCT00955357|26875651|P2|Titration Phase|Withdrawal by Subject|5
7728560|NCT00955357|26875652|P1|Titration Phase|Withdrawal by Subject|3
7728561|NCT00955357|26875651|P2|Titration Phase|Lost to Follow-up|3
7728562|NCT00955357|26875652|P1|Titration Phase|Lost to Follow-up|1
7728563|NCT00955357|26875651|P2|Titration Phase|Protocol Violation|7
7728564|NCT00955357|26875652|P1|Titration Phase|Protocol Violation|3
7728565|NCT00955357|26875651|P2|Titration Phase|Lack of Efficacy|2
7728566|NCT00955357|26875652|P1|Titration Phase|Lack of Efficacy|0
7728567|NCT00955357|26875651|P2|Titration Phase|Adverse Event|46
7728568|NCT00955357|26875652|P1|Titration Phase|Adverse Event|9
7728569|NCT00955305|26875660|P2|Overall Study|Ineligible|7
7728570|NCT00955305|26875661|P1|Overall Study|Ineligible|5
7728571|NCT00955305|26875660|P2|Overall Study|Never started protocol treatment|5
7728572|NCT00955305|26875661|P1|Overall Study|Never started protocol treatment|5
7728573|NCT00955305|26875660|P2|Overall Study|No off-treatment reason submitted|0
7728574|NCT00955305|26875661|P1|Overall Study|No off-treatment reason submitted|1
7728575|NCT00955305|26875660|P2|Overall Study|Lost to Follow-up|1
7728576|NCT00955305|26875661|P1|Overall Study|Lost to Follow-up|0
7728577|NCT00955305|26875660|P2|Overall Study|Maximum response achieved|1
7728578|NCT00955305|26875661|P1|Overall Study|Maximum response achieved|0
7728579|NCT00955305|26875660|P2|Overall Study|Functional decline|0
7728580|NCT00955305|26875661|P1|Overall Study|Functional decline|2
7728581|NCT00955305|26875660|P2|Overall Study|Continued presence of residual disease|1
7728582|NCT00955305|26875661|P1|Overall Study|Continued presence of residual disease|0
7728583|NCT00955305|26875660|P2|Overall Study|Physician Decision|0
7728584|NCT00955305|26875661|P1|Overall Study|Physician Decision|1
7728585|NCT00955305|26875660|P2|Overall Study|Other complicating disease|4
7728586|NCT00955305|26875661|P1|Overall Study|Other complicating disease|2
7728587|NCT00955305|26875660|P2|Overall Study|Alternative therapy|0
7728588|NCT00955305|26875661|P1|Overall Study|Alternative therapy|4
7728589|NCT00955305|26875660|P2|Overall Study|Withdrawal by Subject|4
7728590|NCT00955305|26875661|P1|Overall Study|Withdrawal by Subject|5
7728591|NCT00955305|26875660|P2|Overall Study|Death|1
7728592|NCT00955305|26875661|P1|Overall Study|Death|2
7728593|NCT00955305|26875660|P2|Overall Study|Adverse Event|22
7728594|NCT00955305|26875661|P1|Overall Study|Adverse Event|22
7728595|NCT00955305|26875660|P2|Overall Study|Disease progression|41
7728596|NCT00955305|26875661|P1|Overall Study|Disease progression|39
7728597|NCT00955279|26875674|P3|Overall Study|Withdrawal by Subject|3
7728598|NCT00955279|26875675|P2|Overall Study|Withdrawal by Subject|0
7728599|NCT00955279|26875676|P1|Overall Study|Withdrawal by Subject|2
7728600|NCT00955279|26875674|P3|Overall Study|Lost to Follow-up|1
7728601|NCT00955279|26875675|P2|Overall Study|Lost to Follow-up|3
7728602|NCT00955279|26875676|P1|Overall Study|Lost to Follow-up|0
7728603|NCT00955279|26875674|P3|Overall Study|Death|1
7728604|NCT00955279|26875675|P2|Overall Study|Death|1
7728605|NCT00955279|26875676|P1|Overall Study|Death|1
7728606|NCT00955279|26875674|P3|Overall Study|Other|3
7728607|NCT00955279|26875675|P2|Overall Study|Other|0
7728608|NCT00955279|26875676|P1|Overall Study|Other|0
7728609|NCT00955110|26875884|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
7728610|NCT00955110|26875884|P1|Treatment Phase|Non-compliance with study restrictions|1
7728611|NCT00955110|26875884|P1|Treatment Phase|Administrative reasons|2
7728612|NCT00955110|26875884|P1|Treatment Phase|Adverse Event|2
7728613|NCT00955110|26875884|P1|Qualification Phase|Did not meet eligibility criteria|24
7728614|NCT00954941|26875931|P2|Overall Study|Adverse Event|1
7728615|NCT00954941|26875932|P1|Overall Study|Adverse Event|0
7728616|NCT00954941|26875931|P2|Overall Study|Ineligible|2
7728617|NCT00954941|26875932|P1|Overall Study|Ineligible|2
7728618|NCT00954941|26875931|P2|Overall Study|Physician Decision|2
7728619|NCT00954941|26875932|P1|Overall Study|Physician Decision|2
7728620|NCT00954941|26875931|P2|Overall Study|Insurance Denial|2
7728621|NCT00954941|26875932|P1|Overall Study|Insurance Denial|2
7728622|NCT00954941|26875931|P2|Overall Study|Withdrawal by Subject|0
7728623|NCT00954941|26875932|P1|Overall Study|Withdrawal by Subject|1
7728624|NCT00954941|26875931|P2|Overall Study|Received treatment at home|0
7728625|NCT00954941|26875932|P1|Overall Study|Received treatment at home|1
7728626|NCT00954733|26875948|P1|Overall Study|blood gas machine did not work|1
7728627|NCT00954707|26875952|P1|Overall Study|Lost to Follow-up|33
7728628|NCT00954707|26875952|P1|Overall Study|Withdrawal by Subject|100
7728629|NCT00954707|26875952|P1|Overall Study|Death|34
7728630|NCT00954538|26875974|P6|Part III|Withdrawal by Subject|0
7728631|NCT00954538|26875975|P5|Part III|Withdrawal by Subject|1
7728632|NCT00954538|26875976|P4|Part III|Withdrawal by Subject|0
7728633|NCT00954538|26875977|P3|Part III|Withdrawal by Subject|0
7728634|NCT00954538|26875978|P2|Part III|Withdrawal by Subject|0
7728635|NCT00954538|26875979|P1|Part III|Withdrawal by Subject|0
7728636|NCT00954512|26875996|P6|Overall Study|Progression of Disease|1
7728637|NCT00954512|26875997|P5|Overall Study|Progression of Disease|1
7728638|NCT00954512|26875998|P4|Overall Study|Progression of Disease|1
7728639|NCT00954512|26875999|P3|Overall Study|Progression of Disease|0
7728640|NCT00954512|26876000|P2|Overall Study|Progression of Disease|1
7728641|NCT00954512|26876001|P1|Overall Study|Progression of Disease|2
7728642|NCT00954512|26875996|P6|Overall Study|Symptomatic Deterioration|0
7728643|NCT00954512|26875997|P5|Overall Study|Symptomatic Deterioration|2
7728644|NCT00954512|26875998|P4|Overall Study|Symptomatic Deterioration|0
7728645|NCT00954512|26875999|P3|Overall Study|Symptomatic Deterioration|0
7728646|NCT00954512|26876000|P2|Overall Study|Symptomatic Deterioration|1
7728647|NCT00954512|26876001|P1|Overall Study|Symptomatic Deterioration|0
7728648|NCT00954512|26875996|P6|Overall Study|Physician Decision|0
7728649|NCT00954512|26875997|P5|Overall Study|Physician Decision|0
7728650|NCT00954512|26875998|P4|Overall Study|Physician Decision|1
7728651|NCT00954512|26875999|P3|Overall Study|Physician Decision|0
7728652|NCT00954512|26876000|P2|Overall Study|Physician Decision|1
7728653|NCT00954512|26876001|P1|Overall Study|Physician Decision|0
7728654|NCT00954512|26875996|P6|Overall Study|Adverse Event|2
7728655|NCT00954512|26875997|P5|Overall Study|Adverse Event|1
7728656|NCT00954512|26875998|P4|Overall Study|Adverse Event|0
7728657|NCT00954512|26875999|P3|Overall Study|Adverse Event|0
7728658|NCT00954512|26876000|P2|Overall Study|Adverse Event|0
7728659|NCT00954512|26876001|P1|Overall Study|Adverse Event|0
7728660|NCT00954512|26875996|P6|Overall Study|Withdrawal by Subject|1
7728661|NCT00954512|26875997|P5|Overall Study|Withdrawal by Subject|0
7728662|NCT00954512|26875998|P4|Overall Study|Withdrawal by Subject|0
7728663|NCT00954512|26875999|P3|Overall Study|Withdrawal by Subject|0
7728664|NCT00954512|26876000|P2|Overall Study|Withdrawal by Subject|0
7728665|NCT00954512|26876001|P1|Overall Study|Withdrawal by Subject|0
7728666|NCT00954447|26876022|P2|Overall Study|Other|18
7728667|NCT00954447|26876023|P1|Overall Study|Other|21
7728668|NCT00954447|26876022|P2|Overall Study|Withdrawal by Subject|21
7728669|NCT00954447|26876023|P1|Overall Study|Withdrawal by Subject|26
7728670|NCT00954447|26876022|P2|Overall Study|Lost to Follow-up|14
7728671|NCT00954447|26876023|P1|Overall Study|Lost to Follow-up|8
7728672|NCT00954447|26876022|P2|Overall Study|Protocol Violation|7
7728673|NCT00954447|26876023|P1|Overall Study|Protocol Violation|5
7728674|NCT00954447|26876022|P2|Overall Study|Lack of Efficacy|3
7728675|NCT00954447|26876023|P1|Overall Study|Lack of Efficacy|17
7728676|NCT00954447|26876022|P2|Overall Study|Adverse Event|25
7728677|NCT00954447|26876023|P1|Overall Study|Adverse Event|33
7728678|NCT00954421|26876059|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
7728679|NCT00954421|26876059|P1|6 Months of DBS|Withdrawal by Subject|1
7728680|NCT00954421|26876059|P1|Screening|screen failures|3
7728681|NCT00954174|26876109|P4|Overall Study|Never Treated|3
7728682|NCT00954174|26876110|P3|Overall Study|Never Treated|0
7728683|NCT00954174|26876111|P2|Overall Study|Never Treated|17
7728684|NCT00954174|26876112|P1|Overall Study|Never Treated|4
7728685|NCT00954174|26876109|P4|Overall Study|Ineligible|4
7728686|NCT00954174|26876110|P3|Overall Study|Ineligible|7
7728687|NCT00954174|26876111|P2|Overall Study|Ineligible|47
7728688|NCT00954174|26876112|P1|Overall Study|Ineligible|40
7728689|NCT00954174|26876109|P4|Overall Study|Medical Reason|0
7728690|NCT00954174|26876110|P3|Overall Study|Medical Reason|1
7728691|NCT00954174|26876111|P2|Overall Study|Medical Reason|2
7728692|NCT00954174|26876112|P1|Overall Study|Medical Reason|4
7728693|NCT00954174|26876109|P4|Overall Study|Withdrawal by Subject|3
7728694|NCT00954174|26876110|P3|Overall Study|Withdrawal by Subject|4
7728695|NCT00954174|26876111|P2|Overall Study|Withdrawal by Subject|10
7728696|NCT00954174|26876112|P1|Overall Study|Withdrawal by Subject|14
7728697|NCT00954174|26876109|P4|Overall Study|Lack of Efficacy|6
7728698|NCT00954174|26876110|P3|Overall Study|Lack of Efficacy|8
7728699|NCT00954174|26876111|P2|Overall Study|Lack of Efficacy|22
7728700|NCT00954174|26876112|P1|Overall Study|Lack of Efficacy|32
7728701|NCT00954174|26876109|P4|Overall Study|Death|0
7728702|NCT00954174|26876110|P3|Overall Study|Death|0
7728703|NCT00954174|26876111|P2|Overall Study|Death|2
7728704|NCT00954174|26876112|P1|Overall Study|Death|4
7728705|NCT00954174|26876109|P4|Overall Study|Adverse Event|9
7728706|NCT00954174|26876110|P3|Overall Study|Adverse Event|4
7728707|NCT00954174|26876111|P2|Overall Study|Adverse Event|23
7728708|NCT00954174|26876112|P1|Overall Study|Adverse Event|28
7728709|NCT00954122|26876132|P1|Overall Study|Safety Reason|1
7728710|NCT00954122|26876132|P1|Overall Study|Adverse Event|1
7728711|NCT00954122|26876132|P1|Overall Study|Withdrawal by Subject|5
7728712|NCT00953927|26876149|P2|Overall Study|Other study discontinuation|1
7728713|NCT00953927|26876150|P1|Overall Study|Other study discontinuation|1
7728714|NCT00953927|26876149|P2|Overall Study|Death|4
7728715|NCT00953927|26876150|P1|Overall Study|Death|7
7728716|NCT00953927|26876149|P2|Overall Study|Withdrawal by Subject|25
7728717|NCT00953927|26876150|P1|Overall Study|Withdrawal by Subject|36
7728718|NCT00953927|26876149|P2|Overall Study|Lost to Follow-up|65
7728719|NCT00953927|26876150|P1|Overall Study|Lost to Follow-up|61
7728720|NCT00953745|26876205|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
7728721|NCT00953745|26876206|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
7728722|NCT00953745|26876205|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
7728723|NCT00953745|26876206|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
7728724|NCT00953745|26876205|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
7728725|NCT00953745|26876206|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
7728726|NCT00953745|26876205|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
7728727|NCT00953745|26876206|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
7728728|NCT00953745|26876205|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
7728729|NCT00953745|26876206|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
7728730|NCT00953745|26876205|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
7728731|NCT00953745|26876206|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
7728732|NCT00953706|26876239|P4|Part B (96-Week Open-Label Extension)|Other|2
7728733|NCT00953706|26876240|P3|Part B (96-Week Open-Label Extension)|Other|0
7728734|NCT00953706|26876241|P2|Part B (96-Week Open-Label Extension)|Other|0
7728735|NCT00953706|26876242|P1|Part B (96-Week Open-Label Extension)|Other|0
7728736|NCT00953706|26876239|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
7728737|NCT00953706|26876240|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
7728738|NCT00953706|26876241|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7728739|NCT00953706|26876242|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7728740|NCT00953706|26876239|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
7728741|NCT00953706|26876240|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
7728742|NCT00953706|26876241|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
7728743|NCT00953706|26876242|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
7728744|NCT00953706|26876239|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
7728745|NCT00953706|26876240|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7728746|NCT00953706|26876241|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7728747|NCT00953706|26876242|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7728748|NCT00953706|26876239|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
7728749|NCT00953706|26876240|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7728750|NCT00953706|26876241|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7728751|NCT00953706|26876242|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7728752|NCT00953706|26876239|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
7728753|NCT00953706|26876240|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
7728754|NCT00953706|26876241|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
7728755|NCT00953706|26876242|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
7728756|NCT00953706|26876239|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7728757|NCT00953706|26876240|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7728758|NCT00953706|26876241|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
7728759|NCT00953706|26876242|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7728760|NCT00953706|26876239|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7728761|NCT00953706|26876240|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7728762|NCT00953706|26876241|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
7728763|NCT00953706|26876242|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7728764|NCT00953706|26876239|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7728765|NCT00953706|26876240|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7728766|NCT00953706|26876241|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
7728767|NCT00953706|26876242|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7728768|NCT00953706|26876239|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7728769|NCT00953706|26876240|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7728770|NCT00953706|26876241|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
7728771|NCT00953706|26876242|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7728772|NCT00953706|26876239|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
7728773|NCT00953706|26876240|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
7728774|NCT00953706|26876241|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
7728775|NCT00953706|26876242|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
7728776|NCT00953680|26876274|P2|Period 1|Withdrawal by Subject|1
7728777|NCT00953680|26876275|P1|Period 1|Withdrawal by Subject|0
7728778|NCT00953667|26876287|P1|Overall Study|poor venous access,unable to draw blood|4
7728779|NCT00953667|26876287|P1|Overall Study|Adverse Event|10
7728780|NCT00953667|26876287|P1|Overall Study|Withdrawal by Subject|63
7728781|NCT00953667|26876287|P1|Overall Study|Physician Decision|35
7728782|NCT00953667|26876287|P1|Overall Study|Lost to Follow-up|11
7728783|NCT00953615|26876308|P1|Overall Study|Adverse Event|1
7728784|NCT00953576|26876317|P2|Overall Study|Ineligible after Consent|0
7728785|NCT00953576|26876318|P1|Overall Study|Ineligible after Consent|2
7728786|NCT00953576|26876317|P2|Overall Study|Adverse Event|1
7728787|NCT00953576|26876318|P1|Overall Study|Adverse Event|0
7728788|NCT00953524|26876333|P4|Overall Study|Withdrawal by Subject|0
7728789|NCT00953524|26876334|P3|Overall Study|Withdrawal by Subject|1
7728790|NCT00953524|26876335|P2|Overall Study|Withdrawal by Subject|4
7728791|NCT00953524|26876336|P1|Overall Study|Withdrawal by Subject|2
7728792|NCT00953524|26876333|P4|Overall Study|Lost to Follow-up|0
7728793|NCT00953524|26876334|P3|Overall Study|Lost to Follow-up|1
7728794|NCT00953524|26876335|P2|Overall Study|Lost to Follow-up|1
7728795|NCT00953524|26876336|P1|Overall Study|Lost to Follow-up|0
7728796|NCT00953524|26876333|P4|Overall Study|Protocol Violation|6
7728797|NCT00953524|26876334|P3|Overall Study|Protocol Violation|11
7728798|NCT00953524|26876335|P2|Overall Study|Protocol Violation|10
7728799|NCT00953524|26876336|P1|Overall Study|Protocol Violation|18
7728800|NCT00953524|26876333|P4|Overall Study|Adverse Event|2
7728801|NCT00953524|26876334|P3|Overall Study|Adverse Event|1
7728802|NCT00953524|26876335|P2|Overall Study|Adverse Event|0
7728803|NCT00953524|26876336|P1|Overall Study|Adverse Event|2
7728804|NCT00953407|26876379|P5|Overall Study|Lost to Follow-up|0
7728805|NCT00953407|26876380|P4|Overall Study|Lost to Follow-up|1
7728806|NCT00953407|26876381|P3|Overall Study|Lost to Follow-up|0
7728807|NCT00953407|26876382|P2|Overall Study|Lost to Follow-up|0
7728808|NCT00953407|26876383|P1|Overall Study|Lost to Follow-up|0
7728809|NCT00953407|26876379|P5|Overall Study|Failed inclusion criteria|1
7728810|NCT00953407|26876380|P4|Overall Study|Failed inclusion criteria|1
7728811|NCT00953407|26876381|P3|Overall Study|Failed inclusion criteria|1
7728812|NCT00953407|26876382|P2|Overall Study|Failed inclusion criteria|1
7728813|NCT00953407|26876383|P1|Overall Study|Failed inclusion criteria|1
7728814|NCT00953329|26876395|P1|Overall Study|Lack of Efficacy|1
7728815|NCT00953225|26876408|P2|Overall Study|Withdrawal by Subject|0
7728816|NCT00953225|26876409|P1|Overall Study|Withdrawal by Subject|2
7728817|NCT00953160|26876493|P1|Overall Study|Withdrawal by Subject|4
7728818|NCT00953160|26876493|P1|Overall Study|Lost to Follow-up|23
7728819|NCT00953147|26876502|P3|Overall Study|Other|13
7728820|NCT00953147|26876503|P2|Overall Study|Other|11
7728821|NCT00953147|26876504|P1|Overall Study|Other|4
7728822|NCT00953147|26876502|P3|Overall Study|Physician Decision|3
7728823|NCT00953147|26876503|P2|Overall Study|Physician Decision|7
7728824|NCT00953147|26876504|P1|Overall Study|Physician Decision|2
7728825|NCT00953147|26876502|P3|Overall Study|Lost to Follow-up|4
7728826|NCT00953147|26876503|P2|Overall Study|Lost to Follow-up|9
7728827|NCT00953147|26876504|P1|Overall Study|Lost to Follow-up|8
7728828|NCT00953147|26876502|P3|Overall Study|Withdrawal by Subject|12
7728829|NCT00953147|26876503|P2|Overall Study|Withdrawal by Subject|15
7728830|NCT00953147|26876504|P1|Overall Study|Withdrawal by Subject|13
7728831|NCT00953147|26876502|P3|Overall Study|Protocol Violation|4
7728832|NCT00953147|26876503|P2|Overall Study|Protocol Violation|8
7728833|NCT00953147|26876504|P1|Overall Study|Protocol Violation|2
7728834|NCT00953147|26876502|P3|Overall Study|Adverse Event|6
7728835|NCT00953147|26876503|P2|Overall Study|Adverse Event|16
7728836|NCT00953147|26876504|P1|Overall Study|Adverse Event|8
7728837|NCT00953056|26876582|P6|Overall Study|Serious Adverse Event|1
7728838|NCT00953056|26876583|P5|Overall Study|Serious Adverse Event|0
7728839|NCT00953056|26876584|P4|Overall Study|Serious Adverse Event|0
7728840|NCT00953056|26876585|P3|Overall Study|Serious Adverse Event|0
7728841|NCT00953056|26876586|P2|Overall Study|Serious Adverse Event|0
7728842|NCT00953056|26876587|P1|Overall Study|Serious Adverse Event|0
7728843|NCT00953056|26876582|P6|Overall Study|Withdrew Consent|3
7728844|NCT00953056|26876583|P5|Overall Study|Withdrew Consent|2
7728845|NCT00953056|26876584|P4|Overall Study|Withdrew Consent|0
7728846|NCT00953056|26876585|P3|Overall Study|Withdrew Consent|0
7728847|NCT00953056|26876586|P2|Overall Study|Withdrew Consent|0
7728848|NCT00953056|26876587|P1|Overall Study|Withdrew Consent|0
7728849|NCT00953043|26876611|P2|Overall Study|Physician Decision|2
7728850|NCT00953043|26876612|P1|Overall Study|Physician Decision|0
7728851|NCT00953043|26876611|P2|Overall Study|Withdrawal by Subject|0
7728852|NCT00953043|26876612|P1|Overall Study|Withdrawal by Subject|4
7728853|NCT00953017|26876636|P4|Overall Study|Brown stool prior to procedure|0
7728854|NCT00953017|26876637|P3|Overall Study|Brown stool prior to procedure|1
7728855|NCT00953017|26876638|P2|Overall Study|Brown stool prior to procedure|0
7728856|NCT00953017|26876639|P1|Overall Study|Brown stool prior to procedure|0
7728857|NCT00953017|26876636|P4|Overall Study|Procedure incomplete due to pain/looping|1
7728858|NCT00953017|26876637|P3|Overall Study|Procedure incomplete due to pain/looping|0
7728859|NCT00953017|26876638|P2|Overall Study|Procedure incomplete due to pain/looping|1
7728860|NCT00953017|26876639|P1|Overall Study|Procedure incomplete due to pain/looping|0
7728861|NCT00953017|26876636|P4|Overall Study|Incomplete data|0
7728862|NCT00953017|26876637|P3|Overall Study|Incomplete data|0
7728863|NCT00953017|26876638|P2|Overall Study|Incomplete data|1
7728864|NCT00953017|26876639|P1|Overall Study|Incomplete data|1
7728865|NCT00953017|26876636|P4|Overall Study|DId not show up for colonoscopy|4
7728866|NCT00953017|26876637|P3|Overall Study|DId not show up for colonoscopy|5
7728867|NCT00953017|26876638|P2|Overall Study|DId not show up for colonoscopy|4
7728868|NCT00953017|26876639|P1|Overall Study|DId not show up for colonoscopy|4
7728869|NCT00952848|26876661|P1|Overall Study|Withdrawal by Subject|4
7728870|NCT00952822|26876668|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7728871|NCT00952822|26876669|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
7728872|NCT00952822|26876670|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7728873|NCT00952822|26876671|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7728874|NCT00952822|26876668|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7728875|NCT00952822|26876669|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7728876|NCT00952822|26876670|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
7728877|NCT00952822|26876671|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7728878|NCT00952731|26876703|P2|Overall Study|Drug supply expired|0
7728879|NCT00952731|26876704|P1|Overall Study|Drug supply expired|1
7728880|NCT00952705|26876736|P3|Overall Study|Exclusion criteria not met pre dose|0
7728881|NCT00952705|26876737|P2|Overall Study|Exclusion criteria not met pre dose|1
7728882|NCT00952705|26876738|P1|Overall Study|Exclusion criteria not met pre dose|0
7728883|NCT00952705|26876736|P3|Overall Study|Incarcerated post dose|0
7728884|NCT00952705|26876737|P2|Overall Study|Incarcerated post dose|0
7728885|NCT00952705|26876738|P1|Overall Study|Incarcerated post dose|5
7728886|NCT00952705|26876736|P3|Overall Study|Death|0
7728887|NCT00952705|26876737|P2|Overall Study|Death|0
7728888|NCT00952705|26876738|P1|Overall Study|Death|2
7728889|NCT00952705|26876736|P3|Overall Study|Withdrawal by Subject|1
7728890|NCT00952705|26876737|P2|Overall Study|Withdrawal by Subject|1
7728891|NCT00952705|26876738|P1|Overall Study|Withdrawal by Subject|2
7728892|NCT00952705|26876736|P3|Overall Study|Lost to Follow-up|9
7728893|NCT00952705|26876737|P2|Overall Study|Lost to Follow-up|8
7728894|NCT00952705|26876738|P1|Overall Study|Lost to Follow-up|24
7728895|NCT00952614|26876825|P1|Overall Study|other reason|1
7728896|NCT00952614|26876825|P1|Overall Study|Lost to Follow-up|3
7728897|NCT00952614|26876825|P1|Overall Study|Death|3
7728898|NCT00952588|26876832|P2|Overall Study|Lack of Efficacy|2
7728899|NCT00952588|26876833|P1|Overall Study|Lack of Efficacy|2
7728900|NCT00952588|26876832|P2|Overall Study|Physician Decision|1
7728901|NCT00952588|26876833|P1|Overall Study|Physician Decision|0
7728902|NCT00952588|26876832|P2|Overall Study|Lost to Follow-up|0
7728903|NCT00952588|26876833|P1|Overall Study|Lost to Follow-up|2
7728904|NCT00952588|26876832|P2|Overall Study|Adverse Event|3
7728905|NCT00952588|26876833|P1|Overall Study|Adverse Event|2
7728906|NCT00952588|26876832|P2|Overall Study|Withdrawal by Subject|5
7728907|NCT00952588|26876833|P1|Overall Study|Withdrawal by Subject|2
7728908|NCT00952588|26876832|P2|Overall Study|Death|13
7728909|NCT00952588|26876833|P1|Overall Study|Death|28
7728910|NCT00952523|26876851|P1|Overall Study|Withdrawal by Subject|7
7728911|NCT00952484|26876860|P3|Overall Study|Withdrawal by Subject|0
7728912|NCT00952484|26876861|P2|Overall Study|Withdrawal by Subject|1
7728913|NCT00952484|26876862|P1|Overall Study|Withdrawal by Subject|0
7728914|NCT00952419|26876889|P3|Overall Study|Withdrawal by Subject|0
7728915|NCT00952419|26876890|P2|Overall Study|Withdrawal by Subject|3
7728916|NCT00952419|26876891|P1|Overall Study|Withdrawal by Subject|1
7728917|NCT00952419|26876889|P3|Overall Study|Protocol Violation|0
7728918|NCT00952419|26876890|P2|Overall Study|Protocol Violation|7
7728919|NCT00952419|26876891|P1|Overall Study|Protocol Violation|3
7728920|NCT00952419|26876889|P3|Overall Study|Adverse Event|0
7728921|NCT00952419|26876890|P2|Overall Study|Adverse Event|0
7728922|NCT00952419|26876891|P1|Overall Study|Adverse Event|2
7728923|NCT00952380|26876932|P5|Overall Study|Non-compliant to protocol|0
7728924|NCT00952380|26876933|P4|Overall Study|Non-compliant to protocol|1
7728925|NCT00952380|26876934|P3|Overall Study|Non-compliant to protocol|0
7728926|NCT00952380|26876935|P2|Overall Study|Non-compliant to protocol|0
7728927|NCT00952380|26876936|P1|Overall Study|Non-compliant to protocol|0
7728928|NCT00952380|26876932|P5|Overall Study|Physician Decision|0
7728929|NCT00952380|26876933|P4|Overall Study|Physician Decision|2
7728930|NCT00952380|26876934|P3|Overall Study|Physician Decision|1
7728931|NCT00952380|26876935|P2|Overall Study|Physician Decision|0
7728932|NCT00952380|26876936|P1|Overall Study|Physician Decision|0
7728933|NCT00952380|26876932|P5|Overall Study|Adverse Event|3
7728934|NCT00952380|26876933|P4|Overall Study|Adverse Event|0
7728935|NCT00952380|26876934|P3|Overall Study|Adverse Event|0
7728936|NCT00952380|26876935|P2|Overall Study|Adverse Event|1
7728937|NCT00952380|26876936|P1|Overall Study|Adverse Event|0
7728938|NCT00952380|26876932|P5|Overall Study|Withdrawal by Subject|2
7728939|NCT00952380|26876933|P4|Overall Study|Withdrawal by Subject|0
7728940|NCT00952380|26876934|P3|Overall Study|Withdrawal by Subject|1
7728941|NCT00952380|26876935|P2|Overall Study|Withdrawal by Subject|0
7728942|NCT00952380|26876936|P1|Overall Study|Withdrawal by Subject|0
7728943|NCT00952380|26876932|P5|Overall Study|Other|1
7728944|NCT00952380|26876933|P4|Overall Study|Other|0
7728945|NCT00952380|26876934|P3|Overall Study|Other|0
7728946|NCT00952380|26876935|P2|Overall Study|Other|0
7728947|NCT00952380|26876936|P1|Overall Study|Other|0
7728948|NCT00952367|26877037|P1|Overall Study|Protocol Violation|3
7728949|NCT00952367|26877037|P1|Overall Study|Noncoordination|1
7728950|NCT00952367|26877037|P1|Overall Study|Withdrawal by Subject|2
7728951|NCT00952341|26877052|P2|Cycle 2|Progressive Disease|1
7728952|NCT00952341|26877053|P1|Cycle 2|Progressive Disease|0
7728953|NCT00952341|26877052|P2|Cycle 2|Physician Decision|1
7728954|NCT00952341|26877053|P1|Cycle 2|Physician Decision|1
7728955|NCT00952341|26877052|P2|Cycle 2|Lost to Follow-up|9
7728956|NCT00952341|26877053|P1|Cycle 2|Lost to Follow-up|6
7728957|NCT00952341|26877052|P2|Cycle 2|Protocol Violation|0
7728958|NCT00952341|26877053|P1|Cycle 2|Protocol Violation|1
7728959|NCT00952341|26877052|P2|Cycle 2|Withdrawal by Subject|1
7728960|NCT00952341|26877053|P1|Cycle 2|Withdrawal by Subject|1
7728961|NCT00952341|26877052|P2|Cycle 1|Physician Decision|1
7728962|NCT00952341|26877053|P1|Cycle 1|Physician Decision|0
7728963|NCT00952341|26877052|P2|Cycle 1|Lost to Follow-up|2
7728964|NCT00952341|26877053|P1|Cycle 1|Lost to Follow-up|11
7728965|NCT00952341|26877052|P2|Cycle 1|Protocol Violation|1
7728966|NCT00952341|26877053|P1|Cycle 1|Protocol Violation|2
7728967|NCT00952341|26877052|P2|Cycle 1|Withdrawal by Subject|8
7728968|NCT00952341|26877053|P1|Cycle 1|Withdrawal by Subject|3
7728969|NCT00952341|26877052|P2|Cycle 1|Adverse Event|1
7728970|NCT00952341|26877053|P1|Cycle 1|Adverse Event|4
7728971|NCT00952289|26877115|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
7728972|NCT00952289|26877116|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
7728973|NCT00952289|26877115|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
7728974|NCT00952289|26877116|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
7728975|NCT00952289|26877115|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
7728976|NCT00952289|26877116|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
7728977|NCT00952289|26877115|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
7728978|NCT00952289|26877116|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
7728979|NCT00952289|26877115|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
7728980|NCT00952289|26877116|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
7728981|NCT00952289|26877115|P2|All Participants|Data lost during site relocation|1
7728982|NCT00952289|26877116|P1|All Participants|Data lost during site relocation|0
7728983|NCT00952289|26877115|P2|All Participants|Withdrawal by Subject|10
7728984|NCT00952289|26877116|P1|All Participants|Withdrawal by Subject|1
7728985|NCT00952289|26877115|P2|All Participants|Disease progression|12
7728986|NCT00952289|26877116|P1|All Participants|Disease progression|3
7728987|NCT00952289|26877115|P2|All Participants|Adverse Event|8
7728988|NCT00952289|26877116|P1|All Participants|Adverse Event|8
7728989|NCT00952289|26877115|P2|All Participants|Death|9
7728990|NCT00952289|26877116|P1|All Participants|Death|9
7728991|NCT00952276|26877145|P5|Overall Study|Withdrawal by Subject|0
7728992|NCT00952276|26877146|P4|Overall Study|Withdrawal by Subject|1
7728993|NCT00952276|26877147|P3|Overall Study|Withdrawal by Subject|0
7728994|NCT00952276|26877148|P2|Overall Study|Withdrawal by Subject|0
7728995|NCT00952276|26877149|P1|Overall Study|Withdrawal by Subject|1
7728996|NCT00952068|26877235|P1|Overall Study|Withdrawal by Subject|4
7728997|NCT00952068|26877235|P1|Overall Study|Adverse Event|3
7728998|NCT00951912|26877246|P3|Overall Study|Other: Stroke|0
7728999|NCT00951912|26877247|P2|Overall Study|Other: Stroke|1
7729000|NCT00951912|26877248|P1|Overall Study|Other: Stroke|0
7729001|NCT00951912|26877246|P3|Overall Study|Other: Colon cancer|0
7729002|NCT00951912|26877247|P2|Overall Study|Other: Colon cancer|0
7729003|NCT00951912|26877248|P1|Overall Study|Other: Colon cancer|1
7729004|NCT00951912|26877246|P3|Overall Study|Other:Depression|0
7729005|NCT00951912|26877247|P2|Overall Study|Other:Depression|0
7729006|NCT00951912|26877248|P1|Overall Study|Other:Depression|1
7729007|NCT00951912|26877246|P3|Overall Study|Withdrawal by Subject|0
7729008|NCT00951912|26877247|P2|Overall Study|Withdrawal by Subject|1
7729009|NCT00951912|26877248|P1|Overall Study|Withdrawal by Subject|1
7729010|NCT00951912|26877246|P3|Overall Study|Physician Decision|1
7729011|NCT00951912|26877247|P2|Overall Study|Physician Decision|0
7729012|NCT00951912|26877248|P1|Overall Study|Physician Decision|1
7729013|NCT00951912|26877246|P3|Overall Study|Lost to Follow-up|0
7729014|NCT00951912|26877247|P2|Overall Study|Lost to Follow-up|2
7729015|NCT00951912|26877248|P1|Overall Study|Lost to Follow-up|2
7729016|NCT00951912|26877246|P3|Overall Study|Adverse Event|1
7729017|NCT00951912|26877247|P2|Overall Study|Adverse Event|1
7729018|NCT00951912|26877248|P1|Overall Study|Adverse Event|0
7729019|NCT00951912|26877246|P3|Overall Study|Lack of Efficacy|0
7729020|NCT00951912|26877247|P2|Overall Study|Lack of Efficacy|0
7729021|NCT00951912|26877248|P1|Overall Study|Lack of Efficacy|1
7729022|NCT00951665|26877348|P6|Phase 2a|Disease Progression|5
7729023|NCT00951665|26877349|P5|Phase 2a|Disease Progression|6
7729024|NCT00951665|26877350|P4|Phase 2a|Disease Progression|0
7729025|NCT00951665|26877351|P3|Phase 2a|Disease Progression|0
7729026|NCT00951665|26877352|P2|Phase 2a|Disease Progression|0
7729027|NCT00951665|26877353|P1|Phase 2a|Disease Progression|0
7729028|NCT00951665|26877348|P6|Phase 2a|Withdrawal by Subject|0
7729029|NCT00951665|26877349|P5|Phase 2a|Withdrawal by Subject|2
7729030|NCT00951665|26877350|P4|Phase 2a|Withdrawal by Subject|0
7729031|NCT00951665|26877351|P3|Phase 2a|Withdrawal by Subject|0
7729032|NCT00951665|26877352|P2|Phase 2a|Withdrawal by Subject|0
7729033|NCT00951665|26877353|P1|Phase 2a|Withdrawal by Subject|0
7729034|NCT00951665|26877348|P6|Phase 2a|Physician Decision|1
7729035|NCT00951665|26877349|P5|Phase 2a|Physician Decision|0
7729036|NCT00951665|26877350|P4|Phase 2a|Physician Decision|0
7729037|NCT00951665|26877351|P3|Phase 2a|Physician Decision|0
7729038|NCT00951665|26877352|P2|Phase 2a|Physician Decision|0
7729039|NCT00951665|26877353|P1|Phase 2a|Physician Decision|0
7729040|NCT00951665|26877348|P6|Phase 2a|Lost to Follow-up|0
7729041|NCT00951665|26877349|P5|Phase 2a|Lost to Follow-up|1
7729042|NCT00951665|26877350|P4|Phase 2a|Lost to Follow-up|0
7729043|NCT00951665|26877351|P3|Phase 2a|Lost to Follow-up|0
7729044|NCT00951665|26877352|P2|Phase 2a|Lost to Follow-up|0
7729045|NCT00951665|26877353|P1|Phase 2a|Lost to Follow-up|0
7729046|NCT00951665|26877348|P6|Phase 2a|Death|1
7729047|NCT00951665|26877349|P5|Phase 2a|Death|1
7729048|NCT00951665|26877350|P4|Phase 2a|Death|0
7729049|NCT00951665|26877351|P3|Phase 2a|Death|0
7729050|NCT00951665|26877352|P2|Phase 2a|Death|0
7729051|NCT00951665|26877353|P1|Phase 2a|Death|0
7729052|NCT00951665|26877348|P6|Phase 2a|Adverse Event|0
7729053|NCT00951665|26877349|P5|Phase 2a|Adverse Event|2
7729054|NCT00951665|26877350|P4|Phase 2a|Adverse Event|0
7729055|NCT00951665|26877351|P3|Phase 2a|Adverse Event|0
7729056|NCT00951665|26877352|P2|Phase 2a|Adverse Event|0
7729057|NCT00951665|26877353|P1|Phase 2a|Adverse Event|0
7729058|NCT00951665|26877348|P6|Phase 1b|Protocol Violation|0
7729059|NCT00951665|26877349|P5|Phase 1b|Protocol Violation|0
7729060|NCT00951665|26877350|P4|Phase 1b|Protocol Violation|0
7729061|NCT00951665|26877351|P3|Phase 1b|Protocol Violation|0
7729062|NCT00951665|26877352|P2|Phase 1b|Protocol Violation|0
7729063|NCT00951665|26877353|P1|Phase 1b|Protocol Violation|2
7729064|NCT00951665|26877348|P6|Phase 1b|Disease Progression|0
7729065|NCT00951665|26877349|P5|Phase 1b|Disease Progression|0
7729066|NCT00951665|26877350|P4|Phase 1b|Disease Progression|0
7729067|NCT00951665|26877351|P3|Phase 1b|Disease Progression|14
7729068|NCT00951665|26877352|P2|Phase 1b|Disease Progression|2
7729069|NCT00951665|26877353|P1|Phase 1b|Disease Progression|13
7729070|NCT00951665|26877348|P6|Phase 1b|Withdrawal by Subject|0
7729071|NCT00951665|26877349|P5|Phase 1b|Withdrawal by Subject|0
7729072|NCT00951665|26877350|P4|Phase 1b|Withdrawal by Subject|0
7729073|NCT00951665|26877351|P3|Phase 1b|Withdrawal by Subject|0
7729074|NCT00951665|26877352|P2|Phase 1b|Withdrawal by Subject|1
7729075|NCT00951665|26877353|P1|Phase 1b|Withdrawal by Subject|0
7729076|NCT00951665|26877348|P6|Phase 1b|Physician Decision|0
7729077|NCT00951665|26877349|P5|Phase 1b|Physician Decision|0
7729078|NCT00951665|26877350|P4|Phase 1b|Physician Decision|0
7729079|NCT00951665|26877351|P3|Phase 1b|Physician Decision|1
7729080|NCT00951665|26877352|P2|Phase 1b|Physician Decision|0
7729081|NCT00951665|26877353|P1|Phase 1b|Physician Decision|4
7729082|NCT00951665|26877348|P6|Phase 1b|Death|0
7729083|NCT00951665|26877349|P5|Phase 1b|Death|0
7729084|NCT00951665|26877350|P4|Phase 1b|Death|0
7729085|NCT00951665|26877351|P3|Phase 1b|Death|2
7729086|NCT00951665|26877352|P2|Phase 1b|Death|0
7729087|NCT00951665|26877353|P1|Phase 1b|Death|1
7729088|NCT00951665|26877348|P6|Phase 1b|Adverse Event|0
7729089|NCT00951665|26877349|P5|Phase 1b|Adverse Event|0
7729090|NCT00951665|26877350|P4|Phase 1b|Adverse Event|1
7729091|NCT00951665|26877351|P3|Phase 1b|Adverse Event|0
7729092|NCT00951665|26877352|P2|Phase 1b|Adverse Event|1
7729093|NCT00951665|26877353|P1|Phase 1b|Adverse Event|2
7729094|NCT00951509|26877462|P1|Overall Study|Withdrawal by Subject|2
7729095|NCT00951496|26877473|P3|Overall Study|Did not initiate study treatment|13
7729096|NCT00951496|26877474|P2|Overall Study|Did not initiate study treatment|8
7729097|NCT00951496|26877475|P1|Overall Study|Did not initiate study treatment|10
7729098|NCT00951483|26877503|P2|Overall Study|Withdrawal by Subject|0
7729099|NCT00951483|26877504|P1|Overall Study|Withdrawal by Subject|15
7729100|NCT00951483|26877503|P2|Overall Study|Physician Decision|0
7729101|NCT00951483|26877504|P1|Overall Study|Physician Decision|4
7729102|NCT00951379|26877524|P2|Overall Study|Disease Progression|1
7729103|NCT00951379|26877525|P1|Overall Study|Disease Progression|0
7729104|NCT00951379|26877524|P2|Overall Study|Noncompliance|0
7729105|NCT00951379|26877525|P1|Overall Study|Noncompliance|1
7729106|NCT00951379|26877524|P2|Overall Study|Withdrawal by Subject|0
7729107|NCT00951379|26877525|P1|Overall Study|Withdrawal by Subject|1
7729108|NCT00951379|26877524|P2|Overall Study|Adverse Event|1
7729109|NCT00951379|26877525|P1|Overall Study|Adverse Event|4
7729110|NCT00951275|26877567|P1|Overall Study|Protocol Violation|1
7729111|NCT00951275|26877567|P1|Overall Study|Withdrawal by Subject|4
7729112|NCT00951275|26877567|P1|Overall Study|Adverse Event|7
7729113|NCT00951275|26877567|P1|Overall Study|Administrative Reason|1
7729114|NCT00951171|26877599|P2|Overall Study|Adverse Event|0
7729115|NCT00951171|26877600|P1|Overall Study|Adverse Event|2
7729116|NCT00951080|26877632|P2|Overall Study|Other|22
7729117|NCT00951080|26877633|P1|Overall Study|Other|19
7729118|NCT00951080|26877632|P2|Overall Study|Physician Decision|1
7729119|NCT00951080|26877633|P1|Overall Study|Physician Decision|4
7729120|NCT00951080|26877632|P2|Overall Study|Lost to Follow-up|1
7729121|NCT00951080|26877633|P1|Overall Study|Lost to Follow-up|0
7729122|NCT00951080|26877632|P2|Overall Study|Adverse Event|3
7729123|NCT00951080|26877633|P1|Overall Study|Adverse Event|3
7729124|NCT00951041|26877641|P2|Overall Study|Other|0
7729125|NCT00951041|26877642|P1|Overall Study|Other|3
7729126|NCT00951041|26877641|P2|Overall Study|Lost to Follow-up|0
7729127|NCT00951041|26877642|P1|Overall Study|Lost to Follow-up|1
7729128|NCT00951041|26877641|P2|Overall Study|Withdrawal by Subject|1
7729129|NCT00951041|26877642|P1|Overall Study|Withdrawal by Subject|1
7729130|NCT00951015|26877697|P5|Open-label Phase|Physician Decision|8
7729131|NCT00951015|26877698|P4|Open-label Phase|Physician Decision|0
7729132|NCT00951015|26877699|P3|Open-label Phase|Physician Decision|0
7729133|NCT00951015|26877700|P2|Open-label Phase|Physician Decision|0
7729134|NCT00951015|26877701|P1|Open-label Phase|Physician Decision|0
7729135|NCT00951015|26877697|P5|Open-label Phase|Withdrawal by Subject|14
7729136|NCT00951015|26877698|P4|Open-label Phase|Withdrawal by Subject|0
7729137|NCT00951015|26877699|P3|Open-label Phase|Withdrawal by Subject|0
7729138|NCT00951015|26877700|P2|Open-label Phase|Withdrawal by Subject|0
7729139|NCT00951015|26877701|P1|Open-label Phase|Withdrawal by Subject|0
7729140|NCT00951015|26877697|P5|Open-label Phase|Lost to Follow-up|12
7729141|NCT00951015|26877698|P4|Open-label Phase|Lost to Follow-up|0
7729142|NCT00951015|26877699|P3|Open-label Phase|Lost to Follow-up|0
7729143|NCT00951015|26877700|P2|Open-label Phase|Lost to Follow-up|0
7729144|NCT00951015|26877701|P1|Open-label Phase|Lost to Follow-up|0
7729145|NCT00951015|26877697|P5|Open-label Phase|Protocol Violation|12
7729146|NCT00951015|26877698|P4|Open-label Phase|Protocol Violation|0
7729147|NCT00951015|26877699|P3|Open-label Phase|Protocol Violation|0
7729148|NCT00951015|26877700|P2|Open-label Phase|Protocol Violation|0
7729149|NCT00951015|26877701|P1|Open-label Phase|Protocol Violation|0
7729150|NCT00951015|26877697|P5|Open-label Phase|Lack of Efficacy|1
7729151|NCT00951015|26877698|P4|Open-label Phase|Lack of Efficacy|0
7729152|NCT00951015|26877699|P3|Open-label Phase|Lack of Efficacy|0
7729153|NCT00951015|26877700|P2|Open-label Phase|Lack of Efficacy|0
7729154|NCT00951015|26877701|P1|Open-label Phase|Lack of Efficacy|0
7729155|NCT00951015|26877697|P5|Open-label Phase|Adverse Event|3
7729156|NCT00951015|26877698|P4|Open-label Phase|Adverse Event|0
7729157|NCT00951015|26877699|P3|Open-label Phase|Adverse Event|0
7729158|NCT00951015|26877700|P2|Open-label Phase|Adverse Event|0
7729159|NCT00951015|26877701|P1|Open-label Phase|Adverse Event|0
7729160|NCT00951015|26877697|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
7729161|NCT00951015|26877698|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
7729162|NCT00951015|26877699|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
7729163|NCT00951015|26877700|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
7729164|NCT00951015|26877701|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
7729165|NCT00951015|26877697|P5|Randomization Phase 96 Week|Lost to Follow-up|0
7729166|NCT00951015|26877698|P4|Randomization Phase 96 Week|Lost to Follow-up|2
7729167|NCT00951015|26877699|P3|Randomization Phase 96 Week|Lost to Follow-up|1
7729168|NCT00951015|26877700|P2|Randomization Phase 96 Week|Lost to Follow-up|3
7729169|NCT00951015|26877701|P1|Randomization Phase 96 Week|Lost to Follow-up|0
7729170|NCT00951015|26877697|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7729171|NCT00951015|26877698|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
7729172|NCT00951015|26877699|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7729173|NCT00951015|26877700|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7729174|NCT00951015|26877701|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7729175|NCT00951015|26877697|P5|Randomization Phase 96 Week|Protocol Violation|0
7729176|NCT00951015|26877698|P4|Randomization Phase 96 Week|Protocol Violation|0
7729177|NCT00951015|26877699|P3|Randomization Phase 96 Week|Protocol Violation|1
7729178|NCT00951015|26877700|P2|Randomization Phase 96 Week|Protocol Violation|1
7729179|NCT00951015|26877701|P1|Randomization Phase 96 Week|Protocol Violation|1
7729180|NCT00951015|26877697|P5|Randomization Phase 96 Week|Lack of Efficacy|0
7729181|NCT00951015|26877698|P4|Randomization Phase 96 Week|Lack of Efficacy|0
7729182|NCT00951015|26877699|P3|Randomization Phase 96 Week|Lack of Efficacy|0
7729183|NCT00951015|26877700|P2|Randomization Phase 96 Week|Lack of Efficacy|1
7729184|NCT00951015|26877701|P1|Randomization Phase 96 Week|Lack of Efficacy|1
7729185|NCT00951015|26877697|P5|Randomization Phase 96 Week|Adverse Event|0
7729186|NCT00951015|26877698|P4|Randomization Phase 96 Week|Adverse Event|5
7729187|NCT00951015|26877699|P3|Randomization Phase 96 Week|Adverse Event|2
7729188|NCT00951015|26877700|P2|Randomization Phase 96 Week|Adverse Event|1
7729189|NCT00951015|26877701|P1|Randomization Phase 96 Week|Adverse Event|1
7729190|NCT00950963|26877798|P2|Overall Study|Lost to Follow-up|24
7729191|NCT00950963|26877799|P1|Overall Study|Lost to Follow-up|29
7729192|NCT00950950|26877815|P2|Overall Study|Withdrawal by Subject|1
7729193|NCT00950950|26877816|P1|Overall Study|Withdrawal by Subject|0
7729194|NCT00950950|26877815|P2|Overall Study|Adverse Event|0
7729195|NCT00950950|26877816|P1|Overall Study|Adverse Event|1
7729196|NCT00950911|26877898|P2|Overall Study|Poor performance status|1
7729197|NCT00950911|26877899|P1|Overall Study|Poor performance status|0
7729198|NCT00950911|26877898|P2|Overall Study|Noncompliance|0
7729199|NCT00950911|26877899|P1|Overall Study|Noncompliance|1
7729200|NCT00950911|26877898|P2|Overall Study|Ineligibility determined|0
7729201|NCT00950911|26877899|P1|Overall Study|Ineligibility determined|1
7729202|NCT00950911|26877898|P2|Overall Study|Administrative decision|1
7729203|NCT00950911|26877899|P1|Overall Study|Administrative decision|3
7729204|NCT00950911|26877898|P2|Overall Study|Consent withdrawn|3
7729205|NCT00950911|26877899|P1|Overall Study|Consent withdrawn|1
7729206|NCT00950911|26877898|P2|Overall Study|Disease progression|2
7729207|NCT00950911|26877899|P1|Overall Study|Disease progression|2
7729208|NCT00950911|26877898|P2|Overall Study|Death|6
7729209|NCT00950911|26877899|P1|Overall Study|Death|4
7729210|NCT00950911|26877898|P2|Overall Study|Adverse Event|2
7729211|NCT00950911|26877899|P1|Overall Study|Adverse Event|0
7729212|NCT00950872|26877905|P1|Overall Study|Did not have surgery|2
7729213|NCT00950872|26877905|P1|Overall Study|Withdrawal by Subject|1
7729214|NCT00950859|26877914|P2|Overall Study|Lost to Follow-up|3
7729215|NCT00950859|26877915|P1|Overall Study|Lost to Follow-up|0
7729216|NCT00950859|26877914|P2|Overall Study|Protocol Violation|1
7729217|NCT00950859|26877915|P1|Overall Study|Protocol Violation|1
7729218|NCT00950859|26877914|P2|Overall Study|Insufficient Viral Load Response|3
7729219|NCT00950859|26877915|P1|Overall Study|Insufficient Viral Load Response|12
7729220|NCT00950859|26877914|P2|Overall Study|Adverse Event|3
7729221|NCT00950859|26877915|P1|Overall Study|Adverse Event|3
7729222|NCT00950807|26878014|P10|Treatment Period 3|Adverse Event|0
7729223|NCT00950807|26878015|P9|Treatment Period 3|Adverse Event|0
7729224|NCT00950807|26878016|P8|Treatment Period 3|Adverse Event|0
7729225|NCT00950807|26878017|P7|Treatment Period 3|Adverse Event|1
7729226|NCT00950807|26878018|P6|Treatment Period 3|Adverse Event|0
7729227|NCT00950807|26878019|P5|Treatment Period 3|Adverse Event|0
7729228|NCT00950807|26878020|P4|Treatment Period 3|Adverse Event|0
7729229|NCT00950807|26878021|P3|Treatment Period 3|Adverse Event|0
7729230|NCT00950807|26878022|P2|Treatment Period 3|Adverse Event|0
7729231|NCT00950807|26878023|P1|Treatment Period 3|Adverse Event|0
7729232|NCT00950807|26878014|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729233|NCT00950807|26878015|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729234|NCT00950807|26878016|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
7729235|NCT00950807|26878017|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729236|NCT00950807|26878018|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729237|NCT00950807|26878019|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729238|NCT00950807|26878020|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729239|NCT00950807|26878021|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729240|NCT00950807|26878022|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
7729241|NCT00950807|26878023|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
7729242|NCT00950807|26878014|P10|Treatment Period 3|Withdrawal by Subject|1
7729243|NCT00950807|26878015|P9|Treatment Period 3|Withdrawal by Subject|0
7729244|NCT00950807|26878016|P8|Treatment Period 3|Withdrawal by Subject|0
7729245|NCT00950807|26878017|P7|Treatment Period 3|Withdrawal by Subject|0
7729246|NCT00950807|26878018|P6|Treatment Period 3|Withdrawal by Subject|0
7729247|NCT00950807|26878019|P5|Treatment Period 3|Withdrawal by Subject|0
7729248|NCT00950807|26878020|P4|Treatment Period 3|Withdrawal by Subject|0
7729249|NCT00950807|26878021|P3|Treatment Period 3|Withdrawal by Subject|0
7729250|NCT00950807|26878022|P2|Treatment Period 3|Withdrawal by Subject|0
7729251|NCT00950807|26878023|P1|Treatment Period 3|Withdrawal by Subject|0
7729252|NCT00950807|26878014|P10|Washout Period 2|Adverse Event|0
7729253|NCT00950807|26878015|P9|Washout Period 2|Adverse Event|0
7729254|NCT00950807|26878016|P8|Washout Period 2|Adverse Event|0
7729255|NCT00950807|26878017|P7|Washout Period 2|Adverse Event|0
7729256|NCT00950807|26878018|P6|Washout Period 2|Adverse Event|0
7729257|NCT00950807|26878019|P5|Washout Period 2|Adverse Event|0
7729258|NCT00950807|26878020|P4|Washout Period 2|Adverse Event|1
7729259|NCT00950807|26878021|P3|Washout Period 2|Adverse Event|0
7729260|NCT00950807|26878022|P2|Washout Period 2|Adverse Event|0
7729261|NCT00950807|26878023|P1|Washout Period 2|Adverse Event|3
7729262|NCT00950807|26878014|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
7729263|NCT00950807|26878015|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
7729264|NCT00950807|26878016|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
7729265|NCT00950807|26878017|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
7729266|NCT00950807|26878018|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
7729267|NCT00950807|26878019|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
7729268|NCT00950807|26878020|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
7729269|NCT00950807|26878021|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
7729270|NCT00950807|26878022|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
7729271|NCT00950807|26878023|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
7729272|NCT00950807|26878014|P10|Washout Period 2|Lack of Efficacy|0
7729273|NCT00950807|26878015|P9|Washout Period 2|Lack of Efficacy|0
7729274|NCT00950807|26878016|P8|Washout Period 2|Lack of Efficacy|0
7729275|NCT00950807|26878017|P7|Washout Period 2|Lack of Efficacy|0
7729276|NCT00950807|26878018|P6|Washout Period 2|Lack of Efficacy|0
7729277|NCT00950807|26878019|P5|Washout Period 2|Lack of Efficacy|0
7729278|NCT00950807|26878020|P4|Washout Period 2|Lack of Efficacy|0
7729279|NCT00950807|26878021|P3|Washout Period 2|Lack of Efficacy|0
7729280|NCT00950807|26878022|P2|Washout Period 2|Lack of Efficacy|0
7729281|NCT00950807|26878023|P1|Washout Period 2|Lack of Efficacy|1
7729282|NCT00950807|26878014|P10|Treatment Period 2|Adverse Event|0
7729283|NCT00950807|26878015|P9|Treatment Period 2|Adverse Event|0
7729284|NCT00950807|26878016|P8|Treatment Period 2|Adverse Event|1
7729285|NCT00950807|26878017|P7|Treatment Period 2|Adverse Event|0
7729286|NCT00950807|26878018|P6|Treatment Period 2|Adverse Event|1
7729287|NCT00950807|26878019|P5|Treatment Period 2|Adverse Event|0
7729288|NCT00950807|26878020|P4|Treatment Period 2|Adverse Event|1
7729289|NCT00950807|26878021|P3|Treatment Period 2|Adverse Event|0
7729290|NCT00950807|26878022|P2|Treatment Period 2|Adverse Event|1
7729291|NCT00950807|26878023|P1|Treatment Period 2|Adverse Event|0
7729292|NCT00950807|26878014|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729293|NCT00950807|26878015|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729294|NCT00950807|26878016|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729295|NCT00950807|26878017|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729296|NCT00950807|26878018|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729297|NCT00950807|26878019|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729298|NCT00950807|26878020|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729299|NCT00950807|26878021|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729300|NCT00950807|26878022|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
7729301|NCT00950807|26878023|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
7729302|NCT00950807|26878014|P10|Treatment Period 2|Withdrawal by Subject|0
7729303|NCT00950807|26878015|P9|Treatment Period 2|Withdrawal by Subject|0
7729304|NCT00950807|26878016|P8|Treatment Period 2|Withdrawal by Subject|2
7729305|NCT00950807|26878017|P7|Treatment Period 2|Withdrawal by Subject|1
7729306|NCT00950807|26878018|P6|Treatment Period 2|Withdrawal by Subject|0
7729307|NCT00950807|26878019|P5|Treatment Period 2|Withdrawal by Subject|0
7729308|NCT00950807|26878020|P4|Treatment Period 2|Withdrawal by Subject|0
7729309|NCT00950807|26878021|P3|Treatment Period 2|Withdrawal by Subject|0
7729310|NCT00950807|26878022|P2|Treatment Period 2|Withdrawal by Subject|0
7729311|NCT00950807|26878023|P1|Treatment Period 2|Withdrawal by Subject|0
7729312|NCT00950807|26878014|P10|Treatment Period 2|Lack of Efficacy|0
7729313|NCT00950807|26878015|P9|Treatment Period 2|Lack of Efficacy|0
7729314|NCT00950807|26878016|P8|Treatment Period 2|Lack of Efficacy|0
7729315|NCT00950807|26878017|P7|Treatment Period 2|Lack of Efficacy|0
7729316|NCT00950807|26878018|P6|Treatment Period 2|Lack of Efficacy|0
7729317|NCT00950807|26878019|P5|Treatment Period 2|Lack of Efficacy|0
7729318|NCT00950807|26878020|P4|Treatment Period 2|Lack of Efficacy|0
7729319|NCT00950807|26878021|P3|Treatment Period 2|Lack of Efficacy|0
7729320|NCT00950807|26878022|P2|Treatment Period 2|Lack of Efficacy|0
7729321|NCT00950807|26878023|P1|Treatment Period 2|Lack of Efficacy|1
7729322|NCT00950807|26878014|P10|Washout Period 1|Adverse Event|0
7729323|NCT00950807|26878015|P9|Washout Period 1|Adverse Event|0
7729324|NCT00950807|26878016|P8|Washout Period 1|Adverse Event|0
7729325|NCT00950807|26878017|P7|Washout Period 1|Adverse Event|0
7729326|NCT00950807|26878018|P6|Washout Period 1|Adverse Event|0
7729327|NCT00950807|26878019|P5|Washout Period 1|Adverse Event|1
7729328|NCT00950807|26878020|P4|Washout Period 1|Adverse Event|1
7729329|NCT00950807|26878021|P3|Washout Period 1|Adverse Event|0
7729330|NCT00950807|26878022|P2|Washout Period 1|Adverse Event|0
7729331|NCT00950807|26878023|P1|Washout Period 1|Adverse Event|2
7729332|NCT00950807|26878014|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
7729333|NCT00950807|26878015|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
7729334|NCT00950807|26878016|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
7729335|NCT00950807|26878017|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
7729336|NCT00950807|26878018|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
7729337|NCT00950807|26878019|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
7729338|NCT00950807|26878020|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
7729339|NCT00950807|26878021|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
7729340|NCT00950807|26878022|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
7729341|NCT00950807|26878023|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
7729342|NCT00950807|26878014|P10|Washout Period 1|Withdrawal by Subject|0
7729343|NCT00950807|26878015|P9|Washout Period 1|Withdrawal by Subject|1
7729344|NCT00950807|26878016|P8|Washout Period 1|Withdrawal by Subject|0
7729345|NCT00950807|26878017|P7|Washout Period 1|Withdrawal by Subject|0
7729346|NCT00950807|26878018|P6|Washout Period 1|Withdrawal by Subject|0
7729347|NCT00950807|26878019|P5|Washout Period 1|Withdrawal by Subject|0
7729348|NCT00950807|26878020|P4|Washout Period 1|Withdrawal by Subject|0
7729349|NCT00950807|26878021|P3|Washout Period 1|Withdrawal by Subject|0
7729350|NCT00950807|26878022|P2|Washout Period 1|Withdrawal by Subject|0
7729351|NCT00950807|26878023|P1|Washout Period 1|Withdrawal by Subject|0
7729352|NCT00950807|26878014|P10|Washout Period 1|Lack of Efficacy|0
7729353|NCT00950807|26878015|P9|Washout Period 1|Lack of Efficacy|0
7729354|NCT00950807|26878016|P8|Washout Period 1|Lack of Efficacy|0
7729355|NCT00950807|26878017|P7|Washout Period 1|Lack of Efficacy|1
7729356|NCT00950807|26878018|P6|Washout Period 1|Lack of Efficacy|0
7729357|NCT00950807|26878019|P5|Washout Period 1|Lack of Efficacy|0
7729358|NCT00950807|26878020|P4|Washout Period 1|Lack of Efficacy|0
7729359|NCT00950807|26878021|P3|Washout Period 1|Lack of Efficacy|0
7729360|NCT00950807|26878022|P2|Washout Period 1|Lack of Efficacy|0
7729361|NCT00950807|26878023|P1|Washout Period 1|Lack of Efficacy|0
7729362|NCT00950807|26878014|P10|Treatment Period 1|Adverse Event|0
7729363|NCT00950807|26878015|P9|Treatment Period 1|Adverse Event|0
7729364|NCT00950807|26878016|P8|Treatment Period 1|Adverse Event|0
7729365|NCT00950807|26878017|P7|Treatment Period 1|Adverse Event|0
7729366|NCT00950807|26878018|P6|Treatment Period 1|Adverse Event|1
7729367|NCT00950807|26878019|P5|Treatment Period 1|Adverse Event|0
7729368|NCT00950807|26878020|P4|Treatment Period 1|Adverse Event|0
7729369|NCT00950807|26878021|P3|Treatment Period 1|Adverse Event|0
7729370|NCT00950807|26878022|P2|Treatment Period 1|Adverse Event|0
7729371|NCT00950807|26878023|P1|Treatment Period 1|Adverse Event|0
7729372|NCT00950807|26878014|P10|Treatment Period 1|Withdrawal by Subject|0
7729373|NCT00950807|26878015|P9|Treatment Period 1|Withdrawal by Subject|1
7729374|NCT00950807|26878016|P8|Treatment Period 1|Withdrawal by Subject|0
7729375|NCT00950807|26878017|P7|Treatment Period 1|Withdrawal by Subject|0
7729376|NCT00950807|26878018|P6|Treatment Period 1|Withdrawal by Subject|0
7729377|NCT00950807|26878019|P5|Treatment Period 1|Withdrawal by Subject|1
7729378|NCT00950807|26878020|P4|Treatment Period 1|Withdrawal by Subject|0
7729379|NCT00950807|26878021|P3|Treatment Period 1|Withdrawal by Subject|0
7729380|NCT00950807|26878022|P2|Treatment Period 1|Withdrawal by Subject|0
7729381|NCT00950807|26878023|P1|Treatment Period 1|Withdrawal by Subject|1
7729382|NCT00950807|26878014|P10|Treatment Period 1|Lost to Follow-up|0
7729383|NCT00950807|26878015|P9|Treatment Period 1|Lost to Follow-up|0
7729384|NCT00950807|26878016|P8|Treatment Period 1|Lost to Follow-up|0
7729385|NCT00950807|26878017|P7|Treatment Period 1|Lost to Follow-up|0
7729386|NCT00950807|26878018|P6|Treatment Period 1|Lost to Follow-up|0
7729387|NCT00950807|26878019|P5|Treatment Period 1|Lost to Follow-up|0
7729388|NCT00950807|26878020|P4|Treatment Period 1|Lost to Follow-up|0
7729389|NCT00950807|26878021|P3|Treatment Period 1|Lost to Follow-up|1
7729390|NCT00950807|26878022|P2|Treatment Period 1|Lost to Follow-up|0
7729391|NCT00950807|26878023|P1|Treatment Period 1|Lost to Follow-up|0
7729392|NCT00950807|26878014|P10|Treatment Period 1|Protocol Violation|0
7729393|NCT00950807|26878015|P9|Treatment Period 1|Protocol Violation|0
7729394|NCT00950807|26878016|P8|Treatment Period 1|Protocol Violation|0
7729395|NCT00950807|26878017|P7|Treatment Period 1|Protocol Violation|0
7729396|NCT00950807|26878018|P6|Treatment Period 1|Protocol Violation|0
7729397|NCT00950807|26878019|P5|Treatment Period 1|Protocol Violation|0
7729398|NCT00950807|26878020|P4|Treatment Period 1|Protocol Violation|0
7729399|NCT00950807|26878021|P3|Treatment Period 1|Protocol Violation|0
7729400|NCT00950807|26878022|P2|Treatment Period 1|Protocol Violation|0
7729401|NCT00950807|26878023|P1|Treatment Period 1|Protocol Violation|1
7729402|NCT00950807|26878014|P10|Treatment Period 1|Lack of Efficacy|0
7729403|NCT00950807|26878015|P9|Treatment Period 1|Lack of Efficacy|0
7729404|NCT00950807|26878016|P8|Treatment Period 1|Lack of Efficacy|0
7729405|NCT00950807|26878017|P7|Treatment Period 1|Lack of Efficacy|0
7729406|NCT00950807|26878018|P6|Treatment Period 1|Lack of Efficacy|1
7729407|NCT00950807|26878019|P5|Treatment Period 1|Lack of Efficacy|0
7729408|NCT00950807|26878020|P4|Treatment Period 1|Lack of Efficacy|0
7729409|NCT00950807|26878021|P3|Treatment Period 1|Lack of Efficacy|0
7729410|NCT00950807|26878022|P2|Treatment Period 1|Lack of Efficacy|0
7729411|NCT00950807|26878023|P1|Treatment Period 1|Lack of Efficacy|1
7729412|NCT00950755|26878065|P1|Long-Term Follow-Up|Death|8
7729413|NCT00950755|26878065|P1|Long-Term Follow-Up|Lost to Follow-up|1
7729414|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
7729415|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
7729416|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
7729417|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
7729418|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Death|1
7729419|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
7729420|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
7729421|NCT00950755|26878065|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7729422|NCT00950742|26878091|P2|Overall Study|Dose limiting toxicity|0
7729423|NCT00950742|26878092|P1|Overall Study|Dose limiting toxicity|6
7729424|NCT00950742|26878091|P2|Overall Study|Progressive Disease|2
7729425|NCT00950742|26878092|P1|Overall Study|Progressive Disease|6
7729426|NCT00950742|26878091|P2|Overall Study|Withdrawal by Subject|0
7729427|NCT00950742|26878092|P1|Overall Study|Withdrawal by Subject|3
7729428|NCT00950742|26878091|P2|Overall Study|Other Adverse Event|0
7729429|NCT00950742|26878092|P1|Overall Study|Other Adverse Event|1
7729430|NCT00950690|26878113|P1|Overall Study|Other|163
7729431|NCT00950690|26878113|P1|Overall Study|Lost to Follow-up|40
7729432|NCT00950690|26878113|P1|Overall Study|Lack of Efficacy|22
7729433|NCT00950690|26878113|P1|Overall Study|Adverse Event|15
7729434|NCT00950690|26878113|P1|Overall Study|Death|4
7729435|NCT00950664|26878120|P2|First Intervention|Withdrawal by Subject|2
7729436|NCT00950664|26878121|P1|First Intervention|Withdrawal by Subject|2
7729437|NCT00950664|26878120|P2|First Intervention|Lost to Follow-up|3
7729438|NCT00950664|26878121|P1|First Intervention|Lost to Follow-up|1
7729439|NCT00950651|26878141|P2|Overall Study|Withdrawal by Subject|9
7729440|NCT00950651|26878142|P1|Overall Study|Withdrawal by Subject|8
7729441|NCT00950651|26878141|P2|Overall Study|Protocol Violation|4
7729442|NCT00950651|26878142|P1|Overall Study|Protocol Violation|3
7729443|NCT00950651|26878141|P2|Overall Study|Lack of Efficacy|2
7729444|NCT00950651|26878142|P1|Overall Study|Lack of Efficacy|2
7729445|NCT00950651|26878141|P2|Overall Study|Death|0
7729446|NCT00950651|26878142|P1|Overall Study|Death|1
7729447|NCT00950651|26878141|P2|Overall Study|Adverse Event|20
7729448|NCT00950651|26878142|P1|Overall Study|Adverse Event|17
7729449|NCT00950599|26878235|P10|Follow-Up Period|Subject withdrew Consent|1
7729450|NCT00950599|26878236|P9|Follow-Up Period|Subject withdrew Consent|2
7729451|NCT00950599|26878237|P8|Follow-Up Period|Subject withdrew Consent|0
7729452|NCT00950599|26878238|P7|Follow-Up Period|Subject withdrew Consent|0
7729453|NCT00950599|26878239|P6|Follow-Up Period|Subject withdrew Consent|0
7729454|NCT00950599|26878240|P5|Follow-Up Period|Subject withdrew Consent|0
7729455|NCT00950599|26878241|P4|Follow-Up Period|Subject withdrew Consent|0
7729456|NCT00950599|26878242|P3|Follow-Up Period|Subject withdrew Consent|0
7729457|NCT00950599|26878243|P2|Follow-Up Period|Subject withdrew Consent|0
7729458|NCT00950599|26878244|P1|Follow-Up Period|Subject withdrew Consent|0
7729459|NCT00950599|26878235|P10|Follow-Up Period|Poor/Noncompliance|0
7729460|NCT00950599|26878236|P9|Follow-Up Period|Poor/Noncompliance|1
7729461|NCT00950599|26878237|P8|Follow-Up Period|Poor/Noncompliance|0
7729462|NCT00950599|26878238|P7|Follow-Up Period|Poor/Noncompliance|0
7729463|NCT00950599|26878239|P6|Follow-Up Period|Poor/Noncompliance|0
7729464|NCT00950599|26878240|P5|Follow-Up Period|Poor/Noncompliance|0
7729465|NCT00950599|26878241|P4|Follow-Up Period|Poor/Noncompliance|0
7729466|NCT00950599|26878242|P3|Follow-Up Period|Poor/Noncompliance|0
7729467|NCT00950599|26878243|P2|Follow-Up Period|Poor/Noncompliance|0
7729468|NCT00950599|26878244|P1|Follow-Up Period|Poor/Noncompliance|0
7729469|NCT00950599|26878235|P10|Follow-Up Period|Physician Decision|0
7729470|NCT00950599|26878236|P9|Follow-Up Period|Physician Decision|1
7729471|NCT00950599|26878237|P8|Follow-Up Period|Physician Decision|0
7729472|NCT00950599|26878238|P7|Follow-Up Period|Physician Decision|0
7729473|NCT00950599|26878239|P6|Follow-Up Period|Physician Decision|0
7729474|NCT00950599|26878240|P5|Follow-Up Period|Physician Decision|0
7729475|NCT00950599|26878241|P4|Follow-Up Period|Physician Decision|0
7729476|NCT00950599|26878242|P3|Follow-Up Period|Physician Decision|0
7729477|NCT00950599|26878243|P2|Follow-Up Period|Physician Decision|0
7729478|NCT00950599|26878244|P1|Follow-Up Period|Physician Decision|0
7729479|NCT00950599|26878235|P10|Follow-Up Period|Lost to Follow-up|1
7729480|NCT00950599|26878236|P9|Follow-Up Period|Lost to Follow-up|5
7729481|NCT00950599|26878237|P8|Follow-Up Period|Lost to Follow-up|0
7729482|NCT00950599|26878238|P7|Follow-Up Period|Lost to Follow-up|0
7729483|NCT00950599|26878239|P6|Follow-Up Period|Lost to Follow-up|0
7729484|NCT00950599|26878240|P5|Follow-Up Period|Lost to Follow-up|0
7729485|NCT00950599|26878241|P4|Follow-Up Period|Lost to Follow-up|0
7729486|NCT00950599|26878242|P3|Follow-Up Period|Lost to Follow-up|0
7729487|NCT00950599|26878243|P2|Follow-Up Period|Lost to Follow-up|0
7729488|NCT00950599|26878244|P1|Follow-Up Period|Lost to Follow-up|0
7729489|NCT00950599|26878235|P10|Follow-Up Period|Lack of Efficacy|0
7729490|NCT00950599|26878236|P9|Follow-Up Period|Lack of Efficacy|3
7729491|NCT00950599|26878237|P8|Follow-Up Period|Lack of Efficacy|0
7729492|NCT00950599|26878238|P7|Follow-Up Period|Lack of Efficacy|0
7729493|NCT00950599|26878239|P6|Follow-Up Period|Lack of Efficacy|0
7729494|NCT00950599|26878240|P5|Follow-Up Period|Lack of Efficacy|0
7729495|NCT00950599|26878241|P4|Follow-Up Period|Lack of Efficacy|0
7729496|NCT00950599|26878242|P3|Follow-Up Period|Lack of Efficacy|0
7729497|NCT00950599|26878243|P2|Follow-Up Period|Lack of Efficacy|0
7729498|NCT00950599|26878244|P1|Follow-Up Period|Lack of Efficacy|0
7729499|NCT00950599|26878235|P10|Follow-Up Period|Adverse Event|0
7729500|NCT00950599|26878236|P9|Follow-Up Period|Adverse Event|1
7729501|NCT00950599|26878237|P8|Follow-Up Period|Adverse Event|0
7729502|NCT00950599|26878238|P7|Follow-Up Period|Adverse Event|0
7729503|NCT00950599|26878239|P6|Follow-Up Period|Adverse Event|0
7729504|NCT00950599|26878240|P5|Follow-Up Period|Adverse Event|0
7729505|NCT00950599|26878241|P4|Follow-Up Period|Adverse Event|0
7729506|NCT00950599|26878242|P3|Follow-Up Period|Adverse Event|0
7729507|NCT00950599|26878243|P2|Follow-Up Period|Adverse Event|0
7729508|NCT00950599|26878244|P1|Follow-Up Period|Adverse Event|0
7729509|NCT00950599|26878235|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
7729510|NCT00950599|26878236|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
7729511|NCT00950599|26878237|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
7729512|NCT00950599|26878238|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
7729513|NCT00950599|26878239|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
7729514|NCT00950599|26878240|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
7729515|NCT00950599|26878241|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
7729516|NCT00950599|26878242|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
7729517|NCT00950599|26878243|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
7729518|NCT00950599|26878244|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
7729519|NCT00950599|26878235|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729520|NCT00950599|26878236|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729521|NCT00950599|26878237|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729522|NCT00950599|26878238|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729523|NCT00950599|26878239|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
7729524|NCT00950599|26878240|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
7729525|NCT00950599|26878241|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729526|NCT00950599|26878242|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729527|NCT00950599|26878243|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729528|NCT00950599|26878244|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7729529|NCT00950599|26878235|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
7729530|NCT00950599|26878236|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
7729531|NCT00950599|26878237|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
7729532|NCT00950599|26878238|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
7729533|NCT00950599|26878239|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
7729534|NCT00950599|26878240|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
7729535|NCT00950599|26878241|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
7729536|NCT00950599|26878242|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
7729537|NCT00950599|26878243|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
7729538|NCT00950599|26878244|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
7729539|NCT00950599|26878235|P10|Double-Blind Treatment Period|Lost to Follow-up|0
7729540|NCT00950599|26878236|P9|Double-Blind Treatment Period|Lost to Follow-up|0
7729541|NCT00950599|26878237|P8|Double-Blind Treatment Period|Lost to Follow-up|1
7729542|NCT00950599|26878238|P7|Double-Blind Treatment Period|Lost to Follow-up|0
7729543|NCT00950599|26878239|P6|Double-Blind Treatment Period|Lost to Follow-up|2
7729544|NCT00950599|26878240|P5|Double-Blind Treatment Period|Lost to Follow-up|1
7729545|NCT00950599|26878241|P4|Double-Blind Treatment Period|Lost to Follow-up|1
7729546|NCT00950599|26878242|P3|Double-Blind Treatment Period|Lost to Follow-up|0
7729547|NCT00950599|26878243|P2|Double-Blind Treatment Period|Lost to Follow-up|0
7729548|NCT00950599|26878244|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7729549|NCT00950599|26878235|P10|Double-Blind Treatment Period|Lack of Efficacy|0
7729550|NCT00950599|26878236|P9|Double-Blind Treatment Period|Lack of Efficacy|0
7729551|NCT00950599|26878237|P8|Double-Blind Treatment Period|Lack of Efficacy|1
7729552|NCT00950599|26878238|P7|Double-Blind Treatment Period|Lack of Efficacy|0
7729553|NCT00950599|26878239|P6|Double-Blind Treatment Period|Lack of Efficacy|6
7729554|NCT00950599|26878240|P5|Double-Blind Treatment Period|Lack of Efficacy|3
7729555|NCT00950599|26878241|P4|Double-Blind Treatment Period|Lack of Efficacy|7
7729556|NCT00950599|26878242|P3|Double-Blind Treatment Period|Lack of Efficacy|5
7729557|NCT00950599|26878243|P2|Double-Blind Treatment Period|Lack of Efficacy|5
7729558|NCT00950599|26878244|P1|Double-Blind Treatment Period|Lack of Efficacy|2
7729559|NCT00950599|26878235|P10|Double-Blind Treatment Period|Adverse Event|0
7729560|NCT00950599|26878236|P9|Double-Blind Treatment Period|Adverse Event|0
7729561|NCT00950599|26878237|P8|Double-Blind Treatment Period|Adverse Event|0
7729562|NCT00950599|26878238|P7|Double-Blind Treatment Period|Adverse Event|0
7729563|NCT00950599|26878239|P6|Double-Blind Treatment Period|Adverse Event|1
7729564|NCT00950599|26878240|P5|Double-Blind Treatment Period|Adverse Event|1
7729565|NCT00950599|26878241|P4|Double-Blind Treatment Period|Adverse Event|1
7729566|NCT00950599|26878242|P3|Double-Blind Treatment Period|Adverse Event|1
7729567|NCT00950599|26878243|P2|Double-Blind Treatment Period|Adverse Event|1
7729568|NCT00950599|26878244|P1|Double-Blind Treatment Period|Adverse Event|0
7729569|NCT00950599|26878235|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729570|NCT00950599|26878236|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729571|NCT00950599|26878237|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729572|NCT00950599|26878238|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729573|NCT00950599|26878239|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729574|NCT00950599|26878240|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729575|NCT00950599|26878241|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
7729576|NCT00950599|26878242|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729577|NCT00950599|26878243|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729578|NCT00950599|26878244|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
7729579|NCT00950300|26878830|P2|SFU Period|Withdrawal by Subject|8
7729580|NCT00950300|26878831|P1|SFU Period|Withdrawal by Subject|4
7729581|NCT00950300|26878830|P2|SFU Period|Lost to Follow-up|28
7729582|NCT00950300|26878831|P1|SFU Period|Lost to Follow-up|30
7729583|NCT00950300|26878830|P2|SFU Period|Death|42
7729584|NCT00950300|26878831|P1|SFU Period|Death|44
7729585|NCT00950300|26878830|P2|TFFU Period|Other|3
7729586|NCT00950300|26878831|P1|TFFU Period|Other|4
7729587|NCT00950300|26878830|P2|TFFU Period|Recurrence of Disease|72
7729588|NCT00950300|26878831|P1|TFFU Period|Recurrence of Disease|63
7729589|NCT00950300|26878830|P2|TFFU Period|Failure to Return|16
7729590|NCT00950300|26878831|P1|TFFU Period|Failure to Return|16
7729591|NCT00950300|26878830|P2|TFFU Period|Refused Treatment|11
7729592|NCT00950300|26878831|P1|TFFU Period|Refused Treatment|10
7729593|NCT00950300|26878830|P2|TFFU Period|Death|1
7729594|NCT00950300|26878831|P1|TFFU Period|Death|4
7729595|NCT00950300|26878830|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
7729596|NCT00950300|26878831|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
7729597|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
7729598|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
7729599|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
7729600|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
7729601|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
7729602|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
7729603|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
7729604|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
7729605|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
7729606|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
7729607|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
7729608|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
7729609|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
7729610|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
7729611|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
7729612|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
7729613|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
7729614|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
7729615|NCT00950300|26878830|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
7729616|NCT00950300|26878831|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
7729617|NCT00950248|26878880|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
7729618|NCT00950248|26878881|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
7729619|NCT00950248|26878882|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
7729620|NCT00950248|26878880|P3|Year 2&3 Treatment Randomization|Death|1
7729621|NCT00950248|26878881|P2|Year 2&3 Treatment Randomization|Death|0
7729622|NCT00950248|26878882|P1|Year 2&3 Treatment Randomization|Death|0
7729623|NCT00950248|26878880|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
7729624|NCT00950248|26878881|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
7729625|NCT00950248|26878882|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
7729626|NCT00950248|26878880|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
7729627|NCT00950248|26878881|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
7729628|NCT00950248|26878882|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
7729629|NCT00950248|26878880|P3|Year 1: Baseline|worsening of symptoms|0
7729630|NCT00950248|26878881|P2|Year 1: Baseline|worsening of symptoms|0
7729631|NCT00950248|26878882|P1|Year 1: Baseline|worsening of symptoms|2
7729632|NCT00950248|26878880|P3|Year 1: Baseline|Withdrawal by Subject|0
7729633|NCT00950248|26878881|P2|Year 1: Baseline|Withdrawal by Subject|0
7729634|NCT00950248|26878882|P1|Year 1: Baseline|Withdrawal by Subject|6
7729635|NCT00950170|26878922|P1|Overall Study|Discontinuation of Study by Sponsor|1
7729636|NCT00950170|26878922|P1|Overall Study|Adverse Event|2
7729637|NCT00950170|26878922|P1|Overall Study|Parent/Legal Guardian Request|1
7729638|NCT00949988|26878973|P1|Overall Study|Withdrawal by Subject|3
7729639|NCT00949975|26878988|P4|Overall Study|Other|0
7729640|NCT00949975|26878989|P3|Overall Study|Other|0
7729641|NCT00949975|26878990|P2|Overall Study|Other|0
7729642|NCT00949975|26878991|P1|Overall Study|Other|1
7729643|NCT00949975|26878988|P4|Overall Study|Lost to Follow-up|3
7729644|NCT00949975|26878989|P3|Overall Study|Lost to Follow-up|1
7729645|NCT00949975|26878990|P2|Overall Study|Lost to Follow-up|0
7729646|NCT00949975|26878991|P1|Overall Study|Lost to Follow-up|1
7729647|NCT00949975|26878988|P4|Overall Study|Severe non-compliance|2
7729648|NCT00949975|26878989|P3|Overall Study|Severe non-compliance|0
7729649|NCT00949975|26878990|P2|Overall Study|Severe non-compliance|1
7729650|NCT00949975|26878991|P1|Overall Study|Severe non-compliance|3
7729651|NCT00949975|26878988|P4|Overall Study|Incorrect enrolment|7
7729652|NCT00949975|26878989|P3|Overall Study|Incorrect enrolment|4
7729653|NCT00949975|26878990|P2|Overall Study|Incorrect enrolment|10
7729654|NCT00949975|26878991|P1|Overall Study|Incorrect enrolment|5
7729655|NCT00949975|26878988|P4|Overall Study|Study-specific criteria|0
7729656|NCT00949975|26878989|P3|Overall Study|Study-specific criteria|1
7729657|NCT00949975|26878990|P2|Overall Study|Study-specific criteria|1
7729658|NCT00949975|26878991|P1|Overall Study|Study-specific criteria|0
7729659|NCT00949975|26878988|P4|Overall Study|Safety reason|0
7729660|NCT00949975|26878989|P3|Overall Study|Safety reason|0
7729661|NCT00949975|26878990|P2|Overall Study|Safety reason|1
7729662|NCT00949975|26878991|P1|Overall Study|Safety reason|0
7729663|NCT00949975|26878988|P4|Overall Study|Adverse Event|10
7729664|NCT00949975|26878989|P3|Overall Study|Adverse Event|10
7729665|NCT00949975|26878990|P2|Overall Study|Adverse Event|11
7729666|NCT00949975|26878991|P1|Overall Study|Adverse Event|11
7729667|NCT00949975|26878988|P4|Overall Study|Voluntary discontinuation|6
7729668|NCT00949975|26878989|P3|Overall Study|Voluntary discontinuation|3
7729669|NCT00949975|26878990|P2|Overall Study|Voluntary discontinuation|5
7729670|NCT00949975|26878991|P1|Overall Study|Voluntary discontinuation|6
7729671|NCT00949910|26879109|P1|Overall Study|No Data|9
7729672|NCT00949910|26879109|P1|Overall Study|Other|4
7729673|NCT00949910|26879109|P1|Overall Study|Physician/Participant Decision|7
7729674|NCT00949910|26879109|P1|Overall Study|Serious Adverse Event|6
7729675|NCT00949910|26879109|P1|Overall Study|Adverse Event|83
7729676|NCT00949910|26879109|P1|Overall Study|Prolonged Dosing Interruption|4
7729677|NCT00949910|26879109|P1|Overall Study|Non-Compliance|10
7729678|NCT00949910|26879109|P1|Overall Study|Logistical Reasons|13
7729679|NCT00949910|26879109|P1|Overall Study|Violation of Eligibility|23
7729680|NCT00949910|26879109|P1|Overall Study|Switched to Commercial Treatment|4
7729681|NCT00949910|26879109|P1|Overall Study|Switched to Compassionate/Other Use|174
7729682|NCT00949910|26879109|P1|Overall Study|Unspecified Progression/Deterioration|13
7729683|NCT00949910|26879109|P1|Overall Study|Death from Unknown Cause|5
7729684|NCT00949910|26879109|P1|Overall Study|Death Due to Toxicity|3
7729685|NCT00949910|26879109|P1|Overall Study|Death Due to Adverse Event|115
7729686|NCT00949910|26879109|P1|Overall Study|Death Due to Progression/Deterioration|4
7729687|NCT00949910|26879109|P1|Overall Study|Death Due to Malignant Disease|456
7729688|NCT00949910|26879109|P1|Overall Study|Participant Refusal|390
7729689|NCT00949910|26879109|P1|Overall Study|Study Drug-Related Adverse Event|315
7729690|NCT00949910|26879109|P1|Overall Study|Lost to Follow-up|100
7729691|NCT00949910|26879109|P1|Overall Study|Symptomatic Deterioration|1088
7729692|NCT00949910|26879109|P1|Overall Study|Progressive Disease|3750
7729693|NCT00949884|26879122|P3|Overall Study|Study terminated by sponsor|1
7729694|NCT00949884|26879123|P2|Overall Study|Study terminated by sponsor|0
7729695|NCT00949884|26879124|P1|Overall Study|Study terminated by sponsor|0
7729696|NCT00949884|26879122|P3|Overall Study|Lack of Efficacy|7
7729697|NCT00949884|26879123|P2|Overall Study|Lack of Efficacy|2
7729698|NCT00949884|26879124|P1|Overall Study|Lack of Efficacy|4
7729699|NCT00949884|26879122|P3|Overall Study|Withdrawal by Subject|16
7729700|NCT00949884|26879123|P2|Overall Study|Withdrawal by Subject|4
7729701|NCT00949884|26879124|P1|Overall Study|Withdrawal by Subject|13
7729702|NCT00949884|26879122|P3|Overall Study|Treatment non-compliance|8
7729703|NCT00949884|26879123|P2|Overall Study|Treatment non-compliance|0
7729704|NCT00949884|26879124|P1|Overall Study|Treatment non-compliance|5
7729705|NCT00949884|26879122|P3|Overall Study|Physician Decision|6
7729706|NCT00949884|26879123|P2|Overall Study|Physician Decision|0
7729707|NCT00949884|26879124|P1|Overall Study|Physician Decision|5
7729708|NCT00949884|26879122|P3|Overall Study|Lost to Follow-up|5
7729709|NCT00949884|26879123|P2|Overall Study|Lost to Follow-up|5
7729710|NCT00949884|26879124|P1|Overall Study|Lost to Follow-up|7
7729711|NCT00949884|26879122|P3|Overall Study|Did not meet inclusion/exclusion|3
7729712|NCT00949884|26879123|P2|Overall Study|Did not meet inclusion/exclusion|1
7729713|NCT00949884|26879124|P1|Overall Study|Did not meet inclusion/exclusion|2
7729714|NCT00949884|26879122|P3|Overall Study|Adverse Event|12
7729715|NCT00949884|26879123|P2|Overall Study|Adverse Event|3
7729716|NCT00949884|26879124|P1|Overall Study|Adverse Event|14
7729717|NCT00949715|26879179|P2|Overall Study|Missing 24 month LVEF measurement|0
7729718|NCT00949715|26879180|P1|Overall Study|Missing 24 month LVEF measurement|2
7729719|NCT00949715|26879179|P2|Overall Study|Lost to Follow-up|0
7729720|NCT00949715|26879180|P1|Overall Study|Lost to Follow-up|1
7729721|NCT00949715|26879179|P2|Overall Study|Physician Decision|0
7729722|NCT00949715|26879180|P1|Overall Study|Physician Decision|1
7729723|NCT00949702|26879191|P1|Overall Study|Withdrawal of consent|1
7729724|NCT00949702|26879191|P1|Overall Study|Disease progression|7
7729725|NCT00949702|26879191|P1|Overall Study|Death|40
7729726|NCT00949650|26879208|P2|Overall Study|Other not specified above|0
7729727|NCT00949650|26879209|P1|Overall Study|Other not specified above|5
7729728|NCT00949650|26879208|P2|Overall Study|Not treated|4
7729729|NCT00949650|26879209|P1|Overall Study|Not treated|1
7729730|NCT00949650|26879208|P2|Overall Study|Refusal to continue medication|11
7729731|NCT00949650|26879209|P1|Overall Study|Refusal to continue medication|7
7729732|NCT00949650|26879208|P2|Overall Study|Protocol Violation|4
7729733|NCT00949650|26879209|P1|Overall Study|Protocol Violation|1
7729734|NCT00949650|26879208|P2|Overall Study|Other Adverse Event (AE)|17
7729735|NCT00949650|26879209|P1|Overall Study|Other Adverse Event (AE)|28
7729736|NCT00949650|26879208|P2|Overall Study|Completed 6 courses of chemotherapy|60
7729737|NCT00949650|26879209|P1|Overall Study|Completed 6 courses of chemotherapy|0
7729738|NCT00949650|26879208|P2|Overall Study|Progressive disease|19
7729739|NCT00949650|26879209|P1|Overall Study|Progressive disease|188
7729740|NCT00949533|26879247|P2|Overall Study|Lost to Follow-up|1
7729741|NCT00949533|26879248|P1|Overall Study|Lost to Follow-up|0
7729742|NCT00949325|26879264|P3|Overall Study|Adverse Event|0
7729743|NCT00949325|26879265|P2|Overall Study|Adverse Event|2
7729744|NCT00949325|26879266|P1|Overall Study|Adverse Event|0
7729745|NCT00949117|26879290|P2|Overall Study|Adverse Event|1
7729746|NCT00949117|26879291|P1|Overall Study|Adverse Event|0
7729747|NCT00949117|26879290|P2|Overall Study|Protocol Violation|1
7729748|NCT00949117|26879291|P1|Overall Study|Protocol Violation|1
7729749|NCT00949117|26879290|P2|Overall Study|Lack of Efficacy|3
7729750|NCT00949117|26879291|P1|Overall Study|Lack of Efficacy|2
7729751|NCT00948974|26879332|P2|Overall Study|Lost to Follow-up|20
7729752|NCT00948974|26879333|P1|Overall Study|Lost to Follow-up|23
7729753|NCT00948922|26879351|P3|Overall Study|Not evaluable at time of analysis|0
7729754|NCT00948922|26879352|P2|Overall Study|Not evaluable at time of analysis|3
7729755|NCT00948922|26879353|P1|Overall Study|Not evaluable at time of analysis|0
7729756|NCT00948922|26879351|P3|Overall Study|Transplant eligibility issues|0
7729757|NCT00948922|26879352|P2|Overall Study|Transplant eligibility issues|3
7729758|NCT00948922|26879353|P1|Overall Study|Transplant eligibility issues|2
7729759|NCT00948922|26879351|P3|Overall Study|Insurance issues|0
7729760|NCT00948922|26879352|P2|Overall Study|Insurance issues|0
7729761|NCT00948922|26879353|P1|Overall Study|Insurance issues|1
7729762|NCT00948922|26879351|P3|Overall Study|Disease progression|0
7729763|NCT00948922|26879352|P2|Overall Study|Disease progression|1
7729764|NCT00948922|26879353|P1|Overall Study|Disease progression|0
7729765|NCT00948922|26879351|P3|Overall Study|Death|0
7729766|NCT00948922|26879352|P2|Overall Study|Death|0
7729767|NCT00948922|26879353|P1|Overall Study|Death|3
7729768|NCT00948922|26879351|P3|Overall Study|Withdrawal by Subject|1
7729769|NCT00948922|26879352|P2|Overall Study|Withdrawal by Subject|2
7729770|NCT00948922|26879353|P1|Overall Study|Withdrawal by Subject|0
7729771|NCT00948922|26879351|P3|Overall Study|Did not start study treatment|0
7729772|NCT00948922|26879352|P2|Overall Study|Did not start study treatment|5
7729773|NCT00948922|26879353|P1|Overall Study|Did not start study treatment|2
7729774|NCT00948896|26879376|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729775|NCT00948896|26879377|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729776|NCT00948896|26879378|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729777|NCT00948896|26879379|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729778|NCT00948896|26879380|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
7729779|NCT00948896|26879381|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729780|NCT00948896|26879382|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729781|NCT00948896|26879383|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7729782|NCT00948896|26879376|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
7729783|NCT00948896|26879377|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
7729784|NCT00948896|26879378|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
7729785|NCT00948896|26879379|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
7729786|NCT00948896|26879380|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
7729787|NCT00948896|26879381|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
7729788|NCT00948896|26879382|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
7729789|NCT00948896|26879383|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
7729790|NCT00948896|26879376|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7729791|NCT00948896|26879377|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7729792|NCT00948896|26879378|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7729793|NCT00948896|26879379|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
7729794|NCT00948896|26879380|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7729795|NCT00948896|26879381|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
7729796|NCT00948896|26879382|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7729797|NCT00948896|26879383|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
7729798|NCT00948896|26879376|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7729799|NCT00948896|26879377|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7729800|NCT00948896|26879378|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7729801|NCT00948896|26879379|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7729802|NCT00948896|26879380|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7729803|NCT00948896|26879381|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7729804|NCT00948896|26879382|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7729805|NCT00948896|26879383|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7729806|NCT00948896|26879376|P8|24 Months of Age to 36 Months of Age|Death|0
7729807|NCT00948896|26879377|P7|24 Months of Age to 36 Months of Age|Death|0
7729808|NCT00948896|26879378|P6|24 Months of Age to 36 Months of Age|Death|1
7729809|NCT00948896|26879379|P5|24 Months of Age to 36 Months of Age|Death|0
7729810|NCT00948896|26879380|P4|24 Months of Age to 36 Months of Age|Death|0
7729811|NCT00948896|26879381|P3|24 Months of Age to 36 Months of Age|Death|2
7729812|NCT00948896|26879382|P2|24 Months of Age to 36 Months of Age|Death|2
7729813|NCT00948896|26879383|P1|24 Months of Age to 36 Months of Age|Death|0
7729814|NCT00948896|26879376|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
7729815|NCT00948896|26879377|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
7729816|NCT00948896|26879378|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
7729817|NCT00948896|26879379|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
7729818|NCT00948896|26879380|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
7729819|NCT00948896|26879381|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
7729820|NCT00948896|26879382|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
7729821|NCT00948896|26879383|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
7729822|NCT00948896|26879376|P8|Randomization to 24 Months of Age|Protocol Violation|1
7729823|NCT00948896|26879377|P7|Randomization to 24 Months of Age|Protocol Violation|1
7729824|NCT00948896|26879378|P6|Randomization to 24 Months of Age|Protocol Violation|0
7729825|NCT00948896|26879379|P5|Randomization to 24 Months of Age|Protocol Violation|0
7729826|NCT00948896|26879380|P4|Randomization to 24 Months of Age|Protocol Violation|1
7729827|NCT00948896|26879381|P3|Randomization to 24 Months of Age|Protocol Violation|0
7729828|NCT00948896|26879382|P2|Randomization to 24 Months of Age|Protocol Violation|1
7729829|NCT00948896|26879383|P1|Randomization to 24 Months of Age|Protocol Violation|0
7729830|NCT00948896|26879376|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
7729831|NCT00948896|26879377|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
7729832|NCT00948896|26879378|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
7729833|NCT00948896|26879379|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
7729834|NCT00948896|26879380|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
7729835|NCT00948896|26879381|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
7729836|NCT00948896|26879382|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
7729837|NCT00948896|26879383|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
7729838|NCT00948896|26879376|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
7729839|NCT00948896|26879377|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
7729840|NCT00948896|26879378|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
7729841|NCT00948896|26879379|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
7729842|NCT00948896|26879380|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
7729843|NCT00948896|26879381|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
7729844|NCT00948896|26879382|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
7729845|NCT00948896|26879383|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
7729846|NCT00948896|26879376|P8|Randomization to 24 Months of Age|Death|1
7729847|NCT00948896|26879377|P7|Randomization to 24 Months of Age|Death|2
7729848|NCT00948896|26879378|P6|Randomization to 24 Months of Age|Death|1
7729849|NCT00948896|26879379|P5|Randomization to 24 Months of Age|Death|2
7729850|NCT00948896|26879380|P4|Randomization to 24 Months of Age|Death|0
7729851|NCT00948896|26879381|P3|Randomization to 24 Months of Age|Death|0
7729852|NCT00948896|26879382|P2|Randomization to 24 Months of Age|Death|0
7729853|NCT00948896|26879383|P1|Randomization to 24 Months of Age|Death|1
7729854|NCT00948857|26879419|P2|Overall Study|Lost to Follow-up|0
7729855|NCT00948857|26879420|P1|Overall Study|Lost to Follow-up|1
7729856|NCT00948818|26879428|P2|Overall Study|Other Reason|5
7729857|NCT00948818|26879429|P1|Overall Study|Other Reason|4
7729858|NCT00948818|26879428|P2|Overall Study|Lack of Efficacy|5
7729859|NCT00948818|26879429|P1|Overall Study|Lack of Efficacy|4
7729860|NCT00948818|26879428|P2|Overall Study|Lost to Follow-up|17
7729861|NCT00948818|26879429|P1|Overall Study|Lost to Follow-up|10
7729862|NCT00948818|26879428|P2|Overall Study|Withdrawal by Subject|25
7729863|NCT00948818|26879429|P1|Overall Study|Withdrawal by Subject|25
7729864|NCT00948818|26879428|P2|Overall Study|Protocol Violation|10
7729865|NCT00948818|26879429|P1|Overall Study|Protocol Violation|9
7729866|NCT00948818|26879428|P2|Overall Study|Adverse Event|32
7729867|NCT00948818|26879429|P1|Overall Study|Adverse Event|10
7729868|NCT00948766|26879476|P2|Extension Study|Death|0
7729869|NCT00948766|26879477|P1|Extension Study|Death|4
7729870|NCT00948766|26879476|P2|Extension Study|Administrative Problems|0
7729871|NCT00948766|26879477|P1|Extension Study|Administrative Problems|1
7729872|NCT00948766|26879476|P2|Extension Study|Lost to Follow-up|0
7729873|NCT00948766|26879477|P1|Extension Study|Lost to Follow-up|8
7729874|NCT00948766|26879476|P2|Extension Study|Patient Withdrew Consent|0
7729875|NCT00948766|26879477|P1|Extension Study|Patient Withdrew Consent|32
7729876|NCT00948766|26879476|P2|Extension Study|Study Drug No Longer Required|0
7729877|NCT00948766|26879477|P1|Extension Study|Study Drug No Longer Required|1
7729878|NCT00948766|26879476|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
7729879|NCT00948766|26879477|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
7729880|NCT00948766|26879476|P2|Extension Study|Adverse Event|0
7729881|NCT00948766|26879477|P1|Extension Study|Adverse Event|43
7729882|NCT00948766|26879476|P2|Core Study|Protocol Deviation|10
7729883|NCT00948766|26879477|P1|Core Study|Protocol Deviation|8
7729884|NCT00948766|26879476|P2|Core Study|Death|1
7729885|NCT00948766|26879477|P1|Core Study|Death|1
7729886|NCT00948766|26879476|P2|Core Study|Administrative Problems|2
7729887|NCT00948766|26879477|P1|Core Study|Administrative Problems|2
7729888|NCT00948766|26879476|P2|Core Study|Lost to Follow-up|2
7729889|NCT00948766|26879477|P1|Core Study|Lost to Follow-up|3
7729890|NCT00948766|26879476|P2|Core Study|Patient Withdrew Consent|46
7729891|NCT00948766|26879477|P1|Core Study|Patient Withdrew Consent|27
7729892|NCT00948766|26879476|P2|Core Study|Unsatisfactory Therapeutic Effect|14
7729893|NCT00948766|26879477|P1|Core Study|Unsatisfactory Therapeutic Effect|13
7729894|NCT00948766|26879476|P2|Core Study|Adverse Event|51
7729895|NCT00948766|26879477|P1|Core Study|Adverse Event|73
7729896|NCT00948688|26879493|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
7729897|NCT00948688|26879494|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
7729898|NCT00948688|26879493|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
7729899|NCT00948688|26879494|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
7729900|NCT00948688|26879493|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
7729901|NCT00948688|26879494|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
7729906|NCT00948506|26879536|P2|Overall Study|Withdrawal by Subject|1
7729907|NCT00948506|26879537|P1|Overall Study|Withdrawal by Subject|3
7729908|NCT00948441|26879548|P2|Overall Study|no longer meet inclusion criteria|4
7729909|NCT00948441|26879549|P1|Overall Study|no longer meet inclusion criteria|1
7729910|NCT00948428|26879560|P3|Overall Study|Non-compliance|0
7729911|NCT00948428|26879561|P2|Overall Study|Non-compliance|2
7729912|NCT00948428|26879562|P1|Overall Study|Non-compliance|1
7729913|NCT00948428|26879560|P3|Overall Study|Intercurrent Illness|0
7729914|NCT00948428|26879561|P2|Overall Study|Intercurrent Illness|0
7729915|NCT00948428|26879562|P1|Overall Study|Intercurrent Illness|1
7729916|NCT00948428|26879560|P3|Overall Study|Death|0
7729917|NCT00948428|26879561|P2|Overall Study|Death|0
7729918|NCT00948428|26879562|P1|Overall Study|Death|2
7729919|NCT00948428|26879560|P3|Overall Study|Lost to Follow-up|1
7729920|NCT00948428|26879561|P2|Overall Study|Lost to Follow-up|1
7729921|NCT00948428|26879562|P1|Overall Study|Lost to Follow-up|2
7729922|NCT00948428|26879560|P3|Overall Study|Adverse Event|0
7729923|NCT00948428|26879561|P2|Overall Study|Adverse Event|3
7729924|NCT00948428|26879562|P1|Overall Study|Adverse Event|6
7729925|NCT00948428|26879560|P3|Overall Study|Withdrawal by Subject|7
7729926|NCT00948428|26879561|P2|Overall Study|Withdrawal by Subject|12
7729927|NCT00948428|26879562|P1|Overall Study|Withdrawal by Subject|6
7729928|NCT00948389|26879581|P5|Overall Study|Both Progression and Toxicity|0
7729929|NCT00948389|26879582|P4|Overall Study|Both Progression and Toxicity|0
7729930|NCT00948389|26879583|P3|Overall Study|Both Progression and Toxicity|0
7729931|NCT00948389|26879584|P2|Overall Study|Both Progression and Toxicity|0
7729932|NCT00948389|26879585|P1|Overall Study|Both Progression and Toxicity|1
7729933|NCT00948389|26879581|P5|Overall Study|Thrombocytopenia, Grade 4|0
7729934|NCT00948389|26879582|P4|Overall Study|Thrombocytopenia, Grade 4|1
7729935|NCT00948389|26879583|P3|Overall Study|Thrombocytopenia, Grade 4|0
7729936|NCT00948389|26879584|P2|Overall Study|Thrombocytopenia, Grade 4|0
7729937|NCT00948389|26879585|P1|Overall Study|Thrombocytopenia, Grade 4|2
7729938|NCT00948389|26879581|P5|Overall Study|Disease Progression/Relapse/Death|1
7729939|NCT00948389|26879582|P4|Overall Study|Disease Progression/Relapse/Death|8
7729940|NCT00948389|26879583|P3|Overall Study|Disease Progression/Relapse/Death|7
7729941|NCT00948389|26879584|P2|Overall Study|Disease Progression/Relapse/Death|3
7729942|NCT00948389|26879585|P1|Overall Study|Disease Progression/Relapse/Death|3
7729943|NCT00948246|26879633|P1|Overall Study|Withdrawal by Subject|1
7729944|NCT00948246|26879633|P1|Overall Study|Death|1
7729945|NCT00948246|26879633|P1|Overall Study|Adverse Event|11
7729946|NCT00948246|26879633|P1|Overall Study|Lost to Follow-up|11
7729947|NCT00948194|26879642|P2|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
7729948|NCT00948194|26879643|P1|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
7729949|NCT00948155|26879655|P2|Washout 14 Days|Lost to Follow-up|2
7729950|NCT00948155|26879656|P1|Washout 14 Days|Lost to Follow-up|1
7729951|NCT00948155|26879655|P2|First Intervention 21 Days|Lost to Follow-up|2
7729952|NCT00948155|26879656|P1|First Intervention 21 Days|Lost to Follow-up|2
7729953|NCT00948064|26879703|P3|Phase II|Withdrawal by Subject|0
7729954|NCT00948064|26879704|P2|Phase II|Withdrawal by Subject|1
7729955|NCT00948064|26879705|P1|Phase II|Withdrawal by Subject|0
7729956|NCT00948064|26879703|P3|Phase II|Physician Decision|1
7729957|NCT00948064|26879704|P2|Phase II|Physician Decision|0
7729958|NCT00948064|26879705|P1|Phase II|Physician Decision|0
7729959|NCT00948064|26879703|P3|Phase I|No treatment received|0
7729960|NCT00948064|26879704|P2|Phase I|No treatment received|0
7729961|NCT00948064|26879705|P1|Phase I|No treatment received|1
7729962|NCT00948025|26879718|P2|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
7729963|NCT00948025|26879719|P1|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
7729964|NCT00948025|26879718|P2|Phase 1 (Pilot Phase)|Lost to Follow-up|1
7729965|NCT00948025|26879719|P1|Phase 1 (Pilot Phase)|Lost to Follow-up|7
7729966|NCT00948025|26879718|P2|Phase 1 (Pilot Phase)|Adverse Event|1
7729967|NCT00948025|26879719|P1|Phase 1 (Pilot Phase)|Adverse Event|1
7729968|NCT00947882|26879747|P4|Overall Study|Trial Terminated by Sponsor|70
7729969|NCT00947882|26879748|P3|Overall Study|Trial Terminated by Sponsor|62
7729970|NCT00947882|26879749|P2|Overall Study|Trial Terminated by Sponsor|61
7729971|NCT00947882|26879750|P1|Overall Study|Trial Terminated by Sponsor|62
7729972|NCT00947882|26879747|P4|Overall Study|Other/Unknown|6
7729973|NCT00947882|26879748|P3|Overall Study|Other/Unknown|3
7729974|NCT00947882|26879749|P2|Overall Study|Other/Unknown|13
7729975|NCT00947882|26879750|P1|Overall Study|Other/Unknown|10
7729976|NCT00947882|26879747|P4|Overall Study|Lost to Follow-up|0
7729977|NCT00947882|26879748|P3|Overall Study|Lost to Follow-up|1
7729978|NCT00947882|26879749|P2|Overall Study|Lost to Follow-up|2
7729979|NCT00947882|26879750|P1|Overall Study|Lost to Follow-up|0
7729980|NCT00947882|26879747|P4|Overall Study|Protocol Violation|0
7729981|NCT00947882|26879748|P3|Overall Study|Protocol Violation|1
7729982|NCT00947882|26879749|P2|Overall Study|Protocol Violation|0
7729983|NCT00947882|26879750|P1|Overall Study|Protocol Violation|0
7729984|NCT00947882|26879747|P4|Overall Study|Withdrawal by Subject|2
7729985|NCT00947882|26879748|P3|Overall Study|Withdrawal by Subject|8
7729986|NCT00947882|26879749|P2|Overall Study|Withdrawal by Subject|0
7729987|NCT00947882|26879750|P1|Overall Study|Withdrawal by Subject|2
7729988|NCT00947882|26879747|P4|Overall Study|Adverse Event|4
7729989|NCT00947882|26879748|P3|Overall Study|Adverse Event|4
7729990|NCT00947882|26879749|P2|Overall Study|Adverse Event|1
7729991|NCT00947882|26879750|P1|Overall Study|Adverse Event|0
7729992|NCT00947856|26879778|P2|Follow-up Period|Withdrawal by Subject|0
7729993|NCT00947856|26879779|P1|Follow-up Period|Withdrawal by Subject|1
7729994|NCT00947856|26879778|P2|Follow-up Period|Patient unavailable for site visits|0
7729995|NCT00947856|26879779|P1|Follow-up Period|Patient unavailable for site visits|1
7729996|NCT00947856|26879778|P2|Follow-up Period|Lost to Follow-up|0
7729997|NCT00947856|26879779|P1|Follow-up Period|Lost to Follow-up|7
7729998|NCT00947856|26879778|P2|Follow-up Period|Re-enrolled for Retreatment|3
7729999|NCT00947856|26879779|P1|Follow-up Period|Re-enrolled for Retreatment|2
7730000|NCT00947856|26879778|P2|Follow-up Period|Study Stopped by Sponsor|20
7730001|NCT00947856|26879779|P1|Follow-up Period|Study Stopped by Sponsor|40
7730002|NCT00947856|26879778|P2|Treatment Period|Withdrawal by Subject|1
7730003|NCT00947856|26879779|P1|Treatment Period|Withdrawal by Subject|12
7730004|NCT00947856|26879778|P2|Treatment Period|Study Stopped by Sponsor|4
7730005|NCT00947856|26879779|P1|Treatment Period|Study Stopped by Sponsor|4
7730006|NCT00947856|26879778|P2|Treatment Period|Physician Decision|6
7730007|NCT00947856|26879779|P1|Treatment Period|Physician Decision|14
7730008|NCT00947856|26879778|P2|Treatment Period|Adverse Event|9
7730009|NCT00947856|26879779|P1|Treatment Period|Adverse Event|15
7730010|NCT00947856|26879778|P2|Treatment Period|Progressive Disease|12
7730011|NCT00947856|26879779|P1|Treatment Period|Progressive Disease|33
7730012|NCT00947544|26879868|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
7730013|NCT00947544|26879869|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
7730014|NCT00947531|26879895|P2|Overall Study|Other|1
7730015|NCT00947531|26879896|P1|Overall Study|Other|1
7730016|NCT00947531|26879895|P2|Overall Study|Lack of Efficacy|0
7730017|NCT00947531|26879896|P1|Overall Study|Lack of Efficacy|1
7730018|NCT00947531|26879895|P2|Overall Study|Adverse Event|2
7730019|NCT00947531|26879896|P1|Overall Study|Adverse Event|2
7730020|NCT00947531|26879895|P2|Overall Study|Administrative Reason|1
7730021|NCT00947531|26879896|P1|Overall Study|Administrative Reason|0
7730022|NCT00947531|26879895|P2|Overall Study|Withdrawal by Subject|7
7730023|NCT00947531|26879896|P1|Overall Study|Withdrawal by Subject|10
7730024|NCT00947427|26879934|P2|Overall Study|Protocol Violation|1
7730025|NCT00947427|26879935|P1|Overall Study|Protocol Violation|0
7730026|NCT00947427|26879934|P2|Overall Study|Withdrawal by Subject|3
7730027|NCT00947427|26879935|P1|Overall Study|Withdrawal by Subject|1
7730028|NCT00947349|26879945|P4|Overall Study Standard of Care|Other|1
7730029|NCT00947349|26879946|P3|Overall Study Standard of Care|Other|0
7730030|NCT00947349|26879947|P2|Overall Study Standard of Care|Other|0
7730031|NCT00947349|26879948|P1|Overall Study Standard of Care|Other|0
7730032|NCT00947349|26879945|P4|Overall Study Standard of Care|Withdrawal by Subject|0
7730033|NCT00947349|26879946|P3|Overall Study Standard of Care|Withdrawal by Subject|1
7730034|NCT00947349|26879947|P2|Overall Study Standard of Care|Withdrawal by Subject|0
7730035|NCT00947349|26879948|P1|Overall Study Standard of Care|Withdrawal by Subject|0
7730036|NCT00947349|26879945|P4|Overall Study Standard of Care|Lack of Efficacy|1
7730037|NCT00947349|26879946|P3|Overall Study Standard of Care|Lack of Efficacy|1
7730038|NCT00947349|26879947|P2|Overall Study Standard of Care|Lack of Efficacy|0
7730039|NCT00947349|26879948|P1|Overall Study Standard of Care|Lack of Efficacy|0
7730040|NCT00947349|26879945|P4|Triple Treatment Combination Period|Adverse Event|0
7730041|NCT00947349|26879946|P3|Triple Treatment Combination Period|Adverse Event|0
7730042|NCT00947349|26879947|P2|Triple Treatment Combination Period|Adverse Event|1
7730043|NCT00947349|26879948|P1|Triple Treatment Combination Period|Adverse Event|0
7730044|NCT00947193|26880157|P2|Overall Study|Factor VIII >1%|0
7730045|NCT00947193|26880158|P1|Overall Study|Factor VIII >1%|1
7730046|NCT00947193|26880157|P2|Overall Study|Withdrawal by Subject|0
7730047|NCT00947193|26880158|P1|Overall Study|Withdrawal by Subject|1
7730048|NCT00947193|26880157|P2|Overall Study|Lost to Follow-up|0
7730049|NCT00947193|26880158|P1|Overall Study|Lost to Follow-up|1
7730050|NCT00947154|26880173|P1|Overall Study|Lost to Follow-up|1
7730051|NCT00947115|26880183|P3|Overall Study|Lost to Follow-up|8
7730052|NCT00947115|26880184|P2|Overall Study|Lost to Follow-up|12
7730053|NCT00947115|26880185|P1|Overall Study|Lost to Follow-up|11
7730054|NCT00947115|26880183|P3|Overall Study|Withdrawal by Subject|4
7730055|NCT00947115|26880184|P2|Overall Study|Withdrawal by Subject|3
7730056|NCT00947115|26880185|P1|Overall Study|Withdrawal by Subject|1
7730057|NCT00947115|26880183|P3|Overall Study|Migrated from study area|0
7730058|NCT00947115|26880184|P2|Overall Study|Migrated from study area|0
7730059|NCT00947115|26880185|P1|Overall Study|Migrated from study area|2
7730060|NCT00947115|26880183|P3|Overall Study|Death|1
7730061|NCT00947115|26880184|P2|Overall Study|Death|1
7730062|NCT00947115|26880185|P1|Overall Study|Death|0
7730063|NCT00947115|26880183|P3|Overall Study|Physician Decision|0
7730064|NCT00947115|26880184|P2|Overall Study|Physician Decision|2
7730065|NCT00947115|26880185|P1|Overall Study|Physician Decision|0
7730066|NCT00947115|26880183|P3|Overall Study|Missed reporting interval|2
7730067|NCT00947115|26880184|P2|Overall Study|Missed reporting interval|4
7730068|NCT00947115|26880185|P1|Overall Study|Missed reporting interval|3
7730069|NCT00947011|26880247|P1|Overall Study|Study was terminated,PI left institution|12
7730070|NCT00946998|26880257|P2|Overall Study|Exited prior to first outcome assessment|3
7730071|NCT00946998|26880258|P1|Overall Study|Exited prior to first outcome assessment|5
7730072|NCT00946985|26880272|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
7730073|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
7730074|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
7730075|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
7730076|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
7730077|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
7730078|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
7730079|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
7730080|NCT00946985|26880272|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
7730081|NCT00946920|26880278|P2|Overall Study|Miscellaneous reasons|3
7730082|NCT00946920|26880279|P1|Overall Study|Miscellaneous reasons|18
7730083|NCT00946920|26880278|P2|Overall Study|Protocol Violation|8
7730084|NCT00946920|26880279|P1|Overall Study|Protocol Violation|16
7730085|NCT00946920|26880278|P2|Overall Study|Adverse Event|14
7730086|NCT00946920|26880279|P1|Overall Study|Adverse Event|41
7730087|NCT00946920|26880278|P2|Overall Study|Physician Decision|2
7730088|NCT00946920|26880279|P1|Overall Study|Physician Decision|5
7730089|NCT00946920|26880278|P2|Overall Study|Lost to Follow-up|2
7730090|NCT00946920|26880279|P1|Overall Study|Lost to Follow-up|2
7730091|NCT00946920|26880278|P2|Overall Study|Withdrawal by Subject|15
7730092|NCT00946920|26880279|P1|Overall Study|Withdrawal by Subject|28
7730093|NCT00946881|26880294|P1|Retreatment|Withdrawal by Subject|1
7730094|NCT00946881|26880294|P1|First Treatment|Patient relocated to another state|1
7730095|NCT00946881|26880294|P1|First Treatment|Withdrawal by Subject|1
7730096|NCT00946712|26880325|P2|Overall Study|Ineligible|6
7730097|NCT00946712|26880326|P1|Overall Study|Ineligible|14
7730098|NCT00946712|26880325|P2|Overall Study|On Treatment|4
7730099|NCT00946712|26880326|P1|Overall Study|On Treatment|0
7730100|NCT00946712|26880325|P2|Overall Study|Other reasons|73
7730101|NCT00946712|26880326|P1|Overall Study|Other reasons|61
7730102|NCT00946712|26880325|P2|Overall Study|No treatment given|29
7730103|NCT00946712|26880326|P1|Overall Study|No treatment given|25
7730104|NCT00946712|26880325|P2|Overall Study|Death|22
7730105|NCT00946712|26880326|P1|Overall Study|Death|21
7730106|NCT00946712|26880325|P2|Overall Study|Disease progression|404
7730107|NCT00946712|26880326|P1|Overall Study|Disease progression|308
7730108|NCT00946712|26880325|P2|Overall Study|Adverse Event|124
7730109|NCT00946712|26880326|P1|Overall Study|Adverse Event|118
7730110|NCT00946647|26880345|P5|Phase ll Part|Subj cond no longer required study drug|0
7730111|NCT00946647|26880346|P4|Phase ll Part|Subj cond no longer required study drug|2
7730112|NCT00946647|26880347|P3|Phase ll Part|Subj cond no longer required study drug|0
7730113|NCT00946647|26880348|P2|Phase ll Part|Subj cond no longer required study drug|0
7730114|NCT00946647|26880349|P1|Phase ll Part|Subj cond no longer required study drug|0
7730115|NCT00946647|26880345|P5|Phase ll Part|Protocol Violation|2
7730116|NCT00946647|26880346|P4|Phase ll Part|Protocol Violation|4
7730117|NCT00946647|26880347|P3|Phase ll Part|Protocol Violation|0
7730118|NCT00946647|26880348|P2|Phase ll Part|Protocol Violation|0
7730119|NCT00946647|26880349|P1|Phase ll Part|Protocol Violation|0
7730120|NCT00946647|26880345|P5|Phase ll Part|Disease progression|14
7730121|NCT00946647|26880346|P4|Phase ll Part|Disease progression|6
7730122|NCT00946647|26880347|P3|Phase ll Part|Disease progression|0
7730123|NCT00946647|26880348|P2|Phase ll Part|Disease progression|0
7730124|NCT00946647|26880349|P1|Phase ll Part|Disease progression|0
7730125|NCT00946647|26880345|P5|Phase ll Part|Death|4
7730126|NCT00946647|26880346|P4|Phase ll Part|Death|7
7730127|NCT00946647|26880347|P3|Phase ll Part|Death|0
7730128|NCT00946647|26880348|P2|Phase ll Part|Death|0
7730129|NCT00946647|26880349|P1|Phase ll Part|Death|0
7730130|NCT00946647|26880345|P5|Phase ll Part|Administrative problems|8
7730131|NCT00946647|26880346|P4|Phase ll Part|Administrative problems|3
7730132|NCT00946647|26880347|P3|Phase ll Part|Administrative problems|0
7730133|NCT00946647|26880348|P2|Phase ll Part|Administrative problems|0
7730134|NCT00946647|26880349|P1|Phase ll Part|Administrative problems|0
7730135|NCT00946647|26880345|P5|Phase ll Part|Withdrawal by Subject|6
7730136|NCT00946647|26880346|P4|Phase ll Part|Withdrawal by Subject|8
7730137|NCT00946647|26880347|P3|Phase ll Part|Withdrawal by Subject|0
7730138|NCT00946647|26880348|P2|Phase ll Part|Withdrawal by Subject|0
7730139|NCT00946647|26880349|P1|Phase ll Part|Withdrawal by Subject|0
7730140|NCT00946647|26880345|P5|Phase ll Part|Adverse Event|6
7730141|NCT00946647|26880346|P4|Phase ll Part|Adverse Event|10
7730142|NCT00946647|26880347|P3|Phase ll Part|Adverse Event|0
7730143|NCT00946647|26880348|P2|Phase ll Part|Adverse Event|0
7730144|NCT00946647|26880349|P1|Phase ll Part|Adverse Event|0
7730145|NCT00946647|26880345|P5|Phase ll Part|Untreated|2
7730146|NCT00946647|26880346|P4|Phase ll Part|Untreated|0
7730147|NCT00946647|26880347|P3|Phase ll Part|Untreated|0
7730148|NCT00946647|26880348|P2|Phase ll Part|Untreated|0
7730149|NCT00946647|26880349|P1|Phase ll Part|Untreated|0
7730150|NCT00946647|26880345|P5|Phase 1 Part|Reason missing|0
7730151|NCT00946647|26880346|P4|Phase 1 Part|Reason missing|0
7730152|NCT00946647|26880347|P3|Phase 1 Part|Reason missing|0
7730153|NCT00946647|26880348|P2|Phase 1 Part|Reason missing|1
7730154|NCT00946647|26880349|P1|Phase 1 Part|Reason missing|0
7730155|NCT00946647|26880345|P5|Phase 1 Part|Abnormal values|0
7730156|NCT00946647|26880346|P4|Phase 1 Part|Abnormal values|0
7730157|NCT00946647|26880347|P3|Phase 1 Part|Abnormal values|0
7730158|NCT00946647|26880348|P2|Phase 1 Part|Abnormal values|2
7730159|NCT00946647|26880349|P1|Phase 1 Part|Abnormal values|0
7730160|NCT00946647|26880345|P5|Phase 1 Part|Withdrawal by Subject|0
7730161|NCT00946647|26880346|P4|Phase 1 Part|Withdrawal by Subject|0
7730162|NCT00946647|26880347|P3|Phase 1 Part|Withdrawal by Subject|3
7730163|NCT00946647|26880348|P2|Phase 1 Part|Withdrawal by Subject|4
7730164|NCT00946647|26880349|P1|Phase 1 Part|Withdrawal by Subject|1
7730165|NCT00946647|26880345|P5|Phase 1 Part|Disease progression|0
7730166|NCT00946647|26880346|P4|Phase 1 Part|Disease progression|0
7730167|NCT00946647|26880347|P3|Phase 1 Part|Disease progression|1
7730168|NCT00946647|26880348|P2|Phase 1 Part|Disease progression|6
7730169|NCT00946647|26880349|P1|Phase 1 Part|Disease progression|3
7730170|NCT00946647|26880345|P5|Phase 1 Part|Adverse Event|0
7730171|NCT00946647|26880346|P4|Phase 1 Part|Adverse Event|0
7730172|NCT00946647|26880347|P3|Phase 1 Part|Adverse Event|3
7730173|NCT00946647|26880348|P2|Phase 1 Part|Adverse Event|5
7730174|NCT00946647|26880349|P1|Phase 1 Part|Adverse Event|2
7730175|NCT00946530|26880383|P4|Overall Study|Physician Decision|1
7730176|NCT00946530|26880384|P3|Overall Study|Physician Decision|1
7730177|NCT00946530|26880385|P2|Overall Study|Physician Decision|1
7730178|NCT00946530|26880386|P1|Overall Study|Physician Decision|1
7730179|NCT00946530|26880383|P4|Overall Study|Withdrawal by Subject|3
7730180|NCT00946530|26880384|P3|Overall Study|Withdrawal by Subject|0
7730181|NCT00946530|26880385|P2|Overall Study|Withdrawal by Subject|3
7730182|NCT00946530|26880386|P1|Overall Study|Withdrawal by Subject|0
7730183|NCT00946322|26880418|P1|Post-treatment|participant failure to follow up|2
7730184|NCT00946322|26880418|P1|Pre-treatment|participant failure to follow up|1
7730185|NCT00946309|26880431|P2|Overall Study|Procedure cancelled/discontinued|3
7730186|NCT00946309|26880432|P1|Overall Study|Procedure cancelled/discontinued|0
7730187|NCT00946309|26880431|P2|Overall Study|Lost to Follow-up|1
7730188|NCT00946309|26880432|P1|Overall Study|Lost to Follow-up|0
7730189|NCT00946309|26880431|P2|Overall Study|Protocol Violation|0
7730190|NCT00946309|26880432|P1|Overall Study|Protocol Violation|1
7730191|NCT00946296|26880450|P2|Overall Study|Physician Decision|0
7730192|NCT00946296|26880451|P1|Overall Study|Physician Decision|3
7730193|NCT00946192|26880473|P3|Overall Study|Did not start medication|0
7730194|NCT00946192|26880474|P2|Overall Study|Did not start medication|0
7730195|NCT00946192|26880475|P1|Overall Study|Did not start medication|2
7730196|NCT00946192|26880473|P3|Overall Study|Withdrawal by Subject|3
7730197|NCT00946192|26880474|P2|Overall Study|Withdrawal by Subject|7
7730198|NCT00946192|26880475|P1|Overall Study|Withdrawal by Subject|10
7730199|NCT00946192|26880473|P3|Overall Study|Lost to Follow-up|9
7730200|NCT00946192|26880474|P2|Overall Study|Lost to Follow-up|11
7730201|NCT00946192|26880475|P1|Overall Study|Lost to Follow-up|6
7730202|NCT00946153|26880491|P5|Phase 2|14 days washout for recovery due to AE|4
7730203|NCT00946153|26880492|P4|Phase 2|14 days washout for recovery due to AE|0
7730204|NCT00946153|26880493|P3|Phase 2|14 days washout for recovery due to AE|0
7730205|NCT00946153|26880494|P2|Phase 2|14 days washout for recovery due to AE|0
7730206|NCT00946153|26880495|P1|Phase 2|14 days washout for recovery due to AE|0
7730207|NCT00946153|26880491|P5|Phase 2|Physician Decision|1
7730208|NCT00946153|26880492|P4|Phase 2|Physician Decision|0
7730209|NCT00946153|26880493|P3|Phase 2|Physician Decision|0
7730210|NCT00946153|26880494|P2|Phase 2|Physician Decision|0
7730211|NCT00946153|26880495|P1|Phase 2|Physician Decision|0
7730212|NCT00946153|26880491|P5|Phase 2|Need more reduction of dose|2
7730213|NCT00946153|26880492|P4|Phase 2|Need more reduction of dose|0
7730214|NCT00946153|26880493|P3|Phase 2|Need more reduction of dose|0
7730215|NCT00946153|26880494|P2|Phase 2|Need more reduction of dose|0
7730216|NCT00946153|26880495|P1|Phase 2|Need more reduction of dose|0
7730217|NCT00946153|26880491|P5|Phase 2|Adverse Event|6
7730218|NCT00946153|26880492|P4|Phase 2|Adverse Event|0
7730219|NCT00946153|26880493|P3|Phase 2|Adverse Event|0
7730220|NCT00946153|26880494|P2|Phase 2|Adverse Event|0
7730221|NCT00946153|26880495|P1|Phase 2|Adverse Event|0
7730222|NCT00946114|26880523|P2|Overall Study|Withdrawal by Subject|0
7730223|NCT00946114|26880524|P1|Overall Study|Withdrawal by Subject|2
7730224|NCT00946114|26880523|P2|Overall Study|Other|0
7730225|NCT00946114|26880524|P1|Overall Study|Other|1
7730226|NCT00946114|26880523|P2|Overall Study|Death|2
7730227|NCT00946114|26880524|P1|Overall Study|Death|5
7730228|NCT00946101|26880532|P2|Overall Study|Physician Decision|1
7730229|NCT00946101|26880533|P1|Overall Study|Physician Decision|0
7730230|NCT00946101|26880532|P2|Overall Study|Withdrawal of consent|0
7730231|NCT00946101|26880533|P1|Overall Study|Withdrawal of consent|2
7730232|NCT00946101|26880532|P2|Overall Study|Lost to Follow-up|1
7730233|NCT00946101|26880533|P1|Overall Study|Lost to Follow-up|2
7730234|NCT00946088|26880599|P2|Overall Study|Withdrawal by Subject|1
7730235|NCT00946088|26880600|P1|Overall Study|Withdrawal by Subject|0
7730236|NCT00945945|26880644|P2|Overall Study|Entry Criteria Not Met|1
7730237|NCT00945945|26880645|P1|Overall Study|Entry Criteria Not Met|0
7730238|NCT00945945|26880644|P2|Overall Study|Protocol Violation|2
7730239|NCT00945945|26880645|P1|Overall Study|Protocol Violation|4
7730240|NCT00945945|26880644|P2|Overall Study|Lack of Efficacy|2
7730241|NCT00945945|26880645|P1|Overall Study|Lack of Efficacy|6
7730242|NCT00945945|26880644|P2|Overall Study|Lost to Follow-up|5
7730243|NCT00945945|26880645|P1|Overall Study|Lost to Follow-up|4
7730244|NCT00945945|26880644|P2|Overall Study|Withdrawal by Subject|10
7730245|NCT00945945|26880645|P1|Overall Study|Withdrawal by Subject|7
7730246|NCT00945945|26880644|P2|Overall Study|Adverse Event|35
7730247|NCT00945945|26880645|P1|Overall Study|Adverse Event|15
7730248|NCT00945906|26880671|P1|Overall Study|Moved to another country|2
7730249|NCT00945906|26880671|P1|Overall Study|Unable to return for last visit|2
7730250|NCT00945906|26880671|P1|Overall Study|Did not want to return for last visit|2
7730251|NCT00945906|26880671|P1|Overall Study|Withdrawal by Subject|1
7730252|NCT00945893|26880682|P2|Overall Study|Withdrawal of consent|2
7730253|NCT00945893|26880683|P1|Overall Study|Withdrawal of consent|1
7730254|NCT00945893|26880682|P2|Overall Study|Lost to Follow-up|8
7730255|NCT00945893|26880683|P1|Overall Study|Lost to Follow-up|2
7730256|NCT00945815|26880760|P1|Overall Study|Did not begin protocol therapy|1
7730257|NCT00945815|26880760|P1|Overall Study|Ineligible|3
7730258|NCT00945815|26880760|P1|Overall Study|Not protocol specified|1
7730259|NCT00945815|26880760|P1|Overall Study|Death|3
7730260|NCT00945659|26880792|P3|Overall Study|Lost to Follow-up|17
7730261|NCT00945659|26880793|P2|Overall Study|Lost to Follow-up|20
7730262|NCT00945659|26880794|P1|Overall Study|Lost to Follow-up|7
7730263|NCT00945555|26880851|P1|Overall Study|Other|1
7730264|NCT00945555|26880851|P1|Overall Study|Death|18
7730265|NCT00945555|26880851|P1|Overall Study|Participant continued treatment at home|1
7730266|NCT00945555|26880851|P1|Overall Study|Withdrawal by Subject|2
7730267|NCT00945555|26880851|P1|Overall Study|Worsening condition, intensive care unit|1
7730268|NCT00945555|26880851|P1|Overall Study|Referred to another hospital|5
7730269|NCT00945477|26880862|P1|Overall Study|Withdrawal by Subject|1
7730270|NCT00945477|26880862|P1|Overall Study|Lack of Efficacy|2
7730271|NCT00945477|26880862|P1|Overall Study|Adverse Event|3
7730272|NCT00945321|26880878|P6|Period 4|Lost to Follow-up|1
7730273|NCT00945321|26880879|P5|Period 4|Lost to Follow-up|0
7730274|NCT00945321|26880880|P4|Period 4|Lost to Follow-up|0
7730275|NCT00945321|26880881|P3|Period 4|Lost to Follow-up|0
7730276|NCT00945321|26880882|P2|Period 4|Lost to Follow-up|0
7730277|NCT00945321|26880883|P1|Period 4|Lost to Follow-up|0
7730278|NCT00945321|26880878|P6|Period 1|Adverse Event|0
7730279|NCT00945321|26880879|P5|Period 1|Adverse Event|1
7730280|NCT00945321|26880880|P4|Period 1|Adverse Event|0
7730281|NCT00945321|26880881|P3|Period 1|Adverse Event|0
7730282|NCT00945321|26880882|P2|Period 1|Adverse Event|0
7730283|NCT00945321|26880883|P1|Period 1|Adverse Event|0
7730284|NCT00945243|26881016|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
7730285|NCT00945191|26881022|P1|Overall Study|Investigator's discretion|1
7730286|NCT00945191|26881022|P1|Overall Study|Serious adverse event or adverse event|1
7730287|NCT00945191|26881022|P1|Overall Study|Disease progression|3
7730288|NCT00945191|26881022|P1|Overall Study|Participant relocated to another state|1
7730289|NCT00945191|26881022|P1|Overall Study|Did not achieve a complete response|18
7730290|NCT00945009|26881218|P3|Overall Study|Refusal of further protocol|0
7730291|NCT00945009|26881219|P2|Overall Study|Refusal of further protocol|0
7730292|NCT00945009|26881220|P1|Overall Study|Refusal of further protocol|1
7730293|NCT00945009|26881218|P3|Overall Study|Inevaluable|0
7730294|NCT00945009|26881219|P2|Overall Study|Inevaluable|1
7730295|NCT00945009|26881220|P1|Overall Study|Inevaluable|0
7730296|NCT00945009|26881218|P3|Overall Study|Ineligible|0
7730297|NCT00945009|26881219|P2|Overall Study|Ineligible|1
7730298|NCT00945009|26881220|P1|Overall Study|Ineligible|6
7730299|NCT00945009|26881218|P3|Overall Study|Withdrawal by Subject|0
7730300|NCT00945009|26881219|P2|Overall Study|Withdrawal by Subject|0
7730301|NCT00945009|26881220|P1|Overall Study|Withdrawal by Subject|1
7730302|NCT00945009|26881218|P3|Overall Study|Protocol Violation|0
7730303|NCT00945009|26881219|P2|Overall Study|Protocol Violation|1
7730304|NCT00945009|26881220|P1|Overall Study|Protocol Violation|6
7730305|NCT00945009|26881218|P3|Overall Study|Physician Decision|3
7730306|NCT00945009|26881219|P2|Overall Study|Physician Decision|4
7730307|NCT00945009|26881220|P1|Overall Study|Physician Decision|21
7730308|NCT00945009|26881218|P3|Overall Study|Lack of Efficacy|0
7730309|NCT00945009|26881219|P2|Overall Study|Lack of Efficacy|0
7730310|NCT00945009|26881220|P1|Overall Study|Lack of Efficacy|10
7730311|NCT00944697|26881296|P2|Overall Study|Administrative|1
7730312|NCT00944697|26881297|P1|Overall Study|Administrative|1
7730313|NCT00944697|26881296|P2|Overall Study|Adverse Event|3
7730314|NCT00944697|26881297|P1|Overall Study|Adverse Event|0
7730315|NCT00944697|26881296|P2|Overall Study|Withdrawal by Subject|1
7730316|NCT00944697|26881297|P1|Overall Study|Withdrawal by Subject|1
7730317|NCT00944658|26881329|P2|Treatment 12 Weeks|Adverse Event|2
7730318|NCT00944658|26881330|P1|Treatment 12 Weeks|Adverse Event|0
7730319|NCT00944645|26881342|P2|Period 2|Withdrawal by Subject|6
7730320|NCT00944645|26881343|P1|Period 2|Withdrawal by Subject|7
7730321|NCT00944645|26881342|P2|Period 2|Lost to Follow-up|3
7730322|NCT00944645|26881343|P1|Period 2|Lost to Follow-up|0
7730323|NCT00944645|26881342|P2|Period 2|Adverse Event|0
7730324|NCT00944645|26881343|P1|Period 2|Adverse Event|1
7730325|NCT00944229|26881390|P1|Overall Study|Physician Decision|14
7730326|NCT00944229|26881390|P1|Overall Study|Withdrawal by Subject|11
7730327|NCT00944125|26881396|P2|6 Months to Study Completion|Withdrawal by Subject|2
7730328|NCT00944125|26881397|P1|6 Months to Study Completion|Withdrawal by Subject|0
7730329|NCT00944125|26881396|P2|3 to 6 Months|Withdrawal by Subject|2
7730330|NCT00944125|26881397|P1|3 to 6 Months|Withdrawal by Subject|0
7730331|NCT00944034|26881500|P12|Overall Study|Administrative reason|0
7730332|NCT00944034|26881501|P11|Overall Study|Administrative reason|0
7730333|NCT00944034|26881502|P10|Overall Study|Administrative reason|0
7730334|NCT00944034|26881503|P9|Overall Study|Administrative reason|0
7730335|NCT00944034|26881504|P8|Overall Study|Administrative reason|0
7730336|NCT00944034|26881505|P7|Overall Study|Administrative reason|1
7730337|NCT00944034|26881506|P6|Overall Study|Administrative reason|0
7730338|NCT00944034|26881507|P5|Overall Study|Administrative reason|0
7730339|NCT00944034|26881508|P4|Overall Study|Administrative reason|0
7730340|NCT00944034|26881509|P3|Overall Study|Administrative reason|0
7730341|NCT00944034|26881510|P2|Overall Study|Administrative reason|0
7730342|NCT00944034|26881511|P1|Overall Study|Administrative reason|0
7730343|NCT00944034|26881500|P12|Overall Study|Unable to classify|0
7730344|NCT00944034|26881501|P11|Overall Study|Unable to classify|0
7730345|NCT00944034|26881502|P10|Overall Study|Unable to classify|0
7730346|NCT00944034|26881503|P9|Overall Study|Unable to classify|0
7730347|NCT00944034|26881504|P8|Overall Study|Unable to classify|1
7730348|NCT00944034|26881505|P7|Overall Study|Unable to classify|1
7730349|NCT00944034|26881506|P6|Overall Study|Unable to classify|1
7730350|NCT00944034|26881507|P5|Overall Study|Unable to classify|0
7730351|NCT00944034|26881508|P4|Overall Study|Unable to classify|0
7730352|NCT00944034|26881509|P3|Overall Study|Unable to classify|0
7730353|NCT00944034|26881510|P2|Overall Study|Unable to classify|0
7730354|NCT00944034|26881511|P1|Overall Study|Unable to classify|0
7730355|NCT00944034|26881500|P12|Overall Study|Protocol Violation|0
7730356|NCT00944034|26881501|P11|Overall Study|Protocol Violation|0
7730357|NCT00944034|26881502|P10|Overall Study|Protocol Violation|4
7730358|NCT00944034|26881503|P9|Overall Study|Protocol Violation|1
7730359|NCT00944034|26881504|P8|Overall Study|Protocol Violation|1
7730360|NCT00944034|26881505|P7|Overall Study|Protocol Violation|0
7730361|NCT00944034|26881506|P6|Overall Study|Protocol Violation|3
7730362|NCT00944034|26881507|P5|Overall Study|Protocol Violation|2
7730363|NCT00944034|26881508|P4|Overall Study|Protocol Violation|1
7730364|NCT00944034|26881509|P3|Overall Study|Protocol Violation|0
7730365|NCT00944034|26881510|P2|Overall Study|Protocol Violation|0
7730366|NCT00944034|26881511|P1|Overall Study|Protocol Violation|2
7730367|NCT00944034|26881500|P12|Overall Study|Death|0
7730368|NCT00944034|26881501|P11|Overall Study|Death|0
7730369|NCT00944034|26881502|P10|Overall Study|Death|0
7730370|NCT00944034|26881503|P9|Overall Study|Death|0
7730371|NCT00944034|26881504|P8|Overall Study|Death|0
7730372|NCT00944034|26881505|P7|Overall Study|Death|0
7730373|NCT00944034|26881506|P6|Overall Study|Death|0
7730374|NCT00944034|26881507|P5|Overall Study|Death|0
7730375|NCT00944034|26881508|P4|Overall Study|Death|0
7730376|NCT00944034|26881509|P3|Overall Study|Death|1
7730377|NCT00944034|26881510|P2|Overall Study|Death|0
7730378|NCT00944034|26881511|P1|Overall Study|Death|0
7730379|NCT00944034|26881500|P12|Overall Study|Lost to Follow-up|0
7730380|NCT00944034|26881501|P11|Overall Study|Lost to Follow-up|1
7730381|NCT00944034|26881502|P10|Overall Study|Lost to Follow-up|1
7730382|NCT00944034|26881503|P9|Overall Study|Lost to Follow-up|5
7730383|NCT00944034|26881504|P8|Overall Study|Lost to Follow-up|1
7730384|NCT00944034|26881505|P7|Overall Study|Lost to Follow-up|0
7730385|NCT00944034|26881506|P6|Overall Study|Lost to Follow-up|7
7730386|NCT00944034|26881507|P5|Overall Study|Lost to Follow-up|5
7730387|NCT00944034|26881508|P4|Overall Study|Lost to Follow-up|0
7730388|NCT00944034|26881509|P3|Overall Study|Lost to Follow-up|2
7730389|NCT00944034|26881510|P2|Overall Study|Lost to Follow-up|4
7730390|NCT00944034|26881511|P1|Overall Study|Lost to Follow-up|0
7730391|NCT00944034|26881500|P12|Overall Study|Withdrawal by Subject|4
7730392|NCT00944034|26881501|P11|Overall Study|Withdrawal by Subject|0
7730393|NCT00944034|26881502|P10|Overall Study|Withdrawal by Subject|4
7730394|NCT00944034|26881503|P9|Overall Study|Withdrawal by Subject|3
7730395|NCT00944034|26881504|P8|Overall Study|Withdrawal by Subject|2
7730396|NCT00944034|26881505|P7|Overall Study|Withdrawal by Subject|2
7730397|NCT00944034|26881506|P6|Overall Study|Withdrawal by Subject|8
7730398|NCT00944034|26881507|P5|Overall Study|Withdrawal by Subject|5
7730399|NCT00944034|26881508|P4|Overall Study|Withdrawal by Subject|2
7730400|NCT00944034|26881509|P3|Overall Study|Withdrawal by Subject|6
7730401|NCT00944034|26881510|P2|Overall Study|Withdrawal by Subject|2
7730402|NCT00944034|26881511|P1|Overall Study|Withdrawal by Subject|3
7730403|NCT00944034|26881500|P12|Overall Study|Inappropriate enrollment|0
7730404|NCT00944034|26881501|P11|Overall Study|Inappropriate enrollment|0
7730405|NCT00944034|26881502|P10|Overall Study|Inappropriate enrollment|1
7730406|NCT00944034|26881503|P9|Overall Study|Inappropriate enrollment|1
7730407|NCT00944034|26881504|P8|Overall Study|Inappropriate enrollment|0
7730408|NCT00944034|26881505|P7|Overall Study|Inappropriate enrollment|0
7730409|NCT00944034|26881506|P6|Overall Study|Inappropriate enrollment|1
7730410|NCT00944034|26881507|P5|Overall Study|Inappropriate enrollment|2
7730411|NCT00944034|26881508|P4|Overall Study|Inappropriate enrollment|1
7730412|NCT00944034|26881509|P3|Overall Study|Inappropriate enrollment|0
7730413|NCT00944034|26881510|P2|Overall Study|Inappropriate enrollment|1
7730414|NCT00944034|26881511|P1|Overall Study|Inappropriate enrollment|0
7730415|NCT00943917|26881657|P15|Stage II Continuation|A1C elevation|0
7730416|NCT00943917|26881658|P14|Stage II Continuation|A1C elevation|1
7730417|NCT00943917|26881659|P13|Stage II Continuation|A1C elevation|0
7730418|NCT00943917|26881660|P12|Stage II Continuation|A1C elevation|0
7730419|NCT00943917|26881661|P11|Stage II Continuation|A1C elevation|0
7730420|NCT00943917|26881662|P10|Stage II Continuation|A1C elevation|0
7730421|NCT00943917|26881663|P9|Stage II Continuation|A1C elevation|0
7730422|NCT00943917|26881664|P8|Stage II Continuation|A1C elevation|0
7730423|NCT00943917|26881665|P7|Stage II Continuation|A1C elevation|0
7730424|NCT00943917|26881666|P6|Stage II Continuation|A1C elevation|0
7730425|NCT00943917|26881667|P5|Stage II Continuation|A1C elevation|0
7730426|NCT00943917|26881668|P4|Stage II Continuation|A1C elevation|0
7730427|NCT00943917|26881669|P3|Stage II Continuation|A1C elevation|0
7730428|NCT00943917|26881670|P2|Stage II Continuation|A1C elevation|0
7730429|NCT00943917|26881671|P1|Stage II Continuation|A1C elevation|0
7730430|NCT00943917|26881657|P15|Stage II Continuation|hypoglycemia|0
7730431|NCT00943917|26881658|P14|Stage II Continuation|hypoglycemia|0
7730432|NCT00943917|26881659|P13|Stage II Continuation|hypoglycemia|1
7730433|NCT00943917|26881660|P12|Stage II Continuation|hypoglycemia|0
7730434|NCT00943917|26881661|P11|Stage II Continuation|hypoglycemia|0
7730435|NCT00943917|26881662|P10|Stage II Continuation|hypoglycemia|0
7730436|NCT00943917|26881663|P9|Stage II Continuation|hypoglycemia|0
7730437|NCT00943917|26881664|P8|Stage II Continuation|hypoglycemia|0
7730438|NCT00943917|26881665|P7|Stage II Continuation|hypoglycemia|0
7730439|NCT00943917|26881666|P6|Stage II Continuation|hypoglycemia|0
7730440|NCT00943917|26881667|P5|Stage II Continuation|hypoglycemia|0
7730441|NCT00943917|26881668|P4|Stage II Continuation|hypoglycemia|0
7730442|NCT00943917|26881669|P3|Stage II Continuation|hypoglycemia|0
7730443|NCT00943917|26881670|P2|Stage II Continuation|hypoglycemia|0
7730444|NCT00943917|26881671|P1|Stage II Continuation|hypoglycemia|0
7730445|NCT00943917|26881657|P15|Stage II Continuation|Protocol Violation|0
7730446|NCT00943917|26881658|P14|Stage II Continuation|Protocol Violation|0
7730447|NCT00943917|26881659|P13|Stage II Continuation|Protocol Violation|0
7730448|NCT00943917|26881660|P12|Stage II Continuation|Protocol Violation|1
7730449|NCT00943917|26881661|P11|Stage II Continuation|Protocol Violation|0
7730450|NCT00943917|26881662|P10|Stage II Continuation|Protocol Violation|1
7730451|NCT00943917|26881663|P9|Stage II Continuation|Protocol Violation|0
7730452|NCT00943917|26881664|P8|Stage II Continuation|Protocol Violation|0
7730453|NCT00943917|26881665|P7|Stage II Continuation|Protocol Violation|0
7730454|NCT00943917|26881666|P6|Stage II Continuation|Protocol Violation|0
7730455|NCT00943917|26881667|P5|Stage II Continuation|Protocol Violation|0
7730456|NCT00943917|26881668|P4|Stage II Continuation|Protocol Violation|0
7730457|NCT00943917|26881669|P3|Stage II Continuation|Protocol Violation|0
7730458|NCT00943917|26881670|P2|Stage II Continuation|Protocol Violation|0
7730459|NCT00943917|26881671|P1|Stage II Continuation|Protocol Violation|0
7730460|NCT00943917|26881657|P15|Stage II Continuation|Withdrawal by Subject|3
7730461|NCT00943917|26881658|P14|Stage II Continuation|Withdrawal by Subject|1
7730462|NCT00943917|26881659|P13|Stage II Continuation|Withdrawal by Subject|0
7730463|NCT00943917|26881660|P12|Stage II Continuation|Withdrawal by Subject|0
7730464|NCT00943917|26881661|P11|Stage II Continuation|Withdrawal by Subject|0
7730465|NCT00943917|26881662|P10|Stage II Continuation|Withdrawal by Subject|0
7730466|NCT00943917|26881663|P9|Stage II Continuation|Withdrawal by Subject|0
7730467|NCT00943917|26881664|P8|Stage II Continuation|Withdrawal by Subject|0
7730468|NCT00943917|26881665|P7|Stage II Continuation|Withdrawal by Subject|0
7730469|NCT00943917|26881666|P6|Stage II Continuation|Withdrawal by Subject|0
7730470|NCT00943917|26881667|P5|Stage II Continuation|Withdrawal by Subject|0
7730471|NCT00943917|26881668|P4|Stage II Continuation|Withdrawal by Subject|0
7730472|NCT00943917|26881669|P3|Stage II Continuation|Withdrawal by Subject|0
7730473|NCT00943917|26881670|P2|Stage II Continuation|Withdrawal by Subject|0
7730474|NCT00943917|26881671|P1|Stage II Continuation|Withdrawal by Subject|0
7730475|NCT00943917|26881657|P15|Stage II Continuation|Adverse Event|1
7730476|NCT00943917|26881658|P14|Stage II Continuation|Adverse Event|1
7730477|NCT00943917|26881659|P13|Stage II Continuation|Adverse Event|2
7730478|NCT00943917|26881660|P12|Stage II Continuation|Adverse Event|1
7730479|NCT00943917|26881661|P11|Stage II Continuation|Adverse Event|0
7730480|NCT00943917|26881662|P10|Stage II Continuation|Adverse Event|0
7730481|NCT00943917|26881663|P9|Stage II Continuation|Adverse Event|0
7730482|NCT00943917|26881664|P8|Stage II Continuation|Adverse Event|0
7730483|NCT00943917|26881665|P7|Stage II Continuation|Adverse Event|0
7730484|NCT00943917|26881666|P6|Stage II Continuation|Adverse Event|0
7730485|NCT00943917|26881667|P5|Stage II Continuation|Adverse Event|0
7730486|NCT00943917|26881668|P4|Stage II Continuation|Adverse Event|0
7730487|NCT00943917|26881669|P3|Stage II Continuation|Adverse Event|0
7730488|NCT00943917|26881670|P2|Stage II Continuation|Adverse Event|0
7730489|NCT00943917|26881671|P1|Stage II Continuation|Adverse Event|0
7730490|NCT00943917|26881657|P15|Stage II|Pregnancy|0
7730491|NCT00943917|26881658|P14|Stage II|Pregnancy|0
7730492|NCT00943917|26881659|P13|Stage II|Pregnancy|0
7730493|NCT00943917|26881660|P12|Stage II|Pregnancy|0
7730494|NCT00943917|26881661|P11|Stage II|Pregnancy|0
7730495|NCT00943917|26881662|P10|Stage II|Pregnancy|0
7730496|NCT00943917|26881663|P9|Stage II|Pregnancy|0
7730497|NCT00943917|26881664|P8|Stage II|Pregnancy|0
7730498|NCT00943917|26881665|P7|Stage II|Pregnancy|0
7730499|NCT00943917|26881666|P6|Stage II|Pregnancy|1
7730500|NCT00943917|26881667|P5|Stage II|Pregnancy|0
7730501|NCT00943917|26881668|P4|Stage II|Pregnancy|0
7730502|NCT00943917|26881669|P3|Stage II|Pregnancy|0
7730503|NCT00943917|26881670|P2|Stage II|Pregnancy|0
7730504|NCT00943917|26881671|P1|Stage II|Pregnancy|0
7730505|NCT00943917|26881657|P15|Stage II|Withdrawal by Subject|0
7730506|NCT00943917|26881658|P14|Stage II|Withdrawal by Subject|0
7730507|NCT00943917|26881659|P13|Stage II|Withdrawal by Subject|0
7730508|NCT00943917|26881660|P12|Stage II|Withdrawal by Subject|0
7730509|NCT00943917|26881661|P11|Stage II|Withdrawal by Subject|0
7730510|NCT00943917|26881662|P10|Stage II|Withdrawal by Subject|0
7730511|NCT00943917|26881663|P9|Stage II|Withdrawal by Subject|0
7730512|NCT00943917|26881664|P8|Stage II|Withdrawal by Subject|0
7730513|NCT00943917|26881665|P7|Stage II|Withdrawal by Subject|0
7730514|NCT00943917|26881666|P6|Stage II|Withdrawal by Subject|1
7730515|NCT00943917|26881667|P5|Stage II|Withdrawal by Subject|0
7730516|NCT00943917|26881668|P4|Stage II|Withdrawal by Subject|0
7730517|NCT00943917|26881669|P3|Stage II|Withdrawal by Subject|0
7730518|NCT00943917|26881670|P2|Stage II|Withdrawal by Subject|0
7730519|NCT00943917|26881671|P1|Stage II|Withdrawal by Subject|0
7730520|NCT00943917|26881657|P15|Stage II|Adverse Event|0
7730521|NCT00943917|26881658|P14|Stage II|Adverse Event|0
7730522|NCT00943917|26881659|P13|Stage II|Adverse Event|0
7730523|NCT00943917|26881660|P12|Stage II|Adverse Event|0
7730524|NCT00943917|26881661|P11|Stage II|Adverse Event|0
7730525|NCT00943917|26881662|P10|Stage II|Adverse Event|0
7730526|NCT00943917|26881663|P9|Stage II|Adverse Event|1
7730527|NCT00943917|26881664|P8|Stage II|Adverse Event|0
7730528|NCT00943917|26881665|P7|Stage II|Adverse Event|3
7730529|NCT00943917|26881666|P6|Stage II|Adverse Event|1
7730530|NCT00943917|26881667|P5|Stage II|Adverse Event|0
7730531|NCT00943917|26881668|P4|Stage II|Adverse Event|0
7730532|NCT00943917|26881669|P3|Stage II|Adverse Event|0
7730533|NCT00943917|26881670|P2|Stage II|Adverse Event|0
7730534|NCT00943917|26881671|P1|Stage II|Adverse Event|0
7730535|NCT00943917|26881657|P15|Stage I|Withdrawal by Subject|0
7730536|NCT00943917|26881658|P14|Stage I|Withdrawal by Subject|0
7730537|NCT00943917|26881659|P13|Stage I|Withdrawal by Subject|0
7730538|NCT00943917|26881660|P12|Stage I|Withdrawal by Subject|0
7730539|NCT00943917|26881661|P11|Stage I|Withdrawal by Subject|0
7730540|NCT00943917|26881662|P10|Stage I|Withdrawal by Subject|0
7730541|NCT00943917|26881663|P9|Stage I|Withdrawal by Subject|0
7730542|NCT00943917|26881664|P8|Stage I|Withdrawal by Subject|0
7730543|NCT00943917|26881665|P7|Stage I|Withdrawal by Subject|0
7730544|NCT00943917|26881666|P6|Stage I|Withdrawal by Subject|0
7730545|NCT00943917|26881667|P5|Stage I|Withdrawal by Subject|0
7730546|NCT00943917|26881668|P4|Stage I|Withdrawal by Subject|0
7730547|NCT00943917|26881669|P3|Stage I|Withdrawal by Subject|2
7730548|NCT00943917|26881670|P2|Stage I|Withdrawal by Subject|1
7730549|NCT00943917|26881671|P1|Stage I|Withdrawal by Subject|2
7730550|NCT00943917|26881657|P15|Stage I|A1C elevation|0
7730551|NCT00943917|26881658|P14|Stage I|A1C elevation|0
7730552|NCT00943917|26881659|P13|Stage I|A1C elevation|0
7730553|NCT00943917|26881660|P12|Stage I|A1C elevation|0
7730554|NCT00943917|26881661|P11|Stage I|A1C elevation|0
7730555|NCT00943917|26881662|P10|Stage I|A1C elevation|0
7730556|NCT00943917|26881663|P9|Stage I|A1C elevation|0
7730557|NCT00943917|26881664|P8|Stage I|A1C elevation|0
7730558|NCT00943917|26881665|P7|Stage I|A1C elevation|0
7730559|NCT00943917|26881666|P6|Stage I|A1C elevation|0
7730560|NCT00943917|26881667|P5|Stage I|A1C elevation|0
7730561|NCT00943917|26881668|P4|Stage I|A1C elevation|0
7730562|NCT00943917|26881669|P3|Stage I|A1C elevation|0
7730563|NCT00943917|26881670|P2|Stage I|A1C elevation|0
7730564|NCT00943917|26881671|P1|Stage I|A1C elevation|1
7730565|NCT00943917|26881657|P15|Stage I|hyperglycemia|0
7730566|NCT00943917|26881658|P14|Stage I|hyperglycemia|0
7730567|NCT00943917|26881659|P13|Stage I|hyperglycemia|0
7730568|NCT00943917|26881660|P12|Stage I|hyperglycemia|0
7730569|NCT00943917|26881661|P11|Stage I|hyperglycemia|0
7730570|NCT00943917|26881662|P10|Stage I|hyperglycemia|0
7730571|NCT00943917|26881663|P9|Stage I|hyperglycemia|0
7730572|NCT00943917|26881664|P8|Stage I|hyperglycemia|0
7730573|NCT00943917|26881665|P7|Stage I|hyperglycemia|0
7730574|NCT00943917|26881666|P6|Stage I|hyperglycemia|0
7730575|NCT00943917|26881667|P5|Stage I|hyperglycemia|0
7730576|NCT00943917|26881668|P4|Stage I|hyperglycemia|0
7730577|NCT00943917|26881669|P3|Stage I|hyperglycemia|1
7730578|NCT00943917|26881670|P2|Stage I|hyperglycemia|0
7730579|NCT00943917|26881671|P1|Stage I|hyperglycemia|0
7730580|NCT00943917|26881657|P15|Stage I|Lost to Follow-up|0
7730581|NCT00943917|26881658|P14|Stage I|Lost to Follow-up|0
7730582|NCT00943917|26881659|P13|Stage I|Lost to Follow-up|0
7730583|NCT00943917|26881660|P12|Stage I|Lost to Follow-up|0
7730584|NCT00943917|26881661|P11|Stage I|Lost to Follow-up|0
7730585|NCT00943917|26881662|P10|Stage I|Lost to Follow-up|0
7730586|NCT00943917|26881663|P9|Stage I|Lost to Follow-up|0
7730587|NCT00943917|26881664|P8|Stage I|Lost to Follow-up|0
7730588|NCT00943917|26881665|P7|Stage I|Lost to Follow-up|0
7730589|NCT00943917|26881666|P6|Stage I|Lost to Follow-up|0
7730590|NCT00943917|26881667|P5|Stage I|Lost to Follow-up|0
7730591|NCT00943917|26881668|P4|Stage I|Lost to Follow-up|0
7730592|NCT00943917|26881669|P3|Stage I|Lost to Follow-up|1
7730593|NCT00943917|26881670|P2|Stage I|Lost to Follow-up|0
7730594|NCT00943917|26881671|P1|Stage I|Lost to Follow-up|0
7730595|NCT00943917|26881657|P15|Stage I|Adverse Event|0
7730596|NCT00943917|26881658|P14|Stage I|Adverse Event|0
7730597|NCT00943917|26881659|P13|Stage I|Adverse Event|0
7730598|NCT00943917|26881660|P12|Stage I|Adverse Event|0
7730599|NCT00943917|26881661|P11|Stage I|Adverse Event|0
7730600|NCT00943917|26881662|P10|Stage I|Adverse Event|0
7730601|NCT00943917|26881663|P9|Stage I|Adverse Event|0
7730602|NCT00943917|26881664|P8|Stage I|Adverse Event|0
7730603|NCT00943917|26881665|P7|Stage I|Adverse Event|0
7730604|NCT00943917|26881666|P6|Stage I|Adverse Event|0
7730605|NCT00943917|26881667|P5|Stage I|Adverse Event|0
7730606|NCT00943917|26881668|P4|Stage I|Adverse Event|0
7730607|NCT00943917|26881669|P3|Stage I|Adverse Event|2
7730608|NCT00943917|26881670|P2|Stage I|Adverse Event|2
7730609|NCT00943917|26881671|P1|Stage I|Adverse Event|1
7730610|NCT00943852|26881851|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
7730611|NCT00943852|26881852|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
7730612|NCT00943852|26881853|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
7730613|NCT00943852|26881854|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
7730614|NCT00943852|26881855|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
7730615|NCT00943852|26881856|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
7730616|NCT00943852|26881857|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
7730617|NCT00943852|26881858|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
7730618|NCT00943852|26881859|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
7730619|NCT00943852|26881860|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
7730620|NCT00943852|26881851|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730621|NCT00943852|26881852|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730622|NCT00943852|26881853|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
7730623|NCT00943852|26881854|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730624|NCT00943852|26881855|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730625|NCT00943852|26881856|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730626|NCT00943852|26881857|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730627|NCT00943852|26881858|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730628|NCT00943852|26881859|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730629|NCT00943852|26881860|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7730630|NCT00943852|26881851|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730631|NCT00943852|26881852|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730632|NCT00943852|26881853|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730633|NCT00943852|26881854|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
7730634|NCT00943852|26881855|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730635|NCT00943852|26881856|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730636|NCT00943852|26881857|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730637|NCT00943852|26881858|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730638|NCT00943852|26881859|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730639|NCT00943852|26881860|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7730640|NCT00943852|26881851|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
7730641|NCT00943852|26881852|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
7730642|NCT00943852|26881853|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
7730643|NCT00943852|26881854|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
7730644|NCT00943852|26881855|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
7730645|NCT00943852|26881856|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
7730646|NCT00943852|26881857|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
7730647|NCT00943852|26881858|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
7730648|NCT00943852|26881859|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
7730649|NCT00943852|26881860|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
7730650|NCT00943852|26881851|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730651|NCT00943852|26881852|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730652|NCT00943852|26881853|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730653|NCT00943852|26881854|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730654|NCT00943852|26881855|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730655|NCT00943852|26881856|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730656|NCT00943852|26881857|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
7730657|NCT00943852|26881858|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730658|NCT00943852|26881859|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730659|NCT00943852|26881860|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7730660|NCT00943826|26881873|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
7730661|NCT00943826|26881874|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
7730662|NCT00943826|26881873|P2|After Primary Overall Survival Analysis|Progression of Disease|4
7730663|NCT00943826|26881874|P1|After Primary Overall Survival Analysis|Progression of Disease|2
7730664|NCT00943826|26881873|P2|After Primary Overall Survival Analysis|Administrative reasons|16
7730665|NCT00943826|26881874|P1|After Primary Overall Survival Analysis|Administrative reasons|10
7730666|NCT00943826|26881873|P2|After Primary Overall Survival Analysis|Adverse Event|0
7730667|NCT00943826|26881874|P1|After Primary Overall Survival Analysis|Adverse Event|11
7730668|NCT00943826|26881873|P2|Monotherapy Phase|Failure to return|1
7730669|NCT00943826|26881874|P1|Monotherapy Phase|Failure to return|2
7730670|NCT00943826|26881873|P2|Monotherapy Phase|Withdrew Consent|3
7730671|NCT00943826|26881874|P1|Monotherapy Phase|Withdrew Consent|2
7730672|NCT00943826|26881873|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
7730673|NCT00943826|26881874|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
7730674|NCT00943826|26881873|P2|Monotherapy Phase|Administrative reasons|5
7730675|NCT00943826|26881874|P1|Monotherapy Phase|Administrative reasons|11
7730676|NCT00943826|26881873|P2|Monotherapy Phase|Adverse Event|5
7730677|NCT00943826|26881874|P1|Monotherapy Phase|Adverse Event|42
7730678|NCT00943826|26881873|P2|Maintenance Phase|Failure to return|1
7730679|NCT00943826|26881874|P1|Maintenance Phase|Failure to return|0
7730680|NCT00943826|26881873|P2|Maintenance Phase|Administrative reasons|1
7730681|NCT00943826|26881874|P1|Maintenance Phase|Administrative reasons|4
7730682|NCT00943826|26881873|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
7730683|NCT00943826|26881874|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
7730684|NCT00943826|26881873|P2|Maintenance Phase|Withdrew consent|4
7730685|NCT00943826|26881874|P1|Maintenance Phase|Withdrew consent|2
7730686|NCT00943826|26881873|P2|Maintenance Phase|Adverse Event|30
7730687|NCT00943826|26881874|P1|Maintenance Phase|Adverse Event|31
7730688|NCT00943826|26881873|P2|Concurrent Phase|Protocol Violation|0
7730689|NCT00943826|26881874|P1|Concurrent Phase|Protocol Violation|1
7730690|NCT00943826|26881873|P2|Concurrent Phase|Administrative reasons|1
7730691|NCT00943826|26881874|P1|Concurrent Phase|Administrative reasons|2
7730692|NCT00943826|26881873|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
7730693|NCT00943826|26881874|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
7730694|NCT00943826|26881873|P2|Concurrent Phase|Withdrew consent|7
7730695|NCT00943826|26881874|P1|Concurrent Phase|Withdrew consent|3
7730696|NCT00943826|26881873|P2|Concurrent Phase|Adverse Event|27
7730697|NCT00943826|26881874|P1|Concurrent Phase|Adverse Event|50
7730698|NCT00943787|26881898|P1|Overall Study|Withdrawal by Subject|3
7730699|NCT00943787|26881898|P1|Overall Study|Physician Decision|4
7730700|NCT00943761|26881905|P2|Overall Study|Withdrawal by Subject|1
7730701|NCT00943761|26881906|P1|Overall Study|Withdrawal by Subject|2
7730702|NCT00943761|26881905|P2|Overall Study|Lost to Follow-up|0
7730703|NCT00943761|26881906|P1|Overall Study|Lost to Follow-up|2
7730704|NCT00943735|26881918|P1|Overall Study|Other|3
7730705|NCT00943735|26881918|P1|Overall Study|Other|8
7730706|NCT00943735|26881918|P1|Overall Study|Death|1
7730707|NCT00943735|26881918|P1|Overall Study|Withdrawal by Subject|8
7730708|NCT00943735|26881918|P1|Overall Study|Adverse Event|12
7730709|NCT00943722|26881956|P5|Overall Study|Withdrawal by Subject|8
7730710|NCT00943722|26881957|P4|Overall Study|Withdrawal by Subject|13
7730711|NCT00943722|26881958|P3|Overall Study|Withdrawal by Subject|2
7730712|NCT00943722|26881959|P2|Overall Study|Withdrawal by Subject|13
7730713|NCT00943722|26881960|P1|Overall Study|Withdrawal by Subject|12
7730714|NCT00943722|26881956|P5|Overall Study|Protocol Violation|2
7730715|NCT00943722|26881957|P4|Overall Study|Protocol Violation|0
7730716|NCT00943722|26881958|P3|Overall Study|Protocol Violation|0
7730717|NCT00943722|26881959|P2|Overall Study|Protocol Violation|1
7730718|NCT00943722|26881960|P1|Overall Study|Protocol Violation|0
7730719|NCT00943722|26881956|P5|Overall Study|Pregnancy|0
7730720|NCT00943722|26881957|P4|Overall Study|Pregnancy|0
7730721|NCT00943722|26881958|P3|Overall Study|Pregnancy|1
7730722|NCT00943722|26881959|P2|Overall Study|Pregnancy|0
7730723|NCT00943722|26881960|P1|Overall Study|Pregnancy|0
7730724|NCT00943722|26881956|P5|Overall Study|Physician Decision|1
7730725|NCT00943722|26881957|P4|Overall Study|Physician Decision|0
7730726|NCT00943722|26881958|P3|Overall Study|Physician Decision|0
7730727|NCT00943722|26881959|P2|Overall Study|Physician Decision|0
7730728|NCT00943722|26881960|P1|Overall Study|Physician Decision|1
7730729|NCT00943722|26881956|P5|Overall Study|Lost to Follow-up|11
7730730|NCT00943722|26881957|P4|Overall Study|Lost to Follow-up|8
7730731|NCT00943722|26881958|P3|Overall Study|Lost to Follow-up|10
7730732|NCT00943722|26881959|P2|Overall Study|Lost to Follow-up|8
7730733|NCT00943722|26881960|P1|Overall Study|Lost to Follow-up|12
7730734|NCT00943722|26881956|P5|Overall Study|Adverse Event|0
7730735|NCT00943722|26881957|P4|Overall Study|Adverse Event|1
7730736|NCT00943722|26881958|P3|Overall Study|Adverse Event|0
7730737|NCT00943722|26881959|P2|Overall Study|Adverse Event|0
7730738|NCT00943722|26881960|P1|Overall Study|Adverse Event|0
7730739|NCT00943683|26881990|P2|Overall Study|Patient Moved|0
7730740|NCT00943683|26881991|P1|Overall Study|Patient Moved|1
7730741|NCT00943683|26881990|P2|Overall Study|Withdrawal by Subject|0
7730742|NCT00943683|26881991|P1|Overall Study|Withdrawal by Subject|1
7730743|NCT00943683|26881990|P2|Overall Study|Protocol Violation|2
7730744|NCT00943683|26881991|P1|Overall Study|Protocol Violation|1
7730745|NCT00943683|26881990|P2|Overall Study|Lost to Follow-up|1
7730746|NCT00943683|26881991|P1|Overall Study|Lost to Follow-up|1
7730747|NCT00943683|26881990|P2|Overall Study|Adverse Event|3
7730748|NCT00943683|26881991|P1|Overall Study|Adverse Event|3
7730749|NCT00943670|26881997|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
7730750|NCT00943670|26881997|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
7730751|NCT00943670|26881997|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
7730752|NCT00943670|26881997|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
7730753|NCT00943670|26881997|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
7730754|NCT00943670|26881997|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
7730755|NCT00943670|26881997|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
7730756|NCT00943670|26881997|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
7730757|NCT00943670|26881997|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
7730758|NCT00943670|26881997|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
7730759|NCT00943618|26882087|P3|Overall Study|Discontinued Medication|11
7730760|NCT00943618|26882088|P2|Overall Study|Discontinued Medication|29
7730761|NCT00943618|26882089|P1|Overall Study|Discontinued Medication|17
7730762|NCT00943618|26882087|P3|Overall Study|Lost to Follow-up|20
7730763|NCT00943618|26882088|P2|Overall Study|Lost to Follow-up|48
7730764|NCT00943618|26882089|P1|Overall Study|Lost to Follow-up|38
7730765|NCT00943605|26882099|P2|Overall Study|Study termination|30
7730766|NCT00943605|26882100|P1|Overall Study|Study termination|30
7730767|NCT00943592|26882110|P1|Overall Study|Death|3
7730768|NCT00943579|26882123|P2|Overall Study|Lack of Efficacy|2
7730769|NCT00943579|26882124|P1|Overall Study|Lack of Efficacy|2
7730770|NCT00943579|26882123|P2|Overall Study|Adverse Event|3
7730771|NCT00943579|26882124|P1|Overall Study|Adverse Event|4
7730772|NCT00943397|26882225|P2|Overall Study|Site terminated and other|56
7730773|NCT00943397|26882226|P1|Overall Study|Site terminated and other|12
7730774|NCT00943397|26882225|P2|Overall Study|Withdrawal by Subject|1
7730775|NCT00943397|26882226|P1|Overall Study|Withdrawal by Subject|1
7730776|NCT00943397|26882225|P2|Overall Study|Protocol Violation|5
7730777|NCT00943397|26882226|P1|Overall Study|Protocol Violation|2
7730778|NCT00943397|26882225|P2|Overall Study|Lost to Follow-up|4
7730779|NCT00943397|26882226|P1|Overall Study|Lost to Follow-up|0
7730780|NCT00943397|26882225|P2|Overall Study|Adverse Event|6
7730781|NCT00943397|26882226|P1|Overall Study|Adverse Event|0
7730782|NCT00943384|26882232|P1|Overall Study|Withdrawal by Subject|5
7730783|NCT00943384|26882232|P1|Overall Study|Lost to Follow-up|16
7730784|NCT00943384|26882232|P1|Overall Study|Treated off protocol-protocol violation|5
7730785|NCT00943384|26882232|P1|Overall Study|Dispositioned prior to treatment|23
7730786|NCT00943319|26882246|P1|Overall Study|Death|1
7730787|NCT00943306|26882252|P1|Overall Study|Sponsor decision due to non-compliance|1
7730788|NCT00943306|26882252|P1|Overall Study|Death|1
7730789|NCT00943306|26882252|P1|Overall Study|Physician Decision|1
7730790|NCT00943124|26882554|P2|Period 1|Personal Reasons|1
7730791|NCT00943124|26882555|P1|Period 1|Personal Reasons|0
7730792|NCT00943124|26882554|P2|Period 1|Did Not Follow Study Procedures|0
7730793|NCT00943124|26882555|P1|Period 1|Did Not Follow Study Procedures|1
7730794|NCT00943124|26882554|P2|Period 1|Withdrawal by Subject|1
7730795|NCT00943124|26882555|P1|Period 1|Withdrawal by Subject|1
7730796|NCT00943111|26882577|P3|5 Years Long-term Treatment Period|Other than specified above|2
7730797|NCT00943111|26882578|P2|5 Years Long-term Treatment Period|Other than specified above|0
7730798|NCT00943111|26882579|P1|5 Years Long-term Treatment Period|Other than specified above|0
7730799|NCT00943111|26882577|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
7730800|NCT00943111|26882578|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
7730801|NCT00943111|26882579|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
7730802|NCT00943111|26882577|P3|5 Years Long-term Treatment Period|Pregnancy|4
7730803|NCT00943111|26882578|P2|5 Years Long-term Treatment Period|Pregnancy|0
7730804|NCT00943111|26882579|P1|5 Years Long-term Treatment Period|Pregnancy|0
7730805|NCT00943111|26882577|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
7730806|NCT00943111|26882578|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
7730807|NCT00943111|26882579|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
7730808|NCT00943111|26882577|P3|5 Years Long-term Treatment Period|Adverse Event|9
7730809|NCT00943111|26882578|P2|5 Years Long-term Treatment Period|Adverse Event|0
7730810|NCT00943111|26882579|P1|5 Years Long-term Treatment Period|Adverse Event|0
7730811|NCT00943111|26882577|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
7730812|NCT00943111|26882578|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
7730813|NCT00943111|26882579|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
7730814|NCT00943111|26882577|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
7730815|NCT00943111|26882578|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
7730816|NCT00943111|26882579|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
7730817|NCT00943111|26882577|P3|52-Weeks Primary Analysis Period|Adverse Event|0
7730818|NCT00943111|26882578|P2|52-Weeks Primary Analysis Period|Adverse Event|1
7730819|NCT00943111|26882579|P1|52-Weeks Primary Analysis Period|Adverse Event|2
7730820|NCT00943072|26882647|P2|Overall Study|Other|1
7730821|NCT00943072|26882648|P1|Overall Study|Other|1
7730822|NCT00943072|26882647|P2|Overall Study|Lack of Efficacy|4
7730823|NCT00943072|26882648|P1|Overall Study|Lack of Efficacy|0
7730824|NCT00943072|26882647|P2|Overall Study|Lost to Follow-up|2
7730825|NCT00943072|26882648|P1|Overall Study|Lost to Follow-up|1
7730826|NCT00943072|26882647|P2|Overall Study|Protocol Violation|1
7730827|NCT00943072|26882648|P1|Overall Study|Protocol Violation|0
7730828|NCT00943072|26882647|P2|Overall Study|Withdrawal by Subject|1
7730829|NCT00943072|26882648|P1|Overall Study|Withdrawal by Subject|3
7730830|NCT00943072|26882647|P2|Overall Study|Death|2
7730831|NCT00943072|26882648|P1|Overall Study|Death|0
7730832|NCT00943072|26882647|P2|Overall Study|Adverse Event|3
7730833|NCT00943072|26882648|P1|Overall Study|Adverse Event|0
7730834|NCT00942994|26882666|P2|Overall Study|Protocol deviation|2
7730835|NCT00942994|26882667|P1|Overall Study|Protocol deviation|1
7730836|NCT00942994|26882666|P2|Overall Study|Lost to Follow-up|4
7730837|NCT00942994|26882667|P1|Overall Study|Lost to Follow-up|1
7730838|NCT00942994|26882666|P2|Overall Study|Patient withdrew consent|8
7730839|NCT00942994|26882667|P1|Overall Study|Patient withdrew consent|5
7730840|NCT00942994|26882666|P2|Overall Study|Unsatisfactory therapeutic effect|1
7730841|NCT00942994|26882667|P1|Overall Study|Unsatisfactory therapeutic effect|1
7730842|NCT00942994|26882666|P2|Overall Study|Abnormal laboratory value(s)|0
7730843|NCT00942994|26882667|P1|Overall Study|Abnormal laboratory value(s)|1
7730844|NCT00942994|26882666|P2|Overall Study|Adverse Event|4
7730845|NCT00942994|26882667|P1|Overall Study|Adverse Event|7
7730846|NCT00942968|26882683|P1|Overall Study|Deep vein thrombosis (DVT)|2
7730847|NCT00942968|26882683|P1|Overall Study|Participant required pancreatic biopsy|1
7730848|NCT00942968|26882683|P1|Overall Study|Pulmonary embolism (PE)|1
7730849|NCT00942968|26882683|P1|Overall Study|Inferior vena cava filter placement|4
7730850|NCT00942968|26882683|P1|Overall Study|Progression of disease|12
7730851|NCT00942968|26882683|P1|Overall Study|Physician Decision|11
7730852|NCT00942968|26882683|P1|Overall Study|Sponsor request|5
7730853|NCT00942968|26882683|P1|Overall Study|Withdrawal by Subject|44
7730854|NCT00942968|26882683|P1|Overall Study|Lost to Follow-up|4
7730855|NCT00942968|26882683|P1|Overall Study|Protocol Violation|9
7730856|NCT00942968|26882683|P1|Overall Study|Death|76
7730857|NCT00942968|26882683|P1|Overall Study|Adverse Event|60
7730858|NCT00942877|26882734|P2|Overall Study|Progressive disease|3
7730859|NCT00942877|26882735|P1|Overall Study|Progressive disease|42
7730860|NCT00942877|26882734|P2|Overall Study|Adverse Event|0
7730861|NCT00942877|26882735|P1|Overall Study|Adverse Event|1
7730862|NCT00942877|26882734|P2|Overall Study|Patient was not treated|0
7730863|NCT00942877|26882735|P1|Overall Study|Patient was not treated|1
7730864|NCT00942877|26882734|P2|Overall Study|Refused further treatment|1
7730865|NCT00942877|26882735|P1|Overall Study|Refused further treatment|1
7730866|NCT00942734|26882774|P1|Overall Study|Physician Decision|1
7730867|NCT00942734|26882774|P1|Overall Study|Disease Progression|2
7730868|NCT00942734|26882774|P1|Overall Study|Protocol Violation|3
7730869|NCT00942734|26882774|P1|Overall Study|Adverse Event|2
7730870|NCT00942708|26882778|P1|Overall Study|Withdrawal by Subject|1
7730871|NCT00942604|26882786|P2|Overall Study|Patient relocation|1
7730872|NCT00942604|26882787|P1|Overall Study|Patient relocation|1
7730873|NCT00942604|26882786|P2|Overall Study|Withdrawal by Subject|1
7730874|NCT00942604|26882787|P1|Overall Study|Withdrawal by Subject|0
7730875|NCT00942604|26882786|P2|Overall Study|Adverse Event|1
7730876|NCT00942604|26882787|P1|Overall Study|Adverse Event|0
7730877|NCT00942604|26882786|P2|Overall Study|Protocol Violation|1
7730878|NCT00942604|26882787|P1|Overall Study|Protocol Violation|1
7730879|NCT00942422|26882895|P1|Overall Study|Progressive diease|1
7730880|NCT00942422|26882895|P1|Overall Study|Death|1
7730881|NCT00942422|26882895|P1|Overall Study|Withdrawal by Subject|1
7730882|NCT00942409|26882899|P1|Overall Study|study drug unavailable|2
7730883|NCT00942409|26882899|P1|Overall Study|Lack of Efficacy|1
7730886|NCT00942331|26882922|P2|Overall Study|Did not start treatment|22
7730887|NCT00942331|26882923|P1|Overall Study|Did not start treatment|15
7730888|NCT00942266|26882976|P2|Overall Study|medical deterioration (pneumonia)|1
7730889|NCT00942266|26882977|P1|Overall Study|medical deterioration (pneumonia)|0
7730890|NCT00942266|26882976|P2|Overall Study|Physician Decision|0
7730891|NCT00942266|26882977|P1|Overall Study|Physician Decision|2
7730892|NCT00942266|26882976|P2|Overall Study|Intercurrent illness|1
7730893|NCT00942266|26882977|P1|Overall Study|Intercurrent illness|0
7730894|NCT00942266|26882976|P2|Overall Study|Failure to thrive and pt withdrawal|1
7730895|NCT00942266|26882977|P1|Overall Study|Failure to thrive and pt withdrawal|0
7730896|NCT00942266|26882976|P2|Overall Study|Disease Progression|11
7730897|NCT00942266|26882977|P1|Overall Study|Disease Progression|38
7730898|NCT00942266|26882976|P2|Overall Study|Adverse Event|1
7730899|NCT00942266|26882977|P1|Overall Study|Adverse Event|2
7730900|NCT00942266|26882976|P2|Overall Study|Withdrawal by Subject|0
7730901|NCT00942266|26882977|P1|Overall Study|Withdrawal by Subject|1
7730902|NCT00942188|26882999|P4|Overall Study|Sponsor Decision|1
7730903|NCT00942188|26883000|P3|Overall Study|Sponsor Decision|0
7730904|NCT00942188|26883001|P2|Overall Study|Sponsor Decision|2
7730905|NCT00942188|26883002|P1|Overall Study|Sponsor Decision|0
7730906|NCT00942188|26882999|P4|Overall Study|Physician Decision|0
7730907|NCT00942188|26883000|P3|Overall Study|Physician Decision|1
7730908|NCT00942188|26883001|P2|Overall Study|Physician Decision|0
7730909|NCT00942188|26883002|P1|Overall Study|Physician Decision|0
7730910|NCT00942188|26882999|P4|Overall Study|Withdrawal by Subject|2
7730911|NCT00942188|26883000|P3|Overall Study|Withdrawal by Subject|4
7730912|NCT00942188|26883001|P2|Overall Study|Withdrawal by Subject|3
7730913|NCT00942188|26883002|P1|Overall Study|Withdrawal by Subject|1
7730914|NCT00942188|26882999|P4|Overall Study|Lost to Follow-up|0
7730915|NCT00942188|26883000|P3|Overall Study|Lost to Follow-up|2
7730916|NCT00942188|26883001|P2|Overall Study|Lost to Follow-up|1
7730917|NCT00942188|26883002|P1|Overall Study|Lost to Follow-up|2
7730918|NCT00942188|26882999|P4|Overall Study|Protocol Violation|0
7730919|NCT00942188|26883000|P3|Overall Study|Protocol Violation|0
7730920|NCT00942188|26883001|P2|Overall Study|Protocol Violation|1
7730921|NCT00942188|26883002|P1|Overall Study|Protocol Violation|1
7730922|NCT00942188|26882999|P4|Overall Study|Lack of Efficacy|1
7730923|NCT00942188|26883000|P3|Overall Study|Lack of Efficacy|0
7730924|NCT00942188|26883001|P2|Overall Study|Lack of Efficacy|0
7730925|NCT00942188|26883002|P1|Overall Study|Lack of Efficacy|0
7730926|NCT00942188|26882999|P4|Overall Study|Adverse Event|0
7730927|NCT00942188|26883000|P3|Overall Study|Adverse Event|2
7730928|NCT00942188|26883001|P2|Overall Study|Adverse Event|3
7730929|NCT00942188|26883002|P1|Overall Study|Adverse Event|0
7730930|NCT00942175|26883041|P4|Overall Study|Low Platelet Count|0
7730931|NCT00942175|26883042|P3|Overall Study|Low Platelet Count|0
7730932|NCT00942175|26883043|P2|Overall Study|Low Platelet Count|2
7730933|NCT00942175|26883044|P1|Overall Study|Low Platelet Count|0
7730934|NCT00942175|26883041|P4|Overall Study|Elevated Alanine Amino Transferase|1
7730935|NCT00942175|26883042|P3|Overall Study|Elevated Alanine Amino Transferase|0
7730936|NCT00942175|26883043|P2|Overall Study|Elevated Alanine Amino Transferase|0
7730937|NCT00942175|26883044|P1|Overall Study|Elevated Alanine Amino Transferase|0
7730938|NCT00942175|26883041|P4|Overall Study|Pregnancy|1
7730939|NCT00942175|26883042|P3|Overall Study|Pregnancy|0
7730940|NCT00942175|26883043|P2|Overall Study|Pregnancy|0
7730941|NCT00942175|26883044|P1|Overall Study|Pregnancy|0
7730942|NCT00942175|26883041|P4|Overall Study|Protocol Violation|0
7730943|NCT00942175|26883042|P3|Overall Study|Protocol Violation|2
7730944|NCT00942175|26883043|P2|Overall Study|Protocol Violation|1
7730945|NCT00942175|26883044|P1|Overall Study|Protocol Violation|0
7730946|NCT00942175|26883041|P4|Overall Study|Adverse Event|0
7730947|NCT00942175|26883042|P3|Overall Study|Adverse Event|0
7730948|NCT00942175|26883043|P2|Overall Study|Adverse Event|1
7730949|NCT00942175|26883044|P1|Overall Study|Adverse Event|2
7730950|NCT00942162|26883097|P3|Overall Study|Other|2
7730951|NCT00942162|26883098|P2|Overall Study|Other|13
7730952|NCT00942162|26883099|P1|Overall Study|Other|14
7730953|NCT00942162|26883097|P3|Overall Study|Lost to Follow-up|0
7730954|NCT00942162|26883098|P2|Overall Study|Lost to Follow-up|0
7730955|NCT00942162|26883099|P1|Overall Study|Lost to Follow-up|4
7730956|NCT00942162|26883097|P3|Overall Study|Withdrawal by Subject|0
7730957|NCT00942162|26883098|P2|Overall Study|Withdrawal by Subject|2
7730958|NCT00942162|26883099|P1|Overall Study|Withdrawal by Subject|7
7730959|NCT00942162|26883097|P3|Overall Study|Death|0
7730960|NCT00942162|26883098|P2|Overall Study|Death|35
7730961|NCT00942162|26883099|P1|Overall Study|Death|45
7730962|NCT00942084|26883170|P1|Overall Study|Death|2
7730963|NCT00941928|26883187|P1|Overall Study|Disease Progression|1
7730964|NCT00941928|26883187|P1|Overall Study|Withdrawal by Subject|1
7730965|NCT00941863|26883205|P5|Continued After PCD|Disease progression, recurrence, relapse|18
7730966|NCT00941863|26883206|P4|Continued After PCD|Disease progression, recurrence, relapse|0
7730967|NCT00941863|26883207|P3|Continued After PCD|Disease progression, recurrence, relapse|0
7730968|NCT00941863|26883208|P2|Continued After PCD|Disease progression, recurrence, relapse|0
7730969|NCT00941863|26883209|P1|Continued After PCD|Disease progression, recurrence, relapse|0
7730970|NCT00941863|26883205|P5|Continued After PCD|Withdrawal by Subject|1
7730971|NCT00941863|26883206|P4|Continued After PCD|Withdrawal by Subject|0
7730972|NCT00941863|26883207|P3|Continued After PCD|Withdrawal by Subject|0
7730973|NCT00941863|26883208|P2|Continued After PCD|Withdrawal by Subject|0
7730974|NCT00941863|26883209|P1|Continued After PCD|Withdrawal by Subject|0
7730975|NCT00941863|26883205|P5|Until Primary Completion Date (PCD)|Disease progression|73
7730976|NCT00941863|26883206|P4|Until Primary Completion Date (PCD)|Disease progression|14
7730977|NCT00941863|26883207|P3|Until Primary Completion Date (PCD)|Disease progression|8
7730978|NCT00941863|26883208|P2|Until Primary Completion Date (PCD)|Disease progression|1
7730979|NCT00941863|26883209|P1|Until Primary Completion Date (PCD)|Disease progression|6
7730980|NCT00941863|26883205|P5|Until Primary Completion Date (PCD)|Death|7
7730981|NCT00941863|26883206|P4|Until Primary Completion Date (PCD)|Death|2
7730982|NCT00941863|26883207|P3|Until Primary Completion Date (PCD)|Death|1
7730983|NCT00941863|26883208|P2|Until Primary Completion Date (PCD)|Death|0
7730984|NCT00941863|26883209|P1|Until Primary Completion Date (PCD)|Death|0
7730985|NCT00941863|26883205|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
7730986|NCT00941863|26883206|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7730987|NCT00941863|26883207|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
7730988|NCT00941863|26883208|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7730989|NCT00941863|26883209|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7730990|NCT00941863|26883205|P5|Until Primary Completion Date (PCD)|Physician Decision|1
7730991|NCT00941863|26883206|P4|Until Primary Completion Date (PCD)|Physician Decision|0
7730992|NCT00941863|26883207|P3|Until Primary Completion Date (PCD)|Physician Decision|0
7730993|NCT00941863|26883208|P2|Until Primary Completion Date (PCD)|Physician Decision|0
7730994|NCT00941863|26883209|P1|Until Primary Completion Date (PCD)|Physician Decision|0
7730995|NCT00941863|26883205|P5|Until Primary Completion Date (PCD)|Adverse Event|5
7730996|NCT00941863|26883206|P4|Until Primary Completion Date (PCD)|Adverse Event|1
7730997|NCT00941863|26883207|P3|Until Primary Completion Date (PCD)|Adverse Event|2
7730998|NCT00941863|26883208|P2|Until Primary Completion Date (PCD)|Adverse Event|2
7730999|NCT00941863|26883209|P1|Until Primary Completion Date (PCD)|Adverse Event|1
7731000|NCT00941798|26883236|P2|Overall Study|Death|1
7731001|NCT00941798|26883237|P1|Overall Study|Death|0
7731002|NCT00941798|26883236|P2|Overall Study|Abnormal laboratory values|2
7731003|NCT00941798|26883237|P1|Overall Study|Abnormal laboratory values|1
7731004|NCT00941798|26883236|P2|Overall Study|Abnormal test procedure results|1
7731005|NCT00941798|26883237|P1|Overall Study|Abnormal test procedure results|3
7731006|NCT00941798|26883236|P2|Overall Study|Patient's inability to use device|1
7731007|NCT00941798|26883237|P1|Overall Study|Patient's inability to use device|6
7731008|NCT00941798|26883236|P2|Overall Study|Lack of Efficacy|17
7731009|NCT00941798|26883237|P1|Overall Study|Lack of Efficacy|10
7731010|NCT00941798|26883236|P2|Overall Study|Administrative problems|23
7731011|NCT00941798|26883237|P1|Overall Study|Administrative problems|13
7731012|NCT00941798|26883236|P2|Overall Study|Protocol Violation|20
7731013|NCT00941798|26883237|P1|Overall Study|Protocol Violation|17
7731014|NCT00941798|26883236|P2|Overall Study|Lost to Follow-up|23
7731015|NCT00941798|26883237|P1|Overall Study|Lost to Follow-up|29
7731016|NCT00941798|26883236|P2|Overall Study|Adverse Event|23
7731017|NCT00941798|26883237|P1|Overall Study|Adverse Event|43
7731018|NCT00941798|26883236|P2|Overall Study|Withdrawal by Subject|74
7731019|NCT00941798|26883237|P1|Overall Study|Withdrawal by Subject|72
7731020|NCT00941733|26883267|P2|Overall Study|Protocol Violation|6
7731021|NCT00941733|26883268|P1|Overall Study|Protocol Violation|15
7731022|NCT00941733|26883267|P2|Overall Study|Lost to Follow-up|2
7731023|NCT00941733|26883268|P1|Overall Study|Lost to Follow-up|1
7731024|NCT00941733|26883267|P2|Overall Study|Adverse Event|4
7731025|NCT00941733|26883268|P1|Overall Study|Adverse Event|20
7731026|NCT00941733|26883267|P2|Overall Study|Withdrawal by Subject|6
7731027|NCT00941733|26883268|P1|Overall Study|Withdrawal by Subject|14
7731028|NCT00941733|26883267|P2|Overall Study|Death|10
7731029|NCT00941733|26883268|P1|Overall Study|Death|24
7731030|NCT00941720|26883308|P1|Overall Study|ineligible|2
7731031|NCT00941720|26883308|P1|Overall Study|Insurance denied participation|11
7731032|NCT00941720|26883308|P1|Overall Study|Withdrawal by Subject|1
7731033|NCT00941655|26883355|P2|Overall Study|non-compliant|1
7731034|NCT00941655|26883356|P1|Overall Study|non-compliant|0
7731035|NCT00941655|26883355|P2|Overall Study|withdrew consent|1
7731036|NCT00941655|26883356|P1|Overall Study|withdrew consent|0
7731037|NCT00941655|26883355|P2|Overall Study|refused further treatment|1
7731038|NCT00941655|26883356|P1|Overall Study|refused further treatment|0
7731039|NCT00941655|26883355|P2|Overall Study|progressed while on chemo|2
7731040|NCT00941655|26883356|P1|Overall Study|progressed while on chemo|0
7731041|NCT00941655|26883355|P2|Overall Study|not meet criteria for chemo foll surgery|0
7731042|NCT00941655|26883356|P1|Overall Study|not meet criteria for chemo foll surgery|4
7731043|NCT00941655|26883355|P2|Overall Study|received some chemo, 4 and 9 cycles|0
7731044|NCT00941655|26883356|P1|Overall Study|received some chemo, 4 and 9 cycles|1
7731045|NCT00941603|26883381|P6|Overall Study|Did not meet protocol eligibility|0
7731046|NCT00941603|26883382|P5|Overall Study|Did not meet protocol eligibility|0
7731047|NCT00941603|26883383|P4|Overall Study|Did not meet protocol eligibility|0
7731048|NCT00941603|26883384|P3|Overall Study|Did not meet protocol eligibility|0
7731049|NCT00941603|26883385|P2|Overall Study|Did not meet protocol eligibility|0
7731050|NCT00941603|26883386|P1|Overall Study|Did not meet protocol eligibility|1
7731051|NCT00941603|26883381|P6|Overall Study|Protocol Violation|0
7731052|NCT00941603|26883382|P5|Overall Study|Protocol Violation|0
7731053|NCT00941603|26883383|P4|Overall Study|Protocol Violation|0
7731054|NCT00941603|26883384|P3|Overall Study|Protocol Violation|0
7731055|NCT00941603|26883385|P2|Overall Study|Protocol Violation|1
7731056|NCT00941603|26883386|P1|Overall Study|Protocol Violation|0
7731057|NCT00941603|26883381|P6|Overall Study|Withdrawal by Subject|1
7731058|NCT00941603|26883382|P5|Overall Study|Withdrawal by Subject|0
7731059|NCT00941603|26883383|P4|Overall Study|Withdrawal by Subject|2
7731060|NCT00941603|26883384|P3|Overall Study|Withdrawal by Subject|0
7731061|NCT00941603|26883385|P2|Overall Study|Withdrawal by Subject|0
7731062|NCT00941603|26883386|P1|Overall Study|Withdrawal by Subject|0
7731063|NCT00941603|26883381|P6|Overall Study|Lost to Follow-up|2
7731064|NCT00941603|26883382|P5|Overall Study|Lost to Follow-up|0
7731065|NCT00941603|26883383|P4|Overall Study|Lost to Follow-up|1
7731066|NCT00941603|26883384|P3|Overall Study|Lost to Follow-up|0
7731067|NCT00941603|26883385|P2|Overall Study|Lost to Follow-up|0
7731068|NCT00941603|26883386|P1|Overall Study|Lost to Follow-up|0
7731069|NCT00941603|26883381|P6|Overall Study|Adverse Event|0
7731070|NCT00941603|26883382|P5|Overall Study|Adverse Event|4
7731071|NCT00941603|26883383|P4|Overall Study|Adverse Event|1
7731072|NCT00941603|26883384|P3|Overall Study|Adverse Event|5
7731073|NCT00941603|26883385|P2|Overall Study|Adverse Event|15
7731074|NCT00941603|26883386|P1|Overall Study|Adverse Event|10
7731075|NCT00941330|26883408|P2|Overall Study|Physician Decision|2
7731076|NCT00941330|26883409|P1|Overall Study|Physician Decision|0
7731077|NCT00941330|26883408|P2|Overall Study|Other|0
7731078|NCT00941330|26883409|P1|Overall Study|Other|1
7731079|NCT00941304|26883422|P5|Overall Study|Lost to Follow-up|0
7731080|NCT00941304|26883423|P4|Overall Study|Lost to Follow-up|0
7731081|NCT00941304|26883424|P3|Overall Study|Lost to Follow-up|0
7731082|NCT00941304|26883425|P2|Overall Study|Lost to Follow-up|0
7731083|NCT00941304|26883426|P1|Overall Study|Lost to Follow-up|1
7731084|NCT00941070|26883488|P1|Overall Study|Patient non-compliant|1
7731085|NCT00941031|26883508|P7|Maintenance Period|Lack of Efficacy|13
7731086|NCT00941031|26883509|P6|Maintenance Period|Lack of Efficacy|0
7731087|NCT00941031|26883510|P5|Maintenance Period|Lack of Efficacy|0
7731088|NCT00941031|26883511|P4|Maintenance Period|Lack of Efficacy|0
7731089|NCT00941031|26883512|P3|Maintenance Period|Lack of Efficacy|0
7731090|NCT00941031|26883513|P2|Maintenance Period|Lack of Efficacy|0
7731091|NCT00941031|26883514|P1|Maintenance Period|Lack of Efficacy|0
7731092|NCT00941031|26883508|P7|Maintenance Period|Lost to Follow-up|7
7731093|NCT00941031|26883509|P6|Maintenance Period|Lost to Follow-up|2
7731094|NCT00941031|26883510|P5|Maintenance Period|Lost to Follow-up|2
7731095|NCT00941031|26883511|P4|Maintenance Period|Lost to Follow-up|0
7731096|NCT00941031|26883512|P3|Maintenance Period|Lost to Follow-up|0
7731097|NCT00941031|26883513|P2|Maintenance Period|Lost to Follow-up|0
7731098|NCT00941031|26883514|P1|Maintenance Period|Lost to Follow-up|0
7731099|NCT00941031|26883508|P7|Maintenance Period|Adverse Event|8
7731100|NCT00941031|26883509|P6|Maintenance Period|Adverse Event|2
7731101|NCT00941031|26883510|P5|Maintenance Period|Adverse Event|0
7731102|NCT00941031|26883511|P4|Maintenance Period|Adverse Event|0
7731103|NCT00941031|26883512|P3|Maintenance Period|Adverse Event|0
7731104|NCT00941031|26883513|P2|Maintenance Period|Adverse Event|0
7731105|NCT00941031|26883514|P1|Maintenance Period|Adverse Event|0
7731106|NCT00941031|26883508|P7|Maintenance Period|Protocol Violation|1
7731107|NCT00941031|26883509|P6|Maintenance Period|Protocol Violation|0
7731108|NCT00941031|26883510|P5|Maintenance Period|Protocol Violation|0
7731109|NCT00941031|26883511|P4|Maintenance Period|Protocol Violation|0
7731110|NCT00941031|26883512|P3|Maintenance Period|Protocol Violation|0
7731111|NCT00941031|26883513|P2|Maintenance Period|Protocol Violation|0
7731112|NCT00941031|26883514|P1|Maintenance Period|Protocol Violation|0
7731113|NCT00941031|26883508|P7|Maintenance Period|Administrative Problems|1
7731114|NCT00941031|26883509|P6|Maintenance Period|Administrative Problems|0
7731115|NCT00941031|26883510|P5|Maintenance Period|Administrative Problems|1
7731116|NCT00941031|26883511|P4|Maintenance Period|Administrative Problems|0
7731117|NCT00941031|26883512|P3|Maintenance Period|Administrative Problems|0
7731118|NCT00941031|26883513|P2|Maintenance Period|Administrative Problems|0
7731119|NCT00941031|26883514|P1|Maintenance Period|Administrative Problems|0
7731120|NCT00941031|26883508|P7|Maintenance Period|Withdrawal by Subject|13
7731121|NCT00941031|26883509|P6|Maintenance Period|Withdrawal by Subject|2
7731122|NCT00941031|26883510|P5|Maintenance Period|Withdrawal by Subject|6
7731123|NCT00941031|26883511|P4|Maintenance Period|Withdrawal by Subject|0
7731124|NCT00941031|26883512|P3|Maintenance Period|Withdrawal by Subject|0
7731125|NCT00941031|26883513|P2|Maintenance Period|Withdrawal by Subject|0
7731126|NCT00941031|26883514|P1|Maintenance Period|Withdrawal by Subject|0
7731127|NCT00941031|26883508|P7|Induction Period|Adverse Event|0
7731128|NCT00941031|26883509|P6|Induction Period|Adverse Event|0
7731129|NCT00941031|26883510|P5|Induction Period|Adverse Event|0
7731130|NCT00941031|26883511|P4|Induction Period|Adverse Event|2
7731131|NCT00941031|26883512|P3|Induction Period|Adverse Event|3
7731132|NCT00941031|26883513|P2|Induction Period|Adverse Event|0
7731133|NCT00941031|26883514|P1|Induction Period|Adverse Event|1
7731134|NCT00941031|26883508|P7|Induction Period|Adminstative Problems|0
7731135|NCT00941031|26883509|P6|Induction Period|Adminstative Problems|0
7731136|NCT00941031|26883510|P5|Induction Period|Adminstative Problems|0
7731137|NCT00941031|26883511|P4|Induction Period|Adminstative Problems|0
7731138|NCT00941031|26883512|P3|Induction Period|Adminstative Problems|1
7731139|NCT00941031|26883513|P2|Induction Period|Adminstative Problems|1
7731140|NCT00941031|26883514|P1|Induction Period|Adminstative Problems|1
7731141|NCT00941031|26883508|P7|Induction Period|Withdrawal by Subject|0
7731142|NCT00941031|26883509|P6|Induction Period|Withdrawal by Subject|0
7731143|NCT00941031|26883510|P5|Induction Period|Withdrawal by Subject|0
7731144|NCT00941031|26883511|P4|Induction Period|Withdrawal by Subject|2
7731145|NCT00941031|26883512|P3|Induction Period|Withdrawal by Subject|2
7731146|NCT00941031|26883513|P2|Induction Period|Withdrawal by Subject|2
7731147|NCT00941031|26883514|P1|Induction Period|Withdrawal by Subject|1
7731148|NCT00941031|26883508|P7|Induction Period|Lack of Efficacy|0
7731149|NCT00941031|26883509|P6|Induction Period|Lack of Efficacy|0
7731150|NCT00941031|26883510|P5|Induction Period|Lack of Efficacy|0
7731151|NCT00941031|26883511|P4|Induction Period|Lack of Efficacy|5
7731152|NCT00941031|26883512|P3|Induction Period|Lack of Efficacy|0
7731153|NCT00941031|26883513|P2|Induction Period|Lack of Efficacy|1
7731154|NCT00941031|26883514|P1|Induction Period|Lack of Efficacy|2
7731155|NCT00940992|26883561|P3|Overall Study|Lost to Follow-up|1
7731156|NCT00940992|26883562|P2|Overall Study|Lost to Follow-up|1
7731157|NCT00940992|26883563|P1|Overall Study|Lost to Follow-up|0
7731158|NCT00940992|26883561|P3|Overall Study|subject request|0
7731159|NCT00940992|26883562|P2|Overall Study|subject request|1
7731160|NCT00940992|26883563|P1|Overall Study|subject request|2
7731161|NCT00940992|26883561|P3|Overall Study|Adverse Event|1
7731162|NCT00940992|26883562|P2|Overall Study|Adverse Event|0
7731163|NCT00940992|26883563|P1|Overall Study|Adverse Event|2
7731164|NCT00940888|26883592|P1|Overall Study|Lost to Follow-up|6
7731165|NCT00940888|26883592|P1|Overall Study|Withdrawn - Non-Death|364
7731166|NCT00940888|26883592|P1|Overall Study|Death|461
7731167|NCT00940888|26883592|P1|Overall Study|Unsuccessful Implant|4
7731168|NCT00940875|26883599|P2|Post-Study Treatment|Disease Progression|2
7731169|NCT00940875|26883600|P1|Post-Study Treatment|Disease Progression|0
7731170|NCT00940875|26883599|P2|Post-Study Treatment|Death|1
7731171|NCT00940875|26883600|P1|Post-Study Treatment|Death|0
7731172|NCT00940875|26883599|P2|Treatment Phase|Physician Decision|0
7731173|NCT00940875|26883600|P1|Treatment Phase|Physician Decision|1
7731174|NCT00940875|26883599|P2|Treatment Phase|Disease progression|11
7731175|NCT00940875|26883600|P1|Treatment Phase|Disease progression|9
7731176|NCT00940875|26883599|P2|Treatment Phase|Withdrawal by Subject|0
7731177|NCT00940875|26883600|P1|Treatment Phase|Withdrawal by Subject|3
7731178|NCT00940875|26883599|P2|Treatment Phase|Lack of Efficacy|0
7731179|NCT00940875|26883600|P1|Treatment Phase|Lack of Efficacy|1
7731180|NCT00940875|26883599|P2|Treatment Phase|Death|5
7731181|NCT00940875|26883600|P1|Treatment Phase|Death|3
7731182|NCT00940875|26883599|P2|Treatment Phase|Adverse Event|3
7731183|NCT00940875|26883600|P1|Treatment Phase|Adverse Event|9
7731184|NCT00940823|26883620|P2|Overall Study|Lost to Follow-up|20
7731185|NCT00940823|26883621|P1|Overall Study|Lost to Follow-up|27
7731186|NCT00940823|26883620|P2|Overall Study|Death|12
7731187|NCT00940823|26883621|P1|Overall Study|Death|8
7731188|NCT00940602|26883646|P2|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
7731189|NCT00940602|26883647|P1|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
7731190|NCT00940602|26883646|P2|Overall Study|Adverse Event|2
7731191|NCT00940602|26883647|P1|Overall Study|Adverse Event|7
7731192|NCT00940602|26883646|P2|Overall Study|Patient withdrew consent|13
7731193|NCT00940602|26883647|P1|Overall Study|Patient withdrew consent|26
7731194|NCT00940602|26883646|P2|Overall Study|Lost to Follow-up|1
7731195|NCT00940602|26883647|P1|Overall Study|Lost to Follow-up|3
7731196|NCT00940602|26883646|P2|Overall Study|Death|19
7731197|NCT00940602|26883647|P1|Overall Study|Death|38
7731198|NCT00940602|26883646|P2|Overall Study|Disease progression|2
7731199|NCT00940602|26883647|P1|Overall Study|Disease progression|8
7731200|NCT00940602|26883646|P2|Overall Study|Protocol Deviation (untreated)|0
7731201|NCT00940602|26883647|P1|Overall Study|Protocol Deviation (untreated)|1
7731202|NCT00940602|26883646|P2|Overall Study|Pregnancy|0
7731203|NCT00940602|26883647|P1|Overall Study|Pregnancy|1
7731204|NCT00940602|26883646|P2|Overall Study|Physician Decision|5
7731205|NCT00940602|26883647|P1|Overall Study|Physician Decision|8
7731206|NCT00940602|26883646|P2|Overall Study|Patient/guardian decision|28
7731207|NCT00940602|26883647|P1|Overall Study|Patient/guardian decision|13
7731208|NCT00940602|26883646|P2|Overall Study|Administrative problems|1
7731209|NCT00940602|26883647|P1|Overall Study|Administrative problems|1
7731210|NCT00940498|26883725|P8|Overall Study|Not treated due to disease related pain|0
7731211|NCT00940498|26883726|P7|Overall Study|Not treated due to disease related pain|0
7731212|NCT00940498|26883727|P6|Overall Study|Not treated due to disease related pain|0
7731213|NCT00940498|26883728|P5|Overall Study|Not treated due to disease related pain|1
7731214|NCT00940498|26883729|P4|Overall Study|Not treated due to disease related pain|0
7731215|NCT00940498|26883730|P3|Overall Study|Not treated due to disease related pain|0
7731216|NCT00940498|26883731|P2|Overall Study|Not treated due to disease related pain|0
7731217|NCT00940498|26883732|P1|Overall Study|Not treated due to disease related pain|0
7731218|NCT00940498|26883725|P8|Overall Study|Physician Decision|0
7731219|NCT00940498|26883726|P7|Overall Study|Physician Decision|0
7731220|NCT00940498|26883727|P6|Overall Study|Physician Decision|0
7731221|NCT00940498|26883728|P5|Overall Study|Physician Decision|2
7731222|NCT00940498|26883729|P4|Overall Study|Physician Decision|0
7731223|NCT00940498|26883730|P3|Overall Study|Physician Decision|0
7731224|NCT00940498|26883731|P2|Overall Study|Physician Decision|0
7731225|NCT00940498|26883732|P1|Overall Study|Physician Decision|0
7731226|NCT00940498|26883725|P8|Overall Study|Disease Progression|0
7731227|NCT00940498|26883726|P7|Overall Study|Disease Progression|0
7731228|NCT00940498|26883727|P6|Overall Study|Disease Progression|1
7731229|NCT00940498|26883728|P5|Overall Study|Disease Progression|0
7731230|NCT00940498|26883729|P4|Overall Study|Disease Progression|1
7731231|NCT00940498|26883730|P3|Overall Study|Disease Progression|1
7731232|NCT00940498|26883731|P2|Overall Study|Disease Progression|0
7731233|NCT00940498|26883732|P1|Overall Study|Disease Progression|0
7731234|NCT00940498|26883725|P8|Overall Study|Lost to Follow-up|1
7731235|NCT00940498|26883726|P7|Overall Study|Lost to Follow-up|0
7731236|NCT00940498|26883727|P6|Overall Study|Lost to Follow-up|0
7731237|NCT00940498|26883728|P5|Overall Study|Lost to Follow-up|1
7731238|NCT00940498|26883729|P4|Overall Study|Lost to Follow-up|0
7731239|NCT00940498|26883730|P3|Overall Study|Lost to Follow-up|2
7731240|NCT00940498|26883731|P2|Overall Study|Lost to Follow-up|1
7731241|NCT00940498|26883732|P1|Overall Study|Lost to Follow-up|1
7731242|NCT00940498|26883725|P8|Overall Study|Death|0
7731243|NCT00940498|26883726|P7|Overall Study|Death|1
7731244|NCT00940498|26883727|P6|Overall Study|Death|0
7731245|NCT00940498|26883728|P5|Overall Study|Death|5
7731246|NCT00940498|26883729|P4|Overall Study|Death|1
7731247|NCT00940498|26883730|P3|Overall Study|Death|0
7731248|NCT00940498|26883731|P2|Overall Study|Death|0
7731249|NCT00940498|26883732|P1|Overall Study|Death|2
7731250|NCT00940485|26883850|P2|Overall Study|Others|1
7731251|NCT00940485|26883851|P1|Overall Study|Others|1
7731252|NCT00940485|26883850|P2|Overall Study|Withdrawal by Subject|1
7731253|NCT00940485|26883851|P1|Overall Study|Withdrawal by Subject|1
7731254|NCT00940485|26883850|P2|Overall Study|Adverse Event|0
7731255|NCT00940485|26883851|P1|Overall Study|Adverse Event|8
7731256|NCT00940485|26883850|P2|Overall Study|Lost to Follow-up|3
7731257|NCT00940485|26883851|P1|Overall Study|Lost to Follow-up|2
7731258|NCT00940485|26883850|P2|Overall Study|HBeAb positive at Baseline|2
7731259|NCT00940485|26883851|P1|Overall Study|HBeAb positive at Baseline|3
7731260|NCT00940342|26883889|P3|Overall Study|Adverse Event|1
7731261|NCT00940342|26883890|P2|Overall Study|Adverse Event|2
7731262|NCT00940342|26883891|P1|Overall Study|Adverse Event|0
7731263|NCT00940316|26883902|P3|Treated After Cycle 5|Progressive disease|0
7731264|NCT00940316|26883903|P2|Treated After Cycle 5|Progressive disease|1
7731265|NCT00940316|26883904|P1|Treated After Cycle 5|Progressive disease|0
7731266|NCT00940316|26883902|P3|Treated After Cycle 5|Adverse Event|1
7731267|NCT00940316|26883903|P2|Treated After Cycle 5|Adverse Event|0
7731268|NCT00940316|26883904|P1|Treated After Cycle 5|Adverse Event|0
7731269|NCT00940316|26883902|P3|Moved on to be Treated Cycle 5|Adverse Event|0
7731270|NCT00940316|26883903|P2|Moved on to be Treated Cycle 5|Adverse Event|0
7731271|NCT00940316|26883904|P1|Moved on to be Treated Cycle 5|Adverse Event|2
7731272|NCT00940316|26883902|P3|Reached First Response at 8 Weeks|Progressive disease|0
7731273|NCT00940316|26883903|P2|Reached First Response at 8 Weeks|Progressive disease|3
7731274|NCT00940316|26883904|P1|Reached First Response at 8 Weeks|Progressive disease|1
7731275|NCT00940316|26883902|P3|Reached First Response at 8 Weeks|Adverse Event|0
7731276|NCT00940316|26883903|P2|Reached First Response at 8 Weeks|Adverse Event|1
7731277|NCT00940316|26883904|P1|Reached First Response at 8 Weeks|Adverse Event|2
7731278|NCT00940108|26883947|P4|Overall Study|Diagnosed with H1N1|1
7731279|NCT00940108|26883948|P3|Overall Study|Diagnosed with H1N1|0
7731280|NCT00940108|26883949|P2|Overall Study|Diagnosed with H1N1|0
7731281|NCT00940108|26883950|P1|Overall Study|Diagnosed with H1N1|0
7731282|NCT00940108|26883947|P4|Overall Study|Viral illness after Dose 1|0
7731283|NCT00940108|26883948|P3|Overall Study|Viral illness after Dose 1|0
7731284|NCT00940108|26883949|P2|Overall Study|Viral illness after Dose 1|1
7731285|NCT00940108|26883950|P1|Overall Study|Viral illness after Dose 1|0
7731286|NCT00940108|26883947|P4|Overall Study|Refused - pyrexia after Dose 1|0
7731287|NCT00940108|26883948|P3|Overall Study|Refused - pyrexia after Dose 1|0
7731288|NCT00940108|26883949|P2|Overall Study|Refused - pyrexia after Dose 1|1
7731289|NCT00940108|26883950|P1|Overall Study|Refused - pyrexia after Dose 1|0
7731290|NCT00940108|26883947|P4|Overall Study|Declined further vaccination|0
7731291|NCT00940108|26883948|P3|Overall Study|Declined further vaccination|3
7731292|NCT00940108|26883949|P2|Overall Study|Declined further vaccination|1
7731293|NCT00940108|26883950|P1|Overall Study|Declined further vaccination|0
7731294|NCT00940108|26883947|P4|Overall Study|Dose 2 contraindicated|1
7731295|NCT00940108|26883948|P3|Overall Study|Dose 2 contraindicated|0
7731296|NCT00940108|26883949|P2|Overall Study|Dose 2 contraindicated|1
7731297|NCT00940108|26883950|P1|Overall Study|Dose 2 contraindicated|1
7731298|NCT00940108|26883947|P4|Overall Study|Withdrew Consent|1
7731299|NCT00940108|26883948|P3|Overall Study|Withdrew Consent|0
7731300|NCT00940108|26883949|P2|Overall Study|Withdrew Consent|1
7731301|NCT00940108|26883950|P1|Overall Study|Withdrew Consent|2
7731302|NCT00940108|26883947|P4|Overall Study|Adverse Event|2
7731303|NCT00940108|26883948|P3|Overall Study|Adverse Event|0
7731304|NCT00940108|26883949|P2|Overall Study|Adverse Event|4
7731305|NCT00940108|26883950|P1|Overall Study|Adverse Event|2
7731306|NCT00940017|26884000|P1|Overall Study|Adverse Event|1
7731307|NCT00940017|26884000|P1|Overall Study|did not meet entrance criteria|3
7731308|NCT00939822|26884058|P2|Overall Study|Mental health issues|2
7731309|NCT00939822|26884059|P1|Overall Study|Mental health issues|0
7731310|NCT00939822|26884058|P2|Overall Study|withdrew from study due to busy schedule|1
7731311|NCT00939822|26884059|P1|Overall Study|withdrew from study due to busy schedule|1
7731312|NCT00939822|26884058|P2|Overall Study|Lost to Follow-up|0
7731313|NCT00939822|26884059|P1|Overall Study|Lost to Follow-up|1
7731314|NCT00939809|26884071|P1|Overall Study|Death|1
7731315|NCT00939809|26884071|P1|Overall Study|Adverse Event|2
7731316|NCT00939783|26884086|P1|Overall Study|Enrolled but not treated|1
7731317|NCT00939783|26884086|P1|Overall Study|Protocol Violation|3
7731318|NCT00939783|26884086|P1|Overall Study|Lost to Follow-up|8
7731319|NCT00939783|26884086|P1|Overall Study|Other|16
7731320|NCT00939783|26884086|P1|Overall Study|Withdrawal by Subject|78
7731321|NCT00939783|26884086|P1|Overall Study|Study Terminated by Sponsor|498
7731322|NCT00939783|26884086|P1|Overall Study|Adverse Event|39
7731323|NCT00939783|26884086|P1|Overall Study|Death|6
7731324|NCT00939770|26884101|P8|Overall Study|Withdrawal by Subject|2
7731325|NCT00939770|26884102|P7|Overall Study|Withdrawal by Subject|2
7731326|NCT00939770|26884103|P6|Overall Study|Withdrawal by Subject|0
7731327|NCT00939770|26884104|P5|Overall Study|Withdrawal by Subject|6
7731328|NCT00939770|26884105|P4|Overall Study|Withdrawal by Subject|2
7731329|NCT00939770|26884106|P3|Overall Study|Withdrawal by Subject|5
7731330|NCT00939770|26884107|P2|Overall Study|Withdrawal by Subject|1
7731331|NCT00939770|26884108|P1|Overall Study|Withdrawal by Subject|0
7731332|NCT00939770|26884101|P8|Overall Study|Protocol Violation|0
7731333|NCT00939770|26884102|P7|Overall Study|Protocol Violation|0
7731334|NCT00939770|26884103|P6|Overall Study|Protocol Violation|0
7731335|NCT00939770|26884104|P5|Overall Study|Protocol Violation|1
7731336|NCT00939770|26884105|P4|Overall Study|Protocol Violation|0
7731337|NCT00939770|26884106|P3|Overall Study|Protocol Violation|0
7731338|NCT00939770|26884107|P2|Overall Study|Protocol Violation|0
7731339|NCT00939770|26884108|P1|Overall Study|Protocol Violation|0
7731340|NCT00939770|26884101|P8|Overall Study|Physician Decision|6
7731341|NCT00939770|26884102|P7|Overall Study|Physician Decision|0
7731342|NCT00939770|26884103|P6|Overall Study|Physician Decision|1
7731343|NCT00939770|26884104|P5|Overall Study|Physician Decision|7
7731344|NCT00939770|26884105|P4|Overall Study|Physician Decision|0
7731345|NCT00939770|26884106|P3|Overall Study|Physician Decision|2
7731346|NCT00939770|26884107|P2|Overall Study|Physician Decision|0
7731347|NCT00939770|26884108|P1|Overall Study|Physician Decision|0
7731348|NCT00939770|26884101|P8|Overall Study|Lost to Follow-up|0
7731349|NCT00939770|26884102|P7|Overall Study|Lost to Follow-up|0
7731350|NCT00939770|26884103|P6|Overall Study|Lost to Follow-up|0
7731351|NCT00939770|26884104|P5|Overall Study|Lost to Follow-up|1
7731352|NCT00939770|26884105|P4|Overall Study|Lost to Follow-up|0
7731353|NCT00939770|26884106|P3|Overall Study|Lost to Follow-up|0
7731354|NCT00939770|26884107|P2|Overall Study|Lost to Follow-up|0
7731355|NCT00939770|26884108|P1|Overall Study|Lost to Follow-up|0
7731356|NCT00939770|26884101|P8|Overall Study|Lack of Efficacy|1
7731357|NCT00939770|26884102|P7|Overall Study|Lack of Efficacy|11
7731358|NCT00939770|26884103|P6|Overall Study|Lack of Efficacy|8
7731359|NCT00939770|26884104|P5|Overall Study|Lack of Efficacy|16
7731360|NCT00939770|26884105|P4|Overall Study|Lack of Efficacy|9
7731361|NCT00939770|26884106|P3|Overall Study|Lack of Efficacy|13
7731362|NCT00939770|26884107|P2|Overall Study|Lack of Efficacy|6
7731363|NCT00939770|26884108|P1|Overall Study|Lack of Efficacy|4
7731364|NCT00939770|26884101|P8|Overall Study|Adverse Event|1
7731365|NCT00939770|26884102|P7|Overall Study|Adverse Event|1
7731366|NCT00939770|26884103|P6|Overall Study|Adverse Event|2
7731367|NCT00939770|26884104|P5|Overall Study|Adverse Event|6
7731368|NCT00939770|26884105|P4|Overall Study|Adverse Event|0
7731369|NCT00939770|26884106|P3|Overall Study|Adverse Event|0
7731370|NCT00939770|26884107|P2|Overall Study|Adverse Event|1
7731371|NCT00939770|26884108|P1|Overall Study|Adverse Event|1
7731372|NCT00939692|26884193|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
7731373|NCT00939692|26884194|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
7731374|NCT00939692|26884193|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
7731375|NCT00939692|26884194|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
7731376|NCT00939640|26884209|P1|Overall Study|Physician Decision|1
7731377|NCT00939627|26884230|P3|Overall Study|No off-tx reason given|0
7731378|NCT00939627|26884231|P2|Overall Study|No off-tx reason given|2
7731379|NCT00939627|26884232|P1|Overall Study|No off-tx reason given|0
7731380|NCT00939627|26884230|P3|Overall Study|Not compliant|0
7731381|NCT00939627|26884231|P2|Overall Study|Not compliant|0
7731382|NCT00939627|26884232|P1|Overall Study|Not compliant|2
7731383|NCT00939627|26884230|P3|Overall Study|Other complicating disease|0
7731384|NCT00939627|26884231|P2|Overall Study|Other complicating disease|1
7731385|NCT00939627|26884232|P1|Overall Study|Other complicating disease|1
7731386|NCT00939627|26884230|P3|Overall Study|Withdrawal by Subject|0
7731387|NCT00939627|26884231|P2|Overall Study|Withdrawal by Subject|4
7731388|NCT00939627|26884232|P1|Overall Study|Withdrawal by Subject|2
7731389|NCT00939627|26884230|P3|Overall Study|Death|0
7731390|NCT00939627|26884231|P2|Overall Study|Death|2
7731391|NCT00939627|26884232|P1|Overall Study|Death|0
7731392|NCT00939627|26884230|P3|Overall Study|Adverse Event|0
7731393|NCT00939627|26884231|P2|Overall Study|Adverse Event|7
7731394|NCT00939627|26884232|P1|Overall Study|Adverse Event|6
7731395|NCT00939627|26884230|P3|Overall Study|Disease Progression|0
7731396|NCT00939627|26884231|P2|Overall Study|Disease Progression|12
7731397|NCT00939627|26884232|P1|Overall Study|Disease Progression|16
7731398|NCT00939523|26884272|P1|Overall Study|Physician Decision|2
7731399|NCT00939523|26884272|P1|Overall Study|Lack of Efficacy|1
7731400|NCT00939510|26884279|P1|Overall Study|Withdrawal by Subject|1
7731401|NCT00939484|26884288|P3|Overall Study|Progression/Relapse|3
7731402|NCT00939484|26884289|P2|Overall Study|Progression/Relapse|20
7731403|NCT00939484|26884290|P1|Overall Study|Progression/Relapse|8
7731404|NCT00939393|26884316|P2|Overall Study|Lost to Follow-up|0
7731405|NCT00939393|26884317|P1|Overall Study|Lost to Follow-up|3
7731406|NCT00939393|26884316|P2|Overall Study|Withdrawal by Subject|0
7731407|NCT00939393|26884317|P1|Overall Study|Withdrawal by Subject|1
7731408|NCT00939341|26884348|P1|Overall Study|Incorrect enrolment|8
7731409|NCT00939341|26884348|P1|Overall Study|Protocol Violation|6
7731410|NCT00939341|26884348|P1|Overall Study|Withdrawal by Subject|13
7731411|NCT00939341|26884348|P1|Overall Study|Lost to Follow-up|23
7731412|NCT00939341|26884348|P1|Overall Study|Pregnancy|1
7731413|NCT00939341|26884348|P1|Overall Study|Adverse Event|15
7731414|NCT00939185|26884435|P1|Overall Study|Randomized But Did Not Receive Treatment|10
7731415|NCT00939185|26884435|P1|Overall Study|Withdrawal by Subject|2
7731416|NCT00939185|26884435|P1|Overall Study|Other|3
7731417|NCT00939185|26884435|P1|Overall Study|Lost to Follow-up|6
7731418|NCT00939185|26884435|P1|Overall Study|Lack of Efficacy|1
7731419|NCT00939185|26884435|P1|Overall Study|Adverse Event|3
7731420|NCT00939107|26884473|P2|Overall Study|Lost to Follow-up|12
7731421|NCT00939107|26884474|P1|Overall Study|Lost to Follow-up|14
7731422|NCT00939094|26884488|P2|Overall Study|Abnormal ECG findings|0
7731423|NCT00939094|26884489|P1|Overall Study|Abnormal ECG findings|1
7731424|NCT00939094|26884488|P2|Overall Study|Study stopped by sponsor|2
7731425|NCT00939094|26884489|P1|Overall Study|Study stopped by sponsor|0
7731426|NCT00939094|26884488|P2|Overall Study|Severe non-compliance to protocol|1
7731427|NCT00939094|26884489|P1|Overall Study|Severe non-compliance to protocol|0
7731428|NCT00939094|26884488|P2|Overall Study|Eligibility criteria not fulfilled|0
7731429|NCT00939094|26884489|P1|Overall Study|Eligibility criteria not fulfilled|2
7731430|NCT00939094|26884488|P2|Overall Study|Lost to Follow-up|1
7731431|NCT00939094|26884489|P1|Overall Study|Lost to Follow-up|1
7731432|NCT00939094|26884488|P2|Overall Study|Withdrawal by Subject|6
7731433|NCT00939094|26884489|P1|Overall Study|Withdrawal by Subject|1
7731434|NCT00939094|26884488|P2|Overall Study|Adverse Event|0
7731435|NCT00939094|26884489|P1|Overall Study|Adverse Event|9
7731436|NCT00939055|26884511|P2|Overall Study|Discontinuation prior to procedure|0
7731437|NCT00939055|26884512|P1|Overall Study|Discontinuation prior to procedure|4
7731438|NCT00939029|26884522|P2|Overall Study|Adverse Event|1
7731439|NCT00939029|26884523|P1|Overall Study|Adverse Event|0
7731440|NCT00939029|26884522|P2|Overall Study|Lost to Follow-up|4
7731441|NCT00939029|26884523|P1|Overall Study|Lost to Follow-up|3
7731442|NCT00939029|26884522|P2|Overall Study|Withdrawal by Subject|7
7731443|NCT00939029|26884523|P1|Overall Study|Withdrawal by Subject|3
7731444|NCT00939003|26884535|P2|Open-label Treatment Period|Site Closure|4
7731445|NCT00939003|26884536|P1|Open-label Treatment Period|Site Closure|3
7731446|NCT00939003|26884535|P2|Open-label Treatment Period|Exclusion Criteria|0
7731447|NCT00939003|26884536|P1|Open-label Treatment Period|Exclusion Criteria|1
7731448|NCT00939003|26884535|P2|Open-label Treatment Period|Pregnancy|1
7731449|NCT00939003|26884536|P1|Open-label Treatment Period|Pregnancy|1
7731450|NCT00939003|26884535|P2|Open-label Treatment Period|Lack of Efficacy|9
7731451|NCT00939003|26884536|P1|Open-label Treatment Period|Lack of Efficacy|6
7731452|NCT00939003|26884535|P2|Open-label Treatment Period|Withdrawal by Subject|7
7731453|NCT00939003|26884536|P1|Open-label Treatment Period|Withdrawal by Subject|14
7731454|NCT00939003|26884535|P2|Open-label Treatment Period|Adverse Event|8
7731455|NCT00939003|26884536|P1|Open-label Treatment Period|Adverse Event|4
7731456|NCT00939003|26884535|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
7731457|NCT00939003|26884536|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
7731458|NCT00939003|26884535|P2|Double-blind Treatment Period|Pregnancy|1
7731459|NCT00939003|26884536|P1|Double-blind Treatment Period|Pregnancy|0
7731460|NCT00939003|26884535|P2|Double-blind Treatment Period|Lack of Efficacy|1
7731461|NCT00939003|26884536|P1|Double-blind Treatment Period|Lack of Efficacy|0
7731462|NCT00939003|26884535|P2|Double-blind Treatment Period|Adverse Event|1
7731463|NCT00939003|26884536|P1|Double-blind Treatment Period|Adverse Event|1
7731464|NCT00938964|26884573|P2|Overall Study|Found to Meet Exclusion Criteria|4
7731465|NCT00938964|26884574|P1|Overall Study|Found to Meet Exclusion Criteria|3
7731466|NCT00938964|26884573|P2|Overall Study|Withdrawal by Subject|18
7731467|NCT00938964|26884574|P1|Overall Study|Withdrawal by Subject|22
7731468|NCT00938964|26884573|P2|Overall Study|Lost to Follow-up|3
7731469|NCT00938964|26884574|P1|Overall Study|Lost to Follow-up|2
7731470|NCT00938964|26884573|P2|Overall Study|Death|3
7731471|NCT00938964|26884574|P1|Overall Study|Death|3
7731472|NCT00938886|26884638|P2|Overall Study|Lost to Follow-up|2
7731473|NCT00938886|26884639|P1|Overall Study|Lost to Follow-up|3
7731474|NCT00938886|26884638|P2|Overall Study|Withdrawal by Subject|7
7731475|NCT00938886|26884639|P1|Overall Study|Withdrawal by Subject|4
7731476|NCT00938886|26884638|P2|Overall Study|Death|1
7731477|NCT00938886|26884639|P1|Overall Study|Death|0
7731478|NCT00938860|26884649|P2|Overall Study|Protocol Violation|1
7731479|NCT00938860|26884650|P1|Overall Study|Protocol Violation|3
7731480|NCT00938860|26884649|P2|Overall Study|Death|1
7731481|NCT00938860|26884650|P1|Overall Study|Death|1
7731482|NCT00938860|26884649|P2|Overall Study|Administration problems|0
7731483|NCT00938860|26884650|P1|Overall Study|Administration problems|2
7731484|NCT00938860|26884649|P2|Overall Study|Lost to Follow-up|4
7731485|NCT00938860|26884650|P1|Overall Study|Lost to Follow-up|4
7731486|NCT00938860|26884649|P2|Overall Study|Withdrawal by Subject|8
7731487|NCT00938860|26884650|P1|Overall Study|Withdrawal by Subject|11
7731488|NCT00938860|26884649|P2|Overall Study|Abnormal laboratory values|2
7731489|NCT00938860|26884650|P1|Overall Study|Abnormal laboratory values|2
7731490|NCT00938860|26884649|P2|Overall Study|Adverse Event|1
7731491|NCT00938860|26884650|P1|Overall Study|Adverse Event|2
7731492|NCT00938717|26884683|P2|Overall Study|Other reason|2
7731493|NCT00938717|26884684|P1|Overall Study|Other reason|5
7731494|NCT00938717|26884683|P2|Overall Study|Lack of Efficacy|15
7731495|NCT00938717|26884684|P1|Overall Study|Lack of Efficacy|33
7731496|NCT00938717|26884683|P2|Overall Study|Lost to Follow-up|18
7731497|NCT00938717|26884684|P1|Overall Study|Lost to Follow-up|13
7731498|NCT00938717|26884683|P2|Overall Study|Withdrawal by Subject|24
7731499|NCT00938717|26884684|P1|Overall Study|Withdrawal by Subject|26
7731500|NCT00938717|26884683|P2|Overall Study|Protocol Violation|8
7731501|NCT00938717|26884684|P1|Overall Study|Protocol Violation|11
7731502|NCT00938717|26884683|P2|Overall Study|Adverse Event|41
7731503|NCT00938717|26884684|P1|Overall Study|Adverse Event|10
7731504|NCT00938639|26884735|P2|Overall Study|Participant noncompliance|0
7731505|NCT00938639|26884736|P1|Overall Study|Participant noncompliance|1
7731506|NCT00938639|26884735|P2|Overall Study|Family issues|1
7731507|NCT00938639|26884736|P1|Overall Study|Family issues|1
7731508|NCT00938639|26884735|P2|Overall Study|Lost to Follow-up|2
7731509|NCT00938639|26884736|P1|Overall Study|Lost to Follow-up|1
7731510|NCT00938639|26884735|P2|Overall Study|Moved away from study area|1
7731511|NCT00938639|26884736|P1|Overall Study|Moved away from study area|0
7731512|NCT00938470|26884819|P2|Overall Study|Other Reason|1
7731513|NCT00938470|26884820|P1|Overall Study|Other Reason|0
7731514|NCT00938470|26884819|P2|Overall Study|Death|2
7731515|NCT00938470|26884820|P1|Overall Study|Death|3
7731516|NCT00938470|26884819|P2|Overall Study|Alternate Treatment|0
7731517|NCT00938470|26884820|P1|Overall Study|Alternate Treatment|1
7731518|NCT00938470|26884819|P2|Overall Study|Disease Progression|0
7731519|NCT00938470|26884820|P1|Overall Study|Disease Progression|3
7731520|NCT00938431|26884850|P3|Overall Study|Reached maximum dose early|1
7731521|NCT00938431|26884851|P2|Overall Study|Reached maximum dose early|0
7731522|NCT00938431|26884852|P1|Overall Study|Reached maximum dose early|0
7731523|NCT00938431|26884850|P3|Overall Study|Dosing compliance issue|1
7731524|NCT00938431|26884851|P2|Overall Study|Dosing compliance issue|0
7731525|NCT00938431|26884852|P1|Overall Study|Dosing compliance issue|0
7731526|NCT00938431|26884850|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
7731527|NCT00938431|26884851|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
7731528|NCT00938431|26884852|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
7731529|NCT00938431|26884850|P3|Overall Study|Lack of Efficacy|0
7731530|NCT00938431|26884851|P2|Overall Study|Lack of Efficacy|1
7731531|NCT00938431|26884852|P1|Overall Study|Lack of Efficacy|0
7731532|NCT00938431|26884850|P3|Overall Study|Adverse Event|6
7731533|NCT00938431|26884851|P2|Overall Study|Adverse Event|8
7731534|NCT00938431|26884852|P1|Overall Study|Adverse Event|5
7731535|NCT00938392|26884879|P2|Overall Study|Lost to Follow-up|2
7731536|NCT00938392|26884880|P1|Overall Study|Lost to Follow-up|2
7731537|NCT00938392|26884879|P2|Overall Study|Withdrawal by Subject|1
7731538|NCT00938392|26884880|P1|Overall Study|Withdrawal by Subject|0
7731539|NCT00938392|26884879|P2|Overall Study|Adverse Event|1
7731540|NCT00938392|26884880|P1|Overall Study|Adverse Event|0
7731541|NCT00938366|26884906|P2|Overall Study|Withdrawal by Subject|0
7731542|NCT00938366|26884907|P1|Overall Study|Withdrawal by Subject|1
7731543|NCT00938340|26884927|P1|Overall Study|Adverse Event|1
7731544|NCT00938340|26884927|P1|Overall Study|Protocol Violation|1
7731545|NCT00938340|26884927|P1|Overall Study|Withdrawal by Subject|3
7731546|NCT00938327|26885057|P1|Overall Study|Vaccine not received as out of stock|9
7731547|NCT00938327|26885057|P1|Overall Study|2nd dose received outside of the study|7
7731548|NCT00938327|26885057|P1|Overall Study|Lost to Follow-up|37
7731549|NCT00938327|26885057|P1|Overall Study|Withdrawal by Subject|4
7731550|NCT00938327|26885057|P1|Overall Study|Protocol Violation|1
7731551|NCT00938327|26885057|P1|Overall Study|Adverse Event|2
7731552|NCT00938041|26885125|P1|Overall Study|Adrenal Insufficiency|3
7731553|NCT00938041|26885125|P1|Overall Study|Death|12
7731554|NCT00938041|26885125|P1|Overall Study|Progressive Disease|5
7731555|NCT00938041|26885125|P1|Overall Study|Received Alternative Therapy|1
7731556|NCT00938041|26885125|P1|Overall Study|Lost to Follow-up|6
7731557|NCT00938015|26885134|P1|Overall Study|Reason not related to Etanercept|29
7731558|NCT00938015|26885134|P1|Overall Study|Non-responder|52
7731559|NCT00938015|26885134|P1|Overall Study|Adverse Event|32
7731560|NCT00938015|26885134|P1|Overall Study|Lost to Follow-up|32
7731561|NCT00938015|26885134|P1|Overall Study|Death|2
7731562|NCT00937950|26885150|P1|Overall Study|Other|18
7731563|NCT00937950|26885150|P1|Overall Study|Missing confirmed|4
7731564|NCT00937950|26885150|P1|Overall Study|Lost to Follow-up|144
7731565|NCT00937950|26885150|P1|Overall Study|Migrated/moved from study area|27
7731566|NCT00937950|26885150|P1|Overall Study|Withdrawal by Subject|23
7731567|NCT00937937|26885166|P1|Overall Study|Other|2
7731568|NCT00937937|26885166|P1|Overall Study|Death|1
7731569|NCT00937937|26885166|P1|Overall Study|Progression/relapse|61
7731570|NCT00937937|26885166|P1|Overall Study|Withdrawal by Subject|2
7731571|NCT00937937|26885166|P1|Overall Study|Adverse Event|6
7731572|NCT00937833|26885186|P2|Overall Study|Withdrawal by Subject|6
7731573|NCT00937833|26885187|P1|Overall Study|Withdrawal by Subject|4
7731574|NCT00937833|26885186|P2|Overall Study|Lost to Follow-up|8
7731575|NCT00937833|26885187|P1|Overall Study|Lost to Follow-up|10
7731576|NCT00937833|26885186|P2|Overall Study|Procedure delayed; enrollment closed|1
7731577|NCT00937833|26885187|P1|Overall Study|Procedure delayed; enrollment closed|0
7731578|NCT00937833|26885186|P2|Overall Study|Protocol Violation|2
7731579|NCT00937833|26885187|P1|Overall Study|Protocol Violation|1
7731580|NCT00937768|26885200|P2|Overall Study|No Further Funding|4
7731581|NCT00937768|26885201|P1|Overall Study|No Further Funding|4
7731582|NCT00937768|26885200|P2|Overall Study|Alternate Treatment|1
7731583|NCT00937768|26885201|P1|Overall Study|Alternate Treatment|0
7731584|NCT00937768|26885200|P2|Overall Study|Disease Progression|1
7731585|NCT00937768|26885201|P1|Overall Study|Disease Progression|1
7731586|NCT00937768|26885200|P2|Overall Study|Refused Further Treatment|2
7731587|NCT00937768|26885201|P1|Overall Study|Refused Further Treatment|3
7731588|NCT00937560|26885221|P1|Maintenance Treatment|According to protocol|1
7731589|NCT00937560|26885221|P1|Maintenance Treatment|Withdraw consent|5
7731590|NCT00937560|26885221|P1|Maintenance Treatment|Death|12
7731591|NCT00937560|26885221|P1|Initial Treatment|No end of study page|10
7731592|NCT00937560|26885221|P1|Initial Treatment|Lost to Follow-up|1
7731593|NCT00937560|26885221|P1|Initial Treatment|Adverse Event|1
7731594|NCT00937560|26885221|P1|Initial Treatment|Withdraw consent|3
7731595|NCT00937560|26885221|P1|Initial Treatment|Death|6
7731596|NCT00937547|26885232|P3|Overall Study|misdiagnosis|7
7731597|NCT00937547|26885233|P2|Overall Study|misdiagnosis|6
7731598|NCT00937547|26885234|P1|Overall Study|misdiagnosis|1
7731599|NCT00937521|26885271|P8|Booster Phase|Protocol Deviation|0
7731600|NCT00937521|26885272|P7|Booster Phase|Protocol Deviation|1
7731601|NCT00937521|26885273|P6|Booster Phase|Protocol Deviation|0
7731602|NCT00937521|26885274|P5|Booster Phase|Protocol Deviation|0
7731603|NCT00937521|26885275|P4|Booster Phase|Protocol Deviation|0
7731604|NCT00937521|26885276|P3|Booster Phase|Protocol Deviation|0
7731605|NCT00937521|26885277|P2|Booster Phase|Protocol Deviation|0
7731606|NCT00937521|26885278|P1|Booster Phase|Protocol Deviation|0
7731607|NCT00937521|26885271|P8|Booster Phase|Administrative Reason|0
7731608|NCT00937521|26885272|P7|Booster Phase|Administrative Reason|0
7731609|NCT00937521|26885273|P6|Booster Phase|Administrative Reason|1
7731610|NCT00937521|26885274|P5|Booster Phase|Administrative Reason|1
7731611|NCT00937521|26885275|P4|Booster Phase|Administrative Reason|0
7731612|NCT00937521|26885276|P3|Booster Phase|Administrative Reason|1
7731613|NCT00937521|26885277|P2|Booster Phase|Administrative Reason|0
7731614|NCT00937521|26885278|P1|Booster Phase|Administrative Reason|0
7731615|NCT00937521|26885271|P8|Booster Phase|Lost to Follow-up|0
7731616|NCT00937521|26885272|P7|Booster Phase|Lost to Follow-up|3
7731617|NCT00937521|26885273|P6|Booster Phase|Lost to Follow-up|4
7731618|NCT00937521|26885274|P5|Booster Phase|Lost to Follow-up|4
7731619|NCT00937521|26885275|P4|Booster Phase|Lost to Follow-up|2
7731620|NCT00937521|26885276|P3|Booster Phase|Lost to Follow-up|4
7731621|NCT00937521|26885277|P2|Booster Phase|Lost to Follow-up|2
7731622|NCT00937521|26885278|P1|Booster Phase|Lost to Follow-up|2
7731623|NCT00937521|26885271|P8|Booster Phase|Withdrawal by Subject|2
7731624|NCT00937521|26885272|P7|Booster Phase|Withdrawal by Subject|0
7731625|NCT00937521|26885273|P6|Booster Phase|Withdrawal by Subject|0
7731626|NCT00937521|26885274|P5|Booster Phase|Withdrawal by Subject|0
7731627|NCT00937521|26885275|P4|Booster Phase|Withdrawal by Subject|1
7731628|NCT00937521|26885276|P3|Booster Phase|Withdrawal by Subject|0
7731629|NCT00937521|26885277|P2|Booster Phase|Withdrawal by Subject|0
7731630|NCT00937521|26885278|P1|Booster Phase|Withdrawal by Subject|1
7731631|NCT00937521|26885271|P8|Booster Phase|Adverse Event|0
7731632|NCT00937521|26885272|P7|Booster Phase|Adverse Event|1
7731633|NCT00937521|26885273|P6|Booster Phase|Adverse Event|0
7731634|NCT00937521|26885274|P5|Booster Phase|Adverse Event|0
7731635|NCT00937521|26885275|P4|Booster Phase|Adverse Event|0
7731636|NCT00937521|26885276|P3|Booster Phase|Adverse Event|0
7731637|NCT00937521|26885277|P2|Booster Phase|Adverse Event|0
7731638|NCT00937521|26885278|P1|Booster Phase|Adverse Event|0
7731639|NCT00937521|26885271|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7731640|NCT00937521|26885272|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
7731641|NCT00937521|26885273|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7731642|NCT00937521|26885274|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7731643|NCT00937521|26885275|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7731644|NCT00937521|26885276|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7731645|NCT00937521|26885277|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7731646|NCT00937521|26885278|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
7731647|NCT00937521|26885271|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7731648|NCT00937521|26885272|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
7731649|NCT00937521|26885273|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
7731650|NCT00937521|26885274|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
7731651|NCT00937521|26885275|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7731652|NCT00937521|26885276|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7731653|NCT00937521|26885277|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
7731654|NCT00937521|26885278|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7731655|NCT00937521|26885271|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7731656|NCT00937521|26885272|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7731657|NCT00937521|26885273|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7731658|NCT00937521|26885274|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7731659|NCT00937521|26885275|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
7731660|NCT00937521|26885276|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
7731661|NCT00937521|26885277|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7731662|NCT00937521|26885278|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7731663|NCT00937521|26885271|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7731664|NCT00937521|26885272|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
7731665|NCT00937521|26885273|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
7731666|NCT00937521|26885274|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7731667|NCT00937521|26885275|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
7731668|NCT00937521|26885276|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
7731669|NCT00937521|26885277|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7731670|NCT00937521|26885278|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
7731671|NCT00937521|26885271|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
7731672|NCT00937521|26885272|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
7731673|NCT00937521|26885273|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
7731674|NCT00937521|26885274|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
7731675|NCT00937521|26885275|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
7731676|NCT00937521|26885276|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
7731677|NCT00937521|26885277|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
7731678|NCT00937521|26885278|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
7731679|NCT00937495|26885384|P1|Overall Study|Protocol Violation|2
7731680|NCT00937404|26885390|P1|Overall Study|Withdrawal by Subject|1
7731681|NCT00937404|26885390|P1|Overall Study|Protocol Violation|1
7731682|NCT00937391|26885399|P1|Stage 2|Withdrawal by Subject|1
7731683|NCT00937326|26885466|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
7731684|NCT00937326|26885467|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
7731685|NCT00937326|26885468|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
7731686|NCT00937326|26885469|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
7731687|NCT00937326|26885470|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
7731688|NCT00937326|26885466|P5|Overall Study|Withdrawal by Subject|3
7731689|NCT00937326|26885467|P4|Overall Study|Withdrawal by Subject|4
7731690|NCT00937326|26885468|P3|Overall Study|Withdrawal by Subject|1
7731691|NCT00937326|26885469|P2|Overall Study|Withdrawal by Subject|4
7731692|NCT00937326|26885470|P1|Overall Study|Withdrawal by Subject|3
7731693|NCT00937326|26885466|P5|Overall Study|Death|0
7731694|NCT00937326|26885467|P4|Overall Study|Death|0
7731695|NCT00937326|26885468|P3|Overall Study|Death|1
7731696|NCT00937326|26885469|P2|Overall Study|Death|0
7731697|NCT00937326|26885470|P1|Overall Study|Death|0
7731698|NCT00937326|26885466|P5|Overall Study|Adverse Event|2
7731699|NCT00937326|26885467|P4|Overall Study|Adverse Event|1
7731700|NCT00937326|26885468|P3|Overall Study|Adverse Event|1
7731701|NCT00937326|26885469|P2|Overall Study|Adverse Event|3
7731702|NCT00937326|26885470|P1|Overall Study|Adverse Event|0
7731703|NCT00937157|26885719|P1|Overall Study|Lost to Follow-up|3
7731704|NCT00937157|26885719|P1|Overall Study|Pregnancy|1
7731705|NCT00937040|26885750|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
7731706|NCT00937040|26885751|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
7731707|NCT00937040|26885750|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
7731708|NCT00937040|26885751|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
7731709|NCT00937040|26885750|P2|Overall Study|Withdrawal by Subject|7
7731710|NCT00937040|26885751|P1|Overall Study|Withdrawal by Subject|13
7731711|NCT00937040|26885750|P2|Overall Study|Protocol Violation|0
7731712|NCT00937040|26885751|P1|Overall Study|Protocol Violation|3
7731713|NCT00937040|26885750|P2|Overall Study|Lost to Follow-up|12
7731714|NCT00937040|26885751|P1|Overall Study|Lost to Follow-up|12
7731715|NCT00937040|26885750|P2|Overall Study|Adverse Event|8
7731716|NCT00937040|26885751|P1|Overall Study|Adverse Event|5
7731717|NCT00936975|26885793|P1|Overall Study|Post-Tx scan uninterpretable|2
7731718|NCT00936975|26885793|P1|Overall Study|Disease progression|3
7731719|NCT00936975|26885793|P1|Overall Study|Withdrawal by Subject|1
7731720|NCT00936910|26885802|P1|Overall Study|Lack of Efficacy|3
7731721|NCT00936897|26885811|P2|Overall Study|Death|1
7731722|NCT00936897|26885812|P1|Overall Study|Death|0
7731723|NCT00936897|26885811|P2|Overall Study|Noncompliance|2
7731724|NCT00936897|26885812|P1|Overall Study|Noncompliance|0
7731725|NCT00936897|26885811|P2|Overall Study|Ineligibility Determined|3
7731726|NCT00936897|26885812|P1|Overall Study|Ineligibility Determined|0
7731727|NCT00936897|26885811|P2|Overall Study|Protocol Violation|1
7731728|NCT00936897|26885812|P1|Overall Study|Protocol Violation|1
7731729|NCT00936897|26885811|P2|Overall Study|Administrative Decision|2
7731730|NCT00936897|26885812|P1|Overall Study|Administrative Decision|1
7731731|NCT00936897|26885811|P2|Overall Study|Lost to Follow-up|10
7731732|NCT00936897|26885812|P1|Overall Study|Lost to Follow-up|1
7731733|NCT00936897|26885811|P2|Overall Study|Other|9
7731734|NCT00936897|26885812|P1|Overall Study|Other|3
7731735|NCT00936897|26885811|P2|Overall Study|Adverse Event|13
7731736|NCT00936897|26885812|P1|Overall Study|Adverse Event|4
7731737|NCT00936897|26885811|P2|Overall Study|Withdrawal by Subject|19
7731738|NCT00936897|26885812|P1|Overall Study|Withdrawal by Subject|9
7731739|NCT00936884|26885826|P3|Double-blind|Did not receive study drug|0
7731740|NCT00936884|26885827|P2|Double-blind|Did not receive study drug|1
7731741|NCT00936884|26885828|P1|Double-blind|Did not receive study drug|0
7731742|NCT00936884|26885826|P3|Double-blind|No post baseline diary entry|0
7731743|NCT00936884|26885827|P2|Double-blind|No post baseline diary entry|0
7731744|NCT00936884|26885828|P1|Double-blind|No post baseline diary entry|1
7731745|NCT00936884|26885826|P3|Double-blind|Physician Decision|0
7731746|NCT00936884|26885827|P2|Double-blind|Physician Decision|0
7731747|NCT00936884|26885828|P1|Double-blind|Physician Decision|1
7731748|NCT00936884|26885826|P3|Double-blind|Adverse Event|0
7731749|NCT00936884|26885827|P2|Double-blind|Adverse Event|0
7731750|NCT00936884|26885828|P1|Double-blind|Adverse Event|1
7731751|NCT00936884|26885826|P3|Double-blind|Lack of Efficacy|0
7731752|NCT00936884|26885827|P2|Double-blind|Lack of Efficacy|1
7731753|NCT00936884|26885828|P1|Double-blind|Lack of Efficacy|1
7731754|NCT00936884|26885826|P3|Double-blind|Death|0
7731755|NCT00936884|26885827|P2|Double-blind|Death|1
7731756|NCT00936884|26885828|P1|Double-blind|Death|2
7731757|NCT00936884|26885826|P3|Double-blind|Withdrawal by Subject|0
7731758|NCT00936884|26885827|P2|Double-blind|Withdrawal by Subject|4
7731759|NCT00936884|26885828|P1|Double-blind|Withdrawal by Subject|6
7731767|NCT00936715|26885851|P1|Overall Study|Safety or Tolerability Reasons|4
7731768|NCT00936715|26885851|P1|Overall Study|Protocol Violation|1
7731769|NCT00936715|26885851|P1|Overall Study|Investigators Discretion|1
7731770|NCT00936702|26885855|P1|Overall Study|Other|1
7731771|NCT00936702|26885855|P1|Overall Study|Alternative Treatment|1
7731772|NCT00936702|26885855|P1|Overall Study|Withdrawal by Subject|2
7731773|NCT00936702|26885855|P1|Overall Study|Adverse Event|8
7731774|NCT00936702|26885855|P1|Overall Study|Disease progression|34
7731775|NCT00936611|26885886|P1|Overall Study|Ineligible for Study Drug|3
7731776|NCT00936611|26885886|P1|Overall Study|Still on Active Therapy|7
7731777|NCT00936611|26885886|P1|Overall Study|Still on Follow-up|1
7731778|NCT00936611|26885886|P1|Overall Study|Withdrawal by Subject|2
7731779|NCT00936611|26885886|P1|Overall Study|Lost to Follow-up|1
7731780|NCT00936611|26885886|P1|Overall Study|New Systemic Therapy|22
7731781|NCT00936611|26885886|P1|Overall Study|Progressive Disease|3
7731782|NCT00936598|26885897|P2|Overall Study|Ineligible after consent|0
7731783|NCT00936598|26885898|P1|Overall Study|Ineligible after consent|1
7731784|NCT00936598|26885897|P2|Overall Study|Withdrawal by Subject|0
7731785|NCT00936598|26885898|P1|Overall Study|Withdrawal by Subject|1
7731786|NCT00936221|26886000|P2|Overall Study|Withdrawal by Subject|1
7731787|NCT00936221|26886001|P1|Overall Study|Withdrawal by Subject|1
7731788|NCT00936208|26886015|P2|Overall Study|Protocol Violation|22
7731789|NCT00936208|26886016|P1|Overall Study|Protocol Violation|37
7731790|NCT00936117|26886034|P1|Overall Study|Unable to continue oral medication|3
7731791|NCT00936117|26886034|P1|Overall Study|Adverse Event|7
7731792|NCT00936065|26886042|P3|Overall Study|Withdrawal by Subject|4
7731793|NCT00936065|26886043|P2|Overall Study|Withdrawal by Subject|2
7731794|NCT00936065|26886044|P1|Overall Study|Withdrawal by Subject|0
7731795|NCT00936065|26886042|P3|Overall Study|Protocol Violation|1
7731796|NCT00936065|26886043|P2|Overall Study|Protocol Violation|2
7731797|NCT00936065|26886044|P1|Overall Study|Protocol Violation|1
7731798|NCT00936065|26886042|P3|Overall Study|Lost to Follow-up|0
7731799|NCT00936065|26886043|P2|Overall Study|Lost to Follow-up|0
7731800|NCT00936065|26886044|P1|Overall Study|Lost to Follow-up|1
7731801|NCT00936065|26886042|P3|Overall Study|Lack of Efficacy|1
7731802|NCT00936065|26886043|P2|Overall Study|Lack of Efficacy|0
7731803|NCT00936065|26886044|P1|Overall Study|Lack of Efficacy|1
7731804|NCT00936065|26886042|P3|Overall Study|Adverse Event|1
7731805|NCT00936065|26886043|P2|Overall Study|Adverse Event|0
7731806|NCT00936065|26886044|P1|Overall Study|Adverse Event|1
7731807|NCT00935883|26886150|P2|Treatment Period|Withdrawal by Subject|2
7731808|NCT00935883|26886151|P1|Treatment Period|Withdrawal by Subject|0
7731809|NCT00935883|26886150|P2|Treatment Period|Physician Decision|0
7731810|NCT00935883|26886151|P1|Treatment Period|Physician Decision|1
7731811|NCT00935818|26886178|P2|Overall Study|Physician Decision|1
7731812|NCT00935818|26886179|P1|Overall Study|Physician Decision|0
7731813|NCT00935818|26886178|P2|Overall Study|Adverse Event|7
7731814|NCT00935818|26886179|P1|Overall Study|Adverse Event|6
7731815|NCT00935818|26886178|P2|Overall Study|Lost to Follow-up|42
7731816|NCT00935818|26886179|P1|Overall Study|Lost to Follow-up|40
7731817|NCT00935818|26886178|P2|Overall Study|Withdrawal by Subject|50
7731818|NCT00935818|26886179|P1|Overall Study|Withdrawal by Subject|45
7731819|NCT00935701|26886230|P1|Overall Study|Failure to Transition to Acupuncture|1
7731820|NCT00935584|26886247|P2|Overall Study|Provider dropped out of study|4
7731821|NCT00935584|26886248|P1|Overall Study|Provider dropped out of study|14
7731822|NCT00935584|26886247|P2|Overall Study|Patient changed provider|0
7731823|NCT00935584|26886248|P1|Overall Study|Patient changed provider|3
7731824|NCT00935584|26886247|P2|Overall Study|Relocated|0
7731825|NCT00935584|26886248|P1|Overall Study|Relocated|3
7731826|NCT00935584|26886247|P2|Overall Study|No show|0
7731827|NCT00935584|26886248|P1|Overall Study|No show|9
7731828|NCT00935584|26886247|P2|Overall Study|Lost to Follow-up|0
7731829|NCT00935584|26886248|P1|Overall Study|Lost to Follow-up|8
7731830|NCT00935584|26886247|P2|Overall Study|Death|0
7731831|NCT00935584|26886248|P1|Overall Study|Death|3
7731832|NCT00935584|26886247|P2|Overall Study|Withdrawal by Subject|0
7731833|NCT00935584|26886248|P1|Overall Study|Withdrawal by Subject|9
7731834|NCT00935532|26886260|P2|Overall Study|Loss Glucose Control|0
7731835|NCT00935532|26886261|P1|Overall Study|Loss Glucose Control|4
7731836|NCT00935532|26886260|P2|Overall Study|Sponsor Decision|1
7731837|NCT00935532|26886261|P1|Overall Study|Sponsor Decision|0
7731838|NCT00935532|26886260|P2|Overall Study|Subject Decision|1
7731839|NCT00935532|26886261|P1|Overall Study|Subject Decision|2
7731840|NCT00935532|26886260|P2|Overall Study|Protocol Violation|1
7731841|NCT00935532|26886261|P1|Overall Study|Protocol Violation|2
7731842|NCT00935532|26886260|P2|Overall Study|Physician Decision|2
7731843|NCT00935532|26886261|P1|Overall Study|Physician Decision|1
7731844|NCT00935532|26886260|P2|Overall Study|Lost to Follow-up|0
7731845|NCT00935532|26886261|P1|Overall Study|Lost to Follow-up|1
7731846|NCT00935532|26886260|P2|Overall Study|Death|0
7731847|NCT00935532|26886261|P1|Overall Study|Death|1
7731848|NCT00935532|26886260|P2|Overall Study|Adverse Event|6
7731849|NCT00935532|26886261|P1|Overall Study|Adverse Event|11
7731850|NCT00935493|26886290|P3|Overall Study|Treatment Discontinued|0
7731851|NCT00935493|26886291|P2|Overall Study|Treatment Discontinued|1
7731852|NCT00935493|26886292|P1|Overall Study|Treatment Discontinued|0
7731853|NCT00935493|26886290|P3|Overall Study|Lost to Follow-up|1
7731854|NCT00935493|26886291|P2|Overall Study|Lost to Follow-up|1
7731855|NCT00935493|26886292|P1|Overall Study|Lost to Follow-up|1
7731856|NCT00935272|26886341|P2|Overall Study|Protocol Violation|1
7731857|NCT00935272|26886342|P1|Overall Study|Protocol Violation|0
7731858|NCT00935272|26886341|P2|Overall Study|Physician Decision|0
7731859|NCT00935272|26886342|P1|Overall Study|Physician Decision|1
7731860|NCT00935272|26886341|P2|Overall Study|Withdrawal by Subject|2
7731861|NCT00935272|26886342|P1|Overall Study|Withdrawal by Subject|8
7731862|NCT00935272|26886341|P2|Overall Study|Lost to Follow-up|3
7731863|NCT00935272|26886342|P1|Overall Study|Lost to Follow-up|10
7731864|NCT00935259|26886351|P2|Period 1|Administrative (scheduling conflict)|1
7731865|NCT00935259|26886352|P1|Period 1|Administrative (scheduling conflict)|1
7731866|NCT00935220|26886366|P1|Overall Study|Other reason (not specified)|1
7731867|NCT00935220|26886366|P1|Overall Study|Adverse Event|1
7731868|NCT00935012|26886395|P1|Overall Study|Adverse Event|2
7731869|NCT00935012|26886395|P1|Overall Study|Other|5
7731870|NCT00935012|26886395|P1|Overall Study|Withdrawal by Subject|3
7731871|NCT00935012|26886395|P1|Overall Study|Death|19
7731872|NCT00934947|26886437|P2|Overall Study|Adverse Event|2
7731873|NCT00934947|26886438|P1|Overall Study|Adverse Event|0
7731874|NCT00934856|26886495|P6|Extension Part|Non-compliance with drug|1
7731875|NCT00934856|26886496|P5|Extension Part|Non-compliance with drug|0
7731876|NCT00934856|26886497|P4|Extension Part|Non-compliance with drug|0
7731877|NCT00934856|26886498|P3|Extension Part|Non-compliance with drug|0
7731878|NCT00934856|26886499|P2|Extension Part|Non-compliance with drug|0
7731879|NCT00934856|26886500|P1|Extension Part|Non-compliance with drug|0
7731880|NCT00934856|26886495|P6|Extension Part|Progressive disease|0
7731881|NCT00934856|26886496|P5|Extension Part|Progressive disease|0
7731882|NCT00934856|26886497|P4|Extension Part|Progressive disease|1
7731883|NCT00934856|26886498|P3|Extension Part|Progressive disease|0
7731884|NCT00934856|26886499|P2|Extension Part|Progressive disease|0
7731885|NCT00934856|26886500|P1|Extension Part|Progressive disease|0
7731886|NCT00934856|26886495|P6|Extension Part|Adverse Event|4
7731887|NCT00934856|26886496|P5|Extension Part|Adverse Event|4
7731888|NCT00934856|26886497|P4|Extension Part|Adverse Event|1
7731889|NCT00934856|26886498|P3|Extension Part|Adverse Event|0
7731890|NCT00934856|26886499|P2|Extension Part|Adverse Event|0
7731891|NCT00934856|26886500|P1|Extension Part|Adverse Event|0
7731892|NCT00934856|26886495|P6|Feasibility Part|Withdrawal by Subject|1
7731893|NCT00934856|26886496|P5|Feasibility Part|Withdrawal by Subject|0
7731894|NCT00934856|26886497|P4|Feasibility Part|Withdrawal by Subject|1
7731895|NCT00934856|26886498|P3|Feasibility Part|Withdrawal by Subject|0
7731896|NCT00934856|26886499|P2|Feasibility Part|Withdrawal by Subject|0
7731897|NCT00934856|26886500|P1|Feasibility Part|Withdrawal by Subject|0
7731898|NCT00934856|26886495|P6|Feasibility Part|Adverse Event|2
7731899|NCT00934856|26886496|P5|Feasibility Part|Adverse Event|0
7731900|NCT00934856|26886497|P4|Feasibility Part|Adverse Event|1
7731901|NCT00934856|26886498|P3|Feasibility Part|Adverse Event|0
7731902|NCT00934856|26886499|P2|Feasibility Part|Adverse Event|1
7731903|NCT00934856|26886500|P1|Feasibility Part|Adverse Event|1
7731904|NCT00934856|26886495|P6|Feasibility Part|Physician Decision|0
7731905|NCT00934856|26886496|P5|Feasibility Part|Physician Decision|0
7731906|NCT00934856|26886497|P4|Feasibility Part|Physician Decision|0
7731907|NCT00934856|26886498|P3|Feasibility Part|Physician Decision|1
7731908|NCT00934856|26886499|P2|Feasibility Part|Physician Decision|0
7731909|NCT00934856|26886500|P1|Feasibility Part|Physician Decision|0
7731910|NCT00934856|26886495|P6|Feasibility Part|Progressive disease|0
7731911|NCT00934856|26886496|P5|Feasibility Part|Progressive disease|0
7731912|NCT00934856|26886497|P4|Feasibility Part|Progressive disease|3
7731913|NCT00934856|26886498|P3|Feasibility Part|Progressive disease|2
7731914|NCT00934856|26886499|P2|Feasibility Part|Progressive disease|4
7731915|NCT00934856|26886500|P1|Feasibility Part|Progressive disease|4
7731916|NCT00934843|26886598|P2|Overall Study|Protocol Violation|1
7731917|NCT00934843|26886599|P1|Overall Study|Protocol Violation|0
7731918|NCT00934791|26886615|P2|Overall Study|Withdrawal by Subject|0
7731919|NCT00934791|26886616|P1|Overall Study|Withdrawal by Subject|1
7731920|NCT00934661|26886624|P2|Overall Study|Failure of Combined/Spinal Epidural|0
7731921|NCT00934661|26886625|P1|Overall Study|Failure of Combined/Spinal Epidural|1
7731922|NCT00934648|26886645|P1|Overall Study|Withdrawal by Subject|1
7731923|NCT00934648|26886645|P1|Overall Study|Failure to return|8
7731924|NCT00934622|26886689|P1|Overall Study|2nd Intraoperative exclusion criteria|1
7731925|NCT00934622|26886689|P1|Overall Study|Lost to Follow-up|7
7731926|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
7731927|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
7731928|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
7731929|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
7731930|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
7731931|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
7731932|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
7731933|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
7731934|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
7731935|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
7731936|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
7731937|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
7731938|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
7731939|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
7731940|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
7731941|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
7731942|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
7731943|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
7731944|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
7731945|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
7731946|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
7731947|NCT00934544|26886727|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
7731948|NCT00934544|26886728|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
7731949|NCT00934544|26886729|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
7731950|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
7731951|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
7732112|NCT00932698|26887317|P5|Part 2 (Dose Expansion)|Adverse Event|0
7731952|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
7731953|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
7731954|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
7731955|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
7731956|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
7731957|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
7731958|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
7731959|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
7731960|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
7731961|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
7731962|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
7731963|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
7731964|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
7731965|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
7731966|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
7731967|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
7731968|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
7731969|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
7731970|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
7731971|NCT00934544|26886727|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
7731972|NCT00934544|26886728|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
7731973|NCT00934544|26886729|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
7731974|NCT00934440|26886765|P1|Overall Study|Lost to Follow-up|1
7731975|NCT00934362|26886781|P2|Overall Study|Adverse Event|0
7731976|NCT00934362|26886782|P1|Overall Study|Adverse Event|1
7731977|NCT00934128|26886832|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
7731978|NCT00934128|26886833|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
7731979|NCT00934128|26886832|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
7731980|NCT00934128|26886833|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
7731981|NCT00934128|26886832|P2|Washout Period (1 Hour)|Too tired|0
7731982|NCT00934128|26886833|P1|Washout Period (1 Hour)|Too tired|1
7731983|NCT00934128|26886832|P2|Washout Period (1 Hour)|Pain|0
7731984|NCT00934128|26886833|P1|Washout Period (1 Hour)|Pain|1
7731985|NCT00934128|26886832|P2|Washout Period (1 Hour)|Patient preference|3
7731986|NCT00934128|26886833|P1|Washout Period (1 Hour)|Patient preference|1
7731987|NCT00934128|26886832|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
7731988|NCT00934128|26886833|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
7731989|NCT00934128|26886832|P2|First Intervention (2 Hours)|Adverse Event|1
7731990|NCT00934128|26886833|P1|First Intervention (2 Hours)|Adverse Event|4
7731991|NCT00934128|26886832|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
7731992|NCT00934128|26886833|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
7731993|NCT00934102|26886841|P3|Period 1, One Night of Wear|Personal Reasons|0
7731994|NCT00934102|26886842|P2|Period 1, One Night of Wear|Personal Reasons|0
7731995|NCT00934102|26886843|P1|Period 1, One Night of Wear|Personal Reasons|1
7731996|NCT00934089|26886853|P2|First Intervention Period (14 Days)|Randomized, but not treated|0
7731997|NCT00934089|26886854|P1|First Intervention Period (14 Days)|Randomized, but not treated|1
7731998|NCT00934089|26886853|P2|First Intervention Period (14 Days)|Withdrawal by Subject|0
7731999|NCT00934089|26886854|P1|First Intervention Period (14 Days)|Withdrawal by Subject|1
7732000|NCT00934050|26886924|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
7732001|NCT00934050|26886925|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
7732002|NCT00934050|26886926|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7732003|NCT00934050|26886927|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7732004|NCT00934050|26886928|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7732005|NCT00934050|26886929|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7732006|NCT00934050|26886924|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
7732007|NCT00934050|26886925|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7732008|NCT00934050|26886926|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7732009|NCT00934050|26886927|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7732010|NCT00934050|26886928|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7732011|NCT00934050|26886929|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7732012|NCT00934050|26886924|P6|Enrolled After 15 Dec 2009|Death|1
7732013|NCT00934050|26886925|P5|Enrolled After 15 Dec 2009|Death|0
7732014|NCT00934050|26886926|P4|Enrolled After 15 Dec 2009|Death|0
7732015|NCT00934050|26886927|P3|Enrolled After 15 Dec 2009|Death|0
7732016|NCT00934050|26886928|P2|Enrolled After 15 Dec 2009|Death|0
7732017|NCT00934050|26886929|P1|Enrolled After 15 Dec 2009|Death|0
7732018|NCT00934050|26886924|P6|Enrolled After 15 Dec 2009|Adverse Event|0
7732019|NCT00934050|26886925|P5|Enrolled After 15 Dec 2009|Adverse Event|3
7732020|NCT00934050|26886926|P4|Enrolled After 15 Dec 2009|Adverse Event|0
7732021|NCT00934050|26886927|P3|Enrolled After 15 Dec 2009|Adverse Event|0
7732022|NCT00934050|26886928|P2|Enrolled After 15 Dec 2009|Adverse Event|0
7732023|NCT00934050|26886929|P1|Enrolled After 15 Dec 2009|Adverse Event|0
7732024|NCT00934050|26886924|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7732025|NCT00934050|26886925|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7732026|NCT00934050|26886926|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7732027|NCT00934050|26886927|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
7732028|NCT00934050|26886928|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7732029|NCT00934050|26886929|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7732030|NCT00934050|26886924|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
7732031|NCT00934050|26886925|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
7732032|NCT00934050|26886926|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
7732033|NCT00934050|26886927|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
7732034|NCT00934050|26886928|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
7732035|NCT00934050|26886929|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
7732036|NCT00934050|26886924|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7732037|NCT00934050|26886925|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7732038|NCT00934050|26886926|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
7732039|NCT00934050|26886927|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7732040|NCT00934050|26886928|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7732041|NCT00934050|26886929|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
7732042|NCT00933933|26886952|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
7732043|NCT00933933|26886953|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
7732044|NCT00933933|26886954|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
7732045|NCT00933933|26886952|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
7732046|NCT00933933|26886953|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
7732047|NCT00933933|26886954|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
7732048|NCT00933686|26886972|P2|Overall Study|Failure to show up at endpoint visits|2
7732049|NCT00933686|26886973|P1|Overall Study|Failure to show up at endpoint visits|0
7732050|NCT00933686|26886972|P2|Overall Study|Physician Decision|0
7732051|NCT00933686|26886973|P1|Overall Study|Physician Decision|1
7732052|NCT00933686|26886972|P2|Overall Study|Adverse Event|1
7732053|NCT00933686|26886973|P1|Overall Study|Adverse Event|1
7732054|NCT00933686|26886972|P2|Overall Study|Withdrawal by Subject|5
7732055|NCT00933686|26886973|P1|Overall Study|Withdrawal by Subject|6
7732056|NCT00933686|26886972|P2|Overall Study|Lost to Follow-up|2
7732057|NCT00933686|26886973|P1|Overall Study|Lost to Follow-up|2
7732058|NCT00933686|26886972|P2|Overall Study|Protocol Violation|1
7732059|NCT00933686|26886973|P1|Overall Study|Protocol Violation|0
7732060|NCT00933608|26886993|P2|Overall Study|Physician Decision|0
7732061|NCT00933608|26886994|P1|Overall Study|Physician Decision|1
7732062|NCT00933608|26886993|P2|Overall Study|Adverse Event|2
7732063|NCT00933608|26886994|P1|Overall Study|Adverse Event|4
7732064|NCT00933543|26887002|P2|Overall Study|Other|1
7732065|NCT00933543|26887003|P1|Overall Study|Other|1
7732066|NCT00933543|26887002|P2|Overall Study|Lack of Efficacy|3
7732067|NCT00933543|26887003|P1|Overall Study|Lack of Efficacy|0
7732068|NCT00933543|26887002|P2|Overall Study|Withdrawal by Subject|1
7732069|NCT00933543|26887003|P1|Overall Study|Withdrawal by Subject|0
7732070|NCT00933543|26887002|P2|Overall Study|Lost to Follow-up|1
7732071|NCT00933543|26887003|P1|Overall Study|Lost to Follow-up|0
7732072|NCT00933543|26887002|P2|Overall Study|Adverse Event|1
7732073|NCT00933543|26887003|P1|Overall Study|Adverse Event|2
7732074|NCT00933335|26887072|P2|Overall Study|Co-morbid Illness|0
7732075|NCT00933335|26887073|P1|Overall Study|Co-morbid Illness|1
7732076|NCT00933335|26887072|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
7732077|NCT00933335|26887073|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
7732078|NCT00933335|26887072|P2|Overall Study|Progressive Disease|11
7732079|NCT00933335|26887073|P1|Overall Study|Progressive Disease|0
7732080|NCT00933335|26887072|P2|Overall Study|Withdrawal by Subject|1
7732081|NCT00933335|26887073|P1|Overall Study|Withdrawal by Subject|0
7732082|NCT00933335|26887072|P2|Overall Study|Lost to Follow-up|3
7732083|NCT00933335|26887073|P1|Overall Study|Lost to Follow-up|1
7732084|NCT00933270|26887143|P1|Overall Study|Moved or would not return|10
7732085|NCT00933270|26887143|P1|Overall Study|Death|24
7732086|NCT00933270|26887143|P1|Overall Study|Missed Visit|2
7732087|NCT00933270|26887143|P1|Overall Study|Adverse Event|1
7732088|NCT00933270|26887143|P1|Overall Study|Lost to Follow-up|14
7732089|NCT00933270|26887143|P1|Overall Study|Insufficient Follow-up|10
7732090|NCT00933270|26887143|P1|Overall Study|Withdrawal by Subject|26
7732091|NCT00933244|26887237|P3|Overall Study|Withdrawal by Subject|3
7732092|NCT00933244|26887238|P2|Overall Study|Withdrawal by Subject|1
7732093|NCT00933244|26887239|P1|Overall Study|Withdrawal by Subject|5
7732094|NCT00933166|26887256|P1|Overall Study|Withdrawal by Subject|1
7732095|NCT00933166|26887256|P1|Overall Study|Unavailable|4
7732096|NCT00933166|26887256|P1|Overall Study|Lack of Efficacy|9
7732097|NCT00933166|26887256|P1|Overall Study|Lost to Follow-up|4
7732098|NCT00932893|26887262|P2|Overall Study|Other|144
7732099|NCT00932893|26887263|P1|Overall Study|Other|5
7732100|NCT00932893|26887262|P2|Overall Study|Withdrawal by Subject|2
7732101|NCT00932893|26887263|P1|Overall Study|Withdrawal by Subject|5
7732102|NCT00932893|26887262|P2|Overall Study|Lost to Follow-up|0
7732103|NCT00932893|26887263|P1|Overall Study|Lost to Follow-up|8
7732104|NCT00932893|26887262|P2|Overall Study|Death|24
7732105|NCT00932893|26887263|P1|Overall Study|Death|115
7732106|NCT00932698|26887311|P11|Part 2 (Dose Expansion)|Adverse Event|0
7732107|NCT00932698|26887312|P10|Part 2 (Dose Expansion)|Adverse Event|1
7732108|NCT00932698|26887313|P9|Part 2 (Dose Expansion)|Adverse Event|1
7732109|NCT00932698|26887314|P8|Part 2 (Dose Expansion)|Adverse Event|5
7732110|NCT00932698|26887315|P7|Part 2 (Dose Expansion)|Adverse Event|0
7732111|NCT00932698|26887316|P6|Part 2 (Dose Expansion)|Adverse Event|0
7732113|NCT00932698|26887318|P4|Part 2 (Dose Expansion)|Adverse Event|0
7732114|NCT00932698|26887319|P3|Part 2 (Dose Expansion)|Adverse Event|0
7732115|NCT00932698|26887320|P2|Part 2 (Dose Expansion)|Adverse Event|0
7732116|NCT00932698|26887321|P1|Part 2 (Dose Expansion)|Adverse Event|0
7732117|NCT00932698|26887311|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732118|NCT00932698|26887312|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
7732119|NCT00932698|26887313|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
7732120|NCT00932698|26887314|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
7732121|NCT00932698|26887315|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732122|NCT00932698|26887316|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732123|NCT00932698|26887317|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732124|NCT00932698|26887318|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732125|NCT00932698|26887319|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732126|NCT00932698|26887320|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732127|NCT00932698|26887321|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7732128|NCT00932698|26887311|P11|Part 2 (Dose Expansion)|Progressive Disease|2
7732129|NCT00932698|26887312|P10|Part 2 (Dose Expansion)|Progressive Disease|3
7732130|NCT00932698|26887313|P9|Part 2 (Dose Expansion)|Progressive Disease|8
7732131|NCT00932698|26887314|P8|Part 2 (Dose Expansion)|Progressive Disease|14
7732132|NCT00932698|26887315|P7|Part 2 (Dose Expansion)|Progressive Disease|0
7732133|NCT00932698|26887316|P6|Part 2 (Dose Expansion)|Progressive Disease|0
7732134|NCT00932698|26887317|P5|Part 2 (Dose Expansion)|Progressive Disease|0
7732135|NCT00932698|26887318|P4|Part 2 (Dose Expansion)|Progressive Disease|0
7732136|NCT00932698|26887319|P3|Part 2 (Dose Expansion)|Progressive Disease|0
7732137|NCT00932698|26887320|P2|Part 2 (Dose Expansion)|Progressive Disease|0
7732138|NCT00932698|26887321|P1|Part 2 (Dose Expansion)|Progressive Disease|0
7732139|NCT00932698|26887311|P11|Part 1 (Dose Escalation)|Other|0
7732140|NCT00932698|26887312|P10|Part 1 (Dose Escalation)|Other|0
7732141|NCT00932698|26887313|P9|Part 1 (Dose Escalation)|Other|0
7732142|NCT00932698|26887314|P8|Part 1 (Dose Escalation)|Other|0
7732143|NCT00932698|26887315|P7|Part 1 (Dose Escalation)|Other|1
7732144|NCT00932698|26887316|P6|Part 1 (Dose Escalation)|Other|0
7732145|NCT00932698|26887317|P5|Part 1 (Dose Escalation)|Other|0
7732146|NCT00932698|26887318|P4|Part 1 (Dose Escalation)|Other|0
7732147|NCT00932698|26887319|P3|Part 1 (Dose Escalation)|Other|1
7732148|NCT00932698|26887320|P2|Part 1 (Dose Escalation)|Other|0
7732149|NCT00932698|26887321|P1|Part 1 (Dose Escalation)|Other|0
7732150|NCT00932698|26887311|P11|Part 1 (Dose Escalation)|Adverse Event|0
7732151|NCT00932698|26887312|P10|Part 1 (Dose Escalation)|Adverse Event|0
7732152|NCT00932698|26887313|P9|Part 1 (Dose Escalation)|Adverse Event|0
7732153|NCT00932698|26887314|P8|Part 1 (Dose Escalation)|Adverse Event|0
7732154|NCT00932698|26887315|P7|Part 1 (Dose Escalation)|Adverse Event|0
7732155|NCT00932698|26887316|P6|Part 1 (Dose Escalation)|Adverse Event|1
7732156|NCT00932698|26887317|P5|Part 1 (Dose Escalation)|Adverse Event|0
7732157|NCT00932698|26887318|P4|Part 1 (Dose Escalation)|Adverse Event|0
7732158|NCT00932698|26887319|P3|Part 1 (Dose Escalation)|Adverse Event|0
7732159|NCT00932698|26887320|P2|Part 1 (Dose Escalation)|Adverse Event|0
7732160|NCT00932698|26887321|P1|Part 1 (Dose Escalation)|Adverse Event|0
7732161|NCT00932698|26887311|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732162|NCT00932698|26887312|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732163|NCT00932698|26887313|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732164|NCT00932698|26887314|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732165|NCT00932698|26887315|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7732166|NCT00932698|26887316|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7732167|NCT00932698|26887317|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732168|NCT00932698|26887318|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7732169|NCT00932698|26887319|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732170|NCT00932698|26887320|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7732171|NCT00932698|26887321|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7732172|NCT00932698|26887311|P11|Part 1 (Dose Escalation)|Progressive Disease|0
7732173|NCT00932698|26887312|P10|Part 1 (Dose Escalation)|Progressive Disease|0
7732174|NCT00932698|26887313|P9|Part 1 (Dose Escalation)|Progressive Disease|0
7732175|NCT00932698|26887314|P8|Part 1 (Dose Escalation)|Progressive Disease|0
7732176|NCT00932698|26887315|P7|Part 1 (Dose Escalation)|Progressive Disease|2
7732177|NCT00932698|26887316|P6|Part 1 (Dose Escalation)|Progressive Disease|5
7732178|NCT00932698|26887317|P5|Part 1 (Dose Escalation)|Progressive Disease|3
7732179|NCT00932698|26887318|P4|Part 1 (Dose Escalation)|Progressive Disease|2
7732180|NCT00932698|26887319|P3|Part 1 (Dose Escalation)|Progressive Disease|2
7732181|NCT00932698|26887320|P2|Part 1 (Dose Escalation)|Progressive Disease|2
7732182|NCT00932698|26887321|P1|Part 1 (Dose Escalation)|Progressive Disease|3
7732183|NCT00932646|26887495|P4|Overall Study|Withdrawal by Subject|0
7732184|NCT00932646|26887496|P3|Overall Study|Withdrawal by Subject|3
7732185|NCT00932646|26887497|P2|Overall Study|Withdrawal by Subject|1
7732186|NCT00932646|26887498|P1|Overall Study|Withdrawal by Subject|1
7732187|NCT00932646|26887495|P4|Overall Study|Lost to Follow-up|0
7732188|NCT00932646|26887496|P3|Overall Study|Lost to Follow-up|0
7732189|NCT00932646|26887497|P2|Overall Study|Lost to Follow-up|1
7732190|NCT00932646|26887498|P1|Overall Study|Lost to Follow-up|2
7732191|NCT00932646|26887495|P4|Overall Study|Adverse Event|1
7732192|NCT00932646|26887496|P3|Overall Study|Adverse Event|1
7732193|NCT00932646|26887497|P2|Overall Study|Adverse Event|1
7732194|NCT00932646|26887498|P1|Overall Study|Adverse Event|2
7732195|NCT00932451|26887585|P1|Overall Study|Other reasons|5
7732196|NCT00932451|26887585|P1|Overall Study|Death|726
7732197|NCT00932451|26887585|P1|Overall Study|Lost to Follow-up|22
7732198|NCT00932451|26887585|P1|Overall Study|Withdrawal by Subject|69
7732199|NCT00932425|26887620|P2|Overall Study|Withdrawal by Subject|1
7732200|NCT00932425|26887621|P1|Overall Study|Withdrawal by Subject|0
7732201|NCT00932425|26887620|P2|Overall Study|Lost to Follow-up|1
7732202|NCT00932425|26887621|P1|Overall Study|Lost to Follow-up|0
7732203|NCT00932373|26887654|P11|Overall Study|Lack of Efficacy|0
7732204|NCT00932373|26887655|P10|Overall Study|Lack of Efficacy|1
7732205|NCT00932373|26887656|P9|Overall Study|Lack of Efficacy|0
7732206|NCT00932373|26887657|P8|Overall Study|Lack of Efficacy|0
7732207|NCT00932373|26887658|P7|Overall Study|Lack of Efficacy|0
7732208|NCT00932373|26887659|P6|Overall Study|Lack of Efficacy|0
7732209|NCT00932373|26887660|P5|Overall Study|Lack of Efficacy|0
7732210|NCT00932373|26887661|P4|Overall Study|Lack of Efficacy|0
7732211|NCT00932373|26887662|P3|Overall Study|Lack of Efficacy|0
7732212|NCT00932373|26887663|P2|Overall Study|Lack of Efficacy|0
7732213|NCT00932373|26887664|P1|Overall Study|Lack of Efficacy|0
7732214|NCT00932373|26887654|P11|Overall Study|Clinical progression|0
7732215|NCT00932373|26887655|P10|Overall Study|Clinical progression|0
7732216|NCT00932373|26887656|P9|Overall Study|Clinical progression|0
7732217|NCT00932373|26887657|P8|Overall Study|Clinical progression|0
7732218|NCT00932373|26887658|P7|Overall Study|Clinical progression|1
7732219|NCT00932373|26887659|P6|Overall Study|Clinical progression|0
7732220|NCT00932373|26887660|P5|Overall Study|Clinical progression|0
7732221|NCT00932373|26887661|P4|Overall Study|Clinical progression|0
7732222|NCT00932373|26887662|P3|Overall Study|Clinical progression|0
7732223|NCT00932373|26887663|P2|Overall Study|Clinical progression|0
7732224|NCT00932373|26887664|P1|Overall Study|Clinical progression|0
7732225|NCT00932373|26887654|P11|Overall Study|Withdrawal by Subject|0
7732226|NCT00932373|26887655|P10|Overall Study|Withdrawal by Subject|0
7732227|NCT00932373|26887656|P9|Overall Study|Withdrawal by Subject|1
7732228|NCT00932373|26887657|P8|Overall Study|Withdrawal by Subject|0
7732229|NCT00932373|26887658|P7|Overall Study|Withdrawal by Subject|0
7732230|NCT00932373|26887659|P6|Overall Study|Withdrawal by Subject|0
7732231|NCT00932373|26887660|P5|Overall Study|Withdrawal by Subject|0
7732232|NCT00932373|26887661|P4|Overall Study|Withdrawal by Subject|0
7732233|NCT00932373|26887662|P3|Overall Study|Withdrawal by Subject|0
7732234|NCT00932373|26887663|P2|Overall Study|Withdrawal by Subject|0
7732235|NCT00932373|26887664|P1|Overall Study|Withdrawal by Subject|0
7732236|NCT00932373|26887654|P11|Overall Study|Dose limiting toxicity|0
7732237|NCT00932373|26887655|P10|Overall Study|Dose limiting toxicity|0
7732238|NCT00932373|26887656|P9|Overall Study|Dose limiting toxicity|0
7732239|NCT00932373|26887657|P8|Overall Study|Dose limiting toxicity|0
7732240|NCT00932373|26887658|P7|Overall Study|Dose limiting toxicity|0
7732241|NCT00932373|26887659|P6|Overall Study|Dose limiting toxicity|1
7732242|NCT00932373|26887660|P5|Overall Study|Dose limiting toxicity|0
7732243|NCT00932373|26887661|P4|Overall Study|Dose limiting toxicity|0
7732244|NCT00932373|26887662|P3|Overall Study|Dose limiting toxicity|0
7732245|NCT00932373|26887663|P2|Overall Study|Dose limiting toxicity|0
7732246|NCT00932373|26887664|P1|Overall Study|Dose limiting toxicity|0
7732247|NCT00932373|26887654|P11|Overall Study|Physician Decision|0
7732248|NCT00932373|26887655|P10|Overall Study|Physician Decision|1
7732249|NCT00932373|26887656|P9|Overall Study|Physician Decision|0
7732250|NCT00932373|26887657|P8|Overall Study|Physician Decision|0
7732251|NCT00932373|26887658|P7|Overall Study|Physician Decision|0
7732252|NCT00932373|26887659|P6|Overall Study|Physician Decision|0
7732253|NCT00932373|26887660|P5|Overall Study|Physician Decision|2
7732254|NCT00932373|26887661|P4|Overall Study|Physician Decision|0
7732255|NCT00932373|26887662|P3|Overall Study|Physician Decision|1
7732256|NCT00932373|26887663|P2|Overall Study|Physician Decision|0
7732257|NCT00932373|26887664|P1|Overall Study|Physician Decision|0
7732258|NCT00932373|26887654|P11|Overall Study|Adverse Event|1
7732259|NCT00932373|26887655|P10|Overall Study|Adverse Event|2
7732260|NCT00932373|26887656|P9|Overall Study|Adverse Event|0
7732261|NCT00932373|26887657|P8|Overall Study|Adverse Event|1
7732262|NCT00932373|26887658|P7|Overall Study|Adverse Event|0
7732263|NCT00932373|26887659|P6|Overall Study|Adverse Event|1
7732264|NCT00932373|26887660|P5|Overall Study|Adverse Event|2
7732265|NCT00932373|26887661|P4|Overall Study|Adverse Event|0
7732266|NCT00932373|26887662|P3|Overall Study|Adverse Event|0
7732267|NCT00932373|26887663|P2|Overall Study|Adverse Event|0
7732268|NCT00932373|26887664|P1|Overall Study|Adverse Event|0
7732269|NCT00932373|26887654|P11|Overall Study|Progressive disease|2
7732270|NCT00932373|26887655|P10|Overall Study|Progressive disease|9
7732271|NCT00932373|26887656|P9|Overall Study|Progressive disease|1
7732272|NCT00932373|26887657|P8|Overall Study|Progressive disease|2
7732273|NCT00932373|26887658|P7|Overall Study|Progressive disease|0
7732274|NCT00932373|26887659|P6|Overall Study|Progressive disease|1
7732275|NCT00932373|26887660|P5|Overall Study|Progressive disease|10
7732276|NCT00932373|26887661|P4|Overall Study|Progressive disease|0
7732277|NCT00932373|26887662|P3|Overall Study|Progressive disease|0
7732278|NCT00932373|26887663|P2|Overall Study|Progressive disease|1
7732279|NCT00932373|26887664|P1|Overall Study|Progressive disease|3
7732280|NCT00932360|26887764|P6|Washout (One Week)|Withdrawal by Subject|0
7732281|NCT00932360|26887765|P5|Washout (One Week)|Withdrawal by Subject|2
7732282|NCT00932360|26887766|P4|Washout (One Week)|Withdrawal by Subject|0
7732283|NCT00932360|26887767|P3|Washout (One Week)|Withdrawal by Subject|0
7732284|NCT00932360|26887768|P2|Washout (One Week)|Withdrawal by Subject|0
7732285|NCT00932360|26887769|P1|Washout (One Week)|Withdrawal by Subject|0
7732286|NCT00932165|26887826|P1|Overall Study|Lost to Follow-up|1
7732287|NCT00932126|26887850|P8|Overall Study|Other|2
7732288|NCT00932126|26887851|P7|Overall Study|Other|1
7732289|NCT00932126|26887852|P6|Overall Study|Other|0
7732290|NCT00932126|26887853|P5|Overall Study|Other|1
7732291|NCT00932126|26887854|P4|Overall Study|Other|0
7732292|NCT00932126|26887855|P3|Overall Study|Other|0
7732293|NCT00932126|26887856|P2|Overall Study|Other|0
7732294|NCT00932126|26887857|P1|Overall Study|Other|0
7732295|NCT00932126|26887850|P8|Overall Study|Objective progression or relapse|5
7732296|NCT00932126|26887851|P7|Overall Study|Objective progression or relapse|3
7732297|NCT00932126|26887852|P6|Overall Study|Objective progression or relapse|3
7732298|NCT00932126|26887853|P5|Overall Study|Objective progression or relapse|3
7732299|NCT00932126|26887854|P4|Overall Study|Objective progression or relapse|3
7732300|NCT00932126|26887855|P3|Overall Study|Objective progression or relapse|2
7732301|NCT00932126|26887856|P2|Overall Study|Objective progression or relapse|3
7732302|NCT00932126|26887857|P1|Overall Study|Objective progression or relapse|3
7732303|NCT00932126|26887850|P8|Overall Study|Withdrawal by Subject|1
7732304|NCT00932126|26887851|P7|Overall Study|Withdrawal by Subject|0
7732305|NCT00932126|26887852|P6|Overall Study|Withdrawal by Subject|0
7732306|NCT00932126|26887853|P5|Overall Study|Withdrawal by Subject|0
7732307|NCT00932126|26887854|P4|Overall Study|Withdrawal by Subject|0
7732308|NCT00932126|26887855|P3|Overall Study|Withdrawal by Subject|1
7732309|NCT00932126|26887856|P2|Overall Study|Withdrawal by Subject|0
7732310|NCT00932126|26887857|P1|Overall Study|Withdrawal by Subject|0
7732311|NCT00932126|26887850|P8|Overall Study|Protocol Violation|0
7732312|NCT00932126|26887851|P7|Overall Study|Protocol Violation|0
7732313|NCT00932126|26887852|P6|Overall Study|Protocol Violation|0
7732314|NCT00932126|26887853|P5|Overall Study|Protocol Violation|1
7732315|NCT00932126|26887854|P4|Overall Study|Protocol Violation|0
7732316|NCT00932126|26887855|P3|Overall Study|Protocol Violation|0
7732317|NCT00932126|26887856|P2|Overall Study|Protocol Violation|0
7732318|NCT00932126|26887857|P1|Overall Study|Protocol Violation|0
7732319|NCT00932126|26887850|P8|Overall Study|Adverse Event|2
7732320|NCT00932126|26887851|P7|Overall Study|Adverse Event|1
7732321|NCT00932126|26887852|P6|Overall Study|Adverse Event|0
7732322|NCT00932126|26887853|P5|Overall Study|Adverse Event|0
7732323|NCT00932126|26887854|P4|Overall Study|Adverse Event|0
7732324|NCT00932126|26887855|P3|Overall Study|Adverse Event|0
7732325|NCT00932126|26887856|P2|Overall Study|Adverse Event|0
7732326|NCT00932126|26887857|P1|Overall Study|Adverse Event|0
7732327|NCT00932113|26887895|P2|Overall Study|Lost to Follow-up|0
7732328|NCT00932113|26887896|P1|Overall Study|Lost to Follow-up|1
7732329|NCT00931944|26887946|P1|Overall Study|Other|2
7732330|NCT00931944|26887946|P1|Overall Study|Death|28
7732331|NCT00931944|26887946|P1|Overall Study|Withdrawal Consent (due to other)|2
7732332|NCT00931944|26887946|P1|Overall Study|W/D Consent (due to ALS progression))|19
7732333|NCT00931944|26887946|P1|Overall Study|Adverse Event|4
7732334|NCT00931918|26887965|P2|Overall Study|Did not receive study drug|2
7732335|NCT00931918|26887966|P1|Overall Study|Did not receive study drug|3
7732336|NCT00931918|26887965|P2|Overall Study|Other Reason not Specified|4
7732337|NCT00931918|26887966|P1|Overall Study|Other Reason not Specified|4
7732338|NCT00931918|26887965|P2|Overall Study|Withdrawal by Patient|4
7732339|NCT00931918|26887966|P1|Overall Study|Withdrawal by Patient|3
7732340|NCT00931918|26887965|P2|Overall Study|Symptomatic Deterioration|0
7732341|NCT00931918|26887966|P1|Overall Study|Symptomatic Deterioration|1
7732342|NCT00931918|26887965|P2|Overall Study|Progressive Disease|1
7732343|NCT00931918|26887966|P1|Overall Study|Progressive Disease|2
7732344|NCT00931918|26887965|P2|Overall Study|Adverse Event|6
7732345|NCT00931918|26887966|P1|Overall Study|Adverse Event|4
7732346|NCT00931892|26887992|P2|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
7732347|NCT00931892|26887993|P1|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
7732348|NCT00931801|26888097|P3|Overall Study|Confirmed Virologic Failure|3
7732349|NCT00931801|26888098|P2|Overall Study|Confirmed Virologic Failure|0
7732350|NCT00931801|26888099|P1|Overall Study|Confirmed Virologic Failure|0
7732351|NCT00931801|26888097|P3|Overall Study|Withdrawal by Subject|0
7732352|NCT00931801|26888098|P2|Overall Study|Withdrawal by Subject|0
7732353|NCT00931801|26888099|P1|Overall Study|Withdrawal by Subject|1
7732354|NCT00931801|26888097|P3|Overall Study|Lost to Follow-up|0
7732355|NCT00931801|26888098|P2|Overall Study|Lost to Follow-up|1
7732356|NCT00931801|26888099|P1|Overall Study|Lost to Follow-up|0
7732357|NCT00931801|26888097|P3|Overall Study|Adverse Event|1
7732358|NCT00931801|26888098|P2|Overall Study|Adverse Event|0
7732359|NCT00931801|26888099|P1|Overall Study|Adverse Event|0
7732360|NCT00931762|26888120|P1|Overall Study|Subject withdrew consent|13
7732361|NCT00931762|26888120|P1|Overall Study|Adverse Event (s)|11
7732362|NCT00931762|26888120|P1|Overall Study|Disease Progression|3
7732363|NCT00931762|26888120|P1|Overall Study|Death|1
7732364|NCT00931762|26888120|P1|Overall Study|Administrative Problems|5
7732365|NCT00931762|26888120|P1|Overall Study|Abnormal Laboratory Value (s)|2
7732366|NCT00931723|26888129|P2|Overall Study|Late hospital discharge|0
7732367|NCT00931723|26888130|P1|Overall Study|Late hospital discharge|1
7732368|NCT00931723|26888129|P2|Overall Study|Sponsor decision|0
7732369|NCT00931723|26888130|P1|Overall Study|Sponsor decision|1
7732370|NCT00931723|26888129|P2|Overall Study|Lack or insufficient theraputic response|5
7732371|NCT00931723|26888130|P1|Overall Study|Lack or insufficient theraputic response|2
7732372|NCT00931723|26888129|P2|Overall Study|Took prohibited concomitant medication|1
7732373|NCT00931723|26888130|P1|Overall Study|Took prohibited concomitant medication|0
7732374|NCT00931723|26888129|P2|Overall Study|Safety reasons|1
7732375|NCT00931723|26888130|P1|Overall Study|Safety reasons|0
7732376|NCT00931723|26888129|P2|Overall Study|Severe non-compliance to protocol|0
7732377|NCT00931723|26888130|P1|Overall Study|Severe non-compliance to protocol|2
7732378|NCT00931723|26888129|P2|Overall Study|Study-specific discontinuation criteria|1
7732379|NCT00931723|26888130|P1|Overall Study|Study-specific discontinuation criteria|1
7732380|NCT00931723|26888129|P2|Overall Study|Lost to Follow-up|2
7732381|NCT00931723|26888130|P1|Overall Study|Lost to Follow-up|1
7732382|NCT00931723|26888129|P2|Overall Study|Condition under investigation worsened|2
7732383|NCT00931723|26888130|P1|Overall Study|Condition under investigation worsened|1
7732384|NCT00931723|26888129|P2|Overall Study|Lithium found in blood|1
7732385|NCT00931723|26888130|P1|Overall Study|Lithium found in blood|0
7732386|NCT00931723|26888129|P2|Overall Study|Adverse Event|13
7732387|NCT00931723|26888130|P1|Overall Study|Adverse Event|6
7732388|NCT00931723|26888129|P2|Overall Study|Withdrawal by Subject|13
7732389|NCT00931723|26888130|P1|Overall Study|Withdrawal by Subject|11
7732390|NCT00931710|26888178|P2|Overall Study|Protocol deviation|2
7732391|NCT00931710|26888179|P1|Overall Study|Protocol deviation|1
7732392|NCT00931710|26888178|P2|Overall Study|Lost to Follow-up|5
7732393|NCT00931710|26888179|P1|Overall Study|Lost to Follow-up|6
7732394|NCT00931710|26888178|P2|Overall Study|Patient withdrew consent|9
7732395|NCT00931710|26888179|P1|Overall Study|Patient withdrew consent|4
7732396|NCT00931710|26888178|P2|Overall Study|Unsatisfactory therapeutic effects|12
7732397|NCT00931710|26888179|P1|Overall Study|Unsatisfactory therapeutic effects|5
7732398|NCT00931710|26888178|P2|Overall Study|Abnormal test procedure results|0
7732399|NCT00931710|26888179|P1|Overall Study|Abnormal test procedure results|2
7732400|NCT00931710|26888178|P2|Overall Study|Adverse Event|10
7732401|NCT00931710|26888179|P1|Overall Study|Adverse Event|16
7732402|NCT00931632|26888197|P2|Overall Study|Adverse Event|15
7732403|NCT00931632|26888198|P1|Overall Study|Adverse Event|19
7732404|NCT00931632|26888197|P2|Overall Study|Withdrawal by Subject|3
7732405|NCT00931632|26888198|P1|Overall Study|Withdrawal by Subject|2
7732406|NCT00931528|26888220|P2|Overall Study|Assessment outside of Time Frame|23
7732407|NCT00931528|26888221|P1|Overall Study|Assessment outside of Time Frame|22
7732408|NCT00931528|26888220|P2|Overall Study|Lost to Follow-up|13
7732409|NCT00931528|26888221|P1|Overall Study|Lost to Follow-up|6
7732410|NCT00931528|26888220|P2|Overall Study|Withdrawal by Subject|12
7732411|NCT00931528|26888221|P1|Overall Study|Withdrawal by Subject|4
7732412|NCT00931528|26888220|P2|Overall Study|Protocol Violation|12
7732413|NCT00931528|26888221|P1|Overall Study|Protocol Violation|9
7732414|NCT00931515|26888241|P2|Overall Study|Lost to Follow-up|5
7732415|NCT00931515|26888242|P1|Overall Study|Lost to Follow-up|2
7732416|NCT00931463|26888272|P2|Overall Study|Lost to Follow-up|1
7732417|NCT00931463|26888273|P1|Overall Study|Lost to Follow-up|4
7732418|NCT00931463|26888272|P2|Overall Study|Withdrawal by Subject|0
7732419|NCT00931463|26888273|P1|Overall Study|Withdrawal by Subject|5
7732420|NCT00931463|26888272|P2|Overall Study|Death|4
7732421|NCT00931463|26888273|P1|Overall Study|Death|8
7732422|NCT00931411|26888289|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
7732423|NCT00931411|26888290|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
7732424|NCT00931411|26888289|P2|First Intervention - 42 Days|Lost to Follow-up|0
7732425|NCT00931411|26888290|P1|First Intervention - 42 Days|Lost to Follow-up|2
7732426|NCT00931411|26888289|P2|First Intervention - 42 Days|Adverse Event|3
7732427|NCT00931411|26888290|P1|First Intervention - 42 Days|Adverse Event|2
7732428|NCT00931385|26888311|P4|Overall Study|Lost to Follow-up|1
7732429|NCT00931385|26888312|P3|Overall Study|Lost to Follow-up|0
7732430|NCT00931385|26888313|P2|Overall Study|Lost to Follow-up|0
7732431|NCT00931385|26888314|P1|Overall Study|Lost to Follow-up|0
7732432|NCT00931385|26888311|P4|Overall Study|Withdrawal by Subject|1
7732433|NCT00931385|26888312|P3|Overall Study|Withdrawal by Subject|0
7732434|NCT00931385|26888313|P2|Overall Study|Withdrawal by Subject|1
7732435|NCT00931385|26888314|P1|Overall Study|Withdrawal by Subject|0
7732436|NCT00931385|26888311|P4|Overall Study|Protocol Violation|0
7732437|NCT00931385|26888312|P3|Overall Study|Protocol Violation|1
7732438|NCT00931385|26888313|P2|Overall Study|Protocol Violation|0
7732439|NCT00931385|26888314|P1|Overall Study|Protocol Violation|0
7732440|NCT00931385|26888311|P4|Overall Study|Adverse Event|3
7732441|NCT00931385|26888312|P3|Overall Study|Adverse Event|0
7732442|NCT00931385|26888313|P2|Overall Study|Adverse Event|1
7732443|NCT00931385|26888314|P1|Overall Study|Adverse Event|2
7732444|NCT00931307|26888383|P1|Overall Study|Biomicroscopy|1
7732445|NCT00931307|26888383|P1|Overall Study|Lack of Efficacy|12
7732446|NCT00931268|26888387|P1|Overall Study|Lost to Follow-up|6
7732447|NCT00931255|26888399|P2|Overall Study|Follow up biopsy not done|3
7732448|NCT00931255|26888400|P1|Overall Study|Follow up biopsy not done|2
7732449|NCT00930982|26888437|P2|Overall Study|Withdrawal by Subject|1
7732450|NCT00930982|26888438|P1|Overall Study|Withdrawal by Subject|1
7732451|NCT00930982|26888437|P2|Overall Study|Protocol Violation|5
7732452|NCT00930982|26888438|P1|Overall Study|Protocol Violation|1
7732453|NCT00930982|26888437|P2|Overall Study|Adverse Event|23
7732454|NCT00930982|26888438|P1|Overall Study|Adverse Event|19
7732455|NCT00930969|26888472|P1|Overall Study|Withdrawal by Subject|19
7732456|NCT00930969|26888472|P1|Overall Study|Physician Decision|13
7732457|NCT00930969|26888472|P1|Overall Study|Lost to Follow-up|1
7732458|NCT00930969|26888472|P1|Overall Study|Death|5
7732459|NCT00930930|26888482|P2|Overall Study|patients not compliant|1
7732460|NCT00930930|26888483|P1|Overall Study|patients not compliant|1
7732461|NCT00930930|26888482|P2|Overall Study|excessive lapse btw txs, not eligible|1
7732462|NCT00930930|26888483|P1|Overall Study|excessive lapse btw txs, not eligible|0
7732463|NCT00930930|26888482|P2|Overall Study|Disease progression|3
7732464|NCT00930930|26888483|P1|Overall Study|Disease progression|2
7732465|NCT00930930|26888482|P2|Overall Study|Withdrawal by Subject|1
7732466|NCT00930930|26888483|P1|Overall Study|Withdrawal by Subject|3
7732467|NCT00930930|26888482|P2|Overall Study|Adverse Event|3
7732468|NCT00930930|26888483|P1|Overall Study|Adverse Event|13
7732469|NCT00930930|26888482|P2|Overall Study|Physician Decision|0
7732470|NCT00930930|26888483|P1|Overall Study|Physician Decision|1
7732471|NCT00930930|26888482|P2|Overall Study|Death|0
7732472|NCT00930930|26888483|P1|Overall Study|Death|1
7732473|NCT00930813|26888497|P2|Overall Study|Lost to Follow-up|4
7732474|NCT00930813|26888498|P1|Overall Study|Lost to Follow-up|2
7732475|NCT00930813|26888497|P2|Overall Study|Withdrawal by Subject|5
7732476|NCT00930813|26888498|P1|Overall Study|Withdrawal by Subject|2
7732477|NCT00930813|26888497|P2|Overall Study|Death|5
7732478|NCT00930813|26888498|P1|Overall Study|Death|4
7732479|NCT00930774|26888519|P4|Overall Study|Withdrawal by Subject|0
7732480|NCT00930774|26888520|P3|Overall Study|Withdrawal by Subject|2
7732481|NCT00930774|26888521|P2|Overall Study|Withdrawal by Subject|9
7732482|NCT00930774|26888522|P1|Overall Study|Withdrawal by Subject|1
7732483|NCT00930761|26888562|P2|Overall Study|less than 3 music therapy sessions|3
7732484|NCT00930761|26888563|P1|Overall Study|less than 3 music therapy sessions|0
7732485|NCT00930761|26888562|P2|Overall Study|3 newborns died; 1 mother quit the study|0
7732486|NCT00930761|26888563|P1|Overall Study|3 newborns died; 1 mother quit the study|4
7732487|NCT00930722|26888575|P1|Overall Study|Study terminated by sponsor|2
7732488|NCT00930722|26888575|P1|Overall Study|No longer willing to participate|9
7732489|NCT00930722|26888575|P1|Overall Study|Lost to Follow-up|16
7732490|NCT00930644|26888590|P1|Overall Study|Adverse Event|16
7732491|NCT00930644|26888590|P1|Overall Study|Death|1
7732492|NCT00930644|26888590|P1|Overall Study|Physician Decision|2
7732493|NCT00930644|26888590|P1|Overall Study|Withdrawal by Subject|4
7732494|NCT00930553|26888603|P1|Overall Study|Other than specified above|28
7732495|NCT00930553|26888603|P1|Overall Study|Study terminated by sponsor|24
7732496|NCT00930553|26888603|P1|Overall Study|Death|9
7732497|NCT00930553|26888603|P1|Overall Study|Lost to Follow-up|25
7732498|NCT00930553|26888603|P1|Overall Study|Withdrawal by Subject|88
7732499|NCT00930553|26888603|P1|Overall Study|Pregnancy|1
7732500|NCT00930553|26888603|P1|Overall Study|Protocol Violation|1
7732501|NCT00930553|26888603|P1|Overall Study|Physician Decision|39
7732502|NCT00930553|26888603|P1|Overall Study|Lack of Efficacy|7
7732503|NCT00930553|26888603|P1|Overall Study|Adverse Event|1
7732504|NCT00930176|26888680|P1|Overall Study|Death|1
7732505|NCT00930059|26888687|P2|Overall Study|Adverse Event|6
7732506|NCT00930059|26888688|P1|Overall Study|Adverse Event|1
7732507|NCT00930059|26888687|P2|Overall Study|1 site terminated by sponsor|1
7732508|NCT00930059|26888688|P1|Overall Study|1 site terminated by sponsor|1
7732509|NCT00930059|26888687|P2|Overall Study|Other|0
7732510|NCT00930059|26888688|P1|Overall Study|Other|1
7732511|NCT00930059|26888687|P2|Overall Study|Withdrawal by Subject|4
7732512|NCT00930059|26888688|P1|Overall Study|Withdrawal by Subject|3
7732513|NCT00930059|26888687|P2|Overall Study|Did not meet entrance criteria|1
7732514|NCT00930059|26888688|P1|Overall Study|Did not meet entrance criteria|1
7732515|NCT00930059|26888687|P2|Overall Study|Death|0
7732516|NCT00930059|26888688|P1|Overall Study|Death|1
7732517|NCT00930046|26888718|P2|Overall Study|Wound catheter malfunctioned|2
7732518|NCT00930046|26888719|P1|Overall Study|Wound catheter malfunctioned|1
7732519|NCT00929994|26888727|P1|Overall Study|employment|1
7732520|NCT00929994|26888727|P1|Overall Study|medical issue unrelated to intervention|4
7732521|NCT00929994|26888727|P1|Overall Study|Withdrawal by Subject|1
7732522|NCT00929864|26888746|P2|Overall Study|Non-specified|7
7732523|NCT00929864|26888747|P1|Overall Study|Non-specified|2
7732524|NCT00929864|26888746|P2|Overall Study|Administrative reason by Sponsor|1
7732525|NCT00929864|26888747|P1|Overall Study|Administrative reason by Sponsor|1
7732526|NCT00929864|26888746|P2|Overall Study|Pregnancy|3
7732527|NCT00929864|26888747|P1|Overall Study|Pregnancy|0
7732528|NCT00929864|26888746|P2|Overall Study|Poor or non-compliance|3
7732529|NCT00929864|26888747|P1|Overall Study|Poor or non-compliance|3
7732530|NCT00929864|26888746|P2|Overall Study|No longer met criteria|1
7732531|NCT00929864|26888747|P1|Overall Study|No longer met criteria|2
7732532|NCT00929864|26888746|P2|Overall Study|Withdrawal by Subject|9
7732533|NCT00929864|26888747|P1|Overall Study|Withdrawal by Subject|20
7732534|NCT00929864|26888746|P2|Overall Study|Lost to Follow-up|12
7732535|NCT00929864|26888747|P1|Overall Study|Lost to Follow-up|7
7732536|NCT00929864|26888746|P2|Overall Study|Lack of Efficacy|16
7732537|NCT00929864|26888747|P1|Overall Study|Lack of Efficacy|19
7732538|NCT00929864|26888746|P2|Overall Study|Adverse Event|30
7732539|NCT00929864|26888747|P1|Overall Study|Adverse Event|11
7732540|NCT00929864|26888746|P2|Overall Study|Death|1
7732541|NCT00929864|26888747|P1|Overall Study|Death|1
7732542|NCT00929734|26888803|P2|Overall Study|Withdrawal by Subject|2
7732543|NCT00929734|26888804|P1|Overall Study|Withdrawal by Subject|0
7732544|NCT00929734|26888803|P2|Overall Study|Lost to Follow-up|1
7732545|NCT00929734|26888804|P1|Overall Study|Lost to Follow-up|2
7732546|NCT00929708|26888821|P5|Overall Study|Lost to Follow-up|0
7732547|NCT00929708|26888822|P4|Overall Study|Lost to Follow-up|1
7732548|NCT00929708|26888823|P3|Overall Study|Lost to Follow-up|0
7732549|NCT00929708|26888824|P2|Overall Study|Lost to Follow-up|0
7732550|NCT00929708|26888825|P1|Overall Study|Lost to Follow-up|0
7732551|NCT00929708|26888821|P5|Overall Study|Physician Decision|1
7732552|NCT00929708|26888822|P4|Overall Study|Physician Decision|2
7732553|NCT00929708|26888823|P3|Overall Study|Physician Decision|2
7732554|NCT00929708|26888824|P2|Overall Study|Physician Decision|2
7732555|NCT00929708|26888825|P1|Overall Study|Physician Decision|0
7732556|NCT00929708|26888821|P5|Overall Study|Adverse Event|3
7732557|NCT00929708|26888822|P4|Overall Study|Adverse Event|0
7732558|NCT00929708|26888823|P3|Overall Study|Adverse Event|0
7732559|NCT00929708|26888824|P2|Overall Study|Adverse Event|0
7732560|NCT00929708|26888825|P1|Overall Study|Adverse Event|0
7732561|NCT00929708|26888821|P5|Overall Study|Withdrawal by Subject|1
7732562|NCT00929708|26888822|P4|Overall Study|Withdrawal by Subject|2
7732563|NCT00929708|26888823|P3|Overall Study|Withdrawal by Subject|0
7732564|NCT00929708|26888824|P2|Overall Study|Withdrawal by Subject|0
7732565|NCT00929708|26888825|P1|Overall Study|Withdrawal by Subject|2
7732566|NCT00929708|26888821|P5|Overall Study|Protocol Violation|1
7732567|NCT00929708|26888822|P4|Overall Study|Protocol Violation|1
7732568|NCT00929708|26888823|P3|Overall Study|Protocol Violation|1
7732569|NCT00929708|26888824|P2|Overall Study|Protocol Violation|1
7732570|NCT00929708|26888825|P1|Overall Study|Protocol Violation|2
7732571|NCT00929695|26888879|P2|Overall Study|incorrect stratification|0
7732572|NCT00929695|26888880|P1|Overall Study|incorrect stratification|2
7732573|NCT00929695|26888879|P2|Overall Study|discharge home|3
7732574|NCT00929695|26888880|P1|Overall Study|discharge home|4
7732575|NCT00929695|26888879|P2|Overall Study|Withdrawal by Subject|2
7732576|NCT00929695|26888880|P1|Overall Study|Withdrawal by Subject|0
7732577|NCT00929695|26888879|P2|Overall Study|Death|1
7732578|NCT00929695|26888880|P1|Overall Study|Death|2
7732579|NCT00929669|26888910|P1|Overall Study|elevated glucose levels|1
7732580|NCT00929656|26888917|P2|Overall Study|Lost to Follow-up|1
7732581|NCT00929656|26888918|P1|Overall Study|Lost to Follow-up|0
7732582|NCT00929643|26888932|P1|Overall Study|Protocol Violation|2
7732583|NCT00929526|26888954|P2|Overall Study|Other|6
7732584|NCT00929526|26888955|P1|Overall Study|Other|8
7732585|NCT00929526|26888954|P2|Overall Study|Lost to Follow-up|12
7732586|NCT00929526|26888955|P1|Overall Study|Lost to Follow-up|8
7732587|NCT00929526|26888954|P2|Overall Study|Withdrawal by Subject|11
7732588|NCT00929526|26888955|P1|Overall Study|Withdrawal by Subject|1
7732589|NCT00929240|26889109|P3|Maintenance Phase|Participant not treated|0
7732590|NCT00929240|26889110|P2|Maintenance Phase|Participant not treated|2
7732591|NCT00929240|26889111|P1|Maintenance Phase|Participant not treated|0
7732592|NCT00929240|26889109|P3|Maintenance Phase|Treatment ongoing at study closure|10
7732593|NCT00929240|26889110|P2|Maintenance Phase|Treatment ongoing at study closure|0
7732594|NCT00929240|26889111|P1|Maintenance Phase|Treatment ongoing at study closure|0
7732595|NCT00929240|26889109|P3|Maintenance Phase|Change of treatment|0
7732596|NCT00929240|26889110|P2|Maintenance Phase|Change of treatment|4
7732597|NCT00929240|26889111|P1|Maintenance Phase|Change of treatment|0
7732598|NCT00929240|26889109|P3|Maintenance Phase|Physician Decision|1
7732599|NCT00929240|26889110|P2|Maintenance Phase|Physician Decision|2
7732600|NCT00929240|26889111|P1|Maintenance Phase|Physician Decision|0
7732601|NCT00929240|26889109|P3|Maintenance Phase|Health authority/Study termination|2
7732602|NCT00929240|26889110|P2|Maintenance Phase|Health authority/Study termination|1
7732603|NCT00929240|26889111|P1|Maintenance Phase|Health authority/Study termination|0
7732604|NCT00929240|26889109|P3|Maintenance Phase|Protocol Violation|0
7732605|NCT00929240|26889110|P2|Maintenance Phase|Protocol Violation|1
7732606|NCT00929240|26889111|P1|Maintenance Phase|Protocol Violation|0
7732607|NCT00929240|26889109|P3|Maintenance Phase|Withdrawal by Subject|6
7732608|NCT00929240|26889110|P2|Maintenance Phase|Withdrawal by Subject|2
7732609|NCT00929240|26889111|P1|Maintenance Phase|Withdrawal by Subject|0
7732610|NCT00929240|26889109|P3|Maintenance Phase|Adverse Event|12
7732611|NCT00929240|26889110|P2|Maintenance Phase|Adverse Event|9
7732612|NCT00929240|26889111|P1|Maintenance Phase|Adverse Event|0
7732613|NCT00929240|26889109|P3|Maintenance Phase|Disease progression|60
7732614|NCT00929240|26889110|P2|Maintenance Phase|Disease progression|73
7732615|NCT00929240|26889111|P1|Maintenance Phase|Disease progression|0
7732616|NCT00929240|26889109|P3|Initial Treatment Phase|Physician Decision|0
7732617|NCT00929240|26889110|P2|Initial Treatment Phase|Physician Decision|0
7732618|NCT00929240|26889111|P1|Initial Treatment Phase|Physician Decision|4
7732619|NCT00929240|26889109|P3|Initial Treatment Phase|Health authority/Study termination|0
7732620|NCT00929240|26889110|P2|Initial Treatment Phase|Health authority/Study termination|0
7732621|NCT00929240|26889111|P1|Initial Treatment Phase|Health authority/Study termination|3
7732622|NCT00929240|26889109|P3|Initial Treatment Phase|Death|0
7732623|NCT00929240|26889110|P2|Initial Treatment Phase|Death|0
7732624|NCT00929240|26889111|P1|Initial Treatment Phase|Death|2
7732625|NCT00929240|26889109|P3|Initial Treatment Phase|Protocol Violation|0
7732626|NCT00929240|26889110|P2|Initial Treatment Phase|Protocol Violation|0
7732627|NCT00929240|26889111|P1|Initial Treatment Phase|Protocol Violation|5
7732628|NCT00929240|26889109|P3|Initial Treatment Phase|Withdrawal by Subject|0
7732629|NCT00929240|26889110|P2|Initial Treatment Phase|Withdrawal by Subject|0
7732630|NCT00929240|26889111|P1|Initial Treatment Phase|Withdrawal by Subject|13
7732631|NCT00929240|26889109|P3|Initial Treatment Phase|Disease progression|0
7732632|NCT00929240|26889110|P2|Initial Treatment Phase|Disease progression|0
7732633|NCT00929240|26889111|P1|Initial Treatment Phase|Disease progression|41
7732634|NCT00929240|26889109|P3|Initial Treatment Phase|Adverse Event|0
7732635|NCT00929240|26889110|P2|Initial Treatment Phase|Adverse Event|0
7732636|NCT00929240|26889111|P1|Initial Treatment Phase|Adverse Event|31
7732637|NCT00929201|26889138|P2|Period 1|Withdrawal by Subject|1
7732638|NCT00929201|26889139|P1|Period 1|Withdrawal by Subject|0
7732639|NCT00929162|26889149|P2|Overall Study|Other termination reason|6
7732640|NCT00929162|26889150|P1|Overall Study|Other termination reason|5
7732641|NCT00929162|26889149|P2|Overall Study|Protocol Violation|30
7732642|NCT00929162|26889150|P1|Overall Study|Protocol Violation|32
7732643|NCT00929162|26889149|P2|Overall Study|Withdrawal by Subject|1
7732644|NCT00929162|26889150|P1|Overall Study|Withdrawal by Subject|3
7732645|NCT00929162|26889149|P2|Overall Study|Adverse Event|5
7732646|NCT00929162|26889150|P1|Overall Study|Adverse Event|8
7732647|NCT00929110|26889163|P3|Overall Study|Patient inability to use the device|0
7732648|NCT00929110|26889164|P2|Overall Study|Patient inability to use the device|1
7732649|NCT00929110|26889165|P1|Overall Study|Patient inability to use the device|0
7732650|NCT00929110|26889163|P3|Overall Study|Abnormal test procedure result(s)|1
7732651|NCT00929110|26889164|P2|Overall Study|Abnormal test procedure result(s)|1
7732652|NCT00929110|26889165|P1|Overall Study|Abnormal test procedure result(s)|0
7732653|NCT00929110|26889163|P3|Overall Study|Abnormal laboratory value(s)|0
7732654|NCT00929110|26889164|P2|Overall Study|Abnormal laboratory value(s)|1
7732655|NCT00929110|26889165|P1|Overall Study|Abnormal laboratory value(s)|0
7732656|NCT00929110|26889163|P3|Overall Study|Death|2
7732657|NCT00929110|26889164|P2|Overall Study|Death|2
7732658|NCT00929110|26889165|P1|Overall Study|Death|2
7732659|NCT00929110|26889163|P3|Overall Study|Administrative problems|2
7732660|NCT00929110|26889164|P2|Overall Study|Administrative problems|1
7732661|NCT00929110|26889165|P1|Overall Study|Administrative problems|4
7732662|NCT00929110|26889163|P3|Overall Study|Protocol deviation|4
7732663|NCT00929110|26889164|P2|Overall Study|Protocol deviation|2
7732664|NCT00929110|26889165|P1|Overall Study|Protocol deviation|5
7732665|NCT00929110|26889163|P3|Overall Study|Lost to Follow-up|3
7732666|NCT00929110|26889164|P2|Overall Study|Lost to Follow-up|7
7732667|NCT00929110|26889165|P1|Overall Study|Lost to Follow-up|7
7732668|NCT00929110|26889163|P3|Overall Study|Unsatisfactory therapeutic effect|6
7732669|NCT00929110|26889164|P2|Overall Study|Unsatisfactory therapeutic effect|9
7732670|NCT00929110|26889165|P1|Overall Study|Unsatisfactory therapeutic effect|20
7732671|NCT00929110|26889163|P3|Overall Study|Subject withdrew consent|26
7732672|NCT00929110|26889164|P2|Overall Study|Subject withdrew consent|23
7732673|NCT00929110|26889165|P1|Overall Study|Subject withdrew consent|40
7732674|NCT00929110|26889163|P3|Overall Study|Adverse Event|18
7732675|NCT00929110|26889164|P2|Overall Study|Adverse Event|29
7732676|NCT00929110|26889165|P1|Overall Study|Adverse Event|40
7732677|NCT00928889|26889248|P2|Overall Study|Other|0
7732678|NCT00928889|26889249|P1|Overall Study|Other|1
7732679|NCT00928889|26889248|P2|Overall Study|Adverse Event|0
7732680|NCT00928889|26889249|P1|Overall Study|Adverse Event|1
7732681|NCT00928889|26889248|P2|Overall Study|Protocol Violation|1
7732682|NCT00928889|26889249|P1|Overall Study|Protocol Violation|0
7732683|NCT00928889|26889248|P2|Overall Study|Lost to Follow-up|1
7732684|NCT00928889|26889249|P1|Overall Study|Lost to Follow-up|3
7732685|NCT00928746|26889295|P1|Overall Study|Other|2
7732686|NCT00928746|26889295|P1|Overall Study|Withdrawal by Subject|1
7732687|NCT00928746|26889295|P1|Overall Study|Protocol Violation|1
7732688|NCT00928746|26889295|P1|Overall Study|Adverse Event|2
7732689|NCT00928707|26889345|P2|Overall Study|Protocol Violation|0
7732690|NCT00928707|26889346|P1|Overall Study|Protocol Violation|1
7732691|NCT00928668|26889367|P5|Overall Study|Other reasons not listed above|0
7732692|NCT00928668|26889368|P4|Overall Study|Other reasons not listed above|1
7732693|NCT00928668|26889369|P3|Overall Study|Other reasons not listed above|0
7732694|NCT00928668|26889370|P2|Overall Study|Other reasons not listed above|0
7732695|NCT00928668|26889371|P1|Overall Study|Other reasons not listed above|0
7732696|NCT00928668|26889367|P5|Overall Study|Withdrawal by Subject|0
7732697|NCT00928668|26889368|P4|Overall Study|Withdrawal by Subject|0
7732698|NCT00928668|26889369|P3|Overall Study|Withdrawal by Subject|1
7732699|NCT00928668|26889370|P2|Overall Study|Withdrawal by Subject|1
7732700|NCT00928668|26889371|P1|Overall Study|Withdrawal by Subject|0
7732701|NCT00928668|26889367|P5|Overall Study|Protocol Violation|1
7732702|NCT00928668|26889368|P4|Overall Study|Protocol Violation|0
7732703|NCT00928668|26889369|P3|Overall Study|Protocol Violation|0
7732704|NCT00928668|26889370|P2|Overall Study|Protocol Violation|0
7732705|NCT00928668|26889371|P1|Overall Study|Protocol Violation|0
7732706|NCT00928668|26889367|P5|Overall Study|Adverse Event|0
7732707|NCT00928668|26889368|P4|Overall Study|Adverse Event|0
7732708|NCT00928668|26889369|P3|Overall Study|Adverse Event|0
7732709|NCT00928668|26889370|P2|Overall Study|Adverse Event|0
7732710|NCT00928668|26889371|P1|Overall Study|Adverse Event|1
7732711|NCT00928564|26889424|P2|Overall Study|Lost to Follow-up|0
7732712|NCT00928564|26889425|P1|Overall Study|Lost to Follow-up|6
7732713|NCT00928512|26889438|P5|Overall Study|Administrative Problems|0
7732714|NCT00928512|26889439|P4|Overall Study|Administrative Problems|0
7732715|NCT00928512|26889440|P3|Overall Study|Administrative Problems|0
7732716|NCT00928512|26889441|P2|Overall Study|Administrative Problems|1
7732717|NCT00928512|26889442|P1|Overall Study|Administrative Problems|0
7732718|NCT00928512|26889438|P5|Overall Study|Lost to Follow-up|3
7732719|NCT00928512|26889439|P4|Overall Study|Lost to Follow-up|1
7732720|NCT00928512|26889440|P3|Overall Study|Lost to Follow-up|2
7732721|NCT00928512|26889441|P2|Overall Study|Lost to Follow-up|1
7732722|NCT00928512|26889442|P1|Overall Study|Lost to Follow-up|1
7732723|NCT00928512|26889438|P5|Overall Study|Withdrawal by Subject|0
7732724|NCT00928512|26889439|P4|Overall Study|Withdrawal by Subject|4
7732725|NCT00928512|26889440|P3|Overall Study|Withdrawal by Subject|3
7732726|NCT00928512|26889441|P2|Overall Study|Withdrawal by Subject|0
7732727|NCT00928512|26889442|P1|Overall Study|Withdrawal by Subject|3
7732728|NCT00928512|26889438|P5|Overall Study|Protocol Violation|3
7732729|NCT00928512|26889439|P4|Overall Study|Protocol Violation|1
7732730|NCT00928512|26889440|P3|Overall Study|Protocol Violation|0
7732731|NCT00928512|26889441|P2|Overall Study|Protocol Violation|1
7732732|NCT00928512|26889442|P1|Overall Study|Protocol Violation|0
7732733|NCT00928512|26889438|P5|Overall Study|Lack of Efficacy|3
7732734|NCT00928512|26889439|P4|Overall Study|Lack of Efficacy|7
7732735|NCT00928512|26889440|P3|Overall Study|Lack of Efficacy|4
7732736|NCT00928512|26889441|P2|Overall Study|Lack of Efficacy|0
7732737|NCT00928512|26889442|P1|Overall Study|Lack of Efficacy|2
7732738|NCT00928512|26889438|P5|Overall Study|Adverse Event|6
7732739|NCT00928512|26889439|P4|Overall Study|Adverse Event|8
7732740|NCT00928512|26889440|P3|Overall Study|Adverse Event|2
7732741|NCT00928512|26889441|P2|Overall Study|Adverse Event|3
7732742|NCT00928512|26889442|P1|Overall Study|Adverse Event|4
7732743|NCT00928486|26889554|P1|Overall Study|Withdrawal by Subject|1
7732744|NCT00928486|26889554|P1|Overall Study|Disease Progression|7
7732745|NCT00928486|26889554|P1|Overall Study|Adverse Event|2
7732746|NCT00928434|26889563|P3|Overall Study|Other (not meeting above criteria)|2
7732747|NCT00928434|26889564|P2|Overall Study|Other (not meeting above criteria)|1
7732748|NCT00928434|26889565|P1|Overall Study|Other (not meeting above criteria)|5
7732749|NCT00928434|26889563|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
7732750|NCT00928434|26889564|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
7732751|NCT00928434|26889565|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
7732752|NCT00928434|26889563|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
7732753|NCT00928434|26889564|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
7732754|NCT00928434|26889565|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
7732755|NCT00928434|26889563|P3|Overall Study|Withdrawal by Subject|2
7732756|NCT00928434|26889564|P2|Overall Study|Withdrawal by Subject|3
7732757|NCT00928434|26889565|P1|Overall Study|Withdrawal by Subject|5
7732758|NCT00928434|26889563|P3|Overall Study|Lost to Follow-up|3
7732759|NCT00928434|26889564|P2|Overall Study|Lost to Follow-up|0
7732760|NCT00928434|26889565|P1|Overall Study|Lost to Follow-up|1
7732761|NCT00928434|26889563|P3|Overall Study|Physician Decision|3
7732762|NCT00928434|26889564|P2|Overall Study|Physician Decision|0
7732763|NCT00928434|26889565|P1|Overall Study|Physician Decision|2
7732764|NCT00928434|26889563|P3|Overall Study|Protocol Violation|8
7732765|NCT00928434|26889564|P2|Overall Study|Protocol Violation|0
7732766|NCT00928434|26889565|P1|Overall Study|Protocol Violation|5
7732767|NCT00928434|26889563|P3|Overall Study|Adverse Event|18
7732768|NCT00928434|26889564|P2|Overall Study|Adverse Event|5
7732769|NCT00928434|26889565|P1|Overall Study|Adverse Event|14
7732770|NCT00928408|26889641|P1|Overall Study|Lost to Follow-up|12
7732771|NCT00928408|26889641|P1|Overall Study|Death|5
7732772|NCT00928408|26889641|P1|Overall Study|Withdrawal by Subject|4
7732773|NCT00928408|26889641|P1|Overall Study|Other|2
7732774|NCT00928252|26889687|P1|Overall Study|Physician Decision|3
7732775|NCT00928187|26889747|P3|Overall Study|Protocol Violation|0
7732776|NCT00928187|26889748|P2|Overall Study|Protocol Violation|1
7732777|NCT00928187|26889749|P1|Overall Study|Protocol Violation|0
7732778|NCT00928187|26889747|P3|Overall Study|Withdrawal by Subject|1
7732779|NCT00928187|26889748|P2|Overall Study|Withdrawal by Subject|1
7732780|NCT00928187|26889749|P1|Overall Study|Withdrawal by Subject|0
7732781|NCT00928187|26889747|P3|Overall Study|Lost to Follow-up|1
7732782|NCT00928187|26889748|P2|Overall Study|Lost to Follow-up|2
7732783|NCT00928187|26889749|P1|Overall Study|Lost to Follow-up|1
7732784|NCT00928187|26889747|P3|Overall Study|Death|3
7732785|NCT00928187|26889748|P2|Overall Study|Death|2
7732786|NCT00928187|26889749|P1|Overall Study|Death|1
7732787|NCT00928135|26889799|P2|Overall Study|Withdrawal by Subject|0
7732788|NCT00928135|26889800|P1|Overall Study|Withdrawal by Subject|1
7732789|NCT00928070|26889932|P2|Overall Study|Other|5
7732790|NCT00928070|26889933|P1|Overall Study|Other|5
7732791|NCT00928070|26889932|P2|Overall Study|Randomized but not treated|2
7732792|NCT00928070|26889933|P1|Overall Study|Randomized but not treated|2
7732793|NCT00928070|26889932|P2|Overall Study|Protocol Violation|5
7732794|NCT00928070|26889933|P1|Overall Study|Protocol Violation|6
7732795|NCT00928070|26889932|P2|Overall Study|Did not meet entrance criteria|9
7732796|NCT00928070|26889933|P1|Overall Study|Did not meet entrance criteria|16
7732797|NCT00928070|26889932|P2|Overall Study|Lack of Efficacy|5
7732798|NCT00928070|26889933|P1|Overall Study|Lack of Efficacy|9
7732799|NCT00928070|26889932|P2|Overall Study|Adverse Event|26
7732800|NCT00928070|26889933|P1|Overall Study|Adverse Event|14
7732801|NCT00928070|26889932|P2|Overall Study|Withdrawal by Subject|3
7732802|NCT00928070|26889933|P1|Overall Study|Withdrawal by Subject|10
7732803|NCT00928070|26889932|P2|Overall Study|Lost to Follow-up|2
7732804|NCT00928070|26889933|P1|Overall Study|Lost to Follow-up|1
7732805|NCT00928057|26889991|P2|Overall Study|Protocol Violation|1
7732806|NCT00928057|26889992|P1|Overall Study|Protocol Violation|0
7732807|NCT00928057|26889991|P2|Overall Study|Lost to Follow-up|1
7732808|NCT00928057|26889992|P1|Overall Study|Lost to Follow-up|0
7732809|NCT00928057|26889991|P2|Overall Study|Withdrawal by Subject|0
7732810|NCT00928057|26889992|P1|Overall Study|Withdrawal by Subject|1
7732811|NCT00928057|26889991|P2|Overall Study|Adverse Event|2
7732812|NCT00928057|26889992|P1|Overall Study|Adverse Event|1
7732813|NCT00928018|26890017|P2|Overall Study|Withdrawal by Subject|0
7732814|NCT00928018|26890018|P1|Overall Study|Withdrawal by Subject|1
7732815|NCT00927953|26890048|P2|Overall Study|Death|1
7732816|NCT00927953|26890049|P1|Overall Study|Death|2
7732817|NCT00927940|26890063|P1|Overall Study|Death|1
7732818|NCT00927927|26890083|P15|Overall Study|Withdrawal by Subject|0
7732819|NCT00927927|26890084|P14|Overall Study|Withdrawal by Subject|0
7732820|NCT00927927|26890085|P13|Overall Study|Withdrawal by Subject|0
7732821|NCT00927927|26890086|P12|Overall Study|Withdrawal by Subject|2
7732822|NCT00927927|26890087|P11|Overall Study|Withdrawal by Subject|0
7732823|NCT00927927|26890088|P10|Overall Study|Withdrawal by Subject|0
7732824|NCT00927927|26890089|P9|Overall Study|Withdrawal by Subject|0
7732825|NCT00927927|26890090|P8|Overall Study|Withdrawal by Subject|2
7732826|NCT00927927|26890091|P7|Overall Study|Withdrawal by Subject|0
7732827|NCT00927927|26890092|P6|Overall Study|Withdrawal by Subject|0
7732828|NCT00927927|26890093|P5|Overall Study|Withdrawal by Subject|0
7732829|NCT00927927|26890094|P4|Overall Study|Withdrawal by Subject|0
7732830|NCT00927927|26890095|P3|Overall Study|Withdrawal by Subject|0
7732831|NCT00927927|26890096|P2|Overall Study|Withdrawal by Subject|0
7732832|NCT00927927|26890097|P1|Overall Study|Withdrawal by Subject|0
7732833|NCT00927901|26890144|P4|Treatment Period 4|Subject withdrew consent|0
7732834|NCT00927901|26890145|P3|Treatment Period 4|Subject withdrew consent|1
7732835|NCT00927901|26890146|P2|Treatment Period 4|Subject withdrew consent|0
7732836|NCT00927901|26890147|P1|Treatment Period 4|Subject withdrew consent|0
7732837|NCT00927901|26890144|P4|Treatment Period 4|Adverse Event|1
7732838|NCT00927901|26890145|P3|Treatment Period 4|Adverse Event|0
7732839|NCT00927901|26890146|P2|Treatment Period 4|Adverse Event|0
7732840|NCT00927901|26890147|P1|Treatment Period 4|Adverse Event|0
7732841|NCT00927901|26890144|P4|Treatment Period 1|Subject withdrew consent|0
7732842|NCT00927901|26890145|P3|Treatment Period 1|Subject withdrew consent|1
7732843|NCT00927901|26890146|P2|Treatment Period 1|Subject withdrew consent|0
7732844|NCT00927901|26890147|P1|Treatment Period 1|Subject withdrew consent|0
7732845|NCT00927862|26890188|P2|Overall Study|Missing data needed for endpt analyses|45
7732846|NCT00927862|26890189|P1|Overall Study|Missing data needed for endpt analyses|27
7732847|NCT00927823|26890224|P4|Continuous Dosing Period|Other|3
7732848|NCT00927823|26890225|P3|Continuous Dosing Period|Other|9
7732849|NCT00927823|26890226|P2|Continuous Dosing Period|Other|2
7732850|NCT00927823|26890227|P1|Continuous Dosing Period|Other|1
7732851|NCT00927823|26890224|P4|Continuous Dosing Period|Withdrawal by Subject|2
7732852|NCT00927823|26890225|P3|Continuous Dosing Period|Withdrawal by Subject|2
7732853|NCT00927823|26890226|P2|Continuous Dosing Period|Withdrawal by Subject|0
7732854|NCT00927823|26890227|P1|Continuous Dosing Period|Withdrawal by Subject|1
7732855|NCT00927823|26890224|P4|Continuous Dosing Period|Lost to Follow-up|0
7732856|NCT00927823|26890225|P3|Continuous Dosing Period|Lost to Follow-up|9
7732857|NCT00927823|26890226|P2|Continuous Dosing Period|Lost to Follow-up|1
7732858|NCT00927823|26890227|P1|Continuous Dosing Period|Lost to Follow-up|1
7732859|NCT00927823|26890224|P4|Continuous Dosing Period|Death|0
7732860|NCT00927823|26890225|P3|Continuous Dosing Period|Death|6
7732861|NCT00927823|26890226|P2|Continuous Dosing Period|Death|0
7732862|NCT00927823|26890227|P1|Continuous Dosing Period|Death|0
7732863|NCT00927810|26890295|P4|Overall Study|Abnormal laboratory value(s)|0
7732864|NCT00927810|26890296|P3|Overall Study|Abnormal laboratory value(s)|0
7732865|NCT00927810|26890297|P2|Overall Study|Abnormal laboratory value(s)|1
7732866|NCT00927810|26890298|P1|Overall Study|Abnormal laboratory value(s)|0
7732867|NCT00927810|26890295|P4|Overall Study|Death|0
7732868|NCT00927810|26890296|P3|Overall Study|Death|0
7732869|NCT00927810|26890297|P2|Overall Study|Death|2
7732870|NCT00927810|26890298|P1|Overall Study|Death|0
7732871|NCT00927810|26890295|P4|Overall Study|Lost to Follow-up|1
7732872|NCT00927810|26890296|P3|Overall Study|Lost to Follow-up|1
7732873|NCT00927810|26890297|P2|Overall Study|Lost to Follow-up|2
7732874|NCT00927810|26890298|P1|Overall Study|Lost to Follow-up|0
7732875|NCT00927810|26890295|P4|Overall Study|Withdrawal by Subject|1
7732876|NCT00927810|26890296|P3|Overall Study|Withdrawal by Subject|0
7732877|NCT00927810|26890297|P2|Overall Study|Withdrawal by Subject|3
7732878|NCT00927810|26890298|P1|Overall Study|Withdrawal by Subject|0
7732879|NCT00927784|26890327|P2|Overall Study|Withdrawal by Subject|0
7732880|NCT00927784|26890328|P1|Overall Study|Withdrawal by Subject|1
7732881|NCT00927784|26890327|P2|Overall Study|Death|0
7732882|NCT00927784|26890328|P1|Overall Study|Death|1
7732883|NCT00927758|26890358|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7732884|NCT00927758|26890359|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7732885|NCT00927758|26890360|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7732886|NCT00927758|26890361|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7732887|NCT00927758|26890362|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7732888|NCT00927758|26890363|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7732889|NCT00927758|26890358|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
7732890|NCT00927758|26890359|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7732891|NCT00927758|26890360|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
7732892|NCT00927758|26890361|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7732893|NCT00927758|26890362|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7732894|NCT00927758|26890363|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7732895|NCT00927589|26890371|P1|Overall Study|Non-compliance|1
7732896|NCT00927589|26890371|P1|Overall Study|Disease Progression|8
7732897|NCT00927589|26890371|P1|Overall Study|Adverse Event|2
7732898|NCT00927589|26890371|P1|Overall Study|Withdrawal by Subject|3
7732899|NCT00927589|26890371|P1|Overall Study|Physician Decision|1
7732900|NCT00927589|26890371|P1|Overall Study|Death|1
7732901|NCT00927563|26890401|P1|Overall Study|Withdrawal by Subject|1
7732902|NCT00927563|26890401|P1|Overall Study|Lost to Follow-up|1
7732903|NCT00927485|26890409|P2|Overall Study|noncompliance, prophylactic surgery, inc|2
7732904|NCT00927485|26890410|P1|Overall Study|noncompliance, prophylactic surgery, inc|2
7732905|NCT00927485|26890409|P2|Overall Study|Adverse Event|2
7732906|NCT00927485|26890410|P1|Overall Study|Adverse Event|4
7732907|NCT00927472|26890420|P2|Overall Study|Post treatment Assessment out of window|4
7732908|NCT00927472|26890421|P1|Overall Study|Post treatment Assessment out of window|0
7732909|NCT00927472|26890420|P2|Overall Study|Protocol Violation|1
7732910|NCT00927472|26890421|P1|Overall Study|Protocol Violation|0
7732911|NCT00927472|26890420|P2|Overall Study|Lost to Follow-up|6
7732912|NCT00927472|26890421|P1|Overall Study|Lost to Follow-up|1
7732913|NCT00927472|26890420|P2|Overall Study|Withdrawal by Subject|11
7732914|NCT00927472|26890421|P1|Overall Study|Withdrawal by Subject|10
7732915|NCT00927394|26890447|P2|Overall Study|Randomized in error|1
7732916|NCT00927394|26890448|P1|Overall Study|Randomized in error|0
7732917|NCT00927394|26890447|P2|Overall Study|Protocol deviation|13
7732918|NCT00927394|26890448|P1|Overall Study|Protocol deviation|16
7732919|NCT00927394|26890447|P2|Overall Study|Death|1
7732920|NCT00927394|26890448|P1|Overall Study|Death|1
7732921|NCT00927394|26890447|P2|Overall Study|Administrative Problem|0
7732922|NCT00927394|26890448|P1|Overall Study|Administrative Problem|1
7732923|NCT00927394|26890447|P2|Overall Study|Lost to Follow-up|14
7732924|NCT00927394|26890448|P1|Overall Study|Lost to Follow-up|8
7732925|NCT00927394|26890447|P2|Overall Study|Withdrawal by Subject|24
7732926|NCT00927394|26890448|P1|Overall Study|Withdrawal by Subject|20
7732927|NCT00927394|26890447|P2|Overall Study|Unsatisfactory therapeutic effect|23
7732928|NCT00927394|26890448|P1|Overall Study|Unsatisfactory therapeutic effect|17
7732929|NCT00927394|26890447|P2|Overall Study|Adverse Event|9
7732930|NCT00927394|26890448|P1|Overall Study|Adverse Event|14
7732931|NCT00927368|26890479|P3|Overall Study|cancellation of surgery|2
7732932|NCT00927368|26890480|P2|Overall Study|cancellation of surgery|1
7732933|NCT00927368|26890481|P1|Overall Study|cancellation of surgery|0
7732934|NCT00927368|26890479|P3|Overall Study|ineligible post randomization|1
7732935|NCT00927368|26890480|P2|Overall Study|ineligible post randomization|3
7732936|NCT00927368|26890481|P1|Overall Study|ineligible post randomization|0
7732937|NCT00927368|26890479|P3|Overall Study|equipment failure|0
7732938|NCT00927368|26890480|P2|Overall Study|equipment failure|0
7732939|NCT00927368|26890481|P1|Overall Study|equipment failure|1
7732940|NCT00927368|26890479|P3|Overall Study|Lost to Follow-up|0
7732941|NCT00927368|26890480|P2|Overall Study|Lost to Follow-up|0
7732942|NCT00927368|26890481|P1|Overall Study|Lost to Follow-up|4
7732943|NCT00927368|26890479|P3|Overall Study|enrollment in another study|2
7732944|NCT00927368|26890480|P2|Overall Study|enrollment in another study|1
7732945|NCT00927368|26890481|P1|Overall Study|enrollment in another study|1
7732946|NCT00927355|26890500|P2|Overall Study|Adverse Event|1
7732947|NCT00927355|26890501|P1|Overall Study|Adverse Event|1
7732948|NCT00927251|26890536|P1|Overall Study|Patients not implanted with 4296 lead|8
7732949|NCT00927186|26890542|P2|12 Months Primary Study|Withdrawal by Subject|1
7732950|NCT00927186|26890543|P1|12 Months Primary Study|Withdrawal by Subject|1
7732951|NCT00927186|26890542|P2|12 Months Primary Study|Protocol Violation|1
7732952|NCT00927186|26890543|P1|12 Months Primary Study|Protocol Violation|0
7732953|NCT00927186|26890542|P2|12 Months Primary Study|Lost to Follow-up|0
7732954|NCT00927186|26890543|P1|12 Months Primary Study|Lost to Follow-up|1
7732955|NCT00927186|26890542|P2|12 Months Primary Study|Adverse Event|2
7732956|NCT00927186|26890543|P1|12 Months Primary Study|Adverse Event|5
7732957|NCT00927095|26890673|P3|Overall Study|Physician Decision|1
7732958|NCT00927095|26890674|P2|Overall Study|Physician Decision|2
7732959|NCT00927095|26890675|P1|Overall Study|Physician Decision|1
7732960|NCT00927095|26890673|P3|Overall Study|Withdrawal by Subject|1
7732961|NCT00927095|26890674|P2|Overall Study|Withdrawal by Subject|1
7732962|NCT00927095|26890675|P1|Overall Study|Withdrawal by Subject|2
7732963|NCT00927095|26890673|P3|Overall Study|Adverse Event|0
7732964|NCT00927095|26890674|P2|Overall Study|Adverse Event|1
7732965|NCT00927095|26890675|P1|Overall Study|Adverse Event|3
7732966|NCT00927082|26890687|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
7732967|NCT00927082|26890688|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
7732968|NCT00927082|26890689|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
7732969|NCT00927082|26890690|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
7732970|NCT00927082|26890687|P4|Overall Study|Death|0
7732971|NCT00927082|26890688|P3|Overall Study|Death|1
7732972|NCT00927082|26890689|P2|Overall Study|Death|0
7732973|NCT00927082|26890690|P1|Overall Study|Death|0
7732974|NCT00927082|26890687|P4|Overall Study|Withdrawal by Subject|2
7732975|NCT00927082|26890688|P3|Overall Study|Withdrawal by Subject|7
7732976|NCT00927082|26890689|P2|Overall Study|Withdrawal by Subject|2
7732977|NCT00927082|26890690|P1|Overall Study|Withdrawal by Subject|3
7732978|NCT00927082|26890687|P4|Overall Study|Lost to Follow-up|16
7732979|NCT00927082|26890688|P3|Overall Study|Lost to Follow-up|12
7732980|NCT00927082|26890689|P2|Overall Study|Lost to Follow-up|8
7732981|NCT00927082|26890690|P1|Overall Study|Lost to Follow-up|9
7732982|NCT00927069|26890754|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
7732983|NCT00927069|26890755|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
7732984|NCT00927069|26890756|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
7732985|NCT00927069|26890757|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
7732986|NCT00927069|26890754|P4|Week 12 to Week 24|Withdrawal by Subject|0
7732987|NCT00927069|26890755|P3|Week 12 to Week 24|Withdrawal by Subject|0
7732988|NCT00927069|26890756|P2|Week 12 to Week 24|Withdrawal by Subject|0
7732989|NCT00927069|26890757|P1|Week 12 to Week 24|Withdrawal by Subject|1
7732990|NCT00927069|26890754|P4|Week 12 to Week 24|Lost to Follow-up|0
7732991|NCT00927069|26890755|P3|Week 12 to Week 24|Lost to Follow-up|1
7732992|NCT00927069|26890756|P2|Week 12 to Week 24|Lost to Follow-up|0
7732993|NCT00927069|26890757|P1|Week 12 to Week 24|Lost to Follow-up|0
7732994|NCT00927069|26890754|P4|Week 12 to Week 24|Lack of Efficacy|3
7732995|NCT00927069|26890755|P3|Week 12 to Week 24|Lack of Efficacy|2
7732996|NCT00927069|26890756|P2|Week 12 to Week 24|Lack of Efficacy|0
7732997|NCT00927069|26890757|P1|Week 12 to Week 24|Lack of Efficacy|0
7732998|NCT00927069|26890754|P4|Week 0 to Week 12|Worsening of psoriasis|0
7732999|NCT00927069|26890755|P3|Week 0 to Week 12|Worsening of psoriasis|0
7733000|NCT00927069|26890756|P2|Week 0 to Week 12|Worsening of psoriasis|1
7733001|NCT00927069|26890757|P1|Week 0 to Week 12|Worsening of psoriasis|1
7733002|NCT00926796|26890813|P2|Overall Study|Withdrawal by Subject|0
7733003|NCT00926796|26890814|P1|Overall Study|Withdrawal by Subject|1
7733004|NCT00926796|26890813|P2|Overall Study|Protocol Violation|11
7733005|NCT00926796|26890814|P1|Overall Study|Protocol Violation|15
7733006|NCT00926796|26890813|P2|Overall Study|Lost to Follow-up|13
7733007|NCT00926796|26890814|P1|Overall Study|Lost to Follow-up|22
7733008|NCT00926796|26890813|P2|Overall Study|Adverse Event|14
7733009|NCT00926796|26890814|P1|Overall Study|Adverse Event|7
7733010|NCT00926796|26890813|P2|Overall Study|Ineligible, but positive for gonorrhea|1
7733011|NCT00926796|26890814|P1|Overall Study|Ineligible, but positive for gonorrhea|1
7733012|NCT00926796|26890813|P2|Overall Study|Ineligible, negative for gonorrhea|60
7733013|NCT00926796|26890814|P1|Overall Study|Ineligible, negative for gonorrhea|57
7733014|NCT00926796|26890813|P2|Overall Study|Did not receive randomized treatment|7
7733015|NCT00926796|26890814|P1|Overall Study|Did not receive randomized treatment|4
7733016|NCT00926783|26890835|P2|Overall Study|Incomplete CFAE Procedures|3
7733017|NCT00926783|26890836|P1|Overall Study|Incomplete CFAE Procedures|3
7733018|NCT00926575|26890863|P2|Overall Study|Withdrawal by Subject|9
7733019|NCT00926575|26890864|P1|Overall Study|Withdrawal by Subject|8
7733020|NCT00926575|26890863|P2|Overall Study|Protocol Violation|0
7733021|NCT00926575|26890864|P1|Overall Study|Protocol Violation|1
7733022|NCT00926575|26890863|P2|Overall Study|Physician Decision|2
7733023|NCT00926575|26890864|P1|Overall Study|Physician Decision|1
7733024|NCT00926575|26890863|P2|Overall Study|Lost to Follow-up|1
7733025|NCT00926575|26890864|P1|Overall Study|Lost to Follow-up|1
7733026|NCT00926575|26890863|P2|Overall Study|Death|4
7733027|NCT00926575|26890864|P1|Overall Study|Death|4
7733028|NCT00926575|26890863|P2|Overall Study|Adverse Event|1
7733029|NCT00926575|26890864|P1|Overall Study|Adverse Event|1
7733030|NCT00926536|26890876|P2|Overall Study|Physician Decision|2
7733031|NCT00926536|26890877|P1|Overall Study|Physician Decision|1
7733032|NCT00926393|26890898|P2|Overall Study|Adverse Event|1
7733033|NCT00926393|26890899|P1|Overall Study|Adverse Event|1
7733034|NCT00926393|26890898|P2|Overall Study|Withdrawal by Subject|2
7733035|NCT00926393|26890899|P1|Overall Study|Withdrawal by Subject|1
7733036|NCT00926367|26890944|P2|Overall Study|Skin Irritation|2
7733037|NCT00926367|26890945|P1|Overall Study|Skin Irritation|1
7733038|NCT00926367|26890944|P2|Overall Study|Lost to Follow-up|0
7733039|NCT00926367|26890945|P1|Overall Study|Lost to Follow-up|1
7733040|NCT00926367|26890944|P2|Overall Study|Withdrawal by Subject|1
7733041|NCT00926367|26890945|P1|Overall Study|Withdrawal by Subject|0
7733042|NCT00926328|26890987|P2|Overall Study|Lost to Follow-up|14
7733043|NCT00926328|26890988|P1|Overall Study|Lost to Follow-up|12
7733044|NCT00926289|26890998|P2|Overall Study|Other|3
7733045|NCT00926289|26890999|P1|Overall Study|Other|1
7733046|NCT00926289|26890998|P2|Overall Study|Withdrawal by Subject|4
7733047|NCT00926289|26890999|P1|Overall Study|Withdrawal by Subject|4
7733048|NCT00926289|26890998|P2|Overall Study|Lost to Follow-up|6
7733049|NCT00926289|26890999|P1|Overall Study|Lost to Follow-up|3
7733050|NCT00926289|26890998|P2|Overall Study|Protocol Violation|12
7733051|NCT00926289|26890999|P1|Overall Study|Protocol Violation|8
7733052|NCT00926289|26890998|P2|Overall Study|Adverse Event|11
7733053|NCT00926289|26890999|P1|Overall Study|Adverse Event|9
7733054|NCT00926237|26891067|P2|Overall Study|Withdrawal by Subject|1
7733055|NCT00926237|26891068|P1|Overall Study|Withdrawal by Subject|2
7733056|NCT00926211|26891078|P1|Overall Study|Lost to Follow-up|1
7733057|NCT00926029|26891109|P3|Overall Study|Lost to Follow-up|1
7733058|NCT00926029|26891110|P2|Overall Study|Lost to Follow-up|1
7733059|NCT00926029|26891111|P1|Overall Study|Lost to Follow-up|2
7733060|NCT00926003|26891125|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
7733061|NCT00926003|26891126|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
7733062|NCT00926003|26891127|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
7733063|NCT00926003|26891125|P3|Post-Training Evaluation|Withdrawal by Subject|0
7733064|NCT00926003|26891126|P2|Post-Training Evaluation|Withdrawal by Subject|0
7733065|NCT00926003|26891127|P1|Post-Training Evaluation|Withdrawal by Subject|1
7733066|NCT00925990|26891140|P2|Overall Study|moved out of state, missed medication|2
7733067|NCT00925990|26891141|P1|Overall Study|moved out of state, missed medication|0
7733068|NCT00925990|26891140|P2|Overall Study|Physician Decision|1
7733069|NCT00925990|26891141|P1|Overall Study|Physician Decision|1
7733070|NCT00925990|26891140|P2|Overall Study|Lost to Follow-up|3
7733071|NCT00925990|26891141|P1|Overall Study|Lost to Follow-up|1
7733072|NCT00925990|26891140|P2|Overall Study|Withdrawal by Subject|2
7733073|NCT00925990|26891141|P1|Overall Study|Withdrawal by Subject|2
7733074|NCT00925990|26891140|P2|Overall Study|Adverse Event|3
7733075|NCT00925990|26891141|P1|Overall Study|Adverse Event|1
7733076|NCT00925899|26891176|P2|Part 1|Withdrawal by Subject|9
7733077|NCT00925899|26891177|P1|Part 1|Withdrawal by Subject|10
7733078|NCT00925899|26891176|P2|Part 1|Death|2
7733079|NCT00925899|26891177|P1|Part 1|Death|1
7733080|NCT00925769|26891205|P6|Overall Study|Adverse Event|0
7733081|NCT00925769|26891206|P5|Overall Study|Adverse Event|1
7733082|NCT00925769|26891207|P4|Overall Study|Adverse Event|0
7733083|NCT00925769|26891208|P3|Overall Study|Adverse Event|0
7733084|NCT00925769|26891209|P2|Overall Study|Adverse Event|0
7733085|NCT00925769|26891210|P1|Overall Study|Adverse Event|0
7733086|NCT00925769|26891205|P6|Overall Study|Participant is unable to swallow drug|0
7733087|NCT00925769|26891206|P5|Overall Study|Participant is unable to swallow drug|0
7733088|NCT00925769|26891207|P4|Overall Study|Participant is unable to swallow drug|1
7733089|NCT00925769|26891208|P3|Overall Study|Participant is unable to swallow drug|0
7733090|NCT00925769|26891209|P2|Overall Study|Participant is unable to swallow drug|0
7733091|NCT00925769|26891210|P1|Overall Study|Participant is unable to swallow drug|0
7733092|NCT00925769|26891205|P6|Overall Study|End of study visit not done|0
7733093|NCT00925769|26891206|P5|Overall Study|End of study visit not done|0
7733094|NCT00925769|26891207|P4|Overall Study|End of study visit not done|0
7733095|NCT00925769|26891208|P3|Overall Study|End of study visit not done|1
7733096|NCT00925769|26891209|P2|Overall Study|End of study visit not done|0
7733097|NCT00925769|26891210|P1|Overall Study|End of study visit not done|0
7733098|NCT00925769|26891205|P6|Overall Study|Missing documentation|0
7733099|NCT00925769|26891206|P5|Overall Study|Missing documentation|0
7733100|NCT00925769|26891207|P4|Overall Study|Missing documentation|0
7733101|NCT00925769|26891208|P3|Overall Study|Missing documentation|0
7733102|NCT00925769|26891209|P2|Overall Study|Missing documentation|1
7733103|NCT00925769|26891210|P1|Overall Study|Missing documentation|0
7733104|NCT00925769|26891205|P6|Overall Study|Physician Decision|0
7733105|NCT00925769|26891206|P5|Overall Study|Physician Decision|0
7733106|NCT00925769|26891207|P4|Overall Study|Physician Decision|0
7733107|NCT00925769|26891208|P3|Overall Study|Physician Decision|0
7733108|NCT00925769|26891209|P2|Overall Study|Physician Decision|0
7733109|NCT00925769|26891210|P1|Overall Study|Physician Decision|1
7733110|NCT00925769|26891205|P6|Overall Study|Death|0
7733111|NCT00925769|26891206|P5|Overall Study|Death|0
7733112|NCT00925769|26891207|P4|Overall Study|Death|0
7733113|NCT00925769|26891208|P3|Overall Study|Death|1
7733114|NCT00925769|26891209|P2|Overall Study|Death|0
7733115|NCT00925769|26891210|P1|Overall Study|Death|0
7733116|NCT00925769|26891205|P6|Overall Study|Disease progression|3
7733117|NCT00925769|26891206|P5|Overall Study|Disease progression|2
7733118|NCT00925769|26891207|P4|Overall Study|Disease progression|4
7733119|NCT00925769|26891208|P3|Overall Study|Disease progression|3
7733120|NCT00925769|26891209|P2|Overall Study|Disease progression|5
7733121|NCT00925769|26891210|P1|Overall Study|Disease progression|4
7733122|NCT00925769|26891205|P6|Overall Study|Major toxicity|0
7733123|NCT00925769|26891206|P5|Overall Study|Major toxicity|0
7733124|NCT00925769|26891207|P4|Overall Study|Major toxicity|1
7733125|NCT00925769|26891208|P3|Overall Study|Major toxicity|1
7733126|NCT00925769|26891209|P2|Overall Study|Major toxicity|0
7733127|NCT00925769|26891210|P1|Overall Study|Major toxicity|1
7733128|NCT00925704|26891284|P6|Third Intervention|Withdrew consent|1
7733129|NCT00925704|26891285|P5|Third Intervention|Withdrew consent|0
7733130|NCT00925704|26891286|P4|Third Intervention|Withdrew consent|0
7733131|NCT00925704|26891287|P3|Third Intervention|Withdrew consent|0
7733132|NCT00925704|26891288|P2|Third Intervention|Withdrew consent|0
7733133|NCT00925704|26891289|P1|Third Intervention|Withdrew consent|0
7733134|NCT00925704|26891284|P6|Second Intervention|Withdrawal by Subject|0
7733135|NCT00925704|26891285|P5|Second Intervention|Withdrawal by Subject|1
7733136|NCT00925704|26891286|P4|Second Intervention|Withdrawal by Subject|0
7733137|NCT00925704|26891287|P3|Second Intervention|Withdrawal by Subject|0
7733138|NCT00925704|26891288|P2|Second Intervention|Withdrawal by Subject|0
7733139|NCT00925704|26891289|P1|Second Intervention|Withdrawal by Subject|1
7733140|NCT00925704|26891284|P6|First Intervention|Withdrew consent|0
7733141|NCT00925704|26891285|P5|First Intervention|Withdrew consent|1
7733142|NCT00925704|26891286|P4|First Intervention|Withdrew consent|1
7733143|NCT00925704|26891287|P3|First Intervention|Withdrew consent|0
7733144|NCT00925704|26891288|P2|First Intervention|Withdrew consent|0
7733145|NCT00925704|26891289|P1|First Intervention|Withdrew consent|0
7733146|NCT00925600|26891302|P2|Overall Study|Adverse Event|2
7733147|NCT00925600|26891303|P1|Overall Study|Adverse Event|1
7733148|NCT00925600|26891302|P2|Overall Study|Other|1
7733149|NCT00925600|26891303|P1|Overall Study|Other|3
7733150|NCT00925600|26891302|P2|Overall Study|Requirement for Alternative Therapy|1
7733151|NCT00925600|26891303|P1|Overall Study|Requirement for Alternative Therapy|0
7733152|NCT00925600|26891302|P2|Overall Study|Protocol Deviation|1
7733153|NCT00925600|26891303|P1|Overall Study|Protocol Deviation|0
7733154|NCT00925600|26891302|P2|Overall Study|Ineligibility Determined|0
7733155|NCT00925600|26891303|P1|Overall Study|Ineligibility Determined|2
7733156|NCT00925600|26891302|P2|Overall Study|Noncompliance|0
7733157|NCT00925600|26891303|P1|Overall Study|Noncompliance|2
7733158|NCT00925600|26891302|P2|Overall Study|Administrative Decision|1
7733159|NCT00925600|26891303|P1|Overall Study|Administrative Decision|1
7733160|NCT00925600|26891302|P2|Overall Study|Disease Progression|3
7733161|NCT00925600|26891303|P1|Overall Study|Disease Progression|1
7733162|NCT00925600|26891302|P2|Overall Study|Lost to Follow-up|2
7733163|NCT00925600|26891303|P1|Overall Study|Lost to Follow-up|2
7733164|NCT00925600|26891302|P2|Overall Study|Death|3
7733165|NCT00925600|26891303|P1|Overall Study|Death|4
7733166|NCT00925600|26891302|P2|Overall Study|Withdrawal by Subject|14
7733167|NCT00925600|26891303|P1|Overall Study|Withdrawal by Subject|16
7733168|NCT00925587|26891325|P2|Overall Study|Lost to Follow-up|1
7733169|NCT00925587|26891326|P1|Overall Study|Lost to Follow-up|0
7733170|NCT00925587|26891325|P2|Overall Study|Adverse Event|2
7733171|NCT00925587|26891326|P1|Overall Study|Adverse Event|6
7733172|NCT00925587|26891325|P2|Overall Study|Death|5
7733173|NCT00925587|26891326|P1|Overall Study|Death|5
7733174|NCT00925587|26891325|P2|Overall Study|Withdrawal by Subject|6
7733175|NCT00925587|26891326|P1|Overall Study|Withdrawal by Subject|9
7733176|NCT00925587|26891325|P2|Overall Study|Protocol Violation|4
7733177|NCT00925587|26891326|P1|Overall Study|Protocol Violation|6
7733178|NCT00925587|26891325|P2|Overall Study|Physician Decision|1
7733179|NCT00925587|26891326|P1|Overall Study|Physician Decision|4
7733180|NCT00925587|26891325|P2|Overall Study|Protocol Specified Criteria|6
7733181|NCT00925587|26891326|P1|Overall Study|Protocol Specified Criteria|6
7733182|NCT00925548|26891440|P2|Overall Study|Discontinuation of trial by sponsor|5
7733183|NCT00925548|26891441|P1|Overall Study|Discontinuation of trial by sponsor|10
7733184|NCT00925522|26891467|P1|Overall Study|study closed -- business decision|20
7733185|NCT00925353|26891471|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
7733186|NCT00925301|26891477|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
7733187|NCT00925301|26891478|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7733188|NCT00925301|26891479|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7733189|NCT00925301|26891480|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7733190|NCT00925301|26891477|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
7733191|NCT00925301|26891478|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
7733192|NCT00925301|26891479|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
7733193|NCT00925301|26891480|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
7733194|NCT00925301|26891477|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
7733195|NCT00925301|26891478|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7733196|NCT00925301|26891479|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7733197|NCT00925301|26891480|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7733198|NCT00925301|26891477|P4|6-Month Open-label (Stage 2)|Adverse Event|0
7733199|NCT00925301|26891478|P3|6-Month Open-label (Stage 2)|Adverse Event|2
7733200|NCT00925301|26891479|P2|6-Month Open-label (Stage 2)|Adverse Event|0
7733201|NCT00925301|26891480|P1|6-Month Open-label (Stage 2)|Adverse Event|0
7733202|NCT00925301|26891477|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7733203|NCT00925301|26891478|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
7733204|NCT00925301|26891479|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7733205|NCT00925301|26891480|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7733206|NCT00925301|26891477|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
7733207|NCT00925301|26891478|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
7733208|NCT00925301|26891479|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
7733209|NCT00925301|26891480|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
7733210|NCT00925301|26891477|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7733211|NCT00925301|26891478|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7733212|NCT00925301|26891479|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
7733213|NCT00925301|26891480|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7733214|NCT00925288|26891496|P2|Overall Study|Lost to Follow-up|7
7733215|NCT00925288|26891497|P1|Overall Study|Lost to Follow-up|9
7733216|NCT00925132|26891509|P5|Overall Study|Removed due to disease progression|4
7733217|NCT00925132|26891510|P4|Overall Study|Removed due to disease progression|0
7733218|NCT00925132|26891511|P3|Overall Study|Removed due to disease progression|0
7733219|NCT00925132|26891512|P2|Overall Study|Removed due to disease progression|0
7733220|NCT00925132|26891513|P1|Overall Study|Removed due to disease progression|0
7733221|NCT00925132|26891509|P5|Overall Study|Withdrawal by Subject|1
7733222|NCT00925132|26891510|P4|Overall Study|Withdrawal by Subject|0
7733223|NCT00925132|26891511|P3|Overall Study|Withdrawal by Subject|0
7733224|NCT00925132|26891512|P2|Overall Study|Withdrawal by Subject|0
7733225|NCT00925132|26891513|P1|Overall Study|Withdrawal by Subject|2
7733226|NCT00925015|26891608|P3|Overall Study|Withdrawal by Subject|1
7733227|NCT00925015|26891609|P2|Overall Study|Withdrawal by Subject|0
7733228|NCT00925015|26891610|P1|Overall Study|Withdrawal by Subject|0
7733229|NCT00925015|26891608|P3|Overall Study|Progressive Disease|4
7733230|NCT00925015|26891609|P2|Overall Study|Progressive Disease|3
7733231|NCT00925015|26891610|P1|Overall Study|Progressive Disease|7
7733232|NCT00925015|26891608|P3|Overall Study|Physician Decision|0
7733233|NCT00925015|26891609|P2|Overall Study|Physician Decision|1
7733234|NCT00925015|26891610|P1|Overall Study|Physician Decision|0
7733235|NCT00925015|26891608|P3|Overall Study|Adverse Event|1
7733236|NCT00925015|26891609|P2|Overall Study|Adverse Event|2
7733237|NCT00925015|26891610|P1|Overall Study|Adverse Event|1
7733238|NCT00925002|26891669|P3|Overall Study|Participant withdrew consent|3
7733239|NCT00925002|26891670|P2|Overall Study|Participant withdrew consent|3
7733240|NCT00925002|26891671|P1|Overall Study|Participant withdrew consent|1
7733241|NCT00925002|26891669|P3|Overall Study|Adverse Event|2
7733242|NCT00925002|26891670|P2|Overall Study|Adverse Event|1
7733243|NCT00925002|26891671|P1|Overall Study|Adverse Event|3
7733244|NCT00925002|26891669|P3|Overall Study|Death|5
7733245|NCT00925002|26891670|P2|Overall Study|Death|1
7733246|NCT00925002|26891671|P1|Overall Study|Death|1
7733247|NCT00925002|26891669|P3|Overall Study|Other|0
7733248|NCT00925002|26891670|P2|Overall Study|Other|4
7733249|NCT00925002|26891671|P1|Overall Study|Other|1
7733250|NCT00924950|26891752|P1|Overall Study|Lost to Follow-up|2
7733251|NCT00924898|26891759|P1|Overall Study|Withdrawal by Subject|2
7733252|NCT00924820|26891798|P1|Overall Study|Ineligible, Screen Failure|5
7733253|NCT00924820|26891798|P1|Overall Study|Death|2
7733254|NCT00924781|26891813|P2|Overall Study|Study terminated by sponsor|10
7733255|NCT00924781|26891814|P1|Overall Study|Study terminated by sponsor|12
7733256|NCT00924729|26891848|P2|Overall Study|Protocol Violation|0
7733257|NCT00924729|26891849|P1|Overall Study|Protocol Violation|1
7733258|NCT00924729|26891848|P2|Overall Study|insufficient volume for analysis|0
7733259|NCT00924729|26891849|P1|Overall Study|insufficient volume for analysis|1
7733260|NCT00924703|26891857|P1|Overall Study|Withdrawal by Sponsor|1
7733261|NCT00924703|26891857|P1|Overall Study|Adverse Event|2
7733262|NCT00924703|26891857|P1|Overall Study|Lost to Follow-up|3
7733263|NCT00924703|26891857|P1|Overall Study|Physician Decision|5
7733264|NCT00924703|26891857|P1|Overall Study|Withdrawal by Subject|11
7733265|NCT00924664|26891867|P2|Overall Study|Randomized but not Treated|0
7733266|NCT00924664|26891868|P1|Overall Study|Randomized but not Treated|1
7733267|NCT00924664|26891867|P2|Overall Study|Other|52
7733268|NCT00924664|26891868|P1|Overall Study|Other|29
7733269|NCT00924664|26891867|P2|Overall Study|Study terminated by sponsor|330
7733270|NCT00924664|26891868|P1|Overall Study|Study terminated by sponsor|199
7733271|NCT00924664|26891867|P2|Overall Study|Death|2
7733272|NCT00924664|26891868|P1|Overall Study|Death|0
7733273|NCT00924664|26891867|P2|Overall Study|Pregnancy|1
7733274|NCT00924664|26891868|P1|Overall Study|Pregnancy|1
7733275|NCT00924664|26891867|P2|Overall Study|Protocol Violation|5
7733276|NCT00924664|26891868|P1|Overall Study|Protocol Violation|2
7733277|NCT00924664|26891867|P2|Overall Study|Withdrawal by Subject|71
7733278|NCT00924664|26891868|P1|Overall Study|Withdrawal by Subject|47
7733279|NCT00924664|26891867|P2|Overall Study|Lost to Follow-up|12
7733280|NCT00924664|26891868|P1|Overall Study|Lost to Follow-up|10
7733281|NCT00924664|26891867|P2|Overall Study|Lack of Efficacy|15
7733282|NCT00924664|26891868|P1|Overall Study|Lack of Efficacy|10
7733283|NCT00924664|26891867|P2|Overall Study|Adverse Event|39
7733284|NCT00924664|26891868|P1|Overall Study|Adverse Event|23
7733285|NCT00924651|26891972|P2|Overall Study|Incomplete Form|1
7733286|NCT00924651|26891973|P1|Overall Study|Incomplete Form|2
7733287|NCT00924651|26891972|P2|Overall Study|Changed Mind|1
7733288|NCT00924651|26891973|P1|Overall Study|Changed Mind|10
7733289|NCT00924651|26891972|P2|Overall Study|Medical|3
7733290|NCT00924651|26891973|P1|Overall Study|Medical|1
7733291|NCT00924651|26891972|P2|Overall Study|Noncompliant|4
7733292|NCT00924651|26891973|P1|Overall Study|Noncompliant|1
7733293|NCT00924651|26891972|P2|Overall Study|Overwhelmed|6
7733294|NCT00924651|26891973|P1|Overall Study|Overwhelmed|6
7733295|NCT00924651|26891972|P2|Overall Study|No Reason|7
7733296|NCT00924651|26891973|P1|Overall Study|No Reason|3
7733297|NCT00924651|26891972|P2|Overall Study|Chemo started too soon|3
7733298|NCT00924651|26891973|P1|Overall Study|Chemo started too soon|2
7733299|NCT00924638|26891981|P2|Overall Study|Physician Decision|3
7733300|NCT00924638|26891982|P1|Overall Study|Physician Decision|3
7733301|NCT00924638|26891981|P2|Overall Study|Withdrawal by Subject|7
7733302|NCT00924638|26891982|P1|Overall Study|Withdrawal by Subject|5
7733303|NCT00924638|26891981|P2|Overall Study|Lost to Follow-up|1
7733304|NCT00924638|26891982|P1|Overall Study|Lost to Follow-up|1
7733305|NCT00924638|26891981|P2|Overall Study|Death|2
7733306|NCT00924638|26891982|P1|Overall Study|Death|3
7733307|NCT00924560|26892019|P3|Overall Study|Miscellaneous Reasons|10
7733308|NCT00924560|26892020|P2|Overall Study|Miscellaneous Reasons|10
7733309|NCT00924560|26892021|P1|Overall Study|Miscellaneous Reasons|13
7733310|NCT00924560|26892019|P3|Overall Study|Lost to Follow-up|45
7733311|NCT00924560|26892020|P2|Overall Study|Lost to Follow-up|94
7733312|NCT00924560|26892021|P1|Overall Study|Lost to Follow-up|78
7733313|NCT00924560|26892019|P3|Overall Study|Pregnancy|1
7733314|NCT00924560|26892020|P2|Overall Study|Pregnancy|7
7733315|NCT00924560|26892021|P1|Overall Study|Pregnancy|5
7733316|NCT00924560|26892019|P3|Overall Study|Adverse Event|0
7733317|NCT00924560|26892020|P2|Overall Study|Adverse Event|33
7733318|NCT00924560|26892021|P1|Overall Study|Adverse Event|39
7733319|NCT00924560|26892019|P3|Overall Study|Withdrawal by Subject|18
7733320|NCT00924560|26892020|P2|Overall Study|Withdrawal by Subject|44
7733321|NCT00924560|26892021|P1|Overall Study|Withdrawal by Subject|50
7733322|NCT00924560|26892019|P3|Overall Study|Physician Decision|4
7733323|NCT00924560|26892020|P2|Overall Study|Physician Decision|3
7733324|NCT00924560|26892021|P1|Overall Study|Physician Decision|2
7733325|NCT00924560|26892019|P3|Overall Study|Non Compliance with the Protocol|4
7733326|NCT00924560|26892020|P2|Overall Study|Non Compliance with the Protocol|15
7733327|NCT00924560|26892021|P1|Overall Study|Non Compliance with the Protocol|20
7733328|NCT00924560|26892019|P3|Overall Study|Did Not Meet Protocol Requirements|1
7733329|NCT00924560|26892020|P2|Overall Study|Did Not Meet Protocol Requirements|2
7733330|NCT00924560|26892021|P1|Overall Study|Did Not Meet Protocol Requirements|4
7733331|NCT00924508|26892065|P1|Overall Study|Withdrawal by Subject|3
7733332|NCT00924469|26892079|P2|Overall Study|Lost to Follow-up|1
7733333|NCT00924469|26892080|P1|Overall Study|Lost to Follow-up|0
7733334|NCT00924469|26892079|P2|Overall Study|Withdrawal by Subject|1
7733335|NCT00924469|26892080|P1|Overall Study|Withdrawal by Subject|0
7733336|NCT00924469|26892079|P2|Overall Study|Adverse Event|0
7733337|NCT00924469|26892080|P1|Overall Study|Adverse Event|2
7733338|NCT00924443|26892102|P1|Overall Study|Protocol Violation|1
7733339|NCT00924443|26892102|P1|Overall Study|Physician Decision|2
7733340|NCT00924404|26892112|P2|Overall Study|Lost to Follow-up|4
7733341|NCT00924404|26892113|P1|Overall Study|Lost to Follow-up|6
7733342|NCT00924313|26892184|P1|Overall Study|not imaged due to failed tracer imaging|1
7733343|NCT00924287|26892196|P1|Overall Study|Death|1
7733344|NCT00924170|26892212|P2|Overall Study|Death|0
7733345|NCT00924170|26892213|P1|Overall Study|Death|1
7733346|NCT00924170|26892212|P2|Overall Study|Stopped due to neutralizing antibodies|0
7733347|NCT00924170|26892213|P1|Overall Study|Stopped due to neutralizing antibodies|3
7733348|NCT00924170|26892212|P2|Overall Study|Progressive disease|6
7733349|NCT00924170|26892213|P1|Overall Study|Progressive disease|3
7733350|NCT00924170|26892212|P2|Overall Study|Physician Decision|1
7733351|NCT00924170|26892213|P1|Overall Study|Physician Decision|0
7733352|NCT00924170|26892212|P2|Overall Study|Refused further treatment|1
7733353|NCT00924170|26892213|P1|Overall Study|Refused further treatment|0
7733354|NCT00923975|26892338|P1|Overall Study|Did not meet inclusion criteria|1
7733355|NCT00923936|26892357|P2|Overall Study|Continuing in follow up period|1
7733356|NCT00923936|26892358|P1|Overall Study|Continuing in follow up period|2
7733357|NCT00923936|26892357|P2|Overall Study|Lost to follow up|0
7733358|NCT00923936|26892358|P1|Overall Study|Lost to follow up|2
7733359|NCT00923936|26892357|P2|Overall Study|Adverse Event|1
7733360|NCT00923936|26892358|P1|Overall Study|Adverse Event|2
7733361|NCT00923936|26892357|P2|Overall Study|progressive disease on study|1
7733362|NCT00923936|26892358|P1|Overall Study|progressive disease on study|2
7733363|NCT00923845|26892387|P2|Induction Therapy|Poor performance status|2
7733364|NCT00923845|26892388|P1|Induction Therapy|Poor performance status|0
7733365|NCT00923559|26892420|P2|Overall Study|Lost to Follow-up|3
7733366|NCT00923559|26892421|P1|Overall Study|Lost to Follow-up|2
7733367|NCT00923364|26892442|P2|Overall Study|Did not go to transplant|0
7733368|NCT00923364|26892443|P1|Overall Study|Did not go to transplant|1
7733369|NCT00923364|26892442|P2|Overall Study|Death|0
7733370|NCT00923364|26892443|P1|Overall Study|Death|3
7733371|NCT00923351|26892455|P3|Overall Study|no apheresis/adequate tumor sample|12
7733372|NCT00923351|26892456|P2|Overall Study|no apheresis/adequate tumor sample|0
7733373|NCT00923351|26892457|P1|Overall Study|no apheresis/adequate tumor sample|0
7733374|NCT00923273|26892472|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7733375|NCT00923273|26892473|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
7733376|NCT00923273|26892474|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7733377|NCT00923273|26892475|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7733378|NCT00923273|26892476|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7733379|NCT00923273|26892472|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7733380|NCT00923273|26892473|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
7733381|NCT00923273|26892474|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7733382|NCT00923273|26892475|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7733383|NCT00923273|26892476|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7733384|NCT00923260|26892501|P2|Overall Study|Lost to Follow-up|1
7733385|NCT00923260|26892502|P1|Overall Study|Lost to Follow-up|1
7733386|NCT00923195|26892665|P2|Overall Study|Death|1
7733387|NCT00923195|26892666|P1|Overall Study|Death|0
7733388|NCT00923156|26892677|P3|Overall Study|Lack of Efficacy|1
7733389|NCT00923156|26892678|P2|Overall Study|Lack of Efficacy|0
7733390|NCT00923156|26892679|P1|Overall Study|Lack of Efficacy|0
7733391|NCT00923156|26892677|P3|Overall Study|Death|0
7733392|NCT00923156|26892678|P2|Overall Study|Death|1
7733393|NCT00923156|26892679|P1|Overall Study|Death|0
7733394|NCT00923156|26892677|P3|Overall Study|Withdrawal by Subject|0
7733395|NCT00923156|26892678|P2|Overall Study|Withdrawal by Subject|1
7733396|NCT00923156|26892679|P1|Overall Study|Withdrawal by Subject|0
7733397|NCT00923156|26892677|P3|Overall Study|Abnormal laboratory values|1
7733398|NCT00923156|26892678|P2|Overall Study|Abnormal laboratory values|0
7733399|NCT00923156|26892679|P1|Overall Study|Abnormal laboratory values|0
7733400|NCT00923156|26892677|P3|Overall Study|Adverse Event|1
7733401|NCT00923156|26892678|P2|Overall Study|Adverse Event|2
7733402|NCT00923156|26892679|P1|Overall Study|Adverse Event|0
7733403|NCT00923130|26892705|P1|Overall Study|Refused further treatment|2
7733404|NCT00923130|26892705|P1|Overall Study|Switched to alternative treatment|2
7733405|NCT00923130|26892705|P1|Overall Study|Discontinued treatment due to toxicities|3
7733406|NCT00923130|26892705|P1|Overall Study|Death|1
7733407|NCT00923130|26892705|P1|Overall Study|Stopped treatment due to progression|17
7733408|NCT00923091|26892740|P13|Period VI (Open-Label)|Other Reason|0
7733409|NCT00923091|26892741|P12|Period VI (Open-Label)|Other Reason|0
7733410|NCT00923091|26892742|P11|Period VI (Open-Label)|Other Reason|0
7733411|NCT00923091|26892743|P10|Period VI (Open-Label)|Other Reason|0
7733412|NCT00923091|26892744|P9|Period VI (Open-Label)|Other Reason|0
7733413|NCT00923091|26892745|P8|Period VI (Open-Label)|Other Reason|0
7733414|NCT00923091|26892746|P7|Period VI (Open-Label)|Other Reason|0
7733415|NCT00923091|26892747|P6|Period VI (Open-Label)|Other Reason|0
7733416|NCT00923091|26892748|P5|Period VI (Open-Label)|Other Reason|1
7733417|NCT00923091|26892749|P4|Period VI (Open-Label)|Other Reason|1
7733418|NCT00923091|26892750|P3|Period VI (Open-Label)|Other Reason|0
7733419|NCT00923091|26892751|P2|Period VI (Open-Label)|Other Reason|0
7733420|NCT00923091|26892752|P1|Period VI (Open-Label)|Other Reason|0
7733421|NCT00923091|26892740|P13|Period VI (Open-Label)|Lost to Follow-up|0
7733422|NCT00923091|26892741|P12|Period VI (Open-Label)|Lost to Follow-up|0
7733423|NCT00923091|26892742|P11|Period VI (Open-Label)|Lost to Follow-up|0
7733424|NCT00923091|26892743|P10|Period VI (Open-Label)|Lost to Follow-up|0
7733425|NCT00923091|26892744|P9|Period VI (Open-Label)|Lost to Follow-up|0
7733426|NCT00923091|26892745|P8|Period VI (Open-Label)|Lost to Follow-up|0
7733427|NCT00923091|26892746|P7|Period VI (Open-Label)|Lost to Follow-up|0
7733428|NCT00923091|26892747|P6|Period VI (Open-Label)|Lost to Follow-up|0
7733429|NCT00923091|26892748|P5|Period VI (Open-Label)|Lost to Follow-up|0
7733430|NCT00923091|26892749|P4|Period VI (Open-Label)|Lost to Follow-up|0
7733431|NCT00923091|26892750|P3|Period VI (Open-Label)|Lost to Follow-up|1
7733432|NCT00923091|26892751|P2|Period VI (Open-Label)|Lost to Follow-up|0
7733433|NCT00923091|26892752|P1|Period VI (Open-Label)|Lost to Follow-up|1
7733434|NCT00923091|26892740|P13|Period VI (Open-Label)|Protocol Violation|0
7733435|NCT00923091|26892741|P12|Period VI (Open-Label)|Protocol Violation|0
7733436|NCT00923091|26892742|P11|Period VI (Open-Label)|Protocol Violation|0
7733437|NCT00923091|26892743|P10|Period VI (Open-Label)|Protocol Violation|0
7733438|NCT00923091|26892744|P9|Period VI (Open-Label)|Protocol Violation|0
7733439|NCT00923091|26892745|P8|Period VI (Open-Label)|Protocol Violation|0
7733440|NCT00923091|26892746|P7|Period VI (Open-Label)|Protocol Violation|0
7733441|NCT00923091|26892747|P6|Period VI (Open-Label)|Protocol Violation|0
7733442|NCT00923091|26892748|P5|Period VI (Open-Label)|Protocol Violation|4
7733443|NCT00923091|26892749|P4|Period VI (Open-Label)|Protocol Violation|1
7733444|NCT00923091|26892750|P3|Period VI (Open-Label)|Protocol Violation|3
7733445|NCT00923091|26892751|P2|Period VI (Open-Label)|Protocol Violation|1
7733446|NCT00923091|26892752|P1|Period VI (Open-Label)|Protocol Violation|6
7733447|NCT00923091|26892740|P13|Period VI (Open-Label)|Withdrawal by Subject|0
7733448|NCT00923091|26892741|P12|Period VI (Open-Label)|Withdrawal by Subject|0
7733449|NCT00923091|26892742|P11|Period VI (Open-Label)|Withdrawal by Subject|0
7733450|NCT00923091|26892743|P10|Period VI (Open-Label)|Withdrawal by Subject|0
7733451|NCT00923091|26892744|P9|Period VI (Open-Label)|Withdrawal by Subject|0
7733452|NCT00923091|26892745|P8|Period VI (Open-Label)|Withdrawal by Subject|0
7733453|NCT00923091|26892746|P7|Period VI (Open-Label)|Withdrawal by Subject|0
7733454|NCT00923091|26892747|P6|Period VI (Open-Label)|Withdrawal by Subject|0
7733455|NCT00923091|26892748|P5|Period VI (Open-Label)|Withdrawal by Subject|1
7733456|NCT00923091|26892749|P4|Period VI (Open-Label)|Withdrawal by Subject|0
7733457|NCT00923091|26892750|P3|Period VI (Open-Label)|Withdrawal by Subject|5
7733458|NCT00923091|26892751|P2|Period VI (Open-Label)|Withdrawal by Subject|7
7733459|NCT00923091|26892752|P1|Period VI (Open-Label)|Withdrawal by Subject|15
7733460|NCT00923091|26892740|P13|Period VI (Open-Label)|Adverse Event|0
7733461|NCT00923091|26892741|P12|Period VI (Open-Label)|Adverse Event|0
7733462|NCT00923091|26892742|P11|Period VI (Open-Label)|Adverse Event|0
7733463|NCT00923091|26892743|P10|Period VI (Open-Label)|Adverse Event|0
7733464|NCT00923091|26892744|P9|Period VI (Open-Label)|Adverse Event|0
7733465|NCT00923091|26892745|P8|Period VI (Open-Label)|Adverse Event|0
7733466|NCT00923091|26892746|P7|Period VI (Open-Label)|Adverse Event|0
7733467|NCT00923091|26892747|P6|Period VI (Open-Label)|Adverse Event|0
7733468|NCT00923091|26892748|P5|Period VI (Open-Label)|Adverse Event|1
7733469|NCT00923091|26892749|P4|Period VI (Open-Label)|Adverse Event|1
7733470|NCT00923091|26892750|P3|Period VI (Open-Label)|Adverse Event|4
7733471|NCT00923091|26892751|P2|Period VI (Open-Label)|Adverse Event|0
7733472|NCT00923091|26892752|P1|Period VI (Open-Label)|Adverse Event|17
7733473|NCT00923091|26892740|P13|Period V (Double -Blind)|Lost to Follow-up|0
7733474|NCT00923091|26892741|P12|Period V (Double -Blind)|Lost to Follow-up|0
7733475|NCT00923091|26892742|P11|Period V (Double -Blind)|Lost to Follow-up|1
7733476|NCT00923091|26892743|P10|Period V (Double -Blind)|Lost to Follow-up|0
7733477|NCT00923091|26892744|P9|Period V (Double -Blind)|Lost to Follow-up|0
7733478|NCT00923091|26892745|P8|Period V (Double -Blind)|Lost to Follow-up|0
7733479|NCT00923091|26892746|P7|Period V (Double -Blind)|Lost to Follow-up|0
7733480|NCT00923091|26892747|P6|Period V (Double -Blind)|Lost to Follow-up|0
7733481|NCT00923091|26892748|P5|Period V (Double -Blind)|Lost to Follow-up|0
7733482|NCT00923091|26892749|P4|Period V (Double -Blind)|Lost to Follow-up|0
7733483|NCT00923091|26892750|P3|Period V (Double -Blind)|Lost to Follow-up|0
7733484|NCT00923091|26892751|P2|Period V (Double -Blind)|Lost to Follow-up|0
7733485|NCT00923091|26892752|P1|Period V (Double -Blind)|Lost to Follow-up|0
7733486|NCT00923091|26892740|P13|Period V (Double -Blind)|Protocol Violation|1
7733487|NCT00923091|26892741|P12|Period V (Double -Blind)|Protocol Violation|0
7733488|NCT00923091|26892742|P11|Period V (Double -Blind)|Protocol Violation|0
7733489|NCT00923091|26892743|P10|Period V (Double -Blind)|Protocol Violation|0
7733490|NCT00923091|26892744|P9|Period V (Double -Blind)|Protocol Violation|0
7733491|NCT00923091|26892745|P8|Period V (Double -Blind)|Protocol Violation|0
7733492|NCT00923091|26892746|P7|Period V (Double -Blind)|Protocol Violation|0
7733493|NCT00923091|26892747|P6|Period V (Double -Blind)|Protocol Violation|0
7733494|NCT00923091|26892748|P5|Period V (Double -Blind)|Protocol Violation|0
7733495|NCT00923091|26892749|P4|Period V (Double -Blind)|Protocol Violation|0
7733496|NCT00923091|26892750|P3|Period V (Double -Blind)|Protocol Violation|0
7733497|NCT00923091|26892751|P2|Period V (Double -Blind)|Protocol Violation|0
7733498|NCT00923091|26892752|P1|Period V (Double -Blind)|Protocol Violation|0
7733499|NCT00923091|26892740|P13|Period V (Double -Blind)|Withdrawal by Subject|1
7733500|NCT00923091|26892741|P12|Period V (Double -Blind)|Withdrawal by Subject|0
7733501|NCT00923091|26892742|P11|Period V (Double -Blind)|Withdrawal by Subject|0
7733502|NCT00923091|26892743|P10|Period V (Double -Blind)|Withdrawal by Subject|0
7733503|NCT00923091|26892744|P9|Period V (Double -Blind)|Withdrawal by Subject|1
7733504|NCT00923091|26892745|P8|Period V (Double -Blind)|Withdrawal by Subject|0
7733505|NCT00923091|26892746|P7|Period V (Double -Blind)|Withdrawal by Subject|0
7733506|NCT00923091|26892747|P6|Period V (Double -Blind)|Withdrawal by Subject|0
7733507|NCT00923091|26892748|P5|Period V (Double -Blind)|Withdrawal by Subject|0
7733508|NCT00923091|26892749|P4|Period V (Double -Blind)|Withdrawal by Subject|0
7733509|NCT00923091|26892750|P3|Period V (Double -Blind)|Withdrawal by Subject|0
7733510|NCT00923091|26892751|P2|Period V (Double -Blind)|Withdrawal by Subject|0
7733511|NCT00923091|26892752|P1|Period V (Double -Blind)|Withdrawal by Subject|0
7733512|NCT00923091|26892740|P13|Period IV (Double-Blind)|Protocol Violation|0
7733513|NCT00923091|26892741|P12|Period IV (Double-Blind)|Protocol Violation|0
7733514|NCT00923091|26892742|P11|Period IV (Double-Blind)|Protocol Violation|0
7733515|NCT00923091|26892743|P10|Period IV (Double-Blind)|Protocol Violation|0
7733516|NCT00923091|26892744|P9|Period IV (Double-Blind)|Protocol Violation|0
7733517|NCT00923091|26892745|P8|Period IV (Double-Blind)|Protocol Violation|0
7733518|NCT00923091|26892746|P7|Period IV (Double-Blind)|Protocol Violation|0
7733519|NCT00923091|26892747|P6|Period IV (Double-Blind)|Protocol Violation|0
7733520|NCT00923091|26892748|P5|Period IV (Double-Blind)|Protocol Violation|0
7733521|NCT00923091|26892749|P4|Period IV (Double-Blind)|Protocol Violation|0
7733522|NCT00923091|26892750|P3|Period IV (Double-Blind)|Protocol Violation|0
7733523|NCT00923091|26892751|P2|Period IV (Double-Blind)|Protocol Violation|1
7733524|NCT00923091|26892752|P1|Period IV (Double-Blind)|Protocol Violation|0
7733525|NCT00923091|26892740|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
7733526|NCT00923091|26892741|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
7733527|NCT00923091|26892742|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
7733528|NCT00923091|26892743|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
7733529|NCT00923091|26892744|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
7733530|NCT00923091|26892745|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
7733531|NCT00923091|26892746|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
7733532|NCT00923091|26892747|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
7733533|NCT00923091|26892748|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
7733534|NCT00923091|26892749|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
7733535|NCT00923091|26892750|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
7733536|NCT00923091|26892751|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
7733537|NCT00923091|26892752|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
7733538|NCT00923091|26892740|P13|Period IV (Double-Blind)|Adverse Event|0
7733539|NCT00923091|26892741|P12|Period IV (Double-Blind)|Adverse Event|0
7733540|NCT00923091|26892742|P11|Period IV (Double-Blind)|Adverse Event|0
7733541|NCT00923091|26892743|P10|Period IV (Double-Blind)|Adverse Event|0
7733542|NCT00923091|26892744|P9|Period IV (Double-Blind)|Adverse Event|0
7733543|NCT00923091|26892745|P8|Period IV (Double-Blind)|Adverse Event|0
7733544|NCT00923091|26892746|P7|Period IV (Double-Blind)|Adverse Event|0
7733545|NCT00923091|26892747|P6|Period IV (Double-Blind)|Adverse Event|0
7733546|NCT00923091|26892748|P5|Period IV (Double-Blind)|Adverse Event|0
7733547|NCT00923091|26892749|P4|Period IV (Double-Blind)|Adverse Event|0
7733548|NCT00923091|26892750|P3|Period IV (Double-Blind)|Adverse Event|0
7733549|NCT00923091|26892751|P2|Period IV (Double-Blind)|Adverse Event|0
7733550|NCT00923091|26892752|P1|Period IV (Double-Blind)|Adverse Event|2
7733551|NCT00923091|26892740|P13|Period III (Single-Blind)|Lost to Follow-up|0
7733552|NCT00923091|26892741|P12|Period III (Single-Blind)|Lost to Follow-up|0
7733553|NCT00923091|26892742|P11|Period III (Single-Blind)|Lost to Follow-up|0
7733554|NCT00923091|26892743|P10|Period III (Single-Blind)|Lost to Follow-up|0
7733555|NCT00923091|26892744|P9|Period III (Single-Blind)|Lost to Follow-up|0
7733556|NCT00923091|26892745|P8|Period III (Single-Blind)|Lost to Follow-up|0
7733557|NCT00923091|26892746|P7|Period III (Single-Blind)|Lost to Follow-up|0
7733558|NCT00923091|26892747|P6|Period III (Single-Blind)|Lost to Follow-up|0
7733559|NCT00923091|26892748|P5|Period III (Single-Blind)|Lost to Follow-up|0
7733560|NCT00923091|26892749|P4|Period III (Single-Blind)|Lost to Follow-up|0
7733561|NCT00923091|26892750|P3|Period III (Single-Blind)|Lost to Follow-up|0
7733562|NCT00923091|26892751|P2|Period III (Single-Blind)|Lost to Follow-up|0
7733563|NCT00923091|26892752|P1|Period III (Single-Blind)|Lost to Follow-up|2
7733564|NCT00923091|26892740|P13|Period III (Single-Blind)|Protocol Violation|0
7733565|NCT00923091|26892741|P12|Period III (Single-Blind)|Protocol Violation|0
7733566|NCT00923091|26892742|P11|Period III (Single-Blind)|Protocol Violation|0
7733567|NCT00923091|26892743|P10|Period III (Single-Blind)|Protocol Violation|0
7733568|NCT00923091|26892744|P9|Period III (Single-Blind)|Protocol Violation|0
7733569|NCT00923091|26892745|P8|Period III (Single-Blind)|Protocol Violation|0
7733570|NCT00923091|26892746|P7|Period III (Single-Blind)|Protocol Violation|0
7733571|NCT00923091|26892747|P6|Period III (Single-Blind)|Protocol Violation|0
7733572|NCT00923091|26892748|P5|Period III (Single-Blind)|Protocol Violation|0
7733573|NCT00923091|26892749|P4|Period III (Single-Blind)|Protocol Violation|0
7733574|NCT00923091|26892750|P3|Period III (Single-Blind)|Protocol Violation|0
7733575|NCT00923091|26892751|P2|Period III (Single-Blind)|Protocol Violation|0
7733576|NCT00923091|26892752|P1|Period III (Single-Blind)|Protocol Violation|3
7733577|NCT00923091|26892740|P13|Period III (Single-Blind)|Withdrawal by Subject|0
7733578|NCT00923091|26892741|P12|Period III (Single-Blind)|Withdrawal by Subject|0
7733579|NCT00923091|26892742|P11|Period III (Single-Blind)|Withdrawal by Subject|0
7733580|NCT00923091|26892743|P10|Period III (Single-Blind)|Withdrawal by Subject|0
7733581|NCT00923091|26892744|P9|Period III (Single-Blind)|Withdrawal by Subject|0
7733582|NCT00923091|26892745|P8|Period III (Single-Blind)|Withdrawal by Subject|0
7733583|NCT00923091|26892746|P7|Period III (Single-Blind)|Withdrawal by Subject|0
7733584|NCT00923091|26892747|P6|Period III (Single-Blind)|Withdrawal by Subject|0
7733585|NCT00923091|26892748|P5|Period III (Single-Blind)|Withdrawal by Subject|0
7733586|NCT00923091|26892749|P4|Period III (Single-Blind)|Withdrawal by Subject|0
7733587|NCT00923091|26892750|P3|Period III (Single-Blind)|Withdrawal by Subject|0
7733588|NCT00923091|26892751|P2|Period III (Single-Blind)|Withdrawal by Subject|0
7733589|NCT00923091|26892752|P1|Period III (Single-Blind)|Withdrawal by Subject|10
7733590|NCT00923091|26892740|P13|Period III (Single-Blind)|Adverse Event|0
7733591|NCT00923091|26892741|P12|Period III (Single-Blind)|Adverse Event|0
7733592|NCT00923091|26892742|P11|Period III (Single-Blind)|Adverse Event|0
7733593|NCT00923091|26892743|P10|Period III (Single-Blind)|Adverse Event|0
7733594|NCT00923091|26892744|P9|Period III (Single-Blind)|Adverse Event|0
7733595|NCT00923091|26892745|P8|Period III (Single-Blind)|Adverse Event|0
7733596|NCT00923091|26892746|P7|Period III (Single-Blind)|Adverse Event|0
7733597|NCT00923091|26892747|P6|Period III (Single-Blind)|Adverse Event|0
7733598|NCT00923091|26892748|P5|Period III (Single-Blind)|Adverse Event|0
7733599|NCT00923091|26892749|P4|Period III (Single-Blind)|Adverse Event|0
7733600|NCT00923091|26892750|P3|Period III (Single-Blind)|Adverse Event|0
7733601|NCT00923091|26892751|P2|Period III (Single-Blind)|Adverse Event|0
7733602|NCT00923091|26892752|P1|Period III (Single-Blind)|Adverse Event|5
7733603|NCT00923091|26892740|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733604|NCT00923091|26892741|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733605|NCT00923091|26892742|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733606|NCT00923091|26892743|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733607|NCT00923091|26892744|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733608|NCT00923091|26892745|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733609|NCT00923091|26892746|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733610|NCT00923091|26892747|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7733611|NCT00923091|26892748|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733612|NCT00923091|26892749|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7733613|NCT00923091|26892750|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733614|NCT00923091|26892751|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7733615|NCT00923091|26892752|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7733616|NCT00923091|26892740|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733617|NCT00923091|26892741|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733618|NCT00923091|26892742|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733619|NCT00923091|26892743|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733620|NCT00923091|26892744|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733621|NCT00923091|26892745|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733622|NCT00923091|26892746|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733623|NCT00923091|26892747|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
7733624|NCT00923091|26892748|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733625|NCT00923091|26892749|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733626|NCT00923091|26892750|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733627|NCT00923091|26892751|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733628|NCT00923091|26892752|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7733629|NCT00923091|26892740|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7733630|NCT00923091|26892741|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7733631|NCT00923091|26892742|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7733632|NCT00923091|26892743|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7733633|NCT00923091|26892744|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7733634|NCT00923091|26892745|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
7733635|NCT00923091|26892746|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
7733636|NCT00923091|26892747|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
7733637|NCT00923091|26892748|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
7733638|NCT00923091|26892749|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
7733639|NCT00923091|26892750|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7733640|NCT00923091|26892751|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7733641|NCT00923091|26892752|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7733642|NCT00923091|26892740|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7733643|NCT00923091|26892741|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7733644|NCT00923091|26892742|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7733645|NCT00923091|26892743|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7733646|NCT00923091|26892744|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7733647|NCT00923091|26892745|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7733648|NCT00923091|26892746|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7733649|NCT00923091|26892747|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
7733650|NCT00923091|26892748|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
7733651|NCT00923091|26892749|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
7733652|NCT00923091|26892750|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7733653|NCT00923091|26892751|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
7733654|NCT00923091|26892752|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
7733655|NCT00923091|26892740|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7733656|NCT00923091|26892741|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7733657|NCT00923091|26892742|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7733658|NCT00923091|26892743|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7733659|NCT00923091|26892744|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7733660|NCT00923091|26892745|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
7733661|NCT00923091|26892746|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
7733662|NCT00923091|26892747|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
7733663|NCT00923091|26892748|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
7733664|NCT00923091|26892749|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
7733665|NCT00923091|26892750|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
7733666|NCT00923091|26892751|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
7733667|NCT00923091|26892752|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
7733668|NCT00923078|26892802|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
7733669|NCT00923078|26892803|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
7733670|NCT00923078|26892804|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
7733671|NCT00923078|26892802|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
7733672|NCT00923078|26892803|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
7733673|NCT00923078|26892804|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
7733674|NCT00922987|26892823|P1|Overall Study|Adverse Event|1
7733675|NCT00922987|26892823|P1|Overall Study|Protocol Violation|2
7733676|NCT00922987|26892823|P1|Overall Study|Insufficient clinical response|1
7733677|NCT00922974|26892838|P2|Phase III Component|Protocol Violation|6
7733678|NCT00922974|26892839|P1|Phase III Component|Protocol Violation|8
7733679|NCT00922974|26892838|P2|Phase II Component|Not evaluable for treatment review|0
7733680|NCT00922974|26892839|P1|Phase II Component|Not evaluable for treatment review|5
7733681|NCT00922974|26892838|P2|Phase II Component|Protocol Violation|0
7733682|NCT00922974|26892839|P1|Phase II Component|Protocol Violation|2
7733683|NCT00922935|26892868|P3|Overall Study|Lost to Follow-up|0
7733684|NCT00922935|26892869|P2|Overall Study|Lost to Follow-up|1
7733685|NCT00922935|26892870|P1|Overall Study|Lost to Follow-up|0
7733686|NCT00922935|26892868|P3|Overall Study|Physician Decision|0
7733687|NCT00922935|26892869|P2|Overall Study|Physician Decision|1
7733688|NCT00922935|26892870|P1|Overall Study|Physician Decision|1
7733689|NCT00922935|26892868|P3|Overall Study|Protocol Violation|0
7733690|NCT00922935|26892869|P2|Overall Study|Protocol Violation|3
7733691|NCT00922935|26892870|P1|Overall Study|Protocol Violation|0
7733692|NCT00922779|26892882|P1|Overall Study|Missing|1874
7733693|NCT00922779|26892882|P1|Overall Study|Other|27
7733694|NCT00922779|26892882|P1|Overall Study|Lost to Follow-up|44
7733695|NCT00922779|26892882|P1|Overall Study|Withdrawal by Subject|308
7733696|NCT00922779|26892882|P1|Overall Study|Pregnancy|7
7733697|NCT00922779|26892882|P1|Overall Study|Adverse Event|67
7733698|NCT00922766|26892889|P1|Overall Study|Adverse Event|1
7733699|NCT00922766|26892889|P1|Overall Study|Other|1
7733700|NCT00922766|26892889|P1|Overall Study|Withdrawal by Subject|2
7733701|NCT00922766|26892889|P1|Overall Study|Death|3
7733702|NCT00922636|26892907|P5|Overall Study|Lost to Follow-up|4
7733703|NCT00922636|26892908|P4|Overall Study|Lost to Follow-up|2
7733704|NCT00922636|26892909|P3|Overall Study|Lost to Follow-up|2
7733705|NCT00922636|26892910|P2|Overall Study|Lost to Follow-up|2
7733706|NCT00922636|26892911|P1|Overall Study|Lost to Follow-up|1
7733707|NCT00922636|26892907|P5|Overall Study|Parent/Caregiver Decision|2
7733708|NCT00922636|26892908|P4|Overall Study|Parent/Caregiver Decision|5
7733709|NCT00922636|26892909|P3|Overall Study|Parent/Caregiver Decision|3
7733710|NCT00922636|26892910|P2|Overall Study|Parent/Caregiver Decision|4
7733711|NCT00922636|26892911|P1|Overall Study|Parent/Caregiver Decision|2
7733712|NCT00922636|26892907|P5|Overall Study|Entry Criteria Not Met|0
7733713|NCT00922636|26892908|P4|Overall Study|Entry Criteria Not Met|1
7733714|NCT00922636|26892909|P3|Overall Study|Entry Criteria Not Met|1
7733715|NCT00922636|26892910|P2|Overall Study|Entry Criteria Not Met|0
7733716|NCT00922636|26892911|P1|Overall Study|Entry Criteria Not Met|0
7733717|NCT00922636|26892907|P5|Overall Study|Protocol Violation|0
7733718|NCT00922636|26892908|P4|Overall Study|Protocol Violation|2
7733719|NCT00922636|26892909|P3|Overall Study|Protocol Violation|2
7733720|NCT00922636|26892910|P2|Overall Study|Protocol Violation|0
7733721|NCT00922636|26892911|P1|Overall Study|Protocol Violation|0
7733722|NCT00922636|26892907|P5|Overall Study|Withdrawal by Subject|4
7733723|NCT00922636|26892908|P4|Overall Study|Withdrawal by Subject|2
7733724|NCT00922636|26892909|P3|Overall Study|Withdrawal by Subject|5
7733725|NCT00922636|26892910|P2|Overall Study|Withdrawal by Subject|0
7733726|NCT00922636|26892911|P1|Overall Study|Withdrawal by Subject|0
7733727|NCT00922636|26892907|P5|Overall Study|Sponsor Decision|0
7733728|NCT00922636|26892908|P4|Overall Study|Sponsor Decision|0
7733729|NCT00922636|26892909|P3|Overall Study|Sponsor Decision|2
7733730|NCT00922636|26892910|P2|Overall Study|Sponsor Decision|0
7733731|NCT00922636|26892911|P1|Overall Study|Sponsor Decision|0
7733732|NCT00922636|26892907|P5|Overall Study|Lack of Efficacy|4
7733733|NCT00922636|26892908|P4|Overall Study|Lack of Efficacy|2
7733734|NCT00922636|26892909|P3|Overall Study|Lack of Efficacy|3
7733735|NCT00922636|26892910|P2|Overall Study|Lack of Efficacy|7
7733736|NCT00922636|26892911|P1|Overall Study|Lack of Efficacy|1
7733737|NCT00922636|26892907|P5|Overall Study|Adverse Event|2
7733738|NCT00922636|26892908|P4|Overall Study|Adverse Event|3
7733739|NCT00922636|26892909|P3|Overall Study|Adverse Event|2
7733740|NCT00922636|26892910|P2|Overall Study|Adverse Event|3
7733741|NCT00922636|26892911|P1|Overall Study|Adverse Event|3
7733742|NCT00922623|26893058|P1|Overall Study|Lost to Follow-up|1
7733743|NCT00922623|26893058|P1|Overall Study|Other|4
7733744|NCT00922480|26893066|P2|Extension Study|Others|1
7733745|NCT00922480|26893067|P1|Extension Study|Others|0
7733746|NCT00922480|26893066|P2|Extension Study|Withdrawal by Subject|1
7733747|NCT00922480|26893067|P1|Extension Study|Withdrawal by Subject|1
7733748|NCT00922480|26893066|P2|Extension Study|Adverse Event|1
7733749|NCT00922480|26893067|P1|Extension Study|Adverse Event|1
7733750|NCT00922480|26893066|P2|Extension Study|Protocol Violation|0
7733751|NCT00922480|26893067|P1|Extension Study|Protocol Violation|3
7733752|NCT00922480|26893066|P2|Main Study|Physician Decision|1
7733753|NCT00922480|26893067|P1|Main Study|Physician Decision|0
7733754|NCT00922480|26893066|P2|Main Study|Lost to Follow-up|0
7733755|NCT00922480|26893067|P1|Main Study|Lost to Follow-up|5
7733756|NCT00922480|26893066|P2|Main Study|Withdrawal by Subject|15
7733757|NCT00922480|26893067|P1|Main Study|Withdrawal by Subject|20
7733758|NCT00922480|26893066|P2|Main Study|Lack of Efficacy|0
7733759|NCT00922480|26893067|P1|Main Study|Lack of Efficacy|3
7733760|NCT00922480|26893066|P2|Main Study|Adverse Event|7
7733761|NCT00922480|26893067|P1|Main Study|Adverse Event|6
7733762|NCT00922480|26893066|P2|Main Study|Protocol Violation|6
7733763|NCT00922480|26893067|P1|Main Study|Protocol Violation|3
7733764|NCT00922441|26893078|P3|Overall Study|Withdrawal by Subject|1
7733765|NCT00922441|26893079|P2|Overall Study|Withdrawal by Subject|0
7733766|NCT00922441|26893080|P1|Overall Study|Withdrawal by Subject|0
7733767|NCT00922441|26893078|P3|Overall Study|Protocol Violation|2
7733768|NCT00922441|26893079|P2|Overall Study|Protocol Violation|0
7733769|NCT00922441|26893080|P1|Overall Study|Protocol Violation|0
7733770|NCT00922428|26893088|P1|Overall Study|no medication use or questionable use|13
7733771|NCT00922428|26893088|P1|Overall Study|retrospective/extremely implausible data|2
7733772|NCT00922272|26893117|P2|Double-blind Phase|Positive urine drug screen|1
7733773|NCT00922272|26893118|P1|Double-blind Phase|Positive urine drug screen|1
7733774|NCT00922272|26893117|P2|Double-blind Phase|Noncompliance|1
7733775|NCT00922272|26893118|P1|Double-blind Phase|Noncompliance|1
7733776|NCT00922272|26893117|P2|Double-blind Phase|Withdrawal criteria met|1
7733777|NCT00922272|26893118|P1|Double-blind Phase|Withdrawal criteria met|1
7733778|NCT00922272|26893117|P2|Double-blind Phase|Lost to Follow-up|1
7733779|NCT00922272|26893118|P1|Double-blind Phase|Lost to Follow-up|2
7733780|NCT00922272|26893117|P2|Double-blind Phase|Withdrawal by Subject|1
7733781|NCT00922272|26893118|P1|Double-blind Phase|Withdrawal by Subject|1
7733782|NCT00922272|26893117|P2|Double-blind Phase|Adverse Event|1
7733783|NCT00922272|26893118|P1|Double-blind Phase|Adverse Event|1
7733784|NCT00922272|26893117|P2|Open-label Phase|Withdrawal criteria met|0
7733785|NCT00922272|26893118|P1|Open-label Phase|Withdrawal criteria met|5
7733786|NCT00922272|26893117|P2|Open-label Phase|Failure to meet randomization criteria|0
7733787|NCT00922272|26893118|P1|Open-label Phase|Failure to meet randomization criteria|1
7733788|NCT00922272|26893117|P2|Open-label Phase|Withdrawal by Subject|0
7733789|NCT00922272|26893118|P1|Open-label Phase|Withdrawal by Subject|11
7733790|NCT00922272|26893117|P2|Open-label Phase|Protocol Violation|0
7733791|NCT00922272|26893118|P1|Open-label Phase|Protocol Violation|1
7733792|NCT00922272|26893117|P2|Open-label Phase|Adverse Event|0
7733793|NCT00922272|26893118|P1|Open-label Phase|Adverse Event|5
7733794|NCT00922207|26893183|P3|Overall Study|Abnormality of Laboratory Test|1
7733795|NCT00922207|26893184|P2|Overall Study|Abnormality of Laboratory Test|1
7733796|NCT00922207|26893185|P1|Overall Study|Abnormality of Laboratory Test|0
7733797|NCT00922207|26893183|P3|Overall Study|Withdrew Consent|2
7733798|NCT00922207|26893184|P2|Overall Study|Withdrew Consent|5
7733799|NCT00922207|26893185|P1|Overall Study|Withdrew Consent|2
7733800|NCT00922207|26893183|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
7733801|NCT00922207|26893184|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
7733802|NCT00922207|26893185|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
7733803|NCT00922207|26893183|P3|Overall Study|Violation of Selection Criteria at Entry|0
7733804|NCT00922207|26893184|P2|Overall Study|Violation of Selection Criteria at Entry|1
7733805|NCT00922207|26893185|P1|Overall Study|Violation of Selection Criteria at Entry|0
7733806|NCT00922207|26893183|P3|Overall Study|Insufficient Therapeutic Response|1
7733807|NCT00922207|26893184|P2|Overall Study|Insufficient Therapeutic Response|0
7733808|NCT00922207|26893185|P1|Overall Study|Insufficient Therapeutic Response|0
7733809|NCT00922207|26893183|P3|Overall Study|Adverse Event/Intercurrent Illness|0
7733810|NCT00922207|26893184|P2|Overall Study|Adverse Event/Intercurrent Illness|0
7733811|NCT00922207|26893185|P1|Overall Study|Adverse Event/Intercurrent Illness|3
7733812|NCT00922116|26893221|P1|Overall Study|Other|5
7733813|NCT00922116|26893221|P1|Overall Study|Withdrawal by Subject|4
7733814|NCT00922116|26893221|P1|Overall Study|Lost to Follow-up|1
7733815|NCT00922116|26893221|P1|Overall Study|Death|1
7733816|NCT00922116|26893221|P1|Overall Study|Adverse Event|4
7733817|NCT00921557|26893283|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
7733818|NCT00921557|26893284|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
7733819|NCT00921557|26893285|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
7733820|NCT00921557|26893283|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
7733821|NCT00921557|26893284|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
7733822|NCT00921557|26893285|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
7733823|NCT00921557|26893283|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
7733824|NCT00921557|26893284|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
7733825|NCT00921557|26893285|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
7733826|NCT00921557|26893283|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
7733827|NCT00921557|26893284|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
7733828|NCT00921557|26893285|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
7733829|NCT00921557|26893283|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
7733830|NCT00921557|26893284|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
7733831|NCT00921557|26893285|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
7733832|NCT00921024|26893387|P2|Overall Study|Withdrawal by Subject|3
7733833|NCT00921024|26893388|P1|Overall Study|Withdrawal by Subject|0
7733834|NCT00921024|26893387|P2|Overall Study|Received concomittant therapy|0
7733835|NCT00921024|26893388|P1|Overall Study|Received concomittant therapy|2
7733836|NCT00921024|26893387|P2|Overall Study|Lost to Follow-up|0
7733837|NCT00921024|26893388|P1|Overall Study|Lost to Follow-up|2
7733838|NCT00920907|26893398|P2|Maintenance Period|Adverse Event|1
7733839|NCT00920907|26893399|P1|Maintenance Period|Adverse Event|0
7733840|NCT00920907|26893398|P2|Maintenance Period|Withdrawal by Subject|0
7733841|NCT00920907|26893399|P1|Maintenance Period|Withdrawal by Subject|1
7733842|NCT00920907|26893398|P2|Maintenance Period|Death|1
7733843|NCT00920907|26893399|P1|Maintenance Period|Death|1
7733844|NCT00920907|26893398|P2|Maintenance Period|Study Drug Toxicity|2
7733845|NCT00920907|26893399|P1|Maintenance Period|Study Drug Toxicity|0
7733846|NCT00920907|26893398|P2|Maintenance Period|Administrative (study closure)|2
7733847|NCT00920907|26893399|P1|Maintenance Period|Administrative (study closure)|7
7733848|NCT00920907|26893398|P2|Maintenance Period|Disease Progression|7
7733849|NCT00920907|26893399|P1|Maintenance Period|Disease Progression|3
7733850|NCT00920907|26893398|P2|Induction Period|Withdrawal by Subject|1
7733851|NCT00920907|26893399|P1|Induction Period|Withdrawal by Subject|1
7733852|NCT00920907|26893398|P2|Induction Period|No longer meets study criteria|1
7733853|NCT00920907|26893399|P1|Induction Period|No longer meets study criteria|0
7733854|NCT00920907|26893398|P2|Induction Period|Study Drug Toxicity|6
7733855|NCT00920907|26893399|P1|Induction Period|Study Drug Toxicity|8
7733856|NCT00920907|26893398|P2|Induction Period|Disease Progression|11
7733857|NCT00920907|26893399|P1|Induction Period|Disease Progression|12
7733858|NCT00920907|26893398|P2|Induction Period|Death|1
7733859|NCT00920907|26893399|P1|Induction Period|Death|1
7733860|NCT00920907|26893398|P2|Induction Period|Adverse Event|2
7733861|NCT00920907|26893399|P1|Induction Period|Adverse Event|0
7733862|NCT00920855|26893440|P3|Overall Study|Response plateau; started maintenance|1
7733863|NCT00920855|26893441|P2|Overall Study|Response plateau; started maintenance|0
7733864|NCT00920855|26893442|P1|Overall Study|Response plateau; started maintenance|0
7733865|NCT00920855|26893440|P3|Overall Study|Noncompliance to study medication|1
7733866|NCT00920855|26893441|P2|Overall Study|Noncompliance to study medication|0
7733867|NCT00920855|26893442|P1|Overall Study|Noncompliance to study medication|0
7733868|NCT00920855|26893440|P3|Overall Study|Disease progression|10
7733869|NCT00920855|26893441|P2|Overall Study|Disease progression|1
7733870|NCT00920855|26893442|P1|Overall Study|Disease progression|2
7733871|NCT00920855|26893440|P3|Overall Study|Withdrawal by Subject|6
7733872|NCT00920855|26893441|P2|Overall Study|Withdrawal by Subject|1
7733873|NCT00920855|26893442|P1|Overall Study|Withdrawal by Subject|2
7733874|NCT00920855|26893440|P3|Overall Study|Adverse Event|4
7733875|NCT00920855|26893441|P2|Overall Study|Adverse Event|1
7733876|NCT00920855|26893442|P1|Overall Study|Adverse Event|1
7733877|NCT00920829|26893468|P4|Available for Analysis|Required more treatment|1
7733878|NCT00920829|26893469|P3|Available for Analysis|Required more treatment|0
7733879|NCT00920829|26893470|P2|Available for Analysis|Required more treatment|2
7733880|NCT00920829|26893471|P1|Available for Analysis|Required more treatment|0
7733881|NCT00920829|26893468|P4|Available for Analysis|Protocol Violation|0
7733882|NCT00920829|26893469|P3|Available for Analysis|Protocol Violation|1
7733883|NCT00920829|26893470|P2|Available for Analysis|Protocol Violation|0
7733884|NCT00920829|26893471|P1|Available for Analysis|Protocol Violation|0
7733885|NCT00920829|26893468|P4|Available for Analysis|Death|0
7733886|NCT00920829|26893469|P3|Available for Analysis|Death|0
7733887|NCT00920829|26893470|P2|Available for Analysis|Death|0
7733888|NCT00920829|26893471|P1|Available for Analysis|Death|1
7733889|NCT00920829|26893468|P4|Available for Analysis|Adverse Event|0
7733890|NCT00920829|26893469|P3|Available for Analysis|Adverse Event|1
7733891|NCT00920829|26893470|P2|Available for Analysis|Adverse Event|2
7733892|NCT00920829|26893471|P1|Available for Analysis|Adverse Event|1
7733893|NCT00920829|26893468|P4|Available for Analysis|Required Medical Treatment|0
7733894|NCT00920829|26893469|P3|Available for Analysis|Required Medical Treatment|2
7733895|NCT00920829|26893470|P2|Available for Analysis|Required Medical Treatment|1
7733896|NCT00920829|26893471|P1|Available for Analysis|Required Medical Treatment|0
7733897|NCT00920829|26893468|P4|Available for Analysis|Withdrawal by Subject|10
7733898|NCT00920829|26893469|P3|Available for Analysis|Withdrawal by Subject|6
7733899|NCT00920829|26893470|P2|Available for Analysis|Withdrawal by Subject|6
7733900|NCT00920829|26893471|P1|Available for Analysis|Withdrawal by Subject|6
7733901|NCT00920829|26893468|P4|Allocation|No post randomization data|2
7733902|NCT00920829|26893469|P3|Allocation|No post randomization data|0
7733903|NCT00920829|26893470|P2|Allocation|No post randomization data|1
7733904|NCT00920829|26893471|P1|Allocation|No post randomization data|3
7733905|NCT00920816|26893485|P4|Overall Study|Ongoing|36
7733906|NCT00920816|26893486|P3|Overall Study|Ongoing|70
7733907|NCT00920816|26893487|P2|Overall Study|Ongoing|56
7733908|NCT00920816|26893488|P1|Overall Study|Ongoing|106
7733909|NCT00920816|26893485|P4|Overall Study|Withdrawal by Subject|1
7733910|NCT00920816|26893486|P3|Overall Study|Withdrawal by Subject|1
7733911|NCT00920816|26893487|P2|Overall Study|Withdrawal by Subject|2
7733912|NCT00920816|26893488|P1|Overall Study|Withdrawal by Subject|7
7733913|NCT00920816|26893485|P4|Overall Study|Objective progression or relapse|0
7733914|NCT00920816|26893486|P3|Overall Study|Objective progression or relapse|2
7733915|NCT00920816|26893487|P2|Overall Study|Objective progression or relapse|0
7733916|NCT00920816|26893488|P1|Overall Study|Objective progression or relapse|0
7733917|NCT00920816|26893485|P4|Overall Study|Lost to Follow-up|4
7733918|NCT00920816|26893486|P3|Overall Study|Lost to Follow-up|3
7733919|NCT00920816|26893487|P2|Overall Study|Lost to Follow-up|2
7733920|NCT00920816|26893488|P1|Overall Study|Lost to Follow-up|1
7733921|NCT00920816|26893485|P4|Overall Study|Adverse Event|0
7733922|NCT00920816|26893486|P3|Overall Study|Adverse Event|1
7733923|NCT00920816|26893487|P2|Overall Study|Adverse Event|0
7733924|NCT00920816|26893488|P1|Overall Study|Adverse Event|1
7733925|NCT00920816|26893485|P4|Overall Study|Death|28
7733926|NCT00920816|26893486|P3|Overall Study|Death|58
7733927|NCT00920816|26893487|P2|Overall Study|Death|36
7733928|NCT00920816|26893488|P1|Overall Study|Death|77
7733929|NCT00920790|26893526|P1|Overall Study|aggravation of general condition|14
7733930|NCT00920699|26893538|P3|Overall Study|Lost to Follow-up|2
7733931|NCT00920699|26893539|P2|Overall Study|Lost to Follow-up|0
7733932|NCT00920699|26893540|P1|Overall Study|Lost to Follow-up|0
7733933|NCT00920699|26893538|P3|Overall Study|no longer met eligibility|0
7733934|NCT00920699|26893539|P2|Overall Study|no longer met eligibility|1
7733935|NCT00920699|26893540|P1|Overall Study|no longer met eligibility|0
7733936|NCT00920699|26893538|P3|Overall Study|Withdrawal by Subject|2
7733937|NCT00920699|26893539|P2|Overall Study|Withdrawal by Subject|0
7733938|NCT00920699|26893540|P1|Overall Study|Withdrawal by Subject|2
7733939|NCT00920686|26893557|P3|Overall Study|Study drug dosing criteria not met|12
7733940|NCT00920686|26893558|P2|Overall Study|Study drug dosing criteria not met|19
7733941|NCT00920686|26893559|P1|Overall Study|Study drug dosing criteria not met|17
7733942|NCT00920686|26893557|P3|Overall Study|Lost to Follow-up|1
7733943|NCT00920686|26893558|P2|Overall Study|Lost to Follow-up|3
7733944|NCT00920686|26893559|P1|Overall Study|Lost to Follow-up|2
7733945|NCT00920621|26893638|P4|Overall Study|Blood sample not collected|0
7733946|NCT00920621|26893639|P3|Overall Study|Blood sample not collected|0
7733947|NCT00920621|26893640|P2|Overall Study|Blood sample not collected|14
7733948|NCT00920621|26893641|P1|Overall Study|Blood sample not collected|22
7733949|NCT00920621|26893638|P4|Overall Study|Fetal/neonatal deaths|14
7733950|NCT00920621|26893639|P3|Overall Study|Fetal/neonatal deaths|16
7733951|NCT00920621|26893640|P2|Overall Study|Fetal/neonatal deaths|14
7733952|NCT00920621|26893641|P1|Overall Study|Fetal/neonatal deaths|16
7733953|NCT00920621|26893638|P4|Overall Study|Lost to Follow-up|21
7733954|NCT00920621|26893639|P3|Overall Study|Lost to Follow-up|19
7733955|NCT00920621|26893640|P2|Overall Study|Lost to Follow-up|17
7733956|NCT00920621|26893641|P1|Overall Study|Lost to Follow-up|16
7733957|NCT00920556|26893671|P1|Overall Study|Withdrawal by Subject|1
7733958|NCT00920556|26893671|P1|Overall Study|Physician Decision|7
7733959|NCT00920556|26893671|P1|Overall Study|Adverse Event|16
7733960|NCT00920426|26893720|P4|ITZ111451|Adverse Event|0
7733961|NCT00920426|26893721|P3|ITZ111451|Adverse Event|0
7733962|NCT00920426|26893722|P2|ITZ111451|Adverse Event|0
7733963|NCT00920426|26893723|P1|ITZ111451|Adverse Event|1
7733964|NCT00920218|26893843|P4|Overall Study|Other|0
7733965|NCT00920218|26893844|P3|Overall Study|Other|1
7733966|NCT00920218|26893845|P2|Overall Study|Other|0
7733967|NCT00920218|26893846|P1|Overall Study|Other|0
7733968|NCT00920218|26893843|P4|Overall Study|Transplant failed/malignancy recurrence|3
7733969|NCT00920218|26893844|P3|Overall Study|Transplant failed/malignancy recurrence|2
7733970|NCT00920218|26893845|P2|Overall Study|Transplant failed/malignancy recurrence|1
7733971|NCT00920218|26893846|P1|Overall Study|Transplant failed/malignancy recurrence|0
7733972|NCT00920218|26893843|P4|Overall Study|Lost to Follow-up|3
7733973|NCT00920218|26893844|P3|Overall Study|Lost to Follow-up|0
7733974|NCT00920218|26893845|P2|Overall Study|Lost to Follow-up|1
7733975|NCT00920218|26893846|P1|Overall Study|Lost to Follow-up|0
7733976|NCT00920218|26893843|P4|Overall Study|Migrated/moved from study area|0
7733977|NCT00920218|26893844|P3|Overall Study|Migrated/moved from study area|1
7733978|NCT00920218|26893845|P2|Overall Study|Migrated/moved from study area|0
7733979|NCT00920218|26893846|P1|Overall Study|Migrated/moved from study area|0
7733980|NCT00920218|26893843|P4|Overall Study|Withdrawal by Subject|0
7733981|NCT00920218|26893844|P3|Overall Study|Withdrawal by Subject|2
7733982|NCT00920218|26893845|P2|Overall Study|Withdrawal by Subject|3
7733983|NCT00920218|26893846|P1|Overall Study|Withdrawal by Subject|0
7733984|NCT00920218|26893843|P4|Overall Study|Serious Adverse Event|1
7733985|NCT00920218|26893844|P3|Overall Study|Serious Adverse Event|2
7733986|NCT00920218|26893845|P2|Overall Study|Serious Adverse Event|0
7733987|NCT00920218|26893846|P1|Overall Study|Serious Adverse Event|2
7733988|NCT00920140|26893949|P5|Phase 2|Withdrawal by Subject|1
7733989|NCT00920140|26893950|P4|Phase 2|Withdrawal by Subject|2
7733990|NCT00920140|26893951|P3|Phase 2|Withdrawal by Subject|4
7733991|NCT00920140|26893952|P2|Phase 2|Withdrawal by Subject|0
7733992|NCT00920140|26893953|P1|Phase 2|Withdrawal by Subject|0
7733993|NCT00920140|26893949|P5|Phase 2|Physician Decision|2
7733994|NCT00920140|26893950|P4|Phase 2|Physician Decision|3
7733995|NCT00920140|26893951|P3|Phase 2|Physician Decision|3
7733996|NCT00920140|26893952|P2|Phase 2|Physician Decision|0
7733997|NCT00920140|26893953|P1|Phase 2|Physician Decision|0
7733998|NCT00920140|26893949|P5|Phase 2|Lost to Follow-up|0
7733999|NCT00920140|26893950|P4|Phase 2|Lost to Follow-up|1
7734000|NCT00920140|26893951|P3|Phase 2|Lost to Follow-up|0
7734001|NCT00920140|26893952|P2|Phase 2|Lost to Follow-up|0
7734002|NCT00920140|26893953|P1|Phase 2|Lost to Follow-up|0
7734003|NCT00920140|26893949|P5|Phase 2|Lack of Efficacy|5
7734004|NCT00920140|26893950|P4|Phase 2|Lack of Efficacy|14
7734005|NCT00920140|26893951|P3|Phase 2|Lack of Efficacy|29
7734006|NCT00920140|26893952|P2|Phase 2|Lack of Efficacy|0
7734007|NCT00920140|26893953|P1|Phase 2|Lack of Efficacy|0
7734008|NCT00920140|26893949|P5|Phase 2|Adverse Event|3
7734009|NCT00920140|26893950|P4|Phase 2|Adverse Event|2
7734010|NCT00920140|26893951|P3|Phase 2|Adverse Event|14
7734011|NCT00920140|26893952|P2|Phase 2|Adverse Event|0
7734012|NCT00920140|26893953|P1|Phase 2|Adverse Event|0
7734013|NCT00920140|26893949|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7734014|NCT00920140|26893950|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7734015|NCT00920140|26893951|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7734016|NCT00920140|26893952|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
7734017|NCT00920140|26893953|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7734018|NCT00920140|26893949|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7734019|NCT00920140|26893950|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7734020|NCT00920140|26893951|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7734021|NCT00920140|26893952|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
7734022|NCT00920140|26893953|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
7734023|NCT00920140|26893949|P5|Phase 1 (Dose Escalation)|Adverse Event|0
7734024|NCT00920140|26893950|P4|Phase 1 (Dose Escalation)|Adverse Event|0
7734025|NCT00920140|26893951|P3|Phase 1 (Dose Escalation)|Adverse Event|0
7734026|NCT00920140|26893952|P2|Phase 1 (Dose Escalation)|Adverse Event|3
7734027|NCT00920140|26893953|P1|Phase 1 (Dose Escalation)|Adverse Event|3
7734028|NCT00919893|26894015|P2|Overall Study|Protocol Violation|9
7734029|NCT00919893|26894016|P1|Overall Study|Protocol Violation|19
7734030|NCT00919867|26894028|P6|First Intervention|Physician Decision|1
7734031|NCT00919867|26894029|P5|First Intervention|Physician Decision|0
7734032|NCT00919867|26894030|P4|First Intervention|Physician Decision|0
7734033|NCT00919867|26894031|P3|First Intervention|Physician Decision|0
7734034|NCT00919867|26894032|P2|First Intervention|Physician Decision|0
7734035|NCT00919867|26894033|P1|First Intervention|Physician Decision|0
7734036|NCT00919867|26894028|P6|First Intervention|Withdrawal by Subject|0
7734037|NCT00919867|26894029|P5|First Intervention|Withdrawal by Subject|0
7734038|NCT00919867|26894030|P4|First Intervention|Withdrawal by Subject|0
7734039|NCT00919867|26894031|P3|First Intervention|Withdrawal by Subject|1
7734040|NCT00919867|26894032|P2|First Intervention|Withdrawal by Subject|0
7734041|NCT00919867|26894033|P1|First Intervention|Withdrawal by Subject|0
7734042|NCT00919854|26894054|P1|Overall Study|Adverse Event|1
7734043|NCT00919711|26894092|P2|Overall Study|Noncompliance|0
7734044|NCT00919711|26894093|P1|Overall Study|Noncompliance|1
7734045|NCT00919711|26894092|P2|Overall Study|Death|0
7734046|NCT00919711|26894093|P1|Overall Study|Death|1
7734047|NCT00919711|26894092|P2|Overall Study|Lost to Follow-up|0
7734048|NCT00919711|26894093|P1|Overall Study|Lost to Follow-up|2
7734049|NCT00919711|26894092|P2|Overall Study|Administrative Decision|1
7734050|NCT00919711|26894093|P1|Overall Study|Administrative Decision|0
7734051|NCT00919711|26894092|P2|Overall Study|Other|2
7734052|NCT00919711|26894093|P1|Overall Study|Other|1
7734053|NCT00919711|26894092|P2|Overall Study|Adverse Event|3
7734054|NCT00919711|26894093|P1|Overall Study|Adverse Event|13
7734055|NCT00919711|26894092|P2|Overall Study|Withdrawal by Subject|7
7734056|NCT00919711|26894093|P1|Overall Study|Withdrawal by Subject|15
7734057|NCT00919633|26894109|P4|Overall Study|Viral rebound outside protocol timepoint|0
7734058|NCT00919633|26894110|P3|Overall Study|Viral rebound outside protocol timepoint|1
7734059|NCT00919633|26894111|P2|Overall Study|Viral rebound outside protocol timepoint|0
7734060|NCT00919633|26894112|P1|Overall Study|Viral rebound outside protocol timepoint|0
7734061|NCT00919633|26894109|P4|Overall Study|Request of withdrawal w/o future contact|0
7734062|NCT00919633|26894110|P3|Overall Study|Request of withdrawal w/o future contact|1
7734063|NCT00919633|26894111|P2|Overall Study|Request of withdrawal w/o future contact|0
7734064|NCT00919633|26894112|P1|Overall Study|Request of withdrawal w/o future contact|0
7734065|NCT00919633|26894109|P4|Overall Study|Physician Decision|1
7734066|NCT00919633|26894110|P3|Overall Study|Physician Decision|0
7734067|NCT00919633|26894111|P2|Overall Study|Physician Decision|0
7734068|NCT00919633|26894112|P1|Overall Study|Physician Decision|0
7734069|NCT00919633|26894109|P4|Overall Study|Protocol Violation|1
7734070|NCT00919633|26894110|P3|Overall Study|Protocol Violation|0
7734071|NCT00919633|26894111|P2|Overall Study|Protocol Violation|0
7734072|NCT00919633|26894112|P1|Overall Study|Protocol Violation|0
7734073|NCT00919633|26894109|P4|Overall Study|Withdraw consent post transition to SOC|1
7734074|NCT00919633|26894110|P3|Overall Study|Withdraw consent post transition to SOC|1
7734075|NCT00919633|26894111|P2|Overall Study|Withdraw consent post transition to SOC|0
7734076|NCT00919633|26894112|P1|Overall Study|Withdraw consent post transition to SOC|0
7734077|NCT00919633|26894109|P4|Overall Study|Lost to Follow-up|2
7734078|NCT00919633|26894110|P3|Overall Study|Lost to Follow-up|0
7734079|NCT00919633|26894111|P2|Overall Study|Lost to Follow-up|1
7734080|NCT00919633|26894112|P1|Overall Study|Lost to Follow-up|3
7734081|NCT00919633|26894109|P4|Overall Study|Withdrawal by Subject|3
7734082|NCT00919633|26894110|P3|Overall Study|Withdrawal by Subject|4
7734083|NCT00919633|26894111|P2|Overall Study|Withdrawal by Subject|2
7734084|NCT00919633|26894112|P1|Overall Study|Withdrawal by Subject|1
7734085|NCT00919633|26894109|P4|Overall Study|Lack of Efficacy|3
7734086|NCT00919633|26894110|P3|Overall Study|Lack of Efficacy|2
7734087|NCT00919633|26894111|P2|Overall Study|Lack of Efficacy|3
7734088|NCT00919633|26894112|P1|Overall Study|Lack of Efficacy|17
7734089|NCT00919633|26894109|P4|Overall Study|Death|0
7734090|NCT00919633|26894110|P3|Overall Study|Death|2
7734091|NCT00919633|26894111|P2|Overall Study|Death|0
7734092|NCT00919633|26894112|P1|Overall Study|Death|0
7734093|NCT00919633|26894109|P4|Overall Study|Adverse Event|10
7734094|NCT00919633|26894110|P3|Overall Study|Adverse Event|12
7734095|NCT00919633|26894111|P2|Overall Study|Adverse Event|9
7734096|NCT00919633|26894112|P1|Overall Study|Adverse Event|1
7734097|NCT00919061|26894237|P1|Overall Study|Withdrawal by Subject|1
7734098|NCT00919061|26894237|P1|Overall Study|Adverse Event|1
7734099|NCT00918957|26894250|P2|Overall Study|Withdrawal by Subject|0
7734100|NCT00918957|26894251|P1|Overall Study|Withdrawal by Subject|1
7734101|NCT00918957|26894250|P2|Overall Study|Adverse Event|0
7734102|NCT00918957|26894251|P1|Overall Study|Adverse Event|2
7734103|NCT00918879|26894284|P2|Overall Study|Severe non-compliance to protocol|1
7734104|NCT00918879|26894285|P1|Overall Study|Severe non-compliance to protocol|1
7734105|NCT00918879|26894284|P2|Overall Study|Lost to Follow-up|1
7734106|NCT00918879|26894285|P1|Overall Study|Lost to Follow-up|1
7734107|NCT00918879|26894284|P2|Overall Study|Withdrawal by Subject|4
7734108|NCT00918879|26894285|P1|Overall Study|Withdrawal by Subject|4
7734109|NCT00918749|26894317|P3|Overall Study|No Study Medication Taken|0
7734110|NCT00918749|26894318|P2|Overall Study|No Study Medication Taken|0
7734111|NCT00918749|26894319|P1|Overall Study|No Study Medication Taken|1
7734112|NCT00918749|26894317|P3|Overall Study|Withdrawal by Subject|5
7734113|NCT00918749|26894318|P2|Overall Study|Withdrawal by Subject|3
7734114|NCT00918749|26894319|P1|Overall Study|Withdrawal by Subject|5
7734115|NCT00918749|26894317|P3|Overall Study|Lost to Follow-up|1
7734116|NCT00918749|26894318|P2|Overall Study|Lost to Follow-up|0
7734117|NCT00918749|26894319|P1|Overall Study|Lost to Follow-up|0
7734118|NCT00918749|26894317|P3|Overall Study|Adverse Event|1
7734119|NCT00918749|26894318|P2|Overall Study|Adverse Event|0
7734120|NCT00918749|26894319|P1|Overall Study|Adverse Event|1
7734121|NCT00918736|26894351|P1|Overall Study|Withdrawal by Subject|4
7734122|NCT00918684|26894364|P1|Treatment Phase|Withdrawal by Subject|8
7734123|NCT00918684|26894364|P1|Treatment Phase|Protocol Violation|1
7734124|NCT00918684|26894364|P1|Treatment Phase|Physician Decision|8
7734125|NCT00918684|26894364|P1|Treatment Phase|Lost to Follow-up|2
7734126|NCT00918684|26894364|P1|Treatment Phase|Lack of Efficacy|6
7734127|NCT00918684|26894364|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
7734128|NCT00918645|26894375|P1|Overall Study|Withdrawal by Subject|1
7734129|NCT00918580|26894381|P1|After 6-month FU to 1-year FU|Failed to Return|2
7734130|NCT00918580|26894381|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
7734131|NCT00918580|26894381|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
7734132|NCT00918580|26894381|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
7734133|NCT00918580|26894381|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
7734134|NCT00918580|26894381|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
7734135|NCT00918580|26894381|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
7734136|NCT00918567|26894401|P2|Overall Study|Adverse Event|0
7734137|NCT00918567|26894402|P1|Overall Study|Adverse Event|1
7734138|NCT00918567|26894401|P2|Overall Study|Withdrawal by Subject|1
7734139|NCT00918567|26894402|P1|Overall Study|Withdrawal by Subject|1
7734140|NCT00918567|26894401|P2|Overall Study|Lack of Efficacy|1
7734141|NCT00918567|26894402|P1|Overall Study|Lack of Efficacy|3
7734142|NCT00918463|26894428|P1|Overall Study|Lack of Efficacy|1
7734143|NCT00918463|26894428|P1|Overall Study|Death|1
7734144|NCT00918385|26894436|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
7734145|NCT00918385|26894437|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
7734146|NCT00918385|26894436|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
7734147|NCT00918385|26894437|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
7734148|NCT00918385|26894436|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
7734149|NCT00918385|26894437|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
7734150|NCT00918385|26894436|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
7734151|NCT00918385|26894437|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
7734152|NCT00918385|26894436|P2|Monotherapy|Complicating illness|0
7734153|NCT00918385|26894437|P1|Monotherapy|Complicating illness|1
7734154|NCT00918385|26894436|P2|Monotherapy|Adverse Event|6
7734155|NCT00918385|26894437|P1|Monotherapy|Adverse Event|1
7734156|NCT00918346|26894446|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
7734157|NCT00918346|26894447|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
7734158|NCT00918333|26894463|P2|Overall Study|Withdrawal by Subject|1
7734159|NCT00918333|26894464|P1|Overall Study|Withdrawal by Subject|0
7734160|NCT00918333|26894463|P2|Overall Study|Ineligible|0
7734161|NCT00918333|26894464|P1|Overall Study|Ineligible|1
7734162|NCT00918333|26894463|P2|Overall Study|Inadequate amount of drugs provided|4
7734163|NCT00918333|26894464|P1|Overall Study|Inadequate amount of drugs provided|1
7734164|NCT00918333|26894463|P2|Overall Study|Drug not taken per protocol|0
7734165|NCT00918333|26894464|P1|Overall Study|Drug not taken per protocol|1
7734166|NCT00918281|26894484|P1|Overall Study|Physician Decision|29
7734167|NCT00918255|26894494|P3|Overall Study|Investigator discretion|0
7734168|NCT00918255|26894495|P2|Overall Study|Investigator discretion|0
7734169|NCT00918255|26894496|P1|Overall Study|Investigator discretion|1
7734170|NCT00918255|26894494|P3|Overall Study|Non-compliance|0
7734171|NCT00918255|26894495|P2|Overall Study|Non-compliance|0
7734172|NCT00918255|26894496|P1|Overall Study|Non-compliance|1
7734173|NCT00918255|26894494|P3|Overall Study|Exceeded allowed number of interventions|1
7734174|NCT00918255|26894495|P2|Overall Study|Exceeded allowed number of interventions|0
7734175|NCT00918255|26894496|P1|Overall Study|Exceeded allowed number of interventions|0
7734176|NCT00918255|26894494|P3|Overall Study|Lost to Follow-up|2
7734177|NCT00918255|26894495|P2|Overall Study|Lost to Follow-up|0
7734178|NCT00918255|26894496|P1|Overall Study|Lost to Follow-up|1
7734179|NCT00918255|26894494|P3|Overall Study|Lack of Efficacy|0
7734180|NCT00918255|26894495|P2|Overall Study|Lack of Efficacy|0
7734181|NCT00918255|26894496|P1|Overall Study|Lack of Efficacy|1
7734182|NCT00918255|26894494|P3|Overall Study|Withdrawal by Subject|2
7734183|NCT00918255|26894495|P2|Overall Study|Withdrawal by Subject|0
7734184|NCT00918255|26894496|P1|Overall Study|Withdrawal by Subject|1
7734185|NCT00918255|26894494|P3|Overall Study|Adverse Event|0
7734186|NCT00918255|26894495|P2|Overall Study|Adverse Event|0
7734187|NCT00918255|26894496|P1|Overall Study|Adverse Event|1
7734188|NCT00918203|26894529|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
7734189|NCT00918203|26894530|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
7734190|NCT00918203|26894531|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
7734191|NCT00918203|26894529|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
7734192|NCT00918203|26894530|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
7734193|NCT00918203|26894531|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
7734194|NCT00918203|26894529|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
7734195|NCT00918203|26894530|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
7734196|NCT00918203|26894531|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
7734197|NCT00918203|26894529|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
7734198|NCT00918203|26894530|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
7734199|NCT00918203|26894531|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
7734200|NCT00918138|26894562|P2|Overall Study|Death|0
7734201|NCT00918138|26894563|P1|Overall Study|Death|1
7734202|NCT00918138|26894562|P2|Overall Study|Subject withdrew consent|1
7734203|NCT00918138|26894563|P1|Overall Study|Subject withdrew consent|1
7734204|NCT00917852|26894602|P1|Overall Study|Death|6
7734205|NCT00917644|26894620|P2|Period 2: Second Intervention|family emergency|0
7734206|NCT00917644|26894621|P1|Period 2: Second Intervention|family emergency|1
7734207|NCT00917644|26894620|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
7734208|NCT00917644|26894621|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
7734209|NCT00917644|26894620|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
7734210|NCT00917644|26894621|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
7734211|NCT00917579|26894635|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
7734212|NCT00917579|26894636|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
7734213|NCT00917579|26894635|P2|Washout >= 2 Weeks|Adverse Event|0
7734214|NCT00917579|26894636|P1|Washout >= 2 Weeks|Adverse Event|1
7734215|NCT00917553|26894652|P2|Overall Study|Lost to Follow-up|1
7734216|NCT00917553|26894653|P1|Overall Study|Lost to Follow-up|2
7734217|NCT00917501|26894669|P2|Overall Study|trouble swollowing capsules|1
7734218|NCT00917501|26894670|P1|Overall Study|trouble swollowing capsules|0
7734219|NCT00917501|26894669|P2|Overall Study|Lack of Efficacy|2
7734220|NCT00917501|26894670|P1|Overall Study|Lack of Efficacy|1
7734221|NCT00917501|26894669|P2|Overall Study|Withdrawal by Subject|1
7734222|NCT00917501|26894670|P1|Overall Study|Withdrawal by Subject|3
7734223|NCT00917501|26894669|P2|Overall Study|Lost to Follow-up|1
7734224|NCT00917501|26894670|P1|Overall Study|Lost to Follow-up|4
7734225|NCT00917462|26894676|P1|Overall Study|Clinical Deterioration|1
7734226|NCT00917384|26894686|P2|Overall Study|Withdrawal by Subject|2
7734227|NCT00917384|26894687|P1|Overall Study|Withdrawal by Subject|10
7734228|NCT00917384|26894686|P2|Overall Study|Lost to Follow-up|2
7734229|NCT00917384|26894687|P1|Overall Study|Lost to Follow-up|4
7734230|NCT00917267|26894711|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
7734231|NCT00917267|26894712|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
7734232|NCT00917267|26894711|P2|Overall Study|Sponsor Decision|5
7734233|NCT00917267|26894712|P1|Overall Study|Sponsor Decision|5
7734234|NCT00917267|26894711|P2|Overall Study|Entry Criteria Not Met|0
7734235|NCT00917267|26894712|P1|Overall Study|Entry Criteria Not Met|1
7734236|NCT00917267|26894711|P2|Overall Study|Lost to follow up|2
7734237|NCT00917267|26894712|P1|Overall Study|Lost to follow up|0
7734238|NCT00917267|26894711|P2|Overall Study|Withdrawal by Subject|12
7734239|NCT00917267|26894712|P1|Overall Study|Withdrawal by Subject|5
7734240|NCT00917267|26894711|P2|Overall Study|Protocol Violation|18
7734241|NCT00917267|26894712|P1|Overall Study|Protocol Violation|9
7734242|NCT00917267|26894711|P2|Overall Study|Physician Decision|4
7734243|NCT00917267|26894712|P1|Overall Study|Physician Decision|2
7734244|NCT00917267|26894711|P2|Overall Study|Adverse Event|36
7734245|NCT00917267|26894712|P1|Overall Study|Adverse Event|15
7734246|NCT00917150|26894742|P4|Overall Study|Other than specified|2
7734247|NCT00917150|26894743|P3|Overall Study|Other than specified|2
7734248|NCT00917150|26894744|P2|Overall Study|Other than specified|3
7734249|NCT00917150|26894745|P1|Overall Study|Other than specified|3
7734250|NCT00917150|26894742|P4|Overall Study|Withdrawal by Subject|11
7734251|NCT00917150|26894743|P3|Overall Study|Withdrawal by Subject|18
7734252|NCT00917150|26894744|P2|Overall Study|Withdrawal by Subject|16
7734253|NCT00917150|26894745|P1|Overall Study|Withdrawal by Subject|15
7734254|NCT00917150|26894742|P4|Overall Study|Protocol Violation|5
7734255|NCT00917150|26894743|P3|Overall Study|Protocol Violation|3
7734256|NCT00917150|26894744|P2|Overall Study|Protocol Violation|5
7734257|NCT00917150|26894745|P1|Overall Study|Protocol Violation|5
7734258|NCT00917150|26894742|P4|Overall Study|Physician Decision|1
7734259|NCT00917150|26894743|P3|Overall Study|Physician Decision|0
7734260|NCT00917150|26894744|P2|Overall Study|Physician Decision|2
7734261|NCT00917150|26894745|P1|Overall Study|Physician Decision|0
7734262|NCT00917150|26894742|P4|Overall Study|Lost to Follow-up|2
7734263|NCT00917150|26894743|P3|Overall Study|Lost to Follow-up|4
7734264|NCT00917150|26894744|P2|Overall Study|Lost to Follow-up|0
7734265|NCT00917150|26894745|P1|Overall Study|Lost to Follow-up|1
7734266|NCT00917150|26894742|P4|Overall Study|Death|2
7734267|NCT00917150|26894743|P3|Overall Study|Death|3
7734268|NCT00917150|26894744|P2|Overall Study|Death|4
7734269|NCT00917150|26894745|P1|Overall Study|Death|1
7734270|NCT00917150|26894742|P4|Overall Study|Adverse Event|11
7734271|NCT00917150|26894743|P3|Overall Study|Adverse Event|12
7734272|NCT00917150|26894744|P2|Overall Study|Adverse Event|7
7734273|NCT00917150|26894745|P1|Overall Study|Adverse Event|12
7734274|NCT00917124|26894765|P2|Overall Study|Protocol Violation|6
7734275|NCT00917124|26894766|P1|Overall Study|Protocol Violation|4
7734276|NCT00916929|26894776|P2|Overall Study|Device unable to process impedance data|7
7734277|NCT00916929|26894777|P1|Overall Study|Device unable to process impedance data|0
7734278|NCT00916929|26894776|P2|Overall Study|Moved to another state|1
7734279|NCT00916929|26894777|P1|Overall Study|Moved to another state|0
7734280|NCT00916929|26894776|P2|Overall Study|System explant|0
7734281|NCT00916929|26894777|P1|Overall Study|System explant|1
7734282|NCT00916929|26894776|P2|Overall Study|Transferred to hospice care|1
7734283|NCT00916929|26894777|P1|Overall Study|Transferred to hospice care|1
7734284|NCT00916929|26894776|P2|Overall Study|Left ventricular epicardial lead|2
7734285|NCT00916929|26894777|P1|Overall Study|Left ventricular epicardial lead|1
7734286|NCT00916929|26894776|P2|Overall Study|Withdrawal by Subject|5
7734287|NCT00916929|26894777|P1|Overall Study|Withdrawal by Subject|1
7734288|NCT00916929|26894776|P2|Overall Study|Death|10
7734289|NCT00916929|26894777|P1|Overall Study|Death|5
7734290|NCT00916929|26894776|P2|Overall Study|Lost to Follow-up|3
7734291|NCT00916929|26894777|P1|Overall Study|Lost to Follow-up|1
7734292|NCT00916721|26894787|P2|Overall Study|Protocol Violation|4
7734293|NCT00916721|26894788|P1|Overall Study|Protocol Violation|2
7734294|NCT00916721|26894787|P2|Overall Study|Withdrawal by Subject|2
7734295|NCT00916721|26894788|P1|Overall Study|Withdrawal by Subject|2
7734296|NCT00916721|26894787|P2|Overall Study|Adverse Event|3
7734297|NCT00916721|26894788|P1|Overall Study|Adverse Event|6
7734298|NCT00916721|26894787|P2|Overall Study|Lost to Follow-up|1
7734299|NCT00916721|26894788|P1|Overall Study|Lost to Follow-up|0
7734300|NCT00916617|26894811|P4|Overall Study|Other|2
7734301|NCT00916617|26894812|P3|Overall Study|Other|0
7734302|NCT00916617|26894813|P2|Overall Study|Other|0
7734303|NCT00916617|26894814|P1|Overall Study|Other|2
7734304|NCT00916617|26894811|P4|Overall Study|Lack of Efficacy|0
7734305|NCT00916617|26894812|P3|Overall Study|Lack of Efficacy|0
7734306|NCT00916617|26894813|P2|Overall Study|Lack of Efficacy|0
7734307|NCT00916617|26894814|P1|Overall Study|Lack of Efficacy|1
7734308|NCT00916617|26894811|P4|Overall Study|Lost to Follow-up|0
7734309|NCT00916617|26894812|P3|Overall Study|Lost to Follow-up|0
7734310|NCT00916617|26894813|P2|Overall Study|Lost to Follow-up|1
7734311|NCT00916617|26894814|P1|Overall Study|Lost to Follow-up|2
7734312|NCT00916617|26894811|P4|Overall Study|Discontinuation of Study by Sponsor|1
7734313|NCT00916617|26894812|P3|Overall Study|Discontinuation of Study by Sponsor|3
7734314|NCT00916617|26894813|P2|Overall Study|Discontinuation of Study by Sponsor|13
7734315|NCT00916617|26894814|P1|Overall Study|Discontinuation of Study by Sponsor|8
7734316|NCT00916617|26894811|P4|Overall Study|Physician Decision|0
7734317|NCT00916617|26894812|P3|Overall Study|Physician Decision|0
7734318|NCT00916617|26894813|P2|Overall Study|Physician Decision|1
7734319|NCT00916617|26894814|P1|Overall Study|Physician Decision|1
7734320|NCT00916617|26894811|P4|Overall Study|Caregiver Request|0
7734321|NCT00916617|26894812|P3|Overall Study|Caregiver Request|1
7734322|NCT00916617|26894813|P2|Overall Study|Caregiver Request|2
7734323|NCT00916617|26894814|P1|Overall Study|Caregiver Request|3
7734324|NCT00916617|26894811|P4|Overall Study|Withdrawal by Subject|1
7734325|NCT00916617|26894812|P3|Overall Study|Withdrawal by Subject|0
7734326|NCT00916617|26894813|P2|Overall Study|Withdrawal by Subject|2
7734327|NCT00916617|26894814|P1|Overall Study|Withdrawal by Subject|3
7734328|NCT00916617|26894811|P4|Overall Study|Adverse Event|3
7734329|NCT00916617|26894812|P3|Overall Study|Adverse Event|6
7734330|NCT00916617|26894813|P2|Overall Study|Adverse Event|2
7734331|NCT00916617|26894814|P1|Overall Study|Adverse Event|3
7734332|NCT00916578|26894828|P1|Overall Study|Insurance Denial|2
7734333|NCT00916578|26894828|P1|Overall Study|Withdrawal by Subject|3
7734334|NCT00916578|26894828|P1|Overall Study|Physician Decision|2
7734338|NCT00916370|26894885|P2|Overall Study|Physician Decision|1
7734339|NCT00916370|26894886|P1|Overall Study|Physician Decision|0
7734340|NCT00916370|26894885|P2|Overall Study|Withdrawal by Subject|0
7734341|NCT00916370|26894886|P1|Overall Study|Withdrawal by Subject|2
7734342|NCT00916370|26894885|P2|Overall Study|Death|1
7734343|NCT00916370|26894886|P1|Overall Study|Death|3
7734344|NCT00916357|26895060|P6|Period 2|Weight loss > 3 kilograms (kg)|0
7734345|NCT00916357|26895061|P5|Period 2|Weight loss > 3 kilograms (kg)|0
7734346|NCT00916357|26895062|P4|Period 2|Weight loss > 3 kilograms (kg)|1
7734347|NCT00916357|26895063|P3|Period 2|Weight loss > 3 kilograms (kg)|0
7734348|NCT00916357|26895064|P2|Period 2|Weight loss > 3 kilograms (kg)|0
7734349|NCT00916357|26895065|P1|Period 2|Weight loss > 3 kilograms (kg)|0
7734350|NCT00916357|26895060|P6|Period 1|Withdrawal by Subject|0
7734351|NCT00916357|26895061|P5|Period 1|Withdrawal by Subject|0
7734352|NCT00916357|26895062|P4|Period 1|Withdrawal by Subject|0
7734353|NCT00916357|26895063|P3|Period 1|Withdrawal by Subject|0
7734354|NCT00916357|26895064|P2|Period 1|Withdrawal by Subject|0
7734355|NCT00916357|26895065|P1|Period 1|Withdrawal by Subject|1
7734356|NCT00916344|26895103|P1|Overall Study|Drop-out|5
7734357|NCT00916344|26895103|P1|Overall Study|ICD upgrade|1
7734358|NCT00916344|26895103|P1|Overall Study|Death|2
7734359|NCT00916305|26895110|P2|Overall Study|Withdrawal by Subject|1
7734360|NCT00916305|26895111|P1|Overall Study|Withdrawal by Subject|0
7734361|NCT00916305|26895110|P2|Overall Study|Lost to Follow-up|27
7734362|NCT00916305|26895111|P1|Overall Study|Lost to Follow-up|21
7734363|NCT00916279|26895119|P1|Overall Study|Lost to Follow-up|2
7734364|NCT00916279|26895119|P1|Overall Study|Death|2
7734365|NCT00916149|26895130|P3|Overall Study|Unable to place scalp EEG leads|0
7734366|NCT00916149|26895131|P2|Overall Study|Unable to place scalp EEG leads|0
7734367|NCT00916149|26895132|P1|Overall Study|Unable to place scalp EEG leads|1
7734368|NCT00916149|26895130|P3|Overall Study|Lost to Follow-up|0
7734369|NCT00916149|26895131|P2|Overall Study|Lost to Follow-up|2
7734370|NCT00916149|26895132|P1|Overall Study|Lost to Follow-up|3
7734371|NCT00916058|26895219|P7|Phase 2|Screen Failure|3
7734372|NCT00916058|26895220|P6|Phase 2|Screen Failure|0
7734373|NCT00916058|26895221|P5|Phase 2|Screen Failure|0
7734374|NCT00916058|26895222|P4|Phase 2|Screen Failure|0
7734375|NCT00916058|26895223|P3|Phase 2|Screen Failure|0
7734376|NCT00916058|26895224|P2|Phase 2|Screen Failure|0
7734377|NCT00916058|26895225|P1|Phase 2|Screen Failure|0
7734378|NCT00916058|26895219|P7|Phase 1|Screen Failure|0
7734379|NCT00916058|26895220|P6|Phase 1|Screen Failure|1
7734380|NCT00916058|26895221|P5|Phase 1|Screen Failure|0
7734381|NCT00916058|26895222|P4|Phase 1|Screen Failure|0
7734382|NCT00916058|26895223|P3|Phase 1|Screen Failure|0
7734383|NCT00916058|26895224|P2|Phase 1|Screen Failure|0
7734384|NCT00916058|26895225|P1|Phase 1|Screen Failure|0
7734385|NCT00916006|26895288|P2|Overall Study|Protocol Violation|1
7734386|NCT00916006|26895289|P1|Overall Study|Protocol Violation|0
7734387|NCT00916006|26895288|P2|Overall Study|Withdrawal by Subject|5
7734388|NCT00916006|26895289|P1|Overall Study|Withdrawal by Subject|2
7734389|NCT00916006|26895288|P2|Overall Study|Adverse Event|1
7734390|NCT00916006|26895289|P1|Overall Study|Adverse Event|1
7734391|NCT00915876|26895351|P2|Overall Study|Adverse Event|1
7734392|NCT00915876|26895352|P1|Overall Study|Adverse Event|0
7734393|NCT00915772|26895388|P3|Overall Study|Any other reason|7
7734394|NCT00915772|26895389|P2|Overall Study|Any other reason|7
7734395|NCT00915772|26895390|P1|Overall Study|Any other reason|4
7734396|NCT00915772|26895388|P3|Overall Study|Refused to continue trial medication|4
7734397|NCT00915772|26895389|P2|Overall Study|Refused to continue trial medication|8
7734398|NCT00915772|26895390|P1|Overall Study|Refused to continue trial medication|6
7734399|NCT00915772|26895388|P3|Overall Study|Lack of Efficacy|3
7734400|NCT00915772|26895389|P2|Overall Study|Lack of Efficacy|15
7734401|NCT00915772|26895390|P1|Overall Study|Lack of Efficacy|9
7734402|NCT00915772|26895388|P3|Overall Study|Lost to Follow-up|2
7734403|NCT00915772|26895389|P2|Overall Study|Lost to Follow-up|2
7734404|NCT00915772|26895390|P1|Overall Study|Lost to Follow-up|1
7734405|NCT00915772|26895388|P3|Overall Study|Protocol Violation|2
7734406|NCT00915772|26895389|P2|Overall Study|Protocol Violation|1
7734407|NCT00915772|26895390|P1|Overall Study|Protocol Violation|4
7734408|NCT00915772|26895388|P3|Overall Study|Adverse Event|11
7734409|NCT00915772|26895389|P2|Overall Study|Adverse Event|13
7734410|NCT00915772|26895390|P1|Overall Study|Adverse Event|12
7734411|NCT00915551|26895489|P2|Overall Study|Withdrawal by Subject|1
7734412|NCT00915551|26895490|P1|Overall Study|Withdrawal by Subject|0
7734413|NCT00915525|26895511|P2|Overall Study|Patient Moved|9
7734414|NCT00915525|26895512|P1|Overall Study|Patient Moved|15
7734415|NCT00915525|26895511|P2|Overall Study|Non-Compliance|1
7734416|NCT00915525|26895512|P1|Overall Study|Non-Compliance|3
7734417|NCT00915525|26895511|P2|Overall Study|Study Burden|12
7734418|NCT00915525|26895512|P1|Overall Study|Study Burden|28
7734419|NCT00915525|26895511|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
7734420|NCT00915525|26895512|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
7734421|NCT00915525|26895511|P2|Overall Study|Site Closed|9
7734422|NCT00915525|26895512|P1|Overall Study|Site Closed|27
7734423|NCT00915525|26895511|P2|Overall Study|Other Reason|12
7734424|NCT00915525|26895512|P1|Overall Study|Other Reason|35
7734425|NCT00915525|26895511|P2|Overall Study|Missing|1
7734426|NCT00915525|26895512|P1|Overall Study|Missing|12
7734427|NCT00915525|26895511|P2|Overall Study|Adverse Event|13
7734428|NCT00915525|26895512|P1|Overall Study|Adverse Event|29
7734429|NCT00915525|26895511|P2|Overall Study|Lack of Efficacy|32
7734430|NCT00915525|26895512|P1|Overall Study|Lack of Efficacy|15
7734431|NCT00915525|26895511|P2|Overall Study|Pregnancy|0
7734432|NCT00915525|26895512|P1|Overall Study|Pregnancy|2
7734433|NCT00915525|26895511|P2|Overall Study|Lost to Follow-up|16
7734434|NCT00915525|26895512|P1|Overall Study|Lost to Follow-up|27
7734435|NCT00915525|26895511|P2|Overall Study|Withdrawal by Subject|21
7734436|NCT00915525|26895512|P1|Overall Study|Withdrawal by Subject|59
7734437|NCT00915525|26895511|P2|Overall Study|Protocol Violation|4
7734438|NCT00915525|26895512|P1|Overall Study|Protocol Violation|9
7734439|NCT00915473|26895626|P2|4-week Follow Up|Lost to Follow-up|5
7734440|NCT00915473|26895627|P1|4-week Follow Up|Lost to Follow-up|1
7734441|NCT00915473|26895626|P2|Screening|Withdrawal by Subject|0
7734442|NCT00915473|26895627|P1|Screening|Withdrawal by Subject|1
7734443|NCT00915356|26895644|P5|Overall Study|Withdrawal by Subject|0
7734444|NCT00915356|26895645|P4|Overall Study|Withdrawal by Subject|0
7734445|NCT00915356|26895646|P3|Overall Study|Withdrawal by Subject|0
7734446|NCT00915356|26895647|P2|Overall Study|Withdrawal by Subject|0
7734447|NCT00915356|26895648|P1|Overall Study|Withdrawal by Subject|1
7734448|NCT00915343|26895710|P3|Part B - Open Label Period|Did not attend the last visit|1
7734449|NCT00915343|26895711|P2|Part B - Open Label Period|Did not attend the last visit|0
7734450|NCT00915343|26895712|P1|Part B - Open Label Period|Did not attend the last visit|0
7734451|NCT00915343|26895710|P3|Part B - Open Label Period|Treatment switch|1
7734452|NCT00915343|26895711|P2|Part B - Open Label Period|Treatment switch|0
7734453|NCT00915343|26895712|P1|Part B - Open Label Period|Treatment switch|0
7734454|NCT00915278|26895797|P6|Overall Study|Admission to hospice|0
7734455|NCT00915278|26895798|P5|Overall Study|Admission to hospice|0
7734456|NCT00915278|26895799|P4|Overall Study|Admission to hospice|0
7734457|NCT00915278|26895800|P3|Overall Study|Admission to hospice|1
7734458|NCT00915278|26895801|P2|Overall Study|Admission to hospice|0
7734459|NCT00915278|26895802|P1|Overall Study|Admission to hospice|0
7734460|NCT00915278|26895797|P6|Overall Study|Infusion related AEs|2
7734461|NCT00915278|26895798|P5|Overall Study|Infusion related AEs|0
7734462|NCT00915278|26895799|P4|Overall Study|Infusion related AEs|0
7734463|NCT00915278|26895800|P3|Overall Study|Infusion related AEs|0
7734464|NCT00915278|26895801|P2|Overall Study|Infusion related AEs|0
7734465|NCT00915278|26895802|P1|Overall Study|Infusion related AEs|0
7734466|NCT00915278|26895797|P6|Overall Study|Progressive disease/clinical progression|2
7734467|NCT00915278|26895798|P5|Overall Study|Progressive disease/clinical progression|1
7734468|NCT00915278|26895799|P4|Overall Study|Progressive disease/clinical progression|3
7734469|NCT00915278|26895800|P3|Overall Study|Progressive disease/clinical progression|0
7734470|NCT00915278|26895801|P2|Overall Study|Progressive disease/clinical progression|0
7734471|NCT00915278|26895802|P1|Overall Study|Progressive disease/clinical progression|0
7734472|NCT00915278|26895797|P6|Overall Study|Adverse Event|0
7734473|NCT00915278|26895798|P5|Overall Study|Adverse Event|0
7734474|NCT00915278|26895799|P4|Overall Study|Adverse Event|0
7734475|NCT00915278|26895800|P3|Overall Study|Adverse Event|0
7734476|NCT00915278|26895801|P2|Overall Study|Adverse Event|1
7734477|NCT00915278|26895802|P1|Overall Study|Adverse Event|4
7734478|NCT00915278|26895797|P6|Overall Study|Withdrawal by Subject|4
7734479|NCT00915278|26895798|P5|Overall Study|Withdrawal by Subject|1
7734480|NCT00915278|26895799|P4|Overall Study|Withdrawal by Subject|0
7734481|NCT00915278|26895800|P3|Overall Study|Withdrawal by Subject|0
7734482|NCT00915278|26895801|P2|Overall Study|Withdrawal by Subject|1
7734483|NCT00915278|26895802|P1|Overall Study|Withdrawal by Subject|0
7734484|NCT00915278|26895797|P6|Overall Study|Lost to Follow-up|0
7734485|NCT00915278|26895798|P5|Overall Study|Lost to Follow-up|0
7734486|NCT00915278|26895799|P4|Overall Study|Lost to Follow-up|0
7734487|NCT00915278|26895800|P3|Overall Study|Lost to Follow-up|0
7734488|NCT00915278|26895801|P2|Overall Study|Lost to Follow-up|1
7734489|NCT00915278|26895802|P1|Overall Study|Lost to Follow-up|0
7734490|NCT00915278|26895797|P6|Overall Study|Death|0
7734491|NCT00915278|26895798|P5|Overall Study|Death|0
7734492|NCT00915278|26895799|P4|Overall Study|Death|0
7734493|NCT00915278|26895800|P3|Overall Study|Death|0
7734494|NCT00915278|26895801|P2|Overall Study|Death|0
7734495|NCT00915278|26895802|P1|Overall Study|Death|1
7734496|NCT00915018|26895963|P2|Overall Study|By Sponsor due to Protocol Amendment|105
7734497|NCT00915018|26895964|P1|Overall Study|By Sponsor due to Protocol Amendment|92
7734498|NCT00915018|26895963|P2|Overall Study|Withdrawal by Subject|27
7734499|NCT00915018|26895964|P1|Overall Study|Withdrawal by Subject|38
7734500|NCT00915018|26895963|P2|Overall Study|Lost to Follow-up|5
7734501|NCT00915018|26895964|P1|Overall Study|Lost to Follow-up|10
7734502|NCT00915018|26895963|P2|Overall Study|Death|70
7734503|NCT00915018|26895964|P1|Overall Study|Death|75
7734504|NCT00915005|26895980|P2|Overall Study|Insurance denial|15
7734505|NCT00915005|26895981|P1|Overall Study|Insurance denial|3
7734506|NCT00915005|26895980|P2|Overall Study|Patient preferred protons therapy|0
7734507|NCT00915005|26895981|P1|Overall Study|Patient preferred protons therapy|6
7734508|NCT00915005|26895980|P2|Overall Study|Withdrawal by Subject|4
7734509|NCT00915005|26895981|P1|Overall Study|Withdrawal by Subject|4
7734510|NCT00914966|26895989|P1|Step 2: 2000 Units|Withdrawal by Subject|1
7734511|NCT00914966|26895989|P1|Step 1: 1500 Units|Physician Decision|1
7734512|NCT00914966|26895989|P1|Step 1: 1500 Units|Withdrawal by Subject|1
7734513|NCT00914940|26896001|P1|2 Years to 5 Years Post-transplant|Death|3
7734514|NCT00914940|26896001|P1|D101 to 2 Years Post-transplant|Death|8
7734515|NCT00914940|26896001|P1|D0 to D100 Post-transplant|Death|2
7734516|NCT00914927|26896016|P7|Overall Study|Administrative/Other|0
7734517|NCT00914927|26896017|P6|Overall Study|Administrative/Other|0
7734518|NCT00914927|26896018|P5|Overall Study|Administrative/Other|1
7734519|NCT00914927|26896019|P4|Overall Study|Administrative/Other|0
7734520|NCT00914927|26896020|P3|Overall Study|Administrative/Other|0
7734521|NCT00914927|26896021|P2|Overall Study|Administrative/Other|1
7734522|NCT00914927|26896022|P1|Overall Study|Administrative/Other|2
7734523|NCT00914927|26896016|P7|Overall Study|Lost to Follow-up|0
7734524|NCT00914927|26896017|P6|Overall Study|Lost to Follow-up|0
7734525|NCT00914927|26896018|P5|Overall Study|Lost to Follow-up|0
7734526|NCT00914927|26896019|P4|Overall Study|Lost to Follow-up|1
7734527|NCT00914927|26896020|P3|Overall Study|Lost to Follow-up|0
7734528|NCT00914927|26896021|P2|Overall Study|Lost to Follow-up|0
7734529|NCT00914927|26896022|P1|Overall Study|Lost to Follow-up|0
7734530|NCT00914927|26896016|P7|Overall Study|Withdrawal by Subject|0
7734531|NCT00914927|26896017|P6|Overall Study|Withdrawal by Subject|0
7734532|NCT00914927|26896018|P5|Overall Study|Withdrawal by Subject|0
7734533|NCT00914927|26896019|P4|Overall Study|Withdrawal by Subject|1
7734534|NCT00914927|26896020|P3|Overall Study|Withdrawal by Subject|0
7734535|NCT00914927|26896021|P2|Overall Study|Withdrawal by Subject|1
7734536|NCT00914927|26896022|P1|Overall Study|Withdrawal by Subject|0
7734537|NCT00914927|26896016|P7|Overall Study|Adverse Event|0
7734538|NCT00914927|26896017|P6|Overall Study|Adverse Event|0
7734539|NCT00914927|26896018|P5|Overall Study|Adverse Event|1
7734540|NCT00914927|26896019|P4|Overall Study|Adverse Event|0
7734541|NCT00914927|26896020|P3|Overall Study|Adverse Event|0
7734542|NCT00914927|26896021|P2|Overall Study|Adverse Event|0
7734543|NCT00914927|26896022|P1|Overall Study|Adverse Event|0
7734544|NCT00914849|26896149|P2|Overall Study|Not eligible|1
7734545|NCT00914849|26896150|P1|Overall Study|Not eligible|0
7734546|NCT00914849|26896149|P2|Overall Study|Withdrawal by Subject|0
7734547|NCT00914849|26896150|P1|Overall Study|Withdrawal by Subject|1
7734548|NCT00914810|26896184|P2|Overall Study|Hospitalized and unable to follow up.|1
7734549|NCT00914810|26896185|P1|Overall Study|Hospitalized and unable to follow up.|0
7734550|NCT00914810|26896184|P2|Overall Study|Relocated out of state|0
7734551|NCT00914810|26896185|P1|Overall Study|Relocated out of state|1
7734552|NCT00914810|26896184|P2|Overall Study|Withdrawal by Subject|0
7734553|NCT00914810|26896185|P1|Overall Study|Withdrawal by Subject|1
7734554|NCT00914732|26896196|P3|Overall Study|Adverse Event|0
7734555|NCT00914732|26896197|P2|Overall Study|Adverse Event|0
7734556|NCT00914732|26896198|P1|Overall Study|Adverse Event|1
7734557|NCT00914732|26896196|P3|Overall Study|Withdrawal by Subject|2
7734558|NCT00914732|26896197|P2|Overall Study|Withdrawal by Subject|0
7734559|NCT00914732|26896198|P1|Overall Study|Withdrawal by Subject|3
7734560|NCT00914732|26896196|P3|Overall Study|Lost to Follow-up|9
7734561|NCT00914732|26896197|P2|Overall Study|Lost to Follow-up|7
7734562|NCT00914732|26896198|P1|Overall Study|Lost to Follow-up|6
7734563|NCT00914628|26896227|P2|Overall Study|Patients who did not receive a single dose|1
7734564|NCT00914628|26896228|P1|Overall Study|Patients who did not receive a single dose|7
7734565|NCT00914628|26896227|P2|Overall Study|Study terminated by Sponsor|8
7734566|NCT00914628|26896228|P1|Overall Study|Study terminated by Sponsor|14
7734567|NCT00914628|26896227|P2|Overall Study|Relapse|2
7734568|NCT00914628|26896228|P1|Overall Study|Relapse|1
7734569|NCT00914628|26896227|P2|Overall Study|non-randomized|0
7734570|NCT00914628|26896228|P1|Overall Study|non-randomized|1
7734571|NCT00914628|26896227|P2|Overall Study|Lack of Efficacy|0
7734572|NCT00914628|26896228|P1|Overall Study|Lack of Efficacy|1
7734573|NCT00914628|26896227|P2|Overall Study|Protocol Violation|0
7734574|NCT00914628|26896228|P1|Overall Study|Protocol Violation|1
7734575|NCT00914628|26896227|P2|Overall Study|Medical decision|0
7734576|NCT00914628|26896228|P1|Overall Study|Medical decision|4
7734577|NCT00914628|26896227|P2|Overall Study|Death|17
7734578|NCT00914628|26896228|P1|Overall Study|Death|35
7734579|NCT00914589|26896259|P3|Overall Study|Death|1
7734580|NCT00914589|26896260|P2|Overall Study|Death|1
7734581|NCT00914589|26896261|P1|Overall Study|Death|0
7734582|NCT00914589|26896259|P3|Overall Study|unclassified|7
7734583|NCT00914589|26896260|P2|Overall Study|unclassified|9
7734584|NCT00914589|26896261|P1|Overall Study|unclassified|16
7734585|NCT00914589|26896259|P3|Overall Study|Protocol Violation|3
7734586|NCT00914589|26896260|P2|Overall Study|Protocol Violation|6
7734587|NCT00914589|26896261|P1|Overall Study|Protocol Violation|8
7734588|NCT00914589|26896259|P3|Overall Study|Adverse Event|1
7734589|NCT00914589|26896260|P2|Overall Study|Adverse Event|0
7734590|NCT00914589|26896261|P1|Overall Study|Adverse Event|1
7734591|NCT00914459|26896287|P2|Overall Study|Parent/Legal guardian request|0
7734592|NCT00914459|26896288|P1|Overall Study|Parent/Legal guardian request|1
7734593|NCT00914459|26896287|P2|Overall Study|Protocol Violation|1
7734594|NCT00914459|26896288|P1|Overall Study|Protocol Violation|0
7734595|NCT00914316|26896318|P4|Phase 2|Withdrawal by Subject|0
7734596|NCT00914316|26896319|P3|Phase 2|Withdrawal by Subject|1
7734597|NCT00914316|26896320|P2|Phase 2|Withdrawal by Subject|0
7734598|NCT00914316|26896321|P1|Phase 2|Withdrawal by Subject|1
7734599|NCT00914316|26896318|P4|Phase 1|Adverse Event|0
7734600|NCT00914316|26896319|P3|Phase 1|Adverse Event|0
7734601|NCT00914316|26896320|P2|Phase 1|Adverse Event|0
7734602|NCT00914316|26896321|P1|Phase 1|Adverse Event|1
7734603|NCT00914316|26896318|P4|Phase 1|Withdrawal by Subject|0
7734604|NCT00914316|26896319|P3|Phase 1|Withdrawal by Subject|4
7734605|NCT00914316|26896320|P2|Phase 1|Withdrawal by Subject|2
7734606|NCT00914316|26896321|P1|Phase 1|Withdrawal by Subject|0
7734607|NCT00914316|26896318|P4|Phase 1|Physician Decision|2
7734608|NCT00914316|26896319|P3|Phase 1|Physician Decision|1
7734609|NCT00914316|26896320|P2|Phase 1|Physician Decision|0
7734610|NCT00914316|26896321|P1|Phase 1|Physician Decision|4
7734611|NCT00913978|26896393|P2|Overall Study|Surgeon choice|3
7734612|NCT00913978|26896394|P1|Overall Study|Surgeon choice|1
7734613|NCT00913835|26896411|P2|Lip Dox: Olaratumab Monotherapy|Other|3
7734614|NCT00913835|26896412|P1|Lip Dox: Olaratumab Monotherapy|Other|0
7734615|NCT00913835|26896411|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
7734616|NCT00913835|26896412|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
7734617|NCT00913835|26896411|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
7734618|NCT00913835|26896412|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
7734619|NCT00913835|26896411|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
7734620|NCT00913835|26896412|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
7734621|NCT00913835|26896411|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
7734622|NCT00913835|26896412|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
7734623|NCT00913770|26896451|P3|Overall Study|Refused|8
7734624|NCT00913770|26896452|P2|Overall Study|Refused|10
7734625|NCT00913770|26896453|P1|Overall Study|Refused|11
7734626|NCT00913770|26896451|P3|Overall Study|Unable to contact|13
7734627|NCT00913770|26896452|P2|Overall Study|Unable to contact|19
7734628|NCT00913770|26896453|P1|Overall Study|Unable to contact|24
7734629|NCT00913744|26896466|P2|Overall Study|Death|0
7734630|NCT00913744|26896467|P1|Overall Study|Death|1
7734631|NCT00913744|26896466|P2|Overall Study|Withdrawal by Subject|1
7734632|NCT00913744|26896467|P1|Overall Study|Withdrawal by Subject|2
7734633|NCT00913744|26896466|P2|Overall Study|Adverse Event|0
7734634|NCT00913744|26896467|P1|Overall Study|Adverse Event|2
7734635|NCT00913692|26896473|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
7734636|NCT00913692|26896473|P1|Screening (4 Months)|Not eligible after screening phase.|6
7734637|NCT00913692|26896473|P1|Screening (4 Months)|Physician Decision|3
7734638|NCT00913523|26896567|P3|Overall Study|Inadequate Number of Tampons Used|3
7734639|NCT00913523|26896568|P2|Overall Study|Inadequate Number of Tampons Used|2
7734640|NCT00913523|26896569|P1|Overall Study|Inadequate Number of Tampons Used|7
7734641|NCT00913523|26896567|P3|Overall Study|Pregnancy|0
7734642|NCT00913523|26896568|P2|Overall Study|Pregnancy|3
7734643|NCT00913523|26896569|P1|Overall Study|Pregnancy|1
7734644|NCT00913523|26896567|P3|Overall Study|Protocol Violation|8
7734645|NCT00913523|26896568|P2|Overall Study|Protocol Violation|8
7734646|NCT00913523|26896569|P1|Overall Study|Protocol Violation|5
7734647|NCT00913523|26896567|P3|Overall Study|Adverse Event|0
7734648|NCT00913523|26896568|P2|Overall Study|Adverse Event|0
7734649|NCT00913523|26896569|P1|Overall Study|Adverse Event|1
7734650|NCT00913523|26896567|P3|Overall Study|Lost to Follow-up|1
7734651|NCT00913523|26896568|P2|Overall Study|Lost to Follow-up|1
7734652|NCT00913523|26896569|P1|Overall Study|Lost to Follow-up|1
7734653|NCT00913523|26896567|P3|Overall Study|Withdrawal by Subject|2
7734654|NCT00913523|26896568|P2|Overall Study|Withdrawal by Subject|2
7734655|NCT00913523|26896569|P1|Overall Study|Withdrawal by Subject|3
7734656|NCT00913458|26896601|P7|Phase 3|Unsatisfactory Response per Investigator|4
7734657|NCT00913458|26896602|P6|Phase 3|Unsatisfactory Response per Investigator|11
7734658|NCT00913458|26896603|P5|Phase 3|Unsatisfactory Response per Investigator|14
7734659|NCT00913458|26896604|P4|Phase 3|Unsatisfactory Response per Investigator|0
7734660|NCT00913458|26896605|P3|Phase 3|Unsatisfactory Response per Investigator|0
7734661|NCT00913458|26896606|P2|Phase 3|Unsatisfactory Response per Investigator|0
7734662|NCT00913458|26896607|P1|Phase 3|Unsatisfactory Response per Investigator|0
7734663|NCT00913458|26896601|P7|Phase 3|Withdrawal by Subject|0
7734664|NCT00913458|26896602|P6|Phase 3|Withdrawal by Subject|2
7734665|NCT00913458|26896603|P5|Phase 3|Withdrawal by Subject|1
7734666|NCT00913458|26896604|P4|Phase 3|Withdrawal by Subject|0
7734667|NCT00913458|26896605|P3|Phase 3|Withdrawal by Subject|0
7734668|NCT00913458|26896606|P2|Phase 3|Withdrawal by Subject|0
7734669|NCT00913458|26896607|P1|Phase 3|Withdrawal by Subject|0
7734670|NCT00913458|26896601|P7|Phase 3|Non-Responder|3
7734671|NCT00913458|26896602|P6|Phase 3|Non-Responder|1
7734672|NCT00913458|26896603|P5|Phase 3|Non-Responder|0
7734673|NCT00913458|26896604|P4|Phase 3|Non-Responder|0
7734674|NCT00913458|26896605|P3|Phase 3|Non-Responder|0
7734675|NCT00913458|26896606|P2|Phase 3|Non-Responder|0
7734676|NCT00913458|26896607|P1|Phase 3|Non-Responder|0
7734677|NCT00913458|26896601|P7|Phase 3|Lost to Follow-up|0
7734678|NCT00913458|26896602|P6|Phase 3|Lost to Follow-up|0
7734679|NCT00913458|26896603|P5|Phase 3|Lost to Follow-up|2
7734680|NCT00913458|26896604|P4|Phase 3|Lost to Follow-up|0
7734681|NCT00913458|26896605|P3|Phase 3|Lost to Follow-up|0
7734682|NCT00913458|26896606|P2|Phase 3|Lost to Follow-up|0
7734683|NCT00913458|26896607|P1|Phase 3|Lost to Follow-up|0
7734684|NCT00913458|26896601|P7|Phase 3|Adverse Event|1
7734685|NCT00913458|26896602|P6|Phase 3|Adverse Event|4
7734686|NCT00913458|26896603|P5|Phase 3|Adverse Event|5
7734687|NCT00913458|26896604|P4|Phase 3|Adverse Event|0
7734688|NCT00913458|26896605|P3|Phase 3|Adverse Event|0
7734689|NCT00913458|26896606|P2|Phase 3|Adverse Event|0
7734690|NCT00913458|26896607|P1|Phase 3|Adverse Event|0
7734691|NCT00913458|26896601|P7|Phase 2|Unsatisfactory Response per Investigator|0
7734692|NCT00913458|26896602|P6|Phase 2|Unsatisfactory Response per Investigator|0
7734693|NCT00913458|26896603|P5|Phase 2|Unsatisfactory Response per Investigator|0
7734694|NCT00913458|26896604|P4|Phase 2|Unsatisfactory Response per Investigator|17
7734695|NCT00913458|26896605|P3|Phase 2|Unsatisfactory Response per Investigator|11
7734696|NCT00913458|26896606|P2|Phase 2|Unsatisfactory Response per Investigator|0
7734697|NCT00913458|26896607|P1|Phase 2|Unsatisfactory Response per Investigator|0
7734698|NCT00913458|26896601|P7|Phase 2|Protocol Violation|0
7734699|NCT00913458|26896602|P6|Phase 2|Protocol Violation|0
7734700|NCT00913458|26896603|P5|Phase 2|Protocol Violation|0
7734701|NCT00913458|26896604|P4|Phase 2|Protocol Violation|0
7734702|NCT00913458|26896605|P3|Phase 2|Protocol Violation|0
7734703|NCT00913458|26896606|P2|Phase 2|Protocol Violation|2
7734704|NCT00913458|26896607|P1|Phase 2|Protocol Violation|0
7734705|NCT00913458|26896601|P7|Phase 2|Lost to Follow-up|0
7734706|NCT00913458|26896602|P6|Phase 2|Lost to Follow-up|0
7734707|NCT00913458|26896603|P5|Phase 2|Lost to Follow-up|0
7734708|NCT00913458|26896604|P4|Phase 2|Lost to Follow-up|1
7734709|NCT00913458|26896605|P3|Phase 2|Lost to Follow-up|0
7734710|NCT00913458|26896606|P2|Phase 2|Lost to Follow-up|0
7734711|NCT00913458|26896607|P1|Phase 2|Lost to Follow-up|0
7734712|NCT00913458|26896601|P7|Phase 2|Adverse Event|0
7734713|NCT00913458|26896602|P6|Phase 2|Adverse Event|0
7734714|NCT00913458|26896603|P5|Phase 2|Adverse Event|0
7734715|NCT00913458|26896604|P4|Phase 2|Adverse Event|1
7734716|NCT00913458|26896605|P3|Phase 2|Adverse Event|0
7734717|NCT00913458|26896606|P2|Phase 2|Adverse Event|3
7734718|NCT00913458|26896607|P1|Phase 2|Adverse Event|0
7734719|NCT00913458|26896601|P7|Phase 2|Subject Request|0
7734720|NCT00913458|26896602|P6|Phase 2|Subject Request|0
7734721|NCT00913458|26896603|P5|Phase 2|Subject Request|0
7734722|NCT00913458|26896604|P4|Phase 2|Subject Request|2
7734723|NCT00913458|26896605|P3|Phase 2|Subject Request|1
7734724|NCT00913458|26896606|P2|Phase 2|Subject Request|0
7734725|NCT00913458|26896607|P1|Phase 2|Subject Request|0
7734726|NCT00913458|26896601|P7|Phase 2|Non-Responder|0
7734727|NCT00913458|26896602|P6|Phase 2|Non-Responder|0
7734728|NCT00913458|26896603|P5|Phase 2|Non-Responder|0
7734729|NCT00913458|26896604|P4|Phase 2|Non-Responder|12
7734730|NCT00913458|26896605|P3|Phase 2|Non-Responder|7
7734731|NCT00913458|26896606|P2|Phase 2|Non-Responder|5
7734732|NCT00913458|26896607|P1|Phase 2|Non-Responder|0
7734733|NCT00913458|26896601|P7|Phase 1|Unsatisfactory Response per Investigator|0
7734734|NCT00913458|26896602|P6|Phase 1|Unsatisfactory Response per Investigator|0
7734735|NCT00913458|26896603|P5|Phase 1|Unsatisfactory Response per Investigator|0
7734736|NCT00913458|26896604|P4|Phase 1|Unsatisfactory Response per Investigator|0
7734737|NCT00913458|26896605|P3|Phase 1|Unsatisfactory Response per Investigator|0
7734738|NCT00913458|26896606|P2|Phase 1|Unsatisfactory Response per Investigator|0
7734739|NCT00913458|26896607|P1|Phase 1|Unsatisfactory Response per Investigator|7
7734740|NCT00913458|26896601|P7|Phase 1|Sponsor|0
7734741|NCT00913458|26896602|P6|Phase 1|Sponsor|0
7734742|NCT00913458|26896603|P5|Phase 1|Sponsor|0
7734743|NCT00913458|26896604|P4|Phase 1|Sponsor|0
7734744|NCT00913458|26896605|P3|Phase 1|Sponsor|0
7734745|NCT00913458|26896606|P2|Phase 1|Sponsor|0
7734746|NCT00913458|26896607|P1|Phase 1|Sponsor|2
7734747|NCT00913458|26896601|P7|Phase 1|Protocol Violation|0
7734748|NCT00913458|26896602|P6|Phase 1|Protocol Violation|0
7734749|NCT00913458|26896603|P5|Phase 1|Protocol Violation|0
7734750|NCT00913458|26896604|P4|Phase 1|Protocol Violation|0
7734751|NCT00913458|26896605|P3|Phase 1|Protocol Violation|0
7734752|NCT00913458|26896606|P2|Phase 1|Protocol Violation|0
7734753|NCT00913458|26896607|P1|Phase 1|Protocol Violation|10
7734754|NCT00913458|26896601|P7|Phase 1|Lost to Follow-up|0
7734755|NCT00913458|26896602|P6|Phase 1|Lost to Follow-up|0
7734756|NCT00913458|26896603|P5|Phase 1|Lost to Follow-up|0
7734757|NCT00913458|26896604|P4|Phase 1|Lost to Follow-up|0
7734758|NCT00913458|26896605|P3|Phase 1|Lost to Follow-up|0
7734759|NCT00913458|26896606|P2|Phase 1|Lost to Follow-up|0
7734760|NCT00913458|26896607|P1|Phase 1|Lost to Follow-up|2
7734761|NCT00913458|26896601|P7|Phase 1|Adverse Event|0
7734762|NCT00913458|26896602|P6|Phase 1|Adverse Event|0
7734763|NCT00913458|26896603|P5|Phase 1|Adverse Event|0
7734764|NCT00913458|26896604|P4|Phase 1|Adverse Event|0
7734765|NCT00913458|26896605|P3|Phase 1|Adverse Event|0
7734766|NCT00913458|26896606|P2|Phase 1|Adverse Event|0
7734767|NCT00913458|26896607|P1|Phase 1|Adverse Event|20
7734768|NCT00913458|26896601|P7|Phase 1|Subject Request|0
7734769|NCT00913458|26896602|P6|Phase 1|Subject Request|0
7734770|NCT00913458|26896603|P5|Phase 1|Subject Request|0
7734771|NCT00913458|26896604|P4|Phase 1|Subject Request|0
7734772|NCT00913458|26896605|P3|Phase 1|Subject Request|0
7734773|NCT00913458|26896606|P2|Phase 1|Subject Request|0
7734774|NCT00913458|26896607|P1|Phase 1|Subject Request|17
7734775|NCT00913458|26896601|P7|Phase 1|Non-Responder|0
7734776|NCT00913458|26896602|P6|Phase 1|Non-Responder|0
7734777|NCT00913458|26896603|P5|Phase 1|Non-Responder|0
7734778|NCT00913458|26896604|P4|Phase 1|Non-Responder|0
7734779|NCT00913458|26896605|P3|Phase 1|Non-Responder|0
7734780|NCT00913458|26896606|P2|Phase 1|Non-Responder|0
7734781|NCT00913458|26896607|P1|Phase 1|Non-Responder|54
7734782|NCT00913380|26896700|P2|Clinical Outcomes|Lost to Follow-up|6
7734783|NCT00913380|26896701|P1|Clinical Outcomes|Lost to Follow-up|6
7734784|NCT00912964|26896789|P3|Overall Study|Randomized but never received study drug|0
7734785|NCT00912964|26896790|P2|Overall Study|Randomized but never received study drug|1
7734786|NCT00912964|26896791|P1|Overall Study|Randomized but never received study drug|0
7734787|NCT00912964|26896789|P3|Overall Study|Violation of exclusion criterion|2
7734788|NCT00912964|26896790|P2|Overall Study|Violation of exclusion criterion|0
7734789|NCT00912964|26896791|P1|Overall Study|Violation of exclusion criterion|0
7734790|NCT00912964|26896789|P3|Overall Study|Non-compliance with study procedures|0
7734791|NCT00912964|26896790|P2|Overall Study|Non-compliance with study procedures|0
7734792|NCT00912964|26896791|P1|Overall Study|Non-compliance with study procedures|2
7734793|NCT00912964|26896789|P3|Overall Study|Medical History|0
7734794|NCT00912964|26896790|P2|Overall Study|Medical History|0
7734795|NCT00912964|26896791|P1|Overall Study|Medical History|1
7734796|NCT00912964|26896789|P3|Overall Study|Taking exclusionary medications|8
7734797|NCT00912964|26896790|P2|Overall Study|Taking exclusionary medications|4
7734798|NCT00912964|26896791|P1|Overall Study|Taking exclusionary medications|7
7734799|NCT00912964|26896789|P3|Overall Study|Protocol Violation|8
7734800|NCT00912964|26896790|P2|Overall Study|Protocol Violation|3
7734801|NCT00912964|26896791|P1|Overall Study|Protocol Violation|5
7734802|NCT00912964|26896789|P3|Overall Study|Lost to Follow-up|3
7734803|NCT00912964|26896790|P2|Overall Study|Lost to Follow-up|3
7734804|NCT00912964|26896791|P1|Overall Study|Lost to Follow-up|4
7734805|NCT00912964|26896789|P3|Overall Study|Withdrawal by Subject|18
7734806|NCT00912964|26896790|P2|Overall Study|Withdrawal by Subject|12
7734807|NCT00912964|26896791|P1|Overall Study|Withdrawal by Subject|20
7734808|NCT00912964|26896789|P3|Overall Study|Lack of Efficacy|3
7734809|NCT00912964|26896790|P2|Overall Study|Lack of Efficacy|4
7734810|NCT00912964|26896791|P1|Overall Study|Lack of Efficacy|11
7734811|NCT00912964|26896789|P3|Overall Study|Adverse Event|12
7734812|NCT00912964|26896790|P2|Overall Study|Adverse Event|18
7734813|NCT00912964|26896791|P1|Overall Study|Adverse Event|15
7734814|NCT00912964|26896789|P3|Overall Study|Eligibility criterion not met|0
7734815|NCT00912964|26896790|P2|Overall Study|Eligibility criterion not met|1
7734816|NCT00912964|26896791|P1|Overall Study|Eligibility criterion not met|1
7734817|NCT00912912|26896934|P1|Overall Study|Disease Progression|3
7734818|NCT00912912|26896934|P1|Overall Study|Withdrawal by Subject|1
7734819|NCT00912808|26896961|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7734820|NCT00912808|26896962|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7734821|NCT00912808|26896961|P2|Second Intervention (6 Weeks)|Adverse Event|1
7734822|NCT00912808|26896962|P1|Second Intervention (6 Weeks)|Adverse Event|0
7734823|NCT00912808|26896961|P2|Washout|Withdrawal by Subject|1
7734824|NCT00912808|26896962|P1|Washout|Withdrawal by Subject|0
7734825|NCT00912808|26896961|P2|First Intervention (6 Weeks)|Adverse Event|1
7734826|NCT00912808|26896962|P1|First Intervention (6 Weeks)|Adverse Event|2
7734827|NCT00912782|26896987|P2|Overall Study|Relocated before study completion|1
7734828|NCT00912782|26896988|P1|Overall Study|Relocated before study completion|0
7734829|NCT00912782|26896987|P2|Overall Study|Did not receive vascular access type|2
7734830|NCT00912782|26896988|P1|Overall Study|Did not receive vascular access type|1
7734831|NCT00912782|26896987|P2|Overall Study|Lost to Follow-up|1
7734832|NCT00912782|26896988|P1|Overall Study|Lost to Follow-up|0
7734833|NCT00912782|26896987|P2|Overall Study|Death|1
7734834|NCT00912782|26896988|P1|Overall Study|Death|2
7734835|NCT00912743|26896998|P2|Overall Study|End of treatment form was not collected|0
7734836|NCT00912743|26896999|P1|Overall Study|End of treatment form was not collected|1
7734837|NCT00912743|26896998|P2|Overall Study|Toxicity|1
7734838|NCT00912743|26896999|P1|Overall Study|Toxicity|0
7734839|NCT00912743|26896998|P2|Overall Study|Lack of Efficacy|18
7734840|NCT00912743|26896999|P1|Overall Study|Lack of Efficacy|9
7734841|NCT00912743|26896998|P2|Overall Study|Adverse Event|1
7734842|NCT00912743|26896999|P1|Overall Study|Adverse Event|3
7734843|NCT00912509|26897011|P2|Overall Study|Lack of Efficacy|3
7734844|NCT00912509|26897012|P1|Overall Study|Lack of Efficacy|4
7734845|NCT00912509|26897011|P2|Overall Study|Lost to Follow-up|0
7734846|NCT00912509|26897012|P1|Overall Study|Lost to Follow-up|1
7734847|NCT00912405|26897020|P1|Overall Study|Lost to Follow-up|5
7734848|NCT00912340|26897030|P3|Overall Study|Protocol revised to remove arm|4
7734849|NCT00912340|26897031|P2|Overall Study|Protocol revised to remove arm|0
7734850|NCT00912340|26897032|P1|Overall Study|Protocol revised to remove arm|0
7734851|NCT00912340|26897030|P3|Overall Study|Adverse Event|0
7734852|NCT00912340|26897031|P2|Overall Study|Adverse Event|4
7734853|NCT00912340|26897032|P1|Overall Study|Adverse Event|2
7734854|NCT00912288|26897070|P2|Overall Study|Other|0
7734855|NCT00912288|26897071|P1|Overall Study|Other|1
7734856|NCT00912288|26897070|P2|Overall Study|Study terminated by sponsor|35
7734857|NCT00912288|26897071|P1|Overall Study|Study terminated by sponsor|34
7734858|NCT00912288|26897070|P2|Overall Study|Withdrawal by Subject|3
7734859|NCT00912288|26897071|P1|Overall Study|Withdrawal by Subject|3
7734860|NCT00912288|26897070|P2|Overall Study|Protocol Violation|0
7734861|NCT00912288|26897071|P1|Overall Study|Protocol Violation|1
7734862|NCT00912288|26897070|P2|Overall Study|Lost to Follow-up|0
7734863|NCT00912288|26897071|P1|Overall Study|Lost to Follow-up|1
7734864|NCT00912288|26897070|P2|Overall Study|Adverse Event|1
7734865|NCT00912288|26897071|P1|Overall Study|Adverse Event|1
7734866|NCT00912288|26897070|P2|Overall Study|Death|1
7734867|NCT00912288|26897071|P1|Overall Study|Death|0
7734868|NCT00912223|26897093|P1|Overall Study|Transformed disease|1
7734869|NCT00912223|26897093|P1|Overall Study|Not transplanted|1
7734870|NCT00912223|26897093|P1|Overall Study|Withdrawal by Subject|1
7734871|NCT00912197|26897111|P2|Overall Study|Withdrawal by Subject|3
7734872|NCT00912197|26897112|P1|Overall Study|Withdrawal by Subject|3
7734873|NCT00912093|26897155|P5|The Controlled Phase|Lost to Follow-up|1
7734874|NCT00912093|26897156|P4|The Controlled Phase|Lost to Follow-up|0
7734875|NCT00912093|26897157|P3|The Controlled Phase|Lost to Follow-up|0
7734876|NCT00912093|26897158|P2|The Controlled Phase|Lost to Follow-up|0
7734877|NCT00912093|26897159|P1|The Controlled Phase|Lost to Follow-up|0
7734878|NCT00912093|26897155|P5|The Controlled Phase|Medical Condition|0
7734879|NCT00912093|26897156|P4|The Controlled Phase|Medical Condition|0
7734880|NCT00912093|26897157|P3|The Controlled Phase|Medical Condition|0
7734881|NCT00912093|26897158|P2|The Controlled Phase|Medical Condition|1
7734882|NCT00912093|26897159|P1|The Controlled Phase|Medical Condition|0
7734883|NCT00912093|26897155|P5|The Controlled Phase|Death|0
7734884|NCT00912093|26897156|P4|The Controlled Phase|Death|0
7734885|NCT00912093|26897157|P3|The Controlled Phase|Death|0
7734886|NCT00912093|26897158|P2|The Controlled Phase|Death|1
7734887|NCT00912093|26897159|P1|The Controlled Phase|Death|0
7734888|NCT00912028|26897178|P5|Overall Study|Withdrawal by Subject|0
7734889|NCT00912028|26897179|P4|Overall Study|Withdrawal by Subject|0
7734890|NCT00912028|26897180|P3|Overall Study|Withdrawal by Subject|0
7734891|NCT00912028|26897181|P2|Overall Study|Withdrawal by Subject|0
7734892|NCT00912028|26897182|P1|Overall Study|Withdrawal by Subject|3
7734893|NCT00912028|26897178|P5|Overall Study|Lost to Follow-up|3
7734894|NCT00912028|26897179|P4|Overall Study|Lost to Follow-up|1
7734895|NCT00912028|26897180|P3|Overall Study|Lost to Follow-up|0
7734896|NCT00912028|26897181|P2|Overall Study|Lost to Follow-up|3
7734897|NCT00912028|26897182|P1|Overall Study|Lost to Follow-up|2
7734898|NCT00912015|26897211|P4|Overall Study|Adverse Event|1
7734899|NCT00912015|26897212|P3|Overall Study|Adverse Event|0
7734900|NCT00912015|26897213|P2|Overall Study|Adverse Event|0
7734901|NCT00912015|26897214|P1|Overall Study|Adverse Event|6
7734902|NCT00912015|26897211|P4|Overall Study|Protocol Violation|1
7734903|NCT00912015|26897212|P3|Overall Study|Protocol Violation|0
7734904|NCT00912015|26897213|P2|Overall Study|Protocol Violation|0
7734905|NCT00912015|26897214|P1|Overall Study|Protocol Violation|1
7734906|NCT00912015|26897211|P4|Overall Study|Withdrawal by Subject|0
7734907|NCT00912015|26897212|P3|Overall Study|Withdrawal by Subject|3
7734908|NCT00912015|26897213|P2|Overall Study|Withdrawal by Subject|8
7734909|NCT00912015|26897214|P1|Overall Study|Withdrawal by Subject|8
7734910|NCT00912015|26897211|P4|Overall Study|Lack of Efficacy|0
7734911|NCT00912015|26897212|P3|Overall Study|Lack of Efficacy|0
7734912|NCT00912015|26897213|P2|Overall Study|Lack of Efficacy|0
7734913|NCT00912015|26897214|P1|Overall Study|Lack of Efficacy|1
7734914|NCT00911989|26897230|P1|Overall Study|Adverse Event|1
7734915|NCT00911937|26897236|P2|Overall Study|Other|5
7734916|NCT00911937|26897237|P1|Overall Study|Other|9
7734917|NCT00911937|26897236|P2|Overall Study|Randomized but not treated|13
7734918|NCT00911937|26897237|P1|Overall Study|Randomized but not treated|13
7734919|NCT00911937|26897236|P2|Overall Study|Protocol Violation|23
7734920|NCT00911937|26897237|P1|Overall Study|Protocol Violation|14
7734921|NCT00911937|26897236|P2|Overall Study|Did not meet inclusion criteria|11
7734922|NCT00911937|26897237|P1|Overall Study|Did not meet inclusion criteria|9
7734923|NCT00911937|26897236|P2|Overall Study|Lack of Efficacy|6
7734924|NCT00911937|26897237|P1|Overall Study|Lack of Efficacy|11
7734925|NCT00911937|26897236|P2|Overall Study|Adverse Event|25
7734926|NCT00911937|26897237|P1|Overall Study|Adverse Event|11
7734927|NCT00911937|26897236|P2|Overall Study|Withdrawn due to pregnancy|0
7734928|NCT00911937|26897237|P1|Overall Study|Withdrawn due to pregnancy|1
7734929|NCT00911937|26897236|P2|Overall Study|Withdrawal by Subject|7
7734930|NCT00911937|26897237|P1|Overall Study|Withdrawal by Subject|10
7734931|NCT00911937|26897236|P2|Overall Study|Lost to Follow-up|5
7734932|NCT00911937|26897237|P1|Overall Study|Lost to Follow-up|8
7734933|NCT00911937|26897236|P2|Overall Study|Death|0
7734934|NCT00911937|26897237|P1|Overall Study|Death|1
7734935|NCT00911859|26897304|P3|Follow-up Period|Study terminated by sponsor|27
7734936|NCT00911859|26897305|P2|Follow-up Period|Study terminated by sponsor|33
7734937|NCT00911859|26897306|P1|Follow-up Period|Study terminated by sponsor|5
7734938|NCT00911859|26897304|P3|Follow-up Period|Withdrawal by Subject|4
7734939|NCT00911859|26897305|P2|Follow-up Period|Withdrawal by Subject|4
7734940|NCT00911859|26897306|P1|Follow-up Period|Withdrawal by Subject|0
7734941|NCT00911859|26897304|P3|Follow-up Period|Lost to Follow-up|0
7734942|NCT00911859|26897305|P2|Follow-up Period|Lost to Follow-up|1
7734943|NCT00911859|26897306|P1|Follow-up Period|Lost to Follow-up|1
7734944|NCT00911859|26897304|P3|Follow-up Period|Death|10
7734945|NCT00911859|26897305|P2|Follow-up Period|Death|8
7734946|NCT00911859|26897306|P1|Follow-up Period|Death|5
7734947|NCT00911859|26897304|P3|Maintainance Period|Withdrawal by Subject|3
7734948|NCT00911859|26897305|P2|Maintainance Period|Withdrawal by Subject|0
7734949|NCT00911859|26897306|P1|Maintainance Period|Withdrawal by Subject|0
7734950|NCT00911859|26897304|P3|Maintainance Period|Physician Decision|9
7734951|NCT00911859|26897305|P2|Maintainance Period|Physician Decision|0
7734952|NCT00911859|26897306|P1|Maintainance Period|Physician Decision|0
7734953|NCT00911859|26897304|P3|Maintainance Period|Lack of Efficacy|9
7734954|NCT00911859|26897305|P2|Maintainance Period|Lack of Efficacy|0
7734955|NCT00911859|26897306|P1|Maintainance Period|Lack of Efficacy|0
7734956|NCT00911859|26897304|P3|Treatment Period|Did not receive study treatment|0
7734957|NCT00911859|26897305|P2|Treatment Period|Did not receive study treatment|1
7734958|NCT00911859|26897306|P1|Treatment Period|Did not receive study treatment|0
7734959|NCT00911859|26897304|P3|Treatment Period|Withdrawal by Subject|5
7734960|NCT00911859|26897305|P2|Treatment Period|Withdrawal by Subject|4
7734961|NCT00911859|26897306|P1|Treatment Period|Withdrawal by Subject|0
7734962|NCT00911859|26897304|P3|Treatment Period|Physician Decision|3
7734963|NCT00911859|26897305|P2|Treatment Period|Physician Decision|3
7734964|NCT00911859|26897306|P1|Treatment Period|Physician Decision|3
7734965|NCT00911859|26897304|P3|Treatment Period|Lack of Efficacy|5
7734966|NCT00911859|26897305|P2|Treatment Period|Lack of Efficacy|7
7734967|NCT00911859|26897306|P1|Treatment Period|Lack of Efficacy|1
7734968|NCT00911859|26897304|P3|Treatment Period|Death|5
7734969|NCT00911859|26897305|P2|Treatment Period|Death|3
7734970|NCT00911859|26897306|P1|Treatment Period|Death|1
7734971|NCT00911859|26897304|P3|Treatment Period|Adverse Event|7
7734972|NCT00911859|26897305|P2|Treatment Period|Adverse Event|3
7734973|NCT00911859|26897306|P1|Treatment Period|Adverse Event|3
7734974|NCT00911820|26897332|P2|Overall Study|Withdraw before Receive Treatment|2
7734975|NCT00911820|26897333|P1|Overall Study|Withdraw before Receive Treatment|0
7734976|NCT00911820|26897332|P2|Overall Study|Pathology Not Confirmed|0
7734977|NCT00911820|26897333|P1|Overall Study|Pathology Not Confirmed|1
7734978|NCT00911820|26897332|P2|Overall Study|Still on Therapy|2
7734979|NCT00911820|26897333|P1|Overall Study|Still on Therapy|2
7734980|NCT00911820|26897332|P2|Overall Study|Pursue Radiation|0
7734981|NCT00911820|26897333|P1|Overall Study|Pursue Radiation|1
7734982|NCT00911820|26897332|P2|Overall Study|Pursue surgery|1
7734983|NCT00911820|26897333|P1|Overall Study|Pursue surgery|1
7734984|NCT00911820|26897332|P2|Overall Study|Death|2
7734985|NCT00911820|26897333|P1|Overall Study|Death|1
7734986|NCT00911820|26897332|P2|Overall Study|Withdrawal by Subject|4
7734987|NCT00911820|26897333|P1|Overall Study|Withdrawal by Subject|3
7734988|NCT00911820|26897332|P2|Overall Study|Decline in Performance Status|2
7734989|NCT00911820|26897333|P1|Overall Study|Decline in Performance Status|4
7734990|NCT00911820|26897332|P2|Overall Study|Physician Decision|9
7734991|NCT00911820|26897333|P1|Overall Study|Physician Decision|5
7734992|NCT00911820|26897332|P2|Overall Study|Clinical Progression|5
7734993|NCT00911820|26897333|P1|Overall Study|Clinical Progression|7
7734994|NCT00911820|26897332|P2|Overall Study|Adverse Event|8
7734995|NCT00911820|26897333|P1|Overall Study|Adverse Event|8
7734996|NCT00911820|26897332|P2|Overall Study|RECIST progression|8
7734997|NCT00911820|26897333|P1|Overall Study|RECIST progression|12
7734998|NCT00911807|26897350|P3|Overall Study|Organizational reasons|1
7734999|NCT00911807|26897351|P2|Overall Study|Organizational reasons|3
7735000|NCT00911807|26897352|P1|Overall Study|Organizational reasons|1
7735001|NCT00911807|26897350|P3|Overall Study|Withdrawal by Subject|7
7735002|NCT00911807|26897351|P2|Overall Study|Withdrawal by Subject|10
7735003|NCT00911807|26897352|P1|Overall Study|Withdrawal by Subject|8
7735004|NCT00911807|26897350|P3|Overall Study|Protocol Violation|9
7735005|NCT00911807|26897351|P2|Overall Study|Protocol Violation|4
7735006|NCT00911807|26897352|P1|Overall Study|Protocol Violation|6
7735007|NCT00911807|26897350|P3|Overall Study|Death|1
7735008|NCT00911807|26897351|P2|Overall Study|Death|0
7735009|NCT00911807|26897352|P1|Overall Study|Death|0
7735010|NCT00911807|26897350|P3|Overall Study|Adverse Event|5
7735011|NCT00911807|26897351|P2|Overall Study|Adverse Event|1
7735012|NCT00911807|26897352|P1|Overall Study|Adverse Event|2
7735013|NCT00911768|26897362|P2|Overall Study|Withdrawal by Subject|0
7735014|NCT00911768|26897363|P1|Overall Study|Withdrawal by Subject|1
7735015|NCT00911768|26897362|P2|Overall Study|Protocol Violation|4
7735016|NCT00911768|26897363|P1|Overall Study|Protocol Violation|5
7735017|NCT00911625|26897392|P2|Overall Study|Lost to Follow-up|0
7735018|NCT00911625|26897393|P1|Overall Study|Lost to Follow-up|7
7735019|NCT00911547|26897427|P4|Overall Study|Withdrawal by Subject|8
7735020|NCT00911547|26897428|P3|Overall Study|Withdrawal by Subject|4
7735021|NCT00911547|26897429|P2|Overall Study|Withdrawal by Subject|10
7735022|NCT00911547|26897430|P1|Overall Study|Withdrawal by Subject|3
7735023|NCT00911547|26897427|P4|Overall Study|Protocol Violation|1
7735024|NCT00911547|26897428|P3|Overall Study|Protocol Violation|5
7735025|NCT00911547|26897429|P2|Overall Study|Protocol Violation|5
7735026|NCT00911547|26897430|P1|Overall Study|Protocol Violation|0
7735027|NCT00911547|26897427|P4|Overall Study|Lost to Follow-up|1
7735028|NCT00911547|26897428|P3|Overall Study|Lost to Follow-up|2
7735029|NCT00911547|26897429|P2|Overall Study|Lost to Follow-up|0
7735030|NCT00911547|26897430|P1|Overall Study|Lost to Follow-up|0
7735031|NCT00911547|26897427|P4|Overall Study|Adverse Event|6
7735032|NCT00911547|26897428|P3|Overall Study|Adverse Event|11
7735033|NCT00911547|26897429|P2|Overall Study|Adverse Event|27
7735034|NCT00911547|26897430|P1|Overall Study|Adverse Event|8
7735035|NCT00911534|26897458|P2|Overall Study|Other|2
7735036|NCT00911534|26897459|P1|Overall Study|Other|2
7735037|NCT00911534|26897458|P2|Overall Study|Withdrawal of consent|4
7735038|NCT00911534|26897459|P1|Overall Study|Withdrawal of consent|1
7735039|NCT00911534|26897458|P2|Overall Study|Lack of Efficacy|1
7735040|NCT00911534|26897459|P1|Overall Study|Lack of Efficacy|4
7735041|NCT00911534|26897458|P2|Overall Study|Withdrawal by Subject|1
7735042|NCT00911534|26897459|P1|Overall Study|Withdrawal by Subject|2
7735043|NCT00911534|26897458|P2|Overall Study|Lost to Follow-up|4
7735044|NCT00911534|26897459|P1|Overall Study|Lost to Follow-up|2
7735045|NCT00911534|26897458|P2|Overall Study|Adverse Event|4
7735046|NCT00911534|26897459|P1|Overall Study|Adverse Event|4
7735047|NCT00911508|26897473|P2|Overall Study|Withdrawal by Subject|112
7735048|NCT00911508|26897474|P1|Overall Study|Withdrawal by Subject|79
7735049|NCT00911508|26897473|P2|Overall Study|Lost to Follow-up|18
7735050|NCT00911508|26897474|P1|Overall Study|Lost to Follow-up|27
7735051|NCT00911300|26897549|P2|Overall Study|Randomized; No Study Medication Received|2
7735052|NCT00911300|26897550|P1|Overall Study|Randomized; No Study Medication Received|0
7735053|NCT00911300|26897549|P2|Overall Study|Treatment Stopped by Mistake|1
7735054|NCT00911300|26897550|P1|Overall Study|Treatment Stopped by Mistake|0
7735055|NCT00911300|26897549|P2|Overall Study|Physician Decision|1
7735056|NCT00911300|26897550|P1|Overall Study|Physician Decision|0
7735057|NCT00911300|26897549|P2|Overall Study|Underlying Disease (Myocarditis)|1
7735058|NCT00911300|26897550|P1|Overall Study|Underlying Disease (Myocarditis)|0
7735059|NCT00911300|26897549|P2|Overall Study|Participant Refused Hospital Consulation|1
7735060|NCT00911300|26897550|P1|Overall Study|Participant Refused Hospital Consulation|0
7735061|NCT00911300|26897549|P2|Overall Study|International Normalized Ratio Too High|1
7735062|NCT00911300|26897550|P1|Overall Study|International Normalized Ratio Too High|0
7735063|NCT00911300|26897549|P2|Overall Study|Investigator's Decision; New AF Episode|1
7735064|NCT00911300|26897550|P1|Overall Study|Investigator's Decision; New AF Episode|0
7735065|NCT00911300|26897549|P2|Overall Study|Participant Could Not Stay in Hospital|1
7735066|NCT00911300|26897550|P1|Overall Study|Participant Could Not Stay in Hospital|0
7735067|NCT00911300|26897549|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
7735068|NCT00911300|26897550|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
7735069|NCT00911300|26897549|P2|Overall Study|Nurse Unavailable in Participant's City|0
7735070|NCT00911300|26897550|P1|Overall Study|Nurse Unavailable in Participant's City|1
7735071|NCT00911300|26897549|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
7735072|NCT00911300|26897550|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
7735073|NCT00911300|26897549|P2|Overall Study|Recurrent Tachyarrhythmia|1
7735074|NCT00911300|26897550|P1|Overall Study|Recurrent Tachyarrhythmia|1
7735075|NCT00911300|26897549|P2|Overall Study|Received Commercial Treatment|0
7735076|NCT00911300|26897550|P1|Overall Study|Received Commercial Treatment|1
7735077|NCT00911300|26897549|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
7735078|NCT00911300|26897550|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
7735079|NCT00911300|26897549|P2|Overall Study|Coronary Angiography Performed|0
7735080|NCT00911300|26897550|P1|Overall Study|Coronary Angiography Performed|1
7735081|NCT00911300|26897549|P2|Overall Study|Consent Withdrawn|12
7735082|NCT00911300|26897550|P1|Overall Study|Consent Withdrawn|4
7735083|NCT00911300|26897549|P2|Overall Study|Protocol Violation|2
7735084|NCT00911300|26897550|P1|Overall Study|Protocol Violation|3
7735085|NCT00911300|26897549|P2|Overall Study|Adverse Event|6
7735086|NCT00911300|26897550|P1|Overall Study|Adverse Event|14
7735087|NCT00911300|26897549|P2|Overall Study|Thrombus Persistant in Second TEE|7
7735088|NCT00911300|26897550|P1|Overall Study|Thrombus Persistant in Second TEE|3
7735089|NCT00911300|26897549|P2|Overall Study|Death|0
7735090|NCT00911300|26897550|P1|Overall Study|Death|1
7735091|NCT00911300|26897549|P2|Overall Study|Primary Endpoint Component Occurred|2
7735092|NCT00911300|26897550|P1|Overall Study|Primary Endpoint Component Occurred|1
7735093|NCT00911170|26897587|P2|Long Term Follow-Up|Death|121
7735094|NCT00911170|26897588|P1|Long Term Follow-Up|Death|116
7735095|NCT00911170|26897587|P2|Long Term Follow-Up|Lost to Follow-up|7
7735096|NCT00911170|26897588|P1|Long Term Follow-Up|Lost to Follow-up|8
7735097|NCT00911170|26897587|P2|Long Term Follow-Up|Physician Decision|4
7735098|NCT00911170|26897588|P1|Long Term Follow-Up|Physician Decision|5
7735099|NCT00911170|26897587|P2|Long Term Follow-Up|Withdrawal by Subject|21
7735100|NCT00911170|26897588|P1|Long Term Follow-Up|Withdrawal by Subject|20
7735101|NCT00911170|26897587|P2|Long Term Follow-Up|Continuing in study|269
7735102|NCT00911170|26897588|P1|Long Term Follow-Up|Continuing in study|274
7735103|NCT00911170|26897587|P2|Treatment Period|Death|9
7735104|NCT00911170|26897588|P1|Treatment Period|Death|6
7735105|NCT00911170|26897587|P2|Treatment Period|Lost to Follow-up|1
7735106|NCT00911170|26897588|P1|Treatment Period|Lost to Follow-up|0
7735107|NCT00911170|26897587|P2|Treatment Period|Physician Decision|5
7735108|NCT00911170|26897588|P1|Treatment Period|Physician Decision|5
7735109|NCT00911170|26897587|P2|Treatment Period|Disease progression|2
7735110|NCT00911170|26897588|P1|Treatment Period|Disease progression|0
7735111|NCT00911170|26897587|P2|Treatment Period|Withdrawal by Subject|4
7735112|NCT00911170|26897588|P1|Treatment Period|Withdrawal by Subject|4
7735113|NCT00911170|26897587|P2|Treatment Period|Adverse Event|10
7735114|NCT00911170|26897588|P1|Treatment Period|Adverse Event|9
7735115|NCT00911170|26897587|P2|Treatment Period|Protocol deviation|2
7735116|NCT00911170|26897588|P1|Treatment Period|Protocol deviation|1
7735117|NCT00911170|26897587|P2|Treatment Period|Ineligibility determined|3
7735118|NCT00911170|26897588|P1|Treatment Period|Ineligibility determined|1
7735119|NCT00911170|26897587|P2|Treatment Period|Randomized in error|1
7735120|NCT00911170|26897588|P1|Treatment Period|Randomized in error|1
7735121|NCT00911157|26897612|P2|Overall Study|Need to treat for lung cancer|0
7735122|NCT00911157|26897613|P1|Overall Study|Need to treat for lung cancer|1
7735123|NCT00911157|26897612|P2|Overall Study|Need for prohibited drug (heparin)|0
7735124|NCT00911157|26897613|P1|Overall Study|Need for prohibited drug (heparin)|1
7735125|NCT00911157|26897612|P2|Overall Study|Withdrawal by Subject|1
7735126|NCT00911157|26897613|P1|Overall Study|Withdrawal by Subject|1
7735127|NCT00911157|26897612|P2|Overall Study|Adverse Event|1
7735128|NCT00911157|26897613|P1|Overall Study|Adverse Event|4
7735129|NCT00911144|26897629|P2|Overall Study|Withdrawal by Subject|5
7735130|NCT00911144|26897630|P1|Overall Study|Withdrawal by Subject|16
7735131|NCT00910988|26897684|P4|Overall Study|Lost to Follow-up|0
7735132|NCT00910988|26897685|P3|Overall Study|Lost to Follow-up|3
7735133|NCT00910988|26897686|P2|Overall Study|Lost to Follow-up|4
7735134|NCT00910988|26897687|P1|Overall Study|Lost to Follow-up|2
7735135|NCT00910962|26897732|P3|Overall Study|Reached defined stopping criteria|17
7735136|NCT00910962|26897733|P2|Overall Study|Reached defined stopping criteria|14
7735137|NCT00910962|26897734|P1|Overall Study|Reached defined stopping criteria|12
7735138|NCT00910962|26897732|P3|Overall Study|Withdrawal by Subject|32
7735139|NCT00910962|26897733|P2|Overall Study|Withdrawal by Subject|32
7735140|NCT00910962|26897734|P1|Overall Study|Withdrawal by Subject|25
7735141|NCT00910962|26897732|P3|Overall Study|Physician Decision|6
7735142|NCT00910962|26897733|P2|Overall Study|Physician Decision|6
7735143|NCT00910962|26897734|P1|Overall Study|Physician Decision|0
7735144|NCT00910962|26897732|P3|Overall Study|Lost to Follow-up|1
7735145|NCT00910962|26897733|P2|Overall Study|Lost to Follow-up|3
7735146|NCT00910962|26897734|P1|Overall Study|Lost to Follow-up|0
7735147|NCT00910962|26897732|P3|Overall Study|Protocol Violation|3
7735148|NCT00910962|26897733|P2|Overall Study|Protocol Violation|3
7735149|NCT00910962|26897734|P1|Overall Study|Protocol Violation|1
7735150|NCT00910962|26897732|P3|Overall Study|Adverse Event|17
7735151|NCT00910962|26897733|P2|Overall Study|Adverse Event|20
7735152|NCT00910962|26897734|P1|Overall Study|Adverse Event|5
7735153|NCT00910910|26897826|P2|Overall Study|Untreated before cycle 1|2
7735154|NCT00910910|26897827|P1|Overall Study|Untreated before cycle 1|1
7735155|NCT00910910|26897826|P2|Overall Study|Other|32
7735156|NCT00910910|26897827|P1|Overall Study|Other|114
7735157|NCT00910910|26897826|P2|Overall Study|Completed 13 cycles of treatment|118
7735158|NCT00910910|26897827|P1|Overall Study|Completed 13 cycles of treatment|0
7735159|NCT00910910|26897826|P2|Overall Study|Protocol Violation|2
7735160|NCT00910910|26897827|P1|Overall Study|Protocol Violation|2
7735161|NCT00910910|26897826|P2|Overall Study|Death|3
7735162|NCT00910910|26897827|P1|Overall Study|Death|9
7735163|NCT00910910|26897826|P2|Overall Study|Lost to Follow-up|2
7735164|NCT00910910|26897827|P1|Overall Study|Lost to Follow-up|2
7735165|NCT00910910|26897826|P2|Overall Study|Withdrawal by Subject|5
7735166|NCT00910910|26897827|P1|Overall Study|Withdrawal by Subject|7
7735167|NCT00910910|26897826|P2|Overall Study|PD with histologic change|2
7735168|NCT00910910|26897827|P1|Overall Study|PD with histologic change|0
7735169|NCT00910910|26897826|P2|Overall Study|PD without histologic change|23
7735170|NCT00910910|26897827|P1|Overall Study|PD without histologic change|27
7735171|NCT00910910|26897826|P2|Overall Study|Adverse Event|35
7735172|NCT00910910|26897827|P1|Overall Study|Adverse Event|63
7735173|NCT00910871|26897863|P1|Overall Study|Undefined|1
7735174|NCT00910871|26897863|P1|Overall Study|Subject didn't meet eligibility criteria|5
7735175|NCT00910871|26897863|P1|Overall Study|Withdrawal by Subject|12
7735176|NCT00910871|26897863|P1|Overall Study|Protocol Violation|11
7735177|NCT00910871|26897863|P1|Overall Study|Lost to Follow-up|8
7735178|NCT00910871|26897863|P1|Overall Study|Death|12
7735179|NCT00910871|26897863|P1|Overall Study|Adverse Event|5
7735180|NCT00910858|26897871|P3|Combined Treatment Phase|Other|1
7735181|NCT00910858|26897872|P2|Combined Treatment Phase|Other|2
7735182|NCT00910858|26897873|P1|Combined Treatment Phase|Other|0
7735183|NCT00910858|26897871|P3|Combined Treatment Phase|Protocol Violation|0
7735184|NCT00910858|26897872|P2|Combined Treatment Phase|Protocol Violation|0
7735185|NCT00910858|26897873|P1|Combined Treatment Phase|Protocol Violation|1
7735186|NCT00910858|26897871|P3|Combined Treatment Phase|Withdrawal by Subject|0
7735187|NCT00910858|26897872|P2|Combined Treatment Phase|Withdrawal by Subject|2
7735188|NCT00910858|26897873|P1|Combined Treatment Phase|Withdrawal by Subject|0
7735189|NCT00910858|26897871|P3|Combined Treatment Phase|Lack of therapeutic effect|3
7735190|NCT00910858|26897872|P2|Combined Treatment Phase|Lack of therapeutic effect|6
7735191|NCT00910858|26897873|P1|Combined Treatment Phase|Lack of therapeutic effect|8
7735192|NCT00910858|26897871|P3|Monotherapy Phase|Other|2
7735193|NCT00910858|26897872|P2|Monotherapy Phase|Other|4
7735194|NCT00910858|26897873|P1|Monotherapy Phase|Other|3
7735195|NCT00910858|26897871|P3|Monotherapy Phase|Protocol Violation|0
7735196|NCT00910858|26897872|P2|Monotherapy Phase|Protocol Violation|0
7735197|NCT00910858|26897873|P1|Monotherapy Phase|Protocol Violation|1
7735198|NCT00910858|26897871|P3|Monotherapy Phase|Withdrawal by Subject|1
7735199|NCT00910858|26897872|P2|Monotherapy Phase|Withdrawal by Subject|3
7735200|NCT00910858|26897873|P1|Monotherapy Phase|Withdrawal by Subject|1
7735201|NCT00910858|26897871|P3|Monotherapy Phase|Lack of therapeutic effect|4
7735202|NCT00910858|26897872|P2|Monotherapy Phase|Lack of therapeutic effect|6
7735203|NCT00910858|26897873|P1|Monotherapy Phase|Lack of therapeutic effect|9
7735204|NCT00910858|26897871|P3|Monotherapy Phase|Adverse Event|0
7735205|NCT00910858|26897872|P2|Monotherapy Phase|Adverse Event|2
7735206|NCT00910858|26897873|P1|Monotherapy Phase|Adverse Event|3
7735207|NCT00910858|26897871|P3|Pharmacokinetic Phase|Adverse Event|0
7735208|NCT00910858|26897872|P2|Pharmacokinetic Phase|Adverse Event|0
7735209|NCT00910858|26897873|P1|Pharmacokinetic Phase|Adverse Event|1
7735210|NCT00910728|26897918|P9|Overall Study|Adverse Event|1
7735211|NCT00910728|26897919|P8|Overall Study|Adverse Event|1
7735212|NCT00910728|26897920|P7|Overall Study|Adverse Event|2
7735213|NCT00910728|26897921|P6|Overall Study|Adverse Event|0
7735214|NCT00910728|26897922|P5|Overall Study|Adverse Event|0
7735215|NCT00910728|26897923|P4|Overall Study|Adverse Event|1
7735216|NCT00910728|26897924|P3|Overall Study|Adverse Event|1
7735217|NCT00910728|26897925|P2|Overall Study|Adverse Event|0
7735218|NCT00910728|26897926|P1|Overall Study|Adverse Event|2
7735219|NCT00910728|26897918|P9|Overall Study|(not specified)|0
7735220|NCT00910728|26897919|P8|Overall Study|(not specified)|0
7735221|NCT00910728|26897920|P7|Overall Study|(not specified)|0
7735222|NCT00910728|26897921|P6|Overall Study|(not specified)|0
7735223|NCT00910728|26897922|P5|Overall Study|(not specified)|1
7735224|NCT00910728|26897923|P4|Overall Study|(not specified)|0
7735225|NCT00910728|26897924|P3|Overall Study|(not specified)|1
7735226|NCT00910728|26897925|P2|Overall Study|(not specified)|0
7735227|NCT00910728|26897926|P1|Overall Study|(not specified)|2
7735228|NCT00910728|26897918|P9|Overall Study|Withdrawal by Subject|0
7735229|NCT00910728|26897919|P8|Overall Study|Withdrawal by Subject|0
7735230|NCT00910728|26897920|P7|Overall Study|Withdrawal by Subject|2
7735231|NCT00910728|26897921|P6|Overall Study|Withdrawal by Subject|1
7735232|NCT00910728|26897922|P5|Overall Study|Withdrawal by Subject|3
7735233|NCT00910728|26897923|P4|Overall Study|Withdrawal by Subject|0
7735234|NCT00910728|26897924|P3|Overall Study|Withdrawal by Subject|0
7735235|NCT00910728|26897925|P2|Overall Study|Withdrawal by Subject|0
7735236|NCT00910728|26897926|P1|Overall Study|Withdrawal by Subject|0
7735237|NCT00910728|26897918|P9|Overall Study|Lack of Efficacy|2
7735238|NCT00910728|26897919|P8|Overall Study|Lack of Efficacy|2
7735239|NCT00910728|26897920|P7|Overall Study|Lack of Efficacy|2
7735240|NCT00910728|26897921|P6|Overall Study|Lack of Efficacy|0
7735241|NCT00910728|26897922|P5|Overall Study|Lack of Efficacy|1
7735242|NCT00910728|26897923|P4|Overall Study|Lack of Efficacy|2
7735243|NCT00910728|26897924|P3|Overall Study|Lack of Efficacy|1
7735244|NCT00910728|26897925|P2|Overall Study|Lack of Efficacy|3
7735245|NCT00910728|26897926|P1|Overall Study|Lack of Efficacy|2
7735246|NCT00910715|26898048|P3|Overall Study|Lost to Follow-up|0
7735247|NCT00910715|26898049|P2|Overall Study|Lost to Follow-up|26
7735248|NCT00910715|26898050|P1|Overall Study|Lost to Follow-up|22
7735249|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
7735250|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
7735251|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
7735252|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
7735253|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
7735254|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7735255|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7735256|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7735257|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Time Demands|0
7735258|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Time Demands|0
7735259|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Time Demands|1
7735260|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Time Demands|2
7735261|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
7735262|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7735263|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7735264|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
7735265|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
7735266|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
7735267|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
7735268|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
7735269|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
7735270|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
7735271|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
7735272|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
7735273|NCT00910689|26898064|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
7735274|NCT00910689|26898065|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
7735275|NCT00910689|26898066|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
7735276|NCT00910689|26898067|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
7735277|NCT00910689|26898064|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
7735278|NCT00910689|26898065|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
7735279|NCT00910689|26898066|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
7735280|NCT00910689|26898067|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
7735281|NCT00910689|26898064|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
7735282|NCT00910689|26898065|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
7735283|NCT00910689|26898066|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
7735284|NCT00910689|26898067|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
7735285|NCT00910689|26898064|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
7735286|NCT00910689|26898065|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
7735287|NCT00910689|26898066|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
7735288|NCT00910689|26898067|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
7735289|NCT00910689|26898064|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7735290|NCT00910689|26898065|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7735291|NCT00910689|26898066|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7735292|NCT00910689|26898067|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
7735293|NCT00910689|26898064|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
7735294|NCT00910689|26898065|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
7735295|NCT00910689|26898066|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
7735296|NCT00910689|26898067|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
7735297|NCT00910689|26898064|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7735298|NCT00910689|26898065|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7735299|NCT00910689|26898066|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
7735300|NCT00910689|26898067|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
7735301|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Protocol Violation|0
7735302|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Protocol Violation|0
7735303|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Protocol Violation|0
7735304|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Protocol Violation|1
7735305|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Pregnancy|0
7735306|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Pregnancy|0
7735307|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Pregnancy|2
7735308|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Pregnancy|0
7735309|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
7735310|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
7735311|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
7735312|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
7735313|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
7735314|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
7735315|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
7735316|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
7735317|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Time Demands|8
7735318|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Time Demands|4
7735319|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Time Demands|0
7735320|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Time Demands|1
7735321|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Adverse Event|0
7735322|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Adverse Event|2
7735323|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Adverse Event|3
7735324|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Adverse Event|2
7735325|NCT00910689|26898064|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
7735326|NCT00910689|26898065|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
7735327|NCT00910689|26898066|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
7735328|NCT00910689|26898067|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
7735329|NCT00910689|26898064|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
7735330|NCT00910689|26898065|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
7735331|NCT00910689|26898066|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
7735332|NCT00910689|26898067|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
7735333|NCT00910663|26898099|P2|Period 1|Withdrawal by Subject|1
7735334|NCT00910663|26898100|P1|Period 1|Withdrawal by Subject|0
7735335|NCT00910650|26898110|P1|Overall Study|Death|2
7735336|NCT00910624|26898119|P4|Follow-Up Phase|Administrative|0
7735337|NCT00910624|26898120|P3|Follow-Up Phase|Administrative|1
7735338|NCT00910624|26898121|P2|Follow-Up Phase|Administrative|1
7735339|NCT00910624|26898122|P1|Follow-Up Phase|Administrative|0
7735340|NCT00910624|26898119|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7735341|NCT00910624|26898120|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7735342|NCT00910624|26898121|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7735343|NCT00910624|26898122|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
7735344|NCT00910624|26898119|P4|Follow-Up Phase|Withdrawal by Subject|0
7735345|NCT00910624|26898120|P3|Follow-Up Phase|Withdrawal by Subject|0
7735346|NCT00910624|26898121|P2|Follow-Up Phase|Withdrawal by Subject|0
7735347|NCT00910624|26898122|P1|Follow-Up Phase|Withdrawal by Subject|1
7735348|NCT00910624|26898119|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
7735349|NCT00910624|26898120|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
7735350|NCT00910624|26898121|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
7735351|NCT00910624|26898122|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
7735352|NCT00910624|26898119|P4|Follow-Up Phase|Lost to Follow-up|0
7735353|NCT00910624|26898120|P3|Follow-Up Phase|Lost to Follow-up|2
7735354|NCT00910624|26898121|P2|Follow-Up Phase|Lost to Follow-up|1
7735355|NCT00910624|26898122|P1|Follow-Up Phase|Lost to Follow-up|3
7735356|NCT00910624|26898119|P4|Follow-Up Phase|Adverse Event|0
7735357|NCT00910624|26898120|P3|Follow-Up Phase|Adverse Event|1
7735358|NCT00910624|26898121|P2|Follow-Up Phase|Adverse Event|0
7735359|NCT00910624|26898122|P1|Follow-Up Phase|Adverse Event|0
7735360|NCT00910624|26898119|P4|Treatment Phase|Non-Compliance With Protocol|0
7735361|NCT00910624|26898120|P3|Treatment Phase|Non-Compliance With Protocol|1
7735362|NCT00910624|26898121|P2|Treatment Phase|Non-Compliance With Protocol|1
7735363|NCT00910624|26898122|P1|Treatment Phase|Non-Compliance With Protocol|0
7735364|NCT00910624|26898119|P4|Treatment Phase|Withdrawal by Subject|0
7735365|NCT00910624|26898120|P3|Treatment Phase|Withdrawal by Subject|0
7735366|NCT00910624|26898121|P2|Treatment Phase|Withdrawal by Subject|1
7735367|NCT00910624|26898122|P1|Treatment Phase|Withdrawal by Subject|2
7735368|NCT00910624|26898119|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
7735369|NCT00910624|26898120|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
7735370|NCT00910624|26898121|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7735371|NCT00910624|26898122|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7735372|NCT00910624|26898119|P4|Treatment Phase|Lost to Follow-up|0
7735373|NCT00910624|26898120|P3|Treatment Phase|Lost to Follow-up|1
7735374|NCT00910624|26898121|P2|Treatment Phase|Lost to Follow-up|0
7735375|NCT00910624|26898122|P1|Treatment Phase|Lost to Follow-up|0
7735376|NCT00910624|26898119|P4|Treatment Phase|Treatment Failure|0
7735377|NCT00910624|26898120|P3|Treatment Phase|Treatment Failure|0
7735378|NCT00910624|26898121|P2|Treatment Phase|Treatment Failure|10
7735379|NCT00910624|26898122|P1|Treatment Phase|Treatment Failure|23
7735380|NCT00910624|26898119|P4|Treatment Phase|Adverse Event|0
7735381|NCT00910624|26898120|P3|Treatment Phase|Adverse Event|6
7735382|NCT00910624|26898121|P2|Treatment Phase|Adverse Event|6
7735383|NCT00910624|26898122|P1|Treatment Phase|Adverse Event|2
7735384|NCT00910429|26898158|P2|Overall Study|Lack of Efficacy|1
7735385|NCT00910429|26898159|P1|Overall Study|Lack of Efficacy|4
7735386|NCT00910429|26898158|P2|Overall Study|Drug non-compliance|0
7735387|NCT00910429|26898159|P1|Overall Study|Drug non-compliance|1
7735388|NCT00910429|26898158|P2|Overall Study|Adverse Event|5
7735389|NCT00910429|26898159|P1|Overall Study|Adverse Event|10
7735390|NCT00910429|26898158|P2|Overall Study|Lost to Follow-up|1
7735391|NCT00910429|26898159|P1|Overall Study|Lost to Follow-up|2
7735392|NCT00910429|26898158|P2|Overall Study|Protocol Violation|0
7735393|NCT00910429|26898159|P1|Overall Study|Protocol Violation|1
7735394|NCT00910429|26898158|P2|Overall Study|Withdrawal by Subject|2
7735395|NCT00910429|26898159|P1|Overall Study|Withdrawal by Subject|3
7735396|NCT00910429|26898158|P2|Overall Study|Death|12
7735397|NCT00910429|26898159|P1|Overall Study|Death|18
7735398|NCT00910299|26898221|P2|Overall Study|Didn't receive any study drug|1
7735399|NCT00910299|26898222|P1|Overall Study|Didn't receive any study drug|2
7735400|NCT00910299|26898221|P2|Overall Study|Sponsor Decision|60
7735401|NCT00910299|26898222|P1|Overall Study|Sponsor Decision|58
7735402|NCT00910299|26898221|P2|Overall Study|Withdrawal by Subject|13
7735403|NCT00910299|26898222|P1|Overall Study|Withdrawal by Subject|16
7735404|NCT00910273|26898234|P2|Overall Study|Lost to Follow-up|1
7735405|NCT00910273|26898235|P1|Overall Study|Lost to Follow-up|1
7735406|NCT00910273|26898234|P2|Overall Study|Protocol Violation|0
7735407|NCT00910273|26898235|P1|Overall Study|Protocol Violation|1
7735408|NCT00910273|26898234|P2|Overall Study|Discontinuation of study by sponsor|2
7735409|NCT00910273|26898235|P1|Overall Study|Discontinuation of study by sponsor|8
7735410|NCT00910273|26898234|P2|Overall Study|Withdrawal by Subject|0
7735411|NCT00910273|26898235|P1|Overall Study|Withdrawal by Subject|1
7735412|NCT00910273|26898234|P2|Overall Study|Adverse Event|1
7735413|NCT00910273|26898235|P1|Overall Study|Adverse Event|1
7735414|NCT00910273|26898234|P2|Overall Study|Lack of Efficacy|9
7735415|NCT00910273|26898235|P1|Overall Study|Lack of Efficacy|6
7735416|NCT00910247|26898285|P1|Overall Study|Not collected|4
7735417|NCT00910247|26898285|P1|Overall Study|Withdrawal by Subject|25
7735418|NCT00910247|26898285|P1|Overall Study|Protocol Violation|10
7735419|NCT00910247|26898285|P1|Overall Study|Physician Decision|3
7735420|NCT00910247|26898285|P1|Overall Study|Lost to Follow-up|10
7735421|NCT00910247|26898285|P1|Overall Study|Death|2
7735422|NCT00910247|26898285|P1|Overall Study|Adverse Event|15
7735423|NCT00910091|26898335|P2|Treatment and Survival|Adverse Event|0
7735424|NCT00910091|26898336|P1|Treatment and Survival|Adverse Event|1
7735425|NCT00910091|26898335|P2|Treatment and Survival|Withdrawal by Subject|4
7735426|NCT00910091|26898336|P1|Treatment and Survival|Withdrawal by Subject|3
7735427|NCT00910091|26898335|P2|Pre-assignment|Withdrawal by Subject|2
7735428|NCT00910091|26898336|P1|Pre-assignment|Withdrawal by Subject|0
7735429|NCT00910039|26898364|P1|Overall Study|Physician Decision|1
7735430|NCT00910000|26898381|P6|Overall Study|Withdrawal by Subject|0
7735431|NCT00910000|26898382|P5|Overall Study|Withdrawal by Subject|1
7735432|NCT00910000|26898383|P4|Overall Study|Withdrawal by Subject|0
7735433|NCT00910000|26898384|P3|Overall Study|Withdrawal by Subject|1
7735434|NCT00910000|26898385|P2|Overall Study|Withdrawal by Subject|0
7735435|NCT00910000|26898386|P1|Overall Study|Withdrawal by Subject|0
7735436|NCT00910000|26898381|P6|Overall Study|Adverse Event|1
7735437|NCT00910000|26898382|P5|Overall Study|Adverse Event|0
7735438|NCT00910000|26898383|P4|Overall Study|Adverse Event|2
7735439|NCT00910000|26898384|P3|Overall Study|Adverse Event|2
7735440|NCT00910000|26898385|P2|Overall Study|Adverse Event|3
7735441|NCT00910000|26898386|P1|Overall Study|Adverse Event|0
7735442|NCT00909870|26898404|P2|Overall Study|Other|5
7735443|NCT00909870|26898405|P1|Overall Study|Other|1
7735444|NCT00909870|26898404|P2|Overall Study|Physician Decision|2
7735445|NCT00909870|26898405|P1|Overall Study|Physician Decision|0
7735446|NCT00909870|26898404|P2|Overall Study|Lost to Follow-up|3
7735447|NCT00909870|26898405|P1|Overall Study|Lost to Follow-up|3
7735448|NCT00909870|26898404|P2|Overall Study|Withdrawal by Subject|8
7735449|NCT00909870|26898405|P1|Overall Study|Withdrawal by Subject|5
7735450|NCT00909870|26898404|P2|Overall Study|Protocol Violation|2
7735451|NCT00909870|26898405|P1|Overall Study|Protocol Violation|1
7735452|NCT00909870|26898404|P2|Overall Study|Adverse Event|7
7735453|NCT00909870|26898405|P1|Overall Study|Adverse Event|13
7735454|NCT00909857|26898417|P2|Overall Study|Did not receive study medication|24
7735455|NCT00909857|26898418|P1|Overall Study|Did not receive study medication|19
7735456|NCT00909857|26898417|P2|Overall Study|Other|0
7735457|NCT00909857|26898418|P1|Overall Study|Other|1
7735458|NCT00909857|26898417|P2|Overall Study|Pregnancy|0
7735459|NCT00909857|26898418|P1|Overall Study|Pregnancy|1
7735460|NCT00909857|26898417|P2|Overall Study|Protocol Violation|1
7735461|NCT00909857|26898418|P1|Overall Study|Protocol Violation|2
7735462|NCT00909857|26898417|P2|Overall Study|Lost to Follow-up|5
7735463|NCT00909857|26898418|P1|Overall Study|Lost to Follow-up|2
7735464|NCT00909857|26898417|P2|Overall Study|Adverse Event|5
7735465|NCT00909857|26898418|P1|Overall Study|Adverse Event|5
7735466|NCT00909857|26898417|P2|Overall Study|Withdrawal by Subject|10
7735467|NCT00909857|26898418|P1|Overall Study|Withdrawal by Subject|6
7735468|NCT00909844|26898558|P1|Overall Study|Lost to Follow-up|2
7735469|NCT00909844|26898558|P1|Overall Study|Withdrawal by Subject|1
7735470|NCT00909844|26898558|P1|Overall Study|Adverse Event|1
7735471|NCT00909792|26898576|P2|Period 2|Lost to Follow-up|1
7735472|NCT00909792|26898577|P1|Period 2|Lost to Follow-up|0
7735473|NCT00909792|26898576|P2|Period 2|Biomicroscopy|0
7735474|NCT00909792|26898577|P1|Period 2|Biomicroscopy|1
7735475|NCT00909792|26898576|P2|Period 1|Did not meet inclusion criteria|1
7735476|NCT00909792|26898577|P1|Period 1|Did not meet inclusion criteria|0
7735477|NCT00909779|26898585|P2|Overall Study|Randomized in error|1
7735478|NCT00909779|26898586|P1|Overall Study|Randomized in error|1
7735479|NCT00909779|26898585|P2|Overall Study|Noncompliance|1
7735480|NCT00909779|26898586|P1|Overall Study|Noncompliance|1
7735481|NCT00909779|26898585|P2|Overall Study|Medical Monitor Decision|0
7735482|NCT00909779|26898586|P1|Overall Study|Medical Monitor Decision|1
7735483|NCT00909779|26898585|P2|Overall Study|Site Ceasing Operation|2
7735484|NCT00909779|26898586|P1|Overall Study|Site Ceasing Operation|2
7735485|NCT00909779|26898585|P2|Overall Study|Withdrawal by Subject|80
7735486|NCT00909779|26898586|P1|Overall Study|Withdrawal by Subject|116
7735487|NCT00909779|26898585|P2|Overall Study|Protocol Violation|5
7735488|NCT00909779|26898586|P1|Overall Study|Protocol Violation|2
7735489|NCT00909779|26898585|P2|Overall Study|Physician Decision|2
7735490|NCT00909779|26898586|P1|Overall Study|Physician Decision|8
7735491|NCT00909779|26898585|P2|Overall Study|Lost to Follow-up|15
7735492|NCT00909779|26898586|P1|Overall Study|Lost to Follow-up|19
7735493|NCT00909779|26898585|P2|Overall Study|Lack of Efficacy|4
7735494|NCT00909779|26898586|P1|Overall Study|Lack of Efficacy|7
7735495|NCT00909779|26898585|P2|Overall Study|Adverse Event|55
7735496|NCT00909779|26898586|P1|Overall Study|Adverse Event|53
7735497|NCT00909753|26898610|P2|Period: Second Intervention|Protocol Violation|0
7735498|NCT00909753|26898611|P1|Period: Second Intervention|Protocol Violation|1
7735499|NCT00909753|26898610|P2|Period: Washout of 28 Days|Protocol Violation|3
7735500|NCT00909753|26898611|P1|Period: Washout of 28 Days|Protocol Violation|2
7735501|NCT00909727|26898631|P2|Overall Study|Prohibited Medication|0
7735502|NCT00909727|26898632|P1|Overall Study|Prohibited Medication|1
7735503|NCT00909727|26898631|P2|Overall Study|Withdrawal of Consent|0
7735504|NCT00909727|26898632|P1|Overall Study|Withdrawal of Consent|1
7735505|NCT00909727|26898631|P2|Overall Study|Wrong Genotype|0
7735506|NCT00909727|26898632|P1|Overall Study|Wrong Genotype|1
7735507|NCT00909727|26898631|P2|Overall Study|Adverse Event|0
7735508|NCT00909727|26898632|P1|Overall Study|Adverse Event|1
7735509|NCT00909610|26898655|P2|Period: Second Intervention|Adverse Event|0
7735510|NCT00909610|26898656|P1|Period: Second Intervention|Adverse Event|1
7735511|NCT00909610|26898655|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
7735512|NCT00909610|26898656|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
7735513|NCT00909610|26898655|P2|Period: First Intervention|Adverse Event|1
7735514|NCT00909610|26898656|P1|Period: First Intervention|Adverse Event|0
7735515|NCT00909532|26898817|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
7735516|NCT00909532|26898818|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
7735517|NCT00909532|26898817|P2|Overall Study|Wrong Genotype|0
7735518|NCT00909532|26898818|P1|Overall Study|Wrong Genotype|1
7735519|NCT00909532|26898817|P2|Overall Study|Physician Decision|0
7735520|NCT00909532|26898818|P1|Overall Study|Physician Decision|1
7735521|NCT00909532|26898817|P2|Overall Study|Noncompliance with Study Requirements|2
7735522|NCT00909532|26898818|P1|Overall Study|Noncompliance with Study Requirements|0
7735523|NCT00909532|26898817|P2|Overall Study|Withdrawal of Consent|1
7735524|NCT00909532|26898818|P1|Overall Study|Withdrawal of Consent|1
7735525|NCT00909532|26898817|P2|Overall Study|Prohibited Medication|1
7735526|NCT00909532|26898818|P1|Overall Study|Prohibited Medication|2
7735527|NCT00909532|26898817|P2|Overall Study|Pregnancy|1
7735528|NCT00909532|26898818|P1|Overall Study|Pregnancy|0
7735529|NCT00909532|26898817|P2|Overall Study|Adverse Event|1
7735530|NCT00909532|26898818|P1|Overall Study|Adverse Event|4
7735531|NCT00909480|26898836|P2|Overall Study|Unclassified|19
7735532|NCT00909480|26898837|P1|Overall Study|Unclassified|18
7735533|NCT00909480|26898836|P2|Overall Study|Withdrawal criteria|11
7735534|NCT00909480|26898837|P1|Overall Study|Withdrawal criteria|9
7735535|NCT00909480|26898836|P2|Overall Study|Protocol Violation|8
7735536|NCT00909480|26898837|P1|Overall Study|Protocol Violation|6
7735537|NCT00909480|26898836|P2|Overall Study|Adverse Event|3
7735538|NCT00909480|26898837|P1|Overall Study|Adverse Event|5
7735539|NCT00909428|26898872|P3|Overall Study|Lost to Follow-up|9
7735540|NCT00909428|26898873|P2|Overall Study|Lost to Follow-up|10
7735541|NCT00909428|26898874|P1|Overall Study|Lost to Follow-up|13
7735542|NCT00909389|26898881|P1|Overall Study|No Information|103
7735543|NCT00909389|26898881|P1|Overall Study|Lost to Follow-up|4
7735544|NCT00909389|26898881|P1|Overall Study|Poor Compliance|16
7735545|NCT00909389|26898881|P1|Overall Study|Death|4
7735546|NCT00909389|26898881|P1|Overall Study|Adverse Event|6
7735547|NCT00909363|26898888|P3|Overall Study|Lack of Efficacy|0
7735548|NCT00909363|26898889|P2|Overall Study|Lack of Efficacy|0
7735549|NCT00909363|26898890|P1|Overall Study|Lack of Efficacy|1
7735550|NCT00909363|26898888|P3|Overall Study|Withdrawal by Subject|0
7735551|NCT00909363|26898889|P2|Overall Study|Withdrawal by Subject|0
7735552|NCT00909363|26898890|P1|Overall Study|Withdrawal by Subject|1
7735553|NCT00909181|26898937|P3|Overall Study|Lost to Follow-up|33
7735554|NCT00909181|26898938|P2|Overall Study|Lost to Follow-up|18
7735555|NCT00909181|26898939|P1|Overall Study|Lost to Follow-up|39
7735556|NCT00909090|26898965|P2|Overall Study|Lost to Follow-up|17
7735557|NCT00909090|26898966|P1|Overall Study|Lost to Follow-up|17
7735558|NCT00909038|26898984|P1|Overall Study|Non-evaluable Subjects|230
7735559|NCT00909038|26898984|P1|Overall Study|Protocol Violation|187
7735560|NCT00908960|26898996|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
7735561|NCT00908960|26898997|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
7735562|NCT00908960|26898998|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
7735563|NCT00908895|26899042|P2|Overall Study|Adverse Event|1
7735564|NCT00908895|26899043|P1|Overall Study|Adverse Event|1
7735565|NCT00908895|26899042|P2|Overall Study|algodystrophy|2
7735566|NCT00908895|26899043|P1|Overall Study|algodystrophy|2
7735567|NCT00908895|26899042|P2|Overall Study|Lost to Follow-up|3
7735568|NCT00908895|26899043|P1|Overall Study|Lost to Follow-up|1
7735569|NCT00908596|26899144|P4|Overall Study|Withdrawal by Subject|1
7735570|NCT00908596|26899145|P3|Overall Study|Withdrawal by Subject|3
7735571|NCT00908596|26899146|P2|Overall Study|Withdrawal by Subject|1
7735572|NCT00908596|26899147|P1|Overall Study|Withdrawal by Subject|0
7735573|NCT00908596|26899144|P4|Overall Study|Protocol Violation|0
7735574|NCT00908596|26899145|P3|Overall Study|Protocol Violation|0
7735575|NCT00908596|26899146|P2|Overall Study|Protocol Violation|0
7735576|NCT00908596|26899147|P1|Overall Study|Protocol Violation|1
7735577|NCT00908596|26899144|P4|Overall Study|Death|32
7735578|NCT00908596|26899145|P3|Overall Study|Death|57
7735579|NCT00908596|26899146|P2|Overall Study|Death|5
7735580|NCT00908596|26899147|P1|Overall Study|Death|0
7735581|NCT00908596|26899144|P4|Overall Study|Lost to Follow-up|4
7735582|NCT00908596|26899145|P3|Overall Study|Lost to Follow-up|12
7735583|NCT00908596|26899146|P2|Overall Study|Lost to Follow-up|1
7735584|NCT00908596|26899147|P1|Overall Study|Lost to Follow-up|0
7735585|NCT00908596|26899144|P4|Overall Study|Other reasons|0
7735586|NCT00908596|26899145|P3|Overall Study|Other reasons|2
7735587|NCT00908596|26899146|P2|Overall Study|Other reasons|6
7735588|NCT00908596|26899147|P1|Overall Study|Other reasons|46
7735589|NCT00908583|26899177|P1|Phase 5|Adverse Event|3
7735590|NCT00908583|26899177|P1|Phase 4|Physician Decision|1
7735591|NCT00908583|26899177|P1|Phase 4|Adverse Event|1
7735592|NCT00908583|26899177|P1|Phase 3|Adverse Event|2
7735593|NCT00908583|26899177|P1|Phase 2|Adverse Event|1
7735594|NCT00908583|26899177|P1|Phase 2|Physician Decision|1
7735595|NCT00908583|26899177|P1|Phase 1|Adverse Event|4
7735596|NCT00908583|26899177|P1|Phase 1|Withdrawal by Subject|1
7735597|NCT00908544|26899197|P2|Overall Study|Unable to visit sutdy center|0
7735598|NCT00908544|26899198|P1|Overall Study|Unable to visit sutdy center|1
7735599|NCT00908544|26899197|P2|Overall Study|Relocation abroad|1
7735600|NCT00908544|26899198|P1|Overall Study|Relocation abroad|1
7735601|NCT00908544|26899197|P2|Overall Study|Pregnancy|0
7735602|NCT00908544|26899198|P1|Overall Study|Pregnancy|1
7735603|NCT00908544|26899197|P2|Overall Study|Lack of Efficacy|1
7735604|NCT00908544|26899198|P1|Overall Study|Lack of Efficacy|0
7735605|NCT00908544|26899197|P2|Overall Study|Withdrawal by Subject|4
7735606|NCT00908544|26899198|P1|Overall Study|Withdrawal by Subject|2
7735607|NCT00908375|26899257|P2|Overall Study|Lost to Follow-up|6
7735608|NCT00908375|26899258|P1|Overall Study|Lost to Follow-up|8
7735609|NCT00908375|26899257|P2|Overall Study|Withdrawal by Subject|4
7735610|NCT00908375|26899258|P1|Overall Study|Withdrawal by Subject|2
7735611|NCT00908349|26899268|P1|Overall Study|Various|6
7735612|NCT00908349|26899268|P1|Overall Study|Lost to Follow-up|5
7735613|NCT00908349|26899268|P1|Overall Study|Physician Decision|5
7735614|NCT00908349|26899268|P1|Overall Study|Withdrawal by Subject|9
7735615|NCT00908349|26899268|P1|Overall Study|Adverse Event|10
7735616|NCT00908310|26899272|P1|Overall Study|Other reasons|4
7735617|NCT00908310|26899272|P1|Overall Study|Screening failure|5
7735618|NCT00908310|26899272|P1|Overall Study|Lost to Follow-up|7
7735619|NCT00908310|26899272|P1|Overall Study|Withdrawal by Subject|7
7735620|NCT00908310|26899272|P1|Overall Study|Death|37
7735621|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7735622|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7735623|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7735624|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
7735625|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Other|0
7735626|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Other|0
7735627|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Other|1
7735628|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Other|3
7735629|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7735630|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7735631|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7735632|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
7735633|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
7735634|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
7735635|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
7735636|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
7735637|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
7735638|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
7735639|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
7735640|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
7735641|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Death|0
7735642|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Death|0
7735643|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Death|0
7735644|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Death|2
7735645|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7735646|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7735647|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7735648|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
7735649|NCT00908232|26899276|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7735650|NCT00908232|26899277|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7735651|NCT00908232|26899278|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7735652|NCT00908232|26899279|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
7735653|NCT00908232|26899276|P4|Cycle 1 to 4|Other|0
7735654|NCT00908232|26899277|P3|Cycle 1 to 4|Other|0
7735655|NCT00908232|26899278|P2|Cycle 1 to 4|Other|0
7735656|NCT00908232|26899279|P1|Cycle 1 to 4|Other|1
7735657|NCT00908232|26899276|P4|Cycle 1 to 4|Adverse Event|0
7735658|NCT00908232|26899277|P3|Cycle 1 to 4|Adverse Event|0
7735659|NCT00908232|26899278|P2|Cycle 1 to 4|Adverse Event|0
7735660|NCT00908232|26899279|P1|Cycle 1 to 4|Adverse Event|12
7735661|NCT00908232|26899276|P4|Cycle 1 to 4|Progressive Disease|0
7735662|NCT00908232|26899277|P3|Cycle 1 to 4|Progressive Disease|0
7735663|NCT00908232|26899278|P2|Cycle 1 to 4|Progressive Disease|0
7735664|NCT00908232|26899279|P1|Cycle 1 to 4|Progressive Disease|6
7735665|NCT00908232|26899276|P4|Cycle 1 to 4|Withdrawal by Subject|0
7735666|NCT00908232|26899277|P3|Cycle 1 to 4|Withdrawal by Subject|0
7735667|NCT00908232|26899278|P2|Cycle 1 to 4|Withdrawal by Subject|0
7735668|NCT00908232|26899279|P1|Cycle 1 to 4|Withdrawal by Subject|4
7735669|NCT00908232|26899276|P4|Cycle 1 to 4|Death|0
7735670|NCT00908232|26899277|P3|Cycle 1 to 4|Death|0
7735671|NCT00908232|26899278|P2|Cycle 1 to 4|Death|0
7735672|NCT00908232|26899279|P1|Cycle 1 to 4|Death|5
7735673|NCT00908141|26899297|P2|Overall Study|Withdrawal by Subject|1
7735674|NCT00908141|26899298|P1|Overall Study|Withdrawal by Subject|0
7735675|NCT00908115|26899315|P1|Overall Study|Other|14
7735676|NCT00908076|26899323|P2|Overall Study|Lack of Efficacy|1
7735677|NCT00908076|26899324|P1|Overall Study|Lack of Efficacy|1
7735678|NCT00908037|26899337|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735679|NCT00908037|26899338|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
7735680|NCT00908037|26899339|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735681|NCT00908037|26899340|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735682|NCT00908037|26899341|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735683|NCT00908037|26899342|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735684|NCT00908037|26899343|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735685|NCT00908037|26899344|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735686|NCT00908037|26899345|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735687|NCT00908037|26899346|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735688|NCT00908037|26899347|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735689|NCT00908037|26899348|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7735690|NCT00908037|26899337|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735691|NCT00908037|26899338|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735692|NCT00908037|26899339|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
7735693|NCT00908037|26899340|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735694|NCT00908037|26899341|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735695|NCT00908037|26899342|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735696|NCT00908037|26899343|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735697|NCT00908037|26899344|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735698|NCT00908037|26899345|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735699|NCT00908037|26899346|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735700|NCT00908037|26899347|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735701|NCT00908037|26899348|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7735702|NCT00908037|26899337|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735703|NCT00908037|26899338|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
7735704|NCT00908037|26899339|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735705|NCT00908037|26899340|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735706|NCT00908037|26899341|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735707|NCT00908037|26899342|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735708|NCT00908037|26899343|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735709|NCT00908037|26899344|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735710|NCT00908037|26899345|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735711|NCT00908037|26899346|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735712|NCT00908037|26899347|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735713|NCT00908037|26899348|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7735714|NCT00908037|26899337|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735715|NCT00908037|26899338|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735716|NCT00908037|26899339|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
7735717|NCT00908037|26899340|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735718|NCT00908037|26899341|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735719|NCT00908037|26899342|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735720|NCT00908037|26899343|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735721|NCT00908037|26899344|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735722|NCT00908037|26899345|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735723|NCT00908037|26899346|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735724|NCT00908037|26899347|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735725|NCT00908037|26899348|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7735726|NCT00908037|26899337|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
7735727|NCT00908037|26899338|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735728|NCT00908037|26899339|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
7735729|NCT00908037|26899340|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735730|NCT00908037|26899341|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735731|NCT00908037|26899342|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735732|NCT00908037|26899343|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735733|NCT00908037|26899344|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735734|NCT00908037|26899345|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735735|NCT00908037|26899346|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735736|NCT00908037|26899347|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735737|NCT00908037|26899348|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7735738|NCT00908037|26899337|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
7735739|NCT00908037|26899338|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735740|NCT00908037|26899339|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735741|NCT00908037|26899340|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735742|NCT00908037|26899341|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735743|NCT00908037|26899342|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735744|NCT00908037|26899343|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735745|NCT00908037|26899344|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735746|NCT00908037|26899345|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735747|NCT00908037|26899346|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735748|NCT00908037|26899347|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735749|NCT00908037|26899348|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7735750|NCT00908037|26899337|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735751|NCT00908037|26899338|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735752|NCT00908037|26899339|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735753|NCT00908037|26899340|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735754|NCT00908037|26899341|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735755|NCT00908037|26899342|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7735756|NCT00908037|26899343|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735757|NCT00908037|26899344|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735758|NCT00908037|26899345|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7735759|NCT00908037|26899346|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735760|NCT00908037|26899347|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735761|NCT00908037|26899348|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7735762|NCT00908037|26899337|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735763|NCT00908037|26899338|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735764|NCT00908037|26899339|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735765|NCT00908037|26899340|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
7735766|NCT00908037|26899341|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735767|NCT00908037|26899342|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735768|NCT00908037|26899343|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735769|NCT00908037|26899344|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
7735770|NCT00908037|26899345|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735771|NCT00908037|26899346|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735772|NCT00908037|26899347|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735773|NCT00908037|26899348|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7735774|NCT00908037|26899337|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735775|NCT00908037|26899338|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735776|NCT00908037|26899339|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735777|NCT00908037|26899340|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
7735778|NCT00908037|26899341|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735779|NCT00908037|26899342|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
7735780|NCT00908037|26899343|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735781|NCT00908037|26899344|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
7735782|NCT00908037|26899345|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735783|NCT00908037|26899346|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735784|NCT00908037|26899347|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735785|NCT00908037|26899348|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7735786|NCT00908011|26899497|P2|Overall Study|Withdrawal by Subject|2
7735787|NCT00908011|26899498|P1|Overall Study|Withdrawal by Subject|2
7735788|NCT00907881|26899515|P1|Overall Study|Missing discontinuation information|15
7735789|NCT00907881|26899515|P1|Overall Study|Protocol Violation|1
7735790|NCT00907881|26899515|P1|Overall Study|Withdrawal by Subject|5
7735791|NCT00907881|26899515|P1|Overall Study|Noncompliance|5
7735792|NCT00907881|26899515|P1|Overall Study|Lost to Follow-up|59
7735793|NCT00907803|26899525|P3|Overall Study|Protocol Violation|0
7735794|NCT00907803|26899526|P2|Overall Study|Protocol Violation|1
7735795|NCT00907803|26899527|P1|Overall Study|Protocol Violation|0
7735796|NCT00907803|26899525|P3|Overall Study|Lost to Follow-up|0
7735797|NCT00907803|26899526|P2|Overall Study|Lost to Follow-up|1
7735798|NCT00907803|26899527|P1|Overall Study|Lost to Follow-up|0
7735799|NCT00907803|26899525|P3|Overall Study|Withdrawal by Subject|0
7735800|NCT00907803|26899526|P2|Overall Study|Withdrawal by Subject|1
7735801|NCT00907803|26899527|P1|Overall Study|Withdrawal by Subject|0
7735802|NCT00907803|26899525|P3|Overall Study|Adverse Event|0
7735803|NCT00907803|26899526|P2|Overall Study|Adverse Event|0
7735804|NCT00907803|26899527|P1|Overall Study|Adverse Event|2
7735805|NCT00907803|26899525|P3|Overall Study|Withdrawal of consent - long commute|0
7735806|NCT00907803|26899526|P2|Overall Study|Withdrawal of consent - long commute|0
7735807|NCT00907803|26899527|P1|Overall Study|Withdrawal of consent - long commute|1
7735808|NCT00907777|26899558|P2|Overall Study|Withdrawal by Subject|1
7735809|NCT00907777|26899559|P1|Overall Study|Withdrawal by Subject|0
7735810|NCT00907738|26899586|P5|Overall Study|Disease progression|2
7735811|NCT00907738|26899587|P4|Overall Study|Disease progression|4
7735812|NCT00907738|26899588|P3|Overall Study|Disease progression|6
7735813|NCT00907738|26899589|P2|Overall Study|Disease progression|1
7735814|NCT00907738|26899590|P1|Overall Study|Disease progression|8
7735815|NCT00907738|26899586|P5|Overall Study|not specified or withdrew consent|0
7735816|NCT00907738|26899587|P4|Overall Study|not specified or withdrew consent|0
7735817|NCT00907738|26899588|P3|Overall Study|not specified or withdrew consent|0
7735818|NCT00907738|26899589|P2|Overall Study|not specified or withdrew consent|0
7735819|NCT00907738|26899590|P1|Overall Study|not specified or withdrew consent|3
7735820|NCT00907738|26899586|P5|Overall Study|Adverse Event|0
7735821|NCT00907738|26899587|P4|Overall Study|Adverse Event|0
7735822|NCT00907738|26899588|P3|Overall Study|Adverse Event|1
7735823|NCT00907738|26899589|P2|Overall Study|Adverse Event|0
7735824|NCT00907738|26899590|P1|Overall Study|Adverse Event|2
7735825|NCT00907621|26899608|P2|Overall Study|intercurrent febrile illness|1
7735826|NCT00907621|26899609|P1|Overall Study|intercurrent febrile illness|1
7735827|NCT00907621|26899608|P2|Overall Study|Lost to Follow-up|3
7735828|NCT00907621|26899609|P1|Overall Study|Lost to Follow-up|6
7735829|NCT00907517|26899622|P5|Overall Study|Symptomatic Deterioration|1
7735830|NCT00907517|26899623|P4|Overall Study|Symptomatic Deterioration|0
7735831|NCT00907517|26899624|P3|Overall Study|Symptomatic Deterioration|0
7735832|NCT00907517|26899625|P2|Overall Study|Symptomatic Deterioration|0
7735833|NCT00907517|26899626|P1|Overall Study|Symptomatic Deterioration|0
7735834|NCT00907517|26899622|P5|Overall Study|Progressive Disease|4
7735835|NCT00907517|26899623|P4|Overall Study|Progressive Disease|4
7735836|NCT00907517|26899624|P3|Overall Study|Progressive Disease|4
7735837|NCT00907517|26899625|P2|Overall Study|Progressive Disease|3
7735838|NCT00907517|26899626|P1|Overall Study|Progressive Disease|3
7735839|NCT00907478|26899651|P3|Overall Study|Other|1
7735840|NCT00907478|26899652|P2|Overall Study|Other|0
7735841|NCT00907478|26899653|P1|Overall Study|Other|3
7735842|NCT00907478|26899651|P3|Overall Study|Lost to Follow-up|0
7735843|NCT00907478|26899652|P2|Overall Study|Lost to Follow-up|0
7735844|NCT00907478|26899653|P1|Overall Study|Lost to Follow-up|1
7735845|NCT00907478|26899651|P3|Overall Study|Pregnancy|1
7735846|NCT00907478|26899652|P2|Overall Study|Pregnancy|1
7735847|NCT00907478|26899653|P1|Overall Study|Pregnancy|0
7735848|NCT00907478|26899651|P3|Overall Study|Protocol-specified criteria|3
7735849|NCT00907478|26899652|P2|Overall Study|Protocol-specified criteria|2
7735850|NCT00907478|26899653|P1|Overall Study|Protocol-specified criteria|5
7735851|NCT00907478|26899651|P3|Overall Study|Death|1
7735852|NCT00907478|26899652|P2|Overall Study|Death|2
7735853|NCT00907478|26899653|P1|Overall Study|Death|4
7735854|NCT00907478|26899651|P3|Overall Study|Physician Decision|3
7735855|NCT00907478|26899652|P2|Overall Study|Physician Decision|0
7735856|NCT00907478|26899653|P1|Overall Study|Physician Decision|2
7735857|NCT00907478|26899651|P3|Overall Study|Requirement for alternative therapy|3
7735858|NCT00907478|26899652|P2|Overall Study|Requirement for alternative therapy|2
7735859|NCT00907478|26899653|P1|Overall Study|Requirement for alternative therapy|1
7735860|NCT00907478|26899651|P3|Overall Study|Withdrawal by Subject|6
7735861|NCT00907478|26899652|P2|Overall Study|Withdrawal by Subject|9
7735862|NCT00907478|26899653|P1|Overall Study|Withdrawal by Subject|8
7735863|NCT00907478|26899651|P3|Overall Study|Adverse Event|2
7735864|NCT00907478|26899652|P2|Overall Study|Adverse Event|1
7735865|NCT00907478|26899653|P1|Overall Study|Adverse Event|3
7735866|NCT00907478|26899651|P3|Overall Study|Noncompliance|1
7735867|NCT00907478|26899652|P2|Overall Study|Noncompliance|0
7735868|NCT00907478|26899653|P1|Overall Study|Noncompliance|0
7735869|NCT00907478|26899651|P3|Overall Study|Ineligibility determined|1
7735870|NCT00907478|26899652|P2|Overall Study|Ineligibility determined|0
7735871|NCT00907478|26899653|P1|Overall Study|Ineligibility determined|0
7735872|NCT00907374|26899703|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
7735873|NCT00907374|26899704|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
7735874|NCT00907335|26899718|P2|Overall Study|Lost to Follow-up|0
7735875|NCT00907335|26899719|P1|Overall Study|Lost to Follow-up|2
7735876|NCT00907335|26899718|P2|Overall Study|Adverse Event|1
7735877|NCT00907335|26899719|P1|Overall Study|Adverse Event|4
7735878|NCT00907335|26899718|P2|Overall Study|Withdrawal by Subject|0
7735879|NCT00907335|26899719|P1|Overall Study|Withdrawal by Subject|2
7735880|NCT00907296|26899745|P10|Overall Study|Lost to Follow-up|4
7735881|NCT00907296|26899746|P9|Overall Study|Lost to Follow-up|0
7735882|NCT00907296|26899747|P8|Overall Study|Lost to Follow-up|2
7735883|NCT00907296|26899748|P7|Overall Study|Lost to Follow-up|2
7735884|NCT00907296|26899749|P6|Overall Study|Lost to Follow-up|3
7735885|NCT00907296|26899750|P5|Overall Study|Lost to Follow-up|0
7735886|NCT00907296|26899751|P4|Overall Study|Lost to Follow-up|2
7735887|NCT00907296|26899752|P3|Overall Study|Lost to Follow-up|0
7735888|NCT00907296|26899753|P2|Overall Study|Lost to Follow-up|1
7735889|NCT00907296|26899754|P1|Overall Study|Lost to Follow-up|9
7735890|NCT00907296|26899745|P10|Overall Study|Withdrawal by Subject|2
7735891|NCT00907296|26899746|P9|Overall Study|Withdrawal by Subject|4
7735892|NCT00907296|26899747|P8|Overall Study|Withdrawal by Subject|2
7735893|NCT00907296|26899748|P7|Overall Study|Withdrawal by Subject|3
7735894|NCT00907296|26899749|P6|Overall Study|Withdrawal by Subject|5
7735895|NCT00907296|26899750|P5|Overall Study|Withdrawal by Subject|1
7735896|NCT00907296|26899751|P4|Overall Study|Withdrawal by Subject|1
7735897|NCT00907296|26899752|P3|Overall Study|Withdrawal by Subject|1
7735898|NCT00907296|26899753|P2|Overall Study|Withdrawal by Subject|2
7735899|NCT00907296|26899754|P1|Overall Study|Withdrawal by Subject|7
7735900|NCT00907296|26899745|P10|Overall Study|Adverse Event|1
7735901|NCT00907296|26899746|P9|Overall Study|Adverse Event|0
7735902|NCT00907296|26899747|P8|Overall Study|Adverse Event|0
7735903|NCT00907296|26899748|P7|Overall Study|Adverse Event|1
7735904|NCT00907296|26899749|P6|Overall Study|Adverse Event|0
7735905|NCT00907296|26899750|P5|Overall Study|Adverse Event|0
7735906|NCT00907296|26899751|P4|Overall Study|Adverse Event|0
7735907|NCT00907296|26899752|P3|Overall Study|Adverse Event|0
7735908|NCT00907296|26899753|P2|Overall Study|Adverse Event|0
7735909|NCT00907296|26899754|P1|Overall Study|Adverse Event|2
7735910|NCT00907296|26899745|P10|Overall Study|Noncompliance|0
7735911|NCT00907296|26899746|P9|Overall Study|Noncompliance|0
7735912|NCT00907296|26899747|P8|Overall Study|Noncompliance|2
7735913|NCT00907296|26899748|P7|Overall Study|Noncompliance|0
7735914|NCT00907296|26899749|P6|Overall Study|Noncompliance|1
7735915|NCT00907296|26899750|P5|Overall Study|Noncompliance|0
7735916|NCT00907296|26899751|P4|Overall Study|Noncompliance|0
7735917|NCT00907296|26899752|P3|Overall Study|Noncompliance|1
7735918|NCT00907296|26899753|P2|Overall Study|Noncompliance|1
7735919|NCT00907296|26899754|P1|Overall Study|Noncompliance|1
7735920|NCT00907296|26899745|P10|Overall Study|Protocol Deviation|0
7735921|NCT00907296|26899746|P9|Overall Study|Protocol Deviation|0
7735922|NCT00907296|26899747|P8|Overall Study|Protocol Deviation|0
7735923|NCT00907296|26899748|P7|Overall Study|Protocol Deviation|0
7735924|NCT00907296|26899749|P6|Overall Study|Protocol Deviation|0
7735925|NCT00907296|26899750|P5|Overall Study|Protocol Deviation|0
7735926|NCT00907296|26899751|P4|Overall Study|Protocol Deviation|0
7735927|NCT00907296|26899752|P3|Overall Study|Protocol Deviation|0
7735928|NCT00907296|26899753|P2|Overall Study|Protocol Deviation|1
7735929|NCT00907296|26899754|P1|Overall Study|Protocol Deviation|0
7735930|NCT00907296|26899745|P10|Overall Study|Ineligibility Determined|0
7735931|NCT00907296|26899746|P9|Overall Study|Ineligibility Determined|0
7735932|NCT00907296|26899747|P8|Overall Study|Ineligibility Determined|1
7735933|NCT00907296|26899748|P7|Overall Study|Ineligibility Determined|0
7735934|NCT00907296|26899749|P6|Overall Study|Ineligibility Determined|0
7735935|NCT00907296|26899750|P5|Overall Study|Ineligibility Determined|0
7735936|NCT00907296|26899751|P4|Overall Study|Ineligibility Determined|1
7735937|NCT00907296|26899752|P3|Overall Study|Ineligibility Determined|0
7735938|NCT00907296|26899753|P2|Overall Study|Ineligibility Determined|0
7735939|NCT00907296|26899754|P1|Overall Study|Ineligibility Determined|1
7735940|NCT00907257|26899808|P2|Overall Study|Personal Reasons|1
7735941|NCT00907257|26899809|P1|Overall Study|Personal Reasons|6
7735942|NCT00907257|26899808|P2|Overall Study|Moved|0
7735943|NCT00907257|26899809|P1|Overall Study|Moved|1
7735944|NCT00907257|26899808|P2|Overall Study|Per IRB-Subject became vulnerable|0
7735945|NCT00907257|26899809|P1|Overall Study|Per IRB-Subject became vulnerable|1
7735946|NCT00907257|26899808|P2|Overall Study|Withdrawal by Subject|2
7735947|NCT00907257|26899809|P1|Overall Study|Withdrawal by Subject|1
7735948|NCT00907257|26899808|P2|Overall Study|Lost to Follow-up|3
7735949|NCT00907257|26899809|P1|Overall Study|Lost to Follow-up|3
7735950|NCT00907257|26899808|P2|Overall Study|Protocol Violation|2
7735951|NCT00907257|26899809|P1|Overall Study|Protocol Violation|1
7735952|NCT00907257|26899808|P2|Overall Study|Adverse Event|4
7735953|NCT00907257|26899809|P1|Overall Study|Adverse Event|0
7735954|NCT00907153|26899831|P2|Overall Study|Withdrawal by Subject|3
7735955|NCT00907153|26899832|P1|Overall Study|Withdrawal by Subject|1
7735956|NCT00907153|26899831|P2|Overall Study|Lost to Follow-up|1
7735957|NCT00907153|26899832|P1|Overall Study|Lost to Follow-up|1
7735958|NCT00906971|26899893|P2|Overall Study|Lost to Follow-up|1
7735959|NCT00906971|26899894|P1|Overall Study|Lost to Follow-up|0
7735960|NCT00906971|26899893|P2|Overall Study|Withdrawal by Subject|2
7735961|NCT00906971|26899894|P1|Overall Study|Withdrawal by Subject|8
7735962|NCT00906945|26899922|P6|Overall Study|Physician Decision|1
7735963|NCT00906945|26899923|P5|Overall Study|Physician Decision|0
7735964|NCT00906945|26899924|P4|Overall Study|Physician Decision|0
7735965|NCT00906945|26899925|P3|Overall Study|Physician Decision|0
7735966|NCT00906945|26899926|P2|Overall Study|Physician Decision|0
7735967|NCT00906945|26899927|P1|Overall Study|Physician Decision|0
7735968|NCT00906945|26899922|P6|Overall Study|Found to be not eligible|1
7735969|NCT00906945|26899923|P5|Overall Study|Found to be not eligible|1
7735970|NCT00906945|26899924|P4|Overall Study|Found to be not eligible|1
7735971|NCT00906945|26899925|P3|Overall Study|Found to be not eligible|0
7735972|NCT00906945|26899926|P2|Overall Study|Found to be not eligible|0
7735973|NCT00906945|26899927|P1|Overall Study|Found to be not eligible|0
7735974|NCT00906698|26899987|P6|Overall Study|incl. non compliance, lost to follow-up|0
7735975|NCT00906698|26899988|P5|Overall Study|incl. non compliance, lost to follow-up|0
7735976|NCT00906698|26899989|P4|Overall Study|incl. non compliance, lost to follow-up|0
7735977|NCT00906698|26899990|P3|Overall Study|incl. non compliance, lost to follow-up|0
7735978|NCT00906698|26899991|P2|Overall Study|incl. non compliance, lost to follow-up|1
7735979|NCT00906698|26899992|P1|Overall Study|incl. non compliance, lost to follow-up|0
7735980|NCT00906698|26899987|P6|Overall Study|Withdrawal by Subject|0
7735981|NCT00906698|26899988|P5|Overall Study|Withdrawal by Subject|1
7735982|NCT00906698|26899989|P4|Overall Study|Withdrawal by Subject|0
7735983|NCT00906698|26899990|P3|Overall Study|Withdrawal by Subject|0
7735984|NCT00906698|26899991|P2|Overall Study|Withdrawal by Subject|0
7735985|NCT00906698|26899992|P1|Overall Study|Withdrawal by Subject|0
7735986|NCT00906698|26899987|P6|Overall Study|Disease progression|4
7735987|NCT00906698|26899988|P5|Overall Study|Disease progression|12
7735988|NCT00906698|26899989|P4|Overall Study|Disease progression|4
7735989|NCT00906698|26899990|P3|Overall Study|Disease progression|4
7735990|NCT00906698|26899991|P2|Overall Study|Disease progression|12
7735991|NCT00906698|26899992|P1|Overall Study|Disease progression|3
7735992|NCT00906698|26899987|P6|Overall Study|Adverse Event|1
7735993|NCT00906698|26899988|P5|Overall Study|Adverse Event|4
7735994|NCT00906698|26899989|P4|Overall Study|Adverse Event|0
7735995|NCT00906698|26899990|P3|Overall Study|Adverse Event|2
7735996|NCT00906698|26899991|P2|Overall Study|Adverse Event|0
7735997|NCT00906698|26899992|P1|Overall Study|Adverse Event|0
7735998|NCT00906698|26899987|P6|Overall Study|Dose-limiting toxicity (DLT)|0
7735999|NCT00906698|26899988|P5|Overall Study|Dose-limiting toxicity (DLT)|1
7736000|NCT00906698|26899989|P4|Overall Study|Dose-limiting toxicity (DLT)|0
7736001|NCT00906698|26899990|P3|Overall Study|Dose-limiting toxicity (DLT)|0
7736002|NCT00906698|26899991|P2|Overall Study|Dose-limiting toxicity (DLT)|6
7736003|NCT00906698|26899992|P1|Overall Study|Dose-limiting toxicity (DLT)|0
7736004|NCT00906399|26900094|P7|Year 2|Other|0
7736005|NCT00906399|26900095|P6|Year 2|Other|1
7736006|NCT00906399|26900096|P5|Year 2|Other|3
7736007|NCT00906399|26900097|P4|Year 2|Other|2
7736008|NCT00906399|26900098|P3|Year 2|Other|0
7736009|NCT00906399|26900099|P2|Year 2|Other|0
7736010|NCT00906399|26900100|P1|Year 2|Other|0
7736011|NCT00906399|26900094|P7|Year 2|Death|3
7736012|NCT00906399|26900095|P6|Year 2|Death|0
7736013|NCT00906399|26900096|P5|Year 2|Death|0
7736014|NCT00906399|26900097|P4|Year 2|Death|1
7736015|NCT00906399|26900098|P3|Year 2|Death|0
7736016|NCT00906399|26900099|P2|Year 2|Death|0
7736017|NCT00906399|26900100|P1|Year 2|Death|0
7736018|NCT00906399|26900094|P7|Year 2|Physician Decision|3
7736019|NCT00906399|26900095|P6|Year 2|Physician Decision|6
7736020|NCT00906399|26900096|P5|Year 2|Physician Decision|2
7736021|NCT00906399|26900097|P4|Year 2|Physician Decision|0
7736022|NCT00906399|26900098|P3|Year 2|Physician Decision|0
7736023|NCT00906399|26900099|P2|Year 2|Physician Decision|0
7736024|NCT00906399|26900100|P1|Year 2|Physician Decision|0
7736025|NCT00906399|26900094|P7|Year 2|Withdrawal by Subject|13
7736026|NCT00906399|26900095|P6|Year 2|Withdrawal by Subject|27
7736027|NCT00906399|26900096|P5|Year 2|Withdrawal by Subject|18
7736028|NCT00906399|26900097|P4|Year 2|Withdrawal by Subject|17
7736029|NCT00906399|26900098|P3|Year 2|Withdrawal by Subject|0
7736030|NCT00906399|26900099|P2|Year 2|Withdrawal by Subject|0
7736031|NCT00906399|26900100|P1|Year 2|Withdrawal by Subject|0
7736032|NCT00906399|26900094|P7|Year 2|Lost to Follow-up|4
7736033|NCT00906399|26900095|P6|Year 2|Lost to Follow-up|2
7736034|NCT00906399|26900096|P5|Year 2|Lost to Follow-up|4
7736035|NCT00906399|26900097|P4|Year 2|Lost to Follow-up|1
7736036|NCT00906399|26900098|P3|Year 2|Lost to Follow-up|0
7736037|NCT00906399|26900099|P2|Year 2|Lost to Follow-up|0
7736038|NCT00906399|26900100|P1|Year 2|Lost to Follow-up|0
7736039|NCT00906399|26900094|P7|Year 2|Adverse Event|6
7736040|NCT00906399|26900095|P6|Year 2|Adverse Event|11
7736041|NCT00906399|26900096|P5|Year 2|Adverse Event|8
7736042|NCT00906399|26900097|P4|Year 2|Adverse Event|9
7736043|NCT00906399|26900098|P3|Year 2|Adverse Event|0
7736044|NCT00906399|26900099|P2|Year 2|Adverse Event|0
7736045|NCT00906399|26900100|P1|Year 2|Adverse Event|0
7736046|NCT00906399|26900094|P7|Year 1|Other|0
7736047|NCT00906399|26900095|P6|Year 1|Other|0
7736048|NCT00906399|26900096|P5|Year 1|Other|0
7736049|NCT00906399|26900097|P4|Year 1|Other|0
7736050|NCT00906399|26900098|P3|Year 1|Other|7
7736051|NCT00906399|26900099|P2|Year 1|Other|2
7736052|NCT00906399|26900100|P1|Year 1|Other|4
7736053|NCT00906399|26900094|P7|Year 1|Death|0
7736054|NCT00906399|26900095|P6|Year 1|Death|0
7736055|NCT00906399|26900096|P5|Year 1|Death|0
7736056|NCT00906399|26900097|P4|Year 1|Death|0
7736057|NCT00906399|26900098|P3|Year 1|Death|1
7736058|NCT00906399|26900099|P2|Year 1|Death|1
7736059|NCT00906399|26900100|P1|Year 1|Death|2
7736060|NCT00906399|26900094|P7|Year 1|Physician Decision|0
7736061|NCT00906399|26900095|P6|Year 1|Physician Decision|0
7736062|NCT00906399|26900096|P5|Year 1|Physician Decision|0
7736063|NCT00906399|26900097|P4|Year 1|Physician Decision|0
7736064|NCT00906399|26900098|P3|Year 1|Physician Decision|3
7736065|NCT00906399|26900099|P2|Year 1|Physician Decision|1
7736066|NCT00906399|26900100|P1|Year 1|Physician Decision|0
7736067|NCT00906399|26900094|P7|Year 1|Withdrawal by Subject|0
7736068|NCT00906399|26900095|P6|Year 1|Withdrawal by Subject|0
7736069|NCT00906399|26900096|P5|Year 1|Withdrawal by Subject|0
7736070|NCT00906399|26900097|P4|Year 1|Withdrawal by Subject|0
7736071|NCT00906399|26900098|P3|Year 1|Withdrawal by Subject|36
7736072|NCT00906399|26900099|P2|Year 1|Withdrawal by Subject|32
7736073|NCT00906399|26900100|P1|Year 1|Withdrawal by Subject|30
7736074|NCT00906399|26900094|P7|Year 1|Lost to Follow-up|0
7736075|NCT00906399|26900095|P6|Year 1|Lost to Follow-up|0
7736076|NCT00906399|26900096|P5|Year 1|Lost to Follow-up|0
7736077|NCT00906399|26900097|P4|Year 1|Lost to Follow-up|0
7736078|NCT00906399|26900098|P3|Year 1|Lost to Follow-up|2
7736079|NCT00906399|26900099|P2|Year 1|Lost to Follow-up|4
7736080|NCT00906399|26900100|P1|Year 1|Lost to Follow-up|4
7736081|NCT00906399|26900094|P7|Year 1|Adverse Event|0
7736082|NCT00906399|26900095|P6|Year 1|Adverse Event|0
7736083|NCT00906399|26900096|P5|Year 1|Adverse Event|0
7736084|NCT00906399|26900097|P4|Year 1|Adverse Event|0
7736085|NCT00906399|26900098|P3|Year 1|Adverse Event|24
7736086|NCT00906399|26900099|P2|Year 1|Adverse Event|22
7736087|NCT00906399|26900100|P1|Year 1|Adverse Event|4
7736088|NCT00906399|26900094|P7|Year 1|Randomized But Not Treated|0
7736089|NCT00906399|26900095|P6|Year 1|Randomized But Not Treated|0
7736090|NCT00906399|26900096|P5|Year 1|Randomized But Not Treated|0
7736091|NCT00906399|26900097|P4|Year 1|Randomized But Not Treated|0
7736092|NCT00906399|26900098|P3|Year 1|Randomized But Not Treated|3
7736093|NCT00906399|26900099|P2|Year 1|Randomized But Not Treated|1
7736094|NCT00906399|26900100|P1|Year 1|Randomized But Not Treated|0
7736095|NCT00906373|26900123|P2|Overall Study|Still on treatment at cutoff date|2
7736096|NCT00906373|26900124|P1|Overall Study|Still on treatment at cutoff date|0
7736097|NCT00906373|26900123|P2|Overall Study|Other|1
7736098|NCT00906373|26900124|P1|Overall Study|Other|0
7736099|NCT00906373|26900123|P2|Overall Study|Withdrawal by Subject|5
7736100|NCT00906373|26900124|P1|Overall Study|Withdrawal by Subject|0
7736101|NCT00906347|26900163|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
7736102|NCT00906347|26900164|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
7736103|NCT00906347|26900163|P2|Received Study Drug|Refused study drug|0
7736104|NCT00906347|26900164|P1|Received Study Drug|Refused study drug|1
7736105|NCT00906347|26900163|P2|Received Study Drug|Nonreassuring fetal heart rate|1
7736106|NCT00906347|26900164|P1|Received Study Drug|Nonreassuring fetal heart rate|13
7736107|NCT00906347|26900163|P2|Received Study Drug|8 cm prior to initiation of study drug|30
7736108|NCT00906347|26900164|P1|Received Study Drug|8 cm prior to initiation of study drug|18
7736109|NCT00906282|26900184|P1|Preoperative Chemotherapy|Toxicity|1
7736110|NCT00906282|26900184|P1|Preoperative Chemotherapy|Progressive disease|6
7736111|NCT00906282|26900184|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
7736112|NCT00906282|26900184|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
7736113|NCT00906204|26900198|P2|Secondary Endpoints (Long-term Safety)|Death|1
7736114|NCT00906204|26900199|P1|Secondary Endpoints (Long-term Safety)|Death|0
7736115|NCT00906204|26900198|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
7736116|NCT00906204|26900199|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
7736117|NCT00906204|26900198|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
7736118|NCT00906204|26900199|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
7736119|NCT00906204|26900198|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
7736120|NCT00906204|26900199|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
7736121|NCT00906204|26900198|P2|Primary Endpoint (Early Safety)|Physician Decision|0
7736122|NCT00906204|26900199|P1|Primary Endpoint (Early Safety)|Physician Decision|1
7736123|NCT00906087|26900253|P1|Initial Washout|Physician Decision|1
7736124|NCT00906087|26900253|P1|Initial Washout|Withdrawal by Subject|1
7736125|NCT00906035|26900290|P3|Overall Study|Withdrawal by Subject|0
7736126|NCT00906035|26900291|P2|Overall Study|Withdrawal by Subject|3
7736127|NCT00906035|26900292|P1|Overall Study|Withdrawal by Subject|2
7736128|NCT00905840|26900306|P1|Overall Study|Adverse Event|1
7736129|NCT00905840|26900306|P1|Overall Study|Withdrawal by Subject|1
7736130|NCT00905840|26900306|P1|Overall Study|Death|3
7736131|NCT00905840|26900306|P1|Overall Study|Lost to Follow-up|11
7736132|NCT00905632|26900337|P7|Overall Study|Adverse Event|4
7736133|NCT00905632|26900338|P6|Overall Study|Adverse Event|1
7736134|NCT00905632|26900339|P5|Overall Study|Adverse Event|0
7736135|NCT00905632|26900340|P4|Overall Study|Adverse Event|0
7736136|NCT00905632|26900341|P3|Overall Study|Adverse Event|0
7736137|NCT00905632|26900342|P2|Overall Study|Adverse Event|0
7736138|NCT00905632|26900343|P1|Overall Study|Adverse Event|0
7736139|NCT00905606|26900481|P2|Washout|Withdrawal by Subject|0
7736140|NCT00905606|26900482|P1|Washout|Withdrawal by Subject|1
7736141|NCT00905606|26900481|P2|Period 1|Adverse Event|1
7736142|NCT00905606|26900482|P1|Period 1|Adverse Event|0
7736143|NCT00905567|26900507|P2|Washout|Withdrawal by Subject|1
7736144|NCT00905567|26900508|P1|Washout|Withdrawal by Subject|0
7736145|NCT00905489|26900546|P1|Optional Extension Phase (OEP)|Adverse Event|1
7736146|NCT00905489|26900546|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
7736147|NCT00905489|26900546|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
7736148|NCT00905437|26900636|P2|Overall Study|Other|6
7736149|NCT00905437|26900637|P1|Overall Study|Other|5
7736150|NCT00905437|26900636|P2|Overall Study|Withdrawal by Subject|1
7736151|NCT00905437|26900637|P1|Overall Study|Withdrawal by Subject|0
7736152|NCT00905437|26900636|P2|Overall Study|Lost to Follow-up|1
7736153|NCT00905437|26900637|P1|Overall Study|Lost to Follow-up|0
7736154|NCT00905437|26900636|P2|Overall Study|Adverse Event|2
7736155|NCT00905437|26900637|P1|Overall Study|Adverse Event|3
7736156|NCT00905424|26900657|P2|Overall Study|Non-adherence to visit schedule|1
7736157|NCT00905424|26900658|P1|Overall Study|Non-adherence to visit schedule|0
7736158|NCT00905424|26900657|P2|Overall Study|Positive urine drug screen|1
7736159|NCT00905424|26900658|P1|Overall Study|Positive urine drug screen|0
7736160|NCT00905424|26900657|P2|Overall Study|Sponsor decision|0
7736161|NCT00905424|26900658|P1|Overall Study|Sponsor decision|1
7736162|NCT00905424|26900657|P2|Overall Study|Non-compliance with study medication|0
7736163|NCT00905424|26900658|P1|Overall Study|Non-compliance with study medication|2
7736164|NCT00905424|26900657|P2|Overall Study|Adverse Event|2
7736165|NCT00905424|26900658|P1|Overall Study|Adverse Event|4
7736166|NCT00905424|26900657|P2|Overall Study|Withdrawal by Subject|2
7736167|NCT00905424|26900658|P1|Overall Study|Withdrawal by Subject|1
7736168|NCT00905424|26900657|P2|Overall Study|Lost to Follow-up|3
7736169|NCT00905424|26900658|P1|Overall Study|Lost to Follow-up|3
7736170|NCT00905359|26900700|P2|Overall Study|Withdrawal consent|6
7736171|NCT00905359|26900701|P1|Overall Study|Withdrawal consent|5
7736172|NCT00905359|26900700|P2|Overall Study|Death|0
7736173|NCT00905359|26900701|P1|Overall Study|Death|2
7736174|NCT00905359|26900700|P2|Overall Study|Lost to Follow-up|10
7736175|NCT00905359|26900701|P1|Overall Study|Lost to Follow-up|17
7736176|NCT00905346|26900737|P2|Period 1|Withdrawal by Subject|0
7736177|NCT00905346|26900738|P1|Period 1|Withdrawal by Subject|1
7736178|NCT00905307|26900752|P6|Overall Study|Lack of Efficacy|8
7736179|NCT00905307|26900753|P5|Overall Study|Lack of Efficacy|4
7736180|NCT00905307|26900754|P4|Overall Study|Lack of Efficacy|4
7736181|NCT00905307|26900755|P3|Overall Study|Lack of Efficacy|5
7736182|NCT00905307|26900756|P2|Overall Study|Lack of Efficacy|3
7736183|NCT00905307|26900757|P1|Overall Study|Lack of Efficacy|6
7736184|NCT00905307|26900752|P6|Overall Study|Protocol Violation|0
7736185|NCT00905307|26900753|P5|Overall Study|Protocol Violation|0
7736186|NCT00905307|26900754|P4|Overall Study|Protocol Violation|0
7736187|NCT00905307|26900755|P3|Overall Study|Protocol Violation|1
7736188|NCT00905307|26900756|P2|Overall Study|Protocol Violation|0
7736189|NCT00905307|26900757|P1|Overall Study|Protocol Violation|1
7736190|NCT00905307|26900752|P6|Overall Study|Withdrawal by Subject|13
7736191|NCT00905307|26900753|P5|Overall Study|Withdrawal by Subject|4
7736192|NCT00905307|26900754|P4|Overall Study|Withdrawal by Subject|11
7736193|NCT00905307|26900755|P3|Overall Study|Withdrawal by Subject|15
7736194|NCT00905307|26900756|P2|Overall Study|Withdrawal by Subject|13
7736195|NCT00905307|26900757|P1|Overall Study|Withdrawal by Subject|5
7736196|NCT00905307|26900752|P6|Overall Study|Adverse Event|5
7736197|NCT00905307|26900753|P5|Overall Study|Adverse Event|3
7736198|NCT00905307|26900754|P4|Overall Study|Adverse Event|11
7736199|NCT00905307|26900755|P3|Overall Study|Adverse Event|5
7736200|NCT00905307|26900756|P2|Overall Study|Adverse Event|4
7736201|NCT00905307|26900757|P1|Overall Study|Adverse Event|3
7736202|NCT00905307|26900752|P6|Overall Study|Lost to Follow-up|1
7736203|NCT00905307|26900753|P5|Overall Study|Lost to Follow-up|1
7736204|NCT00905307|26900754|P4|Overall Study|Lost to Follow-up|0
7736205|NCT00905307|26900755|P3|Overall Study|Lost to Follow-up|0
7736206|NCT00905307|26900756|P2|Overall Study|Lost to Follow-up|0
7736207|NCT00905307|26900757|P1|Overall Study|Lost to Follow-up|0
7736208|NCT00905307|26900752|P6|Overall Study|Switched to Open Label Rescue|15
7736209|NCT00905307|26900753|P5|Overall Study|Switched to Open Label Rescue|4
7736210|NCT00905307|26900754|P4|Overall Study|Switched to Open Label Rescue|11
7736211|NCT00905307|26900755|P3|Overall Study|Switched to Open Label Rescue|11
7736212|NCT00905307|26900756|P2|Overall Study|Switched to Open Label Rescue|17
7736213|NCT00905307|26900757|P1|Overall Study|Switched to Open Label Rescue|7
7736214|NCT00905255|26900852|P2|Overall Study|Familial and Personal Reasons|0
7736215|NCT00905255|26900853|P1|Overall Study|Familial and Personal Reasons|1
7736216|NCT00905255|26900852|P2|Overall Study|Withdrawal by Subject|4
7736217|NCT00905255|26900853|P1|Overall Study|Withdrawal by Subject|5
7736218|NCT00905255|26900852|P2|Overall Study|Adverse Event|5
7736219|NCT00905255|26900853|P1|Overall Study|Adverse Event|7
7736220|NCT00905164|26900871|P2|Period 1|Protocol Violation|1
7736221|NCT00905164|26900872|P1|Period 1|Protocol Violation|0
7736222|NCT00905034|26900926|P1|Overall Study|Withdrawal by Subject|1
7736223|NCT00905021|26900930|P1|Overall Study|Adverse Event|2
7736224|NCT00904982|26900950|P4|Overall Study|Withdrawal by Subject|0
7736225|NCT00904982|26900951|P3|Overall Study|Withdrawal by Subject|0
7736226|NCT00904982|26900952|P2|Overall Study|Withdrawal by Subject|0
7736227|NCT00904982|26900953|P1|Overall Study|Withdrawal by Subject|2
7736228|NCT00904969|26900963|P1|Overall Study|Case Aborted; Subject Exited|1
7736229|NCT00904969|26900963|P1|Overall Study|Additional Treatments|11
7736230|NCT00904969|26900963|P1|Overall Study|Withdrawal by Subject|3
7736231|NCT00904969|26900963|P1|Overall Study|Lost to Follow-up|4
7736232|NCT00904917|26901028|P4|Overall Study|Lost to Follow-up|2
7736233|NCT00904917|26901029|P3|Overall Study|Lost to Follow-up|2
7736234|NCT00904917|26901030|P2|Overall Study|Lost to Follow-up|2
7736235|NCT00904917|26901031|P1|Overall Study|Lost to Follow-up|2
7736236|NCT00904839|26901049|P3|Overall Study|Other than above|7
7736237|NCT00904839|26901050|P2|Overall Study|Other than above|9
7736238|NCT00904839|26901051|P1|Overall Study|Other than above|0
7736239|NCT00904839|26901049|P3|Overall Study|Not treated|1
7736240|NCT00904839|26901050|P2|Overall Study|Not treated|0
7736241|NCT00904839|26901051|P1|Overall Study|Not treated|1
7736242|NCT00904839|26901049|P3|Overall Study|Withdrawal by Subject|0
7736243|NCT00904839|26901050|P2|Overall Study|Withdrawal by Subject|2
7736244|NCT00904839|26901051|P1|Overall Study|Withdrawal by Subject|0
7736245|NCT00904839|26901049|P3|Overall Study|Lost to Follow-up|2
7736246|NCT00904839|26901050|P2|Overall Study|Lost to Follow-up|1
7736247|NCT00904839|26901051|P1|Overall Study|Lost to Follow-up|0
7736248|NCT00904839|26901049|P3|Overall Study|Protocol Violation|1
7736249|NCT00904839|26901050|P2|Overall Study|Protocol Violation|1
7736250|NCT00904839|26901051|P1|Overall Study|Protocol Violation|0
7736251|NCT00904839|26901049|P3|Overall Study|Adverse Event|4
7736252|NCT00904839|26901050|P2|Overall Study|Adverse Event|5
7736253|NCT00904839|26901051|P1|Overall Study|Adverse Event|0
7736254|NCT00904748|26901129|P6|Overall Study|Adverse Event|0
7736255|NCT00904748|26901130|P5|Overall Study|Adverse Event|1
7736256|NCT00904748|26901131|P4|Overall Study|Adverse Event|0
7736257|NCT00904748|26901132|P3|Overall Study|Adverse Event|0
7736258|NCT00904748|26901133|P2|Overall Study|Adverse Event|0
7736259|NCT00904748|26901134|P1|Overall Study|Adverse Event|0
7736260|NCT00904748|26901129|P6|Overall Study|Withdrawal by Subject|0
7736261|NCT00904748|26901130|P5|Overall Study|Withdrawal by Subject|0
7736262|NCT00904748|26901131|P4|Overall Study|Withdrawal by Subject|2
7736263|NCT00904748|26901132|P3|Overall Study|Withdrawal by Subject|1
7736264|NCT00904748|26901133|P2|Overall Study|Withdrawal by Subject|1
7736265|NCT00904748|26901134|P1|Overall Study|Withdrawal by Subject|1
7736266|NCT00904722|26901158|P1|Overall Study|Physician Decision|1
7736267|NCT00904670|26901163|P2|Open Label Phase|Lost to Follow-up|0
7736268|NCT00904670|26901164|P1|Open Label Phase|Lost to Follow-up|1
7736269|NCT00904670|26901163|P2|Open Label Phase|Lack of Efficacy|0
7736270|NCT00904670|26901164|P1|Open Label Phase|Lack of Efficacy|1
7736271|NCT00904670|26901163|P2|Open Label Phase|Adverse Event|0
7736272|NCT00904670|26901164|P1|Open Label Phase|Adverse Event|2
7736273|NCT00904670|26901163|P2|Open Label Phase|Withdrawal by Subject|0
7736274|NCT00904670|26901164|P1|Open Label Phase|Withdrawal by Subject|2
7736275|NCT00904371|26901234|P1|Overall Study|Continued with Tritace|1
7736276|NCT00904371|26901234|P1|Overall Study|Discontinued at target blood pressure|2
7736277|NCT00904371|26901234|P1|Overall Study|Lost to Follow-up|4
7736278|NCT00904371|26901234|P1|Overall Study|Adverse Event|2
7736279|NCT00904215|26901259|P1|Overall Study|Other|28
7736280|NCT00904215|26901259|P1|Overall Study|Withdrawal by Subject|9
7736281|NCT00904215|26901259|P1|Overall Study|Lost to Follow-up|63
7736282|NCT00904215|26901259|P1|Overall Study|Protocol Violation|10
7736283|NCT00904215|26901259|P1|Overall Study|Adverse Event|25
7736284|NCT00904150|26901273|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
7736285|NCT00904150|26901274|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
7736286|NCT00904150|26901273|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
7736287|NCT00904150|26901274|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
7736288|NCT00904033|26901296|P4|Overall Study|Unable to obtain final blood draw|2
7736289|NCT00904033|26901297|P3|Overall Study|Unable to obtain final blood draw|0
7736290|NCT00904033|26901298|P2|Overall Study|Unable to obtain final blood draw|0
7736291|NCT00904033|26901299|P1|Overall Study|Unable to obtain final blood draw|0
7736292|NCT00904033|26901296|P4|Overall Study|Physician Decision|0
7736293|NCT00904033|26901297|P3|Overall Study|Physician Decision|1
7736294|NCT00904033|26901298|P2|Overall Study|Physician Decision|0
7736295|NCT00904033|26901299|P1|Overall Study|Physician Decision|0
7736296|NCT00904033|26901296|P4|Overall Study|Withdrawal by Subject|0
7736297|NCT00904033|26901297|P3|Overall Study|Withdrawal by Subject|0
7736298|NCT00904033|26901298|P2|Overall Study|Withdrawal by Subject|1
7736299|NCT00904033|26901299|P1|Overall Study|Withdrawal by Subject|1
7736300|NCT00903968|26901364|P8|Overall Study|Lack of Efficacy|3
7736301|NCT00903968|26901365|P7|Overall Study|Lack of Efficacy|0
7736302|NCT00903968|26901366|P6|Overall Study|Lack of Efficacy|0
7736303|NCT00903968|26901367|P5|Overall Study|Lack of Efficacy|0
7736304|NCT00903968|26901368|P4|Overall Study|Lack of Efficacy|0
7736305|NCT00903968|26901369|P3|Overall Study|Lack of Efficacy|0
7736306|NCT00903968|26901370|P2|Overall Study|Lack of Efficacy|0
7736307|NCT00903968|26901371|P1|Overall Study|Lack of Efficacy|0
7736308|NCT00903968|26901364|P8|Overall Study|Progressive Disease|18
7736309|NCT00903968|26901365|P7|Overall Study|Progressive Disease|0
7736310|NCT00903968|26901366|P6|Overall Study|Progressive Disease|3
7736311|NCT00903968|26901367|P5|Overall Study|Progressive Disease|3
7736312|NCT00903968|26901368|P4|Overall Study|Progressive Disease|3
7736313|NCT00903968|26901369|P3|Overall Study|Progressive Disease|2
7736314|NCT00903968|26901370|P2|Overall Study|Progressive Disease|3
7736315|NCT00903968|26901371|P1|Overall Study|Progressive Disease|2
7736316|NCT00903968|26901364|P8|Overall Study|Physician Decision|0
7736317|NCT00903968|26901365|P7|Overall Study|Physician Decision|0
7736318|NCT00903968|26901366|P6|Overall Study|Physician Decision|1
7736319|NCT00903968|26901367|P5|Overall Study|Physician Decision|0
7736320|NCT00903968|26901368|P4|Overall Study|Physician Decision|0
7736321|NCT00903968|26901369|P3|Overall Study|Physician Decision|0
7736322|NCT00903968|26901370|P2|Overall Study|Physician Decision|0
7736323|NCT00903968|26901371|P1|Overall Study|Physician Decision|0
7736324|NCT00903968|26901364|P8|Overall Study|Non-Compliance|0
7736325|NCT00903968|26901365|P7|Overall Study|Non-Compliance|0
7736326|NCT00903968|26901366|P6|Overall Study|Non-Compliance|1
7736327|NCT00903968|26901367|P5|Overall Study|Non-Compliance|0
7736328|NCT00903968|26901368|P4|Overall Study|Non-Compliance|0
7736329|NCT00903968|26901369|P3|Overall Study|Non-Compliance|0
7736330|NCT00903968|26901370|P2|Overall Study|Non-Compliance|0
7736331|NCT00903968|26901371|P1|Overall Study|Non-Compliance|0
7736332|NCT00903968|26901364|P8|Overall Study|Withdrawal by Subject|4
7736333|NCT00903968|26901365|P7|Overall Study|Withdrawal by Subject|0
7736334|NCT00903968|26901366|P6|Overall Study|Withdrawal by Subject|1
7736335|NCT00903968|26901367|P5|Overall Study|Withdrawal by Subject|1
7736336|NCT00903968|26901368|P4|Overall Study|Withdrawal by Subject|0
7736337|NCT00903968|26901369|P3|Overall Study|Withdrawal by Subject|1
7736338|NCT00903968|26901370|P2|Overall Study|Withdrawal by Subject|0
7736339|NCT00903968|26901371|P1|Overall Study|Withdrawal by Subject|1
7736340|NCT00903968|26901364|P8|Overall Study|DLT|0
7736341|NCT00903968|26901365|P7|Overall Study|DLT|2
7736342|NCT00903968|26901366|P6|Overall Study|DLT|0
7736343|NCT00903968|26901367|P5|Overall Study|DLT|0
7736344|NCT00903968|26901368|P4|Overall Study|DLT|0
7736345|NCT00903968|26901369|P3|Overall Study|DLT|0
7736346|NCT00903968|26901370|P2|Overall Study|DLT|0
7736347|NCT00903968|26901371|P1|Overall Study|DLT|0
7736348|NCT00903968|26901364|P8|Overall Study|Adverse Event|8
7736349|NCT00903968|26901365|P7|Overall Study|Adverse Event|1
7736350|NCT00903968|26901366|P6|Overall Study|Adverse Event|0
7736351|NCT00903968|26901367|P5|Overall Study|Adverse Event|0
7736352|NCT00903968|26901368|P4|Overall Study|Adverse Event|0
7736353|NCT00903968|26901369|P3|Overall Study|Adverse Event|0
7736354|NCT00903968|26901370|P2|Overall Study|Adverse Event|0
7736355|NCT00903968|26901371|P1|Overall Study|Adverse Event|0
7736356|NCT00903929|26901401|P4|Overall Study|Adverse Event|1
7736357|NCT00903929|26901402|P3|Overall Study|Adverse Event|0
7736358|NCT00903929|26901403|P2|Overall Study|Adverse Event|0
7736359|NCT00903929|26901404|P1|Overall Study|Adverse Event|0
7736360|NCT00903929|26901401|P4|Overall Study|Withdrawal by Subject|2
7736361|NCT00903929|26901402|P3|Overall Study|Withdrawal by Subject|1
7736362|NCT00903929|26901403|P2|Overall Study|Withdrawal by Subject|0
7736363|NCT00903929|26901404|P1|Overall Study|Withdrawal by Subject|0
7736364|NCT00903877|26901410|P1|Overall Study|Participation put on hold|4
7736365|NCT00903877|26901410|P1|Overall Study|Lost to Follow-up|1
7736366|NCT00903877|26901410|P1|Overall Study|Adverse Event|2
7736367|NCT00903877|26901410|P1|Overall Study|Withdrawal by Subject|3
7736368|NCT00903877|26901410|P1|Overall Study|Did not meet study criteria|33
7736369|NCT00903786|26901414|P1|Overall Study|Reason other than lack of efficacy|4
7736370|NCT00903786|26901414|P1|Overall Study|Lack of Efficacy|5
7736371|NCT00903786|26901414|P1|Overall Study|Physician Decision|6
7736372|NCT00903760|26901424|P2|Overall Study|Off treatment for long period|1
7736373|NCT00903760|26901425|P1|Overall Study|Off treatment for long period|0
7736374|NCT00903760|26901424|P2|Overall Study|Withdrawal by Subject|2
7736375|NCT00903760|26901425|P1|Overall Study|Withdrawal by Subject|1
7736376|NCT00903760|26901424|P2|Overall Study|Lost to Follow-up|0
7736377|NCT00903760|26901425|P1|Overall Study|Lost to Follow-up|1
7736378|NCT00903760|26901424|P2|Overall Study|Death|1
7736379|NCT00903760|26901425|P1|Overall Study|Death|0
7736380|NCT00903760|26901424|P2|Overall Study|Physician Decision|2
7736381|NCT00903760|26901425|P1|Overall Study|Physician Decision|1
7736382|NCT00903760|26901424|P2|Overall Study|Stem Cell Transplant|4
7736383|NCT00903760|26901425|P1|Overall Study|Stem Cell Transplant|8
7736384|NCT00903760|26901424|P2|Overall Study|Disease Progression/Death|6
7736385|NCT00903760|26901425|P1|Overall Study|Disease Progression/Death|8
7736386|NCT00903695|26901435|P2|Overall Study|lung cancer|0
7736387|NCT00903695|26901436|P1|Overall Study|lung cancer|1
7736388|NCT00903695|26901435|P2|Overall Study|medical exclusion after 1st testing|0
7736389|NCT00903695|26901436|P1|Overall Study|medical exclusion after 1st testing|1
7736390|NCT00903682|26901458|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
7736391|NCT00903682|26901459|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
7736392|NCT00903682|26901458|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
7736393|NCT00903682|26901459|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
7736394|NCT00903682|26901458|P2|Overall Study|Subject Non-Compliant|0
7736395|NCT00903682|26901459|P1|Overall Study|Subject Non-Compliant|1
7736396|NCT00903682|26901458|P2|Overall Study|Subject Reached A Virologic Endpoint|1
7736397|NCT00903682|26901459|P1|Overall Study|Subject Reached A Virologic Endpoint|1
7736398|NCT00903682|26901458|P2|Overall Study|Pregnancy|1
7736399|NCT00903682|26901459|P1|Overall Study|Pregnancy|0
7736400|NCT00903682|26901458|P2|Overall Study|Withdrawal by Subject|0
7736401|NCT00903682|26901459|P1|Overall Study|Withdrawal by Subject|5
7736402|NCT00903682|26901458|P2|Overall Study|Lost to Follow-up|0
7736403|NCT00903682|26901459|P1|Overall Study|Lost to Follow-up|1
7736404|NCT00903682|26901458|P2|Overall Study|Adverse Event|13
7736405|NCT00903682|26901459|P1|Overall Study|Adverse Event|6
7736406|NCT00903630|26901480|P3|Phase 2|Adverse Event|1
7736407|NCT00903630|26901481|P2|Phase 2|Adverse Event|0
7736408|NCT00903630|26901482|P1|Phase 2|Adverse Event|0
7736409|NCT00903617|26901500|P4|Overall Study|Withdrawal by Subject|0
7736410|NCT00903617|26901501|P3|Overall Study|Withdrawal by Subject|3
7736411|NCT00903617|26901502|P2|Overall Study|Withdrawal by Subject|2
7736412|NCT00903617|26901503|P1|Overall Study|Withdrawal by Subject|1
7736413|NCT00903617|26901500|P4|Overall Study|Lost to Follow-up|1
7736414|NCT00903617|26901501|P3|Overall Study|Lost to Follow-up|1
7736415|NCT00903617|26901502|P2|Overall Study|Lost to Follow-up|0
7736416|NCT00903617|26901503|P1|Overall Study|Lost to Follow-up|2
7736417|NCT00903617|26901500|P4|Overall Study|Protocol-defined stopping criteria|0
7736418|NCT00903617|26901501|P3|Overall Study|Protocol-defined stopping criteria|0
7736419|NCT00903617|26901502|P2|Overall Study|Protocol-defined stopping criteria|2
7736420|NCT00903617|26901503|P1|Overall Study|Protocol-defined stopping criteria|0
7736421|NCT00903617|26901500|P4|Overall Study|Adverse Event|0
7736422|NCT00903617|26901501|P3|Overall Study|Adverse Event|1
7736423|NCT00903617|26901502|P2|Overall Study|Adverse Event|1
7736424|NCT00903617|26901503|P1|Overall Study|Adverse Event|0
7736425|NCT00903409|26901606|P2|Overall Study|Lost to Follow-up|6
7736426|NCT00903409|26901607|P1|Overall Study|Lost to Follow-up|2
7736427|NCT00903409|26901606|P2|Overall Study|Other|3
7736428|NCT00903409|26901607|P1|Overall Study|Other|2
7736429|NCT00903409|26901606|P2|Overall Study|Withdrawal by Subject|8
7736430|NCT00903409|26901607|P1|Overall Study|Withdrawal by Subject|8
7736431|NCT00903409|26901606|P2|Overall Study|Laboratory Abnormality|0
7736432|NCT00903409|26901607|P1|Overall Study|Laboratory Abnormality|2
7736433|NCT00903409|26901606|P2|Overall Study|Non-compliance with Protocol|1
7736434|NCT00903409|26901607|P1|Overall Study|Non-compliance with Protocol|1
7736435|NCT00903409|26901606|P2|Overall Study|Adverse Event|9
7736436|NCT00903409|26901607|P1|Overall Study|Adverse Event|11
7736437|NCT00903383|26901658|P4|Overall Study|Patient Decision|1
7736438|NCT00903383|26901659|P3|Overall Study|Patient Decision|0
7736439|NCT00903383|26901660|P2|Overall Study|Patient Decision|0
7736440|NCT00903383|26901661|P1|Overall Study|Patient Decision|0
7736441|NCT00903383|26901658|P4|Overall Study|Patient Decision - Lack of Efficacy|0
7736442|NCT00903383|26901659|P3|Overall Study|Patient Decision - Lack of Efficacy|0
7736443|NCT00903383|26901660|P2|Overall Study|Patient Decision - Lack of Efficacy|1
7736444|NCT00903383|26901661|P1|Overall Study|Patient Decision - Lack of Efficacy|0
7736445|NCT00903383|26901658|P4|Overall Study|Withdrawal by Subject|2
7736446|NCT00903383|26901659|P3|Overall Study|Withdrawal by Subject|0
7736447|NCT00903383|26901660|P2|Overall Study|Withdrawal by Subject|1
7736448|NCT00903383|26901661|P1|Overall Study|Withdrawal by Subject|4
7736449|NCT00903383|26901658|P4|Overall Study|Decision of Sponsor|0
7736450|NCT00903383|26901659|P3|Overall Study|Decision of Sponsor|0
7736451|NCT00903383|26901660|P2|Overall Study|Decision of Sponsor|0
7736452|NCT00903383|26901661|P1|Overall Study|Decision of Sponsor|1
7736453|NCT00903383|26901658|P4|Overall Study|Lost to Follow-up|1
7736454|NCT00903383|26901659|P3|Overall Study|Lost to Follow-up|0
7736455|NCT00903383|26901660|P2|Overall Study|Lost to Follow-up|0
7736456|NCT00903383|26901661|P1|Overall Study|Lost to Follow-up|0
7736457|NCT00903383|26901658|P4|Overall Study|Physician Decision|0
7736458|NCT00903383|26901659|P3|Overall Study|Physician Decision|0
7736459|NCT00903383|26901660|P2|Overall Study|Physician Decision|2
7736460|NCT00903383|26901661|P1|Overall Study|Physician Decision|1
7736461|NCT00903383|26901658|P4|Overall Study|Adverse Event|1
7736462|NCT00903383|26901659|P3|Overall Study|Adverse Event|3
7736463|NCT00903383|26901660|P2|Overall Study|Adverse Event|2
7736464|NCT00903383|26901661|P1|Overall Study|Adverse Event|1
7736465|NCT00903370|26901693|P2|Overall Study|Lost to Follow-up|8
7736466|NCT00903370|26901694|P1|Overall Study|Lost to Follow-up|6
7736467|NCT00903370|26901693|P2|Overall Study|Withdrawal by Subject|6
7736468|NCT00903370|26901694|P1|Overall Study|Withdrawal by Subject|9
7736469|NCT00903370|26901693|P2|Overall Study|Death|10
7736470|NCT00903370|26901694|P1|Overall Study|Death|13
7736471|NCT00903357|26901702|P2|Second Intervention|Lost to Follow-up|0
7736472|NCT00903357|26901703|P1|Second Intervention|Lost to Follow-up|1
7736473|NCT00903357|26901702|P2|Wash Out Period of 2 Weeks|Flu|1
7736474|NCT00903357|26901703|P1|Wash Out Period of 2 Weeks|Flu|0
7736475|NCT00903357|26901702|P2|First Intervention|Flu|1
7736476|NCT00903357|26901703|P1|First Intervention|Flu|0
7736477|NCT00903357|26901702|P2|First Intervention|Withdrawal by Subject|3
7736478|NCT00903357|26901703|P1|First Intervention|Withdrawal by Subject|5
7736479|NCT00903344|26901715|P2|Overall Study|Lost to Follow-up|0
7736480|NCT00903344|26901716|P1|Overall Study|Lost to Follow-up|3
7736481|NCT00903344|26901715|P2|Overall Study|Pregnancy|3
7736482|NCT00903344|26901716|P1|Overall Study|Pregnancy|2
7736483|NCT00903331|26901734|P2|Overall Study|Lung transplant|2
7736484|NCT00903331|26901735|P1|Overall Study|Lung transplant|0
7736485|NCT00903331|26901734|P2|Overall Study|Withdrawal of consent|8
7736486|NCT00903331|26901735|P1|Overall Study|Withdrawal of consent|1
7736487|NCT00903331|26901734|P2|Overall Study|Death|8
7736488|NCT00903331|26901735|P1|Overall Study|Death|4
7736489|NCT00903201|26901746|P3|Overall Study|Withdrawal by Subject|1
7736490|NCT00903201|26901747|P2|Overall Study|Withdrawal by Subject|0
7736491|NCT00903201|26901748|P1|Overall Study|Withdrawal by Subject|1
7736492|NCT00903201|26901746|P3|Overall Study|Physician Decision|1
7736493|NCT00903201|26901747|P2|Overall Study|Physician Decision|0
7736494|NCT00903201|26901748|P1|Overall Study|Physician Decision|1
7736495|NCT00903201|26901746|P3|Overall Study|Lost to Follow-up|0
7736496|NCT00903201|26901747|P2|Overall Study|Lost to Follow-up|1
7736497|NCT00903201|26901748|P1|Overall Study|Lost to Follow-up|0
7736498|NCT00903201|26901746|P3|Overall Study|Protocol Violation|0
7736499|NCT00903201|26901747|P2|Overall Study|Protocol Violation|1
7736500|NCT00903201|26901748|P1|Overall Study|Protocol Violation|2
7736501|NCT00903201|26901746|P3|Overall Study|Adverse Event|0
7736502|NCT00903201|26901747|P2|Overall Study|Adverse Event|4
7736503|NCT00903201|26901748|P1|Overall Study|Adverse Event|1
7736504|NCT00903175|26901806|P2|Period 2 - Second Line|Death|2
7736505|NCT00903175|26901807|P1|Period 2 - Second Line|Death|5
7736506|NCT00903175|26901806|P2|Period 2 - Second Line|Administrative problems|9
7736507|NCT00903175|26901807|P1|Period 2 - Second Line|Administrative problems|19
7736508|NCT00903175|26901806|P2|Period 2 - Second Line|Lost to Follow-up|0
7736509|NCT00903175|26901807|P1|Period 2 - Second Line|Lost to Follow-up|1
7736510|NCT00903175|26901806|P2|Period 2 - Second Line|Withdrawal by Subject|5
7736511|NCT00903175|26901807|P1|Period 2 - Second Line|Withdrawal by Subject|7
7736512|NCT00903175|26901806|P2|Period 2 - Second Line|Adverse Event|20
7736513|NCT00903175|26901807|P1|Period 2 - Second Line|Adverse Event|16
7736514|NCT00903175|26901806|P2|Period 2 - Second Line|Missing|0
7736515|NCT00903175|26901807|P1|Period 2 - Second Line|Missing|1
7736516|NCT00903175|26901806|P2|Period 1 - First Line|Death|10
7736517|NCT00903175|26901807|P1|Period 1 - First Line|Death|17
7736518|NCT00903175|26901806|P2|Period 1 - First Line|Administrative problems|13
7736519|NCT00903175|26901807|P1|Period 1 - First Line|Administrative problems|12
7736520|NCT00903175|26901806|P2|Period 1 - First Line|Withdrawal by Subject|12
7736521|NCT00903175|26901807|P1|Period 1 - First Line|Withdrawal by Subject|8
7736522|NCT00903175|26901806|P2|Period 1 - First Line|Protocol Violation|3
7736523|NCT00903175|26901807|P1|Period 1 - First Line|Protocol Violation|3
7736524|NCT00903175|26901806|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
7736525|NCT00903175|26901807|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
7736526|NCT00903175|26901806|P2|Period 1 - First Line|Abnormal lab value(s)|1
7736527|NCT00903175|26901807|P1|Period 1 - First Line|Abnormal lab value(s)|0
7736528|NCT00903175|26901806|P2|Period 1 - First Line|Adverse Event|50
7736529|NCT00903175|26901807|P1|Period 1 - First Line|Adverse Event|36
7736530|NCT00903032|26901845|P2|Overall Study|Lost to Follow-up|2
7736531|NCT00903032|26901846|P1|Overall Study|Lost to Follow-up|2
7736532|NCT00903032|26901845|P2|Overall Study|Withdrawal by Subject|3
7736533|NCT00903032|26901846|P1|Overall Study|Withdrawal by Subject|5
7736534|NCT00903006|26901856|P4|Overall Study|Progressive Disease|0
7736535|NCT00903006|26901857|P3|Overall Study|Progressive Disease|1
7736536|NCT00903006|26901858|P2|Overall Study|Progressive Disease|3
7736537|NCT00903006|26901859|P1|Overall Study|Progressive Disease|0
7736538|NCT00903006|26901856|P4|Overall Study|Withdrawal by Subject|0
7736539|NCT00903006|26901857|P3|Overall Study|Withdrawal by Subject|0
7736540|NCT00903006|26901858|P2|Overall Study|Withdrawal by Subject|0
7736541|NCT00903006|26901859|P1|Overall Study|Withdrawal by Subject|2
7736542|NCT00902850|26901871|P2|Overall Study|Physician Decision|2
7736543|NCT00902850|26901872|P1|Overall Study|Physician Decision|2
7736544|NCT00902746|26901878|P1|Overall Study|Physician Decision|2
7736545|NCT00902746|26901878|P1|Overall Study|Lost to Follow-up|3
7736546|NCT00902746|26901878|P1|Overall Study|Adverse Event|8
7736547|NCT00902746|26901878|P1|Overall Study|Withdrawal by Subject|16
7736548|NCT00902746|26901878|P1|Overall Study|Protocol Violation|7
7736549|NCT00902668|26901883|P1|Overall Study|Protocol stopped due to slow accrual.|3
7736550|NCT00902577|26901887|P1|Overall Study|FMISO production failure|2
7736551|NCT00902577|26901887|P1|Overall Study|Withdrawal by Subject|6
7736552|NCT00902564|26901916|P1|Overall Study|Withdrawal by Subject|2
7736553|NCT00902538|26901931|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7736554|NCT00902538|26901932|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7736555|NCT00902538|26901933|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
7736556|NCT00902538|26901934|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7736557|NCT00902538|26901935|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7736558|NCT00902538|26901936|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7736559|NCT00902538|26901931|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7736560|NCT00902538|26901932|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
7736561|NCT00902538|26901933|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
7736562|NCT00902538|26901934|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7736563|NCT00902538|26901935|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7736564|NCT00902538|26901936|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7736565|NCT00902538|26901931|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
7736566|NCT00902538|26901932|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
7736567|NCT00902538|26901933|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
7736568|NCT00902538|26901934|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7736569|NCT00902538|26901935|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7736570|NCT00902538|26901936|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7736571|NCT00902538|26901931|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
7736572|NCT00902538|26901932|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
7736573|NCT00902538|26901933|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
7736574|NCT00902538|26901934|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
7736575|NCT00902538|26901935|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
7736576|NCT00902538|26901936|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
7736577|NCT00902538|26901931|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7736578|NCT00902538|26901932|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7736579|NCT00902538|26901933|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7736580|NCT00902538|26901934|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7736581|NCT00902538|26901935|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
7736582|NCT00902538|26901936|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7736583|NCT00902538|26901931|P6|3-Single-blind, Single Treatment|Protocol Violation|0
7736584|NCT00902538|26901932|P5|3-Single-blind, Single Treatment|Protocol Violation|0
7736585|NCT00902538|26901933|P4|3-Single-blind, Single Treatment|Protocol Violation|0
7736586|NCT00902538|26901934|P3|3-Single-blind, Single Treatment|Protocol Violation|0
7736587|NCT00902538|26901935|P2|3-Single-blind, Single Treatment|Protocol Violation|5
7736588|NCT00902538|26901936|P1|3-Single-blind, Single Treatment|Protocol Violation|0
7736589|NCT00902538|26901931|P6|3-Single-blind, Single Treatment|Adverse Event|0
7736590|NCT00902538|26901932|P5|3-Single-blind, Single Treatment|Adverse Event|0
7736591|NCT00902538|26901933|P4|3-Single-blind, Single Treatment|Adverse Event|0
7736592|NCT00902538|26901934|P3|3-Single-blind, Single Treatment|Adverse Event|0
7736593|NCT00902538|26901935|P2|3-Single-blind, Single Treatment|Adverse Event|5
7736594|NCT00902538|26901936|P1|3-Single-blind, Single Treatment|Adverse Event|0
7736595|NCT00902538|26901931|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7736596|NCT00902538|26901932|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7736597|NCT00902538|26901933|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7736598|NCT00902538|26901934|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
7736599|NCT00902538|26901935|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
7736600|NCT00902538|26901936|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
7736601|NCT00902538|26901931|P6|2-Randomized Double-blind 3 Treatments|Other|0
7736602|NCT00902538|26901932|P5|2-Randomized Double-blind 3 Treatments|Other|0
7736603|NCT00902538|26901933|P4|2-Randomized Double-blind 3 Treatments|Other|0
7736604|NCT00902538|26901934|P3|2-Randomized Double-blind 3 Treatments|Other|0
7736605|NCT00902538|26901935|P2|2-Randomized Double-blind 3 Treatments|Other|1
7736606|NCT00902538|26901936|P1|2-Randomized Double-blind 3 Treatments|Other|2
7736607|NCT00902538|26901931|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7736608|NCT00902538|26901932|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7736609|NCT00902538|26901933|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7736610|NCT00902538|26901934|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
7736611|NCT00902538|26901935|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7736612|NCT00902538|26901936|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
7736613|NCT00902538|26901931|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7736614|NCT00902538|26901932|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7736615|NCT00902538|26901933|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7736616|NCT00902538|26901934|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
7736617|NCT00902538|26901935|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
7736618|NCT00902538|26901936|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
7736619|NCT00902538|26901931|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7736620|NCT00902538|26901932|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7736621|NCT00902538|26901933|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7736622|NCT00902538|26901934|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
7736623|NCT00902538|26901935|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
7736624|NCT00902538|26901936|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
7736625|NCT00902538|26901931|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7736626|NCT00902538|26901932|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7736627|NCT00902538|26901933|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7736628|NCT00902538|26901934|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7736629|NCT00902538|26901935|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7736630|NCT00902538|26901936|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
7736631|NCT00902538|26901931|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7736632|NCT00902538|26901932|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7736633|NCT00902538|26901933|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7736634|NCT00902538|26901934|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7736635|NCT00902538|26901935|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7736636|NCT00902538|26901936|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
7736637|NCT00902538|26901931|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7736638|NCT00902538|26901932|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7736639|NCT00902538|26901933|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7736640|NCT00902538|26901934|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7736641|NCT00902538|26901935|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7736642|NCT00902538|26901936|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
7736643|NCT00902538|26901931|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7736644|NCT00902538|26901932|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7736645|NCT00902538|26901933|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7736646|NCT00902538|26901934|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7736647|NCT00902538|26901935|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7736648|NCT00902538|26901936|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
7736649|NCT00902538|26901931|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7736650|NCT00902538|26901932|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7736651|NCT00902538|26901933|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7736652|NCT00902538|26901934|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7736653|NCT00902538|26901935|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7736654|NCT00902538|26901936|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
7736655|NCT00902486|26901970|P6|Follow-up (After Week 24)|Lost to Follow-up|0
7736656|NCT00902486|26901971|P5|Follow-up (After Week 24)|Lost to Follow-up|0
7736657|NCT00902486|26901972|P4|Follow-up (After Week 24)|Lost to Follow-up|1
7736658|NCT00902486|26901973|P3|Follow-up (After Week 24)|Lost to Follow-up|0
7736659|NCT00902486|26901974|P2|Follow-up (After Week 24)|Lost to Follow-up|0
7736660|NCT00902486|26901975|P1|Follow-up (After Week 24)|Lost to Follow-up|0
7736661|NCT00902486|26901970|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7736662|NCT00902486|26901971|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7736663|NCT00902486|26901972|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7736664|NCT00902486|26901973|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
7736665|NCT00902486|26901974|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7736666|NCT00902486|26901975|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7736667|NCT00902486|26901970|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7736668|NCT00902486|26901971|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7736669|NCT00902486|26901972|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
7736670|NCT00902486|26901973|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7736671|NCT00902486|26901974|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7736672|NCT00902486|26901975|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7736673|NCT00902486|26901970|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
7736674|NCT00902486|26901971|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7736675|NCT00902486|26901972|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7736676|NCT00902486|26901973|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7736677|NCT00902486|26901974|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7736678|NCT00902486|26901975|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7736679|NCT00902486|26901970|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7736680|NCT00902486|26901971|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7736681|NCT00902486|26901972|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
7736682|NCT00902486|26901973|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
7736683|NCT00902486|26901974|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7736684|NCT00902486|26901975|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7736685|NCT00902486|26901970|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
7736686|NCT00902486|26901971|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
7736687|NCT00902486|26901972|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7736688|NCT00902486|26901973|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7736689|NCT00902486|26901974|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7736690|NCT00902486|26901975|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7736691|NCT00902486|26901970|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7736692|NCT00902486|26901971|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7736693|NCT00902486|26901972|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
7736694|NCT00902486|26901973|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7736695|NCT00902486|26901974|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7736696|NCT00902486|26901975|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7736697|NCT00902486|26901970|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7736698|NCT00902486|26901971|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7736699|NCT00902486|26901972|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
7736700|NCT00902486|26901973|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7736701|NCT00902486|26901974|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7736702|NCT00902486|26901975|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7736703|NCT00902486|26901970|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
7736704|NCT00902486|26901971|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
7736705|NCT00902486|26901972|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7736706|NCT00902486|26901973|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7736707|NCT00902486|26901974|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7736708|NCT00902486|26901975|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7736709|NCT00902486|26901970|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
7736710|NCT00902486|26901971|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7736711|NCT00902486|26901972|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7736712|NCT00902486|26901973|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7736713|NCT00902486|26901974|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7736714|NCT00902486|26901975|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
7736715|NCT00902486|26901970|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
7736716|NCT00902486|26901971|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7736717|NCT00902486|26901972|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7736718|NCT00902486|26901973|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
7736719|NCT00902486|26901974|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
7736720|NCT00902486|26901975|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7736721|NCT00902330|26902113|P2|Overall Study|No post baseline data|0
7736722|NCT00902330|26902114|P1|Overall Study|No post baseline data|1
7736723|NCT00902330|26902113|P2|Overall Study|Adverse Event|0
7736724|NCT00902330|26902114|P1|Overall Study|Adverse Event|1
7736725|NCT00902330|26902113|P2|Overall Study|Too overwhelmed by treatment|5
7736726|NCT00902330|26902114|P1|Overall Study|Too overwhelmed by treatment|2
7736727|NCT00902304|26902151|P3|Overall Study|includes pregnancy|2
7736728|NCT00902304|26902152|P2|Overall Study|includes pregnancy|9
7736729|NCT00902304|26902153|P1|Overall Study|includes pregnancy|3
7736730|NCT00902304|26902151|P3|Overall Study|Withdrawal by Subject|43
7736731|NCT00902304|26902152|P2|Overall Study|Withdrawal by Subject|22
7736732|NCT00902304|26902153|P1|Overall Study|Withdrawal by Subject|32
7736733|NCT00902304|26902151|P3|Overall Study|Protocol Violation|20
7736734|NCT00902304|26902152|P2|Overall Study|Protocol Violation|18
7736735|NCT00902304|26902153|P1|Overall Study|Protocol Violation|9
7736736|NCT00902304|26902151|P3|Overall Study|Lost to Follow-up|7
7736737|NCT00902304|26902152|P2|Overall Study|Lost to Follow-up|7
7736738|NCT00902304|26902153|P1|Overall Study|Lost to Follow-up|7
7736739|NCT00902304|26902151|P3|Overall Study|Investigator discretion|13
7736740|NCT00902304|26902152|P2|Overall Study|Investigator discretion|5
7736741|NCT00902304|26902153|P1|Overall Study|Investigator discretion|3
7736742|NCT00902304|26902151|P3|Overall Study|Adverse Event|25
7736743|NCT00902304|26902152|P2|Overall Study|Adverse Event|10
7736744|NCT00902304|26902153|P1|Overall Study|Adverse Event|4
7736745|NCT00902278|26902203|P5|Overall Study|Lost to Follow-up|1
7736746|NCT00902278|26902204|P4|Overall Study|Lost to Follow-up|0
7736747|NCT00902278|26902205|P3|Overall Study|Lost to Follow-up|3
7736748|NCT00902278|26902206|P2|Overall Study|Lost to Follow-up|2
7736749|NCT00902278|26902207|P1|Overall Study|Lost to Follow-up|3
7736750|NCT00902278|26902203|P5|Overall Study|Physician Decision|1
7736751|NCT00902278|26902204|P4|Overall Study|Physician Decision|0
7736752|NCT00902278|26902205|P3|Overall Study|Physician Decision|2
7736753|NCT00902278|26902206|P2|Overall Study|Physician Decision|0
7736754|NCT00902278|26902207|P1|Overall Study|Physician Decision|1
7736755|NCT00902265|26902224|P1|Overall Study|Protocol Violation|1
7736756|NCT00902265|26902224|P1|Overall Study|Lack of Efficacy|2
7736757|NCT00902265|26902224|P1|Overall Study|Adverse Event|2
7736758|NCT00902265|26902224|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
7736759|NCT00902174|26902248|P2|Overall Study|Administration problem|1
7736760|NCT00902174|26902249|P1|Overall Study|Administration problem|0
7736761|NCT00902174|26902248|P2|Overall Study|Protocol Violation|1
7736762|NCT00902174|26902249|P1|Overall Study|Protocol Violation|1
7736763|NCT00902174|26902248|P2|Overall Study|Abnormal labs|1
7736764|NCT00902174|26902249|P1|Overall Study|Abnormal labs|1
7736765|NCT00902174|26902248|P2|Overall Study|Withdrawal by Subject|1
7736766|NCT00902174|26902249|P1|Overall Study|Withdrawal by Subject|2
7736767|NCT00902174|26902248|P2|Overall Study|Death|2
7736768|NCT00902174|26902249|P1|Overall Study|Death|2
7736769|NCT00902174|26902248|P2|Overall Study|Lack of Efficacy|5
7736770|NCT00902174|26902249|P1|Overall Study|Lack of Efficacy|1
7736771|NCT00902174|26902248|P2|Overall Study|Adverse Event|7
7736772|NCT00902174|26902249|P1|Overall Study|Adverse Event|27
7736773|NCT00901927|26902324|P1|Overall Study|Withdrawal by Subject|2
7736774|NCT00901927|26902324|P1|Overall Study|Protocol Violation|3
7736775|NCT00901927|26902324|P1|Overall Study|Lack of Efficacy|1
7736776|NCT00901901|26902332|P2|Follow-up Period|Missing|80
7736777|NCT00901901|26902333|P1|Follow-up Period|Missing|94
7736778|NCT00901901|26902332|P2|Follow-up Period|Lost to Follow-up|8
7736779|NCT00901901|26902333|P1|Follow-up Period|Lost to Follow-up|12
7736780|NCT00901901|26902332|P2|Follow-up Period|Withdrawal by Subject|9
7736781|NCT00901901|26902333|P1|Follow-up Period|Withdrawal by Subject|6
7736782|NCT00901901|26902332|P2|Follow-up Period|Protocol driven decision point|36
7736783|NCT00901901|26902333|P1|Follow-up Period|Protocol driven decision point|47
7736784|NCT00901901|26902332|P2|Follow-up Period|Death|208
7736785|NCT00901901|26902333|P1|Follow-up Period|Death|181
7736786|NCT00901901|26902332|P2|Treatment Period|Transfer to treatment continuation study|2
7736787|NCT00901901|26902333|P1|Treatment Period|Transfer to treatment continuation study|5
7736788|NCT00901901|26902332|P2|Treatment Period|Switch to commercial drug|1
7736789|NCT00901901|26902333|P1|Treatment Period|Switch to commercial drug|1
7736790|NCT00901901|26902332|P2|Treatment Period|Protocol Violation|9
7736791|NCT00901901|26902333|P1|Treatment Period|Protocol Violation|5
7736792|NCT00901901|26902332|P2|Treatment Period|Study terminated by sponsor|0
7736793|NCT00901901|26902333|P1|Treatment Period|Study terminated by sponsor|2
7736794|NCT00901901|26902332|P2|Treatment Period|Protocol driven decision point|2
7736795|NCT00901901|26902333|P1|Treatment Period|Protocol driven decision point|0
7736796|NCT00901901|26902332|P2|Treatment Period|Never treated|3
7736797|NCT00901901|26902333|P1|Treatment Period|Never treated|0
7736798|NCT00901901|26902332|P2|Treatment Period|Missing|0
7736799|NCT00901901|26902333|P1|Treatment Period|Missing|1
7736800|NCT00901901|26902332|P2|Treatment Period|Noncompliance with study medication|1
7736801|NCT00901901|26902333|P1|Treatment Period|Noncompliance with study medication|4
7736802|NCT00901901|26902332|P2|Treatment Period|Lost to Follow-up|5
7736803|NCT00901901|26902333|P1|Treatment Period|Lost to Follow-up|3
7736804|NCT00901901|26902332|P2|Treatment Period|Physician Decision|2
7736805|NCT00901901|26902333|P1|Treatment Period|Physician Decision|2
7736806|NCT00901901|26902332|P2|Treatment Period|Withdrawal by Subject|24
7736807|NCT00901901|26902333|P1|Treatment Period|Withdrawal by Subject|26
7736808|NCT00901901|26902332|P2|Treatment Period|Adverse Event|128
7736809|NCT00901901|26902333|P1|Treatment Period|Adverse Event|120
7736810|NCT00901628|26902355|P2|Overall Study|peroneal nerve palsy|1
7736811|NCT00901628|26902356|P1|Overall Study|peroneal nerve palsy|0
7736812|NCT00901628|26902355|P2|Overall Study|disconnection of drain|1
7736813|NCT00901628|26902356|P1|Overall Study|disconnection of drain|0
7736814|NCT00901628|26902355|P2|Overall Study|disconnection of catheter|8
7736815|NCT00901628|26902356|P1|Overall Study|disconnection of catheter|4
7736816|NCT00901576|26902378|P6|Second Intervention|Physician Decision|0
7736817|NCT00901576|26902379|P5|Second Intervention|Physician Decision|0
7736818|NCT00901576|26902380|P4|Second Intervention|Physician Decision|0
7736819|NCT00901576|26902381|P3|Second Intervention|Physician Decision|0
7736820|NCT00901576|26902382|P2|Second Intervention|Physician Decision|0
7736821|NCT00901576|26902383|P1|Second Intervention|Physician Decision|1
7736822|NCT00901576|26902378|P6|Second Intervention|Withdrawal by Subject|1
7736823|NCT00901576|26902379|P5|Second Intervention|Withdrawal by Subject|0
7736824|NCT00901576|26902380|P4|Second Intervention|Withdrawal by Subject|1
7736825|NCT00901576|26902381|P3|Second Intervention|Withdrawal by Subject|0
7736826|NCT00901576|26902382|P2|Second Intervention|Withdrawal by Subject|0
7736827|NCT00901576|26902383|P1|Second Intervention|Withdrawal by Subject|0
7736828|NCT00901485|26902404|P2|Overall Study|Withdrawal by Subject|2
7736829|NCT00901485|26902405|P1|Overall Study|Withdrawal by Subject|1
7736830|NCT00901485|26902404|P2|Overall Study|Lack of Efficacy|2
7736831|NCT00901485|26902405|P1|Overall Study|Lack of Efficacy|0
7736832|NCT00901459|26902437|P1|Overall Study|Withdrawal by Subject|6
7736833|NCT00901394|26902451|P3|Overall Study|Physician Decision|2
7736834|NCT00901394|26902452|P2|Overall Study|Physician Decision|1
7736835|NCT00901394|26902453|P1|Overall Study|Physician Decision|1
7736836|NCT00901342|26902461|P1|Overall Study|Withdrawal by Subject|9
7736837|NCT00901342|26902461|P1|Overall Study|Disease progression|1
7736838|NCT00901342|26902461|P1|Overall Study|Death|4
7736839|NCT00901342|26902461|P1|Overall Study|Adverse Event|1
7736840|NCT00901186|26902499|P2|Overall Study|Protocol deviations|4
7736841|NCT00901186|26902500|P1|Overall Study|Protocol deviations|5
7736842|NCT00901186|26902499|P2|Overall Study|Administration problems|1
7736843|NCT00901186|26902500|P1|Overall Study|Administration problems|0
7736844|NCT00901186|26902499|P2|Overall Study|Adverse Event|4
7736845|NCT00901186|26902500|P1|Overall Study|Adverse Event|2
7736846|NCT00901186|26902499|P2|Overall Study|Lost to Follow-up|0
7736847|NCT00901186|26902500|P1|Overall Study|Lost to Follow-up|2
7736848|NCT00901186|26902499|P2|Overall Study|Abnormal laboratory values|1
7736849|NCT00901186|26902500|P1|Overall Study|Abnormal laboratory values|0
7736850|NCT00901186|26902499|P2|Overall Study|Lack of Efficacy|1
7736851|NCT00901186|26902500|P1|Overall Study|Lack of Efficacy|0
7736852|NCT00900796|26902540|P1|Phase 2|Lost to Follow-up|5
7736853|NCT00900796|26902540|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
7736854|NCT00900796|26902540|P1|Phase 1|Missing information at Week 16|7
7736855|NCT00900796|26902540|P1|Phase 1|Lacked sufficient information|4
7736856|NCT00900757|26902550|P1|Overall Study|screen failure|19
7736857|NCT00900731|26902560|P2|Overall Study|Death|2
7736858|NCT00900731|26902561|P1|Overall Study|Death|0
7736859|NCT00900731|26902560|P2|Overall Study|Lack of Efficacy|3
7736860|NCT00900731|26902561|P1|Overall Study|Lack of Efficacy|1
7736861|NCT00900731|26902560|P2|Overall Study|Lost to Follow-up|3
7736862|NCT00900731|26902561|P1|Overall Study|Lost to Follow-up|2
7736863|NCT00900731|26902560|P2|Overall Study|Abnormal Laboratory Value(s)|4
7736864|NCT00900731|26902561|P1|Overall Study|Abnormal Laboratory Value(s)|2
7736865|NCT00900731|26902560|P2|Overall Study|Abnormal Test Procedure Result(s)|0
7736866|NCT00900731|26902561|P1|Overall Study|Abnormal Test Procedure Result(s)|3
7736867|NCT00900731|26902560|P2|Overall Study|Administrative Problems|4
7736868|NCT00900731|26902561|P1|Overall Study|Administrative Problems|5
7736869|NCT00900731|26902560|P2|Overall Study|Protocol Deviation|11
7736870|NCT00900731|26902561|P1|Overall Study|Protocol Deviation|8
7736871|NCT00900731|26902560|P2|Overall Study|Withdrawal by Subject|7
7736872|NCT00900731|26902561|P1|Overall Study|Withdrawal by Subject|8
7736873|NCT00900731|26902560|P2|Overall Study|Adverse Event|27
7736874|NCT00900731|26902561|P1|Overall Study|Adverse Event|31
7736875|NCT00900627|26902598|P6|Overall Study|Death|24
7736876|NCT00900627|26902599|P5|Overall Study|Death|28
7736877|NCT00900627|26902600|P4|Overall Study|Death|0
7736878|NCT00900627|26902601|P3|Overall Study|Death|0
7736879|NCT00900627|26902602|P2|Overall Study|Death|0
7736880|NCT00900627|26902603|P1|Overall Study|Death|0
7736881|NCT00900627|26902598|P6|Overall Study|Adverse Event|0
7736882|NCT00900627|26902599|P5|Overall Study|Adverse Event|0
7736883|NCT00900627|26902600|P4|Overall Study|Adverse Event|3
7736884|NCT00900627|26902601|P3|Overall Study|Adverse Event|0
7736885|NCT00900627|26902602|P2|Overall Study|Adverse Event|2
7736886|NCT00900627|26902603|P1|Overall Study|Adverse Event|1
7736887|NCT00900627|26902598|P6|Overall Study|Withdrawal by Subject|2
7736888|NCT00900627|26902599|P5|Overall Study|Withdrawal by Subject|1
7736889|NCT00900627|26902600|P4|Overall Study|Withdrawal by Subject|0
7736890|NCT00900627|26902601|P3|Overall Study|Withdrawal by Subject|1
7736891|NCT00900627|26902602|P2|Overall Study|Withdrawal by Subject|0
7736892|NCT00900627|26902603|P1|Overall Study|Withdrawal by Subject|1
7736893|NCT00900627|26902598|P6|Overall Study|Condition under investigation worsened|0
7736894|NCT00900627|26902599|P5|Overall Study|Condition under investigation worsened|0
7736895|NCT00900627|26902600|P4|Overall Study|Condition under investigation worsened|3
7736896|NCT00900627|26902601|P3|Overall Study|Condition under investigation worsened|5
7736897|NCT00900627|26902602|P2|Overall Study|Condition under investigation worsened|0
7736898|NCT00900627|26902603|P1|Overall Study|Condition under investigation worsened|4
7736899|NCT00900601|26902621|P1|Overall Study|Physician Decision|1
7736900|NCT00900159|26902640|P2|Second Intervention|disempanelled for inappropriate behavior|0
7736901|NCT00900159|26902641|P1|Second Intervention|disempanelled for inappropriate behavior|1
7736902|NCT00900146|26902660|P5|Intermediate: Period III|Administrative problems|163
7736903|NCT00900146|26902661|P4|Intermediate: Period III|Administrative problems|90
7736904|NCT00900146|26902662|P3|Intermediate: Period III|Administrative problems|84
7736905|NCT00900146|26902663|P2|Intermediate: Period III|Administrative problems|92
7736906|NCT00900146|26902664|P1|Intermediate: Period III|Administrative problems|85
7736907|NCT00900146|26902660|P5|Intermediate: Period III|Lost to Follow-up|1
7736908|NCT00900146|26902661|P4|Intermediate: Period III|Lost to Follow-up|0
7736909|NCT00900146|26902662|P3|Intermediate: Period III|Lost to Follow-up|0
7736910|NCT00900146|26902663|P2|Intermediate: Period III|Lost to Follow-up|0
7736911|NCT00900146|26902664|P1|Intermediate: Period III|Lost to Follow-up|2
7736912|NCT00900146|26902660|P5|Intermediate: Period III|Withdrawal by Subject|3
7736913|NCT00900146|26902661|P4|Intermediate: Period III|Withdrawal by Subject|0
7736914|NCT00900146|26902662|P3|Intermediate: Period III|Withdrawal by Subject|0
7736915|NCT00900146|26902663|P2|Intermediate: Period III|Withdrawal by Subject|1
7736916|NCT00900146|26902664|P1|Intermediate: Period III|Withdrawal by Subject|0
7736917|NCT00900146|26902660|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
7736918|NCT00900146|26902661|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
7736919|NCT00900146|26902662|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
7736920|NCT00900146|26902663|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
7736921|NCT00900146|26902664|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
7736922|NCT00900146|26902660|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
7736923|NCT00900146|26902661|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
7736924|NCT00900146|26902662|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
7736925|NCT00900146|26902663|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
7736926|NCT00900146|26902664|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
7736927|NCT00900146|26902660|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
7736928|NCT00900146|26902661|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
7736929|NCT00900146|26902662|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
7736930|NCT00900146|26902663|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
7736931|NCT00900146|26902664|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
7736932|NCT00900029|26902781|P5|Overall Study|Death|0
7736933|NCT00900029|26902782|P4|Overall Study|Death|1
7736934|NCT00900029|26902783|P3|Overall Study|Death|0
7736935|NCT00900029|26902784|P2|Overall Study|Death|0
7736936|NCT00900029|26902785|P1|Overall Study|Death|1
7736937|NCT00900029|26902781|P5|Overall Study|Adverse Event|1
7736938|NCT00900029|26902782|P4|Overall Study|Adverse Event|1
7736939|NCT00900029|26902783|P3|Overall Study|Adverse Event|1
7736940|NCT00900029|26902784|P2|Overall Study|Adverse Event|0
7736941|NCT00900029|26902785|P1|Overall Study|Adverse Event|0
7736942|NCT00900029|26902781|P5|Overall Study|Withdrawal by Subject|1
7736943|NCT00900029|26902782|P4|Overall Study|Withdrawal by Subject|1
7736944|NCT00900029|26902783|P3|Overall Study|Withdrawal by Subject|1
7736945|NCT00900029|26902784|P2|Overall Study|Withdrawal by Subject|2
7736946|NCT00900029|26902785|P1|Overall Study|Withdrawal by Subject|2
7736947|NCT00900029|26902781|P5|Overall Study|Lost to Follow-up|4
7736948|NCT00900029|26902782|P4|Overall Study|Lost to Follow-up|4
7736949|NCT00900029|26902783|P3|Overall Study|Lost to Follow-up|1
7736950|NCT00900029|26902784|P2|Overall Study|Lost to Follow-up|2
7736951|NCT00900029|26902785|P1|Overall Study|Lost to Follow-up|0
7736952|NCT00899847|26902802|P1|Overall Study|Lack of suitable allogeneic donor|2
7736953|NCT00899678|26902833|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
7736954|NCT00899678|26902834|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
7736955|NCT00899678|26902835|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
7736956|NCT00899678|26902833|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
7736957|NCT00899678|26902834|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
7736958|NCT00899678|26902835|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
7736959|NCT00899678|26902833|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
7736960|NCT00899678|26902834|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
7736961|NCT00899678|26902835|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
7736962|NCT00899678|26902833|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
7736963|NCT00899678|26902834|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
7736964|NCT00899678|26902835|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
7736965|NCT00899678|26902833|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
7736966|NCT00899678|26902834|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
7736967|NCT00899678|26902835|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
7736968|NCT00899678|26902833|P3|Induction Period (Weeks 0 to 6)|Other reason|0
7736969|NCT00899678|26902834|P2|Induction Period (Weeks 0 to 6)|Other reason|0
7736970|NCT00899678|26902835|P1|Induction Period (Weeks 0 to 6)|Other reason|1
7736971|NCT00899678|26902833|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
7736972|NCT00899678|26902834|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
7736973|NCT00899678|26902835|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
7736974|NCT00899678|26902833|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
7736975|NCT00899678|26902834|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
7736976|NCT00899678|26902835|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
7736977|NCT00899678|26902833|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
7736978|NCT00899678|26902834|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
7736979|NCT00899678|26902835|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
7736980|NCT00899548|26902885|P1|Overall Study|Physician Decision|3
7736981|NCT00899431|26902979|P3|Overall Study|Physician Decision|0
7736982|NCT00899431|26902980|P2|Overall Study|Physician Decision|0
7736983|NCT00899431|26902981|P1|Overall Study|Physician Decision|1
7736984|NCT00899392|26902994|P2|Overall Study|Subject didn't finish/partial pilot data|24
7736985|NCT00899392|26902995|P1|Overall Study|Subject didn't finish/partial pilot data|21
7736986|NCT00899379|26903012|P5|Overall Study|Inc/Exc Criteria Not Met|0
7736987|NCT00899379|26903013|P4|Overall Study|Inc/Exc Criteria Not Met|0
7736988|NCT00899379|26903014|P3|Overall Study|Inc/Exc Criteria Not Met|1
7736989|NCT00899379|26903015|P2|Overall Study|Inc/Exc Criteria Not Met|0
7736990|NCT00899379|26903016|P1|Overall Study|Inc/Exc Criteria Not Met|0
7736991|NCT00899379|26903012|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
7736992|NCT00899379|26903013|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
7736993|NCT00899379|26903014|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
7736994|NCT00899379|26903015|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
7736995|NCT00899379|26903016|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
7736996|NCT00899379|26903012|P5|Overall Study|No Attack Pretreatment|4
7736997|NCT00899379|26903013|P4|Overall Study|No Attack Pretreatment|6
7736998|NCT00899379|26903014|P3|Overall Study|No Attack Pretreatment|5
7736999|NCT00899379|26903015|P2|Overall Study|No Attack Pretreatment|5
7737000|NCT00899379|26903016|P1|Overall Study|No Attack Pretreatment|3
7737001|NCT00899379|26903012|P5|Overall Study|Abnormal Baseline ECG|0
7737002|NCT00899379|26903013|P4|Overall Study|Abnormal Baseline ECG|1
7737003|NCT00899379|26903014|P3|Overall Study|Abnormal Baseline ECG|1
7737004|NCT00899379|26903015|P2|Overall Study|Abnormal Baseline ECG|0
7737005|NCT00899379|26903016|P1|Overall Study|Abnormal Baseline ECG|0
7737006|NCT00899379|26903012|P5|Overall Study|Abnormal Prestudy Labs|2
7737007|NCT00899379|26903013|P4|Overall Study|Abnormal Prestudy Labs|0
7737008|NCT00899379|26903014|P3|Overall Study|Abnormal Prestudy Labs|0
7737009|NCT00899379|26903015|P2|Overall Study|Abnormal Prestudy Labs|0
7737010|NCT00899379|26903016|P1|Overall Study|Abnormal Prestudy Labs|0
7737011|NCT00899379|26903012|P5|Overall Study|Patient Uncooperative|0
7737012|NCT00899379|26903013|P4|Overall Study|Patient Uncooperative|1
7737013|NCT00899379|26903014|P3|Overall Study|Patient Uncooperative|0
7737014|NCT00899379|26903015|P2|Overall Study|Patient Uncooperative|0
7737015|NCT00899379|26903016|P1|Overall Study|Patient Uncooperative|0
7737016|NCT00899379|26903012|P5|Overall Study|Pregnancy|0
7737017|NCT00899379|26903013|P4|Overall Study|Pregnancy|0
7737018|NCT00899379|26903014|P3|Overall Study|Pregnancy|0
7737019|NCT00899379|26903015|P2|Overall Study|Pregnancy|0
7737020|NCT00899379|26903016|P1|Overall Study|Pregnancy|1
7737021|NCT00899379|26903012|P5|Overall Study|Withdrawal by Subject|2
7737022|NCT00899379|26903013|P4|Overall Study|Withdrawal by Subject|7
7737023|NCT00899379|26903014|P3|Overall Study|Withdrawal by Subject|4
7737024|NCT00899379|26903015|P2|Overall Study|Withdrawal by Subject|7
7737025|NCT00899379|26903016|P1|Overall Study|Withdrawal by Subject|4
7737026|NCT00899379|26903012|P5|Overall Study|Lost to Follow-up|5
7737027|NCT00899379|26903013|P4|Overall Study|Lost to Follow-up|2
7737028|NCT00899379|26903014|P3|Overall Study|Lost to Follow-up|0
7737029|NCT00899379|26903015|P2|Overall Study|Lost to Follow-up|1
7737030|NCT00899379|26903016|P1|Overall Study|Lost to Follow-up|3
7737031|NCT00899379|26903012|P5|Overall Study|Study Terminated|1
7737032|NCT00899379|26903013|P4|Overall Study|Study Terminated|3
7737033|NCT00899379|26903014|P3|Overall Study|Study Terminated|3
7737034|NCT00899379|26903015|P2|Overall Study|Study Terminated|0
7737035|NCT00899379|26903016|P1|Overall Study|Study Terminated|3
7737036|NCT00899379|26903012|P5|Overall Study|Not Completed/Entered Extn|3
7737037|NCT00899379|26903013|P4|Overall Study|Not Completed/Entered Extn|4
7737038|NCT00899379|26903014|P3|Overall Study|Not Completed/Entered Extn|6
7737039|NCT00899379|26903015|P2|Overall Study|Not Completed/Entered Extn|1
7737040|NCT00899379|26903016|P1|Overall Study|Not Completed/Entered Extn|5
7737041|NCT00899379|26903012|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
7737042|NCT00899379|26903013|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
7737043|NCT00899379|26903014|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
7737044|NCT00899379|26903015|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
7737045|NCT00899379|26903016|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
7737046|NCT00899379|26903012|P5|Overall Study|Abnormal Baseline ECG|0
7737047|NCT00899379|26903013|P4|Overall Study|Abnormal Baseline ECG|1
7737048|NCT00899379|26903014|P3|Overall Study|Abnormal Baseline ECG|0
7737049|NCT00899379|26903015|P2|Overall Study|Abnormal Baseline ECG|0
7737050|NCT00899379|26903016|P1|Overall Study|Abnormal Baseline ECG|0
7737051|NCT00899379|26903012|P5|Overall Study|Patient Uncooperative|2
7737052|NCT00899379|26903013|P4|Overall Study|Patient Uncooperative|1
7737053|NCT00899379|26903014|P3|Overall Study|Patient Uncooperative|0
7737054|NCT00899379|26903015|P2|Overall Study|Patient Uncooperative|1
7737055|NCT00899379|26903016|P1|Overall Study|Patient Uncooperative|0
7737056|NCT00899379|26903012|P5|Overall Study|Pregnancy|1
7737057|NCT00899379|26903013|P4|Overall Study|Pregnancy|0
7737058|NCT00899379|26903014|P3|Overall Study|Pregnancy|1
7737059|NCT00899379|26903015|P2|Overall Study|Pregnancy|0
7737060|NCT00899379|26903016|P1|Overall Study|Pregnancy|0
7737061|NCT00899379|26903012|P5|Overall Study|Withdrawal by Subject|6
7737062|NCT00899379|26903013|P4|Overall Study|Withdrawal by Subject|3
7737063|NCT00899379|26903014|P3|Overall Study|Withdrawal by Subject|2
7737064|NCT00899379|26903015|P2|Overall Study|Withdrawal by Subject|4
7737065|NCT00899379|26903016|P1|Overall Study|Withdrawal by Subject|2
7737066|NCT00899379|26903012|P5|Overall Study|Protocol Violation|0
7737067|NCT00899379|26903013|P4|Overall Study|Protocol Violation|1
7737068|NCT00899379|26903014|P3|Overall Study|Protocol Violation|1
7737069|NCT00899379|26903015|P2|Overall Study|Protocol Violation|0
7737070|NCT00899379|26903016|P1|Overall Study|Protocol Violation|0
7737071|NCT00899379|26903012|P5|Overall Study|Lost to Follow-up|2
7737072|NCT00899379|26903013|P4|Overall Study|Lost to Follow-up|6
7737073|NCT00899379|26903014|P3|Overall Study|Lost to Follow-up|0
7737074|NCT00899379|26903015|P2|Overall Study|Lost to Follow-up|3
7737075|NCT00899379|26903016|P1|Overall Study|Lost to Follow-up|9
7737076|NCT00899379|26903012|P5|Overall Study|Lack of Efficacy|1
7737077|NCT00899379|26903013|P4|Overall Study|Lack of Efficacy|0
7737078|NCT00899379|26903014|P3|Overall Study|Lack of Efficacy|3
7737079|NCT00899379|26903015|P2|Overall Study|Lack of Efficacy|4
7737080|NCT00899379|26903016|P1|Overall Study|Lack of Efficacy|0
7737081|NCT00899379|26903012|P5|Overall Study|Adverse Event|2
7737082|NCT00899379|26903013|P4|Overall Study|Adverse Event|1
7737083|NCT00899379|26903014|P3|Overall Study|Adverse Event|1
7737084|NCT00899379|26903015|P2|Overall Study|Adverse Event|2
7737085|NCT00899379|26903016|P1|Overall Study|Adverse Event|2
7737086|NCT00899353|26903028|P1|Overall Study|Withdrawal by Subject|2
7737087|NCT00899353|26903028|P1|Overall Study|Lost to Follow-up|1
7737088|NCT00899353|26903028|P1|Overall Study|Adverse Event|2
7737089|NCT00898807|26903064|P2|Overall Study|Death|1
7737090|NCT00898807|26903065|P1|Overall Study|Death|0
7737091|NCT00898807|26903064|P2|Overall Study|Lost to Follow-up|3
7737092|NCT00898807|26903065|P1|Overall Study|Lost to Follow-up|1
7737093|NCT00898807|26903064|P2|Overall Study|Family pressure to discontinue|2
7737094|NCT00898807|26903065|P1|Overall Study|Family pressure to discontinue|2
7737095|NCT00898807|26903064|P2|Overall Study|Withdrawal by Subject|3
7737096|NCT00898807|26903065|P1|Overall Study|Withdrawal by Subject|5
7737097|NCT00898677|26903081|P4|Overall Study|Not Treated: Other (Not Specified)|0
7737098|NCT00898677|26903082|P3|Overall Study|Not Treated: Other (Not Specified)|2
7737099|NCT00898677|26903083|P2|Overall Study|Not Treated: Other (Not Specified)|0
7737100|NCT00898677|26903084|P1|Overall Study|Not Treated: Other (Not Specified)|0
7737101|NCT00898677|26903081|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
7737102|NCT00898677|26903082|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
7737103|NCT00898677|26903083|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
7737104|NCT00898677|26903084|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
7737105|NCT00898677|26903081|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
7737106|NCT00898677|26903082|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
7737107|NCT00898677|26903083|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
7737108|NCT00898677|26903084|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
7737109|NCT00898677|26903081|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
7737110|NCT00898677|26903082|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
7737111|NCT00898677|26903083|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
7737112|NCT00898677|26903084|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
7737113|NCT00898677|26903081|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
7737114|NCT00898677|26903082|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7737115|NCT00898677|26903083|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7737116|NCT00898677|26903084|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7737117|NCT00898677|26903081|P4|Overall Study|Not Treated: Patient uncooperative|0
7737118|NCT00898677|26903082|P3|Overall Study|Not Treated: Patient uncooperative|1
7737119|NCT00898677|26903083|P2|Overall Study|Not Treated: Patient uncooperative|3
7737120|NCT00898677|26903084|P1|Overall Study|Not Treated: Patient uncooperative|2
7737121|NCT00898677|26903081|P4|Overall Study|Not Treated: Withdraw by Subject|3
7737122|NCT00898677|26903082|P3|Overall Study|Not Treated: Withdraw by Subject|11
7737123|NCT00898677|26903083|P2|Overall Study|Not Treated: Withdraw by Subject|16
7737124|NCT00898677|26903084|P1|Overall Study|Not Treated: Withdraw by Subject|2
7737125|NCT00898677|26903081|P4|Overall Study|Not Treated: Protocol Violation|0
7737126|NCT00898677|26903082|P3|Overall Study|Not Treated: Protocol Violation|2
7737127|NCT00898677|26903083|P2|Overall Study|Not Treated: Protocol Violation|0
7737128|NCT00898677|26903084|P1|Overall Study|Not Treated: Protocol Violation|2
7737129|NCT00898677|26903081|P4|Overall Study|Not Treated: Pregnancy|0
7737130|NCT00898677|26903082|P3|Overall Study|Not Treated: Pregnancy|1
7737131|NCT00898677|26903083|P2|Overall Study|Not Treated: Pregnancy|0
7737132|NCT00898677|26903084|P1|Overall Study|Not Treated: Pregnancy|0
7737133|NCT00898677|26903081|P4|Overall Study|Not Treated: Lost to Follow-Up|2
7737134|NCT00898677|26903082|P3|Overall Study|Not Treated: Lost to Follow-Up|5
7737135|NCT00898677|26903083|P2|Overall Study|Not Treated: Lost to Follow-Up|5
7737136|NCT00898677|26903084|P1|Overall Study|Not Treated: Lost to Follow-Up|0
7737137|NCT00898677|26903081|P4|Overall Study|Not Treated: Adverse Event|0
7737138|NCT00898677|26903082|P3|Overall Study|Not Treated: Adverse Event|1
7737139|NCT00898677|26903083|P2|Overall Study|Not Treated: Adverse Event|2
7737140|NCT00898677|26903084|P1|Overall Study|Not Treated: Adverse Event|0
7737141|NCT00898677|26903081|P4|Overall Study|Withdrawal by Subject|1
7737142|NCT00898677|26903082|P3|Overall Study|Withdrawal by Subject|0
7737143|NCT00898677|26903083|P2|Overall Study|Withdrawal by Subject|0
7737144|NCT00898677|26903084|P1|Overall Study|Withdrawal by Subject|0
7737145|NCT00898677|26903081|P4|Overall Study|Protocol Violation|0
7737146|NCT00898677|26903082|P3|Overall Study|Protocol Violation|2
7737147|NCT00898677|26903083|P2|Overall Study|Protocol Violation|1
7737148|NCT00898677|26903084|P1|Overall Study|Protocol Violation|1
7737149|NCT00898677|26903081|P4|Overall Study|Lost to Follow-up|0
7737150|NCT00898677|26903082|P3|Overall Study|Lost to Follow-up|2
7737151|NCT00898677|26903083|P2|Overall Study|Lost to Follow-up|0
7737152|NCT00898677|26903084|P1|Overall Study|Lost to Follow-up|0
7737153|NCT00898677|26903081|P4|Overall Study|Adverse Event|0
7737154|NCT00898677|26903082|P3|Overall Study|Adverse Event|1
7737155|NCT00898677|26903083|P2|Overall Study|Adverse Event|0
7737156|NCT00898677|26903084|P1|Overall Study|Adverse Event|0
7737157|NCT00898443|26903122|P2|Overall Study|Withdrawal by Subject|0
7737158|NCT00898443|26903123|P1|Overall Study|Withdrawal by Subject|1
7737159|NCT00897949|26903138|P3|Overall Study|Did not take study drug|4
7737160|NCT00897949|26903139|P2|Overall Study|Did not take study drug|3
7737161|NCT00897949|26903140|P1|Overall Study|Did not take study drug|9
7737162|NCT00897949|26903138|P3|Overall Study|Lack of Migraine Attack|19
7737163|NCT00897949|26903139|P2|Overall Study|Lack of Migraine Attack|30
7737164|NCT00897949|26903140|P1|Overall Study|Lack of Migraine Attack|29
7737165|NCT00897949|26903138|P3|Overall Study|Need for Concom. Med.|1
7737166|NCT00897949|26903139|P2|Overall Study|Need for Concom. Med.|1
7737167|NCT00897949|26903140|P1|Overall Study|Need for Concom. Med.|0
7737168|NCT00897949|26903138|P3|Overall Study|Abnormal Baseline ECG|4
7737169|NCT00897949|26903139|P2|Overall Study|Abnormal Baseline ECG|2
7737170|NCT00897949|26903140|P1|Overall Study|Abnormal Baseline ECG|2
7737171|NCT00897949|26903138|P3|Overall Study|Abnormal Prestudy Labs|4
7737172|NCT00897949|26903139|P2|Overall Study|Abnormal Prestudy Labs|3
7737173|NCT00897949|26903140|P1|Overall Study|Abnormal Prestudy Labs|2
7737174|NCT00897949|26903138|P3|Overall Study|Withdrawal by Subject|17
7737175|NCT00897949|26903139|P2|Overall Study|Withdrawal by Subject|31
7737176|NCT00897949|26903140|P1|Overall Study|Withdrawal by Subject|24
7737177|NCT00897949|26903138|P3|Overall Study|Lost to Follow-up|17
7737178|NCT00897949|26903139|P2|Overall Study|Lost to Follow-up|23
7737179|NCT00897949|26903140|P1|Overall Study|Lost to Follow-up|30
7737180|NCT00897949|26903138|P3|Overall Study|Patient Uncoorperative|1
7737181|NCT00897949|26903139|P2|Overall Study|Patient Uncoorperative|2
7737182|NCT00897949|26903140|P1|Overall Study|Patient Uncoorperative|0
7737183|NCT00897949|26903138|P3|Overall Study|Withdrawal by Subject|0
7737184|NCT00897949|26903139|P2|Overall Study|Withdrawal by Subject|2
7737185|NCT00897949|26903140|P1|Overall Study|Withdrawal by Subject|1
7737186|NCT00897949|26903138|P3|Overall Study|Protocol Violation|1
7737187|NCT00897949|26903139|P2|Overall Study|Protocol Violation|3
7737188|NCT00897949|26903140|P1|Overall Study|Protocol Violation|6
7737189|NCT00897949|26903138|P3|Overall Study|Lost to Follow-up|1
7737190|NCT00897949|26903139|P2|Overall Study|Lost to Follow-up|2
7737191|NCT00897949|26903140|P1|Overall Study|Lost to Follow-up|0
7737192|NCT00897949|26903138|P3|Overall Study|Adverse Event|0
7737193|NCT00897949|26903139|P2|Overall Study|Adverse Event|1
7737194|NCT00897949|26903140|P1|Overall Study|Adverse Event|1
7737195|NCT00897715|26903174|P2|Overall Study|increased risk of infection|0
7737196|NCT00897715|26903175|P1|Overall Study|increased risk of infection|1
7737197|NCT00897715|26903174|P2|Overall Study|Physician Decision|0
7737198|NCT00897715|26903175|P1|Overall Study|Physician Decision|1
7737199|NCT00897715|26903174|P2|Overall Study|Lost to Follow-up|1
7737200|NCT00897715|26903175|P1|Overall Study|Lost to Follow-up|0
7737201|NCT00897390|26903200|P1|Overall Study|Did not Return for the Clinic Visit|2
7737202|NCT00897390|26903200|P1|Overall Study|Personal Reasons|1
7737203|NCT00897390|26903200|P1|Overall Study|No Longer Met Study Criteria|1
7737204|NCT00897390|26903200|P1|Overall Study|Adverse Event|2
7737205|NCT00897104|26903290|P3|Overall Study|Withdrawal by Subject|1
7737206|NCT00897104|26903291|P2|Overall Study|Withdrawal by Subject|0
7737207|NCT00897104|26903292|P1|Overall Study|Withdrawal by Subject|0
7737208|NCT00897104|26903290|P3|Overall Study|Protocol Violation|0
7737209|NCT00897104|26903291|P2|Overall Study|Protocol Violation|0
7737210|NCT00897104|26903292|P1|Overall Study|Protocol Violation|1
7737211|NCT00897104|26903290|P3|Overall Study|Other|0
7737212|NCT00897104|26903291|P2|Overall Study|Other|0
7737213|NCT00897104|26903292|P1|Overall Study|Other|3
7737214|NCT00897104|26903290|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
7737215|NCT00897104|26903291|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
7737216|NCT00897104|26903292|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
7737217|NCT00897104|26903290|P3|Overall Study|Lack of Migraine Attack|1
7737218|NCT00897104|26903291|P2|Overall Study|Lack of Migraine Attack|22
7737219|NCT00897104|26903292|P1|Overall Study|Lack of Migraine Attack|20
7737220|NCT00897104|26903290|P3|Overall Study|Need for Concom. Med.|1
7737221|NCT00897104|26903291|P2|Overall Study|Need for Concom. Med.|1
7737222|NCT00897104|26903292|P1|Overall Study|Need for Concom. Med.|0
7737223|NCT00897104|26903290|P3|Overall Study|Abnormal Baseline ECG|0
7737224|NCT00897104|26903291|P2|Overall Study|Abnormal Baseline ECG|2
7737225|NCT00897104|26903292|P1|Overall Study|Abnormal Baseline ECG|2
7737226|NCT00897104|26903290|P3|Overall Study|Abnormal Prestudy Labs|0
7737227|NCT00897104|26903291|P2|Overall Study|Abnormal Prestudy Labs|0
7737228|NCT00897104|26903292|P1|Overall Study|Abnormal Prestudy Labs|2
7737229|NCT00897104|26903290|P3|Overall Study|Withdrawal by Subject|3
7737230|NCT00897104|26903291|P2|Overall Study|Withdrawal by Subject|27
7737231|NCT00897104|26903292|P1|Overall Study|Withdrawal by Subject|23
7737232|NCT00897104|26903290|P3|Overall Study|Protocol Violation|0
7737233|NCT00897104|26903291|P2|Overall Study|Protocol Violation|1
7737234|NCT00897104|26903292|P1|Overall Study|Protocol Violation|0
7737235|NCT00897104|26903290|P3|Overall Study|Pregnancy|0
7737236|NCT00897104|26903291|P2|Overall Study|Pregnancy|1
7737237|NCT00897104|26903292|P1|Overall Study|Pregnancy|0
7737238|NCT00897104|26903290|P3|Overall Study|Lost to Follow-up|2
7737239|NCT00897104|26903291|P2|Overall Study|Lost to Follow-up|17
7737240|NCT00897104|26903292|P1|Overall Study|Lost to Follow-up|12
7737241|NCT00896649|26903327|P1|Overall Study|technical difficulties|2
7737242|NCT00896649|26903327|P1|Overall Study|missing documentation|1
7737243|NCT00896649|26903327|P1|Overall Study|Pregnancy|1
7737244|NCT00896649|26903327|P1|Overall Study|Physician Decision|1
7737245|NCT00896532|26903340|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737246|NCT00896532|26903341|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
7737247|NCT00896532|26903342|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737248|NCT00896532|26903343|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737249|NCT00896532|26903344|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737250|NCT00896532|26903345|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737251|NCT00896532|26903346|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737252|NCT00896532|26903347|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737253|NCT00896532|26903348|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737254|NCT00896532|26903349|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737255|NCT00896532|26903350|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737256|NCT00896532|26903351|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737257|NCT00896532|26903352|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737258|NCT00896532|26903353|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737259|NCT00896532|26903354|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737260|NCT00896532|26903355|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737261|NCT00896532|26903356|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737262|NCT00896532|26903357|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737263|NCT00896532|26903358|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737264|NCT00896532|26903359|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737265|NCT00896532|26903360|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737266|NCT00896532|26903361|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737267|NCT00896532|26903362|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7737268|NCT00896532|26903340|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737269|NCT00896532|26903341|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
7737270|NCT00896532|26903342|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737271|NCT00896532|26903343|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737272|NCT00896532|26903344|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737273|NCT00896532|26903345|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737274|NCT00896532|26903346|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737275|NCT00896532|26903347|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737276|NCT00896532|26903348|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737277|NCT00896532|26903349|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737278|NCT00896532|26903350|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737279|NCT00896532|26903351|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737280|NCT00896532|26903352|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737281|NCT00896532|26903353|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737282|NCT00896532|26903354|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737283|NCT00896532|26903355|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737284|NCT00896532|26903356|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737285|NCT00896532|26903357|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737286|NCT00896532|26903358|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737287|NCT00896532|26903359|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737288|NCT00896532|26903360|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737289|NCT00896532|26903361|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737290|NCT00896532|26903362|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7737291|NCT00896532|26903340|P23|Months 48-72: Follow-on Phase|Death|0
7737292|NCT00896532|26903341|P22|Months 48-72: Follow-on Phase|Death|0
7737293|NCT00896532|26903342|P21|Months 48-72: Follow-on Phase|Death|0
7737294|NCT00896532|26903343|P20|Months 48-72: Follow-on Phase|Death|0
7737295|NCT00896532|26903344|P19|Months 48-72: Follow-on Phase|Death|1
7737296|NCT00896532|26903345|P18|Months 48-72: Follow-on Phase|Death|0
7737297|NCT00896532|26903346|P17|Months 48-72: Follow-on Phase|Death|0
7737298|NCT00896532|26903347|P16|Months 48-72: Follow-on Phase|Death|0
7737299|NCT00896532|26903348|P15|Months 48-72: Follow-on Phase|Death|0
7737300|NCT00896532|26903349|P14|Months 48-72: Follow-on Phase|Death|0
7737301|NCT00896532|26903350|P13|Months 48-72: Follow-on Phase|Death|0
7737302|NCT00896532|26903351|P12|Months 48-72: Follow-on Phase|Death|0
7737303|NCT00896532|26903352|P11|Months 48-72: Follow-on Phase|Death|0
7737304|NCT00896532|26903353|P10|Months 48-72: Follow-on Phase|Death|0
7737305|NCT00896532|26903354|P9|Months 48-72: Follow-on Phase|Death|0
7737306|NCT00896532|26903355|P8|Months 48-72: Follow-on Phase|Death|0
7737307|NCT00896532|26903356|P7|Months 48-72: Follow-on Phase|Death|0
7737308|NCT00896532|26903357|P6|Months 48-72: Follow-on Phase|Death|0
7737309|NCT00896532|26903358|P5|Months 48-72: Follow-on Phase|Death|0
7737310|NCT00896532|26903359|P4|Months 48-72: Follow-on Phase|Death|0
7737311|NCT00896532|26903360|P3|Months 48-72: Follow-on Phase|Death|0
7737312|NCT00896532|26903361|P2|Months 48-72: Follow-on Phase|Death|0
7737313|NCT00896532|26903362|P1|Months 48-72: Follow-on Phase|Death|0
7737314|NCT00896532|26903340|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737315|NCT00896532|26903341|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737316|NCT00896532|26903342|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737317|NCT00896532|26903343|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737318|NCT00896532|26903344|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737319|NCT00896532|26903345|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737320|NCT00896532|26903346|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
7737321|NCT00896532|26903347|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737322|NCT00896532|26903348|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737323|NCT00896532|26903349|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737324|NCT00896532|26903350|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737325|NCT00896532|26903351|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737326|NCT00896532|26903352|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737327|NCT00896532|26903353|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737328|NCT00896532|26903354|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737329|NCT00896532|26903355|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737330|NCT00896532|26903356|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737331|NCT00896532|26903357|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737332|NCT00896532|26903358|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737333|NCT00896532|26903359|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737334|NCT00896532|26903360|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737335|NCT00896532|26903361|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737336|NCT00896532|26903362|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7737337|NCT00896532|26903340|P23|Months 36-48: Romosozumab Retreatment|Other|0
7737338|NCT00896532|26903341|P22|Months 36-48: Romosozumab Retreatment|Other|0
7737339|NCT00896532|26903342|P21|Months 36-48: Romosozumab Retreatment|Other|0
7737340|NCT00896532|26903343|P20|Months 36-48: Romosozumab Retreatment|Other|0
7737341|NCT00896532|26903344|P19|Months 36-48: Romosozumab Retreatment|Other|0
7737342|NCT00896532|26903345|P18|Months 36-48: Romosozumab Retreatment|Other|1
7737343|NCT00896532|26903346|P17|Months 36-48: Romosozumab Retreatment|Other|0
7737344|NCT00896532|26903347|P16|Months 36-48: Romosozumab Retreatment|Other|0
7737345|NCT00896532|26903348|P15|Months 36-48: Romosozumab Retreatment|Other|0
7737346|NCT00896532|26903349|P14|Months 36-48: Romosozumab Retreatment|Other|0
7737347|NCT00896532|26903350|P13|Months 36-48: Romosozumab Retreatment|Other|0
7737348|NCT00896532|26903351|P12|Months 36-48: Romosozumab Retreatment|Other|0
7737349|NCT00896532|26903352|P11|Months 36-48: Romosozumab Retreatment|Other|0
7737350|NCT00896532|26903353|P10|Months 36-48: Romosozumab Retreatment|Other|0
7737351|NCT00896532|26903354|P9|Months 36-48: Romosozumab Retreatment|Other|0
7737352|NCT00896532|26903355|P8|Months 36-48: Romosozumab Retreatment|Other|0
7737353|NCT00896532|26903356|P7|Months 36-48: Romosozumab Retreatment|Other|0
7737354|NCT00896532|26903357|P6|Months 36-48: Romosozumab Retreatment|Other|0
7737355|NCT00896532|26903358|P5|Months 36-48: Romosozumab Retreatment|Other|0
7737356|NCT00896532|26903359|P4|Months 36-48: Romosozumab Retreatment|Other|0
7737357|NCT00896532|26903360|P3|Months 36-48: Romosozumab Retreatment|Other|0
7737358|NCT00896532|26903361|P2|Months 36-48: Romosozumab Retreatment|Other|0
7737359|NCT00896532|26903362|P1|Months 36-48: Romosozumab Retreatment|Other|0
7737360|NCT00896532|26903340|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737361|NCT00896532|26903341|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737362|NCT00896532|26903342|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737363|NCT00896532|26903343|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737364|NCT00896532|26903344|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737365|NCT00896532|26903345|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737366|NCT00896532|26903346|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
7737367|NCT00896532|26903347|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737368|NCT00896532|26903348|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737369|NCT00896532|26903349|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737370|NCT00896532|26903350|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737371|NCT00896532|26903351|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737372|NCT00896532|26903352|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737373|NCT00896532|26903353|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737374|NCT00896532|26903354|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737375|NCT00896532|26903355|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737376|NCT00896532|26903356|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737377|NCT00896532|26903357|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737378|NCT00896532|26903358|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737379|NCT00896532|26903359|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737380|NCT00896532|26903360|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737381|NCT00896532|26903361|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737382|NCT00896532|26903362|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7737383|NCT00896532|26903340|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737384|NCT00896532|26903341|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737385|NCT00896532|26903342|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737386|NCT00896532|26903343|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737387|NCT00896532|26903344|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737388|NCT00896532|26903345|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
7737389|NCT00896532|26903346|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
7737390|NCT00896532|26903347|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
7737391|NCT00896532|26903348|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737392|NCT00896532|26903349|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737393|NCT00896532|26903350|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737394|NCT00896532|26903351|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737395|NCT00896532|26903352|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737396|NCT00896532|26903353|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737397|NCT00896532|26903354|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737398|NCT00896532|26903355|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737399|NCT00896532|26903356|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737400|NCT00896532|26903357|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737401|NCT00896532|26903358|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737402|NCT00896532|26903359|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737403|NCT00896532|26903360|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737404|NCT00896532|26903361|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737405|NCT00896532|26903362|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7737406|NCT00896532|26903340|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737407|NCT00896532|26903341|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737408|NCT00896532|26903342|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737409|NCT00896532|26903343|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737410|NCT00896532|26903344|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737411|NCT00896532|26903345|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737412|NCT00896532|26903346|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
7737413|NCT00896532|26903347|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
7737414|NCT00896532|26903348|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737415|NCT00896532|26903349|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737416|NCT00896532|26903350|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737417|NCT00896532|26903351|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737418|NCT00896532|26903352|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737419|NCT00896532|26903353|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737420|NCT00896532|26903354|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737421|NCT00896532|26903355|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737422|NCT00896532|26903356|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737423|NCT00896532|26903357|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737424|NCT00896532|26903358|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737425|NCT00896532|26903359|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737426|NCT00896532|26903360|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737427|NCT00896532|26903361|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737428|NCT00896532|26903362|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7737429|NCT00896532|26903340|P23|Months 24-36: Denosumab Extension Phase|Other|0
7737430|NCT00896532|26903341|P22|Months 24-36: Denosumab Extension Phase|Other|0
7737431|NCT00896532|26903342|P21|Months 24-36: Denosumab Extension Phase|Other|0
7737432|NCT00896532|26903343|P20|Months 24-36: Denosumab Extension Phase|Other|0
7737433|NCT00896532|26903344|P19|Months 24-36: Denosumab Extension Phase|Other|0
7737434|NCT00896532|26903345|P18|Months 24-36: Denosumab Extension Phase|Other|0
7737435|NCT00896532|26903346|P17|Months 24-36: Denosumab Extension Phase|Other|0
7737436|NCT00896532|26903347|P16|Months 24-36: Denosumab Extension Phase|Other|0
7737437|NCT00896532|26903348|P15|Months 24-36: Denosumab Extension Phase|Other|0
7737438|NCT00896532|26903349|P14|Months 24-36: Denosumab Extension Phase|Other|1
7737439|NCT00896532|26903350|P13|Months 24-36: Denosumab Extension Phase|Other|2
7737440|NCT00896532|26903351|P12|Months 24-36: Denosumab Extension Phase|Other|2
7737441|NCT00896532|26903352|P11|Months 24-36: Denosumab Extension Phase|Other|1
7737442|NCT00896532|26903353|P10|Months 24-36: Denosumab Extension Phase|Other|0
7737443|NCT00896532|26903354|P9|Months 24-36: Denosumab Extension Phase|Other|0
7737444|NCT00896532|26903355|P8|Months 24-36: Denosumab Extension Phase|Other|0
7737445|NCT00896532|26903356|P7|Months 24-36: Denosumab Extension Phase|Other|0
7737446|NCT00896532|26903357|P6|Months 24-36: Denosumab Extension Phase|Other|0
7737447|NCT00896532|26903358|P5|Months 24-36: Denosumab Extension Phase|Other|0
7737448|NCT00896532|26903359|P4|Months 24-36: Denosumab Extension Phase|Other|0
7737449|NCT00896532|26903360|P3|Months 24-36: Denosumab Extension Phase|Other|0
7737450|NCT00896532|26903361|P2|Months 24-36: Denosumab Extension Phase|Other|0
7737451|NCT00896532|26903362|P1|Months 24-36: Denosumab Extension Phase|Other|0
7737452|NCT00896532|26903340|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737453|NCT00896532|26903341|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737454|NCT00896532|26903342|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737455|NCT00896532|26903343|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737456|NCT00896532|26903344|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737457|NCT00896532|26903345|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737458|NCT00896532|26903346|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737459|NCT00896532|26903347|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737460|NCT00896532|26903348|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737461|NCT00896532|26903349|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
7737462|NCT00896532|26903350|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
7737463|NCT00896532|26903351|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737464|NCT00896532|26903352|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737465|NCT00896532|26903353|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737466|NCT00896532|26903354|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737467|NCT00896532|26903355|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737468|NCT00896532|26903356|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737469|NCT00896532|26903357|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737470|NCT00896532|26903358|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737471|NCT00896532|26903359|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737472|NCT00896532|26903360|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737473|NCT00896532|26903361|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737474|NCT00896532|26903362|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7737475|NCT00896532|26903340|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737476|NCT00896532|26903341|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737477|NCT00896532|26903342|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737478|NCT00896532|26903343|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737479|NCT00896532|26903344|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737480|NCT00896532|26903345|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737481|NCT00896532|26903346|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737482|NCT00896532|26903347|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737483|NCT00896532|26903348|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737484|NCT00896532|26903349|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737485|NCT00896532|26903350|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
7737486|NCT00896532|26903351|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737487|NCT00896532|26903352|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
7737488|NCT00896532|26903353|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737489|NCT00896532|26903354|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737490|NCT00896532|26903355|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737491|NCT00896532|26903356|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737492|NCT00896532|26903357|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737493|NCT00896532|26903358|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737494|NCT00896532|26903359|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737495|NCT00896532|26903360|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737496|NCT00896532|26903361|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737497|NCT00896532|26903362|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7737498|NCT00896532|26903340|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737499|NCT00896532|26903341|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737500|NCT00896532|26903342|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737501|NCT00896532|26903343|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737502|NCT00896532|26903344|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737503|NCT00896532|26903345|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737504|NCT00896532|26903346|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737792|NCT00895947|26903904|P2|Overall Study|Protocol Violation|2
7737505|NCT00896532|26903347|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737506|NCT00896532|26903348|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737507|NCT00896532|26903349|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737508|NCT00896532|26903350|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
7737509|NCT00896532|26903351|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737510|NCT00896532|26903352|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737511|NCT00896532|26903353|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737512|NCT00896532|26903354|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737513|NCT00896532|26903355|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737514|NCT00896532|26903356|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737515|NCT00896532|26903357|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737516|NCT00896532|26903358|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737517|NCT00896532|26903359|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737518|NCT00896532|26903360|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737519|NCT00896532|26903361|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737520|NCT00896532|26903362|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7737521|NCT00896532|26903340|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737522|NCT00896532|26903341|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737523|NCT00896532|26903342|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737524|NCT00896532|26903343|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737525|NCT00896532|26903344|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737526|NCT00896532|26903345|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737527|NCT00896532|26903346|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737528|NCT00896532|26903347|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737529|NCT00896532|26903348|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737530|NCT00896532|26903349|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737531|NCT00896532|26903350|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737532|NCT00896532|26903351|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737533|NCT00896532|26903352|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737534|NCT00896532|26903353|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737535|NCT00896532|26903354|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
7737536|NCT00896532|26903355|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737537|NCT00896532|26903356|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737538|NCT00896532|26903357|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737539|NCT00896532|26903358|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737540|NCT00896532|26903359|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737541|NCT00896532|26903360|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737542|NCT00896532|26903361|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737543|NCT00896532|26903362|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7737544|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
7737545|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
7737546|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
7737547|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
7737548|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
7737549|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
7737550|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
7737551|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
7737552|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
7737553|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
7737554|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
7737555|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
7737556|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
7737557|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
7737558|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
7737559|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
7737560|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
7737561|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
7737562|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
7737563|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
7737564|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
7737565|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
7737566|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
7737567|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737568|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737569|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737570|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737571|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737572|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737573|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737574|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737793|NCT00895947|26903905|P1|Overall Study|Protocol Violation|4
7737575|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737576|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737577|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737578|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737579|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737580|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737581|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737582|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737583|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737584|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737585|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737586|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
7737587|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737588|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737589|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7737590|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737591|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737592|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737593|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737594|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737595|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737596|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737597|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737598|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737599|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737600|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737601|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737602|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737603|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737604|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737605|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737606|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737607|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737608|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737609|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737610|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
7737611|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737612|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7737613|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737614|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737615|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737616|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737617|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737618|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737619|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737620|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737621|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737622|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737623|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737624|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737625|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737626|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737627|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737628|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737629|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737630|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737631|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737632|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737633|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
7737634|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737635|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7737636|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
7737637|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
7737638|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
7737639|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
7737640|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
7737641|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
7737642|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
7737643|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
7737644|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
7737645|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
7737646|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
7737647|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
7737648|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
7737649|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
7737650|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
7737651|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
7737652|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
7737653|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
7737654|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
7737655|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
7737656|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
7737657|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
7737658|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
7737659|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737660|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737661|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737662|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737663|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737664|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737665|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737666|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737667|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737668|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737669|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737670|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737671|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737672|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737673|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737674|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737675|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737676|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737677|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
7737678|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737679|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
7737680|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737681|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7737682|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737683|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737684|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737685|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737686|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737687|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737688|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737689|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737690|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737691|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737692|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737693|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737694|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737695|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737696|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7737697|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7737698|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7737699|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
7737700|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
7737701|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
7737702|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7737703|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
7737704|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7737705|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737706|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737707|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737708|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737709|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737710|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737711|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737712|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737713|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737714|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737715|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737716|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737717|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737718|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737719|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737720|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7737721|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7737722|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7737723|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7737724|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
7737725|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7737726|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
7737727|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7737728|NCT00896532|26903340|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737729|NCT00896532|26903341|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737730|NCT00896532|26903342|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737731|NCT00896532|26903343|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737732|NCT00896532|26903344|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737733|NCT00896532|26903345|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737734|NCT00896532|26903346|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737735|NCT00896532|26903347|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737736|NCT00896532|26903348|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737737|NCT00896532|26903349|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737738|NCT00896532|26903350|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737739|NCT00896532|26903351|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737740|NCT00896532|26903352|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737741|NCT00896532|26903353|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737742|NCT00896532|26903354|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737743|NCT00896532|26903355|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737744|NCT00896532|26903356|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737745|NCT00896532|26903357|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
7737746|NCT00896532|26903358|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737747|NCT00896532|26903359|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
7737748|NCT00896532|26903360|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737749|NCT00896532|26903361|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737750|NCT00896532|26903362|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7737751|NCT00896480|26903489|P1|Overall Study|Disease progression/recurrence|21
7737752|NCT00896454|26903537|P1|Overall Study|Withdrawal by Subject|1
7737753|NCT00896454|26903537|P1|Overall Study|Ongoing in study|2
7737754|NCT00896454|26903537|P1|Overall Study|Requirement for alternative therapy|3
7737755|NCT00896454|26903537|P1|Overall Study|Other|4
7737756|NCT00896454|26903537|P1|Overall Study|Disease Progression|5
7737757|NCT00896454|26903537|P1|Overall Study|Adverse Event|8
7737758|NCT00896454|26903537|P1|Overall Study|Death|10
7737759|NCT00896363|26903576|P3|Overall Study|Withdrawal by Subject|5
7737760|NCT00896363|26903577|P2|Overall Study|Withdrawal by Subject|5
7737761|NCT00896363|26903578|P1|Overall Study|Withdrawal by Subject|3
7737762|NCT00896363|26903576|P3|Overall Study|Lack of Efficacy|1
7737763|NCT00896363|26903577|P2|Overall Study|Lack of Efficacy|2
7737764|NCT00896363|26903578|P1|Overall Study|Lack of Efficacy|0
7737765|NCT00896363|26903576|P3|Overall Study|Adverse Event|2
7737766|NCT00896363|26903577|P2|Overall Study|Adverse Event|4
7737767|NCT00896363|26903578|P1|Overall Study|Adverse Event|3
7737768|NCT00896337|26903630|P1|Overall Study|Lost to Follow-up|11
7737769|NCT00896337|26903630|P1|Overall Study|Withdrawal by Subject|7
7737770|NCT00896337|26903630|P1|Overall Study|Death|7
7737771|NCT00896233|26903712|P1|Overall Study|Claustrophobia during MRI|1
7737772|NCT00896168|26903733|P2|Overall Study|Other|1
7737773|NCT00896168|26903734|P1|Overall Study|Other|1
7737774|NCT00896168|26903733|P2|Overall Study|Lost to Follow-up|1
7737775|NCT00896168|26903734|P1|Overall Study|Lost to Follow-up|1
7737776|NCT00896168|26903733|P2|Overall Study|Treatment failure|10
7737777|NCT00896168|26903734|P1|Overall Study|Treatment failure|8
7737778|NCT00896168|26903733|P2|Overall Study|Adverse Event|7
7737779|NCT00896168|26903734|P1|Overall Study|Adverse Event|4
7737780|NCT00896051|26903795|P2|Overall Study|Other|1
7737781|NCT00896051|26903796|P1|Overall Study|Other|1
7737782|NCT00896051|26903795|P2|Overall Study|Subject noncompliant|3
7737783|NCT00896051|26903796|P1|Overall Study|Subject noncompliant|1
7737784|NCT00896051|26903795|P2|Overall Study|Withdrawal by Subject|2
7737785|NCT00896051|26903796|P1|Overall Study|Withdrawal by Subject|3
7737786|NCT00896051|26903795|P2|Overall Study|Lost to Follow-up|2
7737787|NCT00896051|26903796|P1|Overall Study|Lost to Follow-up|3
7737788|NCT00896051|26903795|P2|Overall Study|Adverse Event|1
7737789|NCT00896051|26903796|P1|Overall Study|Adverse Event|2
7737790|NCT00895947|26903904|P2|Overall Study|Withdrawal by Subject|0
7737791|NCT00895947|26903905|P1|Overall Study|Withdrawal by Subject|2
7737794|NCT00895947|26903904|P2|Overall Study|Lost to Follow-up|4
7737795|NCT00895947|26903905|P1|Overall Study|Lost to Follow-up|3
7737796|NCT00895947|26903904|P2|Overall Study|Adverse Event|4
7737797|NCT00895947|26903905|P1|Overall Study|Adverse Event|3
7737798|NCT00895895|26903956|P5|Period 2|unsatisfactory response-efficacy|0
7737799|NCT00895895|26903957|P4|Period 2|unsatisfactory response-efficacy|0
7737800|NCT00895895|26903958|P3|Period 2|unsatisfactory response-efficacy|0
7737801|NCT00895895|26903959|P2|Period 2|unsatisfactory response-efficacy|1
7737802|NCT00895895|26903960|P1|Period 2|unsatisfactory response-efficacy|2
7737803|NCT00895895|26903956|P5|Period 2|Withdrawal by Subject|5
7737804|NCT00895895|26903957|P4|Period 2|Withdrawal by Subject|3
7737805|NCT00895895|26903958|P3|Period 2|Withdrawal by Subject|0
7737806|NCT00895895|26903959|P2|Period 2|Withdrawal by Subject|2
7737807|NCT00895895|26903960|P1|Period 2|Withdrawal by Subject|0
7737808|NCT00895895|26903956|P5|Period 2|Protocol Violation|1
7737809|NCT00895895|26903957|P4|Period 2|Protocol Violation|1
7737810|NCT00895895|26903958|P3|Period 2|Protocol Violation|1
7737811|NCT00895895|26903959|P2|Period 2|Protocol Violation|0
7737812|NCT00895895|26903960|P1|Period 2|Protocol Violation|1
7737813|NCT00895895|26903956|P5|Period 2|Other|1
7737814|NCT00895895|26903957|P4|Period 2|Other|1
7737815|NCT00895895|26903958|P3|Period 2|Other|3
7737816|NCT00895895|26903959|P2|Period 2|Other|1
7737817|NCT00895895|26903960|P1|Period 2|Other|1
7737818|NCT00895895|26903956|P5|Period 2|Lost to Follow-up|0
7737819|NCT00895895|26903957|P4|Period 2|Lost to Follow-up|1
7737820|NCT00895895|26903958|P3|Period 2|Lost to Follow-up|1
7737821|NCT00895895|26903959|P2|Period 2|Lost to Follow-up|2
7737822|NCT00895895|26903960|P1|Period 2|Lost to Follow-up|1
7737823|NCT00895895|26903956|P5|Period 2|investigator request|0
7737824|NCT00895895|26903957|P4|Period 2|investigator request|0
7737825|NCT00895895|26903958|P3|Period 2|investigator request|0
7737826|NCT00895895|26903959|P2|Period 2|investigator request|0
7737827|NCT00895895|26903960|P1|Period 2|investigator request|2
7737828|NCT00895895|26903956|P5|Period 2|failed to return|0
7737829|NCT00895895|26903957|P4|Period 2|failed to return|0
7737830|NCT00895895|26903958|P3|Period 2|failed to return|0
7737831|NCT00895895|26903959|P2|Period 2|failed to return|0
7737832|NCT00895895|26903960|P1|Period 2|failed to return|2
7737833|NCT00895895|26903956|P5|Period 2|discontinued by sponsor|37
7737834|NCT00895895|26903957|P4|Period 2|discontinued by sponsor|46
7737835|NCT00895895|26903958|P3|Period 2|discontinued by sponsor|38
7737836|NCT00895895|26903959|P2|Period 2|discontinued by sponsor|44
7737837|NCT00895895|26903960|P1|Period 2|discontinued by sponsor|44
7737838|NCT00895895|26903956|P5|Period 2|Death|0
7737839|NCT00895895|26903957|P4|Period 2|Death|0
7737840|NCT00895895|26903958|P3|Period 2|Death|1
7737841|NCT00895895|26903959|P2|Period 2|Death|0
7737842|NCT00895895|26903960|P1|Period 2|Death|0
7737843|NCT00895895|26903956|P5|Period 2|Adverse Event|5
7737844|NCT00895895|26903957|P4|Period 2|Adverse Event|2
7737845|NCT00895895|26903958|P3|Period 2|Adverse Event|5
7737846|NCT00895895|26903959|P2|Period 2|Adverse Event|3
7737847|NCT00895895|26903960|P1|Period 2|Adverse Event|3
7737848|NCT00895895|26903956|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
7737849|NCT00895895|26903957|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7737850|NCT00895895|26903958|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7737851|NCT00895895|26903959|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7737852|NCT00895895|26903960|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7737853|NCT00895895|26903956|P5|After Period 1, Prior to Period 2|Protocol Violation|1
7737854|NCT00895895|26903957|P4|After Period 1, Prior to Period 2|Protocol Violation|0
7737855|NCT00895895|26903958|P3|After Period 1, Prior to Period 2|Protocol Violation|0
7737856|NCT00895895|26903959|P2|After Period 1, Prior to Period 2|Protocol Violation|0
7737857|NCT00895895|26903960|P1|After Period 1, Prior to Period 2|Protocol Violation|0
7737858|NCT00895895|26903956|P5|After Period 1, Prior to Period 2|Other|0
7737859|NCT00895895|26903957|P4|After Period 1, Prior to Period 2|Other|0
7737860|NCT00895895|26903958|P3|After Period 1, Prior to Period 2|Other|1
7737861|NCT00895895|26903959|P2|After Period 1, Prior to Period 2|Other|0
7737862|NCT00895895|26903960|P1|After Period 1, Prior to Period 2|Other|0
7737863|NCT00895895|26903956|P5|After Period 1, Prior to Period 2|Adverse Event|0
7737864|NCT00895895|26903957|P4|After Period 1, Prior to Period 2|Adverse Event|0
7737865|NCT00895895|26903958|P3|After Period 1, Prior to Period 2|Adverse Event|1
7737866|NCT00895895|26903959|P2|After Period 1, Prior to Period 2|Adverse Event|0
7737867|NCT00895895|26903960|P1|After Period 1, Prior to Period 2|Adverse Event|0
7737868|NCT00895895|26903956|P5|Period 1|randomized and not treated|2
7737869|NCT00895895|26903957|P4|Period 1|randomized and not treated|1
7737870|NCT00895895|26903958|P3|Period 1|randomized and not treated|1
7737871|NCT00895895|26903959|P2|Period 1|randomized and not treated|3
7737872|NCT00895895|26903960|P1|Period 1|randomized and not treated|1
7737873|NCT00895895|26903956|P5|Period 1|unsatisfactory response-efficacy|0
7737874|NCT00895895|26903957|P4|Period 1|unsatisfactory response-efficacy|0
7737875|NCT00895895|26903958|P3|Period 1|unsatisfactory response-efficacy|0
7737876|NCT00895895|26903959|P2|Period 1|unsatisfactory response-efficacy|0
7737877|NCT00895895|26903960|P1|Period 1|unsatisfactory response-efficacy|2
7737878|NCT00895895|26903956|P5|Period 1|Withdrawal by Subject|4
7737879|NCT00895895|26903957|P4|Period 1|Withdrawal by Subject|2
7737880|NCT00895895|26903958|P3|Period 1|Withdrawal by Subject|8
7737881|NCT00895895|26903959|P2|Period 1|Withdrawal by Subject|6
7737882|NCT00895895|26903960|P1|Period 1|Withdrawal by Subject|6
7737883|NCT00895895|26903956|P5|Period 1|Protocol Violation|0
7737884|NCT00895895|26903957|P4|Period 1|Protocol Violation|0
7737885|NCT00895895|26903958|P3|Period 1|Protocol Violation|0
7737886|NCT00895895|26903959|P2|Period 1|Protocol Violation|1
7737887|NCT00895895|26903960|P1|Period 1|Protocol Violation|0
7737888|NCT00895895|26903956|P5|Period 1|Other|1
7737889|NCT00895895|26903957|P4|Period 1|Other|1
7737890|NCT00895895|26903958|P3|Period 1|Other|1
7737891|NCT00895895|26903959|P2|Period 1|Other|2
7737892|NCT00895895|26903960|P1|Period 1|Other|1
7737893|NCT00895895|26903956|P5|Period 1|Lost to Follow-up|3
7737894|NCT00895895|26903957|P4|Period 1|Lost to Follow-up|2
7737895|NCT00895895|26903958|P3|Period 1|Lost to Follow-up|3
7737896|NCT00895895|26903959|P2|Period 1|Lost to Follow-up|1
7737897|NCT00895895|26903960|P1|Period 1|Lost to Follow-up|2
7737898|NCT00895895|26903956|P5|Period 1|investigator request|0
7737899|NCT00895895|26903957|P4|Period 1|investigator request|0
7737900|NCT00895895|26903958|P3|Period 1|investigator request|0
7737901|NCT00895895|26903959|P2|Period 1|investigator request|1
7737902|NCT00895895|26903960|P1|Period 1|investigator request|0
7737903|NCT00895895|26903956|P5|Period 1|failed to return|1
7737904|NCT00895895|26903957|P4|Period 1|failed to return|0
7737905|NCT00895895|26903958|P3|Period 1|failed to return|1
7737906|NCT00895895|26903959|P2|Period 1|failed to return|0
7737907|NCT00895895|26903960|P1|Period 1|failed to return|0
7737908|NCT00895895|26903956|P5|Period 1|discontinued by sponsor|1
7737909|NCT00895895|26903957|P4|Period 1|discontinued by sponsor|1
7737910|NCT00895895|26903958|P3|Period 1|discontinued by sponsor|2
7737911|NCT00895895|26903959|P2|Period 1|discontinued by sponsor|1
7737912|NCT00895895|26903960|P1|Period 1|discontinued by sponsor|2
7737913|NCT00895895|26903956|P5|Period 1|Death|1
7737914|NCT00895895|26903957|P4|Period 1|Death|0
7737915|NCT00895895|26903958|P3|Period 1|Death|0
7737916|NCT00895895|26903959|P2|Period 1|Death|0
7737917|NCT00895895|26903960|P1|Period 1|Death|0
7737918|NCT00895895|26903956|P5|Period 1|Adverse Event|7
7737919|NCT00895895|26903957|P4|Period 1|Adverse Event|6
7737920|NCT00895895|26903958|P3|Period 1|Adverse Event|4
7737921|NCT00895895|26903959|P2|Period 1|Adverse Event|6
7737922|NCT00895895|26903960|P1|Period 1|Adverse Event|7
7737923|NCT00895843|26904074|P2|Overall Study|Protocol Violation|12
7737924|NCT00895843|26904075|P1|Overall Study|Protocol Violation|12
7737925|NCT00895661|26904122|P1|Overall Study|reason unknown|2
7737926|NCT00895661|26904122|P1|Overall Study|Death|1
7737927|NCT00895622|26904132|P3|Overall Study|Protocol Violation|4
7737928|NCT00895622|26904133|P2|Overall Study|Protocol Violation|4
7737929|NCT00895622|26904134|P1|Overall Study|Protocol Violation|5
7737930|NCT00895583|26904169|P2|Overall Study|Other|1
7737931|NCT00895583|26904170|P1|Overall Study|Other|0
7737932|NCT00895583|26904169|P2|Overall Study|Lack of Efficacy|0
7737933|NCT00895583|26904170|P1|Overall Study|Lack of Efficacy|5
7737934|NCT00895583|26904169|P2|Overall Study|Withdrawal by Subject|2
7737935|NCT00895583|26904170|P1|Overall Study|Withdrawal by Subject|4
7737936|NCT00895583|26904169|P2|Overall Study|Protocol Violation|0
7737937|NCT00895583|26904170|P1|Overall Study|Protocol Violation|1
7737938|NCT00895583|26904169|P2|Overall Study|Lost to Follow-up|3
7737939|NCT00895583|26904170|P1|Overall Study|Lost to Follow-up|1
7737940|NCT00895583|26904169|P2|Overall Study|Physician Decision|1
7737941|NCT00895583|26904170|P1|Overall Study|Physician Decision|3
7737942|NCT00895583|26904169|P2|Overall Study|Death|1
7737943|NCT00895583|26904170|P1|Overall Study|Death|2
7737944|NCT00895583|26904169|P2|Overall Study|Adverse Event|4
7737945|NCT00895583|26904170|P1|Overall Study|Adverse Event|28
7737946|NCT00895453|26904260|P3|Overall Study|Lost to Follow-up|23
7737947|NCT00895453|26904261|P2|Overall Study|Lost to Follow-up|25
7737948|NCT00895453|26904262|P1|Overall Study|Lost to Follow-up|25
7737949|NCT00895414|26904270|P2|First Intervention (14 Days)|Physician Decision|1
7737950|NCT00895414|26904271|P1|First Intervention (14 Days)|Physician Decision|0
7737951|NCT00895414|26904270|P2|First Intervention (14 Days)|Withdrawal by Subject|0
7737952|NCT00895414|26904271|P1|First Intervention (14 Days)|Withdrawal by Subject|1
7737953|NCT00895310|26904281|P1|Overall Study|Withdrawal by Subject|1
7737954|NCT00895245|26904297|P1|Overall Study|Lack of Efficacy|6
7737955|NCT00895154|26904375|P2|Overall Study|Withdrawal by Subject|1
7737956|NCT00895154|26904376|P1|Overall Study|Withdrawal by Subject|0
7737957|NCT00895154|26904375|P2|Overall Study|Lost to Follow-up|1
7737958|NCT00895154|26904376|P1|Overall Study|Lost to Follow-up|1
7737959|NCT00895037|26904411|P3|Overall Study|Death|1
7737960|NCT00895037|26904412|P2|Overall Study|Death|2
7737961|NCT00895037|26904413|P1|Overall Study|Death|0
7737962|NCT00895011|26904444|P3|Overall Study|schedule conflict|0
7737963|NCT00895011|26904445|P2|Overall Study|schedule conflict|0
7737964|NCT00895011|26904446|P1|Overall Study|schedule conflict|1
7737965|NCT00895011|26904444|P3|Overall Study|Adverse Event|2
7737966|NCT00895011|26904445|P2|Overall Study|Adverse Event|2
7737967|NCT00895011|26904446|P1|Overall Study|Adverse Event|1
7737968|NCT00895011|26904444|P3|Overall Study|Protocol Violation|3
7737969|NCT00895011|26904445|P2|Overall Study|Protocol Violation|1
7737970|NCT00895011|26904446|P1|Overall Study|Protocol Violation|3
7737971|NCT00895011|26904444|P3|Overall Study|Lost to Follow-up|1
7737972|NCT00895011|26904445|P2|Overall Study|Lost to Follow-up|4
7737973|NCT00895011|26904446|P1|Overall Study|Lost to Follow-up|5
7737974|NCT00895011|26904444|P3|Overall Study|Withdrawal by Subject|2
7737975|NCT00895011|26904445|P2|Overall Study|Withdrawal by Subject|7
7737976|NCT00895011|26904446|P1|Overall Study|Withdrawal by Subject|14
7737977|NCT00894933|26904460|P1|Overall Study|Did not meeting incl/excl criteria|1
7737978|NCT00894933|26904460|P1|Overall Study|Cancelled Procedure|1
7737979|NCT00894933|26904460|P1|Overall Study|Lost to Follow-up|2
7737980|NCT00894803|26904478|P2|Overall Study|Lost to Follow-up|1
7737981|NCT00894803|26904479|P1|Overall Study|Lost to Follow-up|0
7737982|NCT00894803|26904478|P2|Overall Study|Death|4
7737983|NCT00894803|26904479|P1|Overall Study|Death|20
7737984|NCT00894790|26904515|P2|Overall Study|Did not meet entrance criteria|0
7737985|NCT00894790|26904516|P1|Overall Study|Did not meet entrance criteria|1
7737986|NCT00894790|26904515|P2|Overall Study|Lost to Follow-up|1
7737987|NCT00894790|26904516|P1|Overall Study|Lost to Follow-up|0
7737988|NCT00894790|26904515|P2|Overall Study|Protocol Violation|1
7737989|NCT00894790|26904516|P1|Overall Study|Protocol Violation|0
7737990|NCT00894686|26904558|P1|Overall Study|Other|5
7737991|NCT00894686|26904558|P1|Overall Study|Physician Decision|1
7737992|NCT00894686|26904558|P1|Overall Study|Withdrawal by Subject|50
7737993|NCT00894647|26904582|P2|Overall Study|Other, not due to AE|2
7737994|NCT00894647|26904583|P1|Overall Study|Other, not due to AE|1
7737995|NCT00894647|26904582|P2|Overall Study|Non-compliance with study procedures|2
7737996|NCT00894647|26904583|P1|Overall Study|Non-compliance with study procedures|0
7737997|NCT00894647|26904582|P2|Overall Study|Lost to Follow-up|2
7737998|NCT00894647|26904583|P1|Overall Study|Lost to Follow-up|0
7737999|NCT00894647|26904582|P2|Overall Study|Withdrawal by Subject|4
7738000|NCT00894647|26904583|P1|Overall Study|Withdrawal by Subject|4
7738001|NCT00894647|26904582|P2|Overall Study|Adverse Event|4
7738002|NCT00894647|26904583|P1|Overall Study|Adverse Event|5
7738003|NCT00894556|26904596|P4|Treatment Phase|Lack of Qualifying Event|0
7738004|NCT00894556|26904597|P3|Treatment Phase|Lack of Qualifying Event|0
7738005|NCT00894556|26904598|P2|Treatment Phase|Lack of Qualifying Event|1
7738006|NCT00894556|26904599|P1|Treatment Phase|Lack of Qualifying Event|2
7738007|NCT00894556|26904596|P4|Treatment Phase|Lost to Follow-up|0
7738008|NCT00894556|26904597|P3|Treatment Phase|Lost to Follow-up|1
7738009|NCT00894556|26904598|P2|Treatment Phase|Lost to Follow-up|3
7738010|NCT00894556|26904599|P1|Treatment Phase|Lost to Follow-up|2
7738011|NCT00894556|26904596|P4|Baseline Phase|Did not meet Randomization Criteria|85
7738012|NCT00894556|26904597|P3|Baseline Phase|Did not meet Randomization Criteria|0
7738013|NCT00894556|26904598|P2|Baseline Phase|Did not meet Randomization Criteria|0
7738014|NCT00894556|26904599|P1|Baseline Phase|Did not meet Randomization Criteria|0
7738015|NCT00894543|26904610|P2|Week 4 to Week 8|No diary or lost or withdrew|2
7738016|NCT00894543|26904611|P1|Week 4 to Week 8|No diary or lost or withdrew|4
7738017|NCT00894543|26904610|P2|Baseline to Week 4|No diary or lost or withdrew|2
7738018|NCT00894543|26904611|P1|Baseline to Week 4|No diary or lost or withdrew|3
7738019|NCT00894413|26904677|P2|Overall Study|Withdrawal by Subject|4
7738020|NCT00894413|26904678|P1|Overall Study|Withdrawal by Subject|0
7738021|NCT00894413|26904677|P2|Overall Study|Adverse Event|2
7738022|NCT00894413|26904678|P1|Overall Study|Adverse Event|0
7738023|NCT00894413|26904677|P2|Overall Study|Physician Decision|2
7738024|NCT00894413|26904678|P1|Overall Study|Physician Decision|0
7738025|NCT00894387|26904686|P2|Overall Study|GCP non-compliance|2
7738026|NCT00894387|26904687|P1|Overall Study|GCP non-compliance|0
7738027|NCT00894387|26904686|P2|Overall Study|Mis-randomized|9
7738028|NCT00894387|26904687|P1|Overall Study|Mis-randomized|13
7738029|NCT00894387|26904686|P2|Overall Study|Other (Missing)|3
7738030|NCT00894387|26904687|P1|Overall Study|Other (Missing)|5
7738031|NCT00894387|26904686|P2|Overall Study|Patient's request|30
7738032|NCT00894387|26904687|P1|Overall Study|Patient's request|25
7738033|NCT00894387|26904686|P2|Overall Study|Protocol Deviation|0
7738034|NCT00894387|26904687|P1|Overall Study|Protocol Deviation|4
7738035|NCT00894387|26904686|P2|Overall Study|Death|76
7738036|NCT00894387|26904687|P1|Overall Study|Death|77
7738037|NCT00894387|26904686|P2|Overall Study|Administrative problems|2
7738038|NCT00894387|26904687|P1|Overall Study|Administrative problems|2
7738039|NCT00894387|26904686|P2|Overall Study|Lost to Follow-up|5
7738040|NCT00894387|26904687|P1|Overall Study|Lost to Follow-up|3
7738041|NCT00894387|26904686|P2|Overall Study|Unsatisfactory therapeutic effect|1
7738042|NCT00894387|26904687|P1|Overall Study|Unsatisfactory therapeutic effect|0
7738043|NCT00894387|26904686|P2|Overall Study|Abnormal Laboratory values|2
7738044|NCT00894387|26904687|P1|Overall Study|Abnormal Laboratory values|2
7738045|NCT00894387|26904686|P2|Overall Study|Adverse Event|45
7738046|NCT00894387|26904687|P1|Overall Study|Adverse Event|44
7738047|NCT00894361|26904707|P2|Overall Study|deaths and less than 2 years followup|64
7738048|NCT00894361|26904708|P1|Overall Study|deaths and less than 2 years followup|24
7738049|NCT00894322|26904719|P3|Overall Study|Withdrawal by Subject|0
7738050|NCT00894322|26904720|P2|Overall Study|Withdrawal by Subject|0
7738051|NCT00894322|26904721|P1|Overall Study|Withdrawal by Subject|1
7738052|NCT00894166|26904772|P8|Overall Study|Death|0
7738053|NCT00894166|26904773|P7|Overall Study|Death|0
7738054|NCT00894166|26904774|P6|Overall Study|Death|0
7738055|NCT00894166|26904775|P5|Overall Study|Death|0
7738056|NCT00894166|26904776|P4|Overall Study|Death|1
7738057|NCT00894166|26904777|P3|Overall Study|Death|0
7738058|NCT00894166|26904778|P2|Overall Study|Death|0
7738059|NCT00894166|26904779|P1|Overall Study|Death|0
7738060|NCT00894166|26904772|P8|Overall Study|Withdrew or Lost to Follow-Up|34
7738061|NCT00894166|26904773|P7|Overall Study|Withdrew or Lost to Follow-Up|16
7738062|NCT00894166|26904774|P6|Overall Study|Withdrew or Lost to Follow-Up|16
7738063|NCT00894166|26904775|P5|Overall Study|Withdrew or Lost to Follow-Up|24
7738064|NCT00894166|26904776|P4|Overall Study|Withdrew or Lost to Follow-Up|68
7738065|NCT00894166|26904777|P3|Overall Study|Withdrew or Lost to Follow-Up|62
7738066|NCT00894166|26904778|P2|Overall Study|Withdrew or Lost to Follow-Up|63
7738067|NCT00894166|26904779|P1|Overall Study|Withdrew or Lost to Follow-Up|61
7738068|NCT00893971|26904825|P1|Overall Study|Physician Decision|3
7738069|NCT00893789|26904943|P4|Overall Study|Lost to Follow-up|1
7738070|NCT00893789|26904944|P3|Overall Study|Lost to Follow-up|0
7738071|NCT00893789|26904945|P2|Overall Study|Lost to Follow-up|0
7738072|NCT00893789|26904946|P1|Overall Study|Lost to Follow-up|0
7738073|NCT00893789|26904943|P4|Overall Study|Protocol Violation|4
7738074|NCT00893789|26904944|P3|Overall Study|Protocol Violation|1
7738075|NCT00893789|26904945|P2|Overall Study|Protocol Violation|1
7738076|NCT00893789|26904946|P1|Overall Study|Protocol Violation|0
7738077|NCT00893789|26904943|P4|Overall Study|Adverse Event|5
7738078|NCT00893789|26904944|P3|Overall Study|Adverse Event|1
7738079|NCT00893789|26904945|P2|Overall Study|Adverse Event|2
7738080|NCT00893789|26904946|P1|Overall Study|Adverse Event|0
7738081|NCT00893789|26904943|P4|Overall Study|Taking Excluded Concomitant Medication|0
7738082|NCT00893789|26904944|P3|Overall Study|Taking Excluded Concomitant Medication|1
7738083|NCT00893789|26904945|P2|Overall Study|Taking Excluded Concomitant Medication|0
7738084|NCT00893789|26904946|P1|Overall Study|Taking Excluded Concomitant Medication|1
7738085|NCT00893789|26904943|P4|Overall Study|Noncompliance With Study Procedures|0
7738086|NCT00893789|26904944|P3|Overall Study|Noncompliance With Study Procedures|0
7738087|NCT00893789|26904945|P2|Overall Study|Noncompliance With Study Procedures|0
7738088|NCT00893789|26904946|P1|Overall Study|Noncompliance With Study Procedures|1
7738089|NCT00893789|26904943|P4|Overall Study|Noncompliance With Study Drug|2
7738090|NCT00893789|26904944|P3|Overall Study|Noncompliance With Study Drug|1
7738091|NCT00893789|26904945|P2|Overall Study|Noncompliance With Study Drug|0
7738092|NCT00893789|26904946|P1|Overall Study|Noncompliance With Study Drug|1
7738093|NCT00893789|26904943|P4|Overall Study|Withdrawal by Subject|1
7738094|NCT00893789|26904944|P3|Overall Study|Withdrawal by Subject|3
7738095|NCT00893789|26904945|P2|Overall Study|Withdrawal by Subject|1
7738096|NCT00893789|26904946|P1|Overall Study|Withdrawal by Subject|3
7738097|NCT00893763|26905030|P2|Overall Study|extubated|110
7738098|NCT00893763|26905031|P1|Overall Study|extubated|110
7738099|NCT00893737|26905039|P1|Overall Study|Lost to Follow-up|6
7738100|NCT00893737|26905039|P1|Overall Study|Withdrawal by Subject|2
7738101|NCT00893737|26905039|P1|Overall Study|Adverse Event|4
7738102|NCT00893464|26905060|P8|Overall Study|Did not complete therapy/experience PD|2
7738103|NCT00893464|26905061|P7|Overall Study|Did not complete therapy/experience PD|2
7738104|NCT00893464|26905062|P6|Overall Study|Did not complete therapy/experience PD|0
7738105|NCT00893464|26905063|P5|Overall Study|Did not complete therapy/experience PD|0
7738106|NCT00893464|26905064|P4|Overall Study|Did not complete therapy/experience PD|0
7738107|NCT00893464|26905065|P3|Overall Study|Did not complete therapy/experience PD|0
7738108|NCT00893464|26905066|P2|Overall Study|Did not complete therapy/experience PD|0
7738109|NCT00893464|26905067|P1|Overall Study|Did not complete therapy/experience PD|0
7738110|NCT00893113|26905194|P2|Overall Study|Withdrew Consent|7
7738111|NCT00893113|26905195|P1|Overall Study|Withdrew Consent|8
7738112|NCT00893113|26905194|P2|Overall Study|Early Termination|1
7738113|NCT00893113|26905195|P1|Overall Study|Early Termination|1
7738114|NCT00893113|26905194|P2|Overall Study|Lost to Follow-up|8
7738115|NCT00893113|26905195|P1|Overall Study|Lost to Follow-up|4
7738116|NCT00892957|26905225|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
7738117|NCT00892957|26905226|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
7738118|NCT00892957|26905225|P2|Between Postoperative Day 1 and Day 14|Death|2
7738119|NCT00892957|26905226|P1|Between Postoperative Day 1 and Day 14|Death|0
7738120|NCT00892775|26905314|P2|Overall Study|Lost to Follow-up|0
7738121|NCT00892775|26905315|P1|Overall Study|Lost to Follow-up|1
7738122|NCT00892775|26905314|P2|Overall Study|Withdrawal by Subject|1
7738123|NCT00892775|26905315|P1|Overall Study|Withdrawal by Subject|0
7738124|NCT00892775|26905314|P2|Overall Study|Migrated/ moved from study area|0
7738125|NCT00892775|26905315|P1|Overall Study|Migrated/ moved from study area|1
7738126|NCT00892775|26905314|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
7738127|NCT00892775|26905315|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
7738128|NCT00892775|26905314|P2|Overall Study|Subject difficulties with blood drawing|0
7738129|NCT00892775|26905315|P1|Overall Study|Subject difficulties with blood drawing|1
7738130|NCT00892775|26905314|P2|Overall Study|Protocol Violation|0
7738131|NCT00892775|26905315|P1|Overall Study|Protocol Violation|1
7738132|NCT00892723|26905342|P3|Overall Study|Withdrawal by Subject|1
7738133|NCT00892723|26905343|P2|Overall Study|Withdrawal by Subject|1
7738134|NCT00892723|26905344|P1|Overall Study|Withdrawal by Subject|1
7738135|NCT00892723|26905342|P3|Overall Study|Lost to Follow-up|1
7738136|NCT00892723|26905343|P2|Overall Study|Lost to Follow-up|3
7738137|NCT00892723|26905344|P1|Overall Study|Lost to Follow-up|1
7738138|NCT00892437|26905433|P2|Open-Label Extension Phase|Withdrew Consent|1
7738139|NCT00892437|26905434|P1|Open-Label Extension Phase|Withdrew Consent|3
7738140|NCT00892437|26905433|P2|Open-Label Extension Phase|Investigator's Discretion|0
7738141|NCT00892437|26905434|P1|Open-Label Extension Phase|Investigator's Discretion|1
7738142|NCT00892437|26905433|P2|Open-Label Extension Phase|Lost to Follow-up|1
7738143|NCT00892437|26905434|P1|Open-Label Extension Phase|Lost to Follow-up|3
7738144|NCT00892437|26905433|P2|Open-Label Extension Phase|Lack of Efficacy|0
7738145|NCT00892437|26905434|P1|Open-Label Extension Phase|Lack of Efficacy|1
7738146|NCT00892437|26905433|P2|Open-Label Extension Phase|Adverse Event|2
7738147|NCT00892437|26905434|P1|Open-Label Extension Phase|Adverse Event|4
7738148|NCT00892437|26905433|P2|Randomized Phase|Withdrew Consent|0
7738149|NCT00892437|26905434|P1|Randomized Phase|Withdrew Consent|1
7738150|NCT00892437|26905433|P2|Randomized Phase|Investigator's Discretion|0
7738151|NCT00892437|26905434|P1|Randomized Phase|Investigator's Discretion|1
7738152|NCT00892437|26905433|P2|Randomized Phase|Lost to Follow-up|3
7738153|NCT00892437|26905434|P1|Randomized Phase|Lost to Follow-up|1
7738154|NCT00892437|26905433|P2|Randomized Phase|Adverse Event|2
7738155|NCT00892437|26905434|P1|Randomized Phase|Adverse Event|2
7738156|NCT00892437|26905433|P2|Randomized Phase|Randomized but not treated|0
7738157|NCT00892437|26905434|P1|Randomized Phase|Randomized but not treated|6
7738158|NCT00892281|26905453|P2|Overall Study|Visit 4 date out of window|0
7738159|NCT00892281|26905454|P1|Overall Study|Visit 4 date out of window|1
7738160|NCT00892281|26905453|P2|Overall Study|Rash on hand|0
7738161|NCT00892281|26905454|P1|Overall Study|Rash on hand|1
7738162|NCT00892281|26905453|P2|Overall Study|Subject had history of drug abuse|0
7738163|NCT00892281|26905454|P1|Overall Study|Subject had history of drug abuse|1
7738164|NCT00892281|26905453|P2|Overall Study|Non-compliant with visits as scheduled|0
7738165|NCT00892281|26905454|P1|Overall Study|Non-compliant with visits as scheduled|1
7738166|NCT00892281|26905453|P2|Overall Study|Missed visits rescheduled out of window|0
7738167|NCT00892281|26905454|P1|Overall Study|Missed visits rescheduled out of window|1
7738168|NCT00892281|26905453|P2|Overall Study|Missed multiple visits|0
7738169|NCT00892281|26905454|P1|Overall Study|Missed multiple visits|1
7738170|NCT00892281|26905453|P2|Overall Study|No show Visit 2; prescription not filled|0
7738171|NCT00892281|26905454|P1|Overall Study|No show Visit 2; prescription not filled|1
7738172|NCT00892281|26905453|P2|Overall Study|Subject not seen by PI at final visit|0
7738173|NCT00892281|26905454|P1|Overall Study|Subject not seen by PI at final visit|1
7738174|NCT00892281|26905453|P2|Overall Study|Lack of efficacy of study product|0
7738175|NCT00892281|26905454|P1|Overall Study|Lack of efficacy of study product|2
7738176|NCT00892281|26905453|P2|Overall Study|Death in family|0
7738177|NCT00892281|26905454|P1|Overall Study|Death in family|1
7738178|NCT00892281|26905453|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
7738179|NCT00892281|26905454|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
7738180|NCT00892281|26905453|P2|Overall Study|Subject lost interest in program|1
7738181|NCT00892281|26905454|P1|Overall Study|Subject lost interest in program|0
7738182|NCT00892281|26905453|P2|Overall Study|PI complained of inadequate compensation|0
7738183|NCT00892281|26905454|P1|Overall Study|PI complained of inadequate compensation|3
7738184|NCT00892281|26905453|P2|Overall Study|Scheduled for knee replacement|1
7738185|NCT00892281|26905454|P1|Overall Study|Scheduled for knee replacement|0
7738186|NCT00892281|26905453|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
7738187|NCT00892281|26905454|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
7738188|NCT00892281|26905453|P2|Overall Study|Subject missed several visits/lost meds|0
7738189|NCT00892281|26905454|P1|Overall Study|Subject missed several visits/lost meds|1
7738190|NCT00892281|26905453|P2|Overall Study|Subject did not return for any visits|0
7738191|NCT00892281|26905454|P1|Overall Study|Subject did not return for any visits|1
7738192|NCT00892281|26905453|P2|Overall Study|Subject not good candidate for study|0
7738193|NCT00892281|26905454|P1|Overall Study|Subject not good candidate for study|1
7738194|NCT00892281|26905453|P2|Overall Study|Unable to redeem the drug voucher|0
7738195|NCT00892281|26905454|P1|Overall Study|Unable to redeem the drug voucher|1
7738196|NCT00892281|26905453|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
7738197|NCT00892281|26905454|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
7738198|NCT00892281|26905453|P2|Overall Study|Did not meet incl/excl criteria|0
7738199|NCT00892281|26905454|P1|Overall Study|Did not meet incl/excl criteria|1
7738200|NCT00892281|26905453|P2|Overall Study|Last visit not done - death in family|0
7738201|NCT00892281|26905454|P1|Overall Study|Last visit not done - death in family|1
7738202|NCT00892281|26905453|P2|Overall Study|Family emergency|0
7738203|NCT00892281|26905454|P1|Overall Study|Family emergency|1
7738204|NCT00892281|26905453|P2|Overall Study|Subject completed day after study closed|0
7738205|NCT00892281|26905454|P1|Overall Study|Subject completed day after study closed|1
7738206|NCT00892281|26905453|P2|Overall Study|Final visit completed 4 weeks late|1
7738207|NCT00892281|26905454|P1|Overall Study|Final visit completed 4 weeks late|0
7738208|NCT00892281|26905453|P2|Overall Study|Subject unable to keep follow-up visits|0
7738209|NCT00892281|26905454|P1|Overall Study|Subject unable to keep follow-up visits|1
7738210|NCT00892281|26905453|P2|Overall Study|Subject failed to return for final visit|0
7738211|NCT00892281|26905454|P1|Overall Study|Subject failed to return for final visit|2
7738212|NCT00892281|26905453|P2|Overall Study|Withdrawal by Subject|14
7738213|NCT00892281|26905454|P1|Overall Study|Withdrawal by Subject|86
7738214|NCT00892281|26905453|P2|Overall Study|Protocol Violation|2
7738215|NCT00892281|26905454|P1|Overall Study|Protocol Violation|7
7738216|NCT00892281|26905453|P2|Overall Study|Pregnancy|0
7738217|NCT00892281|26905454|P1|Overall Study|Pregnancy|1
7738218|NCT00892281|26905453|P2|Overall Study|Lost to Follow-up|8
7738219|NCT00892281|26905454|P1|Overall Study|Lost to Follow-up|81
7738220|NCT00892281|26905453|P2|Overall Study|Adverse Event|8
7738221|NCT00892281|26905454|P1|Overall Study|Adverse Event|65
7738222|NCT00892177|26905467|P6|Phase II|Withdrawal by Subject|1
7738223|NCT00892177|26905468|P5|Phase II|Withdrawal by Subject|4
7738224|NCT00892177|26905469|P4|Phase II|Withdrawal by Subject|0
7738225|NCT00892177|26905470|P3|Phase II|Withdrawal by Subject|0
7738226|NCT00892177|26905471|P2|Phase II|Withdrawal by Subject|0
7738227|NCT00892177|26905472|P1|Phase II|Withdrawal by Subject|0
7738228|NCT00892177|26905467|P6|Phase II|Ineligible|1
7738229|NCT00892177|26905468|P5|Phase II|Ineligible|1
7738230|NCT00892177|26905469|P4|Phase II|Ineligible|0
7738231|NCT00892177|26905470|P3|Phase II|Ineligible|0
7738232|NCT00892177|26905471|P2|Phase II|Ineligible|0
7738233|NCT00892177|26905472|P1|Phase II|Ineligible|0
7738234|NCT00892151|26905497|P1|Overall Study|Protocol Violation|1
7738235|NCT00892099|26905506|P3|Overall Study|Lost to Follow-up|1
7738236|NCT00892099|26905507|P2|Overall Study|Lost to Follow-up|0
7738237|NCT00892099|26905508|P1|Overall Study|Lost to Follow-up|0
7738238|NCT00892099|26905506|P3|Overall Study|investigator decision|1
7738239|NCT00892099|26905507|P2|Overall Study|investigator decision|0
7738240|NCT00892099|26905508|P1|Overall Study|investigator decision|0
7738241|NCT00892099|26905506|P3|Overall Study|kidney function recovered|0
7738242|NCT00892099|26905507|P2|Overall Study|kidney function recovered|1
7738243|NCT00892099|26905508|P1|Overall Study|kidney function recovered|0
7738244|NCT00892099|26905506|P3|Overall Study|no further details|1
7738245|NCT00892099|26905507|P2|Overall Study|no further details|0
7738246|NCT00892099|26905508|P1|Overall Study|no further details|1
7738247|NCT00892099|26905506|P3|Overall Study|Prolonged hospitalization|1
7738248|NCT00892099|26905507|P2|Overall Study|Prolonged hospitalization|0
7738249|NCT00892099|26905508|P1|Overall Study|Prolonged hospitalization|1
7738250|NCT00892099|26905506|P3|Overall Study|replocated|2
7738251|NCT00892099|26905507|P2|Overall Study|replocated|0
7738252|NCT00892099|26905508|P1|Overall Study|replocated|1
7738253|NCT00892099|26905506|P3|Overall Study|Adverse Event|0
7738254|NCT00892099|26905507|P2|Overall Study|Adverse Event|0
7738255|NCT00892099|26905508|P1|Overall Study|Adverse Event|1
7738256|NCT00892099|26905506|P3|Overall Study|Death|1
7738257|NCT00892099|26905507|P2|Overall Study|Death|0
7738258|NCT00892099|26905508|P1|Overall Study|Death|1
7738259|NCT00892047|26905533|P2|Overall Study|Lack of Efficacy|2
7738260|NCT00892047|26905534|P1|Overall Study|Lack of Efficacy|0
7738261|NCT00892047|26905533|P2|Overall Study|subject burden|3
7738262|NCT00892047|26905534|P1|Overall Study|subject burden|2
7738263|NCT00892047|26905533|P2|Overall Study|Adverse Event|2
7738264|NCT00892047|26905534|P1|Overall Study|Adverse Event|2
7738265|NCT00892008|26905550|P1|Overall Study|Adverse Event|37
7738266|NCT00892008|26905550|P1|Overall Study|Other|378
7738267|NCT00892008|26905550|P1|Overall Study|Lost to Follow-up|142
7738268|NCT00892008|26905550|P1|Overall Study|Lack of Efficacy|3
7738269|NCT00892008|26905550|P1|Overall Study|Death|5
7738270|NCT00891930|26905636|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
7738271|NCT00891930|26905636|P1|Part 2: Panitumumab + Ganitumab|Death|30
7738272|NCT00891930|26905636|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
7738273|NCT00891930|26905636|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
7738274|NCT00891930|26905636|P1|Part 1: Panitumumab +Irinotecan|Death|38
7738275|NCT00891904|26905657|P1|Overall Study|Adverse Event|1
7738276|NCT00891904|26905657|P1|Overall Study|Death|1
7738277|NCT00891839|26905683|P1|Overall Study|Disease progression|3
7738278|NCT00891839|26905683|P1|Overall Study|Withdrawal by Subject|2
7738279|NCT00891839|26905683|P1|Overall Study|Adverse Event|2
7738280|NCT00891813|26905692|P1|Overall Study|Protocol Violation|2
7738281|NCT00891813|26905692|P1|Overall Study|Patient Noncompliance|6
7738282|NCT00891813|26905692|P1|Overall Study|Withdrawal by Subject|1
7738283|NCT00891813|26905692|P1|Overall Study|Adverse Event|3
7738284|NCT00891774|26905698|P1|Overall Study|Protocol Violation|4
7738285|NCT00891774|26905698|P1|Overall Study|Withdrawal by Subject|2
7738286|NCT00891774|26905698|P1|Overall Study|Illness (Self/Mother)|3
7738287|NCT00891774|26905698|P1|Overall Study|Lost to Follow-up|5
7738288|NCT00891735|26905709|P4|Overall Study|Patient's decision to withdraw|8
7738289|NCT00891735|26905710|P3|Overall Study|Patient's decision to withdraw|4
7738290|NCT00891735|26905711|P2|Overall Study|Patient's decision to withdraw|9
7738291|NCT00891735|26905712|P1|Overall Study|Patient's decision to withdraw|4
7738292|NCT00891735|26905709|P4|Overall Study|Physician's decision to withdraw patient|0
7738293|NCT00891735|26905710|P3|Overall Study|Physician's decision to withdraw patient|0
7738294|NCT00891735|26905711|P2|Overall Study|Physician's decision to withdraw patient|0
7738295|NCT00891735|26905712|P1|Overall Study|Physician's decision to withdraw patient|1
7738296|NCT00891735|26905709|P4|Overall Study|Lost to Follow-up|2
7738297|NCT00891735|26905710|P3|Overall Study|Lost to Follow-up|2
7738298|NCT00891735|26905711|P2|Overall Study|Lost to Follow-up|2
7738299|NCT00891735|26905712|P1|Overall Study|Lost to Follow-up|2
7738300|NCT00891735|26905709|P4|Overall Study|Death|5
7738301|NCT00891735|26905710|P3|Overall Study|Death|4
7738302|NCT00891735|26905711|P2|Overall Study|Death|5
7738303|NCT00891735|26905712|P1|Overall Study|Death|8
7738304|NCT00891735|26905709|P4|Overall Study|Adverse Event|0
7738305|NCT00891735|26905710|P3|Overall Study|Adverse Event|2
7738306|NCT00891735|26905711|P2|Overall Study|Adverse Event|0
7738307|NCT00891735|26905712|P1|Overall Study|Adverse Event|2
7738308|NCT00891657|26905752|P2|Overall Study|Withdrawal by Subject|1
7738309|NCT00891657|26905753|P1|Overall Study|Withdrawal by Subject|1
7738310|NCT00891618|26905765|P1|Overall Study|Withdrawal by Subject|1
7738311|NCT00891527|26905769|P1|Overall Study|Withdrawal by Subject|2
7738312|NCT00891462|26905778|P3|Overall Study|Lost to Follow-up|0
7738313|NCT00891462|26905779|P2|Overall Study|Lost to Follow-up|2
7738314|NCT00891462|26905780|P1|Overall Study|Lost to Follow-up|0
7738315|NCT00891462|26905778|P3|Overall Study|Inclusion/exclusion criteria|2
7738316|NCT00891462|26905779|P2|Overall Study|Inclusion/exclusion criteria|2
7738317|NCT00891462|26905780|P1|Overall Study|Inclusion/exclusion criteria|0
7738318|NCT00891462|26905778|P3|Overall Study|Protocol Violation|3
7738319|NCT00891462|26905779|P2|Overall Study|Protocol Violation|1
7738320|NCT00891462|26905780|P1|Overall Study|Protocol Violation|2
7738321|NCT00891462|26905778|P3|Overall Study|Other Reason|3
7738322|NCT00891462|26905779|P2|Overall Study|Other Reason|5
7738323|NCT00891462|26905780|P1|Overall Study|Other Reason|2
7738324|NCT00891462|26905778|P3|Overall Study|COPD exacerbation|1
7738325|NCT00891462|26905779|P2|Overall Study|COPD exacerbation|4
7738326|NCT00891462|26905780|P1|Overall Study|COPD exacerbation|7
7738327|NCT00891462|26905778|P3|Overall Study|Lack of Efficacy|1
7738328|NCT00891462|26905779|P2|Overall Study|Lack of Efficacy|5
7738329|NCT00891462|26905780|P1|Overall Study|Lack of Efficacy|10
7738330|NCT00891462|26905778|P3|Overall Study|Adverse Event|7
7738331|NCT00891462|26905779|P2|Overall Study|Adverse Event|8
7738332|NCT00891462|26905780|P1|Overall Study|Adverse Event|7
7738333|NCT00891462|26905778|P3|Overall Study|Withdrawal by Subject|7
7738334|NCT00891462|26905779|P2|Overall Study|Withdrawal by Subject|6
7738335|NCT00891462|26905780|P1|Overall Study|Withdrawal by Subject|9
7738336|NCT00891371|26905802|P1|Treatment|Lost to Follow-up|1
7738337|NCT00891371|26905802|P1|Treatment|Death|1
7738338|NCT00891371|26905802|P1|Treatment|Adverse Event|2
7738339|NCT00891371|26905802|P1|Treatment|Lack of Efficacy|5
7738340|NCT00891371|26905802|P1|Pre-assignment|Consent withdrawal|1
7738341|NCT00891371|26905802|P1|Pre-assignment|Inclusion/exclusion|5
7738342|NCT00891293|26905824|P1|Overall Study|Sponsor termination|62
7738343|NCT00891293|26905824|P1|Overall Study|Subject withdrew consent|7
7738344|NCT00891293|26905824|P1|Overall Study|Lost to Follow-up|7
7738345|NCT00891293|26905824|P1|Overall Study|Laboratory abnormality|4
7738346|NCT00891293|26905824|P1|Overall Study|Protocol Violation|2
7738347|NCT00891293|26905824|P1|Overall Study|Adverse Event|2
7738348|NCT00891228|26905839|P3|Overall Study|Pregnancy|0
7738349|NCT00891228|26905840|P2|Overall Study|Pregnancy|1
7738350|NCT00891228|26905841|P1|Overall Study|Pregnancy|0
7738351|NCT00891228|26905839|P3|Overall Study|Lost to Follow-up|5
7738352|NCT00891228|26905840|P2|Overall Study|Lost to Follow-up|4
7738353|NCT00891228|26905841|P1|Overall Study|Lost to Follow-up|4
7738354|NCT00891228|26905839|P3|Overall Study|Physician Decision|0
7738355|NCT00891228|26905840|P2|Overall Study|Physician Decision|1
7738356|NCT00891228|26905841|P1|Overall Study|Physician Decision|2
7738357|NCT00891228|26905839|P3|Overall Study|Protocol Violation|2
7738358|NCT00891228|26905840|P2|Overall Study|Protocol Violation|1
7738359|NCT00891228|26905841|P1|Overall Study|Protocol Violation|3
7738360|NCT00891228|26905839|P3|Overall Study|Withdrawal by Subject|5
7738361|NCT00891228|26905840|P2|Overall Study|Withdrawal by Subject|4
7738362|NCT00891228|26905841|P1|Overall Study|Withdrawal by Subject|2
7738363|NCT00891228|26905839|P3|Overall Study|Adverse Event|3
7738364|NCT00891228|26905840|P2|Overall Study|Adverse Event|2
7738365|NCT00891228|26905841|P1|Overall Study|Adverse Event|0
7738366|NCT00891202|26905863|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
7738367|NCT00891202|26905864|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
7738368|NCT00891202|26905865|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
7738369|NCT00891202|26905866|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
7738370|NCT00891202|26905863|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7738371|NCT00891202|26905864|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
7738372|NCT00891202|26905865|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7738373|NCT00891202|26905866|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7738374|NCT00891202|26905863|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7738375|NCT00891202|26905864|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
7738376|NCT00891202|26905865|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7738377|NCT00891202|26905866|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7738378|NCT00891202|26905863|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
7738379|NCT00891202|26905864|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
7738380|NCT00891202|26905865|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
7738381|NCT00891202|26905866|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
7738382|NCT00891046|26906042|P5|Overall Study|Lost to Follow-up|1
7738383|NCT00891046|26906043|P4|Overall Study|Lost to Follow-up|0
7738384|NCT00891046|26906044|P3|Overall Study|Lost to Follow-up|0
7738385|NCT00891046|26906045|P2|Overall Study|Lost to Follow-up|0
7738386|NCT00891046|26906046|P1|Overall Study|Lost to Follow-up|0
7738387|NCT00891046|26906042|P5|Overall Study|Withdrawal by Subject|1
7738388|NCT00891046|26906043|P4|Overall Study|Withdrawal by Subject|1
7738389|NCT00891046|26906044|P3|Overall Study|Withdrawal by Subject|2
7738390|NCT00891046|26906045|P2|Overall Study|Withdrawal by Subject|1
7738391|NCT00891046|26906046|P1|Overall Study|Withdrawal by Subject|2
7738392|NCT00891046|26906042|P5|Overall Study|Adverse Event|14
7738393|NCT00891046|26906043|P4|Overall Study|Adverse Event|0
7738394|NCT00891046|26906044|P3|Overall Study|Adverse Event|2
7738395|NCT00891046|26906045|P2|Overall Study|Adverse Event|3
7738396|NCT00891046|26906046|P1|Overall Study|Adverse Event|4
7738397|NCT00891046|26906042|P5|Overall Study|Participant no longer required drug|1
7738398|NCT00891046|26906043|P4|Overall Study|Participant no longer required drug|0
7738399|NCT00891046|26906044|P3|Overall Study|Participant no longer required drug|0
7738400|NCT00891046|26906045|P2|Overall Study|Participant no longer required drug|2
7738401|NCT00891046|26906046|P1|Overall Study|Participant no longer required drug|0
7738402|NCT00891046|26906042|P5|Overall Study|Administrative problems|1
7738403|NCT00891046|26906043|P4|Overall Study|Administrative problems|0
7738404|NCT00891046|26906044|P3|Overall Study|Administrative problems|0
7738405|NCT00891046|26906045|P2|Overall Study|Administrative problems|0
7738406|NCT00891046|26906046|P1|Overall Study|Administrative problems|0
7738407|NCT00891046|26906042|P5|Overall Study|Unsatisfactory therapeutic effect|20
7738408|NCT00891046|26906043|P4|Overall Study|Unsatisfactory therapeutic effect|2
7738409|NCT00891046|26906044|P3|Overall Study|Unsatisfactory therapeutic effect|19
7738410|NCT00891046|26906045|P2|Overall Study|Unsatisfactory therapeutic effect|2
7738411|NCT00891046|26906046|P1|Overall Study|Unsatisfactory therapeutic effect|5
7738412|NCT00891046|26906042|P5|Overall Study|Protocol Violation|1
7738413|NCT00891046|26906043|P4|Overall Study|Protocol Violation|0
7738414|NCT00891046|26906044|P3|Overall Study|Protocol Violation|0
7738415|NCT00891046|26906045|P2|Overall Study|Protocol Violation|1
7738416|NCT00891046|26906046|P1|Overall Study|Protocol Violation|1
7738417|NCT00891020|26906122|P3|Long-term Extension Period|Administrative|2
7738418|NCT00891020|26906123|P2|Long-term Extension Period|Administrative|2
7738419|NCT00891020|26906124|P1|Long-term Extension Period|Administrative|1
7738420|NCT00891020|26906122|P3|Long-term Extension Period|Failure to return|3
7738421|NCT00891020|26906123|P2|Long-term Extension Period|Failure to return|2
7738422|NCT00891020|26906124|P1|Long-term Extension Period|Failure to return|0
7738423|NCT00891020|26906122|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
7738424|NCT00891020|26906123|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
7738425|NCT00891020|26906124|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
7738426|NCT00891020|26906122|P3|Long-term Extension Period|Protocol Violation|1
7738427|NCT00891020|26906123|P2|Long-term Extension Period|Protocol Violation|1
7738428|NCT00891020|26906124|P1|Long-term Extension Period|Protocol Violation|0
7738429|NCT00891020|26906122|P3|Long-term Extension Period|Insufficient therapeutic response|2
7738430|NCT00891020|26906123|P2|Long-term Extension Period|Insufficient therapeutic response|2
7738431|NCT00891020|26906124|P1|Long-term Extension Period|Insufficient therapeutic response|3
7738432|NCT00891020|26906122|P3|Long-term Extension Period|Death|1
7738433|NCT00891020|26906123|P2|Long-term Extension Period|Death|0
7738434|NCT00891020|26906124|P1|Long-term Extension Period|Death|0
7738435|NCT00891020|26906122|P3|Long-term Extension Period|Adverse Event|10
7738436|NCT00891020|26906123|P2|Long-term Extension Period|Adverse Event|11
7738437|NCT00891020|26906124|P1|Long-term Extension Period|Adverse Event|1
7738438|NCT00891020|26906122|P3|24 Week Treatment Period|Administrative/Other|1
7738439|NCT00891020|26906123|P2|24 Week Treatment Period|Administrative/Other|6
7738440|NCT00891020|26906124|P1|24 Week Treatment Period|Administrative/Other|5
7738441|NCT00891020|26906122|P3|24 Week Treatment Period|Withdrew consent|15
7738442|NCT00891020|26906123|P2|24 Week Treatment Period|Withdrew consent|3
7738443|NCT00891020|26906124|P1|24 Week Treatment Period|Withdrew consent|6
7738444|NCT00891020|26906122|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
7738445|NCT00891020|26906123|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
7738446|NCT00891020|26906124|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
7738447|NCT00891020|26906122|P3|24 Week Treatment Period|Other protocol violation|2
7738448|NCT00891020|26906123|P2|24 Week Treatment Period|Other protocol violation|1
7738449|NCT00891020|26906124|P1|24 Week Treatment Period|Other protocol violation|1
7738450|NCT00891020|26906122|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
7738451|NCT00891020|26906123|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
7738452|NCT00891020|26906124|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
7738453|NCT00891020|26906122|P3|24 Week Treatment Period|Failure to return|5
7738454|NCT00891020|26906123|P2|24 Week Treatment Period|Failure to return|5
7738455|NCT00891020|26906124|P1|24 Week Treatment Period|Failure to return|4
7738456|NCT00891020|26906122|P3|24 Week Treatment Period|Insufficient therapeutic response|15
7738457|NCT00891020|26906123|P2|24 Week Treatment Period|Insufficient therapeutic response|9
7738458|NCT00891020|26906124|P1|24 Week Treatment Period|Insufficient therapeutic response|6
7738459|NCT00891020|26906122|P3|24 Week Treatment Period|Death|0
7738460|NCT00891020|26906123|P2|24 Week Treatment Period|Death|2
7738461|NCT00891020|26906124|P1|24 Week Treatment Period|Death|0
7738462|NCT00891020|26906122|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
7738463|NCT00891020|26906123|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
7738464|NCT00891020|26906124|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
7738465|NCT00890929|26906188|P1|Overall Study|Physician Decision|1
7738466|NCT00890929|26906188|P1|Overall Study|Withdrawal by Subject|3
7738467|NCT00890929|26906188|P1|Overall Study|Death before treatment|2
7738468|NCT00890825|26906206|P2|Overall Study|Alive at data cut off (DCO)|14
7738469|NCT00890825|26906207|P1|Overall Study|Alive at data cut off (DCO)|13
7738470|NCT00890825|26906206|P2|Overall Study|Withdrawal by Subject|0
7738471|NCT00890825|26906207|P1|Overall Study|Withdrawal by Subject|1
7738472|NCT00890695|26906236|P2|Overall Study|Protocol Violation|0
7738473|NCT00890695|26906237|P1|Overall Study|Protocol Violation|1
7738474|NCT00890591|26906271|P1|Overall Study|Lack of Efficacy|20
7738475|NCT00890552|26906277|P1|On-treatment|Early prog disease/ death|10
7738476|NCT00890552|26906277|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
7738477|NCT00890409|26906286|P2|Overall Study|Lost to Follow-up|21
7738478|NCT00890409|26906287|P1|Overall Study|Lost to Follow-up|20
7738479|NCT00890201|26906324|P2|Overall Study|Protocol Violation|56
7738480|NCT00890201|26906325|P1|Overall Study|Protocol Violation|5
7738481|NCT00890097|26906343|P3|Overall Study|Protocol Deviation|1
7738482|NCT00890097|26906344|P2|Overall Study|Protocol Deviation|1
7738483|NCT00890097|26906345|P1|Overall Study|Protocol Deviation|1
7738484|NCT00890097|26906343|P3|Overall Study|Subject Moved|0
7738485|NCT00890097|26906344|P2|Overall Study|Subject Moved|4
7738486|NCT00890097|26906345|P1|Overall Study|Subject Moved|0
7738487|NCT00890097|26906343|P3|Overall Study|Transportation|0
7738488|NCT00890097|26906344|P2|Overall Study|Transportation|2
7738489|NCT00890097|26906345|P1|Overall Study|Transportation|0
7738490|NCT00890097|26906343|P3|Overall Study|Failed inclusion criteria|0
7738491|NCT00890097|26906344|P2|Overall Study|Failed inclusion criteria|4
7738492|NCT00890097|26906345|P1|Overall Study|Failed inclusion criteria|3
7738493|NCT00890097|26906343|P3|Overall Study|Randomization Error|0
7738494|NCT00890097|26906344|P2|Overall Study|Randomization Error|0
7738495|NCT00890097|26906345|P1|Overall Study|Randomization Error|2
7738496|NCT00890097|26906343|P3|Overall Study|Subject Decision|6
7738497|NCT00890097|26906344|P2|Overall Study|Subject Decision|2
7738498|NCT00890097|26906345|P1|Overall Study|Subject Decision|3
7738499|NCT00890097|26906343|P3|Overall Study|Did not attend final visit|0
7738500|NCT00890097|26906344|P2|Overall Study|Did not attend final visit|3
7738501|NCT00890097|26906345|P1|Overall Study|Did not attend final visit|2
7738502|NCT00890097|26906343|P3|Overall Study|Sponsor Decision|7
7738503|NCT00890097|26906344|P2|Overall Study|Sponsor Decision|11
7738504|NCT00890097|26906345|P1|Overall Study|Sponsor Decision|7
7738505|NCT00890097|26906343|P3|Overall Study|Noncompliance|4
7738506|NCT00890097|26906344|P2|Overall Study|Noncompliance|4
7738507|NCT00890097|26906345|P1|Overall Study|Noncompliance|0
7738508|NCT00890097|26906343|P3|Overall Study|Lost to Follow-up|5
7738509|NCT00890097|26906344|P2|Overall Study|Lost to Follow-up|5
7738510|NCT00890097|26906345|P1|Overall Study|Lost to Follow-up|5
7738511|NCT00890097|26906343|P3|Overall Study|Withdrew Consent|9
7738512|NCT00890097|26906344|P2|Overall Study|Withdrew Consent|6
7738513|NCT00890097|26906345|P1|Overall Study|Withdrew Consent|9
7738514|NCT00890097|26906343|P3|Overall Study|Decision Unrelated to an Adverse Event|17
7738515|NCT00890097|26906344|P2|Overall Study|Decision Unrelated to an Adverse Event|12
7738516|NCT00890097|26906345|P1|Overall Study|Decision Unrelated to an Adverse Event|15
7738517|NCT00890097|26906343|P3|Overall Study|Adverse Event|28
7738518|NCT00890097|26906344|P2|Overall Study|Adverse Event|32
7738519|NCT00890097|26906345|P1|Overall Study|Adverse Event|21
7738520|NCT00890084|26906353|P1|Overall Study|Lost to Follow-up|126
7738521|NCT00890084|26906353|P1|Overall Study|Adverse Event|16
7738522|NCT00890045|26906366|P2|Overall Study|Lost to Follow-up|7
7738523|NCT00890045|26906367|P1|Overall Study|Lost to Follow-up|5
7738524|NCT00890045|26906366|P2|Overall Study|Did not receive HeRO Graft|2
7738525|NCT00890045|26906367|P1|Overall Study|Did not receive HeRO Graft|0
7738526|NCT00890045|26906366|P2|Overall Study|Death|1
7738527|NCT00890045|26906367|P1|Overall Study|Death|0
7738528|NCT00889863|26906410|P2|Part II: Randomized Double Blind|Protocol deviation|1
7738529|NCT00889863|26906411|P1|Part II: Randomized Double Blind|Protocol deviation|0
7738530|NCT00889863|26906410|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
7738531|NCT00889863|26906411|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
7738532|NCT00889863|26906410|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
7738533|NCT00889863|26906411|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
7738534|NCT00889863|26906410|P2|Part II: Randomized Double Blind|Adverse Event|4
7738535|NCT00889863|26906411|P1|Part II: Randomized Double Blind|Adverse Event|0
7738536|NCT00889863|26906410|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
7738537|NCT00889863|26906411|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
7738538|NCT00889863|26906410|P2|Part I: Open Label|Adverse Event|0
7738539|NCT00889863|26906411|P1|Part I: Open Label|Adverse Event|4
7738540|NCT00889863|26906410|P2|Part I: Open Label|Death|0
7738541|NCT00889863|26906411|P1|Part I: Open Label|Death|1
7738542|NCT00889720|26906437|P1|Overall Study|Other|4
7738543|NCT00889720|26906437|P1|Overall Study|Withdrawal by Subject|4
7738544|NCT00889707|26906464|P2|Overall Study|Lack of Efficacy|5
7738545|NCT00889707|26906465|P1|Overall Study|Lack of Efficacy|2
7738546|NCT00889707|26906464|P2|Overall Study|Lost to Follow-up|2
7738547|NCT00889707|26906465|P1|Overall Study|Lost to Follow-up|0
7738548|NCT00889707|26906464|P2|Overall Study|Withdrawal by Subject|3
7738549|NCT00889707|26906465|P1|Overall Study|Withdrawal by Subject|4
7738550|NCT00889707|26906464|P2|Overall Study|Adverse Event|0
7738551|NCT00889707|26906465|P1|Overall Study|Adverse Event|1
7738552|NCT00889681|26906473|P1|Overall Study|Insurance disapproval|1
7738553|NCT00889681|26906473|P1|Overall Study|Not meeting qualification Criteria|2
7738554|NCT00889603|26906480|P1|Overall Study|Other|4
7738555|NCT00889603|26906480|P1|Overall Study|No longer willing to participant in stud|4
7738556|NCT00889603|26906480|P1|Overall Study|Lost to Follow-up|19
7738557|NCT00889603|26906480|P1|Overall Study|Death|3
7738558|NCT00889603|26906480|P1|Overall Study|Adverse Event|7
7738559|NCT00889421|26906502|P1|Overall Study|Lack of Efficacy|3
7738560|NCT00889265|26906543|P1|Overall Study|Protocol Violation|1
7738561|NCT00889265|26906543|P1|Overall Study|Lost to Follow-up|5
7738562|NCT00889265|26906543|P1|Overall Study|Adverse Event|1
7738563|NCT00889252|26906550|P2|Overall Study|Protocol Violation|0
7738564|NCT00889252|26906551|P1|Overall Study|Protocol Violation|2
7738565|NCT00889252|26906550|P2|Overall Study|Withdrawal by Subject|0
7738566|NCT00889252|26906551|P1|Overall Study|Withdrawal by Subject|3
7738567|NCT00889252|26906550|P2|Overall Study|Adverse Event|4
7738568|NCT00889252|26906551|P1|Overall Study|Adverse Event|2
7738569|NCT00889005|26906628|P2|Overall Study|Withdrawal by Subject|0
7738570|NCT00889005|26906629|P1|Overall Study|Withdrawal by Subject|4
7738571|NCT00889005|26906628|P2|Overall Study|Lost to Follow-up|2
7738572|NCT00889005|26906629|P1|Overall Study|Lost to Follow-up|4
7738573|NCT00888940|26906643|P2|Overall Study|Randomized Not Treated|13
7738574|NCT00888940|26906644|P1|Overall Study|Randomized Not Treated|11
7738575|NCT00888940|26906643|P2|Overall Study|Lost to Follow-up|5
7738576|NCT00888940|26906644|P1|Overall Study|Lost to Follow-up|5
7738577|NCT00888940|26906643|P2|Overall Study|Adverse Event|3
7738578|NCT00888940|26906644|P1|Overall Study|Adverse Event|12
7738579|NCT00888927|26906656|P4|Overall Study|Withdrawal of consent|1
7738580|NCT00888927|26906657|P3|Overall Study|Withdrawal of consent|0
7738581|NCT00888927|26906658|P2|Overall Study|Withdrawal of consent|0
7738582|NCT00888927|26906659|P1|Overall Study|Withdrawal of consent|0
7738583|NCT00888927|26906656|P4|Overall Study|Adverse Event|1
7738584|NCT00888927|26906657|P3|Overall Study|Adverse Event|0
7738585|NCT00888927|26906658|P2|Overall Study|Adverse Event|0
7738586|NCT00888927|26906659|P1|Overall Study|Adverse Event|0
7738587|NCT00888849|26906675|P2|Overall Study|Lost to Follow-up|2
7738588|NCT00888849|26906676|P1|Overall Study|Lost to Follow-up|1
7738589|NCT00888849|26906675|P2|Overall Study|Death|7
7738590|NCT00888849|26906676|P1|Overall Study|Death|4
7738591|NCT00888654|26906686|P1|Overall Study|Stopped meds due to headaches|1
7738592|NCT00888654|26906686|P1|Overall Study|Change in surg date|1
7738593|NCT00888654|26906686|P1|Overall Study|Inelig. due to contraindication of med|1
7738594|NCT00888654|26906686|P1|Overall Study|Withdrawal by Subject|1
7738595|NCT00888654|26906686|P1|Overall Study|Surgery aborted|2
7738596|NCT00888654|26906686|P1|Overall Study|Not enough oral meds before surgery|3
7738597|NCT00888654|26906686|P1|Overall Study|Problems swallowing oral meds.|1
7738599|NCT00888433|26906728|P2|Overall Study|Missed Visit|1
7738600|NCT00888433|26906729|P1|Overall Study|Missed Visit|2
7738601|NCT00888433|26906728|P2|Overall Study|Withdrawal by Subject|2
7738602|NCT00888433|26906729|P1|Overall Study|Withdrawal by Subject|1
7738603|NCT00888381|26906737|P2|Overall Study|Lost to Follow-up|1
7738604|NCT00888381|26906738|P1|Overall Study|Lost to Follow-up|0
7738605|NCT00888355|26906758|P4|Overall Study|Withdrawal by Subject|3
7738606|NCT00888355|26906759|P3|Overall Study|Withdrawal by Subject|1
7738607|NCT00888355|26906760|P2|Overall Study|Withdrawal by Subject|3
7738608|NCT00888355|26906761|P1|Overall Study|Withdrawal by Subject|0
7738609|NCT00888355|26906758|P4|Overall Study|Protocol Violation|2
7738610|NCT00888355|26906759|P3|Overall Study|Protocol Violation|1
7738611|NCT00888355|26906760|P2|Overall Study|Protocol Violation|2
7738612|NCT00888355|26906761|P1|Overall Study|Protocol Violation|3
7738613|NCT00888355|26906758|P4|Overall Study|Lost to Follow-up|0
7738614|NCT00888355|26906759|P3|Overall Study|Lost to Follow-up|2
7738615|NCT00888355|26906760|P2|Overall Study|Lost to Follow-up|2
7738616|NCT00888355|26906761|P1|Overall Study|Lost to Follow-up|0
7738617|NCT00888355|26906758|P4|Overall Study|Lack of Efficacy|2
7738618|NCT00888355|26906759|P3|Overall Study|Lack of Efficacy|5
7738619|NCT00888355|26906760|P2|Overall Study|Lack of Efficacy|2
7738620|NCT00888355|26906761|P1|Overall Study|Lack of Efficacy|9
7738621|NCT00888355|26906758|P4|Overall Study|Adverse Event|3
7738622|NCT00888355|26906759|P3|Overall Study|Adverse Event|3
7738623|NCT00888355|26906760|P2|Overall Study|Adverse Event|0
7738624|NCT00888355|26906761|P1|Overall Study|Adverse Event|10
7738625|NCT00888329|26906817|P2|Overall Study|Physician Decision|9
7738626|NCT00888329|26906818|P1|Overall Study|Physician Decision|6
7738627|NCT00888238|26906824|P3|Washout Period After Period 2|Adverse Event|1
7738628|NCT00888238|26906825|P2|Washout Period After Period 2|Adverse Event|0
7738629|NCT00888238|26906826|P1|Washout Period After Period 2|Adverse Event|0
7738630|NCT00888173|26906834|P1|Overall Study|Ineligible: required test not done|1
7738631|NCT00888173|26906834|P1|Overall Study|Wrong Primary|1
7738632|NCT00888134|26906842|P1|Follow-up|being followed for long-term survival|1
7738633|NCT00888134|26906842|P1|Treatment With Study Drug|Withdrawal by Subject|1
7738634|NCT00887978|26906852|P2|Overall Study|Lost to Follow-up|1
7738635|NCT00887978|26906853|P1|Overall Study|Lost to Follow-up|0
7738636|NCT00887978|26906852|P2|Overall Study|Withdrawal by Subject|2
7738637|NCT00887978|26906853|P1|Overall Study|Withdrawal by Subject|1
7738638|NCT00887978|26906852|P2|Overall Study|Death|3
7738639|NCT00887978|26906853|P1|Overall Study|Death|2
7738640|NCT00887978|26906852|P2|Overall Study|Clinical Worsening|4
7738641|NCT00887978|26906853|P1|Overall Study|Clinical Worsening|4
7738642|NCT00887978|26906852|P2|Overall Study|Adverse Event|5
7738643|NCT00887978|26906853|P1|Overall Study|Adverse Event|18
7738644|NCT00887926|26906923|P4|Overall Study|Withdrawal by Subject|0
7738645|NCT00887926|26906924|P3|Overall Study|Withdrawal by Subject|0
7738646|NCT00887926|26906925|P2|Overall Study|Withdrawal by Subject|1
7738647|NCT00887926|26906926|P1|Overall Study|Withdrawal by Subject|0
7738648|NCT00887913|26906961|P1|Overall Study|Withdrawal by Subject|6
7738649|NCT00887822|26906969|P2|Overall Study|Randomized but not treated|1
7738650|NCT00887822|26906970|P1|Overall Study|Randomized but not treated|0
7738651|NCT00887822|26906969|P2|Overall Study|Protocol Violation|1
7738652|NCT00887822|26906970|P1|Overall Study|Protocol Violation|0
7738653|NCT00887822|26906969|P2|Overall Study|Death|3
7738654|NCT00887822|26906970|P1|Overall Study|Death|2
7738655|NCT00887822|26906969|P2|Overall Study|Administrative/Other than specified|4
7738656|NCT00887822|26906970|P1|Overall Study|Administrative/Other than specified|5
7738657|NCT00887822|26906969|P2|Overall Study|Refused treatment/Did not cooperate|10
7738658|NCT00887822|26906970|P1|Overall Study|Refused treatment/Did not cooperate|12
7738659|NCT00887822|26906969|P2|Overall Study|Failure to return|11
7738660|NCT00887822|26906970|P1|Overall Study|Failure to return|11
7738661|NCT00887822|26906969|P2|Overall Study|Adverse Event|17
7738662|NCT00887822|26906970|P1|Overall Study|Adverse Event|14
7738663|NCT00887822|26906969|P2|Overall Study|Insufficient therapeutic response|55
7738664|NCT00887822|26906970|P1|Overall Study|Insufficient therapeutic response|53
7738665|NCT00887809|26907002|P2|Overall Study|Death|0
7738666|NCT00887809|26907003|P1|Overall Study|Death|1
7738667|NCT00887809|26907002|P2|Overall Study|Patient Not Treated|0
7738668|NCT00887809|26907003|P1|Overall Study|Patient Not Treated|3
7738669|NCT00887744|26907024|P1|Overall Study|Various reasons|9
7738670|NCT00887744|26907024|P1|Overall Study|Withdrawal by Subject|18
7738671|NCT00887744|26907024|P1|Overall Study|Lost to Follow-up|3
7738672|NCT00887744|26907024|P1|Overall Study|Death|1
7738673|NCT00887744|26907024|P1|Overall Study|Adverse Event|3
7738674|NCT00887679|26907033|P1|Overall Study|Physician Decision|5
7738675|NCT00887679|26907033|P1|Overall Study|Lost to Follow-up|4
7738676|NCT00887679|26907033|P1|Overall Study|Withdrawal by Subject|1
7738677|NCT00887588|26907063|P2|Extension Period|Lost to Follow-up|0
7738678|NCT00887588|26907064|P1|Extension Period|Lost to Follow-up|1
7738679|NCT00887588|26907063|P2|Extension Period|Protocol deviation|0
7738680|NCT00887588|26907064|P1|Extension Period|Protocol deviation|1
7738681|NCT00887588|26907063|P2|Extension Period|Death|1
7738682|NCT00887588|26907064|P1|Extension Period|Death|0
7738683|NCT00887588|26907063|P2|Extension Period|Adverse Event|4
7738684|NCT00887588|26907064|P1|Extension Period|Adverse Event|4
7738685|NCT00887588|26907063|P2|Core Period|Adverse Event|11
7738686|NCT00887588|26907064|P1|Core Period|Adverse Event|9
7738687|NCT00887588|26907063|P2|Core Period|Withdrawal by Subject|8
7738688|NCT00887588|26907064|P1|Core Period|Withdrawal by Subject|6
7738689|NCT00887588|26907063|P2|Core Period|Lost to Follow-up|1
7738690|NCT00887588|26907064|P1|Core Period|Lost to Follow-up|3
7738691|NCT00887588|26907063|P2|Core Period|Death|1
7738692|NCT00887588|26907064|P1|Core Period|Death|1
7738693|NCT00887549|26907145|P1|Maintenance Therapy|Death due to adverse event|1
7738694|NCT00887549|26907145|P1|Maintenance Therapy|Progressive Disease|25
7738695|NCT00887549|26907145|P1|Maintenance Therapy|Physician Decision|1
7738696|NCT00887549|26907145|P1|Maintenance Therapy|Adverse Event|16
7738697|NCT00887549|26907145|P1|Induction Therapy|Death due to Study Drug Toxicity|1
7738698|NCT00887549|26907145|P1|Induction Therapy|Death due to Study Disease|4
7738699|NCT00887549|26907145|P1|Induction Therapy|Progressive Disease|13
7738700|NCT00887549|26907145|P1|Induction Therapy|Physician Decision|1
7738701|NCT00887549|26907145|P1|Induction Therapy|Adverse Event|8
7738702|NCT00887484|26907163|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
7738703|NCT00887484|26907163|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
7738704|NCT00887484|26907163|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
7738717|NCT00887354|26907264|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
7738718|NCT00887354|26907265|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
7738719|NCT00887354|26907264|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
7738720|NCT00887354|26907265|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
7738721|NCT00887354|26907264|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
7738722|NCT00887354|26907265|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
7738723|NCT00887354|26907264|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
7738724|NCT00887354|26907265|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
7738725|NCT00887354|26907264|P2|Open Label Phase (Week 26 to Week 78)|Death|2
7738726|NCT00887354|26907265|P1|Open Label Phase (Week 26 to Week 78)|Death|0
7738727|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
7738728|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
7738729|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
7738730|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
7738731|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
7738732|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
7738733|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
7738734|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
7738735|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
7738736|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
7738737|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
7738738|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
7738739|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
7738740|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
7738741|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
7738742|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
7738743|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
7738744|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
7738745|NCT00887354|26907264|P2|Treatment Phase (Week 0 to Week 26)|Death|1
7738746|NCT00887354|26907265|P1|Treatment Phase (Week 0 to Week 26)|Death|0
7738747|NCT00887341|26907285|P2|Overall Study|Lost to Follow-up|1
7738748|NCT00887341|26907286|P1|Overall Study|Lost to Follow-up|0
7738749|NCT00887341|26907285|P2|Overall Study|Adverse Event|1
7738750|NCT00887341|26907286|P1|Overall Study|Adverse Event|0
7738751|NCT00887341|26907285|P2|Overall Study|Withdrawal by Subject|1
7738752|NCT00887341|26907286|P1|Overall Study|Withdrawal by Subject|1
7738753|NCT00887341|26907285|P2|Overall Study|Refused treatment|0
7738754|NCT00887341|26907286|P1|Overall Study|Refused treatment|1
7738755|NCT00887315|26907322|P2|Overall Study|Study termination|4
7738756|NCT00887315|26907323|P1|Overall Study|Study termination|7
7738757|NCT00887289|26907331|P1|Overall Study|Other|20
7738758|NCT00887289|26907331|P1|Overall Study|Lost to Follow-up|8
7738759|NCT00887289|26907331|P1|Overall Study|Withdrawal by Subject|26
7738760|NCT00887289|26907331|P1|Overall Study|Adverse Event|27
7738761|NCT00887289|26907331|P1|Overall Study|Lack of Efficacy|14
7738762|NCT00887250|26907343|P3|Overall Study|Patient uncooperative|1
7738763|NCT00887250|26907344|P2|Overall Study|Patient uncooperative|0
7738764|NCT00887250|26907345|P1|Overall Study|Patient uncooperative|0
7738765|NCT00887250|26907343|P3|Overall Study|Withdrawal by Subject|2
7738766|NCT00887250|26907344|P2|Overall Study|Withdrawal by Subject|1
7738767|NCT00887250|26907345|P1|Overall Study|Withdrawal by Subject|2
7738768|NCT00887250|26907343|P3|Overall Study|Protocol Violation|1
7738769|NCT00887250|26907344|P2|Overall Study|Protocol Violation|2
7738770|NCT00887250|26907345|P1|Overall Study|Protocol Violation|2
7738771|NCT00887250|26907343|P3|Overall Study|Lost to Follow-up|1
7738772|NCT00887250|26907344|P2|Overall Study|Lost to Follow-up|3
7738773|NCT00887250|26907345|P1|Overall Study|Lost to Follow-up|2
7738774|NCT00887250|26907343|P3|Overall Study|Lack of Efficacy|1
7738775|NCT00887250|26907344|P2|Overall Study|Lack of Efficacy|6
7738776|NCT00887250|26907345|P1|Overall Study|Lack of Efficacy|9
7738777|NCT00887250|26907343|P3|Overall Study|Adverse Event|7
7738778|NCT00887250|26907344|P2|Overall Study|Adverse Event|0
7738779|NCT00887250|26907345|P1|Overall Study|Adverse Event|3
7738780|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
7738781|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
7738782|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
7738783|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
7738784|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
7738785|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
7738786|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Other|12
7738787|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Other|11
7738788|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Other|0
7738789|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
7738790|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
7738791|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
7738792|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
7738793|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
7738794|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
7738795|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
7738796|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
7738797|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
7738798|NCT00887224|26907368|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
7738799|NCT00887224|26907369|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
7738800|NCT00887224|26907370|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
7738801|NCT00887224|26907368|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
7738802|NCT00887224|26907369|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
7738803|NCT00887224|26907370|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
7738804|NCT00887224|26907368|P3|Double-blind (DB) Phase|Protocol Violation|5
7738805|NCT00887224|26907369|P2|Double-blind (DB) Phase|Protocol Violation|8
7738806|NCT00887224|26907370|P1|Double-blind (DB) Phase|Protocol Violation|0
7738807|NCT00887224|26907368|P3|Double-blind (DB) Phase|Other|0
7738808|NCT00887224|26907369|P2|Double-blind (DB) Phase|Other|2
7738809|NCT00887224|26907370|P1|Double-blind (DB) Phase|Other|0
7738810|NCT00887224|26907368|P3|Double-blind (DB) Phase|Lost to Follow-up|8
7738811|NCT00887224|26907369|P2|Double-blind (DB) Phase|Lost to Follow-up|8
7738812|NCT00887224|26907370|P1|Double-blind (DB) Phase|Lost to Follow-up|0
7738813|NCT00887224|26907368|P3|Double-blind (DB) Phase|Lack of Efficacy|33
7738814|NCT00887224|26907369|P2|Double-blind (DB) Phase|Lack of Efficacy|67
7738815|NCT00887224|26907370|P1|Double-blind (DB) Phase|Lack of Efficacy|0
7738816|NCT00887224|26907368|P3|Double-blind (DB) Phase|Failed to return|2
7738817|NCT00887224|26907369|P2|Double-blind (DB) Phase|Failed to return|2
7738818|NCT00887224|26907370|P1|Double-blind (DB) Phase|Failed to return|0
7738819|NCT00887224|26907368|P3|Double-blind (DB) Phase|Adverse Event|2
7738820|NCT00887224|26907369|P2|Double-blind (DB) Phase|Adverse Event|7
7738821|NCT00887224|26907370|P1|Double-blind (DB) Phase|Adverse Event|0
7738822|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
7738823|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
7738824|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
7738825|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
7738826|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
7738827|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
7738828|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Other|0
7738829|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Other|0
7738830|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Other|30
7738831|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
7738832|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
7738833|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
7738834|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
7738835|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
7738836|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
7738837|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Failed to return|0
7738838|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Failed to return|0
7738839|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Failed to return|17
7738840|NCT00887224|26907368|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
7738841|NCT00887224|26907369|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
7738842|NCT00887224|26907370|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
7738843|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
7738844|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
7738845|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
7738846|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
7738847|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
7738848|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
7738849|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Other|0
7738850|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Other|0
7738851|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Other|1
7738852|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
7738853|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
7738854|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
7738855|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
7738856|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
7738857|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
7738858|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Failed to return|0
7738859|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Failed to return|0
7738860|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Failed to return|3
7738861|NCT00887224|26907368|P3|Open-label Stability (OLS) Phase|Adverse Event|0
7738862|NCT00887224|26907369|P2|Open-label Stability (OLS) Phase|Adverse Event|0
7738863|NCT00887224|26907370|P1|Open-label Stability (OLS) Phase|Adverse Event|22
7738864|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
7738865|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
7738866|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
7738867|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Protocol Violation|0
7738868|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Protocol Violation|0
7738869|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Protocol Violation|12
7738870|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Other|0
7738871|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Other|0
7738872|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Other|1
7738873|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
7738874|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
7738875|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
7738876|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
7738877|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
7738878|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
7738879|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Failed to return|0
7738880|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Failed to return|0
7738881|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Failed to return|6
7738882|NCT00887224|26907368|P3|Open-label Response (OLR) Phase|Adverse Event|0
7738883|NCT00887224|26907369|P2|Open-label Response (OLR) Phase|Adverse Event|0
7738884|NCT00887224|26907370|P1|Open-label Response (OLR) Phase|Adverse Event|46
7738885|NCT00887198|26907397|P3|Cross Over (Placebo to AA)|Other|19
7738886|NCT00887198|26907398|P2|Cross Over (Placebo to AA)|Other|0
7738887|NCT00887198|26907399|P1|Cross Over (Placebo to AA)|Other|0
7738888|NCT00887198|26907397|P3|Cross Over (Placebo to AA)|Progressive disease|20
7738889|NCT00887198|26907398|P2|Cross Over (Placebo to AA)|Progressive disease|0
7738890|NCT00887198|26907399|P1|Cross Over (Placebo to AA)|Progressive disease|0
7738891|NCT00887198|26907397|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
7738892|NCT00887198|26907398|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
7738893|NCT00887198|26907399|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
7738894|NCT00887198|26907397|P3|Cross Over (Placebo to AA)|Adverse Event|9
7738895|NCT00887198|26907398|P2|Cross Over (Placebo to AA)|Adverse Event|0
7738896|NCT00887198|26907399|P1|Cross Over (Placebo to AA)|Adverse Event|0
7738897|NCT00887198|26907397|P3|Cross Over (Placebo to AA)|Ongoing|35
7738898|NCT00887198|26907398|P2|Cross Over (Placebo to AA)|Ongoing|0
7738899|NCT00887198|26907399|P1|Cross Over (Placebo to AA)|Ongoing|0
7738900|NCT00887198|26907397|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
7738901|NCT00887198|26907398|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
7738902|NCT00887198|26907399|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
7738903|NCT00887198|26907397|P3|Randomized Period|Randomized, Not treated|0
7738904|NCT00887198|26907398|P2|Randomized Period|Randomized, Not treated|2
7738905|NCT00887198|26907399|P1|Randomized Period|Randomized, Not treated|4
7738906|NCT00887198|26907397|P3|Randomized Period|Other|0
7738907|NCT00887198|26907398|P2|Randomized Period|Other|30
7738908|NCT00887198|26907399|P1|Randomized Period|Other|42
7738909|NCT00887198|26907397|P3|Randomized Period|Progressive disease|0
7738910|NCT00887198|26907398|P2|Randomized Period|Progressive disease|370
7738911|NCT00887198|26907399|P1|Randomized Period|Progressive disease|366
7738912|NCT00887198|26907397|P3|Randomized Period|Withdrawal by Subject|0
7738913|NCT00887198|26907398|P2|Randomized Period|Withdrawal by Subject|56
7738914|NCT00887198|26907399|P1|Randomized Period|Withdrawal by Subject|41
7738915|NCT00887198|26907397|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
7738916|NCT00887198|26907398|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
7738917|NCT00887198|26907399|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
7738918|NCT00887198|26907397|P3|Randomized Period|Lost to Follow-up|0
7738919|NCT00887198|26907398|P2|Randomized Period|Lost to Follow-up|0
7738920|NCT00887198|26907399|P1|Randomized Period|Lost to Follow-up|1
7738921|NCT00887198|26907397|P3|Randomized Period|Adverse Event|0
7738922|NCT00887198|26907398|P2|Randomized Period|Adverse Event|33
7738923|NCT00887198|26907399|P1|Randomized Period|Adverse Event|50
7738924|NCT00887198|26907397|P3|Randomized Period|Ongoing|0
7738925|NCT00887198|26907398|P2|Randomized Period|Ongoing|0
7738926|NCT00887198|26907399|P1|Randomized Period|Ongoing|42
7738927|NCT00887159|26907430|P3|Overall Study|Never started assigned therapy|4
7738928|NCT00887159|26907431|P2|Overall Study|Never started assigned therapy|3
7738929|NCT00887159|26907432|P1|Overall Study|Never started assigned therapy|3
7738930|NCT00887159|26907430|P3|Overall Study|Ineligible|0
7738931|NCT00887159|26907431|P2|Overall Study|Ineligible|1
7738932|NCT00887159|26907432|P1|Overall Study|Ineligible|5
7738933|NCT00887159|26907430|P3|Overall Study|Received more tx instead of observation|0
7738934|NCT00887159|26907431|P2|Overall Study|Received more tx instead of observation|0
7738935|NCT00887159|26907432|P1|Overall Study|Received more tx instead of observation|1
7738936|NCT00887159|26907430|P3|Overall Study|Pt had PD but was SD when re-measured|0
7738937|NCT00887159|26907431|P2|Overall Study|Pt had PD but was SD when re-measured|1
7738938|NCT00887159|26907432|P1|Overall Study|Pt had PD but was SD when re-measured|0
7738939|NCT00887159|26907430|P3|Overall Study|Treatment delayed|0
7738940|NCT00887159|26907431|P2|Overall Study|Treatment delayed|1
7738941|NCT00887159|26907432|P1|Overall Study|Treatment delayed|1
7738942|NCT00887159|26907430|P3|Overall Study|Sympomatic deterioration|0
7738943|NCT00887159|26907431|P2|Overall Study|Sympomatic deterioration|0
7738944|NCT00887159|26907432|P1|Overall Study|Sympomatic deterioration|1
7738945|NCT00887159|26907430|P3|Overall Study|Physician Decision|0
7738946|NCT00887159|26907431|P2|Overall Study|Physician Decision|1
7738947|NCT00887159|26907432|P1|Overall Study|Physician Decision|1
7738948|NCT00887159|26907430|P3|Overall Study|Alternative therapy|0
7738949|NCT00887159|26907431|P2|Overall Study|Alternative therapy|0
7738950|NCT00887159|26907432|P1|Overall Study|Alternative therapy|2
7738951|NCT00887159|26907430|P3|Overall Study|Withdrawal by Subject|2
7738952|NCT00887159|26907431|P2|Overall Study|Withdrawal by Subject|4
7738953|NCT00887159|26907432|P1|Overall Study|Withdrawal by Subject|4
7738954|NCT00887159|26907430|P3|Overall Study|Death|0
7738955|NCT00887159|26907431|P2|Overall Study|Death|2
7738956|NCT00887159|26907432|P1|Overall Study|Death|2
7738957|NCT00887159|26907430|P3|Overall Study|Adverse Event|17
7738958|NCT00887159|26907431|P2|Overall Study|Adverse Event|4
7738959|NCT00887159|26907432|P1|Overall Study|Adverse Event|3
7738960|NCT00887159|26907430|P3|Overall Study|Disease progression|33
7738961|NCT00887159|26907431|P2|Overall Study|Disease progression|39
7738962|NCT00887159|26907432|P1|Overall Study|Disease progression|6
7738963|NCT00887068|26907450|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
7738964|NCT00887068|26907451|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
7738965|NCT00887068|26907450|P2|Overall Study|Withdrawal by Subject|0
7738966|NCT00887068|26907451|P1|Overall Study|Withdrawal by Subject|2
7738967|NCT00886938|26907459|P1|Overall Study|Withdrawal by Subject|1
7738968|NCT00886938|26907459|P1|Overall Study|Adverse Event|1
7738969|NCT00886834|26907472|P2|Overall Study|Protocol Violation|3
7738970|NCT00886834|26907473|P1|Overall Study|Protocol Violation|0
7738971|NCT00886821|26907495|P14|Stage 2|Lost to Follow-up|1
7738972|NCT00886821|26907496|P13|Stage 2|Lost to Follow-up|2
7738973|NCT00886821|26907497|P12|Stage 2|Lost to Follow-up|0
7738974|NCT00886821|26907498|P11|Stage 2|Lost to Follow-up|0
7738975|NCT00886821|26907499|P10|Stage 2|Lost to Follow-up|0
7738976|NCT00886821|26907500|P9|Stage 2|Lost to Follow-up|0
7738977|NCT00886821|26907501|P8|Stage 2|Lost to Follow-up|0
7738978|NCT00886821|26907502|P7|Stage 2|Lost to Follow-up|0
7738979|NCT00886821|26907503|P6|Stage 2|Lost to Follow-up|0
7738980|NCT00886821|26907504|P5|Stage 2|Lost to Follow-up|0
7738981|NCT00886821|26907505|P4|Stage 2|Lost to Follow-up|0
7738982|NCT00886821|26907506|P3|Stage 2|Lost to Follow-up|0
7738983|NCT00886821|26907507|P2|Stage 2|Lost to Follow-up|0
7738984|NCT00886821|26907508|P1|Stage 2|Lost to Follow-up|0
7738985|NCT00886821|26907495|P14|Stage 2|Adverse Event|0
7738986|NCT00886821|26907496|P13|Stage 2|Adverse Event|3
7738987|NCT00886821|26907497|P12|Stage 2|Adverse Event|1
7738988|NCT00886821|26907498|P11|Stage 2|Adverse Event|0
7738989|NCT00886821|26907499|P10|Stage 2|Adverse Event|0
7738990|NCT00886821|26907500|P9|Stage 2|Adverse Event|0
7738991|NCT00886821|26907501|P8|Stage 2|Adverse Event|0
7738992|NCT00886821|26907502|P7|Stage 2|Adverse Event|0
7738993|NCT00886821|26907503|P6|Stage 2|Adverse Event|0
7738994|NCT00886821|26907504|P5|Stage 2|Adverse Event|0
7738995|NCT00886821|26907505|P4|Stage 2|Adverse Event|0
7738996|NCT00886821|26907506|P3|Stage 2|Adverse Event|0
7738997|NCT00886821|26907507|P2|Stage 2|Adverse Event|0
7738998|NCT00886821|26907508|P1|Stage 2|Adverse Event|0
7738999|NCT00886795|26907733|P1|Overall Study|Lack of Efficacy|1
7739000|NCT00886769|26907740|P2|Overall Study|Unsatisfactory therapeutic effect|37
7739001|NCT00886769|26907741|P1|Overall Study|Unsatisfactory therapeutic effect|6
7739002|NCT00886743|26907765|P1|Overall Study|Other|1
7739003|NCT00886743|26907765|P1|Overall Study|Adverse Event|3
7739004|NCT00886639|26907803|P1|Overall Study|non-compliance|2
7739005|NCT00886639|26907803|P1|Overall Study|acute exacerbation|14
7739006|NCT00886613|26907817|P3|Overall Study|Subject withdrew consent (Part A)|2
7739007|NCT00886613|26907818|P2|Overall Study|Subject withdrew consent (Part A)|0
7739008|NCT00886613|26907819|P1|Overall Study|Subject withdrew consent (Part A)|0
7739009|NCT00886613|26907817|P3|Overall Study|Lost to follow-up (Part B)|1
7739010|NCT00886613|26907818|P2|Overall Study|Lost to follow-up (Part B)|0
7739011|NCT00886613|26907819|P1|Overall Study|Lost to follow-up (Part B)|1
7739012|NCT00886613|26907817|P3|Overall Study|Protocol deviation (Part B)|0
7739013|NCT00886613|26907818|P2|Overall Study|Protocol deviation (Part B)|0
7739014|NCT00886613|26907819|P1|Overall Study|Protocol deviation (Part B)|1
7739015|NCT00886600|26907841|P4|Combination Therapy Period|Protocol Violation|0
7739016|NCT00886600|26907842|P3|Combination Therapy Period|Protocol Violation|1
7739017|NCT00886600|26907843|P2|Combination Therapy Period|Protocol Violation|0
7739018|NCT00886600|26907844|P1|Combination Therapy Period|Protocol Violation|0
7739019|NCT00886600|26907841|P4|Combination Therapy Period|Adverse Event|0
7739020|NCT00886600|26907842|P3|Combination Therapy Period|Adverse Event|1
7739021|NCT00886600|26907843|P2|Combination Therapy Period|Adverse Event|0
7739022|NCT00886600|26907844|P1|Combination Therapy Period|Adverse Event|0
7739023|NCT00886600|26907841|P4|Double-blind Monotherapy|Withdrawal by Subject|0
7739024|NCT00886600|26907842|P3|Double-blind Monotherapy|Withdrawal by Subject|0
7739025|NCT00886600|26907843|P2|Double-blind Monotherapy|Withdrawal by Subject|0
7739026|NCT00886600|26907844|P1|Double-blind Monotherapy|Withdrawal by Subject|1
7739027|NCT00886600|26907841|P4|Double-blind Monotherapy|Protocol Violation|1
7739028|NCT00886600|26907842|P3|Double-blind Monotherapy|Protocol Violation|0
7739029|NCT00886600|26907843|P2|Double-blind Monotherapy|Protocol Violation|0
7739030|NCT00886600|26907844|P1|Double-blind Monotherapy|Protocol Violation|0
7739031|NCT00886600|26907841|P4|Double-blind Monotherapy|Adverse Event|1
7739032|NCT00886600|26907842|P3|Double-blind Monotherapy|Adverse Event|1
7739033|NCT00886600|26907843|P2|Double-blind Monotherapy|Adverse Event|1
7739034|NCT00886600|26907844|P1|Double-blind Monotherapy|Adverse Event|1
7739035|NCT00886587|26907868|P2|Overall Study|Withdrawal by Subject|1
7739036|NCT00886587|26907869|P1|Overall Study|Withdrawal by Subject|0
7739037|NCT00886587|26907868|P2|Overall Study|Protocol Violation|0
7739038|NCT00886587|26907869|P1|Overall Study|Protocol Violation|2
7739039|NCT00886587|26907868|P2|Overall Study|Adverse Event|1
7739040|NCT00886587|26907869|P1|Overall Study|Adverse Event|2
7739041|NCT00886483|26907883|P2|Overall Study|Distance to center, poor grades|0
7739042|NCT00886483|26907884|P1|Overall Study|Distance to center, poor grades|1
7739043|NCT00886483|26907883|P2|Overall Study|Pursue medications|2
7739044|NCT00886483|26907884|P1|Overall Study|Pursue medications|1
7739045|NCT00886483|26907883|P2|Overall Study|Lost to Follow-up|1
7739046|NCT00886483|26907884|P1|Overall Study|Lost to Follow-up|0
7739047|NCT00886379|26907905|P5|Overall Study|Final blood draw not obtained|2
7739048|NCT00886379|26907906|P4|Overall Study|Final blood draw not obtained|2
7739049|NCT00886379|26907907|P3|Overall Study|Final blood draw not obtained|4
7739050|NCT00886379|26907908|P2|Overall Study|Final blood draw not obtained|3
7739051|NCT00886379|26907909|P1|Overall Study|Final blood draw not obtained|3
7739052|NCT00886379|26907905|P5|Overall Study|Transferred Schools|1
7739053|NCT00886379|26907906|P4|Overall Study|Transferred Schools|1
7739054|NCT00886379|26907907|P3|Overall Study|Transferred Schools|2
7739055|NCT00886379|26907908|P2|Overall Study|Transferred Schools|0
7739056|NCT00886379|26907909|P1|Overall Study|Transferred Schools|0
7739057|NCT00886340|26907923|P2|Overall Study|Withdrawal by Subject|7
7739058|NCT00886340|26907924|P1|Overall Study|Withdrawal by Subject|0
7739059|NCT00886288|26907932|P2|Overall Study|Lost to Follow-up|0
7739060|NCT00886288|26907933|P1|Overall Study|Lost to Follow-up|86
7739061|NCT00886288|26907932|P2|Overall Study|no respect of the 12 weeks period|227
7739062|NCT00886288|26907933|P1|Overall Study|no respect of the 12 weeks period|657
7739063|NCT00886119|26907989|P2|Period 1|Did not meet inclusion criteria|0
7739064|NCT00886119|26907990|P1|Period 1|Did not meet inclusion criteria|1
7739065|NCT00886015|26907998|P2|Overall Study|Death|2
7739066|NCT00886015|26907999|P1|Overall Study|Death|0
7739067|NCT00885846|26908018|P3|Overall Study|Withdrawal by Subject|2
7739068|NCT00885846|26908019|P2|Overall Study|Withdrawal by Subject|5
7739069|NCT00885846|26908020|P1|Overall Study|Withdrawal by Subject|2
7739070|NCT00885755|26908035|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
7739071|NCT00885755|26908036|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
7739072|NCT00885755|26908037|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
7739073|NCT00885755|26908035|P3|Part I: Trastuzumab+Taxane|Death|1
7739074|NCT00885755|26908036|P2|Part I: Trastuzumab+Taxane|Death|0
7739075|NCT00885755|26908037|P1|Part I: Trastuzumab+Taxane|Death|0
7739076|NCT00885755|26908035|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
7739077|NCT00885755|26908036|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
7739078|NCT00885755|26908037|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
7739079|NCT00885755|26908035|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
7739080|NCT00885755|26908036|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
7739081|NCT00885755|26908037|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
7739082|NCT00885755|26908035|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
7739083|NCT00885755|26908036|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
7739084|NCT00885755|26908037|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
7739085|NCT00885703|26908080|P7|Overall Study|Ineligible (no CM)|1
7739086|NCT00885703|26908081|P6|Overall Study|Ineligible (no CM)|3
7739087|NCT00885703|26908082|P5|Overall Study|Ineligible (no CM)|2
7739088|NCT00885703|26908083|P4|Overall Study|Ineligible (no CM)|1
7739089|NCT00885703|26908084|P3|Overall Study|Ineligible (no CM)|2
7739090|NCT00885703|26908085|P2|Overall Study|Ineligible (no CM)|3
7739091|NCT00885703|26908086|P1|Overall Study|Ineligible (no CM)|1
7739092|NCT00885703|26908080|P7|Overall Study|Withdrawal by Subject|1
7739093|NCT00885703|26908081|P6|Overall Study|Withdrawal by Subject|1
7739094|NCT00885703|26908082|P5|Overall Study|Withdrawal by Subject|3
7739095|NCT00885703|26908083|P4|Overall Study|Withdrawal by Subject|1
7739096|NCT00885703|26908084|P3|Overall Study|Withdrawal by Subject|0
7739097|NCT00885703|26908085|P2|Overall Study|Withdrawal by Subject|0
7739098|NCT00885703|26908086|P1|Overall Study|Withdrawal by Subject|0
7739099|NCT00885703|26908080|P7|Overall Study|Lost to Follow-up|0
7739100|NCT00885703|26908081|P6|Overall Study|Lost to Follow-up|1
7739101|NCT00885703|26908082|P5|Overall Study|Lost to Follow-up|0
7739102|NCT00885703|26908083|P4|Overall Study|Lost to Follow-up|0
7739103|NCT00885703|26908084|P3|Overall Study|Lost to Follow-up|1
7739104|NCT00885703|26908085|P2|Overall Study|Lost to Follow-up|0
7739105|NCT00885703|26908086|P1|Overall Study|Lost to Follow-up|0
7739106|NCT00885703|26908080|P7|Overall Study|Death|4
7739107|NCT00885703|26908081|P6|Overall Study|Death|8
7739108|NCT00885703|26908082|P5|Overall Study|Death|7
7739109|NCT00885703|26908083|P4|Overall Study|Death|7
7739110|NCT00885703|26908084|P3|Overall Study|Death|8
7739111|NCT00885703|26908085|P2|Overall Study|Death|7
7739112|NCT00885703|26908086|P1|Overall Study|Death|9
7739113|NCT00885677|26908144|P2|Overall Study|Inclusion/exclusion not met|27
7739114|NCT00885677|26908145|P1|Overall Study|Inclusion/exclusion not met|25
7739115|NCT00885677|26908144|P2|Overall Study|Heart transplantation|0
7739116|NCT00885677|26908145|P1|Overall Study|Heart transplantation|1
7739117|NCT00885677|26908144|P2|Overall Study|device/lead revision or replacement|6
7739118|NCT00885677|26908145|P1|Overall Study|device/lead revision or replacement|7
7739119|NCT00885677|26908144|P2|Overall Study|premature study closure|44
7739120|NCT00885677|26908145|P1|Overall Study|premature study closure|41
7739121|NCT00885677|26908144|P2|Overall Study|Protocol Violation|54
7739122|NCT00885677|26908145|P1|Overall Study|Protocol Violation|54
7739123|NCT00885677|26908144|P2|Overall Study|Lost to Follow-up|13
7739124|NCT00885677|26908145|P1|Overall Study|Lost to Follow-up|15
7739125|NCT00885677|26908144|P2|Overall Study|Death|34
7739126|NCT00885677|26908145|P1|Overall Study|Death|40
7739127|NCT00885534|26908161|P1|Overall Study|Patient deemed ineligible|1
7739128|NCT00885482|26908165|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
7739129|NCT00885482|26908165|P1|Overall Study|Death|1
7739130|NCT00885482|26908165|P1|Overall Study|Lack of Efficacy|1
7739131|NCT00885482|26908165|P1|Overall Study|Pregnancy|1
7739132|NCT00885378|26908171|P2|Overall Study|Protocol Violation|0
7739133|NCT00885378|26908172|P1|Overall Study|Protocol Violation|2
7739134|NCT00885378|26908171|P2|Overall Study|Poor/Noncompliance|2
7739135|NCT00885378|26908172|P1|Overall Study|Poor/Noncompliance|2
7739136|NCT00885378|26908171|P2|Overall Study|Lost to Follow-up|2
7739137|NCT00885378|26908172|P1|Overall Study|Lost to Follow-up|1
7739138|NCT00885378|26908171|P2|Overall Study|Withdrawal by Subject|2
7739139|NCT00885378|26908172|P1|Overall Study|Withdrawal by Subject|1
7739140|NCT00885378|26908171|P2|Overall Study|Lack of Efficacy|2
7739141|NCT00885378|26908172|P1|Overall Study|Lack of Efficacy|2
7739142|NCT00885365|26908202|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
7739143|NCT00885365|26908203|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
7739144|NCT00885365|26908202|P2|4 Weeks ON Treatment|Protocol Violation|2
7739145|NCT00885365|26908203|P1|4 Weeks ON Treatment|Protocol Violation|1
7739146|NCT00885365|26908202|P2|4 Weeks ON Treatment|Adverse Event|4
7739147|NCT00885365|26908203|P1|4 Weeks ON Treatment|Adverse Event|2
7739148|NCT00885352|26908239|P2|Overall Study|Lab abnormalities|1
7739149|NCT00885352|26908240|P1|Overall Study|Lab abnormalities|1
7739150|NCT00885352|26908239|P2|Overall Study|Excluded medication|2
7739151|NCT00885352|26908240|P1|Overall Study|Excluded medication|2
7739152|NCT00885352|26908239|P2|Overall Study|Contradiction to study medication|2
7739153|NCT00885352|26908240|P1|Overall Study|Contradiction to study medication|0
7739154|NCT00885352|26908239|P2|Overall Study|Withdrawal by Subject|5
7739155|NCT00885352|26908240|P1|Overall Study|Withdrawal by Subject|1
7739156|NCT00885352|26908239|P2|Overall Study|Protocol Violation|2
7739157|NCT00885352|26908240|P1|Overall Study|Protocol Violation|0
7739158|NCT00885352|26908239|P2|Overall Study|Physician Decision|3
7739159|NCT00885352|26908240|P1|Overall Study|Physician Decision|0
7739160|NCT00885352|26908239|P2|Overall Study|Lost to Follow-up|2
7739161|NCT00885352|26908240|P1|Overall Study|Lost to Follow-up|2
7739162|NCT00885352|26908239|P2|Overall Study|Adverse Event|3
7739163|NCT00885352|26908240|P1|Overall Study|Adverse Event|2
7739164|NCT00885170|26908252|P2|Overall Study|Withdrawal by Subject|13
7739165|NCT00885170|26908253|P1|Overall Study|Withdrawal by Subject|13
7739166|NCT00885170|26908252|P2|Overall Study|Protocol Violation|1
7739167|NCT00885170|26908253|P1|Overall Study|Protocol Violation|3
7739168|NCT00885170|26908252|P2|Overall Study|Physician Decision|1
7739169|NCT00885170|26908253|P1|Overall Study|Physician Decision|2
7739170|NCT00885170|26908252|P2|Overall Study|Lost to Follow-up|1
7739171|NCT00885170|26908253|P1|Overall Study|Lost to Follow-up|2
7739172|NCT00885170|26908252|P2|Overall Study|Excessive bone loss|3
7739173|NCT00885170|26908253|P1|Overall Study|Excessive bone loss|6
7739174|NCT00885170|26908252|P2|Overall Study|Adverse Event|4
7739175|NCT00885170|26908253|P1|Overall Study|Adverse Event|12
7739176|NCT00885118|26908312|P5|Overall Study|Other reason not defined above|0
7739177|NCT00885118|26908313|P4|Overall Study|Other reason not defined above|0
7739178|NCT00885118|26908314|P3|Overall Study|Other reason not defined above|1
7739179|NCT00885118|26908315|P2|Overall Study|Other reason not defined above|0
7739180|NCT00885118|26908316|P1|Overall Study|Other reason not defined above|0
7739181|NCT00885118|26908312|P5|Overall Study|Withdrawal by Subject|1
7739182|NCT00885118|26908313|P4|Overall Study|Withdrawal by Subject|0
7739183|NCT00885118|26908314|P3|Overall Study|Withdrawal by Subject|0
7739184|NCT00885118|26908315|P2|Overall Study|Withdrawal by Subject|0
7739185|NCT00885118|26908316|P1|Overall Study|Withdrawal by Subject|0
7739186|NCT00885118|26908312|P5|Overall Study|Adverse Event|0
7739187|NCT00885118|26908313|P4|Overall Study|Adverse Event|0
7739188|NCT00885118|26908314|P3|Overall Study|Adverse Event|0
7739189|NCT00885118|26908315|P2|Overall Study|Adverse Event|0
7739190|NCT00885118|26908316|P1|Overall Study|Adverse Event|1
7739191|NCT00885105|26908455|P2|Overall Study|Protocol Violation|2
7739192|NCT00885105|26908456|P1|Overall Study|Protocol Violation|0
7739193|NCT00885105|26908455|P2|Overall Study|Adverse Event|0
7739194|NCT00885105|26908456|P1|Overall Study|Adverse Event|1
7739195|NCT00885105|26908455|P2|Overall Study|Withdrawal by Subject|8
7739196|NCT00885105|26908456|P1|Overall Study|Withdrawal by Subject|0
7739197|NCT00884949|26908496|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
7739198|NCT00884949|26908496|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
7739199|NCT00884832|26908531|P2|Overall Study|Withdrawal by Subject|1
7739200|NCT00884832|26908532|P1|Overall Study|Withdrawal by Subject|0
7739201|NCT00884793|26908567|P1|Overall Study|Withdrawal by Subject|1
7739202|NCT00884741|26908586|P4|Randomization|Protocol Violation|8
7739203|NCT00884741|26908587|P3|Randomization|Protocol Violation|8
7739204|NCT00884741|26908588|P2|Randomization|Protocol Violation|0
7739205|NCT00884741|26908589|P1|Randomization|Protocol Violation|0
7739206|NCT00884741|26908586|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
7739207|NCT00884741|26908587|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
7739208|NCT00884741|26908588|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
7739209|NCT00884741|26908589|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
7739210|NCT00884741|26908586|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
7739211|NCT00884741|26908587|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
7739212|NCT00884741|26908588|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
7739213|NCT00884741|26908589|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
7739214|NCT00884741|26908586|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
7739215|NCT00884741|26908587|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
7739216|NCT00884741|26908588|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
7739217|NCT00884741|26908589|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
7739218|NCT00884741|26908586|P4|Step 2 Registration: Tissue Analysis|Death|0
7739219|NCT00884741|26908587|P3|Step 2 Registration: Tissue Analysis|Death|0
7739220|NCT00884741|26908588|P2|Step 2 Registration: Tissue Analysis|Death|1
7739221|NCT00884741|26908589|P1|Step 2 Registration: Tissue Analysis|Death|0
7739222|NCT00884741|26908586|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7739223|NCT00884741|26908587|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7739224|NCT00884741|26908588|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
7739225|NCT00884741|26908589|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7739226|NCT00884741|26908586|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
7739227|NCT00884741|26908587|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
7739228|NCT00884741|26908588|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
7739229|NCT00884741|26908589|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
7739230|NCT00884741|26908586|P4|Step 1 Registration: Tissue Screening|Disease progression|0
7739231|NCT00884741|26908587|P3|Step 1 Registration: Tissue Screening|Disease progression|0
7739232|NCT00884741|26908588|P2|Step 1 Registration: Tissue Screening|Disease progression|0
7739233|NCT00884741|26908589|P1|Step 1 Registration: Tissue Screening|Disease progression|12
7739234|NCT00884741|26908586|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7739235|NCT00884741|26908587|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7739236|NCT00884741|26908588|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7739237|NCT00884741|26908589|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
7739238|NCT00884741|26908586|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
7739239|NCT00884741|26908587|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
7739240|NCT00884741|26908588|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
7739241|NCT00884741|26908589|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
7739242|NCT00884741|26908586|P4|Step 1 Registration: Tissue Screening|Death|0
7739243|NCT00884741|26908587|P3|Step 1 Registration: Tissue Screening|Death|0
7739244|NCT00884741|26908588|P2|Step 1 Registration: Tissue Screening|Death|0
7739245|NCT00884741|26908589|P1|Step 1 Registration: Tissue Screening|Death|3
7739246|NCT00884741|26908586|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
7739247|NCT00884741|26908587|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
7739248|NCT00884741|26908588|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
7739249|NCT00884741|26908589|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
7739250|NCT00884650|26908602|P2|Overall Study|Pain Pump Complication|1
7739251|NCT00884650|26908603|P1|Overall Study|Pain Pump Complication|0
7739252|NCT00884650|26908602|P2|Overall Study|Femoral Stress Fracture|0
7739253|NCT00884650|26908603|P1|Overall Study|Femoral Stress Fracture|1
7739254|NCT00884650|26908602|P2|Overall Study|Admitted Post-Op|0
7739255|NCT00884650|26908603|P1|Overall Study|Admitted Post-Op|1
7739256|NCT00884650|26908602|P2|Overall Study|Did not return complete pain diaries|7
7739257|NCT00884650|26908603|P1|Overall Study|Did not return complete pain diaries|7
7739258|NCT00884390|26908651|P2|Overall Study|Other|1
7739259|NCT00884390|26908652|P1|Overall Study|Other|11
7739260|NCT00884390|26908651|P2|Overall Study|Discontinuation of Study by Sponsor|2
7739261|NCT00884390|26908652|P1|Overall Study|Discontinuation of Study by Sponsor|2
7739262|NCT00884390|26908651|P2|Overall Study|Withdrawal by Subject|1
7739263|NCT00884390|26908652|P1|Overall Study|Withdrawal by Subject|4
7739264|NCT00884390|26908651|P2|Overall Study|Protocol Violation|1
7739265|NCT00884390|26908652|P1|Overall Study|Protocol Violation|4
7739266|NCT00884390|26908651|P2|Overall Study|Physician Decision|1
7739267|NCT00884390|26908652|P1|Overall Study|Physician Decision|2
7739268|NCT00884390|26908651|P2|Overall Study|Lost to Follow-up|1
7739269|NCT00884390|26908652|P1|Overall Study|Lost to Follow-up|0
7739270|NCT00884390|26908651|P2|Overall Study|Adverse Event|1
7739271|NCT00884390|26908652|P1|Overall Study|Adverse Event|0
7739272|NCT00884377|26908670|P2|Overall Study|Physician Decision|1
7739273|NCT00884377|26908671|P1|Overall Study|Physician Decision|0
7739274|NCT00884377|26908670|P2|Overall Study|Could not confirm diagnosis|0
7739275|NCT00884377|26908671|P1|Overall Study|Could not confirm diagnosis|1
7739276|NCT00884377|26908670|P2|Overall Study|Withdrawal by Subject|0
7739277|NCT00884377|26908671|P1|Overall Study|Withdrawal by Subject|1
7739278|NCT00884325|26908693|P2|Overall Study|Not provided|0
7739279|NCT00884325|26908694|P1|Overall Study|Not provided|1
7739280|NCT00884325|26908693|P2|Overall Study|Withdrawal by Subject|1
7739281|NCT00884325|26908694|P1|Overall Study|Withdrawal by Subject|1
7739282|NCT00884325|26908693|P2|Overall Study|Lack of Efficacy|1
7739283|NCT00884325|26908694|P1|Overall Study|Lack of Efficacy|0
7739284|NCT00884325|26908693|P2|Overall Study|Lost to Follow-up|2
7739285|NCT00884325|26908694|P1|Overall Study|Lost to Follow-up|1
7739286|NCT00884312|26908704|P2|Overall Study|Did Not Receive Study Drug|1
7739287|NCT00884312|26908705|P1|Overall Study|Did Not Receive Study Drug|0
7739288|NCT00884312|26908704|P2|Overall Study|Other|4
7739289|NCT00884312|26908705|P1|Overall Study|Other|0
7739290|NCT00884312|26908704|P2|Overall Study|Physician Decision|1
7739291|NCT00884312|26908705|P1|Overall Study|Physician Decision|0
7739292|NCT00884312|26908704|P2|Overall Study|Withdrawal by Subject|6
7739293|NCT00884312|26908705|P1|Overall Study|Withdrawal by Subject|0
7739294|NCT00884312|26908704|P2|Overall Study|Fatal Adverse Event|4
7739295|NCT00884312|26908705|P1|Overall Study|Fatal Adverse Event|1
7739296|NCT00884312|26908704|P2|Overall Study|Non-fatal Adverse Event|0
7739297|NCT00884312|26908705|P1|Overall Study|Non-fatal Adverse Event|1
7739298|NCT00884312|26908704|P2|Overall Study|Fatal Progressive Disease|1
7739299|NCT00884312|26908705|P1|Overall Study|Fatal Progressive Disease|0
7739300|NCT00884312|26908704|P2|Overall Study|Non-fatal Progressive Disease|8
7739301|NCT00884312|26908705|P1|Overall Study|Non-fatal Progressive Disease|0
7739302|NCT00884286|26908721|P2|Overall Study|Comprised lung carcinoma|1
7739303|NCT00884286|26908722|P1|Overall Study|Comprised lung carcinoma|0
7739304|NCT00884286|26908721|P2|Overall Study|Not treated|1
7739305|NCT00884286|26908722|P1|Overall Study|Not treated|2
7739306|NCT00884286|26908721|P2|Overall Study|Thrombus in right auricle|0
7739307|NCT00884286|26908722|P1|Overall Study|Thrombus in right auricle|1
7739308|NCT00884286|26908721|P2|Overall Study|Septic shock|0
7739309|NCT00884286|26908722|P1|Overall Study|Septic shock|1
7739310|NCT00884286|26908721|P2|Overall Study|Physician Decision|0
7739311|NCT00884286|26908722|P1|Overall Study|Physician Decision|1
7739312|NCT00884286|26908721|P2|Overall Study|Death|2
7739313|NCT00884286|26908722|P1|Overall Study|Death|2
7739314|NCT00884286|26908721|P2|Overall Study|Toxicity|1
7739315|NCT00884286|26908722|P1|Overall Study|Toxicity|4
7739316|NCT00884286|26908721|P2|Overall Study|Progressive disease|28
7739317|NCT00884286|26908722|P1|Overall Study|Progressive disease|21
7739318|NCT00884273|26908736|P2|Overall Study|Practical reasons|0
7739319|NCT00884273|26908737|P1|Overall Study|Practical reasons|1
7739320|NCT00884273|26908736|P2|Overall Study|Protocol Violation|3
7739321|NCT00884273|26908737|P1|Overall Study|Protocol Violation|1
7739322|NCT00884273|26908736|P2|Overall Study|Adverse Event|2
7739323|NCT00884273|26908737|P1|Overall Study|Adverse Event|0
7739324|NCT00884221|26908763|P2|Overall Study|Cancellation of Cycle and Other Reason|13
7739325|NCT00884221|26908764|P1|Overall Study|Cancellation of Cycle and Other Reason|12
7739326|NCT00884221|26908763|P2|Overall Study|Protocol Violation|13
7739327|NCT00884221|26908764|P1|Overall Study|Protocol Violation|16
7739328|NCT00884221|26908763|P2|Overall Study|Adverse Event|3
7739329|NCT00884221|26908764|P1|Overall Study|Adverse Event|6
7739330|NCT00884221|26908763|P2|Overall Study|Withdrawal by Subject|3
7739331|NCT00884221|26908764|P1|Overall Study|Withdrawal by Subject|0
7739332|NCT00884117|26908800|P1|Overall Study|Other|12
7739333|NCT00884117|26908800|P1|Overall Study|Lost to Follow-up|143
7739334|NCT00884117|26908800|P1|Overall Study|Death|3
7739335|NCT00884117|26908800|P1|Overall Study|Withdrawal by Subject|89
7739336|NCT00884117|26908800|P1|Overall Study|Adverse Event|2
7739337|NCT00884039|26908871|P2|Overall Study|Lack of Efficacy|0
7739338|NCT00884039|26908872|P1|Overall Study|Lack of Efficacy|2
7739339|NCT00884039|26908871|P2|Overall Study|Withdrawal by Subject|1
7739340|NCT00884039|26908872|P1|Overall Study|Withdrawal by Subject|0
7739341|NCT00883779|26908880|P2|Off-study Phase|Other|21
7739342|NCT00883779|26908881|P1|Off-study Phase|Other|18
7739343|NCT00883779|26908880|P2|Off-study Phase|Failure to return|6
7739344|NCT00883779|26908881|P1|Off-study Phase|Failure to return|5
7739345|NCT00883779|26908880|P2|Off-study Phase|Refused treatment|1
7739346|NCT00883779|26908881|P1|Off-study Phase|Refused treatment|1
7739347|NCT00883779|26908880|P2|Off-study Phase|Death|174
7739348|NCT00883779|26908881|P1|Off-study Phase|Death|185
7739349|NCT00883779|26908880|P2|Post-Study Treatment Phase|Ongoing in the study|6
7739350|NCT00883779|26908881|P1|Post-Study Treatment Phase|Ongoing in the study|0
7739351|NCT00883779|26908880|P2|Post-Study Treatment Phase|Other|0
7739352|NCT00883779|26908881|P1|Post-Study Treatment Phase|Other|3
7739353|NCT00883779|26908880|P2|Post-Study Treatment Phase|Disease progression|122
7739354|NCT00883779|26908881|P1|Post-Study Treatment Phase|Disease progression|103
7739355|NCT00883779|26908880|P2|Post-Study Treatment Phase|Refused Treatment|0
7739356|NCT00883779|26908881|P1|Post-Study Treatment Phase|Refused Treatment|3
7739357|NCT00883779|26908880|P2|Post-Study Treatment Phase|Protocol Violation|1
7739358|NCT00883779|26908881|P1|Post-Study Treatment Phase|Protocol Violation|0
7739359|NCT00883779|26908880|P2|Post-Study Treatment Phase|Death|3
7739360|NCT00883779|26908881|P1|Post-Study Treatment Phase|Death|1
7739361|NCT00883779|26908880|P2|Post-Study Treatment Phase|Adverse Event|3
7739362|NCT00883779|26908881|P1|Post-Study Treatment Phase|Adverse Event|2
7739363|NCT00883779|26908880|P2|Primary Study Treatment Phase|Other|0
7739364|NCT00883779|26908881|P1|Primary Study Treatment Phase|Other|3
7739365|NCT00883779|26908880|P2|Primary Study Treatment Phase|Refused Treatment|4
7739366|NCT00883779|26908881|P1|Primary Study Treatment Phase|Refused Treatment|5
7739367|NCT00883779|26908880|P2|Primary Study Treatment Phase|Death|3
7739368|NCT00883779|26908881|P1|Primary Study Treatment Phase|Death|2
7739369|NCT00883779|26908880|P2|Primary Study Treatment Phase|Adverse Event|16
7739370|NCT00883779|26908881|P1|Primary Study Treatment Phase|Adverse Event|16
7739371|NCT00883779|26908880|P2|Primary Study Treatment Phase|Disease progression|59
7739372|NCT00883779|26908881|P1|Primary Study Treatment Phase|Disease progression|75
7739373|NCT00883779|26908880|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
7739374|NCT00883779|26908881|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
7739375|NCT00883753|26908917|P1|Overall Study|Administrative/Other|8
7739376|NCT00883753|26908917|P1|Overall Study|Investigator's decision|17
7739377|NCT00883753|26908917|P1|Overall Study|Withdrew consent|10
7739378|NCT00883753|26908917|P1|Overall Study|Refused treatment|4
7739379|NCT00883753|26908917|P1|Overall Study|Protocol Violation|2
7739380|NCT00883753|26908917|P1|Overall Study|Violation of selection criteria at entry|7
7739381|NCT00883753|26908917|P1|Overall Study|Lost to Follow-up|4
7739382|NCT00883753|26908917|P1|Overall Study|Insufficient therapeutic response|16
7739383|NCT00883753|26908917|P1|Overall Study|Death|2
7739384|NCT00883753|26908917|P1|Overall Study|Adverse Event|37
7739385|NCT00883740|26908957|P2|Second Intervention|No longer willing to participate|1
7739386|NCT00883740|26908958|P1|Second Intervention|No longer willing to participate|0
7739387|NCT00883740|26908957|P2|Second Intervention|Protocol Violation|0
7739388|NCT00883740|26908958|P1|Second Intervention|Protocol Violation|1
7739389|NCT00883740|26908957|P2|First Intervention|Adverse Event|2
7739390|NCT00883740|26908958|P1|First Intervention|Adverse Event|1
7739391|NCT00883740|26908957|P2|First Intervention|Protocol Violation|6
7739392|NCT00883740|26908958|P1|First Intervention|Protocol Violation|3
7739393|NCT00883740|26908957|P2|First Intervention|No longer willing to participate|0
7739394|NCT00883740|26908958|P1|First Intervention|No longer willing to participate|2
7739395|NCT00883740|26908957|P2|First Intervention|Lost to Follow-up|0
7739396|NCT00883740|26908958|P1|First Intervention|Lost to Follow-up|1
7739397|NCT00883688|26908998|P1|Overall Study|Ineligible|2
7739398|NCT00883558|26909006|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
7739399|NCT00883558|26909007|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
7739400|NCT00883558|26909008|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
7739401|NCT00883558|26909006|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
7739402|NCT00883558|26909007|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
7739403|NCT00883558|26909008|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
7739404|NCT00883558|26909006|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
7739488|NCT00883116|26909386|P2|Overall Study|Study drug toxicity|16
7739405|NCT00883558|26909007|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
7739406|NCT00883558|26909008|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
7739407|NCT00883558|26909006|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
7739408|NCT00883558|26909007|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
7739409|NCT00883558|26909008|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
7739410|NCT00883558|26909006|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
7739411|NCT00883558|26909007|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
7739412|NCT00883558|26909008|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
7739413|NCT00883493|26909020|P2|Overall Study|Other|3
7739414|NCT00883493|26909021|P1|Overall Study|Other|5
7739415|NCT00883493|26909020|P2|Overall Study|Study specific disc. criteria|0
7739416|NCT00883493|26909021|P1|Overall Study|Study specific disc. criteria|2
7739417|NCT00883493|26909020|P2|Overall Study|Eligibility Criteria not fullfilled|6
7739418|NCT00883493|26909021|P1|Overall Study|Eligibility Criteria not fullfilled|6
7739419|NCT00883493|26909020|P2|Overall Study|Withdrawal by Subject|20
7739420|NCT00883493|26909021|P1|Overall Study|Withdrawal by Subject|11
7739421|NCT00883493|26909020|P2|Overall Study|Lost to Follow-up|6
7739422|NCT00883493|26909021|P1|Overall Study|Lost to Follow-up|7
7739423|NCT00883493|26909020|P2|Overall Study|Lack of Efficacy|3
7739424|NCT00883493|26909021|P1|Overall Study|Lack of Efficacy|4
7739425|NCT00883493|26909020|P2|Overall Study|Adverse Event|12
7739426|NCT00883493|26909021|P1|Overall Study|Adverse Event|11
7739427|NCT00883337|26909056|P3|Extension Treatment Period|Other than above|5
7739428|NCT00883337|26909057|P2|Extension Treatment Period|Other than above|9
7739429|NCT00883337|26909058|P1|Extension Treatment Period|Other than above|10
7739430|NCT00883337|26909056|P3|Extension Treatment Period|Lost to Follow-up|0
7739431|NCT00883337|26909057|P2|Extension Treatment Period|Lost to Follow-up|0
7739432|NCT00883337|26909058|P1|Extension Treatment Period|Lost to Follow-up|1
7739433|NCT00883337|26909056|P3|Extension Treatment Period|Poor compliance to protocol|1
7739434|NCT00883337|26909057|P2|Extension Treatment Period|Poor compliance to protocol|1
7739435|NCT00883337|26909058|P1|Extension Treatment Period|Poor compliance to protocol|1
7739436|NCT00883337|26909056|P3|Extension Treatment Period|Lack of Efficacy|8
7739437|NCT00883337|26909057|P2|Extension Treatment Period|Lack of Efficacy|8
7739438|NCT00883337|26909058|P1|Extension Treatment Period|Lack of Efficacy|8
7739439|NCT00883337|26909056|P3|Extension Treatment Period|Adverse Event|5
7739440|NCT00883337|26909057|P2|Extension Treatment Period|Adverse Event|5
7739441|NCT00883337|26909058|P1|Extension Treatment Period|Adverse Event|8
7739442|NCT00883337|26909056|P3|Core Treatment Period|Other than above|1
7739443|NCT00883337|26909057|P2|Core Treatment Period|Other than above|1
7739444|NCT00883337|26909058|P1|Core Treatment Period|Other than above|0
7739445|NCT00883337|26909056|P3|Core Treatment Period|Poor compliance to protocol|1
7739446|NCT00883337|26909057|P2|Core Treatment Period|Poor compliance to protocol|0
7739447|NCT00883337|26909058|P1|Core Treatment Period|Poor compliance to protocol|0
7739448|NCT00883337|26909056|P3|Core Treatment Period|Wish to be pregnant|1
7739449|NCT00883337|26909057|P2|Core Treatment Period|Wish to be pregnant|2
7739450|NCT00883337|26909058|P1|Core Treatment Period|Wish to be pregnant|1
7739451|NCT00883337|26909056|P3|Core Treatment Period|Withdrawal by Subject|6
7739452|NCT00883337|26909057|P2|Core Treatment Period|Withdrawal by Subject|2
7739453|NCT00883337|26909058|P1|Core Treatment Period|Withdrawal by Subject|2
7739454|NCT00883337|26909056|P3|Core Treatment Period|Lost to Follow-up|0
7739455|NCT00883337|26909057|P2|Core Treatment Period|Lost to Follow-up|1
7739456|NCT00883337|26909058|P1|Core Treatment Period|Lost to Follow-up|1
7739457|NCT00883337|26909056|P3|Core Treatment Period|Lack of Efficacy|2
7739458|NCT00883337|26909057|P2|Core Treatment Period|Lack of Efficacy|4
7739459|NCT00883337|26909058|P1|Core Treatment Period|Lack of Efficacy|7
7739460|NCT00883337|26909056|P3|Core Treatment Period|Adverse Event|22
7739461|NCT00883337|26909057|P2|Core Treatment Period|Adverse Event|12
7739462|NCT00883337|26909058|P1|Core Treatment Period|Adverse Event|9
7739463|NCT00883181|26909125|P1|Overall Study|Noncompliance|3
7739464|NCT00883181|26909125|P1|Overall Study|Protocol Deviation|3
7739465|NCT00883181|26909125|P1|Overall Study|Other|38
7739466|NCT00883181|26909125|P1|Overall Study|Death|31
7739467|NCT00883181|26909125|P1|Overall Study|Withdrawal by Subject|4
7739468|NCT00883181|26909125|P1|Overall Study|Administrative Reason|24
7739469|NCT00883181|26909125|P1|Overall Study|Disease Progression|94
7739470|NCT00883181|26909125|P1|Overall Study|Non-hematological Adverse Event|55
7739471|NCT00883181|26909125|P1|Overall Study|Hematological Adverse Event|26
7739472|NCT00883129|26909361|P2|Overall Study|Defined Treatment Failure|2
7739473|NCT00883129|26909362|P1|Overall Study|Defined Treatment Failure|0
7739474|NCT00883129|26909361|P2|Overall Study|Death|2
7739475|NCT00883129|26909362|P1|Overall Study|Death|1
7739476|NCT00883129|26909361|P2|Overall Study|Lost to Follow-up|2
7739477|NCT00883129|26909362|P1|Overall Study|Lost to Follow-up|1
7739478|NCT00883129|26909361|P2|Overall Study|Non-compliance|6
7739479|NCT00883129|26909362|P1|Overall Study|Non-compliance|3
7739480|NCT00883129|26909361|P2|Overall Study|Withdrawal by Subject|9
7739481|NCT00883129|26909362|P1|Overall Study|Withdrawal by Subject|8
7739482|NCT00883129|26909361|P2|Overall Study|Adverse Event|15
7739483|NCT00883129|26909362|P1|Overall Study|Adverse Event|7
7739484|NCT00883116|26909386|P2|Overall Study|No longer meets study criteria|2
7739485|NCT00883116|26909387|P1|Overall Study|No longer meets study criteria|2
7739486|NCT00883116|26909386|P2|Overall Study|Withdrawal by Subject|8
7739487|NCT00883116|26909387|P1|Overall Study|Withdrawal by Subject|14
7739489|NCT00883116|26909387|P1|Overall Study|Study drug toxicity|36
7739490|NCT00883116|26909386|P2|Overall Study|Not identified|6
7739491|NCT00883116|26909387|P1|Overall Study|Not identified|3
7739492|NCT00883116|26909386|P2|Overall Study|Maximum clinical benefit|46
7739493|NCT00883116|26909387|P1|Overall Study|Maximum clinical benefit|13
7739494|NCT00883116|26909386|P2|Overall Study|Lost to Follow-up|1
7739495|NCT00883116|26909387|P1|Overall Study|Lost to Follow-up|0
7739496|NCT00883116|26909386|P2|Overall Study|Disease progression|128
7739497|NCT00883116|26909387|P1|Overall Study|Disease progression|130
7739498|NCT00883116|26909386|P2|Overall Study|Death|2
7739499|NCT00883116|26909387|P1|Overall Study|Death|6
7739500|NCT00883116|26909386|P2|Overall Study|Adverse event unrelated to study drug|10
7739501|NCT00883116|26909387|P1|Overall Study|Adverse event unrelated to study drug|5
7739502|NCT00883090|26909409|P1|Overall Study|Withdrawal by Subject|1
7739503|NCT00883090|26909409|P1|Overall Study|Sponsor's decision|1
7739504|NCT00883051|26909429|P5|Overall Study|Did not use study medication|17
7739505|NCT00883051|26909430|P4|Overall Study|Did not use study medication|29
7739506|NCT00883051|26909431|P3|Overall Study|Did not use study medication|29
7739507|NCT00883051|26909432|P2|Overall Study|Did not use study medication|22
7739508|NCT00883051|26909433|P1|Overall Study|Did not use study medication|24
7739509|NCT00883051|26909429|P5|Overall Study|Lost to Follow-up|1
7739510|NCT00883051|26909430|P4|Overall Study|Lost to Follow-up|0
7739511|NCT00883051|26909431|P3|Overall Study|Lost to Follow-up|0
7739512|NCT00883051|26909432|P2|Overall Study|Lost to Follow-up|0
7739513|NCT00883051|26909433|P1|Overall Study|Lost to Follow-up|0
7739514|NCT00882999|26909537|P7|Overall Study|Physician Decision|1
7739515|NCT00882999|26909538|P6|Overall Study|Physician Decision|1
7739516|NCT00882999|26909539|P5|Overall Study|Physician Decision|0
7739517|NCT00882999|26909540|P4|Overall Study|Physician Decision|0
7739518|NCT00882999|26909541|P3|Overall Study|Physician Decision|0
7739519|NCT00882999|26909542|P2|Overall Study|Physician Decision|0
7739520|NCT00882999|26909543|P1|Overall Study|Physician Decision|1
7739521|NCT00882999|26909537|P7|Overall Study|Lost to Follow-up|2
7739522|NCT00882999|26909538|P6|Overall Study|Lost to Follow-up|1
7739523|NCT00882999|26909539|P5|Overall Study|Lost to Follow-up|1
7739524|NCT00882999|26909540|P4|Overall Study|Lost to Follow-up|2
7739525|NCT00882999|26909541|P3|Overall Study|Lost to Follow-up|1
7739526|NCT00882999|26909542|P2|Overall Study|Lost to Follow-up|1
7739527|NCT00882999|26909543|P1|Overall Study|Lost to Follow-up|0
7739528|NCT00882999|26909537|P7|Overall Study|Withdrawal by Subject|5
7739529|NCT00882999|26909538|P6|Overall Study|Withdrawal by Subject|5
7739530|NCT00882999|26909539|P5|Overall Study|Withdrawal by Subject|6
7739531|NCT00882999|26909540|P4|Overall Study|Withdrawal by Subject|3
7739532|NCT00882999|26909541|P3|Overall Study|Withdrawal by Subject|3
7739533|NCT00882999|26909542|P2|Overall Study|Withdrawal by Subject|6
7739534|NCT00882999|26909543|P1|Overall Study|Withdrawal by Subject|7
7739535|NCT00882999|26909537|P7|Overall Study|Death|0
7739536|NCT00882999|26909538|P6|Overall Study|Death|0
7739537|NCT00882999|26909539|P5|Overall Study|Death|0
7739538|NCT00882999|26909540|P4|Overall Study|Death|0
7739539|NCT00882999|26909541|P3|Overall Study|Death|0
7739540|NCT00882999|26909542|P2|Overall Study|Death|1
7739541|NCT00882999|26909543|P1|Overall Study|Death|0
7739542|NCT00882999|26909537|P7|Overall Study|Adverse Event|0
7739543|NCT00882999|26909538|P6|Overall Study|Adverse Event|0
7739544|NCT00882999|26909539|P5|Overall Study|Adverse Event|1
7739545|NCT00882999|26909540|P4|Overall Study|Adverse Event|0
7739546|NCT00882999|26909541|P3|Overall Study|Adverse Event|0
7739547|NCT00882999|26909542|P2|Overall Study|Adverse Event|0
7739548|NCT00882999|26909543|P1|Overall Study|Adverse Event|0
7739549|NCT00882921|26909670|P1|Overall Study|Withdrawal Of Consent|1
7739550|NCT00882921|26909670|P1|Overall Study|Termination By Investigator|3
7739551|NCT00882921|26909670|P1|Overall Study|Lost to Follow-up|2
7739552|NCT00882921|26909670|P1|Overall Study|Other|3
7739553|NCT00882921|26909670|P1|Overall Study|Death|2
7739554|NCT00882908|26909680|P5|Overall Study|Study terminated in error|0
7739555|NCT00882908|26909681|P4|Overall Study|Study terminated in error|1
7739556|NCT00882908|26909682|P3|Overall Study|Study terminated in error|0
7739557|NCT00882908|26909683|P2|Overall Study|Study terminated in error|0
7739558|NCT00882908|26909684|P1|Overall Study|Study terminated in error|0
7739559|NCT00882908|26909680|P5|Overall Study|Subject reached a virologic endpoint|1
7739560|NCT00882908|26909681|P4|Overall Study|Subject reached a virologic endpoint|0
7739561|NCT00882908|26909682|P3|Overall Study|Subject reached a virologic endpoint|0
7739562|NCT00882908|26909683|P2|Overall Study|Subject reached a virologic endpoint|0
7739563|NCT00882908|26909684|P1|Overall Study|Subject reached a virologic endpoint|0
7739564|NCT00882908|26909680|P5|Overall Study|Withdrawal by Subject|2
7739565|NCT00882908|26909681|P4|Overall Study|Withdrawal by Subject|5
7739566|NCT00882908|26909682|P3|Overall Study|Withdrawal by Subject|3
7739567|NCT00882908|26909683|P2|Overall Study|Withdrawal by Subject|0
7739568|NCT00882908|26909684|P1|Overall Study|Withdrawal by Subject|0
7739569|NCT00882908|26909680|P5|Overall Study|Protocol Violation|0
7739570|NCT00882908|26909681|P4|Overall Study|Protocol Violation|0
7739571|NCT00882908|26909682|P3|Overall Study|Protocol Violation|0
7739572|NCT00882908|26909683|P2|Overall Study|Protocol Violation|1
7739573|NCT00882908|26909684|P1|Overall Study|Protocol Violation|0
7739574|NCT00882908|26909680|P5|Overall Study|Lost to Follow-up|2
7739575|NCT00882908|26909681|P4|Overall Study|Lost to Follow-up|1
7739576|NCT00882908|26909682|P3|Overall Study|Lost to Follow-up|3
7739577|NCT00882908|26909683|P2|Overall Study|Lost to Follow-up|5
7739578|NCT00882908|26909684|P1|Overall Study|Lost to Follow-up|3
7739579|NCT00882908|26909680|P5|Overall Study|Adverse Event|1
7739580|NCT00882908|26909681|P4|Overall Study|Adverse Event|0
7739581|NCT00882908|26909682|P3|Overall Study|Adverse Event|1
7739582|NCT00882908|26909683|P2|Overall Study|Adverse Event|0
7739583|NCT00882908|26909684|P1|Overall Study|Adverse Event|0
7739584|NCT00882713|26909790|P1|Overall Study|Other - Reasons|2
7739585|NCT00882713|26909790|P1|Overall Study|Failure to return|2
7739586|NCT00882713|26909790|P1|Overall Study|Insufficient therapeutic response|3
7739587|NCT00882713|26909790|P1|Overall Study|Blood transfusion|2
7739588|NCT00882713|26909790|P1|Overall Study|refused treatment/withdrew consent|4
7739589|NCT00882713|26909790|P1|Overall Study|Administrative reasons|4
7739590|NCT00882713|26909790|P1|Overall Study|Death|3
7739591|NCT00882713|26909790|P1|Overall Study|Adverse Event|2
7739592|NCT00882583|26909883|P2|Overall Study|Adverse Event|1
7739593|NCT00882583|26909884|P1|Overall Study|Adverse Event|0
7739594|NCT00882583|26909883|P2|Overall Study|Physician Decision|0
7739595|NCT00882583|26909884|P1|Overall Study|Physician Decision|1
7739596|NCT00882557|26909892|P2|Overall Study|Randomized Not Treated|1
7739597|NCT00882557|26909893|P1|Overall Study|Randomized Not Treated|0
7739598|NCT00882557|26909892|P2|Overall Study|Trouble with Vein Access|0
7739599|NCT00882557|26909893|P1|Overall Study|Trouble with Vein Access|1
7739600|NCT00882557|26909892|P2|Overall Study|Withdrawal by Subject|0
7739601|NCT00882557|26909893|P1|Overall Study|Withdrawal by Subject|1
7739602|NCT00882518|26909913|P2|Overall Study|Allocating random number by mistake|1
7739603|NCT00882518|26909914|P1|Overall Study|Allocating random number by mistake|0
7739604|NCT00882518|26909913|P2|Overall Study|Central lab closure for National day|0
7739605|NCT00882518|26909914|P1|Overall Study|Central lab closure for National day|1
7739606|NCT00882518|26909913|P2|Overall Study|Incorrect enrolment|2
7739607|NCT00882518|26909914|P1|Overall Study|Incorrect enrolment|4
7739608|NCT00882518|26909913|P2|Overall Study|Severe non-compliance to protocol|1
7739609|NCT00882518|26909914|P1|Overall Study|Severe non-compliance to protocol|3
7739610|NCT00882518|26909913|P2|Overall Study|Lack of Efficacy|9
7739611|NCT00882518|26909914|P1|Overall Study|Lack of Efficacy|12
7739612|NCT00882518|26909913|P2|Overall Study|Withdrawal by Subject|13
7739613|NCT00882518|26909914|P1|Overall Study|Withdrawal by Subject|9
7739614|NCT00882518|26909913|P2|Overall Study|Adverse Event|18
7739615|NCT00882518|26909914|P1|Overall Study|Adverse Event|9
7739616|NCT00882440|26909943|P7|Overall Study|Patient Uncooperative|0
7739617|NCT00882440|26909944|P6|Overall Study|Patient Uncooperative|0
7739618|NCT00882440|26909945|P5|Overall Study|Patient Uncooperative|1
7739619|NCT00882440|26909946|P4|Overall Study|Patient Uncooperative|0
7739620|NCT00882440|26909947|P3|Overall Study|Patient Uncooperative|0
7739621|NCT00882440|26909948|P2|Overall Study|Patient Uncooperative|0
7739622|NCT00882440|26909949|P1|Overall Study|Patient Uncooperative|2
7739623|NCT00882440|26909943|P7|Overall Study|Withdrawal by Subject|1
7739624|NCT00882440|26909944|P6|Overall Study|Withdrawal by Subject|0
7739625|NCT00882440|26909945|P5|Overall Study|Withdrawal by Subject|6
7739626|NCT00882440|26909946|P4|Overall Study|Withdrawal by Subject|0
7739627|NCT00882440|26909947|P3|Overall Study|Withdrawal by Subject|1
7739628|NCT00882440|26909948|P2|Overall Study|Withdrawal by Subject|1
7739629|NCT00882440|26909949|P1|Overall Study|Withdrawal by Subject|2
7739630|NCT00882440|26909943|P7|Overall Study|Protocol Violation|0
7739631|NCT00882440|26909944|P6|Overall Study|Protocol Violation|0
7739632|NCT00882440|26909945|P5|Overall Study|Protocol Violation|1
7739633|NCT00882440|26909946|P4|Overall Study|Protocol Violation|1
7739634|NCT00882440|26909947|P3|Overall Study|Protocol Violation|1
7739635|NCT00882440|26909948|P2|Overall Study|Protocol Violation|0
7739636|NCT00882440|26909949|P1|Overall Study|Protocol Violation|0
7739637|NCT00882440|26909943|P7|Overall Study|Lost to Follow-up|1
7739638|NCT00882440|26909944|P6|Overall Study|Lost to Follow-up|0
7739639|NCT00882440|26909945|P5|Overall Study|Lost to Follow-up|1
7739640|NCT00882440|26909946|P4|Overall Study|Lost to Follow-up|1
7739641|NCT00882440|26909947|P3|Overall Study|Lost to Follow-up|1
7739642|NCT00882440|26909948|P2|Overall Study|Lost to Follow-up|0
7739643|NCT00882440|26909949|P1|Overall Study|Lost to Follow-up|2
7739644|NCT00882440|26909943|P7|Overall Study|Lack of Efficacy|0
7739645|NCT00882440|26909944|P6|Overall Study|Lack of Efficacy|3
7739646|NCT00882440|26909945|P5|Overall Study|Lack of Efficacy|0
7739647|NCT00882440|26909946|P4|Overall Study|Lack of Efficacy|0
7739648|NCT00882440|26909947|P3|Overall Study|Lack of Efficacy|2
7739649|NCT00882440|26909948|P2|Overall Study|Lack of Efficacy|5
7739650|NCT00882440|26909949|P1|Overall Study|Lack of Efficacy|3
7739651|NCT00882440|26909943|P7|Overall Study|Adverse Event|2
7739652|NCT00882440|26909944|P6|Overall Study|Adverse Event|4
7739653|NCT00882440|26909945|P5|Overall Study|Adverse Event|1
7739654|NCT00882440|26909946|P4|Overall Study|Adverse Event|1
7739655|NCT00882440|26909947|P3|Overall Study|Adverse Event|2
7739656|NCT00882440|26909948|P2|Overall Study|Adverse Event|2
7739657|NCT00882440|26909949|P1|Overall Study|Adverse Event|2
7739658|NCT00882362|26909974|P2|Overall Study|change of residence or other commitments|0
7739659|NCT00882362|26909975|P1|Overall Study|change of residence or other commitments|5
7739660|NCT00882362|26909974|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
7739661|NCT00882362|26909975|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
7739662|NCT00882362|26909974|P2|Overall Study|Physician Decision|1
7739663|NCT00882362|26909975|P1|Overall Study|Physician Decision|5
7739664|NCT00882362|26909974|P2|Overall Study|Pregnancy|0
7739665|NCT00882362|26909975|P1|Overall Study|Pregnancy|1
7739666|NCT00882362|26909974|P2|Overall Study|Protocol Violation|2
7739667|NCT00882362|26909975|P1|Overall Study|Protocol Violation|7
7739668|NCT00882362|26909974|P2|Overall Study|Lack of Efficacy|0
7739669|NCT00882362|26909975|P1|Overall Study|Lack of Efficacy|3
7739670|NCT00882362|26909974|P2|Overall Study|Withdrawal by Subject|10
7739671|NCT00882362|26909975|P1|Overall Study|Withdrawal by Subject|13
7739672|NCT00882362|26909974|P2|Overall Study|Adverse Event|10
7739673|NCT00882362|26909975|P1|Overall Study|Adverse Event|13
7739674|NCT00882310|26909981|P1|Overall Study|Adverse Event|1
7739675|NCT00882310|26909981|P1|Overall Study|Progression of disease|4
7739676|NCT00882310|26909981|P1|Overall Study|Death|6
7739677|NCT00882310|26909981|P1|Overall Study|Never received treatment|1
7739678|NCT00882310|26909981|P1|Overall Study|Screen Failure|10
7739679|NCT00882115|26909994|P1|Overall Study|did not respond to DEP challe|6
7739680|NCT00882115|26909994|P1|Overall Study|Withdrawal by Subject|3
7739681|NCT00881959|26910004|P2|Overall Study|Lost to Follow-up|4
7739682|NCT00881959|26910005|P1|Overall Study|Lost to Follow-up|2
7739683|NCT00881894|26910013|P2|Overall Study|Other reasons for premature termination|2
7739684|NCT00881894|26910014|P1|Overall Study|Other reasons for premature termination|1
7739685|NCT00881894|26910013|P2|Overall Study|Consent withdrawn|1
7739686|NCT00881894|26910014|P1|Overall Study|Consent withdrawn|0
7739687|NCT00881868|26910046|P2|Overall Study|Protocol Violation|0
7739688|NCT00881868|26910047|P1|Overall Study|Protocol Violation|2
7739689|NCT00881868|26910046|P2|Overall Study|Physician Decision|0
7739690|NCT00881868|26910047|P1|Overall Study|Physician Decision|4
7739691|NCT00881868|26910046|P2|Overall Study|Lost to Follow-up|1
7739692|NCT00881868|26910047|P1|Overall Study|Lost to Follow-up|2
7739693|NCT00881868|26910046|P2|Overall Study|Adverse Event|1
7739694|NCT00881868|26910047|P1|Overall Study|Adverse Event|0
7739695|NCT00881751|26910061|P2|Overall Study|Withdrawal by Subject|2
7739696|NCT00881751|26910062|P1|Overall Study|Withdrawal by Subject|0
7739697|NCT00881751|26910061|P2|Overall Study|Adverse Event|2
7739698|NCT00881751|26910062|P1|Overall Study|Adverse Event|0
7739699|NCT00881751|26910061|P2|Overall Study|Physician Decision|1
7739700|NCT00881751|26910062|P1|Overall Study|Physician Decision|0
7739701|NCT00881712|26910077|P3|Overall Study|Withdrawal by Subject|0
7739702|NCT00881712|26910078|P2|Overall Study|Withdrawal by Subject|0
7739703|NCT00881712|26910079|P1|Overall Study|Withdrawal by Subject|1
7739704|NCT00881712|26910077|P3|Overall Study|Death|0
7739705|NCT00881712|26910078|P2|Overall Study|Death|0
7739706|NCT00881712|26910079|P1|Overall Study|Death|1
7739707|NCT00881621|26910112|P1|Overall Study|Physician Decision|34
7739708|NCT00881608|26910124|P1|Overall Study|Study prematurely terminated|11
7739709|NCT00881569|26910143|P2|Overall Study|Disease progression|1
7739710|NCT00881569|26910144|P1|Overall Study|Disease progression|1
7739711|NCT00881530|26910160|P6|Overall Study|Other reason not defined above|2
7739712|NCT00881530|26910161|P5|Overall Study|Other reason not defined above|0
7739713|NCT00881530|26910162|P4|Overall Study|Other reason not defined above|0
7739714|NCT00881530|26910163|P3|Overall Study|Other reason not defined above|2
7739715|NCT00881530|26910164|P2|Overall Study|Other reason not defined above|1
7739716|NCT00881530|26910165|P1|Overall Study|Other reason not defined above|1
7739717|NCT00881530|26910160|P6|Overall Study|Refused to continue medication|0
7739718|NCT00881530|26910161|P5|Overall Study|Refused to continue medication|0
7739719|NCT00881530|26910162|P4|Overall Study|Refused to continue medication|2
7739720|NCT00881530|26910163|P3|Overall Study|Refused to continue medication|1
7739721|NCT00881530|26910164|P2|Overall Study|Refused to continue medication|2
7739722|NCT00881530|26910165|P1|Overall Study|Refused to continue medication|7
7739723|NCT00881530|26910160|P6|Overall Study|Lost to Follow-up|0
7739724|NCT00881530|26910161|P5|Overall Study|Lost to Follow-up|1
7739725|NCT00881530|26910162|P4|Overall Study|Lost to Follow-up|3
7739726|NCT00881530|26910163|P3|Overall Study|Lost to Follow-up|1
7739727|NCT00881530|26910164|P2|Overall Study|Lost to Follow-up|1
7739728|NCT00881530|26910165|P1|Overall Study|Lost to Follow-up|0
7739729|NCT00881530|26910160|P6|Overall Study|Not compliant with the protocol|0
7739730|NCT00881530|26910161|P5|Overall Study|Not compliant with the protocol|2
7739731|NCT00881530|26910162|P4|Overall Study|Not compliant with the protocol|0
7739732|NCT00881530|26910163|P3|Overall Study|Not compliant with the protocol|0
7739733|NCT00881530|26910164|P2|Overall Study|Not compliant with the protocol|0
7739734|NCT00881530|26910165|P1|Overall Study|Not compliant with the protocol|0
7739735|NCT00881530|26910160|P6|Overall Study|Lack of Efficacy|1
7739736|NCT00881530|26910161|P5|Overall Study|Lack of Efficacy|1
7739737|NCT00881530|26910162|P4|Overall Study|Lack of Efficacy|0
7739738|NCT00881530|26910163|P3|Overall Study|Lack of Efficacy|0
7739739|NCT00881530|26910164|P2|Overall Study|Lack of Efficacy|0
7739740|NCT00881530|26910165|P1|Overall Study|Lack of Efficacy|1
7739741|NCT00881530|26910160|P6|Overall Study|Adverse Event|2
7739742|NCT00881530|26910161|P5|Overall Study|Adverse Event|10
7739743|NCT00881530|26910162|P4|Overall Study|Adverse Event|4
7739744|NCT00881530|26910163|P3|Overall Study|Adverse Event|1
7739745|NCT00881530|26910164|P2|Overall Study|Adverse Event|1
7739746|NCT00881530|26910165|P1|Overall Study|Adverse Event|5
7739747|NCT00881504|26910221|P1|Overall Study|Withdrawal by Subject|1
7739748|NCT00881361|26910241|P3|Overall Study|Ineligible|2
7739749|NCT00881361|26910242|P2|Overall Study|Ineligible|2
7739750|NCT00881361|26910243|P1|Overall Study|Ineligible|17
7739751|NCT00881361|26910241|P3|Overall Study|Terminated prior to surgery|0
7739752|NCT00881361|26910242|P2|Overall Study|Terminated prior to surgery|7
7739753|NCT00881361|26910243|P1|Overall Study|Terminated prior to surgery|27
7739754|NCT00881335|26910258|P2|Overall Study|Lost to Follow-up|2
7739755|NCT00881335|26910259|P1|Overall Study|Lost to Follow-up|3
7739756|NCT00881205|26910279|P2|Overall Study|Condition no longer requires drug|0
7739757|NCT00881205|26910280|P1|Overall Study|Condition no longer requires drug|1
7739758|NCT00881205|26910279|P2|Overall Study|Administrative problems|1
7739759|NCT00881205|26910280|P1|Overall Study|Administrative problems|1
7739760|NCT00881205|26910279|P2|Overall Study|Lost to Follow-up|1
7739761|NCT00881205|26910280|P1|Overall Study|Lost to Follow-up|0
7739762|NCT00881205|26910279|P2|Overall Study|Withdrawal by Subject|2
7739763|NCT00881205|26910280|P1|Overall Study|Withdrawal by Subject|1
7739764|NCT00881205|26910279|P2|Overall Study|Adverse Event|3
7739765|NCT00881205|26910280|P1|Overall Study|Adverse Event|8
7739766|NCT00880906|26910348|P2|Overall Study|Did not meet criteria following patholog|6
7739767|NCT00880906|26910349|P1|Overall Study|Did not meet criteria following patholog|12
7739768|NCT00880906|26910348|P2|Overall Study|Lost to Follow-up|1
7739769|NCT00880906|26910349|P1|Overall Study|Lost to Follow-up|0
7739770|NCT00880893|26910359|P2|Overall Study|Serious adverse event|0
7739771|NCT00880893|26910360|P1|Overall Study|Serious adverse event|3
7739772|NCT00880893|26910359|P2|Overall Study|Lost to Follow-up|33
7739773|NCT00880893|26910360|P1|Overall Study|Lost to Follow-up|76
7739774|NCT00880893|26910359|P2|Overall Study|Withdrawal by Subject|11
7739775|NCT00880893|26910360|P1|Overall Study|Withdrawal by Subject|15
7739776|NCT00880893|26910359|P2|Overall Study|Protocol Violation|1
7739777|NCT00880893|26910360|P1|Overall Study|Protocol Violation|13
7739778|NCT00880763|26910412|P4|Extension Period (Part 2)|Lack of Efficacy|1
7739779|NCT00880763|26910413|P3|Extension Period (Part 2)|Lack of Efficacy|0
7739780|NCT00880763|26910414|P2|Extension Period (Part 2)|Lack of Efficacy|0
7739781|NCT00880763|26910415|P1|Extension Period (Part 2)|Lack of Efficacy|0
7739782|NCT00880763|26910412|P4|Extension Period (Part 2)|Physician Decision|0
7739783|NCT00880763|26910413|P3|Extension Period (Part 2)|Physician Decision|1
7739784|NCT00880763|26910414|P2|Extension Period (Part 2)|Physician Decision|1
7739785|NCT00880763|26910415|P1|Extension Period (Part 2)|Physician Decision|0
7739786|NCT00880763|26910412|P4|Extension Period (Part 2)|Withdrawal by Subject|1
7739787|NCT00880763|26910413|P3|Extension Period (Part 2)|Withdrawal by Subject|1
7739788|NCT00880763|26910414|P2|Extension Period (Part 2)|Withdrawal by Subject|2
7739789|NCT00880763|26910415|P1|Extension Period (Part 2)|Withdrawal by Subject|0
7739790|NCT00880763|26910412|P4|Extension Period (Part 2)|Adverse Event|1
7739791|NCT00880763|26910413|P3|Extension Period (Part 2)|Adverse Event|1
7739792|NCT00880763|26910414|P2|Extension Period (Part 2)|Adverse Event|0
7739793|NCT00880763|26910415|P1|Extension Period (Part 2)|Adverse Event|0
7739794|NCT00880750|26910447|P2|Second Intervention|Unable to collect urine|0
7739795|NCT00880750|26910448|P1|Second Intervention|Unable to collect urine|1
7739796|NCT00880750|26910447|P2|Second Intervention|Protocol Violation|0
7739797|NCT00880750|26910448|P1|Second Intervention|Protocol Violation|1
7739798|NCT00880750|26910447|P2|Second Intervention|Withdrawal by Subject|2
7739799|NCT00880750|26910448|P1|Second Intervention|Withdrawal by Subject|2
7739800|NCT00880750|26910447|P2|First Intervention|Lost to Follow-up|0
7739801|NCT00880750|26910448|P1|First Intervention|Lost to Follow-up|2
7739802|NCT00880750|26910447|P2|First Intervention|Withdrawal by Subject|0
7739803|NCT00880750|26910448|P1|First Intervention|Withdrawal by Subject|2
7739804|NCT00880750|26910447|P2|First Intervention|Non-compliance with meals|1
7739805|NCT00880750|26910448|P1|First Intervention|Non-compliance with meals|0
7739806|NCT00880750|26910447|P2|First Intervention|Unable to collect urine|0
7739807|NCT00880750|26910448|P1|First Intervention|Unable to collect urine|4
7739808|NCT00880750|26910447|P2|First Intervention|Adverse Event|0
7739809|NCT00880750|26910448|P1|First Intervention|Adverse Event|1
7739810|NCT00880698|26910466|P4|Overall Study|Lost to Follow-up|1
7739811|NCT00880698|26910467|P3|Overall Study|Lost to Follow-up|0
7739812|NCT00880698|26910468|P2|Overall Study|Lost to Follow-up|3
7739813|NCT00880698|26910469|P1|Overall Study|Lost to Follow-up|1
7739814|NCT00880698|26910466|P4|Overall Study|Death|2
7739815|NCT00880698|26910467|P3|Overall Study|Death|1
7739816|NCT00880698|26910468|P2|Overall Study|Death|0
7739817|NCT00880698|26910469|P1|Overall Study|Death|0
7739818|NCT00880685|26910495|P1|Memantine 20mg|Withdrawal by Subject|1
7739819|NCT00880685|26910495|P1|Memantine 10mg|Lost to Follow-up|2
7739820|NCT00880620|26910507|P4|Overall Study|Other|2
7739821|NCT00880620|26910508|P3|Overall Study|Other|2
7739822|NCT00880620|26910509|P2|Overall Study|Other|1
7739823|NCT00880620|26910510|P1|Overall Study|Other|1
7739824|NCT00880620|26910507|P4|Overall Study|Noncompliance|1
7739825|NCT00880620|26910508|P3|Overall Study|Noncompliance|1
7739826|NCT00880620|26910509|P2|Overall Study|Noncompliance|0
7739827|NCT00880620|26910510|P1|Overall Study|Noncompliance|0
7739828|NCT00880620|26910507|P4|Overall Study|Withdrawal by Subject|3
7739829|NCT00880620|26910508|P3|Overall Study|Withdrawal by Subject|1
7739830|NCT00880620|26910509|P2|Overall Study|Withdrawal by Subject|3
7739831|NCT00880620|26910510|P1|Overall Study|Withdrawal by Subject|4
7739832|NCT00880620|26910507|P4|Overall Study|Protocol Violation|2
7739833|NCT00880620|26910508|P3|Overall Study|Protocol Violation|0
7739834|NCT00880620|26910509|P2|Overall Study|Protocol Violation|1
7739835|NCT00880620|26910510|P1|Overall Study|Protocol Violation|0
7739836|NCT00880620|26910507|P4|Overall Study|Lost to Follow-up|0
7739837|NCT00880620|26910508|P3|Overall Study|Lost to Follow-up|1
7739838|NCT00880620|26910509|P2|Overall Study|Lost to Follow-up|1
7739839|NCT00880620|26910510|P1|Overall Study|Lost to Follow-up|0
7739840|NCT00880620|26910507|P4|Overall Study|Lack of Efficacy|1
7739841|NCT00880620|26910508|P3|Overall Study|Lack of Efficacy|0
7739842|NCT00880620|26910509|P2|Overall Study|Lack of Efficacy|4
7739843|NCT00880620|26910510|P1|Overall Study|Lack of Efficacy|12
7739844|NCT00880620|26910507|P4|Overall Study|Death|0
7739845|NCT00880620|26910508|P3|Overall Study|Death|1
7739846|NCT00880620|26910509|P2|Overall Study|Death|0
7739847|NCT00880620|26910510|P1|Overall Study|Death|0
7739848|NCT00880620|26910507|P4|Overall Study|Adverse Event|15
7739849|NCT00880620|26910508|P3|Overall Study|Adverse Event|15
7739850|NCT00880620|26910509|P2|Overall Study|Adverse Event|5
7739851|NCT00880620|26910510|P1|Overall Study|Adverse Event|4
7739852|NCT00880607|26910526|P2|Overall Study|surgery did not extend past L1 level|0
7739853|NCT00880607|26910527|P1|Overall Study|surgery did not extend past L1 level|3
7739854|NCT00880607|26910526|P2|Overall Study|Protocol Violation|1
7739855|NCT00880607|26910527|P1|Overall Study|Protocol Violation|2
7739856|NCT00880607|26910526|P2|Overall Study|Physician Decision|2
7739857|NCT00880607|26910527|P1|Overall Study|Physician Decision|2
7739858|NCT00880568|26910559|P9|Overall Study|Withdrawal by Subject|0
7739859|NCT00880568|26910560|P8|Overall Study|Withdrawal by Subject|1
7739860|NCT00880568|26910561|P7|Overall Study|Withdrawal by Subject|0
7739861|NCT00880568|26910562|P6|Overall Study|Withdrawal by Subject|0
7739862|NCT00880568|26910563|P5|Overall Study|Withdrawal by Subject|0
7739863|NCT00880568|26910564|P4|Overall Study|Withdrawal by Subject|0
7739864|NCT00880568|26910565|P3|Overall Study|Withdrawal by Subject|0
7739865|NCT00880568|26910566|P2|Overall Study|Withdrawal by Subject|0
7739866|NCT00880568|26910567|P1|Overall Study|Withdrawal by Subject|0
7739867|NCT00880568|26910559|P9|Overall Study|Adverse Event|0
7739868|NCT00880568|26910560|P8|Overall Study|Adverse Event|1
7739869|NCT00880568|26910561|P7|Overall Study|Adverse Event|1
7739870|NCT00880568|26910562|P6|Overall Study|Adverse Event|0
7739871|NCT00880568|26910563|P5|Overall Study|Adverse Event|0
7739872|NCT00880568|26910564|P4|Overall Study|Adverse Event|0
7739873|NCT00880568|26910565|P3|Overall Study|Adverse Event|0
7739874|NCT00880568|26910566|P2|Overall Study|Adverse Event|0
7739875|NCT00880568|26910567|P1|Overall Study|Adverse Event|0
7739876|NCT00880568|26910559|P9|Overall Study|Disease progression|3
7739877|NCT00880568|26910560|P8|Overall Study|Disease progression|0
7739878|NCT00880568|26910561|P7|Overall Study|Disease progression|5
7739879|NCT00880568|26910562|P6|Overall Study|Disease progression|3
7739880|NCT00880568|26910563|P5|Overall Study|Disease progression|3
7739881|NCT00880568|26910564|P4|Overall Study|Disease progression|1
7739882|NCT00880568|26910565|P3|Overall Study|Disease progression|3
7739883|NCT00880568|26910566|P2|Overall Study|Disease progression|3
7739884|NCT00880568|26910567|P1|Overall Study|Disease progression|3
7739885|NCT00880555|26910613|P6|Overall Study|Lost to Follow-up|0
7739886|NCT00880555|26910614|P5|Overall Study|Lost to Follow-up|0
7739887|NCT00880555|26910615|P4|Overall Study|Lost to Follow-up|0
7739888|NCT00880555|26910616|P3|Overall Study|Lost to Follow-up|0
7739889|NCT00880555|26910617|P2|Overall Study|Lost to Follow-up|1
7739890|NCT00880555|26910618|P1|Overall Study|Lost to Follow-up|0
7739891|NCT00880555|26910613|P6|Overall Study|Death|1
7739892|NCT00880555|26910614|P5|Overall Study|Death|0
7739893|NCT00880555|26910615|P4|Overall Study|Death|0
7739894|NCT00880555|26910616|P3|Overall Study|Death|0
7739895|NCT00880555|26910617|P2|Overall Study|Death|0
7739896|NCT00880555|26910618|P1|Overall Study|Death|0
7739897|NCT00880555|26910613|P6|Overall Study|Lack of resources (hired rater)|0
7739898|NCT00880555|26910614|P5|Overall Study|Lack of resources (hired rater)|0
7739899|NCT00880555|26910615|P4|Overall Study|Lack of resources (hired rater)|0
7739900|NCT00880555|26910616|P3|Overall Study|Lack of resources (hired rater)|5
7739901|NCT00880555|26910617|P2|Overall Study|Lack of resources (hired rater)|7
7739902|NCT00880555|26910618|P1|Overall Study|Lack of resources (hired rater)|9
7739903|NCT00880555|26910613|P6|Overall Study|Withdrawal by Subject|0
7739904|NCT00880555|26910614|P5|Overall Study|Withdrawal by Subject|0
7739905|NCT00880555|26910615|P4|Overall Study|Withdrawal by Subject|0
7739906|NCT00880555|26910616|P3|Overall Study|Withdrawal by Subject|0
7739907|NCT00880555|26910617|P2|Overall Study|Withdrawal by Subject|1
7739908|NCT00880555|26910618|P1|Overall Study|Withdrawal by Subject|1
7739909|NCT00880555|26910613|P6|Overall Study|Physician Decision|0
7739910|NCT00880555|26910614|P5|Overall Study|Physician Decision|1
7739911|NCT00880555|26910615|P4|Overall Study|Physician Decision|2
7739912|NCT00880555|26910616|P3|Overall Study|Physician Decision|0
7739913|NCT00880555|26910617|P2|Overall Study|Physician Decision|8
7739914|NCT00880555|26910618|P1|Overall Study|Physician Decision|0
7739915|NCT00880542|26910629|P1|REP: Surgical Resection|progressive disease|1
7739916|NCT00880542|26910629|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
7739917|NCT00880542|26910629|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
7739918|NCT00880399|26910646|P3|Overall Study|Withdrawal by Subject|3
7739919|NCT00880399|26910647|P2|Overall Study|Withdrawal by Subject|3
7739920|NCT00880399|26910648|P1|Overall Study|Withdrawal by Subject|6
7739921|NCT00880399|26910646|P3|Overall Study|Physician Decision|3
7739922|NCT00880399|26910647|P2|Overall Study|Physician Decision|0
7739923|NCT00880399|26910648|P1|Overall Study|Physician Decision|5
7739924|NCT00880399|26910646|P3|Overall Study|Lost to Follow-up|3
7739925|NCT00880399|26910647|P2|Overall Study|Lost to Follow-up|5
7739926|NCT00880399|26910648|P1|Overall Study|Lost to Follow-up|8
7739927|NCT00880399|26910646|P3|Overall Study|Study closed/terminated|4
7739928|NCT00880399|26910647|P2|Overall Study|Study closed/terminated|7
7739929|NCT00880399|26910648|P1|Overall Study|Study closed/terminated|3
7739930|NCT00880399|26910646|P3|Overall Study|Protocol Violation|6
7739931|NCT00880399|26910647|P2|Overall Study|Protocol Violation|4
7739932|NCT00880399|26910648|P1|Overall Study|Protocol Violation|4
7739933|NCT00880399|26910646|P3|Overall Study|Lack of Efficacy|2
7739934|NCT00880399|26910647|P2|Overall Study|Lack of Efficacy|4
7739935|NCT00880399|26910648|P1|Overall Study|Lack of Efficacy|1
7739936|NCT00880399|26910646|P3|Overall Study|Adverse Event|5
7739937|NCT00880399|26910647|P2|Overall Study|Adverse Event|6
7739938|NCT00880399|26910648|P1|Overall Study|Adverse Event|4
7739939|NCT00880334|26910711|P2|Randomized Phase|Crossover Participants|37
7739940|NCT00880334|26910712|P1|Randomized Phase|Crossover Participants|0
7739941|NCT00880334|26910711|P2|Randomized Phase|Brain Metastasis|1
7739942|NCT00880334|26910712|P1|Randomized Phase|Brain Metastasis|0
7739943|NCT00880334|26910711|P2|Randomized Phase|Inadequate Labs|1
7739944|NCT00880334|26910712|P1|Randomized Phase|Inadequate Labs|1
7739945|NCT00880334|26910711|P2|Randomized Phase|Withdrawal by Subject|1
7739946|NCT00880334|26910712|P1|Randomized Phase|Withdrawal by Subject|2
7739947|NCT00880334|26910711|P2|Randomized Phase|Physician Decision|0
7739948|NCT00880334|26910712|P1|Randomized Phase|Physician Decision|1
7739949|NCT00880269|26910729|P2|Overall Study|Adverse Event|9
7739950|NCT00880269|26910730|P1|Overall Study|Adverse Event|10
7739951|NCT00880269|26910729|P2|Overall Study|Withdrawal by Subject|4
7739952|NCT00880269|26910730|P1|Overall Study|Withdrawal by Subject|3
7739953|NCT00880269|26910729|P2|Overall Study|Lost to Follow-up|1
7739954|NCT00880269|26910730|P1|Overall Study|Lost to Follow-up|0
7739955|NCT00880269|26910729|P2|Overall Study|Death|2
7739956|NCT00880269|26910730|P1|Overall Study|Death|4
7739957|NCT00880269|26910729|P2|Overall Study|New Cancer Therapy|0
7739958|NCT00880269|26910730|P1|Overall Study|New Cancer Therapy|1
7739959|NCT00880269|26910729|P2|Overall Study|Disease Progression|11
7739960|NCT00880269|26910730|P1|Overall Study|Disease Progression|13
7739961|NCT00880269|26910729|P2|Overall Study|Protocol Violation|0
7739962|NCT00880269|26910730|P1|Overall Study|Protocol Violation|1
7739963|NCT00880256|26910746|P1|Overall Study|Lost to Follow-up|28
7739964|NCT00880191|26910773|P2|Overall Study|Hospitalization/efficacy|1
7739965|NCT00880191|26910774|P1|Overall Study|Hospitalization/efficacy|1
7739966|NCT00880191|26910773|P2|Overall Study|Adverse Event|6
7739967|NCT00880191|26910774|P1|Overall Study|Adverse Event|8
7739968|NCT00880191|26910773|P2|Overall Study|Refused further treatment|1
7739969|NCT00880191|26910774|P1|Overall Study|Refused further treatment|4
7739970|NCT00880165|26910794|P2|Overall Study|Lost to follow|15
7739971|NCT00880165|26910795|P1|Overall Study|Lost to follow|9
7739972|NCT00880165|26910794|P2|Overall Study|Required BIPAP or oxygen treatment|4
7739973|NCT00880165|26910795|P1|Overall Study|Required BIPAP or oxygen treatment|12
7739974|NCT00880165|26910794|P2|Overall Study|Not diagnosed with OSA|8
7739975|NCT00880165|26910795|P1|Overall Study|Not diagnosed with OSA|14
7739976|NCT00880165|26910794|P2|Overall Study|Withdrawal by Subject|23
7739977|NCT00880165|26910795|P1|Overall Study|Withdrawal by Subject|27
7739978|NCT00880100|26910805|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
7739979|NCT00880100|26910805|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
7739980|NCT00880100|26910805|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
7739981|NCT00880087|26910818|P2|Overall Study|Lost to Follow-up|2
7739982|NCT00880087|26910819|P1|Overall Study|Lost to Follow-up|0
7739983|NCT00880048|26910834|P3|Overall Study|Study closed/terminated|6
7739984|NCT00880048|26910835|P2|Overall Study|Study closed/terminated|7
7739985|NCT00880048|26910836|P1|Overall Study|Study closed/terminated|9
7739986|NCT00880048|26910834|P3|Overall Study|Withdrawal by Subject|5
7739987|NCT00880048|26910835|P2|Overall Study|Withdrawal by Subject|8
7739988|NCT00880048|26910836|P1|Overall Study|Withdrawal by Subject|5
7739989|NCT00880048|26910834|P3|Overall Study|Physician Decision|7
7739990|NCT00880048|26910835|P2|Overall Study|Physician Decision|1
7739991|NCT00880048|26910836|P1|Overall Study|Physician Decision|1
7739992|NCT00880048|26910834|P3|Overall Study|Lost to Follow-up|5
7739993|NCT00880048|26910835|P2|Overall Study|Lost to Follow-up|6
7739994|NCT00880048|26910836|P1|Overall Study|Lost to Follow-up|6
7739995|NCT00880048|26910834|P3|Overall Study|Protocol Violation|5
7739996|NCT00880048|26910835|P2|Overall Study|Protocol Violation|6
7739997|NCT00880048|26910836|P1|Overall Study|Protocol Violation|4
7739998|NCT00880048|26910834|P3|Overall Study|Lack of Efficacy|2
7739999|NCT00880048|26910835|P2|Overall Study|Lack of Efficacy|2
7740000|NCT00880048|26910836|P1|Overall Study|Lack of Efficacy|1
7740001|NCT00880048|26910834|P3|Overall Study|Adverse Event|5
7740002|NCT00880048|26910835|P2|Overall Study|Adverse Event|3
7740003|NCT00880048|26910836|P1|Overall Study|Adverse Event|2
7740004|NCT00880009|26910903|P1|Overall Study|Protocol Violation|1
7740005|NCT00880009|26910903|P1|Overall Study|Withdrawal by Subject|1
7740006|NCT00880009|26910903|P1|Overall Study|Study terminated by sponsor|14
7740007|NCT00879996|26910927|P2|Overall Study|put on parole|0
7740008|NCT00879996|26910928|P1|Overall Study|put on parole|1
7740009|NCT00879996|26910927|P2|Overall Study|psychiatric problem|1
7740010|NCT00879996|26910928|P1|Overall Study|psychiatric problem|0
7740011|NCT00879996|26910927|P2|Overall Study|Physician Decision|2
7740012|NCT00879996|26910928|P1|Overall Study|Physician Decision|1
7740013|NCT00879996|26910927|P2|Overall Study|non-compliance|4
7740014|NCT00879996|26910928|P1|Overall Study|non-compliance|6
7740015|NCT00879996|26910927|P2|Overall Study|Lost to Follow-up|6
7740016|NCT00879996|26910928|P1|Overall Study|Lost to Follow-up|7
7740017|NCT00879970|26910943|P5|Period 2 Vitamin D Randomization|Death|0
7740018|NCT00879970|26910944|P4|Period 2 Vitamin D Randomization|Death|2
7740019|NCT00879970|26910945|P3|Period 2 Vitamin D Randomization|Death|0
7740020|NCT00879970|26910946|P2|Period 2 Vitamin D Randomization|Death|0
7740021|NCT00879970|26910947|P1|Period 2 Vitamin D Randomization|Death|0
7740022|NCT00879970|26910943|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
7740023|NCT00879970|26910944|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7740024|NCT00879970|26910945|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7740025|NCT00879970|26910946|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7740026|NCT00879970|26910947|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7740027|NCT00879970|26910943|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
7740028|NCT00879970|26910944|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
7740029|NCT00879970|26910945|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7740030|NCT00879970|26910946|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7740031|NCT00879970|26910947|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7740032|NCT00879970|26910943|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7740033|NCT00879970|26910944|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7740034|NCT00879970|26910945|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
7740035|NCT00879970|26910946|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7740036|NCT00879970|26910947|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
7740037|NCT00879970|26910943|P5|Period 1 TZD Randomization|Death|0
7740038|NCT00879970|26910944|P4|Period 1 TZD Randomization|Death|0
7740039|NCT00879970|26910945|P3|Period 1 TZD Randomization|Death|0
7740040|NCT00879970|26910946|P2|Period 1 TZD Randomization|Death|1
7740041|NCT00879970|26910947|P1|Period 1 TZD Randomization|Death|2
7740042|NCT00879970|26910943|P5|Period 1 TZD Randomization|Lost to Follow-up|0
7740043|NCT00879970|26910944|P4|Period 1 TZD Randomization|Lost to Follow-up|0
7740044|NCT00879970|26910945|P3|Period 1 TZD Randomization|Lost to Follow-up|1
7740045|NCT00879970|26910946|P2|Period 1 TZD Randomization|Lost to Follow-up|0
7740046|NCT00879970|26910947|P1|Period 1 TZD Randomization|Lost to Follow-up|1
7740047|NCT00879970|26910943|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
7740048|NCT00879970|26910944|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
7740049|NCT00879970|26910945|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
7740050|NCT00879970|26910946|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
7740051|NCT00879970|26910947|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
7740052|NCT00879879|26911029|P1|Overall Study|Physician Decision|1
7740053|NCT00879879|26911029|P1|Overall Study|Withdrawal by Subject|1
7740054|NCT00879879|26911029|P1|Overall Study|Death|1
7740055|NCT00879814|26911041|P4|Overall Study|Other|0
7740056|NCT00879814|26911042|P3|Overall Study|Other|1
7740057|NCT00879814|26911043|P2|Overall Study|Other|0
7740058|NCT00879814|26911044|P1|Overall Study|Other|0
7740059|NCT00879814|26911041|P4|Overall Study|Physician Decision|0
7740060|NCT00879814|26911042|P3|Overall Study|Physician Decision|1
7740061|NCT00879814|26911043|P2|Overall Study|Physician Decision|0
7740062|NCT00879814|26911044|P1|Overall Study|Physician Decision|0
7740063|NCT00879814|26911041|P4|Overall Study|Withdrawal by Subject|2
7740064|NCT00879814|26911042|P3|Overall Study|Withdrawal by Subject|1
7740065|NCT00879814|26911043|P2|Overall Study|Withdrawal by Subject|1
7740066|NCT00879814|26911044|P1|Overall Study|Withdrawal by Subject|3
7740067|NCT00879814|26911041|P4|Overall Study|Participant Failed to Return|1
7740068|NCT00879814|26911042|P3|Overall Study|Participant Failed to Return|0
7740069|NCT00879814|26911043|P2|Overall Study|Participant Failed to Return|0
7740070|NCT00879814|26911044|P1|Overall Study|Participant Failed to Return|0
7740071|NCT00879814|26911041|P4|Overall Study|Lost to Follow-up|2
7740072|NCT00879814|26911042|P3|Overall Study|Lost to Follow-up|0
7740073|NCT00879814|26911043|P2|Overall Study|Lost to Follow-up|0
7740074|NCT00879814|26911044|P1|Overall Study|Lost to Follow-up|1
7740075|NCT00879814|26911041|P4|Overall Study|Adverse Event|0
7740076|NCT00879814|26911042|P3|Overall Study|Adverse Event|0
7740077|NCT00879814|26911043|P2|Overall Study|Adverse Event|1
7740078|NCT00879814|26911044|P1|Overall Study|Adverse Event|0
7740079|NCT00879775|26911152|P2|Overall Study|Lost to Follow-up|1
7740080|NCT00879775|26911153|P1|Overall Study|Lost to Follow-up|2
7740081|NCT00879710|26911169|P4|Phase 1 - 6 Weeks|Adverse Event|0
7740082|NCT00879710|26911170|P3|Phase 1 - 6 Weeks|Adverse Event|1
7740083|NCT00879710|26911171|P2|Phase 1 - 6 Weeks|Adverse Event|0
7740084|NCT00879710|26911172|P1|Phase 1 - 6 Weeks|Adverse Event|0
7740085|NCT00879710|26911169|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
7740086|NCT00879710|26911170|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
7740087|NCT00879710|26911171|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
7740088|NCT00879710|26911172|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
7740089|NCT00879697|26911182|P2|Overall Study|Physician Decision|2
7740090|NCT00879697|26911183|P1|Overall Study|Physician Decision|2
7740091|NCT00879684|26911189|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
7740092|NCT00879684|26911190|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
7740093|NCT00879684|26911191|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
7740094|NCT00879684|26911192|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
7740095|NCT00879684|26911193|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
7740096|NCT00879684|26911194|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
7740097|NCT00879684|26911195|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
7740098|NCT00879684|26911189|P7|Stage 2: Expanded Cohort|Progressive Disease|11
7740099|NCT00879684|26911190|P6|Stage 2: Expanded Cohort|Progressive Disease|0
7740100|NCT00879684|26911191|P5|Stage 2: Expanded Cohort|Progressive Disease|0
7740101|NCT00879684|26911192|P4|Stage 2: Expanded Cohort|Progressive Disease|0
7740102|NCT00879684|26911193|P3|Stage 2: Expanded Cohort|Progressive Disease|0
7740103|NCT00879684|26911194|P2|Stage 2: Expanded Cohort|Progressive Disease|0
7740104|NCT00879684|26911195|P1|Stage 2: Expanded Cohort|Progressive Disease|0
7740105|NCT00879684|26911189|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
7740106|NCT00879684|26911190|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
7740107|NCT00879684|26911191|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
7740108|NCT00879684|26911192|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
7740109|NCT00879684|26911193|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
7740110|NCT00879684|26911194|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
7740111|NCT00879684|26911195|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
7740112|NCT00879684|26911189|P7|Stage 1: Dose Escalation|Death|0
7740113|NCT00879684|26911190|P6|Stage 1: Dose Escalation|Death|0
7740114|NCT00879684|26911191|P5|Stage 1: Dose Escalation|Death|0
7740115|NCT00879684|26911192|P4|Stage 1: Dose Escalation|Death|0
7740116|NCT00879684|26911193|P3|Stage 1: Dose Escalation|Death|1
7740117|NCT00879684|26911194|P2|Stage 1: Dose Escalation|Death|0
7740118|NCT00879684|26911195|P1|Stage 1: Dose Escalation|Death|0
7740119|NCT00879684|26911189|P7|Stage 1: Dose Escalation|Investigator declined participation|0
7740120|NCT00879684|26911190|P6|Stage 1: Dose Escalation|Investigator declined participation|0
7740121|NCT00879684|26911191|P5|Stage 1: Dose Escalation|Investigator declined participation|0
7740122|NCT00879684|26911192|P4|Stage 1: Dose Escalation|Investigator declined participation|2
7740123|NCT00879684|26911193|P3|Stage 1: Dose Escalation|Investigator declined participation|2
7740124|NCT00879684|26911194|P2|Stage 1: Dose Escalation|Investigator declined participation|0
7740125|NCT00879684|26911195|P1|Stage 1: Dose Escalation|Investigator declined participation|0
7740126|NCT00879684|26911189|P7|Stage 1: Dose Escalation|Progressive Disease|0
7740127|NCT00879684|26911190|P6|Stage 1: Dose Escalation|Progressive Disease|3
7740128|NCT00879684|26911191|P5|Stage 1: Dose Escalation|Progressive Disease|3
7740129|NCT00879684|26911192|P4|Stage 1: Dose Escalation|Progressive Disease|4
7740130|NCT00879684|26911193|P3|Stage 1: Dose Escalation|Progressive Disease|0
7740131|NCT00879684|26911194|P2|Stage 1: Dose Escalation|Progressive Disease|3
7740132|NCT00879684|26911195|P1|Stage 1: Dose Escalation|Progressive Disease|2
7740133|NCT00879684|26911189|P7|Stage 1: Dose Escalation|Adverse Event|0
7740134|NCT00879684|26911190|P6|Stage 1: Dose Escalation|Adverse Event|0
7740135|NCT00879684|26911191|P5|Stage 1: Dose Escalation|Adverse Event|0
7740136|NCT00879684|26911192|P4|Stage 1: Dose Escalation|Adverse Event|0
7740137|NCT00879684|26911193|P3|Stage 1: Dose Escalation|Adverse Event|0
7740138|NCT00879684|26911194|P2|Stage 1: Dose Escalation|Adverse Event|0
7740139|NCT00879684|26911195|P1|Stage 1: Dose Escalation|Adverse Event|1
7740140|NCT00879658|26911264|P7|Overall Study|misrandomized (never received study med)|0
7740141|NCT00879658|26911265|P6|Overall Study|misrandomized (never received study med)|0
7740142|NCT00879658|26911266|P5|Overall Study|misrandomized (never received study med)|0
7740143|NCT00879658|26911267|P4|Overall Study|misrandomized (never received study med)|1
7740144|NCT00879658|26911268|P3|Overall Study|misrandomized (never received study med)|0
7740145|NCT00879658|26911269|P2|Overall Study|misrandomized (never received study med)|0
7740146|NCT00879658|26911270|P1|Overall Study|misrandomized (never received study med)|0
7740147|NCT00879658|26911264|P7|Overall Study|Lack of Efficacy|0
7740148|NCT00879658|26911265|P6|Overall Study|Lack of Efficacy|0
7740149|NCT00879658|26911266|P5|Overall Study|Lack of Efficacy|0
7740150|NCT00879658|26911267|P4|Overall Study|Lack of Efficacy|0
7740151|NCT00879658|26911268|P3|Overall Study|Lack of Efficacy|2
7740152|NCT00879658|26911269|P2|Overall Study|Lack of Efficacy|0
7740153|NCT00879658|26911270|P1|Overall Study|Lack of Efficacy|0
7740154|NCT00879658|26911264|P7|Overall Study|Withdrawal by Subject|0
7740155|NCT00879658|26911265|P6|Overall Study|Withdrawal by Subject|1
7740156|NCT00879658|26911266|P5|Overall Study|Withdrawal by Subject|0
7740157|NCT00879658|26911267|P4|Overall Study|Withdrawal by Subject|0
7740158|NCT00879658|26911268|P3|Overall Study|Withdrawal by Subject|2
7740159|NCT00879658|26911269|P2|Overall Study|Withdrawal by Subject|0
7740160|NCT00879658|26911270|P1|Overall Study|Withdrawal by Subject|3
7740161|NCT00879658|26911264|P7|Overall Study|Protocol Violation|0
7740162|NCT00879658|26911265|P6|Overall Study|Protocol Violation|0
7740163|NCT00879658|26911266|P5|Overall Study|Protocol Violation|0
7740164|NCT00879658|26911267|P4|Overall Study|Protocol Violation|0
7740165|NCT00879658|26911268|P3|Overall Study|Protocol Violation|0
7740166|NCT00879658|26911269|P2|Overall Study|Protocol Violation|0
7740167|NCT00879658|26911270|P1|Overall Study|Protocol Violation|1
7740168|NCT00879658|26911264|P7|Overall Study|Adverse Event|0
7740169|NCT00879658|26911265|P6|Overall Study|Adverse Event|0
7740170|NCT00879658|26911266|P5|Overall Study|Adverse Event|2
7740171|NCT00879658|26911267|P4|Overall Study|Adverse Event|1
7740172|NCT00879658|26911268|P3|Overall Study|Adverse Event|3
7740173|NCT00879658|26911269|P2|Overall Study|Adverse Event|4
7740174|NCT00879658|26911270|P1|Overall Study|Adverse Event|6
7740175|NCT00879658|26911264|P7|Overall Study|Administrative problems|0
7740176|NCT00879658|26911265|P6|Overall Study|Administrative problems|0
7740177|NCT00879658|26911266|P5|Overall Study|Administrative problems|0
7740178|NCT00879658|26911267|P4|Overall Study|Administrative problems|1
7740179|NCT00879658|26911268|P3|Overall Study|Administrative problems|0
7740180|NCT00879658|26911269|P2|Overall Study|Administrative problems|1
7740181|NCT00879658|26911270|P1|Overall Study|Administrative problems|2
7740182|NCT00879658|26911264|P7|Overall Study|Abnormal laboratory value(s)|0
7740183|NCT00879658|26911265|P6|Overall Study|Abnormal laboratory value(s)|0
7740184|NCT00879658|26911266|P5|Overall Study|Abnormal laboratory value(s)|0
7740185|NCT00879658|26911267|P4|Overall Study|Abnormal laboratory value(s)|1
7740186|NCT00879658|26911268|P3|Overall Study|Abnormal laboratory value(s)|0
7740187|NCT00879658|26911269|P2|Overall Study|Abnormal laboratory value(s)|0
7740188|NCT00879658|26911270|P1|Overall Study|Abnormal laboratory value(s)|3
7740189|NCT00879645|26911356|P4|Overall Study|Adverse Event|0
7740190|NCT00879645|26911357|P3|Overall Study|Adverse Event|0
7740191|NCT00879645|26911358|P2|Overall Study|Adverse Event|0
7740192|NCT00879645|26911359|P1|Overall Study|Adverse Event|1
7740193|NCT00879437|26911386|P2|Overall Study|Death|0
7740194|NCT00879437|26911387|P1|Overall Study|Death|1
7740195|NCT00879437|26911386|P2|Overall Study|Protocol Violation|1
7740196|NCT00879437|26911387|P1|Overall Study|Protocol Violation|0
7740197|NCT00879411|26911438|P1|Overall Study|lost to follow-up (non-AE)|162
7740198|NCT00879398|26911444|P1|Overall Study|Other Reasons|171
7740199|NCT00879398|26911444|P1|Overall Study|Adverse Event|41
7740200|NCT00879398|26911444|P1|Overall Study|Lack of Efficacy|64
7740201|NCT00879398|26911444|P1|Overall Study|Visit Stop|399
7740202|NCT00879333|26911462|P2|Overall Study|Protocol Violation|1
7740203|NCT00879333|26911463|P1|Overall Study|Protocol Violation|1
7740204|NCT00879333|26911462|P2|Overall Study|Disease Progression|169
7740205|NCT00879333|26911463|P1|Overall Study|Disease Progression|292
7740206|NCT00879333|26911462|P2|Overall Study|Death|5
7740207|NCT00879333|26911463|P1|Overall Study|Death|16
7740208|NCT00879333|26911462|P2|Overall Study|Administrative Problems|0
7740209|NCT00879333|26911463|P1|Overall Study|Administrative Problems|2
7740210|NCT00879333|26911462|P2|Overall Study|Lost to Follow-up|1
7740211|NCT00879333|26911463|P1|Overall Study|Lost to Follow-up|2
7740212|NCT00879333|26911462|P2|Overall Study|Withdrawal by Subject|7
7740213|NCT00879333|26911463|P1|Overall Study|Withdrawal by Subject|20
7740214|NCT00879333|26911462|P2|Overall Study|Abnormal Laboratory Value|0
7740215|NCT00879333|26911463|P1|Overall Study|Abnormal Laboratory Value|1
7740216|NCT00879333|26911462|P2|Overall Study|Adverse Event|34
7740217|NCT00879333|26911463|P1|Overall Study|Adverse Event|94
7740218|NCT00879229|26911496|P2|Overall Study|Other|0
7740219|NCT00879229|26911497|P1|Overall Study|Other|1
7740220|NCT00879229|26911496|P2|Overall Study|Clinical status did not improve|0
7740221|NCT00879229|26911497|P1|Overall Study|Clinical status did not improve|1
7740222|NCT00879229|26911496|P2|Overall Study|Withdrawal by Subject|0
7740223|NCT00879229|26911497|P1|Overall Study|Withdrawal by Subject|1
7740224|NCT00879229|26911496|P2|Overall Study|Adverse Event|0
7740225|NCT00879229|26911497|P1|Overall Study|Adverse Event|2
7740226|NCT00879229|26911496|P2|Overall Study|Death|2
7740227|NCT00879229|26911497|P1|Overall Study|Death|4
7740228|NCT00879229|26911496|P2|Overall Study|Study terminated by Sponsor|12
7740229|NCT00879229|26911497|P1|Overall Study|Study terminated by Sponsor|13
7740230|NCT00878995|26911568|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
7740231|NCT00878995|26911569|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
7740232|NCT00878969|26911670|P3|Overall Study|Pregnancy|0
7740233|NCT00878969|26911671|P2|Overall Study|Pregnancy|1
7740234|NCT00878969|26911672|P1|Overall Study|Pregnancy|0
7740235|NCT00878969|26911670|P3|Overall Study|Death|2
7740236|NCT00878969|26911671|P2|Overall Study|Death|0
7740237|NCT00878969|26911672|P1|Overall Study|Death|0
7740238|NCT00878969|26911670|P3|Overall Study|Protocol Violation|0
7740239|NCT00878969|26911671|P2|Overall Study|Protocol Violation|0
7740240|NCT00878969|26911672|P1|Overall Study|Protocol Violation|2
7740241|NCT00878969|26911670|P3|Overall Study|Lost to Follow-up|0
7740242|NCT00878969|26911671|P2|Overall Study|Lost to Follow-up|1
7740243|NCT00878969|26911672|P1|Overall Study|Lost to Follow-up|2
7740244|NCT00878969|26911670|P3|Overall Study|Adverse Event|2
7740245|NCT00878969|26911671|P2|Overall Study|Adverse Event|1
7740246|NCT00878969|26911672|P1|Overall Study|Adverse Event|3
7740247|NCT00878969|26911670|P3|Overall Study|kidney transplant|2
7740248|NCT00878969|26911671|P2|Overall Study|kidney transplant|3
7740249|NCT00878969|26911672|P1|Overall Study|kidney transplant|2
7740250|NCT00878969|26911670|P3|Overall Study|Withdrawal by Subject|3
7740251|NCT00878969|26911671|P2|Overall Study|Withdrawal by Subject|6
7740252|NCT00878969|26911672|P1|Overall Study|Withdrawal by Subject|1
7740253|NCT00878969|26911670|P3|Overall Study|Physician Decision|2
7740254|NCT00878969|26911671|P2|Overall Study|Physician Decision|3
7740255|NCT00878969|26911672|P1|Overall Study|Physician Decision|5
7740256|NCT00878800|26911720|P5|Overall Study|Other|1
7740257|NCT00878800|26911721|P4|Overall Study|Other|0
7740258|NCT00878800|26911722|P3|Overall Study|Other|0
7740259|NCT00878800|26911723|P2|Overall Study|Other|1
7740260|NCT00878800|26911724|P1|Overall Study|Other|1
7740261|NCT00878800|26911720|P5|Overall Study|Death|0
7740262|NCT00878800|26911721|P4|Overall Study|Death|0
7740263|NCT00878800|26911722|P3|Overall Study|Death|1
7740264|NCT00878800|26911723|P2|Overall Study|Death|0
7740265|NCT00878800|26911724|P1|Overall Study|Death|0
7740266|NCT00878800|26911720|P5|Overall Study|Withdrew consent|1
7740267|NCT00878800|26911721|P4|Overall Study|Withdrew consent|1
7740268|NCT00878800|26911722|P3|Overall Study|Withdrew consent|0
7740269|NCT00878800|26911723|P2|Overall Study|Withdrew consent|1
7740270|NCT00878800|26911724|P1|Overall Study|Withdrew consent|1
7740271|NCT00878800|26911720|P5|Overall Study|Progressive disease|13
7740272|NCT00878800|26911721|P4|Overall Study|Progressive disease|5
7740273|NCT00878800|26911722|P3|Overall Study|Progressive disease|6
7740274|NCT00878800|26911723|P2|Overall Study|Progressive disease|5
7740275|NCT00878800|26911724|P1|Overall Study|Progressive disease|1
7740276|NCT00878800|26911720|P5|Overall Study|Adverse Event|1
7740277|NCT00878800|26911721|P4|Overall Study|Adverse Event|0
7740278|NCT00878800|26911722|P3|Overall Study|Adverse Event|2
7740279|NCT00878800|26911723|P2|Overall Study|Adverse Event|0
7740280|NCT00878800|26911724|P1|Overall Study|Adverse Event|0
7740281|NCT00878722|26911759|P8|Overall Study|Relapse|0
7740282|NCT00878722|26911760|P7|Overall Study|Relapse|0
7740283|NCT00878722|26911761|P6|Overall Study|Relapse|0
7740284|NCT00878722|26911762|P5|Overall Study|Relapse|0
7740285|NCT00878722|26911763|P4|Overall Study|Relapse|1
7740286|NCT00878722|26911764|P3|Overall Study|Relapse|0
7740287|NCT00878722|26911765|P2|Overall Study|Relapse|0
7740288|NCT00878722|26911766|P1|Overall Study|Relapse|0
7740289|NCT00878722|26911759|P8|Overall Study|Withdrawal by Subject|2
7740290|NCT00878722|26911760|P7|Overall Study|Withdrawal by Subject|0
7740291|NCT00878722|26911761|P6|Overall Study|Withdrawal by Subject|0
7740292|NCT00878722|26911762|P5|Overall Study|Withdrawal by Subject|0
7740293|NCT00878722|26911763|P4|Overall Study|Withdrawal by Subject|0
7740294|NCT00878722|26911764|P3|Overall Study|Withdrawal by Subject|0
7740295|NCT00878722|26911765|P2|Overall Study|Withdrawal by Subject|0
7740296|NCT00878722|26911766|P1|Overall Study|Withdrawal by Subject|0
7740297|NCT00878722|26911759|P8|Overall Study|Adverse Event|0
7740298|NCT00878722|26911760|P7|Overall Study|Adverse Event|2
7740299|NCT00878722|26911761|P6|Overall Study|Adverse Event|0
7740300|NCT00878722|26911762|P5|Overall Study|Adverse Event|0
7740301|NCT00878722|26911763|P4|Overall Study|Adverse Event|0
7740302|NCT00878722|26911764|P3|Overall Study|Adverse Event|0
7740303|NCT00878722|26911765|P2|Overall Study|Adverse Event|0
7740304|NCT00878722|26911766|P1|Overall Study|Adverse Event|0
7740305|NCT00878722|26911759|P8|Overall Study|Death|2
7740306|NCT00878722|26911760|P7|Overall Study|Death|0
7740307|NCT00878722|26911761|P6|Overall Study|Death|1
7740308|NCT00878722|26911762|P5|Overall Study|Death|0
7740309|NCT00878722|26911763|P4|Overall Study|Death|1
7740310|NCT00878722|26911764|P3|Overall Study|Death|0
7740311|NCT00878722|26911765|P2|Overall Study|Death|0
7740312|NCT00878722|26911766|P1|Overall Study|Death|0
7740313|NCT00878722|26911759|P8|Overall Study|Progressive disease|3
7740314|NCT00878722|26911760|P7|Overall Study|Progressive disease|4
7740315|NCT00878722|26911761|P6|Overall Study|Progressive disease|1
7740316|NCT00878722|26911762|P5|Overall Study|Progressive disease|7
7740317|NCT00878722|26911763|P4|Overall Study|Progressive disease|7
7740318|NCT00878722|26911764|P3|Overall Study|Progressive disease|3
7740319|NCT00878722|26911765|P2|Overall Study|Progressive disease|3
7740320|NCT00878722|26911766|P1|Overall Study|Progressive disease|3
7740321|NCT00878709|26911851|P2|Overall Study|Other Reasons|84
7740322|NCT00878709|26911852|P1|Overall Study|Other Reasons|93
7740323|NCT00878709|26911851|P2|Overall Study|Lost to Follow-up|33
7740324|NCT00878709|26911852|P1|Overall Study|Lost to Follow-up|35
7740325|NCT00878709|26911851|P2|Overall Study|Withdrawal by Subject|120
7740326|NCT00878709|26911852|P1|Overall Study|Withdrawal by Subject|197
7740327|NCT00878553|26911926|P5|PK Study|Withdrawal by Subject|0
7740328|NCT00878553|26911927|P4|PK Study|Withdrawal by Subject|1
7740329|NCT00878553|26911928|P3|PK Study|Withdrawal by Subject|0
7740330|NCT00878553|26911929|P2|PK Study|Withdrawal by Subject|0
7740331|NCT00878553|26911930|P1|PK Study|Withdrawal by Subject|0
7740332|NCT00878553|26911926|P5|Sleep Study|family emergency|0
7740333|NCT00878553|26911927|P4|Sleep Study|family emergency|0
7740334|NCT00878553|26911928|P3|Sleep Study|family emergency|0
7740335|NCT00878553|26911929|P2|Sleep Study|family emergency|0
7740336|NCT00878553|26911930|P1|Sleep Study|family emergency|1
7740337|NCT00878553|26911926|P5|Sleep Study|car accident|0
7740338|NCT00878553|26911927|P4|Sleep Study|car accident|0
7740339|NCT00878553|26911928|P3|Sleep Study|car accident|0
7740340|NCT00878553|26911929|P2|Sleep Study|car accident|0
7740341|NCT00878553|26911930|P1|Sleep Study|car accident|1
7740342|NCT00878553|26911926|P5|Sleep Study|Lost to Follow-up|0
7740343|NCT00878553|26911927|P4|Sleep Study|Lost to Follow-up|0
7740344|NCT00878553|26911928|P3|Sleep Study|Lost to Follow-up|0
7740345|NCT00878553|26911929|P2|Sleep Study|Lost to Follow-up|0
7740346|NCT00878553|26911930|P1|Sleep Study|Lost to Follow-up|1
7740347|NCT00878553|26911926|P5|Sleep Study|Withdrawal by Subject|0
7740348|NCT00878553|26911927|P4|Sleep Study|Withdrawal by Subject|0
7740349|NCT00878553|26911928|P3|Sleep Study|Withdrawal by Subject|0
7740350|NCT00878553|26911929|P2|Sleep Study|Withdrawal by Subject|0
7740351|NCT00878553|26911930|P1|Sleep Study|Withdrawal by Subject|2
7740352|NCT00878501|26911989|P3|Overall Study|Administrative|1
7740353|NCT00878501|26911990|P2|Overall Study|Administrative|0
7740354|NCT00878501|26911991|P1|Overall Study|Administrative|0
7740355|NCT00878501|26911989|P3|Overall Study|Mis-randomisation of patient|0
7740356|NCT00878501|26911990|P2|Overall Study|Mis-randomisation of patient|0
7740357|NCT00878501|26911991|P1|Overall Study|Mis-randomisation of patient|1
7740358|NCT00878501|26911989|P3|Overall Study|Intake of prohibited concom. medication|1
7740359|NCT00878501|26911990|P2|Overall Study|Intake of prohibited concom. medication|0
7740360|NCT00878501|26911991|P1|Overall Study|Intake of prohibited concom. medication|0
7740361|NCT00878501|26911989|P3|Overall Study|Incorrect enrolment|0
7740362|NCT00878501|26911990|P2|Overall Study|Incorrect enrolment|2
7740363|NCT00878501|26911991|P1|Overall Study|Incorrect enrolment|1
7740364|NCT00878501|26911989|P3|Overall Study|Protocol Violation|1
7740365|NCT00878501|26911990|P2|Overall Study|Protocol Violation|0
7740366|NCT00878501|26911991|P1|Overall Study|Protocol Violation|0
7740367|NCT00878501|26911989|P3|Overall Study|Withdrawal by Subject|2
7740368|NCT00878501|26911990|P2|Overall Study|Withdrawal by Subject|1
7740369|NCT00878501|26911991|P1|Overall Study|Withdrawal by Subject|2
7740370|NCT00878501|26911989|P3|Overall Study|Lack of Efficacy|0
7740371|NCT00878501|26911990|P2|Overall Study|Lack of Efficacy|1
7740372|NCT00878501|26911991|P1|Overall Study|Lack of Efficacy|2
7740373|NCT00878501|26911989|P3|Overall Study|Adverse Event|3
7740374|NCT00878501|26911990|P2|Overall Study|Adverse Event|3
7740375|NCT00878501|26911991|P1|Overall Study|Adverse Event|11
7740376|NCT00878215|26912040|P4|Overall Study|Determined to be ineligible|0
7740377|NCT00878215|26912041|P3|Overall Study|Determined to be ineligible|0
7740378|NCT00878215|26912042|P2|Overall Study|Determined to be ineligible|10
7740379|NCT00878215|26912043|P1|Overall Study|Determined to be ineligible|0
7740380|NCT00878189|26912055|P9|Overall Study|Objection Progression or Relapse|3
7740381|NCT00878189|26912056|P8|Overall Study|Objection Progression or Relapse|0
7740382|NCT00878189|26912057|P7|Overall Study|Objection Progression or Relapse|0
7740383|NCT00878189|26912058|P6|Overall Study|Objection Progression or Relapse|0
7740384|NCT00878189|26912059|P5|Overall Study|Objection Progression or Relapse|0
7740385|NCT00878189|26912060|P4|Overall Study|Objection Progression or Relapse|0
7740386|NCT00878189|26912061|P3|Overall Study|Objection Progression or Relapse|0
7740387|NCT00878189|26912062|P2|Overall Study|Objection Progression or Relapse|0
7740388|NCT00878189|26912063|P1|Overall Study|Objection Progression or Relapse|0
7740389|NCT00878189|26912055|P9|Overall Study|Lost to Follow-up|0
7740390|NCT00878189|26912056|P8|Overall Study|Lost to Follow-up|0
7740391|NCT00878189|26912057|P7|Overall Study|Lost to Follow-up|1
7740392|NCT00878189|26912058|P6|Overall Study|Lost to Follow-up|1
7740393|NCT00878189|26912059|P5|Overall Study|Lost to Follow-up|0
7740394|NCT00878189|26912060|P4|Overall Study|Lost to Follow-up|0
7740395|NCT00878189|26912061|P3|Overall Study|Lost to Follow-up|0
7740396|NCT00878189|26912062|P2|Overall Study|Lost to Follow-up|0
7740397|NCT00878189|26912063|P1|Overall Study|Lost to Follow-up|0
7740398|NCT00878189|26912055|P9|Overall Study|Other|4
7740399|NCT00878189|26912056|P8|Overall Study|Other|3
7740400|NCT00878189|26912057|P7|Overall Study|Other|15
7740401|NCT00878189|26912058|P6|Overall Study|Other|18
7740402|NCT00878189|26912059|P5|Overall Study|Other|4
7740403|NCT00878189|26912060|P4|Overall Study|Other|7
7740404|NCT00878189|26912061|P3|Overall Study|Other|4
7740405|NCT00878189|26912062|P2|Overall Study|Other|2
7740406|NCT00878189|26912063|P1|Overall Study|Other|3
7740407|NCT00878189|26912055|P9|Overall Study|Participant Refused to Follow-up|0
7740408|NCT00878189|26912056|P8|Overall Study|Participant Refused to Follow-up|0
7740409|NCT00878189|26912057|P7|Overall Study|Participant Refused to Follow-up|0
7740410|NCT00878189|26912058|P6|Overall Study|Participant Refused to Follow-up|4
7740411|NCT00878189|26912059|P5|Overall Study|Participant Refused to Follow-up|0
7740412|NCT00878189|26912060|P4|Overall Study|Participant Refused to Follow-up|0
7740413|NCT00878189|26912061|P3|Overall Study|Participant Refused to Follow-up|0
7740414|NCT00878189|26912062|P2|Overall Study|Participant Refused to Follow-up|0
7740415|NCT00878189|26912063|P1|Overall Study|Participant Refused to Follow-up|0
7740416|NCT00878189|26912055|P9|Overall Study|Death|1
7740417|NCT00878189|26912056|P8|Overall Study|Death|0
7740418|NCT00878189|26912057|P7|Overall Study|Death|0
7740419|NCT00878189|26912058|P6|Overall Study|Death|0
7740420|NCT00878189|26912059|P5|Overall Study|Death|0
7740421|NCT00878189|26912060|P4|Overall Study|Death|1
7740422|NCT00878189|26912061|P3|Overall Study|Death|0
7740423|NCT00878189|26912062|P2|Overall Study|Death|1
7740424|NCT00878189|26912063|P1|Overall Study|Death|0
7740425|NCT00878072|26912329|P1|Overall Study|Withdrew consent|2
7740426|NCT00877929|26912351|P2|Overall Study|Other reason (not specified)|6
7740427|NCT00877929|26912352|P1|Overall Study|Other reason (not specified)|2
7740428|NCT00877929|26912351|P2|Overall Study|Lack of Efficacy|1
7740429|NCT00877929|26912352|P1|Overall Study|Lack of Efficacy|0
7740430|NCT00877929|26912351|P2|Overall Study|Withdrawal by Subject|4
7740431|NCT00877929|26912352|P1|Overall Study|Withdrawal by Subject|4
7740432|NCT00877929|26912351|P2|Overall Study|Lost to Follow-up|1
7740433|NCT00877929|26912352|P1|Overall Study|Lost to Follow-up|0
7740434|NCT00877929|26912351|P2|Overall Study|Protocol Violation|3
7740435|NCT00877929|26912352|P1|Overall Study|Protocol Violation|3
7740436|NCT00877929|26912351|P2|Overall Study|Adverse Event|20
7740437|NCT00877929|26912352|P1|Overall Study|Adverse Event|11
7740438|NCT00877890|26912440|P2|Overall Study|Loss of Glucose Control|4
7740439|NCT00877890|26912441|P1|Overall Study|Loss of Glucose Control|3
7740440|NCT00877890|26912440|P2|Overall Study|Investigator Decision|2
7740441|NCT00877890|26912441|P1|Overall Study|Investigator Decision|0
7740442|NCT00877890|26912440|P2|Overall Study|Withdrawal of Consent|12
7740443|NCT00877890|26912441|P1|Overall Study|Withdrawal of Consent|6
7740444|NCT00877890|26912440|P2|Overall Study|Protocol Violation|1
7740445|NCT00877890|26912441|P1|Overall Study|Protocol Violation|0
7740446|NCT00877890|26912440|P2|Overall Study|Lost to Follow-up|5
7740447|NCT00877890|26912441|P1|Overall Study|Lost to Follow-up|5
7740448|NCT00877890|26912440|P2|Overall Study|Adverse Event|6
7740449|NCT00877890|26912441|P1|Overall Study|Adverse Event|6
7740450|NCT00877799|26912506|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
7740451|NCT00877799|26912507|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
7740452|NCT00877799|26912508|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7740453|NCT00877799|26912509|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7740454|NCT00877799|26912510|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7740455|NCT00877799|26912506|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7740456|NCT00877799|26912507|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
7740457|NCT00877799|26912508|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7740458|NCT00877799|26912509|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7740459|NCT00877799|26912510|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7740460|NCT00877799|26912506|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7740461|NCT00877799|26912507|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7740462|NCT00877799|26912508|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7740463|NCT00877799|26912509|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
7740464|NCT00877799|26912510|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7740465|NCT00877799|26912506|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
7740466|NCT00877799|26912507|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
7740467|NCT00877799|26912508|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
7740468|NCT00877799|26912509|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
7740469|NCT00877799|26912510|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
7740470|NCT00877799|26912506|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
7740471|NCT00877799|26912507|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
7740472|NCT00877799|26912508|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
7740473|NCT00877799|26912509|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
7740474|NCT00877799|26912510|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
7740475|NCT00877773|26912525|P1|Overall Study|Disease Progression|44
7740476|NCT00877487|26912538|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
7740477|NCT00877487|26912539|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
7740478|NCT00877487|26912538|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
7740479|NCT00877487|26912539|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
7740480|NCT00877487|26912538|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
7740481|NCT00877487|26912539|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
7740482|NCT00877487|26912538|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
7740483|NCT00877487|26912539|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
7740484|NCT00877487|26912538|P2|Open-label Treatment Phase|Out of country for business|0
7740485|NCT00877487|26912539|P1|Open-label Treatment Phase|Out of country for business|1
7740486|NCT00877487|26912538|P2|Open-label Treatment Phase|Lost to Follow-up|0
7740487|NCT00877487|26912539|P1|Open-label Treatment Phase|Lost to Follow-up|1
7740488|NCT00877487|26912538|P2|Open-label Treatment Phase|Withdrawal by Subject|0
7740489|NCT00877487|26912539|P1|Open-label Treatment Phase|Withdrawal by Subject|1
7740490|NCT00877487|26912538|P2|Open-label Treatment Phase|Protocol Violation|0
7740491|NCT00877487|26912539|P1|Open-label Treatment Phase|Protocol Violation|3
7740492|NCT00877487|26912538|P2|Open-label Treatment Phase|Adverse Event|0
7740493|NCT00877487|26912539|P1|Open-label Treatment Phase|Adverse Event|1
7740494|NCT00877383|26912587|P2|Overall Study|Death|2
7740495|NCT00877383|26912588|P1|Overall Study|Death|1
7740496|NCT00877383|26912587|P2|Overall Study|Unsatisfactory therapeutic effect|0
7740497|NCT00877383|26912588|P1|Overall Study|Unsatisfactory therapeutic effect|1
7740498|NCT00877383|26912587|P2|Overall Study|Protocol deviation|6
7740499|NCT00877383|26912588|P1|Overall Study|Protocol deviation|2
7740500|NCT00877383|26912587|P2|Overall Study|Administrative problems|0
7740501|NCT00877383|26912588|P1|Overall Study|Administrative problems|2
7740502|NCT00877383|26912587|P2|Overall Study|Subject no longer requires study drug|0
7740503|NCT00877383|26912588|P1|Overall Study|Subject no longer requires study drug|2
7740504|NCT00877383|26912587|P2|Overall Study|Subject withdrew consent|12
7740505|NCT00877383|26912588|P1|Overall Study|Subject withdrew consent|3
7740506|NCT00877383|26912587|P2|Overall Study|Lost to Follow-up|3
7740507|NCT00877383|26912588|P1|Overall Study|Lost to Follow-up|5
7740508|NCT00877383|26912587|P2|Overall Study|Adverse Event|14
7740509|NCT00877383|26912588|P1|Overall Study|Adverse Event|13
7740510|NCT00877071|26912608|P1|Overall Study|disease progression|2
7740511|NCT00877032|26912641|P7|Overall Study|Did not meet entrance criteria|2
7740512|NCT00877032|26912642|P6|Overall Study|Did not meet entrance criteria|0
7740513|NCT00877032|26912643|P5|Overall Study|Did not meet entrance criteria|0
7740514|NCT00877032|26912644|P4|Overall Study|Did not meet entrance criteria|1
7740515|NCT00877032|26912645|P3|Overall Study|Did not meet entrance criteria|0
7740516|NCT00877032|26912646|P2|Overall Study|Did not meet entrance criteria|0
7740517|NCT00877032|26912647|P1|Overall Study|Did not meet entrance criteria|0
7740518|NCT00877006|26912748|P2|Long-Term Follow-up Period|Other|9
7740519|NCT00877006|26912749|P1|Long-Term Follow-up Period|Other|7
7740520|NCT00877006|26912748|P2|Long-Term Follow-up Period|Death|18
7740521|NCT00877006|26912749|P1|Long-Term Follow-up Period|Death|26
7740522|NCT00877006|26912748|P2|Long-Term Follow-up Period|Lost to Follow-up|9
7740523|NCT00877006|26912749|P1|Long-Term Follow-up Period|Lost to Follow-up|8
7740524|NCT00877006|26912748|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
7740525|NCT00877006|26912749|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
7740526|NCT00877006|26912748|P2|Treatment Period|Randomized but Not Treated|8
7740527|NCT00877006|26912749|P1|Treatment Period|Randomized but Not Treated|3
7740528|NCT00877006|26912748|P2|Treatment Period|Other|4
7740529|NCT00877006|26912749|P1|Treatment Period|Other|4
7740530|NCT00877006|26912748|P2|Treatment Period|Started New Treatment Regimen|5
7740531|NCT00877006|26912749|P1|Treatment Period|Started New Treatment Regimen|2
7740532|NCT00877006|26912748|P2|Treatment Period|Disease Progression|2
7740533|NCT00877006|26912749|P1|Treatment Period|Disease Progression|1
7740534|NCT00877006|26912748|P2|Treatment Period|Lost to Follow-up|1
7740535|NCT00877006|26912749|P1|Treatment Period|Lost to Follow-up|0
7740536|NCT00877006|26912748|P2|Treatment Period|Protocol Violation|0
7740537|NCT00877006|26912749|P1|Treatment Period|Protocol Violation|1
7740538|NCT00877006|26912748|P2|Treatment Period|Withdrawal by Subject|3
7740539|NCT00877006|26912749|P1|Treatment Period|Withdrawal by Subject|2
7740540|NCT00877006|26912748|P2|Treatment Period|Adverse Event|3
7740541|NCT00877006|26912749|P1|Treatment Period|Adverse Event|10
7740542|NCT00877006|26912748|P2|Treatment Period|Death|1
7740543|NCT00877006|26912749|P1|Treatment Period|Death|2
7740544|NCT00876928|26912825|P2|Overall Study|Hypokalemia-affects insulin secretion|0
7740545|NCT00876928|26912826|P1|Overall Study|Hypokalemia-affects insulin secretion|1
7740546|NCT00876928|26912825|P2|Overall Study|Lost to Follow-up|5
7740547|NCT00876928|26912826|P1|Overall Study|Lost to Follow-up|2
7740548|NCT00876733|26912863|P4|Overall Study|Data not available|1
7740549|NCT00876733|26912864|P3|Overall Study|Data not available|7
7740550|NCT00876733|26912865|P2|Overall Study|Data not available|3
7740551|NCT00876733|26912866|P1|Overall Study|Data not available|14
7740552|NCT00876733|26912863|P4|Overall Study|Lost to Follow-up|2
7740553|NCT00876733|26912864|P3|Overall Study|Lost to Follow-up|3
7740554|NCT00876733|26912865|P2|Overall Study|Lost to Follow-up|10
7740555|NCT00876733|26912866|P1|Overall Study|Lost to Follow-up|26
7740556|NCT00876733|26912863|P4|Overall Study|Lack of Efficacy|1
7740557|NCT00876733|26912864|P3|Overall Study|Lack of Efficacy|10
7740558|NCT00876733|26912865|P2|Overall Study|Lack of Efficacy|9
7740559|NCT00876733|26912866|P1|Overall Study|Lack of Efficacy|17
7740560|NCT00876733|26912863|P4|Overall Study|Adverse Event|3
7740561|NCT00876733|26912864|P3|Overall Study|Adverse Event|10
7740562|NCT00876733|26912865|P2|Overall Study|Adverse Event|20
7740563|NCT00876733|26912866|P1|Overall Study|Adverse Event|34
7740564|NCT00876694|26912974|P2|Overall Study|Death|0
7740565|NCT00876694|26912975|P1|Overall Study|Death|1
7740566|NCT00876694|26912974|P2|Overall Study|Administrative problems|1
7740567|NCT00876694|26912975|P1|Overall Study|Administrative problems|1
7740568|NCT00876694|26912974|P2|Overall Study|Abnormal test procedure result(s)|0
7740569|NCT00876694|26912975|P1|Overall Study|Abnormal test procedure result(s)|1
7740570|NCT00876694|26912974|P2|Overall Study|Unsatisfactory therapeutic effect|0
7740571|NCT00876694|26912975|P1|Overall Study|Unsatisfactory therapeutic effect|2
7740572|NCT00876694|26912974|P2|Overall Study|Subject withdrew consent|4
7740573|NCT00876694|26912975|P1|Overall Study|Subject withdrew consent|6
7740574|NCT00876694|26912974|P2|Overall Study|Adverse Event|7
7740575|NCT00876694|26912975|P1|Overall Study|Adverse Event|10
7740576|NCT00876460|26913001|P8|Mono Therapy Phase|Adverse Event|0
7740577|NCT00876460|26913002|P7|Mono Therapy Phase|Adverse Event|0
7740578|NCT00876460|26913003|P6|Mono Therapy Phase|Adverse Event|0
7740579|NCT00876460|26913004|P5|Mono Therapy Phase|Adverse Event|0
7740580|NCT00876460|26913005|P4|Mono Therapy Phase|Adverse Event|1
7740581|NCT00876460|26913006|P3|Mono Therapy Phase|Adverse Event|0
7740582|NCT00876460|26913007|P2|Mono Therapy Phase|Adverse Event|0
7740583|NCT00876460|26913008|P1|Mono Therapy Phase|Adverse Event|0
7740584|NCT00876460|26913001|P8|Mono Therapy Phase|Withdrawal by Subject|0
7740585|NCT00876460|26913002|P7|Mono Therapy Phase|Withdrawal by Subject|0
7740586|NCT00876460|26913003|P6|Mono Therapy Phase|Withdrawal by Subject|0
7740587|NCT00876460|26913004|P5|Mono Therapy Phase|Withdrawal by Subject|0
7740588|NCT00876460|26913005|P4|Mono Therapy Phase|Withdrawal by Subject|0
7740589|NCT00876460|26913006|P3|Mono Therapy Phase|Withdrawal by Subject|0
7740590|NCT00876460|26913007|P2|Mono Therapy Phase|Withdrawal by Subject|1
7740591|NCT00876460|26913008|P1|Mono Therapy Phase|Withdrawal by Subject|0
7740592|NCT00876460|26913001|P8|Mono Therapy Phase|Progressive disease|3
7740593|NCT00876460|26913002|P7|Mono Therapy Phase|Progressive disease|1
7740594|NCT00876460|26913003|P6|Mono Therapy Phase|Progressive disease|0
7740595|NCT00876460|26913004|P5|Mono Therapy Phase|Progressive disease|2
7740596|NCT00876460|26913005|P4|Mono Therapy Phase|Progressive disease|0
7740597|NCT00876460|26913006|P3|Mono Therapy Phase|Progressive disease|0
7740598|NCT00876460|26913007|P2|Mono Therapy Phase|Progressive disease|0
7740599|NCT00876460|26913008|P1|Mono Therapy Phase|Progressive disease|0
7740600|NCT00876460|26913001|P8|Combination Therapy Phase|Not treated|0
7740601|NCT00876460|26913002|P7|Combination Therapy Phase|Not treated|1
7740602|NCT00876460|26913003|P6|Combination Therapy Phase|Not treated|0
7740603|NCT00876460|26913004|P5|Combination Therapy Phase|Not treated|0
7740604|NCT00876460|26913005|P4|Combination Therapy Phase|Not treated|0
7740605|NCT00876460|26913006|P3|Combination Therapy Phase|Not treated|0
7740606|NCT00876460|26913007|P2|Combination Therapy Phase|Not treated|0
7740607|NCT00876460|26913008|P1|Combination Therapy Phase|Not treated|0
7740608|NCT00876460|26913001|P8|Combination Therapy Phase|Other reason not defined above|2
7740609|NCT00876460|26913002|P7|Combination Therapy Phase|Other reason not defined above|1
7740610|NCT00876460|26913003|P6|Combination Therapy Phase|Other reason not defined above|0
7740611|NCT00876460|26913004|P5|Combination Therapy Phase|Other reason not defined above|0
7740612|NCT00876460|26913005|P4|Combination Therapy Phase|Other reason not defined above|0
7740613|NCT00876460|26913006|P3|Combination Therapy Phase|Other reason not defined above|0
7740614|NCT00876460|26913007|P2|Combination Therapy Phase|Other reason not defined above|0
7740615|NCT00876460|26913008|P1|Combination Therapy Phase|Other reason not defined above|0
7740616|NCT00876460|26913001|P8|Combination Therapy Phase|Withdrawal by Subject|0
7740617|NCT00876460|26913002|P7|Combination Therapy Phase|Withdrawal by Subject|0
7740618|NCT00876460|26913003|P6|Combination Therapy Phase|Withdrawal by Subject|0
7740619|NCT00876460|26913004|P5|Combination Therapy Phase|Withdrawal by Subject|1
7740620|NCT00876460|26913005|P4|Combination Therapy Phase|Withdrawal by Subject|0
7740621|NCT00876460|26913006|P3|Combination Therapy Phase|Withdrawal by Subject|0
7740622|NCT00876460|26913007|P2|Combination Therapy Phase|Withdrawal by Subject|1
7740623|NCT00876460|26913008|P1|Combination Therapy Phase|Withdrawal by Subject|1
7740624|NCT00876460|26913001|P8|Combination Therapy Phase|Adverse Event|2
7740625|NCT00876460|26913002|P7|Combination Therapy Phase|Adverse Event|3
7740626|NCT00876460|26913003|P6|Combination Therapy Phase|Adverse Event|0
7740627|NCT00876460|26913004|P5|Combination Therapy Phase|Adverse Event|2
7740628|NCT00876460|26913005|P4|Combination Therapy Phase|Adverse Event|2
7740629|NCT00876460|26913006|P3|Combination Therapy Phase|Adverse Event|0
7740630|NCT00876460|26913007|P2|Combination Therapy Phase|Adverse Event|2
7740631|NCT00876460|26913008|P1|Combination Therapy Phase|Adverse Event|0
7740632|NCT00876460|26913001|P8|Combination Therapy Phase|Dose limiting toxicity|1
7740633|NCT00876460|26913002|P7|Combination Therapy Phase|Dose limiting toxicity|2
7740634|NCT00876460|26913003|P6|Combination Therapy Phase|Dose limiting toxicity|2
7740635|NCT00876460|26913004|P5|Combination Therapy Phase|Dose limiting toxicity|1
7740636|NCT00876460|26913005|P4|Combination Therapy Phase|Dose limiting toxicity|1
7740637|NCT00876460|26913006|P3|Combination Therapy Phase|Dose limiting toxicity|0
7740638|NCT00876460|26913007|P2|Combination Therapy Phase|Dose limiting toxicity|1
7740639|NCT00876460|26913008|P1|Combination Therapy Phase|Dose limiting toxicity|0
7740640|NCT00876460|26913001|P8|Combination Therapy Phase|Progressive disease|1
7740641|NCT00876460|26913002|P7|Combination Therapy Phase|Progressive disease|1
7740642|NCT00876460|26913003|P6|Combination Therapy Phase|Progressive disease|1
7740643|NCT00876460|26913004|P5|Combination Therapy Phase|Progressive disease|3
7740644|NCT00876460|26913005|P4|Combination Therapy Phase|Progressive disease|3
7740645|NCT00876460|26913006|P3|Combination Therapy Phase|Progressive disease|3
7740646|NCT00876460|26913007|P2|Combination Therapy Phase|Progressive disease|3
7740647|NCT00876460|26913008|P1|Combination Therapy Phase|Progressive disease|2
7740648|NCT00876447|26913080|P2|Overall Study|Adverse Event|8
7740649|NCT00876447|26913081|P1|Overall Study|Adverse Event|4
7740650|NCT00876447|26913080|P2|Overall Study|Lack of Efficacy|3
7740651|NCT00876447|26913081|P1|Overall Study|Lack of Efficacy|5
7740652|NCT00876447|26913080|P2|Overall Study|Pregnancy|2
7740653|NCT00876447|26913081|P1|Overall Study|Pregnancy|4
7740654|NCT00876447|26913080|P2|Overall Study|Lost to Follow-up|15
7740655|NCT00876447|26913081|P1|Overall Study|Lost to Follow-up|6
7740656|NCT00876447|26913080|P2|Overall Study|Personal reasons|28
7740657|NCT00876447|26913081|P1|Overall Study|Personal reasons|30
7740658|NCT00876447|26913080|P2|Overall Study|Protocol Violation|3
7740659|NCT00876447|26913081|P1|Overall Study|Protocol Violation|9
7740660|NCT00876447|26913080|P2|Overall Study|Site closure|14
7740661|NCT00876447|26913081|P1|Overall Study|Site closure|19
7740662|NCT00876447|26913080|P2|Overall Study|Other miscellaneous reasons|8
7740663|NCT00876447|26913081|P1|Overall Study|Other miscellaneous reasons|3
7740664|NCT00876395|26913141|P2|Overall Study|Death|0
7740665|NCT00876395|26913142|P1|Overall Study|Death|12
7740666|NCT00876395|26913141|P2|Overall Study|Administrative problems|23
7740667|NCT00876395|26913142|P1|Overall Study|Administrative problems|39
7740668|NCT00876395|26913141|P2|Overall Study|Lost to Follow-up|0
7740669|NCT00876395|26913142|P1|Overall Study|Lost to Follow-up|2
7740670|NCT00876395|26913141|P2|Overall Study|Withdrawal by Subject|33
7740671|NCT00876395|26913142|P1|Overall Study|Withdrawal by Subject|66
7740672|NCT00876395|26913141|P2|Overall Study|Protocol Violation|2
7740673|NCT00876395|26913142|P1|Overall Study|Protocol Violation|5
7740674|NCT00876395|26913141|P2|Overall Study|New cancer therapy|7
7740675|NCT00876395|26913142|P1|Overall Study|New cancer therapy|25
7740676|NCT00876395|26913141|P2|Overall Study|Disease progression|162
7740677|NCT00876395|26913142|P1|Overall Study|Disease progression|259
7740678|NCT00876395|26913141|P2|Overall Study|Abnormal test procedure result(s)|0
7740679|NCT00876395|26913142|P1|Overall Study|Abnormal test procedure result(s)|1
7740680|NCT00876395|26913141|P2|Overall Study|Adverse Event|11
7740681|NCT00876395|26913142|P1|Overall Study|Adverse Event|63
7740682|NCT00876395|26913141|P2|Overall Study|Untreated|1
7740683|NCT00876395|26913142|P1|Overall Study|Untreated|8
7740684|NCT00876343|26913183|P3|Overall Study|Change of residence or other commitments|3
7740685|NCT00876343|26913184|P2|Overall Study|Change of residence or other commitments|2
7740686|NCT00876343|26913185|P1|Overall Study|Change of residence or other commitments|2
7740687|NCT00876343|26913183|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
7740688|NCT00876343|26913184|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
7740689|NCT00876343|26913185|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
7740690|NCT00876343|26913183|P3|Overall Study|Physician Decision|1
7740691|NCT00876343|26913184|P2|Overall Study|Physician Decision|1
7740692|NCT00876343|26913185|P1|Overall Study|Physician Decision|0
7740693|NCT00876343|26913183|P3|Overall Study|Protocol Violation|1
7740694|NCT00876343|26913184|P2|Overall Study|Protocol Violation|1
7740695|NCT00876343|26913185|P1|Overall Study|Protocol Violation|4
7740696|NCT00876343|26913183|P3|Overall Study|Lack of Efficacy|1
7740697|NCT00876343|26913184|P2|Overall Study|Lack of Efficacy|0
7740698|NCT00876343|26913185|P1|Overall Study|Lack of Efficacy|0
7740699|NCT00876343|26913183|P3|Overall Study|Withdrawal by Subject|3
7740700|NCT00876343|26913184|P2|Overall Study|Withdrawal by Subject|4
7740701|NCT00876343|26913185|P1|Overall Study|Withdrawal by Subject|4
7740702|NCT00876343|26913183|P3|Overall Study|Adverse Event|2
7740703|NCT00876343|26913184|P2|Overall Study|Adverse Event|8
7740704|NCT00876343|26913185|P1|Overall Study|Adverse Event|7
7740705|NCT00876265|26913199|P1|Overall Study|Withdrawal by Subject|2
7740706|NCT00876265|26913199|P1|Overall Study|Lost to Follow-up|6
7740707|NCT00876265|26913199|P1|Overall Study|Miscellaneous reasons|4
7740708|NCT00876187|26913219|P5|Overall Study|Other|4
7740709|NCT00876187|26913220|P4|Overall Study|Other|7
7740710|NCT00876187|26913221|P3|Overall Study|Other|9
7740711|NCT00876187|26913222|P2|Overall Study|Other|5
7740712|NCT00876187|26913223|P1|Overall Study|Other|2
7740713|NCT00876187|26913219|P5|Overall Study|Randomized but not treated|3
7740714|NCT00876187|26913220|P4|Overall Study|Randomized but not treated|2
7740715|NCT00876187|26913221|P3|Overall Study|Randomized but not treated|3
7740716|NCT00876187|26913222|P2|Overall Study|Randomized but not treated|1
7740717|NCT00876187|26913223|P1|Overall Study|Randomized but not treated|3
7740718|NCT00876187|26913219|P5|Overall Study|Entered extension study|144
7740719|NCT00876187|26913220|P4|Overall Study|Entered extension study|151
7740720|NCT00876187|26913221|P3|Overall Study|Entered extension study|156
7740721|NCT00876187|26913222|P2|Overall Study|Entered extension study|120
7740722|NCT00876187|26913223|P1|Overall Study|Entered extension study|101
7740723|NCT00876187|26913219|P5|Overall Study|Withdrawal by Subject|37
7740724|NCT00876187|26913220|P4|Overall Study|Withdrawal by Subject|38
7740725|NCT00876187|26913221|P3|Overall Study|Withdrawal by Subject|32
7740726|NCT00876187|26913222|P2|Overall Study|Withdrawal by Subject|26
7740727|NCT00876187|26913223|P1|Overall Study|Withdrawal by Subject|16
7740728|NCT00876187|26913219|P5|Overall Study|Protocol Violation|3
7740729|NCT00876187|26913220|P4|Overall Study|Protocol Violation|6
7740730|NCT00876187|26913221|P3|Overall Study|Protocol Violation|7
7740731|NCT00876187|26913222|P2|Overall Study|Protocol Violation|7
7740732|NCT00876187|26913223|P1|Overall Study|Protocol Violation|6
7740733|NCT00876187|26913219|P5|Overall Study|Lost to Follow-up|11
7740734|NCT00876187|26913220|P4|Overall Study|Lost to Follow-up|8
7740735|NCT00876187|26913221|P3|Overall Study|Lost to Follow-up|8
7740736|NCT00876187|26913222|P2|Overall Study|Lost to Follow-up|10
7740737|NCT00876187|26913223|P1|Overall Study|Lost to Follow-up|9
7740738|NCT00876187|26913219|P5|Overall Study|Lack of Efficacy|59
7740739|NCT00876187|26913220|P4|Overall Study|Lack of Efficacy|34
7740740|NCT00876187|26913221|P3|Overall Study|Lack of Efficacy|45
7740741|NCT00876187|26913222|P2|Overall Study|Lack of Efficacy|34
7740742|NCT00876187|26913223|P1|Overall Study|Lack of Efficacy|59
7740743|NCT00876187|26913219|P5|Overall Study|Adverse Event|10
7740744|NCT00876187|26913220|P4|Overall Study|Adverse Event|29
7740745|NCT00876187|26913221|P3|Overall Study|Adverse Event|19
7740746|NCT00876187|26913222|P2|Overall Study|Adverse Event|12
7740747|NCT00876187|26913223|P1|Overall Study|Adverse Event|14
7740748|NCT00876018|26913324|P3|Overall Study|Withdrew Consent due to Adverse Event|2
7740749|NCT00876018|26913325|P2|Overall Study|Withdrew Consent due to Adverse Event|4
7740750|NCT00876018|26913326|P1|Overall Study|Withdrew Consent due to Adverse Event|5
7740751|NCT00876018|26913324|P3|Overall Study|Lost to Follow-up|1
7740752|NCT00876018|26913325|P2|Overall Study|Lost to Follow-up|1
7740753|NCT00876018|26913326|P1|Overall Study|Lost to Follow-up|0
7740754|NCT00875979|26913381|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
7740755|NCT00875979|26913382|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
7740756|NCT00875979|26913381|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
7740757|NCT00875979|26913382|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
7740758|NCT00875979|26913381|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
7740759|NCT00875979|26913382|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
7740760|NCT00875979|26913381|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
7740761|NCT00875979|26913382|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
7740762|NCT00875979|26913381|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
7740763|NCT00875979|26913382|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
7740764|NCT00875979|26913381|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
7740765|NCT00875979|26913382|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
7740766|NCT00875979|26913381|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
7740767|NCT00875979|26913382|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
7740768|NCT00875979|26913381|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
7740769|NCT00875979|26913382|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
7740770|NCT00875979|26913381|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
7740771|NCT00875979|26913382|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
7740772|NCT00875810|26913405|P1|Overall Study|Device explanted|1
7740773|NCT00875810|26913405|P1|Overall Study|Patient enroled but not implanted|2
7740774|NCT00875810|26913405|P1|Overall Study|Lost to Follow-up|39
7740775|NCT00875810|26913405|P1|Overall Study|Physician Decision|3
7740776|NCT00875810|26913405|P1|Overall Study|Withdrawal by Subject|1
7740777|NCT00875797|26913414|P2|Overall Study|Protocol Violation|3
7740778|NCT00875797|26913415|P1|Overall Study|Protocol Violation|6
7740779|NCT00875706|26913428|P3|Overall Study|Withdrawal by Subject|0
7740780|NCT00875706|26913429|P2|Overall Study|Withdrawal by Subject|0
7740781|NCT00875706|26913430|P1|Overall Study|Withdrawal by Subject|1
7740782|NCT00875667|26913449|P2|Overall Study|Randomized but no Study Drug Given|1
7740783|NCT00875667|26913450|P1|Overall Study|Randomized but no Study Drug Given|3
7740784|NCT00875667|26913449|P2|Overall Study|Miscellaneous|6
7740785|NCT00875667|26913450|P1|Overall Study|Miscellaneous|12
7740786|NCT00875667|26913449|P2|Overall Study|Disease Progression|49
7740787|NCT00875667|26913450|P1|Overall Study|Disease Progression|100
7740788|NCT00875667|26913449|P2|Overall Study|Protocol Violation|0
7740789|NCT00875667|26913450|P1|Overall Study|Protocol Violation|2
7740790|NCT00875667|26913449|P2|Overall Study|Death|2
7740791|NCT00875667|26913450|P1|Overall Study|Death|7
7740792|NCT00875667|26913449|P2|Overall Study|Withdrawal by Subject|5
7740793|NCT00875667|26913450|P1|Overall Study|Withdrawal by Subject|17
7740794|NCT00875667|26913449|P2|Overall Study|Adverse Event|10
7740795|NCT00875667|26913450|P1|Overall Study|Adverse Event|29
7740796|NCT00875615|26913585|P1|Overall Study|Withdrawal by Subject|1
7740797|NCT00875563|26913599|P1|Overall Study|Still be eligible for follow-up|7
7740798|NCT00875563|26913599|P1|Overall Study|No long-term (3-5 year) consent|6
7740799|NCT00875563|26913599|P1|Overall Study|Withdrawal by Subject|7
7740800|NCT00875563|26913599|P1|Overall Study|Death|4
7740801|NCT00875524|26913624|P2|Overall Study|Withdrawal by Subject|5
7740802|NCT00875524|26913625|P1|Overall Study|Withdrawal by Subject|3
7740803|NCT00875524|26913624|P2|Overall Study|Lost to Follow-up|0
7740804|NCT00875524|26913625|P1|Overall Study|Lost to Follow-up|1
7740805|NCT00875524|26913624|P2|Overall Study|Protocol Violation|0
7740806|NCT00875524|26913625|P1|Overall Study|Protocol Violation|4
7740807|NCT00875524|26913624|P2|Overall Study|Serious adverse event|1
7740808|NCT00875524|26913625|P1|Overall Study|Serious adverse event|0
7740809|NCT00875485|26913643|P2|Challenge Dose Epoch|Pregnancy|0
7740810|NCT00875485|26913644|P1|Challenge Dose Epoch|Pregnancy|1
7740811|NCT00875433|26913684|P1|Overall Study|Other|3
7740812|NCT00875433|26913684|P1|Overall Study|Withdrawal by Subject|2
7740813|NCT00875433|26913684|P1|Overall Study|Other Adverse Event|14
7740814|NCT00875433|26913684|P1|Overall Study|Progressive disease|41
7740815|NCT00875420|26913714|P5|Overall Study|Withdrawal by Subject|0
7740816|NCT00875420|26913715|P4|Overall Study|Withdrawal by Subject|0
7740817|NCT00875420|26913716|P3|Overall Study|Withdrawal by Subject|1
7740818|NCT00875420|26913717|P2|Overall Study|Withdrawal by Subject|0
7740819|NCT00875420|26913718|P1|Overall Study|Withdrawal by Subject|0
7740820|NCT00875420|26913714|P5|Overall Study|Sponsor decision|0
7740821|NCT00875420|26913715|P4|Overall Study|Sponsor decision|0
7740822|NCT00875420|26913716|P3|Overall Study|Sponsor decision|0
7740823|NCT00875420|26913717|P2|Overall Study|Sponsor decision|1
7740824|NCT00875420|26913718|P1|Overall Study|Sponsor decision|0
7740825|NCT00875420|26913714|P5|Overall Study|Prohibited medication|0
7740826|NCT00875420|26913715|P4|Overall Study|Prohibited medication|1
7740827|NCT00875420|26913716|P3|Overall Study|Prohibited medication|0
7740828|NCT00875420|26913717|P2|Overall Study|Prohibited medication|0
7740829|NCT00875420|26913718|P1|Overall Study|Prohibited medication|0
7740830|NCT00875420|26913714|P5|Overall Study|Personal reason|1
7740831|NCT00875420|26913715|P4|Overall Study|Personal reason|0
7740832|NCT00875420|26913716|P3|Overall Study|Personal reason|0
7740833|NCT00875420|26913717|P2|Overall Study|Personal reason|0
7740834|NCT00875420|26913718|P1|Overall Study|Personal reason|0
7740835|NCT00875420|26913714|P5|Overall Study|Lost to Follow-up|0
7740836|NCT00875420|26913715|P4|Overall Study|Lost to Follow-up|0
7740837|NCT00875420|26913716|P3|Overall Study|Lost to Follow-up|0
7740838|NCT00875420|26913717|P2|Overall Study|Lost to Follow-up|0
7740839|NCT00875420|26913718|P1|Overall Study|Lost to Follow-up|1
7740840|NCT00875420|26913714|P5|Overall Study|Inability to complete study procedures|1
7740841|NCT00875420|26913715|P4|Overall Study|Inability to complete study procedures|1
7740842|NCT00875420|26913716|P3|Overall Study|Inability to complete study procedures|1
7740843|NCT00875420|26913717|P2|Overall Study|Inability to complete study procedures|0
7740844|NCT00875420|26913718|P1|Overall Study|Inability to complete study procedures|1
7740845|NCT00875420|26913714|P5|Overall Study|Adverse Event|0
7740846|NCT00875420|26913715|P4|Overall Study|Adverse Event|0
7740847|NCT00875420|26913716|P3|Overall Study|Adverse Event|1
7740848|NCT00875420|26913717|P2|Overall Study|Adverse Event|1
7740849|NCT00875420|26913718|P1|Overall Study|Adverse Event|0
7740850|NCT00875056|26913866|P3|Overall Study|Withdrawal by Subject|1
7740851|NCT00875056|26913867|P2|Overall Study|Withdrawal by Subject|0
7740852|NCT00875056|26913868|P1|Overall Study|Withdrawal by Subject|3
7740853|NCT00875056|26913866|P3|Overall Study|Progressive Disease|3
7740854|NCT00875056|26913867|P2|Overall Study|Progressive Disease|8
7740855|NCT00875056|26913868|P1|Overall Study|Progressive Disease|14
7740856|NCT00875056|26913866|P3|Overall Study|Adverse Event|2
7740857|NCT00875056|26913867|P2|Overall Study|Adverse Event|1
7740858|NCT00875056|26913868|P1|Overall Study|Adverse Event|6
7740859|NCT00875017|26913894|P6|Fourth Intervention|Inability to comply with fasting|1
7740860|NCT00875017|26913895|P5|Fourth Intervention|Inability to comply with fasting|0
7740861|NCT00875017|26913896|P4|Fourth Intervention|Inability to comply with fasting|0
7740862|NCT00875017|26913897|P3|Fourth Intervention|Inability to comply with fasting|0
7740863|NCT00875017|26913898|P2|Fourth Intervention|Inability to comply with fasting|0
7740864|NCT00875017|26913899|P1|Fourth Intervention|Inability to comply with fasting|0
7740865|NCT00875017|26913894|P6|Washout|Withdrawal by Subject|0
7740866|NCT00875017|26913895|P5|Washout|Withdrawal by Subject|1
7740867|NCT00875017|26913896|P4|Washout|Withdrawal by Subject|0
7740868|NCT00875017|26913897|P3|Washout|Withdrawal by Subject|0
7740869|NCT00875017|26913898|P2|Washout|Withdrawal by Subject|0
7740870|NCT00875017|26913899|P1|Washout|Withdrawal by Subject|0
7740871|NCT00875017|26913894|P6|Third Intervention|Adverse Event|0
7740872|NCT00875017|26913895|P5|Third Intervention|Adverse Event|0
7740873|NCT00875017|26913896|P4|Third Intervention|Adverse Event|0
7740874|NCT00875017|26913897|P3|Third Intervention|Adverse Event|1
7740875|NCT00875017|26913898|P2|Third Intervention|Adverse Event|1
7740876|NCT00875017|26913899|P1|Third Intervention|Adverse Event|0
7740877|NCT00875017|26913894|P6|Washout|Problems collecting rectal effluent|0
7740878|NCT00875017|26913895|P5|Washout|Problems collecting rectal effluent|0
7740879|NCT00875017|26913896|P4|Washout|Problems collecting rectal effluent|0
7740880|NCT00875017|26913897|P3|Washout|Problems collecting rectal effluent|0
7740881|NCT00875017|26913898|P2|Washout|Problems collecting rectal effluent|1
7740882|NCT00875017|26913899|P1|Washout|Problems collecting rectal effluent|0
7740883|NCT00875017|26913894|P6|Second Intervention|Adverse Event|0
7740884|NCT00875017|26913895|P5|Second Intervention|Adverse Event|0
7740885|NCT00875017|26913896|P4|Second Intervention|Adverse Event|1
7740886|NCT00875017|26913897|P3|Second Intervention|Adverse Event|0
7740887|NCT00875017|26913898|P2|Second Intervention|Adverse Event|0
7740888|NCT00875017|26913899|P1|Second Intervention|Adverse Event|0
7740889|NCT00875017|26913894|P6|Washout|Problem collecting rectal effluent|0
7740890|NCT00875017|26913895|P5|Washout|Problem collecting rectal effluent|0
7740891|NCT00875017|26913896|P4|Washout|Problem collecting rectal effluent|0
7740892|NCT00875017|26913897|P3|Washout|Problem collecting rectal effluent|1
7740893|NCT00875017|26913898|P2|Washout|Problem collecting rectal effluent|0
7740894|NCT00875017|26913899|P1|Washout|Problem collecting rectal effluent|0
7740895|NCT00875017|26913894|P6|First Intervention|Intolerance to nasogastric tube|0
7740896|NCT00875017|26913895|P5|First Intervention|Intolerance to nasogastric tube|1
7740897|NCT00875017|26913896|P4|First Intervention|Intolerance to nasogastric tube|0
7740898|NCT00875017|26913897|P3|First Intervention|Intolerance to nasogastric tube|0
7740899|NCT00875017|26913898|P2|First Intervention|Intolerance to nasogastric tube|0
7740900|NCT00875017|26913899|P1|First Intervention|Intolerance to nasogastric tube|0
7740901|NCT00875017|26913894|P6|First Intervention|Problems collecting rectal effluent|0
7740902|NCT00875017|26913895|P5|First Intervention|Problems collecting rectal effluent|0
7740903|NCT00875017|26913896|P4|First Intervention|Problems collecting rectal effluent|0
7740904|NCT00875017|26913897|P3|First Intervention|Problems collecting rectal effluent|0
7740905|NCT00875017|26913898|P2|First Intervention|Problems collecting rectal effluent|0
7740906|NCT00875017|26913899|P1|First Intervention|Problems collecting rectal effluent|1
7740907|NCT00875017|26913894|P6|First Intervention|Adverse Event|0
7740908|NCT00875017|26913895|P5|First Intervention|Adverse Event|0
7740909|NCT00875017|26913896|P4|First Intervention|Adverse Event|1
7740910|NCT00875017|26913897|P3|First Intervention|Adverse Event|0
7740911|NCT00875017|26913898|P2|First Intervention|Adverse Event|0
7740912|NCT00875017|26913899|P1|First Intervention|Adverse Event|0
7740913|NCT00875017|26913894|P6|First Intervention|Withdrawal by Subject|0
7740914|NCT00875017|26913895|P5|First Intervention|Withdrawal by Subject|0
7740915|NCT00875017|26913896|P4|First Intervention|Withdrawal by Subject|0
7740916|NCT00875017|26913897|P3|First Intervention|Withdrawal by Subject|1
7740917|NCT00875017|26913898|P2|First Intervention|Withdrawal by Subject|0
7740918|NCT00875017|26913899|P1|First Intervention|Withdrawal by Subject|1
7740919|NCT00874939|26913913|P1|Overall Study|Study terminated|4
7740920|NCT00874848|26913946|P2|Overall Study|Physician Decision|2
7740921|NCT00874848|26913947|P1|Overall Study|Physician Decision|0
7740922|NCT00874848|26913946|P2|Overall Study|Failure to comply with protocol|1
7740923|NCT00874848|26913947|P1|Overall Study|Failure to comply with protocol|0
7740924|NCT00874848|26913946|P2|Overall Study|Noncompliance|1
7740925|NCT00874848|26913947|P1|Overall Study|Noncompliance|1
7740926|NCT00874848|26913946|P2|Overall Study|Withdrawal by Subject|4
7740927|NCT00874848|26913947|P1|Overall Study|Withdrawal by Subject|7
7740928|NCT00874848|26913946|P2|Overall Study|Progressive neoplastic disease|18
7740929|NCT00874848|26913947|P1|Overall Study|Progressive neoplastic disease|38
7740930|NCT00874848|26913946|P2|Overall Study|Adverse Event|2
7740931|NCT00874848|26913947|P1|Overall Study|Adverse Event|13
7740932|NCT00874822|26913963|P1|Overall Study|excluded by criteria|8
7740933|NCT00874770|26913971|P4|Overall Study|Subject no Longer Meets Study Criteria|0
7740934|NCT00874770|26913972|P3|Overall Study|Subject no Longer Meets Study Criteria|0
7740935|NCT00874770|26913973|P2|Overall Study|Subject no Longer Meets Study Criteria|0
7740936|NCT00874770|26913974|P1|Overall Study|Subject no Longer Meets Study Criteria|1
7740937|NCT00874770|26913971|P4|Overall Study|Lost to Follow-up|1
7740938|NCT00874770|26913972|P3|Overall Study|Lost to Follow-up|0
7740939|NCT00874770|26913973|P2|Overall Study|Lost to Follow-up|0
7740940|NCT00874770|26913974|P1|Overall Study|Lost to Follow-up|1
7740941|NCT00874770|26913971|P4|Overall Study|Adverse Event|2
7740942|NCT00874770|26913972|P3|Overall Study|Adverse Event|4
7740943|NCT00874770|26913973|P2|Overall Study|Adverse Event|1
7740944|NCT00874770|26913974|P1|Overall Study|Adverse Event|1
7740945|NCT00874770|26913971|P4|Overall Study|Lack of Efficacy|2
7740946|NCT00874770|26913972|P3|Overall Study|Lack of Efficacy|0
7740947|NCT00874770|26913973|P2|Overall Study|Lack of Efficacy|0
7740948|NCT00874770|26913974|P1|Overall Study|Lack of Efficacy|2
7740949|NCT00874731|26914008|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
7740950|NCT00874731|26914009|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
7740951|NCT00874731|26914010|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
7740952|NCT00874731|26914008|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
7740953|NCT00874731|26914009|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
7740954|NCT00874731|26914010|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
7740955|NCT00874731|26914008|P3|Part 1, Day 1: Placebo|Disease Progression|0
7740956|NCT00874731|26914009|P2|Part 1, Day 1: Placebo|Disease Progression|0
7740957|NCT00874731|26914010|P1|Part 1, Day 1: Placebo|Disease Progression|1
7740958|NCT00874549|26914051|P4|Overall Study|Withdrawal by Subject|1
7740959|NCT00874549|26914052|P3|Overall Study|Withdrawal by Subject|0
7740960|NCT00874549|26914053|P2|Overall Study|Withdrawal by Subject|1
7740961|NCT00874549|26914054|P1|Overall Study|Withdrawal by Subject|0
7740962|NCT00874549|26914051|P4|Overall Study|Lost to Follow-up|0
7740963|NCT00874549|26914052|P3|Overall Study|Lost to Follow-up|1
7740964|NCT00874549|26914053|P2|Overall Study|Lost to Follow-up|0
7740965|NCT00874549|26914054|P1|Overall Study|Lost to Follow-up|0
7740966|NCT00874549|26914051|P4|Overall Study|Protocol Violation|1
7740967|NCT00874549|26914052|P3|Overall Study|Protocol Violation|2
7740968|NCT00874549|26914053|P2|Overall Study|Protocol Violation|0
7740969|NCT00874549|26914054|P1|Overall Study|Protocol Violation|1
7740970|NCT00874549|26914051|P4|Overall Study|Adverse Event|0
7740971|NCT00874549|26914052|P3|Overall Study|Adverse Event|1
7740972|NCT00874549|26914053|P2|Overall Study|Adverse Event|0
7740973|NCT00874549|26914054|P1|Overall Study|Adverse Event|0
7740974|NCT00874497|26914131|P2|Overall Study|Withdrawal by Subject|4
7740975|NCT00874497|26914132|P1|Overall Study|Withdrawal by Subject|5
7740976|NCT00874497|26914131|P2|Overall Study|Physician Decision|1
7740977|NCT00874497|26914132|P1|Overall Study|Physician Decision|1
7740978|NCT00874497|26914131|P2|Overall Study|Met Withdrawal Criteria|2
7740979|NCT00874497|26914132|P1|Overall Study|Met Withdrawal Criteria|4
7740980|NCT00874497|26914131|P2|Overall Study|Sponsor Discontinued Trial|3
7740981|NCT00874497|26914132|P1|Overall Study|Sponsor Discontinued Trial|7
7740982|NCT00874497|26914131|P2|Overall Study|Adverse Event|4
7740983|NCT00874497|26914132|P1|Overall Study|Adverse Event|9
7740984|NCT00874497|26914131|P2|Overall Study|Lost to Follow-up|4
7740985|NCT00874497|26914132|P1|Overall Study|Lost to Follow-up|2
7740986|NCT00874432|26914174|P4|Overall Study|Other|3
7740987|NCT00874432|26914175|P3|Overall Study|Other|8
7740988|NCT00874432|26914176|P2|Overall Study|Other|2
7740989|NCT00874432|26914177|P1|Overall Study|Other|1
7740990|NCT00874432|26914174|P4|Overall Study|Physician Decision|0
7740991|NCT00874432|26914175|P3|Overall Study|Physician Decision|0
7740992|NCT00874432|26914176|P2|Overall Study|Physician Decision|0
7740993|NCT00874432|26914177|P1|Overall Study|Physician Decision|1
7740994|NCT00874432|26914174|P4|Overall Study|Withdrawal by Subject|0
7740995|NCT00874432|26914175|P3|Overall Study|Withdrawal by Subject|0
7740996|NCT00874432|26914176|P2|Overall Study|Withdrawal by Subject|0
7740997|NCT00874432|26914177|P1|Overall Study|Withdrawal by Subject|1
7740998|NCT00874276|26914195|P2|Overall Study|Withdrawal by Subject|1
7740999|NCT00874276|26914196|P1|Overall Study|Withdrawal by Subject|1
7741000|NCT00874237|26914216|P6|Overall Study|Withdrawal by Subject|0
7741001|NCT00874237|26914217|P5|Overall Study|Withdrawal by Subject|0
7741002|NCT00874237|26914218|P4|Overall Study|Withdrawal by Subject|0
7741003|NCT00874237|26914219|P3|Overall Study|Withdrawal by Subject|1
7741004|NCT00874237|26914220|P2|Overall Study|Withdrawal by Subject|0
7741005|NCT00874237|26914221|P1|Overall Study|Withdrawal by Subject|0
7741006|NCT00874237|26914216|P6|Overall Study|Physician Decision|0
7741007|NCT00874237|26914217|P5|Overall Study|Physician Decision|0
7741008|NCT00874237|26914218|P4|Overall Study|Physician Decision|0
7741009|NCT00874237|26914219|P3|Overall Study|Physician Decision|0
7741010|NCT00874237|26914220|P2|Overall Study|Physician Decision|1
7741011|NCT00874237|26914221|P1|Overall Study|Physician Decision|0
7741012|NCT00874120|26914239|P2|Second Intervention|Protocol Violation|0
7741013|NCT00874120|26914240|P1|Second Intervention|Protocol Violation|1
7741014|NCT00874120|26914239|P2|Second Intervention|Withdrawal by Subject|0
7741015|NCT00874120|26914240|P1|Second Intervention|Withdrawal by Subject|1
7741016|NCT00874120|26914239|P2|First Intervention|positive drug test|0
7741017|NCT00874120|26914240|P1|First Intervention|positive drug test|1
7741018|NCT00874120|26914239|P2|First Intervention|Protocol Violation|0
7741019|NCT00874120|26914240|P1|First Intervention|Protocol Violation|3
7741020|NCT00874120|26914239|P2|First Intervention|Lost to Follow-up|1
7741021|NCT00874120|26914240|P1|First Intervention|Lost to Follow-up|0
7741022|NCT00874120|26914239|P2|First Intervention|Withdrawal by Subject|0
7741023|NCT00874120|26914240|P1|First Intervention|Withdrawal by Subject|2
7741024|NCT00874120|26914239|P2|First Intervention|Adverse Event|1
7741025|NCT00874120|26914240|P1|First Intervention|Adverse Event|0
7741026|NCT00874029|26914253|P1|Overall Study|Lost to Follow-up|5
7741027|NCT00874029|26914253|P1|Overall Study|Adverse Event|1
7741028|NCT00874029|26914253|P1|Overall Study|Physician Decision|1
7741029|NCT00874029|26914253|P1|Overall Study|Pregnancy|4
7741030|NCT00874029|26914253|P1|Overall Study|Withdrawal by Subject|10
7741031|NCT00873912|26914269|P2|Overall Study|Lost to Follow-up|0
7741032|NCT00873912|26914270|P1|Overall Study|Lost to Follow-up|2
7741033|NCT00873912|26914269|P2|Overall Study|Withdrawal by Subject|0
7741034|NCT00873912|26914270|P1|Overall Study|Withdrawal by Subject|1
7741035|NCT00873860|26914309|P4|Overall Study|Other|0
7741036|NCT00873860|26914310|P3|Overall Study|Other|1
7741037|NCT00873860|26914311|P2|Overall Study|Other|0
7741038|NCT00873860|26914312|P1|Overall Study|Other|1
7741039|NCT00873860|26914309|P4|Overall Study|Death|0
7741040|NCT00873860|26914310|P3|Overall Study|Death|0
7741041|NCT00873860|26914311|P2|Overall Study|Death|0
7741042|NCT00873860|26914312|P1|Overall Study|Death|1
7741043|NCT00873860|26914309|P4|Overall Study|Withdrawal by Subject|0
7741044|NCT00873860|26914310|P3|Overall Study|Withdrawal by Subject|2
7741045|NCT00873860|26914311|P2|Overall Study|Withdrawal by Subject|0
7741046|NCT00873860|26914312|P1|Overall Study|Withdrawal by Subject|1
7741047|NCT00873860|26914309|P4|Overall Study|Lost to Follow-up|1
7741048|NCT00873860|26914310|P3|Overall Study|Lost to Follow-up|0
7741049|NCT00873860|26914311|P2|Overall Study|Lost to Follow-up|0
7741050|NCT00873860|26914312|P1|Overall Study|Lost to Follow-up|1
7741051|NCT00873730|26914400|P2|Overall Study|Sponsor decision|0
7741052|NCT00873730|26914401|P1|Overall Study|Sponsor decision|1
7741053|NCT00873730|26914400|P2|Overall Study|Withdrawal by Subject|1
7741054|NCT00873730|26914401|P1|Overall Study|Withdrawal by Subject|0
7741055|NCT00873730|26914400|P2|Overall Study|Adverse Event|2
7741056|NCT00873730|26914401|P1|Overall Study|Adverse Event|0
7741057|NCT00873730|26914400|P2|Overall Study|Protocol Deviation|2
7741058|NCT00873730|26914401|P1|Overall Study|Protocol Deviation|5
7741059|NCT00873366|26914444|P1|Overall Study|Refused to continue DM-BT testing|3
7741060|NCT00873366|26914444|P1|Overall Study|Off tamoxifen due to side effects|2
7741061|NCT00873366|26914444|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
7741062|NCT00873119|26914469|P2|Overall Study|Not treated|0
7741063|NCT00873119|26914470|P1|Overall Study|Not treated|2
7741064|NCT00873119|26914469|P2|Overall Study|Other|5
7741065|NCT00873119|26914470|P1|Overall Study|Other|2
7741066|NCT00873119|26914469|P2|Overall Study|Death|1
7741067|NCT00873119|26914470|P1|Overall Study|Death|2
7741068|NCT00873119|26914469|P2|Overall Study|Progressive disease|18
7741069|NCT00873119|26914470|P1|Overall Study|Progressive disease|26
7741070|NCT00873119|26914469|P2|Overall Study|Adverse Event|0
7741071|NCT00873119|26914470|P1|Overall Study|Adverse Event|8
7741072|NCT00873119|26914469|P2|Overall Study|Patient request|2
7741073|NCT00873119|26914470|P1|Overall Study|Patient request|4
7741074|NCT00873093|26914491|P5|Overall Study|Ineligible|0
7741075|NCT00873093|26914492|P4|Overall Study|Ineligible|1
7741076|NCT00873093|26914493|P3|Overall Study|Ineligible|0
7741077|NCT00873093|26914494|P2|Overall Study|Ineligible|1
7741078|NCT00873093|26914495|P1|Overall Study|Ineligible|0
7741079|NCT00873093|26914491|P5|Overall Study|Withdrawal by Subject|0
7741080|NCT00873093|26914492|P4|Overall Study|Withdrawal by Subject|0
7741081|NCT00873093|26914493|P3|Overall Study|Withdrawal by Subject|4
7741082|NCT00873093|26914494|P2|Overall Study|Withdrawal by Subject|4
7741083|NCT00873093|26914495|P1|Overall Study|Withdrawal by Subject|1
7741084|NCT00873093|26914491|P5|Overall Study|Physician Decision|2
7741085|NCT00873093|26914492|P4|Overall Study|Physician Decision|10
7741086|NCT00873093|26914493|P3|Overall Study|Physician Decision|10
7741087|NCT00873093|26914494|P2|Overall Study|Physician Decision|17
7741088|NCT00873093|26914495|P1|Overall Study|Physician Decision|0
7741089|NCT00873093|26914491|P5|Overall Study|Death|0
7741090|NCT00873093|26914492|P4|Overall Study|Death|0
7741091|NCT00873093|26914493|P3|Overall Study|Death|2
7741092|NCT00873093|26914494|P2|Overall Study|Death|3
7741093|NCT00873093|26914495|P1|Overall Study|Death|0
7741094|NCT00873093|26914491|P5|Overall Study|Adverse Event|0
7741095|NCT00873093|26914492|P4|Overall Study|Adverse Event|0
7741096|NCT00873093|26914493|P3|Overall Study|Adverse Event|0
7741097|NCT00873093|26914494|P2|Overall Study|Adverse Event|2
7741098|NCT00873093|26914495|P1|Overall Study|Adverse Event|0
7741099|NCT00873041|26914552|P3|Extension Study|Administrative reasons|1
7741100|NCT00873041|26914553|P2|Extension Study|Administrative reasons|0
7741101|NCT00873041|26914554|P1|Extension Study|Administrative reasons|0
7741102|NCT00873041|26914552|P3|Extension Study|Adverse Event|1
7741103|NCT00873041|26914553|P2|Extension Study|Adverse Event|0
7741104|NCT00873041|26914554|P1|Extension Study|Adverse Event|1
7741105|NCT00873041|26914552|P3|Core Study|Protocol deviation|1
7741106|NCT00873041|26914553|P2|Core Study|Protocol deviation|0
7741107|NCT00873041|26914554|P1|Core Study|Protocol deviation|1
7741108|NCT00873041|26914552|P3|Core Study|Abnormal laboratory value|1
7741109|NCT00873041|26914553|P2|Core Study|Abnormal laboratory value|0
7741110|NCT00873041|26914554|P1|Core Study|Abnormal laboratory value|0
7741111|NCT00873041|26914552|P3|Core Study|Lost to Follow-up|0
7741112|NCT00873041|26914553|P2|Core Study|Lost to Follow-up|1
7741113|NCT00873041|26914554|P1|Core Study|Lost to Follow-up|3
7741114|NCT00873041|26914552|P3|Core Study|Withdrawal by Subject|2
7741115|NCT00873041|26914553|P2|Core Study|Withdrawal by Subject|2
7741116|NCT00873041|26914554|P1|Core Study|Withdrawal by Subject|1
7741117|NCT00873041|26914552|P3|Core Study|Adverse Event|1
7741118|NCT00873041|26914553|P2|Core Study|Adverse Event|3
7741119|NCT00873041|26914554|P1|Core Study|Adverse Event|2
7741120|NCT00873015|26914612|P4|Overall Study|Withdrawal by Subject|0
7741121|NCT00873015|26914613|P3|Overall Study|Withdrawal by Subject|0
7741122|NCT00873015|26914614|P2|Overall Study|Withdrawal by Subject|1
7741123|NCT00873015|26914615|P1|Overall Study|Withdrawal by Subject|0
7741124|NCT00872989|26914632|P2|Overall Study|Not protocol specified|8
7741125|NCT00872989|26914633|P1|Overall Study|Not protocol specified|3
7741126|NCT00872989|26914632|P2|Overall Study|Progression/relapse|35
7741127|NCT00872989|26914633|P1|Overall Study|Progression/relapse|47
7741128|NCT00872989|26914632|P2|Overall Study|Withdrawal by Subject|5
7741129|NCT00872989|26914633|P1|Overall Study|Withdrawal by Subject|8
7741130|NCT00872989|26914632|P2|Overall Study|Adverse Event|15
7741131|NCT00872989|26914633|P1|Overall Study|Adverse Event|7
7741132|NCT00872898|26914652|P2|Part Two - Double Blind|Other reasons|0
7741133|NCT00872898|26914653|P1|Part Two - Double Blind|Other reasons|2
7741134|NCT00872898|26914652|P2|Part Two - Double Blind|Lost to Follow-up|2
7741135|NCT00872898|26914653|P1|Part Two - Double Blind|Lost to Follow-up|0
7741136|NCT00872898|26914652|P2|Part Two - Double Blind|Withdrawal by Subject|1
7741137|NCT00872898|26914653|P1|Part Two - Double Blind|Withdrawal by Subject|3
7741138|NCT00872898|26914652|P2|Part Two - Double Blind|Protocol Violation|0
7741139|NCT00872898|26914653|P1|Part Two - Double Blind|Protocol Violation|1
7741140|NCT00872898|26914652|P2|Part Two - Double Blind|Lack of Efficacy|0
7741141|NCT00872898|26914653|P1|Part Two - Double Blind|Lack of Efficacy|1
7741142|NCT00872898|26914652|P2|Part Two - Double Blind|Adverse Event|3
7741143|NCT00872898|26914653|P1|Part Two - Double Blind|Adverse Event|4
7741144|NCT00872599|26914727|P2|Second Washout Period|Adverse Event|1
7741145|NCT00872599|26914728|P1|Second Washout Period|Adverse Event|1
7741146|NCT00872521|26914748|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
7741147|NCT00872521|26914749|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
7741148|NCT00872521|26914750|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
7741149|NCT00872521|26914748|P3|Completed 3-month Follow up|Physician Decision|0
7741150|NCT00872521|26914749|P2|Completed 3-month Follow up|Physician Decision|1
7741151|NCT00872521|26914750|P1|Completed 3-month Follow up|Physician Decision|0
7741152|NCT00872521|26914748|P3|Completed 3-month Follow up|Other|0
7741153|NCT00872521|26914749|P2|Completed 3-month Follow up|Other|2
7741154|NCT00872521|26914750|P1|Completed 3-month Follow up|Other|0
7741155|NCT00872521|26914748|P3|Primary Endpoint Analysis|Patient response missing|1
7741156|NCT00872521|26914749|P2|Primary Endpoint Analysis|Patient response missing|0
7741157|NCT00872521|26914750|P1|Primary Endpoint Analysis|Patient response missing|0
7741158|NCT00872521|26914748|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
7741159|NCT00872521|26914749|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
7741160|NCT00872521|26914750|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
7741161|NCT00872521|26914748|P3|Primary Endpoint Analysis|Patient choice|0
7741162|NCT00872521|26914749|P2|Primary Endpoint Analysis|Patient choice|1
7741163|NCT00872521|26914750|P1|Primary Endpoint Analysis|Patient choice|0
7741164|NCT00872521|26914748|P3|Primary Endpoint Analysis|Other|0
7741165|NCT00872521|26914749|P2|Primary Endpoint Analysis|Other|2
7741166|NCT00872521|26914750|P1|Primary Endpoint Analysis|Other|1
7741167|NCT00872521|26914748|P3|Completed PAD Induction|Death|0
7741168|NCT00872521|26914749|P2|Completed PAD Induction|Death|1
7741169|NCT00872521|26914750|P1|Completed PAD Induction|Death|1
7741170|NCT00872521|26914748|P3|Completed PAD Induction|Adverse Event|0
7741171|NCT00872521|26914749|P2|Completed PAD Induction|Adverse Event|0
7741172|NCT00872521|26914750|P1|Completed PAD Induction|Adverse Event|4
7741173|NCT00872521|26914748|P3|Completed PAD Induction|Disease progression|0
7741174|NCT00872521|26914749|P2|Completed PAD Induction|Disease progression|2
7741175|NCT00872521|26914750|P1|Completed PAD Induction|Disease progression|0
7741176|NCT00872521|26914748|P3|Completed PAD Induction|Patient choice|0
7741177|NCT00872521|26914749|P2|Completed PAD Induction|Patient choice|1
7741178|NCT00872521|26914750|P1|Completed PAD Induction|Patient choice|0
7741179|NCT00872170|26914821|P2|Overall Study|Adverse Event|0
7741180|NCT00872170|26914822|P1|Overall Study|Adverse Event|1
7741181|NCT00872001|26914852|P2|Overall Study|Administrative|15
7741182|NCT00872001|26914853|P1|Overall Study|Administrative|23
7741183|NCT00872001|26914852|P2|Overall Study|Did Not Meet Protocol Eligibility|36
7741184|NCT00872001|26914853|P1|Overall Study|Did Not Meet Protocol Eligibility|38
7741185|NCT00872001|26914852|P2|Overall Study|Protocol Violation|8
7741186|NCT00872001|26914853|P1|Overall Study|Protocol Violation|5
7741187|NCT00872001|26914852|P2|Overall Study|Withdrawal by Subject|30
7741188|NCT00872001|26914853|P1|Overall Study|Withdrawal by Subject|18
7741189|NCT00872001|26914852|P2|Overall Study|Lost to Follow-up|12
7741190|NCT00872001|26914853|P1|Overall Study|Lost to Follow-up|13
7741191|NCT00872001|26914852|P2|Overall Study|Protocol Defined Clinical Event|7
7741192|NCT00872001|26914853|P1|Overall Study|Protocol Defined Clinical Event|5
7741193|NCT00872001|26914852|P2|Overall Study|Adverse Event|23
7741194|NCT00872001|26914853|P1|Overall Study|Adverse Event|34
7741195|NCT00871975|26914861|P1|Overall Study|Motion artifact, tracing uninterpretable|5
7741196|NCT00871975|26914861|P1|Overall Study|Patient unable to void/insufficient vol|13
7741197|NCT00871975|26914861|P1|Overall Study|Catheters could not be inserted|1
7741198|NCT00871975|26914861|P1|Overall Study|Technical difficulty w155-1ith equipment|3
7741199|NCT00871923|26914865|P1|Overall Study|Withdrawal by Subject|1
7741200|NCT00871923|26914865|P1|Overall Study|Death|1
7741201|NCT00871871|26914872|P4|Part II|Protocol Violation|1
7741202|NCT00871871|26914873|P3|Part II|Protocol Violation|0
7741203|NCT00871871|26914874|P2|Part II|Protocol Violation|0
7741204|NCT00871871|26914875|P1|Part II|Protocol Violation|0
7741205|NCT00871871|26914872|P4|Part II|Adverse Event|2
7741206|NCT00871871|26914873|P3|Part II|Adverse Event|1
7741207|NCT00871871|26914874|P2|Part II|Adverse Event|0
7741208|NCT00871871|26914875|P1|Part II|Adverse Event|0
7741209|NCT00871871|26914872|P4|Part II|Withdrawal by Subject|1
7741210|NCT00871871|26914873|P3|Part II|Withdrawal by Subject|2
7741211|NCT00871871|26914874|P2|Part II|Withdrawal by Subject|0
7741212|NCT00871871|26914875|P1|Part II|Withdrawal by Subject|0
7741213|NCT00871871|26914872|P4|Part II|Lack of Efficacy|0
7741214|NCT00871871|26914873|P3|Part II|Lack of Efficacy|1
7741215|NCT00871871|26914874|P2|Part II|Lack of Efficacy|0
7741216|NCT00871871|26914875|P1|Part II|Lack of Efficacy|0
7741217|NCT00871871|26914872|P4|Part I|Laboratory abnormality|0
7741218|NCT00871871|26914873|P3|Part I|Laboratory abnormality|0
7741219|NCT00871871|26914874|P2|Part I|Laboratory abnormality|1
7741220|NCT00871871|26914875|P1|Part I|Laboratory abnormality|0
7741221|NCT00871871|26914872|P4|Part I|Withdrawal by Subject|0
7741222|NCT00871871|26914873|P3|Part I|Withdrawal by Subject|0
7741223|NCT00871871|26914874|P2|Part I|Withdrawal by Subject|0
7741224|NCT00871871|26914875|P1|Part I|Withdrawal by Subject|3
7741225|NCT00871871|26914872|P4|Part I|Adverse Event|0
7741226|NCT00871871|26914873|P3|Part I|Adverse Event|0
7741227|NCT00871871|26914874|P2|Part I|Adverse Event|2
7741228|NCT00871871|26914875|P1|Part I|Adverse Event|0
7741229|NCT00871858|26914897|P2|Overall Study|Lost to Follow-up|1
7741230|NCT00871858|26914898|P1|Overall Study|Lost to Follow-up|0
7741231|NCT00871858|26914897|P2|Overall Study|Withdrawal by Subject|1
7741232|NCT00871858|26914898|P1|Overall Study|Withdrawal by Subject|1
7741233|NCT00871858|26914897|P2|Overall Study|Adverse Event|1
7741234|NCT00871858|26914898|P1|Overall Study|Adverse Event|1
7741235|NCT00871858|26914897|P2|Overall Study|Protocol Violation|4
7741236|NCT00871858|26914898|P1|Overall Study|Protocol Violation|3
7741237|NCT00871780|26914929|P1|Overall Study|Physician Decision|1
7741238|NCT00871780|26914929|P1|Overall Study|Death|1
7741239|NCT00871780|26914929|P1|Overall Study|Voluntary Discontinuation|4
7741240|NCT00871780|26914929|P1|Overall Study|Adverse Event|6
7741241|NCT00871780|26914929|P1|Overall Study|Withdrawal by Subject|9
7741242|NCT00871780|26914929|P1|Overall Study|Enrolled But Not Treated|6
7741243|NCT00871741|26914949|P2|Overall Study|Premature study termination|7
7741244|NCT00871741|26914950|P1|Overall Study|Premature study termination|9
7741245|NCT00871728|26914964|P1|Overall Study|Withdrawal of Informed Consent|5
7741246|NCT00871728|26914964|P1|Overall Study|Participant Non-compliance|1
7741247|NCT00871728|26914964|P1|Overall Study|Failed to Visit Hospital|4
7741248|NCT00871728|26914964|P1|Overall Study|Lost to Follow-up|2
7741249|NCT00871728|26914964|P1|Overall Study|Protocol Violation|7
7741250|NCT00871728|26914964|P1|Overall Study|Adverse Event|1
7741251|NCT00871715|26914977|P3|Overall Study|Lost to Follow-up|9
7741252|NCT00871715|26914978|P2|Overall Study|Lost to Follow-up|6
7741253|NCT00871715|26914979|P1|Overall Study|Lost to Follow-up|3
7741254|NCT00871715|26914977|P3|Overall Study|Physician Decision|2
7741255|NCT00871715|26914978|P2|Overall Study|Physician Decision|0
7741256|NCT00871715|26914979|P1|Overall Study|Physician Decision|6
7741257|NCT00871715|26914977|P3|Overall Study|Withdrawal by Subject|15
7741258|NCT00871715|26914978|P2|Overall Study|Withdrawal by Subject|10
7741259|NCT00871715|26914979|P1|Overall Study|Withdrawal by Subject|6
7741260|NCT00871572|26915056|P4|Overall Study|Withdrawal by Subject|1
7741261|NCT00871572|26915057|P3|Overall Study|Withdrawal by Subject|3
7741262|NCT00871572|26915058|P2|Overall Study|Withdrawal by Subject|2
7741263|NCT00871572|26915059|P1|Overall Study|Withdrawal by Subject|1
7741264|NCT00871572|26915056|P4|Overall Study|Sponsor Decision|0
7741265|NCT00871572|26915057|P3|Overall Study|Sponsor Decision|0
7741266|NCT00871572|26915058|P2|Overall Study|Sponsor Decision|0
7741267|NCT00871572|26915059|P1|Overall Study|Sponsor Decision|1
7741268|NCT00871572|26915056|P4|Overall Study|Protocol Violation|1
7741269|NCT00871572|26915057|P3|Overall Study|Protocol Violation|1
7741270|NCT00871572|26915058|P2|Overall Study|Protocol Violation|0
7741271|NCT00871572|26915059|P1|Overall Study|Protocol Violation|0
7741272|NCT00871572|26915056|P4|Overall Study|Lost to Follow-up|1
7741273|NCT00871572|26915057|P3|Overall Study|Lost to Follow-up|0
7741274|NCT00871572|26915058|P2|Overall Study|Lost to Follow-up|1
7741275|NCT00871572|26915059|P1|Overall Study|Lost to Follow-up|0
7741276|NCT00871572|26915056|P4|Overall Study|Investigator Decision|1
7741277|NCT00871572|26915057|P3|Overall Study|Investigator Decision|0
7741278|NCT00871572|26915058|P2|Overall Study|Investigator Decision|1
7741279|NCT00871572|26915059|P1|Overall Study|Investigator Decision|0
7741280|NCT00871572|26915056|P4|Overall Study|Adverse Event|3
7741281|NCT00871572|26915057|P3|Overall Study|Adverse Event|0
7741282|NCT00871572|26915058|P2|Overall Study|Adverse Event|2
7741283|NCT00871572|26915059|P1|Overall Study|Adverse Event|0
7741284|NCT00871494|26915129|P1|Overall Study|Lost to Follow-up|1
7741285|NCT00871494|26915129|P1|Overall Study|Adverse Event|4
7741286|NCT00871494|26915129|P1|Overall Study|Lack of Efficacy|4
7741287|NCT00871494|26915129|P1|Overall Study|Protocol Violation|5
7741288|NCT00871429|26915136|P1|Overall Study|Questionnaire not completed|1
7741289|NCT00871429|26915136|P1|Overall Study|Withdrawal by Subject|17
7741290|NCT00871429|26915136|P1|Overall Study|Lost to Follow-up|6
7741291|NCT00871403|26915147|P3|Monotherapy Treatment Phase|Adverse Event|0
7741292|NCT00871403|26915148|P2|Monotherapy Treatment Phase|Adverse Event|4
7741293|NCT00871403|26915149|P1|Monotherapy Treatment Phase|Adverse Event|0
7741294|NCT00871403|26915147|P3|Monotherapy Treatment Phase|Disease Progression|1
7741295|NCT00871403|26915148|P2|Monotherapy Treatment Phase|Disease Progression|9
7741296|NCT00871403|26915149|P1|Monotherapy Treatment Phase|Disease Progression|0
7741297|NCT00871403|26915147|P3|Combination Treatment Phase|Physician Decision|3
7741298|NCT00871403|26915148|P2|Combination Treatment Phase|Physician Decision|1
7741299|NCT00871403|26915149|P1|Combination Treatment Phase|Physician Decision|0
7741300|NCT00871403|26915147|P3|Combination Treatment Phase|Withdrawal by Subject|1
7741301|NCT00871403|26915148|P2|Combination Treatment Phase|Withdrawal by Subject|3
7741302|NCT00871403|26915149|P1|Combination Treatment Phase|Withdrawal by Subject|0
7741303|NCT00871403|26915147|P3|Combination Treatment Phase|Disease Progression|5
7741304|NCT00871403|26915148|P2|Combination Treatment Phase|Disease Progression|8
7741305|NCT00871403|26915149|P1|Combination Treatment Phase|Disease Progression|0
7741306|NCT00871403|26915147|P3|Combination Treatment Phase|Adverse Event|2
7741307|NCT00871403|26915148|P2|Combination Treatment Phase|Adverse Event|17
7741308|NCT00871403|26915149|P1|Combination Treatment Phase|Adverse Event|0
7741309|NCT00871403|26915147|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
7741310|NCT00871403|26915148|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
7741311|NCT00871403|26915149|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
7741312|NCT00871403|26915147|P3|Combination Treatment Phase|Randomized but Not Treated|1
7741313|NCT00871403|26915148|P2|Combination Treatment Phase|Randomized but Not Treated|1
7741314|NCT00871403|26915149|P1|Combination Treatment Phase|Randomized but Not Treated|1
7741315|NCT00871377|26915162|P6|Third Intervention (10 Weeks)|Death|0
7741316|NCT00871377|26915163|P5|Third Intervention (10 Weeks)|Death|0
7741317|NCT00871377|26915164|P4|Third Intervention (10 Weeks)|Death|1
7741318|NCT00871377|26915165|P3|Third Intervention (10 Weeks)|Death|0
7741319|NCT00871377|26915166|P2|Third Intervention (10 Weeks)|Death|0
7741320|NCT00871377|26915167|P1|Third Intervention (10 Weeks)|Death|0
7741321|NCT00871377|26915162|P6|Washout (6 Weeks)|Withdrawal by Subject|1
7741322|NCT00871377|26915163|P5|Washout (6 Weeks)|Withdrawal by Subject|0
7741323|NCT00871377|26915164|P4|Washout (6 Weeks)|Withdrawal by Subject|0
7741324|NCT00871377|26915165|P3|Washout (6 Weeks)|Withdrawal by Subject|0
7741325|NCT00871377|26915166|P2|Washout (6 Weeks)|Withdrawal by Subject|0
7741326|NCT00871377|26915167|P1|Washout (6 Weeks)|Withdrawal by Subject|0
7741327|NCT00871377|26915162|P6|Washout (6 Weeks)|Withdrawal by Subject|0
7741328|NCT00871377|26915163|P5|Washout (6 Weeks)|Withdrawal by Subject|0
7741329|NCT00871377|26915164|P4|Washout (6 Weeks)|Withdrawal by Subject|0
7741330|NCT00871377|26915165|P3|Washout (6 Weeks)|Withdrawal by Subject|0
7741331|NCT00871377|26915166|P2|Washout (6 Weeks)|Withdrawal by Subject|0
7741332|NCT00871377|26915167|P1|Washout (6 Weeks)|Withdrawal by Subject|1
7741333|NCT00871377|26915162|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
7741334|NCT00871377|26915163|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
7741335|NCT00871377|26915164|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
7741336|NCT00871377|26915165|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
7741337|NCT00871377|26915166|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
7741338|NCT00871377|26915167|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
7741339|NCT00871377|26915162|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
7741340|NCT00871377|26915163|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
7741341|NCT00871377|26915164|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
7741342|NCT00871377|26915165|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
7741343|NCT00871377|26915166|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
7741344|NCT00871377|26915167|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
7741345|NCT00871351|26915178|P3|Overall Study|Adverse Event|0
7741346|NCT00871351|26915179|P2|Overall Study|Adverse Event|1
7741347|NCT00871351|26915180|P1|Overall Study|Adverse Event|3
7741348|NCT00871351|26915178|P3|Overall Study|Withdrawal by Subject|0
7741349|NCT00871351|26915179|P2|Overall Study|Withdrawal by Subject|0
7741350|NCT00871351|26915180|P1|Overall Study|Withdrawal by Subject|1
7741351|NCT00871338|26915202|P2|Prior to Booster|Lost to Follow-up|0
7741352|NCT00871338|26915203|P1|Prior to Booster|Lost to Follow-up|1
7741353|NCT00871338|26915202|P2|Prior to Booster|Withdrawal by Subject|3
7741354|NCT00871338|26915203|P1|Prior to Booster|Withdrawal by Subject|1
7741355|NCT00871234|26915298|P1|Overall Study|Lost to Follow-up|3
7741356|NCT00871234|26915298|P1|Overall Study|Adverse Event|2
7741357|NCT00871169|26915302|P1|Overall Study|Patient did not receive study treatment|2
7741358|NCT00871169|26915302|P1|Overall Study|Protocol Violation|1
7741359|NCT00871117|26915330|P2|Overall Study|Other|4
7741360|NCT00871117|26915331|P1|Overall Study|Other|0
7741361|NCT00871117|26915330|P2|Overall Study|Lost to Follow-up|6
7741362|NCT00871117|26915331|P1|Overall Study|Lost to Follow-up|5
7741363|NCT00871000|26915365|P2|Overall Study|Withdrawal by Subject|0
7741364|NCT00871000|26915366|P1|Overall Study|Withdrawal by Subject|1
7741365|NCT00870870|26915418|P4|Overall Study|Adverse Event|2
7741366|NCT00870870|26915419|P3|Overall Study|Adverse Event|2
7741367|NCT00870870|26915420|P2|Overall Study|Adverse Event|0
7741368|NCT00870870|26915421|P1|Overall Study|Adverse Event|0
7741369|NCT00870870|26915418|P4|Overall Study|Withdrawal by Subject|3
7741370|NCT00870870|26915419|P3|Overall Study|Withdrawal by Subject|1
7741371|NCT00870870|26915420|P2|Overall Study|Withdrawal by Subject|1
7741372|NCT00870870|26915421|P1|Overall Study|Withdrawal by Subject|0
7741373|NCT00870740|26915465|P6|Overall Study|Other|5
7741374|NCT00870740|26915466|P5|Overall Study|Other|3
7741375|NCT00870740|26915467|P4|Overall Study|Other|4
7741376|NCT00870740|26915468|P3|Overall Study|Other|2
7741377|NCT00870740|26915469|P2|Overall Study|Other|5
7741378|NCT00870740|26915470|P1|Overall Study|Other|2
7741379|NCT00870740|26915465|P6|Overall Study|Death|0
7741380|NCT00870740|26915466|P5|Overall Study|Death|1
7741381|NCT00870740|26915467|P4|Overall Study|Death|0
7741382|NCT00870740|26915468|P3|Overall Study|Death|0
7741383|NCT00870740|26915469|P2|Overall Study|Death|0
7741384|NCT00870740|26915470|P1|Overall Study|Death|0
7741385|NCT00870740|26915465|P6|Overall Study|Subject Non-compliance|1
7741386|NCT00870740|26915466|P5|Overall Study|Subject Non-compliance|0
7741387|NCT00870740|26915467|P4|Overall Study|Subject Non-compliance|0
7741388|NCT00870740|26915468|P3|Overall Study|Subject Non-compliance|0
7741389|NCT00870740|26915469|P2|Overall Study|Subject Non-compliance|0
7741390|NCT00870740|26915470|P1|Overall Study|Subject Non-compliance|0
7741391|NCT00870740|26915465|P6|Overall Study|Investigator Decision|0
7741392|NCT00870740|26915466|P5|Overall Study|Investigator Decision|0
7741393|NCT00870740|26915467|P4|Overall Study|Investigator Decision|0
7741394|NCT00870740|26915468|P3|Overall Study|Investigator Decision|1
7741395|NCT00870740|26915469|P2|Overall Study|Investigator Decision|0
7741396|NCT00870740|26915470|P1|Overall Study|Investigator Decision|2
7741397|NCT00870740|26915465|P6|Overall Study|Consent Withdrawn|5
7741398|NCT00870740|26915466|P5|Overall Study|Consent Withdrawn|6
7741399|NCT00870740|26915467|P4|Overall Study|Consent Withdrawn|6
7741400|NCT00870740|26915468|P3|Overall Study|Consent Withdrawn|4
7741401|NCT00870740|26915469|P2|Overall Study|Consent Withdrawn|3
7741402|NCT00870740|26915470|P1|Overall Study|Consent Withdrawn|6
7741403|NCT00870740|26915465|P6|Overall Study|Adverse Event|6
7741404|NCT00870740|26915466|P5|Overall Study|Adverse Event|1
7741405|NCT00870740|26915467|P4|Overall Study|Adverse Event|2
7741406|NCT00870740|26915468|P3|Overall Study|Adverse Event|3
7741407|NCT00870740|26915469|P2|Overall Study|Adverse Event|1
7741408|NCT00870740|26915470|P1|Overall Study|Adverse Event|2
7741409|NCT00870727|26915546|P2|Overall Study|Adverse Event|1
7741410|NCT00870727|26915547|P1|Overall Study|Adverse Event|0
7741411|NCT00870727|26915546|P2|Overall Study|Lack of Efficacy|3
7741412|NCT00870727|26915547|P1|Overall Study|Lack of Efficacy|1
7741413|NCT00870727|26915546|P2|Overall Study|Lost to Follow-up|1
7741414|NCT00870727|26915547|P1|Overall Study|Lost to Follow-up|0
7741415|NCT00870688|26915563|P1|Overall Study|Granules in the Stools|1
7741416|NCT00870688|26915563|P1|Overall Study|Death, Unrelated|1
7741417|NCT00870688|26915563|P1|Overall Study|Lost to Follow-up|2
7741418|NCT00870584|26915568|P2|Overall Study|Protocol Deviation|2
7741419|NCT00870584|26915569|P1|Overall Study|Protocol Deviation|2
7741420|NCT00870584|26915568|P2|Overall Study|Lost to Follow-up|1
7741421|NCT00870584|26915569|P1|Overall Study|Lost to Follow-up|5
7741422|NCT00870584|26915568|P2|Overall Study|Withdrawal by Subject|7
7741423|NCT00870584|26915569|P1|Overall Study|Withdrawal by Subject|6
7741424|NCT00870584|26915568|P2|Overall Study|Adverse Event|3
7741425|NCT00870584|26915569|P1|Overall Study|Adverse Event|3
7741426|NCT00870233|26915678|P1|Overall Study|Death|1
7741427|NCT00870233|26915678|P1|Overall Study|Incompatible internet browser|2
7741428|NCT00870233|26915678|P1|Overall Study|Did not undergo laparotomy|3
7741429|NCT00870233|26915678|P1|Overall Study|Withdrawal by Subject|18
7741430|NCT00870194|26915687|P2|Overall Study|Subject Decision|2
7741431|NCT00870194|26915688|P1|Overall Study|Subject Decision|7
7741432|NCT00870194|26915687|P2|Overall Study|Entry Criteria Not Met|2
7741433|NCT00870194|26915688|P1|Overall Study|Entry Criteria Not Met|1
7741434|NCT00870194|26915687|P2|Overall Study|Protocol Violation|3
7741435|NCT00870194|26915688|P1|Overall Study|Protocol Violation|3
7741436|NCT00870194|26915687|P2|Overall Study|Physician Decision|1
7741437|NCT00870194|26915688|P1|Overall Study|Physician Decision|3
7741438|NCT00870194|26915687|P2|Overall Study|Lost to Follow-up|0
7741439|NCT00870194|26915688|P1|Overall Study|Lost to Follow-up|2
7741440|NCT00870194|26915687|P2|Overall Study|Lack of Efficacy|1
7741441|NCT00870194|26915688|P1|Overall Study|Lack of Efficacy|0
7741442|NCT00870194|26915687|P2|Overall Study|Adverse Event|5
7741443|NCT00870194|26915688|P1|Overall Study|Adverse Event|10
7741444|NCT00870103|26915726|P1|Overall Study|Lost to Follow-up|2
7741445|NCT00870103|26915726|P1|Overall Study|Physician Decision|2
7741446|NCT00869999|26915731|P1|Overall Study|removed prior to starting therapy|1
7741447|NCT00869999|26915731|P1|Overall Study|Withdrawal by Subject|1
7741448|NCT00869960|26915737|P1|Overall Study|Lost to Follow-up|2
7741449|NCT00869778|26915786|P3|Overall Study|Unblinding|0
7741450|NCT00869778|26915787|P2|Overall Study|Unblinding|0
7741451|NCT00869778|26915788|P1|Overall Study|Unblinding|1
7741452|NCT00869778|26915786|P3|Overall Study|Protocol Violation|5
7741453|NCT00869778|26915787|P2|Overall Study|Protocol Violation|3
7741454|NCT00869778|26915788|P1|Overall Study|Protocol Violation|5
7741455|NCT00869778|26915786|P3|Overall Study|Pregnancy|0
7741456|NCT00869778|26915787|P2|Overall Study|Pregnancy|0
7741457|NCT00869778|26915788|P1|Overall Study|Pregnancy|1
7741458|NCT00869778|26915786|P3|Overall Study|Withdrawal by Subject|5
7741459|NCT00869778|26915787|P2|Overall Study|Withdrawal by Subject|4
7741460|NCT00869778|26915788|P1|Overall Study|Withdrawal by Subject|3
7741461|NCT00869778|26915786|P3|Overall Study|Adverse Event|0
7741462|NCT00869778|26915787|P2|Overall Study|Adverse Event|0
7741463|NCT00869778|26915788|P1|Overall Study|Adverse Event|2
7741464|NCT00869557|26915863|P2|Extension Phase|Withdrew Consent|0
7741465|NCT00869557|26915864|P1|Extension Phase|Withdrew Consent|2
7741466|NCT00869557|26915863|P2|Extension Phase|Investigator's Discretion|0
7741467|NCT00869557|26915864|P1|Extension Phase|Investigator's Discretion|2
7741468|NCT00869557|26915863|P2|Extension Phase|Lost to Follow-up|1
7741469|NCT00869557|26915864|P1|Extension Phase|Lost to Follow-up|3
7741470|NCT00869557|26915863|P2|Extension Phase|Lack of Efficacy|0
7741471|NCT00869557|26915864|P1|Extension Phase|Lack of Efficacy|1
7741472|NCT00869557|26915863|P2|Extension Phase|Adverse Event|2
7741473|NCT00869557|26915864|P1|Extension Phase|Adverse Event|2
7741474|NCT00869557|26915863|P2|Randomized Phase|Withdrew Consent|1
7741475|NCT00869557|26915864|P1|Randomized Phase|Withdrew Consent|0
7741476|NCT00869557|26915863|P2|Randomized Phase|Investigator's Discretion|0
7741477|NCT00869557|26915864|P1|Randomized Phase|Investigator's Discretion|1
7741478|NCT00869557|26915863|P2|Randomized Phase|Lost to Follow-up|1
7741479|NCT00869557|26915864|P1|Randomized Phase|Lost to Follow-up|2
7741480|NCT00869518|26915883|P2|Overall Study|Lost to Follow-up|1
7741481|NCT00869518|26915884|P1|Overall Study|Lost to Follow-up|1
7741482|NCT00869440|26915900|P4|Overall Study|Physician Decision|0
7741483|NCT00869440|26915901|P3|Overall Study|Physician Decision|0
7741484|NCT00869440|26915902|P2|Overall Study|Physician Decision|1
7741485|NCT00869440|26915903|P1|Overall Study|Physician Decision|1
7741486|NCT00869440|26915900|P4|Overall Study|Withdrawal by Subject|0
7741487|NCT00869440|26915901|P3|Overall Study|Withdrawal by Subject|0
7741488|NCT00869440|26915902|P2|Overall Study|Withdrawal by Subject|0
7741489|NCT00869440|26915903|P1|Overall Study|Withdrawal by Subject|1
7741490|NCT00869401|26915937|P5|Overall Study|Withdrawal by Subject|3
7741491|NCT00869401|26915938|P4|Overall Study|Withdrawal by Subject|5
7741492|NCT00869401|26915939|P3|Overall Study|Withdrawal by Subject|0
7741493|NCT00869401|26915940|P2|Overall Study|Withdrawal by Subject|0
7741494|NCT00869401|26915941|P1|Overall Study|Withdrawal by Subject|0
7741495|NCT00869362|26915970|P2|Overall Study|Lost to Follow-up|3
7741496|NCT00869362|26915971|P1|Overall Study|Lost to Follow-up|1
7741497|NCT00869362|26915970|P2|Overall Study|Death|2
7741498|NCT00869362|26915971|P1|Overall Study|Death|0
7741499|NCT00869323|26915992|P1|Maintenance Therapy|concurrent illness|1
7741500|NCT00869258|26916000|P1|Overall Study|Physician Decision|1
7741501|NCT00869128|26916065|P2|Overall Study|lack of Compliance|6
7741502|NCT00869128|26916066|P1|Overall Study|lack of Compliance|6
7741503|NCT00869089|26916070|P1|Overall Study|Screen Fail|1
7741504|NCT00869089|26916070|P1|Overall Study|Withdrawal by Subject|1
7741505|NCT00869089|26916070|P1|Overall Study|Lost to Follow-up|1
7741506|NCT00869050|26916074|P1|Overall Study|Screen Failure|3
7741507|NCT00869024|26916081|P2|Overall Study|Protocol Violation|1
7741508|NCT00869024|26916082|P1|Overall Study|Protocol Violation|0
7741509|NCT00869024|26916081|P2|Overall Study|Lost to Follow-up|1
7741510|NCT00869024|26916082|P1|Overall Study|Lost to Follow-up|0
7741511|NCT00869024|26916081|P2|Overall Study|Death|3
7741512|NCT00869024|26916082|P1|Overall Study|Death|2
7741513|NCT00868998|26916098|P1|Overall Study|Death|1
7741514|NCT00868998|26916098|P1|Overall Study|Progression of disease|2
7741515|NCT00868998|26916098|P1|Overall Study|Withdrawal by Subject|1
7741516|NCT00868998|26916098|P1|Overall Study|Screen Failure|1
7741517|NCT00868790|26916109|P14|Post-study|Excluded Medication|0
7741518|NCT00868790|26916110|P13|Post-study|Excluded Medication|0
7741519|NCT00868790|26916111|P12|Post-study|Excluded Medication|0
7741520|NCT00868790|26916112|P11|Post-study|Excluded Medication|0
7741521|NCT00868790|26916113|P10|Post-study|Excluded Medication|1
7741522|NCT00868790|26916114|P9|Post-study|Excluded Medication|0
7741523|NCT00868790|26916115|P8|Post-study|Excluded Medication|2
7741524|NCT00868790|26916116|P7|Post-study|Excluded Medication|0
7741525|NCT00868790|26916117|P6|Post-study|Excluded Medication|0
7741526|NCT00868790|26916118|P5|Post-study|Excluded Medication|0
7741527|NCT00868790|26916119|P4|Post-study|Excluded Medication|0
7741528|NCT00868790|26916120|P3|Post-study|Excluded Medication|0
7741529|NCT00868790|26916121|P2|Post-study|Excluded Medication|0
7741530|NCT00868790|26916122|P1|Post-study|Excluded Medication|0
7741531|NCT00868790|26916109|P14|Post-study|Withdrawal by Subject|0
7741532|NCT00868790|26916110|P13|Post-study|Withdrawal by Subject|0
7741533|NCT00868790|26916111|P12|Post-study|Withdrawal by Subject|0
7741534|NCT00868790|26916112|P11|Post-study|Withdrawal by Subject|0
7741535|NCT00868790|26916113|P10|Post-study|Withdrawal by Subject|0
7741536|NCT00868790|26916114|P9|Post-study|Withdrawal by Subject|0
7741537|NCT00868790|26916115|P8|Post-study|Withdrawal by Subject|0
7741538|NCT00868790|26916116|P7|Post-study|Withdrawal by Subject|0
7741539|NCT00868790|26916117|P6|Post-study|Withdrawal by Subject|0
7741540|NCT00868790|26916118|P5|Post-study|Withdrawal by Subject|1
7741541|NCT00868790|26916119|P4|Post-study|Withdrawal by Subject|0
7741542|NCT00868790|26916120|P3|Post-study|Withdrawal by Subject|0
7741543|NCT00868790|26916121|P2|Post-study|Withdrawal by Subject|0
7741544|NCT00868790|26916122|P1|Post-study|Withdrawal by Subject|0
7741545|NCT00868790|26916109|P14|Period 4|Abnormal ALT/AST|0
7741546|NCT00868790|26916110|P13|Period 4|Abnormal ALT/AST|0
7741547|NCT00868790|26916111|P12|Period 4|Abnormal ALT/AST|0
7741548|NCT00868790|26916112|P11|Period 4|Abnormal ALT/AST|0
7741549|NCT00868790|26916113|P10|Period 4|Abnormal ALT/AST|0
7741550|NCT00868790|26916114|P9|Period 4|Abnormal ALT/AST|0
7741551|NCT00868790|26916115|P8|Period 4|Abnormal ALT/AST|0
7741552|NCT00868790|26916116|P7|Period 4|Abnormal ALT/AST|0
7741553|NCT00868790|26916117|P6|Period 4|Abnormal ALT/AST|0
7741554|NCT00868790|26916118|P5|Period 4|Abnormal ALT/AST|0
7741555|NCT00868790|26916119|P4|Period 4|Abnormal ALT/AST|0
7741556|NCT00868790|26916120|P3|Period 4|Abnormal ALT/AST|1
7741557|NCT00868790|26916121|P2|Period 4|Abnormal ALT/AST|0
7741558|NCT00868790|26916122|P1|Period 4|Abnormal ALT/AST|0
7741559|NCT00868790|26916109|P14|Period 4|Study Terminated by Sponsor|1
7741560|NCT00868790|26916110|P13|Period 4|Study Terminated by Sponsor|0
7741561|NCT00868790|26916111|P12|Period 4|Study Terminated by Sponsor|1
7741562|NCT00868790|26916112|P11|Period 4|Study Terminated by Sponsor|2
7741563|NCT00868790|26916113|P10|Period 4|Study Terminated by Sponsor|0
7741564|NCT00868790|26916114|P9|Period 4|Study Terminated by Sponsor|2
7741565|NCT00868790|26916115|P8|Period 4|Study Terminated by Sponsor|1
7741566|NCT00868790|26916116|P7|Period 4|Study Terminated by Sponsor|0
7741567|NCT00868790|26916117|P6|Period 4|Study Terminated by Sponsor|0
7741568|NCT00868790|26916118|P5|Period 4|Study Terminated by Sponsor|0
7741569|NCT00868790|26916119|P4|Period 4|Study Terminated by Sponsor|0
7741570|NCT00868790|26916120|P3|Period 4|Study Terminated by Sponsor|0
7741571|NCT00868790|26916121|P2|Period 4|Study Terminated by Sponsor|0
7741572|NCT00868790|26916122|P1|Period 4|Study Terminated by Sponsor|2
7741573|NCT00868790|26916109|P14|Period 4|Lost to Follow-up|0
7741574|NCT00868790|26916110|P13|Period 4|Lost to Follow-up|0
7741575|NCT00868790|26916111|P12|Period 4|Lost to Follow-up|0
7741576|NCT00868790|26916112|P11|Period 4|Lost to Follow-up|0
7741577|NCT00868790|26916113|P10|Period 4|Lost to Follow-up|0
7741578|NCT00868790|26916114|P9|Period 4|Lost to Follow-up|0
7741579|NCT00868790|26916115|P8|Period 4|Lost to Follow-up|1
7741580|NCT00868790|26916116|P7|Period 4|Lost to Follow-up|0
7741581|NCT00868790|26916117|P6|Period 4|Lost to Follow-up|0
7741582|NCT00868790|26916118|P5|Period 4|Lost to Follow-up|0
7741583|NCT00868790|26916119|P4|Period 4|Lost to Follow-up|0
7741584|NCT00868790|26916120|P3|Period 4|Lost to Follow-up|0
7741585|NCT00868790|26916121|P2|Period 4|Lost to Follow-up|0
7741586|NCT00868790|26916122|P1|Period 4|Lost to Follow-up|0
7741587|NCT00868790|26916109|P14|Period 4|Adverse Event|0
7741588|NCT00868790|26916110|P13|Period 4|Adverse Event|1
7741589|NCT00868790|26916111|P12|Period 4|Adverse Event|0
7741590|NCT00868790|26916112|P11|Period 4|Adverse Event|1
7741591|NCT00868790|26916113|P10|Period 4|Adverse Event|0
7741592|NCT00868790|26916114|P9|Period 4|Adverse Event|0
7741593|NCT00868790|26916115|P8|Period 4|Adverse Event|1
7741594|NCT00868790|26916116|P7|Period 4|Adverse Event|0
7741595|NCT00868790|26916117|P6|Period 4|Adverse Event|0
7741596|NCT00868790|26916118|P5|Period 4|Adverse Event|0
7741597|NCT00868790|26916119|P4|Period 4|Adverse Event|0
7741598|NCT00868790|26916120|P3|Period 4|Adverse Event|0
7741599|NCT00868790|26916121|P2|Period 4|Adverse Event|0
7741600|NCT00868790|26916122|P1|Period 4|Adverse Event|0
7741601|NCT00868790|26916109|P14|Period 3|Study Terminated by Sponsor|0
7741602|NCT00868790|26916110|P13|Period 3|Study Terminated by Sponsor|0
7741603|NCT00868790|26916111|P12|Period 3|Study Terminated by Sponsor|0
7741604|NCT00868790|26916112|P11|Period 3|Study Terminated by Sponsor|0
7741605|NCT00868790|26916113|P10|Period 3|Study Terminated by Sponsor|0
7741606|NCT00868790|26916114|P9|Period 3|Study Terminated by Sponsor|0
7741607|NCT00868790|26916115|P8|Period 3|Study Terminated by Sponsor|0
7741608|NCT00868790|26916116|P7|Period 3|Study Terminated by Sponsor|0
7741609|NCT00868790|26916117|P6|Period 3|Study Terminated by Sponsor|0
7741610|NCT00868790|26916118|P5|Period 3|Study Terminated by Sponsor|0
7741611|NCT00868790|26916119|P4|Period 3|Study Terminated by Sponsor|1
7741612|NCT00868790|26916120|P3|Period 3|Study Terminated by Sponsor|0
7741613|NCT00868790|26916121|P2|Period 3|Study Terminated by Sponsor|0
7741614|NCT00868790|26916122|P1|Period 3|Study Terminated by Sponsor|0
7741615|NCT00868790|26916109|P14|Period 3|Protocol Violation|0
7741616|NCT00868790|26916110|P13|Period 3|Protocol Violation|0
7741617|NCT00868790|26916111|P12|Period 3|Protocol Violation|0
7741618|NCT00868790|26916112|P11|Period 3|Protocol Violation|1
7741619|NCT00868790|26916113|P10|Period 3|Protocol Violation|0
7741620|NCT00868790|26916114|P9|Period 3|Protocol Violation|0
7741621|NCT00868790|26916115|P8|Period 3|Protocol Violation|0
7741622|NCT00868790|26916116|P7|Period 3|Protocol Violation|0
7741623|NCT00868790|26916117|P6|Period 3|Protocol Violation|0
7741624|NCT00868790|26916118|P5|Period 3|Protocol Violation|0
7741625|NCT00868790|26916119|P4|Period 3|Protocol Violation|0
7741626|NCT00868790|26916120|P3|Period 3|Protocol Violation|0
7741627|NCT00868790|26916121|P2|Period 3|Protocol Violation|0
7741628|NCT00868790|26916122|P1|Period 3|Protocol Violation|0
7741629|NCT00868790|26916109|P14|Period 3|Adverse Event|0
7741630|NCT00868790|26916110|P13|Period 3|Adverse Event|0
7741631|NCT00868790|26916111|P12|Period 3|Adverse Event|0
7741632|NCT00868790|26916112|P11|Period 3|Adverse Event|0
7741633|NCT00868790|26916113|P10|Period 3|Adverse Event|1
7741634|NCT00868790|26916114|P9|Period 3|Adverse Event|0
7741635|NCT00868790|26916115|P8|Period 3|Adverse Event|0
7741636|NCT00868790|26916116|P7|Period 3|Adverse Event|0
7741637|NCT00868790|26916117|P6|Period 3|Adverse Event|0
7741638|NCT00868790|26916118|P5|Period 3|Adverse Event|0
7741639|NCT00868790|26916119|P4|Period 3|Adverse Event|0
7741640|NCT00868790|26916120|P3|Period 3|Adverse Event|0
7741641|NCT00868790|26916121|P2|Period 3|Adverse Event|0
7741642|NCT00868790|26916122|P1|Period 3|Adverse Event|0
7741643|NCT00868790|26916109|P14|Period 2|Withdrawal by Subject|1
7741644|NCT00868790|26916110|P13|Period 2|Withdrawal by Subject|0
7741645|NCT00868790|26916111|P12|Period 2|Withdrawal by Subject|0
7741646|NCT00868790|26916112|P11|Period 2|Withdrawal by Subject|0
7741647|NCT00868790|26916113|P10|Period 2|Withdrawal by Subject|0
7741648|NCT00868790|26916114|P9|Period 2|Withdrawal by Subject|1
7741649|NCT00868790|26916115|P8|Period 2|Withdrawal by Subject|0
7741650|NCT00868790|26916116|P7|Period 2|Withdrawal by Subject|0
7741651|NCT00868790|26916117|P6|Period 2|Withdrawal by Subject|0
7741652|NCT00868790|26916118|P5|Period 2|Withdrawal by Subject|0
7741653|NCT00868790|26916119|P4|Period 2|Withdrawal by Subject|0
7741654|NCT00868790|26916120|P3|Period 2|Withdrawal by Subject|0
7741655|NCT00868790|26916121|P2|Period 2|Withdrawal by Subject|0
7741656|NCT00868790|26916122|P1|Period 2|Withdrawal by Subject|0
7741657|NCT00868790|26916109|P14|Period 2|Lost to Follow-up|0
7741658|NCT00868790|26916110|P13|Period 2|Lost to Follow-up|0
7741659|NCT00868790|26916111|P12|Period 2|Lost to Follow-up|0
7741660|NCT00868790|26916112|P11|Period 2|Lost to Follow-up|0
7741661|NCT00868790|26916113|P10|Period 2|Lost to Follow-up|0
7741662|NCT00868790|26916114|P9|Period 2|Lost to Follow-up|0
7741663|NCT00868790|26916115|P8|Period 2|Lost to Follow-up|0
7741664|NCT00868790|26916116|P7|Period 2|Lost to Follow-up|0
7741665|NCT00868790|26916117|P6|Period 2|Lost to Follow-up|1
7741666|NCT00868790|26916118|P5|Period 2|Lost to Follow-up|0
7741667|NCT00868790|26916119|P4|Period 2|Lost to Follow-up|0
7741668|NCT00868790|26916120|P3|Period 2|Lost to Follow-up|0
7741669|NCT00868790|26916121|P2|Period 2|Lost to Follow-up|1
7741670|NCT00868790|26916122|P1|Period 2|Lost to Follow-up|0
7741671|NCT00868790|26916109|P14|Period 2|Adverse Event|0
7741672|NCT00868790|26916110|P13|Period 2|Adverse Event|0
7741673|NCT00868790|26916111|P12|Period 2|Adverse Event|0
7741674|NCT00868790|26916112|P11|Period 2|Adverse Event|0
7741675|NCT00868790|26916113|P10|Period 2|Adverse Event|0
7741676|NCT00868790|26916114|P9|Period 2|Adverse Event|1
7741677|NCT00868790|26916115|P8|Period 2|Adverse Event|0
7741678|NCT00868790|26916116|P7|Period 2|Adverse Event|0
7741679|NCT00868790|26916117|P6|Period 2|Adverse Event|0
7741680|NCT00868790|26916118|P5|Period 2|Adverse Event|0
7741681|NCT00868790|26916119|P4|Period 2|Adverse Event|0
7741682|NCT00868790|26916120|P3|Period 2|Adverse Event|0
7741683|NCT00868790|26916121|P2|Period 2|Adverse Event|0
7741684|NCT00868790|26916122|P1|Period 2|Adverse Event|0
7741685|NCT00868790|26916109|P14|Period 1|Lost to Follow-up|0
7741686|NCT00868790|26916110|P13|Period 1|Lost to Follow-up|0
7741687|NCT00868790|26916111|P12|Period 1|Lost to Follow-up|0
7741688|NCT00868790|26916112|P11|Period 1|Lost to Follow-up|0
7741689|NCT00868790|26916113|P10|Period 1|Lost to Follow-up|0
7741690|NCT00868790|26916114|P9|Period 1|Lost to Follow-up|0
7741691|NCT00868790|26916115|P8|Period 1|Lost to Follow-up|0
7741692|NCT00868790|26916116|P7|Period 1|Lost to Follow-up|0
7741693|NCT00868790|26916117|P6|Period 1|Lost to Follow-up|1
7741694|NCT00868790|26916118|P5|Period 1|Lost to Follow-up|0
7741695|NCT00868790|26916119|P4|Period 1|Lost to Follow-up|0
7741696|NCT00868790|26916120|P3|Period 1|Lost to Follow-up|0
7741697|NCT00868790|26916121|P2|Period 1|Lost to Follow-up|0
7741698|NCT00868790|26916122|P1|Period 1|Lost to Follow-up|0
7741699|NCT00868790|26916109|P14|Period 1|Abnormal Triglycerides|0
7741700|NCT00868790|26916110|P13|Period 1|Abnormal Triglycerides|0
7741701|NCT00868790|26916111|P12|Period 1|Abnormal Triglycerides|0
7741702|NCT00868790|26916112|P11|Period 1|Abnormal Triglycerides|0
7741703|NCT00868790|26916113|P10|Period 1|Abnormal Triglycerides|0
7741704|NCT00868790|26916114|P9|Period 1|Abnormal Triglycerides|0
7741705|NCT00868790|26916115|P8|Period 1|Abnormal Triglycerides|0
7741706|NCT00868790|26916116|P7|Period 1|Abnormal Triglycerides|0
7741707|NCT00868790|26916117|P6|Period 1|Abnormal Triglycerides|0
7741708|NCT00868790|26916118|P5|Period 1|Abnormal Triglycerides|1
7741709|NCT00868790|26916119|P4|Period 1|Abnormal Triglycerides|0
7741710|NCT00868790|26916120|P3|Period 1|Abnormal Triglycerides|0
7741711|NCT00868790|26916121|P2|Period 1|Abnormal Triglycerides|0
7741712|NCT00868790|26916122|P1|Period 1|Abnormal Triglycerides|0
7741713|NCT00868790|26916109|P14|Period 1|Withdrawal by Subject|1
7741714|NCT00868790|26916110|P13|Period 1|Withdrawal by Subject|0
7741715|NCT00868790|26916111|P12|Period 1|Withdrawal by Subject|0
7741716|NCT00868790|26916112|P11|Period 1|Withdrawal by Subject|0
7741717|NCT00868790|26916113|P10|Period 1|Withdrawal by Subject|0
7741718|NCT00868790|26916114|P9|Period 1|Withdrawal by Subject|0
7741719|NCT00868790|26916115|P8|Period 1|Withdrawal by Subject|0
7741720|NCT00868790|26916116|P7|Period 1|Withdrawal by Subject|0
7741721|NCT00868790|26916117|P6|Period 1|Withdrawal by Subject|0
7741722|NCT00868790|26916118|P5|Period 1|Withdrawal by Subject|0
7741723|NCT00868790|26916119|P4|Period 1|Withdrawal by Subject|0
7741724|NCT00868790|26916120|P3|Period 1|Withdrawal by Subject|0
7741725|NCT00868790|26916121|P2|Period 1|Withdrawal by Subject|1
7741726|NCT00868790|26916122|P1|Period 1|Withdrawal by Subject|0
7741727|NCT00868790|26916109|P14|Period 1|Protocol Violation|0
7741728|NCT00868790|26916110|P13|Period 1|Protocol Violation|0
7741729|NCT00868790|26916111|P12|Period 1|Protocol Violation|0
7741730|NCT00868790|26916112|P11|Period 1|Protocol Violation|0
7741731|NCT00868790|26916113|P10|Period 1|Protocol Violation|0
7741732|NCT00868790|26916114|P9|Period 1|Protocol Violation|0
7741733|NCT00868790|26916115|P8|Period 1|Protocol Violation|0
7741734|NCT00868790|26916116|P7|Period 1|Protocol Violation|0
7741735|NCT00868790|26916117|P6|Period 1|Protocol Violation|0
7741736|NCT00868790|26916118|P5|Period 1|Protocol Violation|0
7741737|NCT00868790|26916119|P4|Period 1|Protocol Violation|0
7741738|NCT00868790|26916120|P3|Period 1|Protocol Violation|0
7741739|NCT00868790|26916121|P2|Period 1|Protocol Violation|0
7741740|NCT00868790|26916122|P1|Period 1|Protocol Violation|1
7741741|NCT00868790|26916109|P14|Period 1|Adverse Event|1
7741742|NCT00868790|26916110|P13|Period 1|Adverse Event|0
7741743|NCT00868790|26916111|P12|Period 1|Adverse Event|0
7741744|NCT00868790|26916112|P11|Period 1|Adverse Event|0
7741745|NCT00868790|26916113|P10|Period 1|Adverse Event|0
7741746|NCT00868790|26916114|P9|Period 1|Adverse Event|1
7741747|NCT00868790|26916115|P8|Period 1|Adverse Event|3
7741748|NCT00868790|26916116|P7|Period 1|Adverse Event|0
7741749|NCT00868790|26916117|P6|Period 1|Adverse Event|0
7741750|NCT00868790|26916118|P5|Period 1|Adverse Event|0
7741751|NCT00868790|26916119|P4|Period 1|Adverse Event|0
7741752|NCT00868790|26916120|P3|Period 1|Adverse Event|0
7741753|NCT00868790|26916121|P2|Period 1|Adverse Event|0
7741754|NCT00868790|26916122|P1|Period 1|Adverse Event|1
7741755|NCT00868608|26916205|P3|Overall Study|Other - Unspecified|0
7741756|NCT00868608|26916206|P2|Overall Study|Other - Unspecified|0
7741757|NCT00868608|26916207|P1|Overall Study|Other - Unspecified|1
7741758|NCT00868608|26916205|P3|Overall Study|Death|4
7741759|NCT00868608|26916206|P2|Overall Study|Death|2
7741760|NCT00868608|26916207|P1|Overall Study|Death|16
7741761|NCT00868608|26916205|P3|Overall Study|Lost to Follow-up|1
7741762|NCT00868608|26916206|P2|Overall Study|Lost to Follow-up|0
7741763|NCT00868608|26916207|P1|Overall Study|Lost to Follow-up|3
7741764|NCT00868608|26916205|P3|Overall Study|Withdrawal by Subject|0
7741765|NCT00868608|26916206|P2|Overall Study|Withdrawal by Subject|1
7741766|NCT00868608|26916207|P1|Overall Study|Withdrawal by Subject|3
7741767|NCT00868530|26916231|P1|Overall Study|Lost to Follow-up|1
7741768|NCT00868530|26916231|P1|Overall Study|Adverse Event|3
7741769|NCT00868517|26916246|P3|Overall Study|Protocol Violation|0
7741770|NCT00868517|26916247|P2|Overall Study|Protocol Violation|1
7741771|NCT00868517|26916248|P1|Overall Study|Protocol Violation|1
7741772|NCT00868517|26916246|P3|Overall Study|Withdrawal by Subject|2
7741773|NCT00868517|26916247|P2|Overall Study|Withdrawal by Subject|3
7741774|NCT00868517|26916248|P1|Overall Study|Withdrawal by Subject|3
7741775|NCT00868439|26916286|P2|Overall Study|Withdrawal by Subject|1
7741776|NCT00868439|26916287|P1|Overall Study|Withdrawal by Subject|0
7741777|NCT00868439|26916286|P2|Overall Study|Physician Decision|0
7741778|NCT00868439|26916287|P1|Overall Study|Physician Decision|1
7741779|NCT00868439|26916286|P2|Overall Study|Protocol Violation|1
7741780|NCT00868439|26916287|P1|Overall Study|Protocol Violation|1
7741781|NCT00868439|26916286|P2|Overall Study|Death|1
7741782|NCT00868439|26916287|P1|Overall Study|Death|0
7741783|NCT00868439|26916286|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
7741784|NCT00868439|26916287|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
7741785|NCT00868439|26916286|P2|Overall Study|Adverse Event|3
7741786|NCT00868439|26916287|P1|Overall Study|Adverse Event|4
7741787|NCT00868296|26916344|P2|Overall Study|Withdrawal by Subject|1
7741788|NCT00868296|26916345|P1|Overall Study|Withdrawal by Subject|0
7741789|NCT00868296|26916344|P2|Overall Study|Adverse Event|2
7741790|NCT00868296|26916345|P1|Overall Study|Adverse Event|0
7741791|NCT00868231|26916353|P6|Treatment Period 3|Adverse Event|0
7741792|NCT00868231|26916354|P5|Treatment Period 3|Adverse Event|0
7741793|NCT00868231|26916355|P4|Treatment Period 3|Adverse Event|0
7741794|NCT00868231|26916356|P3|Treatment Period 3|Adverse Event|1
7741795|NCT00868231|26916357|P2|Treatment Period 3|Adverse Event|0
7741796|NCT00868231|26916358|P1|Treatment Period 3|Adverse Event|0
7741797|NCT00868231|26916353|P6|Treatment Period 2|Adverse Event|0
7741798|NCT00868231|26916354|P5|Treatment Period 2|Adverse Event|0
7741799|NCT00868231|26916355|P4|Treatment Period 2|Adverse Event|0
7741800|NCT00868231|26916356|P3|Treatment Period 2|Adverse Event|0
7741801|NCT00868231|26916357|P2|Treatment Period 2|Adverse Event|0
7741802|NCT00868231|26916358|P1|Treatment Period 2|Adverse Event|1
7741803|NCT00868231|26916353|P6|Treatment Period 1|Adverse Event|0
7741804|NCT00868231|26916354|P5|Treatment Period 1|Adverse Event|1
7741805|NCT00868231|26916355|P4|Treatment Period 1|Adverse Event|0
7741806|NCT00868231|26916356|P3|Treatment Period 1|Adverse Event|0
7741807|NCT00868231|26916357|P2|Treatment Period 1|Adverse Event|0
7741808|NCT00868231|26916358|P1|Treatment Period 1|Adverse Event|0
7741809|NCT00868192|26916424|P1|Overall Study|Ineligible|4
7741810|NCT00868166|26916441|P2|Overall Study|Non-compliance with IMP|1
7741811|NCT00868166|26916442|P1|Overall Study|Non-compliance with IMP|1
7741812|NCT00868166|26916441|P2|Overall Study|Lack of efficacy, logistics, unwell|10
7741813|NCT00868166|26916442|P1|Overall Study|Lack of efficacy, logistics, unwell|9
7741814|NCT00868166|26916441|P2|Overall Study|Adverse Event|10
7741815|NCT00868166|26916442|P1|Overall Study|Adverse Event|9
7741816|NCT00868166|26916441|P2|Overall Study|Lost to Follow-up|3
7741817|NCT00868166|26916442|P1|Overall Study|Lost to Follow-up|1
7741818|NCT00868166|26916441|P2|Overall Study|Protocol Violation|0
7741819|NCT00868166|26916442|P1|Overall Study|Protocol Violation|1
7741820|NCT00868166|26916441|P2|Overall Study|Withdrawal by Subject|25
7741821|NCT00868166|26916442|P1|Overall Study|Withdrawal by Subject|33
7741822|NCT00868166|26916441|P2|Overall Study|Death|65
7741823|NCT00868166|26916442|P1|Overall Study|Death|58
7741824|NCT00867815|26916504|P1|Overall Study|Lost to Follow-up|1
7741825|NCT00867568|26916524|P1|Overall Study|Withdrawal by Subject|1
7741826|NCT00867568|26916524|P1|Overall Study|Adverse Event|4
7741827|NCT00867568|26916524|P1|Overall Study|Lack of Efficacy|10
7741828|NCT00867503|26916541|P1|Overall Study|Withdrawal by Subject|1
7741829|NCT00867490|26916547|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
7741830|NCT00867490|26916547|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
7741831|NCT00867490|26916547|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
7741832|NCT00867490|26916547|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
7741833|NCT00867490|26916547|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
7741834|NCT00867360|26916589|P2|Overall Study|Physician Decision|1
7741835|NCT00867360|26916590|P1|Overall Study|Physician Decision|0
7741836|NCT00867360|26916589|P2|Overall Study|Withdrawal by Subject|0
7741837|NCT00867360|26916590|P1|Overall Study|Withdrawal by Subject|1
7741838|NCT00867334|26916602|P2|Overall Study|Withdrawal by Subject|0
7741839|NCT00867334|26916603|P1|Overall Study|Withdrawal by Subject|1
7741840|NCT00867334|26916602|P2|Overall Study|Withdrawal by Subject|0
7741841|NCT00867334|26916603|P1|Overall Study|Withdrawal by Subject|1
7741842|NCT00867334|26916602|P2|Overall Study|Withdrawal by Subject|1
7741843|NCT00867334|26916603|P1|Overall Study|Withdrawal by Subject|0
7741844|NCT00867308|26916639|P2|Overall Study|Withdrawal by Subject|2
7741845|NCT00867308|26916640|P1|Overall Study|Withdrawal by Subject|1
7741846|NCT00867308|26916639|P2|Overall Study|Lack of Efficacy|12
7741847|NCT00867308|26916640|P1|Overall Study|Lack of Efficacy|6
7741848|NCT00867308|26916639|P2|Overall Study|Adverse Event|4
7741849|NCT00867308|26916640|P1|Overall Study|Adverse Event|1
7741850|NCT00867308|26916639|P2|Overall Study|Death|0
7741851|NCT00867308|26916640|P1|Overall Study|Death|1
7741852|NCT00867165|26916659|P2|Overall Study|Withdrawal by Subject|0
7741853|NCT00867165|26916660|P1|Overall Study|Withdrawal by Subject|1
7741854|NCT00867165|26916659|P2|Overall Study|Adverse Event|0
7741855|NCT00867165|26916660|P1|Overall Study|Adverse Event|3
7741856|NCT00867113|26916808|P1|Post Treatment After Survival Follow-up|Administrative problems|4
7741857|NCT00867113|26916808|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
7741858|NCT00867113|26916808|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
7741859|NCT00867113|26916808|P1|Post Treatment After Survival Follow-up|Death|1
7741860|NCT00867113|26916808|P1|Treatment Period|Protocol Violation|4
7741861|NCT00867113|26916808|P1|Treatment Period|Disease progression/relapse|1
7741862|NCT00867113|26916808|P1|Treatment Period|Administrative problems|1
7741863|NCT00867113|26916808|P1|Treatment Period|Lost to Follow-up|3
7741864|NCT00867113|26916808|P1|Treatment Period|Withdrawal by Subject|19
7741865|NCT00867113|26916808|P1|Treatment Period|Death|2
7741866|NCT00867113|26916808|P1|Treatment Period|Adverse Event|15
7741867|NCT00867087|26916872|P1|Overall Study|Death|37
7741868|NCT00867087|26916872|P1|Overall Study|Withdrawal by Subject|4
7741869|NCT00867087|26916872|P1|Overall Study|Other|1
7741870|NCT00867035|26916888|P2|Baseline to 1 Week|Withdrawal by Subject|0
7741871|NCT00867035|26916889|P1|Baseline to 1 Week|Withdrawal by Subject|1
7741872|NCT00867035|26916888|P2|Baseline to 1 Hour|Withdrawal by Subject|1
7741873|NCT00867035|26916889|P1|Baseline to 1 Hour|Withdrawal by Subject|1
7741874|NCT00867009|26916915|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
7741875|NCT00867009|26916915|P1|Induction Period|Progressive Disease (PD)|25
7741876|NCT00867009|26916915|P1|Induction Period|Physician Decision|3
7741877|NCT00867009|26916915|P1|Induction Period|Withdrawal by Subject|8
7741878|NCT00867009|26916915|P1|Induction Period|Protocol Violation|1
7741879|NCT00867009|26916915|P1|Induction Period|Death due to Study Disease|4
7741880|NCT00867009|26916915|P1|Induction Period|Death due to serious adverse event|6
7741881|NCT00867009|26916915|P1|Induction Period|Serious Adverse Event|10
7741882|NCT00867009|26916915|P1|Induction Period|Nonserious Adverse Event|5
7741883|NCT00866918|26916924|P2|Overall Study|Secondary malignancy|0
7741884|NCT00866918|26916925|P1|Overall Study|Secondary malignancy|1
7741885|NCT00866918|26916924|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
7741886|NCT00866918|26916925|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
7741887|NCT00866918|26916924|P2|Overall Study|Ineligible|4
7741888|NCT00866918|26916925|P1|Overall Study|Ineligible|2
7741889|NCT00866918|26916924|P2|Overall Study|Physician Decision|2
7741890|NCT00866918|26916925|P1|Overall Study|Physician Decision|10
7741891|NCT00866918|26916924|P2|Overall Study|Lack of Efficacy|1
7741892|NCT00866918|26916925|P1|Overall Study|Lack of Efficacy|1
7741893|NCT00866918|26916924|P2|Overall Study|Death|5
7741894|NCT00866918|26916925|P1|Overall Study|Death|1
7741895|NCT00866814|26916959|P1|Overall Study|Moved to area without study site|1
7741896|NCT00866814|26916959|P1|Overall Study|Unable to meet follow-up requirements|2
7741897|NCT00866814|26916959|P1|Overall Study|No longer wished to participate|1
7741898|NCT00866814|26916959|P1|Overall Study|Death|1
7741899|NCT00866814|26916959|P1|Overall Study|Physician Decision|1
7741900|NCT00866814|26916959|P1|Overall Study|Adverse Event|2
7741901|NCT00866814|26916959|P1|Overall Study|Lost to Follow-up|12
7741902|NCT00866788|26916972|P4|Overall Study|Physician Decision|1
7741903|NCT00866788|26916973|P3|Overall Study|Physician Decision|1
7741904|NCT00866788|26916974|P2|Overall Study|Physician Decision|0
7741905|NCT00866788|26916975|P1|Overall Study|Physician Decision|0
7741906|NCT00866788|26916972|P4|Overall Study|Disease progression|0
7741907|NCT00866788|26916973|P3|Overall Study|Disease progression|1
7741908|NCT00866788|26916974|P2|Overall Study|Disease progression|1
7741909|NCT00866788|26916975|P1|Overall Study|Disease progression|3
7741910|NCT00866788|26916972|P4|Overall Study|Pregnancy|0
7741911|NCT00866788|26916973|P3|Overall Study|Pregnancy|0
7741912|NCT00866788|26916974|P2|Overall Study|Pregnancy|1
7741913|NCT00866788|26916975|P1|Overall Study|Pregnancy|0
7741914|NCT00866788|26916972|P4|Overall Study|Withdrawal by Subject|1
7741915|NCT00866788|26916973|P3|Overall Study|Withdrawal by Subject|0
7741916|NCT00866788|26916974|P2|Overall Study|Withdrawal by Subject|1
7741917|NCT00866788|26916975|P1|Overall Study|Withdrawal by Subject|2
7741918|NCT00866788|26916972|P4|Overall Study|Lost to Follow-up|2
7741919|NCT00866788|26916973|P3|Overall Study|Lost to Follow-up|0
7741920|NCT00866788|26916974|P2|Overall Study|Lost to Follow-up|1
7741921|NCT00866788|26916975|P1|Overall Study|Lost to Follow-up|1
7741922|NCT00866788|26916972|P4|Overall Study|Adverse Event|1
7741923|NCT00866788|26916973|P3|Overall Study|Adverse Event|0
7741924|NCT00866788|26916974|P2|Overall Study|Adverse Event|2
7741925|NCT00866788|26916975|P1|Overall Study|Adverse Event|0
7741926|NCT00866775|26917023|P2|Overall Study|discontinued due to communication error|1
7741927|NCT00866775|26917024|P1|Overall Study|discontinued due to communication error|0
7741928|NCT00866775|26917023|P2|Overall Study|met exit criteria|17
7741929|NCT00866775|26917024|P1|Overall Study|met exit criteria|23
7741930|NCT00866775|26917023|P2|Overall Study|Withdrawal by Subject|4
7741931|NCT00866775|26917024|P1|Overall Study|Withdrawal by Subject|4
7741932|NCT00866775|26917023|P2|Overall Study|Protocol Violation|4
7741933|NCT00866775|26917024|P1|Overall Study|Protocol Violation|3
7741934|NCT00866775|26917023|P2|Overall Study|Physician Decision|3
7741935|NCT00866775|26917024|P1|Overall Study|Physician Decision|0
7741936|NCT00866775|26917023|P2|Overall Study|Lost to Follow-up|4
7741937|NCT00866775|26917024|P1|Overall Study|Lost to Follow-up|0
7741938|NCT00866775|26917023|P2|Overall Study|Death|0
7741939|NCT00866775|26917024|P1|Overall Study|Death|1
7741940|NCT00866775|26917023|P2|Overall Study|Adverse Event|19
7741941|NCT00866775|26917024|P1|Overall Study|Adverse Event|5
7741942|NCT00866723|26917067|P1|Overall Study|Disease Progression|4
7741943|NCT00866723|26917067|P1|Overall Study|Withdrawal by Subject|1
7741944|NCT00866697|26917074|P2|Overall Study|Withdrawal by Subject|57
7741945|NCT00866697|26917075|P1|Overall Study|Withdrawal by Subject|33
7741946|NCT00866697|26917074|P2|Overall Study|Physician Decision|5
7741947|NCT00866697|26917075|P1|Overall Study|Physician Decision|3
7741948|NCT00866697|26917074|P2|Overall Study|Lost to Follow-up|28
7741949|NCT00866697|26917075|P1|Overall Study|Lost to Follow-up|22
7741950|NCT00866697|26917074|P2|Overall Study|Study closed/terminated|138
7741951|NCT00866697|26917075|P1|Overall Study|Study closed/terminated|156
7741952|NCT00866658|26917121|P2|Overall Study|Familial and Personal Reasons|5
7741953|NCT00866658|26917122|P1|Overall Study|Familial and Personal Reasons|4
7741954|NCT00866658|26917121|P2|Overall Study|Protocol Violation|1
7741955|NCT00866658|26917122|P1|Overall Study|Protocol Violation|1
7741956|NCT00866658|26917121|P2|Overall Study|Withdrawal by Subject|0
7741957|NCT00866658|26917122|P1|Overall Study|Withdrawal by Subject|1
7741958|NCT00866658|26917121|P2|Overall Study|Lack of Efficacy|1
7741959|NCT00866658|26917122|P1|Overall Study|Lack of Efficacy|2
7741960|NCT00866658|26917121|P2|Overall Study|Adverse Event|14
7741961|NCT00866658|26917122|P1|Overall Study|Adverse Event|5
7741962|NCT00866619|26917154|P4|Overall Study|Lost to Follow-up|425
7741963|NCT00866619|26917155|P3|Overall Study|Lost to Follow-up|568
7741964|NCT00866619|26917156|P2|Overall Study|Lost to Follow-up|830
7741965|NCT00866619|26917157|P1|Overall Study|Lost to Follow-up|1145
7741966|NCT00866619|26917154|P4|Overall Study|Withdrawal by Subject|144
7741967|NCT00866619|26917155|P3|Overall Study|Withdrawal by Subject|272
7741968|NCT00866619|26917156|P2|Overall Study|Withdrawal by Subject|295
7741969|NCT00866619|26917157|P1|Overall Study|Withdrawal by Subject|587
7741970|NCT00866619|26917154|P4|Overall Study|Protocol Violation|17
7741971|NCT00866619|26917155|P3|Overall Study|Protocol Violation|2
7741972|NCT00866619|26917156|P2|Overall Study|Protocol Violation|39
7741973|NCT00866619|26917157|P1|Overall Study|Protocol Violation|2
7741974|NCT00866619|26917154|P4|Overall Study|Adverse Event|44
7741975|NCT00866619|26917155|P3|Overall Study|Adverse Event|47
7741976|NCT00866619|26917156|P2|Overall Study|Adverse Event|106
7741977|NCT00866619|26917157|P1|Overall Study|Adverse Event|112
7741978|NCT00866606|26917477|P1|Overall Study|Adverse Event|1
7741979|NCT00866606|26917477|P1|Overall Study|Lost to Follow-up|3
7741980|NCT00866359|26917491|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
7741981|NCT00866359|26917492|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
7741982|NCT00866359|26917493|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
7741983|NCT00866359|26917494|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
7741984|NCT00866359|26917491|P4|Treatment Phase (Days 1 to 85)|Other|0
7741985|NCT00866359|26917492|P3|Treatment Phase (Days 1 to 85)|Other|0
7741986|NCT00866359|26917493|P2|Treatment Phase (Days 1 to 85)|Other|0
7741987|NCT00866359|26917494|P1|Treatment Phase (Days 1 to 85)|Other|1
7741988|NCT00866359|26917491|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
7741989|NCT00866359|26917492|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
7741990|NCT00866359|26917493|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
7741991|NCT00866359|26917494|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
7741992|NCT00866359|26917491|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7741993|NCT00866359|26917492|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7741994|NCT00866359|26917493|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7741995|NCT00866359|26917494|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
7741996|NCT00866359|26917491|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7741997|NCT00866359|26917492|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7741998|NCT00866359|26917493|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7741999|NCT00866359|26917494|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
7742000|NCT00866359|26917491|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
7742001|NCT00866359|26917492|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
7742002|NCT00866359|26917493|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
7742003|NCT00866359|26917494|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
7742004|NCT00866333|26917550|P3|Overall Study|Study Terminated by Sponsor|9
7742005|NCT00866333|26917551|P2|Overall Study|Study Terminated by Sponsor|5
7742006|NCT00866333|26917552|P1|Overall Study|Study Terminated by Sponsor|2
7742007|NCT00866333|26917550|P3|Overall Study|Reason not Specified|1
7742008|NCT00866333|26917551|P2|Overall Study|Reason not Specified|1
7742009|NCT00866333|26917552|P1|Overall Study|Reason not Specified|3
7742010|NCT00866333|26917550|P3|Overall Study|Withdrawal of consent|2
7742011|NCT00866333|26917551|P2|Overall Study|Withdrawal of consent|1
7742012|NCT00866333|26917552|P1|Overall Study|Withdrawal of consent|0
7742013|NCT00866320|26917569|P1|Overall Study|Death|2
7742014|NCT00866320|26917569|P1|Overall Study|Withdrawal by Subject|4
7742015|NCT00866307|26917576|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
7742016|NCT00866307|26917577|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
7742017|NCT00866307|26917578|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
7742018|NCT00866307|26917576|P3|Consolidation/Maintenance|Non-compliance|1
7742019|NCT00866307|26917577|P2|Consolidation/Maintenance|Non-compliance|0
7742020|NCT00866307|26917578|P1|Consolidation/Maintenance|Non-compliance|0
7742021|NCT00866307|26917576|P3|Consolidation/Maintenance|Therapy error|0
7742022|NCT00866307|26917577|P2|Consolidation/Maintenance|Therapy error|1
7742023|NCT00866307|26917578|P1|Consolidation/Maintenance|Therapy error|0
7742024|NCT00866307|26917576|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
7742025|NCT00866307|26917577|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
7742026|NCT00866307|26917578|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
7742027|NCT00866307|26917576|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
7742028|NCT00866307|26917577|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
7742029|NCT00866307|26917578|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
7742030|NCT00866307|26917576|P3|Consolidation/Maintenance|Withdrawal by Subject|1
7742031|NCT00866307|26917577|P2|Consolidation/Maintenance|Withdrawal by Subject|1
7742032|NCT00866307|26917578|P1|Consolidation/Maintenance|Withdrawal by Subject|0
7742033|NCT00866307|26917576|P3|Consolidation/Maintenance|Physician Decision|2
7742034|NCT00866307|26917577|P2|Consolidation/Maintenance|Physician Decision|3
7742035|NCT00866307|26917578|P1|Consolidation/Maintenance|Physician Decision|0
7742036|NCT00866307|26917576|P3|Consolidation/Maintenance|Death|1
7742037|NCT00866307|26917577|P2|Consolidation/Maintenance|Death|0
7742038|NCT00866307|26917578|P1|Consolidation/Maintenance|Death|0
7742039|NCT00866307|26917576|P3|Consolidation/Maintenance|Adverse Event|8
7742040|NCT00866307|26917577|P2|Consolidation/Maintenance|Adverse Event|0
7742041|NCT00866307|26917578|P1|Consolidation/Maintenance|Adverse Event|0
7742042|NCT00866307|26917576|P3|Induction|Study was closed at the time|0
7742043|NCT00866307|26917577|P2|Induction|Study was closed at the time|0
7742044|NCT00866307|26917578|P1|Induction|Study was closed at the time|1
7742045|NCT00866307|26917576|P3|Induction|Improper post-induction consent|0
7742046|NCT00866307|26917577|P2|Induction|Improper post-induction consent|0
7742047|NCT00866307|26917578|P1|Induction|Improper post-induction consent|2
7742048|NCT00866307|26917576|P3|Induction|Inadequate cytognetic samples th|0
7742049|NCT00866307|26917577|P2|Induction|Inadequate cytognetic samples th|0
7742050|NCT00866307|26917578|P1|Induction|Inadequate cytognetic samples th|1
7742051|NCT00866307|26917576|P3|Induction|Identification of Patients with Day 29 M|0
7742052|NCT00866307|26917577|P2|Induction|Identification of Patients with Day 29 M|0
7742053|NCT00866307|26917578|P1|Induction|Identification of Patients with Day 29 M|3
7742054|NCT00866307|26917576|P3|Induction|Progressive Disease|0
7742055|NCT00866307|26917577|P2|Induction|Progressive Disease|0
7742056|NCT00866307|26917578|P1|Induction|Progressive Disease|1
7742057|NCT00866307|26917576|P3|Induction|Physician Decision|0
7742058|NCT00866307|26917577|P2|Induction|Physician Decision|0
7742059|NCT00866307|26917578|P1|Induction|Physician Decision|5
7742060|NCT00866307|26917576|P3|Induction|Death|0
7742061|NCT00866307|26917577|P2|Induction|Death|0
7742062|NCT00866307|26917578|P1|Induction|Death|2
7742063|NCT00866307|26917576|P3|Induction|Adverse Event|0
7742064|NCT00866307|26917577|P2|Induction|Adverse Event|0
7742065|NCT00866307|26917578|P1|Induction|Adverse Event|5
7742066|NCT00866294|26917588|P3|Overall Study|Physician Decision|1
7742067|NCT00866294|26917589|P2|Overall Study|Physician Decision|2
7742068|NCT00866294|26917590|P1|Overall Study|Physician Decision|6
7742069|NCT00866294|26917588|P3|Overall Study|Lost to Follow-up|0
7742070|NCT00866294|26917589|P2|Overall Study|Lost to Follow-up|3
7742071|NCT00866294|26917590|P1|Overall Study|Lost to Follow-up|1
7742072|NCT00866294|26917588|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
7742073|NCT00866294|26917589|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
7742074|NCT00866294|26917590|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
7742075|NCT00866294|26917588|P3|Overall Study|Protocol Violation|0
7742076|NCT00866294|26917589|P2|Overall Study|Protocol Violation|0
7742077|NCT00866294|26917590|P1|Overall Study|Protocol Violation|2
7742078|NCT00866294|26917588|P3|Overall Study|Lack of Efficacy|0
7742079|NCT00866294|26917589|P2|Overall Study|Lack of Efficacy|1
7742080|NCT00866294|26917590|P1|Overall Study|Lack of Efficacy|7
7742081|NCT00866294|26917588|P3|Overall Study|Adverse Event|9
7742082|NCT00866294|26917589|P2|Overall Study|Adverse Event|13
7742083|NCT00866294|26917590|P1|Overall Study|Adverse Event|12
7742084|NCT00866281|26917619|P2|Overall Study|New cancer therapy|4
7742085|NCT00866281|26917620|P1|Overall Study|New cancer therapy|0
7742086|NCT00866281|26917619|P2|Overall Study|Disease progression|11
7742087|NCT00866281|26917620|P1|Overall Study|Disease progression|3
7742088|NCT00866281|26917619|P2|Overall Study|Withdrawal by participants|0
7742089|NCT00866281|26917620|P1|Overall Study|Withdrawal by participants|3
7742090|NCT00866281|26917619|P2|Overall Study|Adverse Event|0
7742091|NCT00866281|26917620|P1|Overall Study|Adverse Event|1
7742092|NCT00866177|26917636|P1|Overall Study|Not Treated|151
7742093|NCT00866177|26917636|P1|Overall Study|Withdrawal by Subject|1
7742094|NCT00866047|26917640|P1|Follow-up Period|Lost to Follow-up|5
7742095|NCT00866047|26917640|P1|Treatment Period|Withdrawal by Subject|5
7742096|NCT00866047|26917640|P1|Treatment Period|Physician Decision|14
7742097|NCT00866047|26917640|P1|Treatment Period|Adverse Event|16
7742098|NCT00866047|26917640|P1|Treatment Period|Progressive disease|13
7742099|NCT00865904|26917682|P5|Overall Study|Randomized but not Treated|1
7742100|NCT00865904|26917683|P4|Overall Study|Randomized but not Treated|1
7742101|NCT00865904|26917684|P3|Overall Study|Randomized but not Treated|0
7742102|NCT00865904|26917685|P2|Overall Study|Randomized but not Treated|0
7742103|NCT00865904|26917686|P1|Overall Study|Randomized but not Treated|2
7742104|NCT00865709|26917743|P2|Treatment|Surgery|3
7742105|NCT00865709|26917744|P1|Treatment|Surgery|8
7742106|NCT00865709|26917743|P2|Treatment|Physician Decision|2
7742107|NCT00865709|26917744|P1|Treatment|Physician Decision|3
7742108|NCT00865709|26917743|P2|Treatment|Withdrawal by Subject|7
7742109|NCT00865709|26917744|P1|Treatment|Withdrawal by Subject|10
7742110|NCT00865709|26917743|P2|Treatment|Adverse Event|6
7742111|NCT00865709|26917744|P1|Treatment|Adverse Event|9
7742112|NCT00865566|26917762|P2|Overall Study|HIV infection|7
7742113|NCT00865566|26917763|P1|Overall Study|HIV infection|5
7742114|NCT00865566|26917762|P2|Overall Study|Other; N=245 due to early study closure|139
7742115|NCT00865566|26917763|P1|Overall Study|Other; N=245 due to early study closure|154
7742116|NCT00865566|26917762|P2|Overall Study|Participant unable to adhere|42
7742117|NCT00865566|26917763|P1|Overall Study|Participant unable to adhere|27
7742118|NCT00865566|26917762|P2|Overall Study|Participant relocated|107
7742119|NCT00865566|26917763|P1|Overall Study|Participant relocated|78
7742120|NCT00865566|26917762|P2|Overall Study|Physician Decision|1
7742121|NCT00865566|26917763|P1|Overall Study|Physician Decision|0
7742122|NCT00865566|26917762|P2|Overall Study|Withdrawal by Subject|65
7742123|NCT00865566|26917763|P1|Overall Study|Withdrawal by Subject|45
7742124|NCT00865566|26917762|P2|Overall Study|Lost to Follow-up|315
7742125|NCT00865566|26917763|P1|Overall Study|Lost to Follow-up|314
7742126|NCT00865566|26917762|P2|Overall Study|Death|11
7742127|NCT00865566|26917763|P1|Overall Study|Death|1
7742128|NCT00865514|26917783|P1|Overall Study|Infusion cost exceeded funding|2
7742129|NCT00865345|26917788|P1|Overall Study|Withdrawal by Subject|2
7742130|NCT00865306|26917795|P2|Controlled Trial|Withdrawal by Subject|1
7742131|NCT00865306|26917796|P1|Controlled Trial|Withdrawal by Subject|0
7742132|NCT00865306|26917795|P2|Controlled Trial|Sought treatment for conduct disorder|0
7742133|NCT00865306|26917796|P1|Controlled Trial|Sought treatment for conduct disorder|1
7742134|NCT00865306|26917795|P2|Controlled Trial|Improved btw baseline and first session|0
7742135|NCT00865306|26917796|P1|Controlled Trial|Improved btw baseline and first session|1
7742136|NCT00865306|26917795|P2|Controlled Trial|Difficulty commuting|0
7742137|NCT00865306|26917796|P1|Controlled Trial|Difficulty commuting|2
7742138|NCT00865306|26917795|P2|Controlled Trial|Lost to Follow-up|1
7742139|NCT00865306|26917796|P1|Controlled Trial|Lost to Follow-up|1
7742140|NCT00865280|26917808|P2|Overall Study|Adverse Event|1
7742141|NCT00865280|26917809|P1|Overall Study|Adverse Event|0
7742142|NCT00865280|26917808|P2|Overall Study|Exclusion Condition|0
7742143|NCT00865280|26917809|P1|Overall Study|Exclusion Condition|1
7742144|NCT00865280|26917808|P2|Overall Study|Adverse Event/Lost to Follow-up|0
7742145|NCT00865280|26917809|P1|Overall Study|Adverse Event/Lost to Follow-up|1
7742146|NCT00865280|26917808|P2|Overall Study|End of Treatment/Lost to Follow-up|1
7742147|NCT00865280|26917809|P1|Overall Study|End of Treatment/Lost to Follow-up|0
7742148|NCT00865280|26917808|P2|Overall Study|Withdrawal by Subject|1
7742149|NCT00865280|26917809|P1|Overall Study|Withdrawal by Subject|4
7742150|NCT00865189|26917846|P2|Overall Study|Withdrawal by Subject|0
7742151|NCT00865189|26917847|P1|Overall Study|Withdrawal by Subject|1
7742152|NCT00865189|26917846|P2|Overall Study|Lost to Follow-up|6
7742153|NCT00865189|26917847|P1|Overall Study|Lost to Follow-up|6
7742154|NCT00865189|26917846|P2|Overall Study|Death|11
7742155|NCT00865189|26917847|P1|Overall Study|Death|4
7742156|NCT00865189|26917846|P2|Overall Study|Other|2
7742157|NCT00865189|26917847|P1|Overall Study|Other|1
7742158|NCT00865124|26917875|P3|Overall Study|Withdrawn consent|0
7742159|NCT00865124|26917876|P2|Overall Study|Withdrawn consent|0
7742160|NCT00865124|26917877|P1|Overall Study|Withdrawn consent|2
7742161|NCT00865124|26917875|P3|Overall Study|Physician Decision|0
7742162|NCT00865124|26917876|P2|Overall Study|Physician Decision|1
7742163|NCT00865124|26917877|P1|Overall Study|Physician Decision|2
7742164|NCT00865098|26917894|P1|Overall Study|Progressive disease|1
7742165|NCT00865046|26917906|P3|Overall Study|Withdrawal by Subject|0
7742166|NCT00865046|26917907|P2|Overall Study|Withdrawal by Subject|0
7742167|NCT00865046|26917908|P1|Overall Study|Withdrawal by Subject|5
7742168|NCT00865046|26917906|P3|Overall Study|Death|1
7742169|NCT00865046|26917907|P2|Overall Study|Death|1
7742170|NCT00865046|26917908|P1|Overall Study|Death|0
7742171|NCT00865046|26917906|P3|Overall Study|Lost to Follow-up|0
7742172|NCT00865046|26917907|P2|Overall Study|Lost to Follow-up|4
7742173|NCT00865046|26917908|P1|Overall Study|Lost to Follow-up|1
7742174|NCT00865020|26917918|P2|Overall Study|Randomized but discontinued|4
7742175|NCT00865020|26917919|P1|Overall Study|Randomized but discontinued|2
7742176|NCT00865020|26917918|P2|Overall Study|Death|1
7742177|NCT00865020|26917919|P1|Overall Study|Death|0
7742178|NCT00865020|26917918|P2|Overall Study|Abnormal laboratory value(s)|1
7742179|NCT00865020|26917919|P1|Overall Study|Abnormal laboratory value(s)|0
7742180|NCT00865020|26917918|P2|Overall Study|Administrative problems|2
7742181|NCT00865020|26917919|P1|Overall Study|Administrative problems|0
7742182|NCT00865020|26917918|P2|Overall Study|Protocol deviation|1
7742183|NCT00865020|26917919|P1|Overall Study|Protocol deviation|4
7742184|NCT00865020|26917918|P2|Overall Study|Lost to Follow-up|4
7742185|NCT00865020|26917919|P1|Overall Study|Lost to Follow-up|6
7742186|NCT00865020|26917918|P2|Overall Study|Abnormal test procedure result(s)|8
7742187|NCT00865020|26917919|P1|Overall Study|Abnormal test procedure result(s)|6
7742188|NCT00865020|26917918|P2|Overall Study|Adverse Event|14
7742189|NCT00865020|26917919|P1|Overall Study|Adverse Event|9
7742190|NCT00865020|26917918|P2|Overall Study|Withdrawal by Subject|16
7742191|NCT00865020|26917919|P1|Overall Study|Withdrawal by Subject|22
7742192|NCT00864916|26917935|P2|Overall Study|Withdrawal by Subject|0
7742193|NCT00864916|26917936|P1|Overall Study|Withdrawal by Subject|1
7742194|NCT00864916|26917935|P2|Overall Study|Protocol Violation|0
7742195|NCT00864916|26917936|P1|Overall Study|Protocol Violation|1
7742196|NCT00864916|26917935|P2|Overall Study|Lost to Follow-up|4
7742197|NCT00864916|26917936|P1|Overall Study|Lost to Follow-up|4
7742198|NCT00864851|26917945|P3|Overall Study|Patient uncooperative|0
7742199|NCT00864851|26917946|P2|Overall Study|Patient uncooperative|0
7742200|NCT00864851|26917947|P1|Overall Study|Patient uncooperative|1
7742201|NCT00864851|26917945|P3|Overall Study|Death|0
7742202|NCT00864851|26917946|P2|Overall Study|Death|0
7742203|NCT00864851|26917947|P1|Overall Study|Death|1
7742204|NCT00864851|26917945|P3|Overall Study|Physician Decision|0
7742205|NCT00864851|26917946|P2|Overall Study|Physician Decision|0
7742206|NCT00864851|26917947|P1|Overall Study|Physician Decision|1
7742207|NCT00864851|26917945|P3|Overall Study|Withdrawal by Subject|0
7742208|NCT00864851|26917946|P2|Overall Study|Withdrawal by Subject|1
7742209|NCT00864851|26917947|P1|Overall Study|Withdrawal by Subject|0
7742210|NCT00864721|26917981|P1|Overall Study|Adverse Event|21
7742211|NCT00864721|26917981|P1|Overall Study|Drug hold/delay more than 4 weeks|1
7742212|NCT00864721|26917981|P1|Overall Study|Hospitalized|1
7742213|NCT00864721|26917981|P1|Overall Study|Patient request|11
7742214|NCT00864682|26918001|P3|Overall Study|Protocol Violation|2
7742215|NCT00864682|26918002|P2|Overall Study|Protocol Violation|1
7742216|NCT00864682|26918003|P1|Overall Study|Protocol Violation|2
7742217|NCT00864513|26918042|P1|Overall Study|Withdrawal by Subject|3
7742218|NCT00864253|26918126|P2|Overall Study|Untreated|7
7742219|NCT00864253|26918127|P1|Overall Study|Untreated|7
7742220|NCT00864253|26918126|P2|Overall Study|Ongoing|3
7742221|NCT00864253|26918127|P1|Overall Study|Ongoing|2
7742222|NCT00864253|26918126|P2|Overall Study|Death|0
7742223|NCT00864253|26918127|P1|Overall Study|Death|1
7742224|NCT00864253|26918126|P2|Overall Study|Withdrawal by Subject|18
7742225|NCT00864253|26918127|P1|Overall Study|Withdrawal by Subject|18
7742226|NCT00864253|26918126|P2|Overall Study|Lost to Follow-up|1
7742227|NCT00864253|26918127|P1|Overall Study|Lost to Follow-up|1
7742228|NCT00864253|26918126|P2|Overall Study|Protocol Violation|2
7742229|NCT00864253|26918127|P1|Overall Study|Protocol Violation|0
7742230|NCT00864253|26918126|P2|Overall Study|Physician Decision|15
7742231|NCT00864253|26918127|P1|Overall Study|Physician Decision|11
7742232|NCT00864253|26918126|P2|Overall Study|Unrelated Adverse Event|1
7742233|NCT00864253|26918127|P1|Overall Study|Unrelated Adverse Event|3
7742234|NCT00864253|26918126|P2|Overall Study|Adverse Event|11
7742235|NCT00864253|26918127|P1|Overall Study|Adverse Event|56
7742236|NCT00864227|26918157|P1|Overall Study|Disease Relapse/Progression|3
7742237|NCT00864227|26918157|P1|Overall Study|Withdrawal by Subject|1
7742238|NCT00864097|26918189|P4|Overall Study|Other|1
7742239|NCT00864097|26918190|P3|Overall Study|Other|0
7742240|NCT00864097|26918191|P2|Overall Study|Other|0
7742241|NCT00864097|26918192|P1|Overall Study|Other|0
7742242|NCT00864097|26918189|P4|Overall Study|Randomized but not treated|0
7742243|NCT00864097|26918190|P3|Overall Study|Randomized but not treated|1
7742244|NCT00864097|26918191|P2|Overall Study|Randomized but not treated|0
7742245|NCT00864097|26918192|P1|Overall Study|Randomized but not treated|2
7742246|NCT00864097|26918189|P4|Overall Study|Terminated by sponsor|99
7742247|NCT00864097|26918190|P3|Overall Study|Terminated by sponsor|102
7742248|NCT00864097|26918191|P2|Overall Study|Terminated by sponsor|112
7742249|NCT00864097|26918192|P1|Overall Study|Terminated by sponsor|105
7742250|NCT00864097|26918189|P4|Overall Study|Protocol Violation|1
7742251|NCT00864097|26918190|P3|Overall Study|Protocol Violation|0
7742252|NCT00864097|26918191|P2|Overall Study|Protocol Violation|1
7742253|NCT00864097|26918192|P1|Overall Study|Protocol Violation|2
7742254|NCT00864097|26918189|P4|Overall Study|Withdrawal by Subject|12
7742255|NCT00864097|26918190|P3|Overall Study|Withdrawal by Subject|11
7742256|NCT00864097|26918191|P2|Overall Study|Withdrawal by Subject|11
7742257|NCT00864097|26918192|P1|Overall Study|Withdrawal by Subject|15
7742258|NCT00864097|26918189|P4|Overall Study|Lost to Follow-up|1
7742259|NCT00864097|26918190|P3|Overall Study|Lost to Follow-up|0
7742260|NCT00864097|26918191|P2|Overall Study|Lost to Follow-up|1
7742261|NCT00864097|26918192|P1|Overall Study|Lost to Follow-up|0
7742262|NCT00864097|26918189|P4|Overall Study|Lack of Efficacy|2
7742263|NCT00864097|26918190|P3|Overall Study|Lack of Efficacy|7
7742264|NCT00864097|26918191|P2|Overall Study|Lack of Efficacy|3
7742265|NCT00864097|26918192|P1|Overall Study|Lack of Efficacy|9
7742266|NCT00864097|26918189|P4|Overall Study|Adverse Event|9
7742267|NCT00864097|26918190|P3|Overall Study|Adverse Event|11
7742268|NCT00864097|26918191|P2|Overall Study|Adverse Event|8
7742269|NCT00864097|26918192|P1|Overall Study|Adverse Event|6
7742270|NCT00864097|26918189|P4|Overall Study|Death|0
7742271|NCT00864097|26918190|P3|Overall Study|Death|0
7742272|NCT00864097|26918191|P2|Overall Study|Death|1
7742273|NCT00864097|26918192|P1|Overall Study|Death|0
7742274|NCT00863928|26918327|P2|Overall Study|medication allergy|0
7742275|NCT00863928|26918328|P1|Overall Study|medication allergy|3
7742276|NCT00863928|26918327|P2|Overall Study|surgery cancellation|0
7742277|NCT00863928|26918328|P1|Overall Study|surgery cancellation|4
7742278|NCT00863928|26918327|P2|Overall Study|Withdrawal by Subject|0
7742279|NCT00863928|26918328|P1|Overall Study|Withdrawal by Subject|3
7742280|NCT00863928|26918327|P2|Overall Study|Protocol Violation|0
7742281|NCT00863928|26918328|P1|Overall Study|Protocol Violation|26
7742282|NCT00863798|26918337|P3|Overall Study|Randomized not treated|3
7742283|NCT00863798|26918338|P2|Overall Study|Randomized not treated|2
7742284|NCT00863798|26918339|P1|Overall Study|Randomized not treated|4
7742285|NCT00863798|26918337|P3|Overall Study|Withdrawal by Subject|4
7742286|NCT00863798|26918338|P2|Overall Study|Withdrawal by Subject|7
7742287|NCT00863798|26918339|P1|Overall Study|Withdrawal by Subject|8
7742288|NCT00863798|26918337|P3|Overall Study|Protocol Violation|1
7742289|NCT00863798|26918338|P2|Overall Study|Protocol Violation|1
7742290|NCT00863798|26918339|P1|Overall Study|Protocol Violation|0
7742291|NCT00863798|26918337|P3|Overall Study|Other|1
7742292|NCT00863798|26918338|P2|Overall Study|Other|3
7742293|NCT00863798|26918339|P1|Overall Study|Other|2
7742294|NCT00863798|26918337|P3|Overall Study|Lost to Follow-up|5
7742295|NCT00863798|26918338|P2|Overall Study|Lost to Follow-up|9
7742296|NCT00863798|26918339|P1|Overall Study|Lost to Follow-up|6
7742297|NCT00863798|26918337|P3|Overall Study|Lack of Efficacy|6
7742298|NCT00863798|26918338|P2|Overall Study|Lack of Efficacy|3
7742299|NCT00863798|26918339|P1|Overall Study|Lack of Efficacy|4
7742300|NCT00863798|26918337|P3|Overall Study|Investigator request|1
7742301|NCT00863798|26918338|P2|Overall Study|Investigator request|2
7742302|NCT00863798|26918339|P1|Overall Study|Investigator request|1
7742303|NCT00863798|26918337|P3|Overall Study|Participant failed to return|0
7742304|NCT00863798|26918338|P2|Overall Study|Participant failed to return|1
7742305|NCT00863798|26918339|P1|Overall Study|Participant failed to return|2
7742306|NCT00863798|26918337|P3|Overall Study|Adverse Event|4
7742307|NCT00863798|26918338|P2|Overall Study|Adverse Event|2
7742308|NCT00863798|26918339|P1|Overall Study|Adverse Event|5
7742309|NCT00863772|26918392|P3|Overall Study|Randomized but not Treated|0
7742310|NCT00863772|26918393|P2|Overall Study|Randomized but not Treated|0
7742311|NCT00863772|26918394|P1|Overall Study|Randomized but not Treated|1
7742312|NCT00863772|26918392|P3|Overall Study|Other|4
7742313|NCT00863772|26918393|P2|Overall Study|Other|2
7742314|NCT00863772|26918394|P1|Overall Study|Other|1
7742315|NCT00863772|26918392|P3|Overall Study|Entered extension study|9
7742316|NCT00863772|26918393|P2|Overall Study|Entered extension study|4
7742317|NCT00863772|26918394|P1|Overall Study|Entered extension study|6
7742318|NCT00863772|26918392|P3|Overall Study|Study terminated by sponsor|36
7742319|NCT00863772|26918393|P2|Overall Study|Study terminated by sponsor|45
7742320|NCT00863772|26918394|P1|Overall Study|Study terminated by sponsor|44
7742321|NCT00863772|26918392|P3|Overall Study|Withdrawal by Subject|5
7742322|NCT00863772|26918393|P2|Overall Study|Withdrawal by Subject|7
7742323|NCT00863772|26918394|P1|Overall Study|Withdrawal by Subject|4
7742324|NCT00863772|26918392|P3|Overall Study|Protocol Violation|2
7742325|NCT00863772|26918393|P2|Overall Study|Protocol Violation|0
7742326|NCT00863772|26918394|P1|Overall Study|Protocol Violation|2
7742327|NCT00863772|26918392|P3|Overall Study|Lost to Follow-up|1
7742328|NCT00863772|26918393|P2|Overall Study|Lost to Follow-up|1
7742329|NCT00863772|26918394|P1|Overall Study|Lost to Follow-up|5
7742330|NCT00863772|26918392|P3|Overall Study|Lack of Efficacy|4
7742331|NCT00863772|26918393|P2|Overall Study|Lack of Efficacy|2
7742332|NCT00863772|26918394|P1|Overall Study|Lack of Efficacy|4
7742333|NCT00863772|26918392|P3|Overall Study|Adverse Event|0
7742334|NCT00863772|26918393|P2|Overall Study|Adverse Event|4
7742335|NCT00863772|26918394|P1|Overall Study|Adverse Event|1
7742336|NCT00863746|26918522|P2|Survival Follow up|Consent Withdrawn|8
7742337|NCT00863746|26918523|P1|Survival Follow up|Consent Withdrawn|7
7742338|NCT00863746|26918522|P2|Survival Follow up|Lost to Follow-up|1
7742339|NCT00863746|26918523|P1|Survival Follow up|Lost to Follow-up|2
7742340|NCT00863746|26918522|P2|Survival Follow up|Death|271
7742341|NCT00863746|26918523|P1|Survival Follow up|Death|244
7742342|NCT00863746|26918522|P2|Treatment|Other|0
7742343|NCT00863746|26918523|P1|Treatment|Other|1
7742344|NCT00863746|26918522|P2|Treatment|Protocol Violation|3
7742345|NCT00863746|26918523|P1|Treatment|Protocol Violation|5
7742346|NCT00863746|26918522|P2|Treatment|Lost to Follow-up|0
7742347|NCT00863746|26918523|P1|Treatment|Lost to Follow-up|1
7742348|NCT00863746|26918522|P2|Treatment|Consent withdrawn|14
7742349|NCT00863746|26918523|P1|Treatment|Consent withdrawn|15
7742350|NCT00863746|26918522|P2|Treatment|non-compliant with study medication|0
7742351|NCT00863746|26918523|P1|Treatment|non-compliant with study medication|4
7742352|NCT00863746|26918522|P2|Treatment|Adverse Event|16
7742353|NCT00863746|26918523|P1|Treatment|Adverse Event|41
7742354|NCT00863746|26918522|P2|Treatment|Not treated|2
7742355|NCT00863746|26918523|P1|Treatment|Not treated|4
7742356|NCT00863707|26918549|P2|Overall Study|Randomized, but drug not received|3
7742357|NCT00863707|26918550|P1|Overall Study|Randomized, but drug not received|4
7742358|NCT00863681|26918559|P3|Overall Study|Non-compliance with study drug|0
7742359|NCT00863681|26918560|P2|Overall Study|Non-compliance with study drug|3
7742360|NCT00863681|26918561|P1|Overall Study|Non-compliance with study drug|1
7742361|NCT00863681|26918559|P3|Overall Study|Lack of Efficacy|1
7742362|NCT00863681|26918560|P2|Overall Study|Lack of Efficacy|2
7742363|NCT00863681|26918561|P1|Overall Study|Lack of Efficacy|2
7742364|NCT00863681|26918559|P3|Overall Study|Adverse Event|6
7742365|NCT00863681|26918560|P2|Overall Study|Adverse Event|10
7742366|NCT00863681|26918561|P1|Overall Study|Adverse Event|28
7742367|NCT00863681|26918559|P3|Overall Study|Lost to Follow-up|3
7742368|NCT00863681|26918560|P2|Overall Study|Lost to Follow-up|0
7742369|NCT00863681|26918561|P1|Overall Study|Lost to Follow-up|3
7742370|NCT00863681|26918559|P3|Overall Study|Protocol Violation|0
7742371|NCT00863681|26918560|P2|Overall Study|Protocol Violation|0
7742372|NCT00863681|26918561|P1|Overall Study|Protocol Violation|2
7742373|NCT00863681|26918559|P3|Overall Study|Withdrawal by Subject|2
7742374|NCT00863681|26918560|P2|Overall Study|Withdrawal by Subject|5
7742375|NCT00863681|26918561|P1|Overall Study|Withdrawal by Subject|12
7742376|NCT00863681|26918559|P3|Overall Study|Death|6
7742377|NCT00863681|26918560|P2|Overall Study|Death|23
7742378|NCT00863681|26918561|P1|Overall Study|Death|40
7742379|NCT00863681|26918559|P3|Overall Study|Missing|0
7742380|NCT00863681|26918560|P2|Overall Study|Missing|0
7742381|NCT00863681|26918561|P1|Overall Study|Missing|1
7742382|NCT00863681|26918559|P3|Overall Study|Other|0
7742383|NCT00863681|26918560|P2|Overall Study|Other|0
7742384|NCT00863681|26918561|P1|Overall Study|Other|2
7742385|NCT00863655|26918646|P2|Overall Study|Treatment completed as per protocol|1
7742386|NCT00863655|26918647|P1|Overall Study|Treatment completed as per protocol|5
7742387|NCT00863655|26918646|P2|Overall Study|Disease progression|221
7742388|NCT00863655|26918647|P1|Overall Study|Disease progression|364
7742389|NCT00863655|26918646|P2|Overall Study|New cancer therapy|1
7742390|NCT00863655|26918647|P1|Overall Study|New cancer therapy|5
7742391|NCT00863655|26918646|P2|Overall Study|Death|1
7742392|NCT00863655|26918647|P1|Overall Study|Death|7
7742393|NCT00863655|26918646|P2|Overall Study|Administrative problems|0
7742394|NCT00863655|26918647|P1|Overall Study|Administrative problems|1
7742395|NCT00863655|26918646|P2|Overall Study|Withdrawal by Subject|7
7742396|NCT00863655|26918647|P1|Overall Study|Withdrawal by Subject|47
7742397|NCT00863655|26918646|P2|Overall Study|Adverse Event|8
7742398|NCT00863655|26918647|P1|Overall Study|Adverse Event|52
7742399|NCT00863655|26918646|P2|Overall Study|Protocol Violation|0
7742400|NCT00863655|26918647|P1|Overall Study|Protocol Violation|4
7742401|NCT00863512|26918684|P2|Overall Study|Physician Decision|0
7742402|NCT00863512|26918685|P1|Overall Study|Physician Decision|1
7742403|NCT00863512|26918684|P2|Overall Study|Withdrawal by Subject|0
7742404|NCT00863512|26918685|P1|Overall Study|Withdrawal by Subject|11
7742405|NCT00863512|26918684|P2|Overall Study|Adverse Event|0
7742406|NCT00863512|26918685|P1|Overall Study|Adverse Event|2
7742407|NCT00863330|26918716|P1|Overall Study|study terminated early due to administra|6
7742408|NCT00863317|26918722|P2|Overall Study|Lost to Follow-up|9
7742409|NCT00863317|26918723|P1|Overall Study|Lost to Follow-up|8
7742410|NCT00863304|26918733|P4|Overall Study|Entered extension study|125
7742411|NCT00863304|26918734|P3|Overall Study|Entered extension study|113
7742412|NCT00863304|26918735|P2|Overall Study|Entered extension study|129
7742413|NCT00863304|26918736|P1|Overall Study|Entered extension study|101
7742414|NCT00863304|26918733|P4|Overall Study|Randomized, but not Treated|1
7742415|NCT00863304|26918734|P3|Overall Study|Randomized, but not Treated|4
7742416|NCT00863304|26918735|P2|Overall Study|Randomized, but not Treated|1
7742417|NCT00863304|26918736|P1|Overall Study|Randomized, but not Treated|3
7742418|NCT00863304|26918733|P4|Overall Study|Protocol Violation|0
7742419|NCT00863304|26918734|P3|Overall Study|Protocol Violation|2
7742420|NCT00863304|26918735|P2|Overall Study|Protocol Violation|6
7742421|NCT00863304|26918736|P1|Overall Study|Protocol Violation|2
7742422|NCT00863304|26918733|P4|Overall Study|Other|1
7742423|NCT00863304|26918734|P3|Overall Study|Other|0
7742424|NCT00863304|26918735|P2|Overall Study|Other|0
7742425|NCT00863304|26918736|P1|Overall Study|Other|1
7742426|NCT00863304|26918733|P4|Overall Study|Withdrawal by Subject|18
7742427|NCT00863304|26918734|P3|Overall Study|Withdrawal by Subject|20
7742428|NCT00863304|26918735|P2|Overall Study|Withdrawal by Subject|14
7742429|NCT00863304|26918736|P1|Overall Study|Withdrawal by Subject|19
7742430|NCT00863304|26918733|P4|Overall Study|Lack of Efficacy|28
7742431|NCT00863304|26918734|P3|Overall Study|Lack of Efficacy|30
7742432|NCT00863304|26918735|P2|Overall Study|Lack of Efficacy|26
7742433|NCT00863304|26918736|P1|Overall Study|Lack of Efficacy|57
7742434|NCT00863304|26918733|P4|Overall Study|Lost to Follow-up|2
7742435|NCT00863304|26918734|P3|Overall Study|Lost to Follow-up|4
7742436|NCT00863304|26918735|P2|Overall Study|Lost to Follow-up|5
7742437|NCT00863304|26918736|P1|Overall Study|Lost to Follow-up|1
7742438|NCT00863304|26918733|P4|Overall Study|Adverse Event|16
7742439|NCT00863304|26918734|P3|Overall Study|Adverse Event|14
7742440|NCT00863304|26918735|P2|Overall Study|Adverse Event|4
7742441|NCT00863304|26918736|P1|Overall Study|Adverse Event|10
7742442|NCT00863057|26918935|P4|Period 2 (Weeks 6-10)|Physician Decision|1
7742443|NCT00863057|26918936|P3|Period 2 (Weeks 6-10)|Physician Decision|0
7742444|NCT00863057|26918937|P2|Period 2 (Weeks 6-10)|Physician Decision|0
7742445|NCT00863057|26918938|P1|Period 2 (Weeks 6-10)|Physician Decision|0
7742446|NCT00863057|26918935|P4|Period 2 (Weeks 6-10)|Adverse Event|0
7742447|NCT00863057|26918936|P3|Period 2 (Weeks 6-10)|Adverse Event|1
7742448|NCT00863057|26918937|P2|Period 2 (Weeks 6-10)|Adverse Event|1
7742449|NCT00863057|26918938|P1|Period 2 (Weeks 6-10)|Adverse Event|0
7742450|NCT00863057|26918935|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7742451|NCT00863057|26918936|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7742452|NCT00863057|26918937|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
7742453|NCT00863057|26918938|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7742454|NCT00863057|26918935|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7742455|NCT00863057|26918936|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
7742456|NCT00863057|26918937|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7742457|NCT00863057|26918938|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7742458|NCT00862992|26918997|P3|Overall Study|Withdrawal by Subject|2
7742459|NCT00862992|26918998|P2|Overall Study|Withdrawal by Subject|0
7742460|NCT00862992|26918999|P1|Overall Study|Withdrawal by Subject|0
7742461|NCT00862992|26918997|P3|Overall Study|Physician Decision|0
7742462|NCT00862992|26918998|P2|Overall Study|Physician Decision|0
7742463|NCT00862992|26918999|P1|Overall Study|Physician Decision|1
7742464|NCT00862992|26918997|P3|Overall Study|Adverse Event|1
7742465|NCT00862992|26918998|P2|Overall Study|Adverse Event|1
7742466|NCT00862992|26918999|P1|Overall Study|Adverse Event|2
7742467|NCT00862979|26919027|P2|Overall Study|Death|1
7742468|NCT00862979|26919028|P1|Overall Study|Death|0
7742469|NCT00862979|26919027|P2|Overall Study|Administrative problems|1
7742470|NCT00862979|26919028|P1|Overall Study|Administrative problems|0
7742471|NCT00862979|26919027|P2|Overall Study|Patient withdrew consent|1
7742472|NCT00862979|26919028|P1|Overall Study|Patient withdrew consent|2
7742473|NCT00862979|26919027|P2|Overall Study|Protocol Violation|1
7742474|NCT00862979|26919028|P1|Overall Study|Protocol Violation|0
7742475|NCT00862979|26919027|P2|Overall Study|Adverse Event|3
7742476|NCT00862979|26919028|P1|Overall Study|Adverse Event|6
7742477|NCT00862940|26919046|P2|Overall Study|Administrative or other reason(s)|3
7742478|NCT00862940|26919047|P1|Overall Study|Administrative or other reason(s)|4
7742479|NCT00862940|26919046|P2|Overall Study|Lost to Follow-up|1
7742480|NCT00862940|26919047|P1|Overall Study|Lost to Follow-up|0
7742481|NCT00862940|26919046|P2|Overall Study|Non-compliance|0
7742482|NCT00862940|26919047|P1|Overall Study|Non-compliance|4
7742483|NCT00862940|26919046|P2|Overall Study|Withdrawal by Subject|6
7742484|NCT00862940|26919047|P1|Overall Study|Withdrawal by Subject|4
7742485|NCT00862940|26919046|P2|Overall Study|Protocol Violation|5
7742486|NCT00862940|26919047|P1|Overall Study|Protocol Violation|2
7742487|NCT00862940|26919046|P2|Overall Study|Lack of Efficacy|3
7742488|NCT00862940|26919047|P1|Overall Study|Lack of Efficacy|1
7742489|NCT00862940|26919046|P2|Overall Study|Adverse Event|12
7742490|NCT00862940|26919047|P1|Overall Study|Adverse Event|15
7742491|NCT00862849|26919059|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
7742492|NCT00862849|26919060|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
7742493|NCT00862849|26919061|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
7742494|NCT00862849|26919062|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
7742495|NCT00862849|26919063|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
7742496|NCT00862849|26919064|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
7742497|NCT00862849|26919059|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7742498|NCT00862849|26919060|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7742499|NCT00862849|26919061|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7742500|NCT00862849|26919062|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7742501|NCT00862849|26919063|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
7742502|NCT00862849|26919064|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7742503|NCT00862836|26919087|P1|Overall Study|Withdrawal by Subject|1
7742504|NCT00862823|26919098|P2|First Intervention|Withdrawal by Subject|1
7742505|NCT00862823|26919099|P1|First Intervention|Withdrawal by Subject|1
7742506|NCT00862719|26919148|P4|Overall Study|Veno-Occlusive Disease|0
7742507|NCT00862719|26919149|P3|Overall Study|Veno-Occlusive Disease|1
7742508|NCT00862719|26919150|P2|Overall Study|Veno-Occlusive Disease|0
7742509|NCT00862719|26919151|P1|Overall Study|Veno-Occlusive Disease|0
7742510|NCT00862719|26919148|P4|Overall Study|Engraftment failure|0
7742511|NCT00862719|26919149|P3|Overall Study|Engraftment failure|1
7742512|NCT00862719|26919150|P2|Overall Study|Engraftment failure|0
7742513|NCT00862719|26919151|P1|Overall Study|Engraftment failure|0
7742514|NCT00862719|26919148|P4|Overall Study|Death|1
7742515|NCT00862719|26919149|P3|Overall Study|Death|1
7742516|NCT00862719|26919150|P2|Overall Study|Death|6
7742517|NCT00862719|26919151|P1|Overall Study|Death|5
7742518|NCT00862719|26919148|P4|Overall Study|Disease Progression|0
7742519|NCT00862719|26919149|P3|Overall Study|Disease Progression|1
7742520|NCT00862719|26919150|P2|Overall Study|Disease Progression|0
7742521|NCT00862719|26919151|P1|Overall Study|Disease Progression|5
7742522|NCT00862654|26919174|P4|Overall Study|Included after end of inclusions|0
7742523|NCT00862654|26919175|P3|Overall Study|Included after end of inclusions|1
7742524|NCT00862654|26919176|P2|Overall Study|Included after end of inclusions|0
7742525|NCT00862654|26919177|P1|Overall Study|Included after end of inclusions|0
7742526|NCT00862654|26919174|P4|Overall Study|Never used study drugs|0
7742527|NCT00862654|26919175|P3|Overall Study|Never used study drugs|0
7742528|NCT00862654|26919176|P2|Overall Study|Never used study drugs|0
7742529|NCT00862654|26919177|P1|Overall Study|Never used study drugs|1
7742530|NCT00862654|26919174|P4|Overall Study|Familly constraint|0
7742531|NCT00862654|26919175|P3|Overall Study|Familly constraint|0
7742532|NCT00862654|26919176|P2|Overall Study|Familly constraint|1
7742533|NCT00862654|26919177|P1|Overall Study|Familly constraint|0
7742534|NCT00862654|26919174|P4|Overall Study|Subject mistake|0
7742535|NCT00862654|26919175|P3|Overall Study|Subject mistake|0
7742536|NCT00862654|26919176|P2|Overall Study|Subject mistake|1
7742537|NCT00862654|26919177|P1|Overall Study|Subject mistake|0
7742538|NCT00862654|26919174|P4|Overall Study|Withdrawal by Subject|3
7742539|NCT00862654|26919175|P3|Overall Study|Withdrawal by Subject|2
7742540|NCT00862654|26919176|P2|Overall Study|Withdrawal by Subject|2
7742541|NCT00862654|26919177|P1|Overall Study|Withdrawal by Subject|2
7742542|NCT00862654|26919174|P4|Overall Study|Pregnancy|0
7742543|NCT00862654|26919175|P3|Overall Study|Pregnancy|0
7742544|NCT00862654|26919176|P2|Overall Study|Pregnancy|1
7742545|NCT00862654|26919177|P1|Overall Study|Pregnancy|1
7742546|NCT00862654|26919174|P4|Overall Study|Adverse Event|0
7742547|NCT00862654|26919175|P3|Overall Study|Adverse Event|1
7742548|NCT00862654|26919176|P2|Overall Study|Adverse Event|1
7742549|NCT00862654|26919177|P1|Overall Study|Adverse Event|0
7742550|NCT00862654|26919174|P4|Overall Study|Lost to Follow-up|3
7742551|NCT00862654|26919175|P3|Overall Study|Lost to Follow-up|1
7742552|NCT00862654|26919176|P2|Overall Study|Lost to Follow-up|2
7742553|NCT00862654|26919177|P1|Overall Study|Lost to Follow-up|1
7742554|NCT00862654|26919174|P4|Overall Study|Lack of Efficacy|0
7742555|NCT00862654|26919175|P3|Overall Study|Lack of Efficacy|1
7742556|NCT00862654|26919176|P2|Overall Study|Lack of Efficacy|0
7742557|NCT00862654|26919177|P1|Overall Study|Lack of Efficacy|1
7742558|NCT00862641|26919191|P4|Overall Study|Randomized, but drug not received|4
7742559|NCT00862641|26919192|P3|Overall Study|Randomized, but drug not received|1
7742560|NCT00862641|26919193|P2|Overall Study|Randomized, but drug not received|4
7742561|NCT00862641|26919194|P1|Overall Study|Randomized, but drug not received|1
7742562|NCT00862459|26919288|P3|Overall Study|Administrative problems|0
7742563|NCT00862459|26919289|P2|Overall Study|Administrative problems|1
7742564|NCT00862459|26919290|P1|Overall Study|Administrative problems|0
7742565|NCT00862459|26919288|P3|Overall Study|Inclusion/exclusion criteria not met|0
7742566|NCT00862459|26919289|P2|Overall Study|Inclusion/exclusion criteria not met|1
7742567|NCT00862459|26919290|P1|Overall Study|Inclusion/exclusion criteria not met|0
7742568|NCT00862459|26919288|P3|Overall Study|Unable to hold still for imaging|0
7742569|NCT00862459|26919289|P2|Overall Study|Unable to hold still for imaging|1
7742570|NCT00862459|26919290|P1|Overall Study|Unable to hold still for imaging|0
7742571|NCT00862459|26919288|P3|Overall Study|Intravenous (IV) site problems|1
7742572|NCT00862459|26919289|P2|Overall Study|Intravenous (IV) site problems|0
7742573|NCT00862459|26919290|P1|Overall Study|Intravenous (IV) site problems|1
7742574|NCT00862459|26919288|P3|Overall Study|Operation|0
7742575|NCT00862459|26919289|P2|Overall Study|Operation|1
7742576|NCT00862459|26919290|P1|Overall Study|Operation|1
7742577|NCT00862459|26919288|P3|Overall Study|Personal reasons|0
7742578|NCT00862459|26919289|P2|Overall Study|Personal reasons|0
7742579|NCT00862459|26919290|P1|Overall Study|Personal reasons|1
7742580|NCT00862459|26919288|P3|Overall Study|Adverse Event|0
7742581|NCT00862459|26919289|P2|Overall Study|Adverse Event|1
7742582|NCT00862459|26919290|P1|Overall Study|Adverse Event|0
7742583|NCT00862459|26919288|P3|Overall Study|Withdrawal by Subject|3
7742584|NCT00862459|26919289|P2|Overall Study|Withdrawal by Subject|1
7742585|NCT00862459|26919290|P1|Overall Study|Withdrawal by Subject|1
7742586|NCT00862459|26919288|P3|Overall Study|Protocol Violation|0
7742587|NCT00862459|26919289|P2|Overall Study|Protocol Violation|0
7742588|NCT00862459|26919290|P1|Overall Study|Protocol Violation|1
7742589|NCT00862459|26919288|P3|Overall Study|Lost to Follow-up|2
7742590|NCT00862459|26919289|P2|Overall Study|Lost to Follow-up|2
7742591|NCT00862459|26919290|P1|Overall Study|Lost to Follow-up|1
7742592|NCT00862277|26919441|P3|Overall Study|Protocol Violation|5
7742593|NCT00862277|26919442|P2|Overall Study|Protocol Violation|2
7742594|NCT00862277|26919443|P1|Overall Study|Protocol Violation|1
7742595|NCT00862251|26919457|P3|Overall Study|Withdrawal by Subject|6
7742596|NCT00862251|26919458|P2|Overall Study|Withdrawal by Subject|2
7742597|NCT00862251|26919459|P1|Overall Study|Withdrawal by Subject|9
7742598|NCT00862251|26919457|P3|Overall Study|Protocol Violation|1
7742599|NCT00862251|26919458|P2|Overall Study|Protocol Violation|0
7742600|NCT00862251|26919459|P1|Overall Study|Protocol Violation|2
7742601|NCT00862251|26919457|P3|Overall Study|Lost to Follow-up|1
7742602|NCT00862251|26919458|P2|Overall Study|Lost to Follow-up|0
7742603|NCT00862251|26919459|P1|Overall Study|Lost to Follow-up|0
7742604|NCT00862251|26919457|P3|Overall Study|Adverse Event|1
7742605|NCT00862251|26919458|P2|Overall Study|Adverse Event|3
7742606|NCT00862251|26919459|P1|Overall Study|Adverse Event|8
7742607|NCT00862134|26919519|P2|Overall Study|Withdrew prior to dosing|0
7742608|NCT00862134|26919520|P1|Overall Study|Withdrew prior to dosing|2
7742609|NCT00862134|26919519|P2|Overall Study|Adverse Event|2
7742610|NCT00862134|26919520|P1|Overall Study|Adverse Event|2
7742611|NCT00862134|26919519|P2|Overall Study|Sponsor terminated study|7
7742612|NCT00862134|26919520|P1|Overall Study|Sponsor terminated study|5
7742613|NCT00862134|26919519|P2|Overall Study|Withdrawal by Subject|2
7742614|NCT00862134|26919520|P1|Overall Study|Withdrawal by Subject|1
7742615|NCT00862134|26919519|P2|Overall Study|Physician Decision|1
7742616|NCT00862134|26919520|P1|Overall Study|Physician Decision|0
7742617|NCT00862134|26919519|P2|Overall Study|Death|0
7742618|NCT00862134|26919520|P1|Overall Study|Death|1
7742619|NCT00862121|26919532|P2|Overall Study|Incorrect randomisation|1
7742620|NCT00862121|26919533|P1|Overall Study|Incorrect randomisation|0
7742621|NCT00862121|26919532|P2|Overall Study|Exclusion criterion violation|1
7742622|NCT00862121|26919533|P1|Overall Study|Exclusion criterion violation|0
7742623|NCT00862121|26919532|P2|Overall Study|Protocol Violation|1
7742624|NCT00862121|26919533|P1|Overall Study|Protocol Violation|0
7742625|NCT00862121|26919532|P2|Overall Study|Lack of Efficacy|3
7742626|NCT00862121|26919533|P1|Overall Study|Lack of Efficacy|0
7742627|NCT00862121|26919532|P2|Overall Study|Adverse Event|2
7742628|NCT00862121|26919533|P1|Overall Study|Adverse Event|1
7742629|NCT00862082|26919551|P2|Overall Study|Withdrawal by Subject|1
7742630|NCT00862082|26919552|P1|Overall Study|Withdrawal by Subject|0
7742631|NCT00862082|26919551|P2|Overall Study|Sponsor decision to terminate the study|0
7742632|NCT00862082|26919552|P1|Overall Study|Sponsor decision to terminate the study|5
7742633|NCT00861757|26919607|P4|Overall Study|Withdrawal by Subject|2
7742634|NCT00861757|26919608|P3|Overall Study|Withdrawal by Subject|5
7742635|NCT00861757|26919609|P2|Overall Study|Withdrawal by Subject|5
7742636|NCT00861757|26919610|P1|Overall Study|Withdrawal by Subject|1
7742637|NCT00861757|26919607|P4|Overall Study|Protocol Violation|1
7742638|NCT00861757|26919608|P3|Overall Study|Protocol Violation|4
7742639|NCT00861757|26919609|P2|Overall Study|Protocol Violation|2
7742640|NCT00861757|26919610|P1|Overall Study|Protocol Violation|2
7742641|NCT00861757|26919607|P4|Overall Study|Physician Decision|1
7742642|NCT00861757|26919608|P3|Overall Study|Physician Decision|0
7742643|NCT00861757|26919609|P2|Overall Study|Physician Decision|0
7742644|NCT00861757|26919610|P1|Overall Study|Physician Decision|0
7742645|NCT00861757|26919607|P4|Overall Study|Lost to Follow-up|1
7742646|NCT00861757|26919608|P3|Overall Study|Lost to Follow-up|1
7742647|NCT00861757|26919609|P2|Overall Study|Lost to Follow-up|0
7742648|NCT00861757|26919610|P1|Overall Study|Lost to Follow-up|1
7742649|NCT00861757|26919607|P4|Overall Study|Lack of Efficacy|1
7742650|NCT00861757|26919608|P3|Overall Study|Lack of Efficacy|0
7742651|NCT00861757|26919609|P2|Overall Study|Lack of Efficacy|1
7742652|NCT00861757|26919610|P1|Overall Study|Lack of Efficacy|3
7742653|NCT00861757|26919607|P4|Overall Study|Entry Criteria Not Met|1
7742654|NCT00861757|26919608|P3|Overall Study|Entry Criteria Not Met|1
7742655|NCT00861757|26919609|P2|Overall Study|Entry Criteria Not Met|2
7742656|NCT00861757|26919610|P1|Overall Study|Entry Criteria Not Met|1
7742657|NCT00861757|26919607|P4|Overall Study|Adverse Event|2
7742658|NCT00861757|26919608|P3|Overall Study|Adverse Event|7
7742659|NCT00861757|26919609|P2|Overall Study|Adverse Event|5
7742660|NCT00861757|26919610|P1|Overall Study|Adverse Event|1
7742661|NCT00861744|26919668|P4|Overall Study|Blood draws|1
7742662|NCT00861744|26919669|P3|Overall Study|Blood draws|0
7742663|NCT00861744|26919670|P2|Overall Study|Blood draws|0
7742664|NCT00861744|26919671|P1|Overall Study|Blood draws|0
7742665|NCT00861744|26919668|P4|Overall Study|Migration from study area|0
7742666|NCT00861744|26919669|P3|Overall Study|Migration from study area|1
7742667|NCT00861744|26919670|P2|Overall Study|Migration from study area|3
7742668|NCT00861744|26919671|P1|Overall Study|Migration from study area|0
7742669|NCT00861744|26919668|P4|Overall Study|Protocol Violation|0
7742670|NCT00861744|26919669|P3|Overall Study|Protocol Violation|0
7742671|NCT00861744|26919670|P2|Overall Study|Protocol Violation|1
7742672|NCT00861744|26919671|P1|Overall Study|Protocol Violation|0
7742673|NCT00861744|26919668|P4|Overall Study|Withdrawal by Subject|19
7742674|NCT00861744|26919669|P3|Overall Study|Withdrawal by Subject|6
7742675|NCT00861744|26919670|P2|Overall Study|Withdrawal by Subject|6
7742676|NCT00861744|26919671|P1|Overall Study|Withdrawal by Subject|10
7742677|NCT00861744|26919668|P4|Overall Study|Lost to Follow-up|12
7742678|NCT00861744|26919669|P3|Overall Study|Lost to Follow-up|17
7742679|NCT00861744|26919670|P2|Overall Study|Lost to Follow-up|19
7742680|NCT00861744|26919671|P1|Overall Study|Lost to Follow-up|7
7742681|NCT00861744|26919668|P4|Overall Study|Adverse Event|1
7742682|NCT00861744|26919669|P3|Overall Study|Adverse Event|0
7742683|NCT00861744|26919670|P2|Overall Study|Adverse Event|0
7742684|NCT00861744|26919671|P1|Overall Study|Adverse Event|0
7742685|NCT00861705|26919853|P4|Overall Study|Never Began Treatment|1
7742686|NCT00861705|26919854|P3|Overall Study|Never Began Treatment|0
7742687|NCT00861705|26919855|P2|Overall Study|Never Began Treatment|3
7742688|NCT00861705|26919856|P1|Overall Study|Never Began Treatment|7
7742689|NCT00861692|26919896|P1|Overall Study|Death|6
7742690|NCT00861614|26919908|P2|Overall Study|Other|22
7742691|NCT00861614|26919909|P1|Overall Study|Other|17
7742692|NCT00861614|26919908|P2|Overall Study|Withdrawal by Subject|35
7742693|NCT00861614|26919909|P1|Overall Study|Withdrawal by Subject|34
7742694|NCT00861614|26919908|P2|Overall Study|Adverse Event|23
7742695|NCT00861614|26919909|P1|Overall Study|Adverse Event|27
7742696|NCT00861614|26919908|P2|Overall Study|Death|19
7742697|NCT00861614|26919909|P1|Overall Study|Death|32
7742698|NCT00861614|26919908|P2|Overall Study|Study Drug Toxicity|6
7742699|NCT00861614|26919909|P1|Overall Study|Study Drug Toxicity|79
7742700|NCT00861614|26919908|P2|Overall Study|Disease Progression|263
7742701|NCT00861614|26919909|P1|Overall Study|Disease Progression|182
7742702|NCT00861471|26919994|P1|Overall Study|Physician Decision|2
7742703|NCT00861471|26919994|P1|Overall Study|treatment for lumbar laminectomy|1
7742704|NCT00861471|26919994|P1|Overall Study|Lack of Efficacy|3
7742705|NCT00861471|26919994|P1|Overall Study|Adverse Event|2
7742706|NCT00861471|26919994|P1|Overall Study|Withdrawal by Subject|1
7742707|NCT00861380|26920009|P7|Overall Study|Withdrawal Information not recorded|3020
7742708|NCT00861380|26920010|P6|Overall Study|Withdrawal Information not recorded|6249
7742709|NCT00861380|26920011|P5|Overall Study|Withdrawal Information not recorded|1812
7742710|NCT00861380|26920012|P4|Overall Study|Withdrawal Information not recorded|3689
7742711|NCT00861380|26920013|P3|Overall Study|Withdrawal Information not recorded|8872
7742712|NCT00861380|26920014|P2|Overall Study|Withdrawal Information not recorded|9112
7742713|NCT00861380|26920015|P1|Overall Study|Withdrawal Information not recorded|8427
7742714|NCT00861341|26920111|P1|Overall Study|Withdrawal by Subject|2
7742715|NCT00861198|26920120|P1|Overall Study|SpyGlass Failed|5
7742716|NCT00860951|26920137|P1|Overall Study|Lost to Follow-up|5
7742717|NCT00860951|26920137|P1|Overall Study|Withdrawal by Subject|2
7742718|NCT00860743|26920194|P2|Overall Study|Withdrawal by Subject|0
7742719|NCT00860743|26920195|P1|Overall Study|Withdrawal by Subject|3
7742720|NCT00860574|26920201|P1|Overall Study|Relapse|1
7742721|NCT00860574|26920201|P1|Overall Study|Death|2
7742722|NCT00860470|26920219|P2|Overall Study|Lost to Follow-up|39
7742723|NCT00860470|26920220|P1|Overall Study|Lost to Follow-up|34
7742724|NCT00860470|26920219|P2|Overall Study|Moved away|10
7742725|NCT00860470|26920220|P1|Overall Study|Moved away|8
7742726|NCT00860470|26920219|P2|Overall Study|Death|10
7742727|NCT00860470|26920220|P1|Overall Study|Death|6
7742728|NCT00860405|26920250|P2|Overall Study|Main reason: Follow-up data not complete|4
7742729|NCT00860405|26920251|P1|Overall Study|Main reason: Follow-up data not complete|5
7742730|NCT00860262|26920304|P3|Overall Study|Other|1
7742731|NCT00860262|26920305|P2|Overall Study|Other|3
7742732|NCT00860262|26920306|P1|Overall Study|Other|5
7742733|NCT00860262|26920304|P3|Overall Study|Lack of Efficacy|3
7742734|NCT00860262|26920305|P2|Overall Study|Lack of Efficacy|4
7742735|NCT00860262|26920306|P1|Overall Study|Lack of Efficacy|0
7742736|NCT00860262|26920304|P3|Overall Study|Withdrawal by Subject|6
7742737|NCT00860262|26920305|P2|Overall Study|Withdrawal by Subject|8
7742738|NCT00860262|26920306|P1|Overall Study|Withdrawal by Subject|4
7742739|NCT00860262|26920304|P3|Overall Study|Lost to Follow-up|1
7742740|NCT00860262|26920305|P2|Overall Study|Lost to Follow-up|0
7742741|NCT00860262|26920306|P1|Overall Study|Lost to Follow-up|2
7742742|NCT00860262|26920304|P3|Overall Study|Protocol Violation|0
7742743|NCT00860262|26920305|P2|Overall Study|Protocol Violation|1
7742744|NCT00860262|26920306|P1|Overall Study|Protocol Violation|0
7742745|NCT00860262|26920304|P3|Overall Study|Adverse Event|7
7742746|NCT00860262|26920305|P2|Overall Study|Adverse Event|6
7742747|NCT00860262|26920306|P1|Overall Study|Adverse Event|9
7742748|NCT00860249|26920419|P3|Overall Study|trial was terminated prior to completion|21
7742749|NCT00860249|26920420|P2|Overall Study|trial was terminated prior to completion|18
7742750|NCT00860249|26920421|P1|Overall Study|trial was terminated prior to completion|21
7742751|NCT00860158|26920441|P1|Overall Study|Study Terminated|1
7742752|NCT00860067|26920453|P3|Overall Study|Pregnancy|0
7742753|NCT00860067|26920454|P2|Overall Study|Pregnancy|0
7742754|NCT00860067|26920455|P1|Overall Study|Pregnancy|1
7742755|NCT00860067|26920453|P3|Overall Study|Withdrawal by Subject|0
7742756|NCT00860067|26920454|P2|Overall Study|Withdrawal by Subject|0
7742757|NCT00860067|26920455|P1|Overall Study|Withdrawal by Subject|4
7742758|NCT00860067|26920453|P3|Overall Study|Lost to Follow-up|9
7742759|NCT00860067|26920454|P2|Overall Study|Lost to Follow-up|9
7742760|NCT00860067|26920455|P1|Overall Study|Lost to Follow-up|46
7742761|NCT00860028|26920515|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
7742762|NCT00860028|26920516|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
7742763|NCT00859937|26920558|P2|Overall Study|Protocol Violation|0
7742764|NCT00859937|26920559|P1|Overall Study|Protocol Violation|1
7742765|NCT00859898|26920574|P3|Overall Study|non-specified|1
7742766|NCT00859898|26920575|P2|Overall Study|non-specified|1
7742767|NCT00859898|26920576|P1|Overall Study|non-specified|1
7742768|NCT00859898|26920574|P3|Overall Study|No longer meets criteria|0
7742769|NCT00859898|26920575|P2|Overall Study|No longer meets criteria|1
7742770|NCT00859898|26920576|P1|Overall Study|No longer meets criteria|0
7742771|NCT00859898|26920574|P3|Overall Study|poor/non-compliance|0
7742772|NCT00859898|26920575|P2|Overall Study|poor/non-compliance|0
7742773|NCT00859898|26920576|P1|Overall Study|poor/non-compliance|2
7742774|NCT00859898|26920574|P3|Overall Study|Lost to Follow-up|5
7742775|NCT00859898|26920575|P2|Overall Study|Lost to Follow-up|11
7742776|NCT00859898|26920576|P1|Overall Study|Lost to Follow-up|10
7742777|NCT00859898|26920574|P3|Overall Study|Death|1
7742778|NCT00859898|26920575|P2|Overall Study|Death|0
7742779|NCT00859898|26920576|P1|Overall Study|Death|0
7742780|NCT00859898|26920574|P3|Overall Study|Withdrawal by Subject|11
7742781|NCT00859898|26920575|P2|Overall Study|Withdrawal by Subject|8
7742782|NCT00859898|26920576|P1|Overall Study|Withdrawal by Subject|11
7742783|NCT00859898|26920574|P3|Overall Study|Adverse Event|8
7742784|NCT00859898|26920575|P2|Overall Study|Adverse Event|9
7742785|NCT00859898|26920576|P1|Overall Study|Adverse Event|4
7742786|NCT00859898|26920574|P3|Overall Study|Lack of Efficacy|1
7742787|NCT00859898|26920575|P2|Overall Study|Lack of Efficacy|1
7742788|NCT00859898|26920576|P1|Overall Study|Lack of Efficacy|0
7742789|NCT00859638|26920635|P2|Overall Study|Ill health|1
7742790|NCT00859638|26920636|P1|Overall Study|Ill health|1
7742791|NCT00859638|26920635|P2|Overall Study|Withdrawal by Subject|2
7742792|NCT00859638|26920636|P1|Overall Study|Withdrawal by Subject|3
7742793|NCT00859638|26920635|P2|Overall Study|Lost to Follow-up|1
7742794|NCT00859638|26920636|P1|Overall Study|Lost to Follow-up|6
7742795|NCT00859586|26920642|P1|Overall Study|Donors|4
7742796|NCT00859573|26920658|P2|Overall Study|Physician Decision|1
7742797|NCT00859573|26920659|P1|Overall Study|Physician Decision|1
7742798|NCT00859573|26920658|P2|Overall Study|Withdrawal by Subject|1
7742799|NCT00859573|26920659|P1|Overall Study|Withdrawal by Subject|4
7742800|NCT00859547|26920665|P1|Overall Study|Parent withdrew consent|1
7742801|NCT00859547|26920665|P1|Overall Study|Lost to Follow-up|1
7742802|NCT00859521|26920678|P2|Washout|Withdrawal by Subject|1
7742803|NCT00859521|26920679|P1|Washout|Withdrawal by Subject|0
7742804|NCT00859469|26920700|P1|Overall Study|Death|16
7742805|NCT00859469|26920700|P1|Overall Study|Withdrawal by Subject|1
7742806|NCT00859469|26920700|P1|Overall Study|Lack of Efficacy|9
7742807|NCT00859469|26920700|P1|Overall Study|Adverse Event|2
7742808|NCT00859456|26920706|P1|Overall Study|Non-compliance|3
7742809|NCT00859456|26920706|P1|Overall Study|Progressive disease|2
7742810|NCT00859456|26920706|P1|Overall Study|Adverse Event|3
7742811|NCT00859430|26920712|P2|First Intervention|Withdrawal by Subject|1
7742812|NCT00859430|26920713|P1|First Intervention|Withdrawal by Subject|0
7742813|NCT00859313|26920729|P1|Overall Study|staff error|1
7742814|NCT00859313|26920729|P1|Overall Study|Adverse Event|1
7742815|NCT00859313|26920729|P1|Overall Study|Lack of Efficacy|2
7742816|NCT00859222|26920736|P5|Overall Study|DLT|0
7742817|NCT00859222|26920737|P4|Overall Study|DLT|0
7742818|NCT00859222|26920738|P3|Overall Study|DLT|0
7742819|NCT00859222|26920739|P2|Overall Study|DLT|0
7742820|NCT00859222|26920740|P1|Overall Study|DLT|1
7742821|NCT00859222|26920736|P5|Overall Study|Adverse Event|15
7742822|NCT00859222|26920737|P4|Overall Study|Adverse Event|24
7742823|NCT00859222|26920738|P3|Overall Study|Adverse Event|6
7742824|NCT00859222|26920739|P2|Overall Study|Adverse Event|3
7742825|NCT00859222|26920740|P1|Overall Study|Adverse Event|2
7742826|NCT00859014|26920862|P1|Overall Study|Lost to Follow-up|1
7742827|NCT00859014|26920862|P1|Overall Study|Death|4
7742828|NCT00858988|26920869|P2|Analysis|Lactulose unable to be detected in urine|1
7742829|NCT00858988|26920870|P1|Analysis|Lactulose unable to be detected in urine|2
7742830|NCT00858845|26920886|P2|Overall Study|Patient underwent heart transplant.|1
7742831|NCT00858845|26920887|P1|Overall Study|Patient underwent heart transplant.|0
7742832|NCT00858832|26920899|P2|Overall Study|Adverse Event|1
7742833|NCT00858832|26920900|P1|Overall Study|Adverse Event|0
7742834|NCT00858832|26920899|P2|Overall Study|became ineligible: delivered vaginally|0
7742835|NCT00858832|26920900|P1|Overall Study|became ineligible: delivered vaginally|1
7742836|NCT00858780|26920906|P5|OL Re-Treatment (Failure to Week 48)|Other|1
7742837|NCT00858780|26920907|P4|OL Re-Treatment (Failure to Week 48)|Other|0
7742838|NCT00858780|26920908|P3|OL Re-Treatment (Failure to Week 48)|Other|0
7742839|NCT00858780|26920909|P2|OL Re-Treatment (Failure to Week 48)|Other|0
7742840|NCT00858780|26920910|P1|OL Re-Treatment (Failure to Week 48)|Other|0
7742841|NCT00858780|26920906|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
7742842|NCT00858780|26920907|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7742843|NCT00858780|26920908|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7742844|NCT00858780|26920909|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7742845|NCT00858780|26920910|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7742846|NCT00858780|26920906|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7742847|NCT00858780|26920907|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7742848|NCT00858780|26920908|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7742849|NCT00858780|26920909|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
7742850|NCT00858780|26920910|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7742851|NCT00858780|26920906|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
7742852|NCT00858780|26920907|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7742853|NCT00858780|26920908|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7742854|NCT00858780|26920909|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7742855|NCT00858780|26920910|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
7742856|NCT00858780|26920906|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7742857|NCT00858780|26920907|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7742858|NCT00858780|26920908|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
7742859|NCT00858780|26920909|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7742860|NCT00858780|26920910|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7742861|NCT00858780|26920906|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7742862|NCT00858780|26920907|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7742863|NCT00858780|26920908|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7742864|NCT00858780|26920909|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7742865|NCT00858780|26920910|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
7742866|NCT00858702|26920985|P2|Overall Study|Withdrawal by Subject|0
7742867|NCT00858702|26920986|P1|Overall Study|Withdrawal by Subject|1
7742868|NCT00858702|26920985|P2|Overall Study|Other|1
7742869|NCT00858702|26920986|P1|Overall Study|Other|2
7742870|NCT00858702|26920985|P2|Overall Study|Protocol Violation|1
7742871|NCT00858702|26920986|P1|Overall Study|Protocol Violation|1
7742872|NCT00858702|26920985|P2|Overall Study|Lack of Efficacy|0
7742873|NCT00858702|26920986|P1|Overall Study|Lack of Efficacy|1
7742874|NCT00858637|26921001|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
7742875|NCT00858637|26921002|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7742876|NCT00858637|26921003|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7742877|NCT00858637|26921004|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7742878|NCT00858637|26921005|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7742879|NCT00858637|26921006|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7742880|NCT00858637|26921001|P6|Placebo-controlled Withdrawal Phase|Death|0
7742881|NCT00858637|26921002|P5|Placebo-controlled Withdrawal Phase|Death|1
7742882|NCT00858637|26921003|P4|Placebo-controlled Withdrawal Phase|Death|0
7742883|NCT00858637|26921004|P3|Placebo-controlled Withdrawal Phase|Death|1
7742884|NCT00858637|26921005|P2|Placebo-controlled Withdrawal Phase|Death|0
7742885|NCT00858637|26921006|P1|Placebo-controlled Withdrawal Phase|Death|0
7742886|NCT00858637|26921001|P6|Active Comparison Phase|Other Reasons|0
7742887|NCT00858637|26921002|P5|Active Comparison Phase|Other Reasons|0
7742888|NCT00858637|26921003|P4|Active Comparison Phase|Other Reasons|1
7742889|NCT00858637|26921004|P3|Active Comparison Phase|Other Reasons|0
7742890|NCT00858637|26921005|P2|Active Comparison Phase|Other Reasons|0
7742891|NCT00858637|26921006|P1|Active Comparison Phase|Other Reasons|1
7742892|NCT00858637|26921001|P6|Active Comparison Phase|Withdrawal by Subject|0
7742893|NCT00858637|26921002|P5|Active Comparison Phase|Withdrawal by Subject|0
7742894|NCT00858637|26921003|P4|Active Comparison Phase|Withdrawal by Subject|6
7742895|NCT00858637|26921004|P3|Active Comparison Phase|Withdrawal by Subject|0
7742896|NCT00858637|26921005|P2|Active Comparison Phase|Withdrawal by Subject|0
7742897|NCT00858637|26921006|P1|Active Comparison Phase|Withdrawal by Subject|7
7742898|NCT00858637|26921001|P6|Active Comparison Phase|Physician Decision|0
7742899|NCT00858637|26921002|P5|Active Comparison Phase|Physician Decision|0
7742900|NCT00858637|26921003|P4|Active Comparison Phase|Physician Decision|1
7742901|NCT00858637|26921004|P3|Active Comparison Phase|Physician Decision|0
7742902|NCT00858637|26921005|P2|Active Comparison Phase|Physician Decision|0
7742903|NCT00858637|26921006|P1|Active Comparison Phase|Physician Decision|1
7742904|NCT00858637|26921001|P6|Active Comparison Phase|Death|0
7742905|NCT00858637|26921002|P5|Active Comparison Phase|Death|0
7742906|NCT00858637|26921003|P4|Active Comparison Phase|Death|1
7742907|NCT00858637|26921004|P3|Active Comparison Phase|Death|0
7742908|NCT00858637|26921005|P2|Active Comparison Phase|Death|0
7742909|NCT00858637|26921006|P1|Active Comparison Phase|Death|1
7742910|NCT00858637|26921001|P6|Active Comparison Phase|Adverse Event|0
7742911|NCT00858637|26921002|P5|Active Comparison Phase|Adverse Event|0
7742912|NCT00858637|26921003|P4|Active Comparison Phase|Adverse Event|9
7742913|NCT00858637|26921004|P3|Active Comparison Phase|Adverse Event|0
7742914|NCT00858637|26921005|P2|Active Comparison Phase|Adverse Event|0
7742915|NCT00858637|26921006|P1|Active Comparison Phase|Adverse Event|14
7742916|NCT00858442|26921047|P2|Compression:Start to Finish|Lost to Follow-up|3
7742917|NCT00858442|26921048|P1|Compression:Start to Finish|Lost to Follow-up|1
7742918|NCT00858403|26921058|P1|Overall Study|Disease Progression|1
7742919|NCT00858403|26921058|P1|Overall Study|Death|3
7742920|NCT00858403|26921058|P1|Overall Study|Withdrawal by Subject|1
7742921|NCT00858364|26921079|P2|Overall Study|Still on-study|247
7742922|NCT00858364|26921080|P1|Overall Study|Still on-study|114
7742923|NCT00858364|26921079|P2|Overall Study|Missing|1
7742924|NCT00858364|26921080|P1|Overall Study|Missing|1
7742925|NCT00858364|26921079|P2|Overall Study|Other|17
7742926|NCT00858364|26921080|P1|Overall Study|Other|9
7742927|NCT00858364|26921079|P2|Overall Study|Protocol Deviation|2
7742928|NCT00858364|26921080|P1|Overall Study|Protocol Deviation|0
7742929|NCT00858364|26921079|P2|Overall Study|Noncompliance|4
7742930|NCT00858364|26921080|P1|Overall Study|Noncompliance|3
7742931|NCT00858364|26921079|P2|Overall Study|Lost to Follow-up|54
7742932|NCT00858364|26921080|P1|Overall Study|Lost to Follow-up|24
7742933|NCT00858364|26921079|P2|Overall Study|Ineligibility Determined|10
7742934|NCT00858364|26921080|P1|Overall Study|Ineligibility Determined|1
7742935|NCT00858364|26921079|P2|Overall Study|Withdrawal by Subject|118
7742936|NCT00858364|26921080|P1|Overall Study|Withdrawal by Subject|44
7742937|NCT00858364|26921079|P2|Overall Study|Adverse Event|2
7742938|NCT00858364|26921080|P1|Overall Study|Adverse Event|5
7742939|NCT00858364|26921079|P2|Overall Study|Administrative Decision|2
7742940|NCT00858364|26921080|P1|Overall Study|Administrative Decision|3
7742941|NCT00858247|26921102|P2|Week 12 Follow-up|Withdrawal by Subject|1
7742942|NCT00858247|26921103|P1|Week 12 Follow-up|Withdrawal by Subject|0
7742943|NCT00858247|26921102|P2|Baseline Assessment|Protocol Violation|1
7742944|NCT00858247|26921103|P1|Baseline Assessment|Protocol Violation|0
7742945|NCT00858247|26921102|P2|Baseline Assessment|Poor IV access|0
7742946|NCT00858247|26921103|P1|Baseline Assessment|Poor IV access|1
7742947|NCT00858247|26921102|P2|Baseline Assessment|Withdrawal by Subject|1
7742948|NCT00858247|26921103|P1|Baseline Assessment|Withdrawal by Subject|1
7742949|NCT00858234|26921119|P1|Overall Study|Status unknown|1
7742950|NCT00858234|26921119|P1|Overall Study|Progressive disease|2
7742951|NCT00858234|26921119|P1|Overall Study|Adverse Event|6
7742952|NCT00858208|26921125|P1|Overall Study|Other|10
7742953|NCT00858208|26921125|P1|Overall Study|Participant refused|40
7742954|NCT00858208|26921125|P1|Overall Study|Lost to Follow-up|26
7742955|NCT00858208|26921125|P1|Overall Study|Adverse Event|3
7742956|NCT00858143|26921142|P1|Overall Study|Other|23
7742957|NCT00858143|26921142|P1|Overall Study|Death|7
7742958|NCT00858143|26921142|P1|Overall Study|Lack of Efficacy|4
7742959|NCT00858143|26921142|P1|Overall Study|Adverse Event|16
7742960|NCT00858117|26921199|P1|Follow up for 5 Years|No further data collected for study|9
7742961|NCT00858117|26921199|P1|Follow up for 5 Years|Death|4
7742962|NCT00858117|26921199|P1|Treatment on Study|Adverse Event|2
7742963|NCT00857948|26921262|P4|Overall Study|Protocol Violation|0
7742964|NCT00857948|26921263|P3|Overall Study|Protocol Violation|1
7742965|NCT00857948|26921264|P2|Overall Study|Protocol Violation|0
7742966|NCT00857948|26921265|P1|Overall Study|Protocol Violation|1
7742967|NCT00857948|26921262|P4|Overall Study|Withdrawal by Subject|0
7742968|NCT00857948|26921263|P3|Overall Study|Withdrawal by Subject|0
7742969|NCT00857948|26921264|P2|Overall Study|Withdrawal by Subject|0
7742970|NCT00857948|26921265|P1|Overall Study|Withdrawal by Subject|2
7742971|NCT00857896|26921287|P1|Baseline to Week 4|Withdrawal by Subject|1
7742972|NCT00857818|26921443|P2|Overall Study|Investigator decision|0
7742973|NCT00857818|26921444|P1|Overall Study|Investigator decision|1
7742974|NCT00857818|26921443|P2|Overall Study|Sponsor terminated study|4
7742975|NCT00857818|26921444|P1|Overall Study|Sponsor terminated study|6
7742976|NCT00857818|26921443|P2|Overall Study|Withdrawal by Subject|4
7742977|NCT00857818|26921444|P1|Overall Study|Withdrawal by Subject|0
7742978|NCT00857818|26921443|P2|Overall Study|Adverse Event|0
7742979|NCT00857818|26921444|P1|Overall Study|Adverse Event|3
7742980|NCT00857818|26921443|P2|Overall Study|Lack of Efficacy|0
7742981|NCT00857818|26921444|P1|Overall Study|Lack of Efficacy|1
7742982|NCT00857792|26921472|P1|Overall Study|inadequate image quality for analysis|12
7742983|NCT00857766|26921478|P2|Overall Study|Participant Withdrew Consent|4
7742984|NCT00857766|26921479|P1|Overall Study|Participant Withdrew Consent|4
7742985|NCT00857766|26921478|P2|Overall Study|Investigator Discretion|3
7742986|NCT00857766|26921479|P1|Overall Study|Investigator Discretion|2
7742987|NCT00857766|26921478|P2|Overall Study|Lost to Follow-up|0
7742988|NCT00857766|26921479|P1|Overall Study|Lost to Follow-up|1
7742989|NCT00857766|26921478|P2|Overall Study|Protocol Violation|11
7742990|NCT00857766|26921479|P1|Overall Study|Protocol Violation|11
7742991|NCT00857766|26921478|P2|Overall Study|Adverse Event|12
7742992|NCT00857766|26921479|P1|Overall Study|Adverse Event|13
7742993|NCT00857649|26921521|P2|Overall Study|Other Reasons|3
7742994|NCT00857649|26921522|P1|Overall Study|Other Reasons|1
7742995|NCT00857649|26921521|P2|Overall Study|Nursing Home Placement|9
7742996|NCT00857649|26921522|P1|Overall Study|Nursing Home Placement|2
7742997|NCT00857649|26921521|P2|Overall Study|Withdrawal of Consent|7
7742998|NCT00857649|26921522|P1|Overall Study|Withdrawal of Consent|10
7742999|NCT00857649|26921521|P2|Overall Study|Protocol Violation|2
7743000|NCT00857649|26921522|P1|Overall Study|Protocol Violation|2
7743001|NCT00857649|26921521|P2|Overall Study|Non-compliance|1
7743002|NCT00857649|26921522|P1|Overall Study|Non-compliance|1
7743003|NCT00857649|26921521|P2|Overall Study|Adverse Event|10
7743004|NCT00857649|26921522|P1|Overall Study|Adverse Event|15
7743005|NCT00857623|26921538|P2|Overall Study|Positive for HEP C|1
7743006|NCT00857623|26921539|P1|Overall Study|Positive for HEP C|0
7743007|NCT00857623|26921538|P2|Overall Study|Intake of prohibited medication|1
7743008|NCT00857623|26921539|P1|Overall Study|Intake of prohibited medication|0
7743009|NCT00857623|26921538|P2|Overall Study|Severe non-compliance to protocol|1
7743010|NCT00857623|26921539|P1|Overall Study|Severe non-compliance to protocol|1
7743011|NCT00857623|26921538|P2|Overall Study|Lack of Efficacy|1
7743012|NCT00857623|26921539|P1|Overall Study|Lack of Efficacy|1
7743013|NCT00857623|26921538|P2|Overall Study|Withdrawal by Subject|1
7743014|NCT00857623|26921539|P1|Overall Study|Withdrawal by Subject|2
7743015|NCT00857623|26921538|P2|Overall Study|Study-specific discontinuation criteria|3
7743016|NCT00857623|26921539|P1|Overall Study|Study-specific discontinuation criteria|5
7743017|NCT00857623|26921538|P2|Overall Study|Adverse Event|2
7743018|NCT00857623|26921539|P1|Overall Study|Adverse Event|5
7743019|NCT00857584|26921563|P2|Overall Study|Physician Decision|1
7743020|NCT00857584|26921564|P1|Overall Study|Physician Decision|1
7743021|NCT00857584|26921563|P2|Overall Study|Adverse Event|2
7743022|NCT00857584|26921564|P1|Overall Study|Adverse Event|2
7743023|NCT00857584|26921563|P2|Overall Study|Lack of Efficacy|2
7743024|NCT00857584|26921564|P1|Overall Study|Lack of Efficacy|1
7743025|NCT00857454|26921691|P1|Overall Study|MTE09 enrollment criteria not met|6
7743026|NCT00857454|26921691|P1|Overall Study|Total Testosterone <300 ng/dL|8
7743027|NCT00857454|26921691|P1|Overall Study|Total Testosterone >1050 ng/dL|1
7743028|NCT00857454|26921691|P1|Overall Study|Adverse Event|2
7743029|NCT00857454|26921691|P1|Overall Study|Lost to Follow-up|1
7743030|NCT00857454|26921691|P1|Overall Study|Withdrawal by Subject|2
7743031|NCT00857415|26921704|P2|Overall Study|Deceased with no autopsy|0
7743032|NCT00857415|26921705|P1|Overall Study|Deceased with no autopsy|2
7743033|NCT00857415|26921704|P2|Overall Study|Subject still living at end of study|0
7743034|NCT00857415|26921705|P1|Overall Study|Subject still living at end of study|110
7743035|NCT00857415|26921704|P2|Overall Study|Invalid image or not imaged|0
7743036|NCT00857415|26921705|P1|Overall Study|Invalid image or not imaged|3
7743037|NCT00857415|26921704|P2|Overall Study|Image acquisition failure|0
7743038|NCT00857415|26921705|P1|Overall Study|Image acquisition failure|2
7743039|NCT00857389|26921712|P1|Overall Study|Did not proceed to transplant|2
7743040|NCT00857311|26921726|P4|Overall Study|Lost to Follow-up|0
7743041|NCT00857311|26921727|P3|Overall Study|Lost to Follow-up|0
7743042|NCT00857311|26921728|P2|Overall Study|Lost to Follow-up|0
7743043|NCT00857311|26921729|P1|Overall Study|Lost to Follow-up|1
7743044|NCT00857285|26921741|P2|Overall Study|Randomization criteria not met|1
7743045|NCT00857285|26921742|P1|Overall Study|Randomization criteria not met|1
7743046|NCT00857285|26921741|P2|Overall Study|Withdrawal by Subject|0
7743047|NCT00857285|26921742|P1|Overall Study|Withdrawal by Subject|4
7743048|NCT00857285|26921741|P2|Overall Study|Protocol Violation|1
7743049|NCT00857285|26921742|P1|Overall Study|Protocol Violation|3
7743050|NCT00857285|26921741|P2|Overall Study|Lack of Efficacy|2
7743051|NCT00857285|26921742|P1|Overall Study|Lack of Efficacy|0
7743052|NCT00857285|26921741|P2|Overall Study|Adverse Event|2
7743053|NCT00857285|26921742|P1|Overall Study|Adverse Event|4
7743054|NCT00857259|26921758|P3|Overall Study|Protocol Violation|1
7743055|NCT00857259|26921759|P2|Overall Study|Protocol Violation|0
7743056|NCT00857259|26921760|P1|Overall Study|Protocol Violation|1
7743057|NCT00857246|26921770|P1|ChemoRT|Adverse Event|2
7743058|NCT00857246|26921770|P1|ChemoRT|Withdrawal by Subject|1
7743059|NCT00857246|26921770|P1|Surgery (Curative)|disease progression|6
7743060|NCT00857246|26921770|P1|Induction Regimen|Withdrawal by Subject|1
7743061|NCT00857246|26921770|P1|Induction Regimen|disease-related complications|1
7743062|NCT00857246|26921770|P1|Induction Regimen|Adverse Event|1
7743063|NCT00857233|26921780|P1|Overall Study|Other Reasons|2
7743064|NCT00857233|26921780|P1|Overall Study|Nursing Home Placement|14
7743065|NCT00857233|26921780|P1|Overall Study|Lost to Follow-up|4
7743066|NCT00857233|26921780|P1|Overall Study|Withdrawal of Consent|9
7743067|NCT00857233|26921780|P1|Overall Study|Non-compliance|1
7743068|NCT00857233|26921780|P1|Overall Study|Lack of Efficacy|1
7743069|NCT00857233|26921780|P1|Overall Study|Adverse Event|24
7743070|NCT00857220|26921789|P1|Overall Study|Miscellaneous|8
7743071|NCT00857220|26921789|P1|Overall Study|Site Closed|5
7743072|NCT00857220|26921789|P1|Overall Study|Clinical Hold|6
7743073|NCT00857220|26921789|P1|Overall Study|Withdrawal by Subject|67
7743074|NCT00857220|26921789|P1|Overall Study|Protocol Violation|16
7743075|NCT00857220|26921789|P1|Overall Study|Physician Decision|4
7743076|NCT00857220|26921789|P1|Overall Study|Lost to Follow-up|30
7743077|NCT00857220|26921789|P1|Overall Study|Lack of Efficacy|11
7743078|NCT00857220|26921789|P1|Overall Study|Death|1
7743079|NCT00857220|26921789|P1|Overall Study|Adverse Event|35
7743080|NCT00857207|26921808|P2|Overall Study|Subject chose not to participate after signing consent|0
7743081|NCT00857207|26921809|P1|Overall Study|Subject chose not to participate after signing consent|3
7743082|NCT00857207|26921808|P2|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
7743083|NCT00857207|26921809|P1|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
7743084|NCT00857207|26921808|P2|Overall Study|Withdrawal by Subject|0
7743085|NCT00857207|26921809|P1|Overall Study|Withdrawal by Subject|13
7743086|NCT00856999|26921819|P1|Overall Study|Withdrawal by Subject|5
7743087|NCT00856986|26921829|P5|Extension Period, Weeks 26-52|Unclassified|0
7743088|NCT00856986|26921830|P4|Extension Period, Weeks 26-52|Unclassified|0
7743089|NCT00856986|26921831|P3|Extension Period, Weeks 26-52|Unclassified|11
7743090|NCT00856986|26921832|P2|Extension Period, Weeks 26-52|Unclassified|2
7743091|NCT00856986|26921833|P1|Extension Period, Weeks 26-52|Unclassified|4
7743092|NCT00856986|26921829|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
7743093|NCT00856986|26921830|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
7743094|NCT00856986|26921831|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
7743095|NCT00856986|26921832|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
7743096|NCT00856986|26921833|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
7743097|NCT00856986|26921829|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
7743098|NCT00856986|26921830|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
7743099|NCT00856986|26921831|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
7743100|NCT00856986|26921832|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
7743101|NCT00856986|26921833|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
7743102|NCT00856986|26921829|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7743103|NCT00856986|26921830|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7743104|NCT00856986|26921831|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
7743105|NCT00856986|26921832|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7743106|NCT00856986|26921833|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
7743107|NCT00856986|26921829|P5|Extension Period, Weeks 26-52|Protocol Violation|0
7743108|NCT00856986|26921830|P4|Extension Period, Weeks 26-52|Protocol Violation|0
7743109|NCT00856986|26921831|P3|Extension Period, Weeks 26-52|Protocol Violation|5
7743110|NCT00856986|26921832|P2|Extension Period, Weeks 26-52|Protocol Violation|2
7743111|NCT00856986|26921833|P1|Extension Period, Weeks 26-52|Protocol Violation|6
7743112|NCT00856986|26921829|P5|Extension Period, Weeks 26-52|Adverse Event|0
7743113|NCT00856986|26921830|P4|Extension Period, Weeks 26-52|Adverse Event|0
7743114|NCT00856986|26921831|P3|Extension Period, Weeks 26-52|Adverse Event|10
7743115|NCT00856986|26921832|P2|Extension Period, Weeks 26-52|Adverse Event|3
7743116|NCT00856986|26921833|P1|Extension Period, Weeks 26-52|Adverse Event|3
7743117|NCT00856986|26921829|P5|Main Period, Weeks 0-26|Unclassified|0
7743118|NCT00856986|26921830|P4|Main Period, Weeks 0-26|Unclassified|0
7743119|NCT00856986|26921831|P3|Main Period, Weeks 0-26|Unclassified|7
7743120|NCT00856986|26921832|P2|Main Period, Weeks 0-26|Unclassified|6
7743121|NCT00856986|26921833|P1|Main Period, Weeks 0-26|Unclassified|7
7743122|NCT00856986|26921829|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
7743123|NCT00856986|26921830|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
7743124|NCT00856986|26921831|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
7743125|NCT00856986|26921832|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
7743126|NCT00856986|26921833|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
7743127|NCT00856986|26921829|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
7743128|NCT00856986|26921830|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
7743129|NCT00856986|26921831|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
7743130|NCT00856986|26921832|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
7743131|NCT00856986|26921833|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
7743132|NCT00856986|26921829|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
7743133|NCT00856986|26921830|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
7743134|NCT00856986|26921831|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
7743135|NCT00856986|26921832|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
7743136|NCT00856986|26921833|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
7743137|NCT00856986|26921829|P5|Main Period, Weeks 0-26|Protocol Violation|0
7743138|NCT00856986|26921830|P4|Main Period, Weeks 0-26|Protocol Violation|0
7743139|NCT00856986|26921831|P3|Main Period, Weeks 0-26|Protocol Violation|7
7743140|NCT00856986|26921832|P2|Main Period, Weeks 0-26|Protocol Violation|5
7743141|NCT00856986|26921833|P1|Main Period, Weeks 0-26|Protocol Violation|4
7743142|NCT00856986|26921829|P5|Main Period, Weeks 0-26|Adverse Event|0
7743143|NCT00856986|26921830|P4|Main Period, Weeks 0-26|Adverse Event|0
7743144|NCT00856986|26921831|P3|Main Period, Weeks 0-26|Adverse Event|9
7743145|NCT00856986|26921832|P2|Main Period, Weeks 0-26|Adverse Event|4
7743146|NCT00856986|26921833|P1|Main Period, Weeks 0-26|Adverse Event|6
7743147|NCT00856986|26921829|P5|Run-in Period, Weeks -12-0|Unclassified|0
7743148|NCT00856986|26921830|P4|Run-in Period, Weeks -12-0|Unclassified|24
7743149|NCT00856986|26921831|P3|Run-in Period, Weeks -12-0|Unclassified|0
7743150|NCT00856986|26921832|P2|Run-in Period, Weeks -12-0|Unclassified|0
7743151|NCT00856986|26921833|P1|Run-in Period, Weeks -12-0|Unclassified|0
7743152|NCT00856986|26921829|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7743153|NCT00856986|26921830|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
7743154|NCT00856986|26921831|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7743155|NCT00856986|26921832|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7743156|NCT00856986|26921833|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7743157|NCT00856986|26921829|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7743158|NCT00856986|26921830|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
7743159|NCT00856986|26921831|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7743160|NCT00856986|26921832|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7743161|NCT00856986|26921833|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7743162|NCT00856986|26921829|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7743163|NCT00856986|26921830|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
7743164|NCT00856986|26921831|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7743165|NCT00856986|26921832|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7743166|NCT00856986|26921833|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7743167|NCT00856986|26921829|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
7743168|NCT00856986|26921830|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
7743169|NCT00856986|26921831|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
7743170|NCT00856986|26921832|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
7743171|NCT00856986|26921833|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
7743172|NCT00856986|26921829|P5|Run-in Period, Weeks -12-0|Adverse Event|0
7743173|NCT00856986|26921830|P4|Run-in Period, Weeks -12-0|Adverse Event|92
7743174|NCT00856986|26921831|P3|Run-in Period, Weeks -12-0|Adverse Event|0
7743175|NCT00856986|26921832|P2|Run-in Period, Weeks -12-0|Adverse Event|0
7743176|NCT00856986|26921833|P1|Run-in Period, Weeks -12-0|Adverse Event|0
7743177|NCT00856973|26922003|P3|Overall Study|Other|13
7743178|NCT00856973|26922004|P2|Overall Study|Other|12
7743179|NCT00856973|26922005|P1|Overall Study|Other|11
7743180|NCT00856973|26922003|P3|Overall Study|Withdrawal by Subject|15
7743181|NCT00856973|26922004|P2|Overall Study|Withdrawal by Subject|16
7743182|NCT00856973|26922005|P1|Overall Study|Withdrawal by Subject|13
7743183|NCT00856973|26922003|P3|Overall Study|Protocol Violation|1
7743184|NCT00856973|26922004|P2|Overall Study|Protocol Violation|2
7743185|NCT00856973|26922005|P1|Overall Study|Protocol Violation|1
7743186|NCT00856973|26922003|P3|Overall Study|Physician Decision|1
7743187|NCT00856973|26922004|P2|Overall Study|Physician Decision|3
7743188|NCT00856973|26922005|P1|Overall Study|Physician Decision|0
7743189|NCT00856973|26922003|P3|Overall Study|Lost to Follow-up|5
7743190|NCT00856973|26922004|P2|Overall Study|Lost to Follow-up|3
7743191|NCT00856973|26922005|P1|Overall Study|Lost to Follow-up|6
7743192|NCT00856973|26922003|P3|Overall Study|Adverse Event|3
7743193|NCT00856973|26922004|P2|Overall Study|Adverse Event|5
7743194|NCT00856973|26922005|P1|Overall Study|Adverse Event|5
7743195|NCT00856908|26922085|P2|Overall Study|Lost to Follow-up|0
7743196|NCT00856908|26922086|P1|Overall Study|Lost to Follow-up|1
7743197|NCT00856856|26922111|P1|4-year Clinical Follow-up|Missed visit|1
7743198|NCT00856856|26922111|P1|2-year Clinical Follow-up|Lost to Follow-up|1
7743199|NCT00856843|26922310|P2|Overall Study|Lack of Efficacy|0
7743200|NCT00856843|26922311|P1|Overall Study|Lack of Efficacy|1
7743201|NCT00856843|26922310|P2|Overall Study|Withdrawal by Subject|5
7743202|NCT00856843|26922311|P1|Overall Study|Withdrawal by Subject|1
7743203|NCT00856830|26922347|P4|Irinotecan & Bendamustine|Physician Decision|1
7743204|NCT00856830|26922348|P3|Irinotecan & Bendamustine|Physician Decision|0
7743205|NCT00856830|26922349|P2|Irinotecan & Bendamustine|Physician Decision|0
7743206|NCT00856830|26922350|P1|Irinotecan & Bendamustine|Physician Decision|0
7743207|NCT00856830|26922347|P4|Irinotecan & Bendamustine|Death|2
7743208|NCT00856830|26922348|P3|Irinotecan & Bendamustine|Death|0
7743209|NCT00856830|26922349|P2|Irinotecan & Bendamustine|Death|0
7743210|NCT00856830|26922350|P1|Irinotecan & Bendamustine|Death|0
7743211|NCT00856778|26922361|P1|Overall Study|Lost to Follow-up|5
7743212|NCT00856778|26922361|P1|Overall Study|Study deviation|2
7743213|NCT00856778|26922361|P1|Overall Study|Withdrawal by Subject|10
7743214|NCT00856778|26922361|P1|Overall Study|Adverse Event|7
7743215|NCT00856661|26922404|P2|Overall Study|Physician Judgement|5
7743216|NCT00856661|26922405|P1|Overall Study|Physician Judgement|8
7743217|NCT00856661|26922404|P2|Overall Study|Lost to Follow-up|3
7743218|NCT00856661|26922405|P1|Overall Study|Lost to Follow-up|1
7743219|NCT00856661|26922404|P2|Overall Study|Withdrawal by Subject|2
7743220|NCT00856661|26922405|P1|Overall Study|Withdrawal by Subject|1
7743221|NCT00856661|26922404|P2|Overall Study|Protocol Violation|1
7743222|NCT00856661|26922405|P1|Overall Study|Protocol Violation|2
7743223|NCT00856661|26922404|P2|Overall Study|Death|18
7743224|NCT00856661|26922405|P1|Overall Study|Death|15
7743225|NCT00856635|26922419|P2|Overall Study|Discontinued at Randomization|2
7743226|NCT00856635|26922420|P1|Overall Study|Discontinued at Randomization|2
7743227|NCT00856635|26922419|P2|Overall Study|Other|0
7743228|NCT00856635|26922420|P1|Overall Study|Other|1
7743229|NCT00856635|26922419|P2|Overall Study|Serious Adverse Event|0
7743230|NCT00856635|26922420|P1|Overall Study|Serious Adverse Event|1
7743231|NCT00856635|26922419|P2|Overall Study|Withdrawal by Subject|1
7743232|NCT00856635|26922420|P1|Overall Study|Withdrawal by Subject|3
7743233|NCT00856635|26922419|P2|Overall Study|Pregnancy|0
7743234|NCT00856635|26922420|P1|Overall Study|Pregnancy|1
7743235|NCT00856635|26922419|P2|Overall Study|Lost to Follow-up|5
7743236|NCT00856635|26922420|P1|Overall Study|Lost to Follow-up|2
7743237|NCT00856609|26922430|P2|Overall Study|Adverse Event|0
7743238|NCT00856609|26922431|P1|Overall Study|Adverse Event|1
7743239|NCT00856583|26922443|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
7743240|NCT00856583|26922444|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
7743241|NCT00856583|26922443|P2|Overall Study|Other|104
7743242|NCT00856583|26922444|P1|Overall Study|Other|92
7743243|NCT00856583|26922443|P2|Overall Study|Pregnancy|5
7743244|NCT00856583|26922444|P1|Overall Study|Pregnancy|14
7743245|NCT00856583|26922443|P2|Overall Study|Physician Decision|82
7743246|NCT00856583|26922444|P1|Overall Study|Physician Decision|59
7743247|NCT00856583|26922443|P2|Overall Study|Withdrawal by Subject|919
7743248|NCT00856583|26922444|P1|Overall Study|Withdrawal by Subject|1092
7743249|NCT00856583|26922443|P2|Overall Study|Non-compliance|262
7743250|NCT00856583|26922444|P1|Overall Study|Non-compliance|305
7743251|NCT00856583|26922443|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
7743252|NCT00856583|26922444|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
7743253|NCT00856583|26922443|P2|Overall Study|Serious Adverse Event (SAE)|65
7743254|NCT00856583|26922444|P1|Overall Study|Serious Adverse Event (SAE)|99
7743255|NCT00856583|26922443|P2|Overall Study|Lack of Efficacy|377
7743256|NCT00856583|26922444|P1|Overall Study|Lack of Efficacy|389
7743257|NCT00856557|26922474|P2|Overall Study|No patients with contextual flags|16
7743258|NCT00856557|26922475|P1|Overall Study|No patients with contextual flags|12
7743259|NCT00856544|26922489|P4|Overall Study|Withdrawal by Subject|1
7743260|NCT00856544|26922490|P3|Overall Study|Withdrawal by Subject|0
7743261|NCT00856544|26922491|P2|Overall Study|Withdrawal by Subject|5
7743262|NCT00856544|26922492|P1|Overall Study|Withdrawal by Subject|8
7743263|NCT00856544|26922489|P4|Overall Study|Lost to Follow-up|0
7743264|NCT00856544|26922490|P3|Overall Study|Lost to Follow-up|2
7743265|NCT00856544|26922491|P2|Overall Study|Lost to Follow-up|2
7743266|NCT00856544|26922492|P1|Overall Study|Lost to Follow-up|1
7743267|NCT00856544|26922489|P4|Overall Study|Other|6
7743268|NCT00856544|26922490|P3|Overall Study|Other|1
7743269|NCT00856544|26922491|P2|Overall Study|Other|16
7743270|NCT00856544|26922492|P1|Overall Study|Other|9
7743271|NCT00856544|26922489|P4|Overall Study|Lack of Efficacy|3
7743272|NCT00856544|26922490|P3|Overall Study|Lack of Efficacy|3
7743273|NCT00856544|26922491|P2|Overall Study|Lack of Efficacy|12
7743274|NCT00856544|26922492|P1|Overall Study|Lack of Efficacy|16
7743275|NCT00856544|26922489|P4|Overall Study|Adverse Event|3
7743276|NCT00856544|26922490|P3|Overall Study|Adverse Event|2
7743277|NCT00856544|26922491|P2|Overall Study|Adverse Event|29
7743278|NCT00856544|26922492|P1|Overall Study|Adverse Event|20
7743279|NCT00856544|26922489|P4|Overall Study|Death|0
7743280|NCT00856544|26922490|P3|Overall Study|Death|0
7743281|NCT00856544|26922491|P2|Overall Study|Death|2
7743282|NCT00856544|26922492|P1|Overall Study|Death|0
7743283|NCT00856544|26922489|P4|Overall Study|Randomized but not treated|0
7743284|NCT00856544|26922490|P3|Overall Study|Randomized but not treated|0
7743285|NCT00856544|26922491|P2|Overall Study|Randomized but not treated|0
7743286|NCT00856544|26922492|P1|Overall Study|Randomized but not treated|3
7743287|NCT00856518|26922671|P2|Overall Study|Lost to Follow-up|2
7743288|NCT00856518|26922672|P1|Overall Study|Lost to Follow-up|4
7743289|NCT00856492|26922685|P3|Overall Study|Ineligible or withdrew consent|2
7743290|NCT00856492|26922686|P2|Overall Study|Ineligible or withdrew consent|1
7743291|NCT00856492|26922687|P1|Overall Study|Ineligible or withdrew consent|1
7743292|NCT00856388|26922709|P1|Overall Study|Other|1
7743293|NCT00856375|26922722|P2|Overall Study|Lost to Follow-up|2
7743294|NCT00856375|26922723|P1|Overall Study|Lost to Follow-up|1
7743295|NCT00856375|26922722|P2|Overall Study|Withdrawal by Subject|1
7743296|NCT00856375|26922723|P1|Overall Study|Withdrawal by Subject|2
7743297|NCT00856375|26922722|P2|Overall Study|Sponsor Terminated Study|7
7743298|NCT00856375|26922723|P1|Overall Study|Sponsor Terminated Study|7
7743299|NCT00856375|26922722|P2|Overall Study|Death|30
7743300|NCT00856375|26922723|P1|Overall Study|Death|32
7743301|NCT00856375|26922722|P2|Overall Study|Other|1
7743302|NCT00856375|26922723|P1|Overall Study|Other|0
7743303|NCT00856349|26922739|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
7743304|NCT00856349|26922739|P1|Overall Study|Site closure|78
7743305|NCT00856349|26922739|P1|Overall Study|Device explant|33
7743306|NCT00856349|26922739|P1|Overall Study|Subject relocation|104
7743307|NCT00856349|26922739|P1|Overall Study|Physician Decision|13
7743308|NCT00856349|26922739|P1|Overall Study|Protocol Violation|38
7743309|NCT00856349|26922739|P1|Overall Study|Lost to Follow-up|91
7743310|NCT00856349|26922739|P1|Overall Study|Withdrawal by Subject|116
7743311|NCT00856349|26922739|P1|Overall Study|Death|418
7743312|NCT00856323|26922748|P1|Overall Study|Withdrawal by Subject|2
7743313|NCT00856297|26922760|P5|Overall Study|Unable to classify|0
7743314|NCT00856297|26922761|P4|Overall Study|Unable to classify|0
7743315|NCT00856297|26922762|P3|Overall Study|Unable to classify|0
7743316|NCT00856297|26922763|P2|Overall Study|Unable to classify|0
7743317|NCT00856297|26922764|P1|Overall Study|Unable to classify|2
7743318|NCT00856284|26922797|P3|Overall Study|Randomized in error|1
7743319|NCT00856284|26922798|P2|Overall Study|Randomized in error|0
7743320|NCT00856284|26922799|P1|Overall Study|Randomized in error|0
7743321|NCT00856284|26922797|P3|Overall Study|Other|14
7743322|NCT00856284|26922798|P2|Overall Study|Other|17
7743323|NCT00856284|26922799|P1|Overall Study|Other|15
7743324|NCT00856284|26922797|P3|Overall Study|Investigator discretion|10
7743325|NCT00856284|26922798|P2|Overall Study|Investigator discretion|8
7743326|NCT00856284|26922799|P1|Overall Study|Investigator discretion|9
7743327|NCT00856284|26922797|P3|Overall Study|Pregnancy|0
7743328|NCT00856284|26922798|P2|Overall Study|Pregnancy|2
7743329|NCT00856284|26922799|P1|Overall Study|Pregnancy|1
7743330|NCT00856284|26922797|P3|Overall Study|Voluntary withdrawal|62
7743331|NCT00856284|26922798|P2|Overall Study|Voluntary withdrawal|52
7743332|NCT00856284|26922799|P1|Overall Study|Voluntary withdrawal|48
7743333|NCT00856284|26922797|P3|Overall Study|Lost to Follow-up|28
7743334|NCT00856284|26922798|P2|Overall Study|Lost to Follow-up|22
7743335|NCT00856284|26922799|P1|Overall Study|Lost to Follow-up|20
7743336|NCT00856284|26922797|P3|Overall Study|Major protocol deviation|15
7743337|NCT00856284|26922798|P2|Overall Study|Major protocol deviation|16
7743338|NCT00856284|26922799|P1|Overall Study|Major protocol deviation|24
7743339|NCT00856284|26922797|P3|Overall Study|Adverse Event|82
7743340|NCT00856284|26922798|P2|Overall Study|Adverse Event|74
7743341|NCT00856284|26922799|P1|Overall Study|Adverse Event|60
7743342|NCT00856284|26922797|P3|Overall Study|Hyperglycemic rescue|235
7743343|NCT00856284|26922798|P2|Overall Study|Hyperglycemic rescue|201
7743344|NCT00856284|26922799|P1|Overall Study|Hyperglycemic rescue|231
7743345|NCT00856245|26922825|P1|Overall Study|Was not transplanted|5
7743346|NCT00856206|26922848|P2|Overall Study|Other than specified above|10
7743347|NCT00856206|26922849|P1|Overall Study|Other than specified above|3
7743348|NCT00856206|26922848|P2|Overall Study|Decision by the Sponsor|8
7743349|NCT00856206|26922849|P1|Overall Study|Decision by the Sponsor|4
7743350|NCT00856206|26922848|P2|Overall Study|Death|2
7743351|NCT00856206|26922849|P1|Overall Study|Death|2
7743352|NCT00856206|26922848|P2|Overall Study|Lost to Follow-up|39
7743353|NCT00856206|26922849|P1|Overall Study|Lost to Follow-up|13
7743354|NCT00856206|26922848|P2|Overall Study|Withdrawal by Subject|36
7743355|NCT00856206|26922849|P1|Overall Study|Withdrawal by Subject|15
7743356|NCT00856206|26922848|P2|Overall Study|Lack of Efficacy|2
7743357|NCT00856206|26922849|P1|Overall Study|Lack of Efficacy|1
7743358|NCT00856206|26922848|P2|Overall Study|Adverse Event|46
7743359|NCT00856206|26922849|P1|Overall Study|Adverse Event|10
7743360|NCT00856206|26922848|P2|Overall Study|Protocol Violation|18
7743361|NCT00856206|26922849|P1|Overall Study|Protocol Violation|6
7743362|NCT00856193|26922863|P2|Period 2|Lost to Follow-up|1
7743363|NCT00856193|26922864|P1|Period 2|Lost to Follow-up|0
7743364|NCT00856193|26922863|P2|Period 2|Abnormal test procedure results|1
7743365|NCT00856193|26922864|P1|Period 2|Abnormal test procedure results|0
7743366|NCT00856180|26922876|P1|Overall Study|Progressive Disease|16
7743367|NCT00856180|26922876|P1|Overall Study|Adverse Event|4
7743368|NCT00855959|26922901|P1|Overall Study|Incorrect enrolment|1
7743369|NCT00855959|26922901|P1|Overall Study|Pregnancy|1
7743370|NCT00855959|26922901|P1|Overall Study|Withdrawal by Subject|3
7743371|NCT00855959|26922901|P1|Overall Study|Lost to Follow-up|2
7743372|NCT00855959|26922901|P1|Overall Study|Adverse Event|2
7743373|NCT00855933|26922918|P2|Overall Study|Withdrawal by Subject|1
7743374|NCT00855933|26922919|P1|Overall Study|Withdrawal by Subject|0
7743375|NCT00855920|26922928|P3|Overall Study|Other than specified above|1
7743376|NCT00855920|26922929|P2|Overall Study|Other than specified above|1
7743377|NCT00855920|26922930|P1|Overall Study|Other than specified above|1
7743378|NCT00855920|26922928|P3|Overall Study|Decision by the sponsor|1
7743379|NCT00855920|26922929|P2|Overall Study|Decision by the sponsor|1
7743380|NCT00855920|26922930|P1|Overall Study|Decision by the sponsor|0
7743381|NCT00855920|26922928|P3|Overall Study|Death|0
7743382|NCT00855920|26922929|P2|Overall Study|Death|1
7743383|NCT00855920|26922930|P1|Overall Study|Death|0
7743384|NCT00855920|26922928|P3|Overall Study|Lost to Follow-up|2
7743385|NCT00855920|26922929|P2|Overall Study|Lost to Follow-up|0
7743386|NCT00855920|26922930|P1|Overall Study|Lost to Follow-up|1
7743387|NCT00855920|26922928|P3|Overall Study|Withdrawal by Subject|2
7743388|NCT00855920|26922929|P2|Overall Study|Withdrawal by Subject|3
7743389|NCT00855920|26922930|P1|Overall Study|Withdrawal by Subject|2
7743390|NCT00855920|26922928|P3|Overall Study|Lack of Efficacy|2
7743391|NCT00855920|26922929|P2|Overall Study|Lack of Efficacy|2
7743392|NCT00855920|26922930|P1|Overall Study|Lack of Efficacy|2
7743393|NCT00855920|26922928|P3|Overall Study|Adverse Event|1
7743394|NCT00855920|26922929|P2|Overall Study|Adverse Event|1
7743395|NCT00855920|26922930|P1|Overall Study|Adverse Event|2
7743396|NCT00855920|26922928|P3|Overall Study|Protocol Violation|2
7743397|NCT00855920|26922929|P2|Overall Study|Protocol Violation|0
7743398|NCT00855920|26922930|P1|Overall Study|Protocol Violation|0
7743399|NCT00855894|26922947|P1|Overall Study|Disease progression|1
7743400|NCT00855894|26922947|P1|Overall Study|Patient's decision|1
7743401|NCT00855894|26922947|P1|Overall Study|Death|31
7743402|NCT00855816|26922970|P2|Overall Study|Became ineligible|1
7743403|NCT00855816|26922971|P1|Overall Study|Became ineligible|0
7743404|NCT00855816|26922970|P2|Overall Study|Death|0
7743405|NCT00855816|26922971|P1|Overall Study|Death|1
7743406|NCT00855816|26922970|P2|Overall Study|Lost to Follow-up|5
7743407|NCT00855816|26922971|P1|Overall Study|Lost to Follow-up|3
7743408|NCT00855816|26922970|P2|Overall Study|Withdrawal by Subject|15
7743409|NCT00855816|26922971|P1|Overall Study|Withdrawal by Subject|22
7743410|NCT00855738|26922977|P1|Overall Study|Death|1
7743411|NCT00855738|26922977|P1|Overall Study|Subject Defaulted|1
7743412|NCT00855738|26922977|P1|Overall Study|Adverse Event|1
7743413|NCT00855738|26922977|P1|Overall Study|Lost to Follow-up|2
7743414|NCT00855595|26923005|P2|Overall Study|patient left country|1
7743415|NCT00855595|26923006|P1|Overall Study|patient left country|0
7743416|NCT00855595|26923005|P2|Overall Study|patient moved out of state|0
7743417|NCT00855595|26923006|P1|Overall Study|patient moved out of state|1
7743418|NCT00855595|26923005|P2|Overall Study|Adverse Event|1
7743419|NCT00855595|26923006|P1|Overall Study|Adverse Event|1
7743420|NCT00855595|26923005|P2|Overall Study|Lost to Follow-up|3
7743421|NCT00855595|26923006|P1|Overall Study|Lost to Follow-up|3
7743422|NCT00855595|26923005|P2|Overall Study|Withdrawal by Subject|2
7743423|NCT00855595|26923006|P1|Overall Study|Withdrawal by Subject|1
7743424|NCT00855582|26923045|P3|Overall Study|Withdrawal by Subject|8
7743425|NCT00855582|26923046|P2|Overall Study|Withdrawal by Subject|4
7743426|NCT00855582|26923047|P1|Overall Study|Withdrawal by Subject|7
7743427|NCT00855582|26923045|P3|Overall Study|Entry Criteria Not Met|3
7743428|NCT00855582|26923046|P2|Overall Study|Entry Criteria Not Met|6
7743429|NCT00855582|26923047|P1|Overall Study|Entry Criteria Not Met|8
7743430|NCT00855582|26923045|P3|Overall Study|Protocol Violation|6
7743431|NCT00855582|26923046|P2|Overall Study|Protocol Violation|2
7743432|NCT00855582|26923047|P1|Overall Study|Protocol Violation|6
7743433|NCT00855582|26923045|P3|Overall Study|Physician Decision|1
7743434|NCT00855582|26923046|P2|Overall Study|Physician Decision|0
7743435|NCT00855582|26923047|P1|Overall Study|Physician Decision|0
7743436|NCT00855582|26923045|P3|Overall Study|Lost to Follow-up|1
7743437|NCT00855582|26923046|P2|Overall Study|Lost to Follow-up|3
7743438|NCT00855582|26923047|P1|Overall Study|Lost to Follow-up|1
7743439|NCT00855582|26923045|P3|Overall Study|Lack of Efficacy|8
7743440|NCT00855582|26923046|P2|Overall Study|Lack of Efficacy|3
7743441|NCT00855582|26923047|P1|Overall Study|Lack of Efficacy|1
7743442|NCT00855582|26923045|P3|Overall Study|Death|0
7743443|NCT00855582|26923046|P2|Overall Study|Death|0
7743444|NCT00855582|26923047|P1|Overall Study|Death|1
7743445|NCT00855582|26923045|P3|Overall Study|Adverse Event|3
7743446|NCT00855582|26923046|P2|Overall Study|Adverse Event|6
7743447|NCT00855582|26923047|P1|Overall Study|Adverse Event|2
7743448|NCT00855465|26923136|P2|Follow-up Period (FUP)|Missing|0
7743449|NCT00855465|26923137|P1|Follow-up Period (FUP)|Missing|1
7743450|NCT00855465|26923136|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
7743451|NCT00855465|26923137|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
7743452|NCT00855465|26923136|P2|Follow-up Period (FUP)|Lost to Follow-up|0
7743453|NCT00855465|26923137|P1|Follow-up Period (FUP)|Lost to Follow-up|3
7743454|NCT00855465|26923136|P2|Follow-up Period (FUP)|Death|1
7743455|NCT00855465|26923137|P1|Follow-up Period (FUP)|Death|0
7743456|NCT00855465|26923136|P2|Follow-up Period (FUP)|Adverse Event|1
7743457|NCT00855465|26923137|P1|Follow-up Period (FUP)|Adverse Event|0
7743458|NCT00855465|26923136|P2|Treatment Period|Not treated|0
7743459|NCT00855465|26923137|P1|Treatment Period|Not treated|1
7743460|NCT00855465|26923136|P2|Treatment Period|Withdrawal by Subject|0
7743461|NCT00855465|26923137|P1|Treatment Period|Withdrawal by Subject|2
7743462|NCT00855465|26923136|P2|Treatment Period|Protocol Violation|0
7743463|NCT00855465|26923137|P1|Treatment Period|Protocol Violation|2
7743464|NCT00855465|26923136|P2|Treatment Period|Non-compliance|0
7743465|NCT00855465|26923137|P1|Treatment Period|Non-compliance|1
7743466|NCT00855465|26923136|P2|Treatment Period|Lack of Efficacy|1
7743467|NCT00855465|26923137|P1|Treatment Period|Lack of Efficacy|2
7743468|NCT00855465|26923136|P2|Treatment Period|Death|2
7743469|NCT00855465|26923137|P1|Treatment Period|Death|2
7743470|NCT00855465|26923136|P2|Treatment Period|Adverse Event|2
7743471|NCT00855465|26923137|P1|Treatment Period|Adverse Event|4
7743472|NCT00855439|26923227|P2|Overall Study|Pregnancy|0
7743473|NCT00855439|26923228|P1|Overall Study|Pregnancy|1
7743474|NCT00855439|26923227|P2|Overall Study|Withdrawal by Subject|0
7743475|NCT00855439|26923228|P1|Overall Study|Withdrawal by Subject|2
7743476|NCT00855335|26923286|P5|Overall Study|Other|1
7743477|NCT00855335|26923287|P4|Overall Study|Other|5
7743478|NCT00855335|26923288|P3|Overall Study|Other|2
7743479|NCT00855335|26923289|P2|Overall Study|Other|1
7743480|NCT00855335|26923290|P1|Overall Study|Other|2
7743481|NCT00855335|26923286|P5|Overall Study|Physician Decision|0
7743482|NCT00855335|26923287|P4|Overall Study|Physician Decision|0
7743483|NCT00855335|26923288|P3|Overall Study|Physician Decision|0
7743484|NCT00855335|26923289|P2|Overall Study|Physician Decision|1
7743485|NCT00855335|26923290|P1|Overall Study|Physician Decision|1
7743486|NCT00855335|26923286|P5|Overall Study|Adverse Event|0
7743487|NCT00855335|26923287|P4|Overall Study|Adverse Event|0
7743488|NCT00855335|26923288|P3|Overall Study|Adverse Event|0
7743489|NCT00855335|26923289|P2|Overall Study|Adverse Event|0
7743490|NCT00855335|26923290|P1|Overall Study|Adverse Event|2
7743491|NCT00855335|26923286|P5|Overall Study|Withdrawal by Subject|0
7743492|NCT00855335|26923287|P4|Overall Study|Withdrawal by Subject|1
7743493|NCT00855335|26923288|P3|Overall Study|Withdrawal by Subject|0
7743494|NCT00855335|26923289|P2|Overall Study|Withdrawal by Subject|0
7743495|NCT00855335|26923290|P1|Overall Study|Withdrawal by Subject|0
7743496|NCT00855335|26923286|P5|Overall Study|Lost to Follow-up|0
7743497|NCT00855335|26923287|P4|Overall Study|Lost to Follow-up|1
7743498|NCT00855335|26923288|P3|Overall Study|Lost to Follow-up|3
7743499|NCT00855335|26923289|P2|Overall Study|Lost to Follow-up|0
7743500|NCT00855335|26923290|P1|Overall Study|Lost to Follow-up|0
7743501|NCT00855309|26923377|P2|Overall Study|patient never recieved drug|0
7743502|NCT00855309|26923378|P1|Overall Study|patient never recieved drug|1
7743503|NCT00855218|26923386|P2|Overall Study|Clinical endpoint reached|13
7743504|NCT00855218|26923387|P1|Overall Study|Clinical endpoint reached|10
7743505|NCT00855218|26923386|P2|Overall Study|Progression measurement proven|15
7743506|NCT00855218|26923387|P1|Overall Study|Progression measurement proven|7
7743507|NCT00855218|26923386|P2|Overall Study|Second malignancy|1
7743508|NCT00855218|26923387|P1|Overall Study|Second malignancy|0
7743509|NCT00855218|26923386|P2|Overall Study|Untreatable disease progression|67
7743510|NCT00855218|26923387|P1|Overall Study|Untreatable disease progression|54
7743511|NCT00855218|26923386|P2|Overall Study|Still treated with study medication|1
7743512|NCT00855218|26923387|P1|Overall Study|Still treated with study medication|0
7743513|NCT00855218|26923386|P2|Overall Study|technical problems|1
7743514|NCT00855218|26923387|P1|Overall Study|technical problems|2
7743515|NCT00855218|26923386|P2|Overall Study|patient convenience|0
7743516|NCT00855218|26923387|P1|Overall Study|patient convenience|2
7743517|NCT00855218|26923386|P2|Overall Study|non-compliant with study drug|1
7743518|NCT00855218|26923387|P1|Overall Study|non-compliant with study drug|3
7743519|NCT00855218|26923386|P2|Overall Study|Protocol Violation|9
7743520|NCT00855218|26923387|P1|Overall Study|Protocol Violation|5
7743521|NCT00855218|26923386|P2|Overall Study|Lost to Follow-up|1
7743522|NCT00855218|26923387|P1|Overall Study|Lost to Follow-up|0
7743523|NCT00855218|26923386|P2|Overall Study|Physician Decision|11
7743524|NCT00855218|26923387|P1|Overall Study|Physician Decision|18
7743525|NCT00855218|26923386|P2|Overall Study|Withdrawal by Subject|6
7743526|NCT00855218|26923387|P1|Overall Study|Withdrawal by Subject|10
7743527|NCT00855218|26923386|P2|Overall Study|Adverse Event|27
7743528|NCT00855218|26923387|P1|Overall Study|Adverse Event|43
7743529|NCT00855166|26923405|P2|Overall Study|Subject no longer meets study criteria|1
7743530|NCT00855166|26923406|P1|Overall Study|Subject no longer meets study criteria|1
7743531|NCT00855166|26923405|P2|Overall Study|Administrative reasons by sponsor|0
7743532|NCT00855166|26923406|P1|Overall Study|Administrative reasons by sponsor|1
7743533|NCT00855166|26923405|P2|Overall Study|Poor/non-compliance|0
7743534|NCT00855166|26923406|P1|Overall Study|Poor/non-compliance|2
7743535|NCT00855166|26923405|P2|Overall Study|Withdrawal by Subject|4
7743536|NCT00855166|26923406|P1|Overall Study|Withdrawal by Subject|1
7743537|NCT00855166|26923405|P2|Overall Study|Death|1
7743538|NCT00855166|26923406|P1|Overall Study|Death|0
7743539|NCT00855166|26923405|P2|Overall Study|Adverse Event|2
7743540|NCT00855166|26923406|P1|Overall Study|Adverse Event|0
7743541|NCT00855062|26923426|P2|Step2|Initiation of antiretroviral therapy/ART|1
7743542|NCT00855062|26923427|P1|Step2|Initiation of antiretroviral therapy/ART|0
7743543|NCT00855062|26923426|P2|Step2|Adverse Event|3
7743544|NCT00855062|26923427|P1|Step2|Adverse Event|0
7743545|NCT00855062|26923426|P2|Step2|Early Study Closure|2
7743546|NCT00855062|26923427|P1|Step2|Early Study Closure|6
7743547|NCT00855062|26923426|P2|Step1|Withdrawal by Subject|3
7743548|NCT00855062|26923427|P1|Step1|Withdrawal by Subject|2
7743549|NCT00855062|26923426|P2|Step1|Pregnancy|0
7743550|NCT00855062|26923427|P1|Step1|Pregnancy|1
7743551|NCT00855062|26923426|P2|Step1|Protocol Violation|0
7743552|NCT00855062|26923427|P1|Step1|Protocol Violation|1
7743553|NCT00855062|26923426|P2|Step1|Adverse Event|1
7743554|NCT00855062|26923427|P1|Step1|Adverse Event|1
7743555|NCT00855062|26923426|P2|Step1|Early Study Closure|7
7743556|NCT00855062|26923427|P1|Step1|Early Study Closure|5
7743557|NCT00854906|26923476|P1|Overall Study|One person had no ocular history|1
7743558|NCT00854828|26923487|P4|Overall Study|Missed 24mo visit|8
7743559|NCT00854828|26923488|P3|Overall Study|Missed 24mo visit|8
7743560|NCT00854828|26923489|P2|Overall Study|Missed 24mo visit|1
7743561|NCT00854828|26923490|P1|Overall Study|Missed 24mo visit|1
7743562|NCT00854828|26923487|P4|Overall Study|Withdrawal by Subject|9
7743563|NCT00854828|26923488|P3|Overall Study|Withdrawal by Subject|0
7743564|NCT00854828|26923489|P2|Overall Study|Withdrawal by Subject|1
7743565|NCT00854828|26923490|P1|Overall Study|Withdrawal by Subject|1
7743566|NCT00854828|26923487|P4|Overall Study|Death|0
7743567|NCT00854828|26923488|P3|Overall Study|Death|0
7743568|NCT00854828|26923489|P2|Overall Study|Death|0
7743569|NCT00854828|26923490|P1|Overall Study|Death|1
7743570|NCT00854724|26923504|P2|Second Intervention|Physician Decision|1
7743571|NCT00854724|26923505|P1|Second Intervention|Physician Decision|0
7743572|NCT00854724|26923504|P2|Second Intervention|Protocol Violation|0
7743573|NCT00854724|26923505|P1|Second Intervention|Protocol Violation|1
7743574|NCT00854724|26923504|P2|Washout|Withdrawal by Subject|1
7743575|NCT00854724|26923505|P1|Washout|Withdrawal by Subject|0
7743576|NCT00854724|26923504|P2|Washout|Protocol Violation|0
7743577|NCT00854724|26923505|P1|Washout|Protocol Violation|1
7743578|NCT00854724|26923504|P2|First Intervention|Withdrawal by Subject|1
7743579|NCT00854724|26923505|P1|First Intervention|Withdrawal by Subject|1
7743580|NCT00854620|26923511|P1|Overall Study|Adverse Event|1
7743581|NCT00854607|26923515|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
7743582|NCT00854581|26923563|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
7743583|NCT00854581|26923563|P1|Induction (Up to Day 21)|Physician Decision|1
7743584|NCT00854581|26923563|P1|Induction (Up to Day 21)|Death|1
7743585|NCT00854581|26923563|P1|Induction (Up to Day 21)|Lack of Efficacy|4
7743586|NCT00854373|26923578|P2|Overall Study|Forgot to take study drug|1
7743587|NCT00854373|26923579|P1|Overall Study|Forgot to take study drug|1
7743588|NCT00854373|26923578|P2|Overall Study|Withdrawal by Subject|3
7743589|NCT00854373|26923579|P1|Overall Study|Withdrawal by Subject|1
7743590|NCT00854360|26923593|P4|Overall Study|Other|3
7743591|NCT00854360|26923594|P3|Overall Study|Other|0
7743592|NCT00854360|26923595|P2|Overall Study|Other|0
7743593|NCT00854360|26923596|P1|Overall Study|Other|0
7743594|NCT00854360|26923593|P4|Overall Study|Lack of Efficacy|0
7743595|NCT00854360|26923594|P3|Overall Study|Lack of Efficacy|0
7743596|NCT00854360|26923595|P2|Overall Study|Lack of Efficacy|1
7743597|NCT00854360|26923596|P1|Overall Study|Lack of Efficacy|2
7743598|NCT00854360|26923593|P4|Overall Study|Pregnancy|0
7743599|NCT00854360|26923594|P3|Overall Study|Pregnancy|0
7743600|NCT00854360|26923595|P2|Overall Study|Pregnancy|1
7743601|NCT00854360|26923596|P1|Overall Study|Pregnancy|0
7743602|NCT00854360|26923593|P4|Overall Study|Withdrawal by Subject|1
7743603|NCT00854360|26923594|P3|Overall Study|Withdrawal by Subject|0
7743604|NCT00854360|26923595|P2|Overall Study|Withdrawal by Subject|0
7743605|NCT00854360|26923596|P1|Overall Study|Withdrawal by Subject|0
7743606|NCT00854360|26923593|P4|Overall Study|Adverse Event|6
7743607|NCT00854360|26923594|P3|Overall Study|Adverse Event|2
7743608|NCT00854360|26923595|P2|Overall Study|Adverse Event|1
7743609|NCT00854360|26923596|P1|Overall Study|Adverse Event|0
7743610|NCT00854308|26923628|P2|Overall Study|Sponsor's decision to terminate study|1
7743611|NCT00854308|26923629|P1|Overall Study|Sponsor's decision to terminate study|0
7743612|NCT00854308|26923628|P2|Overall Study|Withdrawal by Subject|2
7743613|NCT00854308|26923629|P1|Overall Study|Withdrawal by Subject|4
7743614|NCT00854308|26923628|P2|Overall Study|Physician Decision|6
7743615|NCT00854308|26923629|P1|Overall Study|Physician Decision|6
7743616|NCT00854308|26923628|P2|Overall Study|Death|5
7743617|NCT00854308|26923629|P1|Overall Study|Death|2
7743618|NCT00854308|26923628|P2|Overall Study|Adverse Event|3
7743619|NCT00854308|26923629|P1|Overall Study|Adverse Event|8
7743620|NCT00854308|26923628|P2|Overall Study|Disease progression|50
7743621|NCT00854308|26923629|P1|Overall Study|Disease progression|42
7743622|NCT00854113|26923654|P11|Overall Study|Withdrawal by Subject|0
7743623|NCT00854113|26923655|P10|Overall Study|Withdrawal by Subject|0
7743624|NCT00854113|26923656|P9|Overall Study|Withdrawal by Subject|1
7743625|NCT00854113|26923657|P8|Overall Study|Withdrawal by Subject|1
7743626|NCT00854113|26923658|P7|Overall Study|Withdrawal by Subject|0
7743627|NCT00854113|26923659|P6|Overall Study|Withdrawal by Subject|0
7743628|NCT00854113|26923660|P5|Overall Study|Withdrawal by Subject|0
7743629|NCT00854113|26923661|P4|Overall Study|Withdrawal by Subject|0
7743630|NCT00854113|26923662|P3|Overall Study|Withdrawal by Subject|0
7743631|NCT00854113|26923663|P2|Overall Study|Withdrawal by Subject|0
7743632|NCT00854113|26923664|P1|Overall Study|Withdrawal by Subject|0
7743633|NCT00854113|26923654|P11|Overall Study|Adverse Event|0
7743634|NCT00854113|26923655|P10|Overall Study|Adverse Event|0
7743635|NCT00854113|26923656|P9|Overall Study|Adverse Event|0
7743636|NCT00854113|26923657|P8|Overall Study|Adverse Event|2
7743637|NCT00854113|26923658|P7|Overall Study|Adverse Event|0
7743638|NCT00854113|26923659|P6|Overall Study|Adverse Event|0
7743639|NCT00854113|26923660|P5|Overall Study|Adverse Event|0
7743640|NCT00854113|26923661|P4|Overall Study|Adverse Event|0
7743641|NCT00854113|26923662|P3|Overall Study|Adverse Event|0
7743642|NCT00854113|26923663|P2|Overall Study|Adverse Event|0
7743643|NCT00854113|26923664|P1|Overall Study|Adverse Event|0
7743644|NCT00854100|26923768|P3|Overall Study|Adverse Event|2
7743645|NCT00854100|26923769|P2|Overall Study|Adverse Event|1
7743646|NCT00854100|26923770|P1|Overall Study|Adverse Event|2
7743647|NCT00854100|26923768|P3|Overall Study|Protocol Violation|3
7743648|NCT00854100|26923769|P2|Overall Study|Protocol Violation|4
7743649|NCT00854100|26923770|P1|Overall Study|Protocol Violation|2
7743650|NCT00854100|26923768|P3|Overall Study|Withdrawal by Subject|2
7743651|NCT00854100|26923769|P2|Overall Study|Withdrawal by Subject|1
7743652|NCT00854100|26923770|P1|Overall Study|Withdrawal by Subject|3
7743653|NCT00854100|26923768|P3|Overall Study|Lost to Follow-up|3
7743654|NCT00854100|26923769|P2|Overall Study|Lost to Follow-up|0
7743655|NCT00854100|26923770|P1|Overall Study|Lost to Follow-up|2
7743656|NCT00854100|26923768|P3|Overall Study|Inability to complete the study visits|1
7743657|NCT00854100|26923769|P2|Overall Study|Inability to complete the study visits|0
7743658|NCT00854100|26923770|P1|Overall Study|Inability to complete the study visits|0
7743659|NCT00853970|26923811|P2|Overall Study|Cancelled surgery|2
7743660|NCT00853970|26923812|P1|Overall Study|Cancelled surgery|4
7743661|NCT00853970|26923811|P2|Overall Study|Withdrawal by Subject|1
7743662|NCT00853970|26923812|P1|Overall Study|Withdrawal by Subject|2
7743663|NCT00853957|26923822|P2|Overall Study|Protocol deviation|3
7743664|NCT00853957|26923823|P1|Overall Study|Protocol deviation|0
7743665|NCT00853957|26923822|P2|Overall Study|Lost to Follow-up|6
7743666|NCT00853957|26923823|P1|Overall Study|Lost to Follow-up|1
7743667|NCT00853957|26923822|P2|Overall Study|Subject withdrew consent|5
7743668|NCT00853957|26923823|P1|Overall Study|Subject withdrew consent|4
7743669|NCT00853957|26923822|P2|Overall Study|Unsatisfactory therapeutic effect|2
7743670|NCT00853957|26923823|P1|Overall Study|Unsatisfactory therapeutic effect|0
7743671|NCT00853957|26923822|P2|Overall Study|Adverse Event|3
7743672|NCT00853957|26923823|P1|Overall Study|Adverse Event|9
7743673|NCT00853905|26923841|P2|Overall Study|never had surgery|0
7743674|NCT00853905|26923842|P1|Overall Study|never had surgery|1
7743675|NCT00853905|26923841|P2|Overall Study|Withdrawal by Subject|1
7743676|NCT00853905|26923842|P1|Overall Study|Withdrawal by Subject|0
7743677|NCT00853905|26923841|P2|Overall Study|Lost to Follow-up|3
7743678|NCT00853905|26923842|P1|Overall Study|Lost to Follow-up|1
7743679|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Death|6
7743680|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Death|1
7743681|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Administrative problems|56
7743682|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Administrative problems|45
7743683|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
7743684|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
7743685|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
7743686|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
7743687|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
7743688|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
7743689|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
7743690|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
7743691|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
7743692|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
7743693|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
7743694|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
7743695|NCT00853827|26923874|P2|Double Blind Period (103 Weeks)|Adverse Event|14
7743696|NCT00853827|26923875|P1|Double Blind Period (103 Weeks)|Adverse Event|25
7743697|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Protocol Violation|0
7743698|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Protocol Violation|12
7743699|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
7743700|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
7743701|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
7743702|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
7743703|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
7743704|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
7743705|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
7743706|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
7743707|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Adverse Event|0
7743708|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Adverse Event|9
7743709|NCT00853827|26923874|P2|Single Blind Period (1 Week)|Other|0
7743710|NCT00853827|26923875|P1|Single Blind Period (1 Week)|Other|4
7743711|NCT00853762|26923891|P4|Overall Study|Randomised but not Treated|0
7743712|NCT00853762|26923892|P3|Overall Study|Randomised but not Treated|2
7743713|NCT00853762|26923893|P2|Overall Study|Randomised but not Treated|2
7743714|NCT00853762|26923894|P1|Overall Study|Randomised but not Treated|0
7743715|NCT00853762|26923891|P4|Overall Study|Other|0
7743716|NCT00853762|26923892|P3|Overall Study|Other|0
7743717|NCT00853762|26923893|P2|Overall Study|Other|2
7743718|NCT00853762|26923894|P1|Overall Study|Other|0
7743719|NCT00853762|26923891|P4|Overall Study|Withdrawal by Subject|0
7743720|NCT00853762|26923892|P3|Overall Study|Withdrawal by Subject|1
7743721|NCT00853762|26923893|P2|Overall Study|Withdrawal by Subject|0
7743722|NCT00853762|26923894|P1|Overall Study|Withdrawal by Subject|0
7743723|NCT00853762|26923891|P4|Overall Study|Protocol Violation|1
7743724|NCT00853762|26923892|P3|Overall Study|Protocol Violation|0
7743725|NCT00853762|26923893|P2|Overall Study|Protocol Violation|0
7743726|NCT00853762|26923894|P1|Overall Study|Protocol Violation|0
7743727|NCT00853762|26923891|P4|Overall Study|Premature Termination|21
7743728|NCT00853762|26923892|P3|Overall Study|Premature Termination|14
7743729|NCT00853762|26923893|P2|Overall Study|Premature Termination|15
7743730|NCT00853762|26923894|P1|Overall Study|Premature Termination|16
7743731|NCT00853749|26923962|P2|Overall Study|Lost to Follow-up|1
7743732|NCT00853749|26923963|P1|Overall Study|Lost to Follow-up|0
7743733|NCT00853723|26923984|P3|Overall Study|Protocol Violation|1
7743734|NCT00853723|26923985|P2|Overall Study|Protocol Violation|2
7743735|NCT00853723|26923986|P1|Overall Study|Protocol Violation|1
7743736|NCT00853723|26923984|P3|Overall Study|Withdrawal by Subject|0
7743737|NCT00853723|26923985|P2|Overall Study|Withdrawal by Subject|1
7743738|NCT00853723|26923986|P1|Overall Study|Withdrawal by Subject|2
7743739|NCT00853723|26923984|P3|Overall Study|Adverse Event|1
7743740|NCT00853723|26923985|P2|Overall Study|Adverse Event|4
7743741|NCT00853723|26923986|P1|Overall Study|Adverse Event|3
7743742|NCT00853658|26924040|P3|Overall Study|Missing study completion information|6
7743743|NCT00853658|26924041|P2|Overall Study|Missing study completion information|4
7743744|NCT00853658|26924042|P1|Overall Study|Missing study completion information|5
7743745|NCT00853658|26924040|P3|Overall Study|Patient's request|11
7743746|NCT00853658|26924041|P2|Overall Study|Patient's request|17
7743747|NCT00853658|26924042|P1|Overall Study|Patient's request|21
7743748|NCT00853658|26924040|P3|Overall Study|Vital Status at study end N/A|10
7743749|NCT00853658|26924041|P2|Overall Study|Vital Status at study end N/A|10
7743750|NCT00853658|26924042|P1|Overall Study|Vital Status at study end N/A|8
7743751|NCT00853658|26924040|P3|Overall Study|Vital Status unknown at study end|0
7743752|NCT00853658|26924041|P2|Overall Study|Vital Status unknown at study end|1
7743753|NCT00853658|26924042|P1|Overall Study|Vital Status unknown at study end|1
7743754|NCT00853658|26924040|P3|Overall Study|Vital Status known (alive) at study end|3
7743755|NCT00853658|26924041|P2|Overall Study|Vital Status known (alive) at study end|3
7743756|NCT00853658|26924042|P1|Overall Study|Vital Status known (alive) at study end|2
7743757|NCT00853658|26924040|P3|Overall Study|IRB request|2
7743758|NCT00853658|26924041|P2|Overall Study|IRB request|0
7743759|NCT00853658|26924042|P1|Overall Study|IRB request|0
7743760|NCT00853658|26924040|P3|Overall Study|H.A. Request|19
7743761|NCT00853658|26924041|P2|Overall Study|H.A. Request|23
7743762|NCT00853658|26924042|P1|Overall Study|H.A. Request|26
7743763|NCT00853658|26924040|P3|Overall Study|Lost to Follow-up|11
7743764|NCT00853658|26924041|P2|Overall Study|Lost to Follow-up|6
7743765|NCT00853658|26924042|P1|Overall Study|Lost to Follow-up|11
7743766|NCT00853658|26924040|P3|Overall Study|Death|753
7743767|NCT00853658|26924041|P2|Overall Study|Death|768
7743768|NCT00853658|26924042|P1|Overall Study|Death|713
7743769|NCT00853593|26924066|P1|Overall Study|Implant not attempted|4
7743770|NCT00853593|26924066|P1|Overall Study|Model 4396 lead not attempted|29
7743771|NCT00853593|26924066|P1|Overall Study|Subjects did not receive a 4396 lead|12
7743772|NCT00853580|26924093|P2|Overall Study|Commenced contraindicated therapy|2
7743773|NCT00853580|26924094|P1|Overall Study|Commenced contraindicated therapy|0
7743774|NCT00853580|26924093|P2|Overall Study|Withdrawal by Subject|8
7743775|NCT00853580|26924094|P1|Overall Study|Withdrawal by Subject|2
7743776|NCT00853580|26924093|P2|Overall Study|Protocol Violation|1
7743777|NCT00853580|26924094|P1|Overall Study|Protocol Violation|2
7743778|NCT00853580|26924093|P2|Overall Study|Lost to Follow-up|5
7743779|NCT00853580|26924094|P1|Overall Study|Lost to Follow-up|3
7743780|NCT00853567|26924141|P1|Overall Study|Study prematurely terminated|71
7743781|NCT00853489|26924151|P2|Overall Study|Lost to Follow-up|2
7743782|NCT00853489|26924152|P1|Overall Study|Lost to Follow-up|5
7743783|NCT00853385|26924167|P5|Overall Study|Other|12
7743784|NCT00853385|26924168|P4|Overall Study|Other|4
7743785|NCT00853385|26924169|P3|Overall Study|Other|4
7743786|NCT00853385|26924170|P2|Overall Study|Other|9
7743787|NCT00853385|26924171|P1|Overall Study|Other|18
7743788|NCT00853385|26924167|P5|Overall Study|Withdrawal by Subject|1
7743789|NCT00853385|26924168|P4|Overall Study|Withdrawal by Subject|1
7743790|NCT00853385|26924169|P3|Overall Study|Withdrawal by Subject|0
7743791|NCT00853385|26924170|P2|Overall Study|Withdrawal by Subject|2
7743792|NCT00853385|26924171|P1|Overall Study|Withdrawal by Subject|4
7743793|NCT00853385|26924167|P5|Overall Study|Lost to Follow-up|0
7743794|NCT00853385|26924168|P4|Overall Study|Lost to Follow-up|0
7743795|NCT00853385|26924169|P3|Overall Study|Lost to Follow-up|0
7743796|NCT00853385|26924170|P2|Overall Study|Lost to Follow-up|1
7743797|NCT00853385|26924171|P1|Overall Study|Lost to Follow-up|2
7743798|NCT00853385|26924167|P5|Overall Study|Lack of Efficacy|6
7743799|NCT00853385|26924168|P4|Overall Study|Lack of Efficacy|3
7743800|NCT00853385|26924169|P3|Overall Study|Lack of Efficacy|3
7743801|NCT00853385|26924170|P2|Overall Study|Lack of Efficacy|7
7743802|NCT00853385|26924171|P1|Overall Study|Lack of Efficacy|6
7743803|NCT00853385|26924167|P5|Overall Study|Adverse Event|22
7743804|NCT00853385|26924168|P4|Overall Study|Adverse Event|5
7743805|NCT00853385|26924169|P3|Overall Study|Adverse Event|2
7743806|NCT00853385|26924170|P2|Overall Study|Adverse Event|24
7743807|NCT00853385|26924171|P1|Overall Study|Adverse Event|24
7743808|NCT00853385|26924167|P5|Overall Study|Death|1
7743809|NCT00853385|26924168|P4|Overall Study|Death|0
7743810|NCT00853385|26924169|P3|Overall Study|Death|0
7743811|NCT00853385|26924170|P2|Overall Study|Death|0
7743812|NCT00853385|26924171|P1|Overall Study|Death|0
7743813|NCT00853372|26924386|P2|Overall Study|Full Consent Withdrawn|1
7743814|NCT00853372|26924387|P1|Overall Study|Full Consent Withdrawn|1
7743815|NCT00853372|26924386|P2|Overall Study|Lost to Follow-up|2
7743816|NCT00853372|26924387|P1|Overall Study|Lost to Follow-up|1
7743817|NCT00853372|26924386|P2|Overall Study|Death|26
7743818|NCT00853372|26924387|P1|Overall Study|Death|30
7743819|NCT00853307|26924436|P2|Overall Study|Reason Not Specified|1
7743820|NCT00853307|26924437|P1|Overall Study|Reason Not Specified|0
7743821|NCT00853307|26924436|P2|Overall Study|Withdrawal by Subject|2
7743822|NCT00853307|26924437|P1|Overall Study|Withdrawal by Subject|1
7743823|NCT00853307|26924436|P2|Overall Study|Adverse Event|2
7743824|NCT00853307|26924437|P1|Overall Study|Adverse Event|1
7743825|NCT00853242|26924464|P7|Overall Study|Other|2
7743826|NCT00853242|26924465|P6|Overall Study|Other|1
7743827|NCT00853242|26924466|P5|Overall Study|Other|0
7743828|NCT00853242|26924467|P4|Overall Study|Other|0
7743829|NCT00853242|26924468|P3|Overall Study|Other|2
7743830|NCT00853242|26924469|P2|Overall Study|Other|0
7743831|NCT00853242|26924470|P1|Overall Study|Other|2
7743832|NCT00853242|26924464|P7|Overall Study|Withdrawal by Subject|2
7743833|NCT00853242|26924465|P6|Overall Study|Withdrawal by Subject|0
7743834|NCT00853242|26924466|P5|Overall Study|Withdrawal by Subject|0
7743835|NCT00853242|26924467|P4|Overall Study|Withdrawal by Subject|4
7743836|NCT00853242|26924468|P3|Overall Study|Withdrawal by Subject|0
7743837|NCT00853242|26924469|P2|Overall Study|Withdrawal by Subject|2
7743838|NCT00853242|26924470|P1|Overall Study|Withdrawal by Subject|1
7743839|NCT00853242|26924464|P7|Overall Study|Noncompliant|0
7743840|NCT00853242|26924465|P6|Overall Study|Noncompliant|0
7743841|NCT00853242|26924466|P5|Overall Study|Noncompliant|1
7743842|NCT00853242|26924467|P4|Overall Study|Noncompliant|0
7743843|NCT00853242|26924468|P3|Overall Study|Noncompliant|0
7743844|NCT00853242|26924469|P2|Overall Study|Noncompliant|0
7743845|NCT00853242|26924470|P1|Overall Study|Noncompliant|0
7743846|NCT00853242|26924464|P7|Overall Study|Adverse Event|1
7743847|NCT00853242|26924465|P6|Overall Study|Adverse Event|1
7743848|NCT00853242|26924466|P5|Overall Study|Adverse Event|3
7743849|NCT00853242|26924467|P4|Overall Study|Adverse Event|0
7743850|NCT00853242|26924468|P3|Overall Study|Adverse Event|1
7743851|NCT00853242|26924469|P2|Overall Study|Adverse Event|1
7743852|NCT00853242|26924470|P1|Overall Study|Adverse Event|0
7743853|NCT00853229|26924512|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
7743854|NCT00853229|26924513|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
7743855|NCT00853151|26924525|P4|Overall Study|Sponsor Decision|0
7743856|NCT00853151|26924526|P3|Overall Study|Sponsor Decision|0
7743857|NCT00853151|26924527|P2|Overall Study|Sponsor Decision|3
7743858|NCT00853151|26924528|P1|Overall Study|Sponsor Decision|0
7743859|NCT00853151|26924525|P4|Overall Study|Physician Decision|0
7743860|NCT00853151|26924526|P3|Overall Study|Physician Decision|1
7743861|NCT00853151|26924527|P2|Overall Study|Physician Decision|2
7743862|NCT00853151|26924528|P1|Overall Study|Physician Decision|0
7743863|NCT00853151|26924525|P4|Overall Study|Withdrawal by Subject|1
7743864|NCT00853151|26924526|P3|Overall Study|Withdrawal by Subject|2
7743865|NCT00853151|26924527|P2|Overall Study|Withdrawal by Subject|4
7743866|NCT00853151|26924528|P1|Overall Study|Withdrawal by Subject|5
7743867|NCT00853151|26924525|P4|Overall Study|Protocol Violation|1
7743868|NCT00853151|26924526|P3|Overall Study|Protocol Violation|0
7743869|NCT00853151|26924527|P2|Overall Study|Protocol Violation|0
7743870|NCT00853151|26924528|P1|Overall Study|Protocol Violation|0
7743871|NCT00853151|26924525|P4|Overall Study|Death|1
7743872|NCT00853151|26924526|P3|Overall Study|Death|0
7743873|NCT00853151|26924527|P2|Overall Study|Death|0
7743874|NCT00853151|26924528|P1|Overall Study|Death|1
7743875|NCT00853151|26924525|P4|Overall Study|Lost to Follow-up|0
7743876|NCT00853151|26924526|P3|Overall Study|Lost to Follow-up|3
7743877|NCT00853151|26924527|P2|Overall Study|Lost to Follow-up|0
7743878|NCT00853151|26924528|P1|Overall Study|Lost to Follow-up|2
7743879|NCT00853151|26924525|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7743880|NCT00853151|26924526|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7743881|NCT00853151|26924527|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7743882|NCT00853151|26924528|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7743883|NCT00853151|26924525|P4|Overall Study|Adverse Event|0
7743884|NCT00853151|26924526|P3|Overall Study|Adverse Event|2
7743885|NCT00853151|26924527|P2|Overall Study|Adverse Event|4
7743886|NCT00853151|26924528|P1|Overall Study|Adverse Event|1
7743887|NCT00853125|26924670|P1|Overall Study|Study participant's donor was CMV +|1
7743888|NCT00853112|26924682|P7|Overall Study|Randomized but not treated|1
7743889|NCT00853112|26924683|P6|Overall Study|Randomized but not treated|0
7743890|NCT00853112|26924684|P5|Overall Study|Randomized but not treated|0
7743891|NCT00853112|26924685|P4|Overall Study|Randomized but not treated|2
7743892|NCT00853112|26924686|P3|Overall Study|Randomized but not treated|0
7743893|NCT00853112|26924687|P2|Overall Study|Randomized but not treated|1
7743894|NCT00853112|26924688|P1|Overall Study|Randomized but not treated|0
7743895|NCT00853099|26924798|P4|Double-blind + Open-label Periods|Other|6
7743896|NCT00853099|26924799|P3|Double-blind + Open-label Periods|Other|0
7743897|NCT00853099|26924800|P2|Double-blind + Open-label Periods|Other|0
7743898|NCT00853099|26924801|P1|Double-blind + Open-label Periods|Other|0
7743899|NCT00853099|26924798|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
7743900|NCT00853099|26924799|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
7743901|NCT00853099|26924800|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
7743902|NCT00853099|26924801|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
7743903|NCT00853099|26924798|P4|Double-blind + Open-label Periods|Adverse Event|47
7743904|NCT00853099|26924799|P3|Double-blind + Open-label Periods|Adverse Event|0
7743905|NCT00853099|26924800|P2|Double-blind + Open-label Periods|Adverse Event|0
7743906|NCT00853099|26924801|P1|Double-blind + Open-label Periods|Adverse Event|0
7743907|NCT00853099|26924798|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
7743908|NCT00853099|26924799|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
7743909|NCT00853099|26924800|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
7743910|NCT00853099|26924801|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
7743911|NCT00853099|26924798|P4|Double-blind Period|Mistreated with rescue study drug|0
7743912|NCT00853099|26924799|P3|Double-blind Period|Mistreated with rescue study drug|1
7743913|NCT00853099|26924800|P2|Double-blind Period|Mistreated with rescue study drug|0
7743914|NCT00853099|26924801|P1|Double-blind Period|Mistreated with rescue study drug|0
7743915|NCT00853099|26924798|P4|Double-blind Period|Other|0
7743916|NCT00853099|26924799|P3|Double-blind Period|Other|1
7743917|NCT00853099|26924800|P2|Double-blind Period|Other|0
7743918|NCT00853099|26924801|P1|Double-blind Period|Other|0
7743919|NCT00853099|26924798|P4|Double-blind Period|Lack of Efficacy|0
7743920|NCT00853099|26924799|P3|Double-blind Period|Lack of Efficacy|16
7743921|NCT00853099|26924800|P2|Double-blind Period|Lack of Efficacy|17
7743922|NCT00853099|26924801|P1|Double-blind Period|Lack of Efficacy|14
7743923|NCT00853099|26924798|P4|Double-blind Period|Withdrawal by Subject|0
7743924|NCT00853099|26924799|P3|Double-blind Period|Withdrawal by Subject|0
7743925|NCT00853099|26924800|P2|Double-blind Period|Withdrawal by Subject|3
7743926|NCT00853099|26924801|P1|Double-blind Period|Withdrawal by Subject|2
7743927|NCT00853099|26924798|P4|Double-blind Period|Adverse Event|0
7743928|NCT00853099|26924799|P3|Double-blind Period|Adverse Event|13
7743929|NCT00853099|26924800|P2|Double-blind Period|Adverse Event|9
7743930|NCT00853099|26924801|P1|Double-blind Period|Adverse Event|7
7743931|NCT00853073|26924843|P2|Overall Study|Withdrawal by Subject|2
7743932|NCT00853073|26924844|P1|Overall Study|Withdrawal by Subject|3
7743933|NCT00853047|26924857|P6|Open-Label Extension Phase|Reason Not Specified|6
7743934|NCT00853047|26924858|P5|Open-Label Extension Phase|Reason Not Specified|0
7743935|NCT00853047|26924859|P4|Open-Label Extension Phase|Reason Not Specified|0
7743936|NCT00853047|26924860|P3|Open-Label Extension Phase|Reason Not Specified|0
7743937|NCT00853047|26924861|P2|Open-Label Extension Phase|Reason Not Specified|0
7743938|NCT00853047|26924862|P1|Open-Label Extension Phase|Reason Not Specified|0
7743939|NCT00853047|26924857|P6|Open-Label Extension Phase|Investigator Decision|1
7743940|NCT00853047|26924858|P5|Open-Label Extension Phase|Investigator Decision|0
7743941|NCT00853047|26924859|P4|Open-Label Extension Phase|Investigator Decision|0
7743942|NCT00853047|26924860|P3|Open-Label Extension Phase|Investigator Decision|0
7743943|NCT00853047|26924861|P2|Open-Label Extension Phase|Investigator Decision|0
7743944|NCT00853047|26924862|P1|Open-Label Extension Phase|Investigator Decision|0
7743945|NCT00853047|26924857|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
7743946|NCT00853047|26924858|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
7743947|NCT00853047|26924859|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
7743948|NCT00853047|26924860|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
7743949|NCT00853047|26924861|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
7743950|NCT00853047|26924862|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
7743951|NCT00853047|26924857|P6|Open-Label Extension Phase|Lost to Follow-up|1
7743952|NCT00853047|26924858|P5|Open-Label Extension Phase|Lost to Follow-up|0
7743953|NCT00853047|26924859|P4|Open-Label Extension Phase|Lost to Follow-up|0
7743954|NCT00853047|26924860|P3|Open-Label Extension Phase|Lost to Follow-up|0
7743955|NCT00853047|26924861|P2|Open-Label Extension Phase|Lost to Follow-up|0
7743956|NCT00853047|26924862|P1|Open-Label Extension Phase|Lost to Follow-up|0
7743957|NCT00853047|26924857|P6|Open-Label Extension Phase|Participant Request|7
7743958|NCT00853047|26924858|P5|Open-Label Extension Phase|Participant Request|0
7743959|NCT00853047|26924859|P4|Open-Label Extension Phase|Participant Request|0
7743960|NCT00853047|26924860|P3|Open-Label Extension Phase|Participant Request|0
7743961|NCT00853047|26924861|P2|Open-Label Extension Phase|Participant Request|0
7743962|NCT00853047|26924862|P1|Open-Label Extension Phase|Participant Request|0
7743963|NCT00853047|26924857|P6|Core Phase|Participant Request|0
7743964|NCT00853047|26924858|P5|Core Phase|Participant Request|0
7743965|NCT00853047|26924859|P4|Core Phase|Participant Request|1
7743966|NCT00853047|26924860|P3|Core Phase|Participant Request|0
7743967|NCT00853047|26924861|P2|Core Phase|Participant Request|0
7743968|NCT00853047|26924862|P1|Core Phase|Participant Request|0
7743969|NCT00853021|26924928|P1|Overall Study|Death|1
7743970|NCT00853021|26924928|P1|Overall Study|Withdrawal by Subject|2
7743971|NCT00853021|26924928|P1|Overall Study|Adverse Event|2
7743972|NCT00852995|26924940|P5|Overall Study|Moved Out of Area|0
7743973|NCT00852995|26924941|P4|Overall Study|Moved Out of Area|0
7743974|NCT00852995|26924942|P3|Overall Study|Moved Out of Area|0
7743975|NCT00852995|26924943|P2|Overall Study|Moved Out of Area|0
7743976|NCT00852995|26924944|P1|Overall Study|Moved Out of Area|1
7743977|NCT00852995|26924940|P5|Overall Study|Protocol Violation|1
7743978|NCT00852995|26924941|P4|Overall Study|Protocol Violation|0
7743979|NCT00852995|26924942|P3|Overall Study|Protocol Violation|0
7743980|NCT00852995|26924943|P2|Overall Study|Protocol Violation|0
7743981|NCT00852995|26924944|P1|Overall Study|Protocol Violation|0
7743982|NCT00852995|26924940|P5|Overall Study|Physician Decision|0
7743983|NCT00852995|26924941|P4|Overall Study|Physician Decision|0
7743984|NCT00852995|26924942|P3|Overall Study|Physician Decision|0
7743985|NCT00852995|26924943|P2|Overall Study|Physician Decision|0
7743986|NCT00852995|26924944|P1|Overall Study|Physician Decision|1
7743987|NCT00852995|26924940|P5|Overall Study|Progressive Disease|1
7743988|NCT00852995|26924941|P4|Overall Study|Progressive Disease|2
7743989|NCT00852995|26924942|P3|Overall Study|Progressive Disease|0
7743990|NCT00852995|26924943|P2|Overall Study|Progressive Disease|0
7743991|NCT00852995|26924944|P1|Overall Study|Progressive Disease|1
7743992|NCT00852995|26924940|P5|Overall Study|Non-Compliance|0
7743993|NCT00852995|26924941|P4|Overall Study|Non-Compliance|2
7743994|NCT00852995|26924942|P3|Overall Study|Non-Compliance|0
7743995|NCT00852995|26924943|P2|Overall Study|Non-Compliance|0
7743996|NCT00852995|26924944|P1|Overall Study|Non-Compliance|0
7743997|NCT00852995|26924940|P5|Overall Study|Withdrawal by Subject|2
7743998|NCT00852995|26924941|P4|Overall Study|Withdrawal by Subject|1
7743999|NCT00852995|26924942|P3|Overall Study|Withdrawal by Subject|0
7744000|NCT00852995|26924943|P2|Overall Study|Withdrawal by Subject|0
7744001|NCT00852995|26924944|P1|Overall Study|Withdrawal by Subject|4
7744002|NCT00852995|26924940|P5|Overall Study|Lost to Follow-up|0
7744003|NCT00852995|26924941|P4|Overall Study|Lost to Follow-up|0
7744004|NCT00852995|26924942|P3|Overall Study|Lost to Follow-up|1
7744005|NCT00852995|26924943|P2|Overall Study|Lost to Follow-up|1
7744006|NCT00852995|26924944|P1|Overall Study|Lost to Follow-up|0
7744007|NCT00852995|26924940|P5|Overall Study|Adverse Event|0
7744008|NCT00852995|26924941|P4|Overall Study|Adverse Event|0
7744009|NCT00852995|26924942|P3|Overall Study|Adverse Event|4
7744010|NCT00852995|26924943|P2|Overall Study|Adverse Event|0
7744011|NCT00852995|26924944|P1|Overall Study|Adverse Event|1
7744012|NCT00852969|26924988|P2|Overall Study|Lost to Follow-up|1
7744013|NCT00852969|26924989|P1|Overall Study|Lost to Follow-up|0
7744014|NCT00852969|26924988|P2|Overall Study|Adverse Event|1
7744015|NCT00852969|26924989|P1|Overall Study|Adverse Event|0
7744016|NCT00852930|26925000|P3|Overall Study|Physician Decision|1
7744017|NCT00852930|26925001|P2|Overall Study|Physician Decision|0
7744018|NCT00852930|26925002|P1|Overall Study|Physician Decision|0
7744019|NCT00852930|26925000|P3|Overall Study|Withdrawal by Subject|1
7744020|NCT00852930|26925001|P2|Overall Study|Withdrawal by Subject|1
7744021|NCT00852930|26925002|P1|Overall Study|Withdrawal by Subject|1
7744022|NCT00852917|26925023|P4|Overall Study|Death|1
7744023|NCT00852917|26925024|P3|Overall Study|Death|0
7744024|NCT00852917|26925025|P2|Overall Study|Death|0
7744025|NCT00852917|26925026|P1|Overall Study|Death|0
7744026|NCT00852917|26925023|P4|Overall Study|Physician Decision|19
7744027|NCT00852917|26925024|P3|Overall Study|Physician Decision|2
7744028|NCT00852917|26925025|P2|Overall Study|Physician Decision|7
7744029|NCT00852917|26925026|P1|Overall Study|Physician Decision|6
7744030|NCT00852917|26925023|P4|Overall Study|Withdrawal by Subject|9
7744031|NCT00852917|26925024|P3|Overall Study|Withdrawal by Subject|10
7744032|NCT00852917|26925025|P2|Overall Study|Withdrawal by Subject|8
7744033|NCT00852917|26925026|P1|Overall Study|Withdrawal by Subject|4
7744034|NCT00852917|26925023|P4|Overall Study|Lack of Efficacy|47
7744035|NCT00852917|26925024|P3|Overall Study|Lack of Efficacy|11
7744036|NCT00852917|26925025|P2|Overall Study|Lack of Efficacy|11
7744037|NCT00852917|26925026|P1|Overall Study|Lack of Efficacy|21
7744038|NCT00852917|26925023|P4|Overall Study|Adverse Event|17
7744039|NCT00852917|26925024|P3|Overall Study|Adverse Event|35
7744040|NCT00852917|26925025|P2|Overall Study|Adverse Event|20
7744041|NCT00852917|26925026|P1|Overall Study|Adverse Event|13
7744042|NCT00852540|26925154|P2|Overall Study|Did Not Receive Study Drug|3
7744043|NCT00852540|26925155|P1|Overall Study|Did Not Receive Study Drug|3
7744044|NCT00852540|26925154|P2|Overall Study|Withdrawal by Subject|1
7744045|NCT00852540|26925155|P1|Overall Study|Withdrawal by Subject|3
7744046|NCT00852540|26925154|P2|Overall Study|Investigator Discretion|3
7744047|NCT00852540|26925155|P1|Overall Study|Investigator Discretion|2
7744048|NCT00852540|26925154|P2|Overall Study|Lost to Follow-up|3
7744049|NCT00852540|26925155|P1|Overall Study|Lost to Follow-up|2
7744050|NCT00852540|26925154|P2|Overall Study|Protocol Violation|2
7744051|NCT00852540|26925155|P1|Overall Study|Protocol Violation|1
7744052|NCT00852540|26925154|P2|Overall Study|Lack of Efficacy|3
7744053|NCT00852540|26925155|P1|Overall Study|Lack of Efficacy|15
7744054|NCT00852540|26925154|P2|Overall Study|Adverse Event|3
7744055|NCT00852540|26925155|P1|Overall Study|Adverse Event|10
7744056|NCT00852475|26925189|P2|Overall Study|Lost to Follow-up|4
7744057|NCT00852475|26925190|P1|Overall Study|Lost to Follow-up|3
7744058|NCT00852397|26925201|P3|Overall Study|Protocol Violation|1
7744059|NCT00852397|26925202|P2|Overall Study|Protocol Violation|0
7744060|NCT00852397|26925203|P1|Overall Study|Protocol Violation|0
7744061|NCT00852397|26925201|P3|Overall Study|Difficulty in study site visit|0
7744062|NCT00852397|26925202|P2|Overall Study|Difficulty in study site visit|0
7744063|NCT00852397|26925203|P1|Overall Study|Difficulty in study site visit|1
7744064|NCT00852397|26925201|P3|Overall Study|Study terminated by sponsor|6
7744065|NCT00852397|26925202|P2|Overall Study|Study terminated by sponsor|1
7744066|NCT00852397|26925203|P1|Overall Study|Study terminated by sponsor|2
7744067|NCT00852397|26925201|P3|Overall Study|Withdrawal by Subject|2
7744068|NCT00852397|26925202|P2|Overall Study|Withdrawal by Subject|1
7744069|NCT00852397|26925203|P1|Overall Study|Withdrawal by Subject|4
7744070|NCT00852397|26925201|P3|Overall Study|Death|1
7744071|NCT00852397|26925202|P2|Overall Study|Death|0
7744072|NCT00852397|26925203|P1|Overall Study|Death|0
7744073|NCT00852397|26925201|P3|Overall Study|Adverse Event|4
7744074|NCT00852397|26925202|P2|Overall Study|Adverse Event|6
7744075|NCT00852397|26925203|P1|Overall Study|Adverse Event|4
7744076|NCT00852241|26925232|P1|Overall Study|Physician Decision|18
7744077|NCT00852202|26925239|P3|Overall Study|pregnancy,moving away and surgery|2
7744078|NCT00852202|26925240|P2|Overall Study|pregnancy,moving away and surgery|0
7744079|NCT00852202|26925241|P1|Overall Study|pregnancy,moving away and surgery|1
7744080|NCT00852202|26925239|P3|Overall Study|Lost to Follow-up|6
7744081|NCT00852202|26925240|P2|Overall Study|Lost to Follow-up|5
7744082|NCT00852202|26925241|P1|Overall Study|Lost to Follow-up|5
7744083|NCT00852202|26925239|P3|Overall Study|Withdrawal by Subject|2
7744084|NCT00852202|26925240|P2|Overall Study|Withdrawal by Subject|1
7744085|NCT00852202|26925241|P1|Overall Study|Withdrawal by Subject|3
7744086|NCT00852202|26925239|P3|Overall Study|Protocol Violation|7
7744087|NCT00852202|26925240|P2|Overall Study|Protocol Violation|2
7744088|NCT00852202|26925241|P1|Overall Study|Protocol Violation|2
7744089|NCT00852202|26925239|P3|Overall Study|Lack of Efficacy|2
7744090|NCT00852202|26925240|P2|Overall Study|Lack of Efficacy|1
7744091|NCT00852202|26925241|P1|Overall Study|Lack of Efficacy|4
7744092|NCT00852202|26925239|P3|Overall Study|Adverse Event|7
7744093|NCT00852202|26925240|P2|Overall Study|Adverse Event|3
7744094|NCT00852202|26925241|P1|Overall Study|Adverse Event|2
7744095|NCT00851903|26925283|P1|Overall Study|Withdrawal by Subject|2
7744096|NCT00851890|26925297|P4|Overall Study|Lost to Follow-up|1
7744097|NCT00851890|26925298|P3|Overall Study|Lost to Follow-up|0
7744098|NCT00851890|26925299|P2|Overall Study|Lost to Follow-up|1
7744099|NCT00851890|26925300|P1|Overall Study|Lost to Follow-up|0
7744100|NCT00851877|26925357|P3|Phase II|Withdrawal by Subject|3
7744101|NCT00851877|26925358|P2|Phase II|Withdrawal by Subject|0
7744102|NCT00851877|26925359|P1|Phase II|Withdrawal by Subject|0
7744103|NCT00851877|26925357|P3|Phase I-1|Death|0
7744104|NCT00851877|26925358|P2|Phase I-1|Death|0
7744105|NCT00851877|26925359|P1|Phase I-1|Death|1
7744106|NCT00851799|26925369|P3|Overall Study|Completed protocol due to pregnancy|1
7744107|NCT00851799|26925370|P2|Overall Study|Completed protocol due to pregnancy|0
7744108|NCT00851799|26925371|P1|Overall Study|Completed protocol due to pregnancy|0
7744109|NCT00851799|26925369|P3|Overall Study|Severe Debilitation|0
7744110|NCT00851799|26925370|P2|Overall Study|Severe Debilitation|1
7744111|NCT00851799|26925371|P1|Overall Study|Severe Debilitation|0
7744112|NCT00851799|26925369|P3|Overall Study|Withdrew consent prior study completion|1
7744113|NCT00851799|26925370|P2|Overall Study|Withdrew consent prior study completion|2
7744114|NCT00851799|26925371|P1|Overall Study|Withdrew consent prior study completion|1
7744115|NCT00851799|26925369|P3|Overall Study|Not willing to adhere to requirements|2
7744116|NCT00851799|26925370|P2|Overall Study|Not willing to adhere to requirements|2
7744117|NCT00851799|26925371|P1|Overall Study|Not willing to adhere to requirements|1
7744118|NCT00851799|26925369|P3|Overall Study|Not able to get to clinic|9
7744119|NCT00851799|26925370|P2|Overall Study|Not able to get to clinic|5
7744120|NCT00851799|26925371|P1|Overall Study|Not able to get to clinic|8
7744121|NCT00851799|26925369|P3|Overall Study|Lost to Follow-up|10
7744122|NCT00851799|26925370|P2|Overall Study|Lost to Follow-up|3
7744123|NCT00851799|26925371|P1|Overall Study|Lost to Follow-up|5
7744124|NCT00851799|26925369|P3|Overall Study|Death|1
7744125|NCT00851799|26925370|P2|Overall Study|Death|0
7744126|NCT00851799|26925371|P1|Overall Study|Death|1
7744127|NCT00851786|26925459|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
7744128|NCT00851786|26925460|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
7744129|NCT00851786|26925459|P2|Overall Study|Site Closure|0
7744130|NCT00851786|26925460|P1|Overall Study|Site Closure|1
7744131|NCT00851786|26925459|P2|Overall Study|Incarceration|0
7744132|NCT00851786|26925460|P1|Overall Study|Incarceration|1
7744133|NCT00851786|26925459|P2|Overall Study|Lost to Follow-up|0
7744134|NCT00851786|26925460|P1|Overall Study|Lost to Follow-up|1
7744135|NCT00851786|26925459|P2|Overall Study|Protocol Violation|1
7744136|NCT00851786|26925460|P1|Overall Study|Protocol Violation|0
7744137|NCT00851786|26925459|P2|Overall Study|Withdrawal by Subject|1
7744138|NCT00851786|26925460|P1|Overall Study|Withdrawal by Subject|0
7744139|NCT00851747|26925473|P3|Overall Study|Physician Decision|6
7744140|NCT00851747|26925474|P2|Overall Study|Physician Decision|6
7744141|NCT00851747|26925475|P1|Overall Study|Physician Decision|6
7744142|NCT00851721|26925484|P2|Overall Study|Adverse Event|1
7744143|NCT00851721|26925485|P1|Overall Study|Adverse Event|0
7744144|NCT00851721|26925484|P2|Overall Study|Death|0
7744145|NCT00851721|26925485|P1|Overall Study|Death|1
7744146|NCT00851721|26925484|P2|Overall Study|planned surgery|0
7744147|NCT00851721|26925485|P1|Overall Study|planned surgery|1
7744148|NCT00851682|26925575|P2|Overall Study|screen failure|0
7744149|NCT00851682|26925576|P1|Overall Study|screen failure|5
7744150|NCT00851643|26925590|P6|Extension Study (Up to 36 Months)|Moved|1
7744151|NCT00851643|26925591|P5|Extension Study (Up to 36 Months)|Moved|0
7744152|NCT00851643|26925592|P4|Extension Study (Up to 36 Months)|Moved|1
7744153|NCT00851643|26925593|P3|Extension Study (Up to 36 Months)|Moved|1
7744154|NCT00851643|26925594|P2|Extension Study (Up to 36 Months)|Moved|2
7744155|NCT00851643|26925595|P1|Extension Study (Up to 36 Months)|Moved|0
7744156|NCT00851643|26925590|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
7744157|NCT00851643|26925591|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
7744158|NCT00851643|26925592|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
7744159|NCT00851643|26925593|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
7744160|NCT00851643|26925594|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
7744161|NCT00851643|26925595|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
7744162|NCT00851643|26925590|P6|Base Study (Up to 12 Months)|Other|1
7744163|NCT00851643|26925591|P5|Base Study (Up to 12 Months)|Other|0
7744164|NCT00851643|26925592|P4|Base Study (Up to 12 Months)|Other|0
7744165|NCT00851643|26925593|P3|Base Study (Up to 12 Months)|Other|0
7744166|NCT00851643|26925594|P2|Base Study (Up to 12 Months)|Other|0
7744167|NCT00851643|26925595|P1|Base Study (Up to 12 Months)|Other|0
7744168|NCT00851643|26925590|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7744169|NCT00851643|26925591|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7744170|NCT00851643|26925592|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7744171|NCT00851643|26925593|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7744172|NCT00851643|26925594|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7744173|NCT00851643|26925595|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
7744174|NCT00851630|26925616|P2|Overall Study|Clinical failure|1
7744175|NCT00851630|26925617|P1|Overall Study|Clinical failure|0
7744176|NCT00851630|26925616|P2|Overall Study|Death|1
7744177|NCT00851630|26925617|P1|Overall Study|Death|2
7744178|NCT00851591|26925631|P2|Overall Study|Withdrawal by Subject|0
7744179|NCT00851591|26925632|P1|Overall Study|Withdrawal by Subject|2
7744180|NCT00851552|26925638|P1|Overall Study|Disease Progression|4
7744181|NCT00851552|26925638|P1|Overall Study|Adverse Event|1
7744182|NCT00851552|26925638|P1|Overall Study|Death|2
7744183|NCT00851318|26925668|P4|Overall Study|Physician Decision|1
7744184|NCT00851318|26925669|P3|Overall Study|Physician Decision|1
7744185|NCT00851318|26925670|P2|Overall Study|Physician Decision|0
7744186|NCT00851318|26925671|P1|Overall Study|Physician Decision|0
7744187|NCT00851318|26925668|P4|Overall Study|Non-compliance with Study Procedures|0
7744188|NCT00851318|26925669|P3|Overall Study|Non-compliance with Study Procedures|1
7744189|NCT00851318|26925670|P2|Overall Study|Non-compliance with Study Procedures|0
7744190|NCT00851318|26925671|P1|Overall Study|Non-compliance with Study Procedures|2
7744191|NCT00851318|26925668|P4|Overall Study|Lack of Efficacy|2
7744192|NCT00851318|26925669|P3|Overall Study|Lack of Efficacy|4
7744193|NCT00851318|26925670|P2|Overall Study|Lack of Efficacy|2
7744194|NCT00851318|26925671|P1|Overall Study|Lack of Efficacy|8
7744195|NCT00851318|26925668|P4|Overall Study|Pregnancy|1
7744196|NCT00851318|26925669|P3|Overall Study|Pregnancy|1
7744197|NCT00851318|26925670|P2|Overall Study|Pregnancy|0
7744198|NCT00851318|26925671|P1|Overall Study|Pregnancy|0
7744199|NCT00851318|26925668|P4|Overall Study|Adverse Event|12
7744200|NCT00851318|26925669|P3|Overall Study|Adverse Event|9
7744201|NCT00851318|26925670|P2|Overall Study|Adverse Event|2
7744202|NCT00851318|26925671|P1|Overall Study|Adverse Event|13
7744203|NCT00851318|26925668|P4|Overall Study|Withdrawal by Subject|3
7744204|NCT00851318|26925669|P3|Overall Study|Withdrawal by Subject|5
7744205|NCT00851318|26925670|P2|Overall Study|Withdrawal by Subject|1
7744206|NCT00851318|26925671|P1|Overall Study|Withdrawal by Subject|7
7744207|NCT00851253|26925707|P2|Overall Study|Disease Progression|0
7744208|NCT00851253|26925708|P1|Overall Study|Disease Progression|1
7744209|NCT00851084|26925718|P2|Overall Study|Other|1
7744210|NCT00851084|26925719|P1|Overall Study|Other|7
7744211|NCT00851084|26925718|P2|Overall Study|Metastatic surgery|6
7744212|NCT00851084|26925719|P1|Overall Study|Metastatic surgery|6
7744213|NCT00851084|26925718|P2|Overall Study|Withdrawal by Subject|12
7744214|NCT00851084|26925719|P1|Overall Study|Withdrawal by Subject|11
7744215|NCT00851084|26925718|P2|Overall Study|Consent withdrawn|2
7744216|NCT00851084|26925719|P1|Overall Study|Consent withdrawn|0
7744217|NCT00851084|26925718|P2|Overall Study|Physician Decision|14
7744218|NCT00851084|26925719|P1|Overall Study|Physician Decision|13
7744219|NCT00851084|26925718|P2|Overall Study|Poor compliance to protocol|1
7744220|NCT00851084|26925719|P1|Overall Study|Poor compliance to protocol|1
7744221|NCT00851084|26925718|P2|Overall Study|Disease progression|47
7744222|NCT00851084|26925719|P1|Overall Study|Disease progression|52
7744223|NCT00851084|26925718|P2|Overall Study|Adverse Event|36
7744224|NCT00851084|26925719|P1|Overall Study|Adverse Event|26
7744225|NCT00851084|26925718|P2|Overall Study|Randomized but not treated|0
7744226|NCT00851084|26925719|P1|Overall Study|Randomized but not treated|1
7744227|NCT00850993|26925747|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
7744228|NCT00850993|26925748|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7744229|NCT00850993|26925749|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7744230|NCT00850993|26925750|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
7744231|NCT00850759|26925779|P4|Overall Study|Lost to Follow-up|3
7744232|NCT00850759|26925780|P3|Overall Study|Lost to Follow-up|5
7744233|NCT00850759|26925781|P2|Overall Study|Lost to Follow-up|5
7744234|NCT00850759|26925782|P1|Overall Study|Lost to Follow-up|7
7744235|NCT00850564|26925863|P1|Overall Study|Withdrawal by Subject|2
7744236|NCT00850538|26925868|P1|Overall Study|Protocol Violation|2
7744237|NCT00850538|26925868|P1|Overall Study|radiology error|2
7744238|NCT00850538|26925868|P1|Overall Study|Withdrawal by Subject|3
7744239|NCT00850538|26925868|P1|Overall Study|specimen unusable|7
7744240|NCT00850538|26925868|P1|Overall Study|specimen missed due to scheduling error|14
7744241|NCT00850538|26925868|P1|Overall Study|unable/unwilling to complete MRI|13
7744242|NCT00850499|26925874|P2|Overall Study|Lack of Efficacy|1
7744243|NCT00850499|26925875|P1|Overall Study|Lack of Efficacy|0
7744244|NCT00850499|26925874|P2|Overall Study|Adverse Event|1
7744245|NCT00850499|26925875|P1|Overall Study|Adverse Event|3
7744246|NCT00850460|26925889|P2|Overall Study|Lost to Follow-up|4
7744247|NCT00850460|26925890|P1|Overall Study|Lost to Follow-up|4
7744248|NCT00850395|26925904|P1|Overall Study|Other|5
7744249|NCT00850395|26925904|P1|Overall Study|Insufficient clinical response|3
7744250|NCT00850395|26925904|P1|Overall Study|Adverse Event|1
7744251|NCT00850395|26925904|P1|Overall Study|Death|1
7744252|NCT00850343|26925924|P4|Overall Study|Physician Decision|1
7744253|NCT00850343|26925925|P3|Overall Study|Physician Decision|1
7744254|NCT00850343|26925926|P2|Overall Study|Physician Decision|1
7744255|NCT00850343|26925927|P1|Overall Study|Physician Decision|2
7744256|NCT00850343|26925924|P4|Overall Study|Non-compliance with Study Procedures|1
7744257|NCT00850343|26925925|P3|Overall Study|Non-compliance with Study Procedures|1
7744258|NCT00850343|26925926|P2|Overall Study|Non-compliance with Study Procedures|0
7744259|NCT00850343|26925927|P1|Overall Study|Non-compliance with Study Procedures|1
7744260|NCT00850343|26925924|P4|Overall Study|Lack of Efficacy|2
7744261|NCT00850343|26925925|P3|Overall Study|Lack of Efficacy|3
7744262|NCT00850343|26925926|P2|Overall Study|Lack of Efficacy|0
7744263|NCT00850343|26925927|P1|Overall Study|Lack of Efficacy|17
7744264|NCT00850343|26925924|P4|Overall Study|Pregnancy|1
7744265|NCT00850343|26925925|P3|Overall Study|Pregnancy|0
7744266|NCT00850343|26925926|P2|Overall Study|Pregnancy|0
7744267|NCT00850343|26925927|P1|Overall Study|Pregnancy|0
7744268|NCT00850343|26925924|P4|Overall Study|Adverse Event|6
7744269|NCT00850343|26925925|P3|Overall Study|Adverse Event|6
7744270|NCT00850343|26925926|P2|Overall Study|Adverse Event|2
7744271|NCT00850343|26925927|P1|Overall Study|Adverse Event|15
7744272|NCT00850343|26925924|P4|Overall Study|Withdrawal by Subject|2
7744273|NCT00850343|26925925|P3|Overall Study|Withdrawal by Subject|3
7744274|NCT00850343|26925926|P2|Overall Study|Withdrawal by Subject|0
7744275|NCT00850343|26925927|P1|Overall Study|Withdrawal by Subject|11
7744276|NCT00850200|26925957|P1|Overall Study|Withdrawal by Subject|1
7744277|NCT00850200|26925957|P1|Overall Study|Did not recieve treatment|2
7744278|NCT00850200|26925957|P1|Overall Study|Physician Decision|2
7744279|NCT00850174|26925967|P2|Second Intervention|Withdrawal by Subject|0
7744280|NCT00850174|26925968|P1|Second Intervention|Withdrawal by Subject|1
7744281|NCT00850174|26925967|P2|Washout: One Week|Withdrawal by Subject|2
7744282|NCT00850174|26925968|P1|Washout: One Week|Withdrawal by Subject|0
7744283|NCT00850135|26925982|P1|Overall Study|Physician Decision|1
7744284|NCT00850070|26926001|P2|Overall Study|Adverse Event|0
7744285|NCT00850070|26926002|P1|Overall Study|Adverse Event|2
7744286|NCT00850070|26926001|P2|Overall Study|Lack of Efficacy|1
7744287|NCT00850070|26926002|P1|Overall Study|Lack of Efficacy|1
7744288|NCT00849940|26926031|P1|Overall Study|Physician Decision|4
7744289|NCT00849901|26926042|P3|Extension Phase|Lack of Efficacy|1
7744290|NCT00849901|26926043|P2|Extension Phase|Lack of Efficacy|4
7744291|NCT00849901|26926044|P1|Extension Phase|Lack of Efficacy|2
7744292|NCT00849901|26926042|P3|Extension Phase|Physician Decision|0
7744293|NCT00849901|26926043|P2|Extension Phase|Physician Decision|2
7744294|NCT00849901|26926044|P1|Extension Phase|Physician Decision|1
7744295|NCT00849901|26926042|P3|Extension Phase|Parent or Caregiver Decision|4
7744296|NCT00849901|26926043|P2|Extension Phase|Parent or Caregiver Decision|4
7744297|NCT00849901|26926044|P1|Extension Phase|Parent or Caregiver Decision|10
7744298|NCT00849901|26926042|P3|Extension Phase|Withdrawal by Subject|3
7744299|NCT00849901|26926043|P2|Extension Phase|Withdrawal by Subject|6
7744300|NCT00849901|26926044|P1|Extension Phase|Withdrawal by Subject|7
7744301|NCT00849901|26926042|P3|Extension Phase|Protocol Violation|4
7744302|NCT00849901|26926043|P2|Extension Phase|Protocol Violation|2
7744303|NCT00849901|26926044|P1|Extension Phase|Protocol Violation|2
7744304|NCT00849901|26926042|P3|Extension Phase|Lost to Follow-up|1
7744305|NCT00849901|26926043|P2|Extension Phase|Lost to Follow-up|0
7744306|NCT00849901|26926044|P1|Extension Phase|Lost to Follow-up|3
7744307|NCT00849901|26926042|P3|Extension Phase|Adverse Event|4
7744308|NCT00849901|26926043|P2|Extension Phase|Adverse Event|8
7744309|NCT00849901|26926044|P1|Extension Phase|Adverse Event|2
7744310|NCT00849901|26926042|P3|Acute Treatment Phase|Lack of Efficacy|2
7744311|NCT00849901|26926043|P2|Acute Treatment Phase|Lack of Efficacy|3
7744312|NCT00849901|26926044|P1|Acute Treatment Phase|Lack of Efficacy|2
7744313|NCT00849901|26926042|P3|Acute Treatment Phase|Sponsor Decision|0
7744314|NCT00849901|26926043|P2|Acute Treatment Phase|Sponsor Decision|0
7744315|NCT00849901|26926044|P1|Acute Treatment Phase|Sponsor Decision|1
7744316|NCT00849901|26926042|P3|Acute Treatment Phase|Physician Decision|1
7744317|NCT00849901|26926043|P2|Acute Treatment Phase|Physician Decision|1
7744318|NCT00849901|26926044|P1|Acute Treatment Phase|Physician Decision|1
7744319|NCT00849901|26926042|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
7744320|NCT00849901|26926043|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
7744321|NCT00849901|26926044|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
7744322|NCT00849901|26926042|P3|Acute Treatment Phase|Withdrawal by Subject|4
7744323|NCT00849901|26926043|P2|Acute Treatment Phase|Withdrawal by Subject|10
7744324|NCT00849901|26926044|P1|Acute Treatment Phase|Withdrawal by Subject|4
7744325|NCT00849901|26926042|P3|Acute Treatment Phase|Protocol Violation|1
7744326|NCT00849901|26926043|P2|Acute Treatment Phase|Protocol Violation|2
7744327|NCT00849901|26926044|P1|Acute Treatment Phase|Protocol Violation|0
7744328|NCT00849901|26926042|P3|Acute Treatment Phase|Lost to Follow-up|1
7744329|NCT00849901|26926043|P2|Acute Treatment Phase|Lost to Follow-up|4
7744330|NCT00849901|26926044|P1|Acute Treatment Phase|Lost to Follow-up|2
7744331|NCT00849901|26926042|P3|Acute Treatment Phase|Adverse Event|3
7744332|NCT00849901|26926043|P2|Acute Treatment Phase|Adverse Event|1
7744333|NCT00849901|26926044|P1|Acute Treatment Phase|Adverse Event|9
7744334|NCT00849875|26926091|P1|Overall Study|Lost to Follow-up|2
7744335|NCT00849875|26926091|P1|Overall Study|Others|6
7744336|NCT00849875|26926091|P1|Overall Study|Ongoing (unknown completion status)|11
7744337|NCT00849875|26926091|P1|Overall Study|Death|28
7744338|NCT00849797|26926188|P2|Washout: One Week|Withdrawal by Subject|2
7744339|NCT00849797|26926189|P1|Washout: One Week|Withdrawal by Subject|0
7744340|NCT00849797|26926188|P2|First Intervention|Adverse Event|1
7744341|NCT00849797|26926189|P1|First Intervention|Adverse Event|0
7744342|NCT00849797|26926188|P2|First Intervention|bad veins|0
7744343|NCT00849797|26926189|P1|First Intervention|bad veins|1
7744344|NCT00849693|26926207|P4|Extension Phase|Lack of Efficacy|1
7744345|NCT00849693|26926208|P3|Extension Phase|Lack of Efficacy|2
7744346|NCT00849693|26926209|P2|Extension Phase|Lack of Efficacy|2
7744347|NCT00849693|26926210|P1|Extension Phase|Lack of Efficacy|2
7744348|NCT00849693|26926207|P4|Extension Phase|Sponsor decision|1
7744349|NCT00849693|26926208|P3|Extension Phase|Sponsor decision|0
7744350|NCT00849693|26926209|P2|Extension Phase|Sponsor decision|0
7744351|NCT00849693|26926210|P1|Extension Phase|Sponsor decision|1
7744352|NCT00849693|26926207|P4|Extension Phase|Physician Decision|0
7744353|NCT00849693|26926208|P3|Extension Phase|Physician Decision|2
7744354|NCT00849693|26926209|P2|Extension Phase|Physician Decision|1
7744355|NCT00849693|26926210|P1|Extension Phase|Physician Decision|1
7744356|NCT00849693|26926207|P4|Extension Phase|Parent or caregiver decision|5
7744357|NCT00849693|26926208|P3|Extension Phase|Parent or caregiver decision|10
7744358|NCT00849693|26926209|P2|Extension Phase|Parent or caregiver decision|4
7744359|NCT00849693|26926210|P1|Extension Phase|Parent or caregiver decision|9
7744360|NCT00849693|26926207|P4|Extension Phase|Withdrawal by Subject|15
7744361|NCT00849693|26926208|P3|Extension Phase|Withdrawal by Subject|10
7744362|NCT00849693|26926209|P2|Extension Phase|Withdrawal by Subject|9
7744363|NCT00849693|26926210|P1|Extension Phase|Withdrawal by Subject|6
7744364|NCT00849693|26926207|P4|Extension Phase|Protocol Violation|3
7744365|NCT00849693|26926208|P3|Extension Phase|Protocol Violation|2
7744366|NCT00849693|26926209|P2|Extension Phase|Protocol Violation|3
7744367|NCT00849693|26926210|P1|Extension Phase|Protocol Violation|0
7744368|NCT00849693|26926207|P4|Extension Phase|Lost to Follow-up|6
7744369|NCT00849693|26926208|P3|Extension Phase|Lost to Follow-up|6
7744370|NCT00849693|26926209|P2|Extension Phase|Lost to Follow-up|5
7744371|NCT00849693|26926210|P1|Extension Phase|Lost to Follow-up|7
7744372|NCT00849693|26926207|P4|Extension Phase|Adverse Event|7
7744373|NCT00849693|26926208|P3|Extension Phase|Adverse Event|3
7744374|NCT00849693|26926209|P2|Extension Phase|Adverse Event|6
7744375|NCT00849693|26926210|P1|Extension Phase|Adverse Event|4
7744376|NCT00849693|26926207|P4|Acute Treatment Phase|Lack of Efficacy|2
7744377|NCT00849693|26926208|P3|Acute Treatment Phase|Lack of Efficacy|1
7744378|NCT00849693|26926209|P2|Acute Treatment Phase|Lack of Efficacy|3
7744379|NCT00849693|26926210|P1|Acute Treatment Phase|Lack of Efficacy|1
7744380|NCT00849693|26926207|P4|Acute Treatment Phase|Sponsor decision|0
7744381|NCT00849693|26926208|P3|Acute Treatment Phase|Sponsor decision|1
7744382|NCT00849693|26926209|P2|Acute Treatment Phase|Sponsor decision|0
7744383|NCT00849693|26926210|P1|Acute Treatment Phase|Sponsor decision|0
7744384|NCT00849693|26926207|P4|Acute Treatment Phase|Physician Decision|1
7744385|NCT00849693|26926208|P3|Acute Treatment Phase|Physician Decision|2
7744386|NCT00849693|26926209|P2|Acute Treatment Phase|Physician Decision|1
7744387|NCT00849693|26926210|P1|Acute Treatment Phase|Physician Decision|2
7744388|NCT00849693|26926207|P4|Acute Treatment Phase|Parent or caregiver decision|7
7744389|NCT00849693|26926208|P3|Acute Treatment Phase|Parent or caregiver decision|7
7744390|NCT00849693|26926209|P2|Acute Treatment Phase|Parent or caregiver decision|6
7744391|NCT00849693|26926210|P1|Acute Treatment Phase|Parent or caregiver decision|7
7744392|NCT00849693|26926207|P4|Acute Treatment Phase|Withdrawal by Subject|8
7744393|NCT00849693|26926208|P3|Acute Treatment Phase|Withdrawal by Subject|3
7744394|NCT00849693|26926209|P2|Acute Treatment Phase|Withdrawal by Subject|5
7744395|NCT00849693|26926210|P1|Acute Treatment Phase|Withdrawal by Subject|5
7744396|NCT00849693|26926207|P4|Acute Treatment Phase|Protocol Violation|6
7744397|NCT00849693|26926208|P3|Acute Treatment Phase|Protocol Violation|2
7744398|NCT00849693|26926209|P2|Acute Treatment Phase|Protocol Violation|5
7744399|NCT00849693|26926210|P1|Acute Treatment Phase|Protocol Violation|1
7744400|NCT00849693|26926207|P4|Acute Treatment Phase|Lost to Follow-up|9
7744401|NCT00849693|26926208|P3|Acute Treatment Phase|Lost to Follow-up|11
7744402|NCT00849693|26926209|P2|Acute Treatment Phase|Lost to Follow-up|8
7744403|NCT00849693|26926210|P1|Acute Treatment Phase|Lost to Follow-up|5
7744404|NCT00849693|26926207|P4|Acute Treatment Phase|Adverse Event|4
7744405|NCT00849693|26926208|P3|Acute Treatment Phase|Adverse Event|6
7744406|NCT00849693|26926209|P2|Acute Treatment Phase|Adverse Event|7
7744407|NCT00849693|26926210|P1|Acute Treatment Phase|Adverse Event|12
7744408|NCT00849680|26926277|P8|Overall Study|Subject unable to comply with protocol|0
7744409|NCT00849680|26926278|P7|Overall Study|Subject unable to comply with protocol|0
7744410|NCT00849680|26926279|P6|Overall Study|Subject unable to comply with protocol|0
7744411|NCT00849680|26926280|P5|Overall Study|Subject unable to comply with protocol|0
7744412|NCT00849680|26926281|P4|Overall Study|Subject unable to comply with protocol|0
7744413|NCT00849680|26926282|P3|Overall Study|Subject unable to comply with protocol|0
7744414|NCT00849680|26926283|P2|Overall Study|Subject unable to comply with protocol|0
7744415|NCT00849680|26926284|P1|Overall Study|Subject unable to comply with protocol|1
7744416|NCT00849680|26926277|P8|Overall Study|Withdrawal by Subject|1
7744417|NCT00849680|26926278|P7|Overall Study|Withdrawal by Subject|1
7744418|NCT00849680|26926279|P6|Overall Study|Withdrawal by Subject|2
7744419|NCT00849680|26926280|P5|Overall Study|Withdrawal by Subject|2
7744420|NCT00849680|26926281|P4|Overall Study|Withdrawal by Subject|2
7744421|NCT00849680|26926282|P3|Overall Study|Withdrawal by Subject|0
7744422|NCT00849680|26926283|P2|Overall Study|Withdrawal by Subject|0
7744423|NCT00849680|26926284|P1|Overall Study|Withdrawal by Subject|2
7744424|NCT00849680|26926277|P8|Overall Study|Subject moved|2
7744425|NCT00849680|26926278|P7|Overall Study|Subject moved|2
7744426|NCT00849680|26926279|P6|Overall Study|Subject moved|2
7744427|NCT00849680|26926280|P5|Overall Study|Subject moved|0
7744428|NCT00849680|26926281|P4|Overall Study|Subject moved|1
7744429|NCT00849680|26926282|P3|Overall Study|Subject moved|3
7744430|NCT00849680|26926283|P2|Overall Study|Subject moved|0
7744431|NCT00849680|26926284|P1|Overall Study|Subject moved|1
7744432|NCT00849680|26926277|P8|Overall Study|Lost to Follow-up|5
7744433|NCT00849680|26926278|P7|Overall Study|Lost to Follow-up|12
7744434|NCT00849680|26926279|P6|Overall Study|Lost to Follow-up|11
7744435|NCT00849680|26926280|P5|Overall Study|Lost to Follow-up|8
7744436|NCT00849680|26926281|P4|Overall Study|Lost to Follow-up|11
7744437|NCT00849680|26926282|P3|Overall Study|Lost to Follow-up|12
7744438|NCT00849680|26926283|P2|Overall Study|Lost to Follow-up|3
7744439|NCT00849680|26926284|P1|Overall Study|Lost to Follow-up|7
7744440|NCT00849680|26926277|P8|Overall Study|Adverse Event|0
7744441|NCT00849680|26926278|P7|Overall Study|Adverse Event|2
7744442|NCT00849680|26926279|P6|Overall Study|Adverse Event|0
7744443|NCT00849680|26926280|P5|Overall Study|Adverse Event|0
7744444|NCT00849680|26926281|P4|Overall Study|Adverse Event|0
7744445|NCT00849680|26926282|P3|Overall Study|Adverse Event|0
7744446|NCT00849680|26926283|P2|Overall Study|Adverse Event|0
7744447|NCT00849680|26926284|P1|Overall Study|Adverse Event|0
7744448|NCT00849524|26926326|P1|Overall Study|Lack of Efficacy|3
7744449|NCT00849472|26926343|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
7744450|NCT00849472|26926343|P1|Pazopanib Postsurgery Treatment|Moved|1
7744451|NCT00849472|26926343|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
7744452|NCT00849472|26926343|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
7744453|NCT00849472|26926343|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
7744454|NCT00849472|26926343|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
7744455|NCT00849472|26926343|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
7744456|NCT00849472|26926343|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
7744457|NCT00849472|26926343|P1|Weekly Paclitaxel|Physician Decision|3
7744458|NCT00849472|26926343|P1|Weekly Paclitaxel|Withdrawal by Subject|1
7744459|NCT00849472|26926343|P1|Weekly Paclitaxel|Adverse Event|11
7744460|NCT00849472|26926343|P1|Weekly Paclitaxel|Disease Progression|1
7744461|NCT00849472|26926343|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
7744462|NCT00849472|26926343|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
7744463|NCT00849472|26926343|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
7744464|NCT00849472|26926343|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
7744465|NCT00849472|26926343|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
7744466|NCT00849381|26926357|P1|Overall Study|Other|4
7744467|NCT00849381|26926357|P1|Overall Study|Withdrawal by Subject|6
7744468|NCT00849381|26926357|P1|Overall Study|Protocol Violation|5
7744469|NCT00849381|26926357|P1|Overall Study|Lost to Follow-up|129
7744470|NCT00849381|26926357|P1|Overall Study|Adverse Event|1
7744471|NCT00849290|26926363|P1|Overall Study|Disease Progression|20
7744472|NCT00849290|26926363|P1|Overall Study|Protocol Violation|5
7744473|NCT00849290|26926363|P1|Overall Study|Lost to Follow-up|2
7744474|NCT00849290|26926363|P1|Overall Study|Withdrawal by Subject|11
7744475|NCT00849290|26926363|P1|Overall Study|Death|14
7744476|NCT00849290|26926363|P1|Overall Study|Adverse Event|3
7744477|NCT00849212|26926374|P1|Overall Study|Miscellaneous|1
7744478|NCT00849212|26926374|P1|Overall Study|Adverse Event|2
7744479|NCT00849212|26926374|P1|Overall Study|Withdrawal by Subject|3
7744480|NCT00849212|26926374|P1|Overall Study|Lack of Efficacy|1
7744481|NCT00849186|26926379|P1|Overall Study|Other|1
7744482|NCT00849186|26926379|P1|Overall Study|not treated|6
7744483|NCT00849186|26926379|P1|Overall Study|Withdrawal by Subject|1
7744484|NCT00849186|26926379|P1|Overall Study|Adverse Event|2
7744485|NCT00849147|26926385|P1|Overall Study|Disease Relapse/Progression|2
7744486|NCT00849147|26926385|P1|Overall Study|Protocol Violation|2
7744487|NCT00849147|26926385|P1|Overall Study|Withdrawal by Subject|1
7744488|NCT00849108|26926418|P2|Cohort 2 Efficacy|Other|9
7744489|NCT00849108|26926419|P1|Cohort 2 Efficacy|Other|0
7744490|NCT00849108|26926418|P2|Cohort 2 Efficacy|Adverse Event|1
7744491|NCT00849108|26926419|P1|Cohort 2 Efficacy|Adverse Event|0
7744492|NCT00849108|26926418|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
7744493|NCT00849108|26926419|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
7744494|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
7744495|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
7744496|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
7744497|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
7744498|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7744499|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7744500|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
7744501|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
7744502|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
7744503|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
7744504|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
7744505|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
7744506|NCT00849056|26926429|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
7744507|NCT00849056|26926430|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7744508|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
7744509|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7744510|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
7744511|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
7744512|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
7744513|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
7744514|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
7744515|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
7744516|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
7744517|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
7744518|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
7744519|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
7744520|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
7744521|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
7744522|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
7744523|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
7744524|NCT00849056|26926429|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
7744525|NCT00849056|26926430|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
7744526|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
7744527|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
7744528|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
7744529|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
7744530|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
7744531|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
7744532|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Physician Decision|1
7744533|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Physician Decision|1
7744534|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Physician Decision|0
7744535|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
7744536|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
7744537|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7744538|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
7744539|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
7744540|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
7744541|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
7744542|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7744543|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
7744544|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Noncompliance|0
7744545|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Noncompliance|1
7744546|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Noncompliance|2
7744547|NCT00849017|26926455|P3|Follow-up Period (8 Weeks)|Adverse Event|0
7744548|NCT00849017|26926456|P2|Follow-up Period (8 Weeks)|Adverse Event|0
7744549|NCT00849017|26926457|P1|Follow-up Period (8 Weeks)|Adverse Event|1
7744550|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
7744551|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
7744552|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
7744553|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Pregnancy|1
7744554|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Pregnancy|0
7744555|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Pregnancy|1
7744556|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
7744557|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
7744558|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
7744559|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
7744560|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
7744561|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
7744562|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
7744563|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
7744564|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
7744565|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
7744566|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
7744567|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
7744568|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Physician Decision|1
7744569|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Physician Decision|2
7744570|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Physician Decision|0
7744571|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
7744572|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
7744573|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
7744574|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
7744575|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
7744576|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
7744577|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Noncompliance|4
7744578|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Noncompliance|3
7744579|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Noncompliance|3
7744580|NCT00849017|26926455|P3|Treatment Period (156 Weeks)|Adverse Event|15
7744581|NCT00849017|26926456|P2|Treatment Period (156 Weeks)|Adverse Event|6
7744582|NCT00849017|26926457|P1|Treatment Period (156 Weeks)|Adverse Event|5
7744583|NCT00848965|26926500|P1|Overall Study|Withdrawal by Subject|1
7744584|NCT00848965|26926500|P1|Overall Study|Adverse Event|1
7744585|NCT00848926|26926542|P1|Follow-up Period|Other|2
7744586|NCT00848926|26926542|P1|Follow-up Period|Withdrawal by Subject|3
7744587|NCT00848926|26926542|P1|Follow-up Period|Lost to Follow-up|7
7744588|NCT00848926|26926542|P1|Treatment Period|Withdrawal by Subject|7
7744589|NCT00848926|26926542|P1|Treatment Period|Physician Decision|12
7744590|NCT00848926|26926542|P1|Treatment Period|Adverse Event|20
7744591|NCT00848926|26926542|P1|Treatment Period|Progressive disease|45
7744592|NCT00848718|26926592|P13|Overall Study|Progressive disease during treatment|2
7744593|NCT00848718|26926593|P12|Overall Study|Progressive disease during treatment|0
7744594|NCT00848718|26926594|P11|Overall Study|Progressive disease during treatment|0
7744595|NCT00848718|26926595|P10|Overall Study|Progressive disease during treatment|0
7744596|NCT00848718|26926596|P9|Overall Study|Progressive disease during treatment|0
7744597|NCT00848718|26926597|P8|Overall Study|Progressive disease during treatment|2
7744598|NCT00848718|26926598|P7|Overall Study|Progressive disease during treatment|0
7744599|NCT00848718|26926599|P6|Overall Study|Progressive disease during treatment|0
7744600|NCT00848718|26926600|P5|Overall Study|Progressive disease during treatment|0
7744601|NCT00848718|26926601|P4|Overall Study|Progressive disease during treatment|0
7744602|NCT00848718|26926602|P3|Overall Study|Progressive disease during treatment|3
7744603|NCT00848718|26926603|P2|Overall Study|Progressive disease during treatment|0
7744604|NCT00848718|26926604|P1|Overall Study|Progressive disease during treatment|3
7744605|NCT00848718|26926592|P13|Overall Study|Withdrawal by Subject|0
7744606|NCT00848718|26926593|P12|Overall Study|Withdrawal by Subject|0
7744607|NCT00848718|26926594|P11|Overall Study|Withdrawal by Subject|1
7744608|NCT00848718|26926595|P10|Overall Study|Withdrawal by Subject|0
7744609|NCT00848718|26926596|P9|Overall Study|Withdrawal by Subject|0
7744610|NCT00848718|26926597|P8|Overall Study|Withdrawal by Subject|0
7744611|NCT00848718|26926598|P7|Overall Study|Withdrawal by Subject|0
7744612|NCT00848718|26926599|P6|Overall Study|Withdrawal by Subject|0
7744613|NCT00848718|26926600|P5|Overall Study|Withdrawal by Subject|0
7744614|NCT00848718|26926601|P4|Overall Study|Withdrawal by Subject|1
7744615|NCT00848718|26926602|P3|Overall Study|Withdrawal by Subject|0
7744616|NCT00848718|26926603|P2|Overall Study|Withdrawal by Subject|0
7744617|NCT00848718|26926604|P1|Overall Study|Withdrawal by Subject|1
7744618|NCT00848718|26926592|P13|Overall Study|Protocol Violation|1
7744619|NCT00848718|26926593|P12|Overall Study|Protocol Violation|0
7744620|NCT00848718|26926594|P11|Overall Study|Protocol Violation|0
7744621|NCT00848718|26926595|P10|Overall Study|Protocol Violation|0
7744622|NCT00848718|26926596|P9|Overall Study|Protocol Violation|0
7744623|NCT00848718|26926597|P8|Overall Study|Protocol Violation|1
7744624|NCT00848718|26926598|P7|Overall Study|Protocol Violation|0
7744625|NCT00848718|26926599|P6|Overall Study|Protocol Violation|0
7744626|NCT00848718|26926600|P5|Overall Study|Protocol Violation|0
7744627|NCT00848718|26926601|P4|Overall Study|Protocol Violation|0
7744628|NCT00848718|26926602|P3|Overall Study|Protocol Violation|0
7744629|NCT00848718|26926603|P2|Overall Study|Protocol Violation|1
7744630|NCT00848718|26926604|P1|Overall Study|Protocol Violation|0
7744631|NCT00848718|26926592|P13|Overall Study|Progressive disease before treatment|2
7744632|NCT00848718|26926593|P12|Overall Study|Progressive disease before treatment|6
7744633|NCT00848718|26926594|P11|Overall Study|Progressive disease before treatment|3
7744634|NCT00848718|26926595|P10|Overall Study|Progressive disease before treatment|7
7744635|NCT00848718|26926596|P9|Overall Study|Progressive disease before treatment|2
7744636|NCT00848718|26926597|P8|Overall Study|Progressive disease before treatment|1
7744637|NCT00848718|26926598|P7|Overall Study|Progressive disease before treatment|2
7744638|NCT00848718|26926599|P6|Overall Study|Progressive disease before treatment|4
7744639|NCT00848718|26926600|P5|Overall Study|Progressive disease before treatment|4
7744640|NCT00848718|26926601|P4|Overall Study|Progressive disease before treatment|3
7744641|NCT00848718|26926602|P3|Overall Study|Progressive disease before treatment|1
7744642|NCT00848718|26926603|P2|Overall Study|Progressive disease before treatment|5
7744643|NCT00848718|26926604|P1|Overall Study|Progressive disease before treatment|1
7744644|NCT00848718|26926592|P13|Overall Study|Physician Decision|1
7744645|NCT00848718|26926593|P12|Overall Study|Physician Decision|0
7744646|NCT00848718|26926594|P11|Overall Study|Physician Decision|0
7744647|NCT00848718|26926595|P10|Overall Study|Physician Decision|2
7744648|NCT00848718|26926596|P9|Overall Study|Physician Decision|1
7744649|NCT00848718|26926597|P8|Overall Study|Physician Decision|0
7744650|NCT00848718|26926598|P7|Overall Study|Physician Decision|0
7744651|NCT00848718|26926599|P6|Overall Study|Physician Decision|1
7744652|NCT00848718|26926600|P5|Overall Study|Physician Decision|1
7744653|NCT00848718|26926601|P4|Overall Study|Physician Decision|0
7744654|NCT00848718|26926602|P3|Overall Study|Physician Decision|0
7744655|NCT00848718|26926603|P2|Overall Study|Physician Decision|1
7744656|NCT00848718|26926604|P1|Overall Study|Physician Decision|0
7744657|NCT00848718|26926592|P13|Overall Study|Lack of Efficacy|0
7744658|NCT00848718|26926593|P12|Overall Study|Lack of Efficacy|0
7744659|NCT00848718|26926594|P11|Overall Study|Lack of Efficacy|0
7744660|NCT00848718|26926595|P10|Overall Study|Lack of Efficacy|0
7744661|NCT00848718|26926596|P9|Overall Study|Lack of Efficacy|0
7744662|NCT00848718|26926597|P8|Overall Study|Lack of Efficacy|0
7744663|NCT00848718|26926598|P7|Overall Study|Lack of Efficacy|1
7744664|NCT00848718|26926599|P6|Overall Study|Lack of Efficacy|0
7744665|NCT00848718|26926600|P5|Overall Study|Lack of Efficacy|0
7744666|NCT00848718|26926601|P4|Overall Study|Lack of Efficacy|0
7744667|NCT00848718|26926602|P3|Overall Study|Lack of Efficacy|1
7744668|NCT00848718|26926603|P2|Overall Study|Lack of Efficacy|0
7744669|NCT00848718|26926604|P1|Overall Study|Lack of Efficacy|0
7744670|NCT00848718|26926592|P13|Overall Study|Adverse Event|2
7744671|NCT00848718|26926593|P12|Overall Study|Adverse Event|0
7744672|NCT00848718|26926594|P11|Overall Study|Adverse Event|0
7744673|NCT00848718|26926595|P10|Overall Study|Adverse Event|0
7744674|NCT00848718|26926596|P9|Overall Study|Adverse Event|1
7744675|NCT00848718|26926597|P8|Overall Study|Adverse Event|1
7744676|NCT00848718|26926598|P7|Overall Study|Adverse Event|0
7744677|NCT00848718|26926599|P6|Overall Study|Adverse Event|0
7744678|NCT00848718|26926600|P5|Overall Study|Adverse Event|1
7744679|NCT00848718|26926601|P4|Overall Study|Adverse Event|1
7744680|NCT00848718|26926602|P3|Overall Study|Adverse Event|1
7744681|NCT00848718|26926603|P2|Overall Study|Adverse Event|2
7744682|NCT00848718|26926604|P1|Overall Study|Adverse Event|2
7744683|NCT00848549|26926705|P2|E2090-E044-314 (Extension Study)|Other|6
7744684|NCT00848549|26926706|P1|E2090-E044-314 (Extension Study)|Other|5
7744685|NCT00848549|26926705|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
7744686|NCT00848549|26926706|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
7744687|NCT00848549|26926705|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
7744688|NCT00848549|26926706|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
7744689|NCT00848549|26926705|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
7744690|NCT00848549|26926706|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
7744691|NCT00848549|26926705|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
7744692|NCT00848549|26926706|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
7744693|NCT00848549|26926705|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
7744694|NCT00848549|26926706|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
7744695|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
7744696|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
7744697|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Other|3
7744698|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Other|4
7744699|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
7744700|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
7744701|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
7744702|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
7744703|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
7744704|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
7744705|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
7744706|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
7744707|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
7744708|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
7744709|NCT00848549|26926705|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
7744710|NCT00848549|26926706|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
7744711|NCT00848536|26926724|P2|Overall Study|Patient Moved|2
7744712|NCT00848536|26926725|P1|Overall Study|Patient Moved|0
7744713|NCT00848536|26926724|P2|Overall Study|Inadequate Control of IOP|1
7744714|NCT00848536|26926725|P1|Overall Study|Inadequate Control of IOP|1
7744715|NCT00848536|26926724|P2|Overall Study|Noncompliance|0
7744716|NCT00848536|26926725|P1|Overall Study|Noncompliance|1
7744717|NCT00848536|26926724|P2|Overall Study|Protocol Violation|1
7744718|NCT00848536|26926725|P1|Overall Study|Protocol Violation|0
7744719|NCT00848536|26926724|P2|Overall Study|Withdrawal by Subject|1
7744720|NCT00848536|26926725|P1|Overall Study|Withdrawal by Subject|0
7744721|NCT00848536|26926724|P2|Overall Study|Adverse Event|2
7744722|NCT00848536|26926725|P1|Overall Study|Adverse Event|2
7744723|NCT00848497|26926790|P2|Overall Study|Withdrawal by Subject|1
7744724|NCT00848497|26926791|P1|Overall Study|Withdrawal by Subject|0
7744725|NCT00848497|26926790|P2|Overall Study|Screen failure|0
7744726|NCT00848497|26926791|P1|Overall Study|Screen failure|2
7744727|NCT00848484|26926805|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
7744728|NCT00848484|26926806|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
7744729|NCT00848484|26926805|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
7744730|NCT00848484|26926806|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
7744731|NCT00848484|26926805|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
7744732|NCT00848484|26926806|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
7744733|NCT00848484|26926805|P2|First Intervention (Treatment Period 1)|Physician Decision|1
7744734|NCT00848484|26926806|P1|First Intervention (Treatment Period 1)|Physician Decision|0
7744735|NCT00848484|26926805|P2|First Intervention (Treatment Period 1)|Adverse Event|1
7744736|NCT00848484|26926806|P1|First Intervention (Treatment Period 1)|Adverse Event|2
7744737|NCT00848393|26926825|P3|Overall Study|surgical complications unrelated to stud|2
7744738|NCT00848393|26926826|P2|Overall Study|surgical complications unrelated to stud|0
7744739|NCT00848393|26926827|P1|Overall Study|surgical complications unrelated to stud|0
7744740|NCT00848393|26926825|P3|Overall Study|Protocol Violation|1
7744741|NCT00848393|26926826|P2|Overall Study|Protocol Violation|0
7744742|NCT00848393|26926827|P1|Overall Study|Protocol Violation|0
7744743|NCT00848354|26926866|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
7744744|NCT00848354|26926867|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
7744745|NCT00848354|26926866|P2|Phase 2 Year 2|Subject Request|1
7744746|NCT00848354|26926867|P1|Phase 2 Year 2|Subject Request|1
7744747|NCT00848354|26926866|P2|Phase 2 Year 2|Protocol Violation|1
7744748|NCT00848354|26926867|P1|Phase 2 Year 2|Protocol Violation|1
7744749|NCT00848354|26926866|P2|Phase 2 Year 2|Unspecified Reason|0
7744750|NCT00848354|26926867|P1|Phase 2 Year 2|Unspecified Reason|1
7744751|NCT00848354|26926866|P2|Phase 2 Year 2|Lost to Follow-up|3
7744752|NCT00848354|26926867|P1|Phase 2 Year 2|Lost to Follow-up|1
7744753|NCT00848354|26926866|P2|Phase 2 Year 2|Failed to return|0
7744754|NCT00848354|26926867|P1|Phase 2 Year 2|Failed to return|3
7744755|NCT00848354|26926866|P2|Phase 2 Year 2|Death|0
7744756|NCT00848354|26926867|P1|Phase 2 Year 2|Death|2
7744757|NCT00848354|26926866|P2|Phase 2 Year 2|Adverse Event|2
7744758|NCT00848354|26926867|P1|Phase 2 Year 2|Adverse Event|12
7744759|NCT00848354|26926866|P2|Phase 2 Year 1|Subject Request|2
7744760|NCT00848354|26926867|P1|Phase 2 Year 1|Subject Request|1
7744761|NCT00848354|26926866|P2|Phase 2 Year 1|Protocol Violation|1
7744762|NCT00848354|26926867|P1|Phase 2 Year 1|Protocol Violation|4
7744763|NCT00848354|26926866|P2|Phase 2 Year 1|Unspecified Reason|0
7744764|NCT00848354|26926867|P1|Phase 2 Year 1|Unspecified Reason|3
7744765|NCT00848354|26926866|P2|Phase 2 Year 1|Lost to Follow-up|0
7744766|NCT00848354|26926867|P1|Phase 2 Year 1|Lost to Follow-up|1
7744767|NCT00848354|26926866|P2|Phase 2 Year 1|Failed to Return|1
7744768|NCT00848354|26926867|P1|Phase 2 Year 1|Failed to Return|1
7744769|NCT00848354|26926866|P2|Phase 2 Year 1|Death|0
7744770|NCT00848354|26926867|P1|Phase 2 Year 1|Death|1
7744771|NCT00848354|26926866|P2|Phase 2 Year 1|Adverse Event|2
7744772|NCT00848354|26926867|P1|Phase 2 Year 1|Adverse Event|7
7744773|NCT00848354|26926866|P2|Phase 1|Lack of Efficacy|1
7744774|NCT00848354|26926867|P1|Phase 1|Lack of Efficacy|0
7744775|NCT00848354|26926866|P2|Phase 1|Withdrawal by Subject|4
7744776|NCT00848354|26926867|P1|Phase 1|Withdrawal by Subject|2
7744777|NCT00848354|26926866|P2|Phase 1|Protocol Violation|1
7744778|NCT00848354|26926867|P1|Phase 1|Protocol Violation|1
7744779|NCT00848354|26926866|P2|Phase 1|Unspecified Reason|1
7744780|NCT00848354|26926867|P1|Phase 1|Unspecified Reason|1
7744781|NCT00848354|26926866|P2|Phase 1|Lost to Follow-up|1
7744782|NCT00848354|26926867|P1|Phase 1|Lost to Follow-up|1
7744783|NCT00848354|26926866|P2|Phase 1|Failed to return|1
7744784|NCT00848354|26926867|P1|Phase 1|Failed to return|0
7744785|NCT00848354|26926866|P2|Phase 1|Discontinuation of study by sponsor|1
7744786|NCT00848354|26926867|P1|Phase 1|Discontinuation of study by sponsor|2
7744787|NCT00848354|26926866|P2|Phase 1|Adverse Event|4
7744788|NCT00848354|26926867|P1|Phase 1|Adverse Event|5
7744789|NCT00848250|26927019|P2|Overall Study|surgery was completed without cardiopulm|1
7744790|NCT00848250|26927020|P1|Overall Study|surgery was completed without cardiopulm|0
7744791|NCT00848211|26927051|P4|Overall Study|Adverse Event|0
7744792|NCT00848211|26927052|P3|Overall Study|Adverse Event|0
7744793|NCT00848211|26927053|P2|Overall Study|Adverse Event|0
7744794|NCT00848211|26927054|P1|Overall Study|Adverse Event|0
7744795|NCT00848211|26927051|P4|Overall Study|Protocol Violation|0
7744796|NCT00848211|26927052|P3|Overall Study|Protocol Violation|1
7744797|NCT00848211|26927053|P2|Overall Study|Protocol Violation|1
7744798|NCT00848211|26927054|P1|Overall Study|Protocol Violation|0
7744799|NCT00848198|26927072|P1|Overall Study|Incomplete Case Report Forms|15
7744800|NCT00848120|26927137|P1|Overall Study|Adverse Event|1
7744801|NCT00848107|26927149|P1|Overall Study|Pregnancy|1
7744802|NCT00848107|26927149|P1|Overall Study|Death|1
7744803|NCT00848107|26927149|P1|Overall Study|Adverse Event|9
7744804|NCT00848107|26927149|P1|Overall Study|Withdrawal by Subject|8
7744805|NCT00848107|26927149|P1|Overall Study|Lost to Follow-up|2
7744806|NCT00848081|26927159|P2|Overall Study|Withdrawal by Subject|3
7744807|NCT00848081|26927160|P1|Overall Study|Withdrawal by Subject|5
7744808|NCT00848081|26927159|P2|Overall Study|Physician Decision|3
7744809|NCT00848081|26927160|P1|Overall Study|Physician Decision|0
7744810|NCT00848081|26927159|P2|Overall Study|Lost to Follow-up|0
7744811|NCT00848081|26927160|P1|Overall Study|Lost to Follow-up|1
7744812|NCT00848081|26927159|P2|Overall Study|Protocol Violation|5
7744813|NCT00848081|26927160|P1|Overall Study|Protocol Violation|8
7744814|NCT00848081|26927159|P2|Overall Study|Adverse Event|7
7744815|NCT00848081|26927160|P1|Overall Study|Adverse Event|6
7744816|NCT00848042|26927177|P3|Overall Study|Other Therapy|0
7744817|NCT00848042|26927178|P2|Overall Study|Other Therapy|0
7744818|NCT00848042|26927179|P1|Overall Study|Other Therapy|3
7744819|NCT00848042|26927177|P3|Overall Study|Death|0
7744820|NCT00848042|26927178|P2|Overall Study|Death|2
7744821|NCT00848042|26927179|P1|Overall Study|Death|1
7744822|NCT00847912|26927215|P2|Overall Study|Withdrawal by Subject|6
7744823|NCT00847912|26927216|P1|Overall Study|Withdrawal by Subject|3
7744824|NCT00847912|26927215|P2|Overall Study|Protocol Violation|7
7744825|NCT00847912|26927216|P1|Overall Study|Protocol Violation|6
7744826|NCT00847886|26927226|P2|Overall Study|Adverse Event|1
7744827|NCT00847886|26927227|P1|Overall Study|Adverse Event|0
7744828|NCT00847808|26927253|P1|Overall Study|Participant Took Excluded Medication|1
7744829|NCT00847808|26927253|P1|Overall Study|Participant Reported Lack of Efficacy|1
7744830|NCT00847808|26927253|P1|Overall Study|Withdrawal by Subject|4
7744831|NCT00847808|26927253|P1|Overall Study|Lost to Follow-up|1
7744832|NCT00847808|26927253|P1|Overall Study|Protocol Violation|1
7744833|NCT00847808|26927253|P1|Overall Study|Adverse Event|7
7744834|NCT00847730|26927270|P1|Overall Study|Multiple interruptions in therapy|8
7744835|NCT00847704|26927274|P1|Overall Study|Withdrawal by Subject|1
7744836|NCT00847665|26927285|P2|Overall Study|Withdrawal by Subject|0
7744837|NCT00847665|26927286|P1|Overall Study|Withdrawal by Subject|1
7744838|NCT00847626|26927309|P11|Overall Study|Other|3
7744839|NCT00847626|26927310|P10|Overall Study|Other|1
7744840|NCT00847626|26927311|P9|Overall Study|Other|1
7744841|NCT00847626|26927312|P8|Overall Study|Other|3
7744842|NCT00847626|26927313|P7|Overall Study|Other|2
7744843|NCT00847626|26927314|P6|Overall Study|Other|2
7744844|NCT00847626|26927315|P5|Overall Study|Other|2
7744845|NCT00847626|26927316|P4|Overall Study|Other|1
7744846|NCT00847626|26927317|P3|Overall Study|Other|4
7744847|NCT00847626|26927318|P2|Overall Study|Other|5
7744848|NCT00847626|26927319|P1|Overall Study|Other|1
7744849|NCT00847626|26927309|P11|Overall Study|Lack of Efficacy|7
7744850|NCT00847626|26927310|P10|Overall Study|Lack of Efficacy|1
7744851|NCT00847626|26927311|P9|Overall Study|Lack of Efficacy|5
7744852|NCT00847626|26927312|P8|Overall Study|Lack of Efficacy|2
7744853|NCT00847626|26927313|P7|Overall Study|Lack of Efficacy|6
7744854|NCT00847626|26927314|P6|Overall Study|Lack of Efficacy|0
7744855|NCT00847626|26927315|P5|Overall Study|Lack of Efficacy|2
7744856|NCT00847626|26927316|P4|Overall Study|Lack of Efficacy|1
7744857|NCT00847626|26927317|P3|Overall Study|Lack of Efficacy|0
7744858|NCT00847626|26927318|P2|Overall Study|Lack of Efficacy|1
7744859|NCT00847626|26927319|P1|Overall Study|Lack of Efficacy|3
7744860|NCT00847626|26927309|P11|Overall Study|Withdrawal by Subject|2
7744861|NCT00847626|26927310|P10|Overall Study|Withdrawal by Subject|5
7744862|NCT00847626|26927311|P9|Overall Study|Withdrawal by Subject|4
7744863|NCT00847626|26927312|P8|Overall Study|Withdrawal by Subject|4
7744864|NCT00847626|26927313|P7|Overall Study|Withdrawal by Subject|8
7744865|NCT00847626|26927314|P6|Overall Study|Withdrawal by Subject|9
7744866|NCT00847626|26927315|P5|Overall Study|Withdrawal by Subject|12
7744867|NCT00847626|26927316|P4|Overall Study|Withdrawal by Subject|8
7744868|NCT00847626|26927317|P3|Overall Study|Withdrawal by Subject|3
7744869|NCT00847626|26927318|P2|Overall Study|Withdrawal by Subject|5
7744870|NCT00847626|26927319|P1|Overall Study|Withdrawal by Subject|5
7744871|NCT00847626|26927309|P11|Overall Study|Lost to Follow-up|1
7744872|NCT00847626|26927310|P10|Overall Study|Lost to Follow-up|0
7744873|NCT00847626|26927311|P9|Overall Study|Lost to Follow-up|1
7744874|NCT00847626|26927312|P8|Overall Study|Lost to Follow-up|3
7744875|NCT00847626|26927313|P7|Overall Study|Lost to Follow-up|1
7744876|NCT00847626|26927314|P6|Overall Study|Lost to Follow-up|3
7744877|NCT00847626|26927315|P5|Overall Study|Lost to Follow-up|0
7744878|NCT00847626|26927316|P4|Overall Study|Lost to Follow-up|1
7744879|NCT00847626|26927317|P3|Overall Study|Lost to Follow-up|1
7744880|NCT00847626|26927318|P2|Overall Study|Lost to Follow-up|1
7744881|NCT00847626|26927319|P1|Overall Study|Lost to Follow-up|0
7744882|NCT00847626|26927309|P11|Overall Study|Protocol Violation|1
7744883|NCT00847626|26927310|P10|Overall Study|Protocol Violation|1
7744884|NCT00847626|26927311|P9|Overall Study|Protocol Violation|0
7744885|NCT00847626|26927312|P8|Overall Study|Protocol Violation|1
7744886|NCT00847626|26927313|P7|Overall Study|Protocol Violation|1
7744887|NCT00847626|26927314|P6|Overall Study|Protocol Violation|1
7744888|NCT00847626|26927315|P5|Overall Study|Protocol Violation|1
7744889|NCT00847626|26927316|P4|Overall Study|Protocol Violation|1
7744890|NCT00847626|26927317|P3|Overall Study|Protocol Violation|2
7744891|NCT00847626|26927318|P2|Overall Study|Protocol Violation|1
7744892|NCT00847626|26927319|P1|Overall Study|Protocol Violation|2
7744893|NCT00847626|26927309|P11|Overall Study|Adverse Event|6
7744894|NCT00847626|26927310|P10|Overall Study|Adverse Event|6
7744895|NCT00847626|26927311|P9|Overall Study|Adverse Event|3
7744896|NCT00847626|26927312|P8|Overall Study|Adverse Event|6
7744897|NCT00847626|26927313|P7|Overall Study|Adverse Event|4
7744898|NCT00847626|26927314|P6|Overall Study|Adverse Event|22
7744899|NCT00847626|26927315|P5|Overall Study|Adverse Event|11
7744900|NCT00847626|26927316|P4|Overall Study|Adverse Event|19
7744901|NCT00847626|26927317|P3|Overall Study|Adverse Event|6
7744902|NCT00847626|26927318|P2|Overall Study|Adverse Event|10
7744903|NCT00847626|26927319|P1|Overall Study|Adverse Event|10
7744904|NCT00847613|26927518|P4|Overall Study|Other|0
7744905|NCT00847613|26927519|P3|Overall Study|Other|2
7744906|NCT00847613|26927520|P2|Overall Study|Other|1
7744907|NCT00847613|26927521|P1|Overall Study|Other|1
7744908|NCT00847613|26927518|P4|Overall Study|Randomized, but not treated|0
7744909|NCT00847613|26927519|P3|Overall Study|Randomized, but not treated|0
7744910|NCT00847613|26927520|P2|Overall Study|Randomized, but not treated|3
7744911|NCT00847613|26927521|P1|Overall Study|Randomized, but not treated|0
7744912|NCT00847613|26927518|P4|Overall Study|Sponsor request|0
7744913|NCT00847613|26927519|P3|Overall Study|Sponsor request|0
7744914|NCT00847613|26927520|P2|Overall Study|Sponsor request|1
7744915|NCT00847613|26927521|P1|Overall Study|Sponsor request|0
7744916|NCT00847613|26927518|P4|Overall Study|Participant moved|0
7744917|NCT00847613|26927519|P3|Overall Study|Participant moved|0
7744918|NCT00847613|26927520|P2|Overall Study|Participant moved|1
7744919|NCT00847613|26927521|P1|Overall Study|Participant moved|4
7744920|NCT00847613|26927518|P4|Overall Study|Withdrawal by Subject|2
7744921|NCT00847613|26927519|P3|Overall Study|Withdrawal by Subject|2
7744922|NCT00847613|26927520|P2|Overall Study|Withdrawal by Subject|11
7744923|NCT00847613|26927521|P1|Overall Study|Withdrawal by Subject|8
7744924|NCT00847613|26927518|P4|Overall Study|Site closure|1
7744925|NCT00847613|26927519|P3|Overall Study|Site closure|0
7744926|NCT00847613|26927520|P2|Overall Study|Site closure|0
7744927|NCT00847613|26927521|P1|Overall Study|Site closure|1
7744928|NCT00847613|26927518|P4|Overall Study|Pregnancy|0
7744929|NCT00847613|26927519|P3|Overall Study|Pregnancy|0
7744930|NCT00847613|26927520|P2|Overall Study|Pregnancy|1
7744931|NCT00847613|26927521|P1|Overall Study|Pregnancy|1
7744932|NCT00847613|26927518|P4|Overall Study|Protocol Violation|1
7744933|NCT00847613|26927519|P3|Overall Study|Protocol Violation|3
7744934|NCT00847613|26927520|P2|Overall Study|Protocol Violation|6
7744935|NCT00847613|26927521|P1|Overall Study|Protocol Violation|6
7744936|NCT00847613|26927518|P4|Overall Study|Lost to Follow-up|3
7744937|NCT00847613|26927519|P3|Overall Study|Lost to Follow-up|0
7744938|NCT00847613|26927520|P2|Overall Study|Lost to Follow-up|0
7744939|NCT00847613|26927521|P1|Overall Study|Lost to Follow-up|5
7744940|NCT00847613|26927518|P4|Overall Study|Study terminated by Sponsor|1
7744941|NCT00847613|26927519|P3|Overall Study|Study terminated by Sponsor|2
7744942|NCT00847613|26927520|P2|Overall Study|Study terminated by Sponsor|0
7744943|NCT00847613|26927521|P1|Overall Study|Study terminated by Sponsor|1
7744944|NCT00847613|26927518|P4|Overall Study|Lack of Efficacy|1
7744945|NCT00847613|26927519|P3|Overall Study|Lack of Efficacy|3
7744946|NCT00847613|26927520|P2|Overall Study|Lack of Efficacy|3
7744947|NCT00847613|26927521|P1|Overall Study|Lack of Efficacy|7
7744948|NCT00847613|26927518|P4|Overall Study|Adverse Event|6
7744949|NCT00847613|26927519|P3|Overall Study|Adverse Event|5
7744950|NCT00847613|26927520|P2|Overall Study|Adverse Event|26
7744951|NCT00847613|26927521|P1|Overall Study|Adverse Event|36
7744952|NCT00847613|26927518|P4|Overall Study|Death|0
7744953|NCT00847613|26927519|P3|Overall Study|Death|0
7744954|NCT00847613|26927520|P2|Overall Study|Death|1
7744955|NCT00847613|26927521|P1|Overall Study|Death|1
7744956|NCT00847613|26927518|P4|Overall Study|Ongoing at cut-off date|64
7744957|NCT00847613|26927519|P3|Overall Study|Ongoing at cut-off date|64
7744958|NCT00847613|26927520|P2|Overall Study|Ongoing at cut-off date|265
7744959|NCT00847613|26927521|P1|Overall Study|Ongoing at cut-off date|250
7744960|NCT00847561|26927772|P2|Overall Study|Unable to schedule|1
7744961|NCT00847561|26927773|P1|Overall Study|Unable to schedule|9
7744962|NCT00847561|26927772|P2|Overall Study|Withdrawal by Subject|3
7744963|NCT00847561|26927773|P1|Overall Study|Withdrawal by Subject|4
7744964|NCT00847535|26927779|P3|Overall Study|Lost to Follow-up|0
7744965|NCT00847535|26927780|P2|Overall Study|Lost to Follow-up|1
7744966|NCT00847535|26927781|P1|Overall Study|Lost to Follow-up|0
7744967|NCT00847535|26927779|P3|Overall Study|Withdrawal by Subject|1
7744968|NCT00847535|26927780|P2|Overall Study|Withdrawal by Subject|1
7744969|NCT00847535|26927781|P1|Overall Study|Withdrawal by Subject|2
7744970|NCT00847405|26927800|P2|Washout of 7 Days|Withdrawal by Subject|0
7744971|NCT00847405|26927801|P1|Washout of 7 Days|Withdrawal by Subject|1
7744972|NCT00847405|26927800|P2|First Intervention|Adverse Event|1
7744973|NCT00847405|26927801|P1|First Intervention|Adverse Event|0
7744974|NCT00847379|26927812|P3|Overall Study|Study terminated by Sponsor|57
7744975|NCT00847379|26927813|P2|Overall Study|Study terminated by Sponsor|57
7744976|NCT00847379|26927814|P1|Overall Study|Study terminated by Sponsor|59
7744977|NCT00847301|26927912|P1|Overall Study|Other reason not defined above|1
7744978|NCT00847301|26927912|P1|Overall Study|No prescription after hospital discharge|1
7744979|NCT00847301|26927912|P1|Overall Study|Lost to Follow-up|1
7744980|NCT00847301|26927912|P1|Overall Study|Switch to other anticoagulants|16
7744981|NCT00847301|26927912|P1|Overall Study|Adverse Event|35
7744982|NCT00847197|26927960|P2|Overall Study|Withdrawal by Subject|1
7744983|NCT00847197|26927961|P1|Overall Study|Withdrawal by Subject|3
7744984|NCT00847197|26927960|P2|Overall Study|Protocol Violation|1
7744985|NCT00847197|26927961|P1|Overall Study|Protocol Violation|0
7744986|NCT00847197|26927960|P2|Overall Study|Adverse Event|3
7744987|NCT00847197|26927961|P1|Overall Study|Adverse Event|21
7744988|NCT00847145|26927985|P8|Overall Study|Protocol Violation|1
7744989|NCT00847145|26927986|P7|Overall Study|Protocol Violation|0
7744990|NCT00847145|26927987|P6|Overall Study|Protocol Violation|0
7744991|NCT00847145|26927988|P5|Overall Study|Protocol Violation|1
7744992|NCT00847145|26927989|P4|Overall Study|Protocol Violation|0
7744993|NCT00847145|26927990|P3|Overall Study|Protocol Violation|3
7744994|NCT00847145|26927991|P2|Overall Study|Protocol Violation|0
7744995|NCT00847145|26927992|P1|Overall Study|Protocol Violation|0
7744996|NCT00847145|26927985|P8|Overall Study|Inappropriate enrollment|0
7744997|NCT00847145|26927986|P7|Overall Study|Inappropriate enrollment|0
7744998|NCT00847145|26927987|P6|Overall Study|Inappropriate enrollment|0
7744999|NCT00847145|26927988|P5|Overall Study|Inappropriate enrollment|1
7745000|NCT00847145|26927989|P4|Overall Study|Inappropriate enrollment|0
7745001|NCT00847145|26927990|P3|Overall Study|Inappropriate enrollment|0
7745002|NCT00847145|26927991|P2|Overall Study|Inappropriate enrollment|0
7745003|NCT00847145|26927992|P1|Overall Study|Inappropriate enrollment|0
7745004|NCT00847145|26927985|P8|Overall Study|Lost to Follow-up|2
7745005|NCT00847145|26927986|P7|Overall Study|Lost to Follow-up|8
7745006|NCT00847145|26927987|P6|Overall Study|Lost to Follow-up|4
7745007|NCT00847145|26927988|P5|Overall Study|Lost to Follow-up|4
7745008|NCT00847145|26927989|P4|Overall Study|Lost to Follow-up|0
7745009|NCT00847145|26927990|P3|Overall Study|Lost to Follow-up|1
7745010|NCT00847145|26927991|P2|Overall Study|Lost to Follow-up|1
7745011|NCT00847145|26927992|P1|Overall Study|Lost to Follow-up|3
7745012|NCT00847145|26927985|P8|Overall Study|Withdrawal by Subject|1
7745013|NCT00847145|26927986|P7|Overall Study|Withdrawal by Subject|1
7745014|NCT00847145|26927987|P6|Overall Study|Withdrawal by Subject|0
7745015|NCT00847145|26927988|P5|Overall Study|Withdrawal by Subject|0
7745016|NCT00847145|26927989|P4|Overall Study|Withdrawal by Subject|1
7745017|NCT00847145|26927990|P3|Overall Study|Withdrawal by Subject|6
7745018|NCT00847145|26927991|P2|Overall Study|Withdrawal by Subject|4
7745019|NCT00847145|26927992|P1|Overall Study|Withdrawal by Subject|3
7745020|NCT00847145|26927985|P8|Overall Study|AE or Death|0
7745021|NCT00847145|26927986|P7|Overall Study|AE or Death|0
7745022|NCT00847145|26927987|P6|Overall Study|AE or Death|0
7745023|NCT00847145|26927988|P5|Overall Study|AE or Death|0
7745024|NCT00847145|26927989|P4|Overall Study|AE or Death|0
7745025|NCT00847145|26927990|P3|Overall Study|AE or Death|1
7745026|NCT00847145|26927991|P2|Overall Study|AE or Death|1
7745027|NCT00847145|26927992|P1|Overall Study|AE or Death|0
7745028|NCT00847132|26928042|P2|Overall Study|Death|1
7745029|NCT00847132|26928043|P1|Overall Study|Death|1
7745030|NCT00847015|26928051|P1|Overall Study|partial cystectomy vs radical cystectomy|1
7745031|NCT00847015|26928051|P1|Overall Study|declined any surgery|1
7745032|NCT00847015|26928051|P1|Overall Study|Withdrawal by Subject|1
7745033|NCT00846846|26928079|P1|Overall Study|Withdrawal by Subject|19
7745034|NCT00846846|26928079|P1|Overall Study|Death|56
7745035|NCT00846807|26928084|P1|Overall Study|Other|60
7745036|NCT00846807|26928084|P1|Overall Study|No prescription after hospital discharge|56
7745037|NCT00846807|26928084|P1|Overall Study|Switch to other anticoagulants|89
7745038|NCT00846807|26928084|P1|Overall Study|Non compliant with European label|7
7745039|NCT00846807|26928084|P1|Overall Study|Withdrawal by Subject|56
7745040|NCT00846807|26928084|P1|Overall Study|Lost to Follow-up|94
7745041|NCT00846807|26928084|P1|Overall Study|Adverse Event|270
7745042|NCT00846768|26928092|P4|Overall Study|Adverse Event|0
7745043|NCT00846768|26928093|P3|Overall Study|Adverse Event|0
7745044|NCT00846768|26928094|P2|Overall Study|Adverse Event|1
7745045|NCT00846768|26928095|P1|Overall Study|Adverse Event|0
7745046|NCT00846742|26928165|P1|Overall Study|Withdrawal by Subject|1
7745047|NCT00846586|26928192|P2|Overall Study|Unsatisfactory therapeutic effect|1
7745048|NCT00846586|26928193|P1|Overall Study|Unsatisfactory therapeutic effect|0
7745049|NCT00846586|26928192|P2|Overall Study|Lost to Follow-up|4
7745050|NCT00846586|26928193|P1|Overall Study|Lost to Follow-up|1
7745051|NCT00846586|26928192|P2|Overall Study|Abnormal test procedure result(s)|0
7745052|NCT00846586|26928193|P1|Overall Study|Abnormal test procedure result(s)|1
7745053|NCT00846586|26928192|P2|Overall Study|Protocol deviation|6
7745054|NCT00846586|26928193|P1|Overall Study|Protocol deviation|2
7745055|NCT00846586|26928192|P2|Overall Study|Death|0
7745056|NCT00846586|26928193|P1|Overall Study|Death|2
7745057|NCT00846586|26928192|P2|Overall Study|Administrative problems|4
7745058|NCT00846586|26928193|P1|Overall Study|Administrative problems|5
7745059|NCT00846586|26928192|P2|Overall Study|Subject withdrew consent|10
7745060|NCT00846586|26928193|P1|Overall Study|Subject withdrew consent|8
7745061|NCT00846586|26928192|P2|Overall Study|Adverse Event|10
7745062|NCT00846586|26928193|P1|Overall Study|Adverse Event|20
7745063|NCT00846521|26928227|P1|Overall Study|Protocol Violation|1
7745064|NCT00846521|26928227|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
7745065|NCT00846521|26928227|P1|Overall Study|Withdrawal by Subject|5
7745066|NCT00846495|26928234|P2|Overall Study|Physician Decision|0
7745067|NCT00846495|26928235|P1|Overall Study|Physician Decision|1
7745068|NCT00846495|26928234|P2|Overall Study|Lack of Efficacy|2
7745069|NCT00846495|26928235|P1|Overall Study|Lack of Efficacy|1
7745070|NCT00846495|26928234|P2|Overall Study|Adverse Event|1
7745071|NCT00846495|26928235|P1|Overall Study|Adverse Event|5
7745072|NCT00846495|26928234|P2|Overall Study|Lost to Follow-up|0
7745073|NCT00846495|26928235|P1|Overall Study|Lost to Follow-up|1
7745074|NCT00846391|26928263|P3|Overall Study|Study Terminated by Sponsor|2
7745075|NCT00846391|26928264|P2|Overall Study|Study Terminated by Sponsor|2
7745076|NCT00846391|26928265|P1|Overall Study|Study Terminated by Sponsor|1
7745077|NCT00846391|26928263|P3|Overall Study|Physician Decision|1
7745078|NCT00846391|26928264|P2|Overall Study|Physician Decision|0
7745079|NCT00846391|26928265|P1|Overall Study|Physician Decision|0
7745080|NCT00846365|26928276|P3|Overall Study|Other|6
7745081|NCT00846365|26928277|P2|Overall Study|Other|1
7745082|NCT00846365|26928278|P1|Overall Study|Other|9
7745083|NCT00846365|26928276|P3|Overall Study|Lack of Efficacy|2
7745084|NCT00846365|26928277|P2|Overall Study|Lack of Efficacy|1
7745085|NCT00846365|26928278|P1|Overall Study|Lack of Efficacy|1
7745086|NCT00846365|26928276|P3|Overall Study|Pregnancy|0
7745087|NCT00846365|26928277|P2|Overall Study|Pregnancy|0
7745088|NCT00846365|26928278|P1|Overall Study|Pregnancy|1
7745089|NCT00846365|26928276|P3|Overall Study|Withdrawal by Subject|9
7745090|NCT00846365|26928277|P2|Overall Study|Withdrawal by Subject|11
7745091|NCT00846365|26928278|P1|Overall Study|Withdrawal by Subject|11
7745092|NCT00846365|26928276|P3|Overall Study|Lost to Follow-up|5
7745093|NCT00846365|26928277|P2|Overall Study|Lost to Follow-up|2
7745094|NCT00846365|26928278|P1|Overall Study|Lost to Follow-up|8
7745095|NCT00846365|26928276|P3|Overall Study|Protocol Violation|0
7745096|NCT00846365|26928277|P2|Overall Study|Protocol Violation|4
7745097|NCT00846365|26928278|P1|Overall Study|Protocol Violation|5
7745098|NCT00846365|26928276|P3|Overall Study|Adverse Event|11
7745099|NCT00846365|26928277|P2|Overall Study|Adverse Event|30
7745100|NCT00846365|26928278|P1|Overall Study|Adverse Event|20
7745101|NCT00846053|26928359|P2|Overall Study|Physician Decision|0
7745102|NCT00846053|26928360|P1|Overall Study|Physician Decision|3
7745103|NCT00846040|26928371|P3|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7745104|NCT00846040|26928372|P2|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
7745105|NCT00846040|26928373|P1|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7745106|NCT00846040|26928371|P3|Baseline: Days 1-5|Withdrawal by Subject|0
7745107|NCT00846040|26928372|P2|Baseline: Days 1-5|Withdrawal by Subject|0
7745108|NCT00846040|26928373|P1|Baseline: Days 1-5|Withdrawal by Subject|1
7745109|NCT00846027|26928390|P1|Overall Study|Subject Not Treated|7
7745110|NCT00846027|26928390|P1|Overall Study|Protocol Violation|2
7745111|NCT00846027|26928390|P1|Overall Study|Investigator Discretion|29
7745112|NCT00846027|26928390|P1|Overall Study|Patient Decision|7
7745113|NCT00846027|26928390|P1|Overall Study|Toxicity|12
7745114|NCT00846027|26928390|P1|Overall Study|Disease Progression|30
7745115|NCT00846027|26928390|P1|Overall Study|Death|3
7745116|NCT00845897|26928413|P3|Overall Study|Too ill to participate|0
7745117|NCT00845897|26928414|P2|Overall Study|Too ill to participate|1
7745118|NCT00845897|26928415|P1|Overall Study|Too ill to participate|0
7745119|NCT00845897|26928413|P3|Overall Study|Ulcer did not heal|1
7745120|NCT00845897|26928414|P2|Overall Study|Ulcer did not heal|0
7745121|NCT00845897|26928415|P1|Overall Study|Ulcer did not heal|1
7745122|NCT00845897|26928413|P3|Overall Study|Withdrawal by Subject|2
7745123|NCT00845897|26928414|P2|Overall Study|Withdrawal by Subject|3
7745124|NCT00845897|26928415|P1|Overall Study|Withdrawal by Subject|0
7745125|NCT00845897|26928413|P3|Overall Study|Lost to Follow-up|0
7745126|NCT00845897|26928414|P2|Overall Study|Lost to Follow-up|1
7745127|NCT00845897|26928415|P1|Overall Study|Lost to Follow-up|1
7745128|NCT00845871|26928426|P1|Assessment Period|Patient withdrew consent|3
7745129|NCT00845871|26928426|P1|Assessment Period|Abnormal test procedure results|1
7745130|NCT00845871|26928426|P1|Assessment Period|Abnormal laboratory values|1
7745131|NCT00845871|26928426|P1|Assessment Period|Adverse Event|2
7745132|NCT00845858|26928454|P3|Overall Study|not eligible|2
7745133|NCT00845858|26928455|P2|Overall Study|not eligible|3
7745134|NCT00845858|26928456|P1|Overall Study|not eligible|0
7745135|NCT00845858|26928454|P3|Overall Study|Protocol Violation|1
7745136|NCT00845858|26928455|P2|Overall Study|Protocol Violation|0
7745137|NCT00845858|26928456|P1|Overall Study|Protocol Violation|0
7745138|NCT00845858|26928454|P3|Overall Study|Adverse Event|4
7745139|NCT00845858|26928455|P2|Overall Study|Adverse Event|8
7745140|NCT00845858|26928456|P1|Overall Study|Adverse Event|3
7745141|NCT00845858|26928454|P3|Overall Study|Withdrawal by Subject|1
7745142|NCT00845858|26928455|P2|Overall Study|Withdrawal by Subject|1
7745143|NCT00845858|26928456|P1|Overall Study|Withdrawal by Subject|5
7745144|NCT00845845|26928469|P2|Overall Study|Lost to Follow-up|4
7745145|NCT00845845|26928470|P1|Overall Study|Lost to Follow-up|0
7745146|NCT00845832|26928481|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
7745147|NCT00845832|26928482|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
7745148|NCT00845832|26928483|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
7745149|NCT00845832|26928481|P3|Safety Follow-Up|Withdrawal by Subject|0
7745150|NCT00845832|26928482|P2|Safety Follow-Up|Withdrawal by Subject|0
7745151|NCT00845832|26928483|P1|Safety Follow-Up|Withdrawal by Subject|1
7745152|NCT00845832|26928481|P3|Treatment Period|Protocol Violation|0
7745153|NCT00845832|26928482|P2|Treatment Period|Protocol Violation|1
7745154|NCT00845832|26928483|P1|Treatment Period|Protocol Violation|1
7745155|NCT00845832|26928481|P3|Treatment Period|Adverse Event|0
7745156|NCT00845832|26928482|P2|Treatment Period|Adverse Event|2
7745157|NCT00845832|26928483|P1|Treatment Period|Adverse Event|0
7745158|NCT00845728|26928529|P2|Overall Study|Withdrawal by Subject|108
7745159|NCT00845728|26928530|P1|Overall Study|Withdrawal by Subject|105
7745160|NCT00845728|26928529|P2|Overall Study|Adverse Event|96
7745161|NCT00845728|26928530|P1|Overall Study|Adverse Event|101
7745162|NCT00845728|26928529|P2|Overall Study|Lack of Efficacy|39
7745163|NCT00845728|26928530|P1|Overall Study|Lack of Efficacy|51
7745164|NCT00845728|26928529|P2|Overall Study|Protocol Violation|24
7745165|NCT00845728|26928530|P1|Overall Study|Protocol Violation|36
7745166|NCT00845728|26928529|P2|Overall Study|Administrative Problems|26
7745167|NCT00845728|26928530|P1|Overall Study|Administrative Problems|34
7745168|NCT00845728|26928529|P2|Overall Study|Death|26
7745169|NCT00845728|26928530|P1|Overall Study|Death|24
7745170|NCT00845728|26928529|P2|Overall Study|Lost to Follow-up|13
7745171|NCT00845728|26928530|P1|Overall Study|Lost to Follow-up|22
7745172|NCT00845728|26928529|P2|Overall Study|Abnormal test procedure result (s)|2
7745173|NCT00845728|26928530|P1|Overall Study|Abnormal test procedure result (s)|7
7745174|NCT00845728|26928529|P2|Overall Study|Patient's inability to use the device|6
7745175|NCT00845728|26928530|P1|Overall Study|Patient's inability to use the device|4
7745176|NCT00845728|26928529|P2|Overall Study|Abnormal laboratory value (s)|2
7745177|NCT00845728|26928530|P1|Overall Study|Abnormal laboratory value (s)|2
7745178|NCT00845676|26928544|P1|Overall Study|Adverse Event|1
7745179|NCT00845676|26928544|P1|Overall Study|Virologic breakthrough at week 20|1
7745180|NCT00845650|26928607|P6|Overall Study|Unable to access IV line|0
7745181|NCT00845650|26928608|P5|Overall Study|Unable to access IV line|0
7745182|NCT00845650|26928609|P4|Overall Study|Unable to access IV line|0
7745183|NCT00845650|26928610|P3|Overall Study|Unable to access IV line|0
7745184|NCT00845650|26928611|P2|Overall Study|Unable to access IV line|0
7745185|NCT00845650|26928612|P1|Overall Study|Unable to access IV line|1
7745186|NCT00845650|26928607|P6|Overall Study|Sponsor hold on dosing|1
7745187|NCT00845650|26928608|P5|Overall Study|Sponsor hold on dosing|1
7745188|NCT00845650|26928609|P4|Overall Study|Sponsor hold on dosing|0
7745189|NCT00845650|26928610|P3|Overall Study|Sponsor hold on dosing|0
7745190|NCT00845650|26928611|P2|Overall Study|Sponsor hold on dosing|0
7745191|NCT00845650|26928612|P1|Overall Study|Sponsor hold on dosing|0
7745192|NCT00845650|26928607|P6|Overall Study|Lost to Follow-up|1
7745193|NCT00845650|26928608|P5|Overall Study|Lost to Follow-up|0
7745194|NCT00845650|26928609|P4|Overall Study|Lost to Follow-up|1
7745195|NCT00845650|26928610|P3|Overall Study|Lost to Follow-up|3
7745196|NCT00845650|26928611|P2|Overall Study|Lost to Follow-up|0
7745197|NCT00845650|26928612|P1|Overall Study|Lost to Follow-up|0
7745198|NCT00845650|26928607|P6|Overall Study|Withdrawal by Subject|0
7745199|NCT00845650|26928608|P5|Overall Study|Withdrawal by Subject|2
7745200|NCT00845650|26928609|P4|Overall Study|Withdrawal by Subject|0
7745201|NCT00845650|26928610|P3|Overall Study|Withdrawal by Subject|0
7745202|NCT00845650|26928611|P2|Overall Study|Withdrawal by Subject|0
7745203|NCT00845650|26928612|P1|Overall Study|Withdrawal by Subject|0
7745204|NCT00845520|26928650|P3|Overall Study|Adverse Event|1
7745205|NCT00845520|26928651|P2|Overall Study|Adverse Event|0
7745206|NCT00845520|26928652|P1|Overall Study|Adverse Event|0
7745207|NCT00845520|26928650|P3|Overall Study|Lost to Follow-up|0
7745208|NCT00845520|26928651|P2|Overall Study|Lost to Follow-up|0
7745209|NCT00845520|26928652|P1|Overall Study|Lost to Follow-up|1
7745210|NCT00845520|26928650|P3|Overall Study|Death|0
7745211|NCT00845520|26928651|P2|Overall Study|Death|2
7745212|NCT00845520|26928652|P1|Overall Study|Death|1
7745213|NCT00845429|26928689|P3|Overall Study|Serious adverse event|1
7745214|NCT00845429|26928690|P2|Overall Study|Serious adverse event|0
7745215|NCT00845429|26928691|P1|Overall Study|Serious adverse event|0
7745216|NCT00845429|26928689|P3|Overall Study|Withdrawal by Subject|2
7745217|NCT00845429|26928690|P2|Overall Study|Withdrawal by Subject|2
7745218|NCT00845429|26928691|P1|Overall Study|Withdrawal by Subject|2
7745219|NCT00845429|26928689|P3|Overall Study|Lost to Follow-up|10
7745220|NCT00845429|26928690|P2|Overall Study|Lost to Follow-up|9
7745221|NCT00845429|26928691|P1|Overall Study|Lost to Follow-up|7
7745222|NCT00845429|26928689|P3|Overall Study|Protocol Violation|7
7745223|NCT00845429|26928690|P2|Overall Study|Protocol Violation|4
7745224|NCT00845429|26928691|P1|Overall Study|Protocol Violation|5
7745225|NCT00845182|26928726|P3|Overall Study|Physician Decision|1
7745226|NCT00845182|26928727|P2|Overall Study|Physician Decision|0
7745227|NCT00845182|26928728|P1|Overall Study|Physician Decision|0
7745228|NCT00845182|26928726|P3|Overall Study|Adverse Event|1
7745229|NCT00845182|26928727|P2|Overall Study|Adverse Event|1
7745230|NCT00845182|26928728|P1|Overall Study|Adverse Event|0
7745231|NCT00845182|26928726|P3|Overall Study|Lost to Follow-up|4
7745232|NCT00845182|26928727|P2|Overall Study|Lost to Follow-up|3
7745233|NCT00845182|26928728|P1|Overall Study|Lost to Follow-up|3
7745234|NCT00845065|26928753|P2|Overall Study|Non-Medical Reasons|11
7745235|NCT00845065|26928754|P1|Overall Study|Non-Medical Reasons|1
7745236|NCT00845065|26928753|P2|Overall Study|Lack of Efficacy|21
7745237|NCT00845065|26928754|P1|Overall Study|Lack of Efficacy|43
7745238|NCT00845065|26928753|P2|Overall Study|Adverse Event|23
7745239|NCT00845065|26928754|P1|Overall Study|Adverse Event|3
7745240|NCT00844896|26928822|P2|Overall Study|Parents did not have time to complete|1
7745241|NCT00844896|26928823|P1|Overall Study|Parents did not have time to complete|0
7745242|NCT00844896|26928822|P2|Overall Study|Lost to Follow-up|16
7745243|NCT00844896|26928823|P1|Overall Study|Lost to Follow-up|12
7745244|NCT00844883|26928845|P1|Overall Study|Bridged to resection|1
7745245|NCT00844883|26928845|P1|Overall Study|Bridged to liver transplant|3
7745246|NCT00844857|26928857|P2|Overall Study|Good Clinical Practice Violations|11
7745247|NCT00844857|26928858|P1|Overall Study|Good Clinical Practice Violations|21
7745248|NCT00844857|26928857|P2|Overall Study|Did Not Take Study Drug|1
7745249|NCT00844857|26928858|P1|Overall Study|Did Not Take Study Drug|3
7745250|NCT00844857|26928857|P2|Overall Study|Lost to Follow-up|3
7745251|NCT00844857|26928858|P1|Overall Study|Lost to Follow-up|2
7745252|NCT00844857|26928857|P2|Overall Study|Entry Criteria Not Met|1
7745253|NCT00844857|26928858|P1|Overall Study|Entry Criteria Not Met|0
7745254|NCT00844857|26928857|P2|Overall Study|Clinical Relapse|1
7745255|NCT00844857|26928858|P1|Overall Study|Clinical Relapse|0
7745256|NCT00844857|26928857|P2|Overall Study|Lack of Efficacy|5
7745257|NCT00844857|26928858|P1|Overall Study|Lack of Efficacy|5
7745258|NCT00844857|26928857|P2|Overall Study|Protocol Violation|0
7745259|NCT00844857|26928858|P1|Overall Study|Protocol Violation|6
7745260|NCT00844857|26928857|P2|Overall Study|Withdrawal by Subject|7
7745261|NCT00844857|26928858|P1|Overall Study|Withdrawal by Subject|8
7745262|NCT00844857|26928857|P2|Overall Study|Parent/Caregiver Decision|2
7745263|NCT00844857|26928858|P1|Overall Study|Parent/Caregiver Decision|6
7745264|NCT00844857|26928857|P2|Overall Study|Physician Decision|0
7745265|NCT00844857|26928858|P1|Overall Study|Physician Decision|2
7745266|NCT00844857|26928857|P2|Overall Study|Sponsor Decision|1
7745267|NCT00844857|26928858|P1|Overall Study|Sponsor Decision|1
7745268|NCT00844857|26928857|P2|Overall Study|Adverse Event|5
7745269|NCT00844857|26928858|P1|Overall Study|Adverse Event|24
7745270|NCT00844844|26928902|P1|Post Treatment Period|Withdrawal by Subject|1
7745271|NCT00844844|26928902|P1|Extension Treatment Period|Adverse Event|2
7745272|NCT00844844|26928902|P1|Treatment Period (26 Weeks)|Protocol Violation|1
7745273|NCT00844844|26928902|P1|Treatment Period (26 Weeks)|Adverse Event|1
7745274|NCT00844831|26928916|P1|Overall Study|Physician Decision|1
7745275|NCT00844831|26928916|P1|Overall Study|Adverse Event|1
7745276|NCT00844831|26928916|P1|Overall Study|Withdrawal by Subject|4
7745277|NCT00844805|26928926|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
7745278|NCT00844805|26928927|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7745279|NCT00844805|26928928|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7745280|NCT00844805|26928929|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7745281|NCT00844805|26928926|P4|Follow-Up Phase|Relapse/Recurrence|4
7745282|NCT00844805|26928927|P3|Follow-Up Phase|Relapse/Recurrence|2
7745283|NCT00844805|26928928|P2|Follow-Up Phase|Relapse/Recurrence|0
7745284|NCT00844805|26928929|P1|Follow-Up Phase|Relapse/Recurrence|0
7745285|NCT00844805|26928926|P4|Follow-Up Phase|Noncompliance With Protocol|1
7745286|NCT00844805|26928927|P3|Follow-Up Phase|Noncompliance With Protocol|0
7745287|NCT00844805|26928928|P2|Follow-Up Phase|Noncompliance With Protocol|0
7745288|NCT00844805|26928929|P1|Follow-Up Phase|Noncompliance With Protocol|0
7745289|NCT00844805|26928926|P4|Follow-Up Phase|Withdrawal by Subject|3
7745290|NCT00844805|26928927|P3|Follow-Up Phase|Withdrawal by Subject|6
7745291|NCT00844805|26928928|P2|Follow-Up Phase|Withdrawal by Subject|0
7745292|NCT00844805|26928929|P1|Follow-Up Phase|Withdrawal by Subject|0
7745293|NCT00844805|26928926|P4|Follow-Up Phase|Adverse Event|0
7745294|NCT00844805|26928927|P3|Follow-Up Phase|Adverse Event|1
7745295|NCT00844805|26928928|P2|Follow-Up Phase|Adverse Event|0
7745296|NCT00844805|26928929|P1|Follow-Up Phase|Adverse Event|0
7745297|NCT00844805|26928926|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
7745298|NCT00844805|26928927|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
7745299|NCT00844805|26928928|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
7745300|NCT00844805|26928929|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
7745301|NCT00844805|26928926|P4|Treatment Phase|Noncompliance With Protocol|0
7745302|NCT00844805|26928927|P3|Treatment Phase|Noncompliance With Protocol|0
7745303|NCT00844805|26928928|P2|Treatment Phase|Noncompliance With Protocol|0
7745304|NCT00844805|26928929|P1|Treatment Phase|Noncompliance With Protocol|1
7745305|NCT00844805|26928926|P4|Treatment Phase|Withdrawal by Subject|0
7745306|NCT00844805|26928927|P3|Treatment Phase|Withdrawal by Subject|0
7745307|NCT00844805|26928928|P2|Treatment Phase|Withdrawal by Subject|4
7745308|NCT00844805|26928929|P1|Treatment Phase|Withdrawal by Subject|3
7745309|NCT00844805|26928926|P4|Treatment Phase|Adverse Event|0
7745310|NCT00844805|26928927|P3|Treatment Phase|Adverse Event|0
7745311|NCT00844805|26928928|P2|Treatment Phase|Adverse Event|1
7745312|NCT00844805|26928929|P1|Treatment Phase|Adverse Event|5
7745313|NCT00844753|26928973|P4|Overall Study|Withdrawal by Subject|3
7745314|NCT00844753|26928974|P3|Overall Study|Withdrawal by Subject|0
7745315|NCT00844753|26928975|P2|Overall Study|Withdrawal by Subject|0
7745316|NCT00844753|26928976|P1|Overall Study|Withdrawal by Subject|1
7745317|NCT00844753|26928973|P4|Overall Study|could not swallow medication|0
7745318|NCT00844753|26928974|P3|Overall Study|could not swallow medication|0
7745319|NCT00844753|26928975|P2|Overall Study|could not swallow medication|0
7745320|NCT00844753|26928976|P1|Overall Study|could not swallow medication|2
7745321|NCT00844753|26928973|P4|Overall Study|Lost to Follow-up|1
7745322|NCT00844753|26928974|P3|Overall Study|Lost to Follow-up|0
7745323|NCT00844753|26928975|P2|Overall Study|Lost to Follow-up|1
7745324|NCT00844753|26928976|P1|Overall Study|Lost to Follow-up|1
7745325|NCT00844753|26928973|P4|Overall Study|Adverse Event|5
7745326|NCT00844753|26928974|P3|Overall Study|Adverse Event|5
7745327|NCT00844753|26928975|P2|Overall Study|Adverse Event|2
7745328|NCT00844753|26928976|P1|Overall Study|Adverse Event|3
7745329|NCT00844753|26928973|P4|Overall Study|Lack of Efficacy|2
7745330|NCT00844753|26928974|P3|Overall Study|Lack of Efficacy|2
7745331|NCT00844753|26928975|P2|Overall Study|Lack of Efficacy|0
7745332|NCT00844753|26928976|P1|Overall Study|Lack of Efficacy|1
7745333|NCT00844649|26928994|P2|Overall Study|Withdrew prior to starting treatment|27
7745334|NCT00844649|26928995|P1|Overall Study|Withdrew prior to starting treatment|11
7745335|NCT00844649|26928994|P2|Overall Study|Other|10
7745336|NCT00844649|26928995|P1|Overall Study|Other|7
7745337|NCT00844649|26928994|P2|Overall Study|Withdrawal by Subject|39
7745338|NCT00844649|26928995|P1|Overall Study|Withdrawal by Subject|28
7745339|NCT00844649|26928994|P2|Overall Study|Protocol Violation|6
7745340|NCT00844649|26928995|P1|Overall Study|Protocol Violation|10
7745341|NCT00844649|26928994|P2|Overall Study|Physician Decision|18
7745342|NCT00844649|26928995|P1|Overall Study|Physician Decision|25
7745343|NCT00844649|26928994|P2|Overall Study|Adverse Event|73
7745344|NCT00844649|26928995|P1|Overall Study|Adverse Event|128
7745345|NCT00844649|26928994|P2|Overall Study|Progressive Disease|245
7745346|NCT00844649|26928995|P1|Overall Study|Progressive Disease|196
7745347|NCT00844597|26929019|P6|Overall Study|Adverse Event|0
7745348|NCT00844597|26929020|P5|Overall Study|Adverse Event|0
7745349|NCT00844597|26929021|P4|Overall Study|Adverse Event|1
7745350|NCT00844597|26929022|P3|Overall Study|Adverse Event|0
7745351|NCT00844597|26929023|P2|Overall Study|Adverse Event|0
7745352|NCT00844597|26929024|P1|Overall Study|Adverse Event|0
7745353|NCT00844558|26929044|P2|Overall Study|Physician Decision|0
7745354|NCT00844558|26929045|P1|Overall Study|Physician Decision|1
7745355|NCT00844558|26929044|P2|Overall Study|Lost to Follow-up|1
7745356|NCT00844558|26929045|P1|Overall Study|Lost to Follow-up|0
7745357|NCT00844558|26929044|P2|Overall Study|Protocol Violation|1
7745358|NCT00844558|26929045|P1|Overall Study|Protocol Violation|1
7745359|NCT00844558|26929044|P2|Overall Study|Death|0
7745360|NCT00844558|26929045|P1|Overall Study|Death|1
7745361|NCT00844558|26929044|P2|Overall Study|Withdrawal by Subject|2
7745362|NCT00844558|26929045|P1|Overall Study|Withdrawal by Subject|9
7745363|NCT00844545|26929061|P1|Post Treatment Period|Withdrawal by Subject|1
7745364|NCT00844545|26929061|P1|Extension Treatment Period|Adverse Event|2
7745365|NCT00844545|26929061|P1|Treatment Period (26 Weeks)|Protocol Violation|1
7745366|NCT00844545|26929061|P1|Treatment Period (26 Weeks)|Adverse Event|1
7745367|NCT00844532|26929075|P1|Overall Study|Lost to Follow-up|7
7745368|NCT00844532|26929075|P1|Overall Study|Withdrawal by Subject|16
7745369|NCT00844532|26929075|P1|Overall Study|Death|16
7745370|NCT00844519|26929161|P2|Overall Study|Adverse Event|0
7745371|NCT00844519|26929162|P1|Overall Study|Adverse Event|1
7745372|NCT00844519|26929161|P2|Overall Study|Withdrawal by Subject|1
7745373|NCT00844519|26929162|P1|Overall Study|Withdrawal by Subject|1
7745374|NCT00844480|26929170|P2|Overall Study|Withdrawal by Subject|3
7745375|NCT00844480|26929171|P1|Overall Study|Withdrawal by Subject|2
7745376|NCT00844428|26929179|P1|Post Treatment Period (Patients Who Disc|Death|1
7745377|NCT00844428|26929179|P1|Extension Treatment Period|Death|1
7745378|NCT00844428|26929179|P1|Screening Period|Screen Failure|3
7745379|NCT00844415|26929195|P1|Overall Study|Withdrawal by Subject|1
7745380|NCT00844376|26929209|P2|Period 1: First Intervention|Withdrawal by Subject|0
7745381|NCT00844376|26929210|P1|Period 1: First Intervention|Withdrawal by Subject|1
7745382|NCT00844194|26929234|P2|Overall Study|Other reason (not specified)|0
7745383|NCT00844194|26929235|P1|Overall Study|Other reason (not specified)|1
7745384|NCT00844194|26929234|P2|Overall Study|Lack of Efficacy|0
7745385|NCT00844194|26929235|P1|Overall Study|Lack of Efficacy|3
7745386|NCT00844194|26929234|P2|Overall Study|Withdrawal by Subject|1
7745387|NCT00844194|26929235|P1|Overall Study|Withdrawal by Subject|2
7745388|NCT00844194|26929234|P2|Overall Study|Lost to Follow-up|1
7745389|NCT00844194|26929235|P1|Overall Study|Lost to Follow-up|1
7745390|NCT00844194|26929234|P2|Overall Study|Protocol Violation|1
7745391|NCT00844194|26929235|P1|Overall Study|Protocol Violation|1
7745392|NCT00844194|26929234|P2|Overall Study|Adverse Event|5
7745393|NCT00844194|26929235|P1|Overall Study|Adverse Event|17
7745394|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7745395|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
7745396|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7745397|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7745398|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Alternative treatment|1
7745399|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7745400|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Physician Decision|0
7745401|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Physician Decision|1
7745402|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Physician Decision|1
7745403|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
7745404|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
7745405|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
7745406|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Death|0
7745407|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Death|3
7745408|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Death|0
7745409|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Adverse Event|0
7745410|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Adverse Event|6
7745411|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Adverse Event|0
7745412|NCT00843882|26929491|P3|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
7745413|NCT00843882|26929492|P2|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
7745414|NCT00843882|26929493|P1|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
7745415|NCT00843882|26929491|P3|Step 1|Never started treatment|0
7745416|NCT00843882|26929492|P2|Step 1|Never started treatment|0
7745417|NCT00843882|26929493|P1|Step 1|Never started treatment|2
7745418|NCT00843882|26929491|P3|Step 1|Off treatment reason unknown|4
7745419|NCT00843882|26929492|P2|Step 1|Off treatment reason unknown|1
7745420|NCT00843882|26929493|P1|Step 1|Off treatment reason unknown|0
7745421|NCT00843882|26929491|P3|Step 1|Patient switched treatment early due to DSMC announcement|0
7745422|NCT00843882|26929492|P2|Step 1|Patient switched treatment early due to DSMC announcement|4
7745423|NCT00843882|26929493|P1|Step 1|Patient switched treatment early due to DSMC announcement|0
7745424|NCT00843882|26929491|P3|Step 1|Alternative therapy|1
7745425|NCT00843882|26929492|P2|Step 1|Alternative therapy|1
7745426|NCT00843882|26929493|P1|Step 1|Alternative therapy|0
7745427|NCT00843882|26929491|P3|Step 1|Other complicating disease|4
7745428|NCT00843882|26929492|P2|Step 1|Other complicating disease|3
7745429|NCT00843882|26929493|P1|Step 1|Other complicating disease|1
7745430|NCT00843882|26929491|P3|Step 1|Patient and physician's decision|1
7745431|NCT00843882|26929492|P2|Step 1|Patient and physician's decision|0
7745432|NCT00843882|26929493|P1|Step 1|Patient and physician's decision|0
7745433|NCT00843882|26929491|P3|Step 1|Physician Decision|1
7745434|NCT00843882|26929492|P2|Step 1|Physician Decision|5
7745435|NCT00843882|26929493|P1|Step 1|Physician Decision|0
7745436|NCT00843882|26929491|P3|Step 1|Withdrawal by Subject|9
7745437|NCT00843882|26929492|P2|Step 1|Withdrawal by Subject|12
7745438|NCT00843882|26929493|P1|Step 1|Withdrawal by Subject|6
7745439|NCT00843882|26929491|P3|Step 1|Death|4
7745440|NCT00843882|26929492|P2|Step 1|Death|2
7745441|NCT00843882|26929493|P1|Step 1|Death|1
7745442|NCT00843882|26929491|P3|Step 1|Adverse Event|20
7745443|NCT00843882|26929492|P2|Step 1|Adverse Event|17
7745444|NCT00843882|26929493|P1|Step 1|Adverse Event|8
7745445|NCT00843882|26929491|P3|Step 1|Lack of Efficacy|21
7745446|NCT00843882|26929492|P2|Step 1|Lack of Efficacy|10
7745447|NCT00843882|26929493|P1|Step 1|Lack of Efficacy|14
7745448|NCT00843856|26929518|P2|Overall Study|Lost to Follow-up|2
7745449|NCT00843856|26929519|P1|Overall Study|Lost to Follow-up|1
7745450|NCT00843843|26929529|P2|Overall Study|Protocol Violation|1
7745451|NCT00843843|26929530|P1|Overall Study|Protocol Violation|1
7745452|NCT00843843|26929529|P2|Overall Study|Physician Decision|1
7745453|NCT00843843|26929530|P1|Overall Study|Physician Decision|1
7745454|NCT00843778|26929543|P1|Overall Study|Withdrawal by Subject|4
7745455|NCT00843778|26929543|P1|Overall Study|Loss of efficacy|2
7745456|NCT00843778|26929543|P1|Overall Study|Lack of Efficacy|14
7745457|NCT00843778|26929543|P1|Overall Study|Adverse Event|15
7745458|NCT00843726|26929578|P2|Overall Study|Withdrawal by Subject|1
7745459|NCT00843726|26929579|P1|Overall Study|Withdrawal by Subject|0
7745460|NCT00843726|26929578|P2|Overall Study|Death|0
7745461|NCT00843726|26929579|P1|Overall Study|Death|1
7745462|NCT00843635|26929601|P3|Overall Study|Adverse Event|0
7745463|NCT00843635|26929602|P2|Overall Study|Adverse Event|2
7745464|NCT00843635|26929603|P1|Overall Study|Adverse Event|2
7745465|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
7745466|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
7745467|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
7745468|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
7745469|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
7745470|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
7745471|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
7745472|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
7745473|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
7745474|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
7745475|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Death|1
7745476|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Death|0
7745477|NCT00843518|26929642|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
7745478|NCT00843518|26929643|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
7745479|NCT00843492|26929673|P2|Overall Study|Deep-vein Thrombosis|0
7745480|NCT00843492|26929674|P1|Overall Study|Deep-vein Thrombosis|1
7745481|NCT00843492|26929673|P2|Overall Study|Visit Not Performed|0
7745482|NCT00843492|26929674|P1|Overall Study|Visit Not Performed|1
7745483|NCT00843492|26929673|P2|Overall Study|Orthopedic Surgery|2
7745484|NCT00843492|26929674|P1|Overall Study|Orthopedic Surgery|0
7745485|NCT00843492|26929673|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
7745486|NCT00843492|26929674|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
7745487|NCT00843492|26929673|P2|Overall Study|Immobilization Stopped|0
7745488|NCT00843492|26929674|P1|Overall Study|Immobilization Stopped|1
7745489|NCT00843492|26929673|P2|Overall Study|Withdrawal by Subject|4
7745490|NCT00843492|26929674|P1|Overall Study|Withdrawal by Subject|0
7745491|NCT00843492|26929673|P2|Overall Study|Lost to Follow-up|4
7745492|NCT00843492|26929674|P1|Overall Study|Lost to Follow-up|4
7745493|NCT00843492|26929673|P2|Overall Study|Adverse Event|3
7745494|NCT00843492|26929674|P1|Overall Study|Adverse Event|0
7745495|NCT00843284|26929745|P1|Overall Study|Death|3
7745496|NCT00843284|26929745|P1|Overall Study|Withdrawal by Subject|4
7745497|NCT00843284|26929745|P1|Overall Study|Other|10
7745498|NCT00843284|26929745|P1|Overall Study|Lost to Follow-up|11
7745499|NCT00843284|26929745|P1|Overall Study|Lack of Efficacy|5
7745500|NCT00843284|26929745|P1|Overall Study|Adverse Event|39
7745501|NCT00843193|26929755|P2|Overall Study|Withdrawal by Subject|3
7745502|NCT00843193|26929756|P1|Overall Study|Withdrawal by Subject|3
7745503|NCT00843193|26929755|P2|Overall Study|Physician Decision|1
7745504|NCT00843193|26929756|P1|Overall Study|Physician Decision|0
7745505|NCT00843193|26929755|P2|Overall Study|Lost to Follow-up|0
7745506|NCT00843193|26929756|P1|Overall Study|Lost to Follow-up|1
7745507|NCT00843193|26929755|P2|Overall Study|Protocol Violation|2
7745508|NCT00843193|26929756|P1|Overall Study|Protocol Violation|1
7745509|NCT00843193|26929755|P2|Overall Study|Lack of Efficacy|1
7745510|NCT00843193|26929756|P1|Overall Study|Lack of Efficacy|1
7745511|NCT00843193|26929755|P2|Overall Study|Adverse Event|4
7745512|NCT00843193|26929756|P1|Overall Study|Adverse Event|2
7745513|NCT00843167|26929807|P2|Treatment Period|Withdrawal by Subject|3
7745514|NCT00843167|26929808|P1|Treatment Period|Withdrawal by Subject|2
7745515|NCT00843167|26929807|P2|Treatment Period|Adverse Event|5
7745516|NCT00843167|26929808|P1|Treatment Period|Adverse Event|1
7745517|NCT00843115|26929821|P1|Overall Study|Syndrome De Glissement|1
7745518|NCT00843115|26929821|P1|Overall Study|week 12 not done|1
7745519|NCT00843115|26929821|P1|Overall Study|hospitalized due to deterioration|1
7745520|NCT00843115|26929821|P1|Overall Study|patient never took the medication|1
7745521|NCT00843115|26929821|P1|Overall Study|patient took for 2 days then stopped|1
7745522|NCT00843115|26929821|P1|Overall Study|Family discontinued meds|1
7745523|NCT00843115|26929821|P1|Overall Study|Physician Decision|1
7745524|NCT00843115|26929821|P1|Overall Study|Does not meet entrance criteria|1
7745525|NCT00843115|26929821|P1|Overall Study|Patient forgot to take meds|1
7745526|NCT00843115|26929821|P1|Overall Study|Family does not want continuation|1
7745527|NCT00843115|26929821|P1|Overall Study|Family wanted meds stopped|1
7745528|NCT00843115|26929821|P1|Overall Study|Withdrawal by Subject|17
7745529|NCT00843115|26929821|P1|Overall Study|Lost to Follow-up|4
7745530|NCT00843115|26929821|P1|Overall Study|Adverse Event|30
7745531|NCT00843115|26929821|P1|Overall Study|Death|4
7745532|NCT00843024|26929877|P6|Double-blind Treatment Phase|Lack of Efficacy|0
7745533|NCT00843024|26929878|P5|Double-blind Treatment Phase|Lack of Efficacy|1
7745534|NCT00843024|26929879|P4|Double-blind Treatment Phase|Lack of Efficacy|0
7745535|NCT00843024|26929880|P3|Double-blind Treatment Phase|Lack of Efficacy|0
7745536|NCT00843024|26929881|P2|Double-blind Treatment Phase|Lack of Efficacy|0
7745537|NCT00843024|26929882|P1|Double-blind Treatment Phase|Lack of Efficacy|0
7745538|NCT00843024|26929877|P6|Double-blind Treatment Phase|Adverse Event|1
7745539|NCT00843024|26929878|P5|Double-blind Treatment Phase|Adverse Event|1
7745540|NCT00843024|26929879|P4|Double-blind Treatment Phase|Adverse Event|0
7745541|NCT00843024|26929880|P3|Double-blind Treatment Phase|Adverse Event|0
7745542|NCT00843024|26929881|P2|Double-blind Treatment Phase|Adverse Event|0
7745543|NCT00843024|26929882|P1|Double-blind Treatment Phase|Adverse Event|0
7745544|NCT00843024|26929877|P6|Double-blind Treatment Phase|Physician Decision|1
7745545|NCT00843024|26929878|P5|Double-blind Treatment Phase|Physician Decision|1
7745546|NCT00843024|26929879|P4|Double-blind Treatment Phase|Physician Decision|3
7745547|NCT00843024|26929880|P3|Double-blind Treatment Phase|Physician Decision|0
7745548|NCT00843024|26929881|P2|Double-blind Treatment Phase|Physician Decision|0
7745549|NCT00843024|26929882|P1|Double-blind Treatment Phase|Physician Decision|0
7745550|NCT00843024|26929877|P6|Double-blind Treatment Phase|Protocol Violation|3
7745551|NCT00843024|26929878|P5|Double-blind Treatment Phase|Protocol Violation|0
7745552|NCT00843024|26929879|P4|Double-blind Treatment Phase|Protocol Violation|0
7745553|NCT00843024|26929880|P3|Double-blind Treatment Phase|Protocol Violation|3
7745554|NCT00843024|26929881|P2|Double-blind Treatment Phase|Protocol Violation|0
7745555|NCT00843024|26929882|P1|Double-blind Treatment Phase|Protocol Violation|0
7745556|NCT00843024|26929877|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
7745557|NCT00843024|26929878|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
7745558|NCT00843024|26929879|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
7745559|NCT00843024|26929880|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
7745560|NCT00843024|26929881|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
7745561|NCT00843024|26929882|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
7745562|NCT00843024|26929877|P6|Double-blind Treatment Phase|Lost to Follow-up|4
7745563|NCT00843024|26929878|P5|Double-blind Treatment Phase|Lost to Follow-up|4
7745564|NCT00843024|26929879|P4|Double-blind Treatment Phase|Lost to Follow-up|4
7745565|NCT00843024|26929880|P3|Double-blind Treatment Phase|Lost to Follow-up|8
7745566|NCT00843024|26929881|P2|Double-blind Treatment Phase|Lost to Follow-up|0
7745567|NCT00843024|26929882|P1|Double-blind Treatment Phase|Lost to Follow-up|0
7745568|NCT00843024|26929877|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
7745569|NCT00843024|26929878|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
7745570|NCT00843024|26929879|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
7745571|NCT00843024|26929880|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
7745572|NCT00843024|26929881|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
7745573|NCT00843024|26929882|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
7745574|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Other|0
7745575|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Other|0
7745576|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Other|0
7745577|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Other|0
7745578|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Other|1
7745579|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Other|0
7745580|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
7745581|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
7745582|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
7745583|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
7745584|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
7745585|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
7745586|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
7745587|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
7745588|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
7745589|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
7745590|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
7745591|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
7745592|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
7745593|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
7745594|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
7745595|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
7745596|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
7745597|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
7745598|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7745599|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7745600|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7745601|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7745602|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
7745603|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
7745604|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7745605|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7745606|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7745607|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7745608|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
7745609|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
7745610|NCT00843024|26929877|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7745611|NCT00843024|26929878|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7745612|NCT00843024|26929879|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7745613|NCT00843024|26929880|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7745614|NCT00843024|26929881|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
7745615|NCT00843024|26929882|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
7745616|NCT00842985|26929947|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
7745617|NCT00842985|26929947|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
7745618|NCT00842985|26929947|P1|First Intervention|Protocol Violation|3
7745619|NCT00842985|26929947|P1|First Intervention|Withdrawal by Subject|3
7745620|NCT00842985|26929947|P1|Screening|Did not meet entrance requirements|27
7745621|NCT00842829|26929965|P3|Continuation Period|Non-compliance to study drug|1
7745622|NCT00842829|26929966|P2|Continuation Period|Non-compliance to study drug|0
7745623|NCT00842829|26929967|P1|Continuation Period|Non-compliance to study drug|0
7745624|NCT00842829|26929965|P3|Continuation Period|Non-compliance to study procedures|2
7745625|NCT00842829|26929966|P2|Continuation Period|Non-compliance to study procedures|0
7745626|NCT00842829|26929967|P1|Continuation Period|Non-compliance to study procedures|0
7745627|NCT00842829|26929965|P3|Continuation Period|Other|7
7745628|NCT00842829|26929966|P2|Continuation Period|Other|0
7745629|NCT00842829|26929967|P1|Continuation Period|Other|0
7745630|NCT00842829|26929965|P3|Continuation Period|Withdrawal by Subject|10
7745631|NCT00842829|26929966|P2|Continuation Period|Withdrawal by Subject|0
7745632|NCT00842829|26929967|P1|Continuation Period|Withdrawal by Subject|0
7745633|NCT00842829|26929965|P3|Continuation Period|Unstable persistent cancer pain|3
7745634|NCT00842829|26929966|P2|Continuation Period|Unstable persistent cancer pain|0
7745635|NCT00842829|26929967|P1|Continuation Period|Unstable persistent cancer pain|0
7745636|NCT00842829|26929965|P3|Continuation Period|Lack of Efficacy|6
7745637|NCT00842829|26929966|P2|Continuation Period|Lack of Efficacy|0
7745638|NCT00842829|26929967|P1|Continuation Period|Lack of Efficacy|0
7745639|NCT00842829|26929965|P3|Continuation Period|Adverse Event|32
7745640|NCT00842829|26929966|P2|Continuation Period|Adverse Event|0
7745641|NCT00842829|26929967|P1|Continuation Period|Adverse Event|0
7745642|NCT00842829|26929965|P3|Treatment Period|Unclear completion status|1
7745643|NCT00842829|26929966|P2|Treatment Period|Unclear completion status|0
7745644|NCT00842829|26929967|P1|Treatment Period|Unclear completion status|0
7745645|NCT00842829|26929965|P3|Treatment Period|Non-compliance to study procedures|4
7745646|NCT00842829|26929966|P2|Treatment Period|Non-compliance to study procedures|0
7745647|NCT00842829|26929967|P1|Treatment Period|Non-compliance to study procedures|0
7745648|NCT00842829|26929965|P3|Treatment Period|Other|18
7745649|NCT00842829|26929966|P2|Treatment Period|Other|0
7745650|NCT00842829|26929967|P1|Treatment Period|Other|0
7745651|NCT00842829|26929965|P3|Treatment Period|Protocol Violation|2
7745652|NCT00842829|26929966|P2|Treatment Period|Protocol Violation|0
7745653|NCT00842829|26929967|P1|Treatment Period|Protocol Violation|0
7745654|NCT00842829|26929965|P3|Treatment Period|Consistently >4 BTP episodes daily|1
7745655|NCT00842829|26929966|P2|Treatment Period|Consistently >4 BTP episodes daily|0
7745656|NCT00842829|26929967|P1|Treatment Period|Consistently >4 BTP episodes daily|0
7745657|NCT00842829|26929965|P3|Treatment Period|Withdrawal by Subject|11
7745658|NCT00842829|26929966|P2|Treatment Period|Withdrawal by Subject|0
7745659|NCT00842829|26929967|P1|Treatment Period|Withdrawal by Subject|0
7745660|NCT00842829|26929965|P3|Treatment Period|Unstable persistent cancer pain|5
7745661|NCT00842829|26929966|P2|Treatment Period|Unstable persistent cancer pain|0
7745662|NCT00842829|26929967|P1|Treatment Period|Unstable persistent cancer pain|0
7745663|NCT00842829|26929965|P3|Treatment Period|Lack of Efficacy|6
7745664|NCT00842829|26929966|P2|Treatment Period|Lack of Efficacy|0
7745665|NCT00842829|26929967|P1|Treatment Period|Lack of Efficacy|0
7745666|NCT00842829|26929965|P3|Treatment Period|Adverse Event|15
7745667|NCT00842829|26929966|P2|Treatment Period|Adverse Event|0
7745668|NCT00842829|26929967|P1|Treatment Period|Adverse Event|0
7745669|NCT00842829|26929965|P3|Dose Titration Period|Non-compliance to study drug|0
7745670|NCT00842829|26929966|P2|Dose Titration Period|Non-compliance to study drug|1
7745671|NCT00842829|26929967|P1|Dose Titration Period|Non-compliance to study drug|2
7745672|NCT00842829|26929965|P3|Dose Titration Period|Non-compliance to study procedures|0
7745673|NCT00842829|26929966|P2|Dose Titration Period|Non-compliance to study procedures|1
7745674|NCT00842829|26929967|P1|Dose Titration Period|Non-compliance to study procedures|1
7745675|NCT00842829|26929965|P3|Dose Titration Period|Other|0
7745676|NCT00842829|26929966|P2|Dose Titration Period|Other|4
7745677|NCT00842829|26929967|P1|Dose Titration Period|Other|5
7745678|NCT00842829|26929965|P3|Dose Titration Period|Withdrawal by Subject|0
7745679|NCT00842829|26929966|P2|Dose Titration Period|Withdrawal by Subject|6
7745680|NCT00842829|26929967|P1|Dose Titration Period|Withdrawal by Subject|2
7745681|NCT00842829|26929965|P3|Dose Titration Period|Unstable persistent cancer pain|0
7745682|NCT00842829|26929966|P2|Dose Titration Period|Unstable persistent cancer pain|0
7745683|NCT00842829|26929967|P1|Dose Titration Period|Unstable persistent cancer pain|1
7745684|NCT00842829|26929965|P3|Dose Titration Period|Lack of Efficacy|0
7745685|NCT00842829|26929966|P2|Dose Titration Period|Lack of Efficacy|1
7745686|NCT00842829|26929967|P1|Dose Titration Period|Lack of Efficacy|4
7745687|NCT00842829|26929965|P3|Dose Titration Period|Adverse Event|0
7745688|NCT00842829|26929966|P2|Dose Titration Period|Adverse Event|10
7745689|NCT00842829|26929967|P1|Dose Titration Period|Adverse Event|11
7745690|NCT00842712|26930026|P7|Randomized Part|Ongoing at cut-off date|2
7745691|NCT00842712|26930027|P6|Randomized Part|Ongoing at cut-off date|0
7745692|NCT00842712|26930028|P5|Randomized Part|Ongoing at cut-off date|0
7745693|NCT00842712|26930029|P4|Randomized Part|Ongoing at cut-off date|0
7745694|NCT00842712|26930030|P3|Randomized Part|Ongoing at cut-off date|0
7745695|NCT00842712|26930031|P2|Randomized Part|Ongoing at cut-off date|0
7745696|NCT00842712|26930032|P1|Randomized Part|Ongoing at cut-off date|0
7745697|NCT00842712|26930026|P7|Randomized Part|Randomized but not treated|4
7745698|NCT00842712|26930027|P6|Randomized Part|Randomized but not treated|1
7745699|NCT00842712|26930028|P5|Randomized Part|Randomized but not treated|0
7745700|NCT00842712|26930029|P4|Randomized Part|Randomized but not treated|0
7745701|NCT00842712|26930030|P3|Randomized Part|Randomized but not treated|0
7745702|NCT00842712|26930031|P2|Randomized Part|Randomized but not treated|0
7745703|NCT00842712|26930032|P1|Randomized Part|Randomized but not treated|0
7745704|NCT00842712|26930026|P7|Safety Run-in Part|Progressive disease|0
7745705|NCT00842712|26930027|P6|Safety Run-in Part|Progressive disease|0
7745706|NCT00842712|26930028|P5|Safety Run-in Part|Progressive disease|0
7745707|NCT00842712|26930029|P4|Safety Run-in Part|Progressive disease|1
7745708|NCT00842712|26930030|P3|Safety Run-in Part|Progressive disease|0
7745709|NCT00842712|26930031|P2|Safety Run-in Part|Progressive disease|1
7745710|NCT00842712|26930032|P1|Safety Run-in Part|Progressive disease|3
7745711|NCT00842712|26930026|P7|Safety Run-in Part|Adverse Event|0
7745712|NCT00842712|26930027|P6|Safety Run-in Part|Adverse Event|0
7745713|NCT00842712|26930028|P5|Safety Run-in Part|Adverse Event|0
7745714|NCT00842712|26930029|P4|Safety Run-in Part|Adverse Event|0
7745715|NCT00842712|26930030|P3|Safety Run-in Part|Adverse Event|0
7745716|NCT00842712|26930031|P2|Safety Run-in Part|Adverse Event|1
7745717|NCT00842712|26930032|P1|Safety Run-in Part|Adverse Event|0
7745718|NCT00842543|26930089|P4|Overall Study|Withdrawal by Subject|4
7745719|NCT00842543|26930090|P3|Overall Study|Withdrawal by Subject|3
7745720|NCT00842543|26930091|P2|Overall Study|Withdrawal by Subject|0
7745721|NCT00842543|26930092|P1|Overall Study|Withdrawal by Subject|2
7745722|NCT00842530|26930106|P2|Overall Study|Withdrawal by Subject|28
7745723|NCT00842530|26930107|P1|Overall Study|Withdrawal by Subject|73
7745724|NCT00842530|26930106|P2|Overall Study|Lost to Follow-up|8
7745725|NCT00842530|26930107|P1|Overall Study|Lost to Follow-up|6
7745726|NCT00842530|26930106|P2|Overall Study|Protocol Violation|14
7745727|NCT00842530|26930107|P1|Overall Study|Protocol Violation|32
7745728|NCT00842530|26930106|P2|Overall Study|Other adverse event|1
7745729|NCT00842530|26930107|P1|Overall Study|Other adverse event|6
7745730|NCT00842530|26930106|P2|Overall Study|Serious adverse event|6
7745731|NCT00842530|26930107|P1|Overall Study|Serious adverse event|0
7745732|NCT00842361|26930137|P2|Overall Study|Unclassified|2
7745733|NCT00842361|26930138|P1|Overall Study|Unclassified|0
7745734|NCT00842361|26930137|P2|Overall Study|Protocol Violation|0
7745735|NCT00842361|26930138|P1|Overall Study|Protocol Violation|1
7745736|NCT00842348|26930158|P2|Study 729|Surgical resection|0
7745737|NCT00842348|26930159|P1|Study 729|Surgical resection|1
7745738|NCT00842348|26930158|P2|Study 729|Sponsor's decision|0
7745739|NCT00842348|26930159|P1|Study 729|Sponsor's decision|1
7745740|NCT00842348|26930158|P2|Study 729|Due to non-availability of IP|1
7745741|NCT00842348|26930159|P1|Study 729|Due to non-availability of IP|0
7745742|NCT00842348|26930158|P2|Study 729|Due to Sponsor stopping the study|1
7745743|NCT00842348|26930159|P1|Study 729|Due to Sponsor stopping the study|1
7745744|NCT00842348|26930158|P2|Study 729|Withdrawal by Subject|4
7745745|NCT00842348|26930159|P1|Study 729|Withdrawal by Subject|2
7745746|NCT00842348|26930158|P2|Study 729|Protocol Violation|1
7745747|NCT00842348|26930159|P1|Study 729|Protocol Violation|1
7745748|NCT00842348|26930158|P2|Study 729|Adverse Event|1
7745749|NCT00842348|26930159|P1|Study 729|Adverse Event|1
7745750|NCT00842348|26930158|P2|Study 729|Disease progression/death|30
7745751|NCT00842348|26930159|P1|Study 729|Disease progression/death|19
7745752|NCT00842348|26930158|P2|Patients Randomised in Study 726|Did not enter Study 729|56
7745753|NCT00842348|26930159|P1|Patients Randomised in Study 726|Did not enter Study 729|59
7745754|NCT00842309|26930178|P2|Overall Study|Withdrawal by Subject|1
7745755|NCT00842309|26930179|P1|Overall Study|Withdrawal by Subject|3
7745756|NCT00842257|26930213|P1|Overall Study|Adverse Event|1
7745757|NCT00842244|26930220|P1|Overall Study|Other|17
7745758|NCT00842244|26930220|P1|Overall Study|Withdrawal by Subject|1
7745759|NCT00842244|26930220|P1|Overall Study|Death|3
7745760|NCT00842153|26930247|P2|Overall Study|Lost to Follow-up|2
7745761|NCT00842153|26930248|P1|Overall Study|Lost to Follow-up|1
7745762|NCT00842153|26930247|P2|Overall Study|Adverse Event|1
7745763|NCT00842153|26930248|P1|Overall Study|Adverse Event|0
7745764|NCT00841906|26930323|P2|Overall Study|Withdrawal by Subject|0
7745765|NCT00841906|26930324|P1|Overall Study|Withdrawal by Subject|2
7745766|NCT00841815|26930349|P2|Washout|Withdrawal by Subject|1
7745767|NCT00841815|26930350|P1|Washout|Withdrawal by Subject|0
7745768|NCT00841776|26930360|P2|Overall Study|Withdrawal by Subject|1
7745769|NCT00841776|26930361|P1|Overall Study|Withdrawal by Subject|0
7745770|NCT00841776|26930360|P2|Overall Study|Lost to Follow-up|1
7745771|NCT00841776|26930361|P1|Overall Study|Lost to Follow-up|2
7745772|NCT00841776|26930360|P2|Overall Study|Lack of Efficacy|1
7745773|NCT00841776|26930361|P1|Overall Study|Lack of Efficacy|0
7745774|NCT00841763|26930379|P4|Overall Study|Unable to Classify|0
7745775|NCT00841763|26930380|P3|Overall Study|Unable to Classify|0
7745776|NCT00841763|26930381|P2|Overall Study|Unable to Classify|1
7745777|NCT00841763|26930382|P1|Overall Study|Unable to Classify|7
7745778|NCT00841763|26930379|P4|Overall Study|Administrative Reasons|0
7745779|NCT00841763|26930380|P3|Overall Study|Administrative Reasons|0
7745780|NCT00841763|26930381|P2|Overall Study|Administrative Reasons|1
7745781|NCT00841763|26930382|P1|Overall Study|Administrative Reasons|3
7745782|NCT00841763|26930379|P4|Overall Study|Protocol Violation|0
7745783|NCT00841763|26930380|P3|Overall Study|Protocol Violation|1
7745784|NCT00841763|26930381|P2|Overall Study|Protocol Violation|3
7745785|NCT00841763|26930382|P1|Overall Study|Protocol Violation|20
7745786|NCT00841763|26930379|P4|Overall Study|Lost to Follow-up|0
7745787|NCT00841763|26930380|P3|Overall Study|Lost to Follow-up|0
7745788|NCT00841763|26930381|P2|Overall Study|Lost to Follow-up|25
7745789|NCT00841763|26930382|P1|Overall Study|Lost to Follow-up|63
7745790|NCT00841763|26930379|P4|Overall Study|Adverse Event|2
7745791|NCT00841763|26930380|P3|Overall Study|Adverse Event|3
7745792|NCT00841763|26930381|P2|Overall Study|Adverse Event|10
7745793|NCT00841763|26930382|P1|Overall Study|Adverse Event|9
7745794|NCT00841763|26930379|P4|Overall Study|Withdrawal by Subject|1
7745795|NCT00841763|26930380|P3|Overall Study|Withdrawal by Subject|4
7745796|NCT00841763|26930381|P2|Overall Study|Withdrawal by Subject|17
7745797|NCT00841763|26930382|P1|Overall Study|Withdrawal by Subject|60
7745798|NCT00841698|26930452|P2|First Intervention|Withdrawal by Subject|0
7745799|NCT00841698|26930453|P1|First Intervention|Withdrawal by Subject|1
7745800|NCT00841672|26930463|P2|Overall Study|Protocol Deviation|1
7745801|NCT00841672|26930464|P1|Overall Study|Protocol Deviation|0
7745802|NCT00841672|26930463|P2|Overall Study|Misrandomized|0
7745803|NCT00841672|26930464|P1|Overall Study|Misrandomized|1
7745804|NCT00841672|26930463|P2|Overall Study|Administrative problems|9
7745805|NCT00841672|26930464|P1|Overall Study|Administrative problems|9
7745806|NCT00841672|26930463|P2|Overall Study|Lost to Follow-up|1
7745807|NCT00841672|26930464|P1|Overall Study|Lost to Follow-up|1
7745808|NCT00841672|26930463|P2|Overall Study|Subject withdrew consent|4
7745809|NCT00841672|26930464|P1|Overall Study|Subject withdrew consent|2
7745810|NCT00841672|26930463|P2|Overall Study|Abnormal test procedure result(s)|1
7745811|NCT00841672|26930464|P1|Overall Study|Abnormal test procedure result(s)|0
7745812|NCT00841672|26930463|P2|Overall Study|Adverse Event|16
7745813|NCT00841672|26930464|P1|Overall Study|Adverse Event|7
7745814|NCT00841659|26930480|P2|Washout: 2 Weeks|Protocol Violation|0
7745815|NCT00841659|26930481|P1|Washout: 2 Weeks|Protocol Violation|1
7745816|NCT00841568|26930489|P1|Overall Study|Creatinine over the withdrawal criteria|1
7745817|NCT00841568|26930489|P1|Overall Study|Withdrawal by Subject|2
7745818|NCT00841568|26930489|P1|Overall Study|Death|1
7745819|NCT00841568|26930489|P1|Overall Study|Adverse Event|1
7745820|NCT00841542|26930517|P2|Period 1|Adverse Event|0
7745821|NCT00841542|26930518|P1|Period 1|Adverse Event|1
7745822|NCT00841321|26930533|P2|Overall Study|Adverse Event|2
7745823|NCT00841321|26930534|P1|Overall Study|Adverse Event|0
7745824|NCT00841321|26930533|P2|Overall Study|Lost to Follow-up|1
7745825|NCT00841321|26930534|P1|Overall Study|Lost to Follow-up|1
7745826|NCT00841100|26930581|P1|Phase 1 (28 Days)|Participant non-compliance|2
7745827|NCT00841100|26930581|P1|Phase 1 (28 Days)|Adverse Event|1
7745828|NCT00841035|26930606|P1|Phase 1 Overall Study|Physician Decision|13
7745829|NCT00840996|26930613|P2|Overall Study|Withdrawal by Subject|0
7745830|NCT00840996|26930614|P1|Overall Study|Withdrawal by Subject|1
7745831|NCT00840970|26930632|P3|Overall Study|Adverse Event|1
7745832|NCT00840970|26930633|P2|Overall Study|Adverse Event|0
7745833|NCT00840970|26930634|P1|Overall Study|Adverse Event|0
7745834|NCT00840879|26930654|P2|Second Intervention|Withdrawal by Subject|0
7745835|NCT00840879|26930655|P1|Second Intervention|Withdrawal by Subject|1
7745836|NCT00840827|26930691|P1|Overall Study|Physician Decision|1
7745837|NCT00840827|26930691|P1|Overall Study|Lack of Efficacy|4
7745838|NCT00840827|26930691|P1|Overall Study|Adverse Event|1
7745839|NCT00840749|26930706|P2|Overall Study|study closed|14
7745840|NCT00840749|26930707|P1|Overall Study|study closed|19
7745841|NCT00840749|26930706|P2|Overall Study|not treated on study arm|11
7745842|NCT00840749|26930707|P1|Overall Study|not treated on study arm|11
7745843|NCT00840749|26930706|P2|Overall Study|Death|2
7745844|NCT00840749|26930707|P1|Overall Study|Death|1
7745845|NCT00840658|26930719|P4|Overall Study|Lost to Follow-up|1
7745846|NCT00840658|26930720|P3|Overall Study|Lost to Follow-up|2
7745847|NCT00840658|26930721|P2|Overall Study|Lost to Follow-up|1
7745848|NCT00840658|26930722|P1|Overall Study|Lost to Follow-up|3
7745849|NCT00840658|26930719|P4|Overall Study|Death|3
7745850|NCT00840658|26930720|P3|Overall Study|Death|3
7745851|NCT00840658|26930721|P2|Overall Study|Death|2
7745852|NCT00840658|26930722|P1|Overall Study|Death|2
7745853|NCT00840632|26930740|P2|Washout|Withdrawal by Subject|1
7745854|NCT00840632|26930741|P1|Washout|Withdrawal by Subject|1
7745855|NCT00840632|26930740|P2|First Intervention|Withdrawal by Subject|1
7745856|NCT00840632|26930741|P1|First Intervention|Withdrawal by Subject|0
7745857|NCT00840463|26930768|P2|Overall Study|Adverse Event|0
7745858|NCT00840463|26930769|P1|Overall Study|Adverse Event|1
7745859|NCT00840450|26930783|P1|Overall Study|Lack of Efficacy|2
7745860|NCT00840450|26930783|P1|Overall Study|Adverse Event|1
7745861|NCT00840411|26930791|P2|Washout|Withdrawal by Subject|0
7745862|NCT00840411|26930792|P1|Washout|Withdrawal by Subject|1
7745863|NCT00840411|26930791|P2|First Intervention|Adverse Event|0
7745864|NCT00840411|26930792|P1|First Intervention|Adverse Event|1
7745865|NCT00840294|26930806|P2|Overall Study|Illness|1
7745866|NCT00840294|26930807|P1|Overall Study|Illness|0
7745867|NCT00840294|26930806|P2|Overall Study|Protocol Violation|3
7745868|NCT00840294|26930807|P1|Overall Study|Protocol Violation|1
7745869|NCT00840294|26930806|P2|Overall Study|Withdrawal by Subject|1
7745870|NCT00840294|26930807|P1|Overall Study|Withdrawal by Subject|2
7745871|NCT00840216|26930828|P2|Washout: 7 Days|Withdrawal by Subject|0
7745872|NCT00840216|26930829|P1|Washout: 7 Days|Withdrawal by Subject|1
7745873|NCT00840203|26930839|P2|Washout|Protocol Violation|0
7745874|NCT00840203|26930840|P1|Washout|Protocol Violation|1
7745875|NCT00840203|26930839|P2|First Intervention|Protocol Violation|1
7745876|NCT00840203|26930840|P1|First Intervention|Protocol Violation|1
7745877|NCT00840177|26930857|P3|Overall Study|Did not start treatment|1
7745878|NCT00840177|26930858|P2|Overall Study|Did not start treatment|0
7745879|NCT00840177|26930859|P1|Overall Study|Did not start treatment|0
7745880|NCT00840177|26930857|P3|Overall Study|Ineligible|3
7745881|NCT00840177|26930858|P2|Overall Study|Ineligible|0
7745882|NCT00840177|26930859|P1|Overall Study|Ineligible|0
7745883|NCT00840177|26930857|P3|Overall Study|not protocol specified|0
7745884|NCT00840177|26930858|P2|Overall Study|not protocol specified|3
7745885|NCT00840177|26930859|P1|Overall Study|not protocol specified|6
7745886|NCT00840177|26930857|P3|Overall Study|Death|5
7745887|NCT00840177|26930858|P2|Overall Study|Death|5
7745888|NCT00840177|26930859|P1|Overall Study|Death|4
7745889|NCT00840177|26930857|P3|Overall Study|Progression/relapse|0
7745890|NCT00840177|26930858|P2|Overall Study|Progression/relapse|0
7745891|NCT00840177|26930859|P1|Overall Study|Progression/relapse|2
7745892|NCT00840177|26930857|P3|Overall Study|Refusal unrelated to adverse events|1
7745893|NCT00840177|26930858|P2|Overall Study|Refusal unrelated to adverse events|0
7745894|NCT00840177|26930859|P1|Overall Study|Refusal unrelated to adverse events|1
7745895|NCT00840177|26930857|P3|Overall Study|Adverse Event|1
7745896|NCT00840177|26930858|P2|Overall Study|Adverse Event|1
7745897|NCT00840177|26930859|P1|Overall Study|Adverse Event|5
7745898|NCT00840086|26930893|P1|Overall Study|Lost to Follow-up|1
7745899|NCT00840086|26930893|P1|Overall Study|Protocol Violation|2
7745900|NCT00840086|26930893|P1|Overall Study|Adverse Event|1
7745901|NCT00840073|26930902|P2|Second Intervention|Missed 72 hour blood draw|1
7745902|NCT00840073|26930903|P1|Second Intervention|Missed 72 hour blood draw|1
7745903|NCT00840060|26930917|P2|Overall Study|Change in emotional/behavioral status|1
7745904|NCT00840060|26930918|P1|Overall Study|Change in emotional/behavioral status|0
7745905|NCT00840060|26930917|P2|Overall Study|Withdrawal by Subject|0
7745906|NCT00840060|26930918|P1|Overall Study|Withdrawal by Subject|1
7745907|NCT00840034|26930928|P2|Taper Phase|Withdrawal by Subject|1
7745908|NCT00840034|26930929|P1|Taper Phase|Withdrawal by Subject|1
7745909|NCT00840034|26930928|P2|Taper Phase|Lost to Follow-up|1
7745910|NCT00840034|26930929|P1|Taper Phase|Lost to Follow-up|1
7745911|NCT00840034|26930928|P2|Taper Phase|Adverse Event|0
7745912|NCT00840034|26930929|P1|Taper Phase|Adverse Event|1
7745913|NCT00840034|26930928|P2|Acute Treatment Phase|Withdrawal by Subject|11
7745914|NCT00840034|26930929|P1|Acute Treatment Phase|Withdrawal by Subject|6
7745915|NCT00840034|26930928|P2|Acute Treatment Phase|Protocol Violation|4
7745916|NCT00840034|26930929|P1|Acute Treatment Phase|Protocol Violation|2
7745917|NCT00840034|26930928|P2|Acute Treatment Phase|Physician Decision|1
7745918|NCT00840034|26930929|P1|Acute Treatment Phase|Physician Decision|0
7745919|NCT00840034|26930928|P2|Acute Treatment Phase|Lost to Follow-up|12
7745920|NCT00840034|26930929|P1|Acute Treatment Phase|Lost to Follow-up|5
7745921|NCT00840034|26930928|P2|Acute Treatment Phase|Lack of Efficacy|0
7745922|NCT00840034|26930929|P1|Acute Treatment Phase|Lack of Efficacy|2
7745923|NCT00840034|26930928|P2|Acute Treatment Phase|Adverse Event|8
7745924|NCT00840034|26930929|P1|Acute Treatment Phase|Adverse Event|6
7745925|NCT00839956|26930982|P1|Overall Study|Withdrawal by Subject|3
7745926|NCT00839956|26930982|P1|Overall Study|Physician Decision|1
7745927|NCT00839956|26930982|P1|Overall Study|Lack of Efficacy|6
7745928|NCT00839956|26930982|P1|Overall Study|Adverse Event|2
7745929|NCT00839917|26931002|P2|Overall Study|Did not receive vaccine|1
7745930|NCT00839917|26931003|P1|Overall Study|Did not receive vaccine|0
7745931|NCT00839917|26931002|P2|Overall Study|Lost to Follow-up|0
7745932|NCT00839917|26931003|P1|Overall Study|Lost to Follow-up|1
7745933|NCT00839852|26931039|P1|Overall Study|Pregnancy|1
7745934|NCT00839852|26931039|P1|Overall Study|Lack of Compliance While in Jail|1
7745935|NCT00839852|26931039|P1|Overall Study|Lost to Follow-up|7
7745936|NCT00839852|26931039|P1|Overall Study|Withdrawal of Consent|16
7745937|NCT00839852|26931039|P1|Overall Study|Protocol Violation|9
7745938|NCT00839852|26931039|P1|Overall Study|Insufficient Therapeutic Response|3
7745939|NCT00839852|26931039|P1|Overall Study|Adverse Event|10
7745940|NCT00839800|26931046|P2|Overall Study|Severe Non-Compliance to Protocol|7
7745941|NCT00839800|26931047|P1|Overall Study|Severe Non-Compliance to Protocol|7
7745942|NCT00839800|26931046|P2|Overall Study|Other|14
7745943|NCT00839800|26931047|P1|Overall Study|Other|8
7745944|NCT00839800|26931046|P2|Overall Study|Safety Reasons|1
7745945|NCT00839800|26931047|P1|Overall Study|Safety Reasons|2
7745946|NCT00839800|26931046|P2|Overall Study|Study-Specific Discontinuation Criteria|13
7745947|NCT00839800|26931047|P1|Overall Study|Study-Specific Discontinuation Criteria|6
7745948|NCT00839800|26931046|P2|Overall Study|Incorrect Enrolment|3
7745949|NCT00839800|26931047|P1|Overall Study|Incorrect Enrolment|3
7745950|NCT00839800|26931046|P2|Overall Study|Withdrawal by Subject|34
7745951|NCT00839800|26931047|P1|Overall Study|Withdrawal by Subject|28
7745952|NCT00839800|26931046|P2|Overall Study|Lost to Follow-up|26
7745953|NCT00839800|26931047|P1|Overall Study|Lost to Follow-up|31
7745954|NCT00839800|26931046|P2|Overall Study|Adverse Event|12
7745955|NCT00839800|26931047|P1|Overall Study|Adverse Event|8
7745956|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
7745957|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
7745958|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
7745959|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
7745960|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
7745961|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
7745962|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
7745963|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
7745964|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
7745965|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
7745966|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
7745967|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
7746041|NCT00839423|26931144|P4|Overall Study|Lost to Follow-up|0
7745968|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
7745969|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
7745970|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
7745971|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
7745972|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
7745973|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
7745974|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
7745975|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
7745976|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
7745977|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7745978|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
7745979|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
7745980|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
7745981|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
7745982|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
7745983|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
7745984|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
7745985|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
7745986|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
7745987|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
7745988|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
7745989|NCT00839527|26931093|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7745990|NCT00839527|26931094|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
7745991|NCT00839527|26931095|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7745992|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
7745993|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
7745994|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
7745995|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
7745996|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
7745997|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
7745998|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7745999|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7746000|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
7746001|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
7746002|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
7746003|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
7746004|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Missing|0
7746005|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Missing|1
7746006|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Missing|0
7746007|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
7746008|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
7746009|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
7746010|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
7746011|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
7746012|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
7746013|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
7746014|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
7746015|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
7746016|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
7746017|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
7746018|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
7746019|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
7746020|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
7746021|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
7746022|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
7746023|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
7746024|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
7746025|NCT00839527|26931093|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
7746026|NCT00839527|26931094|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
7746027|NCT00839527|26931095|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
7746028|NCT00839436|26931130|P3|Overall Study|Study drug no longer available|1
7746029|NCT00839436|26931131|P2|Overall Study|Study drug no longer available|0
7746030|NCT00839436|26931132|P1|Overall Study|Study drug no longer available|0
7746031|NCT00839436|26931130|P3|Overall Study|Withdrawal by Subject|0
7746032|NCT00839436|26931131|P2|Overall Study|Withdrawal by Subject|1
7746033|NCT00839436|26931132|P1|Overall Study|Withdrawal by Subject|0
7746034|NCT00839436|26931130|P3|Overall Study|Developed exclusionary condition|0
7746035|NCT00839436|26931131|P2|Overall Study|Developed exclusionary condition|0
7746036|NCT00839436|26931132|P1|Overall Study|Developed exclusionary condition|1
7746037|NCT00839423|26931144|P4|Overall Study|Administrative or other reasons|0
7746038|NCT00839423|26931145|P3|Overall Study|Administrative or other reasons|1
7746039|NCT00839423|26931146|P2|Overall Study|Administrative or other reasons|0
7746040|NCT00839423|26931147|P1|Overall Study|Administrative or other reasons|3
7746042|NCT00839423|26931145|P3|Overall Study|Lost to Follow-up|1
7746043|NCT00839423|26931146|P2|Overall Study|Lost to Follow-up|0
7746044|NCT00839423|26931147|P1|Overall Study|Lost to Follow-up|1
7746045|NCT00839423|26931144|P4|Overall Study|Withdrawal of consent|1
7746046|NCT00839423|26931145|P3|Overall Study|Withdrawal of consent|4
7746047|NCT00839423|26931146|P2|Overall Study|Withdrawal of consent|0
7746048|NCT00839423|26931147|P1|Overall Study|Withdrawal of consent|4
7746049|NCT00839423|26931144|P4|Overall Study|Protocol Violation|0
7746050|NCT00839423|26931145|P3|Overall Study|Protocol Violation|2
7746051|NCT00839423|26931146|P2|Overall Study|Protocol Violation|1
7746052|NCT00839423|26931147|P1|Overall Study|Protocol Violation|0
7746053|NCT00839423|26931144|P4|Overall Study|Non-compliance|1
7746054|NCT00839423|26931145|P3|Overall Study|Non-compliance|0
7746055|NCT00839423|26931146|P2|Overall Study|Non-compliance|0
7746056|NCT00839423|26931147|P1|Overall Study|Non-compliance|0
7746057|NCT00839423|26931144|P4|Overall Study|Lack of Efficacy|2
7746058|NCT00839423|26931145|P3|Overall Study|Lack of Efficacy|3
7746059|NCT00839423|26931146|P2|Overall Study|Lack of Efficacy|6
7746060|NCT00839423|26931147|P1|Overall Study|Lack of Efficacy|6
7746061|NCT00839423|26931144|P4|Overall Study|Adverse Event|16
7746062|NCT00839423|26931145|P3|Overall Study|Adverse Event|7
7746063|NCT00839423|26931146|P2|Overall Study|Adverse Event|3
7746064|NCT00839423|26931147|P1|Overall Study|Adverse Event|4
7746065|NCT00839332|26931188|P3|Phase 2|Lost to Follow-up|1
7746066|NCT00839332|26931189|P2|Phase 2|Lost to Follow-up|0
7746067|NCT00839332|26931190|P1|Phase 2|Lost to Follow-up|0
7746068|NCT00839332|26931188|P3|Phase 2|Physician Decision|1
7746069|NCT00839332|26931189|P2|Phase 2|Physician Decision|4
7746070|NCT00839332|26931190|P1|Phase 2|Physician Decision|0
7746071|NCT00839332|26931188|P3|Phase 2|Withdrawal by Subject|8
7746072|NCT00839332|26931189|P2|Phase 2|Withdrawal by Subject|5
7746073|NCT00839332|26931190|P1|Phase 2|Withdrawal by Subject|0
7746074|NCT00839332|26931188|P3|Phase 2|Death|2
7746075|NCT00839332|26931189|P2|Phase 2|Death|4
7746076|NCT00839332|26931190|P1|Phase 2|Death|0
7746077|NCT00839332|26931188|P3|Phase 2|Adverse Event|6
7746078|NCT00839332|26931189|P2|Phase 2|Adverse Event|8
7746079|NCT00839332|26931190|P1|Phase 2|Adverse Event|0
7746080|NCT00839332|26931188|P3|Phase 2|Disease Progression|21
7746081|NCT00839332|26931189|P2|Phase 2|Disease Progression|46
7746082|NCT00839332|26931190|P1|Phase 2|Disease Progression|0
7746083|NCT00839332|26931188|P3|Phase 2|Protocol Violation|0
7746084|NCT00839332|26931189|P2|Phase 2|Protocol Violation|1
7746085|NCT00839332|26931190|P1|Phase 2|Protocol Violation|0
7746086|NCT00839332|26931188|P3|Phase 1|Physician Decision|0
7746087|NCT00839332|26931189|P2|Phase 1|Physician Decision|0
7746088|NCT00839332|26931190|P1|Phase 1|Physician Decision|2
7746089|NCT00839332|26931188|P3|Phase 1|Withdrawal by Subject|0
7746090|NCT00839332|26931189|P2|Phase 1|Withdrawal by Subject|0
7746091|NCT00839332|26931190|P1|Phase 1|Withdrawal by Subject|4
7746092|NCT00839332|26931188|P3|Phase 1|Adverse Event|0
7746093|NCT00839332|26931189|P2|Phase 1|Adverse Event|0
7746094|NCT00839332|26931190|P1|Phase 1|Adverse Event|6
7746095|NCT00839332|26931188|P3|Phase 1|Disease Progression|0
7746096|NCT00839332|26931189|P2|Phase 1|Disease Progression|0
7746097|NCT00839332|26931190|P1|Phase 1|Disease Progression|38
7746098|NCT00839306|26931251|P2|Overall Study|Other|18
7746099|NCT00839306|26931252|P1|Overall Study|Other|6
7746100|NCT00839306|26931251|P2|Overall Study|Lack of Efficacy|4
7746101|NCT00839306|26931252|P1|Overall Study|Lack of Efficacy|5
7746102|NCT00839306|26931251|P2|Overall Study|Withdrawal by Subject|7
7746103|NCT00839306|26931252|P1|Overall Study|Withdrawal by Subject|5
7746104|NCT00839306|26931251|P2|Overall Study|Lost to Follow-up|9
7746105|NCT00839306|26931252|P1|Overall Study|Lost to Follow-up|6
7746106|NCT00839306|26931251|P2|Overall Study|Adverse Event|5
7746107|NCT00839306|26931252|P1|Overall Study|Adverse Event|3
7746108|NCT00839254|26931268|P8|Overall Study|Lost to Follow-up|2
7746109|NCT00839254|26931269|P7|Overall Study|Lost to Follow-up|4
7746110|NCT00839254|26931270|P6|Overall Study|Lost to Follow-up|8
7746111|NCT00839254|26931271|P5|Overall Study|Lost to Follow-up|8
7746112|NCT00839254|26931272|P4|Overall Study|Lost to Follow-up|24
7746113|NCT00839254|26931273|P3|Overall Study|Lost to Follow-up|32
7746114|NCT00839254|26931274|P2|Overall Study|Lost to Follow-up|30
7746115|NCT00839254|26931275|P1|Overall Study|Lost to Follow-up|51
7746116|NCT00839254|26931268|P8|Overall Study|Withdrawn due to non-compliance|0
7746117|NCT00839254|26931269|P7|Overall Study|Withdrawn due to non-compliance|0
7746118|NCT00839254|26931270|P6|Overall Study|Withdrawn due to non-compliance|0
7746119|NCT00839254|26931271|P5|Overall Study|Withdrawn due to non-compliance|0
7746120|NCT00839254|26931272|P4|Overall Study|Withdrawn due to non-compliance|0
7746121|NCT00839254|26931273|P3|Overall Study|Withdrawn due to non-compliance|0
7746122|NCT00839254|26931274|P2|Overall Study|Withdrawn due to non-compliance|0
7746123|NCT00839254|26931275|P1|Overall Study|Withdrawn due to non-compliance|2
7746124|NCT00839254|26931268|P8|Overall Study|Parents wanted pneumococcal vaccine|0
7746125|NCT00839254|26931269|P7|Overall Study|Parents wanted pneumococcal vaccine|0
7746126|NCT00839254|26931270|P6|Overall Study|Parents wanted pneumococcal vaccine|1
7746127|NCT00839254|26931271|P5|Overall Study|Parents wanted pneumococcal vaccine|0
7746128|NCT00839254|26931272|P4|Overall Study|Parents wanted pneumococcal vaccine|0
7746129|NCT00839254|26931273|P3|Overall Study|Parents wanted pneumococcal vaccine|0
7746130|NCT00839254|26931274|P2|Overall Study|Parents wanted pneumococcal vaccine|0
7746131|NCT00839254|26931275|P1|Overall Study|Parents wanted pneumococcal vaccine|1
7746132|NCT00839254|26931268|P8|Overall Study|Wrong group allocation|0
7746133|NCT00839254|26931269|P7|Overall Study|Wrong group allocation|1
7746134|NCT00839254|26931270|P6|Overall Study|Wrong group allocation|0
7746135|NCT00839254|26931271|P5|Overall Study|Wrong group allocation|0
7746136|NCT00839254|26931272|P4|Overall Study|Wrong group allocation|0
7746137|NCT00839254|26931273|P3|Overall Study|Wrong group allocation|0
7746138|NCT00839254|26931274|P2|Overall Study|Wrong group allocation|0
7746139|NCT00839254|26931275|P1|Overall Study|Wrong group allocation|0
7746140|NCT00839254|26931268|P8|Overall Study|Withdrawal by Subject|9
7746141|NCT00839254|26931269|P7|Overall Study|Withdrawal by Subject|22
7746142|NCT00839254|26931270|P6|Overall Study|Withdrawal by Subject|15
7746143|NCT00839254|26931271|P5|Overall Study|Withdrawal by Subject|27
7746144|NCT00839254|26931272|P4|Overall Study|Withdrawal by Subject|32
7746145|NCT00839254|26931273|P3|Overall Study|Withdrawal by Subject|54
7746146|NCT00839254|26931274|P2|Overall Study|Withdrawal by Subject|53
7746147|NCT00839254|26931275|P1|Overall Study|Withdrawal by Subject|87
7746148|NCT00839254|26931268|P8|Overall Study|Adverse Event|1
7746149|NCT00839254|26931269|P7|Overall Study|Adverse Event|0
7746150|NCT00839254|26931270|P6|Overall Study|Adverse Event|1
7746151|NCT00839254|26931271|P5|Overall Study|Adverse Event|2
7746152|NCT00839254|26931272|P4|Overall Study|Adverse Event|5
7746153|NCT00839254|26931273|P3|Overall Study|Adverse Event|3
7746154|NCT00839254|26931274|P2|Overall Study|Adverse Event|6
7746155|NCT00839254|26931275|P1|Overall Study|Adverse Event|12
7746156|NCT00839254|26931268|P8|Overall Study|Wrong treatment number allocation|0
7746157|NCT00839254|26931269|P7|Overall Study|Wrong treatment number allocation|0
7746158|NCT00839254|26931270|P6|Overall Study|Wrong treatment number allocation|1
7746159|NCT00839254|26931271|P5|Overall Study|Wrong treatment number allocation|0
7746160|NCT00839254|26931272|P4|Overall Study|Wrong treatment number allocation|0
7746161|NCT00839254|26931273|P3|Overall Study|Wrong treatment number allocation|0
7746162|NCT00839254|26931274|P2|Overall Study|Wrong treatment number allocation|1
7746163|NCT00839254|26931275|P1|Overall Study|Wrong treatment number allocation|0
7746164|NCT00839254|26931268|P8|Overall Study|Physician Decision|1
7746165|NCT00839254|26931269|P7|Overall Study|Physician Decision|0
7746166|NCT00839254|26931270|P6|Overall Study|Physician Decision|0
7746167|NCT00839254|26931271|P5|Overall Study|Physician Decision|0
7746168|NCT00839254|26931272|P4|Overall Study|Physician Decision|0
7746169|NCT00839254|26931273|P3|Overall Study|Physician Decision|0
7746170|NCT00839254|26931274|P2|Overall Study|Physician Decision|1
7746171|NCT00839254|26931275|P1|Overall Study|Physician Decision|0
7746172|NCT00839254|26931268|P8|Overall Study|Protocol Violation|2
7746173|NCT00839254|26931269|P7|Overall Study|Protocol Violation|1
7746174|NCT00839254|26931270|P6|Overall Study|Protocol Violation|0
7746175|NCT00839254|26931271|P5|Overall Study|Protocol Violation|0
7746176|NCT00839254|26931272|P4|Overall Study|Protocol Violation|1
7746177|NCT00839254|26931273|P3|Overall Study|Protocol Violation|1
7746178|NCT00839254|26931274|P2|Overall Study|Protocol Violation|1
7746179|NCT00839254|26931275|P1|Overall Study|Protocol Violation|0
7746180|NCT00839098|26931599|P3|Overall Study|Withdrawal by Subject|7
7746181|NCT00839098|26931600|P2|Overall Study|Withdrawal by Subject|1
7746182|NCT00839098|26931601|P1|Overall Study|Withdrawal by Subject|2
7746183|NCT00839072|26931627|P2|Second Intervention Period|Withdrawal by Subject|0
7746184|NCT00839072|26931628|P1|Second Intervention Period|Withdrawal by Subject|1
7746185|NCT00839072|26931627|P2|First Intervention Period|Adverse Event|1
7746186|NCT00839072|26931628|P1|First Intervention Period|Adverse Event|1
7746187|NCT00839072|26931627|P2|First Intervention Period|Withdrawal by Subject|0
7746188|NCT00839072|26931628|P1|First Intervention Period|Withdrawal by Subject|1
7746189|NCT00838929|26931672|P3|Overall Study|Disease progression|1
7746190|NCT00838929|26931673|P2|Overall Study|Disease progression|2
7746191|NCT00838929|26931674|P1|Overall Study|Disease progression|0
7746192|NCT00838929|26931672|P3|Overall Study|Protocol Violation|0
7746193|NCT00838929|26931673|P2|Overall Study|Protocol Violation|1
7746194|NCT00838929|26931674|P1|Overall Study|Protocol Violation|0
7746195|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Missing|0
7746196|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Missing|3
7746197|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
7746198|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
7746199|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
7746200|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
7746201|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Physician Decision|0
7746202|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Physician Decision|2
7746203|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
7746204|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
7746205|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
7746206|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
7746207|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
7746208|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
7746209|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Noncompliance|5
7746210|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Noncompliance|6
7746211|NCT00838916|26931682|P2|Follow-up Period (8 Weeks)|Adverse Event|5
7746212|NCT00838916|26931683|P1|Follow-up Period (8 Weeks)|Adverse Event|10
7746213|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Pregnancy|0
7746214|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Pregnancy|2
7746215|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Missing|1
7746216|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Missing|3
7746217|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
7746218|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
7746219|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Physician Decision|1
7746220|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Physician Decision|6
7746221|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
7746222|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
7746223|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
7746224|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
7746225|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7746226|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
7746227|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Noncompliance|14
7746228|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Noncompliance|21
7746229|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Protocol Violation|3
7746230|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Protocol Violation|12
7746231|NCT00838916|26931682|P2|Treatment Period (156 Weeks)|Adverse Event|11
7746232|NCT00838916|26931683|P1|Treatment Period (156 Weeks)|Adverse Event|50
7746233|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Missing|1
7746234|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Missing|1
7746235|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Missing|2
7746236|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Missing|1
7746237|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
7746238|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7746239|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7746240|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7746241|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7746242|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7746243|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
7746244|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7746245|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7746246|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7746247|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
7746248|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7746249|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7746250|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
7746251|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7746252|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
7746253|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Physician Decision|1
7746254|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Physician Decision|1
7746255|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Physician Decision|1
7746256|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Physician Decision|1
7746257|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
7746258|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
7746259|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
7746260|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
7746261|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
7746262|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
7746263|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
7746264|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
7746265|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
7746266|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
7746267|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
7746268|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
7746269|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Noncompliance|5
7746270|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Noncompliance|5
7746271|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Noncompliance|8
7746272|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Noncompliance|2
7746273|NCT00838903|26931712|P4|Follow-up Period (8 Weeks)|Adverse Event|1
7746274|NCT00838903|26931713|P3|Follow-up Period (8 Weeks)|Adverse Event|3
7746275|NCT00838903|26931714|P2|Follow-up Period (8 Weeks)|Adverse Event|0
7746276|NCT00838903|26931715|P1|Follow-up Period (8 Weeks)|Adverse Event|0
7746277|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7746278|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7746279|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7746280|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
7746281|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
7746282|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
7746283|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
7746284|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
7746285|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7746286|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7746287|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7746288|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
7746289|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Site closed|0
7746290|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Site closed|1
7746291|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Site closed|0
7746292|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Site closed|0
7746293|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7746294|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
7746295|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7746296|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7746297|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Pregnancy|0
7746298|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Pregnancy|1
7746299|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Pregnancy|0
7746300|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Pregnancy|0
7746301|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7746302|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7746303|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7746304|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
7746305|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
7746306|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7746307|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7746308|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7746309|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7746310|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7746311|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
7746312|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7746313|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
7746314|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
7746315|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
7746316|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
7746317|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Physician Decision|2
7746318|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Physician Decision|1
7746319|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Physician Decision|2
7746320|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Physician Decision|1
7746321|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
7746322|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
7746323|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
7746324|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
7746325|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
7746326|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
7746327|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
7746328|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
7746329|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7746330|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
7746331|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7746332|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7746333|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Noncompliance|6
7746334|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Noncompliance|12
7746335|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Noncompliance|13
7746336|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Noncompliance|9
7746337|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Protocol Violation|5
7746338|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Protocol Violation|6
7746339|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Protocol Violation|6
7746340|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Protocol Violation|1
7746341|NCT00838903|26931712|P4|Treatment Period (156 Weeks)|Adverse Event|25
7746342|NCT00838903|26931713|P3|Treatment Period (156 Weeks)|Adverse Event|17
7746343|NCT00838903|26931714|P2|Treatment Period (156 Weeks)|Adverse Event|13
7746344|NCT00838903|26931715|P1|Treatment Period (156 Weeks)|Adverse Event|5
7746345|NCT00838682|26931770|P2|Overall Study|Withdrawal by Subject|1
7746346|NCT00838682|26931771|P1|Overall Study|Withdrawal by Subject|0
7746347|NCT00838682|26931770|P2|Overall Study|Protocol Violation|1
7746348|NCT00838682|26931771|P1|Overall Study|Protocol Violation|0
7746349|NCT00838682|26931770|P2|Overall Study|detection of exclusion criteria|3
7746350|NCT00838682|26931771|P1|Overall Study|detection of exclusion criteria|4
7746351|NCT00838682|26931770|P2|Overall Study|Lost to Follow-up|14
7746352|NCT00838682|26931771|P1|Overall Study|Lost to Follow-up|21
7746353|NCT00838630|26931789|P2|Washout: 7 Days|Protocol Violation|0
7746354|NCT00838630|26931790|P1|Washout: 7 Days|Protocol Violation|1
7746355|NCT00838630|26931789|P2|First Intervention|Adverse Event|0
7746356|NCT00838630|26931790|P1|First Intervention|Adverse Event|1
7746357|NCT00838578|26931798|P1|Overall Study|Protocol Violation|2
7746358|NCT00838565|26931812|P6|Overall Study|Randomized but not Treated|0
7746359|NCT00838565|26931813|P5|Overall Study|Randomized but not Treated|0
7746360|NCT00838565|26931814|P4|Overall Study|Randomized but not Treated|0
7746361|NCT00838565|26931815|P3|Overall Study|Randomized but not Treated|0
7746362|NCT00838565|26931816|P2|Overall Study|Randomized but not Treated|1
7746363|NCT00838565|26931817|P1|Overall Study|Randomized but not Treated|0
7746364|NCT00838565|26931812|P6|Overall Study|Other|0
7746365|NCT00838565|26931813|P5|Overall Study|Other|0
7746366|NCT00838565|26931814|P4|Overall Study|Other|0
7746367|NCT00838565|26931815|P3|Overall Study|Other|0
7746368|NCT00838565|26931816|P2|Overall Study|Other|2
7746369|NCT00838565|26931817|P1|Overall Study|Other|0
7746370|NCT00838565|26931812|P6|Overall Study|Withdrawal by Subject|2
7746371|NCT00838565|26931813|P5|Overall Study|Withdrawal by Subject|0
7746372|NCT00838565|26931814|P4|Overall Study|Withdrawal by Subject|0
7746373|NCT00838565|26931815|P3|Overall Study|Withdrawal by Subject|1
7746374|NCT00838565|26931816|P2|Overall Study|Withdrawal by Subject|0
7746375|NCT00838565|26931817|P1|Overall Study|Withdrawal by Subject|0
7746376|NCT00838539|26931922|P12|Overall Study|Symptomatic Deterioration|0
7746377|NCT00838539|26931923|P11|Overall Study|Symptomatic Deterioration|0
7746378|NCT00838539|26931924|P10|Overall Study|Symptomatic Deterioration|1
7746379|NCT00838539|26931925|P9|Overall Study|Symptomatic Deterioration|0
7746380|NCT00838539|26931926|P8|Overall Study|Symptomatic Deterioration|0
7746381|NCT00838539|26931927|P7|Overall Study|Symptomatic Deterioration|0
7746382|NCT00838539|26931928|P6|Overall Study|Symptomatic Deterioration|1
7746383|NCT00838539|26931929|P5|Overall Study|Symptomatic Deterioration|0
7746384|NCT00838539|26931930|P4|Overall Study|Symptomatic Deterioration|1
7746385|NCT00838539|26931931|P3|Overall Study|Symptomatic Deterioration|1
7746386|NCT00838539|26931932|P2|Overall Study|Symptomatic Deterioration|0
7746387|NCT00838539|26931933|P1|Overall Study|Symptomatic Deterioration|0
7746388|NCT00838539|26931922|P12|Overall Study|Clinical Progression|0
7746389|NCT00838539|26931923|P11|Overall Study|Clinical Progression|0
7746390|NCT00838539|26931924|P10|Overall Study|Clinical Progression|0
7746391|NCT00838539|26931925|P9|Overall Study|Clinical Progression|0
7746392|NCT00838539|26931926|P8|Overall Study|Clinical Progression|0
7746393|NCT00838539|26931927|P7|Overall Study|Clinical Progression|1
7746394|NCT00838539|26931928|P6|Overall Study|Clinical Progression|0
7746395|NCT00838539|26931929|P5|Overall Study|Clinical Progression|0
7746396|NCT00838539|26931930|P4|Overall Study|Clinical Progression|0
7746397|NCT00838539|26931931|P3|Overall Study|Clinical Progression|0
7746398|NCT00838539|26931932|P2|Overall Study|Clinical Progression|0
7746399|NCT00838539|26931933|P1|Overall Study|Clinical Progression|0
7746400|NCT00838539|26931922|P12|Overall Study|Physician Decision|0
7746401|NCT00838539|26931923|P11|Overall Study|Physician Decision|0
7746402|NCT00838539|26931924|P10|Overall Study|Physician Decision|0
7746403|NCT00838539|26931925|P9|Overall Study|Physician Decision|1
7746404|NCT00838539|26931926|P8|Overall Study|Physician Decision|0
7746405|NCT00838539|26931927|P7|Overall Study|Physician Decision|0
7746406|NCT00838539|26931928|P6|Overall Study|Physician Decision|0
7746407|NCT00838539|26931929|P5|Overall Study|Physician Decision|0
7746408|NCT00838539|26931930|P4|Overall Study|Physician Decision|0
7746409|NCT00838539|26931931|P3|Overall Study|Physician Decision|0
7746410|NCT00838539|26931932|P2|Overall Study|Physician Decision|0
7746411|NCT00838539|26931933|P1|Overall Study|Physician Decision|0
7746412|NCT00838539|26931922|P12|Overall Study|Death|0
7746413|NCT00838539|26931923|P11|Overall Study|Death|0
7746414|NCT00838539|26931924|P10|Overall Study|Death|0
7746415|NCT00838539|26931925|P9|Overall Study|Death|0
7746416|NCT00838539|26931926|P8|Overall Study|Death|0
7746417|NCT00838539|26931927|P7|Overall Study|Death|1
7746418|NCT00838539|26931928|P6|Overall Study|Death|0
7746419|NCT00838539|26931929|P5|Overall Study|Death|0
7746420|NCT00838539|26931930|P4|Overall Study|Death|0
7746421|NCT00838539|26931931|P3|Overall Study|Death|0
7746422|NCT00838539|26931932|P2|Overall Study|Death|0
7746423|NCT00838539|26931933|P1|Overall Study|Death|0
7746424|NCT00838539|26931922|P12|Overall Study|Withdrawal by Subject|0
7746425|NCT00838539|26931923|P11|Overall Study|Withdrawal by Subject|2
7746426|NCT00838539|26931924|P10|Overall Study|Withdrawal by Subject|1
7746427|NCT00838539|26931925|P9|Overall Study|Withdrawal by Subject|0
7746428|NCT00838539|26931926|P8|Overall Study|Withdrawal by Subject|0
7746429|NCT00838539|26931927|P7|Overall Study|Withdrawal by Subject|0
7746430|NCT00838539|26931928|P6|Overall Study|Withdrawal by Subject|0
7746431|NCT00838539|26931929|P5|Overall Study|Withdrawal by Subject|0
7746432|NCT00838539|26931930|P4|Overall Study|Withdrawal by Subject|0
7746433|NCT00838539|26931931|P3|Overall Study|Withdrawal by Subject|0
7746434|NCT00838539|26931932|P2|Overall Study|Withdrawal by Subject|1
7746435|NCT00838539|26931933|P1|Overall Study|Withdrawal by Subject|0
7746436|NCT00838539|26931922|P12|Overall Study|Adverse Event|0
7746437|NCT00838539|26931923|P11|Overall Study|Adverse Event|2
7746438|NCT00838539|26931924|P10|Overall Study|Adverse Event|1
7746439|NCT00838539|26931925|P9|Overall Study|Adverse Event|0
7746440|NCT00838539|26931926|P8|Overall Study|Adverse Event|2
7746441|NCT00838539|26931927|P7|Overall Study|Adverse Event|0
7746442|NCT00838539|26931928|P6|Overall Study|Adverse Event|1
7746443|NCT00838539|26931929|P5|Overall Study|Adverse Event|2
7746444|NCT00838539|26931930|P4|Overall Study|Adverse Event|1
7746445|NCT00838539|26931931|P3|Overall Study|Adverse Event|1
7746446|NCT00838539|26931932|P2|Overall Study|Adverse Event|1
7746447|NCT00838539|26931933|P1|Overall Study|Adverse Event|1
7746448|NCT00838539|26931922|P12|Overall Study|Disease Progression|4
7746449|NCT00838539|26931923|P11|Overall Study|Disease Progression|1
7746450|NCT00838539|26931924|P10|Overall Study|Disease Progression|5
7746451|NCT00838539|26931925|P9|Overall Study|Disease Progression|4
7746452|NCT00838539|26931926|P8|Overall Study|Disease Progression|4
7746453|NCT00838539|26931927|P7|Overall Study|Disease Progression|3
7746454|NCT00838539|26931928|P6|Overall Study|Disease Progression|2
7746455|NCT00838539|26931929|P5|Overall Study|Disease Progression|4
7746456|NCT00838539|26931930|P4|Overall Study|Disease Progression|2
7746457|NCT00838539|26931931|P3|Overall Study|Disease Progression|3
7746458|NCT00838539|26931932|P2|Overall Study|Disease Progression|4
7746459|NCT00838539|26931933|P1|Overall Study|Disease Progression|2
7746460|NCT00838526|26931983|P2|Overall Study|Other|7
7746461|NCT00838526|26931984|P1|Overall Study|Other|11
7746462|NCT00838526|26931983|P2|Overall Study|Lack of Efficacy|3
7746463|NCT00838526|26931984|P1|Overall Study|Lack of Efficacy|2
7746464|NCT00838526|26931983|P2|Overall Study|Withdrawal by Subject|5
7746465|NCT00838526|26931984|P1|Overall Study|Withdrawal by Subject|4
7746466|NCT00838526|26931983|P2|Overall Study|Lost to Follow-up|12
7746467|NCT00838526|26931984|P1|Overall Study|Lost to Follow-up|4
7746468|NCT00838526|26931983|P2|Overall Study|Adverse Event|12
7746469|NCT00838526|26931984|P1|Overall Study|Adverse Event|3
7746470|NCT00838513|26931992|P1|Post Treatment Period (Patients Who Disc|Death|1
7746471|NCT00838513|26931992|P1|Extension Treatment Period|Death|1
7746472|NCT00838513|26931992|P1|Screening Period|Screen Failure|3
7746473|NCT00838435|26932008|P1|Part 2 (7 Years)|Withdrawal by Subject|5
7746474|NCT00838435|26932008|P1|Part 2 (7 Years)|Sponsor Decision|6
7746475|NCT00838435|26932008|P1|Part 2 (7 Years)|Physician Decision|1
7746476|NCT00838435|26932008|P1|Part 2 (7 Years)|Lost to Follow-up|2
7746477|NCT00838435|26932008|P1|Part 2 (7 Years)|Adverse Event|2
7746478|NCT00838435|26932008|P1|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
7746479|NCT00838435|26932008|P1|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
7746480|NCT00838331|26932021|P1|Aged Blood Transfusion|Withdrawal by Subject|9
7746481|NCT00838279|26932027|P2|Washout|Withdrawal by Subject|1
7746482|NCT00838279|26932028|P1|Washout|Withdrawal by Subject|0
7746483|NCT00838279|26932027|P2|Washout|Protocol Violation|0
7746484|NCT00838279|26932028|P1|Washout|Protocol Violation|1
7746485|NCT00838201|26932038|P2|Overall Study|Death|13
7746486|NCT00838201|26932039|P1|Overall Study|Death|11
7746487|NCT00838201|26932038|P2|Overall Study|Adverse Event|9
7746488|NCT00838201|26932039|P1|Overall Study|Adverse Event|5
7746489|NCT00838201|26932038|P2|Overall Study|Lost to Follow-up|3
7746490|NCT00838201|26932039|P1|Overall Study|Lost to Follow-up|4
7746491|NCT00838201|26932038|P2|Overall Study|Consent withdrawn|19
7746492|NCT00838201|26932039|P1|Overall Study|Consent withdrawn|16
7746493|NCT00838201|26932038|P2|Overall Study|Disease progression|3
7746494|NCT00838201|26932039|P1|Overall Study|Disease progression|3
7746495|NCT00838201|26932038|P2|Overall Study|Administrative decision|2
7746496|NCT00838201|26932039|P1|Overall Study|Administrative decision|1
7746497|NCT00838201|26932038|P2|Overall Study|Noncompliance|1
7746498|NCT00838201|26932039|P1|Overall Study|Noncompliance|0
7746499|NCT00838201|26932038|P2|Overall Study|Investigator decision, or other reasons|3
7746500|NCT00838201|26932039|P1|Overall Study|Investigator decision, or other reasons|2
7746501|NCT00838110|26932107|P4|Overall Study|Randomized but not treated|0
7746502|NCT00838110|26932108|P3|Overall Study|Randomized but not treated|0
7746503|NCT00838110|26932109|P2|Overall Study|Randomized but not treated|1
7746504|NCT00838110|26932110|P1|Overall Study|Randomized but not treated|0
7746505|NCT00838110|26932107|P4|Overall Study|Did not meet eligibility criteria|2
7746506|NCT00838110|26932108|P3|Overall Study|Did not meet eligibility criteria|1
7746507|NCT00838110|26932109|P2|Overall Study|Did not meet eligibility criteria|0
7746508|NCT00838110|26932110|P1|Overall Study|Did not meet eligibility criteria|0
7746509|NCT00838110|26932107|P4|Overall Study|Lost to Follow-up|0
7746510|NCT00838110|26932108|P3|Overall Study|Lost to Follow-up|0
7746511|NCT00838110|26932109|P2|Overall Study|Lost to Follow-up|0
7746512|NCT00838110|26932110|P1|Overall Study|Lost to Follow-up|3
7746513|NCT00838110|26932107|P4|Overall Study|Protocol Violation|1
7746514|NCT00838110|26932108|P3|Overall Study|Protocol Violation|1
7746515|NCT00838110|26932109|P2|Overall Study|Protocol Violation|2
7746516|NCT00838110|26932110|P1|Overall Study|Protocol Violation|0
7746517|NCT00838110|26932107|P4|Overall Study|Other|2
7746518|NCT00838110|26932108|P3|Overall Study|Other|3
7746519|NCT00838110|26932109|P2|Overall Study|Other|3
7746520|NCT00838110|26932110|P1|Overall Study|Other|3
7746521|NCT00838110|26932107|P4|Overall Study|Withdrawal by Subject|4
7746522|NCT00838110|26932108|P3|Overall Study|Withdrawal by Subject|3
7746523|NCT00838110|26932109|P2|Overall Study|Withdrawal by Subject|6
7746524|NCT00838110|26932110|P1|Overall Study|Withdrawal by Subject|5
7746525|NCT00838110|26932107|P4|Overall Study|Adverse Event|7
7746526|NCT00838110|26932108|P3|Overall Study|Adverse Event|8
7746527|NCT00838110|26932109|P2|Overall Study|Adverse Event|10
7746528|NCT00838110|26932110|P1|Overall Study|Adverse Event|11
7746529|NCT00838110|26932107|P4|Overall Study|Death|2
7746530|NCT00838110|26932108|P3|Overall Study|Death|1
7746531|NCT00838110|26932109|P2|Overall Study|Death|0
7746532|NCT00838110|26932110|P1|Overall Study|Death|0
7746533|NCT00838097|26932130|P1|Overall Study|Protocol-specified criteria|142
7746534|NCT00838097|26932130|P1|Overall Study|Death|6
7746535|NCT00838097|26932130|P1|Overall Study|Lost to Follow-up|11
7746536|NCT00838097|26932130|P1|Overall Study|Physician Decision|4
7746537|NCT00838097|26932130|P1|Overall Study|Requirement for alternative therapy|2
7746538|NCT00838097|26932130|P1|Overall Study|Withdrawal by Subject|3
7746539|NCT00838097|26932130|P1|Overall Study|Adverse Event|2
7746540|NCT00838097|26932130|P1|Overall Study|Ineligibility determined|6
7746541|NCT00837967|26932154|P2|Washout Period of 7 - 14 Days|Adverse Event|0
7746542|NCT00837967|26932155|P1|Washout Period of 7 - 14 Days|Adverse Event|2
7746543|NCT00837876|26932181|P1|Overall Study|disease progression|24
7746544|NCT00837876|26932181|P1|Overall Study|Withdrawal by Subject|3
7746545|NCT00837876|26932181|P1|Overall Study|Physician Decision|1
7746546|NCT00837876|26932181|P1|Overall Study|Adverse Event|7
7746547|NCT00837876|26932181|P1|Overall Study|Death|2
7746548|NCT00837811|26932203|P3|Overall Study|Sponsor Decision|0
7746549|NCT00837811|26932204|P2|Overall Study|Sponsor Decision|2
7746550|NCT00837811|26932205|P1|Overall Study|Sponsor Decision|0
7746551|NCT00837811|26932203|P3|Overall Study|Withdrawal by Subject|0
7746552|NCT00837811|26932204|P2|Overall Study|Withdrawal by Subject|9
7746553|NCT00837811|26932205|P1|Overall Study|Withdrawal by Subject|1
7746554|NCT00837811|26932203|P3|Overall Study|Physician Decision|1
7746555|NCT00837811|26932204|P2|Overall Study|Physician Decision|2
7746556|NCT00837811|26932205|P1|Overall Study|Physician Decision|0
7746557|NCT00837811|26932203|P3|Overall Study|Lost to Follow-up|0
7746558|NCT00837811|26932204|P2|Overall Study|Lost to Follow-up|3
7746559|NCT00837811|26932205|P1|Overall Study|Lost to Follow-up|1
7746560|NCT00837811|26932203|P3|Overall Study|Lack of Efficacy|0
7746561|NCT00837811|26932204|P2|Overall Study|Lack of Efficacy|11
7746562|NCT00837811|26932205|P1|Overall Study|Lack of Efficacy|0
7746563|NCT00837811|26932203|P3|Overall Study|Death|0
7746564|NCT00837811|26932204|P2|Overall Study|Death|1
7746565|NCT00837811|26932205|P1|Overall Study|Death|1
7746566|NCT00837811|26932203|P3|Overall Study|Adverse Event|0
7746567|NCT00837811|26932204|P2|Overall Study|Adverse Event|6
7746568|NCT00837811|26932205|P1|Overall Study|Adverse Event|4
7746569|NCT00837759|26932290|P1|Overall Study|Lost to Follow-up|1
7746570|NCT00837759|26932290|P1|Overall Study|Protocol Violation|3
7746571|NCT00837694|26932305|P6|Overall Study|Lost to Follow-up|1
7746572|NCT00837694|26932306|P5|Overall Study|Lost to Follow-up|1
7746573|NCT00837694|26932307|P4|Overall Study|Lost to Follow-up|1
7746574|NCT00837694|26932308|P3|Overall Study|Lost to Follow-up|2
7746575|NCT00837694|26932309|P2|Overall Study|Lost to Follow-up|0
7746576|NCT00837694|26932310|P1|Overall Study|Lost to Follow-up|2
7746577|NCT00837616|26932326|P2|Overall Study|Withdrawal by Subject|1
7746578|NCT00837616|26932327|P1|Overall Study|Withdrawal by Subject|0
7746579|NCT00837577|26932366|P2|Open-label Period|Other Reason|1
7746580|NCT00837577|26932367|P1|Open-label Period|Other Reason|1
7746581|NCT00837577|26932366|P2|Open-label Period|Withdrawal by Subject|2
7746582|NCT00837577|26932367|P1|Open-label Period|Withdrawal by Subject|1
7746583|NCT00837577|26932366|P2|Open-label Period|Lack of Efficacy|3
7746584|NCT00837577|26932367|P1|Open-label Period|Lack of Efficacy|4
7746585|NCT00837577|26932366|P2|Open-label Period|Laboratory Adverse Event|1
7746586|NCT00837577|26932367|P1|Open-label Period|Laboratory Adverse Event|0
7746587|NCT00837577|26932366|P2|Open-label Period|Clinical Adverse Event|2
7746588|NCT00837577|26932367|P1|Open-label Period|Clinical Adverse Event|2
7746589|NCT00837577|26932366|P2|Double-blind Period|Withdrawal by Subject|0
7746590|NCT00837577|26932367|P1|Double-blind Period|Withdrawal by Subject|1
7746591|NCT00837577|26932366|P2|Double-blind Period|Clinical Adverse Event|0
7746592|NCT00837577|26932367|P1|Double-blind Period|Clinical Adverse Event|1
7746593|NCT00837486|26932387|P2|Long-term Follow-up Phase - Open Label|Death|0
7746594|NCT00837486|26932388|P1|Long-term Follow-up Phase - Open Label|Death|1
7746595|NCT00837486|26932387|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
7746596|NCT00837486|26932388|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
7746597|NCT00837486|26932387|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
7746598|NCT00837486|26932388|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
7746599|NCT00837486|26932387|P2|Blinded-treatment Phase|Physician Decision|0
7746600|NCT00837486|26932388|P1|Blinded-treatment Phase|Physician Decision|1
7746601|NCT00837473|26932400|P1|Overall Study|Withdrawal by Subject|2
7746602|NCT00837473|26932400|P1|Overall Study|Lost to Follow-up|1
7746603|NCT00837434|26932420|P2|Overall Study|Unable to obtain study drug|0
7746604|NCT00837434|26932421|P1|Overall Study|Unable to obtain study drug|1
7746605|NCT00837434|26932420|P2|Overall Study|Baseline assessments not done in time|0
7746606|NCT00837434|26932421|P1|Overall Study|Baseline assessments not done in time|1
7746607|NCT00837434|26932420|P2|Overall Study|Noncompliant|0
7746608|NCT00837434|26932421|P1|Overall Study|Noncompliant|2
7746609|NCT00837434|26932420|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
7746610|NCT00837434|26932421|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
7746611|NCT00837434|26932420|P2|Overall Study|Lost to Follow-up|1
7746612|NCT00837434|26932421|P1|Overall Study|Lost to Follow-up|1
7746613|NCT00837434|26932420|P2|Overall Study|Physician Decision|0
7746614|NCT00837434|26932421|P1|Overall Study|Physician Decision|3
7746615|NCT00837330|26932441|P2|Overall Study|Lost to Follow-up|3
7746616|NCT00837330|26932442|P1|Overall Study|Lost to Follow-up|1
7746617|NCT00837213|26932465|P2|Overall Study|not stated|1
7746618|NCT00837213|26932466|P1|Overall Study|not stated|1
7746619|NCT00837213|26932465|P2|Overall Study|Withdrawal by Subject|2
7746620|NCT00837213|26932466|P1|Overall Study|Withdrawal by Subject|2
7746621|NCT00837213|26932465|P2|Overall Study|Lost to Follow-up|2
7746622|NCT00837213|26932466|P1|Overall Study|Lost to Follow-up|3
7746623|NCT00837161|26932492|P1|Overall Study|refused hysterectomy|2
7746624|NCT00837148|26932500|P1|Overall Study|Death|1
7746625|NCT00837148|26932500|P1|Overall Study|Adverse Event|1
7746626|NCT00837096|26932506|P2|Overall Study|Not reported|8
7746627|NCT00837096|26932507|P1|Overall Study|Not reported|9
7746628|NCT00837096|26932506|P2|Overall Study|Physician Decision|1
7746629|NCT00837096|26932507|P1|Overall Study|Physician Decision|1
7746630|NCT00836953|26932519|P1|Overall Study|Lost to Follow-up|1
7746631|NCT00836953|26932519|P1|Overall Study|Withdrawal by Subject|1
7746632|NCT00836927|26932530|P5|Overall Study|Withdrawal by Subject|0
7746633|NCT00836927|26932531|P4|Overall Study|Withdrawal by Subject|0
7746634|NCT00836927|26932532|P3|Overall Study|Withdrawal by Subject|0
7746635|NCT00836927|26932533|P2|Overall Study|Withdrawal by Subject|0
7746636|NCT00836927|26932534|P1|Overall Study|Withdrawal by Subject|1
7746637|NCT00836927|26932530|P5|Overall Study|Progressive disease|1
7746638|NCT00836927|26932531|P4|Overall Study|Progressive disease|1
7746639|NCT00836927|26932532|P3|Overall Study|Progressive disease|0
7746640|NCT00836927|26932533|P2|Overall Study|Progressive disease|0
7746641|NCT00836927|26932534|P1|Overall Study|Progressive disease|2
7746642|NCT00836901|26932570|P2|First Intervention|Withdrawal by Subject|0
7746643|NCT00836901|26932571|P1|First Intervention|Withdrawal by Subject|1
7746644|NCT00836875|26932620|P2|Overall Study|Withdrawal by Subject|1
7746645|NCT00836875|26932621|P1|Overall Study|Withdrawal by Subject|0
7746646|NCT00836875|26932620|P2|Overall Study|Death|2
7746647|NCT00836875|26932621|P1|Overall Study|Death|3
7746648|NCT00836810|26932637|P2|Overall Study|New diagnosis|0
7746649|NCT00836810|26932638|P1|Overall Study|New diagnosis|1
7746650|NCT00836745|26932660|P1|Overall Study|Other|2
7746651|NCT00836745|26932660|P1|Overall Study|Objective progression or relapse|4
7746652|NCT00836745|26932660|P1|Overall Study|Adverse Event|3
7746653|NCT00836745|26932660|P1|Overall Study|Lost to Follow-up|10
7746654|NCT00836745|26932660|P1|Overall Study|Death|2
7746655|NCT00836706|26932674|P2|Washout: 7 Days|Withdrawal by Subject|1
7746656|NCT00836706|26932675|P1|Washout: 7 Days|Withdrawal by Subject|0
7746657|NCT00836693|26932685|P2|Overall Study|Lost to Follow-up|0
7746658|NCT00836693|26932686|P1|Overall Study|Lost to Follow-up|1
7746659|NCT00836693|26932685|P2|Overall Study|Protocol Violation|0
7746660|NCT00836693|26932686|P1|Overall Study|Protocol Violation|1
7746661|NCT00836693|26932685|P2|Overall Study|Withdrawal by Subject|4
7746662|NCT00836693|26932686|P1|Overall Study|Withdrawal by Subject|9
7746663|NCT00836693|26932685|P2|Overall Study|Physician Decision|0
7746664|NCT00836693|26932686|P1|Overall Study|Physician Decision|2
7746665|NCT00836693|26932685|P2|Overall Study|Sponsor Decision|1
7746666|NCT00836693|26932686|P1|Overall Study|Sponsor Decision|0
7746667|NCT00836693|26932685|P2|Overall Study|Adverse Event|1
7746668|NCT00836693|26932686|P1|Overall Study|Adverse Event|4
7746669|NCT00836589|26932736|P1|Overall Study|Withdrawal by Subject or Physician|591
7746670|NCT00836589|26932736|P1|Overall Study|Death|429
7746671|NCT00836589|26932736|P1|Overall Study|Lost to Follow-up|246
7746672|NCT00836498|26932769|P2|Overall Study|Withdrawal by Subject|1
7746673|NCT00836498|26932770|P1|Overall Study|Withdrawal by Subject|2
7746674|NCT00836498|26932769|P2|Overall Study|Lost to Follow-up|0
7746675|NCT00836498|26932770|P1|Overall Study|Lost to Follow-up|1
7746676|NCT00836498|26932769|P2|Overall Study|Adverse Event|0
7746677|NCT00836498|26932770|P1|Overall Study|Adverse Event|1
7746678|NCT00836472|26932802|P2|Washout|Withdrawal by Subject|1
7746679|NCT00836472|26932803|P1|Washout|Withdrawal by Subject|1
7746680|NCT00836472|26932802|P2|Washout|Adverse Event|2
7746681|NCT00836472|26932803|P1|Washout|Adverse Event|1
7746682|NCT00836277|26932880|P1|Overall Study|Not evaluable for response|6
7746683|NCT00836186|26932888|P1|Overall Study|Blood could not be drawn|1
7746684|NCT00836095|26932896|P2|Overall Study|Physician Decision|3
7746685|NCT00836095|26932897|P1|Overall Study|Physician Decision|0
7746686|NCT00836056|26932907|P2|First Intervention|Adverse Event|0
7746687|NCT00836056|26932908|P1|First Intervention|Adverse Event|1
7746688|NCT00835991|26932937|P2|Washout|Withdrawal by Subject|1
7746689|NCT00835991|26932938|P1|Washout|Withdrawal by Subject|3
7746690|NCT00835991|26932937|P2|Washout|Protocol Violation|2
7746691|NCT00835991|26932938|P1|Washout|Protocol Violation|0
7746692|NCT00835991|26932937|P2|First Intervention|Adverse Event|1
7746693|NCT00835991|26932938|P1|First Intervention|Adverse Event|0
7746694|NCT00835978|26932956|P4|Overall Study|Study terminated by sponsor|0
7746695|NCT00835978|26932957|P3|Overall Study|Study terminated by sponsor|30
7746696|NCT00835978|26932958|P2|Overall Study|Study terminated by sponsor|8
7746697|NCT00835978|26932959|P1|Overall Study|Study terminated by sponsor|12
7746698|NCT00835978|26932956|P4|Overall Study|Withdrawal by Subject|5
7746699|NCT00835978|26932957|P3|Overall Study|Withdrawal by Subject|0
7746700|NCT00835978|26932958|P2|Overall Study|Withdrawal by Subject|3
7746701|NCT00835978|26932959|P1|Overall Study|Withdrawal by Subject|0
7746702|NCT00835978|26932956|P4|Overall Study|Adverse Event|0
7746703|NCT00835978|26932957|P3|Overall Study|Adverse Event|1
7746704|NCT00835978|26932958|P2|Overall Study|Adverse Event|0
7746705|NCT00835978|26932959|P1|Overall Study|Adverse Event|1
7746706|NCT00835978|26932956|P4|Overall Study|Objective progression or relapse|0
7746707|NCT00835978|26932957|P3|Overall Study|Objective progression or relapse|1
7746708|NCT00835978|26932958|P2|Overall Study|Objective progression or relapse|0
7746709|NCT00835978|26932959|P1|Overall Study|Objective progression or relapse|2
7746710|NCT00835978|26932956|P4|Overall Study|Other|0
7746711|NCT00835978|26932957|P3|Overall Study|Other|8
7746712|NCT00835978|26932958|P2|Overall Study|Other|1
7746713|NCT00835978|26932959|P1|Overall Study|Other|5
7746714|NCT00835978|26932956|P4|Overall Study|Lost to Follow-up|1
7746715|NCT00835978|26932957|P3|Overall Study|Lost to Follow-up|2
7746716|NCT00835978|26932958|P2|Overall Study|Lost to Follow-up|4
7746717|NCT00835978|26932959|P1|Overall Study|Lost to Follow-up|3
7746718|NCT00835978|26932956|P4|Overall Study|Death|4
7746719|NCT00835978|26932957|P3|Overall Study|Death|49
7746720|NCT00835978|26932958|P2|Overall Study|Death|40
7746721|NCT00835978|26932959|P1|Overall Study|Death|33
7746722|NCT00835796|26933070|P2|First Intervention|Withdrawal by Subject|1
7746723|NCT00835796|26933071|P1|First Intervention|Withdrawal by Subject|0
7746724|NCT00835770|26933081|P2|Overall Study|Other|1
7746725|NCT00835770|26933082|P1|Overall Study|Other|2
7746726|NCT00835770|26933081|P2|Overall Study|Other|104
7746727|NCT00835770|26933082|P1|Overall Study|Other|115
7746728|NCT00835770|26933081|P2|Overall Study|Death|6
7746729|NCT00835770|26933082|P1|Overall Study|Death|4
7746730|NCT00835770|26933081|P2|Overall Study|Participant Non-Compliance|9
7746731|NCT00835770|26933082|P1|Overall Study|Participant Non-Compliance|11
7746732|NCT00835770|26933081|P2|Overall Study|Investigator Decision|42
7746733|NCT00835770|26933082|P1|Overall Study|Investigator Decision|42
7746734|NCT00835770|26933081|P2|Overall Study|Consent Withdrawn|156
7746735|NCT00835770|26933082|P1|Overall Study|Consent Withdrawn|144
7746736|NCT00835770|26933081|P2|Overall Study|Lost to Follow-up|19
7746737|NCT00835770|26933082|P1|Overall Study|Lost to Follow-up|22
7746738|NCT00835770|26933081|P2|Overall Study|Adverse Event|124
7746739|NCT00835770|26933082|P1|Overall Study|Adverse Event|113
7746740|NCT00835770|26933081|P2|Overall Study|MS Progression|9
7746741|NCT00835770|26933082|P1|Overall Study|MS Progression|14
7746742|NCT00835770|26933081|P2|Overall Study|MS Relapse|23
7746743|NCT00835770|26933082|P1|Overall Study|MS Relapse|17
7746744|NCT00835731|26933180|P2|Overall Study|Physician Decision|1
7746745|NCT00835731|26933181|P1|Overall Study|Physician Decision|1
7746746|NCT00835731|26933180|P2|Overall Study|Withdrawal by Subject|0
7746747|NCT00835731|26933181|P1|Overall Study|Withdrawal by Subject|1
7746748|NCT00835705|26933201|P2|Second Intervention|Difficulty with vein|0
7746749|NCT00835705|26933202|P1|Second Intervention|Difficulty with vein|1
7746750|NCT00835705|26933201|P2|First Intervention|Difficulty with vein|0
7746751|NCT00835705|26933202|P1|First Intervention|Difficulty with vein|1
7746752|NCT00835692|26933218|P2|First Intervention|Withdrawal by Subject|0
7746753|NCT00835692|26933219|P1|First Intervention|Withdrawal by Subject|1
7746754|NCT00835679|26933231|P4|Overall Study|Withdrawal by Subject|0
7746755|NCT00835679|26933232|P3|Overall Study|Withdrawal by Subject|0
7746756|NCT00835679|26933233|P2|Overall Study|Withdrawal by Subject|0
7746757|NCT00835679|26933234|P1|Overall Study|Withdrawal by Subject|1
7746758|NCT00835666|26933258|P2|Washout|Withdrawal by Subject|0
7746759|NCT00835666|26933259|P1|Washout|Withdrawal by Subject|1
7746760|NCT00835666|26933258|P2|Washout|Protocol Violation|0
7746761|NCT00835666|26933259|P1|Washout|Protocol Violation|1
7746762|NCT00835640|26933269|P2|Second Intervention|Protocol Violation|0
7746763|NCT00835640|26933270|P1|Second Intervention|Protocol Violation|1
7746764|NCT00835575|26933302|P2|Washout of 14 Days|Withdrawal by Subject|0
7746765|NCT00835575|26933303|P1|Washout of 14 Days|Withdrawal by Subject|1
7746766|NCT00835549|26933313|P2|Washout of 7 Days|Withdrawal by Subject|0
7746767|NCT00835549|26933314|P1|Washout of 7 Days|Withdrawal by Subject|2
7746768|NCT00835536|26933324|P2|Washout of 5 Weeks|Withdrawal by Subject|0
7746769|NCT00835536|26933325|P1|Washout of 5 Weeks|Withdrawal by Subject|1
7746770|NCT00835406|26933386|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
7746771|NCT00835406|26933387|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
7746772|NCT00835406|26933386|P2|Period: First Intervention|Withdrawal by Subject|0
7746773|NCT00835406|26933387|P1|Period: First Intervention|Withdrawal by Subject|2
7746774|NCT00835406|26933386|P2|Period: First Intervention|Adverse Event|1
7746775|NCT00835406|26933387|P1|Period: First Intervention|Adverse Event|0
7746776|NCT00835380|26933393|P1|Overall Study|Withdrawal by Subject|2
7746777|NCT00835367|26933400|P2|Second Intervention|Adverse Event|1
7746778|NCT00835367|26933401|P1|Second Intervention|Adverse Event|1
7746779|NCT00835367|26933400|P2|Washout|Withdrawal by Subject|0
7746780|NCT00835367|26933401|P1|Washout|Withdrawal by Subject|1
7746781|NCT00835367|26933400|P2|Washout|Adverse Event|0
7746782|NCT00835367|26933401|P1|Washout|Adverse Event|2
7746783|NCT00835354|26933423|P2|First Intervention|Adverse Event|1
7746784|NCT00835354|26933424|P1|First Intervention|Adverse Event|0
7746785|NCT00835341|26933434|P2|Overall Study|Lost to Follow-up|12
7746786|NCT00835341|26933435|P1|Overall Study|Lost to Follow-up|3
7746787|NCT00835263|26933498|P2|Second Intervention|Adverse Event|0
7746788|NCT00835263|26933499|P1|Second Intervention|Adverse Event|1
7746789|NCT00835237|26933509|P2|Overall Study|Withdrawal by Subject|0
7746790|NCT00835237|26933510|P1|Overall Study|Withdrawal by Subject|2
7746791|NCT00835237|26933509|P2|Overall Study|Lost to Follow-up|0
7746792|NCT00835237|26933510|P1|Overall Study|Lost to Follow-up|4
7746793|NCT00835211|26933550|P2|Washout: 7 Days|Withdrawal by Subject|0
7746794|NCT00835211|26933551|P1|Washout: 7 Days|Withdrawal by Subject|1
7746795|NCT00835211|26933550|P2|Washout: 7 Days|Adverse Event|1
7746796|NCT00835211|26933551|P1|Washout: 7 Days|Adverse Event|2
7746797|NCT00835211|26933550|P2|First Intervention|Withdrawal by Subject|1
7746798|NCT00835211|26933551|P1|First Intervention|Withdrawal by Subject|0
7746799|NCT00835172|26933597|P2|Washout|Protocol Violation|1
7746800|NCT00835172|26933598|P1|Washout|Protocol Violation|0
7746801|NCT00835120|26933624|P1|Overall Study|Withdrawal by Subject|2
7746802|NCT00835120|26933624|P1|Overall Study|Adverse Event|2
7746803|NCT00835120|26933624|P1|Overall Study|Lost to Follow-up|3
7746804|NCT00835120|26933624|P1|Overall Study|Lack of Efficacy|1
7746805|NCT00835081|26933634|P2|Washout of 7 Days|Withdrawal by Subject|0
7746806|NCT00835081|26933635|P1|Washout of 7 Days|Withdrawal by Subject|1
7746807|NCT00835068|26933645|P2|Overall Study|Withdrawal by Subject|0
7746808|NCT00835068|26933646|P1|Overall Study|Withdrawal by Subject|1
7746809|NCT00835068|26933645|P2|Overall Study|Other|0
7746810|NCT00835068|26933646|P1|Overall Study|Other|8
7746811|NCT00835068|26933645|P2|Overall Study|Adverse Event|1
7746812|NCT00835068|26933646|P1|Overall Study|Adverse Event|0
7746813|NCT00835068|26933645|P2|Overall Study|Death|0
7746814|NCT00835068|26933646|P1|Overall Study|Death|1
7746815|NCT00835042|26933666|P2|Washout of 21 Days|Withdrawal by Subject|2
7746816|NCT00835042|26933667|P1|Washout of 21 Days|Withdrawal by Subject|0
7746817|NCT00835042|26933666|P2|First Intervention|Adverse Event|2
7746818|NCT00835042|26933667|P1|First Intervention|Adverse Event|1
7746819|NCT00835042|26933666|P2|First Intervention|Withdrawal by Subject|0
7746820|NCT00835042|26933667|P1|First Intervention|Withdrawal by Subject|3
7746821|NCT00834912|26933753|P6|Treatment Period 2|Withdrawal by Subject|0
7746822|NCT00834912|26933754|P5|Treatment Period 2|Withdrawal by Subject|1
7746823|NCT00834912|26933755|P4|Treatment Period 2|Withdrawal by Subject|0
7746824|NCT00834912|26933756|P3|Treatment Period 2|Withdrawal by Subject|1
7746825|NCT00834912|26933757|P2|Treatment Period 2|Withdrawal by Subject|0
7746826|NCT00834912|26933758|P1|Treatment Period 2|Withdrawal by Subject|0
7746827|NCT00834912|26933753|P6|Treatment Period 1|Adverse Event|0
7746828|NCT00834912|26933754|P5|Treatment Period 1|Adverse Event|0
7746829|NCT00834912|26933755|P4|Treatment Period 1|Adverse Event|1
7746830|NCT00834912|26933756|P3|Treatment Period 1|Adverse Event|0
7746831|NCT00834912|26933757|P2|Treatment Period 1|Adverse Event|1
7746832|NCT00834912|26933758|P1|Treatment Period 1|Adverse Event|0
7746833|NCT00834899|26933780|P2|Overall Study|Withdrawal by Subject|1
7746834|NCT00834899|26933781|P1|Overall Study|Withdrawal by Subject|1
7746835|NCT00834873|26933820|P2|First Intervention|Adverse Event|1
7746836|NCT00834873|26933821|P1|First Intervention|Adverse Event|0
7746837|NCT00834834|26933831|P2|Overall Study|Withdrawal by Subject|3
7746838|NCT00834834|26933832|P1|Overall Study|Withdrawal by Subject|4
7746839|NCT00834795|26933867|P2|Second Intervention|Adverse Event|0
7746840|NCT00834795|26933868|P1|Second Intervention|Adverse Event|1
7746841|NCT00834795|26933867|P2|Washout: 7 Days|Withdrawal by Subject|1
7746842|NCT00834795|26933868|P1|Washout: 7 Days|Withdrawal by Subject|0
7746843|NCT00834756|26933878|P2|Washout: 21 Days|Withdrawal by Subject|0
7746844|NCT00834756|26933879|P1|Washout: 21 Days|Withdrawal by Subject|1
7746845|NCT00834756|26933878|P2|First Intervention|Adverse Event|0
7746846|NCT00834756|26933879|P1|First Intervention|Adverse Event|1
7746847|NCT00834743|26933889|P2|Second Intervention|Withdrawal by Subject|0
7746848|NCT00834743|26933890|P1|Second Intervention|Withdrawal by Subject|1
7746849|NCT00834717|26933900|P2|First Intervention|Withdrawal by Subject|1
7746850|NCT00834717|26933901|P1|First Intervention|Withdrawal by Subject|0
7746851|NCT00834717|26933900|P2|First Intervention|Adverse Event|0
7746852|NCT00834717|26933901|P1|First Intervention|Adverse Event|1
7746853|NCT00834639|26933932|P2|Second Intervention|Physician Decision|2
7746854|NCT00834639|26933933|P1|Second Intervention|Physician Decision|0
7746855|NCT00834613|26933950|P2|First Intervention|Protocol Violation|0
7746856|NCT00834613|26933951|P1|First Intervention|Protocol Violation|1
7746857|NCT00834587|26933961|P2|Washout: 7 Days|Withdrawal by Subject|0
7746858|NCT00834587|26933962|P1|Washout: 7 Days|Withdrawal by Subject|1
7746859|NCT00834522|26934011|P2|Washout|Withdrawal by Subject|1
7746860|NCT00834522|26934012|P1|Washout|Withdrawal by Subject|2
7746861|NCT00834522|26934011|P2|Washout|Adverse Event|0
7746862|NCT00834522|26934012|P1|Washout|Adverse Event|1
7746863|NCT00834444|26934035|P2|Second Intervention|Adverse Event|0
7746864|NCT00834444|26934036|P1|Second Intervention|Adverse Event|1
7746865|NCT00834444|26934035|P2|Washout of 7 Days|Withdrawal by Subject|1
7746866|NCT00834444|26934036|P1|Washout of 7 Days|Withdrawal by Subject|0
7746867|NCT00834444|26934035|P2|First Intervention|Intolerance to Venopuncture|1
7746868|NCT00834444|26934036|P1|First Intervention|Intolerance to Venopuncture|0
7746869|NCT00834444|26934035|P2|First Intervention|Adverse Event|0
7746870|NCT00834444|26934036|P1|First Intervention|Adverse Event|1
7746871|NCT00834431|26934046|P2|Washout of 7 Days|Withdrawal by Subject|1
7746872|NCT00834431|26934047|P1|Washout of 7 Days|Withdrawal by Subject|0
7746873|NCT00834431|26934046|P2|First Intervention|Adverse Event|1
7746874|NCT00834431|26934047|P1|First Intervention|Adverse Event|0
7746875|NCT00834418|26934057|P2|Overall Study|Adverse Event|2
7746876|NCT00834418|26934058|P1|Overall Study|Adverse Event|0
7746877|NCT00834366|26934075|P2|Treatment Period 1|Adverse Event|1
7746878|NCT00834366|26934076|P1|Treatment Period 1|Adverse Event|1
7746879|NCT00834340|26934092|P2|Washout|Withdrawal by Subject|0
7746880|NCT00834340|26934093|P1|Washout|Withdrawal by Subject|1
7746881|NCT00834340|26934092|P2|Washout|Adverse Event|0
7746882|NCT00834340|26934093|P1|Washout|Adverse Event|1
7746883|NCT00834249|26934137|P2|Second Intervention|Adverse Event|0
7746884|NCT00834249|26934138|P1|Second Intervention|Adverse Event|1
7746885|NCT00834249|26934137|P2|Washout: 7 Days|Withdrawal by Subject|1
7746886|NCT00834249|26934138|P1|Washout: 7 Days|Withdrawal by Subject|1
7746887|NCT00834080|26934234|P1|Overall Study|Subject Relocated|1
7746888|NCT00834080|26934234|P1|Overall Study|Physician Decision|1
7746889|NCT00834080|26934234|P1|Overall Study|Other - False positive tests of the UDS|1
7746890|NCT00834080|26934234|P1|Overall Study|Other - Pregnancy|1
7746891|NCT00834080|26934234|P1|Overall Study|Withdrawal by Subject|5
7746892|NCT00834080|26934234|P1|Overall Study|Lost to Follow-up|7
7746893|NCT00834080|26934234|P1|Overall Study|Adverse Event|7
7746894|NCT00834067|26934240|P2|Washout of 21 Days|Protocol Violation|1
7746895|NCT00834067|26934241|P1|Washout of 21 Days|Protocol Violation|0
7746896|NCT00834041|26934263|P2|Overall Study|Lost to Follow-up|1
7746897|NCT00834041|26934264|P1|Overall Study|Lost to Follow-up|0
7746898|NCT00834041|26934263|P2|Overall Study|Withdrawal by Subject|0
7746899|NCT00834041|26934264|P1|Overall Study|Withdrawal by Subject|1
7746900|NCT00833989|26934282|P4|Overall Study|Withdrawal by Subject|1
7746901|NCT00833989|26934283|P3|Overall Study|Withdrawal by Subject|1
7746902|NCT00833989|26934284|P2|Overall Study|Withdrawal by Subject|0
7746903|NCT00833989|26934285|P1|Overall Study|Withdrawal by Subject|3
7746904|NCT00833989|26934282|P4|Overall Study|Physician Decision|1
7746905|NCT00833989|26934283|P3|Overall Study|Physician Decision|0
7746906|NCT00833989|26934284|P2|Overall Study|Physician Decision|0
7746907|NCT00833989|26934285|P1|Overall Study|Physician Decision|0
7746908|NCT00833976|26934389|P1|Overall Study|Physician Decision|1
7746909|NCT00833976|26934389|P1|Overall Study|Did not meet eligibility criteria|41
7746910|NCT00833976|26934389|P1|Overall Study|Lost to Follow-up|4
7746911|NCT00833976|26934389|P1|Overall Study|Withdrawal by Subject|5
7746912|NCT00833937|26934397|P2|Washout|Withdrawal by Subject|0
7746913|NCT00833937|26934398|P1|Washout|Withdrawal by Subject|1
7746914|NCT00833924|26934406|P1|Overall Study|In study follow-up|71
7746915|NCT00833924|26934406|P1|Overall Study|Withdrawal by Subject|13
7746916|NCT00833924|26934406|P1|Overall Study|Lost to Follow-up|2
7746917|NCT00833924|26934406|P1|Overall Study|Conversion|2
7746918|NCT00833924|26934406|P1|Overall Study|Death|21
7746919|NCT00833911|26934411|P1|Maintenance Phase II|Lack of Efficacy|1
7746920|NCT00833911|26934411|P1|Maintenance Phase II|Withdrawal by Subject|1
7746921|NCT00833911|26934411|P1|Maintenance Phase II|Physician Decision|2
7746922|NCT00833911|26934411|P1|Maintenance Phase II|Adverse Event|6
7746923|NCT00833911|26934411|P1|Maintenance Phase I|Lack of Efficacy|4
7746924|NCT00833911|26934411|P1|Maintenance Phase I|Physician Decision|10
7746925|NCT00833911|26934411|P1|Maintenance Phase I|Withdrawal by Subject|11
7746926|NCT00833911|26934411|P1|Maintenance Phase I|Adverse Event|73
7746927|NCT00833911|26934411|P1|Titration|Withdrawal by Subject|3
7746928|NCT00833911|26934411|P1|Titration|Adverse Event|18
7746929|NCT00833898|26934421|P2|Overall Study|Patient did not receive transplant|2
7746930|NCT00833898|26934422|P1|Overall Study|Patient did not receive transplant|0
7746931|NCT00833898|26934421|P2|Overall Study|Lost to Follow-up|7
7746932|NCT00833898|26934422|P1|Overall Study|Lost to Follow-up|7
7746933|NCT00833898|26934421|P2|Overall Study|Withdrawal by Subject|27
7746934|NCT00833898|26934422|P1|Overall Study|Withdrawal by Subject|33
7746935|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
7746936|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7746937|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7746938|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7746939|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7746940|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7746941|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Other|3
7746942|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Other|4
7746943|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Other|0
7746944|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Other|0
7746945|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Other|0
7746946|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Other|0
7746947|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
7746948|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
7746949|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7746950|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7746951|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7746952|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7746953|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
7746954|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
7746955|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746956|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746957|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746958|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746959|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Death|9
7746960|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Death|8
7746961|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Death|0
7746962|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Death|0
7746963|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Death|0
7746964|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Death|0
7746965|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
7746966|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
7746967|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
7746968|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
7746969|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
7746970|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
7746971|NCT00833833|26934481|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
7746972|NCT00833833|26934482|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
7746973|NCT00833833|26934483|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
7746974|NCT00833833|26934484|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
7746975|NCT00833833|26934485|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
7746976|NCT00833833|26934486|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
7746977|NCT00833833|26934481|P6|Phase 1 (as of 01 April 2011)|Other|0
7746978|NCT00833833|26934482|P5|Phase 1 (as of 01 April 2011)|Other|0
7746979|NCT00833833|26934483|P4|Phase 1 (as of 01 April 2011)|Other|1
7746980|NCT00833833|26934484|P3|Phase 1 (as of 01 April 2011)|Other|0
7746981|NCT00833833|26934485|P2|Phase 1 (as of 01 April 2011)|Other|3
7746982|NCT00833833|26934486|P1|Phase 1 (as of 01 April 2011)|Other|1
7746983|NCT00833833|26934481|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746984|NCT00833833|26934482|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746985|NCT00833833|26934483|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746986|NCT00833833|26934484|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
7746987|NCT00833833|26934485|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7746988|NCT00833833|26934486|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
7746989|NCT00833833|26934481|P6|Phase 1 (as of 01 April 2011)|Death|0
7746990|NCT00833833|26934482|P5|Phase 1 (as of 01 April 2011)|Death|0
7746991|NCT00833833|26934483|P4|Phase 1 (as of 01 April 2011)|Death|0
7746992|NCT00833833|26934484|P3|Phase 1 (as of 01 April 2011)|Death|2
7746993|NCT00833833|26934485|P2|Phase 1 (as of 01 April 2011)|Death|1
7746994|NCT00833833|26934486|P1|Phase 1 (as of 01 April 2011)|Death|0
7746995|NCT00833833|26934481|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
7746996|NCT00833833|26934482|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
7746997|NCT00833833|26934483|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
7746998|NCT00833833|26934484|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
7746999|NCT00833833|26934485|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
7747000|NCT00833833|26934486|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
7747001|NCT00833833|26934481|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
7747002|NCT00833833|26934482|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
7747003|NCT00833833|26934483|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
7747004|NCT00833833|26934484|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
7747005|NCT00833833|26934485|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
7747006|NCT00833833|26934486|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
7747007|NCT00833833|26934481|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
7747008|NCT00833833|26934482|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
7747009|NCT00833833|26934483|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
7747010|NCT00833833|26934484|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
7747011|NCT00833833|26934485|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
7747012|NCT00833833|26934486|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
7747013|NCT00833794|26934526|P2|Double-blind Phase|Administrative reason|3
7747014|NCT00833794|26934527|P1|Double-blind Phase|Administrative reason|1
7747015|NCT00833794|26934526|P2|Double-blind Phase|Physician Decision|7
7747016|NCT00833794|26934527|P1|Double-blind Phase|Physician Decision|4
7747017|NCT00833794|26934526|P2|Double-blind Phase|Withdrawal by Subject|6
7747018|NCT00833794|26934527|P1|Double-blind Phase|Withdrawal by Subject|23
7747019|NCT00833794|26934526|P2|Double-blind Phase|Lack of Efficacy|22
7747020|NCT00833794|26934527|P1|Double-blind Phase|Lack of Efficacy|34
7747021|NCT00833794|26934526|P2|Double-blind Phase|Adverse Event|11
7747022|NCT00833794|26934527|P1|Double-blind Phase|Adverse Event|44
7747023|NCT00833794|26934526|P2|Open-label Phase|enrolled in error (immediately D/C)|0
7747024|NCT00833794|26934527|P1|Open-label Phase|enrolled in error (immediately D/C)|1
7747025|NCT00833794|26934526|P2|Open-label Phase|Did not complete wash-out period|0
7747026|NCT00833794|26934527|P1|Open-label Phase|Did not complete wash-out period|12
7747027|NCT00833794|26934526|P2|Open-label Phase|Protocol Violation|0
7747028|NCT00833794|26934527|P1|Open-label Phase|Protocol Violation|47
7747029|NCT00833794|26934526|P2|Open-label Phase|Administrative reason|0
7747030|NCT00833794|26934527|P1|Open-label Phase|Administrative reason|1
7747031|NCT00833794|26934526|P2|Open-label Phase|Physician Decision|0
7747032|NCT00833794|26934527|P1|Open-label Phase|Physician Decision|20
7747033|NCT00833794|26934526|P2|Open-label Phase|Withdrawal by Subject|0
7747034|NCT00833794|26934527|P1|Open-label Phase|Withdrawal by Subject|48
7747035|NCT00833794|26934526|P2|Open-label Phase|Lack of Efficacy|0
7747036|NCT00833794|26934527|P1|Open-label Phase|Lack of Efficacy|28
7747037|NCT00833794|26934526|P2|Open-label Phase|Adverse Event|0
7747038|NCT00833794|26934527|P1|Open-label Phase|Adverse Event|225
7747039|NCT00833755|26934571|P4|Overall Study|Subject had scheduling issues|0
7747040|NCT00833755|26934572|P3|Overall Study|Subject had scheduling issues|0
7747041|NCT00833755|26934573|P2|Overall Study|Subject had scheduling issues|1
7747042|NCT00833755|26934574|P1|Overall Study|Subject had scheduling issues|0
7747043|NCT00833755|26934571|P4|Overall Study|Physician Decision|6
7747044|NCT00833755|26934572|P3|Overall Study|Physician Decision|2
7747045|NCT00833755|26934573|P2|Overall Study|Physician Decision|4
7747046|NCT00833755|26934574|P1|Overall Study|Physician Decision|4
7747047|NCT00833703|26934594|P2|Overall Study|Parent(s)/guardian(s)'s request|1
7747048|NCT00833703|26934595|P1|Overall Study|Parent(s)/guardian(s)'s request|0
7747049|NCT00833690|26934608|P3|Overall Study|Discontinued study drug|0
7747050|NCT00833690|26934609|P2|Overall Study|Discontinued study drug|2
7747051|NCT00833690|26934610|P1|Overall Study|Discontinued study drug|3
7747052|NCT00833690|26934608|P3|Overall Study|Withdrawal by Subject|0
7747053|NCT00833690|26934609|P2|Overall Study|Withdrawal by Subject|0
7747054|NCT00833690|26934610|P1|Overall Study|Withdrawal by Subject|1
7747055|NCT00833638|26934746|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
7747056|NCT00833638|26934747|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
7747057|NCT00833638|26934748|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
7747058|NCT00833638|26934746|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
7747059|NCT00833638|26934747|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
7747060|NCT00833638|26934748|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
7747061|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
7747062|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
7747063|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
7747064|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
7747065|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
7747066|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
7747067|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7747068|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7747069|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7747070|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
7747071|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
7747072|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
7747073|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7747074|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
7747075|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7747076|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
7747077|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
7747078|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
7747079|NCT00833638|26934746|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
7747080|NCT00833638|26934747|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
7747081|NCT00833638|26934748|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
7747082|NCT00833560|26934799|P1|Overall Study|Other|5
7747083|NCT00833560|26934799|P1|Overall Study|Pregression of other disease|1
7747084|NCT00833560|26934799|P1|Overall Study|Death|2
7747085|NCT00833560|26934799|P1|Overall Study|Lack of Efficacy|4
7747086|NCT00833560|26934799|P1|Overall Study|Protocol Violation|6
7747087|NCT00833560|26934799|P1|Overall Study|Adverse Event|11
7747088|NCT00833560|26934799|P1|Overall Study|Toxicity|13
7747089|NCT00833547|26934808|P2|Overall Study|Withdrawal by Subject|2
7747090|NCT00833547|26934809|P1|Overall Study|Withdrawal by Subject|2
7747091|NCT00833482|26934830|P6|Days 21-30|Withdrawal by Subject|0
7747092|NCT00833482|26934831|P5|Days 21-30|Withdrawal by Subject|1
7747093|NCT00833482|26934832|P4|Days 21-30|Withdrawal by Subject|0
7747094|NCT00833482|26934833|P3|Days 21-30|Withdrawal by Subject|0
7747095|NCT00833482|26934834|P2|Days 21-30|Withdrawal by Subject|0
7747096|NCT00833482|26934835|P1|Days 21-30|Withdrawal by Subject|0
7747097|NCT00833482|26934830|P6|Days 21-30|Adverse Event|0
7747098|NCT00833482|26934831|P5|Days 21-30|Adverse Event|0
7747099|NCT00833482|26934832|P4|Days 21-30|Adverse Event|0
7747100|NCT00833482|26934833|P3|Days 21-30|Adverse Event|1
7747101|NCT00833482|26934834|P2|Days 21-30|Adverse Event|0
7747102|NCT00833482|26934835|P1|Days 21-30|Adverse Event|0
7747103|NCT00833482|26934830|P6|Days 11-20|Withdrawal by Subject|0
7747104|NCT00833482|26934831|P5|Days 11-20|Withdrawal by Subject|0
7747105|NCT00833482|26934832|P4|Days 11-20|Withdrawal by Subject|0
7747106|NCT00833482|26934833|P3|Days 11-20|Withdrawal by Subject|0
7747107|NCT00833482|26934834|P2|Days 11-20|Withdrawal by Subject|1
7747108|NCT00833482|26934835|P1|Days 11-20|Withdrawal by Subject|0
7747109|NCT00833482|26934830|P6|Days 11-20|Adverse Event|0
7747110|NCT00833482|26934831|P5|Days 11-20|Adverse Event|0
7747111|NCT00833482|26934832|P4|Days 11-20|Adverse Event|0
7747112|NCT00833482|26934833|P3|Days 11-20|Adverse Event|0
7747113|NCT00833482|26934834|P2|Days 11-20|Adverse Event|2
7747114|NCT00833482|26934835|P1|Days 11-20|Adverse Event|0
7747115|NCT00833469|26934891|P1|Overall Study|Lost to Follow-up|1
7747116|NCT00833469|26934891|P1|Overall Study|Withdrawal by Subject|1
7747117|NCT00833417|26934914|P2|Overall Study|Reason Not Specified|1
7747118|NCT00833417|26934915|P1|Overall Study|Reason Not Specified|0
7747119|NCT00833417|26934914|P2|Overall Study|Disease Progression|17
7747120|NCT00833417|26934915|P1|Overall Study|Disease Progression|18
7747121|NCT00833417|26934914|P2|Overall Study|Sponsor Decision to Terminate Study|2
7747122|NCT00833417|26934915|P1|Overall Study|Sponsor Decision to Terminate Study|1
7747123|NCT00833417|26934914|P2|Overall Study|Patient Decision to Withdraw|23
7747124|NCT00833417|26934915|P1|Overall Study|Patient Decision to Withdraw|4
7747125|NCT00833417|26934914|P2|Overall Study|Physician Decision to Withdraw Patient|7
7747126|NCT00833417|26934915|P1|Overall Study|Physician Decision to Withdraw Patient|3
7747127|NCT00833417|26934914|P2|Overall Study|Lost to Follow-up|2
7747128|NCT00833417|26934915|P1|Overall Study|Lost to Follow-up|1
7747129|NCT00833417|26934914|P2|Overall Study|Death|3
7747130|NCT00833417|26934915|P1|Overall Study|Death|1
7747131|NCT00833417|26934914|P2|Overall Study|Adverse Event|16
7747132|NCT00833417|26934915|P1|Overall Study|Adverse Event|5
7747133|NCT00833261|26934939|P1|Overall Study|Withdrawal by Subject|4
7747134|NCT00833248|26934946|P2|Overall Study|Withdrawal by Subject|1
7747135|NCT00833248|26934947|P1|Overall Study|Withdrawal by Subject|0
7747136|NCT00833248|26934946|P2|Overall Study|Protocol Violation|2
7747137|NCT00833248|26934947|P1|Overall Study|Protocol Violation|1
7747138|NCT00833248|26934946|P2|Overall Study|Adverse Event|0
7747139|NCT00833248|26934947|P1|Overall Study|Adverse Event|3
7747140|NCT00833105|26934969|P1|Overall Study|Adverse Event|2
7747141|NCT00833105|26934969|P1|Overall Study|Withdrawal by Subject|1
7747142|NCT00833092|26934987|P2|Overall Study|constipation|1
7747143|NCT00833092|26934988|P1|Overall Study|constipation|0
7747144|NCT00833092|26934987|P2|Overall Study|Diarrhea|2
7747145|NCT00833092|26934988|P1|Overall Study|Diarrhea|0
7747146|NCT00833092|26934987|P2|Overall Study|Protocol Violation|1
7747147|NCT00833092|26934988|P1|Overall Study|Protocol Violation|2
7747148|NCT00833092|26934987|P2|Overall Study|Withdrawal by Subject|3
7747149|NCT00833092|26934988|P1|Overall Study|Withdrawal by Subject|2
7747150|NCT00833053|26934996|P2|Overall Study|Protocol Violation|1
7747151|NCT00833053|26934997|P1|Overall Study|Protocol Violation|2
7747152|NCT00833053|26934996|P2|Overall Study|Withdrawal by Subject|1
7747153|NCT00833053|26934997|P1|Overall Study|Withdrawal by Subject|0
7747154|NCT00833053|26934996|P2|Overall Study|Treatment Failure|1
7747155|NCT00833053|26934997|P1|Overall Study|Treatment Failure|3
7747156|NCT00833053|26934996|P2|Overall Study|Adverse Event|0
7747157|NCT00833053|26934997|P1|Overall Study|Adverse Event|4
7747158|NCT00833040|26935015|P6|Overall Study|Adverse Event|1
7747159|NCT00833040|26935016|P5|Overall Study|Adverse Event|0
7747160|NCT00833040|26935017|P4|Overall Study|Adverse Event|0
7747161|NCT00833040|26935018|P3|Overall Study|Adverse Event|0
7747162|NCT00833040|26935019|P2|Overall Study|Adverse Event|0
7747163|NCT00833040|26935020|P1|Overall Study|Adverse Event|0
7747164|NCT00833027|26935025|P1|Overall Study|Missing|10
7747165|NCT00833027|26935025|P1|Overall Study|Withdrawal by Subject|16
7747166|NCT00833027|26935025|P1|Overall Study|Protocol Violation|115
7747167|NCT00833027|26935025|P1|Overall Study|Lost to Follow-up|24
7747168|NCT00833027|26935025|P1|Overall Study|Lack of Efficacy|12
7747169|NCT00833027|26935025|P1|Overall Study|Death|1
7747170|NCT00833027|26935025|P1|Overall Study|Adverse Event|33
7747171|NCT00832975|26935030|P1|Overall Study|Other reasons|14
7747172|NCT00832975|26935030|P1|Overall Study|Withdrawal by Subject|3
7747173|NCT00832975|26935030|P1|Overall Study|Physician Decision|4
7747174|NCT00832975|26935030|P1|Overall Study|Death|5
7747175|NCT00832975|26935030|P1|Overall Study|Protocol Violation|6
7747176|NCT00832975|26935030|P1|Overall Study|Lost to Follow-up|7
7747177|NCT00832819|26935044|P3|Overall Study|Protocol Violation|1
7747178|NCT00832819|26935045|P2|Overall Study|Protocol Violation|0
7747179|NCT00832819|26935046|P1|Overall Study|Protocol Violation|0
7747180|NCT00832819|26935044|P3|Overall Study|Adverse Event|0
7747181|NCT00832819|26935045|P2|Overall Study|Adverse Event|1
7747182|NCT00832819|26935046|P1|Overall Study|Adverse Event|0
7747183|NCT00832780|26935052|P1|Overall Study|Physician Decision|1
7747184|NCT00832780|26935052|P1|Overall Study|other complicating condition|2
7747185|NCT00832780|26935052|P1|Overall Study|no reason given|2
7747186|NCT00832780|26935052|P1|Overall Study|Lost to Follow-up|4
7747187|NCT00832780|26935052|P1|Overall Study|Death|16
7747188|NCT00832650|26935094|P3|Overall Study|Randomized but not treated|1
7747189|NCT00832650|26935095|P2|Overall Study|Randomized but not treated|0
7747190|NCT00832650|26935096|P1|Overall Study|Randomized but not treated|0
7747191|NCT00832624|26935136|P1|Overall Study|Study Terminated|10
7747192|NCT00832585|26935146|P1|Overall Study|Lost to Follow-up|1
7747193|NCT00832585|26935146|P1|Overall Study|Withdrawal by Subject|1
7747194|NCT00832455|26935171|P1|Overall Study|Patient moved|1
7747195|NCT00832455|26935171|P1|Overall Study|No improvement|3
7747196|NCT00832455|26935171|P1|Overall Study|Parent dissatisfied|1
7747197|NCT00832455|26935171|P1|Overall Study|Parent misunderstood study|1
7747198|NCT00832455|26935171|P1|Overall Study|Stopped Medication|4
7747199|NCT00832455|26935171|P1|Overall Study|Screening Failure|2
7747200|NCT00832455|26935171|P1|Overall Study|Withdrawal by Subject|17
7747201|NCT00832455|26935171|P1|Overall Study|Protocol Violation|4
7747202|NCT00832455|26935171|P1|Overall Study|Lost to Follow-up|26
7747203|NCT00832455|26935171|P1|Overall Study|Adverse Event|13
7747204|NCT00832416|26935195|P4|Overall Study|Death|0
7747205|NCT00832416|26935196|P3|Overall Study|Death|0
7747206|NCT00832416|26935197|P2|Overall Study|Death|0
7747207|NCT00832416|26935198|P1|Overall Study|Death|1
7747208|NCT00832416|26935195|P4|Overall Study|Adverse Event|10
7747209|NCT00832416|26935196|P3|Overall Study|Adverse Event|41
7747210|NCT00832416|26935197|P2|Overall Study|Adverse Event|19
7747211|NCT00832416|26935198|P1|Overall Study|Adverse Event|21
7747212|NCT00832416|26935195|P4|Overall Study|Administrative|1
7747213|NCT00832416|26935196|P3|Overall Study|Administrative|0
7747214|NCT00832416|26935197|P2|Overall Study|Administrative|0
7747215|NCT00832416|26935198|P1|Overall Study|Administrative|0
7747216|NCT00832416|26935195|P4|Overall Study|Physician Decision|10
7747217|NCT00832416|26935196|P3|Overall Study|Physician Decision|5
7747218|NCT00832416|26935197|P2|Overall Study|Physician Decision|12
7747219|NCT00832416|26935198|P1|Overall Study|Physician Decision|2
7747220|NCT00832416|26935195|P4|Overall Study|Withdrawal by Subject|10
7747221|NCT00832416|26935196|P3|Overall Study|Withdrawal by Subject|2
7747222|NCT00832416|26935197|P2|Overall Study|Withdrawal by Subject|7
7747223|NCT00832416|26935198|P1|Overall Study|Withdrawal by Subject|5
7747224|NCT00832416|26935195|P4|Overall Study|Lack of Efficacy|52
7747225|NCT00832416|26935196|P3|Overall Study|Lack of Efficacy|13
7747226|NCT00832416|26935197|P2|Overall Study|Lack of Efficacy|15
7747227|NCT00832416|26935198|P1|Overall Study|Lack of Efficacy|17
7747228|NCT00832377|26935249|P1|Overall Study|Protocol Violation|1
7747229|NCT00832117|26935295|P1|Overall Study|Disease Progression|11
7747230|NCT00832117|26935295|P1|Overall Study|Death|1
7747231|NCT00832091|26935314|P2|Overall Study|Prohibited Medication|0
7747232|NCT00832091|26935315|P1|Overall Study|Prohibited Medication|1
7747233|NCT00832091|26935314|P2|Overall Study|Withdrawal by Subject|1
7747234|NCT00832091|26935315|P1|Overall Study|Withdrawal by Subject|2
7747235|NCT00832091|26935314|P2|Overall Study|Protocol Violation|0
7747236|NCT00832091|26935315|P1|Overall Study|Protocol Violation|1
7747237|NCT00832091|26935314|P2|Overall Study|Adverse Event|1
7747238|NCT00832091|26935315|P1|Overall Study|Adverse Event|1
7747239|NCT00832078|26935323|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
7747240|NCT00832078|26935324|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
7747241|NCT00832078|26935323|P2|Test Day 1-2 Period|Lack of Efficacy|2
7747242|NCT00832078|26935324|P1|Test Day 1-2 Period|Lack of Efficacy|0
7747243|NCT00832000|26935330|P2|Overall Study|No calls to IVR in period 2|0
7747244|NCT00832000|26935331|P1|Overall Study|No calls to IVR in period 2|2
7747245|NCT00832000|26935330|P2|Overall Study|No calls to IVR in either period|1
7747246|NCT00832000|26935331|P1|Overall Study|No calls to IVR in either period|1
7747247|NCT00832000|26935330|P2|Overall Study|Withdrawal by Subject|0
7747248|NCT00832000|26935331|P1|Overall Study|Withdrawal by Subject|1
7747249|NCT00832000|26935330|P2|Overall Study|Adverse Event|0
7747250|NCT00832000|26935331|P1|Overall Study|Adverse Event|2
7747251|NCT00831844|26935392|P10|Overall Study|Ineligible|0
7747252|NCT00831844|26935393|P9|Overall Study|Ineligible|0
7747253|NCT00831844|26935394|P8|Overall Study|Ineligible|0
7747254|NCT00831844|26935395|P7|Overall Study|Ineligible|0
7747255|NCT00831844|26935396|P6|Overall Study|Ineligible|0
7747256|NCT00831844|26935397|P5|Overall Study|Ineligible|1
7747257|NCT00831844|26935398|P4|Overall Study|Ineligible|0
7747258|NCT00831844|26935399|P3|Overall Study|Ineligible|1
7747259|NCT00831844|26935400|P2|Overall Study|Ineligible|1
7747260|NCT00831844|26935401|P1|Overall Study|Ineligible|0
7747261|NCT00831844|26935392|P10|Overall Study|Withdrawal by Subject|0
7747262|NCT00831844|26935393|P9|Overall Study|Withdrawal by Subject|1
7747263|NCT00831844|26935394|P8|Overall Study|Withdrawal by Subject|1
7747264|NCT00831844|26935395|P7|Overall Study|Withdrawal by Subject|0
7747265|NCT00831844|26935396|P6|Overall Study|Withdrawal by Subject|0
7747266|NCT00831844|26935397|P5|Overall Study|Withdrawal by Subject|0
7747267|NCT00831844|26935398|P4|Overall Study|Withdrawal by Subject|0
7747268|NCT00831844|26935399|P3|Overall Study|Withdrawal by Subject|1
7747269|NCT00831844|26935400|P2|Overall Study|Withdrawal by Subject|0
7747270|NCT00831844|26935401|P1|Overall Study|Withdrawal by Subject|0
7747271|NCT00831844|26935392|P10|Overall Study|Physician Decision|0
7747272|NCT00831844|26935393|P9|Overall Study|Physician Decision|1
7747273|NCT00831844|26935394|P8|Overall Study|Physician Decision|0
7747274|NCT00831844|26935395|P7|Overall Study|Physician Decision|0
7747275|NCT00831844|26935396|P6|Overall Study|Physician Decision|1
7747276|NCT00831844|26935397|P5|Overall Study|Physician Decision|1
7747277|NCT00831844|26935398|P4|Overall Study|Physician Decision|1
7747278|NCT00831844|26935399|P3|Overall Study|Physician Decision|3
7747279|NCT00831844|26935400|P2|Overall Study|Physician Decision|1
7747280|NCT00831844|26935401|P1|Overall Study|Physician Decision|0
7747281|NCT00831844|26935392|P10|Overall Study|Lack of Efficacy|0
7747282|NCT00831844|26935393|P9|Overall Study|Lack of Efficacy|7
7747283|NCT00831844|26935394|P8|Overall Study|Lack of Efficacy|9
7747284|NCT00831844|26935395|P7|Overall Study|Lack of Efficacy|8
7747285|NCT00831844|26935396|P6|Overall Study|Lack of Efficacy|17
7747286|NCT00831844|26935397|P5|Overall Study|Lack of Efficacy|11
7747287|NCT00831844|26935398|P4|Overall Study|Lack of Efficacy|8
7747288|NCT00831844|26935399|P3|Overall Study|Lack of Efficacy|15
7747289|NCT00831844|26935400|P2|Overall Study|Lack of Efficacy|10
7747290|NCT00831844|26935401|P1|Overall Study|Lack of Efficacy|8
7747291|NCT00831844|26935392|P10|Overall Study|Death|0
7747292|NCT00831844|26935393|P9|Overall Study|Death|0
7747293|NCT00831844|26935394|P8|Overall Study|Death|0
7747294|NCT00831844|26935395|P7|Overall Study|Death|0
7747295|NCT00831844|26935396|P6|Overall Study|Death|0
7747296|NCT00831844|26935397|P5|Overall Study|Death|0
7747297|NCT00831844|26935398|P4|Overall Study|Death|1
7747298|NCT00831844|26935399|P3|Overall Study|Death|0
7747299|NCT00831844|26935400|P2|Overall Study|Death|0
7747300|NCT00831844|26935401|P1|Overall Study|Death|0
7747301|NCT00831844|26935392|P10|Overall Study|Adverse Event|0
7747302|NCT00831844|26935393|P9|Overall Study|Adverse Event|0
7747303|NCT00831844|26935394|P8|Overall Study|Adverse Event|0
7747304|NCT00831844|26935395|P7|Overall Study|Adverse Event|2
7747305|NCT00831844|26935396|P6|Overall Study|Adverse Event|1
7747306|NCT00831844|26935397|P5|Overall Study|Adverse Event|1
7747307|NCT00831844|26935398|P4|Overall Study|Adverse Event|0
7747308|NCT00831844|26935399|P3|Overall Study|Adverse Event|0
7747309|NCT00831844|26935400|P2|Overall Study|Adverse Event|0
7747310|NCT00831844|26935401|P1|Overall Study|Adverse Event|2
7747311|NCT00831792|26935423|P1|Overall Study|Lack of Efficacy|1
7747312|NCT00831792|26935423|P1|Overall Study|Death|1
7747313|NCT00831792|26935423|P1|Overall Study|Adverse Event|1
7747314|NCT00831792|26935423|P1|Overall Study|Not Eligible|3
7747315|NCT00831779|26935429|P2|Overall Study|No longer met criteria|1
7747316|NCT00831779|26935430|P1|Overall Study|No longer met criteria|0
7747317|NCT00831779|26935429|P2|Overall Study|Lost to Follow-up|0
7747318|NCT00831779|26935430|P1|Overall Study|Lost to Follow-up|1
7747319|NCT00831701|26935467|P2|Overall Study|Lost to Follow-up|3
7747320|NCT00831701|26935468|P1|Overall Study|Lost to Follow-up|1
7747321|NCT00831701|26935467|P2|Overall Study|Stone expulsion before first medication|2
7747322|NCT00831701|26935468|P1|Overall Study|Stone expulsion before first medication|2
7747323|NCT00831701|26935467|P2|Overall Study|Withdrawal by Subject|0
7747324|NCT00831701|26935468|P1|Overall Study|Withdrawal by Subject|2
7747325|NCT00831493|26935497|P1|Overall Study|Intractable nausea and vomiting|1
7747326|NCT00831441|26935507|P2|Follow Up (30 Days)|missing end of study status|1
7747327|NCT00831441|26935508|P1|Follow Up (30 Days)|missing end of study status|0
7747328|NCT00831441|26935507|P2|Follow Up (30 Days)|non-specified|26
7747329|NCT00831441|26935508|P1|Follow Up (30 Days)|non-specified|16
7747330|NCT00831441|26935507|P2|Follow Up (30 Days)|Death|86
7747331|NCT00831441|26935508|P1|Follow Up (30 Days)|Death|63
7747332|NCT00831441|26935507|P2|Follow Up (30 Days)|Lost to Follow-up|27
7747333|NCT00831441|26935508|P1|Follow Up (30 Days)|Lost to Follow-up|13
7747334|NCT00831441|26935507|P2|Follow Up (30 Days)|Withdrawal by Subject|34
7747335|NCT00831441|26935508|P1|Follow Up (30 Days)|Withdrawal by Subject|41
7747336|NCT00831441|26935507|P2|Randomized|non-specified|266
7747337|NCT00831441|26935508|P1|Randomized|non-specified|276
7747338|NCT00831441|26935507|P2|Randomized|poor/non-compliance|38
7747339|NCT00831441|26935508|P1|Randomized|poor/non-compliance|30
7747340|NCT00831441|26935507|P2|Randomized|Administrative reason by sponsor|2671
7747341|NCT00831441|26935508|P1|Randomized|Administrative reason by sponsor|2780
7747342|NCT00831441|26935507|P2|Randomized|Lost to Follow-up|35
7747343|NCT00831441|26935508|P1|Randomized|Lost to Follow-up|26
7747344|NCT00831441|26935507|P2|Randomized|Withdrawal by Subject|212
7747345|NCT00831441|26935508|P1|Randomized|Withdrawal by Subject|178
7747346|NCT00831441|26935507|P2|Randomized|No longer met criteria|19
7747347|NCT00831441|26935508|P1|Randomized|No longer met criteria|13
7747348|NCT00831441|26935507|P2|Randomized|Physician Decision|35
7747349|NCT00831441|26935508|P1|Randomized|Physician Decision|26
7747350|NCT00831441|26935507|P2|Randomized|Elective procedure|25
7747351|NCT00831441|26935508|P1|Randomized|Elective procedure|26
7747352|NCT00831441|26935507|P2|Randomized|Emergency procedure|2
7747353|NCT00831441|26935508|P1|Randomized|Emergency procedure|2
7747354|NCT00831441|26935507|P2|Randomized|Adverse Event|321
7747355|NCT00831441|26935508|P1|Randomized|Adverse Event|248
7747356|NCT00831441|26935507|P2|Randomized|Death|81
7747357|NCT00831441|26935508|P1|Randomized|Death|82
7747358|NCT00831415|26935540|P1|Overall Study|Death|1
7747359|NCT00831415|26935540|P1|Overall Study|Unsatisfactory response - Efficacy|4
7747360|NCT00831415|26935540|P1|Overall Study|Withdrawal by Subject|35
7747361|NCT00831415|26935540|P1|Overall Study|Protocol Violation|3
7747362|NCT00831415|26935540|P1|Overall Study|Lost to Follow-up|9
7747363|NCT00831415|26935540|P1|Overall Study|Physician Decision|6
7747364|NCT00831415|26935540|P1|Overall Study|Failed to return|3
7747365|NCT00831415|26935540|P1|Overall Study|Adverse Event|14
7747366|NCT00831389|26935549|P2|Overall Study|Withdrawal by Subject|1
7747367|NCT00831389|26935550|P1|Overall Study|Withdrawal by Subject|0
7747368|NCT00831311|26935576|P2|Overall Study|Withdrawal by Subject|4
7747369|NCT00831311|26935577|P1|Overall Study|Withdrawal by Subject|6
7747370|NCT00831311|26935576|P2|Overall Study|Physician Decision|1
7747371|NCT00831311|26935577|P1|Overall Study|Physician Decision|0
7747372|NCT00831311|26935576|P2|Overall Study|Lost to Follow-up|0
7747373|NCT00831311|26935577|P1|Overall Study|Lost to Follow-up|3
7747374|NCT00831311|26935576|P2|Overall Study|Definitive Contraindication|3
7747375|NCT00831311|26935577|P1|Overall Study|Definitive Contraindication|3
7747376|NCT00831233|26935614|P2|Overall Study|Selection Criteria Not Met|0
7747377|NCT00831233|26935615|P1|Overall Study|Selection Criteria Not Met|2
7747378|NCT00831233|26935614|P2|Overall Study|Protocol Violation|0
7747379|NCT00831233|26935615|P1|Overall Study|Protocol Violation|1
7747380|NCT00831233|26935614|P2|Overall Study|Adverse Event|1
7747381|NCT00831233|26935615|P1|Overall Study|Adverse Event|0
7747382|NCT00831181|26935639|P1|Overall Study|Adverse Event|12
7747383|NCT00831129|26935652|P2|Overall Study|9 lost to follow-up reasons uknown|9
7747384|NCT00831129|26935653|P1|Overall Study|9 lost to follow-up reasons uknown|0
7747385|NCT00831129|26935652|P2|Overall Study|Adverse Event|1
7747386|NCT00831129|26935653|P1|Overall Study|Adverse Event|0
7747387|NCT00830960|26935695|P6|Overall Study|No study drug received|7
7747388|NCT00830960|26935696|P5|Overall Study|No study drug received|5
7747389|NCT00830960|26935697|P4|Overall Study|No study drug received|3
7747390|NCT00830960|26935698|P3|Overall Study|No study drug received|4
7747391|NCT00830960|26935699|P2|Overall Study|No study drug received|2
7747392|NCT00830960|26935700|P1|Overall Study|No study drug received|7
7747393|NCT00830960|26935695|P6|Overall Study|Sponsor Decision|7
7747394|NCT00830960|26935696|P5|Overall Study|Sponsor Decision|5
7747395|NCT00830960|26935697|P4|Overall Study|Sponsor Decision|4
7747396|NCT00830960|26935698|P3|Overall Study|Sponsor Decision|3
7747397|NCT00830960|26935699|P2|Overall Study|Sponsor Decision|2
7747398|NCT00830960|26935700|P1|Overall Study|Sponsor Decision|1
7747399|NCT00830960|26935695|P6|Overall Study|Withdrawal by Subject|21
7747400|NCT00830960|26935696|P5|Overall Study|Withdrawal by Subject|16
7747401|NCT00830960|26935697|P4|Overall Study|Withdrawal by Subject|23
7747402|NCT00830960|26935698|P3|Overall Study|Withdrawal by Subject|18
7747403|NCT00830960|26935699|P2|Overall Study|Withdrawal by Subject|19
7747404|NCT00830960|26935700|P1|Overall Study|Withdrawal by Subject|19
7747405|NCT00830960|26935695|P6|Overall Study|Lost to Follow-up|1
7747406|NCT00830960|26935696|P5|Overall Study|Lost to Follow-up|0
7747407|NCT00830960|26935697|P4|Overall Study|Lost to Follow-up|0
7747408|NCT00830960|26935698|P3|Overall Study|Lost to Follow-up|1
7747409|NCT00830960|26935699|P2|Overall Study|Lost to Follow-up|1
7747410|NCT00830960|26935700|P1|Overall Study|Lost to Follow-up|1
7747411|NCT00830960|26935695|P6|Overall Study|Death|1
7747412|NCT00830960|26935696|P5|Overall Study|Death|6
7747413|NCT00830960|26935697|P4|Overall Study|Death|2
7747414|NCT00830960|26935698|P3|Overall Study|Death|3
7747415|NCT00830960|26935699|P2|Overall Study|Death|4
7747416|NCT00830960|26935700|P1|Overall Study|Death|5
7747417|NCT00830947|26935816|P2|Overall Study|Lost to Follow-up|4
7747418|NCT00830947|26935817|P1|Overall Study|Lost to Follow-up|4
7747419|NCT00830869|26935835|P12|Period 2: Part 2|Other|0
7747420|NCT00830869|26935836|P11|Period 2: Part 2|Other|0
7747421|NCT00830869|26935837|P10|Period 2: Part 2|Other|1
7747422|NCT00830869|26935838|P9|Period 2: Part 2|Other|0
7747423|NCT00830869|26935839|P8|Period 2: Part 2|Other|0
7747424|NCT00830869|26935840|P7|Period 2: Part 2|Other|0
7747425|NCT00830869|26935841|P6|Period 2: Part 2|Other|0
7747426|NCT00830869|26935842|P5|Period 2: Part 2|Other|0
7747427|NCT00830869|26935843|P4|Period 2: Part 2|Other|0
7747428|NCT00830869|26935844|P3|Period 2: Part 2|Other|0
7747429|NCT00830869|26935845|P2|Period 2: Part 2|Other|0
7747430|NCT00830869|26935846|P1|Period 2: Part 2|Other|0
7747431|NCT00830869|26935835|P12|Period 2: Part 2|Progressive disease|15
7747432|NCT00830869|26935836|P11|Period 2: Part 2|Progressive disease|8
7747433|NCT00830869|26935837|P10|Period 2: Part 2|Progressive disease|12
7747434|NCT00830869|26935838|P9|Period 2: Part 2|Progressive disease|11
7747435|NCT00830869|26935839|P8|Period 2: Part 2|Progressive disease|14
7747436|NCT00830869|26935840|P7|Period 2: Part 2|Progressive disease|0
7747437|NCT00830869|26935841|P6|Period 2: Part 2|Progressive disease|0
7747438|NCT00830869|26935842|P5|Period 2: Part 2|Progressive disease|0
7747439|NCT00830869|26935843|P4|Period 2: Part 2|Progressive disease|0
7747440|NCT00830869|26935844|P3|Period 2: Part 2|Progressive disease|0
7747441|NCT00830869|26935845|P2|Period 2: Part 2|Progressive disease|0
7747442|NCT00830869|26935846|P1|Period 2: Part 2|Progressive disease|0
7747443|NCT00830869|26935835|P12|Period 2: Part 2|Symptomatic Deterioration|4
7747444|NCT00830869|26935836|P11|Period 2: Part 2|Symptomatic Deterioration|1
7747445|NCT00830869|26935837|P10|Period 2: Part 2|Symptomatic Deterioration|3
7747446|NCT00830869|26935838|P9|Period 2: Part 2|Symptomatic Deterioration|6
7747447|NCT00830869|26935839|P8|Period 2: Part 2|Symptomatic Deterioration|0
7747448|NCT00830869|26935840|P7|Period 2: Part 2|Symptomatic Deterioration|0
7747449|NCT00830869|26935841|P6|Period 2: Part 2|Symptomatic Deterioration|0
7747450|NCT00830869|26935842|P5|Period 2: Part 2|Symptomatic Deterioration|0
7747451|NCT00830869|26935843|P4|Period 2: Part 2|Symptomatic Deterioration|0
7747452|NCT00830869|26935844|P3|Period 2: Part 2|Symptomatic Deterioration|0
7747453|NCT00830869|26935845|P2|Period 2: Part 2|Symptomatic Deterioration|0
7747454|NCT00830869|26935846|P1|Period 2: Part 2|Symptomatic Deterioration|0
7747455|NCT00830869|26935835|P12|Period 2: Part 2|Adverse Event|0
7747456|NCT00830869|26935836|P11|Period 2: Part 2|Adverse Event|2
7747457|NCT00830869|26935837|P10|Period 2: Part 2|Adverse Event|2
7747458|NCT00830869|26935838|P9|Period 2: Part 2|Adverse Event|3
7747459|NCT00830869|26935839|P8|Period 2: Part 2|Adverse Event|4
7747460|NCT00830869|26935840|P7|Period 2: Part 2|Adverse Event|0
7747461|NCT00830869|26935841|P6|Period 2: Part 2|Adverse Event|0
7747462|NCT00830869|26935842|P5|Period 2: Part 2|Adverse Event|0
7747463|NCT00830869|26935843|P4|Period 2: Part 2|Adverse Event|0
7747464|NCT00830869|26935844|P3|Period 2: Part 2|Adverse Event|0
7747465|NCT00830869|26935845|P2|Period 2: Part 2|Adverse Event|0
7747466|NCT00830869|26935846|P1|Period 2: Part 2|Adverse Event|0
7747467|NCT00830869|26935835|P12|Period 2: Part 2|Withdrawal by Subject|1
7747468|NCT00830869|26935836|P11|Period 2: Part 2|Withdrawal by Subject|0
7747469|NCT00830869|26935837|P10|Period 2: Part 2|Withdrawal by Subject|1
7747470|NCT00830869|26935838|P9|Period 2: Part 2|Withdrawal by Subject|2
7747471|NCT00830869|26935839|P8|Period 2: Part 2|Withdrawal by Subject|1
7747472|NCT00830869|26935840|P7|Period 2: Part 2|Withdrawal by Subject|0
7747473|NCT00830869|26935841|P6|Period 2: Part 2|Withdrawal by Subject|0
7747474|NCT00830869|26935842|P5|Period 2: Part 2|Withdrawal by Subject|0
7747475|NCT00830869|26935843|P4|Period 2: Part 2|Withdrawal by Subject|0
7747476|NCT00830869|26935844|P3|Period 2: Part 2|Withdrawal by Subject|0
7747477|NCT00830869|26935845|P2|Period 2: Part 2|Withdrawal by Subject|0
7747478|NCT00830869|26935846|P1|Period 2: Part 2|Withdrawal by Subject|0
7747479|NCT00830869|26935835|P12|Period 2: Part 2|Protocol Violation|0
7747480|NCT00830869|26935836|P11|Period 2: Part 2|Protocol Violation|0
7747481|NCT00830869|26935837|P10|Period 2: Part 2|Protocol Violation|1
7747482|NCT00830869|26935838|P9|Period 2: Part 2|Protocol Violation|0
7747483|NCT00830869|26935839|P8|Period 2: Part 2|Protocol Violation|1
7747484|NCT00830869|26935840|P7|Period 2: Part 2|Protocol Violation|0
7747485|NCT00830869|26935841|P6|Period 2: Part 2|Protocol Violation|0
7747486|NCT00830869|26935842|P5|Period 2: Part 2|Protocol Violation|0
7747487|NCT00830869|26935843|P4|Period 2: Part 2|Protocol Violation|0
7747488|NCT00830869|26935844|P3|Period 2: Part 2|Protocol Violation|0
7747489|NCT00830869|26935845|P2|Period 2: Part 2|Protocol Violation|0
7747490|NCT00830869|26935846|P1|Period 2: Part 2|Protocol Violation|0
7747491|NCT00830869|26935835|P12|Period 1: Part 1|Progressive disease|0
7747492|NCT00830869|26935836|P11|Period 1: Part 1|Progressive disease|0
7747493|NCT00830869|26935837|P10|Period 1: Part 1|Progressive disease|0
7747494|NCT00830869|26935838|P9|Period 1: Part 1|Progressive disease|0
7747495|NCT00830869|26935839|P8|Period 1: Part 1|Progressive disease|0
7747496|NCT00830869|26935840|P7|Period 1: Part 1|Progressive disease|1
7747497|NCT00830869|26935841|P6|Period 1: Part 1|Progressive disease|4
7747498|NCT00830869|26935842|P5|Period 1: Part 1|Progressive disease|4
7747499|NCT00830869|26935843|P4|Period 1: Part 1|Progressive disease|6
7747500|NCT00830869|26935844|P3|Period 1: Part 1|Progressive disease|1
7747501|NCT00830869|26935845|P2|Period 1: Part 1|Progressive disease|0
7747502|NCT00830869|26935846|P1|Period 1: Part 1|Progressive disease|1
7747503|NCT00830869|26935835|P12|Period 1: Part 1|Adverse Event|0
7747504|NCT00830869|26935836|P11|Period 1: Part 1|Adverse Event|0
7747505|NCT00830869|26935837|P10|Period 1: Part 1|Adverse Event|0
7747506|NCT00830869|26935838|P9|Period 1: Part 1|Adverse Event|0
7747507|NCT00830869|26935839|P8|Period 1: Part 1|Adverse Event|0
7747508|NCT00830869|26935840|P7|Period 1: Part 1|Adverse Event|1
7747509|NCT00830869|26935841|P6|Period 1: Part 1|Adverse Event|1
7747510|NCT00830869|26935842|P5|Period 1: Part 1|Adverse Event|0
7747511|NCT00830869|26935843|P4|Period 1: Part 1|Adverse Event|0
7747512|NCT00830869|26935844|P3|Period 1: Part 1|Adverse Event|0
7747513|NCT00830869|26935845|P2|Period 1: Part 1|Adverse Event|0
7747514|NCT00830869|26935846|P1|Period 1: Part 1|Adverse Event|0
7747515|NCT00830869|26935835|P12|Period 1: Part 1|Withdrawal by Subject|0
7747516|NCT00830869|26935836|P11|Period 1: Part 1|Withdrawal by Subject|0
7747517|NCT00830869|26935837|P10|Period 1: Part 1|Withdrawal by Subject|0
7747518|NCT00830869|26935838|P9|Period 1: Part 1|Withdrawal by Subject|0
7747519|NCT00830869|26935839|P8|Period 1: Part 1|Withdrawal by Subject|0
7747520|NCT00830869|26935840|P7|Period 1: Part 1|Withdrawal by Subject|0
7747521|NCT00830869|26935841|P6|Period 1: Part 1|Withdrawal by Subject|0
7747522|NCT00830869|26935842|P5|Period 1: Part 1|Withdrawal by Subject|0
7747523|NCT00830869|26935843|P4|Period 1: Part 1|Withdrawal by Subject|0
7747524|NCT00830869|26935844|P3|Period 1: Part 1|Withdrawal by Subject|0
7747525|NCT00830869|26935845|P2|Period 1: Part 1|Withdrawal by Subject|1
7747526|NCT00830869|26935846|P1|Period 1: Part 1|Withdrawal by Subject|0
7747527|NCT00830869|26935835|P12|Period 1: Part 1|Symptomatic deterioration|0
7747528|NCT00830869|26935836|P11|Period 1: Part 1|Symptomatic deterioration|0
7747529|NCT00830869|26935837|P10|Period 1: Part 1|Symptomatic deterioration|0
7747530|NCT00830869|26935838|P9|Period 1: Part 1|Symptomatic deterioration|0
7747531|NCT00830869|26935839|P8|Period 1: Part 1|Symptomatic deterioration|0
7747532|NCT00830869|26935840|P7|Period 1: Part 1|Symptomatic deterioration|1
7747533|NCT00830869|26935841|P6|Period 1: Part 1|Symptomatic deterioration|1
7747534|NCT00830869|26935842|P5|Period 1: Part 1|Symptomatic deterioration|0
7747535|NCT00830869|26935843|P4|Period 1: Part 1|Symptomatic deterioration|1
7747536|NCT00830869|26935844|P3|Period 1: Part 1|Symptomatic deterioration|0
7747537|NCT00830869|26935845|P2|Period 1: Part 1|Symptomatic deterioration|0
7747538|NCT00830869|26935846|P1|Period 1: Part 1|Symptomatic deterioration|0
7747539|NCT00830804|26935982|P1|Overall Study|Unwilling to adhere to study requirement|1
7747540|NCT00830804|26935982|P1|Overall Study|Consent withdrawn|2
7747541|NCT00830804|26935982|P1|Overall Study|Unable to get to clinic|7
7747542|NCT00830804|26935982|P1|Overall Study|Death|1
7747543|NCT00830804|26935982|P1|Overall Study|Lost to Follow-up|4
7747544|NCT00830765|26936062|P2|Overall Study|Protocol Violation|2
7747545|NCT00830765|26936063|P1|Overall Study|Protocol Violation|3
7747546|NCT00830518|26936096|P2|Overall Study|Reason not Specified|1
7747547|NCT00830518|26936097|P1|Overall Study|Reason not Specified|8
7747548|NCT00830518|26936096|P2|Overall Study|Withdrawal by Patient|0
7747549|NCT00830518|26936097|P1|Overall Study|Withdrawal by Patient|2
7747550|NCT00830518|26936096|P2|Overall Study|Adverse Event|1
7747551|NCT00830518|26936097|P1|Overall Study|Adverse Event|14
7747552|NCT00830518|26936096|P2|Overall Study|Symptomatic Deterioration|1
7747553|NCT00830518|26936097|P1|Overall Study|Symptomatic Deterioration|4
7747554|NCT00830518|26936096|P2|Overall Study|Progressive Disease|8
7747555|NCT00830518|26936097|P1|Overall Study|Progressive Disease|18
7747556|NCT00830440|26936116|P2|Overall Study|Adverse Event|0
7747557|NCT00830440|26936117|P1|Overall Study|Adverse Event|2
7747558|NCT00830440|26936116|P2|Overall Study|unsuccessful procedure|0
7747559|NCT00830440|26936117|P1|Overall Study|unsuccessful procedure|4
7747560|NCT00830440|26936116|P2|Overall Study|Withdrawal by Subject|0
7747561|NCT00830440|26936117|P1|Overall Study|Withdrawal by Subject|1
7747562|NCT00830440|26936116|P2|Overall Study|Protocol Violation|0
7747563|NCT00830440|26936117|P1|Overall Study|Protocol Violation|1
7747564|NCT00830375|26936132|P1|Overall Study|Lost to Follow-up|1
7747565|NCT00830336|26936147|P2|Washout: 21 Days|Withdrawal by Subject|0
7747566|NCT00830336|26936148|P1|Washout: 21 Days|Withdrawal by Subject|1
7747567|NCT00830258|26936175|P2|Washout: 7 Days|Protocol Violation|0
7747568|NCT00830258|26936176|P1|Washout: 7 Days|Protocol Violation|1
7747569|NCT00830258|26936175|P2|First Intervention|Adverse Event|0
7747570|NCT00830258|26936176|P1|First Intervention|Adverse Event|1
7747571|NCT00830219|26936195|P2|Washout of 7 Days|Withdrawal by Subject|1
7747572|NCT00830219|26936196|P1|Washout of 7 Days|Withdrawal by Subject|1
7747573|NCT00830206|26936206|P2|Washout: 21 Days|Withdrawal by Subject|1
7747574|NCT00830206|26936207|P1|Washout: 21 Days|Withdrawal by Subject|1
7747575|NCT00830180|26936215|P1|Overall Study|Other - Unspecified|1
7747576|NCT00830180|26936215|P1|Overall Study|Progressive disease|2
7747577|NCT00830180|26936215|P1|Overall Study|Withdrawal by Subject|5
7747578|NCT00830180|26936215|P1|Overall Study|Insufficient clinical response|1
7747579|NCT00830180|26936215|P1|Overall Study|Death|11
7747580|NCT00830180|26936215|P1|Overall Study|Adverse Event|6
7747581|NCT00830167|26936238|P2|Overall Study|Other|2
7747582|NCT00830167|26936239|P1|Overall Study|Other|2
7747583|NCT00830167|26936238|P2|Overall Study|Protocol Violation|1
7747584|NCT00830167|26936239|P1|Overall Study|Protocol Violation|0
7747585|NCT00830167|26936238|P2|Overall Study|Lost to Follow-up|1
7747586|NCT00830167|26936239|P1|Overall Study|Lost to Follow-up|0
7747587|NCT00830167|26936238|P2|Overall Study|Withdrawal by Subject|0
7747588|NCT00830167|26936239|P1|Overall Study|Withdrawal by Subject|2
7747589|NCT00830167|26936238|P2|Overall Study|Not meeting entrance criteria|5
7747590|NCT00830167|26936239|P1|Overall Study|Not meeting entrance criteria|2
7747591|NCT00830167|26936238|P2|Overall Study|Adverse Event|24
7747592|NCT00830167|26936239|P1|Overall Study|Adverse Event|8
7747593|NCT00830167|26936238|P2|Overall Study|Lack of Efficacy|10
7747594|NCT00830167|26936239|P1|Overall Study|Lack of Efficacy|26
7747595|NCT00830128|26936309|P1|Overall Study|Operating a vehicle|1
7747596|NCT00830128|26936309|P1|Overall Study|Work obligation|1
7747597|NCT00830128|26936309|P1|Overall Study|Relocation|1
7747598|NCT00830128|26936309|P1|Overall Study|Family obligation|1
7747599|NCT00830128|26936309|P1|Overall Study|Withdrawal by Subject|2
7747600|NCT00830128|26936309|P1|Overall Study|Protocol Violation|1
7747601|NCT00830128|26936309|P1|Overall Study|Lack of Efficacy|7
7747602|NCT00830128|26936309|P1|Overall Study|Adverse Event|5
7747603|NCT00830115|26936324|P1|Overall Study|Improvement/recovery|1
7747604|NCT00830115|26936324|P1|Overall Study|Adverse Event|2
7747605|NCT00830063|26936353|P4|Overall Study|Randomized But Not Treated|2
7747606|NCT00830063|26936354|P3|Overall Study|Randomized But Not Treated|0
7747607|NCT00830063|26936355|P2|Overall Study|Randomized But Not Treated|2
7747608|NCT00830063|26936356|P1|Overall Study|Randomized But Not Treated|0
7747609|NCT00830063|26936353|P4|Overall Study|Protocol Violation|2
7747610|NCT00830063|26936354|P3|Overall Study|Protocol Violation|3
7747611|NCT00830063|26936355|P2|Overall Study|Protocol Violation|0
7747612|NCT00830063|26936356|P1|Overall Study|Protocol Violation|1
7747613|NCT00830063|26936353|P4|Overall Study|Withdrawal by Subject|13
7747614|NCT00830063|26936354|P3|Overall Study|Withdrawal by Subject|16
7747615|NCT00830063|26936355|P2|Overall Study|Withdrawal by Subject|10
7747616|NCT00830063|26936356|P1|Overall Study|Withdrawal by Subject|16
7747617|NCT00830063|26936353|P4|Overall Study|Other|6
7747618|NCT00830063|26936354|P3|Overall Study|Other|8
7747619|NCT00830063|26936355|P2|Overall Study|Other|5
7747620|NCT00830063|26936356|P1|Overall Study|Other|5
7747621|NCT00830063|26936353|P4|Overall Study|Lack of Efficacy|32
7747622|NCT00830063|26936354|P3|Overall Study|Lack of Efficacy|25
7747623|NCT00830063|26936355|P2|Overall Study|Lack of Efficacy|23
7747624|NCT00830063|26936356|P1|Overall Study|Lack of Efficacy|51
7747625|NCT00830063|26936353|P4|Overall Study|Preferred Time Entry in Extension Study|126
7747626|NCT00830063|26936354|P3|Overall Study|Preferred Time Entry in Extension Study|127
7747627|NCT00830063|26936355|P2|Overall Study|Preferred Time Entry in Extension Study|139
7747628|NCT00830063|26936356|P1|Overall Study|Preferred Time Entry in Extension Study|119
7747629|NCT00830063|26936353|P4|Overall Study|Lost to Follow-up|1
7747630|NCT00830063|26936354|P3|Overall Study|Lost to Follow-up|3
7747631|NCT00830063|26936355|P2|Overall Study|Lost to Follow-up|0
7747632|NCT00830063|26936356|P1|Overall Study|Lost to Follow-up|0
7747633|NCT00830063|26936353|P4|Overall Study|Death|0
7747634|NCT00830063|26936354|P3|Overall Study|Death|0
7747635|NCT00830063|26936355|P2|Overall Study|Death|0
7747636|NCT00830063|26936356|P1|Overall Study|Death|1
7747637|NCT00830063|26936353|P4|Overall Study|Adverse Event|13
7747638|NCT00830063|26936354|P3|Overall Study|Adverse Event|16
7747639|NCT00830063|26936355|P2|Overall Study|Adverse Event|13
7747640|NCT00830063|26936356|P1|Overall Study|Adverse Event|7
7747641|NCT00830037|26936518|P2|Overall Study|Active when terminated by DSMB|14
7747642|NCT00830037|26936519|P1|Overall Study|Active when terminated by DSMB|15
7747643|NCT00830037|26936518|P2|Overall Study|Lost to Follow-up|2
7747644|NCT00830037|26936519|P1|Overall Study|Lost to Follow-up|1
7747645|NCT00830037|26936518|P2|Overall Study|Withdrawal by Subject|3
7747646|NCT00830037|26936519|P1|Overall Study|Withdrawal by Subject|2
7747647|NCT00830024|26936529|P2|Washout: 7 Days|Withdrawal by Subject|0
7747648|NCT00830024|26936530|P1|Washout: 7 Days|Withdrawal by Subject|1
7747649|NCT00829998|26936540|P2|Washout|Adverse Event|1
7747650|NCT00829998|26936541|P1|Washout|Adverse Event|0
7747651|NCT00829933|26936570|P4|Overall Study|withdrew before treatment started|9
7747652|NCT00829933|26936571|P3|Overall Study|withdrew before treatment started|2
7747653|NCT00829933|26936572|P2|Overall Study|withdrew before treatment started|1
7747654|NCT00829933|26936573|P1|Overall Study|withdrew before treatment started|5
7747655|NCT00829933|26936570|P4|Overall Study|Protocol Violation|0
7747656|NCT00829933|26936571|P3|Overall Study|Protocol Violation|0
7747657|NCT00829933|26936572|P2|Overall Study|Protocol Violation|1
7747658|NCT00829933|26936573|P1|Overall Study|Protocol Violation|2
7747659|NCT00829933|26936570|P4|Overall Study|Pregnancy|2
7747660|NCT00829933|26936571|P3|Overall Study|Pregnancy|0
7747661|NCT00829933|26936572|P2|Overall Study|Pregnancy|0
7747662|NCT00829933|26936573|P1|Overall Study|Pregnancy|0
7747663|NCT00829933|26936570|P4|Overall Study|Physician Decision|1
7747664|NCT00829933|26936571|P3|Overall Study|Physician Decision|8
7747665|NCT00829933|26936572|P2|Overall Study|Physician Decision|7
7747666|NCT00829933|26936573|P1|Overall Study|Physician Decision|5
7747667|NCT00829933|26936570|P4|Overall Study|Lack of Efficacy|0
7747668|NCT00829933|26936571|P3|Overall Study|Lack of Efficacy|0
7747669|NCT00829933|26936572|P2|Overall Study|Lack of Efficacy|1
7747670|NCT00829933|26936573|P1|Overall Study|Lack of Efficacy|0
7747671|NCT00829933|26936570|P4|Overall Study|Death|1
7747672|NCT00829933|26936571|P3|Overall Study|Death|1
7747673|NCT00829933|26936572|P2|Overall Study|Death|0
7747674|NCT00829933|26936573|P1|Overall Study|Death|0
7747675|NCT00829933|26936570|P4|Overall Study|Adverse Event|1
7747676|NCT00829933|26936571|P3|Overall Study|Adverse Event|2
7747677|NCT00829933|26936572|P2|Overall Study|Adverse Event|3
7747678|NCT00829933|26936573|P1|Overall Study|Adverse Event|2
7747679|NCT00829868|26936585|P2|Washout|Physician Decision|0
7747680|NCT00829868|26936586|P1|Washout|Physician Decision|1
7747681|NCT00829829|26936597|P3|Overall Study|Other than specified above|1
7747682|NCT00829829|26936598|P2|Overall Study|Other than specified above|2
7747683|NCT00829829|26936599|P1|Overall Study|Other than specified above|2
7747684|NCT00829829|26936597|P3|Overall Study|Lost to Follow-up|3
7747685|NCT00829829|26936598|P2|Overall Study|Lost to Follow-up|3
7747686|NCT00829829|26936599|P1|Overall Study|Lost to Follow-up|7
7747687|NCT00829829|26936597|P3|Overall Study|Decision by the Sponsor|2
7747688|NCT00829829|26936598|P2|Overall Study|Decision by the Sponsor|0
7747689|NCT00829829|26936599|P1|Overall Study|Decision by the Sponsor|1
7747690|NCT00829829|26936597|P3|Overall Study|Withdrawal by Subject|2
7747691|NCT00829829|26936598|P2|Overall Study|Withdrawal by Subject|4
7747692|NCT00829829|26936599|P1|Overall Study|Withdrawal by Subject|8
7747693|NCT00829829|26936597|P3|Overall Study|Adverse Event|3
7747694|NCT00829829|26936598|P2|Overall Study|Adverse Event|4
7747695|NCT00829829|26936599|P1|Overall Study|Adverse Event|4
7747696|NCT00829829|26936597|P3|Overall Study|Protocol Violation|0
7747697|NCT00829829|26936598|P2|Overall Study|Protocol Violation|3
7747698|NCT00829829|26936599|P1|Overall Study|Protocol Violation|0
7747699|NCT00829790|26936624|P2|Washout of 14 Days|Withdrawal by Subject|1
7747700|NCT00829790|26936625|P1|Washout of 14 Days|Withdrawal by Subject|0
7747701|NCT00829764|26936635|P2|First Intervention|Withdrawal by Subject|1
7747702|NCT00829764|26936636|P1|First Intervention|Withdrawal by Subject|1
7747703|NCT00829764|26936635|P2|First Intervention|Adverse Event|0
7747704|NCT00829764|26936636|P1|First Intervention|Adverse Event|1
7747705|NCT00829712|26936662|P2|Washout of 7 Days|Withdrawal by Subject|1
7747706|NCT00829712|26936663|P1|Washout of 7 Days|Withdrawal by Subject|0
7747707|NCT00829673|26936682|P2|Washout of 7 Days|Withdrawal by Subject|0
7747708|NCT00829673|26936683|P1|Washout of 7 Days|Withdrawal by Subject|1
7747709|NCT00829621|26936693|P2|Overall Study|Lost to Follow-up|4
7747710|NCT00829621|26936694|P1|Overall Study|Lost to Follow-up|3
7747711|NCT00829621|26936693|P2|Overall Study|Death|0
7747712|NCT00829621|26936694|P1|Overall Study|Death|1
7747713|NCT00829530|26936702|P2|Second Intervention|Intolerance to Venopuncture|0
7747714|NCT00829530|26936703|P1|Second Intervention|Intolerance to Venopuncture|1
7747715|NCT00829530|26936702|P2|First Intervention|Intolerance to Venopuncture|1
7747716|NCT00829530|26936703|P1|First Intervention|Intolerance to Venopuncture|0
7747717|NCT00829530|26936702|P2|First Intervention|Adverse Event|1
7747718|NCT00829530|26936703|P1|First Intervention|Adverse Event|0
7747719|NCT00829504|26936717|P2|Second Intervention|Physician Decision|0
7747720|NCT00829504|26936718|P1|Second Intervention|Physician Decision|1
7747721|NCT00829504|26936717|P2|Washout of 7 Days|Withdrawal by Subject|0
7747722|NCT00829504|26936718|P1|Washout of 7 Days|Withdrawal by Subject|1
7747723|NCT00829504|26936717|P2|First Intervention|Adverse Event|0
7747724|NCT00829504|26936718|P1|First Intervention|Adverse Event|1
7747725|NCT00829452|26936728|P2|Second Intervention|Physician Decision|1
7747726|NCT00829452|26936729|P1|Second Intervention|Physician Decision|0
7747727|NCT00829452|26936728|P2|Washout of 42 Days|Withdrawal by Subject|1
7747728|NCT00829452|26936729|P1|Washout of 42 Days|Withdrawal by Subject|0
7747729|NCT00829452|26936728|P2|First Intervention|Withdrawal by Subject|1
7747730|NCT00829452|26936729|P1|First Intervention|Withdrawal by Subject|0
7747731|NCT00829439|26936741|P4|Overall Study|Adverse Event|0
7747732|NCT00829439|26936742|P3|Overall Study|Adverse Event|1
7747733|NCT00829439|26936743|P2|Overall Study|Adverse Event|0
7747734|NCT00829439|26936744|P1|Overall Study|Adverse Event|0
7747735|NCT00829426|26936750|P2|Washout: 7 Days|Withdrawal by Subject|0
7747736|NCT00829426|26936751|P1|Washout: 7 Days|Withdrawal by Subject|1
7747737|NCT00829413|26936759|P1|Overall Study|Indeterminate diagnosis from truth stand|3
7747738|NCT00829413|26936759|P1|Overall Study|Technically inadequate truth standard|2
7747739|NCT00829413|26936759|P1|Overall Study|No truth standard procedure available|9
7747740|NCT00829413|26936759|P1|Overall Study|Training Patients|67
7747741|NCT00829413|26936759|P1|Overall Study|No study drug admimnistered|13
7747742|NCT00829387|26936808|P2|Overall Study|Disqualified by PI|0
7747743|NCT00829387|26936809|P1|Overall Study|Disqualified by PI|1
7747744|NCT00829387|26936808|P2|Overall Study|Withdrawal by Subject|3
7747745|NCT00829387|26936809|P1|Overall Study|Withdrawal by Subject|2
7747746|NCT00829309|26936827|P2|Washout: 7 Days|Protocol Violation|0
7747747|NCT00829309|26936828|P1|Washout: 7 Days|Protocol Violation|1
7747748|NCT00829296|26936838|P2|Overall Study|Adverse Event|4
7747749|NCT00829296|26936839|P1|Overall Study|Adverse Event|5
7747750|NCT00829283|26936853|P2|Overall Study|Lost to Follow-up|25
7747751|NCT00829283|26936854|P1|Overall Study|Lost to Follow-up|7
7747752|NCT00829244|26936864|P2|Overall Study|No embryo cleavage|2
7747753|NCT00829244|26936865|P1|Overall Study|No embryo cleavage|0
7747754|NCT00829244|26936864|P2|Overall Study|All embryos discarded|3
7747755|NCT00829244|26936865|P1|Overall Study|All embryos discarded|0
7747756|NCT00829244|26936864|P2|Overall Study|No fertilization|2
7747757|NCT00829244|26936865|P1|Overall Study|No fertilization|2
7747758|NCT00829244|26936864|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
7747759|NCT00829244|26936865|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
7747760|NCT00829244|26936864|P2|Overall Study|Lack of ovarian response to stimulation|5
7747761|NCT00829244|26936865|P1|Overall Study|Lack of ovarian response to stimulation|9
7747762|NCT00829244|26936864|P2|Overall Study|Protocol Violation|0
7747763|NCT00829244|26936865|P1|Overall Study|Protocol Violation|1
7747764|NCT00829244|26936864|P2|Overall Study|Adverse Event|3
7747765|NCT00829244|26936865|P1|Overall Study|Adverse Event|1
7747766|NCT00829179|26936895|P1|Overall Study|Withdrawal by Subject|1
7747767|NCT00829166|26936901|P2|Overall Study|Reason Not Specified|3
7747768|NCT00829166|26936902|P1|Overall Study|Reason Not Specified|3
7747769|NCT00829166|26936901|P2|Overall Study|Sponsor's Decision|98
7747770|NCT00829166|26936902|P1|Overall Study|Sponsor's Decision|137
7747771|NCT00829166|26936901|P2|Overall Study|Subject's Decision|55
7747772|NCT00829166|26936902|P1|Overall Study|Subject's Decision|41
7747773|NCT00829166|26936901|P2|Overall Study|Physician's Decision|3
7747774|NCT00829166|26936902|P1|Overall Study|Physician's Decision|4
7747775|NCT00829166|26936901|P2|Overall Study|Lost to Follow-up|4
7747776|NCT00829166|26936902|P1|Overall Study|Lost to Follow-up|5
7747777|NCT00829166|26936901|P2|Overall Study|Death|333
7747778|NCT00829166|26936902|P1|Overall Study|Death|305
7747779|NCT00829010|26936965|P5|Overall Study|Migrated/Moved from study area|0
7747780|NCT00829010|26936966|P4|Overall Study|Migrated/Moved from study area|5
7747781|NCT00829010|26936967|P3|Overall Study|Migrated/Moved from study area|0
7747782|NCT00829010|26936968|P2|Overall Study|Migrated/Moved from study area|4
7747783|NCT00829010|26936969|P1|Overall Study|Migrated/Moved from study area|3
7747784|NCT00829010|26936965|P5|Overall Study|Fatality|0
7747785|NCT00829010|26936966|P4|Overall Study|Fatality|3
7747786|NCT00829010|26936967|P3|Overall Study|Fatality|0
7747787|NCT00829010|26936968|P2|Overall Study|Fatality|4
7747788|NCT00829010|26936969|P1|Overall Study|Fatality|5
7747789|NCT00829010|26936965|P5|Overall Study|Lost to Follow-up|0
7747790|NCT00829010|26936966|P4|Overall Study|Lost to Follow-up|0
7747791|NCT00829010|26936967|P3|Overall Study|Lost to Follow-up|2
7747792|NCT00829010|26936968|P2|Overall Study|Lost to Follow-up|0
7747793|NCT00829010|26936969|P1|Overall Study|Lost to Follow-up|1
7747794|NCT00829010|26936965|P5|Overall Study|Withdrawal by Subject|2
7747795|NCT00829010|26936966|P4|Overall Study|Withdrawal by Subject|0
7747796|NCT00829010|26936967|P3|Overall Study|Withdrawal by Subject|1
7747797|NCT00829010|26936968|P2|Overall Study|Withdrawal by Subject|1
7747798|NCT00829010|26936969|P1|Overall Study|Withdrawal by Subject|0
7747799|NCT00829010|26936965|P5|Overall Study|Adverse Event|0
7747800|NCT00829010|26936966|P4|Overall Study|Adverse Event|0
7747801|NCT00829010|26936967|P3|Overall Study|Adverse Event|0
7747802|NCT00829010|26936968|P2|Overall Study|Adverse Event|0
7747803|NCT00829010|26936969|P1|Overall Study|Adverse Event|1
7747804|NCT00828984|26937134|P3|Overall Study|ConMed|1
7747805|NCT00828984|26937135|P2|Overall Study|ConMed|1
7747806|NCT00828984|26937136|P1|Overall Study|ConMed|1
7747807|NCT00828984|26937134|P3|Overall Study|Noncompliant|3
7747808|NCT00828984|26937135|P2|Overall Study|Noncompliant|2
7747809|NCT00828984|26937136|P1|Overall Study|Noncompliant|1
7747810|NCT00828984|26937134|P3|Overall Study|Medical Contraindication|0
7747811|NCT00828984|26937135|P2|Overall Study|Medical Contraindication|1
7747812|NCT00828984|26937136|P1|Overall Study|Medical Contraindication|0
7747813|NCT00828984|26937134|P3|Overall Study|Ineligable|0
7747814|NCT00828984|26937135|P2|Overall Study|Ineligable|2
7747815|NCT00828984|26937136|P1|Overall Study|Ineligable|1
7747816|NCT00828984|26937134|P3|Overall Study|Withdrawal by Subject|4
7747817|NCT00828984|26937135|P2|Overall Study|Withdrawal by Subject|4
7747818|NCT00828984|26937136|P1|Overall Study|Withdrawal by Subject|4
7747819|NCT00828984|26937134|P3|Overall Study|Lost to Follow-up|1
7747820|NCT00828984|26937135|P2|Overall Study|Lost to Follow-up|3
7747821|NCT00828984|26937136|P1|Overall Study|Lost to Follow-up|5
7747822|NCT00828984|26937134|P3|Overall Study|Adverse Event|0
7747823|NCT00828984|26937135|P2|Overall Study|Adverse Event|3
7747824|NCT00828984|26937136|P1|Overall Study|Adverse Event|2
7747825|NCT00828945|26937159|P1|Overall Study|Other|36
7747826|NCT00828945|26937159|P1|Overall Study|Participant was missing|1
7747827|NCT00828945|26937159|P1|Overall Study|Death|4
7747828|NCT00828750|26937191|P1|Overall Study|Normal PC Remained While No Treatment|1
7747829|NCT00828750|26937191|P1|Overall Study|Lack of Efficacy|3
7747830|NCT00828711|26937205|P3|Overall Study|Lost to Follow-up|0
7747831|NCT00828711|26937206|P2|Overall Study|Lost to Follow-up|0
7747832|NCT00828711|26937207|P1|Overall Study|Lost to Follow-up|1
7747833|NCT00828672|26937238|P2|Post-surgery (<30 Days)|No central review materials|1
7747834|NCT00828672|26937239|P1|Post-surgery (<30 Days)|No central review materials|0
7747835|NCT00828672|26937238|P2|Study Treatment|Complete response, no surgery|1
7747836|NCT00828672|26937239|P1|Study Treatment|Complete response, no surgery|1
7747837|NCT00828672|26937238|P2|Study Treatment|Adverse Event|1
7747838|NCT00828672|26937239|P1|Study Treatment|Adverse Event|0
7747839|NCT00828672|26937238|P2|Study Treatment|Lost to Follow-up|0
7747840|NCT00828672|26937239|P1|Study Treatment|Lost to Follow-up|1
7747841|NCT00828568|26937260|P3|Treated - Received at Least One Dose|Protocol Violation|3
7747842|NCT00828568|26937261|P2|Treated - Received at Least One Dose|Protocol Violation|5
7747843|NCT00828568|26937262|P1|Treated - Received at Least One Dose|Protocol Violation|9
7747844|NCT00828568|26937260|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
7747845|NCT00828568|26937261|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
7747846|NCT00828568|26937262|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
7747931|NCT00827918|26937538|P2|Overall Study|Protocol Violation|1
7747847|NCT00828568|26937260|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
7747848|NCT00828568|26937261|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
7747849|NCT00828568|26937262|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
7747850|NCT00828568|26937260|P3|Treated - Received at Least One Dose|Adverse Event|1
7747851|NCT00828568|26937261|P2|Treated - Received at Least One Dose|Adverse Event|8
7747852|NCT00828568|26937262|P1|Treated - Received at Least One Dose|Adverse Event|11
7747853|NCT00828568|26937260|P3|Randomized|Withdrawal by Subject|2
7747854|NCT00828568|26937261|P2|Randomized|Withdrawal by Subject|0
7747855|NCT00828568|26937262|P1|Randomized|Withdrawal by Subject|1
7747856|NCT00828516|26937284|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
7747857|NCT00828464|26937289|P1|Overall Study|Withdrawal by Subject|1
7747858|NCT00828451|26937306|P1|Overall Study|Deterioration in clinical status|1
7747859|NCT00828451|26937306|P1|Overall Study|Withdrawal by Subject|1
7747860|NCT00828451|26937306|P1|Overall Study|Lack of intravenous line|7
7747861|NCT00828451|26937306|P1|Overall Study|Death|2
7747862|NCT00828321|26937332|P2|Second Intervention|Protocol Violation|1
7747863|NCT00828321|26937333|P1|Second Intervention|Protocol Violation|0
7747864|NCT00828321|26937332|P2|Washout of 42 Days|Withdrawal by Subject|0
7747865|NCT00828321|26937333|P1|Washout of 42 Days|Withdrawal by Subject|2
7747866|NCT00828204|26937362|P2|Extension Study|Physician Decision|2
7747867|NCT00828204|26937363|P1|Extension Study|Physician Decision|0
7747868|NCT00828204|26937362|P2|Extension Study|Lost to Follow-up|1
7747869|NCT00828204|26937363|P1|Extension Study|Lost to Follow-up|0
7747870|NCT00828204|26937362|P2|Main Study: After Study Restart|Noncompliance|1
7747871|NCT00828204|26937363|P1|Main Study: After Study Restart|Noncompliance|0
7747872|NCT00828204|26937362|P2|Main Study: After Study Restart|Adverse Event|2
7747873|NCT00828204|26937363|P1|Main Study: After Study Restart|Adverse Event|0
7747874|NCT00828204|26937362|P2|Main Study: Prior to Study Suspension|Study Suspension|0
7747875|NCT00828204|26937363|P1|Main Study: Prior to Study Suspension|Study Suspension|11
7747876|NCT00828204|26937362|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
7747877|NCT00828204|26937363|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
7747878|NCT00828204|26937362|P2|Main Study: Prior to Study Suspension|Adverse Event|0
7747879|NCT00828204|26937363|P1|Main Study: Prior to Study Suspension|Adverse Event|1
7747880|NCT00828139|26937410|P4|Overall Study|Other|2
7747881|NCT00828139|26937411|P3|Overall Study|Other|5
7747882|NCT00828139|26937412|P2|Overall Study|Other|2
7747883|NCT00828139|26937413|P1|Overall Study|Other|4
7747884|NCT00828139|26937410|P4|Overall Study|Disease Progression|39
7747885|NCT00828139|26937411|P3|Overall Study|Disease Progression|35
7747886|NCT00828139|26937412|P2|Overall Study|Disease Progression|33
7747887|NCT00828139|26937413|P1|Overall Study|Disease Progression|24
7747888|NCT00828139|26937410|P4|Overall Study|Refusal unrelated to toxicity|3
7747889|NCT00828139|26937411|P3|Overall Study|Refusal unrelated to toxicity|5
7747890|NCT00828139|26937412|P2|Overall Study|Refusal unrelated to toxicity|4
7747891|NCT00828139|26937413|P1|Overall Study|Refusal unrelated to toxicity|3
7747892|NCT00828139|26937410|P4|Overall Study|Death|2
7747893|NCT00828139|26937411|P3|Overall Study|Death|0
7747894|NCT00828139|26937412|P2|Overall Study|Death|1
7747895|NCT00828139|26937413|P1|Overall Study|Death|2
7747896|NCT00828139|26937410|P4|Overall Study|Adverse Event|5
7747897|NCT00828139|26937411|P3|Overall Study|Adverse Event|10
7747898|NCT00828139|26937412|P2|Overall Study|Adverse Event|1
7747899|NCT00828139|26937413|P1|Overall Study|Adverse Event|8
7747900|NCT00828113|26937433|P2|Overall Study|Lost to Follow-up|5
7747901|NCT00828113|26937434|P1|Overall Study|Lost to Follow-up|3
7747902|NCT00828113|26937433|P2|Overall Study|Withdrawal by Subject|26
7747903|NCT00828113|26937434|P1|Overall Study|Withdrawal by Subject|27
7747904|NCT00828009|26937472|P1|Step 2 - Maintenance Therapy|Other|1
7747905|NCT00828009|26937472|P1|Step 2 - Maintenance Therapy|Complicating disease|2
7747906|NCT00828009|26937472|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
7747907|NCT00828009|26937472|P1|Step 2 - Maintenance Therapy|Death|1
7747908|NCT00828009|26937472|P1|Step 2 - Maintenance Therapy|Adverse Event|13
7747909|NCT00828009|26937472|P1|Step 2 - Maintenance Therapy|Progressive disease|12
7747910|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
7747911|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
7747912|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
7747913|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
7747914|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
7747915|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
7747916|NCT00828009|26937472|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
7747917|NCT00827931|26937515|P2|Overall Study|Other|0
7747918|NCT00827931|26937516|P1|Overall Study|Other|1
7747919|NCT00827931|26937515|P2|Overall Study|Withdrawal by Subject|1
7747920|NCT00827931|26937516|P1|Overall Study|Withdrawal by Subject|0
7747921|NCT00827931|26937515|P2|Overall Study|Lost to Follow-up|0
7747922|NCT00827931|26937516|P1|Overall Study|Lost to Follow-up|1
7747923|NCT00827931|26937515|P2|Overall Study|Adverse Event|0
7747924|NCT00827931|26937516|P1|Overall Study|Adverse Event|1
7747925|NCT00827931|26937515|P2|Overall Study|Death|5
7747926|NCT00827931|26937516|P1|Overall Study|Death|3
7747927|NCT00827918|26937537|P3|Overall Study|Withdrawal by Subject|6
7747928|NCT00827918|26937538|P2|Overall Study|Withdrawal by Subject|2
7747929|NCT00827918|26937539|P1|Overall Study|Withdrawal by Subject|6
7747930|NCT00827918|26937537|P3|Overall Study|Protocol Violation|0
7747932|NCT00827918|26937539|P1|Overall Study|Protocol Violation|0
7747933|NCT00827918|26937537|P3|Overall Study|Progressive Disease|0
7747934|NCT00827918|26937538|P2|Overall Study|Progressive Disease|1
7747935|NCT00827918|26937539|P1|Overall Study|Progressive Disease|1
7747936|NCT00827918|26937537|P3|Overall Study|Pregnancy|0
7747937|NCT00827918|26937538|P2|Overall Study|Pregnancy|1
7747938|NCT00827918|26937539|P1|Overall Study|Pregnancy|0
7747939|NCT00827918|26937537|P3|Overall Study|Physician Decision|0
7747940|NCT00827918|26937538|P2|Overall Study|Physician Decision|0
7747941|NCT00827918|26937539|P1|Overall Study|Physician Decision|1
7747942|NCT00827918|26937537|P3|Overall Study|Lack of Efficacy|15
7747943|NCT00827918|26937538|P2|Overall Study|Lack of Efficacy|4
7747944|NCT00827918|26937539|P1|Overall Study|Lack of Efficacy|16
7747945|NCT00827918|26937537|P3|Overall Study|Adverse Event|0
7747946|NCT00827918|26937538|P2|Overall Study|Adverse Event|0
7747947|NCT00827918|26937539|P1|Overall Study|Adverse Event|4
7747948|NCT00827827|26937567|P2|Overall Study|Burned with water at home|0
7747949|NCT00827827|26937568|P1|Overall Study|Burned with water at home|1
7747950|NCT00827827|26937567|P2|Overall Study|Transportation issues|0
7747951|NCT00827827|26937568|P1|Overall Study|Transportation issues|1
7747952|NCT00827827|26937567|P2|Overall Study|Gout|0
7747953|NCT00827827|26937568|P1|Overall Study|Gout|1
7747954|NCT00827827|26937567|P2|Overall Study|Another cerebrovascular accident (CVA)|0
7747955|NCT00827827|26937568|P1|Overall Study|Another cerebrovascular accident (CVA)|1
7747956|NCT00827827|26937567|P2|Overall Study|Fall at home- hospitalization|0
7747957|NCT00827827|26937568|P1|Overall Study|Fall at home- hospitalization|1
7747958|NCT00827827|26937567|P2|Overall Study|Lost to Follow-up|0
7747959|NCT00827827|26937568|P1|Overall Study|Lost to Follow-up|3
7747960|NCT00827775|26937612|P2|Overall Study|Withdrawal by Subject|5
7747961|NCT00827775|26937613|P1|Overall Study|Withdrawal by Subject|0
7747962|NCT00827632|26937623|P2|Overall Study|Early withdrawal|11
7747963|NCT00827632|26937624|P1|Overall Study|Early withdrawal|14
7747964|NCT00827632|26937623|P2|Overall Study|Lost to Follow-up|12
7747965|NCT00827632|26937624|P1|Overall Study|Lost to Follow-up|8
7747966|NCT00827606|26937636|P2|Overall Study|Adverse Event|2
7747967|NCT00827606|26937637|P1|Overall Study|Adverse Event|4
7747968|NCT00827606|26937636|P2|Overall Study|LDL below 2.59 mmol/L|12
7747969|NCT00827606|26937637|P1|Overall Study|LDL below 2.59 mmol/L|4
7747970|NCT00827606|26937636|P2|Overall Study|Other|13
7747971|NCT00827606|26937637|P1|Overall Study|Other|5
7747972|NCT00827606|26937636|P2|Overall Study|Pregnancy|1
7747973|NCT00827606|26937637|P1|Overall Study|Pregnancy|0
7747974|NCT00827606|26937636|P2|Overall Study|Withdrawal by Subject|6
7747975|NCT00827606|26937637|P1|Overall Study|Withdrawal by Subject|7
7747976|NCT00827606|26937636|P2|Overall Study|Lost to Follow-up|1
7747977|NCT00827606|26937637|P1|Overall Study|Lost to Follow-up|3
7747978|NCT00827606|26937636|P2|Overall Study|Protocol Violation|3
7747979|NCT00827606|26937637|P1|Overall Study|Protocol Violation|4
7747980|NCT00827567|26937698|P1|Overall Study|Progression of Disease/Screen Failure|4
7747981|NCT00827541|26937704|P2|Overall Study|Lack of effectiveness|0
7747982|NCT00827541|26937705|P1|Overall Study|Lack of effectiveness|1
7747983|NCT00827541|26937704|P2|Overall Study|Pathogen not susceptible|0
7747984|NCT00827541|26937705|P1|Overall Study|Pathogen not susceptible|1
7747985|NCT00827541|26937704|P2|Overall Study|Other|3
7747986|NCT00827541|26937705|P1|Overall Study|Other|1
7747987|NCT00827541|26937704|P2|Overall Study|Exitus|8
7747988|NCT00827541|26937705|P1|Overall Study|Exitus|1
7747989|NCT00827502|26937717|P1|Overall Study|Withdrawal by Subject|5
7747990|NCT00827502|26937717|P1|Overall Study|Lost to Follow-up|4
7747991|NCT00827502|26937717|P1|Overall Study|Adverse Event|1
7747992|NCT00827502|26937717|P1|Overall Study|randomized but not treated|11
7747993|NCT00827372|26937723|P1|Overall Study|Lack of Efficacy|3
7747994|NCT00827372|26937723|P1|Overall Study|Adverse Event|5
7747995|NCT00827359|26937731|P1|Overall Study|Ineligible|1
7747996|NCT00827359|26937731|P1|Overall Study|Unacceptable Toxicity|5
7747997|NCT00827359|26937731|P1|Overall Study|Progressive Diseas|19
7747998|NCT00827242|26937745|P2|Overall Study|Lack of Efficacy|0
7747999|NCT00827242|26937746|P1|Overall Study|Lack of Efficacy|1
7748000|NCT00827242|26937745|P2|Overall Study|Death|0
7748001|NCT00827242|26937746|P1|Overall Study|Death|1
7748002|NCT00827242|26937745|P2|Overall Study|Physician Decision|0
7748003|NCT00827242|26937746|P1|Overall Study|Physician Decision|2
7748004|NCT00827242|26937745|P2|Overall Study|Entry Criteria Not Met|1
7748005|NCT00827242|26937746|P1|Overall Study|Entry Criteria Not Met|4
7748006|NCT00827242|26937745|P2|Overall Study|Adverse Event Excluding Death|1
7748007|NCT00827242|26937746|P1|Overall Study|Adverse Event Excluding Death|2
7748008|NCT00827242|26937745|P2|Overall Study|Lost to Follow-up|3
7748009|NCT00827242|26937746|P1|Overall Study|Lost to Follow-up|0
7748010|NCT00827242|26937745|P2|Overall Study|Protocol Violation|3
7748011|NCT00827242|26937746|P1|Overall Study|Protocol Violation|1
7748012|NCT00827242|26937745|P2|Overall Study|Withdrawal by Subject|4
7748013|NCT00827242|26937746|P1|Overall Study|Withdrawal by Subject|2
7748014|NCT00827112|26937784|P2|Overall Study|Other|3
7748015|NCT00827112|26937785|P1|Overall Study|Other|1
7748016|NCT00827112|26937784|P2|Overall Study|Randomized but not treated|3
7748017|NCT00827112|26937785|P1|Overall Study|Randomized but not treated|5
7748018|NCT00827112|26937784|P2|Overall Study|Withdrawal by Subject|1
7748019|NCT00827112|26937785|P1|Overall Study|Withdrawal by Subject|2
7748020|NCT00827112|26937784|P2|Overall Study|Protocol Violation|2
7748021|NCT00827112|26937785|P1|Overall Study|Protocol Violation|0
7748022|NCT00827112|26937784|P2|Overall Study|Pregnancy|1
7748023|NCT00827112|26937785|P1|Overall Study|Pregnancy|0
7748024|NCT00827112|26937784|P2|Overall Study|Lost to Follow-up|2
7748025|NCT00827112|26937785|P1|Overall Study|Lost to Follow-up|3
7748026|NCT00827112|26937784|P2|Overall Study|Lack of Efficacy|0
7748027|NCT00827112|26937785|P1|Overall Study|Lack of Efficacy|2
7748028|NCT00827112|26937784|P2|Overall Study|Adverse Event|0
7748029|NCT00827112|26937785|P1|Overall Study|Adverse Event|2
7748030|NCT00826943|26937838|P6|Overall Study|Withdrawal by Subject|0
7748031|NCT00826943|26937839|P5|Overall Study|Withdrawal by Subject|1
7748032|NCT00826943|26937840|P4|Overall Study|Withdrawal by Subject|0
7748033|NCT00826943|26937841|P3|Overall Study|Withdrawal by Subject|0
7748034|NCT00826943|26937842|P2|Overall Study|Withdrawal by Subject|0
7748035|NCT00826943|26937843|P1|Overall Study|Withdrawal by Subject|0
7748036|NCT00826748|26937864|P3|Overall Study|Samples Did Not pass QC|1
7748037|NCT00826748|26937865|P2|Overall Study|Samples Did Not pass QC|0
7748038|NCT00826748|26937866|P1|Overall Study|Samples Did Not pass QC|0
7748039|NCT00826748|26937864|P3|Overall Study|Physician Decision|1
7748040|NCT00826748|26937865|P2|Overall Study|Physician Decision|0
7748041|NCT00826748|26937866|P1|Overall Study|Physician Decision|0
7748042|NCT00826748|26937864|P3|Overall Study|Withdrawal by Subject|2
7748043|NCT00826748|26937865|P2|Overall Study|Withdrawal by Subject|0
7748044|NCT00826748|26937866|P1|Overall Study|Withdrawal by Subject|0
7748045|NCT00826618|26937874|P1|Overall Study|Withdrawal by Subject|1
7748046|NCT00826540|26937878|P1|Overall Study|Withdrawal by Subject|1
7748047|NCT00826540|26937878|P1|Overall Study|ineligible|3
7748048|NCT00826514|26937884|P2|Overall Study|Withdrawal by Subject|3
7748049|NCT00826514|26937885|P1|Overall Study|Withdrawal by Subject|2
7748050|NCT00826514|26937884|P2|Overall Study|Lack of Efficacy|1
7748051|NCT00826514|26937885|P1|Overall Study|Lack of Efficacy|0
7748052|NCT00826514|26937884|P2|Overall Study|Adverse Event|1
7748053|NCT00826514|26937885|P1|Overall Study|Adverse Event|1
7748054|NCT00826449|26937934|P1|Overall Study|Withdrawal by Subject|1
7748055|NCT00826449|26937934|P1|Overall Study|Disease Progression|4
7748056|NCT00826280|26937943|P3|Overall Study|One or more non-interpretable scan|1
7748057|NCT00826280|26937944|P2|Overall Study|One or more non-interpretable scan|1
7748058|NCT00826280|26937945|P1|Overall Study|One or more non-interpretable scan|0
7748059|NCT00826280|26937943|P3|Overall Study|Machine Failure|0
7748060|NCT00826280|26937944|P2|Overall Study|Machine Failure|1
7748061|NCT00826280|26937945|P1|Overall Study|Machine Failure|1
7748062|NCT00826280|26937943|P3|Overall Study|Interpretation Failure|0
7748063|NCT00826280|26937944|P2|Overall Study|Interpretation Failure|0
7748064|NCT00826280|26937945|P1|Overall Study|Interpretation Failure|1
7748065|NCT00826280|26937943|P3|Overall Study|Reversible ischemic defect not present|44
7748066|NCT00826280|26937944|P2|Overall Study|Reversible ischemic defect not present|40
7748067|NCT00826280|26937945|P1|Overall Study|Reversible ischemic defect not present|43
7748068|NCT00826280|26937943|P3|Overall Study|Sponsor discontinued subject or study|0
7748069|NCT00826280|26937944|P2|Overall Study|Sponsor discontinued subject or study|0
7748070|NCT00826280|26937945|P1|Overall Study|Sponsor discontinued subject or study|1
7748071|NCT00826280|26937943|P3|Overall Study|Lost to Follow-up|0
7748072|NCT00826280|26937944|P2|Overall Study|Lost to Follow-up|1
7748073|NCT00826280|26937945|P1|Overall Study|Lost to Follow-up|0
7748074|NCT00826280|26937943|P3|Overall Study|Adverse Event|0
7748075|NCT00826280|26937944|P2|Overall Study|Adverse Event|3
7748076|NCT00826280|26937945|P1|Overall Study|Adverse Event|1
7748077|NCT00826280|26937943|P3|Overall Study|Randomized but drug not received|1
7748078|NCT00826280|26937944|P2|Overall Study|Randomized but drug not received|0
7748079|NCT00826280|26937945|P1|Overall Study|Randomized but drug not received|1
7748080|NCT00826267|26937974|P3|Overall Study|Other Adverse Event|0
7748081|NCT00826267|26937975|P2|Overall Study|Other Adverse Event|0
7748082|NCT00826267|26937976|P1|Overall Study|Other Adverse Event|1
7748083|NCT00826241|26937994|P1|Overall Study|Pt opt not to proceed w/trmt|1
7748084|NCT00826241|26937994|P1|Overall Study|Pt unable to proceed to registration|1
7748085|NCT00826241|26937994|P1|Overall Study|Screen failure|2
7748086|NCT00826241|26937994|P1|Overall Study|Could not obtain records|1
7748087|NCT00826241|26937994|P1|Overall Study|Lost to Follow-up|9
7748088|NCT00826241|26937994|P1|Overall Study|Patient refused follow-up|3
7748089|NCT00826241|26937994|P1|Overall Study|Progression of disease|1
7748090|NCT00826241|26937994|P1|Overall Study|Non-compliance|1
7748091|NCT00826241|26937994|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
7748092|NCT00826241|26937994|P1|Overall Study|Death|4
7748093|NCT00826241|26937994|P1|Overall Study|Withdrew consent|2
7748094|NCT00826241|26937994|P1|Overall Study|Withdrawal from Follow-up|1
7748095|NCT00826228|26938000|P1|Overall Study|Withdrawal by Subject|1
7748096|NCT00826176|26938022|P2|Overall Study|Administrative|0
7748097|NCT00826176|26938023|P1|Overall Study|Administrative|9
7748098|NCT00826176|26938022|P2|Overall Study|Subject Withdrew Consent|0
7748099|NCT00826176|26938023|P1|Overall Study|Subject Withdrew Consent|3
7748100|NCT00826176|26938022|P2|Overall Study|Lost to Follow-up|0
7748101|NCT00826176|26938023|P1|Overall Study|Lost to Follow-up|1
7748102|NCT00826111|26938072|P2|Overall Study|Physician Decision|1
7748103|NCT00826111|26938073|P1|Overall Study|Physician Decision|1
7748104|NCT00826111|26938072|P2|Overall Study|Withdrawal by Subject|0
7748105|NCT00826111|26938073|P1|Overall Study|Withdrawal by Subject|5
7748106|NCT00826111|26938072|P2|Overall Study|Protocol Violation|0
7748107|NCT00826111|26938073|P1|Overall Study|Protocol Violation|1
7748108|NCT00826111|26938072|P2|Overall Study|Lost to Follow-up|1
7748109|NCT00826111|26938073|P1|Overall Study|Lost to Follow-up|0
7748110|NCT00825994|26938108|P1|Overall Study|Placebo Responder at V2|1
7748111|NCT00825994|26938108|P1|Overall Study|Protocol Violation|1
7748112|NCT00825994|26938108|P1|Overall Study|Lost to Follow-up|1
7748113|NCT00825994|26938108|P1|Overall Study|Withdrawal by Subject|2
7748114|NCT00825916|26938116|P3|Overall Study|Lost to Follow-up|1
7748115|NCT00825916|26938117|P2|Overall Study|Lost to Follow-up|2
7748116|NCT00825916|26938118|P1|Overall Study|Lost to Follow-up|4
7748117|NCT00825825|26938159|P6|Third Medication Period (14 Days)|poor data quality|0
7748118|NCT00825825|26938160|P5|Third Medication Period (14 Days)|poor data quality|0
7748119|NCT00825825|26938161|P4|Third Medication Period (14 Days)|poor data quality|0
7748120|NCT00825825|26938162|P3|Third Medication Period (14 Days)|poor data quality|0
7748121|NCT00825825|26938163|P2|Third Medication Period (14 Days)|poor data quality|1
7748122|NCT00825825|26938164|P1|Third Medication Period (14 Days)|poor data quality|0
7748123|NCT00825825|26938159|P6|Third Medication Period (14 Days)|Protocol Violation|2
7748124|NCT00825825|26938160|P5|Third Medication Period (14 Days)|Protocol Violation|0
7748125|NCT00825825|26938161|P4|Third Medication Period (14 Days)|Protocol Violation|0
7748126|NCT00825825|26938162|P3|Third Medication Period (14 Days)|Protocol Violation|0
7748127|NCT00825825|26938163|P2|Third Medication Period (14 Days)|Protocol Violation|0
7748128|NCT00825825|26938164|P1|Third Medication Period (14 Days)|Protocol Violation|0
7748129|NCT00825825|26938159|P6|Third Medication Period (14 Days)|Adverse Event|0
7748130|NCT00825825|26938160|P5|Third Medication Period (14 Days)|Adverse Event|0
7748131|NCT00825825|26938161|P4|Third Medication Period (14 Days)|Adverse Event|0
7748132|NCT00825825|26938162|P3|Third Medication Period (14 Days)|Adverse Event|0
7748133|NCT00825825|26938163|P2|Third Medication Period (14 Days)|Adverse Event|1
7748134|NCT00825825|26938164|P1|Third Medication Period (14 Days)|Adverse Event|0
7748135|NCT00825825|26938159|P6|Second Medication Period (14 Days)|Protocol Violation|0
7748136|NCT00825825|26938160|P5|Second Medication Period (14 Days)|Protocol Violation|1
7748137|NCT00825825|26938161|P4|Second Medication Period (14 Days)|Protocol Violation|0
7748138|NCT00825825|26938162|P3|Second Medication Period (14 Days)|Protocol Violation|0
7748139|NCT00825825|26938163|P2|Second Medication Period (14 Days)|Protocol Violation|0
7748140|NCT00825825|26938164|P1|Second Medication Period (14 Days)|Protocol Violation|1
7748141|NCT00825825|26938159|P6|Second Medication Period (14 Days)|Physician Decision|0
7748142|NCT00825825|26938160|P5|Second Medication Period (14 Days)|Physician Decision|0
7748143|NCT00825825|26938161|P4|Second Medication Period (14 Days)|Physician Decision|2
7748144|NCT00825825|26938162|P3|Second Medication Period (14 Days)|Physician Decision|0
7748145|NCT00825825|26938163|P2|Second Medication Period (14 Days)|Physician Decision|0
7748146|NCT00825825|26938164|P1|Second Medication Period (14 Days)|Physician Decision|1
7748147|NCT00825825|26938159|P6|First Medication Period (14 Days)|Physician Decision|1
7748148|NCT00825825|26938160|P5|First Medication Period (14 Days)|Physician Decision|0
7748149|NCT00825825|26938161|P4|First Medication Period (14 Days)|Physician Decision|0
7748150|NCT00825825|26938162|P3|First Medication Period (14 Days)|Physician Decision|1
7748151|NCT00825825|26938163|P2|First Medication Period (14 Days)|Physician Decision|0
7748152|NCT00825825|26938164|P1|First Medication Period (14 Days)|Physician Decision|2
7748153|NCT00825825|26938159|P6|First Medication Period (14 Days)|Adverse Event|1
7748154|NCT00825825|26938160|P5|First Medication Period (14 Days)|Adverse Event|0
7748155|NCT00825825|26938161|P4|First Medication Period (14 Days)|Adverse Event|0
7748156|NCT00825825|26938162|P3|First Medication Period (14 Days)|Adverse Event|0
7748157|NCT00825825|26938163|P2|First Medication Period (14 Days)|Adverse Event|0
7748158|NCT00825825|26938164|P1|First Medication Period (14 Days)|Adverse Event|1
7748159|NCT00825812|26938180|P4|Overall Study|Administrative|5
7748160|NCT00825812|26938181|P3|Overall Study|Administrative|3
7748161|NCT00825812|26938182|P2|Overall Study|Administrative|1
7748162|NCT00825812|26938183|P1|Overall Study|Administrative|0
7748163|NCT00825812|26938180|P4|Overall Study|Non-compliance with protocol|1
7748164|NCT00825812|26938181|P3|Overall Study|Non-compliance with protocol|0
7748165|NCT00825812|26938182|P2|Overall Study|Non-compliance with protocol|0
7748166|NCT00825812|26938183|P1|Overall Study|Non-compliance with protocol|0
7748167|NCT00825812|26938180|P4|Overall Study|Subject withdrew consent|2
7748168|NCT00825812|26938181|P3|Overall Study|Subject withdrew consent|3
7748169|NCT00825812|26938182|P2|Overall Study|Subject withdrew consent|0
7748170|NCT00825812|26938183|P1|Overall Study|Subject withdrew consent|0
7748171|NCT00825812|26938180|P4|Overall Study|Adverse Event|1
7748172|NCT00825812|26938181|P3|Overall Study|Adverse Event|0
7748173|NCT00825812|26938182|P2|Overall Study|Adverse Event|0
7748174|NCT00825812|26938183|P1|Overall Study|Adverse Event|0
7748175|NCT00825812|26938180|P4|Overall Study|Never entered follow up|1
7748176|NCT00825812|26938181|P3|Overall Study|Never entered follow up|0
7748177|NCT00825812|26938182|P2|Overall Study|Never entered follow up|0
7748178|NCT00825812|26938183|P1|Overall Study|Never entered follow up|0
7748179|NCT00825682|26938230|P2|Overall Study|personal reasons/ inconvenience|5
7748180|NCT00825682|26938231|P1|Overall Study|personal reasons/ inconvenience|13
7748181|NCT00825305|26938322|P2|Overall Study|Can not be classified|1
7748182|NCT00825305|26938323|P1|Overall Study|Can not be classified|0
7748183|NCT00825305|26938322|P2|Overall Study|Protocol Violation|9
7748184|NCT00825305|26938323|P1|Overall Study|Protocol Violation|9
7748185|NCT00825305|26938322|P2|Overall Study|Inappropriate inclusion|0
7748186|NCT00825305|26938323|P1|Overall Study|Inappropriate inclusion|1
7748187|NCT00825305|26938322|P2|Overall Study|Withdrawal by Subject|12
7748188|NCT00825305|26938323|P1|Overall Study|Withdrawal by Subject|6
7748189|NCT00825305|26938322|P2|Overall Study|Adverse Event|1
7748190|NCT00825305|26938323|P1|Overall Study|Adverse Event|1
7748191|NCT00825175|26938363|P2|Overall Study|Withdrawal by Subject|5
7748192|NCT00825175|26938364|P1|Overall Study|Withdrawal by Subject|0
7748193|NCT00825162|26938373|P3|Overall Study|Unable to attend the study visit|0
7748194|NCT00825162|26938374|P2|Overall Study|Unable to attend the study visit|2
7748195|NCT00825162|26938375|P1|Overall Study|Unable to attend the study visit|5
7748196|NCT00825162|26938373|P3|Overall Study|Move away from the study area|0
7748197|NCT00825162|26938374|P2|Overall Study|Move away from the study area|0
7748198|NCT00825162|26938375|P1|Overall Study|Move away from the study area|1
7748199|NCT00825162|26938373|P3|Overall Study|Physician Decision|0
7748200|NCT00825162|26938374|P2|Overall Study|Physician Decision|0
7748201|NCT00825162|26938375|P1|Overall Study|Physician Decision|2
7748202|NCT00825162|26938373|P3|Overall Study|Lost to Follow-up|3
7748203|NCT00825162|26938374|P2|Overall Study|Lost to Follow-up|6
7748204|NCT00825162|26938375|P1|Overall Study|Lost to Follow-up|9
7748205|NCT00825162|26938373|P3|Overall Study|Withdrawal by Subject|3
7748206|NCT00825162|26938374|P2|Overall Study|Withdrawal by Subject|13
7748207|NCT00825162|26938375|P1|Overall Study|Withdrawal by Subject|11
7748208|NCT00824993|26938401|P2|Overall Study|Death|3
7748209|NCT00824993|26938402|P1|Overall Study|Death|0
7748210|NCT00824993|26938401|P2|Overall Study|Insurance Issue|1
7748211|NCT00824993|26938402|P1|Overall Study|Insurance Issue|2
7748212|NCT00824993|26938401|P2|Overall Study|Non-Compliant|1
7748213|NCT00824993|26938402|P1|Overall Study|Non-Compliant|2
7748214|NCT00824993|26938401|P2|Overall Study|Rapid Bone Loss|1
7748215|NCT00824993|26938402|P1|Overall Study|Rapid Bone Loss|0
7748216|NCT00824993|26938401|P2|Overall Study|Malignancy Relapse|10
7748217|NCT00824993|26938402|P1|Overall Study|Malignancy Relapse|9
7748218|NCT00824993|26938401|P2|Overall Study|Withdrawal by Subject|1
7748219|NCT00824993|26938402|P1|Overall Study|Withdrawal by Subject|1
7748220|NCT00824850|26938410|P2|Overall Study|Withdrawal by Subject|1
7748221|NCT00824850|26938411|P1|Overall Study|Withdrawal by Subject|0
7748222|NCT00824772|26938464|P1|Overall Study|Withdrawal by Subject|8
7748223|NCT00824720|26938484|P3|Overall Study|Protocol Violation|1
7748224|NCT00824720|26938485|P2|Overall Study|Protocol Violation|0
7748225|NCT00824720|26938486|P1|Overall Study|Protocol Violation|0
7748226|NCT00824720|26938484|P3|Overall Study|failed plug insertion|0
7748227|NCT00824720|26938485|P2|Overall Study|failed plug insertion|1
7748228|NCT00824720|26938486|P1|Overall Study|failed plug insertion|3
7748229|NCT00824655|26938502|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
7748230|NCT00824655|26938503|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
7748231|NCT00824655|26938502|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
7748232|NCT00824655|26938503|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
7748233|NCT00824616|26938523|P2|Overall Study|Withdrawal by Subject|1
7748234|NCT00824616|26938524|P1|Overall Study|Withdrawal by Subject|1
7748235|NCT00824616|26938523|P2|Overall Study|Lost to Follow-up|1
7748236|NCT00824616|26938524|P1|Overall Study|Lost to Follow-up|0
7748237|NCT00824616|26938523|P2|Overall Study|Lack of Efficacy|1
7748238|NCT00824616|26938524|P1|Overall Study|Lack of Efficacy|2
7748239|NCT00824616|26938523|P2|Overall Study|Hyperglycemia|1
7748240|NCT00824616|26938524|P1|Overall Study|Hyperglycemia|1
7748241|NCT00824616|26938523|P2|Overall Study|Creatinine/Creatinine Clearance|2
7748242|NCT00824616|26938524|P1|Overall Study|Creatinine/Creatinine Clearance|0
7748243|NCT00824616|26938523|P2|Overall Study|Adverse Event|1
7748244|NCT00824616|26938524|P1|Overall Study|Adverse Event|2
7748245|NCT00824564|26938534|P2|Overall Study|Randomized, but not treated|0
7748246|NCT00824564|26938535|P1|Overall Study|Randomized, but not treated|1
7748247|NCT00824564|26938534|P2|Overall Study|Other|2
7748248|NCT00824564|26938535|P1|Overall Study|Other|1
7748249|NCT00824564|26938534|P2|Overall Study|Withdrawal by Subject|1
7748250|NCT00824564|26938535|P1|Overall Study|Withdrawal by Subject|1
7748251|NCT00824564|26938534|P2|Overall Study|Lost to Follow-up|7
7748252|NCT00824564|26938535|P1|Overall Study|Lost to Follow-up|5
7748253|NCT00824473|26938614|P2|Overall Study|Other|1
7748254|NCT00824473|26938615|P1|Overall Study|Other|1
7748255|NCT00824473|26938614|P2|Overall Study|Withdrawal by Subject|3
7748256|NCT00824473|26938615|P1|Overall Study|Withdrawal by Subject|2
7748257|NCT00824473|26938614|P2|Overall Study|Non-Compliance|2
7748258|NCT00824473|26938615|P1|Overall Study|Non-Compliance|4
7748259|NCT00824473|26938614|P2|Overall Study|Protocol Violation|0
7748260|NCT00824473|26938615|P1|Overall Study|Protocol Violation|2
7748261|NCT00824473|26938614|P2|Overall Study|Lack of Efficacy|2
7748262|NCT00824473|26938615|P1|Overall Study|Lack of Efficacy|2
7748263|NCT00824473|26938614|P2|Overall Study|Adverse Event|5
7748264|NCT00824473|26938615|P1|Overall Study|Adverse Event|4
7748265|NCT00824421|26938696|P3|Overall Study|Other|0
7748266|NCT00824421|26938697|P2|Overall Study|Other|1
7748267|NCT00824421|26938698|P1|Overall Study|Other|0
7748268|NCT00824421|26938696|P3|Overall Study|Randomized but not Treated|0
7748269|NCT00824421|26938697|P2|Overall Study|Randomized but not Treated|1
7748270|NCT00824421|26938698|P1|Overall Study|Randomized but not Treated|1
7748271|NCT00824421|26938696|P3|Overall Study|Withdrawal by Subject|3
7748272|NCT00824421|26938697|P2|Overall Study|Withdrawal by Subject|3
7748273|NCT00824421|26938698|P1|Overall Study|Withdrawal by Subject|2
7748274|NCT00824421|26938696|P3|Overall Study|Pregnancy|1
7748275|NCT00824421|26938697|P2|Overall Study|Pregnancy|0
7748276|NCT00824421|26938698|P1|Overall Study|Pregnancy|1
7748277|NCT00824421|26938696|P3|Overall Study|Lost to Follow-up|0
7748278|NCT00824421|26938697|P2|Overall Study|Lost to Follow-up|3
7748279|NCT00824421|26938698|P1|Overall Study|Lost to Follow-up|2
7748280|NCT00824421|26938696|P3|Overall Study|Lack of Efficacy|4
7748281|NCT00824421|26938697|P2|Overall Study|Lack of Efficacy|7
7748282|NCT00824421|26938698|P1|Overall Study|Lack of Efficacy|5
7748283|NCT00824421|26938696|P3|Overall Study|Death|0
7748284|NCT00824421|26938697|P2|Overall Study|Death|1
7748285|NCT00824421|26938698|P1|Overall Study|Death|0
7748286|NCT00824421|26938696|P3|Overall Study|Adverse Event|6
7748287|NCT00824421|26938697|P2|Overall Study|Adverse Event|6
7748288|NCT00824421|26938698|P1|Overall Study|Adverse Event|6
7748289|NCT00824408|26938749|P5|Randomized Phase|Other reason not defined above|4
7748290|NCT00824408|26938750|P4|Randomized Phase|Other reason not defined above|2
7748291|NCT00824408|26938751|P3|Randomized Phase|Other reason not defined above|4
7748292|NCT00824408|26938752|P2|Randomized Phase|Other reason not defined above|0
7748293|NCT00824408|26938753|P1|Randomized Phase|Other reason not defined above|0
7748294|NCT00824408|26938749|P5|Randomized Phase|Refused to continue medication|2
7748295|NCT00824408|26938750|P4|Randomized Phase|Refused to continue medication|2
7748296|NCT00824408|26938751|P3|Randomized Phase|Refused to continue medication|2
7748297|NCT00824408|26938752|P2|Randomized Phase|Refused to continue medication|0
7748298|NCT00824408|26938753|P1|Randomized Phase|Refused to continue medication|0
7748299|NCT00824408|26938749|P5|Randomized Phase|Adverse Event|5
7748300|NCT00824408|26938750|P4|Randomized Phase|Adverse Event|5
7748301|NCT00824408|26938751|P3|Randomized Phase|Adverse Event|4
7748302|NCT00824408|26938752|P2|Randomized Phase|Adverse Event|0
7748303|NCT00824408|26938753|P1|Randomized Phase|Adverse Event|0
7748304|NCT00824408|26938749|P5|Randomized Phase|Progressive disease|34
7748305|NCT00824408|26938750|P4|Randomized Phase|Progressive disease|36
7748306|NCT00824408|26938751|P3|Randomized Phase|Progressive disease|25
7748307|NCT00824408|26938752|P2|Randomized Phase|Progressive disease|0
7748308|NCT00824408|26938753|P1|Randomized Phase|Progressive disease|0
7748309|NCT00824408|26938749|P5|Randomized Phase|Not treated|1
7748310|NCT00824408|26938750|P4|Randomized Phase|Not treated|1
7748311|NCT00824408|26938751|P3|Randomized Phase|Not treated|1
7748312|NCT00824408|26938752|P2|Randomized Phase|Not treated|0
7748313|NCT00824408|26938753|P1|Randomized Phase|Not treated|0
7748314|NCT00824408|26938749|P5|Run-in Phase|Other reason not defined above|0
7748315|NCT00824408|26938750|P4|Run-in Phase|Other reason not defined above|0
7748316|NCT00824408|26938751|P3|Run-in Phase|Other reason not defined above|0
7748317|NCT00824408|26938752|P2|Run-in Phase|Other reason not defined above|1
7748318|NCT00824408|26938753|P1|Run-in Phase|Other reason not defined above|0
7748319|NCT00824408|26938749|P5|Run-in Phase|Refused to continue medication|0
7748320|NCT00824408|26938750|P4|Run-in Phase|Refused to continue medication|0
7748321|NCT00824408|26938751|P3|Run-in Phase|Refused to continue medication|0
7748322|NCT00824408|26938752|P2|Run-in Phase|Refused to continue medication|0
7748323|NCT00824408|26938753|P1|Run-in Phase|Refused to continue medication|1
7748324|NCT00824408|26938749|P5|Run-in Phase|Adverse Event|0
7748325|NCT00824408|26938750|P4|Run-in Phase|Adverse Event|0
7748326|NCT00824408|26938751|P3|Run-in Phase|Adverse Event|0
7748327|NCT00824408|26938752|P2|Run-in Phase|Adverse Event|1
7748328|NCT00824408|26938753|P1|Run-in Phase|Adverse Event|1
7748329|NCT00824408|26938749|P5|Run-in Phase|Progressive disease|0
7748330|NCT00824408|26938750|P4|Run-in Phase|Progressive disease|0
7748331|NCT00824408|26938751|P3|Run-in Phase|Progressive disease|0
7748332|NCT00824408|26938752|P2|Run-in Phase|Progressive disease|4
7748333|NCT00824408|26938753|P1|Run-in Phase|Progressive disease|4
7748334|NCT00824382|26938805|P4|Overall Study|Investigator's decision|0
7748335|NCT00824382|26938806|P3|Overall Study|Investigator's decision|2
7748336|NCT00824382|26938807|P2|Overall Study|Investigator's decision|1
7748337|NCT00824382|26938808|P1|Overall Study|Investigator's decision|0
7748338|NCT00824382|26938805|P4|Overall Study|Protocol Violation|1
7748339|NCT00824382|26938806|P3|Overall Study|Protocol Violation|0
7748340|NCT00824382|26938807|P2|Overall Study|Protocol Violation|0
7748341|NCT00824382|26938808|P1|Overall Study|Protocol Violation|1
7748342|NCT00824382|26938805|P4|Overall Study|Adverse Event|4
7748343|NCT00824382|26938806|P3|Overall Study|Adverse Event|1
7748344|NCT00824382|26938807|P2|Overall Study|Adverse Event|1
7748345|NCT00824382|26938808|P1|Overall Study|Adverse Event|4
7748346|NCT00824369|26938884|P6|Overall Study|Lost to Follow-up|0
7748347|NCT00824369|26938885|P5|Overall Study|Lost to Follow-up|1
7748348|NCT00824369|26938886|P4|Overall Study|Lost to Follow-up|0
7748349|NCT00824369|26938887|P3|Overall Study|Lost to Follow-up|0
7748350|NCT00824369|26938888|P2|Overall Study|Lost to Follow-up|0
7748351|NCT00824369|26938889|P1|Overall Study|Lost to Follow-up|0
7748352|NCT00824369|26938884|P6|Overall Study|Nolonger willing to participate in study|1
7748353|NCT00824369|26938885|P5|Overall Study|Nolonger willing to participate in study|0
7748354|NCT00824369|26938886|P4|Overall Study|Nolonger willing to participate in study|2
7748355|NCT00824369|26938887|P3|Overall Study|Nolonger willing to participate in study|1
7748356|NCT00824369|26938888|P2|Overall Study|Nolonger willing to participate in study|0
7748357|NCT00824369|26938889|P1|Overall Study|Nolonger willing to participate in study|1
7748358|NCT00824291|26938929|P2|Overall Study|Participant on prohibited medication|0
7748359|NCT00824291|26938930|P1|Overall Study|Participant on prohibited medication|1
7748360|NCT00824291|26938929|P2|Overall Study|Lack of Efficacy|8
7748361|NCT00824291|26938930|P1|Overall Study|Lack of Efficacy|7
7748362|NCT00824291|26938929|P2|Overall Study|Withdrawal by Subject|8
7748363|NCT00824291|26938930|P1|Overall Study|Withdrawal by Subject|14
7748364|NCT00824291|26938929|P2|Overall Study|Protocol Violation|1
7748365|NCT00824291|26938930|P1|Overall Study|Protocol Violation|4
7748366|NCT00824291|26938929|P2|Overall Study|Non-compliance|1
7748367|NCT00824291|26938930|P1|Overall Study|Non-compliance|1
7748368|NCT00824291|26938929|P2|Overall Study|Lost to Follow-up|9
7748369|NCT00824291|26938930|P1|Overall Study|Lost to Follow-up|11
7748370|NCT00824291|26938929|P2|Overall Study|Discontinuation of Study by Sponsor|2
7748371|NCT00824291|26938930|P1|Overall Study|Discontinuation of Study by Sponsor|1
7748372|NCT00824291|26938929|P2|Overall Study|Adverse Event|6
7748373|NCT00824291|26938930|P1|Overall Study|Adverse Event|15
7748374|NCT00824265|26938952|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
7748375|NCT00824265|26938953|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
7748376|NCT00824265|26938952|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
7748377|NCT00824265|26938953|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
7748378|NCT00824265|26938952|P2|Treatment Phase|Withdrawal by Subject|15
7748379|NCT00824265|26938953|P1|Treatment Phase|Withdrawal by Subject|6
7748380|NCT00824265|26938952|P2|Treatment Phase|Physician Decision|12
7748381|NCT00824265|26938953|P1|Treatment Phase|Physician Decision|6
7748382|NCT00824265|26938952|P2|Treatment Phase|Lost to Follow-up|1
7748383|NCT00824265|26938953|P1|Treatment Phase|Lost to Follow-up|1
7748384|NCT00824265|26938952|P2|Treatment Phase|Protocol Violation|0
7748385|NCT00824265|26938953|P1|Treatment Phase|Protocol Violation|1
7748386|NCT00824265|26938952|P2|Treatment Phase|Adverse Event,non-fatal|52
7748387|NCT00824265|26938953|P1|Treatment Phase|Adverse Event,non-fatal|50
7748388|NCT00824161|26939014|P1|Overall Study|Screen Failure|1
7748389|NCT00824161|26939014|P1|Overall Study|Withdrawal by Subject|1
7748390|NCT00824005|26939080|P2|Overall Study|Lost to Follow-up|1
7748391|NCT00824005|26939081|P1|Overall Study|Lost to Follow-up|0
7748392|NCT00824005|26939080|P2|Overall Study|Death|1
7748393|NCT00824005|26939081|P1|Overall Study|Death|0
7748394|NCT00823979|26939116|P3|Overall Study|Study Terminated by Sponsor|7
7748395|NCT00823979|26939117|P2|Overall Study|Study Terminated by Sponsor|5
7748396|NCT00823979|26939118|P1|Overall Study|Study Terminated by Sponsor|5
7748397|NCT00823979|26939116|P3|Overall Study|Randomized but not Treated|1
7748398|NCT00823979|26939117|P2|Overall Study|Randomized but not Treated|3
7748399|NCT00823979|26939118|P1|Overall Study|Randomized but not Treated|4
7748400|NCT00823979|26939116|P3|Overall Study|Other|1
7748401|NCT00823979|26939117|P2|Overall Study|Other|0
7748402|NCT00823979|26939118|P1|Overall Study|Other|2
7748403|NCT00823979|26939116|P3|Overall Study|Adverse Event|4
7748404|NCT00823979|26939117|P2|Overall Study|Adverse Event|2
7748405|NCT00823979|26939118|P1|Overall Study|Adverse Event|0
7748406|NCT00823979|26939116|P3|Overall Study|Pregnancy|0
7748407|NCT00823979|26939117|P2|Overall Study|Pregnancy|1
7748408|NCT00823979|26939118|P1|Overall Study|Pregnancy|0
7748409|NCT00823979|26939116|P3|Overall Study|Protocol Violation|0
7748410|NCT00823979|26939117|P2|Overall Study|Protocol Violation|1
7748411|NCT00823979|26939118|P1|Overall Study|Protocol Violation|1
7748412|NCT00823979|26939116|P3|Overall Study|Withdrawal by Subject|2
7748413|NCT00823979|26939117|P2|Overall Study|Withdrawal by Subject|3
7748414|NCT00823979|26939118|P1|Overall Study|Withdrawal by Subject|2
7748415|NCT00823979|26939116|P3|Overall Study|Lost to Follow-up|0
7748416|NCT00823979|26939117|P2|Overall Study|Lost to Follow-up|1
7748417|NCT00823979|26939118|P1|Overall Study|Lost to Follow-up|2
7748418|NCT00823979|26939116|P3|Overall Study|Lack of Efficacy|9
7748419|NCT00823979|26939117|P2|Overall Study|Lack of Efficacy|16
7748420|NCT00823979|26939118|P1|Overall Study|Lack of Efficacy|13
7748421|NCT00823901|26939163|P2|Overall Study|Lost to Follow-up|1
7748422|NCT00823901|26939164|P1|Overall Study|Lost to Follow-up|2
7748423|NCT00823901|26939163|P2|Overall Study|Lack of Efficacy|0
7748424|NCT00823901|26939164|P1|Overall Study|Lack of Efficacy|1
7748425|NCT00823901|26939163|P2|Overall Study|Adverse Event|1
7748426|NCT00823901|26939164|P1|Overall Study|Adverse Event|1
7748427|NCT00823836|26939172|P2|Long-term Phase|Withdrawal by Subject|1
7748428|NCT00823836|26939173|P1|Long-term Phase|Withdrawal by Subject|1
7748429|NCT00823836|26939172|P2|Long-term Phase|Physician Decision|2
7748430|NCT00823836|26939173|P1|Long-term Phase|Physician Decision|1
7748431|NCT00823836|26939172|P2|Long-term Phase|Adverse Event|2
7748432|NCT00823836|26939173|P1|Long-term Phase|Adverse Event|3
7748433|NCT00823836|26939172|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
7748434|NCT00823836|26939173|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
7748435|NCT00823836|26939172|P2|NV and PR/XR Switching Phases|Physician Decision|2
7748436|NCT00823836|26939173|P1|NV and PR/XR Switching Phases|Physician Decision|5
7748437|NCT00823836|26939172|P2|NV and PR/XR Switching Phases|Protocol Violation|1
7748438|NCT00823836|26939173|P1|NV and PR/XR Switching Phases|Protocol Violation|1
7748439|NCT00823836|26939172|P2|NV and PR/XR Switching Phases|Adverse Event|21
7748440|NCT00823836|26939173|P1|NV and PR/XR Switching Phases|Adverse Event|22
7748441|NCT00823823|26939279|P2|Overall Study|Protocol Violation|5
7748442|NCT00823823|26939280|P1|Overall Study|Protocol Violation|5
7748443|NCT00823823|26939279|P2|Overall Study|Lost to Follow-up|1
7748444|NCT00823823|26939280|P1|Overall Study|Lost to Follow-up|3
7748445|NCT00823719|26939304|P2|Overall Study|Disease Progression|4
7748446|NCT00823719|26939305|P1|Overall Study|Disease Progression|4
7748447|NCT00823719|26939304|P2|Overall Study|Withdrawal by Subject|1
7748448|NCT00823719|26939305|P1|Overall Study|Withdrawal by Subject|0
7748449|NCT00823719|26939304|P2|Overall Study|Physician Decision|4
7748450|NCT00823719|26939305|P1|Overall Study|Physician Decision|1
7748451|NCT00823719|26939304|P2|Overall Study|Adverse Event|2
7748452|NCT00823719|26939305|P1|Overall Study|Adverse Event|1
7748453|NCT00823615|26939358|P2|Period 2|Time/Job Conflict|2
7748454|NCT00823615|26939359|P1|Period 2|Time/Job Conflict|1
7748455|NCT00823615|26939358|P2|Period 2|Lost to Follow-up|0
7748456|NCT00823615|26939359|P1|Period 2|Lost to Follow-up|2
7748457|NCT00823472|26939369|P2|Overall Study|Physician Decision|28
7748458|NCT00823472|26939370|P1|Overall Study|Physician Decision|24
7748459|NCT00823264|26939397|P2|Overall Study|Protocol Violation|0
7748460|NCT00823264|26939398|P1|Overall Study|Protocol Violation|2
7748461|NCT00823212|26939406|P2|Overall Study|Missed 12-month visit|21
7748462|NCT00823212|26939407|P1|Overall Study|Missed 12-month visit|21
7748463|NCT00823212|26939406|P2|Overall Study|Incarcerated|1
7748464|NCT00823212|26939407|P1|Overall Study|Incarcerated|0
7748465|NCT00823212|26939406|P2|Overall Study|Withdrawal by Subject|1
7748466|NCT00823212|26939407|P1|Overall Study|Withdrawal by Subject|6
7748467|NCT00823212|26939406|P2|Overall Study|Death|10
7748468|NCT00823212|26939407|P1|Overall Study|Death|8
7748469|NCT00823199|26939489|P1|Overall Study|Withdrawal by Subject|2
7748470|NCT00823134|26939495|P1|Overall Study|Invalid measurement|1
7748471|NCT00822926|26939568|P2|Second Injection Visit|Withdrawal by Subject|1
7748472|NCT00822926|26939569|P1|Second Injection Visit|Withdrawal by Subject|0
7748473|NCT00822926|26939568|P2|Second Injection Visit|Lost to Follow-up|0
7748474|NCT00822926|26939569|P1|Second Injection Visit|Lost to Follow-up|1
7748475|NCT00822900|26939583|P2|Overall Study|Became a ward of the state|1
7748476|NCT00822900|26939584|P1|Overall Study|Became a ward of the state|2
7748477|NCT00822900|26939583|P2|Overall Study|Death|69
7748478|NCT00822900|26939584|P1|Overall Study|Death|83
7748479|NCT00822900|26939583|P2|Overall Study|Lost to Follow-up|9
7748480|NCT00822900|26939584|P1|Overall Study|Lost to Follow-up|9
7748481|NCT00822900|26939583|P2|Overall Study|Withdrawal by Subject|14
7748482|NCT00822900|26939584|P1|Overall Study|Withdrawal by Subject|14
7748483|NCT00822770|26939614|P2|Overall Study|Death|1
7748484|NCT00822770|26939615|P1|Overall Study|Death|1
7748485|NCT00822770|26939614|P2|Overall Study|Complication/Incomplete treatment|0
7748486|NCT00822770|26939615|P1|Overall Study|Complication/Incomplete treatment|1
7748487|NCT00822770|26939614|P2|Overall Study|Not treated|0
7748488|NCT00822770|26939615|P1|Overall Study|Not treated|1
7748489|NCT00822692|26939637|P2|Overall Study|Lost to Follow-up|25
7748490|NCT00822692|26939638|P1|Overall Study|Lost to Follow-up|17
7748491|NCT00822237|26939776|P2|Dose 2 Vaccination|Lost to Follow-up|9
7748492|NCT00822237|26939777|P1|Dose 2 Vaccination|Lost to Follow-up|2
7748493|NCT00822237|26939776|P2|Dose 2 Vaccination|Withdrawal by Subject|2
7748494|NCT00822237|26939777|P1|Dose 2 Vaccination|Withdrawal by Subject|2
7748495|NCT00822237|26939776|P2|Dose 1 Vaccination|Lost to Follow-up|12
7748496|NCT00822237|26939777|P1|Dose 1 Vaccination|Lost to Follow-up|9
7748497|NCT00822237|26939776|P2|Dose 1 Vaccination|Withdrawal by Subject|14
7748498|NCT00822237|26939777|P1|Dose 1 Vaccination|Withdrawal by Subject|13
7748499|NCT00822237|26939776|P2|Dose 1 Vaccination|Not vaccinated|0
7748500|NCT00822237|26939777|P1|Dose 1 Vaccination|Not vaccinated|3
7748501|NCT00822172|26939858|P2|Overall Study|Other|1
7748502|NCT00822172|26939859|P1|Overall Study|Other|0
7748503|NCT00822172|26939858|P2|Overall Study|site closed|1
7748504|NCT00822172|26939859|P1|Overall Study|site closed|0
7748505|NCT00822172|26939858|P2|Overall Study|Withdrawal by Subject|4
7748506|NCT00822172|26939859|P1|Overall Study|Withdrawal by Subject|1
7748507|NCT00822172|26939858|P2|Overall Study|Lost to Follow-up|1
7748508|NCT00822172|26939859|P1|Overall Study|Lost to Follow-up|3
7748509|NCT00822172|26939858|P2|Overall Study|Death|0
7748510|NCT00822172|26939859|P1|Overall Study|Death|1
7748511|NCT00822172|26939858|P2|Overall Study|Adverse Event|12
7748512|NCT00822172|26939859|P1|Overall Study|Adverse Event|10
7748513|NCT00822120|26939879|P6|PET-directed Therapy|Protocol Violation|0
7748514|NCT00822120|26939880|P5|PET-directed Therapy|Protocol Violation|0
7748515|NCT00822120|26939881|P4|PET-directed Therapy|Protocol Violation|6
7748516|NCT00822120|26939882|P3|PET-directed Therapy|Protocol Violation|0
7748517|NCT00822120|26939883|P2|PET-directed Therapy|Protocol Violation|0
7748518|NCT00822120|26939884|P1|PET-directed Therapy|Protocol Violation|0
7748519|NCT00822120|26939879|P6|PET-directed Therapy|Death|0
7748520|NCT00822120|26939880|P5|PET-directed Therapy|Death|0
7748521|NCT00822120|26939881|P4|PET-directed Therapy|Death|2
7748522|NCT00822120|26939882|P3|PET-directed Therapy|Death|0
7748523|NCT00822120|26939883|P2|PET-directed Therapy|Death|0
7748524|NCT00822120|26939884|P1|PET-directed Therapy|Death|0
7748525|NCT00822120|26939879|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7748526|NCT00822120|26939880|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7748527|NCT00822120|26939881|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
7748528|NCT00822120|26939882|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7748529|NCT00822120|26939883|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7748530|NCT00822120|26939884|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7748531|NCT00822120|26939879|P6|PET-directed Therapy|Adverse Event|0
7748532|NCT00822120|26939880|P5|PET-directed Therapy|Adverse Event|0
7748533|NCT00822120|26939881|P4|PET-directed Therapy|Adverse Event|1
7748534|NCT00822120|26939882|P3|PET-directed Therapy|Adverse Event|0
7748535|NCT00822120|26939883|P2|PET-directed Therapy|Adverse Event|0
7748536|NCT00822120|26939884|P1|PET-directed Therapy|Adverse Event|0
7748537|NCT00822120|26939879|P6|Initial Registration|Ineligible|0
7748538|NCT00822120|26939880|P5|Initial Registration|Ineligible|0
7748539|NCT00822120|26939881|P4|Initial Registration|Ineligible|0
7748540|NCT00822120|26939882|P3|Initial Registration|Ineligible|0
7748541|NCT00822120|26939883|P2|Initial Registration|Ineligible|1
7748542|NCT00822120|26939884|P1|Initial Registration|Ineligible|22
7748543|NCT00822120|26939879|P6|Initial Registration|Reasons not Protocol Specified|0
7748544|NCT00822120|26939880|P5|Initial Registration|Reasons not Protocol Specified|0
7748545|NCT00822120|26939881|P4|Initial Registration|Reasons not Protocol Specified|0
7748546|NCT00822120|26939882|P3|Initial Registration|Reasons not Protocol Specified|0
7748547|NCT00822120|26939883|P2|Initial Registration|Reasons not Protocol Specified|0
7748548|NCT00822120|26939884|P1|Initial Registration|Reasons not Protocol Specified|2
7748549|NCT00822120|26939879|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
7748550|NCT00822120|26939880|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
7748551|NCT00822120|26939881|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
7748552|NCT00822120|26939882|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
7748553|NCT00822120|26939883|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
7748554|NCT00822120|26939884|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
7748555|NCT00822120|26939879|P6|Initial Registration|Adverse Event|0
7748556|NCT00822120|26939880|P5|Initial Registration|Adverse Event|0
7748557|NCT00822120|26939881|P4|Initial Registration|Adverse Event|0
7748558|NCT00822120|26939882|P3|Initial Registration|Adverse Event|0
7748559|NCT00822120|26939883|P2|Initial Registration|Adverse Event|0
7748560|NCT00822120|26939884|P1|Initial Registration|Adverse Event|1
7748561|NCT00821873|26939950|P1|Overall Study|Lost to Follow-up|4
7748562|NCT00821678|26939980|P2|Overall Study|Death|2
7748563|NCT00821678|26939981|P1|Overall Study|Death|0
7748564|NCT00821678|26939980|P2|Overall Study|Lost to Follow-up|12
7748565|NCT00821678|26939981|P1|Overall Study|Lost to Follow-up|13
7748566|NCT00821678|26939980|P2|Overall Study|Withdrawal by Subject|0
7748567|NCT00821678|26939981|P1|Overall Study|Withdrawal by Subject|8
7748568|NCT00821587|26940016|P2|Overall Study|Physician Decision|1
7748569|NCT00821587|26940017|P1|Overall Study|Physician Decision|0
7748570|NCT00821509|26940026|P3|Overall Study|Withdrawal by Subject|34
7748571|NCT00821509|26940027|P2|Overall Study|Withdrawal by Subject|11
7748572|NCT00821509|26940028|P1|Overall Study|Withdrawal by Subject|12
7748573|NCT00821431|26940041|P2|Overall Study|Physician Decision|1
7748574|NCT00821431|26940042|P1|Overall Study|Physician Decision|0
7748575|NCT00821431|26940041|P2|Overall Study|Protocol Violation|1
7748576|NCT00821431|26940042|P1|Overall Study|Protocol Violation|3
7748577|NCT00821431|26940041|P2|Overall Study|Lost to Follow-up|0
7748578|NCT00821431|26940042|P1|Overall Study|Lost to Follow-up|1
7748579|NCT00821431|26940041|P2|Overall Study|Withdrawal by Subject|0
7748580|NCT00821431|26940042|P1|Overall Study|Withdrawal by Subject|5
7748581|NCT00821431|26940041|P2|Overall Study|Adverse Event|3
7748582|NCT00821431|26940042|P1|Overall Study|Adverse Event|6
7748583|NCT00821327|26940050|P1|Overall Study|Other/Unknown|5
7748584|NCT00821327|26940050|P1|Overall Study|Disease Progression|13
7748585|NCT00821327|26940050|P1|Overall Study|Sponsor Request|1
7748586|NCT00821327|26940050|P1|Overall Study|Investigator Request|2
7748587|NCT00821327|26940050|P1|Overall Study|Patient Request|1
7748588|NCT00821327|26940050|P1|Overall Study|Adverse Event|13
7748589|NCT00821236|26940059|P1|Overall Study|Lost to Follow-up|3
7748590|NCT00821093|26940099|P2|Overall Study|Administrative problems|2
7748591|NCT00821093|26940100|P1|Overall Study|Administrative problems|1
7748592|NCT00821093|26940099|P2|Overall Study|Abnormal test procedure result(s)|1
7748593|NCT00821093|26940100|P1|Overall Study|Abnormal test procedure result(s)|1
7748594|NCT00821093|26940099|P2|Overall Study|Death|1
7748595|NCT00821093|26940100|P1|Overall Study|Death|2
7748596|NCT00821093|26940099|P2|Overall Study|Lack of Efficacy|2
7748597|NCT00821093|26940100|P1|Overall Study|Lack of Efficacy|2
7748598|NCT00821093|26940099|P2|Overall Study|Abnormal laboratory value(s)|0
7748599|NCT00821093|26940100|P1|Overall Study|Abnormal laboratory value(s)|2
7748600|NCT00821093|26940099|P2|Overall Study|Protocol deviation|6
7748601|NCT00821093|26940100|P1|Overall Study|Protocol deviation|3
7748602|NCT00821093|26940099|P2|Overall Study|Lost to Follow-up|3
7748603|NCT00821093|26940100|P1|Overall Study|Lost to Follow-up|9
7748604|NCT00821093|26940099|P2|Overall Study|Withdrawal by Subject|13
7748605|NCT00821093|26940100|P1|Overall Study|Withdrawal by Subject|9
7748606|NCT00821093|26940099|P2|Overall Study|Adverse Event|12
7748607|NCT00821093|26940100|P1|Overall Study|Adverse Event|20
7748608|NCT00821015|26940119|P1|Overall Study|Lost to Follow-up|12
7748609|NCT00820898|26940130|P1|Overall Study|Inelgible - wrong primary site|1
7748610|NCT00820755|26940144|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
7748611|NCT00820755|26940145|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
7748612|NCT00820755|26940146|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
7748613|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Other|0
7748614|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Other|0
7748615|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Other|11
7748616|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
7748617|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
7748618|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
7748619|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Progressive disease|0
7748620|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Progressive disease|0
7748621|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Progressive disease|114
7748622|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
7748623|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
7748624|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
7748625|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
7748626|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
7748627|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
7748628|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
7748629|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
7748630|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
7748631|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Death|0
7748632|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Death|0
7748633|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Death|28
7748634|NCT00820755|26940144|P3|Period 1: Combination Therapy Phase|Adverse Event|0
7748635|NCT00820755|26940145|P2|Period 1: Combination Therapy Phase|Adverse Event|0
7748636|NCT00820755|26940146|P1|Period 1: Combination Therapy Phase|Adverse Event|77
7748637|NCT00820599|26940189|P1|Overall Study|Withdrawal by Subject|2
7748638|NCT00820599|26940189|P1|Overall Study|Death|129
7748639|NCT00820248|26940244|P2|Overall Study|No treated|1
7748640|NCT00820248|26940245|P1|Overall Study|No treated|4
7748641|NCT00820222|26940277|P2|Overall Study|Unkown|7
7748642|NCT00820222|26940278|P1|Overall Study|Unkown|11
7748643|NCT00820222|26940277|P2|Overall Study|Sponsor Terminated Study|65
7748644|NCT00820222|26940278|P1|Overall Study|Sponsor Terminated Study|43
7748645|NCT00820222|26940277|P2|Overall Study|Physician Decision|88
7748646|NCT00820222|26940278|P1|Overall Study|Physician Decision|93
7748647|NCT00820222|26940277|P2|Overall Study|Withdrawal by Subject|21
7748648|NCT00820222|26940278|P1|Overall Study|Withdrawal by Subject|19
7748649|NCT00820222|26940277|P2|Overall Study|Lost to Follow-up|9
7748650|NCT00820222|26940278|P1|Overall Study|Lost to Follow-up|10
7748651|NCT00820170|26940309|P5|Overall Study|Progressive Disease|2
7748652|NCT00820170|26940310|P4|Overall Study|Progressive Disease|0
7748653|NCT00820170|26940311|P3|Overall Study|Progressive Disease|0
7748654|NCT00820170|26940312|P2|Overall Study|Progressive Disease|0
7748655|NCT00820170|26940313|P1|Overall Study|Progressive Disease|0
7748656|NCT00820170|26940309|P5|Overall Study|Adverse Event|2
7748657|NCT00820170|26940310|P4|Overall Study|Adverse Event|0
7748658|NCT00820170|26940311|P3|Overall Study|Adverse Event|0
7748659|NCT00820170|26940312|P2|Overall Study|Adverse Event|0
7748660|NCT00820170|26940313|P1|Overall Study|Adverse Event|0
7748661|NCT00820040|26940361|P1|Overall Study|Screen failure|1
7748662|NCT00820040|26940361|P1|Overall Study|Sponsor terminated study|1
7748663|NCT00820040|26940361|P1|Overall Study|Death|1
7748664|NCT00820027|26940373|P4|Overall Study|Withdrawal by Subject|6
7748665|NCT00820027|26940374|P3|Overall Study|Withdrawal by Subject|4
7748666|NCT00820027|26940375|P2|Overall Study|Withdrawal by Subject|4
7748667|NCT00820027|26940376|P1|Overall Study|Withdrawal by Subject|6
7748668|NCT00820027|26940373|P4|Overall Study|Protocol Violation|0
7748669|NCT00820027|26940374|P3|Overall Study|Protocol Violation|4
7748670|NCT00820027|26940375|P2|Overall Study|Protocol Violation|0
7748671|NCT00820027|26940376|P1|Overall Study|Protocol Violation|3
7748672|NCT00820027|26940373|P4|Overall Study|Physician Decision|0
7748673|NCT00820027|26940374|P3|Overall Study|Physician Decision|1
7748674|NCT00820027|26940375|P2|Overall Study|Physician Decision|1
7748675|NCT00820027|26940376|P1|Overall Study|Physician Decision|0
7748676|NCT00820027|26940373|P4|Overall Study|Lack of Efficacy|2
7748677|NCT00820027|26940374|P3|Overall Study|Lack of Efficacy|2
7748678|NCT00820027|26940375|P2|Overall Study|Lack of Efficacy|1
7748679|NCT00820027|26940376|P1|Overall Study|Lack of Efficacy|2
7748680|NCT00820027|26940373|P4|Overall Study|Adverse Event|5
7748681|NCT00820027|26940374|P3|Overall Study|Adverse Event|10
7748682|NCT00820027|26940375|P2|Overall Study|Adverse Event|8
7748683|NCT00820027|26940376|P1|Overall Study|Adverse Event|15
7748684|NCT00819910|26940418|P4|Overall Study|Lost to Follow-up|0
7748685|NCT00819910|26940419|P3|Overall Study|Lost to Follow-up|0
7748686|NCT00819910|26940420|P2|Overall Study|Lost to Follow-up|0
7748687|NCT00819910|26940421|P1|Overall Study|Lost to Follow-up|1
7748688|NCT00819910|26940418|P4|Overall Study|Withdrawal by Subject|0
7748689|NCT00819910|26940419|P3|Overall Study|Withdrawal by Subject|1
7748690|NCT00819910|26940420|P2|Overall Study|Withdrawal by Subject|1
7748691|NCT00819910|26940421|P1|Overall Study|Withdrawal by Subject|1
7748692|NCT00819910|26940418|P4|Overall Study|Adverse Event|1
7748693|NCT00819910|26940419|P3|Overall Study|Adverse Event|2
7748694|NCT00819910|26940420|P2|Overall Study|Adverse Event|0
7748695|NCT00819910|26940421|P1|Overall Study|Adverse Event|0
7748696|NCT00819832|26940453|P6|Overall Study|Sponsor Termination of Study|0
7748697|NCT00819832|26940454|P5|Overall Study|Sponsor Termination of Study|0
7748698|NCT00819832|26940455|P4|Overall Study|Sponsor Termination of Study|0
7748699|NCT00819832|26940456|P3|Overall Study|Sponsor Termination of Study|0
7748700|NCT00819832|26940457|P2|Overall Study|Sponsor Termination of Study|0
7748701|NCT00819832|26940458|P1|Overall Study|Sponsor Termination of Study|3
7748702|NCT00819780|26940479|P2|Overall Study|Still in treatment|17
7748703|NCT00819780|26940480|P1|Overall Study|Still in treatment|25
7748704|NCT00819780|26940479|P2|Overall Study|Did not receive study drug|4
7748705|NCT00819780|26940480|P1|Overall Study|Did not receive study drug|3
7748706|NCT00819767|26940514|P2|Overall Study|Unsatisfactory therapeutic effect|2
7748707|NCT00819767|26940515|P1|Overall Study|Unsatisfactory therapeutic effect|1
7748708|NCT00819741|26940527|P2|Overall Study|Reasons unknown|3
7748709|NCT00819741|26940528|P1|Overall Study|Reasons unknown|3
7748710|NCT00819741|26940527|P2|Overall Study|Unclassified|0
7748711|NCT00819741|26940528|P1|Overall Study|Unclassified|6
7748712|NCT00819741|26940527|P2|Overall Study|Withdrawal by Subject|2
7748713|NCT00819741|26940528|P1|Overall Study|Withdrawal by Subject|2
7748714|NCT00819741|26940527|P2|Overall Study|Protocol Violation|4
7748715|NCT00819741|26940528|P1|Overall Study|Protocol Violation|3
7748716|NCT00819741|26940527|P2|Overall Study|Lost to Follow-up|1
7748717|NCT00819741|26940528|P1|Overall Study|Lost to Follow-up|3
7748718|NCT00819741|26940527|P2|Overall Study|Lack of Efficacy|2
7748719|NCT00819741|26940528|P1|Overall Study|Lack of Efficacy|0
7748720|NCT00819741|26940527|P2|Overall Study|Adverse Event|2
7748721|NCT00819741|26940528|P1|Overall Study|Adverse Event|5
7748722|NCT00819585|26940582|P11|Extension Study|Death|0
7748723|NCT00819585|26940583|P10|Extension Study|Death|0
7748724|NCT00819585|26940584|P9|Extension Study|Death|2
7748725|NCT00819585|26940585|P8|Extension Study|Death|0
7748726|NCT00819585|26940586|P7|Extension Study|Death|0
7748727|NCT00819585|26940587|P6|Extension Study|Death|0
7748728|NCT00819585|26940588|P5|Extension Study|Death|0
7748729|NCT00819585|26940589|P4|Extension Study|Death|0
7748730|NCT00819585|26940590|P3|Extension Study|Death|0
7748731|NCT00819585|26940591|P2|Extension Study|Death|0
7748732|NCT00819585|26940592|P1|Extension Study|Death|0
7748733|NCT00819585|26940582|P11|Extension Study|Lost to Follow-up|1
7748734|NCT00819585|26940583|P10|Extension Study|Lost to Follow-up|1
7748735|NCT00819585|26940584|P9|Extension Study|Lost to Follow-up|2
7748736|NCT00819585|26940585|P8|Extension Study|Lost to Follow-up|0
7748737|NCT00819585|26940586|P7|Extension Study|Lost to Follow-up|0
7748738|NCT00819585|26940587|P6|Extension Study|Lost to Follow-up|0
7748739|NCT00819585|26940588|P5|Extension Study|Lost to Follow-up|0
7748740|NCT00819585|26940589|P4|Extension Study|Lost to Follow-up|0
7748741|NCT00819585|26940590|P3|Extension Study|Lost to Follow-up|0
7748742|NCT00819585|26940591|P2|Extension Study|Lost to Follow-up|0
7748743|NCT00819585|26940592|P1|Extension Study|Lost to Follow-up|0
7748744|NCT00819585|26940582|P11|Extension Study|Subject Withdrew Consent|1
7748745|NCT00819585|26940583|P10|Extension Study|Subject Withdrew Consent|0
7748746|NCT00819585|26940584|P9|Extension Study|Subject Withdrew Consent|3
7748747|NCT00819585|26940585|P8|Extension Study|Subject Withdrew Consent|0
7748748|NCT00819585|26940586|P7|Extension Study|Subject Withdrew Consent|0
7748749|NCT00819585|26940587|P6|Extension Study|Subject Withdrew Consent|0
7748750|NCT00819585|26940588|P5|Extension Study|Subject Withdrew Consent|0
7748751|NCT00819585|26940589|P4|Extension Study|Subject Withdrew Consent|0
7748752|NCT00819585|26940590|P3|Extension Study|Subject Withdrew Consent|0
7748753|NCT00819585|26940591|P2|Extension Study|Subject Withdrew Consent|0
7748754|NCT00819585|26940592|P1|Extension Study|Subject Withdrew Consent|0
7748755|NCT00819585|26940582|P11|Extension Study|Abnormal Laboratory Value(s)|0
7748756|NCT00819585|26940583|P10|Extension Study|Abnormal Laboratory Value(s)|0
7748757|NCT00819585|26940584|P9|Extension Study|Abnormal Laboratory Value(s)|1
7748758|NCT00819585|26940585|P8|Extension Study|Abnormal Laboratory Value(s)|0
7748759|NCT00819585|26940586|P7|Extension Study|Abnormal Laboratory Value(s)|0
7748760|NCT00819585|26940587|P6|Extension Study|Abnormal Laboratory Value(s)|0
7748761|NCT00819585|26940588|P5|Extension Study|Abnormal Laboratory Value(s)|0
7748762|NCT00819585|26940589|P4|Extension Study|Abnormal Laboratory Value(s)|0
7748763|NCT00819585|26940590|P3|Extension Study|Abnormal Laboratory Value(s)|0
7748764|NCT00819585|26940591|P2|Extension Study|Abnormal Laboratory Value(s)|0
7748765|NCT00819585|26940592|P1|Extension Study|Abnormal Laboratory Value(s)|0
7748766|NCT00819585|26940582|P11|Core Study|Protocol Violation|0
7748767|NCT00819585|26940583|P10|Core Study|Protocol Violation|0
7748768|NCT00819585|26940584|P9|Core Study|Protocol Violation|0
7748769|NCT00819585|26940585|P8|Core Study|Protocol Violation|0
7748770|NCT00819585|26940586|P7|Core Study|Protocol Violation|3
7748771|NCT00819585|26940587|P6|Core Study|Protocol Violation|1
7748772|NCT00819585|26940588|P5|Core Study|Protocol Violation|0
7748773|NCT00819585|26940589|P4|Core Study|Protocol Violation|0
7748774|NCT00819585|26940590|P3|Core Study|Protocol Violation|1
7748775|NCT00819585|26940591|P2|Core Study|Protocol Violation|0
7748776|NCT00819585|26940592|P1|Core Study|Protocol Violation|0
7748777|NCT00819585|26940582|P11|Core Study|Death|0
7748778|NCT00819585|26940583|P10|Core Study|Death|0
7748779|NCT00819585|26940584|P9|Core Study|Death|0
7748780|NCT00819585|26940585|P8|Core Study|Death|0
7748781|NCT00819585|26940586|P7|Core Study|Death|1
7748782|NCT00819585|26940587|P6|Core Study|Death|0
7748783|NCT00819585|26940588|P5|Core Study|Death|0
7748784|NCT00819585|26940589|P4|Core Study|Death|0
7748785|NCT00819585|26940590|P3|Core Study|Death|0
7748786|NCT00819585|26940591|P2|Core Study|Death|0
7748787|NCT00819585|26940592|P1|Core Study|Death|0
7748788|NCT00819585|26940582|P11|Core Study|Administrative Problems|0
7748789|NCT00819585|26940583|P10|Core Study|Administrative Problems|0
7748790|NCT00819585|26940584|P9|Core Study|Administrative Problems|0
7748791|NCT00819585|26940585|P8|Core Study|Administrative Problems|0
7748792|NCT00819585|26940586|P7|Core Study|Administrative Problems|2
7748793|NCT00819585|26940587|P6|Core Study|Administrative Problems|0
7748794|NCT00819585|26940588|P5|Core Study|Administrative Problems|0
7748795|NCT00819585|26940589|P4|Core Study|Administrative Problems|0
7748796|NCT00819585|26940590|P3|Core Study|Administrative Problems|0
7748797|NCT00819585|26940591|P2|Core Study|Administrative Problems|0
7748798|NCT00819585|26940592|P1|Core Study|Administrative Problems|0
7748799|NCT00819585|26940582|P11|Core Study|Lost to Follow-up|0
7748800|NCT00819585|26940583|P10|Core Study|Lost to Follow-up|0
7748801|NCT00819585|26940584|P9|Core Study|Lost to Follow-up|0
7748802|NCT00819585|26940585|P8|Core Study|Lost to Follow-up|0
7748803|NCT00819585|26940586|P7|Core Study|Lost to Follow-up|1
7748804|NCT00819585|26940587|P6|Core Study|Lost to Follow-up|1
7748805|NCT00819585|26940588|P5|Core Study|Lost to Follow-up|1
7748806|NCT00819585|26940589|P4|Core Study|Lost to Follow-up|0
7748807|NCT00819585|26940590|P3|Core Study|Lost to Follow-up|2
7748808|NCT00819585|26940591|P2|Core Study|Lost to Follow-up|1
7748809|NCT00819585|26940592|P1|Core Study|Lost to Follow-up|2
7748810|NCT00819585|26940582|P11|Core Study|Subject Withdrew Consent|0
7748811|NCT00819585|26940583|P10|Core Study|Subject Withdrew Consent|0
7748812|NCT00819585|26940584|P9|Core Study|Subject Withdrew Consent|0
7748813|NCT00819585|26940585|P8|Core Study|Subject Withdrew Consent|0
7748814|NCT00819585|26940586|P7|Core Study|Subject Withdrew Consent|3
7748815|NCT00819585|26940587|P6|Core Study|Subject Withdrew Consent|0
7748816|NCT00819585|26940588|P5|Core Study|Subject Withdrew Consent|0
7748817|NCT00819585|26940589|P4|Core Study|Subject Withdrew Consent|1
7748818|NCT00819585|26940590|P3|Core Study|Subject Withdrew Consent|2
7748819|NCT00819585|26940591|P2|Core Study|Subject Withdrew Consent|3
7748820|NCT00819585|26940592|P1|Core Study|Subject Withdrew Consent|0
7748821|NCT00819585|26940582|P11|Core Study|Subject No Longer Requires Study Drug|0
7748822|NCT00819585|26940583|P10|Core Study|Subject No Longer Requires Study Drug|0
7748823|NCT00819585|26940584|P9|Core Study|Subject No Longer Requires Study Drug|0
7748824|NCT00819585|26940585|P8|Core Study|Subject No Longer Requires Study Drug|0
7748825|NCT00819585|26940586|P7|Core Study|Subject No Longer Requires Study Drug|0
7748826|NCT00819585|26940587|P6|Core Study|Subject No Longer Requires Study Drug|0
7748827|NCT00819585|26940588|P5|Core Study|Subject No Longer Requires Study Drug|1
7748828|NCT00819585|26940589|P4|Core Study|Subject No Longer Requires Study Drug|0
7748829|NCT00819585|26940590|P3|Core Study|Subject No Longer Requires Study Drug|0
7748830|NCT00819585|26940591|P2|Core Study|Subject No Longer Requires Study Drug|0
7748831|NCT00819585|26940592|P1|Core Study|Subject No Longer Requires Study Drug|0
7748832|NCT00819585|26940582|P11|Core Study|Unsatisfactory Therapeutic Effect|0
7748833|NCT00819585|26940583|P10|Core Study|Unsatisfactory Therapeutic Effect|0
7748834|NCT00819585|26940584|P9|Core Study|Unsatisfactory Therapeutic Effect|0
7748835|NCT00819585|26940585|P8|Core Study|Unsatisfactory Therapeutic Effect|0
7748836|NCT00819585|26940586|P7|Core Study|Unsatisfactory Therapeutic Effect|1
7748837|NCT00819585|26940587|P6|Core Study|Unsatisfactory Therapeutic Effect|0
7748838|NCT00819585|26940588|P5|Core Study|Unsatisfactory Therapeutic Effect|0
7748839|NCT00819585|26940589|P4|Core Study|Unsatisfactory Therapeutic Effect|0
7748840|NCT00819585|26940590|P3|Core Study|Unsatisfactory Therapeutic Effect|0
7748841|NCT00819585|26940591|P2|Core Study|Unsatisfactory Therapeutic Effect|1
7748842|NCT00819585|26940592|P1|Core Study|Unsatisfactory Therapeutic Effect|0
7748843|NCT00819585|26940582|P11|Core Study|Abnormal Laboratory Value(s)|0
7748844|NCT00819585|26940583|P10|Core Study|Abnormal Laboratory Value(s)|0
7748845|NCT00819585|26940584|P9|Core Study|Abnormal Laboratory Value(s)|0
7748846|NCT00819585|26940585|P8|Core Study|Abnormal Laboratory Value(s)|0
7748847|NCT00819585|26940586|P7|Core Study|Abnormal Laboratory Value(s)|0
7748848|NCT00819585|26940587|P6|Core Study|Abnormal Laboratory Value(s)|0
7748849|NCT00819585|26940588|P5|Core Study|Abnormal Laboratory Value(s)|0
7748850|NCT00819585|26940589|P4|Core Study|Abnormal Laboratory Value(s)|0
7748851|NCT00819585|26940590|P3|Core Study|Abnormal Laboratory Value(s)|0
7748852|NCT00819585|26940591|P2|Core Study|Abnormal Laboratory Value(s)|0
7748853|NCT00819585|26940592|P1|Core Study|Abnormal Laboratory Value(s)|2
7748854|NCT00819585|26940582|P11|Core Study|Adverse Event|0
7748855|NCT00819585|26940583|P10|Core Study|Adverse Event|0
7748856|NCT00819585|26940584|P9|Core Study|Adverse Event|0
7748857|NCT00819585|26940585|P8|Core Study|Adverse Event|0
7748858|NCT00819585|26940586|P7|Core Study|Adverse Event|2
7748859|NCT00819585|26940587|P6|Core Study|Adverse Event|0
7748860|NCT00819585|26940588|P5|Core Study|Adverse Event|1
7748861|NCT00819585|26940589|P4|Core Study|Adverse Event|4
7748862|NCT00819585|26940590|P3|Core Study|Adverse Event|1
7748863|NCT00819585|26940591|P2|Core Study|Adverse Event|1
7748864|NCT00819585|26940592|P1|Core Study|Adverse Event|2
7748865|NCT00819390|26940683|P4|Overall Study|Adverse Event|0
7748866|NCT00819390|26940684|P3|Overall Study|Adverse Event|1
7748867|NCT00819390|26940685|P2|Overall Study|Adverse Event|0
7748868|NCT00819390|26940686|P1|Overall Study|Adverse Event|0
7748869|NCT00819390|26940683|P4|Overall Study|Withdrawal by Subject|0
7748870|NCT00819390|26940684|P3|Overall Study|Withdrawal by Subject|0
7748871|NCT00819390|26940685|P2|Overall Study|Withdrawal by Subject|0
7748872|NCT00819390|26940686|P1|Overall Study|Withdrawal by Subject|2
7748873|NCT00819390|26940683|P4|Overall Study|Lost to Follow-up|0
7748874|NCT00819390|26940684|P3|Overall Study|Lost to Follow-up|0
7748875|NCT00819390|26940685|P2|Overall Study|Lost to Follow-up|1
7748876|NCT00819390|26940686|P1|Overall Study|Lost to Follow-up|1
7748877|NCT00819247|26940822|P3|Overall Study|Other|0
7748878|NCT00819247|26940823|P2|Overall Study|Other|0
7748879|NCT00819247|26940824|P1|Overall Study|Other|1
7748880|NCT00819247|26940822|P3|Overall Study|Bad prostate-specific antigen response|0
7748881|NCT00819247|26940823|P2|Overall Study|Bad prostate-specific antigen response|2
7748882|NCT00819247|26940824|P1|Overall Study|Bad prostate-specific antigen response|3
7748883|NCT00819247|26940822|P3|Overall Study|Mistakenly withdrawn|0
7748884|NCT00819247|26940823|P2|Overall Study|Mistakenly withdrawn|1
7748885|NCT00819247|26940824|P1|Overall Study|Mistakenly withdrawn|0
7748886|NCT00819247|26940822|P3|Overall Study|Protocol Violation|1
7748887|NCT00819247|26940823|P2|Overall Study|Protocol Violation|0
7748888|NCT00819247|26940824|P1|Overall Study|Protocol Violation|1
7748889|NCT00819247|26940822|P3|Overall Study|Withdrawal by Subject|0
7748890|NCT00819247|26940823|P2|Overall Study|Withdrawal by Subject|0
7748891|NCT00819247|26940824|P1|Overall Study|Withdrawal by Subject|1
7748892|NCT00819247|26940822|P3|Overall Study|Insufficient testosterone response|10
7748893|NCT00819247|26940823|P2|Overall Study|Insufficient testosterone response|8
7748894|NCT00819247|26940824|P1|Overall Study|Insufficient testosterone response|5
7748895|NCT00819247|26940822|P3|Overall Study|Adverse Event|3
7748896|NCT00819247|26940823|P2|Overall Study|Adverse Event|5
7748897|NCT00819247|26940824|P1|Overall Study|Adverse Event|0
7748898|NCT00819234|26940850|P10|Overall Study|Lost to Follow-up|2
7748899|NCT00819234|26940851|P9|Overall Study|Lost to Follow-up|1
7748900|NCT00819234|26940852|P8|Overall Study|Lost to Follow-up|1
7748901|NCT00819234|26940853|P7|Overall Study|Lost to Follow-up|1
7748902|NCT00819234|26940854|P6|Overall Study|Lost to Follow-up|1
7748903|NCT00819234|26940855|P5|Overall Study|Lost to Follow-up|1
7748904|NCT00819234|26940856|P4|Overall Study|Lost to Follow-up|2
7748905|NCT00819234|26940857|P3|Overall Study|Lost to Follow-up|0
7748906|NCT00819234|26940858|P2|Overall Study|Lost to Follow-up|2
7748907|NCT00819234|26940859|P1|Overall Study|Lost to Follow-up|2
7748908|NCT00819234|26940850|P10|Overall Study|Protocol Violation|0
7748909|NCT00819234|26940851|P9|Overall Study|Protocol Violation|0
7748910|NCT00819234|26940852|P8|Overall Study|Protocol Violation|0
7748911|NCT00819234|26940853|P7|Overall Study|Protocol Violation|0
7748912|NCT00819234|26940854|P6|Overall Study|Protocol Violation|0
7748913|NCT00819234|26940855|P5|Overall Study|Protocol Violation|0
7748914|NCT00819234|26940856|P4|Overall Study|Protocol Violation|0
7748915|NCT00819234|26940857|P3|Overall Study|Protocol Violation|1
7748916|NCT00819234|26940858|P2|Overall Study|Protocol Violation|0
7748917|NCT00819234|26940859|P1|Overall Study|Protocol Violation|0
7748918|NCT00819234|26940850|P10|Overall Study|Physician Decision|2
7748919|NCT00819234|26940851|P9|Overall Study|Physician Decision|0
7748920|NCT00819234|26940852|P8|Overall Study|Physician Decision|0
7748921|NCT00819234|26940853|P7|Overall Study|Physician Decision|0
7748922|NCT00819234|26940854|P6|Overall Study|Physician Decision|0
7748923|NCT00819234|26940855|P5|Overall Study|Physician Decision|0
7748924|NCT00819234|26940856|P4|Overall Study|Physician Decision|1
7748925|NCT00819234|26940857|P3|Overall Study|Physician Decision|0
7748926|NCT00819234|26940858|P2|Overall Study|Physician Decision|0
7748927|NCT00819234|26940859|P1|Overall Study|Physician Decision|0
7748928|NCT00819234|26940850|P10|Overall Study|Adverse Event|0
7748929|NCT00819234|26940851|P9|Overall Study|Adverse Event|0
7748930|NCT00819234|26940852|P8|Overall Study|Adverse Event|0
7748931|NCT00819234|26940853|P7|Overall Study|Adverse Event|0
7748932|NCT00819234|26940854|P6|Overall Study|Adverse Event|2
7748933|NCT00819234|26940855|P5|Overall Study|Adverse Event|0
7748934|NCT00819234|26940856|P4|Overall Study|Adverse Event|0
7748935|NCT00819234|26940857|P3|Overall Study|Adverse Event|1
7748936|NCT00819234|26940858|P2|Overall Study|Adverse Event|0
7748937|NCT00819234|26940859|P1|Overall Study|Adverse Event|0
7748938|NCT00819234|26940850|P10|Overall Study|Withdrawal by Subject|3
7748939|NCT00819234|26940851|P9|Overall Study|Withdrawal by Subject|5
7748940|NCT00819234|26940852|P8|Overall Study|Withdrawal by Subject|8
7748941|NCT00819234|26940853|P7|Overall Study|Withdrawal by Subject|4
7748942|NCT00819234|26940854|P6|Overall Study|Withdrawal by Subject|4
7748943|NCT00819234|26940855|P5|Overall Study|Withdrawal by Subject|0
7748944|NCT00819234|26940856|P4|Overall Study|Withdrawal by Subject|3
7748945|NCT00819234|26940857|P3|Overall Study|Withdrawal by Subject|6
7748946|NCT00819234|26940858|P2|Overall Study|Withdrawal by Subject|13
7748947|NCT00819234|26940859|P1|Overall Study|Withdrawal by Subject|8
7748948|NCT00819156|26941058|P6|Overall Study|Prostate-specific antigen progression|0
7748949|NCT00819156|26941059|P5|Overall Study|Prostate-specific antigen progression|1
7748950|NCT00819156|26941060|P4|Overall Study|Prostate-specific antigen progression|0
7748951|NCT00819156|26941061|P3|Overall Study|Prostate-specific antigen progression|0
7748952|NCT00819156|26941062|P2|Overall Study|Prostate-specific antigen progression|0
7748953|NCT00819156|26941063|P1|Overall Study|Prostate-specific antigen progression|0
7748954|NCT00819156|26941058|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7748955|NCT00819156|26941059|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
7748956|NCT00819156|26941060|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7748957|NCT00819156|26941061|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7748958|NCT00819156|26941062|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7748959|NCT00819156|26941063|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
7748960|NCT00819156|26941058|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
7748961|NCT00819156|26941059|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
7748962|NCT00819156|26941060|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
7748963|NCT00819156|26941061|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
7748964|NCT00819156|26941062|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
7748965|NCT00819156|26941063|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
7748966|NCT00819156|26941058|P6|Overall Study|Lost to Follow-up|2
7748967|NCT00819156|26941059|P5|Overall Study|Lost to Follow-up|0
7748968|NCT00819156|26941060|P4|Overall Study|Lost to Follow-up|0
7748969|NCT00819156|26941061|P3|Overall Study|Lost to Follow-up|0
7748970|NCT00819156|26941062|P2|Overall Study|Lost to Follow-up|1
7748971|NCT00819156|26941063|P1|Overall Study|Lost to Follow-up|0
7748972|NCT00819156|26941058|P6|Overall Study|Protocol Violation|1
7748973|NCT00819156|26941059|P5|Overall Study|Protocol Violation|0
7748974|NCT00819156|26941060|P4|Overall Study|Protocol Violation|0
7748975|NCT00819156|26941061|P3|Overall Study|Protocol Violation|1
7748976|NCT00819156|26941062|P2|Overall Study|Protocol Violation|0
7748977|NCT00819156|26941063|P1|Overall Study|Protocol Violation|1
7748978|NCT00819156|26941058|P6|Overall Study|Withdrawal by Subject|0
7748979|NCT00819156|26941059|P5|Overall Study|Withdrawal by Subject|1
7748980|NCT00819156|26941060|P4|Overall Study|Withdrawal by Subject|0
7748981|NCT00819156|26941061|P3|Overall Study|Withdrawal by Subject|2
7748982|NCT00819156|26941062|P2|Overall Study|Withdrawal by Subject|3
7748983|NCT00819156|26941063|P1|Overall Study|Withdrawal by Subject|0
7748984|NCT00819156|26941058|P6|Overall Study|Adverse Event|3
7748985|NCT00819156|26941059|P5|Overall Study|Adverse Event|2
7748986|NCT00819156|26941060|P4|Overall Study|Adverse Event|1
7748987|NCT00819156|26941061|P3|Overall Study|Adverse Event|2
7748988|NCT00819156|26941062|P2|Overall Study|Adverse Event|4
7748989|NCT00819156|26941063|P1|Overall Study|Adverse Event|1
7748990|NCT00819091|26941153|P2|Overall Study|Other|2
7748991|NCT00819091|26941154|P1|Overall Study|Other|1
7748992|NCT00819091|26941153|P2|Overall Study|Withdrawal by Subject|2
7748993|NCT00819091|26941154|P1|Overall Study|Withdrawal by Subject|1
7748994|NCT00819091|26941153|P2|Overall Study|Lost to Follow-up|0
7748995|NCT00819091|26941154|P1|Overall Study|Lost to Follow-up|2
7748996|NCT00819091|26941153|P2|Overall Study|Protocol Violation|1
7748997|NCT00819091|26941154|P1|Overall Study|Protocol Violation|0
7748998|NCT00819091|26941153|P2|Overall Study|Adverse Event|5
7748999|NCT00819091|26941154|P1|Overall Study|Adverse Event|3
7749000|NCT00819052|26941180|P2|Overall Study|Death or events leading to death|0
7749001|NCT00819052|26941181|P1|Overall Study|Death or events leading to death|1
7749002|NCT00819052|26941180|P2|Overall Study|Pregnancy|2
7749003|NCT00819052|26941181|P1|Overall Study|Pregnancy|1
7749004|NCT00819052|26941180|P2|Overall Study|Lack of Efficacy|1
7749005|NCT00819052|26941181|P1|Overall Study|Lack of Efficacy|1
7749006|NCT00819052|26941180|P2|Overall Study|Withdrawal by Subject|2
7749007|NCT00819052|26941181|P1|Overall Study|Withdrawal by Subject|1
7749008|NCT00819052|26941180|P2|Overall Study|Lost to Follow-up|2
7749009|NCT00819052|26941181|P1|Overall Study|Lost to Follow-up|1
7749010|NCT00819052|26941180|P2|Overall Study|Protocol Violation|2
7749011|NCT00819052|26941181|P1|Overall Study|Protocol Violation|1
7749012|NCT00819052|26941180|P2|Overall Study|Adverse Event|5
7749013|NCT00819052|26941181|P1|Overall Study|Adverse Event|0
7749014|NCT00819039|26941296|P3|Overall Study|Protocol Violation|0
7749015|NCT00819039|26941297|P2|Overall Study|Protocol Violation|0
7749016|NCT00819039|26941298|P1|Overall Study|Protocol Violation|1
7749017|NCT00819039|26941296|P3|Overall Study|Physician Decision|1
7749018|NCT00819039|26941297|P2|Overall Study|Physician Decision|0
7749019|NCT00819039|26941298|P1|Overall Study|Physician Decision|1
7749020|NCT00819013|26941328|P4|Overall Study|Death|1
7749021|NCT00819013|26941329|P3|Overall Study|Death|0
7749022|NCT00819013|26941330|P2|Overall Study|Death|0
7749023|NCT00819013|26941331|P1|Overall Study|Death|0
7749024|NCT00819013|26941328|P4|Overall Study|Lost to Follow-up|2
7749025|NCT00819013|26941329|P3|Overall Study|Lost to Follow-up|1
7749026|NCT00819013|26941330|P2|Overall Study|Lost to Follow-up|0
7749027|NCT00819013|26941331|P1|Overall Study|Lost to Follow-up|0
7749028|NCT00819013|26941328|P4|Overall Study|Withdrawal by Subject|0
7749029|NCT00819013|26941329|P3|Overall Study|Withdrawal by Subject|1
7749030|NCT00819013|26941330|P2|Overall Study|Withdrawal by Subject|0
7749031|NCT00819013|26941331|P1|Overall Study|Withdrawal by Subject|1
7749032|NCT00819013|26941328|P4|Overall Study|Adverse Event|0
7749033|NCT00819013|26941329|P3|Overall Study|Adverse Event|1
7749034|NCT00819013|26941330|P2|Overall Study|Adverse Event|0
7749035|NCT00819013|26941331|P1|Overall Study|Adverse Event|0
7749036|NCT00819013|26941328|P4|Overall Study|Not meeting continuing study eligibility|1
7749037|NCT00819013|26941329|P3|Overall Study|Not meeting continuing study eligibility|2
7749038|NCT00819013|26941330|P2|Overall Study|Not meeting continuing study eligibility|1
7749039|NCT00819013|26941331|P1|Overall Study|Not meeting continuing study eligibility|2
7749040|NCT00818883|26941397|P2|Overall Study|Other|7
7749041|NCT00818883|26941398|P1|Overall Study|Other|2
7749042|NCT00818883|26941397|P2|Overall Study|Lack of Efficacy|2
7749043|NCT00818883|26941398|P1|Overall Study|Lack of Efficacy|0
7749044|NCT00818883|26941397|P2|Overall Study|Withdrawal by Subject|14
7749045|NCT00818883|26941398|P1|Overall Study|Withdrawal by Subject|16
7749046|NCT00818883|26941397|P2|Overall Study|Lost to Follow-up|2
7749047|NCT00818883|26941398|P1|Overall Study|Lost to Follow-up|3
7749048|NCT00818883|26941397|P2|Overall Study|Protocol Violation|2
7749049|NCT00818883|26941398|P1|Overall Study|Protocol Violation|2
7749050|NCT00818883|26941397|P2|Overall Study|Adverse Event|19
7749051|NCT00818883|26941398|P1|Overall Study|Adverse Event|28
7749052|NCT00818779|26941445|P2|Overall Study|Adverse Event|1
7749053|NCT00818779|26941446|P1|Overall Study|Adverse Event|4
7749054|NCT00818779|26941445|P2|Overall Study|Lost to Follow-up|0
7749055|NCT00818779|26941446|P1|Overall Study|Lost to Follow-up|1
7749056|NCT00818779|26941445|P2|Overall Study|Protocol Violation|0
7749057|NCT00818779|26941446|P1|Overall Study|Protocol Violation|1
7749058|NCT00818766|26941462|P2|Overall Study|Did not Receive Allocated Intervention|0
7749059|NCT00818766|26941463|P1|Overall Study|Did not Receive Allocated Intervention|3
7749060|NCT00818766|26941462|P2|Overall Study|Death|0
7749061|NCT00818766|26941463|P1|Overall Study|Death|1
7749062|NCT00818766|26941462|P2|Overall Study|Could not be Contacted on Day 28|10
7749063|NCT00818766|26941463|P1|Overall Study|Could not be Contacted on Day 28|11
7749064|NCT00818753|26941492|P3|Overall Study|Randomised and not treated|0
7749065|NCT00818753|26941493|P2|Overall Study|Randomised and not treated|0
7749066|NCT00818753|26941494|P1|Overall Study|Randomised and not treated|2
7749067|NCT00818753|26941492|P3|Overall Study|Other reason (not specified)|1
7749068|NCT00818753|26941493|P2|Overall Study|Other reason (not specified)|0
7749069|NCT00818753|26941494|P1|Overall Study|Other reason (not specified)|0
7749070|NCT00818753|26941492|P3|Overall Study|Protocol Violation|0
7749071|NCT00818753|26941493|P2|Overall Study|Protocol Violation|0
7749072|NCT00818753|26941494|P1|Overall Study|Protocol Violation|1
7749073|NCT00818662|26941518|P4|Overall Study|Admitted to long term nursing care|0
7749074|NCT00818662|26941519|P3|Overall Study|Admitted to long term nursing care|0
7749075|NCT00818662|26941520|P2|Overall Study|Admitted to long term nursing care|1
7749076|NCT00818662|26941521|P1|Overall Study|Admitted to long term nursing care|0
7749077|NCT00818662|26941518|P4|Overall Study|Study partner decision|1
7749078|NCT00818662|26941519|P3|Overall Study|Study partner decision|0
7749079|NCT00818662|26941520|P2|Overall Study|Study partner decision|0
7749080|NCT00818662|26941521|P1|Overall Study|Study partner decision|0
7749081|NCT00818662|26941518|P4|Overall Study|Change in living situation|1
7749082|NCT00818662|26941519|P3|Overall Study|Change in living situation|0
7749083|NCT00818662|26941520|P2|Overall Study|Change in living situation|0
7749084|NCT00818662|26941521|P1|Overall Study|Change in living situation|0
7749085|NCT00818662|26941518|P4|Overall Study|Declined move to another study site|0
7749086|NCT00818662|26941519|P3|Overall Study|Declined move to another study site|0
7749087|NCT00818662|26941520|P2|Overall Study|Declined move to another study site|0
7749088|NCT00818662|26941521|P1|Overall Study|Declined move to another study site|1
7749089|NCT00818662|26941518|P4|Overall Study|Moving out of state|1
7749090|NCT00818662|26941519|P3|Overall Study|Moving out of state|0
7749091|NCT00818662|26941520|P2|Overall Study|Moving out of state|0
7749092|NCT00818662|26941521|P1|Overall Study|Moving out of state|0
7749093|NCT00818662|26941518|P4|Overall Study|Caregiver to pursue other treatment|0
7749094|NCT00818662|26941519|P3|Overall Study|Caregiver to pursue other treatment|0
7749095|NCT00818662|26941520|P2|Overall Study|Caregiver to pursue other treatment|1
7749096|NCT00818662|26941521|P1|Overall Study|Caregiver to pursue other treatment|0
7749097|NCT00818662|26941518|P4|Overall Study|Participant's health declined|1
7749098|NCT00818662|26941519|P3|Overall Study|Participant's health declined|0
7749099|NCT00818662|26941520|P2|Overall Study|Participant's health declined|0
7749100|NCT00818662|26941521|P1|Overall Study|Participant's health declined|0
7749101|NCT00818662|26941518|P4|Overall Study|Study Partner Unwilling or Unable|1
7749102|NCT00818662|26941519|P3|Overall Study|Study Partner Unwilling or Unable|1
7749103|NCT00818662|26941520|P2|Overall Study|Study Partner Unwilling or Unable|2
7749104|NCT00818662|26941521|P1|Overall Study|Study Partner Unwilling or Unable|3
7749105|NCT00818662|26941518|P4|Overall Study|Safety Risk|1
7749106|NCT00818662|26941519|P3|Overall Study|Safety Risk|0
7749107|NCT00818662|26941520|P2|Overall Study|Safety Risk|1
7749108|NCT00818662|26941521|P1|Overall Study|Safety Risk|1
7749109|NCT00818662|26941518|P4|Overall Study|Requires a Prohibited Medication|0
7749110|NCT00818662|26941519|P3|Overall Study|Requires a Prohibited Medication|0
7749111|NCT00818662|26941520|P2|Overall Study|Requires a Prohibited Medication|0
7749112|NCT00818662|26941521|P1|Overall Study|Requires a Prohibited Medication|1
7749113|NCT00818662|26941518|P4|Overall Study|Protocol Violation|0
7749114|NCT00818662|26941519|P3|Overall Study|Protocol Violation|0
7749115|NCT00818662|26941520|P2|Overall Study|Protocol Violation|1
7749116|NCT00818662|26941521|P1|Overall Study|Protocol Violation|1
7749117|NCT00818662|26941518|P4|Overall Study|Unwilling or Unable to Participate|4
7749118|NCT00818662|26941519|P3|Overall Study|Unwilling or Unable to Participate|2
7749119|NCT00818662|26941520|P2|Overall Study|Unwilling or Unable to Participate|6
7749120|NCT00818662|26941521|P1|Overall Study|Unwilling or Unable to Participate|4
7749121|NCT00818662|26941518|P4|Overall Study|Lost to Follow-up|1
7749122|NCT00818662|26941519|P3|Overall Study|Lost to Follow-up|0
7749123|NCT00818662|26941520|P2|Overall Study|Lost to Follow-up|0
7749124|NCT00818662|26941521|P1|Overall Study|Lost to Follow-up|0
7749125|NCT00818662|26941518|P4|Overall Study|Physician Decision|0
7749126|NCT00818662|26941519|P3|Overall Study|Physician Decision|0
7749127|NCT00818662|26941520|P2|Overall Study|Physician Decision|0
7749128|NCT00818662|26941521|P1|Overall Study|Physician Decision|1
7749129|NCT00818662|26941518|P4|Overall Study|Death|0
7749130|NCT00818662|26941519|P3|Overall Study|Death|0
7749131|NCT00818662|26941520|P2|Overall Study|Death|3
7749132|NCT00818662|26941521|P1|Overall Study|Death|1
7749133|NCT00818662|26941518|P4|Overall Study|Withdrawal by Subject|2
7749134|NCT00818662|26941519|P3|Overall Study|Withdrawal by Subject|2
7749135|NCT00818662|26941520|P2|Overall Study|Withdrawal by Subject|4
7749136|NCT00818662|26941521|P1|Overall Study|Withdrawal by Subject|5
7749137|NCT00818662|26941518|P4|Overall Study|Adverse Event|3
7749138|NCT00818662|26941519|P3|Overall Study|Adverse Event|4
7749139|NCT00818662|26941520|P2|Overall Study|Adverse Event|14
7749140|NCT00818662|26941521|P1|Overall Study|Adverse Event|5
7749141|NCT00818649|26941607|P1|Overall Study|Adverse Event|1
7749142|NCT00818649|26941607|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
7749143|NCT00818649|26941607|P1|Overall Study|Declining performance status|2
7749144|NCT00818623|26941621|P8|Overall Study|Disease progression|0
7749145|NCT00818623|26941622|P7|Overall Study|Disease progression|1
7749146|NCT00818623|26941623|P6|Overall Study|Disease progression|0
7749147|NCT00818623|26941624|P5|Overall Study|Disease progression|0
7749148|NCT00818623|26941625|P4|Overall Study|Disease progression|0
7749149|NCT00818623|26941626|P3|Overall Study|Disease progression|0
7749150|NCT00818623|26941627|P2|Overall Study|Disease progression|0
7749151|NCT00818623|26941628|P1|Overall Study|Disease progression|0
7749152|NCT00818623|26941621|P8|Overall Study|Lack of trial drug at site|0
7749153|NCT00818623|26941622|P7|Overall Study|Lack of trial drug at site|1
7749154|NCT00818623|26941623|P6|Overall Study|Lack of trial drug at site|0
7749155|NCT00818623|26941624|P5|Overall Study|Lack of trial drug at site|2
7749156|NCT00818623|26941625|P4|Overall Study|Lack of trial drug at site|0
7749157|NCT00818623|26941626|P3|Overall Study|Lack of trial drug at site|0
7749158|NCT00818623|26941627|P2|Overall Study|Lack of trial drug at site|0
7749159|NCT00818623|26941628|P1|Overall Study|Lack of trial drug at site|0
7749160|NCT00818623|26941621|P8|Overall Study|Need of additional treatment|0
7749161|NCT00818623|26941622|P7|Overall Study|Need of additional treatment|0
7749162|NCT00818623|26941623|P6|Overall Study|Need of additional treatment|0
7749163|NCT00818623|26941624|P5|Overall Study|Need of additional treatment|1
7749164|NCT00818623|26941625|P4|Overall Study|Need of additional treatment|0
7749165|NCT00818623|26941626|P3|Overall Study|Need of additional treatment|0
7749166|NCT00818623|26941627|P2|Overall Study|Need of additional treatment|0
7749167|NCT00818623|26941628|P1|Overall Study|Need of additional treatment|0
7749168|NCT00818623|26941621|P8|Overall Study|Protocol Violation|0
7749169|NCT00818623|26941622|P7|Overall Study|Protocol Violation|1
7749170|NCT00818623|26941623|P6|Overall Study|Protocol Violation|0
7749171|NCT00818623|26941624|P5|Overall Study|Protocol Violation|1
7749172|NCT00818623|26941625|P4|Overall Study|Protocol Violation|0
7749173|NCT00818623|26941626|P3|Overall Study|Protocol Violation|0
7749174|NCT00818623|26941627|P2|Overall Study|Protocol Violation|0
7749175|NCT00818623|26941628|P1|Overall Study|Protocol Violation|1
7749176|NCT00818623|26941621|P8|Overall Study|Withdrawal by Subject|1
7749177|NCT00818623|26941622|P7|Overall Study|Withdrawal by Subject|1
7749178|NCT00818623|26941623|P6|Overall Study|Withdrawal by Subject|1
7749179|NCT00818623|26941624|P5|Overall Study|Withdrawal by Subject|0
7749180|NCT00818623|26941625|P4|Overall Study|Withdrawal by Subject|0
7749181|NCT00818623|26941626|P3|Overall Study|Withdrawal by Subject|1
7749182|NCT00818623|26941627|P2|Overall Study|Withdrawal by Subject|1
7749183|NCT00818623|26941628|P1|Overall Study|Withdrawal by Subject|0
7749184|NCT00818623|26941621|P8|Overall Study|Bad prostate specific antigen response|0
7749185|NCT00818623|26941622|P7|Overall Study|Bad prostate specific antigen response|0
7749186|NCT00818623|26941623|P6|Overall Study|Bad prostate specific antigen response|1
7749187|NCT00818623|26941624|P5|Overall Study|Bad prostate specific antigen response|0
7749188|NCT00818623|26941625|P4|Overall Study|Bad prostate specific antigen response|5
7749189|NCT00818623|26941626|P3|Overall Study|Bad prostate specific antigen response|2
7749190|NCT00818623|26941627|P2|Overall Study|Bad prostate specific antigen response|3
7749191|NCT00818623|26941628|P1|Overall Study|Bad prostate specific antigen response|0
7749192|NCT00818623|26941621|P8|Overall Study|Adverse Event|0
7749193|NCT00818623|26941622|P7|Overall Study|Adverse Event|0
7749194|NCT00818623|26941623|P6|Overall Study|Adverse Event|1
7749195|NCT00818623|26941624|P5|Overall Study|Adverse Event|0
7749196|NCT00818623|26941625|P4|Overall Study|Adverse Event|0
7749197|NCT00818623|26941626|P3|Overall Study|Adverse Event|1
7749198|NCT00818623|26941627|P2|Overall Study|Adverse Event|0
7749199|NCT00818623|26941628|P1|Overall Study|Adverse Event|1
7749200|NCT00818519|26941704|P2|Overall Study|participant will leave for long tme|0
7749201|NCT00818519|26941705|P1|Overall Study|participant will leave for long tme|1
7749202|NCT00818519|26941704|P2|Overall Study|participant recovered completely|0
7749203|NCT00818519|26941705|P1|Overall Study|participant recovered completely|1
7749204|NCT00818519|26941704|P2|Overall Study|Withdrawal by Subject|9
7749205|NCT00818519|26941705|P1|Overall Study|Withdrawal by Subject|4
7749206|NCT00818519|26941704|P2|Overall Study|Pregnancy|1
7749207|NCT00818519|26941705|P1|Overall Study|Pregnancy|0
7749208|NCT00818519|26941704|P2|Overall Study|Protocol Violation|1
7749209|NCT00818519|26941705|P1|Overall Study|Protocol Violation|2
7749210|NCT00818519|26941704|P2|Overall Study|Lost to Follow-up|6
7749211|NCT00818519|26941705|P1|Overall Study|Lost to Follow-up|4
7749212|NCT00818519|26941704|P2|Overall Study|Adverse Event|2
7749213|NCT00818519|26941705|P1|Overall Study|Adverse Event|2
7749214|NCT00818454|26941735|P4|Treatment Period 3|Adverse Event|1
7749215|NCT00818454|26941736|P3|Treatment Period 3|Adverse Event|0
7749216|NCT00818454|26941737|P2|Treatment Period 3|Adverse Event|0
7749217|NCT00818454|26941738|P1|Treatment Period 3|Adverse Event|0
7749218|NCT00818454|26941735|P4|Treatment Period 2|Other|0
7749219|NCT00818454|26941736|P3|Treatment Period 2|Other|0
7749220|NCT00818454|26941737|P2|Treatment Period 2|Other|1
7749221|NCT00818454|26941738|P1|Treatment Period 2|Other|2
7749222|NCT00818454|26941735|P4|Washout Period of 1 Week|Other|0
7749223|NCT00818454|26941736|P3|Washout Period of 1 Week|Other|0
7749224|NCT00818454|26941737|P2|Washout Period of 1 Week|Other|2
7749225|NCT00818454|26941738|P1|Washout Period of 1 Week|Other|1
7749226|NCT00818454|26941735|P4|Washout Period of 1 Week|Protocol Violation|0
7749227|NCT00818454|26941736|P3|Washout Period of 1 Week|Protocol Violation|0
7749228|NCT00818454|26941737|P2|Washout Period of 1 Week|Protocol Violation|0
7749229|NCT00818454|26941738|P1|Washout Period of 1 Week|Protocol Violation|2
7749230|NCT00818454|26941735|P4|Washout Period of 1 Week|Adverse Event|0
7749231|NCT00818454|26941736|P3|Washout Period of 1 Week|Adverse Event|0
7749232|NCT00818454|26941737|P2|Washout Period of 1 Week|Adverse Event|1
7749233|NCT00818454|26941738|P1|Washout Period of 1 Week|Adverse Event|1
7749234|NCT00818454|26941735|P4|Treatment Period 1|Other|0
7749235|NCT00818454|26941736|P3|Treatment Period 1|Other|0
7749236|NCT00818454|26941737|P2|Treatment Period 1|Other|0
7749237|NCT00818454|26941738|P1|Treatment Period 1|Other|3
7749238|NCT00818454|26941735|P4|Treatment Period 1|Adverse Event|0
7749239|NCT00818454|26941736|P3|Treatment Period 1|Adverse Event|0
7749240|NCT00818454|26941737|P2|Treatment Period 1|Adverse Event|1
7749241|NCT00818454|26941738|P1|Treatment Period 1|Adverse Event|0
7749242|NCT00818441|26941766|P2|Overall Study|Study terminated by sponsor|2
7749243|NCT00818441|26941767|P1|Overall Study|Study terminated by sponsor|11
7749244|NCT00818441|26941766|P2|Overall Study|Adverse Event|1
7749245|NCT00818441|26941767|P1|Overall Study|Adverse Event|0
7749246|NCT00818441|26941766|P2|Overall Study|Withdrawal by Subject|0
7749247|NCT00818441|26941767|P1|Overall Study|Withdrawal by Subject|2
7749248|NCT00818441|26941766|P2|Overall Study|Lost to Follow-up|1
7749249|NCT00818441|26941767|P1|Overall Study|Lost to Follow-up|2
7749250|NCT00818441|26941766|P2|Overall Study|Other|0
7749251|NCT00818441|26941767|P1|Overall Study|Other|5
7749252|NCT00818441|26941766|P2|Overall Study|Death|26
7749253|NCT00818441|26941767|P1|Overall Study|Death|69
7749254|NCT00818389|26941789|P2|Overall Study|Adverse Event|1
7749255|NCT00818389|26941790|P1|Overall Study|Adverse Event|0
7749256|NCT00818389|26941789|P2|Overall Study|Withdrawal by Subject|2
7749257|NCT00818389|26941790|P1|Overall Study|Withdrawal by Subject|2
7749258|NCT00818389|26941789|P2|Overall Study|ALS Disease Progression|0
7749259|NCT00818389|26941790|P1|Overall Study|ALS Disease Progression|1
7749260|NCT00818389|26941789|P2|Overall Study|Death|3
7749261|NCT00818389|26941790|P1|Overall Study|Death|1
7749262|NCT00818259|26941846|P9|Part V|Adverse Event|0
7749263|NCT00818259|26941847|P8|Part V|Adverse Event|1
7749264|NCT00818259|26941848|P7|Part V|Adverse Event|0
7749265|NCT00818259|26941849|P6|Part V|Adverse Event|0
7749266|NCT00818259|26941850|P5|Part V|Adverse Event|0
7749267|NCT00818259|26941851|P4|Part V|Adverse Event|0
7749268|NCT00818259|26941852|P3|Part V|Adverse Event|0
7749269|NCT00818259|26941853|P2|Part V|Adverse Event|0
7749270|NCT00818259|26941854|P1|Part V|Adverse Event|0
7749271|NCT00818259|26941846|P9|Part IV|Physician Decision|0
7749272|NCT00818259|26941847|P8|Part IV|Physician Decision|0
7749273|NCT00818259|26941848|P7|Part IV|Physician Decision|0
7749274|NCT00818259|26941849|P6|Part IV|Physician Decision|1
7749275|NCT00818259|26941850|P5|Part IV|Physician Decision|0
7749276|NCT00818259|26941851|P4|Part IV|Physician Decision|0
7749277|NCT00818259|26941852|P3|Part IV|Physician Decision|0
7749278|NCT00818259|26941853|P2|Part IV|Physician Decision|0
7749279|NCT00818259|26941854|P1|Part IV|Physician Decision|0
7749280|NCT00818259|26941846|P9|Part II|Not Treated|0
7749281|NCT00818259|26941847|P8|Part II|Not Treated|0
7749282|NCT00818259|26941848|P7|Part II|Not Treated|0
7749283|NCT00818259|26941849|P6|Part II|Not Treated|0
7749284|NCT00818259|26941850|P5|Part II|Not Treated|0
7749285|NCT00818259|26941851|P4|Part II|Not Treated|1
7749286|NCT00818259|26941852|P3|Part II|Not Treated|0
7749287|NCT00818259|26941853|P2|Part II|Not Treated|0
7749288|NCT00818259|26941854|P1|Part II|Not Treated|0
7749289|NCT00818259|26941846|P9|Part II|Lack of Efficacy|0
7749290|NCT00818259|26941847|P8|Part II|Lack of Efficacy|0
7749291|NCT00818259|26941848|P7|Part II|Lack of Efficacy|0
7749292|NCT00818259|26941849|P6|Part II|Lack of Efficacy|0
7749293|NCT00818259|26941850|P5|Part II|Lack of Efficacy|0
7749294|NCT00818259|26941851|P4|Part II|Lack of Efficacy|1
7749295|NCT00818259|26941852|P3|Part II|Lack of Efficacy|0
7749296|NCT00818259|26941853|P2|Part II|Lack of Efficacy|0
7749297|NCT00818259|26941854|P1|Part II|Lack of Efficacy|0
7749298|NCT00818259|26941846|P9|Part II|Physician Decision|0
7749299|NCT00818259|26941847|P8|Part II|Physician Decision|0
7749300|NCT00818259|26941848|P7|Part II|Physician Decision|0
7749301|NCT00818259|26941849|P6|Part II|Physician Decision|0
7749302|NCT00818259|26941850|P5|Part II|Physician Decision|0
7749303|NCT00818259|26941851|P4|Part II|Physician Decision|0
7749304|NCT00818259|26941852|P3|Part II|Physician Decision|1
7749305|NCT00818259|26941853|P2|Part II|Physician Decision|0
7749306|NCT00818259|26941854|P1|Part II|Physician Decision|0
7749307|NCT00818259|26941846|P9|Part I|Withdrawal by Subject|0
7749308|NCT00818259|26941847|P8|Part I|Withdrawal by Subject|0
7749309|NCT00818259|26941848|P7|Part I|Withdrawal by Subject|0
7749310|NCT00818259|26941849|P6|Part I|Withdrawal by Subject|0
7749311|NCT00818259|26941850|P5|Part I|Withdrawal by Subject|0
7749312|NCT00818259|26941851|P4|Part I|Withdrawal by Subject|0
7749313|NCT00818259|26941852|P3|Part I|Withdrawal by Subject|0
7749314|NCT00818259|26941853|P2|Part I|Withdrawal by Subject|0
7749315|NCT00818259|26941854|P1|Part I|Withdrawal by Subject|1
7749316|NCT00818246|26941926|P1|Overall Study|Impossible to match pictures|5
7749317|NCT00818207|26941935|P2|Overall Study|Death|5
7749318|NCT00818207|26941936|P1|Overall Study|Death|3
7749319|NCT00818207|26941935|P2|Overall Study|Withdrawal by Subject|104
7749320|NCT00818207|26941936|P1|Overall Study|Withdrawal by Subject|42
7749321|NCT00818207|26941935|P2|Overall Study|Multiple reasons|12
7749322|NCT00818207|26941936|P1|Overall Study|Multiple reasons|11
7749323|NCT00818207|26941935|P2|Overall Study|Lost to Follow-up|146
7749324|NCT00818207|26941936|P1|Overall Study|Lost to Follow-up|160
7749325|NCT00818207|26941935|P2|Overall Study|Adverse Event|0
7749326|NCT00818207|26941936|P1|Overall Study|Adverse Event|6
7749327|NCT00818168|26941950|P1|Overall Study|Participant Moved|2
7749328|NCT00818168|26941950|P1|Overall Study|Reason for Non-completion Not reported|6
7749329|NCT00818168|26941950|P1|Overall Study|Adverse Event|19
7749330|NCT00818168|26941950|P1|Overall Study|Lost to Follow-up|7
7749331|NCT00818168|26941950|P1|Overall Study|Withdrawal by Subject|16
7749332|NCT00818168|26941950|P1|Overall Study|Pregnancy|2
7749333|NCT00818168|26941950|P1|Overall Study|Lack of Efficacy|18
7749334|NCT00817778|26941990|P2|Overall Study|Poor venous access|0
7749335|NCT00817778|26941991|P1|Overall Study|Poor venous access|1
7749336|NCT00817778|26941990|P2|Overall Study|Study-specific discontinuation criteria|1
7749337|NCT00817778|26941991|P1|Overall Study|Study-specific discontinuation criteria|0
7749338|NCT00817778|26941990|P2|Overall Study|Protocol Violation|1
7749339|NCT00817778|26941991|P1|Overall Study|Protocol Violation|0
7749340|NCT00817778|26941990|P2|Overall Study|Withdrawal by Subject|1
7749341|NCT00817778|26941991|P1|Overall Study|Withdrawal by Subject|1
7749342|NCT00817778|26941990|P2|Overall Study|Adverse Event|0
7749343|NCT00817778|26941991|P1|Overall Study|Adverse Event|1
7749344|NCT00817635|26942021|P5|Overall Study|Protocol Violation|3
7749345|NCT00817635|26942022|P4|Overall Study|Protocol Violation|2
7749346|NCT00817635|26942023|P3|Overall Study|Protocol Violation|3
7749347|NCT00817635|26942024|P2|Overall Study|Protocol Violation|1
7749348|NCT00817635|26942025|P1|Overall Study|Protocol Violation|5
7749349|NCT00817635|26942021|P5|Overall Study|Administrative Problems|1
7749350|NCT00817635|26942022|P4|Overall Study|Administrative Problems|0
7749351|NCT00817635|26942023|P3|Overall Study|Administrative Problems|0
7749352|NCT00817635|26942024|P2|Overall Study|Administrative Problems|0
7749353|NCT00817635|26942025|P1|Overall Study|Administrative Problems|0
7749354|NCT00817635|26942021|P5|Overall Study|Lost to Follow-up|0
7749355|NCT00817635|26942022|P4|Overall Study|Lost to Follow-up|1
7749356|NCT00817635|26942023|P3|Overall Study|Lost to Follow-up|0
7749357|NCT00817635|26942024|P2|Overall Study|Lost to Follow-up|1
7749358|NCT00817635|26942025|P1|Overall Study|Lost to Follow-up|0
7749359|NCT00817635|26942021|P5|Overall Study|Withdrawal by Subject|2
7749360|NCT00817635|26942022|P4|Overall Study|Withdrawal by Subject|1
7749361|NCT00817635|26942023|P3|Overall Study|Withdrawal by Subject|0
7749362|NCT00817635|26942024|P2|Overall Study|Withdrawal by Subject|1
7749363|NCT00817635|26942025|P1|Overall Study|Withdrawal by Subject|2
7749364|NCT00817635|26942021|P5|Overall Study|Abnormal Laboratory Value(s)|1
7749365|NCT00817635|26942022|P4|Overall Study|Abnormal Laboratory Value(s)|0
7749366|NCT00817635|26942023|P3|Overall Study|Abnormal Laboratory Value(s)|0
7749367|NCT00817635|26942024|P2|Overall Study|Abnormal Laboratory Value(s)|1
7749368|NCT00817635|26942025|P1|Overall Study|Abnormal Laboratory Value(s)|1
7749369|NCT00817635|26942021|P5|Overall Study|Adverse Event|1
7749370|NCT00817635|26942022|P4|Overall Study|Adverse Event|1
7749371|NCT00817635|26942023|P3|Overall Study|Adverse Event|0
7749372|NCT00817635|26942024|P2|Overall Study|Adverse Event|0
7749373|NCT00817635|26942025|P1|Overall Study|Adverse Event|1
7749374|NCT00817531|26942102|P1|Overall Study|Lack of Efficacy|1
7749375|NCT00817531|26942102|P1|Overall Study|Adverse Event|1
7749376|NCT00817479|26942108|P2|Overall Study|Physician Decision|1
7749377|NCT00817479|26942109|P1|Overall Study|Physician Decision|1
7749378|NCT00817414|26942122|P5|Overall Study|Protocol Violation|1
7749379|NCT00817414|26942123|P4|Overall Study|Protocol Violation|0
7749380|NCT00817414|26942124|P3|Overall Study|Protocol Violation|0
7749381|NCT00817414|26942125|P2|Overall Study|Protocol Violation|0
7749382|NCT00817414|26942126|P1|Overall Study|Protocol Violation|0
7749383|NCT00817414|26942122|P5|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7749384|NCT00817414|26942123|P4|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
7749385|NCT00817414|26942124|P3|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7749386|NCT00817414|26942125|P2|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7749387|NCT00817414|26942126|P1|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7749388|NCT00817414|26942122|P5|Overall Study|Lost to Follow-up|1
7749389|NCT00817414|26942123|P4|Overall Study|Lost to Follow-up|1
7749390|NCT00817414|26942124|P3|Overall Study|Lost to Follow-up|1
7749391|NCT00817414|26942125|P2|Overall Study|Lost to Follow-up|0
7749392|NCT00817414|26942126|P1|Overall Study|Lost to Follow-up|0
7749393|NCT00817414|26942122|P5|Overall Study|Withdrawal by Subject|0
7749394|NCT00817414|26942123|P4|Overall Study|Withdrawal by Subject|0
7749395|NCT00817414|26942124|P3|Overall Study|Withdrawal by Subject|0
7749396|NCT00817414|26942125|P2|Overall Study|Withdrawal by Subject|1
7749397|NCT00817414|26942126|P1|Overall Study|Withdrawal by Subject|1
7749398|NCT00817414|26942122|P5|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
7749399|NCT00817414|26942123|P4|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
7749400|NCT00817414|26942124|P3|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
7749401|NCT00817414|26942125|P2|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
7749402|NCT00817414|26942126|P1|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
7749403|NCT00817414|26942122|P5|Overall Study|Adverse Event|0
7749404|NCT00817414|26942123|P4|Overall Study|Adverse Event|0
7749405|NCT00817414|26942124|P3|Overall Study|Adverse Event|1
7749406|NCT00817414|26942125|P2|Overall Study|Adverse Event|1
7749407|NCT00817414|26942126|P1|Overall Study|Adverse Event|1
7749408|NCT00817336|26942180|P2|Overall Study|Withdrawal by Subject|1
7749409|NCT00817336|26942181|P1|Overall Study|Withdrawal by Subject|1
7749410|NCT00817206|26942207|P2|Overall Study|Physician Decision|0
7749411|NCT00817206|26942208|P1|Overall Study|Physician Decision|2
7749412|NCT00817206|26942207|P2|Overall Study|Withdrawal by Subject|3
7749413|NCT00817206|26942208|P1|Overall Study|Withdrawal by Subject|7
7749414|NCT00817206|26942207|P2|Overall Study|Death|0
7749415|NCT00817206|26942208|P1|Overall Study|Death|2
7749416|NCT00817206|26942207|P2|Overall Study|Lost to Follow-up|1
7749417|NCT00817206|26942208|P1|Overall Study|Lost to Follow-up|0
7749418|NCT00817206|26942207|P2|Overall Study|Protocol Violation|2
7749419|NCT00817206|26942208|P1|Overall Study|Protocol Violation|0
7749420|NCT00817206|26942207|P2|Overall Study|Adverse Event|3
7749421|NCT00817206|26942208|P1|Overall Study|Adverse Event|10
7749422|NCT00817089|26942218|P4|Second Alcohol Challenge|Lost to Follow-up|0
7749423|NCT00817089|26942219|P3|Second Alcohol Challenge|Lost to Follow-up|0
7749424|NCT00817089|26942220|P2|Second Alcohol Challenge|Lost to Follow-up|1
7749425|NCT00817089|26942221|P1|Second Alcohol Challenge|Lost to Follow-up|0
7749426|NCT00817089|26942218|P4|First Alcohol Challenge|Lost to Follow-up|1
7749427|NCT00817089|26942219|P3|First Alcohol Challenge|Lost to Follow-up|0
7749428|NCT00817089|26942220|P2|First Alcohol Challenge|Lost to Follow-up|0
7749429|NCT00817089|26942221|P1|First Alcohol Challenge|Lost to Follow-up|0
7749430|NCT00817063|26942237|P2|Overall Study|Abnormality of Laboratory Test|1
7749431|NCT00817063|26942238|P1|Overall Study|Abnormality of Laboratory Test|2
7749432|NCT00817063|26942237|P2|Overall Study|Administrative|4
7749433|NCT00817063|26942238|P1|Overall Study|Administrative|10
7749434|NCT00817063|26942237|P2|Overall Study|Early Improvement|4
7749435|NCT00817063|26942238|P1|Overall Study|Early Improvement|19
7749436|NCT00817063|26942237|P2|Overall Study|Withdrawal by Subject|37
7749437|NCT00817063|26942238|P1|Overall Study|Withdrawal by Subject|17
7749438|NCT00817063|26942237|P2|Overall Study|Protocol Violation|8
7749439|NCT00817063|26942238|P1|Overall Study|Protocol Violation|3
7749440|NCT00817063|26942237|P2|Overall Study|Violation of Selection at Entry|4
7749441|NCT00817063|26942238|P1|Overall Study|Violation of Selection at Entry|7
7749442|NCT00817063|26942237|P2|Overall Study|Failure to Return|12
7749443|NCT00817063|26942238|P1|Overall Study|Failure to Return|13
7749444|NCT00817063|26942237|P2|Overall Study|Lack of Efficacy|86
7749445|NCT00817063|26942238|P1|Overall Study|Lack of Efficacy|33
7749446|NCT00817063|26942237|P2|Overall Study|Death|1
7749447|NCT00817063|26942238|P1|Overall Study|Death|1
7749448|NCT00817063|26942237|P2|Overall Study|Adverse Event|13
7749449|NCT00817063|26942238|P1|Overall Study|Adverse Event|32
7749450|NCT00816595|26942366|P2|Overall Study|Withdrawal by Subject|0
7749451|NCT00816595|26942367|P1|Overall Study|Withdrawal by Subject|2
7749452|NCT00816556|26942380|P3|Overall Study|Lost to Follow-up|1
7749453|NCT00816556|26942381|P2|Overall Study|Lost to Follow-up|0
7749454|NCT00816556|26942382|P1|Overall Study|Lost to Follow-up|0
7749455|NCT00816556|26942380|P3|Overall Study|Withdrawal by Subject|1
7749456|NCT00816556|26942381|P2|Overall Study|Withdrawal by Subject|1
7749457|NCT00816556|26942382|P1|Overall Study|Withdrawal by Subject|1
7749458|NCT00816556|26942380|P3|Overall Study|Adverse Event|1
7749459|NCT00816556|26942381|P2|Overall Study|Adverse Event|1
7749460|NCT00816556|26942382|P1|Overall Study|Adverse Event|1
7749461|NCT00816400|26942405|P9|Overall Study|In hospice care at the end of the study|0
7749462|NCT00816400|26942406|P8|Overall Study|In hospice care at the end of the study|0
7749463|NCT00816400|26942407|P7|Overall Study|In hospice care at the end of the study|0
7749464|NCT00816400|26942408|P6|Overall Study|In hospice care at the end of the study|0
7749465|NCT00816400|26942409|P5|Overall Study|In hospice care at the end of the study|0
7749466|NCT00816400|26942410|P4|Overall Study|In hospice care at the end of the study|0
7749467|NCT00816400|26942411|P3|Overall Study|In hospice care at the end of the study|2
7749468|NCT00816400|26942412|P2|Overall Study|In hospice care at the end of the study|0
7749469|NCT00816400|26942413|P1|Overall Study|In hospice care at the end of the study|0
7749470|NCT00816400|26942405|P9|Overall Study|Death|6
7749471|NCT00816400|26942406|P8|Overall Study|Death|5
7749472|NCT00816400|26942407|P7|Overall Study|Death|2
7749473|NCT00816400|26942408|P6|Overall Study|Death|3
7749474|NCT00816400|26942409|P5|Overall Study|Death|2
7749475|NCT00816400|26942410|P4|Overall Study|Death|3
7749476|NCT00816400|26942411|P3|Overall Study|Death|3
7749477|NCT00816400|26942412|P2|Overall Study|Death|3
7749478|NCT00816400|26942413|P1|Overall Study|Death|2
7749479|NCT00816361|26942604|P9|Overall Study|Other|1
7749480|NCT00816361|26942605|P8|Overall Study|Other|0
7749481|NCT00816361|26942606|P7|Overall Study|Other|0
7749482|NCT00816361|26942607|P6|Overall Study|Other|0
7749483|NCT00816361|26942608|P5|Overall Study|Other|0
7749484|NCT00816361|26942609|P4|Overall Study|Other|0
7749485|NCT00816361|26942610|P3|Overall Study|Other|0
7749486|NCT00816361|26942611|P2|Overall Study|Other|0
7749487|NCT00816361|26942612|P1|Overall Study|Other|0
7749488|NCT00816361|26942604|P9|Overall Study|Death|8
7749489|NCT00816361|26942605|P8|Overall Study|Death|7
7749490|NCT00816361|26942606|P7|Overall Study|Death|3
7749491|NCT00816361|26942607|P6|Overall Study|Death|1
7749492|NCT00816361|26942608|P5|Overall Study|Death|1
7749493|NCT00816361|26942609|P4|Overall Study|Death|3
7749494|NCT00816361|26942610|P3|Overall Study|Death|3
7749495|NCT00816361|26942611|P2|Overall Study|Death|3
7749496|NCT00816361|26942612|P1|Overall Study|Death|4
7749497|NCT00816361|26942604|P9|Overall Study|Withdrawal by Subject|1
7749498|NCT00816361|26942605|P8|Overall Study|Withdrawal by Subject|2
7749499|NCT00816361|26942606|P7|Overall Study|Withdrawal by Subject|0
7749500|NCT00816361|26942607|P6|Overall Study|Withdrawal by Subject|2
7749501|NCT00816361|26942608|P5|Overall Study|Withdrawal by Subject|1
7749502|NCT00816361|26942609|P4|Overall Study|Withdrawal by Subject|0
7749503|NCT00816361|26942610|P3|Overall Study|Withdrawal by Subject|0
7749504|NCT00816361|26942611|P2|Overall Study|Withdrawal by Subject|0
7749505|NCT00816361|26942612|P1|Overall Study|Withdrawal by Subject|0
7749506|NCT00816166|26942771|P2|Overall Study|Death|2
7749507|NCT00816166|26942772|P1|Overall Study|Death|4
7749508|NCT00816166|26942771|P2|Overall Study|Lost to Follow-up|10
7749509|NCT00816166|26942772|P1|Overall Study|Lost to Follow-up|6
7749510|NCT00816036|26942804|P2|Overall Study|Withdrawal by Subject|23
7749511|NCT00816036|26942805|P1|Overall Study|Withdrawal by Subject|54
7749512|NCT00816036|26942804|P2|Overall Study|Lost to Follow-up|57
7749513|NCT00816036|26942805|P1|Overall Study|Lost to Follow-up|75
7749514|NCT00816036|26942804|P2|Overall Study|Death|28
7749515|NCT00816036|26942805|P1|Overall Study|Death|47
7749516|NCT00816023|26942819|P4|Overall Study|Randomized Not Treated|11
7749517|NCT00816023|26942820|P3|Overall Study|Randomized Not Treated|6
7749518|NCT00816023|26942821|P2|Overall Study|Randomized Not Treated|4
7749519|NCT00816023|26942822|P1|Overall Study|Randomized Not Treated|6
7749520|NCT00816023|26942819|P4|Overall Study|assessments complete prior to window|1
7749521|NCT00816023|26942820|P3|Overall Study|assessments complete prior to window|2
7749522|NCT00816023|26942821|P2|Overall Study|assessments complete prior to window|1
7749523|NCT00816023|26942822|P1|Overall Study|assessments complete prior to window|1
7749524|NCT00816023|26942819|P4|Overall Study|Physician Decision|0
7749525|NCT00816023|26942820|P3|Overall Study|Physician Decision|1
7749526|NCT00816023|26942821|P2|Overall Study|Physician Decision|0
7749527|NCT00816023|26942822|P1|Overall Study|Physician Decision|0
7749528|NCT00816023|26942819|P4|Overall Study|Withdrawal by Subject|0
7749529|NCT00816023|26942820|P3|Overall Study|Withdrawal by Subject|0
7749530|NCT00816023|26942821|P2|Overall Study|Withdrawal by Subject|0
7749531|NCT00816023|26942822|P1|Overall Study|Withdrawal by Subject|1
7749532|NCT00816023|26942819|P4|Overall Study|Lost to Follow-up|0
7749533|NCT00816023|26942820|P3|Overall Study|Lost to Follow-up|0
7749534|NCT00816023|26942821|P2|Overall Study|Lost to Follow-up|1
7749535|NCT00816023|26942822|P1|Overall Study|Lost to Follow-up|1
7749536|NCT00815919|26942859|P1|Overall Study|Lack of Efficacy|2
7749537|NCT00815919|26942859|P1|Overall Study|AML Relapse|1
7749538|NCT00815919|26942859|P1|Overall Study|Unrelated Fungal Infection|1
7749539|NCT00815659|26942902|P1|Overall Study|Protocol Violation|1
7749540|NCT00815659|26942902|P1|Overall Study|Lost to Follow-up|4
7749541|NCT00815659|26942902|P1|Overall Study|Withdrawal by Subject|9
7749542|NCT00815659|26942902|P1|Overall Study|Adverse Event|9
7749543|NCT00815633|26942945|P1|Overall Study|study terminated|1
7749544|NCT00815516|26942952|P2|Overall Study|Physician Decision|0
7749545|NCT00815516|26942953|P1|Overall Study|Physician Decision|1
7749546|NCT00815516|26942952|P2|Overall Study|Death|1
7749547|NCT00815516|26942953|P1|Overall Study|Death|3
7749548|NCT00815308|26943018|P1|Overall Study|Protocol Violation|6
7749549|NCT00815308|26943018|P1|Overall Study|Withdrawal by Subject|0
7749550|NCT00815308|26943018|P1|Overall Study|Adverse Event|4
7749551|NCT00815295|26943027|P3|Overall Study|Cetuximab hypersensitivity reaction|3
7749552|NCT00815295|26943028|P2|Overall Study|Cetuximab hypersensitivity reaction|1
7749553|NCT00815295|26943029|P1|Overall Study|Cetuximab hypersensitivity reaction|0
7749554|NCT00815191|26943041|P2|Overall Study|Protocol Violation|1
7749555|NCT00815191|26943042|P1|Overall Study|Protocol Violation|1
7749556|NCT00814983|26943079|P2|Overall Study|Graft failure|0
7749557|NCT00814983|26943080|P1|Overall Study|Graft failure|1
7749558|NCT00814983|26943079|P2|Overall Study|Withdrawal by Subject|0
7749559|NCT00814983|26943080|P1|Overall Study|Withdrawal by Subject|1
7749560|NCT00814983|26943079|P2|Overall Study|Screen failure|0
7749561|NCT00814983|26943080|P1|Overall Study|Screen failure|1
7749562|NCT00814892|26943111|P1|Overall Study|Study Termination|1
7749563|NCT00814892|26943111|P1|Overall Study|Disease Progression|1
7749564|NCT00814879|26943123|P2|By Week 48|Death|1
7749565|NCT00814879|26943124|P1|By Week 48|Death|0
7749566|NCT00814879|26943123|P2|By Week 48|Lost to Follow-up|2
7749567|NCT00814879|26943124|P1|By Week 48|Lost to Follow-up|2
7749568|NCT00814879|26943123|P2|By Week 24|Incarceration|1
7749569|NCT00814879|26943124|P1|By Week 24|Incarceration|0
7749570|NCT00814879|26943123|P2|By Week 24|Cancer Diagnosis|0
7749571|NCT00814879|26943124|P1|By Week 24|Cancer Diagnosis|1
7749572|NCT00814801|26943143|P3|Overall Study|Other|4
7749573|NCT00814801|26943144|P2|Overall Study|Other|6
7749574|NCT00814801|26943145|P1|Overall Study|Other|2
7749575|NCT00814801|26943143|P3|Overall Study|Non-compliance|1
7749576|NCT00814801|26943144|P2|Overall Study|Non-compliance|1
7749577|NCT00814801|26943145|P1|Overall Study|Non-compliance|0
7749578|NCT00814801|26943143|P3|Overall Study|Missing or change of caregiver|4
7749579|NCT00814801|26943144|P2|Overall Study|Missing or change of caregiver|2
7749580|NCT00814801|26943145|P1|Overall Study|Missing or change of caregiver|6
7749581|NCT00814801|26943143|P3|Overall Study|Change of patients for CIBIC plus-J|0
7749582|NCT00814801|26943144|P2|Overall Study|Change of patients for CIBIC plus-J|1
7749583|NCT00814801|26943145|P1|Overall Study|Change of patients for CIBIC plus-J|1
7749584|NCT00814801|26943143|P3|Overall Study|Inappropriate as a subject|1
7749585|NCT00814801|26943144|P2|Overall Study|Inappropriate as a subject|1
7749586|NCT00814801|26943145|P1|Overall Study|Inappropriate as a subject|1
7749587|NCT00814801|26943143|P3|Overall Study|Withdrawal by Subject|14
7749588|NCT00814801|26943144|P2|Overall Study|Withdrawal by Subject|11
7749589|NCT00814801|26943145|P1|Overall Study|Withdrawal by Subject|9
7749590|NCT00814801|26943143|P3|Overall Study|Adverse Event|19
7749591|NCT00814801|26943144|P2|Overall Study|Adverse Event|16
7749592|NCT00814801|26943145|P1|Overall Study|Adverse Event|15
7749593|NCT00814710|26943184|P2|Overall Study|Lost to Follow-up|3
7749594|NCT00814710|26943185|P1|Overall Study|Lost to Follow-up|7
7749595|NCT00814710|26943184|P2|Overall Study|Adverse Event|0
7749596|NCT00814710|26943185|P1|Overall Study|Adverse Event|1
7749597|NCT00814658|26943253|P2|Overall Study|Adverse Event|3
7749598|NCT00814658|26943254|P1|Overall Study|Adverse Event|3
7749599|NCT00814658|26943253|P2|Overall Study|Physician Decision|0
7749600|NCT00814658|26943254|P1|Overall Study|Physician Decision|1
7749601|NCT00814658|26943253|P2|Overall Study|Lost to Follow-up|1
7749602|NCT00814658|26943254|P1|Overall Study|Lost to Follow-up|0
7749603|NCT00814632|26943320|P1|Overall Study|Lack of Efficacy|2
7749604|NCT00814580|26943326|P2|Overall Study|Did Not Take Drug|2
7749605|NCT00814580|26943327|P1|Overall Study|Did Not Take Drug|2
7749606|NCT00814580|26943326|P2|Overall Study|Other|3
7749607|NCT00814580|26943327|P1|Overall Study|Other|1
7749608|NCT00814580|26943326|P2|Overall Study|Withdrawal by Subject|2
7749609|NCT00814580|26943327|P1|Overall Study|Withdrawal by Subject|2
7749610|NCT00814580|26943326|P2|Overall Study|Protocol Violation|0
7749611|NCT00814580|26943327|P1|Overall Study|Protocol Violation|2
7749612|NCT00814580|26943326|P2|Overall Study|Lack of Efficacy|25
7749613|NCT00814580|26943327|P1|Overall Study|Lack of Efficacy|18
7749614|NCT00814580|26943326|P2|Overall Study|Adverse Event|15
7749615|NCT00814580|26943327|P1|Overall Study|Adverse Event|6
7749616|NCT00814502|26943457|P2|Overall Study|Withdrawal by Subject|2
7749617|NCT00814502|26943458|P1|Overall Study|Withdrawal by Subject|0
7749618|NCT00814502|26943457|P2|Overall Study|Adverse Event|0
7749619|NCT00814502|26943458|P1|Overall Study|Adverse Event|1
7749620|NCT00814489|26943471|P3|Overall Study|Other|1
7749621|NCT00814489|26943472|P2|Overall Study|Other|0
7749622|NCT00814489|26943473|P1|Overall Study|Other|2
7749623|NCT00814463|26943505|P1|Overall Study|Lost to Follow-up|1
7749624|NCT00814346|26943518|P2|Open Phase (17 Months)|Not otherwise specified|0
7749625|NCT00814346|26943519|P1|Open Phase (17 Months)|Not otherwise specified|1
7749626|NCT00814346|26943518|P2|Open Phase (17 Months)|Lost to Follow-up|0
7749627|NCT00814346|26943519|P1|Open Phase (17 Months)|Lost to Follow-up|2
7749628|NCT00814346|26943518|P2|Open Phase (17 Months)|Consent|0
7749629|NCT00814346|26943519|P1|Open Phase (17 Months)|Consent|2
7749630|NCT00814346|26943518|P2|Open Phase (17 Months)|Adverse Event|0
7749631|NCT00814346|26943519|P1|Open Phase (17 Months)|Adverse Event|5
7749632|NCT00814346|26943518|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
7749633|NCT00814346|26943519|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
7749634|NCT00814346|26943518|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
7749635|NCT00814346|26943519|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
7749636|NCT00814333|26943585|P2|Enrollment|Lost to Follow-up|0
7749637|NCT00814333|26943586|P1|Enrollment|Lost to Follow-up|1
7749638|NCT00814320|26943594|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
7749639|NCT00814320|26943595|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
7749640|NCT00814320|26943594|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
7749641|NCT00814320|26943595|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
7749642|NCT00814320|26943594|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
7749643|NCT00814320|26943595|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
7749644|NCT00814320|26943594|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
7749645|NCT00814320|26943595|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
7749646|NCT00814320|26943594|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
7749647|NCT00814320|26943595|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
7749648|NCT00814320|26943594|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
7749649|NCT00814320|26943595|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
7749650|NCT00814320|26943594|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
7749651|NCT00814320|26943595|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
7749652|NCT00814320|26943594|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
7749653|NCT00814320|26943595|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
7749654|NCT00814320|26943594|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
7749655|NCT00814320|26943595|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
7749656|NCT00814320|26943594|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
7749657|NCT00814320|26943595|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
7749658|NCT00814307|26943727|P4|Overall Study|Death|0
7749659|NCT00814307|26943728|P3|Overall Study|Death|0
7749660|NCT00814307|26943729|P2|Overall Study|Death|1
7749661|NCT00814307|26943730|P1|Overall Study|Death|0
7749662|NCT00814307|26943727|P4|Overall Study|Withdrawal by Subject|2
7749663|NCT00814307|26943728|P3|Overall Study|Withdrawal by Subject|0
7749664|NCT00814307|26943729|P2|Overall Study|Withdrawal by Subject|6
7749665|NCT00814307|26943730|P1|Overall Study|Withdrawal by Subject|4
7749666|NCT00814307|26943727|P4|Overall Study|Protocol Violation|1
7749667|NCT00814307|26943728|P3|Overall Study|Protocol Violation|1
7749668|NCT00814307|26943729|P2|Overall Study|Protocol Violation|8
7749669|NCT00814307|26943730|P1|Overall Study|Protocol Violation|2
7749670|NCT00814307|26943727|P4|Overall Study|Other|1
7749671|NCT00814307|26943728|P3|Overall Study|Other|0
7749672|NCT00814307|26943729|P2|Overall Study|Other|2
7749673|NCT00814307|26943730|P1|Overall Study|Other|1
7749674|NCT00814307|26943727|P4|Overall Study|Lack of Efficacy|4
7749675|NCT00814307|26943728|P3|Overall Study|Lack of Efficacy|3
7749676|NCT00814307|26943729|P2|Overall Study|Lack of Efficacy|1
7749677|NCT00814307|26943730|P1|Overall Study|Lack of Efficacy|1
7749678|NCT00814307|26943727|P4|Overall Study|Adverse Event|2
7749679|NCT00814307|26943728|P3|Overall Study|Adverse Event|3
7749680|NCT00814307|26943729|P2|Overall Study|Adverse Event|9
7749681|NCT00814307|26943730|P1|Overall Study|Adverse Event|3
7749682|NCT00814307|26943727|P4|Overall Study|Randomized but not treated|0
7749683|NCT00814307|26943728|P3|Overall Study|Randomized but not treated|0
7749684|NCT00814307|26943729|P2|Overall Study|Randomized but not treated|0
7749685|NCT00814307|26943730|P1|Overall Study|Randomized but not treated|1
7749686|NCT00814164|26943926|P1|Overall Study|Death|5
7749687|NCT00814164|26943926|P1|Overall Study|not stated|7
7749688|NCT00814164|26943926|P1|Overall Study|Progression|7
7749689|NCT00813995|26943960|P2|Overall Study|Withdrawal by Subject|5
7749690|NCT00813995|26943961|P1|Overall Study|Withdrawal by Subject|0
7749691|NCT00813995|26943960|P2|Overall Study|Subject moved|0
7749692|NCT00813995|26943961|P1|Overall Study|Subject moved|4
7749693|NCT00813995|26943960|P2|Overall Study|Protocol Violation|2
7749694|NCT00813995|26943961|P1|Overall Study|Protocol Violation|3
7749695|NCT00813995|26943960|P2|Overall Study|Other reason|2
7749696|NCT00813995|26943961|P1|Overall Study|Other reason|2
7749697|NCT00813995|26943960|P2|Overall Study|Lost to Follow-up|2
7749698|NCT00813995|26943961|P1|Overall Study|Lost to Follow-up|4
7749699|NCT00813995|26943960|P2|Overall Study|Lack of Efficacy|0
7749700|NCT00813995|26943961|P1|Overall Study|Lack of Efficacy|1
7749701|NCT00813995|26943960|P2|Overall Study|Laboratory adverse event|2
7749702|NCT00813995|26943961|P1|Overall Study|Laboratory adverse event|0
7749703|NCT00813995|26943960|P2|Overall Study|Clinical adverse event|3
7749704|NCT00813995|26943961|P1|Overall Study|Clinical adverse event|9
7749705|NCT00813943|26943984|P3|Overall Study|Ongoing at cut-off date|3
7749706|NCT00813943|26943985|P2|Overall Study|Ongoing at cut-off date|5
7749707|NCT00813943|26943986|P1|Overall Study|Ongoing at cut-off date|5
7749708|NCT00813917|26944016|P2|Overall Study|Lost to Follow-up|1
7749709|NCT00813917|26944017|P1|Overall Study|Lost to Follow-up|3
7749710|NCT00813917|26944016|P2|Overall Study|Withdrawal by Subject|4
7749711|NCT00813917|26944017|P1|Overall Study|Withdrawal by Subject|3
7749712|NCT00813917|26944016|P2|Overall Study|Adverse Event|1
7749713|NCT00813917|26944017|P1|Overall Study|Adverse Event|0
7749714|NCT00813904|26944023|P1|Overall Study|Death|1
7749715|NCT00813865|26944029|P1|Overall Study|Withdrawal by Subject|1
7749716|NCT00813865|26944029|P1|Overall Study|Lost to Follow-up|3
7749717|NCT00813865|26944029|P1|Overall Study|Failure to Respond|3
7749718|NCT00813813|26944037|P2|Overall Study|Other|1
7749719|NCT00813813|26944038|P1|Overall Study|Other|0
7749720|NCT00813813|26944037|P2|Overall Study|Lost to Follow-up|7
7749721|NCT00813813|26944038|P1|Overall Study|Lost to Follow-up|2
7749722|NCT00813813|26944037|P2|Overall Study|Withdrawal by Subject|1
7749723|NCT00813813|26944038|P1|Overall Study|Withdrawal by Subject|1
7749724|NCT00813800|26944054|P1|Overall Study|Physician Decision|1
7749725|NCT00813800|26944054|P1|Overall Study|Worsening of depression|2
7749726|NCT00813800|26944054|P1|Overall Study|Adverse Event|1
7749727|NCT00813800|26944054|P1|Overall Study|Screen Failure after Consent|2
7749728|NCT00813761|26944062|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
7749729|NCT00813761|26944063|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
7749730|NCT00813761|26944064|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
7749731|NCT00813761|26944065|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
7749732|NCT00813761|26944062|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
7749733|NCT00813761|26944063|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
7749734|NCT00813761|26944064|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
7749735|NCT00813761|26944065|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
7749736|NCT00813761|26944062|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
7749737|NCT00813761|26944063|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7749738|NCT00813761|26944064|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7749739|NCT00813761|26944065|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7749740|NCT00813761|26944062|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
7749741|NCT00813761|26944063|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
7749742|NCT00813761|26944064|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
7749743|NCT00813761|26944065|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
7749744|NCT00813761|26944062|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
7749745|NCT00813761|26944063|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
7749746|NCT00813761|26944064|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
7749747|NCT00813761|26944065|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
7749748|NCT00813761|26944062|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
7749749|NCT00813761|26944063|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
7749750|NCT00813761|26944064|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
7749751|NCT00813761|26944065|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
7749752|NCT00813761|26944062|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7749753|NCT00813761|26944063|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7749754|NCT00813761|26944064|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
7749755|NCT00813761|26944065|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7749756|NCT00813761|26944062|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7749757|NCT00813761|26944063|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
7749758|NCT00813761|26944064|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7749759|NCT00813761|26944065|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7749760|NCT00813761|26944062|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7749761|NCT00813761|26944063|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
7749762|NCT00813761|26944064|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7749763|NCT00813761|26944065|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7749764|NCT00813761|26944062|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
7749765|NCT00813761|26944063|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7749766|NCT00813761|26944064|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7749767|NCT00813761|26944065|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7749768|NCT00813761|26944062|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
7749769|NCT00813761|26944063|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
7749770|NCT00813761|26944064|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
7749771|NCT00813761|26944065|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
7749772|NCT00813761|26944062|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7749773|NCT00813761|26944063|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7749774|NCT00813761|26944064|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7749775|NCT00813761|26944065|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
7749776|NCT00813748|26944115|P2|Skin Test Substudy|Physician Decision|1
7749777|NCT00813748|26944116|P1|Skin Test Substudy|Physician Decision|0
7749778|NCT00813709|26944145|P6|Open Label Period|Other|6
7749779|NCT00813709|26944146|P5|Open Label Period|Other|5
7749780|NCT00813709|26944147|P4|Open Label Period|Other|11
7749781|NCT00813709|26944148|P3|Open Label Period|Other|0
7749782|NCT00813709|26944149|P2|Open Label Period|Other|0
7749783|NCT00813709|26944150|P1|Open Label Period|Other|0
7749784|NCT00813709|26944145|P6|Open Label Period|Randomized but not treated|1
7749785|NCT00813709|26944146|P5|Open Label Period|Randomized but not treated|0
7749786|NCT00813709|26944147|P4|Open Label Period|Randomized but not treated|1
7749787|NCT00813709|26944148|P3|Open Label Period|Randomized but not treated|0
7749788|NCT00813709|26944149|P2|Open Label Period|Randomized but not treated|0
7749789|NCT00813709|26944150|P1|Open Label Period|Randomized but not treated|0
7749790|NCT00813709|26944145|P6|Open Label Period|Lack of Efficacy|1
7749791|NCT00813709|26944146|P5|Open Label Period|Lack of Efficacy|1
7749792|NCT00813709|26944147|P4|Open Label Period|Lack of Efficacy|3
7749793|NCT00813709|26944148|P3|Open Label Period|Lack of Efficacy|0
7749794|NCT00813709|26944149|P2|Open Label Period|Lack of Efficacy|0
7749795|NCT00813709|26944150|P1|Open Label Period|Lack of Efficacy|0
7749796|NCT00813709|26944145|P6|Open Label Period|Adverse Event|3
7749797|NCT00813709|26944146|P5|Open Label Period|Adverse Event|4
7749798|NCT00813709|26944147|P4|Open Label Period|Adverse Event|5
7749799|NCT00813709|26944148|P3|Open Label Period|Adverse Event|0
7749800|NCT00813709|26944149|P2|Open Label Period|Adverse Event|0
7749801|NCT00813709|26944150|P1|Open Label Period|Adverse Event|0
7749802|NCT00813709|26944145|P6|Double Blind Period|Other|0
7749803|NCT00813709|26944146|P5|Double Blind Period|Other|0
7749804|NCT00813709|26944147|P4|Double Blind Period|Other|0
7749805|NCT00813709|26944148|P3|Double Blind Period|Other|6
7749806|NCT00813709|26944149|P2|Double Blind Period|Other|9
7749807|NCT00813709|26944150|P1|Double Blind Period|Other|14
7749808|NCT00813709|26944145|P6|Double Blind Period|Randomized but not treated|0
7749809|NCT00813709|26944146|P5|Double Blind Period|Randomized but not treated|0
7749810|NCT00813709|26944147|P4|Double Blind Period|Randomized but not treated|0
7749811|NCT00813709|26944148|P3|Double Blind Period|Randomized but not treated|1
7749812|NCT00813709|26944149|P2|Double Blind Period|Randomized but not treated|3
7749813|NCT00813709|26944150|P1|Double Blind Period|Randomized but not treated|1
7749814|NCT00813709|26944145|P6|Double Blind Period|Switched to open label phase|0
7749815|NCT00813709|26944146|P5|Double Blind Period|Switched to open label phase|0
7749816|NCT00813709|26944147|P4|Double Blind Period|Switched to open label phase|0
7749817|NCT00813709|26944148|P3|Double Blind Period|Switched to open label phase|18
7749818|NCT00813709|26944149|P2|Double Blind Period|Switched to open label phase|26
7749819|NCT00813709|26944150|P1|Double Blind Period|Switched to open label phase|9
7749820|NCT00813709|26944145|P6|Double Blind Period|Lost to Follow-up|0
7749821|NCT00813709|26944146|P5|Double Blind Period|Lost to Follow-up|0
7749822|NCT00813709|26944147|P4|Double Blind Period|Lost to Follow-up|0
7749823|NCT00813709|26944148|P3|Double Blind Period|Lost to Follow-up|2
7749824|NCT00813709|26944149|P2|Double Blind Period|Lost to Follow-up|2
7749825|NCT00813709|26944150|P1|Double Blind Period|Lost to Follow-up|3
7749826|NCT00813709|26944145|P6|Double Blind Period|Adverse Event|0
7749827|NCT00813709|26944146|P5|Double Blind Period|Adverse Event|0
7749828|NCT00813709|26944147|P4|Double Blind Period|Adverse Event|0
7749829|NCT00813709|26944148|P3|Double Blind Period|Adverse Event|4
7749830|NCT00813709|26944149|P2|Double Blind Period|Adverse Event|1
7749831|NCT00813709|26944150|P1|Double Blind Period|Adverse Event|4
7749832|NCT00813592|26944230|P1|Overall Study|Disease assessment was not completed per|2
7749833|NCT00813488|26944239|P2|Open-label Extension|Other|0
7749834|NCT00813488|26944240|P1|Open-label Extension|Other|1
7749835|NCT00813488|26944239|P2|Open-label Extension|Non-compliance study procedures|1
7749836|NCT00813488|26944240|P1|Open-label Extension|Non-compliance study procedures|2
7749837|NCT00813488|26944239|P2|Open-label Extension|Non-compliance study medication|0
7749838|NCT00813488|26944240|P1|Open-label Extension|Non-compliance study medication|4
7749839|NCT00813488|26944239|P2|Open-label Extension|Protocol Violation|2
7749840|NCT00813488|26944240|P1|Open-label Extension|Protocol Violation|1
7749841|NCT00813488|26944239|P2|Open-label Extension|Withdrawal by Subject|2
7749842|NCT00813488|26944240|P1|Open-label Extension|Withdrawal by Subject|0
7749843|NCT00813488|26944239|P2|Open-label Extension|Lack of Efficacy|0
7749844|NCT00813488|26944240|P1|Open-label Extension|Lack of Efficacy|3
7749845|NCT00813488|26944239|P2|Open-label Extension|Adverse Event|2
7749846|NCT00813488|26944240|P1|Open-label Extension|Adverse Event|1
7749847|NCT00813488|26944239|P2|Double-blind Treatment Period 2|Other|0
7749848|NCT00813488|26944240|P1|Double-blind Treatment Period 2|Other|1
7749849|NCT00813488|26944239|P2|Double-blind Treatment Period 2|Protocol Violation|0
7749850|NCT00813488|26944240|P1|Double-blind Treatment Period 2|Protocol Violation|2
7749851|NCT00813488|26944239|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
7749852|NCT00813488|26944240|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
7749853|NCT00813488|26944239|P2|Double-blind Treatment Period 2|Adverse Event|0
7749854|NCT00813488|26944240|P1|Double-blind Treatment Period 2|Adverse Event|1
7749855|NCT00813488|26944239|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
7749856|NCT00813488|26944240|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
7749857|NCT00813488|26944239|P2|Double-blind Treatment Period 1|Protocol Violation|2
7749858|NCT00813488|26944240|P1|Double-blind Treatment Period 1|Protocol Violation|0
7749859|NCT00813488|26944239|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
7749860|NCT00813488|26944240|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
7749861|NCT00813488|26944239|P2|Double-blind Treatment Period 1|Adverse Event|1
7749862|NCT00813488|26944240|P1|Double-blind Treatment Period 1|Adverse Event|1
7749863|NCT00813488|26944239|P2|Titration Period 2|Non-compliance with study procedures|1
7749864|NCT00813488|26944240|P1|Titration Period 2|Non-compliance with study procedures|2
7749865|NCT00813488|26944239|P2|Titration Period 2|Lost to Follow-up|0
7749866|NCT00813488|26944240|P1|Titration Period 2|Lost to Follow-up|1
7749867|NCT00813488|26944239|P2|Titration Period 2|Protocol Violation|2
7749868|NCT00813488|26944240|P1|Titration Period 2|Protocol Violation|3
7749869|NCT00813488|26944239|P2|Titration Period 2|Lack of Efficacy|4
7749870|NCT00813488|26944240|P1|Titration Period 2|Lack of Efficacy|8
7749871|NCT00813488|26944239|P2|Titration Period 2|Adverse Event|3
7749872|NCT00813488|26944240|P1|Titration Period 2|Adverse Event|2
7749873|NCT00813488|26944239|P2|Titration Period 1|Technical Difficulties|1
7749874|NCT00813488|26944240|P1|Titration Period 1|Technical Difficulties|0
7749875|NCT00813488|26944239|P2|Titration Period 1|Non-compliance to study procedures|2
7749876|NCT00813488|26944240|P1|Titration Period 1|Non-compliance to study procedures|2
7749877|NCT00813488|26944239|P2|Titration Period 1|Non-compliance to study medication|1
7749878|NCT00813488|26944240|P1|Titration Period 1|Non-compliance to study medication|4
7749879|NCT00813488|26944239|P2|Titration Period 1|Protocol Violation|3
7749880|NCT00813488|26944240|P1|Titration Period 1|Protocol Violation|4
7749881|NCT00813488|26944239|P2|Titration Period 1|Withdrawal by Subject|2
7749882|NCT00813488|26944240|P1|Titration Period 1|Withdrawal by Subject|2
7749883|NCT00813488|26944239|P2|Titration Period 1|Lack of Efficacy|7
7749884|NCT00813488|26944240|P1|Titration Period 1|Lack of Efficacy|9
7749885|NCT00813488|26944239|P2|Titration Period 1|Adverse Event|1
7749886|NCT00813488|26944240|P1|Titration Period 1|Adverse Event|6
7749887|NCT00813358|26944336|P1|Overall Study|Withdrawal by Subject|20
7749888|NCT00813358|26944336|P1|Overall Study|other endpoints|5
7749889|NCT00813358|26944336|P1|Overall Study|Lost to Follow-up|12
7749890|NCT00813358|26944336|P1|Overall Study|Death|32
7749891|NCT00813293|26944355|P2|Overall Study|Adverse Event|1
7749892|NCT00813293|26944356|P1|Overall Study|Adverse Event|0
7749893|NCT00813293|26944355|P2|Overall Study|Intercurrent illness|0
7749894|NCT00813293|26944356|P1|Overall Study|Intercurrent illness|1
7749895|NCT00813150|26944395|P2|Long Term Follow-up|Progression/Relapse|24
7749896|NCT00813150|26944396|P1|Long Term Follow-up|Progression/Relapse|22
7749897|NCT00813150|26944395|P2|Long Term Follow-up|Lost to Follow-up|0
7749898|NCT00813150|26944396|P1|Long Term Follow-up|Lost to Follow-up|2
7749899|NCT00813150|26944395|P2|Long Term Follow-up|Other|3
7749900|NCT00813150|26944396|P1|Long Term Follow-up|Other|0
7749901|NCT00813150|26944395|P2|Long Term Follow-up|Death|4
7749902|NCT00813150|26944396|P1|Long Term Follow-up|Death|0
7749903|NCT00813150|26944395|P2|Treatment Period|Data not available|2
7749904|NCT00813150|26944396|P1|Treatment Period|Data not available|1
7749905|NCT00813150|26944395|P2|Treatment Period|Reason not specified|4
7749906|NCT00813150|26944396|P1|Treatment Period|Reason not specified|3
7749907|NCT00813150|26944395|P2|Treatment Period|Non compliance|1
7749908|NCT00813150|26944396|P1|Treatment Period|Non compliance|0
7749909|NCT00813150|26944395|P2|Treatment Period|Withdrawal by Subject|3
7749910|NCT00813150|26944396|P1|Treatment Period|Withdrawal by Subject|5
7749911|NCT00813150|26944395|P2|Treatment Period|Protocol Violation|4
7749912|NCT00813150|26944396|P1|Treatment Period|Protocol Violation|3
7749913|NCT00813150|26944395|P2|Treatment Period|Stable disease|2
7749914|NCT00813150|26944396|P1|Treatment Period|Stable disease|1
7749915|NCT00813150|26944395|P2|Treatment Period|Complete response|1
7749916|NCT00813150|26944396|P1|Treatment Period|Complete response|0
7749917|NCT00813150|26944395|P2|Treatment Period|Progressive disease|0
7749918|NCT00813150|26944396|P1|Treatment Period|Progressive disease|1
7749919|NCT00813150|26944395|P2|Treatment Period|Death|0
7749920|NCT00813150|26944396|P1|Treatment Period|Death|2
7749921|NCT00813150|26944395|P2|Treatment Period|Adverse Event|15
7749922|NCT00813150|26944396|P1|Treatment Period|Adverse Event|16
7749923|NCT00813124|26944408|P1|Overall Study|Withdrawal by Subject|1
7749924|NCT00813124|26944408|P1|Overall Study|Ineligible - Participants did not received Azacytidine|9
7749925|NCT00813124|26944408|P1|Overall Study|Death|2
7749926|NCT00813098|26944424|P3|Overall Study|Withdrew Consent|0
7749927|NCT00813098|26944425|P2|Overall Study|Withdrew Consent|1
7749928|NCT00813098|26944426|P1|Overall Study|Withdrew Consent|0
7749929|NCT00813098|26944424|P3|Overall Study|Principal Investigator decision|0
7749930|NCT00813098|26944425|P2|Overall Study|Principal Investigator decision|1
7749931|NCT00813098|26944426|P1|Overall Study|Principal Investigator decision|0
7749932|NCT00813098|26944424|P3|Overall Study|Protocol Violation|1
7749933|NCT00813098|26944425|P2|Overall Study|Protocol Violation|0
7749934|NCT00813098|26944426|P1|Overall Study|Protocol Violation|0
7749935|NCT00813098|26944424|P3|Overall Study|Lost to Follow-up|0
7749936|NCT00813098|26944425|P2|Overall Study|Lost to Follow-up|1
7749937|NCT00813098|26944426|P1|Overall Study|Lost to Follow-up|0
7749938|NCT00813098|26944424|P3|Overall Study|Inability to complete study procedures|0
7749939|NCT00813098|26944425|P2|Overall Study|Inability to complete study procedures|0
7749940|NCT00813098|26944426|P1|Overall Study|Inability to complete study procedures|1
7749941|NCT00813098|26944424|P3|Overall Study|Withdrawal by Subject|0
7749942|NCT00813098|26944425|P2|Overall Study|Withdrawal by Subject|1
7749943|NCT00813098|26944426|P1|Overall Study|Withdrawal by Subject|0
7749944|NCT00813098|26944424|P3|Overall Study|Adverse Event|1
7749945|NCT00813098|26944425|P2|Overall Study|Adverse Event|4
7749946|NCT00813098|26944426|P1|Overall Study|Adverse Event|2
7749947|NCT00812981|26944451|P2|Overall Study|Other|1
7749948|NCT00812981|26944452|P1|Overall Study|Other|0
7749949|NCT00812968|26944490|P1|Overall Study|Study closed due to marketing approval|3
7749950|NCT00812968|26944490|P1|Overall Study|No further treatment required|1
7749951|NCT00812968|26944490|P1|Overall Study|Disease progression|1
7749952|NCT00812968|26944490|P1|Overall Study|Relapse after erythroid response|6
7749953|NCT00812955|26944525|P4|Overall Study|randomized in error|0
7749954|NCT00812955|26944526|P3|Overall Study|randomized in error|1
7749955|NCT00812955|26944527|P2|Overall Study|randomized in error|0
7749956|NCT00812955|26944528|P1|Overall Study|randomized in error|0
7749957|NCT00812955|26944525|P4|Overall Study|Withdrawal by Subject|2
7749958|NCT00812955|26944526|P3|Overall Study|Withdrawal by Subject|1
7749959|NCT00812955|26944527|P2|Overall Study|Withdrawal by Subject|0
7749960|NCT00812955|26944528|P1|Overall Study|Withdrawal by Subject|1
7749961|NCT00812955|26944525|P4|Overall Study|Lost to Follow-up|2
7749962|NCT00812955|26944526|P3|Overall Study|Lost to Follow-up|1
7749963|NCT00812955|26944527|P2|Overall Study|Lost to Follow-up|1
7749964|NCT00812955|26944528|P1|Overall Study|Lost to Follow-up|2
7749965|NCT00812955|26944525|P4|Overall Study|Adverse Event|4
7749966|NCT00812955|26944526|P3|Overall Study|Adverse Event|3
7749967|NCT00812955|26944527|P2|Overall Study|Adverse Event|6
7749968|NCT00812955|26944528|P1|Overall Study|Adverse Event|7
7749969|NCT00812929|26944548|P10|Washout Period 3 (7 Days)|Adverse Event|0
7749970|NCT00812929|26944549|P9|Washout Period 3 (7 Days)|Adverse Event|0
7749971|NCT00812929|26944550|P8|Washout Period 3 (7 Days)|Adverse Event|0
7749972|NCT00812929|26944551|P7|Washout Period 3 (7 Days)|Adverse Event|0
7749973|NCT00812929|26944552|P6|Washout Period 3 (7 Days)|Adverse Event|1
7749974|NCT00812929|26944553|P5|Washout Period 3 (7 Days)|Adverse Event|0
7749975|NCT00812929|26944554|P4|Washout Period 3 (7 Days)|Adverse Event|0
7749976|NCT00812929|26944555|P3|Washout Period 3 (7 Days)|Adverse Event|0
7749977|NCT00812929|26944556|P2|Washout Period 3 (7 Days)|Adverse Event|0
7749978|NCT00812929|26944557|P1|Washout Period 3 (7 Days)|Adverse Event|0
7749979|NCT00812929|26944548|P10|Washout Period 2 (7 Days)|Physician Decision|1
7749980|NCT00812929|26944549|P9|Washout Period 2 (7 Days)|Physician Decision|0
7749981|NCT00812929|26944550|P8|Washout Period 2 (7 Days)|Physician Decision|0
7749982|NCT00812929|26944551|P7|Washout Period 2 (7 Days)|Physician Decision|0
7749983|NCT00812929|26944552|P6|Washout Period 2 (7 Days)|Physician Decision|0
7749984|NCT00812929|26944553|P5|Washout Period 2 (7 Days)|Physician Decision|0
7749985|NCT00812929|26944554|P4|Washout Period 2 (7 Days)|Physician Decision|0
7749986|NCT00812929|26944555|P3|Washout Period 2 (7 Days)|Physician Decision|0
7749987|NCT00812929|26944556|P2|Washout Period 2 (7 Days)|Physician Decision|0
7749988|NCT00812929|26944557|P1|Washout Period 2 (7 Days)|Physician Decision|0
7749989|NCT00812929|26944548|P10|Washout Period 1 (7 Days)|Physician Decision|0
7749990|NCT00812929|26944549|P9|Washout Period 1 (7 Days)|Physician Decision|0
7749991|NCT00812929|26944550|P8|Washout Period 1 (7 Days)|Physician Decision|0
7749992|NCT00812929|26944551|P7|Washout Period 1 (7 Days)|Physician Decision|0
7749993|NCT00812929|26944552|P6|Washout Period 1 (7 Days)|Physician Decision|0
7749994|NCT00812929|26944553|P5|Washout Period 1 (7 Days)|Physician Decision|0
7749995|NCT00812929|26944554|P4|Washout Period 1 (7 Days)|Physician Decision|0
7749996|NCT00812929|26944555|P3|Washout Period 1 (7 Days)|Physician Decision|1
7749997|NCT00812929|26944556|P2|Washout Period 1 (7 Days)|Physician Decision|0
7749998|NCT00812929|26944557|P1|Washout Period 1 (7 Days)|Physician Decision|0
7749999|NCT00812812|26944712|P2|Overall Study|Withdrawal by Subject|2
7750000|NCT00812812|26944713|P1|Overall Study|Withdrawal by Subject|0
7750001|NCT00812812|26944712|P2|Overall Study|Lost to Follow-up|1
7750002|NCT00812812|26944713|P1|Overall Study|Lost to Follow-up|0
7750003|NCT00812812|26944712|P2|Overall Study|Lack of Efficacy|0
7750004|NCT00812812|26944713|P1|Overall Study|Lack of Efficacy|1
7750005|NCT00812812|26944712|P2|Overall Study|Adverse Event|1
7750006|NCT00812812|26944713|P1|Overall Study|Adverse Event|2
7750007|NCT00812708|26944726|P1|Overall Study|Signed consent but later withdrew|3
7750008|NCT00812708|26944726|P1|Overall Study|Surgery cancelled due to uveitis|1
7750009|NCT00812708|26944726|P1|Overall Study|Switched to another study|1
7750010|NCT00812708|26944726|P1|Overall Study|Lack of medical insurance|1
7750011|NCT00812708|26944726|P1|Overall Study|Device could not be implanted|2
7750012|NCT00812565|26944754|P8|Overall Study|Reason Not Specified|0
7750013|NCT00812565|26944755|P7|Overall Study|Reason Not Specified|0
7750014|NCT00812565|26944756|P6|Overall Study|Reason Not Specified|1
7750015|NCT00812565|26944757|P5|Overall Study|Reason Not Specified|0
7750016|NCT00812565|26944758|P4|Overall Study|Reason Not Specified|0
7750017|NCT00812565|26944759|P3|Overall Study|Reason Not Specified|0
7750018|NCT00812565|26944760|P2|Overall Study|Reason Not Specified|0
7750019|NCT00812565|26944761|P1|Overall Study|Reason Not Specified|0
7750020|NCT00812565|26944754|P8|Overall Study|Withdrawal of Consent|0
7750021|NCT00812565|26944755|P7|Overall Study|Withdrawal of Consent|0
7750022|NCT00812565|26944756|P6|Overall Study|Withdrawal of Consent|0
7750023|NCT00812565|26944757|P5|Overall Study|Withdrawal of Consent|1
7750024|NCT00812565|26944758|P4|Overall Study|Withdrawal of Consent|0
7750025|NCT00812565|26944759|P3|Overall Study|Withdrawal of Consent|0
7750026|NCT00812565|26944760|P2|Overall Study|Withdrawal of Consent|0
7750027|NCT00812565|26944761|P1|Overall Study|Withdrawal of Consent|1
7750028|NCT00812565|26944754|P8|Overall Study|Did Not Come to Study Visit|0
7750029|NCT00812565|26944755|P7|Overall Study|Did Not Come to Study Visit|0
7750030|NCT00812565|26944756|P6|Overall Study|Did Not Come to Study Visit|0
7750031|NCT00812565|26944757|P5|Overall Study|Did Not Come to Study Visit|0
7750032|NCT00812565|26944758|P4|Overall Study|Did Not Come to Study Visit|0
7750033|NCT00812565|26944759|P3|Overall Study|Did Not Come to Study Visit|0
7750034|NCT00812565|26944760|P2|Overall Study|Did Not Come to Study Visit|0
7750035|NCT00812565|26944761|P1|Overall Study|Did Not Come to Study Visit|1
7750036|NCT00812565|26944754|P8|Overall Study|Adverse Event|1
7750037|NCT00812565|26944755|P7|Overall Study|Adverse Event|0
7750038|NCT00812565|26944756|P6|Overall Study|Adverse Event|0
7750039|NCT00812565|26944757|P5|Overall Study|Adverse Event|0
7750040|NCT00812565|26944758|P4|Overall Study|Adverse Event|2
7750041|NCT00812565|26944759|P3|Overall Study|Adverse Event|0
7750042|NCT00812565|26944760|P2|Overall Study|Adverse Event|0
7750043|NCT00812565|26944761|P1|Overall Study|Adverse Event|0
7750044|NCT00812565|26944754|P8|Overall Study|Did Not Receive Study Medication|0
7750045|NCT00812565|26944755|P7|Overall Study|Did Not Receive Study Medication|0
7750046|NCT00812565|26944756|P6|Overall Study|Did Not Receive Study Medication|0
7750047|NCT00812565|26944757|P5|Overall Study|Did Not Receive Study Medication|0
7750048|NCT00812565|26944758|P4|Overall Study|Did Not Receive Study Medication|0
7750049|NCT00812565|26944759|P3|Overall Study|Did Not Receive Study Medication|0
7750050|NCT00812565|26944760|P2|Overall Study|Did Not Receive Study Medication|1
7750051|NCT00812565|26944761|P1|Overall Study|Did Not Receive Study Medication|1
7750052|NCT00812487|26944885|P2|Overall Study|Protocol Violation|1
7750053|NCT00812487|26944886|P1|Overall Study|Protocol Violation|0
7750054|NCT00812487|26944885|P2|Overall Study|Transfer to ICU prior to intervention|0
7750055|NCT00812487|26944886|P1|Overall Study|Transfer to ICU prior to intervention|1
7750056|NCT00812487|26944885|P2|Overall Study|Withdrawal by Subject|2
7750057|NCT00812487|26944886|P1|Overall Study|Withdrawal by Subject|3
7750058|NCT00812487|26944885|P2|Overall Study|Lost to Follow-up|0
7750059|NCT00812487|26944886|P1|Overall Study|Lost to Follow-up|2
7750060|NCT00812461|26944912|P2|All Treated Patients|Other Reason|21
7750061|NCT00812461|26944913|P1|All Treated Patients|Other Reason|13
7750062|NCT00812461|26944912|P2|All Treated Patients|Lost to Follow-up|14
7750063|NCT00812461|26944913|P1|All Treated Patients|Lost to Follow-up|11
7750064|NCT00812461|26944912|P2|All Treated Patients|Withdrawal by Subject|54
7750065|NCT00812461|26944913|P1|All Treated Patients|Withdrawal by Subject|45
7750066|NCT00812461|26944912|P2|All Treated Patients|Protocol Violation|27
7750067|NCT00812461|26944913|P1|All Treated Patients|Protocol Violation|36
7750068|NCT00812461|26944912|P2|All Treated Patients|Non-compliance|9
7750069|NCT00812461|26944913|P1|All Treated Patients|Non-compliance|6
7750070|NCT00812461|26944912|P2|All Treated Patients|Lack of Efficacy|7
7750071|NCT00812461|26944913|P1|All Treated Patients|Lack of Efficacy|13
7750072|NCT00812461|26944912|P2|All Treated Patients|Adverse Event|15
7750073|NCT00812461|26944913|P1|All Treated Patients|Adverse Event|8
7750074|NCT00812461|26944912|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
7750075|NCT00812461|26944913|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
7750076|NCT00812331|26944936|P5|Overall Study|Adverse Event|0
7750077|NCT00812331|26944937|P4|Overall Study|Adverse Event|0
7750078|NCT00812331|26944938|P3|Overall Study|Adverse Event|0
7750079|NCT00812331|26944939|P2|Overall Study|Adverse Event|0
7750080|NCT00812331|26944940|P1|Overall Study|Adverse Event|1
7750081|NCT00812253|26945015|P2|Overall Study|Lost to Follow-up|0
7750082|NCT00812253|26945016|P1|Overall Study|Lost to Follow-up|2
7750083|NCT00812253|26945015|P2|Overall Study|Protocol Violation|1
7750084|NCT00812253|26945016|P1|Overall Study|Protocol Violation|1
7750085|NCT00812253|26945015|P2|Overall Study|Withdrawal by Subject|2
7750086|NCT00812253|26945016|P1|Overall Study|Withdrawal by Subject|3
7750087|NCT00812097|26945041|P4|Overall Study|Unknown reasons and patient/doctor moves|5
7750088|NCT00812097|26945042|P3|Overall Study|Unknown reasons and patient/doctor moves|15
7750089|NCT00812097|26945043|P2|Overall Study|Unknown reasons and patient/doctor moves|24
7750090|NCT00812097|26945044|P1|Overall Study|Unknown reasons and patient/doctor moves|111
7750091|NCT00812097|26945041|P4|Overall Study|Explantation of study device(s)|20
7750092|NCT00812097|26945042|P3|Overall Study|Explantation of study device(s)|14
7750093|NCT00812097|26945043|P2|Overall Study|Explantation of study device(s)|29
7750094|NCT00812097|26945044|P1|Overall Study|Explantation of study device(s)|27
7750095|NCT00812097|26945041|P4|Overall Study|Lost to Follow-up|5
7750096|NCT00812097|26945042|P3|Overall Study|Lost to Follow-up|17
7750097|NCT00812097|26945043|P2|Overall Study|Lost to Follow-up|14
7750098|NCT00812097|26945044|P1|Overall Study|Lost to Follow-up|90
7750099|NCT00812097|26945041|P4|Overall Study|Withdrawal by Subject|2
7750100|NCT00812097|26945042|P3|Overall Study|Withdrawal by Subject|8
7750101|NCT00812097|26945043|P2|Overall Study|Withdrawal by Subject|12
7750102|NCT00812097|26945044|P1|Overall Study|Withdrawal by Subject|14
7750103|NCT00812097|26945041|P4|Overall Study|Death|3
7750104|NCT00812097|26945042|P3|Overall Study|Death|3
7750105|NCT00812097|26945043|P2|Overall Study|Death|10
7750106|NCT00812097|26945044|P1|Overall Study|Death|3
7750107|NCT00812006|26945073|P3|Overall Study|Lack of Qualifying Event|2
7750108|NCT00812006|26945074|P2|Overall Study|Lack of Qualifying Event|2
7750109|NCT00812006|26945075|P1|Overall Study|Lack of Qualifying Event|4
7750110|NCT00812006|26945073|P3|Overall Study|Withdrawal by Subject|1
7750111|NCT00812006|26945074|P2|Overall Study|Withdrawal by Subject|1
7750112|NCT00812006|26945075|P1|Overall Study|Withdrawal by Subject|2
7750113|NCT00812006|26945073|P3|Overall Study|Physician Decision|1
7750114|NCT00812006|26945074|P2|Overall Study|Physician Decision|0
7750115|NCT00812006|26945075|P1|Overall Study|Physician Decision|0
7750116|NCT00812006|26945073|P3|Overall Study|Lost to Follow-up|2
7750117|NCT00812006|26945074|P2|Overall Study|Lost to Follow-up|0
7750118|NCT00812006|26945075|P1|Overall Study|Lost to Follow-up|0
7750119|NCT00811954|26945092|P3|Overall Study|Complete Protocol: No follow-up|1
7750120|NCT00811954|26945093|P2|Overall Study|Complete Protocol: No follow-up|0
7750121|NCT00811954|26945094|P1|Overall Study|Complete Protocol: No follow-up|0
7750122|NCT00811954|26945092|P3|Overall Study|Severe Debilitation|1
7750123|NCT00811954|26945093|P2|Overall Study|Severe Debilitation|0
7750124|NCT00811954|26945094|P1|Overall Study|Severe Debilitation|2
7750125|NCT00811954|26945092|P3|Overall Study|Site Closure|1
7750126|NCT00811954|26945093|P2|Overall Study|Site Closure|0
7750127|NCT00811954|26945094|P1|Overall Study|Site Closure|4
7750128|NCT00811954|26945092|P3|Overall Study|Withdraw consent prior study completion|5
7750129|NCT00811954|26945093|P2|Overall Study|Withdraw consent prior study completion|6
7750130|NCT00811954|26945094|P1|Overall Study|Withdraw consent prior study completion|4
7750131|NCT00811954|26945092|P3|Overall Study|Not willing to adhere to requirements|16
7750132|NCT00811954|26945093|P2|Overall Study|Not willing to adhere to requirements|2
7750133|NCT00811954|26945094|P1|Overall Study|Not willing to adhere to requirements|12
7750134|NCT00811954|26945092|P3|Overall Study|Not able to get to clinic|30
7750135|NCT00811954|26945093|P2|Overall Study|Not able to get to clinic|35
7750136|NCT00811954|26945094|P1|Overall Study|Not able to get to clinic|28
7750137|NCT00811954|26945092|P3|Overall Study|Lost to Follow-up|34
7750138|NCT00811954|26945093|P2|Overall Study|Lost to Follow-up|23
7750139|NCT00811954|26945094|P1|Overall Study|Lost to Follow-up|29
7750140|NCT00811954|26945092|P3|Overall Study|Death|13
7750141|NCT00811954|26945093|P2|Overall Study|Death|6
7750142|NCT00811954|26945094|P1|Overall Study|Death|10
7750143|NCT00811941|26945158|P2|All Treated Patients|Other Reason|14
7750144|NCT00811941|26945159|P1|All Treated Patients|Other Reason|4
7750145|NCT00811941|26945158|P2|All Treated Patients|Lost to Follow-up|12
7750146|NCT00811941|26945159|P1|All Treated Patients|Lost to Follow-up|3
7750147|NCT00811941|26945158|P2|All Treated Patients|Withdrawal by Subject|94
7750148|NCT00811941|26945159|P1|All Treated Patients|Withdrawal by Subject|35
7750149|NCT00811941|26945158|P2|All Treated Patients|Protocol Violation|17
7750150|NCT00811941|26945159|P1|All Treated Patients|Protocol Violation|5
7750151|NCT00811941|26945158|P2|All Treated Patients|Non-compliance|8
7750152|NCT00811941|26945159|P1|All Treated Patients|Non-compliance|1
7750153|NCT00811941|26945158|P2|All Treated Patients|Lack of Efficacy|3
7750154|NCT00811941|26945159|P1|All Treated Patients|Lack of Efficacy|2
7750155|NCT00811941|26945158|P2|All Treated Patients|Adverse Event|43
7750156|NCT00811941|26945159|P1|All Treated Patients|Adverse Event|2
7750157|NCT00811941|26945158|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
7750158|NCT00811941|26945159|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
7750159|NCT00811928|26945197|P2|Overall Study|Poor Compliance|5
7750160|NCT00811928|26945198|P1|Overall Study|Poor Compliance|2
7750161|NCT00811928|26945197|P2|Overall Study|Investigator Decision|1
7750162|NCT00811928|26945198|P1|Overall Study|Investigator Decision|2
7750163|NCT00811928|26945197|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
7750164|NCT00811928|26945198|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
7750165|NCT00811928|26945197|P2|Overall Study|Did Not Take Study Drug|0
7750166|NCT00811928|26945198|P1|Overall Study|Did Not Take Study Drug|3
7750167|NCT00811928|26945197|P2|Overall Study|Withdrawal by Subject|12
7750168|NCT00811928|26945198|P1|Overall Study|Withdrawal by Subject|18
7750169|NCT00811928|26945197|P2|Overall Study|AEs and SAEs Including Death|11
7750170|NCT00811928|26945198|P1|Overall Study|AEs and SAEs Including Death|7
7750171|NCT00811733|26945242|P2|Overall Study|Withdrawal by Subject|2
7750172|NCT00811733|26945243|P1|Overall Study|Withdrawal by Subject|1
7750173|NCT00811733|26945242|P2|Overall Study|Investigator Discretion|8
7750174|NCT00811733|26945243|P1|Overall Study|Investigator Discretion|10
7750175|NCT00811720|26945291|P2|All Treated Patients|Other Reason|4
7750176|NCT00811720|26945292|P1|All Treated Patients|Other Reason|7
7750177|NCT00811720|26945291|P2|All Treated Patients|Lost to Follow-up|16
7750178|NCT00811720|26945292|P1|All Treated Patients|Lost to Follow-up|10
7750179|NCT00811720|26945291|P2|All Treated Patients|Withdrawal by Subject|34
7750180|NCT00811720|26945292|P1|All Treated Patients|Withdrawal by Subject|28
7750181|NCT00811720|26945291|P2|All Treated Patients|Protocol Violation|16
7750182|NCT00811720|26945292|P1|All Treated Patients|Protocol Violation|9
7750183|NCT00811720|26945291|P2|All Treated Patients|Non-compliance|14
7750184|NCT00811720|26945292|P1|All Treated Patients|Non-compliance|0
7750185|NCT00811720|26945291|P2|All Treated Patients|Lack of Efficacy|18
7750186|NCT00811720|26945292|P1|All Treated Patients|Lack of Efficacy|22
7750187|NCT00811720|26945291|P2|All Treated Patients|Adverse Event|62
7750188|NCT00811720|26945292|P1|All Treated Patients|Adverse Event|20
7750189|NCT00811720|26945291|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
7750190|NCT00811720|26945292|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
7750191|NCT00811655|26945310|P1|Overall Study|Physician Decision|1
7750192|NCT00811642|26945322|P1|Overall Study|Cumulative use of antifungal agent|2
7750193|NCT00811642|26945322|P1|Overall Study|Withdrawal by Subject|7
7750194|NCT00811642|26945322|P1|Overall Study|Death|2
7750195|NCT00811642|26945322|P1|Overall Study|Protocol Violation|1
7750196|NCT00811642|26945322|P1|Overall Study|Adverse Event|3
7750197|NCT00811577|26945338|P2|Overall Study|Withdrawal by Subject|0
7750198|NCT00811577|26945339|P1|Overall Study|Withdrawal by Subject|3
7750199|NCT00811577|26945338|P2|Overall Study|Lost to Follow-up|1
7750200|NCT00811577|26945339|P1|Overall Study|Lost to Follow-up|7
7750201|NCT00811473|26945399|P2|Overall Study|Safety Reasons|0
7750202|NCT00811473|26945400|P1|Overall Study|Safety Reasons|1
7750203|NCT00811473|26945399|P2|Overall Study|Incorrect Enrollment|0
7750204|NCT00811473|26945400|P1|Overall Study|Incorrect Enrollment|1
7750205|NCT00811473|26945399|P2|Overall Study|Other 2|1
7750206|NCT00811473|26945400|P1|Overall Study|Other 2|4
7750207|NCT00811473|26945399|P2|Overall Study|Condition under investigation worsened|3
7750208|NCT00811473|26945400|P1|Overall Study|Condition under investigation worsened|1
7750209|NCT00811473|26945399|P2|Overall Study|Lack of therapeutic response|1
7750210|NCT00811473|26945400|P1|Overall Study|Lack of therapeutic response|4
7750211|NCT00811473|26945399|P2|Overall Study|Severe non-compliance to protocol|4
7750212|NCT00811473|26945400|P1|Overall Study|Severe non-compliance to protocol|2
7750213|NCT00811473|26945399|P2|Overall Study|Withdrawal by Subject|4
7750214|NCT00811473|26945400|P1|Overall Study|Withdrawal by Subject|2
7750215|NCT00811473|26945399|P2|Overall Study|Lost to Follow-up|1
7750216|NCT00811473|26945400|P1|Overall Study|Lost to Follow-up|5
7750217|NCT00811473|26945399|P2|Overall Study|Adverse Event|12
7750218|NCT00811473|26945400|P1|Overall Study|Adverse Event|3
7750219|NCT00811395|26945431|P6|Extension Treatment|Other than above|0
7750220|NCT00811395|26945432|P5|Extension Treatment|Other than above|0
7750221|NCT00811395|26945433|P4|Extension Treatment|Other than above|0
7750222|NCT00811395|26945434|P3|Extension Treatment|Other than above|1
7750223|NCT00811395|26945435|P2|Extension Treatment|Other than above|0
7750224|NCT00811395|26945436|P1|Extension Treatment|Other than above|0
7750225|NCT00811395|26945431|P6|Extension Treatment|Participant did not wish to continue|1
7750226|NCT00811395|26945432|P5|Extension Treatment|Participant did not wish to continue|0
7750227|NCT00811395|26945433|P4|Extension Treatment|Participant did not wish to continue|1
7750228|NCT00811395|26945434|P3|Extension Treatment|Participant did not wish to continue|0
7750229|NCT00811395|26945435|P2|Extension Treatment|Participant did not wish to continue|3
7750230|NCT00811395|26945436|P1|Extension Treatment|Participant did not wish to continue|0
7750231|NCT00811395|26945431|P6|Extension Treatment|Progressive disease|0
7750232|NCT00811395|26945432|P5|Extension Treatment|Progressive disease|0
7750233|NCT00811395|26945433|P4|Extension Treatment|Progressive disease|0
7750234|NCT00811395|26945434|P3|Extension Treatment|Progressive disease|0
7750235|NCT00811395|26945435|P2|Extension Treatment|Progressive disease|1
7750236|NCT00811395|26945436|P1|Extension Treatment|Progressive disease|1
7750237|NCT00811395|26945431|P6|Extension Treatment|Adverse Event|1
7750238|NCT00811395|26945432|P5|Extension Treatment|Adverse Event|0
7750239|NCT00811395|26945433|P4|Extension Treatment|Adverse Event|2
7750240|NCT00811395|26945434|P3|Extension Treatment|Adverse Event|2
7750241|NCT00811395|26945435|P2|Extension Treatment|Adverse Event|2
7750242|NCT00811395|26945436|P1|Extension Treatment|Adverse Event|1
7750243|NCT00811252|26945542|P3|Overall Study|Administrative or Other Reasons|2
7750244|NCT00811252|26945543|P2|Overall Study|Administrative or Other Reasons|3
7750245|NCT00811252|26945544|P1|Overall Study|Administrative or Other Reasons|0
7750246|NCT00811252|26945542|P3|Overall Study|Lost to Follow-up|2
7750247|NCT00811252|26945543|P2|Overall Study|Lost to Follow-up|0
7750248|NCT00811252|26945544|P1|Overall Study|Lost to Follow-up|0
7750249|NCT00811252|26945542|P3|Overall Study|Withdrawal of Consent|2
7750250|NCT00811252|26945543|P2|Overall Study|Withdrawal of Consent|2
7750251|NCT00811252|26945544|P1|Overall Study|Withdrawal of Consent|1
7750252|NCT00811252|26945542|P3|Overall Study|Protocol Violation|2
7750253|NCT00811252|26945543|P2|Overall Study|Protocol Violation|3
7750254|NCT00811252|26945544|P1|Overall Study|Protocol Violation|3
7750255|NCT00811252|26945542|P3|Overall Study|Lack of Efficacy|0
7750256|NCT00811252|26945543|P2|Overall Study|Lack of Efficacy|2
7750257|NCT00811252|26945544|P1|Overall Study|Lack of Efficacy|7
7750258|NCT00811252|26945542|P3|Overall Study|Adverse Event|15
7750259|NCT00811252|26945543|P2|Overall Study|Adverse Event|10
7750260|NCT00811252|26945544|P1|Overall Study|Adverse Event|6
7750261|NCT00811187|26945590|P2|Overall Study|Unable to place device / procedure abort|3
7750262|NCT00811187|26945591|P1|Overall Study|Unable to place device / procedure abort|3
7750263|NCT00811174|26945597|P1|Overall Study|Sponsors Decision|1
7750264|NCT00811174|26945597|P1|Overall Study|Protocol Violation|2
7750265|NCT00811135|26945608|P1|Overall Study|Ongoing|59
7750266|NCT00811135|26945608|P1|Overall Study|Administrative/Other Unspecified|11
7750267|NCT00811135|26945608|P1|Overall Study|Withdrawal by Subject|3
7750268|NCT00811135|26945608|P1|Overall Study|Refused Treatment|1
7750269|NCT00811135|26945608|P1|Overall Study|Violation of Selection Criteria|1
7750270|NCT00811135|26945608|P1|Overall Study|Protocol Violation|2
7750271|NCT00811135|26945608|P1|Overall Study|Death|3
7750272|NCT00811135|26945608|P1|Overall Study|Adverse Event/Intercurrent Illness|8
7750273|NCT00811070|26945626|P6|Overall Study|Physician Decision|1
7750274|NCT00811070|26945627|P5|Overall Study|Physician Decision|0
7750275|NCT00811070|26945628|P4|Overall Study|Physician Decision|0
7750276|NCT00811070|26945629|P3|Overall Study|Physician Decision|0
7750277|NCT00811070|26945630|P2|Overall Study|Physician Decision|0
7750278|NCT00811070|26945631|P1|Overall Study|Physician Decision|0
7750279|NCT00811070|26945626|P6|Overall Study|Withdrawal by Subject|0
7750280|NCT00811070|26945627|P5|Overall Study|Withdrawal by Subject|0
7750281|NCT00811070|26945628|P4|Overall Study|Withdrawal by Subject|0
7750282|NCT00811070|26945629|P3|Overall Study|Withdrawal by Subject|0
7750283|NCT00811070|26945630|P2|Overall Study|Withdrawal by Subject|1
7750284|NCT00811070|26945631|P1|Overall Study|Withdrawal by Subject|0
7750285|NCT00811070|26945626|P6|Overall Study|Other|0
7750286|NCT00811070|26945627|P5|Overall Study|Other|0
7750287|NCT00811070|26945628|P4|Overall Study|Other|0
7750288|NCT00811070|26945629|P3|Overall Study|Other|0
7750289|NCT00811070|26945630|P2|Overall Study|Other|0
7750290|NCT00811070|26945631|P1|Overall Study|Other|1
7750291|NCT00811070|26945626|P6|Overall Study|Death|0
7750292|NCT00811070|26945627|P5|Overall Study|Death|5
7750293|NCT00811070|26945628|P4|Overall Study|Death|2
7750294|NCT00811070|26945629|P3|Overall Study|Death|0
7750295|NCT00811070|26945630|P2|Overall Study|Death|0
7750296|NCT00811070|26945631|P1|Overall Study|Death|0
7750297|NCT00811057|26945691|P3|Overall Study|Protocol Violation|10
7750298|NCT00811057|26945692|P2|Overall Study|Protocol Violation|10
7750299|NCT00811057|26945693|P1|Overall Study|Protocol Violation|5
7750300|NCT00811018|26945704|P1|Overall Study|Other|26
7750301|NCT00811018|26945704|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
7750302|NCT00811018|26945704|P1|Overall Study|Withdrawal by Subject|70
7750303|NCT00811018|26945704|P1|Overall Study|Sponsor Decision|450
7750304|NCT00811018|26945704|P1|Overall Study|Pregnancy|6
7750305|NCT00811018|26945704|P1|Overall Study|Lost to Follow-up|19
7750306|NCT00811018|26945704|P1|Overall Study|Investigator Decision|57
7750307|NCT00811018|26945704|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
7750308|NCT00811018|26945704|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
7750309|NCT00811018|26945704|P1|Overall Study|Death|147
7750310|NCT00811018|26945704|P1|Overall Study|Adverse Event|79
7750311|NCT00811018|26945704|P1|Overall Study|Additional Chronic Treatment|31
7750312|NCT00810901|26945722|P2|Overall Study|Lost to Follow-up|58
7750313|NCT00810901|26945723|P1|Overall Study|Lost to Follow-up|88
7750314|NCT00810810|26945769|P4|Overall Study|Physician Decision|5
7750315|NCT00810810|26945770|P3|Overall Study|Physician Decision|1
7750316|NCT00810810|26945771|P2|Overall Study|Physician Decision|3
7750317|NCT00810810|26945772|P1|Overall Study|Physician Decision|0
7750318|NCT00810810|26945769|P4|Overall Study|Withdrawal by Subject|8
7750319|NCT00810810|26945770|P3|Overall Study|Withdrawal by Subject|10
7750320|NCT00810810|26945771|P2|Overall Study|Withdrawal by Subject|8
7750321|NCT00810810|26945772|P1|Overall Study|Withdrawal by Subject|0
7750322|NCT00810693|26945825|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
7750323|NCT00810693|26945826|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
7750324|NCT00810693|26945827|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
7750325|NCT00810693|26945825|P3|Follow-up Period (FUP)|Protocol Violation|0
7750326|NCT00810693|26945826|P2|Follow-up Period (FUP)|Protocol Violation|1
7750327|NCT00810693|26945827|P1|Follow-up Period (FUP)|Protocol Violation|0
7750328|NCT00810693|26945825|P3|Follow-up Period (FUP)|Lost to Follow-up|2
7750329|NCT00810693|26945826|P2|Follow-up Period (FUP)|Lost to Follow-up|0
7750330|NCT00810693|26945827|P1|Follow-up Period (FUP)|Lost to Follow-up|1
7750331|NCT00810693|26945825|P3|Follow-up Period (FUP)|Death|1
7750332|NCT00810693|26945826|P2|Follow-up Period (FUP)|Death|0
7750333|NCT00810693|26945827|P1|Follow-up Period (FUP)|Death|2
7750334|NCT00810693|26945825|P3|Follow-up Period (FUP)|Adverse Event|1
7750335|NCT00810693|26945826|P2|Follow-up Period (FUP)|Adverse Event|1
7750336|NCT00810693|26945827|P1|Follow-up Period (FUP)|Adverse Event|3
7750337|NCT00810693|26945825|P3|Treatment Period|Not treated|1
7750338|NCT00810693|26945826|P2|Treatment Period|Not treated|1
7750339|NCT00810693|26945827|P1|Treatment Period|Not treated|0
7750340|NCT00810693|26945825|P3|Treatment Period|Withdrawal by Subject|3
7750341|NCT00810693|26945826|P2|Treatment Period|Withdrawal by Subject|2
7750342|NCT00810693|26945827|P1|Treatment Period|Withdrawal by Subject|6
7750343|NCT00810693|26945825|P3|Treatment Period|Protocol Violation|2
7750344|NCT00810693|26945826|P2|Treatment Period|Protocol Violation|2
7750345|NCT00810693|26945827|P1|Treatment Period|Protocol Violation|1
7750346|NCT00810693|26945825|P3|Treatment Period|Non-compliance|0
7750347|NCT00810693|26945826|P2|Treatment Period|Non-compliance|0
7750348|NCT00810693|26945827|P1|Treatment Period|Non-compliance|1
7750349|NCT00810693|26945825|P3|Treatment Period|Lost to Follow-up|0
7750350|NCT00810693|26945826|P2|Treatment Period|Lost to Follow-up|0
7750351|NCT00810693|26945827|P1|Treatment Period|Lost to Follow-up|1
7750352|NCT00810693|26945825|P3|Treatment Period|Lack of Efficacy|1
7750353|NCT00810693|26945826|P2|Treatment Period|Lack of Efficacy|0
7750354|NCT00810693|26945827|P1|Treatment Period|Lack of Efficacy|0
7750355|NCT00810693|26945825|P3|Treatment Period|Death|2
7750356|NCT00810693|26945826|P2|Treatment Period|Death|1
7750357|NCT00810693|26945827|P1|Treatment Period|Death|0
7750358|NCT00810693|26945825|P3|Treatment Period|Adverse Event|7
7750359|NCT00810693|26945826|P2|Treatment Period|Adverse Event|1
7750360|NCT00810693|26945827|P1|Treatment Period|Adverse Event|8
7750361|NCT00810641|26945859|P3|Overall Study|Withdrawal by Subject|2
7750362|NCT00810641|26945860|P2|Overall Study|Withdrawal by Subject|1
7750363|NCT00810641|26945861|P1|Overall Study|Withdrawal by Subject|0
7750364|NCT00810615|26945871|P2|Overall Study|Withdrawal by Subject|1
7750365|NCT00810615|26945872|P1|Overall Study|Withdrawal by Subject|1
7750366|NCT00810602|26945922|P2|Overall Study|Withdrawal by Subject|3
7750367|NCT00810602|26945923|P1|Overall Study|Withdrawal by Subject|8
7750368|NCT00810511|26945936|P2|Overall Study|deposits on contact lens|1
7750369|NCT00810511|26945937|P1|Overall Study|deposits on contact lens|0
7750370|NCT00810511|26945936|P2|Overall Study|Lost to Follow-up|0
7750371|NCT00810511|26945937|P1|Overall Study|Lost to Follow-up|1
7750372|NCT00810511|26945936|P2|Overall Study|death in the family|1
7750373|NCT00810511|26945937|P1|Overall Study|death in the family|0
7750374|NCT00810511|26945936|P2|Overall Study|Lack of Efficacy|1
7750375|NCT00810511|26945937|P1|Overall Study|Lack of Efficacy|9
7750376|NCT00810511|26945936|P2|Overall Study|Protocol Violation|1
7750377|NCT00810511|26945937|P1|Overall Study|Protocol Violation|0
7750378|NCT00810407|26945985|P1|Overall Study|No Visit After First Day of Treatment|3
7750379|NCT00810407|26945985|P1|Overall Study|Protocol Violation|3
7750380|NCT00810394|26945997|P1|Overall Study|Withdrawal by Subject|3
7750381|NCT00810368|26946005|P2|Overall Study|Lack of Efficacy|0
7750382|NCT00810368|26946006|P1|Overall Study|Lack of Efficacy|2
7750383|NCT00810368|26946005|P2|Overall Study|Lost to Follow-up|2
7750384|NCT00810368|26946006|P1|Overall Study|Lost to Follow-up|4
7750385|NCT00810355|26946027|P3|Overall Study|Withdrawal by Subject|0
7750386|NCT00810355|26946028|P2|Overall Study|Withdrawal by Subject|0
7750387|NCT00810355|26946029|P1|Overall Study|Withdrawal by Subject|1
7750388|NCT00810355|26946027|P3|Overall Study|Lost to Follow-up|11
7750389|NCT00810355|26946028|P2|Overall Study|Lost to Follow-up|17
7750390|NCT00810355|26946029|P1|Overall Study|Lost to Follow-up|13
7750391|NCT00810342|26946045|P2|12-month Followup|Lost to Follow-up|1
7750392|NCT00810342|26946046|P1|12-month Followup|Lost to Follow-up|3
7750393|NCT00810342|26946045|P2|12-month Followup|Pregnancy|10
7750394|NCT00810342|26946046|P1|12-month Followup|Pregnancy|9
7750395|NCT00810342|26946045|P2|6-month Follow-up|Pregnancy|2
7750396|NCT00810342|26946046|P1|6-month Follow-up|Pregnancy|6
7750397|NCT00810342|26946045|P2|6-month Follow-up|Lost to Follow-up|6
7750398|NCT00810342|26946046|P1|6-month Follow-up|Lost to Follow-up|18
7750399|NCT00810342|26946045|P2|Month 1 Follow-up|Pregnancy|0
7750400|NCT00810342|26946046|P1|Month 1 Follow-up|Pregnancy|1
7750401|NCT00810342|26946045|P2|Month 1 Follow-up|Lost to Follow-up|2
7750402|NCT00810342|26946046|P1|Month 1 Follow-up|Lost to Follow-up|4
7750403|NCT00810277|26946079|P1|Overall Study|Adverse Event|1
7750404|NCT00810264|26946092|P1|Overall Study|Death|641
7750405|NCT00810264|26946092|P1|Overall Study|Withdrawal by subject or physician|721
7750406|NCT00810264|26946092|P1|Overall Study|Lost to Follow-up|191
7750407|NCT00810199|26946119|P2|Overall Study|Did not receive study drug|1
7750408|NCT00810199|26946120|P1|Overall Study|Did not receive study drug|2
7750409|NCT00810199|26946119|P2|Overall Study|Failure to return|4
7750410|NCT00810199|26946120|P1|Overall Study|Failure to return|1
7750411|NCT00810199|26946119|P2|Overall Study|Protocol Violation|6
7750412|NCT00810199|26946120|P1|Overall Study|Protocol Violation|2
7750413|NCT00810199|26946119|P2|Overall Study|Administrative/Other|6
7750414|NCT00810199|26946120|P1|Overall Study|Administrative/Other|5
7750415|NCT00810199|26946119|P2|Overall Study|Refused treatment/Did not cooperate|7
7750416|NCT00810199|26946120|P1|Overall Study|Refused treatment/Did not cooperate|7
7750417|NCT00810199|26946119|P2|Overall Study|Insufficient therapeutic response|14
7750418|NCT00810199|26946120|P1|Overall Study|Insufficient therapeutic response|5
7750419|NCT00810199|26946119|P2|Overall Study|Withdrew consent|12
7750420|NCT00810199|26946120|P1|Overall Study|Withdrew consent|9
7750421|NCT00810199|26946119|P2|Overall Study|Death|6
7750422|NCT00810199|26946120|P1|Overall Study|Death|4
7750423|NCT00810199|26946119|P2|Overall Study|Adverse Event|26
7750424|NCT00810199|26946120|P1|Overall Study|Adverse Event|24
7750425|NCT00810108|26946198|P2|Overall Study|Withdrawal by Subject|0
7750426|NCT00810108|26946199|P1|Overall Study|Withdrawal by Subject|1
7750427|NCT00810082|26946213|P2|Overall Study|Lost to Follow-up|4
7750428|NCT00810082|26946214|P1|Overall Study|Lost to Follow-up|0
7750429|NCT00810069|26946222|P3|Double-Blind Period II|Protocol Violation|6
7750430|NCT00810069|26946223|P2|Double-Blind Period II|Protocol Violation|7
7750431|NCT00810069|26946224|P1|Double-Blind Period II|Protocol Violation|0
7750432|NCT00810069|26946222|P3|Double-Blind Period II|Clinical relapse|0
7750433|NCT00810069|26946223|P2|Double-Blind Period II|Clinical relapse|3
7750434|NCT00810069|26946224|P1|Double-Blind Period II|Clinical relapse|0
7750435|NCT00810069|26946222|P3|Double-Blind Period II|Protocol entry criterion not met|1
7750436|NCT00810069|26946223|P2|Double-Blind Period II|Protocol entry criterion not met|0
7750437|NCT00810069|26946224|P1|Double-Blind Period II|Protocol entry criterion not met|0
7750438|NCT00810069|26946222|P3|Double-Blind Period II|Withdrawal by Subject|35
7750439|NCT00810069|26946223|P2|Double-Blind Period II|Withdrawal by Subject|21
7750440|NCT00810069|26946224|P1|Double-Blind Period II|Withdrawal by Subject|0
7750441|NCT00810069|26946222|P3|Double-Blind Period II|Physician Decision|1
7750442|NCT00810069|26946223|P2|Double-Blind Period II|Physician Decision|0
7750443|NCT00810069|26946224|P1|Double-Blind Period II|Physician Decision|0
7750444|NCT00810069|26946222|P3|Double-Blind Period II|Lost to Follow-up|9
7750445|NCT00810069|26946223|P2|Double-Blind Period II|Lost to Follow-up|9
7750446|NCT00810069|26946224|P1|Double-Blind Period II|Lost to Follow-up|0
7750447|NCT00810069|26946222|P3|Double-Blind Period II|Lack of Efficacy|12
7750448|NCT00810069|26946223|P2|Double-Blind Period II|Lack of Efficacy|7
7750449|NCT00810069|26946224|P1|Double-Blind Period II|Lack of Efficacy|0
7750450|NCT00810069|26946222|P3|Double-Blind Period II|Adverse Event|8
7750451|NCT00810069|26946223|P2|Double-Blind Period II|Adverse Event|9
7750452|NCT00810069|26946224|P1|Double-Blind Period II|Adverse Event|0
7750453|NCT00810069|26946222|P3|Lead-in Period I|Randomization criteria not met|0
7750454|NCT00810069|26946223|P2|Lead-in Period I|Randomization criteria not met|0
7750455|NCT00810069|26946224|P1|Lead-in Period I|Randomization criteria not met|158
7750456|NCT00810069|26946222|P3|Lead-in Period I|Protocol entry criterion not met|0
7750457|NCT00810069|26946223|P2|Lead-in Period I|Protocol entry criterion not met|0
7750458|NCT00810069|26946224|P1|Lead-in Period I|Protocol entry criterion not met|5
7750459|NCT00810069|26946222|P3|Lead-in Period I|Withdrawal by Subject|0
7750460|NCT00810069|26946223|P2|Lead-in Period I|Withdrawal by Subject|0
7750461|NCT00810069|26946224|P1|Lead-in Period I|Withdrawal by Subject|46
7750462|NCT00810069|26946222|P3|Lead-in Period I|Protocol Violation|0
7750463|NCT00810069|26946223|P2|Lead-in Period I|Protocol Violation|0
7750464|NCT00810069|26946224|P1|Lead-in Period I|Protocol Violation|1
7750465|NCT00810069|26946222|P3|Lead-in Period I|Physician Decision|0
7750466|NCT00810069|26946223|P2|Lead-in Period I|Physician Decision|0
7750467|NCT00810069|26946224|P1|Lead-in Period I|Physician Decision|1
7750468|NCT00810069|26946222|P3|Lead-in Period I|Lost to Follow-up|0
7750469|NCT00810069|26946223|P2|Lead-in Period I|Lost to Follow-up|0
7750470|NCT00810069|26946224|P1|Lead-in Period I|Lost to Follow-up|19
7750471|NCT00810069|26946222|P3|Lead-in Period I|Lack of Efficacy|0
7750472|NCT00810069|26946223|P2|Lead-in Period I|Lack of Efficacy|0
7750473|NCT00810069|26946224|P1|Lead-in Period I|Lack of Efficacy|1
7750474|NCT00810069|26946222|P3|Lead-in Period I|Adverse Event|0
7750475|NCT00810069|26946223|P2|Lead-in Period I|Adverse Event|0
7750476|NCT00810069|26946224|P1|Lead-in Period I|Adverse Event|43
7750477|NCT00810043|26946269|P3|Overall Study|No longer met enrollment criteria|3
7750478|NCT00810043|26946270|P2|Overall Study|No longer met enrollment criteria|0
7750479|NCT00810043|26946271|P1|Overall Study|No longer met enrollment criteria|0
7750480|NCT00810043|26946269|P3|Overall Study|Non-medical problem|1
7750481|NCT00810043|26946270|P2|Overall Study|Non-medical problem|0
7750482|NCT00810043|26946271|P1|Overall Study|Non-medical problem|0
7750483|NCT00810043|26946269|P3|Overall Study|Unrelated medical problem|0
7750484|NCT00810043|26946270|P2|Overall Study|Unrelated medical problem|1
7750485|NCT00810043|26946271|P1|Overall Study|Unrelated medical problem|0
7750486|NCT00810043|26946269|P3|Overall Study|Death|0
7750487|NCT00810043|26946270|P2|Overall Study|Death|0
7750488|NCT00810043|26946271|P1|Overall Study|Death|2
7750489|NCT00810043|26946269|P3|Overall Study|Physician Decision|2
7750490|NCT00810043|26946270|P2|Overall Study|Physician Decision|0
7750491|NCT00810043|26946271|P1|Overall Study|Physician Decision|0
7750492|NCT00810043|26946269|P3|Overall Study|Lost to Follow-up|0
7750493|NCT00810043|26946270|P2|Overall Study|Lost to Follow-up|0
7750494|NCT00810043|26946271|P1|Overall Study|Lost to Follow-up|1
7750495|NCT00810043|26946269|P3|Overall Study|Withdrawal by Subject|2
7750496|NCT00810043|26946270|P2|Overall Study|Withdrawal by Subject|0
7750497|NCT00810043|26946271|P1|Overall Study|Withdrawal by Subject|1
7750498|NCT00809965|26946293|P3|Overall Study|Other Reason|189
7750499|NCT00809965|26946294|P2|Overall Study|Other Reason|170
7750500|NCT00809965|26946295|P1|Overall Study|Other Reason|167
7750501|NCT00809965|26946293|P3|Overall Study|Withdrawal by Subject|441
7750502|NCT00809965|26946294|P2|Overall Study|Withdrawal by Subject|448
7750503|NCT00809965|26946295|P1|Overall Study|Withdrawal by Subject|405
7750504|NCT00809965|26946293|P3|Overall Study|Lost to Follow-up|18
7750505|NCT00809965|26946294|P2|Overall Study|Lost to Follow-up|10
7750506|NCT00809965|26946295|P1|Overall Study|Lost to Follow-up|17
7750507|NCT00809965|26946293|P3|Overall Study|Death|196
7750508|NCT00809965|26946294|P2|Overall Study|Death|147
7750509|NCT00809965|26946295|P1|Overall Study|Death|194
7750510|NCT00809926|26946317|P2|Overall Study|Protocol deviation|2
7750511|NCT00809926|26946318|P1|Overall Study|Protocol deviation|0
7750512|NCT00809926|26946317|P2|Overall Study|Administrative Problems|1
7750513|NCT00809926|26946318|P1|Overall Study|Administrative Problems|0
7750514|NCT00809926|26946317|P2|Overall Study|Lost to Follow-up|1
7750515|NCT00809926|26946318|P1|Overall Study|Lost to Follow-up|2
7750516|NCT00809926|26946317|P2|Overall Study|Patient withdrew consent|6
7750517|NCT00809926|26946318|P1|Overall Study|Patient withdrew consent|8
7750518|NCT00809926|26946317|P2|Overall Study|Unsatisfactory therapeutic effect|3
7750519|NCT00809926|26946318|P1|Overall Study|Unsatisfactory therapeutic effect|3
7750520|NCT00809926|26946317|P2|Overall Study|Adverse Event|10
7750521|NCT00809926|26946318|P1|Overall Study|Adverse Event|18
7750522|NCT00809835|26946372|P4|Overall Study|Withdrawal by Subject|0
7750523|NCT00809835|26946373|P3|Overall Study|Withdrawal by Subject|1
7750524|NCT00809835|26946374|P2|Overall Study|Withdrawal by Subject|1
7750525|NCT00809835|26946375|P1|Overall Study|Withdrawal by Subject|1
7750526|NCT00809835|26946372|P4|Overall Study|Lost to Follow-up|2
7750527|NCT00809835|26946373|P3|Overall Study|Lost to Follow-up|10
7750528|NCT00809835|26946374|P2|Overall Study|Lost to Follow-up|6
7750529|NCT00809835|26946375|P1|Overall Study|Lost to Follow-up|7
7750530|NCT00809783|26946405|P3|Overall Study|Other|16
7750531|NCT00809783|26946406|P2|Overall Study|Other|21
7750532|NCT00809783|26946407|P1|Overall Study|Other|21
7750533|NCT00809783|26946405|P3|Overall Study|Study Terminated by Sponsor|565
7750534|NCT00809783|26946406|P2|Overall Study|Study Terminated by Sponsor|626
7750535|NCT00809783|26946407|P1|Overall Study|Study Terminated by Sponsor|378
7750536|NCT00809783|26946405|P3|Overall Study|Randomized, but not treated|2
7750537|NCT00809783|26946406|P2|Overall Study|Randomized, but not treated|0
7750538|NCT00809783|26946407|P1|Overall Study|Randomized, but not treated|3
7750539|NCT00809783|26946405|P3|Overall Study|Protocol Violation|5
7750540|NCT00809783|26946406|P2|Overall Study|Protocol Violation|6
7750541|NCT00809783|26946407|P1|Overall Study|Protocol Violation|2
7750542|NCT00809783|26946405|P3|Overall Study|Withdrawal by Subject|64
7750543|NCT00809783|26946406|P2|Overall Study|Withdrawal by Subject|72
7750544|NCT00809783|26946407|P1|Overall Study|Withdrawal by Subject|47
7750545|NCT00809783|26946405|P3|Overall Study|Lost to Follow-up|4
7750546|NCT00809783|26946406|P2|Overall Study|Lost to Follow-up|3
7750547|NCT00809783|26946407|P1|Overall Study|Lost to Follow-up|0
7750548|NCT00809783|26946405|P3|Overall Study|Lack of Efficacy|63
7750549|NCT00809783|26946406|P2|Overall Study|Lack of Efficacy|52
7750550|NCT00809783|26946407|P1|Overall Study|Lack of Efficacy|39
7750551|NCT00809783|26946405|P3|Overall Study|Adverse Event|71
7750552|NCT00809783|26946406|P2|Overall Study|Adverse Event|52
7750553|NCT00809783|26946407|P1|Overall Study|Adverse Event|34
7750554|NCT00809783|26946405|P3|Overall Study|Death|0
7750555|NCT00809783|26946406|P2|Overall Study|Death|0
7750556|NCT00809783|26946407|P1|Overall Study|Death|1
7750557|NCT00809757|26946478|P3|Overall Study|Noncompliance with Medication|1
7750558|NCT00809757|26946479|P2|Overall Study|Noncompliance with Medication|0
7750559|NCT00809757|26946480|P1|Overall Study|Noncompliance with Medication|0
7750560|NCT00809757|26946478|P3|Overall Study|Subject Uncooperative|2
7750561|NCT00809757|26946479|P2|Overall Study|Subject Uncooperative|0
7750562|NCT00809757|26946480|P1|Overall Study|Subject Uncooperative|1
7750563|NCT00809757|26946478|P3|Overall Study|Withdrawal by Subject|3
7750564|NCT00809757|26946479|P2|Overall Study|Withdrawal by Subject|1
7750565|NCT00809757|26946480|P1|Overall Study|Withdrawal by Subject|2
7750566|NCT00809757|26946478|P3|Overall Study|Protocol Violation|1
7750567|NCT00809757|26946479|P2|Overall Study|Protocol Violation|1
7750568|NCT00809757|26946480|P1|Overall Study|Protocol Violation|1
7750569|NCT00809757|26946478|P3|Overall Study|Lost to Follow-up|1
7750570|NCT00809757|26946479|P2|Overall Study|Lost to Follow-up|0
7750571|NCT00809757|26946480|P1|Overall Study|Lost to Follow-up|0
7750572|NCT00809757|26946478|P3|Overall Study|Adverse Event|3
7750573|NCT00809757|26946479|P2|Overall Study|Adverse Event|3
7750574|NCT00809757|26946480|P1|Overall Study|Adverse Event|2
7750575|NCT00809614|26946565|P2|Overall Study|Withdrawal by Subject|1
7750576|NCT00809614|26946566|P1|Overall Study|Withdrawal by Subject|1
7750577|NCT00809614|26946565|P2|Overall Study|Lack of Efficacy|3
7750578|NCT00809614|26946566|P1|Overall Study|Lack of Efficacy|2
7750579|NCT00809471|26946610|P3|Overall Study|Requirement for restricted medication|0
7750580|NCT00809471|26946611|P2|Overall Study|Requirement for restricted medication|1
7750581|NCT00809471|26946612|P1|Overall Study|Requirement for restricted medication|1
7750582|NCT00809471|26946610|P3|Overall Study|Adverse Event|2
7750583|NCT00809471|26946611|P2|Overall Study|Adverse Event|2
7750584|NCT00809471|26946612|P1|Overall Study|Adverse Event|0
7750585|NCT00809471|26946610|P3|Overall Study|Lost to Follow-up|9
7750586|NCT00809471|26946611|P2|Overall Study|Lost to Follow-up|2
7750587|NCT00809471|26946612|P1|Overall Study|Lost to Follow-up|4
7750588|NCT00809471|26946610|P3|Overall Study|Protocol non-compliance|6
7750589|NCT00809471|26946611|P2|Overall Study|Protocol non-compliance|15
7750590|NCT00809471|26946612|P1|Overall Study|Protocol non-compliance|15
7750591|NCT00809445|26946642|P3|6 Month Follow-up|Withdrew consent|1
7750592|NCT00809445|26946643|P2|6 Month Follow-up|Withdrew consent|0
7750593|NCT00809445|26946644|P1|6 Month Follow-up|Withdrew consent|0
7750594|NCT00809445|26946642|P3|6 Month Follow-up|Incarcerated|8
7750595|NCT00809445|26946643|P2|6 Month Follow-up|Incarcerated|8
7750596|NCT00809445|26946644|P1|6 Month Follow-up|Incarcerated|6
7750597|NCT00809445|26946642|P3|6 Month Follow-up|Death|1
7750598|NCT00809445|26946643|P2|6 Month Follow-up|Death|1
7750599|NCT00809445|26946644|P1|6 Month Follow-up|Death|2
7750600|NCT00809445|26946642|P3|6 Month Follow-up|Lost contact|14
7750601|NCT00809445|26946643|P2|6 Month Follow-up|Lost contact|14
7750602|NCT00809445|26946644|P1|6 Month Follow-up|Lost contact|16
7750603|NCT00809445|26946642|P3|1 Month Follow-up|Incarcerated|1
7750604|NCT00809445|26946643|P2|1 Month Follow-up|Incarcerated|0
7750605|NCT00809445|26946644|P1|1 Month Follow-up|Incarcerated|0
7750606|NCT00809445|26946642|P3|1 Month Follow-up|Death|1
7750607|NCT00809445|26946643|P2|1 Month Follow-up|Death|1
7750608|NCT00809445|26946644|P1|1 Month Follow-up|Death|0
7750609|NCT00809445|26946642|P3|1 Month Follow-up|Withdrew consent|1
7750610|NCT00809445|26946643|P2|1 Month Follow-up|Withdrew consent|1
7750611|NCT00809445|26946644|P1|1 Month Follow-up|Withdrew consent|1
7750612|NCT00809445|26946642|P3|1 Month Follow-up|Lost contact|1
7750613|NCT00809445|26946643|P2|1 Month Follow-up|Lost contact|2
7750614|NCT00809445|26946644|P1|1 Month Follow-up|Lost contact|1
7750615|NCT00809354|26946671|P10|Overall Study|Death|0
7750616|NCT00809354|26946672|P9|Overall Study|Death|0
7750617|NCT00809354|26946673|P8|Overall Study|Death|1
7750618|NCT00809354|26946674|P7|Overall Study|Death|0
7750619|NCT00809354|26946675|P6|Overall Study|Death|0
7750620|NCT00809354|26946676|P5|Overall Study|Death|0
7750621|NCT00809354|26946677|P4|Overall Study|Death|0
7750622|NCT00809354|26946678|P3|Overall Study|Death|0
7750623|NCT00809354|26946679|P2|Overall Study|Death|0
7750624|NCT00809354|26946680|P1|Overall Study|Death|0
7750625|NCT00809354|26946671|P10|Overall Study|Randomized but not Treated|1
7750626|NCT00809354|26946672|P9|Overall Study|Randomized but not Treated|2
7750627|NCT00809354|26946673|P8|Overall Study|Randomized but not Treated|1
7750628|NCT00809354|26946674|P7|Overall Study|Randomized but not Treated|1
7750629|NCT00809354|26946675|P6|Overall Study|Randomized but not Treated|0
7750630|NCT00809354|26946676|P5|Overall Study|Randomized but not Treated|5
7750631|NCT00809354|26946677|P4|Overall Study|Randomized but not Treated|0
7750632|NCT00809354|26946678|P3|Overall Study|Randomized but not Treated|6
7750633|NCT00809354|26946679|P2|Overall Study|Randomized but not Treated|1
7750634|NCT00809354|26946680|P1|Overall Study|Randomized but not Treated|3
7750635|NCT00809354|26946671|P10|Overall Study|Withdrawn due to pregnancy|0
7750636|NCT00809354|26946672|P9|Overall Study|Withdrawn due to pregnancy|0
7750637|NCT00809354|26946673|P8|Overall Study|Withdrawn due to pregnancy|0
7750638|NCT00809354|26946674|P7|Overall Study|Withdrawn due to pregnancy|0
7750639|NCT00809354|26946675|P6|Overall Study|Withdrawn due to pregnancy|0
7750640|NCT00809354|26946676|P5|Overall Study|Withdrawn due to pregnancy|0
7750641|NCT00809354|26946677|P4|Overall Study|Withdrawn due to pregnancy|0
7750642|NCT00809354|26946678|P3|Overall Study|Withdrawn due to pregnancy|0
7750643|NCT00809354|26946679|P2|Overall Study|Withdrawn due to pregnancy|1
7750644|NCT00809354|26946680|P1|Overall Study|Withdrawn due to pregnancy|0
7750645|NCT00809354|26946671|P10|Overall Study|Study terminated by sponsor|135
7750646|NCT00809354|26946672|P9|Overall Study|Study terminated by sponsor|127
7750647|NCT00809354|26946673|P8|Overall Study|Study terminated by sponsor|148
7750648|NCT00809354|26946674|P7|Overall Study|Study terminated by sponsor|124
7750649|NCT00809354|26946675|P6|Overall Study|Study terminated by sponsor|133
7750650|NCT00809354|26946676|P5|Overall Study|Study terminated by sponsor|126
7750651|NCT00809354|26946677|P4|Overall Study|Study terminated by sponsor|120
7750652|NCT00809354|26946678|P3|Overall Study|Study terminated by sponsor|129
7750653|NCT00809354|26946679|P2|Overall Study|Study terminated by sponsor|134
7750654|NCT00809354|26946680|P1|Overall Study|Study terminated by sponsor|138
7750655|NCT00809354|26946671|P10|Overall Study|Other|3
7750656|NCT00809354|26946672|P9|Overall Study|Other|4
7750657|NCT00809354|26946673|P8|Overall Study|Other|3
7750658|NCT00809354|26946674|P7|Overall Study|Other|2
7750659|NCT00809354|26946675|P6|Overall Study|Other|3
7750660|NCT00809354|26946676|P5|Overall Study|Other|5
7750661|NCT00809354|26946677|P4|Overall Study|Other|10
7750662|NCT00809354|26946678|P3|Overall Study|Other|7
7750663|NCT00809354|26946679|P2|Overall Study|Other|2
7750664|NCT00809354|26946680|P1|Overall Study|Other|10
7750665|NCT00809354|26946671|P10|Overall Study|Withdrawal by Subject|20
7750666|NCT00809354|26946672|P9|Overall Study|Withdrawal by Subject|18
7750667|NCT00809354|26946673|P8|Overall Study|Withdrawal by Subject|19
7750668|NCT00809354|26946674|P7|Overall Study|Withdrawal by Subject|27
7750669|NCT00809354|26946675|P6|Overall Study|Withdrawal by Subject|29
7750670|NCT00809354|26946676|P5|Overall Study|Withdrawal by Subject|34
7750671|NCT00809354|26946677|P4|Overall Study|Withdrawal by Subject|33
7750672|NCT00809354|26946678|P3|Overall Study|Withdrawal by Subject|31
7750673|NCT00809354|26946679|P2|Overall Study|Withdrawal by Subject|27
7750674|NCT00809354|26946680|P1|Overall Study|Withdrawal by Subject|32
7750675|NCT00809354|26946671|P10|Overall Study|Protocol Violation|3
7750676|NCT00809354|26946672|P9|Overall Study|Protocol Violation|9
7750677|NCT00809354|26946673|P8|Overall Study|Protocol Violation|6
7750678|NCT00809354|26946674|P7|Overall Study|Protocol Violation|4
7750679|NCT00809354|26946675|P6|Overall Study|Protocol Violation|6
7750680|NCT00809354|26946676|P5|Overall Study|Protocol Violation|14
7750681|NCT00809354|26946677|P4|Overall Study|Protocol Violation|12
7750682|NCT00809354|26946678|P3|Overall Study|Protocol Violation|14
7750683|NCT00809354|26946679|P2|Overall Study|Protocol Violation|14
7750684|NCT00809354|26946680|P1|Overall Study|Protocol Violation|7
7750685|NCT00809354|26946671|P10|Overall Study|Lost to Follow-up|0
7750686|NCT00809354|26946672|P9|Overall Study|Lost to Follow-up|4
7750687|NCT00809354|26946673|P8|Overall Study|Lost to Follow-up|5
7750688|NCT00809354|26946674|P7|Overall Study|Lost to Follow-up|0
7750689|NCT00809354|26946675|P6|Overall Study|Lost to Follow-up|2
7750690|NCT00809354|26946676|P5|Overall Study|Lost to Follow-up|6
7750691|NCT00809354|26946677|P4|Overall Study|Lost to Follow-up|13
7750692|NCT00809354|26946678|P3|Overall Study|Lost to Follow-up|8
7750693|NCT00809354|26946679|P2|Overall Study|Lost to Follow-up|11
7750694|NCT00809354|26946680|P1|Overall Study|Lost to Follow-up|10
7750695|NCT00809354|26946671|P10|Overall Study|Lack of Efficacy|38
7750696|NCT00809354|26946672|P9|Overall Study|Lack of Efficacy|18
7750697|NCT00809354|26946673|P8|Overall Study|Lack of Efficacy|15
7750698|NCT00809354|26946674|P7|Overall Study|Lack of Efficacy|21
7750699|NCT00809354|26946675|P6|Overall Study|Lack of Efficacy|19
7750700|NCT00809354|26946676|P5|Overall Study|Lack of Efficacy|40
7750701|NCT00809354|26946677|P4|Overall Study|Lack of Efficacy|15
7750702|NCT00809354|26946678|P3|Overall Study|Lack of Efficacy|22
7750703|NCT00809354|26946679|P2|Overall Study|Lack of Efficacy|23
7750704|NCT00809354|26946680|P1|Overall Study|Lack of Efficacy|23
7750705|NCT00809354|26946671|P10|Overall Study|Adverse Event|26
7750706|NCT00809354|26946672|P9|Overall Study|Adverse Event|46
7750707|NCT00809354|26946673|P8|Overall Study|Adverse Event|40
7750708|NCT00809354|26946674|P7|Overall Study|Adverse Event|44
7750709|NCT00809354|26946675|P6|Overall Study|Adverse Event|33
7750710|NCT00809354|26946676|P5|Overall Study|Adverse Event|26
7750711|NCT00809354|26946677|P4|Overall Study|Adverse Event|53
7750712|NCT00809354|26946678|P3|Overall Study|Adverse Event|37
7750713|NCT00809354|26946679|P2|Overall Study|Adverse Event|45
7750714|NCT00809354|26946680|P1|Overall Study|Adverse Event|32
7750715|NCT00809341|26947162|P2|Overall Study|Physician Decision|1
7750716|NCT00809341|26947163|P1|Overall Study|Physician Decision|0
7750717|NCT00809328|26947171|P1|Overall Study|Withdrawal by Subject|2
7750718|NCT00809328|26947171|P1|Overall Study|Protocol Violation|3
7750719|NCT00809328|26947171|P1|Overall Study|Adverse Event|6
7750720|NCT00809328|26947171|P1|Overall Study|Lack of Efficacy|18
7750721|NCT00809159|26947193|P6|Part 1 and 2|Withdrawal by Subject|1
7750722|NCT00809159|26947194|P5|Part 1 and 2|Withdrawal by Subject|0
7750723|NCT00809159|26947195|P4|Part 1 and 2|Withdrawal by Subject|0
7750724|NCT00809159|26947196|P3|Part 1 and 2|Withdrawal by Subject|4
7750725|NCT00809159|26947197|P2|Part 1 and 2|Withdrawal by Subject|0
7750726|NCT00809159|26947198|P1|Part 1 and 2|Withdrawal by Subject|0
7750727|NCT00809159|26947193|P6|Part 1 and 2|Lost to Follow-up|0
7750728|NCT00809159|26947194|P5|Part 1 and 2|Lost to Follow-up|0
7750729|NCT00809159|26947195|P4|Part 1 and 2|Lost to Follow-up|1
7750730|NCT00809159|26947196|P3|Part 1 and 2|Lost to Follow-up|1
7750731|NCT00809159|26947197|P2|Part 1 and 2|Lost to Follow-up|0
7750732|NCT00809159|26947198|P1|Part 1 and 2|Lost to Follow-up|0
7750733|NCT00809159|26947193|P6|Part 1 and 2|Adverse Event|1
7750734|NCT00809159|26947194|P5|Part 1 and 2|Adverse Event|1
7750735|NCT00809159|26947195|P4|Part 1 and 2|Adverse Event|0
7750736|NCT00809159|26947196|P3|Part 1 and 2|Adverse Event|1
7750737|NCT00809159|26947197|P2|Part 1 and 2|Adverse Event|0
7750738|NCT00809159|26947198|P1|Part 1 and 2|Adverse Event|0
7750739|NCT00809159|26947193|P6|Part 1 and 2|Administrative problems|0
7750740|NCT00809159|26947194|P5|Part 1 and 2|Administrative problems|0
7750741|NCT00809159|26947195|P4|Part 1 and 2|Administrative problems|1
7750742|NCT00809159|26947196|P3|Part 1 and 2|Administrative problems|0
7750743|NCT00809159|26947197|P2|Part 1 and 2|Administrative problems|0
7750744|NCT00809159|26947198|P1|Part 1 and 2|Administrative problems|0
7750745|NCT00809159|26947193|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
7750746|NCT00809159|26947194|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
7750747|NCT00809159|26947195|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
7750748|NCT00809159|26947196|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
7750749|NCT00809159|26947197|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
7750750|NCT00809159|26947198|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
7750751|NCT00809159|26947193|P6|Part 1|Unsatisfactory therapeutic effect|0
7750752|NCT00809159|26947194|P5|Part 1|Unsatisfactory therapeutic effect|0
7750753|NCT00809159|26947195|P4|Part 1|Unsatisfactory therapeutic effect|0
7750754|NCT00809159|26947196|P3|Part 1|Unsatisfactory therapeutic effect|0
7750755|NCT00809159|26947197|P2|Part 1|Unsatisfactory therapeutic effect|1
7750756|NCT00809159|26947198|P1|Part 1|Unsatisfactory therapeutic effect|3
7750757|NCT00809159|26947193|P6|Part 1|Withdrawal by Subject|0
7750758|NCT00809159|26947194|P5|Part 1|Withdrawal by Subject|0
7750759|NCT00809159|26947195|P4|Part 1|Withdrawal by Subject|0
7750760|NCT00809159|26947196|P3|Part 1|Withdrawal by Subject|0
7750761|NCT00809159|26947197|P2|Part 1|Withdrawal by Subject|1
7750762|NCT00809159|26947198|P1|Part 1|Withdrawal by Subject|3
7750763|NCT00809159|26947193|P6|Part 1|Lost to Follow-up|0
7750764|NCT00809159|26947194|P5|Part 1|Lost to Follow-up|0
7750765|NCT00809159|26947195|P4|Part 1|Lost to Follow-up|0
7750766|NCT00809159|26947196|P3|Part 1|Lost to Follow-up|0
7750767|NCT00809159|26947197|P2|Part 1|Lost to Follow-up|0
7750768|NCT00809159|26947198|P1|Part 1|Lost to Follow-up|1
7750769|NCT00809159|26947193|P6|Part 1|Adverse Event|0
7750770|NCT00809159|26947194|P5|Part 1|Adverse Event|0
7750771|NCT00809159|26947195|P4|Part 1|Adverse Event|0
7750772|NCT00809159|26947196|P3|Part 1|Adverse Event|0
7750773|NCT00809159|26947197|P2|Part 1|Adverse Event|1
7750774|NCT00809159|26947198|P1|Part 1|Adverse Event|1
7750775|NCT00809133|26947303|P14|Overall Study|Other not mentioned above|0
7750776|NCT00809133|26947304|P13|Overall Study|Other not mentioned above|0
7750777|NCT00809133|26947305|P12|Overall Study|Other not mentioned above|0
7750778|NCT00809133|26947306|P11|Overall Study|Other not mentioned above|0
7750779|NCT00809133|26947307|P10|Overall Study|Other not mentioned above|0
7750780|NCT00809133|26947308|P9|Overall Study|Other not mentioned above|0
7750781|NCT00809133|26947309|P8|Overall Study|Other not mentioned above|0
7750782|NCT00809133|26947310|P7|Overall Study|Other not mentioned above|0
7750783|NCT00809133|26947311|P6|Overall Study|Other not mentioned above|1
7750784|NCT00809133|26947312|P5|Overall Study|Other not mentioned above|0
7750785|NCT00809133|26947313|P4|Overall Study|Other not mentioned above|0
7750786|NCT00809133|26947314|P3|Overall Study|Other not mentioned above|0
7750787|NCT00809133|26947315|P2|Overall Study|Other not mentioned above|1
7750788|NCT00809133|26947316|P1|Overall Study|Other not mentioned above|0
7750789|NCT00809133|26947303|P14|Overall Study|Consent withdrawn|0
7750790|NCT00809133|26947304|P13|Overall Study|Consent withdrawn|0
7750791|NCT00809133|26947305|P12|Overall Study|Consent withdrawn|0
7750792|NCT00809133|26947306|P11|Overall Study|Consent withdrawn|0
7750793|NCT00809133|26947307|P10|Overall Study|Consent withdrawn|0
7750794|NCT00809133|26947308|P9|Overall Study|Consent withdrawn|0
7750795|NCT00809133|26947309|P8|Overall Study|Consent withdrawn|0
7750796|NCT00809133|26947310|P7|Overall Study|Consent withdrawn|0
7750797|NCT00809133|26947311|P6|Overall Study|Consent withdrawn|0
7750798|NCT00809133|26947312|P5|Overall Study|Consent withdrawn|1
7750799|NCT00809133|26947313|P4|Overall Study|Consent withdrawn|0
7750800|NCT00809133|26947314|P3|Overall Study|Consent withdrawn|0
7750801|NCT00809133|26947315|P2|Overall Study|Consent withdrawn|0
7750802|NCT00809133|26947316|P1|Overall Study|Consent withdrawn|0
7750803|NCT00809133|26947303|P14|Overall Study|Lost to Follow-up|0
7750804|NCT00809133|26947304|P13|Overall Study|Lost to Follow-up|0
7750805|NCT00809133|26947305|P12|Overall Study|Lost to Follow-up|0
7750806|NCT00809133|26947306|P11|Overall Study|Lost to Follow-up|0
7750807|NCT00809133|26947307|P10|Overall Study|Lost to Follow-up|0
7750808|NCT00809133|26947308|P9|Overall Study|Lost to Follow-up|0
7750809|NCT00809133|26947309|P8|Overall Study|Lost to Follow-up|0
7750810|NCT00809133|26947310|P7|Overall Study|Lost to Follow-up|0
7750811|NCT00809133|26947311|P6|Overall Study|Lost to Follow-up|1
7750812|NCT00809133|26947312|P5|Overall Study|Lost to Follow-up|0
7750813|NCT00809133|26947313|P4|Overall Study|Lost to Follow-up|0
7750814|NCT00809133|26947314|P3|Overall Study|Lost to Follow-up|0
7750815|NCT00809133|26947315|P2|Overall Study|Lost to Follow-up|0
7750816|NCT00809133|26947316|P1|Overall Study|Lost to Follow-up|0
7750817|NCT00809133|26947303|P14|Overall Study|Other adverse event|1
7750818|NCT00809133|26947304|P13|Overall Study|Other adverse event|0
7750819|NCT00809133|26947305|P12|Overall Study|Other adverse event|1
7750820|NCT00809133|26947306|P11|Overall Study|Other adverse event|1
7750821|NCT00809133|26947307|P10|Overall Study|Other adverse event|0
7750822|NCT00809133|26947308|P9|Overall Study|Other adverse event|0
7750823|NCT00809133|26947309|P8|Overall Study|Other adverse event|4
7750824|NCT00809133|26947310|P7|Overall Study|Other adverse event|2
7750825|NCT00809133|26947311|P6|Overall Study|Other adverse event|3
7750826|NCT00809133|26947312|P5|Overall Study|Other adverse event|0
7750827|NCT00809133|26947313|P4|Overall Study|Other adverse event|0
7750828|NCT00809133|26947314|P3|Overall Study|Other adverse event|1
7750829|NCT00809133|26947315|P2|Overall Study|Other adverse event|1
7750830|NCT00809133|26947316|P1|Overall Study|Other adverse event|1
7750831|NCT00809133|26947303|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
7750832|NCT00809133|26947304|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
7750833|NCT00809133|26947305|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
7750834|NCT00809133|26947306|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
7750835|NCT00809133|26947307|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
7750836|NCT00809133|26947308|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
7750837|NCT00809133|26947309|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
7750838|NCT00809133|26947310|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
7750839|NCT00809133|26947311|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
7750840|NCT00809133|26947312|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
7750841|NCT00809133|26947313|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
7750842|NCT00809133|26947314|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
7750843|NCT00809133|26947315|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
7750844|NCT00809133|26947316|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
7750845|NCT00809133|26947303|P14|Overall Study|Progressive disease|4
7750846|NCT00809133|26947304|P13|Overall Study|Progressive disease|5
7750847|NCT00809133|26947305|P12|Overall Study|Progressive disease|7
7750848|NCT00809133|26947306|P11|Overall Study|Progressive disease|5
7750849|NCT00809133|26947307|P10|Overall Study|Progressive disease|9
7750850|NCT00809133|26947308|P9|Overall Study|Progressive disease|3
7750851|NCT00809133|26947309|P8|Overall Study|Progressive disease|3
7750852|NCT00809133|26947310|P7|Overall Study|Progressive disease|3
7750853|NCT00809133|26947311|P6|Overall Study|Progressive disease|1
7750854|NCT00809133|26947312|P5|Overall Study|Progressive disease|4
7750855|NCT00809133|26947313|P4|Overall Study|Progressive disease|3
7750856|NCT00809133|26947314|P3|Overall Study|Progressive disease|5
7750857|NCT00809133|26947315|P2|Overall Study|Progressive disease|5
7750858|NCT00809133|26947316|P1|Overall Study|Progressive disease|2
7750859|NCT00809094|26947470|P2|Overall Study|Lost to Follow-up|1
7750860|NCT00809094|26947471|P1|Overall Study|Lost to Follow-up|0
7750861|NCT00808899|26947516|P1|Overall Study|Physician Decision|3
7750862|NCT00808899|26947516|P1|Overall Study|Death|1
7750863|NCT00808808|26947530|P3|Overall Study|Employee was not vaccinated.|2255
7750864|NCT00808808|26947531|P2|Overall Study|Employee was not vaccinated.|2268
7750865|NCT00808808|26947532|P1|Overall Study|Employee was not vaccinated.|2686
7750866|NCT00808808|26947530|P3|Overall Study|Vaccinated; survey not completed|302
7750867|NCT00808808|26947531|P2|Overall Study|Vaccinated; survey not completed|169
7750868|NCT00808808|26947532|P1|Overall Study|Vaccinated; survey not completed|131
7750869|NCT00808665|26947567|P2|Overall Study|Medication stopped by resident|1
7750870|NCT00808665|26947568|P1|Overall Study|Medication stopped by resident|0
7750871|NCT00808665|26947567|P2|Overall Study|Physician Decision|1
7750872|NCT00808665|26947568|P1|Overall Study|Physician Decision|3
7750873|NCT00808665|26947567|P2|Overall Study|required an additional procedure|1
7750874|NCT00808665|26947568|P1|Overall Study|required an additional procedure|0
7750875|NCT00808665|26947567|P2|Overall Study|surgery cancelled|0
7750876|NCT00808665|26947568|P1|Overall Study|surgery cancelled|1
7750877|NCT00808665|26947567|P2|Overall Study|only required minimally invasive surgery|0
7750878|NCT00808665|26947568|P1|Overall Study|only required minimally invasive surgery|1
7750879|NCT00808665|26947567|P2|Overall Study|Withdrawal by Subject|0
7750880|NCT00808665|26947568|P1|Overall Study|Withdrawal by Subject|1
7750881|NCT00808639|26947574|P1|Overall Study|Disease progression before surgery.|1
7750882|NCT00808509|26947582|P2|Randomized Phase|Patient refused rescue therapy|3
7750883|NCT00808509|26947583|P1|Randomized Phase|Patient refused rescue therapy|0
7750884|NCT00808509|26947582|P2|Randomized Phase|Reduced methotrexate dose|2
7750885|NCT00808509|26947583|P1|Randomized Phase|Reduced methotrexate dose|1
7750886|NCT00808509|26947582|P2|Randomized Phase|Did not meet eligibility criteria|0
7750887|NCT00808509|26947583|P1|Randomized Phase|Did not meet eligibility criteria|1
7750888|NCT00808483|26947681|P2|From 5 Months to 12 Months|Lack of Efficacy|0
7750889|NCT00808483|26947682|P1|From 5 Months to 12 Months|Lack of Efficacy|1
7750890|NCT00808483|26947681|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
7750891|NCT00808483|26947682|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
7750892|NCT00808483|26947681|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
7750893|NCT00808483|26947682|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
7750894|NCT00808444|26947719|P2|Overall Study|Lost to Follow-up|1
7750895|NCT00808444|26947720|P1|Overall Study|Lost to Follow-up|0
7750896|NCT00808444|26947719|P2|Overall Study|Withdrawal by Subject|0
7750897|NCT00808444|26947720|P1|Overall Study|Withdrawal by Subject|1
7750898|NCT00808249|26947795|P4|Overall Study|All other reasons|1
7750899|NCT00808249|26947796|P3|Overall Study|All other reasons|3
7750900|NCT00808249|26947797|P2|Overall Study|All other reasons|1
7750901|NCT00808249|26947798|P1|Overall Study|All other reasons|2
7750902|NCT00808249|26947795|P4|Overall Study|study specific discontinuation criteria|0
7750903|NCT00808249|26947796|P3|Overall Study|study specific discontinuation criteria|1
7750904|NCT00808249|26947797|P2|Overall Study|study specific discontinuation criteria|0
7750905|NCT00808249|26947798|P1|Overall Study|study specific discontinuation criteria|1
7750906|NCT00808249|26947795|P4|Overall Study|Lack of Efficacy|0
7750907|NCT00808249|26947796|P3|Overall Study|Lack of Efficacy|0
7750908|NCT00808249|26947797|P2|Overall Study|Lack of Efficacy|1
7750909|NCT00808249|26947798|P1|Overall Study|Lack of Efficacy|1
7750910|NCT00808249|26947795|P4|Overall Study|Protocol Violation|0
7750911|NCT00808249|26947796|P3|Overall Study|Protocol Violation|3
7750912|NCT00808249|26947797|P2|Overall Study|Protocol Violation|3
7750913|NCT00808249|26947798|P1|Overall Study|Protocol Violation|3
7750914|NCT00808249|26947795|P4|Overall Study|Withdrawal by Subject|4
7750915|NCT00808249|26947796|P3|Overall Study|Withdrawal by Subject|2
7750916|NCT00808249|26947797|P2|Overall Study|Withdrawal by Subject|0
7750917|NCT00808249|26947798|P1|Overall Study|Withdrawal by Subject|4
7750918|NCT00808249|26947795|P4|Overall Study|Lost to Follow-up|5
7750919|NCT00808249|26947796|P3|Overall Study|Lost to Follow-up|3
7750920|NCT00808249|26947797|P2|Overall Study|Lost to Follow-up|3
7750921|NCT00808249|26947798|P1|Overall Study|Lost to Follow-up|2
7750922|NCT00808249|26947795|P4|Overall Study|Adverse Event|6
7750923|NCT00808249|26947796|P3|Overall Study|Adverse Event|10
7750924|NCT00808249|26947797|P2|Overall Study|Adverse Event|7
7750925|NCT00808249|26947798|P1|Overall Study|Adverse Event|4
7750926|NCT00808236|26947826|P2|Overall Study|Death|30
7750927|NCT00808236|26947827|P1|Overall Study|Death|18
7750928|NCT00808236|26947826|P2|Overall Study|Physician Decision|1
7750929|NCT00808236|26947827|P1|Overall Study|Physician Decision|0
7750930|NCT00808236|26947826|P2|Overall Study|Lost to Follow-up|1
7750931|NCT00808236|26947827|P1|Overall Study|Lost to Follow-up|1
7750932|NCT00808236|26947826|P2|Overall Study|Pre-defined exclusion|3
7750933|NCT00808236|26947827|P1|Overall Study|Pre-defined exclusion|13
7750934|NCT00808236|26947826|P2|Overall Study|Was not resuscitated|56
7750935|NCT00808236|26947827|P1|Overall Study|Was not resuscitated|50
7750936|NCT00808210|26947857|P2|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
7750937|NCT00808210|26947858|P1|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
7750938|NCT00808210|26947857|P2|Double-Blind TX Period|Other reasons outside Sponsor decision|1
7750939|NCT00808210|26947858|P1|Double-Blind TX Period|Other reasons outside Sponsor decision|1
7750940|NCT00808210|26947857|P2|Double-Blind TX Period|Sponsor decision to terminate study|1
7750941|NCT00808210|26947858|P1|Double-Blind TX Period|Sponsor decision to terminate study|1
7750942|NCT00808210|26947857|P2|Double-Blind TX Period|Adverse Event|1
7750943|NCT00808210|26947858|P1|Double-Blind TX Period|Adverse Event|0
7750944|NCT00808210|26947857|P2|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
7750945|NCT00808210|26947858|P1|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
7750946|NCT00808210|26947857|P2|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
7750947|NCT00808210|26947858|P1|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
7750948|NCT00808132|26947883|P5|Overall Study|Unsatisfactory response|12
7750949|NCT00808132|26947884|P4|Overall Study|Unsatisfactory response|4
7750950|NCT00808132|26947885|P3|Overall Study|Unsatisfactory response|6
7750951|NCT00808132|26947886|P2|Overall Study|Unsatisfactory response|6
7750952|NCT00808132|26947887|P1|Overall Study|Unsatisfactory response|5
7750953|NCT00808132|26947883|P5|Overall Study|Randomized, but not treated|9
7750954|NCT00808132|26947884|P4|Overall Study|Randomized, but not treated|8
7750955|NCT00808132|26947885|P3|Overall Study|Randomized, but not treated|9
7750956|NCT00808132|26947886|P2|Overall Study|Randomized, but not treated|7
7750957|NCT00808132|26947887|P1|Overall Study|Randomized, but not treated|10
7750958|NCT00808132|26947883|P5|Overall Study|Other|15
7750959|NCT00808132|26947884|P4|Overall Study|Other|2
7750960|NCT00808132|26947885|P3|Overall Study|Other|6
7750961|NCT00808132|26947886|P2|Overall Study|Other|4
7750962|NCT00808132|26947887|P1|Overall Study|Other|6
7750963|NCT00808132|26947883|P5|Overall Study|Withdrawal by Subject|16
7750964|NCT00808132|26947884|P4|Overall Study|Withdrawal by Subject|7
7750965|NCT00808132|26947885|P3|Overall Study|Withdrawal by Subject|2
7750966|NCT00808132|26947886|P2|Overall Study|Withdrawal by Subject|18
7750967|NCT00808132|26947887|P1|Overall Study|Withdrawal by Subject|27
7750968|NCT00808132|26947883|P5|Overall Study|Protocol Violation|5
7750969|NCT00808132|26947884|P4|Overall Study|Protocol Violation|9
7750970|NCT00808132|26947885|P3|Overall Study|Protocol Violation|4
7750971|NCT00808132|26947886|P2|Overall Study|Protocol Violation|9
7750972|NCT00808132|26947887|P1|Overall Study|Protocol Violation|8
7750973|NCT00808132|26947883|P5|Overall Study|Lost to Follow-up|9
7750974|NCT00808132|26947884|P4|Overall Study|Lost to Follow-up|8
7750975|NCT00808132|26947885|P3|Overall Study|Lost to Follow-up|11
7750976|NCT00808132|26947886|P2|Overall Study|Lost to Follow-up|10
7750977|NCT00808132|26947887|P1|Overall Study|Lost to Follow-up|8
7750978|NCT00808132|26947883|P5|Overall Study|Physician Decision|0
7750979|NCT00808132|26947884|P4|Overall Study|Physician Decision|0
7750980|NCT00808132|26947885|P3|Overall Study|Physician Decision|0
7750981|NCT00808132|26947886|P2|Overall Study|Physician Decision|1
7750982|NCT00808132|26947887|P1|Overall Study|Physician Decision|0
7750983|NCT00808132|26947883|P5|Overall Study|Death|1
7750984|NCT00808132|26947884|P4|Overall Study|Death|0
7750985|NCT00808132|26947885|P3|Overall Study|Death|0
7750986|NCT00808132|26947886|P2|Overall Study|Death|0
7750987|NCT00808132|26947887|P1|Overall Study|Death|0
7750988|NCT00808132|26947883|P5|Overall Study|Adverse Event|33
7750989|NCT00808132|26947884|P4|Overall Study|Adverse Event|31
7750990|NCT00808132|26947885|P3|Overall Study|Adverse Event|16
7750991|NCT00808132|26947886|P2|Overall Study|Adverse Event|33
7750992|NCT00808132|26947887|P1|Overall Study|Adverse Event|34
7750993|NCT00808080|26947959|P1|Overall Study|Patients Became Ineligible for infusion|6
7750994|NCT00808067|26947966|P2|Overall Study|Excluded from analysis|19
7750995|NCT00808067|26947967|P1|Overall Study|Excluded from analysis|13
7750996|NCT00808067|26947966|P2|Overall Study|Other reason not defined above|5
7750997|NCT00808067|26947967|P1|Overall Study|Other reason not defined above|5
7750998|NCT00808067|26947966|P2|Overall Study|Site closed for cause|19
7750999|NCT00808067|26947967|P1|Overall Study|Site closed for cause|19
7751000|NCT00808067|26947966|P2|Overall Study|Patient elected|9
7751001|NCT00808067|26947967|P1|Overall Study|Patient elected|7
7751002|NCT00808067|26947966|P2|Overall Study|Protocol Violation|11
7751003|NCT00808067|26947967|P1|Overall Study|Protocol Violation|3
7751004|NCT00808067|26947966|P2|Overall Study|Physician Decision|38
7751005|NCT00808067|26947967|P1|Overall Study|Physician Decision|47
7751006|NCT00808067|26947966|P2|Overall Study|Site closed|3
7751007|NCT00808067|26947967|P1|Overall Study|Site closed|4
7751008|NCT00808067|26947966|P2|Overall Study|Withdrawal by Subject|25
7751009|NCT00808067|26947967|P1|Overall Study|Withdrawal by Subject|21
7751010|NCT00808067|26947966|P2|Overall Study|Procedure|7
7751011|NCT00808067|26947967|P1|Overall Study|Procedure|6
7751012|NCT00808067|26947966|P2|Overall Study|Death|1
7751013|NCT00808067|26947967|P1|Overall Study|Death|1
7751014|NCT00808067|26947966|P2|Overall Study|Missing|0
7751015|NCT00808067|26947967|P1|Overall Study|Missing|1
7751016|NCT00808067|26947966|P2|Overall Study|Patient refused to take study medication|76
7751017|NCT00808067|26947967|P1|Overall Study|Patient refused to take study medication|65
7751018|NCT00808067|26947966|P2|Overall Study|Elevated LFT results|3
7751019|NCT00808067|26947967|P1|Overall Study|Elevated LFT results|7
7751020|NCT00808067|26947966|P2|Overall Study|Reduced creatinine clearance|55
7751021|NCT00808067|26947967|P1|Overall Study|Reduced creatinine clearance|53
7751022|NCT00808067|26947966|P2|Overall Study|Hospitalization due to surgery|40
7751023|NCT00808067|26947967|P1|Overall Study|Hospitalization due to surgery|37
7751024|NCT00808067|26947966|P2|Overall Study|Hospitalization (not including surgery)|17
7751025|NCT00808067|26947967|P1|Overall Study|Hospitalization (not including surgery)|18
7751026|NCT00808067|26947966|P2|Overall Study|Adverse Event|121
7751027|NCT00808067|26947967|P1|Overall Study|Adverse Event|111
7751028|NCT00808067|26947966|P2|Overall Study|Outcome event - other|25
7751029|NCT00808067|26947967|P1|Overall Study|Outcome event - other|33
7751030|NCT00808067|26947966|P2|Overall Study|Major/minor bleed|44
7751031|NCT00808067|26947967|P1|Overall Study|Major/minor bleed|30
7751032|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7751033|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
7751034|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7751035|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7751036|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Death|0
7751037|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Death|1
7751038|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Death|0
7751039|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Death|0
7751040|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7751041|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
7751042|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7751043|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7751044|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Other|1
7751045|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Other|1
7751046|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Other|0
7751047|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Other|0
7751048|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
7751049|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
7751050|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
7751051|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
7751052|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
7751053|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
7751054|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
7751055|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
7751056|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
7751057|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
7751058|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
7751059|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
7751060|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7751061|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
7751062|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7751063|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7751064|NCT00808028|26948003|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
7751065|NCT00808028|26948004|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
7751066|NCT00808028|26948005|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
7751067|NCT00808028|26948006|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
7751068|NCT00808028|26948003|P4|Stage 1 (6 Months)|Protocol Violation|1
7751069|NCT00808028|26948004|P3|Stage 1 (6 Months)|Protocol Violation|0
7751070|NCT00808028|26948005|P2|Stage 1 (6 Months)|Protocol Violation|0
7751071|NCT00808028|26948006|P1|Stage 1 (6 Months)|Protocol Violation|0
7751072|NCT00808028|26948003|P4|Stage 1 (6 Months)|Lost to Follow-up|0
7751073|NCT00808028|26948004|P3|Stage 1 (6 Months)|Lost to Follow-up|1
7751074|NCT00808028|26948005|P2|Stage 1 (6 Months)|Lost to Follow-up|0
7751075|NCT00808028|26948006|P1|Stage 1 (6 Months)|Lost to Follow-up|1
7751076|NCT00808028|26948003|P4|Stage 1 (6 Months)|Adverse Event|2
7751077|NCT00808028|26948004|P3|Stage 1 (6 Months)|Adverse Event|1
7751078|NCT00808028|26948005|P2|Stage 1 (6 Months)|Adverse Event|0
7751079|NCT00808028|26948006|P1|Stage 1 (6 Months)|Adverse Event|0
7751080|NCT00808028|26948003|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
7751081|NCT00808028|26948004|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
7751082|NCT00808028|26948005|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
7751083|NCT00808028|26948006|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
7751084|NCT00808028|26948003|P4|Stage 1 (6 Months)|Other|4
7751085|NCT00808028|26948004|P3|Stage 1 (6 Months)|Other|2
7751086|NCT00808028|26948005|P2|Stage 1 (6 Months)|Other|0
7751087|NCT00808028|26948006|P1|Stage 1 (6 Months)|Other|1
7751088|NCT00808028|26948003|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
7751089|NCT00808028|26948004|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
7751090|NCT00808028|26948005|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
7751091|NCT00808028|26948006|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
7751092|NCT00808015|26948042|P1|Overall Study|Enrolled but not treated|4
7751093|NCT00808015|26948042|P1|Overall Study|Other|25
7751094|NCT00808015|26948042|P1|Overall Study|Adverse Event|22
7751095|NCT00808015|26948042|P1|Overall Study|Participants not willing to participate|158
7751096|NCT00808015|26948042|P1|Overall Study|Lost to Follow-up|76
7751097|NCT00808015|26948042|P1|Overall Study|Lack of Efficacy|58
7751098|NCT00808015|26948042|P1|Overall Study|Death|1
7751099|NCT00807937|26948071|P4|Overall Study|All other reasons (not provided)|1
7751100|NCT00807937|26948072|P3|Overall Study|All other reasons (not provided)|0
7751101|NCT00807937|26948073|P2|Overall Study|All other reasons (not provided)|4
7751102|NCT00807937|26948074|P1|Overall Study|All other reasons (not provided)|2
7751103|NCT00807937|26948071|P4|Overall Study|Intake of prohibited medicine|0
7751104|NCT00807937|26948072|P3|Overall Study|Intake of prohibited medicine|2
7751105|NCT00807937|26948073|P2|Overall Study|Intake of prohibited medicine|0
7751106|NCT00807937|26948074|P1|Overall Study|Intake of prohibited medicine|0
7751107|NCT00807937|26948071|P4|Overall Study|Lack of Efficacy|2
7751108|NCT00807937|26948072|P3|Overall Study|Lack of Efficacy|1
7751109|NCT00807937|26948073|P2|Overall Study|Lack of Efficacy|0
7751110|NCT00807937|26948074|P1|Overall Study|Lack of Efficacy|0
7751111|NCT00807937|26948071|P4|Overall Study|Lost to Follow-up|1
7751112|NCT00807937|26948072|P3|Overall Study|Lost to Follow-up|2
7751113|NCT00807937|26948073|P2|Overall Study|Lost to Follow-up|0
7751114|NCT00807937|26948074|P1|Overall Study|Lost to Follow-up|4
7751115|NCT00807937|26948071|P4|Overall Study|Withdrawal by Subject|4
7751116|NCT00807937|26948072|P3|Overall Study|Withdrawal by Subject|1
7751117|NCT00807937|26948073|P2|Overall Study|Withdrawal by Subject|4
7751118|NCT00807937|26948074|P1|Overall Study|Withdrawal by Subject|5
7751119|NCT00807937|26948071|P4|Overall Study|Protocol Violation|3
7751120|NCT00807937|26948072|P3|Overall Study|Protocol Violation|3
7751121|NCT00807937|26948073|P2|Overall Study|Protocol Violation|5
7751122|NCT00807937|26948074|P1|Overall Study|Protocol Violation|4
7751123|NCT00807937|26948071|P4|Overall Study|Adverse Event|4
7751124|NCT00807937|26948072|P3|Overall Study|Adverse Event|5
7751125|NCT00807937|26948073|P2|Overall Study|Adverse Event|12
7751126|NCT00807937|26948074|P1|Overall Study|Adverse Event|12
7751127|NCT00807885|26948109|P9|Overall Study|Lost to Follow-up|0
7751128|NCT00807885|26948110|P8|Overall Study|Lost to Follow-up|0
7751129|NCT00807885|26948111|P7|Overall Study|Lost to Follow-up|0
7751130|NCT00807885|26948112|P6|Overall Study|Lost to Follow-up|1
7751131|NCT00807885|26948113|P5|Overall Study|Lost to Follow-up|0
7751132|NCT00807885|26948114|P4|Overall Study|Lost to Follow-up|0
7751133|NCT00807885|26948115|P3|Overall Study|Lost to Follow-up|0
7751134|NCT00807885|26948116|P2|Overall Study|Lost to Follow-up|0
7751135|NCT00807885|26948117|P1|Overall Study|Lost to Follow-up|0
7751136|NCT00807846|26948166|P2|Overall Study|Other|2
7751137|NCT00807846|26948167|P1|Overall Study|Other|1
7751138|NCT00807846|26948166|P2|Overall Study|Withdrawal by Subject|1
7751139|NCT00807846|26948167|P1|Overall Study|Withdrawal by Subject|2
7751140|NCT00807846|26948166|P2|Overall Study|Protocol Violation|1
7751141|NCT00807846|26948167|P1|Overall Study|Protocol Violation|2
7751142|NCT00807846|26948166|P2|Overall Study|Lack of Efficacy|0
7751143|NCT00807846|26948167|P1|Overall Study|Lack of Efficacy|2
7751144|NCT00807846|26948166|P2|Overall Study|Adverse Event|0
7751145|NCT00807846|26948167|P1|Overall Study|Adverse Event|5
7751146|NCT00807742|26948220|P2|Overall Study|Lost to Follow-up|51
7751147|NCT00807742|26948221|P1|Overall Study|Lost to Follow-up|35
7751148|NCT00807742|26948220|P2|Overall Study|Withdrawal by Subject|1
7751149|NCT00807742|26948221|P1|Overall Study|Withdrawal by Subject|2
7751150|NCT00807742|26948220|P2|Overall Study|Death|2
7751151|NCT00807742|26948221|P1|Overall Study|Death|9
7751152|NCT00807599|26948280|P3|Overall Study|Withdrawal by Subject|1
7751153|NCT00807599|26948281|P2|Overall Study|Withdrawal by Subject|0
7751154|NCT00807599|26948282|P1|Overall Study|Withdrawal by Subject|0
7751155|NCT00807599|26948280|P3|Overall Study|Inadequate response to induction|9
7751156|NCT00807599|26948281|P2|Overall Study|Inadequate response to induction|0
7751157|NCT00807599|26948282|P1|Overall Study|Inadequate response to induction|0
7751158|NCT00807599|26948280|P3|Overall Study|Adverse Event|5
7751159|NCT00807599|26948281|P2|Overall Study|Adverse Event|0
7751160|NCT00807599|26948282|P1|Overall Study|Adverse Event|0
7751161|NCT00807599|26948280|P3|Overall Study|Not treated on protocol study|2
7751162|NCT00807599|26948281|P2|Overall Study|Not treated on protocol study|0
7751163|NCT00807599|26948282|P1|Overall Study|Not treated on protocol study|0
7751164|NCT00807573|26948309|P1|Overall Study|Adverse Event|1
7751165|NCT00807573|26948309|P1|Overall Study|Withdrawal by Subject|1
7751166|NCT00807495|26948355|P5|Overall Study|Reason Not Specified|3
7751167|NCT00807495|26948356|P4|Overall Study|Reason Not Specified|0
7751168|NCT00807495|26948357|P3|Overall Study|Reason Not Specified|2
7751169|NCT00807495|26948358|P2|Overall Study|Reason Not Specified|3
7751170|NCT00807495|26948359|P1|Overall Study|Reason Not Specified|0
7751171|NCT00807495|26948355|P5|Overall Study|Withdrawal by Patient|0
7751172|NCT00807495|26948356|P4|Overall Study|Withdrawal by Patient|0
7751173|NCT00807495|26948357|P3|Overall Study|Withdrawal by Patient|1
7751174|NCT00807495|26948358|P2|Overall Study|Withdrawal by Patient|0
7751175|NCT00807495|26948359|P1|Overall Study|Withdrawal by Patient|2
7751176|NCT00807495|26948355|P5|Overall Study|Adverse Event|2
7751177|NCT00807495|26948356|P4|Overall Study|Adverse Event|1
7751178|NCT00807495|26948357|P3|Overall Study|Adverse Event|1
7751179|NCT00807495|26948358|P2|Overall Study|Adverse Event|3
7751180|NCT00807495|26948359|P1|Overall Study|Adverse Event|6
7751181|NCT00807365|26948405|P1|Overall Study|Study Terminated|5
7751182|NCT00807248|26948413|P4|Overall Study|Other Reason|0
7751183|NCT00807248|26948414|P3|Overall Study|Other Reason|2
7751184|NCT00807248|26948415|P2|Overall Study|Other Reason|0
7751185|NCT00807248|26948416|P1|Overall Study|Other Reason|0
7751186|NCT00807248|26948413|P4|Overall Study|Lost to Follow-up|0
7751187|NCT00807248|26948414|P3|Overall Study|Lost to Follow-up|0
7751188|NCT00807248|26948415|P2|Overall Study|Lost to Follow-up|0
7751189|NCT00807248|26948416|P1|Overall Study|Lost to Follow-up|1
7751190|NCT00807248|26948413|P4|Overall Study|Withdrawal of Consent|5
7751191|NCT00807248|26948414|P3|Overall Study|Withdrawal of Consent|5
7751192|NCT00807248|26948415|P2|Overall Study|Withdrawal of Consent|5
7751193|NCT00807248|26948416|P1|Overall Study|Withdrawal of Consent|5
7751194|NCT00807248|26948413|P4|Overall Study|Protocol Violation|0
7751195|NCT00807248|26948414|P3|Overall Study|Protocol Violation|1
7751196|NCT00807248|26948415|P2|Overall Study|Protocol Violation|1
7751197|NCT00807248|26948416|P1|Overall Study|Protocol Violation|0
7751198|NCT00807248|26948413|P4|Overall Study|Lack of Efficacy|3
7751199|NCT00807248|26948414|P3|Overall Study|Lack of Efficacy|8
7751200|NCT00807248|26948415|P2|Overall Study|Lack of Efficacy|4
7751201|NCT00807248|26948416|P1|Overall Study|Lack of Efficacy|14
7751202|NCT00807248|26948413|P4|Overall Study|Adverse Event|6
7751203|NCT00807248|26948414|P3|Overall Study|Adverse Event|2
7751204|NCT00807248|26948415|P2|Overall Study|Adverse Event|2
7751205|NCT00807248|26948416|P1|Overall Study|Adverse Event|1
7751206|NCT00807235|26948460|P2|Overall Study|Adverse Event|0
7751207|NCT00807235|26948461|P1|Overall Study|Adverse Event|1
7751208|NCT00807144|26948506|P2|Overall Study|Lost to Follow-up|1
7751209|NCT00807144|26948507|P1|Overall Study|Lost to Follow-up|0
7751210|NCT00807092|26948519|P2|Overall Study|CGMS data collection failed|1
7751211|NCT00807092|26948520|P1|Overall Study|CGMS data collection failed|0
7751212|NCT00807092|26948519|P2|Overall Study|Withdrawal by Subject|0
7751213|NCT00807092|26948520|P1|Overall Study|Withdrawal by Subject|1
7751214|NCT00807092|26948519|P2|Overall Study|Protocol Violation|2
7751215|NCT00807092|26948520|P1|Overall Study|Protocol Violation|0
7751216|NCT00807092|26948519|P2|Overall Study|Adverse Event|1
7751217|NCT00807092|26948520|P1|Overall Study|Adverse Event|0
7751218|NCT00807040|26948550|P2|Overall Study|Lost to Follow-up|6
7751219|NCT00807040|26948551|P1|Overall Study|Lost to Follow-up|4
7751220|NCT00807040|26948550|P2|Overall Study|Withdrawal by Subject|6
7751221|NCT00807040|26948551|P1|Overall Study|Withdrawal by Subject|8
7751222|NCT00807040|26948550|P2|Overall Study|Death|29
7751223|NCT00807040|26948551|P1|Overall Study|Death|24
7751224|NCT00807014|26948561|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
7751225|NCT00807014|26948562|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
7751226|NCT00807014|26948561|P2|Overall Study|Recovery|0
7751227|NCT00807014|26948562|P1|Overall Study|Recovery|1
7751228|NCT00807014|26948561|P2|Overall Study|Lost to Follow-up|7
7751229|NCT00807014|26948562|P1|Overall Study|Lost to Follow-up|9
7751230|NCT00807014|26948561|P2|Overall Study|Adverse Event|2
7751231|NCT00807014|26948562|P1|Overall Study|Adverse Event|0
7751232|NCT00807014|26948561|P2|Overall Study|Protocol Violation|8
7751233|NCT00807014|26948562|P1|Overall Study|Protocol Violation|2
7751234|NCT00807014|26948561|P2|Overall Study|Participant Considered Disease Not Cured|7
7751235|NCT00807014|26948562|P1|Overall Study|Participant Considered Disease Not Cured|2
7751236|NCT00807014|26948561|P2|Overall Study|Participant Considered Disease Cured|2
7751237|NCT00807014|26948562|P1|Overall Study|Participant Considered Disease Cured|13
7751238|NCT00807001|26948593|P5|Overall Study|Non-compliance|0
7751239|NCT00807001|26948594|P4|Overall Study|Non-compliance|0
7751240|NCT00807001|26948595|P3|Overall Study|Non-compliance|0
7751241|NCT00807001|26948596|P2|Overall Study|Non-compliance|1
7751242|NCT00807001|26948597|P1|Overall Study|Non-compliance|0
7751243|NCT00806988|26948616|P2|Overall Study|Lost to Follow-up|19
7751244|NCT00806988|26948617|P1|Overall Study|Lost to Follow-up|4
7751245|NCT00806988|26948616|P2|Overall Study|Withdrawal by Subject|8
7751246|NCT00806988|26948617|P1|Overall Study|Withdrawal by Subject|8
7751247|NCT00806988|26948616|P2|Overall Study|Death|16
7751248|NCT00806988|26948617|P1|Overall Study|Death|15
7751249|NCT00806819|26948627|P2|Overall Study|Reasons other than stated above|41
7751250|NCT00806819|26948628|P1|Overall Study|Reasons other than stated above|25
7751251|NCT00806819|26948627|P2|Overall Study|Not treated|3
7751252|NCT00806819|26948628|P1|Overall Study|Not treated|6
7751253|NCT00806819|26948627|P2|Overall Study|Withdrawal by Subject|29
7751254|NCT00806819|26948628|P1|Overall Study|Withdrawal by Subject|32
7751255|NCT00806819|26948627|P2|Overall Study|Lost to Follow-up|0
7751256|NCT00806819|26948628|P1|Overall Study|Lost to Follow-up|1
7751257|NCT00806819|26948627|P2|Overall Study|Protocol Violation|4
7751258|NCT00806819|26948628|P1|Overall Study|Protocol Violation|9
7751259|NCT00806819|26948627|P2|Overall Study|Other AE|40
7751260|NCT00806819|26948628|P1|Overall Study|Other AE|38
7751261|NCT00806819|26948627|P2|Overall Study|Worsening or AE of underlying disease|25
7751262|NCT00806819|26948628|P1|Overall Study|Worsening or AE of underlying disease|18
7751263|NCT00806819|26948627|P2|Overall Study|progressive disease (modified RECIST )|216
7751264|NCT00806819|26948628|P1|Overall Study|progressive disease (modified RECIST )|217
7751265|NCT00806624|26948697|P3|Overall Study|discontinued before start of treatment|1
7751266|NCT00806624|26948698|P2|Overall Study|discontinued before start of treatment|0
7751267|NCT00806624|26948699|P1|Overall Study|discontinued before start of treatment|0
7751268|NCT00806624|26948697|P3|Overall Study|Withdrawal by Subject|3
7751269|NCT00806624|26948698|P2|Overall Study|Withdrawal by Subject|3
7751270|NCT00806624|26948699|P1|Overall Study|Withdrawal by Subject|6
7751271|NCT00806624|26948697|P3|Overall Study|Lost to Follow-up|1
7751272|NCT00806624|26948698|P2|Overall Study|Lost to Follow-up|0
7751273|NCT00806624|26948699|P1|Overall Study|Lost to Follow-up|1
7751274|NCT00806624|26948697|P3|Overall Study|Death|1
7751275|NCT00806624|26948698|P2|Overall Study|Death|1
7751276|NCT00806624|26948699|P1|Overall Study|Death|0
7751277|NCT00806624|26948697|P3|Overall Study|Adverse Event|0
7751278|NCT00806624|26948698|P2|Overall Study|Adverse Event|8
7751279|NCT00806624|26948699|P1|Overall Study|Adverse Event|2
7751280|NCT00806585|26948716|P5|Overall Study|Completion status unknown|12
7751281|NCT00806585|26948717|P4|Overall Study|Completion status unknown|4
7751282|NCT00806585|26948718|P3|Overall Study|Completion status unknown|12
7751283|NCT00806585|26948719|P2|Overall Study|Completion status unknown|14
7751284|NCT00806585|26948720|P1|Overall Study|Completion status unknown|15
7751285|NCT00806585|26948716|P5|Overall Study|Withdrawal by Subject|11
7751286|NCT00806585|26948717|P4|Overall Study|Withdrawal by Subject|3
7751287|NCT00806585|26948718|P3|Overall Study|Withdrawal by Subject|9
7751288|NCT00806585|26948719|P2|Overall Study|Withdrawal by Subject|8
7751289|NCT00806585|26948720|P1|Overall Study|Withdrawal by Subject|10
7751290|NCT00806585|26948716|P5|Overall Study|Adverse Event|2
7751291|NCT00806585|26948717|P4|Overall Study|Adverse Event|4
7751292|NCT00806585|26948718|P3|Overall Study|Adverse Event|3
7751293|NCT00806585|26948719|P2|Overall Study|Adverse Event|5
7751294|NCT00806585|26948720|P1|Overall Study|Adverse Event|1
7751295|NCT00806585|26948716|P5|Overall Study|Lack of Efficacy|0
7751296|NCT00806585|26948717|P4|Overall Study|Lack of Efficacy|0
7751297|NCT00806585|26948718|P3|Overall Study|Lack of Efficacy|0
7751298|NCT00806585|26948719|P2|Overall Study|Lack of Efficacy|0
7751299|NCT00806585|26948720|P1|Overall Study|Lack of Efficacy|1
7751300|NCT00806585|26948716|P5|Overall Study|Lost to Follow-up|5
7751301|NCT00806585|26948717|P4|Overall Study|Lost to Follow-up|2
7751302|NCT00806585|26948718|P3|Overall Study|Lost to Follow-up|2
7751303|NCT00806585|26948719|P2|Overall Study|Lost to Follow-up|1
7751304|NCT00806585|26948720|P1|Overall Study|Lost to Follow-up|2
7751305|NCT00806585|26948716|P5|Overall Study|Physician Decision|1
7751306|NCT00806585|26948717|P4|Overall Study|Physician Decision|0
7751307|NCT00806585|26948718|P3|Overall Study|Physician Decision|3
7751308|NCT00806585|26948719|P2|Overall Study|Physician Decision|2
7751309|NCT00806585|26948720|P1|Overall Study|Physician Decision|0
7751310|NCT00806585|26948716|P5|Overall Study|Protocol Violation|0
7751311|NCT00806585|26948717|P4|Overall Study|Protocol Violation|0
7751312|NCT00806585|26948718|P3|Overall Study|Protocol Violation|2
7751313|NCT00806585|26948719|P2|Overall Study|Protocol Violation|1
7751314|NCT00806585|26948720|P1|Overall Study|Protocol Violation|3
7751315|NCT00806585|26948716|P5|Overall Study|Study terminated by Sponsor|0
7751316|NCT00806585|26948717|P4|Overall Study|Study terminated by Sponsor|2
7751317|NCT00806585|26948718|P3|Overall Study|Study terminated by Sponsor|1
7751318|NCT00806585|26948719|P2|Overall Study|Study terminated by Sponsor|0
7751319|NCT00806585|26948720|P1|Overall Study|Study terminated by Sponsor|0
7751320|NCT00806546|26948752|P1|Overall Study|Various|42
7751321|NCT00806546|26948752|P1|Overall Study|Protocol Violation|49
7751322|NCT00806546|26948752|P1|Overall Study|Withdrawal by Subject|75
7751323|NCT00806546|26948752|P1|Overall Study|Adverse Event|74
7751324|NCT00806546|26948752|P1|Overall Study|Lost to Follow-up|32
7751325|NCT00806546|26948752|P1|Overall Study|Enrolled, not treated|35
7751326|NCT00806494|26948756|P1|Overall Study|Withdrawal by Subject|5
7751327|NCT00806494|26948756|P1|Overall Study|Other|30
7751328|NCT00806494|26948756|P1|Overall Study|Lost to Follow-up|10
7751329|NCT00806494|26948756|P1|Overall Study|Lack of Efficacy|6
7751330|NCT00806494|26948756|P1|Overall Study|Adverse Event|29
7751331|NCT00806442|26948780|P2|Overall Study|Withdrawal by Subject|5
7751332|NCT00806442|26948781|P1|Overall Study|Withdrawal by Subject|1
7751333|NCT00806442|26948780|P2|Overall Study|Lost to Follow-up|2
7751334|NCT00806442|26948781|P1|Overall Study|Lost to Follow-up|3
7751335|NCT00806416|26948803|P4|Period 1 - Part II|Withdrawal by Subject|2
7751336|NCT00806416|26948804|P3|Period 1 - Part II|Withdrawal by Subject|0
7751337|NCT00806416|26948805|P2|Period 1 - Part II|Withdrawal by Subject|0
7751338|NCT00806416|26948806|P1|Period 1 - Part II|Withdrawal by Subject|0
7751339|NCT00806416|26948803|P4|Period 1 - Part I|Withdrawal by Subject|0
7751340|NCT00806416|26948804|P3|Period 1 - Part I|Withdrawal by Subject|0
7751341|NCT00806416|26948805|P2|Period 1 - Part I|Withdrawal by Subject|1
7751342|NCT00806416|26948806|P1|Period 1 - Part I|Withdrawal by Subject|3
7751343|NCT00806416|26948803|P4|Period 1 - Part I|Lost to Follow-up|0
7751344|NCT00806416|26948804|P3|Period 1 - Part I|Lost to Follow-up|0
7751345|NCT00806416|26948805|P2|Period 1 - Part I|Lost to Follow-up|2
7751346|NCT00806416|26948806|P1|Period 1 - Part I|Lost to Follow-up|0
7751347|NCT00806416|26948803|P4|Period 1 - Part I|Adverse Event|0
7751348|NCT00806416|26948804|P3|Period 1 - Part I|Adverse Event|0
7751349|NCT00806416|26948805|P2|Period 1 - Part I|Adverse Event|1
7751350|NCT00806416|26948806|P1|Period 1 - Part I|Adverse Event|0
7751351|NCT00806403|26948819|P2|Overall Study|Death|3
7751352|NCT00806403|26948820|P1|Overall Study|Death|4
7751353|NCT00806351|26948843|P2|Overall Study|Death|4
7751354|NCT00806351|26948844|P1|Overall Study|Death|5
7751355|NCT00806286|26948878|P3|Overall Study|Due to a variety of reasons|1
7751356|NCT00806286|26948879|P2|Overall Study|Due to a variety of reasons|2
7751357|NCT00806286|26948880|P1|Overall Study|Due to a variety of reasons|7
7751358|NCT00806286|26948878|P3|Overall Study|Physician Decision|0
7751359|NCT00806286|26948879|P2|Overall Study|Physician Decision|2
7751360|NCT00806286|26948880|P1|Overall Study|Physician Decision|2
7751361|NCT00806286|26948878|P3|Overall Study|Withdrawal by Subject|1
7751362|NCT00806286|26948879|P2|Overall Study|Withdrawal by Subject|3
7751363|NCT00806286|26948880|P1|Overall Study|Withdrawal by Subject|8
7751364|NCT00806286|26948878|P3|Overall Study|Lost to Follow-up|0
7751365|NCT00806286|26948879|P2|Overall Study|Lost to Follow-up|1
7751366|NCT00806286|26948880|P1|Overall Study|Lost to Follow-up|0
7751367|NCT00806286|26948878|P3|Overall Study|Death|0
7751368|NCT00806286|26948879|P2|Overall Study|Death|6
7751369|NCT00806286|26948880|P1|Overall Study|Death|1
7751370|NCT00806286|26948878|P3|Overall Study|Disease progression|1
7751371|NCT00806286|26948879|P2|Overall Study|Disease progression|38
7751372|NCT00806286|26948880|P1|Overall Study|Disease progression|31
7751373|NCT00806286|26948878|P3|Overall Study|Adverse Event|0
7751374|NCT00806286|26948879|P2|Overall Study|Adverse Event|2
7751375|NCT00806286|26948880|P1|Overall Study|Adverse Event|5
7751376|NCT00806260|26948902|P6|Period 3|Pregnancy|0
7751377|NCT00806260|26948903|P5|Period 3|Pregnancy|0
7751378|NCT00806260|26948904|P4|Period 3|Pregnancy|0
7751379|NCT00806260|26948905|P3|Period 3|Pregnancy|0
7751380|NCT00806260|26948906|P2|Period 3|Pregnancy|0
7751381|NCT00806260|26948907|P1|Period 3|Pregnancy|1
7751382|NCT00806260|26948902|P6|Period 3|Protocol Violation|0
7751383|NCT00806260|26948903|P5|Period 3|Protocol Violation|0
7751384|NCT00806260|26948904|P4|Period 3|Protocol Violation|0
7751385|NCT00806260|26948905|P3|Period 3|Protocol Violation|1
7751386|NCT00806260|26948906|P2|Period 3|Protocol Violation|1
7751387|NCT00806260|26948907|P1|Period 3|Protocol Violation|0
7751388|NCT00806260|26948902|P6|Period 2|sponsor request|0
7751389|NCT00806260|26948903|P5|Period 2|sponsor request|0
7751390|NCT00806260|26948904|P4|Period 2|sponsor request|1
7751391|NCT00806260|26948905|P3|Period 2|sponsor request|1
7751392|NCT00806260|26948906|P2|Period 2|sponsor request|0
7751393|NCT00806260|26948907|P1|Period 2|sponsor request|0
7751394|NCT00806260|26948902|P6|Period 2|Need to take concomitant medication|0
7751395|NCT00806260|26948903|P5|Period 2|Need to take concomitant medication|0
7751396|NCT00806260|26948904|P4|Period 2|Need to take concomitant medication|0
7751397|NCT00806260|26948905|P3|Period 2|Need to take concomitant medication|0
7751398|NCT00806260|26948906|P2|Period 2|Need to take concomitant medication|0
7751399|NCT00806260|26948907|P1|Period 2|Need to take concomitant medication|1
7751400|NCT00806260|26948902|P6|Period 2|Protocol Violation|0
7751401|NCT00806260|26948903|P5|Period 2|Protocol Violation|0
7751402|NCT00806260|26948904|P4|Period 2|Protocol Violation|0
7751403|NCT00806260|26948905|P3|Period 2|Protocol Violation|1
7751404|NCT00806260|26948906|P2|Period 2|Protocol Violation|0
7751405|NCT00806260|26948907|P1|Period 2|Protocol Violation|1
7751406|NCT00806260|26948902|P6|Period 2|Adverse Event|0
7751407|NCT00806260|26948903|P5|Period 2|Adverse Event|0
7751408|NCT00806260|26948904|P4|Period 2|Adverse Event|1
7751409|NCT00806260|26948905|P3|Period 2|Adverse Event|0
7751410|NCT00806260|26948906|P2|Period 2|Adverse Event|0
7751411|NCT00806260|26948907|P1|Period 2|Adverse Event|0
7751412|NCT00806260|26948902|P6|Period 1 (1 Day)|Adverse Event|0
7751413|NCT00806260|26948903|P5|Period 1 (1 Day)|Adverse Event|3
7751414|NCT00806260|26948904|P4|Period 1 (1 Day)|Adverse Event|0
7751415|NCT00806260|26948905|P3|Period 1 (1 Day)|Adverse Event|0
7751416|NCT00806260|26948906|P2|Period 1 (1 Day)|Adverse Event|0
7751417|NCT00806260|26948907|P1|Period 1 (1 Day)|Adverse Event|0
7751418|NCT00806195|26948952|P4|Overall Study|Protocol Violation|9
7751419|NCT00806195|26948953|P3|Overall Study|Protocol Violation|26
7751420|NCT00806195|26948954|P2|Overall Study|Protocol Violation|24
7751421|NCT00806195|26948955|P1|Overall Study|Protocol Violation|34
7751422|NCT00806195|26948952|P4|Overall Study|Administrative Reason|26
7751423|NCT00806195|26948953|P3|Overall Study|Administrative Reason|66
7751424|NCT00806195|26948954|P2|Overall Study|Administrative Reason|35
7751425|NCT00806195|26948955|P1|Overall Study|Administrative Reason|113
7751426|NCT00806195|26948952|P4|Overall Study|Inappropriate Enrollment|0
7751427|NCT00806195|26948953|P3|Overall Study|Inappropriate Enrollment|0
7751428|NCT00806195|26948954|P2|Overall Study|Inappropriate Enrollment|1
7751429|NCT00806195|26948955|P1|Overall Study|Inappropriate Enrollment|0
7751430|NCT00806195|26948952|P4|Overall Study|Lost to Follow-up|34
7751431|NCT00806195|26948953|P3|Overall Study|Lost to Follow-up|90
7751432|NCT00806195|26948954|P2|Overall Study|Lost to Follow-up|66
7751433|NCT00806195|26948955|P1|Overall Study|Lost to Follow-up|217
7751434|NCT00806195|26948952|P4|Overall Study|Withdrawal by Subject|35
7751435|NCT00806195|26948953|P3|Overall Study|Withdrawal by Subject|76
7751436|NCT00806195|26948954|P2|Overall Study|Withdrawal by Subject|31
7751437|NCT00806195|26948955|P1|Overall Study|Withdrawal by Subject|119
7751438|NCT00806195|26948952|P4|Overall Study|Adverse Event|2
7751439|NCT00806195|26948953|P3|Overall Study|Adverse Event|11
7751440|NCT00806195|26948954|P2|Overall Study|Adverse Event|5
7751441|NCT00806195|26948955|P1|Overall Study|Adverse Event|25
7751442|NCT00806195|26948952|P4|Overall Study|Death|0
7751443|NCT00806195|26948953|P3|Overall Study|Death|1
7751444|NCT00806195|26948954|P2|Overall Study|Death|0
7751445|NCT00806195|26948955|P1|Overall Study|Death|6
7751446|NCT00806156|26948969|P2|Overall Study|Lost to Follow-up|1
7751447|NCT00806156|26948970|P1|Overall Study|Lost to Follow-up|0
7751448|NCT00806156|26948969|P2|Overall Study|Consent withdrawn by subject|3
7751449|NCT00806156|26948970|P1|Overall Study|Consent withdrawn by subject|1
7751450|NCT00806156|26948969|P2|Overall Study|Study terminated by Sponsor|40
7751451|NCT00806156|26948970|P1|Overall Study|Study terminated by Sponsor|2
7751452|NCT00806156|26948969|P2|Overall Study|Did not meet eligibility criteria|0
7751453|NCT00806156|26948970|P1|Overall Study|Did not meet eligibility criteria|1
7751454|NCT00806156|26948969|P2|Overall Study|Death|95
7751455|NCT00806156|26948970|P1|Overall Study|Death|35
7751456|NCT00806026|26949070|P6|Overall Study|Adverse Event|9
7751457|NCT00806026|26949071|P5|Overall Study|Adverse Event|9
7751458|NCT00806026|26949072|P4|Overall Study|Adverse Event|17
7751459|NCT00806026|26949073|P3|Overall Study|Adverse Event|44
7751460|NCT00806026|26949074|P2|Overall Study|Adverse Event|35
7751461|NCT00806026|26949075|P1|Overall Study|Adverse Event|52
7751462|NCT00806026|26949070|P6|Overall Study|Protocol Violation|3
7751463|NCT00806026|26949071|P5|Overall Study|Protocol Violation|2
7751464|NCT00806026|26949072|P4|Overall Study|Protocol Violation|0
7751465|NCT00806026|26949073|P3|Overall Study|Protocol Violation|9
7751466|NCT00806026|26949074|P2|Overall Study|Protocol Violation|9
7751467|NCT00806026|26949075|P1|Overall Study|Protocol Violation|6
7751468|NCT00806026|26949070|P6|Overall Study|Other|4
7751469|NCT00806026|26949071|P5|Overall Study|Other|0
7751470|NCT00806026|26949072|P4|Overall Study|Other|2
7751471|NCT00806026|26949073|P3|Overall Study|Other|8
7751472|NCT00806026|26949074|P2|Overall Study|Other|6
7751473|NCT00806026|26949075|P1|Overall Study|Other|3
7751474|NCT00806026|26949070|P6|Overall Study|Withdrawal by Subject|3
7751475|NCT00806026|26949071|P5|Overall Study|Withdrawal by Subject|5
7751476|NCT00806026|26949072|P4|Overall Study|Withdrawal by Subject|2
7751477|NCT00806026|26949073|P3|Overall Study|Withdrawal by Subject|9
7751478|NCT00806026|26949074|P2|Overall Study|Withdrawal by Subject|17
7751479|NCT00806026|26949075|P1|Overall Study|Withdrawal by Subject|14
7751480|NCT00806026|26949070|P6|Overall Study|Lost to Follow-up|6
7751481|NCT00806026|26949071|P5|Overall Study|Lost to Follow-up|6
7751482|NCT00806026|26949072|P4|Overall Study|Lost to Follow-up|2
7751483|NCT00806026|26949073|P3|Overall Study|Lost to Follow-up|8
7751484|NCT00806026|26949074|P2|Overall Study|Lost to Follow-up|15
7751485|NCT00806026|26949075|P1|Overall Study|Lost to Follow-up|8
7751486|NCT00806026|26949070|P6|Overall Study|Lack of Efficacy|7
7751487|NCT00806026|26949071|P5|Overall Study|Lack of Efficacy|8
7751488|NCT00806026|26949072|P4|Overall Study|Lack of Efficacy|4
7751489|NCT00806026|26949073|P3|Overall Study|Lack of Efficacy|13
7751490|NCT00806026|26949074|P2|Overall Study|Lack of Efficacy|18
7751491|NCT00806026|26949075|P1|Overall Study|Lack of Efficacy|5
7751492|NCT00806026|26949070|P6|Overall Study|Did not meet entrance criteria|0
7751493|NCT00806026|26949071|P5|Overall Study|Did not meet entrance criteria|0
7751494|NCT00806026|26949072|P4|Overall Study|Did not meet entrance criteria|1
7751495|NCT00806026|26949073|P3|Overall Study|Did not meet entrance criteria|2
7751496|NCT00806026|26949074|P2|Overall Study|Did not meet entrance criteria|1
7751497|NCT00806026|26949075|P1|Overall Study|Did not meet entrance criteria|4
7751498|NCT00806026|26949070|P6|Overall Study|Death|0
7751499|NCT00806026|26949071|P5|Overall Study|Death|0
7751500|NCT00806026|26949072|P4|Overall Study|Death|1
7751501|NCT00806026|26949073|P3|Overall Study|Death|0
7751502|NCT00806026|26949074|P2|Overall Study|Death|0
7751503|NCT00806026|26949075|P1|Overall Study|Death|0
7751504|NCT00805961|26949170|P1|Maintenance Treatment|Withdrawn Consent|1
7751505|NCT00805961|26949170|P1|Maintenance Treatment|Symptomatic Deterioration|2
7751506|NCT00805961|26949170|P1|Maintenance Treatment|Withdrawal by Subject|5
7751507|NCT00805961|26949170|P1|Maintenance Treatment|Adverse Event|6
7751508|NCT00805961|26949170|P1|Maintenance Treatment|Intercurrent Illness|7
7751509|NCT00805961|26949170|P1|Maintenance Treatment|Lack of Efficacy|13
7751510|NCT00805961|26949170|P1|Treatment-Free Interval|Lack of Efficacy|1
7751511|NCT00805961|26949170|P1|Treatment-Free Interval|Physician Decision|1
7751512|NCT00805961|26949170|P1|Treatment-Free Interval|Intercurrent Illness|2
7751513|NCT00805961|26949170|P1|Treatment-Free Interval|Adverse Event|3
7751514|NCT00805961|26949170|P1|Modality Therapy|Disease Progression|2
7751515|NCT00805961|26949170|P1|Modality Therapy|Adverse Event|1
7751516|NCT00805961|26949170|P1|Modality Therapy|Withdrawal by Subject|1
7751517|NCT00805935|26949194|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
7751518|NCT00805935|26949195|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
7751519|NCT00805935|26949196|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
7751520|NCT00805935|26949197|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
7751521|NCT00805935|26949194|P4|Overall Study|Ectopic pregnancy|0
7751522|NCT00805935|26949195|P3|Overall Study|Ectopic pregnancy|1
7751523|NCT00805935|26949196|P2|Overall Study|Ectopic pregnancy|0
7751524|NCT00805935|26949197|P1|Overall Study|Ectopic pregnancy|0
7751525|NCT00805935|26949194|P4|Overall Study|Chemical pregnancy|2
7751526|NCT00805935|26949195|P3|Overall Study|Chemical pregnancy|3
7751527|NCT00805935|26949196|P2|Overall Study|Chemical pregnancy|5
7751528|NCT00805935|26949197|P1|Overall Study|Chemical pregnancy|0
7751529|NCT00805935|26949194|P4|Overall Study|Biochemical pregnancy|0
7751530|NCT00805935|26949195|P3|Overall Study|Biochemical pregnancy|0
7751531|NCT00805935|26949196|P2|Overall Study|Biochemical pregnancy|1
7751532|NCT00805935|26949197|P1|Overall Study|Biochemical pregnancy|0
7751533|NCT00805935|26949194|P4|Overall Study|Pregnancy loss/miscarriage|0
7751534|NCT00805935|26949195|P3|Overall Study|Pregnancy loss/miscarriage|0
7751535|NCT00805935|26949196|P2|Overall Study|Pregnancy loss/miscarriage|0
7751536|NCT00805935|26949197|P1|Overall Study|Pregnancy loss/miscarriage|2
7751537|NCT00805935|26949194|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
7751538|NCT00805935|26949195|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
7751539|NCT00805935|26949196|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
7751540|NCT00805935|26949197|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
7751541|NCT00805935|26949194|P4|Overall Study|No positive serum pregnancy|5
7751542|NCT00805935|26949195|P3|Overall Study|No positive serum pregnancy|6
7751543|NCT00805935|26949196|P2|Overall Study|No positive serum pregnancy|7
7751544|NCT00805935|26949197|P1|Overall Study|No positive serum pregnancy|8
7751545|NCT00805935|26949194|P4|Overall Study|Lost to Follow-up|0
7751546|NCT00805935|26949195|P3|Overall Study|Lost to Follow-up|0
7751547|NCT00805935|26949196|P2|Overall Study|Lost to Follow-up|0
7751548|NCT00805935|26949197|P1|Overall Study|Lost to Follow-up|1
7751549|NCT00805935|26949194|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
7751550|NCT00805935|26949195|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7751551|NCT00805935|26949196|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7751552|NCT00805935|26949197|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7751553|NCT00805935|26949194|P4|Overall Study|Cycle cancellation for risk of OHSS|0
7751554|NCT00805935|26949195|P3|Overall Study|Cycle cancellation for risk of OHSS|1
7751555|NCT00805935|26949196|P2|Overall Study|Cycle cancellation for risk of OHSS|0
7751556|NCT00805935|26949197|P1|Overall Study|Cycle cancellation for risk of OHSS|1
7751557|NCT00805935|26949194|P4|Overall Study|Cycle cancelled|0
7751558|NCT00805935|26949195|P3|Overall Study|Cycle cancelled|2
7751559|NCT00805935|26949196|P2|Overall Study|Cycle cancelled|0
7751560|NCT00805935|26949197|P1|Overall Study|Cycle cancelled|0
7751561|NCT00805935|26949194|P4|Overall Study|Stimulation Failure|2
7751562|NCT00805935|26949195|P3|Overall Study|Stimulation Failure|2
7751563|NCT00805935|26949196|P2|Overall Study|Stimulation Failure|5
7751564|NCT00805935|26949197|P1|Overall Study|Stimulation Failure|1
7751565|NCT00805792|26949264|P1|Overall Study|Lost to Follow-up|2
7751566|NCT00805792|26949264|P1|Overall Study|Death|3
7751567|NCT00805766|26949272|P1|Increased Dose Period|Withdrawal by Subject|1
7751568|NCT00805766|26949272|P1|Increased Dose Period|Pregnancy|1
7751569|NCT00805766|26949272|P1|Increased Dose Period|Lack of Efficacy|7
7751570|NCT00805766|26949272|P1|Increased Dose Period|Adverse Event|4
7751571|NCT00805766|26949272|P1|Screening Period|Responder|2
7751572|NCT00805766|26949272|P1|Screening Period|Pregnancy|1
7751573|NCT00805766|26949272|P1|Screening Period|Lack of Efficacy|2
7751574|NCT00805766|26949272|P1|Screening Period|Adverse Event|1
7751575|NCT00805740|26949286|P2|Overall Study|Randomized, but not treated|0
7751576|NCT00805740|26949287|P1|Overall Study|Randomized, but not treated|2
7751577|NCT00805740|26949286|P2|Overall Study|Lost to Follow-up|0
7751578|NCT00805740|26949287|P1|Overall Study|Lost to Follow-up|1
7751579|NCT00805740|26949286|P2|Overall Study|Withdrawal by Subject|0
7751580|NCT00805740|26949287|P1|Overall Study|Withdrawal by Subject|1
7751581|NCT00805740|26949286|P2|Overall Study|Death|4
7751582|NCT00805740|26949287|P1|Overall Study|Death|7
7751583|NCT00805675|26949312|P3|Overall Study|Adverse Event|1
7751584|NCT00805675|26949313|P2|Overall Study|Adverse Event|0
7751585|NCT00805675|26949314|P1|Overall Study|Adverse Event|0
7751586|NCT00805545|26949348|P2|Overall Study|Protocol Violation|1
7751587|NCT00805545|26949349|P1|Overall Study|Protocol Violation|3
7751588|NCT00805545|26949348|P2|Overall Study|Protocol Violation|2
7751589|NCT00805545|26949349|P1|Overall Study|Protocol Violation|3
7751590|NCT00805532|26949357|P2|Overall Study|invalid data|1
7751591|NCT00805532|26949358|P1|Overall Study|invalid data|0
7751592|NCT00805480|26949392|P4|Overall Study|Adverse Event|0
7751593|NCT00805480|26949393|P3|Overall Study|Adverse Event|1
7751594|NCT00805480|26949394|P2|Overall Study|Adverse Event|0
7751595|NCT00805480|26949395|P1|Overall Study|Adverse Event|0
7751596|NCT00805480|26949392|P4|Overall Study|Lost to Follow-up|0
7751597|NCT00805480|26949393|P3|Overall Study|Lost to Follow-up|0
7751598|NCT00805480|26949394|P2|Overall Study|Lost to Follow-up|2
7751599|NCT00805480|26949395|P1|Overall Study|Lost to Follow-up|1
7751600|NCT00805480|26949392|P4|Overall Study|Withdrawal by Subject|5
7751601|NCT00805480|26949393|P3|Overall Study|Withdrawal by Subject|11
7751602|NCT00805480|26949394|P2|Overall Study|Withdrawal by Subject|5
7751603|NCT00805480|26949395|P1|Overall Study|Withdrawal by Subject|13
7751604|NCT00805467|26949424|P4|Overall Study|Not reported|7
7751605|NCT00805467|26949425|P3|Overall Study|Not reported|3
7751606|NCT00805467|26949426|P2|Overall Study|Not reported|0
7751607|NCT00805467|26949427|P1|Overall Study|Not reported|0
7751608|NCT00805467|26949424|P4|Overall Study|Physician Decision|6
7751609|NCT00805467|26949425|P3|Overall Study|Physician Decision|2
7751610|NCT00805467|26949426|P2|Overall Study|Physician Decision|1
7751611|NCT00805467|26949427|P1|Overall Study|Physician Decision|0
7751612|NCT00805467|26949424|P4|Overall Study|Death|5
7751613|NCT00805467|26949425|P3|Overall Study|Death|7
7751614|NCT00805467|26949426|P2|Overall Study|Death|2
7751615|NCT00805467|26949427|P1|Overall Study|Death|0
7751616|NCT00805467|26949424|P4|Overall Study|Adverse Event|57
7751617|NCT00805467|26949425|P3|Overall Study|Adverse Event|26
7751618|NCT00805467|26949426|P2|Overall Study|Adverse Event|13
7751619|NCT00805467|26949427|P1|Overall Study|Adverse Event|0
7751620|NCT00805467|26949424|P4|Overall Study|Protocol Violation|5
7751621|NCT00805467|26949425|P3|Overall Study|Protocol Violation|0
7751622|NCT00805467|26949426|P2|Overall Study|Protocol Violation|3
7751623|NCT00805467|26949427|P1|Overall Study|Protocol Violation|0
7751624|NCT00805467|26949424|P4|Overall Study|Withdrawal by Subject|50
7751625|NCT00805467|26949425|P3|Overall Study|Withdrawal by Subject|45
7751626|NCT00805467|26949426|P2|Overall Study|Withdrawal by Subject|6
7751627|NCT00805467|26949427|P1|Overall Study|Withdrawal by Subject|0
7751628|NCT00805467|26949424|P4|Overall Study|Lost to Follow-up|21
7751629|NCT00805467|26949425|P3|Overall Study|Lost to Follow-up|7
7751630|NCT00805467|26949426|P2|Overall Study|Lost to Follow-up|1
7751631|NCT00805467|26949427|P1|Overall Study|Lost to Follow-up|0
7751632|NCT00805467|26949424|P4|Overall Study|Lack of Efficacy|86
7751633|NCT00805467|26949425|P3|Overall Study|Lack of Efficacy|13
7751634|NCT00805467|26949426|P2|Overall Study|Lack of Efficacy|8
7751635|NCT00805467|26949427|P1|Overall Study|Lack of Efficacy|0
7751636|NCT00805441|26949447|P2|Overall Study|Acute Alcohol Withdrawal|1
7751637|NCT00805441|26949448|P1|Overall Study|Acute Alcohol Withdrawal|0
7751638|NCT00805441|26949447|P2|Overall Study|Physician Decision|1
7751639|NCT00805441|26949448|P1|Overall Study|Physician Decision|0
7751640|NCT00805441|26949447|P2|Overall Study|Withdrawal by Subject|9
7751641|NCT00805441|26949448|P1|Overall Study|Withdrawal by Subject|15
7751642|NCT00805441|26949447|P2|Overall Study|Lost to Follow-up|13
7751643|NCT00805441|26949448|P1|Overall Study|Lost to Follow-up|10
7751644|NCT00805441|26949447|P2|Overall Study|Protocol Violation|8
7751645|NCT00805441|26949448|P1|Overall Study|Protocol Violation|4
7751646|NCT00805441|26949447|P2|Overall Study|Lack of Efficacy|2
7751647|NCT00805441|26949448|P1|Overall Study|Lack of Efficacy|0
7751648|NCT00805441|26949447|P2|Overall Study|Adverse Event|2
7751649|NCT00805441|26949448|P1|Overall Study|Adverse Event|5
7751650|NCT00805389|26949483|P5|Overall Study|Withdrawal by Subject|4
7751651|NCT00805389|26949484|P4|Overall Study|Withdrawal by Subject|5
7751652|NCT00805389|26949485|P3|Overall Study|Withdrawal by Subject|4
7751653|NCT00805389|26949486|P2|Overall Study|Withdrawal by Subject|2
7751654|NCT00805389|26949487|P1|Overall Study|Withdrawal by Subject|3
7751655|NCT00805389|26949483|P5|Overall Study|Protocol Violation|0
7751656|NCT00805389|26949484|P4|Overall Study|Protocol Violation|0
7751657|NCT00805389|26949485|P3|Overall Study|Protocol Violation|1
7751658|NCT00805389|26949486|P2|Overall Study|Protocol Violation|0
7751659|NCT00805389|26949487|P1|Overall Study|Protocol Violation|0
7751660|NCT00805389|26949483|P5|Overall Study|Lost to Follow-up|9
7751661|NCT00805389|26949484|P4|Overall Study|Lost to Follow-up|10
7751662|NCT00805389|26949485|P3|Overall Study|Lost to Follow-up|6
7751663|NCT00805389|26949486|P2|Overall Study|Lost to Follow-up|3
7751664|NCT00805389|26949487|P1|Overall Study|Lost to Follow-up|4
7751665|NCT00805389|26949483|P5|Overall Study|Adverse Event|0
7751666|NCT00805389|26949484|P4|Overall Study|Adverse Event|2
7751667|NCT00805389|26949485|P3|Overall Study|Adverse Event|1
7751668|NCT00805389|26949486|P2|Overall Study|Adverse Event|0
7751669|NCT00805389|26949487|P1|Overall Study|Adverse Event|0
7751670|NCT00805285|26949734|P1|Overall Study|Lack of Efficacy|1
7751671|NCT00805207|26949751|P9|Overall Study|Withdrawal by Subject|0
7751672|NCT00805207|26949752|P8|Overall Study|Withdrawal by Subject|0
7751673|NCT00805207|26949753|P7|Overall Study|Withdrawal by Subject|0
7751674|NCT00805207|26949754|P6|Overall Study|Withdrawal by Subject|2
7751675|NCT00805207|26949755|P5|Overall Study|Withdrawal by Subject|1
7751676|NCT00805207|26949756|P4|Overall Study|Withdrawal by Subject|0
7751677|NCT00805207|26949757|P3|Overall Study|Withdrawal by Subject|0
7751678|NCT00805207|26949758|P2|Overall Study|Withdrawal by Subject|1
7751679|NCT00805207|26949759|P1|Overall Study|Withdrawal by Subject|0
7751680|NCT00805207|26949751|P9|Overall Study|Physician Decision|0
7751681|NCT00805207|26949752|P8|Overall Study|Physician Decision|0
7751682|NCT00805207|26949753|P7|Overall Study|Physician Decision|0
7751683|NCT00805207|26949754|P6|Overall Study|Physician Decision|1
7751684|NCT00805207|26949755|P5|Overall Study|Physician Decision|0
7751685|NCT00805207|26949756|P4|Overall Study|Physician Decision|0
7751686|NCT00805207|26949757|P3|Overall Study|Physician Decision|0
7751687|NCT00805207|26949758|P2|Overall Study|Physician Decision|1
7751688|NCT00805207|26949759|P1|Overall Study|Physician Decision|0
7751689|NCT00805207|26949751|P9|Overall Study|Protocol Violation|0
7751690|NCT00805207|26949752|P8|Overall Study|Protocol Violation|0
7751691|NCT00805207|26949753|P7|Overall Study|Protocol Violation|0
7751692|NCT00805207|26949754|P6|Overall Study|Protocol Violation|0
7751693|NCT00805207|26949755|P5|Overall Study|Protocol Violation|0
7751694|NCT00805207|26949756|P4|Overall Study|Protocol Violation|0
7751695|NCT00805207|26949757|P3|Overall Study|Protocol Violation|1
7751696|NCT00805207|26949758|P2|Overall Study|Protocol Violation|0
7751697|NCT00805207|26949759|P1|Overall Study|Protocol Violation|0
7751698|NCT00805194|26949817|P2|Overall Study|Reasons other than stated above|16
7751699|NCT00805194|26949818|P1|Overall Study|Reasons other than stated above|20
7751700|NCT00805194|26949817|P2|Overall Study|Not treated|4
7751701|NCT00805194|26949818|P1|Overall Study|Not treated|3
7751702|NCT00805194|26949817|P2|Overall Study|Withdrawal by Subject|42
7751703|NCT00805194|26949818|P1|Overall Study|Withdrawal by Subject|60
7751704|NCT00805194|26949817|P2|Overall Study|Lost to Follow-up|5
7751705|NCT00805194|26949818|P1|Overall Study|Lost to Follow-up|5
7751706|NCT00805194|26949817|P2|Overall Study|Protocol Violation|9
7751707|NCT00805194|26949818|P1|Overall Study|Protocol Violation|9
7751708|NCT00805194|26949817|P2|Overall Study|Other AE|73
7751709|NCT00805194|26949818|P1|Overall Study|Other AE|84
7751710|NCT00805194|26949817|P2|Overall Study|Worsening or AE of underlying disease|70
7751711|NCT00805194|26949818|P1|Overall Study|Worsening or AE of underlying disease|64
7751712|NCT00805194|26949817|P2|Overall Study|Progressive disease (modified RECIST)|435
7751713|NCT00805194|26949818|P1|Overall Study|Progressive disease (modified RECIST)|404
7751714|NCT00805142|26949852|P2|Maintenance Period|Other|1
7751715|NCT00805142|26949853|P1|Maintenance Period|Other|0
7751716|NCT00805142|26949852|P2|Maintenance Period|Adverse Event|1
7751717|NCT00805142|26949853|P1|Maintenance Period|Adverse Event|0
7751718|NCT00805142|26949852|P2|Titration Period|Other|3
7751719|NCT00805142|26949853|P1|Titration Period|Other|0
7751720|NCT00805142|26949852|P2|Titration Period|Withdrawal of consent|1
7751721|NCT00805142|26949853|P1|Titration Period|Withdrawal of consent|0
7751722|NCT00805142|26949852|P2|Titration Period|Disease Progression|1
7751723|NCT00805142|26949853|P1|Titration Period|Disease Progression|2
7751724|NCT00805142|26949852|P2|Titration Period|Lost to Follow-up|1
7751725|NCT00805142|26949853|P1|Titration Period|Lost to Follow-up|0
7751726|NCT00805142|26949852|P2|Titration Period|Lack of Efficacy|1
7751727|NCT00805142|26949853|P1|Titration Period|Lack of Efficacy|1
7751728|NCT00805142|26949852|P2|Titration Period|Adverse Event|3
7751729|NCT00805142|26949853|P1|Titration Period|Adverse Event|3
7751730|NCT00805025|26949886|P1|Overall Study|Physician Decision|1
7751731|NCT00805025|26949886|P1|Overall Study|Withdrawal by Subject|2
7751732|NCT00805025|26949886|P1|Overall Study|Adverse Event|4
7751733|NCT00805025|26949886|P1|Overall Study|Screened but not enrolled/treated|42
7751734|NCT00804986|26949915|P6|Overall Study|Physician Decision|0
7751735|NCT00804986|26949916|P5|Overall Study|Physician Decision|0
7751736|NCT00804986|26949917|P4|Overall Study|Physician Decision|0
7751737|NCT00804986|26949918|P3|Overall Study|Physician Decision|0
7751738|NCT00804986|26949919|P2|Overall Study|Physician Decision|0
7751739|NCT00804986|26949920|P1|Overall Study|Physician Decision|1
7751740|NCT00804986|26949915|P6|Overall Study|Sponsor Decision|0
7751741|NCT00804986|26949916|P5|Overall Study|Sponsor Decision|0
7751742|NCT00804986|26949917|P4|Overall Study|Sponsor Decision|0
7751743|NCT00804986|26949918|P3|Overall Study|Sponsor Decision|0
7751744|NCT00804986|26949919|P2|Overall Study|Sponsor Decision|1
7751745|NCT00804986|26949920|P1|Overall Study|Sponsor Decision|0
7751746|NCT00804986|26949915|P6|Overall Study|Inclusion/Exclusion criteria not met|1
7751747|NCT00804986|26949916|P5|Overall Study|Inclusion/Exclusion criteria not met|0
7751748|NCT00804986|26949917|P4|Overall Study|Inclusion/Exclusion criteria not met|1
7751749|NCT00804986|26949918|P3|Overall Study|Inclusion/Exclusion criteria not met|0
7751750|NCT00804986|26949919|P2|Overall Study|Inclusion/Exclusion criteria not met|2
7751751|NCT00804986|26949920|P1|Overall Study|Inclusion/Exclusion criteria not met|0
7751752|NCT00804986|26949915|P6|Overall Study|Withdrawal by Subject|3
7751753|NCT00804986|26949916|P5|Overall Study|Withdrawal by Subject|5
7751754|NCT00804986|26949917|P4|Overall Study|Withdrawal by Subject|3
7751755|NCT00804986|26949918|P3|Overall Study|Withdrawal by Subject|0
7751756|NCT00804986|26949919|P2|Overall Study|Withdrawal by Subject|3
7751757|NCT00804986|26949920|P1|Overall Study|Withdrawal by Subject|0
7751758|NCT00804986|26949915|P6|Overall Study|Protocol Violation|0
7751759|NCT00804986|26949916|P5|Overall Study|Protocol Violation|0
7751760|NCT00804986|26949917|P4|Overall Study|Protocol Violation|1
7751761|NCT00804986|26949918|P3|Overall Study|Protocol Violation|0
7751762|NCT00804986|26949919|P2|Overall Study|Protocol Violation|1
7751763|NCT00804986|26949920|P1|Overall Study|Protocol Violation|0
7751764|NCT00804986|26949915|P6|Overall Study|Lost to Follow-up|3
7751765|NCT00804986|26949916|P5|Overall Study|Lost to Follow-up|1
7751766|NCT00804986|26949917|P4|Overall Study|Lost to Follow-up|1
7751767|NCT00804986|26949918|P3|Overall Study|Lost to Follow-up|0
7751768|NCT00804986|26949919|P2|Overall Study|Lost to Follow-up|0
7751769|NCT00804986|26949920|P1|Overall Study|Lost to Follow-up|0
7751770|NCT00804986|26949915|P6|Overall Study|Lack of Efficacy|3
7751771|NCT00804986|26949916|P5|Overall Study|Lack of Efficacy|0
7751772|NCT00804986|26949917|P4|Overall Study|Lack of Efficacy|1
7751773|NCT00804986|26949918|P3|Overall Study|Lack of Efficacy|0
7751774|NCT00804986|26949919|P2|Overall Study|Lack of Efficacy|0
7751775|NCT00804986|26949920|P1|Overall Study|Lack of Efficacy|0
7751776|NCT00804986|26949915|P6|Overall Study|Adverse Event|0
7751777|NCT00804986|26949916|P5|Overall Study|Adverse Event|3
7751778|NCT00804986|26949917|P4|Overall Study|Adverse Event|1
7751779|NCT00804986|26949918|P3|Overall Study|Adverse Event|2
7751780|NCT00804986|26949919|P2|Overall Study|Adverse Event|1
7751781|NCT00804986|26949920|P1|Overall Study|Adverse Event|0
7751782|NCT00804908|26950055|P3|Overall Study|Other|114
7751783|NCT00804908|26950056|P2|Overall Study|Other|116
7751784|NCT00804908|26950057|P1|Overall Study|Other|115
7751785|NCT00804843|26950088|P2|Overall Study|Withdrawal by Subject|2
7751786|NCT00804843|26950089|P1|Overall Study|Withdrawal by Subject|1
7751787|NCT00804843|26950088|P2|Overall Study|Adverse Event|5
7751788|NCT00804843|26950089|P1|Overall Study|Adverse Event|8
7751789|NCT00804843|26950088|P2|Overall Study|Protocol Violation|0
7751790|NCT00804843|26950089|P1|Overall Study|Protocol Violation|1
7751791|NCT00804687|26950107|P6|Period 5: Treatment Period|Positive drug test|0
7751792|NCT00804687|26950108|P5|Period 5: Treatment Period|Positive drug test|0
7751793|NCT00804687|26950109|P4|Period 5: Treatment Period|Positive drug test|0
7751794|NCT00804687|26950110|P3|Period 5: Treatment Period|Positive drug test|0
7751795|NCT00804687|26950111|P2|Period 5: Treatment Period|Positive drug test|0
7751796|NCT00804687|26950112|P1|Period 5: Treatment Period|Positive drug test|1
7751797|NCT00804687|26950107|P6|Period 5: Treatment Period|Positive drugs of abuse|0
7751798|NCT00804687|26950108|P5|Period 5: Treatment Period|Positive drugs of abuse|0
7751799|NCT00804687|26950109|P4|Period 5: Treatment Period|Positive drugs of abuse|0
7751800|NCT00804687|26950110|P3|Period 5: Treatment Period|Positive drugs of abuse|1
7751801|NCT00804687|26950111|P2|Period 5: Treatment Period|Positive drugs of abuse|0
7751802|NCT00804687|26950112|P1|Period 5: Treatment Period|Positive drugs of abuse|0
7751803|NCT00804687|26950107|P6|Period 5: Treatment Period|Withdrawal by Subject|0
7751804|NCT00804687|26950108|P5|Period 5: Treatment Period|Withdrawal by Subject|1
7751805|NCT00804687|26950109|P4|Period 5: Treatment Period|Withdrawal by Subject|0
7751806|NCT00804687|26950110|P3|Period 5: Treatment Period|Withdrawal by Subject|0
7751807|NCT00804687|26950111|P2|Period 5: Treatment Period|Withdrawal by Subject|0
7751808|NCT00804687|26950112|P1|Period 5: Treatment Period|Withdrawal by Subject|0
7751809|NCT00804687|26950107|P6|Period 3: Treatment Period|Positive Drug screen|0
7751810|NCT00804687|26950108|P5|Period 3: Treatment Period|Positive Drug screen|0
7751811|NCT00804687|26950109|P4|Period 3: Treatment Period|Positive Drug screen|1
7751812|NCT00804687|26950110|P3|Period 3: Treatment Period|Positive Drug screen|0
7751813|NCT00804687|26950111|P2|Period 3: Treatment Period|Positive Drug screen|0
7751814|NCT00804687|26950112|P1|Period 3: Treatment Period|Positive Drug screen|0
7751815|NCT00804570|26950191|P2|Overall Study|Withdrawal by Subject|38
7751816|NCT00804570|26950192|P1|Overall Study|Withdrawal by Subject|21
7751817|NCT00804570|26950191|P2|Overall Study|Sponsor decision|4
7751818|NCT00804570|26950192|P1|Overall Study|Sponsor decision|1
7751819|NCT00804570|26950191|P2|Overall Study|Physician Decision|2
7751820|NCT00804570|26950192|P1|Overall Study|Physician Decision|1
7751821|NCT00804570|26950191|P2|Overall Study|Protocol Violation|16
7751822|NCT00804570|26950192|P1|Overall Study|Protocol Violation|12
7751823|NCT00804570|26950191|P2|Overall Study|Entry criteria not met|5
7751824|NCT00804570|26950192|P1|Overall Study|Entry criteria not met|5
7751825|NCT00804570|26950191|P2|Overall Study|Lost to Follow-up|21
7751826|NCT00804570|26950192|P1|Overall Study|Lost to Follow-up|18
7751827|NCT00804570|26950191|P2|Overall Study|Lack of Efficacy|1
7751828|NCT00804570|26950192|P1|Overall Study|Lack of Efficacy|0
7751829|NCT00804570|26950191|P2|Overall Study|Adverse Event|7
7751830|NCT00804570|26950192|P1|Overall Study|Adverse Event|14
7751849|NCT00804141|26950282|P1|Overall Study|Enrolled but not treated|6
7751850|NCT00804141|26950282|P1|Overall Study|Other than specified|30
7751851|NCT00804141|26950282|P1|Overall Study|Lack of Efficacy|46
7751852|NCT00804141|26950282|P1|Overall Study|Withdrawal by Subject|131
7751853|NCT00804141|26950282|P1|Overall Study|Protocol Violation|85
7751854|NCT00804141|26950282|P1|Overall Study|Investigator request|8
7751855|NCT00804141|26950282|P1|Overall Study|Failed to return|96
7751856|NCT00804141|26950282|P1|Overall Study|Death|4
7751857|NCT00804141|26950282|P1|Overall Study|Adverse Event|157
7751858|NCT00803790|26950322|P4|Period 2|Positive Drug Screen or Personal Reasons|0
7751859|NCT00803790|26950323|P3|Period 2|Positive Drug Screen or Personal Reasons|0
7751860|NCT00803790|26950324|P2|Period 2|Positive Drug Screen or Personal Reasons|0
7751861|NCT00803790|26950325|P1|Period 2|Positive Drug Screen or Personal Reasons|1
7751862|NCT00803790|26950322|P4|Period 2|Withdrawal by Subject|0
7751863|NCT00803790|26950323|P3|Period 2|Withdrawal by Subject|0
7751864|NCT00803790|26950324|P2|Period 2|Withdrawal by Subject|0
7751865|NCT00803790|26950325|P1|Period 2|Withdrawal by Subject|1
7751866|NCT00803790|26950322|P4|Period 2|Adverse Event|1
7751867|NCT00803790|26950323|P3|Period 2|Adverse Event|1
7751868|NCT00803790|26950324|P2|Period 2|Adverse Event|0
7751869|NCT00803790|26950325|P1|Period 2|Adverse Event|0
7751870|NCT00803790|26950322|P4|Period 1|Protocol Violation|0
7751871|NCT00803790|26950323|P3|Period 1|Protocol Violation|1
7751872|NCT00803790|26950324|P2|Period 1|Protocol Violation|0
7751873|NCT00803790|26950325|P1|Period 1|Protocol Violation|0
7751874|NCT00803790|26950322|P4|Period 1|positive drug screen or personal reasons|4
7751875|NCT00803790|26950323|P3|Period 1|positive drug screen or personal reasons|0
7751876|NCT00803790|26950324|P2|Period 1|positive drug screen or personal reasons|3
7751877|NCT00803790|26950325|P1|Period 1|positive drug screen or personal reasons|0
7751878|NCT00803790|26950322|P4|Period 1|Withdrawal by Subject|0
7751879|NCT00803790|26950323|P3|Period 1|Withdrawal by Subject|0
7751880|NCT00803790|26950324|P2|Period 1|Withdrawal by Subject|6
7751881|NCT00803790|26950325|P1|Period 1|Withdrawal by Subject|8
7751882|NCT00803790|26950322|P4|Period 1|Lost to Follow-up|0
7751883|NCT00803790|26950323|P3|Period 1|Lost to Follow-up|0
7751884|NCT00803790|26950324|P2|Period 1|Lost to Follow-up|2
7751885|NCT00803790|26950325|P1|Period 1|Lost to Follow-up|1
7751886|NCT00803790|26950322|P4|Period 1|Adverse Event|0
7751887|NCT00803790|26950323|P3|Period 1|Adverse Event|0
7751888|NCT00803790|26950324|P2|Period 1|Adverse Event|1
7751889|NCT00803790|26950325|P1|Period 1|Adverse Event|0
7751890|NCT00803738|26950365|P2|Overall Study|Positive Results for STD or abnormal PAP|8
7751891|NCT00803738|26950366|P1|Overall Study|Positive Results for STD or abnormal PAP|2
7751892|NCT00803738|26950365|P2|Overall Study|Negative Baseline Culture of Candida|63
7751893|NCT00803738|26950366|P1|Overall Study|Negative Baseline Culture of Candida|56
7751894|NCT00803738|26950365|P2|Overall Study|Lack of Efficacy|16
7751895|NCT00803738|26950366|P1|Overall Study|Lack of Efficacy|10
7751896|NCT00803738|26950365|P2|Overall Study|Withdrawal by Subject|4
7751897|NCT00803738|26950366|P1|Overall Study|Withdrawal by Subject|1
7751898|NCT00803738|26950365|P2|Overall Study|Protocol Violation|10
7751899|NCT00803738|26950366|P1|Overall Study|Protocol Violation|18
7751900|NCT00803738|26950365|P2|Overall Study|Lost to Follow-up|4
7751901|NCT00803738|26950366|P1|Overall Study|Lost to Follow-up|4
7751902|NCT00803738|26950365|P2|Overall Study|Adverse Event|5
7751903|NCT00803738|26950366|P1|Overall Study|Adverse Event|3
7751904|NCT00803712|26950378|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
7751905|NCT00803712|26950379|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
7751906|NCT00803712|26950378|P2|Overall Study|Administrative decision|3
7751907|NCT00803712|26950379|P1|Overall Study|Administrative decision|2
7751908|NCT00803712|26950378|P2|Overall Study|Protocol criteria (renal transplant)|8
7751909|NCT00803712|26950379|P1|Overall Study|Protocol criteria (renal transplant)|12
7751910|NCT00803712|26950378|P2|Overall Study|Protocol criteria (other)|2
7751911|NCT00803712|26950379|P1|Overall Study|Protocol criteria (other)|0
7751912|NCT00803712|26950378|P2|Overall Study|"Other in electronic Case Report Form"|1
7751913|NCT00803712|26950379|P1|Overall Study|"Other in electronic Case Report Form"|0
7751914|NCT00803712|26950378|P2|Overall Study|Withdrawal by Subject|4
7751915|NCT00803712|26950379|P1|Overall Study|Withdrawal by Subject|2
7751916|NCT00803712|26950378|P2|Overall Study|Lost to Follow-up|1
7751917|NCT00803712|26950379|P1|Overall Study|Lost to Follow-up|3
7751918|NCT00803712|26950378|P2|Overall Study|Death|7
7751919|NCT00803712|26950379|P1|Overall Study|Death|8
7751920|NCT00803712|26950378|P2|Overall Study|Adverse Event|0
7751921|NCT00803712|26950379|P1|Overall Study|Adverse Event|5
7751922|NCT00803712|26950378|P2|Overall Study|Noncompliance|0
7751923|NCT00803712|26950379|P1|Overall Study|Noncompliance|3
7751924|NCT00803634|26950478|P2|Overall Study|Death|2
7751925|NCT00803634|26950479|P1|Overall Study|Death|3
7751926|NCT00803634|26950478|P2|Overall Study|Lost to Follow-up|3
7751927|NCT00803634|26950479|P1|Overall Study|Lost to Follow-up|2
7751928|NCT00803634|26950478|P2|Overall Study|Withdrew Consent|0
7751929|NCT00803634|26950479|P1|Overall Study|Withdrew Consent|1
7751930|NCT00803595|26950508|P3|Overall Study|Withdrawal by Subject|3
7751931|NCT00803595|26950509|P2|Overall Study|Withdrawal by Subject|2
7751932|NCT00803595|26950510|P1|Overall Study|Withdrawal by Subject|5
7751933|NCT00803595|26950508|P3|Overall Study|Protocol Violation|12
7751934|NCT00803595|26950509|P2|Overall Study|Protocol Violation|2
7751935|NCT00803595|26950510|P1|Overall Study|Protocol Violation|7
7751936|NCT00803595|26950508|P3|Overall Study|Adverse Event|1
7751937|NCT00803595|26950509|P2|Overall Study|Adverse Event|4
7751938|NCT00803595|26950510|P1|Overall Study|Adverse Event|3
7751939|NCT00803569|26950521|P1|Overall Study|Noncompliance|1
7751940|NCT00803569|26950521|P1|Overall Study|Progressive Disease|3
7751941|NCT00803452|26950555|P2|Overall Study|Lost to Follow-up|3
7751942|NCT00803452|26950556|P1|Overall Study|Lost to Follow-up|0
7751943|NCT00803452|26950555|P2|Overall Study|Adverse Event|2
7751944|NCT00803452|26950556|P1|Overall Study|Adverse Event|0
7751945|NCT00803361|26950594|P2|Overall Study|Withdrawal by Subject|6
7751946|NCT00803361|26950595|P1|Overall Study|Withdrawal by Subject|5
7751947|NCT00803361|26950594|P2|Overall Study|Protocol Violation|4
7751948|NCT00803361|26950595|P1|Overall Study|Protocol Violation|2
7751949|NCT00803361|26950594|P2|Overall Study|Physician Decision|0
7751950|NCT00803361|26950595|P1|Overall Study|Physician Decision|1
7751951|NCT00803361|26950594|P2|Overall Study|Lost to Follow-up|2
7751952|NCT00803361|26950595|P1|Overall Study|Lost to Follow-up|1
7751953|NCT00803361|26950594|P2|Overall Study|Lack of Efficacy|13
7751954|NCT00803361|26950595|P1|Overall Study|Lack of Efficacy|4
7751955|NCT00803361|26950594|P2|Overall Study|Adverse Event|3
7751956|NCT00803361|26950595|P1|Overall Study|Adverse Event|13
7751957|NCT00803270|26950642|P2|Overall Study|Lost to Follow-up|2
7751958|NCT00803270|26950643|P1|Overall Study|Lost to Follow-up|1
7751959|NCT00803244|26950653|P2|Overall Study|Any other reason not above-mentioned|10
7751960|NCT00803244|26950654|P1|Overall Study|Any other reason not above-mentioned|4
7751961|NCT00803244|26950653|P2|Overall Study|Withdrawal by Subject|3
7751962|NCT00803244|26950654|P1|Overall Study|Withdrawal by Subject|2
7751963|NCT00803244|26950653|P2|Overall Study|Adverse Event|2
7751964|NCT00803244|26950654|P1|Overall Study|Adverse Event|1
7751965|NCT00803205|26950664|P2|Overall Study|Sponsor Decision|1
7751966|NCT00803205|26950665|P1|Overall Study|Sponsor Decision|0
7751967|NCT00803205|26950664|P2|Overall Study|Acquired a Lung Infection|1
7751968|NCT00803205|26950665|P1|Overall Study|Acquired a Lung Infection|0
7751969|NCT00803205|26950664|P2|Overall Study|Medical Monitor Decision|0
7751970|NCT00803205|26950665|P1|Overall Study|Medical Monitor Decision|1
7751971|NCT00803205|26950664|P2|Overall Study|Protocol Violation|1
7751972|NCT00803205|26950665|P1|Overall Study|Protocol Violation|1
7751973|NCT00803205|26950664|P2|Overall Study|Physician Decision|0
7751974|NCT00803205|26950665|P1|Overall Study|Physician Decision|1
7751975|NCT00803205|26950664|P2|Overall Study|Withdrawal by Subject|9
7751976|NCT00803205|26950665|P1|Overall Study|Withdrawal by Subject|9
7751977|NCT00803205|26950664|P2|Overall Study|Lost to Follow-up|0
7751978|NCT00803205|26950665|P1|Overall Study|Lost to Follow-up|1
7751979|NCT00803205|26950664|P2|Overall Study|Adverse Event|2
7751980|NCT00803205|26950665|P1|Overall Study|Adverse Event|7
7751981|NCT00803179|26950708|P1|Overall Study|Lost to Follow-up|3
7751982|NCT00803101|26950727|P2|Overall Study|Patient did not have surgery|1
7751983|NCT00803101|26950728|P1|Overall Study|Patient did not have surgery|1
7751984|NCT00803101|26950727|P2|Overall Study|Patient did not attend scheduled visit|1
7751985|NCT00803101|26950728|P1|Overall Study|Patient did not attend scheduled visit|2
7751986|NCT00803101|26950727|P2|Overall Study|Patient died outside SAE report period|0
7751987|NCT00803101|26950728|P1|Overall Study|Patient died outside SAE report period|1
7751988|NCT00803101|26950727|P2|Overall Study|Surgery finished outside protocol window|1
7751989|NCT00803101|26950728|P1|Overall Study|Surgery finished outside protocol window|1
7751990|NCT00803101|26950727|P2|Overall Study|Protocol Violation|7
7751991|NCT00803101|26950728|P1|Overall Study|Protocol Violation|1
7751992|NCT00803101|26950727|P2|Overall Study|Lost to Follow-up|2
7751993|NCT00803101|26950728|P1|Overall Study|Lost to Follow-up|2
7751994|NCT00803101|26950727|P2|Overall Study|Withdrawal by Subject|4
7751995|NCT00803101|26950728|P1|Overall Study|Withdrawal by Subject|6
7751996|NCT00803101|26950727|P2|Overall Study|Death / Serious Adverse Event|6
7751997|NCT00803101|26950728|P1|Overall Study|Death / Serious Adverse Event|4
7751998|NCT00803049|26950779|P4|Overall Study|Other than Specified Above|5
7751999|NCT00803049|26950780|P3|Overall Study|Other than Specified Above|2
7752000|NCT00803049|26950781|P2|Overall Study|Other than Specified Above|9
7752001|NCT00803049|26950782|P1|Overall Study|Other than Specified Above|3
7752002|NCT00803049|26950779|P4|Overall Study|Randomized and Not Treated|2
7752003|NCT00803049|26950780|P3|Overall Study|Randomized and Not Treated|0
7752004|NCT00803049|26950781|P2|Overall Study|Randomized and Not Treated|0
7752005|NCT00803049|26950782|P1|Overall Study|Randomized and Not Treated|0
7752006|NCT00803049|26950779|P4|Overall Study|Protocol Violation|0
7752007|NCT00803049|26950780|P3|Overall Study|Protocol Violation|1
7752008|NCT00803049|26950781|P2|Overall Study|Protocol Violation|1
7752009|NCT00803049|26950782|P1|Overall Study|Protocol Violation|0
7752010|NCT00803049|26950779|P4|Overall Study|Withdrawal by Subject|44
7752011|NCT00803049|26950780|P3|Overall Study|Withdrawal by Subject|16
7752012|NCT00803049|26950781|P2|Overall Study|Withdrawal by Subject|43
7752013|NCT00803049|26950782|P1|Overall Study|Withdrawal by Subject|19
7752014|NCT00803049|26950779|P4|Overall Study|Progressive Disease|6
7752015|NCT00803049|26950780|P3|Overall Study|Progressive Disease|6
7752016|NCT00803049|26950781|P2|Overall Study|Progressive Disease|10
7752017|NCT00803049|26950782|P1|Overall Study|Progressive Disease|6
7752018|NCT00803049|26950779|P4|Overall Study|Death|2
7752019|NCT00803049|26950780|P3|Overall Study|Death|0
7752020|NCT00803049|26950781|P2|Overall Study|Death|1
7752021|NCT00803049|26950782|P1|Overall Study|Death|2
7752022|NCT00803049|26950779|P4|Overall Study|Lost to Follow-up|3
7752023|NCT00803049|26950780|P3|Overall Study|Lost to Follow-up|0
7752024|NCT00803049|26950781|P2|Overall Study|Lost to Follow-up|2
7752025|NCT00803049|26950782|P1|Overall Study|Lost to Follow-up|0
7752026|NCT00803049|26950779|P4|Overall Study|Lack of Efficacy|13
7752027|NCT00803049|26950780|P3|Overall Study|Lack of Efficacy|6
7752028|NCT00803049|26950781|P2|Overall Study|Lack of Efficacy|19
7752029|NCT00803049|26950782|P1|Overall Study|Lack of Efficacy|10
7752030|NCT00803049|26950779|P4|Overall Study|Adverse Event|27
7752031|NCT00803049|26950780|P3|Overall Study|Adverse Event|13
7752032|NCT00803049|26950781|P2|Overall Study|Adverse Event|33
7752033|NCT00803049|26950782|P1|Overall Study|Adverse Event|21
7752034|NCT00803023|26950816|P4|Overall Study|Lack of Efficacy|1
7752035|NCT00803023|26950817|P3|Overall Study|Lack of Efficacy|1
7752036|NCT00803023|26950818|P2|Overall Study|Lack of Efficacy|1
7752037|NCT00803023|26950819|P1|Overall Study|Lack of Efficacy|0
7752038|NCT00803023|26950816|P4|Overall Study|Lost to Follow-up|1
7752039|NCT00803023|26950817|P3|Overall Study|Lost to Follow-up|2
7752040|NCT00803023|26950818|P2|Overall Study|Lost to Follow-up|1
7752041|NCT00803023|26950819|P1|Overall Study|Lost to Follow-up|0
7752042|NCT00803023|26950816|P4|Overall Study|Withdrawal by Subject|0
7752043|NCT00803023|26950817|P3|Overall Study|Withdrawal by Subject|0
7752044|NCT00803023|26950818|P2|Overall Study|Withdrawal by Subject|2
7752045|NCT00803023|26950819|P1|Overall Study|Withdrawal by Subject|0
7752046|NCT00803023|26950816|P4|Overall Study|Adverse Event|6
7752047|NCT00803023|26950817|P3|Overall Study|Adverse Event|8
7752048|NCT00803023|26950818|P2|Overall Study|Adverse Event|4
7752049|NCT00803023|26950819|P1|Overall Study|Adverse Event|5
7752050|NCT00802945|26950857|P2|Overall Study|Terminated by sponsor|12
7752051|NCT00802945|26950858|P1|Overall Study|Terminated by sponsor|8
7752052|NCT00802945|26950857|P2|Overall Study|Death|23
7752053|NCT00802945|26950858|P1|Overall Study|Death|27
7752054|NCT00802893|26950889|P1|Overall Study|study terminated|3
7752055|NCT00802867|26950913|P1|Overall Study|Withdrawal by Subject|1
7752056|NCT00802867|26950913|P1|Overall Study|Protocol Violation|6
7752057|NCT00802867|26950913|P1|Overall Study|Lost to Follow-up|6
7752058|NCT00802841|26950936|P2|Overall Study|Treatment duration completed|76
7752059|NCT00802841|26950937|P1|Overall Study|Treatment duration completed|66
7752060|NCT00802841|26950936|P2|Overall Study|Protocol deviation|6
7752061|NCT00802841|26950937|P1|Overall Study|Protocol deviation|2
7752062|NCT00802841|26950936|P2|Overall Study|Withdrawal by Subject|5
7752063|NCT00802841|26950937|P1|Overall Study|Withdrawal by Subject|9
7752064|NCT00802841|26950936|P2|Overall Study|Disease progression|3
7752065|NCT00802841|26950937|P1|Overall Study|Disease progression|7
7752066|NCT00802841|26950936|P2|Overall Study|Adverse Event|2
7752067|NCT00802841|26950937|P1|Overall Study|Adverse Event|8
7752068|NCT00802841|26950936|P2|Overall Study|Death|2
7752069|NCT00802841|26950937|P1|Overall Study|Death|1
7752070|NCT00802841|26950936|P2|Overall Study|Lost to Follow-up|1
7752071|NCT00802841|26950937|P1|Overall Study|Lost to Follow-up|2
7752072|NCT00802841|26950936|P2|Overall Study|Administrative problems|0
7752073|NCT00802841|26950937|P1|Overall Study|Administrative problems|1
7752074|NCT00802737|26950962|P3|Overall Study|Participant too Unwell|0
7752075|NCT00802737|26950963|P2|Overall Study|Participant too Unwell|2
7752076|NCT00802737|26950964|P1|Overall Study|Participant too Unwell|0
7752077|NCT00802737|26950962|P3|Overall Study|Ongoing CLL-Treatment|0
7752078|NCT00802737|26950963|P2|Overall Study|Ongoing CLL-Treatment|1
7752079|NCT00802737|26950964|P1|Overall Study|Ongoing CLL-Treatment|0
7752080|NCT00802737|26950962|P3|Overall Study|Received Prohibited Therapy|0
7752081|NCT00802737|26950963|P2|Overall Study|Received Prohibited Therapy|0
7752082|NCT00802737|26950964|P1|Overall Study|Received Prohibited Therapy|1
7752083|NCT00802737|26950962|P3|Overall Study|Adverse Event|0
7752084|NCT00802737|26950963|P2|Overall Study|Adverse Event|0
7752085|NCT00802737|26950964|P1|Overall Study|Adverse Event|1
7752086|NCT00802737|26950962|P3|Overall Study|Death|1
7752087|NCT00802737|26950963|P2|Overall Study|Death|5
7752088|NCT00802737|26950964|P1|Overall Study|Death|6
7752089|NCT00802737|26950962|P3|Overall Study|Withdrawn due to Disease Progression|0
7752090|NCT00802737|26950963|P2|Overall Study|Withdrawn due to Disease Progression|3
7752091|NCT00802737|26950964|P1|Overall Study|Withdrawn due to Disease Progression|9
7752092|NCT00802672|26951024|P3|Overall Study|other|2
7752093|NCT00802672|26951025|P2|Overall Study|other|1
7752094|NCT00802672|26951026|P1|Overall Study|other|3
7752095|NCT00802672|26951024|P3|Overall Study|Withdrawal by Subject|2
7752096|NCT00802672|26951025|P2|Overall Study|Withdrawal by Subject|1
7752097|NCT00802672|26951026|P1|Overall Study|Withdrawal by Subject|1
7752098|NCT00802672|26951024|P3|Overall Study|Lost to Follow-up|3
7752099|NCT00802672|26951025|P2|Overall Study|Lost to Follow-up|5
7752100|NCT00802672|26951026|P1|Overall Study|Lost to Follow-up|5
7752101|NCT00802672|26951024|P3|Overall Study|Protocol Violation|1
7752102|NCT00802672|26951025|P2|Overall Study|Protocol Violation|1
7752103|NCT00802672|26951026|P1|Overall Study|Protocol Violation|2
7752104|NCT00802672|26951024|P3|Overall Study|Adverse Event|1
7752105|NCT00802672|26951025|P2|Overall Study|Adverse Event|1
7752106|NCT00802672|26951026|P1|Overall Study|Adverse Event|1
7752107|NCT00802672|26951024|P3|Overall Study|Lack of fungal pathogen at baseline|25
7752108|NCT00802672|26951025|P2|Overall Study|Lack of fungal pathogen at baseline|43
7752109|NCT00802672|26951026|P1|Overall Study|Lack of fungal pathogen at baseline|56
7752110|NCT00802659|26951044|P4|Overall Study|Physician Decision|0
7752111|NCT00802659|26951045|P3|Overall Study|Physician Decision|0
7752112|NCT00802659|26951046|P2|Overall Study|Physician Decision|1
7752113|NCT00802659|26951047|P1|Overall Study|Physician Decision|0
7752114|NCT00802529|26951086|P2|Overall Study|Lost to Follow-up|1
7752115|NCT00802529|26951087|P1|Overall Study|Lost to Follow-up|0
7752116|NCT00802464|26951126|P4|Month 8 - Month 14|Lost to Follow-up|0
7752117|NCT00802464|26951127|P3|Month 8 - Month 14|Lost to Follow-up|1
7752118|NCT00802464|26951128|P2|Month 8 - Month 14|Lost to Follow-up|0
7752119|NCT00802464|26951129|P1|Month 8 - Month 14|Lost to Follow-up|0
7752120|NCT00802464|26951126|P4|Month 8 - Month 14|Withdrawal by Subject|0
7752121|NCT00802464|26951127|P3|Month 8 - Month 14|Withdrawal by Subject|0
7752122|NCT00802464|26951128|P2|Month 8 - Month 14|Withdrawal by Subject|1
7752123|NCT00802464|26951129|P1|Month 8 - Month 14|Withdrawal by Subject|1
7752124|NCT00802464|26951126|P4|Month 8 - Month 14|Adverse Event|0
7752125|NCT00802464|26951127|P3|Month 8 - Month 14|Adverse Event|0
7752126|NCT00802464|26951128|P2|Month 8 - Month 14|Adverse Event|1
7752127|NCT00802464|26951129|P1|Month 8 - Month 14|Adverse Event|0
7752128|NCT00802464|26951126|P4|Month 0 - Month 8|Other|0
7752129|NCT00802464|26951127|P3|Month 0 - Month 8|Other|1
7752130|NCT00802464|26951128|P2|Month 0 - Month 8|Other|0
7752131|NCT00802464|26951129|P1|Month 0 - Month 8|Other|0
7752132|NCT00802464|26951126|P4|Month 0 - Month 8|Lost to Follow-up|2
7752133|NCT00802464|26951127|P3|Month 0 - Month 8|Lost to Follow-up|2
7752134|NCT00802464|26951128|P2|Month 0 - Month 8|Lost to Follow-up|1
7752135|NCT00802464|26951129|P1|Month 0 - Month 8|Lost to Follow-up|0
7752136|NCT00802464|26951126|P4|Month 0 - Month 8|Withdrawal by Subject|5
7752137|NCT00802464|26951127|P3|Month 0 - Month 8|Withdrawal by Subject|2
7752138|NCT00802464|26951128|P2|Month 0 - Month 8|Withdrawal by Subject|1
7752139|NCT00802464|26951129|P1|Month 0 - Month 8|Withdrawal by Subject|0
7752140|NCT00802464|26951126|P4|Month 0 - Month 8|Protocol Violation|0
7752141|NCT00802464|26951127|P3|Month 0 - Month 8|Protocol Violation|1
7752142|NCT00802464|26951128|P2|Month 0 - Month 8|Protocol Violation|0
7752143|NCT00802464|26951129|P1|Month 0 - Month 8|Protocol Violation|0
7752144|NCT00802464|26951126|P4|Month 0 - Month 8|Adverse Event|2
7752145|NCT00802464|26951127|P3|Month 0 - Month 8|Adverse Event|1
7752146|NCT00802464|26951128|P2|Month 0 - Month 8|Adverse Event|1
7752147|NCT00802464|26951129|P1|Month 0 - Month 8|Adverse Event|0
7752148|NCT00802438|26951215|P1|Overall Study|Physician Decision|1
7752149|NCT00802438|26951215|P1|Overall Study|Withdrawal by Subject|7
7752150|NCT00802438|26951215|P1|Overall Study|Screen Failure|20
7752151|NCT00802360|26951235|P4|Overall Study|Other|3
7752152|NCT00802360|26951236|P3|Overall Study|Other|6
7752153|NCT00802360|26951237|P2|Overall Study|Other|3
7752154|NCT00802360|26951238|P1|Overall Study|Other|2
7752155|NCT00802360|26951235|P4|Overall Study|Pregnancy loss/miscarriage|3
7752156|NCT00802360|26951236|P3|Overall Study|Pregnancy loss/miscarriage|0
7752157|NCT00802360|26951237|P2|Overall Study|Pregnancy loss/miscarriage|2
7752158|NCT00802360|26951238|P1|Overall Study|Pregnancy loss/miscarriage|0
7752159|NCT00802360|26951235|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
7752160|NCT00802360|26951236|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
7752161|NCT00802360|26951237|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
7752162|NCT00802360|26951238|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
7752163|NCT00802360|26951235|P4|Overall Study|No positive serum pregnancy|10
7752164|NCT00802360|26951236|P3|Overall Study|No positive serum pregnancy|14
7752165|NCT00802360|26951237|P2|Overall Study|No positive serum pregnancy|20
7752166|NCT00802360|26951238|P1|Overall Study|No positive serum pregnancy|17
7752167|NCT00802360|26951235|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
7752168|NCT00802360|26951236|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7752169|NCT00802360|26951237|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7752170|NCT00802360|26951238|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7752171|NCT00802360|26951235|P4|Overall Study|Cycle cancelled|1
7752172|NCT00802360|26951236|P3|Overall Study|Cycle cancelled|1
7752173|NCT00802360|26951237|P2|Overall Study|Cycle cancelled|1
7752174|NCT00802360|26951238|P1|Overall Study|Cycle cancelled|0
7752175|NCT00802360|26951235|P4|Overall Study|Inadequate number of oocytes retrieved|1
7752176|NCT00802360|26951236|P3|Overall Study|Inadequate number of oocytes retrieved|0
7752177|NCT00802360|26951237|P2|Overall Study|Inadequate number of oocytes retrieved|0
7752178|NCT00802360|26951238|P1|Overall Study|Inadequate number of oocytes retrieved|0
7752179|NCT00802360|26951235|P4|Overall Study|Stimulation failure|3
7752180|NCT00802360|26951236|P3|Overall Study|Stimulation failure|3
7752181|NCT00802360|26951237|P2|Overall Study|Stimulation failure|0
7752182|NCT00802360|26951238|P1|Overall Study|Stimulation failure|4
7752183|NCT00802178|26951305|P1|Overall Study|Patients wish and other reason|1
7752184|NCT00802178|26951305|P1|Overall Study|IT and patient wish|8
7752185|NCT00802178|26951305|P1|Overall Study|Lack of efficacy and patient wish|1
7752186|NCT00802178|26951305|P1|Overall Study|Other|32
7752187|NCT00802178|26951305|P1|Overall Study|Withdrawal by Subject|18
7752188|NCT00802178|26951305|P1|Overall Study|Insufficient tolerability (IT)|17
7752189|NCT00802178|26951305|P1|Overall Study|Lack of Efficacy|36
7752190|NCT00802074|26951353|P6|Overall Study|Withdrawal by Subject|0
7752191|NCT00802074|26951354|P5|Overall Study|Withdrawal by Subject|0
7752192|NCT00802074|26951355|P4|Overall Study|Withdrawal by Subject|0
7752193|NCT00802074|26951356|P3|Overall Study|Withdrawal by Subject|0
7752194|NCT00802074|26951357|P2|Overall Study|Withdrawal by Subject|0
7752195|NCT00802074|26951358|P1|Overall Study|Withdrawal by Subject|1
7752196|NCT00802074|26951353|P6|Overall Study|Adverse Event|0
7752197|NCT00802074|26951354|P5|Overall Study|Adverse Event|0
7752198|NCT00802074|26951355|P4|Overall Study|Adverse Event|0
7752199|NCT00802074|26951356|P3|Overall Study|Adverse Event|1
7752200|NCT00802074|26951357|P2|Overall Study|Adverse Event|1
7752201|NCT00802074|26951358|P1|Overall Study|Adverse Event|1
7752202|NCT00801983|26951392|P2|Period 2|Withdrawal by Subject|1
7752203|NCT00801983|26951393|P1|Period 2|Withdrawal by Subject|2
7752204|NCT00801983|26951392|P2|Period 1|Withdrawal by Subject|8
7752205|NCT00801983|26951393|P1|Period 1|Withdrawal by Subject|2
7752206|NCT00801983|26951392|P2|Period 1|Lost to Follow-up|0
7752207|NCT00801983|26951393|P1|Period 1|Lost to Follow-up|2
7752208|NCT00801892|26951408|P2|Sham Crossover Period|Lost to Follow-up|2
7752209|NCT00801892|26951409|P1|Sham Crossover Period|Lost to Follow-up|0
7752210|NCT00801892|26951408|P2|Main Study Period|Withdrawal by Subject|1
7752211|NCT00801892|26951409|P1|Main Study Period|Withdrawal by Subject|0
7752212|NCT00801632|26951469|P1|Overall Study|Re-transplant|1
7752213|NCT00801242|26951547|P1|Overall Study|Miscellaneous reasons|20
7752214|NCT00801242|26951547|P1|Overall Study|Lost to Follow-up|1
7752215|NCT00801242|26951547|P1|Overall Study|Physician Decision|3
7752216|NCT00801242|26951547|P1|Overall Study|Protocol Violation|5
7752217|NCT00801242|26951547|P1|Overall Study|Withdrawal by Subject|13
7752218|NCT00801242|26951547|P1|Overall Study|Adverse Event|10
7752219|NCT00801229|26951560|P2|Received Study Drug/Placebo|Adverse Event|1
7752220|NCT00801229|26951561|P1|Received Study Drug/Placebo|Adverse Event|1
7752221|NCT00801229|26951560|P2|Received Study Drug/Placebo|Lost to Follow-up|1
7752222|NCT00801229|26951561|P1|Received Study Drug/Placebo|Lost to Follow-up|0
7752223|NCT00801229|26951560|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
7752224|NCT00801229|26951561|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
7752225|NCT00801229|26951560|P2|Received Study Drug/Placebo|Simulator sickness|1
7752226|NCT00801229|26951561|P1|Received Study Drug/Placebo|Simulator sickness|1
7752227|NCT00801229|26951560|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
7752228|NCT00801229|26951561|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
7752229|NCT00801229|26951560|P2|Received Study Drug/Placebo|Elevated SGOT level|0
7752230|NCT00801229|26951561|P1|Received Study Drug/Placebo|Elevated SGOT level|1
7752231|NCT00801229|26951560|P2|Signed Consent|Found Ineligible|1
7752232|NCT00801229|26951561|P1|Signed Consent|Found Ineligible|1
7752233|NCT00801229|26951560|P2|Signed Consent|Withdrawal by Subject|2
7752234|NCT00801229|26951561|P1|Signed Consent|Withdrawal by Subject|2
7752235|NCT00801099|26951596|P1|Overall Study|Lost to Follow-up|101
7752236|NCT00800982|26951602|P2|Overall Study|Patient moved out of state|0
7752237|NCT00800982|26951603|P1|Overall Study|Patient moved out of state|1
7752238|NCT00800982|26951602|P2|Overall Study|Withdrawal by Subject|1
7752239|NCT00800982|26951603|P1|Overall Study|Withdrawal by Subject|0
7752240|NCT00800982|26951602|P2|Overall Study|Lost to Follow-up|2
7752241|NCT00800982|26951603|P1|Overall Study|Lost to Follow-up|1
7752242|NCT00800735|26951629|P1|Overall Study|Withdrew Consent|3
7752243|NCT00800735|26951629|P1|Overall Study|Violation of Selection Criteria at Entry|7
7752244|NCT00800735|26951629|P1|Overall Study|Insufficient Therapeutic Response|2
7752245|NCT00800735|26951629|P1|Overall Study|Administrative/Other|2
7752246|NCT00800683|26951635|P2|Overall Study|Other|2
7752247|NCT00800683|26951636|P1|Overall Study|Other|1
7752248|NCT00800683|26951635|P2|Overall Study|Lack of Efficacy|1
7752249|NCT00800683|26951636|P1|Overall Study|Lack of Efficacy|1
7752250|NCT00800683|26951635|P2|Overall Study|Withdrawal by Subject|7
7752251|NCT00800683|26951636|P1|Overall Study|Withdrawal by Subject|1
7752252|NCT00800683|26951635|P2|Overall Study|Lost to Follow-up|1
7752253|NCT00800683|26951636|P1|Overall Study|Lost to Follow-up|3
7752254|NCT00800683|26951635|P2|Overall Study|Adverse Event|8
7752255|NCT00800683|26951636|P1|Overall Study|Adverse Event|11
7752256|NCT00800540|26951682|P2|Period 2: 6 Weeks|Adverse Event|1
7752257|NCT00800540|26951683|P1|Period 2: 6 Weeks|Adverse Event|0
7752258|NCT00800540|26951682|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
7752259|NCT00800540|26951683|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
7752260|NCT00800540|26951682|P2|Period One: 6 Weeks|Noncompliance|0
7752261|NCT00800540|26951683|P1|Period One: 6 Weeks|Noncompliance|1
7752262|NCT00800436|26951718|P7|Overall Study|Withdrawal by Subject|0
7752263|NCT00800436|26951719|P6|Overall Study|Withdrawal by Subject|0
7752264|NCT00800436|26951720|P5|Overall Study|Withdrawal by Subject|0
7752265|NCT00800436|26951721|P4|Overall Study|Withdrawal by Subject|1
7752266|NCT00800436|26951722|P3|Overall Study|Withdrawal by Subject|1
7752267|NCT00800436|26951723|P2|Overall Study|Withdrawal by Subject|0
7752268|NCT00800436|26951724|P1|Overall Study|Withdrawal by Subject|0
7752269|NCT00800384|26951770|P2|Overall Study|Lost to Follow-up|26
7752270|NCT00800384|26951771|P1|Overall Study|Lost to Follow-up|17
7752271|NCT00800384|26951770|P2|Overall Study|Withdrawal by Subject|17
7752272|NCT00800384|26951771|P1|Overall Study|Withdrawal by Subject|24
7752273|NCT00800202|26951809|P2|Overall Study|Disease Progression|18
7752274|NCT00800202|26951810|P1|Overall Study|Disease Progression|54
7752275|NCT00800202|26951809|P2|Overall Study|Other|0
7752276|NCT00800202|26951810|P1|Overall Study|Other|5
7752277|NCT00800202|26951809|P2|Overall Study|Death|0
7752278|NCT00800202|26951810|P1|Overall Study|Death|1
7752279|NCT00800202|26951809|P2|Overall Study|Adverse Event|6
7752280|NCT00800202|26951810|P1|Overall Study|Adverse Event|7
7752281|NCT00800176|26951834|P6|Overall Study|Other|0
7752282|NCT00800176|26951835|P5|Overall Study|Other|2
7752283|NCT00800176|26951836|P4|Overall Study|Other|0
7752284|NCT00800176|26951837|P3|Overall Study|Other|0
7752285|NCT00800176|26951838|P2|Overall Study|Other|0
7752286|NCT00800176|26951839|P1|Overall Study|Other|1
7752287|NCT00800176|26951834|P6|Overall Study|Failure to return|0
7752288|NCT00800176|26951835|P5|Overall Study|Failure to return|0
7752289|NCT00800176|26951836|P4|Overall Study|Failure to return|2
7752290|NCT00800176|26951837|P3|Overall Study|Failure to return|0
7752291|NCT00800176|26951838|P2|Overall Study|Failure to return|3
7752292|NCT00800176|26951839|P1|Overall Study|Failure to return|3
7752293|NCT00800176|26951834|P6|Overall Study|Refused treatment|4
7752294|NCT00800176|26951835|P5|Overall Study|Refused treatment|1
7752295|NCT00800176|26951836|P4|Overall Study|Refused treatment|0
7752296|NCT00800176|26951837|P3|Overall Study|Refused treatment|0
7752297|NCT00800176|26951838|P2|Overall Study|Refused treatment|2
7752298|NCT00800176|26951839|P1|Overall Study|Refused treatment|3
7752299|NCT00800176|26951834|P6|Overall Study|Adverse Event|1
7752300|NCT00800176|26951835|P5|Overall Study|Adverse Event|1
7752301|NCT00800176|26951836|P4|Overall Study|Adverse Event|2
7752302|NCT00800176|26951837|P3|Overall Study|Adverse Event|0
7752303|NCT00800176|26951838|P2|Overall Study|Adverse Event|1
7752304|NCT00800176|26951839|P1|Overall Study|Adverse Event|2
7752305|NCT00799903|26951935|P2|Overall Study|Lost to Follow-up|80
7752306|NCT00799903|26951936|P1|Overall Study|Lost to Follow-up|69
7752307|NCT00799903|26951935|P2|Overall Study|Withdrawal by Subject|175
7752308|NCT00799903|26951936|P1|Overall Study|Withdrawal by Subject|179
7752309|NCT00799903|26951935|P2|Overall Study|Investigator Site Closed|23
7752310|NCT00799903|26951936|P1|Overall Study|Investigator Site Closed|25
7752311|NCT00799825|26951956|P1|Overall Study|Pregnancy|3
7752312|NCT00799825|26951956|P1|Overall Study|Lost to Follow-up|38
7752313|NCT00799825|26951956|P1|Overall Study|Withdrawal by Subject|6
7752314|NCT00799825|26951956|P1|Overall Study|Adverse Event|1
7752315|NCT00799708|26952008|P3|Overall Study|non-compliance|0
7752316|NCT00799708|26952009|P2|Overall Study|non-compliance|0
7752317|NCT00799708|26952010|P1|Overall Study|non-compliance|1
7752318|NCT00799617|26952033|P2|Anemia Trial|Withdrawal by Subject|3
7752319|NCT00799617|26952034|P1|Anemia Trial|Withdrawal by Subject|3
7752320|NCT00799617|26952033|P2|Cognitive Function Trial|Lost to Follow-up|1
7752321|NCT00799617|26952034|P1|Cognitive Function Trial|Lost to Follow-up|0
7752322|NCT00799617|26952033|P2|Bone Trial|Month 12 scan not available|16
7752323|NCT00799617|26952034|P1|Bone Trial|Month 12 scan not available|6
7752324|NCT00799617|26952033|P2|Cardiovascular Trial|Baseline scan not analyzable|2
7752325|NCT00799617|26952034|P1|Cardiovascular Trial|Baseline scan not analyzable|0
7752326|NCT00799617|26952033|P2|Cardiovascular Trial|Month 12 scan not available|15
7752327|NCT00799617|26952034|P1|Cardiovascular Trial|Month 12 scan not available|15
7752328|NCT00799617|26952033|P2|Vitality Trial|Lost to Follow-up|22
7752329|NCT00799617|26952034|P1|Vitality Trial|Lost to Follow-up|7
7752330|NCT00799617|26952033|P2|Physical Function Trial|Lost to Follow-up|11
7752331|NCT00799617|26952034|P1|Physical Function Trial|Lost to Follow-up|6
7752332|NCT00799617|26952033|P2|Sexual Funtion Trial|No Baseline Data|7
7752333|NCT00799617|26952034|P1|Sexual Funtion Trial|No Baseline Data|4
7752334|NCT00799617|26952033|P2|Sexual Funtion Trial|Lost to Follow-up|14
7752335|NCT00799617|26952034|P1|Sexual Funtion Trial|Lost to Follow-up|12
7752336|NCT00799617|26952033|P2|Main Testosterone Trial|Lost to Follow-up|20
7752337|NCT00799617|26952034|P1|Main Testosterone Trial|Lost to Follow-up|18
7752338|NCT00799617|26952033|P2|Main Testosterone Trial|Randomized in error|1
7752339|NCT00799617|26952034|P1|Main Testosterone Trial|Randomized in error|1
7752340|NCT00799591|26952141|P1|Overall Study|Infectious origin not probable|1
7752341|NCT00799591|26952141|P1|Overall Study|Antibiotic changed, no apparent reason|1
7752342|NCT00799591|26952141|P1|Overall Study|Persistance of fever undetermined origin|1
7752343|NCT00799591|26952141|P1|Overall Study|Resistance germ and technical failure|2
7752344|NCT00799591|26952141|P1|Overall Study|New infection|4
7752345|NCT00799591|26952141|P1|Overall Study|Resistant germ|11
7752346|NCT00799591|26952141|P1|Overall Study|Technical failure|12
7752347|NCT00799591|26952141|P1|Overall Study|Death|14
7752348|NCT00799591|26952141|P1|Overall Study|De-escalation of doses|20
7752349|NCT00799487|26952159|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
7752350|NCT00799487|26952160|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
7752351|NCT00799487|26952161|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
7752352|NCT00799487|26952159|P3|Double-Blind Assessment Period|Subject was out of the state|1
7752353|NCT00799487|26952160|P2|Double-Blind Assessment Period|Subject was out of the state|0
7752354|NCT00799487|26952161|P1|Double-Blind Assessment Period|Subject was out of the state|0
7752355|NCT00799487|26952159|P3|Double-Blind Assessment Period|Lost to Follow-up|1
7752356|NCT00799487|26952160|P2|Double-Blind Assessment Period|Lost to Follow-up|0
7752357|NCT00799487|26952161|P1|Double-Blind Assessment Period|Lost to Follow-up|0
7752358|NCT00799487|26952159|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
7752359|NCT00799487|26952160|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
7752360|NCT00799487|26952161|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
7752361|NCT00799487|26952159|P3|Dose Adjustment Period|Missed laboratory day 1|0
7752362|NCT00799487|26952160|P2|Dose Adjustment Period|Missed laboratory day 1|0
7752363|NCT00799487|26952161|P1|Dose Adjustment Period|Missed laboratory day 1|1
7752364|NCT00799487|26952159|P3|Dose Adjustment Period|Child too young (exclusion)|0
7752365|NCT00799487|26952160|P2|Dose Adjustment Period|Child too young (exclusion)|0
7752366|NCT00799487|26952161|P1|Dose Adjustment Period|Child too young (exclusion)|1
7752367|NCT00799487|26952159|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
7752368|NCT00799487|26952160|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
7752369|NCT00799487|26952161|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
7752370|NCT00799487|26952159|P3|Dose Adjustment Period|Withdrawal by Subject|0
7752371|NCT00799487|26952160|P2|Dose Adjustment Period|Withdrawal by Subject|0
7752372|NCT00799487|26952161|P1|Dose Adjustment Period|Withdrawal by Subject|3
7752373|NCT00799487|26952159|P3|Dose Adjustment Period|Investigator Discretion|0
7752374|NCT00799487|26952160|P2|Dose Adjustment Period|Investigator Discretion|0
7752375|NCT00799487|26952161|P1|Dose Adjustment Period|Investigator Discretion|2
7752376|NCT00799487|26952159|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
7752377|NCT00799487|26952160|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
7752378|NCT00799487|26952161|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
7752379|NCT00799487|26952159|P3|Dose Adjustment Period|Adverse Event|0
7752380|NCT00799487|26952160|P2|Dose Adjustment Period|Adverse Event|0
7752381|NCT00799487|26952161|P1|Dose Adjustment Period|Adverse Event|2
7752382|NCT00799487|26952159|P3|Dose Adjustment Period|Lost to Follow-up|0
7752383|NCT00799487|26952160|P2|Dose Adjustment Period|Lost to Follow-up|0
7752384|NCT00799487|26952161|P1|Dose Adjustment Period|Lost to Follow-up|1
7752385|NCT00799422|26952258|P6|First Week of Wear|Adverse Event|0
7752386|NCT00799422|26952259|P5|First Week of Wear|Adverse Event|0
7752387|NCT00799422|26952260|P4|First Week of Wear|Adverse Event|1
7752388|NCT00799422|26952261|P3|First Week of Wear|Adverse Event|0
7752389|NCT00799422|26952262|P2|First Week of Wear|Adverse Event|0
7752390|NCT00799422|26952263|P1|First Week of Wear|Adverse Event|0
7752391|NCT00799422|26952258|P6|First Week of Wear|Lost to Follow-up|0
7752392|NCT00799422|26952259|P5|First Week of Wear|Lost to Follow-up|0
7752393|NCT00799422|26952260|P4|First Week of Wear|Lost to Follow-up|0
7752394|NCT00799422|26952261|P3|First Week of Wear|Lost to Follow-up|1
7752395|NCT00799422|26952262|P2|First Week of Wear|Lost to Follow-up|0
7752396|NCT00799422|26952263|P1|First Week of Wear|Lost to Follow-up|0
7752397|NCT00799409|26952280|P3|Overall Study|medication compliance|0
7752398|NCT00799409|26952281|P2|Overall Study|medication compliance|0
7752399|NCT00799409|26952282|P1|Overall Study|medication compliance|1
7752400|NCT00799409|26952280|P3|Overall Study|Did not attend lab school day 1|0
7752401|NCT00799409|26952281|P2|Overall Study|Did not attend lab school day 1|0
7752402|NCT00799409|26952282|P1|Overall Study|Did not attend lab school day 1|1
7752403|NCT00799409|26952280|P3|Overall Study|Failure to follow study protocol)|0
7752404|NCT00799409|26952281|P2|Overall Study|Failure to follow study protocol)|0
7752405|NCT00799409|26952282|P1|Overall Study|Failure to follow study protocol)|1
7752406|NCT00799409|26952280|P3|Overall Study|Optimal Dose Not Achieved|0
7752407|NCT00799409|26952281|P2|Overall Study|Optimal Dose Not Achieved|0
7752408|NCT00799409|26952282|P1|Overall Study|Optimal Dose Not Achieved|2
7752409|NCT00799409|26952280|P3|Overall Study|Lost to Follow-up|0
7752410|NCT00799409|26952281|P2|Overall Study|Lost to Follow-up|0
7752411|NCT00799409|26952282|P1|Overall Study|Lost to Follow-up|1
7752412|NCT00799409|26952280|P3|Overall Study|Withdrawal by Subject|0
7752413|NCT00799409|26952281|P2|Overall Study|Withdrawal by Subject|0
7752414|NCT00799409|26952282|P1|Overall Study|Withdrawal by Subject|1
7752415|NCT00799396|26952362|P1|Clopidogrel Plus Aspirin|Physician Decision|4
7752416|NCT00799396|26952362|P1|Clopidogrel Plus Aspirin|Adverse Event|2
7752417|NCT00799396|26952362|P1|Clopidogrel Treatment|Withdrawal by Subject|2
7752418|NCT00799396|26952362|P1|Clopidogrel Treatment|Physician Decision|5
7752419|NCT00799396|26952362|P1|Clopidogrel Treatment|Adverse Event|6
7752420|NCT00799383|26952369|P2|Overall Study|Withdrawal by Subject|1
7752421|NCT00799383|26952370|P1|Overall Study|Withdrawal by Subject|0
7752422|NCT00799383|26952369|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
7752423|NCT00799383|26952370|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
7752424|NCT00799383|26952369|P2|Overall Study|Lost to Follow-up|2
7752425|NCT00799383|26952370|P1|Overall Study|Lost to Follow-up|1
7752426|NCT00799383|26952369|P2|Overall Study|Adverse Event|1
7752427|NCT00799383|26952370|P1|Overall Study|Adverse Event|0
7752428|NCT00799383|26952369|P2|Overall Study|Protocol Violation|1
7752429|NCT00799383|26952370|P1|Overall Study|Protocol Violation|1
7752430|NCT00799266|26952399|P2|Overall Study|Subject withdrew consent|0
7752431|NCT00799266|26952400|P1|Overall Study|Subject withdrew consent|3
7752432|NCT00799266|26952399|P2|Overall Study|Adverse Event|1
7752433|NCT00799266|26952400|P1|Overall Study|Adverse Event|0
7752434|NCT00798967|26952440|P2|Overall Study|Randomized in error by site|0
7752435|NCT00798967|26952441|P1|Overall Study|Randomized in error by site|1
7752436|NCT00798967|26952440|P2|Overall Study|Physician Decision|0
7752437|NCT00798967|26952441|P1|Overall Study|Physician Decision|1
7752438|NCT00798967|26952440|P2|Overall Study|Withdrawal by Subject|1
7752439|NCT00798967|26952441|P1|Overall Study|Withdrawal by Subject|0
7752440|NCT00798967|26952440|P2|Overall Study|Adverse Event|3
7752441|NCT00798967|26952441|P1|Overall Study|Adverse Event|2
7752442|NCT00798889|26952449|P1|Overall Study|Enrolled, Not treated|3
7752443|NCT00798889|26952449|P1|Overall Study|Decision of Sponsor|11
7752444|NCT00798889|26952449|P1|Overall Study|Lack of Efficacy|213
7752445|NCT00798889|26952449|P1|Overall Study|Lost to Follow-up|1
7752446|NCT00798889|26952449|P1|Overall Study|Withdrawal by Subject|31
7752447|NCT00798889|26952449|P1|Overall Study|Protocol Violation|2
7752448|NCT00798889|26952449|P1|Overall Study|Adverse Event|53
7752449|NCT00798759|26952455|P2|Overall Study|Other|1
7752450|NCT00798759|26952456|P1|Overall Study|Other|0
7752451|NCT00798759|26952455|P2|Overall Study|Protocol Violation|8
7752452|NCT00798759|26952456|P1|Overall Study|Protocol Violation|4
7752453|NCT00798759|26952455|P2|Overall Study|Lost to Follow-up|1
7752454|NCT00798759|26952456|P1|Overall Study|Lost to Follow-up|1
7752455|NCT00798759|26952455|P2|Overall Study|Adverse Event|3
7752456|NCT00798759|26952456|P1|Overall Study|Adverse Event|3
7752457|NCT00798707|26952474|P3|Overall Study|Randomized not treated|1
7752458|NCT00798707|26952475|P2|Overall Study|Randomized not treated|5
7752459|NCT00798707|26952476|P1|Overall Study|Randomized not treated|4
7752460|NCT00798707|26952474|P3|Overall Study|Withdrawal by Subject|2
7752461|NCT00798707|26952475|P2|Overall Study|Withdrawal by Subject|8
7752462|NCT00798707|26952476|P1|Overall Study|Withdrawal by Subject|3
7752463|NCT00798707|26952474|P3|Overall Study|Protocol Violation|2
7752464|NCT00798707|26952475|P2|Overall Study|Protocol Violation|0
7752465|NCT00798707|26952476|P1|Overall Study|Protocol Violation|4
7752466|NCT00798707|26952474|P3|Overall Study|Other|0
7752467|NCT00798707|26952475|P2|Overall Study|Other|1
7752468|NCT00798707|26952476|P1|Overall Study|Other|0
7752469|NCT00798707|26952474|P3|Overall Study|Lost to Follow-up|6
7752470|NCT00798707|26952475|P2|Overall Study|Lost to Follow-up|6
7752471|NCT00798707|26952476|P1|Overall Study|Lost to Follow-up|5
7752472|NCT00798707|26952474|P3|Overall Study|Lack of Efficacy|1
7752473|NCT00798707|26952475|P2|Overall Study|Lack of Efficacy|2
7752474|NCT00798707|26952476|P1|Overall Study|Lack of Efficacy|2
7752475|NCT00798707|26952474|P3|Overall Study|Investigator|2
7752476|NCT00798707|26952475|P2|Overall Study|Investigator|1
7752477|NCT00798707|26952476|P1|Overall Study|Investigator|0
7752478|NCT00798707|26952474|P3|Overall Study|Failed to return|0
7752479|NCT00798707|26952475|P2|Overall Study|Failed to return|2
7752480|NCT00798707|26952476|P1|Overall Study|Failed to return|2
7752481|NCT00798707|26952474|P3|Overall Study|Adverse Event|8
7752482|NCT00798707|26952475|P2|Overall Study|Adverse Event|8
7752483|NCT00798707|26952476|P1|Overall Study|Adverse Event|6
7752484|NCT00798694|26952528|P2|Overall Study|Physician Decision|0
7752485|NCT00798694|26952529|P1|Overall Study|Physician Decision|1
7752486|NCT00798694|26952528|P2|Overall Study|Lost to Follow-up|1
7752487|NCT00798694|26952529|P1|Overall Study|Lost to Follow-up|1
7752488|NCT00798655|26952553|P1|Overall Study|Did not receive at least one dose of pan|2
7752489|NCT00798603|26952558|P1|Overall Study|Lack of insurance coverage|1
7752490|NCT00798603|26952558|P1|Overall Study|Physician Decision|1
7752491|NCT00798603|26952558|P1|Overall Study|Adverse Event|22
7752492|NCT00798603|26952558|P1|Overall Study|Withdrawal by Subject|10
7752493|NCT00798603|26952558|P1|Overall Study|Still on treatment as of 11/6/2012|1
7752494|NCT00798590|26952580|P2|Overall Study|P.I, Left institution. Study terminated|8
7752495|NCT00798590|26952581|P1|Overall Study|P.I, Left institution. Study terminated|11
7752496|NCT00798434|26952615|P2|Open-Label|Not Treated|1
7752497|NCT00798434|26952616|P1|Open-Label|Not Treated|0
7752498|NCT00798434|26952615|P2|Open-Label|Other|2
7752499|NCT00798434|26952616|P1|Open-Label|Other|1
7752500|NCT00798434|26952615|P2|Open-Label|Protocol Violation|0
7752501|NCT00798434|26952616|P1|Open-Label|Protocol Violation|1
7752502|NCT00798434|26952615|P2|Open-Label|Withdrawal by Subject|7
7752503|NCT00798434|26952616|P1|Open-Label|Withdrawal by Subject|2
7752504|NCT00798434|26952615|P2|Open-Label|Lack of Efficacy|11
7752505|NCT00798434|26952616|P1|Open-Label|Lack of Efficacy|5
7752506|NCT00798434|26952615|P2|Open-Label|Adverse Event|11
7752507|NCT00798434|26952616|P1|Open-Label|Adverse Event|33
7752508|NCT00798434|26952615|P2|Double-Blind|Not Treated|6
7752509|NCT00798434|26952616|P1|Double-Blind|Not Treated|3
7752510|NCT00798434|26952615|P2|Double-Blind|Other|0
7752511|NCT00798434|26952616|P1|Double-Blind|Other|1
7752512|NCT00798434|26952615|P2|Double-Blind|Did Not Meet Entrance Criteria|1
7752513|NCT00798434|26952616|P1|Double-Blind|Did Not Meet Entrance Criteria|2
7752514|NCT00798434|26952615|P2|Double-Blind|Protocol Violation|4
7752515|NCT00798434|26952616|P1|Double-Blind|Protocol Violation|1
7752516|NCT00798434|26952615|P2|Double-Blind|Withdrawal by Subject|14
7752517|NCT00798434|26952616|P1|Double-Blind|Withdrawal by Subject|17
7752518|NCT00798434|26952615|P2|Double-Blind|Lack of Efficacy|12
7752519|NCT00798434|26952616|P1|Double-Blind|Lack of Efficacy|8
7752520|NCT00798434|26952615|P2|Double-Blind|Lost to Follow-up|0
7752521|NCT00798434|26952616|P1|Double-Blind|Lost to Follow-up|1
7752522|NCT00798434|26952615|P2|Double-Blind|Death|1
7752523|NCT00798434|26952616|P1|Double-Blind|Death|0
7752524|NCT00798434|26952615|P2|Double-Blind|Adverse Event|46
7752525|NCT00798434|26952616|P1|Double-Blind|Adverse Event|22
7752526|NCT00798369|26952702|P6|Overall Study|Adminstrative problems|1
7752527|NCT00798369|26952703|P5|Overall Study|Adminstrative problems|0
7752528|NCT00798369|26952704|P4|Overall Study|Adminstrative problems|0
7752529|NCT00798369|26952705|P3|Overall Study|Adminstrative problems|0
7752530|NCT00798369|26952706|P2|Overall Study|Adminstrative problems|0
7752531|NCT00798369|26952707|P1|Overall Study|Adminstrative problems|0
7752532|NCT00798369|26952702|P6|Overall Study|Lost to Follow-up|0
7752533|NCT00798369|26952703|P5|Overall Study|Lost to Follow-up|1
7752534|NCT00798369|26952704|P4|Overall Study|Lost to Follow-up|0
7752535|NCT00798369|26952705|P3|Overall Study|Lost to Follow-up|1
7752536|NCT00798369|26952706|P2|Overall Study|Lost to Follow-up|1
7752537|NCT00798369|26952707|P1|Overall Study|Lost to Follow-up|1
7752538|NCT00798369|26952702|P6|Overall Study|Subject withdrew consent|2
7752539|NCT00798369|26952703|P5|Overall Study|Subject withdrew consent|0
7752540|NCT00798369|26952704|P4|Overall Study|Subject withdrew consent|1
7752541|NCT00798369|26952705|P3|Overall Study|Subject withdrew consent|1
7752542|NCT00798369|26952706|P2|Overall Study|Subject withdrew consent|0
7752543|NCT00798369|26952707|P1|Overall Study|Subject withdrew consent|0
7752544|NCT00798317|26952754|P2|Overall Study|Death|0
7752545|NCT00798317|26952755|P1|Overall Study|Death|1
7752546|NCT00798317|26952754|P2|Overall Study|Adverse Event|0
7752547|NCT00798317|26952755|P1|Overall Study|Adverse Event|2
7752548|NCT00798317|26952754|P2|Overall Study|Lost to Follow-up|2
7752549|NCT00798317|26952755|P1|Overall Study|Lost to Follow-up|2
7752550|NCT00798317|26952754|P2|Overall Study|Withdrawal by Subject|4
7752551|NCT00798317|26952755|P1|Overall Study|Withdrawal by Subject|5
7752552|NCT00798317|26952754|P2|Overall Study|Physician Decision|1
7752553|NCT00798317|26952755|P1|Overall Study|Physician Decision|0
7752554|NCT00798304|26952766|P3|Overall Study|Discontinuation by Sponsor|9
7752555|NCT00798304|26952767|P2|Overall Study|Discontinuation by Sponsor|21
7752556|NCT00798304|26952768|P1|Overall Study|Discontinuation by Sponsor|14
7752557|NCT00798304|26952766|P3|Overall Study|Adverse Event|1
7752558|NCT00798304|26952767|P2|Overall Study|Adverse Event|1
7752559|NCT00798304|26952768|P1|Overall Study|Adverse Event|0
7752560|NCT00798174|26952794|P2|Overall Study|Inability to sedate for DFT testing|0
7752561|NCT00798174|26952795|P1|Overall Study|Inability to sedate for DFT testing|1
7752562|NCT00798174|26952794|P2|Overall Study|inability to implant azygos coil|3
7752563|NCT00798174|26952795|P1|Overall Study|inability to implant azygos coil|3
7752564|NCT00798161|26952806|P7|Overall Study|Other reason (incl. lack of efficacy)|5
7752565|NCT00798161|26952807|P6|Overall Study|Other reason (incl. lack of efficacy)|4
7752566|NCT00798161|26952808|P5|Overall Study|Other reason (incl. lack of efficacy)|2
7752567|NCT00798161|26952809|P4|Overall Study|Other reason (incl. lack of efficacy)|5
7752568|NCT00798161|26952810|P3|Overall Study|Other reason (incl. lack of efficacy)|3
7752569|NCT00798161|26952811|P2|Overall Study|Other reason (incl. lack of efficacy)|5
7752570|NCT00798161|26952812|P1|Overall Study|Other reason (incl. lack of efficacy)|7
7752571|NCT00798161|26952806|P7|Overall Study|Withdrawal by Subject|1
7752572|NCT00798161|26952807|P6|Overall Study|Withdrawal by Subject|3
7752573|NCT00798161|26952808|P5|Overall Study|Withdrawal by Subject|2
7752574|NCT00798161|26952809|P4|Overall Study|Withdrawal by Subject|4
7752575|NCT00798161|26952810|P3|Overall Study|Withdrawal by Subject|5
7752576|NCT00798161|26952811|P2|Overall Study|Withdrawal by Subject|4
7752577|NCT00798161|26952812|P1|Overall Study|Withdrawal by Subject|5
7752578|NCT00798161|26952806|P7|Overall Study|Lost to Follow-up|0
7752579|NCT00798161|26952807|P6|Overall Study|Lost to Follow-up|0
7752580|NCT00798161|26952808|P5|Overall Study|Lost to Follow-up|4
7752581|NCT00798161|26952809|P4|Overall Study|Lost to Follow-up|3
7752582|NCT00798161|26952810|P3|Overall Study|Lost to Follow-up|4
7752583|NCT00798161|26952811|P2|Overall Study|Lost to Follow-up|3
7752584|NCT00798161|26952812|P1|Overall Study|Lost to Follow-up|1
7752585|NCT00798161|26952806|P7|Overall Study|Protocol Violation|0
7752586|NCT00798161|26952807|P6|Overall Study|Protocol Violation|2
7752587|NCT00798161|26952808|P5|Overall Study|Protocol Violation|3
7752588|NCT00798161|26952809|P4|Overall Study|Protocol Violation|3
7752589|NCT00798161|26952810|P3|Overall Study|Protocol Violation|3
7752590|NCT00798161|26952811|P2|Overall Study|Protocol Violation|1
7752591|NCT00798161|26952812|P1|Overall Study|Protocol Violation|2
7752592|NCT00798161|26952806|P7|Overall Study|Adverse Event|4
7752593|NCT00798161|26952807|P6|Overall Study|Adverse Event|2
7752594|NCT00798161|26952808|P5|Overall Study|Adverse Event|5
7752595|NCT00798161|26952809|P4|Overall Study|Adverse Event|6
7752596|NCT00798161|26952810|P3|Overall Study|Adverse Event|6
7752597|NCT00798161|26952811|P2|Overall Study|Adverse Event|4
7752598|NCT00798161|26952812|P1|Overall Study|Adverse Event|3
7752599|NCT00798135|26952919|P1|Overall Study|Physician Decision|1
7752600|NCT00798135|26952919|P1|Overall Study|Disease progression, refractory|1
7752601|NCT00798135|26952919|P1|Overall Study|Disease progression, relapse|11
7752602|NCT00798096|26952925|P1|Overall Study|Ongoing|2
7752603|NCT00797966|26952953|P6|Phase A+|Protocol deviation|4
7752604|NCT00797966|26952954|P5|Phase A+|Protocol deviation|0
7752605|NCT00797966|26952955|P4|Phase A+|Protocol deviation|0
7752606|NCT00797966|26952956|P3|Phase A+|Protocol deviation|0
7752607|NCT00797966|26952957|P2|Phase A+|Protocol deviation|0
7752608|NCT00797966|26952958|P1|Phase A+|Protocol deviation|0
7752609|NCT00797966|26952953|P6|Phase A+|Adverse Event|4
7752610|NCT00797966|26952954|P5|Phase A+|Adverse Event|0
7752611|NCT00797966|26952955|P4|Phase A+|Adverse Event|0
7752612|NCT00797966|26952956|P3|Phase A+|Adverse Event|0
7752613|NCT00797966|26952957|P2|Phase A+|Adverse Event|0
7752614|NCT00797966|26952958|P1|Phase A+|Adverse Event|0
7752615|NCT00797966|26952953|P6|Phase A+|Withdrawal by Subject|6
7752616|NCT00797966|26952954|P5|Phase A+|Withdrawal by Subject|0
7752617|NCT00797966|26952955|P4|Phase A+|Withdrawal by Subject|0
7752618|NCT00797966|26952956|P3|Phase A+|Withdrawal by Subject|0
7752619|NCT00797966|26952957|P2|Phase A+|Withdrawal by Subject|0
7752620|NCT00797966|26952958|P1|Phase A+|Withdrawal by Subject|0
7752621|NCT00797966|26952953|P6|Phase A+|Met withdrawal criteria|5
7752622|NCT00797966|26952954|P5|Phase A+|Met withdrawal criteria|0
7752623|NCT00797966|26952955|P4|Phase A+|Met withdrawal criteria|0
7752624|NCT00797966|26952956|P3|Phase A+|Met withdrawal criteria|0
7752625|NCT00797966|26952957|P2|Phase A+|Met withdrawal criteria|0
7752626|NCT00797966|26952958|P1|Phase A+|Met withdrawal criteria|0
7752627|NCT00797966|26952953|P6|Phase A+|Lost to Follow-up|9
7752628|NCT00797966|26952954|P5|Phase A+|Lost to Follow-up|0
7752629|NCT00797966|26952955|P4|Phase A+|Lost to Follow-up|0
7752630|NCT00797966|26952956|P3|Phase A+|Lost to Follow-up|0
7752631|NCT00797966|26952957|P2|Phase A+|Lost to Follow-up|0
7752632|NCT00797966|26952958|P1|Phase A+|Lost to Follow-up|0
7752633|NCT00797966|26952953|P6|Phase B|Lack of Efficacy|0
7752634|NCT00797966|26952954|P5|Phase B|Lack of Efficacy|0
7752635|NCT00797966|26952955|P4|Phase B|Lack of Efficacy|4
7752636|NCT00797966|26952956|P3|Phase B|Lack of Efficacy|1
7752637|NCT00797966|26952957|P2|Phase B|Lack of Efficacy|1
7752638|NCT00797966|26952958|P1|Phase B|Lack of Efficacy|0
7752639|NCT00797966|26952953|P6|Phase B|Protocol Deviation|0
7752640|NCT00797966|26952954|P5|Phase B|Protocol Deviation|0
7752641|NCT00797966|26952955|P4|Phase B|Protocol Deviation|6
7752642|NCT00797966|26952956|P3|Phase B|Protocol Deviation|2
7752643|NCT00797966|26952957|P2|Phase B|Protocol Deviation|8
7752644|NCT00797966|26952958|P1|Phase B|Protocol Deviation|4
7752645|NCT00797966|26952953|P6|Phase B|Withdrawal by Subject|0
7752646|NCT00797966|26952954|P5|Phase B|Withdrawal by Subject|0
7752647|NCT00797966|26952955|P4|Phase B|Withdrawal by Subject|3
7752648|NCT00797966|26952956|P3|Phase B|Withdrawal by Subject|3
7752649|NCT00797966|26952957|P2|Phase B|Withdrawal by Subject|4
7752650|NCT00797966|26952958|P1|Phase B|Withdrawal by Subject|1
7752651|NCT00797966|26952953|P6|Phase B|Physician Decision|0
7752652|NCT00797966|26952954|P5|Phase B|Physician Decision|0
7752653|NCT00797966|26952955|P4|Phase B|Physician Decision|1
7752654|NCT00797966|26952956|P3|Phase B|Physician Decision|3
7752655|NCT00797966|26952957|P2|Phase B|Physician Decision|0
7752656|NCT00797966|26952958|P1|Phase B|Physician Decision|1
7752657|NCT00797966|26952953|P6|Phase B|Met Withdrawal Criteria|0
7752658|NCT00797966|26952954|P5|Phase B|Met Withdrawal Criteria|0
7752659|NCT00797966|26952955|P4|Phase B|Met Withdrawal Criteria|1
7752660|NCT00797966|26952956|P3|Phase B|Met Withdrawal Criteria|6
7752661|NCT00797966|26952957|P2|Phase B|Met Withdrawal Criteria|3
7752662|NCT00797966|26952958|P1|Phase B|Met Withdrawal Criteria|3
7752663|NCT00797966|26952953|P6|Phase B|Adverse Event|0
7752664|NCT00797966|26952954|P5|Phase B|Adverse Event|0
7752665|NCT00797966|26952955|P4|Phase B|Adverse Event|1
7752666|NCT00797966|26952956|P3|Phase B|Adverse Event|3
7752667|NCT00797966|26952957|P2|Phase B|Adverse Event|1
7752668|NCT00797966|26952958|P1|Phase B|Adverse Event|2
7752669|NCT00797966|26952953|P6|Phase B|Lost to Follow-up|0
7752670|NCT00797966|26952954|P5|Phase B|Lost to Follow-up|0
7752671|NCT00797966|26952955|P4|Phase B|Lost to Follow-up|0
7752672|NCT00797966|26952956|P3|Phase B|Lost to Follow-up|3
7752673|NCT00797966|26952957|P2|Phase B|Lost to Follow-up|1
7752674|NCT00797966|26952958|P1|Phase B|Lost to Follow-up|0
7752675|NCT00797966|26952953|P6|Phase A|Protocol deviation|0
7752676|NCT00797966|26952954|P5|Phase A|Protocol deviation|56
7752677|NCT00797966|26952955|P4|Phase A|Protocol deviation|0
7752678|NCT00797966|26952956|P3|Phase A|Protocol deviation|0
7752679|NCT00797966|26952957|P2|Phase A|Protocol deviation|0
7752680|NCT00797966|26952958|P1|Phase A|Protocol deviation|0
7752681|NCT00797966|26952953|P6|Phase A|Withdrawal by Subject|0
7752682|NCT00797966|26952954|P5|Phase A|Withdrawal by Subject|33
7752683|NCT00797966|26952955|P4|Phase A|Withdrawal by Subject|0
7752684|NCT00797966|26952956|P3|Phase A|Withdrawal by Subject|0
7752685|NCT00797966|26952957|P2|Phase A|Withdrawal by Subject|0
7752686|NCT00797966|26952958|P1|Phase A|Withdrawal by Subject|0
7752687|NCT00797966|26952953|P6|Phase A|Physician Decision|0
7752688|NCT00797966|26952954|P5|Phase A|Physician Decision|13
7752689|NCT00797966|26952955|P4|Phase A|Physician Decision|0
7752690|NCT00797966|26952956|P3|Phase A|Physician Decision|0
7752691|NCT00797966|26952957|P2|Phase A|Physician Decision|0
7752692|NCT00797966|26952958|P1|Phase A|Physician Decision|0
7752693|NCT00797966|26952953|P6|Phase A|Met withdrawal criteria|0
7752694|NCT00797966|26952954|P5|Phase A|Met withdrawal criteria|4
7752695|NCT00797966|26952955|P4|Phase A|Met withdrawal criteria|0
7752696|NCT00797966|26952956|P3|Phase A|Met withdrawal criteria|0
7752697|NCT00797966|26952957|P2|Phase A|Met withdrawal criteria|0
7752698|NCT00797966|26952958|P1|Phase A|Met withdrawal criteria|0
7752699|NCT00797966|26952953|P6|Phase A|Adverse Event|0
7752700|NCT00797966|26952954|P5|Phase A|Adverse Event|46
7752701|NCT00797966|26952955|P4|Phase A|Adverse Event|0
7752702|NCT00797966|26952956|P3|Phase A|Adverse Event|0
7752703|NCT00797966|26952957|P2|Phase A|Adverse Event|0
7752704|NCT00797966|26952958|P1|Phase A|Adverse Event|0
7752705|NCT00797966|26952953|P6|Phase A|Lost to Follow-up|0
7752706|NCT00797966|26952954|P5|Phase A|Lost to Follow-up|33
7752707|NCT00797966|26952955|P4|Phase A|Lost to Follow-up|0
7752708|NCT00797966|26952956|P3|Phase A|Lost to Follow-up|0
7752709|NCT00797966|26952957|P2|Phase A|Lost to Follow-up|0
7752710|NCT00797966|26952958|P1|Phase A|Lost to Follow-up|0
7752711|NCT00797862|26953023|P3|Overall Study|Mis-randomized|1
7752712|NCT00797862|26953024|P2|Overall Study|Mis-randomized|3
7752713|NCT00797862|26953025|P1|Overall Study|Mis-randomized|3
7752714|NCT00797862|26953023|P3|Overall Study|Protocol Violation|8
7752715|NCT00797862|26953024|P2|Overall Study|Protocol Violation|6
7752716|NCT00797862|26953025|P1|Overall Study|Protocol Violation|4
7752717|NCT00797862|26953023|P3|Overall Study|Administrative Problem|0
7752718|NCT00797862|26953024|P2|Overall Study|Administrative Problem|0
7752719|NCT00797862|26953025|P1|Overall Study|Administrative Problem|4
7752720|NCT00797862|26953023|P3|Overall Study|Lost to Follow-up|5
7752721|NCT00797862|26953024|P2|Overall Study|Lost to Follow-up|0
7752722|NCT00797862|26953025|P1|Overall Study|Lost to Follow-up|11
7752723|NCT00797862|26953023|P3|Overall Study|Withdrawal by Subject|7
7752724|NCT00797862|26953024|P2|Overall Study|Withdrawal by Subject|7
7752725|NCT00797862|26953025|P1|Overall Study|Withdrawal by Subject|14
7752726|NCT00797862|26953023|P3|Overall Study|No longer required study medication|0
7752727|NCT00797862|26953024|P2|Overall Study|No longer required study medication|0
7752728|NCT00797862|26953025|P1|Overall Study|No longer required study medication|1
7752729|NCT00797862|26953023|P3|Overall Study|Lack of Efficacy|6
7752730|NCT00797862|26953024|P2|Overall Study|Lack of Efficacy|7
7752731|NCT00797862|26953025|P1|Overall Study|Lack of Efficacy|1
7752732|NCT00797862|26953023|P3|Overall Study|Abnormal Test Procedure Result|1
7752733|NCT00797862|26953024|P2|Overall Study|Abnormal Test Procedure Result|1
7752734|NCT00797862|26953025|P1|Overall Study|Abnormal Test Procedure Result|0
7752735|NCT00797862|26953023|P3|Overall Study|Adverse Event|58
7752736|NCT00797862|26953024|P2|Overall Study|Adverse Event|44
7752737|NCT00797862|26953025|P1|Overall Study|Adverse Event|86
7752738|NCT00797823|26953054|P3|First Period (Initial Randomization)|Physician Decision|0
7752739|NCT00797823|26953055|P2|First Period (Initial Randomization)|Physician Decision|0
7752740|NCT00797823|26953056|P1|First Period (Initial Randomization)|Physician Decision|1
7752741|NCT00797732|26953078|P3|Overall Study|Refused to Participate|123
7752742|NCT00797732|26953079|P2|Overall Study|Refused to Participate|0
7752743|NCT00797732|26953080|P1|Overall Study|Refused to Participate|0
7752744|NCT00797732|26953078|P3|Overall Study|Excluded due to time constraints|24
7752745|NCT00797732|26953079|P2|Overall Study|Excluded due to time constraints|0
7752746|NCT00797732|26953080|P1|Overall Study|Excluded due to time constraints|0
7752747|NCT00797732|26953078|P3|Overall Study|Not meet inclusion criteria|7
7752748|NCT00797732|26953079|P2|Overall Study|Not meet inclusion criteria|0
7752749|NCT00797732|26953080|P1|Overall Study|Not meet inclusion criteria|0
7752750|NCT00797732|26953078|P3|Overall Study|Death|0
7752751|NCT00797732|26953079|P2|Overall Study|Death|0
7752752|NCT00797732|26953080|P1|Overall Study|Death|1
7752753|NCT00797732|26953078|P3|Overall Study|Lost to Follow-up|0
7752754|NCT00797732|26953079|P2|Overall Study|Lost to Follow-up|0
7752755|NCT00797732|26953080|P1|Overall Study|Lost to Follow-up|1
7752756|NCT00797732|26953078|P3|Overall Study|Withdrawal by Subject|0
7752757|NCT00797732|26953079|P2|Overall Study|Withdrawal by Subject|3
7752758|NCT00797732|26953080|P1|Overall Study|Withdrawal by Subject|3
7752759|NCT00797667|26953095|P3|Overall Study|Adverse Event|8
7752760|NCT00797667|26953096|P2|Overall Study|Adverse Event|8
7752761|NCT00797667|26953097|P1|Overall Study|Adverse Event|19
7752762|NCT00797667|26953095|P3|Overall Study|Withdrawal by Subject|2
7752763|NCT00797667|26953096|P2|Overall Study|Withdrawal by Subject|14
7752764|NCT00797667|26953097|P1|Overall Study|Withdrawal by Subject|9
7752765|NCT00797667|26953095|P3|Overall Study|Study Terminated by Sponsor|115
7752766|NCT00797667|26953096|P2|Overall Study|Study Terminated by Sponsor|216
7752767|NCT00797667|26953097|P1|Overall Study|Study Terminated by Sponsor|217
7752768|NCT00797667|26953095|P3|Overall Study|Protocol Violation|0
7752769|NCT00797667|26953096|P2|Overall Study|Protocol Violation|7
7752770|NCT00797667|26953097|P1|Overall Study|Protocol Violation|2
7752771|NCT00797667|26953095|P3|Overall Study|Pregnancy|0
7752772|NCT00797667|26953096|P2|Overall Study|Pregnancy|0
7752773|NCT00797667|26953097|P1|Overall Study|Pregnancy|2
7752774|NCT00797667|26953095|P3|Overall Study|Physician Decision|0
7752775|NCT00797667|26953096|P2|Overall Study|Physician Decision|1
7752776|NCT00797667|26953097|P1|Overall Study|Physician Decision|3
7752777|NCT00797667|26953095|P3|Overall Study|Lost to Follow-up|2
7752778|NCT00797667|26953096|P2|Overall Study|Lost to Follow-up|12
7752779|NCT00797667|26953097|P1|Overall Study|Lost to Follow-up|8
7752780|NCT00797667|26953095|P3|Overall Study|Lack of Efficacy|0
7752781|NCT00797667|26953096|P2|Overall Study|Lack of Efficacy|1
7752782|NCT00797667|26953097|P1|Overall Study|Lack of Efficacy|0
7752783|NCT00797563|26953123|P1|Overall Study|Adverse Event|1
7752784|NCT00797511|26953129|P1|Overall Study|Withdrawal by Subject|1
7752785|NCT00797316|26953147|P2|Overall Study|Unsatisfactory therapeutic effect|13
7752786|NCT00797316|26953148|P1|Overall Study|Unsatisfactory therapeutic effect|0
7752787|NCT00797316|26953147|P2|Overall Study|Patient withdrew consent|6
7752788|NCT00797316|26953148|P1|Overall Study|Patient withdrew consent|12
7752789|NCT00797316|26953147|P2|Overall Study|Protocol Deviation|2
7752790|NCT00797316|26953148|P1|Overall Study|Protocol Deviation|1
7752791|NCT00797316|26953147|P2|Overall Study|Lost to Follow-up|8
7752792|NCT00797316|26953148|P1|Overall Study|Lost to Follow-up|4
7752793|NCT00797316|26953147|P2|Overall Study|Adverse Event|3
7752794|NCT00797316|26953148|P1|Overall Study|Adverse Event|5
7752795|NCT00797316|26953147|P2|Overall Study|Administrative problems|0
7752796|NCT00797316|26953148|P1|Overall Study|Administrative problems|1
7752797|NCT00797225|26953177|P8|Weeks 13 to 24|Sponsor Decision|0
7752798|NCT00797225|26953178|P7|Weeks 13 to 24|Sponsor Decision|1
7752799|NCT00797225|26953179|P6|Weeks 13 to 24|Sponsor Decision|0
7752800|NCT00797225|26953180|P5|Weeks 13 to 24|Sponsor Decision|0
7752801|NCT00797225|26953181|P4|Weeks 13 to 24|Sponsor Decision|0
7752802|NCT00797225|26953182|P3|Weeks 13 to 24|Sponsor Decision|0
7752803|NCT00797225|26953183|P2|Weeks 13 to 24|Sponsor Decision|0
7752804|NCT00797225|26953184|P1|Weeks 13 to 24|Sponsor Decision|0
7752805|NCT00797225|26953177|P8|Weeks 13 to 24|Adverse Event|0
7752806|NCT00797225|26953178|P7|Weeks 13 to 24|Adverse Event|1
7752807|NCT00797225|26953179|P6|Weeks 13 to 24|Adverse Event|0
7752808|NCT00797225|26953180|P5|Weeks 13 to 24|Adverse Event|0
7752809|NCT00797225|26953181|P4|Weeks 13 to 24|Adverse Event|0
7752810|NCT00797225|26953182|P3|Weeks 13 to 24|Adverse Event|0
7752811|NCT00797225|26953183|P2|Weeks 13 to 24|Adverse Event|1
7752812|NCT00797225|26953184|P1|Weeks 13 to 24|Adverse Event|0
7752813|NCT00797225|26953177|P8|Weeks 13 to 24|Lost to Follow-up|0
7752814|NCT00797225|26953178|P7|Weeks 13 to 24|Lost to Follow-up|0
7752815|NCT00797225|26953179|P6|Weeks 13 to 24|Lost to Follow-up|0
7752816|NCT00797225|26953180|P5|Weeks 13 to 24|Lost to Follow-up|1
7752817|NCT00797225|26953181|P4|Weeks 13 to 24|Lost to Follow-up|0
7752818|NCT00797225|26953182|P3|Weeks 13 to 24|Lost to Follow-up|1
7752819|NCT00797225|26953183|P2|Weeks 13 to 24|Lost to Follow-up|0
7752820|NCT00797225|26953184|P1|Weeks 13 to 24|Lost to Follow-up|0
7752821|NCT00797225|26953177|P8|Weeks 13 to 24|Withdrawal by Subject|0
7752822|NCT00797225|26953178|P7|Weeks 13 to 24|Withdrawal by Subject|0
7752823|NCT00797225|26953179|P6|Weeks 13 to 24|Withdrawal by Subject|0
7752824|NCT00797225|26953180|P5|Weeks 13 to 24|Withdrawal by Subject|0
7752825|NCT00797225|26953181|P4|Weeks 13 to 24|Withdrawal by Subject|0
7752826|NCT00797225|26953182|P3|Weeks 13 to 24|Withdrawal by Subject|1
7752827|NCT00797225|26953183|P2|Weeks 13 to 24|Withdrawal by Subject|1
7752828|NCT00797225|26953184|P1|Weeks 13 to 24|Withdrawal by Subject|0
7752829|NCT00797225|26953177|P8|Weeks 13 to 24|Non-compliance|0
7752830|NCT00797225|26953178|P7|Weeks 13 to 24|Non-compliance|0
7752831|NCT00797225|26953179|P6|Weeks 13 to 24|Non-compliance|0
7752832|NCT00797225|26953180|P5|Weeks 13 to 24|Non-compliance|0
7752833|NCT00797225|26953181|P4|Weeks 13 to 24|Non-compliance|0
7752834|NCT00797225|26953182|P3|Weeks 13 to 24|Non-compliance|0
7752835|NCT00797225|26953183|P2|Weeks 13 to 24|Non-compliance|2
7752836|NCT00797225|26953184|P1|Weeks 13 to 24|Non-compliance|0
7752837|NCT00797225|26953177|P8|Weeks 1 to 12|Sponsor Decision|0
7752838|NCT00797225|26953178|P7|Weeks 1 to 12|Sponsor Decision|0
7752839|NCT00797225|26953179|P6|Weeks 1 to 12|Sponsor Decision|0
7752840|NCT00797225|26953180|P5|Weeks 1 to 12|Sponsor Decision|0
7752841|NCT00797225|26953181|P4|Weeks 1 to 12|Sponsor Decision|0
7752842|NCT00797225|26953182|P3|Weeks 1 to 12|Sponsor Decision|0
7752843|NCT00797225|26953183|P2|Weeks 1 to 12|Sponsor Decision|0
7752844|NCT00797225|26953184|P1|Weeks 1 to 12|Sponsor Decision|1
7752845|NCT00797225|26953177|P8|Weeks 1 to 12|Lack of Efficacy|0
7752846|NCT00797225|26953178|P7|Weeks 1 to 12|Lack of Efficacy|0
7752847|NCT00797225|26953179|P6|Weeks 1 to 12|Lack of Efficacy|0
7752848|NCT00797225|26953180|P5|Weeks 1 to 12|Lack of Efficacy|0
7752849|NCT00797225|26953181|P4|Weeks 1 to 12|Lack of Efficacy|0
7752850|NCT00797225|26953182|P3|Weeks 1 to 12|Lack of Efficacy|0
7752851|NCT00797225|26953183|P2|Weeks 1 to 12|Lack of Efficacy|0
7752852|NCT00797225|26953184|P1|Weeks 1 to 12|Lack of Efficacy|1
7752853|NCT00797225|26953177|P8|Weeks 1 to 12|Non-compliance|0
7752854|NCT00797225|26953178|P7|Weeks 1 to 12|Non-compliance|0
7752855|NCT00797225|26953179|P6|Weeks 1 to 12|Non-compliance|0
7752856|NCT00797225|26953180|P5|Weeks 1 to 12|Non-compliance|0
7752857|NCT00797225|26953181|P4|Weeks 1 to 12|Non-compliance|0
7752858|NCT00797225|26953182|P3|Weeks 1 to 12|Non-compliance|0
7752859|NCT00797225|26953183|P2|Weeks 1 to 12|Non-compliance|1
7752860|NCT00797225|26953184|P1|Weeks 1 to 12|Non-compliance|0
7752861|NCT00797225|26953177|P8|Weeks 1 to 12|Adverse Event|0
7752862|NCT00797225|26953178|P7|Weeks 1 to 12|Adverse Event|0
7752863|NCT00797225|26953179|P6|Weeks 1 to 12|Adverse Event|0
7752864|NCT00797225|26953180|P5|Weeks 1 to 12|Adverse Event|0
7752865|NCT00797225|26953181|P4|Weeks 1 to 12|Adverse Event|0
7752866|NCT00797225|26953182|P3|Weeks 1 to 12|Adverse Event|1
7752867|NCT00797225|26953183|P2|Weeks 1 to 12|Adverse Event|0
7752868|NCT00797225|26953184|P1|Weeks 1 to 12|Adverse Event|0
7752869|NCT00797108|26953301|P3|Overall Study|Randomized but not Treated|0
7752870|NCT00797108|26953302|P2|Overall Study|Randomized but not Treated|0
7752871|NCT00797108|26953303|P1|Overall Study|Randomized but not Treated|2
7752872|NCT00797108|26953301|P3|Overall Study|Other|2
7752873|NCT00797108|26953302|P2|Overall Study|Other|0
7752874|NCT00797108|26953303|P1|Overall Study|Other|0
7752875|NCT00797108|26953301|P3|Overall Study|Lack of Efficacy|1
7752876|NCT00797108|26953302|P2|Overall Study|Lack of Efficacy|0
7752877|NCT00797108|26953303|P1|Overall Study|Lack of Efficacy|1
7752878|NCT00797108|26953301|P3|Overall Study|Global Deterioration of Health Status|0
7752879|NCT00797108|26953302|P2|Overall Study|Global Deterioration of Health Status|1
7752880|NCT00797108|26953303|P1|Overall Study|Global Deterioration of Health Status|0
7752881|NCT00797108|26953301|P3|Overall Study|Did Not Meet Entrance Criteria|0
7752882|NCT00797108|26953302|P2|Overall Study|Did Not Meet Entrance Criteria|1
7752883|NCT00797108|26953303|P1|Overall Study|Did Not Meet Entrance Criteria|0
7752884|NCT00797108|26953301|P3|Overall Study|Adverse Event|3
7752885|NCT00797108|26953302|P2|Overall Study|Adverse Event|0
7752886|NCT00797108|26953303|P1|Overall Study|Adverse Event|1
7752887|NCT00796991|26953338|P3|Overall Study|Withdrawal by Subject|1
7752888|NCT00796991|26953339|P2|Overall Study|Withdrawal by Subject|0
7752889|NCT00796991|26953340|P1|Overall Study|Withdrawal by Subject|0
7752890|NCT00796991|26953338|P3|Overall Study|Study Drug Toxicity|5
7752891|NCT00796991|26953339|P2|Overall Study|Study Drug Toxicity|3
7752892|NCT00796991|26953340|P1|Overall Study|Study Drug Toxicity|3
7752893|NCT00796991|26953338|P3|Overall Study|Disease Progression|7
7752894|NCT00796991|26953339|P2|Overall Study|Disease Progression|9
7752895|NCT00796991|26953340|P1|Overall Study|Disease Progression|10
7752896|NCT00796991|26953338|P3|Overall Study|Death|0
7752897|NCT00796991|26953339|P2|Overall Study|Death|0
7752898|NCT00796991|26953340|P1|Overall Study|Death|2
7752899|NCT00796991|26953338|P3|Overall Study|Adverse Event|1
7752900|NCT00796991|26953339|P2|Overall Study|Adverse Event|0
7752901|NCT00796991|26953340|P1|Overall Study|Adverse Event|0
7752902|NCT00796978|26953438|P1|Overall Study|Withdrawal by Subject|3
7752903|NCT00796978|26953438|P1|Overall Study|Adverse Event|4
7752904|NCT00796978|26953438|P1|Overall Study|Cardiac adverse event|5
7752905|NCT00796861|26953464|P1|Overall Study|Death|2
7752906|NCT00796861|26953464|P1|Overall Study|Withdrawal by Subject|2
7752907|NCT00796822|26953470|P2|Overall Study|Adverse Event|0
7752908|NCT00796822|26953471|P1|Overall Study|Adverse Event|1
7752909|NCT00796822|26953470|P2|Overall Study|Lost to Follow-up|0
7752910|NCT00796822|26953471|P1|Overall Study|Lost to Follow-up|2
7752911|NCT00796757|26953479|P1|Overall Study|Other|7
7752912|NCT00796757|26953479|P1|Overall Study|Investigator's decision|2
7752913|NCT00796757|26953479|P1|Overall Study|Participant noncompliance|1
7752914|NCT00796757|26953479|P1|Overall Study|Protocol Violation|1
7752915|NCT00796757|26953479|P1|Overall Study|Death|61
7752916|NCT00796757|26953479|P1|Overall Study|Withdrawal by Subject|14
7752917|NCT00796718|26953513|P1|Overall Study|Withdrawal by Informed Consent|1
7752918|NCT00796718|26953513|P1|Overall Study|Lost to Follow-up|5
7752919|NCT00796718|26953513|P1|Overall Study|Exclusion Criteria|1
7752920|NCT00796718|26953513|P1|Overall Study|Adverse Event|2
7752921|NCT00796666|26953565|P2|Overall Study|Randomized and not treated|0
7752922|NCT00796666|26953566|P1|Overall Study|Randomized and not treated|1
7752923|NCT00796666|26953565|P2|Overall Study|Terminated by sponsor|55
7752924|NCT00796666|26953566|P1|Overall Study|Terminated by sponsor|53
7752925|NCT00796666|26953565|P2|Overall Study|Other|0
7752926|NCT00796666|26953566|P1|Overall Study|Other|1
7752927|NCT00796666|26953565|P2|Overall Study|Protocol Violation|0
7752928|NCT00796666|26953566|P1|Overall Study|Protocol Violation|1
7752929|NCT00796666|26953565|P2|Overall Study|Adverse Event|5
7752930|NCT00796666|26953566|P1|Overall Study|Adverse Event|7
7752931|NCT00796666|26953565|P2|Overall Study|Withdrawal by Subject|0
7752932|NCT00796666|26953566|P1|Overall Study|Withdrawal by Subject|2
7752933|NCT00796666|26953565|P2|Overall Study|Death|4
7752934|NCT00796666|26953566|P1|Overall Study|Death|2
7752935|NCT00796653|26953600|P4|Overall Study|Other reason not described above|4
7752936|NCT00796653|26953601|P3|Overall Study|Other reason not described above|7
7752937|NCT00796653|26953602|P2|Overall Study|Other reason not described above|9
7752938|NCT00796653|26953603|P1|Overall Study|Other reason not described above|4
7752939|NCT00796653|26953600|P4|Overall Study|Non compliance with protocol|2
7752940|NCT00796653|26953601|P3|Overall Study|Non compliance with protocol|0
7752941|NCT00796653|26953602|P2|Overall Study|Non compliance with protocol|2
7752942|NCT00796653|26953603|P1|Overall Study|Non compliance with protocol|2
7752943|NCT00796653|26953600|P4|Overall Study|Lack of Efficacy|2
7752944|NCT00796653|26953601|P3|Overall Study|Lack of Efficacy|3
7752945|NCT00796653|26953602|P2|Overall Study|Lack of Efficacy|1
7752946|NCT00796653|26953603|P1|Overall Study|Lack of Efficacy|8
7752947|NCT00796653|26953600|P4|Overall Study|Withdrawal by Subject|13
7752948|NCT00796653|26953601|P3|Overall Study|Withdrawal by Subject|8
7752949|NCT00796653|26953602|P2|Overall Study|Withdrawal by Subject|8
7752950|NCT00796653|26953603|P1|Overall Study|Withdrawal by Subject|16
7752951|NCT00796653|26953600|P4|Overall Study|Lost to Follow-up|3
7752952|NCT00796653|26953601|P3|Overall Study|Lost to Follow-up|2
7752953|NCT00796653|26953602|P2|Overall Study|Lost to Follow-up|1
7752954|NCT00796653|26953603|P1|Overall Study|Lost to Follow-up|2
7752955|NCT00796653|26953600|P4|Overall Study|Adverse Event|16
7752956|NCT00796653|26953601|P3|Overall Study|Adverse Event|16
7752957|NCT00796653|26953602|P2|Overall Study|Adverse Event|16
7752958|NCT00796653|26953603|P1|Overall Study|Adverse Event|19
7752959|NCT00796614|26953888|P4|Overall Study|Other than stated|0
7752960|NCT00796614|26953889|P3|Overall Study|Other than stated|0
7752961|NCT00796614|26953890|P2|Overall Study|Other than stated|0
7752962|NCT00796614|26953891|P1|Overall Study|Other than stated|1
7752963|NCT00796614|26953888|P4|Overall Study|Withdrawal by Subject|1
7752964|NCT00796614|26953889|P3|Overall Study|Withdrawal by Subject|0
7752965|NCT00796614|26953890|P2|Overall Study|Withdrawal by Subject|0
7752966|NCT00796614|26953891|P1|Overall Study|Withdrawal by Subject|1
7752967|NCT00796614|26953888|P4|Overall Study|Lost to Follow-up|0
7752968|NCT00796614|26953889|P3|Overall Study|Lost to Follow-up|1
7752969|NCT00796614|26953890|P2|Overall Study|Lost to Follow-up|2
7752970|NCT00796614|26953891|P1|Overall Study|Lost to Follow-up|2
7752971|NCT00796614|26953888|P4|Overall Study|Protocol Violation|0
7752972|NCT00796614|26953889|P3|Overall Study|Protocol Violation|2
7752973|NCT00796614|26953890|P2|Overall Study|Protocol Violation|0
7752974|NCT00796614|26953891|P1|Overall Study|Protocol Violation|0
7752975|NCT00796614|26953888|P4|Overall Study|Adverse Event|0
7752976|NCT00796614|26953889|P3|Overall Study|Adverse Event|0
7752977|NCT00796614|26953890|P2|Overall Study|Adverse Event|2
7752978|NCT00796614|26953891|P1|Overall Study|Adverse Event|1
7752979|NCT00796562|26953933|P1|Overall Study|Death|49
7752980|NCT00796549|26953942|P1|Overall Study|Progressive disease|56
7752981|NCT00796549|26953942|P1|Overall Study|Other|2
7752982|NCT00796549|26953942|P1|Overall Study|not entered|149
7752983|NCT00796549|26953942|P1|Overall Study|Adverse Event|11
7752984|NCT00796523|26953959|P2|Overall Study|Lost to Follow-up|7
7752985|NCT00796523|26953960|P1|Overall Study|Lost to Follow-up|9
7752986|NCT00796510|26953970|P2|Overall Study|Study Terminated|0
7752987|NCT00796510|26953971|P1|Overall Study|Study Terminated|2
7752988|NCT00796510|26953970|P2|Overall Study|Death|0
7752989|NCT00796510|26953971|P1|Overall Study|Death|1
7752990|NCT00796445|26953983|P2|Overall Study|Invalid Informed Consent Form|0
7752991|NCT00796445|26953984|P1|Overall Study|Invalid Informed Consent Form|1
7752992|NCT00796445|26953983|P2|Overall Study|Withdrawal by Subject|9
7752993|NCT00796445|26953984|P1|Overall Study|Withdrawal by Subject|18
7752994|NCT00796445|26953983|P2|Overall Study|Other|7
7752995|NCT00796445|26953984|P1|Overall Study|Other|10
7752996|NCT00796445|26953983|P2|Overall Study|Disease progression/recurrence|268
7752997|NCT00796445|26953984|P1|Overall Study|Disease progression/recurrence|537
7752998|NCT00796445|26953983|P2|Overall Study|Adverse event, non-fatal|0
7752999|NCT00796445|26953984|P1|Overall Study|Adverse event, non-fatal|4
7753000|NCT00796445|26953983|P2|Overall Study|Adverse event, serious fatal|5
7753001|NCT00796445|26953984|P1|Overall Study|Adverse event, serious fatal|10
7753002|NCT00796445|26953983|P2|Overall Study|Protocol Violation|3
7753003|NCT00796445|26953984|P1|Overall Study|Protocol Violation|5
7753004|NCT00796419|26954036|P2|Overall Study|Death|1
7753005|NCT00796419|26954037|P1|Overall Study|Death|0
7753006|NCT00796367|26954050|P3|Overall Study|other|3
7753007|NCT00796367|26954051|P2|Overall Study|other|4
7753008|NCT00796367|26954052|P1|Overall Study|other|2
7753009|NCT00796367|26954050|P3|Overall Study|Requirement for restricted medication|2
7753010|NCT00796367|26954051|P2|Overall Study|Requirement for restricted medication|0
7753011|NCT00796367|26954052|P1|Overall Study|Requirement for restricted medication|2
7753012|NCT00796367|26954050|P3|Overall Study|Pregnancy|1
7753013|NCT00796367|26954051|P2|Overall Study|Pregnancy|0
7753014|NCT00796367|26954052|P1|Overall Study|Pregnancy|1
7753015|NCT00796367|26954050|P3|Overall Study|non compliance|1
7753016|NCT00796367|26954051|P2|Overall Study|non compliance|1
7753017|NCT00796367|26954052|P1|Overall Study|non compliance|3
7753018|NCT00796367|26954050|P3|Overall Study|Lack of Efficacy|0
7753019|NCT00796367|26954051|P2|Overall Study|Lack of Efficacy|1
7753020|NCT00796367|26954052|P1|Overall Study|Lack of Efficacy|2
7753021|NCT00796367|26954050|P3|Overall Study|Withdrawal by Subject|12
7753022|NCT00796367|26954051|P2|Overall Study|Withdrawal by Subject|11
7753023|NCT00796367|26954052|P1|Overall Study|Withdrawal by Subject|9
7753024|NCT00796367|26954050|P3|Overall Study|Lost to Follow-up|21
7753025|NCT00796367|26954051|P2|Overall Study|Lost to Follow-up|4
7753026|NCT00796367|26954052|P1|Overall Study|Lost to Follow-up|5
7753027|NCT00796367|26954050|P3|Overall Study|Adverse Event|7
7753028|NCT00796367|26954051|P2|Overall Study|Adverse Event|4
7753029|NCT00796367|26954052|P1|Overall Study|Adverse Event|6
7753030|NCT00796328|26954063|P1|Overall Study|experienced hypotension requiring tx|6
7753031|NCT00796315|26954067|P3|Overall Study|Protocol Violation|0
7753032|NCT00796315|26954068|P2|Overall Study|Protocol Violation|1
7753033|NCT00796315|26954069|P1|Overall Study|Protocol Violation|0
7753034|NCT00796224|26954097|P2|Overall Study|Protocol Violation|1
7753035|NCT00796224|26954098|P1|Overall Study|Protocol Violation|0
7753036|NCT00796224|26954097|P2|Overall Study|Adverse Event|0
7753037|NCT00796224|26954098|P1|Overall Study|Adverse Event|1
7753038|NCT00796120|26954118|P2|Overall Study|Randomized but not treated|3
7753039|NCT00796120|26954119|P1|Overall Study|Randomized but not treated|0
7753040|NCT00796120|26954118|P2|Overall Study|Physician Decision|17
7753041|NCT00796120|26954119|P1|Overall Study|Physician Decision|16
7753042|NCT00796120|26954118|P2|Overall Study|Other|17
7753043|NCT00796120|26954119|P1|Overall Study|Other|6
7753044|NCT00796120|26954118|P2|Overall Study|Participant refusal|4
7753045|NCT00796120|26954119|P1|Overall Study|Participant refusal|3
7753046|NCT00796120|26954118|P2|Overall Study|Progressive disease|13
7753047|NCT00796120|26954119|P1|Overall Study|Progressive disease|22
7753048|NCT00796120|26954118|P2|Overall Study|Adverse Event|6
7753049|NCT00796120|26954119|P1|Overall Study|Adverse Event|11
7753050|NCT00796120|26954118|P2|Overall Study|Death|0
7753051|NCT00796120|26954119|P1|Overall Study|Death|3
7753052|NCT00796107|26954133|P1|Overall Study|Progressive Disease|5
7753053|NCT00796107|26954133|P1|Overall Study|Lack of Efficacy|1
7753054|NCT00796003|26954142|P2|Overall Study|Participants Not treated|2
7753055|NCT00796003|26954143|P1|Overall Study|Participants Not treated|0
7753056|NCT00796003|26954142|P2|Overall Study|Other|1
7753057|NCT00796003|26954143|P1|Overall Study|Other|0
7753058|NCT00796003|26954142|P2|Overall Study|Withdrawal by Subject|1
7753059|NCT00796003|26954143|P1|Overall Study|Withdrawal by Subject|0
7753060|NCT00796003|26954142|P2|Overall Study|Physician Decision|4
7753061|NCT00796003|26954143|P1|Overall Study|Physician Decision|0
7753062|NCT00796003|26954142|P2|Overall Study|Specified organ function not met|1
7753063|NCT00796003|26954143|P1|Overall Study|Specified organ function not met|0
7753064|NCT00796003|26954142|P2|Overall Study|Adverse Event|7
7753065|NCT00796003|26954143|P1|Overall Study|Adverse Event|1
7753066|NCT00796003|26954142|P2|Overall Study|Disease Progression|13
7753067|NCT00796003|26954143|P1|Overall Study|Disease Progression|2
7753068|NCT00795951|26954164|P1|Overall Study|Withdrawal by Subject|1
7753069|NCT00795951|26954164|P1|Overall Study|Lost to Follow-up|1
7753070|NCT00795886|26954257|P1|Overall Study|Death|10
7753071|NCT00795821|26954265|P2|Taper Phase|Withdrawal by Subject|0
7753072|NCT00795821|26954266|P1|Taper Phase|Withdrawal by Subject|4
7753073|NCT00795821|26954265|P2|Taper Phase|Physician Decision|0
7753074|NCT00795821|26954266|P1|Taper Phase|Physician Decision|2
7753075|NCT00795821|26954265|P2|Taper Phase|Lost to Follow-up|0
7753076|NCT00795821|26954266|P1|Taper Phase|Lost to Follow-up|1
7753077|NCT00795821|26954265|P2|Taper Phase|Adverse Event|0
7753078|NCT00795821|26954266|P1|Taper Phase|Adverse Event|2
7753079|NCT00795821|26954265|P2|Long-term Extension Phase|Withdrawal by Subject|25
7753080|NCT00795821|26954266|P1|Long-term Extension Phase|Withdrawal by Subject|25
7753081|NCT00795821|26954265|P2|Long-term Extension Phase|Protocol Violation|5
7753082|NCT00795821|26954266|P1|Long-term Extension Phase|Protocol Violation|3
7753083|NCT00795821|26954265|P2|Long-term Extension Phase|Physician Decision|2
7753084|NCT00795821|26954266|P1|Long-term Extension Phase|Physician Decision|1
7753085|NCT00795821|26954265|P2|Long-term Extension Phase|Lost to Follow-up|16
7753086|NCT00795821|26954266|P1|Long-term Extension Phase|Lost to Follow-up|20
7753087|NCT00795821|26954265|P2|Long-term Extension Phase|Lack of Efficacy|12
7753088|NCT00795821|26954266|P1|Long-term Extension Phase|Lack of Efficacy|16
7753089|NCT00795821|26954265|P2|Long-term Extension Phase|Adverse Event|32
7753090|NCT00795821|26954266|P1|Long-term Extension Phase|Adverse Event|25
7753091|NCT00795821|26954265|P2|Acute Treatment Phase|Withdrawal by Subject|10
7753092|NCT00795821|26954266|P1|Acute Treatment Phase|Withdrawal by Subject|16
7753093|NCT00795821|26954265|P2|Acute Treatment Phase|Protocol Violation|2
7753094|NCT00795821|26954266|P1|Acute Treatment Phase|Protocol Violation|1
7753095|NCT00795821|26954265|P2|Acute Treatment Phase|Physician Decision|1
7753096|NCT00795821|26954266|P1|Acute Treatment Phase|Physician Decision|1
7753097|NCT00795821|26954265|P2|Acute Treatment Phase|Lost to Follow-up|12
7753098|NCT00795821|26954266|P1|Acute Treatment Phase|Lost to Follow-up|9
7753099|NCT00795821|26954265|P2|Acute Treatment Phase|Lack of Efficacy|2
7753100|NCT00795821|26954266|P1|Acute Treatment Phase|Lack of Efficacy|5
7753101|NCT00795821|26954265|P2|Acute Treatment Phase|Death|0
7753102|NCT00795821|26954266|P1|Acute Treatment Phase|Death|1
7753103|NCT00795821|26954265|P2|Acute Treatment Phase|Adverse Event|4
7753104|NCT00795821|26954266|P1|Acute Treatment Phase|Adverse Event|23
7753105|NCT00795717|26954341|P2|Phase II|too busy|1
7753106|NCT00795717|26954342|P1|Phase II|too busy|0
7753107|NCT00795717|26954341|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
7753108|NCT00795717|26954342|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
7753109|NCT00795717|26954341|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
7753110|NCT00795717|26954342|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
7753111|NCT00795717|26954341|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
7753112|NCT00795717|26954342|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
7753113|NCT00795704|26954354|P2|Overall Study|Adverse Event|1
7753114|NCT00795704|26954355|P1|Overall Study|Adverse Event|1
7753115|NCT00795704|26954354|P2|Overall Study|Withdrawal by Subject|2
7753116|NCT00795704|26954355|P1|Overall Study|Withdrawal by Subject|3
7753117|NCT00795639|26954375|P2|Overall Study|Randomized and not treated|1
7753118|NCT00795639|26954376|P1|Overall Study|Randomized and not treated|0
7753119|NCT00795639|26954375|P2|Overall Study|Terminated by sponsor|12
7753120|NCT00795639|26954376|P1|Overall Study|Terminated by sponsor|13
7753121|NCT00795639|26954375|P2|Overall Study|Other|2
7753122|NCT00795639|26954376|P1|Overall Study|Other|0
7753123|NCT00795639|26954375|P2|Overall Study|Adverse Event|2
7753124|NCT00795639|26954376|P1|Overall Study|Adverse Event|5
7753125|NCT00795639|26954375|P2|Overall Study|Pregnancy|0
7753126|NCT00795639|26954376|P1|Overall Study|Pregnancy|1
7753127|NCT00795639|26954375|P2|Overall Study|Withdrawal by Subject|3
7753128|NCT00795639|26954376|P1|Overall Study|Withdrawal by Subject|1
7753129|NCT00795639|26954375|P2|Overall Study|Death|6
7753130|NCT00795639|26954376|P1|Overall Study|Death|1
7753131|NCT00795600|26954388|P2|Overall Study|Unclassified|1
7753132|NCT00795600|26954389|P1|Overall Study|Unclassified|1
7753133|NCT00795600|26954388|P2|Overall Study|Withdrawal by Subject|0
7753134|NCT00795600|26954389|P1|Overall Study|Withdrawal by Subject|1
7753135|NCT00795600|26954388|P2|Overall Study|Protocol Violation|2
7753136|NCT00795600|26954389|P1|Overall Study|Protocol Violation|1
7753137|NCT00795600|26954388|P2|Overall Study|Adverse Event|1
7753138|NCT00795600|26954389|P1|Overall Study|Adverse Event|1
7753139|NCT00795535|26954509|P1|Overall Study|incomplete data and technical problems|20
7753140|NCT00795509|26954516|P1|Overall Study|Protocol Violation|31
7753141|NCT00795184|26954610|P2|Overall Study|Tissue sampling incomplete/conclusive|13
7753142|NCT00795184|26954611|P1|Overall Study|Tissue sampling incomplete/conclusive|8
7753143|NCT00795132|26954672|P1|Overall Study|Relapse|2
7753144|NCT00795132|26954672|P1|Overall Study|Death|1
7753145|NCT00794963|26954699|P2|Overall Study|Withdrawal by Subject|4
7753146|NCT00794963|26954700|P1|Overall Study|Withdrawal by Subject|1
7753147|NCT00794950|26954706|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
7753148|NCT00794950|26954706|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
7753149|NCT00794950|26954706|P1|Beginning Sunitinib Treatment|Physician Decision|5
7753150|NCT00794950|26954706|P1|Beginning Sunitinib Treatment|cystectomy|5
7753151|NCT00794950|26954706|P1|BCG Induction|Adverse Event|1
7753152|NCT00794950|26954706|P1|BCG Induction|noncompliant w. BCG|1
7753153|NCT00794950|26954706|P1|BCG Induction|ineligible|3
7753154|NCT00794950|26954706|P1|BCG Induction|Withdrawal by Subject|2
7753155|NCT00794924|26954715|P2|Overall Study|Adverse Event|2
7753156|NCT00794924|26954716|P1|Overall Study|Adverse Event|6
7753157|NCT00794924|26954715|P2|Overall Study|Withdrawal by Subject|60
7753158|NCT00794924|26954716|P1|Overall Study|Withdrawal by Subject|48
7753159|NCT00794924|26954715|P2|Overall Study|Lost to Follow-up|8
7753160|NCT00794924|26954716|P1|Overall Study|Lost to Follow-up|6
7753161|NCT00794820|26954720|P1|Overall Study|Ineligible/Screen Failure|1
7753162|NCT00794820|26954720|P1|Overall Study|Resistant Disease|2
7753163|NCT00794820|26954720|P1|Overall Study|Secondary Malignancies|2
7753164|NCT00794820|26954720|P1|Overall Study|Adverse Event|11
7753165|NCT00794677|26954728|P2|First Intervention|Withdrawal by Subject|0
7753166|NCT00794677|26954729|P1|First Intervention|Withdrawal by Subject|2
7753167|NCT00794664|26954751|P2|Follow-up Period|Protocol non-compliance|1
7753168|NCT00794664|26954752|P1|Follow-up Period|Protocol non-compliance|0
7753169|NCT00794664|26954751|P2|Follow-up Period|Withdrawal by Subject|2
7753170|NCT00794664|26954752|P1|Follow-up Period|Withdrawal by Subject|0
7753171|NCT00794664|26954751|P2|Follow-up Period|Other|2
7753172|NCT00794664|26954752|P1|Follow-up Period|Other|1
7753173|NCT00794664|26954751|P2|Treatment Period|Adverse Event|8
7753174|NCT00794664|26954752|P1|Treatment Period|Adverse Event|1
7753175|NCT00794664|26954751|P2|Treatment Period|Other|1
7753176|NCT00794664|26954752|P1|Treatment Period|Other|0
7753177|NCT00794664|26954751|P2|Treatment Period|Protocol non-compliance|1
7753178|NCT00794664|26954752|P1|Treatment Period|Protocol non-compliance|0
7753179|NCT00794664|26954751|P2|Treatment Period|Withdrawal by Subject|2
7753180|NCT00794664|26954752|P1|Treatment Period|Withdrawal by Subject|0
7753181|NCT00794573|26954798|P2|Overall Study|Lost to Follow-up|33
7753182|NCT00794573|26954799|P1|Overall Study|Lost to Follow-up|26
7753183|NCT00794573|26954798|P2|Overall Study|Withdrawal by Subject|12
7753184|NCT00794573|26954799|P1|Overall Study|Withdrawal by Subject|9
7753185|NCT00794573|26954798|P2|Overall Study|Death|0
7753186|NCT00794573|26954799|P1|Overall Study|Death|3
7753187|NCT00794417|26954872|P4|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
7753188|NCT00794417|26954873|P3|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7753189|NCT00794417|26954874|P2|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7753190|NCT00794417|26954875|P1|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7753191|NCT00794417|26954872|P4|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
7753192|NCT00794417|26954873|P3|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7753193|NCT00794417|26954874|P2|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7753194|NCT00794417|26954875|P1|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7753195|NCT00794417|26954872|P4|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
7753196|NCT00794417|26954873|P3|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7753197|NCT00794417|26954874|P2|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7753198|NCT00794417|26954875|P1|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7753199|NCT00794417|26954872|P4|Phase 2: Baseline (Day 421) to Day 972|Death|7
7753200|NCT00794417|26954873|P3|Phase 2: Baseline (Day 421) to Day 972|Death|0
7753201|NCT00794417|26954874|P2|Phase 2: Baseline (Day 421) to Day 972|Death|0
7753202|NCT00794417|26954875|P1|Phase 2: Baseline (Day 421) to Day 972|Death|0
7753203|NCT00794417|26954872|P4|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
7753204|NCT00794417|26954873|P3|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
7753205|NCT00794417|26954874|P2|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
7753206|NCT00794417|26954875|P1|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
7753207|NCT00794417|26954872|P4|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7753208|NCT00794417|26954873|P3|Phase 1: Baseline (Day 1) up to Day 751|Death|2
7753209|NCT00794417|26954874|P2|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7753210|NCT00794417|26954875|P1|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7753211|NCT00794365|26954928|P1|Overall Study|Lack of Efficacy|3
7753212|NCT00794365|26954928|P1|Overall Study|Adverse Event|10
7753213|NCT00794365|26954928|P1|Overall Study|Poor Compliance|11
7753214|NCT00794365|26954928|P1|Overall Study|Other|17
7753215|NCT00794365|26954928|P1|Overall Study|Lost to Follow-up|38
7753216|NCT00794339|26954934|P1|Overall Study|Tx not per protocol|1
7753217|NCT00794339|26954934|P1|Overall Study|ATSM imaging not complete or inadequate|3
7753218|NCT00794339|26954934|P1|Overall Study|Tx prior to ATSM|3
7753219|NCT00794339|26954934|P1|Overall Study|Ineligible|4
7753220|NCT00794339|26954934|P1|Overall Study|Withdrawal by Subject|3
7753221|NCT00794196|26955001|P2|Overall Study|Lost to Follow-up|23
7753222|NCT00794196|26955002|P1|Overall Study|Lost to Follow-up|5
7753223|NCT00794157|26955022|P3|Overall Study|Protocol deviation|1
7753224|NCT00794157|26955023|P2|Overall Study|Protocol deviation|1
7753225|NCT00794157|26955024|P1|Overall Study|Protocol deviation|0
7753226|NCT00794157|26955022|P3|Overall Study|Abnormal test procedure result(s)|0
7753227|NCT00794157|26955023|P2|Overall Study|Abnormal test procedure result(s)|1
7753228|NCT00794157|26955024|P1|Overall Study|Abnormal test procedure result(s)|0
7753229|NCT00794157|26955022|P3|Overall Study|Administrative problems|4
7753230|NCT00794157|26955023|P2|Overall Study|Administrative problems|7
7753231|NCT00794157|26955024|P1|Overall Study|Administrative problems|1
7753232|NCT00794157|26955022|P3|Overall Study|Unsatisfactory therapeutic effect|2
7753233|NCT00794157|26955023|P2|Overall Study|Unsatisfactory therapeutic effect|0
7753234|NCT00794157|26955024|P1|Overall Study|Unsatisfactory therapeutic effect|1
7753235|NCT00794157|26955022|P3|Overall Study|Lost to Follow-up|1
7753236|NCT00794157|26955023|P2|Overall Study|Lost to Follow-up|0
7753237|NCT00794157|26955024|P1|Overall Study|Lost to Follow-up|2
7753238|NCT00794157|26955022|P3|Overall Study|Subject withdrew consent|3
7753239|NCT00794157|26955023|P2|Overall Study|Subject withdrew consent|0
7753240|NCT00794157|26955024|P1|Overall Study|Subject withdrew consent|2
7753241|NCT00794157|26955022|P3|Overall Study|Adverse Event|8
7753242|NCT00794157|26955023|P2|Overall Study|Adverse Event|1
7753243|NCT00794157|26955024|P1|Overall Study|Adverse Event|4
7753244|NCT00794118|26955053|P1|Overall Study|Changed hospital center|2
7753245|NCT00794118|26955053|P1|Overall Study|Withdrawal by Subject|9
7753246|NCT00794118|26955053|P1|Overall Study|Lost to Follow-up|16
7753247|NCT00794040|26955113|P2|Overall Study|Physician Decision|1
7753248|NCT00794040|26955114|P1|Overall Study|Physician Decision|0
7753249|NCT00794040|26955113|P2|Overall Study|Withdrawal by Subject|4
7753250|NCT00794040|26955114|P1|Overall Study|Withdrawal by Subject|3
7753251|NCT00793910|26955130|P2|Overall Study|Withdrawal by Subject|1
7753252|NCT00793910|26955131|P1|Overall Study|Withdrawal by Subject|0
7753253|NCT00793910|26955130|P2|Overall Study|decided to undergo LASIK instead of PRK|1
7753254|NCT00793910|26955131|P1|Overall Study|decided to undergo LASIK instead of PRK|2
7753255|NCT00793910|26955130|P2|Overall Study|ineligible based on entry criteria|3
7753256|NCT00793910|26955131|P1|Overall Study|ineligible based on entry criteria|2
7753257|NCT00793910|26955130|P2|Overall Study|did not pick up medications|1
7753258|NCT00793910|26955131|P1|Overall Study|did not pick up medications|1
7753259|NCT00793910|26955130|P2|Overall Study|discarded study pills|1
7753260|NCT00793910|26955131|P1|Overall Study|discarded study pills|0
7753261|NCT00793871|26955145|P1|Overall Study|Study terminated by the Sponsor|7
7753262|NCT00793871|26955145|P1|Overall Study|Lost to Follow-up|3
7753263|NCT00793871|26955145|P1|Overall Study|Death|50
7753264|NCT00793819|26955159|P2|Overall Study|Lost to Follow-up|1
7753265|NCT00793819|26955160|P1|Overall Study|Lost to Follow-up|1
7753266|NCT00793819|26955159|P2|Overall Study|Withdrawal by Subject|3
7753267|NCT00793819|26955160|P1|Overall Study|Withdrawal by Subject|4
7753268|NCT00793819|26955159|P2|Overall Study|Lack of Efficacy|1
7753269|NCT00793819|26955160|P1|Overall Study|Lack of Efficacy|1
7753270|NCT00793819|26955159|P2|Overall Study|Adverse Event|4
7753271|NCT00793819|26955160|P1|Overall Study|Adverse Event|8
7753272|NCT00793793|26955178|P12|Overall Study|reason not specified|4
7753273|NCT00793793|26955179|P11|Overall Study|reason not specified|2
7753274|NCT00793793|26955180|P10|Overall Study|reason not specified|6
7753275|NCT00793793|26955181|P9|Overall Study|reason not specified|7
7753276|NCT00793793|26955182|P8|Overall Study|reason not specified|0
7753277|NCT00793793|26955183|P7|Overall Study|reason not specified|2
7753278|NCT00793793|26955184|P6|Overall Study|reason not specified|1
7753279|NCT00793793|26955185|P5|Overall Study|reason not specified|1
7753280|NCT00793793|26955186|P4|Overall Study|reason not specified|1
7753281|NCT00793793|26955187|P3|Overall Study|reason not specified|0
7753282|NCT00793793|26955188|P2|Overall Study|reason not specified|1
7753283|NCT00793793|26955189|P1|Overall Study|reason not specified|0
7753284|NCT00793793|26955178|P12|Overall Study|Withdrawal by Subject|0
7753285|NCT00793793|26955179|P11|Overall Study|Withdrawal by Subject|0
7753286|NCT00793793|26955180|P10|Overall Study|Withdrawal by Subject|0
7753287|NCT00793793|26955181|P9|Overall Study|Withdrawal by Subject|1
7753288|NCT00793793|26955182|P8|Overall Study|Withdrawal by Subject|0
7753289|NCT00793793|26955183|P7|Overall Study|Withdrawal by Subject|0
7753290|NCT00793793|26955184|P6|Overall Study|Withdrawal by Subject|0
7753291|NCT00793793|26955185|P5|Overall Study|Withdrawal by Subject|1
7753292|NCT00793793|26955186|P4|Overall Study|Withdrawal by Subject|0
7753293|NCT00793793|26955187|P3|Overall Study|Withdrawal by Subject|0
7753294|NCT00793793|26955188|P2|Overall Study|Withdrawal by Subject|0
7753295|NCT00793793|26955189|P1|Overall Study|Withdrawal by Subject|0
7753296|NCT00793793|26955178|P12|Overall Study|Lost to Follow-up|0
7753297|NCT00793793|26955179|P11|Overall Study|Lost to Follow-up|1
7753298|NCT00793793|26955180|P10|Overall Study|Lost to Follow-up|3
7753299|NCT00793793|26955181|P9|Overall Study|Lost to Follow-up|1
7753300|NCT00793793|26955182|P8|Overall Study|Lost to Follow-up|0
7753301|NCT00793793|26955183|P7|Overall Study|Lost to Follow-up|0
7753302|NCT00793793|26955184|P6|Overall Study|Lost to Follow-up|0
7753303|NCT00793793|26955185|P5|Overall Study|Lost to Follow-up|0
7753304|NCT00793793|26955186|P4|Overall Study|Lost to Follow-up|0
7753305|NCT00793793|26955187|P3|Overall Study|Lost to Follow-up|1
7753306|NCT00793793|26955188|P2|Overall Study|Lost to Follow-up|0
7753307|NCT00793793|26955189|P1|Overall Study|Lost to Follow-up|0
7753308|NCT00793793|26955178|P12|Overall Study|Protocol Violation|0
7753309|NCT00793793|26955179|P11|Overall Study|Protocol Violation|0
7753310|NCT00793793|26955180|P10|Overall Study|Protocol Violation|0
7753311|NCT00793793|26955181|P9|Overall Study|Protocol Violation|0
7753312|NCT00793793|26955182|P8|Overall Study|Protocol Violation|0
7753313|NCT00793793|26955183|P7|Overall Study|Protocol Violation|0
7753314|NCT00793793|26955184|P6|Overall Study|Protocol Violation|0
7753315|NCT00793793|26955185|P5|Overall Study|Protocol Violation|0
7753316|NCT00793793|26955186|P4|Overall Study|Protocol Violation|1
7753317|NCT00793793|26955187|P3|Overall Study|Protocol Violation|0
7753318|NCT00793793|26955188|P2|Overall Study|Protocol Violation|0
7753319|NCT00793793|26955189|P1|Overall Study|Protocol Violation|0
7753320|NCT00793793|26955178|P12|Overall Study|Adverse Event|2
7753321|NCT00793793|26955179|P11|Overall Study|Adverse Event|0
7753322|NCT00793793|26955180|P10|Overall Study|Adverse Event|0
7753323|NCT00793793|26955181|P9|Overall Study|Adverse Event|0
7753324|NCT00793793|26955182|P8|Overall Study|Adverse Event|0
7753325|NCT00793793|26955183|P7|Overall Study|Adverse Event|2
7753326|NCT00793793|26955184|P6|Overall Study|Adverse Event|1
7753327|NCT00793793|26955185|P5|Overall Study|Adverse Event|0
7753328|NCT00793793|26955186|P4|Overall Study|Adverse Event|1
7753329|NCT00793793|26955187|P3|Overall Study|Adverse Event|1
7753330|NCT00793793|26955188|P2|Overall Study|Adverse Event|0
7753331|NCT00793793|26955189|P1|Overall Study|Adverse Event|0
7753332|NCT00793780|26955564|P2|Overall Study|Withdrawal by Subject|1
7753333|NCT00793780|26955565|P1|Overall Study|Withdrawal by Subject|2
7753334|NCT00793624|26955596|P4|Overall Study|Other reason not described above|3
7753335|NCT00793624|26955597|P3|Overall Study|Other reason not described above|6
7753336|NCT00793624|26955598|P2|Overall Study|Other reason not described above|4
7753337|NCT00793624|26955599|P1|Overall Study|Other reason not described above|6
7753338|NCT00793624|26955596|P4|Overall Study|Non compliance with protocol|3
7753339|NCT00793624|26955597|P3|Overall Study|Non compliance with protocol|2
7753340|NCT00793624|26955598|P2|Overall Study|Non compliance with protocol|3
7753341|NCT00793624|26955599|P1|Overall Study|Non compliance with protocol|2
7753342|NCT00793624|26955596|P4|Overall Study|Lack of Efficacy|3
7753343|NCT00793624|26955597|P3|Overall Study|Lack of Efficacy|1
7753344|NCT00793624|26955598|P2|Overall Study|Lack of Efficacy|2
7753345|NCT00793624|26955599|P1|Overall Study|Lack of Efficacy|9
7753346|NCT00793624|26955596|P4|Overall Study|Withdrawal by Subject|14
7753347|NCT00793624|26955597|P3|Overall Study|Withdrawal by Subject|11
7753348|NCT00793624|26955598|P2|Overall Study|Withdrawal by Subject|9
7753349|NCT00793624|26955599|P1|Overall Study|Withdrawal by Subject|20
7753350|NCT00793624|26955596|P4|Overall Study|Lost to Follow-up|0
7753351|NCT00793624|26955597|P3|Overall Study|Lost to Follow-up|4
7753352|NCT00793624|26955598|P2|Overall Study|Lost to Follow-up|2
7753353|NCT00793624|26955599|P1|Overall Study|Lost to Follow-up|2
7753354|NCT00793624|26955596|P4|Overall Study|Adverse Event|20
7753355|NCT00793624|26955597|P3|Overall Study|Adverse Event|15
7753356|NCT00793624|26955598|P2|Overall Study|Adverse Event|16
7753357|NCT00793624|26955599|P1|Overall Study|Adverse Event|18
7753358|NCT00793598|26955883|P8|Overall Study|Subject not dosed|0
7753359|NCT00793598|26955884|P7|Overall Study|Subject not dosed|0
7753360|NCT00793598|26955885|P6|Overall Study|Subject not dosed|1
7753361|NCT00793598|26955886|P5|Overall Study|Subject not dosed|0
7753362|NCT00793598|26955887|P4|Overall Study|Subject not dosed|0
7753363|NCT00793598|26955888|P3|Overall Study|Subject not dosed|0
7753364|NCT00793598|26955889|P2|Overall Study|Subject not dosed|0
7753365|NCT00793598|26955890|P1|Overall Study|Subject not dosed|0
7753366|NCT00793598|26955883|P8|Overall Study|Protocol Violation|1
7753367|NCT00793598|26955884|P7|Overall Study|Protocol Violation|0
7753368|NCT00793598|26955885|P6|Overall Study|Protocol Violation|0
7753369|NCT00793598|26955886|P5|Overall Study|Protocol Violation|0
7753370|NCT00793598|26955887|P4|Overall Study|Protocol Violation|0
7753371|NCT00793598|26955888|P3|Overall Study|Protocol Violation|0
7753372|NCT00793598|26955889|P2|Overall Study|Protocol Violation|0
7753373|NCT00793598|26955890|P1|Overall Study|Protocol Violation|0
7753374|NCT00793598|26955883|P8|Overall Study|Patient Request|0
7753375|NCT00793598|26955884|P7|Overall Study|Patient Request|0
7753376|NCT00793598|26955885|P6|Overall Study|Patient Request|0
7753377|NCT00793598|26955886|P5|Overall Study|Patient Request|0
7753378|NCT00793598|26955887|P4|Overall Study|Patient Request|0
7753379|NCT00793598|26955888|P3|Overall Study|Patient Request|0
7753380|NCT00793598|26955889|P2|Overall Study|Patient Request|1
7753381|NCT00793598|26955890|P1|Overall Study|Patient Request|0
7753382|NCT00793585|26955914|P2|Overall Study|Protocol Violation|2
7753383|NCT00793585|26955915|P1|Overall Study|Protocol Violation|1
7753384|NCT00793585|26955914|P2|Overall Study|Adverse Event|1
7753385|NCT00793585|26955915|P1|Overall Study|Adverse Event|1
7753386|NCT00793546|26955934|P2|Overall Study|Other|0
7753387|NCT00793546|26955935|P1|Overall Study|Other|1
7753388|NCT00793546|26955934|P2|Overall Study|Study Terminated by Sponsor|27
7753389|NCT00793546|26955935|P1|Overall Study|Study Terminated by Sponsor|8
7753390|NCT00793546|26955934|P2|Overall Study|Withdrawal by Subject|1
7753391|NCT00793546|26955935|P1|Overall Study|Withdrawal by Subject|1
7753392|NCT00793546|26955934|P2|Overall Study|Lost to Follow-up|0
7753393|NCT00793546|26955935|P1|Overall Study|Lost to Follow-up|1
7753394|NCT00793546|26955934|P2|Overall Study|Death|0
7753395|NCT00793546|26955935|P1|Overall Study|Death|3
7753396|NCT00793403|26955985|P1|Overall Study|Other|73
7753397|NCT00793325|26956032|P1|Overall Study|Lost to Follow-up|1
7753398|NCT00793325|26956032|P1|Overall Study|Protocol Violation|18
7753399|NCT00793182|26956058|P2|Overall Study|Adverse Event|1
7753400|NCT00793182|26956059|P1|Overall Study|Adverse Event|0
7753401|NCT00793104|26956069|P1|Overall Study|Lost to Follow-up|1
7753409|NCT00792935|26956088|P2|Overall Study|Withdrawal by Subject|1
7753410|NCT00792935|26956089|P1|Overall Study|Withdrawal by Subject|0
7753411|NCT00792935|26956088|P2|Overall Study|Protocol Violation|0
7753412|NCT00792935|26956089|P1|Overall Study|Protocol Violation|2
7753413|NCT00792935|26956088|P2|Overall Study|Lost to Follow-up|1
7753414|NCT00792935|26956089|P1|Overall Study|Lost to Follow-up|0
7753415|NCT00792935|26956088|P2|Overall Study|Adverse Event|1
7753416|NCT00792935|26956089|P1|Overall Study|Adverse Event|2
7753417|NCT00792909|26956121|P3|Overall Study|Withdrawal by Subject|0
7753418|NCT00792909|26956122|P2|Overall Study|Withdrawal by Subject|1
7753419|NCT00792909|26956123|P1|Overall Study|Withdrawal by Subject|0
7753420|NCT00792805|26956179|P3|Overall Study|Protocol deviation|1
7753421|NCT00792805|26956180|P2|Overall Study|Protocol deviation|1
7753422|NCT00792805|26956181|P1|Overall Study|Protocol deviation|0
7753423|NCT00792805|26956179|P3|Overall Study|Abnormal laboratory value(s)|1
7753424|NCT00792805|26956180|P2|Overall Study|Abnormal laboratory value(s)|0
7753425|NCT00792805|26956181|P1|Overall Study|Abnormal laboratory value(s)|0
7753426|NCT00792805|26956179|P3|Overall Study|Lost to Follow-up|6
7753427|NCT00792805|26956180|P2|Overall Study|Lost to Follow-up|1
7753428|NCT00792805|26956181|P1|Overall Study|Lost to Follow-up|1
7753429|NCT00792805|26956179|P3|Overall Study|Unsatisfactory therapeutic effect|6
7753430|NCT00792805|26956180|P2|Overall Study|Unsatisfactory therapeutic effect|6
7753431|NCT00792805|26956181|P1|Overall Study|Unsatisfactory therapeutic effect|1
7753432|NCT00792805|26956179|P3|Overall Study|Abnormal test procedure result(s)|0
7753433|NCT00792805|26956180|P2|Overall Study|Abnormal test procedure result(s)|2
7753434|NCT00792805|26956181|P1|Overall Study|Abnormal test procedure result(s)|1
7753435|NCT00792805|26956179|P3|Overall Study|Administrative problems|4
7753436|NCT00792805|26956180|P2|Overall Study|Administrative problems|0
7753437|NCT00792805|26956181|P1|Overall Study|Administrative problems|2
7753438|NCT00792805|26956179|P3|Overall Study|Subject withdrew consent|5
7753439|NCT00792805|26956180|P2|Overall Study|Subject withdrew consent|6
7753440|NCT00792805|26956181|P1|Overall Study|Subject withdrew consent|5
7753441|NCT00792805|26956179|P3|Overall Study|Adverse Event|10
7753442|NCT00792805|26956180|P2|Overall Study|Adverse Event|10
7753443|NCT00792805|26956181|P1|Overall Study|Adverse Event|12
7753444|NCT00792701|26956191|P2|Overall Study|Not protocol specified|0
7753445|NCT00792701|26956192|P1|Overall Study|Not protocol specified|17
7753446|NCT00792701|26956191|P2|Overall Study|Withdrawal by Subject|19
7753447|NCT00792701|26956192|P1|Overall Study|Withdrawal by Subject|1
7753448|NCT00792701|26956191|P2|Overall Study|Ineligible|3
7753449|NCT00792701|26956192|P1|Overall Study|Ineligible|1
7753450|NCT00792701|26956191|P2|Overall Study|Adverse Event|22
7753451|NCT00792701|26956192|P1|Overall Study|Adverse Event|0
7753452|NCT00792636|26956222|P3|Overall Study|Investigator Discretion|2
7753453|NCT00792636|26956223|P2|Overall Study|Investigator Discretion|0
7753454|NCT00792636|26956224|P1|Overall Study|Investigator Discretion|2
7753455|NCT00792636|26956222|P3|Overall Study|Adverse Event|3
7753456|NCT00792636|26956223|P2|Overall Study|Adverse Event|2
7753457|NCT00792636|26956224|P1|Overall Study|Adverse Event|4
7753458|NCT00792636|26956222|P3|Overall Study|Lack of Efficacy|13
7753459|NCT00792636|26956223|P2|Overall Study|Lack of Efficacy|4
7753460|NCT00792636|26956224|P1|Overall Study|Lack of Efficacy|3
7753461|NCT00792636|26956222|P3|Overall Study|Withdrew Consent|9
7753462|NCT00792636|26956223|P2|Overall Study|Withdrew Consent|13
7753463|NCT00792636|26956224|P1|Overall Study|Withdrew Consent|10
7753464|NCT00792636|26956222|P3|Overall Study|Lost to Follow-up|14
7753465|NCT00792636|26956223|P2|Overall Study|Lost to Follow-up|19
7753466|NCT00792636|26956224|P1|Overall Study|Lost to Follow-up|13
7753467|NCT00792636|26956222|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
7753468|NCT00792636|26956223|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
7753469|NCT00792636|26956224|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
7753470|NCT00792636|26956222|P3|Overall Study|Protocol Violation|20
7753471|NCT00792636|26956223|P2|Overall Study|Protocol Violation|23
7753472|NCT00792636|26956224|P1|Overall Study|Protocol Violation|17
7753473|NCT00792623|26956261|P1|Overall Study|Withdrawal by Subject|5
7753474|NCT00792623|26956261|P1|Overall Study|Adverse Event|2
7753475|NCT00792571|26956278|P1|Overall Study|Other|4
7753476|NCT00792571|26956278|P1|Overall Study|Withdrawal by Subject|1
7753477|NCT00792571|26956278|P1|Overall Study|Adverse Event|4
7753478|NCT00792571|26956278|P1|Overall Study|Death|1
7753479|NCT00792467|26956287|P1|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
7753480|NCT00792467|26956287|P1|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
7753481|NCT00792467|26956287|P1|Overall Study|Lost to Follow-up|1
7753482|NCT00792467|26956287|P1|Overall Study|patient request|1
7753483|NCT00792467|26956287|P1|Overall Study|Adverse Event|1
7753484|NCT00792467|26956287|P1|Overall Study|progression of disease|17
7753485|NCT00792298|26956311|P8|Treatment Period 2|Withdrawal by Subject|2
7753486|NCT00792298|26956312|P7|Treatment Period 2|Withdrawal by Subject|0
7753487|NCT00792298|26956313|P6|Treatment Period 2|Withdrawal by Subject|0
7753488|NCT00792298|26956314|P5|Treatment Period 2|Withdrawal by Subject|1
7753489|NCT00792298|26956315|P4|Treatment Period 2|Withdrawal by Subject|2
7753490|NCT00792298|26956316|P3|Treatment Period 2|Withdrawal by Subject|0
7753491|NCT00792298|26956317|P2|Treatment Period 2|Withdrawal by Subject|1
7753492|NCT00792298|26956318|P1|Treatment Period 2|Withdrawal by Subject|1
7753493|NCT00792298|26956311|P8|Treatment Period 2|Pregnancy|0
7753494|NCT00792298|26956312|P7|Treatment Period 2|Pregnancy|0
7753495|NCT00792298|26956313|P6|Treatment Period 2|Pregnancy|0
7753496|NCT00792298|26956314|P5|Treatment Period 2|Pregnancy|0
7753497|NCT00792298|26956315|P4|Treatment Period 2|Pregnancy|0
7753498|NCT00792298|26956316|P3|Treatment Period 2|Pregnancy|1
7753499|NCT00792298|26956317|P2|Treatment Period 2|Pregnancy|0
7753500|NCT00792298|26956318|P1|Treatment Period 2|Pregnancy|0
7753501|NCT00792298|26956311|P8|Treatment Period 2|Physician Decision|0
7753502|NCT00792298|26956312|P7|Treatment Period 2|Physician Decision|1
7753503|NCT00792298|26956313|P6|Treatment Period 2|Physician Decision|0
7753504|NCT00792298|26956314|P5|Treatment Period 2|Physician Decision|0
7753505|NCT00792298|26956315|P4|Treatment Period 2|Physician Decision|0
7753506|NCT00792298|26956316|P3|Treatment Period 2|Physician Decision|0
7753507|NCT00792298|26956317|P2|Treatment Period 2|Physician Decision|0
7753508|NCT00792298|26956318|P1|Treatment Period 2|Physician Decision|0
7753509|NCT00792298|26956311|P8|Treatment Period 2|Lack of Efficacy|0
7753510|NCT00792298|26956312|P7|Treatment Period 2|Lack of Efficacy|0
7753511|NCT00792298|26956313|P6|Treatment Period 2|Lack of Efficacy|0
7753512|NCT00792298|26956314|P5|Treatment Period 2|Lack of Efficacy|1
7753513|NCT00792298|26956315|P4|Treatment Period 2|Lack of Efficacy|0
7753514|NCT00792298|26956316|P3|Treatment Period 2|Lack of Efficacy|0
7753515|NCT00792298|26956317|P2|Treatment Period 2|Lack of Efficacy|0
7753516|NCT00792298|26956318|P1|Treatment Period 2|Lack of Efficacy|0
7753517|NCT00792298|26956311|P8|Washout|Withdrawal by Subject|0
7753518|NCT00792298|26956312|P7|Washout|Withdrawal by Subject|0
7753519|NCT00792298|26956313|P6|Washout|Withdrawal by Subject|1
7753520|NCT00792298|26956314|P5|Washout|Withdrawal by Subject|0
7753521|NCT00792298|26956315|P4|Washout|Withdrawal by Subject|0
7753522|NCT00792298|26956316|P3|Washout|Withdrawal by Subject|1
7753523|NCT00792298|26956317|P2|Washout|Withdrawal by Subject|0
7753524|NCT00792298|26956318|P1|Washout|Withdrawal by Subject|0
7753525|NCT00792298|26956311|P8|Washout|Adverse Event|0
7753526|NCT00792298|26956312|P7|Washout|Adverse Event|0
7753527|NCT00792298|26956313|P6|Washout|Adverse Event|1
7753528|NCT00792298|26956314|P5|Washout|Adverse Event|0
7753529|NCT00792298|26956315|P4|Washout|Adverse Event|0
7753530|NCT00792298|26956316|P3|Washout|Adverse Event|0
7753531|NCT00792298|26956317|P2|Washout|Adverse Event|0
7753532|NCT00792298|26956318|P1|Washout|Adverse Event|0
7753533|NCT00792298|26956311|P8|Treatment Period 1|Protocol Violation|1
7753534|NCT00792298|26956312|P7|Treatment Period 1|Protocol Violation|0
7753535|NCT00792298|26956313|P6|Treatment Period 1|Protocol Violation|0
7753536|NCT00792298|26956314|P5|Treatment Period 1|Protocol Violation|0
7753537|NCT00792298|26956315|P4|Treatment Period 1|Protocol Violation|0
7753538|NCT00792298|26956316|P3|Treatment Period 1|Protocol Violation|0
7753539|NCT00792298|26956317|P2|Treatment Period 1|Protocol Violation|0
7753540|NCT00792298|26956318|P1|Treatment Period 1|Protocol Violation|0
7753541|NCT00792298|26956311|P8|Treatment Period 1|Physician Decision|0
7753542|NCT00792298|26956312|P7|Treatment Period 1|Physician Decision|1
7753543|NCT00792298|26956313|P6|Treatment Period 1|Physician Decision|0
7753544|NCT00792298|26956314|P5|Treatment Period 1|Physician Decision|0
7753545|NCT00792298|26956315|P4|Treatment Period 1|Physician Decision|1
7753546|NCT00792298|26956316|P3|Treatment Period 1|Physician Decision|0
7753547|NCT00792298|26956317|P2|Treatment Period 1|Physician Decision|0
7753548|NCT00792298|26956318|P1|Treatment Period 1|Physician Decision|0
7753549|NCT00792298|26956311|P8|Treatment Period 1|Lost to Follow-up|0
7753550|NCT00792298|26956312|P7|Treatment Period 1|Lost to Follow-up|1
7753551|NCT00792298|26956313|P6|Treatment Period 1|Lost to Follow-up|0
7753552|NCT00792298|26956314|P5|Treatment Period 1|Lost to Follow-up|0
7753553|NCT00792298|26956315|P4|Treatment Period 1|Lost to Follow-up|0
7753554|NCT00792298|26956316|P3|Treatment Period 1|Lost to Follow-up|0
7753555|NCT00792298|26956317|P2|Treatment Period 1|Lost to Follow-up|0
7753556|NCT00792298|26956318|P1|Treatment Period 1|Lost to Follow-up|0
7753557|NCT00792298|26956311|P8|Treatment Period 1|Withdrawal by Subject|0
7753558|NCT00792298|26956312|P7|Treatment Period 1|Withdrawal by Subject|1
7753559|NCT00792298|26956313|P6|Treatment Period 1|Withdrawal by Subject|2
7753560|NCT00792298|26956314|P5|Treatment Period 1|Withdrawal by Subject|0
7753561|NCT00792298|26956315|P4|Treatment Period 1|Withdrawal by Subject|2
7753562|NCT00792298|26956316|P3|Treatment Period 1|Withdrawal by Subject|1
7753563|NCT00792298|26956317|P2|Treatment Period 1|Withdrawal by Subject|0
7753564|NCT00792298|26956318|P1|Treatment Period 1|Withdrawal by Subject|1
7753565|NCT00792298|26956311|P8|Treatment Period 1|Lack of Efficacy|0
7753566|NCT00792298|26956312|P7|Treatment Period 1|Lack of Efficacy|0
7753567|NCT00792298|26956313|P6|Treatment Period 1|Lack of Efficacy|0
7753568|NCT00792298|26956314|P5|Treatment Period 1|Lack of Efficacy|0
7753569|NCT00792298|26956315|P4|Treatment Period 1|Lack of Efficacy|0
7753570|NCT00792298|26956316|P3|Treatment Period 1|Lack of Efficacy|1
7753571|NCT00792298|26956317|P2|Treatment Period 1|Lack of Efficacy|0
7753572|NCT00792298|26956318|P1|Treatment Period 1|Lack of Efficacy|0
7753573|NCT00792298|26956311|P8|Treatment Period 1|Adverse Event|0
7753574|NCT00792298|26956312|P7|Treatment Period 1|Adverse Event|1
7753575|NCT00792298|26956313|P6|Treatment Period 1|Adverse Event|1
7753576|NCT00792298|26956314|P5|Treatment Period 1|Adverse Event|0
7753577|NCT00792298|26956315|P4|Treatment Period 1|Adverse Event|1
7753578|NCT00792298|26956316|P3|Treatment Period 1|Adverse Event|0
7753579|NCT00792298|26956317|P2|Treatment Period 1|Adverse Event|1
7753580|NCT00792298|26956318|P1|Treatment Period 1|Adverse Event|0
7753581|NCT00792259|26956348|P3|Overall Study|Poor Quality Scans|0
7753582|NCT00792259|26956349|P2|Overall Study|Poor Quality Scans|0
7753583|NCT00792259|26956350|P1|Overall Study|Poor Quality Scans|1
7753584|NCT00792116|26956367|P2|Overall Study|Discontnued intervention|0
7753585|NCT00792116|26956368|P1|Overall Study|Discontnued intervention|1
7753586|NCT00792116|26956367|P2|Overall Study|Lost to Follow-up|1
7753587|NCT00792116|26956368|P1|Overall Study|Lost to Follow-up|0
7753588|NCT00792103|26956378|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
7753589|NCT00792103|26956378|P1|Overall Study|Protocol Violation|10
7753590|NCT00792103|26956378|P1|Overall Study|Withdrawal by Subject|52
7753591|NCT00792103|26956378|P1|Overall Study|Adverse Event|25
7753592|NCT00792103|26956378|P1|Overall Study|Lost to Follow-up|17
7753593|NCT00792103|26956378|P1|Overall Study|Enrolled, not treated|15
7753594|NCT00791999|26956397|P4|Overall Study|Reason other than those above|0
7753595|NCT00791999|26956398|P3|Overall Study|Reason other than those above|1
7753596|NCT00791999|26956399|P2|Overall Study|Reason other than those above|0
7753597|NCT00791999|26956400|P1|Overall Study|Reason other than those above|1
7753598|NCT00791999|26956397|P4|Overall Study|Lack of Efficacy|2
7753599|NCT00791999|26956398|P3|Overall Study|Lack of Efficacy|0
7753600|NCT00791999|26956399|P2|Overall Study|Lack of Efficacy|1
7753601|NCT00791999|26956400|P1|Overall Study|Lack of Efficacy|0
7753602|NCT00791999|26956397|P4|Overall Study|Adverse Event|3
7753603|NCT00791999|26956398|P3|Overall Study|Adverse Event|7
7753604|NCT00791999|26956399|P2|Overall Study|Adverse Event|3
7753605|NCT00791999|26956400|P1|Overall Study|Adverse Event|3
7753606|NCT00791999|26956397|P4|Overall Study|Protocol Violation|0
7753607|NCT00791999|26956398|P3|Overall Study|Protocol Violation|1
7753608|NCT00791999|26956399|P2|Overall Study|Protocol Violation|0
7753609|NCT00791999|26956400|P1|Overall Study|Protocol Violation|3
7753610|NCT00791999|26956397|P4|Overall Study|Withdrawal by Subject|2
7753611|NCT00791999|26956398|P3|Overall Study|Withdrawal by Subject|0
7753612|NCT00791999|26956399|P2|Overall Study|Withdrawal by Subject|1
7753613|NCT00791999|26956400|P1|Overall Study|Withdrawal by Subject|0
7753614|NCT00791999|26956397|P4|Overall Study|Protocol planed withdrawal|45
7753615|NCT00791999|26956398|P3|Overall Study|Protocol planed withdrawal|11
7753616|NCT00791999|26956399|P2|Overall Study|Protocol planed withdrawal|11
7753617|NCT00791999|26956400|P1|Overall Study|Protocol planed withdrawal|14
7753618|NCT00791934|26956425|P1|Overall Study|Did not consent for extended follow-up|13
7753619|NCT00791934|26956425|P1|Overall Study|Withdrawal by Subject|2
7753620|NCT00791921|26956435|P2|Overall Study|Reason other than those above|1
7753621|NCT00791921|26956436|P1|Overall Study|Reason other than those above|0
7753622|NCT00791921|26956435|P2|Overall Study|Lack of study drug administration|1
7753623|NCT00791921|26956436|P1|Overall Study|Lack of study drug administration|1
7753624|NCT00791921|26956435|P2|Overall Study|Lack of Efficacy|2
7753625|NCT00791921|26956436|P1|Overall Study|Lack of Efficacy|0
7753626|NCT00791921|26956435|P2|Overall Study|Adverse Event|2
7753627|NCT00791921|26956436|P1|Overall Study|Adverse Event|8
7753628|NCT00791921|26956435|P2|Overall Study|Withdrawal by Subject|2
7753629|NCT00791921|26956436|P1|Overall Study|Withdrawal by Subject|1
7753630|NCT00791921|26956435|P2|Overall Study|Protocol planed|88
7753631|NCT00791921|26956436|P1|Overall Study|Protocol planed|24
7753632|NCT00791778|26956467|P2|Follow-up|Lost to Follow-up|1
7753633|NCT00791778|26956468|P1|Follow-up|Lost to Follow-up|2
7753634|NCT00791778|26956467|P2|Follow-up|Withdrawal by Subject|0
7753635|NCT00791778|26956468|P1|Follow-up|Withdrawal by Subject|3
7753636|NCT00791778|26956467|P2|Double-blind Treatment|Non-compliant with study medication|0
7753637|NCT00791778|26956468|P1|Double-blind Treatment|Non-compliant with study medication|2
7753638|NCT00791778|26956467|P2|Double-blind Treatment|Withdrawal by Subject|9
7753639|NCT00791778|26956468|P1|Double-blind Treatment|Withdrawal by Subject|20
7753640|NCT00791778|26956467|P2|Double-blind Treatment|Protocol Violation|4
7753641|NCT00791778|26956468|P1|Double-blind Treatment|Protocol Violation|0
7753642|NCT00791778|26956467|P2|Double-blind Treatment|Physician Decision|26
7753643|NCT00791778|26956468|P1|Double-blind Treatment|Physician Decision|6
7753644|NCT00791778|26956467|P2|Double-blind Treatment|Adverse Event|9
7753645|NCT00791778|26956468|P1|Double-blind Treatment|Adverse Event|49
7753646|NCT00791765|26956522|P2|Weeks 13 to 24|Other|1
7753647|NCT00791765|26956523|P1|Weeks 13 to 24|Other|0
7753648|NCT00791765|26956522|P2|Weeks 13 to 24|Lost to Follow-up|2
7753649|NCT00791765|26956523|P1|Weeks 13 to 24|Lost to Follow-up|1
7753650|NCT00791765|26956522|P2|Weeks 13 to 24|Disease progression|1
7753651|NCT00791765|26956523|P1|Weeks 13 to 24|Disease progression|0
7753652|NCT00791765|26956522|P2|Weeks 13 to 24|Withdrawal by Subject|1
7753653|NCT00791765|26956523|P1|Weeks 13 to 24|Withdrawal by Subject|2
7753654|NCT00791765|26956522|P2|Weeks 13 to 24|Adverse Event|3
7753655|NCT00791765|26956523|P1|Weeks 13 to 24|Adverse Event|0
7753656|NCT00791765|26956522|P2|Weeks 13 to 24|Protocol deviation|0
7753657|NCT00791765|26956523|P1|Weeks 13 to 24|Protocol deviation|2
7753658|NCT00791765|26956522|P2|Weeks 1 to 12|Ineligibility determined|3
7753659|NCT00791765|26956523|P1|Weeks 1 to 12|Ineligibility determined|0
7753660|NCT00791765|26956522|P2|Weeks 1 to 12|Disease progression|0
7753661|NCT00791765|26956523|P1|Weeks 1 to 12|Disease progression|3
7753662|NCT00791765|26956522|P2|Weeks 1 to 12|Physician Decision|0
7753663|NCT00791765|26956523|P1|Weeks 1 to 12|Physician Decision|1
7753664|NCT00791765|26956522|P2|Weeks 1 to 12|Withdrawal by Subject|0
7753665|NCT00791765|26956523|P1|Weeks 1 to 12|Withdrawal by Subject|3
7753666|NCT00791765|26956522|P2|Weeks 1 to 12|Lost to Follow-up|0
7753667|NCT00791765|26956523|P1|Weeks 1 to 12|Lost to Follow-up|1
7753668|NCT00791765|26956522|P2|Weeks 1 to 12|Adverse Event|1
7753669|NCT00791765|26956523|P1|Weeks 1 to 12|Adverse Event|0
7753670|NCT00791700|26956538|P4|Overall Study|Adverse Event|1
7753671|NCT00791700|26956539|P3|Overall Study|Adverse Event|1
7753672|NCT00791700|26956540|P2|Overall Study|Adverse Event|0
7753673|NCT00791700|26956541|P1|Overall Study|Adverse Event|0
7753674|NCT00791700|26956538|P4|Overall Study|Lost to Follow-up|6
7753675|NCT00791700|26956539|P3|Overall Study|Lost to Follow-up|4
7753676|NCT00791700|26956540|P2|Overall Study|Lost to Follow-up|3
7753677|NCT00791700|26956541|P1|Overall Study|Lost to Follow-up|4
7753678|NCT00791700|26956538|P4|Overall Study|Death|1
7753679|NCT00791700|26956539|P3|Overall Study|Death|0
7753680|NCT00791700|26956540|P2|Overall Study|Death|0
7753681|NCT00791700|26956541|P1|Overall Study|Death|0
7753682|NCT00791700|26956538|P4|Overall Study|Other|1
7753683|NCT00791700|26956539|P3|Overall Study|Other|0
7753684|NCT00791700|26956540|P2|Overall Study|Other|1
7753685|NCT00791700|26956541|P1|Overall Study|Other|0
7753686|NCT00791700|26956538|P4|Overall Study|Withdrawn due to pregnancy|1
7753687|NCT00791700|26956539|P3|Overall Study|Withdrawn due to pregnancy|0
7753688|NCT00791700|26956540|P2|Overall Study|Withdrawn due to pregnancy|0
7753689|NCT00791700|26956541|P1|Overall Study|Withdrawn due to pregnancy|0
7753690|NCT00791700|26956538|P4|Overall Study|Non-compliance with study treatment|4
7753691|NCT00791700|26956539|P3|Overall Study|Non-compliance with study treatment|0
7753692|NCT00791700|26956540|P2|Overall Study|Non-compliance with study treatment|2
7753693|NCT00791700|26956541|P1|Overall Study|Non-compliance with study treatment|0
7753694|NCT00791700|26956538|P4|Overall Study|No longer willing to participate|8
7753695|NCT00791700|26956539|P3|Overall Study|No longer willing to participate|0
7753696|NCT00791700|26956540|P2|Overall Study|No longer willing to participate|1
7753697|NCT00791700|26956541|P1|Overall Study|No longer willing to participate|1
7753698|NCT00791700|26956538|P4|Overall Study|Insufficient clinical response|8
7753699|NCT00791700|26956539|P3|Overall Study|Insufficient clinical response|1
7753700|NCT00791700|26956540|P2|Overall Study|Insufficient clinical response|4
7753701|NCT00791700|26956541|P1|Overall Study|Insufficient clinical response|1
7753702|NCT00791661|26956629|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
7753703|NCT00791661|26956630|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
7753704|NCT00791661|26956631|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
7753705|NCT00791661|26956629|P3|7 Day Wash-out|Adverse Event|1
7753706|NCT00791661|26956630|P2|7 Day Wash-out|Adverse Event|0
7753707|NCT00791661|26956631|P1|7 Day Wash-out|Adverse Event|0
7753708|NCT00791648|26956724|P2|Overall Study|Withdrawal by Subject|1
7753709|NCT00791648|26956725|P1|Overall Study|Withdrawal by Subject|0
7753710|NCT00791648|26956724|P2|Overall Study|Physician Decision|1
7753711|NCT00791648|26956725|P1|Overall Study|Physician Decision|0
7753712|NCT00791557|26956761|P1|Overall Study|Adverse Event|1
7753713|NCT00791518|26956765|P1|Overall Study|Protocol Violation|93
7753714|NCT00791492|26956793|P2|Overall Study|Liver transplantation|1
7753715|NCT00791492|26956794|P1|Overall Study|Liver transplantation|5
7753716|NCT00791492|26956793|P2|Overall Study|Withdrawal by Subject|2
7753717|NCT00791492|26956794|P1|Overall Study|Withdrawal by Subject|1
7753718|NCT00791479|26956842|P6|Overall Study|Withdrawal by Subject|1
7753719|NCT00791479|26956843|P5|Overall Study|Withdrawal by Subject|0
7753720|NCT00791479|26956844|P4|Overall Study|Withdrawal by Subject|1
7753721|NCT00791479|26956845|P3|Overall Study|Withdrawal by Subject|0
7753722|NCT00791479|26956846|P2|Overall Study|Withdrawal by Subject|0
7753723|NCT00791479|26956847|P1|Overall Study|Withdrawal by Subject|0
7753724|NCT00791479|26956842|P6|Overall Study|Protocol Violation|0
7753725|NCT00791479|26956843|P5|Overall Study|Protocol Violation|0
7753726|NCT00791479|26956844|P4|Overall Study|Protocol Violation|1
7753727|NCT00791479|26956845|P3|Overall Study|Protocol Violation|0
7753728|NCT00791479|26956846|P2|Overall Study|Protocol Violation|1
7753729|NCT00791479|26956847|P1|Overall Study|Protocol Violation|2
7753730|NCT00791479|26956842|P6|Overall Study|Lost to Follow-up|1
7753731|NCT00791479|26956843|P5|Overall Study|Lost to Follow-up|0
7753732|NCT00791479|26956844|P4|Overall Study|Lost to Follow-up|0
7753733|NCT00791479|26956845|P3|Overall Study|Lost to Follow-up|0
7753734|NCT00791479|26956846|P2|Overall Study|Lost to Follow-up|1
7753735|NCT00791479|26956847|P1|Overall Study|Lost to Follow-up|0
7753736|NCT00791479|26956842|P6|Overall Study|Adverse Event|1
7753737|NCT00791479|26956843|P5|Overall Study|Adverse Event|0
7753738|NCT00791479|26956844|P4|Overall Study|Adverse Event|2
7753739|NCT00791479|26956845|P3|Overall Study|Adverse Event|0
7753740|NCT00791479|26956846|P2|Overall Study|Adverse Event|1
7753741|NCT00791479|26956847|P1|Overall Study|Adverse Event|0
7753742|NCT00791479|26956842|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
7753743|NCT00791479|26956843|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
7753744|NCT00791479|26956844|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
7753745|NCT00791479|26956845|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
7753746|NCT00791479|26956846|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
7753747|NCT00791479|26956847|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
7753748|NCT00791388|26956946|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
7753749|NCT00791388|26956947|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
7753750|NCT00791388|26956948|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
7753751|NCT00791388|26956949|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
7753752|NCT00791388|26956950|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
7753753|NCT00791388|26956946|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7753754|NCT00791388|26956947|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7753755|NCT00791388|26956948|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7753756|NCT00791388|26956949|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7753757|NCT00791388|26956950|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
7753758|NCT00791388|26956946|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7753759|NCT00791388|26956947|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7753760|NCT00791388|26956948|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7753761|NCT00791388|26956949|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
7753762|NCT00791388|26956950|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7753763|NCT00791258|26956992|P1|Overall Study|Lack of Efficacy|1
7753764|NCT00791258|26956992|P1|Overall Study|Subject required restricted medication|1
7753765|NCT00791258|26956992|P1|Overall Study|Subject incarcerated|1
7753766|NCT00791258|26956992|P1|Overall Study|non-compliance|3
7753767|NCT00791258|26956992|P1|Overall Study|subject left area|2
7753768|NCT00791258|26956992|P1|Overall Study|Did not take medication for >3 days|1
7753769|NCT00791258|26956992|P1|Overall Study|Withdrawal by Subject|40
7753770|NCT00791258|26956992|P1|Overall Study|Protocol Violation|109
7753771|NCT00791258|26956992|P1|Overall Study|Lost to Follow-up|18
7753772|NCT00791258|26956992|P1|Overall Study|Adverse Event|87
7753773|NCT00791128|26957085|P1|Overall Study|abdominal tumor, unrelated to device|1
7753774|NCT00791128|26957085|P1|Overall Study|non-compliance by subject|2
7753775|NCT00791128|26957085|P1|Overall Study|Device migration|2
7753776|NCT00791128|26957085|P1|Overall Study|Adverse Event|4
7753777|NCT00791076|26957116|P1|Overall Study|Study was terminated,PI left institution|8
7753778|NCT00790933|26957136|P5|Overall Study|Reason Not Specified|9
7753779|NCT00790933|26957137|P4|Overall Study|Reason Not Specified|1
7753780|NCT00790933|26957138|P3|Overall Study|Reason Not Specified|4
7753781|NCT00790933|26957139|P2|Overall Study|Reason Not Specified|16
7753782|NCT00790933|26957140|P1|Overall Study|Reason Not Specified|8
7753783|NCT00790933|26957136|P5|Overall Study|Lost to Follow-up|15
7753784|NCT00790933|26957137|P4|Overall Study|Lost to Follow-up|1
7753785|NCT00790933|26957138|P3|Overall Study|Lost to Follow-up|10
7753786|NCT00790933|26957139|P2|Overall Study|Lost to Follow-up|31
7753787|NCT00790933|26957140|P1|Overall Study|Lost to Follow-up|13
7753788|NCT00790933|26957136|P5|Overall Study|Withdrawal by Subject|50
7753789|NCT00790933|26957137|P4|Overall Study|Withdrawal by Subject|6
7753790|NCT00790933|26957138|P3|Overall Study|Withdrawal by Subject|52
7753791|NCT00790933|26957139|P2|Overall Study|Withdrawal by Subject|120
7753792|NCT00790933|26957140|P1|Overall Study|Withdrawal by Subject|123
7753793|NCT00790933|26957136|P5|Overall Study|Study Terminated by Sponsor|0
7753794|NCT00790933|26957137|P4|Overall Study|Study Terminated by Sponsor|0
7753795|NCT00790933|26957138|P3|Overall Study|Study Terminated by Sponsor|1
7753796|NCT00790933|26957139|P2|Overall Study|Study Terminated by Sponsor|0
7753797|NCT00790933|26957140|P1|Overall Study|Study Terminated by Sponsor|0
7753798|NCT00790933|26957136|P5|Overall Study|Lack of Efficacy|121
7753799|NCT00790933|26957137|P4|Overall Study|Lack of Efficacy|1
7753800|NCT00790933|26957138|P3|Overall Study|Lack of Efficacy|130
7753801|NCT00790933|26957139|P2|Overall Study|Lack of Efficacy|176
7753802|NCT00790933|26957140|P1|Overall Study|Lack of Efficacy|192
7753803|NCT00790933|26957136|P5|Overall Study|Protocol Violation(s)|12
7753804|NCT00790933|26957137|P4|Overall Study|Protocol Violation(s)|0
7753805|NCT00790933|26957138|P3|Overall Study|Protocol Violation(s)|7
7753806|NCT00790933|26957139|P2|Overall Study|Protocol Violation(s)|18
7753807|NCT00790933|26957140|P1|Overall Study|Protocol Violation(s)|8
7753808|NCT00790933|26957136|P5|Overall Study|Adverse Event|69
7753809|NCT00790933|26957137|P4|Overall Study|Adverse Event|5
7753810|NCT00790933|26957138|P3|Overall Study|Adverse Event|65
7753811|NCT00790933|26957139|P2|Overall Study|Adverse Event|119
7753812|NCT00790933|26957140|P1|Overall Study|Adverse Event|94
7753813|NCT00790907|26957671|P3|Overall Study|Did Not Receive Study Drug|0
7753814|NCT00790907|26957672|P2|Overall Study|Did Not Receive Study Drug|0
7753815|NCT00790907|26957673|P1|Overall Study|Did Not Receive Study Drug|10
7753816|NCT00790907|26957671|P3|Overall Study|Verbatim Reason on the Case Report Form|29
7753817|NCT00790907|26957672|P2|Overall Study|Verbatim Reason on the Case Report Form|20
7753818|NCT00790907|26957673|P1|Overall Study|Verbatim Reason on the Case Report Form|74
7753819|NCT00790907|26957671|P3|Overall Study|Qualifying Condition Not Present|16
7753820|NCT00790907|26957672|P2|Overall Study|Qualifying Condition Not Present|14
7753821|NCT00790907|26957673|P1|Overall Study|Qualifying Condition Not Present|29
7753822|NCT00790907|26957671|P3|Overall Study|Required Protocol-prohibited Therapy|7
7753823|NCT00790907|26957672|P2|Overall Study|Required Protocol-prohibited Therapy|5
7753824|NCT00790907|26957673|P1|Overall Study|Required Protocol-prohibited Therapy|17
7753825|NCT00790907|26957671|P3|Overall Study|Bleeding Event|21
7753826|NCT00790907|26957672|P2|Overall Study|Bleeding Event|16
7753827|NCT00790907|26957673|P1|Overall Study|Bleeding Event|11
7753828|NCT00790907|26957671|P3|Overall Study|Withdrawal by Subject|5
7753829|NCT00790907|26957672|P2|Overall Study|Withdrawal by Subject|7
7753830|NCT00790907|26957673|P1|Overall Study|Withdrawal by Subject|1
7753831|NCT00790907|26957671|P3|Overall Study|Physician Decision|255
7753832|NCT00790907|26957672|P2|Overall Study|Physician Decision|271
7753833|NCT00790907|26957673|P1|Overall Study|Physician Decision|304
7753834|NCT00790907|26957671|P3|Overall Study|Adverse Event|6
7753835|NCT00790907|26957672|P2|Overall Study|Adverse Event|7
7753836|NCT00790907|26957673|P1|Overall Study|Adverse Event|9
7753837|NCT00790868|26957696|P2|Overall Study|Lost to Follow-up|12
7753838|NCT00790868|26957697|P1|Overall Study|Lost to Follow-up|2
7753839|NCT00790868|26957696|P2|Overall Study|Withdrawal by Subject|5
7753840|NCT00790868|26957697|P1|Overall Study|Withdrawal by Subject|4
7753841|NCT00790842|26957719|P11|Expansion Cohort|Study Closure|0
7753842|NCT00790842|26957720|P10|Expansion Cohort|Study Closure|0
7753843|NCT00790842|26957721|P9|Expansion Cohort|Study Closure|0
7753844|NCT00790842|26957722|P8|Expansion Cohort|Study Closure|0
7753845|NCT00790842|26957723|P7|Expansion Cohort|Study Closure|0
7753846|NCT00790842|26957724|P6|Expansion Cohort|Study Closure|0
7753847|NCT00790842|26957725|P5|Expansion Cohort|Study Closure|0
7753848|NCT00790842|26957726|P4|Expansion Cohort|Study Closure|0
7753849|NCT00790842|26957727|P3|Expansion Cohort|Study Closure|1
7753850|NCT00790842|26957728|P2|Expansion Cohort|Study Closure|0
7753851|NCT00790842|26957729|P1|Expansion Cohort|Study Closure|0
7753852|NCT00790842|26957719|P11|Expansion Cohort|Withdrawal by Subject|0
7753853|NCT00790842|26957720|P10|Expansion Cohort|Withdrawal by Subject|0
7753854|NCT00790842|26957721|P9|Expansion Cohort|Withdrawal by Subject|0
7753855|NCT00790842|26957722|P8|Expansion Cohort|Withdrawal by Subject|0
7753856|NCT00790842|26957723|P7|Expansion Cohort|Withdrawal by Subject|0
7753857|NCT00790842|26957724|P6|Expansion Cohort|Withdrawal by Subject|0
7753858|NCT00790842|26957725|P5|Expansion Cohort|Withdrawal by Subject|0
7753859|NCT00790842|26957726|P4|Expansion Cohort|Withdrawal by Subject|0
7753860|NCT00790842|26957727|P3|Expansion Cohort|Withdrawal by Subject|3
7753861|NCT00790842|26957728|P2|Expansion Cohort|Withdrawal by Subject|0
7753862|NCT00790842|26957729|P1|Expansion Cohort|Withdrawal by Subject|0
7753863|NCT00790842|26957719|P11|Expansion Cohort|Physician Decision|0
7753864|NCT00790842|26957720|P10|Expansion Cohort|Physician Decision|0
7753865|NCT00790842|26957721|P9|Expansion Cohort|Physician Decision|0
7753866|NCT00790842|26957722|P8|Expansion Cohort|Physician Decision|0
7753867|NCT00790842|26957723|P7|Expansion Cohort|Physician Decision|0
7753868|NCT00790842|26957724|P6|Expansion Cohort|Physician Decision|0
7753869|NCT00790842|26957725|P5|Expansion Cohort|Physician Decision|0
7753870|NCT00790842|26957726|P4|Expansion Cohort|Physician Decision|0
7753871|NCT00790842|26957727|P3|Expansion Cohort|Physician Decision|1
7753872|NCT00790842|26957728|P2|Expansion Cohort|Physician Decision|0
7753873|NCT00790842|26957729|P1|Expansion Cohort|Physician Decision|0
7753874|NCT00790842|26957719|P11|Expansion Cohort|Death|0
7753875|NCT00790842|26957720|P10|Expansion Cohort|Death|0
7753876|NCT00790842|26957721|P9|Expansion Cohort|Death|0
7753877|NCT00790842|26957722|P8|Expansion Cohort|Death|0
7753878|NCT00790842|26957723|P7|Expansion Cohort|Death|0
7753879|NCT00790842|26957724|P6|Expansion Cohort|Death|0
7753880|NCT00790842|26957725|P5|Expansion Cohort|Death|0
7753881|NCT00790842|26957726|P4|Expansion Cohort|Death|0
7753882|NCT00790842|26957727|P3|Expansion Cohort|Death|2
7753883|NCT00790842|26957728|P2|Expansion Cohort|Death|0
7753884|NCT00790842|26957729|P1|Expansion Cohort|Death|0
7753885|NCT00790842|26957719|P11|Expansion Cohort|Adverse Event|0
7753886|NCT00790842|26957720|P10|Expansion Cohort|Adverse Event|0
7753887|NCT00790842|26957721|P9|Expansion Cohort|Adverse Event|0
7753888|NCT00790842|26957722|P8|Expansion Cohort|Adverse Event|0
7753889|NCT00790842|26957723|P7|Expansion Cohort|Adverse Event|1
7753890|NCT00790842|26957724|P6|Expansion Cohort|Adverse Event|0
7753891|NCT00790842|26957725|P5|Expansion Cohort|Adverse Event|0
7753892|NCT00790842|26957726|P4|Expansion Cohort|Adverse Event|0
7753893|NCT00790842|26957727|P3|Expansion Cohort|Adverse Event|0
7753894|NCT00790842|26957728|P2|Expansion Cohort|Adverse Event|0
7753895|NCT00790842|26957729|P1|Expansion Cohort|Adverse Event|0
7753896|NCT00790842|26957719|P11|Dose Level 4|Withdrawal by Subject|1
7753897|NCT00790842|26957720|P10|Dose Level 4|Withdrawal by Subject|0
7753898|NCT00790842|26957721|P9|Dose Level 4|Withdrawal by Subject|0
7753899|NCT00790842|26957722|P8|Dose Level 4|Withdrawal by Subject|0
7753900|NCT00790842|26957723|P7|Dose Level 4|Withdrawal by Subject|0
7753901|NCT00790842|26957724|P6|Dose Level 4|Withdrawal by Subject|0
7753902|NCT00790842|26957725|P5|Dose Level 4|Withdrawal by Subject|0
7753903|NCT00790842|26957726|P4|Dose Level 4|Withdrawal by Subject|0
7753904|NCT00790842|26957727|P3|Dose Level 4|Withdrawal by Subject|0
7753905|NCT00790842|26957728|P2|Dose Level 4|Withdrawal by Subject|0
7753906|NCT00790842|26957729|P1|Dose Level 4|Withdrawal by Subject|0
7753907|NCT00790842|26957719|P11|Dose Level 4|Physician Decision|1
7753908|NCT00790842|26957720|P10|Dose Level 4|Physician Decision|0
7753909|NCT00790842|26957721|P9|Dose Level 4|Physician Decision|0
7753910|NCT00790842|26957722|P8|Dose Level 4|Physician Decision|0
7753911|NCT00790842|26957723|P7|Dose Level 4|Physician Decision|1
7753912|NCT00790842|26957724|P6|Dose Level 4|Physician Decision|0
7753913|NCT00790842|26957725|P5|Dose Level 4|Physician Decision|0
7753914|NCT00790842|26957726|P4|Dose Level 4|Physician Decision|0
7753915|NCT00790842|26957727|P3|Dose Level 4|Physician Decision|0
7753916|NCT00790842|26957728|P2|Dose Level 4|Physician Decision|0
7753917|NCT00790842|26957729|P1|Dose Level 4|Physician Decision|0
7753918|NCT00790842|26957719|P11|Dose Level 4|Adverse Event|0
7753919|NCT00790842|26957720|P10|Dose Level 4|Adverse Event|0
7753920|NCT00790842|26957721|P9|Dose Level 4|Adverse Event|0
7753921|NCT00790842|26957722|P8|Dose Level 4|Adverse Event|0
7753922|NCT00790842|26957723|P7|Dose Level 4|Adverse Event|1
7753923|NCT00790842|26957724|P6|Dose Level 4|Adverse Event|0
7753924|NCT00790842|26957725|P5|Dose Level 4|Adverse Event|0
7753925|NCT00790842|26957726|P4|Dose Level 4|Adverse Event|0
7753926|NCT00790842|26957727|P3|Dose Level 4|Adverse Event|0
7753927|NCT00790842|26957728|P2|Dose Level 4|Adverse Event|0
7753928|NCT00790842|26957729|P1|Dose Level 4|Adverse Event|0
7753929|NCT00790842|26957719|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753930|NCT00790842|26957720|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753931|NCT00790842|26957721|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753932|NCT00790842|26957722|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753933|NCT00790842|26957723|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753934|NCT00790842|26957724|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753935|NCT00790842|26957725|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753936|NCT00790842|26957726|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753937|NCT00790842|26957727|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
7753938|NCT00790842|26957728|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753939|NCT00790842|26957729|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
7753940|NCT00790842|26957719|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753941|NCT00790842|26957720|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753942|NCT00790842|26957721|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753943|NCT00790842|26957722|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753944|NCT00790842|26957723|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753945|NCT00790842|26957724|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
7753946|NCT00790842|26957725|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753947|NCT00790842|26957726|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753948|NCT00790842|26957727|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753949|NCT00790842|26957728|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753950|NCT00790842|26957729|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7753951|NCT00790842|26957719|P11|Dose Level 3|Withdrawal by Subject|0
7753952|NCT00790842|26957720|P10|Dose Level 3|Withdrawal by Subject|2
7753953|NCT00790842|26957721|P9|Dose Level 3|Withdrawal by Subject|0
7753954|NCT00790842|26957722|P8|Dose Level 3|Withdrawal by Subject|0
7753955|NCT00790842|26957723|P7|Dose Level 3|Withdrawal by Subject|0
7753956|NCT00790842|26957724|P6|Dose Level 3|Withdrawal by Subject|0
7753957|NCT00790842|26957725|P5|Dose Level 3|Withdrawal by Subject|0
7753958|NCT00790842|26957726|P4|Dose Level 3|Withdrawal by Subject|0
7753959|NCT00790842|26957727|P3|Dose Level 3|Withdrawal by Subject|3
7753960|NCT00790842|26957728|P2|Dose Level 3|Withdrawal by Subject|0
7753961|NCT00790842|26957729|P1|Dose Level 3|Withdrawal by Subject|0
7753962|NCT00790842|26957719|P11|Dose Level 3|Adverse Event|0
7753963|NCT00790842|26957720|P10|Dose Level 3|Adverse Event|0
7753964|NCT00790842|26957721|P9|Dose Level 3|Adverse Event|0
7753965|NCT00790842|26957722|P8|Dose Level 3|Adverse Event|0
7753966|NCT00790842|26957723|P7|Dose Level 3|Adverse Event|0
7753967|NCT00790842|26957724|P6|Dose Level 3|Adverse Event|0
7753968|NCT00790842|26957725|P5|Dose Level 3|Adverse Event|0
7753969|NCT00790842|26957726|P4|Dose Level 3|Adverse Event|0
7753970|NCT00790842|26957727|P3|Dose Level 3|Adverse Event|1
7753971|NCT00790842|26957728|P2|Dose Level 3|Adverse Event|0
7753972|NCT00790842|26957729|P1|Dose Level 3|Adverse Event|0
7753973|NCT00790842|26957719|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753974|NCT00790842|26957720|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753975|NCT00790842|26957721|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
7753976|NCT00790842|26957722|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753977|NCT00790842|26957723|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753978|NCT00790842|26957724|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753979|NCT00790842|26957725|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753980|NCT00790842|26957726|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753981|NCT00790842|26957727|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753982|NCT00790842|26957728|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753983|NCT00790842|26957729|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
7753984|NCT00790842|26957719|P11|Dose Level 2|Withdrawal by Subject|0
7753985|NCT00790842|26957720|P10|Dose Level 2|Withdrawal by Subject|0
7753986|NCT00790842|26957721|P9|Dose Level 2|Withdrawal by Subject|0
7753987|NCT00790842|26957722|P8|Dose Level 2|Withdrawal by Subject|0
7753988|NCT00790842|26957723|P7|Dose Level 2|Withdrawal by Subject|0
7753989|NCT00790842|26957724|P6|Dose Level 2|Withdrawal by Subject|0
7753990|NCT00790842|26957725|P5|Dose Level 2|Withdrawal by Subject|0
7753991|NCT00790842|26957726|P4|Dose Level 2|Withdrawal by Subject|0
7753992|NCT00790842|26957727|P3|Dose Level 2|Withdrawal by Subject|0
7753993|NCT00790842|26957728|P2|Dose Level 2|Withdrawal by Subject|1
7753994|NCT00790842|26957729|P1|Dose Level 2|Withdrawal by Subject|0
7753995|NCT00790842|26957719|P11|Dose Level 2|Physician Decision|0
7753996|NCT00790842|26957720|P10|Dose Level 2|Physician Decision|0
7753997|NCT00790842|26957721|P9|Dose Level 2|Physician Decision|0
7753998|NCT00790842|26957722|P8|Dose Level 2|Physician Decision|0
7753999|NCT00790842|26957723|P7|Dose Level 2|Physician Decision|0
7754000|NCT00790842|26957724|P6|Dose Level 2|Physician Decision|0
7754001|NCT00790842|26957725|P5|Dose Level 2|Physician Decision|0
7754002|NCT00790842|26957726|P4|Dose Level 2|Physician Decision|0
7754003|NCT00790842|26957727|P3|Dose Level 2|Physician Decision|0
7754004|NCT00790842|26957728|P2|Dose Level 2|Physician Decision|1
7754005|NCT00790842|26957729|P1|Dose Level 2|Physician Decision|0
7754006|NCT00790842|26957719|P11|Dose Level 2|Death|0
7754007|NCT00790842|26957720|P10|Dose Level 2|Death|0
7754008|NCT00790842|26957721|P9|Dose Level 2|Death|0
7754009|NCT00790842|26957722|P8|Dose Level 2|Death|0
7754010|NCT00790842|26957723|P7|Dose Level 2|Death|0
7754011|NCT00790842|26957724|P6|Dose Level 2|Death|0
7754012|NCT00790842|26957725|P5|Dose Level 2|Death|1
7754013|NCT00790842|26957726|P4|Dose Level 2|Death|0
7754014|NCT00790842|26957727|P3|Dose Level 2|Death|0
7754015|NCT00790842|26957728|P2|Dose Level 2|Death|1
7754016|NCT00790842|26957729|P1|Dose Level 2|Death|0
7754017|NCT00790842|26957719|P11|Dose Level 1|Withdrawal by Subject|0
7754018|NCT00790842|26957720|P10|Dose Level 1|Withdrawal by Subject|0
7754019|NCT00790842|26957721|P9|Dose Level 1|Withdrawal by Subject|0
7754020|NCT00790842|26957722|P8|Dose Level 1|Withdrawal by Subject|0
7754021|NCT00790842|26957723|P7|Dose Level 1|Withdrawal by Subject|0
7754022|NCT00790842|26957724|P6|Dose Level 1|Withdrawal by Subject|0
7754023|NCT00790842|26957725|P5|Dose Level 1|Withdrawal by Subject|0
7754024|NCT00790842|26957726|P4|Dose Level 1|Withdrawal by Subject|0
7754025|NCT00790842|26957727|P3|Dose Level 1|Withdrawal by Subject|0
7754026|NCT00790842|26957728|P2|Dose Level 1|Withdrawal by Subject|0
7754027|NCT00790842|26957729|P1|Dose Level 1|Withdrawal by Subject|1
7754028|NCT00790842|26957719|P11|Dose Level 1|Physician Decision|0
7754029|NCT00790842|26957720|P10|Dose Level 1|Physician Decision|0
7754030|NCT00790842|26957721|P9|Dose Level 1|Physician Decision|0
7754031|NCT00790842|26957722|P8|Dose Level 1|Physician Decision|1
7754032|NCT00790842|26957723|P7|Dose Level 1|Physician Decision|0
7754033|NCT00790842|26957724|P6|Dose Level 1|Physician Decision|0
7754034|NCT00790842|26957725|P5|Dose Level 1|Physician Decision|0
7754035|NCT00790842|26957726|P4|Dose Level 1|Physician Decision|0
7754036|NCT00790842|26957727|P3|Dose Level 1|Physician Decision|0
7754037|NCT00790842|26957728|P2|Dose Level 1|Physician Decision|0
7754038|NCT00790842|26957729|P1|Dose Level 1|Physician Decision|1
7754039|NCT00790842|26957719|P11|Dose Level 1|Adverse Event|0
7754040|NCT00790842|26957720|P10|Dose Level 1|Adverse Event|0
7754041|NCT00790842|26957721|P9|Dose Level 1|Adverse Event|0
7754042|NCT00790842|26957722|P8|Dose Level 1|Adverse Event|1
7754043|NCT00790842|26957723|P7|Dose Level 1|Adverse Event|0
7754044|NCT00790842|26957724|P6|Dose Level 1|Adverse Event|0
7754045|NCT00790842|26957725|P5|Dose Level 1|Adverse Event|0
7754046|NCT00790842|26957726|P4|Dose Level 1|Adverse Event|2
7754047|NCT00790842|26957727|P3|Dose Level 1|Adverse Event|0
7754048|NCT00790842|26957728|P2|Dose Level 1|Adverse Event|0
7754049|NCT00790842|26957729|P1|Dose Level 1|Adverse Event|1
7754050|NCT00790790|26957797|P3|Study Period 2: Therapy Phase|Physician Decision|0
7754051|NCT00790790|26957798|P2|Study Period 2: Therapy Phase|Physician Decision|1
7754052|NCT00790790|26957799|P1|Study Period 2: Therapy Phase|Physician Decision|0
7754053|NCT00790790|26957797|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
7754054|NCT00790790|26957798|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
7754055|NCT00790790|26957799|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
7754056|NCT00790790|26957797|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
7754057|NCT00790790|26957798|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
7754058|NCT00790790|26957799|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
7754059|NCT00790790|26957797|P3|Study Period 2: Therapy Phase|Protocol Violation|0
7754060|NCT00790790|26957798|P2|Study Period 2: Therapy Phase|Protocol Violation|1
7754061|NCT00790790|26957799|P1|Study Period 2: Therapy Phase|Protocol Violation|1
7754062|NCT00790790|26957797|P3|Study Period 2: Therapy Phase|Adverse Event|16
7754063|NCT00790790|26957798|P2|Study Period 2: Therapy Phase|Adverse Event|16
7754064|NCT00790790|26957799|P1|Study Period 2: Therapy Phase|Adverse Event|3
7754065|NCT00790751|26957876|P4|Overall Study|Physician Decision|1
7754066|NCT00790751|26957877|P3|Overall Study|Physician Decision|0
7754067|NCT00790751|26957878|P2|Overall Study|Physician Decision|0
7754068|NCT00790751|26957879|P1|Overall Study|Physician Decision|0
7754069|NCT00790751|26957876|P4|Overall Study|Death|0
7754070|NCT00790751|26957877|P3|Overall Study|Death|1
7754071|NCT00790751|26957878|P2|Overall Study|Death|0
7754072|NCT00790751|26957879|P1|Overall Study|Death|0
7754073|NCT00790751|26957876|P4|Overall Study|Requirement for restricted medication|0
7754074|NCT00790751|26957877|P3|Overall Study|Requirement for restricted medication|0
7754075|NCT00790751|26957878|P2|Overall Study|Requirement for restricted medication|2
7754076|NCT00790751|26957879|P1|Overall Study|Requirement for restricted medication|0
7754077|NCT00790751|26957876|P4|Overall Study|Adverse Event|4
7754078|NCT00790751|26957877|P3|Overall Study|Adverse Event|5
7754079|NCT00790751|26957878|P2|Overall Study|Adverse Event|3
7754080|NCT00790751|26957879|P1|Overall Study|Adverse Event|5
7754081|NCT00790751|26957876|P4|Overall Study|Lost to Follow-up|5
7754082|NCT00790751|26957877|P3|Overall Study|Lost to Follow-up|4
7754083|NCT00790751|26957878|P2|Overall Study|Lost to Follow-up|9
7754084|NCT00790751|26957879|P1|Overall Study|Lost to Follow-up|4
7754085|NCT00790751|26957876|P4|Overall Study|Protocol non-compliance|11
7754086|NCT00790751|26957877|P3|Overall Study|Protocol non-compliance|10
7754087|NCT00790751|26957878|P2|Overall Study|Protocol non-compliance|16
7754088|NCT00790751|26957879|P1|Overall Study|Protocol non-compliance|16
7754089|NCT00790647|26957938|P1|Overall Study|Adverse Event|1
7754090|NCT00790582|26957947|P2|Overall Study|Withdrawal by Subject|51
7754091|NCT00790582|26957948|P1|Overall Study|Withdrawal by Subject|7
7754092|NCT00790582|26957947|P2|Overall Study|Lost to Follow-up|3
7754093|NCT00790582|26957948|P1|Overall Study|Lost to Follow-up|3
7754094|NCT00790582|26957947|P2|Overall Study|Physician Decision|1
7754095|NCT00790582|26957948|P1|Overall Study|Physician Decision|7
7754096|NCT00790582|26957947|P2|Overall Study|Death|32
7754097|NCT00790582|26957948|P1|Overall Study|Death|14
7754098|NCT00790569|26957959|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
7754099|NCT00790569|26957960|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
7754100|NCT00790569|26957961|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
7754101|NCT00790569|26957959|P3|End of Treatment (6 Month Interview)|Incarcerated|3
7754102|NCT00790569|26957960|P2|End of Treatment (6 Month Interview)|Incarcerated|0
7754103|NCT00790569|26957961|P1|End of Treatment (6 Month Interview)|Incarcerated|0
7754104|NCT00790569|26957959|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
7754105|NCT00790569|26957960|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
7754106|NCT00790569|26957961|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
7754107|NCT00790569|26957959|P3|End of Treatment (6 Month Interview)|Hospitalized|0
7754108|NCT00790569|26957960|P2|End of Treatment (6 Month Interview)|Hospitalized|0
7754109|NCT00790569|26957961|P1|End of Treatment (6 Month Interview)|Hospitalized|2
7754110|NCT00790569|26957959|P3|End of Treatment (6 Month Interview)|Death|1
7754111|NCT00790569|26957960|P2|End of Treatment (6 Month Interview)|Death|2
7754112|NCT00790569|26957961|P1|End of Treatment (6 Month Interview)|Death|0
7754113|NCT00790569|26957959|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
7754114|NCT00790569|26957960|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
7754115|NCT00790569|26957961|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
7754116|NCT00790556|26958002|P2|Treatment Period 1|Withdrawal by Subject|0
7754117|NCT00790556|26958003|P1|Treatment Period 1|Withdrawal by Subject|1
7754118|NCT00790556|26958002|P2|Treatment Period 1|Physician Decision|0
7754119|NCT00790556|26958003|P1|Treatment Period 1|Physician Decision|1
7754120|NCT00790452|26958026|P2|Overall Study|Drug supply issue|0
7754121|NCT00790452|26958027|P1|Overall Study|Drug supply issue|1
7754122|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|New treatment|0
7754123|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|New treatment|2
7754124|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
7754125|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
7754126|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Disease progression|0
7754127|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Disease progression|5
7754128|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Death|0
7754129|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Death|1
7754130|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Administrative problems|0
7754131|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Administrative problems|2
7754132|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
7754133|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
7754134|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
7754135|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
7754136|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
7754137|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
7754138|NCT00790400|26958035|P2|Everolimus Period (Core or Extension)|Adverse Event|0
7754139|NCT00790400|26958036|P1|Everolimus Period (Core or Extension)|Adverse Event|9
7754140|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Death|0
7754141|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Death|1
7754142|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Administrative problems|0
7754143|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Administrative problems|1
7754144|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
7754145|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
7754146|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
7754147|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
7754148|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Adverse Event|4
7754149|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Adverse Event|2
7754150|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Progressive disease|9
7754151|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Progressive disease|0
7754152|NCT00790400|26958035|P2|Double-blind Period (Core Phase)|Protocol Violation|0
7754153|NCT00790400|26958036|P1|Double-blind Period (Core Phase)|Protocol Violation|1
7754154|NCT00790296|26958126|P2|Overall Study|Adverse Event|1
7754155|NCT00790296|26958127|P1|Overall Study|Adverse Event|0
7754156|NCT00790296|26958126|P2|Overall Study|Did not meet study eligibility criteria|1
7754157|NCT00790296|26958127|P1|Overall Study|Did not meet study eligibility criteria|1
7754158|NCT00790218|26958149|P3|Overall Study|Death|0
7754159|NCT00790218|26958150|P2|Overall Study|Death|0
7754160|NCT00790218|26958151|P1|Overall Study|Death|1
7754161|NCT00790205|26958161|P2|Overall Study|Withdrawal by Subject|363
7754162|NCT00790205|26958162|P1|Overall Study|Withdrawal by Subject|299
7754163|NCT00790205|26958161|P2|Overall Study|Lost to Follow-up|71
7754164|NCT00790205|26958162|P1|Overall Study|Lost to Follow-up|61
7754165|NCT00790088|26958223|P1|Overall Study|Physician Decision|4
7754166|NCT00790088|26958223|P1|Overall Study|Lost to Follow-up|7
7754167|NCT00790088|26958223|P1|Overall Study|Withdrawal by Subject|17
7754168|NCT00790088|26958223|P1|Overall Study|Protocol Violation|11
7754169|NCT00790036|26958269|P2|Overall Study|Subject/guardian decision|7
7754170|NCT00790036|26958270|P1|Overall Study|Subject/guardian decision|20
7754171|NCT00790036|26958269|P2|Overall Study|Withdrawal by Subject|7
7754172|NCT00790036|26958270|P1|Overall Study|Withdrawal by Subject|18
7754173|NCT00790036|26958269|P2|Overall Study|Protocol Violation|2
7754174|NCT00790036|26958270|P1|Overall Study|Protocol Violation|10
7754175|NCT00790036|26958269|P2|Overall Study|Lost to Follow-up|2
7754176|NCT00790036|26958270|P1|Overall Study|Lost to Follow-up|1
7754177|NCT00790036|26958269|P2|Overall Study|Disease progression|48
7754178|NCT00790036|26958270|P1|Overall Study|Disease progression|24
7754179|NCT00790036|26958269|P2|Overall Study|Death|0
7754180|NCT00790036|26958270|P1|Overall Study|Death|1
7754181|NCT00790036|26958269|P2|Overall Study|Adverse Event|44
7754182|NCT00790036|26958270|P1|Overall Study|Adverse Event|113
7754183|NCT00790036|26958269|P2|Overall Study|Administrative problems|9
7754184|NCT00790036|26958270|P1|Overall Study|Administrative problems|5
7754185|NCT00790036|26958269|P2|Overall Study|Abnormal lab values|2
7754186|NCT00790036|26958270|P1|Overall Study|Abnormal lab values|3
7754187|NCT00790023|26958284|P3|Overall Study|Other|8
7754188|NCT00790023|26958285|P2|Overall Study|Other|5
7754189|NCT00790023|26958286|P1|Overall Study|Other|5
7754190|NCT00790023|26958284|P3|Overall Study|Lost to Follow-up|1
7754191|NCT00790023|26958285|P2|Overall Study|Lost to Follow-up|0
7754192|NCT00790023|26958286|P1|Overall Study|Lost to Follow-up|0
7754193|NCT00790023|26958284|P3|Overall Study|Withdrawal by Subject|6
7754194|NCT00790023|26958285|P2|Overall Study|Withdrawal by Subject|0
7754195|NCT00790023|26958286|P1|Overall Study|Withdrawal by Subject|2
7754196|NCT00790023|26958284|P3|Overall Study|Protocol Violation|2
7754197|NCT00790023|26958285|P2|Overall Study|Protocol Violation|4
7754198|NCT00790023|26958286|P1|Overall Study|Protocol Violation|2
7754199|NCT00790023|26958284|P3|Overall Study|Adverse Event|4
7754200|NCT00790023|26958285|P2|Overall Study|Adverse Event|1
7754201|NCT00790023|26958286|P1|Overall Study|Adverse Event|2
7754202|NCT00789958|26958385|P1|Overall Study|Not eligible/not analyzable|26
7754203|NCT00789958|26958385|P1|Overall Study|not protocol specified|1
7754204|NCT00789958|26958385|P1|Overall Study|Progression|3
7754205|NCT00789958|26958385|P1|Overall Study|Withdrawal by Subject|4
7754206|NCT00789958|26958385|P1|Overall Study|Adverse Event|3
7754207|NCT00789880|26958404|P6|Overall Study|Withdrawal by Subject|0
7754208|NCT00789880|26958405|P5|Overall Study|Withdrawal by Subject|2
7754209|NCT00789880|26958406|P4|Overall Study|Withdrawal by Subject|0
7754210|NCT00789880|26958407|P3|Overall Study|Withdrawal by Subject|0
7754211|NCT00789880|26958408|P2|Overall Study|Withdrawal by Subject|0
7754212|NCT00789880|26958409|P1|Overall Study|Withdrawal by Subject|1
7754213|NCT00789880|26958404|P6|Overall Study|Protocol Violation|0
7754214|NCT00789880|26958405|P5|Overall Study|Protocol Violation|0
7754215|NCT00789880|26958406|P4|Overall Study|Protocol Violation|1
7754216|NCT00789880|26958407|P3|Overall Study|Protocol Violation|0
7754217|NCT00789880|26958408|P2|Overall Study|Protocol Violation|1
7754218|NCT00789880|26958409|P1|Overall Study|Protocol Violation|0
7754219|NCT00789880|26958404|P6|Overall Study|Adverse Event|0
7754220|NCT00789880|26958405|P5|Overall Study|Adverse Event|1
7754221|NCT00789880|26958406|P4|Overall Study|Adverse Event|0
7754222|NCT00789880|26958407|P3|Overall Study|Adverse Event|0
7754223|NCT00789880|26958408|P2|Overall Study|Adverse Event|0
7754224|NCT00789880|26958409|P1|Overall Study|Adverse Event|0
7754225|NCT00789854|26958466|P3|Overall Study|Other|5
7754226|NCT00789854|26958467|P2|Overall Study|Other|0
7754227|NCT00789854|26958468|P1|Overall Study|Other|6
7754228|NCT00789854|26958466|P3|Overall Study|Safety reasons|2
7754229|NCT00789854|26958467|P2|Overall Study|Safety reasons|0
7754230|NCT00789854|26958468|P1|Overall Study|Safety reasons|0
7754231|NCT00789854|26958466|P3|Overall Study|Severe non-compliance to the protocol|0
7754232|NCT00789854|26958467|P2|Overall Study|Severe non-compliance to the protocol|0
7754233|NCT00789854|26958468|P1|Overall Study|Severe non-compliance to the protocol|3
7754234|NCT00789854|26958466|P3|Overall Study|Eligibility criteria not fulfilled|1
7754235|NCT00789854|26958467|P2|Overall Study|Eligibility criteria not fulfilled|5
7754236|NCT00789854|26958468|P1|Overall Study|Eligibility criteria not fulfilled|2
7754237|NCT00789854|26958466|P3|Overall Study|Withdrawal by Subject|17
7754238|NCT00789854|26958467|P2|Overall Study|Withdrawal by Subject|6
7754239|NCT00789854|26958468|P1|Overall Study|Withdrawal by Subject|9
7754240|NCT00789854|26958466|P3|Overall Study|Lost to Follow-up|4
7754241|NCT00789854|26958467|P2|Overall Study|Lost to Follow-up|1
7754242|NCT00789854|26958468|P1|Overall Study|Lost to Follow-up|1
7754243|NCT00789854|26958466|P3|Overall Study|Adverse Event|18
7754244|NCT00789854|26958467|P2|Overall Study|Adverse Event|23
7754245|NCT00789854|26958468|P1|Overall Study|Adverse Event|28
7754246|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
7754247|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
7754248|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|Disease progression|0
7754249|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|Disease progression|1
7754250|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|Death|0
7754251|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|Death|1
7754252|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|Administrative problems|0
7754253|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|Administrative problems|7
7754254|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
7754255|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
7754256|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
7754257|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
7754258|NCT00789828|26958565|P2|Open-label Extension Period (4 Years)|Adverse Event|0
7754259|NCT00789828|26958566|P1|Open-label Extension Period (4 Years)|Adverse Event|10
7754260|NCT00789828|26958565|P2|Core Period (48 Weeks)|Lost to Follow-up|1
7754261|NCT00789828|26958566|P1|Core Period (48 Weeks)|Lost to Follow-up|0
7754262|NCT00789828|26958565|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
7754263|NCT00789828|26958566|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
7754264|NCT00789828|26958565|P2|Core Period (48 Weeks)|Administrative problems|1
7754265|NCT00789828|26958566|P1|Core Period (48 Weeks)|Administrative problems|0
7754266|NCT00789815|26958600|P2|Overall Study|Intubation due to massive bleeding|0
7754267|NCT00789815|26958601|P1|Overall Study|Intubation due to massive bleeding|1
7754268|NCT00789815|26958600|P2|Overall Study|Protocol Violation|1
7754269|NCT00789815|26958601|P1|Overall Study|Protocol Violation|6
7754270|NCT00789737|26958711|P2|Overall Study|Other|7
7754271|NCT00789737|26958712|P1|Overall Study|Other|11
7754272|NCT00789737|26958711|P2|Overall Study|hyperglycemia that met protocol-specifie|4
7754273|NCT00789737|26958712|P1|Overall Study|hyperglycemia that met protocol-specifie|0
7754274|NCT00789737|26958711|P2|Overall Study|Lack of Efficacy|0
7754275|NCT00789737|26958712|P1|Overall Study|Lack of Efficacy|3
7754276|NCT00789737|26958711|P2|Overall Study|Protocol Violation|0
7754277|NCT00789737|26958712|P1|Overall Study|Protocol Violation|3
7754278|NCT00789737|26958711|P2|Overall Study|Adverse Event|8
7754279|NCT00789737|26958712|P1|Overall Study|Adverse Event|8
7754280|NCT00789737|26958711|P2|Overall Study|Lost to Follow-up|14
7754281|NCT00789737|26958712|P1|Overall Study|Lost to Follow-up|10
7754282|NCT00789737|26958711|P2|Overall Study|Withdrawal by Subject|22
7754283|NCT00789737|26958712|P1|Overall Study|Withdrawal by Subject|13
7754284|NCT00789698|26958755|P4|Overall Study|Administrative|1
7754285|NCT00789698|26958756|P3|Overall Study|Administrative|3
7754286|NCT00789698|26958757|P2|Overall Study|Administrative|3
7754287|NCT00789698|26958758|P1|Overall Study|Administrative|0
7754288|NCT00789698|26958755|P4|Overall Study|Withdrawal by Subject|19
7754289|NCT00789698|26958756|P3|Overall Study|Withdrawal by Subject|12
7754290|NCT00789698|26958757|P2|Overall Study|Withdrawal by Subject|15
7754291|NCT00789698|26958758|P1|Overall Study|Withdrawal by Subject|14
7754292|NCT00789698|26958755|P4|Overall Study|Protocol Violation|1
7754293|NCT00789698|26958756|P3|Overall Study|Protocol Violation|2
7754294|NCT00789698|26958757|P2|Overall Study|Protocol Violation|1
7754295|NCT00789698|26958758|P1|Overall Study|Protocol Violation|6
7754296|NCT00789698|26958755|P4|Overall Study|Lost to Follow-up|9
7754297|NCT00789698|26958756|P3|Overall Study|Lost to Follow-up|2
7754298|NCT00789698|26958757|P2|Overall Study|Lost to Follow-up|5
7754299|NCT00789698|26958758|P1|Overall Study|Lost to Follow-up|5
7754300|NCT00789698|26958755|P4|Overall Study|Adverse Event|4
7754301|NCT00789698|26958756|P3|Overall Study|Adverse Event|3
7754302|NCT00789698|26958757|P2|Overall Study|Adverse Event|5
7754303|NCT00789698|26958758|P1|Overall Study|Adverse Event|5
7754304|NCT00789698|26958755|P4|Overall Study|Lack of Efficacy|18
7754305|NCT00789698|26958756|P3|Overall Study|Lack of Efficacy|5
7754306|NCT00789698|26958757|P2|Overall Study|Lack of Efficacy|4
7754307|NCT00789698|26958758|P1|Overall Study|Lack of Efficacy|10
7754308|NCT00789581|26958813|P2|Adjuvant Therapy|Other|1
7754309|NCT00789581|26958814|P1|Adjuvant Therapy|Other|0
7754310|NCT00789581|26958813|P2|Adjuvant Therapy|Protocol Violation|1
7754311|NCT00789581|26958814|P1|Adjuvant Therapy|Protocol Violation|1
7754312|NCT00789581|26958813|P2|Adjuvant Therapy|Intercurrent Illness|3
7754313|NCT00789581|26958814|P1|Adjuvant Therapy|Intercurrent Illness|1
7754314|NCT00789581|26958813|P2|Adjuvant Therapy|Disease recurrence|1
7754315|NCT00789581|26958814|P1|Adjuvant Therapy|Disease recurrence|2
7754316|NCT00789581|26958813|P2|Adjuvant Therapy|Withdrawal by Subject|5
7754317|NCT00789581|26958814|P1|Adjuvant Therapy|Withdrawal by Subject|14
7754318|NCT00789581|26958813|P2|Adjuvant Therapy|Adverse Event|44
7754319|NCT00789581|26958814|P1|Adjuvant Therapy|Adverse Event|20
7754320|NCT00789581|26958813|P2|Adjuvant Therapy|Never treated|2
7754321|NCT00789581|26958814|P1|Adjuvant Therapy|Never treated|2
7754322|NCT00789581|26958813|P2|AC Therapy|Other|2
7754323|NCT00789581|26958814|P1|AC Therapy|Other|0
7754324|NCT00789581|26958813|P2|AC Therapy|Never Treated|4
7754325|NCT00789581|26958814|P1|AC Therapy|Never Treated|1
7754326|NCT00789581|26958813|P2|AC Therapy|Intercurrent Illness|0
7754327|NCT00789581|26958814|P1|AC Therapy|Intercurrent Illness|1
7754328|NCT00789581|26958813|P2|AC Therapy|Disease recurrence|1
7754329|NCT00789581|26958814|P1|AC Therapy|Disease recurrence|3
7754330|NCT00789581|26958813|P2|AC Therapy|Withdrawal by Subject|7
7754331|NCT00789581|26958814|P1|AC Therapy|Withdrawal by Subject|4
7754332|NCT00789581|26958813|P2|AC Therapy|Adverse Event|3
7754333|NCT00789581|26958814|P1|AC Therapy|Adverse Event|2
7754334|NCT00789555|26958825|P3|Overall Study|Protocol Violation|13
7754335|NCT00789555|26958826|P2|Overall Study|Protocol Violation|9
7754336|NCT00789555|26958827|P1|Overall Study|Protocol Violation|6
7754337|NCT00789555|26958825|P3|Overall Study|Treatment failure|12
7754338|NCT00789555|26958826|P2|Overall Study|Treatment failure|8
7754339|NCT00789555|26958827|P1|Overall Study|Treatment failure|11
7754340|NCT00789555|26958825|P3|Overall Study|Patient decision unnrelated to adv event|26
7754341|NCT00789555|26958826|P2|Overall Study|Patient decision unnrelated to adv event|29
7754342|NCT00789555|26958827|P1|Overall Study|Patient decision unnrelated to adv event|38
7754343|NCT00789555|26958825|P3|Overall Study|Lost to Follow-up|18
7754344|NCT00789555|26958826|P2|Overall Study|Lost to Follow-up|10
7754345|NCT00789555|26958827|P1|Overall Study|Lost to Follow-up|9
7754346|NCT00789555|26958825|P3|Overall Study|Adverse Event|10
7754347|NCT00789555|26958826|P2|Overall Study|Adverse Event|7
7754348|NCT00789555|26958827|P1|Overall Study|Adverse Event|17
7754349|NCT00789555|26958825|P3|Overall Study|Protocol Amendment|80
7754350|NCT00789555|26958826|P2|Overall Study|Protocol Amendment|76
7754351|NCT00789555|26958827|P1|Overall Study|Protocol Amendment|78
7754352|NCT00789529|26958852|P2|Overall Study|Other Reason|0
7754353|NCT00789529|26958853|P1|Overall Study|Other Reason|1
7754354|NCT00789529|26958852|P2|Overall Study|Withdrawal by Subject|1
7754355|NCT00789529|26958853|P1|Overall Study|Withdrawal by Subject|0
7754356|NCT00789477|26958866|P5|Overall Study|Other|0
7754357|NCT00789477|26958867|P4|Overall Study|Other|3
7754358|NCT00789477|26958868|P3|Overall Study|Other|1
7754359|NCT00789477|26958869|P2|Overall Study|Other|0
7754360|NCT00789477|26958870|P1|Overall Study|Other|2
7754361|NCT00789477|26958866|P5|Overall Study|Lack of Efficacy|0
7754362|NCT00789477|26958867|P4|Overall Study|Lack of Efficacy|0
7754363|NCT00789477|26958868|P3|Overall Study|Lack of Efficacy|0
7754364|NCT00789477|26958869|P2|Overall Study|Lack of Efficacy|0
7754365|NCT00789477|26958870|P1|Overall Study|Lack of Efficacy|2
7754366|NCT00789477|26958866|P5|Overall Study|Lost to Follow-up|4
7754367|NCT00789477|26958867|P4|Overall Study|Lost to Follow-up|2
7754368|NCT00789477|26958868|P3|Overall Study|Lost to Follow-up|4
7754369|NCT00789477|26958869|P2|Overall Study|Lost to Follow-up|1
7754370|NCT00789477|26958870|P1|Overall Study|Lost to Follow-up|0
7754371|NCT00789477|26958866|P5|Overall Study|Death|0
7754372|NCT00789477|26958867|P4|Overall Study|Death|2
7754373|NCT00789477|26958868|P3|Overall Study|Death|2
7754374|NCT00789477|26958869|P2|Overall Study|Death|1
7754375|NCT00789477|26958870|P1|Overall Study|Death|1
7754376|NCT00789477|26958866|P5|Overall Study|Adverse Event|0
7754377|NCT00789477|26958867|P4|Overall Study|Adverse Event|0
7754378|NCT00789477|26958868|P3|Overall Study|Adverse Event|1
7754379|NCT00789477|26958869|P2|Overall Study|Adverse Event|3
7754380|NCT00789477|26958870|P1|Overall Study|Adverse Event|3
7754381|NCT00789477|26958866|P5|Overall Study|Protocol Violation|0
7754382|NCT00789477|26958867|P4|Overall Study|Protocol Violation|1
7754383|NCT00789477|26958868|P3|Overall Study|Protocol Violation|0
7754384|NCT00789477|26958869|P2|Overall Study|Protocol Violation|0
7754385|NCT00789477|26958870|P1|Overall Study|Protocol Violation|1
7754386|NCT00789477|26958866|P5|Overall Study|Withdrawal by Subject|3
7754387|NCT00789477|26958867|P4|Overall Study|Withdrawal by Subject|2
7754388|NCT00789477|26958868|P3|Overall Study|Withdrawal by Subject|3
7754389|NCT00789477|26958869|P2|Overall Study|Withdrawal by Subject|1
7754390|NCT00789477|26958870|P1|Overall Study|Withdrawal by Subject|2
7754391|NCT00789373|26958915|P3|Maintenance|Participants On-Going at Data Cut-Off|0
7754392|NCT00789373|26958916|P2|Maintenance|Participants On-Going at Data Cut-Off|4
7754393|NCT00789373|26958917|P1|Maintenance|Participants On-Going at Data Cut-Off|0
7754394|NCT00789373|26958915|P3|Maintenance|Sponsor Decision|2
7754395|NCT00789373|26958916|P2|Maintenance|Sponsor Decision|0
7754396|NCT00789373|26958917|P1|Maintenance|Sponsor Decision|0
7754397|NCT00789373|26958915|P3|Maintenance|Withdrawal by Subject|8
7754398|NCT00789373|26958916|P2|Maintenance|Withdrawal by Subject|21
7754399|NCT00789373|26958917|P1|Maintenance|Withdrawal by Subject|0
7754400|NCT00789373|26958915|P3|Maintenance|Progressive Disease|152
7754401|NCT00789373|26958916|P2|Maintenance|Progressive Disease|253
7754402|NCT00789373|26958917|P1|Maintenance|Progressive Disease|0
7754403|NCT00789373|26958915|P3|Maintenance|Lost to Follow-up|0
7754404|NCT00789373|26958916|P2|Maintenance|Lost to Follow-up|2
7754405|NCT00789373|26958917|P1|Maintenance|Lost to Follow-up|0
7754406|NCT00789373|26958915|P3|Maintenance|Protocol entry criteria not met|0
7754407|NCT00789373|26958916|P2|Maintenance|Protocol entry criteria not met|2
7754408|NCT00789373|26958917|P1|Maintenance|Protocol entry criteria not met|0
7754409|NCT00789373|26958915|P3|Maintenance|Investigator Decision|2
7754410|NCT00789373|26958916|P2|Maintenance|Investigator Decision|4
7754411|NCT00789373|26958917|P1|Maintenance|Investigator Decision|0
7754412|NCT00789373|26958915|P3|Maintenance|Death due to toxicity|2
7754413|NCT00789373|26958916|P2|Maintenance|Death due to toxicity|1
7754414|NCT00789373|26958917|P1|Maintenance|Death due to toxicity|0
7754415|NCT00789373|26958915|P3|Maintenance|Death due to adverse event|1
7754416|NCT00789373|26958916|P2|Maintenance|Death due to adverse event|4
7754417|NCT00789373|26958917|P1|Maintenance|Death due to adverse event|0
7754418|NCT00789373|26958915|P3|Maintenance|Death due to study disease|1
7754419|NCT00789373|26958916|P2|Maintenance|Death due to study disease|3
7754420|NCT00789373|26958917|P1|Maintenance|Death due to study disease|0
7754421|NCT00789373|26958915|P3|Maintenance|Adverse Event|12
7754422|NCT00789373|26958916|P2|Maintenance|Adverse Event|65
7754423|NCT00789373|26958917|P1|Maintenance|Adverse Event|0
7754424|NCT00789373|26958915|P3|Induction|Withdrawal by Subject|0
7754425|NCT00789373|26958916|P2|Induction|Withdrawal by Subject|0
7754426|NCT00789373|26958917|P1|Induction|Withdrawal by Subject|37
7754427|NCT00789373|26958915|P3|Induction|Progressive Disease|0
7754428|NCT00789373|26958916|P2|Induction|Progressive Disease|0
7754429|NCT00789373|26958917|P1|Induction|Progressive Disease|220
7754430|NCT00789373|26958915|P3|Induction|Protocol Violation|0
7754431|NCT00789373|26958916|P2|Induction|Protocol Violation|0
7754432|NCT00789373|26958917|P1|Induction|Protocol Violation|1
7754433|NCT00789373|26958915|P3|Induction|Lost to Follow-up|0
7754434|NCT00789373|26958916|P2|Induction|Lost to Follow-up|0
7754435|NCT00789373|26958917|P1|Induction|Lost to Follow-up|6
7754436|NCT00789373|26958915|P3|Induction|Protocol entry criteria not met|0
7754437|NCT00789373|26958916|P2|Induction|Protocol entry criteria not met|0
7754438|NCT00789373|26958917|P1|Induction|Protocol entry criteria not met|9
7754439|NCT00789373|26958915|P3|Induction|Investigator decision|0
7754440|NCT00789373|26958916|P2|Induction|Investigator decision|0
7754441|NCT00789373|26958917|P1|Induction|Investigator decision|7
7754442|NCT00789373|26958915|P3|Induction|Death due to procedure|0
7754443|NCT00789373|26958916|P2|Induction|Death due to procedure|0
7754444|NCT00789373|26958917|P1|Induction|Death due to procedure|1
7754445|NCT00789373|26958915|P3|Induction|Death due to toxicity|0
7754446|NCT00789373|26958916|P2|Induction|Death due to toxicity|0
7754447|NCT00789373|26958917|P1|Induction|Death due to toxicity|11
7754448|NCT00789373|26958915|P3|Induction|Death due to adverse event|0
7754449|NCT00789373|26958916|P2|Induction|Death due to adverse event|0
7754450|NCT00789373|26958917|P1|Induction|Death due to adverse event|19
7754451|NCT00789373|26958915|P3|Induction|Death Due to study disease|0
7754452|NCT00789373|26958916|P2|Induction|Death Due to study disease|0
7754453|NCT00789373|26958917|P1|Induction|Death Due to study disease|24
7754454|NCT00789373|26958915|P3|Induction|Adverse Event|0
7754455|NCT00789373|26958916|P2|Induction|Adverse Event|0
7754456|NCT00789373|26958917|P1|Induction|Adverse Event|64
7754457|NCT00789360|26958944|P2|Overall Study|Protocol Violation|1
7754458|NCT00789360|26958945|P1|Overall Study|Protocol Violation|3
7754459|NCT00789321|26958955|P2|Overall Study|Adverse Event|1
7754460|NCT00789321|26958956|P1|Overall Study|Adverse Event|0
7754461|NCT00789191|26958978|P2|Overall Study|Unclassified|3
7754462|NCT00789191|26958979|P1|Overall Study|Unclassified|5
7754463|NCT00789191|26958978|P2|Overall Study|Withdrawal Criteria|4
7754464|NCT00789191|26958979|P1|Overall Study|Withdrawal Criteria|2
7754465|NCT00789191|26958978|P2|Overall Study|Protocol Violation|3
7754466|NCT00789191|26958979|P1|Overall Study|Protocol Violation|5
7754467|NCT00789191|26958978|P2|Overall Study|Lack of Efficacy|5
7754468|NCT00789191|26958979|P1|Overall Study|Lack of Efficacy|0
7754469|NCT00789191|26958978|P2|Overall Study|Adverse Event|4
7754470|NCT00789191|26958979|P1|Overall Study|Adverse Event|2
7754471|NCT00789035|26959036|P5|Overall Study|Other reason not defined above|1
7754472|NCT00789035|26959037|P4|Overall Study|Other reason not defined above|0
7754473|NCT00789035|26959038|P3|Overall Study|Other reason not defined above|1
7754474|NCT00789035|26959039|P2|Overall Study|Other reason not defined above|3
7754475|NCT00789035|26959040|P1|Overall Study|Other reason not defined above|2
7754476|NCT00789035|26959036|P5|Overall Study|Withdrawal by Subject|0
7754477|NCT00789035|26959037|P4|Overall Study|Withdrawal by Subject|0
7754478|NCT00789035|26959038|P3|Overall Study|Withdrawal by Subject|0
7754479|NCT00789035|26959039|P2|Overall Study|Withdrawal by Subject|2
7754480|NCT00789035|26959040|P1|Overall Study|Withdrawal by Subject|0
7754481|NCT00789035|26959036|P5|Overall Study|Protocol Violation|0
7754482|NCT00789035|26959037|P4|Overall Study|Protocol Violation|0
7754483|NCT00789035|26959038|P3|Overall Study|Protocol Violation|0
7754484|NCT00789035|26959039|P2|Overall Study|Protocol Violation|0
7754485|NCT00789035|26959040|P1|Overall Study|Protocol Violation|1
7754486|NCT00789035|26959036|P5|Overall Study|Lack of Efficacy|2
7754487|NCT00789035|26959037|P4|Overall Study|Lack of Efficacy|0
7754488|NCT00789035|26959038|P3|Overall Study|Lack of Efficacy|0
7754489|NCT00789035|26959039|P2|Overall Study|Lack of Efficacy|0
7754490|NCT00789035|26959040|P1|Overall Study|Lack of Efficacy|3
7754491|NCT00789035|26959036|P5|Overall Study|Adverse Event|3
7754492|NCT00789035|26959037|P4|Overall Study|Adverse Event|1
7754493|NCT00789035|26959038|P3|Overall Study|Adverse Event|0
7754494|NCT00789035|26959039|P2|Overall Study|Adverse Event|2
7754495|NCT00789035|26959040|P1|Overall Study|Adverse Event|0
7754496|NCT00788957|26959099|P6|Part 3|On-study at time of data cut-off|0
7754497|NCT00788957|26959100|P5|Part 3|On-study at time of data cut-off|1
7754498|NCT00788957|26959101|P4|Part 3|On-study at time of data cut-off|0
7754499|NCT00788957|26959102|P3|Part 3|On-study at time of data cut-off|0
7754500|NCT00788957|26959103|P2|Part 3|On-study at time of data cut-off|0
7754501|NCT00788957|26959104|P1|Part 3|On-study at time of data cut-off|0
7754502|NCT00788957|26959099|P6|Part 3|Death|9
7754503|NCT00788957|26959100|P5|Part 3|Death|8
7754504|NCT00788957|26959101|P4|Part 3|Death|0
7754505|NCT00788957|26959102|P3|Part 3|Death|0
7754506|NCT00788957|26959103|P2|Part 3|Death|0
7754507|NCT00788957|26959104|P1|Part 3|Death|0
7754508|NCT00788957|26959099|P6|Part 3|Withdrawal by Subject|2
7754509|NCT00788957|26959100|P5|Part 3|Withdrawal by Subject|0
7754510|NCT00788957|26959101|P4|Part 3|Withdrawal by Subject|0
7754511|NCT00788957|26959102|P3|Part 3|Withdrawal by Subject|0
7754512|NCT00788957|26959103|P2|Part 3|Withdrawal by Subject|0
7754513|NCT00788957|26959104|P1|Part 3|Withdrawal by Subject|0
7754514|NCT00788957|26959099|P6|Part 2|On-study at time of data cut-off|0
7754515|NCT00788957|26959100|P5|Part 2|On-study at time of data cut-off|0
7754516|NCT00788957|26959101|P4|Part 2|On-study at time of data cut-off|1
7754517|NCT00788957|26959102|P3|Part 2|On-study at time of data cut-off|1
7754518|NCT00788957|26959103|P2|Part 2|On-study at time of data cut-off|1
7754519|NCT00788957|26959104|P1|Part 2|On-study at time of data cut-off|0
7754520|NCT00788957|26959099|P6|Part 2|Lost to Follow-up|0
7754521|NCT00788957|26959100|P5|Part 2|Lost to Follow-up|0
7754522|NCT00788957|26959101|P4|Part 2|Lost to Follow-up|0
7754523|NCT00788957|26959102|P3|Part 2|Lost to Follow-up|3
7754524|NCT00788957|26959103|P2|Part 2|Lost to Follow-up|0
7754525|NCT00788957|26959104|P1|Part 2|Lost to Follow-up|0
7754526|NCT00788957|26959099|P6|Part 2|Death|0
7754527|NCT00788957|26959100|P5|Part 2|Death|0
7754528|NCT00788957|26959101|P4|Part 2|Death|37
7754529|NCT00788957|26959102|P3|Part 2|Death|35
7754530|NCT00788957|26959103|P2|Part 2|Death|32
7754531|NCT00788957|26959104|P1|Part 2|Death|0
7754532|NCT00788957|26959099|P6|Part 2|Withdrawal by Subject|0
7754533|NCT00788957|26959100|P5|Part 2|Withdrawal by Subject|0
7754534|NCT00788957|26959101|P4|Part 2|Withdrawal by Subject|3
7754535|NCT00788957|26959102|P3|Part 2|Withdrawal by Subject|5
7754536|NCT00788957|26959103|P2|Part 2|Withdrawal by Subject|9
7754537|NCT00788957|26959104|P1|Part 2|Withdrawal by Subject|0
7754538|NCT00788957|26959099|P6|Part 1|Lost to Follow-up|0
7754539|NCT00788957|26959100|P5|Part 1|Lost to Follow-up|0
7754540|NCT00788957|26959101|P4|Part 1|Lost to Follow-up|0
7754541|NCT00788957|26959102|P3|Part 1|Lost to Follow-up|0
7754542|NCT00788957|26959103|P2|Part 1|Lost to Follow-up|0
7754543|NCT00788957|26959104|P1|Part 1|Lost to Follow-up|1
7754544|NCT00788957|26959099|P6|Part 1|Death|0
7754545|NCT00788957|26959100|P5|Part 1|Death|0
7754546|NCT00788957|26959101|P4|Part 1|Death|0
7754547|NCT00788957|26959102|P3|Part 1|Death|0
7754548|NCT00788957|26959103|P2|Part 1|Death|0
7754549|NCT00788957|26959104|P1|Part 1|Death|8
7754550|NCT00788827|26959177|P1|Overall Study|Lack of Efficacy|2
7754551|NCT00788775|26959191|P2|Overall Study|Patient's measurable disease resected.|0
7754552|NCT00788775|26959192|P1|Overall Study|Patient's measurable disease resected.|1
7754553|NCT00788775|26959191|P2|Overall Study|Patient Non-Compliance|0
7754554|NCT00788775|26959192|P1|Overall Study|Patient Non-Compliance|1
7754555|NCT00788775|26959191|P2|Overall Study|Withdrawal by Subject|2
7754556|NCT00788775|26959192|P1|Overall Study|Withdrawal by Subject|0
7754557|NCT00788775|26959191|P2|Overall Study|Progressive Disease|6
7754558|NCT00788775|26959192|P1|Overall Study|Progressive Disease|8
7754559|NCT00788710|26959207|P3|Overall Study|Withdrawal by Subject|0
7754560|NCT00788710|26959208|P2|Overall Study|Withdrawal by Subject|2
7754561|NCT00788710|26959209|P1|Overall Study|Withdrawal by Subject|2
7754562|NCT00788710|26959207|P3|Overall Study|Protocol Violation|1
7754563|NCT00788710|26959208|P2|Overall Study|Protocol Violation|1
7754564|NCT00788710|26959209|P1|Overall Study|Protocol Violation|0
7754565|NCT00788710|26959207|P3|Overall Study|Physician Decision|0
7754566|NCT00788710|26959208|P2|Overall Study|Physician Decision|1
7754567|NCT00788710|26959209|P1|Overall Study|Physician Decision|2
7754568|NCT00788710|26959207|P3|Overall Study|Lost to Follow-up|0
7754569|NCT00788710|26959208|P2|Overall Study|Lost to Follow-up|1
7754570|NCT00788710|26959209|P1|Overall Study|Lost to Follow-up|0
7754571|NCT00788710|26959207|P3|Overall Study|Lack of Efficacy|1
7754572|NCT00788710|26959208|P2|Overall Study|Lack of Efficacy|0
7754573|NCT00788710|26959209|P1|Overall Study|Lack of Efficacy|0
7754574|NCT00788710|26959207|P3|Overall Study|Adverse Event|4
7754575|NCT00788710|26959208|P2|Overall Study|Adverse Event|3
7754576|NCT00788710|26959209|P1|Overall Study|Adverse Event|1
7754577|NCT00788697|26959223|P1|Overall Study|Indeterminate diagnosis from truth stand|17
7754578|NCT00788697|26959223|P1|Overall Study|Technically inadequate truth standard|1
7754579|NCT00788697|26959223|P1|Overall Study|no truth standard procedure available|5
7754580|NCT00788697|26959223|P1|Overall Study|Training Patients|74
7754581|NCT00788697|26959223|P1|Overall Study|No study drug administered|12
7754582|NCT00788593|26959270|P3|Second Intervention Period|Other|1
7754583|NCT00788593|26959271|P2|Second Intervention Period|Other|0
7754584|NCT00788593|26959272|P1|Second Intervention Period|Other|0
7754585|NCT00788593|26959270|P3|Second Intervention Period|Lost to Follow-up|0
7754586|NCT00788593|26959271|P2|Second Intervention Period|Lost to Follow-up|1
7754587|NCT00788593|26959272|P1|Second Intervention Period|Lost to Follow-up|0
7754588|NCT00788593|26959270|P3|First Intervention Period|Adverse Event|0
7754589|NCT00788593|26959271|P2|First Intervention Period|Adverse Event|1
7754590|NCT00788593|26959272|P1|First Intervention Period|Adverse Event|0
7754591|NCT00788593|26959270|P3|Placebo Run-in Phase|Protocol Violation|0
7754592|NCT00788593|26959271|P2|Placebo Run-in Phase|Protocol Violation|0
7754593|NCT00788593|26959272|P1|Placebo Run-in Phase|Protocol Violation|2
7754594|NCT00788593|26959270|P3|Placebo Run-in Phase|Withdrawal by Subject|0
7754595|NCT00788593|26959271|P2|Placebo Run-in Phase|Withdrawal by Subject|0
7754596|NCT00788593|26959272|P1|Placebo Run-in Phase|Withdrawal by Subject|2
7754597|NCT00788593|26959270|P3|Placebo Run-in Phase|Adverse Event|0
7754598|NCT00788593|26959271|P2|Placebo Run-in Phase|Adverse Event|0
7754599|NCT00788593|26959272|P1|Placebo Run-in Phase|Adverse Event|2
7754600|NCT00788372|26959289|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
7754601|NCT00788372|26959289|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
7754602|NCT00788372|26959289|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
7754603|NCT00788372|26959289|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
7754604|NCT00788372|26959289|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
7754605|NCT00788372|26959289|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
7754606|NCT00788372|26959289|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
7754607|NCT00788151|26959318|P2|Overall Study|Enrolled but not treated|1
7754608|NCT00788151|26959319|P1|Overall Study|Enrolled but not treated|1
7754609|NCT00788151|26959318|P2|Overall Study|Withdrawal by Subject|6
7754610|NCT00788151|26959319|P1|Overall Study|Withdrawal by Subject|13
7754611|NCT00788151|26959318|P2|Overall Study|Protocol Violation|1
7754612|NCT00788151|26959319|P1|Overall Study|Protocol Violation|0
7754613|NCT00788151|26959318|P2|Overall Study|Other adverse event|2
7754614|NCT00788151|26959319|P1|Overall Study|Other adverse event|0
7754615|NCT00788073|26959363|P2|Placebo Then STX209|Protocol Violation|1
7754616|NCT00788073|26959364|P1|Placebo Then STX209|Protocol Violation|0
7754617|NCT00788073|26959363|P2|Placebo Then STX209|Adverse Event|0
7754618|NCT00788073|26959364|P1|Placebo Then STX209|Adverse Event|2
7754619|NCT00788073|26959363|P2|STX209 Then Placebo|unable to return due to travel|1
7754620|NCT00788073|26959364|P1|STX209 Then Placebo|unable to return due to travel|0
7754621|NCT00788073|26959363|P2|STX209 Then Placebo|Withdrawal by Subject|1
7754622|NCT00788073|26959364|P1|STX209 Then Placebo|Withdrawal by Subject|0
7754623|NCT00788073|26959363|P2|STX209 Then Placebo|Lost to Follow-up|1
7754624|NCT00788073|26959364|P1|STX209 Then Placebo|Lost to Follow-up|0
7754625|NCT00788073|26959363|P2|STX209 Then Placebo|Adverse Event|0
7754626|NCT00788073|26959364|P1|STX209 Then Placebo|Adverse Event|1
7754627|NCT00787930|26959389|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
7754628|NCT00787917|26959404|P2|Open Label|Administrative problems|0
7754629|NCT00787917|26959405|P1|Open Label|Administrative problems|3
7754630|NCT00787917|26959404|P2|Open Label|Unsatisfactory therapeutic effect|0
7754631|NCT00787917|26959405|P1|Open Label|Unsatisfactory therapeutic effect|1
7754632|NCT00787917|26959404|P2|Blinded Treatment|Administrative problems|2
7754633|NCT00787917|26959405|P1|Blinded Treatment|Administrative problems|3
7754634|NCT00787917|26959404|P2|Blinded Treatment|Lack of Efficacy|0
7754635|NCT00787917|26959405|P1|Blinded Treatment|Lack of Efficacy|1
7754636|NCT00787917|26959404|P2|Blinded Treatment|Adverse Event|0
7754637|NCT00787917|26959405|P1|Blinded Treatment|Adverse Event|1
7754638|NCT00787891|26959435|P2|Maintenance Double-blind Phase (Part 2)|Other|2
7754639|NCT00787891|26959436|P1|Maintenance Double-blind Phase (Part 2)|Other|5
7754640|NCT00787891|26959435|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
7754641|NCT00787891|26959436|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
7754642|NCT00787891|26959435|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
7754643|NCT00787891|26959436|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
7754644|NCT00787891|26959435|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
7754645|NCT00787891|26959436|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
7754646|NCT00787891|26959435|P2|Short-term Double-blind Phase (Part 1)|Other|2
7754647|NCT00787891|26959436|P1|Short-term Double-blind Phase (Part 1)|Other|0
7754648|NCT00787891|26959435|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
7754649|NCT00787891|26959436|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
7754650|NCT00787891|26959435|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
7754651|NCT00787891|26959436|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
7754652|NCT00787891|26959435|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
7754653|NCT00787891|26959436|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
7754654|NCT00787891|26959435|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
7754655|NCT00787891|26959436|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
7754656|NCT00787891|26959435|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
7754657|NCT00787891|26959436|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
7754658|NCT00787839|26959463|P1|Overall Study|Failure to have the OGTT was most common|404
7754659|NCT00787800|26959486|P2|Overall Study|Death|2
7754660|NCT00787800|26959487|P1|Overall Study|Death|0
7754661|NCT00787800|26959486|P2|Overall Study|Withdrawal by Subject|5
7754662|NCT00787800|26959487|P1|Overall Study|Withdrawal by Subject|3
7754663|NCT00787787|26959503|P1|Overall Study|Adverse Event|3
7754664|NCT00787787|26959503|P1|Overall Study|Lack of Efficacy|4
7754665|NCT00787644|26959531|P2|Overall Study|Withdrawal by Subject|1
7754666|NCT00787644|26959532|P1|Overall Study|Withdrawal by Subject|1
7754667|NCT00787644|26959531|P2|Overall Study|Lost to Follow-up|1
7754668|NCT00787644|26959532|P1|Overall Study|Lost to Follow-up|1
7754669|NCT00787605|26959553|P2|Overall Study|Lack of Efficacy|9
7754670|NCT00787605|26959554|P1|Overall Study|Lack of Efficacy|13
7754671|NCT00787605|26959553|P2|Overall Study|Withdrawal by Subject|13
7754672|NCT00787605|26959554|P1|Overall Study|Withdrawal by Subject|6
7754673|NCT00787605|26959553|P2|Overall Study|Protocol Violation|3
7754674|NCT00787605|26959554|P1|Overall Study|Protocol Violation|7
7754675|NCT00787605|26959553|P2|Overall Study|Lost to Follow-up|6
7754676|NCT00787605|26959554|P1|Overall Study|Lost to Follow-up|3
7754677|NCT00787605|26959553|P2|Overall Study|Adverse Event|25
7754678|NCT00787605|26959554|P1|Overall Study|Adverse Event|14
7754679|NCT00787605|26959553|P2|Overall Study|Administrative Problems|0
7754680|NCT00787605|26959554|P1|Overall Study|Administrative Problems|3
7754681|NCT00787566|26959573|P3|Overall Study|AE related to chemotherapy|0
7754682|NCT00787566|26959574|P2|Overall Study|AE related to chemotherapy|1
7754683|NCT00787566|26959575|P1|Overall Study|AE related to chemotherapy|0
7754684|NCT00787527|26959583|P1|Overall Study|Toxicity|3
7754685|NCT00787319|26959600|P1|Overall Study|Inactive disease|5
7754686|NCT00787319|26959600|P1|Overall Study|Stabilized disease findings|3
7754687|NCT00787319|26959600|P1|Overall Study|No health insurance reimbursement|2
7754688|NCT00787319|26959600|P1|Overall Study|Unresponsiveness to visit invitation|1
7754689|NCT00787319|26959600|P1|Overall Study|Budget exhausted/exceeded|1
7754690|NCT00787319|26959600|P1|Overall Study|Lack of Efficacy|1
7754691|NCT00787319|26959600|P1|Overall Study|Objective progression or relapse|30
7754692|NCT00787319|26959600|P1|Overall Study|Adverse Event|3
7754693|NCT00787319|26959600|P1|Overall Study|Withdrawal by Subject|15
7754694|NCT00787319|26959600|P1|Overall Study|Lost to Follow-up|2
7754695|NCT00787267|26959612|P1|Overall Study|Withdrawal by Subject|1
7754696|NCT00787267|26959612|P1|Overall Study|No Reason Provided|1
7754697|NCT00787267|26959612|P1|Overall Study|Screen failure/Ineligible|10
7754698|NCT00787254|26959622|P2|Overall Study|Physician Decision|8
7754699|NCT00787254|26959623|P1|Overall Study|Physician Decision|4
7754700|NCT00787254|26959622|P2|Overall Study|Institution closed|0
7754701|NCT00787254|26959623|P1|Overall Study|Institution closed|1
7754702|NCT00787254|26959622|P2|Overall Study|NSAIDs discontinuation|2
7754703|NCT00787254|26959623|P1|Overall Study|NSAIDs discontinuation|1
7754704|NCT00787254|26959622|P2|Overall Study|Lack of Efficacy|15
7754705|NCT00787254|26959623|P1|Overall Study|Lack of Efficacy|4
7754706|NCT00787254|26959622|P2|Overall Study|Withdrawal by Subject|11
7754707|NCT00787254|26959623|P1|Overall Study|Withdrawal by Subject|16
7754708|NCT00787254|26959622|P2|Overall Study|Protocol Violation|23
7754709|NCT00787254|26959623|P1|Overall Study|Protocol Violation|26
7754710|NCT00787254|26959622|P2|Overall Study|Adverse Event|23
7754711|NCT00787254|26959623|P1|Overall Study|Adverse Event|24
7754712|NCT00787202|26959747|P5|Overall Study|Randomized, not treated|0
7754713|NCT00787202|26959748|P4|Overall Study|Randomized, not treated|0
7754714|NCT00787202|26959749|P3|Overall Study|Randomized, not treated|0
7754715|NCT00787202|26959750|P2|Overall Study|Randomized, not treated|0
7754716|NCT00787202|26959751|P1|Overall Study|Randomized, not treated|1
7754717|NCT00787202|26959747|P5|Overall Study|Protocol Violation|1
7754718|NCT00787202|26959748|P4|Overall Study|Protocol Violation|0
7754719|NCT00787202|26959749|P3|Overall Study|Protocol Violation|0
7754720|NCT00787202|26959750|P2|Overall Study|Protocol Violation|1
7754721|NCT00787202|26959751|P1|Overall Study|Protocol Violation|2
7754722|NCT00787202|26959747|P5|Overall Study|Withdrawal by Subject|0
7754723|NCT00787202|26959748|P4|Overall Study|Withdrawal by Subject|0
7754724|NCT00787202|26959749|P3|Overall Study|Withdrawal by Subject|2
7754725|NCT00787202|26959750|P2|Overall Study|Withdrawal by Subject|2
7754726|NCT00787202|26959751|P1|Overall Study|Withdrawal by Subject|2
7754727|NCT00787202|26959747|P5|Overall Study|Lost to Follow-up|0
7754728|NCT00787202|26959748|P4|Overall Study|Lost to Follow-up|0
7754729|NCT00787202|26959749|P3|Overall Study|Lost to Follow-up|0
7754730|NCT00787202|26959750|P2|Overall Study|Lost to Follow-up|0
7754731|NCT00787202|26959751|P1|Overall Study|Lost to Follow-up|1
7754732|NCT00787202|26959747|P5|Overall Study|Lack of Efficacy|1
7754733|NCT00787202|26959748|P4|Overall Study|Lack of Efficacy|2
7754734|NCT00787202|26959749|P3|Overall Study|Lack of Efficacy|5
7754735|NCT00787202|26959750|P2|Overall Study|Lack of Efficacy|6
7754736|NCT00787202|26959751|P1|Overall Study|Lack of Efficacy|5
7754737|NCT00787202|26959747|P5|Overall Study|Adverse Event|2
7754738|NCT00787202|26959748|P4|Overall Study|Adverse Event|0
7754739|NCT00787202|26959749|P3|Overall Study|Adverse Event|0
7754740|NCT00787202|26959750|P2|Overall Study|Adverse Event|2
7754741|NCT00787202|26959751|P1|Overall Study|Adverse Event|3
7754742|NCT00787189|26959804|P2|Overall Study|Lost to Follow-up|2
7754743|NCT00787189|26959805|P1|Overall Study|Lost to Follow-up|2
7754744|NCT00787150|26959814|P3|Overall Study|Dosing incorrect study durg|0
7754745|NCT00787150|26959815|P2|Overall Study|Dosing incorrect study durg|0
7754746|NCT00787150|26959816|P1|Overall Study|Dosing incorrect study durg|2
7754747|NCT00787150|26959814|P3|Overall Study|Withdrawal by Subject|0
7754748|NCT00787150|26959815|P2|Overall Study|Withdrawal by Subject|1
7754749|NCT00787150|26959816|P1|Overall Study|Withdrawal by Subject|2
7754750|NCT00787150|26959814|P3|Overall Study|Physician Decision|1
7754751|NCT00787150|26959815|P2|Overall Study|Physician Decision|2
7754752|NCT00787150|26959816|P1|Overall Study|Physician Decision|1
7754753|NCT00787150|26959814|P3|Overall Study|Adverse Event|4
7754754|NCT00787150|26959815|P2|Overall Study|Adverse Event|4
7754755|NCT00787150|26959816|P1|Overall Study|Adverse Event|4
7754756|NCT00787137|26959861|P3|Overall Study|Study Termination|1
7754757|NCT00787137|26959862|P2|Overall Study|Study Termination|0
7754758|NCT00787137|26959863|P1|Overall Study|Study Termination|0
7754759|NCT00786864|26959938|P2|Overall Study|Sustained serious back injury|0
7754760|NCT00786864|26959939|P1|Overall Study|Sustained serious back injury|1
7754761|NCT00786864|26959938|P2|Overall Study|Lost to Follow-up|1
7754762|NCT00786864|26959939|P1|Overall Study|Lost to Follow-up|0
7754763|NCT00786838|26959951|P1|Overall Study|Withdrawal by Subject|4
7754764|NCT00786838|26959951|P1|Overall Study|Progressive disease|31
7754765|NCT00786838|26959951|P1|Overall Study|Adverse Event|6
7754766|NCT00786838|26959951|P1|Overall Study|Death|4
7754767|NCT00786838|26959951|P1|Overall Study|Physician Decision|4
7754768|NCT00786799|26959987|P2|Overall Study|Lost to Follow-up|1
7754769|NCT00786799|26959988|P1|Overall Study|Lost to Follow-up|1
7754770|NCT00786565|26960018|P1|Post Surgery|Adapt AO implanted posterior side up|1
7754771|NCT00786565|26960018|P1|Post Surgery|Abnormal macular pucker|1
7754772|NCT00786565|26960018|P1|Enrollment Prior to Surgery|Protocol Violation|3
7754773|NCT00786565|26960018|P1|Enrollment Prior to Surgery|Site Closed|3
7754774|NCT00786474|26960075|P2|Overall Study|Other|4
7754775|NCT00786474|26960076|P1|Overall Study|Other|4
7754776|NCT00786474|26960075|P2|Overall Study|Physician Decision|1
7754777|NCT00786474|26960076|P1|Overall Study|Physician Decision|2
7754778|NCT00786474|26960075|P2|Overall Study|Lost to Follow-up|3
7754779|NCT00786474|26960076|P1|Overall Study|Lost to Follow-up|3
7754780|NCT00786474|26960075|P2|Overall Study|Withdrawal by Subject|31
7754781|NCT00786474|26960076|P1|Overall Study|Withdrawal by Subject|23
7754782|NCT00786474|26960075|P2|Overall Study|Death|4
7754783|NCT00786474|26960076|P1|Overall Study|Death|5
7754784|NCT00786422|26960088|P1|Follow-up Period|End-of-study done up to 4 days early|2
7754785|NCT00786422|26960088|P1|Follow-up Period|Death|1
7754786|NCT00786422|26960088|P1|Rivaroxaban Treatment|Adverse Event|2
7754787|NCT00786422|26960088|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
7754788|NCT00786422|26960088|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
7754789|NCT00786422|26960088|P1|Rivaroxaban Treatment|Physician Decision|1
7754790|NCT00786422|26960088|P1|Rivaroxaban Treatment|Lack of Efficacy|1
7754791|NCT00786422|26960088|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
7754792|NCT00786422|26960088|P1|Rivaroxaban Treatment|Death|2
7754793|NCT00786409|26960104|P1|Overall Study|Lost to Follow-up|1
7754794|NCT00786409|26960104|P1|Overall Study|Pregnancy|2
7754795|NCT00786409|26960104|P1|Overall Study|Adverse Event|2
7754796|NCT00786409|26960104|P1|Overall Study|Withdrawal by Subject|2
7754797|NCT00786188|26960121|P2|Overall Study|Withdrawal by Subject|0
7754798|NCT00786188|26960122|P1|Overall Study|Withdrawal by Subject|2
7754799|NCT00786188|26960121|P2|Overall Study|Adverse Event|1
7754800|NCT00786188|26960122|P1|Overall Study|Adverse Event|3
7754801|NCT00786032|26960148|P1|Overall Study|Did not complete in the timeframe|6
7754802|NCT00786032|26960148|P1|Overall Study|Withdrawal by Subject|14
7754803|NCT00786032|26960148|P1|Overall Study|Death|4
7754804|NCT00785980|26960169|P1|7 Day Washout Period|Protocol Violation|3
7754805|NCT00785928|26960187|P7|Treatment Phase|Withdrawal by Subject|0
7754806|NCT00785928|26960188|P6|Treatment Phase|Withdrawal by Subject|0
7754807|NCT00785928|26960189|P5|Treatment Phase|Withdrawal by Subject|1
7754808|NCT00785928|26960190|P4|Treatment Phase|Withdrawal by Subject|0
7754809|NCT00785928|26960191|P3|Treatment Phase|Withdrawal by Subject|0
7754810|NCT00785928|26960192|P2|Treatment Phase|Withdrawal by Subject|2
7754811|NCT00785928|26960193|P1|Treatment Phase|Withdrawal by Subject|1
7754812|NCT00785928|26960187|P7|Treatment Phase|Sponsor Decision|1
7754813|NCT00785928|26960188|P6|Treatment Phase|Sponsor Decision|0
7754814|NCT00785928|26960189|P5|Treatment Phase|Sponsor Decision|0
7754815|NCT00785928|26960190|P4|Treatment Phase|Sponsor Decision|0
7754816|NCT00785928|26960191|P3|Treatment Phase|Sponsor Decision|0
7754817|NCT00785928|26960192|P2|Treatment Phase|Sponsor Decision|0
7754818|NCT00785928|26960193|P1|Treatment Phase|Sponsor Decision|1
7754819|NCT00785928|26960187|P7|Treatment Phase|Physician Decision|0
7754820|NCT00785928|26960188|P6|Treatment Phase|Physician Decision|0
7754821|NCT00785928|26960189|P5|Treatment Phase|Physician Decision|1
7754822|NCT00785928|26960190|P4|Treatment Phase|Physician Decision|0
7754823|NCT00785928|26960191|P3|Treatment Phase|Physician Decision|0
7754824|NCT00785928|26960192|P2|Treatment Phase|Physician Decision|0
7754825|NCT00785928|26960193|P1|Treatment Phase|Physician Decision|0
7754826|NCT00785928|26960187|P7|Treatment Phase|Lack of Efficacy|0
7754827|NCT00785928|26960188|P6|Treatment Phase|Lack of Efficacy|0
7754828|NCT00785928|26960189|P5|Treatment Phase|Lack of Efficacy|0
7754829|NCT00785928|26960190|P4|Treatment Phase|Lack of Efficacy|0
7754830|NCT00785928|26960191|P3|Treatment Phase|Lack of Efficacy|1
7754831|NCT00785928|26960192|P2|Treatment Phase|Lack of Efficacy|1
7754832|NCT00785928|26960193|P1|Treatment Phase|Lack of Efficacy|0
7754833|NCT00785928|26960187|P7|Treatment Phase|Inadequate Response|0
7754834|NCT00785928|26960188|P6|Treatment Phase|Inadequate Response|0
7754835|NCT00785928|26960189|P5|Treatment Phase|Inadequate Response|0
7754836|NCT00785928|26960190|P4|Treatment Phase|Inadequate Response|0
7754837|NCT00785928|26960191|P3|Treatment Phase|Inadequate Response|0
7754838|NCT00785928|26960192|P2|Treatment Phase|Inadequate Response|1
7754839|NCT00785928|26960193|P1|Treatment Phase|Inadequate Response|0
7754840|NCT00785928|26960187|P7|Treatment Phase|Adverse Event|2
7754841|NCT00785928|26960188|P6|Treatment Phase|Adverse Event|0
7754842|NCT00785928|26960189|P5|Treatment Phase|Adverse Event|0
7754843|NCT00785928|26960190|P4|Treatment Phase|Adverse Event|0
7754844|NCT00785928|26960191|P3|Treatment Phase|Adverse Event|2
7754845|NCT00785928|26960192|P2|Treatment Phase|Adverse Event|1
7754846|NCT00785928|26960193|P1|Treatment Phase|Adverse Event|1
7754847|NCT00785785|26960340|P2|Optional Extension Phase|Study terminated by sponsor|37
7754848|NCT00785785|26960341|P1|Optional Extension Phase|Study terminated by sponsor|3
7754849|NCT00785785|26960340|P2|Optional Extension Phase|Protocol deviation|2
7754850|NCT00785785|26960341|P1|Optional Extension Phase|Protocol deviation|0
7754851|NCT00785785|26960340|P2|Optional Extension Phase|Disease progression|70
7754852|NCT00785785|26960341|P1|Optional Extension Phase|Disease progression|22
7754853|NCT00785785|26960340|P2|Optional Extension Phase|Death|5
7754854|NCT00785785|26960341|P1|Optional Extension Phase|Death|1
7754855|NCT00785785|26960340|P2|Optional Extension Phase|Administrative problems|0
7754856|NCT00785785|26960341|P1|Optional Extension Phase|Administrative problems|2
7754857|NCT00785785|26960340|P2|Optional Extension Phase|Lost to Follow-up|0
7754858|NCT00785785|26960341|P1|Optional Extension Phase|Lost to Follow-up|1
7754859|NCT00785785|26960340|P2|Optional Extension Phase|Withdrawal by Subject|6
7754860|NCT00785785|26960341|P1|Optional Extension Phase|Withdrawal by Subject|6
7754861|NCT00785785|26960340|P2|Optional Extension Phase|Adverse Event|5
7754862|NCT00785785|26960341|P1|Optional Extension Phase|Adverse Event|4
7754863|NCT00785785|26960340|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
7754864|NCT00785785|26960341|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
7754865|NCT00785785|26960340|P2|Core Phase up to 36 Months|Protocol deviation|6
7754866|NCT00785785|26960341|P1|Core Phase up to 36 Months|Protocol deviation|5
7754867|NCT00785785|26960340|P2|Core Phase up to 36 Months|Disease progression|119
7754868|NCT00785785|26960341|P1|Core Phase up to 36 Months|Disease progression|139
7754869|NCT00785785|26960340|P2|Core Phase up to 36 Months|Death|8
7754870|NCT00785785|26960341|P1|Core Phase up to 36 Months|Death|5
7754871|NCT00785785|26960340|P2|Core Phase up to 36 Months|Administrative problems|3
7754872|NCT00785785|26960341|P1|Core Phase up to 36 Months|Administrative problems|3
7754873|NCT00785785|26960340|P2|Core Phase up to 36 Months|Lost to Follow-up|7
7754874|NCT00785785|26960341|P1|Core Phase up to 36 Months|Lost to Follow-up|3
7754875|NCT00785785|26960340|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
7754876|NCT00785785|26960341|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
7754877|NCT00785785|26960340|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
7754878|NCT00785785|26960341|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
7754879|NCT00785785|26960340|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
7754880|NCT00785785|26960341|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
7754881|NCT00785785|26960340|P2|Core Phase up to 36 Months|Adverse Event|21
7754882|NCT00785785|26960341|P1|Core Phase up to 36 Months|Adverse Event|31
7754883|NCT00785785|26960340|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
7754884|NCT00785785|26960341|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
7754885|NCT00785707|26960355|P1|Overall Study|Lost to Follow-up|7
7754886|NCT00785629|26960364|P4|Overall Study|Withdrawal by Subject|2
7754887|NCT00785629|26960365|P3|Overall Study|Withdrawal by Subject|2
7754888|NCT00785629|26960366|P2|Overall Study|Withdrawal by Subject|1
7754889|NCT00785629|26960367|P1|Overall Study|Withdrawal by Subject|0
7754890|NCT00785629|26960364|P4|Overall Study|administrative decision|4
7754891|NCT00785629|26960365|P3|Overall Study|administrative decision|3
7754892|NCT00785629|26960366|P2|Overall Study|administrative decision|1
7754893|NCT00785629|26960367|P1|Overall Study|administrative decision|5
7754894|NCT00785629|26960364|P4|Overall Study|Protocol Violation|5
7754895|NCT00785629|26960365|P3|Overall Study|Protocol Violation|4
7754896|NCT00785629|26960366|P2|Overall Study|Protocol Violation|2
7754897|NCT00785629|26960367|P1|Overall Study|Protocol Violation|1
7754898|NCT00785629|26960364|P4|Overall Study|Adverse Event|5
7754899|NCT00785629|26960365|P3|Overall Study|Adverse Event|1
7754900|NCT00785629|26960366|P2|Overall Study|Adverse Event|1
7754901|NCT00785629|26960367|P1|Overall Study|Adverse Event|2
7754902|NCT00785577|26960380|P5|Study Period 3: 1-Week Washout Phase|Death|1
7754903|NCT00785577|26960381|P4|Study Period 3: 1-Week Washout Phase|Death|0
7754904|NCT00785577|26960382|P3|Study Period 3: 1-Week Washout Phase|Death|0
7754905|NCT00785577|26960383|P2|Study Period 3: 1-Week Washout Phase|Death|0
7754906|NCT00785577|26960384|P1|Study Period 3: 1-Week Washout Phase|Death|0
7754907|NCT00785577|26960380|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7754908|NCT00785577|26960381|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
7754909|NCT00785577|26960382|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7754910|NCT00785577|26960383|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7754911|NCT00785577|26960384|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7754912|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
7754913|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
7754914|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
7754915|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
7754916|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
7754917|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
7754918|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7754919|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7754920|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
7754921|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7754922|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7754923|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
7754924|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7754925|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7754926|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
7754927|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Protocol Violation|1
7754928|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Protocol Violation|0
7754929|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Protocol Violation|1
7754930|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Protocol Violation|1
7754931|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Protocol Violation|1
7754932|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Physician Decision|0
7754933|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Physician Decision|0
7754934|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Physician Decision|0
7754935|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Physician Decision|0
7754936|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Physician Decision|1
7754937|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
7754938|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
7754939|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
7754940|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
7754941|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
7754942|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
7754943|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
7754944|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
7754945|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
7754946|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
7754947|NCT00785577|26960380|P5|Study Period 2: Therapy Phase|Adverse Event|17
7754948|NCT00785577|26960381|P4|Study Period 2: Therapy Phase|Adverse Event|10
7754949|NCT00785577|26960382|P3|Study Period 2: Therapy Phase|Adverse Event|14
7754950|NCT00785577|26960383|P2|Study Period 2: Therapy Phase|Adverse Event|7
7754951|NCT00785577|26960384|P1|Study Period 2: Therapy Phase|Adverse Event|5
7754952|NCT00785538|26960524|P4|Treatment Period|Withdrawal by Subject|1
7754953|NCT00785538|26960525|P3|Treatment Period|Withdrawal by Subject|0
7754954|NCT00785538|26960526|P2|Treatment Period|Withdrawal by Subject|0
7754955|NCT00785538|26960527|P1|Treatment Period|Withdrawal by Subject|0
7754956|NCT00785538|26960524|P4|Treatment Period|Adverse Event|0
7754957|NCT00785538|26960525|P3|Treatment Period|Adverse Event|2
7754958|NCT00785538|26960526|P2|Treatment Period|Adverse Event|2
7754959|NCT00785538|26960527|P1|Treatment Period|Adverse Event|1
7754960|NCT00785512|26960575|P2|Overall Study|Lack of compliance|1
7754961|NCT00785512|26960576|P1|Overall Study|Lack of compliance|0
7754962|NCT00785512|26960575|P2|Overall Study|Physician Decision|0
7754963|NCT00785512|26960576|P1|Overall Study|Physician Decision|0
7754964|NCT00785512|26960575|P2|Overall Study|IVRS Programing Error|0
7754965|NCT00785512|26960576|P1|Overall Study|IVRS Programing Error|0
7754966|NCT00785512|26960575|P2|Overall Study|Precedure Refused|0
7754967|NCT00785512|26960576|P1|Overall Study|Precedure Refused|0
7754968|NCT00785512|26960575|P2|Overall Study|Lost to Follow-up|0
7754969|NCT00785512|26960576|P1|Overall Study|Lost to Follow-up|3
7754970|NCT00785512|26960575|P2|Overall Study|Withdrawal by Subject|1
7754971|NCT00785512|26960576|P1|Overall Study|Withdrawal by Subject|0
7754972|NCT00785512|26960575|P2|Overall Study|Lack of Efficacy|2
7754973|NCT00785512|26960576|P1|Overall Study|Lack of Efficacy|0
7754974|NCT00785512|26960575|P2|Overall Study|Adverse Event|0
7754975|NCT00785512|26960576|P1|Overall Study|Adverse Event|0
7754976|NCT00785512|26960575|P2|Overall Study|Inclusion/Exclusion not meet|0
7754977|NCT00785512|26960576|P1|Overall Study|Inclusion/Exclusion not meet|0
7754978|NCT00785486|26960585|P1|Midazolam Alone|Withdrawal by Subject|1
7754979|NCT00785356|26960609|P1|Overall Study|Study prematurely terminated|8
7755001|NCT00785213|26960642|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
7755002|NCT00785213|26960642|P1|Quinine Sulfate Alone|Adverse Event|4
7755003|NCT00785044|26960653|P1|Overall Study|Withdrawal by Subject|1
7755004|NCT00785044|26960653|P1|Overall Study|Lost to Follow-up|266
7755005|NCT00785044|26960653|P1|Overall Study|Death|77
7755006|NCT00785044|26960653|P1|Overall Study|Dosed at non-participating sites|152
7755007|NCT00784979|26960658|P1|Overall Study|incomplete data|6
7755008|NCT00784927|26960662|P1|Overall Study|Ineligible|1
7755009|NCT00784927|26960662|P1|Overall Study|Protocol Violation|1
7755010|NCT00784927|26960662|P1|Overall Study|Cancel Prior to Initiating Treatment|1
7755011|NCT00784875|26960674|P4|Period D|Lost to Follow-up|1
7755012|NCT00784875|26960675|P3|Period D|Lost to Follow-up|1
7755013|NCT00784875|26960676|P2|Period D|Lost to Follow-up|0
7755014|NCT00784875|26960677|P1|Period D|Lost to Follow-up|1
7755015|NCT00784875|26960674|P4|Period D|Sponsor Decision|0
7755016|NCT00784875|26960675|P3|Period D|Sponsor Decision|1
7755017|NCT00784875|26960676|P2|Period D|Sponsor Decision|1
7755018|NCT00784875|26960677|P1|Period D|Sponsor Decision|1
7755019|NCT00784875|26960674|P4|Period D|Physician Decision|0
7755020|NCT00784875|26960675|P3|Period D|Physician Decision|0
7755021|NCT00784875|26960676|P2|Period D|Physician Decision|1
7755022|NCT00784875|26960677|P1|Period D|Physician Decision|0
7755023|NCT00784875|26960674|P4|Period D|Withdrawal by Subject|0
7755024|NCT00784875|26960675|P3|Period D|Withdrawal by Subject|2
7755025|NCT00784875|26960676|P2|Period D|Withdrawal by Subject|0
7755026|NCT00784875|26960677|P1|Period D|Withdrawal by Subject|2
7755027|NCT00784875|26960674|P4|Period D|Protocol Violation|0
7755028|NCT00784875|26960675|P3|Period D|Protocol Violation|0
7755029|NCT00784875|26960676|P2|Period D|Protocol Violation|0
7755030|NCT00784875|26960677|P1|Period D|Protocol Violation|1
7755031|NCT00784875|26960674|P4|Period D|Adverse Event|0
7755032|NCT00784875|26960675|P3|Period D|Adverse Event|2
7755033|NCT00784875|26960676|P2|Period D|Adverse Event|2
7755034|NCT00784875|26960677|P1|Period D|Adverse Event|0
7755035|NCT00784875|26960674|P4|Period C|Sponsor Decision|2
7755036|NCT00784875|26960675|P3|Period C|Sponsor Decision|4
7755037|NCT00784875|26960676|P2|Period C|Sponsor Decision|5
7755038|NCT00784875|26960677|P1|Period C|Sponsor Decision|5
7755039|NCT00784875|26960674|P4|Period C|Physician Decision|1
7755040|NCT00784875|26960675|P3|Period C|Physician Decision|1
7755041|NCT00784875|26960676|P2|Period C|Physician Decision|0
7755042|NCT00784875|26960677|P1|Period C|Physician Decision|0
7755043|NCT00784875|26960674|P4|Period C|Withdrawal by Subject|0
7755044|NCT00784875|26960675|P3|Period C|Withdrawal by Subject|2
7755045|NCT00784875|26960676|P2|Period C|Withdrawal by Subject|1
7755046|NCT00784875|26960677|P1|Period C|Withdrawal by Subject|1
7755047|NCT00784875|26960674|P4|Period C|Lack of Efficacy|0
7755048|NCT00784875|26960675|P3|Period C|Lack of Efficacy|1
7755049|NCT00784875|26960676|P2|Period C|Lack of Efficacy|0
7755050|NCT00784875|26960677|P1|Period C|Lack of Efficacy|0
7755051|NCT00784875|26960674|P4|Period C|Protocol Violation|2
7755052|NCT00784875|26960675|P3|Period C|Protocol Violation|1
7755053|NCT00784875|26960676|P2|Period C|Protocol Violation|0
7755054|NCT00784875|26960677|P1|Period C|Protocol Violation|0
7755055|NCT00784875|26960674|P4|Period C|Adverse Event|2
7755056|NCT00784875|26960675|P3|Period C|Adverse Event|4
7755057|NCT00784875|26960676|P2|Period C|Adverse Event|0
7755058|NCT00784875|26960677|P1|Period C|Adverse Event|1
7755059|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
7755060|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
7755061|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
7755062|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
7755063|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
7755064|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
7755065|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
7755066|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
7755067|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Physician Decision|0
7755068|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Physician Decision|1
7755069|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Physician Decision|0
7755070|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Physician Decision|0
7755071|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
7755072|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
7755073|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
7755074|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
7755075|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
7755076|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
7755077|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
7755078|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
7755079|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Protocol Violation|3
7755080|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Protocol Violation|2
7755081|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Protocol Violation|1
7755082|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Protocol Violation|1
7755083|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Adverse Event|1
7755084|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Adverse Event|2
7755085|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Adverse Event|3
7755086|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Adverse Event|0
7755087|NCT00784875|26960674|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
7755088|NCT00784875|26960675|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
7755089|NCT00784875|26960676|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
7755090|NCT00784875|26960677|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
7755091|NCT00784875|26960674|P4|Period A - Baseline|Lost to Follow-up|2
7755092|NCT00784875|26960675|P3|Period A - Baseline|Lost to Follow-up|0
7755093|NCT00784875|26960676|P2|Period A - Baseline|Lost to Follow-up|0
7755094|NCT00784875|26960677|P1|Period A - Baseline|Lost to Follow-up|0
7755095|NCT00784875|26960674|P4|Period A - Baseline|Sponsor Decision|113
7755096|NCT00784875|26960675|P3|Period A - Baseline|Sponsor Decision|0
7755097|NCT00784875|26960676|P2|Period A - Baseline|Sponsor Decision|0
7755098|NCT00784875|26960677|P1|Period A - Baseline|Sponsor Decision|0
7755099|NCT00784875|26960674|P4|Period A - Baseline|Physician Decision|2
7755100|NCT00784875|26960675|P3|Period A - Baseline|Physician Decision|0
7755101|NCT00784875|26960676|P2|Period A - Baseline|Physician Decision|0
7755102|NCT00784875|26960677|P1|Period A - Baseline|Physician Decision|0
7755103|NCT00784875|26960674|P4|Period A - Baseline|Withdrawal by Subject|27
7755104|NCT00784875|26960675|P3|Period A - Baseline|Withdrawal by Subject|0
7755105|NCT00784875|26960676|P2|Period A - Baseline|Withdrawal by Subject|0
7755106|NCT00784875|26960677|P1|Period A - Baseline|Withdrawal by Subject|0
7755107|NCT00784875|26960674|P4|Period A - Baseline|Protocol Violation|25
7755108|NCT00784875|26960675|P3|Period A - Baseline|Protocol Violation|0
7755109|NCT00784875|26960676|P2|Period A - Baseline|Protocol Violation|0
7755110|NCT00784875|26960677|P1|Period A - Baseline|Protocol Violation|0
7755111|NCT00784875|26960674|P4|Period A - Baseline|Adverse Event|8
7755112|NCT00784875|26960675|P3|Period A - Baseline|Adverse Event|0
7755113|NCT00784875|26960676|P2|Period A - Baseline|Adverse Event|0
7755114|NCT00784875|26960677|P1|Period A - Baseline|Adverse Event|0
7755115|NCT00784875|26960674|P4|Period A - Baseline|Entry Criteria Not Met|5
7755116|NCT00784875|26960675|P3|Period A - Baseline|Entry Criteria Not Met|0
7755117|NCT00784875|26960676|P2|Period A - Baseline|Entry Criteria Not Met|0
7755118|NCT00784875|26960677|P1|Period A - Baseline|Entry Criteria Not Met|0
7755119|NCT00784836|26960797|P1|Overall Study|Early Study Termination|3
7755120|NCT00784810|26960804|P2|Overall Study|Lost to Follow-up|1
7755121|NCT00784810|26960805|P1|Overall Study|Lost to Follow-up|1
7755122|NCT00784810|26960804|P2|Overall Study|Administrative|8
7755123|NCT00784810|26960805|P1|Overall Study|Administrative|5
7755124|NCT00784810|26960804|P2|Overall Study|Withdrawal by Subject|9
7755125|NCT00784810|26960805|P1|Overall Study|Withdrawal by Subject|11
7755126|NCT00784810|26960804|P2|Overall Study|Lack of Efficacy|11
7755127|NCT00784810|26960805|P1|Overall Study|Lack of Efficacy|14
7755128|NCT00784810|26960804|P2|Overall Study|Adverse Event|20
7755129|NCT00784810|26960805|P1|Overall Study|Adverse Event|32
7755130|NCT00784784|26960815|P2|Overall Study|Withdrawal by Subject|2
7755131|NCT00784784|26960816|P1|Overall Study|Withdrawal by Subject|2
7755132|NCT00784758|26960826|P2|Overall Study|Adverse Event|0
7755133|NCT00784758|26960827|P1|Overall Study|Adverse Event|1
7755134|NCT00784758|26960826|P2|Overall Study|Withdrawal by Subject|0
7755135|NCT00784758|26960827|P1|Overall Study|Withdrawal by Subject|3
7755136|NCT00784719|26960876|P7|Overall Study|Withdrawal by Subject|1
7755137|NCT00784719|26960877|P6|Overall Study|Withdrawal by Subject|0
7755138|NCT00784719|26960878|P5|Overall Study|Withdrawal by Subject|2
7755139|NCT00784719|26960879|P4|Overall Study|Withdrawal by Subject|0
7755140|NCT00784719|26960880|P3|Overall Study|Withdrawal by Subject|0
7755141|NCT00784719|26960881|P2|Overall Study|Withdrawal by Subject|0
7755142|NCT00784719|26960882|P1|Overall Study|Withdrawal by Subject|1
7755143|NCT00784719|26960876|P7|Overall Study|Other|3
7755144|NCT00784719|26960877|P6|Overall Study|Other|1
7755145|NCT00784719|26960878|P5|Overall Study|Other|2
7755146|NCT00784719|26960879|P4|Overall Study|Other|0
7755147|NCT00784719|26960880|P3|Overall Study|Other|1
7755148|NCT00784719|26960881|P2|Overall Study|Other|1
7755149|NCT00784719|26960882|P1|Overall Study|Other|2
7755150|NCT00784719|26960876|P7|Overall Study|Lost to Follow-up|0
7755151|NCT00784719|26960877|P6|Overall Study|Lost to Follow-up|1
7755152|NCT00784719|26960878|P5|Overall Study|Lost to Follow-up|1
7755153|NCT00784719|26960879|P4|Overall Study|Lost to Follow-up|0
7755154|NCT00784719|26960880|P3|Overall Study|Lost to Follow-up|0
7755155|NCT00784719|26960881|P2|Overall Study|Lost to Follow-up|0
7755156|NCT00784719|26960882|P1|Overall Study|Lost to Follow-up|0
7755157|NCT00784719|26960876|P7|Overall Study|Adverse Event|1
7755158|NCT00784719|26960877|P6|Overall Study|Adverse Event|1
7755159|NCT00784719|26960878|P5|Overall Study|Adverse Event|1
7755160|NCT00784719|26960879|P4|Overall Study|Adverse Event|0
7755161|NCT00784719|26960880|P3|Overall Study|Adverse Event|0
7755162|NCT00784719|26960881|P2|Overall Study|Adverse Event|2
7755163|NCT00784719|26960882|P1|Overall Study|Adverse Event|0
7755164|NCT00784693|26961054|P2|Overall Study|Other|0
7755165|NCT00784693|26961055|P1|Overall Study|Other|1
7755166|NCT00784693|26961054|P2|Overall Study|Randomized but not Treated|0
7755167|NCT00784693|26961055|P1|Overall Study|Randomized but not Treated|1
7755168|NCT00784693|26961054|P2|Overall Study|Withdrawal by Subject|4
7755169|NCT00784693|26961055|P1|Overall Study|Withdrawal by Subject|0
7755170|NCT00784693|26961054|P2|Overall Study|Lack of Efficacy|1
7755171|NCT00784693|26961055|P1|Overall Study|Lack of Efficacy|1
7755172|NCT00784693|26961054|P2|Overall Study|Lost to Follow-up|1
7755173|NCT00784693|26961055|P1|Overall Study|Lost to Follow-up|0
7755174|NCT00784654|26961098|P3|Randomized Withdrawal Period|Family reasons|1
7755175|NCT00784654|26961099|P2|Randomized Withdrawal Period|Family reasons|0
7755176|NCT00784654|26961100|P1|Randomized Withdrawal Period|Family reasons|0
7755177|NCT00784654|26961098|P3|Randomized Withdrawal Period|Did not complete a visit|0
7755178|NCT00784654|26961099|P2|Randomized Withdrawal Period|Did not complete a visit|1
7755179|NCT00784654|26961100|P1|Randomized Withdrawal Period|Did not complete a visit|0
7755180|NCT00784654|26961098|P3|Randomized Withdrawal Period|Adverse Event|1
7755181|NCT00784654|26961099|P2|Randomized Withdrawal Period|Adverse Event|1
7755182|NCT00784654|26961100|P1|Randomized Withdrawal Period|Adverse Event|0
7755183|NCT00784654|26961098|P3|Randomized Withdrawal Period|Protocol Violation|1
7755184|NCT00784654|26961099|P2|Randomized Withdrawal Period|Protocol Violation|2
7755185|NCT00784654|26961100|P1|Randomized Withdrawal Period|Protocol Violation|0
7755186|NCT00784654|26961098|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
7755187|NCT00784654|26961099|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
7755188|NCT00784654|26961100|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
7755189|NCT00784654|26961098|P3|Randomized Withdrawal Period|Lack of Efficacy|18
7755190|NCT00784654|26961099|P2|Randomized Withdrawal Period|Lack of Efficacy|5
7755191|NCT00784654|26961100|P1|Randomized Withdrawal Period|Lack of Efficacy|0
7755192|NCT00784654|26961098|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
7755193|NCT00784654|26961099|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
7755194|NCT00784654|26961100|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
7755195|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
7755196|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
7755197|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
7755198|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
7755199|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
7755200|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
7755201|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
7755202|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
7755203|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
7755204|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
7755205|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
7755206|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
7755207|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
7755208|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
7755209|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
7755210|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
7755211|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
7755212|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
7755213|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
7755214|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
7755215|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
7755216|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
7755217|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
7755218|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
7755219|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
7755220|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
7755221|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
7755222|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
7755223|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
7755224|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
7755225|NCT00784654|26961098|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
7755226|NCT00784654|26961099|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
7755227|NCT00784654|26961100|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
7755228|NCT00784563|26961148|P3|Year 3|Adverse Event|1
7755229|NCT00784563|26961149|P2|Year 3|Adverse Event|0
7755230|NCT00784563|26961150|P1|Year 3|Adverse Event|0
7755231|NCT00784563|26961148|P3|Year 3|Withdrawal by Subject|2
7755232|NCT00784563|26961149|P2|Year 3|Withdrawal by Subject|0
7755233|NCT00784563|26961150|P1|Year 3|Withdrawal by Subject|0
7755234|NCT00784563|26961148|P3|Years 1 & 2|Adverse Event|0
7755235|NCT00784563|26961149|P2|Years 1 & 2|Adverse Event|3
7755236|NCT00784563|26961150|P1|Years 1 & 2|Adverse Event|0
7755237|NCT00784563|26961148|P3|Years 1 & 2|Withdrawal by Subject|0
7755238|NCT00784563|26961149|P2|Years 1 & 2|Withdrawal by Subject|2
7755239|NCT00784563|26961150|P1|Years 1 & 2|Withdrawal by Subject|3
7755240|NCT00784550|26961168|P2|Overall Study|Withdrawal by Subject|13
7755241|NCT00784550|26961169|P1|Overall Study|Withdrawal by Subject|4
7755242|NCT00784550|26961168|P2|Overall Study|Physician Decision|3
7755243|NCT00784550|26961169|P1|Overall Study|Physician Decision|2
7755244|NCT00784550|26961168|P2|Overall Study|Lost to Follow-up|5
7755245|NCT00784550|26961169|P1|Overall Study|Lost to Follow-up|8
7755246|NCT00784550|26961168|P2|Overall Study|Protocol Violation|10
7755247|NCT00784550|26961169|P1|Overall Study|Protocol Violation|10
7755248|NCT00784550|26961168|P2|Overall Study|Lack of Efficacy|1
7755249|NCT00784550|26961169|P1|Overall Study|Lack of Efficacy|0
7755250|NCT00784550|26961168|P2|Overall Study|Adverse Event|10
7755251|NCT00784550|26961169|P1|Overall Study|Adverse Event|12
7755252|NCT00784459|26961195|P2|Overall Study|Adverse Event|2
7755253|NCT00784459|26961196|P1|Overall Study|Adverse Event|0
7755254|NCT00784368|26961207|P3|Overall Study|Withdrawal of informed consent|0
7755255|NCT00784368|26961208|P2|Overall Study|Withdrawal of informed consent|1
7755256|NCT00784368|26961209|P1|Overall Study|Withdrawal of informed consent|0
7755257|NCT00784368|26961207|P3|Overall Study|Worsening of symptoms|0
7755258|NCT00784368|26961208|P2|Overall Study|Worsening of symptoms|1
7755259|NCT00784368|26961209|P1|Overall Study|Worsening of symptoms|0
7755260|NCT00784368|26961207|P3|Overall Study|Worsening of complications|1
7755261|NCT00784368|26961208|P2|Overall Study|Worsening of complications|0
7755262|NCT00784368|26961209|P1|Overall Study|Worsening of complications|0
7755263|NCT00784368|26961207|P3|Overall Study|Diagnosis of fever|1
7755264|NCT00784368|26961208|P2|Overall Study|Diagnosis of fever|0
7755265|NCT00784368|26961209|P1|Overall Study|Diagnosis of fever|0
7755266|NCT00784368|26961207|P3|Overall Study|Adverse Event|2
7755267|NCT00784368|26961208|P2|Overall Study|Adverse Event|9
7755268|NCT00784368|26961209|P1|Overall Study|Adverse Event|6
7755269|NCT00784368|26961207|P3|Overall Study|Lack of Efficacy|1
7755270|NCT00784368|26961208|P2|Overall Study|Lack of Efficacy|0
7755271|NCT00784368|26961209|P1|Overall Study|Lack of Efficacy|2
7755272|NCT00784368|26961207|P3|Overall Study|Physician Decision|6
7755273|NCT00784368|26961208|P2|Overall Study|Physician Decision|0
7755274|NCT00784368|26961209|P1|Overall Study|Physician Decision|0
7755275|NCT00784277|26961285|P7|ER Treatment|Other|2
7755276|NCT00784277|26961286|P6|ER Treatment|Other|3
7755277|NCT00784277|26961287|P5|ER Treatment|Other|1
7755278|NCT00784277|26961288|P4|ER Treatment|Other|0
7755279|NCT00784277|26961289|P3|ER Treatment|Other|0
7755280|NCT00784277|26961290|P2|ER Treatment|Other|0
7755281|NCT00784277|26961291|P1|ER Treatment|Other|0
7755282|NCT00784277|26961285|P7|ER Treatment|Study Medication Non-Compliant|3
7755283|NCT00784277|26961286|P6|ER Treatment|Study Medication Non-Compliant|3
7755284|NCT00784277|26961287|P5|ER Treatment|Study Medication Non-Compliant|2
7755285|NCT00784277|26961288|P4|ER Treatment|Study Medication Non-Compliant|0
7755286|NCT00784277|26961289|P3|ER Treatment|Study Medication Non-Compliant|0
7755287|NCT00784277|26961290|P2|ER Treatment|Study Medication Non-Compliant|0
7755288|NCT00784277|26961291|P1|ER Treatment|Study Medication Non-Compliant|0
7755289|NCT00784277|26961285|P7|ER Treatment|Withdrawal by Subject|3
7755290|NCT00784277|26961286|P6|ER Treatment|Withdrawal by Subject|5
7755291|NCT00784277|26961287|P5|ER Treatment|Withdrawal by Subject|2
7755292|NCT00784277|26961288|P4|ER Treatment|Withdrawal by Subject|0
7755293|NCT00784277|26961289|P3|ER Treatment|Withdrawal by Subject|0
7755294|NCT00784277|26961290|P2|ER Treatment|Withdrawal by Subject|0
7755295|NCT00784277|26961291|P1|ER Treatment|Withdrawal by Subject|0
7755296|NCT00784277|26961285|P7|ER Treatment|Lost to Follow-up|0
7755297|NCT00784277|26961286|P6|ER Treatment|Lost to Follow-up|2
7755298|NCT00784277|26961287|P5|ER Treatment|Lost to Follow-up|0
7755299|NCT00784277|26961288|P4|ER Treatment|Lost to Follow-up|0
7755300|NCT00784277|26961289|P3|ER Treatment|Lost to Follow-up|0
7755301|NCT00784277|26961290|P2|ER Treatment|Lost to Follow-up|0
7755302|NCT00784277|26961291|P1|ER Treatment|Lost to Follow-up|0
7755303|NCT00784277|26961285|P7|ER Treatment|Lack of Efficacy|0
7755304|NCT00784277|26961286|P6|ER Treatment|Lack of Efficacy|4
7755305|NCT00784277|26961287|P5|ER Treatment|Lack of Efficacy|3
7755306|NCT00784277|26961288|P4|ER Treatment|Lack of Efficacy|0
7755307|NCT00784277|26961289|P3|ER Treatment|Lack of Efficacy|0
7755308|NCT00784277|26961290|P2|ER Treatment|Lack of Efficacy|0
7755309|NCT00784277|26961291|P1|ER Treatment|Lack of Efficacy|0
7755310|NCT00784277|26961285|P7|ER Treatment|Adverse Event|7
7755311|NCT00784277|26961286|P6|ER Treatment|Adverse Event|7
7755312|NCT00784277|26961287|P5|ER Treatment|Adverse Event|1
7755313|NCT00784277|26961288|P4|ER Treatment|Adverse Event|0
7755314|NCT00784277|26961289|P3|ER Treatment|Adverse Event|0
7755315|NCT00784277|26961290|P2|ER Treatment|Adverse Event|0
7755316|NCT00784277|26961291|P1|ER Treatment|Adverse Event|0
7755317|NCT00784277|26961285|P7|IR Treatment|Other|0
7755318|NCT00784277|26961286|P6|IR Treatment|Other|0
7755319|NCT00784277|26961287|P5|IR Treatment|Other|0
7755320|NCT00784277|26961288|P4|IR Treatment|Other|2
7755321|NCT00784277|26961289|P3|IR Treatment|Other|3
7755322|NCT00784277|26961290|P2|IR Treatment|Other|3
7755323|NCT00784277|26961291|P1|IR Treatment|Other|2
7755324|NCT00784277|26961285|P7|IR Treatment|Resolution Of Pain|0
7755325|NCT00784277|26961286|P6|IR Treatment|Resolution Of Pain|0
7755326|NCT00784277|26961287|P5|IR Treatment|Resolution Of Pain|0
7755327|NCT00784277|26961288|P4|IR Treatment|Resolution Of Pain|0
7755328|NCT00784277|26961289|P3|IR Treatment|Resolution Of Pain|0
7755329|NCT00784277|26961290|P2|IR Treatment|Resolution Of Pain|1
7755330|NCT00784277|26961291|P1|IR Treatment|Resolution Of Pain|0
7755331|NCT00784277|26961285|P7|IR Treatment|Withdrawal by Subject|0
7755332|NCT00784277|26961286|P6|IR Treatment|Withdrawal by Subject|0
7755333|NCT00784277|26961287|P5|IR Treatment|Withdrawal by Subject|0
7755334|NCT00784277|26961288|P4|IR Treatment|Withdrawal by Subject|6
7755335|NCT00784277|26961289|P3|IR Treatment|Withdrawal by Subject|4
7755336|NCT00784277|26961290|P2|IR Treatment|Withdrawal by Subject|1
7755337|NCT00784277|26961291|P1|IR Treatment|Withdrawal by Subject|5
7755338|NCT00784277|26961285|P7|IR Treatment|Lost to Follow-up|0
7755339|NCT00784277|26961286|P6|IR Treatment|Lost to Follow-up|0
7755340|NCT00784277|26961287|P5|IR Treatment|Lost to Follow-up|0
7755341|NCT00784277|26961288|P4|IR Treatment|Lost to Follow-up|0
7755342|NCT00784277|26961289|P3|IR Treatment|Lost to Follow-up|1
7755343|NCT00784277|26961290|P2|IR Treatment|Lost to Follow-up|0
7755344|NCT00784277|26961291|P1|IR Treatment|Lost to Follow-up|1
7755345|NCT00784277|26961285|P7|IR Treatment|Lack of Efficacy|0
7755346|NCT00784277|26961286|P6|IR Treatment|Lack of Efficacy|0
7755347|NCT00784277|26961287|P5|IR Treatment|Lack of Efficacy|0
7755348|NCT00784277|26961288|P4|IR Treatment|Lack of Efficacy|0
7755349|NCT00784277|26961289|P3|IR Treatment|Lack of Efficacy|1
7755350|NCT00784277|26961290|P2|IR Treatment|Lack of Efficacy|4
7755351|NCT00784277|26961291|P1|IR Treatment|Lack of Efficacy|4
7755352|NCT00784277|26961285|P7|IR Treatment|Adverse Event|0
7755353|NCT00784277|26961286|P6|IR Treatment|Adverse Event|0
7755354|NCT00784277|26961287|P5|IR Treatment|Adverse Event|0
7755355|NCT00784277|26961288|P4|IR Treatment|Adverse Event|35
7755356|NCT00784277|26961289|P3|IR Treatment|Adverse Event|19
7755357|NCT00784277|26961290|P2|IR Treatment|Adverse Event|8
7755358|NCT00784277|26961291|P1|IR Treatment|Adverse Event|4
7755359|NCT00784238|26961308|P1|Overall Study|Other|14
7755360|NCT00784238|26961308|P1|Overall Study|Withdrawal by Subject|26
7755361|NCT00784238|26961308|P1|Overall Study|Pregnancy|1
7755362|NCT00784238|26961308|P1|Overall Study|Lost to Follow-up|29
7755363|NCT00784238|26961308|P1|Overall Study|Lack of Efficacy|33
7755364|NCT00784238|26961308|P1|Overall Study|Death|2
7755365|NCT00784238|26961308|P1|Overall Study|Adverse Event|14
7755366|NCT00784147|26961380|P2|Overall Study|Death|0
7755367|NCT00784147|26961381|P1|Overall Study|Death|2
7755368|NCT00784147|26961380|P2|Overall Study|Protocol Violation|1
7755369|NCT00784147|26961381|P1|Overall Study|Protocol Violation|1
7755370|NCT00784147|26961380|P2|Overall Study|Physician Decision|1
7755371|NCT00784147|26961381|P1|Overall Study|Physician Decision|2
7755372|NCT00784147|26961380|P2|Overall Study|Withdrawal by Subject|3
7755373|NCT00784147|26961381|P1|Overall Study|Withdrawal by Subject|1
7755374|NCT00784147|26961380|P2|Overall Study|Lost to Follow-up|4
7755375|NCT00784147|26961381|P1|Overall Study|Lost to Follow-up|2
7755376|NCT00784134|26961401|P2|Overall Study|Lost to Follow-up|6
7755377|NCT00784134|26961402|P1|Overall Study|Lost to Follow-up|3
7755378|NCT00784043|26961525|P2|Overall Study|Protocol Terminated|1
7755379|NCT00784043|26961526|P1|Overall Study|Protocol Terminated|23
7755380|NCT00784043|26961525|P2|Overall Study|Withdrawal by Subject|5
7755381|NCT00784043|26961526|P1|Overall Study|Withdrawal by Subject|8
7755382|NCT00783835|26961561|P1|Overall Study|Participant not Adherent|3
7755383|NCT00783835|26961561|P1|Overall Study|Lost to Follow-up|1
7755384|NCT00783835|26961561|P1|Overall Study|Withdrawal by Subject|2
7755385|NCT00783835|26961561|P1|Overall Study|Medical Criteria|1
7755386|NCT00783835|26961561|P1|Overall Study|Adverse Event|3
7755387|NCT00783796|26961573|P1|Overall Study|Received commercial XIENCE V stent|1
7755388|NCT00783796|26961573|P1|Overall Study|Received non-XIENCE V stent|1
7755389|NCT00783796|26961573|P1|Overall Study|Did not receive any stent|4
7755390|NCT00783718|26961678|P7|Maintenance Phase|Lost to Follow-up|2
7755391|NCT00783718|26961679|P6|Maintenance Phase|Lost to Follow-up|0
7755392|NCT00783718|26961680|P5|Maintenance Phase|Lost to Follow-up|2
7755393|NCT00783718|26961681|P4|Maintenance Phase|Lost to Follow-up|0
7755394|NCT00783718|26961682|P3|Maintenance Phase|Lost to Follow-up|0
7755395|NCT00783718|26961683|P2|Maintenance Phase|Lost to Follow-up|0
7755396|NCT00783718|26961684|P1|Maintenance Phase|Lost to Follow-up|3
7755397|NCT00783718|26961678|P7|Maintenance Phase|Withdrawal by Subject|20
7755398|NCT00783718|26961679|P6|Maintenance Phase|Withdrawal by Subject|2
7755399|NCT00783718|26961680|P5|Maintenance Phase|Withdrawal by Subject|5
7755400|NCT00783718|26961681|P4|Maintenance Phase|Withdrawal by Subject|2
7755401|NCT00783718|26961682|P3|Maintenance Phase|Withdrawal by Subject|0
7755402|NCT00783718|26961683|P2|Maintenance Phase|Withdrawal by Subject|0
7755403|NCT00783718|26961684|P1|Maintenance Phase|Withdrawal by Subject|6
7755404|NCT00783718|26961678|P7|Maintenance Phase|Lack of Efficacy|155
7755405|NCT00783718|26961679|P6|Maintenance Phase|Lack of Efficacy|33
7755406|NCT00783718|26961680|P5|Maintenance Phase|Lack of Efficacy|31
7755407|NCT00783718|26961681|P4|Maintenance Phase|Lack of Efficacy|61
7755408|NCT00783718|26961682|P3|Maintenance Phase|Lack of Efficacy|0
7755409|NCT00783718|26961683|P2|Maintenance Phase|Lack of Efficacy|0
7755410|NCT00783718|26961684|P1|Maintenance Phase|Lack of Efficacy|83
7755411|NCT00783718|26961678|P7|Maintenance Phase|Protocol Violation|2
7755412|NCT00783718|26961679|P6|Maintenance Phase|Protocol Violation|0
7755413|NCT00783718|26961680|P5|Maintenance Phase|Protocol Violation|0
7755414|NCT00783718|26961681|P4|Maintenance Phase|Protocol Violation|0
7755415|NCT00783718|26961682|P3|Maintenance Phase|Protocol Violation|0
7755416|NCT00783718|26961683|P2|Maintenance Phase|Protocol Violation|0
7755417|NCT00783718|26961684|P1|Maintenance Phase|Protocol Violation|1
7755418|NCT00783718|26961678|P7|Maintenance Phase|Adverse Event|16
7755419|NCT00783718|26961679|P6|Maintenance Phase|Adverse Event|6
7755420|NCT00783718|26961680|P5|Maintenance Phase|Adverse Event|7
7755421|NCT00783718|26961681|P4|Maintenance Phase|Adverse Event|15
7755422|NCT00783718|26961682|P3|Maintenance Phase|Adverse Event|0
7755423|NCT00783718|26961683|P2|Maintenance Phase|Adverse Event|0
7755424|NCT00783718|26961684|P1|Maintenance Phase|Adverse Event|12
7755425|NCT00783718|26961678|P7|Induction Phase|Lost to Follow-up|0
7755426|NCT00783718|26961679|P6|Induction Phase|Lost to Follow-up|0
7755427|NCT00783718|26961680|P5|Induction Phase|Lost to Follow-up|0
7755428|NCT00783718|26961681|P4|Induction Phase|Lost to Follow-up|0
7755429|NCT00783718|26961682|P3|Induction Phase|Lost to Follow-up|1
7755430|NCT00783718|26961683|P2|Induction Phase|Lost to Follow-up|0
7755431|NCT00783718|26961684|P1|Induction Phase|Lost to Follow-up|1
7755432|NCT00783718|26961678|P7|Induction Phase|Withdrawal by Subject|0
7755433|NCT00783718|26961679|P6|Induction Phase|Withdrawal by Subject|0
7755434|NCT00783718|26961680|P5|Induction Phase|Withdrawal by Subject|0
7755435|NCT00783718|26961681|P4|Induction Phase|Withdrawal by Subject|0
7755436|NCT00783718|26961682|P3|Induction Phase|Withdrawal by Subject|8
7755437|NCT00783718|26961683|P2|Induction Phase|Withdrawal by Subject|4
7755438|NCT00783718|26961684|P1|Induction Phase|Withdrawal by Subject|3
7755439|NCT00783718|26961678|P7|Induction Phase|Lack of Efficacy|0
7755440|NCT00783718|26961679|P6|Induction Phase|Lack of Efficacy|0
7755441|NCT00783718|26961680|P5|Induction Phase|Lack of Efficacy|0
7755442|NCT00783718|26961681|P4|Induction Phase|Lack of Efficacy|0
7755443|NCT00783718|26961682|P3|Induction Phase|Lack of Efficacy|14
7755444|NCT00783718|26961683|P2|Induction Phase|Lack of Efficacy|2
7755445|NCT00783718|26961684|P1|Induction Phase|Lack of Efficacy|5
7755446|NCT00783718|26961678|P7|Induction Phase|Protocol Violation|0
7755447|NCT00783718|26961679|P6|Induction Phase|Protocol Violation|0
7755448|NCT00783718|26961680|P5|Induction Phase|Protocol Violation|0
7755449|NCT00783718|26961681|P4|Induction Phase|Protocol Violation|0
7755450|NCT00783718|26961682|P3|Induction Phase|Protocol Violation|6
7755451|NCT00783718|26961683|P2|Induction Phase|Protocol Violation|1
7755452|NCT00783718|26961684|P1|Induction Phase|Protocol Violation|1
7755453|NCT00783718|26961678|P7|Induction Phase|Adverse Event|0
7755454|NCT00783718|26961679|P6|Induction Phase|Adverse Event|0
7755455|NCT00783718|26961680|P5|Induction Phase|Adverse Event|0
7755456|NCT00783718|26961681|P4|Induction Phase|Adverse Event|0
7755457|NCT00783718|26961682|P3|Induction Phase|Adverse Event|7
7755458|NCT00783718|26961683|P2|Induction Phase|Adverse Event|0
7755459|NCT00783718|26961684|P1|Induction Phase|Adverse Event|4
7755460|NCT00783705|26961712|P2|Overall Study|Lost to Follow-up|3
7755461|NCT00783705|26961713|P1|Overall Study|Lost to Follow-up|1
7755462|NCT00783705|26961712|P2|Overall Study|Withdrawal by Subject|2
7755463|NCT00783705|26961713|P1|Overall Study|Withdrawal by Subject|3
7755464|NCT00783705|26961712|P2|Overall Study|Adverse Event|0
7755465|NCT00783705|26961713|P1|Overall Study|Adverse Event|2
7755466|NCT00783692|26961760|P7|Maintenance Phase|Other|1
7755467|NCT00783692|26961761|P6|Maintenance Phase|Other|1
7755468|NCT00783692|26961762|P5|Maintenance Phase|Other|0
7755469|NCT00783692|26961763|P4|Maintenance Phase|Other|1
7755470|NCT00783692|26961764|P3|Maintenance Phase|Other|0
7755471|NCT00783692|26961765|P2|Maintenance Phase|Other|0
7755472|NCT00783692|26961766|P1|Maintenance Phase|Other|0
7755473|NCT00783692|26961760|P7|Maintenance Phase|Lost to Follow-up|5
7755474|NCT00783692|26961761|P6|Maintenance Phase|Lost to Follow-up|2
7755475|NCT00783692|26961762|P5|Maintenance Phase|Lost to Follow-up|3
7755476|NCT00783692|26961763|P4|Maintenance Phase|Lost to Follow-up|1
7755477|NCT00783692|26961764|P3|Maintenance Phase|Lost to Follow-up|0
7755478|NCT00783692|26961765|P2|Maintenance Phase|Lost to Follow-up|0
7755479|NCT00783692|26961766|P1|Maintenance Phase|Lost to Follow-up|2
7755480|NCT00783692|26961760|P7|Maintenance Phase|Withdrawal by Subject|24
7755481|NCT00783692|26961761|P6|Maintenance Phase|Withdrawal by Subject|9
7755482|NCT00783692|26961762|P5|Maintenance Phase|Withdrawal by Subject|6
7755483|NCT00783692|26961763|P4|Maintenance Phase|Withdrawal by Subject|7
7755484|NCT00783692|26961764|P3|Maintenance Phase|Withdrawal by Subject|0
7755485|NCT00783692|26961765|P2|Maintenance Phase|Withdrawal by Subject|0
7755486|NCT00783692|26961766|P1|Maintenance Phase|Withdrawal by Subject|7
7755487|NCT00783692|26961760|P7|Maintenance Phase|Lack of Efficacy|177
7755488|NCT00783692|26961761|P6|Maintenance Phase|Lack of Efficacy|48
7755489|NCT00783692|26961762|P5|Maintenance Phase|Lack of Efficacy|58
7755490|NCT00783692|26961763|P4|Maintenance Phase|Lack of Efficacy|64
7755491|NCT00783692|26961764|P3|Maintenance Phase|Lack of Efficacy|0
7755492|NCT00783692|26961765|P2|Maintenance Phase|Lack of Efficacy|0
7755493|NCT00783692|26961766|P1|Maintenance Phase|Lack of Efficacy|79
7755494|NCT00783692|26961760|P7|Maintenance Phase|Protocol Violation|4
7755495|NCT00783692|26961761|P6|Maintenance Phase|Protocol Violation|3
7755496|NCT00783692|26961762|P5|Maintenance Phase|Protocol Violation|2
7755497|NCT00783692|26961763|P4|Maintenance Phase|Protocol Violation|1
7755498|NCT00783692|26961764|P3|Maintenance Phase|Protocol Violation|0
7755499|NCT00783692|26961765|P2|Maintenance Phase|Protocol Violation|0
7755500|NCT00783692|26961766|P1|Maintenance Phase|Protocol Violation|0
7755501|NCT00783692|26961760|P7|Maintenance Phase|Adverse Event|38
7755502|NCT00783692|26961761|P6|Maintenance Phase|Adverse Event|9
7755503|NCT00783692|26961762|P5|Maintenance Phase|Adverse Event|12
7755504|NCT00783692|26961763|P4|Maintenance Phase|Adverse Event|15
7755505|NCT00783692|26961764|P3|Maintenance Phase|Adverse Event|0
7755506|NCT00783692|26961765|P2|Maintenance Phase|Adverse Event|0
7755507|NCT00783692|26961766|P1|Maintenance Phase|Adverse Event|7
7755508|NCT00783692|26961760|P7|Induction Phase|Other|0
7755509|NCT00783692|26961761|P6|Induction Phase|Other|0
7755510|NCT00783692|26961762|P5|Induction Phase|Other|0
7755511|NCT00783692|26961763|P4|Induction Phase|Other|0
7755512|NCT00783692|26961764|P3|Induction Phase|Other|2
7755513|NCT00783692|26961765|P2|Induction Phase|Other|0
7755514|NCT00783692|26961766|P1|Induction Phase|Other|0
7755515|NCT00783692|26961760|P7|Induction Phase|Lost to Follow-up|0
7755516|NCT00783692|26961761|P6|Induction Phase|Lost to Follow-up|0
7755517|NCT00783692|26961762|P5|Induction Phase|Lost to Follow-up|0
7755518|NCT00783692|26961763|P4|Induction Phase|Lost to Follow-up|0
7755519|NCT00783692|26961764|P3|Induction Phase|Lost to Follow-up|3
7755520|NCT00783692|26961765|P2|Induction Phase|Lost to Follow-up|0
7755521|NCT00783692|26961766|P1|Induction Phase|Lost to Follow-up|0
7755522|NCT00783692|26961760|P7|Induction Phase|Withdrawal by Subject|0
7755523|NCT00783692|26961761|P6|Induction Phase|Withdrawal by Subject|0
7755524|NCT00783692|26961762|P5|Induction Phase|Withdrawal by Subject|0
7755525|NCT00783692|26961763|P4|Induction Phase|Withdrawal by Subject|0
7755526|NCT00783692|26961764|P3|Induction Phase|Withdrawal by Subject|16
7755527|NCT00783692|26961765|P2|Induction Phase|Withdrawal by Subject|9
7755528|NCT00783692|26961766|P1|Induction Phase|Withdrawal by Subject|3
7755529|NCT00783692|26961760|P7|Induction Phase|Lack of Efficacy|0
7755530|NCT00783692|26961761|P6|Induction Phase|Lack of Efficacy|0
7755531|NCT00783692|26961762|P5|Induction Phase|Lack of Efficacy|0
7755532|NCT00783692|26961763|P4|Induction Phase|Lack of Efficacy|0
7755533|NCT00783692|26961764|P3|Induction Phase|Lack of Efficacy|28
7755534|NCT00783692|26961765|P2|Induction Phase|Lack of Efficacy|3
7755535|NCT00783692|26961766|P1|Induction Phase|Lack of Efficacy|1
7755536|NCT00783692|26961760|P7|Induction Phase|Protocol Violation|0
7755537|NCT00783692|26961761|P6|Induction Phase|Protocol Violation|0
7755538|NCT00783692|26961762|P5|Induction Phase|Protocol Violation|0
7755539|NCT00783692|26961763|P4|Induction Phase|Protocol Violation|0
7755540|NCT00783692|26961764|P3|Induction Phase|Protocol Violation|1
7755541|NCT00783692|26961765|P2|Induction Phase|Protocol Violation|0
7755542|NCT00783692|26961766|P1|Induction Phase|Protocol Violation|0
7755543|NCT00783692|26961760|P7|Induction Phase|Adverse Event|0
7755544|NCT00783692|26961761|P6|Induction Phase|Adverse Event|0
7755545|NCT00783692|26961762|P5|Induction Phase|Adverse Event|0
7755546|NCT00783692|26961763|P4|Induction Phase|Adverse Event|0
7755547|NCT00783692|26961764|P3|Induction Phase|Adverse Event|24
7755548|NCT00783692|26961765|P2|Induction Phase|Adverse Event|9
7755549|NCT00783692|26961766|P1|Induction Phase|Adverse Event|7
7755550|NCT00783432|26961812|P2|Overall Study|Protocol Violation|9
7755551|NCT00783432|26961813|P1|Overall Study|Protocol Violation|6
7755552|NCT00783432|26961812|P2|Overall Study|subject moved|5
7755553|NCT00783432|26961813|P1|Overall Study|subject moved|3
7755554|NCT00783432|26961812|P2|Overall Study|Withdrawal by Subject|20
7755555|NCT00783432|26961813|P1|Overall Study|Withdrawal by Subject|23
7755556|NCT00783432|26961812|P2|Overall Study|Lost to Follow-up|6
7755557|NCT00783432|26961813|P1|Overall Study|Lost to Follow-up|11
7755558|NCT00783432|26961812|P2|Overall Study|Lack of Efficacy|21
7755559|NCT00783432|26961813|P1|Overall Study|Lack of Efficacy|20
7755560|NCT00783432|26961812|P2|Overall Study|Adverse Event|17
7755561|NCT00783432|26961813|P1|Overall Study|Adverse Event|22
7755562|NCT00783302|26961834|P1|Overall Study|Withdrawal by Subject|3
7755563|NCT00783302|26961834|P1|Overall Study|Physician Decision|1
7755564|NCT00783302|26961834|P1|Overall Study|Protocol Violation|3
7755565|NCT00783302|26961834|P1|Overall Study|Technical Problems|11
7755566|NCT00783302|26961834|P1|Overall Study|Lost to Follow-up|17
7755567|NCT00783289|26961856|P4|Overall Study|Protocol Violation|0
7755568|NCT00783289|26961857|P3|Overall Study|Protocol Violation|0
7755569|NCT00783289|26961858|P2|Overall Study|Protocol Violation|1
7755570|NCT00783289|26961859|P1|Overall Study|Protocol Violation|0
7755571|NCT00783263|26961889|P4|Overall Study|Withdrawal by Subject|2
7755572|NCT00783263|26961890|P3|Overall Study|Withdrawal by Subject|1
7755573|NCT00783263|26961891|P2|Overall Study|Withdrawal by Subject|1
7755574|NCT00783263|26961892|P1|Overall Study|Withdrawal by Subject|0
7755575|NCT00783263|26961889|P4|Overall Study|Lost to Follow-up|0
7755576|NCT00783263|26961890|P3|Overall Study|Lost to Follow-up|0
7755577|NCT00783263|26961891|P2|Overall Study|Lost to Follow-up|1
7755578|NCT00783263|26961892|P1|Overall Study|Lost to Follow-up|1
7755579|NCT00783263|26961889|P4|Overall Study|Adverse Event|1
7755580|NCT00783263|26961890|P3|Overall Study|Adverse Event|2
7755581|NCT00783263|26961891|P2|Overall Study|Adverse Event|0
7755582|NCT00783263|26961892|P1|Overall Study|Adverse Event|3
7755583|NCT00783224|26961922|P4|Overall Study|Inappropriate as a study subject|1
7755584|NCT00783224|26961923|P3|Overall Study|Inappropriate as a study subject|0
7755585|NCT00783224|26961924|P2|Overall Study|Inappropriate as a study subject|0
7755586|NCT00783224|26961925|P1|Overall Study|Inappropriate as a study subject|0
7755587|NCT00783224|26961922|P4|Overall Study|Discarded the Investigational Drug Used|1
7755588|NCT00783224|26961923|P3|Overall Study|Discarded the Investigational Drug Used|0
7755589|NCT00783224|26961924|P2|Overall Study|Discarded the Investigational Drug Used|0
7755590|NCT00783224|26961925|P1|Overall Study|Discarded the Investigational Drug Used|0
7755591|NCT00783224|26961922|P4|Overall Study|Adverse Event|0
7755592|NCT00783224|26961923|P3|Overall Study|Adverse Event|1
7755593|NCT00783224|26961924|P2|Overall Study|Adverse Event|0
7755594|NCT00783224|26961925|P1|Overall Study|Adverse Event|0
7755595|NCT00783198|26961937|P3|Overall Study|Administrative|2
7755596|NCT00783198|26961938|P2|Overall Study|Administrative|1
7755597|NCT00783198|26961939|P1|Overall Study|Administrative|2
7755598|NCT00783198|26961937|P3|Overall Study|Did not meet protocol eligibility|0
7755599|NCT00783198|26961938|P2|Overall Study|Did not meet protocol eligibility|1
7755600|NCT00783198|26961939|P1|Overall Study|Did not meet protocol eligibility|0
7755601|NCT00783198|26961937|P3|Overall Study|Noncompliance with protocol|10
7755602|NCT00783198|26961938|P2|Overall Study|Noncompliance with protocol|7
7755603|NCT00783198|26961939|P1|Overall Study|Noncompliance with protocol|7
7755604|NCT00783198|26961937|P3|Overall Study|Withdrawal by Subject|20
7755605|NCT00783198|26961938|P2|Overall Study|Withdrawal by Subject|14
7755606|NCT00783198|26961939|P1|Overall Study|Withdrawal by Subject|22
7755607|NCT00783198|26961937|P3|Overall Study|Lost to Follow-up|7
7755608|NCT00783198|26961938|P2|Overall Study|Lost to Follow-up|1
7755609|NCT00783198|26961939|P1|Overall Study|Lost to Follow-up|11
7755610|NCT00783198|26961937|P3|Overall Study|Adverse Event|3
7755611|NCT00783198|26961938|P2|Overall Study|Adverse Event|19
7755612|NCT00783198|26961939|P1|Overall Study|Adverse Event|15
7755613|NCT00783094|26961962|P3|Open-Label Extension Period|Lack of Efficacy|0
7755614|NCT00783094|26961963|P2|Open-Label Extension Period|Lack of Efficacy|4
7755615|NCT00783094|26961964|P1|Open-Label Extension Period|Lack of Efficacy|1
7755616|NCT00783094|26961962|P3|Open-Label Extension Period|Physician Decision|3
7755617|NCT00783094|26961963|P2|Open-Label Extension Period|Physician Decision|2
7755618|NCT00783094|26961964|P1|Open-Label Extension Period|Physician Decision|4
7755619|NCT00783094|26961962|P3|Open-Label Extension Period|Withdrawal by Subject|3
7755620|NCT00783094|26961963|P2|Open-Label Extension Period|Withdrawal by Subject|1
7755621|NCT00783094|26961964|P1|Open-Label Extension Period|Withdrawal by Subject|1
7755622|NCT00783094|26961962|P3|Open-Label Extension Period|Protocol Violation|7
7755623|NCT00783094|26961963|P2|Open-Label Extension Period|Protocol Violation|5
7755624|NCT00783094|26961964|P1|Open-Label Extension Period|Protocol Violation|4
7755625|NCT00783094|26961962|P3|Open-Label Extension Period|Death|1
7755626|NCT00783094|26961963|P2|Open-Label Extension Period|Death|0
7755627|NCT00783094|26961964|P1|Open-Label Extension Period|Death|0
7755628|NCT00783094|26961962|P3|Open-Label Extension Period|Adverse Event|16
7755629|NCT00783094|26961963|P2|Open-Label Extension Period|Adverse Event|7
7755630|NCT00783094|26961964|P1|Open-Label Extension Period|Adverse Event|12
7755631|NCT00783094|26961962|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
7755632|NCT00783094|26961963|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
7755633|NCT00783094|26961964|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
7755634|NCT00783094|26961962|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
7755635|NCT00783094|26961963|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
7755636|NCT00783094|26961964|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
7755637|NCT00783094|26961962|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
7755638|NCT00783094|26961963|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
7755639|NCT00783094|26961964|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
7755640|NCT00783094|26961962|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
7755641|NCT00783094|26961963|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
7755642|NCT00783094|26961964|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
7755643|NCT00783094|26961962|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
7755644|NCT00783094|26961963|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
7755645|NCT00783094|26961964|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
7755646|NCT00782834|26962040|P1|Treatment Phase|fibrous tumor not GIST|1
7755647|NCT00782795|26962080|P2|Overall Study|Withdrawal by Subject|2
7755648|NCT00782795|26962081|P1|Overall Study|Withdrawal by Subject|1
7755649|NCT00782717|26962121|P2|Overall Study|Exited in error|2
7755650|NCT00782717|26962122|P1|Overall Study|Exited in error|0
7755651|NCT00782717|26962121|P2|Overall Study|Did not meet entrance criteria|3
7755652|NCT00782717|26962122|P1|Overall Study|Did not meet entrance criteria|1
7755653|NCT00782717|26962121|P2|Overall Study|Enrollment close prior to surgery|0
7755654|NCT00782717|26962122|P1|Overall Study|Enrollment close prior to surgery|1
7755655|NCT00782717|26962121|P2|Overall Study|Treatment failure|14
7755656|NCT00782717|26962122|P1|Overall Study|Treatment failure|3
7755657|NCT00782717|26962121|P2|Overall Study|Noncompliance|1
7755658|NCT00782717|26962122|P1|Overall Study|Noncompliance|2
7755659|NCT00782717|26962121|P2|Overall Study|Patient decision unrelated to AE|3
7755660|NCT00782717|26962122|P1|Overall Study|Patient decision unrelated to AE|6
7755661|NCT00782717|26962121|P2|Overall Study|Adverse Event|5
7755662|NCT00782717|26962122|P1|Overall Study|Adverse Event|2
7755663|NCT00782626|26962149|P1|Overall Study|Other Complicating Disease|1
7755664|NCT00782626|26962149|P1|Overall Study|Progressive Disease|5
7755665|NCT00782626|26962149|P1|Overall Study|Adverse Event|1
7755666|NCT00782509|26962156|P3|Overall Study|Lack of Efficacy|2
7755667|NCT00782509|26962157|P2|Overall Study|Lack of Efficacy|5
7755668|NCT00782509|26962158|P1|Overall Study|Lack of Efficacy|10
7755669|NCT00782509|26962156|P3|Overall Study|Other reasons not stated above|3
7755670|NCT00782509|26962157|P2|Overall Study|Other reasons not stated above|2
7755671|NCT00782509|26962158|P1|Overall Study|Other reasons not stated above|5
7755672|NCT00782509|26962156|P3|Overall Study|Non compliance with protocol|0
7755673|NCT00782509|26962157|P2|Overall Study|Non compliance with protocol|0
7755674|NCT00782509|26962158|P1|Overall Study|Non compliance with protocol|2
7755675|NCT00782509|26962156|P3|Overall Study|Withdrawal by Subject|8
7755676|NCT00782509|26962157|P2|Overall Study|Withdrawal by Subject|5
7755677|NCT00782509|26962158|P1|Overall Study|Withdrawal by Subject|3
7755678|NCT00782509|26962156|P3|Overall Study|Lost to Follow-up|3
7755679|NCT00782509|26962157|P2|Overall Study|Lost to Follow-up|2
7755680|NCT00782509|26962158|P1|Overall Study|Lost to Follow-up|1
7755681|NCT00782509|26962156|P3|Overall Study|Adverse Event|20
7755682|NCT00782509|26962157|P2|Overall Study|Adverse Event|10
7755683|NCT00782509|26962158|P1|Overall Study|Adverse Event|20
7755684|NCT00782496|26962351|P2|Overall Study|Lost to Follow-up|15
7755685|NCT00782496|26962352|P1|Overall Study|Lost to Follow-up|14
7755686|NCT00782483|26962359|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
7755687|NCT00782418|26962363|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7755688|NCT00782418|26962364|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7755689|NCT00782418|26962365|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7755690|NCT00782418|26962366|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7755691|NCT00782418|26962367|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7755692|NCT00782418|26962368|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7755693|NCT00782418|26962369|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7755694|NCT00782418|26962363|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
7755695|NCT00782418|26962364|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
7755696|NCT00782418|26962365|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
7755697|NCT00782418|26962366|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
7755698|NCT00782418|26962367|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
7755699|NCT00782418|26962368|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
7755700|NCT00782418|26962369|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
7755701|NCT00782340|26962406|P3|Open Label Titration|Randomized in error|0
7755702|NCT00782340|26962407|P2|Open Label Titration|Randomized in error|0
7755703|NCT00782340|26962408|P1|Open Label Titration|Randomized in error|6
7755704|NCT00782340|26962406|P3|Open Label Titration|Lost to Follow-up|0
7755705|NCT00782340|26962407|P2|Open Label Titration|Lost to Follow-up|0
7755706|NCT00782340|26962408|P1|Open Label Titration|Lost to Follow-up|5
7755707|NCT00782340|26962406|P3|Open Label Titration|Did not meet responder criteria|0
7755708|NCT00782340|26962407|P2|Open Label Titration|Did not meet responder criteria|0
7755709|NCT00782340|26962408|P1|Open Label Titration|Did not meet responder criteria|2
7755710|NCT00782340|26962406|P3|Open Label Titration|Enrollment capped|0
7755711|NCT00782340|26962407|P2|Open Label Titration|Enrollment capped|0
7755712|NCT00782340|26962408|P1|Open Label Titration|Enrollment capped|16
7755713|NCT00782340|26962406|P3|Open Label Titration|Withdrawal by Subject|0
7755714|NCT00782340|26962407|P2|Open Label Titration|Withdrawal by Subject|0
7755715|NCT00782340|26962408|P1|Open Label Titration|Withdrawal by Subject|5
7755716|NCT00782340|26962406|P3|Open Label Titration|Protocol Violation|0
7755717|NCT00782340|26962407|P2|Open Label Titration|Protocol Violation|0
7755718|NCT00782340|26962408|P1|Open Label Titration|Protocol Violation|5
7755719|NCT00782340|26962406|P3|Open Label Titration|Treatment failure|0
7755720|NCT00782340|26962407|P2|Open Label Titration|Treatment failure|0
7755721|NCT00782340|26962408|P1|Open Label Titration|Treatment failure|50
7755722|NCT00782340|26962406|P3|Open Label Titration|Adverse Event|0
7755723|NCT00782340|26962407|P2|Open Label Titration|Adverse Event|0
7755724|NCT00782340|26962408|P1|Open Label Titration|Adverse Event|12
7755725|NCT00782275|26962478|P1|Overall Study|Other|3
7755726|NCT00782275|26962478|P1|Overall Study|Not started treatment|1
7755727|NCT00782275|26962478|P1|Overall Study|Physician Decision|4
7755728|NCT00782275|26962478|P1|Overall Study|Progressive Disease|21
7755729|NCT00782275|26962478|P1|Overall Study|Withdrawal by Subject|1
7755730|NCT00782275|26962478|P1|Overall Study|Adverse Event|11
7755731|NCT00782210|26962487|P3|Overall Study|Other reason not described above|3
7755732|NCT00782210|26962488|P2|Overall Study|Other reason not described above|2
7755733|NCT00782210|26962489|P1|Overall Study|Other reason not described above|3
7755734|NCT00782210|26962487|P3|Overall Study|Lack of Efficacy|1
7755735|NCT00782210|26962488|P2|Overall Study|Lack of Efficacy|4
7755736|NCT00782210|26962489|P1|Overall Study|Lack of Efficacy|13
7755737|NCT00782210|26962487|P3|Overall Study|Non compliance with protocol|2
7755738|NCT00782210|26962488|P2|Overall Study|Non compliance with protocol|3
7755739|NCT00782210|26962489|P1|Overall Study|Non compliance with protocol|0
7755740|NCT00782210|26962487|P3|Overall Study|Withdrawal by Subject|11
7755741|NCT00782210|26962488|P2|Overall Study|Withdrawal by Subject|8
7755742|NCT00782210|26962489|P1|Overall Study|Withdrawal by Subject|11
7755743|NCT00782210|26962487|P3|Overall Study|Lost to Follow-up|2
7755744|NCT00782210|26962488|P2|Overall Study|Lost to Follow-up|1
7755745|NCT00782210|26962489|P1|Overall Study|Lost to Follow-up|2
7755746|NCT00782210|26962487|P3|Overall Study|Adverse Event|16
7755747|NCT00782210|26962488|P2|Overall Study|Adverse Event|17
7755748|NCT00782210|26962489|P1|Overall Study|Adverse Event|21
7755749|NCT00782184|26962682|P2|Overall Study|Withdrawal by Subject|2
7755750|NCT00782184|26962683|P1|Overall Study|Withdrawal by Subject|3
7755751|NCT00782184|26962682|P2|Overall Study|Protocol Violation|1
7755752|NCT00782184|26962683|P1|Overall Study|Protocol Violation|0
7755753|NCT00782184|26962682|P2|Overall Study|Adverse Event|2
7755754|NCT00782184|26962683|P1|Overall Study|Adverse Event|1
7755755|NCT00782171|26962720|P2|Overall Study|not eligible|6
7755756|NCT00782171|26962721|P1|Overall Study|not eligible|8
7755757|NCT00782171|26962720|P2|Overall Study|others|9
7755758|NCT00782171|26962721|P1|Overall Study|others|7
7755759|NCT00782171|26962720|P2|Overall Study|complications|1
7755760|NCT00782171|26962721|P1|Overall Study|complications|3
7755761|NCT00782171|26962720|P2|Overall Study|Withdrawal by Subject|1
7755762|NCT00782171|26962721|P1|Overall Study|Withdrawal by Subject|2
7755763|NCT00782171|26962720|P2|Overall Study|Lost to Follow-up|2
7755764|NCT00782171|26962721|P1|Overall Study|Lost to Follow-up|2
7755765|NCT00782067|26962753|P1|Overall Study|Protocol deviation|2
7755766|NCT00782067|26962753|P1|Overall Study|Disease progression|43
7755767|NCT00782067|26962753|P1|Overall Study|Death|9
7755768|NCT00782067|26962753|P1|Overall Study|Administrative problems|14
7755769|NCT00782067|26962753|P1|Overall Study|Lost to Follow-up|2
7755770|NCT00782067|26962753|P1|Overall Study|Subject withdrew consent|11
7755771|NCT00782067|26962753|P1|Overall Study|Adverse Event|35
7755772|NCT00781963|26962765|P2|Overall Study|Refused follow-up|0
7755773|NCT00781963|26962766|P1|Overall Study|Refused follow-up|9
7755774|NCT00781963|26962765|P2|Overall Study|Withdrawal by Subject|1
7755775|NCT00781963|26962766|P1|Overall Study|Withdrawal by Subject|3
7755776|NCT00781963|26962765|P2|Overall Study|Lost to Follow-up|1
7755777|NCT00781963|26962766|P1|Overall Study|Lost to Follow-up|2
7755778|NCT00781963|26962765|P2|Overall Study|Death|0
7755779|NCT00781963|26962766|P1|Overall Study|Death|3
7755780|NCT00781937|26962795|P2|Follow up Period (Week 56-68)|Unclassified|4
7755781|NCT00781937|26962796|P1|Follow up Period (Week 56-68)|Unclassified|5
7755782|NCT00781937|26962795|P2|Follow up Period (Week 56-68)|Protocol Violation|1
7755783|NCT00781937|26962796|P1|Follow up Period (Week 56-68)|Protocol Violation|1
7755784|NCT00781937|26962795|P2|Main Trial Period Through Week 56|Unclassified|15
7755785|NCT00781937|26962796|P1|Main Trial Period Through Week 56|Unclassified|10
7755786|NCT00781937|26962795|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
7755787|NCT00781937|26962796|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
7755788|NCT00781937|26962795|P2|Main Trial Period Through Week 56|Protocol Violation|5
7755789|NCT00781937|26962796|P1|Main Trial Period Through Week 56|Protocol Violation|8
7755790|NCT00781937|26962795|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
7755791|NCT00781937|26962796|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
7755792|NCT00781937|26962795|P2|Main Trial Period Through Week 56|Adverse Event|18
7755793|NCT00781937|26962796|P1|Main Trial Period Through Week 56|Adverse Event|18
7755794|NCT00781911|26962854|P2|Overall Study|Sponsor Decision|0
7755795|NCT00781911|26962855|P1|Overall Study|Sponsor Decision|1
7755796|NCT00781911|26962854|P2|Overall Study|Physician Decision|2
7755797|NCT00781911|26962855|P1|Overall Study|Physician Decision|0
7755798|NCT00781911|26962854|P2|Overall Study|Withdrawal by Subject|2
7755799|NCT00781911|26962855|P1|Overall Study|Withdrawal by Subject|1
7755800|NCT00781911|26962854|P2|Overall Study|Adverse Event|4
7755801|NCT00781911|26962855|P1|Overall Study|Adverse Event|4
7755802|NCT00781885|26962890|P1|Overall Study|Physician Decision|1
7755803|NCT00781859|26962907|P2|Overall Study|Death|0
7755804|NCT00781859|26962908|P1|Overall Study|Death|3
7755805|NCT00781859|26962907|P2|Overall Study|Lost to Follow-up|3
7755806|NCT00781859|26962908|P1|Overall Study|Lost to Follow-up|6
7755807|NCT00781859|26962907|P2|Overall Study|Withdrawal by Subject|4
7755808|NCT00781859|26962908|P1|Overall Study|Withdrawal by Subject|8
7755809|NCT00781859|26962907|P2|Overall Study|Adverse Event|2
7755810|NCT00781859|26962908|P1|Overall Study|Adverse Event|2
7755811|NCT00781768|26962918|P2|Overall Study|Not transplanted.|2
7755812|NCT00781768|26962919|P1|Overall Study|Not transplanted.|0
7755813|NCT00781599|26962927|P2|Overall Study|Lost to Follow-up|4
7755814|NCT00781599|26962928|P1|Overall Study|Lost to Follow-up|7
7755815|NCT00781456|26962953|P2|Overall Study|Other Reason, Unknown|1
7755816|NCT00781456|26962954|P1|Overall Study|Other Reason, Unknown|0
7755817|NCT00781456|26962953|P2|Overall Study|Lost to Follow-up|5
7755818|NCT00781456|26962954|P1|Overall Study|Lost to Follow-up|10
7755819|NCT00781456|26962953|P2|Overall Study|Noncompliance With Protocol|1
7755820|NCT00781456|26962954|P1|Overall Study|Noncompliance With Protocol|1
7755821|NCT00781456|26962953|P2|Overall Study|Protocol Violation|1
7755822|NCT00781456|26962954|P1|Overall Study|Protocol Violation|4
7755823|NCT00781456|26962953|P2|Overall Study|Withdrawal by Subject|5
7755824|NCT00781456|26962954|P1|Overall Study|Withdrawal by Subject|3
7755825|NCT00781456|26962953|P2|Overall Study|Adverse Event|3
7755826|NCT00781456|26962954|P1|Overall Study|Adverse Event|3
7755827|NCT00781391|26962977|P3|Overall Study|Lost to Follow-up|1
7755828|NCT00781391|26962978|P2|Overall Study|Lost to Follow-up|0
7755829|NCT00781391|26962979|P1|Overall Study|Lost to Follow-up|0
7755830|NCT00781391|26962977|P3|Overall Study|Withdrawal by Subject|25
7755831|NCT00781391|26962978|P2|Overall Study|Withdrawal by Subject|37
7755832|NCT00781391|26962979|P1|Overall Study|Withdrawal by Subject|47
7755833|NCT00781391|26962977|P3|Overall Study|Death|706
7755834|NCT00781391|26962978|P2|Overall Study|Death|730
7755835|NCT00781391|26962979|P1|Overall Study|Death|789
7755836|NCT00781391|26962977|P3|Overall Study|Protocol Violation|20
7755837|NCT00781391|26962978|P2|Overall Study|Protocol Violation|17
7755838|NCT00781391|26962979|P1|Overall Study|Protocol Violation|19
7755839|NCT00781391|26962977|P3|Overall Study|never received study drug|32
7755840|NCT00781391|26962978|P2|Overall Study|never received study drug|23
7755841|NCT00781391|26962979|P1|Overall Study|never received study drug|24
7755842|NCT00781365|26963013|P2|Overall Study|Language barrier|0
7755843|NCT00781365|26963014|P1|Overall Study|Language barrier|1
7755844|NCT00781365|26963013|P2|Overall Study|Did Not Attend Visit|28
7755845|NCT00781365|26963014|P1|Overall Study|Did Not Attend Visit|20
7755846|NCT00781365|26963013|P2|Overall Study|Withdrawal by Subject|8
7755847|NCT00781365|26963014|P1|Overall Study|Withdrawal by Subject|13
7755848|NCT00781326|26963024|P1|Phase I|Physician Decision|2
7755849|NCT00781326|26963024|P1|Phase I|Withdrawal by Subject|1
7755850|NCT00781326|26963024|P1|Phase I|Adverse Event|1
7755851|NCT00781274|26963028|P1|Overall Study|Withdrawal by Subject|2
7755852|NCT00780975|26963051|P1|Overall Study|Toxicity|5
7755853|NCT00780975|26963051|P1|Overall Study|Progressive disease|3
7755854|NCT00780910|26963069|P1|Overall Study|Adverse Event|2
7755855|NCT00780559|26963131|P2|Overall Study|Death|0
7755856|NCT00780559|26963132|P1|Overall Study|Death|1
7755857|NCT00780559|26963131|P2|Overall Study|Lost to Follow-up|7
7755858|NCT00780559|26963132|P1|Overall Study|Lost to Follow-up|2
7755859|NCT00780416|26963200|P2|Overall Study|Withdrawal by Subject|6
7755860|NCT00780416|26963201|P1|Overall Study|Withdrawal by Subject|8
7755861|NCT00780416|26963200|P2|Overall Study|Protocol Violation|0
7755862|NCT00780416|26963201|P1|Overall Study|Protocol Violation|1
7755863|NCT00780416|26963200|P2|Overall Study|Physician Decision|3
7755864|NCT00780416|26963201|P1|Overall Study|Physician Decision|3
7755865|NCT00780273|26963246|P1|Overall Study|Lost to Follow-up|1
7755866|NCT00780273|26963246|P1|Overall Study|Death|1
7755867|NCT00780143|26963269|P1|Overall Study|Adverse Event|1
7755868|NCT00780143|26963269|P1|Overall Study|Toxicity|1
7755869|NCT00780143|26963269|P1|Overall Study|Progressive disease|1
7755870|NCT00779909|26963300|P4|Overall Study|Withdrawal by Subject|0
7755871|NCT00779909|26963301|P3|Overall Study|Withdrawal by Subject|0
7755872|NCT00779909|26963302|P2|Overall Study|Withdrawal by Subject|1
7755873|NCT00779909|26963303|P1|Overall Study|Withdrawal by Subject|0
7755874|NCT00779909|26963300|P4|Overall Study|Lost to Follow-up|1
7755875|NCT00779909|26963301|P3|Overall Study|Lost to Follow-up|0
7755876|NCT00779909|26963302|P2|Overall Study|Lost to Follow-up|0
7755877|NCT00779909|26963303|P1|Overall Study|Lost to Follow-up|1
7755878|NCT00779857|26963367|P1|Overall Study|Missed Visit|2
7755879|NCT00779857|26963367|P1|Overall Study|Withdrawal by Subject|3
7755880|NCT00779857|26963367|P1|Overall Study|Death|1
7755881|NCT00779779|26963372|P1|Overall Study|Lost to Follow-up|5
7755882|NCT00779779|26963372|P1|Overall Study|Withdrawal by Subject|4
7755883|NCT00779779|26963372|P1|Overall Study|Protocol Violation|14
7755884|NCT00779779|26963372|P1|Overall Study|Adverse Event|1
7755885|NCT00779766|26963381|P2|Month 72|Other|1
7755886|NCT00779766|26963382|P1|Month 72|Other|0
7755887|NCT00779766|26963381|P2|Month 72|Lost to Follow-up|8
7755888|NCT00779766|26963382|P1|Month 72|Lost to Follow-up|6
7755889|NCT00779766|26963381|P2|Month 72|Migrated/moved from study area|109
7755890|NCT00779766|26963382|P1|Month 72|Migrated/moved from study area|124
7755891|NCT00779766|26963381|P2|Month 72|Withdrawal by Subject|71
7755892|NCT00779766|26963382|P1|Month 72|Withdrawal by Subject|55
7755893|NCT00779766|26963381|P2|Month 48|Other|0
7755894|NCT00779766|26963382|P1|Month 48|Other|1
7755895|NCT00779766|26963381|P2|Month 48|Lost to Follow-up|30
7755896|NCT00779766|26963382|P1|Month 48|Lost to Follow-up|29
7755897|NCT00779766|26963381|P2|Month 48|Migrated/moved from study area|75
7755898|NCT00779766|26963382|P1|Month 48|Migrated/moved from study area|76
7755899|NCT00779766|26963381|P2|Month 48|Withdrawal by Subject|63
7755900|NCT00779766|26963382|P1|Month 48|Withdrawal by Subject|68
7755901|NCT00779766|26963381|P2|Month 24|Other|27
7755902|NCT00779766|26963382|P1|Month 24|Other|18
7755903|NCT00779766|26963381|P2|Month 24|Lost to Follow-up|9
7755904|NCT00779766|26963382|P1|Month 24|Lost to Follow-up|9
7755905|NCT00779766|26963381|P2|Month 24|Migrated/moved from study area|162
7755906|NCT00779766|26963382|P1|Month 24|Migrated/moved from study area|138
7755907|NCT00779766|26963381|P2|Month 24|Withdrawal by Subject|127
7755908|NCT00779766|26963382|P1|Month 24|Withdrawal by Subject|159
7755909|NCT00779766|26963381|P2|Month 24|Protocol Violation|1
7755910|NCT00779766|26963382|P1|Month 24|Protocol Violation|3
7755911|NCT00779766|26963381|P2|Month 24|Adverse Event|3
7755912|NCT00779766|26963382|P1|Month 24|Adverse Event|3
7755913|NCT00779766|26963381|P2|Month 24|Serious Adverse Event|3
7755914|NCT00779766|26963382|P1|Month 24|Serious Adverse Event|2
7755915|NCT00779675|26963470|P1|Extended Treatment Period|Lost to Follow-up|6
7755916|NCT00779675|26963470|P1|Extended Treatment Period|Protocol defined clinical event|1
7755917|NCT00779675|26963470|P1|Extended Treatment Period|Treatment Failure|11
7755918|NCT00779675|26963470|P1|Extended Treatment Period|Adverse Event|6
7755919|NCT00779675|26963470|P1|Extended Treatment Period|Protocol Violation|13
7755920|NCT00779675|26963470|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
7755921|NCT00779675|26963470|P1|Treatment Period|Administrative|3
7755922|NCT00779675|26963470|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
7755923|NCT00779675|26963470|P1|Treatment Period|Protocol Violation|54
7755924|NCT00779675|26963470|P1|Treatment Period|Withdrawal by Subject|46
7755925|NCT00779675|26963470|P1|Treatment Period|Lost to Follow-up|23
7755926|NCT00779675|26963470|P1|Treatment Period|Transferred to Another Study|38
7755927|NCT00779675|26963470|P1|Treatment Period|Treatment Failure|80
7755928|NCT00779675|26963470|P1|Treatment Period|Adverse Event|87
7755929|NCT00779584|26963498|P9|Overall Study|Ongoing in Study|0
7755930|NCT00779584|26963499|P8|Overall Study|Ongoing in Study|0
7755931|NCT00779584|26963500|P7|Overall Study|Ongoing in Study|0
7755932|NCT00779584|26963501|P6|Overall Study|Ongoing in Study|1
7755933|NCT00779584|26963502|P5|Overall Study|Ongoing in Study|1
7755934|NCT00779584|26963503|P4|Overall Study|Ongoing in Study|0
7755935|NCT00779584|26963504|P3|Overall Study|Ongoing in Study|0
7755936|NCT00779584|26963505|P2|Overall Study|Ongoing in Study|0
7755937|NCT00779584|26963506|P1|Overall Study|Ongoing in Study|0
7755938|NCT00779584|26963498|P9|Overall Study|Symptomatic Deterioration|0
7755939|NCT00779584|26963499|P8|Overall Study|Symptomatic Deterioration|0
7755940|NCT00779584|26963500|P7|Overall Study|Symptomatic Deterioration|1
7755941|NCT00779584|26963501|P6|Overall Study|Symptomatic Deterioration|1
7755942|NCT00779584|26963502|P5|Overall Study|Symptomatic Deterioration|0
7755943|NCT00779584|26963503|P4|Overall Study|Symptomatic Deterioration|0
7755944|NCT00779584|26963504|P3|Overall Study|Symptomatic Deterioration|1
7755945|NCT00779584|26963505|P2|Overall Study|Symptomatic Deterioration|1
7755946|NCT00779584|26963506|P1|Overall Study|Symptomatic Deterioration|1
7755947|NCT00779584|26963498|P9|Overall Study|Adverse Event|1
7755948|NCT00779584|26963499|P8|Overall Study|Adverse Event|1
7755949|NCT00779584|26963500|P7|Overall Study|Adverse Event|2
7755950|NCT00779584|26963501|P6|Overall Study|Adverse Event|0
7755951|NCT00779584|26963502|P5|Overall Study|Adverse Event|0
7755952|NCT00779584|26963503|P4|Overall Study|Adverse Event|0
7755953|NCT00779584|26963504|P3|Overall Study|Adverse Event|2
7755954|NCT00779584|26963505|P2|Overall Study|Adverse Event|0
7755955|NCT00779584|26963506|P1|Overall Study|Adverse Event|1
7755956|NCT00779584|26963498|P9|Overall Study|Progression of Disease|1
7755957|NCT00779584|26963499|P8|Overall Study|Progression of Disease|2
7755958|NCT00779584|26963500|P7|Overall Study|Progression of Disease|4
7755959|NCT00779584|26963501|P6|Overall Study|Progression of Disease|1
7755960|NCT00779584|26963502|P5|Overall Study|Progression of Disease|5
7755961|NCT00779584|26963503|P4|Overall Study|Progression of Disease|6
7755962|NCT00779584|26963504|P3|Overall Study|Progression of Disease|2
7755963|NCT00779584|26963505|P2|Overall Study|Progression of Disease|1
7755964|NCT00779584|26963506|P1|Overall Study|Progression of Disease|0
7755965|NCT00779584|26963498|P9|Overall Study|Lost to Follow-up|0
7755966|NCT00779584|26963499|P8|Overall Study|Lost to Follow-up|0
7755967|NCT00779584|26963500|P7|Overall Study|Lost to Follow-up|0
7755968|NCT00779584|26963501|P6|Overall Study|Lost to Follow-up|0
7755969|NCT00779584|26963502|P5|Overall Study|Lost to Follow-up|1
7755970|NCT00779584|26963503|P4|Overall Study|Lost to Follow-up|0
7755971|NCT00779584|26963504|P3|Overall Study|Lost to Follow-up|0
7755972|NCT00779584|26963505|P2|Overall Study|Lost to Follow-up|0
7755973|NCT00779584|26963506|P1|Overall Study|Lost to Follow-up|0
7755974|NCT00779584|26963498|P9|Overall Study|Withdrawal by Subject|0
7755975|NCT00779584|26963499|P8|Overall Study|Withdrawal by Subject|0
7755976|NCT00779584|26963500|P7|Overall Study|Withdrawal by Subject|1
7755977|NCT00779584|26963501|P6|Overall Study|Withdrawal by Subject|2
7755978|NCT00779584|26963502|P5|Overall Study|Withdrawal by Subject|0
7755979|NCT00779584|26963503|P4|Overall Study|Withdrawal by Subject|0
7755980|NCT00779584|26963504|P3|Overall Study|Withdrawal by Subject|2
7755981|NCT00779584|26963505|P2|Overall Study|Withdrawal by Subject|1
7755982|NCT00779584|26963506|P1|Overall Study|Withdrawal by Subject|1
7755983|NCT00779584|26963498|P9|Overall Study|Protocol Violation|0
7755984|NCT00779584|26963499|P8|Overall Study|Protocol Violation|0
7755985|NCT00779584|26963500|P7|Overall Study|Protocol Violation|0
7755986|NCT00779584|26963501|P6|Overall Study|Protocol Violation|1
7755987|NCT00779584|26963502|P5|Overall Study|Protocol Violation|0
7755988|NCT00779584|26963503|P4|Overall Study|Protocol Violation|0
7755989|NCT00779584|26963504|P3|Overall Study|Protocol Violation|0
7755990|NCT00779584|26963505|P2|Overall Study|Protocol Violation|0
7755991|NCT00779584|26963506|P1|Overall Study|Protocol Violation|0
7755992|NCT00779506|26963597|P1|Overall Study|Lost to Follow-up|1
7755993|NCT00779506|26963597|P1|Overall Study|Withdrawal by Subject|6
7755994|NCT00779506|26963597|P1|Overall Study|Protocol Violation|5
7755995|NCT00779506|26963597|P1|Overall Study|Lack of Efficacy|11
7755996|NCT00779506|26963597|P1|Overall Study|Adverse Event|4
7755997|NCT00779506|26963597|P1|Overall Study|Screening Failed|2
7755998|NCT00779467|26963611|P4|Overall Study|unavailable research staff|1
7755999|NCT00779467|26963612|P3|Overall Study|unavailable research staff|0
7756000|NCT00779467|26963613|P2|Overall Study|unavailable research staff|0
7756001|NCT00779467|26963614|P1|Overall Study|unavailable research staff|0
7756002|NCT00779467|26963611|P4|Overall Study|technical issue|1
7756003|NCT00779467|26963612|P3|Overall Study|technical issue|2
7756004|NCT00779467|26963613|P2|Overall Study|technical issue|0
7756005|NCT00779467|26963614|P1|Overall Study|technical issue|0
7756006|NCT00779467|26963611|P4|Overall Study|missing data|4
7756007|NCT00779467|26963612|P3|Overall Study|missing data|1
7756008|NCT00779467|26963613|P2|Overall Study|missing data|0
7756009|NCT00779467|26963614|P1|Overall Study|missing data|1
7756010|NCT00779467|26963611|P4|Overall Study|failed inclusion criteria|2
7756011|NCT00779467|26963612|P3|Overall Study|failed inclusion criteria|1
7756012|NCT00779467|26963613|P2|Overall Study|failed inclusion criteria|3
7756013|NCT00779467|26963614|P1|Overall Study|failed inclusion criteria|3
7756014|NCT00779467|26963611|P4|Overall Study|Lack of Efficacy|11
7756015|NCT00779467|26963612|P3|Overall Study|Lack of Efficacy|6
7756016|NCT00779467|26963613|P2|Overall Study|Lack of Efficacy|2
7756017|NCT00779467|26963614|P1|Overall Study|Lack of Efficacy|11
7756018|NCT00779402|26963654|P2|Long-term Follow-up|Completed Protocol Visits|2
7756019|NCT00779402|26963655|P1|Long-term Follow-up|Completed Protocol Visits|6
7756020|NCT00779402|26963654|P2|Long-term Follow-up|Closure of Study|4
7756021|NCT00779402|26963655|P1|Long-term Follow-up|Closure of Study|8
7756022|NCT00779402|26963654|P2|Long-term Follow-up|Other|0
7756023|NCT00779402|26963655|P1|Long-term Follow-up|Other|5
7756024|NCT00779402|26963654|P2|Long-term Follow-up|Patient refused to continue|0
7756025|NCT00779402|26963655|P1|Long-term Follow-up|Patient refused to continue|2
7756026|NCT00779402|26963654|P2|Surveillance Phase|Completed Protocol Visits|2
7756027|NCT00779402|26963655|P1|Surveillance Phase|Completed Protocol Visits|3
7756028|NCT00779402|26963654|P2|Surveillance Phase|Closure of study|6
7756029|NCT00779402|26963655|P1|Surveillance Phase|Closure of study|5
7756030|NCT00779402|26963654|P2|Surveillance Phase|Withdrawal by Subject|1
7756031|NCT00779402|26963655|P1|Surveillance Phase|Withdrawal by Subject|4
7756032|NCT00779402|26963654|P2|Surveillance Phase|Other|5
7756033|NCT00779402|26963655|P1|Surveillance Phase|Other|5
7756034|NCT00779402|26963654|P2|Surveillance Phase|Intercurrent Illness|0
7756035|NCT00779402|26963655|P1|Surveillance Phase|Intercurrent Illness|2
7756036|NCT00779402|26963654|P2|Surveillance Phase|Death|1
7756037|NCT00779402|26963655|P1|Surveillance Phase|Death|0
7756038|NCT00779402|26963654|P2|Surveillance Phase|Lost to Follow-up|1
7756039|NCT00779402|26963655|P1|Surveillance Phase|Lost to Follow-up|2
7756040|NCT00779402|26963654|P2|Surveillance Phase|Patient refused to continue|14
7756041|NCT00779402|26963655|P1|Surveillance Phase|Patient refused to continue|22
7756042|NCT00779402|26963654|P2|Surveillance Phase|Protocol Violation|1
7756043|NCT00779402|26963655|P1|Surveillance Phase|Protocol Violation|0
7756044|NCT00779402|26963654|P2|Treatment Phase 1|Completed Protocol Visits|6
7756045|NCT00779402|26963655|P1|Treatment Phase 1|Completed Protocol Visits|3
7756046|NCT00779402|26963654|P2|Treatment Phase 1|Closure of Study|2
7756047|NCT00779402|26963655|P1|Treatment Phase 1|Closure of Study|3
7756048|NCT00779402|26963654|P2|Treatment Phase 1|Other|2
7756049|NCT00779402|26963655|P1|Treatment Phase 1|Other|4
7756050|NCT00779402|26963654|P2|Treatment Phase 1|Withdrawal by Subject|0
7756051|NCT00779402|26963655|P1|Treatment Phase 1|Withdrawal by Subject|1
7756052|NCT00779402|26963654|P2|Treatment Phase 1|Intercurrent Illness|1
7756053|NCT00779402|26963655|P1|Treatment Phase 1|Intercurrent Illness|1
7756054|NCT00779402|26963654|P2|Treatment Phase 1|Death|1
7756055|NCT00779402|26963655|P1|Treatment Phase 1|Death|0
7756056|NCT00779402|26963654|P2|Treatment Phase 1|Lost to Follow-up|1
7756057|NCT00779402|26963655|P1|Treatment Phase 1|Lost to Follow-up|0
7756058|NCT00779402|26963654|P2|Treatment Phase 1|Patient Refused to Continue|2
7756059|NCT00779402|26963655|P1|Treatment Phase 1|Patient Refused to Continue|17
7756060|NCT00779402|26963654|P2|Treatment Phase 1|Protocol Violation|0
7756061|NCT00779402|26963655|P1|Treatment Phase 1|Protocol Violation|1
7756062|NCT00779402|26963654|P2|Treatment Phase 1|Adverse Event|0
7756063|NCT00779402|26963655|P1|Treatment Phase 1|Adverse Event|2
7756064|NCT00779402|26963654|P2|Treatment Phase 1|Disease Progression|0
7756065|NCT00779402|26963655|P1|Treatment Phase 1|Disease Progression|1
7756066|NCT00779324|26963665|P2|Overall Study|Missed visit|1
7756067|NCT00779324|26963666|P1|Overall Study|Missed visit|1
7756068|NCT00779324|26963665|P2|Overall Study|Withdrawal by Subject|2
7756069|NCT00779324|26963666|P1|Overall Study|Withdrawal by Subject|4
7756070|NCT00779324|26963665|P2|Overall Study|Lost to Follow-up|1
7756071|NCT00779324|26963666|P1|Overall Study|Lost to Follow-up|2
7756072|NCT00779259|26963725|P1|Quinine Alone|Adverse Event|2
7756073|NCT00779246|26963746|P2|Overall Study|Missing sufficient data for analysis|53
7756074|NCT00779246|26963747|P1|Overall Study|Missing sufficient data for analysis|33
7756075|NCT00779142|26963766|P1|Overall Study|Screen Failures|3
7756076|NCT00779038|26963798|P1|Overall Study|Study Prematurely Terminated|13
7756077|NCT00779025|26963807|P1|Overall Study|Withdrawal by Subject|1
7756078|NCT00778999|26963818|P2|Overall Study|Did not receive recFSH|20
7756079|NCT00778999|26963819|P1|Overall Study|Did not receive recFSH|14
7756080|NCT00778999|26963818|P2|Overall Study|Discontinuation: no embryo transfer|14
7756081|NCT00778999|26963819|P1|Overall Study|Discontinuation: no embryo transfer|14
7756082|NCT00778921|26963828|P3|Overall Study|Not treated|2
7756083|NCT00778921|26963829|P2|Overall Study|Not treated|2
7756084|NCT00778921|26963830|P1|Overall Study|Not treated|0
7756085|NCT00778921|26963828|P3|Overall Study|Protocol Violation|2
7756086|NCT00778921|26963829|P2|Overall Study|Protocol Violation|0
7756087|NCT00778921|26963830|P1|Overall Study|Protocol Violation|3
7756088|NCT00778921|26963828|P3|Overall Study|Administrative Problems|0
7756089|NCT00778921|26963829|P2|Overall Study|Administrative Problems|2
7756090|NCT00778921|26963830|P1|Overall Study|Administrative Problems|1
7756091|NCT00778921|26963828|P3|Overall Study|Lost to Follow-up|1
7756092|NCT00778921|26963829|P2|Overall Study|Lost to Follow-up|2
7756093|NCT00778921|26963830|P1|Overall Study|Lost to Follow-up|0
7756094|NCT00778921|26963828|P3|Overall Study|Patient withdrew request|6
7756095|NCT00778921|26963829|P2|Overall Study|Patient withdrew request|1
7756096|NCT00778921|26963830|P1|Overall Study|Patient withdrew request|3
7756097|NCT00778921|26963828|P3|Overall Study|Patient No Longer Requires Study Drug|0
7756098|NCT00778921|26963829|P2|Overall Study|Patient No Longer Requires Study Drug|1
7756099|NCT00778921|26963830|P1|Overall Study|Patient No Longer Requires Study Drug|0
7756100|NCT00778921|26963828|P3|Overall Study|Unsatisfactory therapeutic response|1
7756101|NCT00778921|26963829|P2|Overall Study|Unsatisfactory therapeutic response|1
7756102|NCT00778921|26963830|P1|Overall Study|Unsatisfactory therapeutic response|1
7756103|NCT00778921|26963828|P3|Overall Study|Abnormal Test Procedure Result(s)|2
7756104|NCT00778921|26963829|P2|Overall Study|Abnormal Test Procedure Result(s)|0
7756105|NCT00778921|26963830|P1|Overall Study|Abnormal Test Procedure Result(s)|0
7756106|NCT00778921|26963828|P3|Overall Study|Abnormal Laboratory Value(s)|0
7756107|NCT00778921|26963829|P2|Overall Study|Abnormal Laboratory Value(s)|0
7756108|NCT00778921|26963830|P1|Overall Study|Abnormal Laboratory Value(s)|1
7756109|NCT00778921|26963828|P3|Overall Study|Adverse Event|14
7756110|NCT00778921|26963829|P2|Overall Study|Adverse Event|10
7756111|NCT00778921|26963830|P1|Overall Study|Adverse Event|9
7756112|NCT00778895|26963847|P3|ESFU Phase|Other|0
7756113|NCT00778895|26963848|P2|ESFU Phase|Other|0
7756114|NCT00778895|26963849|P1|ESFU Phase|Other|2
7756115|NCT00778895|26963847|P3|ESFU Phase|Lost to Follow-up|2
7756116|NCT00778895|26963848|P2|ESFU Phase|Lost to Follow-up|7
7756117|NCT00778895|26963849|P1|ESFU Phase|Lost to Follow-up|6
7756118|NCT00778895|26963847|P3|ESFU Phase|Withdrawal by Subject|0
7756119|NCT00778895|26963848|P2|ESFU Phase|Withdrawal by Subject|4
7756120|NCT00778895|26963849|P1|ESFU Phase|Withdrawal by Subject|1
7756121|NCT00778895|26963847|P3|ESFU Phase|Adverse Event|0
7756122|NCT00778895|26963848|P2|ESFU Phase|Adverse Event|1
7756123|NCT00778895|26963849|P1|ESFU Phase|Adverse Event|2
7756124|NCT00778895|26963847|P3|Active Phase|Other|0
7756125|NCT00778895|26963848|P2|Active Phase|Other|0
7756126|NCT00778895|26963849|P1|Active Phase|Other|2
7756127|NCT00778895|26963847|P3|Active Phase|Lost to Follow-up|0
7756128|NCT00778895|26963848|P2|Active Phase|Lost to Follow-up|1
7756129|NCT00778895|26963849|P1|Active Phase|Lost to Follow-up|1
7756130|NCT00778895|26963847|P3|Active Phase|Withdrawal by Subject|0
7756131|NCT00778895|26963848|P2|Active Phase|Withdrawal by Subject|4
7756132|NCT00778895|26963849|P1|Active Phase|Withdrawal by Subject|1
7756133|NCT00778895|26963847|P3|Active Phase|Adverse Event|0
7756134|NCT00778895|26963848|P2|Active Phase|Adverse Event|1
7756135|NCT00778895|26963849|P1|Active Phase|Adverse Event|3
7756136|NCT00778830|26963893|P2|Overall Study|Ongoing at data cut-off|1
7756137|NCT00778830|26963894|P1|Overall Study|Ongoing at data cut-off|0
7756138|NCT00778817|26963906|P1|Overall Study|Withdrawal by Subject|2
7756139|NCT00778817|26963906|P1|Overall Study|Adverse Event|2
7756140|NCT00778622|26963933|P3|Overall Study|Other|1
7756141|NCT00778622|26963934|P2|Overall Study|Other|0
7756142|NCT00778622|26963935|P1|Overall Study|Other|1
7756143|NCT00778622|26963933|P3|Overall Study|immigration|0
7756144|NCT00778622|26963934|P2|Overall Study|immigration|0
7756145|NCT00778622|26963935|P1|Overall Study|immigration|1
7756146|NCT00778622|26963933|P3|Overall Study|Lack of Efficacy|0
7756147|NCT00778622|26963934|P2|Overall Study|Lack of Efficacy|0
7756148|NCT00778622|26963935|P1|Overall Study|Lack of Efficacy|2
7756149|NCT00778622|26963933|P3|Overall Study|Protocol Violation|0
7756150|NCT00778622|26963934|P2|Overall Study|Protocol Violation|3
7756151|NCT00778622|26963935|P1|Overall Study|Protocol Violation|0
7756152|NCT00778622|26963933|P3|Overall Study|Lost to Follow-up|2
7756153|NCT00778622|26963934|P2|Overall Study|Lost to Follow-up|3
7756154|NCT00778622|26963935|P1|Overall Study|Lost to Follow-up|3
7756155|NCT00778622|26963933|P3|Overall Study|Withdrawal by Subject|5
7756156|NCT00778622|26963934|P2|Overall Study|Withdrawal by Subject|5
7756157|NCT00778622|26963935|P1|Overall Study|Withdrawal by Subject|4
7756158|NCT00778622|26963933|P3|Overall Study|Adverse Event|7
7756159|NCT00778622|26963934|P2|Overall Study|Adverse Event|4
7756160|NCT00778622|26963935|P1|Overall Study|Adverse Event|5
7756161|NCT00778375|26963988|P1|Overall Study|Ineligible|3
7756162|NCT00778336|26964002|P4|3 Month Follow Up|Death|0
7756163|NCT00778336|26964003|P3|3 Month Follow Up|Death|2
7756164|NCT00778336|26964004|P2|3 Month Follow Up|Death|3
7756165|NCT00778336|26964005|P1|3 Month Follow Up|Death|8
7756166|NCT00778336|26964002|P4|3 Month Follow Up|Lost to Follow-up|0
7756167|NCT00778336|26964003|P3|3 Month Follow Up|Lost to Follow-up|3
7756168|NCT00778336|26964004|P2|3 Month Follow Up|Lost to Follow-up|20
7756169|NCT00778336|26964005|P1|3 Month Follow Up|Lost to Follow-up|15
7756170|NCT00778336|26964002|P4|Index Procedure-Discharge|Death|0
7756171|NCT00778336|26964003|P3|Index Procedure-Discharge|Death|2
7756172|NCT00778336|26964004|P2|Index Procedure-Discharge|Death|3
7756173|NCT00778336|26964005|P1|Index Procedure-Discharge|Death|6
7756174|NCT00778258|26964043|P9|Overall Study|Other|0
7756175|NCT00778258|26964044|P8|Overall Study|Other|0
7756176|NCT00778258|26964045|P7|Overall Study|Other|1
7756177|NCT00778258|26964046|P6|Overall Study|Other|0
7756178|NCT00778258|26964047|P5|Overall Study|Other|0
7756179|NCT00778258|26964048|P4|Overall Study|Other|0
7756180|NCT00778258|26964049|P3|Overall Study|Other|0
7756181|NCT00778258|26964050|P2|Overall Study|Other|0
7756182|NCT00778258|26964051|P1|Overall Study|Other|0
7756183|NCT00778258|26964043|P9|Overall Study|Non-compliance|0
7756184|NCT00778258|26964044|P8|Overall Study|Non-compliance|0
7756185|NCT00778258|26964045|P7|Overall Study|Non-compliance|0
7756186|NCT00778258|26964046|P6|Overall Study|Non-compliance|0
7756187|NCT00778258|26964047|P5|Overall Study|Non-compliance|0
7756188|NCT00778258|26964048|P4|Overall Study|Non-compliance|1
7756189|NCT00778258|26964049|P3|Overall Study|Non-compliance|0
7756190|NCT00778258|26964050|P2|Overall Study|Non-compliance|0
7756191|NCT00778258|26964051|P1|Overall Study|Non-compliance|0
7756192|NCT00778258|26964043|P9|Overall Study|New Contraindication|0
7756193|NCT00778258|26964044|P8|Overall Study|New Contraindication|1
7756194|NCT00778258|26964045|P7|Overall Study|New Contraindication|0
7756195|NCT00778258|26964046|P6|Overall Study|New Contraindication|0
7756196|NCT00778258|26964047|P5|Overall Study|New Contraindication|0
7756197|NCT00778258|26964048|P4|Overall Study|New Contraindication|0
7756198|NCT00778258|26964049|P3|Overall Study|New Contraindication|0
7756199|NCT00778258|26964050|P2|Overall Study|New Contraindication|0
7756200|NCT00778258|26964051|P1|Overall Study|New Contraindication|0
7756201|NCT00778258|26964043|P9|Overall Study|Withdrawal by Subject|4
7756202|NCT00778258|26964044|P8|Overall Study|Withdrawal by Subject|12
7756203|NCT00778258|26964045|P7|Overall Study|Withdrawal by Subject|12
7756204|NCT00778258|26964046|P6|Overall Study|Withdrawal by Subject|6
7756205|NCT00778258|26964047|P5|Overall Study|Withdrawal by Subject|0
7756206|NCT00778258|26964048|P4|Overall Study|Withdrawal by Subject|2
7756207|NCT00778258|26964049|P3|Overall Study|Withdrawal by Subject|8
7756208|NCT00778258|26964050|P2|Overall Study|Withdrawal by Subject|2
7756209|NCT00778258|26964051|P1|Overall Study|Withdrawal by Subject|6
7756210|NCT00778258|26964043|P9|Overall Study|Lost to Follow-up|0
7756211|NCT00778258|26964044|P8|Overall Study|Lost to Follow-up|2
7756212|NCT00778258|26964045|P7|Overall Study|Lost to Follow-up|2
7756213|NCT00778258|26964046|P6|Overall Study|Lost to Follow-up|3
7756214|NCT00778258|26964047|P5|Overall Study|Lost to Follow-up|0
7756215|NCT00778258|26964048|P4|Overall Study|Lost to Follow-up|0
7756216|NCT00778258|26964049|P3|Overall Study|Lost to Follow-up|2
7756217|NCT00778258|26964050|P2|Overall Study|Lost to Follow-up|0
7756218|NCT00778258|26964051|P1|Overall Study|Lost to Follow-up|0
7756219|NCT00778258|26964043|P9|Overall Study|Adverse Event|0
7756220|NCT00778258|26964044|P8|Overall Study|Adverse Event|0
7756221|NCT00778258|26964045|P7|Overall Study|Adverse Event|0
7756222|NCT00778258|26964046|P6|Overall Study|Adverse Event|1
7756223|NCT00778258|26964047|P5|Overall Study|Adverse Event|0
7756224|NCT00778258|26964048|P4|Overall Study|Adverse Event|0
7756225|NCT00778258|26964049|P3|Overall Study|Adverse Event|0
7756226|NCT00778258|26964050|P2|Overall Study|Adverse Event|0
7756227|NCT00778258|26964051|P1|Overall Study|Adverse Event|1
7756228|NCT00778102|26964118|P2|Overall Study|Administrative Reason|10
7756229|NCT00778102|26964119|P1|Overall Study|Administrative Reason|7
7756230|NCT00778102|26964118|P2|Overall Study|Withdrawal by Subject|1
7756231|NCT00778102|26964119|P1|Overall Study|Withdrawal by Subject|1
7756232|NCT00778102|26964118|P2|Overall Study|Refused Treatment|3
7756233|NCT00778102|26964119|P1|Overall Study|Refused Treatment|2
7756234|NCT00778102|26964118|P2|Overall Study|Protocol Violation|1
7756235|NCT00778102|26964119|P1|Overall Study|Protocol Violation|0
7756236|NCT00778102|26964118|P2|Overall Study|Violation of Selection Criteria|1
7756237|NCT00778102|26964119|P1|Overall Study|Violation of Selection Criteria|1
7756238|NCT00778102|26964118|P2|Overall Study|Lost to Follow-up|0
7756239|NCT00778102|26964119|P1|Overall Study|Lost to Follow-up|1
7756240|NCT00778102|26964118|P2|Overall Study|Death|1
7756241|NCT00778102|26964119|P1|Overall Study|Death|1
7756242|NCT00778102|26964118|P2|Overall Study|Adverse Event|5
7756243|NCT00778102|26964119|P1|Overall Study|Adverse Event|8
7756244|NCT00777946|26964154|P3|Overall Study|Randomized in error|0
7756245|NCT00777946|26964155|P2|Overall Study|Randomized in error|1
7756246|NCT00777946|26964156|P1|Overall Study|Randomized in error|1
7756247|NCT00777946|26964154|P3|Overall Study|Protocol deviation|1
7756248|NCT00777946|26964155|P2|Overall Study|Protocol deviation|1
7756249|NCT00777946|26964156|P1|Overall Study|Protocol deviation|2
7756250|NCT00777946|26964154|P3|Overall Study|Lost to Follow-up|0
7756251|NCT00777946|26964155|P2|Overall Study|Lost to Follow-up|1
7756252|NCT00777946|26964156|P1|Overall Study|Lost to Follow-up|3
7756253|NCT00777946|26964154|P3|Overall Study|Patient withdrew consent|3
7756254|NCT00777946|26964155|P2|Overall Study|Patient withdrew consent|2
7756255|NCT00777946|26964156|P1|Overall Study|Patient withdrew consent|3
7756256|NCT00777946|26964154|P3|Overall Study|Condition no longer required study drug|0
7756257|NCT00777946|26964155|P2|Overall Study|Condition no longer required study drug|0
7756258|NCT00777946|26964156|P1|Overall Study|Condition no longer required study drug|1
7756259|NCT00777946|26964154|P3|Overall Study|Lack of Efficacy|9
7756260|NCT00777946|26964155|P2|Overall Study|Lack of Efficacy|0
7756261|NCT00777946|26964156|P1|Overall Study|Lack of Efficacy|0
7756262|NCT00777946|26964154|P3|Overall Study|Adverse Event|3
7756263|NCT00777946|26964155|P2|Overall Study|Adverse Event|1
7756264|NCT00777946|26964156|P1|Overall Study|Adverse Event|11
7756265|NCT00777920|26964179|P1|Overall Study|Other, not specified|4
7756266|NCT00777920|26964179|P1|Overall Study|Clinical status did not improve|1
7756267|NCT00777920|26964179|P1|Overall Study|Investigator's discretion|1
7756268|NCT00777920|26964179|P1|Overall Study|Lost to Follow-up|1
7756269|NCT00777920|26964179|P1|Overall Study|Withdrawal of Consent|4
7756270|NCT00777920|26964179|P1|Overall Study|Adverse Event|39
7756271|NCT00777829|26964193|P2|Overall Study|Withdrawal by Subject|2
7756272|NCT00777829|26964194|P1|Overall Study|Withdrawal by Subject|0
7756273|NCT00777803|26964204|P2|Overall Study|Non-compliance|2
7756274|NCT00777803|26964205|P1|Overall Study|Non-compliance|2
7756275|NCT00777803|26964204|P2|Overall Study|Adverse Event|0
7756276|NCT00777803|26964205|P1|Overall Study|Adverse Event|1
7756277|NCT00777803|26964204|P2|Overall Study|Lost to Follow-up|5
7756278|NCT00777803|26964205|P1|Overall Study|Lost to Follow-up|12
7756279|NCT00777608|26964284|P2|Overall Study|Investigator Decision|2
7756280|NCT00777608|26964285|P1|Overall Study|Investigator Decision|1
7756281|NCT00777608|26964284|P2|Overall Study|Protocol Violation|0
7756282|NCT00777608|26964285|P1|Overall Study|Protocol Violation|1
7756283|NCT00777608|26964284|P2|Overall Study|Withdrawal by Subject|3
7756284|NCT00777608|26964285|P1|Overall Study|Withdrawal by Subject|1
7756285|NCT00777608|26964284|P2|Overall Study|Lost to Follow-up|1
7756286|NCT00777608|26964285|P1|Overall Study|Lost to Follow-up|1
7756287|NCT00777556|26964295|P1|Overall Study|Did not complete all 3 follow-up visits|20
7756288|NCT00777556|26964295|P1|Overall Study|Dispensed but did not use product|12
7756289|NCT00777556|26964295|P1|Overall Study|Inappropriate self-selection|34
7756290|NCT00777491|26964304|P2|Overall Study|Did not receive any protocol treatment|0
7756291|NCT00777491|26964305|P1|Overall Study|Did not receive any protocol treatment|2
7756292|NCT00777491|26964304|P2|Overall Study|Protocol Violation|2
7756293|NCT00777491|26964305|P1|Overall Study|Protocol Violation|0
7756294|NCT00777296|26964340|P4|Overall Study|CRF form not completed|0
7756295|NCT00777296|26964341|P3|Overall Study|CRF form not completed|2
7756296|NCT00777296|26964342|P2|Overall Study|CRF form not completed|0
7756297|NCT00777296|26964343|P1|Overall Study|CRF form not completed|0
7756298|NCT00777296|26964340|P4|Overall Study|Withdrawal by Subject|0
7756299|NCT00777296|26964341|P3|Overall Study|Withdrawal by Subject|0
7756300|NCT00777296|26964342|P2|Overall Study|Withdrawal by Subject|0
7756301|NCT00777296|26964343|P1|Overall Study|Withdrawal by Subject|1
7756302|NCT00777296|26964340|P4|Overall Study|Adverse Event|1
7756303|NCT00777296|26964341|P3|Overall Study|Adverse Event|0
7756304|NCT00777296|26964342|P2|Overall Study|Adverse Event|1
7756305|NCT00777296|26964343|P1|Overall Study|Adverse Event|0
7756306|NCT00777257|26964385|P3|Overall Study|Withdrawal by Subject|5
7756307|NCT00777257|26964386|P2|Overall Study|Withdrawal by Subject|6
7756308|NCT00777257|26964387|P1|Overall Study|Withdrawal by Subject|3
7756309|NCT00777257|26964385|P3|Overall Study|Protocol Violation|2
7756310|NCT00777257|26964386|P2|Overall Study|Protocol Violation|2
7756311|NCT00777257|26964387|P1|Overall Study|Protocol Violation|2
7756312|NCT00777257|26964385|P3|Overall Study|Lost to Follow-up|2
7756313|NCT00777257|26964386|P2|Overall Study|Lost to Follow-up|3
7756314|NCT00777257|26964387|P1|Overall Study|Lost to Follow-up|3
7756315|NCT00777257|26964385|P3|Overall Study|Adverse Event|0
7756316|NCT00777257|26964386|P2|Overall Study|Adverse Event|1
7756317|NCT00777257|26964387|P1|Overall Study|Adverse Event|3
7756318|NCT00777205|26964406|P2|Overall Study|Protocol Violation|56
7756319|NCT00777205|26964407|P1|Overall Study|Protocol Violation|0
7756320|NCT00777205|26964406|P2|Overall Study|Death|2
7756321|NCT00777205|26964407|P1|Overall Study|Death|0
7756322|NCT00777205|26964406|P2|Overall Study|Withdrawal by Subject|4
7756323|NCT00777205|26964407|P1|Overall Study|Withdrawal by Subject|6
7756324|NCT00777205|26964406|P2|Overall Study|Lost to Follow-up|9
7756325|NCT00777205|26964407|P1|Overall Study|Lost to Follow-up|25
7756326|NCT00777153|26964441|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
7756327|NCT00777153|26964442|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
7756328|NCT00777153|26964443|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
7756329|NCT00777153|26964441|P3|Overall Study|Withdrawal by Subject|3
7756330|NCT00777153|26964442|P2|Overall Study|Withdrawal by Subject|4
7756331|NCT00777153|26964443|P1|Overall Study|Withdrawal by Subject|3
7756332|NCT00777153|26964441|P3|Overall Study|Death|33
7756333|NCT00777153|26964442|P2|Overall Study|Death|73
7756334|NCT00777153|26964443|P1|Overall Study|Death|85
7756335|NCT00777153|26964441|P3|Overall Study|Lost to Follow-up|0
7756336|NCT00777153|26964442|P2|Overall Study|Lost to Follow-up|1
7756337|NCT00777153|26964443|P1|Overall Study|Lost to Follow-up|1
7756338|NCT00777101|26964468|P2|Overall Study|Failed to Return|1
7756339|NCT00777101|26964469|P1|Overall Study|Failed to Return|0
7756340|NCT00777101|26964468|P2|Overall Study|Discontinuation of Study by Sponsor|0
7756341|NCT00777101|26964469|P1|Overall Study|Discontinuation of Study by Sponsor|1
7756342|NCT00777101|26964468|P2|Overall Study|Lost to Follow-up|1
7756343|NCT00777101|26964469|P1|Overall Study|Lost to Follow-up|2
7756344|NCT00777101|26964468|P2|Overall Study|Withdrawal by Subject|6
7756345|NCT00777101|26964469|P1|Overall Study|Withdrawal by Subject|11
7756346|NCT00777101|26964468|P2|Overall Study|Death|43
7756347|NCT00777101|26964469|P1|Overall Study|Death|48
7756348|NCT00777088|26964487|P1|Overall Study|PED Treatment not attempted|1
7756349|NCT00777049|26964512|P2|Overall Study|No treatment (elevated liver enzymes)|1
7756350|NCT00777049|26964513|P1|Overall Study|No treatment (elevated liver enzymes)|0
7756351|NCT00777049|26964512|P2|Overall Study|Withdrawal by Subject|0
7756352|NCT00777049|26964513|P1|Overall Study|Withdrawal by Subject|1
7756353|NCT00777036|26964522|P3|Follow-Up|Death|0
7756354|NCT00777036|26964523|P2|Follow-Up|Death|8
7756355|NCT00777036|26964524|P1|Follow-Up|Death|1
7756356|NCT00777036|26964522|P3|Follow-Up|Withdrawal by Subject|4
7756357|NCT00777036|26964523|P2|Follow-Up|Withdrawal by Subject|0
7756358|NCT00777036|26964524|P1|Follow-Up|Withdrawal by Subject|1
7756359|NCT00777036|26964522|P3|Follow-Up|Reason Not Specified|0
7756360|NCT00777036|26964523|P2|Follow-Up|Reason Not Specified|0
7756361|NCT00777036|26964524|P1|Follow-Up|Reason Not Specified|2
7756362|NCT00777036|26964522|P3|Follow-Up|Lost to Follow-up|0
7756363|NCT00777036|26964523|P2|Follow-Up|Lost to Follow-up|0
7756364|NCT00777036|26964524|P1|Follow-Up|Lost to Follow-up|1
7756365|NCT00777036|26964522|P3|On Treatment|Progressive Disease|6
7756366|NCT00777036|26964523|P2|On Treatment|Progressive Disease|4
7756367|NCT00777036|26964524|P1|On Treatment|Progressive Disease|5
7756368|NCT00777036|26964522|P3|On Treatment|Study Drug Toxicity|1
7756369|NCT00777036|26964523|P2|On Treatment|Study Drug Toxicity|0
7756370|NCT00777036|26964524|P1|On Treatment|Study Drug Toxicity|0
7756371|NCT00777036|26964522|P3|On Treatment|Death|0
7756372|NCT00777036|26964523|P2|On Treatment|Death|2
7756373|NCT00777036|26964524|P1|On Treatment|Death|0
7756374|NCT00777036|26964522|P3|On Treatment|Withdrawal by Subject|3
7756375|NCT00777036|26964523|P2|On Treatment|Withdrawal by Subject|2
7756376|NCT00777036|26964524|P1|On Treatment|Withdrawal by Subject|3
7756377|NCT00777036|26964522|P3|On Treatment|Maximum Clinical Benefit|1
7756378|NCT00777036|26964523|P2|On Treatment|Maximum Clinical Benefit|0
7756379|NCT00777036|26964524|P1|On Treatment|Maximum Clinical Benefit|2
7756380|NCT00777036|26964522|P3|On Treatment|Non-compliance with Study Drug|0
7756381|NCT00777036|26964523|P2|On Treatment|Non-compliance with Study Drug|0
7756382|NCT00777036|26964524|P1|On Treatment|Non-compliance with Study Drug|1
7756383|NCT00777036|26964522|P3|On Treatment|Failure to Meet Study Criteria|0
7756384|NCT00777036|26964523|P2|On Treatment|Failure to Meet Study Criteria|1
7756385|NCT00777036|26964524|P1|On Treatment|Failure to Meet Study Criteria|0
7756386|NCT00777036|26964522|P3|On Treatment|Reason Not Specified|12
7756387|NCT00777036|26964523|P2|On Treatment|Reason Not Specified|7
7756388|NCT00777036|26964524|P1|On Treatment|Reason Not Specified|4
7756389|NCT00777023|26964620|P3|Overall Study|Last dose date unknown|1
7756390|NCT00777023|26964621|P2|Overall Study|Last dose date unknown|3
7756391|NCT00777023|26964622|P1|Overall Study|Last dose date unknown|3
7756392|NCT00777023|26964620|P3|Overall Study|Reasons not specified|2
7756393|NCT00777023|26964621|P2|Overall Study|Reasons not specified|4
7756394|NCT00777023|26964622|P1|Overall Study|Reasons not specified|4
7756395|NCT00777023|26964620|P3|Overall Study|Missing data|0
7756396|NCT00777023|26964621|P2|Overall Study|Missing data|1
7756397|NCT00777023|26964622|P1|Overall Study|Missing data|1
7756398|NCT00777023|26964620|P3|Overall Study|Withdrawal by Subject|8
7756399|NCT00777023|26964621|P2|Overall Study|Withdrawal by Subject|7
7756400|NCT00777023|26964622|P1|Overall Study|Withdrawal by Subject|7
7756401|NCT00777023|26964620|P3|Overall Study|Death|0
7756402|NCT00777023|26964621|P2|Overall Study|Death|1
7756403|NCT00777023|26964622|P1|Overall Study|Death|0
7756404|NCT00777023|26964620|P3|Overall Study|Lost to Follow-up|3
7756405|NCT00777023|26964621|P2|Overall Study|Lost to Follow-up|3
7756406|NCT00777023|26964622|P1|Overall Study|Lost to Follow-up|2
7756407|NCT00777023|26964620|P3|Overall Study|Protocol Violation|1
7756408|NCT00777023|26964621|P2|Overall Study|Protocol Violation|1
7756409|NCT00777023|26964622|P1|Overall Study|Protocol Violation|2
7756410|NCT00777023|26964620|P3|Overall Study|Lack of Efficacy|14
7756411|NCT00777023|26964621|P2|Overall Study|Lack of Efficacy|0
7756412|NCT00777023|26964622|P1|Overall Study|Lack of Efficacy|1
7756413|NCT00777023|26964620|P3|Overall Study|Adverse Event|8
7756414|NCT00777023|26964621|P2|Overall Study|Adverse Event|21
7756415|NCT00777023|26964622|P1|Overall Study|Adverse Event|15
7756416|NCT00776997|26964639|P1|Overall Study|Adverse Event|2
7756417|NCT00776984|26964648|P2|Overall Study|Other|9
7756418|NCT00776984|26964649|P1|Overall Study|Other|5
7756419|NCT00776984|26964648|P2|Overall Study|Lack of Efficacy|1
7756420|NCT00776984|26964649|P1|Overall Study|Lack of Efficacy|0
7756421|NCT00776984|26964648|P2|Overall Study|Withdrawal by Subject|7
7756422|NCT00776984|26964649|P1|Overall Study|Withdrawal by Subject|12
7756423|NCT00776984|26964648|P2|Overall Study|Lost to Follow-up|0
7756424|NCT00776984|26964649|P1|Overall Study|Lost to Follow-up|2
7756425|NCT00776984|26964648|P2|Overall Study|Protocol Violation|2
7756426|NCT00776984|26964649|P1|Overall Study|Protocol Violation|4
7756427|NCT00776984|26964648|P2|Overall Study|Adverse Event|2
7756428|NCT00776984|26964649|P1|Overall Study|Adverse Event|8
7756429|NCT00776919|26964723|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
7756430|NCT00776919|26964724|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
7756431|NCT00776919|26964725|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
7756432|NCT00776919|26964726|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
7756433|NCT00776919|26964723|P4|Overall Study|Protocol Violation|1
7756434|NCT00776919|26964724|P3|Overall Study|Protocol Violation|0
7756435|NCT00776919|26964725|P2|Overall Study|Protocol Violation|2
7756436|NCT00776919|26964726|P1|Overall Study|Protocol Violation|1
7756437|NCT00776919|26964723|P4|Overall Study|Adverse Event|2
7756438|NCT00776919|26964724|P3|Overall Study|Adverse Event|2
7756439|NCT00776919|26964725|P2|Overall Study|Adverse Event|0
7756440|NCT00776919|26964726|P1|Overall Study|Adverse Event|1
7756441|NCT00776919|26964723|P4|Overall Study|Lost to Follow-up|8
7756442|NCT00776919|26964724|P3|Overall Study|Lost to Follow-up|11
7756443|NCT00776919|26964725|P2|Overall Study|Lost to Follow-up|12
7756444|NCT00776919|26964726|P1|Overall Study|Lost to Follow-up|8
7756445|NCT00776919|26964723|P4|Overall Study|Withdrawal by Subject|26
7756446|NCT00776919|26964724|P3|Overall Study|Withdrawal by Subject|15
7756447|NCT00776919|26964725|P2|Overall Study|Withdrawal by Subject|14
7756448|NCT00776919|26964726|P1|Overall Study|Withdrawal by Subject|16
7756449|NCT00776789|26964790|P2|Overall Study|Poor quality video|1
7756450|NCT00776789|26964791|P1|Overall Study|Poor quality video|1
7756451|NCT00776789|26964790|P2|Overall Study|Consent refusal|2
7756452|NCT00776789|26964791|P1|Overall Study|Consent refusal|2
7756453|NCT00776659|26964803|P1|Overall Study|Study Terminated by Sponsor|1
7756454|NCT00776659|26964803|P1|Overall Study|Withdrawal by Subject|10
7756455|NCT00776659|26964803|P1|Overall Study|Lost to Follow-up|15
7756456|NCT00776555|26964830|P2|Overall Study|Study terminated|0
7756457|NCT00776555|26964831|P1|Overall Study|Study terminated|3
7756458|NCT00776230|26964849|P3|Overall Study|Subject missed Visit 4|0
7756459|NCT00776230|26964850|P2|Overall Study|Subject missed Visit 4|1
7756460|NCT00776230|26964851|P1|Overall Study|Subject missed Visit 4|0
7756461|NCT00776230|26964849|P3|Overall Study|Withdrawal by Subject|0
7756462|NCT00776230|26964850|P2|Overall Study|Withdrawal by Subject|1
7756463|NCT00776230|26964851|P1|Overall Study|Withdrawal by Subject|0
7756464|NCT00776230|26964849|P3|Overall Study|Not vaccinated at Day 0|0
7756465|NCT00776230|26964850|P2|Overall Study|Not vaccinated at Day 0|0
7756466|NCT00776230|26964851|P1|Overall Study|Not vaccinated at Day 0|1
7756467|NCT00776230|26964849|P3|Overall Study|Lost to Follow-up|5
7756468|NCT00776230|26964850|P2|Overall Study|Lost to Follow-up|1
7756469|NCT00776230|26964851|P1|Overall Study|Lost to Follow-up|2
7756470|NCT00776100|26964861|P2|Overall Study|Disease Progression|0
7756471|NCT00776100|26964862|P1|Overall Study|Disease Progression|1
7756472|NCT00776009|26964884|P6|Period 3: Third Intervention|Withdrawal by Subject|0
7756473|NCT00776009|26964885|P5|Period 3: Third Intervention|Withdrawal by Subject|0
7756474|NCT00776009|26964886|P4|Period 3: Third Intervention|Withdrawal by Subject|0
7756475|NCT00776009|26964887|P3|Period 3: Third Intervention|Withdrawal by Subject|0
7756476|NCT00776009|26964888|P2|Period 3: Third Intervention|Withdrawal by Subject|0
7756477|NCT00776009|26964889|P1|Period 3: Third Intervention|Withdrawal by Subject|1
7756478|NCT00776009|26964884|P6|Period 2: Second Intervention|Protocol Violation|0
7756479|NCT00776009|26964885|P5|Period 2: Second Intervention|Protocol Violation|0
7756480|NCT00776009|26964886|P4|Period 2: Second Intervention|Protocol Violation|0
7756481|NCT00776009|26964887|P3|Period 2: Second Intervention|Protocol Violation|1
7756482|NCT00776009|26964888|P2|Period 2: Second Intervention|Protocol Violation|0
7756483|NCT00776009|26964889|P1|Period 2: Second Intervention|Protocol Violation|1
7756484|NCT00776009|26964884|P6|Period 2: Second Intervention|Withdrawal by Subject|1
7756485|NCT00776009|26964885|P5|Period 2: Second Intervention|Withdrawal by Subject|0
7756486|NCT00776009|26964886|P4|Period 2: Second Intervention|Withdrawal by Subject|0
7756487|NCT00776009|26964887|P3|Period 2: Second Intervention|Withdrawal by Subject|0
7756488|NCT00776009|26964888|P2|Period 2: Second Intervention|Withdrawal by Subject|0
7756489|NCT00776009|26964889|P1|Period 2: Second Intervention|Withdrawal by Subject|0
7756490|NCT00776009|26964884|P6|Period 1: First Intervention|Protocol Violation|0
7756491|NCT00776009|26964885|P5|Period 1: First Intervention|Protocol Violation|1
7756492|NCT00776009|26964886|P4|Period 1: First Intervention|Protocol Violation|0
7756493|NCT00776009|26964887|P3|Period 1: First Intervention|Protocol Violation|0
7756494|NCT00776009|26964888|P2|Period 1: First Intervention|Protocol Violation|1
7756495|NCT00776009|26964889|P1|Period 1: First Intervention|Protocol Violation|0
7756496|NCT00776009|26964884|P6|Period 1: First Intervention|Withdrawal by Subject|0
7756497|NCT00776009|26964885|P5|Period 1: First Intervention|Withdrawal by Subject|1
7756498|NCT00776009|26964886|P4|Period 1: First Intervention|Withdrawal by Subject|0
7756499|NCT00776009|26964887|P3|Period 1: First Intervention|Withdrawal by Subject|1
7756500|NCT00776009|26964888|P2|Period 1: First Intervention|Withdrawal by Subject|0
7756501|NCT00776009|26964889|P1|Period 1: First Intervention|Withdrawal by Subject|0
7756502|NCT00775983|26964911|P2|Overall Study|Protocol Violation|2
7756503|NCT00775983|26964912|P1|Overall Study|Protocol Violation|1
7756504|NCT00775606|26965038|P2|Overall Study|Study sponsor terminated funding|0
7756505|NCT00775606|26965039|P1|Overall Study|Study sponsor terminated funding|3
7756506|NCT00775593|26965049|P1|Overall Study|Death|1
7756507|NCT00775593|26965049|P1|Overall Study|Unmet eligibility criteria|6
7756508|NCT00775528|26965056|P1|Overall Study|Protocol Violation|1
7756509|NCT00775463|26965065|P2|Overall Study|Lack of Efficacy|1
7756510|NCT00775463|26965066|P1|Overall Study|Lack of Efficacy|1
7756511|NCT00775463|26965065|P2|Overall Study|Lost to Follow-up|0
7756512|NCT00775463|26965066|P1|Overall Study|Lost to Follow-up|1
7756513|NCT00775463|26965065|P2|Overall Study|Protocol Violation|2
7756514|NCT00775463|26965066|P1|Overall Study|Protocol Violation|2
7756515|NCT00775463|26965065|P2|Overall Study|Adverse Event|9
7756516|NCT00775463|26965066|P1|Overall Study|Adverse Event|7
7756517|NCT00775463|26965065|P2|Overall Study|Withdrawal by Subject|1
7756518|NCT00775463|26965066|P1|Overall Study|Withdrawal by Subject|0
7756519|NCT00775450|26965103|P5|Overall Study|Withdrawal by Subject|1
7756520|NCT00775450|26965104|P4|Overall Study|Withdrawal by Subject|0
7756521|NCT00775450|26965105|P3|Overall Study|Withdrawal by Subject|0
7756522|NCT00775450|26965106|P2|Overall Study|Withdrawal by Subject|0
7756523|NCT00775450|26965107|P1|Overall Study|Withdrawal by Subject|1
7756524|NCT00775450|26965103|P5|Overall Study|Protocol Violation|1
7756525|NCT00775450|26965104|P4|Overall Study|Protocol Violation|0
7756526|NCT00775450|26965105|P3|Overall Study|Protocol Violation|0
7756527|NCT00775450|26965106|P2|Overall Study|Protocol Violation|0
7756528|NCT00775450|26965107|P1|Overall Study|Protocol Violation|0
7756529|NCT00775450|26965103|P5|Overall Study|Serious Adverse Event|0
7756530|NCT00775450|26965104|P4|Overall Study|Serious Adverse Event|0
7756531|NCT00775450|26965105|P3|Overall Study|Serious Adverse Event|0
7756532|NCT00775450|26965106|P2|Overall Study|Serious Adverse Event|0
7756533|NCT00775450|26965107|P1|Overall Study|Serious Adverse Event|2
7756534|NCT00775437|26965134|P1|Overall Study|Lost to Follow-up|1
7756535|NCT00775437|26965134|P1|Overall Study|Withdrawal by Subject|3
7756536|NCT00775437|26965134|P1|Overall Study|Loss of efficacy|2
7756537|NCT00775268|26965196|P2|After Completion|Participant missed scan appointment|0
7756538|NCT00775268|26965197|P1|After Completion|Participant missed scan appointment|1
7756539|NCT00775268|26965196|P2|After 2 Cycles|Participant refused to be scanned further|0
7756540|NCT00775268|26965197|P1|After 2 Cycles|Participant refused to be scanned further|1
7756541|NCT00775268|26965196|P2|Baseline|Not treated-ineligible per CT|1
7756542|NCT00775268|26965197|P1|Baseline|Not treated-ineligible per CT|0
7756543|NCT00775268|26965196|P2|Baseline|Drug not synthesize dose|0
7756544|NCT00775268|26965197|P1|Baseline|Drug not synthesize dose|1
7756545|NCT00775203|26965229|P2|Overall Study|Physician Decision|1
7756546|NCT00775203|26965230|P1|Overall Study|Physician Decision|0
7756547|NCT00775203|26965229|P2|Overall Study|Entered other study|0
7756548|NCT00775203|26965230|P1|Overall Study|Entered other study|1
7756549|NCT00775203|26965229|P2|Overall Study|Protocol Violation|1
7756550|NCT00775203|26965230|P1|Overall Study|Protocol Violation|0
7756551|NCT00775203|26965229|P2|Overall Study|Noncompliance|2
7756552|NCT00775203|26965230|P1|Overall Study|Noncompliance|4
7756553|NCT00775203|26965229|P2|Overall Study|Administrative reason|0
7756554|NCT00775203|26965230|P1|Overall Study|Administrative reason|2
7756555|NCT00775203|26965229|P2|Overall Study|Lost to Follow-up|15
7756556|NCT00775203|26965230|P1|Overall Study|Lost to Follow-up|11
7756557|NCT00775203|26965229|P2|Overall Study|Withdrawal by Subject|9
7756558|NCT00775203|26965230|P1|Overall Study|Withdrawal by Subject|11
7756559|NCT00775203|26965229|P2|Overall Study|Lack of Efficacy|9
7756560|NCT00775203|26965230|P1|Overall Study|Lack of Efficacy|8
7756561|NCT00775203|26965229|P2|Overall Study|Adverse Event|6
7756562|NCT00775203|26965230|P1|Overall Study|Adverse Event|25
7756563|NCT00775190|26965264|P2|Overall Study|Protocol Violation|0
7756564|NCT00775190|26965265|P1|Overall Study|Protocol Violation|1
7756565|NCT00775190|26965264|P2|Overall Study|Withdrawal by Subject|2
7756566|NCT00775190|26965265|P1|Overall Study|Withdrawal by Subject|1
7756567|NCT00775190|26965264|P2|Overall Study|Lost to Follow-up|3
7756568|NCT00775190|26965265|P1|Overall Study|Lost to Follow-up|2
7756569|NCT00775138|26965291|P4|Overall Study|Adverse Event|0
7756570|NCT00775138|26965292|P3|Overall Study|Adverse Event|1
7756571|NCT00775138|26965293|P2|Overall Study|Adverse Event|0
7756572|NCT00775138|26965294|P1|Overall Study|Adverse Event|0
7756573|NCT00775138|26965291|P4|Overall Study|Withdrawal by Subject|2
7756574|NCT00775138|26965292|P3|Overall Study|Withdrawal by Subject|2
7756575|NCT00775138|26965293|P2|Overall Study|Withdrawal by Subject|0
7756576|NCT00775138|26965294|P1|Overall Study|Withdrawal by Subject|0
7756577|NCT00775021|26965340|P2|Second Intervention|Adverse Event|1
7756578|NCT00775021|26965341|P1|Second Intervention|Adverse Event|0
7756579|NCT00775021|26965340|P2|First Intervention|Lost to Follow-up|0
7756580|NCT00775021|26965341|P1|First Intervention|Lost to Follow-up|1
7756581|NCT00774995|26965359|P4|Overall Study|Protocol Violation|0
7756582|NCT00774995|26965360|P3|Overall Study|Protocol Violation|1
7756583|NCT00774995|26965361|P2|Overall Study|Protocol Violation|0
7756584|NCT00774995|26965362|P1|Overall Study|Protocol Violation|0
7756585|NCT00774930|26965402|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
7756586|NCT00774930|26965403|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
7756587|NCT00774930|26965402|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
7756588|NCT00774930|26965403|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
7756589|NCT00774930|26965402|P2|LTOLE Phase|Disease Progression|5
7756590|NCT00774930|26965403|P1|LTOLE Phase|Disease Progression|2
7756591|NCT00774930|26965402|P2|LTOLE Phase|Sponsor decision|1
7756592|NCT00774930|26965403|P1|LTOLE Phase|Sponsor decision|2
7756593|NCT00774930|26965402|P2|LTOLE Phase|Physician Decision|1
7756594|NCT00774930|26965403|P1|LTOLE Phase|Physician Decision|4
7756595|NCT00774930|26965402|P2|LTOLE Phase|Subject decision|5
7756596|NCT00774930|26965403|P1|LTOLE Phase|Subject decision|0
7756597|NCT00774930|26965402|P2|LTOLE Phase|Adverse Event|3
7756598|NCT00774930|26965403|P1|LTOLE Phase|Adverse Event|7
7756599|NCT00774930|26965402|P2|IOL Phase|Brain radiation|1
7756600|NCT00774930|26965403|P1|IOL Phase|Brain radiation|0
7756601|NCT00774930|26965402|P2|IOL Phase|Other|0
7756602|NCT00774930|26965403|P1|IOL Phase|Other|1
7756603|NCT00774930|26965402|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
7756604|NCT00774930|26965403|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
7756605|NCT00774930|26965402|P2|IOL Phase|Subject Consumed Prohibited Medication|0
7756606|NCT00774930|26965403|P1|IOL Phase|Subject Consumed Prohibited Medication|1
7756607|NCT00774930|26965402|P2|IOL Phase|Disease Progression|1
7756608|NCT00774930|26965403|P1|IOL Phase|Disease Progression|2
7756609|NCT00774930|26965402|P2|IOL Phase|Sponsor Decision|0
7756610|NCT00774930|26965403|P1|IOL Phase|Sponsor Decision|1
7756611|NCT00774930|26965402|P2|IOL Phase|Physician Decision|2
7756612|NCT00774930|26965403|P1|IOL Phase|Physician Decision|3
7756613|NCT00774930|26965402|P2|IOL Phase|Subject Decision|3
7756614|NCT00774930|26965403|P1|IOL Phase|Subject Decision|4
7756615|NCT00774930|26965402|P2|IOL Phase|Adverse Event|1
7756616|NCT00774930|26965403|P1|IOL Phase|Adverse Event|1
7756617|NCT00774930|26965402|P2|DB Phase|Started Nonprotocol Radiation therapy|1
7756618|NCT00774930|26965403|P1|DB Phase|Started Nonprotocol Radiation therapy|0
7756619|NCT00774930|26965402|P2|DB Phase|Disease Progression|1
7756620|NCT00774930|26965403|P1|DB Phase|Disease Progression|1
7756621|NCT00774930|26965402|P2|DB Phase|Sponsor Decision|1
7756622|NCT00774930|26965403|P1|DB Phase|Sponsor Decision|0
7756623|NCT00774930|26965402|P2|DB Phase|Subject Decision|5
7756624|NCT00774930|26965403|P1|DB Phase|Subject Decision|1
7756625|NCT00774930|26965402|P2|DB Phase|Adverse Event|2
7756626|NCT00774930|26965403|P1|DB Phase|Adverse Event|1
7756627|NCT00774930|26965402|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
7756628|NCT00774930|26965403|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
7756629|NCT00774852|26965431|P2|Overall Study|Subject received prohibited medication|0
7756630|NCT00774852|26965432|P1|Overall Study|Subject received prohibited medication|1
7756631|NCT00774852|26965431|P2|Overall Study|Protocol Violation|0
7756632|NCT00774852|26965432|P1|Overall Study|Protocol Violation|1
7756633|NCT00774852|26965431|P2|Overall Study|Subject non-compliance|1
7756634|NCT00774852|26965432|P1|Overall Study|Subject non-compliance|0
7756635|NCT00774852|26965431|P2|Overall Study|Non-responder|11
7756636|NCT00774852|26965432|P1|Overall Study|Non-responder|15
7756637|NCT00774852|26965431|P2|Overall Study|Withdrawal by Subject|2
7756638|NCT00774852|26965432|P1|Overall Study|Withdrawal by Subject|2
7756639|NCT00774852|26965431|P2|Overall Study|Pregnancy|2
7756640|NCT00774852|26965432|P1|Overall Study|Pregnancy|1
7756641|NCT00774852|26965431|P2|Overall Study|Physician Decision|6
7756642|NCT00774852|26965432|P1|Overall Study|Physician Decision|2
7756643|NCT00774852|26965431|P2|Overall Study|Lost to Follow-up|5
7756644|NCT00774852|26965432|P1|Overall Study|Lost to Follow-up|9
7756645|NCT00774852|26965431|P2|Overall Study|Lack of Efficacy|7
7756646|NCT00774852|26965432|P1|Overall Study|Lack of Efficacy|3
7756647|NCT00774852|26965431|P2|Overall Study|Death|1
7756648|NCT00774852|26965432|P1|Overall Study|Death|2
7756649|NCT00774852|26965431|P2|Overall Study|Adverse Event|6
7756650|NCT00774852|26965432|P1|Overall Study|Adverse Event|9
7756651|NCT00774800|26965480|P1|Intervention 4|Withdrawal by Subject|1
7756652|NCT00774787|26965502|P1|Overall Study|Lost to Follow-up|1
7756653|NCT00774748|26965509|P1|Overall Study|Lost to Follow-up|3
7756654|NCT00774566|26965530|P2|Overall Study|Protocol Violation|15
7756655|NCT00774566|26965531|P1|Overall Study|Protocol Violation|18
7756656|NCT00774397|26965556|P7|Overall Study|Other than those stated above|1
7756657|NCT00774397|26965557|P6|Overall Study|Other than those stated above|0
7756658|NCT00774397|26965558|P5|Overall Study|Other than those stated above|2
7756659|NCT00774397|26965559|P4|Overall Study|Other than those stated above|2
7756660|NCT00774397|26965560|P3|Overall Study|Other than those stated above|3
7756661|NCT00774397|26965561|P2|Overall Study|Other than those stated above|1
7756662|NCT00774397|26965562|P1|Overall Study|Other than those stated above|1
7756663|NCT00774397|26965556|P7|Overall Study|Not treated|1
7756664|NCT00774397|26965557|P6|Overall Study|Not treated|0
7756665|NCT00774397|26965558|P5|Overall Study|Not treated|1
7756666|NCT00774397|26965559|P4|Overall Study|Not treated|0
7756667|NCT00774397|26965560|P3|Overall Study|Not treated|0
7756668|NCT00774397|26965561|P2|Overall Study|Not treated|0
7756669|NCT00774397|26965562|P1|Overall Study|Not treated|0
7756670|NCT00774397|26965556|P7|Overall Study|Refused to continue trial medication|3
7756671|NCT00774397|26965557|P6|Overall Study|Refused to continue trial medication|2
7756672|NCT00774397|26965558|P5|Overall Study|Refused to continue trial medication|6
7756673|NCT00774397|26965559|P4|Overall Study|Refused to continue trial medication|2
7756674|NCT00774397|26965560|P3|Overall Study|Refused to continue trial medication|2
7756675|NCT00774397|26965561|P2|Overall Study|Refused to continue trial medication|3
7756676|NCT00774397|26965562|P1|Overall Study|Refused to continue trial medication|1
7756677|NCT00774397|26965556|P7|Overall Study|Lost to Follow-up|0
7756678|NCT00774397|26965557|P6|Overall Study|Lost to Follow-up|1
7756679|NCT00774397|26965558|P5|Overall Study|Lost to Follow-up|0
7756680|NCT00774397|26965559|P4|Overall Study|Lost to Follow-up|1
7756681|NCT00774397|26965560|P3|Overall Study|Lost to Follow-up|1
7756682|NCT00774397|26965561|P2|Overall Study|Lost to Follow-up|1
7756683|NCT00774397|26965562|P1|Overall Study|Lost to Follow-up|0
7756684|NCT00774397|26965556|P7|Overall Study|Protocol Violation|0
7756685|NCT00774397|26965557|P6|Overall Study|Protocol Violation|1
7756686|NCT00774397|26965558|P5|Overall Study|Protocol Violation|2
7756687|NCT00774397|26965559|P4|Overall Study|Protocol Violation|1
7756688|NCT00774397|26965560|P3|Overall Study|Protocol Violation|3
7756689|NCT00774397|26965561|P2|Overall Study|Protocol Violation|1
7756690|NCT00774397|26965562|P1|Overall Study|Protocol Violation|0
7756691|NCT00774397|26965556|P7|Overall Study|Lack of Efficacy|9
7756692|NCT00774397|26965557|P6|Overall Study|Lack of Efficacy|15
7756693|NCT00774397|26965558|P5|Overall Study|Lack of Efficacy|27
7756694|NCT00774397|26965559|P4|Overall Study|Lack of Efficacy|3
7756695|NCT00774397|26965560|P3|Overall Study|Lack of Efficacy|5
7756696|NCT00774397|26965561|P2|Overall Study|Lack of Efficacy|4
7756697|NCT00774397|26965562|P1|Overall Study|Lack of Efficacy|11
7756698|NCT00774397|26965556|P7|Overall Study|Adverse Event|16
7756699|NCT00774397|26965557|P6|Overall Study|Adverse Event|3
7756700|NCT00774397|26965558|P5|Overall Study|Adverse Event|8
7756701|NCT00774397|26965559|P4|Overall Study|Adverse Event|8
7756702|NCT00774397|26965560|P3|Overall Study|Adverse Event|16
7756703|NCT00774397|26965561|P2|Overall Study|Adverse Event|3
7756704|NCT00774397|26965562|P1|Overall Study|Adverse Event|1
7756705|NCT00774306|26965798|P4|Overall Study|Death|0
7756706|NCT00774306|26965799|P3|Overall Study|Death|0
7756707|NCT00774306|26965800|P2|Overall Study|Death|1
7756708|NCT00774306|26965801|P1|Overall Study|Death|1
7756709|NCT00774306|26965798|P4|Overall Study|Lost to Follow-up|5
7756710|NCT00774306|26965799|P3|Overall Study|Lost to Follow-up|4
7756711|NCT00774306|26965800|P2|Overall Study|Lost to Follow-up|0
7756712|NCT00774306|26965801|P1|Overall Study|Lost to Follow-up|6
7756713|NCT00774306|26965798|P4|Overall Study|Withdrawal by Subject|0
7756714|NCT00774306|26965799|P3|Overall Study|Withdrawal by Subject|1
7756715|NCT00774306|26965800|P2|Overall Study|Withdrawal by Subject|1
7756716|NCT00774306|26965801|P1|Overall Study|Withdrawal by Subject|6
7756717|NCT00774306|26965798|P4|Overall Study|Protocol Violation|0
7756718|NCT00774306|26965799|P3|Overall Study|Protocol Violation|3
7756719|NCT00774306|26965800|P2|Overall Study|Protocol Violation|0
7756720|NCT00774306|26965801|P1|Overall Study|Protocol Violation|2
7756721|NCT00774306|26965798|P4|Overall Study|Adverse Event|0
7756722|NCT00774306|26965799|P3|Overall Study|Adverse Event|0
7756723|NCT00774306|26965800|P2|Overall Study|Adverse Event|0
7756724|NCT00774306|26965801|P1|Overall Study|Adverse Event|3
7756725|NCT00774046|26965882|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
7756726|NCT00774046|26965882|P1|Enrollment|Desired other therapy/refused|28
7756727|NCT00774046|26965882|P1|Screening|Not eligible|56
7756728|NCT00773968|26965892|P1|Overall Study|Other|8
7756729|NCT00773968|26965892|P1|Overall Study|Screen Failure|17
7756730|NCT00773968|26965892|P1|Overall Study|Withdrawal by Subject|11
7756731|NCT00773968|26965892|P1|Overall Study|Protocol Violation|1
7756732|NCT00773968|26965892|P1|Overall Study|Lack of Efficacy|3
7756733|NCT00773968|26965892|P1|Overall Study|Failure to Return|2
7756734|NCT00773968|26965892|P1|Overall Study|Death|1
7756735|NCT00773968|26965892|P1|Overall Study|Adverse Event|2
7756736|NCT00773838|26965908|P1|Overall Study|Withdrawal by Subject|21
7756737|NCT00773838|26965908|P1|Overall Study|Protocol Violation|2
7756738|NCT00773838|26965908|P1|Overall Study|Progressive Disease|82
7756739|NCT00773838|26965908|P1|Overall Study|Physician Decision|8
7756740|NCT00773838|26965908|P1|Overall Study|Lost to Follow-up|1
7756741|NCT00773838|26965908|P1|Overall Study|Adverse Event|29
7756742|NCT00773747|26965932|P2|Overall Study|Not Treated|0
7756743|NCT00773747|26965933|P1|Overall Study|Not Treated|2
7756744|NCT00773747|26965932|P2|Overall Study|Death|8
7756745|NCT00773747|26965933|P1|Overall Study|Death|5
7756746|NCT00773747|26965932|P2|Overall Study|Adverse Event|62
7756747|NCT00773747|26965933|P1|Overall Study|Adverse Event|61
7756748|NCT00773747|26965932|P2|Overall Study|Withdrawal by Subject|61
7756749|NCT00773747|26965933|P1|Overall Study|Withdrawal by Subject|89
7756750|NCT00773747|26965932|P2|Overall Study|Protocol Violation|2
7756751|NCT00773747|26965933|P1|Overall Study|Protocol Violation|2
7756752|NCT00773747|26965932|P2|Overall Study|Lost to Follow-up|1
7756753|NCT00773747|26965933|P1|Overall Study|Lost to Follow-up|0
7756754|NCT00773747|26965932|P2|Overall Study|Physician Decision|18
7756755|NCT00773747|26965933|P1|Overall Study|Physician Decision|26
7756756|NCT00773747|26965932|P2|Overall Study|Lack of Efficacy|144
7756757|NCT00773747|26965933|P1|Overall Study|Lack of Efficacy|112
7756758|NCT00773734|26965951|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7756759|NCT00773734|26965952|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7756760|NCT00773734|26965953|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
7756761|NCT00773734|26965954|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
7756762|NCT00773734|26965955|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7756763|NCT00773734|26965956|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7756764|NCT00773734|26965951|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7756765|NCT00773734|26965952|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7756766|NCT00773734|26965953|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
7756767|NCT00773734|26965954|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
7756768|NCT00773734|26965955|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7756769|NCT00773734|26965956|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7756770|NCT00773734|26965951|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7756771|NCT00773734|26965952|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7756772|NCT00773734|26965953|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
7756773|NCT00773734|26965954|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
7756774|NCT00773734|26965955|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7756775|NCT00773734|26965956|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7756776|NCT00773734|26965951|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
7756777|NCT00773734|26965952|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
7756778|NCT00773734|26965953|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
7756779|NCT00773734|26965954|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
7756780|NCT00773734|26965955|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
7756781|NCT00773734|26965956|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
7756782|NCT00773734|26965951|P6|Extension: Active Treatment Week 24-52|Other|1
7756783|NCT00773734|26965952|P5|Extension: Active Treatment Week 24-52|Other|0
7756784|NCT00773734|26965953|P4|Extension: Active Treatment Week 24-52|Other|2
7756785|NCT00773734|26965954|P3|Extension: Active Treatment Week 24-52|Other|1
7756786|NCT00773734|26965955|P2|Extension: Active Treatment Week 24-52|Other|0
7756787|NCT00773734|26965956|P1|Extension: Active Treatment Week 24-52|Other|0
7756788|NCT00773734|26965951|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
7756789|NCT00773734|26965952|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
7756790|NCT00773734|26965953|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
7756791|NCT00773734|26965954|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
7756792|NCT00773734|26965955|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
7756793|NCT00773734|26965956|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
7756794|NCT00773734|26965951|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
7756795|NCT00773734|26965952|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
7756796|NCT00773734|26965953|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
7756797|NCT00773734|26965954|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
7756798|NCT00773734|26965955|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
7756799|NCT00773734|26965956|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
7756800|NCT00773734|26965951|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
7756801|NCT00773734|26965952|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
7756802|NCT00773734|26965953|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
7756803|NCT00773734|26965954|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
7756804|NCT00773734|26965955|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
7756805|NCT00773734|26965956|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
7756806|NCT00773734|26965951|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
7756807|NCT00773734|26965952|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
7756808|NCT00773734|26965953|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
7756809|NCT00773734|26965954|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
7756810|NCT00773734|26965955|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
7756811|NCT00773734|26965956|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
7756812|NCT00773734|26965951|P6|Core: Active Treatment Phase Week 16-24|Other|0
7756813|NCT00773734|26965952|P5|Core: Active Treatment Phase Week 16-24|Other|0
7756814|NCT00773734|26965953|P4|Core: Active Treatment Phase Week 16-24|Other|0
7756815|NCT00773734|26965954|P3|Core: Active Treatment Phase Week 16-24|Other|0
7756816|NCT00773734|26965955|P2|Core: Active Treatment Phase Week 16-24|Other|1
7756817|NCT00773734|26965956|P1|Core: Active Treatment Phase Week 16-24|Other|0
7756818|NCT00773734|26965951|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7756819|NCT00773734|26965952|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
7756820|NCT00773734|26965953|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7756821|NCT00773734|26965954|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7756822|NCT00773734|26965955|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7756823|NCT00773734|26965956|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
7756824|NCT00773734|26965951|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7756825|NCT00773734|26965952|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7756826|NCT00773734|26965953|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7756827|NCT00773734|26965954|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
7756828|NCT00773734|26965955|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
7756829|NCT00773734|26965956|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7756830|NCT00773734|26965951|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
7756831|NCT00773734|26965952|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7756832|NCT00773734|26965953|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7756833|NCT00773734|26965954|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
7756834|NCT00773734|26965955|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
7756835|NCT00773734|26965956|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7756836|NCT00773734|26965951|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7756837|NCT00773734|26965952|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7756838|NCT00773734|26965953|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
7756839|NCT00773734|26965954|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
7756840|NCT00773734|26965955|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
7756841|NCT00773734|26965956|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7756842|NCT00773734|26965951|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
7756843|NCT00773734|26965952|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
7756844|NCT00773734|26965953|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7756845|NCT00773734|26965954|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7756846|NCT00773734|26965955|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
7756847|NCT00773734|26965956|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7756848|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
7756849|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
7756850|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
7756851|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
7756852|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
7756853|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
7756934|NCT00773175|26966683|P1|Overall Study|Consent Withdrawn|0
7756854|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7756855|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7756856|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7756857|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
7756858|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
7756859|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
7756860|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7756861|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7756862|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
7756863|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7756864|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7756865|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
7756866|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
7756867|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
7756868|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
7756869|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
7756870|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
7756871|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
7756872|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
7756873|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
7756874|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
7756875|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
7756876|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
7756877|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
7756878|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
7756879|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
7756880|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
7756881|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
7756882|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
7756883|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
7756884|NCT00773734|26965951|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
7756885|NCT00773734|26965952|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
7756886|NCT00773734|26965953|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
7756887|NCT00773734|26965954|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
7756888|NCT00773734|26965955|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
7756889|NCT00773734|26965956|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
7756890|NCT00773513|26966524|P2|Overall Study|Death|545
7756891|NCT00773513|26966525|P1|Overall Study|Death|531
7756892|NCT00773513|26966524|P2|Overall Study|Reason Not Specified|126
7756893|NCT00773513|26966525|P1|Overall Study|Reason Not Specified|159
7756894|NCT00773513|26966524|P2|Overall Study|Insufficient Therapeutic Response|18
7756895|NCT00773513|26966525|P1|Overall Study|Insufficient Therapeutic Response|1
7756896|NCT00773513|26966524|P2|Overall Study|Failure to Return|8
7756897|NCT00773513|26966525|P1|Overall Study|Failure to Return|22
7756898|NCT00773513|26966524|P2|Overall Study|Refused Treatment / Did not Cooperate|32
7756899|NCT00773513|26966525|P1|Overall Study|Refused Treatment / Did not Cooperate|26
7756900|NCT00773513|26966524|P2|Overall Study|Withdrew Consent|69
7756901|NCT00773513|26966525|P1|Overall Study|Withdrew Consent|68
7756902|NCT00773513|26966524|P2|Overall Study|Adverse Event / Intercurrent Illness|48
7756903|NCT00773513|26966525|P1|Overall Study|Adverse Event / Intercurrent Illness|40
7756904|NCT00773513|26966524|P2|Overall Study|Renal Transplant|263
7756905|NCT00773513|26966525|P1|Overall Study|Renal Transplant|254
7756906|NCT00773461|26966554|P2|Overall Study|Withdrawal by Subject|1
7756907|NCT00773461|26966555|P1|Overall Study|Withdrawal by Subject|4
7756908|NCT00773461|26966554|P2|Overall Study|Adverse Event|3
7756909|NCT00773461|26966555|P1|Overall Study|Adverse Event|1
7756910|NCT00773383|26966609|P1|Overall Study|No study dose received|1
7756911|NCT00773383|26966609|P1|Overall Study|Other|2
7756912|NCT00773383|26966609|P1|Overall Study|Progression of Disease|23
7756913|NCT00773383|26966609|P1|Overall Study|Death|1
7756914|NCT00773383|26966609|P1|Overall Study|Adverse Event|4
7756915|NCT00773292|26966644|P1|Treatment 48 Weeks|Lack of Efficacy|1
7756916|NCT00773292|26966644|P1|Treatment 48 Weeks|Adverse Event|1
7756917|NCT00773279|26966649|P2|Period 2|Unclassified|2
7756918|NCT00773279|26966650|P1|Period 2|Unclassified|2
7756919|NCT00773279|26966649|P2|Period 2|Protocol Violation|3
7756920|NCT00773279|26966650|P1|Period 2|Protocol Violation|0
7756921|NCT00773279|26966649|P2|Period 2|Lack of Efficacy|0
7756922|NCT00773279|26966650|P1|Period 2|Lack of Efficacy|1
7756923|NCT00773279|26966649|P2|Period 2|Adverse Event|1
7756924|NCT00773279|26966650|P1|Period 2|Adverse Event|0
7756925|NCT00773279|26966649|P2|Period 1|Unclassified|1
7756926|NCT00773279|26966650|P1|Period 1|Unclassified|5
7756927|NCT00773279|26966649|P2|Period 1|Lack of Efficacy|2
7756928|NCT00773279|26966650|P1|Period 1|Lack of Efficacy|0
7756929|NCT00773279|26966649|P2|Period 1|Adverse Event|1
7756930|NCT00773279|26966650|P1|Period 1|Adverse Event|2
7756931|NCT00773253|26966671|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
7756932|NCT00773253|26966672|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
7756933|NCT00773175|26966682|P2|Overall Study|Consent Withdrawn|2
7756935|NCT00773175|26966682|P2|Overall Study|Adverse Event|0
7756936|NCT00773175|26966683|P1|Overall Study|Adverse Event|2
7756937|NCT00773136|26966775|P1|Overall Study|Physician Decision|2
7756938|NCT00773097|26966780|P1|Overall Study|Physician Decision|6
7756939|NCT00773097|26966780|P1|Overall Study|Withdrawal by Subject|1
7756940|NCT00772967|26966786|P6|Crossover Treatment 3|Adverse Event|0
7756941|NCT00772967|26966787|P5|Crossover Treatment 3|Adverse Event|1
7756942|NCT00772967|26966788|P4|Crossover Treatment 3|Adverse Event|0
7756943|NCT00772967|26966789|P3|Crossover Treatment 3|Adverse Event|0
7756944|NCT00772967|26966790|P2|Crossover Treatment 3|Adverse Event|0
7756945|NCT00772967|26966791|P1|Crossover Treatment 3|Adverse Event|0
7756946|NCT00772967|26966786|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
7756947|NCT00772967|26966787|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
7756948|NCT00772967|26966788|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
7756949|NCT00772967|26966789|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
7756950|NCT00772967|26966790|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
7756951|NCT00772967|26966791|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
7756952|NCT00772967|26966786|P6|Crossover Treatment 1|Adverse Event (Pain)|0
7756953|NCT00772967|26966787|P5|Crossover Treatment 1|Adverse Event (Pain)|0
7756954|NCT00772967|26966788|P4|Crossover Treatment 1|Adverse Event (Pain)|1
7756955|NCT00772967|26966789|P3|Crossover Treatment 1|Adverse Event (Pain)|0
7756956|NCT00772967|26966790|P2|Crossover Treatment 1|Adverse Event (Pain)|0
7756957|NCT00772967|26966791|P1|Crossover Treatment 1|Adverse Event (Pain)|0
7756958|NCT00772954|26966811|P3|Overall Study|Adverse Event|1
7756959|NCT00772954|26966812|P2|Overall Study|Adverse Event|0
7756960|NCT00772954|26966813|P1|Overall Study|Adverse Event|0
7756961|NCT00772941|26966821|P1|Overall Study|GPSP Violation|90
7756962|NCT00772941|26966821|P1|Overall Study|Poor Compliance|7
7756963|NCT00772941|26966821|P1|Overall Study|Missed Visits|374
7756964|NCT00772941|26966821|P1|Overall Study|Study not completed|16
7756965|NCT00772941|26966821|P1|Overall Study|CRFs not available|195
7756966|NCT00772928|26966852|P2|Overall Study|Did not receive vaccine|1
7756967|NCT00772928|26966853|P1|Overall Study|Did not receive vaccine|0
7756968|NCT00772928|26966852|P2|Overall Study|Withdrawal by Subject|22
7756969|NCT00772928|26966853|P1|Overall Study|Withdrawal by Subject|25
7756970|NCT00772928|26966852|P2|Overall Study|Protocol Violation|12
7756971|NCT00772928|26966853|P1|Overall Study|Protocol Violation|10
7756972|NCT00772928|26966852|P2|Overall Study|Lost to Follow-up|6
7756973|NCT00772928|26966853|P1|Overall Study|Lost to Follow-up|9
7756974|NCT00772889|26966874|P3|Overall Study|Lost to Follow-up|7
7756975|NCT00772889|26966875|P2|Overall Study|Lost to Follow-up|6
7756976|NCT00772889|26966876|P1|Overall Study|Lost to Follow-up|6
7756977|NCT00772889|26966874|P3|Overall Study|Withdrawal by Subject|9
7756978|NCT00772889|26966875|P2|Overall Study|Withdrawal by Subject|8
7756979|NCT00772889|26966876|P1|Overall Study|Withdrawal by Subject|9
7756980|NCT00772889|26966874|P3|Overall Study|Adverse Event|0
7756981|NCT00772889|26966875|P2|Overall Study|Adverse Event|4
7756982|NCT00772889|26966876|P1|Overall Study|Adverse Event|7
7756983|NCT00772707|26966934|P1|Overall Study|Withdrawn|3
7756984|NCT00772668|26966939|P1|Overall Study|Physician Decision|3
7756985|NCT00772629|26966948|P2|Overall Study|Subject was not vaccinated|0
7756986|NCT00772629|26966949|P1|Overall Study|Subject was not vaccinated|1
7756987|NCT00772603|26966958|P3|Overall Study|Other|2
7756988|NCT00772603|26966959|P2|Overall Study|Other|0
7756989|NCT00772603|26966960|P1|Overall Study|Other|2
7756990|NCT00772603|26966958|P3|Overall Study|Physician Decision|1
7756991|NCT00772603|26966959|P2|Overall Study|Physician Decision|0
7756992|NCT00772603|26966960|P1|Overall Study|Physician Decision|0
7756993|NCT00772603|26966958|P3|Overall Study|Lost to Follow-up|2
7756994|NCT00772603|26966959|P2|Overall Study|Lost to Follow-up|5
7756995|NCT00772603|26966960|P1|Overall Study|Lost to Follow-up|1
7756996|NCT00772603|26966958|P3|Overall Study|Protocol Violation|1
7756997|NCT00772603|26966959|P2|Overall Study|Protocol Violation|1
7756998|NCT00772603|26966960|P1|Overall Study|Protocol Violation|0
7756999|NCT00772603|26966958|P3|Overall Study|Subject Non-compliance|4
7757000|NCT00772603|26966959|P2|Overall Study|Subject Non-compliance|6
7757001|NCT00772603|26966960|P1|Overall Study|Subject Non-compliance|1
7757002|NCT00772603|26966958|P3|Overall Study|Adverse Event|10
7757003|NCT00772603|26966959|P2|Overall Study|Adverse Event|18
7757004|NCT00772603|26966960|P1|Overall Study|Adverse Event|37
7757005|NCT00772603|26966958|P3|Overall Study|Withdrawal by Subject|6
7757006|NCT00772603|26966959|P2|Overall Study|Withdrawal by Subject|10
7757007|NCT00772603|26966960|P1|Overall Study|Withdrawal by Subject|11
7757008|NCT00772577|26966999|P2|Overall Study|Protocol Deviation|2
7757009|NCT00772577|26967000|P1|Overall Study|Protocol Deviation|3
7757010|NCT00772577|26966999|P2|Overall Study|Administrative problems|1
7757011|NCT00772577|26967000|P1|Overall Study|Administrative problems|2
7757012|NCT00772577|26966999|P2|Overall Study|Lost to Follow-up|3
7757013|NCT00772577|26967000|P1|Overall Study|Lost to Follow-up|4
7757014|NCT00772577|26966999|P2|Overall Study|Patient withdrew consent|5
7757015|NCT00772577|26967000|P1|Overall Study|Patient withdrew consent|8
7757016|NCT00772577|26966999|P2|Overall Study|Unsatisfactory therapeutic effect|8
7757017|NCT00772577|26967000|P1|Overall Study|Unsatisfactory therapeutic effect|0
7757018|NCT00772577|26966999|P2|Overall Study|Abnormal laboratory values|1
7757019|NCT00772577|26967000|P1|Overall Study|Abnormal laboratory values|0
7757020|NCT00772577|26966999|P2|Overall Study|Adverse Event|3
7757021|NCT00772577|26967000|P1|Overall Study|Adverse Event|6
7757022|NCT00772538|26967016|P2|Overall Study|Other|7
7757023|NCT00772538|26967017|P1|Overall Study|Other|7
7757024|NCT00772538|26967016|P2|Overall Study|Lack of Efficacy|1
7757025|NCT00772538|26967017|P1|Overall Study|Lack of Efficacy|0
7757026|NCT00772538|26967016|P2|Overall Study|Withdrawal by Subject|8
7757027|NCT00772538|26967017|P1|Overall Study|Withdrawal by Subject|3
7757028|NCT00772538|26967016|P2|Overall Study|Lost to Follow-up|1
7757029|NCT00772538|26967017|P1|Overall Study|Lost to Follow-up|1
7757030|NCT00772538|26967016|P2|Overall Study|Protocol Violation|3
7757031|NCT00772538|26967017|P1|Overall Study|Protocol Violation|3
7757032|NCT00772538|26967016|P2|Overall Study|Adverse Event|6
7757033|NCT00772538|26967017|P1|Overall Study|Adverse Event|6
7757034|NCT00772447|26967089|P2|Overall Study|all others|2
7757035|NCT00772447|26967090|P1|Overall Study|all others|2
7757036|NCT00772447|26967089|P2|Overall Study|Protocol Violation|1
7757037|NCT00772447|26967090|P1|Overall Study|Protocol Violation|0
7757038|NCT00772447|26967089|P2|Overall Study|incorrect enrolment|4
7757039|NCT00772447|26967090|P1|Overall Study|incorrect enrolment|3
7757040|NCT00772447|26967089|P2|Overall Study|Lost to Follow-up|4
7757041|NCT00772447|26967090|P1|Overall Study|Lost to Follow-up|2
7757042|NCT00772447|26967089|P2|Overall Study|Physician Decision|8
7757043|NCT00772447|26967090|P1|Overall Study|Physician Decision|4
7757044|NCT00772447|26967089|P2|Overall Study|Withdrawal by Subject|5
7757045|NCT00772447|26967090|P1|Overall Study|Withdrawal by Subject|9
7757046|NCT00772382|26967118|P1|Overall Study|Other Reasons|10
7757047|NCT00772382|26967118|P1|Overall Study|Withdrawal by Subject|10
7757048|NCT00772382|26967118|P1|Overall Study|Protocol Violation|1
7757049|NCT00772382|26967118|P1|Overall Study|Physician Decision|5
7757050|NCT00772382|26967118|P1|Overall Study|Lack of Efficacy|4
7757051|NCT00772382|26967118|P1|Overall Study|Death|6
7757052|NCT00772382|26967118|P1|Overall Study|Adverse Event|19
7757053|NCT00772369|26967123|P1|Overall Study|Did not return record release form|1
7757054|NCT00772330|26967128|P1|Overall Study|Lost to Follow-up|3
7757055|NCT00772148|26967144|P2|Maintenance Phase (Week 52)|Administrative/other|2
7757056|NCT00772148|26967145|P1|Maintenance Phase (Week 52)|Administrative/other|1
7757057|NCT00772148|26967144|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
7757058|NCT00772148|26967145|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
7757059|NCT00772148|26967144|P2|Maintenance Phase (Week 52)|Adverse Event|0
7757060|NCT00772148|26967145|P1|Maintenance Phase (Week 52)|Adverse Event|1
7757061|NCT00772148|26967144|P2|Maintenance Phase (Week 52)|Death|2
7757062|NCT00772148|26967145|P1|Maintenance Phase (Week 52)|Death|2
7757063|NCT00772148|26967144|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
7757064|NCT00772148|26967145|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
7757065|NCT00772148|26967144|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
7757066|NCT00772148|26967145|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
7757067|NCT00772148|26967144|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
7757068|NCT00772148|26967145|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
7757069|NCT00772109|26967165|P4|Overall Study|Withdrawal by Subject|16
7757070|NCT00772109|26967166|P3|Overall Study|Withdrawal by Subject|6
7757071|NCT00772109|26967167|P2|Overall Study|Withdrawal by Subject|8
7757072|NCT00772109|26967168|P1|Overall Study|Withdrawal by Subject|8
7757073|NCT00772109|26967165|P4|Overall Study|Lost to Follow-up|9
7757074|NCT00772109|26967166|P3|Overall Study|Lost to Follow-up|5
7757075|NCT00772109|26967167|P2|Overall Study|Lost to Follow-up|3
7757076|NCT00772109|26967168|P1|Overall Study|Lost to Follow-up|7
7757077|NCT00772109|26967165|P4|Overall Study|Protocol Violation|6
7757078|NCT00772109|26967166|P3|Overall Study|Protocol Violation|7
7757079|NCT00772109|26967167|P2|Overall Study|Protocol Violation|8
7757080|NCT00772109|26967168|P1|Overall Study|Protocol Violation|5
7757081|NCT00772109|26967165|P4|Overall Study|Serious adverse event|0
7757082|NCT00772109|26967166|P3|Overall Study|Serious adverse event|1
7757083|NCT00772109|26967167|P2|Overall Study|Serious adverse event|0
7757084|NCT00772109|26967168|P1|Overall Study|Serious adverse event|1
7757085|NCT00772070|26967192|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
7757086|NCT00772070|26967193|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
7757087|NCT00772070|26967192|P2|Overall Study|Withdrawal by Subject|2
7757088|NCT00772070|26967193|P1|Overall Study|Withdrawal by Subject|0
7757089|NCT00772070|26967192|P2|Overall Study|Lost to Follow-up|8
7757090|NCT00772070|26967193|P1|Overall Study|Lost to Follow-up|0
7757091|NCT00772031|26967205|P2|Overall Study|Lost to Follow-up|33
7757092|NCT00772031|26967206|P1|Overall Study|Lost to Follow-up|20
7757093|NCT00772031|26967205|P2|Overall Study|Early termination of trial|10
7757094|NCT00772031|26967206|P1|Overall Study|Early termination of trial|12
7757095|NCT00772005|26967232|P4|Overall Study|Non-compliance with drug administration|1
7757096|NCT00772005|26967233|P3|Overall Study|Non-compliance with drug administration|1
7757097|NCT00772005|26967234|P2|Overall Study|Non-compliance with drug administration|0
7757098|NCT00772005|26967235|P1|Overall Study|Non-compliance with drug administration|3
7757099|NCT00772005|26967232|P4|Overall Study|Non-compliance with study procedures|1
7757100|NCT00772005|26967233|P3|Overall Study|Non-compliance with study procedures|0
7757101|NCT00772005|26967234|P2|Overall Study|Non-compliance with study procedures|1
7757102|NCT00772005|26967235|P1|Overall Study|Non-compliance with study procedures|1
7757103|NCT00772005|26967232|P4|Overall Study|Lost to Follow-up|3
7757104|NCT00772005|26967233|P3|Overall Study|Lost to Follow-up|6
7757105|NCT00772005|26967234|P2|Overall Study|Lost to Follow-up|3
7757106|NCT00772005|26967235|P1|Overall Study|Lost to Follow-up|7
7757107|NCT00772005|26967232|P4|Overall Study|Protocol Violation|6
7757108|NCT00772005|26967233|P3|Overall Study|Protocol Violation|1
7757109|NCT00772005|26967234|P2|Overall Study|Protocol Violation|4
7757110|NCT00772005|26967235|P1|Overall Study|Protocol Violation|2
7757111|NCT00772005|26967232|P4|Overall Study|Withdrawal by Subject|2
7757112|NCT00772005|26967233|P3|Overall Study|Withdrawal by Subject|10
7757113|NCT00772005|26967234|P2|Overall Study|Withdrawal by Subject|7
7757114|NCT00772005|26967235|P1|Overall Study|Withdrawal by Subject|3
7757115|NCT00772005|26967232|P4|Overall Study|Lack of Efficacy|0
7757116|NCT00772005|26967233|P3|Overall Study|Lack of Efficacy|0
7757117|NCT00772005|26967234|P2|Overall Study|Lack of Efficacy|1
7757118|NCT00772005|26967235|P1|Overall Study|Lack of Efficacy|0
7757119|NCT00772005|26967232|P4|Overall Study|Adverse Event|13
7757120|NCT00772005|26967233|P3|Overall Study|Adverse Event|10
7757121|NCT00772005|26967234|P2|Overall Study|Adverse Event|14
7757122|NCT00772005|26967235|P1|Overall Study|Adverse Event|9
7757123|NCT00771953|26967923|P2|Overall Study|Withdrawal by Subject|3
7757124|NCT00771953|26967924|P1|Overall Study|Withdrawal by Subject|0
7757125|NCT00771953|26967923|P2|Overall Study|Other complicating disease|0
7757126|NCT00771953|26967924|P1|Overall Study|Other complicating disease|1
7757127|NCT00771953|26967923|P2|Overall Study|Sponsor decision|0
7757128|NCT00771953|26967924|P1|Overall Study|Sponsor decision|1
7757129|NCT00771953|26967923|P2|Overall Study|Progression before active Tx|2
7757130|NCT00771953|26967924|P1|Overall Study|Progression before active Tx|1
7757131|NCT00771953|26967923|P2|Overall Study|Death|2
7757132|NCT00771953|26967924|P1|Overall Study|Death|2
7757133|NCT00771953|26967923|P2|Overall Study|Adverse Event|3
7757134|NCT00771953|26967924|P1|Overall Study|Adverse Event|5
7757135|NCT00771927|26967934|P2|Overall Study|Other reason|27
7757136|NCT00771927|26967935|P1|Overall Study|Other reason|23
7757137|NCT00771927|26967934|P2|Overall Study|Withdrawal by Subject|17
7757138|NCT00771927|26967935|P1|Overall Study|Withdrawal by Subject|16
7757139|NCT00771927|26967934|P2|Overall Study|Lost to Follow-up|46
7757140|NCT00771927|26967935|P1|Overall Study|Lost to Follow-up|46
7757141|NCT00771927|26967934|P2|Overall Study|Lack of Efficacy|42
7757142|NCT00771927|26967935|P1|Overall Study|Lack of Efficacy|70
7757143|NCT00771927|26967934|P2|Overall Study|Adverse Event|105
7757144|NCT00771927|26967935|P1|Overall Study|Adverse Event|100
7757145|NCT00771914|26967947|P4|Overall Study|Lost to Follow-up|1
7757146|NCT00771914|26967948|P3|Overall Study|Lost to Follow-up|0
7757147|NCT00771914|26967949|P2|Overall Study|Lost to Follow-up|0
7757148|NCT00771914|26967950|P1|Overall Study|Lost to Follow-up|0
7757149|NCT00771914|26967947|P4|Overall Study|Physician Decision|1
7757150|NCT00771914|26967948|P3|Overall Study|Physician Decision|0
7757151|NCT00771914|26967949|P2|Overall Study|Physician Decision|0
7757152|NCT00771914|26967950|P1|Overall Study|Physician Decision|0
7757153|NCT00771901|26967963|P3|Overall Study|Dissat w/# of study medication (40/day)|4
7757154|NCT00771901|26967964|P2|Overall Study|Dissat w/# of study medication (40/day)|0
7757155|NCT00771901|26967965|P1|Overall Study|Dissat w/# of study medication (40/day)|0
7757156|NCT00771849|26968012|P2|Overall Study|Not vaccinated|1
7757157|NCT00771849|26968013|P1|Overall Study|Not vaccinated|0
7757158|NCT00771849|26968012|P2|Overall Study|Withdrawal by Subject|1
7757159|NCT00771849|26968013|P1|Overall Study|Withdrawal by Subject|1
7757160|NCT00771849|26968012|P2|Overall Study|Lost to Follow-up|2
7757161|NCT00771849|26968013|P1|Overall Study|Lost to Follow-up|1
7757162|NCT00771810|26968024|P3|Overall Study|Other|1
7757163|NCT00771810|26968025|P2|Overall Study|Other|0
7757164|NCT00771810|26968026|P1|Overall Study|Other|0
7757165|NCT00771810|26968024|P3|Overall Study|Withdrawal by Subject|0
7757166|NCT00771810|26968025|P2|Overall Study|Withdrawal by Subject|2
7757167|NCT00771810|26968026|P1|Overall Study|Withdrawal by Subject|1
7757168|NCT00771810|26968024|P3|Overall Study|Protocol Violation|1
7757169|NCT00771810|26968025|P2|Overall Study|Protocol Violation|1
7757170|NCT00771810|26968026|P1|Overall Study|Protocol Violation|0
7757171|NCT00771810|26968024|P3|Overall Study|Physician Decision|2
7757172|NCT00771810|26968025|P2|Overall Study|Physician Decision|2
7757173|NCT00771810|26968026|P1|Overall Study|Physician Decision|1
7757174|NCT00771810|26968024|P3|Overall Study|Lost to Follow-up|1
7757175|NCT00771810|26968025|P2|Overall Study|Lost to Follow-up|0
7757176|NCT00771810|26968026|P1|Overall Study|Lost to Follow-up|0
7757177|NCT00771810|26968024|P3|Overall Study|Adverse Event|2
7757178|NCT00771810|26968025|P2|Overall Study|Adverse Event|0
7757179|NCT00771810|26968026|P1|Overall Study|Adverse Event|3
7757180|NCT00771758|26968064|P3|Overall Study|Other|0
7757181|NCT00771758|26968065|P2|Overall Study|Other|2
7757182|NCT00771758|26968066|P1|Overall Study|Other|3
7757183|NCT00771758|26968064|P3|Overall Study|Withdrawal by Subject|0
7757184|NCT00771758|26968065|P2|Overall Study|Withdrawal by Subject|0
7757185|NCT00771758|26968066|P1|Overall Study|Withdrawal by Subject|1
7757186|NCT00771758|26968064|P3|Overall Study|Protocol Violation|0
7757187|NCT00771758|26968065|P2|Overall Study|Protocol Violation|0
7757188|NCT00771758|26968066|P1|Overall Study|Protocol Violation|1
7757189|NCT00771758|26968064|P3|Overall Study|Lost to Follow-up|0
7757190|NCT00771758|26968065|P2|Overall Study|Lost to Follow-up|0
7757191|NCT00771758|26968066|P1|Overall Study|Lost to Follow-up|1
7757192|NCT00771758|26968064|P3|Overall Study|Lack of Efficacy|1
7757193|NCT00771758|26968065|P2|Overall Study|Lack of Efficacy|2
7757194|NCT00771758|26968066|P1|Overall Study|Lack of Efficacy|0
7757195|NCT00771758|26968064|P3|Overall Study|Adverse Event|1
7757196|NCT00771758|26968065|P2|Overall Study|Adverse Event|8
7757197|NCT00771758|26968066|P1|Overall Study|Adverse Event|2
7757198|NCT00771667|26968227|P10|Maintenance Phase|Other|3
7757199|NCT00771667|26968228|P9|Maintenance Phase|Other|3
7757200|NCT00771667|26968229|P8|Maintenance Phase|Other|2
7757201|NCT00771667|26968230|P7|Maintenance Phase|Other|2
7757202|NCT00771667|26968231|P6|Maintenance Phase|Other|1
7757203|NCT00771667|26968232|P5|Maintenance Phase|Other|0
7757204|NCT00771667|26968233|P4|Maintenance Phase|Other|0
7757205|NCT00771667|26968234|P3|Maintenance Phase|Other|0
7757206|NCT00771667|26968235|P2|Maintenance Phase|Other|0
7757207|NCT00771667|26968236|P1|Maintenance Phase|Other|0
7757208|NCT00771667|26968227|P10|Maintenance Phase|Lack of Efficacy|7
7757209|NCT00771667|26968228|P9|Maintenance Phase|Lack of Efficacy|11
7757210|NCT00771667|26968229|P8|Maintenance Phase|Lack of Efficacy|2
7757211|NCT00771667|26968230|P7|Maintenance Phase|Lack of Efficacy|3
7757212|NCT00771667|26968231|P6|Maintenance Phase|Lack of Efficacy|3
7757213|NCT00771667|26968232|P5|Maintenance Phase|Lack of Efficacy|1
7757214|NCT00771667|26968233|P4|Maintenance Phase|Lack of Efficacy|0
7757215|NCT00771667|26968234|P3|Maintenance Phase|Lack of Efficacy|0
7757216|NCT00771667|26968235|P2|Maintenance Phase|Lack of Efficacy|0
7757217|NCT00771667|26968236|P1|Maintenance Phase|Lack of Efficacy|0
7757218|NCT00771667|26968227|P10|Maintenance Phase|Adverse Event|7
7757219|NCT00771667|26968228|P9|Maintenance Phase|Adverse Event|8
7757220|NCT00771667|26968229|P8|Maintenance Phase|Adverse Event|1
7757221|NCT00771667|26968230|P7|Maintenance Phase|Adverse Event|5
7757222|NCT00771667|26968231|P6|Maintenance Phase|Adverse Event|3
7757223|NCT00771667|26968232|P5|Maintenance Phase|Adverse Event|1
7757224|NCT00771667|26968233|P4|Maintenance Phase|Adverse Event|0
7757225|NCT00771667|26968234|P3|Maintenance Phase|Adverse Event|0
7757226|NCT00771667|26968235|P2|Maintenance Phase|Adverse Event|0
7757227|NCT00771667|26968236|P1|Maintenance Phase|Adverse Event|0
7757228|NCT00771667|26968227|P10|Induction Phase|Other|0
7757229|NCT00771667|26968228|P9|Induction Phase|Other|0
7757230|NCT00771667|26968229|P8|Induction Phase|Other|0
7757231|NCT00771667|26968230|P7|Induction Phase|Other|0
7757232|NCT00771667|26968231|P6|Induction Phase|Other|0
7757233|NCT00771667|26968232|P5|Induction Phase|Other|0
7757234|NCT00771667|26968233|P4|Induction Phase|Other|4
7757235|NCT00771667|26968234|P3|Induction Phase|Other|3
7757236|NCT00771667|26968235|P2|Induction Phase|Other|6
7757237|NCT00771667|26968236|P1|Induction Phase|Other|4
7757238|NCT00771667|26968227|P10|Induction Phase|Lost to Follow-up|0
7757239|NCT00771667|26968228|P9|Induction Phase|Lost to Follow-up|0
7757240|NCT00771667|26968229|P8|Induction Phase|Lost to Follow-up|0
7757241|NCT00771667|26968230|P7|Induction Phase|Lost to Follow-up|0
7757242|NCT00771667|26968231|P6|Induction Phase|Lost to Follow-up|0
7757243|NCT00771667|26968232|P5|Induction Phase|Lost to Follow-up|0
7757244|NCT00771667|26968233|P4|Induction Phase|Lost to Follow-up|0
7757245|NCT00771667|26968234|P3|Induction Phase|Lost to Follow-up|1
7757246|NCT00771667|26968235|P2|Induction Phase|Lost to Follow-up|0
7757247|NCT00771667|26968236|P1|Induction Phase|Lost to Follow-up|1
7757248|NCT00771667|26968227|P10|Induction Phase|Lack of Efficacy|0
7757249|NCT00771667|26968228|P9|Induction Phase|Lack of Efficacy|0
7757250|NCT00771667|26968229|P8|Induction Phase|Lack of Efficacy|0
7757251|NCT00771667|26968230|P7|Induction Phase|Lack of Efficacy|0
7757252|NCT00771667|26968231|P6|Induction Phase|Lack of Efficacy|0
7757253|NCT00771667|26968232|P5|Induction Phase|Lack of Efficacy|0
7757254|NCT00771667|26968233|P4|Induction Phase|Lack of Efficacy|3
7757255|NCT00771667|26968234|P3|Induction Phase|Lack of Efficacy|4
7757256|NCT00771667|26968235|P2|Induction Phase|Lack of Efficacy|2
7757257|NCT00771667|26968236|P1|Induction Phase|Lack of Efficacy|9
7757258|NCT00771667|26968227|P10|Induction Phase|Adverse Event|0
7757259|NCT00771667|26968228|P9|Induction Phase|Adverse Event|0
7757260|NCT00771667|26968229|P8|Induction Phase|Adverse Event|0
7757261|NCT00771667|26968230|P7|Induction Phase|Adverse Event|0
7757262|NCT00771667|26968231|P6|Induction Phase|Adverse Event|0
7757263|NCT00771667|26968232|P5|Induction Phase|Adverse Event|0
7757264|NCT00771667|26968233|P4|Induction Phase|Adverse Event|1
7757265|NCT00771667|26968234|P3|Induction Phase|Adverse Event|4
7757266|NCT00771667|26968235|P2|Induction Phase|Adverse Event|2
7757267|NCT00771667|26968236|P1|Induction Phase|Adverse Event|5
7757268|NCT00771615|26968281|P9|Overall Study|Lost to Follow-up|0
7757269|NCT00771615|26968282|P8|Overall Study|Lost to Follow-up|0
7757270|NCT00771615|26968283|P7|Overall Study|Lost to Follow-up|1
7757271|NCT00771615|26968284|P6|Overall Study|Lost to Follow-up|1
7757272|NCT00771615|26968285|P5|Overall Study|Lost to Follow-up|0
7757273|NCT00771615|26968286|P4|Overall Study|Lost to Follow-up|1
7757274|NCT00771615|26968287|P3|Overall Study|Lost to Follow-up|1
7757275|NCT00771615|26968288|P2|Overall Study|Lost to Follow-up|1
7757276|NCT00771615|26968289|P1|Overall Study|Lost to Follow-up|1
7757277|NCT00771615|26968281|P9|Overall Study|Withdrawal by Subject|0
7757278|NCT00771615|26968282|P8|Overall Study|Withdrawal by Subject|1
7757279|NCT00771615|26968283|P7|Overall Study|Withdrawal by Subject|0
7757280|NCT00771615|26968284|P6|Overall Study|Withdrawal by Subject|0
7757281|NCT00771615|26968285|P5|Overall Study|Withdrawal by Subject|0
7757282|NCT00771615|26968286|P4|Overall Study|Withdrawal by Subject|0
7757283|NCT00771615|26968287|P3|Overall Study|Withdrawal by Subject|0
7757284|NCT00771615|26968288|P2|Overall Study|Withdrawal by Subject|1
7757285|NCT00771615|26968289|P1|Overall Study|Withdrawal by Subject|0
7757286|NCT00771472|26968550|P2|Overall Study|Protocol Violation|0
7757287|NCT00771472|26968551|P1|Overall Study|Protocol Violation|1
7757288|NCT00771472|26968550|P2|Overall Study|Progressive Disease|1
7757289|NCT00771472|26968551|P1|Overall Study|Progressive Disease|3
7757290|NCT00771472|26968550|P2|Overall Study|Physician Decision|3
7757291|NCT00771472|26968551|P1|Overall Study|Physician Decision|2
7757292|NCT00771316|26968571|P2|Overall Study|Discontinued due to early termination|0
7757293|NCT00771316|26968572|P1|Overall Study|Discontinued due to early termination|1
7757294|NCT00771316|26968571|P2|Overall Study|Patient withdrew consent|0
7757295|NCT00771316|26968572|P1|Overall Study|Patient withdrew consent|1
7757296|NCT00771316|26968571|P2|Overall Study|Adverse Event|1
7757297|NCT00771316|26968572|P1|Overall Study|Adverse Event|0
7757298|NCT00770991|26968624|P2|Overall Study|Pregnancy|0
7757299|NCT00770991|26968625|P1|Overall Study|Pregnancy|1
7757300|NCT00770991|26968624|P2|Overall Study|Adverse Event|5
7757301|NCT00770991|26968625|P1|Overall Study|Adverse Event|1
7757302|NCT00770991|26968624|P2|Overall Study|Withdrawal by Subject|0
7757303|NCT00770991|26968625|P1|Overall Study|Withdrawal by Subject|1
7757304|NCT00770991|26968624|P2|Overall Study|Physician Decision|0
7757305|NCT00770991|26968625|P1|Overall Study|Physician Decision|2
7757306|NCT00770965|26968641|P4|Excluded Set|Withdrawal by Subject|3
7757307|NCT00770965|26968642|P3|Excluded Set|Withdrawal by Subject|2
7757308|NCT00770965|26968643|P2|Excluded Set|Withdrawal by Subject|1
7757309|NCT00770965|26968644|P1|Excluded Set|Withdrawal by Subject|1
7757310|NCT00770965|26968641|P4|Excluded Set|Administrative problems|10
7757311|NCT00770965|26968642|P3|Excluded Set|Administrative problems|12
7757312|NCT00770965|26968643|P2|Excluded Set|Administrative problems|12
7757313|NCT00770965|26968644|P1|Excluded Set|Administrative problems|14
7757314|NCT00770965|26968641|P4|Safety Set|Protocol deviation|0
7757315|NCT00770965|26968642|P3|Safety Set|Protocol deviation|1
7757316|NCT00770965|26968643|P2|Safety Set|Protocol deviation|0
7757317|NCT00770965|26968644|P1|Safety Set|Protocol deviation|0
7757318|NCT00770965|26968641|P4|Safety Set|Withdrawal by Subject|1
7757319|NCT00770965|26968642|P3|Safety Set|Withdrawal by Subject|0
7757320|NCT00770965|26968643|P2|Safety Set|Withdrawal by Subject|0
7757321|NCT00770965|26968644|P1|Safety Set|Withdrawal by Subject|0
7757322|NCT00770913|26968665|P3|Overall Study|Incorrect drug was allocated|0
7757323|NCT00770913|26968666|P2|Overall Study|Incorrect drug was allocated|0
7757324|NCT00770913|26968667|P1|Overall Study|Incorrect drug was allocated|1
7757325|NCT00770913|26968665|P3|Overall Study|Protocol Violation|1
7757326|NCT00770913|26968666|P2|Overall Study|Protocol Violation|0
7757327|NCT00770913|26968667|P1|Overall Study|Protocol Violation|3
7757328|NCT00770913|26968665|P3|Overall Study|Physician Decision|1
7757329|NCT00770913|26968666|P2|Overall Study|Physician Decision|1
7757330|NCT00770913|26968667|P1|Overall Study|Physician Decision|0
7757331|NCT00770913|26968665|P3|Overall Study|Refusal to continue participation|5
7757332|NCT00770913|26968666|P2|Overall Study|Refusal to continue participation|4
7757333|NCT00770913|26968667|P1|Overall Study|Refusal to continue participation|6
7757334|NCT00770913|26968665|P3|Overall Study|Adverse Event|6
7757335|NCT00770913|26968666|P2|Overall Study|Adverse Event|3
7757336|NCT00770913|26968667|P1|Overall Study|Adverse Event|1
7757355|NCT00770770|26968712|P2|Overall Study|Study Terminated|0
7757356|NCT00770770|26968713|P1|Overall Study|Study Terminated|8
7757357|NCT00770770|26968712|P2|Overall Study|Death|1
7757358|NCT00770770|26968713|P1|Overall Study|Death|0
7757359|NCT00770770|26968712|P2|Overall Study|Withdrawal by Subject|0
7757360|NCT00770770|26968713|P1|Overall Study|Withdrawal by Subject|1
7757361|NCT00770770|26968712|P2|Overall Study|Lost to Follow-up|0
7757362|NCT00770770|26968713|P1|Overall Study|Lost to Follow-up|1
7757363|NCT00770692|26968731|P4|Overall Study|Investigator judgment|1
7757364|NCT00770692|26968732|P3|Overall Study|Investigator judgment|1
7757365|NCT00770692|26968733|P2|Overall Study|Investigator judgment|0
7757366|NCT00770692|26968734|P1|Overall Study|Investigator judgment|2
7757367|NCT00770692|26968731|P4|Overall Study|Adverse Event|4
7757368|NCT00770692|26968732|P3|Overall Study|Adverse Event|4
7757369|NCT00770692|26968733|P2|Overall Study|Adverse Event|0
7757370|NCT00770692|26968734|P1|Overall Study|Adverse Event|3
7757371|NCT00770692|26968731|P4|Overall Study|Withdrawal by Subject|6
7757372|NCT00770692|26968732|P3|Overall Study|Withdrawal by Subject|9
7757373|NCT00770692|26968733|P2|Overall Study|Withdrawal by Subject|9
7757374|NCT00770692|26968734|P1|Overall Study|Withdrawal by Subject|7
7757375|NCT00770679|26968760|P1|Overall Study|Follow-up LDL measurement not collected|3
7757376|NCT00770679|26968760|P1|Overall Study|Lost to Follow-up|3
7757377|NCT00770653|26968768|P2|Overall Study|Physician Decision|0
7757378|NCT00770653|26968769|P1|Overall Study|Physician Decision|1
7757379|NCT00770653|26968768|P2|Overall Study|Lost to Follow-up|2
7757380|NCT00770653|26968769|P1|Overall Study|Lost to Follow-up|1
7757381|NCT00770653|26968768|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
7757382|NCT00770653|26968769|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
7757383|NCT00770653|26968768|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
7757384|NCT00770653|26968769|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
7757385|NCT00770653|26968768|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
7757386|NCT00770653|26968769|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
7757387|NCT00770653|26968768|P2|Overall Study|Lack of Compliance|4
7757388|NCT00770653|26968769|P1|Overall Study|Lack of Compliance|1
7757389|NCT00770653|26968768|P2|Overall Study|Withdrawal by Subject|7
7757390|NCT00770653|26968769|P1|Overall Study|Withdrawal by Subject|4
7757391|NCT00770653|26968768|P2|Overall Study|Protocol Violation|6
7757392|NCT00770653|26968769|P1|Overall Study|Protocol Violation|8
7757393|NCT00770653|26968768|P2|Overall Study|Adverse Event|5
7757394|NCT00770653|26968769|P1|Overall Study|Adverse Event|13
7757395|NCT00770601|26968837|P1|Overall Study|Withdrawal by Subject|1
7757396|NCT00770588|26968843|P2|Overall Study|Withdrawal by Subject|1
7757397|NCT00770588|26968844|P1|Overall Study|Withdrawal by Subject|1
7757398|NCT00770588|26968843|P2|Overall Study|Lost to Follow-up|1
7757399|NCT00770588|26968844|P1|Overall Study|Lost to Follow-up|1
7757400|NCT00770588|26968843|P2|Overall Study|Death caused by progression of disease|91
7757401|NCT00770588|26968844|P1|Overall Study|Death caused by progression of disease|70
7757402|NCT00770588|26968843|P2|Overall Study|Adverse Event|2
7757403|NCT00770588|26968844|P1|Overall Study|Adverse Event|9
7757404|NCT00770562|26968860|P2|Overall Study|Did not take treatment|1
7757405|NCT00770562|26968861|P1|Overall Study|Did not take treatment|1
7757406|NCT00770510|26968872|P1|Overall Study|Withdrawal by Subject|2
7757407|NCT00770510|26968872|P1|Overall Study|Pregnancy|1
7757408|NCT00770510|26968872|P1|Overall Study|Lost to Follow-up|2
7757409|NCT00770484|26968911|P2|Overall Study|Withdrawal by Subject|0
7757410|NCT00770484|26968912|P1|Overall Study|Withdrawal by Subject|1
7757411|NCT00770432|26968920|P2|Overall Study|Non-compliance|1
7757412|NCT00770432|26968921|P1|Overall Study|Non-compliance|0
7757413|NCT00770432|26968920|P2|Overall Study|Other|6
7757414|NCT00770432|26968921|P1|Overall Study|Other|4
7757415|NCT00770367|26968929|P2|Second Intervention|Lost to Follow-up|0
7757416|NCT00770367|26968930|P1|Second Intervention|Lost to Follow-up|2
7757417|NCT00770367|26968929|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
7757418|NCT00770367|26968930|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
7757419|NCT00770367|26968929|P2|First Intervention|Withdrawal by Subject|2
7757420|NCT00770367|26968930|P1|First Intervention|Withdrawal by Subject|0
7757421|NCT00770341|26968941|P3|Overall Study|Not treated|0
7757422|NCT00770341|26968942|P2|Overall Study|Not treated|0
7757423|NCT00770341|26968943|P1|Overall Study|Not treated|1
7757424|NCT00770341|26968941|P3|Overall Study|Other|0
7757425|NCT00770341|26968942|P2|Overall Study|Other|0
7757426|NCT00770341|26968943|P1|Overall Study|Other|1
7757427|NCT00770341|26968941|P3|Overall Study|Lack of Efficacy|1
7757428|NCT00770341|26968942|P2|Overall Study|Lack of Efficacy|0
7757429|NCT00770341|26968943|P1|Overall Study|Lack of Efficacy|3
7757430|NCT00770341|26968941|P3|Overall Study|Laboratory adverse event|0
7757431|NCT00770341|26968942|P2|Overall Study|Laboratory adverse event|3
7757432|NCT00770341|26968943|P1|Overall Study|Laboratory adverse event|3
7757433|NCT00770341|26968941|P3|Overall Study|Clinical Adverse Event|2
7757434|NCT00770341|26968942|P2|Overall Study|Clinical Adverse Event|1
7757435|NCT00770341|26968943|P1|Overall Study|Clinical Adverse Event|3
7757436|NCT00770341|26968941|P3|Overall Study|Withdrawal by Subject|0
7757437|NCT00770341|26968942|P2|Overall Study|Withdrawal by Subject|1
7757438|NCT00770341|26968943|P1|Overall Study|Withdrawal by Subject|0
7757439|NCT00770341|26968941|P3|Overall Study|Did not meet eligibility criteria|0
7757440|NCT00770341|26968942|P2|Overall Study|Did not meet eligibility criteria|0
7757441|NCT00770341|26968943|P1|Overall Study|Did not meet eligibility criteria|1
7757442|NCT00770328|26968969|P2|Overall Study|Lost to Follow-up|2
7757443|NCT00770328|26968970|P1|Overall Study|Lost to Follow-up|2
7757444|NCT00770328|26968969|P2|Overall Study|Adverse Event|2
7757445|NCT00770328|26968970|P1|Overall Study|Adverse Event|11
7757446|NCT00770315|26968986|P4|Overall Study|Noncompliance with Protocol|9
7757447|NCT00770315|26968987|P3|Overall Study|Noncompliance with Protocol|7
7757448|NCT00770315|26968988|P2|Overall Study|Noncompliance with Protocol|4
7757449|NCT00770315|26968989|P1|Overall Study|Noncompliance with Protocol|7
7757450|NCT00770315|26968986|P4|Overall Study|Withdrawal by Subject|20
7757451|NCT00770315|26968987|P3|Overall Study|Withdrawal by Subject|24
7757452|NCT00770315|26968988|P2|Overall Study|Withdrawal by Subject|17
7757453|NCT00770315|26968989|P1|Overall Study|Withdrawal by Subject|13
7757454|NCT00770315|26968986|P4|Overall Study|Lost to Follow-up|3
7757455|NCT00770315|26968987|P3|Overall Study|Lost to Follow-up|10
7757456|NCT00770315|26968988|P2|Overall Study|Lost to Follow-up|5
7757457|NCT00770315|26968989|P1|Overall Study|Lost to Follow-up|9
7757458|NCT00770315|26968986|P4|Overall Study|Adverse Event|6
7757459|NCT00770315|26968987|P3|Overall Study|Adverse Event|16
7757460|NCT00770315|26968988|P2|Overall Study|Adverse Event|17
7757461|NCT00770315|26968989|P1|Overall Study|Adverse Event|11
7757462|NCT00770289|26969015|P1|Overall Study|Other|6
7757463|NCT00770224|26969024|P2|Step 2: Maintenance|Ineligible|2
7757464|NCT00770224|26969025|P1|Step 2: Maintenance|Ineligible|0
7757465|NCT00770224|26969024|P2|Step 2: Maintenance|Other reason not protocol specified|7
7757466|NCT00770224|26969025|P1|Step 2: Maintenance|Other reason not protocol specified|0
7757467|NCT00770224|26969024|P2|Step 2: Maintenance|Death|2
7757468|NCT00770224|26969025|P1|Step 2: Maintenance|Death|0
7757469|NCT00770224|26969024|P2|Step 2: Maintenance|Progression/relapse|1
7757470|NCT00770224|26969025|P1|Step 2: Maintenance|Progression/relapse|0
7757471|NCT00770224|26969024|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
7757472|NCT00770224|26969025|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
7757473|NCT00770224|26969024|P2|Step 2: Maintenance|Adverse Event|10
7757474|NCT00770224|26969025|P1|Step 2: Maintenance|Adverse Event|0
7757475|NCT00770224|26969024|P2|Step 1: Induction|No protocol treatment given|0
7757476|NCT00770224|26969025|P1|Step 1: Induction|No protocol treatment given|1
7757477|NCT00770224|26969024|P2|Step 1: Induction|Ineligible|0
7757478|NCT00770224|26969025|P1|Step 1: Induction|Ineligible|2
7757479|NCT00770224|26969024|P2|Step 1: Induction|Other reason not protocol specified|0
7757480|NCT00770224|26969025|P1|Step 1: Induction|Other reason not protocol specified|2
7757481|NCT00770224|26969024|P2|Step 1: Induction|Refusal unrelated to adverse event|0
7757482|NCT00770224|26969025|P1|Step 1: Induction|Refusal unrelated to adverse event|6
7757483|NCT00770224|26969024|P2|Step 1: Induction|Adverse Event|0
7757484|NCT00770224|26969025|P1|Step 1: Induction|Adverse Event|3
7757485|NCT00770211|26969037|P2|Overall Study|Withdrawal by Subject|2
7757486|NCT00770211|26969038|P1|Overall Study|Withdrawal by Subject|0
7757487|NCT00770211|26969037|P2|Overall Study|Lost to Follow-up|0
7757488|NCT00770211|26969038|P1|Overall Study|Lost to Follow-up|1
7757489|NCT00770146|26969054|P2|Follow-up Period|Other|5
7757490|NCT00770146|26969055|P1|Follow-up Period|Other|4
7757491|NCT00770146|26969054|P2|Follow-up Period|Adverse Event|2
7757492|NCT00770146|26969055|P1|Follow-up Period|Adverse Event|0
7757493|NCT00770146|26969054|P2|Follow-up Period|Withdrawal by Subject|13
7757494|NCT00770146|26969055|P1|Follow-up Period|Withdrawal by Subject|7
7757495|NCT00770146|26969054|P2|Treatment Period|Protocol non-compliance|1
7757496|NCT00770146|26969055|P1|Treatment Period|Protocol non-compliance|0
7757497|NCT00770146|26969054|P2|Treatment Period|Other|5
7757498|NCT00770146|26969055|P1|Treatment Period|Other|1
7757499|NCT00770146|26969054|P2|Treatment Period|Adverse Event|26
7757500|NCT00770146|26969055|P1|Treatment Period|Adverse Event|2
7757501|NCT00770146|26969054|P2|Treatment Period|Withdrawal by Subject|13
7757502|NCT00770146|26969055|P1|Treatment Period|Withdrawal by Subject|6
7757503|NCT00770120|26969144|P1|Overall Study|Reason under Review|1
7757504|NCT00770120|26969144|P1|Overall Study|Never Received Treatment/Not Analyzable|1
7757505|NCT00770120|26969144|P1|Overall Study|Ineligible|1
7757506|NCT00770120|26969144|P1|Overall Study|Withdrawal by Subject|2
7757507|NCT00770120|26969144|P1|Overall Study|Death|3
7757508|NCT00770120|26969144|P1|Overall Study|Not Protocol Specified|11
7757509|NCT00770120|26969144|P1|Overall Study|Adverse Event|11
7757510|NCT00770120|26969144|P1|Overall Study|Progression|31
7757511|NCT00770029|26969153|P2|Overall Study|Adverse Event|0
7757512|NCT00770029|26969154|P1|Overall Study|Adverse Event|1
7757513|NCT00770029|26969153|P2|Overall Study|Withdrawal by Subject|3
7757514|NCT00770029|26969154|P1|Overall Study|Withdrawal by Subject|3
7757515|NCT00770029|26969153|P2|Overall Study|Lost to Follow-up|0
7757516|NCT00770029|26969154|P1|Overall Study|Lost to Follow-up|2
7757517|NCT00769860|26969215|P2|Overall Study|Withdrawal by Subject|0
7757518|NCT00769860|26969216|P1|Overall Study|Withdrawal by Subject|2
7757519|NCT00769704|26969254|P2|Overall Study|Other|2
7757520|NCT00769704|26969255|P1|Overall Study|Other|1
7757521|NCT00769704|26969254|P2|Overall Study|Withdrawal by Subject|5
7757522|NCT00769704|26969255|P1|Overall Study|Withdrawal by Subject|12
7757523|NCT00769704|26969254|P2|Overall Study|Death|190
7757524|NCT00769704|26969255|P1|Overall Study|Death|95
7757525|NCT00769704|26969254|P2|Overall Study|Lost to Follow-up|2
7757526|NCT00769704|26969255|P1|Overall Study|Lost to Follow-up|3
7757527|NCT00769561|26969305|P2|Overall Study|Lost to Follow-up|3
7757528|NCT00769561|26969306|P1|Overall Study|Lost to Follow-up|1
7757529|NCT00769561|26969305|P2|Overall Study|Withdrawal by Subject|2
7757530|NCT00769561|26969306|P1|Overall Study|Withdrawal by Subject|2
7757531|NCT00769483|26969332|P6|Overall Study|Withdrawal by Subject|0
7757532|NCT00769483|26969333|P5|Overall Study|Withdrawal by Subject|1
7757533|NCT00769483|26969334|P4|Overall Study|Withdrawal by Subject|0
7757534|NCT00769483|26969335|P3|Overall Study|Withdrawal by Subject|0
7757535|NCT00769483|26969336|P2|Overall Study|Withdrawal by Subject|1
7757536|NCT00769483|26969337|P1|Overall Study|Withdrawal by Subject|0
7757537|NCT00769184|26969409|P2|No Treatment (6 Weeks)|Adverse Event|1
7757538|NCT00769184|26969410|P1|No Treatment (6 Weeks)|Adverse Event|1
7757539|NCT00769184|26969409|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
7757540|NCT00769184|26969410|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
7757541|NCT00769184|26969409|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
7757542|NCT00769184|26969410|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
7757543|NCT00769132|26969418|P4|Period 4|Withdrawal by Subject|0
7757544|NCT00769132|26969419|P3|Period 4|Withdrawal by Subject|0
7757545|NCT00769132|26969420|P2|Period 4|Withdrawal by Subject|1
7757546|NCT00769132|26969421|P1|Period 4|Withdrawal by Subject|0
7757547|NCT00769132|26969418|P4|Period 3|Withdrawal by Subject|0
7757548|NCT00769132|26969419|P3|Period 3|Withdrawal by Subject|0
7757549|NCT00769132|26969420|P2|Period 3|Withdrawal by Subject|0
7757550|NCT00769132|26969421|P1|Period 3|Withdrawal by Subject|1
7757551|NCT00769132|26969418|P4|Period 2|Withdrawal by Subject|1
7757552|NCT00769132|26969419|P3|Period 2|Withdrawal by Subject|0
7757553|NCT00769132|26969420|P2|Period 2|Withdrawal by Subject|0
7757554|NCT00769132|26969421|P1|Period 2|Withdrawal by Subject|0
7757555|NCT00769132|26969418|P4|Period 1|Adverse Event|1
7757556|NCT00769132|26969419|P3|Period 1|Adverse Event|0
7757557|NCT00769132|26969420|P2|Period 1|Adverse Event|0
7757558|NCT00769132|26969421|P1|Period 1|Adverse Event|1
7757559|NCT00769119|26969437|P2|Overall Study|Disallowed medication|0
7757560|NCT00769119|26969438|P1|Overall Study|Disallowed medication|1
7757561|NCT00769119|26969437|P2|Overall Study|Adverse Event|1
7757562|NCT00769119|26969438|P1|Overall Study|Adverse Event|1
7757563|NCT00769119|26969437|P2|Overall Study|Voluntary discontinuation|2
7757564|NCT00769119|26969438|P1|Overall Study|Voluntary discontinuation|0
7757565|NCT00769067|26969484|P2|Overall Study|Withdrawal by Subject|1
7757566|NCT00769067|26969485|P1|Overall Study|Withdrawal by Subject|0
7757567|NCT00769067|26969484|P2|Overall Study|Other|3
7757568|NCT00769067|26969485|P1|Overall Study|Other|1
7757569|NCT00769067|26969484|P2|Overall Study|Study terminated by sponsor|3
7757570|NCT00769067|26969485|P1|Overall Study|Study terminated by sponsor|1
7757571|NCT00769067|26969484|P2|Overall Study|Lost to Follow-up|1
7757572|NCT00769067|26969485|P1|Overall Study|Lost to Follow-up|3
7757573|NCT00769067|26969484|P2|Overall Study|Death|86
7757574|NCT00769067|26969485|P1|Overall Study|Death|89
7757575|NCT00769002|26969535|P2|Overall Study|Study was not completed, no data|9
7757576|NCT00769002|26969536|P1|Overall Study|Study was not completed, no data|9
7757577|NCT00768989|26969543|P2|On or After Week 36|Sponsor Termination|26
7757578|NCT00768989|26969544|P1|On or After Week 36|Sponsor Termination|45
7757579|NCT00768989|26969543|P2|On or After Week 36|Did not attend termination visit|0
7757580|NCT00768989|26969544|P1|On or After Week 36|Did not attend termination visit|2
7757581|NCT00768989|26969543|P2|On or After Week 36|Protocol Violation|0
7757582|NCT00768989|26969544|P1|On or After Week 36|Protocol Violation|1
7757583|NCT00768989|26969543|P2|On or After Week 36|Poor Compliance|0
7757584|NCT00768989|26969544|P1|On or After Week 36|Poor Compliance|1
7757585|NCT00768989|26969543|P2|On or After Week 36|Lost to Follow-up|0
7757586|NCT00768989|26969544|P1|On or After Week 36|Lost to Follow-up|1
7757587|NCT00768989|26969543|P2|On or After Week 36|Adverse Event|1
7757588|NCT00768989|26969544|P1|On or After Week 36|Adverse Event|0
7757589|NCT00768989|26969543|P2|On or After Week 36|Lack of Efficacy|0
7757590|NCT00768989|26969544|P1|On or After Week 36|Lack of Efficacy|1
7757591|NCT00768989|26969543|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
7757592|NCT00768989|26969544|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
7757593|NCT00768989|26969543|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
7757594|NCT00768989|26969544|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
7757595|NCT00768989|26969543|P2|Week 24 to Prior to Week 36|Adverse Event|0
7757596|NCT00768989|26969544|P1|Week 24 to Prior to Week 36|Adverse Event|1
7757597|NCT00768989|26969543|P2|Prior to Week 24|Protocol Violation|2
7757598|NCT00768989|26969544|P1|Prior to Week 24|Protocol Violation|0
7757599|NCT00768989|26969543|P2|Prior to Week 24|Lost to Follow-up|1
7757600|NCT00768989|26969544|P1|Prior to Week 24|Lost to Follow-up|0
7757601|NCT00768989|26969543|P2|Prior to Week 24|Adverse Event|0
7757602|NCT00768989|26969544|P1|Prior to Week 24|Adverse Event|3
7757603|NCT00768989|26969543|P2|Prior to Week 24|Withdrawal by Subject|0
7757604|NCT00768989|26969544|P1|Prior to Week 24|Withdrawal by Subject|1
7757605|NCT00768898|26969592|P1|Overall Study|Headache|1
7757606|NCT00768898|26969592|P1|Overall Study|Unrelated injury|1
7757607|NCT00768755|26969616|P4|Phase 2|Randomized but not treated|2
7757608|NCT00768755|26969617|P3|Phase 2|Randomized but not treated|0
7757609|NCT00768755|26969618|P2|Phase 2|Randomized but not treated|0
7757610|NCT00768755|26969619|P1|Phase 2|Randomized but not treated|0
7757611|NCT00768755|26969616|P4|Phase 2|Study Terminated by Sponsor|14
7757612|NCT00768755|26969617|P3|Phase 2|Study Terminated by Sponsor|7
7757613|NCT00768755|26969618|P2|Phase 2|Study Terminated by Sponsor|13
7757614|NCT00768755|26969619|P1|Phase 2|Study Terminated by Sponsor|0
7757615|NCT00768755|26969616|P4|Phase 2|Other|4
7757616|NCT00768755|26969617|P3|Phase 2|Other|2
7757617|NCT00768755|26969618|P2|Phase 2|Other|1
7757618|NCT00768755|26969619|P1|Phase 2|Other|0
7757619|NCT00768755|26969616|P4|Phase 2|Withdrawal by Subject|1
7757620|NCT00768755|26969617|P3|Phase 2|Withdrawal by Subject|0
7757621|NCT00768755|26969618|P2|Phase 2|Withdrawal by Subject|1
7757622|NCT00768755|26969619|P1|Phase 2|Withdrawal by Subject|0
7757623|NCT00768755|26969616|P4|Phase 2|Lost to Follow-up|4
7757624|NCT00768755|26969617|P3|Phase 2|Lost to Follow-up|1
7757625|NCT00768755|26969618|P2|Phase 2|Lost to Follow-up|1
7757626|NCT00768755|26969619|P1|Phase 2|Lost to Follow-up|0
7757627|NCT00768755|26969616|P4|Phase 2|Protocol Violation|1
7757628|NCT00768755|26969617|P3|Phase 2|Protocol Violation|0
7757629|NCT00768755|26969618|P2|Phase 2|Protocol Violation|2
7757630|NCT00768755|26969619|P1|Phase 2|Protocol Violation|0
7757631|NCT00768755|26969616|P4|Phase 2|Death|31
7757632|NCT00768755|26969617|P3|Phase 2|Death|48
7757633|NCT00768755|26969618|P2|Phase 2|Death|37
7757634|NCT00768755|26969619|P1|Phase 2|Death|0
7757635|NCT00768755|26969616|P4|Phase 1|Other|0
7757636|NCT00768755|26969617|P3|Phase 1|Other|0
7757637|NCT00768755|26969618|P2|Phase 1|Other|0
7757638|NCT00768755|26969619|P1|Phase 1|Other|4
7757639|NCT00768755|26969616|P4|Phase 1|Death|0
7757640|NCT00768755|26969617|P3|Phase 1|Death|0
7757641|NCT00768755|26969618|P2|Phase 1|Death|0
7757642|NCT00768755|26969619|P1|Phase 1|Death|6
7757643|NCT00768664|26969667|P1|Overall Study|Participant refused|1
7757644|NCT00768664|26969667|P1|Overall Study|Other|9
7757645|NCT00768664|26969667|P1|Overall Study|Lost to Follow-up|2
7757646|NCT00768664|26969667|P1|Overall Study|Death|57
7757647|NCT00768651|26969686|P1|Overall Study|Withdrawal by Subject|1
7757648|NCT00768560|26969725|P6|Intervention Set 1|Adverse Event|0
7757649|NCT00768560|26969726|P5|Intervention Set 1|Adverse Event|0
7757650|NCT00768560|26969727|P4|Intervention Set 1|Adverse Event|0
7757651|NCT00768560|26969728|P3|Intervention Set 1|Adverse Event|0
7757652|NCT00768560|26969729|P2|Intervention Set 1|Adverse Event|1
7757653|NCT00768560|26969730|P1|Intervention Set 1|Adverse Event|0
7757654|NCT00768469|26969767|P2|Overall Study|Withdrawal by Subject|1
7757655|NCT00768469|26969768|P1|Overall Study|Withdrawal by Subject|0
7757656|NCT00768469|26969767|P2|Overall Study|Disease Progression|4
7757657|NCT00768469|26969768|P1|Overall Study|Disease Progression|3
7757658|NCT00768469|26969767|P2|Overall Study|Adverse Event|2
7757659|NCT00768469|26969768|P1|Overall Study|Adverse Event|0
7757660|NCT00768430|26969783|P2|7 Day Endpoint|Withdrawal by Subject|3
7757661|NCT00768430|26969784|P1|7 Day Endpoint|Withdrawal by Subject|2
7757662|NCT00768300|26969792|P2|Overall Study|Missing data|0
7757663|NCT00768300|26969793|P1|Overall Study|Missing data|1
7757664|NCT00768300|26969792|P2|Overall Study|Treated but never dosed with Study drug|0
7757665|NCT00768300|26969793|P1|Overall Study|Treated but never dosed with Study drug|1
7757666|NCT00768300|26969792|P2|Overall Study|Began prohibited concomitant medication|1
7757667|NCT00768300|26969793|P1|Overall Study|Began prohibited concomitant medication|0
7757668|NCT00768300|26969792|P2|Overall Study|Lost to Follow-up|1
7757669|NCT00768300|26969793|P1|Overall Study|Lost to Follow-up|0
7757670|NCT00768300|26969792|P2|Overall Study|Received lung transplant|1
7757671|NCT00768300|26969793|P1|Overall Study|Received lung transplant|1
7757672|NCT00768300|26969792|P2|Overall Study|Screen failure following randomization|0
7757673|NCT00768300|26969793|P1|Overall Study|Screen failure following randomization|1
7757674|NCT00768300|26969792|P2|Overall Study|Subject moved to pursue lung transplant|1
7757675|NCT00768300|26969793|P1|Overall Study|Subject moved to pursue lung transplant|1
7757676|NCT00768300|26969792|P2|Overall Study|Death|5
7757677|NCT00768300|26969793|P1|Overall Study|Death|21
7757678|NCT00768300|26969792|P2|Overall Study|Study discontinued by Sponsor|140
7757679|NCT00768300|26969793|P1|Overall Study|Study discontinued by Sponsor|271
7757680|NCT00768300|26969792|P2|Overall Study|Physician Decision|3
7757681|NCT00768300|26969793|P1|Overall Study|Physician Decision|2
7757682|NCT00768300|26969792|P2|Overall Study|Withdrawal by Subject|7
7757683|NCT00768300|26969793|P1|Overall Study|Withdrawal by Subject|13
7757684|NCT00768300|26969792|P2|Overall Study|Protocol Violation|1
7757685|NCT00768300|26969793|P1|Overall Study|Protocol Violation|6
7757686|NCT00768300|26969792|P2|Overall Study|Adverse Event|2
7757687|NCT00768300|26969793|P1|Overall Study|Adverse Event|10
7757688|NCT00768300|26969792|P2|Overall Study|Randomized but not treated|1
7757689|NCT00768300|26969793|P1|Overall Study|Randomized but not treated|1
7757690|NCT00768248|26969877|P2|Overall Study|Research coordinator didn't collect data|1
7757691|NCT00768248|26969878|P1|Overall Study|Research coordinator didn't collect data|1
7757692|NCT00768222|26969894|P2|Overall Study|Protocol Violation|2
7757693|NCT00768222|26969895|P1|Overall Study|Protocol Violation|0
7757694|NCT00768222|26969894|P2|Overall Study|Withdrawal by Subject|1
7757695|NCT00768222|26969895|P1|Overall Study|Withdrawal by Subject|3
7757696|NCT00768222|26969894|P2|Overall Study|Lost to Follow-up|1
7757697|NCT00768222|26969895|P1|Overall Study|Lost to Follow-up|1
7757698|NCT00768144|26969917|P1|Overall Study|Pt Withdrew Consent|1
7757699|NCT00768144|26969917|P1|Overall Study|Patient or MD Decision to End Treatment|1
7757700|NCT00768144|26969917|P1|Overall Study|Progressive Disease|21
7757701|NCT00768144|26969917|P1|Overall Study|Adverse Event|13
7757702|NCT00768079|26969930|P3|Overall Study|Participant incarcerated|0
7757703|NCT00768079|26969931|P2|Overall Study|Participant incarcerated|1
7757704|NCT00768079|26969932|P1|Overall Study|Participant incarcerated|0
7757705|NCT00768079|26969930|P3|Overall Study|Lost to Follow-up|4
7757706|NCT00768079|26969931|P2|Overall Study|Lost to Follow-up|0
7757707|NCT00768079|26969932|P1|Overall Study|Lost to Follow-up|2
7757708|NCT00768066|26969989|P3|Overall Study|Did not receive study product injection.|0
7757709|NCT00768066|26969990|P2|Overall Study|Did not receive study product injection.|3
7757710|NCT00768066|26969991|P1|Overall Study|Did not receive study product injection.|3
7757711|NCT00768053|26970023|P1|Overall Study|Lost to Follow-up|1
7757712|NCT00768053|26970023|P1|Overall Study|Adverse Event|10
7757713|NCT00768040|26970054|P2|Overall Study|Abnormal laboratory value|1
7757714|NCT00768040|26970055|P1|Overall Study|Abnormal laboratory value|1
7757715|NCT00768040|26970054|P2|Overall Study|Adverse Event|2
7757716|NCT00768040|26970055|P1|Overall Study|Adverse Event|3
7757717|NCT00767819|26970064|P3|Overall Study|Lost to Follow-up|0
7757718|NCT00767819|26970065|P2|Overall Study|Lost to Follow-up|0
7757719|NCT00767819|26970066|P1|Overall Study|Lost to Follow-up|1
7757720|NCT00767819|26970064|P3|Overall Study|Abnormal lab values|0
7757721|NCT00767819|26970065|P2|Overall Study|Abnormal lab values|0
7757722|NCT00767819|26970066|P1|Overall Study|Abnormal lab values|1
7757723|NCT00767819|26970064|P3|Overall Study|Adverse Event|0
7757724|NCT00767819|26970065|P2|Overall Study|Adverse Event|0
7757725|NCT00767819|26970066|P1|Overall Study|Adverse Event|2
7757726|NCT00767819|26970064|P3|Overall Study|Death|0
7757727|NCT00767819|26970065|P2|Overall Study|Death|3
7757728|NCT00767819|26970066|P1|Overall Study|Death|2
7757729|NCT00767819|26970064|P3|Overall Study|Administrative problems|0
7757730|NCT00767819|26970065|P2|Overall Study|Administrative problems|1
7757731|NCT00767819|26970066|P1|Overall Study|Administrative problems|0
7757732|NCT00767819|26970064|P3|Overall Study|Withdrawal by Subject|0
7757733|NCT00767819|26970065|P2|Overall Study|Withdrawal by Subject|1
7757734|NCT00767819|26970066|P1|Overall Study|Withdrawal by Subject|1
7757735|NCT00767819|26970064|P3|Overall Study|Unsatisfactory therapeutic effect|0
7757736|NCT00767819|26970065|P2|Overall Study|Unsatisfactory therapeutic effect|14
7757737|NCT00767819|26970066|P1|Overall Study|Unsatisfactory therapeutic effect|18
7757738|NCT00767806|26970091|P2|Overall Study|Sponsor Decision|1
7757739|NCT00767806|26970092|P1|Overall Study|Sponsor Decision|0
7757740|NCT00767806|26970091|P2|Overall Study|Entry Criteria Not Met|1
7757741|NCT00767806|26970092|P1|Overall Study|Entry Criteria Not Met|1
7757742|NCT00767806|26970091|P2|Overall Study|Lost to Follow-up|4
7757743|NCT00767806|26970092|P1|Overall Study|Lost to Follow-up|1
7757744|NCT00767806|26970091|P2|Overall Study|Physician Decision|3
7757745|NCT00767806|26970092|P1|Overall Study|Physician Decision|4
7757746|NCT00767806|26970091|P2|Overall Study|Lack of Efficacy|9
7757747|NCT00767806|26970092|P1|Overall Study|Lack of Efficacy|1
7757748|NCT00767806|26970091|P2|Overall Study|Protocol Violation|5
7757749|NCT00767806|26970092|P1|Overall Study|Protocol Violation|6
7757750|NCT00767806|26970091|P2|Overall Study|Withdrawal by Subject|13
7757751|NCT00767806|26970092|P1|Overall Study|Withdrawal by Subject|8
7757752|NCT00767806|26970091|P2|Overall Study|Adverse Event|11
7757753|NCT00767806|26970092|P1|Overall Study|Adverse Event|30
7757754|NCT00767676|26970169|P1|Overall Study|Investigator error|54
7757755|NCT00767520|26970192|P2|Overall Study|Randomized in error and Never treated|2
7757756|NCT00767520|26970193|P1|Overall Study|Randomized in error and Never treated|0
7757757|NCT00767520|26970192|P2|Overall Study|Participants still on treatment|15
7757758|NCT00767520|26970193|P1|Overall Study|Participants still on treatment|11
7757759|NCT00767455|26970246|P1|Overall Study|Investigator error|19
7757760|NCT00767325|26970280|P1|Overall Study|Missed visit due to family reasons|1
7757761|NCT00767325|26970280|P1|Overall Study|No longer met study criteria|2
7757762|NCT00767325|26970280|P1|Overall Study|Lost to Follow-up|3
7757763|NCT00767325|26970280|P1|Overall Study|Adverse Event|7
7757764|NCT00767325|26970280|P1|Overall Study|Lack of Efficacy|2
7757765|NCT00767104|26970291|P2|Overall Study|Lost to Follow-up|2
7757766|NCT00767104|26970292|P1|Overall Study|Lost to Follow-up|1
7757767|NCT00767039|26970302|P2|Overall Study|Death|2
7757768|NCT00767039|26970303|P1|Overall Study|Death|5
7757769|NCT00767000|26970334|P5|Optional 104-week Extension|Study terminated by sponsor|4
7757770|NCT00767000|26970335|P4|Optional 104-week Extension|Study terminated by sponsor|2
7757771|NCT00767000|26970336|P3|Optional 104-week Extension|Study terminated by sponsor|7
7757772|NCT00767000|26970337|P2|Optional 104-week Extension|Study terminated by sponsor|3
7757773|NCT00767000|26970338|P1|Optional 104-week Extension|Study terminated by sponsor|7
7757774|NCT00767000|26970334|P5|54-week Study|Reason not reported|0
7757775|NCT00767000|26970335|P4|54-week Study|Reason not reported|1
7757776|NCT00767000|26970336|P3|54-week Study|Reason not reported|0
7757777|NCT00767000|26970337|P2|54-week Study|Reason not reported|0
7757778|NCT00767000|26970338|P1|54-week Study|Reason not reported|0
7757779|NCT00767000|26970334|P5|54-week Study|Study terminated by sponsor|194
7757780|NCT00767000|26970335|P4|54-week Study|Study terminated by sponsor|196
7757781|NCT00767000|26970336|P3|54-week Study|Study terminated by sponsor|89
7757782|NCT00767000|26970337|P2|54-week Study|Study terminated by sponsor|102
7757783|NCT00767000|26970338|P1|54-week Study|Study terminated by sponsor|90
7757784|NCT00767000|26970334|P5|54-week Study|Withdrawal by Subject|13
7757785|NCT00767000|26970335|P4|54-week Study|Withdrawal by Subject|11
7757786|NCT00767000|26970336|P3|54-week Study|Withdrawal by Subject|5
7757787|NCT00767000|26970337|P2|54-week Study|Withdrawal by Subject|3
7757788|NCT00767000|26970338|P1|54-week Study|Withdrawal by Subject|2
7757789|NCT00767000|26970334|P5|54-week Study|Protocol Violation|0
7757790|NCT00767000|26970335|P4|54-week Study|Protocol Violation|2
7757791|NCT00767000|26970336|P3|54-week Study|Protocol Violation|1
7757792|NCT00767000|26970337|P2|54-week Study|Protocol Violation|0
7757793|NCT00767000|26970338|P1|54-week Study|Protocol Violation|0
7757794|NCT00767000|26970334|P5|54-week Study|Progressive disease|0
7757795|NCT00767000|26970335|P4|54-week Study|Progressive disease|0
7757796|NCT00767000|26970336|P3|54-week Study|Progressive disease|1
7757797|NCT00767000|26970337|P2|54-week Study|Progressive disease|0
7757798|NCT00767000|26970338|P1|54-week Study|Progressive disease|0
7757799|NCT00767000|26970334|P5|54-week Study|Physician Decision|1
7757800|NCT00767000|26970335|P4|54-week Study|Physician Decision|1
7757801|NCT00767000|26970336|P3|54-week Study|Physician Decision|1
7757802|NCT00767000|26970337|P2|54-week Study|Physician Decision|0
7757803|NCT00767000|26970338|P1|54-week Study|Physician Decision|4
7757804|NCT00767000|26970334|P5|54-week Study|Lost to Follow-up|2
7757805|NCT00767000|26970335|P4|54-week Study|Lost to Follow-up|4
7757806|NCT00767000|26970336|P3|54-week Study|Lost to Follow-up|1
7757807|NCT00767000|26970337|P2|54-week Study|Lost to Follow-up|0
7757808|NCT00767000|26970338|P1|54-week Study|Lost to Follow-up|4
7757809|NCT00767000|26970334|P5|54-week Study|Lack of Efficacy|5
7757810|NCT00767000|26970335|P4|54-week Study|Lack of Efficacy|0
7757811|NCT00767000|26970336|P3|54-week Study|Lack of Efficacy|1
7757812|NCT00767000|26970337|P2|54-week Study|Lack of Efficacy|0
7757813|NCT00767000|26970338|P1|54-week Study|Lack of Efficacy|2
7757814|NCT00767000|26970334|P5|54-week Study|Interruption of study medication|0
7757815|NCT00767000|26970335|P4|54-week Study|Interruption of study medication|0
7757816|NCT00767000|26970336|P3|54-week Study|Interruption of study medication|1
7757817|NCT00767000|26970337|P2|54-week Study|Interruption of study medication|0
7757818|NCT00767000|26970338|P1|54-week Study|Interruption of study medication|0
7757819|NCT00767000|26970334|P5|54-week Study|Hypoglycemia|0
7757820|NCT00767000|26970335|P4|54-week Study|Hypoglycemia|0
7757821|NCT00767000|26970336|P3|54-week Study|Hypoglycemia|0
7757822|NCT00767000|26970337|P2|54-week Study|Hypoglycemia|1
7757823|NCT00767000|26970338|P1|54-week Study|Hypoglycemia|0
7757824|NCT00767000|26970334|P5|54-week Study|Hyperglycemia|1
7757825|NCT00767000|26970335|P4|54-week Study|Hyperglycemia|0
7757826|NCT00767000|26970336|P3|54-week Study|Hyperglycemia|1
7757827|NCT00767000|26970337|P2|54-week Study|Hyperglycemia|0
7757828|NCT00767000|26970338|P1|54-week Study|Hyperglycemia|0
7757829|NCT00767000|26970334|P5|54-week Study|Creaninine/creatinine clearance|4
7757830|NCT00767000|26970335|P4|54-week Study|Creaninine/creatinine clearance|2
7757831|NCT00767000|26970336|P3|54-week Study|Creaninine/creatinine clearance|2
7757832|NCT00767000|26970337|P2|54-week Study|Creaninine/creatinine clearance|1
7757833|NCT00767000|26970338|P1|54-week Study|Creaninine/creatinine clearance|2
7757834|NCT00767000|26970334|P5|54-week Study|Adverse Event|4
7757835|NCT00767000|26970335|P4|54-week Study|Adverse Event|8
7757836|NCT00767000|26970336|P3|54-week Study|Adverse Event|6
7757837|NCT00767000|26970337|P2|54-week Study|Adverse Event|6
7757838|NCT00767000|26970338|P1|54-week Study|Adverse Event|4
7757839|NCT00766831|26970380|P1|Overall Study|Other|28
7757840|NCT00766831|26970380|P1|Overall Study|Non cooperation by participants|14
7757841|NCT00766831|26970380|P1|Overall Study|Withdrawal of consent|26
7757842|NCT00766831|26970380|P1|Overall Study|Physician Decision|5
7757843|NCT00766831|26970380|P1|Overall Study|Protocol Violation|15
7757844|NCT00766831|26970380|P1|Overall Study|Adverse Event|20
7757845|NCT00766831|26970380|P1|Overall Study|Lost to Follow-up|3
7757846|NCT00766831|26970380|P1|Overall Study|Withdrawal by Subject|4
7757847|NCT00766675|26970416|P1|Overall Study|Insufficient therapy|1
7757848|NCT00766675|26970416|P1|Overall Study|Receive other anti-neoplastic treatment|1
7757849|NCT00766675|26970416|P1|Overall Study|Participant took prohibited medication|1
7757850|NCT00766675|26970416|P1|Overall Study|Protocol Violation|8
7757851|NCT00766675|26970416|P1|Overall Study|Withdrawal by Subject|11
7757852|NCT00766675|26970416|P1|Overall Study|Lost to Follow-up|2
7757853|NCT00766675|26970416|P1|Overall Study|Adverse Event|16
7757854|NCT00766636|26970445|P2|Overall Study|Disease Progression|0
7757855|NCT00766636|26970446|P1|Overall Study|Disease Progression|1
7757856|NCT00766636|26970445|P2|Overall Study|Adverse Event|0
7757857|NCT00766636|26970446|P1|Overall Study|Adverse Event|1
7757858|NCT00766636|26970445|P2|Overall Study|Incomplete Treatment|1
7757859|NCT00766636|26970446|P1|Overall Study|Incomplete Treatment|0
7757860|NCT00766636|26970445|P2|Overall Study|Withdrawal by Subject|1
7757861|NCT00766636|26970446|P1|Overall Study|Withdrawal by Subject|1
7757862|NCT00766597|26970452|P1|Overall Study|Without CCR5-tropic virus|5
7757863|NCT00766597|26970452|P1|Overall Study|Unexpected closure of study|4
7757864|NCT00766532|26970464|P1|Overall Study|Protocol Violation|2
7757865|NCT00766506|26970470|P2|Overall Study|Other|2
7757866|NCT00766506|26970471|P1|Overall Study|Other|2
7757867|NCT00766506|26970470|P2|Overall Study|Use rescue medication after 3 hours|0
7757868|NCT00766506|26970471|P1|Overall Study|Use rescue medication after 3 hours|3
7757869|NCT00766493|26970495|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
7757870|NCT00766493|26970495|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
7757871|NCT00766493|26970495|P1|30 Days Post-Procedure|Discontinued|7
7757872|NCT00766467|26970505|P2|Overall Study|Physician Decision|0
7757873|NCT00766467|26970506|P1|Overall Study|Physician Decision|1
7757874|NCT00766467|26970505|P2|Overall Study|Tumor Progression on Study|1
7757875|NCT00766467|26970506|P1|Overall Study|Tumor Progression on Study|0
7757876|NCT00766467|26970505|P2|Overall Study|Protocol Violation|4
7757877|NCT00766467|26970506|P1|Overall Study|Protocol Violation|2
7757878|NCT00766467|26970505|P2|Overall Study|Adverse Event|1
7757879|NCT00766467|26970506|P1|Overall Study|Adverse Event|1
7757880|NCT00766467|26970505|P2|Overall Study|Withdrawal by Subject|2
7757881|NCT00766467|26970506|P1|Overall Study|Withdrawal by Subject|7
7757882|NCT00766415|26970518|P2|Overall Study|Withdrawal by Subject|1
7757883|NCT00766415|26970519|P1|Overall Study|Withdrawal by Subject|0
7757884|NCT00766376|26970567|P1|Overall Study|Withdrawal by Subject|27
7757885|NCT00766363|26970576|P4|Overall Study|Adverse Event Prior to Randomization|0
7757886|NCT00766363|26970577|P3|Overall Study|Adverse Event Prior to Randomization|0
7757887|NCT00766363|26970578|P2|Overall Study|Adverse Event Prior to Randomization|1
7757888|NCT00766363|26970579|P1|Overall Study|Adverse Event Prior to Randomization|0
7757889|NCT00766363|26970576|P4|Overall Study|Withdrawal by Subject|0
7757890|NCT00766363|26970577|P3|Overall Study|Withdrawal by Subject|0
7757891|NCT00766363|26970578|P2|Overall Study|Withdrawal by Subject|0
7757892|NCT00766363|26970579|P1|Overall Study|Withdrawal by Subject|1
7757893|NCT00766142|26970616|P1|Overall Study|Protocol Violation|4
7757894|NCT00766090|26970632|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757895|NCT00766090|26970633|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757896|NCT00766090|26970634|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757897|NCT00766090|26970635|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757898|NCT00766090|26970636|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757899|NCT00766090|26970637|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757900|NCT00766090|26970638|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757901|NCT00766090|26970639|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
7757902|NCT00766090|26970640|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757903|NCT00766090|26970641|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757904|NCT00766090|26970642|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757905|NCT00766090|26970643|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7757906|NCT00766090|26970632|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7757907|NCT00766090|26970633|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757908|NCT00766090|26970634|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757909|NCT00766090|26970635|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757910|NCT00766090|26970636|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757911|NCT00766090|26970637|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757912|NCT00766090|26970638|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757913|NCT00766090|26970639|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757914|NCT00766090|26970640|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7757915|NCT00766090|26970641|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757916|NCT00766090|26970642|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7757917|NCT00766090|26970643|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7757918|NCT00766090|26970632|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
7757919|NCT00766090|26970633|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
7757920|NCT00766090|26970634|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
7757921|NCT00766090|26970635|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
7757922|NCT00766090|26970636|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
7757923|NCT00766090|26970637|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
7757924|NCT00766090|26970638|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
7757925|NCT00766090|26970639|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
7757926|NCT00766090|26970640|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
7757927|NCT00766090|26970641|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
7757928|NCT00766090|26970642|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
7757929|NCT00766090|26970643|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
7757930|NCT00766090|26970632|P12|Washout Period 2 (14 Days)|Physician Decision|0
7757931|NCT00766090|26970633|P11|Washout Period 2 (14 Days)|Physician Decision|0
7757932|NCT00766090|26970634|P10|Washout Period 2 (14 Days)|Physician Decision|0
7757933|NCT00766090|26970635|P9|Washout Period 2 (14 Days)|Physician Decision|0
7757934|NCT00766090|26970636|P8|Washout Period 2 (14 Days)|Physician Decision|0
7757935|NCT00766090|26970637|P7|Washout Period 2 (14 Days)|Physician Decision|0
7757936|NCT00766090|26970638|P6|Washout Period 2 (14 Days)|Physician Decision|0
7757937|NCT00766090|26970639|P5|Washout Period 2 (14 Days)|Physician Decision|0
7757938|NCT00766090|26970640|P4|Washout Period 2 (14 Days)|Physician Decision|0
7757939|NCT00766090|26970641|P3|Washout Period 2 (14 Days)|Physician Decision|1
7757940|NCT00766090|26970642|P2|Washout Period 2 (14 Days)|Physician Decision|0
7757941|NCT00766090|26970643|P1|Washout Period 2 (14 Days)|Physician Decision|0
7757942|NCT00766090|26970632|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757943|NCT00766090|26970633|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757944|NCT00766090|26970634|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757945|NCT00766090|26970635|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757946|NCT00766090|26970636|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757947|NCT00766090|26970637|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757948|NCT00766090|26970638|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757949|NCT00766090|26970639|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757950|NCT00766090|26970640|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757951|NCT00766090|26970641|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
7757952|NCT00766090|26970642|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757953|NCT00766090|26970643|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7757954|NCT00766090|26970632|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757955|NCT00766090|26970633|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757956|NCT00766090|26970634|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757957|NCT00766090|26970635|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757958|NCT00766090|26970636|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757959|NCT00766090|26970637|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757960|NCT00766090|26970638|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757961|NCT00766090|26970639|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
7757962|NCT00766090|26970640|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757963|NCT00766090|26970641|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757964|NCT00766090|26970642|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757965|NCT00766090|26970643|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7757966|NCT00766090|26970632|P12|Washout Period 1 (14 Days)|Protocol Violation|0
7757967|NCT00766090|26970633|P11|Washout Period 1 (14 Days)|Protocol Violation|0
7757968|NCT00766090|26970634|P10|Washout Period 1 (14 Days)|Protocol Violation|0
7757969|NCT00766090|26970635|P9|Washout Period 1 (14 Days)|Protocol Violation|0
7757970|NCT00766090|26970636|P8|Washout Period 1 (14 Days)|Protocol Violation|0
7757971|NCT00766090|26970637|P7|Washout Period 1 (14 Days)|Protocol Violation|0
7757972|NCT00766090|26970638|P6|Washout Period 1 (14 Days)|Protocol Violation|0
7757973|NCT00766090|26970639|P5|Washout Period 1 (14 Days)|Protocol Violation|0
7757974|NCT00766090|26970640|P4|Washout Period 1 (14 Days)|Protocol Violation|0
7757975|NCT00766090|26970641|P3|Washout Period 1 (14 Days)|Protocol Violation|1
7757976|NCT00766090|26970642|P2|Washout Period 1 (14 Days)|Protocol Violation|0
7757977|NCT00766090|26970643|P1|Washout Period 1 (14 Days)|Protocol Violation|0
7757978|NCT00766090|26970632|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757979|NCT00766090|26970633|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757980|NCT00766090|26970634|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757981|NCT00766090|26970635|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757982|NCT00766090|26970636|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757983|NCT00766090|26970637|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757984|NCT00766090|26970638|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757985|NCT00766090|26970639|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757986|NCT00766090|26970640|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7757987|NCT00766090|26970641|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757988|NCT00766090|26970642|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7757989|NCT00766090|26970643|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7757990|NCT00766090|26970632|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757991|NCT00766090|26970633|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757992|NCT00766090|26970634|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757993|NCT00766090|26970635|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757994|NCT00766090|26970636|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757995|NCT00766090|26970637|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757996|NCT00766090|26970638|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757997|NCT00766090|26970639|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757998|NCT00766090|26970640|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7757999|NCT00766090|26970641|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7758000|NCT00766090|26970642|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7758001|NCT00766090|26970643|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
7758002|NCT00766090|26970632|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758003|NCT00766090|26970633|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758004|NCT00766090|26970634|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758005|NCT00766090|26970635|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
7758006|NCT00766090|26970636|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758007|NCT00766090|26970637|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758008|NCT00766090|26970638|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758009|NCT00766090|26970639|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758010|NCT00766090|26970640|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758011|NCT00766090|26970641|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758012|NCT00766090|26970642|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758013|NCT00766090|26970643|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7758014|NCT00766051|26970684|P2|Overall Study|Withdrawal by Subject|0
7758015|NCT00766051|26970685|P1|Overall Study|Withdrawal by Subject|2
7758016|NCT00766038|26970697|P2|Overall Study|Lost to Follow-up|14
7758017|NCT00766038|26970698|P1|Overall Study|Lost to Follow-up|15
7758018|NCT00765999|26970714|P1|Overall Study|Other Miscellaneous Reasons|51
7758019|NCT00765999|26970714|P1|Overall Study|Study Terminated by Sponsor|2
7758020|NCT00765999|26970714|P1|Overall Study|Lost to Follow-up|131
7758021|NCT00765999|26970714|P1|Overall Study|Consent Withdrawn|202
7758022|NCT00765999|26970714|P1|Overall Study|Protocol Violation|95
7758023|NCT00765999|26970714|P1|Overall Study|Insufficient Therapeutic Response|100
7758024|NCT00765999|26970714|P1|Overall Study|Adverse Event|203
7758025|NCT00765882|26970741|P3|Overall Study|Other Reason|2
7758026|NCT00765882|26970742|P2|Overall Study|Other Reason|1
7758027|NCT00765882|26970743|P1|Overall Study|Other Reason|3
7758028|NCT00765882|26970741|P3|Overall Study|Lost to Follow-up|6
7758029|NCT00765882|26970742|P2|Overall Study|Lost to Follow-up|9
7758030|NCT00765882|26970743|P1|Overall Study|Lost to Follow-up|1
7758031|NCT00765882|26970741|P3|Overall Study|Withdrawal by Subject|6
7758032|NCT00765882|26970742|P2|Overall Study|Withdrawal by Subject|6
7758033|NCT00765882|26970743|P1|Overall Study|Withdrawal by Subject|2
7758034|NCT00765882|26970741|P3|Overall Study|Protocol Violation|1
7758035|NCT00765882|26970742|P2|Overall Study|Protocol Violation|3
7758036|NCT00765882|26970743|P1|Overall Study|Protocol Violation|4
7758037|NCT00765882|26970741|P3|Overall Study|Lack of Efficacy|1
7758038|NCT00765882|26970742|P2|Overall Study|Lack of Efficacy|0
7758039|NCT00765882|26970743|P1|Overall Study|Lack of Efficacy|4
7758040|NCT00765882|26970741|P3|Overall Study|Adverse Event|20
7758041|NCT00765882|26970742|P2|Overall Study|Adverse Event|21
7758042|NCT00765882|26970743|P1|Overall Study|Adverse Event|10
7758043|NCT00765843|26970789|P3|Overall Study|Adverse Event|1
7758044|NCT00765843|26970790|P2|Overall Study|Adverse Event|0
7758045|NCT00765843|26970791|P1|Overall Study|Adverse Event|0
7758046|NCT00765843|26970789|P3|Overall Study|did not return to receive intervention|0
7758047|NCT00765843|26970790|P2|Overall Study|did not return to receive intervention|1
7758048|NCT00765843|26970791|P1|Overall Study|did not return to receive intervention|0
7758049|NCT00765843|26970789|P3|Overall Study|Lost to Follow-up|2
7758050|NCT00765843|26970790|P2|Overall Study|Lost to Follow-up|3
7758051|NCT00765843|26970791|P1|Overall Study|Lost to Follow-up|1
7758052|NCT00765817|26970801|P2|Overall Study|Subject decision|11
7758053|NCT00765817|26970802|P1|Overall Study|Subject decision|7
7758054|NCT00765817|26970801|P2|Overall Study|Protocol Violation|1
7758055|NCT00765817|26970802|P1|Overall Study|Protocol Violation|1
7758056|NCT00765817|26970801|P2|Overall Study|Physician Decision|1
7758057|NCT00765817|26970802|P1|Overall Study|Physician Decision|2
7758058|NCT00765817|26970801|P2|Overall Study|Lost to Follow-up|3
7758059|NCT00765817|26970802|P1|Overall Study|Lost to Follow-up|1
7758060|NCT00765817|26970801|P2|Overall Study|Loss of glucose control|2
7758061|NCT00765817|26970802|P1|Overall Study|Loss of glucose control|0
7758062|NCT00765817|26970801|P2|Overall Study|Entry criteria not met|2
7758063|NCT00765817|26970802|P1|Overall Study|Entry criteria not met|2
7758064|NCT00765817|26970801|P2|Overall Study|Death|1
7758065|NCT00765817|26970802|P1|Overall Study|Death|0
7758066|NCT00765817|26970801|P2|Overall Study|Adverse Event|1
7758067|NCT00765817|26970802|P1|Overall Study|Adverse Event|13
7758068|NCT00765726|26970850|P1|Overall Study|Discontinuation of study by sponsor|8
7758069|NCT00765726|26970850|P1|Overall Study|Withdrawal by Subject|1
7758070|NCT00765674|26970858|P4|Overall Study|Randomized in Error - No Study Drug|1
7758071|NCT00765674|26970859|P3|Overall Study|Randomized in Error - No Study Drug|0
7758072|NCT00765674|26970860|P2|Overall Study|Randomized in Error - No Study Drug|1
7758073|NCT00765674|26970861|P1|Overall Study|Randomized in Error - No Study Drug|0
7758074|NCT00765674|26970858|P4|Overall Study|Lost to Follow-up|1
7758075|NCT00765674|26970859|P3|Overall Study|Lost to Follow-up|2
7758076|NCT00765674|26970860|P2|Overall Study|Lost to Follow-up|6
7758077|NCT00765674|26970861|P1|Overall Study|Lost to Follow-up|4
7758078|NCT00765674|26970858|P4|Overall Study|Withdrawal by Subject|8
7758079|NCT00765674|26970859|P3|Overall Study|Withdrawal by Subject|3
7758080|NCT00765674|26970860|P2|Overall Study|Withdrawal by Subject|7
7758081|NCT00765674|26970861|P1|Overall Study|Withdrawal by Subject|5
7758082|NCT00765674|26970858|P4|Overall Study|Protocol Violation|0
7758083|NCT00765674|26970859|P3|Overall Study|Protocol Violation|1
7758084|NCT00765674|26970860|P2|Overall Study|Protocol Violation|0
7758085|NCT00765674|26970861|P1|Overall Study|Protocol Violation|2
7758086|NCT00765674|26970858|P4|Overall Study|Lack of Efficacy|2
7758087|NCT00765674|26970859|P3|Overall Study|Lack of Efficacy|1
7758088|NCT00765674|26970860|P2|Overall Study|Lack of Efficacy|3
7758089|NCT00765674|26970861|P1|Overall Study|Lack of Efficacy|2
7758090|NCT00765674|26970858|P4|Overall Study|Abnormal Test Procedure Result(s)|2
7758091|NCT00765674|26970859|P3|Overall Study|Abnormal Test Procedure Result(s)|1
7758092|NCT00765674|26970860|P2|Overall Study|Abnormal Test Procedure Result(s)|3
7758093|NCT00765674|26970861|P1|Overall Study|Abnormal Test Procedure Result(s)|1
7758094|NCT00765674|26970858|P4|Overall Study|Abnormal Laboratory Value(s)|0
7758095|NCT00765674|26970859|P3|Overall Study|Abnormal Laboratory Value(s)|1
7758096|NCT00765674|26970860|P2|Overall Study|Abnormal Laboratory Value(s)|0
7758097|NCT00765674|26970861|P1|Overall Study|Abnormal Laboratory Value(s)|0
7758098|NCT00765674|26970858|P4|Overall Study|Adverse Event|11
7758099|NCT00765674|26970859|P3|Overall Study|Adverse Event|8
7758100|NCT00765674|26970860|P2|Overall Study|Adverse Event|2
7758101|NCT00765674|26970861|P1|Overall Study|Adverse Event|7
7758102|NCT00765388|26970928|P2|Period 1|Hip operation|1
7758103|NCT00765388|26970929|P1|Period 1|Hip operation|0
7758104|NCT00765388|26970928|P2|Period 1|Herpes Zoster|1
7758105|NCT00765388|26970929|P1|Period 1|Herpes Zoster|0
7758106|NCT00765388|26970928|P2|Period 1|Lost to Follow-up|1
7758107|NCT00765388|26970929|P1|Period 1|Lost to Follow-up|0
7758108|NCT00765388|26970928|P2|Period 1|Lack of Efficacy|2
7758109|NCT00765388|26970929|P1|Period 1|Lack of Efficacy|1
7758110|NCT00765362|26970963|P1|Overall Study|Lost to Follow-up|95
7758111|NCT00765362|26970963|P1|Overall Study|Withdrawal by Subject|13
7758112|NCT00765362|26970963|P1|Overall Study|Protocol Violation|18
7758113|NCT00765362|26970963|P1|Overall Study|Adverse Event|2
7758114|NCT00765362|26970963|P1|Overall Study|Death|9
7758115|NCT00765336|26970971|P2|Overall Study|Adverse Event|1
7758116|NCT00765336|26970972|P1|Overall Study|Adverse Event|2
7758117|NCT00765336|26970971|P2|Overall Study|Lost to Follow-up|9
7758118|NCT00765336|26970972|P1|Overall Study|Lost to Follow-up|7
7758119|NCT00765336|26970971|P2|Overall Study|Withdrawal by Subject|4
7758120|NCT00765336|26970972|P1|Overall Study|Withdrawal by Subject|6
7758121|NCT00765336|26970971|P2|Overall Study|Protocol Violation|2
7758122|NCT00765336|26970972|P1|Overall Study|Protocol Violation|4
7758123|NCT00765245|26970980|P2|Overall Study|Death|0
7758124|NCT00765245|26970981|P1|Overall Study|Death|1
7758125|NCT00765245|26970980|P2|Overall Study|Physician Decision|0
7758126|NCT00765245|26970981|P1|Overall Study|Physician Decision|1
7758127|NCT00765245|26970980|P2|Overall Study|Adverse Event|0
7758128|NCT00765245|26970981|P1|Overall Study|Adverse Event|5
7758129|NCT00765245|26970980|P2|Overall Study|Withdrawal by Subject|0
7758130|NCT00765245|26970981|P1|Overall Study|Withdrawal by Subject|3
7758131|NCT00765245|26970980|P2|Overall Study|disease progression|2
7758132|NCT00765245|26970981|P1|Overall Study|disease progression|3
7758133|NCT00765102|26971027|P1|Overall Study|Protocol Violation|1
7758134|NCT00765102|26971027|P1|Overall Study|Withdrawal by Subject|2
7758135|NCT00765102|26971027|P1|Overall Study|Physician Decision|4
7758136|NCT00765102|26971027|P1|Overall Study|Adverse Event|6
7758137|NCT00765102|26971027|P1|Overall Study|Progressive disease|18
7758138|NCT00765076|26971052|P3|Overall Study|Withdrawal by Subject|1
7758139|NCT00765076|26971053|P2|Overall Study|Withdrawal by Subject|0
7758140|NCT00765076|26971054|P1|Overall Study|Withdrawal by Subject|0
7758141|NCT00765076|26971052|P3|Overall Study|Adverse Event|0
7758142|NCT00765076|26971053|P2|Overall Study|Adverse Event|0
7758143|NCT00765076|26971054|P1|Overall Study|Adverse Event|1
7758144|NCT00765063|26971107|P1|Overall Study|Adverse Event|4
7758145|NCT00765063|26971107|P1|Overall Study|Protocol Violation|6
7758146|NCT00765063|26971107|P1|Overall Study|Other|16
7758147|NCT00765063|26971107|P1|Overall Study|Withdrawal by Subject|1
7758148|NCT00765063|26971107|P1|Overall Study|Lack of Efficacy|5
7758149|NCT00765037|26971123|P1|Overall Study|Adverse Event|1
7758150|NCT00765037|26971123|P1|Overall Study|Lost to Follow-up|5
7758151|NCT00764946|26971130|P3|Overall Study|Never Treated|1
7758152|NCT00764946|26971131|P2|Overall Study|Never Treated|1
7758153|NCT00764946|26971132|P1|Overall Study|Never Treated|1
7758154|NCT00764946|26971130|P3|Overall Study|Withdrawal by Subject|2
7758155|NCT00764946|26971131|P2|Overall Study|Withdrawal by Subject|6
7758156|NCT00764946|26971132|P1|Overall Study|Withdrawal by Subject|3
7758157|NCT00764946|26971130|P3|Overall Study|Adverse Event|1
7758158|NCT00764946|26971131|P2|Overall Study|Adverse Event|2
7758159|NCT00764946|26971132|P1|Overall Study|Adverse Event|3
7758160|NCT00764946|26971130|P3|Overall Study|Physician Decision|0
7758161|NCT00764946|26971131|P2|Overall Study|Physician Decision|4
7758162|NCT00764946|26971132|P1|Overall Study|Physician Decision|2
7758163|NCT00764946|26971130|P3|Overall Study|Lost to Follow-up|0
7758164|NCT00764946|26971131|P2|Overall Study|Lost to Follow-up|4
7758165|NCT00764946|26971132|P1|Overall Study|Lost to Follow-up|3
7758166|NCT00764946|26971130|P3|Overall Study|Lack of Efficacy|0
7758167|NCT00764946|26971131|P2|Overall Study|Lack of Efficacy|0
7758168|NCT00764946|26971132|P1|Overall Study|Lack of Efficacy|1
7758169|NCT00764881|26971160|P2|Overall Study|no treatment or no observation|2
7758170|NCT00764881|26971161|P1|Overall Study|no treatment or no observation|2
7758171|NCT00764881|26971160|P2|Overall Study|Possibly noncompliant (study drug)|2
7758172|NCT00764881|26971161|P1|Overall Study|Possibly noncompliant (study drug)|0
7758173|NCT00764881|26971160|P2|Overall Study|Carcinoma detected|0
7758174|NCT00764881|26971161|P1|Overall Study|Carcinoma detected|1
7758175|NCT00764881|26971160|P2|Overall Study|Wished to become pregnant|0
7758176|NCT00764881|26971161|P1|Overall Study|Wished to become pregnant|1
7758177|NCT00764881|26971160|P2|Overall Study|Accidentally discontinued study drug|0
7758178|NCT00764881|26971161|P1|Overall Study|Accidentally discontinued study drug|1
7758179|NCT00764881|26971160|P2|Overall Study|Noncompliant|0
7758180|NCT00764881|26971161|P1|Overall Study|Noncompliant|1
7758181|NCT00764881|26971160|P2|Overall Study|Lost to Follow-up|0
7758182|NCT00764881|26971161|P1|Overall Study|Lost to Follow-up|2
7758183|NCT00764881|26971160|P2|Overall Study|Protocol Violation|2
7758184|NCT00764881|26971161|P1|Overall Study|Protocol Violation|2
7758185|NCT00764881|26971160|P2|Overall Study|Withdrawal by Subject|3
7758186|NCT00764881|26971161|P1|Overall Study|Withdrawal by Subject|1
7758187|NCT00764881|26971160|P2|Overall Study|Adverse Event|1
7758188|NCT00764881|26971161|P1|Overall Study|Adverse Event|5
7758189|NCT00764868|26971385|P1|Overall Study|Sponsor requested withdrawal|1
7758190|NCT00764868|26971385|P1|Overall Study|Positive drug screen|2
7758191|NCT00764868|26971385|P1|Overall Study|Met an exclusion criteria|1
7758192|NCT00764868|26971385|P1|Overall Study|Subject sent to boarding school|1
7758193|NCT00764868|26971385|P1|Overall Study|Misuse and compliance of study drug|1
7758194|NCT00764868|26971385|P1|Overall Study|Out of town|1
7758195|NCT00764868|26971385|P1|Overall Study|Prohibited medication|1
7758196|NCT00764868|26971385|P1|Overall Study|Pregnancy|3
7758197|NCT00764868|26971385|P1|Overall Study|Subject moved|7
7758198|NCT00764868|26971385|P1|Overall Study|Lack of Efficacy|5
7758199|NCT00764868|26971385|P1|Overall Study|Lost to Follow-up|25
7758200|NCT00764868|26971385|P1|Overall Study|Non-compliance|16
7758201|NCT00764868|26971385|P1|Overall Study|Withdrawal by Subject|31
7758202|NCT00764868|26971385|P1|Overall Study|Adverse Event|18
7758203|NCT00764790|26971394|P3|Overall Study|Lost to Follow-up|23
7758204|NCT00764790|26971395|P2|Overall Study|Lost to Follow-up|29
7758205|NCT00764790|26971396|P1|Overall Study|Lost to Follow-up|28
7758206|NCT00764790|26971394|P3|Overall Study|Withdrawal by Subject|6
7758207|NCT00764790|26971395|P2|Overall Study|Withdrawal by Subject|12
7758208|NCT00764790|26971396|P1|Overall Study|Withdrawal by Subject|10
7758209|NCT00764790|26971394|P3|Overall Study|Protocol Violation|1
7758210|NCT00764790|26971395|P2|Overall Study|Protocol Violation|0
7758211|NCT00764790|26971396|P1|Overall Study|Protocol Violation|0
7758212|NCT00764751|26971430|P2|Overall Study|Psoriasis flare up on the scalp|0
7758213|NCT00764751|26971431|P1|Overall Study|Psoriasis flare up on the scalp|1
7758214|NCT00764751|26971430|P2|Overall Study|Adverse Event|1
7758215|NCT00764751|26971431|P1|Overall Study|Adverse Event|1
7758216|NCT00764699|26971494|P1|Overall Study|PI left and study terminated|3
7758217|NCT00764673|26971498|P1|Overall Study|Revision of Device|2
7758218|NCT00764673|26971498|P1|Overall Study|Withdrawal by Subject|6
7758219|NCT00764673|26971498|P1|Overall Study|Lost to Follow-up|3
7758220|NCT00764673|26971498|P1|Overall Study|Death|1
7758221|NCT00764660|26971508|P2|Overall Study|Did Not Meet Protocol Eligibility|0
7758222|NCT00764660|26971509|P1|Overall Study|Did Not Meet Protocol Eligibility|1
7758223|NCT00764660|26971508|P2|Overall Study|Noncompliance With Protocol|1
7758224|NCT00764660|26971509|P1|Overall Study|Noncompliance With Protocol|5
7758225|NCT00764660|26971508|P2|Overall Study|Withdrawal by Subject|3
7758226|NCT00764660|26971509|P1|Overall Study|Withdrawal by Subject|7
7758227|NCT00764660|26971508|P2|Overall Study|Lost to Follow-up|4
7758228|NCT00764660|26971509|P1|Overall Study|Lost to Follow-up|3
7758229|NCT00764660|26971508|P2|Overall Study|Adverse Event|3
7758230|NCT00764660|26971509|P1|Overall Study|Adverse Event|6
7758231|NCT00764517|26971543|P2|Overall Study|Physician Decision|0
7758232|NCT00764517|26971544|P1|Overall Study|Physician Decision|3
7758233|NCT00764517|26971543|P2|Overall Study|Death|11
7758234|NCT00764517|26971544|P1|Overall Study|Death|3
7758235|NCT00764517|26971543|P2|Overall Study|Adverse Event|3
7758236|NCT00764517|26971544|P1|Overall Study|Adverse Event|9
7758237|NCT00764504|26971565|P3|Overall Study|Lost to Follow-up|72
7758238|NCT00764504|26971566|P2|Overall Study|Lost to Follow-up|34
7758239|NCT00764504|26971567|P1|Overall Study|Lost to Follow-up|40
7758240|NCT00764504|26971565|P3|Overall Study|Withdrawal by Subject|4
7758241|NCT00764504|26971566|P2|Overall Study|Withdrawal by Subject|7
7758242|NCT00764504|26971567|P1|Overall Study|Withdrawal by Subject|1
7758243|NCT00764504|26971565|P3|Overall Study|Physician Decision|0
7758244|NCT00764504|26971566|P2|Overall Study|Physician Decision|0
7758245|NCT00764504|26971567|P1|Overall Study|Physician Decision|1
7758246|NCT00764504|26971565|P3|Overall Study|Revision of Device|14
7758247|NCT00764504|26971566|P2|Overall Study|Revision of Device|23
7758248|NCT00764504|26971567|P1|Overall Study|Revision of Device|12
7758249|NCT00764504|26971565|P3|Overall Study|Death|13
7758250|NCT00764504|26971566|P2|Overall Study|Death|6
7758251|NCT00764504|26971567|P1|Overall Study|Death|12
7758252|NCT00764491|26971595|P2|Overall Study|Lost to Follow-up|17
7758253|NCT00764491|26971596|P1|Overall Study|Lost to Follow-up|35
7758254|NCT00764478|26971617|P3|Overall Study|Protocol Violation|1
7758255|NCT00764478|26971618|P2|Overall Study|Protocol Violation|1
7758256|NCT00764478|26971619|P1|Overall Study|Protocol Violation|0
7758257|NCT00764478|26971617|P3|Overall Study|Lost to Follow-up|5
7758258|NCT00764478|26971618|P2|Overall Study|Lost to Follow-up|8
7758259|NCT00764478|26971619|P1|Overall Study|Lost to Follow-up|7
7758260|NCT00764478|26971617|P3|Overall Study|Withdrawal by Subject|1
7758261|NCT00764478|26971618|P2|Overall Study|Withdrawal by Subject|12
7758262|NCT00764478|26971619|P1|Overall Study|Withdrawal by Subject|7
7758263|NCT00764478|26971617|P3|Overall Study|Adverse Event|1
7758264|NCT00764478|26971618|P2|Overall Study|Adverse Event|1
7758265|NCT00764478|26971619|P1|Overall Study|Adverse Event|1
7758266|NCT00764465|26971699|P6|Overall Study|Withdrawal by Subject|0
7758267|NCT00764465|26971700|P5|Overall Study|Withdrawal by Subject|0
7758268|NCT00764465|26971701|P4|Overall Study|Withdrawal by Subject|0
7758269|NCT00764465|26971702|P3|Overall Study|Withdrawal by Subject|1
7758270|NCT00764465|26971703|P2|Overall Study|Withdrawal by Subject|1
7758271|NCT00764465|26971704|P1|Overall Study|Withdrawal by Subject|0
7758272|NCT00764465|26971699|P6|Overall Study|Adverse Event|1
7758273|NCT00764465|26971700|P5|Overall Study|Adverse Event|1
7758274|NCT00764465|26971701|P4|Overall Study|Adverse Event|1
7758275|NCT00764465|26971702|P3|Overall Study|Adverse Event|0
7758276|NCT00764465|26971703|P2|Overall Study|Adverse Event|0
7758277|NCT00764465|26971704|P1|Overall Study|Adverse Event|2
7758278|NCT00764361|26971732|P2|Overall Study|Adverse Event|1
7758279|NCT00764361|26971733|P1|Overall Study|Adverse Event|0
7758280|NCT00764361|26971732|P2|Overall Study|Withdrawal by Subject|3
7758281|NCT00764361|26971733|P1|Overall Study|Withdrawal by Subject|2
7758282|NCT00764322|26971741|P1|Overall Study|No CYP2D6 genotyping|9
7758283|NCT00764322|26971741|P1|Overall Study|Withdrawal by Subject|11
7758284|NCT00763971|26971768|P3|Overall Study|Participation in 489-326 required|0
7758285|NCT00763971|26971769|P2|Overall Study|Participation in 489-326 required|0
7758286|NCT00763971|26971770|P1|Overall Study|Participation in 489-326 required|1
7758287|NCT00763971|26971768|P3|Overall Study|Performed final visit on phone|0
7758288|NCT00763971|26971769|P2|Overall Study|Performed final visit on phone|1
7758289|NCT00763971|26971770|P1|Overall Study|Performed final visit on phone|0
7758290|NCT00763971|26971768|P3|Overall Study|Lack of availability|0
7758291|NCT00763971|26971769|P2|Overall Study|Lack of availability|1
7758292|NCT00763971|26971770|P1|Overall Study|Lack of availability|0
7758293|NCT00763971|26971768|P3|Overall Study|Subject wanted dose reduction|0
7758294|NCT00763971|26971769|P2|Overall Study|Subject wanted dose reduction|1
7758295|NCT00763971|26971770|P1|Overall Study|Subject wanted dose reduction|0
7758296|NCT00763971|26971768|P3|Overall Study|Moved to another country|0
7758297|NCT00763971|26971769|P2|Overall Study|Moved to another country|1
7758298|NCT00763971|26971770|P1|Overall Study|Moved to another country|0
7758299|NCT00763971|26971768|P3|Overall Study|Medical monitor decision|1
7758300|NCT00763971|26971769|P2|Overall Study|Medical monitor decision|0
7758301|NCT00763971|26971770|P1|Overall Study|Medical monitor decision|0
7758302|NCT00763971|26971768|P3|Overall Study|Randomization error|1
7758303|NCT00763971|26971769|P2|Overall Study|Randomization error|0
7758304|NCT00763971|26971770|P1|Overall Study|Randomization error|0
7758305|NCT00763971|26971768|P3|Overall Study|Due to holiday season|1
7758306|NCT00763971|26971769|P2|Overall Study|Due to holiday season|0
7758307|NCT00763971|26971770|P1|Overall Study|Due to holiday season|2
7758308|NCT00763971|26971768|P3|Overall Study|Sponsor decision|0
7758309|NCT00763971|26971769|P2|Overall Study|Sponsor decision|0
7758310|NCT00763971|26971770|P1|Overall Study|Sponsor decision|1
7758311|NCT00763971|26971768|P3|Overall Study|Exclusion criteria met|0
7758312|NCT00763971|26971769|P2|Overall Study|Exclusion criteria met|0
7758313|NCT00763971|26971770|P1|Overall Study|Exclusion criteria met|1
7758314|NCT00763971|26971768|P3|Overall Study|Personal reason|0
7758315|NCT00763971|26971769|P2|Overall Study|Personal reason|0
7758316|NCT00763971|26971770|P1|Overall Study|Personal reason|3
7758317|NCT00763971|26971768|P3|Overall Study|Unable to swallow capsule|1
7758318|NCT00763971|26971769|P2|Overall Study|Unable to swallow capsule|1
7758319|NCT00763971|26971770|P1|Overall Study|Unable to swallow capsule|2
7758320|NCT00763971|26971768|P3|Overall Study|Lack of Efficacy|54
7758321|NCT00763971|26971769|P2|Overall Study|Lack of Efficacy|22
7758322|NCT00763971|26971770|P1|Overall Study|Lack of Efficacy|11
7758323|NCT00763971|26971768|P3|Overall Study|Lost to Follow-up|0
7758324|NCT00763971|26971769|P2|Overall Study|Lost to Follow-up|1
7758325|NCT00763971|26971770|P1|Overall Study|Lost to Follow-up|0
7758326|NCT00763971|26971768|P3|Overall Study|Withdrawal by Subject|5
7758327|NCT00763971|26971769|P2|Overall Study|Withdrawal by Subject|5
7758328|NCT00763971|26971770|P1|Overall Study|Withdrawal by Subject|4
7758329|NCT00763971|26971768|P3|Overall Study|Protocol Violation|2
7758330|NCT00763971|26971769|P2|Overall Study|Protocol Violation|3
7758331|NCT00763971|26971770|P1|Overall Study|Protocol Violation|3
7758332|NCT00763971|26971768|P3|Overall Study|Adverse Event|4
7758333|NCT00763971|26971769|P2|Overall Study|Adverse Event|2
7758334|NCT00763971|26971770|P1|Overall Study|Adverse Event|5
7758335|NCT00763958|26971801|P2|Overall Study|Believed they were receiving placebo|5
7758336|NCT00763958|26971802|P1|Overall Study|Believed they were receiving placebo|0
7758337|NCT00763958|26971801|P2|Overall Study|Lost to Follow-up|2
7758338|NCT00763958|26971802|P1|Overall Study|Lost to Follow-up|10
7758339|NCT00763958|26971801|P2|Overall Study|did not meet final criteria|4
7758340|NCT00763958|26971802|P1|Overall Study|did not meet final criteria|4
7758341|NCT00763815|26971937|P2|Overall Study|Sponsor's Decision|1
7758342|NCT00763815|26971938|P1|Overall Study|Sponsor's Decision|0
7758343|NCT00763815|26971937|P2|Overall Study|Protocol Violation|5
7758344|NCT00763815|26971938|P1|Overall Study|Protocol Violation|2
7758345|NCT00763815|26971937|P2|Overall Study|Withdrawal by Subject|12
7758346|NCT00763815|26971938|P1|Overall Study|Withdrawal by Subject|7
7758347|NCT00763815|26971937|P2|Overall Study|Physician Decision|0
7758348|NCT00763815|26971938|P1|Overall Study|Physician Decision|1
7758349|NCT00763815|26971937|P2|Overall Study|Familial and Personal Reasons|16
7758350|NCT00763815|26971938|P1|Overall Study|Familial and Personal Reasons|9
7758351|NCT00763815|26971937|P2|Overall Study|Early Termination|0
7758352|NCT00763815|26971938|P1|Overall Study|Early Termination|1
7758353|NCT00763815|26971937|P2|Overall Study|Lost to Follow-up|4
7758354|NCT00763815|26971938|P1|Overall Study|Lost to Follow-up|2
7758355|NCT00763815|26971937|P2|Overall Study|Poor Compliance to Protocol|6
7758356|NCT00763815|26971938|P1|Overall Study|Poor Compliance to Protocol|6
7758357|NCT00763815|26971937|P2|Overall Study|Lack of Efficacy|11
7758358|NCT00763815|26971938|P1|Overall Study|Lack of Efficacy|10
7758359|NCT00763815|26971937|P2|Overall Study|Adverse Event|29
7758360|NCT00763815|26971938|P1|Overall Study|Adverse Event|14
7758361|NCT00763698|26971966|P1|Overall Study|Withdrawal by Subject|1
7758362|NCT00763698|26971966|P1|Overall Study|Death|4
7758363|NCT00763698|26971966|P1|Overall Study|Unsuccessful Implant|5
7758364|NCT00763451|26971983|P4|Overall Study|Study Site Reason|1
7758365|NCT00763451|26971984|P3|Overall Study|Study Site Reason|1
7758366|NCT00763451|26971985|P2|Overall Study|Study Site Reason|1
7758367|NCT00763451|26971986|P1|Overall Study|Study Site Reason|0
7758368|NCT00763451|26971983|P4|Overall Study|Randomized but not Treated|0
7758369|NCT00763451|26971984|P3|Overall Study|Randomized but not Treated|0
7758370|NCT00763451|26971985|P2|Overall Study|Randomized but not Treated|1
7758371|NCT00763451|26971986|P1|Overall Study|Randomized but not Treated|1
7758372|NCT00763451|26971983|P4|Overall Study|Familial and Personal Reasons|4
7758373|NCT00763451|26971984|P3|Overall Study|Familial and Personal Reasons|5
7758374|NCT00763451|26971985|P2|Overall Study|Familial and Personal Reasons|3
7758375|NCT00763451|26971986|P1|Overall Study|Familial and Personal Reasons|5
7758376|NCT00763451|26971983|P4|Overall Study|Poor Compliance to Protocol|2
7758377|NCT00763451|26971984|P3|Overall Study|Poor Compliance to Protocol|2
7758378|NCT00763451|26971985|P2|Overall Study|Poor Compliance to Protocol|1
7758379|NCT00763451|26971986|P1|Overall Study|Poor Compliance to Protocol|1
7758380|NCT00763451|26971983|P4|Overall Study|Protocol Violation|0
7758381|NCT00763451|26971984|P3|Overall Study|Protocol Violation|1
7758382|NCT00763451|26971985|P2|Overall Study|Protocol Violation|0
7758383|NCT00763451|26971986|P1|Overall Study|Protocol Violation|0
7758384|NCT00763451|26971983|P4|Overall Study|Withdrawal by Subject|7
7758385|NCT00763451|26971984|P3|Overall Study|Withdrawal by Subject|9
7758386|NCT00763451|26971985|P2|Overall Study|Withdrawal by Subject|6
7758387|NCT00763451|26971986|P1|Overall Study|Withdrawal by Subject|1
7758388|NCT00763451|26971983|P4|Overall Study|Lack of Efficacy|2
7758389|NCT00763451|26971984|P3|Overall Study|Lack of Efficacy|3
7758390|NCT00763451|26971985|P2|Overall Study|Lack of Efficacy|4
7758391|NCT00763451|26971986|P1|Overall Study|Lack of Efficacy|1
7758392|NCT00763451|26971983|P4|Overall Study|Adverse Event|14
7758393|NCT00763451|26971984|P3|Overall Study|Adverse Event|19
7758394|NCT00763451|26971985|P2|Overall Study|Adverse Event|6
7758395|NCT00763451|26971986|P1|Overall Study|Adverse Event|4
7758396|NCT00763386|26972045|P2|Overall Study|Study Prosthesis Removed|0
7758397|NCT00763386|26972046|P1|Overall Study|Study Prosthesis Removed|1
7758398|NCT00763386|26972045|P2|Overall Study|CRF missing|1
7758399|NCT00763386|26972046|P1|Overall Study|CRF missing|0
7758400|NCT00763386|26972045|P2|Overall Study|Withdrawal by Subject|1
7758401|NCT00763386|26972046|P1|Overall Study|Withdrawal by Subject|0
7758402|NCT00763386|26972045|P2|Overall Study|Lost to Follow-up|3
7758403|NCT00763386|26972046|P1|Overall Study|Lost to Follow-up|3
7758404|NCT00763386|26972045|P2|Overall Study|Death|2
7758405|NCT00763386|26972046|P1|Overall Study|Death|1
7758406|NCT00763386|26972045|P2|Overall Study|Adverse Event|33
7758407|NCT00763386|26972046|P1|Overall Study|Adverse Event|43
7758408|NCT00763321|26972079|P3|Double-blind Period|Other|3
7758409|NCT00763321|26972080|P2|Double-blind Period|Other|2
7758410|NCT00763321|26972081|P1|Double-blind Period|Other|0
7758411|NCT00763321|26972079|P3|Double-blind Period|Withdrawal by Subject|3
7758412|NCT00763321|26972080|P2|Double-blind Period|Withdrawal by Subject|2
7758413|NCT00763321|26972081|P1|Double-blind Period|Withdrawal by Subject|0
7758414|NCT00763321|26972079|P3|Double-blind Period|Lost to Follow-up|2
7758415|NCT00763321|26972080|P2|Double-blind Period|Lost to Follow-up|4
7758416|NCT00763321|26972081|P1|Double-blind Period|Lost to Follow-up|0
7758417|NCT00763321|26972079|P3|Double-blind Period|Adverse Event|4
7758418|NCT00763321|26972080|P2|Double-blind Period|Adverse Event|4
7758419|NCT00763321|26972081|P1|Double-blind Period|Adverse Event|0
7758420|NCT00763321|26972079|P3|Double-blind Period|Lack of Efficacy|17
7758421|NCT00763321|26972080|P2|Double-blind Period|Lack of Efficacy|9
7758422|NCT00763321|26972081|P1|Double-blind Period|Lack of Efficacy|0
7758423|NCT00763321|26972079|P3|Open-label Period|Other|0
7758424|NCT00763321|26972080|P2|Open-label Period|Other|0
7758425|NCT00763321|26972081|P1|Open-label Period|Other|4
7758426|NCT00763321|26972079|P3|Open-label Period|Lack of Efficacy|0
7758427|NCT00763321|26972080|P2|Open-label Period|Lack of Efficacy|0
7758428|NCT00763321|26972081|P1|Open-label Period|Lack of Efficacy|2
7758429|NCT00763321|26972079|P3|Open-label Period|Did not meet DB randomization criteria|0
7758430|NCT00763321|26972080|P2|Open-label Period|Did not meet DB randomization criteria|0
7758431|NCT00763321|26972081|P1|Open-label Period|Did not meet DB randomization criteria|5
7758432|NCT00763321|26972079|P3|Open-label Period|Subject noncompliant|0
7758433|NCT00763321|26972080|P2|Open-label Period|Subject noncompliant|0
7758434|NCT00763321|26972081|P1|Open-label Period|Subject noncompliant|7
7758435|NCT00763321|26972079|P3|Open-label Period|Withdrawal by Subject|0
7758436|NCT00763321|26972080|P2|Open-label Period|Withdrawal by Subject|0
7758437|NCT00763321|26972081|P1|Open-label Period|Withdrawal by Subject|7
7758438|NCT00763321|26972079|P3|Open-label Period|Lost to Follow-up|0
7758439|NCT00763321|26972080|P2|Open-label Period|Lost to Follow-up|0
7758440|NCT00763321|26972081|P1|Open-label Period|Lost to Follow-up|14
7758441|NCT00763321|26972079|P3|Open-label Period|Adverse Event|0
7758442|NCT00763321|26972080|P2|Open-label Period|Adverse Event|0
7758443|NCT00763321|26972081|P1|Open-label Period|Adverse Event|24
7758444|NCT00763282|26972092|P2|Overall Study|Lost to Follow-up|26
7758445|NCT00763282|26972093|P1|Overall Study|Lost to Follow-up|22
7758446|NCT00763282|26972092|P2|Overall Study|Death|3
7758447|NCT00763282|26972093|P1|Overall Study|Death|4
7758448|NCT00763282|26972092|P2|Overall Study|Withdrawal by Subject|5
7758449|NCT00763282|26972093|P1|Overall Study|Withdrawal by Subject|6
7758450|NCT00763269|26972109|P2|Overall Study|Lost to Follow-up|13
7758451|NCT00763269|26972110|P1|Overall Study|Lost to Follow-up|12
7758452|NCT00763256|26972124|P2|Overall Study|Didn't return for appointments|10
7758453|NCT00763256|26972125|P1|Overall Study|Didn't return for appointments|7
7758454|NCT00763139|26972161|P2|Overall Study|med change not allowed by protocol|0
7758455|NCT00763139|26972162|P1|Overall Study|med change not allowed by protocol|1
7758456|NCT00763139|26972161|P2|Overall Study|Withdrawal by Subject|1
7758457|NCT00763139|26972162|P1|Overall Study|Withdrawal by Subject|0
7758458|NCT00763139|26972161|P2|Overall Study|Adverse Event|2
7758459|NCT00763139|26972162|P1|Overall Study|Adverse Event|4
7758460|NCT00763035|26972224|P2|Second Intervention|Physician Decision|0
7758461|NCT00763035|26972225|P1|Second Intervention|Physician Decision|2
7758462|NCT00763035|26972224|P2|Second Intervention|Adverse Event|0
7758463|NCT00763035|26972225|P1|Second Intervention|Adverse Event|1
7758464|NCT00763035|26972224|P2|First Intervention|Adverse Event|1
7758465|NCT00763035|26972225|P1|First Intervention|Adverse Event|0
7758466|NCT00763035|26972224|P2|First Intervention|Did not meeting inclusion/exclusion|0
7758467|NCT00763035|26972225|P1|First Intervention|Did not meeting inclusion/exclusion|1
7758468|NCT00763009|26972243|P1|Overall Study|Coronary Anatomy unsuitable|1
7758469|NCT00762996|26972248|P4|Period One|Withdrawal by Subject|0
7758470|NCT00762996|26972249|P3|Period One|Withdrawal by Subject|1
7758471|NCT00762996|26972250|P2|Period One|Withdrawal by Subject|0
7758472|NCT00762996|26972251|P1|Period One|Withdrawal by Subject|0
7758473|NCT00762996|26972248|P4|Period One|Adverse Event|0
7758474|NCT00762996|26972249|P3|Period One|Adverse Event|1
7758475|NCT00762996|26972250|P2|Period One|Adverse Event|0
7758476|NCT00762996|26972251|P1|Period One|Adverse Event|0
7758477|NCT00762996|26972248|P4|Period One|ineligible|1
7758478|NCT00762996|26972249|P3|Period One|ineligible|1
7758479|NCT00762996|26972250|P2|Period One|ineligible|0
7758480|NCT00762996|26972251|P1|Period One|ineligible|0
7758481|NCT00762996|26972248|P4|Period One|Protocol Violation|0
7758482|NCT00762996|26972249|P3|Period One|Protocol Violation|1
7758483|NCT00762996|26972250|P2|Period One|Protocol Violation|0
7758484|NCT00762996|26972251|P1|Period One|Protocol Violation|0
7758485|NCT00762970|26972264|P3|Overall Study|Difficulty of handling lens|0
7758486|NCT00762970|26972265|P2|Overall Study|Difficulty of handling lens|2
7758487|NCT00762970|26972266|P1|Overall Study|Difficulty of handling lens|1
7758488|NCT00762970|26972264|P3|Overall Study|Lost to Follow-up|0
7758489|NCT00762970|26972265|P2|Overall Study|Lost to Follow-up|2
7758490|NCT00762970|26972266|P1|Overall Study|Lost to Follow-up|1
7758491|NCT00762970|26972264|P3|Overall Study|Protocol Violation|1
7758492|NCT00762970|26972265|P2|Overall Study|Protocol Violation|1
7758493|NCT00762970|26972266|P1|Overall Study|Protocol Violation|3
7758494|NCT00762970|26972264|P3|Overall Study|Withdrawal by Subject|0
7758495|NCT00762970|26972265|P2|Overall Study|Withdrawal by Subject|4
7758496|NCT00762970|26972266|P1|Overall Study|Withdrawal by Subject|7
7758497|NCT00762892|26972284|P2|Overall Study|Incarceration|0
7758498|NCT00762892|26972285|P1|Overall Study|Incarceration|1
7758499|NCT00762892|26972284|P2|Overall Study|Pregnancy|0
7758500|NCT00762892|26972285|P1|Overall Study|Pregnancy|1
7758501|NCT00762892|26972284|P2|Overall Study|Death|0
7758502|NCT00762892|26972285|P1|Overall Study|Death|1
7758503|NCT00762892|26972284|P2|Overall Study|Withdrawal by Subject|1
7758504|NCT00762892|26972285|P1|Overall Study|Withdrawal by Subject|0
7758505|NCT00762892|26972284|P2|Overall Study|Lost to Follow-up|5
7758506|NCT00762892|26972285|P1|Overall Study|Lost to Follow-up|2
7758507|NCT00762788|26972314|P6|Overall Study|Lost to Follow-up|21
7758508|NCT00762788|26972315|P5|Overall Study|Lost to Follow-up|13
7758509|NCT00762788|26972316|P4|Overall Study|Lost to Follow-up|26
7758510|NCT00762788|26972317|P3|Overall Study|Lost to Follow-up|21
7758511|NCT00762788|26972318|P2|Overall Study|Lost to Follow-up|37
7758512|NCT00762788|26972319|P1|Overall Study|Lost to Follow-up|26
7758513|NCT00762762|26972341|P2|Overall Study|Did not report for appointments|10
7758514|NCT00762762|26972342|P1|Overall Study|Did not report for appointments|8
7758515|NCT00762723|26972359|P3|Overall Study|Study Terminated slow enrollement|3
7758516|NCT00762723|26972360|P2|Overall Study|Study Terminated slow enrollement|5
7758517|NCT00762723|26972361|P1|Overall Study|Study Terminated slow enrollement|5
7758518|NCT00762606|26972534|P2|Overall Study|Lost to Follow-up|13
7758519|NCT00762606|26972535|P1|Overall Study|Lost to Follow-up|18
7758520|NCT00762502|26972580|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
7758521|NCT00762502|26972581|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
7758522|NCT00762502|26972582|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
7758523|NCT00762502|26972580|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
7758524|NCT00762502|26972581|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
7758525|NCT00762502|26972582|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
7758526|NCT00762502|26972580|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
7758527|NCT00762502|26972581|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
7758528|NCT00762502|26972582|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
7758529|NCT00762476|26972596|P2|Overall Study|Seasonal allergies|0
7758530|NCT00762476|26972597|P1|Overall Study|Seasonal allergies|1
7758531|NCT00762476|26972596|P2|Overall Study|non-compliance with study visits|2
7758532|NCT00762476|26972597|P1|Overall Study|non-compliance with study visits|0
7758533|NCT00762476|26972596|P2|Overall Study|antibiotic use|1
7758534|NCT00762476|26972597|P1|Overall Study|antibiotic use|0
7758535|NCT00762476|26972596|P2|Overall Study|Withdrawal by Subject|12
7758536|NCT00762476|26972597|P1|Overall Study|Withdrawal by Subject|6
7758537|NCT00762476|26972596|P2|Overall Study|Physician Decision|14
7758538|NCT00762476|26972597|P1|Overall Study|Physician Decision|2
7758539|NCT00762476|26972596|P2|Overall Study|Protocol Violation|6
7758540|NCT00762476|26972597|P1|Overall Study|Protocol Violation|5
7758541|NCT00762476|26972596|P2|Overall Study|Lost to Follow-up|0
7758542|NCT00762476|26972597|P1|Overall Study|Lost to Follow-up|2
7758543|NCT00762476|26972596|P2|Overall Study|Adverse Event|1
7758544|NCT00762476|26972597|P1|Overall Study|Adverse Event|7
7758545|NCT00762463|26972609|P4|Extension Phase (Week 6 to Week 12)|Other|1
7758546|NCT00762463|26972610|P3|Extension Phase (Week 6 to Week 12)|Other|0
7758547|NCT00762463|26972611|P2|Extension Phase (Week 6 to Week 12)|Other|0
7758548|NCT00762463|26972612|P1|Extension Phase (Week 6 to Week 12)|Other|0
7758549|NCT00762463|26972609|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
7758550|NCT00762463|26972610|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
7758551|NCT00762463|26972611|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
7758552|NCT00762463|26972612|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
7758553|NCT00762463|26972609|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7758554|NCT00762463|26972610|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
7758555|NCT00762463|26972611|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7758556|NCT00762463|26972612|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7758557|NCT00762463|26972609|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
7758558|NCT00762463|26972610|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
7758559|NCT00762463|26972611|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
7758560|NCT00762463|26972612|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
7758561|NCT00762463|26972609|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
7758562|NCT00762463|26972610|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
7758563|NCT00762463|26972611|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
7758564|NCT00762463|26972612|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
7758565|NCT00762463|26972609|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
7758566|NCT00762463|26972610|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
7758567|NCT00762463|26972611|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
7758568|NCT00762463|26972612|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
7758569|NCT00762463|26972609|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
7758570|NCT00762463|26972610|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
7758571|NCT00762463|26972611|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
7758572|NCT00762463|26972612|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
7758573|NCT00762463|26972609|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
7758574|NCT00762463|26972610|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
7758575|NCT00762463|26972611|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
7758576|NCT00762463|26972612|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
7758577|NCT00762411|26972718|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
7758578|NCT00762411|26972719|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
7758579|NCT00762411|26972718|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
7758580|NCT00762411|26972719|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
7758581|NCT00762411|26972718|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
7758582|NCT00762411|26972719|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
7758583|NCT00762411|26972718|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
7758584|NCT00762411|26972719|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
7758585|NCT00762411|26972718|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
7758586|NCT00762411|26972719|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
7758587|NCT00762411|26972718|P2|Safety Follow Up (SFU)-Optional|Death|8
7758588|NCT00762411|26972719|P1|Safety Follow Up (SFU)-Optional|Death|1
7758589|NCT00762411|26972718|P2|Delayed Start|Caregiver Decision|1
7758590|NCT00762411|26972719|P1|Delayed Start|Caregiver Decision|1
7758591|NCT00762411|26972718|P2|Delayed Start|Sponsor Decision|20
7758592|NCT00762411|26972719|P1|Delayed Start|Sponsor Decision|16
7758593|NCT00762411|26972718|P2|Delayed Start|Protocol Violation|1
7758594|NCT00762411|26972719|P1|Delayed Start|Protocol Violation|0
7758595|NCT00762411|26972718|P2|Delayed Start|Adverse Event|4
7758596|NCT00762411|26972719|P1|Delayed Start|Adverse Event|0
7758597|NCT00762411|26972718|P2|Initial Treatment|Entry Criteria Exclusion|1
7758598|NCT00762411|26972719|P1|Initial Treatment|Entry Criteria Exclusion|0
7758599|NCT00762411|26972718|P2|Initial Treatment|Abnormal Lab/ECG Result|4
7758600|NCT00762411|26972719|P1|Initial Treatment|Abnormal Lab/ECG Result|6
7758601|NCT00762411|26972718|P2|Initial Treatment|Caregiver Decision|16
7758602|NCT00762411|26972719|P1|Initial Treatment|Caregiver Decision|21
7758603|NCT00762411|26972718|P2|Initial Treatment|Lost to Follow-up|0
7758604|NCT00762411|26972719|P1|Initial Treatment|Lost to Follow-up|5
7758605|NCT00762411|26972718|P2|Initial Treatment|Sponsor Decision|401
7758606|NCT00762411|26972719|P1|Initial Treatment|Sponsor Decision|293
7758607|NCT00762411|26972718|P2|Initial Treatment|Physician Decision|0
7758608|NCT00762411|26972719|P1|Initial Treatment|Physician Decision|1
7758609|NCT00762411|26972718|P2|Initial Treatment|Withdrawal by Subject|52
7758610|NCT00762411|26972719|P1|Initial Treatment|Withdrawal by Subject|65
7758611|NCT00762411|26972718|P2|Initial Treatment|Protocol Violation|1
7758612|NCT00762411|26972719|P1|Initial Treatment|Protocol Violation|4
7758613|NCT00762411|26972718|P2|Initial Treatment|Adverse Event|40
7758614|NCT00762411|26972719|P1|Initial Treatment|Adverse Event|132
7758615|NCT00762411|26972718|P2|Initial Treatment|Death|6
7758616|NCT00762411|26972719|P1|Initial Treatment|Death|7
7758617|NCT00762385|26972783|P2|Second Intervention|Protocol Violation|3
7758618|NCT00762385|26972784|P1|Second Intervention|Protocol Violation|3
7758619|NCT00762385|26972783|P2|First Intervention|Protocol Violation|1
7758620|NCT00762385|26972784|P1|First Intervention|Protocol Violation|0
7758621|NCT00762385|26972783|P2|First Intervention|Ineligible|0
7758622|NCT00762385|26972784|P1|First Intervention|Ineligible|1
7758623|NCT00762385|26972783|P2|First Intervention|Lost to Follow-up|2
7758624|NCT00762385|26972784|P1|First Intervention|Lost to Follow-up|0
7758625|NCT00762385|26972783|P2|First Intervention|Lens Issue|1
7758626|NCT00762385|26972784|P1|First Intervention|Lens Issue|1
7758627|NCT00762372|26972797|P3|Overall Study|Adverse Event|0
7758628|NCT00762372|26972798|P2|Overall Study|Adverse Event|0
7758629|NCT00762372|26972799|P1|Overall Study|Adverse Event|1
7758630|NCT00762359|26972875|P2|Overall Study|Withdrew consent|0
7758631|NCT00762359|26972876|P1|Overall Study|Withdrew consent|1
7758632|NCT00762359|26972875|P2|Overall Study|Removal|1
7758633|NCT00762359|26972876|P1|Overall Study|Removal|0
7758634|NCT00762359|26972875|P2|Overall Study|Physician Decision|3
7758635|NCT00762359|26972876|P1|Overall Study|Physician Decision|2
7758636|NCT00762359|26972875|P2|Overall Study|Institution closed|3
7758637|NCT00762359|26972876|P1|Overall Study|Institution closed|2
7758638|NCT00762359|26972875|P2|Overall Study|Lack of Efficacy|4
7758639|NCT00762359|26972876|P1|Overall Study|Lack of Efficacy|0
7758640|NCT00762359|26972875|P2|Overall Study|Withdrawal by Subject|10
7758641|NCT00762359|26972876|P1|Overall Study|Withdrawal by Subject|13
7758642|NCT00762359|26972875|P2|Overall Study|Protocol Violation|13
7758643|NCT00762359|26972876|P1|Overall Study|Protocol Violation|21
7758644|NCT00762359|26972875|P2|Overall Study|Adverse Event|23
7758645|NCT00762359|26972876|P1|Overall Study|Adverse Event|20
7758646|NCT00762268|26973021|P2|Overall Study|Withdrawal by Subject|3
7758647|NCT00762268|26973022|P1|Overall Study|Withdrawal by Subject|3
7758648|NCT00762229|26973034|P2|Overall Study|did not recveive intervention|1
7758649|NCT00762229|26973035|P1|Overall Study|did not recveive intervention|0
7758650|NCT00762229|26973034|P2|Overall Study|Lost to Follow-up|1
7758651|NCT00762229|26973035|P1|Overall Study|Lost to Follow-up|1
7758652|NCT00762164|26973132|P2|Overall Study|Withdrawal by Subject|1
7758653|NCT00762164|26973133|P1|Overall Study|Withdrawal by Subject|0
7758654|NCT00762164|26973132|P2|Overall Study|Discontinued medication|0
7758655|NCT00762164|26973133|P1|Overall Study|Discontinued medication|2
7758656|NCT00762164|26973132|P2|Overall Study|Lost to Follow-up|1
7758657|NCT00762164|26973133|P1|Overall Study|Lost to Follow-up|1
7758658|NCT00762086|26973143|P2|Overall Study|Ineligible to participate in the study|0
7758659|NCT00762086|26973144|P1|Overall Study|Ineligible to participate in the study|1
7758660|NCT00762086|26973143|P2|Overall Study|Withdrawal by Subject|2
7758661|NCT00762086|26973144|P1|Overall Study|Withdrawal by Subject|2
7758662|NCT00762086|26973143|P2|Overall Study|Non compliance|0
7758663|NCT00762086|26973144|P1|Overall Study|Non compliance|1
7758664|NCT00762086|26973143|P2|Overall Study|Lost to Follow-up|2
7758665|NCT00762086|26973144|P1|Overall Study|Lost to Follow-up|0
7758666|NCT00762086|26973143|P2|Overall Study|Adverse Event|0
7758667|NCT00762086|26973144|P1|Overall Study|Adverse Event|2
7758668|NCT00762073|26973154|P4|Overall Study|Not on treatment for >/= 77 days|0
7758669|NCT00762073|26973155|P3|Overall Study|Not on treatment for >/= 77 days|0
7758670|NCT00762073|26973156|P2|Overall Study|Not on treatment for >/= 77 days|0
7758671|NCT00762073|26973157|P1|Overall Study|Not on treatment for >/= 77 days|1
7758672|NCT00762073|26973154|P4|Overall Study|Withdrawal by Subject|1
7758673|NCT00762073|26973155|P3|Overall Study|Withdrawal by Subject|1
7758674|NCT00762073|26973156|P2|Overall Study|Withdrawal by Subject|2
7758675|NCT00762073|26973157|P1|Overall Study|Withdrawal by Subject|1
7758676|NCT00762073|26973154|P4|Overall Study|Significant Subject Noncompliance|1
7758677|NCT00762073|26973155|P3|Overall Study|Significant Subject Noncompliance|0
7758678|NCT00762073|26973156|P2|Overall Study|Significant Subject Noncompliance|1
7758679|NCT00762073|26973157|P1|Overall Study|Significant Subject Noncompliance|0
7758680|NCT00762073|26973154|P4|Overall Study|Adverse Event|1
7758681|NCT00762073|26973155|P3|Overall Study|Adverse Event|1
7758682|NCT00762073|26973156|P2|Overall Study|Adverse Event|0
7758683|NCT00762073|26973157|P1|Overall Study|Adverse Event|1
7758684|NCT00762073|26973154|P4|Overall Study|Lack of Efficacy|0
7758685|NCT00762073|26973155|P3|Overall Study|Lack of Efficacy|0
7758686|NCT00762073|26973156|P2|Overall Study|Lack of Efficacy|1
7758687|NCT00762073|26973157|P1|Overall Study|Lack of Efficacy|1
7758688|NCT00762034|26973221|P2|Maintenance Period|Other|1
7758689|NCT00762034|26973222|P1|Maintenance Period|Other|1
7758690|NCT00762034|26973221|P2|Maintenance Period|Death due to study disease|3
7758691|NCT00762034|26973222|P1|Maintenance Period|Death due to study disease|3
7758692|NCT00762034|26973221|P2|Maintenance Period|Death not due to study disease|5
7758693|NCT00762034|26973222|P1|Maintenance Period|Death not due to study disease|2
7758694|NCT00762034|26973221|P2|Maintenance Period|Withdrawal by Subject|14
7758695|NCT00762034|26973222|P1|Maintenance Period|Withdrawal by Subject|34
7758696|NCT00762034|26973221|P2|Maintenance Period|Physician Decision|20
7758697|NCT00762034|26973222|P1|Maintenance Period|Physician Decision|25
7758698|NCT00762034|26973221|P2|Maintenance Period|Progressive Disease|224
7758699|NCT00762034|26973222|P1|Maintenance Period|Progressive Disease|186
7758700|NCT00762034|26973221|P2|Maintenance Period|Adverse Event|26
7758701|NCT00762034|26973222|P1|Maintenance Period|Adverse Event|42
7758702|NCT00762034|26973221|P2|Maintenance Period|Entry Criterion Not Met|2
7758703|NCT00762034|26973222|P1|Maintenance Period|Entry Criterion Not Met|0
7758704|NCT00762034|26973221|P2|Maintenance Period|Protocol Violation|3
7758705|NCT00762034|26973222|P1|Maintenance Period|Protocol Violation|1
7758706|NCT00762034|26973221|P2|Induction Period|Deaths Due to Study Disease|9
7758707|NCT00762034|26973222|P1|Induction Period|Deaths Due to Study Disease|9
7758708|NCT00762034|26973221|P2|Induction Period|Deaths Not Due to Study Disease|14
7758709|NCT00762034|26973222|P1|Induction Period|Deaths Not Due to Study Disease|19
7758710|NCT00762034|26973221|P2|Induction Period|Withdrawal by Subject|19
7758711|NCT00762034|26973222|P1|Induction Period|Withdrawal by Subject|15
7758712|NCT00762034|26973221|P2|Induction Period|Physician Decision|20
7758713|NCT00762034|26973222|P1|Induction Period|Physician Decision|21
7758714|NCT00762034|26973221|P2|Induction Period|Progressive Disease|55
7758715|NCT00762034|26973222|P1|Induction Period|Progressive Disease|73
7758716|NCT00762034|26973221|P2|Induction Period|Lost to Follow-up|1
7758717|NCT00762034|26973222|P1|Induction Period|Lost to Follow-up|1
7758718|NCT00762034|26973221|P2|Induction Period|Adverse Event|38
7758719|NCT00762034|26973222|P1|Induction Period|Adverse Event|27
7758720|NCT00762034|26973221|P2|Induction Period|Entry Criterion Not Met|11
7758721|NCT00762034|26973222|P1|Induction Period|Entry Criterion Not Met|12
7758722|NCT00762034|26973221|P2|Induction Period|Protocol Violation|2
7758723|NCT00762034|26973222|P1|Induction Period|Protocol Violation|1
7758724|NCT00761969|26973294|P2|Overall Study|Lost to Follow-up|93
7758725|NCT00761969|26973295|P1|Overall Study|Lost to Follow-up|88
7758726|NCT00761969|26973294|P2|Overall Study|Death|47
7758727|NCT00761969|26973295|P1|Overall Study|Death|112
7758728|NCT00761956|26973305|P2|Overall Study|Adverse Event|34
7758729|NCT00761956|26973306|P1|Overall Study|Adverse Event|26
7758730|NCT00761956|26973305|P2|Overall Study|Death|1
7758731|NCT00761956|26973306|P1|Overall Study|Death|0
7758732|NCT00761956|26973305|P2|Overall Study|Withdrawal by Subject|8
7758733|NCT00761956|26973306|P1|Overall Study|Withdrawal by Subject|3
7758734|NCT00761956|26973305|P2|Overall Study|Lost to Follow-up|11
7758735|NCT00761956|26973306|P1|Overall Study|Lost to Follow-up|6
7758736|NCT00761891|26973333|P1|Overall Study|Withdrawal by Subject|10
7758737|NCT00761865|26973340|P2|Overall Study|Lost to Follow-up|7
7758738|NCT00761865|26973341|P1|Overall Study|Lost to Follow-up|8
7758739|NCT00761774|26973362|P1|Overall Study|IP stopped by hospital physician|1
7758740|NCT00761774|26973362|P1|Overall Study|Subject IP non-compliance|1
7758741|NCT00761774|26973362|P1|Overall Study|Coordinator leaving site|1
7758742|NCT00761774|26973362|P1|Overall Study|Patient moved out of study area|1
7758743|NCT00761774|26973362|P1|Overall Study|Investigator clinical judgement|1
7758744|NCT00761774|26973362|P1|Overall Study|Sponsor decision|1
7758745|NCT00761774|26973362|P1|Overall Study|Medical decision to read SUSAR reports|1
7758746|NCT00761774|26973362|P1|Overall Study|Reclassification of seizures|1
7758747|NCT00761774|26973362|P1|Overall Study|End of study|2
7758748|NCT00761774|26973362|P1|Overall Study|Non-compliance|4
7758749|NCT00761774|26973362|P1|Overall Study|Withdrawal by Subject|9
7758750|NCT00761774|26973362|P1|Overall Study|Lost to Follow-up|2
7758751|NCT00761774|26973362|P1|Overall Study|Lack of Efficacy|37
7758752|NCT00761774|26973362|P1|Overall Study|Adverse Event|17
7758753|NCT00761761|26973373|P2|Overall Study|Withdrawal by Subject|0
7758754|NCT00761761|26973374|P1|Overall Study|Withdrawal by Subject|3
7758755|NCT00761761|26973373|P2|Overall Study|Lost to Follow-up|1
7758756|NCT00761761|26973374|P1|Overall Study|Lost to Follow-up|3
7758757|NCT00761748|26973386|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
7758758|NCT00761748|26973387|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
7758759|NCT00761748|26973386|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
7758760|NCT00761748|26973387|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
7758761|NCT00761735|26973393|P1|Overall Study|Administrative|1
7758762|NCT00761735|26973393|P1|Overall Study|Non-compliance with protocol|1
7758763|NCT00761735|26973393|P1|Overall Study|Withdrawal by Subject|6
7758764|NCT00761735|26973393|P1|Overall Study|Lost to Follow-up|6
7758765|NCT00761631|26973409|P6|Overall Study|Other|1
7758766|NCT00761631|26973410|P5|Overall Study|Other|1
7758767|NCT00761631|26973411|P4|Overall Study|Other|0
7758768|NCT00761631|26973412|P3|Overall Study|Other|0
7758769|NCT00761631|26973413|P2|Overall Study|Other|0
7758770|NCT00761631|26973414|P1|Overall Study|Other|0
7758771|NCT00761631|26973409|P6|Overall Study|Physician Decision|0
7758772|NCT00761631|26973410|P5|Overall Study|Physician Decision|0
7758773|NCT00761631|26973411|P4|Overall Study|Physician Decision|0
7758774|NCT00761631|26973412|P3|Overall Study|Physician Decision|0
7758775|NCT00761631|26973413|P2|Overall Study|Physician Decision|0
7758776|NCT00761631|26973414|P1|Overall Study|Physician Decision|1
7758777|NCT00761631|26973409|P6|Overall Study|Failed to return|2
7758778|NCT00761631|26973410|P5|Overall Study|Failed to return|5
7758779|NCT00761631|26973411|P4|Overall Study|Failed to return|1
7758780|NCT00761631|26973412|P3|Overall Study|Failed to return|1
7758781|NCT00761631|26973413|P2|Overall Study|Failed to return|0
7758782|NCT00761631|26973414|P1|Overall Study|Failed to return|1
7758783|NCT00761631|26973409|P6|Overall Study|Randomized, not treated|0
7758784|NCT00761631|26973410|P5|Overall Study|Randomized, not treated|0
7758785|NCT00761631|26973411|P4|Overall Study|Randomized, not treated|0
7758786|NCT00761631|26973412|P3|Overall Study|Randomized, not treated|0
7758787|NCT00761631|26973413|P2|Overall Study|Randomized, not treated|0
7758788|NCT00761631|26973414|P1|Overall Study|Randomized, not treated|1
7758789|NCT00761631|26973409|P6|Overall Study|Protocol Violation|1
7758790|NCT00761631|26973410|P5|Overall Study|Protocol Violation|5
7758791|NCT00761631|26973411|P4|Overall Study|Protocol Violation|1
7758792|NCT00761631|26973412|P3|Overall Study|Protocol Violation|0
7758793|NCT00761631|26973413|P2|Overall Study|Protocol Violation|0
7758794|NCT00761631|26973414|P1|Overall Study|Protocol Violation|2
7758795|NCT00761631|26973409|P6|Overall Study|Lost to Follow-up|1
7758796|NCT00761631|26973410|P5|Overall Study|Lost to Follow-up|6
7758797|NCT00761631|26973411|P4|Overall Study|Lost to Follow-up|1
7758798|NCT00761631|26973412|P3|Overall Study|Lost to Follow-up|7
7758799|NCT00761631|26973413|P2|Overall Study|Lost to Follow-up|4
7758800|NCT00761631|26973414|P1|Overall Study|Lost to Follow-up|2
7758801|NCT00761631|26973409|P6|Overall Study|Parent/legal guardian request|0
7758802|NCT00761631|26973410|P5|Overall Study|Parent/legal guardian request|5
7758803|NCT00761631|26973411|P4|Overall Study|Parent/legal guardian request|0
7758804|NCT00761631|26973412|P3|Overall Study|Parent/legal guardian request|8
7758805|NCT00761631|26973413|P2|Overall Study|Parent/legal guardian request|3
7758806|NCT00761631|26973414|P1|Overall Study|Parent/legal guardian request|8
7758807|NCT00761605|26973449|P1|Overall Study|Other|21
7758808|NCT00761605|26973449|P1|Overall Study|Withdrawal by Subject|37
7758809|NCT00761605|26973449|P1|Overall Study|Lost to Follow-up|29
7758810|NCT00761605|26973449|P1|Overall Study|Lack of Efficacy|26
7758811|NCT00761605|26973449|P1|Overall Study|Death|2
7758812|NCT00761605|26973449|P1|Overall Study|Adverse Event|26
7758813|NCT00761579|26973493|P1|Overall Study|Intake of prohibited concomitant drug|1
7758814|NCT00761579|26973493|P1|Overall Study|Lost survey form|1
7758815|NCT00761579|26973493|P1|Overall Study|Aggravation of symptoms by changing drug|1
7758816|NCT00761579|26973493|P1|Overall Study|Aggravation of depression|1
7758817|NCT00761579|26973493|P1|Overall Study|Drug overdose|1
7758818|NCT00761579|26973493|P1|Overall Study|Protocol deviation|1
7758819|NCT00761579|26973493|P1|Overall Study|Lack of compliance|2
7758820|NCT00761579|26973493|P1|Overall Study|Withdrawal by Subject|34
7758821|NCT00761579|26973493|P1|Overall Study|Pregnancy|1
7758822|NCT00761579|26973493|P1|Overall Study|Lost to Follow-up|16
7758823|NCT00761579|26973493|P1|Overall Study|Lack of Efficacy|21
7758824|NCT00761579|26973493|P1|Overall Study|Death|2
7758825|NCT00761579|26973493|P1|Overall Study|Adverse Event|10
7758826|NCT00761527|26973526|P1|Overall Study|Unknown reason|2
7758827|NCT00761527|26973526|P1|Overall Study|Lost to Follow-up|9
7758828|NCT00761527|26973526|P1|Overall Study|Poor Compliance|8
7758829|NCT00761527|26973526|P1|Overall Study|Adverse Event|3
7758830|NCT00761514|26973533|P1|Overall Study|Unable to pay for medications|1
7758831|NCT00761514|26973533|P1|Overall Study|Problem complying with study visit|1
7758832|NCT00761514|26973533|P1|Overall Study|Health insurance didn't cover study drug|1
7758833|NCT00761514|26973533|P1|Overall Study|Lost to Follow-up|1
7758834|NCT00761514|26973533|P1|Overall Study|Withdrawal by Subject|2
7758835|NCT00761514|26973533|P1|Overall Study|Adverse Event|1
7758836|NCT00761462|26973540|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
7758837|NCT00761462|26973541|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
7758838|NCT00761462|26973540|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
7758839|NCT00761462|26973541|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
7758840|NCT00761462|26973540|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
7758841|NCT00761462|26973541|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
7758842|NCT00761462|26973540|P2|Treatment|Subjects never received study medication|12
7758843|NCT00761462|26973541|P1|Treatment|Subjects never received study medication|23
7758844|NCT00761319|26973555|P2|Overall Study|Missing|0
7758845|NCT00761319|26973556|P1|Overall Study|Missing|1
7758846|NCT00761319|26973555|P2|Overall Study|Nonspecified|2
7758847|NCT00761319|26973556|P1|Overall Study|Nonspecified|2
7758848|NCT00761319|26973555|P2|Overall Study|Lost to Follow-up|1
7758849|NCT00761319|26973556|P1|Overall Study|Lost to Follow-up|1
7758850|NCT00761319|26973555|P2|Overall Study|Noncompliance|3
7758851|NCT00761319|26973556|P1|Overall Study|Noncompliance|4
7758852|NCT00761319|26973555|P2|Overall Study|Withdrawal by Subject|7
7758853|NCT00761319|26973556|P1|Overall Study|Withdrawal by Subject|8
7758854|NCT00761319|26973555|P2|Overall Study|Adverse Event|7
7758855|NCT00761319|26973556|P1|Overall Study|Adverse Event|11
7758856|NCT00761319|26973555|P2|Overall Study|Protocol Violation|14
7758857|NCT00761319|26973556|P1|Overall Study|Protocol Violation|21
7758858|NCT00761306|26973564|P1|Overall Study|Administrative or Other Reasons|5
7758859|NCT00761306|26973564|P1|Overall Study|Lost to Follow-up|1
7758860|NCT00761306|26973564|P1|Overall Study|Withdrawal of Consent|3
7758861|NCT00761306|26973564|P1|Overall Study|Protocol Violation|2
7758862|NCT00761306|26973564|P1|Overall Study|Lack of Efficacy|4
7758863|NCT00761306|26973564|P1|Overall Study|Adverse Event|5
7758864|NCT00761280|26973575|P2|First Dose to End of Study|Lost to Follow-up|1
7758865|NCT00761280|26973576|P1|First Dose to End of Study|Lost to Follow-up|0
7758866|NCT00761280|26973575|P2|First Dose to End of Study|Death|0
7758867|NCT00761280|26973576|P1|First Dose to End of Study|Death|1
7758868|NCT00761280|26973575|P2|First Dose to End of Study|Sponsor decision|2
7758869|NCT00761280|26973576|P1|First Dose to End of Study|Sponsor decision|1
7758870|NCT00761280|26973575|P2|First Dose to End of Study|Progressive disease|3
7758871|NCT00761280|26973576|P1|First Dose to End of Study|Progressive disease|5
7758872|NCT00761280|26973575|P2|First Dose to End of Study|End of trial|5
7758873|NCT00761280|26973576|P1|First Dose to End of Study|End of trial|5
7758874|NCT00761280|26973575|P2|Randomization to First Dose|Other|0
7758875|NCT00761280|26973576|P1|Randomization to First Dose|Other|1
7758876|NCT00761280|26973575|P2|Randomization to First Dose|Sponsor decision|0
7758877|NCT00761280|26973576|P1|Randomization to First Dose|Sponsor decision|1
7758878|NCT00761280|26973575|P2|Randomization to First Dose|Withdrawal by Subject|2
7758879|NCT00761280|26973576|P1|Randomization to First Dose|Withdrawal by Subject|0
7758880|NCT00761267|26973607|P3|Overall Study|Withdrawal by Subject|0
7758881|NCT00761267|26973608|P2|Overall Study|Withdrawal by Subject|1
7758882|NCT00761267|26973609|P1|Overall Study|Withdrawal by Subject|0
7758883|NCT00761267|26973607|P3|Overall Study|Randomized but not treated|0
7758884|NCT00761267|26973608|P2|Overall Study|Randomized but not treated|1
7758885|NCT00761267|26973609|P1|Overall Study|Randomized but not treated|1
7758886|NCT00761267|26973607|P3|Overall Study|Lost to Follow-up|1
7758887|NCT00761267|26973608|P2|Overall Study|Lost to Follow-up|0
7758888|NCT00761267|26973609|P1|Overall Study|Lost to Follow-up|0
7758889|NCT00761267|26973607|P3|Overall Study|Death|5
7758890|NCT00761267|26973608|P2|Overall Study|Death|2
7758891|NCT00761267|26973609|P1|Overall Study|Death|1
7758892|NCT00761215|26973660|P3|Overall Study|Bacteremia|0
7758893|NCT00761215|26973661|P2|Overall Study|Bacteremia|0
7758894|NCT00761215|26973662|P1|Overall Study|Bacteremia|1
7758895|NCT00761215|26973660|P3|Overall Study|Withdrawal by Subject|0
7758896|NCT00761215|26973661|P2|Overall Study|Withdrawal by Subject|0
7758897|NCT00761215|26973662|P1|Overall Study|Withdrawal by Subject|1
7758898|NCT00761215|26973660|P3|Overall Study|Lost to Follow-up|6
7758899|NCT00761215|26973661|P2|Overall Study|Lost to Follow-up|3
7758900|NCT00761215|26973662|P1|Overall Study|Lost to Follow-up|6
7758901|NCT00761215|26973660|P3|Overall Study|Randomized but didn't receive drug|2
7758902|NCT00761215|26973661|P2|Overall Study|Randomized but didn't receive drug|1
7758903|NCT00761215|26973662|P1|Overall Study|Randomized but didn't receive drug|1
7758904|NCT00761189|26973704|P1|Overall Study|Other|13
7758905|NCT00761189|26973704|P1|Overall Study|Withdrawal by Subject|49
7758906|NCT00761189|26973704|P1|Overall Study|Lost to Follow-up|36
7758907|NCT00761189|26973704|P1|Overall Study|Lack of Efficacy|45
7758908|NCT00761189|26973704|P1|Overall Study|Adverse Event|42
7758909|NCT00761176|26973721|P2|Overall Study|Withdrawal by Subject|1
7758910|NCT00761176|26973722|P1|Overall Study|Withdrawal by Subject|1
7758911|NCT00761176|26973721|P2|Overall Study|Death|0
7758912|NCT00761176|26973722|P1|Overall Study|Death|1
7758913|NCT00761150|26973731|P3|Double-blind Period|Other|3
7758914|NCT00761150|26973732|P2|Double-blind Period|Other|3
7758915|NCT00761150|26973733|P1|Double-blind Period|Other|0
7758916|NCT00761150|26973731|P3|Double-blind Period|Noncompliance|0
7758917|NCT00761150|26973732|P2|Double-blind Period|Noncompliance|1
7758918|NCT00761150|26973733|P1|Double-blind Period|Noncompliance|0
7758919|NCT00761150|26973731|P3|Double-blind Period|Did not meet DB randomization criteria|1
7758920|NCT00761150|26973732|P2|Double-blind Period|Did not meet DB randomization criteria|0
7758921|NCT00761150|26973733|P1|Double-blind Period|Did not meet DB randomization criteria|0
7758922|NCT00761150|26973731|P3|Double-blind Period|Lost to Follow-up|1
7758923|NCT00761150|26973732|P2|Double-blind Period|Lost to Follow-up|2
7758924|NCT00761150|26973733|P1|Double-blind Period|Lost to Follow-up|0
7758925|NCT00761150|26973731|P3|Double-blind Period|Withdrawal by Subject|2
7758926|NCT00761150|26973732|P2|Double-blind Period|Withdrawal by Subject|3
7758927|NCT00761150|26973733|P1|Double-blind Period|Withdrawal by Subject|0
7758928|NCT00761150|26973731|P3|Double-blind Period|Adverse Event|3
7758929|NCT00761150|26973732|P2|Double-blind Period|Adverse Event|3
7758930|NCT00761150|26973733|P1|Double-blind Period|Adverse Event|0
7758931|NCT00761150|26973731|P3|Double-blind Period|Lack of Efficacy|19
7758932|NCT00761150|26973732|P2|Double-blind Period|Lack of Efficacy|2
7758933|NCT00761150|26973733|P1|Double-blind Period|Lack of Efficacy|0
7758934|NCT00761150|26973731|P3|Open-label Period|Other|0
7758935|NCT00761150|26973732|P2|Open-label Period|Other|0
7758936|NCT00761150|26973733|P1|Open-label Period|Other|5
7758937|NCT00761150|26973731|P3|Open-label Period|Noncompliance|0
7758938|NCT00761150|26973732|P2|Open-label Period|Noncompliance|0
7758939|NCT00761150|26973733|P1|Open-label Period|Noncompliance|2
7758940|NCT00761150|26973731|P3|Open-label Period|Withdrawal by Subject|0
7758941|NCT00761150|26973732|P2|Open-label Period|Withdrawal by Subject|0
7758942|NCT00761150|26973733|P1|Open-label Period|Withdrawal by Subject|5
7758943|NCT00761150|26973731|P3|Open-label Period|Lack of Efficacy|0
7758944|NCT00761150|26973732|P2|Open-label Period|Lack of Efficacy|0
7758945|NCT00761150|26973733|P1|Open-label Period|Lack of Efficacy|4
7758946|NCT00761150|26973731|P3|Open-label Period|Lost to Follow-up|0
7758947|NCT00761150|26973732|P2|Open-label Period|Lost to Follow-up|0
7758948|NCT00761150|26973733|P1|Open-label Period|Lost to Follow-up|7
7758949|NCT00761150|26973731|P3|Open-label Period|Did not meet DB randomization criteria|0
7758950|NCT00761150|26973732|P2|Open-label Period|Did not meet DB randomization criteria|0
7758951|NCT00761150|26973733|P1|Open-label Period|Did not meet DB randomization criteria|11
7758952|NCT00761150|26973731|P3|Open-label Period|Adverse Event|0
7758953|NCT00761150|26973732|P2|Open-label Period|Adverse Event|0
7758954|NCT00761150|26973733|P1|Open-label Period|Adverse Event|36
7758955|NCT00760994|26973806|P3|Overall Study|Lost to Follow-up|3
7758956|NCT00760994|26973807|P2|Overall Study|Lost to Follow-up|4
7758957|NCT00760994|26973808|P1|Overall Study|Lost to Follow-up|4
7758958|NCT00760929|26973823|P4|Overall Study|Violation of Selection Criteria at Entry|1
7758959|NCT00760929|26973824|P3|Overall Study|Violation of Selection Criteria at Entry|0
7758960|NCT00760929|26973825|P2|Overall Study|Violation of Selection Criteria at Entry|0
7758961|NCT00760929|26973826|P1|Overall Study|Violation of Selection Criteria at Entry|0
7758962|NCT00760929|26973823|P4|Overall Study|Death|0
7758963|NCT00760929|26973824|P3|Overall Study|Death|1
7758964|NCT00760929|26973825|P2|Overall Study|Death|0
7758965|NCT00760929|26973826|P1|Overall Study|Death|0
7758966|NCT00760929|26973823|P4|Overall Study|Other|1
7758967|NCT00760929|26973824|P3|Overall Study|Other|2
7758968|NCT00760929|26973825|P2|Overall Study|Other|0
7758969|NCT00760929|26973826|P1|Overall Study|Other|2
7758970|NCT00760929|26973823|P4|Overall Study|Progression of Disease|42
7758971|NCT00760929|26973824|P3|Overall Study|Progression of Disease|38
7758972|NCT00760929|26973825|P2|Overall Study|Progression of Disease|26
7758973|NCT00760929|26973826|P1|Overall Study|Progression of Disease|21
7758974|NCT00760929|26973823|P4|Overall Study|Lost to Follow-up|0
7758975|NCT00760929|26973824|P3|Overall Study|Lost to Follow-up|1
7758976|NCT00760929|26973825|P2|Overall Study|Lost to Follow-up|0
7758977|NCT00760929|26973826|P1|Overall Study|Lost to Follow-up|0
7758978|NCT00760929|26973823|P4|Overall Study|Withdrawal by Subject|1
7758979|NCT00760929|26973824|P3|Overall Study|Withdrawal by Subject|9
7758980|NCT00760929|26973825|P2|Overall Study|Withdrawal by Subject|0
7758981|NCT00760929|26973826|P1|Overall Study|Withdrawal by Subject|1
7758982|NCT00760929|26973823|P4|Overall Study|Lack of Efficacy|0
7758983|NCT00760929|26973824|P3|Overall Study|Lack of Efficacy|1
7758984|NCT00760929|26973825|P2|Overall Study|Lack of Efficacy|2
7758985|NCT00760929|26973826|P1|Overall Study|Lack of Efficacy|0
7758986|NCT00760929|26973823|P4|Overall Study|Adverse Event|10
7758987|NCT00760929|26973824|P3|Overall Study|Adverse Event|6
7758988|NCT00760929|26973825|P2|Overall Study|Adverse Event|0
7758989|NCT00760929|26973826|P1|Overall Study|Adverse Event|2
7758990|NCT00760877|26973849|P2|Overall Study|Treatment failure|0
7758991|NCT00760877|26973850|P1|Overall Study|Treatment failure|1
7758992|NCT00760877|26973849|P2|Overall Study|Participants transferred to AMN107A2408|1
7758993|NCT00760877|26973850|P1|Overall Study|Participants transferred to AMN107A2408|11
7758994|NCT00760877|26973849|P2|Overall Study|Physician Decision|2
7758995|NCT00760877|26973850|P1|Overall Study|Physician Decision|1
7758996|NCT00760877|26973849|P2|Overall Study|Participant not eligible to cross-over|1
7758997|NCT00760877|26973850|P1|Overall Study|Participant not eligible to cross-over|0
7758998|NCT00760877|26973849|P2|Overall Study|Participant diagnosed with AML|1
7758999|NCT00760877|26973850|P1|Overall Study|Participant diagnosed with AML|0
7759000|NCT00760877|26973849|P2|Overall Study|Adverse Event|12
7759001|NCT00760877|26973850|P1|Overall Study|Adverse Event|19
7759002|NCT00760877|26973849|P2|Overall Study|Withdrawal by Subject|3
7759003|NCT00760877|26973850|P1|Overall Study|Withdrawal by Subject|7
7759004|NCT00760877|26973849|P2|Overall Study|Death|1
7759005|NCT00760877|26973850|P1|Overall Study|Death|2
7759006|NCT00760877|26973849|P2|Overall Study|Pregnancy|4
7759007|NCT00760877|26973850|P1|Overall Study|Pregnancy|1
7759008|NCT00760877|26973849|P2|Overall Study|Non-compliance with protocol treatment|1
7759009|NCT00760877|26973850|P1|Overall Study|Non-compliance with protocol treatment|2
7759010|NCT00760877|26973849|P2|Overall Study|Protocol Violation|0
7759011|NCT00760877|26973850|P1|Overall Study|Protocol Violation|1
7759012|NCT00760838|26973868|P2|Overall Study|Withdrawal by Subject|1
7759013|NCT00760838|26973869|P1|Overall Study|Withdrawal by Subject|1
7759014|NCT00760838|26973868|P2|Overall Study|Lost to Follow-up|0
7759015|NCT00760838|26973869|P1|Overall Study|Lost to Follow-up|2
7759016|NCT00760838|26973868|P2|Overall Study|Lack of Efficacy|0
7759017|NCT00760838|26973869|P1|Overall Study|Lack of Efficacy|1
7759018|NCT00760838|26973868|P2|Overall Study|Adverse Event|1
7759019|NCT00760838|26973869|P1|Overall Study|Adverse Event|1
7759020|NCT00760747|26973887|P2|Study Period III|Physician Decision|1
7759021|NCT00760747|26973888|P1|Study Period III|Physician Decision|0
7759022|NCT00760747|26973887|P2|Study Period III|Protocol Violation|1
7759023|NCT00760747|26973888|P1|Study Period III|Protocol Violation|1
7759024|NCT00760747|26973887|P2|Study Period III|Parent/Caregiver Decision|1
7759025|NCT00760747|26973888|P1|Study Period III|Parent/Caregiver Decision|0
7759026|NCT00760747|26973887|P2|Study Period III|Lack of Efficacy|0
7759027|NCT00760747|26973888|P1|Study Period III|Lack of Efficacy|1
7759028|NCT00760747|26973887|P2|Study Period III|Adverse Event|0
7759029|NCT00760747|26973888|P1|Study Period III|Adverse Event|1
7759030|NCT00760747|26973887|P2|Study Period II|No drug administered|1
7759031|NCT00760747|26973888|P1|Study Period II|No drug administered|0
7759032|NCT00760747|26973887|P2|Study Period II|Withdrawal by Subject|0
7759033|NCT00760747|26973888|P1|Study Period II|Withdrawal by Subject|1
7759034|NCT00760747|26973887|P2|Study Period II|Protocol Violation|3
7759035|NCT00760747|26973888|P1|Study Period II|Protocol Violation|6
7759036|NCT00760747|26973887|P2|Study Period II|Parent/Caregiver Decision|0
7759037|NCT00760747|26973888|P1|Study Period II|Parent/Caregiver Decision|3
7759038|NCT00760747|26973887|P2|Study Period II|Lack of Efficacy|6
7759039|NCT00760747|26973888|P1|Study Period II|Lack of Efficacy|0
7759040|NCT00760747|26973887|P2|Study Period II|Adverse Event|4
7759041|NCT00760747|26973888|P1|Study Period II|Adverse Event|3
7759042|NCT00760669|26973916|P1|Overall Study|Took drug before entering in contract|5
7759043|NCT00760669|26973916|P1|Overall Study|Participants with overlapping cases|1
7759044|NCT00760669|26973916|P1|Overall Study|Participants missing efficacy assessment|6
7759045|NCT00760669|26973916|P1|Overall Study|Not assessed for overall improvement|18
7759046|NCT00760617|26973933|P3|Overall Study|Lost to Follow-up|5
7759047|NCT00760617|26973934|P2|Overall Study|Lost to Follow-up|0
7759048|NCT00760617|26973935|P1|Overall Study|Lost to Follow-up|0
7759049|NCT00760617|26973933|P3|Overall Study|Adverse Event|0
7759050|NCT00760617|26973934|P2|Overall Study|Adverse Event|2
7759051|NCT00760617|26973935|P1|Overall Study|Adverse Event|5
7759052|NCT00760552|26974049|P2|Overall Study|Lost to Follow-up|10
7759053|NCT00760552|26974050|P1|Overall Study|Lost to Follow-up|11
7759054|NCT00760552|26974049|P2|Overall Study|Death|0
7759055|NCT00760552|26974050|P1|Overall Study|Death|2
7759056|NCT00760513|26974086|P2|Overall Study|Withdrawal by Subject|7
7759057|NCT00760513|26974087|P1|Overall Study|Withdrawal by Subject|5
7759058|NCT00760487|26974097|P1|Overall Study|Unilateral implantation|3
7759059|NCT00760474|26974103|P2|Period 2 (P2)|Adverse Event|1
7759060|NCT00760474|26974104|P1|Period 2 (P2)|Adverse Event|0
7759061|NCT00760474|26974103|P2|Period 2 (P2)|Lost to Follow-up|0
7759062|NCT00760474|26974104|P1|Period 2 (P2)|Lost to Follow-up|1
7759063|NCT00760474|26974103|P2|Placebo Washout Period|Other|1
7759064|NCT00760474|26974104|P1|Placebo Washout Period|Other|0
7759065|NCT00760474|26974103|P2|Period 1 (P1)|Discontinued then re-entered|1
7759066|NCT00760474|26974104|P1|Period 1 (P1)|Discontinued then re-entered|1
7759067|NCT00760383|26974161|P2|Overall Study|moved away; withdrew; medical reasons|7
7759068|NCT00760383|26974162|P1|Overall Study|moved away; withdrew; medical reasons|5
7759069|NCT00760266|26974174|P2|Overall Study|Administrative Problems|1
7759070|NCT00760266|26974175|P1|Overall Study|Administrative Problems|0
7759071|NCT00760266|26974174|P2|Overall Study|Lost to Follow-up|1
7759072|NCT00760266|26974175|P1|Overall Study|Lost to Follow-up|2
7759073|NCT00760266|26974174|P2|Overall Study|Patient withdrew consent|3
7759074|NCT00760266|26974175|P1|Overall Study|Patient withdrew consent|3
7759075|NCT00760266|26974174|P2|Overall Study|Protocol deviation|4
7759076|NCT00760266|26974175|P1|Overall Study|Protocol deviation|2
7759077|NCT00760266|26974174|P2|Overall Study|Lack of Efficacy|2
7759078|NCT00760266|26974175|P1|Overall Study|Lack of Efficacy|2
7759079|NCT00760266|26974174|P2|Overall Study|Abnormal test procedure result(s)|0
7759080|NCT00760266|26974175|P1|Overall Study|Abnormal test procedure result(s)|1
7759081|NCT00760266|26974174|P2|Overall Study|Abnormal laboratory value(s)|0
7759082|NCT00760266|26974175|P1|Overall Study|Abnormal laboratory value(s)|1
7759083|NCT00760266|26974174|P2|Overall Study|Adverse Event|7
7759084|NCT00760266|26974175|P1|Overall Study|Adverse Event|13
7759085|NCT00760214|26974192|P3|Overall Study|Other|6
7759086|NCT00760214|26974193|P2|Overall Study|Other|4
7759087|NCT00760214|26974194|P1|Overall Study|Other|3
7759088|NCT00760214|26974192|P3|Overall Study|Physician Decision|1
7759089|NCT00760214|26974193|P2|Overall Study|Physician Decision|1
7759090|NCT00760214|26974194|P1|Overall Study|Physician Decision|1
7759091|NCT00760214|26974192|P3|Overall Study|Pregnancy|1
7759092|NCT00760214|26974193|P2|Overall Study|Pregnancy|0
7759093|NCT00760214|26974194|P1|Overall Study|Pregnancy|0
7759094|NCT00760214|26974192|P3|Overall Study|Lack of Efficacy|4
7759095|NCT00760214|26974193|P2|Overall Study|Lack of Efficacy|2
7759096|NCT00760214|26974194|P1|Overall Study|Lack of Efficacy|3
7759097|NCT00760214|26974192|P3|Overall Study|Withdrawal by Subject|13
7759098|NCT00760214|26974193|P2|Overall Study|Withdrawal by Subject|14
7759099|NCT00760214|26974194|P1|Overall Study|Withdrawal by Subject|12
7759100|NCT00760214|26974192|P3|Overall Study|Lost to Follow-up|1
7759101|NCT00760214|26974193|P2|Overall Study|Lost to Follow-up|0
7759102|NCT00760214|26974194|P1|Overall Study|Lost to Follow-up|0
7759103|NCT00760214|26974192|P3|Overall Study|Protocol Violation|3
7759104|NCT00760214|26974193|P2|Overall Study|Protocol Violation|0
7759105|NCT00760214|26974194|P1|Overall Study|Protocol Violation|3
7759106|NCT00760214|26974192|P3|Overall Study|Adverse Event|12
7759107|NCT00760214|26974193|P2|Overall Study|Adverse Event|9
7759108|NCT00760214|26974194|P1|Overall Study|Adverse Event|8
7759109|NCT00760084|26974235|P1|Overall Study|Progressive Disease|3
7759110|NCT00760084|26974235|P1|Overall Study|Withdrawal by Subject|2
7759111|NCT00760084|26974235|P1|Overall Study|Physician Decision|5
7759112|NCT00759954|26974278|P2|Overall Study|Adverse Event|2
7759113|NCT00759954|26974279|P1|Overall Study|Adverse Event|1
7759114|NCT00759954|26974278|P2|Overall Study|Personal reason|0
7759115|NCT00759954|26974279|P1|Overall Study|Personal reason|1
7759116|NCT00759941|26974293|P2|Overall Study|Exited in error by site|1
7759117|NCT00759941|26974294|P1|Overall Study|Exited in error by site|1
7759118|NCT00759941|26974293|P2|Overall Study|Adverse Event|0
7759119|NCT00759941|26974294|P1|Overall Study|Adverse Event|1
7759120|NCT00759941|26974293|P2|Overall Study|Use of medication|0
7759121|NCT00759941|26974294|P1|Overall Study|Use of medication|1
7759122|NCT00759915|26974308|P2|Overall Study|Adverse Event|1
7759123|NCT00759915|26974309|P1|Overall Study|Adverse Event|0
7759124|NCT00759915|26974308|P2|Overall Study|Withdrawal by Subject|0
7759125|NCT00759915|26974309|P1|Overall Study|Withdrawal by Subject|1
7759126|NCT00759902|26974323|P2|Overall Study|Adverse Event|1
7759127|NCT00759902|26974324|P1|Overall Study|Adverse Event|0
7759128|NCT00759876|26974336|P1|Overall Study|Sponsor terminated study early|36
7759129|NCT00759863|26974360|P2|Overall Study|Death, moved, or lost contact|18
7759130|NCT00759863|26974361|P1|Overall Study|Death, moved, or lost contact|20
7759131|NCT00759785|26974386|P2|Overall Study|Withdrawal by Subject|1
7759132|NCT00759785|26974387|P1|Overall Study|Withdrawal by Subject|0
7759133|NCT00759785|26974386|P2|Overall Study|Physician Decision|1
7759134|NCT00759785|26974387|P1|Overall Study|Physician Decision|0
7759135|NCT00759785|26974386|P2|Overall Study|Protocol Violation|0
7759136|NCT00759785|26974387|P1|Overall Study|Protocol Violation|1
7759137|NCT00759785|26974386|P2|Overall Study|Participant sample lost|1
7759138|NCT00759785|26974387|P1|Overall Study|Participant sample lost|0
7759139|NCT00759785|26974386|P2|Overall Study|Participant sample not evaluable|2
7759140|NCT00759785|26974387|P1|Overall Study|Participant sample not evaluable|11
7759141|NCT00759759|26974410|P2|Overall Study|Withdrawal by Subject|1
7759142|NCT00759759|26974411|P1|Overall Study|Withdrawal by Subject|2
7759143|NCT00759759|26974410|P2|Overall Study|Didn't receive drug in period 2|0
7759144|NCT00759759|26974411|P1|Overall Study|Didn't receive drug in period 2|1
7759145|NCT00759759|26974410|P2|Overall Study|didn't return for period 2|0
7759146|NCT00759759|26974411|P1|Overall Study|didn't return for period 2|1
7759147|NCT00759681|26974429|P2|Overall Study|Lost to Follow-up|5
7759148|NCT00759681|26974430|P1|Overall Study|Lost to Follow-up|8
7759149|NCT00759681|26974429|P2|Overall Study|Death|5
7759150|NCT00759681|26974430|P1|Overall Study|Death|2
7759151|NCT00759655|26974457|P1|Overall Study|Termination of the study by sponsor|1
7759152|NCT00759564|26974485|P5|Washout Period (at Least 14 Days)|Adverse Event|1
7759153|NCT00759564|26974486|P4|Washout Period (at Least 14 Days)|Adverse Event|0
7759154|NCT00759564|26974487|P3|Washout Period (at Least 14 Days)|Adverse Event|0
7759155|NCT00759564|26974488|P2|Washout Period (at Least 14 Days)|Adverse Event|0
7759156|NCT00759564|26974489|P1|Washout Period (at Least 14 Days)|Adverse Event|0
7759157|NCT00759395|26974666|P2|Overall Study|Lack of Efficacy|2
7759158|NCT00759395|26974667|P1|Overall Study|Lack of Efficacy|0
7759159|NCT00759395|26974666|P2|Overall Study|Withdrawal by Subject|0
7759160|NCT00759395|26974667|P1|Overall Study|Withdrawal by Subject|1
7759161|NCT00759395|26974666|P2|Overall Study|Adverse Event|0
7759162|NCT00759395|26974667|P1|Overall Study|Adverse Event|1
7759163|NCT00759356|26974683|P2|Overall Study|Subject was unable to return|0
7759164|NCT00759356|26974684|P1|Overall Study|Subject was unable to return|1
7759165|NCT00759356|26974683|P2|Overall Study|Withdrawal by Subject|2
7759166|NCT00759356|26974684|P1|Overall Study|Withdrawal by Subject|0
7759167|NCT00759356|26974683|P2|Overall Study|Adverse Event|1
7759168|NCT00759356|26974684|P1|Overall Study|Adverse Event|0
7759169|NCT00759174|26974764|P2|Overall Study|Other|2
7759170|NCT00759174|26974765|P1|Overall Study|Other|0
7759171|NCT00759148|26974789|P2|Overall Study|Reason not given|0
7759172|NCT00759148|26974790|P1|Overall Study|Reason not given|1
7759173|NCT00759148|26974789|P2|Overall Study|Treatment Failure|10
7759174|NCT00759148|26974790|P1|Overall Study|Treatment Failure|6
7759175|NCT00759148|26974789|P2|Overall Study|Lost to Follow-up|9
7759176|NCT00759148|26974790|P1|Overall Study|Lost to Follow-up|3
7759177|NCT00759148|26974789|P2|Overall Study|Withdrawal by Subject|7
7759178|NCT00759148|26974790|P1|Overall Study|Withdrawal by Subject|3
7759179|NCT00759148|26974789|P2|Overall Study|Adverse Event|6
7759180|NCT00759148|26974790|P1|Overall Study|Adverse Event|1
7759181|NCT00759109|26974800|P2|Overall Study|Lost during study|0
7759182|NCT00759109|26974801|P1|Overall Study|Lost during study|1
7759183|NCT00759109|26974800|P2|Overall Study|Participant had a liver transplant|1
7759184|NCT00759109|26974801|P1|Overall Study|Participant had a liver transplant|0
7759185|NCT00759109|26974800|P2|Overall Study|Participant moved to a different city|1
7759186|NCT00759109|26974801|P1|Overall Study|Participant moved to a different city|0
7759187|NCT00759109|26974800|P2|Overall Study|HCV RNA negative|0
7759188|NCT00759109|26974801|P1|Overall Study|HCV RNA negative|1
7759189|NCT00759109|26974800|P2|Overall Study|Started new therapy|6
7759190|NCT00759109|26974801|P1|Overall Study|Started new therapy|2
7759191|NCT00759109|26974800|P2|Overall Study|Lost to Follow-up|6
7759192|NCT00759109|26974801|P1|Overall Study|Lost to Follow-up|4
7759193|NCT00759109|26974800|P2|Overall Study|Death|3
7759194|NCT00759109|26974801|P1|Overall Study|Death|4
7759195|NCT00759109|26974800|P2|Overall Study|Withdrawal by Subject|5
7759196|NCT00759109|26974801|P1|Overall Study|Withdrawal by Subject|9
7759197|NCT00759109|26974800|P2|Overall Study|Inability to comply|1
7759198|NCT00759109|26974801|P1|Overall Study|Inability to comply|1
7759199|NCT00759109|26974800|P2|Overall Study|Adverse Event|12
7759200|NCT00759109|26974801|P1|Overall Study|Adverse Event|17
7759201|NCT00759031|26974823|P2|First Intervention (1 Day)|Screening failure|0
7759202|NCT00759031|26974824|P1|First Intervention (1 Day)|Screening failure|1
7759203|NCT00759031|26974823|P2|First Intervention (1 Day)|Withdrawal by Subject|1
7759204|NCT00759031|26974824|P1|First Intervention (1 Day)|Withdrawal by Subject|0
7759205|NCT00759031|26974823|P2|First Intervention (1 Day)|Physician Decision|0
7759206|NCT00759031|26974824|P1|First Intervention (1 Day)|Physician Decision|1
7759207|NCT00758771|26974883|P2|Overall Study|Did not meet eligibility criteria|4
7759208|NCT00758771|26974884|P1|Overall Study|Did not meet eligibility criteria|2
7759209|NCT00758771|26974883|P2|Overall Study|Withdrawal by Subject|1
7759210|NCT00758771|26974884|P1|Overall Study|Withdrawal by Subject|1
7759211|NCT00758706|26974942|P2|Overall Study|Adverse Event|4
7759212|NCT00758706|26974943|P1|Overall Study|Adverse Event|4
7759213|NCT00758680|26974979|P10|Overall Study|Withdrawal by Subject|0
7759214|NCT00758680|26974980|P9|Overall Study|Withdrawal by Subject|1
7759215|NCT00758680|26974981|P8|Overall Study|Withdrawal by Subject|0
7759216|NCT00758680|26974982|P7|Overall Study|Withdrawal by Subject|1
7759217|NCT00758680|26974983|P6|Overall Study|Withdrawal by Subject|0
7759218|NCT00758680|26974984|P5|Overall Study|Withdrawal by Subject|0
7759219|NCT00758680|26974985|P4|Overall Study|Withdrawal by Subject|0
7759220|NCT00758680|26974986|P3|Overall Study|Withdrawal by Subject|0
7759221|NCT00758680|26974987|P2|Overall Study|Withdrawal by Subject|0
7759222|NCT00758680|26974988|P1|Overall Study|Withdrawal by Subject|0
7759223|NCT00758680|26974979|P10|Overall Study|Laboratory Adverse Event|0
7759224|NCT00758680|26974980|P9|Overall Study|Laboratory Adverse Event|1
7759225|NCT00758680|26974981|P8|Overall Study|Laboratory Adverse Event|0
7759226|NCT00758680|26974982|P7|Overall Study|Laboratory Adverse Event|0
7759227|NCT00758680|26974983|P6|Overall Study|Laboratory Adverse Event|0
7759228|NCT00758680|26974984|P5|Overall Study|Laboratory Adverse Event|0
7759229|NCT00758680|26974985|P4|Overall Study|Laboratory Adverse Event|0
7759230|NCT00758680|26974986|P3|Overall Study|Laboratory Adverse Event|0
7759231|NCT00758680|26974987|P2|Overall Study|Laboratory Adverse Event|0
7759232|NCT00758680|26974988|P1|Overall Study|Laboratory Adverse Event|0
7759233|NCT00758680|26974979|P10|Overall Study|Adverse Event|1
7759234|NCT00758680|26974980|P9|Overall Study|Adverse Event|0
7759235|NCT00758680|26974981|P8|Overall Study|Adverse Event|1
7759236|NCT00758680|26974982|P7|Overall Study|Adverse Event|0
7759237|NCT00758680|26974983|P6|Overall Study|Adverse Event|0
7759238|NCT00758680|26974984|P5|Overall Study|Adverse Event|0
7759239|NCT00758680|26974985|P4|Overall Study|Adverse Event|0
7759240|NCT00758680|26974986|P3|Overall Study|Adverse Event|0
7759241|NCT00758680|26974987|P2|Overall Study|Adverse Event|0
7759242|NCT00758680|26974988|P1|Overall Study|Adverse Event|0
7759243|NCT00758602|26975041|P2|Overall Study|Reason not specified|3
7759244|NCT00758602|26975042|P1|Overall Study|Reason not specified|3
7759245|NCT00758602|26975041|P2|Overall Study|Death|1
7759246|NCT00758602|26975042|P1|Overall Study|Death|0
7759247|NCT00758602|26975041|P2|Overall Study|Protocol Violation|2
7759248|NCT00758602|26975042|P1|Overall Study|Protocol Violation|0
7759249|NCT00758602|26975041|P2|Overall Study|Withdrawal by Subject|3
7759250|NCT00758602|26975042|P1|Overall Study|Withdrawal by Subject|1
7759251|NCT00758602|26975041|P2|Overall Study|Lost to Follow-up|3
7759252|NCT00758602|26975042|P1|Overall Study|Lost to Follow-up|4
7759253|NCT00758602|26975041|P2|Overall Study|Adverse Event|10
7759254|NCT00758602|26975042|P1|Overall Study|Adverse Event|11
7759255|NCT00758589|26975068|P4|Overall Study|Palm stopped to work|1
7759256|NCT00758589|26975069|P3|Overall Study|Palm stopped to work|0
7759257|NCT00758589|26975070|P2|Overall Study|Palm stopped to work|0
7759258|NCT00758589|26975071|P1|Overall Study|Palm stopped to work|0
7759259|NCT00758589|26975068|P4|Overall Study|Withdrawal by Subject|1
7759260|NCT00758589|26975069|P3|Overall Study|Withdrawal by Subject|1
7759261|NCT00758589|26975070|P2|Overall Study|Withdrawal by Subject|1
7759262|NCT00758589|26975071|P1|Overall Study|Withdrawal by Subject|0
7759263|NCT00758589|26975068|P4|Overall Study|Adverse Event|4
7759264|NCT00758589|26975069|P3|Overall Study|Adverse Event|5
7759265|NCT00758589|26975070|P2|Overall Study|Adverse Event|2
7759266|NCT00758589|26975071|P1|Overall Study|Adverse Event|3
7759267|NCT00758524|26975167|P17|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759268|NCT00758524|26975168|P16|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759269|NCT00758524|26975169|P15|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759270|NCT00758524|26975170|P14|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759271|NCT00758524|26975171|P13|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759272|NCT00758524|26975172|P12|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759273|NCT00758524|26975173|P11|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759274|NCT00758524|26975174|P10|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759275|NCT00758524|26975175|P9|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759276|NCT00758524|26975176|P8|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759277|NCT00758524|26975177|P7|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
7759278|NCT00758524|26975178|P6|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759279|NCT00758524|26975179|P5|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759280|NCT00758524|26975180|P4|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759281|NCT00758524|26975181|P3|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759282|NCT00758524|26975182|P2|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759283|NCT00758524|26975183|P1|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7759284|NCT00758524|26975167|P17|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759285|NCT00758524|26975168|P16|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759286|NCT00758524|26975169|P15|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759287|NCT00758524|26975170|P14|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759288|NCT00758524|26975171|P13|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759289|NCT00758524|26975172|P12|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759290|NCT00758524|26975173|P11|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759291|NCT00758524|26975174|P10|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759292|NCT00758524|26975175|P9|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
7759293|NCT00758524|26975176|P8|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759294|NCT00758524|26975177|P7|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759295|NCT00758524|26975178|P6|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759296|NCT00758524|26975179|P5|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759297|NCT00758524|26975180|P4|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759298|NCT00758524|26975181|P3|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759299|NCT00758524|26975182|P2|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759300|NCT00758524|26975183|P1|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7759301|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759302|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759303|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759304|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759305|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759306|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759307|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759308|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759309|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759310|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759311|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759312|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759313|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759314|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759315|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759316|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Reason not Specified|1
7759317|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Reason not Specified|0
7759318|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759319|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759320|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759321|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759322|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759323|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759324|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759325|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759326|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759327|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759328|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759329|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759330|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759331|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759332|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759333|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
7759334|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7759335|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759336|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759337|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759338|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759339|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759340|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759341|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759342|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759343|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759344|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759345|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759346|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759347|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
7759348|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759349|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759350|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759351|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7759352|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759353|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759354|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759355|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759356|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759357|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759358|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759359|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759360|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759361|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759362|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759363|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759364|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759365|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Administrative Problems|1
7759366|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Administrative Problems|1
7759367|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759368|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Administrative Problems|0
7759369|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759370|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759371|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759372|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759373|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759374|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759375|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759376|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759377|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759378|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759379|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759380|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
7759381|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
7759382|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759383|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
7759384|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
7759385|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7759386|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Adverse Event|0
7759387|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Adverse Event|0
7759388|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Adverse Event|0
7759389|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Adverse Event|0
7759390|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Adverse Event|0
7759391|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Adverse Event|0
7759392|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Adverse Event|0
7759393|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Adverse Event|0
7759394|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Adverse Event|0
7759395|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Adverse Event|0
7759396|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Adverse Event|0
7759397|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Adverse Event|1
7759398|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Adverse Event|2
7759399|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Adverse Event|3
7759400|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Adverse Event|1
7759401|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Adverse Event|1
7759402|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Adverse Event|2
7759403|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759404|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759405|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759406|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759407|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759408|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759409|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759410|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759411|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759412|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759413|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759414|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7759415|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
7759416|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7759417|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
7759418|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7759419|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7759420|NCT00758524|26975167|P17|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759421|NCT00758524|26975168|P16|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759422|NCT00758524|26975169|P15|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759423|NCT00758524|26975170|P14|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759424|NCT00758524|26975171|P13|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759425|NCT00758524|26975172|P12|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759426|NCT00758524|26975173|P11|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759427|NCT00758524|26975174|P10|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759428|NCT00758524|26975175|P9|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759429|NCT00758524|26975176|P8|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759430|NCT00758524|26975177|P7|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759431|NCT00758524|26975178|P6|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
7759432|NCT00758524|26975179|P5|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
7759433|NCT00758524|26975180|P4|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7759434|NCT00758524|26975181|P3|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
7759435|NCT00758524|26975182|P2|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
7759436|NCT00758524|26975183|P1|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
7759437|NCT00758498|26975301|P3|Overall Study|Noncompliance to study procedures|1
7759438|NCT00758498|26975302|P2|Overall Study|Noncompliance to study procedures|0
7759439|NCT00758498|26975303|P1|Overall Study|Noncompliance to study procedures|0
7759440|NCT00758498|26975301|P3|Overall Study|Withdrawal by Subject|1
7759441|NCT00758498|26975302|P2|Overall Study|Withdrawal by Subject|0
7759442|NCT00758498|26975303|P1|Overall Study|Withdrawal by Subject|0
7759443|NCT00758498|26975301|P3|Overall Study|Subject legally detained out of state|0
7759444|NCT00758498|26975302|P2|Overall Study|Subject legally detained out of state|0
7759445|NCT00758498|26975303|P1|Overall Study|Subject legally detained out of state|1
7759446|NCT00758498|26975301|P3|Overall Study|Adverse Event|3
7759447|NCT00758498|26975302|P2|Overall Study|Adverse Event|2
7759448|NCT00758498|26975303|P1|Overall Study|Adverse Event|2
7759449|NCT00758485|26975388|P2|Overall Study|Not Treated|2
7759450|NCT00758485|26975389|P1|Overall Study|Not Treated|1
7759451|NCT00758485|26975388|P2|Overall Study|Lost to Follow-up|1
7759452|NCT00758485|26975389|P1|Overall Study|Lost to Follow-up|0
7759453|NCT00758459|26975401|P2|Overall Study|Withdrawal by Subject|1
7759454|NCT00758459|26975402|P1|Overall Study|Withdrawal by Subject|0
7759455|NCT00758459|26975401|P2|Overall Study|Protocol Violation|1
7759456|NCT00758459|26975402|P1|Overall Study|Protocol Violation|0
7759457|NCT00758459|26975401|P2|Overall Study|Adverse Event|2
7759458|NCT00758459|26975402|P1|Overall Study|Adverse Event|3
7759459|NCT00758394|26975447|P4|3rd Intervention|Lost to Follow-up|1
7759460|NCT00758394|26975448|P3|3rd Intervention|Lost to Follow-up|0
7759461|NCT00758394|26975449|P2|3rd Intervention|Lost to Follow-up|0
7759462|NCT00758394|26975450|P1|3rd Intervention|Lost to Follow-up|1
7759463|NCT00758394|26975447|P4|2nd Intervention Order|Lost to Follow-up|0
7759464|NCT00758394|26975448|P3|2nd Intervention Order|Lost to Follow-up|0
7759465|NCT00758394|26975449|P2|2nd Intervention Order|Lost to Follow-up|1
7759466|NCT00758394|26975450|P1|2nd Intervention Order|Lost to Follow-up|0
7759467|NCT00758264|26975479|P3|Active Phase|Other|4
7759468|NCT00758264|26975480|P2|Active Phase|Other|0
7759469|NCT00758264|26975481|P1|Active Phase|Other|0
7759470|NCT00758264|26975479|P3|Active Phase|Lost to Follow-up|0
7759471|NCT00758264|26975480|P2|Active Phase|Lost to Follow-up|0
7759472|NCT00758264|26975481|P1|Active Phase|Lost to Follow-up|1
7759473|NCT00758264|26975479|P3|Active Phase|Withdrawal by Subject|1
7759474|NCT00758264|26975480|P2|Active Phase|Withdrawal by Subject|0
7759475|NCT00758264|26975481|P1|Active Phase|Withdrawal by Subject|0
7759476|NCT00758160|26975540|P1|Overall Study|Withdrawal by Subject|8
7759477|NCT00758160|26975540|P1|Overall Study|Protocol Violation|12
7759478|NCT00758160|26975540|P1|Overall Study|Lost to Follow-up|14
7759479|NCT00758160|26975540|P1|Overall Study|Lack of Efficacy|10
7759480|NCT00758160|26975540|P1|Overall Study|Adverse Event|15
7759481|NCT00758160|26975540|P1|Overall Study|Administration Problems|3
7759482|NCT00758160|26975540|P1|Overall Study|No Longer Requires Study Medication|4
7759483|NCT00758069|26975561|P3|Overall Study|Incorrect Study Drug|0
7759484|NCT00758069|26975562|P2|Overall Study|Incorrect Study Drug|0
7759485|NCT00758069|26975563|P1|Overall Study|Incorrect Study Drug|1
7759486|NCT00758069|26975561|P3|Overall Study|Lack of Efficacy|1
7759487|NCT00758069|26975562|P2|Overall Study|Lack of Efficacy|0
7759488|NCT00758069|26975563|P1|Overall Study|Lack of Efficacy|0
7759489|NCT00758043|26975578|P4|Overall Study|Other Reasons|5
7759490|NCT00758043|26975579|P3|Overall Study|Other Reasons|0
7759491|NCT00758043|26975580|P2|Overall Study|Other Reasons|1
7759492|NCT00758043|26975581|P1|Overall Study|Other Reasons|0
7759493|NCT00758043|26975578|P4|Overall Study|Non-Compliant With study Drug|1
7759494|NCT00758043|26975579|P3|Overall Study|Non-Compliant With study Drug|0
7759495|NCT00758043|26975580|P2|Overall Study|Non-Compliant With study Drug|0
7759496|NCT00758043|26975581|P1|Overall Study|Non-Compliant With study Drug|0
7759497|NCT00758043|26975578|P4|Overall Study|Required Prohibited Medication|3
7759498|NCT00758043|26975579|P3|Overall Study|Required Prohibited Medication|1
7759499|NCT00758043|26975580|P2|Overall Study|Required Prohibited Medication|0
7759500|NCT00758043|26975581|P1|Overall Study|Required Prohibited Medication|0
7759501|NCT00758043|26975578|P4|Overall Study|Withdrawal by Subject|4
7759502|NCT00758043|26975579|P3|Overall Study|Withdrawal by Subject|1
7759503|NCT00758043|26975580|P2|Overall Study|Withdrawal by Subject|1
7759504|NCT00758043|26975581|P1|Overall Study|Withdrawal by Subject|0
7759505|NCT00758043|26975578|P4|Overall Study|Lost to Follow-up|5
7759506|NCT00758043|26975579|P3|Overall Study|Lost to Follow-up|2
7759507|NCT00758043|26975580|P2|Overall Study|Lost to Follow-up|2
7759508|NCT00758043|26975581|P1|Overall Study|Lost to Follow-up|0
7759509|NCT00758043|26975578|P4|Overall Study|Refused Further Treatment|8
7759510|NCT00758043|26975579|P3|Overall Study|Refused Further Treatment|5
7759511|NCT00758043|26975580|P2|Overall Study|Refused Further Treatment|11
7759512|NCT00758043|26975581|P1|Overall Study|Refused Further Treatment|0
7759513|NCT00758043|26975578|P4|Overall Study|Lack of Efficacy|12
7759514|NCT00758043|26975579|P3|Overall Study|Lack of Efficacy|18
7759515|NCT00758043|26975580|P2|Overall Study|Lack of Efficacy|6
7759516|NCT00758043|26975581|P1|Overall Study|Lack of Efficacy|0
7759517|NCT00758043|26975578|P4|Overall Study|Adverse Event|62
7759518|NCT00758043|26975579|P3|Overall Study|Adverse Event|12
7759519|NCT00758043|26975580|P2|Overall Study|Adverse Event|20
7759520|NCT00758043|26975581|P1|Overall Study|Adverse Event|1
7759521|NCT00757848|26975621|P2|Overall Study|Incorrect enrolment|0
7759522|NCT00757848|26975622|P1|Overall Study|Incorrect enrolment|1
7759523|NCT00757848|26975621|P2|Overall Study|Adverse Event|2
7759524|NCT00757848|26975622|P1|Overall Study|Adverse Event|1
7759525|NCT00757848|26975621|P2|Overall Study|Voluntary discontinuation|0
7759526|NCT00757848|26975622|P1|Overall Study|Voluntary discontinuation|1
7759527|NCT00757783|26975691|P2|Overall Study|Other|2
7759528|NCT00757783|26975692|P1|Overall Study|Other|1
7759529|NCT00757783|26975691|P2|Overall Study|Withdrawal by Subject|1
7759530|NCT00757783|26975692|P1|Overall Study|Withdrawal by Subject|2
7759531|NCT00757783|26975691|P2|Overall Study|Protocol Violation|0
7759532|NCT00757783|26975692|P1|Overall Study|Protocol Violation|1
7759533|NCT00757783|26975691|P2|Overall Study|Lost to Follow-up|1
7759534|NCT00757783|26975692|P1|Overall Study|Lost to Follow-up|1
7759535|NCT00757783|26975691|P2|Overall Study|Adverse Event|2
7759536|NCT00757783|26975692|P1|Overall Study|Adverse Event|0
7759537|NCT00757705|26975728|P1|Overall Study|Other|18
7759538|NCT00757705|26975728|P1|Overall Study|Non-compliant|9
7759539|NCT00757705|26975728|P1|Overall Study|Ineligible to continue|8
7759540|NCT00757705|26975728|P1|Overall Study|Insufficient Response|26
7759541|NCT00757705|26975728|P1|Overall Study|Withdrawal by Subject|25
7759542|NCT00757705|26975728|P1|Overall Study|Lost to Follow-up|16
7759543|NCT00757705|26975728|P1|Overall Study|Adverse Event|19
7759544|NCT00757627|26975757|P1|Overall Study|Other|1
7759545|NCT00757627|26975757|P1|Overall Study|Withdrawal by Subject|27
7759546|NCT00757627|26975757|P1|Overall Study|Lost to Follow-up|28
7759547|NCT00757627|26975757|P1|Overall Study|Lack of Efficacy|10
7759548|NCT00757627|26975757|P1|Overall Study|Adverse Event|15
7759549|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Other|0
7759550|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Other|1
7759551|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
7759552|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
7759553|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
7759554|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
7759555|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
7759556|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
7759557|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
7759558|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
7759559|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
7759560|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
7759561|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
7759562|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
7759563|NCT00757588|26975892|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
7759564|NCT00757588|26975893|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
7759565|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Other|1
7759566|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Other|0
7759567|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
7759568|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
7759569|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
7759570|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
7759571|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
7759742|NCT00755846|26976514|P4|Overall Study|Hyperglycemic Rescue|8
7759572|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
7759573|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Death|0
7759574|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Death|1
7759575|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
7759576|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
7759577|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
7759578|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
7759579|NCT00757588|26975892|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
7759580|NCT00757588|26975893|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
7759581|NCT00757237|26975934|P2|Overall Study|Other|2
7759582|NCT00757237|26975935|P1|Overall Study|Other|0
7759583|NCT00757237|26975934|P2|Overall Study|Safety or Tolerability|5
7759584|NCT00757237|26975935|P1|Overall Study|Safety or Tolerability|3
7759585|NCT00757237|26975934|P2|Overall Study|Withdrawal by Subject|12
7759586|NCT00757237|26975935|P1|Overall Study|Withdrawal by Subject|8
7759587|NCT00757237|26975934|P2|Overall Study|Physician Decision|3
7759588|NCT00757237|26975935|P1|Overall Study|Physician Decision|2
7759589|NCT00757237|26975934|P2|Overall Study|Protocol Violation|2
7759590|NCT00757237|26975935|P1|Overall Study|Protocol Violation|0
7759591|NCT00757237|26975934|P2|Overall Study|Lost to Follow-up|1
7759592|NCT00757237|26975935|P1|Overall Study|Lost to Follow-up|0
7759593|NCT00757172|26975963|P1|Overall Study|Progression|4
7759594|NCT00757172|26975963|P1|Overall Study|Physician Decision|3
7759595|NCT00757172|26975963|P1|Overall Study|Withdrawal by Subject|4
7759596|NCT00757003|26975971|P1|Overall Study|Not implanted|1
7759597|NCT00757003|26975971|P1|Overall Study|Surgically explanted|2
7759598|NCT00757003|26975971|P1|Overall Study|Withdrawal by Subject|4
7759599|NCT00757003|26975971|P1|Overall Study|Lost to Follow-up|9
7759600|NCT00757003|26975971|P1|Overall Study|Death|33
7759601|NCT00756938|26976018|P4|Optional Extension|Adverse Event|1
7759602|NCT00756938|26976019|P3|Optional Extension|Adverse Event|0
7759603|NCT00756938|26976020|P2|Optional Extension|Adverse Event|0
7759604|NCT00756938|26976021|P1|Optional Extension|Adverse Event|0
7759605|NCT00756938|26976018|P4|Optional Extension|Withdrawal by Subject|10
7759606|NCT00756938|26976019|P3|Optional Extension|Withdrawal by Subject|0
7759607|NCT00756938|26976020|P2|Optional Extension|Withdrawal by Subject|0
7759608|NCT00756938|26976021|P1|Optional Extension|Withdrawal by Subject|0
7759609|NCT00756938|26976018|P4|Optional Extension|Protocol Violation|1
7759610|NCT00756938|26976019|P3|Optional Extension|Protocol Violation|0
7759611|NCT00756938|26976020|P2|Optional Extension|Protocol Violation|0
7759612|NCT00756938|26976021|P1|Optional Extension|Protocol Violation|0
7759613|NCT00756938|26976018|P4|Optional Extension|Lost to Follow-up|1
7759614|NCT00756938|26976019|P3|Optional Extension|Lost to Follow-up|0
7759615|NCT00756938|26976020|P2|Optional Extension|Lost to Follow-up|0
7759616|NCT00756938|26976021|P1|Optional Extension|Lost to Follow-up|0
7759617|NCT00756938|26976018|P4|Optional Extension|Physician Decision|3
7759618|NCT00756938|26976019|P3|Optional Extension|Physician Decision|0
7759619|NCT00756938|26976020|P2|Optional Extension|Physician Decision|0
7759620|NCT00756938|26976021|P1|Optional Extension|Physician Decision|0
7759621|NCT00756938|26976018|P4|Optional Extension|Protocol-specific criteria met|9
7759622|NCT00756938|26976019|P3|Optional Extension|Protocol-specific criteria met|0
7759623|NCT00756938|26976020|P2|Optional Extension|Protocol-specific criteria met|0
7759624|NCT00756938|26976021|P1|Optional Extension|Protocol-specific criteria met|0
7759625|NCT00756938|26976018|P4|Optional Extension|End of Study|11
7759626|NCT00756938|26976019|P3|Optional Extension|End of Study|0
7759627|NCT00756938|26976020|P2|Optional Extension|End of Study|0
7759628|NCT00756938|26976021|P1|Optional Extension|End of Study|0
7759629|NCT00756938|26976018|P4|Optional Extension|Lack of Efficacy|1
7759630|NCT00756938|26976019|P3|Optional Extension|Lack of Efficacy|0
7759631|NCT00756938|26976020|P2|Optional Extension|Lack of Efficacy|0
7759632|NCT00756938|26976021|P1|Optional Extension|Lack of Efficacy|0
7759633|NCT00756938|26976018|P4|12-week Base Study|Lost to Follow-up|0
7759634|NCT00756938|26976019|P3|12-week Base Study|Lost to Follow-up|0
7759635|NCT00756938|26976020|P2|12-week Base Study|Lost to Follow-up|0
7759636|NCT00756938|26976021|P1|12-week Base Study|Lost to Follow-up|1
7759637|NCT00756938|26976018|P4|12-week Base Study|Protocol Violation|0
7759638|NCT00756938|26976019|P3|12-week Base Study|Protocol Violation|1
7759639|NCT00756938|26976020|P2|12-week Base Study|Protocol Violation|0
7759640|NCT00756938|26976021|P1|12-week Base Study|Protocol Violation|0
7759641|NCT00756938|26976018|P4|12-week Base Study|Protocol-specific Criteria Met|0
7759642|NCT00756938|26976019|P3|12-week Base Study|Protocol-specific Criteria Met|1
7759643|NCT00756938|26976020|P2|12-week Base Study|Protocol-specific Criteria Met|0
7759644|NCT00756938|26976021|P1|12-week Base Study|Protocol-specific Criteria Met|1
7759645|NCT00756886|26976049|P2|Overall Study|Ineligible|4
7759646|NCT00756886|26976050|P1|Overall Study|Ineligible|9
7759647|NCT00756886|26976049|P2|Overall Study|Lack of Efficacy|0
7759648|NCT00756886|26976050|P1|Overall Study|Lack of Efficacy|1
7759649|NCT00756886|26976049|P2|Overall Study|Adverse Event|3
7759650|NCT00756886|26976050|P1|Overall Study|Adverse Event|0
7759651|NCT00756886|26976049|P2|Overall Study|Lost to Follow-up|0
7759652|NCT00756886|26976050|P1|Overall Study|Lost to Follow-up|1
7759653|NCT00756730|26976058|P2|Overall Study|persistent low-level viremmia|1
7759654|NCT00756730|26976059|P1|Overall Study|persistent low-level viremmia|0
7759655|NCT00756730|26976058|P2|Overall Study|discontinued due to rash prior to week 4|1
7759656|NCT00756730|26976059|P1|Overall Study|discontinued due to rash prior to week 4|0
7759657|NCT00756717|26976079|P1|Overall Study|Withdrawal by Subject|2
7759658|NCT00756652|26976096|P2|Re-Op Phase|Withdrawn after explant|0
7759659|NCT00756652|26976097|P1|Re-Op Phase|Withdrawn after explant|14
7759660|NCT00756652|26976096|P2|Re-Op Phase|Site Closed|0
7759661|NCT00756652|26976097|P1|Re-Op Phase|Site Closed|2454
7759662|NCT00756652|26976096|P2|Re-Op Phase|Lost to Follow-up|0
7759663|NCT00756652|26976097|P1|Re-Op Phase|Lost to Follow-up|340
7759664|NCT00756652|26976096|P2|Re-Op Phase|Death|0
7759665|NCT00756652|26976097|P1|Re-Op Phase|Death|6
7759666|NCT00756652|26976096|P2|Re-Op Phase|Withdrawal by Subject|0
7759667|NCT00756652|26976097|P1|Re-Op Phase|Withdrawal by Subject|62
7759668|NCT00756652|26976096|P2|Original Phase|Not due for F/U at Phase One closure|2
7759669|NCT00756652|26976097|P1|Original Phase|Not due for F/U at Phase One closure|11076
7759670|NCT00756652|26976096|P2|Original Phase|Death|1
7759671|NCT00756652|26976097|P1|Original Phase|Death|168
7759672|NCT00756652|26976096|P2|Original Phase|Participants without data|466
7759673|NCT00756652|26976097|P1|Original Phase|Participants without data|3259
7759674|NCT00756652|26976096|P2|Original Phase|Unknown Discontinuation Reason|0
7759675|NCT00756652|26976097|P1|Original Phase|Unknown Discontinuation Reason|2
7759676|NCT00756652|26976096|P2|Original Phase|Participant Noncompliance|424
7759677|NCT00756652|26976097|P1|Original Phase|Participant Noncompliance|18622
7759678|NCT00756652|26976096|P2|Original Phase|Other Discontinuation|5
7759679|NCT00756652|26976097|P1|Original Phase|Other Discontinuation|797
7759680|NCT00756652|26976096|P2|Original Phase|Lost to Follow-up|0
7759681|NCT00756652|26976097|P1|Original Phase|Lost to Follow-up|601
7759682|NCT00756652|26976096|P2|Original Phase|Withdrawal by Subject|23
7759683|NCT00756652|26976097|P1|Original Phase|Withdrawal by Subject|864
7759684|NCT00756574|26976208|P2|Overall Study|Lost to Follow-up|4
7759685|NCT00756574|26976209|P1|Overall Study|Lost to Follow-up|4
7759686|NCT00756574|26976208|P2|Overall Study|Withdrawal by Subject|7
7759687|NCT00756574|26976209|P1|Overall Study|Withdrawal by Subject|9
7759688|NCT00756470|26976258|P1|Overall Study|Adverse Event|4
7759689|NCT00756470|26976258|P1|Overall Study|Withdrawal by Subject|1
7759690|NCT00756457|26976265|P2|Overall Study|Lost to Follow-up|2
7759691|NCT00756457|26976266|P1|Overall Study|Lost to Follow-up|1
7759692|NCT00756444|26976296|P2|Overall Study|Ineligibility Determined|0
7759693|NCT00756444|26976297|P1|Overall Study|Ineligibility Determined|1
7759694|NCT00756444|26976296|P2|Overall Study|Disease Progression|7
7759695|NCT00756444|26976297|P1|Overall Study|Disease Progression|2
7759696|NCT00756444|26976296|P2|Overall Study|Death|4
7759697|NCT00756444|26976297|P1|Overall Study|Death|5
7759698|NCT00756444|26976296|P2|Overall Study|Lost to Follow-up|1
7759699|NCT00756444|26976297|P1|Overall Study|Lost to Follow-up|0
7759700|NCT00756444|26976296|P2|Overall Study|Withdrawal by Subject|8
7759701|NCT00756444|26976297|P1|Overall Study|Withdrawal by Subject|6
7759702|NCT00756444|26976296|P2|Overall Study|Adverse Event|1
7759703|NCT00756444|26976297|P1|Overall Study|Adverse Event|1
7759704|NCT00756314|26976308|P2|Overall Study|Lost to Follow-up|59
7759705|NCT00756314|26976309|P1|Overall Study|Lost to Follow-up|2
7759706|NCT00756275|26976325|P2|Overall Study|Withdrawal by Subject|7
7759707|NCT00756275|26976326|P1|Overall Study|Withdrawal by Subject|4
7759708|NCT00756275|26976325|P2|Overall Study|Lost to Follow-up|21
7759709|NCT00756275|26976326|P1|Overall Study|Lost to Follow-up|25
7759710|NCT00756002|26976390|P2|Double-Blind Treatment Period|Other|2
7759711|NCT00756002|26976391|P1|Double-Blind Treatment Period|Other|2
7759712|NCT00756002|26976390|P2|Double-Blind Treatment Period|Protocol Violation|5
7759713|NCT00756002|26976391|P1|Double-Blind Treatment Period|Protocol Violation|6
7759714|NCT00756002|26976390|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
7759715|NCT00756002|26976391|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
7759716|NCT00756002|26976390|P2|Double-Blind Treatment Period|Lost to Follow-up|1
7759717|NCT00756002|26976391|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7759718|NCT00756002|26976390|P2|Double-Blind Treatment Period|Lack of Efficacy|1
7759719|NCT00756002|26976391|P1|Double-Blind Treatment Period|Lack of Efficacy|1
7759720|NCT00755937|26976485|P1|Observational Follow-up|Lost to Follow-up|148
7759721|NCT00755937|26976485|P1|Recruitment|Unknown if infliximab received|164
7759722|NCT00755846|26976512|P6|Overall Study|Participant Non-compliance|0
7759723|NCT00755846|26976513|P5|Overall Study|Participant Non-compliance|1
7759724|NCT00755846|26976514|P4|Overall Study|Participant Non-compliance|0
7759725|NCT00755846|26976515|P3|Overall Study|Participant Non-compliance|0
7759726|NCT00755846|26976516|P2|Overall Study|Participant Non-compliance|0
7759727|NCT00755846|26976517|P1|Overall Study|Participant Non-compliance|0
7759728|NCT00755846|26976512|P6|Overall Study|Administrative Error|0
7759729|NCT00755846|26976513|P5|Overall Study|Administrative Error|0
7759730|NCT00755846|26976514|P4|Overall Study|Administrative Error|0
7759731|NCT00755846|26976515|P3|Overall Study|Administrative Error|0
7759732|NCT00755846|26976516|P2|Overall Study|Administrative Error|1
7759733|NCT00755846|26976517|P1|Overall Study|Administrative Error|0
7759734|NCT00755846|26976512|P6|Overall Study|Physician Decision|1
7759735|NCT00755846|26976513|P5|Overall Study|Physician Decision|0
7759736|NCT00755846|26976514|P4|Overall Study|Physician Decision|1
7759737|NCT00755846|26976515|P3|Overall Study|Physician Decision|0
7759738|NCT00755846|26976516|P2|Overall Study|Physician Decision|3
7759739|NCT00755846|26976517|P1|Overall Study|Physician Decision|1
7759740|NCT00755846|26976512|P6|Overall Study|Hyperglycemic Rescue|7
7759741|NCT00755846|26976513|P5|Overall Study|Hyperglycemic Rescue|8
7759743|NCT00755846|26976515|P3|Overall Study|Hyperglycemic Rescue|5
7759744|NCT00755846|26976516|P2|Overall Study|Hyperglycemic Rescue|7
7759745|NCT00755846|26976517|P1|Overall Study|Hyperglycemic Rescue|21
7759746|NCT00755846|26976512|P6|Overall Study|Withdrawal by Subject|1
7759747|NCT00755846|26976513|P5|Overall Study|Withdrawal by Subject|0
7759748|NCT00755846|26976514|P4|Overall Study|Withdrawal by Subject|2
7759749|NCT00755846|26976515|P3|Overall Study|Withdrawal by Subject|5
7759750|NCT00755846|26976516|P2|Overall Study|Withdrawal by Subject|3
7759751|NCT00755846|26976517|P1|Overall Study|Withdrawal by Subject|2
7759752|NCT00755846|26976512|P6|Overall Study|Lost to Follow-up|2
7759753|NCT00755846|26976513|P5|Overall Study|Lost to Follow-up|4
7759754|NCT00755846|26976514|P4|Overall Study|Lost to Follow-up|0
7759755|NCT00755846|26976515|P3|Overall Study|Lost to Follow-up|1
7759756|NCT00755846|26976516|P2|Overall Study|Lost to Follow-up|2
7759757|NCT00755846|26976517|P1|Overall Study|Lost to Follow-up|0
7759758|NCT00755846|26976512|P6|Overall Study|Protocol Violation|1
7759759|NCT00755846|26976513|P5|Overall Study|Protocol Violation|1
7759760|NCT00755846|26976514|P4|Overall Study|Protocol Violation|1
7759761|NCT00755846|26976515|P3|Overall Study|Protocol Violation|1
7759762|NCT00755846|26976516|P2|Overall Study|Protocol Violation|1
7759763|NCT00755846|26976517|P1|Overall Study|Protocol Violation|1
7759764|NCT00755846|26976512|P6|Overall Study|Adverse Event|2
7759765|NCT00755846|26976513|P5|Overall Study|Adverse Event|3
7759766|NCT00755846|26976514|P4|Overall Study|Adverse Event|1
7759767|NCT00755846|26976515|P3|Overall Study|Adverse Event|0
7759768|NCT00755846|26976516|P2|Overall Study|Adverse Event|0
7759769|NCT00755846|26976517|P1|Overall Study|Adverse Event|0
7759770|NCT00755807|26976617|P2|Open-label Extension Phase|Sponsor Decision|1
7759771|NCT00755807|26976618|P1|Open-label Extension Phase|Sponsor Decision|0
7759772|NCT00755807|26976617|P2|Open-label Extension Phase|Lost to Follow-up|0
7759773|NCT00755807|26976618|P1|Open-label Extension Phase|Lost to Follow-up|2
7759774|NCT00755807|26976617|P2|Open-label Extension Phase|Withdrawal by Subject|3
7759775|NCT00755807|26976618|P1|Open-label Extension Phase|Withdrawal by Subject|1
7759776|NCT00755807|26976617|P2|Open-label Extension Phase|Lack of Efficacy|3
7759777|NCT00755807|26976618|P1|Open-label Extension Phase|Lack of Efficacy|3
7759778|NCT00755807|26976617|P2|Open-label Extension Phase|Protocol Violation|2
7759779|NCT00755807|26976618|P1|Open-label Extension Phase|Protocol Violation|5
7759780|NCT00755807|26976617|P2|Open-label Extension Phase|Adverse Event|7
7759781|NCT00755807|26976618|P1|Open-label Extension Phase|Adverse Event|7
7759782|NCT00755807|26976617|P2|Acute Phase|Physician Decision|1
7759783|NCT00755807|26976618|P1|Acute Phase|Physician Decision|0
7759784|NCT00755807|26976617|P2|Acute Phase|Lack of Efficacy|1
7759785|NCT00755807|26976618|P1|Acute Phase|Lack of Efficacy|0
7759786|NCT00755807|26976617|P2|Acute Phase|Withdrawal by Subject|2
7759787|NCT00755807|26976618|P1|Acute Phase|Withdrawal by Subject|1
7759788|NCT00755807|26976617|P2|Acute Phase|Protocol Violation|3
7759789|NCT00755807|26976618|P1|Acute Phase|Protocol Violation|1
7759790|NCT00755807|26976617|P2|Acute Phase|Adverse Event|5
7759791|NCT00755807|26976618|P1|Acute Phase|Adverse Event|16
7759792|NCT00755716|26976698|P3|Overall Study|work schedule issues|1
7759793|NCT00755716|26976699|P2|Overall Study|work schedule issues|1
7759794|NCT00755716|26976700|P1|Overall Study|work schedule issues|0
7759795|NCT00755716|26976698|P3|Overall Study|Lost to Follow-up|1
7759796|NCT00755716|26976699|P2|Overall Study|Lost to Follow-up|3
7759797|NCT00755716|26976700|P1|Overall Study|Lost to Follow-up|5
7759798|NCT00755716|26976698|P3|Overall Study|Lack of Efficacy|0
7759799|NCT00755716|26976699|P2|Overall Study|Lack of Efficacy|0
7759800|NCT00755716|26976700|P1|Overall Study|Lack of Efficacy|2
7759801|NCT00755716|26976698|P3|Overall Study|Adverse Event|1
7759802|NCT00755716|26976699|P2|Overall Study|Adverse Event|4
7759803|NCT00755716|26976700|P1|Overall Study|Adverse Event|1
7759804|NCT00755417|26976714|P3|Overall Study|Not specified or missing data|12
7759805|NCT00755417|26976715|P2|Overall Study|Not specified or missing data|18
7759806|NCT00755417|26976716|P1|Overall Study|Not specified or missing data|9
7759807|NCT00755417|26976714|P3|Overall Study|Withdrawal by Subject|12
7759808|NCT00755417|26976715|P2|Overall Study|Withdrawal by Subject|12
7759809|NCT00755417|26976716|P1|Overall Study|Withdrawal by Subject|12
7759810|NCT00755417|26976714|P3|Overall Study|Lost to Follow-up|1
7759811|NCT00755417|26976715|P2|Overall Study|Lost to Follow-up|0
7759812|NCT00755417|26976716|P1|Overall Study|Lost to Follow-up|3
7759813|NCT00755417|26976714|P3|Overall Study|Protocol Violation|1
7759814|NCT00755417|26976715|P2|Overall Study|Protocol Violation|1
7759815|NCT00755417|26976716|P1|Overall Study|Protocol Violation|2
7759816|NCT00755417|26976714|P3|Overall Study|Lack of Efficacy|9
7759817|NCT00755417|26976715|P2|Overall Study|Lack of Efficacy|4
7759818|NCT00755417|26976716|P1|Overall Study|Lack of Efficacy|8
7759819|NCT00755417|26976714|P3|Overall Study|Adverse Event|7
7759820|NCT00755417|26976715|P2|Overall Study|Adverse Event|20
7759821|NCT00755417|26976716|P1|Overall Study|Adverse Event|28
7759822|NCT00755326|26976735|P2|Overall Study|Lost to Follow-up|3
7759823|NCT00755326|26976736|P1|Overall Study|Lost to Follow-up|2
7759824|NCT00755222|26976786|P2|Overall Study|Protocol Violation|0
7759825|NCT00755222|26976787|P1|Overall Study|Protocol Violation|2
7759826|NCT00755222|26976786|P2|Overall Study|Adverse Event|0
7759827|NCT00755222|26976787|P1|Overall Study|Adverse Event|2
7759828|NCT00755222|26976786|P2|Overall Study|Withdrawal by Subject|2
7759829|NCT00755222|26976787|P1|Overall Study|Withdrawal by Subject|4
7759830|NCT00755196|26976801|P1|Overall Study|Lack of Efficiency|1
7759831|NCT00755196|26976801|P1|Overall Study|Lost to Follow-up|1
7759832|NCT00755183|26976808|P2|Overall Study|Administrative|1
7759833|NCT00755183|26976809|P1|Overall Study|Administrative|2
7759834|NCT00755183|26976808|P2|Overall Study|Withdrawal by Subject|2
7759835|NCT00755183|26976809|P1|Overall Study|Withdrawal by Subject|0
7759836|NCT00755183|26976808|P2|Overall Study|Protocol Violation|1
7759837|NCT00755183|26976809|P1|Overall Study|Protocol Violation|0
7759838|NCT00755183|26976808|P2|Overall Study|Adverse Event|2
7759839|NCT00755183|26976809|P1|Overall Study|Adverse Event|5
7759840|NCT00755105|26976833|P3|Overall Study|Withdrawal by Subject|4
7759841|NCT00755105|26976834|P2|Overall Study|Withdrawal by Subject|11
7759842|NCT00755105|26976835|P1|Overall Study|Withdrawal by Subject|9
7759843|NCT00755079|26976845|P2|Overall Study|Withdrawal by Subject|2
7759844|NCT00755079|26976846|P1|Overall Study|Withdrawal by Subject|0
7759845|NCT00755079|26976845|P2|Overall Study|Adverse Event|1
7759846|NCT00755079|26976846|P1|Overall Study|Adverse Event|0
7759847|NCT00755079|26976845|P2|Overall Study|Lost to Follow-up|3
7759848|NCT00755079|26976846|P1|Overall Study|Lost to Follow-up|1
7759849|NCT00754936|26976865|P1|Overall Study|Inter-current medical events|3
7759850|NCT00754936|26976865|P1|Overall Study|Side Effects|3
7759851|NCT00754936|26976865|P1|Overall Study|Withdrawal by Subject|2
7759852|NCT00754936|26976865|P1|Overall Study|Physician Decision|1
7759853|NCT00754936|26976865|P1|Overall Study|Lost to Follow-up|3
7759854|NCT00754793|26976905|P2|Overall Study|voluntary withdrawn from study|1
7759855|NCT00754793|26976906|P1|Overall Study|voluntary withdrawn from study|0
7759856|NCT00754741|26976924|P3|Overall Study|Died or disenrolled|54
7759857|NCT00754741|26976925|P2|Overall Study|Died or disenrolled|69
7759858|NCT00754741|26976926|P1|Overall Study|Died or disenrolled|57
7759859|NCT00754650|26976973|P1|Overall Study|Disease Progression|2
7759860|NCT00754624|26976978|P1|Overall Study|Lost to Follow-up|3
7759861|NCT00754624|26976978|P1|Overall Study|Various|12
7759862|NCT00754624|26976978|P1|Overall Study|Withdrawal by Subject|28
7759863|NCT00754624|26976978|P1|Overall Study|Protocol Violation|1
7759864|NCT00754624|26976978|P1|Overall Study|Physician Decision|8
7759865|NCT00754624|26976978|P1|Overall Study|Death|1
7759866|NCT00754624|26976978|P1|Overall Study|Adverse Event|16
7759867|NCT00754572|26976988|P1|Overall Study|Lost to Follow-up|1
7759868|NCT00754572|26976988|P1|Overall Study|Administrative Reason|3
7759869|NCT00754572|26976988|P1|Overall Study|Death|1
7759870|NCT00754572|26976988|P1|Overall Study|Lack of Efficacy|2
7759871|NCT00754572|26976988|P1|Overall Study|Withdrawal by Subject|3
7759872|NCT00754572|26976988|P1|Overall Study|Protocol Violation|3
7759873|NCT00754572|26976988|P1|Overall Study|Other|39
7759874|NCT00754572|26976988|P1|Overall Study|Adverse Event|19
7759875|NCT00754559|26977015|P1|Overall Study|Withdrawal by Subject|3
7759876|NCT00754559|26977015|P1|Overall Study|Other|5
7759877|NCT00754559|26977015|P1|Overall Study|Administrative reason|1
7759878|NCT00754559|26977015|P1|Overall Study|Lost to Follow-up|2
7759879|NCT00754559|26977015|P1|Overall Study|Lack of Efficacy|10
7759880|NCT00754559|26977015|P1|Overall Study|Protocol Violation|11
7759881|NCT00754559|26977015|P1|Overall Study|Adverse Event|15
7759882|NCT00754442|26977115|P2|Overall Study|Withdrawal by Subject|3
7759883|NCT00754442|26977116|P1|Overall Study|Withdrawal by Subject|5
7759884|NCT00754390|26977123|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
7759885|NCT00754390|26977123|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
7759886|NCT00754390|26977123|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
7759887|NCT00754390|26977123|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
7759888|NCT00754338|26977145|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
7759889|NCT00754338|26977146|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
7759890|NCT00754338|26977147|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
7759891|NCT00754338|26977148|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
7759892|NCT00754338|26977145|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
7759893|NCT00754338|26977146|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
7759894|NCT00754338|26977147|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
7759895|NCT00754338|26977148|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
7759896|NCT00754325|26977180|P2|Initial Treatment|Disease Progression|35
7759897|NCT00754325|26977181|P1|Initial Treatment|Disease Progression|35
7759898|NCT00754325|26977180|P2|Initial Treatment|Sponsor Request|1
7759899|NCT00754325|26977181|P1|Initial Treatment|Sponsor Request|0
7759900|NCT00754325|26977180|P2|Initial Treatment|Physician Decision|0
7759901|NCT00754325|26977181|P1|Initial Treatment|Physician Decision|2
7759902|NCT00754325|26977180|P2|Initial Treatment|Withdrawal by Subject|2
7759903|NCT00754325|26977181|P1|Initial Treatment|Withdrawal by Subject|2
7759904|NCT00754325|26977180|P2|Initial Treatment|Adverse Event|6
7759905|NCT00754325|26977181|P1|Initial Treatment|Adverse Event|7
7759906|NCT00754325|26977180|P2|Initial Treatment|Continuing Active Treatment|5
7759907|NCT00754325|26977181|P1|Initial Treatment|Continuing Active Treatment|4
7759908|NCT00754234|26977234|P1|Overall Study|Withdrawal by Subject|3
7759909|NCT00754065|26977320|P2|Overall Study|Reason not specified or unknown, etc.|27
7759910|NCT00754065|26977321|P1|Overall Study|Reason not specified or unknown, etc.|21
7759911|NCT00754065|26977320|P2|Overall Study|Pregnancy|0
7759912|NCT00754065|26977321|P1|Overall Study|Pregnancy|6
7759913|NCT00754065|26977320|P2|Overall Study|Withdrawal by Subject|5
7759914|NCT00754065|26977321|P1|Overall Study|Withdrawal by Subject|4
7759915|NCT00754065|26977320|P2|Overall Study|Protocol Violation|10
7759916|NCT00754065|26977321|P1|Overall Study|Protocol Violation|12
7759917|NCT00754065|26977320|P2|Overall Study|Lost to Follow-up|11
7759918|NCT00754065|26977321|P1|Overall Study|Lost to Follow-up|7
7759919|NCT00754065|26977320|P2|Overall Study|Adverse Event|25
7759920|NCT00754065|26977321|P1|Overall Study|Adverse Event|19
7759921|NCT00754065|26977320|P2|Overall Study|Never received treatment|2
7759922|NCT00754065|26977321|P1|Overall Study|Never received treatment|12
7759923|NCT00754052|26977561|P2|Overall Study|Study terminated by Sponsor|3
7759924|NCT00754052|26977562|P1|Overall Study|Study terminated by Sponsor|5
7759925|NCT00754013|26977576|P2|Overall Study|didn't return after study termed|4
7759926|NCT00754013|26977577|P1|Overall Study|didn't return after study termed|3
7759927|NCT00754013|26977576|P2|Overall Study|Lost to Follow-up|1
7759928|NCT00754013|26977577|P1|Overall Study|Lost to Follow-up|1
7759929|NCT00753922|26977614|P4|Overall Study|Discontinuation Due to Explantation|4
7759930|NCT00753922|26977615|P3|Overall Study|Discontinuation Due to Explantation|14
7759931|NCT00753922|26977616|P2|Overall Study|Discontinuation Due to Explantation|14
7759932|NCT00753922|26977617|P1|Overall Study|Discontinuation Due to Explantation|14
7759933|NCT00753922|26977614|P4|Overall Study|Death|1
7759934|NCT00753922|26977615|P3|Overall Study|Death|2
7759935|NCT00753922|26977616|P2|Overall Study|Death|23
7759936|NCT00753922|26977617|P1|Overall Study|Death|2
7759937|NCT00753922|26977614|P4|Overall Study|Patients Not Completing Visit|0
7759938|NCT00753922|26977615|P3|Overall Study|Patients Not Completing Visit|1
7759939|NCT00753922|26977616|P2|Overall Study|Patients Not Completing Visit|0
7759940|NCT00753922|26977617|P1|Overall Study|Patients Not Completing Visit|11
7759941|NCT00753922|26977614|P4|Overall Study|Patient Non-compliance|11
7759942|NCT00753922|26977615|P3|Overall Study|Patient Non-compliance|14
7759943|NCT00753922|26977616|P2|Overall Study|Patient Non-compliance|22
7759944|NCT00753922|26977617|P1|Overall Study|Patient Non-compliance|55
7759945|NCT00753922|26977614|P4|Overall Study|Withdrawal by Subject|2
7759946|NCT00753922|26977615|P3|Overall Study|Withdrawal by Subject|4
7759947|NCT00753922|26977616|P2|Overall Study|Withdrawal by Subject|11
7759948|NCT00753922|26977617|P1|Overall Study|Withdrawal by Subject|9
7759949|NCT00753922|26977614|P4|Overall Study|Lost to Follow-up|5
7759950|NCT00753922|26977615|P3|Overall Study|Lost to Follow-up|28
7759951|NCT00753922|26977616|P2|Overall Study|Lost to Follow-up|24
7759952|NCT00753922|26977617|P1|Overall Study|Lost to Follow-up|155
7759953|NCT00753896|26977647|P1|Overall Study|Entry Criteria Not Met|4
7759954|NCT00753896|26977647|P1|Overall Study|Withdrawal by Subject|4
7759955|NCT00753896|26977647|P1|Overall Study|Protocol Violation|1
7759956|NCT00753896|26977647|P1|Overall Study|Lost to Follow-up|2
7759957|NCT00753896|26977647|P1|Overall Study|Death|1
7759958|NCT00753896|26977647|P1|Overall Study|Adverse Event|4
7759959|NCT00753766|26977663|P2|Overall Study|Physician Decision|0
7759960|NCT00753766|26977664|P1|Overall Study|Physician Decision|1
7759961|NCT00753714|26977686|P2|Overall Study|Other|5
7759962|NCT00753714|26977687|P1|Overall Study|Other|7
7759963|NCT00753714|26977686|P2|Overall Study|Death|3
7759964|NCT00753714|26977687|P1|Overall Study|Death|3
7759965|NCT00753714|26977686|P2|Overall Study|Withdrawal by Subject|1
7759966|NCT00753714|26977687|P1|Overall Study|Withdrawal by Subject|2
7759967|NCT00753714|26977686|P2|Overall Study|Lost to Follow-up|1
7759968|NCT00753714|26977687|P1|Overall Study|Lost to Follow-up|0
7759969|NCT00753714|26977686|P2|Overall Study|Protocol Violation|0
7759970|NCT00753714|26977687|P1|Overall Study|Protocol Violation|1
7759971|NCT00753714|26977686|P2|Overall Study|Adverse Event|18
7759972|NCT00753714|26977687|P1|Overall Study|Adverse Event|26
7759973|NCT00753714|26977686|P2|Overall Study|Lack of Efficacy|34
7759974|NCT00753714|26977687|P1|Overall Study|Lack of Efficacy|21
7759975|NCT00753688|26977703|P2|Overall Study|Adverse Event|1
7759976|NCT00753688|26977704|P1|Overall Study|Adverse Event|0
7759977|NCT00753688|26977703|P2|Overall Study|Ongoing - in Follow-up|31
7759978|NCT00753688|26977704|P1|Overall Study|Ongoing - in Follow-up|15
7759979|NCT00753688|26977703|P2|Overall Study|Participant Withdrew Consent|2
7759980|NCT00753688|26977704|P1|Overall Study|Participant Withdrew Consent|2
7759981|NCT00753688|26977703|P2|Overall Study|Missing|9
7759982|NCT00753688|26977704|P1|Overall Study|Missing|4
7759983|NCT00753688|26977703|P2|Overall Study|Death|203
7759984|NCT00753688|26977704|P1|Overall Study|Death|102
7759985|NCT00753675|26977733|P3|Overall Study|Lost to Follow-up|0
7759986|NCT00753675|26977734|P2|Overall Study|Lost to Follow-up|0
7759987|NCT00753675|26977735|P1|Overall Study|Lost to Follow-up|1
7759988|NCT00753675|26977733|P3|Overall Study|Withdrawal by Subject|0
7759989|NCT00753675|26977734|P2|Overall Study|Withdrawal by Subject|1
7759990|NCT00753675|26977735|P1|Overall Study|Withdrawal by Subject|0
7759991|NCT00753675|26977733|P3|Overall Study|Objective progression of disease|35
7759992|NCT00753675|26977734|P2|Overall Study|Objective progression of disease|35
7759993|NCT00753675|26977735|P1|Overall Study|Objective progression of disease|35
7759994|NCT00753675|26977733|P3|Overall Study|Adverse Event|4
7759995|NCT00753675|26977734|P2|Overall Study|Adverse Event|9
7759996|NCT00753675|26977735|P1|Overall Study|Adverse Event|11
7759997|NCT00753675|26977733|P3|Overall Study|Death|4
7759998|NCT00753675|26977734|P2|Overall Study|Death|2
7759999|NCT00753675|26977735|P1|Overall Study|Death|1
7760000|NCT00753675|26977733|P3|Overall Study|other reason|13
7760001|NCT00753675|26977734|P2|Overall Study|other reason|12
7760002|NCT00753675|26977735|P1|Overall Study|other reason|11
7760003|NCT00753649|26977757|P2|Overall Study|Protocol Violation|0
7760004|NCT00753649|26977758|P1|Overall Study|Protocol Violation|2
7760005|NCT00753649|26977757|P2|Overall Study|Lost to follow-up-complete vaccination|0
7760006|NCT00753649|26977758|P1|Overall Study|Lost to follow-up-complete vaccination|1
7760007|NCT00753649|26977757|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
7760008|NCT00753649|26977758|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
7760009|NCT00753649|26977757|P2|Overall Study|Migrated/moved from study area|0
7760010|NCT00753649|26977758|P1|Overall Study|Migrated/moved from study area|1
7760011|NCT00753623|26977790|P2|Phase II (14 Days)|Physician Decision|1
7760012|NCT00753623|26977791|P1|Phase II (14 Days)|Physician Decision|0
7760013|NCT00753623|26977790|P2|Washout (7 Days)|Physician Decision|0
7760014|NCT00753623|26977791|P1|Washout (7 Days)|Physician Decision|1
7760015|NCT00753623|26977790|P2|Phase I (14 Days)|Adverse Event|1
7760016|NCT00753623|26977791|P1|Phase I (14 Days)|Adverse Event|0
7760017|NCT00753623|26977790|P2|Phase I (14 Days)|Physician Decision|2
7760018|NCT00753623|26977791|P1|Phase I (14 Days)|Physician Decision|1
7760019|NCT00753623|26977790|P2|Phase I (14 Days)|Withdrawal by Subject|1
7760020|NCT00753623|26977791|P1|Phase I (14 Days)|Withdrawal by Subject|1
7760021|NCT00753545|26977799|P2|Overall Study|Voluntary Discontinuation of Patient|3
7760022|NCT00753545|26977800|P1|Overall Study|Voluntary Discontinuation of Patient|7
7760023|NCT00753545|26977799|P2|Overall Study|Protocol Violation|0
7760024|NCT00753545|26977800|P1|Overall Study|Protocol Violation|1
7760025|NCT00753545|26977799|P2|Overall Study|Lost to Follow-up|3
7760026|NCT00753545|26977800|P1|Overall Study|Lost to Follow-up|2
7760027|NCT00753545|26977799|P2|Overall Study|Death|112
7760028|NCT00753545|26977800|P1|Overall Study|Death|98
7760029|NCT00753519|26977838|P2|Overall Study|Withdrawal by Subject|2
7760030|NCT00753519|26977839|P1|Overall Study|Withdrawal by Subject|0
7760031|NCT00753506|26977861|P2|Overall Study|Other reason|1
7760032|NCT00753506|26977862|P1|Overall Study|Other reason|1
7760033|NCT00753506|26977861|P2|Overall Study|Lost to Follow-up|0
7760034|NCT00753506|26977862|P1|Overall Study|Lost to Follow-up|2
7760035|NCT00753506|26977861|P2|Overall Study|Withdrawal by Subject|1
7760036|NCT00753506|26977862|P1|Overall Study|Withdrawal by Subject|4
7760037|NCT00753454|26977868|P1|Overall Study|Investigator Decision|1
7760038|NCT00753454|26977868|P1|Overall Study|Withdrawal by Subject|5
7760039|NCT00753454|26977868|P1|Overall Study|Lost to Follow-up|3
7760040|NCT00753454|26977868|P1|Overall Study|Lack of Efficacy|1
7760041|NCT00753454|26977868|P1|Overall Study|Adverse Event|4
7760042|NCT00753415|26977902|P10|Part B|Disease progression|1
7760043|NCT00753415|26977903|P9|Part B|Disease progression|2
7760044|NCT00753415|26977904|P8|Part B|Disease progression|0
7760045|NCT00753415|26977905|P7|Part B|Disease progression|0
7760046|NCT00753415|26977906|P6|Part B|Disease progression|0
7760047|NCT00753415|26977907|P5|Part B|Disease progression|0
7760048|NCT00753415|26977908|P4|Part B|Disease progression|0
7760049|NCT00753415|26977909|P3|Part B|Disease progression|0
7760050|NCT00753415|26977910|P2|Part B|Disease progression|0
7760051|NCT00753415|26977911|P1|Part B|Disease progression|0
7760052|NCT00753415|26977902|P10|Part B|Lost to Follow-up|0
7760053|NCT00753415|26977903|P9|Part B|Lost to Follow-up|1
7760054|NCT00753415|26977904|P8|Part B|Lost to Follow-up|1
7760055|NCT00753415|26977905|P7|Part B|Lost to Follow-up|0
7760056|NCT00753415|26977906|P6|Part B|Lost to Follow-up|0
7760057|NCT00753415|26977907|P5|Part B|Lost to Follow-up|0
7760058|NCT00753415|26977908|P4|Part B|Lost to Follow-up|0
7760059|NCT00753415|26977909|P3|Part B|Lost to Follow-up|0
7760060|NCT00753415|26977910|P2|Part B|Lost to Follow-up|0
7760061|NCT00753415|26977911|P1|Part B|Lost to Follow-up|0
7760062|NCT00753415|26977902|P10|Part A|Withdrawal by Subject|0
7760063|NCT00753415|26977903|P9|Part A|Withdrawal by Subject|0
7760064|NCT00753415|26977904|P8|Part A|Withdrawal by Subject|0
7760065|NCT00753415|26977905|P7|Part A|Withdrawal by Subject|0
7760066|NCT00753415|26977906|P6|Part A|Withdrawal by Subject|0
7760067|NCT00753415|26977907|P5|Part A|Withdrawal by Subject|0
7760068|NCT00753415|26977908|P4|Part A|Withdrawal by Subject|0
7760069|NCT00753415|26977909|P3|Part A|Withdrawal by Subject|1
7760070|NCT00753415|26977910|P2|Part A|Withdrawal by Subject|0
7760071|NCT00753415|26977911|P1|Part A|Withdrawal by Subject|0
7760072|NCT00753415|26977902|P10|Part A|Disease progression|0
7760073|NCT00753415|26977903|P9|Part A|Disease progression|0
7760074|NCT00753415|26977904|P8|Part A|Disease progression|0
7760075|NCT00753415|26977905|P7|Part A|Disease progression|0
7760076|NCT00753415|26977906|P6|Part A|Disease progression|0
7760077|NCT00753415|26977907|P5|Part A|Disease progression|0
7760078|NCT00753415|26977908|P4|Part A|Disease progression|2
7760079|NCT00753415|26977909|P3|Part A|Disease progression|1
7760080|NCT00753415|26977910|P2|Part A|Disease progression|0
7760081|NCT00753415|26977911|P1|Part A|Disease progression|1
7760082|NCT00753272|26978001|P2|Overall Study|Other|1088
7760083|NCT00753272|26978002|P1|Overall Study|Other|1104
7760084|NCT00753272|26978001|P2|Overall Study|Lost to Follow-up|497
7760085|NCT00753272|26978002|P1|Overall Study|Lost to Follow-up|491
7760086|NCT00753272|26978001|P2|Overall Study|Withdrawal by Subject|2407
7760087|NCT00753272|26978002|P1|Overall Study|Withdrawal by Subject|2481
7760088|NCT00753272|26978001|P2|Overall Study|Protocol Violation|46
7760089|NCT00753272|26978002|P1|Overall Study|Protocol Violation|28
7760090|NCT00753272|26978001|P2|Overall Study|Adverse Event|869
7760091|NCT00753272|26978002|P1|Overall Study|Adverse Event|878
7760092|NCT00753012|26978086|P2|Overall Study|Confounded endpoint data|0
7760093|NCT00753012|26978087|P1|Overall Study|Confounded endpoint data|1
7760094|NCT00753012|26978086|P2|Overall Study|Lost to Follow-up|0
7760095|NCT00753012|26978087|P1|Overall Study|Lost to Follow-up|4
7760096|NCT00753012|26978086|P2|Overall Study|Withdrawal by Subject|1
7760097|NCT00753012|26978087|P1|Overall Study|Withdrawal by Subject|0
7760098|NCT00753012|26978086|P2|Overall Study|Adverse Event|0
7760099|NCT00753012|26978087|P1|Overall Study|Adverse Event|2
7760100|NCT00753012|26978086|P2|Overall Study|Ineligible, abnormal cardiac histo|0
7760101|NCT00753012|26978087|P1|Overall Study|Ineligible, abnormal cardiac histo|1
7760102|NCT00752986|26978100|P3|Overall Study|Protocol Violation|0
7760103|NCT00752986|26978101|P2|Overall Study|Protocol Violation|0
7760104|NCT00752986|26978102|P1|Overall Study|Protocol Violation|3
7760105|NCT00752986|26978100|P3|Overall Study|Withdrawal by Subject|2
7760106|NCT00752986|26978101|P2|Overall Study|Withdrawal by Subject|1
7760107|NCT00752986|26978102|P1|Overall Study|Withdrawal by Subject|2
7760108|NCT00752895|26978142|P2|Overall Study|Withdrawal by Subject|3
7760109|NCT00752895|26978143|P1|Overall Study|Withdrawal by Subject|8
7760110|NCT00752856|26978153|P2|Overall Study|randomized but did not do viral kinetics|1
7760111|NCT00752856|26978154|P1|Overall Study|randomized but did not do viral kinetics|0
7760112|NCT00752791|26978166|P1|Overall Study|Protocol deviation|1
7760113|NCT00752791|26978166|P1|Overall Study|Switched to hemodialysis|2
7760114|NCT00752791|26978166|P1|Overall Study|Renal transplant|3
7760115|NCT00752791|26978166|P1|Overall Study|Death|1
7760116|NCT00752791|26978166|P1|Overall Study|Physician Decision|1
7760117|NCT00752791|26978166|P1|Overall Study|Withdrawal by Subject|1
7760118|NCT00752791|26978166|P1|Overall Study|Adverse Event|7
7760119|NCT00752726|26978178|P2|Overall Study|Other Reason|2
7760120|NCT00752726|26978179|P1|Overall Study|Other Reason|1
7760121|NCT00752726|26978178|P2|Overall Study|Withdrawal by Subject|10
7760122|NCT00752726|26978179|P1|Overall Study|Withdrawal by Subject|5
7760123|NCT00752726|26978178|P2|Overall Study|Adverse Event|0
7760124|NCT00752726|26978179|P1|Overall Study|Adverse Event|3
7760125|NCT00752726|26978178|P2|Overall Study|Lost to Follow-up|1
7760126|NCT00752726|26978179|P1|Overall Study|Lost to Follow-up|2
7760127|NCT00752622|26978204|P1|Interventional Phase|Premature Study Termination|5
7760128|NCT00752622|26978204|P1|Interventional Phase|Physician Decision|1
7760129|NCT00752622|26978204|P1|Interventional Phase|Non-responder|2
7760130|NCT00752622|26978204|P1|Observational Phase|Other|2
7760131|NCT00752622|26978204|P1|Observational Phase|Adverse Event|1
7760132|NCT00752622|26978204|P1|Observational Phase|Withdrawal by Subject|2
7760133|NCT00752622|26978204|P1|Observational Phase|Non-responder|2
7760134|NCT00752622|26978204|P1|Observational Phase|Premature Study Termination|36
7760135|NCT00752622|26978204|P1|Induction Phase|Premature study termination|14
7760136|NCT00752622|26978204|P1|Induction Phase|Withdrawal by Subject|1
7760137|NCT00752622|26978204|P1|Induction Phase|Non-responder|14
7760138|NCT00752622|26978204|P1|Induction Phase|Other|3
7760139|NCT00752622|26978204|P1|Induction Phase|Adverse Event|3
7760140|NCT00752609|26978217|P2|Overall Study|Received Aranesp in error|0
7760141|NCT00752609|26978218|P1|Overall Study|Received Aranesp in error|1
7760142|NCT00752609|26978217|P2|Overall Study|Met exclusion criteria|0
7760143|NCT00752609|26978218|P1|Overall Study|Met exclusion criteria|1
7760144|NCT00752609|26978217|P2|Overall Study|Death|0
7760145|NCT00752609|26978218|P1|Overall Study|Death|1
7760146|NCT00752609|26978217|P2|Overall Study|Physician Decision|0
7760147|NCT00752609|26978218|P1|Overall Study|Physician Decision|1
7760148|NCT00752609|26978217|P2|Overall Study|Withdrawal by Subject|0
7760149|NCT00752609|26978218|P1|Overall Study|Withdrawal by Subject|3
7760150|NCT00752609|26978217|P2|Overall Study|Adverse Event|2
7760151|NCT00752609|26978218|P1|Overall Study|Adverse Event|2
7760152|NCT00752557|26978240|P3|Overall Study|Lost to Follow-up|1
7760153|NCT00752557|26978241|P2|Overall Study|Lost to Follow-up|0
7760154|NCT00752557|26978242|P1|Overall Study|Lost to Follow-up|1
7760155|NCT00752557|26978240|P3|Overall Study|Unspecified resaons|2
7760156|NCT00752557|26978241|P2|Overall Study|Unspecified resaons|2
7760157|NCT00752557|26978242|P1|Overall Study|Unspecified resaons|0
7760158|NCT00752557|26978240|P3|Overall Study|Withdrawal by Subject|3
7760159|NCT00752557|26978241|P2|Overall Study|Withdrawal by Subject|3
7760160|NCT00752557|26978242|P1|Overall Study|Withdrawal by Subject|4
7760161|NCT00752232|26978274|P7|Overall Study|Caregiver could not attend the subject|0
7760162|NCT00752232|26978275|P6|Overall Study|Caregiver could not attend the subject|0
7760163|NCT00752232|26978276|P5|Overall Study|Caregiver could not attend the subject|1
7760164|NCT00752232|26978277|P4|Overall Study|Caregiver could not attend the subject|0
7760165|NCT00752232|26978278|P3|Overall Study|Caregiver could not attend the subject|0
7760166|NCT00752232|26978279|P2|Overall Study|Caregiver could not attend the subject|0
7760167|NCT00752232|26978280|P1|Overall Study|Caregiver could not attend the subject|0
7760168|NCT00752232|26978274|P7|Overall Study|Group home admission|0
7760169|NCT00752232|26978275|P6|Overall Study|Group home admission|0
7760170|NCT00752232|26978276|P5|Overall Study|Group home admission|0
7760171|NCT00752232|26978277|P4|Overall Study|Group home admission|1
7760172|NCT00752232|26978278|P3|Overall Study|Group home admission|0
7760173|NCT00752232|26978279|P2|Overall Study|Group home admission|0
7760174|NCT00752232|26978280|P1|Overall Study|Group home admission|0
7760175|NCT00752232|26978274|P7|Overall Study|Subject request|0
7760176|NCT00752232|26978275|P6|Overall Study|Subject request|0
7760177|NCT00752232|26978276|P5|Overall Study|Subject request|0
7760178|NCT00752232|26978277|P4|Overall Study|Subject request|0
7760179|NCT00752232|26978278|P3|Overall Study|Subject request|1
7760180|NCT00752232|26978279|P2|Overall Study|Subject request|0
7760181|NCT00752232|26978280|P1|Overall Study|Subject request|0
7760182|NCT00752232|26978274|P7|Overall Study|Investigator request|0
7760183|NCT00752232|26978275|P6|Overall Study|Investigator request|0
7760184|NCT00752232|26978276|P5|Overall Study|Investigator request|1
7760185|NCT00752232|26978277|P4|Overall Study|Investigator request|0
7760186|NCT00752232|26978278|P3|Overall Study|Investigator request|0
7760187|NCT00752232|26978279|P2|Overall Study|Investigator request|0
7760188|NCT00752232|26978280|P1|Overall Study|Investigator request|0
7760189|NCT00752232|26978274|P7|Overall Study|Caregiver request|0
7760190|NCT00752232|26978275|P6|Overall Study|Caregiver request|0
7760191|NCT00752232|26978276|P5|Overall Study|Caregiver request|1
7760192|NCT00752232|26978277|P4|Overall Study|Caregiver request|0
7760193|NCT00752232|26978278|P3|Overall Study|Caregiver request|0
7760194|NCT00752232|26978279|P2|Overall Study|Caregiver request|0
7760195|NCT00752232|26978280|P1|Overall Study|Caregiver request|2
7760196|NCT00752232|26978274|P7|Overall Study|Protocol Violation|0
7760197|NCT00752232|26978275|P6|Overall Study|Protocol Violation|1
7760198|NCT00752232|26978276|P5|Overall Study|Protocol Violation|0
7760199|NCT00752232|26978277|P4|Overall Study|Protocol Violation|0
7760200|NCT00752232|26978278|P3|Overall Study|Protocol Violation|0
7760201|NCT00752232|26978279|P2|Overall Study|Protocol Violation|0
7760202|NCT00752232|26978280|P1|Overall Study|Protocol Violation|0
7760203|NCT00752219|26978354|P2|Overall Study|Other|0
7760204|NCT00752219|26978355|P1|Overall Study|Other|3
7760205|NCT00752219|26978354|P2|Overall Study|Randomized but not treated|0
7760206|NCT00752219|26978355|P1|Overall Study|Randomized but not treated|1
7760207|NCT00752219|26978354|P2|Overall Study|Lost to Follow-up|2
7760208|NCT00752219|26978355|P1|Overall Study|Lost to Follow-up|1
7760209|NCT00752219|26978354|P2|Overall Study|Protocol deviation|0
7760210|NCT00752219|26978355|P1|Overall Study|Protocol deviation|1
7760211|NCT00752219|26978354|P2|Overall Study|Adverse Event|3
7760212|NCT00752219|26978355|P1|Overall Study|Adverse Event|5
7760213|NCT00752219|26978354|P2|Overall Study|Clinical failure|1
7760214|NCT00752219|26978355|P1|Overall Study|Clinical failure|0
7760215|NCT00752206|26978381|P2|Overall Study|Pregnancy|0
7760216|NCT00752206|26978382|P1|Overall Study|Pregnancy|1
7760217|NCT00752206|26978381|P2|Overall Study|Disease progression|11
7760218|NCT00752206|26978382|P1|Overall Study|Disease progression|8
7760219|NCT00752128|26978400|P1|Overall Study|Withdrawal by Subject|4
7760220|NCT00752089|26978414|P1|Overall Study|Cannot continue the study|1
7760221|NCT00752089|26978414|P1|Overall Study|Not capable of wearing partial denture|1
7760222|NCT00752089|26978414|P1|Overall Study|Could not attend visit 9|1
7760223|NCT00752089|26978414|P1|Overall Study|Protocol Deviation|2
7760224|NCT00752089|26978414|P1|Overall Study|Adverse Event|1
7760225|NCT00751998|26978428|P1|Overall Study|Withdrawal by Subject|2
7760226|NCT00751998|26978428|P1|Overall Study|Death|11
7760227|NCT00751998|26978428|P1|Overall Study|Lost to Follow-up|7
7760228|NCT00751933|26978447|P4|Overall Study|Physician Decision|1
7760229|NCT00751933|26978448|P3|Overall Study|Physician Decision|1
7760230|NCT00751933|26978449|P2|Overall Study|Physician Decision|0
7760231|NCT00751933|26978450|P1|Overall Study|Physician Decision|0
7760232|NCT00751933|26978447|P4|Overall Study|Withdrawal by Subject|0
7760233|NCT00751933|26978448|P3|Overall Study|Withdrawal by Subject|0
7760234|NCT00751933|26978449|P2|Overall Study|Withdrawal by Subject|1
7760235|NCT00751933|26978450|P1|Overall Study|Withdrawal by Subject|0
7760236|NCT00751881|26978458|P3|Extension Study Period|Other than specified above|18
7760237|NCT00751881|26978459|P2|Extension Study Period|Other than specified above|30
7760238|NCT00751881|26978460|P1|Extension Study Period|Other than specified above|26
7760239|NCT00751881|26978458|P3|Extension Study Period|Poor Compliance to Protocol|1
7760240|NCT00751881|26978459|P2|Extension Study Period|Poor Compliance to Protocol|2
7760241|NCT00751881|26978460|P1|Extension Study Period|Poor Compliance to Protocol|3
7760242|NCT00751881|26978458|P3|Extension Study Period|Lost to Follow-up|6
7760243|NCT00751881|26978459|P2|Extension Study Period|Lost to Follow-up|9
7760244|NCT00751881|26978460|P1|Extension Study Period|Lost to Follow-up|4
7760245|NCT00751881|26978458|P3|Extension Study Period|Lack of Efficacy|20
7760246|NCT00751881|26978459|P2|Extension Study Period|Lack of Efficacy|10
7760247|NCT00751881|26978460|P1|Extension Study Period|Lack of Efficacy|14
7760248|NCT00751881|26978458|P3|Extension Study Period|Adverse Event|21
7760249|NCT00751881|26978459|P2|Extension Study Period|Adverse Event|20
7760250|NCT00751881|26978460|P1|Extension Study Period|Adverse Event|18
7760251|NCT00751881|26978458|P3|Core Treatment Period|Other:participant's decision/unspecified|16
7760252|NCT00751881|26978459|P2|Core Treatment Period|Other:participant's decision/unspecified|22
7760253|NCT00751881|26978460|P1|Core Treatment Period|Other:participant's decision/unspecified|19
7760254|NCT00751881|26978458|P3|Core Treatment Period|Other: tolerability complaints|0
7760255|NCT00751881|26978459|P2|Core Treatment Period|Other: tolerability complaints|0
7760256|NCT00751881|26978460|P1|Core Treatment Period|Other: tolerability complaints|2
7760257|NCT00751881|26978458|P3|Core Treatment Period|Other: MS treatment change|4
7760258|NCT00751881|26978459|P2|Core Treatment Period|Other: MS treatment change|4
7760259|NCT00751881|26978460|P1|Core Treatment Period|Other: MS treatment change|6
7760260|NCT00751881|26978458|P3|Core Treatment Period|Other: personal/family constraints|10
7760261|NCT00751881|26978459|P2|Core Treatment Period|Other: personal/family constraints|7
7760262|NCT00751881|26978460|P1|Core Treatment Period|Other: personal/family constraints|6
7760263|NCT00751881|26978458|P3|Core Treatment Period|Other: wish to parent|4
7760264|NCT00751881|26978459|P2|Core Treatment Period|Other: wish to parent|7
7760265|NCT00751881|26978460|P1|Core Treatment Period|Other: wish to parent|5
7760266|NCT00751881|26978458|P3|Core Treatment Period|Other: protocol deviation|7
7760267|NCT00751881|26978459|P2|Core Treatment Period|Other: protocol deviation|3
7760268|NCT00751881|26978460|P1|Core Treatment Period|Other: protocol deviation|3
7760269|NCT00751881|26978458|P3|Core Treatment Period|Lost to Follow-up|3
7760270|NCT00751881|26978459|P2|Core Treatment Period|Lost to Follow-up|4
7760271|NCT00751881|26978460|P1|Core Treatment Period|Lost to Follow-up|6
7760272|NCT00751881|26978458|P3|Core Treatment Period|Poor compliance to protocol|4
7760273|NCT00751881|26978459|P2|Core Treatment Period|Poor compliance to protocol|3
7760274|NCT00751881|26978460|P1|Core Treatment Period|Poor compliance to protocol|15
7760275|NCT00751881|26978458|P3|Core Treatment Period|Lack of Efficacy|20
7760276|NCT00751881|26978459|P2|Core Treatment Period|Lack of Efficacy|30
7760277|NCT00751881|26978460|P1|Core Treatment Period|Lack of Efficacy|37
7760278|NCT00751881|26978458|P3|Core Treatment Period|Adverse Event|58
7760279|NCT00751881|26978459|P2|Core Treatment Period|Adverse Event|54
7760280|NCT00751881|26978460|P1|Core Treatment Period|Adverse Event|26
7760281|NCT00751881|26978458|P3|Core Treatment Period|Not treated|2
7760282|NCT00751881|26978459|P2|Core Treatment Period|Not treated|1
7760283|NCT00751881|26978460|P1|Core Treatment Period|Not treated|1
7760284|NCT00751790|26978507|P1|Overall Study|Withdrawal by Subject|1
7760285|NCT00751790|26978507|P1|Overall Study|Death|3
7760286|NCT00751790|26978507|P1|Overall Study|Lost to Follow-up|1
7760287|NCT00751621|26978538|P1|Overall Study|Poor adherence to asthma treatment|1
7760288|NCT00751621|26978538|P1|Overall Study|Subject moved to another country|1
7760289|NCT00751621|26978538|P1|Overall Study|Withdrawal by Subject|1
7760290|NCT00751621|26978538|P1|Overall Study|Adverse Event|1
7760291|NCT00751400|26978572|P1|Overall Study|Lost to Follow-up|10
7760292|NCT00751348|26978587|P2|Overall Study|Migration from study area|0
7760293|NCT00751348|26978588|P1|Overall Study|Migration from study area|1
7760294|NCT00751348|26978587|P2|Overall Study|Withdrawal by Subject|2
7760295|NCT00751348|26978588|P1|Overall Study|Withdrawal by Subject|5
7760296|NCT00751296|26978621|P1|Overall Study|Adverse Event|2
7760297|NCT00751140|26978649|P1|Overall Study|benign angioma excluded from analysis|1
7760298|NCT00751114|26978659|P2|Overall Study|Move to another city|0
7760299|NCT00751114|26978660|P1|Overall Study|Move to another city|1
7760300|NCT00751114|26978659|P2|Overall Study|Out of country for 2 months|0
7760301|NCT00751114|26978660|P1|Overall Study|Out of country for 2 months|1
7760302|NCT00751114|26978659|P2|Overall Study|Not Treated|1
7760303|NCT00751114|26978660|P1|Overall Study|Not Treated|13
7760304|NCT00751114|26978659|P2|Overall Study|Lack of Efficacy|7
7760305|NCT00751114|26978660|P1|Overall Study|Lack of Efficacy|0
7760306|NCT00751114|26978659|P2|Overall Study|Lost to Follow-up|7
7760307|NCT00751114|26978660|P1|Overall Study|Lost to Follow-up|4
7760308|NCT00751114|26978659|P2|Overall Study|Withdrawal by Subject|4
7760309|NCT00751114|26978660|P1|Overall Study|Withdrawal by Subject|9
7760310|NCT00751114|26978659|P2|Overall Study|Protocol Violation|9
7760311|NCT00751114|26978660|P1|Overall Study|Protocol Violation|8
7760312|NCT00751114|26978659|P2|Overall Study|Adverse Event|4
7760313|NCT00751114|26978660|P1|Overall Study|Adverse Event|2
7760314|NCT00751101|26978685|P2|Overall Study|Physician Decision|1
7760315|NCT00751101|26978686|P1|Overall Study|Physician Decision|0
7760316|NCT00751101|26978685|P2|Overall Study|Never began capecitabine|0
7760317|NCT00751101|26978686|P1|Overall Study|Never began capecitabine|1
7760318|NCT00751101|26978685|P2|Overall Study|No HFS / Never Started Patch/|4
7760319|NCT00751101|26978686|P1|Overall Study|No HFS / Never Started Patch/|0
7760320|NCT00751101|26978685|P2|Overall Study|Withdrawal by Subject|0
7760321|NCT00751101|26978686|P1|Overall Study|Withdrawal by Subject|1
7760322|NCT00751036|26978706|P2|Overall Study|Missing end of Treatment Page|3
7760323|NCT00751036|26978707|P1|Overall Study|Missing end of Treatment Page|2
7760324|NCT00751036|26978706|P2|Overall Study|Protocol Violation|0
7760325|NCT00751036|26978707|P1|Overall Study|Protocol Violation|1
7760326|NCT00751036|26978706|P2|Overall Study|Lost to Follow-up|1
7760327|NCT00751036|26978707|P1|Overall Study|Lost to Follow-up|0
7760328|NCT00751036|26978706|P2|Overall Study|Death|3
7760329|NCT00751036|26978707|P1|Overall Study|Death|3
7760330|NCT00751036|26978706|P2|Overall Study|Withdrawal by Subject|2
7760331|NCT00751036|26978707|P1|Overall Study|Withdrawal by Subject|5
7760332|NCT00751036|26978706|P2|Overall Study|Administrative Problems|4
7760333|NCT00751036|26978707|P1|Overall Study|Administrative Problems|3
7760334|NCT00751036|26978706|P2|Overall Study|Adverse Event|4
7760335|NCT00751036|26978707|P1|Overall Study|Adverse Event|6
7760336|NCT00751036|26978706|P2|Overall Study|Disease Progression|29
7760337|NCT00751036|26978707|P1|Overall Study|Disease Progression|28
7760338|NCT00751023|26978721|P2|Overall Study|Lost to Follow-up|7
7760339|NCT00751023|26978722|P1|Overall Study|Lost to Follow-up|11
7760340|NCT00750919|26978742|P1|Overall Study|Other|36
7760341|NCT00750919|26978742|P1|Overall Study|Could not cooperate, unrelated to trial|4
7760342|NCT00750919|26978742|P1|Overall Study|Lack of Efficacy|8
7760343|NCT00750919|26978742|P1|Overall Study|Withdrawal by Subject|1
7760344|NCT00750919|26978742|P1|Overall Study|Adverse Event|9
7760345|NCT00750893|26978750|P1|Overall Study|Other|17
7760346|NCT00750893|26978750|P1|Overall Study|Lost to Follow-up|510
7760347|NCT00750893|26978750|P1|Overall Study|Withdrawal by Subject|10
7760348|NCT00750893|26978750|P1|Overall Study|Adverse Event|5
7760349|NCT00750880|26978762|P1|Overall Study|Administrative|11
7760350|NCT00750880|26978762|P1|Overall Study|Physician Decision|20
7760351|NCT00750880|26978762|P1|Overall Study|Withdrawal by Subject|33
7760352|NCT00750880|26978762|P1|Overall Study|Protocol Violation|15
7760353|NCT00750880|26978762|P1|Overall Study|Lost to Follow-up|10
7760354|NCT00750880|26978762|P1|Overall Study|Lack of Efficacy|46
7760355|NCT00750880|26978762|P1|Overall Study|Death|4
7760356|NCT00750880|26978762|P1|Overall Study|Adverse Event|76
7760357|NCT00750867|26978785|P1|Overall Study|Adverse Event|2
7760358|NCT00750737|26978806|P2|Overall Study|Withdrawal by Subject|3
7760359|NCT00750737|26978807|P1|Overall Study|Withdrawal by Subject|3
7760360|NCT00750438|26978822|P2|Overall Study|Withdrawal by Subject|1
7760361|NCT00750438|26978823|P1|Overall Study|Withdrawal by Subject|1
7760362|NCT00750438|26978822|P2|Overall Study|Physician Decision|2
7760363|NCT00750438|26978823|P1|Overall Study|Physician Decision|2
7760364|NCT00750438|26978822|P2|Overall Study|Protocol Violation|1
7760365|NCT00750438|26978823|P1|Overall Study|Protocol Violation|4
7760366|NCT00750308|26978889|P12|Third Treatment|Withdrawal by Subject|0
7760367|NCT00750308|26978890|P11|Third Treatment|Withdrawal by Subject|0
7760368|NCT00750308|26978891|P10|Third Treatment|Withdrawal by Subject|0
7760369|NCT00750308|26978892|P9|Third Treatment|Withdrawal by Subject|0
7760370|NCT00750308|26978893|P8|Third Treatment|Withdrawal by Subject|0
7760371|NCT00750308|26978894|P7|Third Treatment|Withdrawal by Subject|0
7760372|NCT00750308|26978895|P6|Third Treatment|Withdrawal by Subject|0
7760373|NCT00750308|26978896|P5|Third Treatment|Withdrawal by Subject|0
7760374|NCT00750308|26978897|P4|Third Treatment|Withdrawal by Subject|0
7760375|NCT00750308|26978898|P3|Third Treatment|Withdrawal by Subject|0
7760376|NCT00750308|26978899|P2|Third Treatment|Withdrawal by Subject|1
7760377|NCT00750308|26978900|P1|Third Treatment|Withdrawal by Subject|0
7760378|NCT00750308|26978889|P12|Second Treatment|Withdrawal by Subject|0
7760379|NCT00750308|26978890|P11|Second Treatment|Withdrawal by Subject|0
7760380|NCT00750308|26978891|P10|Second Treatment|Withdrawal by Subject|0
7760381|NCT00750308|26978892|P9|Second Treatment|Withdrawal by Subject|0
7760382|NCT00750308|26978893|P8|Second Treatment|Withdrawal by Subject|0
7760383|NCT00750308|26978894|P7|Second Treatment|Withdrawal by Subject|0
7760384|NCT00750308|26978895|P6|Second Treatment|Withdrawal by Subject|0
7760385|NCT00750308|26978896|P5|Second Treatment|Withdrawal by Subject|1
7760386|NCT00750308|26978897|P4|Second Treatment|Withdrawal by Subject|0
7760387|NCT00750308|26978898|P3|Second Treatment|Withdrawal by Subject|0
7760388|NCT00750308|26978899|P2|Second Treatment|Withdrawal by Subject|0
7760389|NCT00750308|26978900|P1|Second Treatment|Withdrawal by Subject|0
7760390|NCT00750308|26978889|P12|Second Treatment|Adverse Event|0
7760391|NCT00750308|26978890|P11|Second Treatment|Adverse Event|0
7760392|NCT00750308|26978891|P10|Second Treatment|Adverse Event|0
7760393|NCT00750308|26978892|P9|Second Treatment|Adverse Event|1
7760394|NCT00750308|26978893|P8|Second Treatment|Adverse Event|0
7760395|NCT00750308|26978894|P7|Second Treatment|Adverse Event|0
7760396|NCT00750308|26978895|P6|Second Treatment|Adverse Event|1
7760397|NCT00750308|26978896|P5|Second Treatment|Adverse Event|0
7760398|NCT00750308|26978897|P4|Second Treatment|Adverse Event|0
7760399|NCT00750308|26978898|P3|Second Treatment|Adverse Event|0
7760400|NCT00750308|26978899|P2|Second Treatment|Adverse Event|0
7760401|NCT00750308|26978900|P1|Second Treatment|Adverse Event|0
7760402|NCT00750308|26978889|P12|First Treatment|Withdrawal by Subject|0
7760403|NCT00750308|26978890|P11|First Treatment|Withdrawal by Subject|0
7760404|NCT00750308|26978891|P10|First Treatment|Withdrawal by Subject|0
7760405|NCT00750308|26978892|P9|First Treatment|Withdrawal by Subject|0
7760406|NCT00750308|26978893|P8|First Treatment|Withdrawal by Subject|1
7760407|NCT00750308|26978894|P7|First Treatment|Withdrawal by Subject|0
7760408|NCT00750308|26978895|P6|First Treatment|Withdrawal by Subject|0
7760409|NCT00750308|26978896|P5|First Treatment|Withdrawal by Subject|0
7760410|NCT00750308|26978897|P4|First Treatment|Withdrawal by Subject|1
7760411|NCT00750308|26978898|P3|First Treatment|Withdrawal by Subject|0
7760412|NCT00750308|26978899|P2|First Treatment|Withdrawal by Subject|0
7760413|NCT00750308|26978900|P1|First Treatment|Withdrawal by Subject|0
7760414|NCT00750308|26978889|P12|First Treatment|Adverse Event|1
7760415|NCT00750308|26978890|P11|First Treatment|Adverse Event|1
7760416|NCT00750308|26978891|P10|First Treatment|Adverse Event|0
7760417|NCT00750308|26978892|P9|First Treatment|Adverse Event|0
7760418|NCT00750308|26978893|P8|First Treatment|Adverse Event|0
7760419|NCT00750308|26978894|P7|First Treatment|Adverse Event|0
7760420|NCT00750308|26978895|P6|First Treatment|Adverse Event|0
7760421|NCT00750308|26978896|P5|First Treatment|Adverse Event|0
7760422|NCT00750308|26978897|P4|First Treatment|Adverse Event|0
7760423|NCT00750308|26978898|P3|First Treatment|Adverse Event|0
7760424|NCT00750308|26978899|P2|First Treatment|Adverse Event|1
7760425|NCT00750308|26978900|P1|First Treatment|Adverse Event|0
7760426|NCT00750269|26978950|P5|Overall Study|Fiducials could not be placed|1
7760427|NCT00750269|26978951|P4|Overall Study|Fiducials could not be placed|0
7760428|NCT00750269|26978952|P3|Overall Study|Fiducials could not be placed|0
7760429|NCT00750269|26978953|P2|Overall Study|Fiducials could not be placed|0
7760430|NCT00750269|26978954|P1|Overall Study|Fiducials could not be placed|0
7760431|NCT00750269|26978950|P5|Overall Study|SBRT plan could not be drawn|1
7760432|NCT00750269|26978951|P4|Overall Study|SBRT plan could not be drawn|0
7760433|NCT00750269|26978952|P3|Overall Study|SBRT plan could not be drawn|0
7760434|NCT00750269|26978953|P2|Overall Study|SBRT plan could not be drawn|0
7760435|NCT00750269|26978954|P1|Overall Study|SBRT plan could not be drawn|0
7760436|NCT00750269|26978950|P5|Overall Study|Site error|0
7760437|NCT00750269|26978951|P4|Overall Study|Site error|1
7760438|NCT00750269|26978952|P3|Overall Study|Site error|0
7760439|NCT00750269|26978953|P2|Overall Study|Site error|0
7760440|NCT00750269|26978954|P1|Overall Study|Site error|0
7760441|NCT00750269|26978950|P5|Overall Study|Patient too large for positioning|0
7760442|NCT00750269|26978951|P4|Overall Study|Patient too large for positioning|0
7760443|NCT00750269|26978952|P3|Overall Study|Patient too large for positioning|1
7760444|NCT00750269|26978953|P2|Overall Study|Patient too large for positioning|0
7760445|NCT00750269|26978954|P1|Overall Study|Patient too large for positioning|0
7760446|NCT00750269|26978950|P5|Overall Study|Physician Decision|2
7760447|NCT00750269|26978951|P4|Overall Study|Physician Decision|0
7760448|NCT00750269|26978952|P3|Overall Study|Physician Decision|0
7760449|NCT00750269|26978953|P2|Overall Study|Physician Decision|0
7760450|NCT00750269|26978954|P1|Overall Study|Physician Decision|0
7760451|NCT00750269|26978950|P5|Overall Study|Withdrawal by Subject|2
7760452|NCT00750269|26978951|P4|Overall Study|Withdrawal by Subject|2
7760453|NCT00750269|26978952|P3|Overall Study|Withdrawal by Subject|2
7760454|NCT00750269|26978953|P2|Overall Study|Withdrawal by Subject|0
7760455|NCT00750269|26978954|P1|Overall Study|Withdrawal by Subject|0
7760456|NCT00750269|26978950|P5|Overall Study|Protocol Violation|4
7760457|NCT00750269|26978951|P4|Overall Study|Protocol Violation|2
7760458|NCT00750269|26978952|P3|Overall Study|Protocol Violation|1
7760459|NCT00750269|26978953|P2|Overall Study|Protocol Violation|1
7760460|NCT00750269|26978954|P1|Overall Study|Protocol Violation|0
7760461|NCT00750204|26979001|P2|Overall Study|study halted prematurely|1
7760462|NCT00750204|26979002|P1|Overall Study|study halted prematurely|1
7760463|NCT00750152|26979032|P2|Overall Study|Other|8
7760464|NCT00750152|26979033|P1|Overall Study|Other|7
7760465|NCT00750152|26979032|P2|Overall Study|Termination by sponsor|0
7760466|NCT00750152|26979033|P1|Overall Study|Termination by sponsor|1
7760467|NCT00750152|26979032|P2|Overall Study|Non-compliance|1
7760468|NCT00750152|26979033|P1|Overall Study|Non-compliance|0
7760469|NCT00750152|26979032|P2|Overall Study|Physician Decision|1
7760470|NCT00750152|26979033|P1|Overall Study|Physician Decision|1
7760471|NCT00750152|26979032|P2|Overall Study|Withdrawal by Subject|3
7760472|NCT00750152|26979033|P1|Overall Study|Withdrawal by Subject|3
7760473|NCT00750152|26979032|P2|Overall Study|Lost to Follow-up|13
7760474|NCT00750152|26979033|P1|Overall Study|Lost to Follow-up|8
7760475|NCT00750152|26979032|P2|Overall Study|Adverse Event|1
7760476|NCT00750152|26979033|P1|Overall Study|Adverse Event|2
7760477|NCT00750139|26979045|P4|Overall Study|Non-specific|33
7760478|NCT00750139|26979046|P3|Overall Study|Non-specific|79
7760479|NCT00750139|26979047|P2|Overall Study|Non-specific|42
7760480|NCT00750139|26979048|P1|Overall Study|Non-specific|62
7760481|NCT00750139|26979045|P4|Overall Study|Termination by sponsor|1
7760482|NCT00750139|26979046|P3|Overall Study|Termination by sponsor|0
7760483|NCT00750139|26979047|P2|Overall Study|Termination by sponsor|0
7760484|NCT00750139|26979048|P1|Overall Study|Termination by sponsor|4
7760485|NCT00750139|26979045|P4|Overall Study|Non-compliance|3
7760486|NCT00750139|26979046|P3|Overall Study|Non-compliance|1
7760487|NCT00750139|26979047|P2|Overall Study|Non-compliance|0
7760488|NCT00750139|26979048|P1|Overall Study|Non-compliance|1
7760489|NCT00750139|26979045|P4|Overall Study|Physician Decision|0
7760490|NCT00750139|26979046|P3|Overall Study|Physician Decision|0
7760491|NCT00750139|26979047|P2|Overall Study|Physician Decision|1
7760492|NCT00750139|26979048|P1|Overall Study|Physician Decision|1
7760493|NCT00750139|26979045|P4|Overall Study|Withdrawal by Subject|2
7760494|NCT00750139|26979046|P3|Overall Study|Withdrawal by Subject|6
7760495|NCT00750139|26979047|P2|Overall Study|Withdrawal by Subject|2
7760496|NCT00750139|26979048|P1|Overall Study|Withdrawal by Subject|3
7760497|NCT00750139|26979045|P4|Overall Study|Lost to Follow-up|6
7760498|NCT00750139|26979046|P3|Overall Study|Lost to Follow-up|15
7760499|NCT00750139|26979047|P2|Overall Study|Lost to Follow-up|12
7760500|NCT00750139|26979048|P1|Overall Study|Lost to Follow-up|17
7760501|NCT00750139|26979045|P4|Overall Study|Adverse Event|1
7760502|NCT00750139|26979046|P3|Overall Study|Adverse Event|0
7760503|NCT00750139|26979047|P2|Overall Study|Adverse Event|2
7760504|NCT00750139|26979048|P1|Overall Study|Adverse Event|1
7760505|NCT00750061|26979064|P2|Overall Study|Physician Decision|1
7760506|NCT00750061|26979065|P1|Overall Study|Physician Decision|0
7760507|NCT00750061|26979064|P2|Overall Study|Withdrawal by Subject|1
7760508|NCT00750061|26979065|P1|Overall Study|Withdrawal by Subject|0
7760509|NCT00750061|26979064|P2|Overall Study|Adverse Event|0
7760510|NCT00750061|26979065|P1|Overall Study|Adverse Event|2
7760511|NCT00749996|26979075|P2|Overall Study|Death|0
7760512|NCT00749996|26979076|P1|Overall Study|Death|1
7760513|NCT00749996|26979075|P2|Overall Study|Adverse Event|0
7760514|NCT00749996|26979076|P1|Overall Study|Adverse Event|1
7760515|NCT00749996|26979075|P2|Overall Study|Pregnancy|2
7760516|NCT00749996|26979076|P1|Overall Study|Pregnancy|0
7760517|NCT00749996|26979075|P2|Overall Study|Physician Decision|0
7760518|NCT00749996|26979076|P1|Overall Study|Physician Decision|2
7760519|NCT00749996|26979075|P2|Overall Study|Protocol Violation|3
7760520|NCT00749996|26979076|P1|Overall Study|Protocol Violation|2
7760521|NCT00749996|26979075|P2|Overall Study|Withdrawal by Subject|4
7760522|NCT00749996|26979076|P1|Overall Study|Withdrawal by Subject|5
7760523|NCT00749996|26979075|P2|Overall Study|Lost to Follow-up|4
7760524|NCT00749996|26979076|P1|Overall Study|Lost to Follow-up|7
7760525|NCT00749944|26979099|P2|Overall Study|Withdrawal by Subject|0
7760526|NCT00749944|26979100|P1|Overall Study|Withdrawal by Subject|2
7760527|NCT00749944|26979099|P2|Overall Study|Other|0
7760528|NCT00749944|26979100|P1|Overall Study|Other|1
7760529|NCT00749944|26979099|P2|Overall Study|Lost to Follow-up|1
7760530|NCT00749944|26979100|P1|Overall Study|Lost to Follow-up|2
7760531|NCT00749892|26979179|P1|Overall Study|Withdrawal by Subject|3
7760532|NCT00749775|26979215|P1|Overall Study|No drug administration|3
7760533|NCT00749775|26979215|P1|Overall Study|No visit after first day of treatment|44
7760534|NCT00749775|26979215|P1|Overall Study|Lost to Follow-up|36
7760535|NCT00749775|26979215|P1|Overall Study|Protocol Violation|24
7760536|NCT00749684|26979252|P1|Overall Study|Missing|9
7760537|NCT00749684|26979252|P1|Overall Study|AE+discontinuation on participants wish|1
7760538|NCT00749684|26979252|P1|Overall Study|Therapy according to protocol + AE|2
7760539|NCT00749684|26979252|P1|Overall Study|Progressive Desease|31
7760540|NCT00749684|26979252|P1|Overall Study|Not Documented|1
7760541|NCT00749684|26979252|P1|Overall Study|Participant's Wish|10
7760542|NCT00749684|26979252|P1|Overall Study|Adverse Event|27
7760543|NCT00749684|26979252|P1|Overall Study|Death|1
7760544|NCT00749580|26979300|P2|Overall Study|Adverse Event|1
7760545|NCT00749580|26979301|P1|Overall Study|Adverse Event|0
7760546|NCT00749580|26979300|P2|Overall Study|Lost to Follow-up|8
7760547|NCT00749580|26979301|P1|Overall Study|Lost to Follow-up|4
7760548|NCT00749463|26979335|P3|Overall Study|Withdrawal by Subject|0
7760549|NCT00749463|26979336|P2|Overall Study|Withdrawal by Subject|0
7760550|NCT00749463|26979337|P1|Overall Study|Withdrawal by Subject|1
7760551|NCT00749463|26979335|P3|Overall Study|Adverse Event|1
7760552|NCT00749463|26979336|P2|Overall Study|Adverse Event|4
7760553|NCT00749463|26979337|P1|Overall Study|Adverse Event|0
7760554|NCT00749411|26979365|P2|Overall Study|Protocol-defined stopping criteria|1
7760555|NCT00749411|26979366|P1|Overall Study|Protocol-defined stopping criteria|0
7760556|NCT00749411|26979365|P2|Overall Study|Protocol Violation|1
7760557|NCT00749411|26979366|P1|Overall Study|Protocol Violation|1
7760558|NCT00749411|26979365|P2|Overall Study|Lack of Efficacy|1
7760559|NCT00749411|26979366|P1|Overall Study|Lack of Efficacy|0
7760560|NCT00749411|26979365|P2|Overall Study|Adverse Event|2
7760561|NCT00749411|26979366|P1|Overall Study|Adverse Event|0
7760562|NCT00749398|26979374|P1|Overall Study|Unknown reason|1
7760563|NCT00749398|26979374|P1|Overall Study|Reason not specified|2
7760564|NCT00749398|26979374|P1|Overall Study|Lost to Follow-up|11
7760565|NCT00749398|26979374|P1|Overall Study|Withdrawal by Subject|17
7760566|NCT00749398|26979374|P1|Overall Study|Serious adverse event|11
7760567|NCT00749398|26979374|P1|Overall Study|Adverse Event|4
7760568|NCT00749398|26979374|P1|Overall Study|Lack of Efficacy|7
7760569|NCT00749203|26979417|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
7760570|NCT00749203|26979418|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
7760571|NCT00749203|26979417|P2|Second Infusion at 2 Weeks|Protocol Violation|1
7760572|NCT00749203|26979418|P1|Second Infusion at 2 Weeks|Protocol Violation|0
7760573|NCT00749203|26979417|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
7760574|NCT00749203|26979418|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
7760575|NCT00749203|26979417|P2|no Infusion at Week 1|delayed-onset sedation|1
7760576|NCT00749203|26979418|P1|no Infusion at Week 1|delayed-onset sedation|0
7760577|NCT00749203|26979417|P2|no Infusion at Week 1|Withdrawal by Subject|1
7760578|NCT00749203|26979418|P1|no Infusion at Week 1|Withdrawal by Subject|0
7760579|NCT00749203|26979417|P2|no Infusion at Week 1|Lost to Follow-up|1
7760580|NCT00749203|26979418|P1|no Infusion at Week 1|Lost to Follow-up|0
7760581|NCT00749190|26979439|P7|Overall Study|Other reason not defined above|0
7760582|NCT00749190|26979440|P6|Overall Study|Other reason not defined above|0
7760583|NCT00749190|26979441|P5|Overall Study|Other reason not defined above|0
7760584|NCT00749190|26979442|P4|Overall Study|Other reason not defined above|1
7760585|NCT00749190|26979443|P3|Overall Study|Other reason not defined above|0
7760586|NCT00749190|26979444|P2|Overall Study|Other reason not defined above|0
7760587|NCT00749190|26979445|P1|Overall Study|Other reason not defined above|0
7760588|NCT00749190|26979439|P7|Overall Study|Protocol Violation|1
7760589|NCT00749190|26979440|P6|Overall Study|Protocol Violation|0
7760590|NCT00749190|26979441|P5|Overall Study|Protocol Violation|0
7760591|NCT00749190|26979442|P4|Overall Study|Protocol Violation|0
7760592|NCT00749190|26979443|P3|Overall Study|Protocol Violation|0
7760593|NCT00749190|26979444|P2|Overall Study|Protocol Violation|1
7760594|NCT00749190|26979445|P1|Overall Study|Protocol Violation|0
7760595|NCT00749190|26979439|P7|Overall Study|Withdrawal by Subject|0
7760596|NCT00749190|26979440|P6|Overall Study|Withdrawal by Subject|1
7760597|NCT00749190|26979441|P5|Overall Study|Withdrawal by Subject|0
7760598|NCT00749190|26979442|P4|Overall Study|Withdrawal by Subject|0
7760599|NCT00749190|26979443|P3|Overall Study|Withdrawal by Subject|0
7760600|NCT00749190|26979444|P2|Overall Study|Withdrawal by Subject|1
7760601|NCT00749190|26979445|P1|Overall Study|Withdrawal by Subject|2
7760602|NCT00749190|26979439|P7|Overall Study|Lack of Efficacy|0
7760603|NCT00749190|26979440|P6|Overall Study|Lack of Efficacy|1
7760604|NCT00749190|26979441|P5|Overall Study|Lack of Efficacy|0
7760605|NCT00749190|26979442|P4|Overall Study|Lack of Efficacy|0
7760606|NCT00749190|26979443|P3|Overall Study|Lack of Efficacy|1
7760607|NCT00749190|26979444|P2|Overall Study|Lack of Efficacy|1
7760608|NCT00749190|26979445|P1|Overall Study|Lack of Efficacy|3
7760609|NCT00749190|26979439|P7|Overall Study|Adverse Event|0
7760610|NCT00749190|26979440|P6|Overall Study|Adverse Event|3
7760611|NCT00749190|26979441|P5|Overall Study|Adverse Event|0
7760612|NCT00749190|26979442|P4|Overall Study|Adverse Event|4
7760613|NCT00749190|26979443|P3|Overall Study|Adverse Event|0
7760614|NCT00749190|26979444|P2|Overall Study|Adverse Event|2
7760615|NCT00749190|26979445|P1|Overall Study|Adverse Event|0
7760616|NCT00748969|26979554|P2|Overall Study|Withdrawal by Subject|1
7760617|NCT00748969|26979555|P1|Overall Study|Withdrawal by Subject|0
7760618|NCT00748969|26979554|P2|Overall Study|Withdrawal by Subject|0
7760619|NCT00748969|26979555|P1|Overall Study|Withdrawal by Subject|1
7760620|NCT00748709|26979605|P1|Overall Study|Other Reasons|1
7760621|NCT00748709|26979605|P1|Overall Study|Withdrawal by Subject|1
7760622|NCT00748709|26979605|P1|Overall Study|Other Adverse Event|1
7760623|NCT00748709|26979605|P1|Overall Study|Drug reducing Toxity|2
7760624|NCT00748709|26979605|P1|Overall Study|Progressive disease|15
7760625|NCT00748566|26979648|P1|Overall Study|Other|9
7760626|NCT00748566|26979648|P1|Overall Study|Study terminated by sponsor|5
7760627|NCT00748566|26979648|P1|Overall Study|Withdrawal by Subject|22
7760628|NCT00748566|26979648|P1|Overall Study|Protocol Violation|13
7760629|NCT00748566|26979648|P1|Overall Study|Lost to Follow-up|1
7760630|NCT00748566|26979648|P1|Overall Study|Lack of Efficacy|12
7760631|NCT00748566|26979648|P1|Overall Study|Death|1
7760632|NCT00748566|26979648|P1|Overall Study|Adverse Event|49
7760633|NCT00748553|26979678|P2|Overall Study|noncompliance|0
7760634|NCT00748553|26979679|P1|Overall Study|noncompliance|1
7760635|NCT00748553|26979678|P2|Overall Study|disease progression|0
7760636|NCT00748553|26979679|P1|Overall Study|disease progression|2
7760637|NCT00748553|26979678|P2|Overall Study|Adverse Event|1
7760638|NCT00748553|26979679|P1|Overall Study|Adverse Event|0
7760639|NCT00748540|26979686|P1|Overall Study|Physician Decision|1
7760640|NCT00748241|26979712|P1|Overall Study|Death|2
7760641|NCT00748241|26979712|P1|Overall Study|Lost to Follow-up|5
7760642|NCT00748241|26979712|P1|Overall Study|Implant failure|1
7760643|NCT00748215|26979722|P2|Overall Study|Adverse Event|5
7760644|NCT00748215|26979723|P1|Overall Study|Adverse Event|0
7760645|NCT00748215|26979722|P2|Overall Study|Non-compliant|2
7760646|NCT00748215|26979723|P1|Overall Study|Non-compliant|0
7760647|NCT00748215|26979722|P2|Overall Study|Change in patient condition|3
7760648|NCT00748215|26979723|P1|Overall Study|Change in patient condition|0
7760649|NCT00748215|26979722|P2|Overall Study|Treatment change|1
7760650|NCT00748215|26979723|P1|Overall Study|Treatment change|2
7760651|NCT00748215|26979722|P2|Overall Study|Withdrawal by Subject|7
7760652|NCT00748215|26979723|P1|Overall Study|Withdrawal by Subject|7
7760653|NCT00748189|26979731|P2|Overall Study|Study terminated by Sponsor|79
7760654|NCT00748189|26979732|P1|Overall Study|Study terminated by Sponsor|70
7760655|NCT00748189|26979731|P2|Overall Study|Lost to Follow-up|15
7760656|NCT00748189|26979732|P1|Overall Study|Lost to Follow-up|8
7760657|NCT00748189|26979731|P2|Overall Study|Physician Decision|5
7760658|NCT00748189|26979732|P1|Overall Study|Physician Decision|16
7760659|NCT00748189|26979731|P2|Overall Study|Withdrawal by Subject|29
7760660|NCT00748189|26979732|P1|Overall Study|Withdrawal by Subject|23
7760661|NCT00748189|26979731|P2|Overall Study|Death|84
7760662|NCT00748189|26979732|P1|Overall Study|Death|99
7760663|NCT00748098|26979787|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
7760664|NCT00748098|26979788|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
7760665|NCT00748098|26979787|P2|Second Treatment Intervention Period|Lost to Follow-up|1
7760666|NCT00748098|26979788|P1|Second Treatment Intervention Period|Lost to Follow-up|1
7760667|NCT00748098|26979787|P2|Second Treatment Intervention Period|Adverse Event|1
7760668|NCT00748098|26979788|P1|Second Treatment Intervention Period|Adverse Event|4
7760669|NCT00748098|26979787|P2|1-Week Washout Period|Withdrawal by Subject|0
7760670|NCT00748098|26979788|P1|1-Week Washout Period|Withdrawal by Subject|2
7760671|NCT00748098|26979787|P2|1-Week Washout Period|Adverse Event|1
7760672|NCT00748098|26979788|P1|1-Week Washout Period|Adverse Event|0
7760673|NCT00748098|26979787|P2|First Taper Period|Protocol Stopping Criteria Met|1
7760674|NCT00748098|26979788|P1|First Taper Period|Protocol Stopping Criteria Met|0
7760675|NCT00748098|26979787|P2|First Taper Period|Withdrawal by Subject|0
7760676|NCT00748098|26979788|P1|First Taper Period|Withdrawal by Subject|2
7760677|NCT00748098|26979787|P2|First Taper Period|Protocol Violation|0
7760678|NCT00748098|26979788|P1|First Taper Period|Protocol Violation|1
7760679|NCT00748098|26979787|P2|First Treatment Intervention Period|Withdrawal by Subject|0
7760680|NCT00748098|26979788|P1|First Treatment Intervention Period|Withdrawal by Subject|2
7760681|NCT00748098|26979787|P2|First Treatment Intervention Period|Lost to Follow-up|0
7760682|NCT00748098|26979788|P1|First Treatment Intervention Period|Lost to Follow-up|1
7760683|NCT00748098|26979787|P2|First Treatment Intervention Period|Protocol Violation|0
7760684|NCT00748098|26979788|P1|First Treatment Intervention Period|Protocol Violation|1
7760685|NCT00748098|26979787|P2|First Treatment Intervention Period|Adverse Event|1
7760686|NCT00748098|26979788|P1|First Treatment Intervention Period|Adverse Event|1
7760687|NCT00748033|26979864|P2|Overall Study|Adverse Event|1
7760688|NCT00748033|26979865|P1|Overall Study|Adverse Event|0
7760689|NCT00747812|26979893|P2|Overall Study|Research Site Staff Relocation|3
7760690|NCT00747812|26979894|P1|Overall Study|Research Site Staff Relocation|5
7760691|NCT00747643|26979932|P2|Overall Study|Withdrawal by Subject|27
7760692|NCT00747643|26979933|P1|Overall Study|Withdrawal by Subject|36
7760693|NCT00747617|26979947|P2|Overall Study|Lost to Follow-up|1
7760694|NCT00747617|26979948|P1|Overall Study|Lost to Follow-up|3
7760695|NCT00747565|26979958|P2|Overall Study|Lost to Follow-up|1
7760696|NCT00747565|26979959|P1|Overall Study|Lost to Follow-up|4
7760697|NCT00747565|26979958|P2|Overall Study|Withdrawal by Subject|6
7760698|NCT00747565|26979959|P1|Overall Study|Withdrawal by Subject|10
7760699|NCT00747474|26979972|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760700|NCT00747474|26979973|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760701|NCT00747474|26979974|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760702|NCT00747474|26979975|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760703|NCT00747474|26979976|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
7760704|NCT00747474|26979977|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760705|NCT00747474|26979978|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760706|NCT00747474|26979979|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760707|NCT00747474|26979980|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760708|NCT00747474|26979981|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760709|NCT00747474|26979982|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760710|NCT00747474|26979983|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7760711|NCT00747461|26980009|P1|Overall Study|study terminated by sponsor|5
7760712|NCT00747435|26980014|P1|Overall Study|Still undergoing follow up|1
7760713|NCT00747435|26980014|P1|Overall Study|Withdrawal by Subject|3
7760714|NCT00747435|26980014|P1|Overall Study|Lost to Follow-up|2
7760715|NCT00747344|26980024|P4|After Controlled Period|Adverse Event|1
7760716|NCT00747344|26980025|P3|After Controlled Period|Adverse Event|0
7760717|NCT00747344|26980026|P2|After Controlled Period|Adverse Event|0
7760718|NCT00747344|26980027|P1|After Controlled Period|Adverse Event|0
7760719|NCT00747344|26980024|P4|Controlled Period|Other|0
7760720|NCT00747344|26980025|P3|Controlled Period|Other|0
7760721|NCT00747344|26980026|P2|Controlled Period|Other|3
7760722|NCT00747344|26980027|P1|Controlled Period|Other|0
7760723|NCT00747344|26980024|P4|Controlled Period|Lack of Efficacy|0
7760724|NCT00747344|26980025|P3|Controlled Period|Lack of Efficacy|0
7760725|NCT00747344|26980026|P2|Controlled Period|Lack of Efficacy|1
7760726|NCT00747344|26980027|P1|Controlled Period|Lack of Efficacy|2
7760727|NCT00747344|26980024|P4|Controlled Period|Adverse Event|0
7760728|NCT00747344|26980025|P3|Controlled Period|Adverse Event|0
7760729|NCT00747344|26980026|P2|Controlled Period|Adverse Event|0
7760730|NCT00747344|26980027|P1|Controlled Period|Adverse Event|3
7760731|NCT00747227|26980041|P2|Overall Study|Illness|1
7760732|NCT00747227|26980042|P1|Overall Study|Illness|1
7760733|NCT00747227|26980041|P2|Overall Study|Lost to Follow-up|2
7760734|NCT00747227|26980042|P1|Overall Study|Lost to Follow-up|1
7760735|NCT00747227|26980041|P2|Overall Study|Withdrawal by Subject|0
7760736|NCT00747227|26980042|P1|Overall Study|Withdrawal by Subject|1
7760737|NCT00747227|26980041|P2|Overall Study|Death|1
7760738|NCT00747227|26980042|P1|Overall Study|Death|3
7760739|NCT00747149|26980071|P2|Overall Study|Not reported|4
7760740|NCT00747149|26980072|P1|Overall Study|Not reported|1
7760741|NCT00747149|26980071|P2|Overall Study|Severe non-compliance to protocol|1
7760742|NCT00747149|26980072|P1|Overall Study|Severe non-compliance to protocol|0
7760743|NCT00747149|26980071|P2|Overall Study|Incorrect enrollment|6
7760744|NCT00747149|26980072|P1|Overall Study|Incorrect enrollment|0
7760745|NCT00747149|26980071|P2|Overall Study|Did not receive treatment|1
7760746|NCT00747149|26980072|P1|Overall Study|Did not receive treatment|0
7760747|NCT00747149|26980071|P2|Overall Study|Withdrawal by Subject|6
7760748|NCT00747149|26980072|P1|Overall Study|Withdrawal by Subject|0
7760749|NCT00747149|26980071|P2|Overall Study|Lost to Follow-up|10
7760750|NCT00747149|26980072|P1|Overall Study|Lost to Follow-up|0
7760751|NCT00747149|26980071|P2|Overall Study|Adverse Event|15
7760752|NCT00747149|26980072|P1|Overall Study|Adverse Event|0
7760753|NCT00747006|26980087|P3|Overall Study|Physician Decision|1
7760754|NCT00747006|26980088|P2|Overall Study|Physician Decision|0
7760755|NCT00747006|26980089|P1|Overall Study|Physician Decision|2
7760756|NCT00747006|26980087|P3|Overall Study|Lost to Follow-up|0
7760757|NCT00747006|26980088|P2|Overall Study|Lost to Follow-up|1
7760758|NCT00747006|26980089|P1|Overall Study|Lost to Follow-up|0
7760759|NCT00747006|26980087|P3|Overall Study|Adverse Event|0
7760760|NCT00747006|26980088|P2|Overall Study|Adverse Event|0
7760761|NCT00747006|26980089|P1|Overall Study|Adverse Event|1
7760762|NCT00746941|26980167|P4|Overall Study|Adverse Event|1
7760763|NCT00746941|26980168|P3|Overall Study|Adverse Event|0
7760764|NCT00746941|26980169|P2|Overall Study|Adverse Event|0
7760765|NCT00746941|26980170|P1|Overall Study|Adverse Event|0
7760766|NCT00746941|26980167|P4|Overall Study|Other, reason not provided|4
7760767|NCT00746941|26980168|P3|Overall Study|Other, reason not provided|0
7760768|NCT00746941|26980169|P2|Overall Study|Other, reason not provided|4
7760769|NCT00746941|26980170|P1|Overall Study|Other, reason not provided|2
7760770|NCT00746941|26980167|P4|Overall Study|Withdrawal by Subject|2
7760771|NCT00746941|26980168|P3|Overall Study|Withdrawal by Subject|0
7760772|NCT00746941|26980169|P2|Overall Study|Withdrawal by Subject|0
7760773|NCT00746941|26980170|P1|Overall Study|Withdrawal by Subject|3
7760774|NCT00746941|26980167|P4|Overall Study|Physician Decision|0
7760775|NCT00746941|26980168|P3|Overall Study|Physician Decision|2
7760776|NCT00746941|26980169|P2|Overall Study|Physician Decision|0
7760777|NCT00746941|26980170|P1|Overall Study|Physician Decision|0
7760778|NCT00746941|26980167|P4|Overall Study|Death|6
7760779|NCT00746941|26980168|P3|Overall Study|Death|0
7760780|NCT00746941|26980169|P2|Overall Study|Death|0
7760781|NCT00746941|26980170|P1|Overall Study|Death|2
7760782|NCT00746798|26980228|P4|Overall Study|Participant unable to return for visit|0
7760783|NCT00746798|26980229|P3|Overall Study|Participant unable to return for visit|0
7760784|NCT00746798|26980230|P2|Overall Study|Participant unable to return for visit|0
7760785|NCT00746798|26980231|P1|Overall Study|Participant unable to return for visit|1
7760786|NCT00746798|26980228|P4|Overall Study|Death|0
7760787|NCT00746798|26980229|P3|Overall Study|Death|2
7760788|NCT00746798|26980230|P2|Overall Study|Death|0
7760789|NCT00746798|26980231|P1|Overall Study|Death|0
7760790|NCT00746798|26980228|P4|Overall Study|Withdrawal by Subject|0
7760791|NCT00746798|26980229|P3|Overall Study|Withdrawal by Subject|1
7760792|NCT00746798|26980230|P2|Overall Study|Withdrawal by Subject|1
7760793|NCT00746798|26980231|P1|Overall Study|Withdrawal by Subject|0
7760794|NCT00746798|26980228|P4|Overall Study|Protocol Violation|0
7760795|NCT00746798|26980229|P3|Overall Study|Protocol Violation|0
7760796|NCT00746798|26980230|P2|Overall Study|Protocol Violation|1
7760797|NCT00746798|26980231|P1|Overall Study|Protocol Violation|0
7760798|NCT00746785|26980256|P3|Overall Study|Lost to Follow-up|27
7760799|NCT00746785|26980257|P2|Overall Study|Lost to Follow-up|25
7760800|NCT00746785|26980258|P1|Overall Study|Lost to Follow-up|29
7760801|NCT00746733|26980266|P2|Third Intervention|Withdrawal by Subject|1
7760802|NCT00746733|26980267|P1|Third Intervention|Withdrawal by Subject|1
7760803|NCT00746733|26980266|P2|Second Intervention|Adverse Event|0
7760804|NCT00746733|26980267|P1|Second Intervention|Adverse Event|1
7760805|NCT00746590|26980357|P1|Overall Study|Death|1
7760806|NCT00746564|26980361|P1|Overall Study|Required Pacemaker/ICD Implant|2
7760807|NCT00746551|26980376|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
7760808|NCT00746551|26980377|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
7760809|NCT00746551|26980376|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
7760810|NCT00746551|26980377|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
7760811|NCT00746551|26980376|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
7760812|NCT00746551|26980377|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
7760813|NCT00746356|26980428|P2|Overall Study|Patient relocated|0
7760814|NCT00746356|26980429|P1|Overall Study|Patient relocated|1
7760815|NCT00746356|26980428|P2|Overall Study|Removal of Device|1
7760816|NCT00746356|26980429|P1|Overall Study|Removal of Device|0
7760817|NCT00746356|26980428|P2|Overall Study|Lost to Follow-up|0
7760818|NCT00746356|26980429|P1|Overall Study|Lost to Follow-up|1
7760819|NCT00746356|26980428|P2|Overall Study|Death|3
7760820|NCT00746356|26980429|P1|Overall Study|Death|7
7760821|NCT00746356|26980428|P2|Overall Study|Withdrawal by Subject|3
7760822|NCT00746356|26980429|P1|Overall Study|Withdrawal by Subject|2
7760823|NCT00746330|26980441|P4|Period 1|Abnormal test procedure result|0
7760824|NCT00746330|26980442|P3|Period 1|Abnormal test procedure result|1
7760825|NCT00746330|26980443|P2|Period 1|Abnormal test procedure result|0
7760826|NCT00746330|26980444|P1|Period 1|Abnormal test procedure result|0
7760827|NCT00746252|26980474|P2|Overall Study|weight gain >7.5 %|2
7760828|NCT00746252|26980475|P1|Overall Study|weight gain >7.5 %|1
7760829|NCT00746096|26980510|P2|Overall Study|No study drug treatment|1
7760830|NCT00746096|26980511|P1|Overall Study|No study drug treatment|1
7760831|NCT00746096|26980510|P2|Overall Study|Protocol Violation|0
7760832|NCT00746096|26980511|P1|Overall Study|Protocol Violation|1
7760833|NCT00746096|26980510|P2|Overall Study|Lost to Follow-up|1
7760834|NCT00746096|26980511|P1|Overall Study|Lost to Follow-up|2
7760835|NCT00746096|26980510|P2|Overall Study|Withdrawal by Subject|1
7760836|NCT00746096|26980511|P1|Overall Study|Withdrawal by Subject|5
7760837|NCT00746096|26980510|P2|Overall Study|Adverse Event|0
7760838|NCT00746096|26980511|P1|Overall Study|Adverse Event|1
7760839|NCT00745901|26980542|P2|Overall Study|Patient didn't take any study medication|3
7760840|NCT00745901|26980543|P1|Overall Study|Patient didn't take any study medication|7
7760841|NCT00745901|26980542|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
7760842|NCT00745901|26980543|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
7760843|NCT00745901|26980542|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
7760844|NCT00745901|26980543|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
7760845|NCT00745901|26980542|P2|Overall Study|Patient's next menses did not start with|0
7760846|NCT00745901|26980543|P1|Overall Study|Patient's next menses did not start with|1
7760847|NCT00745901|26980542|P2|Overall Study|Lack of compliance|2
7760848|NCT00745901|26980543|P1|Overall Study|Lack of compliance|2
7760849|NCT00745901|26980542|P2|Overall Study|Pregnancy|4
7760850|NCT00745901|26980543|P1|Overall Study|Pregnancy|2
7760851|NCT00745901|26980542|P2|Overall Study|Lost to Follow-up|4
7760852|NCT00745901|26980543|P1|Overall Study|Lost to Follow-up|7
7760853|NCT00745901|26980542|P2|Overall Study|Withdrawal by Subject|0
7760854|NCT00745901|26980543|P1|Overall Study|Withdrawal by Subject|1
7760855|NCT00745901|26980542|P2|Overall Study|Protocol Violation|1
7760856|NCT00745901|26980543|P1|Overall Study|Protocol Violation|0
7760857|NCT00745901|26980542|P2|Overall Study|Adverse Event|4
7760858|NCT00745901|26980543|P1|Overall Study|Adverse Event|3
7760859|NCT00745875|26980589|P2|Overall Study|Continuing study treatment|4
7760860|NCT00745875|26980590|P1|Overall Study|Continuing study treatment|4
7760861|NCT00745849|26980598|P2|Second Intervention|Lost to Follow-up|1
7760862|NCT00745849|26980599|P1|Second Intervention|Lost to Follow-up|2
7760863|NCT00745849|26980598|P2|First Intervention|Lost to Follow-up|1
7760864|NCT00745849|26980599|P1|First Intervention|Lost to Follow-up|1
7760865|NCT00745849|26980598|P2|First Intervention|Withdrawal by Subject|1
7760866|NCT00745849|26980599|P1|First Intervention|Withdrawal by Subject|0
7760867|NCT00745823|26980607|P2|Overall Study|Study Terminated by Sponsor|349
7760868|NCT00745823|26980608|P1|Overall Study|Study Terminated by Sponsor|326
7760869|NCT00745823|26980607|P2|Overall Study|Withdrawal by Subject|8
7760870|NCT00745823|26980608|P1|Overall Study|Withdrawal by Subject|14
7760871|NCT00745823|26980607|P2|Overall Study|Pregnancy|4
7760872|NCT00745823|26980608|P1|Overall Study|Pregnancy|0
7760873|NCT00745823|26980607|P2|Overall Study|Physician Decision|5
7760874|NCT00745823|26980608|P1|Overall Study|Physician Decision|10
7760875|NCT00745823|26980607|P2|Overall Study|Lost to Follow-up|11
7760876|NCT00745823|26980608|P1|Overall Study|Lost to Follow-up|10
7760877|NCT00745823|26980607|P2|Overall Study|Lack of Efficacy|6
7760878|NCT00745823|26980608|P1|Overall Study|Lack of Efficacy|20
7760879|NCT00745823|26980607|P2|Overall Study|Adverse Event|3
7760880|NCT00745823|26980608|P1|Overall Study|Adverse Event|5
7760881|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
7760882|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
7760883|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7760884|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7760885|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7760886|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7760887|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Death|1
7760888|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Death|0
7760889|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Death|0
7760890|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Death|0
7760891|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Death|0
7760892|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Death|0
7760893|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
7760894|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7760895|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7760896|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7760897|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7760898|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7760899|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
7760900|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
7760901|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7760902|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7760903|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7760904|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7760905|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
7760906|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
7760907|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7760908|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7760909|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7760910|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7760911|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
7760912|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
7760913|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7760914|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7760915|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7760916|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7760917|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
7760918|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
7760919|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7760920|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7760921|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7760922|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7760923|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
7760924|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
7760925|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7760926|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7760927|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7760928|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7760929|NCT00745615|26980636|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
7760930|NCT00745615|26980637|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
7760931|NCT00745615|26980638|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7760932|NCT00745615|26980639|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7760933|NCT00745615|26980640|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7760934|NCT00745615|26980641|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7760935|NCT00745615|26980636|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7760936|NCT00745615|26980637|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7760937|NCT00745615|26980638|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7760938|NCT00745615|26980639|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7760939|NCT00745615|26980640|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
7760940|NCT00745615|26980641|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7760941|NCT00745615|26980636|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
7760942|NCT00745615|26980637|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
7760943|NCT00745615|26980638|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
7760944|NCT00745615|26980639|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
7760945|NCT00745615|26980640|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
7760946|NCT00745615|26980641|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
7760947|NCT00745615|26980636|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
7760948|NCT00745615|26980637|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
7760949|NCT00745615|26980638|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
7760950|NCT00745615|26980639|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
7760951|NCT00745615|26980640|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
7760952|NCT00745615|26980641|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
7760953|NCT00745615|26980636|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
7760954|NCT00745615|26980637|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
7760955|NCT00745615|26980638|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
7760956|NCT00745615|26980639|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
7760957|NCT00745615|26980640|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
7760958|NCT00745615|26980641|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
7760959|NCT00745615|26980636|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7760960|NCT00745615|26980637|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7760961|NCT00745615|26980638|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
7760962|NCT00745615|26980639|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7760963|NCT00745615|26980640|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
7760964|NCT00745615|26980641|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
7760965|NCT00745498|26980690|P3|Overall Study|Edophthalmitis after preoperative IVB|0
7760966|NCT00745498|26980691|P2|Overall Study|Edophthalmitis after preoperative IVB|0
7760967|NCT00745498|26980692|P1|Overall Study|Edophthalmitis after preoperative IVB|1
7760968|NCT00745498|26980690|P3|Overall Study|Non-PDR related VH|1
7760969|NCT00745498|26980691|P2|Overall Study|Non-PDR related VH|1
7760970|NCT00745498|26980692|P1|Overall Study|Non-PDR related VH|0
7760971|NCT00745498|26980690|P3|Overall Study|Injection of intravitreal silicone oil o|4
7760972|NCT00745498|26980691|P2|Overall Study|Injection of intravitreal silicone oil o|4
7760973|NCT00745498|26980692|P1|Overall Study|Injection of intravitreal silicone oil o|3
7760974|NCT00745498|26980690|P3|Overall Study|Lost to Follow-up|3
7760975|NCT00745498|26980691|P2|Overall Study|Lost to Follow-up|1
7760976|NCT00745498|26980692|P1|Overall Study|Lost to Follow-up|1
7760977|NCT00745420|26980706|P1|Overall Study|Ineligible|1
7760978|NCT00745368|26980723|P1|Overall Study|Unable to provide sample|3
7760979|NCT00745251|26980745|P2|Overall Study|Withdrawal by Subject|1
7760980|NCT00745251|26980746|P1|Overall Study|Withdrawal by Subject|1
7760981|NCT00745251|26980745|P2|Overall Study|Adverse Event|2
7760982|NCT00745251|26980746|P1|Overall Study|Adverse Event|1
7760983|NCT00745121|26980756|P2|Overall Study|Withdrawal by Subject|2
7760984|NCT00745121|26980757|P1|Overall Study|Withdrawal by Subject|4
7760985|NCT00745121|26980756|P2|Overall Study|Lost to Follow-up|0
7760986|NCT00745121|26980757|P1|Overall Study|Lost to Follow-up|1
7760987|NCT00745121|26980756|P2|Overall Study|Adverse Event|0
7760988|NCT00745121|26980757|P1|Overall Study|Adverse Event|1
7760989|NCT00745121|26980756|P2|Overall Study|Death|0
7760990|NCT00745121|26980757|P1|Overall Study|Death|3
7760991|NCT00745095|26980769|P6|Overall Study|Ineligible due to GFR criteria|28
7760992|NCT00745095|26980770|P5|Overall Study|Ineligible due to GFR criteria|30
7760993|NCT00745095|26980771|P4|Overall Study|Ineligible due to GFR criteria|3
7760994|NCT00745095|26980772|P3|Overall Study|Ineligible due to GFR criteria|3
7760995|NCT00745095|26980773|P2|Overall Study|Ineligible due to GFR criteria|2
7760996|NCT00745095|26980774|P1|Overall Study|Ineligible due to GFR criteria|0
7760997|NCT00745095|26980769|P6|Overall Study|Declined to participate|95
7760998|NCT00745095|26980770|P5|Overall Study|Declined to participate|92
7760999|NCT00745095|26980771|P4|Overall Study|Declined to participate|0
7761000|NCT00745095|26980772|P3|Overall Study|Declined to participate|0
7761001|NCT00745095|26980773|P2|Overall Study|Declined to participate|0
7761002|NCT00745095|26980774|P1|Overall Study|Declined to participate|1
7761003|NCT00744991|26980803|P1|Overall Study|Protocol Entry Criteria Unmet|1
7761004|NCT00744991|26980803|P1|Overall Study|Adverse Event|2
7761005|NCT00744991|26980803|P1|Overall Study|Physician Decision|3
7761006|NCT00744991|26980803|P1|Overall Study|Withdrawal by Subject|8
7761007|NCT00744991|26980803|P1|Overall Study|Progressive Disease|11
7761008|NCT00744978|26980820|P2|Period 2|Adverse Event|1
7761009|NCT00744978|26980821|P1|Period 2|Adverse Event|0
7761010|NCT00744978|26980820|P2|Period 1|Randomized but not Treated|1
7761011|NCT00744978|26980821|P1|Period 1|Randomized but not Treated|1
7761012|NCT00744978|26980820|P2|Period 1|Adverse Event|0
7761013|NCT00744978|26980821|P1|Period 1|Adverse Event|4
7761014|NCT00744978|26980820|P2|Period 1|Other|2
7761015|NCT00744978|26980821|P1|Period 1|Other|0
7761016|NCT00744978|26980820|P2|Period 1|Withdrawal by Subject|2
7761017|NCT00744978|26980821|P1|Period 1|Withdrawal by Subject|0
7761018|NCT00744978|26980820|P2|Period 1|Lost to Follow-up|0
7761019|NCT00744978|26980821|P1|Period 1|Lost to Follow-up|1
7761020|NCT00744939|26980902|P1|Overall Study|incorrect race|1
7761021|NCT00744939|26980902|P1|Overall Study|coma|1
7761022|NCT00744939|26980902|P1|Overall Study|Failed inclusion/exclusion criteria|19
7761023|NCT00744939|26980902|P1|Overall Study|Did not receive Magnevist|7
7761024|NCT00744939|26980902|P1|Overall Study|Medical history exclusionary|1
7761025|NCT00744939|26980902|P1|Overall Study|Lost to Follow-up|12
7761026|NCT00744939|26980902|P1|Overall Study|distance|4
7761027|NCT00744939|26980902|P1|Overall Study|Death|24
7761028|NCT00744939|26980902|P1|Overall Study|Protocol Violation|13
7761029|NCT00744939|26980902|P1|Overall Study|Withdrawal by Subject|9
7761030|NCT00744874|26980938|P1|Overall Study|Unable to accomodate schedule|1
7761031|NCT00744874|26980938|P1|Overall Study|Study Device not available at procedure|1
7761032|NCT00744874|26980938|P1|Overall Study|Withdrawal by Subject|1
7761033|NCT00744874|26980938|P1|Overall Study|Lost to Follow-up|1
7761034|NCT00744861|26980958|P4|Pivotal Stage 2|Study Terminated by Sponsor|63
7761035|NCT00744861|26980959|P3|Pivotal Stage 2|Study Terminated by Sponsor|60
7761036|NCT00744861|26980960|P2|Pivotal Stage 2|Study Terminated by Sponsor|0
7761037|NCT00744861|26980961|P1|Pivotal Stage 2|Study Terminated by Sponsor|0
7761038|NCT00744861|26980958|P4|Pivotal Stage 2|Withdrawal by Subject|14
7761039|NCT00744861|26980959|P3|Pivotal Stage 2|Withdrawal by Subject|20
7761040|NCT00744861|26980960|P2|Pivotal Stage 2|Withdrawal by Subject|0
7761041|NCT00744861|26980961|P1|Pivotal Stage 2|Withdrawal by Subject|0
7761042|NCT00744861|26980958|P4|Pivotal Stage 2|Protocol Violation|1
7761043|NCT00744861|26980959|P3|Pivotal Stage 2|Protocol Violation|0
7761044|NCT00744861|26980960|P2|Pivotal Stage 2|Protocol Violation|0
7761045|NCT00744861|26980961|P1|Pivotal Stage 2|Protocol Violation|0
7761046|NCT00744861|26980958|P4|Pivotal Stage 2|Physician Decision|1
7761047|NCT00744861|26980959|P3|Pivotal Stage 2|Physician Decision|3
7761048|NCT00744861|26980960|P2|Pivotal Stage 2|Physician Decision|0
7761049|NCT00744861|26980961|P1|Pivotal Stage 2|Physician Decision|0
7761050|NCT00744861|26980958|P4|Pivotal Stage 2|Lost to Follow-up|14
7761051|NCT00744861|26980959|P3|Pivotal Stage 2|Lost to Follow-up|13
7761052|NCT00744861|26980960|P2|Pivotal Stage 2|Lost to Follow-up|0
7761053|NCT00744861|26980961|P1|Pivotal Stage 2|Lost to Follow-up|0
7761054|NCT00744861|26980958|P4|Pivotal Stage 2|Death|1
7761055|NCT00744861|26980959|P3|Pivotal Stage 2|Death|0
7761056|NCT00744861|26980960|P2|Pivotal Stage 2|Death|0
7761057|NCT00744861|26980961|P1|Pivotal Stage 2|Death|0
7761058|NCT00744861|26980958|P4|Pivotal Stage 2|Adverse Event|11
7761059|NCT00744861|26980959|P3|Pivotal Stage 2|Adverse Event|6
7761060|NCT00744861|26980960|P2|Pivotal Stage 2|Adverse Event|0
7761061|NCT00744861|26980961|P1|Pivotal Stage 2|Adverse Event|0
7761062|NCT00744861|26980958|P4|Feasibility Stage 1|Pregnancy|0
7761063|NCT00744861|26980959|P3|Feasibility Stage 1|Pregnancy|0
7761064|NCT00744861|26980960|P2|Feasibility Stage 1|Pregnancy|1
7761065|NCT00744861|26980961|P1|Feasibility Stage 1|Pregnancy|0
7761066|NCT00744861|26980958|P4|Feasibility Stage 1|Withdrawal by Subject|0
7761067|NCT00744861|26980959|P3|Feasibility Stage 1|Withdrawal by Subject|0
7761068|NCT00744861|26980960|P2|Feasibility Stage 1|Withdrawal by Subject|1
7761069|NCT00744861|26980961|P1|Feasibility Stage 1|Withdrawal by Subject|1
7761070|NCT00744796|26980978|P1|Post-Operative 6-9 Months|Lost to Follow-up|12
7761071|NCT00744757|26980984|P1|Overall Study|Adverse Event|2
7761072|NCT00744757|26980984|P1|Overall Study|Death|6
7761073|NCT00744757|26980984|P1|Overall Study|Withdrawal by Subject|1
7761074|NCT00744757|26980984|P1|Overall Study|Physician Decision|5
7761075|NCT00744757|26980984|P1|Overall Study|Objective disease progression|7
7761076|NCT00744653|26981009|P1|Overall Study|Physician Decision|3
7761077|NCT00744653|26981009|P1|Overall Study|Lost to Follow-up|1
7761078|NCT00744653|26981009|P1|Overall Study|Death|1
7761079|NCT00744653|26981009|P1|Overall Study|antineoplastic treatment|11
7761080|NCT00744627|26981017|P2|Overall Study|Other|0
7761081|NCT00744627|26981018|P1|Overall Study|Other|1
7761082|NCT00744627|26981017|P2|Overall Study|Lost to Follow-up|1
7761083|NCT00744627|26981018|P1|Overall Study|Lost to Follow-up|2
7761084|NCT00744627|26981017|P2|Overall Study|Voluntary Withdrawal|6
7761085|NCT00744627|26981018|P1|Overall Study|Voluntary Withdrawal|9
7761086|NCT00744627|26981017|P2|Overall Study|Protocol Deviations|2
7761087|NCT00744627|26981018|P1|Overall Study|Protocol Deviations|0
7761088|NCT00744627|26981017|P2|Overall Study|Noncompliance|1
7761089|NCT00744627|26981018|P1|Overall Study|Noncompliance|0
7761090|NCT00744627|26981017|P2|Overall Study|Lack of Efficacy|3
7761091|NCT00744627|26981018|P1|Overall Study|Lack of Efficacy|7
7761092|NCT00744627|26981017|P2|Overall Study|Adverse Event|9
7761093|NCT00744627|26981018|P1|Overall Study|Adverse Event|6
7761094|NCT00744523|26981074|P2|30 Days After the Procedure|Insufficient follow-up|5
7761095|NCT00744523|26981075|P1|30 Days After the Procedure|Insufficient follow-up|0
7761096|NCT00744497|26981095|P2|Overall Study|Not defined|13
7761097|NCT00744497|26981096|P1|Overall Study|Not defined|19
7761098|NCT00744497|26981095|P2|Overall Study|Maximum clinical benefit|142
7761099|NCT00744497|26981096|P1|Overall Study|Maximum clinical benefit|141
7761100|NCT00744497|26981095|P2|Overall Study|Patient requested to stop study drug|80
7761101|NCT00744497|26981096|P1|Overall Study|Patient requested to stop study drug|65
7761102|NCT00744497|26981095|P2|Overall Study|Adverse event unrelated to study drug|122
7761103|NCT00744497|26981096|P1|Overall Study|Adverse event unrelated to study drug|78
7761104|NCT00744497|26981095|P2|Overall Study|Study drug toxicity|141
7761105|NCT00744497|26981096|P1|Overall Study|Study drug toxicity|68
7761106|NCT00744497|26981095|P2|Overall Study|Disease progression|219
7761107|NCT00744497|26981096|P1|Overall Study|Disease progression|312
7761108|NCT00744497|26981095|P2|Overall Study|Administrative Reason By Sponsor|8
7761109|NCT00744497|26981096|P1|Overall Study|Administrative Reason By Sponsor|25
7761110|NCT00744497|26981095|P2|Overall Study|No longer meets study criteria|3
7761111|NCT00744497|26981096|P1|Overall Study|No longer meets study criteria|7
7761112|NCT00744497|26981095|P2|Overall Study|Poor compliance/noncompliance|5
7761113|NCT00744497|26981096|P1|Overall Study|Poor compliance/noncompliance|9
7761114|NCT00744497|26981095|P2|Overall Study|Lost to Follow-up|2
7761115|NCT00744497|26981096|P1|Overall Study|Lost to Follow-up|4
7761116|NCT00744497|26981095|P2|Overall Study|Death|9
7761117|NCT00744497|26981096|P1|Overall Study|Death|11
7761118|NCT00744497|26981095|P2|Overall Study|Withdrawal by Subject|18
7761119|NCT00744497|26981096|P1|Overall Study|Withdrawal by Subject|21
7761120|NCT00744471|26981134|P4|Overall Study|Lost to Follow-up|0
7761121|NCT00744471|26981135|P3|Overall Study|Lost to Follow-up|2
7761122|NCT00744471|26981136|P2|Overall Study|Lost to Follow-up|0
7761123|NCT00744471|26981137|P1|Overall Study|Lost to Follow-up|0
7761124|NCT00744471|26981134|P4|Overall Study|Lack of Efficacy|31
7761125|NCT00744471|26981135|P3|Overall Study|Lack of Efficacy|19
7761126|NCT00744471|26981136|P2|Overall Study|Lack of Efficacy|37
7761127|NCT00744471|26981137|P1|Overall Study|Lack of Efficacy|83
7761128|NCT00744471|26981134|P4|Overall Study|Other|2
7761129|NCT00744471|26981135|P3|Overall Study|Other|6
7761130|NCT00744471|26981136|P2|Overall Study|Other|3
7761131|NCT00744471|26981137|P1|Overall Study|Other|2
7761132|NCT00744471|26981134|P4|Overall Study|Entered extension study|91
7761133|NCT00744471|26981135|P3|Overall Study|Entered extension study|100
7761134|NCT00744471|26981136|P2|Overall Study|Entered extension study|84
7761135|NCT00744471|26981137|P1|Overall Study|Entered extension study|41
7761136|NCT00744471|26981134|P4|Overall Study|Protocol Violation|2
7761137|NCT00744471|26981135|P3|Overall Study|Protocol Violation|1
7761138|NCT00744471|26981136|P2|Overall Study|Protocol Violation|4
7761139|NCT00744471|26981137|P1|Overall Study|Protocol Violation|1
7761140|NCT00744471|26981134|P4|Overall Study|Withdrawal by Subject|12
7761141|NCT00744471|26981135|P3|Overall Study|Withdrawal by Subject|15
7761142|NCT00744471|26981136|P2|Overall Study|Withdrawal by Subject|9
7761143|NCT00744471|26981137|P1|Overall Study|Withdrawal by Subject|9
7761144|NCT00744471|26981134|P4|Overall Study|Adverse Event|9
7761145|NCT00744471|26981135|P3|Overall Study|Adverse Event|5
7761146|NCT00744471|26981136|P2|Overall Study|Adverse Event|7
7761147|NCT00744471|26981137|P1|Overall Study|Adverse Event|6
7761148|NCT00744471|26981134|P4|Overall Study|Death|1
7761149|NCT00744471|26981135|P3|Overall Study|Death|0
7761150|NCT00744471|26981136|P2|Overall Study|Death|0
7761151|NCT00744471|26981137|P1|Overall Study|Death|0
7761152|NCT00744471|26981134|P4|Overall Study|Randomized but not treated|0
7761153|NCT00744471|26981135|P3|Overall Study|Randomized but not treated|4
7761154|NCT00744471|26981136|P2|Overall Study|Randomized but not treated|1
7761155|NCT00744471|26981137|P1|Overall Study|Randomized but not treated|1
7761156|NCT00744328|26981289|P3|Overall Study|Found ineligible after randomization|1
7761157|NCT00744328|26981290|P2|Overall Study|Found ineligible after randomization|0
7761158|NCT00744328|26981291|P1|Overall Study|Found ineligible after randomization|0
7761159|NCT00744328|26981289|P3|Overall Study|Withdrawal by Subject|4
7761160|NCT00744328|26981290|P2|Overall Study|Withdrawal by Subject|3
7761161|NCT00744328|26981291|P1|Overall Study|Withdrawal by Subject|5
7761162|NCT00744328|26981289|P3|Overall Study|Lost to Follow-up|3
7761163|NCT00744328|26981290|P2|Overall Study|Lost to Follow-up|5
7761164|NCT00744328|26981291|P1|Overall Study|Lost to Follow-up|2
7761165|NCT00744263|26981304|P2|Overall Study|Other|2
7761166|NCT00744263|26981305|P1|Overall Study|Other|2
7761167|NCT00744263|26981304|P2|Overall Study|Adverse Event|0
7761168|NCT00744263|26981305|P1|Overall Study|Adverse Event|1
7761169|NCT00744263|26981304|P2|Overall Study|Protocol Violation|5
7761170|NCT00744263|26981305|P1|Overall Study|Protocol Violation|3
7761171|NCT00744263|26981304|P2|Overall Study|Physician Decision|23
7761172|NCT00744263|26981305|P1|Overall Study|Physician Decision|20
7761173|NCT00744263|26981304|P2|Overall Study|Withdrawal by Subject|150
7761174|NCT00744263|26981305|P1|Overall Study|Withdrawal by Subject|166
7761175|NCT00744263|26981304|P2|Overall Study|Lost to Follow-up|2135
7761176|NCT00744263|26981305|P1|Overall Study|Lost to Follow-up|2038
7761177|NCT00744263|26981304|P2|Overall Study|Death|3005
7761178|NCT00744263|26981305|P1|Overall Study|Death|3006
7761179|NCT00744237|26981328|P3|Overall Study|Adverse Event|5
7761180|NCT00744237|26981329|P2|Overall Study|Adverse Event|13
7761181|NCT00744237|26981330|P1|Overall Study|Adverse Event|9
7761182|NCT00744237|26981328|P3|Overall Study|Administrative. Site Closed|1
7761183|NCT00744237|26981329|P2|Overall Study|Administrative. Site Closed|1
7761184|NCT00744237|26981330|P1|Overall Study|Administrative. Site Closed|1
7761185|NCT00744237|26981328|P3|Overall Study|Poor Compliance|0
7761186|NCT00744237|26981329|P2|Overall Study|Poor Compliance|2
7761187|NCT00744237|26981330|P1|Overall Study|Poor Compliance|0
7761188|NCT00744237|26981328|P3|Overall Study|Prohibited Concomitant Medication|1
7761189|NCT00744237|26981329|P2|Overall Study|Prohibited Concomitant Medication|0
7761190|NCT00744237|26981330|P1|Overall Study|Prohibited Concomitant Medication|0
7761191|NCT00744237|26981328|P3|Overall Study|Study Drug Error|0
7761192|NCT00744237|26981329|P2|Overall Study|Study Drug Error|0
7761193|NCT00744237|26981330|P1|Overall Study|Study Drug Error|1
7761194|NCT00744237|26981328|P3|Overall Study|Dosing Error|1
7761195|NCT00744237|26981329|P2|Overall Study|Dosing Error|0
7761196|NCT00744237|26981330|P1|Overall Study|Dosing Error|1
7761197|NCT00744237|26981328|P3|Overall Study|Inclusion/Exclusion criteria not met|0
7761198|NCT00744237|26981329|P2|Overall Study|Inclusion/Exclusion criteria not met|0
7761199|NCT00744237|26981330|P1|Overall Study|Inclusion/Exclusion criteria not met|1
7761200|NCT00744237|26981328|P3|Overall Study|Protocol Violation|3
7761201|NCT00744237|26981329|P2|Overall Study|Protocol Violation|4
7761202|NCT00744237|26981330|P1|Overall Study|Protocol Violation|3
7761203|NCT00744237|26981328|P3|Overall Study|Lost to Follow-up|1
7761204|NCT00744237|26981329|P2|Overall Study|Lost to Follow-up|1
7761205|NCT00744237|26981330|P1|Overall Study|Lost to Follow-up|1
7761206|NCT00744237|26981328|P3|Overall Study|Withdrawal by Subject|3
7761207|NCT00744237|26981329|P2|Overall Study|Withdrawal by Subject|5
7761208|NCT00744237|26981330|P1|Overall Study|Withdrawal by Subject|9
7761209|NCT00744237|26981328|P3|Overall Study|Lack of Efficacy|0
7761210|NCT00744237|26981329|P2|Overall Study|Lack of Efficacy|1
7761211|NCT00744237|26981330|P1|Overall Study|Lack of Efficacy|1
7761212|NCT00744055|26981364|P2|Overall Study|Lost to Follow-up|1
7761213|NCT00744055|26981365|P1|Overall Study|Lost to Follow-up|0
7761214|NCT00744055|26981364|P2|Overall Study|Protocol Violation|1
7761215|NCT00744055|26981365|P1|Overall Study|Protocol Violation|1
7761216|NCT00744055|26981364|P2|Overall Study|Physician Decision|2
7761217|NCT00744055|26981365|P1|Overall Study|Physician Decision|0
7761218|NCT00744055|26981364|P2|Overall Study|Lack of Efficacy|1
7761219|NCT00744055|26981365|P1|Overall Study|Lack of Efficacy|0
7761220|NCT00744055|26981364|P2|Overall Study|Withdrawal by Subject|9
7761221|NCT00744055|26981365|P1|Overall Study|Withdrawal by Subject|6
7761222|NCT00744042|26981373|P1|Overall Study|Withdrawal by Subject|1
7761223|NCT00743652|26981419|P5|Overall Study|Lost to Follow-up|0
7761224|NCT00743652|26981420|P4|Overall Study|Lost to Follow-up|0
7761225|NCT00743652|26981421|P3|Overall Study|Lost to Follow-up|0
7761226|NCT00743652|26981422|P2|Overall Study|Lost to Follow-up|0
7761227|NCT00743652|26981423|P1|Overall Study|Lost to Follow-up|1
7761228|NCT00743652|26981419|P5|Overall Study|Other|0
7761229|NCT00743652|26981420|P4|Overall Study|Other|0
7761230|NCT00743652|26981421|P3|Overall Study|Other|0
7761231|NCT00743652|26981422|P2|Overall Study|Other|1
7761232|NCT00743652|26981423|P1|Overall Study|Other|1
7761233|NCT00743652|26981419|P5|Overall Study|Investigator Request|0
7761234|NCT00743652|26981420|P4|Overall Study|Investigator Request|2
7761235|NCT00743652|26981421|P3|Overall Study|Investigator Request|0
7761236|NCT00743652|26981422|P2|Overall Study|Investigator Request|0
7761237|NCT00743652|26981423|P1|Overall Study|Investigator Request|0
7761238|NCT00743652|26981419|P5|Overall Study|Death|0
7761239|NCT00743652|26981420|P4|Overall Study|Death|0
7761240|NCT00743652|26981421|P3|Overall Study|Death|0
7761241|NCT00743652|26981422|P2|Overall Study|Death|0
7761242|NCT00743652|26981423|P1|Overall Study|Death|2
7761243|NCT00743652|26981419|P5|Overall Study|Adverse Event|0
7761244|NCT00743652|26981420|P4|Overall Study|Adverse Event|0
7761245|NCT00743652|26981421|P3|Overall Study|Adverse Event|0
7761246|NCT00743652|26981422|P2|Overall Study|Adverse Event|0
7761247|NCT00743652|26981423|P1|Overall Study|Adverse Event|3
7761248|NCT00743652|26981419|P5|Overall Study|Parent/Legal Guardian Request|0
7761249|NCT00743652|26981420|P4|Overall Study|Parent/Legal Guardian Request|2
7761250|NCT00743652|26981421|P3|Overall Study|Parent/Legal Guardian Request|2
7761251|NCT00743652|26981422|P2|Overall Study|Parent/Legal Guardian Request|2
7761252|NCT00743652|26981423|P1|Overall Study|Parent/Legal Guardian Request|3
7761253|NCT00743509|26981507|P1|Overall Study|Withdrawal by Subject|2
7761254|NCT00743483|26981512|P1|Treatment Period|Adverse Event|1
7761255|NCT00743483|26981512|P1|Baseline Period|Physician Decision|1
7761256|NCT00743444|26981516|P2|Washout Period|Adverse Event|1
7761257|NCT00743444|26981517|P1|Washout Period|Adverse Event|0
7761258|NCT00743444|26981516|P2|First Intervention|Catheter placement problems|1
7761259|NCT00743444|26981517|P1|First Intervention|Catheter placement problems|0
7761260|NCT00743431|26981526|P1|Overall Study|No documentation available|13
7761261|NCT00743431|26981526|P1|Overall Study|Reason for discontinuation not specified|29
7761262|NCT00743431|26981526|P1|Overall Study|Death|9
7761263|NCT00743431|26981526|P1|Overall Study|Withdrawal by Subject|13
7761264|NCT00743431|26981526|P1|Overall Study|Tumor progression|56
7761265|NCT00743431|26981526|P1|Overall Study|Toxicity|6
7761266|NCT00743366|26981530|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
7761267|NCT00743366|26981531|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
7761268|NCT00743340|26981537|P1|Overall Study|Participant Relocated|1
7761269|NCT00743340|26981537|P1|Overall Study|Rolled over to other Gilead Study|23
7761270|NCT00743340|26981537|P1|Overall Study|Pregnancy|1
7761271|NCT00743340|26981537|P1|Overall Study|Virologic failure|8
7761272|NCT00743340|26981537|P1|Overall Study|Protocol Violation|1
7761273|NCT00743340|26981537|P1|Overall Study|Withdrawal from the Study|5
7761274|NCT00743340|26981537|P1|Overall Study|Lost to Follow-up|1
7761275|NCT00743340|26981537|P1|Overall Study|Study medication non-compliance|1
7761276|NCT00743288|26981541|P7|Overall Study|Worsening of condition (Not PD)|0
7761277|NCT00743288|26981542|P6|Overall Study|Worsening of condition (Not PD)|0
7761278|NCT00743288|26981543|P5|Overall Study|Worsening of condition (Not PD)|0
7761279|NCT00743288|26981544|P4|Overall Study|Worsening of condition (Not PD)|1
7761280|NCT00743288|26981545|P3|Overall Study|Worsening of condition (Not PD)|1
7761281|NCT00743288|26981546|P2|Overall Study|Worsening of condition (Not PD)|2
7761282|NCT00743288|26981547|P1|Overall Study|Worsening of condition (Not PD)|0
7761283|NCT00743288|26981541|P7|Overall Study|Progressive disease (PD)|6
7761284|NCT00743288|26981542|P6|Overall Study|Progressive disease (PD)|3
7761285|NCT00743288|26981543|P5|Overall Study|Progressive disease (PD)|5
7761286|NCT00743288|26981544|P4|Overall Study|Progressive disease (PD)|4
7761287|NCT00743288|26981545|P3|Overall Study|Progressive disease (PD)|1
7761288|NCT00743288|26981546|P2|Overall Study|Progressive disease (PD)|0
7761289|NCT00743288|26981547|P1|Overall Study|Progressive disease (PD)|2
7761290|NCT00743288|26981541|P7|Overall Study|Withdrawal by Subject|1
7761291|NCT00743288|26981542|P6|Overall Study|Withdrawal by Subject|1
7761292|NCT00743288|26981543|P5|Overall Study|Withdrawal by Subject|0
7761293|NCT00743288|26981544|P4|Overall Study|Withdrawal by Subject|0
7761294|NCT00743288|26981545|P3|Overall Study|Withdrawal by Subject|1
7761295|NCT00743288|26981546|P2|Overall Study|Withdrawal by Subject|0
7761296|NCT00743288|26981547|P1|Overall Study|Withdrawal by Subject|0
7761297|NCT00743288|26981541|P7|Overall Study|Adverse Event|2
7761298|NCT00743288|26981542|P6|Overall Study|Adverse Event|1
7761299|NCT00743288|26981543|P5|Overall Study|Adverse Event|1
7761300|NCT00743288|26981544|P4|Overall Study|Adverse Event|2
7761301|NCT00743288|26981545|P3|Overall Study|Adverse Event|2
7761302|NCT00743288|26981546|P2|Overall Study|Adverse Event|1
7761303|NCT00743288|26981547|P1|Overall Study|Adverse Event|1
7761304|NCT00743275|26981561|P2|Overall Study|Protocol Violation|1
7761305|NCT00743275|26981562|P1|Overall Study|Protocol Violation|0
7761306|NCT00743249|26981582|P2|Overall Study|Unsuccessful insertion of stent|1
7761307|NCT00743249|26981583|P1|Overall Study|Unsuccessful insertion of stent|2
7761308|NCT00743249|26981582|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
7761309|NCT00743249|26981583|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
7761310|NCT00743249|26981582|P2|Overall Study|Adverse Event|4
7761311|NCT00743249|26981583|P1|Overall Study|Adverse Event|0
7761312|NCT00743197|26981593|P2|Overall Study|Study terminated due to departure of PI.|2
7761313|NCT00743197|26981594|P1|Overall Study|Study terminated due to departure of PI.|1
7761314|NCT00743145|26981600|P1|Overall Study|Pregnancy|1
7761315|NCT00743145|26981600|P1|Overall Study|Adverse Event|2
7761316|NCT00743145|26981600|P1|Overall Study|Withdrawal by Subject|1
7761317|NCT00743119|26981614|P1|Overall Study|Withdrawal by Subject|1
7761318|NCT00743119|26981614|P1|Overall Study|unreliable|3
7761319|NCT00743106|26981628|P2|Overall Study|Met intraoperative exclusion criterion|5
7761320|NCT00743106|26981629|P1|Overall Study|Met intraoperative exclusion criterion|8
7761321|NCT00742924|26981656|P4|Overall Study|Withdrawal by Subject|0
7761322|NCT00742924|26981657|P3|Overall Study|Withdrawal by Subject|1
7761323|NCT00742924|26981658|P2|Overall Study|Withdrawal by Subject|1
7761324|NCT00742924|26981659|P1|Overall Study|Withdrawal by Subject|0
7761325|NCT00742924|26981656|P4|Overall Study|Physician Decision|1
7761326|NCT00742924|26981657|P3|Overall Study|Physician Decision|0
7761327|NCT00742924|26981658|P2|Overall Study|Physician Decision|0
7761328|NCT00742924|26981659|P1|Overall Study|Physician Decision|0
7761329|NCT00742924|26981656|P4|Overall Study|Lack of Efficacy|4
7761330|NCT00742924|26981657|P3|Overall Study|Lack of Efficacy|2
7761331|NCT00742924|26981658|P2|Overall Study|Lack of Efficacy|1
7761332|NCT00742924|26981659|P1|Overall Study|Lack of Efficacy|5
7761333|NCT00742924|26981656|P4|Overall Study|Adverse Event|1
7761334|NCT00742924|26981657|P3|Overall Study|Adverse Event|1
7761335|NCT00742924|26981658|P2|Overall Study|Adverse Event|0
7761336|NCT00742924|26981659|P1|Overall Study|Adverse Event|0
7761337|NCT00742885|26981671|P2|Overall Study|Lost to Follow-up|0
7761338|NCT00742885|26981672|P1|Overall Study|Lost to Follow-up|1
7761339|NCT00742859|26981731|P4|Overall Study|Site error|1
7761340|NCT00742859|26981732|P3|Overall Study|Site error|1
7761341|NCT00742859|26981733|P2|Overall Study|Site error|0
7761342|NCT00742859|26981734|P1|Overall Study|Site error|0
7761343|NCT00742859|26981731|P4|Overall Study|Sponsor request patient out of town|1
7761344|NCT00742859|26981732|P3|Overall Study|Sponsor request patient out of town|1
7761345|NCT00742859|26981733|P2|Overall Study|Sponsor request patient out of town|0
7761346|NCT00742859|26981734|P1|Overall Study|Sponsor request patient out of town|0
7761347|NCT00742859|26981731|P4|Overall Study|Sponsor req visit schedule noncompliance|1
7761348|NCT00742859|26981732|P3|Overall Study|Sponsor req visit schedule noncompliance|0
7761349|NCT00742859|26981733|P2|Overall Study|Sponsor req visit schedule noncompliance|0
7761350|NCT00742859|26981734|P1|Overall Study|Sponsor req visit schedule noncompliance|0
7761351|NCT00742859|26981731|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
7761352|NCT00742859|26981732|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
7761353|NCT00742859|26981733|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
7761354|NCT00742859|26981734|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
7761355|NCT00742859|26981731|P4|Overall Study|Endpoint|2
7761356|NCT00742859|26981732|P3|Overall Study|Endpoint|1
7761357|NCT00742859|26981733|P2|Overall Study|Endpoint|1
7761358|NCT00742859|26981734|P1|Overall Study|Endpoint|0
7761359|NCT00742859|26981731|P4|Overall Study|Withdrawal by Subject|1
7761360|NCT00742859|26981732|P3|Overall Study|Withdrawal by Subject|4
7761361|NCT00742859|26981733|P2|Overall Study|Withdrawal by Subject|2
7761362|NCT00742859|26981734|P1|Overall Study|Withdrawal by Subject|4
7761363|NCT00742859|26981731|P4|Overall Study|Physician Decision|0
7761364|NCT00742859|26981732|P3|Overall Study|Physician Decision|0
7761365|NCT00742859|26981733|P2|Overall Study|Physician Decision|2
7761366|NCT00742859|26981734|P1|Overall Study|Physician Decision|1
7761367|NCT00742859|26981731|P4|Overall Study|Death|1
7761368|NCT00742859|26981732|P3|Overall Study|Death|0
7761369|NCT00742859|26981733|P2|Overall Study|Death|0
7761370|NCT00742859|26981734|P1|Overall Study|Death|1
7761371|NCT00742859|26981731|P4|Overall Study|Adverse Event|1
7761372|NCT00742859|26981732|P3|Overall Study|Adverse Event|3
7761373|NCT00742859|26981733|P2|Overall Study|Adverse Event|6
7761374|NCT00742859|26981734|P1|Overall Study|Adverse Event|5
7761375|NCT00742781|26981748|P1|Overall Study|Withdrawal by Subject|3
7761376|NCT00742625|26981757|P1|Consolidation|Non protocol therapy|13
7761377|NCT00742625|26981757|P1|Consolidation|Refused|1
7761378|NCT00742625|26981757|P1|Consolidation|Death|1
7761379|NCT00742625|26981757|P1|Consolidation|Adverse Event|1
7761380|NCT00742625|26981757|P1|Consolidation|Progression|5
7761381|NCT00742625|26981757|P1|Remission Induction|Other, not specified|5
7761382|NCT00742625|26981757|P1|Remission Induction|Non protocol treatment|17
7761383|NCT00742625|26981757|P1|Remission Induction|Refusal|5
7761384|NCT00742625|26981757|P1|Remission Induction|Death|10
7761385|NCT00742625|26981757|P1|Remission Induction|Adverse Event|3
7761386|NCT00742625|26981757|P1|Remission Induction|Failed induction|8
7761387|NCT00742625|26981757|P1|Remission Induction|Progression|6
7761388|NCT00742560|26981782|P5|Overall Study|MIssing|1
7761389|NCT00742560|26981783|P4|Overall Study|MIssing|0
7761390|NCT00742560|26981784|P3|Overall Study|MIssing|0
7761391|NCT00742560|26981785|P2|Overall Study|MIssing|0
7761392|NCT00742560|26981786|P1|Overall Study|MIssing|0
7761393|NCT00742560|26981782|P5|Overall Study|Other|9
7761394|NCT00742560|26981783|P4|Overall Study|Other|9
7761395|NCT00742560|26981784|P3|Overall Study|Other|8
7761396|NCT00742560|26981785|P2|Overall Study|Other|1
7761397|NCT00742560|26981786|P1|Overall Study|Other|0
7761398|NCT00742560|26981782|P5|Overall Study|New Multiple Myeloma Therapy|4
7761399|NCT00742560|26981783|P4|Overall Study|New Multiple Myeloma Therapy|3
7761400|NCT00742560|26981784|P3|Overall Study|New Multiple Myeloma Therapy|2
7761401|NCT00742560|26981785|P2|Overall Study|New Multiple Myeloma Therapy|0
7761402|NCT00742560|26981786|P1|Overall Study|New Multiple Myeloma Therapy|1
7761403|NCT00742560|26981782|P5|Overall Study|Disease Progression|16
7761404|NCT00742560|26981783|P4|Overall Study|Disease Progression|17
7761405|NCT00742560|26981784|P3|Overall Study|Disease Progression|5
7761406|NCT00742560|26981785|P2|Overall Study|Disease Progression|0
7761407|NCT00742560|26981786|P1|Overall Study|Disease Progression|1
7761408|NCT00742560|26981782|P5|Overall Study|Investigator's Decision|0
7761409|NCT00742560|26981783|P4|Overall Study|Investigator's Decision|1
7761410|NCT00742560|26981784|P3|Overall Study|Investigator's Decision|4
7761411|NCT00742560|26981785|P2|Overall Study|Investigator's Decision|0
7761412|NCT00742560|26981786|P1|Overall Study|Investigator's Decision|0
7761413|NCT00742560|26981782|P5|Overall Study|Subject's Decision|3
7761414|NCT00742560|26981783|P4|Overall Study|Subject's Decision|3
7761415|NCT00742560|26981784|P3|Overall Study|Subject's Decision|2
7761416|NCT00742560|26981785|P2|Overall Study|Subject's Decision|0
7761417|NCT00742560|26981786|P1|Overall Study|Subject's Decision|1
7761418|NCT00742560|26981782|P5|Overall Study|Death|3
7761419|NCT00742560|26981783|P4|Overall Study|Death|2
7761420|NCT00742560|26981784|P3|Overall Study|Death|0
7761421|NCT00742560|26981785|P2|Overall Study|Death|2
7761422|NCT00742560|26981786|P1|Overall Study|Death|0
7761423|NCT00742560|26981782|P5|Overall Study|Adverse Event|1
7761424|NCT00742560|26981783|P4|Overall Study|Adverse Event|1
7761425|NCT00742560|26981784|P3|Overall Study|Adverse Event|1
7761426|NCT00742560|26981785|P2|Overall Study|Adverse Event|0
7761427|NCT00742560|26981786|P1|Overall Study|Adverse Event|0
7761428|NCT00742508|26981860|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
7761429|NCT00742508|26981861|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
7761430|NCT00742508|26981860|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
7761431|NCT00742508|26981861|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
7761432|NCT00742508|26981860|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
7761433|NCT00742508|26981861|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
7761434|NCT00742508|26981860|P2|8-Week Primary Evaluation Period|Protocol Violation|0
7761435|NCT00742508|26981861|P1|8-Week Primary Evaluation Period|Protocol Violation|1
7761436|NCT00742508|26981860|P2|8-Week Primary Evaluation Period|Adverse Event|4
7761437|NCT00742508|26981861|P1|8-Week Primary Evaluation Period|Adverse Event|2
7761438|NCT00742417|26981934|P2|Intensive Period|Adverse Event|0
7761439|NCT00742417|26981935|P1|Intensive Period|Adverse Event|2
7761440|NCT00742417|26981934|P2|Intensive Period|Withdrawal by Subject|1
7761441|NCT00742417|26981935|P1|Intensive Period|Withdrawal by Subject|1
7761442|NCT00742417|26981934|P2|Randomized|Physician Decision|0
7761443|NCT00742417|26981935|P1|Randomized|Physician Decision|1
7761444|NCT00742417|26981934|P2|Randomized|Withdrawal by Subject|0
7761445|NCT00742417|26981935|P1|Randomized|Withdrawal by Subject|1
7761446|NCT00742417|26981934|P2|Randomized|Withdrawal by legal representative|1
7761447|NCT00742417|26981935|P1|Randomized|Withdrawal by legal representative|0
7761448|NCT00742391|26981959|P2|Overall Study|Protocol Violation|0
7761449|NCT00742391|26981960|P1|Overall Study|Protocol Violation|1
7761450|NCT00742391|26981959|P2|Overall Study|Lost to Follow-up|0
7761451|NCT00742391|26981960|P1|Overall Study|Lost to Follow-up|1
7761452|NCT00742391|26981959|P2|Overall Study|Adverse Event|1
7761453|NCT00742391|26981960|P1|Overall Study|Adverse Event|2
7761454|NCT00742326|26981970|P2|Overall Study|Physician Decision|1
7761455|NCT00742326|26981971|P1|Overall Study|Physician Decision|0
7761456|NCT00742274|26981990|P2|Overall Study|Removed for medical reasons|1
7761457|NCT00742274|26981991|P1|Overall Study|Removed for medical reasons|1
7761458|NCT00742274|26981990|P2|Overall Study|Withdrawal by Subject|2
7761459|NCT00742274|26981991|P1|Overall Study|Withdrawal by Subject|1
7761460|NCT00742274|26981990|P2|Overall Study|Death|0
7761461|NCT00742274|26981991|P1|Overall Study|Death|1
7761462|NCT00742235|26981999|P2|Overall Study|Lost to Follow-up|31
7761463|NCT00742235|26982000|P1|Overall Study|Lost to Follow-up|0
7761464|NCT00742209|26982013|P5|Overall Study|Investigator Discretion|1
7761465|NCT00742209|26982014|P4|Overall Study|Investigator Discretion|1
7761466|NCT00742209|26982015|P3|Overall Study|Investigator Discretion|5
7761467|NCT00742209|26982016|P2|Overall Study|Investigator Discretion|0
7761468|NCT00742209|26982017|P1|Overall Study|Investigator Discretion|0
7761469|NCT00742209|26982013|P5|Overall Study|Lack of Efficacy|1
7761470|NCT00742209|26982014|P4|Overall Study|Lack of Efficacy|3
7761471|NCT00742209|26982015|P3|Overall Study|Lack of Efficacy|1
7761472|NCT00742209|26982016|P2|Overall Study|Lack of Efficacy|1
7761473|NCT00742209|26982017|P1|Overall Study|Lack of Efficacy|6
7761474|NCT00742209|26982013|P5|Overall Study|Lost to Follow-up|3
7761475|NCT00742209|26982014|P4|Overall Study|Lost to Follow-up|5
7761476|NCT00742209|26982015|P3|Overall Study|Lost to Follow-up|5
7761477|NCT00742209|26982016|P2|Overall Study|Lost to Follow-up|4
7761478|NCT00742209|26982017|P1|Overall Study|Lost to Follow-up|3
7761479|NCT00742209|26982013|P5|Overall Study|Protocol Violation|3
7761480|NCT00742209|26982014|P4|Overall Study|Protocol Violation|5
7761481|NCT00742209|26982015|P3|Overall Study|Protocol Violation|4
7761482|NCT00742209|26982016|P2|Overall Study|Protocol Violation|5
7761483|NCT00742209|26982017|P1|Overall Study|Protocol Violation|6
7761484|NCT00742209|26982013|P5|Overall Study|Participant Withdrew Consent|4
7761485|NCT00742209|26982014|P4|Overall Study|Participant Withdrew Consent|7
7761486|NCT00742209|26982015|P3|Overall Study|Participant Withdrew Consent|14
7761487|NCT00742209|26982016|P2|Overall Study|Participant Withdrew Consent|4
7761488|NCT00742209|26982017|P1|Overall Study|Participant Withdrew Consent|8
7761489|NCT00742209|26982013|P5|Overall Study|Adverse Event|13
7761490|NCT00742209|26982014|P4|Overall Study|Adverse Event|16
7761491|NCT00742209|26982015|P3|Overall Study|Adverse Event|17
7761492|NCT00742209|26982016|P2|Overall Study|Adverse Event|4
7761493|NCT00742209|26982017|P1|Overall Study|Adverse Event|11
7761494|NCT00742183|26982120|P2|Overall Study|Lack of Efficacy|3
7761495|NCT00742183|26982121|P1|Overall Study|Lack of Efficacy|0
7761496|NCT00742183|26982120|P2|Overall Study|Withdrawal by Subject|0
7761497|NCT00742183|26982121|P1|Overall Study|Withdrawal by Subject|1
7761498|NCT00742183|26982120|P2|Overall Study|Required skin-graft|1
7761499|NCT00742183|26982121|P1|Overall Study|Required skin-graft|1
7761500|NCT00742183|26982120|P2|Overall Study|Lost to Follow-up|4
7761501|NCT00742183|26982121|P1|Overall Study|Lost to Follow-up|4
7761502|NCT00742183|26982120|P2|Overall Study|Physician Decision|2
7761503|NCT00742183|26982121|P1|Overall Study|Physician Decision|0
7761504|NCT00742183|26982120|P2|Overall Study|Death|0
7761505|NCT00742183|26982121|P1|Overall Study|Death|1
7761506|NCT00742183|26982120|P2|Overall Study|Adverse Event|2
7761507|NCT00742183|26982121|P1|Overall Study|Adverse Event|2
7761508|NCT00742079|26982140|P2|Overall Study|Lost to Follow-up|1
7761509|NCT00742079|26982141|P1|Overall Study|Lost to Follow-up|0
7761510|NCT00742027|26982159|P1|Overall Study|Administrative Problems|1
7761511|NCT00742027|26982159|P1|Overall Study|Missing|2
7761512|NCT00742027|26982159|P1|Overall Study|Follow up Phase Completed As Per Protocol|2
7761513|NCT00742027|26982159|P1|Overall Study|Lost to Follow-up|4
7761514|NCT00742027|26982159|P1|Overall Study|Death|7
7761515|NCT00742027|26982159|P1|Overall Study|Withdrawal by Subject|18
7761516|NCT00742027|26982159|P1|Overall Study|New Cancer Therapy|19
7761517|NCT00742027|26982159|P1|Overall Study|Disease Progression|76
7761518|NCT00742001|26982176|P3|Overall Study|Withdrawn; health exclusion (flu)|1
7761519|NCT00742001|26982177|P2|Overall Study|Withdrawn; health exclusion (flu)|0
7761520|NCT00742001|26982178|P1|Overall Study|Withdrawn; health exclusion (flu)|0
7761521|NCT00741988|26982194|P2|Overall Study|Lack of Efficacy|0
7761522|NCT00741988|26982195|P1|Overall Study|Lack of Efficacy|2
7761523|NCT00741988|26982194|P2|Overall Study|Adverse Event|4
7761524|NCT00741988|26982195|P1|Overall Study|Adverse Event|2
7761525|NCT00741936|26982207|P2|Overall Study|Low compliance|0
7761526|NCT00741936|26982208|P1|Overall Study|Low compliance|3
7761527|NCT00741936|26982207|P2|Overall Study|Lack of Efficacy|2
7761528|NCT00741936|26982208|P1|Overall Study|Lack of Efficacy|0
7761529|NCT00741936|26982207|P2|Overall Study|Protocol Violation|0
7761530|NCT00741936|26982208|P1|Overall Study|Protocol Violation|2
7761531|NCT00741936|26982207|P2|Overall Study|Pregnancy|1
7761532|NCT00741936|26982208|P1|Overall Study|Pregnancy|0
7761533|NCT00741936|26982207|P2|Overall Study|Adverse Event|4
7761534|NCT00741936|26982208|P1|Overall Study|Adverse Event|3
7761535|NCT00741936|26982207|P2|Overall Study|Lost to Follow-up|1
7761536|NCT00741936|26982208|P1|Overall Study|Lost to Follow-up|1
7761537|NCT00741819|26982243|P1|Overall Study|Disease progression|1
7761538|NCT00741819|26982243|P1|Overall Study|Death|1
7761539|NCT00741819|26982243|P1|Overall Study|Withdrawal by Subject|3
7761540|NCT00741819|26982243|P1|Overall Study|Adverse Event|3
7761541|NCT00741611|26982257|P3|Overall Study|Withdrawal by Subject|2
7761542|NCT00741611|26982258|P2|Overall Study|Withdrawal by Subject|2
7761543|NCT00741611|26982259|P1|Overall Study|Withdrawal by Subject|0
7761544|NCT00741611|26982257|P3|Overall Study|Death|1
7761545|NCT00741611|26982258|P2|Overall Study|Death|0
7761546|NCT00741611|26982259|P1|Overall Study|Death|0
7761547|NCT00741598|26982278|P2|Overall Study|Withdrawal by Subject|2
7761548|NCT00741598|26982279|P1|Overall Study|Withdrawal by Subject|3
7761549|NCT00741598|26982278|P2|Overall Study|Pregnancy|0
7761550|NCT00741598|26982279|P1|Overall Study|Pregnancy|1
7761551|NCT00741598|26982278|P2|Overall Study|Physician Decision|1
7761552|NCT00741598|26982279|P1|Overall Study|Physician Decision|1
7761553|NCT00741598|26982278|P2|Overall Study|Lack of Efficacy|2
7761554|NCT00741598|26982279|P1|Overall Study|Lack of Efficacy|1
7761555|NCT00741598|26982278|P2|Overall Study|Lost to Follow-up|4
7761556|NCT00741598|26982279|P1|Overall Study|Lost to Follow-up|3
7761557|NCT00741338|26982334|P2|Overall Study|Adverse Event|1
7761558|NCT00741338|26982335|P1|Overall Study|Adverse Event|0
7761559|NCT00741286|26982345|P2|Overall Study|Primary Outcome|1
7761560|NCT00741286|26982346|P1|Overall Study|Primary Outcome|1
7761561|NCT00741286|26982345|P2|Overall Study|Protocol Violation|2
7761562|NCT00741286|26982346|P1|Overall Study|Protocol Violation|3
7761563|NCT00741286|26982345|P2|Overall Study|Adverse Event|6
7761564|NCT00741286|26982346|P1|Overall Study|Adverse Event|1
7761565|NCT00741286|26982345|P2|Overall Study|Lost to Follow-up|10
7761566|NCT00741286|26982346|P1|Overall Study|Lost to Follow-up|15
7761567|NCT00741260|26982380|P7|Overall Study|Other|1
7761568|NCT00741260|26982381|P6|Overall Study|Other|3
7761569|NCT00741260|26982382|P5|Overall Study|Other|1
7761570|NCT00741260|26982383|P4|Overall Study|Other|2
7761571|NCT00741260|26982384|P3|Overall Study|Other|1
7761572|NCT00741260|26982385|P2|Overall Study|Other|1
7761573|NCT00741260|26982386|P1|Overall Study|Other|2
7761574|NCT00741260|26982380|P7|Overall Study|Physician Decision|0
7761575|NCT00741260|26982381|P6|Overall Study|Physician Decision|0
7761576|NCT00741260|26982382|P5|Overall Study|Physician Decision|0
7761577|NCT00741260|26982383|P4|Overall Study|Physician Decision|0
7761578|NCT00741260|26982384|P3|Overall Study|Physician Decision|0
7761579|NCT00741260|26982385|P2|Overall Study|Physician Decision|1
7761580|NCT00741260|26982386|P1|Overall Study|Physician Decision|1
7761581|NCT00741260|26982380|P7|Overall Study|Withdrawal by Subject|1
7761582|NCT00741260|26982381|P6|Overall Study|Withdrawal by Subject|3
7761583|NCT00741260|26982382|P5|Overall Study|Withdrawal by Subject|1
7761584|NCT00741260|26982383|P4|Overall Study|Withdrawal by Subject|0
7761585|NCT00741260|26982384|P3|Overall Study|Withdrawal by Subject|0
7761586|NCT00741260|26982385|P2|Overall Study|Withdrawal by Subject|0
7761587|NCT00741260|26982386|P1|Overall Study|Withdrawal by Subject|0
7761588|NCT00741260|26982380|P7|Overall Study|Death|1
7761589|NCT00741260|26982381|P6|Overall Study|Death|2
7761590|NCT00741260|26982382|P5|Overall Study|Death|2
7761591|NCT00741260|26982383|P4|Overall Study|Death|1
7761592|NCT00741260|26982384|P3|Overall Study|Death|0
7761593|NCT00741260|26982385|P2|Overall Study|Death|1
7761594|NCT00741260|26982386|P1|Overall Study|Death|0
7761595|NCT00741260|26982380|P7|Overall Study|Disease Progression|4
7761596|NCT00741260|26982381|P6|Overall Study|Disease Progression|37
7761597|NCT00741260|26982382|P5|Overall Study|Disease Progression|5
7761598|NCT00741260|26982383|P4|Overall Study|Disease Progression|3
7761599|NCT00741260|26982384|P3|Overall Study|Disease Progression|3
7761600|NCT00741260|26982385|P2|Overall Study|Disease Progression|5
7761601|NCT00741260|26982386|P1|Overall Study|Disease Progression|3
7761602|NCT00741091|26982435|P1|Overall Study|Missed Visit|22
7761603|NCT00741091|26982435|P1|Overall Study|Withdrawal by Subject|6
7761604|NCT00741091|26982435|P1|Overall Study|Lost to Follow-up|16
7761605|NCT00741091|26982435|P1|Overall Study|Death|13
7761606|NCT00741039|26982445|P2|Overall Study|Patient non-compliance|0
7761607|NCT00741039|26982446|P1|Overall Study|Patient non-compliance|2
7761608|NCT00741013|26982483|P3|Overall Study|Discovered failed screen after enrolled|0
7761609|NCT00741013|26982484|P2|Overall Study|Discovered failed screen after enrolled|2
7761610|NCT00741013|26982485|P1|Overall Study|Discovered failed screen after enrolled|0
7761611|NCT00741013|26982483|P3|Overall Study|Withdrawal by Subject|1
7761612|NCT00741013|26982484|P2|Overall Study|Withdrawal by Subject|0
7761613|NCT00741013|26982485|P1|Overall Study|Withdrawal by Subject|0
7761614|NCT00741013|26982483|P3|Overall Study|Adverse Event|0
7761615|NCT00741013|26982484|P2|Overall Study|Adverse Event|0
7761616|NCT00741013|26982485|P1|Overall Study|Adverse Event|1
7761617|NCT00740870|26982496|P1|Overall Study|Further testing contraindicated implant|17
7761618|NCT00740870|26982496|P1|Overall Study|Not Catheterized|4
7761619|NCT00740857|26982518|P3|Overall Study|Withdrawal by Subject|0
7761620|NCT00740857|26982519|P2|Overall Study|Withdrawal by Subject|0
7761621|NCT00740857|26982520|P1|Overall Study|Withdrawal by Subject|1
7761622|NCT00740792|26982575|P4|Overall Study|administrative|2
7761623|NCT00740792|26982576|P3|Overall Study|administrative|8
7761624|NCT00740792|26982577|P2|Overall Study|administrative|3
7761625|NCT00740792|26982578|P1|Overall Study|administrative|3
7761626|NCT00740792|26982575|P4|Overall Study|Withdrawal by Subject|0
7761627|NCT00740792|26982576|P3|Overall Study|Withdrawal by Subject|0
7761628|NCT00740792|26982577|P2|Overall Study|Withdrawal by Subject|1
7761629|NCT00740792|26982578|P1|Overall Study|Withdrawal by Subject|1
7761630|NCT00740792|26982575|P4|Overall Study|Protocol Violation|2
7761631|NCT00740792|26982576|P3|Overall Study|Protocol Violation|0
7761632|NCT00740792|26982577|P2|Overall Study|Protocol Violation|1
7761633|NCT00740792|26982578|P1|Overall Study|Protocol Violation|0
7761634|NCT00740792|26982575|P4|Overall Study|Lost to Follow-up|0
7761635|NCT00740792|26982576|P3|Overall Study|Lost to Follow-up|0
7761636|NCT00740792|26982577|P2|Overall Study|Lost to Follow-up|1
7761637|NCT00740792|26982578|P1|Overall Study|Lost to Follow-up|2
7761638|NCT00740792|26982575|P4|Overall Study|Lack of Efficacy|3
7761639|NCT00740792|26982576|P3|Overall Study|Lack of Efficacy|0
7761640|NCT00740792|26982577|P2|Overall Study|Lack of Efficacy|1
7761641|NCT00740792|26982578|P1|Overall Study|Lack of Efficacy|1
7761642|NCT00740792|26982575|P4|Overall Study|Adverse Event|3
7761643|NCT00740792|26982576|P3|Overall Study|Adverse Event|1
7761644|NCT00740792|26982577|P2|Overall Study|Adverse Event|1
7761645|NCT00740792|26982578|P1|Overall Study|Adverse Event|3
7761646|NCT00740779|26982599|P3|Overall Study|Lost to Follow-up|5
7761647|NCT00740779|26982600|P2|Overall Study|Lost to Follow-up|3
7761648|NCT00740779|26982601|P1|Overall Study|Lost to Follow-up|2
7761649|NCT00740779|26982599|P3|Overall Study|Withdrawal by Subject|2
7761650|NCT00740779|26982600|P2|Overall Study|Withdrawal by Subject|4
7761651|NCT00740779|26982601|P1|Overall Study|Withdrawal by Subject|2
7761652|NCT00740779|26982599|P3|Overall Study|Lack of Efficacy|2
7761653|NCT00740779|26982600|P2|Overall Study|Lack of Efficacy|0
7761654|NCT00740779|26982601|P1|Overall Study|Lack of Efficacy|0
7761655|NCT00740779|26982599|P3|Overall Study|Protocol Violation|1
7761656|NCT00740779|26982600|P2|Overall Study|Protocol Violation|1
7761657|NCT00740779|26982601|P1|Overall Study|Protocol Violation|1
7761658|NCT00740779|26982599|P3|Overall Study|Adverse Event|3
7761659|NCT00740779|26982600|P2|Overall Study|Adverse Event|6
7761660|NCT00740779|26982601|P1|Overall Study|Adverse Event|4
7761661|NCT00740714|26982618|P3|Overall Study|Withdrawal by Subject|29
7761662|NCT00740714|26982619|P2|Overall Study|Withdrawal by Subject|19
7761663|NCT00740714|26982620|P1|Overall Study|Withdrawal by Subject|17
7761664|NCT00740636|26982696|P2|Overall Study|Death|0
7761665|NCT00740636|26982697|P1|Overall Study|Death|1
7761666|NCT00740636|26982696|P2|Overall Study|Progressive Disease|0
7761667|NCT00740636|26982697|P1|Overall Study|Progressive Disease|1
7761668|NCT00740636|26982696|P2|Overall Study|Patient Not Treated|1
7761669|NCT00740636|26982697|P1|Overall Study|Patient Not Treated|0
7761670|NCT00740636|26982696|P2|Overall Study|Patient Ineligible|1
7761671|NCT00740636|26982697|P1|Overall Study|Patient Ineligible|0
7761672|NCT00740636|26982696|P2|Overall Study|Adverse Event|2
7761673|NCT00740636|26982697|P1|Overall Study|Adverse Event|0
7761674|NCT00740597|26982703|P1|Overall Study|insurance would not cover treatment|1
7761675|NCT00740584|26982707|P1|Overall Study|Withdrawal by Subject|1
7761676|NCT00740480|26982712|P1|Overall Study|Physician Decision|1
7761677|NCT00740480|26982712|P1|Overall Study|Adverse Event|1
7761678|NCT00740220|26982737|P1|Overall Study|screen failures (non-COPD patients)|9
7761679|NCT00740051|26982769|P2|Overall Study|Other reason (not specified)|1
7761680|NCT00740051|26982770|P1|Overall Study|Other reason (not specified)|4
7761681|NCT00740051|26982769|P2|Overall Study|Withdrawal by Subject|8
7761682|NCT00740051|26982770|P1|Overall Study|Withdrawal by Subject|6
7761683|NCT00740051|26982769|P2|Overall Study|Lost to Follow-up|8
7761684|NCT00740051|26982770|P1|Overall Study|Lost to Follow-up|3
7761685|NCT00740051|26982769|P2|Overall Study|Protocol Violation|6
7761686|NCT00740051|26982770|P1|Overall Study|Protocol Violation|2
7761687|NCT00740051|26982769|P2|Overall Study|Adverse Event|4
7761688|NCT00740051|26982770|P1|Overall Study|Adverse Event|1
7761689|NCT00740051|26982769|P2|Overall Study|Lack of Efficacy|5
7761690|NCT00740051|26982770|P1|Overall Study|Lack of Efficacy|2
7761691|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761692|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761693|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
7761694|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761695|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761696|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761697|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761698|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
7761699|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7761700|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7761701|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7761702|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7761703|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
7761704|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7761705|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7761706|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
7761707|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7761708|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
7761709|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761710|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761711|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
7761712|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761713|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761714|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761715|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761716|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761717|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7761718|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
7761719|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
7761720|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
7761721|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7761722|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7761723|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
7761724|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
7761725|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7761726|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
7761727|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7761728|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
7761729|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
7761730|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7761731|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7761732|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
7761733|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7761734|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
7761735|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7761736|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761737|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761738|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761739|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761740|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761741|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761742|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
7761743|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761744|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7761745|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7761746|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
7761747|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
7761748|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7761749|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7761750|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
7761751|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
7761752|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
7761753|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
7761754|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761755|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761756|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761757|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761758|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761759|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761760|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7761761|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
7761762|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
7761763|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761764|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
7761765|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761766|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761767|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
7761768|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761769|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761770|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761771|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7761772|NCT00739973|26982873|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
7761773|NCT00739973|26982874|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
7761774|NCT00739973|26982875|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
7761775|NCT00739973|26982876|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7761776|NCT00739973|26982877|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
7761777|NCT00739973|26982878|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
7761778|NCT00739973|26982879|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
7761779|NCT00739973|26982880|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7761780|NCT00739973|26982881|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7761781|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761782|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761783|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761784|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761785|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761786|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761787|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761788|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7761789|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
7761790|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761791|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761792|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761793|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761794|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761795|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761796|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761797|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7761798|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
7761799|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761800|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761801|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761802|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761803|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761804|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761805|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761806|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7761807|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
7761808|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761809|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761810|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761811|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761812|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761813|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761814|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761815|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7761816|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
7761817|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761818|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761819|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761820|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761821|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761822|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761823|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761824|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7761825|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
7761826|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761827|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761828|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761829|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761830|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761831|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761832|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761833|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7761834|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
7761835|NCT00739973|26982873|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761836|NCT00739973|26982874|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761837|NCT00739973|26982875|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761838|NCT00739973|26982876|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761839|NCT00739973|26982877|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761840|NCT00739973|26982878|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761841|NCT00739973|26982879|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761842|NCT00739973|26982880|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7761843|NCT00739973|26982881|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
7761844|NCT00739934|26982972|P1|Voriconazole Oral|Other|3
7761845|NCT00739934|26982972|P1|Voriconazole IV|Adverse Event|6
7761846|NCT00739908|26982994|P2|Overall Study|Relocation|1
7761847|NCT00739908|26982995|P1|Overall Study|Relocation|0
7761848|NCT00739908|26982994|P2|Overall Study|Lack of Efficacy|1
7761849|NCT00739908|26982995|P1|Overall Study|Lack of Efficacy|0
7761850|NCT00739908|26982994|P2|Overall Study|Non-Compliance With Study Medication|3
7761851|NCT00739908|26982995|P1|Overall Study|Non-Compliance With Study Medication|0
7761852|NCT00739908|26982994|P2|Overall Study|Non-Compliance With Study Procedures|3
7761853|NCT00739908|26982995|P1|Overall Study|Non-Compliance With Study Procedures|2
7761854|NCT00739908|26982994|P2|Overall Study|Lost to Follow-up|9
7761855|NCT00739908|26982995|P1|Overall Study|Lost to Follow-up|14
7761856|NCT00739908|26982994|P2|Overall Study|Withdrawal by Subject|2
7761857|NCT00739908|26982995|P1|Overall Study|Withdrawal by Subject|4
7761858|NCT00739908|26982994|P2|Overall Study|Adverse Event|6
7761859|NCT00739908|26982995|P1|Overall Study|Adverse Event|5
7761860|NCT00739882|26983015|P2|Open-label Period|Other|5
7761861|NCT00739882|26983016|P1|Open-label Period|Other|9
7761862|NCT00739882|26983015|P2|Open-label Period|Adverse Event|0
7761863|NCT00739882|26983016|P1|Open-label Period|Adverse Event|1
7761864|NCT00739882|26983015|P2|Double-blind Period|Other|8
7761865|NCT00739882|26983016|P1|Double-blind Period|Other|16
7761866|NCT00739882|26983015|P2|Double-blind Period|Lack of Efficacy|1
7761867|NCT00739882|26983016|P1|Double-blind Period|Lack of Efficacy|1
7761868|NCT00739882|26983015|P2|Double-blind Period|Protocol Violation|0
7761869|NCT00739882|26983016|P1|Double-blind Period|Protocol Violation|1
7761870|NCT00739882|26983015|P2|Double-blind Period|Adverse Event|2
7761871|NCT00739882|26983016|P1|Double-blind Period|Adverse Event|1
7761872|NCT00739674|26983077|P2|Overall Study|Erectile dysfunction|1
7761873|NCT00739674|26983078|P1|Overall Study|Erectile dysfunction|0
7761874|NCT00739674|26983077|P2|Overall Study|Home monitoring off meds|0
7761875|NCT00739674|26983078|P1|Overall Study|Home monitoring off meds|1
7761876|NCT00739674|26983077|P2|Overall Study|Unable to attend visit|1
7761877|NCT00739674|26983078|P1|Overall Study|Unable to attend visit|3
7761878|NCT00739674|26983077|P2|Overall Study|Non compliant|0
7761879|NCT00739674|26983078|P1|Overall Study|Non compliant|4
7761880|NCT00739674|26983077|P2|Overall Study|Patient moved|2
7761881|NCT00739674|26983078|P1|Overall Study|Patient moved|3
7761882|NCT00739674|26983077|P2|Overall Study|Clinic closed|4
7761883|NCT00739674|26983078|P1|Overall Study|Clinic closed|6
7761884|NCT00739674|26983077|P2|Overall Study|Reason missing|0
7761885|NCT00739674|26983078|P1|Overall Study|Reason missing|2
7761886|NCT00739674|26983077|P2|Overall Study|Withdrawal by Subject|9
7761887|NCT00739674|26983078|P1|Overall Study|Withdrawal by Subject|9
7761888|NCT00739674|26983077|P2|Overall Study|Protocol Violation|5
7761889|NCT00739674|26983078|P1|Overall Study|Protocol Violation|5
7761890|NCT00739674|26983077|P2|Overall Study|Lost to Follow-up|30
7761891|NCT00739674|26983078|P1|Overall Study|Lost to Follow-up|52
7761892|NCT00739674|26983077|P2|Overall Study|Lack of Efficacy|0
7761893|NCT00739674|26983078|P1|Overall Study|Lack of Efficacy|1
7761894|NCT00739674|26983077|P2|Overall Study|Death|0
7761895|NCT00739674|26983078|P1|Overall Study|Death|1
7761896|NCT00739674|26983077|P2|Overall Study|Adverse Event|13
7761897|NCT00739674|26983078|P1|Overall Study|Adverse Event|22
7761898|NCT00739674|26983077|P2|Overall Study|Dietician consultation >30 days|9
7761899|NCT00739674|26983078|P1|Overall Study|Dietician consultation >30 days|1
7761900|NCT00739674|26983077|P2|Overall Study|No follow-up data|18
7761901|NCT00739674|26983078|P1|Overall Study|No follow-up data|33
7761902|NCT00739674|26983077|P2|Overall Study|Site 212 removal|13
7761903|NCT00739674|26983078|P1|Overall Study|Site 212 removal|19
7761904|NCT00739674|26983077|P2|Overall Study|Screening failures|17
7761905|NCT00739674|26983078|P1|Overall Study|Screening failures|19
7761906|NCT00739661|26983106|P2|Overall Study|Reason for discontinuation not available|1
7761907|NCT00739661|26983107|P1|Overall Study|Reason for discontinuation not available|1
7761908|NCT00739661|26983106|P2|Overall Study|Disease progression, radiographic|37
7761909|NCT00739661|26983107|P1|Overall Study|Disease progression, radiographic|33
7761910|NCT00739661|26983106|P2|Overall Study|Patient decision to withdraw|4
7761911|NCT00739661|26983107|P1|Overall Study|Patient decision to withdraw|9
7761912|NCT00739661|26983106|P2|Overall Study|Physician decision to withdraw patient|0
7761913|NCT00739661|26983107|P1|Overall Study|Physician decision to withdraw patient|1
7761914|NCT00739661|26983106|P2|Overall Study|Adverse Event|0
7761915|NCT00739661|26983107|P1|Overall Study|Adverse Event|2
7761916|NCT00739648|26983119|P2|Overall Study|Do not know|6
7761917|NCT00739648|26983120|P1|Overall Study|Do not know|4
7761918|NCT00739648|26983119|P2|Overall Study|Death|0
7761919|NCT00739648|26983120|P1|Overall Study|Death|2
7761920|NCT00739648|26983119|P2|Overall Study|Lost to Follow-up|7
7761921|NCT00739648|26983120|P1|Overall Study|Lost to Follow-up|4
7761922|NCT00739648|26983119|P2|Overall Study|Withdrawal by Subject|25
7761923|NCT00739648|26983120|P1|Overall Study|Withdrawal by Subject|13
7761924|NCT00739648|26983119|P2|Overall Study|Adverse Event|15
7761925|NCT00739648|26983120|P1|Overall Study|Adverse Event|3
7761926|NCT00739596|26983134|P2|Overall Study|Protocol Deviation|1
7761927|NCT00739596|26983135|P1|Overall Study|Protocol Deviation|1
7761928|NCT00739596|26983134|P2|Overall Study|Lost to Follow-up|2
7761929|NCT00739596|26983135|P1|Overall Study|Lost to Follow-up|0
7761930|NCT00739596|26983134|P2|Overall Study|Patient Withdrew Consent|8
7761931|NCT00739596|26983135|P1|Overall Study|Patient Withdrew Consent|8
7761932|NCT00739596|26983134|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
7761933|NCT00739596|26983135|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
7761934|NCT00739596|26983134|P2|Overall Study|Adverse Event|6
7761935|NCT00739596|26983135|P1|Overall Study|Adverse Event|12
7761936|NCT00739310|26983177|P1|Overall Study|Lost to Follow-up|2
7761937|NCT00739310|26983177|P1|Overall Study|Withdrawal by Subject|1
7761938|NCT00739310|26983177|P1|Overall Study|Poor adherance to prescribed therapy|4
7761939|NCT00739297|26983182|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
7761940|NCT00739297|26983183|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
7761941|NCT00739297|26983184|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7761942|NCT00739297|26983185|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7761943|NCT00739297|26983186|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7761944|NCT00739297|26983187|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7761945|NCT00739297|26983188|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7761946|NCT00739297|26983182|P7|First Washout Period of 4-7 Days|Adverse Event|2
7761947|NCT00739297|26983183|P6|First Washout Period of 4-7 Days|Adverse Event|0
7761948|NCT00739297|26983184|P5|First Washout Period of 4-7 Days|Adverse Event|0
7761949|NCT00739297|26983185|P4|First Washout Period of 4-7 Days|Adverse Event|2
7761950|NCT00739297|26983186|P3|First Washout Period of 4-7 Days|Adverse Event|0
7761951|NCT00739297|26983187|P2|First Washout Period of 4-7 Days|Adverse Event|0
7761952|NCT00739297|26983188|P1|First Washout Period of 4-7 Days|Adverse Event|0
7761953|NCT00739102|26983216|P1|Overall Study|Withdrawal by Subject|10
7761954|NCT00739102|26983216|P1|Overall Study|Death|5
7761955|NCT00739063|26983232|P1|Overall Study|Screen failures|8
7761956|NCT00738894|26983277|P2|Overall Study|Death|0
7761957|NCT00738894|26983278|P1|Overall Study|Death|2
7761958|NCT00738894|26983277|P2|Overall Study|Physician Decision|5
7761959|NCT00738894|26983278|P1|Overall Study|Physician Decision|4
7761960|NCT00738894|26983277|P2|Overall Study|Withdrawal by Subject|15
7761961|NCT00738894|26983278|P1|Overall Study|Withdrawal by Subject|10
7761962|NCT00738894|26983277|P2|Overall Study|Lost to Follow-up|13
7761963|NCT00738894|26983278|P1|Overall Study|Lost to Follow-up|23
7761964|NCT00738881|26983291|P2|Overall Study|Withdrawal by Subject|2
7761965|NCT00738881|26983292|P1|Overall Study|Withdrawal by Subject|0
7761966|NCT00738699|26983306|P2|Overall Study|Other|0
7761967|NCT00738699|26983307|P1|Overall Study|Other|2
7761968|NCT00738699|26983306|P2|Overall Study|Discontinuation of study by Sponsor|72
7761969|NCT00738699|26983307|P1|Overall Study|Discontinuation of study by Sponsor|123
7761970|NCT00738699|26983306|P2|Overall Study|Death|68
7761971|NCT00738699|26983307|P1|Overall Study|Death|144
7761972|NCT00738699|26983306|P2|Overall Study|Lost to Follow-up|0
7761973|NCT00738699|26983307|P1|Overall Study|Lost to Follow-up|1
7761974|NCT00738699|26983306|P2|Overall Study|Withdrawal by Subject|0
7761975|NCT00738699|26983307|P1|Overall Study|Withdrawal by Subject|5
7761976|NCT00738673|26983325|P2|Overall Study|Withdrawal by Subject|1
7761977|NCT00738673|26983326|P1|Overall Study|Withdrawal by Subject|3
7761978|NCT00738673|26983325|P2|Overall Study|Protocol Violation|2
7761979|NCT00738673|26983326|P1|Overall Study|Protocol Violation|1
7761980|NCT00738673|26983325|P2|Overall Study|Lack of Efficacy|8
7761981|NCT00738673|26983326|P1|Overall Study|Lack of Efficacy|19
7761982|NCT00738673|26983325|P2|Overall Study|Adverse Event|0
7761983|NCT00738673|26983326|P1|Overall Study|Adverse Event|1
7761984|NCT00738530|26983364|P2|Overall Study|Withdrawal by Subject|8
7761985|NCT00738530|26983365|P1|Overall Study|Withdrawal by Subject|6
7761986|NCT00738530|26983364|P2|Overall Study|Lost to Follow-up|6
7761987|NCT00738530|26983365|P1|Overall Study|Lost to Follow-up|8
7761988|NCT00738530|26983364|P2|Overall Study|Death|224
7761989|NCT00738530|26983365|P1|Overall Study|Death|220
7761990|NCT00738400|26983400|P2|Overall Study|Non-compliant with study medication|1
7761991|NCT00738400|26983401|P1|Overall Study|Non-compliant with study medication|0
7761992|NCT00738400|26983400|P2|Overall Study|Protocol Violation|0
7761993|NCT00738400|26983401|P1|Overall Study|Protocol Violation|1
7761994|NCT00738400|26983400|P2|Overall Study|Lost to Follow-up|3
7761995|NCT00738400|26983401|P1|Overall Study|Lost to Follow-up|0
7761996|NCT00738400|26983400|P2|Overall Study|Lack of Efficacy|1
7761997|NCT00738400|26983401|P1|Overall Study|Lack of Efficacy|0
7761998|NCT00738400|26983400|P2|Overall Study|Withdrawal by Subject|1
7761999|NCT00738400|26983401|P1|Overall Study|Withdrawal by Subject|0
7762000|NCT00738400|26983400|P2|Overall Study|Adverse Event|1
7762001|NCT00738400|26983401|P1|Overall Study|Adverse Event|3
7762002|NCT00738374|26983422|P4|Maintenance Treatment/Observation Phase|Other|0
7762003|NCT00738374|26983423|P3|Maintenance Treatment/Observation Phase|Other|0
7762004|NCT00738374|26983424|P2|Maintenance Treatment/Observation Phase|Other|1
7762005|NCT00738374|26983425|P1|Maintenance Treatment/Observation Phase|Other|0
7762006|NCT00738374|26983422|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
7762007|NCT00738374|26983423|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
7762008|NCT00738374|26983424|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
7762009|NCT00738374|26983425|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
7762010|NCT00738374|26983422|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
7762011|NCT00738374|26983423|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7762012|NCT00738374|26983424|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7762013|NCT00738374|26983425|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7762014|NCT00738374|26983422|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
7762015|NCT00738374|26983423|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
7762016|NCT00738374|26983424|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
7762017|NCT00738374|26983425|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
7762018|NCT00738374|26983422|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
7762019|NCT00738374|26983423|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
7762020|NCT00738374|26983424|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
7762021|NCT00738374|26983425|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
7762022|NCT00738374|26983422|P4|Induction Treatment Phase|Withdrawal by Subject|0
7762023|NCT00738374|26983423|P3|Induction Treatment Phase|Withdrawal by Subject|0
7762024|NCT00738374|26983424|P2|Induction Treatment Phase|Withdrawal by Subject|0
7762025|NCT00738374|26983425|P1|Induction Treatment Phase|Withdrawal by Subject|1
7762026|NCT00738374|26983422|P4|Induction Treatment Phase|Non-compliance|0
7762027|NCT00738374|26983423|P3|Induction Treatment Phase|Non-compliance|0
7762028|NCT00738374|26983424|P2|Induction Treatment Phase|Non-compliance|0
7762029|NCT00738374|26983425|P1|Induction Treatment Phase|Non-compliance|1
7762030|NCT00738374|26983422|P4|Induction Treatment Phase|Protocol Violation|0
7762031|NCT00738374|26983423|P3|Induction Treatment Phase|Protocol Violation|0
7762032|NCT00738374|26983424|P2|Induction Treatment Phase|Protocol Violation|0
7762033|NCT00738374|26983425|P1|Induction Treatment Phase|Protocol Violation|2
7762034|NCT00738374|26983422|P4|Induction Treatment Phase|Physician Decision|0
7762035|NCT00738374|26983423|P3|Induction Treatment Phase|Physician Decision|0
7762036|NCT00738374|26983424|P2|Induction Treatment Phase|Physician Decision|0
7762037|NCT00738374|26983425|P1|Induction Treatment Phase|Physician Decision|2
7762038|NCT00738374|26983422|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
7762039|NCT00738374|26983423|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
7762040|NCT00738374|26983424|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
7762041|NCT00738374|26983425|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
7762042|NCT00738374|26983422|P4|Induction Treatment Phase|Adverse Event|0
7762043|NCT00738374|26983423|P3|Induction Treatment Phase|Adverse Event|0
7762044|NCT00738374|26983424|P2|Induction Treatment Phase|Adverse Event|0
7762045|NCT00738374|26983425|P1|Induction Treatment Phase|Adverse Event|14
7762046|NCT00738283|26983463|P1|Overall Study|Discharge home prior to end of study|1
7762047|NCT00738283|26983463|P1|Overall Study|Transfer to another facility|2
7762048|NCT00738283|26983463|P1|Overall Study|Death|1
7762049|NCT00738101|26983467|P1|Overall Study|Repeat enrollment|1
7762050|NCT00738101|26983467|P1|Overall Study|Death|1
7762051|NCT00738101|26983467|P1|Overall Study|Physician Decision|5
7762052|NCT00738062|26983482|P3|Open-Label Extension|Study Terminated|0
7762053|NCT00738062|26983483|P2|Open-Label Extension|Study Terminated|0
7762054|NCT00738062|26983484|P1|Open-Label Extension|Study Terminated|2
7762055|NCT00738062|26983482|P3|Open-Label Extension|Protocol Violation|0
7762056|NCT00738062|26983483|P2|Open-Label Extension|Protocol Violation|0
7762057|NCT00738062|26983484|P1|Open-Label Extension|Protocol Violation|1
7762058|NCT00738062|26983482|P3|Open-Label Extension|Withdrawal by Subject|0
7762059|NCT00738062|26983483|P2|Open-Label Extension|Withdrawal by Subject|0
7762060|NCT00738062|26983484|P1|Open-Label Extension|Withdrawal by Subject|6
7762061|NCT00738062|26983482|P3|Open-Label Extension|Lack of Efficacy|0
7762062|NCT00738062|26983483|P2|Open-Label Extension|Lack of Efficacy|0
7762063|NCT00738062|26983484|P1|Open-Label Extension|Lack of Efficacy|2
7762064|NCT00738062|26983482|P3|Open-Label Extension|Physician Decision|0
7762065|NCT00738062|26983483|P2|Open-Label Extension|Physician Decision|0
7762066|NCT00738062|26983484|P1|Open-Label Extension|Physician Decision|1
7762067|NCT00738062|26983482|P3|Open-Label Extension|Adverse Event|0
7762068|NCT00738062|26983483|P2|Open-Label Extension|Adverse Event|0
7762069|NCT00738062|26983484|P1|Open-Label Extension|Adverse Event|5
7762070|NCT00738062|26983482|P3|Open Label Treatment|Investigator Decision|0
7762071|NCT00738062|26983483|P2|Open Label Treatment|Investigator Decision|0
7762072|NCT00738062|26983484|P1|Open Label Treatment|Investigator Decision|1
7762073|NCT00738062|26983482|P3|Open Label Treatment|Withdrawal by Subject|0
7762074|NCT00738062|26983483|P2|Open Label Treatment|Withdrawal by Subject|0
7762075|NCT00738062|26983484|P1|Open Label Treatment|Withdrawal by Subject|9
7762076|NCT00738062|26983482|P3|Open Label Treatment|Protocol Violation|0
7762077|NCT00738062|26983483|P2|Open Label Treatment|Protocol Violation|0
7762078|NCT00738062|26983484|P1|Open Label Treatment|Protocol Violation|2
7762079|NCT00738062|26983482|P3|Open Label Treatment|Adverse Event|0
7762080|NCT00738062|26983483|P2|Open Label Treatment|Adverse Event|0
7762081|NCT00738062|26983484|P1|Open Label Treatment|Adverse Event|11
7762082|NCT00738062|26983482|P3|Open Label Treatment|Lack of Efficacy|0
7762083|NCT00738062|26983483|P2|Open Label Treatment|Lack of Efficacy|0
7762084|NCT00738062|26983484|P1|Open Label Treatment|Lack of Efficacy|5
7762085|NCT00737711|26983597|P1|Overall Study|Other|5
7762086|NCT00737711|26983597|P1|Overall Study|Blood transfusion|6
7762087|NCT00737711|26983597|P1|Overall Study|Withdrawal by Subject|5
7762088|NCT00737711|26983597|P1|Overall Study|Protocol Violation|1
7762089|NCT00737711|26983597|P1|Overall Study|Failure to return|4
7762090|NCT00737711|26983597|P1|Overall Study|Death|8
7762091|NCT00737711|26983597|P1|Overall Study|Adverse Event|2
7762092|NCT00737698|26983631|P3|Overall Study|Death|1
7762093|NCT00737698|26983632|P2|Overall Study|Death|0
7762094|NCT00737698|26983633|P1|Overall Study|Death|0
7762095|NCT00737698|26983631|P3|Overall Study|Withdrawal by Subject|3
7762096|NCT00737698|26983632|P2|Overall Study|Withdrawal by Subject|5
7762097|NCT00737698|26983633|P1|Overall Study|Withdrawal by Subject|6
7762098|NCT00737672|26983643|P2|Overall Study|Physician Decision|2
7762099|NCT00737672|26983644|P1|Overall Study|Physician Decision|0
7762100|NCT00737672|26983643|P2|Overall Study|Miscellaneous|1
7762101|NCT00737672|26983644|P1|Overall Study|Miscellaneous|7
7762102|NCT00737672|26983643|P2|Overall Study|Lost to Follow-up|0
7762103|NCT00737672|26983644|P1|Overall Study|Lost to Follow-up|1
7762104|NCT00737672|26983643|P2|Overall Study|Withdrawal by Subject|2
7762105|NCT00737672|26983644|P1|Overall Study|Withdrawal by Subject|1
7762106|NCT00737672|26983643|P2|Overall Study|Death|22
7762107|NCT00737672|26983644|P1|Overall Study|Death|23
7762108|NCT00737672|26983643|P2|Overall Study|Graft Abandonment|56
7762109|NCT00737672|26983644|P1|Overall Study|Graft Abandonment|48
7762110|NCT00737633|26983682|P2|Overall Study|protocol non-compliance|1
7762111|NCT00737633|26983683|P1|Overall Study|protocol non-compliance|0
7762112|NCT00737633|26983682|P2|Overall Study|Lost to Follow-up|1
7762113|NCT00737633|26983683|P1|Overall Study|Lost to Follow-up|0
7762114|NCT00737633|26983682|P2|Overall Study|Study terminated by sponsor|55
7762115|NCT00737633|26983683|P1|Overall Study|Study terminated by sponsor|44
7762116|NCT00737568|26983706|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
7762117|NCT00737568|26983707|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
7762118|NCT00737568|26983706|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
7762119|NCT00737568|26983707|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
7762120|NCT00737568|26983706|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
7762121|NCT00737568|26983707|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
7762122|NCT00737568|26983706|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
7762123|NCT00737568|26983707|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
7762124|NCT00737568|26983706|P2|Treatment Period Through Week 240|Protocol Violation|3
7762125|NCT00737568|26983707|P1|Treatment Period Through Week 240|Protocol Violation|2
7762126|NCT00737568|26983706|P2|Treatment Period Through Week 240|Lost to Follow-up|3
7762127|NCT00737568|26983707|P1|Treatment Period Through Week 240|Lost to Follow-up|3
7762128|NCT00737568|26983706|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
7762129|NCT00737568|26983707|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
7762130|NCT00737568|26983706|P2|Treatment Period Through Week 240|Withdrew Consent|6
7762131|NCT00737568|26983707|P1|Treatment Period Through Week 240|Withdrew Consent|5
7762132|NCT00737568|26983706|P2|Treatment Period Through Week 240|Investigator's Discretion|5
7762133|NCT00737568|26983707|P1|Treatment Period Through Week 240|Investigator's Discretion|6
7762134|NCT00737529|26983737|P1|Overall Study|Other|4
7762135|NCT00737529|26983737|P1|Overall Study|Protocol Violation|1
7762136|NCT00737529|26983737|P1|Overall Study|Death|4
7762137|NCT00737529|26983737|P1|Overall Study|Withdrawal by Subject|5
7762138|NCT00737529|26983737|P1|Overall Study|Adverse Event|24
7762139|NCT00737529|26983737|P1|Overall Study|Disease Progression|95
7762140|NCT00737477|26983751|P1|Overall Study|Other|4
7762141|NCT00737477|26983751|P1|Overall Study|Renal Transplantation|10
7762142|NCT00737477|26983751|P1|Overall Study|Withdrawal by Subject|1
7762143|NCT00737477|26983751|P1|Overall Study|Treatment Refusal|1
7762144|NCT00737477|26983751|P1|Overall Study|Death|9
7762145|NCT00737477|26983751|P1|Overall Study|Adverse Event|9
7762146|NCT00737464|26983767|P1|Overall Study|Other reasons|4
7762147|NCT00737464|26983767|P1|Overall Study|Refused Treatment / Withdrew Consent|6
7762148|NCT00737464|26983767|P1|Overall Study|Other - Failure to Return|1
7762149|NCT00737464|26983767|P1|Overall Study|Death|6
7762150|NCT00737464|26983767|P1|Overall Study|Adverse Event|1
7762151|NCT00737438|26983788|P1|Overall Study|Patient ineligible|1
7762152|NCT00737438|26983788|P1|Overall Study|Withdrawal by Subject|2
7762153|NCT00737282|26983801|P1|Overall Study|Study prematurely terminated|175
7762154|NCT00737100|26983844|P3|Overall Study|Reason discontinued not explained above|1
7762155|NCT00737100|26983845|P2|Overall Study|Reason discontinued not explained above|1
7762156|NCT00737100|26983846|P1|Overall Study|Reason discontinued not explained above|1
7762157|NCT00737100|26983844|P3|Overall Study|Withdrawal by Subject|3
7762158|NCT00737100|26983845|P2|Overall Study|Withdrawal by Subject|0
7762159|NCT00737100|26983846|P1|Overall Study|Withdrawal by Subject|0
7762160|NCT00737100|26983844|P3|Overall Study|Lost to Follow-up|0
7762161|NCT00737100|26983845|P2|Overall Study|Lost to Follow-up|1
7762162|NCT00737100|26983846|P1|Overall Study|Lost to Follow-up|0
7762163|NCT00737100|26983844|P3|Overall Study|Adverse Event|3
7762164|NCT00737100|26983845|P2|Overall Study|Adverse Event|5
7762165|NCT00737100|26983846|P1|Overall Study|Adverse Event|6
7762166|NCT00737061|26983890|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
7762167|NCT00737061|26983890|P1|1 Year Wearing Period|Discontinued reilance|3
7762168|NCT00737061|26983890|P1|1 Year Wearing Period|Withdrawal by Subject|2
7762169|NCT00737061|26983890|P1|1 Year Wearing Period|Lost to Follow-up|11
7762170|NCT00737061|26983890|P1|Waiting Period|Elected surgical tubal ligation|5
7762171|NCT00737061|26983890|P1|Waiting Period|Alternative contraception failure|3
7762172|NCT00737061|26983890|P1|Waiting Period|Deemed patent following HSG|26
7762173|NCT00737061|26983890|P1|Waiting Period|Bilateral placement failure|34
7762174|NCT00737061|26983890|P1|Waiting Period|Withdrawal by Subject|1
7762175|NCT00737061|26983890|P1|Waiting Period|Lost to Follow-up|6
7762176|NCT00737048|26983907|P3|Overall Study|Worsening of the symptoms|3
7762177|NCT00737048|26983908|P2|Overall Study|Worsening of the symptoms|5
7762178|NCT00737048|26983909|P1|Overall Study|Worsening of the symptoms|3
7762179|NCT00737048|26983907|P3|Overall Study|Adverse Event|0
7762180|NCT00737048|26983908|P2|Overall Study|Adverse Event|1
7762181|NCT00737048|26983909|P1|Overall Study|Adverse Event|0
7762182|NCT00737048|26983907|P3|Overall Study|Physician Decision|1
7762183|NCT00737048|26983908|P2|Overall Study|Physician Decision|0
7762184|NCT00737048|26983909|P1|Overall Study|Physician Decision|0
7762185|NCT00736996|26983953|P3|Overall Study|Lost to Follow-up|2
7762186|NCT00736996|26983954|P2|Overall Study|Lost to Follow-up|9
7762187|NCT00736996|26983955|P1|Overall Study|Lost to Follow-up|1
7762188|NCT00736957|26983969|P1|Overall Study|Physician Decision|5
7762189|NCT00736957|26983969|P1|Overall Study|not eligible for Treatment Period I|22
7762190|NCT00736957|26983969|P1|Overall Study|did not attend hospital appointments|1
7762191|NCT00736957|26983969|P1|Overall Study|violation of eligibility criteria|2
7762192|NCT00736957|26983969|P1|Overall Study|Withdrawal by Subject|49
7762193|NCT00736957|26983969|P1|Overall Study|Adverse Event|43
7762194|NCT00736944|26983979|P1|Definitive Treatment|Physician Decision|1
7762195|NCT00736944|26983979|P1|Induction|Death|1
7762196|NCT00736879|26984013|P4|Follow up Period - No Drug Treatment|non-specified|0
7762197|NCT00736879|26984014|P3|Follow up Period - No Drug Treatment|non-specified|0
7762198|NCT00736879|26984015|P2|Follow up Period - No Drug Treatment|non-specified|2
7762199|NCT00736879|26984016|P1|Follow up Period - No Drug Treatment|non-specified|1
7762200|NCT00736879|26984013|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7762201|NCT00736879|26984014|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7762202|NCT00736879|26984015|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
7762203|NCT00736879|26984016|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7762204|NCT00736879|26984013|P4|Double Blind Treatment Period|non-specified|0
7762205|NCT00736879|26984014|P3|Double Blind Treatment Period|non-specified|0
7762206|NCT00736879|26984015|P2|Double Blind Treatment Period|non-specified|1
7762207|NCT00736879|26984016|P1|Double Blind Treatment Period|non-specified|0
7762208|NCT00736879|26984013|P4|Double Blind Treatment Period|No longer met criteria|0
7762209|NCT00736879|26984014|P3|Double Blind Treatment Period|No longer met criteria|0
7762210|NCT00736879|26984015|P2|Double Blind Treatment Period|No longer met criteria|1
7762211|NCT00736879|26984016|P1|Double Blind Treatment Period|No longer met criteria|0
7762212|NCT00736879|26984013|P4|Double Blind Treatment Period|Poor non-compliance|1
7762213|NCT00736879|26984014|P3|Double Blind Treatment Period|Poor non-compliance|1
7762214|NCT00736879|26984015|P2|Double Blind Treatment Period|Poor non-compliance|0
7762215|NCT00736879|26984016|P1|Double Blind Treatment Period|Poor non-compliance|0
7762216|NCT00736879|26984013|P4|Double Blind Treatment Period|Lost to Follow-up|1
7762217|NCT00736879|26984014|P3|Double Blind Treatment Period|Lost to Follow-up|2
7762218|NCT00736879|26984015|P2|Double Blind Treatment Period|Lost to Follow-up|0
7762219|NCT00736879|26984016|P1|Double Blind Treatment Period|Lost to Follow-up|0
7762220|NCT00736879|26984013|P4|Double Blind Treatment Period|Withdrawal by Subject|3
7762221|NCT00736879|26984014|P3|Double Blind Treatment Period|Withdrawal by Subject|3
7762222|NCT00736879|26984015|P2|Double Blind Treatment Period|Withdrawal by Subject|1
7762223|NCT00736879|26984016|P1|Double Blind Treatment Period|Withdrawal by Subject|2
7762224|NCT00736879|26984013|P4|Double Blind Treatment Period|Adverse Event|0
7762225|NCT00736879|26984014|P3|Double Blind Treatment Period|Adverse Event|1
7762226|NCT00736879|26984015|P2|Double Blind Treatment Period|Adverse Event|1
7762227|NCT00736879|26984016|P1|Double Blind Treatment Period|Adverse Event|0
7762228|NCT00736879|26984013|P4|Double Blind Treatment Period|Lack of Efficacy|0
7762229|NCT00736879|26984014|P3|Double Blind Treatment Period|Lack of Efficacy|0
7762230|NCT00736879|26984015|P2|Double Blind Treatment Period|Lack of Efficacy|0
7762231|NCT00736879|26984016|P1|Double Blind Treatment Period|Lack of Efficacy|1
7762232|NCT00736853|26984070|P3|Double-Blind Period|Ineligible to participate the study|0
7762233|NCT00736853|26984071|P2|Double-Blind Period|Ineligible to participate the study|1
7762234|NCT00736853|26984072|P1|Double-Blind Period|Ineligible to participate the study|0
7762235|NCT00736853|26984070|P3|Double-Blind Period|Withdrawal by Subject|4
7762236|NCT00736853|26984071|P2|Double-Blind Period|Withdrawal by Subject|1
7762237|NCT00736853|26984072|P1|Double-Blind Period|Withdrawal by Subject|0
7762238|NCT00736853|26984070|P3|Double-Blind Period|Adverse Event|2
7762239|NCT00736853|26984071|P2|Double-Blind Period|Adverse Event|3
7762240|NCT00736853|26984072|P1|Double-Blind Period|Adverse Event|0
7762241|NCT00736853|26984070|P3|Double-Blind Period|Lack of Efficacy|42
7762242|NCT00736853|26984071|P2|Double-Blind Period|Lack of Efficacy|19
7762243|NCT00736853|26984072|P1|Double-Blind Period|Lack of Efficacy|0
7762244|NCT00736853|26984070|P3|Open-Label Period|Unable to attend hospital appointments|0
7762245|NCT00736853|26984071|P2|Open-Label Period|Unable to attend hospital appointments|0
7762246|NCT00736853|26984072|P1|Open-Label Period|Unable to attend hospital appointments|1
7762247|NCT00736853|26984070|P3|Open-Label Period|Failed to meet the transfer criteria|0
7762248|NCT00736853|26984071|P2|Open-Label Period|Failed to meet the transfer criteria|0
7762249|NCT00736853|26984072|P1|Open-Label Period|Failed to meet the transfer criteria|40
7762250|NCT00736853|26984070|P3|Open-Label Period|Started but not treated|0
7762251|NCT00736853|26984071|P2|Open-Label Period|Started but not treated|0
7762252|NCT00736853|26984072|P1|Open-Label Period|Started but not treated|42
7762253|NCT00736853|26984070|P3|Open-Label Period|Withdrawal by Subject|0
7762254|NCT00736853|26984071|P2|Open-Label Period|Withdrawal by Subject|0
7762255|NCT00736853|26984072|P1|Open-Label Period|Withdrawal by Subject|16
7762256|NCT00736853|26984070|P3|Open-Label Period|Adverse Event|0
7762257|NCT00736853|26984071|P2|Open-Label Period|Adverse Event|0
7762258|NCT00736853|26984072|P1|Open-Label Period|Adverse Event|31
7762259|NCT00736853|26984070|P3|Open-Label Period|Physician Decision|0
7762260|NCT00736853|26984071|P2|Open-Label Period|Physician Decision|0
7762261|NCT00736853|26984072|P1|Open-Label Period|Physician Decision|2
7762262|NCT00736840|26984112|P1|Overall Study|Lost to Follow-up|13
7762263|NCT00736723|26984119|P2|Overall Study|Withdrawal by Subject|3
7762264|NCT00736723|26984120|P1|Overall Study|Withdrawal by Subject|4
7762265|NCT00736645|26984130|P4|Overall Study|Adverse Event|0
7762266|NCT00736645|26984131|P3|Overall Study|Adverse Event|0
7762267|NCT00736645|26984132|P2|Overall Study|Adverse Event|2
7762268|NCT00736645|26984133|P1|Overall Study|Adverse Event|0
7762269|NCT00736502|26984183|P1|Overall Study|Lost to Follow-up|27
7762270|NCT00736502|26984183|P1|Overall Study|Lack of Efficacy|16
7762271|NCT00736502|26984183|P1|Overall Study|Adverse Event|22
7762272|NCT00736489|26984189|P6|Period 1|Withdrawal by Subject|1
7762273|NCT00736489|26984190|P5|Period 1|Withdrawal by Subject|0
7762274|NCT00736489|26984191|P4|Period 1|Withdrawal by Subject|0
7762275|NCT00736489|26984192|P3|Period 1|Withdrawal by Subject|0
7762276|NCT00736489|26984193|P2|Period 1|Withdrawal by Subject|0
7762277|NCT00736489|26984194|P1|Period 1|Withdrawal by Subject|0
7762278|NCT00736489|26984189|P6|Period 1|Lost to Follow-up|0
7762279|NCT00736489|26984190|P5|Period 1|Lost to Follow-up|0
7762280|NCT00736489|26984191|P4|Period 1|Lost to Follow-up|0
7762281|NCT00736489|26984192|P3|Period 1|Lost to Follow-up|0
7762282|NCT00736489|26984193|P2|Period 1|Lost to Follow-up|0
7762283|NCT00736489|26984194|P1|Period 1|Lost to Follow-up|1
7762284|NCT00736476|26984348|P2|Overall Study|Adverse Event|0
7762285|NCT00736476|26984349|P1|Overall Study|Adverse Event|1
7762286|NCT00736450|26984369|P1|Overall Study|Physician Decision|1
7762287|NCT00736450|26984369|P1|Overall Study|Withdrawal by Subject|5
7762288|NCT00736450|26984369|P1|Overall Study|Not ABC gene eligible|19
7762289|NCT00736385|26984377|P2|Overall Study|Adverse Event|1
7762290|NCT00736385|26984378|P1|Overall Study|Adverse Event|0
7762291|NCT00736385|26984377|P2|Overall Study|Withdrawal by Subject|2
7762292|NCT00736385|26984378|P1|Overall Study|Withdrawal by Subject|2
7762293|NCT00736333|26984390|P1|Overall Study|Other|4
7762294|NCT00736333|26984390|P1|Overall Study|Death|7
7762295|NCT00736333|26984390|P1|Overall Study|Withdrawal by Subject|10
7762296|NCT00736333|26984390|P1|Overall Study|Toxicity|6
7762297|NCT00736333|26984390|P1|Overall Study|Tumor Progression|75
7762298|NCT00736333|26984390|P1|Overall Study|Data Missing|2
7762299|NCT00736333|26984390|P1|Overall Study|Did Not Receive Drug or Not Documented|7
7762300|NCT00736255|26984401|P2|Overall Study|Non-compliance|1
7762301|NCT00736255|26984402|P1|Overall Study|Non-compliance|1
7762302|NCT00736255|26984401|P2|Overall Study|Physician Decision|0
7762303|NCT00736255|26984402|P1|Overall Study|Physician Decision|1
7762304|NCT00736255|26984401|P2|Overall Study|Adverse Event|0
7762305|NCT00736255|26984402|P1|Overall Study|Adverse Event|1
7762306|NCT00736190|26984449|P1|Overall Study|Adverse Event|1
7762307|NCT00736190|26984449|P1|Overall Study|Withdrawal by Subject|1
7762308|NCT00736190|26984449|P1|Overall Study|Pregnancy|1
7762309|NCT00736099|26984479|P2|Overall Study|Other reason|10
7762310|NCT00736099|26984480|P1|Overall Study|Other reason|43
7762311|NCT00736099|26984479|P2|Overall Study|Lack of Efficacy|8
7762312|NCT00736099|26984480|P1|Overall Study|Lack of Efficacy|15
7762313|NCT00736099|26984479|P2|Overall Study|Withdrawal by Subject|13
7762314|NCT00736099|26984480|P1|Overall Study|Withdrawal by Subject|42
7762315|NCT00736099|26984479|P2|Overall Study|Lost to Follow-up|5
7762316|NCT00736099|26984480|P1|Overall Study|Lost to Follow-up|12
7762317|NCT00736099|26984479|P2|Overall Study|Protocol Violation|4
7762318|NCT00736099|26984480|P1|Overall Study|Protocol Violation|10
7762319|NCT00736099|26984479|P2|Overall Study|Adverse Event|18
7762320|NCT00736099|26984480|P1|Overall Study|Adverse Event|61
7762321|NCT00736034|26984589|P1|Overall Study|Adverse Event|2
7762322|NCT00735943|26984597|P1|Overall Study|Adverse Event|1
7762323|NCT00735943|26984597|P1|Overall Study|Lost to Follow-up|1
7762324|NCT00735904|26984622|P1|Overall Study|Other|8
7762325|NCT00735904|26984622|P1|Overall Study|Study Terminated by Sponsor|5
7762326|NCT00735904|26984622|P1|Overall Study|Withdrawal by Subject|1
7762327|NCT00735904|26984622|P1|Overall Study|Protocol Violation|1
7762328|NCT00735904|26984622|P1|Overall Study|Death|20
7762329|NCT00735904|26984622|P1|Overall Study|Adverse Event|3
7762330|NCT00735878|26984632|P3|Phase I- Dose Determination|Withdrawal by Subject|1
7762331|NCT00735878|26984633|P2|Phase I- Dose Determination|Withdrawal by Subject|0
7762332|NCT00735878|26984634|P1|Phase I- Dose Determination|Withdrawal by Subject|0
7762333|NCT00735709|26984713|P4|Overall Study|Excluded medication|1
7762334|NCT00735709|26984714|P3|Overall Study|Excluded medication|0
7762335|NCT00735709|26984715|P2|Overall Study|Excluded medication|0
7762336|NCT00735709|26984716|P1|Overall Study|Excluded medication|1
7762337|NCT00735709|26984713|P4|Overall Study|Lost to Follow-up|1
7762338|NCT00735709|26984714|P3|Overall Study|Lost to Follow-up|1
7762339|NCT00735709|26984715|P2|Overall Study|Lost to Follow-up|1
7762340|NCT00735709|26984716|P1|Overall Study|Lost to Follow-up|0
7762341|NCT00735709|26984713|P4|Overall Study|Voluntary Withdrawal|7
7762342|NCT00735709|26984714|P3|Overall Study|Voluntary Withdrawal|5
7762343|NCT00735709|26984715|P2|Overall Study|Voluntary Withdrawal|3
7762344|NCT00735709|26984716|P1|Overall Study|Voluntary Withdrawal|1
7762345|NCT00735709|26984713|P4|Overall Study|Protocol deviations|1
7762346|NCT00735709|26984714|P3|Overall Study|Protocol deviations|1
7762347|NCT00735709|26984715|P2|Overall Study|Protocol deviations|2
7762348|NCT00735709|26984716|P1|Overall Study|Protocol deviations|1
7762349|NCT00735709|26984713|P4|Overall Study|Noncompliance|0
7762350|NCT00735709|26984714|P3|Overall Study|Noncompliance|1
7762351|NCT00735709|26984715|P2|Overall Study|Noncompliance|0
7762352|NCT00735709|26984716|P1|Overall Study|Noncompliance|0
7762353|NCT00735709|26984713|P4|Overall Study|Lack of Efficacy|3
7762354|NCT00735709|26984714|P3|Overall Study|Lack of Efficacy|2
7762355|NCT00735709|26984715|P2|Overall Study|Lack of Efficacy|4
7762356|NCT00735709|26984716|P1|Overall Study|Lack of Efficacy|8
7762357|NCT00735709|26984713|P4|Overall Study|Adverse Event|5
7762358|NCT00735709|26984714|P3|Overall Study|Adverse Event|1
7762359|NCT00735709|26984715|P2|Overall Study|Adverse Event|3
7762360|NCT00735709|26984716|P1|Overall Study|Adverse Event|2
7762361|NCT00735696|26984826|P1|Overall Study|Enrolled but never Treated|1
7762362|NCT00735696|26984826|P1|Overall Study|Withdrawal by Subject|1
7762363|NCT00735644|26984854|P5|Overall Study|Withdrawal by Subject|0
7762364|NCT00735644|26984855|P4|Overall Study|Withdrawal by Subject|1
7762365|NCT00735644|26984856|P3|Overall Study|Withdrawal by Subject|1
7762366|NCT00735644|26984857|P2|Overall Study|Withdrawal by Subject|1
7762367|NCT00735644|26984858|P1|Overall Study|Withdrawal by Subject|0
7762368|NCT00735644|26984854|P5|Overall Study|Did not receive study vaccine|0
7762369|NCT00735644|26984855|P4|Overall Study|Did not receive study vaccine|0
7762370|NCT00735644|26984856|P3|Overall Study|Did not receive study vaccine|0
7762371|NCT00735644|26984857|P2|Overall Study|Did not receive study vaccine|1
7762372|NCT00735644|26984858|P1|Overall Study|Did not receive study vaccine|0
7762373|NCT00735553|26984902|P1|Overall Study|Study prematurely terminated|77
7762374|NCT00735475|26984912|P2|Overall Study|Withdrawal by Subject|5
7762375|NCT00735475|26984913|P1|Overall Study|Withdrawal by Subject|4
7762376|NCT00735475|26984912|P2|Overall Study|Physician Decision|1
7762377|NCT00735475|26984913|P1|Overall Study|Physician Decision|0
7762378|NCT00735475|26984912|P2|Overall Study|Lost to Follow-up|3
7762379|NCT00735475|26984913|P1|Overall Study|Lost to Follow-up|3
7762380|NCT00735475|26984912|P2|Overall Study|Death|1
7762381|NCT00735475|26984913|P1|Overall Study|Death|1
7762382|NCT00735475|26984912|P2|Overall Study|Adverse Event|1
7762383|NCT00735475|26984913|P1|Overall Study|Adverse Event|0
7762384|NCT00735397|26984973|P1|Overall Study|Administrative/Other|502
7762385|NCT00735397|26984973|P1|Overall Study|Inadequate therapeutic effect|202
7762386|NCT00735397|26984973|P1|Overall Study|Participant choice|252
7762387|NCT00735397|26984973|P1|Overall Study|Lost to Follow-up|33
7762388|NCT00735397|26984973|P1|Overall Study|Adverse Event|194
7762389|NCT00735371|26984987|P4|Overall Study|Exclusion criteria|0
7762390|NCT00735371|26984988|P3|Overall Study|Exclusion criteria|0
7762391|NCT00735371|26984989|P2|Overall Study|Exclusion criteria|0
7762392|NCT00735371|26984990|P1|Overall Study|Exclusion criteria|1
7762393|NCT00735371|26984987|P4|Overall Study|Prior Vyvanse Exposure|0
7762394|NCT00735371|26984988|P3|Overall Study|Prior Vyvanse Exposure|0
7762395|NCT00735371|26984989|P2|Overall Study|Prior Vyvanse Exposure|1
7762396|NCT00735371|26984990|P1|Overall Study|Prior Vyvanse Exposure|1
7762397|NCT00735371|26984987|P4|Overall Study|Protocol Violation|0
7762398|NCT00735371|26984988|P3|Overall Study|Protocol Violation|2
7762399|NCT00735371|26984989|P2|Overall Study|Protocol Violation|1
7762400|NCT00735371|26984990|P1|Overall Study|Protocol Violation|0
7762401|NCT00735371|26984987|P4|Overall Study|Sponsor Decision|1
7762402|NCT00735371|26984988|P3|Overall Study|Sponsor Decision|0
7762403|NCT00735371|26984989|P2|Overall Study|Sponsor Decision|1
7762404|NCT00735371|26984990|P1|Overall Study|Sponsor Decision|3
7762405|NCT00735371|26984987|P4|Overall Study|Lack of Efficacy|4
7762406|NCT00735371|26984988|P3|Overall Study|Lack of Efficacy|0
7762407|NCT00735371|26984989|P2|Overall Study|Lack of Efficacy|2
7762408|NCT00735371|26984990|P1|Overall Study|Lack of Efficacy|4
7762409|NCT00735371|26984987|P4|Overall Study|Lost to Follow-up|1
7762410|NCT00735371|26984988|P3|Overall Study|Lost to Follow-up|3
7762411|NCT00735371|26984989|P2|Overall Study|Lost to Follow-up|1
7762412|NCT00735371|26984990|P1|Overall Study|Lost to Follow-up|1
7762413|NCT00735371|26984987|P4|Overall Study|Withdrawal by Subject|0
7762414|NCT00735371|26984988|P3|Overall Study|Withdrawal by Subject|2
7762415|NCT00735371|26984989|P2|Overall Study|Withdrawal by Subject|2
7762416|NCT00735371|26984990|P1|Overall Study|Withdrawal by Subject|0
7762417|NCT00735371|26984987|P4|Overall Study|Protocol Violation|3
7762418|NCT00735371|26984988|P3|Overall Study|Protocol Violation|0
7762419|NCT00735371|26984989|P2|Overall Study|Protocol Violation|2
7762420|NCT00735371|26984990|P1|Overall Study|Protocol Violation|2
7762421|NCT00735371|26984987|P4|Overall Study|Adverse Event|1
7762422|NCT00735371|26984988|P3|Overall Study|Adverse Event|4
7762423|NCT00735371|26984989|P2|Overall Study|Adverse Event|3
7762424|NCT00735371|26984990|P1|Overall Study|Adverse Event|3
7762425|NCT00735254|26985018|P4|Overall Study|Protocol Violation|0
7762426|NCT00735254|26985019|P3|Overall Study|Protocol Violation|1
7762427|NCT00735254|26985020|P2|Overall Study|Protocol Violation|1
7762428|NCT00735254|26985021|P1|Overall Study|Protocol Violation|1
7762429|NCT00735072|26985033|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
7762430|NCT00735072|26985034|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
7762431|NCT00735072|26985033|P2|Overall Study|interrupted study med during ARV change|0
7762432|NCT00735072|26985034|P1|Overall Study|interrupted study med during ARV change|1
7762433|NCT00735007|26985048|P1|Overall Study|Protocol Violation|1
7762434|NCT00735007|26985048|P1|Overall Study|Adverse Event|4
7762435|NCT00734994|26985073|P1|Overall Study|Withdrawal by Subject|1
7762436|NCT00734929|26985093|P2|Overall Study|No intervention/ screen fail|3
7762437|NCT00734929|26985094|P1|Overall Study|No intervention/ screen fail|5
7762438|NCT00734929|26985093|P2|Overall Study|Lost to Follow-up|2
7762439|NCT00734929|26985094|P1|Overall Study|Lost to Follow-up|1
7762440|NCT00734851|26985151|P1|Overall Study|Physician Decision|18
7762441|NCT00734851|26985151|P1|Overall Study|Lost to Follow-up|1
7762442|NCT00734851|26985151|P1|Overall Study|Withdrawal by Subject|2
7762443|NCT00734747|26985172|P1|6 Month Follow-up|Did not meet inclusion criteria|3
7762444|NCT00734747|26985172|P1|SRS Procedure|No staples placed|3
7762445|NCT00734656|26985186|P4|Lab Session 4|Withdrawal by Subject|1
7762446|NCT00734656|26985187|P3|Lab Session 4|Withdrawal by Subject|0
7762447|NCT00734656|26985188|P2|Lab Session 4|Withdrawal by Subject|0
7762448|NCT00734656|26985189|P1|Lab Session 4|Withdrawal by Subject|0
7762449|NCT00734656|26985186|P4|Washout 3|Withdrawal by Subject|1
7762450|NCT00734656|26985187|P3|Washout 3|Withdrawal by Subject|0
7762451|NCT00734656|26985188|P2|Washout 3|Withdrawal by Subject|0
7762452|NCT00734656|26985189|P1|Washout 3|Withdrawal by Subject|1
7762453|NCT00734656|26985186|P4|Washout 2|Withdrawal by Subject|0
7762454|NCT00734656|26985187|P3|Washout 2|Withdrawal by Subject|1
7762455|NCT00734656|26985188|P2|Washout 2|Withdrawal by Subject|1
7762456|NCT00734656|26985189|P1|Washout 2|Withdrawal by Subject|1
7762457|NCT00734656|26985186|P4|Lab Session 2|Withdrawal by Subject|1
7762458|NCT00734656|26985187|P3|Lab Session 2|Withdrawal by Subject|0
7762459|NCT00734656|26985188|P2|Lab Session 2|Withdrawal by Subject|0
7762460|NCT00734656|26985189|P1|Lab Session 2|Withdrawal by Subject|1
7762461|NCT00734656|26985186|P4|Washout 1|Withdrawal by Subject|3
7762462|NCT00734656|26985187|P3|Washout 1|Withdrawal by Subject|2
7762463|NCT00734656|26985188|P2|Washout 1|Withdrawal by Subject|5
7762464|NCT00734656|26985189|P1|Washout 1|Withdrawal by Subject|1
7762465|NCT00734656|26985186|P4|Lab Session 1|Withdrawal by Subject|0
7762466|NCT00734656|26985187|P3|Lab Session 1|Withdrawal by Subject|0
7762467|NCT00734656|26985188|P2|Lab Session 1|Withdrawal by Subject|0
7762468|NCT00734656|26985189|P1|Lab Session 1|Withdrawal by Subject|2
7762469|NCT00734630|26985213|P2|Overall Study|Poor Compliance|1
7762470|NCT00734630|26985214|P1|Overall Study|Poor Compliance|1
7762471|NCT00734630|26985213|P2|Overall Study|Tested Positive for Illegal Drug Use|1
7762472|NCT00734630|26985214|P1|Overall Study|Tested Positive for Illegal Drug Use|1
7762473|NCT00734630|26985213|P2|Overall Study|Randomized in Error|1
7762474|NCT00734630|26985214|P1|Overall Study|Randomized in Error|0
7762475|NCT00734630|26985213|P2|Overall Study|Adverse Event|6
7762476|NCT00734630|26985214|P1|Overall Study|Adverse Event|3
7762477|NCT00734630|26985213|P2|Overall Study|Inclusion/Exclusion criteria not met|1
7762478|NCT00734630|26985214|P1|Overall Study|Inclusion/Exclusion criteria not met|0
7762479|NCT00734630|26985213|P2|Overall Study|Protocol Violation|3
7762480|NCT00734630|26985214|P1|Overall Study|Protocol Violation|0
7762481|NCT00734630|26985213|P2|Overall Study|Lost to Follow-up|7
7762482|NCT00734630|26985214|P1|Overall Study|Lost to Follow-up|13
7762483|NCT00734630|26985213|P2|Overall Study|Withdrawal by Subject|9
7762484|NCT00734630|26985214|P1|Overall Study|Withdrawal by Subject|7
7762485|NCT00734630|26985213|P2|Overall Study|Lack of Efficacy|4
7762486|NCT00734630|26985214|P1|Overall Study|Lack of Efficacy|4
7762487|NCT00734617|26985224|P2|Overall Study|Withdrawal by Subject|95
7762488|NCT00734617|26985225|P1|Overall Study|Withdrawal by Subject|103
7762489|NCT00734617|26985224|P2|Overall Study|Adverse Event|7
7762490|NCT00734617|26985225|P1|Overall Study|Adverse Event|4
7762491|NCT00734604|26985237|P6|Overall Study|Lack of Efficacy|0
7762492|NCT00734604|26985238|P5|Overall Study|Lack of Efficacy|0
7762493|NCT00734604|26985239|P4|Overall Study|Lack of Efficacy|0
7762494|NCT00734604|26985240|P3|Overall Study|Lack of Efficacy|1
7762495|NCT00734604|26985241|P2|Overall Study|Lack of Efficacy|1
7762496|NCT00734604|26985242|P1|Overall Study|Lack of Efficacy|0
7762497|NCT00734604|26985237|P6|Overall Study|Withdrawal by Subject|1
7762498|NCT00734604|26985238|P5|Overall Study|Withdrawal by Subject|2
7762499|NCT00734604|26985239|P4|Overall Study|Withdrawal by Subject|1
7762500|NCT00734604|26985240|P3|Overall Study|Withdrawal by Subject|0
7762501|NCT00734604|26985241|P2|Overall Study|Withdrawal by Subject|2
7762502|NCT00734604|26985242|P1|Overall Study|Withdrawal by Subject|0
7762503|NCT00734604|26985237|P6|Overall Study|Sponsor Decision|0
7762504|NCT00734604|26985238|P5|Overall Study|Sponsor Decision|2
7762505|NCT00734604|26985239|P4|Overall Study|Sponsor Decision|0
7762506|NCT00734604|26985240|P3|Overall Study|Sponsor Decision|1
7762507|NCT00734604|26985241|P2|Overall Study|Sponsor Decision|2
7762508|NCT00734604|26985242|P1|Overall Study|Sponsor Decision|1
7762509|NCT00734604|26985237|P6|Overall Study|Protocol Violation|0
7762510|NCT00734604|26985238|P5|Overall Study|Protocol Violation|1
7762511|NCT00734604|26985239|P4|Overall Study|Protocol Violation|0
7762512|NCT00734604|26985240|P3|Overall Study|Protocol Violation|0
7762513|NCT00734604|26985241|P2|Overall Study|Protocol Violation|2
7762514|NCT00734604|26985242|P1|Overall Study|Protocol Violation|0
7762515|NCT00734604|26985237|P6|Overall Study|Physician Decision|0
7762516|NCT00734604|26985238|P5|Overall Study|Physician Decision|0
7762517|NCT00734604|26985239|P4|Overall Study|Physician Decision|0
7762518|NCT00734604|26985240|P3|Overall Study|Physician Decision|1
7762519|NCT00734604|26985241|P2|Overall Study|Physician Decision|1
7762520|NCT00734604|26985242|P1|Overall Study|Physician Decision|0
7762521|NCT00734604|26985237|P6|Overall Study|Lost to Follow-up|3
7762522|NCT00734604|26985238|P5|Overall Study|Lost to Follow-up|2
7762523|NCT00734604|26985239|P4|Overall Study|Lost to Follow-up|4
7762524|NCT00734604|26985240|P3|Overall Study|Lost to Follow-up|2
7762525|NCT00734604|26985241|P2|Overall Study|Lost to Follow-up|2
7762526|NCT00734604|26985242|P1|Overall Study|Lost to Follow-up|1
7762527|NCT00734604|26985237|P6|Overall Study|Serious Adverse Event|1
7762528|NCT00734604|26985238|P5|Overall Study|Serious Adverse Event|0
7762529|NCT00734604|26985239|P4|Overall Study|Serious Adverse Event|2
7762530|NCT00734604|26985240|P3|Overall Study|Serious Adverse Event|1
7762531|NCT00734604|26985241|P2|Overall Study|Serious Adverse Event|0
7762532|NCT00734604|26985242|P1|Overall Study|Serious Adverse Event|1
7762533|NCT00734604|26985237|P6|Overall Study|Adverse Event|1
7762534|NCT00734604|26985238|P5|Overall Study|Adverse Event|1
7762535|NCT00734604|26985239|P4|Overall Study|Adverse Event|2
7762536|NCT00734604|26985240|P3|Overall Study|Adverse Event|0
7762537|NCT00734604|26985241|P2|Overall Study|Adverse Event|2
7762538|NCT00734604|26985242|P1|Overall Study|Adverse Event|0
7762539|NCT00734591|26985292|P2|Prospective Period|Other|2
7762540|NCT00734591|26985293|P1|Prospective Period|Other|2
7762541|NCT00734591|26985292|P2|Prospective Period|Study Terminated|0
7762542|NCT00734591|26985293|P1|Prospective Period|Study Terminated|1
7762543|NCT00734591|26985292|P2|Prospective Period|Lost to Follow-up|33
7762544|NCT00734591|26985293|P1|Prospective Period|Lost to Follow-up|37
7762545|NCT00734591|26985292|P2|Prospective Period|Withdrawal by Subject|9
7762546|NCT00734591|26985293|P1|Prospective Period|Withdrawal by Subject|11
7762547|NCT00734591|26985292|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
7762548|NCT00734591|26985293|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
7762549|NCT00734591|26985292|P2|Screening for Prospective Period|Site did not participate|1488
7762550|NCT00734591|26985293|P1|Screening for Prospective Period|Site did not participate|1604
7762551|NCT00734578|26985308|P3|Overall Study|Exclusion criteria|0
7762552|NCT00734578|26985309|P2|Overall Study|Exclusion criteria|0
7762553|NCT00734578|26985310|P1|Overall Study|Exclusion criteria|1
7762554|NCT00734578|26985308|P3|Overall Study|Randomized in error|0
7762555|NCT00734578|26985309|P2|Overall Study|Randomized in error|0
7762556|NCT00734578|26985310|P1|Overall Study|Randomized in error|1
7762557|NCT00734578|26985308|P3|Overall Study|Lack of Efficacy|5
7762558|NCT00734578|26985309|P2|Overall Study|Lack of Efficacy|2
7762559|NCT00734578|26985310|P1|Overall Study|Lack of Efficacy|3
7762560|NCT00734578|26985308|P3|Overall Study|Lost to Follow-up|5
7762561|NCT00734578|26985309|P2|Overall Study|Lost to Follow-up|3
7762562|NCT00734578|26985310|P1|Overall Study|Lost to Follow-up|9
7762563|NCT00734578|26985308|P3|Overall Study|Withdrawal by Subject|11
7762564|NCT00734578|26985309|P2|Overall Study|Withdrawal by Subject|8
7762565|NCT00734578|26985310|P1|Overall Study|Withdrawal by Subject|7
7762566|NCT00734578|26985308|P3|Overall Study|Protocol Violation|3
7762567|NCT00734578|26985309|P2|Overall Study|Protocol Violation|6
7762568|NCT00734578|26985310|P1|Overall Study|Protocol Violation|8
7762569|NCT00734578|26985308|P3|Overall Study|Adverse Event|1
7762570|NCT00734578|26985309|P2|Overall Study|Adverse Event|6
7762571|NCT00734578|26985310|P1|Overall Study|Adverse Event|4
7762572|NCT00734539|26985344|P2|Main Study|Enrolled in error; ineligible|0
7762573|NCT00734539|26985345|P1|Main Study|Enrolled in error; ineligible|1
7762574|NCT00734539|26985344|P2|Main Study|Withdrawal by Subject|3
7762575|NCT00734539|26985345|P1|Main Study|Withdrawal by Subject|1
7762576|NCT00734539|26985344|P2|Main Study|Physician Decision|0
7762577|NCT00734539|26985345|P1|Main Study|Physician Decision|2
7762578|NCT00734539|26985344|P2|Main Study|Death|32
7762579|NCT00734539|26985345|P1|Main Study|Death|33
7762580|NCT00734474|26985387|P9|Overall Study|Lack of Efficacy|6
7762581|NCT00734474|26985388|P8|Overall Study|Lack of Efficacy|4
7762582|NCT00734474|26985389|P7|Overall Study|Lack of Efficacy|0
7762583|NCT00734474|26985390|P6|Overall Study|Lack of Efficacy|0
7762584|NCT00734474|26985391|P5|Overall Study|Lack of Efficacy|0
7762585|NCT00734474|26985392|P4|Overall Study|Lack of Efficacy|0
7762586|NCT00734474|26985393|P3|Overall Study|Lack of Efficacy|4
7762587|NCT00734474|26985394|P2|Overall Study|Lack of Efficacy|0
7762588|NCT00734474|26985395|P1|Overall Study|Lack of Efficacy|0
7762589|NCT00734474|26985387|P9|Overall Study|Death|1
7762590|NCT00734474|26985388|P8|Overall Study|Death|2
7762591|NCT00734474|26985389|P7|Overall Study|Death|0
7762592|NCT00734474|26985390|P6|Overall Study|Death|0
7762593|NCT00734474|26985391|P5|Overall Study|Death|0
7762594|NCT00734474|26985392|P4|Overall Study|Death|0
7762595|NCT00734474|26985393|P3|Overall Study|Death|1
7762596|NCT00734474|26985394|P2|Overall Study|Death|0
7762597|NCT00734474|26985395|P1|Overall Study|Death|0
7762598|NCT00734474|26985387|P9|Overall Study|Sponsor Decision|0
7762599|NCT00734474|26985388|P8|Overall Study|Sponsor Decision|0
7762600|NCT00734474|26985389|P7|Overall Study|Sponsor Decision|0
7762601|NCT00734474|26985390|P6|Overall Study|Sponsor Decision|0
7762602|NCT00734474|26985391|P5|Overall Study|Sponsor Decision|2
7762603|NCT00734474|26985392|P4|Overall Study|Sponsor Decision|0
7762604|NCT00734474|26985393|P3|Overall Study|Sponsor Decision|0
7762605|NCT00734474|26985394|P2|Overall Study|Sponsor Decision|0
7762606|NCT00734474|26985395|P1|Overall Study|Sponsor Decision|0
7762607|NCT00734474|26985387|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
7762608|NCT00734474|26985388|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
7762609|NCT00734474|26985389|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
7762610|NCT00734474|26985390|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
7762611|NCT00734474|26985391|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
7762612|NCT00734474|26985392|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
7762613|NCT00734474|26985393|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
7762614|NCT00734474|26985394|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
7762615|NCT00734474|26985395|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
7762616|NCT00734474|26985387|P9|Overall Study|Protocol Violation|1
7762617|NCT00734474|26985388|P8|Overall Study|Protocol Violation|3
7762618|NCT00734474|26985389|P7|Overall Study|Protocol Violation|0
7762619|NCT00734474|26985390|P6|Overall Study|Protocol Violation|0
7762620|NCT00734474|26985391|P5|Overall Study|Protocol Violation|3
7762621|NCT00734474|26985392|P4|Overall Study|Protocol Violation|0
7762622|NCT00734474|26985393|P3|Overall Study|Protocol Violation|4
7762623|NCT00734474|26985394|P2|Overall Study|Protocol Violation|0
7762624|NCT00734474|26985395|P1|Overall Study|Protocol Violation|0
7762625|NCT00734474|26985387|P9|Overall Study|Adverse Event|39
7762626|NCT00734474|26985388|P8|Overall Study|Adverse Event|65
7762627|NCT00734474|26985389|P7|Overall Study|Adverse Event|1
7762628|NCT00734474|26985390|P6|Overall Study|Adverse Event|0
7762629|NCT00734474|26985391|P5|Overall Study|Adverse Event|64
7762630|NCT00734474|26985392|P4|Overall Study|Adverse Event|1
7762631|NCT00734474|26985393|P3|Overall Study|Adverse Event|63
7762632|NCT00734474|26985394|P2|Overall Study|Adverse Event|4
7762633|NCT00734474|26985395|P1|Overall Study|Adverse Event|4
7762634|NCT00734474|26985387|P9|Overall Study|Physician Decision|9
7762635|NCT00734474|26985388|P8|Overall Study|Physician Decision|9
7762636|NCT00734474|26985389|P7|Overall Study|Physician Decision|0
7762637|NCT00734474|26985390|P6|Overall Study|Physician Decision|0
7762638|NCT00734474|26985391|P5|Overall Study|Physician Decision|11
7762639|NCT00734474|26985392|P4|Overall Study|Physician Decision|1
7762640|NCT00734474|26985393|P3|Overall Study|Physician Decision|4
7762641|NCT00734474|26985394|P2|Overall Study|Physician Decision|0
7762642|NCT00734474|26985395|P1|Overall Study|Physician Decision|0
7762643|NCT00734474|26985387|P9|Overall Study|Withdrawal by Subject|21
7762644|NCT00734474|26985388|P8|Overall Study|Withdrawal by Subject|36
7762645|NCT00734474|26985389|P7|Overall Study|Withdrawal by Subject|0
7762646|NCT00734474|26985390|P6|Overall Study|Withdrawal by Subject|2
7762647|NCT00734474|26985391|P5|Overall Study|Withdrawal by Subject|24
7762648|NCT00734474|26985392|P4|Overall Study|Withdrawal by Subject|0
7762649|NCT00734474|26985393|P3|Overall Study|Withdrawal by Subject|18
7762650|NCT00734474|26985394|P2|Overall Study|Withdrawal by Subject|1
7762651|NCT00734474|26985395|P1|Overall Study|Withdrawal by Subject|2
7762652|NCT00734474|26985387|P9|Overall Study|Lost to Follow-up|4
7762653|NCT00734474|26985388|P8|Overall Study|Lost to Follow-up|9
7762654|NCT00734474|26985389|P7|Overall Study|Lost to Follow-up|0
7762655|NCT00734474|26985390|P6|Overall Study|Lost to Follow-up|1
7762656|NCT00734474|26985391|P5|Overall Study|Lost to Follow-up|11
7762657|NCT00734474|26985392|P4|Overall Study|Lost to Follow-up|0
7762658|NCT00734474|26985393|P3|Overall Study|Lost to Follow-up|13
7762659|NCT00734474|26985394|P2|Overall Study|Lost to Follow-up|0
7762660|NCT00734474|26985395|P1|Overall Study|Lost to Follow-up|1
7762661|NCT00734474|26985387|P9|Overall Study|Entry Criteria Not Met|1
7762662|NCT00734474|26985388|P8|Overall Study|Entry Criteria Not Met|1
7762663|NCT00734474|26985389|P7|Overall Study|Entry Criteria Not Met|0
7762664|NCT00734474|26985390|P6|Overall Study|Entry Criteria Not Met|1
7762665|NCT00734474|26985391|P5|Overall Study|Entry Criteria Not Met|3
7762666|NCT00734474|26985392|P4|Overall Study|Entry Criteria Not Met|0
7762667|NCT00734474|26985393|P3|Overall Study|Entry Criteria Not Met|5
7762668|NCT00734474|26985394|P2|Overall Study|Entry Criteria Not Met|0
7762669|NCT00734474|26985395|P1|Overall Study|Entry Criteria Not Met|0
7762670|NCT00734214|26985685|P2|Overall Study|MD withdrawal|0
7762671|NCT00734214|26985686|P1|Overall Study|MD withdrawal|1
7762672|NCT00734214|26985685|P2|Overall Study|Withdrawal by Subject|4
7762673|NCT00734214|26985686|P1|Overall Study|Withdrawal by Subject|3
7762674|NCT00734162|26985696|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
7762675|NCT00734162|26985697|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
7762676|NCT00734162|26985698|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
7762677|NCT00734162|26985699|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
7762678|NCT00734162|26985696|P4|Open-Label Phase|Lost to Follow-up|1
7762679|NCT00734162|26985697|P3|Open-Label Phase|Lost to Follow-up|0
7762680|NCT00734162|26985698|P2|Open-Label Phase|Lost to Follow-up|2
7762681|NCT00734162|26985699|P1|Open-Label Phase|Lost to Follow-up|1
7762682|NCT00734162|26985696|P4|Open-Label Phase|Withdrew Consent|1
7762683|NCT00734162|26985697|P3|Open-Label Phase|Withdrew Consent|1
7762684|NCT00734162|26985698|P2|Open-Label Phase|Withdrew Consent|0
7762685|NCT00734162|26985699|P1|Open-Label Phase|Withdrew Consent|1
7762686|NCT00734162|26985696|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7762687|NCT00734162|26985697|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7762688|NCT00734162|26985698|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7762689|NCT00734162|26985699|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
7762690|NCT00734162|26985696|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
7762691|NCT00734162|26985697|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7762692|NCT00734162|26985698|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7762693|NCT00734162|26985699|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7762694|NCT00734162|26985696|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
7762695|NCT00734162|26985697|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
7762696|NCT00734162|26985698|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
7762697|NCT00734162|26985699|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
7762698|NCT00734149|26985923|P1|Overall Study|Withdrawal by Subject|1
7762699|NCT00734097|26985930|P1|Open Label|Protocol Violation|4
7762700|NCT00734097|26985930|P1|Open Label|Withdrawal by Subject|5
7762701|NCT00734097|26985930|P1|Open Label|Lost to Follow-up|7
7762702|NCT00734097|26985930|P1|Screening|Unconfirmed pregnancy|1
7762703|NCT00734097|26985930|P1|Screening|Lost to Follow-up|2
7762704|NCT00734097|26985930|P1|Screening|Withdrawal by Subject|5
7762705|NCT00734097|26985930|P1|Screening|Protocol Violation|12
7762706|NCT00734071|26985947|P2|Overall Study|Other|2
7762707|NCT00734071|26985948|P1|Overall Study|Other|1
7762708|NCT00734071|26985947|P2|Overall Study|Lost to Follow-up|8
7762709|NCT00734071|26985948|P1|Overall Study|Lost to Follow-up|16
7762710|NCT00734071|26985947|P2|Overall Study|Voluntary Withdrawal|7
7762711|NCT00734071|26985948|P1|Overall Study|Voluntary Withdrawal|9
7762712|NCT00734071|26985947|P2|Overall Study|Protocol Deviations|4
7762713|NCT00734071|26985948|P1|Overall Study|Protocol Deviations|3
7762714|NCT00734071|26985947|P2|Overall Study|Noncompliance|2
7762715|NCT00734071|26985948|P1|Overall Study|Noncompliance|2
7762716|NCT00734071|26985947|P2|Overall Study|Lack of Efficacy|1
7762717|NCT00734071|26985948|P1|Overall Study|Lack of Efficacy|3
7762718|NCT00734071|26985947|P2|Overall Study|Adverse Event|3
7762719|NCT00734071|26985948|P1|Overall Study|Adverse Event|4
7762720|NCT00734032|26986006|P4|Overall Study|Adverse Event|0
7762721|NCT00734032|26986007|P3|Overall Study|Adverse Event|0
7762722|NCT00734032|26986008|P2|Overall Study|Adverse Event|1
7762723|NCT00734032|26986009|P1|Overall Study|Adverse Event|0
7762724|NCT00733980|26986065|P2|Overall Study|Withdrawal by Subject|2
7762725|NCT00733980|26986066|P1|Overall Study|Withdrawal by Subject|6
7762726|NCT00733980|26986065|P2|Overall Study|Physician Decision|3
7762727|NCT00733980|26986066|P1|Overall Study|Physician Decision|2
7762728|NCT00733980|26986065|P2|Overall Study|Lost to Follow-up|11
7762729|NCT00733980|26986066|P1|Overall Study|Lost to Follow-up|6
7762730|NCT00733980|26986065|P2|Overall Study|Protocol defined stopping criteria reach|1
7762731|NCT00733980|26986066|P1|Overall Study|Protocol defined stopping criteria reach|1
7762732|NCT00733980|26986065|P2|Overall Study|Protocol Violation|1
7762733|NCT00733980|26986066|P1|Overall Study|Protocol Violation|2
7762734|NCT00733980|26986065|P2|Overall Study|Lack of Efficacy|1
7762735|NCT00733980|26986066|P1|Overall Study|Lack of Efficacy|0
7762736|NCT00733980|26986065|P2|Overall Study|Adverse Event|2
7762737|NCT00733980|26986066|P1|Overall Study|Adverse Event|5
7762738|NCT00733954|26986110|P2|Overall Study|Withdrawal by Subject|0
7762739|NCT00733954|26986111|P1|Overall Study|Withdrawal by Subject|2
7762740|NCT00733954|26986110|P2|Overall Study|Protocol Violation|0
7762741|NCT00733954|26986111|P1|Overall Study|Protocol Violation|1
7762742|NCT00733954|26986110|P2|Overall Study|Lost to Follow-up|2
7762743|NCT00733954|26986111|P1|Overall Study|Lost to Follow-up|5
7762744|NCT00733902|26986157|P4|Overall Study|Randomized but not treated|1
7762745|NCT00733902|26986158|P3|Overall Study|Randomized but not treated|2
7762746|NCT00733902|26986159|P2|Overall Study|Randomized but not treated|2
7762747|NCT00733902|26986160|P1|Overall Study|Randomized but not treated|2
7762748|NCT00733902|26986157|P4|Overall Study|Entered extension study|109
7762749|NCT00733902|26986158|P3|Overall Study|Entered extension study|111
7762750|NCT00733902|26986159|P2|Overall Study|Entered extension study|124
7762751|NCT00733902|26986160|P1|Overall Study|Entered extension study|89
7762752|NCT00733902|26986157|P4|Overall Study|Withdrawal by Subject|16
7762753|NCT00733902|26986158|P3|Overall Study|Withdrawal by Subject|4
7762754|NCT00733902|26986159|P2|Overall Study|Withdrawal by Subject|5
7762755|NCT00733902|26986160|P1|Overall Study|Withdrawal by Subject|10
7762756|NCT00733902|26986157|P4|Overall Study|Protocol Violation|3
7762757|NCT00733902|26986158|P3|Overall Study|Protocol Violation|3
7762758|NCT00733902|26986159|P2|Overall Study|Protocol Violation|6
7762759|NCT00733902|26986160|P1|Overall Study|Protocol Violation|4
7762760|NCT00733902|26986157|P4|Overall Study|Lack of Efficacy|23
7762761|NCT00733902|26986158|P3|Overall Study|Lack of Efficacy|34
7762762|NCT00733902|26986159|P2|Overall Study|Lack of Efficacy|21
7762763|NCT00733902|26986160|P1|Overall Study|Lack of Efficacy|56
7762764|NCT00733902|26986157|P4|Overall Study|Adverse Event|11
7762765|NCT00733902|26986158|P3|Overall Study|Adverse Event|7
7762766|NCT00733902|26986159|P2|Overall Study|Adverse Event|4
7762767|NCT00733902|26986160|P1|Overall Study|Adverse Event|3
7762768|NCT00733902|26986157|P4|Overall Study|Death|1
7762769|NCT00733902|26986158|P3|Overall Study|Death|0
7762770|NCT00733902|26986159|P2|Overall Study|Death|0
7762771|NCT00733902|26986160|P1|Overall Study|Death|0
7762772|NCT00733824|26986283|P5|Phase I|Withdrawal by Subject|0
7762773|NCT00733824|26986284|P4|Phase I|Withdrawal by Subject|0
7762774|NCT00733824|26986285|P3|Phase I|Withdrawal by Subject|0
7762775|NCT00733824|26986286|P2|Phase I|Withdrawal by Subject|0
7762776|NCT00733824|26986287|P1|Phase I|Withdrawal by Subject|1
7762777|NCT00733746|26986306|P1|Overall Study|Ineligible|5
7762778|NCT00733499|26986321|P2|10 Year Followup|missing, unable to locate|2
7762779|NCT00733499|26986322|P1|10 Year Followup|missing, unable to locate|0
7762780|NCT00733499|26986321|P2|10 Year Followup|Withdrawal by Subject|5
7762781|NCT00733499|26986322|P1|10 Year Followup|Withdrawal by Subject|5
7762782|NCT00733499|26986321|P2|10 Year Followup|Lost to Follow-up|2
7762783|NCT00733499|26986322|P1|10 Year Followup|Lost to Follow-up|3
7762784|NCT00733499|26986321|P2|10 Year Followup|Adverse Event|3
7762785|NCT00733499|26986322|P1|10 Year Followup|Adverse Event|3
7762786|NCT00733499|26986321|P2|10 Year Followup|Death|7
7762787|NCT00733499|26986322|P1|10 Year Followup|Death|9
7762788|NCT00733499|26986321|P2|5 Year Followup|Withdrawal by Subject|1
7762789|NCT00733499|26986322|P1|5 Year Followup|Withdrawal by Subject|4
7762790|NCT00733499|26986321|P2|5 Year Followup|missing, unable to locate|1
7762791|NCT00733499|26986322|P1|5 Year Followup|missing, unable to locate|0
7762792|NCT00733499|26986321|P2|5 Year Followup|Death|19
7762793|NCT00733499|26986322|P1|5 Year Followup|Death|13
7762794|NCT00733499|26986321|P2|5 Year Followup|Lost to Follow-up|0
7762795|NCT00733499|26986322|P1|5 Year Followup|Lost to Follow-up|2
7762796|NCT00733499|26986321|P2|5 Year Followup|Revision of Study Implant|1
7762797|NCT00733499|26986322|P1|5 Year Followup|Revision of Study Implant|0
7762798|NCT00733499|26986321|P2|5 Year Followup|Non device related AE|1
7762799|NCT00733499|26986322|P1|5 Year Followup|Non device related AE|0
7762800|NCT00733499|26986321|P2|5 Year Followup|Adverse Event|2
7762801|NCT00733499|26986322|P1|5 Year Followup|Adverse Event|2
7762802|NCT00733499|26986321|P2|24 Months Follow-up|Death|1
7762803|NCT00733499|26986322|P1|24 Months Follow-up|Death|0
7762804|NCT00733499|26986321|P2|12 Months Follow-up|Death|1
7762805|NCT00733499|26986322|P1|12 Months Follow-up|Death|2
7762806|NCT00733499|26986321|P2|6 Months Follow-up|Adverse Event|1
7762807|NCT00733499|26986322|P1|6 Months Follow-up|Adverse Event|0
7762808|NCT00733499|26986321|P2|6 Months Follow-up|Death|2
7762809|NCT00733499|26986322|P1|6 Months Follow-up|Death|0
7762810|NCT00733499|26986321|P2|3 Months Follow-up|Death|2
7762811|NCT00733499|26986322|P1|3 Months Follow-up|Death|1
7762812|NCT00733499|26986321|P2|Pre-operative|Protocol Violation|1
7762813|NCT00733499|26986322|P1|Pre-operative|Protocol Violation|0
7762814|NCT00733421|26986382|P2|Overall Study|Withdrawal by Subject|1
7762815|NCT00733421|26986383|P1|Overall Study|Withdrawal by Subject|1
7762816|NCT00733408|26986405|P1|Overall Study|Adverse Event|4
7762817|NCT00733369|26986417|P2|Overall Study|Protocol Violation|4
7762818|NCT00733369|26986418|P1|Overall Study|Protocol Violation|4
7762819|NCT00733369|26986417|P2|Overall Study|Adverse Event|4
7762820|NCT00733369|26986418|P1|Overall Study|Adverse Event|4
7762821|NCT00733369|26986417|P2|Overall Study|Lost to Follow-up|1
7762822|NCT00733369|26986418|P1|Overall Study|Lost to Follow-up|2
7762823|NCT00733304|26986717|P3|Overall Study|Withdrawal by Subject|0
7762824|NCT00733304|26986718|P2|Overall Study|Withdrawal by Subject|1
7762825|NCT00733304|26986719|P1|Overall Study|Withdrawal by Subject|1
7762826|NCT00733304|26986717|P3|Overall Study|Physician Decision|3
7762827|NCT00733304|26986718|P2|Overall Study|Physician Decision|1
7762828|NCT00733304|26986719|P1|Overall Study|Physician Decision|3
7762829|NCT00733304|26986717|P3|Overall Study|Lost to Follow-up|0
7762830|NCT00733304|26986718|P2|Overall Study|Lost to Follow-up|1
7762831|NCT00733304|26986719|P1|Overall Study|Lost to Follow-up|0
7762832|NCT00733304|26986717|P3|Overall Study|Lack of Efficacy|2
7762833|NCT00733304|26986718|P2|Overall Study|Lack of Efficacy|0
7762834|NCT00733304|26986719|P1|Overall Study|Lack of Efficacy|0
7762835|NCT00733304|26986717|P3|Overall Study|Adverse Event|0
7762836|NCT00733304|26986718|P2|Overall Study|Adverse Event|0
7762837|NCT00733304|26986719|P1|Overall Study|Adverse Event|3
7762838|NCT00733291|26986801|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7762839|NCT00733291|26986802|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7762840|NCT00733291|26986803|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7762841|NCT00733291|26986804|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
7762842|NCT00733226|26986833|P2|Overall Study|moved to another place|0
7762843|NCT00733226|26986834|P1|Overall Study|moved to another place|2
7762844|NCT00733226|26986833|P2|Overall Study|Lost to Follow-up|0
7762845|NCT00733226|26986834|P1|Overall Study|Lost to Follow-up|2
7762846|NCT00733226|26986833|P2|Overall Study|Withdrawal by Subject|0
7762847|NCT00733226|26986834|P1|Overall Study|Withdrawal by Subject|1
7762848|NCT00733005|26986883|P2|Overall Study|Protocol Violation|0
7762849|NCT00733005|26986884|P1|Overall Study|Protocol Violation|2
7762850|NCT00733005|26986883|P2|Overall Study|Withdrawal by Subject|1
7762851|NCT00733005|26986884|P1|Overall Study|Withdrawal by Subject|0
7762852|NCT00733005|26986883|P2|Overall Study|Treatment Failure|1
7762853|NCT00733005|26986884|P1|Overall Study|Treatment Failure|0
7762854|NCT00733005|26986883|P2|Overall Study|Adverse Event|1
7762855|NCT00733005|26986884|P1|Overall Study|Adverse Event|0
7762856|NCT00732992|26986894|P2|Overall Study|Withdrawal by Subject|0
7762857|NCT00732992|26986895|P1|Overall Study|Withdrawal by Subject|1
7762858|NCT00732992|26986894|P2|Overall Study|Global Deterioration of Health Status|0
7762859|NCT00732992|26986895|P1|Overall Study|Global Deterioration of Health Status|1
7762860|NCT00732992|26986894|P2|Overall Study|Objective Progression or Relapse|5
7762861|NCT00732992|26986895|P1|Overall Study|Objective Progression or Relapse|3
7762862|NCT00732992|26986894|P2|Overall Study|Adverse Event|1
7762863|NCT00732992|26986895|P1|Overall Study|Adverse Event|1
7762864|NCT00732940|26986914|P2|Overall Study|Lost to Follow-up|0
7762865|NCT00732940|26986915|P1|Overall Study|Lost to Follow-up|1
7762866|NCT00732940|26986914|P2|Overall Study|Adverse Event|1
7762867|NCT00732940|26986915|P1|Overall Study|Adverse Event|0
7762868|NCT00732940|26986914|P2|Overall Study|Withdrawal by Subject|2
7762869|NCT00732940|26986915|P1|Overall Study|Withdrawal by Subject|1
7762870|NCT00732875|26986996|P1|Overall Study|Lack of Efficacy|13
7762871|NCT00732875|26986996|P1|Overall Study|Withdrawal by Subject|6
7762872|NCT00732875|26986996|P1|Overall Study|Adverse Event|16
7762873|NCT00732758|26987004|P2|Overall Study|Lost to Follow-up|16
7762874|NCT00732758|26987005|P1|Overall Study|Lost to Follow-up|8
7762875|NCT00732641|26987045|P2|Overall Study|Other|5
7762876|NCT00732641|26987046|P1|Overall Study|Other|18
7762877|NCT00732641|26987045|P2|Overall Study|Unable to Complete|1
7762878|NCT00732641|26987046|P1|Overall Study|Unable to Complete|1
7762879|NCT00732641|26987045|P2|Overall Study|Withdrawal by Subject|2
7762880|NCT00732641|26987046|P1|Overall Study|Withdrawal by Subject|4
7762881|NCT00732641|26987045|P2|Overall Study|Physician Decision|0
7762882|NCT00732641|26987046|P1|Overall Study|Physician Decision|6
7762883|NCT00732641|26987045|P2|Overall Study|Serious Adverse Events|3
7762884|NCT00732641|26987046|P1|Overall Study|Serious Adverse Events|12
7762885|NCT00732641|26987045|P2|Overall Study|Relapse or Progressive Disease|101
7762886|NCT00732641|26987046|P1|Overall Study|Relapse or Progressive Disease|65
7762887|NCT00732615|26987066|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
7762888|NCT00732615|26987067|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
7762889|NCT00732615|26987066|P2|Overall Study|Physician Decision|0
7762890|NCT00732615|26987067|P1|Overall Study|Physician Decision|3
7762891|NCT00732615|26987066|P2|Overall Study|Adverse Event|2
7762892|NCT00732615|26987067|P1|Overall Study|Adverse Event|0
7762893|NCT00732615|26987066|P2|Overall Study|Lost to Follow-up|1
7762894|NCT00732615|26987067|P1|Overall Study|Lost to Follow-up|0
7762895|NCT00732615|26987066|P2|Overall Study|Withdrawal by Subject|1
7762896|NCT00732615|26987067|P1|Overall Study|Withdrawal by Subject|3
7762897|NCT00732498|26987079|P1|Overall Study|Physician Decision|3
7762898|NCT00732498|26987079|P1|Overall Study|Adverse Event|2
7762899|NCT00732498|26987079|P1|Overall Study|Ineligible|1
7762900|NCT00732472|26987090|P4|Overall Study|Withdrawal by Subject|1
7762901|NCT00732472|26987091|P3|Overall Study|Withdrawal by Subject|0
7762902|NCT00732472|26987092|P2|Overall Study|Withdrawal by Subject|2
7762903|NCT00732472|26987093|P1|Overall Study|Withdrawal by Subject|0
7762904|NCT00732472|26987090|P4|Overall Study|Protocol Violation|1
7762905|NCT00732472|26987091|P3|Overall Study|Protocol Violation|0
7762906|NCT00732472|26987092|P2|Overall Study|Protocol Violation|0
7762907|NCT00732472|26987093|P1|Overall Study|Protocol Violation|0
7762908|NCT00732472|26987090|P4|Overall Study|Adverse Event|1
7762909|NCT00732472|26987091|P3|Overall Study|Adverse Event|1
7762910|NCT00732472|26987092|P2|Overall Study|Adverse Event|1
7762911|NCT00732472|26987093|P1|Overall Study|Adverse Event|0
7762912|NCT00732381|26987193|P2|Overall Study|Treatment Failure|1
7762913|NCT00732381|26987194|P1|Overall Study|Treatment Failure|1
7762914|NCT00732381|26987193|P2|Overall Study|Adverse Event|0
7762915|NCT00732381|26987194|P1|Overall Study|Adverse Event|1
7762916|NCT00732303|26987202|P1|Overall Study|Study Terminated|2
7762917|NCT00732251|26987208|P1|Overall Study|Early Term due to Site Closure|1
7762918|NCT00732251|26987208|P1|Overall Study|Withdrawal by Subject|3
7762919|NCT00732251|26987208|P1|Overall Study|Lost to Follow-up|3
7762920|NCT00732238|26987216|P2|Overall Study|Asymptomatic bacteriuria|0
7762921|NCT00732238|26987217|P1|Overall Study|Asymptomatic bacteriuria|1
7762922|NCT00732238|26987216|P2|Overall Study|Bacteremia|1
7762923|NCT00732238|26987217|P1|Overall Study|Bacteremia|4
7762924|NCT00732199|26987318|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
7762925|NCT00732199|26987319|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
7762926|NCT00732199|26987318|P2|Overall Study|Withdrawal by Subject|18
7762927|NCT00732199|26987319|P1|Overall Study|Withdrawal by Subject|25
7762928|NCT00732160|26987334|P4|Overall Study|scheduling|1
7762929|NCT00732160|26987335|P3|Overall Study|scheduling|2
7762930|NCT00732160|26987336|P2|Overall Study|scheduling|4
7762931|NCT00732160|26987337|P1|Overall Study|scheduling|4
7762932|NCT00732160|26987334|P4|Overall Study|Adverse Event|1
7762933|NCT00732160|26987335|P3|Overall Study|Adverse Event|1
7762934|NCT00732160|26987336|P2|Overall Study|Adverse Event|0
7762935|NCT00732160|26987337|P1|Overall Study|Adverse Event|1
7762936|NCT00732069|26987351|P6|Washout After First Study Drug|Adverse Event|0
7762937|NCT00732069|26987352|P5|Washout After First Study Drug|Adverse Event|0
7762938|NCT00732069|26987353|P4|Washout After First Study Drug|Adverse Event|0
7762939|NCT00732069|26987354|P3|Washout After First Study Drug|Adverse Event|0
7762940|NCT00732069|26987355|P2|Washout After First Study Drug|Adverse Event|0
7762941|NCT00732069|26987356|P1|Washout After First Study Drug|Adverse Event|1
7762942|NCT00731939|26987374|P1|Overall Study|Did not meet enrollment criteria|2
7762943|NCT00731939|26987374|P1|Overall Study|Withdrawal by Subject|2
7762944|NCT00731939|26987374|P1|Overall Study|Not implanted with study device|9
7762945|NCT00731939|26987374|P1|Overall Study|Lost to Follow-up|15
7762946|NCT00731939|26987374|P1|Overall Study|Adverse Event|6
7762947|NCT00731822|26987451|P2|Overall Study|Lost to Follow-up|0
7762948|NCT00731822|26987452|P1|Overall Study|Lost to Follow-up|1
7762949|NCT00731822|26987451|P2|Overall Study|Protocol Violation|0
7762950|NCT00731822|26987452|P1|Overall Study|Protocol Violation|1
7762951|NCT00731822|26987451|P2|Overall Study|Adverse Event|1
7762952|NCT00731822|26987452|P1|Overall Study|Adverse Event|2
7762953|NCT00731783|26987466|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
7762954|NCT00731783|26987467|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
7762955|NCT00731783|26987466|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
7762956|NCT00731783|26987467|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
7762957|NCT00731783|26987466|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
7762958|NCT00731783|26987467|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
7762959|NCT00731783|26987466|P2|One Month Follow-Up Visit|Lost to Follow-up|22
7762960|NCT00731783|26987467|P1|One Month Follow-Up Visit|Lost to Follow-up|14
7762961|NCT00731731|26987501|P3|Overall Study|Cancel prior to treatment|2
7762962|NCT00731731|26987502|P2|Overall Study|Cancel prior to treatment|0
7762963|NCT00731731|26987503|P1|Overall Study|Cancel prior to treatment|0
7762964|NCT00731731|26987501|P3|Overall Study|Protocol Violation|1
7762965|NCT00731731|26987502|P2|Overall Study|Protocol Violation|0
7762966|NCT00731731|26987503|P1|Overall Study|Protocol Violation|0
7762967|NCT00731692|26987521|P3|Extension Phase|Adverse Event|15
7762968|NCT00731692|26987522|P2|Extension Phase|Adverse Event|1
7762969|NCT00731692|26987523|P1|Extension Phase|Adverse Event|1
7762970|NCT00731692|26987521|P3|Extension Phase|Withdrawal by Subject|3
7762971|NCT00731692|26987522|P2|Extension Phase|Withdrawal by Subject|5
7762972|NCT00731692|26987523|P1|Extension Phase|Withdrawal by Subject|4
7762973|NCT00731692|26987521|P3|Extension Phase|Lost to Follow-up|4
7762974|NCT00731692|26987522|P2|Extension Phase|Lost to Follow-up|1
7762975|NCT00731692|26987523|P1|Extension Phase|Lost to Follow-up|0
7762976|NCT00731692|26987521|P3|Extension Phase|Abnormal lab values|1
7762977|NCT00731692|26987522|P2|Extension Phase|Abnormal lab values|0
7762978|NCT00731692|26987523|P1|Extension Phase|Abnormal lab values|0
7762979|NCT00731692|26987521|P3|Extension Phase|Abnormal test procedure|1
7762980|NCT00731692|26987522|P2|Extension Phase|Abnormal test procedure|0
7762981|NCT00731692|26987523|P1|Extension Phase|Abnormal test procedure|0
7762982|NCT00731692|26987521|P3|Extension Phase|Admin Problems: Terminated # patients|277
7762983|NCT00731692|26987522|P2|Extension Phase|Admin Problems: Terminated # patients|189
7762984|NCT00731692|26987523|P1|Extension Phase|Admin Problems: Terminated # patients|69
7762985|NCT00731692|26987521|P3|Core Study (36 Months)|Withdrawal by Subject|46
7762986|NCT00731692|26987522|P2|Core Study (36 Months)|Withdrawal by Subject|32
7762987|NCT00731692|26987523|P1|Core Study (36 Months)|Withdrawal by Subject|12
7762988|NCT00731692|26987521|P3|Core Study (36 Months)|Adverse Event|29
7762989|NCT00731692|26987522|P2|Core Study (36 Months)|Adverse Event|28
7762990|NCT00731692|26987523|P1|Core Study (36 Months)|Adverse Event|25
7762991|NCT00731692|26987521|P3|Core Study (36 Months)|Abnormal Lab values|5
7762992|NCT00731692|26987522|P2|Core Study (36 Months)|Abnormal Lab values|19
7762993|NCT00731692|26987523|P1|Core Study (36 Months)|Abnormal Lab values|6
7762994|NCT00731692|26987521|P3|Core Study (36 Months)|Protocol Violation|8
7762995|NCT00731692|26987522|P2|Core Study (36 Months)|Protocol Violation|5
7762996|NCT00731692|26987523|P1|Core Study (36 Months)|Protocol Violation|4
7762997|NCT00731692|26987521|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
7762998|NCT00731692|26987522|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
7762999|NCT00731692|26987523|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
7763000|NCT00731692|26987521|P3|Core Study (36 Months)|Administrative|6
7763001|NCT00731692|26987522|P2|Core Study (36 Months)|Administrative|2
7763002|NCT00731692|26987523|P1|Core Study (36 Months)|Administrative|2
7763003|NCT00731692|26987521|P3|Core Study (36 Months)|Lost to Follow-up|3
7763004|NCT00731692|26987522|P2|Core Study (36 Months)|Lost to Follow-up|3
7763005|NCT00731692|26987523|P1|Core Study (36 Months)|Lost to Follow-up|1
7763006|NCT00731692|26987521|P3|Core Study (36 Months)|Death|2
7763007|NCT00731692|26987522|P2|Core Study (36 Months)|Death|1
7763008|NCT00731692|26987523|P1|Core Study (36 Months)|Death|2
7763009|NCT00731692|26987521|P3|Core Study (36 Months)|Physician Decision|2
7763010|NCT00731692|26987522|P2|Core Study (36 Months)|Physician Decision|0
7763011|NCT00731692|26987523|P1|Core Study (36 Months)|Physician Decision|1
7763012|NCT00731692|26987521|P3|Core Study (36 Months)|Lack of Efficacy|64
7763013|NCT00731692|26987522|P2|Core Study (36 Months)|Lack of Efficacy|23
7763014|NCT00731692|26987523|P1|Core Study (36 Months)|Lack of Efficacy|11
7763015|NCT00731679|26987569|P2|Overall Study|Pregnancy|1
7763016|NCT00731679|26987570|P1|Overall Study|Pregnancy|0
7763017|NCT00731679|26987569|P2|Overall Study|Noncompliance|1
7763018|NCT00731679|26987570|P1|Overall Study|Noncompliance|0
7763019|NCT00731679|26987569|P2|Overall Study|Lost to Follow-up|8
7763020|NCT00731679|26987570|P1|Overall Study|Lost to Follow-up|7
7763021|NCT00731679|26987569|P2|Overall Study|Withdrawal by Subject|8
7763022|NCT00731679|26987570|P1|Overall Study|Withdrawal by Subject|8
7763023|NCT00731679|26987569|P2|Overall Study|Adverse Event|8
7763024|NCT00731679|26987570|P1|Overall Study|Adverse Event|7
7763025|NCT00731666|26987578|P1|Overall Study|Withdrawal by Subject|2
7763026|NCT00731666|26987578|P1|Overall Study|Lost to Follow-up|8
7763027|NCT00731666|26987578|P1|Overall Study|Adverse Event|2
7763028|NCT00731549|26987629|P1|Overall Study|Lack of efficacy without AE|6
7763029|NCT00731549|26987629|P1|Overall Study|Lack of efficacy with AE|37
7763030|NCT00731549|26987629|P1|Overall Study|Adverse Event|31
7763031|NCT00731549|26987629|P1|Overall Study|Protocol deviation|1
7763032|NCT00731549|26987629|P1|Overall Study|Withdrawal by Subject|89
7763033|NCT00731549|26987629|P1|Overall Study|Physician Decision|16
7763034|NCT00731549|26987629|P1|Overall Study|Met withdrawal criteria|24
7763035|NCT00731549|26987629|P1|Overall Study|Lost to Follow-up|19
7763036|NCT00731133|26987669|P1|Overall Study|Withdrawal by Subject|10
7763037|NCT00731120|26987677|P3|Overall Study|Other|1
7763038|NCT00731120|26987678|P2|Overall Study|Other|0
7763039|NCT00731120|26987679|P1|Overall Study|Other|4
7763040|NCT00731120|26987677|P3|Overall Study|Lost to Follow-up|17
7763041|NCT00731120|26987678|P2|Overall Study|Lost to Follow-up|15
7763042|NCT00731120|26987679|P1|Overall Study|Lost to Follow-up|10
7763043|NCT00731120|26987677|P3|Overall Study|Withdrawal of Consent|4
7763044|NCT00731120|26987678|P2|Overall Study|Withdrawal of Consent|8
7763045|NCT00731120|26987679|P1|Overall Study|Withdrawal of Consent|13
7763046|NCT00731120|26987677|P3|Overall Study|Protocol Deviations|1
7763047|NCT00731120|26987678|P2|Overall Study|Protocol Deviations|6
7763048|NCT00731120|26987679|P1|Overall Study|Protocol Deviations|1
7763049|NCT00731120|26987677|P3|Overall Study|Noncompliance with Study Drug|1
7763050|NCT00731120|26987678|P2|Overall Study|Noncompliance with Study Drug|3
7763051|NCT00731120|26987679|P1|Overall Study|Noncompliance with Study Drug|3
7763052|NCT00731120|26987677|P3|Overall Study|Lack of Efficacy|4
7763053|NCT00731120|26987678|P2|Overall Study|Lack of Efficacy|5
7763054|NCT00731120|26987679|P1|Overall Study|Lack of Efficacy|4
7763055|NCT00731120|26987677|P3|Overall Study|Adverse Event|8
7763056|NCT00731120|26987678|P2|Overall Study|Adverse Event|6
7763057|NCT00731120|26987679|P1|Overall Study|Adverse Event|7
7763058|NCT00731042|26987796|P2|Second Intervention|Did not meet inclusion criteria|2
7763059|NCT00731042|26987797|P1|Second Intervention|Did not meet inclusion criteria|0
7763060|NCT00730925|26987808|P1|Overall Study|Other|1
7763061|NCT00730925|26987808|P1|Overall Study|Switch to combination therapy|8
7763062|NCT00730925|26987808|P1|Overall Study|Withdrawal by Subject|1
7763063|NCT00730925|26987808|P1|Overall Study|Protocol Violation|1
7763064|NCT00730925|26987808|P1|Overall Study|Other Averse Event|7
7763065|NCT00730925|26987808|P1|Overall Study|Dose reducing Event|2
7763066|NCT00730925|26987808|P1|Overall Study|Progressive Disease|21
7763067|NCT00730912|26987818|P3|Overall Study|Discontinued|1
7763068|NCT00730912|26987819|P2|Overall Study|Discontinued|0
7763069|NCT00730912|26987820|P1|Overall Study|Discontinued|0
7763070|NCT00730886|26987833|P2|Overall Study|Physician Decision|0
7763071|NCT00730886|26987834|P1|Overall Study|Physician Decision|1
7763072|NCT00730886|26987833|P2|Overall Study|Lost to Follow-up|0
7763073|NCT00730886|26987834|P1|Overall Study|Lost to Follow-up|1
7763074|NCT00730847|26987858|P1|Overall Study|Other|24
7763075|NCT00730847|26987858|P1|Overall Study|Unknown completion status|21
7763076|NCT00730847|26987858|P1|Overall Study|Lost to Follow-up|67
7763077|NCT00730847|26987858|P1|Overall Study|Withdrawal by Subject|16
7763078|NCT00730847|26987858|P1|Overall Study|Protocol Violation|2
7763079|NCT00730847|26987858|P1|Overall Study|Adverse Event|1
7763080|NCT00730756|26987867|P2|Overall Study|Withdrew Consent|1
7763081|NCT00730756|26987868|P1|Overall Study|Withdrew Consent|0
7763082|NCT00730756|26987867|P2|Overall Study|Lost to Follow-up|1
7763083|NCT00730756|26987868|P1|Overall Study|Lost to Follow-up|0
7763084|NCT00730756|26987867|P2|Overall Study|Protocol Deviation|2
7763085|NCT00730756|26987868|P1|Overall Study|Protocol Deviation|1
7763086|NCT00730756|26987867|P2|Overall Study|Lack of Efficacy|1
7763087|NCT00730756|26987868|P1|Overall Study|Lack of Efficacy|1
7763088|NCT00730756|26987867|P2|Overall Study|Adverse Event|0
7763089|NCT00730756|26987868|P1|Overall Study|Adverse Event|2
7763090|NCT00730691|26987902|P5|Overall Study|Other|2
7763091|NCT00730691|26987903|P4|Overall Study|Other|2
7763092|NCT00730691|26987904|P3|Overall Study|Other|1
7763093|NCT00730691|26987905|P2|Overall Study|Other|1
7763094|NCT00730691|26987906|P1|Overall Study|Other|1
7763095|NCT00730691|26987902|P5|Overall Study|Lost to Follow-up|13
7763096|NCT00730691|26987903|P4|Overall Study|Lost to Follow-up|15
7763097|NCT00730691|26987904|P3|Overall Study|Lost to Follow-up|13
7763098|NCT00730691|26987905|P2|Overall Study|Lost to Follow-up|8
7763099|NCT00730691|26987906|P1|Overall Study|Lost to Follow-up|11
7763100|NCT00730691|26987902|P5|Overall Study|Withdrawal of Consent|3
7763101|NCT00730691|26987903|P4|Overall Study|Withdrawal of Consent|6
7763102|NCT00730691|26987904|P3|Overall Study|Withdrawal of Consent|3
7763103|NCT00730691|26987905|P2|Overall Study|Withdrawal of Consent|9
7763104|NCT00730691|26987906|P1|Overall Study|Withdrawal of Consent|7
7763105|NCT00730691|26987902|P5|Overall Study|Protocol Deviations|5
7763106|NCT00730691|26987903|P4|Overall Study|Protocol Deviations|7
7763107|NCT00730691|26987904|P3|Overall Study|Protocol Deviations|3
7763108|NCT00730691|26987905|P2|Overall Study|Protocol Deviations|5
7763109|NCT00730691|26987906|P1|Overall Study|Protocol Deviations|3
7763110|NCT00730691|26987902|P5|Overall Study|Non-compliance with Study Drug|3
7763111|NCT00730691|26987903|P4|Overall Study|Non-compliance with Study Drug|3
7763112|NCT00730691|26987904|P3|Overall Study|Non-compliance with Study Drug|6
7763113|NCT00730691|26987905|P2|Overall Study|Non-compliance with Study Drug|1
7763114|NCT00730691|26987906|P1|Overall Study|Non-compliance with Study Drug|6
7763115|NCT00730691|26987902|P5|Overall Study|Lack of Efficacy|1
7763116|NCT00730691|26987903|P4|Overall Study|Lack of Efficacy|1
7763117|NCT00730691|26987904|P3|Overall Study|Lack of Efficacy|2
7763118|NCT00730691|26987905|P2|Overall Study|Lack of Efficacy|4
7763119|NCT00730691|26987906|P1|Overall Study|Lack of Efficacy|4
7763120|NCT00730691|26987902|P5|Overall Study|Adverse Event|23
7763121|NCT00730691|26987903|P4|Overall Study|Adverse Event|11
7763122|NCT00730691|26987904|P3|Overall Study|Adverse Event|11
7763123|NCT00730691|26987905|P2|Overall Study|Adverse Event|8
7763124|NCT00730691|26987906|P1|Overall Study|Adverse Event|4
7763125|NCT00730639|26987998|P5|Overall Study|Treatment on-going|4
7763126|NCT00730639|26987999|P4|Overall Study|Treatment on-going|4
7763127|NCT00730639|26988000|P3|Overall Study|Treatment on-going|5
7763128|NCT00730639|26988001|P2|Overall Study|Treatment on-going|5
7763129|NCT00730639|26988002|P1|Overall Study|Treatment on-going|2
7763130|NCT00730639|26987998|P5|Overall Study|Withdrawal by Subject|4
7763131|NCT00730639|26987999|P4|Overall Study|Withdrawal by Subject|3
7763132|NCT00730639|26988000|P3|Overall Study|Withdrawal by Subject|6
7763133|NCT00730639|26988001|P2|Overall Study|Withdrawal by Subject|0
7763134|NCT00730639|26988002|P1|Overall Study|Withdrawal by Subject|0
7763135|NCT00730639|26987998|P5|Overall Study|Protocol Violation|0
7763136|NCT00730639|26987999|P4|Overall Study|Protocol Violation|0
7763137|NCT00730639|26988000|P3|Overall Study|Protocol Violation|1
7763138|NCT00730639|26988001|P2|Overall Study|Protocol Violation|0
7763139|NCT00730639|26988002|P1|Overall Study|Protocol Violation|0
7763140|NCT00730639|26987998|P5|Overall Study|non-specified|3
7763141|NCT00730639|26987999|P4|Overall Study|non-specified|2
7763142|NCT00730639|26988000|P3|Overall Study|non-specified|4
7763143|NCT00730639|26988001|P2|Overall Study|non-specified|0
7763144|NCT00730639|26988002|P1|Overall Study|non-specified|0
7763145|NCT00730639|26987998|P5|Overall Study|Disease Progression|88
7763146|NCT00730639|26987999|P4|Overall Study|Disease Progression|32
7763147|NCT00730639|26988000|P3|Overall Study|Disease Progression|48
7763148|NCT00730639|26988001|P2|Overall Study|Disease Progression|13
7763149|NCT00730639|26988002|P1|Overall Study|Disease Progression|12
7763150|NCT00730639|26987998|P5|Overall Study|Death|2
7763151|NCT00730639|26987999|P4|Overall Study|Death|0
7763152|NCT00730639|26988000|P3|Overall Study|Death|0
7763153|NCT00730639|26988001|P2|Overall Study|Death|0
7763154|NCT00730639|26988002|P1|Overall Study|Death|0
7763155|NCT00730639|26987998|P5|Overall Study|Completed Maximum Cycles|6
7763156|NCT00730639|26987999|P4|Overall Study|Completed Maximum Cycles|3
7763157|NCT00730639|26988000|P3|Overall Study|Completed Maximum Cycles|11
7763158|NCT00730639|26988001|P2|Overall Study|Completed Maximum Cycles|0
7763159|NCT00730639|26988002|P1|Overall Study|Completed Maximum Cycles|0
7763160|NCT00730639|26987998|P5|Overall Study|Complete Response|1
7763161|NCT00730639|26987999|P4|Overall Study|Complete Response|2
7763162|NCT00730639|26988000|P3|Overall Study|Complete Response|2
7763163|NCT00730639|26988001|P2|Overall Study|Complete Response|0
7763164|NCT00730639|26988002|P1|Overall Study|Complete Response|0
7763165|NCT00730639|26987998|P5|Overall Study|Adverse Event|23
7763166|NCT00730639|26987999|P4|Overall Study|Adverse Event|8
7763167|NCT00730639|26988000|P3|Overall Study|Adverse Event|9
7763168|NCT00730639|26988001|P2|Overall Study|Adverse Event|0
7763169|NCT00730639|26988002|P1|Overall Study|Adverse Event|3
7763170|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
7763171|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
7763172|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
7763173|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
7763174|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
7763175|NCT00730405|26988090|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7763176|NCT00730405|26988091|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
7763177|NCT00730405|26988092|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7763178|NCT00730405|26988093|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7763179|NCT00730405|26988094|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7763180|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Other Protocol violation|0
7763181|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Other Protocol violation|0
7763182|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Other Protocol violation|1
7763183|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Other Protocol violation|0
7763184|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Other Protocol violation|0
7763185|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Mis-randomized|0
7763186|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Mis-randomized|0
7763187|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Mis-randomized|0
7763188|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Mis-randomized|1
7763189|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Mis-randomized|0
7763190|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7763191|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7763192|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
7763193|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7763194|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7763195|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
7763196|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
7763197|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
7763198|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
7763199|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
7763200|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Missing|0
7763201|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Missing|0
7763202|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Missing|2
7763203|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Missing|0
7763204|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Missing|0
7763205|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Non-compliance|0
7763206|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Non-compliance|0
7763207|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Non-compliance|2
7763208|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Non-compliance|0
7763209|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Non-compliance|1
7763210|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Use of restricted medication|0
7763211|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Use of restricted medication|0
7763212|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Use of restricted medication|0
7763213|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Use of restricted medication|1
7763214|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Use of restricted medication|0
7763215|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7763216|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7763217|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7763218|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
7763219|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
7763220|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7763221|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7763222|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
7763223|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
7763224|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7763225|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7763226|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
7763227|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7763549|NCT00729469|26988809|P1|Overall Study|Adverse Event|14
7763228|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7763229|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7763230|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7763231|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7763232|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7763233|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7763234|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
7763235|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
7763236|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7763237|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7763238|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7763239|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7763240|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7763241|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7763242|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
7763243|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7763244|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7763245|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7763246|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7763247|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
7763248|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7763249|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7763250|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Did not met eligibility|0
7763251|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Did not met eligibility|0
7763252|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Did not met eligibility|1
7763253|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Did not met eligibility|0
7763254|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Did not met eligibility|0
7763255|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Change of location|0
7763256|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Change of location|1
7763257|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Change of location|0
7763258|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Change of location|1
7763259|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Change of location|1
7763260|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Death|0
7763261|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Death|1
7763262|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Death|0
7763263|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Death|1
7763264|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Death|0
7763265|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
7763266|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
7763267|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
7763268|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
7763269|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
7763270|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
7763271|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
7763272|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
7763273|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
7763274|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
7763275|NCT00730405|26988090|P5|Overall Study-follow-up Phase|Adverse Event|4
7763276|NCT00730405|26988091|P4|Overall Study-follow-up Phase|Adverse Event|3
7763277|NCT00730405|26988092|P3|Overall Study-follow-up Phase|Adverse Event|2
7763278|NCT00730405|26988093|P2|Overall Study-follow-up Phase|Adverse Event|6
7763279|NCT00730405|26988094|P1|Overall Study-follow-up Phase|Adverse Event|2
7763280|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
7763281|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
7763282|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
7763283|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
7763284|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
7763285|NCT00730405|26988090|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
7763286|NCT00730405|26988091|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7763287|NCT00730405|26988092|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7763288|NCT00730405|26988093|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7763289|NCT00730405|26988094|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7763290|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Pregnancy|0
7763291|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Pregnancy|0
7763292|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Pregnancy|0
7763293|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Pregnancy|1
7763294|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Pregnancy|0
7763295|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Change of location|0
7763296|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Change of location|1
7763297|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Change of location|0
7763298|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Change of location|0
7763299|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Change of location|0
7763300|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7763301|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7763302|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
7763303|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7763304|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7763305|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7763306|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
7763307|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7763308|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7763309|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7763310|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Study drug interrupted|0
7763311|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Study drug interrupted|0
7763312|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Study drug interrupted|0
7763313|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Study drug interrupted|1
7763314|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Study drug interrupted|0
7763315|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Misrandomized|0
7763316|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Misrandomized|0
7763317|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Misrandomized|0
7763318|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Misrandomized|1
7763319|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Misrandomized|0
7763320|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7763321|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7763322|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
7763323|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7763324|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7763325|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
7763326|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
7763327|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
7763328|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
7763329|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
7763330|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
7763331|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
7763332|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
7763333|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
7763334|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
7763335|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7763336|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7763337|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7763338|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7763339|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
7763340|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
7763341|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
7763342|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
7763343|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
7763344|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
7763345|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Did not met eligibility|0
7763346|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Did not met eligibility|0
7763347|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Did not met eligibility|1
7763348|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Did not met eligibility|0
7763349|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Did not met eligibility|0
7763350|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
7763351|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
7763352|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
7763353|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
7763354|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
7763355|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
7763356|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
7763357|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
7763358|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
7763359|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
7763360|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
7763361|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
7763362|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
7763363|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
7763364|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
7763365|NCT00730405|26988090|P5|Overall Study-Treatment Phase|Adverse Event|4
7763366|NCT00730405|26988091|P4|Overall Study-Treatment Phase|Adverse Event|8
7763367|NCT00730405|26988092|P3|Overall Study-Treatment Phase|Adverse Event|4
7763368|NCT00730405|26988093|P2|Overall Study-Treatment Phase|Adverse Event|10
7763369|NCT00730405|26988094|P1|Overall Study-Treatment Phase|Adverse Event|5
7763370|NCT00730327|26988141|P2|Overall Study|Subject withdrew (reason not specified)|7
7763371|NCT00730327|26988142|P1|Overall Study|Subject withdrew (reason not specified)|2
7763372|NCT00730327|26988141|P2|Overall Study|Withdrawal by Subject|13
7763373|NCT00730327|26988142|P1|Overall Study|Withdrawal by Subject|3
7763374|NCT00730327|26988141|P2|Overall Study|Adverse Event|1
7763375|NCT00730327|26988142|P1|Overall Study|Adverse Event|8
7763376|NCT00730327|26988141|P2|Overall Study|Lost to Follow-up|16
7763377|NCT00730327|26988142|P1|Overall Study|Lost to Follow-up|14
7763378|NCT00730275|26988167|P4|Overall Study|Withdrawal by Subject|1
7763379|NCT00730275|26988168|P3|Overall Study|Withdrawal by Subject|0
7763380|NCT00730275|26988169|P2|Overall Study|Withdrawal by Subject|0
7763381|NCT00730275|26988170|P1|Overall Study|Withdrawal by Subject|0
7763382|NCT00730236|26988196|P1|Overall Study|Non-compliance|1
7763383|NCT00730236|26988196|P1|Overall Study|Withdrawal by Subject|1
7763384|NCT00730236|26988196|P1|Overall Study|Adverse Event|4
7763385|NCT00730171|26988211|P1|Overall Study|Other|61
7763386|NCT00730171|26988211|P1|Overall Study|Insufficient Therapeutic Response|141
7763387|NCT00730171|26988211|P1|Overall Study|Lost to Follow-up|121
7763388|NCT00730171|26988211|P1|Overall Study|Withdrawal by Subject|202
7763389|NCT00730171|26988211|P1|Overall Study|Protocol Violation|48
7763390|NCT00730171|26988211|P1|Overall Study|Adverse Event|193
7763391|NCT00730171|26988211|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
7763392|NCT00730158|26988221|P2|Overall Study|Withdrawal by Subject|1
7763393|NCT00730158|26988222|P1|Overall Study|Withdrawal by Subject|1
7763394|NCT00730132|26988260|P1|Overall Study|Death|1
7763395|NCT00730132|26988260|P1|Overall Study|Protocol Violation|154
7763396|NCT00730041|26988278|P2|Overall Study|Lost to Follow-up|2
7763397|NCT00730041|26988279|P1|Overall Study|Lost to Follow-up|0
7763398|NCT00730028|26988302|P5|Overall Study|Randomization Error|2
7763399|NCT00730028|26988303|P4|Overall Study|Randomization Error|0
7763400|NCT00730028|26988304|P3|Overall Study|Randomization Error|0
7763401|NCT00730028|26988305|P2|Overall Study|Randomization Error|0
7763402|NCT00730028|26988306|P1|Overall Study|Randomization Error|1
7763403|NCT00730028|26988302|P5|Overall Study|Treatment Failure|1
7763404|NCT00730028|26988303|P4|Overall Study|Treatment Failure|0
7763405|NCT00730028|26988304|P3|Overall Study|Treatment Failure|0
7763406|NCT00730028|26988305|P2|Overall Study|Treatment Failure|5
7763407|NCT00730028|26988306|P1|Overall Study|Treatment Failure|5
7763408|NCT00730028|26988302|P5|Overall Study|Physician Decision|2
7763409|NCT00730028|26988303|P4|Overall Study|Physician Decision|3
7763410|NCT00730028|26988304|P3|Overall Study|Physician Decision|2
7763411|NCT00730028|26988305|P2|Overall Study|Physician Decision|3
7763412|NCT00730028|26988306|P1|Overall Study|Physician Decision|3
7763413|NCT00730028|26988302|P5|Overall Study|Withdrawal by Subject|9
7763414|NCT00730028|26988303|P4|Overall Study|Withdrawal by Subject|5
7763415|NCT00730028|26988304|P3|Overall Study|Withdrawal by Subject|4
7763416|NCT00730028|26988305|P2|Overall Study|Withdrawal by Subject|5
7763417|NCT00730028|26988306|P1|Overall Study|Withdrawal by Subject|9
7763418|NCT00730028|26988302|P5|Overall Study|Protocol Violation|0
7763419|NCT00730028|26988303|P4|Overall Study|Protocol Violation|2
7763420|NCT00730028|26988304|P3|Overall Study|Protocol Violation|1
7763421|NCT00730028|26988305|P2|Overall Study|Protocol Violation|1
7763422|NCT00730028|26988306|P1|Overall Study|Protocol Violation|6
7763423|NCT00730028|26988302|P5|Overall Study|Lost to Follow-up|25
7763424|NCT00730028|26988303|P4|Overall Study|Lost to Follow-up|26
7763425|NCT00730028|26988304|P3|Overall Study|Lost to Follow-up|22
7763426|NCT00730028|26988305|P2|Overall Study|Lost to Follow-up|26
7763427|NCT00730028|26988306|P1|Overall Study|Lost to Follow-up|13
7763428|NCT00730028|26988302|P5|Overall Study|Adverse Event|43
7763429|NCT00730028|26988303|P4|Overall Study|Adverse Event|20
7763430|NCT00730028|26988304|P3|Overall Study|Adverse Event|16
7763431|NCT00730028|26988305|P2|Overall Study|Adverse Event|26
7763432|NCT00730028|26988306|P1|Overall Study|Adverse Event|23
7763433|NCT00730015|26988356|P3|Overall Study|Other Reason|1
7763434|NCT00730015|26988357|P2|Overall Study|Other Reason|0
7763435|NCT00730015|26988358|P1|Overall Study|Other Reason|1
7763436|NCT00730015|26988356|P3|Overall Study|Lack of Efficacy|8
7763437|NCT00730015|26988357|P2|Overall Study|Lack of Efficacy|2
7763438|NCT00730015|26988358|P1|Overall Study|Lack of Efficacy|1
7763439|NCT00730015|26988356|P3|Overall Study|Lost to Follow-up|3
7763440|NCT00730015|26988357|P2|Overall Study|Lost to Follow-up|10
7763441|NCT00730015|26988358|P1|Overall Study|Lost to Follow-up|4
7763442|NCT00730015|26988356|P3|Overall Study|Withdrawal by Subject|8
7763443|NCT00730015|26988357|P2|Overall Study|Withdrawal by Subject|12
7763444|NCT00730015|26988358|P1|Overall Study|Withdrawal by Subject|12
7763445|NCT00730015|26988356|P3|Overall Study|Protocol Violation|4
7763446|NCT00730015|26988357|P2|Overall Study|Protocol Violation|6
7763447|NCT00730015|26988358|P1|Overall Study|Protocol Violation|2
7763448|NCT00730015|26988356|P3|Overall Study|Adverse Event|8
7763449|NCT00730015|26988357|P2|Overall Study|Adverse Event|10
7763450|NCT00730015|26988358|P1|Overall Study|Adverse Event|11
7763451|NCT00729937|26988398|P6|Overall Study|Incarcerated|0
7763452|NCT00729937|26988399|P5|Overall Study|Incarcerated|0
7763453|NCT00729937|26988400|P4|Overall Study|Incarcerated|1
7763454|NCT00729937|26988401|P3|Overall Study|Incarcerated|1
7763455|NCT00729937|26988402|P2|Overall Study|Incarcerated|2
7763456|NCT00729937|26988403|P1|Overall Study|Incarcerated|0
7763457|NCT00729937|26988398|P6|Overall Study|Did not meet eligibility criteria|0
7763458|NCT00729937|26988399|P5|Overall Study|Did not meet eligibility criteria|0
7763459|NCT00729937|26988400|P4|Overall Study|Did not meet eligibility criteria|0
7763460|NCT00729937|26988401|P3|Overall Study|Did not meet eligibility criteria|0
7763461|NCT00729937|26988402|P2|Overall Study|Did not meet eligibility criteria|1
7763462|NCT00729937|26988403|P1|Overall Study|Did not meet eligibility criteria|2
7763463|NCT00729937|26988398|P6|Overall Study|Randomized but not treated|3
7763464|NCT00729937|26988399|P5|Overall Study|Randomized but not treated|1
7763465|NCT00729937|26988400|P4|Overall Study|Randomized but not treated|0
7763466|NCT00729937|26988401|P3|Overall Study|Randomized but not treated|1
7763467|NCT00729937|26988402|P2|Overall Study|Randomized but not treated|6
7763468|NCT00729937|26988403|P1|Overall Study|Randomized but not treated|12
7763469|NCT00729937|26988398|P6|Overall Study|Withdrawal by Subject|2
7763470|NCT00729937|26988399|P5|Overall Study|Withdrawal by Subject|4
7763471|NCT00729937|26988400|P4|Overall Study|Withdrawal by Subject|0
7763472|NCT00729937|26988401|P3|Overall Study|Withdrawal by Subject|6
7763473|NCT00729937|26988402|P2|Overall Study|Withdrawal by Subject|5
7763474|NCT00729937|26988403|P1|Overall Study|Withdrawal by Subject|3
7763475|NCT00729937|26988398|P6|Overall Study|Death|1
7763476|NCT00729937|26988399|P5|Overall Study|Death|0
7763477|NCT00729937|26988400|P4|Overall Study|Death|0
7763478|NCT00729937|26988401|P3|Overall Study|Death|1
7763479|NCT00729937|26988402|P2|Overall Study|Death|0
7763480|NCT00729937|26988403|P1|Overall Study|Death|1
7763481|NCT00729937|26988398|P6|Overall Study|Physician Decision|8
7763482|NCT00729937|26988399|P5|Overall Study|Physician Decision|5
7763483|NCT00729937|26988400|P4|Overall Study|Physician Decision|0
7763484|NCT00729937|26988401|P3|Overall Study|Physician Decision|2
7763485|NCT00729937|26988402|P2|Overall Study|Physician Decision|16
7763486|NCT00729937|26988403|P1|Overall Study|Physician Decision|7
7763487|NCT00729937|26988398|P6|Overall Study|Lost to Follow-up|23
7763488|NCT00729937|26988399|P5|Overall Study|Lost to Follow-up|18
7763489|NCT00729937|26988400|P4|Overall Study|Lost to Follow-up|33
7763490|NCT00729937|26988401|P3|Overall Study|Lost to Follow-up|18
7763491|NCT00729937|26988402|P2|Overall Study|Lost to Follow-up|58
7763492|NCT00729937|26988403|P1|Overall Study|Lost to Follow-up|49
7763493|NCT00729859|26988607|P3|Overall Study|Withdrawal by Subject|0
7763494|NCT00729859|26988608|P2|Overall Study|Withdrawal by Subject|1
7763495|NCT00729859|26988609|P1|Overall Study|Withdrawal by Subject|0
7763496|NCT00729859|26988607|P3|Overall Study|Adverse Event|0
7763497|NCT00729859|26988608|P2|Overall Study|Adverse Event|1
7763498|NCT00729859|26988609|P1|Overall Study|Adverse Event|0
7763499|NCT00729833|26988653|P4|Overall Study|Unspecified Reasons|1
7763500|NCT00729833|26988654|P3|Overall Study|Unspecified Reasons|5
7763501|NCT00729833|26988655|P2|Overall Study|Unspecified Reasons|5
7763502|NCT00729833|26988656|P1|Overall Study|Unspecified Reasons|11
7763503|NCT00729833|26988653|P4|Overall Study|Withdrawal by Subject|0
7763504|NCT00729833|26988654|P3|Overall Study|Withdrawal by Subject|3
7763505|NCT00729833|26988655|P2|Overall Study|Withdrawal by Subject|1
7763506|NCT00729833|26988656|P1|Overall Study|Withdrawal by Subject|3
7763507|NCT00729833|26988653|P4|Overall Study|Lost to Follow-up|0
7763508|NCT00729833|26988654|P3|Overall Study|Lost to Follow-up|0
7763509|NCT00729833|26988655|P2|Overall Study|Lost to Follow-up|0
7763510|NCT00729833|26988656|P1|Overall Study|Lost to Follow-up|1
7763511|NCT00729833|26988653|P4|Overall Study|Study Terminated by Sponsor|0
7763512|NCT00729833|26988654|P3|Overall Study|Study Terminated by Sponsor|1
7763513|NCT00729833|26988655|P2|Overall Study|Study Terminated by Sponsor|0
7763514|NCT00729833|26988656|P1|Overall Study|Study Terminated by Sponsor|0
7763515|NCT00729833|26988653|P4|Overall Study|Death|5
7763516|NCT00729833|26988654|P3|Overall Study|Death|3
7763517|NCT00729833|26988655|P2|Overall Study|Death|1
7763518|NCT00729833|26988656|P1|Overall Study|Death|5
7763519|NCT00729690|26988714|P3|Overall Study|IT Catheter Malfunction|2
7763520|NCT00729690|26988715|P2|Overall Study|IT Catheter Malfunction|2
7763521|NCT00729690|26988716|P1|Overall Study|IT Catheter Malfunction|0
7763522|NCT00729651|26988746|P2|Overall Study|Subject's private reason|0
7763523|NCT00729651|26988747|P1|Overall Study|Subject's private reason|2
7763524|NCT00729651|26988746|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
7763525|NCT00729651|26988747|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
7763526|NCT00729651|26988746|P2|Overall Study|Adverse Event|3
7763527|NCT00729651|26988747|P1|Overall Study|Adverse Event|7
7763528|NCT00729651|26988746|P2|Overall Study|Protocol Violation|1
7763529|NCT00729651|26988747|P1|Overall Study|Protocol Violation|0
7763530|NCT00729651|26988746|P2|Overall Study|Lost to Follow-up|4
7763531|NCT00729651|26988747|P1|Overall Study|Lost to Follow-up|5
7763532|NCT00729651|26988746|P2|Overall Study|Withdrawal by Subject|6
7763533|NCT00729651|26988747|P1|Overall Study|Withdrawal by Subject|5
7763534|NCT00729612|26988759|P1|Overall Study|Non evaluable for response|10
7763535|NCT00729586|26988768|P2|Overall Study|never treated|0
7763536|NCT00729586|26988769|P1|Overall Study|never treated|1
7763537|NCT00729586|26988768|P2|Overall Study|Ineligible|1
7763538|NCT00729586|26988769|P1|Overall Study|Ineligible|0
7763539|NCT00729560|26988782|P1|Overall Study|Withdrawal by Subject|3
7763540|NCT00729469|26988808|P2|Overall Study|Other-Not mentioned|4
7763541|NCT00729469|26988809|P1|Overall Study|Other-Not mentioned|9
7763542|NCT00729469|26988808|P2|Overall Study|Withdrawal by Subject|8
7763543|NCT00729469|26988809|P1|Overall Study|Withdrawal by Subject|19
7763544|NCT00729469|26988808|P2|Overall Study|Protocol Violation|1
7763545|NCT00729469|26988809|P1|Overall Study|Protocol Violation|2
7763546|NCT00729469|26988808|P2|Overall Study|Lost to Follow-up|9
7763547|NCT00729469|26988809|P1|Overall Study|Lost to Follow-up|9
7763548|NCT00729469|26988808|P2|Overall Study|Adverse Event|25
7763550|NCT00729378|26988862|P2|36-months|Lost to Follow-up|6
7763551|NCT00729378|26988863|P1|36-months|Lost to Follow-up|15
7763552|NCT00729378|26988862|P2|24-months|Lost to Follow-up|51
7763553|NCT00729378|26988863|P1|24-months|Lost to Follow-up|72
7763554|NCT00729378|26988862|P2|12-months|Lost to Follow-up|65
7763555|NCT00729378|26988863|P1|12-months|Lost to Follow-up|100
7763556|NCT00729378|26988862|P2|Baseline|Withdrawal by Subject|59
7763557|NCT00729378|26988863|P1|Baseline|Withdrawal by Subject|66
7763558|NCT00729378|26988862|P2|Baseline|Did not complete study measurements|33
7763559|NCT00729378|26988863|P1|Baseline|Did not complete study measurements|72
7763560|NCT00729365|26989062|P3|Overall Study|Physician Decision|7
7763561|NCT00729365|26989063|P2|Overall Study|Physician Decision|6
7763562|NCT00729365|26989064|P1|Overall Study|Physician Decision|33
7763563|NCT00729326|26989077|P2|Overall Study|Sponsor Decision|2
7763564|NCT00729326|26989078|P1|Overall Study|Sponsor Decision|1
7763565|NCT00729326|26989077|P2|Overall Study|Subject Decision|4
7763566|NCT00729326|26989078|P1|Overall Study|Subject Decision|4
7763567|NCT00729326|26989077|P2|Overall Study|Protocol Violation|2
7763568|NCT00729326|26989078|P1|Overall Study|Protocol Violation|3
7763569|NCT00729326|26989077|P2|Overall Study|Physician Decision|1
7763570|NCT00729326|26989078|P1|Overall Study|Physician Decision|0
7763571|NCT00729326|26989077|P2|Overall Study|Lost to Follow-up|0
7763572|NCT00729326|26989078|P1|Overall Study|Lost to Follow-up|2
7763573|NCT00729248|26989120|P1|Overall Study|Physician Decision|2
7763574|NCT00729183|26989127|P2|Overall Study|Withdrawal by Subject|7
7763575|NCT00729183|26989128|P1|Overall Study|Withdrawal by Subject|9
7763576|NCT00729183|26989127|P2|Overall Study|Protocol Violation|0
7763577|NCT00729183|26989128|P1|Overall Study|Protocol Violation|1
7763578|NCT00729183|26989127|P2|Overall Study|Physician Decision|1
7763579|NCT00729183|26989128|P1|Overall Study|Physician Decision|1
7763580|NCT00729183|26989127|P2|Overall Study|Lost to Follow-up|1
7763581|NCT00729183|26989128|P1|Overall Study|Lost to Follow-up|3
7763582|NCT00729183|26989127|P2|Overall Study|Lack of Efficacy|1
7763583|NCT00729183|26989128|P1|Overall Study|Lack of Efficacy|0
7763584|NCT00729183|26989127|P2|Overall Study|Adverse Event|5
7763585|NCT00729183|26989128|P1|Overall Study|Adverse Event|11
7763586|NCT00729157|26989160|P1|Overall Study|Withdrawal by Subject|1
7763587|NCT00728988|26989203|P2|Overall Study|Withdrawal by Subject|6
7763588|NCT00728988|26989204|P1|Overall Study|Withdrawal by Subject|2
7763589|NCT00728988|26989203|P2|Overall Study|Other|77
7763590|NCT00728988|26989204|P1|Overall Study|Other|85
7763591|NCT00728988|26989203|P2|Overall Study|Adverse Event|2
7763592|NCT00728988|26989204|P1|Overall Study|Adverse Event|3
7763593|NCT00728988|26989203|P2|Overall Study|Death|1
7763594|NCT00728988|26989204|P1|Overall Study|Death|1
7763595|NCT00728988|26989203|P2|Overall Study|Not Treated|2
7763596|NCT00728988|26989204|P1|Overall Study|Not Treated|2
7763597|NCT00728962|26989222|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
7763598|NCT00728962|26989222|P1|Permanent Prosthesis Placement|Adverse Event|3
7763599|NCT00728962|26989222|P1|Implant Placement Surgery|Protocol Violation|1
7763600|NCT00728962|26989222|P1|Implant Placement Surgery|Lost to Follow-up|1
7763601|NCT00728962|26989222|P1|Implant Placement Surgery|Adverse Event|8
7763602|NCT00728949|26989228|P2|Overall Study|On treatment at cutoff date|0
7763603|NCT00728949|26989229|P1|Overall Study|On treatment at cutoff date|1
7763604|NCT00728949|26989228|P2|Overall Study|Abnormal Lab Results|2
7763605|NCT00728949|26989229|P1|Overall Study|Abnormal Lab Results|0
7763606|NCT00728949|26989228|P2|Overall Study|Withdrawal by Subject|2
7763607|NCT00728949|26989229|P1|Overall Study|Withdrawal by Subject|2
7763608|NCT00728949|26989228|P2|Overall Study|Adverse Event|0
7763609|NCT00728949|26989229|P1|Overall Study|Adverse Event|8
7763610|NCT00728936|26989254|P7|Overall Study|Withdrawal by Subject|0
7763611|NCT00728936|26989255|P6|Overall Study|Withdrawal by Subject|1
7763612|NCT00728936|26989256|P5|Overall Study|Withdrawal by Subject|0
7763613|NCT00728936|26989257|P4|Overall Study|Withdrawal by Subject|0
7763614|NCT00728936|26989258|P3|Overall Study|Withdrawal by Subject|0
7763615|NCT00728936|26989259|P2|Overall Study|Withdrawal by Subject|0
7763616|NCT00728936|26989260|P1|Overall Study|Withdrawal by Subject|0
7763617|NCT00728884|26989293|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
7763618|NCT00728884|26989293|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
7763619|NCT00728754|26989329|P2|One Year Post Placement Follow-up|Adverse Event|0
7763620|NCT00728754|26989330|P1|One Year Post Placement Follow-up|Adverse Event|1
7763621|NCT00728754|26989329|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
7763622|NCT00728754|26989330|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
7763623|NCT00728754|26989329|P2|Permanent Prosthesis Placement|Adverse Event|1
7763624|NCT00728754|26989330|P1|Permanent Prosthesis Placement|Adverse Event|1
7763625|NCT00728689|26989359|P2|Washout Period (Days 4 - 10)|Death in family|0
7763626|NCT00728689|26989360|P1|Washout Period (Days 4 - 10)|Death in family|1
7763627|NCT00728494|26989389|P2|Overall Study|No data available|1
7763628|NCT00728494|26989390|P1|Overall Study|No data available|0
7763629|NCT00728494|26989389|P2|Overall Study|Lack of Efficacy|4
7763630|NCT00728494|26989390|P1|Overall Study|Lack of Efficacy|2
7763631|NCT00728494|26989389|P2|Overall Study|Withdrawal by Subject|2
7763632|NCT00728494|26989390|P1|Overall Study|Withdrawal by Subject|0
7763633|NCT00728494|26989389|P2|Overall Study|Adverse Event|0
7763634|NCT00728494|26989390|P1|Overall Study|Adverse Event|7
7763635|NCT00728481|26989408|P2|Overall Study|Incorrectly assigned to opposite arm|0
7763636|NCT00728481|26989409|P1|Overall Study|Incorrectly assigned to opposite arm|1
7763637|NCT00728481|26989408|P2|Overall Study|Study medication non-compliance|2
7763638|NCT00728481|26989409|P1|Overall Study|Study medication non-compliance|0
7763639|NCT00728481|26989408|P2|Overall Study|Adverse Event|1
7763640|NCT00728481|26989409|P1|Overall Study|Adverse Event|0
7763641|NCT00728481|26989408|P2|Overall Study|Withdrawal by Subject|1
7763642|NCT00728481|26989409|P1|Overall Study|Withdrawal by Subject|0
7763643|NCT00728468|26989425|P1|Overall Study|Study terminated by sponsor|1
7763644|NCT00728468|26989425|P1|Overall Study|Objective progression or relapse|9
7763645|NCT00728468|26989425|P1|Overall Study|Protocol Violation|4
7763646|NCT00728468|26989425|P1|Overall Study|Death|1
7763647|NCT00728468|26989425|P1|Overall Study|Enrolled but not treated|1
7763648|NCT00728416|26989449|P2|Overall Study|Withdrawal by Subject|0
7763649|NCT00728416|26989450|P1|Overall Study|Withdrawal by Subject|1
7763650|NCT00728416|26989449|P2|Overall Study|Treatment Failure|1
7763651|NCT00728416|26989450|P1|Overall Study|Treatment Failure|0
7763652|NCT00728416|26989449|P2|Overall Study|Adverse Event|1
7763653|NCT00728416|26989450|P1|Overall Study|Adverse Event|1
7763654|NCT00728182|26989466|P2|Overall Study|Protocol Noncompliance|1
7763655|NCT00728182|26989467|P1|Overall Study|Protocol Noncompliance|0
7763656|NCT00728182|26989466|P2|Overall Study|Death|2
7763657|NCT00728182|26989467|P1|Overall Study|Death|0
7763658|NCT00728182|26989466|P2|Overall Study|Lost to Follow-up|0
7763659|NCT00728182|26989467|P1|Overall Study|Lost to Follow-up|2
7763660|NCT00728182|26989466|P2|Overall Study|Adverse Event|0
7763661|NCT00728182|26989467|P1|Overall Study|Adverse Event|1
7763662|NCT00728130|26989495|P1|Overall Study|Physician Decision|1
7763663|NCT00728130|26989495|P1|Overall Study|Paperwork not completed in time|1
7763664|NCT00728130|26989495|P1|Overall Study|Withdrawal by Subject|1
7763665|NCT00727961|26989500|P1|Overall Study|Progression|30
7763666|NCT00727961|26989500|P1|Overall Study|Patient's refusal|2
7763667|NCT00727961|26989500|P1|Overall Study|Adverse Event|4
7763668|NCT00727961|26989500|P1|Overall Study|Lost to Follow-up|1
7763669|NCT00727909|26989510|P4|Overall Study|Death|0
7763670|NCT00727909|26989511|P3|Overall Study|Death|1
7763671|NCT00727909|26989512|P2|Overall Study|Death|0
7763672|NCT00727909|26989513|P1|Overall Study|Death|0
7763673|NCT00727909|26989510|P4|Overall Study|Withdrawal by Subject|5
7763674|NCT00727909|26989511|P3|Overall Study|Withdrawal by Subject|8
7763675|NCT00727909|26989512|P2|Overall Study|Withdrawal by Subject|11
7763676|NCT00727909|26989513|P1|Overall Study|Withdrawal by Subject|5
7763677|NCT00727844|26989610|P4|Initial Randomization|Physician Decision|0
7763678|NCT00727844|26989611|P3|Initial Randomization|Physician Decision|0
7763679|NCT00727844|26989612|P2|Initial Randomization|Physician Decision|0
7763680|NCT00727844|26989613|P1|Initial Randomization|Physician Decision|2
7763681|NCT00727714|26989627|P1|Overall Study|Lost to Follow-up|2
7763682|NCT00727649|26989637|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
7763683|NCT00727649|26989638|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
7763684|NCT00727649|26989637|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
7763685|NCT00727649|26989638|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
7763686|NCT00727649|26989637|P2|Second Intervention (4-weeks)|Death|0
7763687|NCT00727649|26989638|P1|Second Intervention (4-weeks)|Death|1
7763688|NCT00727649|26989637|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
7763689|NCT00727649|26989638|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
7763690|NCT00727649|26989637|P2|Wash-out (2-weeks)|Lost to Follow-up|1
7763691|NCT00727649|26989638|P1|Wash-out (2-weeks)|Lost to Follow-up|3
7763692|NCT00727649|26989637|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
7763693|NCT00727649|26989638|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
7763694|NCT00727649|26989637|P2|First Intervention (4-weeks)|Lost to Follow-up|2
7763695|NCT00727649|26989638|P1|First Intervention (4-weeks)|Lost to Follow-up|1
7763696|NCT00727571|26989680|P4|Overall Study|Other|0
7763697|NCT00727571|26989681|P3|Overall Study|Other|6
7763698|NCT00727571|26989682|P2|Overall Study|Other|4
7763699|NCT00727571|26989683|P1|Overall Study|Other|0
7763700|NCT00727571|26989680|P4|Overall Study|AE not leading to hospitalization|0
7763701|NCT00727571|26989681|P3|Overall Study|AE not leading to hospitalization|2
7763702|NCT00727571|26989682|P2|Overall Study|AE not leading to hospitalization|0
7763703|NCT00727571|26989683|P1|Overall Study|AE not leading to hospitalization|0
7763704|NCT00727571|26989680|P4|Overall Study|Hospitalization|1
7763705|NCT00727571|26989681|P3|Overall Study|Hospitalization|0
7763706|NCT00727571|26989682|P2|Overall Study|Hospitalization|1
7763707|NCT00727571|26989683|P1|Overall Study|Hospitalization|0
7763708|NCT00727571|26989680|P4|Overall Study|Dismissed from nursing home|0
7763709|NCT00727571|26989681|P3|Overall Study|Dismissed from nursing home|5
7763710|NCT00727571|26989682|P2|Overall Study|Dismissed from nursing home|9
7763711|NCT00727571|26989683|P1|Overall Study|Dismissed from nursing home|0
7763712|NCT00727571|26989680|P4|Overall Study|Subject Non Compliance|4
7763713|NCT00727571|26989681|P3|Overall Study|Subject Non Compliance|0
7763714|NCT00727571|26989682|P2|Overall Study|Subject Non Compliance|6
7763715|NCT00727571|26989683|P1|Overall Study|Subject Non Compliance|0
7763716|NCT00727571|26989680|P4|Overall Study|Withdrawal by Subject|0
7763717|NCT00727571|26989681|P3|Overall Study|Withdrawal by Subject|11
7763718|NCT00727571|26989682|P2|Overall Study|Withdrawal by Subject|10
7763719|NCT00727571|26989683|P1|Overall Study|Withdrawal by Subject|0
7763720|NCT00727571|26989680|P4|Overall Study|Physician Decision|0
7763721|NCT00727571|26989681|P3|Overall Study|Physician Decision|0
7763722|NCT00727571|26989682|P2|Overall Study|Physician Decision|5
7763723|NCT00727571|26989683|P1|Overall Study|Physician Decision|0
7763724|NCT00727571|26989680|P4|Overall Study|Death|1
7763725|NCT00727571|26989681|P3|Overall Study|Death|5
7763726|NCT00727571|26989682|P2|Overall Study|Death|19
7763727|NCT00727571|26989683|P1|Overall Study|Death|0
7763728|NCT00727571|26989680|P4|Overall Study|Ineligibility determined|0
7763729|NCT00727571|26989681|P3|Overall Study|Ineligibility determined|1
7763730|NCT00727571|26989682|P2|Overall Study|Ineligibility determined|1
7763731|NCT00727571|26989683|P1|Overall Study|Ineligibility determined|1
7763732|NCT00727558|26989710|P2|Overall Study|Lost to Follow-up|0
7763733|NCT00727558|26989711|P1|Overall Study|Lost to Follow-up|1
7763734|NCT00727558|26989710|P2|Overall Study|Subject unable to return for follow-up|1
7763735|NCT00727558|26989711|P1|Overall Study|Subject unable to return for follow-up|1
7763736|NCT00727558|26989710|P2|Overall Study|Adverse Event|1
7763737|NCT00727558|26989711|P1|Overall Study|Adverse Event|0
7763738|NCT00727558|26989710|P2|Overall Study|Lens issue|1
7763739|NCT00727558|26989711|P1|Overall Study|Lens issue|0
7763740|NCT00727532|26989729|P1|Overall Study|Withdrawal by Subject|1
7763741|NCT00727532|26989729|P1|Overall Study|Adverse Event|1
7763742|NCT00727506|26989741|P6|Overall Study|Other reason not described above|1
7763743|NCT00727506|26989742|P5|Overall Study|Other reason not described above|1
7763744|NCT00727506|26989743|P4|Overall Study|Other reason not described above|4
7763745|NCT00727506|26989744|P3|Overall Study|Other reason not described above|1
7763746|NCT00727506|26989745|P2|Overall Study|Other reason not described above|0
7763747|NCT00727506|26989746|P1|Overall Study|Other reason not described above|0
7763748|NCT00727506|26989741|P6|Overall Study|Refused to continue medication|2
7763749|NCT00727506|26989742|P5|Overall Study|Refused to continue medication|1
7763750|NCT00727506|26989743|P4|Overall Study|Refused to continue medication|3
7763751|NCT00727506|26989744|P3|Overall Study|Refused to continue medication|2
7763752|NCT00727506|26989745|P2|Overall Study|Refused to continue medication|1
7763753|NCT00727506|26989746|P1|Overall Study|Refused to continue medication|0
7763754|NCT00727506|26989741|P6|Overall Study|Progressive disease|28
7763755|NCT00727506|26989742|P5|Overall Study|Progressive disease|38
7763756|NCT00727506|26989743|P4|Overall Study|Progressive disease|28
7763757|NCT00727506|26989744|P3|Overall Study|Progressive disease|9
7763758|NCT00727506|26989745|P2|Overall Study|Progressive disease|7
7763759|NCT00727506|26989746|P1|Overall Study|Progressive disease|4
7763760|NCT00727506|26989741|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
7763761|NCT00727506|26989742|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
7763762|NCT00727506|26989743|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
7763763|NCT00727506|26989744|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
7763764|NCT00727506|26989745|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
7763765|NCT00727506|26989746|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
7763766|NCT00727506|26989741|P6|Overall Study|Adverse Event|8
7763767|NCT00727506|26989742|P5|Overall Study|Adverse Event|1
7763768|NCT00727506|26989743|P4|Overall Study|Adverse Event|4
7763769|NCT00727506|26989744|P3|Overall Study|Adverse Event|4
7763770|NCT00727506|26989745|P2|Overall Study|Adverse Event|0
7763771|NCT00727506|26989746|P1|Overall Study|Adverse Event|0
7763772|NCT00727441|26989842|P3|Overall Study|Withdrawal by Subject|0
7763773|NCT00727441|26989843|P2|Overall Study|Withdrawal by Subject|1
7763774|NCT00727441|26989844|P1|Overall Study|Withdrawal by Subject|0
7763775|NCT00727441|26989842|P3|Overall Study|Physician Decision|0
7763776|NCT00727441|26989843|P2|Overall Study|Physician Decision|1
7763777|NCT00727441|26989844|P1|Overall Study|Physician Decision|0
7763778|NCT00727441|26989842|P3|Overall Study|Death|1
7763779|NCT00727441|26989843|P2|Overall Study|Death|1
7763780|NCT00727441|26989844|P1|Overall Study|Death|0
7763781|NCT00727441|26989842|P3|Overall Study|Eligibility|7
7763782|NCT00727441|26989843|P2|Overall Study|Eligibility|5
7763783|NCT00727441|26989844|P1|Overall Study|Eligibility|7
7763784|NCT00727441|26989842|P3|Overall Study|Disease Progression|17
7763785|NCT00727441|26989843|P2|Overall Study|Disease Progression|14
7763786|NCT00727441|26989844|P1|Overall Study|Disease Progression|11
7763787|NCT00727415|26989864|P1|Phase I|Dose Limiting Toxicity|2
7763788|NCT00727402|26989873|P1|Overall Study|Physician Decision|116
7763789|NCT00727311|26989902|P1|Overall Study|Multiple reasons|39
7763790|NCT00727311|26989902|P1|Overall Study|Other|97
7763791|NCT00727311|26989902|P1|Overall Study|Withdrawal by Subject|77
7763792|NCT00727311|26989902|P1|Overall Study|Lost to Follow-up|73
7763793|NCT00727311|26989902|P1|Overall Study|Lack of Efficacy|242
7763794|NCT00727311|26989902|P1|Overall Study|Adverse Event|58
7763795|NCT00727311|26989902|P1|Overall Study|Missing end of therapy data|205
7763796|NCT00727311|26989902|P1|Overall Study|Did not receive drug|316
7763797|NCT00727272|26989915|P3|Washout Period B|Withdrawal by Subject|1
7763798|NCT00727272|26989916|P2|Washout Period B|Withdrawal by Subject|0
7763799|NCT00727272|26989917|P1|Washout Period B|Withdrawal by Subject|0
7763800|NCT00727272|26989915|P3|Washout Period A|Adverse Event|1
7763801|NCT00727272|26989916|P2|Washout Period A|Adverse Event|0
7763802|NCT00727272|26989917|P1|Washout Period A|Adverse Event|0
7763803|NCT00727259|26989934|P1|Overall Study|Not all questionnaires completed|1055
7763804|NCT00727246|26989943|P4|Overall Study|withdrawn|0
7763805|NCT00727246|26989944|P3|Overall Study|withdrawn|1
7763806|NCT00727246|26989945|P2|Overall Study|withdrawn|0
7763807|NCT00727246|26989946|P1|Overall Study|withdrawn|0
7763808|NCT00727246|26989943|P4|Overall Study|incidental finding|1
7763809|NCT00727246|26989944|P3|Overall Study|incidental finding|0
7763810|NCT00727246|26989945|P2|Overall Study|incidental finding|0
7763811|NCT00727246|26989946|P1|Overall Study|incidental finding|0
7763812|NCT00727246|26989943|P4|Overall Study|could not complete MRI|1
7763813|NCT00727246|26989944|P3|Overall Study|could not complete MRI|0
7763814|NCT00727246|26989945|P2|Overall Study|could not complete MRI|1
7763815|NCT00727246|26989946|P1|Overall Study|could not complete MRI|0
7763816|NCT00727194|26989969|P3|Treatment Period 2|Lack of Efficacy|0
7763817|NCT00727194|26989970|P2|Treatment Period 2|Lack of Efficacy|1
7763818|NCT00727194|26989971|P1|Treatment Period 2|Lack of Efficacy|0
7763819|NCT00727194|26989969|P3|Screening Period|History of thymoma|1
7763820|NCT00727194|26989970|P2|Screening Period|History of thymoma|0
7763821|NCT00727194|26989971|P1|Screening Period|History of thymoma|0
7763822|NCT00727194|26989969|P3|Screening Period|Severe infections|2
7763823|NCT00727194|26989970|P2|Screening Period|Severe infections|0
7763824|NCT00727194|26989971|P1|Screening Period|Severe infections|0
7763825|NCT00727194|26989969|P3|Screening Period|Not stable on concomitant MG therapy|2
7763826|NCT00727194|26989970|P2|Screening Period|Not stable on concomitant MG therapy|0
7763827|NCT00727194|26989971|P1|Screening Period|Not stable on concomitant MG therapy|0
7763828|NCT00727194|26989969|P3|Screening Period|Lacked AChR antibodies|5
7763829|NCT00727194|26989970|P2|Screening Period|Lacked AChR antibodies|0
7763830|NCT00727194|26989971|P1|Screening Period|Lacked AChR antibodies|0
7763831|NCT00727194|26989969|P3|Screening Period|Low QMG scores|6
7763832|NCT00727194|26989970|P2|Screening Period|Low QMG scores|0
7763833|NCT00727194|26989971|P1|Screening Period|Low QMG scores|0
7763834|NCT00727025|26990043|P1|Overall Study|Physician Decision|23
7763835|NCT00726999|26990055|P2|Overall Study|Protocol Violation|0
7763836|NCT00726999|26990056|P1|Overall Study|Protocol Violation|1
7763837|NCT00726999|26990055|P2|Overall Study|Withdrawal by Subject|0
7763838|NCT00726999|26990056|P1|Overall Study|Withdrawal by Subject|2
7763839|NCT00726999|26990055|P2|Overall Study|Physician Decision|1
7763840|NCT00726999|26990056|P1|Overall Study|Physician Decision|0
7763841|NCT00726986|26990068|P1|Maintenance Phase|Lack of Efficacy|2
7763842|NCT00726986|26990068|P1|Maintenance Phase|Adverse Event|1
7763843|NCT00726986|26990068|P1|Induction Phase|Secondary Disease|2
7763844|NCT00726986|26990068|P1|Induction Phase|Lack of Efficacy|5
7763845|NCT00726986|26990068|P1|Induction Phase|Death|2
7763846|NCT00726986|26990068|P1|Induction Phase|Withdrawal by Subject|2
7763847|NCT00726986|26990068|P1|Induction Phase|Adverse Event|4
7763848|NCT00726895|26990075|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7763849|NCT00726895|26990076|P1|Washout Period of 7 Days|Withdrawal by Subject|0
7763850|NCT00726882|26990089|P1|Overall Study|Other|10
7763851|NCT00726882|26990089|P1|Overall Study|Lost to Follow-up|7
7763852|NCT00726882|26990089|P1|Overall Study|Withdrawal by Subject|5
7763853|NCT00726752|26990104|P1|Overall Study|Lack of Efficacy|6
7763854|NCT00726661|26990166|P2|Overall Study|Other|35
7763855|NCT00726661|26990167|P1|Overall Study|Other|47
7763856|NCT00726661|26990166|P2|Overall Study|Physician Decision|13
7763857|NCT00726661|26990167|P1|Overall Study|Physician Decision|25
7763858|NCT00726661|26990166|P2|Overall Study|Death|159
7763859|NCT00726661|26990167|P1|Overall Study|Death|475
7763860|NCT00726661|26990166|P2|Overall Study|Trial terminated by sponsor|187
7763861|NCT00726661|26990167|P1|Overall Study|Trial terminated by sponsor|214
7763862|NCT00726661|26990166|P2|Overall Study|Withdrawal by Subject|13
7763863|NCT00726661|26990167|P1|Overall Study|Withdrawal by Subject|17
7763864|NCT00726661|26990166|P2|Overall Study|Lost to Follow-up|11
7763865|NCT00726661|26990167|P1|Overall Study|Lost to Follow-up|36
7763866|NCT00726622|26990184|P2|Overall Study|Metastasis|0
7763867|NCT00726622|26990185|P1|Overall Study|Metastasis|2
7763868|NCT00726622|26990184|P2|Overall Study|Physician Decision|1
7763869|NCT00726622|26990185|P1|Overall Study|Physician Decision|0
7763870|NCT00726622|26990184|P2|Overall Study|Withdrawal by Subject|2
7763871|NCT00726622|26990185|P1|Overall Study|Withdrawal by Subject|16
7763872|NCT00726609|26990203|P1|Overall Study|Other|3
7763873|NCT00726609|26990203|P1|Overall Study|Missing|42
7763874|NCT00726609|26990203|P1|Overall Study|Other|16
7763875|NCT00726609|26990203|P1|Overall Study|Lack of Efficacy|25
7763876|NCT00726609|26990203|P1|Overall Study|Withdrawal by Subject|2
7763877|NCT00726609|26990203|P1|Overall Study|Adverse Event|10
7763878|NCT00726557|26990207|P1|Overall Study|Inclusion criteria not met|15
7763879|NCT00726557|26990207|P1|Overall Study|Treatment less than 3 months|17
7763880|NCT00726557|26990207|P1|Overall Study|No follow-up documentation available|55
7763881|NCT00726557|26990207|P1|Overall Study|No end of treatment documentation|37
7763882|NCT00726557|26990207|P1|Overall Study|Screening failure|4
7763883|NCT00726453|26990214|P2|38 mm Length Group|Death|3
7763884|NCT00726453|26990215|P1|38 mm Length Group|Death|0
7763885|NCT00726453|26990214|P2|Primary Enrollment Group|Withdrawal by Subject|0
7763886|NCT00726453|26990215|P1|Primary Enrollment Group|Withdrawal by Subject|13
7763887|NCT00726453|26990214|P2|Primary Enrollment Group|Death|0
7763888|NCT00726453|26990215|P1|Primary Enrollment Group|Death|18
7763889|NCT00726388|26990236|P1|Overall Study|Enrolled, Not Treated|79
7763890|NCT00726388|26990236|P1|Overall Study|Other|5
7763891|NCT00726388|26990236|P1|Overall Study|Participants Non-compliant With Study Procedures|5
7763892|NCT00726388|26990236|P1|Overall Study|Lost to Follow-up|10
7763893|NCT00726388|26990236|P1|Overall Study|Adverse Event|3
7763894|NCT00726388|26990236|P1|Overall Study|Withdrawal by Subject|5
7763895|NCT00726323|26990262|P2|Overall Study|Metastatic lesions inferred cyst|1
7763896|NCT00726323|26990263|P1|Overall Study|Metastatic lesions inferred cyst|0
7763897|NCT00726323|26990262|P2|Overall Study|Participant wished to discontinue|1
7763898|NCT00726323|26990263|P1|Overall Study|Participant wished to discontinue|0
7763899|NCT00726323|26990262|P2|Overall Study|Death|0
7763900|NCT00726323|26990263|P1|Overall Study|Death|1
7763901|NCT00726323|26990262|P2|Overall Study|Adverse Event|9
7763902|NCT00726323|26990263|P1|Overall Study|Adverse Event|9
7763903|NCT00726323|26990262|P2|Overall Study|Clinical progression|3
7763904|NCT00726323|26990263|P1|Overall Study|Clinical progression|0
7763905|NCT00726323|26990262|P2|Overall Study|Progressive disease|16
7763906|NCT00726323|26990263|P1|Overall Study|Progressive disease|23
7763907|NCT00726323|26990262|P2|Overall Study|Physician Decision|0
7763908|NCT00726323|26990263|P1|Overall Study|Physician Decision|1
7763909|NCT00726323|26990262|P2|Overall Study|Withdrawal by Subject|1
7763910|NCT00726323|26990263|P1|Overall Study|Withdrawal by Subject|3
7763911|NCT00726232|26990293|P8|Expansion Phase|Unspecified reason|0
7763912|NCT00726232|26990294|P7|Expansion Phase|Unspecified reason|1
7763913|NCT00726232|26990295|P6|Expansion Phase|Unspecified reason|0
7763914|NCT00726232|26990296|P5|Expansion Phase|Unspecified reason|0
7763915|NCT00726232|26990297|P4|Expansion Phase|Unspecified reason|0
7763916|NCT00726232|26990298|P3|Expansion Phase|Unspecified reason|0
7763917|NCT00726232|26990299|P2|Expansion Phase|Unspecified reason|0
7763918|NCT00726232|26990300|P1|Expansion Phase|Unspecified reason|0
7763919|NCT00726232|26990293|P8|Expansion Phase|Per Investigator: lack of response|7
7763920|NCT00726232|26990294|P7|Expansion Phase|Per Investigator: lack of response|1
7763921|NCT00726232|26990295|P6|Expansion Phase|Per Investigator: lack of response|0
7763922|NCT00726232|26990296|P5|Expansion Phase|Per Investigator: lack of response|0
7763923|NCT00726232|26990297|P4|Expansion Phase|Per Investigator: lack of response|0
7763924|NCT00726232|26990298|P3|Expansion Phase|Per Investigator: lack of response|0
7763925|NCT00726232|26990299|P2|Expansion Phase|Per Investigator: lack of response|0
7763926|NCT00726232|26990300|P1|Expansion Phase|Per Investigator: lack of response|0
7763927|NCT00726232|26990293|P8|Expansion Phase|Termination of the trial by sponsor|16
7763928|NCT00726232|26990294|P7|Expansion Phase|Termination of the trial by sponsor|10
7763929|NCT00726232|26990295|P6|Expansion Phase|Termination of the trial by sponsor|0
7763930|NCT00726232|26990296|P5|Expansion Phase|Termination of the trial by sponsor|0
7763931|NCT00726232|26990297|P4|Expansion Phase|Termination of the trial by sponsor|0
7763932|NCT00726232|26990298|P3|Expansion Phase|Termination of the trial by sponsor|0
7763933|NCT00726232|26990299|P2|Expansion Phase|Termination of the trial by sponsor|0
7763934|NCT00726232|26990300|P1|Expansion Phase|Termination of the trial by sponsor|0
7763935|NCT00726232|26990293|P8|Expansion Phase|Disease progression|0
7763936|NCT00726232|26990294|P7|Expansion Phase|Disease progression|4
7763937|NCT00726232|26990295|P6|Expansion Phase|Disease progression|0
7763938|NCT00726232|26990296|P5|Expansion Phase|Disease progression|0
7763939|NCT00726232|26990297|P4|Expansion Phase|Disease progression|0
7763940|NCT00726232|26990298|P3|Expansion Phase|Disease progression|0
7763941|NCT00726232|26990299|P2|Expansion Phase|Disease progression|0
7763942|NCT00726232|26990300|P1|Expansion Phase|Disease progression|0
7763943|NCT00726232|26990293|P8|Expansion Phase|Withdrawal by Subject|3
7763944|NCT00726232|26990294|P7|Expansion Phase|Withdrawal by Subject|2
7763945|NCT00726232|26990295|P6|Expansion Phase|Withdrawal by Subject|0
7763946|NCT00726232|26990296|P5|Expansion Phase|Withdrawal by Subject|0
7763947|NCT00726232|26990297|P4|Expansion Phase|Withdrawal by Subject|0
7763948|NCT00726232|26990298|P3|Expansion Phase|Withdrawal by Subject|0
7763949|NCT00726232|26990299|P2|Expansion Phase|Withdrawal by Subject|0
7763950|NCT00726232|26990300|P1|Expansion Phase|Withdrawal by Subject|0
7763951|NCT00726232|26990293|P8|Expansion Phase|Adverse Event|11
7763952|NCT00726232|26990294|P7|Expansion Phase|Adverse Event|6
7763953|NCT00726232|26990295|P6|Expansion Phase|Adverse Event|0
7763954|NCT00726232|26990296|P5|Expansion Phase|Adverse Event|0
7763955|NCT00726232|26990297|P4|Expansion Phase|Adverse Event|0
7763956|NCT00726232|26990298|P3|Expansion Phase|Adverse Event|0
7763957|NCT00726232|26990299|P2|Expansion Phase|Adverse Event|0
7763958|NCT00726232|26990300|P1|Expansion Phase|Adverse Event|0
7763959|NCT00726232|26990293|P8|Expansion Phase|Death|1
7763960|NCT00726232|26990294|P7|Expansion Phase|Death|0
7763961|NCT00726232|26990295|P6|Expansion Phase|Death|0
7763962|NCT00726232|26990296|P5|Expansion Phase|Death|0
7763963|NCT00726232|26990297|P4|Expansion Phase|Death|0
7763964|NCT00726232|26990298|P3|Expansion Phase|Death|0
7763965|NCT00726232|26990299|P2|Expansion Phase|Death|0
7763966|NCT00726232|26990300|P1|Expansion Phase|Death|0
7763967|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Unspecified reason|0
7763968|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Unspecified reason|0
7763969|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Unspecified reason|0
7763970|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Unspecified reason|0
7763971|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Unspecified reason|0
7763972|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Unspecified reason|0
7763973|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Unspecified reason|0
7763974|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Unspecified reason|1
7763975|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7763976|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7763977|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
7763978|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
7763979|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
7763980|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7763981|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7763982|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
7763983|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
7763984|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
7763985|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7763986|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
7763987|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
7763988|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7763989|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7763990|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
7763991|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Disease progression|0
7763992|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Disease progression|0
7763993|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Disease progression|0
7763994|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Disease progression|0
7763995|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Disease progression|0
7763996|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Disease progression|0
7763997|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Disease progression|1
7763998|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Disease progression|3
7763999|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7764000|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7764001|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
7764002|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7764003|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
7764004|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7764005|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7764006|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
7764007|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Adverse Event|0
7764008|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Adverse Event|0
7764009|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Adverse Event|3
7764010|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Adverse Event|7
7764011|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Adverse Event|1
7764012|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Adverse Event|2
7764013|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Adverse Event|2
7764014|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Adverse Event|2
7764015|NCT00726232|26990293|P8|Initial Phase (Dose-finding)|Death|0
7764016|NCT00726232|26990294|P7|Initial Phase (Dose-finding)|Death|0
7764017|NCT00726232|26990295|P6|Initial Phase (Dose-finding)|Death|0
7764018|NCT00726232|26990296|P5|Initial Phase (Dose-finding)|Death|1
7764019|NCT00726232|26990297|P4|Initial Phase (Dose-finding)|Death|0
7764020|NCT00726232|26990298|P3|Initial Phase (Dose-finding)|Death|0
7764021|NCT00726232|26990299|P2|Initial Phase (Dose-finding)|Death|0
7764022|NCT00726232|26990300|P1|Initial Phase (Dose-finding)|Death|0
7764023|NCT00726063|26990352|P2|Overall Study|Adverse Event|7
7764024|NCT00726063|26990353|P1|Overall Study|Adverse Event|9
7764025|NCT00725985|26990367|P12|LTFU (No Cladribine) (48 Weeks)|Other|14
7764026|NCT00725985|26990368|P11|LTFU (No Cladribine) (48 Weeks)|Other|36
7764027|NCT00725985|26990369|P10|LTFU (No Cladribine) (48 Weeks)|Other|34
7764028|NCT00725985|26990370|P9|LTFU (No Cladribine) (48 Weeks)|Other|0
7764029|NCT00725985|26990371|P8|LTFU (No Cladribine) (48 Weeks)|Other|0
7764030|NCT00725985|26990372|P7|LTFU (No Cladribine) (48 Weeks)|Other|0
7764031|NCT00725985|26990373|P6|LTFU (No Cladribine) (48 Weeks)|Other|0
7764032|NCT00725985|26990374|P5|LTFU (No Cladribine) (48 Weeks)|Other|0
7764033|NCT00725985|26990375|P4|LTFU (No Cladribine) (48 Weeks)|Other|0
7764034|NCT00725985|26990376|P3|LTFU (No Cladribine) (48 Weeks)|Other|0
7764035|NCT00725985|26990377|P2|LTFU (No Cladribine) (48 Weeks)|Other|0
7764036|NCT00725985|26990378|P1|LTFU (No Cladribine) (48 Weeks)|Other|0
7764037|NCT00725985|26990367|P12|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764038|NCT00725985|26990368|P11|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764039|NCT00725985|26990369|P10|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764040|NCT00725985|26990370|P9|LTFU (Cladribine Treatment) (48 Weeks)|Other|16
7764041|NCT00725985|26990371|P8|LTFU (Cladribine Treatment) (48 Weeks)|Other|8
7764042|NCT00725985|26990372|P7|LTFU (Cladribine Treatment) (48 Weeks)|Other|9
7764043|NCT00725985|26990373|P6|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764044|NCT00725985|26990374|P5|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764045|NCT00725985|26990375|P4|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764046|NCT00725985|26990376|P3|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764047|NCT00725985|26990377|P2|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764048|NCT00725985|26990378|P1|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7764049|NCT00725985|26990367|P12|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764050|NCT00725985|26990368|P11|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764051|NCT00725985|26990369|P10|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764052|NCT00725985|26990370|P9|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1
7764053|NCT00725985|26990371|P8|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764054|NCT00725985|26990372|P7|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764055|NCT00725985|26990373|P6|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764056|NCT00725985|26990374|P5|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764057|NCT00725985|26990375|P4|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764058|NCT00725985|26990376|P3|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764059|NCT00725985|26990377|P2|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764060|NCT00725985|26990378|P1|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7764061|NCT00725985|26990367|P12|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764062|NCT00725985|26990368|P11|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764063|NCT00725985|26990369|P10|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764064|NCT00725985|26990370|P9|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764065|NCT00725985|26990371|P8|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1
7764066|NCT00725985|26990372|P7|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764067|NCT00725985|26990373|P6|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764068|NCT00725985|26990374|P5|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764069|NCT00725985|26990375|P4|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764070|NCT00725985|26990376|P3|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764071|NCT00725985|26990377|P2|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764072|NCT00725985|26990378|P1|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7764073|NCT00725985|26990367|P12|OLMP (Up to 96 Weeks)|Other|0
7764074|NCT00725985|26990368|P11|OLMP (Up to 96 Weeks)|Other|0
7764075|NCT00725985|26990369|P10|OLMP (Up to 96 Weeks)|Other|0
7764076|NCT00725985|26990370|P9|OLMP (Up to 96 Weeks)|Other|0
7764077|NCT00725985|26990371|P8|OLMP (Up to 96 Weeks)|Other|0
7764078|NCT00725985|26990372|P7|OLMP (Up to 96 Weeks)|Other|0
7764079|NCT00725985|26990373|P6|OLMP (Up to 96 Weeks)|Other|44
7764080|NCT00725985|26990374|P5|OLMP (Up to 96 Weeks)|Other|20
7764081|NCT00725985|26990375|P4|OLMP (Up to 96 Weeks)|Other|15
7764082|NCT00725985|26990376|P3|OLMP (Up to 96 Weeks)|Other|0
7764083|NCT00725985|26990377|P2|OLMP (Up to 96 Weeks)|Other|0
7764084|NCT00725985|26990378|P1|OLMP (Up to 96 Weeks)|Other|0
7764085|NCT00725985|26990367|P12|OLMP (Up to 96 Weeks)|Disease progression|0
7764086|NCT00725985|26990368|P11|OLMP (Up to 96 Weeks)|Disease progression|0
7764087|NCT00725985|26990369|P10|OLMP (Up to 96 Weeks)|Disease progression|0
7764088|NCT00725985|26990370|P9|OLMP (Up to 96 Weeks)|Disease progression|0
7764089|NCT00725985|26990371|P8|OLMP (Up to 96 Weeks)|Disease progression|0
7764090|NCT00725985|26990372|P7|OLMP (Up to 96 Weeks)|Disease progression|0
7764091|NCT00725985|26990373|P6|OLMP (Up to 96 Weeks)|Disease progression|4
7764092|NCT00725985|26990374|P5|OLMP (Up to 96 Weeks)|Disease progression|0
7764093|NCT00725985|26990375|P4|OLMP (Up to 96 Weeks)|Disease progression|0
7764094|NCT00725985|26990376|P3|OLMP (Up to 96 Weeks)|Disease progression|0
7764095|NCT00725985|26990377|P2|OLMP (Up to 96 Weeks)|Disease progression|0
7764096|NCT00725985|26990378|P1|OLMP (Up to 96 Weeks)|Disease progression|0
7764097|NCT00725985|26990367|P12|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764098|NCT00725985|26990368|P11|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764099|NCT00725985|26990369|P10|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764100|NCT00725985|26990370|P9|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764101|NCT00725985|26990371|P8|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764102|NCT00725985|26990372|P7|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764103|NCT00725985|26990373|P6|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764104|NCT00725985|26990374|P5|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764105|NCT00725985|26990375|P4|OLMP (Up to 96 Weeks)|Lost to Follow-up|1
7764106|NCT00725985|26990376|P3|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764107|NCT00725985|26990377|P2|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764108|NCT00725985|26990378|P1|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7764109|NCT00725985|26990367|P12|OLMP (Up to 96 Weeks)|Death|0
7764110|NCT00725985|26990368|P11|OLMP (Up to 96 Weeks)|Death|0
7764111|NCT00725985|26990369|P10|OLMP (Up to 96 Weeks)|Death|0
7764112|NCT00725985|26990370|P9|OLMP (Up to 96 Weeks)|Death|0
7764113|NCT00725985|26990371|P8|OLMP (Up to 96 Weeks)|Death|0
7764114|NCT00725985|26990372|P7|OLMP (Up to 96 Weeks)|Death|0
7764115|NCT00725985|26990373|P6|OLMP (Up to 96 Weeks)|Death|0
7764116|NCT00725985|26990374|P5|OLMP (Up to 96 Weeks)|Death|1
7764117|NCT00725985|26990375|P4|OLMP (Up to 96 Weeks)|Death|0
7764118|NCT00725985|26990376|P3|OLMP (Up to 96 Weeks)|Death|0
7764119|NCT00725985|26990377|P2|OLMP (Up to 96 Weeks)|Death|0
7764120|NCT00725985|26990378|P1|OLMP (Up to 96 Weeks)|Death|0
7764121|NCT00725985|26990367|P12|OLMP (Up to 96 Weeks)|Adverse Event|0
7764122|NCT00725985|26990368|P11|OLMP (Up to 96 Weeks)|Adverse Event|0
7764123|NCT00725985|26990369|P10|OLMP (Up to 96 Weeks)|Adverse Event|0
7764124|NCT00725985|26990370|P9|OLMP (Up to 96 Weeks)|Adverse Event|0
7764125|NCT00725985|26990371|P8|OLMP (Up to 96 Weeks)|Adverse Event|0
7764126|NCT00725985|26990372|P7|OLMP (Up to 96 Weeks)|Adverse Event|0
7764127|NCT00725985|26990373|P6|OLMP (Up to 96 Weeks)|Adverse Event|5
7764128|NCT00725985|26990374|P5|OLMP (Up to 96 Weeks)|Adverse Event|2
7764129|NCT00725985|26990375|P4|OLMP (Up to 96 Weeks)|Adverse Event|2
7764130|NCT00725985|26990376|P3|OLMP (Up to 96 Weeks)|Adverse Event|0
7764131|NCT00725985|26990377|P2|OLMP (Up to 96 Weeks)|Adverse Event|0
7764132|NCT00725985|26990378|P1|OLMP (Up to 96 Weeks)|Adverse Event|0
7764133|NCT00725985|26990367|P12|ITP- Treatment Disposition|Other|0
7764134|NCT00725985|26990368|P11|ITP- Treatment Disposition|Other|0
7764135|NCT00725985|26990369|P10|ITP- Treatment Disposition|Other|0
7764136|NCT00725985|26990370|P9|ITP- Treatment Disposition|Other|0
7764137|NCT00725985|26990371|P8|ITP- Treatment Disposition|Other|0
7764138|NCT00725985|26990372|P7|ITP- Treatment Disposition|Other|0
7764139|NCT00725985|26990373|P6|ITP- Treatment Disposition|Other|0
7764140|NCT00725985|26990374|P5|ITP- Treatment Disposition|Other|0
7764141|NCT00725985|26990375|P4|ITP- Treatment Disposition|Other|0
7764142|NCT00725985|26990376|P3|ITP- Treatment Disposition|Other|24
7764143|NCT00725985|26990377|P2|ITP- Treatment Disposition|Other|38
7764144|NCT00725985|26990378|P1|ITP- Treatment Disposition|Other|50
7764145|NCT00725985|26990367|P12|ITP- Treatment Disposition|Converted to CDMS|0
7764146|NCT00725985|26990368|P11|ITP- Treatment Disposition|Converted to CDMS|0
7764147|NCT00725985|26990369|P10|ITP- Treatment Disposition|Converted to CDMS|0
7764148|NCT00725985|26990370|P9|ITP- Treatment Disposition|Converted to CDMS|0
7764149|NCT00725985|26990371|P8|ITP- Treatment Disposition|Converted to CDMS|0
7764150|NCT00725985|26990372|P7|ITP- Treatment Disposition|Converted to CDMS|0
7764151|NCT00725985|26990373|P6|ITP- Treatment Disposition|Converted to CDMS|0
7764152|NCT00725985|26990374|P5|ITP- Treatment Disposition|Converted to CDMS|0
7764153|NCT00725985|26990375|P4|ITP- Treatment Disposition|Converted to CDMS|0
7764154|NCT00725985|26990376|P3|ITP- Treatment Disposition|Converted to CDMS|71
7764155|NCT00725985|26990377|P2|ITP- Treatment Disposition|Converted to CDMS|27
7764156|NCT00725985|26990378|P1|ITP- Treatment Disposition|Converted to CDMS|30
7764157|NCT00725985|26990367|P12|ITP- Treatment Disposition|Randomized but not treated|0
7764158|NCT00725985|26990368|P11|ITP- Treatment Disposition|Randomized but not treated|0
7764159|NCT00725985|26990369|P10|ITP- Treatment Disposition|Randomized but not treated|0
7764160|NCT00725985|26990370|P9|ITP- Treatment Disposition|Randomized but not treated|0
7764161|NCT00725985|26990371|P8|ITP- Treatment Disposition|Randomized but not treated|0
7764162|NCT00725985|26990372|P7|ITP- Treatment Disposition|Randomized but not treated|0
7764163|NCT00725985|26990373|P6|ITP- Treatment Disposition|Randomized but not treated|0
7764164|NCT00725985|26990374|P5|ITP- Treatment Disposition|Randomized but not treated|0
7764165|NCT00725985|26990375|P4|ITP- Treatment Disposition|Randomized but not treated|0
7764166|NCT00725985|26990376|P3|ITP- Treatment Disposition|Randomized but not treated|0
7764167|NCT00725985|26990377|P2|ITP- Treatment Disposition|Randomized but not treated|0
7764168|NCT00725985|26990378|P1|ITP- Treatment Disposition|Randomized but not treated|1
7764169|NCT00725985|26990367|P12|ITP- Treatment Disposition|Lost to Follow-up|0
7764170|NCT00725985|26990368|P11|ITP- Treatment Disposition|Lost to Follow-up|0
7764171|NCT00725985|26990369|P10|ITP- Treatment Disposition|Lost to Follow-up|0
7764172|NCT00725985|26990370|P9|ITP- Treatment Disposition|Lost to Follow-up|0
7764173|NCT00725985|26990371|P8|ITP- Treatment Disposition|Lost to Follow-up|0
7764174|NCT00725985|26990372|P7|ITP- Treatment Disposition|Lost to Follow-up|0
7764175|NCT00725985|26990373|P6|ITP- Treatment Disposition|Lost to Follow-up|0
7764176|NCT00725985|26990374|P5|ITP- Treatment Disposition|Lost to Follow-up|0
7764177|NCT00725985|26990375|P4|ITP- Treatment Disposition|Lost to Follow-up|0
7764178|NCT00725985|26990376|P3|ITP- Treatment Disposition|Lost to Follow-up|2
7764179|NCT00725985|26990377|P2|ITP- Treatment Disposition|Lost to Follow-up|0
7764180|NCT00725985|26990378|P1|ITP- Treatment Disposition|Lost to Follow-up|0
7764181|NCT00725985|26990367|P12|ITP- Treatment Disposition|Adverse Event|0
7764182|NCT00725985|26990368|P11|ITP- Treatment Disposition|Adverse Event|0
7764183|NCT00725985|26990369|P10|ITP- Treatment Disposition|Adverse Event|0
7764184|NCT00725985|26990370|P9|ITP- Treatment Disposition|Adverse Event|0
7764185|NCT00725985|26990371|P8|ITP- Treatment Disposition|Adverse Event|0
7764186|NCT00725985|26990372|P7|ITP- Treatment Disposition|Adverse Event|0
7764187|NCT00725985|26990373|P6|ITP- Treatment Disposition|Adverse Event|0
7764188|NCT00725985|26990374|P5|ITP- Treatment Disposition|Adverse Event|0
7764189|NCT00725985|26990375|P4|ITP- Treatment Disposition|Adverse Event|0
7764190|NCT00725985|26990376|P3|ITP- Treatment Disposition|Adverse Event|5
7764191|NCT00725985|26990377|P2|ITP- Treatment Disposition|Adverse Event|10
7764192|NCT00725985|26990378|P1|ITP- Treatment Disposition|Adverse Event|20
7764193|NCT00725920|26990550|P2|Overall Study|Lack of Efficacy|6
7764194|NCT00725920|26990551|P1|Overall Study|Lack of Efficacy|3
7764195|NCT00725842|26990557|P1|Overall Study|No Visit 1 data|1
7764196|NCT00725842|26990557|P1|Overall Study|Inclusion criterion not met|1
7764197|NCT00725842|26990557|P1|Overall Study|Consent date prior to study start date|5
7764198|NCT00725842|26990557|P1|Overall Study|Positive HCV-RNA at Visit 2|13
7764199|NCT00725842|26990557|P1|Overall Study|Death|1
7764200|NCT00725842|26990557|P1|Overall Study|Lost to Follow-up|19
7764201|NCT00725764|26990564|P1|Overall Study|Decline in performance status|1
7764202|NCT00725764|26990564|P1|Overall Study|Participant non compliant with protocol|1
7764203|NCT00725764|26990564|P1|Overall Study|Death|1
7764204|NCT00725764|26990564|P1|Overall Study|Lost to Follow-up|1
7764205|NCT00725764|26990564|P1|Overall Study|Progressive Disease|7
7764206|NCT00725764|26990564|P1|Overall Study|Physician Decision|1
7764207|NCT00725764|26990564|P1|Overall Study|Withdrawal by Subject|2
7764208|NCT00725725|26990597|P3|Overall Study|Protocol Violation|0
7764209|NCT00725725|26990598|P2|Overall Study|Protocol Violation|1
7764210|NCT00725725|26990599|P1|Overall Study|Protocol Violation|0
7764211|NCT00725725|26990597|P3|Overall Study|Withdrawal by Subject|1
7764212|NCT00725725|26990598|P2|Overall Study|Withdrawal by Subject|0
7764213|NCT00725725|26990599|P1|Overall Study|Withdrawal by Subject|1
7764214|NCT00725725|26990597|P3|Overall Study|Lost to Follow-up|2
7764215|NCT00725725|26990598|P2|Overall Study|Lost to Follow-up|0
7764216|NCT00725725|26990599|P1|Overall Study|Lost to Follow-up|2
7764217|NCT00725725|26990597|P3|Overall Study|Adverse Event|2
7764218|NCT00725725|26990598|P2|Overall Study|Adverse Event|3
7764219|NCT00725725|26990599|P1|Overall Study|Adverse Event|1
7764220|NCT00725712|26990642|P2|Overall Study|Hospitalized, unable to continue|1
7764221|NCT00725712|26990643|P1|Overall Study|Hospitalized, unable to continue|0
7764222|NCT00725712|26990642|P2|Overall Study|Other: Death|0
7764223|NCT00725712|26990643|P1|Overall Study|Other: Death|1
7764224|NCT00725712|26990642|P2|Overall Study|Death|0
7764225|NCT00725712|26990643|P1|Overall Study|Death|2
7764226|NCT00725712|26990642|P2|Overall Study|Adverse Event|5
7764227|NCT00725712|26990643|P1|Overall Study|Adverse Event|5
7764228|NCT00725712|26990642|P2|Overall Study|Clinical progression not based on RECIST|3
7764229|NCT00725712|26990643|P1|Overall Study|Clinical progression not based on RECIST|0
7764230|NCT00725712|26990642|P2|Overall Study|Progressive disease|16
7764231|NCT00725712|26990643|P1|Overall Study|Progressive disease|37
7764232|NCT00725712|26990642|P2|Overall Study|Protocol Violation|0
7764233|NCT00725712|26990643|P1|Overall Study|Protocol Violation|1
7764234|NCT00725712|26990642|P2|Overall Study|Withdrawal by Subject|1
7764235|NCT00725712|26990643|P1|Overall Study|Withdrawal by Subject|2
7764236|NCT00725621|26990679|P1|Overall Study|Reason not specified|55
7764237|NCT00725621|26990679|P1|Overall Study|Prepared for elective surgery|1
7764238|NCT00725621|26990679|P1|Overall Study|Switched to other drug|1
7764239|NCT00725621|26990679|P1|Overall Study|Switched to other study|1
7764240|NCT00725621|26990679|P1|Overall Study|Continued treatment by other physician|6
7764241|NCT00725621|26990679|P1|Overall Study|Non-compliance|8
7764242|NCT00725621|26990679|P1|Overall Study|Lost to Follow-up|52
7764243|NCT00725621|26990679|P1|Overall Study|Physician Decision|19
7764244|NCT00725621|26990679|P1|Overall Study|Withdrawal by Subject|57
7764245|NCT00725621|26990679|P1|Overall Study|Lack of Efficacy|46
7764246|NCT00725621|26990679|P1|Overall Study|Adverse Event|25
7764247|NCT00725608|26990702|P1|Overall Study|Other|7
7764248|NCT00725608|26990702|P1|Overall Study|Individual reasons|86
7764249|NCT00725608|26990702|P1|Overall Study|Adverse Event|14
7764250|NCT00725608|26990702|P1|Overall Study|Lost to Follow-up|60
7764251|NCT00725543|26990708|P1|Overall Study|Other|119
7764252|NCT00725543|26990708|P1|Overall Study|Non-compliance|2
7764253|NCT00725543|26990708|P1|Overall Study|Lost to Follow-up|4
7764254|NCT00725543|26990708|P1|Overall Study|Physician Decision|5
7764255|NCT00725543|26990708|P1|Overall Study|Withdrawal by Subject|10
7764256|NCT00725543|26990708|P1|Overall Study|Lack of Efficacy|3
7764257|NCT00725543|26990708|P1|Overall Study|Adverse Event|10
7764258|NCT00725491|26990733|P2|Overall Study|No/too few embryos/ bad quality embryos|2
7764259|NCT00725491|26990734|P1|Overall Study|No/too few embryos/ bad quality embryos|3
7764260|NCT00725491|26990733|P2|Overall Study|Fertilization failure|1
7764261|NCT00725491|26990734|P1|Overall Study|Fertilization failure|0
7764262|NCT00725491|26990733|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
7764263|NCT00725491|26990734|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
7764264|NCT00725491|26990733|P2|Overall Study|Risk for hyperstimulation|9
7764265|NCT00725491|26990734|P1|Overall Study|Risk for hyperstimulation|2
7764266|NCT00725491|26990733|P2|Overall Study|Pregnancy|3
7764267|NCT00725491|26990734|P1|Overall Study|Pregnancy|0
7764268|NCT00725491|26990733|P2|Overall Study|Adverse Event|2
7764269|NCT00725491|26990734|P1|Overall Study|Adverse Event|3
7764270|NCT00725452|26990740|P1|Overall Study|Lost to Follow-up|1
7764271|NCT00725452|26990740|P1|Overall Study|Withdrawal by Subject|3
7764272|NCT00725452|26990740|P1|Overall Study|Physician Decision|1
7764273|NCT00725452|26990740|P1|Overall Study|Reason not specified|1
7764274|NCT00725452|26990740|P1|Overall Study|Lack of Efficacy|2
7764275|NCT00725452|26990740|P1|Overall Study|Adverse Event|3
7764276|NCT00725322|26990759|P2|Washout (28 Days)|Protocol Violation|1
7764277|NCT00725322|26990760|P1|Washout (28 Days)|Protocol Violation|0
7764278|NCT00725322|26990759|P2|Washout (28 Days)|Withdrawal by Subject|0
7764279|NCT00725322|26990760|P1|Washout (28 Days)|Withdrawal by Subject|2
7764280|NCT00725296|26990768|P1|Overall Study|Other|38
7764281|NCT00725296|26990768|P1|Overall Study|Lost to Follow-up|1
7764282|NCT00725296|26990768|P1|Overall Study|Non-Compliance|2
7764283|NCT00725296|26990768|P1|Overall Study|Withdrawal by Subject|3
7764284|NCT00725296|26990768|P1|Overall Study|Lack of Efficacy|7
7764285|NCT00725296|26990768|P1|Overall Study|Adverse Event|11
7764286|NCT00725283|26990777|P1|Overall Study|Withdrawal by Subject|10
7764287|NCT00725283|26990777|P1|Overall Study|Other|6
7764288|NCT00725283|26990777|P1|Overall Study|Death|5
7764289|NCT00725283|26990777|P1|Overall Study|Missing Code|3
7764290|NCT00725205|26990798|P1|Overall Study|Treatment Failure|41
7764291|NCT00725205|26990798|P1|Overall Study|Protocol Defined Clinical Event|1
7764292|NCT00725205|26990798|P1|Overall Study|Other|8
7764293|NCT00725205|26990798|P1|Overall Study|Non-compliance With Protocol|14
7764294|NCT00725205|26990798|P1|Overall Study|Investigator Discontinued|1
7764295|NCT00725205|26990798|P1|Overall Study|Adverse Event|22
7764296|NCT00725101|26990811|P1|Overall Study|not specified/no reason given|11
7764297|NCT00725101|26990811|P1|Overall Study|Withdrawal by Subject|127
7764298|NCT00725101|26990811|P1|Overall Study|Protocol Violation|1
7764299|NCT00725101|26990811|P1|Overall Study|Lost to Follow-up|353
7764300|NCT00725101|26990811|P1|Overall Study|Death|3
7764301|NCT00725075|26990834|P3|Overall Study|Other|0
7764302|NCT00725075|26990835|P2|Overall Study|Other|0
7764303|NCT00725075|26990836|P1|Overall Study|Other|1
7764304|NCT00725075|26990834|P3|Overall Study|Inclusion/Exclusion Criteria|1
7764305|NCT00725075|26990835|P2|Overall Study|Inclusion/Exclusion Criteria|0
7764306|NCT00725075|26990836|P1|Overall Study|Inclusion/Exclusion Criteria|1
7764307|NCT00725075|26990834|P3|Overall Study|Worsening of Disease|2
7764308|NCT00725075|26990835|P2|Overall Study|Worsening of Disease|1
7764309|NCT00725075|26990836|P1|Overall Study|Worsening of Disease|2
7764310|NCT00725075|26990834|P3|Overall Study|Adverse Event|1
7764311|NCT00725075|26990835|P2|Overall Study|Adverse Event|1
7764312|NCT00725075|26990836|P1|Overall Study|Adverse Event|2
7764313|NCT00725075|26990834|P3|Overall Study|Withdrawal by Subject|4
7764314|NCT00725075|26990835|P2|Overall Study|Withdrawal by Subject|5
7764315|NCT00725075|26990836|P1|Overall Study|Withdrawal by Subject|4
7764316|NCT00725075|26990834|P3|Overall Study|Lost to Follow-up|0
7764317|NCT00725075|26990835|P2|Overall Study|Lost to Follow-up|0
7764318|NCT00725075|26990836|P1|Overall Study|Lost to Follow-up|1
7764319|NCT00725075|26990834|P3|Overall Study|Protocol Violation|1
7764320|NCT00725075|26990835|P2|Overall Study|Protocol Violation|0
7764321|NCT00725075|26990836|P1|Overall Study|Protocol Violation|0
7764322|NCT00725075|26990834|P3|Overall Study|Use of Excluded Medication|0
7764323|NCT00725075|26990835|P2|Overall Study|Use of Excluded Medication|1
7764324|NCT00725075|26990836|P1|Overall Study|Use of Excluded Medication|0
7764325|NCT00725010|26990889|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
7764326|NCT00725010|26990889|P1|Overall Study|No further documentation|1
7764327|NCT00725010|26990889|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
7764328|NCT00725010|26990889|P1|Overall Study|Hepatopathy probably not Temodal-related|1
7764329|NCT00725010|26990889|P1|Overall Study|Lost to Follow-up|1
7764330|NCT00725010|26990889|P1|Overall Study|Death|1
7764331|NCT00725010|26990889|P1|Overall Study|Withdrawal by Subject|2
7764332|NCT00725010|26990889|P1|Overall Study|Tumor Progression|7
7764333|NCT00725010|26990889|P1|Overall Study|Toxicity|9
7764334|NCT00724971|26990922|P1|Overall Study|Withdrawal by Subject|1
7764335|NCT00724971|26990922|P1|Overall Study|Adverse Event|5
7764336|NCT00724958|26990937|P1|Overall Study|No documentation for end of therapy|13
7764337|NCT00724958|26990937|P1|Overall Study|Other Reason|76
7764338|NCT00724958|26990937|P1|Overall Study|Remission|7
7764339|NCT00724958|26990937|P1|Overall Study|No Response|18
7764340|NCT00724958|26990937|P1|Overall Study|Loss of Response|40
7764341|NCT00724958|26990937|P1|Overall Study|Adverse Event|28
7764342|NCT00724945|26990946|P2|Period 2|lens physiology issue|0
7764343|NCT00724945|26990947|P1|Period 2|lens physiology issue|1
7764344|NCT00724945|26990946|P2|Period 2|lens comfort issue|0
7764345|NCT00724945|26990947|P1|Period 2|lens comfort issue|3
7764346|NCT00724945|26990946|P2|Period 1|Lost to Follow-up|0
7764347|NCT00724945|26990947|P1|Period 1|Lost to Follow-up|1
7764348|NCT00724945|26990946|P2|Period 1|Adverse Event|1
7764349|NCT00724945|26990947|P1|Period 1|Adverse Event|1
7764350|NCT00724945|26990946|P2|Period 1|non-compliance|0
7764351|NCT00724945|26990947|P1|Period 1|non-compliance|1
7764352|NCT00724932|26990959|P2|Overall Study|Not treated|3
7764353|NCT00724932|26990960|P1|Overall Study|Not treated|4
7764354|NCT00724932|26990959|P2|Overall Study|Lost to Follow-up|0
7764355|NCT00724932|26990960|P1|Overall Study|Lost to Follow-up|1
7764356|NCT00724893|26991031|P2|Overall Study|Unknown, missing data|1
7764357|NCT00724893|26991032|P1|Overall Study|Unknown, missing data|1
7764358|NCT00724893|26991031|P2|Overall Study|Lost to Follow-up|52
7764359|NCT00724893|26991032|P1|Overall Study|Lost to Follow-up|0
7764360|NCT00724893|26991031|P2|Overall Study|Assigned shorter treatment|2
7764361|NCT00724893|26991032|P1|Overall Study|Assigned shorter treatment|0
7764362|NCT00724893|26991031|P2|Overall Study|Financial reasons|2
7764363|NCT00724893|26991032|P1|Overall Study|Financial reasons|0
7764364|NCT00724893|26991031|P2|Overall Study|Substance abuse|3
7764365|NCT00724893|26991032|P1|Overall Study|Substance abuse|0
7764366|NCT00724893|26991031|P2|Overall Study|Incarceration|9
7764367|NCT00724893|26991032|P1|Overall Study|Incarceration|0
7764368|NCT00724893|26991031|P2|Overall Study|Geographic reasons|11
7764369|NCT00724893|26991032|P1|Overall Study|Geographic reasons|0
7764370|NCT00724893|26991031|P2|Overall Study|Patient choice|26
7764371|NCT00724893|26991032|P1|Overall Study|Patient choice|0
7764372|NCT00724893|26991031|P2|Overall Study|Reason not specified|7
7764373|NCT00724893|26991032|P1|Overall Study|Reason not specified|193
7764374|NCT00724893|26991031|P2|Overall Study|Lack of virologic response|202
7764375|NCT00724893|26991032|P1|Overall Study|Lack of virologic response|94
7764376|NCT00724893|26991031|P2|Overall Study|Withdrawal by Subject|1
7764377|NCT00724893|26991032|P1|Overall Study|Withdrawal by Subject|0
7764378|NCT00724893|26991031|P2|Overall Study|Adverse Event|142
7764379|NCT00724893|26991032|P1|Overall Study|Adverse Event|76
7764380|NCT00724867|26991100|P1|Overall Study|Elected to exit due to site closure|2
7764381|NCT00724867|26991100|P1|Overall Study|Subject moved out of state|1
7764382|NCT00724867|26991100|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
7764383|NCT00724867|26991100|P1|Overall Study|Subject incarcerated|1
7764384|NCT00724867|26991100|P1|Overall Study|Sponsor decision to end study|14
7764385|NCT00724867|26991100|P1|Overall Study|Withdrawal by Subject|31
7764386|NCT00724867|26991100|P1|Overall Study|Protocol Violation|1
7764387|NCT00724867|26991100|P1|Overall Study|Physician Decision|17
7764388|NCT00724867|26991100|P1|Overall Study|Non-compliance with study drug|6
7764389|NCT00724867|26991100|P1|Overall Study|Lost to Follow-up|12
7764390|NCT00724867|26991100|P1|Overall Study|Lack of Efficacy|14
7764391|NCT00724867|26991100|P1|Overall Study|Adverse Event|25
7764392|NCT00724854|26991140|P2|Overall Study|Adverse event + lack of efficacy|1
7764393|NCT00724854|26991141|P1|Overall Study|Adverse event + lack of efficacy|2
7764394|NCT00724854|26991140|P2|Overall Study|Withdrawal by Subject|0
7764395|NCT00724854|26991141|P1|Overall Study|Withdrawal by Subject|5
7764396|NCT00724854|26991140|P2|Overall Study|Change of treatment|0
7764397|NCT00724854|26991141|P1|Overall Study|Change of treatment|7
7764398|NCT00724854|26991140|P2|Overall Study|Death|0
7764399|NCT00724854|26991141|P1|Overall Study|Death|11
7764400|NCT00724854|26991140|P2|Overall Study|Other|3
7764401|NCT00724854|26991141|P1|Overall Study|Other|42
7764402|NCT00724854|26991140|P2|Overall Study|Adverse Event|4
7764403|NCT00724854|26991141|P1|Overall Study|Adverse Event|62
7764404|NCT00724854|26991140|P2|Overall Study|Lost to Follow-up|10
7764405|NCT00724854|26991141|P1|Overall Study|Lost to Follow-up|87
7764406|NCT00724854|26991140|P2|Overall Study|Lack of Efficacy|13
7764407|NCT00724854|26991141|P1|Overall Study|Lack of Efficacy|187
7764408|NCT00724815|26991158|P2|Overall Study|Other Various|5
7764409|NCT00724815|26991159|P1|Overall Study|Other Various|3
7764410|NCT00724815|26991158|P2|Overall Study|Lost to Follow-up|1
7764411|NCT00724815|26991159|P1|Overall Study|Lost to Follow-up|4
7764412|NCT00724815|26991158|P2|Overall Study|Adverse Event|3
7764413|NCT00724815|26991159|P1|Overall Study|Adverse Event|5
7764414|NCT00724815|26991158|P2|Overall Study|Randomized, not treated|30
7764415|NCT00724815|26991159|P1|Overall Study|Randomized, not treated|31
7764416|NCT00724711|26991192|P2|Overall Study|Protocol Violation|0
7764417|NCT00724711|26991193|P1|Overall Study|Protocol Violation|1
7764418|NCT00724711|26991192|P2|Overall Study|Lost to Follow-up|5
7764419|NCT00724711|26991193|P1|Overall Study|Lost to Follow-up|4
7764420|NCT00724711|26991192|P2|Overall Study|Withdrawal by Subject|4
7764421|NCT00724711|26991193|P1|Overall Study|Withdrawal by Subject|5
7764422|NCT00724711|26991192|P2|Overall Study|Physician Decision|3
7764423|NCT00724711|26991193|P1|Overall Study|Physician Decision|0
7764424|NCT00724711|26991192|P2|Overall Study|Lack of Efficacy|1
7764425|NCT00724711|26991193|P1|Overall Study|Lack of Efficacy|0
7764426|NCT00724711|26991192|P2|Overall Study|Pregnancy|1
7764427|NCT00724711|26991193|P1|Overall Study|Pregnancy|0
7764428|NCT00724711|26991192|P2|Overall Study|Adverse Event|3
7764429|NCT00724711|26991193|P1|Overall Study|Adverse Event|7
7764430|NCT00724698|26991225|P1|Overall Study|No Info|25
7764431|NCT00724698|26991225|P1|Overall Study|Lost to Follow-up|36
7764432|NCT00724698|26991225|P1|Overall Study|Poor Compliance|16
7764433|NCT00724698|26991225|P1|Overall Study|Failure of Therapy|4
7764434|NCT00724698|26991225|P1|Overall Study|Adverse Event|9
7764435|NCT00724503|26991278|P2|Overall Study|Not otherwise specified|7
7764436|NCT00724503|26991279|P1|Overall Study|Not otherwise specified|4
7764437|NCT00724503|26991278|P2|Overall Study|Adverse Event|0
7764438|NCT00724503|26991279|P1|Overall Study|Adverse Event|1
7764439|NCT00724503|26991278|P2|Overall Study|Death|182
7764440|NCT00724503|26991279|P1|Overall Study|Death|190
7764441|NCT00724503|26991278|P2|Overall Study|Withdrawal by Subject|23
7764442|NCT00724503|26991279|P1|Overall Study|Withdrawal by Subject|11
7764443|NCT00724503|26991278|P2|Overall Study|Lost to Follow-up|8
7764444|NCT00724503|26991279|P1|Overall Study|Lost to Follow-up|4
7764445|NCT00724451|26991303|P1|Overall Study|Investigator + Participant Decision|13
7764446|NCT00724451|26991303|P1|Overall Study|Withdrawal by Subject|45
7764447|NCT00724451|26991303|P1|Overall Study|Physician Decision|116
7764448|NCT00724451|26991303|P1|Overall Study|Unknown; No Data Sources Available|9
7764449|NCT00724451|26991303|P1|Overall Study|Never Started Treatment|89
7764450|NCT00724451|26991303|P1|Overall Study|Participant Refused Treatment|89
7764451|NCT00724451|26991303|P1|Overall Study|Not Eligible for Treatment|431
7764452|NCT00724451|26991303|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
7764453|NCT00724451|26991303|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
7764454|NCT00724373|26991309|P1|Overall Study|Tolerability|23
7764455|NCT00724373|26991309|P1|Overall Study|Drug Relapse|1
7764456|NCT00724373|26991309|P1|Overall Study|Acute HCV infection|1
7764457|NCT00724373|26991309|P1|Overall Study|Viral Relapse|1
7764458|NCT00724373|26991309|P1|Overall Study|Only to have 24 week regimen|1
7764459|NCT00724373|26991309|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
7764460|NCT00724373|26991309|P1|Overall Study|Participant moved away|1
7764461|NCT00724373|26991309|P1|Overall Study|HCV RNA negative after 4 weeks|9
7764462|NCT00724373|26991309|P1|Overall Study|Non-compliance|2
7764463|NCT00724373|26991309|P1|Overall Study|Lost to Follow-up|7
7764464|NCT00724373|26991309|P1|Overall Study|Lack of Efficacy|82
7764465|NCT00724373|26991309|P1|Overall Study|Adverse Event|41
7764466|NCT00724282|26991334|P1|Overall Study|Physician Decision|1
7764467|NCT00724282|26991334|P1|Overall Study|Withdrawal by Subject|3
7764468|NCT00724243|26991338|P1|Overall Study|Adverse Event|5
7764469|NCT00724243|26991338|P1|Overall Study|Lack of Efficacy|10
7764470|NCT00724152|26991348|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
7764471|NCT00724152|26991349|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
7764472|NCT00724152|26991350|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
7764473|NCT00724152|26991348|P3|Two-arm Study Period|Withdrawal by Subject|0
7764474|NCT00724152|26991349|P2|Two-arm Study Period|Withdrawal by Subject|2
7764475|NCT00724152|26991350|P1|Two-arm Study Period|Withdrawal by Subject|3
7764476|NCT00724126|26991367|P2|Overall Study|Subject had to leave vicinity of site|1
7764477|NCT00724126|26991368|P1|Overall Study|Subject had to leave vicinity of site|0
7764478|NCT00724126|26991367|P2|Overall Study|Subject randomized although ineligible|1
7764479|NCT00724126|26991368|P1|Overall Study|Subject randomized although ineligible|1
7764480|NCT00724126|26991367|P2|Overall Study|Noncompliance|1
7764481|NCT00724126|26991368|P1|Overall Study|Noncompliance|2
7764482|NCT00724126|26991367|P2|Overall Study|Lost to Follow-up|6
7764483|NCT00724126|26991368|P1|Overall Study|Lost to Follow-up|6
7764484|NCT00724126|26991367|P2|Overall Study|Withdrawal by Subject|6
7764485|NCT00724126|26991368|P1|Overall Study|Withdrawal by Subject|8
7764486|NCT00724126|26991367|P2|Overall Study|Adverse Event|0
7764487|NCT00724126|26991368|P1|Overall Study|Adverse Event|2
7764488|NCT00724061|26991376|P1|Dose Escalation Phase|Disease Progression|3
7764489|NCT00724061|26991376|P1|Dose Escalation Phase|Adverse Event|2
7764490|NCT00723957|26991396|P2|Overall Study|Never received treatment|3
7764491|NCT00723957|26991397|P1|Overall Study|Never received treatment|3
7764492|NCT00723957|26991396|P2|Overall Study|Reason not analyzed|0
7764493|NCT00723957|26991397|P1|Overall Study|Reason not analyzed|1
7764494|NCT00723957|26991396|P2|Overall Study|Withdrawal by Subject|5
7764495|NCT00723957|26991397|P1|Overall Study|Withdrawal by Subject|7
7764496|NCT00723957|26991396|P2|Overall Study|Study drug toxicity|6
7764497|NCT00723957|26991397|P1|Overall Study|Study drug toxicity|4
7764498|NCT00723957|26991396|P2|Overall Study|Investigator decision|1
7764499|NCT00723957|26991397|P1|Overall Study|Investigator decision|1
7764500|NCT00723957|26991396|P2|Overall Study|Maximum clinical benefit|5
7764501|NCT00723957|26991397|P1|Overall Study|Maximum clinical benefit|4
7764502|NCT00723957|26991396|P2|Overall Study|Disease progression|25
7764503|NCT00723957|26991397|P1|Overall Study|Disease progression|27
7764504|NCT00723957|26991396|P2|Overall Study|Death|4
7764505|NCT00723957|26991397|P1|Overall Study|Death|3
7764506|NCT00723957|26991396|P2|Overall Study|Adverse event unrelated to study drug|4
7764507|NCT00723957|26991397|P1|Overall Study|Adverse event unrelated to study drug|1
7764508|NCT00723944|26991421|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
7764509|NCT00723944|26991422|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
7764510|NCT00723944|26991421|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
7764511|NCT00723944|26991422|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
7764512|NCT00723944|26991421|P2|Permanent Prosthesis Placement|Adverse Event|7
7764513|NCT00723944|26991422|P1|Permanent Prosthesis Placement|Adverse Event|1
7764514|NCT00723892|26991435|P2|Overall Study|Drug addiction|0
7764515|NCT00723892|26991436|P1|Overall Study|Drug addiction|1
7764516|NCT00723892|26991435|P2|Overall Study|Intercurrent infection|0
7764517|NCT00723892|26991436|P1|Overall Study|Intercurrent infection|2
7764518|NCT00723892|26991435|P2|Overall Study|Alcohol abuse|1
7764519|NCT00723892|26991436|P1|Overall Study|Alcohol abuse|0
7764520|NCT00723892|26991435|P2|Overall Study|Weight loss|3
7764521|NCT00723892|26991436|P1|Overall Study|Weight loss|1
7764522|NCT00723892|26991435|P2|Overall Study|Study end|3
7764523|NCT00723892|26991436|P1|Overall Study|Study end|1
7764524|NCT00723892|26991435|P2|Overall Study|Other|3
7764525|NCT00723892|26991436|P1|Overall Study|Other|6
7764526|NCT00723892|26991435|P2|Overall Study|Multiple reasons|12
7764527|NCT00723892|26991436|P1|Overall Study|Multiple reasons|17
7764528|NCT00723892|26991435|P2|Overall Study|Bad tolerance|5
7764529|NCT00723892|26991436|P1|Overall Study|Bad tolerance|5
7764530|NCT00723892|26991435|P2|Overall Study|End planned|7
7764531|NCT00723892|26991436|P1|Overall Study|End planned|11
7764532|NCT00723892|26991435|P2|Overall Study|Withdrawal by Subject|9
7764533|NCT00723892|26991436|P1|Overall Study|Withdrawal by Subject|6
7764534|NCT00723892|26991435|P2|Overall Study|Virological criterion|9
7764535|NCT00723892|26991436|P1|Overall Study|Virological criterion|24
7764536|NCT00723892|26991435|P2|Overall Study|Participant not tracked|35
7764537|NCT00723892|26991436|P1|Overall Study|Participant not tracked|33
7764538|NCT00723840|26991443|P1|Overall Study|Unspecified reason|2
7764539|NCT00723840|26991443|P1|Overall Study|Other Medical Event|2
7764540|NCT00723840|26991443|P1|Overall Study|Serious Adverse Events|3
7764541|NCT00723840|26991443|P1|Overall Study|Withdrawal by Subject|55
7764542|NCT00723840|26991443|P1|Overall Study|Failure to return|18
7764543|NCT00723840|26991443|P1|Overall Study|Lost to Follow-up|2
7764544|NCT00723801|26991464|P2|Overall Study|Protocol Violation|1
7764545|NCT00723801|26991465|P1|Overall Study|Protocol Violation|2
7764546|NCT00723801|26991464|P2|Overall Study|Lost to Follow-up|2
7764547|NCT00723801|26991465|P1|Overall Study|Lost to Follow-up|1
7764548|NCT00723710|26991490|P1|Overall Study|Physician Decision|2
7764549|NCT00723710|26991490|P1|Overall Study|Withdrawal by Subject|36
7764550|NCT00723710|26991490|P1|Overall Study|Adverse Event|88
7764551|NCT00723710|26991490|P1|Overall Study|Disease progression|48
7764552|NCT00723697|26991494|P1|Overall Study|Other exclusion criteria applied|6
7764553|NCT00723697|26991494|P1|Overall Study|Missing Informed Consent Form|10
7764554|NCT00723697|26991494|P1|Overall Study|Physician questionnaires not received|2
7764555|NCT00723606|26991515|P2|Overall Study|Withdrawal by Subject|2
7764556|NCT00723606|26991516|P1|Overall Study|Withdrawal by Subject|0
7764557|NCT00723606|26991515|P2|Overall Study|Other|0
7764558|NCT00723606|26991516|P1|Overall Study|Other|2
7764559|NCT00723606|26991515|P2|Overall Study|Adverse Event|5
7764560|NCT00723606|26991516|P1|Overall Study|Adverse Event|2
7764561|NCT00723554|26991536|P1|Overall Study|Non-compliance|1
7764562|NCT00723554|26991536|P1|Overall Study|Lost to Follow-up|1
7764563|NCT00723554|26991536|P1|Overall Study|Other|3
7764564|NCT00723554|26991536|P1|Overall Study|Withdrawal of consent|3
7764565|NCT00723554|26991536|P1|Overall Study|Inhaled medication other than iloprost|4
7764566|NCT00723554|26991536|P1|Overall Study|Investigator's judgement|5
7764567|NCT00723554|26991536|P1|Overall Study|Adverse Event|12
7764568|NCT00723528|26991586|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
7764569|NCT00723528|26991587|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7764570|NCT00723528|26991588|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7764571|NCT00723528|26991589|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7764572|NCT00723528|26991590|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7764573|NCT00723528|26991591|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7764574|NCT00723528|26991592|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7764575|NCT00723528|26991586|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
7764576|NCT00723528|26991587|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7764735|NCT00723294|26991799|P1|Overall Study|Did not undergo surgery|1
7764577|NCT00723528|26991588|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7764578|NCT00723528|26991589|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7764579|NCT00723528|26991590|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7764580|NCT00723528|26991591|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7764581|NCT00723528|26991592|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7764582|NCT00723528|26991586|P7|Period 2: After Controlled Period|Adverse Event|1
7764583|NCT00723528|26991587|P6|Period 2: After Controlled Period|Adverse Event|0
7764584|NCT00723528|26991588|P5|Period 2: After Controlled Period|Adverse Event|1
7764585|NCT00723528|26991589|P4|Period 2: After Controlled Period|Adverse Event|0
7764586|NCT00723528|26991590|P3|Period 2: After Controlled Period|Adverse Event|0
7764587|NCT00723528|26991591|P2|Period 2: After Controlled Period|Adverse Event|0
7764588|NCT00723528|26991592|P1|Period 2: After Controlled Period|Adverse Event|0
7764589|NCT00723528|26991586|P7|Period 2: After Controlled Period|Other|0
7764590|NCT00723528|26991587|P6|Period 2: After Controlled Period|Other|4
7764591|NCT00723528|26991588|P5|Period 2: After Controlled Period|Other|1
7764592|NCT00723528|26991589|P4|Period 2: After Controlled Period|Other|0
7764593|NCT00723528|26991590|P3|Period 2: After Controlled Period|Other|0
7764594|NCT00723528|26991591|P2|Period 2: After Controlled Period|Other|0
7764595|NCT00723528|26991592|P1|Period 2: After Controlled Period|Other|0
7764596|NCT00723528|26991586|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7764597|NCT00723528|26991587|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
7764598|NCT00723528|26991588|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7764599|NCT00723528|26991589|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7764600|NCT00723528|26991590|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7764601|NCT00723528|26991591|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7764602|NCT00723528|26991592|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7764603|NCT00723528|26991586|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
7764604|NCT00723528|26991587|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
7764605|NCT00723528|26991588|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
7764606|NCT00723528|26991589|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
7764607|NCT00723528|26991590|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
7764608|NCT00723528|26991591|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
7764609|NCT00723528|26991592|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
7764610|NCT00723528|26991586|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7764611|NCT00723528|26991587|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7764612|NCT00723528|26991588|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7764613|NCT00723528|26991589|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7764614|NCT00723528|26991590|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
7764615|NCT00723528|26991591|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7764616|NCT00723528|26991592|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
7764617|NCT00723528|26991586|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7764618|NCT00723528|26991587|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7764619|NCT00723528|26991588|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7764620|NCT00723528|26991589|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7764621|NCT00723528|26991590|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
7764622|NCT00723528|26991591|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7764623|NCT00723528|26991592|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7764624|NCT00723528|26991586|P7|Period 1: Controlled Period (CP)|Physician Decision|0
7764625|NCT00723528|26991587|P6|Period 1: Controlled Period (CP)|Physician Decision|0
7764626|NCT00723528|26991588|P5|Period 1: Controlled Period (CP)|Physician Decision|0
7764627|NCT00723528|26991589|P4|Period 1: Controlled Period (CP)|Physician Decision|0
7764628|NCT00723528|26991590|P3|Period 1: Controlled Period (CP)|Physician Decision|1
7764629|NCT00723528|26991591|P2|Period 1: Controlled Period (CP)|Physician Decision|0
7764630|NCT00723528|26991592|P1|Period 1: Controlled Period (CP)|Physician Decision|0
7764631|NCT00723528|26991586|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7764632|NCT00723528|26991587|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7764633|NCT00723528|26991588|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7764634|NCT00723528|26991589|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7764635|NCT00723528|26991590|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7764636|NCT00723528|26991591|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7764637|NCT00723528|26991592|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
7764638|NCT00723528|26991586|P7|Period 1: Controlled Period (CP)|Adverse Event|0
7764639|NCT00723528|26991587|P6|Period 1: Controlled Period (CP)|Adverse Event|0
7764640|NCT00723528|26991588|P5|Period 1: Controlled Period (CP)|Adverse Event|0
7764641|NCT00723528|26991589|P4|Period 1: Controlled Period (CP)|Adverse Event|0
7764642|NCT00723528|26991590|P3|Period 1: Controlled Period (CP)|Adverse Event|1
7764643|NCT00723528|26991591|P2|Period 1: Controlled Period (CP)|Adverse Event|0
7764644|NCT00723528|26991592|P1|Period 1: Controlled Period (CP)|Adverse Event|0
7764645|NCT00723489|26991654|P4|Overall Study|Samples Collected Out of Window|0
7764646|NCT00723489|26991655|P3|Overall Study|Samples Collected Out of Window|0
7764647|NCT00723489|26991656|P2|Overall Study|Samples Collected Out of Window|3
7764648|NCT00723489|26991657|P1|Overall Study|Samples Collected Out of Window|0
7764649|NCT00723489|26991654|P4|Overall Study|Prohibited Medication|1
7764650|NCT00723489|26991655|P3|Overall Study|Prohibited Medication|0
7764651|NCT00723489|26991656|P2|Overall Study|Prohibited Medication|0
7764652|NCT00723489|26991657|P1|Overall Study|Prohibited Medication|0
7764653|NCT00723489|26991654|P4|Overall Study|Seropositive at baseline|0
7764654|NCT00723489|26991655|P3|Overall Study|Seropositive at baseline|0
7764655|NCT00723489|26991656|P2|Overall Study|Seropositive at baseline|0
7764656|NCT00723489|26991657|P1|Overall Study|Seropositive at baseline|1
7764657|NCT00723489|26991654|P4|Overall Study|Withdrawal by Subject|1
7764658|NCT00723489|26991655|P3|Overall Study|Withdrawal by Subject|0
7764659|NCT00723489|26991656|P2|Overall Study|Withdrawal by Subject|0
7764660|NCT00723489|26991657|P1|Overall Study|Withdrawal by Subject|0
7764661|NCT00723489|26991654|P4|Overall Study|Pregnancy|1
7764662|NCT00723489|26991655|P3|Overall Study|Pregnancy|0
7764663|NCT00723489|26991656|P2|Overall Study|Pregnancy|0
7764664|NCT00723489|26991657|P1|Overall Study|Pregnancy|0
7764665|NCT00723489|26991654|P4|Overall Study|Physician Decision|0
7764666|NCT00723489|26991655|P3|Overall Study|Physician Decision|0
7764667|NCT00723489|26991656|P2|Overall Study|Physician Decision|1
7764668|NCT00723489|26991657|P1|Overall Study|Physician Decision|0
7764669|NCT00723450|26991685|P3|Randomized Phase|Withdrawal by Subject|22
7764670|NCT00723450|26991686|P2|Randomized Phase|Withdrawal by Subject|14
7764671|NCT00723450|26991687|P1|Randomized Phase|Withdrawal by Subject|0
7764672|NCT00723450|26991685|P3|Randomized Phase|Physician Decision|1
7764673|NCT00723450|26991686|P2|Randomized Phase|Physician Decision|3
7764674|NCT00723450|26991687|P1|Randomized Phase|Physician Decision|0
7764675|NCT00723450|26991685|P3|Randomized Phase|Lost to Follow-up|3
7764676|NCT00723450|26991686|P2|Randomized Phase|Lost to Follow-up|2
7764677|NCT00723450|26991687|P1|Randomized Phase|Lost to Follow-up|0
7764678|NCT00723450|26991685|P3|Randomized Phase|Protocol Violation|13
7764679|NCT00723450|26991686|P2|Randomized Phase|Protocol Violation|9
7764680|NCT00723450|26991687|P1|Randomized Phase|Protocol Violation|0
7764681|NCT00723450|26991685|P3|Randomized Phase|Lack of Efficacy|11
7764682|NCT00723450|26991686|P2|Randomized Phase|Lack of Efficacy|11
7764683|NCT00723450|26991687|P1|Randomized Phase|Lack of Efficacy|0
7764684|NCT00723450|26991685|P3|Randomized Phase|Adverse Event|17
7764685|NCT00723450|26991686|P2|Randomized Phase|Adverse Event|26
7764686|NCT00723450|26991687|P1|Randomized Phase|Adverse Event|0
7764687|NCT00723450|26991685|P3|Open-Label Phase|Withdrawal by Subject|0
7764688|NCT00723450|26991686|P2|Open-Label Phase|Withdrawal by Subject|0
7764689|NCT00723450|26991687|P1|Open-Label Phase|Withdrawal by Subject|37
7764690|NCT00723450|26991685|P3|Open-Label Phase|Physician Decision|0
7764691|NCT00723450|26991686|P2|Open-Label Phase|Physician Decision|0
7764692|NCT00723450|26991687|P1|Open-Label Phase|Physician Decision|2
7764693|NCT00723450|26991685|P3|Open-Label Phase|Lost to Follow-up|0
7764694|NCT00723450|26991686|P2|Open-Label Phase|Lost to Follow-up|0
7764695|NCT00723450|26991687|P1|Open-Label Phase|Lost to Follow-up|7
7764696|NCT00723450|26991685|P3|Open-Label Phase|Protocol Violation|0
7764697|NCT00723450|26991686|P2|Open-Label Phase|Protocol Violation|0
7764698|NCT00723450|26991687|P1|Open-Label Phase|Protocol Violation|35
7764699|NCT00723450|26991685|P3|Open-Label Phase|Lack of Efficacy|0
7764700|NCT00723450|26991686|P2|Open-Label Phase|Lack of Efficacy|0
7764701|NCT00723450|26991687|P1|Open-Label Phase|Lack of Efficacy|18
7764702|NCT00723450|26991685|P3|Open-Label Phase|Adverse Event|0
7764703|NCT00723450|26991686|P2|Open-Label Phase|Adverse Event|0
7764704|NCT00723450|26991687|P1|Open-Label Phase|Adverse Event|26
7764705|NCT00723398|26991733|P5|Overall Study|Lost to Follow-up|0
7764706|NCT00723398|26991734|P4|Overall Study|Lost to Follow-up|0
7764707|NCT00723398|26991735|P3|Overall Study|Lost to Follow-up|0
7764708|NCT00723398|26991736|P2|Overall Study|Lost to Follow-up|1
7764709|NCT00723398|26991737|P1|Overall Study|Lost to Follow-up|0
7764710|NCT00723398|26991733|P5|Overall Study|Adverse Event|4
7764711|NCT00723398|26991734|P4|Overall Study|Adverse Event|1
7764712|NCT00723398|26991735|P3|Overall Study|Adverse Event|3
7764713|NCT00723398|26991736|P2|Overall Study|Adverse Event|5
7764714|NCT00723398|26991737|P1|Overall Study|Adverse Event|0
7764715|NCT00723398|26991733|P5|Overall Study|Physician Decision|1
7764716|NCT00723398|26991734|P4|Overall Study|Physician Decision|0
7764717|NCT00723398|26991735|P3|Overall Study|Physician Decision|5
7764718|NCT00723398|26991736|P2|Overall Study|Physician Decision|2
7764719|NCT00723398|26991737|P1|Overall Study|Physician Decision|2
7764720|NCT00723398|26991733|P5|Overall Study|Protocol Violation|0
7764721|NCT00723398|26991734|P4|Overall Study|Protocol Violation|0
7764722|NCT00723398|26991735|P3|Overall Study|Protocol Violation|5
7764723|NCT00723398|26991736|P2|Overall Study|Protocol Violation|1
7764724|NCT00723398|26991737|P1|Overall Study|Protocol Violation|2
7764725|NCT00723398|26991733|P5|Overall Study|Withdrawal by Subject|4
7764726|NCT00723398|26991734|P4|Overall Study|Withdrawal by Subject|4
7764727|NCT00723398|26991735|P3|Overall Study|Withdrawal by Subject|4
7764728|NCT00723398|26991736|P2|Overall Study|Withdrawal by Subject|6
7764729|NCT00723398|26991737|P1|Overall Study|Withdrawal by Subject|2
7764730|NCT00723294|26991799|P1|Overall Study|No treatment due to probe failure|1
7764731|NCT00723294|26991799|P1|Overall Study|Withdrawal by Subject|1
7764732|NCT00723294|26991799|P1|Overall Study|Benign lesion|1
7764733|NCT00723294|26991799|P1|Overall Study|Treated by non-credentialed surgeon|1
7764734|NCT00723294|26991799|P1|Overall Study|Treated prior to registration|1
7764736|NCT00723294|26991799|P1|Overall Study|No cryoabalation|2
7764737|NCT00723294|26991799|P1|Overall Study|1.0-Tesla MRI|1
7764738|NCT00723294|26991799|P1|Overall Study|No MRI tumor enhancement|1
7764739|NCT00723294|26991799|P1|Overall Study|>25% intraductal component|1
7764740|NCT00723294|26991799|P1|Overall Study|Lobular histology|2
7764741|NCT00723255|26991804|P1|Overall Study|Ineligible: Wrong Primary|2
7764742|NCT00723255|26991804|P1|Overall Study|Ineligible: Second primary|1
7764743|NCT00723255|26991804|P1|Overall Study|Ineligible: Inadequate pathology|1
7764744|NCT00723229|26991831|P2|First Intervention|Lost to Follow-up|3
7764745|NCT00723229|26991832|P1|First Intervention|Lost to Follow-up|7
7764746|NCT00723203|26991844|P1|Overall Study|Withdrawal by Subject|3
7764747|NCT00723190|26991848|P1|Overall Study|Other-Not included in safety population|2
7764748|NCT00723190|26991848|P1|Overall Study|Other-Premature Discontinuation|9
7764749|NCT00723190|26991848|P1|Overall Study|Protocol Violation|15
7764750|NCT00723190|26991848|P1|Overall Study|Lack of Efficacy|16
7764751|NCT00723190|26991848|P1|Overall Study|Adverse Event|18
7764752|NCT00723190|26991848|P1|Overall Study|Lost to Follow-up|37
7764753|NCT00723190|26991848|P1|Overall Study|Withdrawal by Subject|45
7764754|NCT00723125|26991881|P2|Overall Study|Adverse Event|0
7764755|NCT00723125|26991882|P1|Overall Study|Adverse Event|2
7764756|NCT00723125|26991881|P2|Overall Study|Withdrawal by Subject|6
7764757|NCT00723125|26991882|P1|Overall Study|Withdrawal by Subject|15
7764758|NCT00723125|26991881|P2|Overall Study|Met Dx|0
7764759|NCT00723125|26991882|P1|Overall Study|Met Dx|1
7764760|NCT00723021|26991933|P5|Intervention Period 4|Adverse Event|1
7764761|NCT00723021|26991934|P4|Intervention Period 4|Adverse Event|0
7764762|NCT00723021|26991935|P3|Intervention Period 4|Adverse Event|0
7764763|NCT00723021|26991936|P2|Intervention Period 4|Adverse Event|0
7764764|NCT00723021|26991937|P1|Intervention Period 4|Adverse Event|0
7764765|NCT00723008|26991991|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
7764766|NCT00723008|26991992|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
7764767|NCT00723008|26991991|P2|4-Week Unblinded Treatment|Adverse Event|0
7764768|NCT00723008|26991992|P1|4-Week Unblinded Treatment|Adverse Event|1
7764769|NCT00723008|26991991|P2|4-Week Double Blinded|Lost to Follow-up|3
7764770|NCT00723008|26991992|P1|4-Week Double Blinded|Lost to Follow-up|4
7764771|NCT00723008|26991991|P2|4-Week Double Blinded|Withdrawal by Subject|1
7764772|NCT00723008|26991992|P1|4-Week Double Blinded|Withdrawal by Subject|1
7764773|NCT00723008|26991991|P2|4-Week Double Blinded|Lack of Efficacy|1
7764774|NCT00723008|26991992|P1|4-Week Double Blinded|Lack of Efficacy|0
7764775|NCT00723008|26991991|P2|Enrollment|Lost to Follow-up|0
7764776|NCT00723008|26991992|P1|Enrollment|Lost to Follow-up|1
7764777|NCT00722800|26992024|P2|Overall Study|Physician Decision|0
7764778|NCT00722800|26992025|P1|Overall Study|Physician Decision|1
7764779|NCT00722800|26992024|P2|Overall Study|Withdrawal by Subject|0
7764780|NCT00722800|26992025|P1|Overall Study|Withdrawal by Subject|1
7764781|NCT00722761|26992037|P2|Overall Study|Withdrawal by Subject|2
7764782|NCT00722761|26992038|P1|Overall Study|Withdrawal by Subject|5
7764783|NCT00722761|26992037|P2|Overall Study|Lost to Follow-up|4
7764784|NCT00722761|26992038|P1|Overall Study|Lost to Follow-up|1
7764785|NCT00722423|26992095|P2|Overall Study|Protocol Violation|1
7764786|NCT00722423|26992096|P1|Overall Study|Protocol Violation|0
7764787|NCT00722371|26992111|P7|Overall Study|Withdrawal by Subject|26
7764788|NCT00722371|26992112|P6|Overall Study|Withdrawal by Subject|18
7764789|NCT00722371|26992113|P5|Overall Study|Withdrawal by Subject|19
7764790|NCT00722371|26992114|P4|Overall Study|Withdrawal by Subject|23
7764791|NCT00722371|26992115|P3|Overall Study|Withdrawal by Subject|19
7764792|NCT00722371|26992116|P2|Overall Study|Withdrawal by Subject|27
7764793|NCT00722371|26992117|P1|Overall Study|Withdrawal by Subject|18
7764794|NCT00722371|26992111|P7|Overall Study|Protocol Violation|1
7764795|NCT00722371|26992112|P6|Overall Study|Protocol Violation|2
7764796|NCT00722371|26992113|P5|Overall Study|Protocol Violation|4
7764797|NCT00722371|26992114|P4|Overall Study|Protocol Violation|1
7764798|NCT00722371|26992115|P3|Overall Study|Protocol Violation|0
7764799|NCT00722371|26992116|P2|Overall Study|Protocol Violation|1
7764800|NCT00722371|26992117|P1|Overall Study|Protocol Violation|6
7764801|NCT00722371|26992111|P7|Overall Study|Pregnancy|0
7764802|NCT00722371|26992112|P6|Overall Study|Pregnancy|1
7764803|NCT00722371|26992113|P5|Overall Study|Pregnancy|0
7764804|NCT00722371|26992114|P4|Overall Study|Pregnancy|0
7764805|NCT00722371|26992115|P3|Overall Study|Pregnancy|0
7764806|NCT00722371|26992116|P2|Overall Study|Pregnancy|1
7764807|NCT00722371|26992117|P1|Overall Study|Pregnancy|1
7764808|NCT00722371|26992111|P7|Overall Study|Physician Decision|4
7764809|NCT00722371|26992112|P6|Overall Study|Physician Decision|3
7764810|NCT00722371|26992113|P5|Overall Study|Physician Decision|2
7764811|NCT00722371|26992114|P4|Overall Study|Physician Decision|5
7764812|NCT00722371|26992115|P3|Overall Study|Physician Decision|2
7764813|NCT00722371|26992116|P2|Overall Study|Physician Decision|2
7764814|NCT00722371|26992117|P1|Overall Study|Physician Decision|5
7764815|NCT00722371|26992111|P7|Overall Study|Lost to Follow-up|13
7764816|NCT00722371|26992112|P6|Overall Study|Lost to Follow-up|16
7764817|NCT00722371|26992113|P5|Overall Study|Lost to Follow-up|8
7764818|NCT00722371|26992114|P4|Overall Study|Lost to Follow-up|13
7764819|NCT00722371|26992115|P3|Overall Study|Lost to Follow-up|21
7764820|NCT00722371|26992116|P2|Overall Study|Lost to Follow-up|14
7764821|NCT00722371|26992117|P1|Overall Study|Lost to Follow-up|11
7764822|NCT00722371|26992111|P7|Overall Study|Lack of Efficacy|0
7764823|NCT00722371|26992112|P6|Overall Study|Lack of Efficacy|3
7764824|NCT00722371|26992113|P5|Overall Study|Lack of Efficacy|2
7764825|NCT00722371|26992114|P4|Overall Study|Lack of Efficacy|6
7764826|NCT00722371|26992115|P3|Overall Study|Lack of Efficacy|6
7764827|NCT00722371|26992116|P2|Overall Study|Lack of Efficacy|6
7764828|NCT00722371|26992117|P1|Overall Study|Lack of Efficacy|4
7764829|NCT00722371|26992111|P7|Overall Study|Hypoglycemia|0
7764830|NCT00722371|26992112|P6|Overall Study|Hypoglycemia|0
7764831|NCT00722371|26992113|P5|Overall Study|Hypoglycemia|0
7764832|NCT00722371|26992114|P4|Overall Study|Hypoglycemia|0
7764833|NCT00722371|26992115|P3|Overall Study|Hypoglycemia|0
7764834|NCT00722371|26992116|P2|Overall Study|Hypoglycemia|0
7764835|NCT00722371|26992117|P1|Overall Study|Hypoglycemia|1
7764836|NCT00722371|26992111|P7|Overall Study|Hyperglycemia|1
7764837|NCT00722371|26992112|P6|Overall Study|Hyperglycemia|1
7764838|NCT00722371|26992113|P5|Overall Study|Hyperglycemia|5
7764839|NCT00722371|26992114|P4|Overall Study|Hyperglycemia|2
7764840|NCT00722371|26992115|P3|Overall Study|Hyperglycemia|4
7764841|NCT00722371|26992116|P2|Overall Study|Hyperglycemia|6
7764842|NCT00722371|26992117|P1|Overall Study|Hyperglycemia|2
7764843|NCT00722371|26992111|P7|Overall Study|Excluded medication|1
7764844|NCT00722371|26992112|P6|Overall Study|Excluded medication|0
7764845|NCT00722371|26992113|P5|Overall Study|Excluded medication|0
7764846|NCT00722371|26992114|P4|Overall Study|Excluded medication|0
7764847|NCT00722371|26992115|P3|Overall Study|Excluded medication|1
7764848|NCT00722371|26992116|P2|Overall Study|Excluded medication|1
7764849|NCT00722371|26992117|P1|Overall Study|Excluded medication|0
7764850|NCT00722371|26992111|P7|Overall Study|Creatinine / Creatinine clearance|1
7764851|NCT00722371|26992112|P6|Overall Study|Creatinine / Creatinine clearance|1
7764852|NCT00722371|26992113|P5|Overall Study|Creatinine / Creatinine clearance|2
7764853|NCT00722371|26992114|P4|Overall Study|Creatinine / Creatinine clearance|3
7764854|NCT00722371|26992115|P3|Overall Study|Creatinine / Creatinine clearance|2
7764855|NCT00722371|26992116|P2|Overall Study|Creatinine / Creatinine clearance|1
7764856|NCT00722371|26992117|P1|Overall Study|Creatinine / Creatinine clearance|2
7764857|NCT00722371|26992111|P7|Overall Study|Contraindication|0
7764858|NCT00722371|26992112|P6|Overall Study|Contraindication|0
7764859|NCT00722371|26992113|P5|Overall Study|Contraindication|0
7764860|NCT00722371|26992114|P4|Overall Study|Contraindication|0
7764861|NCT00722371|26992115|P3|Overall Study|Contraindication|1
7764862|NCT00722371|26992116|P2|Overall Study|Contraindication|0
7764863|NCT00722371|26992117|P1|Overall Study|Contraindication|0
7764864|NCT00722371|26992111|P7|Overall Study|Adverse Event|4
7764865|NCT00722371|26992112|P6|Overall Study|Adverse Event|8
7764866|NCT00722371|26992113|P5|Overall Study|Adverse Event|6
7764867|NCT00722371|26992114|P4|Overall Study|Adverse Event|10
7764868|NCT00722371|26992115|P3|Overall Study|Adverse Event|9
7764869|NCT00722371|26992116|P2|Overall Study|Adverse Event|13
7764870|NCT00722371|26992117|P1|Overall Study|Adverse Event|6
7764871|NCT00722137|26992170|P2|Overall Study|Randomized But Not Treated|3
7764872|NCT00722137|26992171|P1|Overall Study|Randomized But Not Treated|2
7764873|NCT00722137|26992170|P2|Overall Study|Other Reason Unknown|4
7764874|NCT00722137|26992171|P1|Overall Study|Other Reason Unknown|3
7764875|NCT00722137|26992170|P2|Overall Study|Withdrawal by Subject|9
7764876|NCT00722137|26992171|P1|Overall Study|Withdrawal by Subject|6
7764877|NCT00722137|26992170|P2|Overall Study|Death|7
7764878|NCT00722137|26992171|P1|Overall Study|Death|12
7764879|NCT00722137|26992170|P2|Overall Study|Adverse Event|21
7764880|NCT00722137|26992171|P1|Overall Study|Adverse Event|17
7764881|NCT00722137|26992170|P2|Overall Study|Overt Disease Progression|4
7764882|NCT00722137|26992171|P1|Overall Study|Overt Disease Progression|5
7764883|NCT00721968|26992249|P2|Overall Study|Lost to Follow-up|0
7764884|NCT00721968|26992250|P1|Overall Study|Lost to Follow-up|2
7764885|NCT00721955|26992261|P3|Overall Study|Adverse Event|2
7764886|NCT00721955|26992262|P2|Overall Study|Adverse Event|0
7764887|NCT00721955|26992263|P1|Overall Study|Adverse Event|0
7764888|NCT00721799|26992277|P1|Overall Study|withdraw by subject after scan 1|1
7764889|NCT00721799|26992277|P1|Overall Study|Withdrawal by Subject|7
7764890|NCT00721734|26992317|P5|Overall Study|Other|0
7764891|NCT00721734|26992318|P4|Overall Study|Other|1
7764892|NCT00721734|26992319|P3|Overall Study|Other|0
7764893|NCT00721734|26992320|P2|Overall Study|Other|0
7764894|NCT00721734|26992321|P1|Overall Study|Other|0
7764895|NCT00721734|26992317|P5|Overall Study|Withdrawal by Subject|1
7764896|NCT00721734|26992318|P4|Overall Study|Withdrawal by Subject|0
7764897|NCT00721734|26992319|P3|Overall Study|Withdrawal by Subject|0
7764898|NCT00721734|26992320|P2|Overall Study|Withdrawal by Subject|1
7764899|NCT00721734|26992321|P1|Overall Study|Withdrawal by Subject|2
7764900|NCT00721734|26992317|P5|Overall Study|Adverse Event|3
7764901|NCT00721734|26992318|P4|Overall Study|Adverse Event|0
7764902|NCT00721734|26992319|P3|Overall Study|Adverse Event|4
7764903|NCT00721734|26992320|P2|Overall Study|Adverse Event|1
7764904|NCT00721734|26992321|P1|Overall Study|Adverse Event|3
7764905|NCT00721734|26992317|P5|Overall Study|Progressive Disease|2
7764906|NCT00721734|26992318|P4|Overall Study|Progressive Disease|5
7764907|NCT00721734|26992319|P3|Overall Study|Progressive Disease|4
7764908|NCT00721734|26992320|P2|Overall Study|Progressive Disease|10
7764909|NCT00721734|26992321|P1|Overall Study|Progressive Disease|3
7764910|NCT00721630|26992433|P1|Overall Study|Participant found to be ineligible|1
7764911|NCT00721578|26992462|P2|Overall Study|Withdrawal by Subject|1
7764912|NCT00721578|26992463|P1|Overall Study|Withdrawal by Subject|1
7764913|NCT00721578|26992462|P2|Overall Study|Death|1
7764914|NCT00721578|26992463|P1|Overall Study|Death|1
7764915|NCT00721409|26992518|P3|Overall Study|Objective progression or relapse|62
7764916|NCT00721409|26992519|P2|Overall Study|Objective progression or relapse|55
7764917|NCT00721409|26992520|P1|Overall Study|Objective progression or relapse|8
7764918|NCT00721409|26992518|P3|Overall Study|Withdrawal by Subject|5
7764919|NCT00721409|26992519|P2|Overall Study|Withdrawal by Subject|6
7764920|NCT00721409|26992520|P1|Overall Study|Withdrawal by Subject|1
7764921|NCT00721409|26992518|P3|Overall Study|Lost to Follow-up|1
7764922|NCT00721409|26992519|P2|Overall Study|Lost to Follow-up|0
7764923|NCT00721409|26992520|P1|Overall Study|Lost to Follow-up|0
7764924|NCT00721409|26992518|P3|Overall Study|Adverse Event|2
7764925|NCT00721409|26992519|P2|Overall Study|Adverse Event|13
7764926|NCT00721409|26992520|P1|Overall Study|Adverse Event|0
7764927|NCT00721409|26992518|P3|Overall Study|Reason not specified|2
7764928|NCT00721409|26992519|P2|Overall Study|Reason not specified|0
7764929|NCT00721409|26992520|P1|Overall Study|Reason not specified|1
7764930|NCT00721409|26992518|P3|Overall Study|Randomized not Treated|4
7764931|NCT00721409|26992519|P2|Overall Study|Randomized not Treated|1
7764932|NCT00721409|26992520|P1|Overall Study|Randomized not Treated|0
7764933|NCT00721409|26992518|P3|Overall Study|Death|0
7764934|NCT00721409|26992519|P2|Overall Study|Death|1
7764935|NCT00721409|26992520|P1|Overall Study|Death|0
7764936|NCT00721409|26992518|P3|Overall Study|Global deterioration of health status|3
7764937|NCT00721409|26992519|P2|Overall Study|Global deterioration of health status|6
7764938|NCT00721409|26992520|P1|Overall Study|Global deterioration of health status|2
7764939|NCT00721396|26992647|P4|Overall Study|Administrative reason|0
7764940|NCT00721396|26992648|P3|Overall Study|Administrative reason|1
7764941|NCT00721396|26992649|P2|Overall Study|Administrative reason|0
7764942|NCT00721396|26992650|P1|Overall Study|Administrative reason|3
7764943|NCT00721396|26992647|P4|Overall Study|Inappropriate enrollment|0
7764944|NCT00721396|26992648|P3|Overall Study|Inappropriate enrollment|0
7764945|NCT00721396|26992649|P2|Overall Study|Inappropriate enrollment|2
7764946|NCT00721396|26992650|P1|Overall Study|Inappropriate enrollment|0
7764947|NCT00721396|26992647|P4|Overall Study|Protocol Violation|0
7764948|NCT00721396|26992648|P3|Overall Study|Protocol Violation|1
7764949|NCT00721396|26992649|P2|Overall Study|Protocol Violation|3
7764950|NCT00721396|26992650|P1|Overall Study|Protocol Violation|4
7764951|NCT00721396|26992647|P4|Overall Study|Lost to Follow-up|3
7764952|NCT00721396|26992648|P3|Overall Study|Lost to Follow-up|3
7764953|NCT00721396|26992649|P2|Overall Study|Lost to Follow-up|9
7764954|NCT00721396|26992650|P1|Overall Study|Lost to Follow-up|7
7764955|NCT00721396|26992647|P4|Overall Study|Withdrawal by Subject|7
7764956|NCT00721396|26992648|P3|Overall Study|Withdrawal by Subject|3
7764957|NCT00721396|26992649|P2|Overall Study|Withdrawal by Subject|15
7764958|NCT00721396|26992650|P1|Overall Study|Withdrawal by Subject|12
7764959|NCT00721396|26992647|P4|Overall Study|Adverse Event|0
7764960|NCT00721396|26992648|P3|Overall Study|Adverse Event|2
7764961|NCT00721396|26992649|P2|Overall Study|Adverse Event|7
7764962|NCT00721396|26992650|P1|Overall Study|Adverse Event|4
7764963|NCT00721279|26992701|P2|Overall Study|Other|16
7764964|NCT00721279|26992702|P1|Overall Study|Other|12
7764965|NCT00721279|26992701|P2|Overall Study|Withdrawal by Subject|3
7764966|NCT00721279|26992702|P1|Overall Study|Withdrawal by Subject|13
7764967|NCT00721279|26992701|P2|Overall Study|Tolerability insufficient|2
7764968|NCT00721279|26992702|P1|Overall Study|Tolerability insufficient|5
7764969|NCT00721279|26992701|P2|Overall Study|Lack of Efficacy|3
7764970|NCT00721279|26992702|P1|Overall Study|Lack of Efficacy|6
7764971|NCT00721227|26992730|P2|Overall Study|Noncompliance with scheduled visits.|0
7764972|NCT00721227|26992731|P1|Overall Study|Noncompliance with scheduled visits.|1
7764973|NCT00721227|26992730|P2|Overall Study|Lost to Follow-up|0
7764974|NCT00721227|26992731|P1|Overall Study|Lost to Follow-up|3
7764975|NCT00721214|26992741|P1|Overall Study|Death|3
7764976|NCT00721214|26992741|P1|Overall Study|Chose another center for transplant|1
7764977|NCT00721149|26992791|P1|Overall Study|Physician Decision|1
7764978|NCT00721123|26992825|P1|Overall Study|Withdrawal by Subject|5
7764979|NCT00721123|26992825|P1|Overall Study|Failure to Return|9
7764980|NCT00721123|26992825|P1|Overall Study|Refused Treatment|41
7764981|NCT00721123|26992825|P1|Overall Study|Protocol Violation|1
7764982|NCT00721123|26992825|P1|Overall Study|Insufficient Therapeutic Response|21
7764983|NCT00721123|26992825|P1|Overall Study|Death|10
7764984|NCT00721123|26992825|P1|Overall Study|Adverse Event|96
7764985|NCT00721110|26992903|P4|Overall Study|vertical incision|0
7764986|NCT00721110|26992904|P3|Overall Study|vertical incision|1
7764987|NCT00721110|26992905|P2|Overall Study|vertical incision|0
7764988|NCT00721110|26992906|P1|Overall Study|vertical incision|0
7764989|NCT00721110|26992903|P4|Overall Study|Ultram use|0
7764990|NCT00721110|26992904|P3|Overall Study|Ultram use|0
7764991|NCT00721110|26992905|P2|Overall Study|Ultram use|0
7764992|NCT00721110|26992906|P1|Overall Study|Ultram use|1
7764993|NCT00720941|26992934|P2|Overall Study|Ongoing|23
7764994|NCT00720941|26992935|P1|Overall Study|Ongoing|34
7764995|NCT00720941|26992934|P2|Overall Study|Withdrawal by Subject|35
7764996|NCT00720941|26992935|P1|Overall Study|Withdrawal by Subject|27
7764997|NCT00720941|26992934|P2|Overall Study|Physician Decision|5
7764998|NCT00720941|26992935|P1|Overall Study|Physician Decision|1
7764999|NCT00720941|26992934|P2|Overall Study|Lost to Follow-up|15
7765000|NCT00720941|26992935|P1|Overall Study|Lost to Follow-up|17
7765001|NCT00720941|26992934|P2|Overall Study|Protocol Violation|2
7765002|NCT00720941|26992935|P1|Overall Study|Protocol Violation|0
7765003|NCT00720941|26992934|P2|Overall Study|Death|335
7765004|NCT00720941|26992935|P1|Overall Study|Death|334
7765005|NCT00720876|26992975|P1|Overall Study|found to be ineligible after starting tx|2
7765006|NCT00720798|26992981|P1|Overall Study|Reason not Specified|83
7765007|NCT00720798|26992981|P1|Overall Study|Failure to Return|46
7765008|NCT00720798|26992981|P1|Overall Study|Refused Treatment|151
7765009|NCT00720798|26992981|P1|Overall Study|Protocol Violation|4
7765010|NCT00720798|26992981|P1|Overall Study|Insufficient Therapeutic Response|129
7765011|NCT00720798|26992981|P1|Overall Study|Death|39
7765012|NCT00720798|26992981|P1|Overall Study|Adverse Event|304
7765013|NCT00720759|26993004|P4|Overall Study|Lost to Follow-up|0
7765014|NCT00720759|26993005|P3|Overall Study|Lost to Follow-up|1
7765015|NCT00720759|26993006|P2|Overall Study|Lost to Follow-up|1
7765016|NCT00720759|26993007|P1|Overall Study|Lost to Follow-up|0
7765017|NCT00720499|26993027|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
7765018|NCT00720499|26993028|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
7765019|NCT00720499|26993027|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
7765020|NCT00720499|26993028|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
7765021|NCT00720499|26993027|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
7765022|NCT00720499|26993028|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
7765023|NCT00720434|26993121|P4|Open-Label Period (Week 5-72)|Other|2
7765024|NCT00720434|26993122|P3|Open-Label Period (Week 5-72)|Other|3
7765025|NCT00720434|26993123|P2|Open-Label Period (Week 5-72)|Other|3
7765026|NCT00720434|26993124|P1|Open-Label Period (Week 5-72)|Other|4
7765027|NCT00720434|26993121|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
7765028|NCT00720434|26993122|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
7765029|NCT00720434|26993123|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
7765030|NCT00720434|26993124|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
7765031|NCT00720434|26993121|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7765032|NCT00720434|26993122|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7765033|NCT00720434|26993123|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7765034|NCT00720434|26993124|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
7765035|NCT00720434|26993121|P4|Open-Label Period (Week 5-72)|Adverse Event|2
7765036|NCT00720434|26993122|P3|Open-Label Period (Week 5-72)|Adverse Event|0
7765037|NCT00720434|26993123|P2|Open-Label Period (Week 5-72)|Adverse Event|0
7765038|NCT00720434|26993124|P1|Open-Label Period (Week 5-72)|Adverse Event|0
7765039|NCT00720434|26993121|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7765040|NCT00720434|26993122|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7765041|NCT00720434|26993123|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
7765042|NCT00720434|26993124|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7765043|NCT00720382|26993148|P2|Overall Study|administrative|5
7765044|NCT00720382|26993149|P1|Overall Study|administrative|14
7765045|NCT00720382|26993148|P2|Overall Study|Lost to Follow-up|14
7765046|NCT00720382|26993149|P1|Overall Study|Lost to Follow-up|28
7765047|NCT00720382|26993148|P2|Overall Study|Withdrawal by Subject|11
7765048|NCT00720382|26993149|P1|Overall Study|Withdrawal by Subject|47
7765049|NCT00720382|26993148|P2|Overall Study|Non-Compliance|5
7765050|NCT00720382|26993149|P1|Overall Study|Non-Compliance|15
7765051|NCT00720382|26993148|P2|Overall Study|Lack of Efficacy|7
7765052|NCT00720382|26993149|P1|Overall Study|Lack of Efficacy|18
7765053|NCT00720382|26993148|P2|Overall Study|Adverse Event|17
7765054|NCT00720382|26993149|P1|Overall Study|Adverse Event|54
7765055|NCT00720356|26993168|P1|Follow up Until Death|Alive at last data collection|4
7765056|NCT00720356|26993168|P1|Follow up Until Death|Withdrawal by Subject|1
7765057|NCT00720356|26993168|P1|Went on to be Treated Cycle 3|Physician Decision|1
7765058|NCT00720356|26993168|P1|Went on to be Treated Cycle 3|Adverse Event|1
7765059|NCT00720356|26993168|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
7765060|NCT00720356|26993168|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
7765061|NCT00720356|26993168|P1|Registration to Study|Determined to have methylated MGMT|67
7765062|NCT00720343|26993182|P1|Overall Study|No data|3
7765063|NCT00720343|26993182|P1|Overall Study|Physician Decision|3
7765064|NCT00720278|26993216|P3|Overall Study|eligibility criteria violation|1
7765065|NCT00720278|26993217|P2|Overall Study|eligibility criteria violation|0
7765066|NCT00720278|26993218|P1|Overall Study|eligibility criteria violation|1
7765067|NCT00720278|26993216|P3|Overall Study|Non-compliance|0
7765068|NCT00720278|26993217|P2|Overall Study|Non-compliance|0
7765069|NCT00720278|26993218|P1|Overall Study|Non-compliance|1
7765070|NCT00720278|26993216|P3|Overall Study|Lost to Follow-up|1
7765071|NCT00720278|26993217|P2|Overall Study|Lost to Follow-up|0
7765072|NCT00720278|26993218|P1|Overall Study|Lost to Follow-up|0
7765073|NCT00720278|26993216|P3|Overall Study|Withdrawal by Subject|0
7765074|NCT00720278|26993217|P2|Overall Study|Withdrawal by Subject|1
7765075|NCT00720278|26993218|P1|Overall Study|Withdrawal by Subject|0
7765076|NCT00720278|26993216|P3|Overall Study|Adverse Event|4
7765077|NCT00720278|26993217|P2|Overall Study|Adverse Event|3
7765078|NCT00720278|26993218|P1|Overall Study|Adverse Event|5
7765079|NCT00720226|26993240|P2|Overall Study|Withdrawal by Subject|4
7765080|NCT00720226|26993241|P1|Overall Study|Withdrawal by Subject|7
7765081|NCT00720213|26993249|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
7765082|NCT00720213|26993250|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
7765083|NCT00720213|26993251|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
7765084|NCT00720122|26993289|P1|Overall Study|Withdrawal by Subject|7
7765085|NCT00720122|26993289|P1|Overall Study|Physician Decision|1
7765086|NCT00720122|26993289|P1|Overall Study|Lost to Follow-up|1
7765087|NCT00720109|26993293|P3|Risk Stratification Period|Development of second malignant neoplasm|0
7765088|NCT00720109|26993294|P2|Risk Stratification Period|Development of second malignant neoplasm|1
7765089|NCT00720109|26993295|P1|Risk Stratification Period|Development of second malignant neoplasm|0
7765090|NCT00720109|26993293|P3|Risk Stratification Period|Disease progression or relapse|0
7765091|NCT00720109|26993294|P2|Risk Stratification Period|Disease progression or relapse|2
7765092|NCT00720109|26993295|P1|Risk Stratification Period|Disease progression or relapse|0
7765093|NCT00720109|26993293|P3|Risk Stratification Period|Bone marrow transplant|7
7765094|NCT00720109|26993294|P2|Risk Stratification Period|Bone marrow transplant|9
7765095|NCT00720109|26993295|P1|Risk Stratification Period|Bone marrow transplant|0
7765096|NCT00720109|26993293|P3|Risk Stratification Period|Physician Decision|1
7765097|NCT00720109|26993294|P2|Risk Stratification Period|Physician Decision|2
7765098|NCT00720109|26993295|P1|Risk Stratification Period|Physician Decision|0
7765099|NCT00720109|26993293|P3|Risk Stratification Period|Adverse Event|0
7765100|NCT00720109|26993294|P2|Risk Stratification Period|Adverse Event|1
7765101|NCT00720109|26993295|P1|Risk Stratification Period|Adverse Event|0
7765102|NCT00720109|26993293|P3|Induction Period|Physician Decision|0
7765103|NCT00720109|26993294|P2|Induction Period|Physician Decision|0
7765104|NCT00720109|26993295|P1|Induction Period|Physician Decision|1
7765105|NCT00720109|26993293|P3|Induction Period|Bone Marrow Transplant|0
7765106|NCT00720109|26993294|P2|Induction Period|Bone Marrow Transplant|0
7765107|NCT00720109|26993295|P1|Induction Period|Bone Marrow Transplant|2
7765108|NCT00720109|26993293|P3|Induction Period|Did not meet eligibility criteria|0
7765109|NCT00720109|26993294|P2|Induction Period|Did not meet eligibility criteria|0
7765110|NCT00720109|26993295|P1|Induction Period|Did not meet eligibility criteria|3
7765111|NCT00720096|26993315|P2|Overall Study|Withdrawal by Subject|2
7765112|NCT00720096|26993316|P1|Overall Study|Withdrawal by Subject|0
7765113|NCT00720083|26993328|P2|Overall Study|Ineligible|2
7765114|NCT00720083|26993329|P1|Overall Study|Ineligible|1
7765115|NCT00720057|26993337|P2|Overall Study|Withdrawal by Subject|1
7765116|NCT00720057|26993338|P1|Overall Study|Withdrawal by Subject|0
7765117|NCT00720057|26993337|P2|Overall Study|Protocol Violation|0
7765118|NCT00720057|26993338|P1|Overall Study|Protocol Violation|1
7765119|NCT00720057|26993337|P2|Overall Study|Lost to Follow-up|2
7765120|NCT00720057|26993338|P1|Overall Study|Lost to Follow-up|0
7765121|NCT00719953|26993354|P1|Overall Study|Adverse Event|4
7765122|NCT00719901|26993367|P1|Overall Study|Availability of Study Drug|1
7765123|NCT00719901|26993367|P1|Overall Study|Disease Progression|3
7765124|NCT00719901|26993367|P1|Overall Study|Alternate Treatment|1
7765125|NCT00719901|26993367|P1|Overall Study|Withdrawal by Subject|1
7765126|NCT00719901|26993367|P1|Overall Study|Adverse Event|5
7765127|NCT00719862|26993379|P2|Overall Study|Other|3
7765128|NCT00719862|26993380|P1|Overall Study|Other|2
7765129|NCT00719862|26993379|P2|Overall Study|Lost to Follow-up|1
7765130|NCT00719862|26993380|P1|Overall Study|Lost to Follow-up|0
7765131|NCT00719862|26993379|P2|Overall Study|Withdrawal by Subject|0
7765132|NCT00719862|26993380|P1|Overall Study|Withdrawal by Subject|1
7765133|NCT00719862|26993379|P2|Overall Study|Non-Compliance|0
7765134|NCT00719862|26993380|P1|Overall Study|Non-Compliance|1
7765135|NCT00719862|26993379|P2|Overall Study|Lack of Efficacy|0
7765136|NCT00719862|26993380|P1|Overall Study|Lack of Efficacy|3
7765137|NCT00719862|26993379|P2|Overall Study|Adverse Event|2
7765138|NCT00719862|26993380|P1|Overall Study|Adverse Event|1
7765139|NCT00719849|26993398|P2|Overall Study|Death|1
7765140|NCT00719849|26993399|P1|Overall Study|Death|0
7765141|NCT00719810|26993438|P3|Overall Study|Withdrawal by Subject|2
7765142|NCT00719810|26993439|P2|Overall Study|Withdrawal by Subject|1
7765143|NCT00719810|26993440|P1|Overall Study|Withdrawal by Subject|1
7765144|NCT00719810|26993438|P3|Overall Study|Physician Decision|0
7765145|NCT00719810|26993439|P2|Overall Study|Physician Decision|1
7765146|NCT00719810|26993440|P1|Overall Study|Physician Decision|0
7765147|NCT00719810|26993438|P3|Overall Study|Lost to Follow-up|3
7765148|NCT00719810|26993439|P2|Overall Study|Lost to Follow-up|0
7765149|NCT00719810|26993440|P1|Overall Study|Lost to Follow-up|2
7765150|NCT00719810|26993438|P3|Overall Study|Adverse Event|3
7765151|NCT00719810|26993439|P2|Overall Study|Adverse Event|2
7765152|NCT00719810|26993440|P1|Overall Study|Adverse Event|0
7765153|NCT00719732|26993451|P1|Overall Study|Illness not associated with device|1
7765154|NCT00719732|26993451|P1|Overall Study|Unilateral (not bilateral) implantation|1
7765155|NCT00719732|26993451|P1|Overall Study|Lost to Follow-up|20
7765156|NCT00719706|26993457|P2|Overall Study|Protocol Violation|0
7765157|NCT00719706|26993458|P1|Overall Study|Protocol Violation|3
7765158|NCT00719706|26993457|P2|Overall Study|Withdrawal by Subject|2
7765159|NCT00719706|26993458|P1|Overall Study|Withdrawal by Subject|1
7765160|NCT00719706|26993457|P2|Overall Study|Adverse Event|4
7765161|NCT00719706|26993458|P1|Overall Study|Adverse Event|5
7765162|NCT00719680|26993472|P1|Overall Study|Withdrawal by Subject|3
7765163|NCT00719680|26993472|P1|Overall Study|Lost to Follow-up|1
7765164|NCT00719680|26993472|P1|Overall Study|Adverse Event|1
7765165|NCT00719563|26993528|P2|Overall Study|Lost to Follow-up|3
7765166|NCT00719563|26993529|P1|Overall Study|Lost to Follow-up|5
7765167|NCT00719563|26993528|P2|Overall Study|Noncompliant|1
7765168|NCT00719563|26993529|P1|Overall Study|Noncompliant|1
7765169|NCT00719563|26993528|P2|Overall Study|Unknown reasons|6
7765170|NCT00719563|26993529|P1|Overall Study|Unknown reasons|4
7765171|NCT00719563|26993528|P2|Overall Study|Personal reasons|7
7765172|NCT00719563|26993529|P1|Overall Study|Personal reasons|6
7765173|NCT00719563|26993528|P2|Overall Study|Lack of Efficacy|7
7765174|NCT00719563|26993529|P1|Overall Study|Lack of Efficacy|3
7765175|NCT00719563|26993528|P2|Overall Study|Medical condition changed|5
7765176|NCT00719563|26993529|P1|Overall Study|Medical condition changed|3
7765177|NCT00719563|26993528|P2|Overall Study|Adverse Event|13
7765178|NCT00719563|26993529|P1|Overall Study|Adverse Event|16
7765179|NCT00719537|26993561|P2|Overall Study|Lost to Follow-up|1
7765180|NCT00719537|26993562|P1|Overall Study|Lost to Follow-up|0
7765181|NCT00719537|26993561|P2|Overall Study|Withdrawal by Subject|0
7765182|NCT00719537|26993562|P1|Overall Study|Withdrawal by Subject|1
7765183|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Various Reasons|25
7765184|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
7765185|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
7765186|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
7765187|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Disease progression|3
7765188|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Death|6
7765189|NCT00719472|26993568|P1|Received Cycle 2 Treatment|Adverse Event|12
7765190|NCT00719472|26993568|P1|Received Cycle 1 Treatment|Various Reasons|13
7765191|NCT00719472|26993568|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
7765192|NCT00719472|26993568|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
7765193|NCT00719472|26993568|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
7765194|NCT00719472|26993568|P1|Received Cycle 1 Treatment|Death|5
7765195|NCT00719472|26993568|P1|Received Cycle 1 Treatment|Adverse Event|8
7765196|NCT00719472|26993568|P1|Enrolled in Study|Various Reasons|17
7765197|NCT00719472|26993568|P1|Enrolled in Study|Subject decision to withdraw|8
7765198|NCT00719472|26993568|P1|Enrolled in Study|Physician decision to withdraw patient|1
7765199|NCT00719355|26993579|P2|Overall Study|Moved|1
7765200|NCT00719355|26993580|P1|Overall Study|Moved|0
7765201|NCT00719355|26993579|P2|Overall Study|Compliance|6
7765202|NCT00719355|26993580|P1|Overall Study|Compliance|4
7765203|NCT00719355|26993579|P2|Overall Study|Medical|5
7765204|NCT00719355|26993580|P1|Overall Study|Medical|14
7765205|NCT00719355|26993579|P2|Overall Study|Death|1
7765206|NCT00719355|26993580|P1|Overall Study|Death|0
7765207|NCT00719264|26993609|P2|Overall Study|Disease Progression|107
7765208|NCT00719264|26993610|P1|Overall Study|Disease Progression|104
7765209|NCT00719264|26993609|P2|Overall Study|New Cancer Therapy|2
7765210|NCT00719264|26993610|P1|Overall Study|New Cancer Therapy|4
7765211|NCT00719264|26993609|P2|Overall Study|Protocol Deviation|3
7765212|NCT00719264|26993610|P1|Overall Study|Protocol Deviation|1
7765213|NCT00719264|26993609|P2|Overall Study|Withdrawal by Subject|7
7765214|NCT00719264|26993610|P1|Overall Study|Withdrawal by Subject|12
7765215|NCT00719264|26993609|P2|Overall Study|Lost to Follow-up|1
7765216|NCT00719264|26993610|P1|Overall Study|Lost to Follow-up|1
7765217|NCT00719264|26993609|P2|Overall Study|Administrative Problems|4
7765218|NCT00719264|26993610|P1|Overall Study|Administrative Problems|6
7765219|NCT00719264|26993609|P2|Overall Study|Death|10
7765220|NCT00719264|26993610|P1|Overall Study|Death|13
7765221|NCT00719264|26993609|P2|Overall Study|Adverse Event|49
7765222|NCT00719264|26993610|P1|Overall Study|Adverse Event|41
7765223|NCT00719212|26993629|P1|Overall Study|Withdrawal by Subject|1
7765224|NCT00719212|26993629|P1|Overall Study|Lost to Follow-up|2
7765225|NCT00719212|26993629|P1|Overall Study|Death|41
7765226|NCT00719043|26993677|P7|Overall Study|Withdrawal by Subject|14
7765227|NCT00719043|26993678|P6|Overall Study|Withdrawal by Subject|18
7765228|NCT00719043|26993679|P5|Overall Study|Withdrawal by Subject|16
7765229|NCT00719043|26993680|P4|Overall Study|Withdrawal by Subject|10
7765230|NCT00719043|26993681|P3|Overall Study|Withdrawal by Subject|9
7765231|NCT00719043|26993682|P2|Overall Study|Withdrawal by Subject|14
7765232|NCT00719043|26993683|P1|Overall Study|Withdrawal by Subject|12
7765233|NCT00719043|26993677|P7|Overall Study|Other|1
7765234|NCT00719043|26993678|P6|Overall Study|Other|2
7765235|NCT00719043|26993679|P5|Overall Study|Other|0
7765236|NCT00719043|26993680|P4|Overall Study|Other|2
7765237|NCT00719043|26993681|P3|Overall Study|Other|1
7765238|NCT00719043|26993682|P2|Overall Study|Other|0
7765239|NCT00719043|26993683|P1|Overall Study|Other|1
7765240|NCT00719043|26993677|P7|Overall Study|Protocol Violation|0
7765241|NCT00719043|26993678|P6|Overall Study|Protocol Violation|1
7765242|NCT00719043|26993679|P5|Overall Study|Protocol Violation|0
7765243|NCT00719043|26993680|P4|Overall Study|Protocol Violation|0
7765244|NCT00719043|26993681|P3|Overall Study|Protocol Violation|0
7765245|NCT00719043|26993682|P2|Overall Study|Protocol Violation|0
7765246|NCT00719043|26993683|P1|Overall Study|Protocol Violation|0
7765247|NCT00719043|26993677|P7|Overall Study|Lost to Follow-up|9
7765248|NCT00719043|26993678|P6|Overall Study|Lost to Follow-up|9
7765249|NCT00719043|26993679|P5|Overall Study|Lost to Follow-up|10
7765250|NCT00719043|26993680|P4|Overall Study|Lost to Follow-up|9
7765251|NCT00719043|26993681|P3|Overall Study|Lost to Follow-up|8
7765252|NCT00719043|26993682|P2|Overall Study|Lost to Follow-up|10
7765253|NCT00719043|26993683|P1|Overall Study|Lost to Follow-up|14
7765254|NCT00719043|26993677|P7|Overall Study|Adverse Event|4
7765255|NCT00719043|26993678|P6|Overall Study|Adverse Event|4
7765256|NCT00719043|26993679|P5|Overall Study|Adverse Event|1
7765257|NCT00719043|26993680|P4|Overall Study|Adverse Event|2
7765258|NCT00719043|26993681|P3|Overall Study|Adverse Event|2
7765259|NCT00719043|26993682|P2|Overall Study|Adverse Event|1
7765260|NCT00719043|26993683|P1|Overall Study|Adverse Event|5
7765261|NCT00718887|26993807|P2|Overall Study|Not identified|7
7765262|NCT00718887|26993808|P1|Overall Study|Not identified|2
7765263|NCT00718887|26993807|P2|Overall Study|Withdrawal by Subject|2
7765264|NCT00718887|26993808|P1|Overall Study|Withdrawal by Subject|3
7765265|NCT00718861|26993832|P2|Overall Study|Death|5
7765266|NCT00718861|26993833|P1|Overall Study|Death|1
7765267|NCT00718861|26993832|P2|Overall Study|Administrative Problems|1
7765268|NCT00718861|26993833|P1|Overall Study|Administrative Problems|1
7765269|NCT00718861|26993832|P2|Overall Study|Lost to Follow-up|1
7765270|NCT00718861|26993833|P1|Overall Study|Lost to Follow-up|2
7765271|NCT00718861|26993832|P2|Overall Study|Adverse Event|1
7765272|NCT00718861|26993833|P1|Overall Study|Adverse Event|2
7765273|NCT00718861|26993832|P2|Overall Study|Withdrawal by Subject|10
7765274|NCT00718861|26993833|P1|Overall Study|Withdrawal by Subject|15
7765275|NCT00718809|26993861|P2|Overall Study|Noncompliance|0
7765276|NCT00718809|26993862|P1|Overall Study|Noncompliance|1
7765277|NCT00718809|26993861|P2|Overall Study|Lost to Follow-up|0
7765278|NCT00718809|26993862|P1|Overall Study|Lost to Follow-up|1
7765279|NCT00718809|26993861|P2|Overall Study|Withdrawal by Subject|1
7765280|NCT00718809|26993862|P1|Overall Study|Withdrawal by Subject|0
7765281|NCT00718809|26993861|P2|Overall Study|Adverse Event|1
7765282|NCT00718809|26993862|P1|Overall Study|Adverse Event|1
7765283|NCT00718809|26993861|P2|Overall Study|Disease progression|7
7765284|NCT00718809|26993862|P1|Overall Study|Disease progression|9
7765285|NCT00718770|26993876|P1|Overall Study|Adverse Event|1
7765286|NCT00718770|26993876|P1|Overall Study|Lack of Efficacy|1
7765287|NCT00718770|26993876|P1|Overall Study|Adverse Event|1
7765288|NCT00718770|26993876|P1|Overall Study|Lack of Efficacy|1
7765289|NCT00718770|26993876|P1|Overall Study|Adverse Event|1
7765290|NCT00718770|26993876|P1|Overall Study|Lack of Efficacy|1
7765291|NCT00718770|26993876|P1|Overall Study|Lack of Efficacy|1
7765292|NCT00718770|26993876|P1|Overall Study|Adverse Event|1
7765293|NCT00718718|26993887|P10|Week 12 to End of Study|Other|0
7765294|NCT00718718|26993888|P9|Week 12 to End of Study|Other|0
7765295|NCT00718718|26993889|P8|Week 12 to End of Study|Other|0
7765296|NCT00718718|26993890|P7|Week 12 to End of Study|Other|1
7765297|NCT00718718|26993891|P6|Week 12 to End of Study|Other|0
7765298|NCT00718718|26993892|P5|Week 12 to End of Study|Other|0
7765299|NCT00718718|26993893|P4|Week 12 to End of Study|Other|1
7765300|NCT00718718|26993894|P3|Week 12 to End of Study|Other|0
7765301|NCT00718718|26993895|P2|Week 12 to End of Study|Other|1
7765302|NCT00718718|26993896|P1|Week 12 to End of Study|Other|0
7765303|NCT00718718|26993887|P10|Week 12 to End of Study|Lost to Follow-up|0
7765304|NCT00718718|26993888|P9|Week 12 to End of Study|Lost to Follow-up|1
7765305|NCT00718718|26993889|P8|Week 12 to End of Study|Lost to Follow-up|0
7765306|NCT00718718|26993890|P7|Week 12 to End of Study|Lost to Follow-up|0
7765307|NCT00718718|26993891|P6|Week 12 to End of Study|Lost to Follow-up|0
7765308|NCT00718718|26993892|P5|Week 12 to End of Study|Lost to Follow-up|0
7765309|NCT00718718|26993893|P4|Week 12 to End of Study|Lost to Follow-up|0
7765310|NCT00718718|26993894|P3|Week 12 to End of Study|Lost to Follow-up|0
7765311|NCT00718718|26993895|P2|Week 12 to End of Study|Lost to Follow-up|0
7765312|NCT00718718|26993896|P1|Week 12 to End of Study|Lost to Follow-up|0
7765313|NCT00718718|26993887|P10|Week 12 to End of Study|Withdrawal by Subject|0
7765314|NCT00718718|26993888|P9|Week 12 to End of Study|Withdrawal by Subject|0
7765315|NCT00718718|26993889|P8|Week 12 to End of Study|Withdrawal by Subject|0
7765316|NCT00718718|26993890|P7|Week 12 to End of Study|Withdrawal by Subject|1
7765317|NCT00718718|26993891|P6|Week 12 to End of Study|Withdrawal by Subject|2
7765318|NCT00718718|26993892|P5|Week 12 to End of Study|Withdrawal by Subject|0
7765319|NCT00718718|26993893|P4|Week 12 to End of Study|Withdrawal by Subject|0
7765320|NCT00718718|26993894|P3|Week 12 to End of Study|Withdrawal by Subject|0
7765321|NCT00718718|26993895|P2|Week 12 to End of Study|Withdrawal by Subject|0
7765322|NCT00718718|26993896|P1|Week 12 to End of Study|Withdrawal by Subject|0
7765323|NCT00718718|26993887|P10|Week 12 to End of Study|Death|0
7765324|NCT00718718|26993888|P9|Week 12 to End of Study|Death|0
7765325|NCT00718718|26993889|P8|Week 12 to End of Study|Death|0
7765326|NCT00718718|26993890|P7|Week 12 to End of Study|Death|0
7765327|NCT00718718|26993891|P6|Week 12 to End of Study|Death|1
7765328|NCT00718718|26993892|P5|Week 12 to End of Study|Death|0
7765329|NCT00718718|26993893|P4|Week 12 to End of Study|Death|0
7765330|NCT00718718|26993894|P3|Week 12 to End of Study|Death|0
7765331|NCT00718718|26993895|P2|Week 12 to End of Study|Death|0
7765332|NCT00718718|26993896|P1|Week 12 to End of Study|Death|0
7765333|NCT00718718|26993887|P10|Week 12 to End of Study|Adverse Event|0
7765334|NCT00718718|26993888|P9|Week 12 to End of Study|Adverse Event|0
7765335|NCT00718718|26993889|P8|Week 12 to End of Study|Adverse Event|1
7765336|NCT00718718|26993890|P7|Week 12 to End of Study|Adverse Event|0
7765337|NCT00718718|26993891|P6|Week 12 to End of Study|Adverse Event|0
7765338|NCT00718718|26993892|P5|Week 12 to End of Study|Adverse Event|0
7765339|NCT00718718|26993893|P4|Week 12 to End of Study|Adverse Event|0
7765340|NCT00718718|26993894|P3|Week 12 to End of Study|Adverse Event|0
7765341|NCT00718718|26993895|P2|Week 12 to End of Study|Adverse Event|0
7765342|NCT00718718|26993896|P1|Week 12 to End of Study|Adverse Event|0
7765343|NCT00718718|26993887|P10|Prior to Week 12|Other|0
7765344|NCT00718718|26993888|P9|Prior to Week 12|Other|0
7765345|NCT00718718|26993889|P8|Prior to Week 12|Other|0
7765346|NCT00718718|26993890|P7|Prior to Week 12|Other|0
7765347|NCT00718718|26993891|P6|Prior to Week 12|Other|0
7765348|NCT00718718|26993892|P5|Prior to Week 12|Other|0
7765349|NCT00718718|26993893|P4|Prior to Week 12|Other|0
7765350|NCT00718718|26993894|P3|Prior to Week 12|Other|1
7765351|NCT00718718|26993895|P2|Prior to Week 12|Other|0
7765352|NCT00718718|26993896|P1|Prior to Week 12|Other|1
7765353|NCT00718718|26993887|P10|Prior to Week 12|Withdrawal by Subject|0
7765354|NCT00718718|26993888|P9|Prior to Week 12|Withdrawal by Subject|1
7765355|NCT00718718|26993889|P8|Prior to Week 12|Withdrawal by Subject|1
7765356|NCT00718718|26993890|P7|Prior to Week 12|Withdrawal by Subject|1
7765357|NCT00718718|26993891|P6|Prior to Week 12|Withdrawal by Subject|0
7765358|NCT00718718|26993892|P5|Prior to Week 12|Withdrawal by Subject|3
7765359|NCT00718718|26993893|P4|Prior to Week 12|Withdrawal by Subject|0
7765360|NCT00718718|26993894|P3|Prior to Week 12|Withdrawal by Subject|0
7765361|NCT00718718|26993895|P2|Prior to Week 12|Withdrawal by Subject|0
7765362|NCT00718718|26993896|P1|Prior to Week 12|Withdrawal by Subject|0
7765363|NCT00718718|26993887|P10|Prior to Week 12|Adverse Event|0
7765364|NCT00718718|26993888|P9|Prior to Week 12|Adverse Event|1
7765365|NCT00718718|26993889|P8|Prior to Week 12|Adverse Event|1
7765366|NCT00718718|26993890|P7|Prior to Week 12|Adverse Event|0
7765367|NCT00718718|26993891|P6|Prior to Week 12|Adverse Event|0
7765368|NCT00718718|26993892|P5|Prior to Week 12|Adverse Event|0
7765369|NCT00718718|26993893|P4|Prior to Week 12|Adverse Event|0
7765370|NCT00718718|26993894|P3|Prior to Week 12|Adverse Event|0
7765371|NCT00718718|26993895|P2|Prior to Week 12|Adverse Event|0
7765372|NCT00718718|26993896|P1|Prior to Week 12|Adverse Event|0
7765373|NCT00718666|26993939|P3|Booster Phase Year 5|Lost to Follow-up|4
7765374|NCT00718666|26993940|P2|Booster Phase Year 5|Lost to Follow-up|0
7765375|NCT00718666|26993941|P1|Booster Phase Year 5|Lost to Follow-up|1
7765376|NCT00718666|26993939|P3|Booster Phase Year 5|Withdrawal by Subject|1
7765377|NCT00718666|26993940|P2|Booster Phase Year 5|Withdrawal by Subject|0
7765378|NCT00718666|26993941|P1|Booster Phase Year 5|Withdrawal by Subject|0
7765379|NCT00718666|26993939|P3|Booster Phase Year 5|Declined v-4 serology|0
7765380|NCT00718666|26993940|P2|Booster Phase Year 5|Declined v-4 serology|0
7765381|NCT00718666|26993941|P1|Booster Phase Year 5|Declined v-4 serology|1
7765382|NCT00718666|26993939|P3|Booster Phase Year 5|No active participation request|1
7765383|NCT00718666|26993940|P2|Booster Phase Year 5|No active participation request|0
7765384|NCT00718666|26993941|P1|Booster Phase Year 5|No active participation request|0
7765385|NCT00718640|26994025|P1|Overall Study|Unresolved toxicity after 2 weeks|2
7765386|NCT00718640|26994025|P1|Overall Study|Death|1
7765387|NCT00718640|26994025|P1|Overall Study|Adverse Event|4
7765388|NCT00718549|26994037|P3|Maintenance/ Observation Phase|Relapse|2
7765389|NCT00718549|26994038|P2|Maintenance/ Observation Phase|Relapse|3
7765390|NCT00718549|26994039|P1|Maintenance/ Observation Phase|Relapse|0
7765391|NCT00718549|26994037|P3|Maintenance/ Observation Phase|Progression|14
7765392|NCT00718549|26994038|P2|Maintenance/ Observation Phase|Progression|5
7765393|NCT00718549|26994039|P1|Maintenance/ Observation Phase|Progression|0
7765394|NCT00718549|26994037|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
7765395|NCT00718549|26994038|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
7765396|NCT00718549|26994039|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
7765397|NCT00718549|26994037|P3|Maintenance/ Observation Phase|Death|2
7765398|NCT00718549|26994038|P2|Maintenance/ Observation Phase|Death|1
7765399|NCT00718549|26994039|P1|Maintenance/ Observation Phase|Death|0
7765400|NCT00718549|26994037|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
7765401|NCT00718549|26994038|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
7765402|NCT00718549|26994039|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
7765403|NCT00718549|26994037|P3|Induction Phase|Early Termination - No Additional Info|0
7765404|NCT00718549|26994038|P2|Induction Phase|Early Termination - No Additional Info|0
7765405|NCT00718549|26994039|P1|Induction Phase|Early Termination - No Additional Info|59
7765406|NCT00718549|26994037|P3|Induction Phase|Eligibility Criteria Violation|0
7765407|NCT00718549|26994038|P2|Induction Phase|Eligibility Criteria Violation|0
7765408|NCT00718549|26994039|P1|Induction Phase|Eligibility Criteria Violation|2
7765409|NCT00718549|26994037|P3|Induction Phase|Disease Progression|0
7765410|NCT00718549|26994038|P2|Induction Phase|Disease Progression|0
7765411|NCT00718549|26994039|P1|Induction Phase|Disease Progression|1
7765412|NCT00718523|26994064|P2|Overall Study|Death|17
7765413|NCT00718523|26994065|P1|Overall Study|Death|13
7765414|NCT00718523|26994064|P2|Overall Study|Withdrawal by Subject|7
7765415|NCT00718523|26994065|P1|Overall Study|Withdrawal by Subject|5
7765416|NCT00718510|26994077|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7765417|NCT00718510|26994078|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7765418|NCT00718510|26994077|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
7765419|NCT00718510|26994078|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
7765420|NCT00718419|26994090|P2|Overall Study|Death Due to Adverse Events|0
7765421|NCT00718419|26994091|P1|Overall Study|Death Due to Adverse Events|1
7765422|NCT00718419|26994090|P2|Overall Study|Death Due to Study Drug Related|1
7765423|NCT00718419|26994091|P1|Overall Study|Death Due to Study Drug Related|0
7765424|NCT00718419|26994090|P2|Overall Study|Death Due to Progressive Disease|0
7765425|NCT00718419|26994091|P1|Overall Study|Death Due to Progressive Disease|2
7765426|NCT00718419|26994090|P2|Overall Study|Progressive Disease|25
7765427|NCT00718419|26994091|P1|Overall Study|Progressive Disease|7
7765428|NCT00718419|26994090|P2|Overall Study|Withdrawal by Subject|5
7765429|NCT00718419|26994091|P1|Overall Study|Withdrawal by Subject|0
7765430|NCT00718419|26994090|P2|Overall Study|Sponsor decision|1
7765431|NCT00718419|26994091|P1|Overall Study|Sponsor decision|0
7765432|NCT00718419|26994090|P2|Overall Study|Physician Decision|6
7765433|NCT00718419|26994091|P1|Overall Study|Physician Decision|1
7765434|NCT00718419|26994090|P2|Overall Study|Adverse Event|1
7765435|NCT00718419|26994091|P1|Overall Study|Adverse Event|2
7765436|NCT00718328|26994107|P2|Overall Study|Lost to Follow-up|0
7765437|NCT00718328|26994108|P1|Overall Study|Lost to Follow-up|1
7765438|NCT00718315|26994117|P3|Overall Study|Use of ATB and Corticoids|2
7765439|NCT00718315|26994118|P2|Overall Study|Use of ATB and Corticoids|1
7765440|NCT00718315|26994119|P1|Overall Study|Use of ATB and Corticoids|0
7765441|NCT00718315|26994117|P3|Overall Study|Other|1
7765442|NCT00718315|26994118|P2|Overall Study|Other|0
7765443|NCT00718315|26994119|P1|Overall Study|Other|0
7765444|NCT00718315|26994117|P3|Overall Study|Disease progression|1
7765445|NCT00718315|26994118|P2|Overall Study|Disease progression|1
7765446|NCT00718315|26994119|P1|Overall Study|Disease progression|0
7765447|NCT00718315|26994117|P3|Overall Study|Use of Minocyclin|1
7765448|NCT00718315|26994118|P2|Overall Study|Use of Minocyclin|1
7765449|NCT00718315|26994119|P1|Overall Study|Use of Minocyclin|1
7765450|NCT00718315|26994117|P3|Overall Study|Erlotinib dose decreased|1
7765451|NCT00718315|26994118|P2|Overall Study|Erlotinib dose decreased|3
7765452|NCT00718315|26994119|P1|Overall Study|Erlotinib dose decreased|4
7765453|NCT00718315|26994117|P3|Overall Study|Protocol Violation|3
7765454|NCT00718315|26994118|P2|Overall Study|Protocol Violation|5
7765455|NCT00718315|26994119|P1|Overall Study|Protocol Violation|5
7765456|NCT00718315|26994117|P3|Overall Study|Lost to Follow-up|4
7765457|NCT00718315|26994118|P2|Overall Study|Lost to Follow-up|3
7765458|NCT00718315|26994119|P1|Overall Study|Lost to Follow-up|2
7765459|NCT00718315|26994117|P3|Overall Study|Death|5
7765460|NCT00718315|26994118|P2|Overall Study|Death|6
7765461|NCT00718315|26994119|P1|Overall Study|Death|6
7765462|NCT00718315|26994117|P3|Overall Study|Adverse Event|3
7765463|NCT00718315|26994118|P2|Overall Study|Adverse Event|2
7765464|NCT00718315|26994119|P1|Overall Study|Adverse Event|1
7765465|NCT00718237|26994170|P2|Overall Study|Withdrawal by Subject|10
7765466|NCT00718237|26994171|P1|Overall Study|Withdrawal by Subject|9
7765467|NCT00718237|26994170|P2|Overall Study|Physician Decision|0
7765468|NCT00718237|26994171|P1|Overall Study|Physician Decision|1
7765469|NCT00718237|26994170|P2|Overall Study|Lost to Follow-up|2
7765470|NCT00718237|26994171|P1|Overall Study|Lost to Follow-up|2
7765471|NCT00718237|26994170|P2|Overall Study|Adverse Event|3
7765472|NCT00718237|26994171|P1|Overall Study|Adverse Event|1
7765473|NCT00718159|26994188|P7|Overall Study|Investigator Decision|1
7765474|NCT00718159|26994189|P6|Overall Study|Investigator Decision|1
7765475|NCT00718159|26994190|P5|Overall Study|Investigator Decision|0
7765476|NCT00718159|26994191|P4|Overall Study|Investigator Decision|0
7765477|NCT00718159|26994192|P3|Overall Study|Investigator Decision|0
7765478|NCT00718159|26994193|P2|Overall Study|Investigator Decision|0
7765479|NCT00718159|26994194|P1|Overall Study|Investigator Decision|0
7765480|NCT00718159|26994188|P7|Overall Study|Death due to Study Drug Toxicity|0
7765481|NCT00718159|26994189|P6|Overall Study|Death due to Study Drug Toxicity|0
7765482|NCT00718159|26994190|P5|Overall Study|Death due to Study Drug Toxicity|0
7765483|NCT00718159|26994191|P4|Overall Study|Death due to Study Drug Toxicity|2
7765484|NCT00718159|26994192|P3|Overall Study|Death due to Study Drug Toxicity|1
7765485|NCT00718159|26994193|P2|Overall Study|Death due to Study Drug Toxicity|0
7765486|NCT00718159|26994194|P1|Overall Study|Death due to Study Drug Toxicity|0
7765487|NCT00718159|26994188|P7|Overall Study|Death due to Adverse Event|0
7765488|NCT00718159|26994189|P6|Overall Study|Death due to Adverse Event|0
7765489|NCT00718159|26994190|P5|Overall Study|Death due to Adverse Event|2
7765490|NCT00718159|26994191|P4|Overall Study|Death due to Adverse Event|2
7765491|NCT00718159|26994192|P3|Overall Study|Death due to Adverse Event|0
7765492|NCT00718159|26994193|P2|Overall Study|Death due to Adverse Event|0
7765493|NCT00718159|26994194|P1|Overall Study|Death due to Adverse Event|0
7765494|NCT00718159|26994188|P7|Overall Study|Progressive Disease|0
7765495|NCT00718159|26994189|P6|Overall Study|Progressive Disease|0
7765496|NCT00718159|26994190|P5|Overall Study|Progressive Disease|6
7765497|NCT00718159|26994191|P4|Overall Study|Progressive Disease|0
7765498|NCT00718159|26994192|P3|Overall Study|Progressive Disease|2
7765499|NCT00718159|26994193|P2|Overall Study|Progressive Disease|3
7765500|NCT00718159|26994194|P1|Overall Study|Progressive Disease|3
7765501|NCT00718081|26994251|P3|Overall Study|Lack of Efficacy|21
7765502|NCT00718081|26994252|P2|Overall Study|Lack of Efficacy|3
7765503|NCT00718081|26994253|P1|Overall Study|Lack of Efficacy|7
7765504|NCT00718081|26994251|P3|Overall Study|Adverse Event|0
7765505|NCT00718081|26994252|P2|Overall Study|Adverse Event|1
7765506|NCT00718081|26994253|P1|Overall Study|Adverse Event|0
7765507|NCT00718042|26994270|P6|Donor Follow-up|Lost to Follow-up|0
7765508|NCT00718042|26994271|P5|Donor Follow-up|Lost to Follow-up|19
7765509|NCT00718042|26994272|P4|Donor Follow-up|Lost to Follow-up|0
7765510|NCT00718042|26994273|P3|Donor Follow-up|Lost to Follow-up|0
7765511|NCT00718042|26994274|P2|Donor Follow-up|Lost to Follow-up|0
7765512|NCT00718042|26994275|P1|Donor Follow-up|Lost to Follow-up|13
7765513|NCT00718042|26994270|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7765514|NCT00718042|26994271|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7765515|NCT00718042|26994272|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7765516|NCT00718042|26994273|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7765517|NCT00718042|26994274|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
7765518|NCT00718042|26994275|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7765519|NCT00718042|26994270|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7765520|NCT00718042|26994271|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7765521|NCT00718042|26994272|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7765522|NCT00718042|26994273|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
7765523|NCT00718042|26994274|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
7765524|NCT00718042|26994275|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7765525|NCT00718042|26994270|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7765526|NCT00718042|26994271|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
7765527|NCT00718042|26994272|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7765528|NCT00718042|26994273|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7765529|NCT00718042|26994274|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7765530|NCT00718042|26994275|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
7765531|NCT00718042|26994270|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7765532|NCT00718042|26994271|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
7765533|NCT00718042|26994272|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7765534|NCT00718042|26994273|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7765535|NCT00718042|26994274|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7765536|NCT00718042|26994275|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7765537|NCT00717886|26994331|P1|Overall Study|Treatment Failure|1
7765538|NCT00717886|26994331|P1|Overall Study|Withdrawal by Subject|3
7765539|NCT00717860|26994346|P2|Overall Study|Withdrew consent|3
7765540|NCT00717860|26994347|P1|Overall Study|Withdrew consent|7
7765541|NCT00717860|26994346|P2|Overall Study|Discontinued for other reason|1
7765542|NCT00717860|26994347|P1|Overall Study|Discontinued for other reason|6
7765543|NCT00717860|26994346|P2|Overall Study|Lack of Efficacy|13
7765544|NCT00717860|26994347|P1|Overall Study|Lack of Efficacy|7
7765545|NCT00717860|26994346|P2|Overall Study|Laboratory adverse experience|2
7765546|NCT00717860|26994347|P1|Overall Study|Laboratory adverse experience|2
7765547|NCT00717860|26994346|P2|Overall Study|Clinical adverse experience|9
7765548|NCT00717860|26994347|P1|Overall Study|Clinical adverse experience|5
7765549|NCT00717769|26994360|P3|Overall Study|Withdrew consent|0
7765550|NCT00717769|26994361|P2|Overall Study|Withdrew consent|2
7765551|NCT00717769|26994362|P1|Overall Study|Withdrew consent|2
7765552|NCT00717769|26994360|P3|Overall Study|Sponsor decision|10
7765553|NCT00717769|26994361|P2|Overall Study|Sponsor decision|0
7765554|NCT00717769|26994362|P1|Overall Study|Sponsor decision|1
7765555|NCT00717769|26994360|P3|Overall Study|Protocol Violation|0
7765556|NCT00717769|26994361|P2|Overall Study|Protocol Violation|2
7765557|NCT00717769|26994362|P1|Overall Study|Protocol Violation|0
7765558|NCT00717769|26994360|P3|Overall Study|Lack of Efficacy|0
7765559|NCT00717769|26994361|P2|Overall Study|Lack of Efficacy|2
7765560|NCT00717769|26994362|P1|Overall Study|Lack of Efficacy|1
7765561|NCT00717769|26994360|P3|Overall Study|Lost to Follow-up|0
7765562|NCT00717769|26994361|P2|Overall Study|Lost to Follow-up|4
7765563|NCT00717769|26994362|P1|Overall Study|Lost to Follow-up|3
7765564|NCT00717769|26994360|P3|Overall Study|Lack of compliance|0
7765565|NCT00717769|26994361|P2|Overall Study|Lack of compliance|2
7765566|NCT00717769|26994362|P1|Overall Study|Lack of compliance|0
7765567|NCT00717769|26994360|P3|Overall Study|Adverse Event|1
7765568|NCT00717769|26994361|P2|Overall Study|Adverse Event|6
7765569|NCT00717769|26994362|P1|Overall Study|Adverse Event|9
7765570|NCT00717756|26994407|P1|Overall Study|Withdrawal by Subject|1
7765571|NCT00717522|26994430|P1|Overall Study|Death|1
7765572|NCT00717522|26994430|P1|Overall Study|Adverse Event|1
7765573|NCT00717522|26994430|P1|Overall Study|Disease Progression|5
7765574|NCT00717366|26994466|P2|Extension Period (52 Weeks)|Withdrew consent|1
7765575|NCT00717366|26994467|P1|Extension Period (52 Weeks)|Withdrew consent|1
7765576|NCT00717366|26994466|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
7765577|NCT00717366|26994467|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
7765578|NCT00717366|26994466|P2|Extension Period (52 Weeks)|Renal transplant|13
7765579|NCT00717366|26994467|P1|Extension Period (52 Weeks)|Renal transplant|3
7765580|NCT00717366|26994466|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
7765581|NCT00717366|26994467|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
7765582|NCT00717366|26994466|P2|Core Study Period (20 Weeks)|Death|1
7765583|NCT00717366|26994467|P1|Core Study Period (20 Weeks)|Death|0
7765584|NCT00717366|26994466|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
7765585|NCT00717366|26994467|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
7765586|NCT00717366|26994466|P2|Core Study Period (20 Weeks)|Renal transplant|9
7765587|NCT00717366|26994467|P1|Core Study Period (20 Weeks)|Renal transplant|4
7765588|NCT00717314|26994491|P2|Overall Study|Withdrawal by Subject|3
7765589|NCT00717314|26994492|P1|Overall Study|Withdrawal by Subject|1
7765590|NCT00717314|26994491|P2|Overall Study|Lost to Follow-up|5
7765591|NCT00717314|26994492|P1|Overall Study|Lost to Follow-up|1
7765592|NCT00717314|26994491|P2|Overall Study|Protocol Violation|0
7765593|NCT00717314|26994492|P1|Overall Study|Protocol Violation|1
7765594|NCT00717314|26994491|P2|Overall Study|Adverse Event|2
7765595|NCT00717314|26994492|P1|Overall Study|Adverse Event|3
7765596|NCT00717275|26994529|P1|Overall Study|Premature study termination.|3
7765597|NCT00717249|26994535|P2|Overall Study|Headaches|0
7765598|NCT00717249|26994536|P1|Overall Study|Headaches|1
7765599|NCT00717249|26994535|P2|Overall Study|Subject relocated|0
7765600|NCT00717249|26994536|P1|Overall Study|Subject relocated|1
7765601|NCT00717249|26994535|P2|Overall Study|Diagnosed with Multiple Scletosis|0
7765602|NCT00717249|26994536|P1|Overall Study|Diagnosed with Multiple Scletosis|1
7765603|NCT00717249|26994535|P2|Overall Study|Diagnosed with Diabetes|0
7765604|NCT00717249|26994536|P1|Overall Study|Diagnosed with Diabetes|1
7765605|NCT00717249|26994535|P2|Overall Study|Gastric Surgery|1
7765606|NCT00717249|26994536|P1|Overall Study|Gastric Surgery|0
7765607|NCT00717249|26994535|P2|Overall Study|Unsatisfactory Physiological Response|1
7765608|NCT00717249|26994536|P1|Overall Study|Unsatisfactory Physiological Response|0
7765609|NCT00717249|26994535|P2|Overall Study|Subject became Ineligible|1
7765610|NCT00717249|26994536|P1|Overall Study|Subject became Ineligible|1
7765611|NCT00717249|26994535|P2|Overall Study|Protocol Violation|2
7765612|NCT00717249|26994536|P1|Overall Study|Protocol Violation|0
7765613|NCT00717249|26994535|P2|Overall Study|Pregnancy|3
7765614|NCT00717249|26994536|P1|Overall Study|Pregnancy|6
7765615|NCT00717249|26994535|P2|Overall Study|Withdrawal by Subject|2
7765616|NCT00717249|26994536|P1|Overall Study|Withdrawal by Subject|1
7765617|NCT00717249|26994535|P2|Overall Study|Lost to Follow-up|0
7765618|NCT00717249|26994536|P1|Overall Study|Lost to Follow-up|2
7765619|NCT00717249|26994535|P2|Overall Study|Adverse Event|2
7765620|NCT00717249|26994536|P1|Overall Study|Adverse Event|4
7765621|NCT00717249|26994535|P2|Overall Study|Unsatisfactory visual Response|2
7765622|NCT00717249|26994536|P1|Overall Study|Unsatisfactory visual Response|0
7765623|NCT00717249|26994535|P2|Overall Study|Lens Discomfort|1
7765624|NCT00717249|26994536|P1|Overall Study|Lens Discomfort|4
7765625|NCT00717236|26994550|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
7765626|NCT00717236|26994551|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
7765627|NCT00717236|26994550|P2|Open-Label Period|Other: Completion Accidently Performed|0
7765628|NCT00717236|26994551|P1|Open-Label Period|Other: Completion Accidently Performed|1
7765629|NCT00717236|26994550|P2|Open-Label Period|Other: Administration of Golimumab|0
7765630|NCT00717236|26994551|P1|Open-Label Period|Other: Administration of Golimumab|1
7765631|NCT00717236|26994550|P2|Open-Label Period|Other: Cataract Surgery|0
7765632|NCT00717236|26994551|P1|Open-Label Period|Other: Cataract Surgery|1
7765633|NCT00717236|26994550|P2|Open-Label Period|Other: Sponsor Request|0
7765634|NCT00717236|26994551|P1|Open-Label Period|Other: Sponsor Request|3
7765635|NCT00717236|26994550|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
7765636|NCT00717236|26994551|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
7765637|NCT00717236|26994550|P2|Open-Label Period|Other: Investigator Decision|0
7765638|NCT00717236|26994551|P1|Open-Label Period|Other: Investigator Decision|1
7765639|NCT00717236|26994550|P2|Open-Label Period|Other: Moved|0
7765640|NCT00717236|26994551|P1|Open-Label Period|Other: Moved|1
7765641|NCT00717236|26994550|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
7765642|NCT00717236|26994551|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
7765643|NCT00717236|26994550|P2|Open-Label Period|Other: Lack of Compliance|1
7765644|NCT00717236|26994551|P1|Open-Label Period|Other: Lack of Compliance|1
7765645|NCT00717236|26994550|P2|Open-Label Period|Other: Peripheral Neuropathy|1
7765646|NCT00717236|26994551|P1|Open-Label Period|Other: Peripheral Neuropathy|0
7765647|NCT00717236|26994550|P2|Open-Label Period|Loss of Efficacy|1
7765648|NCT00717236|26994551|P1|Open-Label Period|Loss of Efficacy|6
7765649|NCT00717236|26994550|P2|Open-Label Period|Withdrawal by Subject|2
7765650|NCT00717236|26994551|P1|Open-Label Period|Withdrawal by Subject|20
7765651|NCT00717236|26994550|P2|Open-Label Period|Lost to Follow-up|4
7765652|NCT00717236|26994551|P1|Open-Label Period|Lost to Follow-up|28
7765653|NCT00717236|26994550|P2|Open-Label Period|Lack of Efficacy|8
7765654|NCT00717236|26994551|P1|Open-Label Period|Lack of Efficacy|30
7765655|NCT00717236|26994550|P2|Open-Label Period|Adverse Event|4
7765656|NCT00717236|26994551|P1|Open-Label Period|Adverse Event|29
7765657|NCT00717236|26994550|P2|Double-Blind Period|Other: Investigator Decision|1
7765658|NCT00717236|26994551|P1|Double-Blind Period|Other: Investigator Decision|0
7765659|NCT00717236|26994550|P2|Double-Blind Period|Other: Transportation problems|1
7765660|NCT00717236|26994551|P1|Double-Blind Period|Other: Transportation problems|0
7765661|NCT00717236|26994550|P2|Double-Blind Period|Other: Prohibited medication taken|2
7765662|NCT00717236|26994551|P1|Double-Blind Period|Other: Prohibited medication taken|2
7765663|NCT00717236|26994550|P2|Double-Blind Period|Other: Stopped taking DMARD|0
7765664|NCT00717236|26994551|P1|Double-Blind Period|Other: Stopped taking DMARD|1
7765665|NCT00717236|26994550|P2|Double-Blind Period|Other: Subject moved|1
7765666|NCT00717236|26994551|P1|Double-Blind Period|Other: Subject moved|1
7765667|NCT00717236|26994550|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
7765668|NCT00717236|26994551|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
7765669|NCT00717236|26994550|P2|Double-Blind Period|Other: Inappropriate randomization|0
7765670|NCT00717236|26994551|P1|Double-Blind Period|Other: Inappropriate randomization|1
7765671|NCT00717236|26994550|P2|Double-Blind Period|Other: Sponsor request|0
7765672|NCT00717236|26994551|P1|Double-Blind Period|Other: Sponsor request|1
7765673|NCT00717236|26994550|P2|Double-Blind Period|Other: History of cancer|0
7765674|NCT00717236|26994551|P1|Double-Blind Period|Other: History of cancer|1
7765675|NCT00717236|26994550|P2|Double-Blind Period|Other: History of adenoid grown|0
7765676|NCT00717236|26994551|P1|Double-Blind Period|Other: History of adenoid grown|1
7765677|NCT00717236|26994550|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
7765678|NCT00717236|26994551|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
7765679|NCT00717236|26994550|P2|Double-Blind Period|Other: subject withdrew consent|1
7765680|NCT00717236|26994551|P1|Double-Blind Period|Other: subject withdrew consent|1
7765681|NCT00717236|26994550|P2|Double-Blind Period|Other: Screening failure|0
7765682|NCT00717236|26994551|P1|Double-Blind Period|Other: Screening failure|1
7765683|NCT00717236|26994550|P2|Double-Blind Period|Other: Site withdrew|0
7765684|NCT00717236|26994551|P1|Double-Blind Period|Other: Site withdrew|2
7765685|NCT00717236|26994550|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
7765686|NCT00717236|26994551|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
7765687|NCT00717236|26994550|P2|Double-Blind Period|Other: Protocol Violation|0
7765688|NCT00717236|26994551|P1|Double-Blind Period|Other: Protocol Violation|2
7765689|NCT00717236|26994550|P2|Double-Blind Period|Other: Pregnancy|0
7765690|NCT00717236|26994551|P1|Double-Blind Period|Other: Pregnancy|1
7765691|NCT00717236|26994550|P2|Double-Blind Period|Other: Death|0
7765692|NCT00717236|26994551|P1|Double-Blind Period|Other: Death|1
7765693|NCT00717236|26994550|P2|Double-Blind Period|Loss of efficacy|0
7765694|NCT00717236|26994551|P1|Double-Blind Period|Loss of efficacy|3
7765695|NCT00717236|26994550|P2|Double-Blind Period|Withdrawal by Subject|2
7765696|NCT00717236|26994551|P1|Double-Blind Period|Withdrawal by Subject|10
7765697|NCT00717236|26994550|P2|Double-Blind Period|Lost to Follow-up|5
7765698|NCT00717236|26994551|P1|Double-Blind Period|Lost to Follow-up|3
7765699|NCT00717236|26994550|P2|Double-Blind Period|Lack of Efficacy|6
7765700|NCT00717236|26994551|P1|Double-Blind Period|Lack of Efficacy|6
7765701|NCT00717236|26994550|P2|Double-Blind Period|Adverse Event|6
7765702|NCT00717236|26994551|P1|Double-Blind Period|Adverse Event|33
7765703|NCT00717197|26994620|P1|Overall Study|Physician Decision|1
7765704|NCT00717197|26994620|P1|Overall Study|Tumor Progression|1
7765705|NCT00717197|26994620|P1|Overall Study|Unable to purchase study drug|5
7765706|NCT00717093|26994626|P2|Overall Study|Randomized but not treated|0
7765707|NCT00717093|26994627|P1|Overall Study|Randomized but not treated|1
7765708|NCT00717093|26994626|P2|Overall Study|Other|1
7765709|NCT00717093|26994627|P1|Overall Study|Other|0
7765710|NCT00717093|26994626|P2|Overall Study|Withdrawal by Subject|19
7765711|NCT00717093|26994627|P1|Overall Study|Withdrawal by Subject|12
7765712|NCT00717093|26994626|P2|Overall Study|Lost to Follow-up|6
7765713|NCT00717093|26994627|P1|Overall Study|Lost to Follow-up|9
7765714|NCT00717093|26994626|P2|Overall Study|Lack of Efficacy|13
7765715|NCT00717093|26994627|P1|Overall Study|Lack of Efficacy|3
7765716|NCT00717093|26994626|P2|Overall Study|Adverse Event|9
7765717|NCT00717093|26994627|P1|Overall Study|Adverse Event|19
7765718|NCT00717067|26994644|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7765719|NCT00717067|26994645|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7765720|NCT00717067|26994646|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
7765721|NCT00717067|26994647|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7765722|NCT00717067|26994648|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7765723|NCT00716976|26994755|P2|Overall Study|Ineligibles|2
7765724|NCT00716976|26994756|P1|Overall Study|Ineligibles|4
7765725|NCT00716976|26994755|P2|Overall Study|Radiation during protocol|0
7765726|NCT00716976|26994756|P1|Overall Study|Radiation during protocol|1
7765727|NCT00716976|26994755|P2|Overall Study|Premature discontinuation cisplatin|4
7765728|NCT00716976|26994756|P1|Overall Study|Premature discontinuation cisplatin|5
7765729|NCT00716976|26994755|P2|Overall Study|Withdrawal by Subject|1
7765730|NCT00716976|26994756|P1|Overall Study|Withdrawal by Subject|5
7765731|NCT00716976|26994755|P2|Overall Study|Physician Decision|2
7765732|NCT00716976|26994756|P1|Overall Study|Physician Decision|2
7765733|NCT00716976|26994755|P2|Overall Study|Death|0
7765734|NCT00716976|26994756|P1|Overall Study|Death|1
7765735|NCT00716976|26994755|P2|Overall Study|Adverse Event|0
7765736|NCT00716976|26994756|P1|Overall Study|Adverse Event|2
7765737|NCT00716859|26994796|P2|Overall Study|Not treated|1
7765738|NCT00716859|26994797|P1|Overall Study|Not treated|1
7765739|NCT00716859|26994796|P2|Overall Study|Withdrawal by Subject|3
7765740|NCT00716859|26994797|P1|Overall Study|Withdrawal by Subject|1
7765741|NCT00716859|26994796|P2|Overall Study|Lack of Efficacy|0
7765742|NCT00716859|26994797|P1|Overall Study|Lack of Efficacy|3
7765743|NCT00716859|26994796|P2|Overall Study|Adverse Event|1
7765744|NCT00716859|26994797|P1|Overall Study|Adverse Event|4
7765745|NCT00716625|26994882|P1|Overall Study|Safety was not Assessable|1
7765746|NCT00716482|26994913|P1|Overall Study|inclusion/exclusion criteria not met|25
7765747|NCT00716482|26994913|P1|Overall Study|technical/machine error|28
7765748|NCT00716482|26994913|P1|Overall Study|no pathology obtained|10
7765749|NCT00716482|26994913|P1|Overall Study|Inadequate acquisition or analysis|50
7765750|NCT00716482|26994913|P1|Overall Study|Lost to Follow-up|6
7765751|NCT00716456|26994926|P3|Overall Study|Adverse Event|0
7765752|NCT00716456|26994927|P2|Overall Study|Adverse Event|2
7765753|NCT00716456|26994928|P1|Overall Study|Adverse Event|0
7765754|NCT00716417|26994979|P10|Overall Study|On patient request due to toxicities|0
7765755|NCT00716417|26994980|P9|Overall Study|On patient request due to toxicities|0
7765756|NCT00716417|26994981|P8|Overall Study|On patient request due to toxicities|1
7765757|NCT00716417|26994982|P7|Overall Study|On patient request due to toxicities|0
7765758|NCT00716417|26994983|P6|Overall Study|On patient request due to toxicities|0
7765759|NCT00716417|26994984|P5|Overall Study|On patient request due to toxicities|0
7765760|NCT00716417|26994985|P4|Overall Study|On patient request due to toxicities|0
7765761|NCT00716417|26994986|P3|Overall Study|On patient request due to toxicities|0
7765762|NCT00716417|26994987|P2|Overall Study|On patient request due to toxicities|0
7765763|NCT00716417|26994988|P1|Overall Study|On patient request due to toxicities|0
7765764|NCT00716417|26994979|P10|Overall Study|Dose limiting toxicity (DLT)|0
7765765|NCT00716417|26994980|P9|Overall Study|Dose limiting toxicity (DLT)|0
7765766|NCT00716417|26994981|P8|Overall Study|Dose limiting toxicity (DLT)|0
7765767|NCT00716417|26994982|P7|Overall Study|Dose limiting toxicity (DLT)|0
7765768|NCT00716417|26994983|P6|Overall Study|Dose limiting toxicity (DLT)|0
7765769|NCT00716417|26994984|P5|Overall Study|Dose limiting toxicity (DLT)|1
7765770|NCT00716417|26994985|P4|Overall Study|Dose limiting toxicity (DLT)|0
7765771|NCT00716417|26994986|P3|Overall Study|Dose limiting toxicity (DLT)|0
7765772|NCT00716417|26994987|P2|Overall Study|Dose limiting toxicity (DLT)|0
7765773|NCT00716417|26994988|P1|Overall Study|Dose limiting toxicity (DLT)|0
7765774|NCT00716417|26994979|P10|Overall Study|Progressive disease|0
7765775|NCT00716417|26994980|P9|Overall Study|Progressive disease|5
7765776|NCT00716417|26994981|P8|Overall Study|Progressive disease|1
7765777|NCT00716417|26994982|P7|Overall Study|Progressive disease|3
7765778|NCT00716417|26994983|P6|Overall Study|Progressive disease|3
7765779|NCT00716417|26994984|P5|Overall Study|Progressive disease|0
7765780|NCT00716417|26994985|P4|Overall Study|Progressive disease|8
7765781|NCT00716417|26994986|P3|Overall Study|Progressive disease|3
7765782|NCT00716417|26994987|P2|Overall Study|Progressive disease|5
7765783|NCT00716417|26994988|P1|Overall Study|Progressive disease|3
7765784|NCT00716417|26994979|P10|Overall Study|Withdrawal by Subject|0
7765785|NCT00716417|26994980|P9|Overall Study|Withdrawal by Subject|0
7765786|NCT00716417|26994981|P8|Overall Study|Withdrawal by Subject|0
7765787|NCT00716417|26994982|P7|Overall Study|Withdrawal by Subject|1
7765788|NCT00716417|26994983|P6|Overall Study|Withdrawal by Subject|0
7765789|NCT00716417|26994984|P5|Overall Study|Withdrawal by Subject|0
7765790|NCT00716417|26994985|P4|Overall Study|Withdrawal by Subject|2
7765791|NCT00716417|26994986|P3|Overall Study|Withdrawal by Subject|0
7765792|NCT00716417|26994987|P2|Overall Study|Withdrawal by Subject|1
7765793|NCT00716417|26994988|P1|Overall Study|Withdrawal by Subject|0
7765794|NCT00716417|26994979|P10|Overall Study|Adverse Event|3
7765795|NCT00716417|26994980|P9|Overall Study|Adverse Event|0
7765796|NCT00716417|26994981|P8|Overall Study|Adverse Event|1
7765797|NCT00716417|26994982|P7|Overall Study|Adverse Event|3
7765798|NCT00716417|26994983|P6|Overall Study|Adverse Event|0
7765799|NCT00716417|26994984|P5|Overall Study|Adverse Event|0
7765800|NCT00716417|26994985|P4|Overall Study|Adverse Event|1
7765801|NCT00716417|26994986|P3|Overall Study|Adverse Event|2
7765802|NCT00716417|26994987|P2|Overall Study|Adverse Event|0
7765803|NCT00716417|26994988|P1|Overall Study|Adverse Event|0
7765804|NCT00716274|26995035|P6|Study Period III (16-Weeks)|Adverse Event|0
7765805|NCT00716274|26995036|P5|Study Period III (16-Weeks)|Adverse Event|1
7765806|NCT00716274|26995037|P4|Study Period III (16-Weeks)|Adverse Event|0
7765807|NCT00716274|26995038|P3|Study Period III (16-Weeks)|Adverse Event|0
7765808|NCT00716274|26995039|P2|Study Period III (16-Weeks)|Adverse Event|0
7765809|NCT00716274|26995040|P1|Study Period III (16-Weeks)|Adverse Event|0
7765810|NCT00716274|26995035|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7765811|NCT00716274|26995036|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
7765812|NCT00716274|26995037|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
7765813|NCT00716274|26995038|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7765814|NCT00716274|26995039|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7765815|NCT00716274|26995040|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7765816|NCT00716274|26995035|P6|Study Period III (16-Weeks)|Physician Decision|0
7765817|NCT00716274|26995036|P5|Study Period III (16-Weeks)|Physician Decision|1
7765818|NCT00716274|26995037|P4|Study Period III (16-Weeks)|Physician Decision|0
7765819|NCT00716274|26995038|P3|Study Period III (16-Weeks)|Physician Decision|0
7765820|NCT00716274|26995039|P2|Study Period III (16-Weeks)|Physician Decision|0
7765821|NCT00716274|26995040|P1|Study Period III (16-Weeks)|Physician Decision|0
7765822|NCT00716274|26995035|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
7765823|NCT00716274|26995036|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
7765824|NCT00716274|26995037|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
7765825|NCT00716274|26995038|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
7765826|NCT00716274|26995039|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
7765827|NCT00716274|26995040|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
7765828|NCT00716274|26995035|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
7765829|NCT00716274|26995036|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
7765830|NCT00716274|26995037|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
7765831|NCT00716274|26995038|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
7765832|NCT00716274|26995039|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
7765833|NCT00716274|26995040|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
7765834|NCT00716274|26995035|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7765835|NCT00716274|26995036|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7765836|NCT00716274|26995037|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7765837|NCT00716274|26995038|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7765838|NCT00716274|26995039|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
7765839|NCT00716274|26995040|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
7765840|NCT00716274|26995035|P6|Study Period II (16-Weeks)|Physician Decision|1
7765841|NCT00716274|26995036|P5|Study Period II (16-Weeks)|Physician Decision|0
7765842|NCT00716274|26995037|P4|Study Period II (16-Weeks)|Physician Decision|0
7765843|NCT00716274|26995038|P3|Study Period II (16-Weeks)|Physician Decision|0
7765844|NCT00716274|26995039|P2|Study Period II (16-Weeks)|Physician Decision|1
7765845|NCT00716274|26995040|P1|Study Period II (16-Weeks)|Physician Decision|3
7765929|NCT00715676|26995453|P1|Overall Study|Use of Exclusionary Medication|0
7765846|NCT00716274|26995035|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
7765847|NCT00716274|26995036|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
7765848|NCT00716274|26995037|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
7765849|NCT00716274|26995038|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
7765850|NCT00716274|26995039|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
7765851|NCT00716274|26995040|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
7765852|NCT00716274|26995035|P6|Study Period II (16-Weeks)|Protocol Violation|1
7765853|NCT00716274|26995036|P5|Study Period II (16-Weeks)|Protocol Violation|0
7765854|NCT00716274|26995037|P4|Study Period II (16-Weeks)|Protocol Violation|0
7765855|NCT00716274|26995038|P3|Study Period II (16-Weeks)|Protocol Violation|0
7765856|NCT00716274|26995039|P2|Study Period II (16-Weeks)|Protocol Violation|3
7765857|NCT00716274|26995040|P1|Study Period II (16-Weeks)|Protocol Violation|0
7765858|NCT00716274|26995035|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7765859|NCT00716274|26995036|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7765860|NCT00716274|26995037|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7765861|NCT00716274|26995038|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7765862|NCT00716274|26995039|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7765863|NCT00716274|26995040|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
7765864|NCT00716144|26995174|P4|Overall Study|Clinical Depression|0
7765865|NCT00716144|26995175|P3|Overall Study|Clinical Depression|0
7765866|NCT00716144|26995176|P2|Overall Study|Clinical Depression|1
7765867|NCT00716144|26995177|P1|Overall Study|Clinical Depression|0
7765868|NCT00716144|26995174|P4|Overall Study|Adverse event: left foot pain|0
7765869|NCT00716144|26995175|P3|Overall Study|Adverse event: left foot pain|0
7765870|NCT00716144|26995176|P2|Overall Study|Adverse event: left foot pain|1
7765871|NCT00716144|26995177|P1|Overall Study|Adverse event: left foot pain|0
7765872|NCT00716144|26995174|P4|Overall Study|Withdrew consent, allowed use of data|0
7765873|NCT00716144|26995175|P3|Overall Study|Withdrew consent, allowed use of data|1
7765874|NCT00716144|26995176|P2|Overall Study|Withdrew consent, allowed use of data|0
7765875|NCT00716144|26995177|P1|Overall Study|Withdrew consent, allowed use of data|0
7765876|NCT00716144|26995174|P4|Overall Study|Intercurrent illness|0
7765877|NCT00716144|26995175|P3|Overall Study|Intercurrent illness|1
7765878|NCT00716144|26995176|P2|Overall Study|Intercurrent illness|0
7765879|NCT00716144|26995177|P1|Overall Study|Intercurrent illness|0
7765880|NCT00716144|26995174|P4|Overall Study|Physician Decision|2
7765881|NCT00716144|26995175|P3|Overall Study|Physician Decision|2
7765882|NCT00716144|26995176|P2|Overall Study|Physician Decision|1
7765883|NCT00716144|26995177|P1|Overall Study|Physician Decision|0
7765884|NCT00716144|26995174|P4|Overall Study|Protocol Violation|0
7765885|NCT00716144|26995175|P3|Overall Study|Protocol Violation|1
7765886|NCT00716144|26995176|P2|Overall Study|Protocol Violation|0
7765887|NCT00716144|26995177|P1|Overall Study|Protocol Violation|2
7765888|NCT00716144|26995174|P4|Overall Study|Non-compliance|0
7765889|NCT00716144|26995175|P3|Overall Study|Non-compliance|0
7765890|NCT00716144|26995176|P2|Overall Study|Non-compliance|0
7765891|NCT00716144|26995177|P1|Overall Study|Non-compliance|1
7765892|NCT00716144|26995174|P4|Overall Study|Adverse Event|2
7765893|NCT00716144|26995175|P3|Overall Study|Adverse Event|0
7765894|NCT00716144|26995176|P2|Overall Study|Adverse Event|0
7765895|NCT00716144|26995177|P1|Overall Study|Adverse Event|0
7765896|NCT00716144|26995174|P4|Overall Study|Lost to Follow-up|2
7765897|NCT00716144|26995175|P3|Overall Study|Lost to Follow-up|1
7765898|NCT00716144|26995176|P2|Overall Study|Lost to Follow-up|2
7765899|NCT00716144|26995177|P1|Overall Study|Lost to Follow-up|2
7765900|NCT00716144|26995174|P4|Overall Study|Withdrawal by Subject|6
7765901|NCT00716144|26995175|P3|Overall Study|Withdrawal by Subject|6
7765902|NCT00716144|26995176|P2|Overall Study|Withdrawal by Subject|2
7765903|NCT00716144|26995177|P1|Overall Study|Withdrawal by Subject|4
7765904|NCT00716092|26995202|P3|Overall Study|Other incl. Lack of Efficacy|0
7765905|NCT00716092|26995203|P2|Overall Study|Other incl. Lack of Efficacy|1
7765906|NCT00716092|26995204|P1|Overall Study|Other incl. Lack of Efficacy|2
7765907|NCT00715949|26995257|P1|Overall Study|could not finish first test|4
7765908|NCT00715910|26995265|P6|Booster and ESFU Phase|Other|0
7765909|NCT00715910|26995266|P5|Booster and ESFU Phase|Other|1
7765910|NCT00715910|26995267|P4|Booster and ESFU Phase|Other|5
7765911|NCT00715910|26995268|P3|Booster and ESFU Phase|Other|0
7765912|NCT00715910|26995269|P2|Booster and ESFU Phase|Other|0
7765913|NCT00715910|26995270|P1|Booster and ESFU Phase|Other|0
7765914|NCT00715910|26995265|P6|Booster and ESFU Phase|Lost to Follow-up|13
7765915|NCT00715910|26995266|P5|Booster and ESFU Phase|Lost to Follow-up|1
7765916|NCT00715910|26995267|P4|Booster and ESFU Phase|Lost to Follow-up|6
7765917|NCT00715910|26995268|P3|Booster and ESFU Phase|Lost to Follow-up|0
7765918|NCT00715910|26995269|P2|Booster and ESFU Phase|Lost to Follow-up|0
7765919|NCT00715910|26995270|P1|Booster and ESFU Phase|Lost to Follow-up|0
7765920|NCT00715793|26995389|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
7765921|NCT00715793|26995390|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
7765922|NCT00715793|26995389|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
7765923|NCT00715793|26995390|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
7765924|NCT00715676|26995451|P3|Overall Study|Elevated Blood Glucose|0
7765925|NCT00715676|26995452|P2|Overall Study|Elevated Blood Glucose|1
7765926|NCT00715676|26995453|P1|Overall Study|Elevated Blood Glucose|0
7765927|NCT00715676|26995451|P3|Overall Study|Use of Exclusionary Medication|1
7765928|NCT00715676|26995452|P2|Overall Study|Use of Exclusionary Medication|0
7765930|NCT00715676|26995451|P3|Overall Study|Did Not Meet Entry Criteria|1
7765931|NCT00715676|26995452|P2|Overall Study|Did Not Meet Entry Criteria|0
7765932|NCT00715676|26995453|P1|Overall Study|Did Not Meet Entry Criteria|0
7765933|NCT00715676|26995451|P3|Overall Study|Terminated by Sponsor|0
7765934|NCT00715676|26995452|P2|Overall Study|Terminated by Sponsor|0
7765935|NCT00715676|26995453|P1|Overall Study|Terminated by Sponsor|1
7765936|NCT00715676|26995451|P3|Overall Study|Lost to Follow-up|1
7765937|NCT00715676|26995452|P2|Overall Study|Lost to Follow-up|2
7765938|NCT00715676|26995453|P1|Overall Study|Lost to Follow-up|1
7765939|NCT00715676|26995451|P3|Overall Study|Withdrawal by Subject|8
7765940|NCT00715676|26995452|P2|Overall Study|Withdrawal by Subject|3
7765941|NCT00715676|26995453|P1|Overall Study|Withdrawal by Subject|1
7765942|NCT00715676|26995451|P3|Overall Study|Adverse Event|21
7765943|NCT00715676|26995452|P2|Overall Study|Adverse Event|5
7765944|NCT00715676|26995453|P1|Overall Study|Adverse Event|3
7765945|NCT00715624|26995496|P2|Overall Study|Other|1
7765946|NCT00715624|26995497|P1|Overall Study|Other|0
7765947|NCT00715624|26995496|P2|Overall Study|Incorrect randomization (not treated)|1
7765948|NCT00715624|26995497|P1|Overall Study|Incorrect randomization (not treated)|0
7765949|NCT00715624|26995496|P2|Overall Study|Sponsor decision|4
7765950|NCT00715624|26995497|P1|Overall Study|Sponsor decision|0
7765951|NCT00715624|26995496|P2|Overall Study|Poor compliance|13
7765952|NCT00715624|26995497|P1|Overall Study|Poor compliance|6
7765953|NCT00715624|26995496|P2|Overall Study|Familial and personal reasons|22
7765954|NCT00715624|26995497|P1|Overall Study|Familial and personal reasons|10
7765955|NCT00715624|26995496|P2|Overall Study|Withdrawal by Subject|25
7765956|NCT00715624|26995497|P1|Overall Study|Withdrawal by Subject|11
7765957|NCT00715624|26995496|P2|Overall Study|Protocol Violation|0
7765958|NCT00715624|26995497|P1|Overall Study|Protocol Violation|1
7765959|NCT00715624|26995496|P2|Overall Study|Lost to Follow-up|2
7765960|NCT00715624|26995497|P1|Overall Study|Lost to Follow-up|1
7765961|NCT00715624|26995496|P2|Overall Study|Lack of Efficacy|11
7765962|NCT00715624|26995497|P1|Overall Study|Lack of Efficacy|11
7765963|NCT00715624|26995496|P2|Overall Study|Adverse Event|37
7765964|NCT00715624|26995497|P1|Overall Study|Adverse Event|12
7765965|NCT00715559|26995525|P1|Overall Study|medication not tolerated - nausea|1
7765966|NCT00715520|26995535|P3|Overall Study|Withdrawal by Subject|1
7765967|NCT00715520|26995536|P2|Overall Study|Withdrawal by Subject|0
7765968|NCT00715520|26995537|P1|Overall Study|Withdrawal by Subject|2
7765969|NCT00715520|26995535|P3|Overall Study|Screen failure|1
7765970|NCT00715520|26995536|P2|Overall Study|Screen failure|1
7765971|NCT00715520|26995537|P1|Overall Study|Screen failure|8
7765972|NCT00715429|26995552|P2|Overall Study|Did not complete the study diary|1
7765973|NCT00715429|26995553|P1|Overall Study|Did not complete the study diary|0
7765974|NCT00715403|26995568|P7|Overall Study|Other reason not defined above|0
7765975|NCT00715403|26995569|P6|Overall Study|Other reason not defined above|1
7765976|NCT00715403|26995570|P5|Overall Study|Other reason not defined above|1
7765977|NCT00715403|26995571|P4|Overall Study|Other reason not defined above|0
7765978|NCT00715403|26995572|P3|Overall Study|Other reason not defined above|1
7765979|NCT00715403|26995573|P2|Overall Study|Other reason not defined above|0
7765980|NCT00715403|26995574|P1|Overall Study|Other reason not defined above|0
7765981|NCT00715403|26995568|P7|Overall Study|Protocol Violation|0
7765982|NCT00715403|26995569|P6|Overall Study|Protocol Violation|1
7765983|NCT00715403|26995570|P5|Overall Study|Protocol Violation|0
7765984|NCT00715403|26995571|P4|Overall Study|Protocol Violation|0
7765985|NCT00715403|26995572|P3|Overall Study|Protocol Violation|0
7765986|NCT00715403|26995573|P2|Overall Study|Protocol Violation|0
7765987|NCT00715403|26995574|P1|Overall Study|Protocol Violation|0
7765988|NCT00715403|26995568|P7|Overall Study|Other Adverse Event than DLT|0
7765989|NCT00715403|26995569|P6|Overall Study|Other Adverse Event than DLT|2
7765990|NCT00715403|26995570|P5|Overall Study|Other Adverse Event than DLT|0
7765991|NCT00715403|26995571|P4|Overall Study|Other Adverse Event than DLT|0
7765992|NCT00715403|26995572|P3|Overall Study|Other Adverse Event than DLT|0
7765993|NCT00715403|26995573|P2|Overall Study|Other Adverse Event than DLT|0
7765994|NCT00715403|26995574|P1|Overall Study|Other Adverse Event than DLT|1
7765995|NCT00715403|26995568|P7|Overall Study|Dose limiting Toxicity (DLT)|0
7765996|NCT00715403|26995569|P6|Overall Study|Dose limiting Toxicity (DLT)|1
7765997|NCT00715403|26995570|P5|Overall Study|Dose limiting Toxicity (DLT)|0
7765998|NCT00715403|26995571|P4|Overall Study|Dose limiting Toxicity (DLT)|0
7765999|NCT00715403|26995572|P3|Overall Study|Dose limiting Toxicity (DLT)|0
7766000|NCT00715403|26995573|P2|Overall Study|Dose limiting Toxicity (DLT)|0
7766001|NCT00715403|26995574|P1|Overall Study|Dose limiting Toxicity (DLT)|0
7766002|NCT00715403|26995568|P7|Overall Study|Progressive disease|1
7766003|NCT00715403|26995569|P6|Overall Study|Progressive disease|14
7766004|NCT00715403|26995570|P5|Overall Study|Progressive disease|5
7766005|NCT00715403|26995571|P4|Overall Study|Progressive disease|9
7766006|NCT00715403|26995572|P3|Overall Study|Progressive disease|3
7766007|NCT00715403|26995573|P2|Overall Study|Progressive disease|1
7766008|NCT00715403|26995574|P1|Overall Study|Progressive disease|0
7766009|NCT00715299|26995713|P1|Overall Study|failed the pre-screen exercise test|2
7766010|NCT00715299|26995713|P1|Overall Study|Adverse Event|3
7766011|NCT00715299|26995713|P1|Overall Study|Withdrawal by Subject|1
7766012|NCT00715208|26995719|P2|Overall Study|Lack of Efficacy|2
7766013|NCT00715208|26995720|P1|Overall Study|Lack of Efficacy|0
7766014|NCT00715208|26995719|P2|Overall Study|Adverse Event|6
7766015|NCT00715208|26995720|P1|Overall Study|Adverse Event|0
7766016|NCT00715208|26995719|P2|Overall Study|Withdrawal by Subject|1
7766017|NCT00715208|26995720|P1|Overall Study|Withdrawal by Subject|1
7766018|NCT00715117|26995736|P2|Overall Study|Crohn's flare and rescue with steroids|1
7766019|NCT00715117|26995737|P1|Overall Study|Crohn's flare and rescue with steroids|0
7766020|NCT00715078|26995805|P3|Overall Study|Unable to start due to disease prog.|1
7766021|NCT00715078|26995806|P2|Overall Study|Unable to start due to disease prog.|0
7766022|NCT00715078|26995807|P1|Overall Study|Unable to start due to disease prog.|0
7766023|NCT00715078|26995805|P3|Overall Study|Withdrawal by Subject|1
7766024|NCT00715078|26995806|P2|Overall Study|Withdrawal by Subject|0
7766025|NCT00715078|26995807|P1|Overall Study|Withdrawal by Subject|1
7766026|NCT00715078|26995805|P3|Overall Study|Death|36
7766027|NCT00715078|26995806|P2|Overall Study|Death|36
7766028|NCT00715078|26995807|P1|Overall Study|Death|29
7766029|NCT00715026|26995815|P1|Overall Study|Surgery done on non-study consented hip|1
7766030|NCT00715026|26995815|P1|Overall Study|Protocol Violation|1
7766031|NCT00715026|26995815|P1|Overall Study|Lost to Follow-up|3
7766032|NCT00715026|26995815|P1|Overall Study|Withdrawal by Subject|5
7766033|NCT00714948|26995820|P1|Overall Study|Adverse Event|2
7766034|NCT00714870|26995826|P2|Overall Study|did not attend minimum of 4 sessions|0
7766035|NCT00714870|26995827|P1|Overall Study|did not attend minimum of 4 sessions|4
7766036|NCT00714870|26995826|P2|Overall Study|patient unable to come b/c back pain|0
7766037|NCT00714870|26995827|P1|Overall Study|patient unable to come b/c back pain|1
7766038|NCT00714870|26995826|P2|Overall Study|Lost to Follow-up|5
7766039|NCT00714870|26995827|P1|Overall Study|Lost to Follow-up|22
7766040|NCT00714714|26995851|P1|Overall Study|Adverse Event|1
7766041|NCT00714688|26995860|P3|Overall Study|Other|5
7766042|NCT00714688|26995861|P2|Overall Study|Other|6
7766043|NCT00714688|26995862|P1|Overall Study|Other|1
7766044|NCT00714688|26995860|P3|Overall Study|Sponsor's Decision|0
7766045|NCT00714688|26995861|P2|Overall Study|Sponsor's Decision|2
7766046|NCT00714688|26995862|P1|Overall Study|Sponsor's Decision|0
7766047|NCT00714688|26995860|P3|Overall Study|Ineligible to Continue the Study|1
7766048|NCT00714688|26995861|P2|Overall Study|Ineligible to Continue the Study|1
7766049|NCT00714688|26995862|P1|Overall Study|Ineligible to Continue the Study|0
7766050|NCT00714688|26995860|P3|Overall Study|Subject Non-compliant|5
7766051|NCT00714688|26995861|P2|Overall Study|Subject Non-compliant|5
7766052|NCT00714688|26995862|P1|Overall Study|Subject Non-compliant|3
7766053|NCT00714688|26995860|P3|Overall Study|Adverse Event|19
7766054|NCT00714688|26995861|P2|Overall Study|Adverse Event|15
7766055|NCT00714688|26995862|P1|Overall Study|Adverse Event|2
7766056|NCT00714688|26995860|P3|Overall Study|Lost to Follow-up|0
7766057|NCT00714688|26995861|P2|Overall Study|Lost to Follow-up|2
7766058|NCT00714688|26995862|P1|Overall Study|Lost to Follow-up|5
7766059|NCT00714688|26995860|P3|Overall Study|Withdrawal by Subject|3
7766060|NCT00714688|26995861|P2|Overall Study|Withdrawal by Subject|3
7766061|NCT00714688|26995862|P1|Overall Study|Withdrawal by Subject|4
7766062|NCT00714688|26995860|P3|Overall Study|Lack of Efficacy|4
7766063|NCT00714688|26995861|P2|Overall Study|Lack of Efficacy|1
7766064|NCT00714688|26995862|P1|Overall Study|Lack of Efficacy|14
7766065|NCT00714493|26995904|P1|Overall Study|OTHER|2
7766066|NCT00714493|26995904|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
7766067|NCT00714493|26995904|P1|Overall Study|Protocol Violation|12
7766068|NCT00714493|26995904|P1|Overall Study|Lost to Follow-up|3
7766069|NCT00714493|26995904|P1|Overall Study|Lack of Efficacy|10
7766070|NCT00714493|26995904|P1|Overall Study|Death|3
7766071|NCT00714493|26995904|P1|Overall Study|Adverse Event|11
7766072|NCT00714415|26995916|P2|Overall Study|Death|0
7766073|NCT00714415|26995917|P1|Overall Study|Death|1
7766074|NCT00714415|26995916|P2|Overall Study|Lack of Efficacy|0
7766075|NCT00714415|26995917|P1|Overall Study|Lack of Efficacy|1
7766076|NCT00714285|26995967|P4|Overall Study|Migrated/moved from study area|0
7766077|NCT00714285|26995968|P3|Overall Study|Migrated/moved from study area|0
7766078|NCT00714285|26995969|P2|Overall Study|Migrated/moved from study area|1
7766079|NCT00714285|26995970|P1|Overall Study|Migrated/moved from study area|0
7766080|NCT00714285|26995967|P4|Overall Study|Lost to Follow-up|1
7766081|NCT00714285|26995968|P3|Overall Study|Lost to Follow-up|0
7766082|NCT00714285|26995969|P2|Overall Study|Lost to Follow-up|2
7766083|NCT00714285|26995970|P1|Overall Study|Lost to Follow-up|0
7766084|NCT00714259|26996031|P1|Overall Study|Death|2
7766085|NCT00714168|26996077|P2|Overall Study|Non-study medical condition|2
7766086|NCT00714168|26996078|P1|Overall Study|Non-study medical condition|3
7766087|NCT00714168|26996077|P2|Overall Study|Relocation|3
7766088|NCT00714168|26996078|P1|Overall Study|Relocation|4
7766089|NCT00714168|26996077|P2|Overall Study|Lost to Follow-up|50
7766090|NCT00714168|26996078|P1|Overall Study|Lost to Follow-up|32
7766091|NCT00714168|26996077|P2|Overall Study|Pregnancy|4
7766092|NCT00714168|26996078|P1|Overall Study|Pregnancy|5
7766093|NCT00714051|26996094|P2|Overall Study|Death|1
7766094|NCT00714051|26996095|P1|Overall Study|Death|0
7766095|NCT00714051|26996094|P2|Overall Study|Withdrawal by Subject|0
7766096|NCT00714051|26996095|P1|Overall Study|Withdrawal by Subject|1
7766097|NCT00713830|26996103|P2|Overall Study|Sponsor Decision|10
7766098|NCT00713830|26996104|P1|Overall Study|Sponsor Decision|4
7766099|NCT00713830|26996103|P2|Overall Study|Familial and Personal Reasons|34
7766100|NCT00713830|26996104|P1|Overall Study|Familial and Personal Reasons|9
7766101|NCT00713830|26996103|P2|Overall Study|Poor Compliance to Protocol|14
7766102|NCT00713830|26996104|P1|Overall Study|Poor Compliance to Protocol|7
7766103|NCT00713830|26996103|P2|Overall Study|Withdrawal by Subject|23
7766104|NCT00713830|26996104|P1|Overall Study|Withdrawal by Subject|13
7766105|NCT00713830|26996103|P2|Overall Study|Lost to Follow-up|9
7766106|NCT00713830|26996104|P1|Overall Study|Lost to Follow-up|2
7766107|NCT00713830|26996103|P2|Overall Study|Lack of Efficacy|16
7766108|NCT00713830|26996104|P1|Overall Study|Lack of Efficacy|24
7766109|NCT00713830|26996103|P2|Overall Study|Adverse Event|71
7766110|NCT00713830|26996104|P1|Overall Study|Adverse Event|23
7766111|NCT00713700|26996161|P1|Overall Study|Withdrawal by Subject|1
7766112|NCT00713700|26996161|P1|Overall Study|Lost to Follow-up|3
7766113|NCT00713648|26996187|P1|Overall Study|Development of antibodies|3
7766114|NCT00713648|26996187|P1|Overall Study|According to Protocol|2
7766115|NCT00713648|26996187|P1|Overall Study|Unclassified|2
7766116|NCT00713648|26996187|P1|Overall Study|Adverse Event|1
7766117|NCT00713609|26996200|P6|Overall Study|Protocol Violation|0
7766118|NCT00713609|26996201|P5|Overall Study|Protocol Violation|2
7766119|NCT00713609|26996202|P4|Overall Study|Protocol Violation|1
7766120|NCT00713609|26996203|P3|Overall Study|Protocol Violation|1
7766121|NCT00713609|26996204|P2|Overall Study|Protocol Violation|3
7766122|NCT00713609|26996205|P1|Overall Study|Protocol Violation|6
7766123|NCT00713609|26996200|P6|Overall Study|Withdrawal by Subject|7
7766124|NCT00713609|26996201|P5|Overall Study|Withdrawal by Subject|5
7766125|NCT00713609|26996202|P4|Overall Study|Withdrawal by Subject|1
7766126|NCT00713609|26996203|P3|Overall Study|Withdrawal by Subject|5
7766127|NCT00713609|26996204|P2|Overall Study|Withdrawal by Subject|1
7766128|NCT00713609|26996205|P1|Overall Study|Withdrawal by Subject|6
7766129|NCT00713609|26996200|P6|Overall Study|Non-Compliance with Study Treatment|0
7766130|NCT00713609|26996201|P5|Overall Study|Non-Compliance with Study Treatment|1
7766131|NCT00713609|26996202|P4|Overall Study|Non-Compliance with Study Treatment|0
7766132|NCT00713609|26996203|P3|Overall Study|Non-Compliance with Study Treatment|2
7766133|NCT00713609|26996204|P2|Overall Study|Non-Compliance with Study Treatment|1
7766134|NCT00713609|26996205|P1|Overall Study|Non-Compliance with Study Treatment|1
7766135|NCT00713609|26996200|P6|Overall Study|Lack of Efficacy|0
7766136|NCT00713609|26996201|P5|Overall Study|Lack of Efficacy|1
7766137|NCT00713609|26996202|P4|Overall Study|Lack of Efficacy|0
7766138|NCT00713609|26996203|P3|Overall Study|Lack of Efficacy|0
7766139|NCT00713609|26996204|P2|Overall Study|Lack of Efficacy|3
7766140|NCT00713609|26996205|P1|Overall Study|Lack of Efficacy|1
7766141|NCT00713609|26996200|P6|Overall Study|Lost to Follow-up|0
7766142|NCT00713609|26996201|P5|Overall Study|Lost to Follow-up|7
7766143|NCT00713609|26996202|P4|Overall Study|Lost to Follow-up|5
7766144|NCT00713609|26996203|P3|Overall Study|Lost to Follow-up|5
7766145|NCT00713609|26996204|P2|Overall Study|Lost to Follow-up|7
7766146|NCT00713609|26996205|P1|Overall Study|Lost to Follow-up|5
7766147|NCT00713609|26996200|P6|Overall Study|Adverse Event|1
7766148|NCT00713609|26996201|P5|Overall Study|Adverse Event|3
7766149|NCT00713609|26996202|P4|Overall Study|Adverse Event|2
7766150|NCT00713609|26996203|P3|Overall Study|Adverse Event|2
7766151|NCT00713609|26996204|P2|Overall Study|Adverse Event|0
7766152|NCT00713609|26996205|P1|Overall Study|Adverse Event|2
7766153|NCT00713596|26996240|P3|Overall Study|Study was terminated|2
7766154|NCT00713596|26996241|P2|Overall Study|Study was terminated|3
7766155|NCT00713596|26996242|P1|Overall Study|Study was terminated|2
7766156|NCT00713544|26996268|P6|Overall Study|Hepatotoxicity - not an AE|0
7766157|NCT00713544|26996269|P5|Overall Study|Hepatotoxicity - not an AE|1
7766158|NCT00713544|26996270|P4|Overall Study|Hepatotoxicity - not an AE|0
7766159|NCT00713544|26996271|P3|Overall Study|Hepatotoxicity - not an AE|0
7766160|NCT00713544|26996272|P2|Overall Study|Hepatotoxicity - not an AE|0
7766161|NCT00713544|26996273|P1|Overall Study|Hepatotoxicity - not an AE|0
7766162|NCT00713544|26996268|P6|Overall Study|Incorrect enrollment|0
7766163|NCT00713544|26996269|P5|Overall Study|Incorrect enrollment|0
7766164|NCT00713544|26996270|P4|Overall Study|Incorrect enrollment|0
7766165|NCT00713544|26996271|P3|Overall Study|Incorrect enrollment|0
7766166|NCT00713544|26996272|P2|Overall Study|Incorrect enrollment|1
7766167|NCT00713544|26996273|P1|Overall Study|Incorrect enrollment|0
7766168|NCT00713544|26996268|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
7766169|NCT00713544|26996269|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
7766170|NCT00713544|26996270|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
7766171|NCT00713544|26996271|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
7766172|NCT00713544|26996272|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
7766173|NCT00713544|26996273|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
7766174|NCT00713544|26996268|P6|Overall Study|Lost to Follow-up|0
7766175|NCT00713544|26996269|P5|Overall Study|Lost to Follow-up|0
7766176|NCT00713544|26996270|P4|Overall Study|Lost to Follow-up|0
7766177|NCT00713544|26996271|P3|Overall Study|Lost to Follow-up|1
7766178|NCT00713544|26996272|P2|Overall Study|Lost to Follow-up|0
7766179|NCT00713544|26996273|P1|Overall Study|Lost to Follow-up|0
7766180|NCT00713544|26996268|P6|Overall Study|Lack of Efficacy|0
7766181|NCT00713544|26996269|P5|Overall Study|Lack of Efficacy|1
7766182|NCT00713544|26996270|P4|Overall Study|Lack of Efficacy|1
7766183|NCT00713544|26996271|P3|Overall Study|Lack of Efficacy|0
7766184|NCT00713544|26996272|P2|Overall Study|Lack of Efficacy|1
7766185|NCT00713544|26996273|P1|Overall Study|Lack of Efficacy|0
7766186|NCT00713544|26996268|P6|Overall Study|Physician Decision|2
7766187|NCT00713544|26996269|P5|Overall Study|Physician Decision|0
7766188|NCT00713544|26996270|P4|Overall Study|Physician Decision|0
7766189|NCT00713544|26996271|P3|Overall Study|Physician Decision|0
7766190|NCT00713544|26996272|P2|Overall Study|Physician Decision|0
7766191|NCT00713544|26996273|P1|Overall Study|Physician Decision|0
7766192|NCT00713544|26996268|P6|Overall Study|Protocol Violation|1
7766193|NCT00713544|26996269|P5|Overall Study|Protocol Violation|0
7766194|NCT00713544|26996270|P4|Overall Study|Protocol Violation|0
7766195|NCT00713544|26996271|P3|Overall Study|Protocol Violation|0
7766196|NCT00713544|26996272|P2|Overall Study|Protocol Violation|0
7766197|NCT00713544|26996273|P1|Overall Study|Protocol Violation|0
7766198|NCT00713544|26996268|P6|Overall Study|Withdrawal by Subject|1
7766199|NCT00713544|26996269|P5|Overall Study|Withdrawal by Subject|3
7766200|NCT00713544|26996270|P4|Overall Study|Withdrawal by Subject|2
7766201|NCT00713544|26996271|P3|Overall Study|Withdrawal by Subject|3
7766202|NCT00713544|26996272|P2|Overall Study|Withdrawal by Subject|0
7766203|NCT00713544|26996273|P1|Overall Study|Withdrawal by Subject|2
7766204|NCT00713544|26996268|P6|Overall Study|Adverse Event|5
7766205|NCT00713544|26996269|P5|Overall Study|Adverse Event|3
7766206|NCT00713544|26996270|P4|Overall Study|Adverse Event|7
7766207|NCT00713544|26996271|P3|Overall Study|Adverse Event|7
7766208|NCT00713544|26996272|P2|Overall Study|Adverse Event|3
7766209|NCT00713544|26996273|P1|Overall Study|Adverse Event|5
7766210|NCT00713349|26996334|P1|Overall Study|Protocol Violation|1
7766211|NCT00713323|26996340|P1|Overall Study|Treatment that may interact with Sativex|1
7766212|NCT00713323|26996340|P1|Overall Study|Subject travelling to Dominica Republic|1
7766213|NCT00713323|26996340|P1|Overall Study|Subject travelling to USA|1
7766214|NCT00713323|26996340|P1|Overall Study|Pain resolved|1
7766215|NCT00713323|26996340|P1|Overall Study|Non-compliance|1
7766216|NCT00713323|26996340|P1|Overall Study|Pain free|1
7766217|NCT00713323|26996340|P1|Overall Study|Surgery cured allodynic pain|1
7766218|NCT00713323|26996340|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
7766219|NCT00713323|26996340|P1|Overall Study|Low creatine clearance at screening|1
7766220|NCT00713323|26996340|P1|Overall Study|Lack of Efficacy|36
7766221|NCT00713323|26996340|P1|Overall Study|Lost to Follow-up|11
7766222|NCT00713323|26996340|P1|Overall Study|Withdrawal by Subject|15
7766223|NCT00713323|26996340|P1|Overall Study|Adverse Event|75
7766224|NCT00713310|26996353|P2|Overall Study|Withdrawal by Subject|2
7766225|NCT00713310|26996354|P1|Overall Study|Withdrawal by Subject|0
7766226|NCT00713310|26996353|P2|Overall Study|Lack of Efficacy|2
7766227|NCT00713310|26996354|P1|Overall Study|Lack of Efficacy|0
7766228|NCT00713310|26996353|P2|Overall Study|Adverse Event|2
7766229|NCT00713310|26996354|P1|Overall Study|Adverse Event|5
7766230|NCT00713258|26996368|P2|Overall Study|Other|1
7766231|NCT00713258|26996369|P1|Overall Study|Other|1
7766232|NCT00713258|26996368|P2|Overall Study|Non-Compliance|1
7766233|NCT00713258|26996369|P1|Overall Study|Non-Compliance|2
7766234|NCT00713258|26996368|P2|Overall Study|Adverse Event|4
7766235|NCT00713258|26996369|P1|Overall Study|Adverse Event|2
7766236|NCT00713219|26996377|P1|Overall Study|Protocol Violation|1
7766237|NCT00713219|26996377|P1|Overall Study|Death|1
7766242|NCT00712985|26996390|P1|Overall Study|Lack of Efficacy|3
7766243|NCT00712985|26996390|P1|Overall Study|1 patient moved out of state|1
7766244|NCT00712985|26996390|P1|Overall Study|1 withdrew prior to start of drug|1
7766245|NCT00712959|26996396|P2|Overall Study|Withdrawal by Subject|0
7766246|NCT00712959|26996397|P1|Overall Study|Withdrawal by Subject|3
7766247|NCT00712959|26996396|P2|Overall Study|Lost to Follow-up|2
7766248|NCT00712959|26996397|P1|Overall Study|Lost to Follow-up|13
7766249|NCT00712959|26996396|P2|Overall Study|Protocol Violation|1
7766250|NCT00712959|26996397|P1|Overall Study|Protocol Violation|3
7766251|NCT00712933|26996415|P1|Overall Study|Withdrawal by Subject|151
7766252|NCT00712933|26996415|P1|Overall Study|Protocol Violation|4
7766253|NCT00712933|26996415|P1|Overall Study|Physician Decision|36
7766254|NCT00712933|26996415|P1|Overall Study|Participant received medication|1
7766255|NCT00712933|26996415|P1|Overall Study|Not committed to contraception|1
7766256|NCT00712933|26996415|P1|Overall Study|Other Physician decision|1
7766257|NCT00712933|26996415|P1|Overall Study|Death of patient|1
7766258|NCT00712933|26996415|P1|Overall Study|Participant travelled overseas|2
7766259|NCT00712933|26996415|P1|Overall Study|Participant hospitalized|1
7766260|NCT00712933|26996415|P1|Overall Study|Involved in Clinical research|3
7766261|NCT00712933|26996415|P1|Overall Study|Hip replacement surgery|1
7766262|NCT00712933|26996415|P1|Overall Study|Withdrew consent|4
7766263|NCT00712933|26996415|P1|Overall Study|Sponsor decision|14
7766264|NCT00712933|26996415|P1|Overall Study|Other Pregnancy|37
7766265|NCT00712933|26996415|P1|Overall Study|Non-compliance with study drug|13
7766266|NCT00712933|26996415|P1|Overall Study|Lost to Follow-up|22
7766267|NCT00712933|26996415|P1|Overall Study|Lack of Efficacy|6
7766268|NCT00712933|26996415|P1|Overall Study|Adverse Event|69
7766269|NCT00712920|26996445|P3|Overall Study|Non-compliance|0
7766270|NCT00712920|26996446|P2|Overall Study|Non-compliance|0
7766271|NCT00712920|26996447|P1|Overall Study|Non-compliance|3
7766272|NCT00712920|26996445|P3|Overall Study|Other|3
7766273|NCT00712920|26996446|P2|Overall Study|Other|7
7766274|NCT00712920|26996447|P1|Overall Study|Other|5
7766275|NCT00712920|26996445|P3|Overall Study|Lack of Efficacy|1
7766276|NCT00712920|26996446|P2|Overall Study|Lack of Efficacy|0
7766277|NCT00712920|26996447|P1|Overall Study|Lack of Efficacy|1
7766278|NCT00712920|26996445|P3|Overall Study|Lost to Follow-up|0
7766279|NCT00712920|26996446|P2|Overall Study|Lost to Follow-up|4
7766280|NCT00712920|26996447|P1|Overall Study|Lost to Follow-up|1
7766281|NCT00712920|26996445|P3|Overall Study|Withdrawal by Subject|1
7766282|NCT00712920|26996446|P2|Overall Study|Withdrawal by Subject|2
7766283|NCT00712920|26996447|P1|Overall Study|Withdrawal by Subject|4
7766284|NCT00712920|26996445|P3|Overall Study|Adverse Event|7
7766285|NCT00712920|26996446|P2|Overall Study|Adverse Event|4
7766286|NCT00712920|26996447|P1|Overall Study|Adverse Event|3
7766287|NCT00712725|26996475|P8|Overall Study|Protocol Specified Criteria|1
7766288|NCT00712725|26996476|P7|Overall Study|Protocol Specified Criteria|2
7766289|NCT00712725|26996477|P6|Overall Study|Protocol Specified Criteria|0
7766290|NCT00712725|26996478|P5|Overall Study|Protocol Specified Criteria|1
7766291|NCT00712725|26996479|P4|Overall Study|Protocol Specified Criteria|2
7766292|NCT00712725|26996480|P3|Overall Study|Protocol Specified Criteria|1
7766293|NCT00712725|26996481|P2|Overall Study|Protocol Specified Criteria|0
7766294|NCT00712725|26996482|P1|Overall Study|Protocol Specified Criteria|3
7766295|NCT00712725|26996475|P8|Overall Study|Lack of Qualifying Event|6
7766296|NCT00712725|26996476|P7|Overall Study|Lack of Qualifying Event|11
7766297|NCT00712725|26996477|P6|Overall Study|Lack of Qualifying Event|13
7766298|NCT00712725|26996478|P5|Overall Study|Lack of Qualifying Event|11
7766299|NCT00712725|26996479|P4|Overall Study|Lack of Qualifying Event|8
7766300|NCT00712725|26996480|P3|Overall Study|Lack of Qualifying Event|6
7766301|NCT00712725|26996481|P2|Overall Study|Lack of Qualifying Event|2
7766302|NCT00712725|26996482|P1|Overall Study|Lack of Qualifying Event|16
7766303|NCT00712725|26996475|P8|Overall Study|Withdrawal by Subject|2
7766304|NCT00712725|26996476|P7|Overall Study|Withdrawal by Subject|1
7766305|NCT00712725|26996477|P6|Overall Study|Withdrawal by Subject|1
7766306|NCT00712725|26996478|P5|Overall Study|Withdrawal by Subject|1
7766307|NCT00712725|26996479|P4|Overall Study|Withdrawal by Subject|2
7766308|NCT00712725|26996480|P3|Overall Study|Withdrawal by Subject|1
7766309|NCT00712725|26996481|P2|Overall Study|Withdrawal by Subject|1
7766310|NCT00712725|26996482|P1|Overall Study|Withdrawal by Subject|2
7766311|NCT00712725|26996475|P8|Overall Study|Protocol Violation|1
7766312|NCT00712725|26996476|P7|Overall Study|Protocol Violation|1
7766313|NCT00712725|26996477|P6|Overall Study|Protocol Violation|0
7766314|NCT00712725|26996478|P5|Overall Study|Protocol Violation|2
7766315|NCT00712725|26996479|P4|Overall Study|Protocol Violation|3
7766316|NCT00712725|26996480|P3|Overall Study|Protocol Violation|1
7766317|NCT00712725|26996481|P2|Overall Study|Protocol Violation|0
7766318|NCT00712725|26996482|P1|Overall Study|Protocol Violation|2
7766319|NCT00712725|26996475|P8|Overall Study|Pregnancy|0
7766320|NCT00712725|26996476|P7|Overall Study|Pregnancy|2
7766321|NCT00712725|26996477|P6|Overall Study|Pregnancy|0
7766322|NCT00712725|26996478|P5|Overall Study|Pregnancy|1
7766323|NCT00712725|26996479|P4|Overall Study|Pregnancy|0
7766324|NCT00712725|26996480|P3|Overall Study|Pregnancy|0
7766325|NCT00712725|26996481|P2|Overall Study|Pregnancy|1
7766326|NCT00712725|26996482|P1|Overall Study|Pregnancy|0
7766327|NCT00712725|26996475|P8|Overall Study|Physician Decision|0
7766328|NCT00712725|26996476|P7|Overall Study|Physician Decision|2
7766329|NCT00712725|26996477|P6|Overall Study|Physician Decision|0
7766330|NCT00712725|26996478|P5|Overall Study|Physician Decision|1
7766331|NCT00712725|26996479|P4|Overall Study|Physician Decision|0
7766332|NCT00712725|26996480|P3|Overall Study|Physician Decision|0
7766333|NCT00712725|26996481|P2|Overall Study|Physician Decision|0
7766334|NCT00712725|26996482|P1|Overall Study|Physician Decision|2
7766335|NCT00712725|26996475|P8|Overall Study|Lost to Follow-up|1
7766336|NCT00712725|26996476|P7|Overall Study|Lost to Follow-up|3
7766337|NCT00712725|26996477|P6|Overall Study|Lost to Follow-up|2
7766338|NCT00712725|26996478|P5|Overall Study|Lost to Follow-up|2
7766339|NCT00712725|26996479|P4|Overall Study|Lost to Follow-up|1
7766340|NCT00712725|26996480|P3|Overall Study|Lost to Follow-up|1
7766341|NCT00712725|26996481|P2|Overall Study|Lost to Follow-up|2
7766342|NCT00712725|26996482|P1|Overall Study|Lost to Follow-up|3
7766343|NCT00712725|26996475|P8|Overall Study|Adverse Event|0
7766344|NCT00712725|26996476|P7|Overall Study|Adverse Event|0
7766345|NCT00712725|26996477|P6|Overall Study|Adverse Event|0
7766346|NCT00712725|26996478|P5|Overall Study|Adverse Event|0
7766347|NCT00712725|26996479|P4|Overall Study|Adverse Event|1
7766348|NCT00712725|26996480|P3|Overall Study|Adverse Event|0
7766349|NCT00712725|26996481|P2|Overall Study|Adverse Event|0
7766350|NCT00712725|26996482|P1|Overall Study|Adverse Event|1
7766351|NCT00712712|26996540|P1|Overall Study|Withdrawal by Subject|1
7766352|NCT00712712|26996540|P1|Overall Study|Death|8
7766353|NCT00712712|26996540|P1|Overall Study|Radiofrequency not done|3
7766354|NCT00712712|26996540|P1|Overall Study|Protocol Violation|11
7766355|NCT00712673|26996569|P4|Overall Study|Protocol Violation|0
7766356|NCT00712673|26996570|P3|Overall Study|Protocol Violation|2
7766357|NCT00712673|26996571|P2|Overall Study|Protocol Violation|0
7766358|NCT00712673|26996572|P1|Overall Study|Protocol Violation|0
7766359|NCT00712673|26996569|P4|Overall Study|Investigator's Decision|0
7766360|NCT00712673|26996570|P3|Overall Study|Investigator's Decision|0
7766361|NCT00712673|26996571|P2|Overall Study|Investigator's Decision|0
7766362|NCT00712673|26996572|P1|Overall Study|Investigator's Decision|1
7766363|NCT00712673|26996569|P4|Overall Study|Familial and Personal Reasons|2
7766364|NCT00712673|26996570|P3|Overall Study|Familial and Personal Reasons|5
7766365|NCT00712673|26996571|P2|Overall Study|Familial and Personal Reasons|0
7766366|NCT00712673|26996572|P1|Overall Study|Familial and Personal Reasons|5
7766367|NCT00712673|26996569|P4|Overall Study|Withdrawal by Subject|20
7766368|NCT00712673|26996570|P3|Overall Study|Withdrawal by Subject|15
7766369|NCT00712673|26996571|P2|Overall Study|Withdrawal by Subject|7
7766370|NCT00712673|26996572|P1|Overall Study|Withdrawal by Subject|6
7766371|NCT00712673|26996569|P4|Overall Study|Lost to Follow-up|0
7766372|NCT00712673|26996570|P3|Overall Study|Lost to Follow-up|2
7766373|NCT00712673|26996571|P2|Overall Study|Lost to Follow-up|0
7766374|NCT00712673|26996572|P1|Overall Study|Lost to Follow-up|1
7766375|NCT00712673|26996569|P4|Overall Study|Poor Compliance to Protocol|16
7766376|NCT00712673|26996570|P3|Overall Study|Poor Compliance to Protocol|4
7766377|NCT00712673|26996571|P2|Overall Study|Poor Compliance to Protocol|3
7766378|NCT00712673|26996572|P1|Overall Study|Poor Compliance to Protocol|3
7766379|NCT00712673|26996569|P4|Overall Study|Lack of Efficacy|6
7766380|NCT00712673|26996570|P3|Overall Study|Lack of Efficacy|8
7766381|NCT00712673|26996571|P2|Overall Study|Lack of Efficacy|8
7766382|NCT00712673|26996572|P1|Overall Study|Lack of Efficacy|2
7766383|NCT00712673|26996569|P4|Overall Study|Adverse Event|26
7766384|NCT00712673|26996570|P3|Overall Study|Adverse Event|21
7766385|NCT00712673|26996571|P2|Overall Study|Adverse Event|3
7766386|NCT00712673|26996572|P1|Overall Study|Adverse Event|3
7766387|NCT00712543|26996636|P2|Day 8-14|Lost to Follow-up|2
7766388|NCT00712543|26996637|P1|Day 8-14|Lost to Follow-up|0
7766389|NCT00712348|26996671|P1|Overall Study|Withdrawal by Subject|1
7766390|NCT00712335|26996683|P5|Overall Study|Other Reason|0
7766391|NCT00712335|26996684|P4|Overall Study|Other Reason|0
7766392|NCT00712335|26996685|P3|Overall Study|Other Reason|1
7766393|NCT00712335|26996686|P2|Overall Study|Other Reason|3
7766394|NCT00712335|26996687|P1|Overall Study|Other Reason|0
7766395|NCT00712335|26996683|P5|Overall Study|Lack of Efficacy|0
7766396|NCT00712335|26996684|P4|Overall Study|Lack of Efficacy|1
7766397|NCT00712335|26996685|P3|Overall Study|Lack of Efficacy|1
7766398|NCT00712335|26996686|P2|Overall Study|Lack of Efficacy|0
7766399|NCT00712335|26996687|P1|Overall Study|Lack of Efficacy|0
7766400|NCT00712335|26996683|P5|Overall Study|Protocol Violation|0
7766401|NCT00712335|26996684|P4|Overall Study|Protocol Violation|0
7766402|NCT00712335|26996685|P3|Overall Study|Protocol Violation|1
7766403|NCT00712335|26996686|P2|Overall Study|Protocol Violation|2
7766404|NCT00712335|26996687|P1|Overall Study|Protocol Violation|1
7766405|NCT00712335|26996683|P5|Overall Study|Lost to Follow-up|0
7766406|NCT00712335|26996684|P4|Overall Study|Lost to Follow-up|1
7766407|NCT00712335|26996685|P3|Overall Study|Lost to Follow-up|0
7766408|NCT00712335|26996686|P2|Overall Study|Lost to Follow-up|5
7766409|NCT00712335|26996687|P1|Overall Study|Lost to Follow-up|2
7766410|NCT00712335|26996683|P5|Overall Study|Withdrawal by Subject|0
7766411|NCT00712335|26996684|P4|Overall Study|Withdrawal by Subject|3
7766412|NCT00712335|26996685|P3|Overall Study|Withdrawal by Subject|2
7766413|NCT00712335|26996686|P2|Overall Study|Withdrawal by Subject|7
7766414|NCT00712335|26996687|P1|Overall Study|Withdrawal by Subject|0
7766415|NCT00712270|26996817|P1|Overall Study|Screen Failure|3
7766416|NCT00712270|26996817|P1|Overall Study|Withdrawal by Subject|11
7766417|NCT00712166|26996881|P2|Overall Study|Noncompliance|1
7766418|NCT00712166|26996882|P1|Overall Study|Noncompliance|0
7766419|NCT00712010|26996925|P1|Washout (7 Days)|Withdrawal by Subject|1
7766420|NCT00711971|26996964|P3|Overall Study|Lost to Follow-up|1
7766421|NCT00711971|26996965|P2|Overall Study|Lost to Follow-up|4
7766422|NCT00711971|26996966|P1|Overall Study|Lost to Follow-up|3
7766423|NCT00711958|26997000|P2|Overall Study|Progression of disease|0
7766424|NCT00711958|26997001|P1|Overall Study|Progression of disease|1
7766425|NCT00711958|26997000|P2|Overall Study|Death|5
7766426|NCT00711958|26997001|P1|Overall Study|Death|10
7766427|NCT00711958|26997000|P2|Overall Study|Lost to Follow-up|2
7766428|NCT00711958|26997001|P1|Overall Study|Lost to Follow-up|2
7766429|NCT00711958|26997000|P2|Overall Study|Protocol Violation|0
7766430|NCT00711958|26997001|P1|Overall Study|Protocol Violation|1
7766431|NCT00711958|26997000|P2|Overall Study|Adverse Event|7
7766432|NCT00711958|26997001|P1|Overall Study|Adverse Event|9
7766433|NCT00711958|26997000|P2|Overall Study|Clinical deterioration|0
7766434|NCT00711958|26997001|P1|Overall Study|Clinical deterioration|1
7766435|NCT00711958|26997000|P2|Overall Study|Lack of Efficacy|1
7766436|NCT00711958|26997001|P1|Overall Study|Lack of Efficacy|3
7766437|NCT00711958|26997000|P2|Overall Study|Withdrawal by Subject|8
7766438|NCT00711958|26997001|P1|Overall Study|Withdrawal by Subject|6
7766439|NCT00711880|26997009|P2|Overall Study|Lack of Efficacy|5
7766440|NCT00711880|26997010|P1|Overall Study|Lack of Efficacy|1
7766441|NCT00711880|26997009|P2|Overall Study|Patient non-compliance|0
7766442|NCT00711880|26997010|P1|Overall Study|Patient non-compliance|1
7766443|NCT00711880|26997009|P2|Overall Study|Adverse Event|2
7766444|NCT00711880|26997010|P1|Overall Study|Adverse Event|11
7766445|NCT00711802|26997072|P8|Overall Study|Reason not reported|0
7766446|NCT00711802|26997073|P7|Overall Study|Reason not reported|1
7766447|NCT00711802|26997074|P6|Overall Study|Reason not reported|0
7766448|NCT00711802|26997075|P5|Overall Study|Reason not reported|1
7766449|NCT00711802|26997076|P4|Overall Study|Reason not reported|0
7766450|NCT00711802|26997077|P3|Overall Study|Reason not reported|1
7766451|NCT00711802|26997078|P2|Overall Study|Reason not reported|1
7766452|NCT00711802|26997079|P1|Overall Study|Reason not reported|0
7766453|NCT00711802|26997072|P8|Overall Study|Lost to Follow-up|2
7766454|NCT00711802|26997073|P7|Overall Study|Lost to Follow-up|4
7766455|NCT00711802|26997074|P6|Overall Study|Lost to Follow-up|6
7766456|NCT00711802|26997075|P5|Overall Study|Lost to Follow-up|10
7766457|NCT00711802|26997076|P4|Overall Study|Lost to Follow-up|1
7766458|NCT00711802|26997077|P3|Overall Study|Lost to Follow-up|3
7766459|NCT00711802|26997078|P2|Overall Study|Lost to Follow-up|0
7766460|NCT00711802|26997079|P1|Overall Study|Lost to Follow-up|0
7766461|NCT00711802|26997072|P8|Overall Study|Withdrawal by Subject|0
7766462|NCT00711802|26997073|P7|Overall Study|Withdrawal by Subject|0
7766463|NCT00711802|26997074|P6|Overall Study|Withdrawal by Subject|0
7766464|NCT00711802|26997075|P5|Overall Study|Withdrawal by Subject|0
7766465|NCT00711802|26997076|P4|Overall Study|Withdrawal by Subject|1
7766466|NCT00711802|26997077|P3|Overall Study|Withdrawal by Subject|0
7766467|NCT00711802|26997078|P2|Overall Study|Withdrawal by Subject|1
7766468|NCT00711802|26997079|P1|Overall Study|Withdrawal by Subject|0
7766469|NCT00711802|26997072|P8|Overall Study|Physician Decision|0
7766470|NCT00711802|26997073|P7|Overall Study|Physician Decision|0
7766471|NCT00711802|26997074|P6|Overall Study|Physician Decision|0
7766472|NCT00711802|26997075|P5|Overall Study|Physician Decision|0
7766473|NCT00711802|26997076|P4|Overall Study|Physician Decision|0
7766474|NCT00711802|26997077|P3|Overall Study|Physician Decision|0
7766475|NCT00711802|26997078|P2|Overall Study|Physician Decision|2
7766476|NCT00711802|26997079|P1|Overall Study|Physician Decision|0
7766477|NCT00711802|26997072|P8|Overall Study|Protocol Violation|0
7766478|NCT00711802|26997073|P7|Overall Study|Protocol Violation|0
7766479|NCT00711802|26997074|P6|Overall Study|Protocol Violation|0
7766480|NCT00711802|26997075|P5|Overall Study|Protocol Violation|0
7766481|NCT00711802|26997076|P4|Overall Study|Protocol Violation|1
7766482|NCT00711802|26997077|P3|Overall Study|Protocol Violation|0
7766483|NCT00711802|26997078|P2|Overall Study|Protocol Violation|0
7766484|NCT00711802|26997079|P1|Overall Study|Protocol Violation|0
7766485|NCT00711802|26997072|P8|Overall Study|Microbiological failure|0
7766486|NCT00711802|26997073|P7|Overall Study|Microbiological failure|0
7766487|NCT00711802|26997074|P6|Overall Study|Microbiological failure|1
7766488|NCT00711802|26997075|P5|Overall Study|Microbiological failure|0
7766489|NCT00711802|26997076|P4|Overall Study|Microbiological failure|0
7766490|NCT00711802|26997077|P3|Overall Study|Microbiological failure|0
7766491|NCT00711802|26997078|P2|Overall Study|Microbiological failure|1
7766492|NCT00711802|26997079|P1|Overall Study|Microbiological failure|0
7766493|NCT00711802|26997072|P8|Overall Study|Adverse Event|0
7766494|NCT00711802|26997073|P7|Overall Study|Adverse Event|0
7766495|NCT00711802|26997074|P6|Overall Study|Adverse Event|1
7766496|NCT00711802|26997075|P5|Overall Study|Adverse Event|1
7766497|NCT00711802|26997076|P4|Overall Study|Adverse Event|0
7766498|NCT00711802|26997077|P3|Overall Study|Adverse Event|0
7766499|NCT00711802|26997078|P2|Overall Study|Adverse Event|0
7766500|NCT00711802|26997079|P1|Overall Study|Adverse Event|0
7766501|NCT00711802|26997072|P8|Overall Study|Not treated (no further detail)|0
7766502|NCT00711802|26997073|P7|Overall Study|Not treated (no further detail)|0
7766503|NCT00711802|26997074|P6|Overall Study|Not treated (no further detail)|0
7766504|NCT00711802|26997075|P5|Overall Study|Not treated (no further detail)|2
7766505|NCT00711802|26997076|P4|Overall Study|Not treated (no further detail)|0
7766506|NCT00711802|26997077|P3|Overall Study|Not treated (no further detail)|2
7766507|NCT00711802|26997078|P2|Overall Study|Not treated (no further detail)|1
7766508|NCT00711802|26997079|P1|Overall Study|Not treated (no further detail)|2
7766509|NCT00711646|26997122|P2|Overall Study|patient non-compliance|0
7766510|NCT00711646|26997123|P1|Overall Study|patient non-compliance|1
7766511|NCT00711646|26997122|P2|Overall Study|administrative decision|1
7766512|NCT00711646|26997123|P1|Overall Study|administrative decision|0
7766513|NCT00711646|26997122|P2|Overall Study|Lost to Follow-up|0
7766514|NCT00711646|26997123|P1|Overall Study|Lost to Follow-up|1
7766515|NCT00711646|26997122|P2|Overall Study|Protocol Violation|1
7766516|NCT00711646|26997123|P1|Overall Study|Protocol Violation|0
7766517|NCT00711646|26997122|P2|Overall Study|Withdrawal by Subject|0
7766518|NCT00711646|26997123|P1|Overall Study|Withdrawal by Subject|4
7766519|NCT00711646|26997122|P2|Overall Study|Adverse Event|1
7766520|NCT00711646|26997123|P1|Overall Study|Adverse Event|6
7766521|NCT00711594|26997145|P4|Overall Study|Withdrawal by Subject|2
7766522|NCT00711594|26997146|P3|Overall Study|Withdrawal by Subject|0
7766523|NCT00711594|26997147|P2|Overall Study|Withdrawal by Subject|1
7766524|NCT00711594|26997148|P1|Overall Study|Withdrawal by Subject|0
7766525|NCT00711594|26997145|P4|Overall Study|Other Adverse Event|16
7766526|NCT00711594|26997146|P3|Overall Study|Other Adverse Event|0
7766527|NCT00711594|26997147|P2|Overall Study|Other Adverse Event|0
7766528|NCT00711594|26997148|P1|Overall Study|Other Adverse Event|1
7766529|NCT00711594|26997145|P4|Overall Study|Progressive disease|44
7766530|NCT00711594|26997146|P3|Overall Study|Progressive disease|6
7766531|NCT00711594|26997147|P2|Overall Study|Progressive disease|2
7766532|NCT00711594|26997148|P1|Overall Study|Progressive disease|2
7766533|NCT00711555|26997185|P1|Overall Study|Adverse Event|3
7766534|NCT00711529|26997194|P2|Overall Study|Withdrawal by Subject|6
7766535|NCT00711529|26997195|P1|Overall Study|Withdrawal by Subject|2
7766536|NCT00711529|26997194|P2|Overall Study|Protocol Violation|0
7766537|NCT00711529|26997195|P1|Overall Study|Protocol Violation|2
7766538|NCT00711516|26997219|P2|Overall Study|Protocol Violation|1
7766539|NCT00711516|26997220|P1|Overall Study|Protocol Violation|0
7766540|NCT00711516|26997219|P2|Overall Study|Withdrawal by Subject|1
7766541|NCT00711516|26997220|P1|Overall Study|Withdrawal by Subject|0
7766542|NCT00711516|26997219|P2|Overall Study|Adverse Event|1
7766543|NCT00711516|26997220|P1|Overall Study|Adverse Event|1
7766544|NCT00711477|26997327|P2|Overall Study|Noncompliance|1
7766545|NCT00711477|26997328|P1|Overall Study|Noncompliance|0
7766546|NCT00711477|26997327|P2|Overall Study|Lost to Follow-up|1
7766547|NCT00711477|26997328|P1|Overall Study|Lost to Follow-up|0
7766548|NCT00711477|26997327|P2|Overall Study|Adverse Event|1
7766549|NCT00711477|26997328|P1|Overall Study|Adverse Event|3
7766550|NCT00711425|26997374|P1|Overall Study|Lost to Follow-up|1
7766551|NCT00711425|26997374|P1|Overall Study|Death|2
7766552|NCT00711425|26997374|P1|Overall Study|Protocol Violation|1
7766553|NCT00711412|26997380|P1|Survival Follow up Until Death|Other|12
7766554|NCT00711412|26997380|P1|Evaluation for Response and Surgery|Death|1
7766555|NCT00711412|26997380|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
7766556|NCT00711412|26997380|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
7766557|NCT00711412|26997380|P1|Evaluation for Response and Surgery|Progressive Disease|2
7766558|NCT00711412|26997380|P1|Combination Treatment|Progressive Disease|1
7766559|NCT00711412|26997380|P1|Evaluated for Combination Treatment|Progressive disease|2
7766560|NCT00711412|26997380|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
7766561|NCT00711412|26997380|P1|Evaluated for Combination Treatment|Death|1
7766562|NCT00711412|26997380|P1|Evaluated for Combination Treatment|Adverse Event|2
7766563|NCT00711412|26997380|P1|Induction Treatment|Other|1
7766564|NCT00711412|26997380|P1|Induction Treatment|Adverse Event|1
7766565|NCT00711412|26997380|P1|Induction Treatment|Death|2
7766566|NCT00711243|26997458|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
7766567|NCT00711243|26997459|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7766568|NCT00711243|26997460|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7766569|NCT00711243|26997461|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7766570|NCT00711243|26997462|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7766571|NCT00711243|26997463|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7766572|NCT00711243|26997458|P6|Treated Cycle 5 After First Response|Decline in performance status|1
7766573|NCT00711243|26997459|P5|Treated Cycle 5 After First Response|Decline in performance status|0
7766574|NCT00711243|26997460|P4|Treated Cycle 5 After First Response|Decline in performance status|0
7766575|NCT00711243|26997461|P3|Treated Cycle 5 After First Response|Decline in performance status|0
7766576|NCT00711243|26997462|P2|Treated Cycle 5 After First Response|Decline in performance status|0
7766577|NCT00711243|26997463|P1|Treated Cycle 5 After First Response|Decline in performance status|0
7766578|NCT00711243|26997458|P6|Treated Cycle 5 After First Response|Death|2
7766579|NCT00711243|26997459|P5|Treated Cycle 5 After First Response|Death|0
7766580|NCT00711243|26997460|P4|Treated Cycle 5 After First Response|Death|0
7766581|NCT00711243|26997461|P3|Treated Cycle 5 After First Response|Death|0
7766582|NCT00711243|26997462|P2|Treated Cycle 5 After First Response|Death|0
7766583|NCT00711243|26997463|P1|Treated Cycle 5 After First Response|Death|0
7766584|NCT00711243|26997458|P6|Treated Cycle 5 After First Response|Progressive disease|1
7766585|NCT00711243|26997459|P5|Treated Cycle 5 After First Response|Progressive disease|1
7766586|NCT00711243|26997460|P4|Treated Cycle 5 After First Response|Progressive disease|0
7766587|NCT00711243|26997461|P3|Treated Cycle 5 After First Response|Progressive disease|0
7766588|NCT00711243|26997462|P2|Treated Cycle 5 After First Response|Progressive disease|2
7766589|NCT00711243|26997463|P1|Treated Cycle 5 After First Response|Progressive disease|1
7766590|NCT00711243|26997458|P6|Reached First Response/4 Cycles|Progressive disease|0
7766591|NCT00711243|26997459|P5|Reached First Response/4 Cycles|Progressive disease|0
7766592|NCT00711243|26997460|P4|Reached First Response/4 Cycles|Progressive disease|1
7766593|NCT00711243|26997461|P3|Reached First Response/4 Cycles|Progressive disease|0
7766594|NCT00711243|26997462|P2|Reached First Response/4 Cycles|Progressive disease|0
7766595|NCT00711243|26997463|P1|Reached First Response/4 Cycles|Progressive disease|0
7766596|NCT00711243|26997458|P6|Reached First Response/4 Cycles|Death|2
7766597|NCT00711243|26997459|P5|Reached First Response/4 Cycles|Death|0
7766598|NCT00711243|26997460|P4|Reached First Response/4 Cycles|Death|0
7766599|NCT00711243|26997461|P3|Reached First Response/4 Cycles|Death|0
7766600|NCT00711243|26997462|P2|Reached First Response/4 Cycles|Death|0
7766601|NCT00711243|26997463|P1|Reached First Response/4 Cycles|Death|0
7766602|NCT00711243|26997458|P6|Registed and Started Treatment|Withdrawal by Subject|1
7766603|NCT00711243|26997459|P5|Registed and Started Treatment|Withdrawal by Subject|0
7766604|NCT00711243|26997460|P4|Registed and Started Treatment|Withdrawal by Subject|0
7766605|NCT00711243|26997461|P3|Registed and Started Treatment|Withdrawal by Subject|0
7766606|NCT00711243|26997462|P2|Registed and Started Treatment|Withdrawal by Subject|0
7766607|NCT00711243|26997463|P1|Registed and Started Treatment|Withdrawal by Subject|0
7766608|NCT00711191|26997486|P3|Overall Study|Withdrawal by Subject|3
7766609|NCT00711191|26997487|P2|Overall Study|Withdrawal by Subject|1
7766610|NCT00711191|26997488|P1|Overall Study|Withdrawal by Subject|0
7766611|NCT00711191|26997486|P3|Overall Study|Objective progression or relapse|7
7766612|NCT00711191|26997487|P2|Overall Study|Objective progression or relapse|3
7766613|NCT00711191|26997488|P1|Overall Study|Objective progression or relapse|2
7766614|NCT00711191|26997486|P3|Overall Study|Adverse Event|2
7766615|NCT00711191|26997487|P2|Overall Study|Adverse Event|1
7766616|NCT00711191|26997488|P1|Overall Study|Adverse Event|1
7766617|NCT00711113|26997525|P1|Overall Study|Implant lost|2
7766618|NCT00711113|26997525|P1|Overall Study|Lost to Follow-up|9
7766619|NCT00711100|26997531|P1|Overall Study|Withdrawal by Subject|8
7766620|NCT00711100|26997531|P1|Overall Study|Lack of Efficacy|5
7766621|NCT00711087|26997549|P2|Overall Study|Lost to Follow-up|0
7766622|NCT00711087|26997550|P1|Overall Study|Lost to Follow-up|1
7766623|NCT00711009|26997562|P2|Overall Study|Dose adjustment|0
7766624|NCT00711009|26997563|P1|Overall Study|Dose adjustment|1
7766625|NCT00711009|26997562|P2|Overall Study|Site closing|1
7766626|NCT00711009|26997563|P1|Overall Study|Site closing|0
7766627|NCT00711009|26997562|P2|Overall Study|Pregnancy|0
7766628|NCT00711009|26997563|P1|Overall Study|Pregnancy|1
7766629|NCT00711009|26997562|P2|Overall Study|Virologic Failure|1
7766630|NCT00711009|26997563|P1|Overall Study|Virologic Failure|2
7766631|NCT00711009|26997562|P2|Overall Study|Participant Noncompliant|1
7766632|NCT00711009|26997563|P1|Overall Study|Participant Noncompliant|0
7766633|NCT00711009|26997562|P2|Overall Study|Lost to Follow-up|9
7766634|NCT00711009|26997563|P1|Overall Study|Lost to Follow-up|3
7766635|NCT00711009|26997562|P2|Overall Study|Withdrawal by Subject|2
7766636|NCT00711009|26997563|P1|Overall Study|Withdrawal by Subject|4
7766637|NCT00711009|26997562|P2|Overall Study|Adverse Event/HIV-Related Event|5
7766638|NCT00711009|26997563|P1|Overall Study|Adverse Event/HIV-Related Event|4
7766639|NCT00710970|26997744|P1|Overall Study|Never took drug|2
7766640|NCT00710970|26997744|P1|Overall Study|Lost to Follow-up|8
7766641|NCT00710879|26997771|P2|Overall Study|Protocol Violation|3
7766642|NCT00710879|26997772|P1|Overall Study|Protocol Violation|0
7766643|NCT00710879|26997771|P2|Overall Study|Lost to Follow-up|1
7766644|NCT00710879|26997772|P1|Overall Study|Lost to Follow-up|2
7766645|NCT00710866|26997784|P2|Overall Study|Failed to meet eligibility|1
7766646|NCT00710866|26997785|P1|Overall Study|Failed to meet eligibility|1
7766647|NCT00710866|26997784|P2|Overall Study|Lost to Follow-up|0
7766648|NCT00710866|26997785|P1|Overall Study|Lost to Follow-up|1
7766649|NCT00710866|26997784|P2|Overall Study|Withdrawal by Subject|1
7766650|NCT00710866|26997785|P1|Overall Study|Withdrawal by Subject|2
7766651|NCT00710866|26997784|P2|Overall Study|Protocol Violation|4
7766652|NCT00710866|26997785|P1|Overall Study|Protocol Violation|5
7766653|NCT00710762|26997831|P2|Overall Study|Reason other than listed above|2
7766654|NCT00710762|26997832|P1|Overall Study|Reason other than listed above|2
7766655|NCT00710762|26997831|P2|Overall Study|Lost to Follow-up|0
7766656|NCT00710762|26997832|P1|Overall Study|Lost to Follow-up|1
7766657|NCT00710762|26997831|P2|Overall Study|Other Adverse Event|7
7766658|NCT00710762|26997832|P1|Overall Study|Other Adverse Event|7
7766659|NCT00710762|26997831|P2|Overall Study|Adverse Event other disease worsening|1
7766660|NCT00710762|26997832|P1|Overall Study|Adverse Event other disease worsening|2
7766661|NCT00710762|26997831|P2|Overall Study|Progressive disease|30
7766662|NCT00710762|26997832|P1|Overall Study|Progressive disease|27
7766663|NCT00710749|26997848|P2|First Intervention|Withdrawal by Subject|0
7766664|NCT00710749|26997849|P1|First Intervention|Withdrawal by Subject|1
7766665|NCT00710684|26997860|P3|Overall Study|Did not continue after week 24|16
7766666|NCT00710684|26997861|P2|Overall Study|Did not continue after week 24|21
7766667|NCT00710684|26997862|P1|Overall Study|Did not continue after week 24|25
7766668|NCT00710684|26997860|P3|Overall Study|Missing|0
7766669|NCT00710684|26997861|P2|Overall Study|Missing|0
7766670|NCT00710684|26997862|P1|Overall Study|Missing|1
7766671|NCT00710684|26997860|P3|Overall Study|Withdrawal by Subject|11
7766672|NCT00710684|26997861|P2|Overall Study|Withdrawal by Subject|18
7766673|NCT00710684|26997862|P1|Overall Study|Withdrawal by Subject|24
7766674|NCT00710684|26997860|P3|Overall Study|Physician Decision|4
7766675|NCT00710684|26997861|P2|Overall Study|Physician Decision|2
7766676|NCT00710684|26997862|P1|Overall Study|Physician Decision|0
7766677|NCT00710684|26997860|P3|Overall Study|Lost to Follow-up|7
7766678|NCT00710684|26997861|P2|Overall Study|Lost to Follow-up|6
7766679|NCT00710684|26997862|P1|Overall Study|Lost to Follow-up|4
7766680|NCT00710684|26997860|P3|Overall Study|Protocol Violation|5
7766681|NCT00710684|26997861|P2|Overall Study|Protocol Violation|5
7766682|NCT00710684|26997862|P1|Overall Study|Protocol Violation|5
7766683|NCT00710684|26997860|P3|Overall Study|Lack of Efficacy|5
7766684|NCT00710684|26997861|P2|Overall Study|Lack of Efficacy|3
7766685|NCT00710684|26997862|P1|Overall Study|Lack of Efficacy|4
7766686|NCT00710684|26997860|P3|Overall Study|Adverse Event|16
7766687|NCT00710684|26997861|P2|Overall Study|Adverse Event|19
7766688|NCT00710684|26997862|P1|Overall Study|Adverse Event|11
7766689|NCT00710606|26997919|P2|Overall Study|Adverse Event|2
7766690|NCT00710606|26997920|P1|Overall Study|Adverse Event|0
7766691|NCT00710593|26997932|P2|Overall Study|Prem disc vaccine, completed all visits|2
7766692|NCT00710593|26997933|P1|Overall Study|Prem disc vaccine, completed all visits|6
7766693|NCT00710593|26997932|P2|Overall Study|Protocol Violation|1
7766694|NCT00710593|26997933|P1|Overall Study|Protocol Violation|1
7766695|NCT00710593|26997932|P2|Overall Study|Failure to adhere or complete study eval|1
7766696|NCT00710593|26997933|P1|Overall Study|Failure to adhere or complete study eval|1
7766697|NCT00710593|26997932|P2|Overall Study|Moved out of area|0
7766698|NCT00710593|26997933|P1|Overall Study|Moved out of area|1
7766699|NCT00710593|26997932|P2|Overall Study|Lost to Follow-up|1
7766700|NCT00710593|26997933|P1|Overall Study|Lost to Follow-up|3
7766701|NCT00710593|26997932|P2|Overall Study|Unable to complete Wk 48 within window|0
7766702|NCT00710593|26997933|P1|Overall Study|Unable to complete Wk 48 within window|2
7766703|NCT00710593|26997932|P2|Overall Study|Incarceration|0
7766704|NCT00710593|26997933|P1|Overall Study|Incarceration|1
7766705|NCT00710554|26997976|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
7766706|NCT00710554|26997977|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
7766707|NCT00710554|26997976|P2|Overall Study|Lack of Efficacy|12
7766708|NCT00710554|26997977|P1|Overall Study|Lack of Efficacy|11
7766709|NCT00710554|26997976|P2|Overall Study|Lost to Follow-up|1
7766710|NCT00710554|26997977|P1|Overall Study|Lost to Follow-up|7
7766711|NCT00710554|26997976|P2|Overall Study|Withdrawal by Subject|3
7766712|NCT00710554|26997977|P1|Overall Study|Withdrawal by Subject|7
7766713|NCT00710554|26997976|P2|Overall Study|Adverse Event|7
7766714|NCT00710554|26997977|P1|Overall Study|Adverse Event|24
7766715|NCT00710424|26998005|P2|Overall Study|Felt good so stopped treatment|1
7766716|NCT00710424|26998006|P1|Overall Study|Felt good so stopped treatment|0
7766717|NCT00710424|26998005|P2|Overall Study|Subject preferred paracetamol|1
7766718|NCT00710424|26998006|P1|Overall Study|Subject preferred paracetamol|0
7766719|NCT00710424|26998005|P2|Overall Study|Ceased treatment due to travel|0
7766720|NCT00710424|26998006|P1|Overall Study|Ceased treatment due to travel|1
7766721|NCT00710424|26998005|P2|Overall Study|Subject thought medication changed|0
7766722|NCT00710424|26998006|P1|Overall Study|Subject thought medication changed|1
7766723|NCT00710424|26998005|P2|Overall Study|Did not meet entry criteria at visit 1|0
7766724|NCT00710424|26998006|P1|Overall Study|Did not meet entry criteria at visit 1|1
7766725|NCT00710424|26998005|P2|Overall Study|Non-compliance with stable analgesia|0
7766726|NCT00710424|26998006|P1|Overall Study|Non-compliance with stable analgesia|1
7766727|NCT00710424|26998005|P2|Overall Study|Refused medication, no side effects|0
7766728|NCT00710424|26998006|P1|Overall Study|Refused medication, no side effects|1
7766729|NCT00710424|26998005|P2|Overall Study|Lost to Follow-up|1
7766730|NCT00710424|26998006|P1|Overall Study|Lost to Follow-up|0
7766731|NCT00710424|26998005|P2|Overall Study|Withdrawal by Subject|3
7766732|NCT00710424|26998006|P1|Overall Study|Withdrawal by Subject|5
7766733|NCT00710424|26998005|P2|Overall Study|Lack of Efficacy|5
7766734|NCT00710424|26998006|P1|Overall Study|Lack of Efficacy|4
7766735|NCT00710424|26998005|P2|Overall Study|Adverse Event|12
7766736|NCT00710424|26998006|P1|Overall Study|Adverse Event|30
7766737|NCT00710385|26998030|P1|Overall Study|Undisclosed excessive methadone use|1
7766738|NCT00710385|26998030|P1|Overall Study|Physician Decision|1
7766739|NCT00710385|26998030|P1|Overall Study|Undisclosed back pain|1
7766740|NCT00710385|26998030|P1|Overall Study|Withdrawal by Subject|1
7766741|NCT00710385|26998030|P1|Overall Study|Did not qualify|1
7766742|NCT00710034|26998075|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
7766743|NCT00710034|26998076|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
7766744|NCT00710034|26998075|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
7766745|NCT00710034|26998076|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
7766746|NCT00710034|26998075|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
7766747|NCT00710034|26998076|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
7766748|NCT00710034|26998075|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
7766749|NCT00710034|26998076|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
7766750|NCT00710034|26998075|P2|Completed 12 Weeks of Treatment|Adverse Event|1
7766751|NCT00710034|26998076|P1|Completed 12 Weeks of Treatment|Adverse Event|0
7766752|NCT00710034|26998075|P2|Completed 6 Weeks of Treatment|Physician Decision|0
7766753|NCT00710034|26998076|P1|Completed 6 Weeks of Treatment|Physician Decision|1
7766754|NCT00710034|26998075|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
7766755|NCT00710034|26998076|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
7766756|NCT00710034|26998075|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
7766757|NCT00710034|26998076|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
7766758|NCT00710034|26998075|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
7766759|NCT00710034|26998076|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
7766760|NCT00710034|26998075|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
7766761|NCT00710034|26998076|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
7766762|NCT00710034|26998075|P2|Completed 6 Weeks of Treatment|Adverse Event|12
7766763|NCT00710034|26998076|P1|Completed 6 Weeks of Treatment|Adverse Event|5
7766764|NCT00710021|26998093|P3|Overall Study|Physician Decision|0
7766765|NCT00710021|26998094|P2|Overall Study|Physician Decision|1
7766766|NCT00710021|26998095|P1|Overall Study|Physician Decision|0
7766767|NCT00710021|26998093|P3|Overall Study|Subject misrandomized|1
7766768|NCT00710021|26998094|P2|Overall Study|Subject misrandomized|1
7766769|NCT00710021|26998095|P1|Overall Study|Subject misrandomized|0
7766770|NCT00710021|26998093|P3|Overall Study|Subject's Decision|0
7766771|NCT00710021|26998094|P2|Overall Study|Subject's Decision|1
7766772|NCT00710021|26998095|P1|Overall Study|Subject's Decision|0
7766773|NCT00710021|26998093|P3|Overall Study|Lost to Follow-up|0
7766774|NCT00710021|26998094|P2|Overall Study|Lost to Follow-up|0
7766775|NCT00710021|26998095|P1|Overall Study|Lost to Follow-up|1
7766776|NCT00709995|26998210|P2|Overall Study|Withdrawal by Subject|3
7766777|NCT00709995|26998211|P1|Overall Study|Withdrawal by Subject|1
7766778|NCT00709995|26998210|P2|Overall Study|Adverse Event|2
7766779|NCT00709995|26998211|P1|Overall Study|Adverse Event|4
7766780|NCT00709956|26998229|P2|Overall Study|Inclusion/exclusion criteria violation|3
7766781|NCT00709956|26998230|P1|Overall Study|Inclusion/exclusion criteria violation|2
7766782|NCT00709956|26998229|P2|Overall Study|Withdrawal by Subject|1
7766783|NCT00709956|26998230|P1|Overall Study|Withdrawal by Subject|1
7766784|NCT00709852|26998260|P2|Period 2|No 72-hour follow-up|0
7766785|NCT00709852|26998261|P1|Period 2|No 72-hour follow-up|3
7766786|NCT00709852|26998260|P2|Period 2|Lost to Follow-up|0
7766787|NCT00709852|26998261|P1|Period 2|Lost to Follow-up|1
7766788|NCT00709852|26998260|P2|Period 2|Adverse Event|1
7766789|NCT00709852|26998261|P1|Period 2|Adverse Event|1
7766790|NCT00709852|26998260|P2|Period 2|Protocol Violation|1
7766791|NCT00709852|26998261|P1|Period 2|Protocol Violation|4
7766792|NCT00709852|26998260|P2|Period 1|Lost to Follow-up|0
7766793|NCT00709852|26998261|P1|Period 1|Lost to Follow-up|1
7766794|NCT00709852|26998260|P2|Period 1|Defective scanner|1
7766795|NCT00709852|26998261|P1|Period 1|Defective scanner|0
7766796|NCT00709852|26998260|P2|Period 1|Protocol Violation|0
7766797|NCT00709852|26998261|P1|Period 1|Protocol Violation|1
7766798|NCT00709852|26998260|P2|Period 1|Withdrawal by Subject|2
7766799|NCT00709852|26998261|P1|Period 1|Withdrawal by Subject|4
7766800|NCT00709852|26998260|P2|Period 1|Adverse Event|0
7766801|NCT00709852|26998261|P1|Period 1|Adverse Event|2
7766802|NCT00709761|26998425|P1|Overall Study|Lost to Follow-up|2
7766803|NCT00709761|26998425|P1|Overall Study|study closed/terminated|17
7766804|NCT00709761|26998425|P1|Overall Study|Withdrawal by Subject|8
7766805|NCT00709735|26998436|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
7766806|NCT00709735|26998437|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
7766807|NCT00709735|26998436|P2|Overall Study|Relapse into Opioid Abuse|1
7766808|NCT00709735|26998437|P1|Overall Study|Relapse into Opioid Abuse|0
7766809|NCT00709735|26998436|P2|Overall Study|Lost to Follow-up|1
7766810|NCT00709735|26998437|P1|Overall Study|Lost to Follow-up|1
7766811|NCT00709722|26998445|P1|Overall Study|Adverse Event|1
7766812|NCT00709618|26998460|P1|Overall Study|Study Closed/Terminated|25
7766813|NCT00709618|26998460|P1|Overall Study|Lost to Follow-up|1
7766814|NCT00709618|26998460|P1|Overall Study|Withdrawal by Subject|4
7766815|NCT00709592|26998472|P2|Overall Study|Unable to proceed to transplant|1
7766816|NCT00709592|26998473|P1|Overall Study|Unable to proceed to transplant|0
7766817|NCT00709319|26998495|P1|Overall Study|Withdrawal by Subject|2
7766818|NCT00709319|26998495|P1|Overall Study|Death|4
7766819|NCT00709228|26998524|P1|Overall Study|Non-compliance|5
7766820|NCT00709228|26998524|P1|Overall Study|Lost to Follow-up|6
7766821|NCT00709228|26998524|P1|Overall Study|Disease progression|1
7766822|NCT00709228|26998524|P1|Overall Study|Discontinued follow-up|5
7766823|NCT00709228|26998524|P1|Overall Study|Did not enter follow-up|4
7766824|NCT00709228|26998524|P1|Overall Study|Discontinued treatment|14
7766825|NCT00709228|26998524|P1|Overall Study|Adverse events|2
7766826|NCT00709228|26998524|P1|Overall Study|Eligibility criteria not met|281
7766827|NCT00709228|26998524|P1|Overall Study|Not treated|14
7766828|NCT00709202|26998530|P2|Overall Study|Withdrawal by Subject|6
7766829|NCT00709202|26998531|P1|Overall Study|Withdrawal by Subject|6
7766830|NCT00709124|26998559|P2|Overall Study|encephalopathy; can't do assessment|0
7766831|NCT00709124|26998560|P1|Overall Study|encephalopathy; can't do assessment|1
7766832|NCT00709124|26998559|P2|Overall Study|Death|1
7766833|NCT00709124|26998560|P1|Overall Study|Death|3
7766834|NCT00709111|26998594|P1|Overall Study|Unable to attend clinic visits|1
7766835|NCT00709111|26998594|P1|Overall Study|Withdrawal by Subject|1
7766836|NCT00709098|26998635|P3|Open-label Period|Lost to Follow-up|1
7766837|NCT00709098|26998636|P2|Open-label Period|Lost to Follow-up|0
7766838|NCT00709098|26998637|P1|Open-label Period|Lost to Follow-up|0
7766839|NCT00709098|26998635|P3|Open-label Period|Death|1
7766840|NCT00709098|26998636|P2|Open-label Period|Death|0
7766841|NCT00709098|26998637|P1|Open-label Period|Death|0
7766842|NCT00709098|26998635|P3|Open-label Period|Administrative reason|5
7766843|NCT00709098|26998636|P2|Open-label Period|Administrative reason|0
7766844|NCT00709098|26998637|P1|Open-label Period|Administrative reason|0
7766845|NCT00709098|26998635|P3|Open-label Period|Withdrawal of consent|7
7766846|NCT00709098|26998636|P2|Open-label Period|Withdrawal of consent|0
7766847|NCT00709098|26998637|P1|Open-label Period|Withdrawal of consent|0
7766848|NCT00709098|26998635|P3|Double-blind Period|Lost to Follow-up|0
7766849|NCT00709098|26998636|P2|Double-blind Period|Lost to Follow-up|1
7766850|NCT00709098|26998637|P1|Double-blind Period|Lost to Follow-up|1
7766851|NCT00709098|26998635|P3|Double-blind Period|Death|0
7766852|NCT00709098|26998636|P2|Double-blind Period|Death|1
7766853|NCT00709098|26998637|P1|Double-blind Period|Death|1
7766854|NCT00709098|26998635|P3|Double-blind Period|Administrative reason|0
7766855|NCT00709098|26998636|P2|Double-blind Period|Administrative reason|3
7766856|NCT00709098|26998637|P1|Double-blind Period|Administrative reason|1
7766857|NCT00709098|26998635|P3|Double-blind Period|Withdrawal of consent|0
7766858|NCT00709098|26998636|P2|Double-blind Period|Withdrawal of consent|3
7766859|NCT00709098|26998637|P1|Double-blind Period|Withdrawal of consent|3
7766860|NCT00709059|26998656|P1|Overall Study|Serious side effects|11
7766861|NCT00709059|26998656|P1|Overall Study|Side effects|20
7766862|NCT00709059|26998656|P1|Overall Study|Disease complication|3
7766863|NCT00709059|26998656|P1|Overall Study|Physician Decision|7
7766864|NCT00709059|26998656|P1|Overall Study|Withdrawal by Subject|19
7766865|NCT00709059|26998656|P1|Overall Study|Lost to Follow-up|34
7766866|NCT00708916|26998691|P1|Overall Study|Adverse Event|2
7766867|NCT00708916|26998691|P1|Overall Study|Subject Noncompliance|2
7766868|NCT00708734|26998712|P1|Overall Study|leg fracture|1
7766869|NCT00708734|26998712|P1|Overall Study|vertigo|1
7766870|NCT00708734|26998712|P1|Overall Study|knee replacement|1
7766871|NCT00708734|26998712|P1|Overall Study|leg injury|1
7766872|NCT00708734|26998712|P1|Overall Study|moved|1
7766873|NCT00708734|26998712|P1|Overall Study|scheduling conflict|2
7766874|NCT00708708|26998732|P1|Overall Study|Missing values|392
7766875|NCT00708708|26998732|P1|Overall Study|Adverse Event|3
7766876|NCT00708708|26998732|P1|Overall Study|Pregnancy|3
7766877|NCT00708708|26998732|P1|Overall Study|Lack of compliance|3
7766878|NCT00708708|26998732|P1|Overall Study|Lack of effectiveness|4
7766879|NCT00708708|26998732|P1|Overall Study|Administrative reasons|7
7766880|NCT00708708|26998732|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
7766881|NCT00708708|26998732|P1|Overall Study|Good effectiveness|9
7766882|NCT00708708|26998732|P1|Overall Study|Other unspecified|11
7766883|NCT00708708|26998732|P1|Overall Study|Another therapy along with Enbrel|15
7766884|NCT00708708|26998732|P1|Overall Study|Intolerance|42
7766885|NCT00708708|26998732|P1|Overall Study|Withdrawal by Subject|51
7766886|NCT00708708|26998732|P1|Overall Study|Lost to Follow-up|52
7766887|NCT00708708|26998732|P1|Overall Study|Another therapy instead of Enbrel|141
7766888|NCT00708682|26998780|P1|Toddler Dose|Failed to Return|4
7766889|NCT00708682|26998780|P1|Toddler Dose|Lost to Follow-up|3
7766890|NCT00708682|26998780|P1|Toddler Dose|Parent/Legal Guardian Request|1
7766891|NCT00708682|26998780|P1|After Infant Series|Parent/Legal Guardian Request|1
7766892|NCT00708682|26998780|P1|Infant Series|Other|19
7766893|NCT00708682|26998780|P1|Infant Series|Failed to return|2
7766894|NCT00708682|26998780|P1|Infant Series|Parent/legal guardian request|6
7766895|NCT00708682|26998780|P1|Infant Series|Protocol Violation|1
7766896|NCT00708682|26998780|P1|Infant Series|Lost to Follow-up|4
7766897|NCT00708682|26998780|P1|Infant Series|Adverse Event|1
7766898|NCT00708643|26998801|P2|Overall Study|Adverse Event|1
7766899|NCT00708643|26998802|P1|Overall Study|Adverse Event|0
7766900|NCT00708552|26998822|P4|Overall Study|Withdrawal by Subject|10
7766901|NCT00708552|26998823|P3|Overall Study|Withdrawal by Subject|8
7766902|NCT00708552|26998824|P2|Overall Study|Withdrawal by Subject|7
7766903|NCT00708552|26998825|P1|Overall Study|Withdrawal by Subject|12
7766904|NCT00708552|26998822|P4|Overall Study|Physician Decision|0
7766905|NCT00708552|26998823|P3|Overall Study|Physician Decision|0
7766906|NCT00708552|26998824|P2|Overall Study|Physician Decision|2
7766907|NCT00708552|26998825|P1|Overall Study|Physician Decision|1
7766908|NCT00708552|26998822|P4|Overall Study|Lost to Follow-up|1
7766909|NCT00708552|26998823|P3|Overall Study|Lost to Follow-up|0
7766910|NCT00708552|26998824|P2|Overall Study|Lost to Follow-up|2
7766911|NCT00708552|26998825|P1|Overall Study|Lost to Follow-up|4
7766912|NCT00708552|26998822|P4|Overall Study|Protocol Violation|4
7766913|NCT00708552|26998823|P3|Overall Study|Protocol Violation|2
7766914|NCT00708552|26998824|P2|Overall Study|Protocol Violation|0
7766915|NCT00708552|26998825|P1|Overall Study|Protocol Violation|0
7766916|NCT00708552|26998822|P4|Overall Study|Lack of Efficacy|0
7766917|NCT00708552|26998823|P3|Overall Study|Lack of Efficacy|1
7766918|NCT00708552|26998824|P2|Overall Study|Lack of Efficacy|4
7766919|NCT00708552|26998825|P1|Overall Study|Lack of Efficacy|0
7766920|NCT00708552|26998822|P4|Overall Study|Adverse Event|6
7766921|NCT00708552|26998823|P3|Overall Study|Adverse Event|4
7766922|NCT00708552|26998824|P2|Overall Study|Adverse Event|3
7766923|NCT00708552|26998825|P1|Overall Study|Adverse Event|10
7766924|NCT00708500|26998987|P3|FOLLOWUP|Non-compliance with protocol|1
7766925|NCT00708500|26998988|P2|FOLLOWUP|Non-compliance with protocol|0
7766926|NCT00708500|26998989|P1|FOLLOWUP|Non-compliance with protocol|5
7766927|NCT00708500|26998987|P3|FOLLOWUP|Subject withdrew consent|5
7766928|NCT00708500|26998988|P2|FOLLOWUP|Subject withdrew consent|4
7766929|NCT00708500|26998989|P1|FOLLOWUP|Subject withdrew consent|31
7766930|NCT00708500|26998987|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
7766931|NCT00708500|26998988|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
7766932|NCT00708500|26998989|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
7766933|NCT00708500|26998987|P3|FOLLOWUP|Lost to Follow-up|4
7766934|NCT00708500|26998988|P2|FOLLOWUP|Lost to Follow-up|6
7766935|NCT00708500|26998989|P1|FOLLOWUP|Lost to Follow-up|1
7766936|NCT00708500|26998987|P3|FOLLOWUP|Adverse Event|0
7766937|NCT00708500|26998988|P2|FOLLOWUP|Adverse Event|1
7766938|NCT00708500|26998989|P1|FOLLOWUP|Adverse Event|0
7766939|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
7766940|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
7766941|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
7766942|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
7766943|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
7766944|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
7766945|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
7766946|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
7766947|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
7766948|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
7766949|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
7766950|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
7766951|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
7766952|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
7766953|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
7766954|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
7766955|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
7766956|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
7766957|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
7766958|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
7766959|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
7766960|NCT00708500|26998987|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
7766961|NCT00708500|26998988|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
7766962|NCT00708500|26998989|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
7766963|NCT00708500|26998987|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
7766964|NCT00708500|26998988|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
7766965|NCT00708500|26998989|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
7766966|NCT00708500|26998987|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
7766967|NCT00708500|26998988|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
7766968|NCT00708500|26998989|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
7766969|NCT00708500|26998987|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
7766970|NCT00708500|26998988|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
7766971|NCT00708500|26998989|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
7766972|NCT00708500|26998987|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
7766973|NCT00708500|26998988|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
7766974|NCT00708500|26998989|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
7766975|NCT00708500|26998987|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
7766976|NCT00708500|26998988|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
7766977|NCT00708500|26998989|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
7766978|NCT00708461|26999008|P2|Overall Study|left workforce|180
7766979|NCT00708461|26999009|P1|Overall Study|left workforce|115
7766980|NCT00708461|26999008|P2|Overall Study|Withdrawal by Subject|9
7766981|NCT00708461|26999009|P1|Overall Study|Withdrawal by Subject|8
7766982|NCT00708461|26999008|P2|Overall Study|Lost to Follow-up|11
7766983|NCT00708461|26999009|P1|Overall Study|Lost to Follow-up|18
7766984|NCT00708435|26999017|P2|Overall Study|Refused hospitalization|0
7766985|NCT00708435|26999018|P1|Overall Study|Refused hospitalization|1
7766986|NCT00708435|26999017|P2|Overall Study|Intervention by primary care physician|0
7766987|NCT00708435|26999018|P1|Overall Study|Intervention by primary care physician|1
7766988|NCT00708435|26999017|P2|Overall Study|Protocol Violation|1
7766989|NCT00708435|26999018|P1|Overall Study|Protocol Violation|0
7766990|NCT00708435|26999017|P2|Overall Study|Adverse Event|0
7766991|NCT00708435|26999018|P1|Overall Study|Adverse Event|1
7766992|NCT00708435|26999017|P2|Overall Study|Withdrawal by Subject|7
7766993|NCT00708435|26999018|P1|Overall Study|Withdrawal by Subject|3
7766994|NCT00708435|26999017|P2|Overall Study|Lost to Follow-up|4
7766995|NCT00708435|26999018|P1|Overall Study|Lost to Follow-up|9
7766996|NCT00708435|26999017|P2|Overall Study|Death / Serious Adverse Event|5
7766997|NCT00708435|26999018|P1|Overall Study|Death / Serious Adverse Event|10
7766998|NCT00708422|26999045|P2|Overall Study|Withdrawal by Subject|0
7766999|NCT00708422|26999046|P1|Overall Study|Withdrawal by Subject|1
7767000|NCT00708422|26999045|P2|Overall Study|Adverse Event|1
7767001|NCT00708422|26999046|P1|Overall Study|Adverse Event|3
7767002|NCT00708305|26999054|P4|Period 3|Other Reason|0
7767003|NCT00708305|26999055|P3|Period 3|Other Reason|0
7767004|NCT00708305|26999056|P2|Period 3|Other Reason|0
7767005|NCT00708305|26999057|P1|Period 3|Other Reason|1
7767006|NCT00708305|26999054|P4|Period 3|Protocol Violation|0
7767007|NCT00708305|26999055|P3|Period 3|Protocol Violation|0
7767008|NCT00708305|26999056|P2|Period 3|Protocol Violation|2
7767009|NCT00708305|26999057|P1|Period 3|Protocol Violation|0
7767010|NCT00708305|26999054|P4|Period 2|Other Reason|1
7767011|NCT00708305|26999055|P3|Period 2|Other Reason|0
7767012|NCT00708305|26999056|P2|Period 2|Other Reason|0
7767013|NCT00708305|26999057|P1|Period 2|Other Reason|1
7767014|NCT00708305|26999054|P4|Period 2|Protocol Violation|0
7767015|NCT00708305|26999055|P3|Period 2|Protocol Violation|0
7767016|NCT00708305|26999056|P2|Period 2|Protocol Violation|1
7767017|NCT00708305|26999057|P1|Period 2|Protocol Violation|0
7767018|NCT00708305|26999054|P4|Period 2|Lost to Follow-up|0
7767019|NCT00708305|26999055|P3|Period 2|Lost to Follow-up|0
7767020|NCT00708305|26999056|P2|Period 2|Lost to Follow-up|1
7767021|NCT00708305|26999057|P1|Period 2|Lost to Follow-up|0
7767022|NCT00708305|26999054|P4|Period 1|Other Reason|2
7767023|NCT00708305|26999055|P3|Period 1|Other Reason|0
7767024|NCT00708305|26999056|P2|Period 1|Other Reason|0
7767025|NCT00708305|26999057|P1|Period 1|Other Reason|0
7767026|NCT00708305|26999054|P4|Period 1|Protocol Violation|0
7767027|NCT00708305|26999055|P3|Period 1|Protocol Violation|1
7767028|NCT00708305|26999056|P2|Period 1|Protocol Violation|0
7767029|NCT00708305|26999057|P1|Period 1|Protocol Violation|1
7767030|NCT00708227|26999093|P4|Overall Study|Withdrawal by Subject|1
7767031|NCT00708227|26999094|P3|Overall Study|Withdrawal by Subject|0
7767032|NCT00708227|26999095|P2|Overall Study|Withdrawal by Subject|2
7767033|NCT00708227|26999096|P1|Overall Study|Withdrawal by Subject|1
7767034|NCT00708227|26999093|P4|Overall Study|Physician Decision|2
7767035|NCT00708227|26999094|P3|Overall Study|Physician Decision|1
7767036|NCT00708227|26999095|P2|Overall Study|Physician Decision|3
7767037|NCT00708227|26999096|P1|Overall Study|Physician Decision|0
7767038|NCT00708214|26999129|P3|Overall Study|Progressive Disease|5
7767039|NCT00708214|26999130|P2|Overall Study|Progressive Disease|6
7767040|NCT00708214|26999131|P1|Overall Study|Progressive Disease|4
7767041|NCT00708214|26999129|P3|Overall Study|Other|1
7767042|NCT00708214|26999130|P2|Overall Study|Other|1
7767043|NCT00708214|26999131|P1|Overall Study|Other|0
7767044|NCT00708214|26999129|P3|Overall Study|Other Adverse Event|2
7767045|NCT00708214|26999130|P2|Overall Study|Other Adverse Event|6
7767046|NCT00708214|26999131|P1|Overall Study|Other Adverse Event|3
7767047|NCT00708201|26999174|P2|Overall Study|Protocol Violation|1
7767048|NCT00708201|26999175|P1|Overall Study|Protocol Violation|0
7767049|NCT00708201|26999174|P2|Overall Study|Lost to Follow-up|0
7767050|NCT00708201|26999175|P1|Overall Study|Lost to Follow-up|2
7767051|NCT00708201|26999174|P2|Overall Study|Withdrawal by Subject|1
7767052|NCT00708201|26999175|P1|Overall Study|Withdrawal by Subject|1
7767053|NCT00708201|26999174|P2|Overall Study|Adverse Event|4
7767054|NCT00708201|26999175|P1|Overall Study|Adverse Event|4
7767055|NCT00708175|26999199|P2|Overall Study|BMD loss >7%|3
7767056|NCT00708175|26999200|P1|Overall Study|BMD loss >7%|2
7767057|NCT00708175|26999199|P2|Overall Study|Withdrawal by Subject|7
7767058|NCT00708175|26999200|P1|Overall Study|Withdrawal by Subject|5
7767059|NCT00708175|26999199|P2|Overall Study|Lost to Follow-up|3
7767060|NCT00708175|26999200|P1|Overall Study|Lost to Follow-up|5
7767061|NCT00708175|26999199|P2|Overall Study|Protocol Violation|3
7767062|NCT00708175|26999200|P1|Overall Study|Protocol Violation|2
7767063|NCT00708175|26999199|P2|Overall Study|Adverse Event|5
7767064|NCT00708175|26999200|P1|Overall Study|Adverse Event|4
7767065|NCT00708162|26999216|P2|Open-Label Phase|Other|0
7767066|NCT00708162|26999217|P1|Open-Label Phase|Other|1
7767067|NCT00708162|26999216|P2|Open-Label Phase|Adverse Event|2
7767068|NCT00708162|26999217|P1|Open-Label Phase|Adverse Event|1
7767069|NCT00708162|26999216|P2|Open-Label Phase|Death|1
7767070|NCT00708162|26999217|P1|Open-Label Phase|Death|3
7767071|NCT00708162|26999216|P2|Open-Label Phase|Investigator's Discretion|2
7767072|NCT00708162|26999217|P1|Open-Label Phase|Investigator's Discretion|3
7767073|NCT00708162|26999216|P2|Open-Label Phase|Lack of Efficacy|4
7767074|NCT00708162|26999217|P1|Open-Label Phase|Lack of Efficacy|7
7767075|NCT00708162|26999216|P2|Open-Label Phase|Participant Noncompliance|7
7767076|NCT00708162|26999217|P1|Open-Label Phase|Participant Noncompliance|7
7767077|NCT00708162|26999216|P2|Open-Label Phase|Withdrew Consent|6
7767078|NCT00708162|26999217|P1|Open-Label Phase|Withdrew Consent|12
7767079|NCT00708162|26999216|P2|Open-Label Phase|Lost to Follow-up|8
7767080|NCT00708162|26999217|P1|Open-Label Phase|Lost to Follow-up|10
7767081|NCT00708162|26999216|P2|Randomized Phase|Pregnancy|0
7767082|NCT00708162|26999217|P1|Randomized Phase|Pregnancy|3
7767083|NCT00708162|26999216|P2|Randomized Phase|Death|9
7767084|NCT00708162|26999217|P1|Randomized Phase|Death|2
7767085|NCT00708162|26999216|P2|Randomized Phase|Investigator's Discretion|10
7767086|NCT00708162|26999217|P1|Randomized Phase|Investigator's Discretion|7
7767087|NCT00708162|26999216|P2|Randomized Phase|Adverse Event|12
7767088|NCT00708162|26999217|P1|Randomized Phase|Adverse Event|8
7767089|NCT00708162|26999216|P2|Randomized Phase|Protocol Violation|11
7767090|NCT00708162|26999217|P1|Randomized Phase|Protocol Violation|10
7767091|NCT00708162|26999216|P2|Randomized Phase|Lack of Efficacy|19
7767092|NCT00708162|26999217|P1|Randomized Phase|Lack of Efficacy|14
7767093|NCT00708162|26999216|P2|Randomized Phase|Withdrew Consent|22
7767094|NCT00708162|26999217|P1|Randomized Phase|Withdrew Consent|31
7767095|NCT00708162|26999216|P2|Randomized Phase|Lost to Follow-up|34
7767096|NCT00708162|26999217|P1|Randomized Phase|Lost to Follow-up|34
7767097|NCT00708162|26999216|P2|Randomized Phase|Participant Noncompliance|32
7767098|NCT00708162|26999217|P1|Randomized Phase|Participant Noncompliance|40
7767099|NCT00708162|26999216|P2|Randomized Phase|Randomized but Not Treated|5
7767100|NCT00708162|26999217|P1|Randomized Phase|Randomized but Not Treated|7
7767101|NCT00708123|26999258|P5|Period 4|Protocol Violation|0
7767102|NCT00708123|26999259|P4|Period 4|Protocol Violation|0
7767103|NCT00708123|26999260|P3|Period 4|Protocol Violation|0
7767104|NCT00708123|26999261|P2|Period 4|Protocol Violation|1
7767105|NCT00708123|26999262|P1|Period 4|Protocol Violation|0
7767106|NCT00708123|26999258|P5|Period 3|Lost to Follow-up|0
7767107|NCT00708123|26999259|P4|Period 3|Lost to Follow-up|1
7767108|NCT00708123|26999260|P3|Period 3|Lost to Follow-up|1
7767109|NCT00708123|26999261|P2|Period 3|Lost to Follow-up|0
7767110|NCT00708123|26999262|P1|Period 3|Lost to Follow-up|0
7767111|NCT00708123|26999258|P5|Period 2|Other Reason|0
7767112|NCT00708123|26999259|P4|Period 2|Other Reason|0
7767113|NCT00708123|26999260|P3|Period 2|Other Reason|0
7767114|NCT00708123|26999261|P2|Period 2|Other Reason|0
7767115|NCT00708123|26999262|P1|Period 2|Other Reason|1
7767116|NCT00708123|26999258|P5|Period 2|Protocol Violation|0
7767117|NCT00708123|26999259|P4|Period 2|Protocol Violation|1
7767118|NCT00708123|26999260|P3|Period 2|Protocol Violation|0
7767119|NCT00708123|26999261|P2|Period 2|Protocol Violation|0
7767120|NCT00708123|26999262|P1|Period 2|Protocol Violation|0
7767121|NCT00708123|26999258|P5|Period 1|Adverse Event|0
7767122|NCT00708123|26999259|P4|Period 1|Adverse Event|0
7767123|NCT00708123|26999260|P3|Period 1|Adverse Event|1
7767124|NCT00708123|26999261|P2|Period 1|Adverse Event|0
7767125|NCT00708123|26999262|P1|Period 1|Adverse Event|0
7767126|NCT00708123|26999258|P5|Period 1|Protocol Violation|0
7767127|NCT00708123|26999259|P4|Period 1|Protocol Violation|1
7767128|NCT00708123|26999260|P3|Period 1|Protocol Violation|0
7767129|NCT00708123|26999261|P2|Period 1|Protocol Violation|1
7767130|NCT00708123|26999262|P1|Period 1|Protocol Violation|0
7767131|NCT00708097|26999395|P5|Period 2|Protocol Violation|0
7767132|NCT00708097|26999396|P4|Period 2|Protocol Violation|1
7767133|NCT00708097|26999397|P3|Period 2|Protocol Violation|1
7767134|NCT00708097|26999398|P2|Period 2|Protocol Violation|1
7767135|NCT00708097|26999399|P1|Period 2|Protocol Violation|0
7767136|NCT00708097|26999395|P5|Period 1|Other Reason|1
7767137|NCT00708097|26999396|P4|Period 1|Other Reason|0
7767138|NCT00708097|26999397|P3|Period 1|Other Reason|0
7767139|NCT00708097|26999398|P2|Period 1|Other Reason|0
7767140|NCT00708097|26999399|P1|Period 1|Other Reason|0
7767141|NCT00708097|26999395|P5|Period 1|Protocol Violation|0
7767142|NCT00708097|26999396|P4|Period 1|Protocol Violation|2
7767143|NCT00708097|26999397|P3|Period 1|Protocol Violation|0
7767144|NCT00708097|26999398|P2|Period 1|Protocol Violation|1
7767145|NCT00708097|26999399|P1|Period 1|Protocol Violation|0
7767146|NCT00708032|26999509|P2|Overall Study|Withdrawal by Subject|1
7767147|NCT00708032|26999510|P1|Overall Study|Withdrawal by Subject|0
7767148|NCT00708032|26999509|P2|Overall Study|Protocol Violation|1
7767149|NCT00708032|26999510|P1|Overall Study|Protocol Violation|4
7767150|NCT00708032|26999509|P2|Overall Study|Did not meet protocol criteria|2
7767151|NCT00708032|26999510|P1|Overall Study|Did not meet protocol criteria|1
7767152|NCT00708032|26999509|P2|Overall Study|Visit out of range at month 12|1
7767153|NCT00708032|26999510|P1|Overall Study|Visit out of range at month 12|4
7767154|NCT00708032|26999509|P2|Overall Study|Poor vision|6
7767155|NCT00708032|26999510|P1|Overall Study|Poor vision|0
7767156|NCT00708032|26999509|P2|Overall Study|Pregnancy|1
7767157|NCT00708032|26999510|P1|Overall Study|Pregnancy|0
7767158|NCT00708032|26999509|P2|Overall Study|Lost to Follow-up|2
7767159|NCT00708032|26999510|P1|Overall Study|Lost to Follow-up|1
7767160|NCT00708032|26999509|P2|Overall Study|Adverse Event|2
7767161|NCT00708032|26999510|P1|Overall Study|Adverse Event|0
7767162|NCT00707993|26999537|P2|Overall Study|Other|0
7767163|NCT00707993|26999538|P1|Overall Study|Other|2
7767164|NCT00707993|26999537|P2|Overall Study|Hyperglycemic Rescue|47
7767165|NCT00707993|26999538|P1|Overall Study|Hyperglycemic Rescue|55
7767166|NCT00707993|26999537|P2|Overall Study|Withdrawal by Subject|16
7767167|NCT00707993|26999538|P1|Overall Study|Withdrawal by Subject|12
7767168|NCT00707993|26999537|P2|Overall Study|Lost to Follow-up|4
7767169|NCT00707993|26999538|P1|Overall Study|Lost to Follow-up|0
7767170|NCT00707993|26999537|P2|Overall Study|Protocol Violation|7
7767171|NCT00707993|26999538|P1|Overall Study|Protocol Violation|4
7767172|NCT00707993|26999537|P2|Overall Study|Adverse Event|20
7767173|NCT00707993|26999538|P1|Overall Study|Adverse Event|16
7767174|NCT00707980|26999580|P1|Overall Study|Other|39
7767175|NCT00707980|26999580|P1|Overall Study|Lost to Follow-up|59
7767176|NCT00707980|26999580|P1|Overall Study|Withdrawal of Consent|81
7767177|NCT00707980|26999580|P1|Overall Study|Protocol Deviations|19
7767178|NCT00707980|26999580|P1|Overall Study|Non-Compliance with Study Drug|28
7767179|NCT00707980|26999580|P1|Overall Study|Lack of Efficacy|35
7767180|NCT00707980|26999580|P1|Overall Study|Adverse Event|49
7767181|NCT00707954|26999664|P5|Overall Study|Physician Decision|1
7767182|NCT00707954|26999665|P4|Overall Study|Physician Decision|0
7767183|NCT00707954|26999666|P3|Overall Study|Physician Decision|0
7767184|NCT00707954|26999667|P2|Overall Study|Physician Decision|0
7767185|NCT00707954|26999668|P1|Overall Study|Physician Decision|0
7767186|NCT00707746|26999709|P2|Treatment Period|Ineligibility|1
7767187|NCT00707746|26999710|P1|Treatment Period|Ineligibility|0
7767188|NCT00707746|26999709|P2|Treatment Period|Adverse Event|4
7767189|NCT00707746|26999710|P1|Treatment Period|Adverse Event|2
7767190|NCT00707577|26999771|P2|Overall Study|Pregnancy|1
7767191|NCT00707577|26999772|P1|Overall Study|Pregnancy|4
7767192|NCT00707577|26999771|P2|Overall Study|Left employment|10
7767193|NCT00707577|26999772|P1|Overall Study|Left employment|13
7767194|NCT00707577|26999771|P2|Overall Study|Lost to Follow-up|25
7767195|NCT00707577|26999772|P1|Overall Study|Lost to Follow-up|34
7767196|NCT00707577|26999771|P2|Overall Study|Withdrawal by Subject|2
7767197|NCT00707577|26999772|P1|Overall Study|Withdrawal by Subject|3
7767198|NCT00707486|26999778|P1|Overall Study|Withdrawal by Subject|1
7767199|NCT00707434|26999814|P1|Overall Study|Adverse Event|1
7767200|NCT00707239|26999825|P3|Overall Study|Other|5
7767201|NCT00707239|26999826|P2|Overall Study|Other|3
7767202|NCT00707239|26999827|P1|Overall Study|Other|8
7767203|NCT00707239|26999825|P3|Overall Study|Randomized, but not treated|1
7767204|NCT00707239|26999826|P2|Overall Study|Randomized, but not treated|1
7767205|NCT00707239|26999827|P1|Overall Study|Randomized, but not treated|1
7767206|NCT00707239|26999825|P3|Overall Study|Lack of Efficacy|0
7767207|NCT00707239|26999826|P2|Overall Study|Lack of Efficacy|2
7767208|NCT00707239|26999827|P1|Overall Study|Lack of Efficacy|1
7767209|NCT00707239|26999825|P3|Overall Study|Protocol Violation|1
7767210|NCT00707239|26999826|P2|Overall Study|Protocol Violation|0
7767211|NCT00707239|26999827|P1|Overall Study|Protocol Violation|0
7767212|NCT00707239|26999825|P3|Overall Study|Physician Decision|2
7767213|NCT00707239|26999826|P2|Overall Study|Physician Decision|1
7767214|NCT00707239|26999827|P1|Overall Study|Physician Decision|1
7767215|NCT00707239|26999825|P3|Overall Study|Death|3
7767216|NCT00707239|26999826|P2|Overall Study|Death|1
7767217|NCT00707239|26999827|P1|Overall Study|Death|3
7767218|NCT00707239|26999825|P3|Overall Study|Adverse Event|2
7767219|NCT00707239|26999826|P2|Overall Study|Adverse Event|3
7767220|NCT00707239|26999827|P1|Overall Study|Adverse Event|5
7767221|NCT00707174|26999875|P2|Overall Study|Withdrawal by Subject|1
7767222|NCT00707174|26999876|P1|Overall Study|Withdrawal by Subject|4
7767223|NCT00707174|26999875|P2|Overall Study|Adverse Event|6
7767224|NCT00707174|26999876|P1|Overall Study|Adverse Event|1
7767225|NCT00707161|26999882|P1|Overall Study|Physician Decision|6
7767226|NCT00707057|26999888|P2|Overall Study|Dosed incorrectly|1
7767227|NCT00707057|26999889|P1|Overall Study|Dosed incorrectly|0
7767228|NCT00707057|26999888|P2|Overall Study|Withdrawal by Subject|3
7767229|NCT00707057|26999889|P1|Overall Study|Withdrawal by Subject|8
7767230|NCT00707031|26999923|P2|Overall Study|Sponsor Decision|8
7767231|NCT00707031|26999924|P1|Overall Study|Sponsor Decision|9
7767232|NCT00707031|26999923|P2|Overall Study|Serious Noncompliance|3
7767233|NCT00707031|26999924|P1|Overall Study|Serious Noncompliance|2
7767234|NCT00707031|26999923|P2|Overall Study|Familial or Personal Reasons|15
7767235|NCT00707031|26999924|P1|Overall Study|Familial or Personal Reasons|12
7767236|NCT00707031|26999923|P2|Overall Study|Poor Compliance to Protocol|13
7767237|NCT00707031|26999924|P1|Overall Study|Poor Compliance to Protocol|7
7767238|NCT00707031|26999923|P2|Overall Study|Withdrawal by Subject|8
7767239|NCT00707031|26999924|P1|Overall Study|Withdrawal by Subject|7
7767240|NCT00707031|26999923|P2|Overall Study|Protocol Violation|0
7767241|NCT00707031|26999924|P1|Overall Study|Protocol Violation|1
7767242|NCT00707031|26999923|P2|Overall Study|Lost to Follow-up|1
7767243|NCT00707031|26999924|P1|Overall Study|Lost to Follow-up|2
7767244|NCT00707031|26999923|P2|Overall Study|Lack of Efficacy|6
7767245|NCT00707031|26999924|P1|Overall Study|Lack of Efficacy|19
7767246|NCT00707031|26999923|P2|Overall Study|Adverse Event|45
7767247|NCT00707031|26999924|P1|Overall Study|Adverse Event|45
7767248|NCT00706992|26999953|P7|Overall Study|Disease progression before treatment|0
7767249|NCT00706992|26999954|P6|Overall Study|Disease progression before treatment|0
7767250|NCT00706992|26999955|P5|Overall Study|Disease progression before treatment|1
7767251|NCT00706992|26999956|P4|Overall Study|Disease progression before treatment|0
7767252|NCT00706992|26999957|P3|Overall Study|Disease progression before treatment|0
7767253|NCT00706992|26999958|P2|Overall Study|Disease progression before treatment|0
7767254|NCT00706992|26999959|P1|Overall Study|Disease progression before treatment|0
7767255|NCT00706992|26999953|P7|Overall Study|Study termination|3
7767256|NCT00706992|26999954|P6|Overall Study|Study termination|2
7767257|NCT00706992|26999955|P5|Overall Study|Study termination|3
7767258|NCT00706992|26999956|P4|Overall Study|Study termination|2
7767259|NCT00706992|26999957|P3|Overall Study|Study termination|6
7767260|NCT00706992|26999958|P2|Overall Study|Study termination|5
7767261|NCT00706992|26999959|P1|Overall Study|Study termination|5
7767262|NCT00706966|26999991|P1|Overall Study|Adverse Event|1
7767263|NCT00706914|27000027|P3|Overall Study|Protocol Violation|1
7767264|NCT00706914|27000028|P2|Overall Study|Protocol Violation|1
7767265|NCT00706914|27000029|P1|Overall Study|Protocol Violation|3
7767266|NCT00706914|27000027|P3|Overall Study|Adverse Event|0
7767267|NCT00706914|27000028|P2|Overall Study|Adverse Event|2
7767268|NCT00706914|27000029|P1|Overall Study|Adverse Event|2
7767269|NCT00706914|27000027|P3|Overall Study|Lost to Follow-up|0
7767270|NCT00706914|27000028|P2|Overall Study|Lost to Follow-up|0
7767271|NCT00706914|27000029|P1|Overall Study|Lost to Follow-up|1
7767272|NCT00706914|27000027|P3|Overall Study|Lack of Efficacy|0
7767273|NCT00706914|27000028|P2|Overall Study|Lack of Efficacy|1
7767274|NCT00706914|27000029|P1|Overall Study|Lack of Efficacy|0
7767275|NCT00706901|27000052|P3|Overall Study|Death|0
7767276|NCT00706901|27000053|P2|Overall Study|Death|0
7767277|NCT00706901|27000054|P1|Overall Study|Death|1
7767278|NCT00706901|27000052|P3|Overall Study|In Jail|1
7767279|NCT00706901|27000053|P2|Overall Study|In Jail|0
7767280|NCT00706901|27000054|P1|Overall Study|In Jail|1
7767281|NCT00706901|27000052|P3|Overall Study|Withdrawal by Subject|5
7767282|NCT00706901|27000053|P2|Overall Study|Withdrawal by Subject|2
7767283|NCT00706901|27000054|P1|Overall Study|Withdrawal by Subject|4
7767284|NCT00706901|27000052|P3|Overall Study|Lost to Follow-up|2
7767285|NCT00706901|27000053|P2|Overall Study|Lost to Follow-up|3
7767286|NCT00706901|27000054|P1|Overall Study|Lost to Follow-up|2
7767287|NCT00706849|27000079|P2|Follow-up Period|Protocol non-compliance|1
7767288|NCT00706849|27000080|P1|Follow-up Period|Protocol non-compliance|0
7767289|NCT00706849|27000079|P2|Follow-up Period|Withdrawal by Subject|2
7767290|NCT00706849|27000080|P1|Follow-up Period|Withdrawal by Subject|0
7767291|NCT00706849|27000079|P2|Treatment Period|Other|1
7767292|NCT00706849|27000080|P1|Treatment Period|Other|0
7767293|NCT00706849|27000079|P2|Treatment Period|Adverse Event|9
7767294|NCT00706849|27000080|P1|Treatment Period|Adverse Event|0
7767295|NCT00706797|27000158|P2|Overall Study|Other|0
7767296|NCT00706797|27000159|P1|Overall Study|Other|1
7767297|NCT00706797|27000158|P2|Overall Study|Lost to Follow-up|2
7767298|NCT00706797|27000159|P1|Overall Study|Lost to Follow-up|1
7767299|NCT00706797|27000158|P2|Overall Study|Protocol Violation|2
7767300|NCT00706797|27000159|P1|Overall Study|Protocol Violation|3
7767301|NCT00706797|27000158|P2|Overall Study|Discontinuation of study by sponsor|63
7767302|NCT00706797|27000159|P1|Overall Study|Discontinuation of study by sponsor|52
7767303|NCT00706797|27000158|P2|Overall Study|Death|0
7767304|NCT00706797|27000159|P1|Overall Study|Death|1
7767305|NCT00706797|27000158|P2|Overall Study|Withdrawal by Subject|1
7767306|NCT00706797|27000159|P1|Overall Study|Withdrawal by Subject|8
7767307|NCT00706797|27000158|P2|Overall Study|Adverse Event|3
7767308|NCT00706797|27000159|P1|Overall Study|Adverse Event|0
7767309|NCT00706797|27000158|P2|Overall Study|Lack of Efficacy|0
7767310|NCT00706797|27000159|P1|Overall Study|Lack of Efficacy|3
7767311|NCT00706706|27000228|P1|Overall Study|Study endpoint had reached|45
7767312|NCT00706706|27000228|P1|Overall Study|Lost to Follow-up|7
7767313|NCT00706706|27000228|P1|Overall Study|Death|53
7767314|NCT00706654|27000238|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
7767315|NCT00706654|27000239|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
7767316|NCT00706654|27000240|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
7767317|NCT00706654|27000241|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
7767318|NCT00706654|27000238|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
7767319|NCT00706654|27000239|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
7767320|NCT00706654|27000240|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
7767321|NCT00706654|27000241|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
7767322|NCT00706654|27000238|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
7767323|NCT00706654|27000239|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
7767324|NCT00706654|27000240|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
7767325|NCT00706654|27000241|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
7767326|NCT00706654|27000238|P4|Depot Maintenance Phase|Protocol Deviation|1
7767327|NCT00706654|27000239|P3|Depot Maintenance Phase|Protocol Deviation|3
7767328|NCT00706654|27000240|P2|Depot Maintenance Phase|Protocol Deviation|2
7767329|NCT00706654|27000241|P1|Depot Maintenance Phase|Protocol Deviation|0
7767330|NCT00706654|27000238|P4|Depot Maintenance Phase|Withdrew Consent|14
7767331|NCT00706654|27000239|P3|Depot Maintenance Phase|Withdrew Consent|29
7767332|NCT00706654|27000240|P2|Depot Maintenance Phase|Withdrew Consent|21
7767333|NCT00706654|27000241|P1|Depot Maintenance Phase|Withdrew Consent|0
7767334|NCT00706654|27000238|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
7767335|NCT00706654|27000239|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
7767336|NCT00706654|27000240|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
7767337|NCT00706654|27000241|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
7767338|NCT00706654|27000238|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
7767339|NCT00706654|27000239|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
7767340|NCT00706654|27000240|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
7767341|NCT00706654|27000241|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
7767342|NCT00706654|27000238|P4|Depot Maintenance Phase|Lost to Follow-up|6
7767343|NCT00706654|27000239|P3|Depot Maintenance Phase|Lost to Follow-up|10
7767344|NCT00706654|27000240|P2|Depot Maintenance Phase|Lost to Follow-up|4
7767345|NCT00706654|27000241|P1|Depot Maintenance Phase|Lost to Follow-up|0
7767346|NCT00706654|27000238|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767347|NCT00706654|27000239|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767348|NCT00706654|27000240|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767349|NCT00706654|27000241|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
7767350|NCT00706654|27000238|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767351|NCT00706654|27000239|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767352|NCT00706654|27000240|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767353|NCT00706654|27000241|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
7767354|NCT00706654|27000238|P4|Oral Stabilization Phase|Adverse Event|0
7767355|NCT00706654|27000239|P3|Oral Stabilization Phase|Adverse Event|0
7767356|NCT00706654|27000240|P2|Oral Stabilization Phase|Adverse Event|0
7767357|NCT00706654|27000241|P1|Oral Stabilization Phase|Adverse Event|21
7767358|NCT00706654|27000238|P4|Oral Stabilization Phase|Protocol Deviation|0
7767359|NCT00706654|27000239|P3|Oral Stabilization Phase|Protocol Deviation|0
7767360|NCT00706654|27000240|P2|Oral Stabilization Phase|Protocol Deviation|0
7767361|NCT00706654|27000241|P1|Oral Stabilization Phase|Protocol Deviation|2
7767362|NCT00706654|27000238|P4|Oral Stabilization Phase|Withdrew consent|0
7767363|NCT00706654|27000239|P3|Oral Stabilization Phase|Withdrew consent|0
7767364|NCT00706654|27000240|P2|Oral Stabilization Phase|Withdrew consent|0
7767365|NCT00706654|27000241|P1|Oral Stabilization Phase|Withdrew consent|55
7767366|NCT00706654|27000238|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
7767367|NCT00706654|27000239|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
7767368|NCT00706654|27000240|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
7767369|NCT00706654|27000241|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
7767370|NCT00706654|27000238|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
7767371|NCT00706654|27000239|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
7767372|NCT00706654|27000240|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
7767373|NCT00706654|27000241|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
7767374|NCT00706654|27000238|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7767375|NCT00706654|27000239|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7767376|NCT00706654|27000240|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7767377|NCT00706654|27000241|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
7767378|NCT00706654|27000238|P4|Oral Stabilization Phase|Lost to Follow-up|0
7767379|NCT00706654|27000239|P3|Oral Stabilization Phase|Lost to Follow-up|0
7767380|NCT00706654|27000240|P2|Oral Stabilization Phase|Lost to Follow-up|0
7767381|NCT00706654|27000241|P1|Oral Stabilization Phase|Lost to Follow-up|17
7767382|NCT00706654|27000238|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
7767383|NCT00706654|27000239|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
7767384|NCT00706654|27000240|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
7767385|NCT00706654|27000241|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
7767386|NCT00706654|27000238|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
7767387|NCT00706654|27000239|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
7767388|NCT00706654|27000240|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
7767389|NCT00706654|27000241|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
7767390|NCT00706654|27000238|P4|Conversion Phase|Adverse Event|0
7767391|NCT00706654|27000239|P3|Conversion Phase|Adverse Event|0
7767392|NCT00706654|27000240|P2|Conversion Phase|Adverse Event|0
7767393|NCT00706654|27000241|P1|Conversion Phase|Adverse Event|18
7767394|NCT00706654|27000238|P4|Conversion Phase|Withdrew Consent|0
7767395|NCT00706654|27000239|P3|Conversion Phase|Withdrew Consent|0
7767396|NCT00706654|27000240|P2|Conversion Phase|Withdrew Consent|0
7767397|NCT00706654|27000241|P1|Conversion Phase|Withdrew Consent|38
7767398|NCT00706654|27000238|P4|Conversion Phase|Withdrawn by Investigator|0
7767399|NCT00706654|27000239|P3|Conversion Phase|Withdrawn by Investigator|0
7767400|NCT00706654|27000240|P2|Conversion Phase|Withdrawn by Investigator|0
7767401|NCT00706654|27000241|P1|Conversion Phase|Withdrawn by Investigator|14
7767402|NCT00706654|27000238|P4|Conversion Phase|Met Withdrawal Criteria|0
7767403|NCT00706654|27000239|P3|Conversion Phase|Met Withdrawal Criteria|0
7767404|NCT00706654|27000240|P2|Conversion Phase|Met Withdrawal Criteria|0
7767405|NCT00706654|27000241|P1|Conversion Phase|Met Withdrawal Criteria|2
7767406|NCT00706654|27000238|P4|Conversion Phase|Sponsor Discontinued Trial|0
7767407|NCT00706654|27000239|P3|Conversion Phase|Sponsor Discontinued Trial|0
7767408|NCT00706654|27000240|P2|Conversion Phase|Sponsor Discontinued Trial|0
7767409|NCT00706654|27000241|P1|Conversion Phase|Sponsor Discontinued Trial|8
7767410|NCT00706654|27000238|P4|Conversion Phase|Lost to Follow-up|0
7767411|NCT00706654|27000239|P3|Conversion Phase|Lost to Follow-up|0
7767412|NCT00706654|27000240|P2|Conversion Phase|Lost to Follow-up|0
7767413|NCT00706654|27000241|P1|Conversion Phase|Lost to Follow-up|4
7767414|NCT00706641|27000260|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
7767415|NCT00706641|27000260|P1|Dasatinib Administration|Ineligible after start of therapy|1
7767416|NCT00706641|27000260|P1|Dasatinib Administration|Withdrawal by Subject|1
7767417|NCT00706628|27000274|P4|Overall Study|Not treated|0
7767418|NCT00706628|27000275|P3|Overall Study|Not treated|0
7767419|NCT00706628|27000276|P2|Overall Study|Not treated|1
7767420|NCT00706628|27000277|P1|Overall Study|Not treated|1
7767421|NCT00706628|27000274|P4|Overall Study|Other than those stated above|0
7767422|NCT00706628|27000275|P3|Overall Study|Other than those stated above|0
7767423|NCT00706628|27000276|P2|Overall Study|Other than those stated above|0
7767424|NCT00706628|27000277|P1|Overall Study|Other than those stated above|4
7767425|NCT00706628|27000274|P4|Overall Study|Progressive disease|1
7767426|NCT00706628|27000275|P3|Overall Study|Progressive disease|8
7767427|NCT00706628|27000276|P2|Overall Study|Progressive disease|13
7767428|NCT00706628|27000277|P1|Overall Study|Progressive disease|20
7767429|NCT00706628|27000274|P4|Overall Study|Consent withdrawn|0
7767430|NCT00706628|27000275|P3|Overall Study|Consent withdrawn|3
7767431|NCT00706628|27000276|P2|Overall Study|Consent withdrawn|1
7767432|NCT00706628|27000277|P1|Overall Study|Consent withdrawn|6
7767433|NCT00706628|27000274|P4|Overall Study|Non compliant with protocol|0
7767434|NCT00706628|27000275|P3|Overall Study|Non compliant with protocol|0
7767435|NCT00706628|27000276|P2|Overall Study|Non compliant with protocol|1
7767436|NCT00706628|27000277|P1|Overall Study|Non compliant with protocol|0
7767437|NCT00706628|27000274|P4|Overall Study|Other Adverse Event|2
7767438|NCT00706628|27000275|P3|Overall Study|Other Adverse Event|5
7767439|NCT00706628|27000276|P2|Overall Study|Other Adverse Event|5
7767440|NCT00706628|27000277|P1|Overall Study|Other Adverse Event|16
7767441|NCT00706511|27000382|P4|Overall Study|Withdrawal by Subject|0
7767442|NCT00706511|27000383|P3|Overall Study|Withdrawal by Subject|0
7767443|NCT00706511|27000384|P2|Overall Study|Withdrawal by Subject|0
7767444|NCT00706511|27000385|P1|Overall Study|Withdrawal by Subject|1
7767445|NCT00706433|27000476|P4|Overall Study|new job|1
7767446|NCT00706433|27000477|P3|Overall Study|new job|0
7767447|NCT00706433|27000478|P2|Overall Study|new job|0
7767448|NCT00706433|27000479|P1|Overall Study|new job|0
7767449|NCT00706433|27000476|P4|Overall Study|Protocol Violation|0
7767450|NCT00706433|27000477|P3|Overall Study|Protocol Violation|0
7767451|NCT00706433|27000478|P2|Overall Study|Protocol Violation|0
7767452|NCT00706433|27000479|P1|Overall Study|Protocol Violation|1
7767453|NCT00706433|27000476|P4|Overall Study|Adverse Event|0
7767454|NCT00706433|27000477|P3|Overall Study|Adverse Event|1
7767455|NCT00706433|27000478|P2|Overall Study|Adverse Event|0
7767456|NCT00706433|27000479|P1|Overall Study|Adverse Event|0
7767457|NCT00706433|27000476|P4|Overall Study|Withdrawal by Subject|1
7767458|NCT00706433|27000477|P3|Overall Study|Withdrawal by Subject|3
7767459|NCT00706433|27000478|P2|Overall Study|Withdrawal by Subject|2
7767460|NCT00706433|27000479|P1|Overall Study|Withdrawal by Subject|1
7767461|NCT00706433|27000476|P4|Overall Study|Lost to Follow-up|0
7767462|NCT00706433|27000477|P3|Overall Study|Lost to Follow-up|6
7767463|NCT00706433|27000478|P2|Overall Study|Lost to Follow-up|1
7767464|NCT00706433|27000479|P1|Overall Study|Lost to Follow-up|3
7767465|NCT00706381|27000806|P4|Overall Study|Lost to Follow-up|0
7767466|NCT00706381|27000807|P3|Overall Study|Lost to Follow-up|1
7767467|NCT00706381|27000808|P2|Overall Study|Lost to Follow-up|1
7767468|NCT00706381|27000809|P1|Overall Study|Lost to Follow-up|0
7767469|NCT00706355|27000830|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
7767470|NCT00706355|27000831|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7767471|NCT00706355|27000832|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7767472|NCT00706355|27000833|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7767473|NCT00706355|27000830|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
7767474|NCT00706355|27000831|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
7767475|NCT00706355|27000832|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
7767476|NCT00706355|27000833|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
7767477|NCT00706355|27000830|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7767478|NCT00706355|27000831|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
7767479|NCT00706355|27000832|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7767480|NCT00706355|27000833|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7767481|NCT00706355|27000830|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
7767482|NCT00706355|27000831|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
7767483|NCT00706355|27000832|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
7767484|NCT00706355|27000833|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
7767485|NCT00706355|27000830|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7767486|NCT00706355|27000831|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7767487|NCT00706355|27000832|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
7767488|NCT00706355|27000833|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7767489|NCT00706355|27000830|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7767490|NCT00706355|27000831|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7767491|NCT00706355|27000832|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
7767492|NCT00706355|27000833|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7767493|NCT00706355|27000830|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7767494|NCT00706355|27000831|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7767495|NCT00706355|27000832|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
7767496|NCT00706355|27000833|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7767497|NCT00706355|27000830|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7767498|NCT00706355|27000831|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7767499|NCT00706355|27000832|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7767500|NCT00706355|27000833|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
7767501|NCT00706355|27000830|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7767502|NCT00706355|27000831|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7767503|NCT00706355|27000832|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7767504|NCT00706355|27000833|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
7767505|NCT00706342|27000885|P1|Overall Study|WIthdrawal of consent|1
7767506|NCT00706342|27000885|P1|Overall Study|Ongoing|6
7767507|NCT00706342|27000885|P1|Overall Study|Non-responder Week 12|1
7767508|NCT00706342|27000885|P1|Overall Study|Investigator discretion|2
7767509|NCT00706342|27000885|P1|Overall Study|Withdrew from the study on his own.|1
7767510|NCT00706342|27000885|P1|Overall Study|Death|1
7767511|NCT00706342|27000885|P1|Overall Study|Withdrawn due to failure to respond|1
7767512|NCT00706342|27000885|P1|Overall Study|Not responding to treatment|2
7767513|NCT00706342|27000885|P1|Overall Study|Adverse Event|3
7767514|NCT00706238|27000953|P1|Overall Study|Other|1
7767515|NCT00706238|27000953|P1|Overall Study|Disease progression|4
7767516|NCT00706134|27000970|P4|Overall Study|Did not meet study criteria|0
7767517|NCT00706134|27000971|P3|Overall Study|Did not meet study criteria|0
7767518|NCT00706134|27000972|P2|Overall Study|Did not meet study criteria|0
7767519|NCT00706134|27000973|P1|Overall Study|Did not meet study criteria|2
7767520|NCT00706134|27000970|P4|Overall Study|Unsatisfactory therapeutic effect|5
7767521|NCT00706134|27000971|P3|Overall Study|Unsatisfactory therapeutic effect|3
7767522|NCT00706134|27000972|P2|Overall Study|Unsatisfactory therapeutic effect|3
7767523|NCT00706134|27000973|P1|Overall Study|Unsatisfactory therapeutic effect|9
7767524|NCT00706134|27000970|P4|Overall Study|Withdrawal by Subject|0
7767525|NCT00706134|27000971|P3|Overall Study|Withdrawal by Subject|1
7767526|NCT00706134|27000972|P2|Overall Study|Withdrawal by Subject|2
7767527|NCT00706134|27000973|P1|Overall Study|Withdrawal by Subject|1
7767528|NCT00706134|27000970|P4|Overall Study|Protocol Violation|3
7767529|NCT00706134|27000971|P3|Overall Study|Protocol Violation|0
7767530|NCT00706134|27000972|P2|Overall Study|Protocol Violation|6
7767531|NCT00706134|27000973|P1|Overall Study|Protocol Violation|0
7767532|NCT00706134|27000970|P4|Overall Study|Lost to Follow-up|0
7767533|NCT00706134|27000971|P3|Overall Study|Lost to Follow-up|0
7767534|NCT00706134|27000972|P2|Overall Study|Lost to Follow-up|1
7767535|NCT00706134|27000973|P1|Overall Study|Lost to Follow-up|0
7767536|NCT00706134|27000970|P4|Overall Study|Adverse Event|3
7767537|NCT00706134|27000971|P3|Overall Study|Adverse Event|2
7767538|NCT00706134|27000972|P2|Overall Study|Adverse Event|7
7767539|NCT00706134|27000973|P1|Overall Study|Adverse Event|8
7767540|NCT00706095|27001039|P3|Overall Study|Withdrawal by Subject|0
7767541|NCT00706095|27001040|P2|Overall Study|Withdrawal by Subject|0
7767542|NCT00706095|27001041|P1|Overall Study|Withdrawal by Subject|1
7767543|NCT00706095|27001039|P3|Overall Study|Clinical Progression|2
7767544|NCT00706095|27001040|P2|Overall Study|Clinical Progression|2
7767545|NCT00706095|27001041|P1|Overall Study|Clinical Progression|1
7767546|NCT00706095|27001039|P3|Overall Study|Progressive Disease|3
7767547|NCT00706095|27001040|P2|Overall Study|Progressive Disease|5
7767548|NCT00706095|27001041|P1|Overall Study|Progressive Disease|4
7767549|NCT00706030|27001059|P4|Overall Study|Death|0
7767550|NCT00706030|27001060|P3|Overall Study|Death|1
7767551|NCT00706030|27001061|P2|Overall Study|Death|0
7767552|NCT00706030|27001062|P1|Overall Study|Death|0
7767553|NCT00706030|27001059|P4|Overall Study|No treatment received|1
7767554|NCT00706030|27001060|P3|Overall Study|No treatment received|0
7767555|NCT00706030|27001061|P2|Overall Study|No treatment received|0
7767556|NCT00706030|27001062|P1|Overall Study|No treatment received|0
7767557|NCT00706030|27001059|P4|Overall Study|Symptomatic Deterioration|0
7767558|NCT00706030|27001060|P3|Overall Study|Symptomatic Deterioration|1
7767559|NCT00706030|27001061|P2|Overall Study|Symptomatic Deterioration|0
7767560|NCT00706030|27001062|P1|Overall Study|Symptomatic Deterioration|0
7767561|NCT00706030|27001059|P4|Overall Study|Failed to return|0
7767562|NCT00706030|27001060|P3|Overall Study|Failed to return|1
7767563|NCT00706030|27001061|P2|Overall Study|Failed to return|0
7767564|NCT00706030|27001062|P1|Overall Study|Failed to return|0
7767565|NCT00706030|27001059|P4|Overall Study|Protocol Violation|1
7767566|NCT00706030|27001060|P3|Overall Study|Protocol Violation|1
7767567|NCT00706030|27001061|P2|Overall Study|Protocol Violation|0
7767568|NCT00706030|27001062|P1|Overall Study|Protocol Violation|0
7767569|NCT00706030|27001059|P4|Overall Study|Not recorded|0
7767570|NCT00706030|27001060|P3|Overall Study|Not recorded|2
7767571|NCT00706030|27001061|P2|Overall Study|Not recorded|0
7767572|NCT00706030|27001062|P1|Overall Study|Not recorded|0
7767573|NCT00706030|27001059|P4|Overall Study|Physician Decision|0
7767574|NCT00706030|27001060|P3|Overall Study|Physician Decision|2
7767575|NCT00706030|27001061|P2|Overall Study|Physician Decision|0
7767576|NCT00706030|27001062|P1|Overall Study|Physician Decision|0
7767577|NCT00706030|27001059|P4|Overall Study|Withdrawal by Subject|0
7767578|NCT00706030|27001060|P3|Overall Study|Withdrawal by Subject|2
7767579|NCT00706030|27001061|P2|Overall Study|Withdrawal by Subject|0
7767580|NCT00706030|27001062|P1|Overall Study|Withdrawal by Subject|1
7767581|NCT00706030|27001059|P4|Overall Study|Adverse Event|2
7767582|NCT00706030|27001060|P3|Overall Study|Adverse Event|4
7767583|NCT00706030|27001061|P2|Overall Study|Adverse Event|0
7767584|NCT00706030|27001062|P1|Overall Study|Adverse Event|1
7767585|NCT00706030|27001059|P4|Overall Study|Disease Progression|12
7767586|NCT00706030|27001060|P3|Overall Study|Disease Progression|46
7767587|NCT00706030|27001061|P2|Overall Study|Disease Progression|6
7767588|NCT00706030|27001062|P1|Overall Study|Disease Progression|4
7767589|NCT00706004|27001077|P1|Overall Study|Did not meet eligibility criteria|2
7767590|NCT00705939|27001105|P3|Overall Study|Physician Decision|0
7767591|NCT00705939|27001106|P2|Overall Study|Physician Decision|1
7767592|NCT00705939|27001107|P1|Overall Study|Physician Decision|0
7767593|NCT00705939|27001105|P3|Overall Study|Withdrawal by Subject|3
7767594|NCT00705939|27001106|P2|Overall Study|Withdrawal by Subject|1
7767595|NCT00705939|27001107|P1|Overall Study|Withdrawal by Subject|0
7767596|NCT00705939|27001105|P3|Overall Study|Protocol Violation|1
7767597|NCT00705939|27001106|P2|Overall Study|Protocol Violation|0
7767598|NCT00705939|27001107|P1|Overall Study|Protocol Violation|0
7767599|NCT00705783|27001161|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
7767600|NCT00705783|27001162|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
7767601|NCT00705783|27001163|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
7767602|NCT00705783|27001161|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
7767603|NCT00705783|27001162|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
7767604|NCT00705783|27001163|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
7767605|NCT00705783|27001161|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
7767606|NCT00705783|27001162|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
7767607|NCT00705783|27001163|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
7767608|NCT00705783|27001161|P3|Depot Maintenance Phase|Protocol Deviation|0
7767609|NCT00705783|27001162|P2|Depot Maintenance Phase|Protocol Deviation|2
7767610|NCT00705783|27001163|P1|Depot Maintenance Phase|Protocol Deviation|0
7767611|NCT00705783|27001161|P3|Depot Maintenance Phase|Withdrew Consent|4
7767612|NCT00705783|27001162|P2|Depot Maintenance Phase|Withdrew Consent|14
7767613|NCT00705783|27001163|P1|Depot Maintenance Phase|Withdrew Consent|0
7767614|NCT00705783|27001161|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
7767615|NCT00705783|27001162|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
7767616|NCT00705783|27001163|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
7767617|NCT00705783|27001161|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
7767618|NCT00705783|27001162|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
7767619|NCT00705783|27001163|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
7767620|NCT00705783|27001161|P3|Depot Maintenance Phase|Lost to Follow-up|3
7767621|NCT00705783|27001162|P2|Depot Maintenance Phase|Lost to Follow-up|5
7767622|NCT00705783|27001163|P1|Depot Maintenance Phase|Lost to Follow-up|0
7767623|NCT00705783|27001161|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
7767624|NCT00705783|27001162|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
7767625|NCT00705783|27001163|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
7767626|NCT00705783|27001161|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767627|NCT00705783|27001162|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767628|NCT00705783|27001163|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
7767629|NCT00705783|27001161|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767630|NCT00705783|27001162|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767631|NCT00705783|27001163|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
7767632|NCT00705783|27001161|P3|Depot Stabilization Phase|Adverse Event|0
7767633|NCT00705783|27001162|P2|Depot Stabilization Phase|Adverse Event|0
7767634|NCT00705783|27001163|P1|Depot Stabilization Phase|Adverse Event|17
7767635|NCT00705783|27001161|P3|Depot Stabilization Phase|Withdrew Consent|0
7767636|NCT00705783|27001162|P2|Depot Stabilization Phase|Withdrew Consent|0
7767637|NCT00705783|27001163|P1|Depot Stabilization Phase|Withdrew Consent|29
7767638|NCT00705783|27001161|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
7767639|NCT00705783|27001162|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
7767640|NCT00705783|27001163|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
7767641|NCT00705783|27001161|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
7767642|NCT00705783|27001162|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
7767643|NCT00705783|27001163|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
7767644|NCT00705783|27001161|P3|Depot Stabilization Phase|Lost to Follow-up|0
7767645|NCT00705783|27001162|P2|Depot Stabilization Phase|Lost to Follow-up|0
7767646|NCT00705783|27001163|P1|Depot Stabilization Phase|Lost to Follow-up|11
7767647|NCT00705783|27001161|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
7767648|NCT00705783|27001162|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
7767649|NCT00705783|27001163|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
7767650|NCT00705783|27001161|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767651|NCT00705783|27001162|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7767652|NCT00705783|27001163|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
7767653|NCT00705783|27001161|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767654|NCT00705783|27001162|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7767655|NCT00705783|27001163|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
7767656|NCT00705783|27001161|P3|Oral Stabilization Phase|Adverse Event|0
7767657|NCT00705783|27001162|P2|Oral Stabilization Phase|Adverse Event|0
7767658|NCT00705783|27001163|P1|Oral Stabilization Phase|Adverse Event|14
7767659|NCT00705783|27001161|P3|Oral Stabilization Phase|Withdrew Consent|0
7767660|NCT00705783|27001162|P2|Oral Stabilization Phase|Withdrew Consent|0
7767661|NCT00705783|27001163|P1|Oral Stabilization Phase|Withdrew Consent|29
7767662|NCT00705783|27001161|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
7767663|NCT00705783|27001162|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
7767664|NCT00705783|27001163|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
7767665|NCT00705783|27001161|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
7767666|NCT00705783|27001162|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
7767667|NCT00705783|27001163|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
7767668|NCT00705783|27001161|P3|Oral Stabilization Phase|Lost to Follow-up|0
7767669|NCT00705783|27001162|P2|Oral Stabilization Phase|Lost to Follow-up|0
7767670|NCT00705783|27001163|P1|Oral Stabilization Phase|Lost to Follow-up|7
7767671|NCT00705783|27001161|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
7767672|NCT00705783|27001162|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
7767673|NCT00705783|27001163|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
7767674|NCT00705783|27001161|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
7767675|NCT00705783|27001162|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
7767676|NCT00705783|27001163|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
7767677|NCT00705783|27001161|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
7767678|NCT00705783|27001162|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
7767679|NCT00705783|27001163|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
7767680|NCT00705783|27001161|P3|Conversion Phase|Adverse Event|0
7767681|NCT00705783|27001162|P2|Conversion Phase|Adverse Event|0
7767682|NCT00705783|27001163|P1|Conversion Phase|Adverse Event|11
7767683|NCT00705783|27001161|P3|Conversion Phase|Protocol Deviation|0
7767684|NCT00705783|27001162|P2|Conversion Phase|Protocol Deviation|0
7767685|NCT00705783|27001163|P1|Conversion Phase|Protocol Deviation|2
7767686|NCT00705783|27001161|P3|Conversion Phase|Withdrew Consent|0
7767687|NCT00705783|27001162|P2|Conversion Phase|Withdrew Consent|0
7767688|NCT00705783|27001163|P1|Conversion Phase|Withdrew Consent|24
7767689|NCT00705783|27001161|P3|Conversion Phase|Withdrawn by Investigator|0
7767690|NCT00705783|27001162|P2|Conversion Phase|Withdrawn by Investigator|0
7767691|NCT00705783|27001163|P1|Conversion Phase|Withdrawn by Investigator|4
7767692|NCT00705783|27001161|P3|Conversion Phase|Met Withdrawal Criteria|0
7767693|NCT00705783|27001162|P2|Conversion Phase|Met Withdrawal Criteria|0
7767694|NCT00705783|27001163|P1|Conversion Phase|Met Withdrawal Criteria|4
7767695|NCT00705783|27001161|P3|Conversion Phase|Lost to Follow-up|0
7767696|NCT00705783|27001162|P2|Conversion Phase|Lost to Follow-up|0
7767697|NCT00705783|27001163|P1|Conversion Phase|Lost to Follow-up|13
7767698|NCT00705783|27001161|P3|Conversion Phase|Sponsor Discontinued Study|0
7767699|NCT00705783|27001162|P2|Conversion Phase|Sponsor Discontinued Study|0
7767700|NCT00705783|27001163|P1|Conversion Phase|Sponsor Discontinued Study|54
7767701|NCT00705757|27001193|P3|Overall Study|Withdrawal by Subject|2
7767702|NCT00705757|27001194|P2|Overall Study|Withdrawal by Subject|1
7767703|NCT00705757|27001195|P1|Overall Study|Withdrawal by Subject|1
7767704|NCT00705757|27001193|P3|Overall Study|Lost to Follow-up|6
7767705|NCT00705757|27001194|P2|Overall Study|Lost to Follow-up|6
7767706|NCT00705757|27001195|P1|Overall Study|Lost to Follow-up|7
7767707|NCT00705757|27001193|P3|Overall Study|Lack of Efficacy|3
7767708|NCT00705757|27001194|P2|Overall Study|Lack of Efficacy|1
7767709|NCT00705757|27001195|P1|Overall Study|Lack of Efficacy|5
7767710|NCT00705718|27001205|P2|Overall Study|Follow up not done|4
7767711|NCT00705718|27001206|P1|Overall Study|Follow up not done|1
7767712|NCT00705718|27001205|P2|Overall Study|Not due for Visit|12
7767713|NCT00705718|27001206|P1|Overall Study|Not due for Visit|0
7767714|NCT00705718|27001205|P2|Overall Study|Death|6
7767715|NCT00705718|27001206|P1|Overall Study|Death|6
7767741|NCT00705666|27001266|P1|Overall Study|Untreated|5
7767742|NCT00705666|27001266|P1|Overall Study|Lack of data|3
7767743|NCT00705666|27001266|P1|Overall Study|Other|2
7767744|NCT00705666|27001266|P1|Overall Study|Other|12
7767745|NCT00705666|27001266|P1|Overall Study|Adverse Event|4
7767746|NCT00705666|27001266|P1|Overall Study|Death|1
7767747|NCT00705666|27001266|P1|Overall Study|Lost to Follow-up|5
7767748|NCT00705666|27001266|P1|Overall Study|Physician Decision|7
7767749|NCT00705666|27001266|P1|Overall Study|Withdrawal by Subject|21
7767750|NCT00705666|27001266|P1|Overall Study|No post-treatment questionnaire|279
7767751|NCT00705614|27001277|P2|Switch to Remicade|Administrative Reason|9
7767752|NCT00705614|27001278|P1|Switch to Remicade|Administrative Reason|0
7767753|NCT00705614|27001277|P2|Switch to Remicade|Withdrawal by Subject|12
7767754|NCT00705614|27001278|P1|Switch to Remicade|Withdrawal by Subject|0
7767755|NCT00705614|27001277|P2|Switch to Remicade|Lost to Follow-up|23
7767756|NCT00705614|27001278|P1|Switch to Remicade|Lost to Follow-up|0
7767757|NCT00705614|27001277|P2|Switch to Remicade|Adverse Event|5
7767758|NCT00705614|27001278|P1|Switch to Remicade|Adverse Event|0
7767759|NCT00705614|27001277|P2|Initial Intervention|Status completion unknown|0
7767760|NCT00705614|27001278|P1|Initial Intervention|Status completion unknown|3
7767761|NCT00705614|27001277|P2|Initial Intervention|Administrative Reason|38
7767762|NCT00705614|27001278|P1|Initial Intervention|Administrative Reason|51
7767763|NCT00705614|27001277|P2|Initial Intervention|Withdrawal by Subject|71
7767764|NCT00705614|27001278|P1|Initial Intervention|Withdrawal by Subject|114
7767765|NCT00705614|27001277|P2|Initial Intervention|Lost to Follow-up|191
7767766|NCT00705614|27001278|P1|Initial Intervention|Lost to Follow-up|310
7767767|NCT00705614|27001277|P2|Initial Intervention|Adverse Event|21
7767768|NCT00705614|27001278|P1|Initial Intervention|Adverse Event|40
7767769|NCT00705575|27001327|P2|Overall Study|Withdrawal by Subject|10
7767770|NCT00705575|27001328|P1|Overall Study|Withdrawal by Subject|5
7767771|NCT00705575|27001327|P2|Overall Study|Protocol Violation|2
7767772|NCT00705575|27001328|P1|Overall Study|Protocol Violation|2
7767773|NCT00705575|27001327|P2|Overall Study|Lost to Follow-up|4
7767774|NCT00705575|27001328|P1|Overall Study|Lost to Follow-up|3
7767775|NCT00705575|27001327|P2|Overall Study|Adverse Event|15
7767776|NCT00705575|27001328|P1|Overall Study|Adverse Event|11
7767777|NCT00705575|27001327|P2|Overall Study|Abnormal test procedure result(s)|12
7767778|NCT00705575|27001328|P1|Overall Study|Abnormal test procedure result(s)|2
7767779|NCT00705575|27001327|P2|Overall Study|Abnormal laboratory value(s)|3
7767780|NCT00705575|27001328|P1|Overall Study|Abnormal laboratory value(s)|0
7767781|NCT00705536|27001342|P4|Start Period 1|Withdrawal by Subject|1
7767782|NCT00705536|27001343|P3|Start Period 1|Withdrawal by Subject|0
7767783|NCT00705536|27001344|P2|Start Period 1|Withdrawal by Subject|0
7767784|NCT00705536|27001345|P1|Start Period 1|Withdrawal by Subject|0
7767785|NCT00705523|27001406|P2|Overall Study|Lost to Follow-up|3
7767786|NCT00705523|27001407|P1|Overall Study|Lost to Follow-up|2
7767787|NCT00705484|27001417|P2|Overall Study|Administrative|59
7767788|NCT00705484|27001418|P1|Overall Study|Administrative|89
7767789|NCT00705484|27001417|P2|Overall Study|Withdrawal by Subject|72
7767790|NCT00705484|27001418|P1|Overall Study|Withdrawal by Subject|96
7767791|NCT00705484|27001417|P2|Overall Study|Lost to Follow-up|250
7767792|NCT00705484|27001418|P1|Overall Study|Lost to Follow-up|169
7767793|NCT00705484|27001417|P2|Overall Study|Adverse Event|27
7767794|NCT00705484|27001418|P1|Overall Study|Adverse Event|28
7767795|NCT00705432|27001432|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
7767796|NCT00705432|27001433|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
7767797|NCT00705432|27001434|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
7767798|NCT00705432|27001435|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
7767799|NCT00705432|27001436|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
7767800|NCT00705432|27001437|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
7767801|NCT00705432|27001432|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
7767802|NCT00705432|27001433|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
7767803|NCT00705432|27001434|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
7767804|NCT00705432|27001435|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
7767805|NCT00705432|27001436|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
7767806|NCT00705432|27001437|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
7767807|NCT00705432|27001432|P6|Treatment Period|Non medical reason|7
7767808|NCT00705432|27001433|P5|Treatment Period|Non medical reason|7
7767809|NCT00705432|27001434|P4|Treatment Period|Non medical reason|4
7767810|NCT00705432|27001435|P3|Treatment Period|Non medical reason|37
7767811|NCT00705432|27001436|P2|Treatment Period|Non medical reason|32
7767812|NCT00705432|27001437|P1|Treatment Period|Non medical reason|26
7767813|NCT00705432|27001432|P6|Treatment Period|Treatment failure|14
7767814|NCT00705432|27001433|P5|Treatment Period|Treatment failure|13
7767815|NCT00705432|27001434|P4|Treatment Period|Treatment failure|25
7767816|NCT00705432|27001435|P3|Treatment Period|Treatment failure|33
7767817|NCT00705432|27001436|P2|Treatment Period|Treatment failure|42
7767818|NCT00705432|27001437|P1|Treatment Period|Treatment failure|92
7767819|NCT00705432|27001432|P6|Treatment Period|Adverse Event|9
7767820|NCT00705432|27001433|P5|Treatment Period|Adverse Event|8
7767821|NCT00705432|27001434|P4|Treatment Period|Adverse Event|12
7767822|NCT00705432|27001435|P3|Treatment Period|Adverse Event|51
7767823|NCT00705432|27001436|P2|Treatment Period|Adverse Event|37
7767824|NCT00705432|27001437|P1|Treatment Period|Adverse Event|45
7767825|NCT00705406|27001474|P2|Overall Study|Did not receive study drug|2
7767826|NCT00705406|27001475|P1|Overall Study|Did not receive study drug|1
7767827|NCT00705406|27001474|P2|Overall Study|Lost to Follow-up|3
7767828|NCT00705406|27001475|P1|Overall Study|Lost to Follow-up|3
7767829|NCT00705367|27001499|P2|Long-term Extension Period|Administrative reason by sponsor|0
7767830|NCT00705367|27001500|P1|Long-term Extension Period|Administrative reason by sponsor|3
7767831|NCT00705367|27001499|P2|Long-term Extension Period|No longer met study criteria|0
7767832|NCT00705367|27001500|P1|Long-term Extension Period|No longer met study criteria|1
7767833|NCT00705367|27001499|P2|Long-term Extension Period|Lack of Efficacy|0
7767834|NCT00705367|27001500|P1|Long-term Extension Period|Lack of Efficacy|1
7767835|NCT00705367|27001499|P2|Long-term Extension Period|Withdrawal by Subject|0
7767836|NCT00705367|27001500|P1|Long-term Extension Period|Withdrawal by Subject|2
7767837|NCT00705367|27001499|P2|Long-term Extension Period|Adverse Event|0
7767838|NCT00705367|27001500|P1|Long-term Extension Period|Adverse Event|2
7767839|NCT00705341|27001527|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
7767840|NCT00705341|27001528|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
7767841|NCT00705341|27001529|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
7767842|NCT00705341|27001530|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
7767843|NCT00705341|27001527|P4|Phase 2: Trial|Withdrawal by Subject|4
7767844|NCT00705341|27001528|P3|Phase 2: Trial|Withdrawal by Subject|6
7767845|NCT00705341|27001529|P2|Phase 2: Trial|Withdrawal by Subject|0
7767846|NCT00705341|27001530|P1|Phase 2: Trial|Withdrawal by Subject|0
7767847|NCT00705289|27001538|P1|Overall Study|Subject or treating physician's choice|131
7767848|NCT00705263|27001562|P1|Overall Study|Withdrawal by Subject|2
7767849|NCT00705250|27001566|P1|Overall Study|Patient died in car accident|1
7767850|NCT00705250|27001566|P1|Overall Study|Withdrawal by Subject|1
7767851|NCT00705224|27001570|P1|Overall Study|Lost to Follow-up|5
7767852|NCT00705224|27001570|P1|Overall Study|Withdrawal by Subject|3
7767853|NCT00705224|27001570|P1|Overall Study|Lack of Efficacy|2
7767854|NCT00705224|27001570|P1|Overall Study|Adverse Event|1
7767855|NCT00705159|27001586|P4|Overall Study|Screen Failure|1
7767856|NCT00705159|27001587|P3|Overall Study|Screen Failure|0
7767857|NCT00705159|27001588|P2|Overall Study|Screen Failure|0
7767858|NCT00705159|27001589|P1|Overall Study|Screen Failure|0
7767859|NCT00705159|27001586|P4|Overall Study|Lost to Follow-up|2
7767860|NCT00705159|27001587|P3|Overall Study|Lost to Follow-up|3
7767861|NCT00705159|27001588|P2|Overall Study|Lost to Follow-up|0
7767862|NCT00705159|27001589|P1|Overall Study|Lost to Follow-up|0
7767863|NCT00705159|27001586|P4|Overall Study|Adverse Event|0
7767864|NCT00705159|27001587|P3|Overall Study|Adverse Event|1
7767865|NCT00705159|27001588|P2|Overall Study|Adverse Event|0
7767866|NCT00705159|27001589|P1|Overall Study|Adverse Event|0
7767867|NCT00705159|27001586|P4|Overall Study|Protocol Violation|0
7767868|NCT00705159|27001587|P3|Overall Study|Protocol Violation|0
7767869|NCT00705159|27001588|P2|Overall Study|Protocol Violation|1
7767870|NCT00705159|27001589|P1|Overall Study|Protocol Violation|0
7767871|NCT00705159|27001586|P4|Overall Study|Withdrawal by Subject|1
7767872|NCT00705159|27001587|P3|Overall Study|Withdrawal by Subject|1
7767873|NCT00705159|27001588|P2|Overall Study|Withdrawal by Subject|1
7767874|NCT00705159|27001589|P1|Overall Study|Withdrawal by Subject|0
7767875|NCT00705146|27001609|P2|Overall Study|Lost to Follow-up|1
7767876|NCT00705146|27001610|P1|Overall Study|Lost to Follow-up|1
7767877|NCT00705016|27001646|P3|Overall Study|Other|6
7767878|NCT00705016|27001647|P2|Overall Study|Other|6
7767879|NCT00705016|27001648|P1|Overall Study|Other|9
7767880|NCT00705016|27001646|P3|Overall Study|Symptomatic Deterioration|1
7767881|NCT00705016|27001647|P2|Overall Study|Symptomatic Deterioration|1
7767882|NCT00705016|27001648|P1|Overall Study|Symptomatic Deterioration|3
7767883|NCT00705016|27001646|P3|Overall Study|Progressive Disease|33
7767884|NCT00705016|27001647|P2|Overall Study|Progressive Disease|29
7767885|NCT00705016|27001648|P1|Overall Study|Progressive Disease|33
7767886|NCT00705016|27001646|P3|Overall Study|Withdrawal by Subject|2
7767887|NCT00705016|27001647|P2|Overall Study|Withdrawal by Subject|3
7767888|NCT00705016|27001648|P1|Overall Study|Withdrawal by Subject|4
7767889|NCT00705016|27001646|P3|Overall Study|Protocol Violation|1
7767890|NCT00705016|27001647|P2|Overall Study|Protocol Violation|1
7767891|NCT00705016|27001648|P1|Overall Study|Protocol Violation|0
7767892|NCT00705016|27001646|P3|Overall Study|Death|5
7767893|NCT00705016|27001647|P2|Overall Study|Death|7
7767894|NCT00705016|27001648|P1|Overall Study|Death|5
7767895|NCT00705016|27001646|P3|Overall Study|Adverse Event|10
7767896|NCT00705016|27001647|P2|Overall Study|Adverse Event|11
7767897|NCT00705016|27001648|P1|Overall Study|Adverse Event|6
7767898|NCT00704964|27001699|P1|Overall Study|Not completed on time|328
7767899|NCT00704808|27001760|P1|Overall Study|Treatment change|1
7767900|NCT00704808|27001760|P1|Overall Study|Lost to Follow-up|1
7767901|NCT00704808|27001760|P1|Overall Study|Adverse Event|1
7767902|NCT00704808|27001760|P1|Overall Study|Early therapy discontinuation|16
7767903|NCT00704808|27001760|P1|Overall Study|Patient's decision|11
7767904|NCT00704808|27001760|P1|Overall Study|Tumor progression|80
7767905|NCT00704808|27001760|P1|Overall Study|Death|7
7767906|NCT00704808|27001760|P1|Overall Study|Discontinued prior to starting treatment|14
7767907|NCT00704730|27001771|P2|Overall Study|Withdrawal by Subject|13
7767908|NCT00704730|27001772|P1|Overall Study|Withdrawal by Subject|9
7767909|NCT00704730|27001771|P2|Overall Study|data unavailable|0
7767910|NCT00704730|27001772|P1|Overall Study|data unavailable|1
7767911|NCT00704730|27001771|P2|Overall Study|Disease progression per PI|67
7767912|NCT00704730|27001772|P1|Overall Study|Disease progression per PI|58
7767913|NCT00704730|27001771|P2|Overall Study|Did not receive drug|2
7767914|NCT00704730|27001772|P1|Overall Study|Did not receive drug|5
7767915|NCT00704730|27001771|P2|Overall Study|Physician Decision|0
7767916|NCT00704730|27001772|P1|Overall Study|Physician Decision|2
7767917|NCT00704730|27001771|P2|Overall Study|Death|5
7767918|NCT00704730|27001772|P1|Overall Study|Death|11
7767919|NCT00704730|27001771|P2|Overall Study|Adverse Event|9
7767920|NCT00704730|27001772|P1|Overall Study|Adverse Event|35
7767921|NCT00704535|27001792|P1|Overall Study|Completed status not on Case Report Form|124
7767922|NCT00704535|27001792|P1|Overall Study|Protocol Violation|10
7767923|NCT00704535|27001792|P1|Overall Study|Lost to Follow-up|8
7767924|NCT00704535|27001792|P1|Overall Study|Death|2
7767925|NCT00704535|27001792|P1|Overall Study|Adverse Event|2
7767926|NCT00704522|27001805|P2|Overall Study|No information on therapy end|2
7767927|NCT00704522|27001806|P1|Overall Study|No information on therapy end|27
7767928|NCT00704522|27001805|P2|Overall Study|Undefined causes|7
7767929|NCT00704522|27001806|P1|Overall Study|Undefined causes|9
7767930|NCT00704522|27001805|P2|Overall Study|Adverse Event|1
7767931|NCT00704522|27001806|P1|Overall Study|Adverse Event|9
7767932|NCT00704522|27001805|P2|Overall Study|Withdrawal by Subject|8
7767933|NCT00704522|27001806|P1|Overall Study|Withdrawal by Subject|17
7767934|NCT00704522|27001805|P2|Overall Study|Failure to appear again at hospital|10
7767935|NCT00704522|27001806|P1|Overall Study|Failure to appear again at hospital|56
7767936|NCT00704522|27001805|P2|Overall Study|Lack of Efficacy|17
7767937|NCT00704522|27001806|P1|Overall Study|Lack of Efficacy|65
7767938|NCT00704418|27001826|P2|Overall Study|Over-enrolled/surgery postponed|6
7767939|NCT00704418|27001827|P1|Overall Study|Over-enrolled/surgery postponed|3
7767940|NCT00704418|27001826|P2|Overall Study|Withdrawal by Subject|0
7767941|NCT00704418|27001827|P1|Overall Study|Withdrawal by Subject|2
7767942|NCT00704405|27001840|P5|Overall Study (C Population)|Lost to Follow-up|0
7767943|NCT00704405|27001841|P4|Overall Study (C Population)|Lost to Follow-up|0
7767944|NCT00704405|27001842|P3|Overall Study (C Population)|Lost to Follow-up|0
7767945|NCT00704405|27001843|P2|Overall Study (C Population)|Lost to Follow-up|2
7767946|NCT00704405|27001844|P1|Overall Study (C Population)|Lost to Follow-up|0
7767947|NCT00704405|27001840|P5|Overall Study (C Population)|Withdrawal by Subject|0
7767948|NCT00704405|27001841|P4|Overall Study (C Population)|Withdrawal by Subject|1
7767949|NCT00704405|27001842|P3|Overall Study (C Population)|Withdrawal by Subject|1
7767950|NCT00704405|27001843|P2|Overall Study (C Population)|Withdrawal by Subject|1
7767951|NCT00704405|27001844|P1|Overall Study (C Population)|Withdrawal by Subject|1
7767952|NCT00704405|27001840|P5|Overall Study (NC Population)|Other|1
7767953|NCT00704405|27001841|P4|Overall Study (NC Population)|Other|0
7767954|NCT00704405|27001842|P3|Overall Study (NC Population)|Other|0
7767955|NCT00704405|27001843|P2|Overall Study (NC Population)|Other|0
7767956|NCT00704405|27001844|P1|Overall Study (NC Population)|Other|0
7767957|NCT00704405|27001840|P5|Overall Study (NC Population)|Withdrawal by Subject|2
7767958|NCT00704405|27001841|P4|Overall Study (NC Population)|Withdrawal by Subject|2
7767959|NCT00704405|27001842|P3|Overall Study (NC Population)|Withdrawal by Subject|2
7767960|NCT00704405|27001843|P2|Overall Study (NC Population)|Withdrawal by Subject|3
7767961|NCT00704405|27001844|P1|Overall Study (NC Population)|Withdrawal by Subject|2
7767962|NCT00704405|27001840|P5|Overall Study (NC Population)|Lost to Follow-up|2
7767963|NCT00704405|27001841|P4|Overall Study (NC Population)|Lost to Follow-up|2
7767964|NCT00704405|27001842|P3|Overall Study (NC Population)|Lost to Follow-up|1
7767965|NCT00704405|27001843|P2|Overall Study (NC Population)|Lost to Follow-up|1
7767966|NCT00704405|27001844|P1|Overall Study (NC Population)|Lost to Follow-up|2
7767967|NCT00704405|27001840|P5|Overall Study (NC Population)|Adverse Event|0
7767968|NCT00704405|27001841|P4|Overall Study (NC Population)|Adverse Event|0
7767969|NCT00704405|27001842|P3|Overall Study (NC Population)|Adverse Event|0
7767970|NCT00704405|27001843|P2|Overall Study (NC Population)|Adverse Event|0
7767971|NCT00704405|27001844|P1|Overall Study (NC Population)|Adverse Event|1
7767972|NCT00704340|27001902|P2|Overall Study|Death|1
7767973|NCT00704340|27001903|P1|Overall Study|Death|0
7767974|NCT00704340|27001902|P2|Overall Study|Lost to Follow-up|1
7767975|NCT00704340|27001903|P1|Overall Study|Lost to Follow-up|2
7767976|NCT00704184|27001934|P5|Open-Label Treatment|Withdrawal by Subject|0
7767977|NCT00704184|27001935|P4|Open-Label Treatment|Withdrawal by Subject|3
7767978|NCT00704184|27001936|P3|Open-Label Treatment|Withdrawal by Subject|0
7767979|NCT00704184|27001937|P2|Open-Label Treatment|Withdrawal by Subject|0
7767980|NCT00704184|27001938|P1|Open-Label Treatment|Withdrawal by Subject|1
7767981|NCT00704184|27001934|P5|Open-Label Treatment|Physician Decision|1
7767982|NCT00704184|27001935|P4|Open-Label Treatment|Physician Decision|0
7767983|NCT00704184|27001936|P3|Open-Label Treatment|Physician Decision|0
7767984|NCT00704184|27001937|P2|Open-Label Treatment|Physician Decision|0
7767985|NCT00704184|27001938|P1|Open-Label Treatment|Physician Decision|0
7767986|NCT00704184|27001934|P5|Open-Label Treatment|Lack of Efficacy|1
7767987|NCT00704184|27001935|P4|Open-Label Treatment|Lack of Efficacy|2
7767988|NCT00704184|27001936|P3|Open-Label Treatment|Lack of Efficacy|2
7767989|NCT00704184|27001937|P2|Open-Label Treatment|Lack of Efficacy|2
7767990|NCT00704184|27001938|P1|Open-Label Treatment|Lack of Efficacy|0
7767991|NCT00704184|27001934|P5|Open-Label Treatment|Adverse Event|1
7767992|NCT00704184|27001935|P4|Open-Label Treatment|Adverse Event|0
7767993|NCT00704184|27001936|P3|Open-Label Treatment|Adverse Event|2
7767994|NCT00704184|27001937|P2|Open-Label Treatment|Adverse Event|0
7767995|NCT00704184|27001938|P1|Open-Label Treatment|Adverse Event|0
7767996|NCT00704184|27001934|P5|Double-Blind Treatment|Withdrawal by Subject|0
7767997|NCT00704184|27001935|P4|Double-Blind Treatment|Withdrawal by Subject|0
7767998|NCT00704184|27001936|P3|Double-Blind Treatment|Withdrawal by Subject|0
7767999|NCT00704184|27001937|P2|Double-Blind Treatment|Withdrawal by Subject|0
7768000|NCT00704184|27001938|P1|Double-Blind Treatment|Withdrawal by Subject|1
7768001|NCT00704171|27001977|P2|Overall Study|Withdrawal by Subject|0
7768002|NCT00704171|27001978|P1|Overall Study|Withdrawal by Subject|1
7768003|NCT00704132|27001996|P2|Overall Study|Withdrawal by Subject|1
7768004|NCT00704132|27001997|P1|Overall Study|Withdrawal by Subject|0
7768005|NCT00704132|27001996|P2|Overall Study|Lack of Efficacy|1
7768006|NCT00704132|27001997|P1|Overall Study|Lack of Efficacy|0
7768007|NCT00704132|27001996|P2|Overall Study|Clinical Adverse Experience|0
7768008|NCT00704132|27001997|P1|Overall Study|Clinical Adverse Experience|1
7768009|NCT00703963|27002025|P2|Overall Study|Physician Decision|1
7768010|NCT00703963|27002026|P1|Overall Study|Physician Decision|0
7768011|NCT00703963|27002025|P2|Overall Study|Withdrawal by Subject|13
7768012|NCT00703963|27002026|P1|Overall Study|Withdrawal by Subject|7
7768013|NCT00703924|27002047|P2|Overall Study|Withdrawal by Subject|1
7768014|NCT00703924|27002048|P1|Overall Study|Withdrawal by Subject|1
7768015|NCT00703911|27002064|P1|Overall Study|Withdrawal by Subject|2
7768016|NCT00703911|27002064|P1|Overall Study|Lost to Follow-up|1
7768017|NCT00703911|27002064|P1|Overall Study|Physician Decision|6
7768018|NCT00703911|27002064|P1|Overall Study|Death|1
7768019|NCT00703846|27002097|P1|Overall Study|Did Not Receive Study Drug|2
7768020|NCT00703846|27002097|P1|Overall Study|Other|14
7768021|NCT00703846|27002097|P1|Overall Study|Death|1
7768022|NCT00703846|27002097|P1|Overall Study|Withdrawal by Subject|40
7768023|NCT00703846|27002097|P1|Overall Study|Noncompliance with Study Treatment|2
7768024|NCT00703846|27002097|P1|Overall Study|Lack of Efficacy|15
7768025|NCT00703846|27002097|P1|Overall Study|Lost to Follow-up|55
7768026|NCT00703846|27002097|P1|Overall Study|Adverse Event|8
7768027|NCT00703820|27002113|P2|Overall Study|Withdrawal by Subject|1
7768028|NCT00703820|27002114|P1|Overall Study|Withdrawal by Subject|2
7768029|NCT00703820|27002113|P2|Overall Study|Physician Decision|5
7768030|NCT00703820|27002114|P1|Overall Study|Physician Decision|4
7768031|NCT00703820|27002113|P2|Overall Study|Received non-protocol therapy|0
7768032|NCT00703820|27002114|P1|Overall Study|Received non-protocol therapy|1
7768033|NCT00703820|27002113|P2|Overall Study|Lack of Efficacy|11
7768034|NCT00703820|27002114|P1|Overall Study|Lack of Efficacy|11
7768035|NCT00703820|27002113|P2|Overall Study|Death|0
7768036|NCT00703820|27002114|P1|Overall Study|Death|5
7768037|NCT00703820|27002113|P2|Overall Study|Adverse Event|17
7768038|NCT00703820|27002114|P1|Overall Study|Adverse Event|12
7768039|NCT00703781|27002127|P2|Overall Study|Cancelled surgery|0
7768040|NCT00703781|27002128|P1|Overall Study|Cancelled surgery|1
7768041|NCT00703781|27002127|P2|Overall Study|Withdrawal by Subject|2
7768042|NCT00703781|27002128|P1|Overall Study|Withdrawal by Subject|1
7768043|NCT00703677|27002173|P1|Overall Study|Dropout-withdrawal not related to drug|3
7768044|NCT00703534|27002213|P2|Overall Study|Severe Non Compliance|5
7768045|NCT00703534|27002214|P1|Overall Study|Severe Non Compliance|1
7768046|NCT00703534|27002213|P2|Overall Study|Lost to Follow-up|4
7768047|NCT00703534|27002214|P1|Overall Study|Lost to Follow-up|1
7768048|NCT00703534|27002213|P2|Overall Study|Incorrect Enrollment|6
7768049|NCT00703534|27002214|P1|Overall Study|Incorrect Enrollment|6
7768050|NCT00703534|27002213|P2|Overall Study|Withdrawal by Subject|7
7768051|NCT00703534|27002214|P1|Overall Study|Withdrawal by Subject|8
7768052|NCT00703534|27002213|P2|Overall Study|Adverse Event|3
7768053|NCT00703534|27002214|P1|Overall Study|Adverse Event|14
7768054|NCT00703326|27002286|P2|Overall Study|Withdrawal by Subject|20
7768055|NCT00703326|27002287|P1|Overall Study|Withdrawal by Subject|42
7768056|NCT00703326|27002286|P2|Overall Study|Lost to Follow-up|8
7768057|NCT00703326|27002287|P1|Overall Study|Lost to Follow-up|25
7768058|NCT00703326|27002286|P2|Overall Study|Still on study|197
7768059|NCT00703326|27002287|P1|Overall Study|Still on study|380
7768060|NCT00703157|27002319|P2|Overall Study|source data permanently lost/ other|1
7768061|NCT00703157|27002320|P1|Overall Study|source data permanently lost/ other|4
7768062|NCT00703157|27002319|P2|Overall Study|Lost to Follow-up|1
7768063|NCT00703157|27002320|P1|Overall Study|Lost to Follow-up|0
7768064|NCT00703118|27002354|P3|Overall Study|Other|1
7768065|NCT00703118|27002355|P2|Overall Study|Other|0
7768066|NCT00703118|27002356|P1|Overall Study|Other|0
7768067|NCT00703118|27002354|P3|Overall Study|Withdrawal by Subject|13
7768068|NCT00703118|27002355|P2|Overall Study|Withdrawal by Subject|7
7768069|NCT00703118|27002356|P1|Overall Study|Withdrawal by Subject|8
7768070|NCT00703118|27002354|P3|Overall Study|Lost to Follow-up|4
7768071|NCT00703118|27002355|P2|Overall Study|Lost to Follow-up|4
7768072|NCT00703118|27002356|P1|Overall Study|Lost to Follow-up|6
7768073|NCT00703118|27002354|P3|Overall Study|Subject Ineligible To Continue The Trial|2
7768074|NCT00703118|27002355|P2|Overall Study|Subject Ineligible To Continue The Trial|3
7768075|NCT00703118|27002356|P1|Overall Study|Subject Ineligible To Continue The Trial|6
7768076|NCT00703118|27002354|P3|Overall Study|Adverse Event|2
7768077|NCT00703118|27002355|P2|Overall Study|Adverse Event|2
7768078|NCT00703118|27002356|P1|Overall Study|Adverse Event|1
7768079|NCT00703092|27002387|P1|Overall Study|Withdrawal by Subject|2
7768080|NCT00703014|27002595|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
7768081|NCT00703014|27002596|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
7768082|NCT00703014|27002597|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
7768083|NCT00703014|27002598|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
7768084|NCT00703014|27002595|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
7768085|NCT00703014|27002596|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
7768086|NCT00703014|27002597|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
7768087|NCT00703014|27002598|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
7768088|NCT00702962|27002618|P2|Overall Study|Hospitalized for other health disorder|0
7768089|NCT00702962|27002619|P1|Overall Study|Hospitalized for other health disorder|1
7768090|NCT00702962|27002618|P2|Overall Study|Progressive disease|1
7768091|NCT00702962|27002619|P1|Overall Study|Progressive disease|0
7768092|NCT00702949|27002630|P3|Overall Study|Other Medical Reason/unknown|3
7768093|NCT00702949|27002631|P2|Overall Study|Other Medical Reason/unknown|1
7768094|NCT00702949|27002632|P1|Overall Study|Other Medical Reason/unknown|1
7768095|NCT00702949|27002630|P3|Overall Study|Adverse Event|3
7768096|NCT00702949|27002631|P2|Overall Study|Adverse Event|6
7768097|NCT00702949|27002632|P1|Overall Study|Adverse Event|1
7768098|NCT00702949|27002630|P3|Overall Study|Refusal|2
7768099|NCT00702949|27002631|P2|Overall Study|Refusal|2
7768100|NCT00702949|27002632|P1|Overall Study|Refusal|3
7768101|NCT00702923|27002657|P1|Overall Study|Adverse Event|1
7768102|NCT00702845|27002680|P2|Overall Study|Not randomized|1
7768103|NCT00702845|27002681|P1|Overall Study|Not randomized|0
7768104|NCT00702845|27002680|P2|Overall Study|Patient's decision|1
7768105|NCT00702845|27002681|P1|Overall Study|Patient's decision|2
7768106|NCT00702845|27002680|P2|Overall Study|No or abnormal fertilization|2
7768107|NCT00702845|27002681|P1|Overall Study|No or abnormal fertilization|4
7768108|NCT00702845|27002680|P2|Overall Study|No/too few/bad quality embryos retrieved|1
7768109|NCT00702845|27002681|P1|Overall Study|No/too few/bad quality embryos retrieved|7
7768110|NCT00702845|27002680|P2|Overall Study|Insufficient ovarian response|0
7768111|NCT00702845|27002681|P1|Overall Study|Insufficient ovarian response|1
7768112|NCT00702845|27002680|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
7768113|NCT00702845|27002681|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
7768114|NCT00702845|27002680|P2|Overall Study|Too high ovarian response|1
7768115|NCT00702845|27002681|P1|Overall Study|Too high ovarian response|5
7768116|NCT00702845|27002680|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
7768117|NCT00702845|27002681|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
7768118|NCT00702715|27002743|P2|Overall Study|Lost to Follow-up|0
7768119|NCT00702715|27002744|P1|Overall Study|Lost to Follow-up|1
7768120|NCT00702702|27002757|P1|Overall Study|Study prematurely terminated|56
7768121|NCT00702689|27002765|P1|Overall Study|Adverse Event|1
7768122|NCT00702689|27002765|P1|Overall Study|Recurrent malignancy|1
7768123|NCT00702689|27002765|P1|Overall Study|Withdrawal by Subject|4
7768124|NCT00702650|27002776|P1|Overall Study|Adverse Event|3
7768125|NCT00702650|27002776|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
7768126|NCT00702650|27002776|P1|Overall Study|Sponsor Request|1
7768127|NCT00702650|27002776|P1|Overall Study|Non-Compliance with Site Directives|1
7768128|NCT00702650|27002776|P1|Overall Study|Lost to Follow-up|2
7768129|NCT00702650|27002776|P1|Overall Study|Non-Compliance of Study Drug|3
7768130|NCT00702650|27002776|P1|Overall Study|Withdrawal by Subject|9
7768131|NCT00702520|27002838|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
7768132|NCT00702520|27002839|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
7768133|NCT00702520|27002840|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
7768134|NCT00702520|27002841|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
7768135|NCT00702520|27002838|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
7768136|NCT00702520|27002839|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
7768137|NCT00702520|27002840|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
7768138|NCT00702520|27002841|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
7768139|NCT00702520|27002838|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7768140|NCT00702520|27002839|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7768141|NCT00702520|27002840|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
7768142|NCT00702520|27002841|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7768143|NCT00702507|27002857|P1|Follow-up Phase|Late Enrollment|1
7768144|NCT00702507|27002857|P1|Follow-up Phase|Lost to Follow-up|23
7768145|NCT00702507|27002857|P1|Follow-up Phase|Protocol Violation|2
7768146|NCT00702507|27002857|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
7768147|NCT00702507|27002857|P1|Initial Treatment Phase|Negative Candida Culture|34
7768148|NCT00702507|27002857|P1|Initial Treatment Phase|Lost to Follow-up|2
7768149|NCT00702507|27002857|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
7768150|NCT00702507|27002857|P1|Initial Treatment Phase|Adverse Event|2
7768151|NCT00702403|27002894|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
7768152|NCT00702403|27002894|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
7768153|NCT00702403|27002894|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
7768154|NCT00702403|27002894|P1|From Engraftment to Study Completion|Suicide|1
7768155|NCT00702403|27002894|P1|From Engraftment to Study Completion|Liver GVHD|1
7768156|NCT00702403|27002894|P1|From Engraftment to Study Completion|Adenocarcinoma|1
7768157|NCT00702403|27002894|P1|From Engraftment to Study Completion|Non-compliance|2
7768158|NCT00702403|27002894|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
7768159|NCT00702403|27002894|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
7768160|NCT00702403|27002894|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
7768161|NCT00702403|27002894|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
7768162|NCT00702403|27002894|P1|From Consent to Engraftment|Myocardial infarction|1
7768163|NCT00702403|27002894|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
7768164|NCT00702403|27002894|P1|From Consent to Engraftment|Critically ill|2
7768165|NCT00702403|27002894|P1|From Consent to Engraftment|Progressive leukemia|6
7768166|NCT00702325|27002948|P2|Overall Study|Incorrectly Discontinued|1
7768167|NCT00702325|27002949|P1|Overall Study|Incorrectly Discontinued|0
7768168|NCT00702325|27002948|P2|Overall Study|Withdrew consent|1
7768169|NCT00702325|27002949|P1|Overall Study|Withdrew consent|0
7768170|NCT00702325|27002948|P2|Overall Study|Didn't follow study medication dosage|2
7768171|NCT00702325|27002949|P1|Overall Study|Didn't follow study medication dosage|0
7768172|NCT00702325|27002948|P2|Overall Study|Termination due to lab results|0
7768173|NCT00702325|27002949|P1|Overall Study|Termination due to lab results|1
7768174|NCT00702325|27002948|P2|Overall Study|Severe noncompliance to protocol|3
7768175|NCT00702325|27002949|P1|Overall Study|Severe noncompliance to protocol|3
7768176|NCT00702325|27002948|P2|Overall Study|Developed study discontinuation criteria|28
7768177|NCT00702325|27002949|P1|Overall Study|Developed study discontinuation criteria|18
7768178|NCT00702325|27002948|P2|Overall Study|Incorrect enrollment|7
7768179|NCT00702325|27002949|P1|Overall Study|Incorrect enrollment|5
7768180|NCT00702325|27002948|P2|Overall Study|Lost to Follow-up|4
7768181|NCT00702325|27002949|P1|Overall Study|Lost to Follow-up|3
7768182|NCT00702325|27002948|P2|Overall Study|Withdrawal by Subject|7
7768183|NCT00702325|27002949|P1|Overall Study|Withdrawal by Subject|7
7768184|NCT00702325|27002948|P2|Overall Study|Adverse Event|0
7768185|NCT00702325|27002949|P1|Overall Study|Adverse Event|1
7768186|NCT00702221|27003045|P2|Overall Study|Adverse Event|3
7768187|NCT00702221|27003046|P1|Overall Study|Adverse Event|4
7768188|NCT00702208|27003052|P1|Overall Study|Unsatisfactory colposcopy|2
7768189|NCT00702208|27003052|P1|Overall Study|Did not self-lavage|1
7768190|NCT00702208|27003052|P1|Overall Study|Lost to Follow-up|28
7768191|NCT00702143|27003061|P3|Overall Study|Lost to Follow-up|1
7768192|NCT00702143|27003062|P2|Overall Study|Lost to Follow-up|0
7768193|NCT00702143|27003063|P1|Overall Study|Lost to Follow-up|0
7768194|NCT00702052|27003075|P1|Overall Study|Withdrawal by Subject|5
7768195|NCT00702052|27003075|P1|Overall Study|Disease Progression|30
7768196|NCT00702052|27003075|P1|Overall Study|Adverse Event|23
7768197|NCT00701805|27003132|P4|Overall Study|Resumption criteria were not met|0
7768198|NCT00701805|27003133|P3|Overall Study|Resumption criteria were not met|0
7768199|NCT00701805|27003134|P2|Overall Study|Resumption criteria were not met|1
7768200|NCT00701805|27003135|P1|Overall Study|Resumption criteria were not met|0
7768201|NCT00701805|27003132|P4|Overall Study|Difficult to travel to dialysis site|0
7768202|NCT00701805|27003133|P3|Overall Study|Difficult to travel to dialysis site|1
7768203|NCT00701805|27003134|P2|Overall Study|Difficult to travel to dialysis site|0
7768204|NCT00701805|27003135|P1|Overall Study|Difficult to travel to dialysis site|0
7768205|NCT00701805|27003132|P4|Overall Study|Physician decision, change of therapy|1
7768206|NCT00701805|27003133|P3|Overall Study|Physician decision, change of therapy|0
7768207|NCT00701805|27003134|P2|Overall Study|Physician decision, change of therapy|0
7768208|NCT00701805|27003135|P1|Overall Study|Physician decision, change of therapy|0
7768209|NCT00701805|27003132|P4|Overall Study|Admitted to hospital for 2 weeks|0
7768210|NCT00701805|27003133|P3|Overall Study|Admitted to hospital for 2 weeks|1
7768211|NCT00701805|27003134|P2|Overall Study|Admitted to hospital for 2 weeks|0
7768212|NCT00701805|27003135|P1|Overall Study|Admitted to hospital for 2 weeks|0
7768213|NCT00701805|27003132|P4|Overall Study|Missed 7 consecutive doses|0
7768214|NCT00701805|27003133|P3|Overall Study|Missed 7 consecutive doses|0
7768215|NCT00701805|27003134|P2|Overall Study|Missed 7 consecutive doses|1
7768216|NCT00701805|27003135|P1|Overall Study|Missed 7 consecutive doses|0
7768217|NCT00701805|27003132|P4|Overall Study|Adverse Event|0
7768218|NCT00701805|27003133|P3|Overall Study|Adverse Event|1
7768219|NCT00701805|27003134|P2|Overall Study|Adverse Event|1
7768220|NCT00701805|27003135|P1|Overall Study|Adverse Event|0
7768221|NCT00701805|27003132|P4|Overall Study|Withdrawal by Subject|3
7768222|NCT00701805|27003133|P3|Overall Study|Withdrawal by Subject|4
7768223|NCT00701805|27003134|P2|Overall Study|Withdrawal by Subject|1
7768224|NCT00701805|27003135|P1|Overall Study|Withdrawal by Subject|3
7768225|NCT00701779|27003185|P1|Overall Study|Withdrawal by Subject|2
7768226|NCT00701779|27003185|P1|Overall Study|Lost to Follow-up|1
7768227|NCT00701779|27003185|P1|Overall Study|Adverse Event|6
7768228|NCT00701727|27003197|P2|Second Treatment Period|Withdrawal by Subject|0
7768229|NCT00701727|27003198|P1|Second Treatment Period|Withdrawal by Subject|2
7768230|NCT00701727|27003197|P2|First Treatment Period|Lost to Follow-up|1
7768231|NCT00701727|27003198|P1|First Treatment Period|Lost to Follow-up|0
7768232|NCT00701727|27003197|P2|First Treatment Period|sponsor decision|1
7768233|NCT00701727|27003198|P1|First Treatment Period|sponsor decision|0
7768234|NCT00701727|27003197|P2|First Treatment Period|Withdrawal by Subject|0
7768235|NCT00701727|27003198|P1|First Treatment Period|Withdrawal by Subject|1
7768236|NCT00701727|27003197|P2|First Treatment Period|Adverse Event|0
7768237|NCT00701727|27003198|P1|First Treatment Period|Adverse Event|0
7768238|NCT00701701|27003233|P2|Overall Study|Adverse Event|1
7768239|NCT00701701|27003234|P1|Overall Study|Adverse Event|0
7768240|NCT00701701|27003233|P2|Overall Study|Withdrawal by Subject|1
7768241|NCT00701701|27003234|P1|Overall Study|Withdrawal by Subject|0
7768242|NCT00701662|27003269|P1|Overall Study|Lack of Efficacy|1
7768243|NCT00701558|27003294|P1|Overall Study|Lost to Follow-up|8
7768244|NCT00701558|27003294|P1|Overall Study|Death|7
7768245|NCT00701441|27003302|P2|Overall Study|failure in cpap compliance|4
7768246|NCT00701441|27003303|P1|Overall Study|failure in cpap compliance|0
7768247|NCT00701415|27003315|P2|Overall Study|Social/family issues and needle phobia|0
7768248|NCT00701415|27003316|P1|Overall Study|Social/family issues and needle phobia|1
7768249|NCT00701415|27003315|P2|Overall Study|Adverse Event|1
7768250|NCT00701415|27003316|P1|Overall Study|Adverse Event|0
7768251|NCT00701363|27003375|P4|Treatment Phase 2|Withdrawal by Subject|0
7768252|NCT00701363|27003376|P3|Treatment Phase 2|Withdrawal by Subject|1
7768253|NCT00701363|27003377|P2|Treatment Phase 2|Withdrawal by Subject|0
7768254|NCT00701363|27003378|P1|Treatment Phase 2|Withdrawal by Subject|0
7768255|NCT00701363|27003375|P4|Treatment Phase 2|Adverse Event|0
7768256|NCT00701363|27003376|P3|Treatment Phase 2|Adverse Event|1
7768257|NCT00701363|27003377|P2|Treatment Phase 2|Adverse Event|0
7768258|NCT00701363|27003378|P1|Treatment Phase 2|Adverse Event|0
7768259|NCT00701363|27003375|P4|Treatment Phase 1|Lack of Efficacy|0
7768260|NCT00701363|27003376|P3|Treatment Phase 1|Lack of Efficacy|0
7768261|NCT00701363|27003377|P2|Treatment Phase 1|Lack of Efficacy|0
7768262|NCT00701363|27003378|P1|Treatment Phase 1|Lack of Efficacy|1
7768263|NCT00701363|27003375|P4|Treatment Phase 1|Withdrawal by Subject|0
7768264|NCT00701363|27003376|P3|Treatment Phase 1|Withdrawal by Subject|0
7768265|NCT00701363|27003377|P2|Treatment Phase 1|Withdrawal by Subject|0
7768266|NCT00701363|27003378|P1|Treatment Phase 1|Withdrawal by Subject|5
7768267|NCT00701363|27003375|P4|Treatment Phase 1|Protocol Violation|0
7768268|NCT00701363|27003376|P3|Treatment Phase 1|Protocol Violation|0
7768269|NCT00701363|27003377|P2|Treatment Phase 1|Protocol Violation|0
7768270|NCT00701363|27003378|P1|Treatment Phase 1|Protocol Violation|1
7768271|NCT00701363|27003375|P4|Treatment Phase 1|Adverse Event|0
7768272|NCT00701363|27003376|P3|Treatment Phase 1|Adverse Event|0
7768273|NCT00701363|27003377|P2|Treatment Phase 1|Adverse Event|0
7768274|NCT00701363|27003378|P1|Treatment Phase 1|Adverse Event|7
7768275|NCT00701363|27003375|P4|Treatment Phase 1|Does not meet entry Criteria|0
7768276|NCT00701363|27003376|P3|Treatment Phase 1|Does not meet entry Criteria|0
7768277|NCT00701363|27003377|P2|Treatment Phase 1|Does not meet entry Criteria|0
7768278|NCT00701363|27003378|P1|Treatment Phase 1|Does not meet entry Criteria|1
7768279|NCT00701363|27003375|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7768280|NCT00701363|27003376|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7768281|NCT00701363|27003377|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7768282|NCT00701363|27003378|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
7768283|NCT00701311|27003418|P1|Overall Study|Withdrawal by Subject|2
7768284|NCT00701311|27003418|P1|Overall Study|Adverse Event|3
7768285|NCT00701311|27003418|P1|Overall Study|Lack of Efficacy|3
7768286|NCT00701129|27003422|P1|Overall Study|Death|2
7768287|NCT00701103|27003444|P11|Overall Study|Other|0
7768288|NCT00701103|27003445|P10|Overall Study|Other|1
7768289|NCT00701103|27003446|P9|Overall Study|Other|1
7768290|NCT00701103|27003447|P8|Overall Study|Other|0
7768291|NCT00701103|27003448|P7|Overall Study|Other|0
7768292|NCT00701103|27003449|P6|Overall Study|Other|0
7768293|NCT00701103|27003450|P5|Overall Study|Other|0
7768294|NCT00701103|27003451|P4|Overall Study|Other|0
7768295|NCT00701103|27003452|P3|Overall Study|Other|0
7768296|NCT00701103|27003453|P2|Overall Study|Other|0
7768297|NCT00701103|27003454|P1|Overall Study|Other|0
7768298|NCT00701103|27003444|P11|Overall Study|Withdrawal by Subject|0
7768299|NCT00701103|27003445|P10|Overall Study|Withdrawal by Subject|0
7768300|NCT00701103|27003446|P9|Overall Study|Withdrawal by Subject|0
7768301|NCT00701103|27003447|P8|Overall Study|Withdrawal by Subject|0
7768302|NCT00701103|27003448|P7|Overall Study|Withdrawal by Subject|0
7768303|NCT00701103|27003449|P6|Overall Study|Withdrawal by Subject|0
7768304|NCT00701103|27003450|P5|Overall Study|Withdrawal by Subject|0
7768305|NCT00701103|27003451|P4|Overall Study|Withdrawal by Subject|0
7768306|NCT00701103|27003452|P3|Overall Study|Withdrawal by Subject|1
7768307|NCT00701103|27003453|P2|Overall Study|Withdrawal by Subject|1
7768308|NCT00701103|27003454|P1|Overall Study|Withdrawal by Subject|0
7768309|NCT00701103|27003444|P11|Overall Study|Progressive Disease|11
7768310|NCT00701103|27003445|P10|Overall Study|Progressive Disease|8
7768311|NCT00701103|27003446|P9|Overall Study|Progressive Disease|8
7768312|NCT00701103|27003447|P8|Overall Study|Progressive Disease|7
7768313|NCT00701103|27003448|P7|Overall Study|Progressive Disease|7
7768314|NCT00701103|27003449|P6|Overall Study|Progressive Disease|5
7768315|NCT00701103|27003450|P5|Overall Study|Progressive Disease|6
7768316|NCT00701103|27003451|P4|Overall Study|Progressive Disease|5
7768317|NCT00701103|27003452|P3|Overall Study|Progressive Disease|6
7768318|NCT00701103|27003453|P2|Overall Study|Progressive Disease|2
7768319|NCT00701103|27003454|P1|Overall Study|Progressive Disease|5
7768320|NCT00701103|27003444|P11|Overall Study|Adverse Event|0
7768321|NCT00701103|27003445|P10|Overall Study|Adverse Event|2
7768322|NCT00701103|27003446|P9|Overall Study|Adverse Event|0
7768323|NCT00701103|27003447|P8|Overall Study|Adverse Event|0
7768324|NCT00701103|27003448|P7|Overall Study|Adverse Event|1
7768325|NCT00701103|27003449|P6|Overall Study|Adverse Event|1
7768326|NCT00701103|27003450|P5|Overall Study|Adverse Event|0
7768327|NCT00701103|27003451|P4|Overall Study|Adverse Event|1
7768328|NCT00701103|27003452|P3|Overall Study|Adverse Event|1
7768329|NCT00701103|27003453|P2|Overall Study|Adverse Event|0
7768330|NCT00701103|27003454|P1|Overall Study|Adverse Event|0
7768331|NCT00701090|27003560|P2|Overall Study|Other|12
7768332|NCT00701090|27003561|P1|Overall Study|Other|7
7768333|NCT00701090|27003560|P2|Overall Study|Withdrawal by Subject|16
7768334|NCT00701090|27003561|P1|Overall Study|Withdrawal by Subject|11
7768335|NCT00701090|27003560|P2|Overall Study|Protocol Violation|3
7768336|NCT00701090|27003561|P1|Overall Study|Protocol Violation|2
7768337|NCT00701090|27003560|P2|Overall Study|Physician Decision|4
7768338|NCT00701090|27003561|P1|Overall Study|Physician Decision|3
7768339|NCT00701090|27003560|P2|Overall Study|Lost to Follow-up|9
7768340|NCT00701090|27003561|P1|Overall Study|Lost to Follow-up|9
7768341|NCT00701090|27003560|P2|Overall Study|Lack of Efficacy|4
7768342|NCT00701090|27003561|P1|Overall Study|Lack of Efficacy|5
7768343|NCT00701090|27003560|P2|Overall Study|Death|1
7768344|NCT00701090|27003561|P1|Overall Study|Death|0
7768345|NCT00701090|27003560|P2|Overall Study|Adverse Event|2
7768346|NCT00701090|27003561|P1|Overall Study|Adverse Event|11
7768347|NCT00701064|27003579|P2|Overall Study|initiated other PTSD treatment|2
7768348|NCT00701064|27003580|P1|Overall Study|initiated other PTSD treatment|2
7768349|NCT00701064|27003579|P2|Overall Study|Withdrawal by Subject|1
7768350|NCT00701064|27003580|P1|Overall Study|Withdrawal by Subject|1
7768351|NCT00701064|27003579|P2|Overall Study|Protocol Violation|1
7768352|NCT00701064|27003580|P1|Overall Study|Protocol Violation|1
7768353|NCT00701051|27003592|P3|Exercise Intervention|time conflict; non-study related illness|3
7768354|NCT00701051|27003593|P2|Exercise Intervention|time conflict; non-study related illness|5
7768355|NCT00701051|27003594|P1|Exercise Intervention|time conflict; non-study related illness|0
7768356|NCT00701051|27003592|P3|Screening|Time conflicts|0
7768357|NCT00701051|27003593|P2|Screening|Time conflicts|0
7768358|NCT00701051|27003594|P1|Screening|Time conflicts|19
7768359|NCT00701051|27003592|P3|Screening|Failed Screening|0
7768360|NCT00701051|27003593|P2|Screening|Failed Screening|0
7768361|NCT00701051|27003594|P1|Screening|Failed Screening|40
7768362|NCT00701038|27003612|P2|Overall Study|study amended pilot group of patients|4
7768363|NCT00701038|27003613|P1|Overall Study|study amended pilot group of patients|4
7768364|NCT00700999|27003621|P2|Overall Study|Withdrawal by Subject|1
7768365|NCT00700999|27003622|P1|Overall Study|Withdrawal by Subject|8
7768366|NCT00700999|27003621|P2|Overall Study|Excluded - did not meet study criteria|1
7768367|NCT00700999|27003622|P1|Overall Study|Excluded - did not meet study criteria|0
7768368|NCT00700999|27003621|P2|Overall Study|Lost to Follow-up|7
7768369|NCT00700999|27003622|P1|Overall Study|Lost to Follow-up|7
7768370|NCT00700882|27003637|P1|Overall Study|No KIT mutation|51
7768371|NCT00700882|27003637|P1|Overall Study|Ineligible|2
7768372|NCT00700882|27003637|P1|Overall Study|Never received treatment|6
7768373|NCT00700817|27003646|P5|Week 52-78 (Extension Period 2)|Unclassified|1
7768374|NCT00700817|27003647|P4|Week 52-78 (Extension Period 2)|Unclassified|0
7768375|NCT00700817|27003648|P3|Week 52-78 (Extension Period 2)|Unclassified|0
7768376|NCT00700817|27003649|P2|Week 52-78 (Extension Period 2)|Unclassified|4
7768377|NCT00700817|27003650|P1|Week 52-78 (Extension Period 2)|Unclassified|2
7768378|NCT00700817|27003646|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
7768379|NCT00700817|27003647|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
7768380|NCT00700817|27003648|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
7768381|NCT00700817|27003649|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
7768382|NCT00700817|27003650|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
7768383|NCT00700817|27003646|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7768384|NCT00700817|27003647|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7768385|NCT00700817|27003648|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7768386|NCT00700817|27003649|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
7768387|NCT00700817|27003650|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
7768388|NCT00700817|27003646|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
7768389|NCT00700817|27003647|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
7768390|NCT00700817|27003648|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
7768391|NCT00700817|27003649|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
7768392|NCT00700817|27003650|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
7768393|NCT00700817|27003646|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
7768394|NCT00700817|27003647|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
7768395|NCT00700817|27003648|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
7768396|NCT00700817|27003649|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
7768397|NCT00700817|27003650|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
7768398|NCT00700817|27003646|P5|Week 26-52 (Extension Period 1)|Unclassified|0
7768399|NCT00700817|27003647|P4|Week 26-52 (Extension Period 1)|Unclassified|0
7768400|NCT00700817|27003648|P3|Week 26-52 (Extension Period 1)|Unclassified|1
7768401|NCT00700817|27003649|P2|Week 26-52 (Extension Period 1)|Unclassified|3
7768402|NCT00700817|27003650|P1|Week 26-52 (Extension Period 1)|Unclassified|4
7768403|NCT00700817|27003646|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
7768404|NCT00700817|27003647|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
7768405|NCT00700817|27003648|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
7768406|NCT00700817|27003649|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
7768407|NCT00700817|27003650|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
7768408|NCT00700817|27003646|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
7768409|NCT00700817|27003647|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
7768410|NCT00700817|27003648|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
7768411|NCT00700817|27003649|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
7768412|NCT00700817|27003650|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
7768413|NCT00700817|27003646|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
7768414|NCT00700817|27003647|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
7768415|NCT00700817|27003648|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
7768416|NCT00700817|27003649|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
7768417|NCT00700817|27003650|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
7768418|NCT00700817|27003646|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
7768419|NCT00700817|27003647|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
7768420|NCT00700817|27003648|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
7768421|NCT00700817|27003649|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
7768422|NCT00700817|27003650|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
7768423|NCT00700817|27003646|P5|Week 0-26 (Main Period)|Unclassified|0
7768424|NCT00700817|27003647|P4|Week 0-26 (Main Period)|Unclassified|0
7768425|NCT00700817|27003648|P3|Week 0-26 (Main Period)|Unclassified|8
7768426|NCT00700817|27003649|P2|Week 0-26 (Main Period)|Unclassified|4
7768427|NCT00700817|27003650|P1|Week 0-26 (Main Period)|Unclassified|14
7768428|NCT00700817|27003646|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
7768429|NCT00700817|27003647|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
7768430|NCT00700817|27003648|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
7768431|NCT00700817|27003649|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
7768432|NCT00700817|27003650|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
7768433|NCT00700817|27003646|P5|Week 0-26 (Main Period)|Protocol Violation|0
7768434|NCT00700817|27003647|P4|Week 0-26 (Main Period)|Protocol Violation|0
7768435|NCT00700817|27003648|P3|Week 0-26 (Main Period)|Protocol Violation|4
7768436|NCT00700817|27003649|P2|Week 0-26 (Main Period)|Protocol Violation|4
7768437|NCT00700817|27003650|P1|Week 0-26 (Main Period)|Protocol Violation|14
7768438|NCT00700817|27003646|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
7768439|NCT00700817|27003647|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
7768440|NCT00700817|27003648|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
7768441|NCT00700817|27003649|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
7768442|NCT00700817|27003650|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
7768443|NCT00700817|27003646|P5|Week 0-26 (Main Period)|Adverse Event|0
7768444|NCT00700817|27003647|P4|Week 0-26 (Main Period)|Adverse Event|0
7768445|NCT00700817|27003648|P3|Week 0-26 (Main Period)|Adverse Event|4
7768446|NCT00700817|27003649|P2|Week 0-26 (Main Period)|Adverse Event|15
7768447|NCT00700817|27003650|P1|Week 0-26 (Main Period)|Adverse Event|14
7768448|NCT00700804|27004032|P2|Overall Study|Loose Stools|1
7768449|NCT00700804|27004033|P1|Overall Study|Loose Stools|1
7768450|NCT00700804|27004032|P2|Overall Study|Protocol Violation|1
7768451|NCT00700804|27004033|P1|Overall Study|Protocol Violation|1
7768452|NCT00700804|27004032|P2|Overall Study|Withdrawal by Subject|2
7768453|NCT00700804|27004033|P1|Overall Study|Withdrawal by Subject|1
7768454|NCT00700778|27004041|P1|Overall Study|Inconclusive data due to inadequate sample collection|2
7768455|NCT00700752|27004045|P2|First Intervention|Withdrawal by Subject|2
7768456|NCT00700752|27004046|P1|First Intervention|Withdrawal by Subject|0
7768457|NCT00700739|27004054|P2|Overall Study|Lost to Follow-up|4
7768458|NCT00700739|27004055|P1|Overall Study|Lost to Follow-up|4
7768459|NCT00700713|27004094|P3|Overall Study|Withdrawal by Subject|1
7768460|NCT00700713|27004095|P2|Overall Study|Withdrawal by Subject|0
7768461|NCT00700713|27004096|P1|Overall Study|Withdrawal by Subject|0
7768462|NCT00700713|27004094|P3|Overall Study|Protocol Violation|1
7768463|NCT00700713|27004095|P2|Overall Study|Protocol Violation|0
7768464|NCT00700713|27004096|P1|Overall Study|Protocol Violation|1
7768465|NCT00700635|27004113|P3|Overall Study|Withdrawal by Subject|1
7768466|NCT00700635|27004114|P2|Overall Study|Withdrawal by Subject|3
7768467|NCT00700635|27004115|P1|Overall Study|Withdrawal by Subject|7
7768468|NCT00700635|27004113|P3|Overall Study|Protocol Violation|0
7768469|NCT00700635|27004114|P2|Overall Study|Protocol Violation|2
7768470|NCT00700635|27004115|P1|Overall Study|Protocol Violation|2
7768471|NCT00700635|27004113|P3|Overall Study|Lost to Follow-up|0
7768472|NCT00700635|27004114|P2|Overall Study|Lost to Follow-up|3
7768473|NCT00700635|27004115|P1|Overall Study|Lost to Follow-up|1
7768474|NCT00700635|27004113|P3|Overall Study|Adverse Event|0
7768475|NCT00700635|27004114|P2|Overall Study|Adverse Event|0
7768476|NCT00700635|27004115|P1|Overall Study|Adverse Event|1
7768477|NCT00700622|27004137|P2|Overall Study|Other|1
7768478|NCT00700622|27004138|P1|Overall Study|Other|3
7768479|NCT00700622|27004137|P2|Overall Study|Withdrawal by Subject|1
7768480|NCT00700622|27004138|P1|Overall Study|Withdrawal by Subject|4
7768481|NCT00700622|27004137|P2|Overall Study|Protocol Violation|1
7768482|NCT00700622|27004138|P1|Overall Study|Protocol Violation|0
7768483|NCT00700622|27004137|P2|Overall Study|Physician Decision|1
7768484|NCT00700622|27004138|P1|Overall Study|Physician Decision|2
7768485|NCT00700622|27004137|P2|Overall Study|Lost to Follow-up|1
7768486|NCT00700622|27004138|P1|Overall Study|Lost to Follow-up|0
7768487|NCT00700622|27004137|P2|Overall Study|Adverse Event|0
7768488|NCT00700622|27004138|P1|Overall Study|Adverse Event|4
7768489|NCT00700570|27004146|P2|Overall Study|Withdrawal by Subject|6
7768490|NCT00700570|27004147|P1|Overall Study|Withdrawal by Subject|1
7768491|NCT00700570|27004146|P2|Overall Study|Disease Progression|11
7768492|NCT00700570|27004147|P1|Overall Study|Disease Progression|8
7768493|NCT00700570|27004146|P2|Overall Study|Discretion of Investigator or Sponsor|3
7768494|NCT00700570|27004147|P1|Overall Study|Discretion of Investigator or Sponsor|0
7768495|NCT00700570|27004146|P2|Overall Study|Adverse Event|6
7768496|NCT00700570|27004147|P1|Overall Study|Adverse Event|2
7768497|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
7768498|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7768499|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7768500|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7768501|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7768502|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
7768503|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7768504|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7768505|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7768506|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7768507|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
7768508|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7768509|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7768510|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7768511|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7768512|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
7768513|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7768514|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7768515|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7768516|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7768517|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
7768518|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
7768519|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
7768520|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
7768521|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
7768522|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
7768523|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7768524|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7768525|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7768526|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7768527|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
7768528|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7768529|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7768530|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7768531|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7768532|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Death|1
7768533|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Death|0
7768534|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Death|0
7768535|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Death|0
7768536|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Death|0
7768537|NCT00700427|27004163|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
7768538|NCT00700427|27004164|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
7768539|NCT00700427|27004165|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
7768540|NCT00700427|27004166|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
7768541|NCT00700427|27004167|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
7768542|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Death|0
7768543|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Death|0
7768544|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Death|1
7768545|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Death|0
7768546|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Death|0
7768547|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7768548|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7768549|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
7768550|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7768551|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7768552|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
7768553|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
7768554|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
7768555|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
7768556|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
7768557|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7768558|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
7768559|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7768560|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7768561|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7768562|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7768563|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
7768564|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7768565|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7768566|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7768567|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7768568|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
7768569|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
7768570|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7768571|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7768572|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7768573|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
7768574|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
7768575|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7768576|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7768577|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7768578|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
7768579|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
7768580|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7768581|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7768582|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7768583|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
7768584|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
7768585|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7768586|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7768587|NCT00700427|27004163|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7768588|NCT00700427|27004164|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
7768589|NCT00700427|27004165|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
7768590|NCT00700427|27004166|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7768591|NCT00700427|27004167|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7768592|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7768593|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7768594|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7768595|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
7768596|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7768597|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7768598|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7768599|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7768600|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
7768601|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7768602|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7768603|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7768604|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7768605|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
7768606|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7768607|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7768608|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7768609|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7768610|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
7768611|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7768612|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7768613|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7768614|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7768615|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
7768616|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7768617|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7768618|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7768619|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7768620|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
7768621|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7768622|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7768623|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7768624|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7768625|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
7768626|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7768627|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7768628|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7768629|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7768630|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
7768631|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7768632|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7768633|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7768634|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7768635|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
7768636|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7768637|NCT00700427|27004163|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7768638|NCT00700427|27004164|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7768639|NCT00700427|27004165|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7768640|NCT00700427|27004166|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
7768641|NCT00700427|27004167|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7768642|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7768643|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7768644|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7768645|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7768646|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
7768647|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7768648|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7768649|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7768650|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7768651|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
7768652|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7768653|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7768654|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7768655|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7768656|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
7768657|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7768658|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7768659|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7768660|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7768661|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
7768662|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7768663|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7768664|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7768665|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7768666|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
7768667|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7768668|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7768669|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7768670|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7768671|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
7768672|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7768673|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7768674|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7768675|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7768676|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
7768677|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7768678|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7768679|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7768680|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7768681|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
7768682|NCT00700427|27004163|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7768683|NCT00700427|27004164|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7768684|NCT00700427|27004165|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7768685|NCT00700427|27004166|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7768686|NCT00700427|27004167|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
7768687|NCT00700401|27004189|P1|Overall Study|Withdrawal by Subject|2
7768688|NCT00700401|27004189|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
7768689|NCT00700401|27004189|P1|Overall Study|Treatment never started|1
7768690|NCT00700401|27004189|P1|Overall Study|Lost to Follow-up|1
7768691|NCT00700401|27004189|P1|Overall Study|Refused Treatment|2
7768692|NCT00700401|27004189|P1|Overall Study|Adverse Event|5
7768693|NCT00700401|27004189|P1|Overall Study|Detectable HCV RNA after Week 4|82
7768694|NCT00700310|27004225|P4|Overall Study|Randomized, Not Treated|2
7768695|NCT00700310|27004226|P3|Overall Study|Randomized, Not Treated|2
7768696|NCT00700310|27004227|P2|Overall Study|Randomized, Not Treated|0
7768697|NCT00700310|27004228|P1|Overall Study|Randomized, Not Treated|2
7768698|NCT00700310|27004225|P4|Overall Study|Administrative/Other|3
7768699|NCT00700310|27004226|P3|Overall Study|Administrative/Other|1
7768700|NCT00700310|27004227|P2|Overall Study|Administrative/Other|3
7768701|NCT00700310|27004228|P1|Overall Study|Administrative/Other|1
7768702|NCT00700310|27004225|P4|Overall Study|Lack of Efficacy|1
7768703|NCT00700310|27004226|P3|Overall Study|Lack of Efficacy|0
7768704|NCT00700310|27004227|P2|Overall Study|Lack of Efficacy|3
7768705|NCT00700310|27004228|P1|Overall Study|Lack of Efficacy|0
7768706|NCT00700310|27004225|P4|Overall Study|Withdrawal by Subject|8
7768707|NCT00700310|27004226|P3|Overall Study|Withdrawal by Subject|8
7768708|NCT00700310|27004227|P2|Overall Study|Withdrawal by Subject|9
7768709|NCT00700310|27004228|P1|Overall Study|Withdrawal by Subject|8
7768710|NCT00700310|27004225|P4|Overall Study|Lost to Follow-up|1
7768711|NCT00700310|27004226|P3|Overall Study|Lost to Follow-up|0
7768712|NCT00700310|27004227|P2|Overall Study|Lost to Follow-up|1
7768713|NCT00700310|27004228|P1|Overall Study|Lost to Follow-up|4
7768714|NCT00700310|27004225|P4|Overall Study|Adverse Event|11
7768715|NCT00700310|27004226|P3|Overall Study|Adverse Event|5
7768716|NCT00700310|27004227|P2|Overall Study|Adverse Event|10
7768717|NCT00700310|27004228|P1|Overall Study|Adverse Event|6
7768718|NCT00700271|27004248|P2|Overall Study|Lost to Follow-up|2
7768719|NCT00700271|27004249|P1|Overall Study|Lost to Follow-up|2
7768720|NCT00700271|27004248|P2|Overall Study|Withdrawal by Subject|4
7768721|NCT00700271|27004249|P1|Overall Study|Withdrawal by Subject|6
7768722|NCT00700271|27004248|P2|Overall Study|Administrative Reasons|0
7768723|NCT00700271|27004249|P1|Overall Study|Administrative Reasons|1
7768724|NCT00700271|27004248|P2|Overall Study|Protocol Violation|0
7768725|NCT00700271|27004249|P1|Overall Study|Protocol Violation|1
7768726|NCT00700271|27004248|P2|Overall Study|Adverse Event|6
7768727|NCT00700271|27004249|P1|Overall Study|Adverse Event|4
7768728|NCT00700180|27004277|P2|Overall Study|Lost to Follow-up|5
7768729|NCT00700180|27004278|P1|Overall Study|Lost to Follow-up|4
7768730|NCT00700180|27004277|P2|Overall Study|Alive in follow-up|27
7768731|NCT00700180|27004278|P1|Overall Study|Alive in follow-up|46
7768732|NCT00700180|27004277|P2|Overall Study|Alive on treatment|3
7768733|NCT00700180|27004278|P1|Overall Study|Alive on treatment|5
7768734|NCT00700180|27004277|P2|Overall Study|Death|114
7768735|NCT00700180|27004278|P1|Overall Study|Death|99
7768736|NCT00700115|27004307|P2|Overall Study|Lost to Follow-up|1
7768737|NCT00700115|27004308|P1|Overall Study|Lost to Follow-up|0
7768738|NCT00700115|27004307|P2|Overall Study|Withdrawal by Subject|0
7768739|NCT00700115|27004308|P1|Overall Study|Withdrawal by Subject|1
7768740|NCT00700102|27004318|P2|Overall Study|Lost to Follow-up|10
7768741|NCT00700102|27004319|P1|Overall Study|Lost to Follow-up|8
7768742|NCT00700102|27004318|P2|Overall Study|Died|385
7768743|NCT00700102|27004319|P1|Overall Study|Died|394
7768744|NCT00700011|27004458|P2|Overall Study|Death|1
7768745|NCT00700011|27004459|P1|Overall Study|Death|0
7768746|NCT00699998|27004475|P4|Overall Study|Lost to Follow-up|1
7768747|NCT00699998|27004476|P3|Overall Study|Lost to Follow-up|3
7768748|NCT00699998|27004477|P2|Overall Study|Lost to Follow-up|1
7768749|NCT00699998|27004478|P1|Overall Study|Lost to Follow-up|2
7768750|NCT00699998|27004475|P4|Overall Study|Physician Decision|1
7768751|NCT00699998|27004476|P3|Overall Study|Physician Decision|1
7768752|NCT00699998|27004477|P2|Overall Study|Physician Decision|2
7768753|NCT00699998|27004478|P1|Overall Study|Physician Decision|3
7768754|NCT00699998|27004475|P4|Overall Study|Withdrawal by Subject|80
7768755|NCT00699998|27004476|P3|Overall Study|Withdrawal by Subject|202
7768756|NCT00699998|27004477|P2|Overall Study|Withdrawal by Subject|83
7768757|NCT00699998|27004478|P1|Overall Study|Withdrawal by Subject|194
7768758|NCT00699972|27004523|P3|Overall Study|Randomized, Not Treated|1
7768759|NCT00699972|27004524|P2|Overall Study|Randomized, Not Treated|0
7768760|NCT00699972|27004525|P1|Overall Study|Randomized, Not Treated|1
7768761|NCT00699972|27004523|P3|Overall Study|Administrative/Other|4
7768762|NCT00699972|27004524|P2|Overall Study|Administrative/Other|1
7768763|NCT00699972|27004525|P1|Overall Study|Administrative/Other|3
7768764|NCT00699972|27004523|P3|Overall Study|Lack of Efficacy|2
7768765|NCT00699972|27004524|P2|Overall Study|Lack of Efficacy|0
7768766|NCT00699972|27004525|P1|Overall Study|Lack of Efficacy|2
7768767|NCT00699972|27004523|P3|Overall Study|Withdrawal by Subject|4
7768768|NCT00699972|27004524|P2|Overall Study|Withdrawal by Subject|7
7768769|NCT00699972|27004525|P1|Overall Study|Withdrawal by Subject|3
7768770|NCT00699972|27004523|P3|Overall Study|Lost to Follow-up|0
7768771|NCT00699972|27004524|P2|Overall Study|Lost to Follow-up|2
7768772|NCT00699972|27004525|P1|Overall Study|Lost to Follow-up|0
7768773|NCT00699972|27004523|P3|Overall Study|Adverse Event|24
7768774|NCT00699972|27004524|P2|Overall Study|Adverse Event|9
7768775|NCT00699972|27004525|P1|Overall Study|Adverse Event|7
7768776|NCT00699907|27004542|P3|Overall Study|No usable sample|8
7768777|NCT00699907|27004543|P2|Overall Study|No usable sample|9
7768778|NCT00699907|27004544|P1|Overall Study|No usable sample|0
7768779|NCT00699907|27004542|P3|Overall Study|Withdrawal by Subject|0
7768780|NCT00699907|27004543|P2|Overall Study|Withdrawal by Subject|1
7768781|NCT00699907|27004544|P1|Overall Study|Withdrawal by Subject|2
7768782|NCT00699842|27004579|P3|Overall Study|Death|0
7768783|NCT00699842|27004580|P2|Overall Study|Death|1
7768784|NCT00699842|27004581|P1|Overall Study|Death|0
7768785|NCT00699816|27004594|P2|Overall Study|Protocol Violation|3
7768786|NCT00699816|27004595|P1|Overall Study|Protocol Violation|1
7768787|NCT00699751|27004622|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
7768788|NCT00699751|27004623|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
7768789|NCT00699751|27004622|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
7768790|NCT00699751|27004623|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
7768791|NCT00699751|27004622|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
7768792|NCT00699751|27004623|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
7768793|NCT00699751|27004622|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
7768794|NCT00699751|27004623|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
7768795|NCT00699751|27004622|P2|Period 1: Without/Before Drug Switch|Other|20
7768796|NCT00699751|27004623|P1|Period 1: Without/Before Drug Switch|Other|30
7768797|NCT00699751|27004622|P2|Period 1: Without/Before Drug Switch|Subject Request|23
7768798|NCT00699751|27004623|P1|Period 1: Without/Before Drug Switch|Subject Request|43
7768799|NCT00699751|27004622|P2|Period 1: Without/Before Drug Switch|Death|29
7768800|NCT00699751|27004623|P1|Period 1: Without/Before Drug Switch|Death|28
7768801|NCT00699751|27004622|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
7768802|NCT00699751|27004623|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
7768803|NCT00699699|27004708|P1|Overall Study|Individual different reasons|21
7768804|NCT00699699|27004708|P1|Overall Study|Adverse Event|36
7768805|NCT00699660|27004717|P2|Overall Study|missing reports and recording failures|6
7768806|NCT00699660|27004718|P1|Overall Study|missing reports and recording failures|10
7768807|NCT00699660|27004717|P2|Overall Study|Lost to Follow-up|2
7768808|NCT00699660|27004718|P1|Overall Study|Lost to Follow-up|4
7768809|NCT00699608|27004730|P6|Second Intervention|Withdrawal by Subject|0
7768810|NCT00699608|27004731|P5|Second Intervention|Withdrawal by Subject|0
7768811|NCT00699608|27004732|P4|Second Intervention|Withdrawal by Subject|1
7768812|NCT00699608|27004733|P3|Second Intervention|Withdrawal by Subject|0
7768813|NCT00699608|27004734|P2|Second Intervention|Withdrawal by Subject|0
7768814|NCT00699608|27004735|P1|Second Intervention|Withdrawal by Subject|0
7768815|NCT00699608|27004730|P6|Second Intervention|Adverse Event|0
7768816|NCT00699608|27004731|P5|Second Intervention|Adverse Event|0
7768817|NCT00699608|27004732|P4|Second Intervention|Adverse Event|0
7768818|NCT00699608|27004733|P3|Second Intervention|Adverse Event|1
7768819|NCT00699608|27004734|P2|Second Intervention|Adverse Event|0
7768820|NCT00699608|27004735|P1|Second Intervention|Adverse Event|0
7768821|NCT00699608|27004730|P6|First Intervention|Protocol Violation|0
7768822|NCT00699608|27004731|P5|First Intervention|Protocol Violation|1
7768823|NCT00699608|27004732|P4|First Intervention|Protocol Violation|0
7768824|NCT00699608|27004733|P3|First Intervention|Protocol Violation|0
7768825|NCT00699608|27004734|P2|First Intervention|Protocol Violation|0
7768826|NCT00699608|27004735|P1|First Intervention|Protocol Violation|0
7768827|NCT00699608|27004730|P6|First Intervention|Withdrawal by Subject|0
7768828|NCT00699608|27004731|P5|First Intervention|Withdrawal by Subject|0
7768829|NCT00699608|27004732|P4|First Intervention|Withdrawal by Subject|0
7768830|NCT00699608|27004733|P3|First Intervention|Withdrawal by Subject|1
7768831|NCT00699608|27004734|P2|First Intervention|Withdrawal by Subject|0
7768832|NCT00699608|27004735|P1|First Intervention|Withdrawal by Subject|0
7768833|NCT00699582|27004788|P3|Overall Study|Randomized, Not Treated|0
7768834|NCT00699582|27004789|P2|Overall Study|Randomized, Not Treated|1
7768835|NCT00699582|27004790|P1|Overall Study|Randomized, Not Treated|2
7768836|NCT00699582|27004788|P3|Overall Study|Administrative/Other|0
7768837|NCT00699582|27004789|P2|Overall Study|Administrative/Other|3
7768838|NCT00699582|27004790|P1|Overall Study|Administrative/Other|4
7768839|NCT00699582|27004788|P3|Overall Study|Progressive Disease|0
7768840|NCT00699582|27004789|P2|Overall Study|Progressive Disease|0
7768841|NCT00699582|27004790|P1|Overall Study|Progressive Disease|1
7768842|NCT00699582|27004788|P3|Overall Study|Lack of Efficacy|1
7768843|NCT00699582|27004789|P2|Overall Study|Lack of Efficacy|0
7768844|NCT00699582|27004790|P1|Overall Study|Lack of Efficacy|1
7768845|NCT00699582|27004788|P3|Overall Study|Withdrawal by Subject|4
7768846|NCT00699582|27004789|P2|Overall Study|Withdrawal by Subject|7
7768847|NCT00699582|27004790|P1|Overall Study|Withdrawal by Subject|6
7768848|NCT00699582|27004788|P3|Overall Study|Adverse Event|23
7768849|NCT00699582|27004789|P2|Overall Study|Adverse Event|11
7768850|NCT00699582|27004790|P1|Overall Study|Adverse Event|4
7768851|NCT00699413|27004845|P2|Overall Study|Study terminated by sponsor|2
7768852|NCT00699413|27004846|P1|Overall Study|Study terminated by sponsor|4
7768853|NCT00699413|27004845|P2|Overall Study|Withdrawal by Subject|2
7768854|NCT00699413|27004846|P1|Overall Study|Withdrawal by Subject|0
7768855|NCT00699374|27004900|P2|Overall Study|Died 28 days after last dose|9
7768856|NCT00699374|27004901|P1|Overall Study|Died 28 days after last dose|5
7768857|NCT00699374|27004900|P2|Overall Study|Randomized but not treated|2
7768858|NCT00699374|27004901|P1|Overall Study|Randomized but not treated|4
7768859|NCT00699374|27004900|P2|Overall Study|Study terminated by sponsor|28
7768860|NCT00699374|27004901|P1|Overall Study|Study terminated by sponsor|13
7768861|NCT00699374|27004900|P2|Overall Study|Protocol Violation|6
7768862|NCT00699374|27004901|P1|Overall Study|Protocol Violation|2
7768863|NCT00699374|27004900|P2|Overall Study|Other|15
7768864|NCT00699374|27004901|P1|Overall Study|Other|18
7768865|NCT00699374|27004900|P2|Overall Study|Objective progression or relapse|277
7768866|NCT00699374|27004901|P1|Overall Study|Objective progression or relapse|281
7768867|NCT00699374|27004900|P2|Overall Study|Withdrawal by Subject|44
7768868|NCT00699374|27004901|P1|Overall Study|Withdrawal by Subject|34
7768869|NCT00699374|27004900|P2|Overall Study|Lost to Follow-up|5
7768870|NCT00699374|27004901|P1|Overall Study|Lost to Follow-up|3
7768871|NCT00699374|27004900|P2|Overall Study|Global deterioration of health status|8
7768872|NCT00699374|27004901|P1|Overall Study|Global deterioration of health status|7
7768873|NCT00699374|27004900|P2|Overall Study|Adverse Event|67
7768874|NCT00699374|27004901|P1|Overall Study|Adverse Event|70
7768875|NCT00699374|27004900|P2|Overall Study|Death|83
7768876|NCT00699374|27004901|P1|Overall Study|Death|93
7768877|NCT00699348|27004913|P1|Overall Study|Other|5
7768878|NCT00699348|27004913|P1|Overall Study|Renal transplantation|10
7768879|NCT00699348|27004913|P1|Overall Study|Blood transfusion|24
7768880|NCT00699348|27004913|P1|Overall Study|Failure to return|1
7768881|NCT00699348|27004913|P1|Overall Study|Lack of Efficacy|8
7768882|NCT00699348|27004913|P1|Overall Study|Protocol Violation|10
7768883|NCT00699348|27004913|P1|Overall Study|Withdrawal by Subject|11
7768884|NCT00699348|27004913|P1|Overall Study|Adverse Event|15
7768885|NCT00699348|27004913|P1|Overall Study|Death|6
7768886|NCT00699335|27004922|P1|Overall Study|Missing data|52
7768887|NCT00699335|27004922|P1|Overall Study|Combination of multiple reasons|176
7768888|NCT00699283|27004955|P2|Overall Study|AE of unknown type|0
7768889|NCT00699283|27004956|P1|Overall Study|AE of unknown type|1
7768890|NCT00699283|27004955|P2|Overall Study|AE, non-serious non-fatal|1
7768891|NCT00699283|27004956|P1|Overall Study|AE, non-serious non-fatal|8
7768892|NCT00699283|27004955|P2|Overall Study|SAE, non-fatal|1
7768893|NCT00699283|27004956|P1|Overall Study|SAE, non-fatal|1
7768894|NCT00699283|27004955|P2|Overall Study|Other Reason|1
7768895|NCT00699283|27004956|P1|Overall Study|Other Reason|5
7768896|NCT00699283|27004955|P2|Overall Study|Withdrawal by Subject|0
7768897|NCT00699283|27004956|P1|Overall Study|Withdrawal by Subject|1
7768898|NCT00699283|27004955|P2|Overall Study|Lost to Follow-up|0
7768899|NCT00699283|27004956|P1|Overall Study|Lost to Follow-up|2
7768900|NCT00699283|27004955|P2|Overall Study|Lack of Efficacy|5
7768901|NCT00699283|27004956|P1|Overall Study|Lack of Efficacy|15
7768902|NCT00699192|27004969|P3|Overall Study|Protocol Violation|0
7768903|NCT00699192|27004970|P2|Overall Study|Protocol Violation|2
7768904|NCT00699192|27004971|P1|Overall Study|Protocol Violation|2
7768905|NCT00699192|27004969|P3|Overall Study|Administrative problems|1
7768906|NCT00699192|27004970|P2|Overall Study|Administrative problems|3
7768907|NCT00699192|27004971|P1|Overall Study|Administrative problems|1
7768908|NCT00699192|27004969|P3|Overall Study|Withdrawal by Subject|4
7768909|NCT00699192|27004970|P2|Overall Study|Withdrawal by Subject|2
7768910|NCT00699192|27004971|P1|Overall Study|Withdrawal by Subject|3
7768911|NCT00699192|27004969|P3|Overall Study|Lack of Efficacy|1
7768912|NCT00699192|27004970|P2|Overall Study|Lack of Efficacy|0
7768913|NCT00699192|27004971|P1|Overall Study|Lack of Efficacy|0
7768914|NCT00699192|27004969|P3|Overall Study|Abnormal test procedure result(s)|1
7768915|NCT00699192|27004970|P2|Overall Study|Abnormal test procedure result(s)|0
7768916|NCT00699192|27004971|P1|Overall Study|Abnormal test procedure result(s)|0
7768917|NCT00699192|27004969|P3|Overall Study|Adverse Event|3
7768918|NCT00699192|27004970|P2|Overall Study|Adverse Event|4
7768919|NCT00699192|27004971|P1|Overall Study|Adverse Event|9
7768920|NCT00699192|27004969|P3|Overall Study|Missing|1
7768921|NCT00699192|27004970|P2|Overall Study|Missing|1
7768922|NCT00699192|27004971|P1|Overall Study|Missing|1
7768923|NCT00699153|27004993|P2|Overall Study|Travel Problem|0
7768924|NCT00699153|27004994|P1|Overall Study|Travel Problem|1
7768925|NCT00699153|27004993|P2|Overall Study|Protocol Violation|0
7768926|NCT00699153|27004994|P1|Overall Study|Protocol Violation|1
7768927|NCT00699153|27004993|P2|Overall Study|Adverse Event|2
7768928|NCT00699153|27004994|P1|Overall Study|Adverse Event|0
7768929|NCT00699153|27004993|P2|Overall Study|Lost to Follow-up|0
7768930|NCT00699153|27004994|P1|Overall Study|Lost to Follow-up|1
7768931|NCT00698997|27005029|P2|Overall Study|Withdrawal by Subject|27
7768932|NCT00698997|27005030|P1|Overall Study|Withdrawal by Subject|7
7768933|NCT00698997|27005029|P2|Overall Study|Lost to Follow-up|0
7768934|NCT00698997|27005030|P1|Overall Study|Lost to Follow-up|3
7768935|NCT00698932|27005044|P2|Overall Study|Death|0
7768936|NCT00698932|27005045|P1|Overall Study|Death|1
7768937|NCT00698932|27005044|P2|Overall Study|Safety reasons|2
7768938|NCT00698932|27005045|P1|Overall Study|Safety reasons|0
7768939|NCT00698932|27005044|P2|Overall Study|Severe non-compliance to protocol|2
7768940|NCT00698932|27005045|P1|Overall Study|Severe non-compliance to protocol|1
7768941|NCT00698932|27005044|P2|Overall Study|Lost to Follow-up|1
7768942|NCT00698932|27005045|P1|Overall Study|Lost to Follow-up|6
7768943|NCT00698932|27005044|P2|Overall Study|Withdrawal by Subject|23
7768944|NCT00698932|27005045|P1|Overall Study|Withdrawal by Subject|11
7768945|NCT00698932|27005044|P2|Overall Study|Study specific discontinuation criteria|4
7768946|NCT00698932|27005045|P1|Overall Study|Study specific discontinuation criteria|3
7768947|NCT00698932|27005044|P2|Overall Study|Incorrect enrollment|2
7768948|NCT00698932|27005045|P1|Overall Study|Incorrect enrollment|0
7768949|NCT00698932|27005044|P2|Overall Study|Adverse Event|2
7768950|NCT00698932|27005045|P1|Overall Study|Adverse Event|0
7768951|NCT00698841|27005071|P1|Overall Study|Other|2
7768952|NCT00698841|27005071|P1|Overall Study|Study drug toxicity|2
7768953|NCT00698841|27005071|P1|Overall Study|Failure to meet eligibility criteria|2
7768954|NCT00698841|27005071|P1|Overall Study|Disease progression|7
7768955|NCT00698841|27005071|P1|Overall Study|Adverse Event|3
7768956|NCT00698841|27005071|P1|Overall Study|Withdrawal by Subject|2
7768957|NCT00698828|27005085|P3|Overall Study|Withdrew consent (not treated)|0
7768958|NCT00698828|27005086|P2|Overall Study|Withdrew consent (not treated)|0
7768959|NCT00698828|27005087|P1|Overall Study|Withdrew consent (not treated)|2
7768960|NCT00698828|27005085|P3|Overall Study|Withdrew consent|4
7768961|NCT00698828|27005086|P2|Overall Study|Withdrew consent|7
7768962|NCT00698828|27005087|P1|Overall Study|Withdrew consent|0
7768963|NCT00698828|27005085|P3|Overall Study|Lost to Follow-up|0
7768964|NCT00698828|27005086|P2|Overall Study|Lost to Follow-up|1
7768965|NCT00698828|27005087|P1|Overall Study|Lost to Follow-up|1
7768966|NCT00698828|27005085|P3|Overall Study|Investigator/Sponsor decision|2
7768967|NCT00698828|27005086|P2|Overall Study|Investigator/Sponsor decision|0
7768968|NCT00698828|27005087|P1|Overall Study|Investigator/Sponsor decision|1
7768969|NCT00698828|27005085|P3|Overall Study|Exacerbation of COPD (Not treated)|0
7768970|NCT00698828|27005086|P2|Overall Study|Exacerbation of COPD (Not treated)|0
7768971|NCT00698828|27005087|P1|Overall Study|Exacerbation of COPD (Not treated)|1
7768972|NCT00698828|27005085|P3|Overall Study|Exacerbation of COPD|0
7768973|NCT00698828|27005086|P2|Overall Study|Exacerbation of COPD|3
7768974|NCT00698828|27005087|P1|Overall Study|Exacerbation of COPD|1
7768975|NCT00698828|27005085|P3|Overall Study|Death|1
7768976|NCT00698828|27005086|P2|Overall Study|Death|0
7768977|NCT00698828|27005087|P1|Overall Study|Death|0
7768978|NCT00698828|27005085|P3|Overall Study|Adverse Event|4
7768979|NCT00698828|27005086|P2|Overall Study|Adverse Event|4
7768980|NCT00698828|27005087|P1|Overall Study|Adverse Event|3
7768981|NCT00698815|27005122|P3|Overall Study|Did not receive protocol treatment|2
7768982|NCT00698815|27005123|P2|Overall Study|Did not receive protocol treatment|2
7768983|NCT00698815|27005124|P1|Overall Study|Did not receive protocol treatment|1
7768984|NCT00698815|27005122|P3|Overall Study|MD discretion|2
7768985|NCT00698815|27005123|P2|Overall Study|MD discretion|7
7768986|NCT00698815|27005124|P1|Overall Study|MD discretion|2
7768987|NCT00698815|27005122|P3|Overall Study|Withdrawal by Subject|2
7768988|NCT00698815|27005123|P2|Overall Study|Withdrawal by Subject|3
7768989|NCT00698815|27005124|P1|Overall Study|Withdrawal by Subject|6
7768990|NCT00698815|27005122|P3|Overall Study|Death|4
7768991|NCT00698815|27005123|P2|Overall Study|Death|2
7768992|NCT00698815|27005124|P1|Overall Study|Death|1
7768993|NCT00698685|27005141|P1|Overall Study|Off study pre transplant by clinic MD|1
7768994|NCT00698685|27005141|P1|Overall Study|Sister withdrew as donor|1
7768995|NCT00698646|27005149|P3|Overall Study|Administrative problems|1
7768996|NCT00698646|27005150|P2|Overall Study|Administrative problems|0
7768997|NCT00698646|27005151|P1|Overall Study|Administrative problems|1
7768998|NCT00698646|27005149|P3|Overall Study|Lost to Follow-up|2
7768999|NCT00698646|27005150|P2|Overall Study|Lost to Follow-up|0
7769000|NCT00698646|27005151|P1|Overall Study|Lost to Follow-up|0
7769001|NCT00698646|27005149|P3|Overall Study|Withdrawal by Subject|8
7769002|NCT00698646|27005150|P2|Overall Study|Withdrawal by Subject|11
7769003|NCT00698646|27005151|P1|Overall Study|Withdrawal by Subject|10
7769004|NCT00698646|27005149|P3|Overall Study|Protocol Deviation|3
7769005|NCT00698646|27005150|P2|Overall Study|Protocol Deviation|2
7769006|NCT00698646|27005151|P1|Overall Study|Protocol Deviation|6
7769007|NCT00698646|27005149|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
7769008|NCT00698646|27005150|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
7769009|NCT00698646|27005151|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
7769010|NCT00698646|27005149|P3|Overall Study|Adverse Event|8
7769011|NCT00698646|27005150|P2|Overall Study|Adverse Event|7
7769012|NCT00698646|27005151|P1|Overall Study|Adverse Event|8
7769013|NCT00698581|27005176|P2|Overall Study|AE of unknown type|0
7769014|NCT00698581|27005177|P1|Overall Study|AE of unknown type|1
7769015|NCT00698581|27005176|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7769016|NCT00698581|27005177|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7769017|NCT00698581|27005176|P2|Overall Study|AE, non-serious non-fatal|0
7769018|NCT00698581|27005177|P1|Overall Study|AE, non-serious non-fatal|4
7769019|NCT00698581|27005176|P2|Overall Study|SAE, non-fatal|0
7769020|NCT00698581|27005177|P1|Overall Study|SAE, non-fatal|1
7769021|NCT00698581|27005176|P2|Overall Study|Other reason|1
7769022|NCT00698581|27005177|P1|Overall Study|Other reason|9
7769023|NCT00698581|27005176|P2|Overall Study|Withdrawal by Subject|0
7769024|NCT00698581|27005177|P1|Overall Study|Withdrawal by Subject|6
7769025|NCT00698581|27005176|P2|Overall Study|Lack of Efficacy|11
7769026|NCT00698581|27005177|P1|Overall Study|Lack of Efficacy|23
7769027|NCT00698516|27005188|P1|Overall Study|Withdrawal by Subject|3
7769028|NCT00698516|27005188|P1|Overall Study|Study Termination|2
7769029|NCT00698451|27005206|P1|Overall Study|Disease progression|3
7769030|NCT00698451|27005206|P1|Overall Study|Withdrawal by Subject|6
7769031|NCT00698451|27005206|P1|Overall Study|Protocol Violation|6
7769032|NCT00698451|27005206|P1|Overall Study|Physician Decision|2
7769033|NCT00698451|27005206|P1|Overall Study|Adverse Event|22
7769034|NCT00698204|27005213|P2|Overall Study|Withdrawal by Subject|0
7769035|NCT00698204|27005214|P1|Overall Study|Withdrawal by Subject|1
7769036|NCT00698009|27005274|P1|Overall Study|Withdrawal by Subject|1
7769037|NCT00697827|27005280|P2|Overall Study|enrolled but not treated|1
7769038|NCT00697827|27005281|P1|Overall Study|enrolled but not treated|2
7769039|NCT00697788|27005308|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769040|NCT00697788|27005309|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769121|NCT00696800|27005758|P2|Overall Study|Not treated|2
7769041|NCT00697788|27005310|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769042|NCT00697788|27005311|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
7769043|NCT00697788|27005312|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769044|NCT00697788|27005313|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769045|NCT00697788|27005314|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769046|NCT00697788|27005315|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7769047|NCT00697788|27005308|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769048|NCT00697788|27005309|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769049|NCT00697788|27005310|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769050|NCT00697788|27005311|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769051|NCT00697788|27005312|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769052|NCT00697788|27005313|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769053|NCT00697788|27005314|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
7769054|NCT00697788|27005315|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769055|NCT00697619|27005370|P2|Overall Study|Adverse Event|6
7769056|NCT00697619|27005371|P1|Overall Study|Adverse Event|4
7769057|NCT00697619|27005370|P2|Overall Study|Lack of Efficacy|2
7769058|NCT00697619|27005371|P1|Overall Study|Lack of Efficacy|2
7769059|NCT00697593|27005377|P1|Overall Study|Suspension of the study by sponsor|12
7769060|NCT00697593|27005377|P1|Overall Study|Lack of Efficacy|3
7769061|NCT00697593|27005377|P1|Overall Study|Protocol Violation|1
7769062|NCT00697593|27005377|P1|Overall Study|Adverse Event|3
7769063|NCT00697515|27005421|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
7769064|NCT00697515|27005422|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
7769065|NCT00697515|27005421|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
7769066|NCT00697515|27005422|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
7769067|NCT00697515|27005421|P2|First Intervention (Crossover Period)|Adverse Event|2
7769068|NCT00697515|27005422|P1|First Intervention (Crossover Period)|Adverse Event|0
7769069|NCT00697515|27005421|P2|First Intervention (Crossover Period)|Natural disaster|9
7769070|NCT00697515|27005422|P1|First Intervention (Crossover Period)|Natural disaster|8
7769071|NCT00697515|27005421|P2|Dose Optimization Period|elevated QTc|0
7769072|NCT00697515|27005422|P1|Dose Optimization Period|elevated QTc|1
7769073|NCT00697515|27005421|P2|Dose Optimization Period|called to active duty|0
7769074|NCT00697515|27005422|P1|Dose Optimization Period|called to active duty|1
7769075|NCT00697515|27005421|P2|Dose Optimization Period|sponsor request|0
7769076|NCT00697515|27005422|P1|Dose Optimization Period|sponsor request|2
7769077|NCT00697515|27005421|P2|Dose Optimization Period|Lost to Follow-up|0
7769078|NCT00697515|27005422|P1|Dose Optimization Period|Lost to Follow-up|2
7769079|NCT00697515|27005421|P2|Dose Optimization Period|Withdrawal by Subject|0
7769080|NCT00697515|27005422|P1|Dose Optimization Period|Withdrawal by Subject|5
7769081|NCT00697515|27005421|P2|Dose Optimization Period|Adverse Event|0
7769082|NCT00697515|27005422|P1|Dose Optimization Period|Adverse Event|4
7769083|NCT00697463|27005450|P1|Overall Study|Withdrawal by Subject|1
7769084|NCT00697346|27005457|P3|Overall Study|Reason not Specified|1
7769085|NCT00697346|27005458|P2|Overall Study|Reason not Specified|0
7769086|NCT00697346|27005459|P1|Overall Study|Reason not Specified|3
7769087|NCT00697346|27005457|P3|Overall Study|Withdrawal by Subject|0
7769088|NCT00697346|27005458|P2|Overall Study|Withdrawal by Subject|2
7769089|NCT00697346|27005459|P1|Overall Study|Withdrawal by Subject|2
7769090|NCT00697346|27005457|P3|Overall Study|Symptomatic Deterioration|0
7769091|NCT00697346|27005458|P2|Overall Study|Symptomatic Deterioration|1
7769092|NCT00697346|27005459|P1|Overall Study|Symptomatic Deterioration|0
7769093|NCT00697346|27005457|P3|Overall Study|Progressive Disease|0
7769094|NCT00697346|27005458|P2|Overall Study|Progressive Disease|18
7769095|NCT00697346|27005459|P1|Overall Study|Progressive Disease|19
7769096|NCT00697346|27005457|P3|Overall Study|Adverse Event|0
7769097|NCT00697346|27005458|P2|Overall Study|Adverse Event|5
7769098|NCT00697346|27005459|P1|Overall Study|Adverse Event|4
7769099|NCT00697255|27005567|P2|Stage 1b|Insufficient ovarian response|1
7769100|NCT00697255|27005568|P1|Stage 1b|Insufficient ovarian response|0
7769101|NCT00697255|27005567|P2|Stage 1b|Not growing of dominant follicle|1
7769102|NCT00697255|27005568|P1|Stage 1b|Not growing of dominant follicle|0
7769103|NCT00697255|27005567|P2|Stage 1a|Not growing of dominant follicle|0
7769104|NCT00697255|27005568|P1|Stage 1a|Not growing of dominant follicle|1
7769105|NCT00697255|27005567|P2|Stage 1a|Multifollicular growth|0
7769106|NCT00697255|27005568|P1|Stage 1a|Multifollicular growth|1
7769107|NCT00697255|27005567|P2|Stage 1a|Insufficient ovarian response|0
7769108|NCT00697255|27005568|P1|Stage 1a|Insufficient ovarian response|1
7769109|NCT00697112|27005656|P1|Overall Study|Did not meet inclusion criteria|1
7769110|NCT00697112|27005656|P1|Overall Study|Lost to Follow-up|1
7769111|NCT00697112|27005656|P1|Overall Study|Adverse Event|8
7769115|NCT00696878|27005684|P1|Overall Study|Other reason (not specified)|55
7769116|NCT00696878|27005684|P1|Overall Study|Trial stopped|32
7769117|NCT00696878|27005684|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
7769118|NCT00696878|27005684|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
7769119|NCT00696878|27005684|P1|Overall Study|Withdrawal by Subject|87
7769120|NCT00696878|27005684|P1|Overall Study|Adverse Event|8
7769122|NCT00696800|27005759|P1|Overall Study|Not treated|1
7769123|NCT00696800|27005758|P2|Overall Study|Other Reasons|3
7769124|NCT00696800|27005759|P1|Overall Study|Other Reasons|5
7769125|NCT00696800|27005758|P2|Overall Study|No/too few/bad quality embryos|18
7769126|NCT00696800|27005759|P1|Overall Study|No/too few/bad quality embryos|24
7769127|NCT00696800|27005758|P2|Overall Study|No/abnormal fertilization|13
7769128|NCT00696800|27005759|P1|Overall Study|No/abnormal fertilization|11
7769129|NCT00696800|27005758|P2|Overall Study|No/too few/bad quality oocytes|3
7769130|NCT00696800|27005759|P1|Overall Study|No/too few/bad quality oocytes|4
7769131|NCT00696800|27005758|P2|Overall Study|Too high ovarian response|1
7769132|NCT00696800|27005759|P1|Overall Study|Too high ovarian response|6
7769133|NCT00696800|27005758|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
7769134|NCT00696800|27005759|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
7769135|NCT00696800|27005758|P2|Overall Study|Insufficient ovarian response|1
7769136|NCT00696800|27005759|P1|Overall Study|Insufficient ovarian response|4
7769137|NCT00696800|27005758|P2|Overall Study|Insufficient ovarian response on Day 8|1
7769138|NCT00696800|27005759|P1|Overall Study|Insufficient ovarian response on Day 8|4
7769139|NCT00696800|27005758|P2|Overall Study|Insufficient compliance with medication|1
7769140|NCT00696800|27005759|P1|Overall Study|Insufficient compliance with medication|2
7769141|NCT00696800|27005758|P2|Overall Study|Adverse Event|3
7769142|NCT00696800|27005759|P1|Overall Study|Adverse Event|16
7769143|NCT00696787|27005812|P3|Overall Study|Failed to return|1
7769144|NCT00696787|27005813|P2|Overall Study|Failed to return|3
7769145|NCT00696787|27005814|P1|Overall Study|Failed to return|1
7769146|NCT00696787|27005812|P3|Overall Study|Withdrawal by Subject|2
7769147|NCT00696787|27005813|P2|Overall Study|Withdrawal by Subject|3
7769148|NCT00696787|27005814|P1|Overall Study|Withdrawal by Subject|0
7769149|NCT00696787|27005812|P3|Overall Study|Lost to Follow-up|3
7769150|NCT00696787|27005813|P2|Overall Study|Lost to Follow-up|0
7769151|NCT00696787|27005814|P1|Overall Study|Lost to Follow-up|4
7769152|NCT00696787|27005812|P3|Overall Study|Lack of Efficacy|0
7769153|NCT00696787|27005813|P2|Overall Study|Lack of Efficacy|1
7769154|NCT00696787|27005814|P1|Overall Study|Lack of Efficacy|0
7769155|NCT00696787|27005812|P3|Overall Study|Discontinuation by Sponsor|14
7769156|NCT00696787|27005813|P2|Overall Study|Discontinuation by Sponsor|13
7769157|NCT00696787|27005814|P1|Overall Study|Discontinuation by Sponsor|9
7769158|NCT00696787|27005812|P3|Overall Study|Adverse Event|6
7769159|NCT00696787|27005813|P2|Overall Study|Adverse Event|0
7769160|NCT00696787|27005814|P1|Overall Study|Adverse Event|1
7769161|NCT00696774|27005828|P3|Period III|Lack of Efficacy|0
7769162|NCT00696774|27005829|P2|Period III|Lack of Efficacy|2
7769163|NCT00696774|27005830|P1|Period III|Lack of Efficacy|0
7769164|NCT00696774|27005828|P3|Period III|Sponsor Decision|0
7769165|NCT00696774|27005829|P2|Period III|Sponsor Decision|0
7769166|NCT00696774|27005830|P1|Period III|Sponsor Decision|2
7769167|NCT00696774|27005828|P3|Period III|Withdrawal by Subject|0
7769168|NCT00696774|27005829|P2|Period III|Withdrawal by Subject|2
7769169|NCT00696774|27005830|P1|Period III|Withdrawal by Subject|1
7769170|NCT00696774|27005828|P3|Period III|Protocol Violation|0
7769171|NCT00696774|27005829|P2|Period III|Protocol Violation|1
7769172|NCT00696774|27005830|P1|Period III|Protocol Violation|1
7769173|NCT00696774|27005828|P3|Period III|Lost to Follow-up|0
7769174|NCT00696774|27005829|P2|Period III|Lost to Follow-up|1
7769175|NCT00696774|27005830|P1|Period III|Lost to Follow-up|2
7769176|NCT00696774|27005828|P3|Period III|Adverse Event|0
7769177|NCT00696774|27005829|P2|Period III|Adverse Event|1
7769178|NCT00696774|27005830|P1|Period III|Adverse Event|1
7769179|NCT00696774|27005828|P3|Period II|Lack of Efficacy|2
7769180|NCT00696774|27005829|P2|Period II|Lack of Efficacy|0
7769181|NCT00696774|27005830|P1|Period II|Lack of Efficacy|0
7769182|NCT00696774|27005828|P3|Period II|Sponsor Decision|0
7769183|NCT00696774|27005829|P2|Period II|Sponsor Decision|0
7769184|NCT00696774|27005830|P1|Period II|Sponsor Decision|0
7769185|NCT00696774|27005828|P3|Period II|Withdrawal by Subject|4
7769186|NCT00696774|27005829|P2|Period II|Withdrawal by Subject|0
7769187|NCT00696774|27005830|P1|Period II|Withdrawal by Subject|0
7769188|NCT00696774|27005828|P3|Period II|Protocol Violation|11
7769189|NCT00696774|27005829|P2|Period II|Protocol Violation|0
7769190|NCT00696774|27005830|P1|Period II|Protocol Violation|0
7769191|NCT00696774|27005828|P3|Period II|Lost to Follow-up|4
7769192|NCT00696774|27005829|P2|Period II|Lost to Follow-up|0
7769193|NCT00696774|27005830|P1|Period II|Lost to Follow-up|0
7769194|NCT00696774|27005828|P3|Period II|Adverse Event|15
7769195|NCT00696774|27005829|P2|Period II|Adverse Event|0
7769196|NCT00696774|27005830|P1|Period II|Adverse Event|0
7769197|NCT00696709|27005902|P5|Overall Study|Adverse Event|0
7769198|NCT00696709|27005903|P4|Overall Study|Adverse Event|1
7769199|NCT00696709|27005904|P3|Overall Study|Adverse Event|0
7769200|NCT00696709|27005905|P2|Overall Study|Adverse Event|0
7769201|NCT00696709|27005906|P1|Overall Study|Adverse Event|0
7769202|NCT00696709|27005902|P5|Overall Study|Lost to Follow-up|0
7769203|NCT00696709|27005903|P4|Overall Study|Lost to Follow-up|0
7769204|NCT00696709|27005904|P3|Overall Study|Lost to Follow-up|0
7769205|NCT00696709|27005905|P2|Overall Study|Lost to Follow-up|1
7769206|NCT00696709|27005906|P1|Overall Study|Lost to Follow-up|1
7769207|NCT00696709|27005902|P5|Overall Study|Protocol Violation|0
7769208|NCT00696709|27005903|P4|Overall Study|Protocol Violation|0
7769209|NCT00696709|27005904|P3|Overall Study|Protocol Violation|0
7769210|NCT00696709|27005905|P2|Overall Study|Protocol Violation|0
7769211|NCT00696709|27005906|P1|Overall Study|Protocol Violation|1
7769212|NCT00696709|27005902|P5|Overall Study|Withdrawal by Subject|3
7769213|NCT00696709|27005903|P4|Overall Study|Withdrawal by Subject|4
7769214|NCT00696709|27005904|P3|Overall Study|Withdrawal by Subject|1
7769215|NCT00696709|27005905|P2|Overall Study|Withdrawal by Subject|2
7769216|NCT00696709|27005906|P1|Overall Study|Withdrawal by Subject|1
7769217|NCT00696696|27005942|P1|Overall Study|Death|3
7769218|NCT00696696|27005942|P1|Overall Study|Physician Decision|2
7769219|NCT00696696|27005942|P1|Overall Study|Withdrawal by Subject|8
7769220|NCT00696696|27005942|P1|Overall Study|Adverse Event|5
7769221|NCT00696657|27005957|P9|Overall Study|Adverse Event|5
7769222|NCT00696657|27005958|P8|Overall Study|Adverse Event|2
7769223|NCT00696657|27005959|P7|Overall Study|Adverse Event|14
7769224|NCT00696657|27005960|P6|Overall Study|Adverse Event|9
7769225|NCT00696657|27005961|P5|Overall Study|Adverse Event|6
7769226|NCT00696657|27005962|P4|Overall Study|Adverse Event|7
7769227|NCT00696657|27005963|P3|Overall Study|Adverse Event|3
7769228|NCT00696657|27005964|P2|Overall Study|Adverse Event|0
7769229|NCT00696657|27005965|P1|Overall Study|Adverse Event|0
7769230|NCT00696657|27005957|P9|Overall Study|Unclassified|1
7769231|NCT00696657|27005958|P8|Overall Study|Unclassified|0
7769232|NCT00696657|27005959|P7|Overall Study|Unclassified|0
7769233|NCT00696657|27005960|P6|Overall Study|Unclassified|2
7769234|NCT00696657|27005961|P5|Overall Study|Unclassified|4
7769235|NCT00696657|27005962|P4|Overall Study|Unclassified|2
7769236|NCT00696657|27005963|P3|Overall Study|Unclassified|3
7769237|NCT00696657|27005964|P2|Overall Study|Unclassified|1
7769238|NCT00696657|27005965|P1|Overall Study|Unclassified|0
7769239|NCT00696657|27005957|P9|Overall Study|Withdrawal criteria|2
7769240|NCT00696657|27005958|P8|Overall Study|Withdrawal criteria|1
7769241|NCT00696657|27005959|P7|Overall Study|Withdrawal criteria|1
7769242|NCT00696657|27005960|P6|Overall Study|Withdrawal criteria|0
7769243|NCT00696657|27005961|P5|Overall Study|Withdrawal criteria|0
7769244|NCT00696657|27005962|P4|Overall Study|Withdrawal criteria|2
7769245|NCT00696657|27005963|P3|Overall Study|Withdrawal criteria|2
7769246|NCT00696657|27005964|P2|Overall Study|Withdrawal criteria|3
7769247|NCT00696657|27005965|P1|Overall Study|Withdrawal criteria|1
7769248|NCT00696657|27005957|P9|Overall Study|Lack of Efficacy|0
7769249|NCT00696657|27005958|P8|Overall Study|Lack of Efficacy|0
7769250|NCT00696657|27005959|P7|Overall Study|Lack of Efficacy|0
7769251|NCT00696657|27005960|P6|Overall Study|Lack of Efficacy|0
7769252|NCT00696657|27005961|P5|Overall Study|Lack of Efficacy|0
7769253|NCT00696657|27005962|P4|Overall Study|Lack of Efficacy|0
7769254|NCT00696657|27005963|P3|Overall Study|Lack of Efficacy|0
7769255|NCT00696657|27005964|P2|Overall Study|Lack of Efficacy|1
7769256|NCT00696657|27005965|P1|Overall Study|Lack of Efficacy|0
7769257|NCT00696657|27005957|P9|Overall Study|Protocol Violation|1
7769258|NCT00696657|27005958|P8|Overall Study|Protocol Violation|0
7769259|NCT00696657|27005959|P7|Overall Study|Protocol Violation|0
7769260|NCT00696657|27005960|P6|Overall Study|Protocol Violation|1
7769261|NCT00696657|27005961|P5|Overall Study|Protocol Violation|0
7769262|NCT00696657|27005962|P4|Overall Study|Protocol Violation|0
7769263|NCT00696657|27005963|P3|Overall Study|Protocol Violation|0
7769264|NCT00696657|27005964|P2|Overall Study|Protocol Violation|0
7769265|NCT00696657|27005965|P1|Overall Study|Protocol Violation|0
7769266|NCT00696436|27006334|P5|Overall Study|Missing|0
7769267|NCT00696436|27006335|P4|Overall Study|Missing|0
7769268|NCT00696436|27006336|P3|Overall Study|Missing|1
7769269|NCT00696436|27006337|P2|Overall Study|Missing|1
7769270|NCT00696436|27006338|P1|Overall Study|Missing|0
7769271|NCT00696436|27006334|P5|Overall Study|Administrative Decision|0
7769272|NCT00696436|27006335|P4|Overall Study|Administrative Decision|0
7769273|NCT00696436|27006336|P3|Overall Study|Administrative Decision|0
7769274|NCT00696436|27006337|P2|Overall Study|Administrative Decision|0
7769275|NCT00696436|27006338|P1|Overall Study|Administrative Decision|1
7769276|NCT00696436|27006334|P5|Overall Study|Participant Non-compliance|0
7769277|NCT00696436|27006335|P4|Overall Study|Participant Non-compliance|2
7769278|NCT00696436|27006336|P3|Overall Study|Participant Non-compliance|1
7769279|NCT00696436|27006337|P2|Overall Study|Participant Non-compliance|0
7769280|NCT00696436|27006338|P1|Overall Study|Participant Non-compliance|0
7769281|NCT00696436|27006334|P5|Overall Study|Administrative Error|0
7769282|NCT00696436|27006335|P4|Overall Study|Administrative Error|0
7769283|NCT00696436|27006336|P3|Overall Study|Administrative Error|2
7769284|NCT00696436|27006337|P2|Overall Study|Administrative Error|0
7769285|NCT00696436|27006338|P1|Overall Study|Administrative Error|2
7769286|NCT00696436|27006334|P5|Overall Study|Participant Unavailability|0
7769287|NCT00696436|27006335|P4|Overall Study|Participant Unavailability|1
7769288|NCT00696436|27006336|P3|Overall Study|Participant Unavailability|2
7769289|NCT00696436|27006337|P2|Overall Study|Participant Unavailability|0
7769290|NCT00696436|27006338|P1|Overall Study|Participant Unavailability|2
7769291|NCT00696436|27006334|P5|Overall Study|Lack of Efficacy|4
7769292|NCT00696436|27006335|P4|Overall Study|Lack of Efficacy|2
7769293|NCT00696436|27006336|P3|Overall Study|Lack of Efficacy|5
7769294|NCT00696436|27006337|P2|Overall Study|Lack of Efficacy|1
7769295|NCT00696436|27006338|P1|Overall Study|Lack of Efficacy|3
7769296|NCT00696436|27006334|P5|Overall Study|Withdrawal by Subject|1
7769297|NCT00696436|27006335|P4|Overall Study|Withdrawal by Subject|7
7769298|NCT00696436|27006336|P3|Overall Study|Withdrawal by Subject|5
7769299|NCT00696436|27006337|P2|Overall Study|Withdrawal by Subject|11
7769300|NCT00696436|27006338|P1|Overall Study|Withdrawal by Subject|4
7769301|NCT00696436|27006334|P5|Overall Study|Lost to Follow-up|3
7769302|NCT00696436|27006335|P4|Overall Study|Lost to Follow-up|4
7769303|NCT00696436|27006336|P3|Overall Study|Lost to Follow-up|2
7769304|NCT00696436|27006337|P2|Overall Study|Lost to Follow-up|6
7769305|NCT00696436|27006338|P1|Overall Study|Lost to Follow-up|1
7769306|NCT00696436|27006334|P5|Overall Study|Protocol Violation|1
7769307|NCT00696436|27006335|P4|Overall Study|Protocol Violation|0
7769308|NCT00696436|27006336|P3|Overall Study|Protocol Violation|2
7769309|NCT00696436|27006337|P2|Overall Study|Protocol Violation|2
7769310|NCT00696436|27006338|P1|Overall Study|Protocol Violation|3
7769311|NCT00696436|27006334|P5|Overall Study|Adverse Event|4
7769312|NCT00696436|27006335|P4|Overall Study|Adverse Event|6
7769313|NCT00696436|27006336|P3|Overall Study|Adverse Event|8
7769314|NCT00696436|27006337|P2|Overall Study|Adverse Event|9
7769315|NCT00696436|27006338|P1|Overall Study|Adverse Event|7
7769316|NCT00696423|27006422|P2|Overall Study|Lost to Follow-up|5
7769317|NCT00696423|27006423|P1|Overall Study|Lost to Follow-up|0
7769318|NCT00696410|27006455|P2|Overall Study|Physician Decision|0
7769319|NCT00696410|27006456|P1|Overall Study|Physician Decision|3
7769320|NCT00696410|27006455|P2|Overall Study|Withdrawal by Subject|0
7769321|NCT00696410|27006456|P1|Overall Study|Withdrawal by Subject|8
7769322|NCT00696410|27006455|P2|Overall Study|Lost to Follow-up|0
7769323|NCT00696410|27006456|P1|Overall Study|Lost to Follow-up|2
7769324|NCT00696384|27006470|P3|Double Blind Phase|Physician Decision|0
7769325|NCT00696384|27006471|P2|Double Blind Phase|Physician Decision|2
7769326|NCT00696384|27006472|P1|Double Blind Phase|Physician Decision|0
7769327|NCT00696384|27006470|P3|Double Blind Phase|Lack of Efficacy|0
7769328|NCT00696384|27006471|P2|Double Blind Phase|Lack of Efficacy|1
7769329|NCT00696384|27006472|P1|Double Blind Phase|Lack of Efficacy|0
7769330|NCT00696384|27006470|P3|Double Blind Phase|Withdrawal by Subject|3
7769331|NCT00696384|27006471|P2|Double Blind Phase|Withdrawal by Subject|4
7769332|NCT00696384|27006472|P1|Double Blind Phase|Withdrawal by Subject|0
7769333|NCT00696384|27006470|P3|Double Blind Phase|Lost to Follow-up|1
7769334|NCT00696384|27006471|P2|Double Blind Phase|Lost to Follow-up|2
7769335|NCT00696384|27006472|P1|Double Blind Phase|Lost to Follow-up|0
7769336|NCT00696384|27006470|P3|Double Blind Phase|Adverse Event|2
7769337|NCT00696384|27006471|P2|Double Blind Phase|Adverse Event|2
7769338|NCT00696384|27006472|P1|Double Blind Phase|Adverse Event|0
7769339|NCT00696384|27006470|P3|Open Label Phase|Physician Decision|0
7769340|NCT00696384|27006471|P2|Open Label Phase|Physician Decision|0
7769341|NCT00696384|27006472|P1|Open Label Phase|Physician Decision|4
7769342|NCT00696384|27006470|P3|Open Label Phase|Lack of Efficacy|0
7769343|NCT00696384|27006471|P2|Open Label Phase|Lack of Efficacy|0
7769344|NCT00696384|27006472|P1|Open Label Phase|Lack of Efficacy|3
7769345|NCT00696384|27006470|P3|Open Label Phase|Other|0
7769346|NCT00696384|27006471|P2|Open Label Phase|Other|0
7769347|NCT00696384|27006472|P1|Open Label Phase|Other|6
7769348|NCT00696384|27006470|P3|Open Label Phase|Withdrawal by Subject|0
7769349|NCT00696384|27006471|P2|Open Label Phase|Withdrawal by Subject|0
7769350|NCT00696384|27006472|P1|Open Label Phase|Withdrawal by Subject|37
7769351|NCT00696384|27006470|P3|Open Label Phase|Lost to Follow-up|0
7769352|NCT00696384|27006471|P2|Open Label Phase|Lost to Follow-up|0
7769353|NCT00696384|27006472|P1|Open Label Phase|Lost to Follow-up|24
7769354|NCT00696384|27006470|P3|Open Label Phase|Protocol Violation|0
7769355|NCT00696384|27006471|P2|Open Label Phase|Protocol Violation|0
7769356|NCT00696384|27006472|P1|Open Label Phase|Protocol Violation|18
7769357|NCT00696384|27006470|P3|Open Label Phase|Adverse Event|0
7769358|NCT00696384|27006471|P2|Open Label Phase|Adverse Event|0
7769359|NCT00696384|27006472|P1|Open Label Phase|Adverse Event|27
7769360|NCT00696241|27006496|P5|Overall Study|Other|1
7769361|NCT00696241|27006497|P4|Overall Study|Other|2
7769362|NCT00696241|27006498|P3|Overall Study|Other|5
7769363|NCT00696241|27006499|P2|Overall Study|Other|1
7769364|NCT00696241|27006500|P1|Overall Study|Other|6
7769365|NCT00696241|27006496|P5|Overall Study|Lack of Efficacy|3
7769366|NCT00696241|27006497|P4|Overall Study|Lack of Efficacy|5
7769367|NCT00696241|27006498|P3|Overall Study|Lack of Efficacy|4
7769368|NCT00696241|27006499|P2|Overall Study|Lack of Efficacy|5
7769369|NCT00696241|27006500|P1|Overall Study|Lack of Efficacy|1
7769370|NCT00696241|27006496|P5|Overall Study|Withdrawal by Subject|0
7769371|NCT00696241|27006497|P4|Overall Study|Withdrawal by Subject|1
7769372|NCT00696241|27006498|P3|Overall Study|Withdrawal by Subject|6
7769373|NCT00696241|27006499|P2|Overall Study|Withdrawal by Subject|8
7769374|NCT00696241|27006500|P1|Overall Study|Withdrawal by Subject|4
7769375|NCT00696241|27006496|P5|Overall Study|Lost to Follow-up|0
7769376|NCT00696241|27006497|P4|Overall Study|Lost to Follow-up|2
7769377|NCT00696241|27006498|P3|Overall Study|Lost to Follow-up|1
7769378|NCT00696241|27006499|P2|Overall Study|Lost to Follow-up|4
7769379|NCT00696241|27006500|P1|Overall Study|Lost to Follow-up|1
7769380|NCT00696241|27006496|P5|Overall Study|Protocol Violation|3
7769381|NCT00696241|27006497|P4|Overall Study|Protocol Violation|0
7769382|NCT00696241|27006498|P3|Overall Study|Protocol Violation|2
7769383|NCT00696241|27006499|P2|Overall Study|Protocol Violation|1
7769384|NCT00696241|27006500|P1|Overall Study|Protocol Violation|1
7769385|NCT00696241|27006496|P5|Overall Study|Adverse Event|5
7769386|NCT00696241|27006497|P4|Overall Study|Adverse Event|4
7769387|NCT00696241|27006498|P3|Overall Study|Adverse Event|6
7769388|NCT00696241|27006499|P2|Overall Study|Adverse Event|3
7769389|NCT00696241|27006500|P1|Overall Study|Adverse Event|11
7769390|NCT00696137|27006582|P1|Overall Study|Withdrawal by Subject|2
7769391|NCT00696072|27006588|P2|Overall Study|Non-specified|2
7769392|NCT00696072|27006589|P1|Overall Study|Non-specified|1
7769393|NCT00696072|27006588|P2|Overall Study|Disease Progression|30
7769394|NCT00696072|27006589|P1|Overall Study|Disease Progression|32
7769395|NCT00696072|27006588|P2|Overall Study|Sponsor Request|1
7769396|NCT00696072|27006589|P1|Overall Study|Sponsor Request|0
7769397|NCT00696072|27006588|P2|Overall Study|Investigator Request|4
7769398|NCT00696072|27006589|P1|Overall Study|Investigator Request|1
7769399|NCT00696072|27006588|P2|Overall Study|Patient Request|7
7769400|NCT00696072|27006589|P1|Overall Study|Patient Request|3
7769401|NCT00696072|27006588|P2|Overall Study|Adverse Event|6
7769402|NCT00696072|27006589|P1|Overall Study|Adverse Event|10
7769403|NCT00696072|27006588|P2|Overall Study|continuing active treatment|13
7769404|NCT00696072|27006589|P1|Overall Study|continuing active treatment|10
7769405|NCT00696020|27006610|P4|Overall Study|Other not stated above|1
7769406|NCT00696020|27006611|P3|Overall Study|Other not stated above|1
7769407|NCT00696020|27006612|P2|Overall Study|Other not stated above|0
7769408|NCT00696020|27006613|P1|Overall Study|Other not stated above|0
7769409|NCT00696020|27006610|P4|Overall Study|Withdrawal by Subject|1
7769410|NCT00696020|27006611|P3|Overall Study|Withdrawal by Subject|0
7769411|NCT00696020|27006612|P2|Overall Study|Withdrawal by Subject|1
7769412|NCT00696020|27006613|P1|Overall Study|Withdrawal by Subject|0
7769413|NCT00696020|27006610|P4|Overall Study|Protocol Violation|1
7769414|NCT00696020|27006611|P3|Overall Study|Protocol Violation|0
7769415|NCT00696020|27006612|P2|Overall Study|Protocol Violation|0
7769416|NCT00696020|27006613|P1|Overall Study|Protocol Violation|0
7769417|NCT00696020|27006610|P4|Overall Study|Lack of Efficacy|0
7769418|NCT00696020|27006611|P3|Overall Study|Lack of Efficacy|0
7769419|NCT00696020|27006612|P2|Overall Study|Lack of Efficacy|0
7769420|NCT00696020|27006613|P1|Overall Study|Lack of Efficacy|1
7769421|NCT00696020|27006610|P4|Overall Study|Adverse Event|1
7769422|NCT00696020|27006611|P3|Overall Study|Adverse Event|2
7769423|NCT00696020|27006612|P2|Overall Study|Adverse Event|1
7769424|NCT00696020|27006613|P1|Overall Study|Adverse Event|3
7769425|NCT00695955|27006721|P1|Cohort 2|Other|5
7769426|NCT00695955|27006721|P1|Cohort 2|Lack of Efficacy|4
7769427|NCT00695955|27006721|P1|Cohort 2|Withdrawal by Subject|28
7769428|NCT00695955|27006721|P1|Cohort 2|Lost to Follow-up|38
7769429|NCT00695955|27006721|P1|Cohort 2|Protocol Violation|5
7769430|NCT00695955|27006721|P1|Cohort 2|Adverse Event|24
7769431|NCT00695955|27006721|P1|Cohort 1|Other|16
7769432|NCT00695955|27006721|P1|Cohort 1|Lack of Efficacy|3
7769433|NCT00695955|27006721|P1|Cohort 1|Withdrawal by Subject|25
7769434|NCT00695955|27006721|P1|Cohort 1|Lost to Follow-up|30
7769435|NCT00695955|27006721|P1|Cohort 1|Protocol Violation|2
7769436|NCT00695955|27006721|P1|Cohort 1|Adverse Event|26
7769437|NCT00695903|27006733|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
7769438|NCT00695903|27006734|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
7769439|NCT00695903|27006733|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
7769440|NCT00695903|27006734|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
7769441|NCT00695903|27006733|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
7769442|NCT00695903|27006734|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
7769443|NCT00695903|27006733|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
7769444|NCT00695903|27006734|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
7769445|NCT00695903|27006733|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
7769446|NCT00695903|27006734|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
7769447|NCT00695903|27006733|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
7769448|NCT00695903|27006734|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
7769449|NCT00695903|27006733|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
7769450|NCT00695903|27006734|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
7769451|NCT00695903|27006733|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
7769452|NCT00695903|27006734|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
7769453|NCT00695903|27006733|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
7769454|NCT00695903|27006734|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
7769455|NCT00695864|27006746|P1|Placebo|Physician Decision|4
7769456|NCT00695864|27006746|P1|Placebo|Withdrawal by Subject|1
7769477|NCT00695669|27006773|P4|Overall Study|Lost to Follow-up|4
7769478|NCT00695669|27006774|P3|Overall Study|Lost to Follow-up|1
7769479|NCT00695669|27006775|P2|Overall Study|Lost to Follow-up|4
7769480|NCT00695669|27006776|P1|Overall Study|Lost to Follow-up|4
7769481|NCT00695669|27006773|P4|Overall Study|Adverse Event|0
7769482|NCT00695669|27006774|P3|Overall Study|Adverse Event|2
7769483|NCT00695669|27006775|P2|Overall Study|Adverse Event|0
7769484|NCT00695669|27006776|P1|Overall Study|Adverse Event|0
7769485|NCT00695565|27006861|P2|Overall Study|Subject did not follow instructions|1
7769486|NCT00695565|27006862|P1|Overall Study|Subject did not follow instructions|1
7769487|NCT00695565|27006861|P2|Overall Study|Lack of Efficacy|1
7769488|NCT00695565|27006862|P1|Overall Study|Lack of Efficacy|1
7769489|NCT00695565|27006861|P2|Overall Study|Withdrawal by Subject|1
7769490|NCT00695565|27006862|P1|Overall Study|Withdrawal by Subject|1
7769491|NCT00695565|27006861|P2|Overall Study|Protocol Violation|1
7769492|NCT00695565|27006862|P1|Overall Study|Protocol Violation|3
7769493|NCT00695565|27006861|P2|Overall Study|Adverse Event|1
7769494|NCT00695565|27006862|P1|Overall Study|Adverse Event|3
7769495|NCT00695565|27006861|P2|Overall Study|Lost to Follow-up|4
7769496|NCT00695565|27006862|P1|Overall Study|Lost to Follow-up|4
7769497|NCT00695396|27006935|P3|Overall Study|Withdrawal by Subject|0
7769498|NCT00695396|27006936|P2|Overall Study|Withdrawal by Subject|2
7769499|NCT00695396|27006937|P1|Overall Study|Withdrawal by Subject|2
7769500|NCT00695396|27006935|P3|Overall Study|Study Closed Prematurely|8
7769501|NCT00695396|27006936|P2|Overall Study|Study Closed Prematurely|6
7769502|NCT00695396|27006937|P1|Overall Study|Study Closed Prematurely|5
7769503|NCT00695318|27006953|P2|Overall Study|Study Terminated|0
7769504|NCT00695318|27006954|P1|Overall Study|Study Terminated|1
7769505|NCT00695318|27006953|P2|Overall Study|Death|1
7769506|NCT00695318|27006954|P1|Overall Study|Death|1
7769507|NCT00695318|27006953|P2|Overall Study|Withdrawal by Subject|0
7769508|NCT00695318|27006954|P1|Overall Study|Withdrawal by Subject|2
7769509|NCT00695318|27006953|P2|Overall Study|Lost to Follow-up|0
7769510|NCT00695318|27006954|P1|Overall Study|Lost to Follow-up|1
7769511|NCT00695136|27006984|P1|Overall Study|unrelated adverse event|1
7769512|NCT00695136|27006984|P1|Overall Study|Withdrawal by Subject|1
7769513|NCT00695110|27006988|P1|Treatment Period 4|Adverse Event|1
7769514|NCT00695110|27006988|P1|Treatment Period 3|Withdrawal by Subject|1
7769515|NCT00695110|27006988|P1|Treatment Period 1|Withdrawal by Subject|2
7769516|NCT00695110|27006988|P1|Treatment Period 1|Adverse Event|1
7769517|NCT00695019|27007011|P3|Overall Study|Various|4
7769518|NCT00695019|27007012|P2|Overall Study|Various|5
7769519|NCT00695019|27007013|P1|Overall Study|Various|4
7769520|NCT00695019|27007011|P3|Overall Study|Lack of Efficacy|1
7769521|NCT00695019|27007012|P2|Overall Study|Lack of Efficacy|0
7769522|NCT00695019|27007013|P1|Overall Study|Lack of Efficacy|0
7769523|NCT00695019|27007011|P3|Overall Study|Protocol Violation|1
7769524|NCT00695019|27007012|P2|Overall Study|Protocol Violation|3
7769525|NCT00695019|27007013|P1|Overall Study|Protocol Violation|1
7769526|NCT00695019|27007011|P3|Overall Study|Withdrawal by Subject|4
7769527|NCT00695019|27007012|P2|Overall Study|Withdrawal by Subject|6
7769528|NCT00695019|27007013|P1|Overall Study|Withdrawal by Subject|8
7769529|NCT00694707|27007047|P5|Overall Study|Notification of Past Head Injury|0
7769530|NCT00694707|27007048|P4|Overall Study|Notification of Past Head Injury|1
7769531|NCT00694707|27007049|P3|Overall Study|Notification of Past Head Injury|0
7769532|NCT00694707|27007050|P2|Overall Study|Notification of Past Head Injury|0
7769533|NCT00694707|27007051|P1|Overall Study|Notification of Past Head Injury|0
7769534|NCT00694707|27007047|P5|Overall Study|Administrative Reasons|0
7769535|NCT00694707|27007048|P4|Overall Study|Administrative Reasons|2
7769536|NCT00694707|27007049|P3|Overall Study|Administrative Reasons|0
7769537|NCT00694707|27007050|P2|Overall Study|Administrative Reasons|1
7769538|NCT00694707|27007051|P1|Overall Study|Administrative Reasons|0
7769539|NCT00694707|27007047|P5|Overall Study|Arrest by Police|0
7769540|NCT00694707|27007048|P4|Overall Study|Arrest by Police|0
7769541|NCT00694707|27007049|P3|Overall Study|Arrest by Police|0
7769542|NCT00694707|27007050|P2|Overall Study|Arrest by Police|1
7769543|NCT00694707|27007051|P1|Overall Study|Arrest by Police|0
7769544|NCT00694707|27007047|P5|Overall Study|Death in the Family|0
7769545|NCT00694707|27007048|P4|Overall Study|Death in the Family|0
7769546|NCT00694707|27007049|P3|Overall Study|Death in the Family|0
7769547|NCT00694707|27007050|P2|Overall Study|Death in the Family|0
7769548|NCT00694707|27007051|P1|Overall Study|Death in the Family|1
7769549|NCT00694707|27007047|P5|Overall Study|Jeopardizing Parole Status|0
7769550|NCT00694707|27007048|P4|Overall Study|Jeopardizing Parole Status|0
7769551|NCT00694707|27007049|P3|Overall Study|Jeopardizing Parole Status|0
7769552|NCT00694707|27007050|P2|Overall Study|Jeopardizing Parole Status|0
7769553|NCT00694707|27007051|P1|Overall Study|Jeopardizing Parole Status|1
7769554|NCT00694707|27007047|P5|Overall Study|Lost to Follow-up|0
7769555|NCT00694707|27007048|P4|Overall Study|Lost to Follow-up|0
7769556|NCT00694707|27007049|P3|Overall Study|Lost to Follow-up|2
7769557|NCT00694707|27007050|P2|Overall Study|Lost to Follow-up|1
7769558|NCT00694707|27007051|P1|Overall Study|Lost to Follow-up|0
7769559|NCT00694707|27007047|P5|Overall Study|Withdrawal of Consent|15
7769560|NCT00694707|27007048|P4|Overall Study|Withdrawal of Consent|16
7769561|NCT00694707|27007049|P3|Overall Study|Withdrawal of Consent|22
7769562|NCT00694707|27007050|P2|Overall Study|Withdrawal of Consent|18
7769563|NCT00694707|27007051|P1|Overall Study|Withdrawal of Consent|14
7769564|NCT00694707|27007047|P5|Overall Study|Protocol Violation|1
7769565|NCT00694707|27007048|P4|Overall Study|Protocol Violation|3
7769566|NCT00694707|27007049|P3|Overall Study|Protocol Violation|1
7769567|NCT00694707|27007050|P2|Overall Study|Protocol Violation|2
7769568|NCT00694707|27007051|P1|Overall Study|Protocol Violation|1
7769569|NCT00694707|27007047|P5|Overall Study|Insufficient Therapeutic Response|10
7769570|NCT00694707|27007048|P4|Overall Study|Insufficient Therapeutic Response|15
7769571|NCT00694707|27007049|P3|Overall Study|Insufficient Therapeutic Response|17
7769572|NCT00694707|27007050|P2|Overall Study|Insufficient Therapeutic Response|18
7769573|NCT00694707|27007051|P1|Overall Study|Insufficient Therapeutic Response|33
7769574|NCT00694707|27007047|P5|Overall Study|Adverse Event|13
7769575|NCT00694707|27007048|P4|Overall Study|Adverse Event|12
7769576|NCT00694707|27007049|P3|Overall Study|Adverse Event|8
7769577|NCT00694707|27007050|P2|Overall Study|Adverse Event|14
7769578|NCT00694707|27007051|P1|Overall Study|Adverse Event|22
7769579|NCT00694707|27007047|P5|Overall Study|Did Not Receive Treatment|1
7769580|NCT00694707|27007048|P4|Overall Study|Did Not Receive Treatment|1
7769581|NCT00694707|27007049|P3|Overall Study|Did Not Receive Treatment|1
7769582|NCT00694707|27007050|P2|Overall Study|Did Not Receive Treatment|0
7769583|NCT00694707|27007051|P1|Overall Study|Did Not Receive Treatment|0
7769584|NCT00694551|27007080|P3|Overall Study|Disease Progression|1
7769585|NCT00694551|27007081|P2|Overall Study|Disease Progression|0
7769586|NCT00694551|27007082|P1|Overall Study|Disease Progression|1
7769587|NCT00694369|27007111|P5|Overall Study|Withdrawal by Subject|2
7769588|NCT00694369|27007112|P4|Overall Study|Withdrawal by Subject|1
7769589|NCT00694369|27007113|P3|Overall Study|Withdrawal by Subject|1
7769590|NCT00694369|27007114|P2|Overall Study|Withdrawal by Subject|1
7769591|NCT00694369|27007115|P1|Overall Study|Withdrawal by Subject|1
7769592|NCT00694369|27007111|P5|Overall Study|Protocol Violation|0
7769593|NCT00694369|27007112|P4|Overall Study|Protocol Violation|0
7769594|NCT00694369|27007113|P3|Overall Study|Protocol Violation|0
7769595|NCT00694369|27007114|P2|Overall Study|Protocol Violation|1
7769596|NCT00694369|27007115|P1|Overall Study|Protocol Violation|0
7769597|NCT00694369|27007111|P5|Overall Study|Physician Decision|1
7769598|NCT00694369|27007112|P4|Overall Study|Physician Decision|0
7769599|NCT00694369|27007113|P3|Overall Study|Physician Decision|0
7769600|NCT00694369|27007114|P2|Overall Study|Physician Decision|0
7769601|NCT00694369|27007115|P1|Overall Study|Physician Decision|0
7769602|NCT00694369|27007111|P5|Overall Study|Lost to Follow-up|0
7769603|NCT00694369|27007112|P4|Overall Study|Lost to Follow-up|1
7769604|NCT00694369|27007113|P3|Overall Study|Lost to Follow-up|1
7769605|NCT00694369|27007114|P2|Overall Study|Lost to Follow-up|0
7769606|NCT00694369|27007115|P1|Overall Study|Lost to Follow-up|0
7769607|NCT00694369|27007111|P5|Overall Study|Adverse Event|3
7769608|NCT00694369|27007112|P4|Overall Study|Adverse Event|1
7769609|NCT00694369|27007113|P3|Overall Study|Adverse Event|0
7769610|NCT00694369|27007114|P2|Overall Study|Adverse Event|1
7769611|NCT00694369|27007115|P1|Overall Study|Adverse Event|0
7769612|NCT00694356|27007135|P3|Overall Study|Progressive Disease|6
7769613|NCT00694356|27007136|P2|Overall Study|Progressive Disease|6
7769614|NCT00694356|27007137|P1|Overall Study|Progressive Disease|2
7769615|NCT00694356|27007135|P3|Overall Study|Adverse Event|0
7769616|NCT00694356|27007136|P2|Overall Study|Adverse Event|0
7769617|NCT00694356|27007137|P1|Overall Study|Adverse Event|1
7769618|NCT00694304|27007172|P1|Overall Study|Administrative or Other Reasons|32
7769619|NCT00694304|27007172|P1|Overall Study|Lost to Follow-up|15
7769620|NCT00694304|27007172|P1|Overall Study|Withdrawal of Consent|61
7769621|NCT00694304|27007172|P1|Overall Study|Protocol Violation|6
7769622|NCT00694304|27007172|P1|Overall Study|Non-compliance With Study Product|16
7769623|NCT00694304|27007172|P1|Overall Study|Lack of Efficacy|35
7769624|NCT00694304|27007172|P1|Overall Study|Adverse Event|42
7769625|NCT00694161|27007185|P1|Part 2 (After Week 6 up to Month 12)|Death|1
7769626|NCT00694161|27007185|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
7769627|NCT00694161|27007185|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
7769628|NCT00694122|27007224|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
7769629|NCT00694122|27007225|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
7769630|NCT00694122|27007224|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
7769631|NCT00694122|27007225|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
7769632|NCT00694122|27007224|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
7769633|NCT00694122|27007225|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
7769634|NCT00694109|27007241|P1|Overall Study|Consented but no additional treatment|3
7769635|NCT00694109|27007241|P1|Overall Study|Other|2
7769636|NCT00694109|27007241|P1|Overall Study|Enrolled but not treated|1
7769637|NCT00694109|27007241|P1|Overall Study|Pregnancy|1
7769638|NCT00694109|27007241|P1|Overall Study|Withdrawal by Subject|13
7769639|NCT00694109|27007241|P1|Overall Study|Lack of Efficacy|2
7769640|NCT00694109|27007241|P1|Overall Study|Not consent of more 2 years of treatment|18
7769641|NCT00694109|27007241|P1|Overall Study|Adverse Event|74
7769642|NCT00694109|27007241|P1|Overall Study|Physician Decision|3
7769643|NCT00694096|27007265|P1|Overall Study|Withdrawal by Subject|5
7769644|NCT00693784|27007305|P1|Overall Study|Withdrawal by Subject|2
7769645|NCT00693784|27007305|P1|Overall Study|Lost to Follow-up|2
7769646|NCT00693706|27007318|P2|Overall Study|Protocol Violation|1
7769647|NCT00693706|27007319|P1|Overall Study|Protocol Violation|0
7769648|NCT00693693|27007346|P3|Overall Study|Lost to Follow-up|2
7769649|NCT00693693|27007347|P2|Overall Study|Lost to Follow-up|1
7769650|NCT00693693|27007348|P1|Overall Study|Lost to Follow-up|1
7769651|NCT00693472|27007407|P4|Part 2|Withdrew - reason unrelated to treatment|2
7769652|NCT00693472|27007408|P3|Part 2|Withdrew - reason unrelated to treatment|1
7769653|NCT00693472|27007409|P2|Part 2|Withdrew - reason unrelated to treatment|0
7769654|NCT00693472|27007410|P1|Part 2|Withdrew - reason unrelated to treatment|0
7769655|NCT00693472|27007407|P4|Part 2|Adverse Event|0
7769656|NCT00693472|27007408|P3|Part 2|Adverse Event|1
7769657|NCT00693472|27007409|P2|Part 2|Adverse Event|0
7769658|NCT00693472|27007410|P1|Part 2|Adverse Event|0
7769659|NCT00693472|27007407|P4|Part 1|Withdrew - reason unrelated to treatment|0
7769660|NCT00693472|27007408|P3|Part 1|Withdrew - reason unrelated to treatment|0
7769661|NCT00693472|27007409|P2|Part 1|Withdrew - reason unrelated to treatment|2
7769662|NCT00693472|27007410|P1|Part 1|Withdrew - reason unrelated to treatment|5
7769663|NCT00693472|27007407|P4|Part 1|Lost to Follow-up|0
7769664|NCT00693472|27007408|P3|Part 1|Lost to Follow-up|0
7769665|NCT00693472|27007409|P2|Part 1|Lost to Follow-up|1
7769666|NCT00693472|27007410|P1|Part 1|Lost to Follow-up|0
7769667|NCT00693472|27007407|P4|Part 1|Adverse Event|0
7769668|NCT00693472|27007408|P3|Part 1|Adverse Event|0
7769669|NCT00693472|27007409|P2|Part 1|Adverse Event|1
7769670|NCT00693472|27007410|P1|Part 1|Adverse Event|1
7769671|NCT00693420|27007430|P2|Overall Study|Personal Reasons|4
7769672|NCT00693420|27007431|P1|Overall Study|Personal Reasons|1
7769673|NCT00693420|27007430|P2|Overall Study|Sponsor Request - Conflict of Interest|2
7769674|NCT00693420|27007431|P1|Overall Study|Sponsor Request - Conflict of Interest|0
7769675|NCT00693420|27007430|P2|Overall Study|Protocol Violation|2
7769676|NCT00693420|27007431|P1|Overall Study|Protocol Violation|0
7769677|NCT00693420|27007430|P2|Overall Study|Withdrawal by Subject|0
7769678|NCT00693420|27007431|P1|Overall Study|Withdrawal by Subject|1
7769679|NCT00693420|27007430|P2|Overall Study|Lost to Follow-up|3
7769680|NCT00693420|27007431|P1|Overall Study|Lost to Follow-up|0
7769681|NCT00693420|27007430|P2|Overall Study|Adverse Event|4
7769682|NCT00693420|27007431|P1|Overall Study|Adverse Event|4
7769683|NCT00693225|27007470|P2|Overall Study|Adverse Event|3
7769684|NCT00693225|27007471|P1|Overall Study|Adverse Event|1
7769685|NCT00693225|27007470|P2|Overall Study|Lost to Follow-up|2
7769686|NCT00693225|27007471|P1|Overall Study|Lost to Follow-up|1
7769687|NCT00693017|27007494|P2|Overall Study|Death|1
7769688|NCT00693017|27007495|P1|Overall Study|Death|0
7769689|NCT00693017|27007494|P2|Overall Study|Sponsor Decision|1
7769690|NCT00693017|27007495|P1|Overall Study|Sponsor Decision|2
7769691|NCT00692913|27007526|P2|Overall Study|Withdrawal by Subject|20
7769692|NCT00692913|27007527|P1|Overall Study|Withdrawal by Subject|15
7769693|NCT00692913|27007526|P2|Overall Study|Protocol Violation|1
7769694|NCT00692913|27007527|P1|Overall Study|Protocol Violation|1
7769695|NCT00692913|27007526|P2|Overall Study|Physician Decision|0
7769696|NCT00692913|27007527|P1|Overall Study|Physician Decision|2
7769697|NCT00692913|27007526|P2|Overall Study|Lost to Follow-up|5
7769698|NCT00692913|27007527|P1|Overall Study|Lost to Follow-up|3
7769699|NCT00692913|27007526|P2|Overall Study|Adverse Event|4
7769700|NCT00692913|27007527|P1|Overall Study|Adverse Event|8
7769701|NCT00692770|27007549|P2|Overall Study|Randomized but not treated|4
7769702|NCT00692770|27007550|P1|Overall Study|Randomized but not treated|3
7769703|NCT00692770|27007549|P2|Overall Study|Study terminated by sponsor|2
7769704|NCT00692770|27007550|P1|Overall Study|Study terminated by sponsor|2
7769705|NCT00692770|27007549|P2|Overall Study|Clinical endpoint reached|43
7769706|NCT00692770|27007550|P1|Overall Study|Clinical endpoint reached|16
7769707|NCT00692770|27007549|P2|Overall Study|Radiological and clinical progression|8
7769708|NCT00692770|27007550|P1|Overall Study|Radiological and clinical progression|8
7769709|NCT00692770|27007549|P2|Overall Study|Completed all planned assessments|101
7769710|NCT00692770|27007550|P1|Overall Study|Completed all planned assessments|79
7769711|NCT00692770|27007549|P2|Overall Study|Protocol driven decision point|7
7769712|NCT00692770|27007550|P1|Overall Study|Protocol driven decision point|3
7769713|NCT00692770|27007549|P2|Overall Study|Disease progression, recurrence/relapse|279
7769714|NCT00692770|27007550|P1|Overall Study|Disease progression, recurrence/relapse|170
7769715|NCT00692770|27007549|P2|Overall Study|Physician decision not protocol driven|14
7769716|NCT00692770|27007550|P1|Overall Study|Physician decision not protocol driven|10
7769717|NCT00692770|27007549|P2|Overall Study|Progression by clinical judgment|3
7769718|NCT00692770|27007550|P1|Overall Study|Progression by clinical judgment|2
7769719|NCT00692770|27007549|P2|Overall Study|Non-compliant with study medication|5
7769720|NCT00692770|27007550|P1|Overall Study|Non-compliant with study medication|11
7769721|NCT00692770|27007549|P2|Overall Study|Lost to Follow-up|3
7769722|NCT00692770|27007550|P1|Overall Study|Lost to Follow-up|7
7769723|NCT00692770|27007549|P2|Overall Study|Death|5
7769724|NCT00692770|27007550|P1|Overall Study|Death|10
7769725|NCT00692770|27007549|P2|Overall Study|Adverse Event|41
7769726|NCT00692770|27007550|P1|Overall Study|Adverse Event|136
7769727|NCT00692770|27007549|P2|Overall Study|Withdrawal by Subject|36
7769728|NCT00692770|27007550|P1|Overall Study|Withdrawal by Subject|97
7769729|NCT00692770|27007549|P2|Overall Study|Protocol Violation|7
7769730|NCT00692770|27007550|P1|Overall Study|Protocol Violation|2
7769731|NCT00692406|27007596|P1|Overall Study|PI dropped, bad data|57
7769732|NCT00692237|27007667|P2|Overall Study|Adverse Event|1
7769733|NCT00692237|27007668|P1|Overall Study|Adverse Event|0
7769734|NCT00692237|27007667|P2|Overall Study|Withdrawal by Subject|3
7769735|NCT00692237|27007668|P1|Overall Study|Withdrawal by Subject|1
7769736|NCT00692003|27007755|P2|Overall Study|Sponsor Decision|1
7769737|NCT00692003|27007756|P1|Overall Study|Sponsor Decision|5
7769738|NCT00691938|27007771|P7|Overall Study|QTc prolongation|0
7769739|NCT00691938|27007772|P6|Overall Study|QTc prolongation|0
7769740|NCT00691938|27007773|P5|Overall Study|QTc prolongation|0
7769741|NCT00691938|27007774|P4|Overall Study|QTc prolongation|0
7769742|NCT00691938|27007775|P3|Overall Study|QTc prolongation|0
7769743|NCT00691938|27007776|P2|Overall Study|QTc prolongation|0
7769744|NCT00691938|27007777|P1|Overall Study|QTc prolongation|1
7769745|NCT00691704|27007844|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
7769746|NCT00691704|27007844|P1|Two Years of Maintenance Therapy|Physician Decision|4
7769747|NCT00691704|27007844|P1|Two Years of Maintenance Therapy|Disease Progression|8
7769748|NCT00691704|27007844|P1|Induction Therapy|Active Hepatitis|1
7769749|NCT00691704|27007844|P1|Induction Therapy|Disease Progression|1
7769750|NCT00691483|27007905|P2|Overall Study|Randomized by not treated|1
7769751|NCT00691483|27007906|P1|Overall Study|Randomized by not treated|7
7769752|NCT00691483|27007905|P2|Overall Study|Other known cause|1
7769753|NCT00691483|27007906|P1|Overall Study|Other known cause|6
7769754|NCT00691483|27007905|P2|Overall Study|Withdrawal by Subject|7
7769755|NCT00691483|27007906|P1|Overall Study|Withdrawal by Subject|24
7769756|NCT00691483|27007905|P2|Overall Study|Lost to Follow-up|10
7769757|NCT00691483|27007906|P1|Overall Study|Lost to Follow-up|17
7769758|NCT00691483|27007905|P2|Overall Study|Adverse Event|6
7769759|NCT00691483|27007906|P1|Overall Study|Adverse Event|14
7769760|NCT00691301|27007949|P1|Overall Study|Did not initiate study treatment|1
7769761|NCT00691301|27007949|P1|Overall Study|other reason|3
7769762|NCT00691301|27007949|P1|Overall Study|Concurrent illness|2
7769763|NCT00691301|27007949|P1|Overall Study|Withdrawal by Subject|4
7769764|NCT00691301|27007949|P1|Overall Study|Lack of Efficacy|32
7769765|NCT00691301|27007949|P1|Overall Study|Death|2
7769766|NCT00691301|27007949|P1|Overall Study|Adverse Event|10
7769767|NCT00691210|27007969|P8|Overall Study|Lack of Efficacy|0
7769768|NCT00691210|27007970|P7|Overall Study|Lack of Efficacy|0
7769769|NCT00691210|27007971|P6|Overall Study|Lack of Efficacy|1
7769770|NCT00691210|27007972|P5|Overall Study|Lack of Efficacy|0
7769771|NCT00691210|27007973|P4|Overall Study|Lack of Efficacy|1
7769772|NCT00691210|27007974|P3|Overall Study|Lack of Efficacy|0
7769773|NCT00691210|27007975|P2|Overall Study|Lack of Efficacy|0
7769774|NCT00691210|27007976|P1|Overall Study|Lack of Efficacy|0
7769775|NCT00691210|27007969|P8|Overall Study|Progression of Disease|0
7769776|NCT00691210|27007970|P7|Overall Study|Progression of Disease|0
7769777|NCT00691210|27007971|P6|Overall Study|Progression of Disease|0
7769778|NCT00691210|27007972|P5|Overall Study|Progression of Disease|0
7769779|NCT00691210|27007973|P4|Overall Study|Progression of Disease|2
7769780|NCT00691210|27007974|P3|Overall Study|Progression of Disease|0
7769781|NCT00691210|27007975|P2|Overall Study|Progression of Disease|0
7769782|NCT00691210|27007976|P1|Overall Study|Progression of Disease|0
7769783|NCT00691132|27008011|P2|Overall Study|Withdrawal by Subject|10
7769784|NCT00691132|27008012|P1|Overall Study|Withdrawal by Subject|10
7769785|NCT00691132|27008011|P2|Overall Study|Adverse Event|3
7769786|NCT00691132|27008012|P1|Overall Study|Adverse Event|2
7769787|NCT00691093|27008031|P1|Overall Study|Ongoing at Date of Cut-Off|4
7769788|NCT00691093|27008031|P1|Overall Study|Lack of Efficacy|1
7769789|NCT00691093|27008031|P1|Overall Study|Lost to Follow-up|1
7769790|NCT00691093|27008031|P1|Overall Study|Adverse Event|1
7769791|NCT00691054|27008065|P1|Overall Study|Withdrawal by Subject|1
7769792|NCT00691028|27008077|P4|Double-blind Period|not come to a hospital.|0
7769793|NCT00691028|27008078|P3|Double-blind Period|not come to a hospital.|0
7769794|NCT00691028|27008079|P2|Double-blind Period|not come to a hospital.|1
7769795|NCT00691028|27008080|P1|Double-blind Period|not come to a hospital.|0
7769796|NCT00691028|27008077|P4|Double-blind Period|Withdrawal by Subject|0
7769797|NCT00691028|27008078|P3|Double-blind Period|Withdrawal by Subject|1
7769798|NCT00691028|27008079|P2|Double-blind Period|Withdrawal by Subject|0
7769799|NCT00691028|27008080|P1|Double-blind Period|Withdrawal by Subject|1
7769800|NCT00691028|27008077|P4|Double-blind Period|Lack of Efficacy|0
7769801|NCT00691028|27008078|P3|Double-blind Period|Lack of Efficacy|2
7769802|NCT00691028|27008079|P2|Double-blind Period|Lack of Efficacy|3
7769803|NCT00691028|27008080|P1|Double-blind Period|Lack of Efficacy|4
7769804|NCT00691028|27008077|P4|Double-blind Period|Adverse Event|0
7769805|NCT00691028|27008078|P3|Double-blind Period|Adverse Event|6
7769806|NCT00691028|27008079|P2|Double-blind Period|Adverse Event|9
7769807|NCT00691028|27008080|P1|Double-blind Period|Adverse Event|8
7769808|NCT00691028|27008077|P4|Open-label Period|not come to a hospital|1
7769809|NCT00691028|27008078|P3|Open-label Period|not come to a hospital|0
7769810|NCT00691028|27008079|P2|Open-label Period|not come to a hospital|0
7769811|NCT00691028|27008080|P1|Open-label Period|not come to a hospital|0
7769812|NCT00691028|27008077|P4|Open-label Period|Withdrawal by Subject|3
7769813|NCT00691028|27008078|P3|Open-label Period|Withdrawal by Subject|0
7769814|NCT00691028|27008079|P2|Open-label Period|Withdrawal by Subject|0
7769815|NCT00691028|27008080|P1|Open-label Period|Withdrawal by Subject|0
7769816|NCT00691028|27008077|P4|Open-label Period|Adverse Event|16
7769817|NCT00691028|27008078|P3|Open-label Period|Adverse Event|0
7769818|NCT00691028|27008079|P2|Open-label Period|Adverse Event|0
7769819|NCT00691028|27008080|P1|Open-label Period|Adverse Event|0
7769820|NCT00691015|27008113|P1|Overall Study|Refused further treatment|1
7769821|NCT00690898|27008163|P1|TREATMENT|Other (not otherwise specified)|1
7769822|NCT00690898|27008163|P1|TREATMENT|Withdrawal by Subject|4
7769823|NCT00690898|27008163|P1|TREATMENT|Lack of Efficacy|18
7769824|NCT00690898|27008163|P1|TREATMENT|Adverse Event|3
7769825|NCT00690898|27008163|P1|SCREENING|Screen failure|18
7769826|NCT00690820|27008183|P2|Period 1|Withdrawal by Subject|1
7769827|NCT00690820|27008184|P1|Period 1|Withdrawal by Subject|0
7769828|NCT00690794|27008206|P2|Overall Study|Other not specified|3
7769829|NCT00690794|27008207|P1|Overall Study|Other not specified|1
7769830|NCT00690794|27008206|P2|Overall Study|Noncompliance|2
7769831|NCT00690794|27008207|P1|Overall Study|Noncompliance|1
7769832|NCT00690794|27008206|P2|Overall Study|Protocol Violation|7
7769833|NCT00690794|27008207|P1|Overall Study|Protocol Violation|6
7769834|NCT00690794|27008206|P2|Overall Study|Withdrawal by Subject|9
7769835|NCT00690794|27008207|P1|Overall Study|Withdrawal by Subject|0
7769836|NCT00690794|27008206|P2|Overall Study|Lost to Follow-up|4
7769837|NCT00690794|27008207|P1|Overall Study|Lost to Follow-up|1
7769838|NCT00690794|27008206|P2|Overall Study|Adverse Event|10
7769839|NCT00690794|27008207|P1|Overall Study|Adverse Event|12
7769840|NCT00690755|27008222|P7|Overall Study|Physician Decision|0
7769841|NCT00690755|27008223|P6|Overall Study|Physician Decision|4
7769842|NCT00690755|27008224|P5|Overall Study|Physician Decision|0
7769843|NCT00690755|27008225|P4|Overall Study|Physician Decision|5
7769844|NCT00690755|27008226|P3|Overall Study|Physician Decision|46
7769845|NCT00690755|27008227|P2|Overall Study|Physician Decision|0
7769846|NCT00690755|27008228|P1|Overall Study|Physician Decision|2
7769847|NCT00690612|27008244|P1|Overall Study|Withdrawal by Subject|2
7769848|NCT00690612|27008244|P1|Overall Study|Adverse Event|1
7769849|NCT00690573|27008249|P1|Overall Study|Withdrawal by Subject|1
7769850|NCT00690573|27008249|P1|Overall Study|Lack of Efficacy|8
7769851|NCT00690482|27008268|P2|Overall Study|withdrew consent at rand.day|1
7769852|NCT00690482|27008269|P1|Overall Study|withdrew consent at rand.day|0
7769853|NCT00690482|27008268|P2|Overall Study|Intake of prohibited medicine|0
7769854|NCT00690482|27008269|P1|Overall Study|Intake of prohibited medicine|1
7769855|NCT00690482|27008268|P2|Overall Study|Study-specific discontinuation criteria|0
7769856|NCT00690482|27008269|P1|Overall Study|Study-specific discontinuation criteria|1
7769857|NCT00690482|27008268|P2|Overall Study|Incorrect enrolment|1
7769858|NCT00690482|27008269|P1|Overall Study|Incorrect enrolment|0
7769859|NCT00690482|27008268|P2|Overall Study|Adverse Event|1
7769860|NCT00690482|27008269|P1|Overall Study|Adverse Event|2
7769861|NCT00690443|27008303|P2|Overall Study|Adverse Event|2
7769862|NCT00690443|27008304|P1|Overall Study|Adverse Event|1
7769863|NCT00690430|27008314|P3|Extension Phase|Early Termination|3
7769864|NCT00690430|27008315|P2|Extension Phase|Early Termination|1
7769865|NCT00690430|27008316|P1|Extension Phase|Early Termination|10
7769866|NCT00690430|27008314|P3|Extension Phase|Withdrawal by Subject|2
7769867|NCT00690430|27008315|P2|Extension Phase|Withdrawal by Subject|0
7769868|NCT00690430|27008316|P1|Extension Phase|Withdrawal by Subject|0
7769869|NCT00690430|27008314|P3|Extension Phase|Death|1
7769870|NCT00690430|27008315|P2|Extension Phase|Death|1
7769871|NCT00690430|27008316|P1|Extension Phase|Death|1
7769872|NCT00690430|27008314|P3|Extension Phase|Adverse Event|2
7769873|NCT00690430|27008315|P2|Extension Phase|Adverse Event|1
7769874|NCT00690430|27008316|P1|Extension Phase|Adverse Event|2
7769875|NCT00690430|27008314|P3|Extension Phase|Administrative Problems|1
7769876|NCT00690430|27008315|P2|Extension Phase|Administrative Problems|1
7769877|NCT00690430|27008316|P1|Extension Phase|Administrative Problems|0
7769878|NCT00690430|27008314|P3|Extension Phase|Abnormal test procedure results|0
7769879|NCT00690430|27008315|P2|Extension Phase|Abnormal test procedure results|0
7769880|NCT00690430|27008316|P1|Extension Phase|Abnormal test procedure results|1
7769881|NCT00690430|27008314|P3|Extension Phase|Abnormal Lab Values|0
7769882|NCT00690430|27008315|P2|Extension Phase|Abnormal Lab Values|0
7769883|NCT00690430|27008316|P1|Extension Phase|Abnormal Lab Values|1
7769884|NCT00690430|27008314|P3|Extension Phase|Lack of Efficacy|4
7769885|NCT00690430|27008315|P2|Extension Phase|Lack of Efficacy|1
7769886|NCT00690430|27008316|P1|Extension Phase|Lack of Efficacy|3
7769887|NCT00690430|27008314|P3|Core Phase|Early Termination|0
7769888|NCT00690430|27008315|P2|Core Phase|Early Termination|5
7769889|NCT00690430|27008316|P1|Core Phase|Early Termination|0
7769890|NCT00690430|27008314|P3|Core Phase|Administrative Problems|0
7769891|NCT00690430|27008315|P2|Core Phase|Administrative Problems|1
7769892|NCT00690430|27008316|P1|Core Phase|Administrative Problems|0
7769893|NCT00690430|27008314|P3|Core Phase|Lack of Efficacy|0
7769894|NCT00690430|27008315|P2|Core Phase|Lack of Efficacy|10
7769895|NCT00690430|27008316|P1|Core Phase|Lack of Efficacy|8
7769896|NCT00690430|27008314|P3|Core Phase|Subject no longer requires study drug|0
7769897|NCT00690430|27008315|P2|Core Phase|Subject no longer requires study drug|0
7769898|NCT00690430|27008316|P1|Core Phase|Subject no longer requires study drug|1
7769899|NCT00690430|27008314|P3|Core Phase|Withdrawal by Subject|0
7769900|NCT00690430|27008315|P2|Core Phase|Withdrawal by Subject|3
7769901|NCT00690430|27008316|P1|Core Phase|Withdrawal by Subject|3
7769902|NCT00690430|27008314|P3|Core Phase|Protocol Violation|0
7769903|NCT00690430|27008315|P2|Core Phase|Protocol Violation|0
7769904|NCT00690430|27008316|P1|Core Phase|Protocol Violation|1
7769905|NCT00690430|27008314|P3|Core Phase|Death|0
7769906|NCT00690430|27008315|P2|Core Phase|Death|2
7769907|NCT00690430|27008316|P1|Core Phase|Death|0
7769908|NCT00690430|27008314|P3|Core Phase|Adverse Event|0
7769909|NCT00690430|27008315|P2|Core Phase|Adverse Event|1
7769910|NCT00690430|27008316|P1|Core Phase|Adverse Event|5
7769911|NCT00690430|27008314|P3|Core Phase|Abnormal Laboratory value|0
7769912|NCT00690430|27008315|P2|Core Phase|Abnormal Laboratory value|1
7769913|NCT00690430|27008316|P1|Core Phase|Abnormal Laboratory value|0
7769914|NCT00690378|27008345|P2|Overall Study|Social problem|0
7769915|NCT00690378|27008346|P1|Overall Study|Social problem|1
7769916|NCT00690378|27008345|P2|Overall Study|Did not meet inc/exc criteria|11
7769917|NCT00690378|27008346|P1|Overall Study|Did not meet inc/exc criteria|13
7769918|NCT00690378|27008345|P2|Overall Study|Lost to Follow-up|3
7769919|NCT00690378|27008346|P1|Overall Study|Lost to Follow-up|2
7769920|NCT00690378|27008345|P2|Overall Study|Protocol Violation|0
7769921|NCT00690378|27008346|P1|Overall Study|Protocol Violation|1
7769922|NCT00690378|27008345|P2|Overall Study|Withdrawal by Subject|0
7769923|NCT00690378|27008346|P1|Overall Study|Withdrawal by Subject|2
7769924|NCT00690378|27008345|P2|Overall Study|Adverse Event|0
7769925|NCT00690378|27008346|P1|Overall Study|Adverse Event|1
7769926|NCT00689936|27008443|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
7769927|NCT00689936|27008444|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
7769928|NCT00689936|27008445|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
7769929|NCT00689936|27008443|P3|Active Treatment Phase|Miscellaneous|47
7769930|NCT00689936|27008444|P2|Active Treatment Phase|Miscellaneous|34
7769931|NCT00689936|27008445|P1|Active Treatment Phase|Miscellaneous|52
7769932|NCT00689936|27008443|P3|Active Treatment Phase|Study Close Out|21
7769933|NCT00689936|27008444|P2|Active Treatment Phase|Study Close Out|26
7769934|NCT00689936|27008445|P1|Active Treatment Phase|Study Close Out|64
7769935|NCT00689936|27008443|P3|Active Treatment Phase|Protocol Violation|4
7769936|NCT00689936|27008444|P2|Active Treatment Phase|Protocol Violation|2
7769937|NCT00689936|27008445|P1|Active Treatment Phase|Protocol Violation|2
7769938|NCT00689936|27008443|P3|Active Treatment Phase|Lost to Follow-up|2
7769939|NCT00689936|27008444|P2|Active Treatment Phase|Lost to Follow-up|2
7769940|NCT00689936|27008445|P1|Active Treatment Phase|Lost to Follow-up|0
7769941|NCT00689936|27008443|P3|Active Treatment Phase|Death|37
7769942|NCT00689936|27008444|P2|Active Treatment Phase|Death|28
7769943|NCT00689936|27008445|P1|Active Treatment Phase|Death|60
7769944|NCT00689936|27008443|P3|Active Treatment Phase|Withdrawal by Subject|21
7769945|NCT00689936|27008444|P2|Active Treatment Phase|Withdrawal by Subject|16
7769946|NCT00689936|27008445|P1|Active Treatment Phase|Withdrawal by Subject|16
7769947|NCT00689936|27008443|P3|Active Treatment Phase|Disease Progression|339
7769948|NCT00689936|27008444|P2|Active Treatment Phase|Disease Progression|362
7769949|NCT00689936|27008445|P1|Active Treatment Phase|Disease Progression|273
7769950|NCT00689936|27008443|P3|Active Treatment Phase|Adverse Event|76
7769951|NCT00689936|27008444|P2|Active Treatment Phase|Adverse Event|71
7769952|NCT00689936|27008445|P1|Active Treatment Phase|Adverse Event|68
7769953|NCT00689871|27008594|P4|Overall Study|Physician Decision|0
7769954|NCT00689871|27008595|P3|Overall Study|Physician Decision|1
7769955|NCT00689871|27008596|P2|Overall Study|Physician Decision|1
7769956|NCT00689871|27008597|P1|Overall Study|Physician Decision|2
7769957|NCT00689871|27008594|P4|Overall Study|Death|2
7769958|NCT00689871|27008595|P3|Overall Study|Death|2
7769959|NCT00689871|27008596|P2|Overall Study|Death|10
7769960|NCT00689871|27008597|P1|Overall Study|Death|1
7769961|NCT00689871|27008594|P4|Overall Study|Withdrawal by Subject|1
7769962|NCT00689871|27008595|P3|Overall Study|Withdrawal by Subject|4
7769963|NCT00689871|27008596|P2|Overall Study|Withdrawal by Subject|3
7769964|NCT00689871|27008597|P1|Overall Study|Withdrawal by Subject|13
7769965|NCT00689871|27008594|P4|Overall Study|Explanted of All Study Devices|3
7769966|NCT00689871|27008595|P3|Overall Study|Explanted of All Study Devices|29
7769967|NCT00689871|27008596|P2|Overall Study|Explanted of All Study Devices|25
7769968|NCT00689871|27008597|P1|Overall Study|Explanted of All Study Devices|36
7769969|NCT00689871|27008594|P4|Overall Study|Lost to Follow-up|1
7769970|NCT00689871|27008595|P3|Overall Study|Lost to Follow-up|37
7769971|NCT00689871|27008596|P2|Overall Study|Lost to Follow-up|13
7769972|NCT00689871|27008597|P1|Overall Study|Lost to Follow-up|123
7769973|NCT00689793|27008624|P2|Overall Study|Lost to Follow-up|5
7769974|NCT00689793|27008625|P1|Overall Study|Lost to Follow-up|4
7769975|NCT00689728|27008644|P3|Optional Follow-Up|Withdrawal by Subject|3
7769976|NCT00689728|27008645|P2|Optional Follow-Up|Withdrawal by Subject|4
7769977|NCT00689728|27008646|P1|Optional Follow-Up|Withdrawal by Subject|2
7769978|NCT00689728|27008644|P3|Optional Follow-Up|Protocol Violation|1
7769979|NCT00689728|27008645|P2|Optional Follow-Up|Protocol Violation|0
7769980|NCT00689728|27008646|P1|Optional Follow-Up|Protocol Violation|0
7769981|NCT00689728|27008644|P3|Optional Follow-Up|Lost to Follow-up|1
7769982|NCT00689728|27008645|P2|Optional Follow-Up|Lost to Follow-up|1
7769983|NCT00689728|27008646|P1|Optional Follow-Up|Lost to Follow-up|0
7769984|NCT00689728|27008644|P3|Optional Follow-Up|Lack of Efficacy|1
7769985|NCT00689728|27008645|P2|Optional Follow-Up|Lack of Efficacy|1
7769986|NCT00689728|27008646|P1|Optional Follow-Up|Lack of Efficacy|0
7769987|NCT00689728|27008644|P3|Optional Follow-Up|Adverse Event|0
7769988|NCT00689728|27008645|P2|Optional Follow-Up|Adverse Event|0
7769989|NCT00689728|27008646|P1|Optional Follow-Up|Adverse Event|1
7769990|NCT00689728|27008644|P3|Rescue|Withdrawal by Subject|1
7769991|NCT00689728|27008645|P2|Rescue|Withdrawal by Subject|1
7769992|NCT00689728|27008646|P1|Rescue|Withdrawal by Subject|1
7769993|NCT00689728|27008644|P3|Rescue|Adverse Event|0
7769994|NCT00689728|27008645|P2|Rescue|Adverse Event|1
7769995|NCT00689728|27008646|P1|Rescue|Adverse Event|0
7769996|NCT00689728|27008644|P3|Double-Blind Treatment|Lack of Efficacy|2
7769997|NCT00689728|27008645|P2|Double-Blind Treatment|Lack of Efficacy|1
7769998|NCT00689728|27008646|P1|Double-Blind Treatment|Lack of Efficacy|0
7769999|NCT00689728|27008644|P3|Double-Blind Treatment|Withdrawal by Subject|2
7770000|NCT00689728|27008645|P2|Double-Blind Treatment|Withdrawal by Subject|3
7770001|NCT00689728|27008646|P1|Double-Blind Treatment|Withdrawal by Subject|3
7770002|NCT00689728|27008644|P3|Double-Blind Treatment|Protocol Violation|1
7770003|NCT00689728|27008645|P2|Double-Blind Treatment|Protocol Violation|0
7770004|NCT00689728|27008646|P1|Double-Blind Treatment|Protocol Violation|0
7770005|NCT00689728|27008644|P3|Double-Blind Treatment|Adverse Event|0
7770006|NCT00689728|27008645|P2|Double-Blind Treatment|Adverse Event|0
7770007|NCT00689728|27008646|P1|Double-Blind Treatment|Adverse Event|1
7770008|NCT00689611|27008729|P2|Overall Study|Lost to Follow-up|28
7770009|NCT00689611|27008730|P1|Overall Study|Lost to Follow-up|27
7770010|NCT00689611|27008729|P2|Overall Study|Withdrawal by Subject|9
7770011|NCT00689611|27008730|P1|Overall Study|Withdrawal by Subject|8
7770012|NCT00689611|27008729|P2|Overall Study|Death|9
7770013|NCT00689611|27008730|P1|Overall Study|Death|6
7770014|NCT00689481|27008740|P2|Overall Study|Subject early term, left on vacation|1
7770015|NCT00689481|27008741|P1|Overall Study|Subject early term, left on vacation|0
7770016|NCT00689481|27008740|P2|Overall Study|Excluded medication started during study|1
7770017|NCT00689481|27008741|P1|Overall Study|Excluded medication started during study|0
7770018|NCT00689481|27008740|P2|Overall Study|Withdrawal by Subject|4
7770019|NCT00689481|27008741|P1|Overall Study|Withdrawal by Subject|8
7770020|NCT00689481|27008740|P2|Overall Study|Non-compliance with study treatment|1
7770021|NCT00689481|27008741|P1|Overall Study|Non-compliance with study treatment|1
7770022|NCT00689481|27008740|P2|Overall Study|Lack of Efficacy|3
7770023|NCT00689481|27008741|P1|Overall Study|Lack of Efficacy|4
7770024|NCT00689481|27008740|P2|Overall Study|Lost to Follow-up|3
7770025|NCT00689481|27008741|P1|Overall Study|Lost to Follow-up|4
7770026|NCT00689481|27008740|P2|Overall Study|Adverse Event|1
7770027|NCT00689481|27008741|P1|Overall Study|Adverse Event|7
7770028|NCT00689390|27008759|P2|Overall Study|Administrative|0
7770029|NCT00689390|27008760|P1|Overall Study|Administrative|37
7770030|NCT00689390|27008759|P2|Overall Study|Did Not Meet Protocol Eligibility|0
7770031|NCT00689390|27008760|P1|Overall Study|Did Not Meet Protocol Eligibility|1
7770032|NCT00689390|27008759|P2|Overall Study|Non-Compliance With Protocol|0
7770033|NCT00689390|27008760|P1|Overall Study|Non-Compliance With Protocol|21
7770034|NCT00689390|27008759|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
7770035|NCT00689390|27008760|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
7770036|NCT00689390|27008759|P2|Overall Study|Withdrawal by Subject|3
7770037|NCT00689390|27008760|P1|Overall Study|Withdrawal by Subject|117
7770038|NCT00689390|27008759|P2|Overall Study|Lost to Follow-up|7
7770039|NCT00689390|27008760|P1|Overall Study|Lost to Follow-up|179
7770040|NCT00689390|27008759|P2|Overall Study|Adverse Event|0
7770041|NCT00689390|27008760|P1|Overall Study|Adverse Event|19
7770042|NCT00689351|27008778|P2|After Infant Series|Parent/legal guardian request|0
7770043|NCT00689351|27008779|P1|After Infant Series|Parent/legal guardian request|1
7770044|NCT00689351|27008778|P2|Infant Series of Dosing|Lost to Follow-up|1
7770045|NCT00689351|27008779|P1|Infant Series of Dosing|Lost to Follow-up|0
7770046|NCT00689351|27008778|P2|Infant Series of Dosing|Adverse Event|0
7770047|NCT00689351|27008779|P1|Infant Series of Dosing|Adverse Event|1
7770048|NCT00689351|27008778|P2|Infant Series of Dosing|Parent/legal guardian request|0
7770049|NCT00689351|27008779|P1|Infant Series of Dosing|Parent/legal guardian request|5
7770050|NCT00689338|27008811|P1|Overall Study|Protocol Violation|15
7770051|NCT00689338|27008811|P1|Overall Study|Withdrawal by Subject|3
7770052|NCT00689338|27008811|P1|Overall Study|Lost to Follow-up|5
7770053|NCT00689338|27008811|P1|Overall Study|Did not Meet Entrance Criteria|27
7770054|NCT00689338|27008811|P1|Overall Study|Other|8
7770055|NCT00689338|27008811|P1|Overall Study|Lack of Efficacy|6
7770056|NCT00689338|27008811|P1|Overall Study|Insufficient Clinical Response|1
7770057|NCT00689338|27008811|P1|Overall Study|Adverse Event|13
7770058|NCT00689338|27008811|P1|Overall Study|Death|65
7770059|NCT00689299|27008824|P3|Overall Study|Protocol Violation|0
7770060|NCT00689299|27008825|P2|Overall Study|Protocol Violation|0
7770061|NCT00689299|27008826|P1|Overall Study|Protocol Violation|1
7770062|NCT00689299|27008824|P3|Overall Study|Withdrawal by Subject|3
7770063|NCT00689299|27008825|P2|Overall Study|Withdrawal by Subject|1
7770064|NCT00689299|27008826|P1|Overall Study|Withdrawal by Subject|4
7770065|NCT00689299|27008824|P3|Overall Study|Lost to Follow-up|1
7770066|NCT00689299|27008825|P2|Overall Study|Lost to Follow-up|1
7770067|NCT00689299|27008826|P1|Overall Study|Lost to Follow-up|0
7770068|NCT00689299|27008824|P3|Overall Study|Adverse Event|1
7770069|NCT00689299|27008825|P2|Overall Study|Adverse Event|1
7770070|NCT00689299|27008826|P1|Overall Study|Adverse Event|2
7770071|NCT00689273|27008836|P2|Overall Study|Randomized but not Treated|0
7770072|NCT00689273|27008837|P1|Overall Study|Randomized but not Treated|1
7770073|NCT00689273|27008836|P2|Overall Study|Other|2
7770074|NCT00689273|27008837|P1|Overall Study|Other|6
7770075|NCT00689273|27008836|P2|Overall Study|Lost to Follow-up|2
7770076|NCT00689273|27008837|P1|Overall Study|Lost to Follow-up|0
7770077|NCT00689273|27008836|P2|Overall Study|Lack of Efficacy|0
7770078|NCT00689273|27008837|P1|Overall Study|Lack of Efficacy|3
7770079|NCT00689273|27008836|P2|Overall Study|Adverse Event|1
7770080|NCT00689273|27008837|P1|Overall Study|Adverse Event|3
7770081|NCT00689221|27008903|P2|Overall Study|Ongoing at cut-off date|36
7770082|NCT00689221|27008904|P1|Overall Study|Ongoing at cut-off date|39
7770083|NCT00689117|27008933|P4|Overall Study|Dispensing Error|0
7770084|NCT00689117|27008934|P3|Overall Study|Dispensing Error|0
7770085|NCT00689117|27008935|P2|Overall Study|Dispensing Error|1
7770086|NCT00689117|27008936|P1|Overall Study|Dispensing Error|0
7770087|NCT00689117|27008933|P4|Overall Study|Personal Reason|0
7770088|NCT00689117|27008934|P3|Overall Study|Personal Reason|0
7770089|NCT00689117|27008935|P2|Overall Study|Personal Reason|1
7770090|NCT00689117|27008936|P1|Overall Study|Personal Reason|0
7770091|NCT00689117|27008933|P4|Overall Study|Patient Withdrew from Study|1
7770092|NCT00689117|27008934|P3|Overall Study|Patient Withdrew from Study|0
7770093|NCT00689117|27008935|P2|Overall Study|Patient Withdrew from Study|0
7770094|NCT00689117|27008936|P1|Overall Study|Patient Withdrew from Study|0
7770095|NCT00689117|27008933|P4|Overall Study|Transportation|0
7770096|NCT00689117|27008934|P3|Overall Study|Transportation|0
7770097|NCT00689117|27008935|P2|Overall Study|Transportation|0
7770098|NCT00689117|27008936|P1|Overall Study|Transportation|1
7770099|NCT00689117|27008933|P4|Overall Study|Fear of Birth Defects|0
7770100|NCT00689117|27008934|P3|Overall Study|Fear of Birth Defects|1
7770101|NCT00689117|27008935|P2|Overall Study|Fear of Birth Defects|0
7770102|NCT00689117|27008936|P1|Overall Study|Fear of Birth Defects|0
7770103|NCT00689117|27008933|P4|Overall Study|Incarceration|0
7770104|NCT00689117|27008934|P3|Overall Study|Incarceration|0
7770105|NCT00689117|27008935|P2|Overall Study|Incarceration|0
7770106|NCT00689117|27008936|P1|Overall Study|Incarceration|2
7770107|NCT00689117|27008933|P4|Overall Study|Pregnancy|2
7770108|NCT00689117|27008934|P3|Overall Study|Pregnancy|0
7770109|NCT00689117|27008935|P2|Overall Study|Pregnancy|2
7770110|NCT00689117|27008936|P1|Overall Study|Pregnancy|0
7770111|NCT00689117|27008933|P4|Overall Study|Use of Prohibitive Medication|0
7770112|NCT00689117|27008934|P3|Overall Study|Use of Prohibitive Medication|3
7770113|NCT00689117|27008935|P2|Overall Study|Use of Prohibitive Medication|1
7770114|NCT00689117|27008936|P1|Overall Study|Use of Prohibitive Medication|2
7770115|NCT00689117|27008933|P4|Overall Study|Change/Discontinuation of Birth Control|0
7770116|NCT00689117|27008934|P3|Overall Study|Change/Discontinuation of Birth Control|1
7770117|NCT00689117|27008935|P2|Overall Study|Change/Discontinuation of Birth Control|1
7770118|NCT00689117|27008936|P1|Overall Study|Change/Discontinuation of Birth Control|1
7770119|NCT00689117|27008933|P4|Overall Study|Non-compliance with Treatment Regimen|0
7770120|NCT00689117|27008934|P3|Overall Study|Non-compliance with Treatment Regimen|0
7770121|NCT00689117|27008935|P2|Overall Study|Non-compliance with Treatment Regimen|1
7770122|NCT00689117|27008936|P1|Overall Study|Non-compliance with Treatment Regimen|0
7770123|NCT00689117|27008933|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7770124|NCT00689117|27008934|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7770125|NCT00689117|27008935|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7770126|NCT00689117|27008936|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7770127|NCT00689117|27008933|P4|Overall Study|Unable to Comply with Visit Schedule|1
7770128|NCT00689117|27008934|P3|Overall Study|Unable to Comply with Visit Schedule|1
7770129|NCT00689117|27008935|P2|Overall Study|Unable to Comply with Visit Schedule|0
7770130|NCT00689117|27008936|P1|Overall Study|Unable to Comply with Visit Schedule|0
7770131|NCT00689117|27008933|P4|Overall Study|Withdrawal by Subject|13
7770132|NCT00689117|27008934|P3|Overall Study|Withdrawal by Subject|26
7770133|NCT00689117|27008935|P2|Overall Study|Withdrawal by Subject|18
7770134|NCT00689117|27008936|P1|Overall Study|Withdrawal by Subject|19
7770135|NCT00689117|27008933|P4|Overall Study|Non-Compliance with Study Treatment|1
7770136|NCT00689117|27008934|P3|Overall Study|Non-Compliance with Study Treatment|3
7770137|NCT00689117|27008935|P2|Overall Study|Non-Compliance with Study Treatment|3
7770138|NCT00689117|27008936|P1|Overall Study|Non-Compliance with Study Treatment|3
7770139|NCT00689117|27008933|P4|Overall Study|Lack of Efficacy|2
7770140|NCT00689117|27008934|P3|Overall Study|Lack of Efficacy|2
7770141|NCT00689117|27008935|P2|Overall Study|Lack of Efficacy|2
7770142|NCT00689117|27008936|P1|Overall Study|Lack of Efficacy|1
7770143|NCT00689117|27008933|P4|Overall Study|Lost to Follow-up|11
7770144|NCT00689117|27008934|P3|Overall Study|Lost to Follow-up|17
7770145|NCT00689117|27008935|P2|Overall Study|Lost to Follow-up|19
7770146|NCT00689117|27008936|P1|Overall Study|Lost to Follow-up|26
7770147|NCT00689117|27008933|P4|Overall Study|Adverse Event|0
7770148|NCT00689117|27008934|P3|Overall Study|Adverse Event|5
7770149|NCT00689117|27008935|P2|Overall Study|Adverse Event|0
7770150|NCT00689117|27008936|P1|Overall Study|Adverse Event|6
7770151|NCT00689104|27008966|P4|Overall Study|Non-compliance with study procedures|0
7770152|NCT00689104|27008967|P3|Overall Study|Non-compliance with study procedures|1
7770153|NCT00689104|27008968|P2|Overall Study|Non-compliance with study procedures|0
7770154|NCT00689104|27008969|P1|Overall Study|Non-compliance with study procedures|0
7770155|NCT00689104|27008966|P4|Overall Study|Physician Decision|0
7770156|NCT00689104|27008967|P3|Overall Study|Physician Decision|0
7770157|NCT00689104|27008968|P2|Overall Study|Physician Decision|0
7770158|NCT00689104|27008969|P1|Overall Study|Physician Decision|1
7770159|NCT00689104|27008966|P4|Overall Study|Randomized but never received study drug|0
7770160|NCT00689104|27008967|P3|Overall Study|Randomized but never received study drug|1
7770161|NCT00689104|27008968|P2|Overall Study|Randomized but never received study drug|1
7770162|NCT00689104|27008969|P1|Overall Study|Randomized but never received study drug|2
7770163|NCT00689104|27008966|P4|Overall Study|Protocol Violation|3
7770164|NCT00689104|27008967|P3|Overall Study|Protocol Violation|5
7770165|NCT00689104|27008968|P2|Overall Study|Protocol Violation|3
7770166|NCT00689104|27008969|P1|Overall Study|Protocol Violation|2
7770167|NCT00689104|27008966|P4|Overall Study|Lost to Follow-up|5
7770168|NCT00689104|27008967|P3|Overall Study|Lost to Follow-up|2
7770169|NCT00689104|27008968|P2|Overall Study|Lost to Follow-up|3
7770170|NCT00689104|27008969|P1|Overall Study|Lost to Follow-up|4
7770171|NCT00689104|27008966|P4|Overall Study|Withdrawal by Subject|11
7770172|NCT00689104|27008967|P3|Overall Study|Withdrawal by Subject|18
7770173|NCT00689104|27008968|P2|Overall Study|Withdrawal by Subject|11
7770174|NCT00689104|27008969|P1|Overall Study|Withdrawal by Subject|12
7770175|NCT00689104|27008966|P4|Overall Study|Lack of Efficacy|3
7770176|NCT00689104|27008967|P3|Overall Study|Lack of Efficacy|2
7770177|NCT00689104|27008968|P2|Overall Study|Lack of Efficacy|6
7770178|NCT00689104|27008969|P1|Overall Study|Lack of Efficacy|5
7770179|NCT00689104|27008966|P4|Overall Study|Adverse Event|24
7770180|NCT00689104|27008967|P3|Overall Study|Adverse Event|16
7770181|NCT00689104|27008968|P2|Overall Study|Adverse Event|25
7770182|NCT00689104|27008969|P1|Overall Study|Adverse Event|13
7770183|NCT00689104|27008966|P4|Overall Study|Eligibility criterion not met|4
7770184|NCT00689104|27008967|P3|Overall Study|Eligibility criterion not met|0
7770185|NCT00689104|27008968|P2|Overall Study|Eligibility criterion not met|8
7770186|NCT00689104|27008969|P1|Overall Study|Eligibility criterion not met|5
7770187|NCT00689052|27009175|P2|Overall Study|Early termination of the trial|24
7770188|NCT00689052|27009176|P1|Overall Study|Early termination of the trial|22
7770189|NCT00689052|27009175|P2|Overall Study|Withdrawal by Subject|0
7770190|NCT00689052|27009176|P1|Overall Study|Withdrawal by Subject|2
7770191|NCT00689052|27009175|P2|Overall Study|Lost to Follow-up|0
7770192|NCT00689052|27009176|P1|Overall Study|Lost to Follow-up|2
7770193|NCT00689052|27009175|P2|Overall Study|Protocol Violation|0
7770194|NCT00689052|27009176|P1|Overall Study|Protocol Violation|1
7770195|NCT00689052|27009175|P2|Overall Study|Adverse Event|6
7770196|NCT00689052|27009176|P1|Overall Study|Adverse Event|4
7770197|NCT00689026|27009208|P2|Overall Study|Withdrawal by Subject|6
7770198|NCT00689026|27009209|P1|Overall Study|Withdrawal by Subject|13
7770199|NCT00688909|27009220|P1|Overall Study|Protocol Violation|2
7770200|NCT00688909|27009220|P1|Overall Study|Administrative problems|1
7770201|NCT00688909|27009220|P1|Overall Study|Patient withdrew consent|2
7770202|NCT00688909|27009220|P1|Overall Study|Adverse Event|28
7770203|NCT00688870|27009231|P2|Infant Series|Parent or legal guardian request|0
7770204|NCT00688870|27009232|P1|Infant Series|Parent or legal guardian request|4
7770205|NCT00688844|27009264|P1|Overall Study|Lost to Follow-up|10
7770206|NCT00688753|27009274|P1|Overall Study|Lost to Follow-up|3
7770207|NCT00688753|27009274|P1|Overall Study|Protocol Violation|1
7770208|NCT00688753|27009274|P1|Overall Study|Adverse Event|20
7770209|NCT00688753|27009274|P1|Overall Study|Withdrawal by Subject|3
7770210|NCT00688753|27009274|P1|Overall Study|Death|9
7770211|NCT00688753|27009274|P1|Overall Study|Missing|1
7770212|NCT00688753|27009274|P1|Overall Study|Disease progression|55
7770213|NCT00688740|27009285|P2|Overall Study|Violation of Inclusion Criteria|3
7770214|NCT00688740|27009286|P1|Overall Study|Violation of Inclusion Criteria|1
7770215|NCT00688740|27009285|P2|Overall Study|Breast Cancer Relapse|4
7770216|NCT00688740|27009286|P1|Overall Study|Breast Cancer Relapse|1
7770217|NCT00688740|27009285|P2|Overall Study|Consent Withdrawn|17
7770218|NCT00688740|27009286|P1|Overall Study|Consent Withdrawn|17
7770219|NCT00688740|27009285|P2|Overall Study|Lost to Follow-up|1
7770220|NCT00688740|27009286|P1|Overall Study|Lost to Follow-up|0
7770221|NCT00688740|27009285|P2|Overall Study|Death|2
7770222|NCT00688740|27009286|P1|Overall Study|Death|2
7770223|NCT00688740|27009285|P2|Overall Study|Adverse Event|8
7770224|NCT00688740|27009286|P1|Overall Study|Adverse Event|45
7770225|NCT00688701|27009299|P4|Overall Study|Poor compliance to protocol|0
7770226|NCT00688701|27009300|P3|Overall Study|Poor compliance to protocol|1
7770227|NCT00688701|27009301|P2|Overall Study|Poor compliance to protocol|1
7770228|NCT00688701|27009302|P1|Overall Study|Poor compliance to protocol|0
7770229|NCT00688701|27009299|P4|Overall Study|Withdrawal by Subject|8
7770230|NCT00688701|27009300|P3|Overall Study|Withdrawal by Subject|4
7770231|NCT00688701|27009301|P2|Overall Study|Withdrawal by Subject|3
7770232|NCT00688701|27009302|P1|Overall Study|Withdrawal by Subject|3
7770233|NCT00688701|27009299|P4|Overall Study|Lack of Efficacy|0
7770234|NCT00688701|27009300|P3|Overall Study|Lack of Efficacy|0
7770235|NCT00688701|27009301|P2|Overall Study|Lack of Efficacy|1
7770236|NCT00688701|27009302|P1|Overall Study|Lack of Efficacy|0
7770237|NCT00688701|27009299|P4|Overall Study|Adverse Event|3
7770238|NCT00688701|27009300|P3|Overall Study|Adverse Event|5
7770239|NCT00688701|27009301|P2|Overall Study|Adverse Event|0
7770240|NCT00688701|27009302|P1|Overall Study|Adverse Event|1
7770241|NCT00688688|27009343|P3|Overall Study|Violation of exclusion criterion|0
7770242|NCT00688688|27009344|P2|Overall Study|Violation of exclusion criterion|1
7770243|NCT00688688|27009345|P1|Overall Study|Violation of exclusion criterion|0
7770244|NCT00688688|27009343|P3|Overall Study|Site closure|0
7770245|NCT00688688|27009344|P2|Overall Study|Site closure|1
7770246|NCT00688688|27009345|P1|Overall Study|Site closure|0
7770247|NCT00688688|27009343|P3|Overall Study|Taking exclusionary medications|0
7770248|NCT00688688|27009344|P2|Overall Study|Taking exclusionary medications|0
7770249|NCT00688688|27009345|P1|Overall Study|Taking exclusionary medications|1
7770250|NCT00688688|27009343|P3|Overall Study|Non-compliance with study procedures|4
7770251|NCT00688688|27009344|P2|Overall Study|Non-compliance with study procedures|3
7770252|NCT00688688|27009345|P1|Overall Study|Non-compliance with study procedures|5
7770253|NCT00688688|27009343|P3|Overall Study|Randomized but never received study drug|0
7770254|NCT00688688|27009344|P2|Overall Study|Randomized but never received study drug|0
7770255|NCT00688688|27009345|P1|Overall Study|Randomized but never received study drug|1
7770256|NCT00688688|27009343|P3|Overall Study|Protocol Violation|11
7770257|NCT00688688|27009344|P2|Overall Study|Protocol Violation|9
7770258|NCT00688688|27009345|P1|Overall Study|Protocol Violation|6
7770259|NCT00688688|27009343|P3|Overall Study|Lost to Follow-up|7
7770260|NCT00688688|27009344|P2|Overall Study|Lost to Follow-up|7
7770261|NCT00688688|27009345|P1|Overall Study|Lost to Follow-up|14
7770262|NCT00688688|27009343|P3|Overall Study|Withdrawal by Subject|65
7770263|NCT00688688|27009344|P2|Overall Study|Withdrawal by Subject|75
7770264|NCT00688688|27009345|P1|Overall Study|Withdrawal by Subject|66
7770265|NCT00688688|27009343|P3|Overall Study|Lack of Efficacy|45
7770266|NCT00688688|27009344|P2|Overall Study|Lack of Efficacy|25
7770267|NCT00688688|27009345|P1|Overall Study|Lack of Efficacy|34
7770268|NCT00688688|27009343|P3|Overall Study|Adverse Event|50
7770269|NCT00688688|27009344|P2|Overall Study|Adverse Event|51
7770270|NCT00688688|27009345|P1|Overall Study|Adverse Event|52
7770271|NCT00688688|27009343|P3|Overall Study|Eligibility criterion not met|10
7770272|NCT00688688|27009344|P2|Overall Study|Eligibility criterion not met|7
7770273|NCT00688688|27009345|P1|Overall Study|Eligibility criterion not met|7
7770274|NCT00688636|27009447|P2|Overall Study|Adverse Event|1
7770275|NCT00688636|27009448|P1|Overall Study|Adverse Event|2
7770276|NCT00688623|27009462|P1|Overall Study|Protocol Violation|2
7770277|NCT00688623|27009462|P1|Overall Study|disease progression|23
7770278|NCT00688623|27009462|P1|Overall Study|Death|3
7770279|NCT00688623|27009462|P1|Overall Study|Withdrawal by Subject|4
7770280|NCT00688623|27009462|P1|Overall Study|abnormal lab value|1
7770281|NCT00688623|27009462|P1|Overall Study|Adverse Event|22
7770282|NCT00688597|27009476|P3|Overall Study|Physician Decision|0
7770283|NCT00688597|27009477|P2|Overall Study|Physician Decision|0
7770284|NCT00688597|27009478|P1|Overall Study|Physician Decision|1
7770285|NCT00688597|27009476|P3|Overall Study|Adverse Event|0
7770286|NCT00688597|27009477|P2|Overall Study|Adverse Event|0
7770287|NCT00688597|27009478|P1|Overall Study|Adverse Event|2
7770288|NCT00688545|27009491|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
7770289|NCT00688545|27009492|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
7770290|NCT00688545|27009491|P2|Overall Study|Withdrawal by Subject|3
7770291|NCT00688545|27009492|P1|Overall Study|Withdrawal by Subject|2
7770292|NCT00688545|27009491|P2|Overall Study|Insurance/cost of drug|1
7770293|NCT00688545|27009492|P1|Overall Study|Insurance/cost of drug|0
7770294|NCT00688545|27009491|P2|Overall Study|Lost to Follow-up|4
7770295|NCT00688545|27009492|P1|Overall Study|Lost to Follow-up|1
7770296|NCT00688519|27009502|P2|Overall Study|Pregnancy|1
7770297|NCT00688519|27009503|P1|Overall Study|Pregnancy|0
7770298|NCT00688519|27009502|P2|Overall Study|Subject moved out of area|0
7770299|NCT00688519|27009503|P1|Overall Study|Subject moved out of area|1
7770300|NCT00688519|27009502|P2|Overall Study|Investigator decision|0
7770301|NCT00688519|27009503|P1|Overall Study|Investigator decision|1
7770302|NCT00688519|27009502|P2|Overall Study|Subject moved out of state|0
7770303|NCT00688519|27009503|P1|Overall Study|Subject moved out of state|1
7770304|NCT00688519|27009502|P2|Overall Study|Non-compliance|1
7770305|NCT00688519|27009503|P1|Overall Study|Non-compliance|0
7770306|NCT00688519|27009502|P2|Overall Study|Prohibited medication|0
7770307|NCT00688519|27009503|P1|Overall Study|Prohibited medication|1
7770308|NCT00688519|27009502|P2|Overall Study|Withdrawal by Subject|6
7770309|NCT00688519|27009503|P1|Overall Study|Withdrawal by Subject|7
7770310|NCT00688519|27009502|P2|Overall Study|Lack of Efficacy|1
7770311|NCT00688519|27009503|P1|Overall Study|Lack of Efficacy|3
7770312|NCT00688519|27009502|P2|Overall Study|Lost to Follow-up|3
7770313|NCT00688519|27009503|P1|Overall Study|Lost to Follow-up|3
7770314|NCT00688519|27009502|P2|Overall Study|Adverse Event|3
7770315|NCT00688519|27009503|P1|Overall Study|Adverse Event|2
7770316|NCT00688467|27009521|P2|Treatment Period 2|Adverse Event|1
7770317|NCT00688467|27009522|P1|Treatment Period 2|Adverse Event|0
7770318|NCT00688467|27009521|P2|Treatment Period 2|Protocol Violation|1
7770319|NCT00688467|27009522|P1|Treatment Period 2|Protocol Violation|0
7770320|NCT00688467|27009521|P2|Treatment Period 1|Did not meet protocol eligibility|1
7770321|NCT00688467|27009522|P1|Treatment Period 1|Did not meet protocol eligibility|0
7770322|NCT00688467|27009521|P2|Treatment Period 1|Adverse Event|1
7770323|NCT00688467|27009522|P1|Treatment Period 1|Adverse Event|2
7770324|NCT00688376|27009554|P2|Blinded Extension Phase|Other|0
7770325|NCT00688376|27009555|P1|Blinded Extension Phase|Other|1
7770326|NCT00688376|27009554|P2|Blinded Extension Phase|Physician Decision|0
7770327|NCT00688376|27009555|P1|Blinded Extension Phase|Physician Decision|1
7770328|NCT00688376|27009554|P2|Blinded Extension Phase|Withdrawal by Subject|1
7770329|NCT00688376|27009555|P1|Blinded Extension Phase|Withdrawal by Subject|0
7770330|NCT00688376|27009554|P2|Blinded Extension Phase|Adverse Event|4
7770331|NCT00688376|27009555|P1|Blinded Extension Phase|Adverse Event|3
7770332|NCT00688376|27009554|P2|Double-Blind Phase|Not treated|1
7770333|NCT00688376|27009555|P1|Double-Blind Phase|Not treated|0
7770334|NCT00688376|27009554|P2|Double-Blind Phase|Withdrawal by Subject|0
7770335|NCT00688376|27009555|P1|Double-Blind Phase|Withdrawal by Subject|1
7770336|NCT00688376|27009554|P2|Double-Blind Phase|Protocol Violation|2
7770337|NCT00688376|27009555|P1|Double-Blind Phase|Protocol Violation|1
7770338|NCT00688376|27009554|P2|Double-Blind Phase|Adverse Event|4
7770339|NCT00688376|27009555|P1|Double-Blind Phase|Adverse Event|4
7770340|NCT00688324|27009569|P1|Overall Study|Lost to Follow-up|1
7770341|NCT00688324|27009569|P1|Overall Study|Physician Decision|5
7770342|NCT00688324|27009569|P1|Overall Study|Withdrawal by Subject|2
7770343|NCT00688259|27009614|P2|Overall Study|Hospitalized at Follow-up|1
7770344|NCT00688259|27009615|P1|Overall Study|Hospitalized at Follow-up|0
7770345|NCT00688259|27009614|P2|Overall Study|Declined Interview|3
7770346|NCT00688259|27009615|P1|Overall Study|Declined Interview|2
7770347|NCT00688259|27009614|P2|Overall Study|Withdrawal by Subject|0
7770348|NCT00688259|27009615|P1|Overall Study|Withdrawal by Subject|2
7770349|NCT00688259|27009614|P2|Overall Study|Physician Decision|0
7770350|NCT00688259|27009615|P1|Overall Study|Physician Decision|1
7770351|NCT00688259|27009614|P2|Overall Study|Lost to Follow-up|4
7770352|NCT00688259|27009615|P1|Overall Study|Lost to Follow-up|2
7770353|NCT00688181|27009631|P1|Overall Study|Non-clinical Reason|2
7770354|NCT00688181|27009631|P1|Overall Study|Unknown Reason|4
7770355|NCT00688181|27009631|P1|Overall Study|Lost to Follow-up|17
7770356|NCT00688155|27009642|P4|Overall Study|Withdrawal by Subject|1
7770357|NCT00688155|27009643|P3|Overall Study|Withdrawal by Subject|1
7770358|NCT00688155|27009644|P2|Overall Study|Withdrawal by Subject|2
7770359|NCT00688155|27009645|P1|Overall Study|Withdrawal by Subject|2
7770360|NCT00688103|27009665|P2|Overall Study|complex reasons|9
7770361|NCT00688103|27009666|P1|Overall Study|complex reasons|11
7770362|NCT00688103|27009665|P2|Overall Study|Withdrawal by Subject|2
7770363|NCT00688103|27009666|P1|Overall Study|Withdrawal by Subject|4
7770364|NCT00688103|27009665|P2|Overall Study|Lack of Efficacy|1
7770365|NCT00688103|27009666|P1|Overall Study|Lack of Efficacy|11
7770366|NCT00688103|27009665|P2|Overall Study|Adverse Event|1
7770367|NCT00688103|27009666|P1|Overall Study|Adverse Event|4
7770368|NCT00688064|27009678|P2|Overall Study|Any other reasons|3
7770369|NCT00688064|27009679|P1|Overall Study|Any other reasons|1
7770370|NCT00688064|27009678|P2|Overall Study|Pregnancy|0
7770371|NCT00688064|27009679|P1|Overall Study|Pregnancy|1
7770372|NCT00688064|27009678|P2|Overall Study|Lack of Efficacy|1
7770373|NCT00688064|27009679|P1|Overall Study|Lack of Efficacy|0
7770374|NCT00688064|27009678|P2|Overall Study|Lost to Follow-up|10
7770375|NCT00688064|27009679|P1|Overall Study|Lost to Follow-up|10
7770376|NCT00688064|27009678|P2|Overall Study|Withdrawal by Subject|7
7770377|NCT00688064|27009679|P1|Overall Study|Withdrawal by Subject|7
7770378|NCT00688064|27009678|P2|Overall Study|Adverse Event|4
7770379|NCT00688064|27009679|P1|Overall Study|Adverse Event|2
7770380|NCT00688064|27009678|P2|Overall Study|Protocol Violation|1
7770381|NCT00688064|27009679|P1|Overall Study|Protocol Violation|0
7770382|NCT00687973|27009695|P2|Overall Study|Withdrawal by Subject|3
7770383|NCT00687973|27009696|P1|Overall Study|Withdrawal by Subject|3
7770384|NCT00687973|27009695|P2|Overall Study|Administrative Reasons|2
7770385|NCT00687973|27009696|P1|Overall Study|Administrative Reasons|0
7770386|NCT00687973|27009695|P2|Overall Study|Protocol Violation|2
7770387|NCT00687973|27009696|P1|Overall Study|Protocol Violation|1
7770388|NCT00687973|27009695|P2|Overall Study|Lack of Efficacy|3
7770389|NCT00687973|27009696|P1|Overall Study|Lack of Efficacy|2
7770390|NCT00687973|27009695|P2|Overall Study|Adverse Event|28
7770391|NCT00687973|27009696|P1|Overall Study|Adverse Event|18
7770392|NCT00687804|27009758|P3|Open-Label Extension Study|Death|3
7770393|NCT00687804|27009759|P2|Open-Label Extension Study|Death|3
7770394|NCT00687804|27009760|P1|Open-Label Extension Study|Death|2
7770395|NCT00687804|27009758|P3|Open-Label Extension Study|Administrative problems|0
7770396|NCT00687804|27009759|P2|Open-Label Extension Study|Administrative problems|1
7770397|NCT00687804|27009760|P1|Open-Label Extension Study|Administrative problems|1
7770398|NCT00687804|27009758|P3|Open-Label Extension Study|Lost to Follow-up|2
7770399|NCT00687804|27009759|P2|Open-Label Extension Study|Lost to Follow-up|1
7770400|NCT00687804|27009760|P1|Open-Label Extension Study|Lost to Follow-up|2
7770401|NCT00687804|27009758|P3|Open-Label Extension Study|Subject withdrew consent|4
7770402|NCT00687804|27009759|P2|Open-Label Extension Study|Subject withdrew consent|4
7770403|NCT00687804|27009760|P1|Open-Label Extension Study|Subject withdrew consent|3
7770404|NCT00687804|27009758|P3|Open-Label Extension Study|Adverse Event|2
7770405|NCT00687804|27009759|P2|Open-Label Extension Study|Adverse Event|2
7770406|NCT00687804|27009760|P1|Open-Label Extension Study|Adverse Event|2
7770407|NCT00687804|27009758|P3|Core Study|Protocol Violation|0
7770408|NCT00687804|27009759|P2|Core Study|Protocol Violation|1
7770409|NCT00687804|27009760|P1|Core Study|Protocol Violation|1
7770410|NCT00687804|27009758|P3|Core Study|Death|2
7770411|NCT00687804|27009759|P2|Core Study|Death|2
7770412|NCT00687804|27009760|P1|Core Study|Death|2
7770413|NCT00687804|27009758|P3|Core Study|Lost to Follow-up|0
7770414|NCT00687804|27009759|P2|Core Study|Lost to Follow-up|1
7770415|NCT00687804|27009760|P1|Core Study|Lost to Follow-up|0
7770416|NCT00687804|27009758|P3|Core Study|Withdrawal by Subject|7
7770417|NCT00687804|27009759|P2|Core Study|Withdrawal by Subject|7
7770418|NCT00687804|27009760|P1|Core Study|Withdrawal by Subject|4
7770419|NCT00687804|27009758|P3|Core Study|Lack of Efficacy|1
7770420|NCT00687804|27009759|P2|Core Study|Lack of Efficacy|1
7770421|NCT00687804|27009760|P1|Core Study|Lack of Efficacy|1
7770422|NCT00687804|27009758|P3|Core Study|Abnormal laboratory value(s)|0
7770423|NCT00687804|27009759|P2|Core Study|Abnormal laboratory value(s)|0
7770424|NCT00687804|27009760|P1|Core Study|Abnormal laboratory value(s)|1
7770425|NCT00687804|27009758|P3|Core Study|Adverse Event|3
7770426|NCT00687804|27009759|P2|Core Study|Adverse Event|3
7770427|NCT00687804|27009760|P1|Core Study|Adverse Event|5
7770428|NCT00687739|27009807|P4|Overall Study|Adverse Event|0
7770429|NCT00687739|27009808|P3|Overall Study|Adverse Event|1
7770430|NCT00687739|27009809|P2|Overall Study|Adverse Event|1
7770431|NCT00687739|27009810|P1|Overall Study|Adverse Event|0
7770432|NCT00687739|27009807|P4|Overall Study|Lost to Follow-up|2
7770433|NCT00687739|27009808|P3|Overall Study|Lost to Follow-up|1
7770434|NCT00687739|27009809|P2|Overall Study|Lost to Follow-up|2
7770435|NCT00687739|27009810|P1|Overall Study|Lost to Follow-up|2
7770436|NCT00687609|27009852|P1|Overall Study|Withdrawal by Subject|2
7770437|NCT00687609|27009852|P1|Overall Study|Physician Decision|1
7770438|NCT00687531|27009875|P1|Overall Study|Lost to Follow-up|26
7770439|NCT00687531|27009875|P1|Overall Study|Adverse Event|5
7770440|NCT00687531|27009875|P1|Overall Study|Did not meet protocol eligibility|104
7770441|NCT00687440|27009898|P1|Overall Study|Missing|1
7770442|NCT00687440|27009898|P1|Overall Study|Other|1
7770443|NCT00687440|27009898|P1|Overall Study|Death|2
7770444|NCT00687440|27009898|P1|Overall Study|Lack of Efficacy|2
7770445|NCT00687440|27009898|P1|Overall Study|Lost to Follow-up|3
7770446|NCT00687440|27009898|P1|Overall Study|Adverse Event|3
7770447|NCT00687401|27009902|P1|Overall Study|For reasons different from those above|4
7770448|NCT00687401|27009902|P1|Overall Study|Did not return for visit|3
7770449|NCT00687401|27009902|P1|Overall Study|Withdrawal by Subject|4
7770450|NCT00687401|27009902|P1|Overall Study|Lack of Efficacy|6
7770451|NCT00687401|27009902|P1|Overall Study|Adverse Event|6
7770452|NCT00687401|27009902|P1|Overall Study|Protocol Violation|7
7770453|NCT00687362|27009907|P1|Overall Study|Withdrawal by Subject|1
7770454|NCT00687362|27009907|P1|Overall Study|Protocol Violation|2
7770455|NCT00687323|27009911|P1|Overall Study|Screen failure|148
7770456|NCT00687323|27009911|P1|Overall Study|Excluded from efficacy evaluations|6
7770457|NCT00687323|27009911|P1|Overall Study|Withdrawal by Subject|1
7770458|NCT00687323|27009911|P1|Overall Study|Death|25
7770459|NCT00687297|27009927|P2|Induction|Other|1
7770460|NCT00687297|27009928|P1|Induction|Other|0
7770461|NCT00687297|27009927|P2|Induction|Physician Decision|2
7770462|NCT00687297|27009928|P1|Induction|Physician Decision|0
7770463|NCT00687297|27009927|P2|Induction|Patient Noncompliance|0
7770464|NCT00687297|27009928|P1|Induction|Patient Noncompliance|1
7770465|NCT00687297|27009927|P2|Induction|Ineligible|1
7770466|NCT00687297|27009928|P1|Induction|Ineligible|0
7770467|NCT00687297|27009927|P2|Induction|Lack of Efficacy|21
7770468|NCT00687297|27009928|P1|Induction|Lack of Efficacy|17
7770469|NCT00687297|27009927|P2|Induction|Death|11
7770470|NCT00687297|27009928|P1|Induction|Death|7
7770471|NCT00687297|27009927|P2|Induction|Adverse Event|15
7770472|NCT00687297|27009928|P1|Induction|Adverse Event|16
7770473|NCT00687297|27009927|P2|Induction|Withdrawal by Subject|4
7770474|NCT00687297|27009928|P1|Induction|Withdrawal by Subject|4
7770475|NCT00687297|27009927|P2|Randomization|Withdrew before treatment, ineligible|1
7770476|NCT00687297|27009928|P1|Randomization|Withdrew before treatment, ineligible|1
7770477|NCT00687297|27009927|P2|Randomization|Withdrawal by Subject|0
7770478|NCT00687297|27009928|P1|Randomization|Withdrawal by Subject|2
7770479|NCT00687271|27009942|P4|Overall Study|Withdrawal by Subject|0
7770480|NCT00687271|27009943|P3|Overall Study|Withdrawal by Subject|3
7770481|NCT00687271|27009944|P2|Overall Study|Withdrawal by Subject|1
7770482|NCT00687271|27009945|P1|Overall Study|Withdrawal by Subject|0
7770483|NCT00687271|27009942|P4|Overall Study|Protocol Violation|0
7770484|NCT00687271|27009943|P3|Overall Study|Protocol Violation|1
7770485|NCT00687271|27009944|P2|Overall Study|Protocol Violation|1
7770486|NCT00687271|27009945|P1|Overall Study|Protocol Violation|2
7770487|NCT00687271|27009942|P4|Overall Study|Lost to Follow-up|0
7770488|NCT00687271|27009943|P3|Overall Study|Lost to Follow-up|0
7770489|NCT00687271|27009944|P2|Overall Study|Lost to Follow-up|1
7770490|NCT00687271|27009945|P1|Overall Study|Lost to Follow-up|0
7770491|NCT00687271|27009942|P4|Overall Study|Adverse Event|0
7770492|NCT00687271|27009943|P3|Overall Study|Adverse Event|1
7770493|NCT00687271|27009944|P2|Overall Study|Adverse Event|3
7770494|NCT00687271|27009945|P1|Overall Study|Adverse Event|1
7770495|NCT00687219|27009983|P1|Overall Study|Lack of Efficacy|1
7770496|NCT00687219|27009983|P1|Overall Study|Withdrawal by Subject|1
7770497|NCT00687219|27009983|P1|Overall Study|HCV-RNA positive conversion|34
7770498|NCT00687219|27009983|P1|Overall Study|Discontinuance criteria met|7
7770499|NCT00687219|27009983|P1|Overall Study|Adverse Event|8
7770500|NCT00687193|27009995|P6|Overall Study|Protocol Violation|0
7770501|NCT00687193|27009996|P5|Overall Study|Protocol Violation|2
7770502|NCT00687193|27009997|P4|Overall Study|Protocol Violation|1
7770503|NCT00687193|27009998|P3|Overall Study|Protocol Violation|0
7770504|NCT00687193|27009999|P2|Overall Study|Protocol Violation|2
7770505|NCT00687193|27010000|P1|Overall Study|Protocol Violation|1
7770506|NCT00687193|27009995|P6|Overall Study|Lack of Efficacy|2
7770507|NCT00687193|27009996|P5|Overall Study|Lack of Efficacy|0
7770508|NCT00687193|27009997|P4|Overall Study|Lack of Efficacy|0
7770509|NCT00687193|27009998|P3|Overall Study|Lack of Efficacy|0
7770510|NCT00687193|27009999|P2|Overall Study|Lack of Efficacy|1
7770511|NCT00687193|27010000|P1|Overall Study|Lack of Efficacy|1
7770512|NCT00687193|27009995|P6|Overall Study|Adverse Event|2
7770513|NCT00687193|27009996|P5|Overall Study|Adverse Event|0
7770514|NCT00687193|27009997|P4|Overall Study|Adverse Event|3
7770515|NCT00687193|27009998|P3|Overall Study|Adverse Event|2
7770516|NCT00687193|27009999|P2|Overall Study|Adverse Event|1
7770517|NCT00687193|27010000|P1|Overall Study|Adverse Event|0
7770518|NCT00686998|27010210|P3|Overall Study|Safety Reasons|0
7770519|NCT00686998|27010211|P2|Overall Study|Safety Reasons|0
7770520|NCT00686998|27010212|P1|Overall Study|Safety Reasons|1
7770521|NCT00686998|27010210|P3|Overall Study|Other|1
7770522|NCT00686998|27010211|P2|Overall Study|Other|0
7770523|NCT00686998|27010212|P1|Overall Study|Other|0
7770524|NCT00686998|27010210|P3|Overall Study|Lack of Efficacy|0
7770525|NCT00686998|27010211|P2|Overall Study|Lack of Efficacy|5
7770526|NCT00686998|27010212|P1|Overall Study|Lack of Efficacy|7
7770527|NCT00686998|27010210|P3|Overall Study|Withdrawal by Subject|2
7770528|NCT00686998|27010211|P2|Overall Study|Withdrawal by Subject|1
7770529|NCT00686998|27010212|P1|Overall Study|Withdrawal by Subject|2
7770530|NCT00686998|27010210|P3|Overall Study|Adverse Event|1
7770531|NCT00686998|27010211|P2|Overall Study|Adverse Event|2
7770532|NCT00686998|27010212|P1|Overall Study|Adverse Event|3
7770533|NCT00686972|27010220|P1|Overall Study|P.I, Left institution. Study terminated|51
7770534|NCT00686959|27010226|P2|Overall Study|Participants censored (no death events)|117
7770535|NCT00686959|27010227|P1|Overall Study|Participants censored (no death events)|124
7770536|NCT00686920|27010247|P2|Overall Study|Principal Investigator Decision|0
7770537|NCT00686920|27010248|P1|Overall Study|Principal Investigator Decision|2
7770538|NCT00686920|27010247|P2|Overall Study|Noncompliance|0
7770539|NCT00686920|27010248|P1|Overall Study|Noncompliance|9
7770540|NCT00686920|27010247|P2|Overall Study|Transferred to Nursing Home|0
7770541|NCT00686920|27010248|P1|Overall Study|Transferred to Nursing Home|1
7770542|NCT00686920|27010247|P2|Overall Study|Moved to Another State|0
7770543|NCT00686920|27010248|P1|Overall Study|Moved to Another State|1
7770544|NCT00686920|27010247|P2|Overall Study|Lost to Follow-up|3
7770545|NCT00686920|27010248|P1|Overall Study|Lost to Follow-up|15
7770546|NCT00686920|27010247|P2|Overall Study|Personal Reason|1
7770547|NCT00686920|27010248|P1|Overall Study|Personal Reason|0
7770548|NCT00686920|27010247|P2|Overall Study|Adverse Event|2
7770549|NCT00686920|27010248|P1|Overall Study|Adverse Event|10
7770550|NCT00686920|27010247|P2|Overall Study|Protocol Violation|1
7770551|NCT00686920|27010248|P1|Overall Study|Protocol Violation|2
7770552|NCT00686920|27010247|P2|Overall Study|Withdrawal by Subject|5
7770553|NCT00686920|27010248|P1|Overall Study|Withdrawal by Subject|23
7770554|NCT00686920|27010247|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
7770555|NCT00686920|27010248|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
7770556|NCT00686920|27010247|P2|Overall Study|Liver Transplant|8
7770557|NCT00686920|27010248|P1|Overall Study|Liver Transplant|23
7770558|NCT00686920|27010247|P2|Overall Study|Death|14
7770559|NCT00686920|27010248|P1|Overall Study|Death|45
7770560|NCT00686894|27010260|P1|Overall Study|Protocol Violation|4
7770561|NCT00686894|27010260|P1|Overall Study|Relapse|2
7770562|NCT00686881|27010266|P2|Overall Study|Never received study drug|6
7770563|NCT00686881|27010267|P1|Overall Study|Never received study drug|2
7770564|NCT00686881|27010266|P2|Overall Study|Study discontinuation|32
7770565|NCT00686881|27010267|P1|Overall Study|Study discontinuation|35
7770566|NCT00686881|27010266|P2|Overall Study|Irregular visits|0
7770567|NCT00686881|27010267|P1|Overall Study|Irregular visits|1
7770568|NCT00686881|27010266|P2|Overall Study|Did not meet protocol eligibility|0
7770569|NCT00686881|27010267|P1|Overall Study|Did not meet protocol eligibility|1
7770570|NCT00686881|27010266|P2|Overall Study|Circumstances of site|1
7770571|NCT00686881|27010267|P1|Overall Study|Circumstances of site|1
7770572|NCT00686881|27010266|P2|Overall Study|Physician Decision|0
7770573|NCT00686881|27010267|P1|Overall Study|Physician Decision|1
7770574|NCT00686881|27010266|P2|Overall Study|Lack of Efficacy|3
7770575|NCT00686881|27010267|P1|Overall Study|Lack of Efficacy|4
7770576|NCT00686881|27010266|P2|Overall Study|Onset of malignant tumor|11
7770577|NCT00686881|27010267|P1|Overall Study|Onset of malignant tumor|11
7770578|NCT00686881|27010266|P2|Overall Study|Met discontinuation criteria|0
7770579|NCT00686881|27010267|P1|Overall Study|Met discontinuation criteria|5
7770580|NCT00686881|27010266|P2|Overall Study|Treatment-related adverse event|9
7770581|NCT00686881|27010267|P1|Overall Study|Treatment-related adverse event|10
7770582|NCT00686881|27010266|P2|Overall Study|Lost to Follow-up|1
7770583|NCT00686881|27010267|P1|Overall Study|Lost to Follow-up|0
7770584|NCT00686881|27010266|P2|Overall Study|Withdrawal by Subject|18
7770585|NCT00686881|27010267|P1|Overall Study|Withdrawal by Subject|11
7770586|NCT00686855|27010279|P2|Overall Study|Progressive GVHD|1
7770587|NCT00686855|27010280|P1|Overall Study|Progressive GVHD|0
7770588|NCT00686855|27010279|P2|Overall Study|Lost to Follow-up|0
7770589|NCT00686855|27010280|P1|Overall Study|Lost to Follow-up|1
7770590|NCT00686829|27010290|P1|Overall Study|Sponsor discontinued VCV|47
7770591|NCT00686829|27010290|P1|Overall Study|Protocol Violation|3
7770592|NCT00686829|27010290|P1|Overall Study|Withdrawal by Subject|14
7770593|NCT00686829|27010290|P1|Overall Study|Lost to Follow-up|4
7770594|NCT00686829|27010290|P1|Overall Study|Lack of Efficacy|6
7770595|NCT00686829|27010290|P1|Overall Study|Adverse Event|5
7770596|NCT00686790|27010320|P1|Overall Study|Lost to Follow-up|12
7770597|NCT00686790|27010320|P1|Overall Study|Death|1
7770598|NCT00686790|27010320|P1|Overall Study|Withdrawal by Subject|1
7770599|NCT00686790|27010320|P1|Overall Study|Adverse Event|2
7770600|NCT00686777|27010328|P1|Overall Study|No Visit|1
7770601|NCT00686777|27010328|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
7770602|NCT00686777|27010328|P1|Overall Study|Withdrawal by Subject|2
7770603|NCT00686777|27010328|P1|Overall Study|Pregnancy|1
7770604|NCT00686777|27010328|P1|Overall Study|Adverse Event|2
7770605|NCT00686725|27010336|P2|Overall Study|Other|3
7770606|NCT00686725|27010337|P1|Overall Study|Other|1
7770607|NCT00686725|27010336|P2|Overall Study|Protocol Violation|3
7770608|NCT00686725|27010337|P1|Overall Study|Protocol Violation|1
7770609|NCT00686725|27010336|P2|Overall Study|Withdrawal by Subject|4
7770610|NCT00686725|27010337|P1|Overall Study|Withdrawal by Subject|13
7770611|NCT00686725|27010336|P2|Overall Study|Death|3
7770612|NCT00686725|27010337|P1|Overall Study|Death|6
7770613|NCT00686725|27010336|P2|Overall Study|Lost to Follow-up|5
7770614|NCT00686725|27010337|P1|Overall Study|Lost to Follow-up|7
7770615|NCT00686725|27010336|P2|Overall Study|Progressive Disease|23
7770616|NCT00686725|27010337|P1|Overall Study|Progressive Disease|17
7770617|NCT00686725|27010336|P2|Overall Study|Adverse Event|1
7770618|NCT00686725|27010337|P1|Overall Study|Adverse Event|1
7770619|NCT00686712|27010362|P3|Overall Study|Adverse Event|0
7770620|NCT00686712|27010363|P2|Overall Study|Adverse Event|1
7770621|NCT00686712|27010364|P1|Overall Study|Adverse Event|1
7770622|NCT00686712|27010362|P3|Overall Study|Lost to Follow-up|3
7770623|NCT00686712|27010363|P2|Overall Study|Lost to Follow-up|2
7770624|NCT00686712|27010364|P1|Overall Study|Lost to Follow-up|1
7770625|NCT00686712|27010362|P3|Overall Study|Protocol Violation|10
7770626|NCT00686712|27010363|P2|Overall Study|Protocol Violation|8
7770627|NCT00686712|27010364|P1|Overall Study|Protocol Violation|8
7770628|NCT00686699|27010392|P2|Treatment Period 1|Adverse Event|2
7770629|NCT00686699|27010393|P1|Treatment Period 1|Adverse Event|0
7770630|NCT00686686|27010417|P1|Overall Study|Lost to Follow-up|3
7770631|NCT00686686|27010417|P1|Overall Study|Adverse Event|2
7770632|NCT00686686|27010417|P1|Overall Study|Non-compliance|1
7770633|NCT00686647|27010425|P1|Overall Study|Death|1
7770634|NCT00686647|27010425|P1|Overall Study|Lost to Follow-up|1
7770635|NCT00686634|27010431|P1|Overall Study|Protocol Violation|6
7770636|NCT00686595|27010438|P1|Overall Study|Poor Compliance|1
7770637|NCT00686595|27010438|P1|Overall Study|Lack of Efficacy|1
7770638|NCT00686595|27010438|P1|Overall Study|Lost to Follow-up|1
7770639|NCT00686595|27010438|P1|Overall Study|Protocol Violation|1
7770640|NCT00686595|27010438|P1|Overall Study|Adverse Event|3
7770641|NCT00686543|27010498|P4|Overall Study|Protocol Violation|1
7770642|NCT00686543|27010499|P3|Overall Study|Protocol Violation|2
7770643|NCT00686543|27010500|P2|Overall Study|Protocol Violation|0
7770644|NCT00686543|27010501|P1|Overall Study|Protocol Violation|3
7770645|NCT00686543|27010498|P4|Overall Study|Withdrawal by Subject|0
7770646|NCT00686543|27010499|P3|Overall Study|Withdrawal by Subject|0
7770647|NCT00686543|27010500|P2|Overall Study|Withdrawal by Subject|0
7770648|NCT00686543|27010501|P1|Overall Study|Withdrawal by Subject|2
7770649|NCT00686543|27010498|P4|Overall Study|Adverse Event|2
7770650|NCT00686543|27010499|P3|Overall Study|Adverse Event|3
7770651|NCT00686543|27010500|P2|Overall Study|Adverse Event|1
7770652|NCT00686543|27010501|P1|Overall Study|Adverse Event|9
7770653|NCT00686517|27010522|P3|Treatment|Protocol Violation|0
7770654|NCT00686517|27010523|P2|Treatment|Protocol Violation|1
7770655|NCT00686517|27010524|P1|Treatment|Protocol Violation|2
7770656|NCT00686517|27010522|P3|Treatment|Poor Protocol Compliance|0
7770657|NCT00686517|27010523|P2|Treatment|Poor Protocol Compliance|0
7770658|NCT00686517|27010524|P1|Treatment|Poor Protocol Compliance|1
7770659|NCT00686517|27010522|P3|Treatment|Adverse Event|0
7770660|NCT00686517|27010523|P2|Treatment|Adverse Event|0
7770661|NCT00686517|27010524|P1|Treatment|Adverse Event|2
7770662|NCT00686517|27010522|P3|Treatment|Serious Adverse Event|1
7770663|NCT00686517|27010523|P2|Treatment|Serious Adverse Event|2
7770664|NCT00686517|27010524|P1|Treatment|Serious Adverse Event|1
7770665|NCT00686374|27010547|P1|Overall Study|Other, not specified|4
7770666|NCT00686374|27010547|P1|Overall Study|Missing reason|33
7770667|NCT00686374|27010547|P1|Overall Study|Lost to Follow-up|1
7770668|NCT00686374|27010547|P1|Overall Study|Withdrew consent|5
7770669|NCT00686374|27010547|P1|Overall Study|Adverse Event|8
7770670|NCT00686374|27010547|P1|Overall Study|Lack of Efficacy|10
7770671|NCT00686335|27010558|P1|Run-in Period|violation of inclusion/exclusion criteri|3
7770672|NCT00686335|27010558|P1|Run-in Period|asthma exacerbation|1
7770673|NCT00686335|27010558|P1|Run-in Period|Adverse Event|1
7770674|NCT00686205|27010602|P2|Overall Study|Specimens not confirmed HIV positive|981
7770675|NCT00686205|27010603|P1|Overall Study|Specimens not confirmed HIV positive|0
7770676|NCT00686205|27010602|P2|Overall Study|Specimen handling procedure altered|0
7770677|NCT00686205|27010603|P1|Overall Study|Specimen handling procedure altered|5878
7770678|NCT00686205|27010602|P2|Overall Study|Withdrawal by Subject|0
7770679|NCT00686205|27010603|P1|Overall Study|Withdrawal by Subject|2
7770680|NCT00686205|27010602|P2|Overall Study|Protocol Violation|0
7770681|NCT00686205|27010603|P1|Overall Study|Protocol Violation|127
7770682|NCT00686166|27010609|P1|Overall Study|Did not begin protocol therapy|4
7770683|NCT00686166|27010609|P1|Overall Study|Ineligible|5
7770684|NCT00686166|27010609|P1|Overall Study|Not Protocol Specified|1
7770685|NCT00686166|27010609|P1|Overall Study|Death|1
7770686|NCT00686166|27010609|P1|Overall Study|Progression/Relapse|1
7770687|NCT00686166|27010609|P1|Overall Study|Withdrawal by Subject|1
7770688|NCT00686166|27010609|P1|Overall Study|Adverse Event|7
7770689|NCT00686127|27010621|P2|Overall Study|Withdrawal by Subject|6
7770690|NCT00686127|27010622|P1|Overall Study|Withdrawal by Subject|14
7770691|NCT00686075|27010638|P10|Overall Study|Other|1
7770692|NCT00686075|27010639|P9|Overall Study|Other|0
7770693|NCT00686075|27010640|P8|Overall Study|Other|0
7770694|NCT00686075|27010641|P7|Overall Study|Other|0
7770695|NCT00686075|27010642|P6|Overall Study|Other|0
7770696|NCT00686075|27010643|P5|Overall Study|Other|0
7770697|NCT00686075|27010644|P4|Overall Study|Other|0
7770698|NCT00686075|27010645|P3|Overall Study|Other|0
7770699|NCT00686075|27010646|P2|Overall Study|Other|1
7770700|NCT00686075|27010647|P1|Overall Study|Other|1
7770701|NCT00686075|27010638|P10|Overall Study|Lost to Follow-up|3
7770702|NCT00686075|27010639|P9|Overall Study|Lost to Follow-up|2
7770703|NCT00686075|27010640|P8|Overall Study|Lost to Follow-up|0
7770704|NCT00686075|27010641|P7|Overall Study|Lost to Follow-up|0
7770705|NCT00686075|27010642|P6|Overall Study|Lost to Follow-up|3
7770706|NCT00686075|27010643|P5|Overall Study|Lost to Follow-up|3
7770707|NCT00686075|27010644|P4|Overall Study|Lost to Follow-up|2
7770708|NCT00686075|27010645|P3|Overall Study|Lost to Follow-up|3
7770709|NCT00686075|27010646|P2|Overall Study|Lost to Follow-up|6
7770710|NCT00686075|27010647|P1|Overall Study|Lost to Follow-up|3
7770711|NCT00686075|27010638|P10|Overall Study|Withdrawal by Subject|6
7770712|NCT00686075|27010639|P9|Overall Study|Withdrawal by Subject|4
7770713|NCT00686075|27010640|P8|Overall Study|Withdrawal by Subject|2
7770714|NCT00686075|27010641|P7|Overall Study|Withdrawal by Subject|0
7770715|NCT00686075|27010642|P6|Overall Study|Withdrawal by Subject|0
7770716|NCT00686075|27010643|P5|Overall Study|Withdrawal by Subject|1
7770717|NCT00686075|27010644|P4|Overall Study|Withdrawal by Subject|7
7770718|NCT00686075|27010645|P3|Overall Study|Withdrawal by Subject|3
7770719|NCT00686075|27010646|P2|Overall Study|Withdrawal by Subject|3
7770720|NCT00686075|27010647|P1|Overall Study|Withdrawal by Subject|4
7770721|NCT00686036|27010841|P2|Overall Study|Other reasons not identified|4
7770722|NCT00686036|27010842|P1|Overall Study|Other reasons not identified|0
7770723|NCT00686036|27010841|P2|Overall Study|PSA ≥ 10ng/mL|0
7770724|NCT00686036|27010842|P1|Overall Study|PSA ≥ 10ng/mL|1
7770725|NCT00686036|27010841|P2|Overall Study|Study terminated by AstraZeneca|1
7770726|NCT00686036|27010842|P1|Overall Study|Study terminated by AstraZeneca|2
7770727|NCT00686036|27010841|P2|Overall Study|Withdrawal by Subject|1
7770728|NCT00686036|27010842|P1|Overall Study|Withdrawal by Subject|3
7770729|NCT00686036|27010841|P2|Overall Study|Adverse Event|0
7770730|NCT00686036|27010842|P1|Overall Study|Adverse Event|3
7770731|NCT00685945|27010854|P1|L-NMMA + Bradykinin|Physician Decision|1
7770732|NCT00685919|27010884|P4|Overall Study|Physician Decision|0
7770733|NCT00685919|27010885|P3|Overall Study|Physician Decision|0
7770734|NCT00685919|27010886|P2|Overall Study|Physician Decision|0
7770735|NCT00685919|27010887|P1|Overall Study|Physician Decision|1
7770736|NCT00685919|27010884|P4|Overall Study|Withdrawal by Subject|0
7770737|NCT00685919|27010885|P3|Overall Study|Withdrawal by Subject|1
7770738|NCT00685919|27010886|P2|Overall Study|Withdrawal by Subject|0
7770739|NCT00685919|27010887|P1|Overall Study|Withdrawal by Subject|0
7770740|NCT00685802|27010934|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7770741|NCT00685802|27010935|P1|Washout Period of 7 Days|Withdrawal by Subject|0
7770742|NCT00685802|27010934|P2|Washout Period of 7 Days|Protocol Violation|0
7770743|NCT00685802|27010935|P1|Washout Period of 7 Days|Protocol Violation|2
7770744|NCT00685763|27010945|P1|Overall Study|Protocol Violation|1
7770745|NCT00685763|27010945|P1|Overall Study|Intercurrent death-incomplete treatment|1
7770746|NCT00685750|27010956|P7|Overall Study|Eligibility criteria not fulfilled|0
7770747|NCT00685750|27010957|P6|Overall Study|Eligibility criteria not fulfilled|0
7770748|NCT00685750|27010958|P5|Overall Study|Eligibility criteria not fulfilled|0
7770749|NCT00685750|27010959|P4|Overall Study|Eligibility criteria not fulfilled|0
7770750|NCT00685750|27010960|P3|Overall Study|Eligibility criteria not fulfilled|1
7770751|NCT00685750|27010961|P2|Overall Study|Eligibility criteria not fulfilled|0
7770752|NCT00685750|27010962|P1|Overall Study|Eligibility criteria not fulfilled|0
7770753|NCT00685750|27010956|P7|Overall Study|Patient didn't receive the treatment|1
7770754|NCT00685750|27010957|P6|Overall Study|Patient didn't receive the treatment|0
7770755|NCT00685750|27010958|P5|Overall Study|Patient didn't receive the treatment|0
7770756|NCT00685750|27010959|P4|Overall Study|Patient didn't receive the treatment|0
7770757|NCT00685750|27010960|P3|Overall Study|Patient didn't receive the treatment|0
7770758|NCT00685750|27010961|P2|Overall Study|Patient didn't receive the treatment|0
7770759|NCT00685750|27010962|P1|Overall Study|Patient didn't receive the treatment|0
7770760|NCT00685750|27010956|P7|Overall Study|Tumor sampling failure|0
7770761|NCT00685750|27010957|P6|Overall Study|Tumor sampling failure|0
7770762|NCT00685750|27010958|P5|Overall Study|Tumor sampling failure|0
7770763|NCT00685750|27010959|P4|Overall Study|Tumor sampling failure|0
7770764|NCT00685750|27010960|P3|Overall Study|Tumor sampling failure|1
7770765|NCT00685750|27010961|P2|Overall Study|Tumor sampling failure|0
7770766|NCT00685750|27010962|P1|Overall Study|Tumor sampling failure|0
7770767|NCT00685698|27010990|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
7770768|NCT00685698|27010990|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
7770769|NCT00685698|27010990|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
7770770|NCT00685698|27010990|P1|Overall Study|Adverse Event|3
7770771|NCT00685698|27010990|P1|Overall Study|Protocol Violation|6
7770772|NCT00685698|27010990|P1|Overall Study|Withdrawal by Subject|1
7770773|NCT00685685|27011025|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7770774|NCT00685685|27011026|P1|Washout Period of 7 Days|Withdrawal by Subject|0
7770775|NCT00685685|27011025|P2|Washout Period of 7 Days|Adverse Event|0
7770776|NCT00685685|27011026|P1|Washout Period of 7 Days|Adverse Event|2
7770777|NCT00685399|27011179|P8|Extension|Adverse Event|0
7770778|NCT00685399|27011180|P7|Extension|Adverse Event|0
7770779|NCT00685399|27011181|P6|Extension|Adverse Event|0
7770780|NCT00685399|27011182|P5|Extension|Adverse Event|0
7770781|NCT00685399|27011183|P4|Extension|Adverse Event|2
7770782|NCT00685399|27011184|P3|Extension|Adverse Event|0
7770783|NCT00685399|27011185|P2|Extension|Adverse Event|0
7770784|NCT00685399|27011186|P1|Extension|Adverse Event|0
7770785|NCT00685399|27011179|P8|Extension|Lack of Efficacy|0
7770786|NCT00685399|27011180|P7|Extension|Lack of Efficacy|0
7770787|NCT00685399|27011181|P6|Extension|Lack of Efficacy|0
7770788|NCT00685399|27011182|P5|Extension|Lack of Efficacy|0
7770789|NCT00685399|27011183|P4|Extension|Lack of Efficacy|2
7770790|NCT00685399|27011184|P3|Extension|Lack of Efficacy|0
7770791|NCT00685399|27011185|P2|Extension|Lack of Efficacy|0
7770792|NCT00685399|27011186|P1|Extension|Lack of Efficacy|0
7770793|NCT00685399|27011179|P8|Extension|Protocol Violation|0
7770794|NCT00685399|27011180|P7|Extension|Protocol Violation|0
7770795|NCT00685399|27011181|P6|Extension|Protocol Violation|0
7770796|NCT00685399|27011182|P5|Extension|Protocol Violation|0
7770797|NCT00685399|27011183|P4|Extension|Protocol Violation|1
7770798|NCT00685399|27011184|P3|Extension|Protocol Violation|0
7770799|NCT00685399|27011185|P2|Extension|Protocol Violation|0
7770800|NCT00685399|27011186|P1|Extension|Protocol Violation|0
7770801|NCT00685399|27011179|P8|Extension|Withdrawal by Subject|0
7770802|NCT00685399|27011180|P7|Extension|Withdrawal by Subject|0
7770803|NCT00685399|27011181|P6|Extension|Withdrawal by Subject|0
7770804|NCT00685399|27011182|P5|Extension|Withdrawal by Subject|0
7770805|NCT00685399|27011183|P4|Extension|Withdrawal by Subject|1
7770806|NCT00685399|27011184|P3|Extension|Withdrawal by Subject|0
7770807|NCT00685399|27011185|P2|Extension|Withdrawal by Subject|0
7770808|NCT00685399|27011186|P1|Extension|Withdrawal by Subject|0
7770809|NCT00685399|27011179|P8|Extension|Administrative Issues|0
7770810|NCT00685399|27011180|P7|Extension|Administrative Issues|0
7770811|NCT00685399|27011181|P6|Extension|Administrative Issues|0
7770812|NCT00685399|27011182|P5|Extension|Administrative Issues|0
7770813|NCT00685399|27011183|P4|Extension|Administrative Issues|1
7770814|NCT00685399|27011184|P3|Extension|Administrative Issues|0
7770815|NCT00685399|27011185|P2|Extension|Administrative Issues|0
7770816|NCT00685399|27011186|P1|Extension|Administrative Issues|0
7770817|NCT00685399|27011179|P8|Treatment Period 2|Lack of Efficacy|0
7770818|NCT00685399|27011180|P7|Treatment Period 2|Lack of Efficacy|0
7770819|NCT00685399|27011181|P6|Treatment Period 2|Lack of Efficacy|1
7770820|NCT00685399|27011182|P5|Treatment Period 2|Lack of Efficacy|0
7770821|NCT00685399|27011183|P4|Treatment Period 2|Lack of Efficacy|0
7770822|NCT00685399|27011184|P3|Treatment Period 2|Lack of Efficacy|2
7770823|NCT00685399|27011185|P2|Treatment Period 2|Lack of Efficacy|10
7770824|NCT00685399|27011186|P1|Treatment Period 2|Lack of Efficacy|0
7770825|NCT00685399|27011179|P8|Treatment Period 2|Adverse Event|0
7770826|NCT00685399|27011180|P7|Treatment Period 2|Adverse Event|0
7770827|NCT00685399|27011181|P6|Treatment Period 2|Adverse Event|1
7770828|NCT00685399|27011182|P5|Treatment Period 2|Adverse Event|0
7770829|NCT00685399|27011183|P4|Treatment Period 2|Adverse Event|0
7770830|NCT00685399|27011184|P3|Treatment Period 2|Adverse Event|0
7770831|NCT00685399|27011185|P2|Treatment Period 2|Adverse Event|0
7770832|NCT00685399|27011186|P1|Treatment Period 2|Adverse Event|0
7770833|NCT00685399|27011179|P8|Treatment Period 2|Withdrawal by Subject|2
7770834|NCT00685399|27011180|P7|Treatment Period 2|Withdrawal by Subject|0
7770835|NCT00685399|27011181|P6|Treatment Period 2|Withdrawal by Subject|0
7770836|NCT00685399|27011182|P5|Treatment Period 2|Withdrawal by Subject|0
7770837|NCT00685399|27011183|P4|Treatment Period 2|Withdrawal by Subject|0
7770838|NCT00685399|27011184|P3|Treatment Period 2|Withdrawal by Subject|0
7770839|NCT00685399|27011185|P2|Treatment Period 2|Withdrawal by Subject|0
7770840|NCT00685399|27011186|P1|Treatment Period 2|Withdrawal by Subject|0
7770841|NCT00685399|27011179|P8|Treatment Period 2|Administrative Problems|0
7770842|NCT00685399|27011180|P7|Treatment Period 2|Administrative Problems|0
7770843|NCT00685399|27011181|P6|Treatment Period 2|Administrative Problems|0
7770844|NCT00685399|27011182|P5|Treatment Period 2|Administrative Problems|0
7770845|NCT00685399|27011183|P4|Treatment Period 2|Administrative Problems|0
7770846|NCT00685399|27011184|P3|Treatment Period 2|Administrative Problems|1
7770847|NCT00685399|27011185|P2|Treatment Period 2|Administrative Problems|2
7770848|NCT00685399|27011186|P1|Treatment Period 2|Administrative Problems|0
7770849|NCT00685399|27011179|P8|Treatment Period 1|Lack of Efficacy|0
7770850|NCT00685399|27011180|P7|Treatment Period 1|Lack of Efficacy|0
7770851|NCT00685399|27011181|P6|Treatment Period 1|Lack of Efficacy|0
7770852|NCT00685399|27011182|P5|Treatment Period 1|Lack of Efficacy|0
7770853|NCT00685399|27011183|P4|Treatment Period 1|Lack of Efficacy|0
7770854|NCT00685399|27011184|P3|Treatment Period 1|Lack of Efficacy|0
7770855|NCT00685399|27011185|P2|Treatment Period 1|Lack of Efficacy|0
7770856|NCT00685399|27011186|P1|Treatment Period 1|Lack of Efficacy|1
7770857|NCT00685399|27011179|P8|Treatment Period 1|Administrative|0
7770858|NCT00685399|27011180|P7|Treatment Period 1|Administrative|0
7770859|NCT00685399|27011181|P6|Treatment Period 1|Administrative|0
7770860|NCT00685399|27011182|P5|Treatment Period 1|Administrative|0
7770861|NCT00685399|27011183|P4|Treatment Period 1|Administrative|0
7770862|NCT00685399|27011184|P3|Treatment Period 1|Administrative|0
7770863|NCT00685399|27011185|P2|Treatment Period 1|Administrative|0
7770864|NCT00685399|27011186|P1|Treatment Period 1|Administrative|2
7770865|NCT00685399|27011179|P8|Treatment Period 1|Protocol Violation|0
7770866|NCT00685399|27011180|P7|Treatment Period 1|Protocol Violation|0
7770867|NCT00685399|27011181|P6|Treatment Period 1|Protocol Violation|0
7770868|NCT00685399|27011182|P5|Treatment Period 1|Protocol Violation|0
7770869|NCT00685399|27011183|P4|Treatment Period 1|Protocol Violation|0
7770870|NCT00685399|27011184|P3|Treatment Period 1|Protocol Violation|0
7770871|NCT00685399|27011185|P2|Treatment Period 1|Protocol Violation|0
7770872|NCT00685399|27011186|P1|Treatment Period 1|Protocol Violation|1
7770873|NCT00685399|27011179|P8|Treatment Period 1|Withdrawal by Subject|0
7770874|NCT00685399|27011180|P7|Treatment Period 1|Withdrawal by Subject|0
7770875|NCT00685399|27011181|P6|Treatment Period 1|Withdrawal by Subject|0
7770876|NCT00685399|27011182|P5|Treatment Period 1|Withdrawal by Subject|0
7770877|NCT00685399|27011183|P4|Treatment Period 1|Withdrawal by Subject|0
7770878|NCT00685399|27011184|P3|Treatment Period 1|Withdrawal by Subject|0
7770879|NCT00685399|27011185|P2|Treatment Period 1|Withdrawal by Subject|0
7770880|NCT00685399|27011186|P1|Treatment Period 1|Withdrawal by Subject|2
7770881|NCT00685373|27011219|P1|Overall Study|Protocol Violation|1
7770882|NCT00685373|27011219|P1|Overall Study|Lost to Follow-up|2
7770883|NCT00685373|27011219|P1|Overall Study|Condition no longer requires study drug|1
7770884|NCT00685373|27011219|P1|Overall Study|Lack of Efficacy|3
7770885|NCT00685373|27011219|P1|Overall Study|Withdrawal by Subject|5
7770886|NCT00685373|27011219|P1|Overall Study|Adverse Event|3
7770887|NCT00685334|27011228|P2|Overall Study|Chose to enter hospital|1
7770888|NCT00685334|27011229|P1|Overall Study|Chose to enter hospital|1
7770889|NCT00685334|27011228|P2|Overall Study|Lost to Follow-up|0
7770890|NCT00685334|27011229|P1|Overall Study|Lost to Follow-up|4
7770891|NCT00685334|27011228|P2|Overall Study|Withdrawal by Subject|6
7770892|NCT00685334|27011229|P1|Overall Study|Withdrawal by Subject|5
7770893|NCT00685178|27011254|P4|Overall Study|Pregnancy|1
7770894|NCT00685178|27011255|P3|Overall Study|Pregnancy|0
7770895|NCT00685178|27011256|P2|Overall Study|Pregnancy|0
7770896|NCT00685178|27011257|P1|Overall Study|Pregnancy|0
7770897|NCT00685178|27011254|P4|Overall Study|administrative (disciplinary) discharge|2
7770898|NCT00685178|27011255|P3|Overall Study|administrative (disciplinary) discharge|0
7770899|NCT00685178|27011256|P2|Overall Study|administrative (disciplinary) discharge|1
7770900|NCT00685178|27011257|P1|Overall Study|administrative (disciplinary) discharge|0
7770901|NCT00685178|27011254|P4|Overall Study|incarcerated|0
7770902|NCT00685178|27011255|P3|Overall Study|incarcerated|7
7770903|NCT00685178|27011256|P2|Overall Study|incarcerated|3
7770904|NCT00685178|27011257|P1|Overall Study|incarcerated|1
7770905|NCT00685178|27011254|P4|Overall Study|voluntary study discharge|1
7770906|NCT00685178|27011255|P3|Overall Study|voluntary study discharge|1
7770907|NCT00685178|27011256|P2|Overall Study|voluntary study discharge|5
7770908|NCT00685178|27011257|P1|Overall Study|voluntary study discharge|4
7770909|NCT00685178|27011254|P4|Overall Study|missed 3 consecutive methadone clin days|6
7770910|NCT00685178|27011255|P3|Overall Study|missed 3 consecutive methadone clin days|2
7770911|NCT00685178|27011256|P2|Overall Study|missed 3 consecutive methadone clin days|5
7770912|NCT00685178|27011257|P1|Overall Study|missed 3 consecutive methadone clin days|7
7770913|NCT00685178|27011254|P4|Overall Study|Adverse Event|4
7770914|NCT00685178|27011255|P3|Overall Study|Adverse Event|2
7770915|NCT00685178|27011256|P2|Overall Study|Adverse Event|5
7770916|NCT00685178|27011257|P1|Overall Study|Adverse Event|1
7770917|NCT00685165|27011271|P2|Washout Period of 14 Days|Adverse Event|0
7770918|NCT00685165|27011272|P1|Washout Period of 14 Days|Adverse Event|1
7770919|NCT00685035|27011291|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
7770920|NCT00685035|27011292|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
7770921|NCT00684996|27011316|P1|Overall Study|Other reasons not protocol specified|1
7770922|NCT00684996|27011316|P1|Overall Study|Progression/relapse|2
7770923|NCT00684996|27011316|P1|Overall Study|Refusal unrelated to adverse event|1
7770924|NCT00684996|27011316|P1|Overall Study|Adverse Event|1
7770925|NCT00684814|27011348|P2|Second Intervention|Adverse Event|0
7770926|NCT00684814|27011349|P1|Second Intervention|Adverse Event|1
7770927|NCT00684814|27011348|P2|Washout Period of 7 Days|Withdrawal by Subject|2
7770928|NCT00684814|27011349|P1|Washout Period of 7 Days|Withdrawal by Subject|1
7770929|NCT00684814|27011348|P2|Washout Period of 7 Days|Adverse Event|2
7770930|NCT00684814|27011349|P1|Washout Period of 7 Days|Adverse Event|1
7770931|NCT00684762|27011401|P2|Washout Period of 7 Days|Withdrawal by Subject|2
7770932|NCT00684762|27011402|P1|Washout Period of 7 Days|Withdrawal by Subject|2
7770933|NCT00684671|27011430|P3|Overall Study|Alcoholic dependance|0
7770934|NCT00684671|27011431|P2|Overall Study|Alcoholic dependance|0
7770935|NCT00684671|27011432|P1|Overall Study|Alcoholic dependance|1
7770936|NCT00684671|27011430|P3|Overall Study|Lost to Follow-up|0
7770937|NCT00684671|27011431|P2|Overall Study|Lost to Follow-up|0
7770938|NCT00684671|27011432|P1|Overall Study|Lost to Follow-up|1
7770939|NCT00684671|27011430|P3|Overall Study|Adverse Event|0
7770940|NCT00684671|27011431|P2|Overall Study|Adverse Event|0
7770941|NCT00684671|27011432|P1|Overall Study|Adverse Event|1
7770942|NCT00684645|27011461|P1|Overall Study|Other|15
7770943|NCT00684645|27011461|P1|Overall Study|Lost to Follow-up|3
7770944|NCT00684645|27011461|P1|Overall Study|Adverse Event|27
7770945|NCT00684645|27011461|P1|Overall Study|Progressive disease|67
7770946|NCT00684645|27011461|P1|Overall Study|Death|2
7770947|NCT00684593|27011481|P2|Overall Study|Adverse Event|2
7770948|NCT00684593|27011482|P1|Overall Study|Adverse Event|0
7770949|NCT00684567|27011494|P1|Monotherapy Period|Progression of primary disease|11
7770950|NCT00684567|27011494|P1|Monotherapy Period|Death|1
7770951|NCT00684567|27011494|P1|Monotherapy Period|Adverse Event|2
7770952|NCT00684567|27011494|P1|Concomitant Radiotherapy Period|Adverse Event|2
7770953|NCT00684515|27011527|P3|Overall Study|Protocol-Defined Clinical Event|0
7770954|NCT00684515|27011528|P2|Overall Study|Protocol-Defined Clinical Event|0
7770955|NCT00684515|27011529|P1|Overall Study|Protocol-Defined Clinical Event|1
7770956|NCT00684515|27011527|P3|Overall Study|Adverse Event|1
7770957|NCT00684515|27011528|P2|Overall Study|Adverse Event|3
7770958|NCT00684515|27011529|P1|Overall Study|Adverse Event|3
7770959|NCT00684424|27011552|P1|Overall Study|Other|2
7770960|NCT00684424|27011552|P1|Overall Study|Lost to Follow-up|2
7770961|NCT00684424|27011552|P1|Overall Study|Adverse Event|1
7770962|NCT00684411|27011567|P1|Overall Study|Adverse Event|1
7770963|NCT00684411|27011567|P1|Overall Study|Disease Progression|10
7770964|NCT00684411|27011567|P1|Overall Study|New Primary Cancer|1
7770965|NCT00684307|27011589|P5|Overall Study|Criteria from the CSR|3
7770966|NCT00684307|27011590|P4|Overall Study|Criteria from the CSR|3
7770967|NCT00684307|27011591|P3|Overall Study|Criteria from the CSR|1
7770968|NCT00684307|27011592|P2|Overall Study|Criteria from the CSR|0
7770969|NCT00684307|27011593|P1|Overall Study|Criteria from the CSR|0
7770970|NCT00684307|27011589|P5|Overall Study|Participant not willing to continue|8
7770971|NCT00684307|27011590|P4|Overall Study|Participant not willing to continue|5
7770972|NCT00684307|27011591|P3|Overall Study|Participant not willing to continue|11
7770973|NCT00684307|27011592|P2|Overall Study|Participant not willing to continue|10
7770974|NCT00684307|27011593|P1|Overall Study|Participant not willing to continue|7
7770975|NCT00684307|27011589|P5|Overall Study|Severe non compliance to protocol|2
7770976|NCT00684307|27011590|P4|Overall Study|Severe non compliance to protocol|1
7770977|NCT00684307|27011591|P3|Overall Study|Severe non compliance to protocol|0
7770978|NCT00684307|27011592|P2|Overall Study|Severe non compliance to protocol|0
7770979|NCT00684307|27011593|P1|Overall Study|Severe non compliance to protocol|1
7770980|NCT00684307|27011589|P5|Overall Study|Interupted IP for more than 7 days|3
7770981|NCT00684307|27011590|P4|Overall Study|Interupted IP for more than 7 days|3
7770982|NCT00684307|27011591|P3|Overall Study|Interupted IP for more than 7 days|1
7770983|NCT00684307|27011592|P2|Overall Study|Interupted IP for more than 7 days|4
7770984|NCT00684307|27011593|P1|Overall Study|Interupted IP for more than 7 days|0
7770985|NCT00684307|27011589|P5|Overall Study|Incorrect enrolment or randomization|0
7770986|NCT00684307|27011590|P4|Overall Study|Incorrect enrolment or randomization|0
7770987|NCT00684307|27011591|P3|Overall Study|Incorrect enrolment or randomization|0
7770988|NCT00684307|27011592|P2|Overall Study|Incorrect enrolment or randomization|0
7770989|NCT00684307|27011593|P1|Overall Study|Incorrect enrolment or randomization|4
7770990|NCT00684307|27011589|P5|Overall Study|Fullfillment of exclusion criteria|1
7770991|NCT00684307|27011590|P4|Overall Study|Fullfillment of exclusion criteria|3
7770992|NCT00684307|27011591|P3|Overall Study|Fullfillment of exclusion criteria|0
7770993|NCT00684307|27011592|P2|Overall Study|Fullfillment of exclusion criteria|0
7770994|NCT00684307|27011593|P1|Overall Study|Fullfillment of exclusion criteria|1
7770995|NCT00684307|27011589|P5|Overall Study|Development of increasing Liver Function|0
7770996|NCT00684307|27011590|P4|Overall Study|Development of increasing Liver Function|1
7770997|NCT00684307|27011591|P3|Overall Study|Development of increasing Liver Function|0
7770998|NCT00684307|27011592|P2|Overall Study|Development of increasing Liver Function|2
7770999|NCT00684307|27011593|P1|Overall Study|Development of increasing Liver Function|0
7771000|NCT00684307|27011589|P5|Overall Study|Adverse Event|8
7771001|NCT00684307|27011590|P4|Overall Study|Adverse Event|16
7771002|NCT00684307|27011591|P3|Overall Study|Adverse Event|15
7771003|NCT00684307|27011592|P2|Overall Study|Adverse Event|6
7771004|NCT00684307|27011593|P1|Overall Study|Adverse Event|11
7771005|NCT00684203|27011675|P6|Overall Study|Did not meet protocol eligibility|0
7771006|NCT00684203|27011676|P5|Overall Study|Did not meet protocol eligibility|0
7771007|NCT00684203|27011677|P4|Overall Study|Did not meet protocol eligibility|0
7771008|NCT00684203|27011678|P3|Overall Study|Did not meet protocol eligibility|0
7771009|NCT00684203|27011679|P2|Overall Study|Did not meet protocol eligibility|1
7771010|NCT00684203|27011680|P1|Overall Study|Did not meet protocol eligibility|0
7771011|NCT00684203|27011675|P6|Overall Study|Withdrawal by Subject|0
7771012|NCT00684203|27011676|P5|Overall Study|Withdrawal by Subject|0
7771013|NCT00684203|27011677|P4|Overall Study|Withdrawal by Subject|0
7771014|NCT00684203|27011678|P3|Overall Study|Withdrawal by Subject|1
7771015|NCT00684203|27011679|P2|Overall Study|Withdrawal by Subject|2
7771016|NCT00684203|27011680|P1|Overall Study|Withdrawal by Subject|0
7771017|NCT00684203|27011675|P6|Overall Study|Protocol-defined clinical event|0
7771018|NCT00684203|27011676|P5|Overall Study|Protocol-defined clinical event|0
7771019|NCT00684203|27011677|P4|Overall Study|Protocol-defined clinical event|0
7771020|NCT00684203|27011678|P3|Overall Study|Protocol-defined clinical event|0
7771021|NCT00684203|27011679|P2|Overall Study|Protocol-defined clinical event|1
7771022|NCT00684203|27011680|P1|Overall Study|Protocol-defined clinical event|3
7771023|NCT00684203|27011675|P6|Overall Study|Adverse Event|0
7771024|NCT00684203|27011676|P5|Overall Study|Adverse Event|0
7771025|NCT00684203|27011677|P4|Overall Study|Adverse Event|0
7771026|NCT00684203|27011678|P3|Overall Study|Adverse Event|8
7771027|NCT00684203|27011679|P2|Overall Study|Adverse Event|4
7771028|NCT00684203|27011680|P1|Overall Study|Adverse Event|6
7771029|NCT00684177|27011741|P2|Overall Study|Other|2
7771030|NCT00684177|27011742|P1|Overall Study|Other|1
7771031|NCT00684177|27011741|P2|Overall Study|Withdrawal by Subject|2
7771032|NCT00684177|27011742|P1|Overall Study|Withdrawal by Subject|1
7771033|NCT00684177|27011741|P2|Overall Study|Physician Decision|0
7771034|NCT00684177|27011742|P1|Overall Study|Physician Decision|2
7771035|NCT00684177|27011741|P2|Overall Study|Lost to Follow-up|1
7771036|NCT00684177|27011742|P1|Overall Study|Lost to Follow-up|2
7771037|NCT00684177|27011741|P2|Overall Study|Protocol Violation|0
7771038|NCT00684177|27011742|P1|Overall Study|Protocol Violation|1
7771039|NCT00684177|27011741|P2|Overall Study|Lack of Efficacy|15
7771040|NCT00684177|27011742|P1|Overall Study|Lack of Efficacy|10
7771041|NCT00684177|27011741|P2|Overall Study|Adverse Event|3
7771042|NCT00684177|27011742|P1|Overall Study|Adverse Event|4
7771043|NCT00684073|27011777|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
7771044|NCT00684073|27011777|P1|Selection|request of the sponsor|1
7771045|NCT00684073|27011777|P1|Selection|Lost to Follow-up|1
7771046|NCT00684073|27011777|P1|Selection|noncompliance|1
7771047|NCT00684073|27011777|P1|Selection|Death|1
7771048|NCT00684073|27011777|P1|Selection|Selection/non-selection criteria|3
7771049|NCT00684060|27011787|P2|Overall Study|Death|1
7771050|NCT00684060|27011788|P1|Overall Study|Death|0
7771051|NCT00684060|27011787|P2|Overall Study|Unable to collect MRI|2
7771052|NCT00684060|27011788|P1|Overall Study|Unable to collect MRI|1
7771053|NCT00684060|27011787|P2|Overall Study|New stenosis identified|0
7771054|NCT00684060|27011788|P1|Overall Study|New stenosis identified|1
7771055|NCT00684060|27011787|P2|Overall Study|Lost to Follow-up|0
7771056|NCT00684060|27011788|P1|Overall Study|Lost to Follow-up|1
7771057|NCT00684021|27011827|P4|Overall Study|Death|0
7771058|NCT00684021|27011828|P3|Overall Study|Death|0
7771059|NCT00684021|27011829|P2|Overall Study|Death|0
7771060|NCT00684021|27011830|P1|Overall Study|Death|1
7771061|NCT00684021|27011827|P4|Overall Study|MRI not performed|2
7771062|NCT00684021|27011828|P3|Overall Study|MRI not performed|1
7771063|NCT00684021|27011829|P2|Overall Study|MRI not performed|1
7771064|NCT00684021|27011830|P1|Overall Study|MRI not performed|0
7771065|NCT00684021|27011827|P4|Overall Study|MRI Contraindicated|0
7771066|NCT00684021|27011828|P3|Overall Study|MRI Contraindicated|1
7771067|NCT00684021|27011829|P2|Overall Study|MRI Contraindicated|1
7771068|NCT00684021|27011830|P1|Overall Study|MRI Contraindicated|1
7771069|NCT00683917|27011891|P1|Overall Study|Study prematurely terminated|10
7771070|NCT00683904|27011901|P2|Dose Level 2|Adverse Event|2
7771071|NCT00683904|27011902|P1|Dose Level 2|Adverse Event|0
7771072|NCT00683904|27011901|P2|Dose Level 1|Adverse Event|0
7771073|NCT00683904|27011902|P1|Dose Level 1|Adverse Event|1
7771074|NCT00683904|27011901|P2|Dose Level 1|Disease progression|0
7771075|NCT00683904|27011902|P1|Dose Level 1|Disease progression|2
7771076|NCT00683878|27011938|P3|Overall Study|Non-compliance, not met criteria etc.|0
7771077|NCT00683878|27011939|P2|Overall Study|Non-compliance, not met criteria etc.|2
7771078|NCT00683878|27011940|P1|Overall Study|Non-compliance, not met criteria etc.|3
7771079|NCT00683878|27011938|P3|Overall Study|Lost to Follow-up|4
7771080|NCT00683878|27011939|P2|Overall Study|Lost to Follow-up|2
7771081|NCT00683878|27011940|P1|Overall Study|Lost to Follow-up|4
7771082|NCT00683878|27011938|P3|Overall Study|Death|0
7771083|NCT00683878|27011939|P2|Overall Study|Death|1
7771084|NCT00683878|27011940|P1|Overall Study|Death|0
7771085|NCT00683878|27011938|P3|Overall Study|Withdrawal by Subject|6
7771086|NCT00683878|27011939|P2|Overall Study|Withdrawal by Subject|8
7771087|NCT00683878|27011940|P1|Overall Study|Withdrawal by Subject|9
7771088|NCT00683878|27011938|P3|Overall Study|Adverse Event|3
7771089|NCT00683878|27011939|P2|Overall Study|Adverse Event|3
7771090|NCT00683878|27011940|P1|Overall Study|Adverse Event|4
7771091|NCT00683878|27011938|P3|Overall Study|Lack of Efficacy|1
7771092|NCT00683878|27011939|P2|Overall Study|Lack of Efficacy|0
7771093|NCT00683878|27011940|P1|Overall Study|Lack of Efficacy|3
7771094|NCT00683800|27012014|P2|Overall Study|Randomized, not treated|33
7771095|NCT00683800|27012015|P1|Overall Study|Randomized, not treated|35
7771096|NCT00683800|27012014|P2|Overall Study|Lack of Efficacy|104
7771097|NCT00683800|27012015|P1|Overall Study|Lack of Efficacy|61
7771098|NCT00683800|27012014|P2|Overall Study|Withdrawal by Subject|64
7771099|NCT00683800|27012015|P1|Overall Study|Withdrawal by Subject|66
7771100|NCT00683800|27012014|P2|Overall Study|Protocol Violation|16
7771101|NCT00683800|27012015|P1|Overall Study|Protocol Violation|13
7771102|NCT00683800|27012014|P2|Overall Study|Other|2
7771103|NCT00683800|27012015|P1|Overall Study|Other|5
7771104|NCT00683800|27012014|P2|Overall Study|Lost to Follow-up|44
7771105|NCT00683800|27012015|P1|Overall Study|Lost to Follow-up|57
7771106|NCT00683800|27012014|P2|Overall Study|Death|1
7771107|NCT00683800|27012015|P1|Overall Study|Death|0
7771108|NCT00683800|27012014|P2|Overall Study|Adverse Event|102
7771109|NCT00683800|27012015|P1|Overall Study|Adverse Event|195
7771110|NCT00683787|27012082|P3|Overall Study|Adverse Event|2
7771111|NCT00683787|27012083|P2|Overall Study|Adverse Event|0
7771112|NCT00683787|27012084|P1|Overall Study|Adverse Event|0
7771113|NCT00683787|27012082|P3|Overall Study|Progression|0
7771114|NCT00683787|27012083|P2|Overall Study|Progression|3
7771115|NCT00683787|27012084|P1|Overall Study|Progression|3
7771116|NCT00683774|27012103|P2|Overall Study|Physician Decision|0
7771117|NCT00683774|27012104|P1|Overall Study|Physician Decision|3
7771118|NCT00683774|27012103|P2|Overall Study|Withdrawal by Subject|1
7771119|NCT00683774|27012104|P1|Overall Study|Withdrawal by Subject|0
7771120|NCT00683696|27012114|P2|Overall Study|Death|30
7771121|NCT00683696|27012115|P1|Overall Study|Death|46
7771122|NCT00683696|27012114|P2|Overall Study|Vital status follow-up only|3
7771123|NCT00683696|27012115|P1|Overall Study|Vital status follow-up only|3
7771124|NCT00683696|27012114|P2|Overall Study|Lost to Follow-up|6
7771125|NCT00683696|27012115|P1|Overall Study|Lost to Follow-up|5
7771126|NCT00683696|27012114|P2|Overall Study|Withdrawn prior to study closure|28
7771127|NCT00683696|27012115|P1|Overall Study|Withdrawn prior to study closure|13
7771128|NCT00683696|27012114|P2|Overall Study|Withdrawn due to study closure|338
7771129|NCT00683696|27012115|P1|Overall Study|Withdrawn due to study closure|337
7771130|NCT00683657|27012134|P2|Overall Study|Subject Withdrew Consent|0
7771131|NCT00683657|27012135|P1|Overall Study|Subject Withdrew Consent|1
7771132|NCT00683657|27012134|P2|Overall Study|Adverse Event|1
7771133|NCT00683657|27012135|P1|Overall Study|Adverse Event|0
7771134|NCT00683644|27012151|P2|Overall Study|Low copper, other health problems,|6
7771135|NCT00683644|27012152|P1|Overall Study|Low copper, other health problems,|7
7771136|NCT00683644|27012151|P2|Overall Study|Adverse Event|2
7771137|NCT00683644|27012152|P1|Overall Study|Adverse Event|1
7771138|NCT00683644|27012151|P2|Overall Study|Lost to Follow-up|4
7771139|NCT00683644|27012152|P1|Overall Study|Lost to Follow-up|1
7771140|NCT00683644|27012151|P2|Overall Study|Withdrawal by Subject|2
7771141|NCT00683644|27012152|P1|Overall Study|Withdrawal by Subject|4
7771142|NCT00683618|27012165|P3|Extension Treatment Period|Protocol Violation|0
7771143|NCT00683618|27012166|P2|Extension Treatment Period|Protocol Violation|0
7771144|NCT00683618|27012167|P1|Extension Treatment Period|Protocol Violation|1
7771145|NCT00683618|27012165|P3|Extension Treatment Period|Adverse Event|0
7771146|NCT00683618|27012166|P2|Extension Treatment Period|Adverse Event|0
7771147|NCT00683618|27012167|P1|Extension Treatment Period|Adverse Event|1
7771148|NCT00683618|27012165|P3|Extension Treatment Period|Withdrawal by Subject|0
7771149|NCT00683618|27012166|P2|Extension Treatment Period|Withdrawal by Subject|0
7771150|NCT00683618|27012167|P1|Extension Treatment Period|Withdrawal by Subject|1
7771151|NCT00683618|27012165|P3|Randomised Treatment Period|Reason not provided|2
7771152|NCT00683618|27012166|P2|Randomised Treatment Period|Reason not provided|0
7771153|NCT00683618|27012167|P1|Randomised Treatment Period|Reason not provided|0
7771154|NCT00683618|27012165|P3|Randomised Treatment Period|Adverse Event|2
7771155|NCT00683618|27012166|P2|Randomised Treatment Period|Adverse Event|0
7771156|NCT00683618|27012167|P1|Randomised Treatment Period|Adverse Event|2
7771157|NCT00683618|27012165|P3|Randomised Treatment Period|Protocol Violation|0
7771158|NCT00683618|27012166|P2|Randomised Treatment Period|Protocol Violation|1
7771159|NCT00683618|27012167|P1|Randomised Treatment Period|Protocol Violation|0
7771160|NCT00683618|27012165|P3|Randomised Treatment Period|Withdrawal by Subject|2
7771161|NCT00683618|27012166|P2|Randomised Treatment Period|Withdrawal by Subject|1
7771162|NCT00683618|27012167|P1|Randomised Treatment Period|Withdrawal by Subject|4
7771163|NCT00683592|27012217|P2|Overall Study|Other|1
7771164|NCT00683592|27012218|P1|Overall Study|Other|1
7771165|NCT00683592|27012217|P2|Overall Study|Non-compliance|5
7771166|NCT00683592|27012218|P1|Overall Study|Non-compliance|3
7771167|NCT00683592|27012217|P2|Overall Study|Physician Decision|1
7771168|NCT00683592|27012218|P1|Overall Study|Physician Decision|0
7771169|NCT00683592|27012217|P2|Overall Study|Lack of Efficacy|7
7771170|NCT00683592|27012218|P1|Overall Study|Lack of Efficacy|3
7771171|NCT00683592|27012217|P2|Overall Study|Lost to Follow-up|17
7771172|NCT00683592|27012218|P1|Overall Study|Lost to Follow-up|17
7771173|NCT00683592|27012217|P2|Overall Study|Withdrawal by Subject|11
7771174|NCT00683592|27012218|P1|Overall Study|Withdrawal by Subject|11
7771175|NCT00683592|27012217|P2|Overall Study|Adverse Event|4
7771176|NCT00683592|27012218|P1|Overall Study|Adverse Event|12
7771177|NCT00683475|27012236|P2|Overall Study|Never Treated: Progressive Disease|0
7771178|NCT00683475|27012237|P1|Overall Study|Never Treated: Progressive Disease|1
7771179|NCT00683475|27012236|P2|Overall Study|Never Treated: Adverse Event|3
7771180|NCT00683475|27012237|P1|Overall Study|Never Treated: Adverse Event|2
7771181|NCT00683475|27012236|P2|Overall Study|Withdrawal by Subject|0
7771182|NCT00683475|27012237|P1|Overall Study|Withdrawal by Subject|1
7771183|NCT00683449|27012272|P5|Overall Study|Lost to Follow-up|0
7771184|NCT00683449|27012273|P4|Overall Study|Lost to Follow-up|0
7771185|NCT00683449|27012274|P3|Overall Study|Lost to Follow-up|0
7771186|NCT00683449|27012275|P2|Overall Study|Lost to Follow-up|1
7771187|NCT00683449|27012276|P1|Overall Study|Lost to Follow-up|0
7771188|NCT00683384|27012302|P1|Overall Study|Adverse Event|1
7771189|NCT00683384|27012302|P1|Overall Study|Death|1
7771190|NCT00683293|27012312|P2|Overall Study|Withdrawal by Subject|3
7771191|NCT00683293|27012313|P1|Overall Study|Withdrawal by Subject|2
7771192|NCT00682929|27012376|P3|Overall Study|lag in DEA renewal|0
7771193|NCT00682929|27012377|P2|Overall Study|lag in DEA renewal|0
7771194|NCT00682929|27012378|P1|Overall Study|lag in DEA renewal|1
7771195|NCT00682929|27012376|P3|Overall Study|dosing compliance < 80%|0
7771196|NCT00682929|27012377|P2|Overall Study|dosing compliance < 80%|2
7771197|NCT00682929|27012378|P1|Overall Study|dosing compliance < 80%|0
7771198|NCT00682929|27012376|P3|Overall Study|Withdrawal by Subject|1
7771199|NCT00682929|27012377|P2|Overall Study|Withdrawal by Subject|2
7771200|NCT00682929|27012378|P1|Overall Study|Withdrawal by Subject|1
7771201|NCT00682929|27012376|P3|Overall Study|Adverse Event|1
7771202|NCT00682929|27012377|P2|Overall Study|Adverse Event|1
7771203|NCT00682929|27012378|P1|Overall Study|Adverse Event|4
7771204|NCT00682890|27012547|P2|Overall Study|heavy menstrual bleeding|0
7771205|NCT00682890|27012548|P1|Overall Study|heavy menstrual bleeding|1
7771206|NCT00682890|27012547|P2|Overall Study|subject moved away|1
7771207|NCT00682890|27012548|P1|Overall Study|subject moved away|0
7771208|NCT00682890|27012547|P2|Overall Study|Lost to Follow-up|1
7771209|NCT00682890|27012548|P1|Overall Study|Lost to Follow-up|1
7771210|NCT00682786|27012590|P2|Overall Study|Did not receive irinotecan|1
7771211|NCT00682786|27012591|P1|Overall Study|Did not receive irinotecan|0
7771212|NCT00682786|27012590|P2|Overall Study|Withdrawal by Subject|2
7771213|NCT00682786|27012591|P1|Overall Study|Withdrawal by Subject|2
7771214|NCT00682643|27012640|P2|Overall Study|Did Not Receive Study Drug|1
7771215|NCT00682643|27012641|P1|Overall Study|Did Not Receive Study Drug|1
7771216|NCT00682643|27012640|P2|Overall Study|Withdrawal by Subject|53
7771217|NCT00682643|27012641|P1|Overall Study|Withdrawal by Subject|19
7771218|NCT00682643|27012640|P2|Overall Study|Physician Decision|6
7771219|NCT00682643|27012641|P1|Overall Study|Physician Decision|2
7771220|NCT00682643|27012640|P2|Overall Study|Lost to Follow-up|6
7771221|NCT00682643|27012641|P1|Overall Study|Lost to Follow-up|1
7771222|NCT00682643|27012640|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
7771223|NCT00682643|27012641|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
7771224|NCT00682643|27012640|P2|Overall Study|Protocol Violation|76
7771225|NCT00682643|27012641|P1|Overall Study|Protocol Violation|38
7771226|NCT00682643|27012640|P2|Overall Study|Lack of Efficacy|0
7771227|NCT00682643|27012641|P1|Overall Study|Lack of Efficacy|2
7771228|NCT00682643|27012640|P2|Overall Study|Adverse Event|23
7771229|NCT00682643|27012641|P1|Overall Study|Adverse Event|12
7771230|NCT00682539|27012715|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
7771231|NCT00682539|27012716|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
7771232|NCT00682539|27012717|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
7771233|NCT00682539|27012715|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
7771234|NCT00682539|27012716|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
7771235|NCT00682539|27012717|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
7771236|NCT00682461|27012730|P2|Overall Study|Withdrawal by Subject|19
7771237|NCT00682461|27012731|P1|Overall Study|Withdrawal by Subject|12
7771238|NCT00682461|27012730|P2|Overall Study|Lost to Follow-up|5
7771239|NCT00682461|27012731|P1|Overall Study|Lost to Follow-up|8
7771240|NCT00682461|27012730|P2|Overall Study|Adverse Event|7
7771241|NCT00682461|27012731|P1|Overall Study|Adverse Event|5
7771242|NCT00682448|27012747|P2|Overall Study|Withdrawal by Subject|0
7771243|NCT00682448|27012748|P1|Overall Study|Withdrawal by Subject|2
7771244|NCT00682448|27012747|P2|Overall Study|Pregnancy|1
7771245|NCT00682448|27012748|P1|Overall Study|Pregnancy|0
7771246|NCT00682448|27012747|P2|Overall Study|Lost to Follow-up|3
7771247|NCT00682448|27012748|P1|Overall Study|Lost to Follow-up|1
7771248|NCT00682448|27012747|P2|Overall Study|Lack of Efficacy|0
7771249|NCT00682448|27012748|P1|Overall Study|Lack of Efficacy|1
7771250|NCT00682448|27012747|P2|Overall Study|Adverse Event|2
7771251|NCT00682448|27012748|P1|Overall Study|Adverse Event|1
7771252|NCT00682435|27012756|P1|Overall Study|Erroneously enrolled twice|2
7771253|NCT00682435|27012756|P1|Overall Study|Insufficient data|5
7771254|NCT00681863|27012789|P1|Overall Study|Other|18
7771255|NCT00681863|27012789|P1|Overall Study|Lack of Efficacy|2
7771256|NCT00681863|27012789|P1|Overall Study|Lost to Follow-up|2
7771257|NCT00681863|27012789|P1|Overall Study|Adverse Event|1
7771258|NCT00681824|27012837|P3|Overall Study|Death|0
7771259|NCT00681824|27012838|P2|Overall Study|Death|1
7771260|NCT00681824|27012839|P1|Overall Study|Death|0
7771261|NCT00681824|27012837|P3|Overall Study|scheduling conflict|0
7771262|NCT00681824|27012838|P2|Overall Study|scheduling conflict|0
7771263|NCT00681824|27012839|P1|Overall Study|scheduling conflict|1
7771264|NCT00681824|27012837|P3|Overall Study|withdrawn by investigator|1
7771265|NCT00681824|27012838|P2|Overall Study|withdrawn by investigator|0
7771266|NCT00681824|27012839|P1|Overall Study|withdrawn by investigator|0
7771267|NCT00681811|27012857|P2|Overall Study|Non-compliance|1
7771268|NCT00681811|27012858|P1|Overall Study|Non-compliance|0
7771269|NCT00681811|27012857|P2|Overall Study|Withdrawal by Subject|2
7771270|NCT00681811|27012858|P1|Overall Study|Withdrawal by Subject|2
7771271|NCT00681811|27012857|P2|Overall Study|Adverse Event|1
7771272|NCT00681811|27012858|P1|Overall Study|Adverse Event|1
7771273|NCT00681668|27012886|P1|Overall Study|Withdrawal by Subject|1
7771274|NCT00681668|27012886|P1|Overall Study|Protocol Violation|1
7771275|NCT00681629|27012895|P2|Overall Study|Adverse Event|0
7771276|NCT00681629|27012896|P1|Overall Study|Adverse Event|1
7771277|NCT00681629|27012895|P2|Overall Study|Study termination|2
7771278|NCT00681629|27012896|P1|Overall Study|Study termination|4
7771279|NCT00681590|27012942|P2|Overall Study|Withdrawal by Subject|12
7771280|NCT00681590|27012943|P1|Overall Study|Withdrawal by Subject|2
7771281|NCT00681564|27012953|P2|Overall Study|Death|1
7771282|NCT00681564|27012954|P1|Overall Study|Death|0
7771283|NCT00681564|27012953|P2|Overall Study|Withdrawal by Subject|1
7771284|NCT00681564|27012954|P1|Overall Study|Withdrawal by Subject|0
7771285|NCT00681564|27012953|P2|Overall Study|Lost to Follow-up|6
7771286|NCT00681564|27012954|P1|Overall Study|Lost to Follow-up|6
7771287|NCT00681187|27013046|P2|Overall Study|Adverse Event|1
7771288|NCT00681187|27013047|P1|Overall Study|Adverse Event|0
7771289|NCT00681187|27013046|P2|Overall Study|Death|1
7771290|NCT00681187|27013047|P1|Overall Study|Death|0
7771291|NCT00681187|27013046|P2|Overall Study|Withdrawal by Subject|0
7771292|NCT00681187|27013047|P1|Overall Study|Withdrawal by Subject|1
7771293|NCT00681109|27013082|P3|Overall Study|Lost to Follow-up|0
7771294|NCT00681109|27013083|P2|Overall Study|Lost to Follow-up|6
7771295|NCT00681109|27013084|P1|Overall Study|Lost to Follow-up|2
7771296|NCT00680992|27013125|P3|Overall Study|Ineligibility Determined|0
7771297|NCT00680992|27013126|P2|Overall Study|Ineligibility Determined|1
7771298|NCT00680992|27013127|P1|Overall Study|Ineligibility Determined|0
7771299|NCT00680992|27013125|P3|Overall Study|Death|0
7771300|NCT00680992|27013126|P2|Overall Study|Death|1
7771301|NCT00680992|27013127|P1|Overall Study|Death|5
7771302|NCT00680992|27013125|P3|Overall Study|Pregnancy|1
7771303|NCT00680992|27013126|P2|Overall Study|Pregnancy|0
7771304|NCT00680992|27013127|P1|Overall Study|Pregnancy|5
7771305|NCT00680992|27013125|P3|Overall Study|Requirement for Alternative Therapy|0
7771306|NCT00680992|27013126|P2|Overall Study|Requirement for Alternative Therapy|2
7771307|NCT00680992|27013127|P1|Overall Study|Requirement for Alternative Therapy|8
7771308|NCT00680992|27013125|P3|Overall Study|Noncompliance|0
7771309|NCT00680992|27013126|P2|Overall Study|Noncompliance|6
7771310|NCT00680992|27013127|P1|Overall Study|Noncompliance|4
7771311|NCT00680992|27013125|P3|Overall Study|Lost to Follow-up|0
7771312|NCT00680992|27013126|P2|Overall Study|Lost to Follow-up|14
7771313|NCT00680992|27013127|P1|Overall Study|Lost to Follow-up|12
7771314|NCT00680992|27013125|P3|Overall Study|Disease Progression|0
7771315|NCT00680992|27013126|P2|Overall Study|Disease Progression|9
7771316|NCT00680992|27013127|P1|Overall Study|Disease Progression|21
7771317|NCT00680992|27013125|P3|Overall Study|Other|1
7771318|NCT00680992|27013126|P2|Overall Study|Other|14
7771319|NCT00680992|27013127|P1|Overall Study|Other|19
7771320|NCT00680992|27013125|P3|Overall Study|Adverse Event|1
7771321|NCT00680992|27013126|P2|Overall Study|Adverse Event|19
7771322|NCT00680992|27013127|P1|Overall Study|Adverse Event|21
7771323|NCT00680992|27013125|P3|Overall Study|Withdrawal by Subject|1
7771324|NCT00680992|27013126|P2|Overall Study|Withdrawal by Subject|11
7771325|NCT00680992|27013127|P1|Overall Study|Withdrawal by Subject|33
7771326|NCT00680992|27013125|P3|Overall Study|End of Trial|3
7771327|NCT00680992|27013126|P2|Overall Study|End of Trial|12
7771328|NCT00680992|27013127|P1|Overall Study|End of Trial|32
7771329|NCT00680992|27013125|P3|Overall Study|Administrative Decision|5
7771330|NCT00680992|27013126|P2|Overall Study|Administrative Decision|42
7771331|NCT00680992|27013127|P1|Overall Study|Administrative Decision|83
7771332|NCT00680992|27013125|P3|Overall Study|Complete Resection (as per protocol)|0
7771333|NCT00680992|27013126|P2|Overall Study|Complete Resection (as per protocol)|121
7771334|NCT00680992|27013127|P1|Overall Study|Complete Resection (as per protocol)|25
7771335|NCT00680914|27013161|P2|Overall Study|serious adverse event (SAE)|1
7771336|NCT00680914|27013162|P1|Overall Study|serious adverse event (SAE)|0
7771337|NCT00680914|27013161|P2|Overall Study|Lost to Follow-up|0
7771338|NCT00680914|27013162|P1|Overall Study|Lost to Follow-up|4
7771339|NCT00680914|27013161|P2|Overall Study|Consent withdrawal|3
7771340|NCT00680914|27013162|P1|Overall Study|Consent withdrawal|6
7771341|NCT00680901|27013196|P2|Overall Study|Ongoing: In Follow Up|41
7771342|NCT00680901|27013197|P1|Overall Study|Ongoing: In Follow Up|45
7771343|NCT00680901|27013196|P2|Overall Study|Ongoing: On Study Treatment|13
7771344|NCT00680901|27013197|P1|Overall Study|Ongoing: On Study Treatment|16
7771345|NCT00680901|27013196|P2|Overall Study|Physician Decision|1
7771346|NCT00680901|27013197|P1|Overall Study|Physician Decision|0
7771347|NCT00680901|27013196|P2|Overall Study|Withdrawal by Subject|13
7771348|NCT00680901|27013197|P1|Overall Study|Withdrawal by Subject|4
7771349|NCT00680901|27013196|P2|Overall Study|Lost to Follow-up|8
7771350|NCT00680901|27013197|P1|Overall Study|Lost to Follow-up|8
7771351|NCT00680836|27013235|P2|Overall Study|Physician Decision|1
7771352|NCT00680836|27013236|P1|Overall Study|Physician Decision|2
7771353|NCT00680836|27013235|P2|Overall Study|Lost to Follow-up|1
7771354|NCT00680836|27013236|P1|Overall Study|Lost to Follow-up|3
7771355|NCT00680836|27013235|P2|Overall Study|Withdrawal by Subject|0
7771356|NCT00680836|27013236|P1|Overall Study|Withdrawal by Subject|3
7771357|NCT00680771|27013290|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
7771358|NCT00680771|27013291|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
7771359|NCT00680771|27013290|P2|Overall Study|Sleep Apnea suspected after PSG|0
7771360|NCT00680771|27013291|P1|Overall Study|Sleep Apnea suspected after PSG|1
7771361|NCT00680771|27013290|P2|Overall Study|Withdrawal by Subject|0
7771362|NCT00680771|27013291|P1|Overall Study|Withdrawal by Subject|1
7771363|NCT00680745|27013301|P4|Overall Study|False Treatment|0
7771364|NCT00680745|27013302|P3|Overall Study|False Treatment|3
7771365|NCT00680745|27013303|P2|Overall Study|False Treatment|1
7771366|NCT00680745|27013304|P1|Overall Study|False Treatment|0
7771367|NCT00680745|27013301|P4|Overall Study|Subject No Longer Meets Study Criteria|2
7771368|NCT00680745|27013302|P3|Overall Study|Subject No Longer Meets Study Criteria|0
7771369|NCT00680745|27013303|P2|Overall Study|Subject No Longer Meets Study Criteria|2
7771370|NCT00680745|27013304|P1|Overall Study|Subject No Longer Meets Study Criteria|0
7771371|NCT00680745|27013301|P4|Overall Study|Poor/Non-compliance|0
7771372|NCT00680745|27013302|P3|Overall Study|Poor/Non-compliance|0
7771373|NCT00680745|27013303|P2|Overall Study|Poor/Non-compliance|3
7771374|NCT00680745|27013304|P1|Overall Study|Poor/Non-compliance|0
7771375|NCT00680745|27013301|P4|Overall Study|Adverse Event|3
7771376|NCT00680745|27013302|P3|Overall Study|Adverse Event|3
7771377|NCT00680745|27013303|P2|Overall Study|Adverse Event|3
7771378|NCT00680745|27013304|P1|Overall Study|Adverse Event|5
7771379|NCT00680745|27013301|P4|Overall Study|Death|0
7771380|NCT00680745|27013302|P3|Overall Study|Death|1
7771381|NCT00680745|27013303|P2|Overall Study|Death|0
7771382|NCT00680745|27013304|P1|Overall Study|Death|1
7771383|NCT00680745|27013301|P4|Overall Study|Lost to Follow-up|0
7771384|NCT00680745|27013302|P3|Overall Study|Lost to Follow-up|1
7771385|NCT00680745|27013303|P2|Overall Study|Lost to Follow-up|1
7771386|NCT00680745|27013304|P1|Overall Study|Lost to Follow-up|0
7771387|NCT00680745|27013301|P4|Overall Study|Withdrawal by Subject|8
7771388|NCT00680745|27013302|P3|Overall Study|Withdrawal by Subject|2
7771389|NCT00680745|27013303|P2|Overall Study|Withdrawal by Subject|3
7771390|NCT00680745|27013304|P1|Overall Study|Withdrawal by Subject|8
7771391|NCT00680407|27013378|P3|Overall Study|Withdrawal by Subject|2
7771392|NCT00680407|27013379|P2|Overall Study|Withdrawal by Subject|2
7771393|NCT00680407|27013380|P1|Overall Study|Withdrawal by Subject|5
7771394|NCT00680407|27013378|P3|Overall Study|Lost to Follow-up|1
7771395|NCT00680407|27013379|P2|Overall Study|Lost to Follow-up|3
7771396|NCT00680407|27013380|P1|Overall Study|Lost to Follow-up|3
7771397|NCT00680368|27013394|P1|Overall Study|not supervised, not eligible|15
7771398|NCT00680186|27013422|P2|Overall Study|Other|1
7771399|NCT00680186|27013423|P1|Overall Study|Other|4
7771400|NCT00680186|27013422|P2|Overall Study|Withdrawal by Subject|39
7771401|NCT00680186|27013423|P1|Overall Study|Withdrawal by Subject|32
7771402|NCT00680186|27013422|P2|Overall Study|Lost to Follow-up|6
7771403|NCT00680186|27013423|P1|Overall Study|Lost to Follow-up|11
7771404|NCT00680186|27013422|P2|Overall Study|Protocol Violation|26
7771405|NCT00680186|27013423|P1|Overall Study|Protocol Violation|31
7771406|NCT00680186|27013422|P2|Overall Study|Adverse Event|44
7771407|NCT00680186|27013423|P1|Overall Study|Adverse Event|47
7771408|NCT00680121|27013449|P2|Overall Study|Lost to Follow-up|23
7771409|NCT00680121|27013450|P1|Overall Study|Lost to Follow-up|27
7771410|NCT00680056|27013464|P2|Second Intervention|Protocol Violation|1
7771411|NCT00680056|27013465|P1|Second Intervention|Protocol Violation|3
7771412|NCT00680056|27013464|P2|First Intervention|Mainly Exacerbation of COPD|2
7771413|NCT00680056|27013465|P1|First Intervention|Mainly Exacerbation of COPD|1
7771414|NCT00680043|27013476|P3|Overall Study|Renal Transplant|4
7771415|NCT00680043|27013477|P2|Overall Study|Renal Transplant|0
7771416|NCT00680043|27013478|P1|Overall Study|Renal Transplant|1
7771417|NCT00680043|27013476|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
7771418|NCT00680043|27013477|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
7771419|NCT00680043|27013478|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
7771420|NCT00680043|27013476|P3|Overall Study|Withdrawal by Subject|0
7771421|NCT00680043|27013477|P2|Overall Study|Withdrawal by Subject|0
7771422|NCT00680043|27013478|P1|Overall Study|Withdrawal by Subject|1
7771423|NCT00680017|27013494|P2|Overall Study|Lost to Follow-up|0
7771424|NCT00680017|27013495|P1|Overall Study|Lost to Follow-up|2
7771425|NCT00680017|27013494|P2|Overall Study|Withdrawal by Subject|5
7771426|NCT00680017|27013495|P1|Overall Study|Withdrawal by Subject|2
7771427|NCT00680017|27013494|P2|Overall Study|Adverse Event|7
7771428|NCT00680017|27013495|P1|Overall Study|Adverse Event|13
7771429|NCT00679939|27013514|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
7771430|NCT00679939|27013515|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
7771431|NCT00679939|27013514|P2|24-Week Open-Label (OL) Period|Physician Decision|0
7771432|NCT00679939|27013515|P1|24-Week Open-Label (OL) Period|Physician Decision|1
7771433|NCT00679939|27013514|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
7771434|NCT00679939|27013515|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
7771435|NCT00679939|27013514|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
7771436|NCT00679939|27013515|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
7771437|NCT00679939|27013514|P2|24-Week Open-Label (OL) Period|Adverse Event|1
7771438|NCT00679939|27013515|P1|24-Week Open-Label (OL) Period|Adverse Event|0
7771439|NCT00679939|27013514|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
7771440|NCT00679939|27013515|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7771441|NCT00679939|27013514|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
7771442|NCT00679939|27013515|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
7771443|NCT00679939|27013514|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
7771444|NCT00679939|27013515|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
7771445|NCT00679939|27013514|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
7771446|NCT00679939|27013515|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
7771447|NCT00679939|27013514|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
7771448|NCT00679939|27013515|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
7771449|NCT00679913|27013681|P2|Overall Study|Protocol Violation|13
7771450|NCT00679913|27013682|P1|Overall Study|Protocol Violation|18
7771451|NCT00679783|27013697|P7|Overall Study|Ongoing at data cut-off|0
7771452|NCT00679783|27013698|P6|Overall Study|Ongoing at data cut-off|0
7771453|NCT00679783|27013699|P5|Overall Study|Ongoing at data cut-off|1
7771454|NCT00679783|27013700|P4|Overall Study|Ongoing at data cut-off|9
7771455|NCT00679783|27013701|P3|Overall Study|Ongoing at data cut-off|0
7771456|NCT00679783|27013702|P2|Overall Study|Ongoing at data cut-off|2
7771457|NCT00679783|27013703|P1|Overall Study|Ongoing at data cut-off|2
7771458|NCT00679783|27013697|P7|Overall Study|Not Captured|0
7771459|NCT00679783|27013698|P6|Overall Study|Not Captured|0
7771460|NCT00679783|27013699|P5|Overall Study|Not Captured|0
7771461|NCT00679783|27013700|P4|Overall Study|Not Captured|5
7771462|NCT00679783|27013701|P3|Overall Study|Not Captured|0
7771463|NCT00679783|27013702|P2|Overall Study|Not Captured|0
7771464|NCT00679783|27013703|P1|Overall Study|Not Captured|0
7771465|NCT00679783|27013697|P7|Overall Study|Withdrawal by Subject|0
7771466|NCT00679783|27013698|P6|Overall Study|Withdrawal by Subject|0
7771467|NCT00679783|27013699|P5|Overall Study|Withdrawal by Subject|0
7771468|NCT00679783|27013700|P4|Overall Study|Withdrawal by Subject|1
7771469|NCT00679783|27013701|P3|Overall Study|Withdrawal by Subject|1
7771470|NCT00679783|27013702|P2|Overall Study|Withdrawal by Subject|0
7771471|NCT00679783|27013703|P1|Overall Study|Withdrawal by Subject|0
7771472|NCT00679783|27013697|P7|Overall Study|Lack of Efficacy|0
7771473|NCT00679783|27013698|P6|Overall Study|Lack of Efficacy|0
7771474|NCT00679783|27013699|P5|Overall Study|Lack of Efficacy|0
7771475|NCT00679783|27013700|P4|Overall Study|Lack of Efficacy|2
7771476|NCT00679783|27013701|P3|Overall Study|Lack of Efficacy|0
7771477|NCT00679783|27013702|P2|Overall Study|Lack of Efficacy|1
7771478|NCT00679783|27013703|P1|Overall Study|Lack of Efficacy|0
7771479|NCT00679783|27013697|P7|Overall Study|Adverse Event|1
7771480|NCT00679783|27013698|P6|Overall Study|Adverse Event|0
7771481|NCT00679783|27013699|P5|Overall Study|Adverse Event|0
7771482|NCT00679783|27013700|P4|Overall Study|Adverse Event|3
7771483|NCT00679783|27013701|P3|Overall Study|Adverse Event|0
7771484|NCT00679783|27013702|P2|Overall Study|Adverse Event|0
7771485|NCT00679783|27013703|P1|Overall Study|Adverse Event|0
7771486|NCT00679627|27013756|P2|Overall Study|Early Study Closure|405
7771487|NCT00679627|27013757|P1|Overall Study|Early Study Closure|425
7771488|NCT00679627|27013756|P2|Overall Study|Lost to Follow-up|26
7771489|NCT00679627|27013757|P1|Overall Study|Lost to Follow-up|22
7771490|NCT00679627|27013756|P2|Overall Study|Withdrawal by Subject|172
7771491|NCT00679627|27013757|P1|Overall Study|Withdrawal by Subject|168
7771492|NCT00679627|27013756|P2|Overall Study|Adverse Event|53
7771493|NCT00679627|27013757|P1|Overall Study|Adverse Event|43
7771494|NCT00679627|27013756|P2|Overall Study|Death|29
7771495|NCT00679627|27013757|P1|Overall Study|Death|41
7771496|NCT00679549|27013781|P2|Overall Study|missing outcome echocardiograms|5
7771497|NCT00679549|27013782|P1|Overall Study|missing outcome echocardiograms|4
7771498|NCT00679549|27013781|P2|Overall Study|dropout|4
7771499|NCT00679549|27013782|P1|Overall Study|dropout|2
7771500|NCT00679432|27013792|P4|Overall Study|Randomization error, return to prior Rx|0
7771501|NCT00679432|27013793|P3|Overall Study|Randomization error, return to prior Rx|3
7771502|NCT00679432|27013794|P2|Overall Study|Randomization error, return to prior Rx|0
7771503|NCT00679432|27013795|P1|Overall Study|Randomization error, return to prior Rx|0
7771504|NCT00679432|27013792|P4|Overall Study|Infectious colitis, normal histology|3
7771505|NCT00679432|27013793|P3|Overall Study|Infectious colitis, normal histology|8
7771506|NCT00679432|27013794|P2|Overall Study|Infectious colitis, normal histology|4
7771507|NCT00679432|27013795|P1|Overall Study|Infectious colitis, normal histology|5
7771508|NCT00679432|27013792|P4|Overall Study|Lack of Efficacy|8
7771509|NCT00679432|27013793|P3|Overall Study|Lack of Efficacy|14
7771510|NCT00679432|27013794|P2|Overall Study|Lack of Efficacy|9
7771511|NCT00679432|27013795|P1|Overall Study|Lack of Efficacy|13
7771512|NCT00679432|27013792|P4|Overall Study|Sponsor decision|0
7771513|NCT00679432|27013793|P3|Overall Study|Sponsor decision|0
7771514|NCT00679432|27013794|P2|Overall Study|Sponsor decision|0
7771515|NCT00679432|27013795|P1|Overall Study|Sponsor decision|1
7771516|NCT00679432|27013792|P4|Overall Study|Physician Decision|2
7771517|NCT00679432|27013793|P3|Overall Study|Physician Decision|2
7771518|NCT00679432|27013794|P2|Overall Study|Physician Decision|2
7771519|NCT00679432|27013795|P1|Overall Study|Physician Decision|3
7771520|NCT00679432|27013792|P4|Overall Study|Lost to Follow-up|2
7771521|NCT00679432|27013793|P3|Overall Study|Lost to Follow-up|4
7771522|NCT00679432|27013794|P2|Overall Study|Lost to Follow-up|5
7771523|NCT00679432|27013795|P1|Overall Study|Lost to Follow-up|1
7771524|NCT00679432|27013792|P4|Overall Study|Withdrawal by Subject|9
7771525|NCT00679432|27013793|P3|Overall Study|Withdrawal by Subject|10
7771526|NCT00679432|27013794|P2|Overall Study|Withdrawal by Subject|11
7771527|NCT00679432|27013795|P1|Overall Study|Withdrawal by Subject|8
7771528|NCT00679432|27013792|P4|Overall Study|Protocol Violation|1
7771529|NCT00679432|27013793|P3|Overall Study|Protocol Violation|2
7771530|NCT00679432|27013794|P2|Overall Study|Protocol Violation|1
7771531|NCT00679432|27013795|P1|Overall Study|Protocol Violation|1
7771532|NCT00679432|27013792|P4|Overall Study|Adverse Event|7
7771533|NCT00679432|27013793|P3|Overall Study|Adverse Event|10
7771534|NCT00679432|27013794|P2|Overall Study|Adverse Event|6
7771535|NCT00679432|27013795|P1|Overall Study|Adverse Event|5
7771536|NCT00679367|27013838|P1|Overall Study|Withdrawal by Subject|1
7771537|NCT00679367|27013838|P1|Overall Study|Lack of Efficacy|3
7771538|NCT00679367|27013838|P1|Overall Study|inability to swallow oral drugs|1
7771539|NCT00679367|27013838|P1|Overall Study|Adverse Event|7
7771540|NCT00679354|27013844|P1|Overall Study|Ineligible|1
7771541|NCT00679354|27013844|P1|Overall Study|Physician Decision|4
7771542|NCT00679354|27013844|P1|Overall Study|Lack of Efficacy|22
7771543|NCT00679354|27013844|P1|Overall Study|Death|3
7771544|NCT00679341|27013862|P2|Overall Study|Physician/patient decision to withdraw|6
7771545|NCT00679341|27013863|P1|Overall Study|Physician/patient decision to withdraw|0
7771546|NCT00679341|27013862|P2|Overall Study|Not treated|2
7771547|NCT00679341|27013863|P1|Overall Study|Not treated|0
7771548|NCT00679341|27013862|P2|Overall Study|Physician Decision|0
7771549|NCT00679341|27013863|P1|Overall Study|Physician Decision|1
7771550|NCT00679341|27013862|P2|Overall Study|Other|0
7771551|NCT00679341|27013863|P1|Overall Study|Other|1
7771552|NCT00679341|27013862|P2|Overall Study|Death|1
7771553|NCT00679341|27013863|P1|Overall Study|Death|1
7771554|NCT00679341|27013862|P2|Overall Study|Subject/guardian decision to discontinue|0
7771555|NCT00679341|27013863|P1|Overall Study|Subject/guardian decision to discontinue|3
7771556|NCT00679341|27013862|P2|Overall Study|Adverse Event|6
7771557|NCT00679341|27013863|P1|Overall Study|Adverse Event|5
7771558|NCT00679341|27013862|P2|Overall Study|Disease progression|36
7771559|NCT00679341|27013863|P1|Overall Study|Disease progression|42
7771560|NCT00679302|27013883|P2|Overall Study|Lost to Follow-up|4
7771561|NCT00679302|27013884|P1|Overall Study|Lost to Follow-up|8
7771562|NCT00679289|27013895|P3|Overall Study|Physician Decision|1
7771563|NCT00679289|27013896|P2|Overall Study|Physician Decision|0
7771564|NCT00679289|27013897|P1|Overall Study|Physician Decision|1
7771565|NCT00679289|27013895|P3|Overall Study|Adverse Event|3
7771566|NCT00679289|27013896|P2|Overall Study|Adverse Event|0
7771567|NCT00679289|27013897|P1|Overall Study|Adverse Event|0
7771568|NCT00679289|27013895|P3|Overall Study|Withdrawal by Subject|1
7771569|NCT00679289|27013896|P2|Overall Study|Withdrawal by Subject|1
7771570|NCT00679289|27013897|P1|Overall Study|Withdrawal by Subject|0
7771571|NCT00679289|27013895|P3|Overall Study|Progressive disease|18
7771572|NCT00679289|27013896|P2|Overall Study|Progressive disease|5
7771573|NCT00679289|27013897|P1|Overall Study|Progressive disease|4
7771574|NCT00679263|27013919|P3|Visit 2/Dose 1|subject not compliance|0
7771575|NCT00679263|27013920|P2|Visit 2/Dose 1|subject not compliance|1
7771576|NCT00679263|27013921|P1|Visit 2/Dose 1|subject not compliance|1
7771577|NCT00679263|27013919|P3|Visit 2/Dose 1|Adverse Event|0
7771578|NCT00679263|27013920|P2|Visit 2/Dose 1|Adverse Event|0
7771579|NCT00679263|27013921|P1|Visit 2/Dose 1|Adverse Event|1
7771580|NCT00679211|27013932|P1|Overall Study|Other|1
7771581|NCT00679211|27013932|P1|Overall Study|Transferred to extension study TDM4529g|12
7771582|NCT00679211|27013932|P1|Overall Study|Refused to undergo protocol procedures|1
7771583|NCT00679211|27013932|P1|Overall Study|Physician Decision|5
7771584|NCT00679211|27013932|P1|Overall Study|Withdrawal by Subject|2
7771585|NCT00679211|27013932|P1|Overall Study|Adverse Event|7
7771586|NCT00679211|27013932|P1|Overall Study|Progressive disease|82
7771587|NCT00679172|27013949|P5|Overall Study|Other not specified|0
7771588|NCT00679172|27013950|P4|Overall Study|Other not specified|0
7771589|NCT00679172|27013951|P3|Overall Study|Other not specified|1
7771590|NCT00679172|27013952|P2|Overall Study|Other not specified|0
7771591|NCT00679172|27013953|P1|Overall Study|Other not specified|0
7771592|NCT00679172|27013949|P5|Overall Study|Non-compliance|0
7771593|NCT00679172|27013950|P4|Overall Study|Non-compliance|1
7771594|NCT00679172|27013951|P3|Overall Study|Non-compliance|0
7771595|NCT00679172|27013952|P2|Overall Study|Non-compliance|1
7771596|NCT00679172|27013953|P1|Overall Study|Non-compliance|1
7771597|NCT00679081|27014016|P1|Overall Study|Lost to Follow-up|1
7771598|NCT00679055|27014026|P2|Overall Study|Study Terminated|1
7771599|NCT00679055|27014027|P1|Overall Study|Study Terminated|2
7771600|NCT00679055|27014026|P2|Overall Study|Other|3
7771601|NCT00679055|27014027|P1|Overall Study|Other|0
7771602|NCT00679055|27014026|P2|Overall Study|Adverse Event|1
7771603|NCT00679055|27014027|P1|Overall Study|Adverse Event|0
7771604|NCT00679042|27014037|P1|10-Year Follow Up|In follow-up (ongoing)|5
7771605|NCT00679042|27014037|P1|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
7771606|NCT00679042|27014037|P1|5-Year Follow Up|Death|1
7771607|NCT00679042|27014037|P1|5-Year Follow Up|In follow-up (ongoing)|6
7771608|NCT00679042|27014037|P1|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
7771609|NCT00679029|27014045|P1|Overall Study|Lost to Follow-up|1
7771610|NCT00679029|27014045|P1|Overall Study|Withdrawal by Subject|1
7771611|NCT00679029|27014045|P1|Overall Study|Adverse Event|3
7771612|NCT00678899|27014052|P1|Overall Study|Adverse Event|1
7771613|NCT00678886|27014061|P4|Overall Study|Other|0
7771614|NCT00678886|27014062|P3|Overall Study|Other|1
7771615|NCT00678886|27014063|P2|Overall Study|Other|0
7771616|NCT00678886|27014064|P1|Overall Study|Other|0
7771617|NCT00678886|27014061|P4|Overall Study|Lost to Follow-up|2
7771618|NCT00678886|27014062|P3|Overall Study|Lost to Follow-up|3
7771619|NCT00678886|27014063|P2|Overall Study|Lost to Follow-up|0
7771620|NCT00678886|27014064|P1|Overall Study|Lost to Follow-up|0
7771621|NCT00678886|27014061|P4|Overall Study|Physician Decision|1
7771622|NCT00678886|27014062|P3|Overall Study|Physician Decision|1
7771623|NCT00678886|27014063|P2|Overall Study|Physician Decision|0
7771624|NCT00678886|27014064|P1|Overall Study|Physician Decision|0
7771625|NCT00678886|27014061|P4|Overall Study|Withdrawal by Subject|6
7771626|NCT00678886|27014062|P3|Overall Study|Withdrawal by Subject|4
7771627|NCT00678886|27014063|P2|Overall Study|Withdrawal by Subject|0
7771628|NCT00678886|27014064|P1|Overall Study|Withdrawal by Subject|0
7771629|NCT00678795|27014133|P2|Overall Study|Lack of Efficacy|1
7771630|NCT00678795|27014134|P1|Overall Study|Lack of Efficacy|1
7771631|NCT00678795|27014133|P2|Overall Study|Lost to Follow-up|1
7771632|NCT00678795|27014134|P1|Overall Study|Lost to Follow-up|0
7771633|NCT00678795|27014133|P2|Overall Study|Protocol Violation|1
7771634|NCT00678795|27014134|P1|Overall Study|Protocol Violation|0
7771635|NCT00678795|27014133|P2|Overall Study|Withdrawal by Subject|0
7771636|NCT00678795|27014134|P1|Overall Study|Withdrawal by Subject|3
7771637|NCT00678795|27014133|P2|Overall Study|Adverse Event|3
7771638|NCT00678795|27014134|P1|Overall Study|Adverse Event|7
7771639|NCT00678691|27014156|P2|Overall Study|Adverse Event|4
7771640|NCT00678691|27014157|P1|Overall Study|Adverse Event|6
7771641|NCT00678652|27014167|P4|Overall Study|Relocation|0
7771642|NCT00678652|27014168|P3|Overall Study|Relocation|0
7771643|NCT00678652|27014169|P2|Overall Study|Relocation|0
7771644|NCT00678652|27014170|P1|Overall Study|Relocation|1
7771645|NCT00678652|27014167|P4|Overall Study|Pregnancy|0
7771646|NCT00678652|27014168|P3|Overall Study|Pregnancy|1
7771647|NCT00678652|27014169|P2|Overall Study|Pregnancy|0
7771648|NCT00678652|27014170|P1|Overall Study|Pregnancy|0
7771649|NCT00678652|27014167|P4|Overall Study|Protocol Violation|0
7771650|NCT00678652|27014168|P3|Overall Study|Protocol Violation|0
7771651|NCT00678652|27014169|P2|Overall Study|Protocol Violation|0
7771652|NCT00678652|27014170|P1|Overall Study|Protocol Violation|2
7771653|NCT00678639|27014194|P2|Overall Study|Lost to Follow-up at 30 days|0
7771654|NCT00678639|27014195|P1|Overall Study|Lost to Follow-up at 30 days|2
7771655|NCT00678587|27014210|P2|Overall Study|Withdrew Consent|3
7771656|NCT00678587|27014211|P1|Overall Study|Withdrew Consent|8
7771657|NCT00678587|27014210|P2|Overall Study|Investigator Discretion|6
7771658|NCT00678587|27014211|P1|Overall Study|Investigator Discretion|2
7771659|NCT00678587|27014210|P2|Overall Study|Lost to Follow-up|5
7771660|NCT00678587|27014211|P1|Overall Study|Lost to Follow-up|3
7771661|NCT00678587|27014210|P2|Overall Study|Study Closed/Terminated|0
7771662|NCT00678587|27014211|P1|Overall Study|Study Closed/Terminated|1
7771663|NCT00678587|27014210|P2|Overall Study|Protocol Violation|1
7771664|NCT00678587|27014211|P1|Overall Study|Protocol Violation|2
7771665|NCT00678587|27014210|P2|Overall Study|Lack of Efficacy|0
7771666|NCT00678587|27014211|P1|Overall Study|Lack of Efficacy|1
7771667|NCT00678587|27014210|P2|Overall Study|Adverse Event|3
7771668|NCT00678587|27014211|P1|Overall Study|Adverse Event|3
7771669|NCT00678561|27014260|P8|Overall Study|Withdrawal by Subject|1
7771670|NCT00678561|27014261|P7|Overall Study|Withdrawal by Subject|0
7771671|NCT00678561|27014262|P6|Overall Study|Withdrawal by Subject|0
7771672|NCT00678561|27014263|P5|Overall Study|Withdrawal by Subject|0
7771673|NCT00678561|27014264|P4|Overall Study|Withdrawal by Subject|0
7771674|NCT00678561|27014265|P3|Overall Study|Withdrawal by Subject|0
7771675|NCT00678561|27014266|P2|Overall Study|Withdrawal by Subject|0
7771676|NCT00678561|27014267|P1|Overall Study|Withdrawal by Subject|0
7771677|NCT00678561|27014260|P8|Overall Study|Protocol Violation|0
7771678|NCT00678561|27014261|P7|Overall Study|Protocol Violation|0
7771679|NCT00678561|27014262|P6|Overall Study|Protocol Violation|1
7771680|NCT00678561|27014263|P5|Overall Study|Protocol Violation|1
7771681|NCT00678561|27014264|P4|Overall Study|Protocol Violation|0
7771682|NCT00678561|27014265|P3|Overall Study|Protocol Violation|0
7771683|NCT00678561|27014266|P2|Overall Study|Protocol Violation|0
7771684|NCT00678561|27014267|P1|Overall Study|Protocol Violation|0
7771685|NCT00678561|27014260|P8|Overall Study|Adverse Event|0
7771686|NCT00678561|27014261|P7|Overall Study|Adverse Event|0
7771687|NCT00678561|27014262|P6|Overall Study|Adverse Event|0
7771688|NCT00678561|27014263|P5|Overall Study|Adverse Event|1
7771689|NCT00678561|27014264|P4|Overall Study|Adverse Event|0
7771690|NCT00678561|27014265|P3|Overall Study|Adverse Event|1
7771691|NCT00678561|27014266|P2|Overall Study|Adverse Event|1
7771692|NCT00678561|27014267|P1|Overall Study|Adverse Event|0
7771693|NCT00678392|27014384|P2|Overall Study|Other|53
7771694|NCT00678392|27014385|P1|Overall Study|Other|56
7771695|NCT00678392|27014384|P2|Overall Study|Randomized But Not Treated|7
7771696|NCT00678392|27014385|P1|Overall Study|Randomized But Not Treated|2
7771697|NCT00678392|27014384|P2|Overall Study|Withdrawal by Subject|4
7771698|NCT00678392|27014385|P1|Overall Study|Withdrawal by Subject|4
7771699|NCT00678392|27014384|P2|Overall Study|Sponsor's Decision|2
7771700|NCT00678392|27014385|P1|Overall Study|Sponsor's Decision|1
7771701|NCT00678392|27014384|P2|Overall Study|Objective Progression or Relapse|8
7771702|NCT00678392|27014385|P1|Overall Study|Objective Progression or Relapse|3
7771703|NCT00678392|27014384|P2|Overall Study|Lost to Follow-up|13
7771704|NCT00678392|27014385|P1|Overall Study|Lost to Follow-up|15
7771705|NCT00678392|27014384|P2|Overall Study|Death|269
7771706|NCT00678392|27014385|P1|Overall Study|Death|280
7771707|NCT00678392|27014384|P2|Overall Study|Adverse Event|6
7771708|NCT00678392|27014385|P1|Overall Study|Adverse Event|0
7771709|NCT00678379|27014420|P3|Overall Study|Incomplete Data|3
7771710|NCT00678379|27014421|P2|Overall Study|Incomplete Data|3
7771711|NCT00678379|27014422|P1|Overall Study|Incomplete Data|4
7771712|NCT00678379|27014420|P3|Overall Study|Injection performed after tonsillectomy|1
7771713|NCT00678379|27014421|P2|Overall Study|Injection performed after tonsillectomy|0
7771714|NCT00678379|27014422|P1|Overall Study|Injection performed after tonsillectomy|2
7771715|NCT00678301|27014450|P2|Overall Study|Lost to Follow-up|1
7771716|NCT00678301|27014451|P1|Overall Study|Lost to Follow-up|3
7771717|NCT00678301|27014450|P2|Overall Study|Withdrawal by Subject|0
7771718|NCT00678301|27014451|P1|Overall Study|Withdrawal by Subject|4
7771719|NCT00678301|27014450|P2|Overall Study|Adverse Event|0
7771720|NCT00678301|27014451|P1|Overall Study|Adverse Event|1
7771721|NCT00678301|27014450|P2|Overall Study|Non-compliance with study procedures|1
7771722|NCT00678301|27014451|P1|Overall Study|Non-compliance with study procedures|0
7771723|NCT00678288|27014509|P2|Overall Study|Disease progression/recurrence/relapse|1
7771724|NCT00678288|27014510|P1|Overall Study|Disease progression/recurrence/relapse|6
7771725|NCT00678288|27014509|P2|Overall Study|Reason not reported|0
7771726|NCT00678288|27014510|P1|Overall Study|Reason not reported|1
7771727|NCT00678288|27014509|P2|Overall Study|Switch to commercial drug|1
7771728|NCT00678288|27014510|P1|Overall Study|Switch to commercial drug|0
7771729|NCT00678288|27014509|P2|Overall Study|Not compliant with study medication|1
7771730|NCT00678288|27014510|P1|Overall Study|Not compliant with study medication|0
7771731|NCT00678288|27014509|P2|Overall Study|Study terminated by the sponsor|0
7771732|NCT00678288|27014510|P1|Overall Study|Study terminated by the sponsor|2
7771733|NCT00678288|27014509|P2|Overall Study|Withdrawal by Subject|1
7771734|NCT00678288|27014510|P1|Overall Study|Withdrawal by Subject|1
7771735|NCT00678288|27014509|P2|Overall Study|Adverse Event|2
7771736|NCT00678288|27014510|P1|Overall Study|Adverse Event|0
7771737|NCT00678210|27014565|P4|Overall Study|Other|0
7771738|NCT00678210|27014566|P3|Overall Study|Other|1
7771739|NCT00678210|27014567|P2|Overall Study|Other|0
7771740|NCT00678210|27014568|P1|Overall Study|Other|1
7771741|NCT00678210|27014565|P4|Overall Study|Withdrawal by Subject|7
7771742|NCT00678210|27014566|P3|Overall Study|Withdrawal by Subject|1
7771743|NCT00678210|27014567|P2|Overall Study|Withdrawal by Subject|4
7771744|NCT00678210|27014568|P1|Overall Study|Withdrawal by Subject|3
7771745|NCT00678210|27014565|P4|Overall Study|Lost to Follow-up|1
7771746|NCT00678210|27014566|P3|Overall Study|Lost to Follow-up|0
7771747|NCT00678210|27014567|P2|Overall Study|Lost to Follow-up|2
7771748|NCT00678210|27014568|P1|Overall Study|Lost to Follow-up|4
7771749|NCT00678210|27014565|P4|Overall Study|Lack of Efficacy|9
7771750|NCT00678210|27014566|P3|Overall Study|Lack of Efficacy|1
7771751|NCT00678210|27014567|P2|Overall Study|Lack of Efficacy|3
7771752|NCT00678210|27014568|P1|Overall Study|Lack of Efficacy|2
7771753|NCT00678210|27014565|P4|Overall Study|Adverse Event|3
7771754|NCT00678210|27014566|P3|Overall Study|Adverse Event|3
7771755|NCT00678210|27014567|P2|Overall Study|Adverse Event|2
7771756|NCT00678210|27014568|P1|Overall Study|Adverse Event|1
7771757|NCT00678080|27014604|P2|Overall Study|Withdrawal by Subject|1
7771758|NCT00678080|27014605|P1|Overall Study|Withdrawal by Subject|0
7771759|NCT00678080|27014604|P2|Overall Study|Lost to Follow-up|0
7771760|NCT00678080|27014605|P1|Overall Study|Lost to Follow-up|1
7771761|NCT00678080|27014604|P2|Overall Study|Physician Decision|0
7771762|NCT00678080|27014605|P1|Overall Study|Physician Decision|2
7771763|NCT00678041|27014631|P2|Overall Study|Physician Decision|5
7771764|NCT00678041|27014632|P1|Overall Study|Physician Decision|5
7771765|NCT00677833|27014685|P4|Overall Study|Lost to Follow-up|0
7771766|NCT00677833|27014686|P3|Overall Study|Lost to Follow-up|1
7771767|NCT00677833|27014687|P2|Overall Study|Lost to Follow-up|0
7771768|NCT00677833|27014688|P1|Overall Study|Lost to Follow-up|0
7771769|NCT00677833|27014685|P4|Overall Study|Withdrawal by Subject|3
7771770|NCT00677833|27014686|P3|Overall Study|Withdrawal by Subject|1
7771771|NCT00677833|27014687|P2|Overall Study|Withdrawal by Subject|0
7771772|NCT00677833|27014688|P1|Overall Study|Withdrawal by Subject|4
7771773|NCT00677820|27014738|P2|Overall Study|Lost to Follow-up|0
7771774|NCT00677820|27014739|P1|Overall Study|Lost to Follow-up|1
7771775|NCT00677807|27014760|P3|Overall Study|Protocol Deviation|0
7771776|NCT00677807|27014761|P2|Overall Study|Protocol Deviation|3
7771777|NCT00677807|27014762|P1|Overall Study|Protocol Deviation|1
7771778|NCT00677807|27014760|P3|Overall Study|Death|1
7771779|NCT00677807|27014761|P2|Overall Study|Death|1
7771780|NCT00677807|27014762|P1|Overall Study|Death|0
7771781|NCT00677807|27014760|P3|Overall Study|Administrative problems|2
7771782|NCT00677807|27014761|P2|Overall Study|Administrative problems|1
7771783|NCT00677807|27014762|P1|Overall Study|Administrative problems|1
7771784|NCT00677807|27014760|P3|Overall Study|Lost to Follow-up|2
7771785|NCT00677807|27014761|P2|Overall Study|Lost to Follow-up|2
7771786|NCT00677807|27014762|P1|Overall Study|Lost to Follow-up|2
7771787|NCT00677807|27014760|P3|Overall Study|Withdrawal by Subject|6
7771788|NCT00677807|27014761|P2|Overall Study|Withdrawal by Subject|3
7771789|NCT00677807|27014762|P1|Overall Study|Withdrawal by Subject|10
7771790|NCT00677807|27014760|P3|Overall Study|Participant no longer needs study drug|1
7771791|NCT00677807|27014761|P2|Overall Study|Participant no longer needs study drug|0
7771792|NCT00677807|27014762|P1|Overall Study|Participant no longer needs study drug|0
7771793|NCT00677807|27014760|P3|Overall Study|Lack of Efficacy|2
7771794|NCT00677807|27014761|P2|Overall Study|Lack of Efficacy|0
7771795|NCT00677807|27014762|P1|Overall Study|Lack of Efficacy|0
7771796|NCT00677807|27014760|P3|Overall Study|Adverse Event|6
7771797|NCT00677807|27014761|P2|Overall Study|Adverse Event|1
7771798|NCT00677807|27014762|P1|Overall Study|Adverse Event|4
7771799|NCT00677534|27014808|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
7771800|NCT00677534|27014808|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
7771801|NCT00677534|27014808|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
7771802|NCT00677365|27014816|P4|Overall Study|Other reason|1
7771803|NCT00677365|27014817|P3|Overall Study|Other reason|0
7771804|NCT00677365|27014818|P2|Overall Study|Other reason|0
7771805|NCT00677365|27014819|P1|Overall Study|Other reason|0
7771806|NCT00677365|27014816|P4|Overall Study|Withdrawal by Subject|0
7771807|NCT00677365|27014817|P3|Overall Study|Withdrawal by Subject|1
7771808|NCT00677365|27014818|P2|Overall Study|Withdrawal by Subject|0
7771809|NCT00677365|27014819|P1|Overall Study|Withdrawal by Subject|0
7771810|NCT00677365|27014816|P4|Overall Study|Adverse Event|2
7771811|NCT00677365|27014817|P3|Overall Study|Adverse Event|1
7771812|NCT00677365|27014818|P2|Overall Study|Adverse Event|1
7771813|NCT00677365|27014819|P1|Overall Study|Adverse Event|2
7771814|NCT00677352|27014851|P2|Tapering Phase|Job transfer|1
7771815|NCT00677352|27014852|P1|Tapering Phase|Job transfer|0
7771816|NCT00677352|27014851|P2|Tapering Phase|Pregnancy|1
7771817|NCT00677352|27014852|P1|Tapering Phase|Pregnancy|0
7771818|NCT00677352|27014851|P2|Tapering Phase|Withdrawal by Subject|3
7771819|NCT00677352|27014852|P1|Tapering Phase|Withdrawal by Subject|5
7771820|NCT00677352|27014851|P2|Tapering Phase|Adverse Event|5
7771821|NCT00677352|27014852|P1|Tapering Phase|Adverse Event|1
7771822|NCT00677352|27014851|P2|Treatment Phase|Not treated|2
7771823|NCT00677352|27014852|P1|Treatment Phase|Not treated|0
7771824|NCT00677352|27014851|P2|Treatment Phase|Transference or work related matter|5
7771825|NCT00677352|27014852|P1|Treatment Phase|Transference or work related matter|0
7771826|NCT00677352|27014851|P2|Treatment Phase|Protocol Violation|1
7771827|NCT00677352|27014852|P1|Treatment Phase|Protocol Violation|1
7771828|NCT00677352|27014851|P2|Treatment Phase|Pregnancy|1
7771829|NCT00677352|27014852|P1|Treatment Phase|Pregnancy|0
7771830|NCT00677352|27014851|P2|Treatment Phase|Physician Decision|0
7771831|NCT00677352|27014852|P1|Treatment Phase|Physician Decision|1
7771832|NCT00677352|27014851|P2|Treatment Phase|Withdrawal by Subject|7
7771833|NCT00677352|27014852|P1|Treatment Phase|Withdrawal by Subject|7
7771834|NCT00677352|27014851|P2|Treatment Phase|Lost to Follow-up|1
7771835|NCT00677352|27014852|P1|Treatment Phase|Lost to Follow-up|0
7771836|NCT00677352|27014851|P2|Treatment Phase|Lack of Efficacy|3
7771837|NCT00677352|27014852|P1|Treatment Phase|Lack of Efficacy|2
7771838|NCT00677352|27014851|P2|Treatment Phase|Adverse Event|22
7771839|NCT00677352|27014852|P1|Treatment Phase|Adverse Event|14
7771840|NCT00677235|27014872|P2|Overall Study|Adverse Experience|0
7771841|NCT00677235|27014873|P1|Overall Study|Adverse Experience|1
7771842|NCT00677235|27014872|P2|Overall Study|Death|36
7771843|NCT00677235|27014873|P1|Overall Study|Death|37
7771844|NCT00677235|27014872|P2|Overall Study|Lost to Follow-up|1
7771845|NCT00677235|27014873|P1|Overall Study|Lost to Follow-up|2
7771846|NCT00677235|27014872|P2|Overall Study|Withdrawal by Subject|1
7771847|NCT00677235|27014873|P1|Overall Study|Withdrawal by Subject|1
7771848|NCT00677092|27014913|P1|Overall Study|Death Prior to Receiving Treatment|1
7771849|NCT00677092|27014913|P1|Overall Study|Withdrawal by Subject|3
7771850|NCT00677092|27014913|P1|Overall Study|Lost to Follow-up|1
7771851|NCT00677092|27014913|P1|Overall Study|Adverse Event|1
7771852|NCT00677014|27014930|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
7771853|NCT00677014|27014931|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
7771854|NCT00677014|27014932|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
7771855|NCT00677014|27014930|P3|Overall Study|Death|7
7771856|NCT00677014|27014931|P2|Overall Study|Death|15
7771857|NCT00677014|27014932|P1|Overall Study|Death|6
7771858|NCT00677014|27014930|P3|Overall Study|Lost to Follow-up|24
7771859|NCT00677014|27014931|P2|Overall Study|Lost to Follow-up|12
7771860|NCT00677014|27014932|P1|Overall Study|Lost to Follow-up|20
7771861|NCT00676715|27014985|P4|Overall Study|Participants Ongoing|24
7771862|NCT00676715|27014986|P3|Overall Study|Participants Ongoing|17
7771863|NCT00676715|27014987|P2|Overall Study|Participants Ongoing|29
7771864|NCT00676715|27014988|P1|Overall Study|Participants Ongoing|29
7771865|NCT00676715|27014985|P4|Overall Study|Adverse Event|0
7771866|NCT00676715|27014986|P3|Overall Study|Adverse Event|2
7771867|NCT00676715|27014987|P2|Overall Study|Adverse Event|1
7771868|NCT00676715|27014988|P1|Overall Study|Adverse Event|0
7771869|NCT00676715|27014985|P4|Overall Study|Death|0
7771870|NCT00676715|27014986|P3|Overall Study|Death|1
7771871|NCT00676715|27014987|P2|Overall Study|Death|1
7771872|NCT00676715|27014988|P1|Overall Study|Death|1
7771873|NCT00676715|27014985|P4|Overall Study|Lost to Follow-up|3
7771874|NCT00676715|27014986|P3|Overall Study|Lost to Follow-up|7
7771875|NCT00676715|27014987|P2|Overall Study|Lost to Follow-up|1
7771876|NCT00676715|27014988|P1|Overall Study|Lost to Follow-up|1
7771877|NCT00676715|27014985|P4|Overall Study|Other|3
7771878|NCT00676715|27014986|P3|Overall Study|Other|4
7771879|NCT00676715|27014987|P2|Overall Study|Other|6
7771880|NCT00676715|27014988|P1|Overall Study|Other|2
7771881|NCT00676715|27014985|P4|Overall Study|Withdrawal by Subject|10
7771882|NCT00676715|27014986|P3|Overall Study|Withdrawal by Subject|10
7771883|NCT00676715|27014987|P2|Overall Study|Withdrawal by Subject|9
7771884|NCT00676715|27014988|P1|Overall Study|Withdrawal by Subject|7
7771885|NCT00676689|27015018|P1|Overall Study|Continuing FU|49
7771886|NCT00676689|27015018|P1|Overall Study|Withdrawal by Subject|3
7771887|NCT00676689|27015018|P1|Overall Study|Physician Decision|1
7771888|NCT00676689|27015018|P1|Overall Study|Lost to Follow-up|4
7771889|NCT00676689|27015018|P1|Overall Study|Death|2
7771890|NCT00676689|27015018|P1|Overall Study|Screen Failure|2
7771891|NCT00676663|27015030|P2|Overall Study|Lost to Follow-up|3
7771892|NCT00676663|27015031|P1|Overall Study|Lost to Follow-up|1
7771893|NCT00676663|27015030|P2|Overall Study|Withdrew Consent|8
7771894|NCT00676663|27015031|P1|Overall Study|Withdrew Consent|1
7771895|NCT00676663|27015030|P2|Overall Study|Death|27
7771896|NCT00676663|27015031|P1|Overall Study|Death|43
7771897|NCT00676650|27015047|P2|Overall Study|Randomized but not treated|4
7771898|NCT00676650|27015048|P1|Overall Study|Randomized but not treated|3
7771899|NCT00676650|27015047|P2|Overall Study|Withdrawal by Subject|24
7771900|NCT00676650|27015048|P1|Overall Study|Withdrawal by Subject|48
7771901|NCT00676650|27015047|P2|Overall Study|Study terminated by sponsor|43
7771902|NCT00676650|27015048|P1|Overall Study|Study terminated by sponsor|57
7771903|NCT00676650|27015047|P2|Overall Study|Protocol Violation|1
7771904|NCT00676650|27015048|P1|Overall Study|Protocol Violation|3
7771905|NCT00676650|27015047|P2|Overall Study|Other|10
7771906|NCT00676650|27015048|P1|Overall Study|Other|14
7771907|NCT00676650|27015047|P2|Overall Study|Objective progression or relapse|140
7771908|NCT00676650|27015048|P1|Overall Study|Objective progression or relapse|189
7771909|NCT00676650|27015047|P2|Overall Study|Lost to Follow-up|1
7771910|NCT00676650|27015048|P1|Overall Study|Lost to Follow-up|0
7771911|NCT00676650|27015047|P2|Overall Study|Global deterioration of health status|31
7771912|NCT00676650|27015048|P1|Overall Study|Global deterioration of health status|66
7771913|NCT00676650|27015047|P2|Overall Study|Adverse Event|21
7771914|NCT00676650|27015048|P1|Overall Study|Adverse Event|159
7771915|NCT00676650|27015047|P2|Overall Study|Death|14
7771916|NCT00676650|27015048|P1|Overall Study|Death|45
7771917|NCT00676520|27015090|P1|Overall Study|Other Reason|18
7771918|NCT00676520|27015090|P1|Overall Study|Ineligible for Randomization to DAPT|209
7771919|NCT00676520|27015090|P1|Overall Study|Physician Decision|20
7771920|NCT00676520|27015090|P1|Overall Study|Death|159
7771921|NCT00676520|27015090|P1|Overall Study|Lost to Follow-up|162
7771922|NCT00676520|27015090|P1|Overall Study|Withdrawal by Subject|163
7771923|NCT00676494|27015147|P1|Overall Study|Withdrawal by Subject|6
7771924|NCT00676494|27015147|P1|Overall Study|Missed Visit|8
7771925|NCT00676403|27015164|P6|Overall Study|Withdrawal by Subject|1
7771926|NCT00676403|27015165|P5|Overall Study|Withdrawal by Subject|0
7771927|NCT00676403|27015166|P4|Overall Study|Withdrawal by Subject|0
7771928|NCT00676403|27015167|P3|Overall Study|Withdrawal by Subject|0
7771929|NCT00676403|27015168|P2|Overall Study|Withdrawal by Subject|0
7771930|NCT00676403|27015169|P1|Overall Study|Withdrawal by Subject|0
7771931|NCT00676403|27015164|P6|Overall Study|Reason Unspecified|1
7771932|NCT00676403|27015165|P5|Overall Study|Reason Unspecified|0
7771933|NCT00676403|27015166|P4|Overall Study|Reason Unspecified|0
7771934|NCT00676403|27015167|P3|Overall Study|Reason Unspecified|1
7771935|NCT00676403|27015168|P2|Overall Study|Reason Unspecified|0
7771936|NCT00676403|27015169|P1|Overall Study|Reason Unspecified|1
7771937|NCT00676403|27015164|P6|Overall Study|Lost to Follow-up|1
7771938|NCT00676403|27015165|P5|Overall Study|Lost to Follow-up|0
7771939|NCT00676403|27015166|P4|Overall Study|Lost to Follow-up|0
7771940|NCT00676403|27015167|P3|Overall Study|Lost to Follow-up|0
7771941|NCT00676403|27015168|P2|Overall Study|Lost to Follow-up|0
7771942|NCT00676403|27015169|P1|Overall Study|Lost to Follow-up|0
7771943|NCT00676403|27015164|P6|Overall Study|Adverse Event|2
7771944|NCT00676403|27015165|P5|Overall Study|Adverse Event|1
7771945|NCT00676403|27015166|P4|Overall Study|Adverse Event|5
7771946|NCT00676403|27015167|P3|Overall Study|Adverse Event|0
7771947|NCT00676403|27015168|P2|Overall Study|Adverse Event|2
7771948|NCT00676403|27015169|P1|Overall Study|Adverse Event|1
7771949|NCT00676338|27015312|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7771950|NCT00676338|27015313|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
7771951|NCT00676338|27015314|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7771952|NCT00676338|27015315|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7771953|NCT00676338|27015312|P4|Overall Study|Entry Criteria Not Met|1
7771954|NCT00676338|27015313|P3|Overall Study|Entry Criteria Not Met|1
7771955|NCT00676338|27015314|P2|Overall Study|Entry Criteria Not Met|2
7771956|NCT00676338|27015315|P1|Overall Study|Entry Criteria Not Met|0
7771957|NCT00676338|27015312|P4|Overall Study|Withdrawal by Subject|6
7771958|NCT00676338|27015313|P3|Overall Study|Withdrawal by Subject|12
7771959|NCT00676338|27015314|P2|Overall Study|Withdrawal by Subject|9
7771960|NCT00676338|27015315|P1|Overall Study|Withdrawal by Subject|17
7771961|NCT00676338|27015312|P4|Overall Study|Protocol Violation|5
7771962|NCT00676338|27015313|P3|Overall Study|Protocol Violation|2
7771963|NCT00676338|27015314|P2|Overall Study|Protocol Violation|9
7771964|NCT00676338|27015315|P1|Overall Study|Protocol Violation|5
7771965|NCT00676338|27015312|P4|Overall Study|Physician Decision|3
7771966|NCT00676338|27015313|P3|Overall Study|Physician Decision|2
7771967|NCT00676338|27015314|P2|Overall Study|Physician Decision|3
7771968|NCT00676338|27015315|P1|Overall Study|Physician Decision|3
7771969|NCT00676338|27015312|P4|Overall Study|Lost to Follow-up|4
7771970|NCT00676338|27015313|P3|Overall Study|Lost to Follow-up|3
7771971|NCT00676338|27015314|P2|Overall Study|Lost to Follow-up|1
7771972|NCT00676338|27015315|P1|Overall Study|Lost to Follow-up|4
7771973|NCT00676338|27015312|P4|Overall Study|Adverse Event|1
7771974|NCT00676338|27015313|P3|Overall Study|Adverse Event|5
7771975|NCT00676338|27015314|P2|Overall Study|Adverse Event|6
7771976|NCT00676338|27015315|P1|Overall Study|Adverse Event|6
7771977|NCT00676208|27015367|P2|Overall Study|Incomplete data|4
7771978|NCT00676208|27015368|P1|Overall Study|Incomplete data|2
7771979|NCT00676208|27015367|P2|Overall Study|Lost to Follow-up|2
7771980|NCT00676208|27015368|P1|Overall Study|Lost to Follow-up|0
7771981|NCT00676195|27015376|P1|Overall Study|Physician Decision|1
7771982|NCT00676195|27015376|P1|Overall Study|Adverse Event|1
7771983|NCT00676195|27015376|P1|Overall Study|Lost to Follow-up|1
7771984|NCT00676143|27015401|P2|Overall Study|Vasogenic edema recurrence|3
7771985|NCT00676143|27015402|P1|Overall Study|Vasogenic edema recurrence|1
7771986|NCT00676143|27015401|P2|Overall Study|Participant participation unknown|4
7771987|NCT00676143|27015402|P1|Overall Study|Participant participation unknown|1
7771988|NCT00676143|27015401|P2|Overall Study|Other|20
7771989|NCT00676143|27015402|P1|Overall Study|Other|11
7771990|NCT00676143|27015401|P2|Overall Study|Loss of caregiver|3
7771991|NCT00676143|27015402|P1|Overall Study|Loss of caregiver|5
7771992|NCT00676143|27015401|P2|Overall Study|Failed to return|1
7771993|NCT00676143|27015402|P1|Overall Study|Failed to return|2
7771994|NCT00676143|27015401|P2|Overall Study|Discontinuation of study by sponsor|88
7771995|NCT00676143|27015402|P1|Overall Study|Discontinuation of study by sponsor|65
7771996|NCT00676143|27015401|P2|Overall Study|Withdrawal by Subject|42
7771997|NCT00676143|27015402|P1|Overall Study|Withdrawal by Subject|24
7771998|NCT00676143|27015401|P2|Overall Study|Protocol Violation|8
7771999|NCT00676143|27015402|P1|Overall Study|Protocol Violation|4
7772000|NCT00676143|27015401|P2|Overall Study|Physician Decision|8
7772001|NCT00676143|27015402|P1|Overall Study|Physician Decision|5
7772002|NCT00676143|27015401|P2|Overall Study|Lost to Follow-up|13
7772003|NCT00676143|27015402|P1|Overall Study|Lost to Follow-up|0
7772004|NCT00676143|27015401|P2|Overall Study|Lack of Efficacy|6
7772005|NCT00676143|27015402|P1|Overall Study|Lack of Efficacy|0
7772006|NCT00676143|27015401|P2|Overall Study|Death|4
7772007|NCT00676143|27015402|P1|Overall Study|Death|4
7772008|NCT00676143|27015401|P2|Overall Study|Adverse Event|60
7772009|NCT00676143|27015402|P1|Overall Study|Adverse Event|34
7772010|NCT00676130|27015442|P2|Overall Study|Withdrawal by Subject|1
7772011|NCT00676130|27015443|P1|Overall Study|Withdrawal by Subject|0
7772012|NCT00676130|27015442|P2|Overall Study|Found ineligible|2
7772013|NCT00676130|27015443|P1|Overall Study|Found ineligible|3
7772014|NCT00676130|27015442|P2|Overall Study|Lost to Follow-up|1
7772015|NCT00676130|27015443|P1|Overall Study|Lost to Follow-up|0
7772016|NCT00676091|27015453|P2|Toddler Dose|Parent or legal guardian request|0
7772017|NCT00676091|27015454|P1|Toddler Dose|Parent or legal guardian request|1
7772018|NCT00676091|27015453|P2|Toddler Dose|Failed to return|0
7772019|NCT00676091|27015454|P1|Toddler Dose|Failed to return|2
7772020|NCT00676091|27015453|P2|After Infant Series|Failed to return|1
7772021|NCT00676091|27015454|P1|After Infant Series|Failed to return|1
7772022|NCT00676091|27015453|P2|After Infant Series|Protocol Violation|1
7772023|NCT00676091|27015454|P1|After Infant Series|Protocol Violation|0
7772024|NCT00676091|27015453|P2|After Infant Series|Adverse Event|1
7772025|NCT00676091|27015454|P1|After Infant Series|Adverse Event|0
7772026|NCT00676091|27015453|P2|Infant Series|Died prior to receiving 7vPnC|1
7772027|NCT00676091|27015454|P1|Infant Series|Died prior to receiving 7vPnC|0
7772028|NCT00676091|27015453|P2|Infant Series|Lost to Follow-up|0
7772029|NCT00676091|27015454|P1|Infant Series|Lost to Follow-up|1
7772030|NCT00676091|27015453|P2|Infant Series|Failed to return|3
7772031|NCT00676091|27015454|P1|Infant Series|Failed to return|1
7772032|NCT00676091|27015453|P2|Infant Series|Adverse Event|3
7772033|NCT00676091|27015454|P1|Infant Series|Adverse Event|2
7772034|NCT00676091|27015453|P2|Infant Series|Protocol Violation|3
7772035|NCT00676091|27015454|P1|Infant Series|Protocol Violation|6
7772036|NCT00676091|27015453|P2|Infant Series|Parent or legal guardian request|8
7772037|NCT00676091|27015454|P1|Infant Series|Parent or legal guardian request|10
7772038|NCT00676052|27015511|P6|Overall Study|Withdrawal by Subject|0
7772039|NCT00676052|27015512|P5|Overall Study|Withdrawal by Subject|0
7772040|NCT00676052|27015513|P4|Overall Study|Withdrawal by Subject|0
7772041|NCT00676052|27015514|P3|Overall Study|Withdrawal by Subject|1
7772042|NCT00676052|27015515|P2|Overall Study|Withdrawal by Subject|0
7772043|NCT00676052|27015516|P1|Overall Study|Withdrawal by Subject|1
7772044|NCT00676052|27015511|P6|Overall Study|Physician Decision|1
7772045|NCT00676052|27015512|P5|Overall Study|Physician Decision|0
7772046|NCT00676052|27015513|P4|Overall Study|Physician Decision|0
7772047|NCT00676052|27015514|P3|Overall Study|Physician Decision|1
7772048|NCT00676052|27015515|P2|Overall Study|Physician Decision|1
7772049|NCT00676052|27015516|P1|Overall Study|Physician Decision|1
7772050|NCT00676052|27015511|P6|Overall Study|Lost to Follow-up|0
7772051|NCT00676052|27015512|P5|Overall Study|Lost to Follow-up|1
7772052|NCT00676052|27015513|P4|Overall Study|Lost to Follow-up|0
7772053|NCT00676052|27015514|P3|Overall Study|Lost to Follow-up|0
7772054|NCT00676052|27015515|P2|Overall Study|Lost to Follow-up|0
7772055|NCT00676052|27015516|P1|Overall Study|Lost to Follow-up|0
7772056|NCT00676052|27015511|P6|Overall Study|Protocol Violation|2
7772057|NCT00676052|27015512|P5|Overall Study|Protocol Violation|1
7772058|NCT00676052|27015513|P4|Overall Study|Protocol Violation|2
7772059|NCT00676052|27015514|P3|Overall Study|Protocol Violation|2
7772060|NCT00676052|27015515|P2|Overall Study|Protocol Violation|3
7772061|NCT00676052|27015516|P1|Overall Study|Protocol Violation|5
7772062|NCT00676052|27015511|P6|Overall Study|Lack of Efficacy|1
7772063|NCT00676052|27015512|P5|Overall Study|Lack of Efficacy|2
7772064|NCT00676052|27015513|P4|Overall Study|Lack of Efficacy|1
7772065|NCT00676052|27015514|P3|Overall Study|Lack of Efficacy|1
7772066|NCT00676052|27015515|P2|Overall Study|Lack of Efficacy|2
7772067|NCT00676052|27015516|P1|Overall Study|Lack of Efficacy|2
7772068|NCT00676052|27015511|P6|Overall Study|Adverse Event|2
7772069|NCT00676052|27015512|P5|Overall Study|Adverse Event|2
7772070|NCT00676052|27015513|P4|Overall Study|Adverse Event|2
7772071|NCT00676052|27015514|P3|Overall Study|Adverse Event|1
7772072|NCT00676052|27015515|P2|Overall Study|Adverse Event|1
7772073|NCT00676052|27015516|P1|Overall Study|Adverse Event|0
7772074|NCT00675948|27015586|P2|Overall Study|Patient feels unable to take medication|1
7772075|NCT00675948|27015587|P1|Overall Study|Patient feels unable to take medication|0
7772076|NCT00675948|27015586|P2|Overall Study|Patient unable to comply with diaries|0
7772077|NCT00675948|27015587|P1|Overall Study|Patient unable to comply with diaries|1
7772078|NCT00675948|27015586|P2|Overall Study|Patient died|0
7772079|NCT00675948|27015587|P1|Overall Study|Patient died|1
7772080|NCT00675948|27015586|P2|Overall Study|Sponsor decision|1
7772081|NCT00675948|27015587|P1|Overall Study|Sponsor decision|0
7772082|NCT00675948|27015586|P2|Overall Study|Pain under control|0
7772083|NCT00675948|27015587|P1|Overall Study|Pain under control|1
7772084|NCT00675948|27015586|P2|Overall Study|Protocol Violation|0
7772085|NCT00675948|27015587|P1|Overall Study|Protocol Violation|1
7772086|NCT00675948|27015586|P2|Overall Study|Lost to Follow-up|0
7772087|NCT00675948|27015587|P1|Overall Study|Lost to Follow-up|2
7772088|NCT00675948|27015586|P2|Overall Study|Withdrawal by Subject|0
7772089|NCT00675948|27015587|P1|Overall Study|Withdrawal by Subject|7
7772090|NCT00675948|27015586|P2|Overall Study|Lack of Efficacy|0
7772091|NCT00675948|27015587|P1|Overall Study|Lack of Efficacy|3
7772092|NCT00675948|27015586|P2|Overall Study|Adverse Event|1
7772093|NCT00675948|27015587|P1|Overall Study|Adverse Event|23
7772094|NCT00675766|27015650|P4|Overall Study|Lost to Follow-up|26
7772095|NCT00675766|27015651|P3|Overall Study|Lost to Follow-up|21
7772096|NCT00675766|27015652|P2|Overall Study|Lost to Follow-up|5
7772097|NCT00675766|27015653|P1|Overall Study|Lost to Follow-up|6
7772098|NCT00675597|27015663|P1|Overall Study|Withdrawal by Subject|3
7772099|NCT00675506|27015717|P2|Overall Study|Schedule conflict|1
7772100|NCT00675506|27015718|P1|Overall Study|Schedule conflict|0
7772101|NCT00675506|27015717|P2|Overall Study|Declined participation|0
7772102|NCT00675506|27015718|P1|Overall Study|Declined participation|1
7772103|NCT00675506|27015717|P2|Overall Study|Disclosed history of cancer|0
7772104|NCT00675506|27015718|P1|Overall Study|Disclosed history of cancer|1
7772105|NCT00675506|27015717|P2|Overall Study|Hypersensitivity Reaction|0
7772106|NCT00675506|27015718|P1|Overall Study|Hypersensitivity Reaction|1
7772107|NCT00675506|27015717|P2|Overall Study|Elevated IGF-1|0
7772108|NCT00675506|27015718|P1|Overall Study|Elevated IGF-1|2
7772109|NCT00675506|27015717|P2|Overall Study|Elevated IGF-1 prior to treatment|0
7772110|NCT00675506|27015718|P1|Overall Study|Elevated IGF-1 prior to treatment|1
7772111|NCT00675506|27015717|P2|Overall Study|Elevated fasting glucose|1
7772112|NCT00675506|27015718|P1|Overall Study|Elevated fasting glucose|2
7772113|NCT00675506|27015717|P2|Overall Study|Lost interest|5
7772114|NCT00675506|27015718|P1|Overall Study|Lost interest|3
7772115|NCT00675506|27015717|P2|Overall Study|Lost to Follow-up|5
7772116|NCT00675506|27015718|P1|Overall Study|Lost to Follow-up|1
7772117|NCT00675441|27015734|P1|Overall Study|Death|1
7772118|NCT00675441|27015734|P1|Overall Study|Withdrawal by Subject|2
7772119|NCT00675428|27015740|P2|Overall Study|Physician Decision|0
7772120|NCT00675428|27015741|P1|Overall Study|Physician Decision|1
7772121|NCT00675428|27015740|P2|Overall Study|No Disease Response After Cycle 6|1
7772122|NCT00675428|27015741|P1|Overall Study|No Disease Response After Cycle 6|0
7772123|NCT00675428|27015740|P2|Overall Study|Disease Progression|2
7772124|NCT00675428|27015741|P1|Overall Study|Disease Progression|2
7772125|NCT00675103|27015783|P1|Overall Study|Adverse Event|1
7772126|NCT00675103|27015783|P1|Overall Study|Lack of Efficacy|2
7772127|NCT00675025|27015790|P2|Overall Study|Withdrawal by Subject|6
7772128|NCT00675025|27015791|P1|Overall Study|Withdrawal by Subject|4
7772129|NCT00675025|27015790|P2|Overall Study|Lost to Follow-up|4
7772130|NCT00675025|27015791|P1|Overall Study|Lost to Follow-up|6
7772131|NCT00675025|27015790|P2|Overall Study|Adverse Event|11
7772132|NCT00675025|27015791|P1|Overall Study|Adverse Event|6
7772133|NCT00675025|27015790|P2|Overall Study|Study Terminated by Sponsor|42
7772134|NCT00675025|27015791|P1|Overall Study|Study Terminated by Sponsor|38
7772135|NCT00674986|27015799|P2|Overall Study|Other reasons|8
7772136|NCT00674986|27015800|P1|Overall Study|Other reasons|4
7772137|NCT00674986|27015799|P2|Overall Study|Lost to Follow-up|53
7772138|NCT00674986|27015800|P1|Overall Study|Lost to Follow-up|25
7772139|NCT00674986|27015799|P2|Overall Study|Subject withdrew consent|19
7772140|NCT00674986|27015800|P1|Overall Study|Subject withdrew consent|12
7772141|NCT00674986|27015799|P2|Overall Study|Adverse Event|1
7772142|NCT00674986|27015800|P1|Overall Study|Adverse Event|2
7772143|NCT00674973|27015821|P2|Overall Study|Protocol Violation|1
7772144|NCT00674973|27015822|P1|Overall Study|Protocol Violation|0
7772145|NCT00674973|27015821|P2|Overall Study|Death|15
7772146|NCT00674973|27015822|P1|Overall Study|Death|19
7772147|NCT00674973|27015821|P2|Overall Study|Adverse Event|9
7772148|NCT00674973|27015822|P1|Overall Study|Adverse Event|2
7772149|NCT00674973|27015821|P2|Overall Study|Failure to Return|0
7772150|NCT00674973|27015822|P1|Overall Study|Failure to Return|1
7772151|NCT00674973|27015821|P2|Overall Study|Refused Treatment|5
7772152|NCT00674973|27015822|P1|Overall Study|Refused Treatment|1
7772153|NCT00674973|27015821|P2|Overall Study|Insufficient Therapeutic Response|72
7772154|NCT00674973|27015822|P1|Overall Study|Insufficient Therapeutic Response|77
7772160|NCT00674700|27016013|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
7772161|NCT00674700|27016014|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
7772162|NCT00674700|27016015|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
7772163|NCT00674700|27016013|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
7772164|NCT00674700|27016014|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
7772165|NCT00674700|27016015|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
7772166|NCT00674700|27016013|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
7772167|NCT00674700|27016014|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
7772168|NCT00674700|27016015|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
7772169|NCT00674700|27016013|P3|Year 1|Any other reason not above-mentioned|6
7772170|NCT00674700|27016014|P2|Year 1|Any other reason not above-mentioned|7
7772171|NCT00674700|27016015|P1|Year 1|Any other reason not above-mentioned|7
7772172|NCT00674700|27016013|P3|Year 1|Withdrawal by Subject|6
7772173|NCT00674700|27016014|P2|Year 1|Withdrawal by Subject|7
7772174|NCT00674700|27016015|P1|Year 1|Withdrawal by Subject|7
7772175|NCT00674700|27016013|P3|Year 1|Adverse Event|5
7772176|NCT00674700|27016014|P2|Year 1|Adverse Event|20
7772177|NCT00674700|27016015|P1|Year 1|Adverse Event|17
7772178|NCT00674661|27016028|P2|Overall Study|Withdrawal by Subject|5
7772179|NCT00674661|27016029|P1|Overall Study|Withdrawal by Subject|0
7772180|NCT00674661|27016028|P2|Overall Study|Lost to Follow-up|3
7772181|NCT00674661|27016029|P1|Overall Study|Lost to Follow-up|6
7772182|NCT00674661|27016028|P2|Overall Study|Other|7
7772183|NCT00674661|27016029|P1|Overall Study|Other|5
7772184|NCT00674570|27016127|P3|Overall Study|Withdrawal by Subject|0
7772185|NCT00674570|27016128|P2|Overall Study|Withdrawal by Subject|2
7772186|NCT00674570|27016129|P1|Overall Study|Withdrawal by Subject|0
7772187|NCT00674362|27016168|P2|Open Label|Other: Subject moved to extension study|0
7772188|NCT00674362|27016169|P1|Open Label|Other: Subject moved to extension study|1
7772189|NCT00674362|27016168|P2|Open Label|Adverse Event|0
7772190|NCT00674362|27016169|P1|Open Label|Adverse Event|1
7772191|NCT00674362|27016168|P2|Double Blind|Other: Surgery|1
7772192|NCT00674362|27016169|P1|Double Blind|Other: Surgery|0
7772193|NCT00674362|27016168|P2|Double Blind|Other: Loss of Patient Compliance|1
7772194|NCT00674362|27016169|P1|Double Blind|Other: Loss of Patient Compliance|0
7772195|NCT00674362|27016168|P2|Double Blind|Withdrawal by Subject|3
7772196|NCT00674362|27016169|P1|Double Blind|Withdrawal by Subject|4
7772197|NCT00674362|27016168|P2|Double Blind|Loss of efficacy|1
7772198|NCT00674362|27016169|P1|Double Blind|Loss of efficacy|0
7772199|NCT00674362|27016168|P2|Double Blind|Lack of Efficacy|6
7772200|NCT00674362|27016169|P1|Double Blind|Lack of Efficacy|2
7772201|NCT00674362|27016168|P2|Double Blind|Adverse Event|6
7772202|NCT00674362|27016169|P1|Double Blind|Adverse Event|6
7772203|NCT00674323|27016237|P3|Overall Study|Protocol Violation|0
7772204|NCT00674323|27016238|P2|Overall Study|Protocol Violation|0
7772205|NCT00674323|27016239|P1|Overall Study|Protocol Violation|1
7772206|NCT00674323|27016237|P3|Overall Study|Adverse Event|0
7772207|NCT00674323|27016238|P2|Overall Study|Adverse Event|1
7772208|NCT00674323|27016239|P1|Overall Study|Adverse Event|0
7772209|NCT00674154|27016290|P2|Overall Study|Did not want parathyroidectomy|2
7772210|NCT00674154|27016291|P1|Overall Study|Did not want parathyroidectomy|0
7772211|NCT00674154|27016290|P2|Overall Study|Withdrawal by Subject|1
7772212|NCT00674154|27016291|P1|Overall Study|Withdrawal by Subject|3
7772213|NCT00674128|27016299|P2|Overall Study|Withdrawal by Subject|23
7772214|NCT00674128|27016300|P1|Overall Study|Withdrawal by Subject|25
7772215|NCT00673933|27016325|P1|Overall Study|Lost to Follow-up|1
7772216|NCT00673933|27016325|P1|Overall Study|Withdrawal by Subject|2
7772217|NCT00673920|27016349|P8|Week 24 to Week 48|Adminstrative/Other|0
7772218|NCT00673920|27016350|P7|Week 24 to Week 48|Adminstrative/Other|0
7772219|NCT00673920|27016351|P6|Week 24 to Week 48|Adminstrative/Other|0
7772220|NCT00673920|27016352|P5|Week 24 to Week 48|Adminstrative/Other|0
7772221|NCT00673920|27016353|P4|Week 24 to Week 48|Adminstrative/Other|1
7772222|NCT00673920|27016354|P3|Week 24 to Week 48|Adminstrative/Other|0
7772223|NCT00673920|27016355|P2|Week 24 to Week 48|Adminstrative/Other|0
7772224|NCT00673920|27016356|P1|Week 24 to Week 48|Adminstrative/Other|0
7772225|NCT00673920|27016349|P8|Week 24 to Week 48|Death|0
7772226|NCT00673920|27016350|P7|Week 24 to Week 48|Death|0
7772227|NCT00673920|27016351|P6|Week 24 to Week 48|Death|1
7772228|NCT00673920|27016352|P5|Week 24 to Week 48|Death|0
7772229|NCT00673920|27016353|P4|Week 24 to Week 48|Death|0
7772230|NCT00673920|27016354|P3|Week 24 to Week 48|Death|0
7772231|NCT00673920|27016355|P2|Week 24 to Week 48|Death|0
7772232|NCT00673920|27016356|P1|Week 24 to Week 48|Death|0
7772233|NCT00673920|27016349|P8|Week 24 to Week 48|Insufficient therapeutic response|0
7772234|NCT00673920|27016350|P7|Week 24 to Week 48|Insufficient therapeutic response|0
7772235|NCT00673920|27016351|P6|Week 24 to Week 48|Insufficient therapeutic response|1
7772236|NCT00673920|27016352|P5|Week 24 to Week 48|Insufficient therapeutic response|0
7772237|NCT00673920|27016353|P4|Week 24 to Week 48|Insufficient therapeutic response|0
7772238|NCT00673920|27016354|P3|Week 24 to Week 48|Insufficient therapeutic response|0
7772239|NCT00673920|27016355|P2|Week 24 to Week 48|Insufficient therapeutic response|0
7772240|NCT00673920|27016356|P1|Week 24 to Week 48|Insufficient therapeutic response|0
7772241|NCT00673920|27016349|P8|Week 24 to Week 48|Failure to return|0
7772242|NCT00673920|27016350|P7|Week 24 to Week 48|Failure to return|0
7772243|NCT00673920|27016351|P6|Week 24 to Week 48|Failure to return|1
7772244|NCT00673920|27016352|P5|Week 24 to Week 48|Failure to return|0
7772245|NCT00673920|27016353|P4|Week 24 to Week 48|Failure to return|0
7772246|NCT00673920|27016354|P3|Week 24 to Week 48|Failure to return|0
7772247|NCT00673920|27016355|P2|Week 24 to Week 48|Failure to return|0
7772248|NCT00673920|27016356|P1|Week 24 to Week 48|Failure to return|0
7772249|NCT00673920|27016349|P8|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772250|NCT00673920|27016350|P7|Week 24 to Week 48|Adverse event/intercurrent illness|1
7772251|NCT00673920|27016351|P6|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772252|NCT00673920|27016352|P5|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772253|NCT00673920|27016353|P4|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772254|NCT00673920|27016354|P3|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772255|NCT00673920|27016355|P2|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772256|NCT00673920|27016356|P1|Week 24 to Week 48|Adverse event/intercurrent illness|0
7772257|NCT00673920|27016349|P8|Baseline up to Week 48|Adverse event/intercurrent illness|0
7772258|NCT00673920|27016350|P7|Baseline up to Week 48|Adverse event/intercurrent illness|0
7772259|NCT00673920|27016351|P6|Baseline up to Week 48|Adverse event/intercurrent illness|0
7772260|NCT00673920|27016352|P5|Baseline up to Week 48|Adverse event/intercurrent illness|0
7772261|NCT00673920|27016353|P4|Baseline up to Week 48|Adverse event/intercurrent illness|0
7772262|NCT00673920|27016354|P3|Baseline up to Week 48|Adverse event/intercurrent illness|1
7772263|NCT00673920|27016355|P2|Baseline up to Week 48|Adverse event/intercurrent illness|1
7772264|NCT00673920|27016356|P1|Baseline up to Week 48|Adverse event/intercurrent illness|0
7772265|NCT00673920|27016349|P8|Baseline up to Week 48|Administrative/Other|0
7772266|NCT00673920|27016350|P7|Baseline up to Week 48|Administrative/Other|0
7772267|NCT00673920|27016351|P6|Baseline up to Week 48|Administrative/Other|0
7772268|NCT00673920|27016352|P5|Baseline up to Week 48|Administrative/Other|0
7772269|NCT00673920|27016353|P4|Baseline up to Week 48|Administrative/Other|0
7772270|NCT00673920|27016354|P3|Baseline up to Week 48|Administrative/Other|2
7772271|NCT00673920|27016355|P2|Baseline up to Week 48|Administrative/Other|1
7772272|NCT00673920|27016356|P1|Baseline up to Week 48|Administrative/Other|0
7772273|NCT00673920|27016349|P8|Baseline up to Week 48|Violation of selection criteria at entry|0
7772274|NCT00673920|27016350|P7|Baseline up to Week 48|Violation of selection criteria at entry|0
7772275|NCT00673920|27016351|P6|Baseline up to Week 48|Violation of selection criteria at entry|0
7772276|NCT00673920|27016352|P5|Baseline up to Week 48|Violation of selection criteria at entry|0
7772277|NCT00673920|27016353|P4|Baseline up to Week 48|Violation of selection criteria at entry|0
7772278|NCT00673920|27016354|P3|Baseline up to Week 48|Violation of selection criteria at entry|1
7772279|NCT00673920|27016355|P2|Baseline up to Week 48|Violation of selection criteria at entry|0
7772280|NCT00673920|27016356|P1|Baseline up to Week 48|Violation of selection criteria at entry|0
7772281|NCT00673920|27016349|P8|Baseline up to Week 48|Protocol Violation|0
7772282|NCT00673920|27016350|P7|Baseline up to Week 48|Protocol Violation|0
7772283|NCT00673920|27016351|P6|Baseline up to Week 48|Protocol Violation|0
7772284|NCT00673920|27016352|P5|Baseline up to Week 48|Protocol Violation|0
7772285|NCT00673920|27016353|P4|Baseline up to Week 48|Protocol Violation|0
7772286|NCT00673920|27016354|P3|Baseline up to Week 48|Protocol Violation|1
7772287|NCT00673920|27016355|P2|Baseline up to Week 48|Protocol Violation|0
7772288|NCT00673920|27016356|P1|Baseline up to Week 48|Protocol Violation|0
7772289|NCT00673920|27016349|P8|Baseline up to Week 48|Insufficient therapeutic response|0
7772290|NCT00673920|27016350|P7|Baseline up to Week 48|Insufficient therapeutic response|0
7772291|NCT00673920|27016351|P6|Baseline up to Week 48|Insufficient therapeutic response|0
7772292|NCT00673920|27016352|P5|Baseline up to Week 48|Insufficient therapeutic response|0
7772293|NCT00673920|27016353|P4|Baseline up to Week 48|Insufficient therapeutic response|0
7772294|NCT00673920|27016354|P3|Baseline up to Week 48|Insufficient therapeutic response|0
7772295|NCT00673920|27016355|P2|Baseline up to Week 48|Insufficient therapeutic response|1
7772296|NCT00673920|27016356|P1|Baseline up to Week 48|Insufficient therapeutic response|2
7772297|NCT00673920|27016349|P8|Baseline up to Week 48|Refused treatment|0
7772298|NCT00673920|27016350|P7|Baseline up to Week 48|Refused treatment|0
7772299|NCT00673920|27016351|P6|Baseline up to Week 48|Refused treatment|0
7772300|NCT00673920|27016352|P5|Baseline up to Week 48|Refused treatment|0
7772301|NCT00673920|27016353|P4|Baseline up to Week 48|Refused treatment|0
7772302|NCT00673920|27016354|P3|Baseline up to Week 48|Refused treatment|0
7772303|NCT00673920|27016355|P2|Baseline up to Week 48|Refused treatment|0
7772304|NCT00673920|27016356|P1|Baseline up to Week 48|Refused treatment|1
7772305|NCT00673920|27016349|P8|Baseline up to Week 48|Withdrew consent|0
7772306|NCT00673920|27016350|P7|Baseline up to Week 48|Withdrew consent|0
7772307|NCT00673920|27016351|P6|Baseline up to Week 48|Withdrew consent|0
7772308|NCT00673920|27016352|P5|Baseline up to Week 48|Withdrew consent|0
7772309|NCT00673920|27016353|P4|Baseline up to Week 48|Withdrew consent|0
7772310|NCT00673920|27016354|P3|Baseline up to Week 48|Withdrew consent|2
7772311|NCT00673920|27016355|P2|Baseline up to Week 48|Withdrew consent|0
7772312|NCT00673920|27016356|P1|Baseline up to Week 48|Withdrew consent|1
7772313|NCT00673894|27016502|P2|First Intervention 4 Weeks|Adverse Event|0
7772314|NCT00673894|27016503|P1|First Intervention 4 Weeks|Adverse Event|1
7772315|NCT00673894|27016502|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
7772316|NCT00673894|27016503|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
7772317|NCT00673881|27016511|P1|Overall Study|Withdrawal by Subject|1
7772318|NCT00673816|27016525|P1|Overall Study|Withdrawal by Subject|1
7772319|NCT00673816|27016525|P1|Overall Study|Adverse Event|1
7772320|NCT00673790|27016535|P3|Overall Study|Randomization criteria not met|0
7772321|NCT00673790|27016536|P2|Overall Study|Randomization criteria not met|1
7772322|NCT00673790|27016537|P1|Overall Study|Randomization criteria not met|0
7772323|NCT00673790|27016535|P3|Overall Study|Unconfirmed pregnancy|0
7772324|NCT00673790|27016536|P2|Overall Study|Unconfirmed pregnancy|1
7772325|NCT00673790|27016537|P1|Overall Study|Unconfirmed pregnancy|0
7772326|NCT00673790|27016535|P3|Overall Study|Participated in two Nebivolol studies|1
7772327|NCT00673790|27016536|P2|Overall Study|Participated in two Nebivolol studies|0
7772328|NCT00673790|27016537|P1|Overall Study|Participated in two Nebivolol studies|0
7772329|NCT00673790|27016535|P3|Overall Study|Poor compliance|0
7772330|NCT00673790|27016536|P2|Overall Study|Poor compliance|0
7772331|NCT00673790|27016537|P1|Overall Study|Poor compliance|1
7772332|NCT00673790|27016535|P3|Overall Study|Sponsor Terminated due to PI oversight|0
7772333|NCT00673790|27016536|P2|Overall Study|Sponsor Terminated due to PI oversight|1
7772334|NCT00673790|27016537|P1|Overall Study|Sponsor Terminated due to PI oversight|0
7772335|NCT00673790|27016535|P3|Overall Study|Lost to Follow-up|5
7772336|NCT00673790|27016536|P2|Overall Study|Lost to Follow-up|6
7772337|NCT00673790|27016537|P1|Overall Study|Lost to Follow-up|6
7772338|NCT00673790|27016535|P3|Overall Study|Withdrawal by Subject|1
7772339|NCT00673790|27016536|P2|Overall Study|Withdrawal by Subject|4
7772340|NCT00673790|27016537|P1|Overall Study|Withdrawal by Subject|7
7772341|NCT00673790|27016535|P3|Overall Study|Protocol Violation|1
7772342|NCT00673790|27016536|P2|Overall Study|Protocol Violation|9
7772343|NCT00673790|27016537|P1|Overall Study|Protocol Violation|6
7772344|NCT00673790|27016535|P3|Overall Study|Lack of Efficacy|2
7772345|NCT00673790|27016536|P2|Overall Study|Lack of Efficacy|2
7772346|NCT00673790|27016537|P1|Overall Study|Lack of Efficacy|2
7772347|NCT00673790|27016535|P3|Overall Study|Adverse Event|2
7772348|NCT00673790|27016536|P2|Overall Study|Adverse Event|14
7772349|NCT00673790|27016537|P1|Overall Study|Adverse Event|23
7772350|NCT00673673|27016575|P1|Overall Study|Investigators' discretion|2
7772351|NCT00673673|27016575|P1|Overall Study|Withdrawal by Subject|3
7772352|NCT00673673|27016575|P1|Overall Study|Adverse Event|4
7772353|NCT00673673|27016575|P1|Overall Study|Progressive disease|27
7772354|NCT00673660|27016581|P1|Overall Study|Lost to Follow-up|107
7772355|NCT00673465|27016603|P12|Part 1/Period 2 (United States)|Protocol Violation|0
7772356|NCT00673465|27016604|P11|Part 1/Period 2 (United States)|Protocol Violation|0
7772357|NCT00673465|27016605|P10|Part 1/Period 2 (United States)|Protocol Violation|0
7772358|NCT00673465|27016606|P9|Part 1/Period 2 (United States)|Protocol Violation|0
7772359|NCT00673465|27016607|P8|Part 1/Period 2 (United States)|Protocol Violation|0
7772360|NCT00673465|27016608|P7|Part 1/Period 2 (United States)|Protocol Violation|0
7772361|NCT00673465|27016609|P6|Part 1/Period 2 (United States)|Protocol Violation|0
7772362|NCT00673465|27016610|P5|Part 1/Period 2 (United States)|Protocol Violation|1
7772363|NCT00673465|27016611|P4|Part 1/Period 2 (United States)|Protocol Violation|0
7772364|NCT00673465|27016612|P3|Part 1/Period 2 (United States)|Protocol Violation|0
7772365|NCT00673465|27016613|P2|Part 1/Period 2 (United States)|Protocol Violation|0
7772366|NCT00673465|27016614|P1|Part 1/Period 2 (United States)|Protocol Violation|0
7772367|NCT00673465|27016603|P12|Part 1/Period 1 (United States)|Protocol Violation|0
7772368|NCT00673465|27016604|P11|Part 1/Period 1 (United States)|Protocol Violation|0
7772369|NCT00673465|27016605|P10|Part 1/Period 1 (United States)|Protocol Violation|0
7772370|NCT00673465|27016606|P9|Part 1/Period 1 (United States)|Protocol Violation|0
7772371|NCT00673465|27016607|P8|Part 1/Period 1 (United States)|Protocol Violation|0
7772372|NCT00673465|27016608|P7|Part 1/Period 1 (United States)|Protocol Violation|0
7772373|NCT00673465|27016609|P6|Part 1/Period 1 (United States)|Protocol Violation|1
7772374|NCT00673465|27016610|P5|Part 1/Period 1 (United States)|Protocol Violation|1
7772375|NCT00673465|27016611|P4|Part 1/Period 1 (United States)|Protocol Violation|0
7772376|NCT00673465|27016612|P3|Part 1/Period 1 (United States)|Protocol Violation|0
7772377|NCT00673465|27016613|P2|Part 1/Period 1 (United States)|Protocol Violation|0
7772378|NCT00673465|27016614|P1|Part 1/Period 1 (United States)|Protocol Violation|0
7772379|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
7772380|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
7772381|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Physician Decision|0
7772382|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Physician Decision|2
7772383|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Sponsor Decision|3
7772384|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Sponsor Decision|0
7772385|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Protocol Violation|3
7772386|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Protocol Violation|2
7772387|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
7772388|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
7772389|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
7772390|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
7772391|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
7772392|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
7772393|NCT00673452|27016663|P2|Continuation Double-Blind Phase|Adverse Event|13
7772394|NCT00673452|27016664|P1|Continuation Double-Blind Phase|Adverse Event|5
7772395|NCT00673452|27016663|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
7772396|NCT00673452|27016664|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
7772397|NCT00673452|27016663|P2|Acute Double-Blind Phase|Sponsor Decision|1
7772398|NCT00673452|27016664|P1|Acute Double-Blind Phase|Sponsor Decision|0
7772399|NCT00673452|27016663|P2|Acute Double-Blind Phase|Protocol Violation|3
7772400|NCT00673452|27016664|P1|Acute Double-Blind Phase|Protocol Violation|5
7772401|NCT00673452|27016663|P2|Acute Double-Blind Phase|Physician Decision|6
7772402|NCT00673452|27016664|P1|Acute Double-Blind Phase|Physician Decision|0
7772403|NCT00673452|27016663|P2|Acute Double-Blind Phase|Lost to Follow-up|19
7772404|NCT00673452|27016664|P1|Acute Double-Blind Phase|Lost to Follow-up|16
7772405|NCT00673452|27016663|P2|Acute Double-Blind Phase|Lack of Efficacy|14
7772406|NCT00673452|27016664|P1|Acute Double-Blind Phase|Lack of Efficacy|9
7772407|NCT00673452|27016663|P2|Acute Double-Blind Phase|Adverse Event|24
7772408|NCT00673452|27016664|P1|Acute Double-Blind Phase|Adverse Event|41
7772409|NCT00673387|27016728|P8|Overall Study|Lost to Follow-up|5
7772410|NCT00673387|27016729|P7|Overall Study|Lost to Follow-up|8
7772411|NCT00673387|27016730|P6|Overall Study|Lost to Follow-up|5
7772412|NCT00673387|27016731|P5|Overall Study|Lost to Follow-up|6
7772413|NCT00673387|27016732|P4|Overall Study|Lost to Follow-up|6
7772414|NCT00673387|27016733|P3|Overall Study|Lost to Follow-up|5
7772415|NCT00673387|27016734|P2|Overall Study|Lost to Follow-up|6
7772416|NCT00673387|27016735|P1|Overall Study|Lost to Follow-up|8
7772417|NCT00673387|27016728|P8|Overall Study|Protocol Violation|3
7772418|NCT00673387|27016729|P7|Overall Study|Protocol Violation|1
7772419|NCT00673387|27016730|P6|Overall Study|Protocol Violation|1
7772420|NCT00673387|27016731|P5|Overall Study|Protocol Violation|0
7772421|NCT00673387|27016732|P4|Overall Study|Protocol Violation|2
7772422|NCT00673387|27016733|P3|Overall Study|Protocol Violation|1
7772423|NCT00673387|27016734|P2|Overall Study|Protocol Violation|0
7772424|NCT00673387|27016735|P1|Overall Study|Protocol Violation|3
7772425|NCT00673387|27016728|P8|Overall Study|Physician Decision|1
7772426|NCT00673387|27016729|P7|Overall Study|Physician Decision|1
7772427|NCT00673387|27016730|P6|Overall Study|Physician Decision|5
7772428|NCT00673387|27016731|P5|Overall Study|Physician Decision|0
7772429|NCT00673387|27016732|P4|Overall Study|Physician Decision|0
7772430|NCT00673387|27016733|P3|Overall Study|Physician Decision|0
7772431|NCT00673387|27016734|P2|Overall Study|Physician Decision|0
7772432|NCT00673387|27016735|P1|Overall Study|Physician Decision|0
7772433|NCT00673387|27016728|P8|Overall Study|Adverse Event|5
7772434|NCT00673387|27016729|P7|Overall Study|Adverse Event|5
7772435|NCT00673387|27016730|P6|Overall Study|Adverse Event|2
7772436|NCT00673387|27016731|P5|Overall Study|Adverse Event|6
7772437|NCT00673387|27016732|P4|Overall Study|Adverse Event|2
7772438|NCT00673387|27016733|P3|Overall Study|Adverse Event|5
7772439|NCT00673387|27016734|P2|Overall Study|Adverse Event|1
7772440|NCT00673387|27016735|P1|Overall Study|Adverse Event|3
7772441|NCT00673387|27016728|P8|Overall Study|Withdrawal by Subject|21
7772442|NCT00673387|27016729|P7|Overall Study|Withdrawal by Subject|15
7772443|NCT00673387|27016730|P6|Overall Study|Withdrawal by Subject|21
7772444|NCT00673387|27016731|P5|Overall Study|Withdrawal by Subject|18
7772445|NCT00673387|27016732|P4|Overall Study|Withdrawal by Subject|16
7772446|NCT00673387|27016733|P3|Overall Study|Withdrawal by Subject|20
7772447|NCT00673387|27016734|P2|Overall Study|Withdrawal by Subject|16
7772448|NCT00673387|27016735|P1|Overall Study|Withdrawal by Subject|15
7772449|NCT00673361|27016951|P1|Overall Study|Screen Failure|2
7772450|NCT00673257|27016987|P1|Overall Study|Unable to obtain specimen|1
7772451|NCT00673257|27016987|P1|Overall Study|Withdrawal by Subject|4
7772452|NCT00673231|27017005|P4|Overall Study|Study criteria,compliance,safety, other|4
7772453|NCT00673231|27017006|P3|Overall Study|Study criteria,compliance,safety, other|7
7772454|NCT00673231|27017007|P2|Overall Study|Study criteria,compliance,safety, other|5
7772455|NCT00673231|27017008|P1|Overall Study|Study criteria,compliance,safety, other|8
7772456|NCT00673231|27017005|P4|Overall Study|Death|0
7772457|NCT00673231|27017006|P3|Overall Study|Death|1
7772458|NCT00673231|27017007|P2|Overall Study|Death|0
7772459|NCT00673231|27017008|P1|Overall Study|Death|0
7772460|NCT00673231|27017005|P4|Overall Study|Lost to Follow-up|2
7772461|NCT00673231|27017006|P3|Overall Study|Lost to Follow-up|1
7772462|NCT00673231|27017007|P2|Overall Study|Lost to Follow-up|2
7772463|NCT00673231|27017008|P1|Overall Study|Lost to Follow-up|1
7772464|NCT00673231|27017005|P4|Overall Study|Adverse Event|6
7772465|NCT00673231|27017006|P3|Overall Study|Adverse Event|9
7772466|NCT00673231|27017007|P2|Overall Study|Adverse Event|5
7772467|NCT00673231|27017008|P1|Overall Study|Adverse Event|6
7772468|NCT00673231|27017005|P4|Overall Study|Withdrawal by Subject|6
7772469|NCT00673231|27017006|P3|Overall Study|Withdrawal by Subject|8
7772470|NCT00673231|27017007|P2|Overall Study|Withdrawal by Subject|10
7772471|NCT00673231|27017008|P1|Overall Study|Withdrawal by Subject|14
7772472|NCT00673179|27017040|P2|Overall Study|Toxicity/Complications|0
7772473|NCT00673179|27017041|P1|Overall Study|Toxicity/Complications|3
7772474|NCT00673049|27017090|P4|After Progression on Erlotinib|study terminated by sponsor|4
7772475|NCT00673049|27017091|P3|After Progression on Erlotinib|study terminated by sponsor|0
7772476|NCT00673049|27017092|P2|After Progression on Erlotinib|study terminated by sponsor|0
7772477|NCT00673049|27017093|P1|After Progression on Erlotinib|study terminated by sponsor|0
7772478|NCT00673049|27017090|P4|After Progression on Erlotinib|Withdrawal by Subject|5
7772479|NCT00673049|27017091|P3|After Progression on Erlotinib|Withdrawal by Subject|0
7772480|NCT00673049|27017092|P2|After Progression on Erlotinib|Withdrawal by Subject|0
7772481|NCT00673049|27017093|P1|After Progression on Erlotinib|Withdrawal by Subject|0
7772482|NCT00673049|27017090|P4|After Progression on Erlotinib|Lost to Follow-up|3
7772483|NCT00673049|27017091|P3|After Progression on Erlotinib|Lost to Follow-up|0
7772484|NCT00673049|27017092|P2|After Progression on Erlotinib|Lost to Follow-up|0
7772485|NCT00673049|27017093|P1|After Progression on Erlotinib|Lost to Follow-up|0
7772486|NCT00673049|27017090|P4|After Progression on Erlotinib|Death|71
7772487|NCT00673049|27017091|P3|After Progression on Erlotinib|Death|0
7772488|NCT00673049|27017092|P2|After Progression on Erlotinib|Death|0
7772489|NCT00673049|27017093|P1|After Progression on Erlotinib|Death|0
7772490|NCT00673049|27017090|P4|Before Progression on Erlotinib|Switched to figitumumab|0
7772491|NCT00673049|27017091|P3|Before Progression on Erlotinib|Switched to figitumumab|0
7772492|NCT00673049|27017092|P2|Before Progression on Erlotinib|Switched to figitumumab|83
7772493|NCT00673049|27017093|P1|Before Progression on Erlotinib|Switched to figitumumab|0
7772494|NCT00673049|27017090|P4|Before Progression on Erlotinib|study terminated by sponsor|0
7772495|NCT00673049|27017091|P3|Before Progression on Erlotinib|study terminated by sponsor|0
7772496|NCT00673049|27017092|P2|Before Progression on Erlotinib|study terminated by sponsor|14
7772497|NCT00673049|27017093|P1|Before Progression on Erlotinib|study terminated by sponsor|18
7772498|NCT00673049|27017090|P4|Before Progression on Erlotinib|Other|0
7772499|NCT00673049|27017091|P3|Before Progression on Erlotinib|Other|0
7772500|NCT00673049|27017092|P2|Before Progression on Erlotinib|Other|2
7772501|NCT00673049|27017093|P1|Before Progression on Erlotinib|Other|1
7772502|NCT00673049|27017090|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
7772503|NCT00673049|27017091|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
7772504|NCT00673049|27017092|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
7772505|NCT00673049|27017093|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
7772506|NCT00673049|27017090|P4|Before Progression on Erlotinib|Lost to Follow-up|0
7772507|NCT00673049|27017091|P3|Before Progression on Erlotinib|Lost to Follow-up|0
7772508|NCT00673049|27017092|P2|Before Progression on Erlotinib|Lost to Follow-up|5
7772509|NCT00673049|27017093|P1|Before Progression on Erlotinib|Lost to Follow-up|9
7772510|NCT00673049|27017090|P4|Before Progression on Erlotinib|Death|0
7772511|NCT00673049|27017091|P3|Before Progression on Erlotinib|Death|1
7772512|NCT00673049|27017092|P2|Before Progression on Erlotinib|Death|167
7772513|NCT00673049|27017093|P1|Before Progression on Erlotinib|Death|235
7772514|NCT00673049|27017090|P4|Before Progression on Erlotinib|Randomized but not treated|0
7772515|NCT00673049|27017091|P3|Before Progression on Erlotinib|Randomized but not treated|0
7772516|NCT00673049|27017092|P2|Before Progression on Erlotinib|Randomized but not treated|1
7772517|NCT00673049|27017093|P1|Before Progression on Erlotinib|Randomized but not treated|3
7772518|NCT00672984|27017117|P3|Third Intervention|Adverse Event|1
7772519|NCT00672984|27017118|P2|Third Intervention|Adverse Event|0
7772520|NCT00672984|27017119|P1|Third Intervention|Adverse Event|1
7772521|NCT00672984|27017117|P3|Second Intervention|Protocol Violation|1
7772522|NCT00672984|27017118|P2|Second Intervention|Protocol Violation|1
7772523|NCT00672984|27017119|P1|Second Intervention|Protocol Violation|0
7772524|NCT00672984|27017117|P3|Second Intervention|Withdrawal by Subject|0
7772525|NCT00672984|27017118|P2|Second Intervention|Withdrawal by Subject|3
7772526|NCT00672984|27017119|P1|Second Intervention|Withdrawal by Subject|0
7772527|NCT00672984|27017117|P3|Second Intervention|Non-compliance with facility policies|0
7772528|NCT00672984|27017118|P2|Second Intervention|Non-compliance with facility policies|2
7772529|NCT00672984|27017119|P1|Second Intervention|Non-compliance with facility policies|0
7772530|NCT00672984|27017117|P3|First Intervention|Sponsor decision|0
7772531|NCT00672984|27017118|P2|First Intervention|Sponsor decision|0
7772532|NCT00672984|27017119|P1|First Intervention|Sponsor decision|3
7772533|NCT00672984|27017117|P3|First Intervention|Withdrawal by Subject|2
7772534|NCT00672984|27017118|P2|First Intervention|Withdrawal by Subject|2
7772535|NCT00672984|27017119|P1|First Intervention|Withdrawal by Subject|1
7772536|NCT00672984|27017117|P3|First Intervention|Adverse Event|0
7772537|NCT00672984|27017118|P2|First Intervention|Adverse Event|0
7772538|NCT00672984|27017119|P1|First Intervention|Adverse Event|5
7772539|NCT00672958|27017170|P2|Overall Study|Reason not specified|3
7772540|NCT00672958|27017171|P1|Overall Study|Reason not specified|0
7772541|NCT00672958|27017170|P2|Overall Study|Lost to Follow-up|17
7772542|NCT00672958|27017171|P1|Overall Study|Lost to Follow-up|22
7772543|NCT00672958|27017170|P2|Overall Study|Voluntary withdrawal|8
7772544|NCT00672958|27017171|P1|Overall Study|Voluntary withdrawal|12
7772545|NCT00672958|27017170|P2|Overall Study|Protocol deviations|5
7772546|NCT00672958|27017171|P1|Overall Study|Protocol deviations|11
7772547|NCT00672958|27017170|P2|Overall Study|Non-compliance with study drug|3
7772548|NCT00672958|27017171|P1|Overall Study|Non-compliance with study drug|2
7772549|NCT00672958|27017170|P2|Overall Study|Lack of Efficacy|11
7772550|NCT00672958|27017171|P1|Overall Study|Lack of Efficacy|6
7772551|NCT00672958|27017170|P2|Overall Study|Adverse Event|9
7772552|NCT00672958|27017171|P1|Overall Study|Adverse Event|11
7772553|NCT00672841|27017237|P2|Overall Study|Pregnancy|1
7772554|NCT00672841|27017238|P1|Overall Study|Pregnancy|0
7772555|NCT00672841|27017237|P2|Overall Study|Adverse Event|3
7772556|NCT00672841|27017238|P1|Overall Study|Adverse Event|0
7772557|NCT00672841|27017237|P2|Overall Study|Antifungal therapy, negative glucan|4
7772558|NCT00672841|27017238|P1|Overall Study|Antifungal therapy, negative glucan|0
7772559|NCT00672841|27017237|P2|Overall Study|icteric specimens|3
7772560|NCT00672841|27017238|P1|Overall Study|icteric specimens|0
7772561|NCT00672841|27017237|P2|Overall Study|Comfort care|4
7772562|NCT00672841|27017238|P1|Overall Study|Comfort care|1
7772563|NCT00672646|27017260|P3|Overall Study|Withdrawal by Subject|1
7772564|NCT00672646|27017261|P2|Overall Study|Withdrawal by Subject|0
7772565|NCT00672646|27017262|P1|Overall Study|Withdrawal by Subject|0
7772566|NCT00672646|27017260|P3|Overall Study|Lost to Follow-up|2
7772567|NCT00672646|27017261|P2|Overall Study|Lost to Follow-up|1
7772568|NCT00672646|27017262|P1|Overall Study|Lost to Follow-up|0
7772569|NCT00672633|27017287|P2|Overall Study|Withdrawal by Subject|1
7772570|NCT00672633|27017288|P1|Overall Study|Withdrawal by Subject|0
7772571|NCT00672620|27017302|P4|Overall Study|Reason not Specified|1
7772572|NCT00672620|27017303|P3|Overall Study|Reason not Specified|2
7772573|NCT00672620|27017304|P2|Overall Study|Reason not Specified|3
7772574|NCT00672620|27017305|P1|Overall Study|Reason not Specified|3
7772575|NCT00672620|27017302|P4|Overall Study|Lost to Follow-up|11
7772576|NCT00672620|27017303|P3|Overall Study|Lost to Follow-up|8
7772577|NCT00672620|27017304|P2|Overall Study|Lost to Follow-up|19
7772578|NCT00672620|27017305|P1|Overall Study|Lost to Follow-up|8
7772579|NCT00672620|27017302|P4|Overall Study|Withdrawal of Consent|6
7772580|NCT00672620|27017303|P3|Overall Study|Withdrawal of Consent|5
7772581|NCT00672620|27017304|P2|Overall Study|Withdrawal of Consent|12
7772582|NCT00672620|27017305|P1|Overall Study|Withdrawal of Consent|6
7772583|NCT00672620|27017302|P4|Overall Study|Protocol Deviations|5
7772584|NCT00672620|27017303|P3|Overall Study|Protocol Deviations|2
7772585|NCT00672620|27017304|P2|Overall Study|Protocol Deviations|7
7772586|NCT00672620|27017305|P1|Overall Study|Protocol Deviations|5
7772587|NCT00672620|27017302|P4|Overall Study|Noncompliance with Study Drug|2
7772588|NCT00672620|27017303|P3|Overall Study|Noncompliance with Study Drug|0
7772589|NCT00672620|27017304|P2|Overall Study|Noncompliance with Study Drug|4
7772590|NCT00672620|27017305|P1|Overall Study|Noncompliance with Study Drug|3
7772591|NCT00672620|27017302|P4|Overall Study|Lack of Efficacy|0
7772592|NCT00672620|27017303|P3|Overall Study|Lack of Efficacy|2
7772593|NCT00672620|27017304|P2|Overall Study|Lack of Efficacy|2
7772594|NCT00672620|27017305|P1|Overall Study|Lack of Efficacy|1
7772595|NCT00672620|27017302|P4|Overall Study|Adverse Event|17
7772596|NCT00672620|27017303|P3|Overall Study|Adverse Event|12
7772597|NCT00672620|27017304|P2|Overall Study|Adverse Event|7
7772598|NCT00672620|27017305|P1|Overall Study|Adverse Event|7
7772599|NCT00672555|27017370|P1|Overall Study|Did not want to answer questionnaire|2
7772600|NCT00672555|27017370|P1|Overall Study|Lost to Follow-up|4
7772601|NCT00672490|27017381|P2|Overall Study|No reason was provided|2
7772602|NCT00672490|27017382|P1|Overall Study|No reason was provided|6
7772603|NCT00672490|27017381|P2|Overall Study|Lost to Follow-up|5
7772604|NCT00672490|27017382|P1|Overall Study|Lost to Follow-up|1
7772605|NCT00672490|27017381|P2|Overall Study|Intolerance|2
7772606|NCT00672490|27017382|P1|Overall Study|Intolerance|0
7772607|NCT00672490|27017381|P2|Overall Study|Violation of Concomitant Medicine|0
7772608|NCT00672490|27017382|P1|Overall Study|Violation of Concomitant Medicine|1
7772609|NCT00672490|27017381|P2|Overall Study|Adverse Event|8
7772610|NCT00672490|27017382|P1|Overall Study|Adverse Event|5
7772611|NCT00672490|27017381|P2|Overall Study|Mismatch Include/Exclude Criteria|0
7772612|NCT00672490|27017382|P1|Overall Study|Mismatch Include/Exclude Criteria|1
7772613|NCT00672490|27017381|P2|Overall Study|Lack of Compliance|7
7772614|NCT00672490|27017382|P1|Overall Study|Lack of Compliance|2
7772615|NCT00672490|27017381|P2|Overall Study|Withdrawal by Subject|8
7772616|NCT00672490|27017382|P1|Overall Study|Withdrawal by Subject|8
7772617|NCT00672477|27017406|P2|Overall Study|no study drug for low GFR, health cond.|3
7772618|NCT00672477|27017407|P1|Overall Study|no study drug for low GFR, health cond.|1
7772619|NCT00672477|27017406|P2|Overall Study|Lack of Efficacy|1
7772620|NCT00672477|27017407|P1|Overall Study|Lack of Efficacy|1
7772621|NCT00672477|27017406|P2|Overall Study|Withdrawal by Subject|3
7772622|NCT00672477|27017407|P1|Overall Study|Withdrawal by Subject|5
7772623|NCT00672477|27017406|P2|Overall Study|Protocol Violation|1
7772624|NCT00672477|27017407|P1|Overall Study|Protocol Violation|1
7772625|NCT00672477|27017406|P2|Overall Study|Physician Decision|0
7772626|NCT00672477|27017407|P1|Overall Study|Physician Decision|2
7772627|NCT00672477|27017406|P2|Overall Study|Death|11
7772628|NCT00672477|27017407|P1|Overall Study|Death|7
7772629|NCT00672477|27017406|P2|Overall Study|Adverse Event|7
7772630|NCT00672477|27017407|P1|Overall Study|Adverse Event|10
7772631|NCT00672256|27017460|P1|Overall Study|PI dropped, bad data|44
7772632|NCT00672139|27017485|P2|Overall Study|hospice discharge, caregiver requests|2
7772633|NCT00672139|27017486|P1|Overall Study|hospice discharge, caregiver requests|3
7772634|NCT00672139|27017485|P2|Overall Study|Protocol Violation|1
7772635|NCT00672139|27017486|P1|Overall Study|Protocol Violation|1
7772636|NCT00672139|27017485|P2|Overall Study|Lack of Efficacy|1
7772637|NCT00672139|27017486|P1|Overall Study|Lack of Efficacy|4
7772638|NCT00672139|27017485|P2|Overall Study|Physician Decision|0
7772639|NCT00672139|27017486|P1|Overall Study|Physician Decision|2
7772640|NCT00672139|27017485|P2|Overall Study|Adverse Event|7
7772641|NCT00672139|27017486|P1|Overall Study|Adverse Event|4
7772642|NCT00672139|27017485|P2|Overall Study|Withdrawal by Subject|11
7772643|NCT00672139|27017486|P1|Overall Study|Withdrawal by Subject|2
7772644|NCT00672139|27017485|P2|Overall Study|Death|23
7772645|NCT00672139|27017486|P1|Overall Study|Death|14
7772646|NCT00671931|27017543|P5|Overall Study|Physician Decision|1
7772647|NCT00671931|27017544|P4|Overall Study|Physician Decision|2
7772648|NCT00671931|27017545|P3|Overall Study|Physician Decision|0
7772649|NCT00671931|27017546|P2|Overall Study|Physician Decision|0
7772650|NCT00671931|27017547|P1|Overall Study|Physician Decision|1
7772651|NCT00671879|27017567|P3|Overall Study|Withdrawal by Subject|6
7772652|NCT00671879|27017568|P2|Overall Study|Withdrawal by Subject|4
7772653|NCT00671879|27017569|P1|Overall Study|Withdrawal by Subject|0
7772654|NCT00671853|27017582|P2|Overall Study|Non-adherence with study procedures|4
7772655|NCT00671853|27017583|P1|Overall Study|Non-adherence with study procedures|1
7772656|NCT00671853|27017582|P2|Overall Study|Physician Decision|2
7772657|NCT00671853|27017583|P1|Overall Study|Physician Decision|0
7772658|NCT00671853|27017582|P2|Overall Study|Lost to Follow-up|8
7772659|NCT00671853|27017583|P1|Overall Study|Lost to Follow-up|8
7772660|NCT00671853|27017582|P2|Overall Study|Withdrawal by Subject|5
7772661|NCT00671853|27017583|P1|Overall Study|Withdrawal by Subject|1
7772662|NCT00671853|27017582|P2|Overall Study|Adverse Event|1
7772663|NCT00671853|27017583|P1|Overall Study|Adverse Event|7
7772664|NCT00671853|27017582|P2|Overall Study|Lack of Efficacy|7
7772665|NCT00671853|27017583|P1|Overall Study|Lack of Efficacy|3
7772666|NCT00671788|27017599|P1|Overall Study|Other|1
7772667|NCT00671788|27017599|P1|Overall Study|MD Decision|1
7772668|NCT00671788|27017599|P1|Overall Study|Ineligible|1
7772669|NCT00671788|27017599|P1|Overall Study|Refused further treatment|3
7772670|NCT00671788|27017599|P1|Overall Study|Adverse Event|8
7772671|NCT00671749|27017606|P1|Overall Study|Lost to Follow-up|1
7772672|NCT00671749|27017606|P1|Overall Study|Protocol Violation|1
7772673|NCT00671749|27017606|P1|Overall Study|Withdrawal by Subject|4
7772674|NCT00671749|27017606|P1|Overall Study|Adverse Event|2
7772675|NCT00671658|27017661|P1|Overall Study|Physician Decision|5
7772676|NCT00671554|27017669|P1|Overall Study|Disease progression|3
7772677|NCT00671437|27017708|P1|Overall Study|Ineligible post-hoc|1
7772678|NCT00671437|27017708|P1|Overall Study|Adverse Event|3
7772679|NCT00671437|27017708|P1|Overall Study|Cutaneous SCC of head and neck|3
7772680|NCT00671437|27017708|P1|Overall Study|Progressive disease before C1 week 8|8
7772681|NCT00671060|27017742|P2|Overall Study|Physician Decision|1
7772682|NCT00671060|27017743|P1|Overall Study|Physician Decision|0
7772683|NCT00671060|27017742|P2|Overall Study|Protocol Violation|0
7772684|NCT00671060|27017743|P1|Overall Study|Protocol Violation|1
7772685|NCT00671034|27017752|P3|Overall Study|includes Alternative therapy, etc.|7
7772686|NCT00671034|27017753|P2|Overall Study|includes Alternative therapy, etc.|1
7772687|NCT00671034|27017754|P1|Overall Study|includes Alternative therapy, etc.|6
7772688|NCT00671034|27017752|P3|Overall Study|Refusal|5
7772689|NCT00671034|27017753|P2|Overall Study|Refusal|3
7772690|NCT00671034|27017754|P1|Overall Study|Refusal|5
7772691|NCT00671034|27017752|P3|Overall Study|VHR ALL feature|5
7772692|NCT00671034|27017753|P2|Overall Study|VHR ALL feature|3
7772693|NCT00671034|27017754|P1|Overall Study|VHR ALL feature|8
7772694|NCT00671034|27017752|P3|Overall Study|Physician Decision|5
7772695|NCT00671034|27017753|P2|Overall Study|Physician Decision|4
7772696|NCT00671034|27017754|P1|Overall Study|Physician Decision|12
7772697|NCT00671034|27017752|P3|Overall Study|Death|1
7772698|NCT00671034|27017753|P2|Overall Study|Death|2
7772699|NCT00671034|27017754|P1|Overall Study|Death|3
7772700|NCT00671034|27017752|P3|Overall Study|Adverse Event|1
7772701|NCT00671034|27017753|P2|Overall Study|Adverse Event|7
7772702|NCT00671034|27017754|P1|Overall Study|Adverse Event|5
7772703|NCT00670930|27017809|P2|Overall Study|Lost to Follow-up|0
7772704|NCT00670930|27017810|P1|Overall Study|Lost to Follow-up|1
7772705|NCT00670930|27017809|P2|Overall Study|Adminstrative Problem|1
7772706|NCT00670930|27017810|P1|Overall Study|Adminstrative Problem|0
7772707|NCT00670800|27017826|P2|Overall Study|2 controls were insulin resistant|2
7772708|NCT00670800|27017827|P1|Overall Study|2 controls were insulin resistant|0
7772709|NCT00670748|27017858|P4|Overall Study|Not off study|1
7772710|NCT00670748|27017859|P3|Overall Study|Not off study|1
7772711|NCT00670748|27017860|P2|Overall Study|Not off study|1
7772712|NCT00670748|27017861|P1|Overall Study|Not off study|2
7772713|NCT00670748|27017858|P4|Overall Study|Death during treatment|0
7772714|NCT00670748|27017859|P3|Overall Study|Death during treatment|1
7772715|NCT00670748|27017860|P2|Overall Study|Death during treatment|1
7772716|NCT00670748|27017861|P1|Overall Study|Death during treatment|1
7772717|NCT00670540|27017896|P1|Overall Study|missing information inclusion criteria|1
7772718|NCT00670540|27017896|P1|Overall Study|controls randomised for no follow up|2770
7772719|NCT00670540|27017896|P1|Overall Study|refused to participate|189
7772720|NCT00670540|27017896|P1|Overall Study|not living in France|348
7772721|NCT00670540|27017896|P1|Overall Study|ineligible|17
7772722|NCT00670488|27017916|P10|Overall Study|Withdrawal by Subject|0
7772723|NCT00670488|27017917|P9|Overall Study|Withdrawal by Subject|1
7772724|NCT00670488|27017918|P8|Overall Study|Withdrawal by Subject|0
7772725|NCT00670488|27017919|P7|Overall Study|Withdrawal by Subject|1
7772726|NCT00670488|27017920|P6|Overall Study|Withdrawal by Subject|0
7772727|NCT00670488|27017921|P5|Overall Study|Withdrawal by Subject|0
7772728|NCT00670488|27017922|P4|Overall Study|Withdrawal by Subject|1
7772729|NCT00670488|27017923|P3|Overall Study|Withdrawal by Subject|0
7772730|NCT00670488|27017924|P2|Overall Study|Withdrawal by Subject|1
7772731|NCT00670488|27017925|P1|Overall Study|Withdrawal by Subject|0
7772732|NCT00670488|27017916|P10|Overall Study|Progressive Disease|1
7772733|NCT00670488|27017917|P9|Overall Study|Progressive Disease|2
7772734|NCT00670488|27017918|P8|Overall Study|Progressive Disease|2
7772735|NCT00670488|27017919|P7|Overall Study|Progressive Disease|11
7772736|NCT00670488|27017920|P6|Overall Study|Progressive Disease|4
7772737|NCT00670488|27017921|P5|Overall Study|Progressive Disease|2
7772738|NCT00670488|27017922|P4|Overall Study|Progressive Disease|2
7772739|NCT00670488|27017923|P3|Overall Study|Progressive Disease|3
7772740|NCT00670488|27017924|P2|Overall Study|Progressive Disease|41
7772741|NCT00670488|27017925|P1|Overall Study|Progressive Disease|2
7772742|NCT00670488|27017916|P10|Overall Study|Physician Decision|0
7772743|NCT00670488|27017917|P9|Overall Study|Physician Decision|0
7772744|NCT00670488|27017918|P8|Overall Study|Physician Decision|0
7772745|NCT00670488|27017919|P7|Overall Study|Physician Decision|0
7772746|NCT00670488|27017920|P6|Overall Study|Physician Decision|0
7772747|NCT00670488|27017921|P5|Overall Study|Physician Decision|0
7772748|NCT00670488|27017922|P4|Overall Study|Physician Decision|1
7772749|NCT00670488|27017923|P3|Overall Study|Physician Decision|0
7772750|NCT00670488|27017924|P2|Overall Study|Physician Decision|9
7772751|NCT00670488|27017925|P1|Overall Study|Physician Decision|1
7772752|NCT00670488|27017916|P10|Overall Study|Adverse Event|1
7772753|NCT00670488|27017917|P9|Overall Study|Adverse Event|0
7772754|NCT00670488|27017918|P8|Overall Study|Adverse Event|1
7772755|NCT00670488|27017919|P7|Overall Study|Adverse Event|5
7772756|NCT00670488|27017920|P6|Overall Study|Adverse Event|1
7772757|NCT00670488|27017921|P5|Overall Study|Adverse Event|1
7772758|NCT00670488|27017922|P4|Overall Study|Adverse Event|3
7772759|NCT00670488|27017923|P3|Overall Study|Adverse Event|0
7772760|NCT00670488|27017924|P2|Overall Study|Adverse Event|7
7772761|NCT00670488|27017925|P1|Overall Study|Adverse Event|0
7772762|NCT00670449|27018112|P4|Overall Study|Abnormal Laboratory Value(s)|0
7772763|NCT00670449|27018113|P3|Overall Study|Abnormal Laboratory Value(s)|0
7772764|NCT00670449|27018114|P2|Overall Study|Abnormal Laboratory Value(s)|2
7772765|NCT00670449|27018115|P1|Overall Study|Abnormal Laboratory Value(s)|0
7772766|NCT00670449|27018112|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
7772767|NCT00670449|27018113|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
7772768|NCT00670449|27018114|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
7772769|NCT00670449|27018115|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
7772770|NCT00670449|27018112|P4|Overall Study|Subject Withdrew Consent|1
7772771|NCT00670449|27018113|P3|Overall Study|Subject Withdrew Consent|0
7772772|NCT00670449|27018114|P2|Overall Study|Subject Withdrew Consent|2
7772773|NCT00670449|27018115|P1|Overall Study|Subject Withdrew Consent|0
7772774|NCT00670449|27018112|P4|Overall Study|Administrative Problems|1
7772775|NCT00670449|27018113|P3|Overall Study|Administrative Problems|0
7772776|NCT00670449|27018114|P2|Overall Study|Administrative Problems|2
7772777|NCT00670449|27018115|P1|Overall Study|Administrative Problems|0
7772778|NCT00670449|27018112|P4|Overall Study|Protocol Deviation|1
7772779|NCT00670449|27018113|P3|Overall Study|Protocol Deviation|0
7772780|NCT00670449|27018114|P2|Overall Study|Protocol Deviation|2
7772781|NCT00670449|27018115|P1|Overall Study|Protocol Deviation|1
7772782|NCT00670449|27018112|P4|Overall Study|Adverse Event|5
7772783|NCT00670449|27018113|P3|Overall Study|Adverse Event|8
7772784|NCT00670449|27018114|P2|Overall Study|Adverse Event|2
7772785|NCT00670449|27018115|P1|Overall Study|Adverse Event|6
7772786|NCT00670306|27018139|P1|Overall Study|incl/excl criterias did not meet|19
7772787|NCT00670306|27018139|P1|Overall Study|Lost to Follow-up|8
7772788|NCT00670306|27018139|P1|Overall Study|Physician Decision|1
7772789|NCT00670306|27018139|P1|Overall Study|Withdrawal by Subject|9
7772790|NCT00670306|27018139|P1|Overall Study|Lack of Efficacy|10
7772791|NCT00670306|27018139|P1|Overall Study|Adverse Event|8
7772792|NCT00670228|27018178|P2|Overall Study|Not meeting the selection criteria|0
7772793|NCT00670228|27018179|P1|Overall Study|Not meeting the selection criteria|2
7772794|NCT00670228|27018178|P2|Overall Study|Not treated|2
7772795|NCT00670228|27018179|P1|Overall Study|Not treated|2
7772796|NCT00670228|27018178|P2|Overall Study|Death or MACE|1
7772797|NCT00670228|27018179|P1|Overall Study|Death or MACE|0
7772798|NCT00670228|27018178|P2|Overall Study|Adverse Event|0
7772799|NCT00670228|27018179|P1|Overall Study|Adverse Event|1
7772800|NCT00670111|27018203|P3|Enrollment to One Month|Physician Decision|0
7772801|NCT00670111|27018204|P2|Enrollment to One Month|Physician Decision|0
7772802|NCT00670111|27018205|P1|Enrollment to One Month|Physician Decision|1
7772803|NCT00670111|27018203|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
7772804|NCT00670111|27018204|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
7772805|NCT00670111|27018205|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
7772806|NCT00670111|27018203|P3|Enrollment to One Month|Testing Failure|13
7772807|NCT00670111|27018204|P2|Enrollment to One Month|Testing Failure|0
7772808|NCT00670111|27018205|P1|Enrollment to One Month|Testing Failure|0
7772809|NCT00670046|27018215|P2|Overall Study|Withdrawal by Subject|1
7772810|NCT00670046|27018216|P1|Overall Study|Withdrawal by Subject|0
7772811|NCT00670046|27018215|P2|Overall Study|Lost to Follow-up|1
7772812|NCT00670046|27018216|P1|Overall Study|Lost to Follow-up|1
7772813|NCT00670007|27018230|P1|Overall Study|Withdrawal by Subject|4
7772814|NCT00670007|27018230|P1|Overall Study|Adverse Event|1
7772815|NCT00670007|27018230|P1|Overall Study|Adverse event, serious fatal|1
7772816|NCT00670007|27018230|P1|Overall Study|Travel/Vacation|1
7772817|NCT00670007|27018230|P1|Overall Study|Lung transplant|1
7772818|NCT00670007|27018230|P1|Overall Study|Drug abuse|1
7772819|NCT00669955|27018257|P2|Overall Study|not compliant with study drug/visit|3
7772820|NCT00669955|27018258|P1|Overall Study|not compliant with study drug/visit|2
7772821|NCT00669955|27018257|P2|Overall Study|Investigator Sponsor Judgement|1
7772822|NCT00669955|27018258|P1|Overall Study|Investigator Sponsor Judgement|0
7772823|NCT00669955|27018257|P2|Overall Study|Protocol Violation|7
7772824|NCT00669955|27018258|P1|Overall Study|Protocol Violation|2
7772825|NCT00669955|27018257|P2|Overall Study|Lost to Follow-up|7
7772826|NCT00669955|27018258|P1|Overall Study|Lost to Follow-up|5
7772827|NCT00669955|27018257|P2|Overall Study|Withdrawal by Subject|3
7772828|NCT00669955|27018258|P1|Overall Study|Withdrawal by Subject|2
7772829|NCT00669955|27018257|P2|Overall Study|Death|1
7772830|NCT00669955|27018258|P1|Overall Study|Death|0
7772831|NCT00669955|27018257|P2|Overall Study|Adverse Event|5
7772832|NCT00669955|27018258|P1|Overall Study|Adverse Event|3
7772833|NCT00669942|27018288|P12|Parts 2 and 3|Protocol Violation|0
7772834|NCT00669942|27018289|P11|Parts 2 and 3|Protocol Violation|0
7772835|NCT00669942|27018290|P10|Parts 2 and 3|Protocol Violation|0
7772836|NCT00669942|27018291|P9|Parts 2 and 3|Protocol Violation|0
7772837|NCT00669942|27018292|P8|Parts 2 and 3|Protocol Violation|0
7772838|NCT00669942|27018293|P7|Parts 2 and 3|Protocol Violation|0
7772839|NCT00669942|27018294|P6|Parts 2 and 3|Protocol Violation|1
7772840|NCT00669942|27018295|P5|Parts 2 and 3|Protocol Violation|0
7772841|NCT00669942|27018296|P4|Parts 2 and 3|Protocol Violation|0
7772842|NCT00669942|27018297|P3|Parts 2 and 3|Protocol Violation|0
7772843|NCT00669942|27018298|P2|Parts 2 and 3|Protocol Violation|0
7772844|NCT00669942|27018299|P1|Parts 2 and 3|Protocol Violation|0
7772845|NCT00669942|27018288|P12|Parts 2 and 3|Withdrawal by Subject|0
7772846|NCT00669942|27018289|P11|Parts 2 and 3|Withdrawal by Subject|0
7772847|NCT00669942|27018290|P10|Parts 2 and 3|Withdrawal by Subject|0
7772848|NCT00669942|27018291|P9|Parts 2 and 3|Withdrawal by Subject|2
7772849|NCT00669942|27018292|P8|Parts 2 and 3|Withdrawal by Subject|0
7772850|NCT00669942|27018293|P7|Parts 2 and 3|Withdrawal by Subject|0
7772851|NCT00669942|27018294|P6|Parts 2 and 3|Withdrawal by Subject|1
7772852|NCT00669942|27018295|P5|Parts 2 and 3|Withdrawal by Subject|0
7772853|NCT00669942|27018296|P4|Parts 2 and 3|Withdrawal by Subject|0
7772854|NCT00669942|27018297|P3|Parts 2 and 3|Withdrawal by Subject|0
7772855|NCT00669942|27018298|P2|Parts 2 and 3|Withdrawal by Subject|0
7772856|NCT00669942|27018299|P1|Parts 2 and 3|Withdrawal by Subject|0
7772857|NCT00669942|27018288|P12|Parts 2 and 3|Adverse Event|0
7772858|NCT00669942|27018289|P11|Parts 2 and 3|Adverse Event|0
7772859|NCT00669942|27018290|P10|Parts 2 and 3|Adverse Event|0
7772860|NCT00669942|27018291|P9|Parts 2 and 3|Adverse Event|1
7772861|NCT00669942|27018292|P8|Parts 2 and 3|Adverse Event|2
7772862|NCT00669942|27018293|P7|Parts 2 and 3|Adverse Event|0
7772863|NCT00669942|27018294|P6|Parts 2 and 3|Adverse Event|0
7772864|NCT00669942|27018295|P5|Parts 2 and 3|Adverse Event|0
7772865|NCT00669942|27018296|P4|Parts 2 and 3|Adverse Event|0
7772866|NCT00669942|27018297|P3|Parts 2 and 3|Adverse Event|0
7772867|NCT00669942|27018298|P2|Parts 2 and 3|Adverse Event|0
7772868|NCT00669942|27018299|P1|Parts 2 and 3|Adverse Event|0
7772869|NCT00669903|27018382|P4|Overall Study|Protocol Violation|0
7772870|NCT00669903|27018383|P3|Overall Study|Protocol Violation|0
7772871|NCT00669903|27018384|P2|Overall Study|Protocol Violation|1
7772872|NCT00669903|27018385|P1|Overall Study|Protocol Violation|0
7772873|NCT00669903|27018382|P4|Overall Study|Lost to Follow-up|1
7772874|NCT00669903|27018383|P3|Overall Study|Lost to Follow-up|0
7772875|NCT00669903|27018384|P2|Overall Study|Lost to Follow-up|1
7772876|NCT00669903|27018385|P1|Overall Study|Lost to Follow-up|1
7772877|NCT00669903|27018382|P4|Overall Study|Withdrawal by Subject|2
7772878|NCT00669903|27018383|P3|Overall Study|Withdrawal by Subject|2
7772879|NCT00669903|27018384|P2|Overall Study|Withdrawal by Subject|2
7772880|NCT00669903|27018385|P1|Overall Study|Withdrawal by Subject|0
7772881|NCT00669903|27018382|P4|Overall Study|Adverse Event|1
7772882|NCT00669903|27018383|P3|Overall Study|Adverse Event|3
7772883|NCT00669903|27018384|P2|Overall Study|Adverse Event|1
7772884|NCT00669903|27018385|P1|Overall Study|Adverse Event|0
7772885|NCT00669877|27018415|P1|Overall Study|Disease Progression/Death|4
7772886|NCT00669864|27018420|P1|Overall Study|Other|2
7772887|NCT00669864|27018420|P1|Overall Study|Withdrawal by Subject|3
7772888|NCT00669864|27018420|P1|Overall Study|Protocol Violation|2
7772889|NCT00669864|27018420|P1|Overall Study|Lost to Follow-up|2
7772890|NCT00669669|27018434|P1|Overall Study|To late to start treatment|1
7772891|NCT00669617|27018439|P5|Period 3|Lost to Follow-up|0
7772892|NCT00669617|27018440|P4|Period 3|Lost to Follow-up|0
7772893|NCT00669617|27018441|P3|Period 3|Lost to Follow-up|0
7772894|NCT00669617|27018442|P2|Period 3|Lost to Follow-up|0
7772895|NCT00669617|27018443|P1|Period 3|Lost to Follow-up|1
7772896|NCT00669617|27018439|P5|Period 1|Protocol Deviation|1
7772897|NCT00669617|27018440|P4|Period 1|Protocol Deviation|0
7772898|NCT00669617|27018441|P3|Period 1|Protocol Deviation|0
7772899|NCT00669617|27018442|P2|Period 1|Protocol Deviation|0
7772900|NCT00669617|27018443|P1|Period 1|Protocol Deviation|0
7772901|NCT00669617|27018439|P5|Period 1|Withdrawal by Subject|0
7772902|NCT00669617|27018440|P4|Period 1|Withdrawal by Subject|0
7772903|NCT00669617|27018441|P3|Period 1|Withdrawal by Subject|1
7772904|NCT00669617|27018442|P2|Period 1|Withdrawal by Subject|0
7772905|NCT00669617|27018443|P1|Period 1|Withdrawal by Subject|0
7772906|NCT00669409|27018495|P11|Part 2|Withdrawal by Subject|0
7772907|NCT00669409|27018496|P10|Part 2|Withdrawal by Subject|1
7772908|NCT00669409|27018497|P9|Part 2|Withdrawal by Subject|0
7772909|NCT00669409|27018498|P8|Part 2|Withdrawal by Subject|0
7772910|NCT00669409|27018499|P7|Part 2|Withdrawal by Subject|0
7772911|NCT00669409|27018500|P6|Part 2|Withdrawal by Subject|0
7772912|NCT00669409|27018501|P5|Part 2|Withdrawal by Subject|0
7772913|NCT00669409|27018502|P4|Part 2|Withdrawal by Subject|0
7772914|NCT00669409|27018503|P3|Part 2|Withdrawal by Subject|0
7772915|NCT00669409|27018504|P2|Part 2|Withdrawal by Subject|0
7772916|NCT00669409|27018505|P1|Part 2|Withdrawal by Subject|0
7772917|NCT00669396|27018889|P2|Overall Study|Lost to Follow-up|12
7772918|NCT00669396|27018890|P1|Overall Study|Lost to Follow-up|10
7772919|NCT00669331|27018917|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
7772920|NCT00669331|27018918|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
7772921|NCT00669331|27018917|P2|Blinded Treatment Period|Physician Decision|3
7772922|NCT00669331|27018918|P1|Blinded Treatment Period|Physician Decision|3
7772923|NCT00669331|27018917|P2|Blinded Treatment Period|Death|2
7772924|NCT00669331|27018918|P1|Blinded Treatment Period|Death|0
7772925|NCT00669331|27018917|P2|Blinded Treatment Period|Lost to Follow-up|2
7772926|NCT00669331|27018918|P1|Blinded Treatment Period|Lost to Follow-up|3
7772927|NCT00669331|27018917|P2|Blinded Treatment Period|Withdrawal by Subject|19
7772928|NCT00669331|27018918|P1|Blinded Treatment Period|Withdrawal by Subject|17
7772929|NCT00669331|27018917|P2|Blinded Treatment Period|Protocol Violation|1
7772930|NCT00669331|27018918|P1|Blinded Treatment Period|Protocol Violation|1
7772931|NCT00669331|27018917|P2|Blinded Treatment Period|Adverse Event|10
7772932|NCT00669331|27018918|P1|Blinded Treatment Period|Adverse Event|16
7772933|NCT00669331|27018917|P2|Randomisation to First Dose|Randomised in error|10
7772934|NCT00669331|27018918|P1|Randomisation to First Dose|Randomised in error|3
7772935|NCT00669331|27018917|P2|Randomisation to First Dose|Sponsor decision|1
7772936|NCT00669331|27018918|P1|Randomisation to First Dose|Sponsor decision|0
7772937|NCT00669331|27018917|P2|Randomisation to First Dose|Death|0
7772938|NCT00669331|27018918|P1|Randomisation to First Dose|Death|1
7772939|NCT00669331|27018917|P2|Randomisation to First Dose|Lost to Follow-up|0
7772940|NCT00669331|27018918|P1|Randomisation to First Dose|Lost to Follow-up|2
7772941|NCT00669331|27018917|P2|Randomisation to First Dose|Withdrawal by Subject|2
7772942|NCT00669331|27018918|P1|Randomisation to First Dose|Withdrawal by Subject|3
7772943|NCT00669331|27018917|P2|Randomisation to First Dose|Protocol Violation|0
7772944|NCT00669331|27018918|P1|Randomisation to First Dose|Protocol Violation|1
7772945|NCT00669331|27018917|P2|Randomisation to First Dose|Adverse Event|0
7772946|NCT00669331|27018918|P1|Randomisation to First Dose|Adverse Event|1
7772947|NCT00669318|27018960|P1|Overall Study|Withdrawal by Subject|2
7772948|NCT00669240|27018977|P1|Overall Study|Enrolled but no dosing record|1
7772949|NCT00669240|27018977|P1|Overall Study|Enrolled but not treated|15
7772950|NCT00669240|27018977|P1|Overall Study|Other|19
7772951|NCT00669240|27018977|P1|Overall Study|Adverse Event|21
7772952|NCT00669240|27018977|P1|Overall Study|Lost to Follow-up|34
7772953|NCT00669240|27018977|P1|Overall Study|Withdrawal by Subject|42
7772954|NCT00669240|27018977|P1|Overall Study|Lack of Efficacy|33
7772955|NCT00669162|27019026|P1|Overall Study|Withdrawal by Subject|1
7772956|NCT00669110|27019032|P2|Overall Study|Withdrawal by Subject|2
7772957|NCT00669110|27019033|P1|Overall Study|Withdrawal by Subject|0
7772958|NCT00669110|27019032|P2|Overall Study|Protocol Violation|5
7772959|NCT00669110|27019033|P1|Overall Study|Protocol Violation|0
7772960|NCT00669110|27019032|P2|Overall Study|Lost to Follow-up|0
7772961|NCT00669110|27019033|P1|Overall Study|Lost to Follow-up|1
7772962|NCT00669110|27019032|P2|Overall Study|Physician Decision|1
7772963|NCT00669110|27019033|P1|Overall Study|Physician Decision|0
7772964|NCT00669110|27019032|P2|Overall Study|Caregiver request|2
7772965|NCT00669110|27019033|P1|Overall Study|Caregiver request|3
7772966|NCT00669110|27019032|P2|Overall Study|Adverse Event|3
7772967|NCT00669110|27019033|P1|Overall Study|Adverse Event|4
7772968|NCT00669071|27019069|P1|Overall Study|Final visit 40 days out of window|1
7772969|NCT00669071|27019069|P1|Overall Study|Lost to Follow-up|3
7772970|NCT00669032|27019090|P2|Overall Study|No fulfilment of the selection criteria|5
7772971|NCT00669032|27019091|P1|Overall Study|No fulfilment of the selection criteria|5
7772972|NCT00669032|27019090|P2|Overall Study|Physician Decision|1
7772973|NCT00669032|27019091|P1|Overall Study|Physician Decision|1
7772974|NCT00669032|27019090|P2|Overall Study|Adverse Event|16
7772975|NCT00669032|27019091|P1|Overall Study|Adverse Event|12
7772976|NCT00669032|27019090|P2|Overall Study|Withdrawal by Subject|13
7772977|NCT00669032|27019091|P1|Overall Study|Withdrawal by Subject|12
7772978|NCT00669032|27019090|P2|Overall Study|Lack of Efficacy|19
7772979|NCT00669032|27019091|P1|Overall Study|Lack of Efficacy|8
7772980|NCT00669032|27019090|P2|Overall Study|Lost to Follow-up|5
7772981|NCT00669032|27019091|P1|Overall Study|Lost to Follow-up|6
7772982|NCT00668863|27019137|P1|Overall Study|Physician Decision|1
7772983|NCT00668863|27019137|P1|Overall Study|Subject's work scheduling problem|1
7772984|NCT00668863|27019137|P1|Overall Study|Surgery|1
7772985|NCT00668863|27019137|P1|Overall Study|Withdrawal by Subject|1
7772986|NCT00668863|27019137|P1|Overall Study|Global Deterioration of Health Status|4
7772987|NCT00668863|27019137|P1|Overall Study|Study Terminated by Sponsor|8
7772988|NCT00668863|27019137|P1|Overall Study|Adverse Event|13
7772989|NCT00668863|27019137|P1|Overall Study|Objective Progression or Relapse|42
7772990|NCT00668746|27019169|P2|Overall Study|Lost to Follow-up|1
7772991|NCT00668746|27019170|P1|Overall Study|Lost to Follow-up|2
7772992|NCT00668733|27019190|P2|Overall Study|Withdrawal by Subject|4
7772993|NCT00668733|27019191|P1|Overall Study|Withdrawal by Subject|0
7772994|NCT00668733|27019190|P2|Overall Study|Lost to Follow-up|3
7772995|NCT00668733|27019191|P1|Overall Study|Lost to Follow-up|2
7772996|NCT00668707|27019199|P2|Overall Study|Death|4
7772997|NCT00668707|27019200|P1|Overall Study|Death|11
7772998|NCT00668707|27019199|P2|Overall Study|Protocol Violation|12
7772999|NCT00668707|27019200|P1|Overall Study|Protocol Violation|10
7773000|NCT00668707|27019199|P2|Overall Study|Lost to Follow-up|6
7773001|NCT00668707|27019200|P1|Overall Study|Lost to Follow-up|3
7773002|NCT00668707|27019199|P2|Overall Study|Withdrawal by Subject|100
7773003|NCT00668707|27019200|P1|Overall Study|Withdrawal by Subject|117
7773004|NCT00668707|27019199|P2|Overall Study|Cancer Recurrence|58
7773005|NCT00668707|27019200|P1|Overall Study|Cancer Recurrence|58
7773006|NCT00668395|27019267|P3|Overall Study|Physician Decision|0
7773007|NCT00668395|27019268|P2|Overall Study|Physician Decision|1
7773008|NCT00668395|27019269|P1|Overall Study|Physician Decision|1
7773009|NCT00668395|27019267|P3|Overall Study|Adverse Event|0
7773010|NCT00668395|27019268|P2|Overall Study|Adverse Event|1
7773011|NCT00668395|27019269|P1|Overall Study|Adverse Event|1
7773012|NCT00668395|27019267|P3|Overall Study|Withdrawal by Subject|1
7773013|NCT00668395|27019268|P2|Overall Study|Withdrawal by Subject|4
7773014|NCT00668395|27019269|P1|Overall Study|Withdrawal by Subject|4
7773015|NCT00668317|27019281|P1|Overall Study|Adverse Event|2
7773016|NCT00668200|27019296|P1|Overall Study|Lost to Follow-up|1
7773017|NCT00668200|27019296|P1|Overall Study|Withdrawal by Subject|2
7773018|NCT00668148|27019302|P1|Overall Study|Withdrawal of Consent|2
7773019|NCT00668148|27019302|P1|Overall Study|Progressive Disease Before Treatment|2
7773020|NCT00668148|27019302|P1|Overall Study|Subject Non-compliance|1
7773021|NCT00668148|27019302|P1|Overall Study|Adverse Event|5
7773022|NCT00667992|27019341|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
7773023|NCT00667992|27019342|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
7773024|NCT00667992|27019341|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
7773025|NCT00667992|27019342|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
7773026|NCT00667992|27019341|P2|Wash-out|Withdrawal by Subject|0
7773027|NCT00667992|27019342|P1|Wash-out|Withdrawal by Subject|1
7773028|NCT00667992|27019341|P2|Wash-out|Failure to wash-out|2
7773029|NCT00667992|27019342|P1|Wash-out|Failure to wash-out|2
7773030|NCT00667992|27019341|P2|Wash-out|Not within one doubling dilution|3
7773031|NCT00667992|27019342|P1|Wash-out|Not within one doubling dilution|4
7773032|NCT00667992|27019341|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
7773033|NCT00667992|27019342|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
7773034|NCT00667992|27019341|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
7773035|NCT00667992|27019342|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
7773036|NCT00667992|27019341|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
7773037|NCT00667992|27019342|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
7773038|NCT00667992|27019341|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
7773039|NCT00667992|27019342|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
7773040|NCT00667992|27019341|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
7773041|NCT00667992|27019342|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
7773042|NCT00667992|27019341|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
7773043|NCT00667992|27019342|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
7773044|NCT00667992|27019341|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
7773045|NCT00667992|27019342|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
7773046|NCT00667992|27019341|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
7773047|NCT00667992|27019342|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
7773048|NCT00667888|27019398|P2|Overall Study|Ineligible after SIM|2
7773049|NCT00667888|27019399|P1|Overall Study|Ineligible after SIM|0
7773050|NCT00667888|27019398|P2|Overall Study|Proceed with other treatment|3
7773051|NCT00667888|27019399|P1|Overall Study|Proceed with other treatment|3
7773052|NCT00667888|27019398|P2|Overall Study|Withdrawal by Subject|3
7773053|NCT00667888|27019399|P1|Overall Study|Withdrawal by Subject|6
7773054|NCT00667888|27019398|P2|Overall Study|Death|1
7773055|NCT00667888|27019399|P1|Overall Study|Death|1
7773056|NCT00667875|27019408|P3|Overall Study|Withdrawal by Subject|7
7773057|NCT00667875|27019409|P2|Overall Study|Withdrawal by Subject|9
7773058|NCT00667875|27019410|P1|Overall Study|Withdrawal by Subject|10
7773059|NCT00667875|27019408|P3|Overall Study|Adverse Event|6
7773060|NCT00667875|27019409|P2|Overall Study|Adverse Event|2
7773061|NCT00667875|27019410|P1|Overall Study|Adverse Event|0
7773062|NCT00667862|27019427|P1|Overall Study|Withdrawal by Subject|3
7773063|NCT00667862|27019427|P1|Overall Study|Disease Progression|22
7773064|NCT00667862|27019427|P1|Overall Study|Death|1
7773065|NCT00667862|27019427|P1|Overall Study|Adverse Event|9
7773066|NCT00667810|27019455|P4|Overall Study|Other|0
7773067|NCT00667810|27019456|P3|Overall Study|Other|5
7773068|NCT00667810|27019457|P2|Overall Study|Other|6
7773069|NCT00667810|27019458|P1|Overall Study|Other|6
7773070|NCT00667810|27019455|P4|Overall Study|Vasogenic Edema Recurrence|0
7773071|NCT00667810|27019456|P3|Overall Study|Vasogenic Edema Recurrence|0
7773072|NCT00667810|27019457|P2|Overall Study|Vasogenic Edema Recurrence|3
7773073|NCT00667810|27019458|P1|Overall Study|Vasogenic Edema Recurrence|0
7773074|NCT00667810|27019455|P4|Overall Study|Loss of Caregiver|0
7773075|NCT00667810|27019456|P3|Overall Study|Loss of Caregiver|3
7773076|NCT00667810|27019457|P2|Overall Study|Loss of Caregiver|1
7773077|NCT00667810|27019458|P1|Overall Study|Loss of Caregiver|0
7773078|NCT00667810|27019455|P4|Overall Study|Failed to Return|0
7773079|NCT00667810|27019456|P3|Overall Study|Failed to Return|2
7773080|NCT00667810|27019457|P2|Overall Study|Failed to Return|0
7773081|NCT00667810|27019458|P1|Overall Study|Failed to Return|0
7773082|NCT00667810|27019455|P4|Overall Study|Discontinuation of Study by Sponsor|0
7773083|NCT00667810|27019456|P3|Overall Study|Discontinuation of Study by Sponsor|155
7773084|NCT00667810|27019457|P2|Overall Study|Discontinuation of Study by Sponsor|118
7773085|NCT00667810|27019458|P1|Overall Study|Discontinuation of Study by Sponsor|130
7773086|NCT00667810|27019455|P4|Overall Study|Withdrawal by Subject|1
7773087|NCT00667810|27019456|P3|Overall Study|Withdrawal by Subject|29
7773088|NCT00667810|27019457|P2|Overall Study|Withdrawal by Subject|20
7773089|NCT00667810|27019458|P1|Overall Study|Withdrawal by Subject|14
7773090|NCT00667810|27019455|P4|Overall Study|Protocol Violation|0
7773091|NCT00667810|27019456|P3|Overall Study|Protocol Violation|0
7773092|NCT00667810|27019457|P2|Overall Study|Protocol Violation|2
7773093|NCT00667810|27019458|P1|Overall Study|Protocol Violation|0
7773094|NCT00667810|27019455|P4|Overall Study|Physician Decision|0
7773095|NCT00667810|27019456|P3|Overall Study|Physician Decision|2
7773096|NCT00667810|27019457|P2|Overall Study|Physician Decision|1
7773097|NCT00667810|27019458|P1|Overall Study|Physician Decision|1
7773098|NCT00667810|27019455|P4|Overall Study|Lost to Follow-up|0
7773099|NCT00667810|27019456|P3|Overall Study|Lost to Follow-up|2
7773100|NCT00667810|27019457|P2|Overall Study|Lost to Follow-up|4
7773101|NCT00667810|27019458|P1|Overall Study|Lost to Follow-up|1
7773102|NCT00667810|27019455|P4|Overall Study|Lack of Efficacy|0
7773103|NCT00667810|27019456|P3|Overall Study|Lack of Efficacy|2
7773104|NCT00667810|27019457|P2|Overall Study|Lack of Efficacy|0
7773105|NCT00667810|27019458|P1|Overall Study|Lack of Efficacy|1
7773106|NCT00667810|27019455|P4|Overall Study|Death|0
7773107|NCT00667810|27019456|P3|Overall Study|Death|3
7773108|NCT00667810|27019457|P2|Overall Study|Death|1
7773109|NCT00667810|27019458|P1|Overall Study|Death|1
7773110|NCT00667810|27019455|P4|Overall Study|Adverse Event|1
7773111|NCT00667810|27019456|P3|Overall Study|Adverse Event|19
7773112|NCT00667810|27019457|P2|Overall Study|Adverse Event|14
7773113|NCT00667810|27019458|P1|Overall Study|Adverse Event|13
7773114|NCT00667732|27019534|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
7773115|NCT00667732|27019535|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
7773116|NCT00667732|27019536|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
7773117|NCT00667732|27019534|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
7773118|NCT00667732|27019535|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
7773119|NCT00667732|27019536|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
7773120|NCT00667732|27019534|P3|Run -In (8 Weeks)|Adverse Event|0
7773121|NCT00667732|27019535|P2|Run -In (8 Weeks)|Adverse Event|0
7773122|NCT00667732|27019536|P1|Run -In (8 Weeks)|Adverse Event|4
7773123|NCT00667719|27019547|P1|Overall Study|Lost to Follow-up|8
7773124|NCT00667719|27019547|P1|Overall Study|Withdrawal by Subject|17
7773125|NCT00667719|27019547|P1|Overall Study|Protocol Violation|3
7773126|NCT00667719|27019547|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
7773127|NCT00667719|27019547|P1|Overall Study|Abnormal Test Procedure|1
7773128|NCT00667719|27019547|P1|Overall Study|Adverse Event|39
7773129|NCT00667602|27019585|P3|Overall Study|Protocol Violation|0
7773130|NCT00667602|27019586|P2|Overall Study|Protocol Violation|1
7773131|NCT00667602|27019587|P1|Overall Study|Protocol Violation|0
7773132|NCT00667602|27019585|P3|Overall Study|Administrative reason|2
7773133|NCT00667602|27019586|P2|Overall Study|Administrative reason|0
7773134|NCT00667602|27019587|P1|Overall Study|Administrative reason|0
7773135|NCT00667602|27019585|P3|Overall Study|Lost to Follow-up|6
7773136|NCT00667602|27019586|P2|Overall Study|Lost to Follow-up|5
7773137|NCT00667602|27019587|P1|Overall Study|Lost to Follow-up|4
7773138|NCT00667602|27019585|P3|Overall Study|Withdrawal by Subject|10
7773139|NCT00667602|27019586|P2|Overall Study|Withdrawal by Subject|9
7773140|NCT00667602|27019587|P1|Overall Study|Withdrawal by Subject|4
7773141|NCT00667576|27019655|P5|Overall Study|Missed Visit|0
7773142|NCT00667576|27019656|P4|Overall Study|Missed Visit|1
7773143|NCT00667576|27019657|P3|Overall Study|Missed Visit|0
7773144|NCT00667576|27019658|P2|Overall Study|Missed Visit|0
7773145|NCT00667576|27019659|P1|Overall Study|Missed Visit|0
7773146|NCT00667576|27019655|P5|Overall Study|Physician Decision|0
7773147|NCT00667576|27019656|P4|Overall Study|Physician Decision|1
7773148|NCT00667576|27019657|P3|Overall Study|Physician Decision|0
7773149|NCT00667576|27019658|P2|Overall Study|Physician Decision|0
7773150|NCT00667576|27019659|P1|Overall Study|Physician Decision|0
7773151|NCT00667576|27019655|P5|Overall Study|Protocol Violation|0
7773152|NCT00667576|27019656|P4|Overall Study|Protocol Violation|1
7773153|NCT00667576|27019657|P3|Overall Study|Protocol Violation|0
7773154|NCT00667576|27019658|P2|Overall Study|Protocol Violation|0
7773155|NCT00667576|27019659|P1|Overall Study|Protocol Violation|0
7773156|NCT00667576|27019655|P5|Overall Study|Lost to Follow-up|0
7773157|NCT00667576|27019656|P4|Overall Study|Lost to Follow-up|0
7773158|NCT00667576|27019657|P3|Overall Study|Lost to Follow-up|1
7773159|NCT00667576|27019658|P2|Overall Study|Lost to Follow-up|0
7773160|NCT00667576|27019659|P1|Overall Study|Lost to Follow-up|0
7773161|NCT00667576|27019655|P5|Overall Study|Adverse Event|0
7773162|NCT00667576|27019656|P4|Overall Study|Adverse Event|0
7773163|NCT00667576|27019657|P3|Overall Study|Adverse Event|0
7773164|NCT00667576|27019658|P2|Overall Study|Adverse Event|1
7773165|NCT00667576|27019659|P1|Overall Study|Adverse Event|1
7773166|NCT00667576|27019655|P5|Overall Study|Withdrawal by Subject|1
7773167|NCT00667576|27019656|P4|Overall Study|Withdrawal by Subject|1
7773168|NCT00667576|27019657|P3|Overall Study|Withdrawal by Subject|1
7773169|NCT00667576|27019658|P2|Overall Study|Withdrawal by Subject|0
7773170|NCT00667576|27019659|P1|Overall Study|Withdrawal by Subject|1
7773171|NCT00667563|27019706|P1|Overall Study|Protocol Violation|24
7773172|NCT00667459|27019726|P2|Overall Study|Lost to Follow-up|43
7773173|NCT00667459|27019727|P1|Overall Study|Lost to Follow-up|8
7773174|NCT00667459|27019726|P2|Overall Study|Death|2
7773175|NCT00667459|27019727|P1|Overall Study|Death|0
7773176|NCT00667446|27019769|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
7773177|NCT00667446|27019770|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
7773178|NCT00667446|27019769|P2|Treatment Period (36 Months)|Therapeutic Failure|1
7773179|NCT00667446|27019770|P1|Treatment Period (36 Months)|Therapeutic Failure|1
7773180|NCT00667446|27019769|P2|Treatment Period (36 Months)|Protocol Violation|1
7773181|NCT00667446|27019770|P1|Treatment Period (36 Months)|Protocol Violation|1
7773182|NCT00667446|27019769|P2|Treatment Period (36 Months)|Lost to Follow-up|0
7773183|NCT00667446|27019770|P1|Treatment Period (36 Months)|Lost to Follow-up|1
7773184|NCT00667446|27019769|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
7773185|NCT00667446|27019770|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
7773186|NCT00667446|27019769|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
7773187|NCT00667446|27019770|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
7773188|NCT00667446|27019769|P2|Treatment Period (36 Months)|Personal reasons|2
7773189|NCT00667446|27019770|P1|Treatment Period (36 Months)|Personal reasons|2
7773190|NCT00667446|27019769|P2|Treatment Period (36 Months)|Other|2
7773191|NCT00667446|27019770|P1|Treatment Period (36 Months)|Other|2
7773192|NCT00667446|27019769|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
7773193|NCT00667446|27019770|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
7773194|NCT00667420|27019792|P1|Overall Study|Withdrawal by Subject|2
7773195|NCT00667420|27019792|P1|Overall Study|Physician Decision|1
7773196|NCT00667420|27019792|P1|Overall Study|Lack of Efficacy|5
7773197|NCT00667420|27019792|P1|Overall Study|Adverse Event|2
7773198|NCT00667394|27019802|P2|Overall Study|Progressive disease|0
7773199|NCT00667394|27019803|P1|Overall Study|Progressive disease|1
7773200|NCT00667394|27019802|P2|Overall Study|Adverse Event|0
7773201|NCT00667394|27019803|P1|Overall Study|Adverse Event|3
7773202|NCT00667368|27019830|P2|Overall Study|Discontinued early|17
7773203|NCT00667368|27019831|P1|Overall Study|Discontinued early|24
7773204|NCT00667368|27019830|P2|Overall Study|Lost to Follow-up|155
7773205|NCT00667368|27019831|P1|Overall Study|Lost to Follow-up|176
7773206|NCT00667355|27019839|P1|Overall Study|Other reason was not specified|5
7773207|NCT00667355|27019839|P1|Overall Study|Lost to Follow-up|1
7773208|NCT00667355|27019839|P1|Overall Study|Adverse Event|5
7773209|NCT00667342|27019864|P3|Overall Study|Ineligible|1
7773210|NCT00667342|27019865|P2|Overall Study|Ineligible|0
7773211|NCT00667342|27019866|P1|Overall Study|Ineligible|0
7773212|NCT00667342|27019864|P3|Overall Study|Adverse Event|1
7773213|NCT00667342|27019865|P2|Overall Study|Adverse Event|0
7773214|NCT00667342|27019866|P1|Overall Study|Adverse Event|0
7773215|NCT00667342|27019864|P3|Overall Study|Relapse or tumor progression|7
7773216|NCT00667342|27019865|P2|Overall Study|Relapse or tumor progression|0
7773217|NCT00667342|27019866|P1|Overall Study|Relapse or tumor progression|9
7773218|NCT00667342|27019864|P3|Overall Study|Physician Decision|0
7773219|NCT00667342|27019865|P2|Overall Study|Physician Decision|0
7773220|NCT00667342|27019866|P1|Overall Study|Physician Decision|3
7773221|NCT00667342|27019864|P3|Overall Study|Withdrawal by Subject|0
7773222|NCT00667342|27019865|P2|Overall Study|Withdrawal by Subject|0
7773223|NCT00667342|27019866|P1|Overall Study|Withdrawal by Subject|1
7773224|NCT00667342|27019864|P3|Overall Study|Protocol Violation|0
7773225|NCT00667342|27019865|P2|Overall Study|Protocol Violation|0
7773226|NCT00667342|27019866|P1|Overall Study|Protocol Violation|1
7773227|NCT00667277|27019904|P1|Overall Study|Withdrawal by Subject|2
7773228|NCT00667251|27019911|P2|Overall Study|Symptomatic progression|2
7773229|NCT00667251|27019912|P1|Overall Study|Symptomatic progression|1
7773230|NCT00667251|27019911|P2|Overall Study|Intercurrent Illness|3
7773231|NCT00667251|27019912|P1|Overall Study|Intercurrent Illness|4
7773232|NCT00667251|27019911|P2|Overall Study|Other/missing|84
7773233|NCT00667251|27019912|P1|Overall Study|Other/missing|46
7773234|NCT00667251|27019911|P2|Overall Study|Withdrawal by Subject|2
7773235|NCT00667251|27019912|P1|Overall Study|Withdrawal by Subject|6
7773236|NCT00667251|27019911|P2|Overall Study|Adverse Event|4
7773237|NCT00667251|27019912|P1|Overall Study|Adverse Event|13
7773238|NCT00667225|27019938|P2|Overall Study|Lost to Follow-up|1
7773239|NCT00667225|27019939|P1|Overall Study|Lost to Follow-up|0
7773240|NCT00667225|27019938|P2|Overall Study|Subject had no more lesions to treat.|0
7773241|NCT00667225|27019939|P1|Overall Study|Subject had no more lesions to treat.|1
7773242|NCT00667095|27019960|P2|Overall Study|Withdrawal by Subject|1
7773243|NCT00667095|27019961|P1|Overall Study|Withdrawal by Subject|0
7773244|NCT00667017|27019977|P1|Overall Study|Withdrawal by Subject|1
7773245|NCT00666965|27020006|P4|Overall Study|Withdrawal by Subject|2
7773246|NCT00666965|27020007|P3|Overall Study|Withdrawal by Subject|0
7773247|NCT00666965|27020008|P2|Overall Study|Withdrawal by Subject|0
7773248|NCT00666965|27020009|P1|Overall Study|Withdrawal by Subject|0
7773249|NCT00666965|27020006|P4|Overall Study|Discontinuation criteria|2
7773250|NCT00666965|27020007|P3|Overall Study|Discontinuation criteria|1
7773251|NCT00666965|27020008|P2|Overall Study|Discontinuation criteria|1
7773252|NCT00666965|27020009|P1|Overall Study|Discontinuation criteria|2
7773253|NCT00666965|27020006|P4|Overall Study|Protocol Violation|2
7773254|NCT00666965|27020007|P3|Overall Study|Protocol Violation|0
7773255|NCT00666965|27020008|P2|Overall Study|Protocol Violation|0
7773256|NCT00666965|27020009|P1|Overall Study|Protocol Violation|0
7773257|NCT00666965|27020006|P4|Overall Study|Lack of Efficacy|0
7773258|NCT00666965|27020007|P3|Overall Study|Lack of Efficacy|0
7773259|NCT00666965|27020008|P2|Overall Study|Lack of Efficacy|1
7773260|NCT00666965|27020009|P1|Overall Study|Lack of Efficacy|1
7773261|NCT00666965|27020006|P4|Overall Study|Adverse Event|9
7773262|NCT00666965|27020007|P3|Overall Study|Adverse Event|1
7773263|NCT00666965|27020008|P2|Overall Study|Adverse Event|2
7773264|NCT00666965|27020009|P1|Overall Study|Adverse Event|0
7773265|NCT00666926|27020039|P16|Overall Study|Death|0
7773266|NCT00666926|27020040|P15|Overall Study|Death|0
7773267|NCT00666926|27020041|P14|Overall Study|Death|0
7773268|NCT00666926|27020042|P13|Overall Study|Death|0
7773269|NCT00666926|27020043|P12|Overall Study|Death|1
7773270|NCT00666926|27020044|P11|Overall Study|Death|0
7773271|NCT00666926|27020045|P10|Overall Study|Death|0
7773272|NCT00666926|27020046|P9|Overall Study|Death|0
7773273|NCT00666926|27020047|P8|Overall Study|Death|0
7773274|NCT00666926|27020048|P7|Overall Study|Death|0
7773275|NCT00666926|27020049|P6|Overall Study|Death|0
7773276|NCT00666926|27020050|P5|Overall Study|Death|0
7773277|NCT00666926|27020051|P4|Overall Study|Death|0
7773278|NCT00666926|27020052|P3|Overall Study|Death|0
7773279|NCT00666926|27020053|P2|Overall Study|Death|0
7773280|NCT00666926|27020054|P1|Overall Study|Death|0
7773281|NCT00666926|27020039|P16|Overall Study|Withdrawal by Subject|3
7773282|NCT00666926|27020040|P15|Overall Study|Withdrawal by Subject|3
7773283|NCT00666926|27020041|P14|Overall Study|Withdrawal by Subject|1
7773284|NCT00666926|27020042|P13|Overall Study|Withdrawal by Subject|0
7773285|NCT00666926|27020043|P12|Overall Study|Withdrawal by Subject|3
7773286|NCT00666926|27020044|P11|Overall Study|Withdrawal by Subject|0
7773287|NCT00666926|27020045|P10|Overall Study|Withdrawal by Subject|3
7773288|NCT00666926|27020046|P9|Overall Study|Withdrawal by Subject|0
7773289|NCT00666926|27020047|P8|Overall Study|Withdrawal by Subject|1
7773290|NCT00666926|27020048|P7|Overall Study|Withdrawal by Subject|0
7773291|NCT00666926|27020049|P6|Overall Study|Withdrawal by Subject|0
7773292|NCT00666926|27020050|P5|Overall Study|Withdrawal by Subject|0
7773293|NCT00666926|27020051|P4|Overall Study|Withdrawal by Subject|0
7773294|NCT00666926|27020052|P3|Overall Study|Withdrawal by Subject|0
7773295|NCT00666926|27020053|P2|Overall Study|Withdrawal by Subject|0
7773296|NCT00666926|27020054|P1|Overall Study|Withdrawal by Subject|0
7773297|NCT00666926|27020039|P16|Overall Study|Other|4
7773298|NCT00666926|27020040|P15|Overall Study|Other|4
7773299|NCT00666926|27020041|P14|Overall Study|Other|2
7773300|NCT00666926|27020042|P13|Overall Study|Other|3
7773301|NCT00666926|27020043|P12|Overall Study|Other|26
7773302|NCT00666926|27020044|P11|Overall Study|Other|3
7773303|NCT00666926|27020045|P10|Overall Study|Other|5
7773304|NCT00666926|27020046|P9|Overall Study|Other|3
7773305|NCT00666926|27020047|P8|Overall Study|Other|0
7773306|NCT00666926|27020048|P7|Overall Study|Other|4
7773307|NCT00666926|27020049|P6|Overall Study|Other|3
7773308|NCT00666926|27020050|P5|Overall Study|Other|3
7773309|NCT00666926|27020051|P4|Overall Study|Other|3
7773310|NCT00666926|27020052|P3|Overall Study|Other|3
7773311|NCT00666926|27020053|P2|Overall Study|Other|4
7773312|NCT00666926|27020054|P1|Overall Study|Other|2
7773313|NCT00666926|27020039|P16|Overall Study|Lost to Follow-up|0
7773314|NCT00666926|27020040|P15|Overall Study|Lost to Follow-up|0
7773315|NCT00666926|27020041|P14|Overall Study|Lost to Follow-up|0
7773316|NCT00666926|27020042|P13|Overall Study|Lost to Follow-up|0
7773317|NCT00666926|27020043|P12|Overall Study|Lost to Follow-up|0
7773318|NCT00666926|27020044|P11|Overall Study|Lost to Follow-up|0
7773319|NCT00666926|27020045|P10|Overall Study|Lost to Follow-up|0
7773320|NCT00666926|27020046|P9|Overall Study|Lost to Follow-up|0
7773321|NCT00666926|27020047|P8|Overall Study|Lost to Follow-up|0
7773322|NCT00666926|27020048|P7|Overall Study|Lost to Follow-up|0
7773323|NCT00666926|27020049|P6|Overall Study|Lost to Follow-up|0
7773324|NCT00666926|27020050|P5|Overall Study|Lost to Follow-up|0
7773325|NCT00666926|27020051|P4|Overall Study|Lost to Follow-up|1
7773326|NCT00666926|27020052|P3|Overall Study|Lost to Follow-up|0
7773327|NCT00666926|27020053|P2|Overall Study|Lost to Follow-up|0
7773328|NCT00666926|27020054|P1|Overall Study|Lost to Follow-up|0
7773329|NCT00666926|27020039|P16|Overall Study|Lack of Efficacy|0
7773330|NCT00666926|27020040|P15|Overall Study|Lack of Efficacy|0
7773331|NCT00666926|27020041|P14|Overall Study|Lack of Efficacy|0
7773332|NCT00666926|27020042|P13|Overall Study|Lack of Efficacy|0
7773333|NCT00666926|27020043|P12|Overall Study|Lack of Efficacy|1
7773334|NCT00666926|27020044|P11|Overall Study|Lack of Efficacy|0
7773335|NCT00666926|27020045|P10|Overall Study|Lack of Efficacy|0
7773336|NCT00666926|27020046|P9|Overall Study|Lack of Efficacy|0
7773337|NCT00666926|27020047|P8|Overall Study|Lack of Efficacy|0
7773338|NCT00666926|27020048|P7|Overall Study|Lack of Efficacy|0
7773339|NCT00666926|27020049|P6|Overall Study|Lack of Efficacy|1
7773340|NCT00666926|27020050|P5|Overall Study|Lack of Efficacy|0
7773341|NCT00666926|27020051|P4|Overall Study|Lack of Efficacy|0
7773342|NCT00666926|27020052|P3|Overall Study|Lack of Efficacy|0
7773343|NCT00666926|27020053|P2|Overall Study|Lack of Efficacy|0
7773344|NCT00666926|27020054|P1|Overall Study|Lack of Efficacy|0
7773345|NCT00666926|27020039|P16|Overall Study|Laboratory abnormality|1
7773346|NCT00666926|27020040|P15|Overall Study|Laboratory abnormality|0
7773347|NCT00666926|27020041|P14|Overall Study|Laboratory abnormality|0
7773348|NCT00666926|27020042|P13|Overall Study|Laboratory abnormality|0
7773349|NCT00666926|27020043|P12|Overall Study|Laboratory abnormality|0
7773350|NCT00666926|27020044|P11|Overall Study|Laboratory abnormality|1
7773351|NCT00666926|27020045|P10|Overall Study|Laboratory abnormality|0
7773352|NCT00666926|27020046|P9|Overall Study|Laboratory abnormality|0
7773353|NCT00666926|27020047|P8|Overall Study|Laboratory abnormality|0
7773354|NCT00666926|27020048|P7|Overall Study|Laboratory abnormality|0
7773355|NCT00666926|27020049|P6|Overall Study|Laboratory abnormality|0
7773356|NCT00666926|27020050|P5|Overall Study|Laboratory abnormality|0
7773357|NCT00666926|27020051|P4|Overall Study|Laboratory abnormality|0
7773358|NCT00666926|27020052|P3|Overall Study|Laboratory abnormality|0
7773359|NCT00666926|27020053|P2|Overall Study|Laboratory abnormality|0
7773360|NCT00666926|27020054|P1|Overall Study|Laboratory abnormality|0
7773361|NCT00666926|27020039|P16|Overall Study|Adverse Event|0
7773362|NCT00666926|27020040|P15|Overall Study|Adverse Event|0
7773363|NCT00666926|27020041|P14|Overall Study|Adverse Event|1
7773364|NCT00666926|27020042|P13|Overall Study|Adverse Event|0
7773365|NCT00666926|27020043|P12|Overall Study|Adverse Event|2
7773366|NCT00666926|27020044|P11|Overall Study|Adverse Event|2
7773367|NCT00666926|27020045|P10|Overall Study|Adverse Event|2
7773368|NCT00666926|27020046|P9|Overall Study|Adverse Event|0
7773369|NCT00666926|27020047|P8|Overall Study|Adverse Event|0
7773370|NCT00666926|27020048|P7|Overall Study|Adverse Event|0
7773371|NCT00666926|27020049|P6|Overall Study|Adverse Event|0
7773372|NCT00666926|27020050|P5|Overall Study|Adverse Event|0
7773373|NCT00666926|27020051|P4|Overall Study|Adverse Event|0
7773374|NCT00666926|27020052|P3|Overall Study|Adverse Event|0
7773375|NCT00666926|27020053|P2|Overall Study|Adverse Event|0
7773376|NCT00666926|27020054|P1|Overall Study|Adverse Event|0
7773377|NCT00666835|27020363|P2|Overall Study|Physician Decision|2
7773378|NCT00666835|27020364|P1|Overall Study|Physician Decision|1
7773379|NCT00666835|27020363|P2|Overall Study|Planned operation|0
7773380|NCT00666835|27020364|P1|Overall Study|Planned operation|2
7773381|NCT00666835|27020363|P2|Overall Study|Hemoglobulin concentration|3
7773382|NCT00666835|27020364|P1|Overall Study|Hemoglobulin concentration|4
7773383|NCT00666835|27020363|P2|Overall Study|Kidney Transplantation (NTX)|2
7773384|NCT00666835|27020364|P1|Overall Study|Kidney Transplantation (NTX)|10
7773385|NCT00666835|27020363|P2|Overall Study|Death|4
7773386|NCT00666835|27020364|P1|Overall Study|Death|15
7773387|NCT00666835|27020363|P2|Overall Study|Protocol Violation|0
7773388|NCT00666835|27020364|P1|Overall Study|Protocol Violation|2
7773389|NCT00666835|27020363|P2|Overall Study|Adverse Event|6
7773390|NCT00666835|27020364|P1|Overall Study|Adverse Event|7
7773391|NCT00666835|27020363|P2|Overall Study|Incl./excl. not fulfilled|2
7773392|NCT00666835|27020364|P1|Overall Study|Incl./excl. not fulfilled|7
7773393|NCT00666835|27020363|P2|Overall Study|Lack of Efficacy|1
7773394|NCT00666835|27020364|P1|Overall Study|Lack of Efficacy|0
7773395|NCT00666835|27020363|P2|Overall Study|Withdrawal by Subject|2
7773396|NCT00666835|27020364|P1|Overall Study|Withdrawal by Subject|5
7773397|NCT00666757|27020374|P2|Overall Study|Sponsor decision|1
7773398|NCT00666757|27020375|P1|Overall Study|Sponsor decision|0
7773399|NCT00666757|27020374|P2|Overall Study|Physician Decision|2
7773400|NCT00666757|27020375|P1|Overall Study|Physician Decision|0
7773401|NCT00666757|27020374|P2|Overall Study|Lack of Efficacy|6
7773402|NCT00666757|27020375|P1|Overall Study|Lack of Efficacy|3
7773403|NCT00666757|27020374|P2|Overall Study|Withdrawal by Subject|17
7773404|NCT00666757|27020375|P1|Overall Study|Withdrawal by Subject|13
7773405|NCT00666757|27020374|P2|Overall Study|Adverse Event|12
7773406|NCT00666757|27020375|P1|Overall Study|Adverse Event|22
7773407|NCT00666757|27020374|P2|Overall Study|Protocol Violation|24
7773408|NCT00666757|27020375|P1|Overall Study|Protocol Violation|23
7773409|NCT00666757|27020374|P2|Overall Study|Lost to Follow-up|35
7773410|NCT00666757|27020375|P1|Overall Study|Lost to Follow-up|39
7773411|NCT00666718|27020434|P2|Overall Study|Physician Decision|2
7773412|NCT00666718|27020435|P1|Overall Study|Physician Decision|0
7773413|NCT00666718|27020434|P2|Overall Study|Withdrawal by Subject|12
7773414|NCT00666718|27020435|P1|Overall Study|Withdrawal by Subject|7
7773415|NCT00666718|27020434|P2|Overall Study|Protocol Violation|3
7773416|NCT00666718|27020435|P1|Overall Study|Protocol Violation|1
7773417|NCT00666718|27020434|P2|Overall Study|Entry Criteria Not Met|0
7773418|NCT00666718|27020435|P1|Overall Study|Entry Criteria Not Met|2
7773419|NCT00666718|27020434|P2|Overall Study|Lost to Follow-up|0
7773420|NCT00666718|27020435|P1|Overall Study|Lost to Follow-up|1
7773421|NCT00666718|27020434|P2|Overall Study|Death|0
7773422|NCT00666718|27020435|P1|Overall Study|Death|1
7773423|NCT00666718|27020434|P2|Overall Study|Adverse Event|1
7773424|NCT00666718|27020435|P1|Overall Study|Adverse Event|0
7773425|NCT00666705|27020461|P1|Overall Study|Withdrawal by Subject|1
7773426|NCT00666679|27020480|P2|Second Intervention|Death|1
7773427|NCT00666679|27020481|P1|Second Intervention|Death|0
7773428|NCT00666679|27020480|P2|Second Intervention|Adverse Event|0
7773429|NCT00666679|27020481|P1|Second Intervention|Adverse Event|1
7773430|NCT00666679|27020480|P2|Washout Period of 1 Week|Protocol Violation|1
7773431|NCT00666679|27020481|P1|Washout Period of 1 Week|Protocol Violation|0
7773432|NCT00666679|27020480|P2|Washout Period of 1 Week|Lost to Follow-up|1
7773433|NCT00666679|27020481|P1|Washout Period of 1 Week|Lost to Follow-up|0
7773434|NCT00666679|27020480|P2|First Intervention|Randomized did not start treatment|1
7773435|NCT00666679|27020481|P1|First Intervention|Randomized did not start treatment|1
7773436|NCT00666679|27020480|P2|First Intervention|Withdrawal by Subject|0
7773437|NCT00666679|27020481|P1|First Intervention|Withdrawal by Subject|1
7773438|NCT00666679|27020480|P2|First Intervention|Protocol Violation|0
7773439|NCT00666679|27020481|P1|First Intervention|Protocol Violation|1
7773440|NCT00666679|27020480|P2|First Intervention|Lost to Follow-up|0
7773441|NCT00666679|27020481|P1|First Intervention|Lost to Follow-up|1
7773442|NCT00666588|27020511|P4|Overall Study|inevaluable|0
7773443|NCT00666588|27020512|P3|Overall Study|inevaluable|0
7773444|NCT00666588|27020513|P2|Overall Study|inevaluable|0
7773445|NCT00666588|27020514|P1|Overall Study|inevaluable|2
7773446|NCT00666588|27020511|P4|Overall Study|ineligible|2
7773447|NCT00666588|27020512|P3|Overall Study|ineligible|0
7773448|NCT00666588|27020513|P2|Overall Study|ineligible|0
7773449|NCT00666588|27020514|P1|Overall Study|ineligible|2
7773450|NCT00666562|27020547|P3|Overall Study|Concomitant Medication|0
7773451|NCT00666562|27020548|P2|Overall Study|Concomitant Medication|1
7773452|NCT00666562|27020549|P1|Overall Study|Concomitant Medication|0
7773453|NCT00666562|27020547|P3|Overall Study|Withdrawal by Subject|0
7773454|NCT00666562|27020548|P2|Overall Study|Withdrawal by Subject|1
7773455|NCT00666562|27020549|P1|Overall Study|Withdrawal by Subject|0
7773456|NCT00666536|27020596|P2|Overall Study|Lost to Follow-up|3
7773457|NCT00666536|27020597|P1|Overall Study|Lost to Follow-up|4
7773458|NCT00666536|27020596|P2|Overall Study|Withdrawal by Subject|9
7773459|NCT00666536|27020597|P1|Overall Study|Withdrawal by Subject|10
7773460|NCT00666536|27020596|P2|Overall Study|Protocol deviation(s)|6
7773461|NCT00666536|27020597|P1|Overall Study|Protocol deviation(s)|8
7773462|NCT00666536|27020596|P2|Overall Study|Unsatisfactory therapeutic effect|0
7773463|NCT00666536|27020597|P1|Overall Study|Unsatisfactory therapeutic effect|2
7773464|NCT00666536|27020596|P2|Overall Study|Adverse Event|19
7773465|NCT00666536|27020597|P1|Overall Study|Adverse Event|9
7773466|NCT00666458|27020615|P2|Overall Study|Medical history of anemia|0
7773467|NCT00666458|27020616|P1|Overall Study|Medical history of anemia|1
7773468|NCT00666458|27020615|P2|Overall Study|Safety reasons|0
7773469|NCT00666458|27020616|P1|Overall Study|Safety reasons|1
7773470|NCT00666458|27020615|P2|Overall Study|Severe non-compliance to the protocol|1
7773471|NCT00666458|27020616|P1|Overall Study|Severe non-compliance to the protocol|1
7773472|NCT00666458|27020615|P2|Overall Study|Study specific discontinuation criteria|7
7773473|NCT00666458|27020616|P1|Overall Study|Study specific discontinuation criteria|14
7773474|NCT00666458|27020615|P2|Overall Study|Incorrect enrollment|1
7773475|NCT00666458|27020616|P1|Overall Study|Incorrect enrollment|7
7773476|NCT00666458|27020615|P2|Overall Study|Administrative reason by sponsor|1
7773477|NCT00666458|27020616|P1|Overall Study|Administrative reason by sponsor|1
7773478|NCT00666458|27020615|P2|Overall Study|Lost to Follow-up|3
7773479|NCT00666458|27020616|P1|Overall Study|Lost to Follow-up|0
7773480|NCT00666458|27020615|P2|Overall Study|Withdrawal by Subject|4
7773481|NCT00666458|27020616|P1|Overall Study|Withdrawal by Subject|5
7773482|NCT00666458|27020615|P2|Overall Study|Adverse Event|7
7773483|NCT00666458|27020616|P1|Overall Study|Adverse Event|8
7773484|NCT00666328|27020704|P1|Overall Study|No longer met eligibility criteria|1
7773485|NCT00666328|27020704|P1|Overall Study|Lost to Follow-up|2
7773486|NCT00666328|27020704|P1|Overall Study|Death|2
7773487|NCT00666276|27020717|P1|Overall Study|Protocol Violation|34
7773488|NCT00666263|27020741|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
7773489|NCT00666263|27020742|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
7773490|NCT00666263|27020741|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
7773491|NCT00666263|27020742|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
7773492|NCT00666263|27020741|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
7773493|NCT00666263|27020742|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
7773494|NCT00666224|27020886|P2|Open-Label|Undefined/Unknown|1
7773495|NCT00666224|27020887|P1|Open-Label|Undefined/Unknown|1
7773496|NCT00666224|27020886|P2|Open-Label|Noncompliance|1
7773497|NCT00666224|27020887|P1|Open-Label|Noncompliance|2
7773498|NCT00666224|27020886|P2|Open-Label|Pregnancy|5
7773499|NCT00666224|27020887|P1|Open-Label|Pregnancy|1
7773500|NCT00666224|27020886|P2|Open-Label|Physician Decision|5
7773501|NCT00666224|27020887|P1|Open-Label|Physician Decision|7
7773502|NCT00666224|27020886|P2|Open-Label|Withdrawal by Subject|25
7773503|NCT00666224|27020887|P1|Open-Label|Withdrawal by Subject|12
7773504|NCT00666224|27020886|P2|Open-Label|Lost to Follow-up|5
7773505|NCT00666224|27020887|P1|Open-Label|Lost to Follow-up|4
7773506|NCT00666224|27020886|P2|Open-Label|Adverse Event|43
7773507|NCT00666224|27020887|P1|Open-Label|Adverse Event|8
7773508|NCT00666224|27020886|P2|Double-Blind|Undefined/Unknown|1
7773509|NCT00666224|27020887|P1|Double-Blind|Undefined/Unknown|4
7773510|NCT00666224|27020886|P2|Double-Blind|Death|0
7773511|NCT00666224|27020887|P1|Double-Blind|Death|1
7773512|NCT00666224|27020886|P2|Double-Blind|Noncompliance|0
7773513|NCT00666224|27020887|P1|Double-Blind|Noncompliance|1
7773514|NCT00666224|27020886|P2|Double-Blind|Pregnancy|2
7773515|NCT00666224|27020887|P1|Double-Blind|Pregnancy|3
7773516|NCT00666224|27020886|P2|Double-Blind|Sponsor decision|0
7773517|NCT00666224|27020887|P1|Double-Blind|Sponsor decision|1
7773518|NCT00666224|27020886|P2|Double-Blind|Physician Decision|3
7773519|NCT00666224|27020887|P1|Double-Blind|Physician Decision|0
7773520|NCT00666224|27020886|P2|Double-Blind|Withdrawal by Subject|14
7773521|NCT00666224|27020887|P1|Double-Blind|Withdrawal by Subject|18
7773522|NCT00666224|27020886|P2|Double-Blind|Lost to Follow-up|2
7773523|NCT00666224|27020887|P1|Double-Blind|Lost to Follow-up|2
7773524|NCT00666224|27020886|P2|Double-Blind|Adverse Event|5
7773525|NCT00666224|27020887|P1|Double-Blind|Adverse Event|15
7773526|NCT00666211|27020906|P2|Overall Study|Physician Decision|1
7773527|NCT00666211|27020907|P1|Overall Study|Physician Decision|0
7773528|NCT00666211|27020906|P2|Overall Study|off tx for other complicating disease|1
7773529|NCT00666211|27020907|P1|Overall Study|off tx for other complicating disease|0
7773530|NCT00666211|27020906|P2|Overall Study|Death|2
7773531|NCT00666211|27020907|P1|Overall Study|Death|0
7773532|NCT00666211|27020906|P2|Overall Study|hospital admission|5
7773533|NCT00666211|27020907|P1|Overall Study|hospital admission|0
7773534|NCT00666211|27020906|P2|Overall Study|toxicity|2
7773535|NCT00666211|27020907|P1|Overall Study|toxicity|0
7773536|NCT00666211|27020906|P2|Overall Study|Lost to Follow-up|0
7773537|NCT00666211|27020907|P1|Overall Study|Lost to Follow-up|2
7773538|NCT00666211|27020906|P2|Overall Study|disease progression|8
7773539|NCT00666211|27020907|P1|Overall Study|disease progression|1
7773540|NCT00666211|27020906|P2|Overall Study|patient non-compliant|6
7773541|NCT00666211|27020907|P1|Overall Study|patient non-compliant|6
7773542|NCT00666211|27020906|P2|Overall Study|went off medication, no more pain|0
7773543|NCT00666211|27020907|P1|Overall Study|went off medication, no more pain|1
7773544|NCT00666211|27020906|P2|Overall Study|Withdrawal by Subject|13
7773545|NCT00666211|27020907|P1|Overall Study|Withdrawal by Subject|10
7773546|NCT00666198|27020925|P1|Overall Study|No Drug Administration|4
7773547|NCT00666198|27020925|P1|Overall Study|Safety Not Assessable|6
7773548|NCT00666198|27020925|P1|Overall Study|No Visit After First Day of Treatment|13
7773549|NCT00666198|27020925|P1|Overall Study|Protocol Violation|10
7773550|NCT00665925|27020953|P4|Overall Study|Due to exclusion criteria|0
7773551|NCT00665925|27020954|P3|Overall Study|Due to exclusion criteria|0
7773552|NCT00665925|27020955|P2|Overall Study|Due to exclusion criteria|0
7773553|NCT00665925|27020956|P1|Overall Study|Due to exclusion criteria|1
7773554|NCT00665925|27020953|P4|Overall Study|Enrolled by mistake|1
7773555|NCT00665925|27020954|P3|Overall Study|Enrolled by mistake|0
7773556|NCT00665925|27020955|P2|Overall Study|Enrolled by mistake|0
7773557|NCT00665925|27020956|P1|Overall Study|Enrolled by mistake|0
7773558|NCT00665925|27020953|P4|Overall Study|Adverse Event|5
7773559|NCT00665925|27020954|P3|Overall Study|Adverse Event|10
7773560|NCT00665925|27020955|P2|Overall Study|Adverse Event|5
7773561|NCT00665925|27020956|P1|Overall Study|Adverse Event|1
7773562|NCT00665925|27020953|P4|Overall Study|Severe Non-Compliance to Protocol|1
7773563|NCT00665925|27020954|P3|Overall Study|Severe Non-Compliance to Protocol|1
7773564|NCT00665925|27020955|P2|Overall Study|Severe Non-Compliance to Protocol|0
7773565|NCT00665925|27020956|P1|Overall Study|Severe Non-Compliance to Protocol|0
7773566|NCT00665925|27020953|P4|Overall Study|Physician Decision|2
7773567|NCT00665925|27020954|P3|Overall Study|Physician Decision|1
7773568|NCT00665925|27020955|P2|Overall Study|Physician Decision|0
7773569|NCT00665925|27020956|P1|Overall Study|Physician Decision|0
7773570|NCT00665925|27020953|P4|Overall Study|Withdrawal by Subject|2
7773571|NCT00665925|27020954|P3|Overall Study|Withdrawal by Subject|3
7773572|NCT00665925|27020955|P2|Overall Study|Withdrawal by Subject|2
7773573|NCT00665925|27020956|P1|Overall Study|Withdrawal by Subject|2
7773574|NCT00665925|27020953|P4|Overall Study|Lost to Follow-up|2
7773575|NCT00665925|27020954|P3|Overall Study|Lost to Follow-up|2
7773576|NCT00665925|27020955|P2|Overall Study|Lost to Follow-up|2
7773577|NCT00665925|27020956|P1|Overall Study|Lost to Follow-up|1
7773578|NCT00665925|27020953|P4|Overall Study|Lack of Efficacy|8
7773579|NCT00665925|27020954|P3|Overall Study|Lack of Efficacy|9
7773580|NCT00665925|27020955|P2|Overall Study|Lack of Efficacy|8
7773581|NCT00665925|27020956|P1|Overall Study|Lack of Efficacy|10
7773582|NCT00665847|27021367|P1|Overall Study|Switch to Commercial Medication|1
7773583|NCT00665847|27021367|P1|Overall Study|Subject ineligible to continue the trial|1
7773584|NCT00665847|27021367|P1|Overall Study|Resistance to TMC125|1
7773585|NCT00665847|27021367|P1|Overall Study|Subject reached a virologic endpoint|4
7773586|NCT00665847|27021367|P1|Overall Study|Subject non-compliant|8
7773587|NCT00665847|27021367|P1|Overall Study|Withdrawal by Subject|2
7773588|NCT00665847|27021367|P1|Overall Study|Adverse Event|8
7773589|NCT00665652|27021384|P1|Overall Study|No longer met inclusion criteria.|1
7773590|NCT00665652|27021384|P1|Overall Study|Death|1
7773591|NCT00665652|27021384|P1|Overall Study|Adverse Event|4
7773592|NCT00665626|27021390|P2|Overall Study|Death|0
7773593|NCT00665626|27021391|P1|Overall Study|Death|1
7773594|NCT00665626|27021390|P2|Overall Study|Unably to comply with dosing regimen|1
7773595|NCT00665626|27021391|P1|Overall Study|Unably to comply with dosing regimen|0
7773596|NCT00665626|27021390|P2|Overall Study|Did not fulfil inclusion criteria|1
7773597|NCT00665626|27021391|P1|Overall Study|Did not fulfil inclusion criteria|0
7773598|NCT00665626|27021390|P2|Overall Study|Due to exclusion criteria|1
7773599|NCT00665626|27021391|P1|Overall Study|Due to exclusion criteria|0
7773600|NCT00665626|27021390|P2|Overall Study|Adverse Event|9
7773601|NCT00665626|27021391|P1|Overall Study|Adverse Event|1
7773602|NCT00665626|27021390|P2|Overall Study|Protocol Violation|2
7773603|NCT00665626|27021391|P1|Overall Study|Protocol Violation|0
7773604|NCT00665626|27021390|P2|Overall Study|Withdrawal by Subject|1
7773605|NCT00665626|27021391|P1|Overall Study|Withdrawal by Subject|0
7773606|NCT00665626|27021390|P2|Overall Study|Lost to Follow-up|2
7773607|NCT00665626|27021391|P1|Overall Study|Lost to Follow-up|0
7773608|NCT00665626|27021390|P2|Overall Study|Lack of Efficacy|5
7773609|NCT00665626|27021391|P1|Overall Study|Lack of Efficacy|8
7773610|NCT00665561|27021459|P2|Overall Study|Withdrawn due to pregnancy|1
7773611|NCT00665561|27021460|P1|Overall Study|Withdrawn due to pregnancy|0
7773612|NCT00665561|27021459|P2|Overall Study|Site closed|0
7773613|NCT00665561|27021460|P1|Overall Study|Site closed|8
7773614|NCT00665561|27021459|P2|Overall Study|Other|108
7773615|NCT00665561|27021460|P1|Overall Study|Other|123
7773616|NCT00665561|27021459|P2|Overall Study|Withdrawal by Subject|65
7773617|NCT00665561|27021460|P1|Overall Study|Withdrawal by Subject|74
7773618|NCT00665561|27021459|P2|Overall Study|Lost to Follow-up|264
7773619|NCT00665561|27021460|P1|Overall Study|Lost to Follow-up|203
7773620|NCT00665561|27021459|P2|Overall Study|Does not meet entrance criteria|21
7773621|NCT00665561|27021460|P1|Overall Study|Does not meet entrance criteria|19
7773622|NCT00665561|27021459|P2|Overall Study|Death recorded on subject summary pages|75
7773623|NCT00665561|27021460|P1|Overall Study|Death recorded on subject summary pages|75
7773624|NCT00665444|27021510|P1|Overall Study|Study Terminated by Study Sponsor|1
7773625|NCT00665444|27021510|P1|Overall Study|Physician Decision|1
7773626|NCT00665431|27021522|P3|Overall Study|Other|2
7773627|NCT00665431|27021523|P2|Overall Study|Other|7
7773628|NCT00665431|27021524|P1|Overall Study|Other|4
7773629|NCT00665431|27021522|P3|Overall Study|Lost to Follow-up|1
7773630|NCT00665431|27021523|P2|Overall Study|Lost to Follow-up|3
7773631|NCT00665431|27021524|P1|Overall Study|Lost to Follow-up|3
7773632|NCT00665431|27021522|P3|Overall Study|Withdrawal by Subject|15
7773633|NCT00665431|27021523|P2|Overall Study|Withdrawal by Subject|25
7773634|NCT00665431|27021524|P1|Overall Study|Withdrawal by Subject|17
7773635|NCT00665431|27021522|P3|Overall Study|Adverse Event|6
7773636|NCT00665431|27021523|P2|Overall Study|Adverse Event|22
7773637|NCT00665431|27021524|P1|Overall Study|Adverse Event|16
7773638|NCT00665392|27021565|P1|Overall Study|not treated|1
7773639|NCT00665366|27021577|P2|Overall Study|Other reasons|1
7773640|NCT00665366|27021578|P1|Overall Study|Other reasons|4
7773641|NCT00665366|27021577|P2|Overall Study|No longer meets study criteria|1
7773642|NCT00665366|27021578|P1|Overall Study|No longer meets study criteria|0
7773643|NCT00665366|27021577|P2|Overall Study|Pregnancy|0
7773644|NCT00665366|27021578|P1|Overall Study|Pregnancy|1
7773645|NCT00665366|27021577|P2|Overall Study|Poor compliance/noncompliance|5
7773646|NCT00665366|27021578|P1|Overall Study|Poor compliance/noncompliance|3
7773647|NCT00665366|27021577|P2|Overall Study|Lost to Follow-up|5
7773648|NCT00665366|27021578|P1|Overall Study|Lost to Follow-up|3
7773649|NCT00665366|27021577|P2|Overall Study|Withdrawal by Subject|14
7773650|NCT00665366|27021578|P1|Overall Study|Withdrawal by Subject|11
7773651|NCT00665366|27021577|P2|Overall Study|Adverse Event|23
7773652|NCT00665366|27021578|P1|Overall Study|Adverse Event|25
7773653|NCT00665366|27021577|P2|Overall Study|Lack of Efficacy|10
7773654|NCT00665366|27021578|P1|Overall Study|Lack of Efficacy|11
7773655|NCT00665353|27021606|P1|Study Step 2|Lack of Efficacy|12
7773656|NCT00665353|27021606|P1|Study Step 2|Lost to Follow-up|2
7773657|NCT00665353|27021606|P1|Study Step 1|Withdrawal by Subject|2
7773658|NCT00665353|27021606|P1|Study Step 1|Adverse Event|1
7773659|NCT00665002|27021623|P1|Overall Study|Cytogenetic resistance|1
7773660|NCT00665002|27021623|P1|Overall Study|Progression/relapse during treatment|11
7773661|NCT00664859|27021631|P3|Overall Study|Other|2
7773662|NCT00664859|27021632|P2|Overall Study|Other|1
7773663|NCT00664859|27021633|P1|Overall Study|Other|0
7773664|NCT00664859|27021631|P3|Overall Study|Lost to Follow-up|1
7773665|NCT00664859|27021632|P2|Overall Study|Lost to Follow-up|2
7773666|NCT00664859|27021633|P1|Overall Study|Lost to Follow-up|2
7773667|NCT00664859|27021631|P3|Overall Study|Withdrawal by Subject|3
7773668|NCT00664859|27021632|P2|Overall Study|Withdrawal by Subject|1
7773669|NCT00664859|27021633|P1|Overall Study|Withdrawal by Subject|4
7773670|NCT00664859|27021631|P3|Overall Study|Laboratory abnormality|4
7773671|NCT00664859|27021632|P2|Overall Study|Laboratory abnormality|1
7773672|NCT00664859|27021633|P1|Overall Study|Laboratory abnormality|2
7773673|NCT00664859|27021631|P3|Overall Study|Noncompliance with protocol|4
7773674|NCT00664859|27021632|P2|Overall Study|Noncompliance with protocol|0
7773675|NCT00664859|27021633|P1|Overall Study|Noncompliance with protocol|1
7773676|NCT00664859|27021631|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
7773677|NCT00664859|27021632|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
7773678|NCT00664859|27021633|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
7773679|NCT00664859|27021631|P3|Overall Study|Adverse Event|3
7773680|NCT00664859|27021632|P2|Overall Study|Adverse Event|1
7773681|NCT00664859|27021633|P1|Overall Study|Adverse Event|2
7773682|NCT00664742|27021653|P1|Overall Study|Lost to Follow-up|92
7773683|NCT00664742|27021653|P1|Overall Study|Withdrawal by Subject|31
7773684|NCT00664742|27021653|P1|Overall Study|Withdrawn due to adverse events|3
7773685|NCT00664560|27021661|P3|Overall Study|Other|5
7773686|NCT00664560|27021662|P2|Overall Study|Other|4
7773687|NCT00664560|27021663|P1|Overall Study|Other|11
7773688|NCT00664560|27021661|P3|Overall Study|Lost to Follow-up|0
7773689|NCT00664560|27021662|P2|Overall Study|Lost to Follow-up|2
7773690|NCT00664560|27021663|P1|Overall Study|Lost to Follow-up|0
7773691|NCT00664560|27021661|P3|Overall Study|Withdrawal by Subject|7
7773692|NCT00664560|27021662|P2|Overall Study|Withdrawal by Subject|13
7773693|NCT00664560|27021663|P1|Overall Study|Withdrawal by Subject|9
7773694|NCT00664560|27021661|P3|Overall Study|Adverse Event|7
7773695|NCT00664560|27021662|P2|Overall Study|Adverse Event|16
7773696|NCT00664560|27021663|P1|Overall Study|Adverse Event|19
7773697|NCT00664534|27021706|P2|Overall Study|Sponsor decision|6
7773698|NCT00664534|27021707|P1|Overall Study|Sponsor decision|8
7773699|NCT00664534|27021706|P2|Overall Study|Physician Decision|0
7773700|NCT00664534|27021707|P1|Overall Study|Physician Decision|8
7773701|NCT00664534|27021706|P2|Overall Study|Withdrawal by Subject|6
7773702|NCT00664534|27021707|P1|Overall Study|Withdrawal by Subject|7
7773703|NCT00664534|27021706|P2|Overall Study|Protocol Violation|8
7773704|NCT00664534|27021707|P1|Overall Study|Protocol Violation|10
7773705|NCT00664534|27021706|P2|Overall Study|Lost to Follow-up|10
7773706|NCT00664534|27021707|P1|Overall Study|Lost to Follow-up|6
7773707|NCT00664534|27021706|P2|Overall Study|Adverse Event|3
7773708|NCT00664534|27021707|P1|Overall Study|Adverse Event|2
7773709|NCT00664521|27021735|P2|Overall Study|Other|0
7773710|NCT00664521|27021736|P1|Overall Study|Other|1
7773711|NCT00664521|27021735|P2|Overall Study|Lost to Follow-up|0
7773712|NCT00664521|27021736|P1|Overall Study|Lost to Follow-up|1
7773713|NCT00664521|27021735|P2|Overall Study|Adverse Event|1
7773714|NCT00664521|27021736|P1|Overall Study|Adverse Event|4
7773715|NCT00664326|27021762|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
7773716|NCT00664326|27021762|P1|Overall Study|Death|2
7773717|NCT00664326|27021762|P1|Overall Study|Other Reasons|3
7773718|NCT00664326|27021762|P1|Overall Study|Physician Decision|1
7773719|NCT00664326|27021762|P1|Overall Study|Withdrawal by Subject|1
7773720|NCT00664326|27021762|P1|Overall Study|Noncompliance with study medication|3
7773721|NCT00664326|27021762|P1|Overall Study|Adverse Event|14
7773722|NCT00664209|27021781|P1|Study Treatment Period|Withdrawal by Subject|2
7773723|NCT00664209|27021781|P1|Study Treatment Period|Physician Decision|4
7773724|NCT00664209|27021781|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
7773725|NCT00664105|27021789|P1|Overall Study|Disease progression|7
7773726|NCT00664105|27021789|P1|Overall Study|Adverse Event|9
7773727|NCT00664105|27021789|P1|Overall Study|Withdrawal by Subject|5
7773728|NCT00664105|27021789|P1|Overall Study|Death|3
7773729|NCT00664066|27021796|P1|Overall Study|Study terminated|3
7773730|NCT00663962|27021802|P2|Overall Study|somnolence|0
7773731|NCT00663962|27021803|P1|Overall Study|somnolence|1
7773732|NCT00663923|27021809|P1|Overall Study|Lost to Follow-up|2
7773733|NCT00663871|27021825|P2|Overall Study|Withdrawal by Subject|2
7773734|NCT00663871|27021826|P1|Overall Study|Withdrawal by Subject|5
7773735|NCT00663871|27021825|P2|Overall Study|Lost to Follow-up|5
7773736|NCT00663871|27021826|P1|Overall Study|Lost to Follow-up|5
7773737|NCT00663858|27021873|P3|Overall Study|Other|4
7773738|NCT00663858|27021874|P2|Overall Study|Other|2
7773739|NCT00663858|27021875|P1|Overall Study|Other|8
7773740|NCT00663858|27021873|P3|Overall Study|Protocol Violation|4
7773741|NCT00663858|27021874|P2|Overall Study|Protocol Violation|3
7773742|NCT00663858|27021875|P1|Overall Study|Protocol Violation|5
7773743|NCT00663858|27021873|P3|Overall Study|Withdrawal by Subject|3
7773744|NCT00663858|27021874|P2|Overall Study|Withdrawal by Subject|3
7773745|NCT00663858|27021875|P1|Overall Study|Withdrawal by Subject|7
7773746|NCT00663858|27021873|P3|Overall Study|Lack of Efficacy|3
7773747|NCT00663858|27021874|P2|Overall Study|Lack of Efficacy|1
7773748|NCT00663858|27021875|P1|Overall Study|Lack of Efficacy|5
7773749|NCT00663858|27021873|P3|Overall Study|Adverse Event|6
7773750|NCT00663858|27021874|P2|Overall Study|Adverse Event|1
7773751|NCT00663858|27021875|P1|Overall Study|Adverse Event|9
7773752|NCT00663702|27021913|P2|Overall Study|Lack of Efficacy|3
7773753|NCT00663702|27021914|P1|Overall Study|Lack of Efficacy|3
7773754|NCT00663702|27021913|P2|Overall Study|Death|1
7773755|NCT00663702|27021914|P1|Overall Study|Death|1
7773756|NCT00663702|27021913|P2|Overall Study|Lost to Follow-up|0
7773757|NCT00663702|27021914|P1|Overall Study|Lost to Follow-up|3
7773758|NCT00663702|27021913|P2|Overall Study|Pregnancy|1
7773759|NCT00663702|27021914|P1|Overall Study|Pregnancy|0
7773760|NCT00663702|27021913|P2|Overall Study|Withdrawal by Subject|1
7773761|NCT00663702|27021914|P1|Overall Study|Withdrawal by Subject|3
7773762|NCT00663702|27021913|P2|Overall Study|Adverse Event|4
7773763|NCT00663702|27021914|P1|Overall Study|Adverse Event|8
7773764|NCT00663260|27021950|P3|Overall Study|non-compliance, not met criteria, etc.|3
7773765|NCT00663260|27021951|P2|Overall Study|non-compliance, not met criteria, etc.|2
7773766|NCT00663260|27021952|P1|Overall Study|non-compliance, not met criteria, etc.|3
7773767|NCT00663260|27021950|P3|Overall Study|Lost to Follow-up|0
7773768|NCT00663260|27021951|P2|Overall Study|Lost to Follow-up|1
7773769|NCT00663260|27021952|P1|Overall Study|Lost to Follow-up|0
7773770|NCT00663260|27021950|P3|Overall Study|Death|1
7773771|NCT00663260|27021951|P2|Overall Study|Death|0
7773772|NCT00663260|27021952|P1|Overall Study|Death|1
7773773|NCT00663260|27021950|P3|Overall Study|Withdrawal by Subject|6
7773774|NCT00663260|27021951|P2|Overall Study|Withdrawal by Subject|1
7773775|NCT00663260|27021952|P1|Overall Study|Withdrawal by Subject|3
7773776|NCT00663260|27021950|P3|Overall Study|Adverse Event|6
7773777|NCT00663260|27021951|P2|Overall Study|Adverse Event|7
7773778|NCT00663260|27021952|P1|Overall Study|Adverse Event|12
7773779|NCT00663260|27021950|P3|Overall Study|Lack of Efficacy|0
7773780|NCT00663260|27021951|P2|Overall Study|Lack of Efficacy|0
7773781|NCT00663260|27021952|P1|Overall Study|Lack of Efficacy|2
7773782|NCT00663234|27021966|P1|Overall Study|Not willing to adhere to requirements|1
7773783|NCT00663208|27021999|P7|Follow-up Period|Other reason|1
7773784|NCT00663208|27022000|P6|Follow-up Period|Other reason|0
7773785|NCT00663208|27022001|P5|Follow-up Period|Other reason|0
7773786|NCT00663208|27022002|P4|Follow-up Period|Other reason|0
7773787|NCT00663208|27022003|P3|Follow-up Period|Other reason|0
7773788|NCT00663208|27022004|P2|Follow-up Period|Other reason|0
7773789|NCT00663208|27022005|P1|Follow-up Period|Other reason|1
7773790|NCT00663208|27021999|P7|Follow-up Period|Lost to Follow-up|0
7773791|NCT00663208|27022000|P6|Follow-up Period|Lost to Follow-up|0
7773792|NCT00663208|27022001|P5|Follow-up Period|Lost to Follow-up|0
7773793|NCT00663208|27022002|P4|Follow-up Period|Lost to Follow-up|2
7773794|NCT00663208|27022003|P3|Follow-up Period|Lost to Follow-up|3
7773795|NCT00663208|27022004|P2|Follow-up Period|Lost to Follow-up|0
7773796|NCT00663208|27022005|P1|Follow-up Period|Lost to Follow-up|2
7773797|NCT00663208|27021999|P7|Treatment Period|Lost to Follow-up|0
7773798|NCT00663208|27022000|P6|Treatment Period|Lost to Follow-up|0
7773799|NCT00663208|27022001|P5|Treatment Period|Lost to Follow-up|0
7773800|NCT00663208|27022002|P4|Treatment Period|Lost to Follow-up|0
7773801|NCT00663208|27022003|P3|Treatment Period|Lost to Follow-up|0
7773802|NCT00663208|27022004|P2|Treatment Period|Lost to Follow-up|1
7773803|NCT00663208|27022005|P1|Treatment Period|Lost to Follow-up|0
7773804|NCT00663117|27022183|P2|Overall Study|Lack of Efficacy|0
7773805|NCT00663117|27022184|P1|Overall Study|Lack of Efficacy|1
7773806|NCT00663052|27022198|P2|Overall Study|Other|1
7773807|NCT00663052|27022199|P1|Overall Study|Other|0
7773808|NCT00663052|27022198|P2|Overall Study|Unsatisfactory Response - Efficacy|1
7773809|NCT00663052|27022199|P1|Overall Study|Unsatisfactory Response - Efficacy|1
7773810|NCT00663052|27022198|P2|Overall Study|Withdrawal by Subject|5
7773811|NCT00663052|27022199|P1|Overall Study|Withdrawal by Subject|2
7773812|NCT00663052|27022198|P2|Overall Study|Protocol Violation|0
7773813|NCT00663052|27022199|P1|Overall Study|Protocol Violation|1
7773814|NCT00663052|27022198|P2|Overall Study|Discontinuation of Study by Sponsor|0
7773815|NCT00663052|27022199|P1|Overall Study|Discontinuation of Study by Sponsor|2
7773816|NCT00663052|27022198|P2|Overall Study|Adverse Event|3
7773817|NCT00663052|27022199|P1|Overall Study|Adverse Event|6
7773818|NCT00663026|27022305|P3|Overall Study|Withdrawal by Subject|1
7773819|NCT00663026|27022306|P2|Overall Study|Withdrawal by Subject|0
7773820|NCT00663026|27022307|P1|Overall Study|Withdrawal by Subject|0
7773821|NCT00663026|27022305|P3|Overall Study|Caregiver Request|0
7773822|NCT00663026|27022306|P2|Overall Study|Caregiver Request|2
7773823|NCT00663026|27022307|P1|Overall Study|Caregiver Request|0
7773824|NCT00663026|27022305|P3|Overall Study|Adverse Event|3
7773825|NCT00663026|27022306|P2|Overall Study|Adverse Event|2
7773826|NCT00663026|27022307|P1|Overall Study|Adverse Event|0
7773827|NCT00663026|27022305|P3|Overall Study|Other|0
7773828|NCT00663026|27022306|P2|Overall Study|Other|2
7773829|NCT00663026|27022307|P1|Overall Study|Other|1
7773830|NCT00663026|27022305|P3|Overall Study|Lost to Follow-up|0
7773831|NCT00663026|27022306|P2|Overall Study|Lost to Follow-up|0
7773832|NCT00663026|27022307|P1|Overall Study|Lost to Follow-up|1
7773833|NCT00662909|27022330|P3|Overall Study|Eligibility criterion not met|1
7773834|NCT00662909|27022331|P2|Overall Study|Eligibility criterion not met|1
7773835|NCT00662909|27022332|P1|Overall Study|Eligibility criterion not met|0
7773836|NCT00662909|27022330|P3|Overall Study|Physician Decision|2
7773837|NCT00662909|27022331|P2|Overall Study|Physician Decision|1
7773838|NCT00662909|27022332|P1|Overall Study|Physician Decision|1
7773839|NCT00662909|27022330|P3|Overall Study|Non-compliance with study procedures|2
7773840|NCT00662909|27022331|P2|Overall Study|Non-compliance with study procedures|3
7773841|NCT00662909|27022332|P1|Overall Study|Non-compliance with study procedures|3
7773842|NCT00662909|27022330|P3|Overall Study|Randomized- never received study drug|0
7773843|NCT00662909|27022331|P2|Overall Study|Randomized- never received study drug|0
7773844|NCT00662909|27022332|P1|Overall Study|Randomized- never received study drug|1
7773845|NCT00662909|27022330|P3|Overall Study|Protocol Violation|5
7773846|NCT00662909|27022331|P2|Overall Study|Protocol Violation|4
7773847|NCT00662909|27022332|P1|Overall Study|Protocol Violation|7
7773848|NCT00662909|27022330|P3|Overall Study|Lost to Follow-up|3
7773849|NCT00662909|27022331|P2|Overall Study|Lost to Follow-up|9
7773850|NCT00662909|27022332|P1|Overall Study|Lost to Follow-up|2
7773851|NCT00662909|27022330|P3|Overall Study|Withdrawal by Subject|16
7773852|NCT00662909|27022331|P2|Overall Study|Withdrawal by Subject|22
7773853|NCT00662909|27022332|P1|Overall Study|Withdrawal by Subject|29
7773854|NCT00662909|27022330|P3|Overall Study|Lack of Efficacy|5
7773855|NCT00662909|27022331|P2|Overall Study|Lack of Efficacy|1
7773856|NCT00662909|27022332|P1|Overall Study|Lack of Efficacy|9
7773857|NCT00662909|27022330|P3|Overall Study|Adverse Event|19
7773858|NCT00662909|27022331|P2|Overall Study|Adverse Event|18
7773859|NCT00662909|27022332|P1|Overall Study|Adverse Event|17
7773860|NCT00662857|27022430|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
7773861|NCT00662857|27022431|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
7773862|NCT00662857|27022430|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
7773863|NCT00662857|27022431|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
7773864|NCT00662857|27022430|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
7773865|NCT00662857|27022431|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
7773866|NCT00662831|27022446|P2|Overall Study|Adverse Event|16
7773867|NCT00662831|27022447|P1|Overall Study|Adverse Event|23
7773868|NCT00662831|27022446|P2|Overall Study|Protocol Violation|4
7773869|NCT00662831|27022447|P1|Overall Study|Protocol Violation|8
7773870|NCT00662831|27022446|P2|Overall Study|Other|31
7773871|NCT00662831|27022447|P1|Overall Study|Other|62
7773872|NCT00662831|27022446|P2|Overall Study|Withdrawal by Subject|1
7773873|NCT00662831|27022447|P1|Overall Study|Withdrawal by Subject|2
7773874|NCT00662831|27022446|P2|Overall Study|Lost to Follow-up|0
7773875|NCT00662831|27022447|P1|Overall Study|Lost to Follow-up|1
7773876|NCT00662831|27022446|P2|Overall Study|Lack of Efficacy|6
7773877|NCT00662831|27022447|P1|Overall Study|Lack of Efficacy|6
7773878|NCT00662831|27022446|P2|Overall Study|Death|1
7773879|NCT00662831|27022447|P1|Overall Study|Death|4
7773880|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
7773881|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
7773882|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
7773883|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
7773884|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
7773885|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7773886|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7773887|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7773888|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
7773889|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7773890|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
7773891|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
7773892|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
7773893|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
7773894|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
7773895|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
7773896|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
7773897|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
7773898|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
7773899|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
7773900|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
7773901|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
7773902|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
7773903|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
7773904|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
7773905|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Adverse Event|10
7773906|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Adverse Event|6
7773907|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Adverse Event|0
7773908|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Adverse Event|9
7773909|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Adverse Event|6
7773910|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Administrative problems|0
7773911|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Administrative problems|1
7773912|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Administrative problems|0
7773913|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Administrative problems|0
7773914|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Administrative problems|0
7773915|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
7773916|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
7773917|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
7773918|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
7773919|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
7773920|NCT00662649|27022527|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
7773921|NCT00662649|27022528|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
7773922|NCT00662649|27022529|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
7773923|NCT00662649|27022530|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
7773924|NCT00662649|27022531|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
7773925|NCT00662649|27022527|P5|Core Study (24 Months)|Death|0
7773926|NCT00662649|27022528|P4|Core Study (24 Months)|Death|0
7773927|NCT00662649|27022529|P3|Core Study (24 Months)|Death|2
7773928|NCT00662649|27022530|P2|Core Study (24 Months)|Death|0
7773929|NCT00662649|27022531|P1|Core Study (24 Months)|Death|1
7773930|NCT00662649|27022527|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
7773931|NCT00662649|27022528|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
7773932|NCT00662649|27022529|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
7773933|NCT00662649|27022530|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
7773934|NCT00662649|27022531|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
7773935|NCT00662649|27022527|P5|Core Study (24 Months)|Protocol Violation|0
7773936|NCT00662649|27022528|P4|Core Study (24 Months)|Protocol Violation|0
7773937|NCT00662649|27022529|P3|Core Study (24 Months)|Protocol Violation|4
7773938|NCT00662649|27022530|P2|Core Study (24 Months)|Protocol Violation|5
7773939|NCT00662649|27022531|P1|Core Study (24 Months)|Protocol Violation|5
7773940|NCT00662649|27022527|P5|Core Study (24 Months)|Lost to Follow-up|0
7773941|NCT00662649|27022528|P4|Core Study (24 Months)|Lost to Follow-up|0
7773942|NCT00662649|27022529|P3|Core Study (24 Months)|Lost to Follow-up|7
7773943|NCT00662649|27022530|P2|Core Study (24 Months)|Lost to Follow-up|5
7773944|NCT00662649|27022531|P1|Core Study (24 Months)|Lost to Follow-up|3
7773945|NCT00662649|27022527|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
7773946|NCT00662649|27022528|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
7773947|NCT00662649|27022529|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
7773948|NCT00662649|27022530|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
7773949|NCT00662649|27022531|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
7773950|NCT00662649|27022527|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
7773951|NCT00662649|27022528|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
7773952|NCT00662649|27022529|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
7773953|NCT00662649|27022530|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
7773954|NCT00662649|27022531|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
7773955|NCT00662649|27022527|P5|Core Study (24 Months)|Adverse Event|0
7773956|NCT00662649|27022528|P4|Core Study (24 Months)|Adverse Event|0
7773957|NCT00662649|27022529|P3|Core Study (24 Months)|Adverse Event|18
7773958|NCT00662649|27022530|P2|Core Study (24 Months)|Adverse Event|13
7773959|NCT00662649|27022531|P1|Core Study (24 Months)|Adverse Event|22
7773960|NCT00662649|27022527|P5|Core Study (24 Months)|Withdrawal by Subject|0
7773961|NCT00662649|27022528|P4|Core Study (24 Months)|Withdrawal by Subject|0
7773962|NCT00662649|27022529|P3|Core Study (24 Months)|Withdrawal by Subject|28
7773963|NCT00662649|27022530|P2|Core Study (24 Months)|Withdrawal by Subject|17
7773964|NCT00662649|27022531|P1|Core Study (24 Months)|Withdrawal by Subject|31
7773965|NCT00662558|27022571|P2|Overall Study|Randomized But Did Not Receive Treatment|8
7773966|NCT00662558|27022572|P1|Overall Study|Randomized But Did Not Receive Treatment|2
7773967|NCT00662558|27022571|P2|Overall Study|Withdrawal by Subject|12
7773968|NCT00662558|27022572|P1|Overall Study|Withdrawal by Subject|7
7773969|NCT00662558|27022571|P2|Overall Study|Other|14
7773970|NCT00662558|27022572|P1|Overall Study|Other|9
7773971|NCT00662558|27022571|P2|Overall Study|Lost to Follow-up|10
7773972|NCT00662558|27022572|P1|Overall Study|Lost to Follow-up|13
7773973|NCT00662558|27022571|P2|Overall Study|Lack of Efficacy|7
7773974|NCT00662558|27022572|P1|Overall Study|Lack of Efficacy|4
7773975|NCT00662558|27022571|P2|Overall Study|Adverse Event|59
7773976|NCT00662558|27022572|P1|Overall Study|Adverse Event|21
7773977|NCT00662532|27022623|P2|Overall Study|Lost to Follow-up|1
7773978|NCT00662532|27022624|P1|Overall Study|Lost to Follow-up|0
7773979|NCT00662532|27022623|P2|Overall Study|Adverse Event|1
7773980|NCT00662532|27022624|P1|Overall Study|Adverse Event|0
7773981|NCT00662363|27022639|P2|Overall Study|Protocol Violation|1
7773982|NCT00662363|27022640|P1|Overall Study|Protocol Violation|1
7773983|NCT00662363|27022639|P2|Overall Study|Discharged early from rehab|1
7773984|NCT00662363|27022640|P1|Overall Study|Discharged early from rehab|4
7773985|NCT00662363|27022639|P2|Overall Study|Adverse Event|3
7773986|NCT00662363|27022640|P1|Overall Study|Adverse Event|0
7773987|NCT00662363|27022639|P2|Overall Study|Withdrawal by Subject|5
7773988|NCT00662363|27022640|P1|Overall Study|Withdrawal by Subject|6
7773989|NCT00662311|27022651|P3|Overall Study|Respiratory Infection|0
7773990|NCT00662311|27022652|P2|Overall Study|Respiratory Infection|0
7773991|NCT00662311|27022653|P1|Overall Study|Respiratory Infection|1
7773992|NCT00662259|27022688|P2|Overall Study|Adverse Event|0
7773993|NCT00662259|27022689|P1|Overall Study|Adverse Event|2
7773994|NCT00662129|27022731|P1|Overall Study|Ineligible|1
7773995|NCT00662129|27022731|P1|Overall Study|Cancel prior to beginning treatment|1
7773996|NCT00662129|27022731|P1|Overall Study|Protocol Violation|1
7773997|NCT00662038|27022741|P1|Overall Study|Continued treatment|5
7773998|NCT00662038|27022741|P1|Overall Study|Adverse Event|358
7773999|NCT00662038|27022741|P1|Overall Study|Death|95
7774000|NCT00662038|27022741|P1|Overall Study|Lost to Follow-up|1
7774001|NCT00662038|27022741|P1|Overall Study|Lung transplantation|44
7774002|NCT00662038|27022741|P1|Overall Study|Physician Decision|19
7774003|NCT00662038|27022741|P1|Overall Study|Sponsor decision|1
7774004|NCT00662038|27022741|P1|Overall Study|Withdrawal by Subject|83
7774005|NCT00662038|27022741|P1|Overall Study|Withdrawn consent|22
7774006|NCT00662038|27022741|P1|Overall Study|Reason not specified|3
7774007|NCT00662025|27022745|P1|Overall Study|Domestic circumstances|1
7774008|NCT00662025|27022745|P1|Overall Study|Target lesion cannot be evaluated|1
7774009|NCT00662025|27022745|P1|Overall Study|Results of other clinical study|2
7774010|NCT00662025|27022745|P1|Overall Study|Withdrawal by Subject|1
7774011|NCT00662025|27022745|P1|Overall Study|Adverse Event|7
7774012|NCT00662025|27022745|P1|Overall Study|Objective progression or relapse|51
7774013|NCT00662012|27022765|P1|Overall Study|Withdrawal by Subject|1
7774014|NCT00662012|27022765|P1|Overall Study|Death|1
7774015|NCT00662012|27022765|P1|Overall Study|Lost to Follow-up|85
7774016|NCT00661999|27022773|P3|Overall Study|Other Medical Problems|9
7774017|NCT00661999|27022774|P2|Overall Study|Other Medical Problems|4
7774018|NCT00661999|27022775|P1|Overall Study|Other Medical Problems|4
7774019|NCT00661999|27022773|P3|Overall Study|Alternative Treatment|0
7774020|NCT00661999|27022774|P2|Overall Study|Alternative Treatment|0
7774021|NCT00661999|27022775|P1|Overall Study|Alternative Treatment|1
7774022|NCT00661999|27022773|P3|Overall Study|Withdrawal by Subject|14
7774023|NCT00661999|27022774|P2|Overall Study|Withdrawal by Subject|23
7774024|NCT00661999|27022775|P1|Overall Study|Withdrawal by Subject|30
7774025|NCT00661999|27022773|P3|Overall Study|Other Reasons|23
7774026|NCT00661999|27022774|P2|Overall Study|Other Reasons|12
7774027|NCT00661999|27022775|P1|Overall Study|Other Reasons|5
7774028|NCT00661999|27022773|P3|Overall Study|Death|3
7774029|NCT00661999|27022774|P2|Overall Study|Death|6
7774030|NCT00661999|27022775|P1|Overall Study|Death|8
7774031|NCT00661999|27022773|P3|Overall Study|Adverse Event|8
7774032|NCT00661999|27022774|P2|Overall Study|Adverse Event|5
7774033|NCT00661999|27022775|P1|Overall Study|Adverse Event|11
7774034|NCT00661830|27022852|P2|Overall Study|Other reason|5
7774035|NCT00661830|27022853|P1|Overall Study|Other reason|1
7774036|NCT00661830|27022852|P2|Overall Study|Withdrawal by Subject|1
7774037|NCT00661830|27022853|P1|Overall Study|Withdrawal by Subject|1
7774038|NCT00661830|27022852|P2|Overall Study|Lost to Follow-up|3
7774039|NCT00661830|27022853|P1|Overall Study|Lost to Follow-up|1
7774040|NCT00661830|27022852|P2|Overall Study|Death|33
7774041|NCT00661830|27022853|P1|Overall Study|Death|37
7774042|NCT00661778|27022865|P1|Overall Study|Withdrawal of Consent|1
7774043|NCT00661778|27022865|P1|Overall Study|Protocol Violation|2
7774044|NCT00661778|27022865|P1|Overall Study|Reason not Specified|6
7774045|NCT00661778|27022865|P1|Overall Study|Adverse Event|18
7774046|NCT00661778|27022865|P1|Overall Study|Disease Progression|23
7774047|NCT00661726|27022872|P1|Overall Study|Adverse Event|1
7774048|NCT00661713|27022895|P8|Overall Study|Inappropriate Enrollment|0
7774049|NCT00661713|27022896|P7|Overall Study|Inappropriate Enrollment|1
7774050|NCT00661713|27022897|P6|Overall Study|Inappropriate Enrollment|0
7774051|NCT00661713|27022898|P5|Overall Study|Inappropriate Enrollment|0
7774052|NCT00661713|27022899|P4|Overall Study|Inappropriate Enrollment|0
7774053|NCT00661713|27022900|P3|Overall Study|Inappropriate Enrollment|0
7774054|NCT00661713|27022901|P2|Overall Study|Inappropriate Enrollment|0
7774055|NCT00661713|27022902|P1|Overall Study|Inappropriate Enrollment|0
7774056|NCT00661713|27022895|P8|Overall Study|Adverse Event|0
7774057|NCT00661713|27022896|P7|Overall Study|Adverse Event|1
7774058|NCT00661713|27022897|P6|Overall Study|Adverse Event|0
7774059|NCT00661713|27022898|P5|Overall Study|Adverse Event|0
7774060|NCT00661713|27022899|P4|Overall Study|Adverse Event|0
7774061|NCT00661713|27022900|P3|Overall Study|Adverse Event|0
7774062|NCT00661713|27022901|P2|Overall Study|Adverse Event|0
7774063|NCT00661713|27022902|P1|Overall Study|Adverse Event|0
7774064|NCT00661713|27022895|P8|Overall Study|Administrative Reason|0
7774065|NCT00661713|27022896|P7|Overall Study|Administrative Reason|1
7774066|NCT00661713|27022897|P6|Overall Study|Administrative Reason|2
7774067|NCT00661713|27022898|P5|Overall Study|Administrative Reason|2
7774068|NCT00661713|27022899|P4|Overall Study|Administrative Reason|2
7774069|NCT00661713|27022900|P3|Overall Study|Administrative Reason|0
7774070|NCT00661713|27022901|P2|Overall Study|Administrative Reason|1
7774071|NCT00661713|27022902|P1|Overall Study|Administrative Reason|0
7774072|NCT00661713|27022895|P8|Overall Study|Lost to Follow-up|1
7774073|NCT00661713|27022896|P7|Overall Study|Lost to Follow-up|14
7774074|NCT00661713|27022897|P6|Overall Study|Lost to Follow-up|7
7774075|NCT00661713|27022898|P5|Overall Study|Lost to Follow-up|5
7774076|NCT00661713|27022899|P4|Overall Study|Lost to Follow-up|2
7774077|NCT00661713|27022900|P3|Overall Study|Lost to Follow-up|2
7774078|NCT00661713|27022901|P2|Overall Study|Lost to Follow-up|7
7774079|NCT00661713|27022902|P1|Overall Study|Lost to Follow-up|2
7774080|NCT00661713|27022895|P8|Overall Study|Withdrawal by Subject|9
7774081|NCT00661713|27022896|P7|Overall Study|Withdrawal by Subject|45
7774082|NCT00661713|27022897|P6|Overall Study|Withdrawal by Subject|26
7774083|NCT00661713|27022898|P5|Overall Study|Withdrawal by Subject|12
7774084|NCT00661713|27022899|P4|Overall Study|Withdrawal by Subject|21
7774085|NCT00661713|27022900|P3|Overall Study|Withdrawal by Subject|12
7774086|NCT00661713|27022901|P2|Overall Study|Withdrawal by Subject|25
7774087|NCT00661713|27022902|P1|Overall Study|Withdrawal by Subject|11
7774088|NCT00661713|27022895|P8|Overall Study|Protocol Violation|1
7774089|NCT00661713|27022896|P7|Overall Study|Protocol Violation|2
7774090|NCT00661713|27022897|P6|Overall Study|Protocol Violation|2
7774091|NCT00661713|27022898|P5|Overall Study|Protocol Violation|0
7774092|NCT00661713|27022899|P4|Overall Study|Protocol Violation|3
7774093|NCT00661713|27022900|P3|Overall Study|Protocol Violation|3
7774094|NCT00661713|27022901|P2|Overall Study|Protocol Violation|6
7774095|NCT00661713|27022902|P1|Overall Study|Protocol Violation|1
7774096|NCT00661713|27022895|P8|Overall Study|Unable to Classify|0
7774097|NCT00661713|27022896|P7|Overall Study|Unable to Classify|0
7774098|NCT00661713|27022897|P6|Overall Study|Unable to Classify|0
7774099|NCT00661713|27022898|P5|Overall Study|Unable to Classify|0
7774100|NCT00661713|27022899|P4|Overall Study|Unable to Classify|0
7774101|NCT00661713|27022900|P3|Overall Study|Unable to Classify|0
7774102|NCT00661713|27022901|P2|Overall Study|Unable to Classify|0
7774103|NCT00661713|27022902|P1|Overall Study|Unable to Classify|1
7774104|NCT00661713|27022895|P8|Overall Study|Death|0
7774105|NCT00661713|27022896|P7|Overall Study|Death|0
7774106|NCT00661713|27022897|P6|Overall Study|Death|0
7774107|NCT00661713|27022898|P5|Overall Study|Death|1
7774108|NCT00661713|27022899|P4|Overall Study|Death|0
7774109|NCT00661713|27022900|P3|Overall Study|Death|0
7774110|NCT00661713|27022901|P2|Overall Study|Death|0
7774111|NCT00661713|27022902|P1|Overall Study|Death|1
7774112|NCT00661687|27022994|P1|Overall Study|Adverse Event|2
7774113|NCT00661687|27022994|P1|Overall Study|Physician Decision|1
7774114|NCT00661687|27022994|P1|Overall Study|Inability to maintain wearing schedule|3
7774115|NCT00661687|27022994|P1|Overall Study|Positive slit lamp findings|4
7774116|NCT00661687|27022994|P1|Overall Study|Study related symptoms and complaints|5
7774117|NCT00661661|27023022|P2|Overall Study|Not assigned treatment|0
7774118|NCT00661661|27023023|P1|Overall Study|Not assigned treatment|1
7774119|NCT00661661|27023022|P2|Overall Study|Other|7
7774120|NCT00661661|27023023|P1|Overall Study|Other|22
7774121|NCT00661661|27023022|P2|Overall Study|Withdrawal by Subject|5
7774122|NCT00661661|27023023|P1|Overall Study|Withdrawal by Subject|15
7774123|NCT00661661|27023022|P2|Overall Study|Lost to Follow-up|1
7774124|NCT00661661|27023023|P1|Overall Study|Lost to Follow-up|0
7774125|NCT00661661|27023022|P2|Overall Study|Lack of Efficacy|2
7774126|NCT00661661|27023023|P1|Overall Study|Lack of Efficacy|3
7774127|NCT00661661|27023022|P2|Overall Study|Adverse Event|24
7774128|NCT00661661|27023023|P1|Overall Study|Adverse Event|99
7774129|NCT00661622|27023099|P2|Overall Study|Protocol Violation|0
7774130|NCT00661622|27023100|P1|Overall Study|Protocol Violation|1
7774131|NCT00661609|27023114|P1|Overall Study|Disease progression|3
7774132|NCT00661609|27023114|P1|Overall Study|Survival follow up stage discontinued|11
7774133|NCT00661609|27023114|P1|Overall Study|PI Decision|1
7774134|NCT00661609|27023114|P1|Overall Study|Withdrawal by Subject|2
7774135|NCT00661609|27023114|P1|Overall Study|Death|20
7774136|NCT00661609|27023114|P1|Overall Study|Adverse Event|4
7774137|NCT00661531|27023181|P1|Overall Study|Withdrawal by Subject|3
7774138|NCT00661505|27023186|P1|Overall Study|Other|2
7774139|NCT00661505|27023186|P1|Overall Study|Lost to Follow-up|3
7774140|NCT00661505|27023186|P1|Overall Study|Withdrawal by Subject|8
7774141|NCT00661505|27023186|P1|Overall Study|Protocol Violation|14
7774142|NCT00661505|27023186|P1|Overall Study|Adverse Event|3
7774143|NCT00661492|27023214|P2|Overall Study|Other|0
7774144|NCT00661492|27023215|P1|Overall Study|Other|1
7774145|NCT00661492|27023214|P2|Overall Study|Lost to Follow-up|1
7774146|NCT00661492|27023215|P1|Overall Study|Lost to Follow-up|0
7774147|NCT00661492|27023214|P2|Overall Study|Investigator Request|0
7774148|NCT00661492|27023215|P1|Overall Study|Investigator Request|1
7774149|NCT00661492|27023214|P2|Overall Study|Patient Request|1
7774150|NCT00661492|27023215|P1|Overall Study|Patient Request|6
7774151|NCT00661492|27023214|P2|Overall Study|Disease Progression|14
7774152|NCT00661492|27023215|P1|Overall Study|Disease Progression|44
7774153|NCT00661492|27023214|P2|Overall Study|Adverse Event|13
7774154|NCT00661492|27023215|P1|Overall Study|Adverse Event|16
7774155|NCT00661427|27023290|P2|Overall Study|Patient not treated|2
7774156|NCT00661427|27023291|P1|Overall Study|Patient not treated|0
7774157|NCT00661427|27023290|P2|Overall Study|Adverse Event|5
7774158|NCT00661427|27023291|P1|Overall Study|Adverse Event|5
7774159|NCT00661388|27023299|P1|Overall Study|Administrative reasons|1
7774160|NCT00661388|27023299|P1|Overall Study|Dialysis initiation|1
7774161|NCT00661388|27023299|P1|Overall Study|Renal transplantation|1
7774162|NCT00661388|27023299|P1|Overall Study|Protocol Violation|7
7774163|NCT00661388|27023299|P1|Overall Study|Adverse Event|14
7774164|NCT00661362|27023322|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
7774165|NCT00661362|27023323|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
7774166|NCT00661362|27023322|P2|Overall Study|Safety reasons|0
7774167|NCT00661362|27023323|P1|Overall Study|Safety reasons|1
7774168|NCT00661362|27023322|P2|Overall Study|Severe non-compliance to protocol|1
7774169|NCT00661362|27023323|P1|Overall Study|Severe non-compliance to protocol|0
7774170|NCT00661362|27023322|P2|Overall Study|Lost to Follow-up|1
7774171|NCT00661362|27023323|P1|Overall Study|Lost to Follow-up|3
7774172|NCT00661362|27023322|P2|Overall Study|Withdrawal by Subject|23
7774173|NCT00661362|27023323|P1|Overall Study|Withdrawal by Subject|13
7774174|NCT00661362|27023322|P2|Overall Study|Study specific discontinuation criteria|11
7774175|NCT00661362|27023323|P1|Overall Study|Study specific discontinuation criteria|4
7774176|NCT00661362|27023322|P2|Overall Study|Incorrect enrollment|0
7774177|NCT00661362|27023323|P1|Overall Study|Incorrect enrollment|2
7774178|NCT00661362|27023322|P2|Overall Study|Adverse Event|4
7774179|NCT00661362|27023323|P1|Overall Study|Adverse Event|5
7774180|NCT00661271|27023341|P2|Overall Study|Lost to Follow-up|25
7774181|NCT00661271|27023342|P1|Overall Study|Lost to Follow-up|28
7774182|NCT00661258|27023352|P2|Overall Study|caught by police and in detox center|1
7774183|NCT00661258|27023353|P1|Overall Study|caught by police and in detox center|2
7774184|NCT00661258|27023352|P2|Overall Study|Death|0
7774185|NCT00661258|27023353|P1|Overall Study|Death|1
7774186|NCT00661193|27023363|P2|Overall Study|Not protocol specified|0
7774187|NCT00661193|27023364|P1|Overall Study|Not protocol specified|1
7774188|NCT00661193|27023363|P2|Overall Study|Progression|24
7774189|NCT00661193|27023364|P1|Overall Study|Progression|27
7774190|NCT00661193|27023363|P2|Overall Study|Withdrawal by Subject|1
7774191|NCT00661193|27023364|P1|Overall Study|Withdrawal by Subject|3
7774192|NCT00661193|27023363|P2|Overall Study|Adverse Event|1
7774193|NCT00661193|27023364|P1|Overall Study|Adverse Event|2
7774194|NCT00661089|27023589|P2|Overall Study|death at 8 weeks due to new stroke|1
7774195|NCT00661089|27023590|P1|Overall Study|death at 8 weeks due to new stroke|0
7774196|NCT00661089|27023589|P2|Overall Study|1 subject withdrawal|1
7774197|NCT00661089|27023590|P1|Overall Study|1 subject withdrawal|0
7774198|NCT00660907|27023638|P2|Overall Study|Various|8
7774199|NCT00660907|27023639|P1|Overall Study|Various|11
7774200|NCT00660907|27023638|P2|Overall Study|Death|3
7774201|NCT00660907|27023639|P1|Overall Study|Death|1
7774202|NCT00660907|27023638|P2|Overall Study|Safety|0
7774203|NCT00660907|27023639|P1|Overall Study|Safety|1
7774204|NCT00660907|27023638|P2|Overall Study|Poor/Non-Compliance|1
7774205|NCT00660907|27023639|P1|Overall Study|Poor/Non-Compliance|5
7774206|NCT00660907|27023638|P2|Overall Study|Lost to Follow-up|3
7774207|NCT00660907|27023639|P1|Overall Study|Lost to Follow-up|3
7774208|NCT00660907|27023638|P2|Overall Study|Withdrawal by Subject|32
7774209|NCT00660907|27023639|P1|Overall Study|Withdrawal by Subject|23
7774210|NCT00660907|27023638|P2|Overall Study|Subject No Longer Meets Study Criteria|27
7774211|NCT00660907|27023639|P1|Overall Study|Subject No Longer Meets Study Criteria|6
7774212|NCT00660907|27023638|P2|Overall Study|Adverse Event|19
7774213|NCT00660907|27023639|P1|Overall Study|Adverse Event|33
7774214|NCT00660907|27023638|P2|Overall Study|Incorrect Enrollment|1
7774215|NCT00660907|27023639|P1|Overall Study|Incorrect Enrollment|1
7774216|NCT00660829|27023653|P2|Overall Study|Other|4
7774217|NCT00660829|27023654|P1|Overall Study|Other|9
7774218|NCT00660829|27023653|P2|Overall Study|Lost to Follow-up|2
7774219|NCT00660829|27023654|P1|Overall Study|Lost to Follow-up|3
7774220|NCT00660829|27023653|P2|Overall Study|Withdrawal by Subject|2
7774221|NCT00660829|27023654|P1|Overall Study|Withdrawal by Subject|1
7774222|NCT00660829|27023653|P2|Overall Study|Non-Compliance|4
7774223|NCT00660829|27023654|P1|Overall Study|Non-Compliance|0
7774224|NCT00660829|27023653|P2|Overall Study|Lack of Efficacy|3
7774225|NCT00660829|27023654|P1|Overall Study|Lack of Efficacy|2
7774226|NCT00660829|27023653|P2|Overall Study|Adverse Event|4
7774227|NCT00660829|27023654|P1|Overall Study|Adverse Event|3
7774228|NCT00660816|27023672|P2|Overall Study|Complicating Disease|1
7774229|NCT00660816|27023673|P1|Overall Study|Complicating Disease|0
7774230|NCT00660816|27023672|P2|Overall Study|Disease Progression|12
7774231|NCT00660816|27023673|P1|Overall Study|Disease Progression|16
7774232|NCT00660816|27023672|P2|Overall Study|Protocol Violation|0
7774233|NCT00660816|27023673|P1|Overall Study|Protocol Violation|1
7774234|NCT00660816|27023672|P2|Overall Study|Physician Decision|2
7774235|NCT00660816|27023673|P1|Overall Study|Physician Decision|0
7774236|NCT00660816|27023672|P2|Overall Study|Lack of Efficacy|0
7774237|NCT00660816|27023673|P1|Overall Study|Lack of Efficacy|1
7774238|NCT00660816|27023672|P2|Overall Study|Death|2
7774239|NCT00660816|27023673|P1|Overall Study|Death|0
7774240|NCT00660816|27023672|P2|Overall Study|Withdrawal by Subject|0
7774241|NCT00660816|27023673|P1|Overall Study|Withdrawal by Subject|1
7774242|NCT00660816|27023672|P2|Overall Study|Adverse Event|2
7774243|NCT00660816|27023673|P1|Overall Study|Adverse Event|1
7774244|NCT00660790|27023685|P1|3 Months to 2 Years|Withdrawal by Subject|17
7774245|NCT00660790|27023685|P1|Baseline to 3 Months|Withdrawal by Subject|2
7774246|NCT00660790|27023685|P1|Baseline to 3 Months|Death|1
7774247|NCT00660699|27023689|P1|Overall Study|Withdrawal by Subject|2
7774248|NCT00660660|27023705|P2|Overall Study|New medication after randomization|0
7774249|NCT00660660|27023706|P1|Overall Study|New medication after randomization|1
7774250|NCT00660660|27023705|P2|Overall Study|Incorrect enrollment and other|1
7774251|NCT00660660|27023706|P1|Overall Study|Incorrect enrollment and other|0
7774252|NCT00660660|27023705|P2|Overall Study|Withdrawal by Subject|0
7774253|NCT00660660|27023706|P1|Overall Study|Withdrawal by Subject|3
7774254|NCT00660660|27023705|P2|Overall Study|Lack of Efficacy|2
7774255|NCT00660660|27023706|P1|Overall Study|Lack of Efficacy|0
7774256|NCT00660660|27023705|P2|Overall Study|Lost to Follow-up|6
7774257|NCT00660660|27023706|P1|Overall Study|Lost to Follow-up|0
7774258|NCT00660660|27023705|P2|Overall Study|Adverse Event|0
7774259|NCT00660660|27023706|P1|Overall Study|Adverse Event|1
7774260|NCT00660595|27023806|P2|Overall Study|Non Specified reasons|0
7774261|NCT00660595|27023807|P1|Overall Study|Non Specified reasons|5
7774262|NCT00660595|27023806|P2|Overall Study|Participant left hospital|0
7774263|NCT00660595|27023807|P1|Overall Study|Participant left hospital|1
7774264|NCT00660595|27023806|P2|Overall Study|Did not consent to participate in study|8
7774265|NCT00660595|27023807|P1|Overall Study|Did not consent to participate in study|12
7774266|NCT00660595|27023806|P2|Overall Study|Lost to Follow-up|1
7774267|NCT00660595|27023807|P1|Overall Study|Lost to Follow-up|0
7774268|NCT00660400|27023874|P1|Overall Study|Withdrawal by Subject|1
7774269|NCT00660400|27023874|P1|Overall Study|Intracranial hemorrhage|1
7774270|NCT00660400|27023874|P1|Overall Study|Suboptimal organ function|1
7774271|NCT00660400|27023874|P1|Overall Study|Lack of insurance approval|1
7774272|NCT00660387|27023883|P2|Overall Study|Protocol Violation|0
7774273|NCT00660387|27023884|P1|Overall Study|Protocol Violation|1
7774274|NCT00660387|27023883|P2|Overall Study|Lack of Efficacy|1
7774275|NCT00660387|27023884|P1|Overall Study|Lack of Efficacy|0
7774276|NCT00660387|27023883|P2|Overall Study|Adverse Event|2
7774277|NCT00660387|27023884|P1|Overall Study|Adverse Event|1
7774278|NCT00660348|27023938|P2|Overall Study|Withdrawal by Subject|0
7774279|NCT00660348|27023939|P1|Overall Study|Withdrawal by Subject|1
7774280|NCT00660309|27023947|P2|Overall Study|Withdrawal by Subject|3
7774281|NCT00660309|27023948|P1|Overall Study|Withdrawal by Subject|0
7774282|NCT00660309|27023947|P2|Overall Study|Adverse Event|0
7774283|NCT00660309|27023948|P1|Overall Study|Adverse Event|2
7774284|NCT00660192|27023989|P2|Overall Study|Lost to Follow-up|3
7774285|NCT00660192|27023990|P1|Overall Study|Lost to Follow-up|2
7774286|NCT00660179|27024001|P3|Overall Study|Incorrect randomization|0
7774287|NCT00660179|27024002|P2|Overall Study|Incorrect randomization|0
7774288|NCT00660179|27024003|P1|Overall Study|Incorrect randomization|1
7774289|NCT00660179|27024001|P3|Overall Study|Administrative reason|1
7774290|NCT00660179|27024002|P2|Overall Study|Administrative reason|0
7774291|NCT00660179|27024003|P1|Overall Study|Administrative reason|0
7774292|NCT00660179|27024001|P3|Overall Study|Lost to Follow-up|2
7774293|NCT00660179|27024002|P2|Overall Study|Lost to Follow-up|5
7774294|NCT00660179|27024003|P1|Overall Study|Lost to Follow-up|7
7774295|NCT00660179|27024001|P3|Overall Study|Withdrawal of consent|4
7774296|NCT00660179|27024002|P2|Overall Study|Withdrawal of consent|6
7774297|NCT00660179|27024003|P1|Overall Study|Withdrawal of consent|4
7774298|NCT00660179|27024001|P3|Overall Study|Death|34
7774299|NCT00660179|27024002|P2|Overall Study|Death|47
7774300|NCT00660179|27024003|P1|Overall Study|Death|44
7774301|NCT00660023|27024048|P1|Overall Study|Other Screening Failure|9
7774302|NCT00660023|27024048|P1|Overall Study|Missed Pregnancy Test|1
7774303|NCT00660023|27024048|P1|Overall Study|Withdrawal by Subject|1
7774304|NCT00660023|27024048|P1|Overall Study|Renal Transplantation|3
7774305|NCT00660023|27024048|P1|Overall Study|Blood Transfusion|5
7774306|NCT00660023|27024048|P1|Overall Study|Death|8
7774307|NCT00660023|27024048|P1|Overall Study|Adverse Event|2
7774308|NCT00660010|27024059|P1|Overall Study|Noncompliance with visit schedule|3
7774309|NCT00660010|27024059|P1|Overall Study|Adverse Event|1
7774310|NCT00660010|27024059|P1|Overall Study|Lost to Follow-up|3
7774311|NCT00660010|27024059|P1|Overall Study|Withdrawal by Subject|2
7774312|NCT00659984|27024073|P1|Overall Study|Adverse Event|1
7774313|NCT00659880|27024093|P1|Overall Study|Lost to Follow-up|5
7774314|NCT00659815|27024106|P2|Overall Study|Withdrawal by Subject|1
7774315|NCT00659815|27024107|P1|Overall Study|Withdrawal by Subject|1
7774316|NCT00659815|27024106|P2|Overall Study|Inability to maintain wearing schedule|2
7774317|NCT00659815|27024107|P1|Overall Study|Inability to maintain wearing schedule|1
7774318|NCT00659815|27024106|P2|Overall Study|Study related symptoms and complaints|1
7774319|NCT00659815|27024107|P1|Overall Study|Study related symptoms and complaints|2
7774320|NCT00659646|27024184|P2|Overall Study|protocol noncompliance after randomized|0
7774321|NCT00659646|27024185|P1|Overall Study|protocol noncompliance after randomized|1
7774322|NCT00659646|27024184|P2|Overall Study|Lost to Follow-up|0
7774323|NCT00659646|27024185|P1|Overall Study|Lost to Follow-up|1
7774324|NCT00659646|27024184|P2|Overall Study|Adverse Event|0
7774325|NCT00659646|27024185|P1|Overall Study|Adverse Event|1
7774326|NCT00659646|27024184|P2|Overall Study|Protocol Violation|8
7774327|NCT00659646|27024185|P1|Overall Study|Protocol Violation|12
7774328|NCT00659607|27024209|P1|Overall Study|Inconsistent BP measuring date|2
7774329|NCT00659607|27024209|P1|Overall Study|No recorded efficacy data|15
7774330|NCT00659607|27024209|P1|Overall Study|'Unable to evaluate' for the final asses|67
7774331|NCT00659607|27024209|P1|Overall Study|Unknown measuring date of blood pressure|85
7774332|NCT00659607|27024209|P1|Overall Study|No blood pressure recorded|147
7774333|NCT00659581|27024227|P1|Overall Study|Other|6393
7774334|NCT00659581|27024227|P1|Overall Study|Lack of Efficacy|1183
7774335|NCT00659581|27024227|P1|Overall Study|Adverse Event|1006
7774336|NCT00659529|27024239|P1|Overall Study|Screen failure|9
7774337|NCT00659529|27024239|P1|Overall Study|Protocol Violation|3
7774338|NCT00659529|27024239|P1|Overall Study|Withdrawal by Subject|4
7774339|NCT00659490|27024246|P3|Overall Study|Lost to Follow-up|1
7774340|NCT00659490|27024247|P2|Overall Study|Lost to Follow-up|0
7774341|NCT00659490|27024248|P1|Overall Study|Lost to Follow-up|2
7774342|NCT00659438|27024321|P2|Overall Study|Lost to Follow-up|0
7774343|NCT00659438|27024322|P1|Overall Study|Lost to Follow-up|1
7774344|NCT00659438|27024321|P2|Overall Study|Death|6
7774345|NCT00659438|27024322|P1|Overall Study|Death|11
7774346|NCT00659438|27024321|P2|Overall Study|Withdrawal by Subject|2
7774347|NCT00659438|27024322|P1|Overall Study|Withdrawal by Subject|2
7774348|NCT00659425|27024354|P10|Overall Study|Other|6
7774349|NCT00659425|27024355|P9|Overall Study|Other|0
7774350|NCT00659425|27024356|P8|Overall Study|Other|2
7774351|NCT00659425|27024357|P7|Overall Study|Other|3
7774352|NCT00659425|27024358|P6|Overall Study|Other|0
7774353|NCT00659425|27024359|P5|Overall Study|Other|4
7774354|NCT00659425|27024360|P4|Overall Study|Other|2
7774355|NCT00659425|27024361|P3|Overall Study|Other|1
7774356|NCT00659425|27024362|P2|Overall Study|Other|1
7774357|NCT00659425|27024363|P1|Overall Study|Other|0
7774358|NCT00659425|27024354|P10|Overall Study|Investigator Discretion|0
7774359|NCT00659425|27024355|P9|Overall Study|Investigator Discretion|0
7774360|NCT00659425|27024356|P8|Overall Study|Investigator Discretion|3
7774361|NCT00659425|27024357|P7|Overall Study|Investigator Discretion|0
7774362|NCT00659425|27024358|P6|Overall Study|Investigator Discretion|1
7774363|NCT00659425|27024359|P5|Overall Study|Investigator Discretion|0
7774364|NCT00659425|27024360|P4|Overall Study|Investigator Discretion|0
7774365|NCT00659425|27024361|P3|Overall Study|Investigator Discretion|0
7774366|NCT00659425|27024362|P2|Overall Study|Investigator Discretion|0
7774367|NCT00659425|27024363|P1|Overall Study|Investigator Discretion|0
7774368|NCT00659425|27024354|P10|Overall Study|Adverse Event|4
7774369|NCT00659425|27024355|P9|Overall Study|Adverse Event|1
7774370|NCT00659425|27024356|P8|Overall Study|Adverse Event|3
7774371|NCT00659425|27024357|P7|Overall Study|Adverse Event|0
7774372|NCT00659425|27024358|P6|Overall Study|Adverse Event|1
7774373|NCT00659425|27024359|P5|Overall Study|Adverse Event|0
7774374|NCT00659425|27024360|P4|Overall Study|Adverse Event|0
7774375|NCT00659425|27024361|P3|Overall Study|Adverse Event|0
7774376|NCT00659425|27024362|P2|Overall Study|Adverse Event|0
7774377|NCT00659425|27024363|P1|Overall Study|Adverse Event|0
7774378|NCT00659425|27024354|P10|Overall Study|Death|0
7774379|NCT00659425|27024355|P9|Overall Study|Death|0
7774380|NCT00659425|27024356|P8|Overall Study|Death|0
7774381|NCT00659425|27024357|P7|Overall Study|Death|1
7774382|NCT00659425|27024358|P6|Overall Study|Death|0
7774383|NCT00659425|27024359|P5|Overall Study|Death|0
7774384|NCT00659425|27024360|P4|Overall Study|Death|1
7774385|NCT00659425|27024361|P3|Overall Study|Death|0
7774386|NCT00659425|27024362|P2|Overall Study|Death|0
7774387|NCT00659425|27024363|P1|Overall Study|Death|0
7774388|NCT00659425|27024354|P10|Overall Study|Disease progression|3
7774389|NCT00659425|27024355|P9|Overall Study|Disease progression|5
7774390|NCT00659425|27024356|P8|Overall Study|Disease progression|3
7774391|NCT00659425|27024357|P7|Overall Study|Disease progression|4
7774392|NCT00659425|27024358|P6|Overall Study|Disease progression|2
7774393|NCT00659425|27024359|P5|Overall Study|Disease progression|0
7774394|NCT00659425|27024360|P4|Overall Study|Disease progression|1
7774395|NCT00659425|27024361|P3|Overall Study|Disease progression|0
7774396|NCT00659425|27024362|P2|Overall Study|Disease progression|0
7774397|NCT00659425|27024363|P1|Overall Study|Disease progression|1
7774398|NCT00659373|27024594|P2|Overall Study|Assessment Missed|2
7774399|NCT00659373|27024595|P1|Overall Study|Assessment Missed|2
7774400|NCT00659373|27024594|P2|Overall Study|Withdrawal by Subject|5
7774401|NCT00659373|27024595|P1|Overall Study|Withdrawal by Subject|3
7774402|NCT00659334|27024617|P7|Overall Study|Screen Failure|1
7774403|NCT00659334|27024618|P6|Overall Study|Screen Failure|0
7774404|NCT00659334|27024619|P5|Overall Study|Screen Failure|0
7774405|NCT00659334|27024620|P4|Overall Study|Screen Failure|0
7774406|NCT00659334|27024621|P3|Overall Study|Screen Failure|0
7774407|NCT00659334|27024622|P2|Overall Study|Screen Failure|5
7774408|NCT00659334|27024623|P1|Overall Study|Screen Failure|8
7774409|NCT00659269|27024650|P2|Overall Study|Physician Decision|1
7774410|NCT00659269|27024651|P1|Overall Study|Physician Decision|1
7774411|NCT00659230|27024681|P2|Overall Study|Did not return post-randomization|3
7774412|NCT00659230|27024682|P1|Overall Study|Did not return post-randomization|2
7774413|NCT00659230|27024681|P2|Overall Study|Lost source documentation|4
7774414|NCT00659230|27024682|P1|Overall Study|Lost source documentation|5
7774415|NCT00659230|27024681|P2|Overall Study|Lost to Follow-up|5
7774416|NCT00659230|27024682|P1|Overall Study|Lost to Follow-up|2
7774417|NCT00659061|27024705|P2|Overall Study|Migration due to political unrest|15
7774418|NCT00659061|27024706|P1|Overall Study|Migration due to political unrest|21
7774419|NCT00658996|27024724|P2|Second Intervention|Positive slit lamp finding|1
7774420|NCT00658996|27024725|P1|Second Intervention|Positive slit lamp finding|0
7774421|NCT00658996|27024724|P2|Second Intervention|Developed a stye on upper lid|0
7774422|NCT00658996|27024725|P1|Second Intervention|Developed a stye on upper lid|1
7774423|NCT00658996|27024724|P2|Crossover Period|Ineligible|1
7774424|NCT00658996|27024725|P1|Crossover Period|Ineligible|1
7774425|NCT00658996|27024724|P2|Crossover Period|Physician Decision|0
7774426|NCT00658996|27024725|P1|Crossover Period|Physician Decision|1
7774427|NCT00658996|27024724|P2|First Intervention|Lack of lenses|1
7774428|NCT00658996|27024725|P1|First Intervention|Lack of lenses|0
7774429|NCT00658996|27024724|P2|First Intervention|Positive slit lamp finding|0
7774430|NCT00658996|27024725|P1|First Intervention|Positive slit lamp finding|1
7774431|NCT00658879|27024735|P1|Overall Study|Protocol Violation|1
7774432|NCT00658814|27024752|P2|Maintenance Therapy|Not eligible|0
7774433|NCT00658814|27024753|P1|Maintenance Therapy|Not eligible|1
7774434|NCT00658814|27024752|P2|Maintenance Therapy|Not protocol specified|0
7774435|NCT00658814|27024753|P1|Maintenance Therapy|Not protocol specified|1
7774436|NCT00658814|27024752|P2|Maintenance Therapy|Adverse Event|1
7774437|NCT00658814|27024753|P1|Maintenance Therapy|Adverse Event|1
7774438|NCT00658814|27024752|P2|Consolidation Therapy|Not eligible|2
7774439|NCT00658814|27024753|P1|Consolidation Therapy|Not eligible|2
7774440|NCT00658814|27024752|P2|Consolidation Therapy|Not protocol specified|1
7774441|NCT00658814|27024753|P1|Consolidation Therapy|Not protocol specified|0
7774442|NCT00658814|27024752|P2|Remission Induction Chemotherapy|Not eligible|2
7774443|NCT00658814|27024753|P1|Remission Induction Chemotherapy|Not eligible|1
7774444|NCT00658814|27024752|P2|Remission Induction Chemotherapy|Not protocol specified|4
7774445|NCT00658814|27024753|P1|Remission Induction Chemotherapy|Not protocol specified|2
7774446|NCT00658814|27024752|P2|Remission Induction Chemotherapy|Death|4
7774447|NCT00658814|27024753|P1|Remission Induction Chemotherapy|Death|1
7774448|NCT00658814|27024752|P2|Remission Induction Chemotherapy|Progression/Relapse|1
7774449|NCT00658814|27024753|P1|Remission Induction Chemotherapy|Progression/Relapse|0
7774450|NCT00658814|27024752|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
7774451|NCT00658814|27024753|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
7774452|NCT00658814|27024752|P2|Remission Induction Chemotherapy|Adverse Event|3
7774453|NCT00658814|27024753|P1|Remission Induction Chemotherapy|Adverse Event|1
7774454|NCT00658788|27024767|P1|Overall Study|Treatment Discontinuation|32
7774455|NCT00658788|27024767|P1|Overall Study|Lost to Follow-up|18
7774456|NCT00658788|27024767|P1|Overall Study|Withdrawal by Subject|13
7774457|NCT00658788|27024767|P1|Overall Study|Adverse Event|11
7774458|NCT00658775|27024822|P2|Overall Study|Other|8
7774459|NCT00658775|27024823|P1|Overall Study|Other|7
7774460|NCT00658775|27024822|P2|Overall Study|Withdrawal of consent|7
7774461|NCT00658775|27024823|P1|Overall Study|Withdrawal of consent|8
7774462|NCT00658775|27024822|P2|Overall Study|Withdrawal by Subject|4
7774463|NCT00658775|27024823|P1|Overall Study|Withdrawal by Subject|6
7774464|NCT00658775|27024822|P2|Overall Study|Lost to Follow-up|18
7774465|NCT00658775|27024823|P1|Overall Study|Lost to Follow-up|17
7774466|NCT00658775|27024822|P2|Overall Study|Adverse Event|6
7774467|NCT00658775|27024823|P1|Overall Study|Adverse Event|4
7774468|NCT00658723|27024846|P3|Overall Study|Withdrawal by Subject|1
7774469|NCT00658723|27024847|P2|Overall Study|Withdrawal by Subject|0
7774470|NCT00658723|27024848|P1|Overall Study|Withdrawal by Subject|1
7774471|NCT00658723|27024846|P3|Overall Study|Scheduling Issue|0
7774472|NCT00658723|27024847|P2|Overall Study|Scheduling Issue|1
7774473|NCT00658723|27024848|P1|Overall Study|Scheduling Issue|1
7774474|NCT00658723|27024846|P3|Overall Study|Death|4
7774475|NCT00658723|27024847|P2|Overall Study|Death|1
7774476|NCT00658723|27024848|P1|Overall Study|Death|2
7774477|NCT00658723|27024846|P3|Overall Study|Lost to Follow-up|2
7774478|NCT00658723|27024847|P2|Overall Study|Lost to Follow-up|2
7774479|NCT00658723|27024848|P1|Overall Study|Lost to Follow-up|0
7774480|NCT00658684|27024886|P4|Overall Study|Pregnancy|0
7774481|NCT00658684|27024887|P3|Overall Study|Pregnancy|0
7774482|NCT00658684|27024888|P2|Overall Study|Pregnancy|1
7774483|NCT00658684|27024889|P1|Overall Study|Pregnancy|1
7774484|NCT00658684|27024886|P4|Overall Study|Protocol Violation|0
7774485|NCT00658684|27024887|P3|Overall Study|Protocol Violation|0
7774486|NCT00658684|27024888|P2|Overall Study|Protocol Violation|1
7774487|NCT00658684|27024889|P1|Overall Study|Protocol Violation|1
7774488|NCT00658684|27024886|P4|Overall Study|Lack of Efficacy|0
7774489|NCT00658684|27024887|P3|Overall Study|Lack of Efficacy|0
7774490|NCT00658684|27024888|P2|Overall Study|Lack of Efficacy|1
7774491|NCT00658684|27024889|P1|Overall Study|Lack of Efficacy|1
7774492|NCT00658684|27024886|P4|Overall Study|Withdrawal by Subject|1
7774493|NCT00658684|27024887|P3|Overall Study|Withdrawal by Subject|1
7774494|NCT00658684|27024888|P2|Overall Study|Withdrawal by Subject|4
7774495|NCT00658684|27024889|P1|Overall Study|Withdrawal by Subject|6
7774496|NCT00658684|27024886|P4|Overall Study|Adverse Event|0
7774497|NCT00658684|27024887|P3|Overall Study|Adverse Event|2
7774498|NCT00658684|27024888|P2|Overall Study|Adverse Event|8
7774499|NCT00658684|27024889|P1|Overall Study|Adverse Event|10
7774500|NCT00658658|27024944|P5|Overall Study|Other|1
7774501|NCT00658658|27024945|P4|Overall Study|Other|0
7774502|NCT00658658|27024946|P3|Overall Study|Other|0
7774503|NCT00658658|27024947|P2|Overall Study|Other|0
7774504|NCT00658658|27024948|P1|Overall Study|Other|0
7774505|NCT00658658|27024944|P5|Overall Study|Protocol-specified Criteria|0
7774506|NCT00658658|27024945|P4|Overall Study|Protocol-specified Criteria|0
7774507|NCT00658658|27024946|P3|Overall Study|Protocol-specified Criteria|0
7774508|NCT00658658|27024947|P2|Overall Study|Protocol-specified Criteria|0
7774509|NCT00658658|27024948|P1|Overall Study|Protocol-specified Criteria|1
7774510|NCT00658658|27024944|P5|Overall Study|Disease Progression|3
7774511|NCT00658658|27024945|P4|Overall Study|Disease Progression|1
7774512|NCT00658658|27024946|P3|Overall Study|Disease Progression|0
7774513|NCT00658658|27024947|P2|Overall Study|Disease Progression|1
7774514|NCT00658658|27024948|P1|Overall Study|Disease Progression|0
7774515|NCT00658658|27024944|P5|Overall Study|Death|1
7774516|NCT00658658|27024945|P4|Overall Study|Death|1
7774517|NCT00658658|27024946|P3|Overall Study|Death|0
7774518|NCT00658658|27024947|P2|Overall Study|Death|0
7774519|NCT00658658|27024948|P1|Overall Study|Death|4
7774520|NCT00658658|27024944|P5|Overall Study|Withdrawal by Subject|0
7774521|NCT00658658|27024945|P4|Overall Study|Withdrawal by Subject|0
7774522|NCT00658658|27024946|P3|Overall Study|Withdrawal by Subject|0
7774523|NCT00658658|27024947|P2|Overall Study|Withdrawal by Subject|1
7774524|NCT00658658|27024948|P1|Overall Study|Withdrawal by Subject|0
7774525|NCT00658632|27025007|P2|Overall Study|Other|8
7774526|NCT00658632|27025008|P1|Overall Study|Other|7
7774527|NCT00658632|27025007|P2|Overall Study|Pregnancy|1
7774528|NCT00658632|27025008|P1|Overall Study|Pregnancy|1
7774529|NCT00658632|27025007|P2|Overall Study|Withdrawal of consent|14
7774530|NCT00658632|27025008|P1|Overall Study|Withdrawal of consent|8
7774531|NCT00658632|27025007|P2|Overall Study|Lack of Efficacy|1
7774532|NCT00658632|27025008|P1|Overall Study|Lack of Efficacy|0
7774533|NCT00658632|27025007|P2|Overall Study|Withdrawal by Subject|7
7774534|NCT00658632|27025008|P1|Overall Study|Withdrawal by Subject|10
7774535|NCT00658632|27025007|P2|Overall Study|Lost to Follow-up|23
7774536|NCT00658632|27025008|P1|Overall Study|Lost to Follow-up|25
7774537|NCT00658632|27025007|P2|Overall Study|Adverse Event|11
7774538|NCT00658632|27025008|P1|Overall Study|Adverse Event|13
7774539|NCT00658606|27025049|P2|Overall Study|Lack of Compliance|3
7774540|NCT00658606|27025050|P1|Overall Study|Lack of Compliance|0
7774541|NCT00658606|27025049|P2|Overall Study|Withdrawal by Subject|16
7774542|NCT00658606|27025050|P1|Overall Study|Withdrawal by Subject|7
7774543|NCT00658606|27025049|P2|Overall Study|Lost to Follow-up|0
7774544|NCT00658606|27025050|P1|Overall Study|Lost to Follow-up|1
7774545|NCT00658606|27025049|P2|Overall Study|Lack of Efficacy|3
7774546|NCT00658606|27025050|P1|Overall Study|Lack of Efficacy|6
7774547|NCT00658606|27025049|P2|Overall Study|Adverse Event|1
7774548|NCT00658606|27025050|P1|Overall Study|Adverse Event|2
7774549|NCT00658567|27025079|P3|Overall Study|At Discretion of Sponsor|1
7774550|NCT00658567|27025080|P2|Overall Study|At Discretion of Sponsor|1
7774551|NCT00658567|27025081|P1|Overall Study|At Discretion of Sponsor|1
7774552|NCT00658567|27025079|P3|Overall Study|Physician Decision|0
7774553|NCT00658567|27025080|P2|Overall Study|Physician Decision|1
7774554|NCT00658567|27025081|P1|Overall Study|Physician Decision|0
7774555|NCT00658567|27025079|P3|Overall Study|Voluntary Withdrawal of Consent|2
7774556|NCT00658567|27025080|P2|Overall Study|Voluntary Withdrawal of Consent|0
7774557|NCT00658567|27025081|P1|Overall Study|Voluntary Withdrawal of Consent|2
7774558|NCT00658567|27025079|P3|Overall Study|Adverse Event|3
7774559|NCT00658567|27025080|P2|Overall Study|Adverse Event|2
7774560|NCT00658567|27025081|P1|Overall Study|Adverse Event|5
7774561|NCT00658541|27025092|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7774562|NCT00658541|27025093|P1|Washout Period of 7 Days|Withdrawal by Subject|0
7774563|NCT00658541|27025092|P2|Washout Period of 7 Days|Withdrawal by Subject|1
7774564|NCT00658541|27025093|P1|Washout Period of 7 Days|Withdrawal by Subject|1
7774565|NCT00658528|27025105|P2|Overall Study|Other|4
7774566|NCT00658528|27025106|P1|Overall Study|Other|8
7774567|NCT00658528|27025105|P2|Overall Study|Withdrawal of consent|6
7774568|NCT00658528|27025106|P1|Overall Study|Withdrawal of consent|5
7774569|NCT00658528|27025105|P2|Overall Study|Withdrawal by Subject|6
7774570|NCT00658528|27025106|P1|Overall Study|Withdrawal by Subject|8
7774571|NCT00658528|27025105|P2|Overall Study|Lost to Follow-up|22
7774572|NCT00658528|27025106|P1|Overall Study|Lost to Follow-up|14
7774573|NCT00658528|27025105|P2|Overall Study|Adverse Event|7
7774574|NCT00658528|27025106|P1|Overall Study|Adverse Event|5
7774575|NCT00658359|27025146|P3|Overall Study|Lack of Efficacy|0
7774576|NCT00658359|27025147|P2|Overall Study|Lack of Efficacy|1
7774577|NCT00658359|27025148|P1|Overall Study|Lack of Efficacy|0
7774578|NCT00658359|27025146|P3|Overall Study|Lost to Follow-up|4
7774579|NCT00658359|27025147|P2|Overall Study|Lost to Follow-up|2
7774580|NCT00658359|27025148|P1|Overall Study|Lost to Follow-up|2
7774581|NCT00658359|27025146|P3|Overall Study|Withdrawal by Subject|2
7774582|NCT00658359|27025147|P2|Overall Study|Withdrawal by Subject|4
7774583|NCT00658359|27025148|P1|Overall Study|Withdrawal by Subject|7
7774584|NCT00658359|27025146|P3|Overall Study|Includes protocol Amendments 3 and 4|29
7774585|NCT00658359|27025147|P2|Overall Study|Includes protocol Amendments 3 and 4|31
7774586|NCT00658359|27025148|P1|Overall Study|Includes protocol Amendments 3 and 4|2
7774587|NCT00658359|27025146|P3|Overall Study|Protocol Violation|0
7774588|NCT00658359|27025147|P2|Overall Study|Protocol Violation|0
7774589|NCT00658359|27025148|P1|Overall Study|Protocol Violation|1
7774590|NCT00658359|27025146|P3|Overall Study|Adverse Event|9
7774591|NCT00658359|27025147|P2|Overall Study|Adverse Event|6
7774592|NCT00658359|27025148|P1|Overall Study|Adverse Event|13
7774593|NCT00658359|27025146|P3|Overall Study|Death|2
7774594|NCT00658359|27025147|P2|Overall Study|Death|1
7774595|NCT00658359|27025148|P1|Overall Study|Death|3
7774596|NCT00658333|27025236|P2|Overall Study|Adverse Event|1
7774597|NCT00658333|27025237|P1|Overall Study|Adverse Event|2
7774598|NCT00658320|27025247|P2|Extension Study: After Month 24|Subject withdrew consent|0
7774599|NCT00658320|27025248|P1|Extension Study: After Month 24|Subject withdrew consent|2
7774600|NCT00658320|27025247|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
7774601|NCT00658320|27025248|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
7774602|NCT00658320|27025247|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
7774603|NCT00658320|27025248|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
7774604|NCT00658320|27025247|P2|Core Study: 12 Months|Subject withdrew consent|3
7774605|NCT00658320|27025248|P1|Core Study: 12 Months|Subject withdrew consent|5
7774606|NCT00658021|27025283|P3|Long-term Safety Follow-up Period|Physician Decision|0
7774607|NCT00658021|27025284|P2|Long-term Safety Follow-up Period|Physician Decision|2
7774608|NCT00658021|27025285|P1|Long-term Safety Follow-up Period|Physician Decision|0
7774609|NCT00658021|27025283|P3|Long-term Safety Follow-up Period|Withdrawal by Subject|0
7774610|NCT00658021|27025284|P2|Long-term Safety Follow-up Period|Withdrawal by Subject|1
7774611|NCT00658021|27025285|P1|Long-term Safety Follow-up Period|Withdrawal by Subject|0
7774612|NCT00658021|27025283|P3|28-Week Treatment Period|Did not receive treatment|0
7774613|NCT00658021|27025284|P2|28-Week Treatment Period|Did not receive treatment|0
7774614|NCT00658021|27025285|P1|28-Week Treatment Period|Did not receive treatment|2
7774615|NCT00658021|27025283|P3|28-Week Treatment Period|Other|1
7774616|NCT00658021|27025284|P2|28-Week Treatment Period|Other|3
7774617|NCT00658021|27025285|P1|28-Week Treatment Period|Other|2
7774618|NCT00658021|27025283|P3|28-Week Treatment Period|Loss of glucose control|10
7774619|NCT00658021|27025284|P2|28-Week Treatment Period|Loss of glucose control|1
7774620|NCT00658021|27025285|P1|28-Week Treatment Period|Loss of glucose control|1
7774621|NCT00658021|27025283|P3|28-Week Treatment Period|Withdrawal by parent/guardian|1
7774622|NCT00658021|27025284|P2|28-Week Treatment Period|Withdrawal by parent/guardian|1
7774623|NCT00658021|27025285|P1|28-Week Treatment Period|Withdrawal by parent/guardian|1
7774624|NCT00658021|27025283|P3|28-Week Treatment Period|Physician Decision|1
7774625|NCT00658021|27025284|P2|28-Week Treatment Period|Physician Decision|2
7774626|NCT00658021|27025285|P1|28-Week Treatment Period|Physician Decision|1
7774627|NCT00658021|27025283|P3|28-Week Treatment Period|Withdrawal by Subject|3
7774628|NCT00658021|27025284|P2|28-Week Treatment Period|Withdrawal by Subject|1
7774629|NCT00658021|27025285|P1|28-Week Treatment Period|Withdrawal by Subject|1
7774630|NCT00658021|27025283|P3|28-Week Treatment Period|Protocol Violation|1
7774631|NCT00658021|27025284|P2|28-Week Treatment Period|Protocol Violation|2
7774632|NCT00658021|27025285|P1|28-Week Treatment Period|Protocol Violation|0
7774633|NCT00658021|27025283|P3|28-Week Treatment Period|Developed study withdrawal criteria|0
7774634|NCT00658021|27025284|P2|28-Week Treatment Period|Developed study withdrawal criteria|2
7774635|NCT00658021|27025285|P1|28-Week Treatment Period|Developed study withdrawal criteria|0
7774636|NCT00658021|27025283|P3|28-Week Treatment Period|Adverse Event|0
7774637|NCT00658021|27025284|P2|28-Week Treatment Period|Adverse Event|1
7774638|NCT00658021|27025285|P1|28-Week Treatment Period|Adverse Event|3
7774639|NCT00657709|27025320|P5|Overall Study|Protocol Violation|2
7774640|NCT00657709|27025321|P4|Overall Study|Protocol Violation|1
7774641|NCT00657709|27025322|P3|Overall Study|Protocol Violation|0
7774642|NCT00657709|27025323|P2|Overall Study|Protocol Violation|2
7774643|NCT00657709|27025324|P1|Overall Study|Protocol Violation|0
7774644|NCT00657709|27025320|P5|Overall Study|Lost to Follow-up|21
7774645|NCT00657709|27025321|P4|Overall Study|Lost to Follow-up|1
7774646|NCT00657709|27025322|P3|Overall Study|Lost to Follow-up|7
7774647|NCT00657709|27025323|P2|Overall Study|Lost to Follow-up|9
7774648|NCT00657709|27025324|P1|Overall Study|Lost to Follow-up|9
7774649|NCT00657709|27025320|P5|Overall Study|Withdrawal by Subject|9
7774650|NCT00657709|27025321|P4|Overall Study|Withdrawal by Subject|5
7774651|NCT00657709|27025322|P3|Overall Study|Withdrawal by Subject|15
7774652|NCT00657709|27025323|P2|Overall Study|Withdrawal by Subject|15
7774653|NCT00657709|27025324|P1|Overall Study|Withdrawal by Subject|7
7774654|NCT00657709|27025320|P5|Overall Study|AE or Death|1
7774655|NCT00657709|27025321|P4|Overall Study|AE or Death|7
7774656|NCT00657709|27025322|P3|Overall Study|AE or Death|6
7774657|NCT00657709|27025323|P2|Overall Study|AE or Death|7
7774658|NCT00657709|27025324|P1|Overall Study|AE or Death|7
7774659|NCT00657618|27025373|P1|Overall Study|didn't start due to schedule conflicts|1
7774660|NCT00657618|27025373|P1|Overall Study|negative for leishmaniasis|2
7774661|NCT00657618|27025373|P1|Overall Study|Withdrawal by Subject|8
7774662|NCT00657618|27025373|P1|Overall Study|Adverse Event|32
7774663|NCT00657553|27025385|P2|Overall Study|low accrual, no analysis run|5
7774664|NCT00657553|27025386|P1|Overall Study|low accrual, no analysis run|5
7774665|NCT00657540|27025394|P2|Overall Study|Lost to Follow-up|4
7774666|NCT00657540|27025395|P1|Overall Study|Lost to Follow-up|1
7774667|NCT00657371|27025409|P1|Overall Study|Pre-existing medical condition|4
7774668|NCT00657371|27025409|P1|Overall Study|Device- related reasons|13
7774669|NCT00657371|27025409|P1|Overall Study|Protocol Violation|2
7774670|NCT00657371|27025409|P1|Overall Study|Unable to intubate the cecum|5
7774671|NCT00657371|27025409|P1|Overall Study|Poor bowel preparation|15
7774672|NCT00657358|27025414|P1|Overall Study|Lack of Efficacy|6
7774673|NCT00657267|27025426|P1|Overall Study|Adverse Event|9
7774674|NCT00657267|27025426|P1|Overall Study|Progressive disease|45
7774675|NCT00657150|27025436|P2|Treatment|Other|15
7774676|NCT00657150|27025437|P1|Treatment|Other|13
7774677|NCT00657150|27025436|P2|Treatment|Withdrawal by Subject|20
7774678|NCT00657150|27025437|P1|Treatment|Withdrawal by Subject|23
7774679|NCT00657150|27025436|P2|Treatment|Lost to Follow-up|0
7774680|NCT00657150|27025437|P1|Treatment|Lost to Follow-up|1
7774681|NCT00657150|27025436|P2|Treatment|Non-compliant with protocol|9
7774682|NCT00657150|27025437|P1|Treatment|Non-compliant with protocol|10
7774683|NCT00657150|27025436|P2|Treatment|Adverse Event|53
7774684|NCT00657150|27025437|P1|Treatment|Adverse Event|60
7774685|NCT00657150|27025436|P2|Overall Study|Other|38
7774686|NCT00657150|27025437|P1|Overall Study|Other|38
7774687|NCT00657150|27025436|P2|Overall Study|Withdrawal by Subject|36
7774688|NCT00657150|27025437|P1|Overall Study|Withdrawal by Subject|51
7774689|NCT00657150|27025436|P2|Overall Study|Lost to Follow-up|0
7774690|NCT00657150|27025437|P1|Overall Study|Lost to Follow-up|2
7774691|NCT00657150|27025436|P2|Overall Study|Non-compliant with protocol|9
7774692|NCT00657150|27025437|P1|Overall Study|Non-compliant with protocol|5
7774693|NCT00657150|27025436|P2|Overall Study|Adverse Event|10
7774694|NCT00657150|27025437|P1|Overall Study|Adverse Event|19
7774695|NCT00657046|27025468|P3|Overall Study|Surgery|1
7774696|NCT00657046|27025469|P2|Overall Study|Surgery|0
7774697|NCT00657046|27025470|P1|Overall Study|Surgery|0
7774698|NCT00657046|27025468|P3|Overall Study|Death|1
7774699|NCT00657046|27025469|P2|Overall Study|Death|0
7774700|NCT00657046|27025470|P1|Overall Study|Death|0
7774701|NCT00657046|27025468|P3|Overall Study|Withdrawal by Subject|0
7774702|NCT00657046|27025469|P2|Overall Study|Withdrawal by Subject|0
7774703|NCT00657046|27025470|P1|Overall Study|Withdrawal by Subject|1
7774704|NCT00657046|27025468|P3|Overall Study|Protocol Violation|0
7774705|NCT00657046|27025469|P2|Overall Study|Protocol Violation|2
7774706|NCT00657046|27025470|P1|Overall Study|Protocol Violation|2
7774707|NCT00657046|27025468|P3|Overall Study|Adverse Event|0
7774708|NCT00657046|27025469|P2|Overall Study|Adverse Event|1
7774709|NCT00657046|27025470|P1|Overall Study|Adverse Event|1
7774710|NCT00657020|27025502|P2|PERIOD 1|Adverse Event|1
7774711|NCT00657020|27025503|P1|PERIOD 1|Adverse Event|0
7774712|NCT00656851|27025553|P2|Overall Study|Withdrawal by Subject|4
7774713|NCT00656851|27025554|P1|Overall Study|Withdrawal by Subject|0
7774714|NCT00656799|27025576|P1|Overall Study|Death|2
7774715|NCT00656669|27025598|P1|AC (Cycles 6-9)|Did not start segment 3|1
7774716|NCT00656669|27025598|P1|AC (Cycles 6-9)|Adverse Event|1
7774717|NCT00656669|27025598|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
7774718|NCT00656669|27025598|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
7774719|NCT00656617|27025637|P1|Overall Study|Move to different clinical trial|2
7774720|NCT00656617|27025637|P1|Overall Study|Insurance Issues|2
7774721|NCT00656617|27025637|P1|Overall Study|Death|2
7774722|NCT00656617|27025637|P1|Overall Study|Adverse Event|1
7774723|NCT00656513|27025646|P3|Overall Study|Missing baseline form|5
7774724|NCT00656513|27025647|P2|Overall Study|Missing baseline form|5
7774725|NCT00656513|27025648|P1|Overall Study|Missing baseline form|0
7774726|NCT00656513|27025646|P3|Overall Study|Treatment completed outside of timeframe|1
7774727|NCT00656513|27025647|P2|Overall Study|Treatment completed outside of timeframe|3
7774728|NCT00656513|27025648|P1|Overall Study|Treatment completed outside of timeframe|0
7774729|NCT00656513|27025646|P3|Overall Study|Incomplete treatment|0
7774730|NCT00656513|27025647|P2|Overall Study|Incomplete treatment|0
7774731|NCT00656513|27025648|P1|Overall Study|Incomplete treatment|3
7774732|NCT00656513|27025646|P3|Overall Study|Missing data|9
7774733|NCT00656513|27025647|P2|Overall Study|Missing data|11
7774734|NCT00656513|27025648|P1|Overall Study|Missing data|0
7774735|NCT00656513|27025646|P3|Overall Study|Death|1
7774736|NCT00656513|27025647|P2|Overall Study|Death|0
7774737|NCT00656513|27025648|P1|Overall Study|Death|0
7774738|NCT00656513|27025646|P3|Overall Study|Withdrawal by Subject|4
7774739|NCT00656513|27025647|P2|Overall Study|Withdrawal by Subject|11
7774740|NCT00656513|27025648|P1|Overall Study|Withdrawal by Subject|0
7774741|NCT00656513|27025646|P3|Overall Study|Protocol Violation|2
7774742|NCT00656513|27025647|P2|Overall Study|Protocol Violation|0
7774743|NCT00656513|27025648|P1|Overall Study|Protocol Violation|1
7774745|NCT00656370|27025713|P1|Overall Study|Alternates|3
7774746|NCT00656370|27025713|P1|Overall Study|Screen Failures|7
7774747|NCT00656292|27025742|P2|Overall Study|Screen failure|2
7774748|NCT00656292|27025743|P1|Overall Study|Screen failure|1
7774749|NCT00656292|27025742|P2|Overall Study|Withdrawal by Subject|3
7774750|NCT00656292|27025743|P1|Overall Study|Withdrawal by Subject|2
7774751|NCT00656175|27025770|P2|Overall Study|Transportation issues|1
7774752|NCT00656175|27025771|P1|Overall Study|Transportation issues|0
7774753|NCT00656175|27025770|P2|Overall Study|Adverse Event|0
7774754|NCT00656175|27025771|P1|Overall Study|Adverse Event|1
7774755|NCT00656136|27025779|P2|Overall Study|Unknown and others|4
7774756|NCT00656136|27025780|P1|Overall Study|Unknown and others|4
7774757|NCT00656136|27025779|P2|Overall Study|Patient refused to take study medication|10
7774758|NCT00656136|27025780|P1|Overall Study|Patient refused to take study medication|7
7774759|NCT00656136|27025779|P2|Overall Study|Protocol Violation|3
7774760|NCT00656136|27025780|P1|Overall Study|Protocol Violation|2
7774761|NCT00656136|27025779|P2|Overall Study|Other Adverse Event|51
7774762|NCT00656136|27025780|P1|Overall Study|Other Adverse Event|5
7774763|NCT00656136|27025779|P2|Overall Study|Progressive disease|322
7774764|NCT00656136|27025780|P1|Overall Study|Progressive disease|177
7774765|NCT00656084|27025790|P1|Overall Study|Investigator Request|1
7774766|NCT00656084|27025790|P1|Overall Study|Patient Request|1
7774767|NCT00656084|27025790|P1|Overall Study|Withdrawal by Subject|1
7774768|NCT00656084|27025790|P1|Overall Study|Adverse Event|4
7774769|NCT00656058|27025797|P1|Overall Study|Withdrawal by Subject|4
7774770|NCT00656058|27025797|P1|Overall Study|Withdrawal by Subject|2
7774771|NCT00656019|27025810|P4|Overall Study|Lost to Follow-up|0
7774772|NCT00656019|27025811|P3|Overall Study|Lost to Follow-up|0
7774773|NCT00656019|27025812|P2|Overall Study|Lost to Follow-up|1
7774774|NCT00656019|27025813|P1|Overall Study|Lost to Follow-up|2
7774775|NCT00656019|27025810|P4|Overall Study|Withdrawal by Subject|0
7774776|NCT00656019|27025811|P3|Overall Study|Withdrawal by Subject|0
7774777|NCT00656019|27025812|P2|Overall Study|Withdrawal by Subject|0
7774778|NCT00656019|27025813|P1|Overall Study|Withdrawal by Subject|2
7774779|NCT00656019|27025810|P4|Overall Study|Not Eligible|0
7774780|NCT00656019|27025811|P3|Overall Study|Not Eligible|0
7774781|NCT00656019|27025812|P2|Overall Study|Not Eligible|0
7774782|NCT00656019|27025813|P1|Overall Study|Not Eligible|10
7774783|NCT00655980|27025826|P3|Overall Study|surgery canceled; or subject or anesthes|5
7774784|NCT00655980|27025827|P2|Overall Study|surgery canceled; or subject or anesthes|31
7774785|NCT00655980|27025828|P1|Overall Study|surgery canceled; or subject or anesthes|26
7774786|NCT00655928|27025841|P2|Overall Study|Physician Decision|1
7774787|NCT00655928|27025842|P1|Overall Study|Physician Decision|1
7774788|NCT00655928|27025841|P2|Overall Study|Withdrawal by Subject|1
7774789|NCT00655928|27025842|P1|Overall Study|Withdrawal by Subject|2
7774790|NCT00655889|27025848|P1|Overall Study|Protocol Violation|1
7774791|NCT00655889|27025848|P1|Overall Study|Inadequate cell growth|1
7774792|NCT00655876|27025855|P2|Overall Study|Protocol Violation|7
7774793|NCT00655876|27025856|P1|Overall Study|Protocol Violation|9
7774794|NCT00655863|27025875|P3|Overall Study|Lost to Follow-up|1
7774795|NCT00655863|27025876|P2|Overall Study|Lost to Follow-up|0
7774796|NCT00655863|27025877|P1|Overall Study|Lost to Follow-up|0
7774797|NCT00655850|27025936|P1|Overall Study|Withdrawal by Subject|1
7774798|NCT00655850|27025936|P1|Overall Study|Death|2
7774799|NCT00655824|27025943|P1|Overall Study|Deterioration of Trial Disease|2
7774800|NCT00655824|27025943|P1|Overall Study|Withdrawal by Subject|4
7774801|NCT00655824|27025943|P1|Overall Study|Protocol Violation|1
7774802|NCT00655824|27025943|P1|Overall Study|Early Termination of Study by Sponsor|74
7774803|NCT00655824|27025943|P1|Overall Study|Adverse Event|3
7774804|NCT00655746|27025991|P1|Overall Study|Withdrawal by Subject|1
7774805|NCT00655733|27026010|P2|Overall Study|Physician Decision|1
7774806|NCT00655733|27026011|P1|Overall Study|Physician Decision|0
7774807|NCT00655733|27026010|P2|Overall Study|Withdrawal by Subject|3
7774808|NCT00655733|27026011|P1|Overall Study|Withdrawal by Subject|3
7774809|NCT00655733|27026010|P2|Overall Study|Adverse Event|2
7774810|NCT00655733|27026011|P1|Overall Study|Adverse Event|2
7774811|NCT00655733|27026010|P2|Overall Study|Lost to Follow-up|2
7774812|NCT00655733|27026011|P1|Overall Study|Lost to Follow-up|2
7774813|NCT00655668|27026044|P1|Overall Study|Withdrawal by Subject|2
7774814|NCT00655668|27026044|P1|Overall Study|New Lymphoma Treatment Started|4
7774815|NCT00655668|27026044|P1|Overall Study|Other|1
7774816|NCT00655668|27026044|P1|Overall Study|Study Terminated|9
7774817|NCT00655668|27026044|P1|Overall Study|Disease Progression|27
7774818|NCT00655668|27026044|P1|Overall Study|Death|5
7774819|NCT00655668|27026044|P1|Overall Study|Adverse Event|6
7774820|NCT00655629|27026071|P2|Overall Study|consent withdrawn|4
7774821|NCT00655629|27026072|P1|Overall Study|consent withdrawn|6
7774822|NCT00655629|27026071|P2|Overall Study|Protocol Violation|3
7774823|NCT00655629|27026072|P1|Overall Study|Protocol Violation|5
7774824|NCT00655629|27026071|P2|Overall Study|Lost to Follow-up|3
7774825|NCT00655629|27026072|P1|Overall Study|Lost to Follow-up|4
7774826|NCT00655629|27026071|P2|Overall Study|Lack of Efficacy|12
7774827|NCT00655629|27026072|P1|Overall Study|Lack of Efficacy|2
7774828|NCT00655629|27026071|P2|Overall Study|Adverse Event|1
7774829|NCT00655629|27026072|P1|Overall Study|Adverse Event|4
7774830|NCT00655564|27026108|P1|Overall Study|Desired Alternate Therapy|1
7774831|NCT00655564|27026108|P1|Overall Study|Lost to Follow-up|1
7774832|NCT00655564|27026108|P1|Overall Study|Adverse Event|1
7774833|NCT00655551|27026116|P3|Period 4 (up to 7 Days)|Adverse Event|0
7774834|NCT00655551|27026117|P2|Period 4 (up to 7 Days)|Adverse Event|2
7774835|NCT00655551|27026118|P1|Period 4 (up to 7 Days)|Adverse Event|0
7774836|NCT00655551|27026116|P3|Period 3 (up to 7 Days)|Adverse Event|4
7774837|NCT00655551|27026117|P2|Period 3 (up to 7 Days)|Adverse Event|0
7774838|NCT00655551|27026118|P1|Period 3 (up to 7 Days)|Adverse Event|0
7774839|NCT00655551|27026116|P3|Period 2 (up to 7 Days)|Adverse Event|0
7774840|NCT00655551|27026117|P2|Period 2 (up to 7 Days)|Adverse Event|1
7774841|NCT00655551|27026118|P1|Period 2 (up to 7 Days)|Adverse Event|0
7774842|NCT00655551|27026116|P3|All Periods Combined|Adverse Event|4
7774843|NCT00655551|27026117|P2|All Periods Combined|Adverse Event|3
7774844|NCT00655551|27026118|P1|All Periods Combined|Adverse Event|0
7774845|NCT00655499|27026155|P1|Overall Study|not eligible|4
7774846|NCT00655486|27026162|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
7774847|NCT00655486|27026162|P1|Overall Study|Other: Could not tolerate BID dosing|1
7774848|NCT00655486|27026162|P1|Overall Study|Other: Pregnancy|1
7774849|NCT00655486|27026162|P1|Overall Study|Unsatisfactory compliance|2
7774850|NCT00655486|27026162|P1|Overall Study|Protocol Violation|1
7774851|NCT00655486|27026162|P1|Overall Study|Withdrawal by Subject|4
7774852|NCT00655486|27026162|P1|Overall Study|Lack of Efficacy|8
7774853|NCT00655486|27026162|P1|Overall Study|Adverse Event|10
7774854|NCT00655356|27026190|P2|Overall Study|Other Reason|0
7774855|NCT00655356|27026191|P1|Overall Study|Other Reason|1
7774856|NCT00655356|27026190|P2|Overall Study|Protocol Violation|1
7774857|NCT00655356|27026191|P1|Overall Study|Protocol Violation|2
7774858|NCT00655356|27026190|P2|Overall Study|Adverse Event|1
7774859|NCT00655356|27026191|P1|Overall Study|Adverse Event|1
7774860|NCT00655356|27026190|P2|Overall Study|Sponsor Request|4
7774861|NCT00655356|27026191|P1|Overall Study|Sponsor Request|10
7774862|NCT00655356|27026190|P2|Overall Study|Withdrawal by Subject|4
7774863|NCT00655356|27026191|P1|Overall Study|Withdrawal by Subject|3
7774864|NCT00654940|27026255|P2|Period 1|Intolerable Pain Level|0
7774865|NCT00654940|27026256|P1|Period 1|Intolerable Pain Level|1
7774866|NCT00654940|27026255|P2|Period 1|Adverse Event|1
7774867|NCT00654940|27026256|P1|Period 1|Adverse Event|0
7774868|NCT00654901|27026280|P4|Overall Study|Withdrawal by Subject|0
7774869|NCT00654901|27026281|P3|Overall Study|Withdrawal by Subject|1
7774870|NCT00654901|27026282|P2|Overall Study|Withdrawal by Subject|0
7774871|NCT00654901|27026283|P1|Overall Study|Withdrawal by Subject|3
7774872|NCT00654901|27026280|P4|Overall Study|Lost to Follow-up|0
7774873|NCT00654901|27026281|P3|Overall Study|Lost to Follow-up|1
7774874|NCT00654901|27026282|P2|Overall Study|Lost to Follow-up|0
7774875|NCT00654901|27026283|P1|Overall Study|Lost to Follow-up|1
7774876|NCT00654875|27026303|P2|Overall Study|Administrative Problems|0
7774877|NCT00654875|27026304|P1|Overall Study|Administrative Problems|1
7774878|NCT00654875|27026303|P2|Overall Study|Abnormal Test Procedure Result(s)|0
7774879|NCT00654875|27026304|P1|Overall Study|Abnormal Test Procedure Result(s)|1
7774880|NCT00654875|27026303|P2|Overall Study|Lost to Follow-up|3
7774881|NCT00654875|27026304|P1|Overall Study|Lost to Follow-up|1
7774882|NCT00654875|27026303|P2|Overall Study|Lack of Efficacy|2
7774883|NCT00654875|27026304|P1|Overall Study|Lack of Efficacy|2
7774884|NCT00654875|27026303|P2|Overall Study|Protocol Violation|3
7774885|NCT00654875|27026304|P1|Overall Study|Protocol Violation|3
7774886|NCT00654875|27026303|P2|Overall Study|Withdrawal by Subject|4
7774887|NCT00654875|27026304|P1|Overall Study|Withdrawal by Subject|4
7774888|NCT00654875|27026303|P2|Overall Study|Adverse Event|5
7774889|NCT00654875|27026304|P1|Overall Study|Adverse Event|5
7774890|NCT00654745|27026337|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
7774891|NCT00654745|27026337|P1|Overall Study|Withdrawal by Subject|10
7774892|NCT00654745|27026337|P1|Overall Study|Protocol Violation|11
7774893|NCT00654745|27026337|P1|Overall Study|Lost to Follow-up|7
7774894|NCT00654745|27026337|P1|Overall Study|Adverse Event|12
7774895|NCT00654732|27026377|P2|Overall Study|Adverse Event|6
7774896|NCT00654732|27026378|P1|Overall Study|Adverse Event|4
7774897|NCT00654641|27026391|P2|Overall Study|Lost to Follow-up|3
7774898|NCT00654641|27026392|P1|Overall Study|Lost to Follow-up|2
7774899|NCT00654628|27026398|P1|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
7774900|NCT00654628|27026398|P1|6 -Week Extension Period (Single Site)|Adverse Event|4
7774901|NCT00654628|27026398|P1|6-week Active Treatment Period|Out of window period|1
7774902|NCT00654628|27026398|P1|6-week Active Treatment Period|Transferred to branch hospital|1
7774903|NCT00654628|27026398|P1|6-week Active Treatment Period|Lost to Follow-up|10
7774904|NCT00654628|27026398|P1|6-week Active Treatment Period|Adverse Event|9
7774905|NCT00654498|27026447|P2|Overall Study|Other reason not defined above|5
7774906|NCT00654498|27026448|P1|Overall Study|Other reason not defined above|4
7774907|NCT00654498|27026447|P2|Overall Study|Withdrawal by Subject|0
7774908|NCT00654498|27026448|P1|Overall Study|Withdrawal by Subject|1
7774909|NCT00654498|27026447|P2|Overall Study|Lost to Follow-up|5
7774910|NCT00654498|27026448|P1|Overall Study|Lost to Follow-up|1
7774911|NCT00654498|27026447|P2|Overall Study|Protocol Violation|1
7774912|NCT00654498|27026448|P1|Overall Study|Protocol Violation|1
7774913|NCT00654498|27026447|P2|Overall Study|Adverse Event|1
7774914|NCT00654498|27026448|P1|Overall Study|Adverse Event|6
7774915|NCT00654498|27026447|P2|Overall Study|Not Treated|0
7774916|NCT00654498|27026448|P1|Overall Study|Not Treated|1
7774917|NCT00654420|27026480|P4|Phase II|Missing Disposition Record|0
7774918|NCT00654420|27026481|P3|Phase II|Missing Disposition Record|1
7774919|NCT00654420|27026482|P2|Phase II|Missing Disposition Record|0
7774920|NCT00654420|27026483|P1|Phase II|Missing Disposition Record|0
7774921|NCT00654420|27026480|P4|Phase II|Withdrawal by Subject|1
7774922|NCT00654420|27026481|P3|Phase II|Withdrawal by Subject|4
7774923|NCT00654420|27026482|P2|Phase II|Withdrawal by Subject|0
7774924|NCT00654420|27026483|P1|Phase II|Withdrawal by Subject|0
7774925|NCT00654420|27026480|P4|Phase II|Progressive Disease|29
7774926|NCT00654420|27026481|P3|Phase II|Progressive Disease|29
7774927|NCT00654420|27026482|P2|Phase II|Progressive Disease|0
7774928|NCT00654420|27026483|P1|Phase II|Progressive Disease|0
7774929|NCT00654420|27026480|P4|Phase II|Physician Decision|4
7774930|NCT00654420|27026481|P3|Phase II|Physician Decision|0
7774931|NCT00654420|27026482|P2|Phase II|Physician Decision|0
7774932|NCT00654420|27026483|P1|Phase II|Physician Decision|0
7774933|NCT00654420|27026480|P4|Phase II|Lost to Follow-up|1
7774934|NCT00654420|27026481|P3|Phase II|Lost to Follow-up|0
7774935|NCT00654420|27026482|P2|Phase II|Lost to Follow-up|0
7774936|NCT00654420|27026483|P1|Phase II|Lost to Follow-up|0
7774937|NCT00654420|27026480|P4|Phase II|Adverse Event|3
7774938|NCT00654420|27026481|P3|Phase II|Adverse Event|3
7774939|NCT00654420|27026482|P2|Phase II|Adverse Event|0
7774940|NCT00654420|27026483|P1|Phase II|Adverse Event|0
7774941|NCT00654420|27026480|P4|Phase I (Dose Escalation)|Progressive Disease|0
7774942|NCT00654420|27026481|P3|Phase I (Dose Escalation)|Progressive Disease|0
7774943|NCT00654420|27026482|P2|Phase I (Dose Escalation)|Progressive Disease|15
7774944|NCT00654420|27026483|P1|Phase I (Dose Escalation)|Progressive Disease|4
7774945|NCT00654420|27026480|P4|Phase I (Dose Escalation)|Adverse Event|0
7774946|NCT00654420|27026481|P3|Phase I (Dose Escalation)|Adverse Event|0
7774947|NCT00654420|27026482|P2|Phase I (Dose Escalation)|Adverse Event|1
7774948|NCT00654420|27026483|P1|Phase I (Dose Escalation)|Adverse Event|0
7774949|NCT00654381|27026509|P6|Extension Stage|Closure of the trial site|1
7774950|NCT00654381|27026510|P5|Extension Stage|Closure of the trial site|1
7774951|NCT00654381|27026511|P4|Extension Stage|Closure of the trial site|0
7774952|NCT00654381|27026512|P3|Extension Stage|Closure of the trial site|0
7774953|NCT00654381|27026513|P2|Extension Stage|Closure of the trial site|0
7774954|NCT00654381|27026514|P1|Extension Stage|Closure of the trial site|0
7774955|NCT00654381|27026509|P6|Extension Stage|Withdrawal by Subject|1
7774956|NCT00654381|27026510|P5|Extension Stage|Withdrawal by Subject|1
7774957|NCT00654381|27026511|P4|Extension Stage|Withdrawal by Subject|1
7774958|NCT00654381|27026512|P3|Extension Stage|Withdrawal by Subject|1
7774959|NCT00654381|27026513|P2|Extension Stage|Withdrawal by Subject|0
7774960|NCT00654381|27026514|P1|Extension Stage|Withdrawal by Subject|0
7774961|NCT00654381|27026509|P6|Extension Stage|Lack of Efficacy|0
7774962|NCT00654381|27026510|P5|Extension Stage|Lack of Efficacy|0
7774963|NCT00654381|27026511|P4|Extension Stage|Lack of Efficacy|0
7774964|NCT00654381|27026512|P3|Extension Stage|Lack of Efficacy|1
7774965|NCT00654381|27026513|P2|Extension Stage|Lack of Efficacy|0
7774966|NCT00654381|27026514|P1|Extension Stage|Lack of Efficacy|0
7774967|NCT00654381|27026509|P6|Extension Stage|Protocol Violation|0
7774968|NCT00654381|27026510|P5|Extension Stage|Protocol Violation|0
7774969|NCT00654381|27026511|P4|Extension Stage|Protocol Violation|1
7774970|NCT00654381|27026512|P3|Extension Stage|Protocol Violation|0
7774971|NCT00654381|27026513|P2|Extension Stage|Protocol Violation|0
7774972|NCT00654381|27026514|P1|Extension Stage|Protocol Violation|0
7774973|NCT00654381|27026509|P6|Extension Stage|Adverse Event|1
7774974|NCT00654381|27026510|P5|Extension Stage|Adverse Event|1
7774975|NCT00654381|27026511|P4|Extension Stage|Adverse Event|7
7774976|NCT00654381|27026512|P3|Extension Stage|Adverse Event|9
7774977|NCT00654381|27026513|P2|Extension Stage|Adverse Event|2
7774978|NCT00654381|27026514|P1|Extension Stage|Adverse Event|1
7774979|NCT00654381|27026509|P6|2nd Stage|Investigator's decision|0
7774980|NCT00654381|27026510|P5|2nd Stage|Investigator's decision|0
7774981|NCT00654381|27026511|P4|2nd Stage|Investigator's decision|1
7774982|NCT00654381|27026512|P3|2nd Stage|Investigator's decision|1
7774983|NCT00654381|27026513|P2|2nd Stage|Investigator's decision|0
7774984|NCT00654381|27026514|P1|2nd Stage|Investigator's decision|0
7774985|NCT00654381|27026509|P6|2nd Stage|Withdrawal by Subject|1
7774986|NCT00654381|27026510|P5|2nd Stage|Withdrawal by Subject|1
7774987|NCT00654381|27026511|P4|2nd Stage|Withdrawal by Subject|0
7774988|NCT00654381|27026512|P3|2nd Stage|Withdrawal by Subject|0
7774989|NCT00654381|27026513|P2|2nd Stage|Withdrawal by Subject|0
7774990|NCT00654381|27026514|P1|2nd Stage|Withdrawal by Subject|0
7774991|NCT00654381|27026509|P6|2nd Stage|Adverse Event|2
7774992|NCT00654381|27026510|P5|2nd Stage|Adverse Event|7
7774993|NCT00654381|27026511|P4|2nd Stage|Adverse Event|3
7774994|NCT00654381|27026512|P3|2nd Stage|Adverse Event|2
7774995|NCT00654381|27026513|P2|2nd Stage|Adverse Event|0
7774996|NCT00654381|27026514|P1|2nd Stage|Adverse Event|2
7774997|NCT00654381|27026509|P6|1st Stage|Investigator's decision|0
7774998|NCT00654381|27026510|P5|1st Stage|Investigator's decision|0
7774999|NCT00654381|27026511|P4|1st Stage|Investigator's decision|1
7775000|NCT00654381|27026512|P3|1st Stage|Investigator's decision|0
7775001|NCT00654381|27026513|P2|1st Stage|Investigator's decision|0
7775002|NCT00654381|27026514|P1|1st Stage|Investigator's decision|0
7775003|NCT00654381|27026509|P6|1st Stage|Withdrawal by Subject|1
7775004|NCT00654381|27026510|P5|1st Stage|Withdrawal by Subject|0
7775005|NCT00654381|27026511|P4|1st Stage|Withdrawal by Subject|1
7775006|NCT00654381|27026512|P3|1st Stage|Withdrawal by Subject|0
7775007|NCT00654381|27026513|P2|1st Stage|Withdrawal by Subject|0
7775008|NCT00654381|27026514|P1|1st Stage|Withdrawal by Subject|0
7775009|NCT00654381|27026509|P6|1st Stage|Adverse Event|1
7775010|NCT00654381|27026510|P5|1st Stage|Adverse Event|2
7775011|NCT00654381|27026511|P4|1st Stage|Adverse Event|3
7775012|NCT00654381|27026512|P3|1st Stage|Adverse Event|3
7775013|NCT00654381|27026513|P2|1st Stage|Adverse Event|3
7775014|NCT00654381|27026514|P1|1st Stage|Adverse Event|3
7775015|NCT00654368|27026551|P3|Overall Study|Adverse Event|6
7775016|NCT00654368|27026552|P2|Overall Study|Adverse Event|9
7775017|NCT00654368|27026553|P1|Overall Study|Adverse Event|14
7775018|NCT00654368|27026551|P3|Overall Study|Other|3
7775019|NCT00654368|27026552|P2|Overall Study|Other|2
7775020|NCT00654368|27026553|P1|Overall Study|Other|0
7775021|NCT00654368|27026551|P3|Overall Study|Pregnancy|2
7775022|NCT00654368|27026552|P2|Overall Study|Pregnancy|0
7775023|NCT00654368|27026553|P1|Overall Study|Pregnancy|0
7775024|NCT00654368|27026551|P3|Overall Study|Death|0
7775025|NCT00654368|27026552|P2|Overall Study|Death|0
7775026|NCT00654368|27026553|P1|Overall Study|Death|1
7775027|NCT00654368|27026551|P3|Overall Study|Physician Decision|2
7775028|NCT00654368|27026552|P2|Overall Study|Physician Decision|0
7775029|NCT00654368|27026553|P1|Overall Study|Physician Decision|0
7775030|NCT00654368|27026551|P3|Overall Study|Requirement for alternative therapy|1
7775031|NCT00654368|27026552|P2|Overall Study|Requirement for alternative therapy|1
7775032|NCT00654368|27026553|P1|Overall Study|Requirement for alternative therapy|1
7775033|NCT00654368|27026551|P3|Overall Study|Disease progression|13
7775034|NCT00654368|27026552|P2|Overall Study|Disease progression|31
7775035|NCT00654368|27026553|P1|Overall Study|Disease progression|21
7775036|NCT00654368|27026551|P3|Overall Study|Withdrawal by Subject|2
7775037|NCT00654368|27026552|P2|Overall Study|Withdrawal by Subject|2
7775038|NCT00654368|27026553|P1|Overall Study|Withdrawal by Subject|5
7775039|NCT00654368|27026551|P3|Overall Study|Non-compliance|2
7775040|NCT00654368|27026552|P2|Overall Study|Non-compliance|1
7775041|NCT00654368|27026553|P1|Overall Study|Non-compliance|2
7775042|NCT00654368|27026551|P3|Overall Study|Protocol deviation|1
7775043|NCT00654368|27026552|P2|Overall Study|Protocol deviation|2
7775044|NCT00654368|27026553|P1|Overall Study|Protocol deviation|3
7775045|NCT00654368|27026551|P3|Overall Study|Ineligibility determined|0
7775046|NCT00654368|27026552|P2|Overall Study|Ineligibility determined|0
7775047|NCT00654368|27026553|P1|Overall Study|Ineligibility determined|6
7775048|NCT00654355|27026586|P2|Overall Study|Lost to Follow-up|2
7775049|NCT00654355|27026587|P1|Overall Study|Lost to Follow-up|2
7775050|NCT00654238|27026618|P1|Overall Study|Screen Failures|4
7775051|NCT00654186|27026623|P1|Overall Study|Withdrawal by Subject|5
7775052|NCT00654095|27026648|P1|Overall Study|Did not meet inclusion criteria|1
7775053|NCT00654095|27026648|P1|Overall Study|Adverse reaction did not improve (5)|4
7775054|NCT00654095|27026648|P1|Overall Study|Elevated alanine aminotransferase (4)|7
7775055|NCT00654095|27026648|P1|Overall Study|Withdrawal by Subject|5
7775056|NCT00654095|27026648|P1|Overall Study|Adverse Event|11
7775057|NCT00654095|27026648|P1|Overall Study|Elevated alanine aminotransferase (3)|1
7775058|NCT00654095|27026648|P1|Overall Study|Elevated triglyceride level (2)|1
7775059|NCT00654095|27026648|P1|Overall Study|Drop in low density lipoprotein (1)|2
7775060|NCT00654004|27026671|P2|Overall Study|Lost to Follow-up|0
7775061|NCT00654004|27026672|P1|Overall Study|Lost to Follow-up|1
7775062|NCT00653991|27026688|P2|6 Month Follow-up|Participant would not respond|141
7775063|NCT00653991|27026689|P1|6 Month Follow-up|Participant would not respond|133
7775064|NCT00653991|27026688|P2|3 Month Follow-up|Participant would not respond|157
7775065|NCT00653991|27026689|P1|3 Month Follow-up|Participant would not respond|150
7775066|NCT00653939|27026701|P2|Overall Study|Other|6
7775067|NCT00653939|27026702|P1|Overall Study|Other|2
7775068|NCT00653939|27026701|P2|Overall Study|Disease Progression|3
7775069|NCT00653939|27026702|P1|Overall Study|Disease Progression|2
7775070|NCT00653939|27026701|P2|Overall Study|Physician Decision|0
7775071|NCT00653939|27026702|P1|Overall Study|Physician Decision|4
7775072|NCT00653939|27026701|P2|Overall Study|Withdrawal by Subject|3
7775073|NCT00653939|27026702|P1|Overall Study|Withdrawal by Subject|3
7775074|NCT00653939|27026701|P2|Overall Study|Adverse Event|3
7775075|NCT00653939|27026702|P1|Overall Study|Adverse Event|1
7775076|NCT00653523|27026727|P1|Overall Study|Adverse reaction did not improve (4)|1
7775077|NCT00653523|27026727|P1|Overall Study|Elevated alanine aminotransferase (3)|2
7775078|NCT00653523|27026727|P1|Overall Study|Withdrawal by Subject|6
7775079|NCT00653523|27026727|P1|Overall Study|Adverse Event|7
7775080|NCT00653523|27026727|P1|Overall Study|Elevated creatine phosphokinase (2)|1
7775081|NCT00653523|27026727|P1|Overall Study|Drop in low density lipoprotein (1)|2
7775082|NCT00653432|27026733|P2|Overall Study|Other - Reason Not Provided|3
7775083|NCT00653432|27026734|P1|Overall Study|Other - Reason Not Provided|5
7775084|NCT00653432|27026733|P2|Overall Study|Use/Need of Con Therapy|1
7775085|NCT00653432|27026734|P1|Overall Study|Use/Need of Con Therapy|2
7775086|NCT00653432|27026733|P2|Overall Study|Lost to Follow-up|6
7775087|NCT00653432|27026734|P1|Overall Study|Lost to Follow-up|7
7775088|NCT00653432|27026733|P2|Overall Study|Withdrawal by Subject|5
7775089|NCT00653432|27026734|P1|Overall Study|Withdrawal by Subject|4
7775090|NCT00653432|27026733|P2|Overall Study|Adverse Event|1
7775091|NCT00653432|27026734|P1|Overall Study|Adverse Event|4
7775092|NCT00653328|27026758|P1|Overall Study|Drug manufacturer no longing making drug|2
7775093|NCT00653328|27026758|P1|Overall Study|Disease progression|10
7775094|NCT00653328|27026758|P1|Overall Study|Adverse Event|2
7775095|NCT00653328|27026758|P1|Overall Study|Withdrawal by Subject|1
7775096|NCT00653263|27026765|P1|Overall Study|Physician Decision|1
7775097|NCT00653263|27026765|P1|Overall Study|Withdrawal by Subject|1
7775098|NCT00653224|27026773|P2|Overall Study|Other|4
7775099|NCT00653224|27026774|P1|Overall Study|Other|2
7775100|NCT00653224|27026773|P2|Overall Study|Lost to Follow-up|0
7775101|NCT00653224|27026774|P1|Overall Study|Lost to Follow-up|1
7775102|NCT00653224|27026773|P2|Overall Study|Loss of efficacy|0
7775103|NCT00653224|27026774|P1|Overall Study|Loss of efficacy|1
7775104|NCT00653224|27026773|P2|Overall Study|Lack of Efficacy|2
7775105|NCT00653224|27026774|P1|Overall Study|Lack of Efficacy|1
7775106|NCT00653224|27026773|P2|Overall Study|Adverse Event|1
7775107|NCT00653224|27026774|P1|Overall Study|Adverse Event|2
7775108|NCT00653159|27026960|P2|Overall Study|Lost to Follow-up|2
7775109|NCT00653159|27026961|P1|Overall Study|Lost to Follow-up|1
7775110|NCT00653159|27026960|P2|Overall Study|Adverse Event|1
7775111|NCT00653159|27026961|P1|Overall Study|Adverse Event|4
7775112|NCT00653068|27026988|P1|Overall Study|Ineligible|2
7775113|NCT00653068|27026988|P1|Overall Study|Withdrawal by Subject|1
7775114|NCT00653068|27026988|P1|Overall Study|Physician Decision|4
7775115|NCT00653068|27026988|P1|Overall Study|Lack of Efficacy|34
7775116|NCT00653068|27026988|P1|Overall Study|Death|9
7775117|NCT00652951|27027002|P3|Booster Phase|Other|0
7775118|NCT00652951|27027003|P2|Booster Phase|Other|0
7775119|NCT00652951|27027004|P1|Booster Phase|Other|1
7775120|NCT00652951|27027002|P3|Booster Phase|Adverse event, non-fatal|0
7775121|NCT00652951|27027003|P2|Booster Phase|Adverse event, non-fatal|1
7775122|NCT00652951|27027004|P1|Booster Phase|Adverse event, non-fatal|0
7775123|NCT00652938|27027141|P3|Overall Study|fear of blood sampling|0
7775124|NCT00652938|27027142|P2|Overall Study|fear of blood sampling|1
7775125|NCT00652938|27027143|P1|Overall Study|fear of blood sampling|0
7775126|NCT00652938|27027141|P3|Overall Study|Lost to Follow-up|2
7775127|NCT00652938|27027142|P2|Overall Study|Lost to Follow-up|0
7775128|NCT00652938|27027143|P1|Overall Study|Lost to Follow-up|0
7775129|NCT00652938|27027141|P3|Overall Study|Withdrawal by Subject|1
7775130|NCT00652938|27027142|P2|Overall Study|Withdrawal by Subject|6
7775131|NCT00652938|27027143|P1|Overall Study|Withdrawal by Subject|0
7775132|NCT00652938|27027141|P3|Overall Study|Adverse Event|2
7775133|NCT00652938|27027142|P2|Overall Study|Adverse Event|0
7775134|NCT00652938|27027143|P1|Overall Study|Adverse Event|1
7775135|NCT00652899|27027208|P1|Overall Study|Treating physician decision|1
7775136|NCT00652899|27027208|P1|Overall Study|Death|1
7775137|NCT00652834|27027218|P1|Overall Study|Lost to Follow-up|2
7775138|NCT00652834|27027218|P1|Overall Study|Withdrawal by Subject|3
7775139|NCT00652743|27027225|P3|Months 36-42|Other|8
7775140|NCT00652743|27027226|P2|Months 36-42|Other|2
7775141|NCT00652743|27027227|P1|Months 36-42|Other|4
7775142|NCT00652743|27027225|P3|Months 36-42|Migrated/moved from study area|0
7775143|NCT00652743|27027226|P2|Months 36-42|Migrated/moved from study area|0
7775144|NCT00652743|27027227|P1|Months 36-42|Migrated/moved from study area|1
7775145|NCT00652743|27027225|P3|Months 36-42|Lost to Follow-up|0
7775146|NCT00652743|27027226|P2|Months 36-42|Lost to Follow-up|1
7775147|NCT00652743|27027227|P1|Months 36-42|Lost to Follow-up|0
7775148|NCT00652743|27027225|P3|Months 36-42|Withdrawal by Subject|0
7775149|NCT00652743|27027226|P2|Months 36-42|Withdrawal by Subject|1
7775150|NCT00652743|27027227|P1|Months 36-42|Withdrawal by Subject|1
7775151|NCT00652743|27027225|P3|Months 36-42|Serious Adverse Events|1
7775152|NCT00652743|27027226|P2|Months 36-42|Serious Adverse Events|1
7775153|NCT00652743|27027227|P1|Months 36-42|Serious Adverse Events|0
7775154|NCT00652743|27027225|P3|Months 24-30|Other|11
7775155|NCT00652743|27027226|P2|Months 24-30|Other|1
7775156|NCT00652743|27027227|P1|Months 24-30|Other|5
7775157|NCT00652743|27027225|P3|Months 12-18|Lost to Follow-up|7
7775158|NCT00652743|27027226|P2|Months 12-18|Lost to Follow-up|2
7775159|NCT00652743|27027227|P1|Months 12-18|Lost to Follow-up|1
7775160|NCT00652626|27027309|P7|Extension Phase|Death|1
7775161|NCT00652626|27027310|P6|Extension Phase|Death|1
7775162|NCT00652626|27027311|P5|Extension Phase|Death|0
7775163|NCT00652626|27027312|P4|Extension Phase|Death|0
7775164|NCT00652626|27027313|P3|Extension Phase|Death|0
7775165|NCT00652626|27027314|P2|Extension Phase|Death|0
7775166|NCT00652626|27027315|P1|Extension Phase|Death|0
7775167|NCT00652626|27027309|P7|Extension Phase|Physician Decision|1
7775168|NCT00652626|27027310|P6|Extension Phase|Physician Decision|1
7775169|NCT00652626|27027311|P5|Extension Phase|Physician Decision|0
7775170|NCT00652626|27027312|P4|Extension Phase|Physician Decision|0
7775171|NCT00652626|27027313|P3|Extension Phase|Physician Decision|0
7775172|NCT00652626|27027314|P2|Extension Phase|Physician Decision|0
7775173|NCT00652626|27027315|P1|Extension Phase|Physician Decision|0
7775174|NCT00652626|27027309|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
7775175|NCT00652626|27027310|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
7775176|NCT00652626|27027311|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
7775177|NCT00652626|27027312|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
7775178|NCT00652626|27027313|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
7775179|NCT00652626|27027314|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
7775180|NCT00652626|27027315|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
7775181|NCT00652626|27027309|P7|Extension Phase|Adverse Event|1
7775182|NCT00652626|27027310|P6|Extension Phase|Adverse Event|2
7775183|NCT00652626|27027311|P5|Extension Phase|Adverse Event|0
7775184|NCT00652626|27027312|P4|Extension Phase|Adverse Event|0
7775185|NCT00652626|27027313|P3|Extension Phase|Adverse Event|0
7775186|NCT00652626|27027314|P2|Extension Phase|Adverse Event|0
7775187|NCT00652626|27027315|P1|Extension Phase|Adverse Event|0
7775188|NCT00652626|27027309|P7|Extension Phase|Withdrawal by Subject|0
7775189|NCT00652626|27027310|P6|Extension Phase|Withdrawal by Subject|2
7775190|NCT00652626|27027311|P5|Extension Phase|Withdrawal by Subject|0
7775191|NCT00652626|27027312|P4|Extension Phase|Withdrawal by Subject|0
7775192|NCT00652626|27027313|P3|Extension Phase|Withdrawal by Subject|0
7775193|NCT00652626|27027314|P2|Extension Phase|Withdrawal by Subject|0
7775194|NCT00652626|27027315|P1|Extension Phase|Withdrawal by Subject|0
7775195|NCT00652626|27027309|P7|Initial Treatment Phase|Lost to Follow-up|0
7775196|NCT00652626|27027310|P6|Initial Treatment Phase|Lost to Follow-up|0
7775197|NCT00652626|27027311|P5|Initial Treatment Phase|Lost to Follow-up|1
7775198|NCT00652626|27027312|P4|Initial Treatment Phase|Lost to Follow-up|0
7775199|NCT00652626|27027313|P3|Initial Treatment Phase|Lost to Follow-up|0
7775200|NCT00652626|27027314|P2|Initial Treatment Phase|Lost to Follow-up|0
7775201|NCT00652626|27027315|P1|Initial Treatment Phase|Lost to Follow-up|0
7775202|NCT00652626|27027309|P7|Initial Treatment Phase|Sponsor Request|0
7775203|NCT00652626|27027310|P6|Initial Treatment Phase|Sponsor Request|0
7775204|NCT00652626|27027311|P5|Initial Treatment Phase|Sponsor Request|0
7775205|NCT00652626|27027312|P4|Initial Treatment Phase|Sponsor Request|0
7775206|NCT00652626|27027313|P3|Initial Treatment Phase|Sponsor Request|1
7775207|NCT00652626|27027314|P2|Initial Treatment Phase|Sponsor Request|0
7775208|NCT00652626|27027315|P1|Initial Treatment Phase|Sponsor Request|0
7775209|NCT00652626|27027309|P7|Initial Treatment Phase|Physician Decision|0
7775210|NCT00652626|27027310|P6|Initial Treatment Phase|Physician Decision|0
7775211|NCT00652626|27027311|P5|Initial Treatment Phase|Physician Decision|1
7775212|NCT00652626|27027312|P4|Initial Treatment Phase|Physician Decision|0
7775213|NCT00652626|27027313|P3|Initial Treatment Phase|Physician Decision|0
7775214|NCT00652626|27027314|P2|Initial Treatment Phase|Physician Decision|0
7775215|NCT00652626|27027315|P1|Initial Treatment Phase|Physician Decision|0
7775216|NCT00652626|27027309|P7|Initial Treatment Phase|Protocol Violation|0
7775217|NCT00652626|27027310|P6|Initial Treatment Phase|Protocol Violation|0
7775218|NCT00652626|27027311|P5|Initial Treatment Phase|Protocol Violation|0
7775219|NCT00652626|27027312|P4|Initial Treatment Phase|Protocol Violation|1
7775220|NCT00652626|27027313|P3|Initial Treatment Phase|Protocol Violation|0
7775221|NCT00652626|27027314|P2|Initial Treatment Phase|Protocol Violation|0
7775222|NCT00652626|27027315|P1|Initial Treatment Phase|Protocol Violation|0
7775223|NCT00652626|27027309|P7|Initial Treatment Phase|Adverse Event|0
7775224|NCT00652626|27027310|P6|Initial Treatment Phase|Adverse Event|0
7775225|NCT00652626|27027311|P5|Initial Treatment Phase|Adverse Event|1
7775226|NCT00652626|27027312|P4|Initial Treatment Phase|Adverse Event|0
7775227|NCT00652626|27027313|P3|Initial Treatment Phase|Adverse Event|0
7775228|NCT00652626|27027314|P2|Initial Treatment Phase|Adverse Event|0
7775229|NCT00652626|27027315|P1|Initial Treatment Phase|Adverse Event|0
7775230|NCT00652366|27027393|P5|Overall Study|Other|0
7775231|NCT00652366|27027394|P4|Overall Study|Other|4
7775232|NCT00652366|27027395|P3|Overall Study|Other|3
7775233|NCT00652366|27027396|P2|Overall Study|Other|2
7775234|NCT00652366|27027397|P1|Overall Study|Other|5
7775235|NCT00652366|27027393|P5|Overall Study|Refused treatment|5
7775236|NCT00652366|27027394|P4|Overall Study|Refused treatment|17
7775237|NCT00652366|27027395|P3|Overall Study|Refused treatment|6
7775238|NCT00652366|27027396|P2|Overall Study|Refused treatment|7
7775239|NCT00652366|27027397|P1|Overall Study|Refused treatment|3
7775240|NCT00652366|27027393|P5|Overall Study|Protocol Violation|0
7775241|NCT00652366|27027394|P4|Overall Study|Protocol Violation|0
7775242|NCT00652366|27027395|P3|Overall Study|Protocol Violation|0
7775243|NCT00652366|27027396|P2|Overall Study|Protocol Violation|0
7775244|NCT00652366|27027397|P1|Overall Study|Protocol Violation|1
7775245|NCT00652366|27027393|P5|Overall Study|Violation of Selection Criteria|0
7775246|NCT00652366|27027394|P4|Overall Study|Violation of Selection Criteria|0
7775247|NCT00652366|27027395|P3|Overall Study|Violation of Selection Criteria|1
7775248|NCT00652366|27027396|P2|Overall Study|Violation of Selection Criteria|0
7775249|NCT00652366|27027397|P1|Overall Study|Violation of Selection Criteria|0
7775250|NCT00652366|27027393|P5|Overall Study|Lack of Efficacy|13
7775251|NCT00652366|27027394|P4|Overall Study|Lack of Efficacy|133
7775252|NCT00652366|27027395|P3|Overall Study|Lack of Efficacy|53
7775253|NCT00652366|27027396|P2|Overall Study|Lack of Efficacy|58
7775254|NCT00652366|27027397|P1|Overall Study|Lack of Efficacy|84
7775255|NCT00652366|27027393|P5|Overall Study|Death|5
7775256|NCT00652366|27027394|P4|Overall Study|Death|8
7775257|NCT00652366|27027395|P3|Overall Study|Death|1
7775258|NCT00652366|27027396|P2|Overall Study|Death|4
7775259|NCT00652366|27027397|P1|Overall Study|Death|5
7775260|NCT00652366|27027393|P5|Overall Study|Adverse Event|13
7775261|NCT00652366|27027394|P4|Overall Study|Adverse Event|17
7775262|NCT00652366|27027395|P3|Overall Study|Adverse Event|7
7775263|NCT00652366|27027396|P2|Overall Study|Adverse Event|4
7775264|NCT00652366|27027397|P1|Overall Study|Adverse Event|8
7775265|NCT00652340|27027432|P2|Overall Study|Had not progressed.|3
7775266|NCT00652340|27027433|P1|Overall Study|Had not progressed.|4
7775267|NCT00652327|27027443|P2|Overall Study|Lost to Follow-up|3
7775268|NCT00652327|27027444|P1|Overall Study|Lost to Follow-up|0
7775269|NCT00652327|27027443|P2|Overall Study|Adverse Event|2
7775270|NCT00652327|27027444|P1|Overall Study|Adverse Event|0
7775271|NCT00652093|27027486|P6|Overall Study|Physician Decision|0
7775272|NCT00652093|27027487|P5|Overall Study|Physician Decision|1
7775273|NCT00652093|27027488|P4|Overall Study|Physician Decision|0
7775274|NCT00652093|27027489|P3|Overall Study|Physician Decision|0
7775275|NCT00652093|27027490|P2|Overall Study|Physician Decision|0
7775276|NCT00652093|27027491|P1|Overall Study|Physician Decision|0
7775277|NCT00652093|27027486|P6|Overall Study|Withdrawal by Subject|0
7775278|NCT00652093|27027487|P5|Overall Study|Withdrawal by Subject|1
7775279|NCT00652093|27027488|P4|Overall Study|Withdrawal by Subject|0
7775280|NCT00652093|27027489|P3|Overall Study|Withdrawal by Subject|1
7775281|NCT00652093|27027490|P2|Overall Study|Withdrawal by Subject|0
7775282|NCT00652093|27027491|P1|Overall Study|Withdrawal by Subject|0
7775283|NCT00652028|27027581|P4|Overall Study|Physician Decision|0
7775284|NCT00652028|27027582|P3|Overall Study|Physician Decision|1
7775285|NCT00652028|27027583|P2|Overall Study|Physician Decision|0
7775286|NCT00652028|27027584|P1|Overall Study|Physician Decision|0
7775287|NCT00652028|27027581|P4|Overall Study|No Longer Meets Entry Criteria|0
7775288|NCT00652028|27027582|P3|Overall Study|No Longer Meets Entry Criteria|0
7775289|NCT00652028|27027583|P2|Overall Study|No Longer Meets Entry Criteria|1
7775290|NCT00652028|27027584|P1|Overall Study|No Longer Meets Entry Criteria|0
7775291|NCT00652028|27027581|P4|Overall Study|Adverse Event|0
7775292|NCT00652028|27027582|P3|Overall Study|Adverse Event|0
7775293|NCT00652028|27027583|P2|Overall Study|Adverse Event|0
7775294|NCT00652028|27027584|P1|Overall Study|Adverse Event|1
7775295|NCT00651937|27027628|P2|Overall Study|Withdrawal by Subject|1
7775296|NCT00651937|27027629|P1|Overall Study|Withdrawal by Subject|4
7775297|NCT00651924|27027639|P2|Overall Study|Withdrawal by Subject|5
7775298|NCT00651924|27027640|P1|Overall Study|Withdrawal by Subject|0
7775299|NCT00651924|27027639|P2|Overall Study|Withdrawal by PI|2
7775300|NCT00651924|27027640|P1|Overall Study|Withdrawal by PI|0
7775301|NCT00651820|27027646|P1|Overall Study|Lost to Follow-up|2
7775302|NCT00651755|27027678|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
7775303|NCT00651755|27027679|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
7775304|NCT00651755|27027678|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
7775305|NCT00651755|27027679|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
7775306|NCT00651664|27027705|P10|Overall Study|Reason not Specified|0
7775307|NCT00651664|27027706|P9|Overall Study|Reason not Specified|0
7775308|NCT00651664|27027707|P8|Overall Study|Reason not Specified|0
7775309|NCT00651664|27027708|P7|Overall Study|Reason not Specified|1
7775310|NCT00651664|27027709|P6|Overall Study|Reason not Specified|0
7775311|NCT00651664|27027710|P5|Overall Study|Reason not Specified|0
7775312|NCT00651664|27027711|P4|Overall Study|Reason not Specified|0
7775313|NCT00651664|27027712|P3|Overall Study|Reason not Specified|0
7775314|NCT00651664|27027713|P2|Overall Study|Reason not Specified|0
7775315|NCT00651664|27027714|P1|Overall Study|Reason not Specified|0
7775316|NCT00651664|27027705|P10|Overall Study|Symptomatic Deterioration|0
7775317|NCT00651664|27027706|P9|Overall Study|Symptomatic Deterioration|1
7775318|NCT00651664|27027707|P8|Overall Study|Symptomatic Deterioration|0
7775319|NCT00651664|27027708|P7|Overall Study|Symptomatic Deterioration|1
7775320|NCT00651664|27027709|P6|Overall Study|Symptomatic Deterioration|0
7775321|NCT00651664|27027710|P5|Overall Study|Symptomatic Deterioration|0
7775322|NCT00651664|27027711|P4|Overall Study|Symptomatic Deterioration|1
7775323|NCT00651664|27027712|P3|Overall Study|Symptomatic Deterioration|0
7775324|NCT00651664|27027713|P2|Overall Study|Symptomatic Deterioration|0
7775325|NCT00651664|27027714|P1|Overall Study|Symptomatic Deterioration|0
7775326|NCT00651664|27027705|P10|Overall Study|Patient Declined Further Treatment|1
7775327|NCT00651664|27027706|P9|Overall Study|Patient Declined Further Treatment|0
7775328|NCT00651664|27027707|P8|Overall Study|Patient Declined Further Treatment|0
7775329|NCT00651664|27027708|P7|Overall Study|Patient Declined Further Treatment|0
7775330|NCT00651664|27027709|P6|Overall Study|Patient Declined Further Treatment|1
7775331|NCT00651664|27027710|P5|Overall Study|Patient Declined Further Treatment|1
7775332|NCT00651664|27027711|P4|Overall Study|Patient Declined Further Treatment|1
7775333|NCT00651664|27027712|P3|Overall Study|Patient Declined Further Treatment|0
7775334|NCT00651664|27027713|P2|Overall Study|Patient Declined Further Treatment|0
7775335|NCT00651664|27027714|P1|Overall Study|Patient Declined Further Treatment|0
7775336|NCT00651664|27027705|P10|Overall Study|Progressive Disease|5
7775337|NCT00651664|27027706|P9|Overall Study|Progressive Disease|5
7775338|NCT00651664|27027707|P8|Overall Study|Progressive Disease|6
7775339|NCT00651664|27027708|P7|Overall Study|Progressive Disease|3
7775340|NCT00651664|27027709|P6|Overall Study|Progressive Disease|1
7775341|NCT00651664|27027710|P5|Overall Study|Progressive Disease|4
7775342|NCT00651664|27027711|P4|Overall Study|Progressive Disease|12
7775343|NCT00651664|27027712|P3|Overall Study|Progressive Disease|3
7775344|NCT00651664|27027713|P2|Overall Study|Progressive Disease|3
7775345|NCT00651664|27027714|P1|Overall Study|Progressive Disease|3
7775346|NCT00651664|27027705|P10|Overall Study|Unsatisfactory Therapeutic Response|1
7775347|NCT00651664|27027706|P9|Overall Study|Unsatisfactory Therapeutic Response|0
7775348|NCT00651664|27027707|P8|Overall Study|Unsatisfactory Therapeutic Response|1
7775349|NCT00651664|27027708|P7|Overall Study|Unsatisfactory Therapeutic Response|0
7775350|NCT00651664|27027709|P6|Overall Study|Unsatisfactory Therapeutic Response|1
7775351|NCT00651664|27027710|P5|Overall Study|Unsatisfactory Therapeutic Response|1
7775352|NCT00651664|27027711|P4|Overall Study|Unsatisfactory Therapeutic Response|0
7775353|NCT00651664|27027712|P3|Overall Study|Unsatisfactory Therapeutic Response|0
7775354|NCT00651664|27027713|P2|Overall Study|Unsatisfactory Therapeutic Response|0
7775355|NCT00651664|27027714|P1|Overall Study|Unsatisfactory Therapeutic Response|0
7775356|NCT00651664|27027705|P10|Overall Study|Occurrence of Adverse Event(s)|0
7775357|NCT00651664|27027706|P9|Overall Study|Occurrence of Adverse Event(s)|1
7775358|NCT00651664|27027707|P8|Overall Study|Occurrence of Adverse Event(s)|0
7775359|NCT00651664|27027708|P7|Overall Study|Occurrence of Adverse Event(s)|1
7775360|NCT00651664|27027709|P6|Overall Study|Occurrence of Adverse Event(s)|0
7775361|NCT00651664|27027710|P5|Overall Study|Occurrence of Adverse Event(s)|0
7775362|NCT00651664|27027711|P4|Overall Study|Occurrence of Adverse Event(s)|0
7775363|NCT00651664|27027712|P3|Overall Study|Occurrence of Adverse Event(s)|0
7775364|NCT00651664|27027713|P2|Overall Study|Occurrence of Adverse Event(s)|0
7775365|NCT00651664|27027714|P1|Overall Study|Occurrence of Adverse Event(s)|0
7775366|NCT00651313|27027886|P2|Overall Study|Adminstrative Discontinuation|3
7775367|NCT00651313|27027887|P1|Overall Study|Adminstrative Discontinuation|2
7775368|NCT00651313|27027886|P2|Overall Study|Lost to Follow-up|1
7775369|NCT00651313|27027887|P1|Overall Study|Lost to Follow-up|1
7775370|NCT00651313|27027886|P2|Overall Study|Withdrawal by Subject|1
7775371|NCT00651313|27027887|P1|Overall Study|Withdrawal by Subject|3
7775372|NCT00651313|27027886|P2|Overall Study|Adverse Event|1
7775373|NCT00651313|27027887|P1|Overall Study|Adverse Event|0
7775374|NCT00651261|27027895|P2|Overall Study|Never treated|3
7775375|NCT00651261|27027896|P1|Overall Study|Never treated|5
7775376|NCT00651261|27027895|P2|Overall Study|Other disease or participant decisions|23
7775377|NCT00651261|27027896|P1|Overall Study|Other disease or participant decisions|23
7775378|NCT00651261|27027895|P2|Overall Study|Alternative therapy|107
7775379|NCT00651261|27027896|P1|Overall Study|Alternative therapy|109
7775380|NCT00651261|27027895|P2|Overall Study|Disease progression|58
7775381|NCT00651261|27027896|P1|Overall Study|Disease progression|58
7775382|NCT00651261|27027895|P2|Overall Study|Induction failure|35
7775383|NCT00651261|27027896|P1|Overall Study|Induction failure|24
7775384|NCT00651261|27027895|P2|Overall Study|Withdrawal by Subject|40
7775385|NCT00651261|27027896|P1|Overall Study|Withdrawal by Subject|22
7775386|NCT00651261|27027895|P2|Overall Study|Death|18
7775387|NCT00651261|27027896|P1|Overall Study|Death|18
7775388|NCT00651261|27027895|P2|Overall Study|Adverse Event|22
7775389|NCT00651261|27027896|P1|Overall Study|Adverse Event|32
7775390|NCT00651183|27027912|P2|Overall Study|missing|0
7775391|NCT00651183|27027913|P1|Overall Study|missing|1
7775392|NCT00651183|27027912|P2|Overall Study|Other reasons|2
7775393|NCT00651183|27027913|P1|Overall Study|Other reasons|4
7775394|NCT00651183|27027912|P2|Overall Study|Lost to Follow-up|1
7775395|NCT00651183|27027913|P1|Overall Study|Lost to Follow-up|3
7775396|NCT00651183|27027912|P2|Overall Study|Withdrawal by Subject|3
7775397|NCT00651183|27027913|P1|Overall Study|Withdrawal by Subject|6
7775398|NCT00651183|27027912|P2|Overall Study|Tolerability insufficient +Patients wish|1
7775399|NCT00651183|27027913|P1|Overall Study|Tolerability insufficient +Patients wish|0
7775400|NCT00651183|27027912|P2|Overall Study|Tolerability insufficient|2
7775401|NCT00651183|27027913|P1|Overall Study|Tolerability insufficient|5
7775402|NCT00651183|27027912|P2|Overall Study|Efficacy insufficient + patients wish|1
7775403|NCT00651183|27027913|P1|Overall Study|Efficacy insufficient + patients wish|0
7775404|NCT00651183|27027912|P2|Overall Study|Lack of Efficacy|0
7775405|NCT00651183|27027913|P1|Overall Study|Lack of Efficacy|1
7775406|NCT00651157|27027925|P1|Overall Study|Protocol Violation|1
7775407|NCT00651157|27027925|P1|Overall Study|Death|1
7775408|NCT00651118|27027935|P4|Overall Study|Withdrawal by Subject|1
7775409|NCT00651118|27027936|P3|Overall Study|Withdrawal by Subject|1
7775410|NCT00651118|27027937|P2|Overall Study|Withdrawal by Subject|1
7775411|NCT00651118|27027938|P1|Overall Study|Withdrawal by Subject|0
7775412|NCT00651118|27027935|P4|Overall Study|administrative|1
7775413|NCT00651118|27027936|P3|Overall Study|administrative|2
7775414|NCT00651118|27027937|P2|Overall Study|administrative|4
7775415|NCT00651118|27027938|P1|Overall Study|administrative|1
7775416|NCT00651118|27027935|P4|Overall Study|Lost to Follow-up|2
7775417|NCT00651118|27027936|P3|Overall Study|Lost to Follow-up|1
7775418|NCT00651118|27027937|P2|Overall Study|Lost to Follow-up|0
7775419|NCT00651118|27027938|P1|Overall Study|Lost to Follow-up|2
7775420|NCT00651118|27027935|P4|Overall Study|Protocol Violation|2
7775421|NCT00651118|27027936|P3|Overall Study|Protocol Violation|6
7775422|NCT00651118|27027937|P2|Overall Study|Protocol Violation|2
7775423|NCT00651118|27027938|P1|Overall Study|Protocol Violation|2
7775424|NCT00651118|27027935|P4|Overall Study|Adverse Event|1
7775425|NCT00651118|27027936|P3|Overall Study|Adverse Event|1
7775426|NCT00651118|27027937|P2|Overall Study|Adverse Event|0
7775427|NCT00651118|27027938|P1|Overall Study|Adverse Event|4
7775428|NCT00650845|27028007|P2|Overall Study|Protocol Violation|13
7775429|NCT00650845|27028008|P1|Overall Study|Protocol Violation|0
7775430|NCT00650845|27028007|P2|Overall Study|Withdrawal by Subject|0
7775431|NCT00650845|27028008|P1|Overall Study|Withdrawal by Subject|5
7775432|NCT00650806|27028028|P4|Overall Study|Other|0
7775433|NCT00650806|27028029|P3|Overall Study|Other|2
7775434|NCT00650806|27028030|P2|Overall Study|Other|1
7775435|NCT00650806|27028031|P1|Overall Study|Other|1
7775436|NCT00650806|27028028|P4|Overall Study|Study terminated by sponsor|4
7775437|NCT00650806|27028029|P3|Overall Study|Study terminated by sponsor|5
7775438|NCT00650806|27028030|P2|Overall Study|Study terminated by sponsor|3
7775439|NCT00650806|27028031|P1|Overall Study|Study terminated by sponsor|2
7775440|NCT00650806|27028028|P4|Overall Study|Noncompliance with study drug regimen|0
7775441|NCT00650806|27028029|P3|Overall Study|Noncompliance with study drug regimen|0
7775442|NCT00650806|27028030|P2|Overall Study|Noncompliance with study drug regimen|1
7775443|NCT00650806|27028031|P1|Overall Study|Noncompliance with study drug regimen|1
7775444|NCT00650806|27028028|P4|Overall Study|Withdrawal by Subject|6
7775445|NCT00650806|27028029|P3|Overall Study|Withdrawal by Subject|8
7775446|NCT00650806|27028030|P2|Overall Study|Withdrawal by Subject|5
7775447|NCT00650806|27028031|P1|Overall Study|Withdrawal by Subject|7
7775448|NCT00650806|27028028|P4|Overall Study|Pregnancy|1
7775449|NCT00650806|27028029|P3|Overall Study|Pregnancy|0
7775450|NCT00650806|27028030|P2|Overall Study|Pregnancy|0
7775451|NCT00650806|27028031|P1|Overall Study|Pregnancy|0
7775452|NCT00650806|27028028|P4|Overall Study|Protocol Violation|1
7775453|NCT00650806|27028029|P3|Overall Study|Protocol Violation|0
7775454|NCT00650806|27028030|P2|Overall Study|Protocol Violation|0
7775455|NCT00650806|27028031|P1|Overall Study|Protocol Violation|0
7775456|NCT00650806|27028028|P4|Overall Study|Lost to Follow-up|10
7775457|NCT00650806|27028029|P3|Overall Study|Lost to Follow-up|11
7775458|NCT00650806|27028030|P2|Overall Study|Lost to Follow-up|6
7775459|NCT00650806|27028031|P1|Overall Study|Lost to Follow-up|7
7775460|NCT00650806|27028028|P4|Overall Study|Adverse Event|4
7775461|NCT00650806|27028029|P3|Overall Study|Adverse Event|3
7775462|NCT00650806|27028030|P2|Overall Study|Adverse Event|5
7775463|NCT00650806|27028031|P1|Overall Study|Adverse Event|0
7775464|NCT00650767|27028073|P4|Overall Study|Other|0
7775465|NCT00650767|27028074|P3|Overall Study|Other|0
7775466|NCT00650767|27028075|P2|Overall Study|Other|1
7775467|NCT00650767|27028076|P1|Overall Study|Other|1
7775468|NCT00650767|27028073|P4|Overall Study|Lost to Follow-up|0
7775469|NCT00650767|27028074|P3|Overall Study|Lost to Follow-up|1
7775470|NCT00650767|27028075|P2|Overall Study|Lost to Follow-up|1
7775471|NCT00650767|27028076|P1|Overall Study|Lost to Follow-up|1
7775472|NCT00650767|27028073|P4|Overall Study|Withdrawal by Subject|3
7775473|NCT00650767|27028074|P3|Overall Study|Withdrawal by Subject|3
7775474|NCT00650767|27028075|P2|Overall Study|Withdrawal by Subject|4
7775475|NCT00650767|27028076|P1|Overall Study|Withdrawal by Subject|2
7775476|NCT00650767|27028073|P4|Overall Study|Death|0
7775477|NCT00650767|27028074|P3|Overall Study|Death|0
7775478|NCT00650767|27028075|P2|Overall Study|Death|0
7775479|NCT00650767|27028076|P1|Overall Study|Death|1
7775480|NCT00650767|27028073|P4|Overall Study|Adverse Event|8
7775481|NCT00650767|27028074|P3|Overall Study|Adverse Event|10
7775482|NCT00650767|27028075|P2|Overall Study|Adverse Event|3
7775483|NCT00650767|27028076|P1|Overall Study|Adverse Event|0
7775484|NCT00650585|27028580|P2|Overall Study|Excluded/ruled ineligible|129
7775485|NCT00650585|27028581|P1|Overall Study|Excluded/ruled ineligible|357
7775486|NCT00650585|27028580|P2|Overall Study|No parental consent|866
7775487|NCT00650585|27028581|P1|Overall Study|No parental consent|935
7775488|NCT00650585|27028580|P2|Overall Study|Lost to Follow-up|482
7775489|NCT00650585|27028581|P1|Overall Study|Lost to Follow-up|505
7775490|NCT00650104|27028625|P1|Overall Study|Sponsor Terminated Dosing|1
7775491|NCT00650104|27028625|P1|Overall Study|Non-compliance|2
7775492|NCT00650104|27028625|P1|Overall Study|Lost to Follow-up|1
7775493|NCT00650104|27028625|P1|Overall Study|Physician Decision|7
7775494|NCT00650104|27028625|P1|Overall Study|Withdrawal by Subject|11
7775495|NCT00650104|27028625|P1|Overall Study|Death|2
7775496|NCT00650104|27028625|P1|Overall Study|Adverse Event|17
7775497|NCT00650091|27028640|P3|Amended Study Design|Other|0
7775498|NCT00650091|27028641|P2|Amended Study Design|Other|3
7775499|NCT00650091|27028642|P1|Amended Study Design|Other|1
7775500|NCT00650091|27028640|P3|Amended Study Design|Lung transplantation|0
7775501|NCT00650091|27028641|P2|Amended Study Design|Lung transplantation|2
7775502|NCT00650091|27028642|P1|Amended Study Design|Lung transplantation|4
7775503|NCT00650091|27028640|P3|Amended Study Design|Adverse Event|0
7775504|NCT00650091|27028641|P2|Amended Study Design|Adverse Event|4
7775505|NCT00650091|27028642|P1|Amended Study Design|Adverse Event|1
7775506|NCT00650091|27028640|P3|Amended Study Design|Physician Decision|0
7775507|NCT00650091|27028641|P2|Amended Study Design|Physician Decision|0
7775508|NCT00650091|27028642|P1|Amended Study Design|Physician Decision|5
7775509|NCT00650091|27028640|P3|Amended Study Design|Withdrawal by Subject|0
7775510|NCT00650091|27028641|P2|Amended Study Design|Withdrawal by Subject|11
7775511|NCT00650091|27028642|P1|Amended Study Design|Withdrawal by Subject|12
7775512|NCT00649428|27028685|P2|Overall Study|Physician Decision|1
7775513|NCT00649428|27028686|P1|Overall Study|Physician Decision|0
7775514|NCT00649428|27028685|P2|Overall Study|Protocol Violation|2
7775515|NCT00649428|27028686|P1|Overall Study|Protocol Violation|6
7775516|NCT00649428|27028685|P2|Overall Study|Insufficient manufacturing yield|1
7775517|NCT00649428|27028686|P1|Overall Study|Insufficient manufacturing yield|5
7775518|NCT00649428|27028685|P2|Overall Study|Lost to Follow-up|3
7775519|NCT00649428|27028686|P1|Overall Study|Lost to Follow-up|1
7775520|NCT00649428|27028685|P2|Overall Study|Withdrawal by Subject|6
7775521|NCT00649428|27028686|P1|Overall Study|Withdrawal by Subject|6
7775522|NCT00649428|27028685|P2|Overall Study|Adverse Event|2
7775523|NCT00649428|27028686|P1|Overall Study|Adverse Event|2
7775524|NCT00649389|27028702|P4|Overall Study|Other|6
7775525|NCT00649389|27028703|P3|Overall Study|Other|1
7775526|NCT00649389|27028704|P2|Overall Study|Other|9
7775527|NCT00649389|27028705|P1|Overall Study|Other|3
7775528|NCT00649389|27028702|P4|Overall Study|Withdrawal by Subject|23
7775529|NCT00649389|27028703|P3|Overall Study|Withdrawal by Subject|19
7775530|NCT00649389|27028704|P2|Overall Study|Withdrawal by Subject|21
7775531|NCT00649389|27028705|P1|Overall Study|Withdrawal by Subject|20
7775532|NCT00649389|27028702|P4|Overall Study|Protocol Violation|8
7775533|NCT00649389|27028703|P3|Overall Study|Protocol Violation|9
7775534|NCT00649389|27028704|P2|Overall Study|Protocol Violation|13
7775535|NCT00649389|27028705|P1|Overall Study|Protocol Violation|11
7775536|NCT00649389|27028702|P4|Overall Study|Lost to Follow-up|26
7775537|NCT00649389|27028703|P3|Overall Study|Lost to Follow-up|21
7775538|NCT00649389|27028704|P2|Overall Study|Lost to Follow-up|17
7775539|NCT00649389|27028705|P1|Overall Study|Lost to Follow-up|15
7775540|NCT00649389|27028702|P4|Overall Study|Adverse Event|48
7775541|NCT00649389|27028703|P3|Overall Study|Adverse Event|38
7775542|NCT00649389|27028704|P2|Overall Study|Adverse Event|46
7775543|NCT00649389|27028705|P1|Overall Study|Adverse Event|22
7775544|NCT00649220|27028727|P1|Overall Study|Withdrawal by Subject|1
7775545|NCT00649220|27028727|P1|Overall Study|Adverse Event|2
7775546|NCT00648895|27028748|P2|Overall Study|Lack of Efficacy|1
7775547|NCT00648895|27028749|P1|Overall Study|Lack of Efficacy|0
7775548|NCT00648739|27028755|P7|Overall Study|Follow-up Visits Not Completed|0
7775549|NCT00648739|27028756|P6|Overall Study|Follow-up Visits Not Completed|0
7775550|NCT00648739|27028757|P5|Overall Study|Follow-up Visits Not Completed|0
7775551|NCT00648739|27028758|P4|Overall Study|Follow-up Visits Not Completed|0
7775552|NCT00648739|27028759|P3|Overall Study|Follow-up Visits Not Completed|0
7775553|NCT00648739|27028760|P2|Overall Study|Follow-up Visits Not Completed|1
7775554|NCT00648739|27028761|P1|Overall Study|Follow-up Visits Not Completed|0
7775555|NCT00648739|27028755|P7|Overall Study|Positive Human Anti-human Antibody|0
7775556|NCT00648739|27028756|P6|Overall Study|Positive Human Anti-human Antibody|0
7775557|NCT00648739|27028757|P5|Overall Study|Positive Human Anti-human Antibody|0
7775558|NCT00648739|27028758|P4|Overall Study|Positive Human Anti-human Antibody|0
7775559|NCT00648739|27028759|P3|Overall Study|Positive Human Anti-human Antibody|1
7775560|NCT00648739|27028760|P2|Overall Study|Positive Human Anti-human Antibody|0
7775561|NCT00648739|27028761|P1|Overall Study|Positive Human Anti-human Antibody|0
7775562|NCT00648739|27028755|P7|Overall Study|Death|0
7775563|NCT00648739|27028756|P6|Overall Study|Death|0
7775564|NCT00648739|27028757|P5|Overall Study|Death|0
7775565|NCT00648739|27028758|P4|Overall Study|Death|0
7775566|NCT00648739|27028759|P3|Overall Study|Death|0
7775567|NCT00648739|27028760|P2|Overall Study|Death|1
7775568|NCT00648739|27028761|P1|Overall Study|Death|0
7775569|NCT00648739|27028755|P7|Overall Study|Investigator Considered it Advisable|1
7775570|NCT00648739|27028756|P6|Overall Study|Investigator Considered it Advisable|1
7775571|NCT00648739|27028757|P5|Overall Study|Investigator Considered it Advisable|0
7775572|NCT00648739|27028758|P4|Overall Study|Investigator Considered it Advisable|0
7775573|NCT00648739|27028759|P3|Overall Study|Investigator Considered it Advisable|0
7775574|NCT00648739|27028760|P2|Overall Study|Investigator Considered it Advisable|0
7775575|NCT00648739|27028761|P1|Overall Study|Investigator Considered it Advisable|0
7775576|NCT00648739|27028755|P7|Overall Study|Lack of Efficacy|0
7775577|NCT00648739|27028756|P6|Overall Study|Lack of Efficacy|2
7775578|NCT00648739|27028757|P5|Overall Study|Lack of Efficacy|1
7775579|NCT00648739|27028758|P4|Overall Study|Lack of Efficacy|0
7775580|NCT00648739|27028759|P3|Overall Study|Lack of Efficacy|0
7775581|NCT00648739|27028760|P2|Overall Study|Lack of Efficacy|0
7775582|NCT00648739|27028761|P1|Overall Study|Lack of Efficacy|0
7775583|NCT00648739|27028755|P7|Overall Study|Withdrawal by Subject|0
7775584|NCT00648739|27028756|P6|Overall Study|Withdrawal by Subject|2
7775585|NCT00648739|27028757|P5|Overall Study|Withdrawal by Subject|0
7775586|NCT00648739|27028758|P4|Overall Study|Withdrawal by Subject|0
7775587|NCT00648739|27028759|P3|Overall Study|Withdrawal by Subject|1
7775588|NCT00648739|27028760|P2|Overall Study|Withdrawal by Subject|0
7775589|NCT00648739|27028761|P1|Overall Study|Withdrawal by Subject|1
7775590|NCT00648739|27028755|P7|Overall Study|Adverse Event|0
7775591|NCT00648739|27028756|P6|Overall Study|Adverse Event|0
7775592|NCT00648739|27028757|P5|Overall Study|Adverse Event|1
7775593|NCT00648739|27028758|P4|Overall Study|Adverse Event|2
7775594|NCT00648739|27028759|P3|Overall Study|Adverse Event|1
7775595|NCT00648739|27028760|P2|Overall Study|Adverse Event|0
7775596|NCT00648739|27028761|P1|Overall Study|Adverse Event|1
7775597|NCT00648167|27029095|P1|Overall Study|unable to swallow tablets|1
7775598|NCT00648167|27029095|P1|Overall Study|Adverse Event|6
7775599|NCT00648037|27029115|P1|Overall Study|Other|1
7775600|NCT00648037|27029115|P1|Overall Study|Relapse|2
7775601|NCT00648037|27029115|P1|Overall Study|Adverse Event|11
7775602|NCT00648037|27029115|P1|Overall Study|Withdrawal by Subject|1
7775603|NCT00648037|27029115|P1|Overall Study|Not Treated|1
7775604|NCT00647699|27029134|P2|Overall Study|Withdrawal by Subject|8
7775605|NCT00647699|27029135|P1|Overall Study|Withdrawal by Subject|3
7775606|NCT00647699|27029134|P2|Overall Study|Lost to Follow-up|4
7775607|NCT00647699|27029135|P1|Overall Study|Lost to Follow-up|5
7775608|NCT00647556|27029143|P2|Overall Study|Surgery for pre-existing neck pain|0
7775609|NCT00647556|27029144|P1|Overall Study|Surgery for pre-existing neck pain|1
7775610|NCT00647556|27029143|P2|Overall Study|Withdrawal by Subject|0
7775611|NCT00647556|27029144|P1|Overall Study|Withdrawal by Subject|1
7775612|NCT00647556|27029143|P2|Overall Study|Protocol Violation|1
7775613|NCT00647556|27029144|P1|Overall Study|Protocol Violation|0
7775614|NCT00647556|27029143|P2|Overall Study|Lost to Follow-up|0
7775615|NCT00647556|27029144|P1|Overall Study|Lost to Follow-up|1
7775616|NCT00647556|27029143|P2|Overall Study|Adverse Event|1
7775617|NCT00647556|27029144|P1|Overall Study|Adverse Event|0
7775618|NCT00647426|27029158|P1|Overall Study|Withdrawal by Subject|2
7775619|NCT00647348|27029180|P2|Overall Study|Lost to Follow-up|6
7775620|NCT00647348|27029181|P1|Overall Study|Lost to Follow-up|3
7775621|NCT00647296|27029207|P4|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
7775622|NCT00647296|27029208|P3|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
7775623|NCT00647296|27029209|P2|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
7775624|NCT00647296|27029210|P1|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
7775625|NCT00647296|27029207|P4|Part 2: 76-week Double-Blind Treatment|Death|5
7775626|NCT00647296|27029208|P3|Part 2: 76-week Double-Blind Treatment|Death|0
7775627|NCT00647296|27029209|P2|Part 2: 76-week Double-Blind Treatment|Death|7
7775628|NCT00647296|27029210|P1|Part 2: 76-week Double-Blind Treatment|Death|0
7775629|NCT00647296|27029207|P4|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7775630|NCT00647296|27029208|P3|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7775631|NCT00647296|27029209|P2|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
7775632|NCT00647296|27029210|P1|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7775633|NCT00647296|27029207|P4|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
7775634|NCT00647296|27029208|P3|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
7775635|NCT00647296|27029209|P2|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
7775636|NCT00647296|27029210|P1|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
7775637|NCT00647296|27029207|P4|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
7775638|NCT00647296|27029208|P3|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
7775639|NCT00647296|27029209|P2|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
7775640|NCT00647296|27029210|P1|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
7775641|NCT00647296|27029207|P4|Part 2: 4-week Placebo Washout|Death|0
7775642|NCT00647296|27029208|P3|Part 2: 4-week Placebo Washout|Death|0
7775643|NCT00647296|27029209|P2|Part 2: 4-week Placebo Washout|Death|0
7775644|NCT00647296|27029210|P1|Part 2: 4-week Placebo Washout|Death|3
7775645|NCT00647296|27029207|P4|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7775646|NCT00647296|27029208|P3|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7775647|NCT00647296|27029209|P2|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7775648|NCT00647296|27029210|P1|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
7775649|NCT00647296|27029207|P4|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7775650|NCT00647296|27029208|P3|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7775651|NCT00647296|27029209|P2|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7775652|NCT00647296|27029210|P1|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
7775653|NCT00647296|27029207|P4|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7775654|NCT00647296|27029208|P3|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7775655|NCT00647296|27029209|P2|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
7775656|NCT00647296|27029210|P1|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7775657|NCT00647296|27029207|P4|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
7775658|NCT00647296|27029208|P3|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
7775659|NCT00647296|27029209|P2|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
7775660|NCT00647296|27029210|P1|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
7775661|NCT00647296|27029207|P4|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
7775662|NCT00647296|27029208|P3|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7775663|NCT00647296|27029209|P2|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7775664|NCT00647296|27029210|P1|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7775665|NCT00647270|27029264|P3|Period 2, Placebo Switched to Adalimumab|Other|0
7775666|NCT00647270|27029265|P2|Period 2, Placebo Switched to Adalimumab|Other|6
7775667|NCT00647270|27029266|P1|Period 2, Placebo Switched to Adalimumab|Other|2
7775668|NCT00647270|27029264|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
7775669|NCT00647270|27029265|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
7775670|NCT00647270|27029266|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
7775671|NCT00647270|27029264|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
7775672|NCT00647270|27029265|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
7775673|NCT00647270|27029266|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
7775674|NCT00647270|27029264|P3|Period 1, Placebo-control (12 Weeks)|Other|8
7775675|NCT00647270|27029265|P2|Period 1, Placebo-control (12 Weeks)|Other|4
7775676|NCT00647270|27029266|P1|Period 1, Placebo-control (12 Weeks)|Other|4
7775677|NCT00647270|27029264|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
7775678|NCT00647270|27029265|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
7775679|NCT00647270|27029266|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
7775680|NCT00647270|27029264|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
7775681|NCT00647270|27029265|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
7775682|NCT00647270|27029266|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
7775683|NCT00647270|27029264|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
7775684|NCT00647270|27029265|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
7775685|NCT00647270|27029266|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
7775686|NCT00646958|27029292|P3|Overall Study|Did not receive study drug|2
7775687|NCT00646958|27029293|P2|Overall Study|Did not receive study drug|0
7775688|NCT00646958|27029294|P1|Overall Study|Did not receive study drug|2
7775689|NCT00646958|27029292|P3|Overall Study|Withdrawal by Subject|0
7775690|NCT00646958|27029293|P2|Overall Study|Withdrawal by Subject|2
7775691|NCT00646958|27029294|P1|Overall Study|Withdrawal by Subject|1
7775692|NCT00646958|27029292|P3|Overall Study|Abnormal screening lab tests|0
7775693|NCT00646958|27029293|P2|Overall Study|Abnormal screening lab tests|1
7775694|NCT00646958|27029294|P1|Overall Study|Abnormal screening lab tests|1
7775695|NCT00646958|27029292|P3|Overall Study|Protocol Violation|0
7775696|NCT00646958|27029293|P2|Overall Study|Protocol Violation|1
7775697|NCT00646958|27029294|P1|Overall Study|Protocol Violation|1
7775698|NCT00646958|27029292|P3|Overall Study|Lost to Follow-up|7
7775699|NCT00646958|27029293|P2|Overall Study|Lost to Follow-up|5
7775700|NCT00646958|27029294|P1|Overall Study|Lost to Follow-up|1
7775701|NCT00646958|27029292|P3|Overall Study|Adverse Event|0
7775702|NCT00646958|27029293|P2|Overall Study|Adverse Event|0
7775703|NCT00646958|27029294|P1|Overall Study|Adverse Event|4
7775704|NCT00646958|27029292|P3|Overall Study|Lack of Efficacy|0
7775705|NCT00646958|27029293|P2|Overall Study|Lack of Efficacy|0
7775706|NCT00646958|27029294|P1|Overall Study|Lack of Efficacy|1
7775707|NCT00646906|27029309|P7|Crossover Period 2|Physician Decision|1
7775708|NCT00646906|27029310|P6|Crossover Period 2|Physician Decision|0
7775709|NCT00646906|27029311|P5|Crossover Period 2|Physician Decision|0
7775710|NCT00646906|27029312|P4|Crossover Period 2|Physician Decision|0
7775711|NCT00646906|27029313|P3|Crossover Period 2|Physician Decision|0
7775712|NCT00646906|27029314|P2|Crossover Period 2|Physician Decision|0
7775713|NCT00646906|27029315|P1|Crossover Period 2|Physician Decision|0
7775714|NCT00646906|27029309|P7|Crossover Period 2|Withdrawal by Subject|0
7775715|NCT00646906|27029310|P6|Crossover Period 2|Withdrawal by Subject|0
7775716|NCT00646906|27029311|P5|Crossover Period 2|Withdrawal by Subject|0
7775717|NCT00646906|27029312|P4|Crossover Period 2|Withdrawal by Subject|1
7775718|NCT00646906|27029313|P3|Crossover Period 2|Withdrawal by Subject|2
7775719|NCT00646906|27029314|P2|Crossover Period 2|Withdrawal by Subject|1
7775720|NCT00646906|27029315|P1|Crossover Period 2|Withdrawal by Subject|0
7775721|NCT00646906|27029309|P7|Crossover Period 1|Withdrawal by Subject|0
7775722|NCT00646906|27029310|P6|Crossover Period 1|Withdrawal by Subject|1
7775723|NCT00646906|27029311|P5|Crossover Period 1|Withdrawal by Subject|0
7775724|NCT00646906|27029312|P4|Crossover Period 1|Withdrawal by Subject|0
7775725|NCT00646906|27029313|P3|Crossover Period 1|Withdrawal by Subject|0
7775726|NCT00646906|27029314|P2|Crossover Period 1|Withdrawal by Subject|0
7775727|NCT00646906|27029315|P1|Crossover Period 1|Withdrawal by Subject|1
7775728|NCT00646776|27029334|P2|Overall Study|Investigator discretion|4
7775729|NCT00646776|27029335|P1|Overall Study|Investigator discretion|0
7775730|NCT00646776|27029334|P2|Overall Study|Adverse Event|9
7775731|NCT00646776|27029335|P1|Overall Study|Adverse Event|1
7775732|NCT00646451|27029431|P2|Overall Study|Exacerbation of pre-existing condition|0
7775733|NCT00646451|27029432|P1|Overall Study|Exacerbation of pre-existing condition|1
7775734|NCT00646451|27029431|P2|Overall Study|Adverse Event|0
7775735|NCT00646451|27029432|P1|Overall Study|Adverse Event|3
7775736|NCT00646399|27029442|P2|Overall Study|Other Reason|11
7775737|NCT00646399|27029443|P1|Overall Study|Other Reason|11
7775738|NCT00646399|27029442|P2|Overall Study|Withdrawal by Subject|10
7775739|NCT00646399|27029443|P1|Overall Study|Withdrawal by Subject|9
7775740|NCT00646399|27029442|P2|Overall Study|Death|53
7775741|NCT00646399|27029443|P1|Overall Study|Death|63
7775742|NCT00646282|27029451|P2|Overall Study|Protocol terminated|4
7775743|NCT00646282|27029452|P1|Overall Study|Protocol terminated|4
7775744|NCT00646113|27029458|P1|Overall Study|Adverse Event|3
7775745|NCT00646113|27029458|P1|Overall Study|Lost to Follow-up|5
7775746|NCT00645944|27029479|P2|Received Medication|Protocol Violation|1
7775747|NCT00645944|27029480|P1|Received Medication|Protocol Violation|2
7775748|NCT00645944|27029479|P2|Received Medication|Lost to Follow-up|0
7775749|NCT00645944|27029480|P1|Received Medication|Lost to Follow-up|1
7775750|NCT00645944|27029479|P2|Received Medication|Withdrawal by Subject|1
7775751|NCT00645944|27029480|P1|Received Medication|Withdrawal by Subject|1
7775752|NCT00645944|27029479|P2|Received Medication|Adverse Event|1
7775753|NCT00645944|27029480|P1|Received Medication|Adverse Event|2
7775754|NCT00645944|27029479|P2|Randomized|Withdrawal by Subject|2
7775755|NCT00645944|27029480|P1|Randomized|Withdrawal by Subject|1
7775756|NCT00645853|27029488|P2|Overall Study|recall of ICF, planned operation, death|4
7775757|NCT00645853|27029489|P1|Overall Study|recall of ICF, planned operation, death|7
7775758|NCT00645853|27029488|P2|Overall Study|Discontinuation criteria|2
7775759|NCT00645853|27029489|P1|Overall Study|Discontinuation criteria|2
7775760|NCT00645853|27029488|P2|Overall Study|Protocol Violation|2
7775761|NCT00645853|27029489|P1|Overall Study|Protocol Violation|0
7775762|NCT00645853|27029488|P2|Overall Study|Withdrawal by Subject|2
7775763|NCT00645853|27029489|P1|Overall Study|Withdrawal by Subject|5
7775764|NCT00645853|27029488|P2|Overall Study|AZ study closure in Hungary|40
7775765|NCT00645853|27029489|P1|Overall Study|AZ study closure in Hungary|60
7775766|NCT00645853|27029488|P2|Overall Study|Adverse Event|7
7775767|NCT00645853|27029489|P1|Overall Study|Adverse Event|18
7775768|NCT00645840|27029507|P1|Overall Study|Protocol Violation|3
7775769|NCT00645788|27029525|P4|Overall Study|Pulmonary exacerbation|9
7775770|NCT00645788|27029526|P3|Overall Study|Pulmonary exacerbation|11
7775771|NCT00645788|27029527|P2|Overall Study|Pulmonary exacerbation|16
7775772|NCT00645788|27029528|P1|Overall Study|Pulmonary exacerbation|13
7775773|NCT00645788|27029525|P4|Overall Study|Withdrawal by Subject|2
7775774|NCT00645788|27029526|P3|Overall Study|Withdrawal by Subject|0
7775775|NCT00645788|27029527|P2|Overall Study|Withdrawal by Subject|1
7775776|NCT00645788|27029528|P1|Overall Study|Withdrawal by Subject|0
7775777|NCT00645788|27029525|P4|Overall Study|Protocol Violation|0
7775778|NCT00645788|27029526|P3|Overall Study|Protocol Violation|2
7775779|NCT00645788|27029527|P2|Overall Study|Protocol Violation|0
7775780|NCT00645788|27029528|P1|Overall Study|Protocol Violation|1
7775781|NCT00645788|27029525|P4|Overall Study|Lost to Follow-up|0
7775782|NCT00645788|27029526|P3|Overall Study|Lost to Follow-up|0
7775783|NCT00645788|27029527|P2|Overall Study|Lost to Follow-up|0
7775784|NCT00645788|27029528|P1|Overall Study|Lost to Follow-up|1
7775785|NCT00645788|27029525|P4|Overall Study|Adverse Event|3
7775786|NCT00645788|27029526|P3|Overall Study|Adverse Event|5
7775787|NCT00645788|27029527|P2|Overall Study|Adverse Event|9
7775788|NCT00645788|27029528|P1|Overall Study|Adverse Event|4
7775789|NCT00645788|27029525|P4|Overall Study|Did not receive study drug|0
7775790|NCT00645788|27029526|P3|Overall Study|Did not receive study drug|0
7775791|NCT00645788|27029527|P2|Overall Study|Did not receive study drug|1
7775792|NCT00645788|27029528|P1|Overall Study|Did not receive study drug|1
7775793|NCT00645671|27029606|P2|Overall Study|Physician Decision|1
7775794|NCT00645671|27029607|P1|Overall Study|Physician Decision|0
7775795|NCT00645671|27029606|P2|Overall Study|Adverse Event|1
7775796|NCT00645671|27029607|P1|Overall Study|Adverse Event|0
7775797|NCT00645671|27029606|P2|Overall Study|Withdrawal by Subject|4
7775798|NCT00645671|27029607|P1|Overall Study|Withdrawal by Subject|0
7775799|NCT00645671|27029606|P2|Overall Study|Protocol Violation|0
7775800|NCT00645671|27029607|P1|Overall Study|Protocol Violation|1
7775801|NCT00645593|27029621|P2|Overall Study|Later found to be ineligible|0
7775802|NCT00645593|27029622|P1|Overall Study|Later found to be ineligible|1
7775803|NCT00645567|27029634|P1|Overall Study|Adverse Event|1
7775804|NCT00645528|27029642|P1|Overall Study|Did not show up for Visit 2|7
7775805|NCT00645411|27029664|P4|Overall Study|Unable to classify|4
7775806|NCT00645411|27029665|P3|Overall Study|Unable to classify|3
7775807|NCT00645411|27029666|P2|Overall Study|Unable to classify|0
7775808|NCT00645411|27029667|P1|Overall Study|Unable to classify|0
7775809|NCT00645411|27029664|P4|Overall Study|Inappropriate enrollment|1
7775810|NCT00645411|27029665|P3|Overall Study|Inappropriate enrollment|4
7775811|NCT00645411|27029666|P2|Overall Study|Inappropriate enrollment|0
7775812|NCT00645411|27029667|P1|Overall Study|Inappropriate enrollment|0
7775813|NCT00645411|27029664|P4|Overall Study|Protocol Violation|0
7775814|NCT00645411|27029665|P3|Overall Study|Protocol Violation|1
7775815|NCT00645411|27029666|P2|Overall Study|Protocol Violation|0
7775816|NCT00645411|27029667|P1|Overall Study|Protocol Violation|1
7775817|NCT00645411|27029664|P4|Overall Study|Lost to Follow-up|75
7775818|NCT00645411|27029665|P3|Overall Study|Lost to Follow-up|124
7775819|NCT00645411|27029666|P2|Overall Study|Lost to Follow-up|5
7775820|NCT00645411|27029667|P1|Overall Study|Lost to Follow-up|10
7775821|NCT00645411|27029664|P4|Overall Study|Withdrawal by Subject|21
7775822|NCT00645411|27029665|P3|Overall Study|Withdrawal by Subject|19
7775823|NCT00645411|27029666|P2|Overall Study|Withdrawal by Subject|1
7775824|NCT00645411|27029667|P1|Overall Study|Withdrawal by Subject|2
7775825|NCT00645411|27029664|P4|Overall Study|Adverse Event|2
7775826|NCT00645411|27029665|P3|Overall Study|Adverse Event|0
7775827|NCT00645411|27029666|P2|Overall Study|Adverse Event|0
7775828|NCT00645411|27029667|P1|Overall Study|Adverse Event|0
7775829|NCT00645164|27029709|P1|Overall Study|Protocol Violation|1
7775830|NCT00645164|27029709|P1|Overall Study|Withdrawal by Subject|4
7775831|NCT00645164|27029709|P1|Overall Study|Lost to Follow-up|2
7775832|NCT00645099|27029715|P2|Overall Study|Other|5
7775833|NCT00645099|27029716|P1|Overall Study|Other|9
7775834|NCT00645099|27029715|P2|Overall Study|Adverse Event|5
7775835|NCT00645099|27029716|P1|Overall Study|Adverse Event|11
7775836|NCT00645099|27029715|P2|Overall Study|Lost to Follow-up|4
7775837|NCT00645099|27029716|P1|Overall Study|Lost to Follow-up|6
7775838|NCT00645099|27029715|P2|Overall Study|Withdrawal by Subject|22
7775839|NCT00645099|27029716|P1|Overall Study|Withdrawal by Subject|30
7775840|NCT00645099|27029715|P2|Overall Study|Lack of Efficacy|6
7775841|NCT00645099|27029716|P1|Overall Study|Lack of Efficacy|15
7775842|NCT00644995|27029785|P2|Overall Study|Refused|0
7775843|NCT00644995|27029786|P1|Overall Study|Refused|1
7775844|NCT00644995|27029785|P2|Overall Study|Lost to Follow-up|4
7775845|NCT00644995|27029786|P1|Overall Study|Lost to Follow-up|1
7775846|NCT00644969|27029806|P2|Post Treatment Phase|Other|0
7775847|NCT00644969|27029807|P1|Post Treatment Phase|Other|1
7775848|NCT00644969|27029806|P2|Post Treatment Phase|Lost to Follow-up|1
7775849|NCT00644969|27029807|P1|Post Treatment Phase|Lost to Follow-up|4
7775850|NCT00644969|27029806|P2|Post Treatment Phase|Withdrawal by Subject|2
7775851|NCT00644969|27029807|P1|Post Treatment Phase|Withdrawal by Subject|4
7775852|NCT00644969|27029806|P2|Post Treatment Phase|Death|0
7775853|NCT00644969|27029807|P1|Post Treatment Phase|Death|1
7775854|NCT00644969|27029806|P2|Treatment Phase|Other|1
7775855|NCT00644969|27029807|P1|Treatment Phase|Other|4
7775856|NCT00644969|27029806|P2|Treatment Phase|Lost to Follow-up|2
7775857|NCT00644969|27029807|P1|Treatment Phase|Lost to Follow-up|2
7775858|NCT00644969|27029806|P2|Treatment Phase|Withdrawal by Subject|0
7775859|NCT00644969|27029807|P1|Treatment Phase|Withdrawal by Subject|4
7775860|NCT00644969|27029806|P2|Treatment Phase|Adverse Event|0
7775861|NCT00644969|27029807|P1|Treatment Phase|Adverse Event|3
7775862|NCT00644969|27029806|P2|Treatment Phase|Randomized, not treated|0
7775863|NCT00644969|27029807|P1|Treatment Phase|Randomized, not treated|1
7775864|NCT00644917|27029853|P1|Overall Study|Withdrawal by Subject|2
7775865|NCT00644878|27029861|P1|Overall Study|Treatment duration completed as per protocol|11
7775866|NCT00644878|27029861|P1|Overall Study|Protocol deviation|2
7775867|NCT00644878|27029861|P1|Overall Study|Abnormal laboratory value|3
7775868|NCT00644878|27029861|P1|Overall Study|Adverse Event|2
7775869|NCT00644787|27029872|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
7775870|NCT00644787|27029873|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
7775871|NCT00644787|27029874|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
7775872|NCT00644787|27029872|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
7775873|NCT00644787|27029873|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
7775874|NCT00644787|27029874|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
7775875|NCT00644787|27029872|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
7775876|NCT00644787|27029873|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
7775877|NCT00644787|27029874|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
7775878|NCT00644787|27029872|P3|Period 2: Double Blind Phase|Adverse Event|4
7775879|NCT00644787|27029873|P2|Period 2: Double Blind Phase|Adverse Event|2
7775880|NCT00644787|27029874|P1|Period 2: Double Blind Phase|Adverse Event|0
7775881|NCT00644787|27029872|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
7775882|NCT00644787|27029873|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
7775883|NCT00644787|27029874|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
7775884|NCT00644787|27029872|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
7775885|NCT00644787|27029873|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
7775886|NCT00644787|27029874|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
7775887|NCT00644787|27029872|P3|Period 1: Titration Phase|Worsening of symptoms|0
7775888|NCT00644787|27029873|P2|Period 1: Titration Phase|Worsening of symptoms|0
7775889|NCT00644787|27029874|P1|Period 1: Titration Phase|Worsening of symptoms|1
7775890|NCT00644787|27029872|P3|Period 1: Titration Phase|Worsening of complications|0
7775891|NCT00644787|27029873|P2|Period 1: Titration Phase|Worsening of complications|0
7775892|NCT00644787|27029874|P1|Period 1: Titration Phase|Worsening of complications|1
7775893|NCT00644787|27029872|P3|Period 1: Titration Phase|Worsening of underlying disease|0
7775894|NCT00644787|27029873|P2|Period 1: Titration Phase|Worsening of underlying disease|0
7775895|NCT00644787|27029874|P1|Period 1: Titration Phase|Worsening of underlying disease|5
7775896|NCT00644787|27029872|P3|Period 1: Titration Phase|Physician Decision|0
7775897|NCT00644787|27029873|P2|Period 1: Titration Phase|Physician Decision|0
7775898|NCT00644787|27029874|P1|Period 1: Titration Phase|Physician Decision|1
7775899|NCT00644787|27029872|P3|Period 1: Titration Phase|Withdrawal by Subject|0
7775900|NCT00644787|27029873|P2|Period 1: Titration Phase|Withdrawal by Subject|0
7775901|NCT00644787|27029874|P1|Period 1: Titration Phase|Withdrawal by Subject|2
7775902|NCT00644787|27029872|P3|Period 1: Titration Phase|Adverse Event|0
7775903|NCT00644787|27029873|P2|Period 1: Titration Phase|Adverse Event|0
7775904|NCT00644787|27029874|P1|Period 1: Titration Phase|Adverse Event|11
7775905|NCT00644423|27029918|P2|Overall Study|Lost to Follow-up|1
7775906|NCT00644423|27029919|P1|Overall Study|Lost to Follow-up|1
7775907|NCT00644358|27029937|P1|Overall Study|Other Unspecified|11
7775908|NCT00644358|27029937|P1|Overall Study|Noncompliance|14
7775909|NCT00644358|27029937|P1|Overall Study|Protocol Violation|5
7775910|NCT00644358|27029937|P1|Overall Study|Lack of Effectiveness|39
7775911|NCT00644358|27029937|P1|Overall Study|Consent Withdrawal|64
7775912|NCT00644358|27029937|P1|Overall Study|Lost to Follow-up|105
7775913|NCT00644358|27029937|P1|Overall Study|Adverse Event|124
7775914|NCT00644332|27029944|P1|Overall Study|Could Not Attend Scheduled Visits|1
7775915|NCT00644332|27029944|P1|Overall Study|Did Not Meet Eligibility Requirements|1
7775916|NCT00644332|27029944|P1|Overall Study|Completion Status Unknown|2
7775917|NCT00644332|27029944|P1|Overall Study|Withdrawal by Subject|6
7775918|NCT00644332|27029944|P1|Overall Study|Adverse Event|11
7775919|NCT00644228|27029970|P2|Maintenance|On Treatment|40
7775920|NCT00644228|27029971|P1|Maintenance|On Treatment|26
7775921|NCT00644228|27029970|P2|Maintenance|Not Protocol-Specified|15
7775922|NCT00644228|27029971|P1|Maintenance|Not Protocol-Specified|14
7775923|NCT00644228|27029970|P2|Maintenance|Death|3
7775924|NCT00644228|27029971|P1|Maintenance|Death|3
7775925|NCT00644228|27029970|P2|Maintenance|Progression/Relapse|42
7775926|NCT00644228|27029971|P1|Maintenance|Progression/Relapse|67
7775927|NCT00644228|27029970|P2|Maintenance|Withdrawal by Subject|4
7775928|NCT00644228|27029971|P1|Maintenance|Withdrawal by Subject|6
7775929|NCT00644228|27029970|P2|Maintenance|Adverse Event|31
7775930|NCT00644228|27029971|P1|Maintenance|Adverse Event|27
7775931|NCT00644228|27029970|P2|Induction Therapy|Not Protocol-Specified|28
7775932|NCT00644228|27029971|P1|Induction Therapy|Not Protocol-Specified|24
7775933|NCT00644228|27029970|P2|Induction Therapy|Death|7
7775934|NCT00644228|27029971|P1|Induction Therapy|Death|3
7775935|NCT00644228|27029970|P2|Induction Therapy|Progression/Relapse|12
7775936|NCT00644228|27029971|P1|Induction Therapy|Progression/Relapse|24
7775937|NCT00644228|27029970|P2|Induction Therapy|Withdrawal by Subject|3
7775938|NCT00644228|27029971|P1|Induction Therapy|Withdrawal by Subject|10
7775939|NCT00644228|27029970|P2|Induction Therapy|Adverse Event|55
7775940|NCT00644228|27029971|P1|Induction Therapy|Adverse Event|22
7775941|NCT00644228|27029970|P2|Randomization & Eligibility|Invalid Consent|1
7775942|NCT00644228|27029971|P1|Randomization & Eligibility|Invalid Consent|0
7775943|NCT00644228|27029970|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
7775944|NCT00644228|27029971|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
7775945|NCT00644228|27029970|P2|Randomization & Eligibility|Ineligible|21
7775946|NCT00644228|27029971|P1|Randomization & Eligibility|Ineligible|31
7775947|NCT00644059|27030000|P3|Overall Study|Unable to classify|3
7775948|NCT00644059|27030001|P2|Overall Study|Unable to classify|2
7775949|NCT00644059|27030002|P1|Overall Study|Unable to classify|6
7775950|NCT00644059|27030000|P3|Overall Study|Protocol Deviation/violation|15
7775951|NCT00644059|27030001|P2|Overall Study|Protocol Deviation/violation|19
7775952|NCT00644059|27030002|P1|Overall Study|Protocol Deviation/violation|20
7775953|NCT00644059|27030000|P3|Overall Study|Inappropriate Enrollment|0
7775954|NCT00644059|27030001|P2|Overall Study|Inappropriate Enrollment|3
7775955|NCT00644059|27030002|P1|Overall Study|Inappropriate Enrollment|1
7775956|NCT00644059|27030000|P3|Overall Study|Adverse Event|1
7775957|NCT00644059|27030001|P2|Overall Study|Adverse Event|5
7775958|NCT00644059|27030002|P1|Overall Study|Adverse Event|8
7775959|NCT00644059|27030000|P3|Overall Study|Withdrawal by Subject|30
7775960|NCT00644059|27030001|P2|Overall Study|Withdrawal by Subject|60
7775961|NCT00644059|27030002|P1|Overall Study|Withdrawal by Subject|52
7775962|NCT00644059|27030000|P3|Overall Study|Lost to Follow-up|16
7775963|NCT00644059|27030001|P2|Overall Study|Lost to Follow-up|34
7775964|NCT00644059|27030002|P1|Overall Study|Lost to Follow-up|37
7775965|NCT00643916|27030092|P6|Overall Study|Not Vaccinated|0
7775966|NCT00643916|27030093|P5|Overall Study|Not Vaccinated|2
7775967|NCT00643916|27030094|P4|Overall Study|Not Vaccinated|0
7775968|NCT00643916|27030095|P3|Overall Study|Not Vaccinated|3
7775969|NCT00643916|27030096|P2|Overall Study|Not Vaccinated|2
7775970|NCT00643916|27030097|P1|Overall Study|Not Vaccinated|2
7775971|NCT00643916|27030092|P6|Overall Study|Withdrawal by Subject|1
7775972|NCT00643916|27030093|P5|Overall Study|Withdrawal by Subject|0
7775973|NCT00643916|27030094|P4|Overall Study|Withdrawal by Subject|1
7775974|NCT00643916|27030095|P3|Overall Study|Withdrawal by Subject|2
7775975|NCT00643916|27030096|P2|Overall Study|Withdrawal by Subject|2
7775976|NCT00643916|27030097|P1|Overall Study|Withdrawal by Subject|2
7775977|NCT00643916|27030092|P6|Overall Study|Lost to Follow-up|0
7775978|NCT00643916|27030093|P5|Overall Study|Lost to Follow-up|0
7775979|NCT00643916|27030094|P4|Overall Study|Lost to Follow-up|0
7775980|NCT00643916|27030095|P3|Overall Study|Lost to Follow-up|0
7775981|NCT00643916|27030096|P2|Overall Study|Lost to Follow-up|1
7775982|NCT00643916|27030097|P1|Overall Study|Lost to Follow-up|0
7775983|NCT00643916|27030092|P6|Overall Study|Protocol Violation|0
7775984|NCT00643916|27030093|P5|Overall Study|Protocol Violation|0
7775985|NCT00643916|27030094|P4|Overall Study|Protocol Violation|1
7775986|NCT00643916|27030095|P3|Overall Study|Protocol Violation|1
7775987|NCT00643916|27030096|P2|Overall Study|Protocol Violation|1
7775988|NCT00643916|27030097|P1|Overall Study|Protocol Violation|0
7775989|NCT00643851|27030126|P3|Overall Study|Non-compl., not met criteria, etc.|6
7775990|NCT00643851|27030127|P2|Overall Study|Non-compl., not met criteria, etc.|4
7775991|NCT00643851|27030128|P1|Overall Study|Non-compl., not met criteria, etc.|3
7775992|NCT00643851|27030126|P3|Overall Study|Withdrawal by Subject|9
7775993|NCT00643851|27030127|P2|Overall Study|Withdrawal by Subject|15
7775994|NCT00643851|27030128|P1|Overall Study|Withdrawal by Subject|8
7775995|NCT00643851|27030126|P3|Overall Study|Lost to Follow-up|9
7775996|NCT00643851|27030127|P2|Overall Study|Lost to Follow-up|6
7775997|NCT00643851|27030128|P1|Overall Study|Lost to Follow-up|4
7775998|NCT00643851|27030126|P3|Overall Study|Adverse Event|6
7775999|NCT00643851|27030127|P2|Overall Study|Adverse Event|6
7776000|NCT00643851|27030128|P1|Overall Study|Adverse Event|2
7776001|NCT00643851|27030126|P3|Overall Study|Lack of Efficacy|0
7776002|NCT00643851|27030127|P2|Overall Study|Lack of Efficacy|1
7776003|NCT00643851|27030128|P1|Overall Study|Lack of Efficacy|0
7776004|NCT00643851|27030126|P3|Overall Study|Death|0
7776005|NCT00643851|27030127|P2|Overall Study|Death|1
7776006|NCT00643851|27030128|P1|Overall Study|Death|0
7776007|NCT00643760|27030156|P5|Overall Study|Withdrawal by Subject|1
7776008|NCT00643760|27030157|P4|Overall Study|Withdrawal by Subject|4
7776009|NCT00643760|27030158|P3|Overall Study|Withdrawal by Subject|2
7776010|NCT00643760|27030159|P2|Overall Study|Withdrawal by Subject|1
7776011|NCT00643760|27030160|P1|Overall Study|Withdrawal by Subject|3
7776012|NCT00643760|27030156|P5|Overall Study|Investigator Discretion|0
7776013|NCT00643760|27030157|P4|Overall Study|Investigator Discretion|2
7776014|NCT00643760|27030158|P3|Overall Study|Investigator Discretion|0
7776015|NCT00643760|27030159|P2|Overall Study|Investigator Discretion|0
7776016|NCT00643760|27030160|P1|Overall Study|Investigator Discretion|0
7776017|NCT00643760|27030156|P5|Overall Study|Lost to Follow-up|3
7776018|NCT00643760|27030157|P4|Overall Study|Lost to Follow-up|3
7776019|NCT00643760|27030158|P3|Overall Study|Lost to Follow-up|1
7776020|NCT00643760|27030159|P2|Overall Study|Lost to Follow-up|2
7776021|NCT00643760|27030160|P1|Overall Study|Lost to Follow-up|6
7776022|NCT00643760|27030156|P5|Overall Study|Protocol Violation|6
7776023|NCT00643760|27030157|P4|Overall Study|Protocol Violation|4
7776024|NCT00643760|27030158|P3|Overall Study|Protocol Violation|4
7776025|NCT00643760|27030159|P2|Overall Study|Protocol Violation|6
7776026|NCT00643760|27030160|P1|Overall Study|Protocol Violation|7
7776027|NCT00643760|27030156|P5|Overall Study|Lack of Efficacy|3
7776028|NCT00643760|27030157|P4|Overall Study|Lack of Efficacy|4
7776029|NCT00643760|27030158|P3|Overall Study|Lack of Efficacy|0
7776030|NCT00643760|27030159|P2|Overall Study|Lack of Efficacy|1
7776031|NCT00643760|27030160|P1|Overall Study|Lack of Efficacy|3
7776032|NCT00643760|27030156|P5|Overall Study|Adverse Event|6
7776033|NCT00643760|27030157|P4|Overall Study|Adverse Event|21
7776034|NCT00643760|27030158|P3|Overall Study|Adverse Event|12
7776035|NCT00643760|27030159|P2|Overall Study|Adverse Event|5
7776036|NCT00643760|27030160|P1|Overall Study|Adverse Event|11
7776037|NCT00643682|27030264|P2|Overall Study|did not keep appointment|509
7776038|NCT00643682|27030265|P1|Overall Study|did not keep appointment|522
7776039|NCT00643604|27030277|P1|Overall Study|Death|1
7776040|NCT00643565|27030305|P2|Overall Study|Adverse Event|8
7776041|NCT00643565|27030306|P1|Overall Study|Adverse Event|5
7776042|NCT00643565|27030305|P2|Overall Study|Administrative|16
7776043|NCT00643565|27030306|P1|Overall Study|Administrative|22
7776044|NCT00643565|27030305|P2|Overall Study|Did Not Cooperate|1
7776045|NCT00643565|27030306|P1|Overall Study|Did Not Cooperate|0
7776046|NCT00643565|27030305|P2|Overall Study|Protocol Violation|0
7776047|NCT00643565|27030306|P1|Overall Study|Protocol Violation|3
7776048|NCT00643565|27030305|P2|Overall Study|Progression of Disease|14
7776049|NCT00643565|27030306|P1|Overall Study|Progression of Disease|18
7776050|NCT00643565|27030305|P2|Overall Study|Recurrence of Disease|1
7776051|NCT00643565|27030306|P1|Overall Study|Recurrence of Disease|2
7776052|NCT00643565|27030305|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
7776053|NCT00643565|27030306|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
7776054|NCT00643565|27030305|P2|Overall Study|Other|8
7776055|NCT00643565|27030306|P1|Overall Study|Other|7
7776056|NCT00643565|27030305|P2|Overall Study|Lost to Follow-up|6
7776057|NCT00643565|27030306|P1|Overall Study|Lost to Follow-up|0
7776058|NCT00643565|27030305|P2|Overall Study|Withdrawal by Subject|1
7776059|NCT00643565|27030306|P1|Overall Study|Withdrawal by Subject|4
7776060|NCT00643565|27030305|P2|Overall Study|Death|11
7776061|NCT00643565|27030306|P1|Overall Study|Death|12
7776062|NCT00643487|27030328|P1|Overall Study|Technical difficulty|3
7776063|NCT00643448|27030335|P3|Overall Study|QTcF>550 ms|0
7776064|NCT00643448|27030336|P2|Overall Study|QTcF>550 ms|3
7776065|NCT00643448|27030337|P1|Overall Study|QTcF>550 ms|0
7776066|NCT00643448|27030335|P3|Overall Study|Adverse Event|2
7776067|NCT00643448|27030336|P2|Overall Study|Adverse Event|2
7776068|NCT00643448|27030337|P1|Overall Study|Adverse Event|2
7776069|NCT00643448|27030335|P3|Overall Study|Lack of Efficacy|4
7776070|NCT00643448|27030336|P2|Overall Study|Lack of Efficacy|0
7776071|NCT00643448|27030337|P1|Overall Study|Lack of Efficacy|2
7776072|NCT00643279|27030354|P2|Overall Study|Physician Decision|1
7776073|NCT00643279|27030355|P1|Overall Study|Physician Decision|0
7776074|NCT00643279|27030354|P2|Overall Study|Lost to Follow-up|1
7776075|NCT00643279|27030355|P1|Overall Study|Lost to Follow-up|0
7776076|NCT00643279|27030354|P2|Overall Study|Withdrawal by Subject|0
7776077|NCT00643279|27030355|P1|Overall Study|Withdrawal by Subject|3
7776078|NCT00643279|27030354|P2|Overall Study|Death|11
7776079|NCT00643279|27030355|P1|Overall Study|Death|13
7776080|NCT00643201|27030377|P2|Completed Study Follow Up|non-specified|0
7776081|NCT00643201|27030378|P1|Completed Study Follow Up|non-specified|1
7776082|NCT00643201|27030377|P2|Completed Study Follow Up|Lost to Follow-up|16
7776083|NCT00643201|27030378|P1|Completed Study Follow Up|Lost to Follow-up|18
7776084|NCT00643201|27030377|P2|Completed Study Follow Up|Withdrawal by Subject|29
7776085|NCT00643201|27030378|P1|Completed Study Follow Up|Withdrawal by Subject|23
7776086|NCT00643201|27030377|P2|Completed Study Follow Up|Death|34
7776087|NCT00643201|27030378|P1|Completed Study Follow Up|Death|28
7776088|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Other|107
7776089|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Other|107
7776090|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
7776091|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
7776092|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
7776093|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
7776094|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
7776095|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
7776096|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
7776097|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
7776098|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
7776099|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
7776100|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
7776101|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
7776102|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
7776103|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
7776104|NCT00643201|27030377|P2|Randomized, Completed 6 Months of Study|Death|26
7776105|NCT00643201|27030378|P1|Randomized, Completed 6 Months of Study|Death|20
7776106|NCT00643162|27030426|P2|Overall Study|Withdrawal by Subject|1
7776107|NCT00643162|27030427|P1|Overall Study|Withdrawal by Subject|1
7776108|NCT00643123|27030439|P2|Overall Study|Withdrawal by Subject|1
7776109|NCT00643123|27030440|P1|Overall Study|Withdrawal by Subject|1
7776110|NCT00643123|27030439|P2|Overall Study|Lost to Follow-up|0
7776111|NCT00643123|27030440|P1|Overall Study|Lost to Follow-up|4
7776112|NCT00643006|27030472|P2|Overall Study|Lost to Follow-up|4
7776113|NCT00643006|27030473|P1|Overall Study|Lost to Follow-up|5
7776114|NCT00642993|27030483|P2|Overall Study|Administrative|0
7776115|NCT00642993|27030484|P1|Overall Study|Administrative|1
7776116|NCT00642993|27030483|P2|Overall Study|Did not meet protocol eligibility|1
7776117|NCT00642993|27030484|P1|Overall Study|Did not meet protocol eligibility|0
7776118|NCT00642993|27030483|P2|Overall Study|Protocol Violation|4
7776119|NCT00642993|27030484|P1|Overall Study|Protocol Violation|1
7776120|NCT00642993|27030483|P2|Overall Study|Withdrew - reason unrelated to treatment|3
7776121|NCT00642993|27030484|P1|Overall Study|Withdrew - reason unrelated to treatment|11
7776122|NCT00642993|27030483|P2|Overall Study|Lost to Follow-up|4
7776123|NCT00642993|27030484|P1|Overall Study|Lost to Follow-up|8
7776124|NCT00642993|27030483|P2|Overall Study|Adverse Event|4
7776125|NCT00642993|27030484|P1|Overall Study|Adverse Event|85
7776126|NCT00642954|27030503|P5|Overall Study|Adverse Event|6
7776127|NCT00642954|27030504|P4|Overall Study|Adverse Event|0
7776128|NCT00642954|27030505|P3|Overall Study|Adverse Event|0
7776129|NCT00642954|27030506|P2|Overall Study|Adverse Event|1
7776130|NCT00642954|27030507|P1|Overall Study|Adverse Event|1
7776131|NCT00642954|27030503|P5|Overall Study|Withdrawal by Subject|1
7776132|NCT00642954|27030504|P4|Overall Study|Withdrawal by Subject|0
7776133|NCT00642954|27030505|P3|Overall Study|Withdrawal by Subject|0
7776134|NCT00642954|27030506|P2|Overall Study|Withdrawal by Subject|0
7776135|NCT00642954|27030507|P1|Overall Study|Withdrawal by Subject|0
7776136|NCT00642954|27030503|P5|Overall Study|Progressive Disease|9
7776137|NCT00642954|27030504|P4|Overall Study|Progressive Disease|3
7776138|NCT00642954|27030505|P3|Overall Study|Progressive Disease|3
7776139|NCT00642954|27030506|P2|Overall Study|Progressive Disease|3
7776140|NCT00642954|27030507|P1|Overall Study|Progressive Disease|3
7776141|NCT00642941|27030541|P12|Overall Study|Disease progression|7
7776142|NCT00642941|27030542|P11|Overall Study|Disease progression|12
7776143|NCT00642941|27030543|P10|Overall Study|Disease progression|7
7776144|NCT00642941|27030544|P9|Overall Study|Disease progression|10
7776145|NCT00642941|27030545|P8|Overall Study|Disease progression|12
7776146|NCT00642941|27030546|P7|Overall Study|Disease progression|18
7776147|NCT00642941|27030547|P6|Overall Study|Disease progression|39
7776148|NCT00642941|27030548|P5|Overall Study|Disease progression|23
7776149|NCT00642941|27030549|P4|Overall Study|Disease progression|36
7776150|NCT00642941|27030550|P3|Overall Study|Disease progression|5
7776151|NCT00642941|27030551|P2|Overall Study|Disease progression|50
7776152|NCT00642941|27030552|P1|Overall Study|Disease progression|60
7776153|NCT00642941|27030541|P12|Overall Study|Other|1
7776154|NCT00642941|27030542|P11|Overall Study|Other|0
7776155|NCT00642941|27030543|P10|Overall Study|Other|0
7776156|NCT00642941|27030544|P9|Overall Study|Other|0
7776157|NCT00642941|27030545|P8|Overall Study|Other|1
7776158|NCT00642941|27030546|P7|Overall Study|Other|0
7776159|NCT00642941|27030547|P6|Overall Study|Other|1
7776160|NCT00642941|27030548|P5|Overall Study|Other|0
7776161|NCT00642941|27030549|P4|Overall Study|Other|1
7776162|NCT00642941|27030550|P3|Overall Study|Other|1
7776163|NCT00642941|27030551|P2|Overall Study|Other|1
7776164|NCT00642941|27030552|P1|Overall Study|Other|1
7776165|NCT00642941|27030541|P12|Overall Study|Adverse Event|0
7776166|NCT00642941|27030542|P11|Overall Study|Adverse Event|0
7776167|NCT00642941|27030543|P10|Overall Study|Adverse Event|1
7776168|NCT00642941|27030544|P9|Overall Study|Adverse Event|0
7776169|NCT00642941|27030545|P8|Overall Study|Adverse Event|1
7776170|NCT00642941|27030546|P7|Overall Study|Adverse Event|1
7776171|NCT00642941|27030547|P6|Overall Study|Adverse Event|0
7776172|NCT00642941|27030548|P5|Overall Study|Adverse Event|0
7776173|NCT00642941|27030549|P4|Overall Study|Adverse Event|0
7776174|NCT00642941|27030550|P3|Overall Study|Adverse Event|0
7776175|NCT00642941|27030551|P2|Overall Study|Adverse Event|1
7776176|NCT00642941|27030552|P1|Overall Study|Adverse Event|1
7776177|NCT00642941|27030541|P12|Overall Study|Protocol Violation|0
7776178|NCT00642941|27030542|P11|Overall Study|Protocol Violation|0
7776179|NCT00642941|27030543|P10|Overall Study|Protocol Violation|0
7776180|NCT00642941|27030544|P9|Overall Study|Protocol Violation|0
7776181|NCT00642941|27030545|P8|Overall Study|Protocol Violation|0
7776182|NCT00642941|27030546|P7|Overall Study|Protocol Violation|1
7776183|NCT00642941|27030547|P6|Overall Study|Protocol Violation|0
7776184|NCT00642941|27030548|P5|Overall Study|Protocol Violation|0
7776185|NCT00642941|27030549|P4|Overall Study|Protocol Violation|0
7776186|NCT00642941|27030550|P3|Overall Study|Protocol Violation|0
7776187|NCT00642941|27030551|P2|Overall Study|Protocol Violation|0
7776188|NCT00642941|27030552|P1|Overall Study|Protocol Violation|0
7776189|NCT00642941|27030541|P12|Overall Study|Withdrawal by Subject|1
7776190|NCT00642941|27030542|P11|Overall Study|Withdrawal by Subject|0
7776191|NCT00642941|27030543|P10|Overall Study|Withdrawal by Subject|0
7776192|NCT00642941|27030544|P9|Overall Study|Withdrawal by Subject|1
7776193|NCT00642941|27030545|P8|Overall Study|Withdrawal by Subject|0
7776194|NCT00642941|27030546|P7|Overall Study|Withdrawal by Subject|2
7776195|NCT00642941|27030547|P6|Overall Study|Withdrawal by Subject|0
7776196|NCT00642941|27030548|P5|Overall Study|Withdrawal by Subject|0
7776197|NCT00642941|27030549|P4|Overall Study|Withdrawal by Subject|2
7776198|NCT00642941|27030550|P3|Overall Study|Withdrawal by Subject|0
7776199|NCT00642941|27030551|P2|Overall Study|Withdrawal by Subject|0
7776200|NCT00642941|27030552|P1|Overall Study|Withdrawal by Subject|1
7776201|NCT00642941|27030541|P12|Overall Study|Study closed by Sponsor|0
7776202|NCT00642941|27030542|P11|Overall Study|Study closed by Sponsor|0
7776203|NCT00642941|27030543|P10|Overall Study|Study closed by Sponsor|0
7776204|NCT00642941|27030544|P9|Overall Study|Study closed by Sponsor|0
7776205|NCT00642941|27030545|P8|Overall Study|Study closed by Sponsor|0
7776206|NCT00642941|27030546|P7|Overall Study|Study closed by Sponsor|0
7776207|NCT00642941|27030547|P6|Overall Study|Study closed by Sponsor|0
7776208|NCT00642941|27030548|P5|Overall Study|Study closed by Sponsor|0
7776209|NCT00642941|27030549|P4|Overall Study|Study closed by Sponsor|0
7776210|NCT00642941|27030550|P3|Overall Study|Study closed by Sponsor|0
7776211|NCT00642941|27030551|P2|Overall Study|Study closed by Sponsor|1
7776212|NCT00642941|27030552|P1|Overall Study|Study closed by Sponsor|0
7776213|NCT00642941|27030541|P12|Overall Study|Death|1
7776214|NCT00642941|27030542|P11|Overall Study|Death|0
7776215|NCT00642941|27030543|P10|Overall Study|Death|0
7776216|NCT00642941|27030544|P9|Overall Study|Death|0
7776217|NCT00642941|27030545|P8|Overall Study|Death|0
7776218|NCT00642941|27030546|P7|Overall Study|Death|0
7776219|NCT00642941|27030547|P6|Overall Study|Death|1
7776220|NCT00642941|27030548|P5|Overall Study|Death|2
7776221|NCT00642941|27030549|P4|Overall Study|Death|1
7776222|NCT00642941|27030550|P3|Overall Study|Death|1
7776223|NCT00642941|27030551|P2|Overall Study|Death|0
7776224|NCT00642941|27030552|P1|Overall Study|Death|4
7776225|NCT00642941|27030541|P12|Overall Study|Physician Decision|1
7776226|NCT00642941|27030542|P11|Overall Study|Physician Decision|0
7776227|NCT00642941|27030543|P10|Overall Study|Physician Decision|1
7776228|NCT00642941|27030544|P9|Overall Study|Physician Decision|0
7776229|NCT00642941|27030545|P8|Overall Study|Physician Decision|0
7776230|NCT00642941|27030546|P7|Overall Study|Physician Decision|1
7776231|NCT00642941|27030547|P6|Overall Study|Physician Decision|0
7776232|NCT00642941|27030548|P5|Overall Study|Physician Decision|0
7776233|NCT00642941|27030549|P4|Overall Study|Physician Decision|0
7776234|NCT00642941|27030550|P3|Overall Study|Physician Decision|0
7776235|NCT00642941|27030551|P2|Overall Study|Physician Decision|1
7776236|NCT00642941|27030552|P1|Overall Study|Physician Decision|3
7776237|NCT00642902|27030690|P4|Overall Study|Other|4
7776238|NCT00642902|27030691|P3|Overall Study|Other|1
7776239|NCT00642902|27030692|P2|Overall Study|Other|5
7776240|NCT00642902|27030693|P1|Overall Study|Other|1
7776241|NCT00642902|27030690|P4|Overall Study|Randomized, but not treated|0
7776242|NCT00642902|27030691|P3|Overall Study|Randomized, but not treated|1
7776243|NCT00642902|27030692|P2|Overall Study|Randomized, but not treated|0
7776244|NCT00642902|27030693|P1|Overall Study|Randomized, but not treated|0
7776245|NCT00642902|27030690|P4|Overall Study|Premature termination of clinical trial|35
7776246|NCT00642902|27030691|P3|Overall Study|Premature termination of clinical trial|35
7776247|NCT00642902|27030692|P2|Overall Study|Premature termination of clinical trial|32
7776248|NCT00642902|27030693|P1|Overall Study|Premature termination of clinical trial|37
7776249|NCT00642902|27030690|P4|Overall Study|Death|0
7776250|NCT00642902|27030691|P3|Overall Study|Death|0
7776251|NCT00642902|27030692|P2|Overall Study|Death|0
7776252|NCT00642902|27030693|P1|Overall Study|Death|1
7776253|NCT00642902|27030690|P4|Overall Study|Lack of Efficacy|0
7776254|NCT00642902|27030691|P3|Overall Study|Lack of Efficacy|3
7776255|NCT00642902|27030692|P2|Overall Study|Lack of Efficacy|3
7776256|NCT00642902|27030693|P1|Overall Study|Lack of Efficacy|0
7776257|NCT00642902|27030690|P4|Overall Study|Lost to Follow-up|0
7776258|NCT00642902|27030691|P3|Overall Study|Lost to Follow-up|0
7776259|NCT00642902|27030692|P2|Overall Study|Lost to Follow-up|1
7776260|NCT00642902|27030693|P1|Overall Study|Lost to Follow-up|1
7776261|NCT00642902|27030690|P4|Overall Study|Adverse Event|1
7776262|NCT00642902|27030691|P3|Overall Study|Adverse Event|3
7776263|NCT00642902|27030692|P2|Overall Study|Adverse Event|1
7776264|NCT00642902|27030693|P1|Overall Study|Adverse Event|0
7776265|NCT00642850|27030715|P1|Overall Study|Other reasons|7
7776266|NCT00642850|27030715|P1|Overall Study|Blood transfusion|6
7776267|NCT00642850|27030715|P1|Overall Study|Kidney transplantation|8
7776268|NCT00642850|27030715|P1|Overall Study|Protocol Violation|2
7776269|NCT00642850|27030715|P1|Overall Study|Lack of Efficacy|1
7776270|NCT00642850|27030715|P1|Overall Study|Adverse Event|2
7776271|NCT00642850|27030715|P1|Overall Study|Death|7
7776272|NCT00642811|27030731|P6|Overall Study|Other|0
7776273|NCT00642811|27030732|P5|Overall Study|Other|0
7776274|NCT00642811|27030733|P4|Overall Study|Other|1
7776275|NCT00642811|27030734|P3|Overall Study|Other|0
7776276|NCT00642811|27030735|P2|Overall Study|Other|1
7776277|NCT00642811|27030736|P1|Overall Study|Other|0
7776278|NCT00642811|27030731|P6|Overall Study|Severe Non-compliance to protocol|0
7776279|NCT00642811|27030732|P5|Overall Study|Severe Non-compliance to protocol|0
7776280|NCT00642811|27030733|P4|Overall Study|Severe Non-compliance to protocol|0
7776281|NCT00642811|27030734|P3|Overall Study|Severe Non-compliance to protocol|0
7776282|NCT00642811|27030735|P2|Overall Study|Severe Non-compliance to protocol|0
7776283|NCT00642811|27030736|P1|Overall Study|Severe Non-compliance to protocol|1
7776284|NCT00642811|27030731|P6|Overall Study|Developement of discontinuation criteria|0
7776285|NCT00642811|27030732|P5|Overall Study|Developement of discontinuation criteria|1
7776286|NCT00642811|27030733|P4|Overall Study|Developement of discontinuation criteria|0
7776287|NCT00642811|27030734|P3|Overall Study|Developement of discontinuation criteria|0
7776288|NCT00642811|27030735|P2|Overall Study|Developement of discontinuation criteria|0
7776289|NCT00642811|27030736|P1|Overall Study|Developement of discontinuation criteria|0
7776290|NCT00642811|27030731|P6|Overall Study|Adverse Event|1
7776291|NCT00642811|27030732|P5|Overall Study|Adverse Event|0
7776292|NCT00642811|27030733|P4|Overall Study|Adverse Event|0
7776293|NCT00642811|27030734|P3|Overall Study|Adverse Event|0
7776294|NCT00642811|27030735|P2|Overall Study|Adverse Event|3
7776295|NCT00642811|27030736|P1|Overall Study|Adverse Event|2
7776296|NCT00642772|27030758|P1|Overall Study|Withdrawal by Subject|7
7776297|NCT00642772|27030758|P1|Overall Study|Lost to Follow-up|3
7776298|NCT00642759|27030762|P1|Overall Study|Protocol Violation|1
7776299|NCT00642746|27030771|P2|Overall Study|Patient unevaluable|0
7776300|NCT00642746|27030772|P1|Overall Study|Patient unevaluable|1
7776301|NCT00642707|27030786|P4|Overall Study|Withdrawal by Subject|0
7776302|NCT00642707|27030787|P3|Overall Study|Withdrawal by Subject|0
7776303|NCT00642707|27030788|P2|Overall Study|Withdrawal by Subject|0
7776304|NCT00642707|27030789|P1|Overall Study|Withdrawal by Subject|1
7776305|NCT00642707|27030786|P4|Overall Study|Adverse Event|2
7776306|NCT00642707|27030787|P3|Overall Study|Adverse Event|0
7776307|NCT00642707|27030788|P2|Overall Study|Adverse Event|0
7776308|NCT00642707|27030789|P1|Overall Study|Adverse Event|0
7776309|NCT00642668|27030824|P1|Overall Study|Blood Transfusion|2
7776310|NCT00642668|27030824|P1|Overall Study|Dialysis Initiation|5
7776311|NCT00642668|27030824|P1|Overall Study|Failure to Return|1
7776312|NCT00642668|27030824|P1|Overall Study|Insufficient Therapeutic Response|1
7776313|NCT00642668|27030824|P1|Overall Study|Death|2
7776314|NCT00642668|27030824|P1|Overall Study|Adverse Event|2
7776315|NCT00642668|27030824|P1|Overall Study|Lost to Follow-up|1
7776316|NCT00642642|27030832|P1|Treatment & Follow Up|Lost to Follow-up|10
7776317|NCT00642642|27030832|P1|Treatment & Follow Up|Withdrawal by Subject|5
7776318|NCT00642642|27030832|P1|Treatment & Follow Up|Adverse Event|2
7776319|NCT00642616|27030849|P4|Overall Study|Physician Decision|1
7776320|NCT00642616|27030850|P3|Overall Study|Physician Decision|1
7776321|NCT00642616|27030851|P2|Overall Study|Physician Decision|0
7776322|NCT00642616|27030852|P1|Overall Study|Physician Decision|0
7776323|NCT00642616|27030849|P4|Overall Study|Protocol Violation|0
7776324|NCT00642616|27030850|P3|Overall Study|Protocol Violation|2
7776325|NCT00642616|27030851|P2|Overall Study|Protocol Violation|0
7776326|NCT00642616|27030852|P1|Overall Study|Protocol Violation|0
7776327|NCT00642616|27030849|P4|Overall Study|Withdrawal by Subject|1
7776328|NCT00642616|27030850|P3|Overall Study|Withdrawal by Subject|1
7776329|NCT00642616|27030851|P2|Overall Study|Withdrawal by Subject|1
7776330|NCT00642616|27030852|P1|Overall Study|Withdrawal by Subject|0
7776331|NCT00642616|27030849|P4|Overall Study|Study Terminated by Sponsor|5
7776332|NCT00642616|27030850|P3|Overall Study|Study Terminated by Sponsor|4
7776333|NCT00642616|27030851|P2|Overall Study|Study Terminated by Sponsor|6
7776334|NCT00642616|27030852|P1|Overall Study|Study Terminated by Sponsor|7
7776335|NCT00642616|27030849|P4|Overall Study|Adverse Event|0
7776336|NCT00642616|27030850|P3|Overall Study|Adverse Event|1
7776337|NCT00642616|27030851|P2|Overall Study|Adverse Event|0
7776338|NCT00642616|27030852|P1|Overall Study|Adverse Event|2
7776339|NCT00642473|27030885|P2|Overall Study|Other|2
7776340|NCT00642473|27030886|P1|Overall Study|Other|2
7776341|NCT00642473|27030885|P2|Overall Study|Progression or death|4
7776342|NCT00642473|27030886|P1|Overall Study|Progression or death|2
7776343|NCT00642473|27030885|P2|Overall Study|Withdrawal by Subject|5
7776344|NCT00642473|27030886|P1|Overall Study|Withdrawal by Subject|0
7776345|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
7776346|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
7776347|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
7776348|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
7776349|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
7776350|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
7776351|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
7776352|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
7776353|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
7776354|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
7776355|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
7776356|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
7776357|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Death|3
7776358|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Death|0
7776359|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Death|0
7776360|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Death|0
7776361|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Death|0
7776362|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Death|0
7776363|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Other|2
7776364|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Other|2
7776365|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Other|0
7776366|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Other|0
7776367|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Other|0
7776368|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Other|0
7776369|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
7776370|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
7776371|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7776372|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7776373|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7776374|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7776375|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
7776376|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
7776377|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7776378|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7776379|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7776380|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7776381|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
7776382|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
7776383|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7776384|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7776385|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7776386|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7776387|NCT00642460|27030900|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
7776388|NCT00642460|27030901|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
7776389|NCT00642460|27030902|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
7776390|NCT00642460|27030903|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
7776391|NCT00642460|27030904|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
7776392|NCT00642460|27030905|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
7776393|NCT00642460|27030900|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
7776394|NCT00642460|27030901|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
7776395|NCT00642460|27030902|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
7776396|NCT00642460|27030903|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
7776397|NCT00642460|27030904|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
7776398|NCT00642460|27030905|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
7776399|NCT00642460|27030900|P6|Part II: Open-Label Up to Week 92|Failure to return|0
7776400|NCT00642460|27030901|P5|Part II: Open-Label Up to Week 92|Failure to return|0
7776401|NCT00642460|27030902|P4|Part II: Open-Label Up to Week 92|Failure to return|0
7776402|NCT00642460|27030903|P3|Part II: Open-Label Up to Week 92|Failure to return|0
7776403|NCT00642460|27030904|P2|Part II: Open-Label Up to Week 92|Failure to return|1
7776404|NCT00642460|27030905|P1|Part II: Open-Label Up to Week 92|Failure to return|0
7776405|NCT00642460|27030900|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
7776406|NCT00642460|27030901|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
7776407|NCT00642460|27030902|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
7776408|NCT00642460|27030903|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
7776409|NCT00642460|27030904|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
7776410|NCT00642460|27030905|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
7776411|NCT00642460|27030900|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7776412|NCT00642460|27030901|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7776413|NCT00642460|27030902|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7776414|NCT00642460|27030903|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7776415|NCT00642460|27030904|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
7776416|NCT00642460|27030905|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
7776417|NCT00642460|27030900|P6|Part II: Open-Label Up to Week 92|Death|0
7776418|NCT00642460|27030901|P5|Part II: Open-Label Up to Week 92|Death|0
7776419|NCT00642460|27030902|P4|Part II: Open-Label Up to Week 92|Death|2
7776420|NCT00642460|27030903|P3|Part II: Open-Label Up to Week 92|Death|0
7776421|NCT00642460|27030904|P2|Part II: Open-Label Up to Week 92|Death|1
7776422|NCT00642460|27030905|P1|Part II: Open-Label Up to Week 92|Death|0
7776423|NCT00642460|27030900|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
7776424|NCT00642460|27030901|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
7776425|NCT00642460|27030902|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
7776426|NCT00642460|27030903|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
7776427|NCT00642460|27030904|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
7776428|NCT00642460|27030905|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
7776429|NCT00642460|27030900|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
7776430|NCT00642460|27030901|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
7776431|NCT00642460|27030902|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
7776432|NCT00642460|27030903|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
7776433|NCT00642460|27030904|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
7776434|NCT00642460|27030905|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
7776435|NCT00642460|27030900|P6|Part I: 12 Week Double-Blind|Adverse Event|0
7776436|NCT00642460|27030901|P5|Part I: 12 Week Double-Blind|Adverse Event|0
7776437|NCT00642460|27030902|P4|Part I: 12 Week Double-Blind|Adverse Event|0
7776438|NCT00642460|27030903|P3|Part I: 12 Week Double-Blind|Adverse Event|1
7776439|NCT00642460|27030904|P2|Part I: 12 Week Double-Blind|Adverse Event|1
7776440|NCT00642460|27030905|P1|Part I: 12 Week Double-Blind|Adverse Event|0
7776441|NCT00642369|27030980|P2|Overall Study|Lack of Efficacy|2
7776442|NCT00642369|27030981|P1|Overall Study|Lack of Efficacy|2
7776443|NCT00642369|27030980|P2|Overall Study|misdiagnosis|1
7776444|NCT00642369|27030981|P1|Overall Study|misdiagnosis|0
7776445|NCT00642369|27030980|P2|Overall Study|Withdrawal by Subject|0
7776446|NCT00642369|27030981|P1|Overall Study|Withdrawal by Subject|1
7776447|NCT00642369|27030980|P2|Overall Study|Adverse Event|3
7776448|NCT00642369|27030981|P1|Overall Study|Adverse Event|2
7776449|NCT00642356|27030991|P2|Overall Study|Lack of Efficacy|0
7776450|NCT00642356|27030992|P1|Overall Study|Lack of Efficacy|1
7776451|NCT00642356|27030991|P2|Overall Study|Protocol Violation|3
7776452|NCT00642356|27030992|P1|Overall Study|Protocol Violation|0
7776453|NCT00642356|27030991|P2|Overall Study|Adverse Event|0
7776454|NCT00642356|27030992|P1|Overall Study|Adverse Event|1
7776455|NCT00642304|27031000|P1|Overall Study|Transplantation|1
7776456|NCT00642304|27031000|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
7776457|NCT00642304|27031000|P1|Overall Study|Blood transfusion|2
7776458|NCT00642304|27031000|P1|Overall Study|Death|1
7776459|NCT00642304|27031000|P1|Overall Study|Adverse Event|1
7776460|NCT00642278|27031016|P7|Overall Study|Other|0
7776461|NCT00642278|27031017|P6|Overall Study|Other|1
7776462|NCT00642278|27031018|P5|Overall Study|Other|0
7776463|NCT00642278|27031019|P4|Overall Study|Other|1
7776464|NCT00642278|27031020|P3|Overall Study|Other|0
7776465|NCT00642278|27031021|P2|Overall Study|Other|1
7776466|NCT00642278|27031022|P1|Overall Study|Other|2
7776467|NCT00642278|27031016|P7|Overall Study|Noncompliance with study drug regimen|0
7776468|NCT00642278|27031017|P6|Overall Study|Noncompliance with study drug regimen|0
7776469|NCT00642278|27031018|P5|Overall Study|Noncompliance with study drug regimen|0
7776470|NCT00642278|27031019|P4|Overall Study|Noncompliance with study drug regimen|1
7776471|NCT00642278|27031020|P3|Overall Study|Noncompliance with study drug regimen|0
7776472|NCT00642278|27031021|P2|Overall Study|Noncompliance with study drug regimen|0
7776473|NCT00642278|27031022|P1|Overall Study|Noncompliance with study drug regimen|0
7776474|NCT00642278|27031016|P7|Overall Study|Withdrawal by Subject|2
7776475|NCT00642278|27031017|P6|Overall Study|Withdrawal by Subject|2
7776476|NCT00642278|27031018|P5|Overall Study|Withdrawal by Subject|6
7776477|NCT00642278|27031019|P4|Overall Study|Withdrawal by Subject|3
7776478|NCT00642278|27031020|P3|Overall Study|Withdrawal by Subject|1
7776479|NCT00642278|27031021|P2|Overall Study|Withdrawal by Subject|1
7776480|NCT00642278|27031022|P1|Overall Study|Withdrawal by Subject|1
7776481|NCT00642278|27031016|P7|Overall Study|Protocol Violation|2
7776482|NCT00642278|27031017|P6|Overall Study|Protocol Violation|1
7776483|NCT00642278|27031018|P5|Overall Study|Protocol Violation|0
7776484|NCT00642278|27031019|P4|Overall Study|Protocol Violation|1
7776485|NCT00642278|27031020|P3|Overall Study|Protocol Violation|1
7776486|NCT00642278|27031021|P2|Overall Study|Protocol Violation|0
7776487|NCT00642278|27031022|P1|Overall Study|Protocol Violation|0
7776488|NCT00642278|27031016|P7|Overall Study|Physician Decision|0
7776489|NCT00642278|27031017|P6|Overall Study|Physician Decision|0
7776490|NCT00642278|27031018|P5|Overall Study|Physician Decision|0
7776491|NCT00642278|27031019|P4|Overall Study|Physician Decision|1
7776492|NCT00642278|27031020|P3|Overall Study|Physician Decision|0
7776493|NCT00642278|27031021|P2|Overall Study|Physician Decision|0
7776494|NCT00642278|27031022|P1|Overall Study|Physician Decision|0
7776495|NCT00642278|27031016|P7|Overall Study|Lost to Follow-up|1
7776496|NCT00642278|27031017|P6|Overall Study|Lost to Follow-up|1
7776497|NCT00642278|27031018|P5|Overall Study|Lost to Follow-up|0
7776498|NCT00642278|27031019|P4|Overall Study|Lost to Follow-up|1
7776499|NCT00642278|27031020|P3|Overall Study|Lost to Follow-up|0
7776500|NCT00642278|27031021|P2|Overall Study|Lost to Follow-up|1
7776501|NCT00642278|27031022|P1|Overall Study|Lost to Follow-up|5
7776502|NCT00642278|27031016|P7|Overall Study|Lack of Efficacy|0
7776503|NCT00642278|27031017|P6|Overall Study|Lack of Efficacy|0
7776504|NCT00642278|27031018|P5|Overall Study|Lack of Efficacy|0
7776505|NCT00642278|27031019|P4|Overall Study|Lack of Efficacy|0
7776506|NCT00642278|27031020|P3|Overall Study|Lack of Efficacy|0
7776507|NCT00642278|27031021|P2|Overall Study|Lack of Efficacy|1
7776508|NCT00642278|27031022|P1|Overall Study|Lack of Efficacy|0
7776509|NCT00642278|27031016|P7|Overall Study|Adverse Event|0
7776510|NCT00642278|27031017|P6|Overall Study|Adverse Event|2
7776511|NCT00642278|27031018|P5|Overall Study|Adverse Event|2
7776512|NCT00642278|27031019|P4|Overall Study|Adverse Event|1
7776513|NCT00642278|27031020|P3|Overall Study|Adverse Event|3
7776514|NCT00642278|27031021|P2|Overall Study|Adverse Event|1
7776515|NCT00642278|27031022|P1|Overall Study|Adverse Event|2
7776516|NCT00642174|27031075|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
7776517|NCT00642174|27031076|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
7776518|NCT00642018|27031092|P2|Overall Study|Entry Criteria Not Met|1
7776519|NCT00642018|27031093|P1|Overall Study|Entry Criteria Not Met|0
7776520|NCT00642018|27031092|P2|Overall Study|Death|3
7776521|NCT00642018|27031093|P1|Overall Study|Death|0
7776522|NCT00642018|27031092|P2|Overall Study|Protocol Violation|1
7776523|NCT00642018|27031093|P1|Overall Study|Protocol Violation|0
7776524|NCT00642018|27031092|P2|Overall Study|Physician Decision|10
7776525|NCT00642018|27031093|P1|Overall Study|Physician Decision|0
7776526|NCT00642018|27031092|P2|Overall Study|Progressive Disease|18
7776527|NCT00642018|27031093|P1|Overall Study|Progressive Disease|13
7776528|NCT00642018|27031092|P2|Overall Study|Withdrawal by Subject|10
7776529|NCT00642018|27031093|P1|Overall Study|Withdrawal by Subject|4
7776530|NCT00642018|27031092|P2|Overall Study|Adverse Event|36
7776531|NCT00642018|27031093|P1|Overall Study|Adverse Event|11
7776532|NCT00641719|27031160|P2|Overall Study|Reason Not Specified|2
7776533|NCT00641719|27031161|P1|Overall Study|Reason Not Specified|1
7776534|NCT00641719|27031160|P2|Overall Study|Withdrawal by Subject|4
7776535|NCT00641719|27031161|P1|Overall Study|Withdrawal by Subject|4
7776536|NCT00641719|27031160|P2|Overall Study|Adverse Event|29
7776537|NCT00641719|27031161|P1|Overall Study|Adverse Event|24
7776538|NCT00641719|27031160|P2|Overall Study|Lack of Efficacy|2
7776539|NCT00641719|27031161|P1|Overall Study|Lack of Efficacy|1
7776540|NCT00641706|27031185|P2|Overall Study|Lead Investigator Decision|1
7776541|NCT00641706|27031186|P1|Overall Study|Lead Investigator Decision|0
7776542|NCT00641706|27031185|P2|Overall Study|Clinical Decline|0
7776543|NCT00641706|27031186|P1|Overall Study|Clinical Decline|1
7776544|NCT00641706|27031185|P2|Overall Study|Withdrawal by Subject|1
7776545|NCT00641706|27031186|P1|Overall Study|Withdrawal by Subject|6
7776546|NCT00641706|27031185|P2|Overall Study|Adverse Event|1
7776547|NCT00641706|27031186|P1|Overall Study|Adverse Event|2
7776548|NCT00641667|27031198|P1|Overall Study|Worsening of underlying disease|3
7776549|NCT00641667|27031198|P1|Overall Study|Physician Decision|1
7776550|NCT00641667|27031198|P1|Overall Study|Adverse Event|1
7776551|NCT00641667|27031198|P1|Overall Study|Withdrawal by Subject|1
7776552|NCT00641537|27031226|P8|24-Week Supplemental Follow-up Period|Other|1
7776553|NCT00641537|27031227|P7|24-Week Supplemental Follow-up Period|Other|1
7776554|NCT00641537|27031228|P6|24-Week Supplemental Follow-up Period|Other|0
7776555|NCT00641537|27031229|P5|24-Week Supplemental Follow-up Period|Other|3
7776556|NCT00641537|27031230|P4|24-Week Supplemental Follow-up Period|Other|1
7776557|NCT00641537|27031231|P3|24-Week Supplemental Follow-up Period|Other|2
7776558|NCT00641537|27031232|P2|24-Week Supplemental Follow-up Period|Other|2
7776559|NCT00641537|27031233|P1|24-Week Supplemental Follow-up Period|Other|0
7776560|NCT00641537|27031226|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7776561|NCT00641537|27031227|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7776562|NCT00641537|27031228|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7776563|NCT00641537|27031229|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
7776564|NCT00641537|27031230|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
7776565|NCT00641537|27031231|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7776566|NCT00641537|27031232|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7776567|NCT00641537|27031233|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7776568|NCT00641537|27031226|P8|96-week Period|Other|6
7776569|NCT00641537|27031227|P7|96-week Period|Other|4
7776570|NCT00641537|27031228|P6|96-week Period|Other|6
7776571|NCT00641537|27031229|P5|96-week Period|Other|11
7776572|NCT00641537|27031230|P4|96-week Period|Other|9
7776573|NCT00641537|27031231|P3|96-week Period|Other|14
7776574|NCT00641537|27031232|P2|96-week Period|Other|7
7776575|NCT00641537|27031233|P1|96-week Period|Other|4
7776576|NCT00641537|27031226|P8|96-week Period|Death|0
7776577|NCT00641537|27031227|P7|96-week Period|Death|0
7776578|NCT00641537|27031228|P6|96-week Period|Death|0
7776579|NCT00641537|27031229|P5|96-week Period|Death|0
7776580|NCT00641537|27031230|P4|96-week Period|Death|0
7776581|NCT00641537|27031231|P3|96-week Period|Death|1
7776582|NCT00641537|27031232|P2|96-week Period|Death|0
7776583|NCT00641537|27031233|P1|96-week Period|Death|2
7776584|NCT00641537|27031226|P8|96-week Period|Protocol Violation|0
7776585|NCT00641537|27031227|P7|96-week Period|Protocol Violation|0
7776586|NCT00641537|27031228|P6|96-week Period|Protocol Violation|1
7776587|NCT00641537|27031229|P5|96-week Period|Protocol Violation|0
7776588|NCT00641537|27031230|P4|96-week Period|Protocol Violation|1
7776589|NCT00641537|27031231|P3|96-week Period|Protocol Violation|0
7776590|NCT00641537|27031232|P2|96-week Period|Protocol Violation|1
7776591|NCT00641537|27031233|P1|96-week Period|Protocol Violation|0
7776592|NCT00641537|27031226|P8|96-week Period|Lost to Follow-up|0
7776593|NCT00641537|27031227|P7|96-week Period|Lost to Follow-up|1
7776594|NCT00641537|27031228|P6|96-week Period|Lost to Follow-up|0
7776595|NCT00641537|27031229|P5|96-week Period|Lost to Follow-up|4
7776596|NCT00641537|27031230|P4|96-week Period|Lost to Follow-up|2
7776597|NCT00641537|27031231|P3|96-week Period|Lost to Follow-up|2
7776598|NCT00641537|27031232|P2|96-week Period|Lost to Follow-up|1
7776599|NCT00641537|27031233|P1|96-week Period|Lost to Follow-up|3
7776600|NCT00641537|27031226|P8|96-week Period|Adverse Event|0
7776601|NCT00641537|27031227|P7|96-week Period|Adverse Event|0
7776602|NCT00641537|27031228|P6|96-week Period|Adverse Event|0
7776603|NCT00641537|27031229|P5|96-week Period|Adverse Event|2
7776604|NCT00641537|27031230|P4|96-week Period|Adverse Event|0
7776605|NCT00641537|27031231|P3|96-week Period|Adverse Event|3
7776606|NCT00641537|27031232|P2|96-week Period|Adverse Event|1
7776607|NCT00641537|27031233|P1|96-week Period|Adverse Event|0
7776608|NCT00641147|27031321|P2|Completed 16 Months.|Lost to Follow-up|0
7776609|NCT00641147|27031322|P1|Completed 16 Months.|Lost to Follow-up|1
7776610|NCT00641147|27031321|P2|Completed 16 Months.|Physician Decision|0
7776611|NCT00641147|27031322|P1|Completed 16 Months.|Physician Decision|1
7776612|NCT00641147|27031321|P2|Completed 12 Months.|Withdrawal by Subject|1
7776613|NCT00641147|27031322|P1|Completed 12 Months.|Withdrawal by Subject|0
7776614|NCT00641147|27031321|P2|Completed 12 Months.|Physician Decision|1
7776615|NCT00641147|27031322|P1|Completed 12 Months.|Physician Decision|1
7776616|NCT00641147|27031321|P2|Completed 8 Months.|Withdrawal by Subject|1
7776617|NCT00641147|27031322|P1|Completed 8 Months.|Withdrawal by Subject|0
7776618|NCT00641147|27031321|P2|Completed 8 Months.|non compliance|0
7776619|NCT00641147|27031322|P1|Completed 8 Months.|non compliance|1
7776620|NCT00641147|27031321|P2|Completed 8 Months.|Physician Decision|1
7776621|NCT00641147|27031322|P1|Completed 8 Months.|Physician Decision|2
7776622|NCT00641147|27031321|P2|Completed 4 Months.|Adverse Event|0
7776623|NCT00641147|27031322|P1|Completed 4 Months.|Adverse Event|1
7776624|NCT00641147|27031321|P2|Completed 4 Months.|Physician Decision|0
7776625|NCT00641147|27031322|P1|Completed 4 Months.|Physician Decision|1
7776626|NCT00641056|27031375|P2|Overall Study|Sponsor Decision|2
7776627|NCT00641056|27031376|P1|Overall Study|Sponsor Decision|1
7776628|NCT00641056|27031375|P2|Overall Study|Subject Decision|19
7776629|NCT00641056|27031376|P1|Overall Study|Subject Decision|6
7776630|NCT00641056|27031375|P2|Overall Study|Entry Criteria Not Met|0
7776631|NCT00641056|27031376|P1|Overall Study|Entry Criteria Not Met|3
7776632|NCT00641056|27031375|P2|Overall Study|Protocol Violation|0
7776633|NCT00641056|27031376|P1|Overall Study|Protocol Violation|2
7776634|NCT00641056|27031375|P2|Overall Study|Physician Decision|1
7776635|NCT00641056|27031376|P1|Overall Study|Physician Decision|3
7776636|NCT00641056|27031375|P2|Overall Study|Lost to Follow-up|1
7776637|NCT00641056|27031376|P1|Overall Study|Lost to Follow-up|2
7776638|NCT00641056|27031375|P2|Overall Study|Adverse Event|2
7776639|NCT00641056|27031376|P1|Overall Study|Adverse Event|12
7776640|NCT00641043|27031404|P2|Overall Study|Other incl. lack of efficacy|2
7776641|NCT00641043|27031405|P1|Overall Study|Other incl. lack of efficacy|4
7776642|NCT00641043|27031404|P2|Overall Study|Withdrawal by Subject|4
7776643|NCT00641043|27031405|P1|Overall Study|Withdrawal by Subject|4
7776644|NCT00641043|27031404|P2|Overall Study|Lost to Follow-up|2
7776645|NCT00641043|27031405|P1|Overall Study|Lost to Follow-up|3
7776646|NCT00641043|27031404|P2|Overall Study|Protocol Violation|3
7776647|NCT00641043|27031405|P1|Overall Study|Protocol Violation|2
7776648|NCT00641043|27031404|P2|Overall Study|Adverse Event|4
7776649|NCT00641043|27031405|P1|Overall Study|Adverse Event|6
7776650|NCT00640926|27031442|P3|Overall Study|Withdrawal by Subject|1
7776651|NCT00640926|27031443|P2|Overall Study|Withdrawal by Subject|0
7776652|NCT00640926|27031444|P1|Overall Study|Withdrawal by Subject|1
7776653|NCT00640926|27031442|P3|Overall Study|Lost to Follow-up|2
7776654|NCT00640926|27031443|P2|Overall Study|Lost to Follow-up|1
7776655|NCT00640926|27031444|P1|Overall Study|Lost to Follow-up|3
7776656|NCT00640926|27031442|P3|Overall Study|Protocol Violation|2
7776657|NCT00640926|27031443|P2|Overall Study|Protocol Violation|0
7776658|NCT00640926|27031444|P1|Overall Study|Protocol Violation|2
7776659|NCT00640926|27031442|P3|Overall Study|Lack of Efficacy|1
7776660|NCT00640926|27031443|P2|Overall Study|Lack of Efficacy|2
7776661|NCT00640926|27031444|P1|Overall Study|Lack of Efficacy|0
7776662|NCT00640926|27031442|P3|Overall Study|Adverse Event|2
7776663|NCT00640926|27031443|P2|Overall Study|Adverse Event|3
7776664|NCT00640926|27031444|P1|Overall Study|Adverse Event|2
7776665|NCT00640835|27031457|P2|Overall Study|Other Reason|4
7776666|NCT00640835|27031458|P1|Overall Study|Other Reason|19
7776667|NCT00640835|27031457|P2|Overall Study|Lost to Follow-up|13
7776668|NCT00640835|27031458|P1|Overall Study|Lost to Follow-up|17
7776669|NCT00640835|27031457|P2|Overall Study|Protocol Violation|2
7776670|NCT00640835|27031458|P1|Overall Study|Protocol Violation|2
7776671|NCT00640835|27031457|P2|Overall Study|Sponsor's Decision|7
7776672|NCT00640835|27031458|P1|Overall Study|Sponsor's Decision|11
7776673|NCT00640835|27031457|P2|Overall Study|Physician Decision|14
7776674|NCT00640835|27031458|P1|Overall Study|Physician Decision|10
7776675|NCT00640835|27031457|P2|Overall Study|Withdrawal by Subject|14
7776676|NCT00640835|27031458|P1|Overall Study|Withdrawal by Subject|12
7776677|NCT00640835|27031457|P2|Overall Study|Adverse Event|3
7776678|NCT00640835|27031458|P1|Overall Study|Adverse Event|5
7776679|NCT00640614|27031522|P2|Overall Study|Lost to Follow-up|0
7776680|NCT00640614|27031523|P1|Overall Study|Lost to Follow-up|1
7776681|NCT00640601|27031565|P1|Overall Study|treatment naive, combination therapy|10
7776682|NCT00640601|27031565|P1|Overall Study|Physician Decision|8
7776683|NCT00640601|27031565|P1|Overall Study|Lost to Follow-up|9
7776684|NCT00640601|27031565|P1|Overall Study|Lack of Efficacy|16
7776685|NCT00640601|27031565|P1|Overall Study|Protocol Violation|6
7776686|NCT00640601|27031565|P1|Overall Study|Withdrawal by Subject|20
7776687|NCT00640601|27031565|P1|Overall Study|Adverse Event|43
7776688|NCT00640562|27031581|P2|Overall Study|Glycosylated Hemoglobin >8|0
7776689|NCT00640562|27031582|P1|Overall Study|Glycosylated Hemoglobin >8|1
7776690|NCT00640562|27031581|P2|Overall Study|Low study drug dose|1
7776691|NCT00640562|27031582|P1|Overall Study|Low study drug dose|0
7776692|NCT00640562|27031581|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
7776693|NCT00640562|27031582|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
7776694|NCT00640562|27031581|P2|Overall Study|Known risperidone intolerance|1
7776695|NCT00640562|27031582|P1|Overall Study|Known risperidone intolerance|0
7776696|NCT00640562|27031581|P2|Overall Study|Withdrawal by Subject|10
7776697|NCT00640562|27031582|P1|Overall Study|Withdrawal by Subject|6
7776698|NCT00640562|27031581|P2|Overall Study|Protocol Violation|4
7776699|NCT00640562|27031582|P1|Overall Study|Protocol Violation|2
7776700|NCT00640562|27031581|P2|Overall Study|Lack of Efficacy|4
7776701|NCT00640562|27031582|P1|Overall Study|Lack of Efficacy|1
7776702|NCT00640562|27031581|P2|Overall Study|Adverse Event|5
7776703|NCT00640562|27031582|P1|Overall Study|Adverse Event|8
7776704|NCT00640510|27031610|P2|Overall Study|Physician Decision|1
7776705|NCT00640510|27031611|P1|Overall Study|Physician Decision|0
7776706|NCT00640510|27031610|P2|Overall Study|Protocol Violation|0
7776707|NCT00640510|27031611|P1|Overall Study|Protocol Violation|1
7776708|NCT00640510|27031610|P2|Overall Study|Lack of Efficacy|1
7776709|NCT00640510|27031611|P1|Overall Study|Lack of Efficacy|0
7776710|NCT00640393|27031623|P3|Part 2|Adverse Event|0
7776711|NCT00640393|27031624|P2|Part 2|Adverse Event|1
7776712|NCT00640393|27031625|P1|Part 2|Adverse Event|0
7776713|NCT00640393|27031623|P3|Part 2|Non-adherence|0
7776714|NCT00640393|27031624|P2|Part 2|Non-adherence|1
7776715|NCT00640393|27031625|P1|Part 2|Non-adherence|0
7776716|NCT00640393|27031623|P3|Part 2|Withdrawal by Subject|1
7776717|NCT00640393|27031624|P2|Part 2|Withdrawal by Subject|6
7776718|NCT00640393|27031625|P1|Part 2|Withdrawal by Subject|0
7776719|NCT00640393|27031623|P3|Part 2|Lost to Follow-up|2
7776720|NCT00640393|27031624|P2|Part 2|Lost to Follow-up|2
7776721|NCT00640393|27031625|P1|Part 2|Lost to Follow-up|0
7776722|NCT00640393|27031623|P3|Randomization|Never randomized by site|0
7776723|NCT00640393|27031624|P2|Randomization|Never randomized by site|0
7776724|NCT00640393|27031625|P1|Randomization|Never randomized by site|2
7776725|NCT00640393|27031623|P3|Randomization|Withdrawn per protocol|0
7776726|NCT00640393|27031624|P2|Randomization|Withdrawn per protocol|0
7776727|NCT00640393|27031625|P1|Randomization|Withdrawn per protocol|17
7776728|NCT00640393|27031623|P3|Part 1|Withdrawal by Subject|0
7776729|NCT00640393|27031624|P2|Part 1|Withdrawal by Subject|0
7776730|NCT00640393|27031625|P1|Part 1|Withdrawal by Subject|3
7776731|NCT00640393|27031623|P3|Part 1|Lost to Follow-up|0
7776732|NCT00640393|27031624|P2|Part 1|Lost to Follow-up|0
7776733|NCT00640393|27031625|P1|Part 1|Lost to Follow-up|2
7776734|NCT00640341|27031690|P3|Overall Study|Adverse event and positive slit lamp|0
7776735|NCT00640341|27031691|P2|Overall Study|Adverse event and positive slit lamp|0
7776736|NCT00640341|27031692|P1|Overall Study|Adverse event and positive slit lamp|1
7776737|NCT00640341|27031690|P3|Overall Study|Ineligable at Baseline|2
7776738|NCT00640341|27031691|P2|Overall Study|Ineligable at Baseline|3
7776739|NCT00640341|27031692|P1|Overall Study|Ineligable at Baseline|5
7776740|NCT00640341|27031690|P3|Overall Study|Poor fit/Uncomfortable|0
7776741|NCT00640341|27031691|P2|Overall Study|Poor fit/Uncomfortable|0
7776742|NCT00640341|27031692|P1|Overall Study|Poor fit/Uncomfortable|4
7776743|NCT00640341|27031690|P3|Overall Study|Unacceptable Lens Movement|0
7776744|NCT00640341|27031691|P2|Overall Study|Unacceptable Lens Movement|0
7776745|NCT00640341|27031692|P1|Overall Study|Unacceptable Lens Movement|1
7776746|NCT00640341|27031690|P3|Overall Study|Withdrawal by Subject|1
7776747|NCT00640341|27031691|P2|Overall Study|Withdrawal by Subject|0
7776748|NCT00640341|27031692|P1|Overall Study|Withdrawal by Subject|4
7776749|NCT00640341|27031690|P3|Overall Study|Lost to Follow-up|0
7776750|NCT00640341|27031691|P2|Overall Study|Lost to Follow-up|0
7776751|NCT00640341|27031692|P1|Overall Study|Lost to Follow-up|2
7776752|NCT00640341|27031690|P3|Overall Study|Failure to Follow Subject Instructions|0
7776753|NCT00640341|27031691|P2|Overall Study|Failure to Follow Subject Instructions|0
7776754|NCT00640341|27031692|P1|Overall Study|Failure to Follow Subject Instructions|1
7776755|NCT00640341|27031690|P3|Overall Study|Inability to Maintain Wearing Schedule|0
7776756|NCT00640341|27031691|P2|Overall Study|Inability to Maintain Wearing Schedule|1
7776757|NCT00640341|27031692|P1|Overall Study|Inability to Maintain Wearing Schedule|1
7776758|NCT00640341|27031690|P3|Overall Study|Study Related Symptoms/Complaints|2
7776759|NCT00640341|27031691|P2|Overall Study|Study Related Symptoms/Complaints|1
7776760|NCT00640341|27031692|P1|Overall Study|Study Related Symptoms/Complaints|2
7776761|NCT00640341|27031690|P3|Overall Study|Positive Slit Lamp Findings|1
7776762|NCT00640341|27031691|P2|Overall Study|Positive Slit Lamp Findings|0
7776763|NCT00640341|27031692|P1|Overall Study|Positive Slit Lamp Findings|0
7776764|NCT00640341|27031690|P3|Overall Study|Adverse Event|1
7776765|NCT00640341|27031691|P2|Overall Study|Adverse Event|0
7776766|NCT00640341|27031692|P1|Overall Study|Adverse Event|0
7776767|NCT00640328|27031712|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7776768|NCT00640328|27031713|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7776769|NCT00640328|27031714|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
7776770|NCT00640328|27031715|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7776771|NCT00640328|27031716|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
7776772|NCT00640328|27031717|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7776773|NCT00640328|27031712|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7776774|NCT00640328|27031713|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7776775|NCT00640328|27031714|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7776776|NCT00640328|27031715|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
7776777|NCT00640328|27031716|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7776778|NCT00640328|27031717|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7776779|NCT00640328|27031712|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7776780|NCT00640328|27031713|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
7776781|NCT00640328|27031714|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7776782|NCT00640328|27031715|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7776783|NCT00640328|27031716|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7776784|NCT00640328|27031717|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7776785|NCT00640328|27031712|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
7776786|NCT00640328|27031713|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
7776787|NCT00640328|27031714|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
7776788|NCT00640328|27031715|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
7776789|NCT00640328|27031716|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
7776790|NCT00640328|27031717|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
7776791|NCT00640315|27031883|P2|Overall Study|Withdrawal by Subject|1
7776792|NCT00640315|27031884|P1|Overall Study|Withdrawal by Subject|0
7776793|NCT00640289|27032010|P1|Overall Study|Missing status|5
7776794|NCT00640289|27032010|P1|Overall Study|Transferred to another center|1
7776795|NCT00640289|27032010|P1|Overall Study|Data collected under different amendment|2
7776796|NCT00640289|27032010|P1|Overall Study|Lost to Follow-up|1
7776797|NCT00640289|27032010|P1|Overall Study|Withdrawal by Subject|1
7776798|NCT00640289|27032010|P1|Overall Study|Death|3
7776799|NCT00640224|27032122|P4|Overall Study|Headaches|0
7776800|NCT00640224|27032123|P3|Overall Study|Headaches|0
7776801|NCT00640224|27032124|P2|Overall Study|Headaches|1
7776802|NCT00640224|27032125|P1|Overall Study|Headaches|0
7776803|NCT00640224|27032122|P4|Overall Study|Withdrawal by Subject|0
7776804|NCT00640224|27032123|P3|Overall Study|Withdrawal by Subject|0
7776805|NCT00640224|27032124|P2|Overall Study|Withdrawal by Subject|0
7776806|NCT00640224|27032125|P1|Overall Study|Withdrawal by Subject|1
7776807|NCT00640224|27032122|P4|Overall Study|Lost to Follow-up|0
7776808|NCT00640224|27032123|P3|Overall Study|Lost to Follow-up|0
7776809|NCT00640224|27032124|P2|Overall Study|Lost to Follow-up|2
7776810|NCT00640224|27032125|P1|Overall Study|Lost to Follow-up|5
7776811|NCT00640146|27032225|P2|Overall Study|Randomized but not treated|3
7776812|NCT00640146|27032226|P1|Overall Study|Randomized but not treated|1
7776813|NCT00640146|27032225|P2|Overall Study|Withdrawal by Subject|1
7776814|NCT00640146|27032226|P1|Overall Study|Withdrawal by Subject|1
7776815|NCT00640146|27032225|P2|Overall Study|Lack of Efficacy|1
7776816|NCT00640146|27032226|P1|Overall Study|Lack of Efficacy|0
7776817|NCT00640146|27032225|P2|Overall Study|Lost to Follow-up|1
7776818|NCT00640146|27032226|P1|Overall Study|Lost to Follow-up|0
7776819|NCT00640146|27032225|P2|Overall Study|Adverse Event|0
7776820|NCT00640146|27032226|P1|Overall Study|Adverse Event|2
7776821|NCT00640133|27032238|P2|Open Label Phase (Month 4-12)|Adverse Event|0
7776822|NCT00640133|27032239|P1|Open Label Phase (Month 4-12)|Adverse Event|1
7776823|NCT00640133|27032238|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
7776824|NCT00640133|27032239|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
7776825|NCT00640133|27032238|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
7776826|NCT00640133|27032239|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
7776827|NCT00640042|27032259|P1|Enrollment|Did not receive study drug|83
7776828|NCT00640016|27032275|P4|Overall Study|Adverse Event|1
7776829|NCT00640016|27032276|P3|Overall Study|Adverse Event|0
7776830|NCT00640016|27032277|P2|Overall Study|Adverse Event|0
7776831|NCT00640016|27032278|P1|Overall Study|Adverse Event|0
7776832|NCT00640016|27032275|P4|Overall Study|Study termination|2
7776833|NCT00640016|27032276|P3|Overall Study|Study termination|3
7776834|NCT00640016|27032277|P2|Overall Study|Study termination|1
7776835|NCT00640016|27032278|P1|Overall Study|Study termination|2
7776836|NCT00640016|27032275|P4|Overall Study|Withdrawal by Subject|0
7776837|NCT00640016|27032276|P3|Overall Study|Withdrawal by Subject|0
7776838|NCT00640016|27032277|P2|Overall Study|Withdrawal by Subject|1
7776839|NCT00640016|27032278|P1|Overall Study|Withdrawal by Subject|0
7776840|NCT00639769|27032330|P1|Overall Study|Withdrawal by Subject|4
7776841|NCT00639769|27032330|P1|Overall Study|Disease progression|26
7776842|NCT00639769|27032330|P1|Overall Study|Lack of Efficacy|1
7776843|NCT00639769|27032330|P1|Overall Study|Adverse Event|7
7776844|NCT00639769|27032330|P1|Overall Study|Death|2
7776845|NCT00639678|27032347|P4|Overall Study|Lack of Compliance|0
7776846|NCT00639678|27032348|P3|Overall Study|Lack of Compliance|1
7776847|NCT00639678|27032349|P2|Overall Study|Lack of Compliance|0
7776848|NCT00639678|27032350|P1|Overall Study|Lack of Compliance|0
7776849|NCT00639678|27032347|P4|Overall Study|Adverse Event|0
7776850|NCT00639678|27032348|P3|Overall Study|Adverse Event|0
7776851|NCT00639678|27032349|P2|Overall Study|Adverse Event|1
7776852|NCT00639678|27032350|P1|Overall Study|Adverse Event|0
7776853|NCT00639678|27032347|P4|Overall Study|Lost to Follow-up|0
7776854|NCT00639678|27032348|P3|Overall Study|Lost to Follow-up|6
7776855|NCT00639678|27032349|P2|Overall Study|Lost to Follow-up|0
7776856|NCT00639678|27032350|P1|Overall Study|Lost to Follow-up|1
7776857|NCT00639678|27032347|P4|Overall Study|Withdrawal by Subject|0
7776858|NCT00639678|27032348|P3|Overall Study|Withdrawal by Subject|4
7776859|NCT00639678|27032349|P2|Overall Study|Withdrawal by Subject|0
7776860|NCT00639678|27032350|P1|Overall Study|Withdrawal by Subject|3
7776861|NCT00639509|27032415|P1|Overall Study|Death|1
7776862|NCT00639457|27032423|P2|Overall Study|Withdrawal by Subject|3
7776863|NCT00639457|27032424|P1|Overall Study|Withdrawal by Subject|2
7776864|NCT00639379|27032483|P2|Period 1 - 2 Weeks|lens issue|0
7776865|NCT00639379|27032484|P1|Period 1 - 2 Weeks|lens issue|3
7776866|NCT00639379|27032483|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
7776867|NCT00639379|27032484|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
7776868|NCT00639223|27032500|P2|Overall Study|Lost to Follow-up|2
7776869|NCT00639223|27032501|P1|Overall Study|Lost to Follow-up|0
7776870|NCT00639002|27032541|P1|Overall Study|Lack of Efficacy|1
7776871|NCT00639002|27032541|P1|Overall Study|Physician Decision|6
7776872|NCT00639002|27032541|P1|Overall Study|Disease progression|3
7776873|NCT00639002|27032541|P1|Overall Study|Protocol Violation|1
7776874|NCT00639002|27032541|P1|Overall Study|Adverse Event|1
7776875|NCT00639002|27032541|P1|Overall Study|Death|1
7776876|NCT00638989|27032550|P3|Overall Study|Lost to Follow-up|1
7776877|NCT00638989|27032551|P2|Overall Study|Lost to Follow-up|0
7776878|NCT00638989|27032552|P1|Overall Study|Lost to Follow-up|0
7776879|NCT00638963|27032592|P2|Overall Study|Withdrawal by Subject|0
7776880|NCT00638963|27032593|P1|Overall Study|Withdrawal by Subject|1
7776881|NCT00638846|27032634|P2|Overall Study|lens issue|3
7776882|NCT00638846|27032635|P1|Overall Study|lens issue|1
7776883|NCT00638846|27032634|P2|Overall Study|Lost to Follow-up|2
7776884|NCT00638846|27032635|P1|Overall Study|Lost to Follow-up|3
7776885|NCT00638846|27032634|P2|Overall Study|Adverse Event|1
7776886|NCT00638846|27032635|P1|Overall Study|Adverse Event|0
7776887|NCT00638690|27032679|P2|Overall Study|Lost to Follow-up|2
7776888|NCT00638690|27032680|P1|Overall Study|Lost to Follow-up|4
7776889|NCT00638690|27032679|P2|Overall Study|Withdrawal by Subject|5
7776890|NCT00638690|27032680|P1|Overall Study|Withdrawal by Subject|22
7776891|NCT00638690|27032679|P2|Overall Study|Death|335
7776892|NCT00638690|27032680|P1|Overall Study|Death|655
7776893|NCT00638508|27032700|P2|Overall Study|Physician Decision|2
7776894|NCT00638508|27032701|P1|Overall Study|Physician Decision|5
7776895|NCT00638456|27032747|P2|Overall Study|Withdrawal by Subject|2
7776896|NCT00638456|27032748|P1|Overall Study|Withdrawal by Subject|6
7776897|NCT00638443|27032758|P2|First Intervention|Adverse Event|1
7776898|NCT00638443|27032759|P1|First Intervention|Adverse Event|2
7776899|NCT00638404|27032789|P2|Overall Study|Physician Decision|0
7776900|NCT00638404|27032790|P1|Overall Study|Physician Decision|8
7776901|NCT00638378|27032802|P1|Overall Study|Physician Decision|4
7776902|NCT00638378|27032802|P1|Overall Study|Disease progression|15
7776903|NCT00638378|27032802|P1|Overall Study|Adverse Event|1
7776904|NCT00638378|27032802|P1|Overall Study|Death|2
7776905|NCT00638235|27032842|P9|Overall Study|Lost to Follow-up|18
7776906|NCT00638235|27032843|P8|Overall Study|Lost to Follow-up|1
7776907|NCT00638235|27032844|P7|Overall Study|Lost to Follow-up|0
7776908|NCT00638235|27032845|P6|Overall Study|Lost to Follow-up|26
7776909|NCT00638235|27032846|P5|Overall Study|Lost to Follow-up|13
7776910|NCT00638235|27032847|P4|Overall Study|Lost to Follow-up|10
7776911|NCT00638235|27032848|P3|Overall Study|Lost to Follow-up|18
7776912|NCT00638235|27032849|P2|Overall Study|Lost to Follow-up|3
7776913|NCT00638235|27032850|P1|Overall Study|Lost to Follow-up|31
7776914|NCT00638183|27033260|P1|Overall Study|Other reason not defined above|27
7776915|NCT00638183|27033260|P1|Overall Study|Lost to Follow-up|46
7776916|NCT00638183|27033260|P1|Overall Study|Physician Decision|9
7776917|NCT00638183|27033260|P1|Overall Study|Lack of Efficacy|14
7776918|NCT00638183|27033260|P1|Overall Study|Adverse Event|23
7776919|NCT00638157|27033269|P2|Overall Study|Randomized, not treated|0
7776920|NCT00638157|27033270|P1|Overall Study|Randomized, not treated|2
7776921|NCT00638157|27033269|P2|Overall Study|Other|2
7776922|NCT00638157|27033270|P1|Overall Study|Other|1
7776923|NCT00638157|27033269|P2|Overall Study|Physician Decision|0
7776924|NCT00638157|27033270|P1|Overall Study|Physician Decision|1
7776925|NCT00638157|27033269|P2|Overall Study|Lost to Follow-up|0
7776926|NCT00638157|27033270|P1|Overall Study|Lost to Follow-up|1
7776927|NCT00638157|27033269|P2|Overall Study|Microbiological failure|0
7776928|NCT00638157|27033270|P1|Overall Study|Microbiological failure|1
7776929|NCT00638157|27033269|P2|Overall Study|Clinical (symptomatic) failure|1
7776930|NCT00638157|27033270|P1|Overall Study|Clinical (symptomatic) failure|1
7776931|NCT00638157|27033269|P2|Overall Study|Adverse Event|1
7776932|NCT00638157|27033270|P1|Overall Study|Adverse Event|0
7776933|NCT00638027|27033280|P2|Overall Study|Adverse Event|2
7776934|NCT00638027|27033281|P1|Overall Study|Adverse Event|0
7776935|NCT00637806|27033328|P4|Extension Phase|Study Discontinued|1
7776936|NCT00637806|27033329|P3|Extension Phase|Study Discontinued|0
7776937|NCT00637806|27033330|P2|Extension Phase|Study Discontinued|0
7776938|NCT00637806|27033331|P1|Extension Phase|Study Discontinued|0
7776939|NCT00637806|27033328|P4|Double-blind Phase|Study Discontinued|0
7776940|NCT00637806|27033329|P3|Double-blind Phase|Study Discontinued|1
7776941|NCT00637806|27033330|P2|Double-blind Phase|Study Discontinued|0
7776942|NCT00637806|27033331|P1|Double-blind Phase|Study Discontinued|2
7776943|NCT00637728|27033366|P3|Double-blind Phase|Study Discontinued|0
7776944|NCT00637728|27033367|P2|Double-blind Phase|Study Discontinued|1
7776945|NCT00637728|27033368|P1|Double-blind Phase|Study Discontinued|1
7776946|NCT00637728|27033366|P3|Double-blind Phase|Non-compliance|0
7776947|NCT00637728|27033367|P2|Double-blind Phase|Non-compliance|0
7776948|NCT00637728|27033368|P1|Double-blind Phase|Non-compliance|2
7776949|NCT00637728|27033366|P3|Double-blind Phase|Adverse Event|0
7776950|NCT00637728|27033367|P2|Double-blind Phase|Adverse Event|0
7776951|NCT00637728|27033368|P1|Double-blind Phase|Adverse Event|1
7776952|NCT00637572|27033383|P2|Overall Study|Illicit Drug Use|0
7776953|NCT00637572|27033384|P1|Overall Study|Illicit Drug Use|1
7776954|NCT00637572|27033383|P2|Overall Study|Withdrawal by Subject|2
7776955|NCT00637572|27033384|P1|Overall Study|Withdrawal by Subject|0
7776956|NCT00637572|27033383|P2|Overall Study|Physician Decision|1
7776957|NCT00637572|27033384|P1|Overall Study|Physician Decision|1
7776958|NCT00637572|27033383|P2|Overall Study|Lost to Follow-up|1
7776959|NCT00637572|27033384|P1|Overall Study|Lost to Follow-up|0
7776960|NCT00637572|27033383|P2|Overall Study|Death|1
7776961|NCT00637572|27033384|P1|Overall Study|Death|0
7776962|NCT00637572|27033383|P2|Overall Study|Adverse Event|2
7776963|NCT00637572|27033384|P1|Overall Study|Adverse Event|1
7776964|NCT00637416|27033423|P2|Overall Study|Unable to take study drug|1
7776965|NCT00637416|27033424|P1|Overall Study|Unable to take study drug|0
7776966|NCT00637416|27033423|P2|Overall Study|Lost to Follow-up|1
7776967|NCT00637416|27033424|P1|Overall Study|Lost to Follow-up|1
7776968|NCT00637377|27033434|P4|Overall Study|Other (no further information available)|5
7776969|NCT00637377|27033435|P3|Overall Study|Other (no further information available)|10
7776970|NCT00637377|27033436|P2|Overall Study|Other (no further information available)|6
7776971|NCT00637377|27033437|P1|Overall Study|Other (no further information available)|7
7776972|NCT00637377|27033434|P4|Overall Study|Withdrawal by Subject|11
7776973|NCT00637377|27033435|P3|Overall Study|Withdrawal by Subject|13
7776974|NCT00637377|27033436|P2|Overall Study|Withdrawal by Subject|15
7776975|NCT00637377|27033437|P1|Overall Study|Withdrawal by Subject|11
7776976|NCT00637377|27033434|P4|Overall Study|Protocol Violation|0
7776977|NCT00637377|27033435|P3|Overall Study|Protocol Violation|1
7776978|NCT00637377|27033436|P2|Overall Study|Protocol Violation|1
7776979|NCT00637377|27033437|P1|Overall Study|Protocol Violation|2
7776980|NCT00637377|27033434|P4|Overall Study|Lost to Follow-up|2
7776981|NCT00637377|27033435|P3|Overall Study|Lost to Follow-up|2
7776982|NCT00637377|27033436|P2|Overall Study|Lost to Follow-up|1
7776983|NCT00637377|27033437|P1|Overall Study|Lost to Follow-up|4
7776984|NCT00637377|27033434|P4|Overall Study|Lack of Efficacy|1
7776985|NCT00637377|27033435|P3|Overall Study|Lack of Efficacy|1
7776986|NCT00637377|27033436|P2|Overall Study|Lack of Efficacy|0
7776987|NCT00637377|27033437|P1|Overall Study|Lack of Efficacy|0
7776988|NCT00637377|27033434|P4|Overall Study|Death|1
7776989|NCT00637377|27033435|P3|Overall Study|Death|2
7776990|NCT00637377|27033436|P2|Overall Study|Death|3
7776991|NCT00637377|27033437|P1|Overall Study|Death|1
7776992|NCT00637377|27033434|P4|Overall Study|Adverse Event|9
7776993|NCT00637377|27033435|P3|Overall Study|Adverse Event|8
7776994|NCT00637377|27033436|P2|Overall Study|Adverse Event|6
7776995|NCT00637377|27033437|P1|Overall Study|Adverse Event|2
7776996|NCT00637273|27033486|P3|Overall Study|Loss of Glucose Control|1
7776997|NCT00637273|27033487|P2|Overall Study|Loss of Glucose Control|1
7776998|NCT00637273|27033488|P1|Overall Study|Loss of Glucose Control|1
7776999|NCT00637273|27033486|P3|Overall Study|Administrative|0
7777000|NCT00637273|27033487|P2|Overall Study|Administrative|0
7777001|NCT00637273|27033488|P1|Overall Study|Administrative|2
7777002|NCT00637273|27033486|P3|Overall Study|Investigator Decision|1
7777003|NCT00637273|27033487|P2|Overall Study|Investigator Decision|3
7777004|NCT00637273|27033488|P1|Overall Study|Investigator Decision|1
7777005|NCT00637273|27033486|P3|Overall Study|Withdrawal of Consent|18
7777006|NCT00637273|27033487|P2|Overall Study|Withdrawal of Consent|6
7777007|NCT00637273|27033488|P1|Overall Study|Withdrawal of Consent|18
7777008|NCT00637273|27033486|P3|Overall Study|Protocol Violation|1
7777009|NCT00637273|27033487|P2|Overall Study|Protocol Violation|4
7777010|NCT00637273|27033488|P1|Overall Study|Protocol Violation|2
7777011|NCT00637273|27033486|P3|Overall Study|Lost to Follow-up|13
7777012|NCT00637273|27033487|P2|Overall Study|Lost to Follow-up|9
7777013|NCT00637273|27033488|P1|Overall Study|Lost to Follow-up|8
7777014|NCT00637273|27033486|P3|Overall Study|Adverse Event|7
7777015|NCT00637273|27033487|P2|Overall Study|Adverse Event|5
7777016|NCT00637273|27033488|P1|Overall Study|Adverse Event|11
7777017|NCT00637195|27033546|P2|Overall Study|Withdrawal by Subject|1
7777018|NCT00637195|27033547|P1|Overall Study|Withdrawal by Subject|0
7777019|NCT00637195|27033546|P2|Overall Study|Other|0
7777020|NCT00637195|27033547|P1|Overall Study|Other|2
7777021|NCT00637195|27033546|P2|Overall Study|Lost to Follow-up|0
7777022|NCT00637195|27033547|P1|Overall Study|Lost to Follow-up|1
7777023|NCT00637156|27033583|P2|Overall Study|Lost to Follow-up|16
7777024|NCT00637156|27033584|P1|Overall Study|Lost to Follow-up|10
7777025|NCT00637156|27033583|P2|Overall Study|Death|1
7777026|NCT00637156|27033584|P1|Overall Study|Death|0
7777027|NCT00637156|27033583|P2|Overall Study|Withdrawal by Subject|7
7777028|NCT00637156|27033584|P1|Overall Study|Withdrawal by Subject|0
7777029|NCT00637000|27033626|P2|Overall Study|Withdrawal by Subject|3
7777030|NCT00637000|27033627|P1|Overall Study|Withdrawal by Subject|4
7777031|NCT00636987|27033667|P1|Overall Study|5 year visit window not complete|69
7777032|NCT00636987|27033667|P1|Overall Study|Lost to Follow-up|63
7777033|NCT00636987|27033667|P1|Overall Study|Explanted|13
7777034|NCT00636987|27033667|P1|Overall Study|Death|44
7777035|NCT00636961|27033677|P2|Period 2|Adverse Event|0
7777036|NCT00636961|27033678|P1|Period 2|Adverse Event|1
7777037|NCT00636961|27033677|P2|Period 1|Administrative problems|1
7777038|NCT00636961|27033678|P1|Period 1|Administrative problems|1
7777039|NCT00636818|27033692|P1|Overall Study|Withdrawal by Subject|4
7777040|NCT00636818|27033692|P1|Overall Study|Protocol Violation|1
7777041|NCT00636818|27033692|P1|Overall Study|Entry Criteria Exclusion|3
7777042|NCT00636818|27033692|P1|Overall Study|Lost to Follow-up|2
7777043|NCT00636818|27033692|P1|Overall Study|Adverse Event|1
7777044|NCT00636792|27033717|P1|Overall Study|Other|3
7777045|NCT00636792|27033717|P1|Overall Study|Withdrawal by Subject|3
7777046|NCT00636792|27033717|P1|Overall Study|Progressive Disease|4
7777047|NCT00636792|27033717|P1|Overall Study|Physician Decision|7
7777048|NCT00636792|27033717|P1|Overall Study|Adverse Event|16
7777049|NCT00636675|27033733|P2|Overall Study|Withdrawal by Subject|10
7777050|NCT00636675|27033734|P1|Overall Study|Withdrawal by Subject|19
7777051|NCT00636675|27033733|P2|Overall Study|Lost to Follow-up|31
7777052|NCT00636675|27033734|P1|Overall Study|Lost to Follow-up|121
7777053|NCT00636636|27033777|P2|Overall Study|Withdrawal by Subject|9
7777054|NCT00636636|27033778|P1|Overall Study|Withdrawal by Subject|4
7777055|NCT00636636|27033777|P2|Overall Study|Death|1
7777056|NCT00636636|27033778|P1|Overall Study|Death|0
7777057|NCT00636636|27033777|P2|Overall Study|Lost to Follow-up|1
7777058|NCT00636636|27033778|P1|Overall Study|Lost to Follow-up|0
7777059|NCT00636636|27033777|P2|Overall Study|Protocol Violation|2
7777060|NCT00636636|27033778|P1|Overall Study|Protocol Violation|2
7777061|NCT00636636|27033777|P2|Overall Study|Lack of Efficacy|12
7777062|NCT00636636|27033778|P1|Overall Study|Lack of Efficacy|7
7777063|NCT00636636|27033777|P2|Overall Study|Adverse Event|8
7777064|NCT00636636|27033778|P1|Overall Study|Adverse Event|19
7777065|NCT00636636|27033777|P2|Overall Study|Other reason|6
7777066|NCT00636636|27033778|P1|Overall Study|Other reason|4
7777067|NCT00636610|27033794|P2|Overall Study|Reason for discontinuation not available|2
7777068|NCT00636610|27033795|P1|Overall Study|Reason for discontinuation not available|3
7777069|NCT00636610|27033794|P2|Overall Study|Disease progression - clinical|3
7777070|NCT00636610|27033795|P1|Overall Study|Disease progression - clinical|8
7777071|NCT00636610|27033794|P2|Overall Study|Disease progression - radiographic|51
7777072|NCT00636610|27033795|P1|Overall Study|Disease progression - radiographic|41
7777073|NCT00636610|27033794|P2|Overall Study|Subject decision to withdraw|11
7777074|NCT00636610|27033795|P1|Overall Study|Subject decision to withdraw|15
7777075|NCT00636610|27033794|P2|Overall Study|Physician decision to withdraw patient|9
7777076|NCT00636610|27033795|P1|Overall Study|Physician decision to withdraw patient|15
7777077|NCT00636610|27033794|P2|Overall Study|Death|3
7777078|NCT00636610|27033795|P1|Overall Study|Death|6
7777079|NCT00636610|27033794|P2|Overall Study|Adverse Event|4
7777080|NCT00636610|27033795|P1|Overall Study|Adverse Event|4
7777081|NCT00636506|27033805|P1|Overall Study|Procedure aborted|1
7777082|NCT00636506|27033805|P1|Overall Study|Withdrawal by Subject|6
7777083|NCT00636506|27033805|P1|Overall Study|Explanted|1
7777084|NCT00636506|27033805|P1|Overall Study|Lost to Follow-up|8
7777085|NCT00636441|27033852|P7|Overall Study|Screen Failure|17
7777086|NCT00636441|27033853|P6|Overall Study|Screen Failure|0
7777087|NCT00636441|27033854|P5|Overall Study|Screen Failure|0
7777088|NCT00636441|27033855|P4|Overall Study|Screen Failure|0
7777089|NCT00636441|27033856|P3|Overall Study|Screen Failure|0
7777090|NCT00636441|27033857|P2|Overall Study|Screen Failure|0
7777091|NCT00636441|27033858|P1|Overall Study|Screen Failure|0
7777092|NCT00636441|27033852|P7|Overall Study|Late, ineligible|1
7777093|NCT00636441|27033853|P6|Overall Study|Late, ineligible|0
7777094|NCT00636441|27033854|P5|Overall Study|Late, ineligible|0
7777095|NCT00636441|27033855|P4|Overall Study|Late, ineligible|0
7777096|NCT00636441|27033856|P3|Overall Study|Late, ineligible|0
7777097|NCT00636441|27033857|P2|Overall Study|Late, ineligible|0
7777098|NCT00636441|27033858|P1|Overall Study|Late, ineligible|0
7777099|NCT00636441|27033852|P7|Overall Study|Adverse Event|0
7777100|NCT00636441|27033853|P6|Overall Study|Adverse Event|1
7777101|NCT00636441|27033854|P5|Overall Study|Adverse Event|0
7777102|NCT00636441|27033855|P4|Overall Study|Adverse Event|0
7777103|NCT00636441|27033856|P3|Overall Study|Adverse Event|1
7777104|NCT00636441|27033857|P2|Overall Study|Adverse Event|1
7777105|NCT00636441|27033858|P1|Overall Study|Adverse Event|0
7777106|NCT00636363|27033901|P3|Overall Study|Withdrawal by Subject|2
7777107|NCT00636363|27033902|P2|Overall Study|Withdrawal by Subject|3
7777108|NCT00636363|27033903|P1|Overall Study|Withdrawal by Subject|1
7777109|NCT00636363|27033901|P3|Overall Study|Lost to Follow-up|2
7777110|NCT00636363|27033902|P2|Overall Study|Lost to Follow-up|4
7777111|NCT00636363|27033903|P1|Overall Study|Lost to Follow-up|3
7777112|NCT00636363|27033901|P3|Overall Study|Protocol Violation|0
7777113|NCT00636363|27033902|P2|Overall Study|Protocol Violation|3
7777114|NCT00636363|27033903|P1|Overall Study|Protocol Violation|0
7777115|NCT00636363|27033901|P3|Overall Study|Lack of motivation|1
7777116|NCT00636363|27033902|P2|Overall Study|Lack of motivation|0
7777117|NCT00636363|27033903|P1|Overall Study|Lack of motivation|1
7777118|NCT00636363|27033901|P3|Overall Study|Missed > 1 visit|3
7777119|NCT00636363|27033902|P2|Overall Study|Missed > 1 visit|1
7777120|NCT00636363|27033903|P1|Overall Study|Missed > 1 visit|0
7777121|NCT00636363|27033901|P3|Overall Study|Met ineligibility criteria|3
7777122|NCT00636363|27033902|P2|Overall Study|Met ineligibility criteria|0
7777123|NCT00636363|27033903|P1|Overall Study|Met ineligibility criteria|0
7777124|NCT00636363|27033901|P3|Overall Study|Study related symptoms/complaints|4
7777125|NCT00636363|27033902|P2|Overall Study|Study related symptoms/complaints|7
7777126|NCT00636363|27033903|P1|Overall Study|Study related symptoms/complaints|8
7777127|NCT00636363|27033901|P3|Overall Study|Positive slit lamp finding|1
7777128|NCT00636363|27033902|P2|Overall Study|Positive slit lamp finding|2
7777129|NCT00636363|27033903|P1|Overall Study|Positive slit lamp finding|0
7777130|NCT00636363|27033901|P3|Overall Study|Adverse Event|1
7777131|NCT00636363|27033902|P2|Overall Study|Adverse Event|0
7777132|NCT00636363|27033903|P1|Overall Study|Adverse Event|0
7777133|NCT00636363|27033901|P3|Overall Study|Conjunctivitis|1
7777134|NCT00636363|27033902|P2|Overall Study|Conjunctivitis|0
7777135|NCT00636363|27033903|P1|Overall Study|Conjunctivitis|0
7777136|NCT00636207|27033924|P7|Overall Study|Withdrawal by Subject|0
7777137|NCT00636207|27033925|P6|Overall Study|Withdrawal by Subject|0
7777138|NCT00636207|27033926|P5|Overall Study|Withdrawal by Subject|1
7777139|NCT00636207|27033927|P4|Overall Study|Withdrawal by Subject|0
7777140|NCT00636207|27033928|P3|Overall Study|Withdrawal by Subject|0
7777141|NCT00636207|27033929|P2|Overall Study|Withdrawal by Subject|1
7777142|NCT00636207|27033930|P1|Overall Study|Withdrawal by Subject|0
7777143|NCT00636207|27033924|P7|Overall Study|Adverse Event|0
7777144|NCT00636207|27033925|P6|Overall Study|Adverse Event|0
7777145|NCT00636207|27033926|P5|Overall Study|Adverse Event|0
7777146|NCT00636207|27033927|P4|Overall Study|Adverse Event|0
7777147|NCT00636207|27033928|P3|Overall Study|Adverse Event|0
7777148|NCT00636207|27033929|P2|Overall Study|Adverse Event|0
7777149|NCT00636207|27033930|P1|Overall Study|Adverse Event|1
7777150|NCT00636194|27033994|P2|Overall Study|Protocol Violation|0
7777151|NCT00636194|27033995|P1|Overall Study|Protocol Violation|2
7777152|NCT00636194|27033994|P2|Overall Study|Study related symptoms and complaints|0
7777153|NCT00636194|27033995|P1|Overall Study|Study related symptoms and complaints|1
7777154|NCT00636181|27034008|P3|Overall Study|Withdrawal by Subject|10
7777155|NCT00636181|27034009|P2|Overall Study|Withdrawal by Subject|6
7777156|NCT00636181|27034010|P1|Overall Study|Withdrawal by Subject|8
7777157|NCT00636168|27034038|P2|Long Term Follow-Up|Death|9
7777158|NCT00636168|27034039|P1|Long Term Follow-Up|Death|8
7777159|NCT00636168|27034038|P2|Long Term Follow-Up|Participant withdrew consent|2
7777160|NCT00636168|27034039|P1|Long Term Follow-Up|Participant withdrew consent|0
7777161|NCT00636168|27034038|P2|Long Term Follow-Up|Lost to Follow-up|3
7777162|NCT00636168|27034039|P1|Long Term Follow-Up|Lost to Follow-up|3
7777163|NCT00636168|27034038|P2|Treated With Study Drug|Other reason|3
7777164|NCT00636168|27034039|P1|Treated With Study Drug|Other reason|1
7777165|NCT00636168|27034038|P2|Treated With Study Drug|No longer meets study criteria|0
7777166|NCT00636168|27034039|P1|Treated With Study Drug|No longer meets study criteria|1
7777167|NCT00636168|27034038|P2|Treated With Study Drug|Pregnancy|0
7777168|NCT00636168|27034039|P1|Treated With Study Drug|Pregnancy|1
7777169|NCT00636168|27034038|P2|Treated With Study Drug|Death|0
7777170|NCT00636168|27034039|P1|Treated With Study Drug|Death|3
7777171|NCT00636168|27034038|P2|Treated With Study Drug|Poor/non-compliance|3
7777172|NCT00636168|27034039|P1|Treated With Study Drug|Poor/non-compliance|1
7777173|NCT00636168|27034038|P2|Treated With Study Drug|Participant withdrew consent|21
7777174|NCT00636168|27034039|P1|Treated With Study Drug|Participant withdrew consent|16
7777175|NCT00636168|27034038|P2|Treated With Study Drug|Adverse Event|22
7777176|NCT00636168|27034039|P1|Treated With Study Drug|Adverse Event|250
7777177|NCT00636168|27034038|P2|Treated With Study Drug|Recurrence of disease|282
7777178|NCT00636168|27034039|P1|Treated With Study Drug|Recurrence of disease|135
7777179|NCT00636168|27034038|P2|Randomized to Study Drug|No longer meets study criteria|0
7777180|NCT00636168|27034039|P1|Randomized to Study Drug|No longer meets study criteria|1
7777181|NCT00636168|27034038|P2|Randomized to Study Drug|Adverse Event|0
7777182|NCT00636168|27034039|P1|Randomized to Study Drug|Adverse Event|1
7777183|NCT00636168|27034038|P2|Randomized to Study Drug|Withdrawal by Subject|2
7777184|NCT00636168|27034039|P1|Randomized to Study Drug|Withdrawal by Subject|2
7777185|NCT00636155|27034067|P1|Overall Study|Physician Decision|5
7777186|NCT00636155|27034067|P1|Overall Study|Stem cell transplant|1
7777187|NCT00636155|27034067|P1|Overall Study|Withdrawal by Subject|3
7777188|NCT00636155|27034067|P1|Overall Study|Lack of Efficacy|1
7777189|NCT00636155|27034067|P1|Overall Study|Adverse Event|8
7777190|NCT00635999|27034109|P3|Overall Study|Withdrawal by Subject|1
7777191|NCT00635999|27034110|P2|Overall Study|Withdrawal by Subject|2
7777192|NCT00635999|27034111|P1|Overall Study|Withdrawal by Subject|4
7777193|NCT00635882|27034128|P6|Overall Study|Protocol Violation|0
7777194|NCT00635882|27034129|P5|Overall Study|Protocol Violation|0
7777195|NCT00635882|27034130|P4|Overall Study|Protocol Violation|0
7777196|NCT00635882|27034131|P3|Overall Study|Protocol Violation|0
7777197|NCT00635882|27034132|P2|Overall Study|Protocol Violation|0
7777198|NCT00635882|27034133|P1|Overall Study|Protocol Violation|1
7777199|NCT00635804|27034263|P8|Overall Study|Withdrawal by Subject|0
7777200|NCT00635804|27034264|P7|Overall Study|Withdrawal by Subject|0
7777201|NCT00635804|27034265|P6|Overall Study|Withdrawal by Subject|0
7777202|NCT00635804|27034266|P5|Overall Study|Withdrawal by Subject|0
7777203|NCT00635804|27034267|P4|Overall Study|Withdrawal by Subject|0
7777204|NCT00635804|27034268|P3|Overall Study|Withdrawal by Subject|0
7777205|NCT00635804|27034269|P2|Overall Study|Withdrawal by Subject|0
7777206|NCT00635804|27034270|P1|Overall Study|Withdrawal by Subject|1
7777207|NCT00635804|27034263|P8|Overall Study|Adverse Event|0
7777208|NCT00635804|27034264|P7|Overall Study|Adverse Event|0
7777209|NCT00635804|27034265|P6|Overall Study|Adverse Event|1
7777210|NCT00635804|27034266|P5|Overall Study|Adverse Event|0
7777211|NCT00635804|27034267|P4|Overall Study|Adverse Event|0
7777212|NCT00635804|27034268|P3|Overall Study|Adverse Event|0
7777213|NCT00635804|27034269|P2|Overall Study|Adverse Event|0
7777214|NCT00635804|27034270|P1|Overall Study|Adverse Event|0
7777215|NCT00635778|27034374|P7|Overall Study|Progressive disease|4
7777216|NCT00635778|27034375|P6|Overall Study|Progressive disease|14
7777217|NCT00635778|27034376|P5|Overall Study|Progressive disease|5
7777218|NCT00635778|27034377|P4|Overall Study|Progressive disease|4
7777219|NCT00635778|27034378|P3|Overall Study|Progressive disease|3
7777220|NCT00635778|27034379|P2|Overall Study|Progressive disease|3
7777221|NCT00635778|27034380|P1|Overall Study|Progressive disease|0
7777222|NCT00635778|27034374|P7|Overall Study|Withdrawal by Subject|1
7777223|NCT00635778|27034375|P6|Overall Study|Withdrawal by Subject|1
7777224|NCT00635778|27034376|P5|Overall Study|Withdrawal by Subject|0
7777225|NCT00635778|27034377|P4|Overall Study|Withdrawal by Subject|1
7777226|NCT00635778|27034378|P3|Overall Study|Withdrawal by Subject|0
7777227|NCT00635778|27034379|P2|Overall Study|Withdrawal by Subject|0
7777228|NCT00635778|27034380|P1|Overall Study|Withdrawal by Subject|0
7777229|NCT00635778|27034374|P7|Overall Study|Adverse Event|1
7777230|NCT00635778|27034375|P6|Overall Study|Adverse Event|6
7777231|NCT00635778|27034376|P5|Overall Study|Adverse Event|3
7777232|NCT00635778|27034377|P4|Overall Study|Adverse Event|3
7777233|NCT00635778|27034378|P3|Overall Study|Adverse Event|0
7777234|NCT00635778|27034379|P2|Overall Study|Adverse Event|0
7777235|NCT00635778|27034380|P1|Overall Study|Adverse Event|1
7777236|NCT00635661|27034451|P1|Overall Study|Withdrawal by Subject|4
7777237|NCT00635648|27034455|P1|Overall Study|Other reason|2
7777238|NCT00635648|27034455|P1|Overall Study|Noncompliance with protocol|1
7777239|NCT00635648|27034455|P1|Overall Study|No improvement after 7-10 days treatment|4
7777240|NCT00635648|27034455|P1|Overall Study|Use of other antifungal agent needed|1
7777241|NCT00635648|27034455|P1|Overall Study|Rapid progression of baseline disease|4
7777242|NCT00635648|27034455|P1|Overall Study|Physician Decision|4
7777243|NCT00635648|27034455|P1|Overall Study|Withdrawal by Subject|9
7777244|NCT00635648|27034455|P1|Overall Study|Adverse Event|12
7777245|NCT00635570|27034477|P2|Overall Study|Early termination(No sexual activity)|1
7777246|NCT00635570|27034478|P1|Overall Study|Early termination(No sexual activity)|1
7777247|NCT00635570|27034477|P2|Overall Study|Did not complete survey|1
7777248|NCT00635570|27034478|P1|Overall Study|Did not complete survey|2
7777249|NCT00635570|27034477|P2|Overall Study|Physician Decision|0
7777250|NCT00635570|27034478|P1|Overall Study|Physician Decision|1
7777251|NCT00635570|27034477|P2|Overall Study|Adverse Event|0
7777252|NCT00635570|27034478|P1|Overall Study|Adverse Event|2
7777253|NCT00635570|27034477|P2|Overall Study|Withdrawal by Subject|1
7777254|NCT00635570|27034478|P1|Overall Study|Withdrawal by Subject|1
7777255|NCT00635570|27034477|P2|Overall Study|Lost to Follow-up|8
7777256|NCT00635570|27034478|P1|Overall Study|Lost to Follow-up|8
7777257|NCT00635492|27034492|P2|Overall Study|Withdrawal by Subject|45
7777258|NCT00635492|27034493|P1|Overall Study|Withdrawal by Subject|82
7777259|NCT00635492|27034492|P2|Overall Study|Sponsor decision|3
7777260|NCT00635492|27034493|P1|Overall Study|Sponsor decision|2
7777261|NCT00635492|27034492|P2|Overall Study|Physician Decision|22
7777262|NCT00635492|27034493|P1|Overall Study|Physician Decision|32
7777263|NCT00635492|27034492|P2|Overall Study|Lost to Follow-up|172
7777264|NCT00635492|27034493|P1|Overall Study|Lost to Follow-up|151
7777265|NCT00635492|27034492|P2|Overall Study|Death|40
7777266|NCT00635492|27034493|P1|Overall Study|Death|12
7777267|NCT00635427|27034566|P5|Overall Study|Withdrawal Of Consent|2
7777268|NCT00635427|27034567|P4|Overall Study|Withdrawal Of Consent|2
7777269|NCT00635427|27034568|P3|Overall Study|Withdrawal Of Consent|0
7777270|NCT00635427|27034569|P2|Overall Study|Withdrawal Of Consent|0
7777271|NCT00635427|27034570|P1|Overall Study|Withdrawal Of Consent|0
7777272|NCT00635427|27034566|P5|Overall Study|Termination Of Study By Sponsor|6
7777273|NCT00635427|27034567|P4|Overall Study|Termination Of Study By Sponsor|6
7777274|NCT00635427|27034568|P3|Overall Study|Termination Of Study By Sponsor|10
7777275|NCT00635427|27034569|P2|Overall Study|Termination Of Study By Sponsor|6
7777276|NCT00635427|27034570|P1|Overall Study|Termination Of Study By Sponsor|12
7777277|NCT00635427|27034566|P5|Overall Study|Death|0
7777278|NCT00635427|27034567|P4|Overall Study|Death|1
7777279|NCT00635427|27034568|P3|Overall Study|Death|0
7777280|NCT00635427|27034569|P2|Overall Study|Death|0
7777281|NCT00635427|27034570|P1|Overall Study|Death|0
7777282|NCT00635427|27034566|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7777283|NCT00635427|27034567|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7777284|NCT00635427|27034568|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
7777285|NCT00635427|27034569|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7777286|NCT00635427|27034570|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7777287|NCT00635349|27034609|P2|Overall Study|Adverse Event|9
7777288|NCT00635349|27034610|P1|Overall Study|Adverse Event|11
7777289|NCT00635349|27034609|P2|Overall Study|Lost to Follow-up|3
7777290|NCT00635349|27034610|P1|Overall Study|Lost to Follow-up|4
7777291|NCT00635349|27034609|P2|Overall Study|Withdrawal by Subject|8
7777292|NCT00635349|27034610|P1|Overall Study|Withdrawal by Subject|3
7777293|NCT00635349|27034609|P2|Overall Study|Protocol Violation|22
7777294|NCT00635349|27034610|P1|Overall Study|Protocol Violation|18
7777295|NCT00635349|27034609|P2|Overall Study|Other|6
7777296|NCT00635349|27034610|P1|Overall Study|Other|8
7777297|NCT00635219|27034664|P5|Overall Study|Administrative or Other Reasons|1
7777298|NCT00635219|27034665|P4|Overall Study|Administrative or Other Reasons|0
7777299|NCT00635219|27034666|P3|Overall Study|Administrative or Other Reasons|1
7777300|NCT00635219|27034667|P2|Overall Study|Administrative or Other Reasons|1
7777301|NCT00635219|27034668|P1|Overall Study|Administrative or Other Reasons|0
7777302|NCT00635219|27034664|P5|Overall Study|Lost to Follow-up|3
7777303|NCT00635219|27034665|P4|Overall Study|Lost to Follow-up|0
7777304|NCT00635219|27034666|P3|Overall Study|Lost to Follow-up|2
7777305|NCT00635219|27034667|P2|Overall Study|Lost to Follow-up|0
7777306|NCT00635219|27034668|P1|Overall Study|Lost to Follow-up|0
7777307|NCT00635219|27034664|P5|Overall Study|Withdrawal of Consent|8
7777308|NCT00635219|27034665|P4|Overall Study|Withdrawal of Consent|11
7777309|NCT00635219|27034666|P3|Overall Study|Withdrawal of Consent|8
7777310|NCT00635219|27034667|P2|Overall Study|Withdrawal of Consent|6
7777311|NCT00635219|27034668|P1|Overall Study|Withdrawal of Consent|8
7777312|NCT00635219|27034664|P5|Overall Study|Protocol Violation|4
7777313|NCT00635219|27034665|P4|Overall Study|Protocol Violation|2
7777314|NCT00635219|27034666|P3|Overall Study|Protocol Violation|3
7777315|NCT00635219|27034667|P2|Overall Study|Protocol Violation|2
7777316|NCT00635219|27034668|P1|Overall Study|Protocol Violation|0
7777317|NCT00635219|27034664|P5|Overall Study|Non-compliance With Study Product|1
7777318|NCT00635219|27034665|P4|Overall Study|Non-compliance With Study Product|2
7777319|NCT00635219|27034666|P3|Overall Study|Non-compliance With Study Product|0
7777320|NCT00635219|27034667|P2|Overall Study|Non-compliance With Study Product|0
7777321|NCT00635219|27034668|P1|Overall Study|Non-compliance With Study Product|0
7777322|NCT00635219|27034664|P5|Overall Study|Lack of Efficacy|6
7777323|NCT00635219|27034665|P4|Overall Study|Lack of Efficacy|4
7777324|NCT00635219|27034666|P3|Overall Study|Lack of Efficacy|3
7777325|NCT00635219|27034667|P2|Overall Study|Lack of Efficacy|6
7777326|NCT00635219|27034668|P1|Overall Study|Lack of Efficacy|5
7777327|NCT00635219|27034664|P5|Overall Study|Adverse Event|19
7777328|NCT00635219|27034665|P4|Overall Study|Adverse Event|15
7777329|NCT00635219|27034666|P3|Overall Study|Adverse Event|18
7777330|NCT00635219|27034667|P2|Overall Study|Adverse Event|10
7777331|NCT00635219|27034668|P1|Overall Study|Adverse Event|12
7777332|NCT00635154|27034731|P1|Overall Study|Still on treatment|21
7777333|NCT00635154|27034731|P1|Overall Study|Other|4
7777334|NCT00635154|27034731|P1|Overall Study|Alternative Treatment|8
7777335|NCT00635102|27034774|P2|Overall Study|Withdrawal by Subject|8
7777336|NCT00635102|27034775|P1|Overall Study|Withdrawal by Subject|7
7777337|NCT00635089|27034869|P1|Overall Study|Other|31
7777338|NCT00635089|27034869|P1|Overall Study|Lost to Follow-up|8
7777339|NCT00635089|27034869|P1|Overall Study|Protocol Deviation|4
7777340|NCT00635089|27034869|P1|Overall Study|Lack of Efficacy|28
7777341|NCT00635089|27034869|P1|Overall Study|Adverse Event|7
7777342|NCT00635050|27034896|P1|Overall Study|Withdrawal by Subject|1
7777343|NCT00635024|27034903|P1|Overall Study|Adverse Event|1
7777344|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Other|1
7777345|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Other|0
7777346|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Other|5
7777347|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Other|0
7777348|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Other|0
7777349|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
7777350|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
7777351|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
7777352|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
7777353|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
7777354|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
7777355|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
7777356|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7777357|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7777358|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7777359|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Protocol Violation|1
7777360|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Protocol Violation|0
7777361|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Protocol Violation|0
7777362|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Protocol Violation|0
7777363|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Protocol Violation|0
7777364|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Physician Decision|0
7777365|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Physician Decision|0
7777366|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Physician Decision|1
7777367|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Physician Decision|1
7777368|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Physician Decision|0
7777369|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
7777370|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
7777371|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
7777372|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
7777373|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
7777374|NCT00634933|27034923|P5|Part B: Week 24 to Week 52|Adverse Event|0
7777375|NCT00634933|27034924|P4|Part B: Week 24 to Week 52|Adverse Event|1
7777376|NCT00634933|27034925|P3|Part B: Week 24 to Week 52|Adverse Event|1
7777377|NCT00634933|27034926|P2|Part B: Week 24 to Week 52|Adverse Event|1
7777378|NCT00634933|27034927|P1|Part B: Week 24 to Week 52|Adverse Event|0
7777379|NCT00634933|27034923|P5|Between Part A and Part B|Physician Decision|0
7777380|NCT00634933|27034924|P4|Between Part A and Part B|Physician Decision|0
7777381|NCT00634933|27034925|P3|Between Part A and Part B|Physician Decision|0
7777382|NCT00634933|27034926|P2|Between Part A and Part B|Physician Decision|1
7777383|NCT00634933|27034927|P1|Between Part A and Part B|Physician Decision|0
7777384|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Other|0
7777385|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Other|0
7777386|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Other|5
7777387|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Other|8
7777388|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Other|1
7777389|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
7777390|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
7777391|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
7777392|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
7777393|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
7777394|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
7777395|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
7777396|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
7777397|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
7777398|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
7777399|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
7777400|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
7777401|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
7777402|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
7777403|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
7777404|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Investigator Request|0
7777405|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Investigator Request|0
7777406|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Investigator Request|1
7777407|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Investigator Request|1
7777408|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Investigator Request|1
7777409|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Failed to Return|0
7777410|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Failed to Return|0
7777411|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Failed to Return|0
7777412|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Failed to Return|0
7777413|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Failed to Return|1
7777414|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Death|0
7777415|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Death|0
7777416|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Death|0
7777417|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Death|0
7777418|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Death|1
7777419|NCT00634933|27034923|P5|Part A: Baseline to Week 24|Adverse Event|0
7777420|NCT00634933|27034924|P4|Part A: Baseline to Week 24|Adverse Event|0
7777421|NCT00634933|27034925|P3|Part A: Baseline to Week 24|Adverse Event|8
7777422|NCT00634933|27034926|P2|Part A: Baseline to Week 24|Adverse Event|4
7777423|NCT00634933|27034927|P1|Part A: Baseline to Week 24|Adverse Event|4
7777424|NCT00634920|27034996|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
7777425|NCT00634920|27034997|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
7777426|NCT00634920|27034998|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
7777427|NCT00634920|27034996|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
7777428|NCT00634920|27034997|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
7777429|NCT00634920|27034998|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
7777430|NCT00634920|27034996|P3|Period 2 - Post-Randomization|Death|0
7777431|NCT00634920|27034997|P2|Period 2 - Post-Randomization|Death|5
7777432|NCT00634920|27034998|P1|Period 2 - Post-Randomization|Death|2
7777433|NCT00634920|27034996|P3|Period 2 - Post-Randomization|Rejection|0
7777434|NCT00634920|27034997|P2|Period 2 - Post-Randomization|Rejection|5
7777435|NCT00634920|27034998|P1|Period 2 - Post-Randomization|Rejection|11
7777436|NCT00634920|27034996|P3|Period 2 - Post-Randomization|Adverse Event|0
7777437|NCT00634920|27034997|P2|Period 2 - Post-Randomization|Adverse Event|9
7777438|NCT00634920|27034998|P1|Period 2 - Post-Randomization|Adverse Event|37
7777439|NCT00634920|27034996|P3|Period 1 - Pre-Randomization|Other issues|6
7777440|NCT00634920|27034997|P2|Period 1 - Pre-Randomization|Other issues|0
7777441|NCT00634920|27034998|P1|Period 1 - Pre-Randomization|Other issues|0
7777442|NCT00634920|27034996|P3|Period 1 - Pre-Randomization|Non-Compliance|3
7777443|NCT00634920|27034997|P2|Period 1 - Pre-Randomization|Non-Compliance|0
7777444|NCT00634920|27034998|P1|Period 1 - Pre-Randomization|Non-Compliance|0
7777445|NCT00634920|27034996|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
7777446|NCT00634920|27034997|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
7777447|NCT00634920|27034998|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
7777448|NCT00634920|27034996|P3|Period 1 - Pre-Randomization|Rejections|55
7777449|NCT00634920|27034997|P2|Period 1 - Pre-Randomization|Rejections|0
7777450|NCT00634920|27034998|P1|Period 1 - Pre-Randomization|Rejections|0
7777451|NCT00634920|27034996|P3|Period 1 - Pre-Randomization|Wound healing problems|16
7777452|NCT00634920|27034997|P2|Period 1 - Pre-Randomization|Wound healing problems|0
7777453|NCT00634920|27034998|P1|Period 1 - Pre-Randomization|Wound healing problems|0
7777454|NCT00634920|27034996|P3|Period 1 - Pre-Randomization|Adverse Event|36
7777455|NCT00634920|27034997|P2|Period 1 - Pre-Randomization|Adverse Event|0
7777456|NCT00634920|27034998|P1|Period 1 - Pre-Randomization|Adverse Event|0
7777457|NCT00634907|27035042|P2|Overall Study|Withdrawal by Subject|8
7777458|NCT00634907|27035043|P1|Overall Study|Withdrawal by Subject|11
7777459|NCT00634907|27035042|P2|Overall Study|Physician Decision|9
7777460|NCT00634907|27035043|P1|Overall Study|Physician Decision|3
7777461|NCT00634907|27035042|P2|Overall Study|Withdrawal by Subject|0
7777462|NCT00634907|27035043|P1|Overall Study|Withdrawal by Subject|3
7777463|NCT00634842|27035067|P2|Overall Study|Subject off study drug for too long|1
7777464|NCT00634842|27035068|P1|Overall Study|Subject off study drug for too long|0
7777465|NCT00634842|27035067|P2|Overall Study|No wish to keep taking Avandia|1
7777466|NCT00634842|27035068|P1|Overall Study|No wish to keep taking Avandia|0
7777467|NCT00634842|27035067|P2|Overall Study|No need of study drug to treat diabetes|1
7777468|NCT00634842|27035068|P1|Overall Study|No need of study drug to treat diabetes|0
7777469|NCT00634842|27035067|P2|Overall Study|Discontinued due to injection|2
7777470|NCT00634842|27035068|P1|Overall Study|Discontinued due to injection|0
7777471|NCT00634842|27035067|P2|Overall Study|Lack of time and intolerance to drug|1
7777472|NCT00634842|27035068|P1|Overall Study|Lack of time and intolerance to drug|0
7777473|NCT00634842|27035067|P2|Overall Study|Withdrawal by Subject|3
7777474|NCT00634842|27035068|P1|Overall Study|Withdrawal by Subject|1
7777475|NCT00634842|27035067|P2|Overall Study|Physician Decision|0
7777476|NCT00634842|27035068|P1|Overall Study|Physician Decision|1
7777477|NCT00634842|27035067|P2|Overall Study|Lost to Follow-up|2
7777478|NCT00634842|27035068|P1|Overall Study|Lost to Follow-up|1
7777479|NCT00634842|27035067|P2|Overall Study|Inclusion criteria were not met|0
7777480|NCT00634842|27035068|P1|Overall Study|Inclusion criteria were not met|1
7777481|NCT00634842|27035067|P2|Overall Study|Move to another state|0
7777482|NCT00634842|27035068|P1|Overall Study|Move to another state|1
7777483|NCT00634842|27035067|P2|Overall Study|Protocol Violation|4
7777484|NCT00634842|27035068|P1|Overall Study|Protocol Violation|8
7777485|NCT00634842|27035067|P2|Overall Study|Adverse Event|3
7777486|NCT00634842|27035068|P1|Overall Study|Adverse Event|2
7777487|NCT00634803|27035083|P3|Overall Study|Lost to Follow-up|7
7777488|NCT00634803|27035084|P2|Overall Study|Lost to Follow-up|7
7777489|NCT00634803|27035085|P1|Overall Study|Lost to Follow-up|6
7777490|NCT00634751|27035103|P4|Pancreatic and Bilial Tract Cancer|Death|1
7777491|NCT00634751|27035104|P3|Pancreatic and Bilial Tract Cancer|Death|1
7777492|NCT00634751|27035105|P2|Pancreatic and Bilial Tract Cancer|Death|0
7777493|NCT00634751|27035106|P1|Pancreatic and Bilial Tract Cancer|Death|0
7777494|NCT00634751|27035103|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7777495|NCT00634751|27035104|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7777496|NCT00634751|27035105|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
7777497|NCT00634751|27035106|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7777498|NCT00634751|27035103|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
7777499|NCT00634751|27035104|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
7777500|NCT00634751|27035105|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
7777501|NCT00634751|27035106|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
7777502|NCT00634647|27035124|P1|Overall Study|declined to participate before treatment|1
7777503|NCT00634647|27035124|P1|Overall Study|refused further treatment|3
7777504|NCT00634647|27035124|P1|Overall Study|death on study|3
7777505|NCT00634569|27035144|P2|Overall Study|Physician Decision|1
7777506|NCT00634569|27035145|P1|Overall Study|Physician Decision|0
7777507|NCT00634569|27035144|P2|Overall Study|Withdrawal by Subject|4
7777508|NCT00634569|27035145|P1|Overall Study|Withdrawal by Subject|0
7777509|NCT00634543|27035159|P2|Overall Study|Lost to Follow-up|1
7777510|NCT00634543|27035160|P1|Overall Study|Lost to Follow-up|0
7777511|NCT00634543|27035159|P2|Overall Study|Withdrawal by Subject|4
7777512|NCT00634543|27035160|P1|Overall Study|Withdrawal by Subject|4
7777513|NCT00634543|27035159|P2|Overall Study|Adverse Event|11
7777514|NCT00634543|27035160|P1|Overall Study|Adverse Event|11
7777515|NCT00634543|27035159|P2|Overall Study|Protocol Violation|3
7777516|NCT00634543|27035160|P1|Overall Study|Protocol Violation|3
7777517|NCT00634543|27035159|P2|Overall Study|Other|2
7777518|NCT00634543|27035160|P1|Overall Study|Other|1
7777519|NCT00634504|27035178|P2|Overall Study|Protocol Violation|0
7777520|NCT00634504|27035179|P1|Overall Study|Protocol Violation|1
7777521|NCT00634244|27035238|P3|Overall Study|Other complicating disease|0
7777522|NCT00634244|27035239|P2|Overall Study|Other complicating disease|1
7777523|NCT00634244|27035240|P1|Overall Study|Other complicating disease|0
7777524|NCT00634244|27035238|P3|Overall Study|Disease progression/relapse|0
7777525|NCT00634244|27035239|P2|Overall Study|Disease progression/relapse|1
7777526|NCT00634244|27035240|P1|Overall Study|Disease progression/relapse|0
7777527|NCT00634244|27035238|P3|Overall Study|Physician Decision|0
7777528|NCT00634244|27035239|P2|Overall Study|Physician Decision|1
7777529|NCT00634244|27035240|P1|Overall Study|Physician Decision|0
7777530|NCT00634244|27035238|P3|Overall Study|Withdrawal by Subject|0
7777531|NCT00634244|27035239|P2|Overall Study|Withdrawal by Subject|1
7777532|NCT00634244|27035240|P1|Overall Study|Withdrawal by Subject|0
7777533|NCT00634244|27035238|P3|Overall Study|Adverse Event|0
7777534|NCT00634244|27035239|P2|Overall Study|Adverse Event|2
7777535|NCT00634244|27035240|P1|Overall Study|Adverse Event|0
7777536|NCT00634244|27035238|P3|Overall Study|Death|0
7777537|NCT00634244|27035239|P2|Overall Study|Death|6
7777538|NCT00634244|27035240|P1|Overall Study|Death|1
7777539|NCT00634244|27035238|P3|Overall Study|Never started treatment|0
7777540|NCT00634244|27035239|P2|Overall Study|Never started treatment|1
7777541|NCT00634244|27035240|P1|Overall Study|Never started treatment|0
7777542|NCT00634179|27035251|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
7777543|NCT00634114|27035270|P3|Overall Study|Other reason|1
7777544|NCT00634114|27035271|P2|Overall Study|Other reason|1
7777545|NCT00634114|27035272|P1|Overall Study|Other reason|1
7777546|NCT00634114|27035270|P3|Overall Study|Difficult to continue|1
7777547|NCT00634114|27035271|P2|Overall Study|Difficult to continue|1
7777548|NCT00634114|27035272|P1|Overall Study|Difficult to continue|3
7777549|NCT00634114|27035270|P3|Overall Study|Recurrence of reflux esophagitis|21
7777550|NCT00634114|27035271|P2|Overall Study|Recurrence of reflux esophagitis|15
7777551|NCT00634114|27035272|P1|Overall Study|Recurrence of reflux esophagitis|5
7777552|NCT00634114|27035270|P3|Overall Study|Incorrect enrolment|0
7777553|NCT00634114|27035271|P2|Overall Study|Incorrect enrolment|1
7777554|NCT00634114|27035272|P1|Overall Study|Incorrect enrolment|0
7777555|NCT00634114|27035270|P3|Overall Study|Pregnancy|0
7777556|NCT00634114|27035271|P2|Overall Study|Pregnancy|0
7777557|NCT00634114|27035272|P1|Overall Study|Pregnancy|1
7777558|NCT00634114|27035270|P3|Overall Study|Protocol Violation|1
7777559|NCT00634114|27035271|P2|Overall Study|Protocol Violation|3
7777560|NCT00634114|27035272|P1|Overall Study|Protocol Violation|3
7777561|NCT00634114|27035270|P3|Overall Study|Lost to Follow-up|1
7777562|NCT00634114|27035271|P2|Overall Study|Lost to Follow-up|0
7777563|NCT00634114|27035272|P1|Overall Study|Lost to Follow-up|0
7777564|NCT00634114|27035270|P3|Overall Study|Withdrawal by Subject|11
7777565|NCT00634114|27035271|P2|Overall Study|Withdrawal by Subject|6
7777566|NCT00634114|27035272|P1|Overall Study|Withdrawal by Subject|9
7777567|NCT00634114|27035270|P3|Overall Study|Adverse Event|3
7777568|NCT00634114|27035271|P2|Overall Study|Adverse Event|8
7777569|NCT00634114|27035272|P1|Overall Study|Adverse Event|6
7777570|NCT00634101|27035288|P2|Overall Study|Lost to Follow-up|0
7777571|NCT00634101|27035289|P1|Overall Study|Lost to Follow-up|2
7777572|NCT00634101|27035288|P2|Overall Study|Study Terminated|3
7777573|NCT00634101|27035289|P1|Overall Study|Study Terminated|3
7777574|NCT00634088|27035323|P4|Time Period 3: Dose Level 3|Progressive disease|0
7777575|NCT00634088|27035324|P3|Time Period 3: Dose Level 3|Progressive disease|1
7777576|NCT00634088|27035325|P2|Time Period 3: Dose Level 3|Progressive disease|0
7777577|NCT00634088|27035326|P1|Time Period 3: Dose Level 3|Progressive disease|0
7777578|NCT00634088|27035323|P4|Time Period 2: Dose Level 2|Progressive disease|0
7777579|NCT00634088|27035324|P3|Time Period 2: Dose Level 2|Progressive disease|0
7777580|NCT00634088|27035325|P2|Time Period 2: Dose Level 2|Progressive disease|1
7777581|NCT00634088|27035326|P1|Time Period 2: Dose Level 2|Progressive disease|0
7777582|NCT00634088|27035323|P4|Time Period 2: Dose Level 2|Adverse Event|0
7777583|NCT00634088|27035324|P3|Time Period 2: Dose Level 2|Adverse Event|0
7777584|NCT00634088|27035325|P2|Time Period 2: Dose Level 2|Adverse Event|2
7777585|NCT00634088|27035326|P1|Time Period 2: Dose Level 2|Adverse Event|0
7777586|NCT00634088|27035323|P4|Time Period 1: Dose Level 1|Adverse Event|0
7777587|NCT00634088|27035324|P3|Time Period 1: Dose Level 1|Adverse Event|0
7777588|NCT00634088|27035325|P2|Time Period 1: Dose Level 1|Adverse Event|0
7777589|NCT00634088|27035326|P1|Time Period 1: Dose Level 1|Adverse Event|3
7777590|NCT00634088|27035323|P4|Time Period 1: Dose Level 1|Physician Decision|0
7777591|NCT00634088|27035324|P3|Time Period 1: Dose Level 1|Physician Decision|0
7777592|NCT00634088|27035325|P2|Time Period 1: Dose Level 1|Physician Decision|0
7777593|NCT00634088|27035326|P1|Time Period 1: Dose Level 1|Physician Decision|1
7777594|NCT00634088|27035323|P4|Time Period 1: Dose Level 1|Disease progression|0
7777595|NCT00634088|27035324|P3|Time Period 1: Dose Level 1|Disease progression|0
7777596|NCT00634088|27035325|P2|Time Period 1: Dose Level 1|Disease progression|0
7777597|NCT00634088|27035326|P1|Time Period 1: Dose Level 1|Disease progression|2
7777598|NCT00634049|27035377|P1|Overall Study|Screening failure|1
7777599|NCT00634049|27035377|P1|Overall Study|Died prior to receiving study drug|1
7777600|NCT00634049|27035377|P1|Overall Study|Never received study drug|1
7777601|NCT00634036|27035456|P2|Overall Study|Withdrawal by Subject|1
7777602|NCT00634036|27035457|P1|Overall Study|Withdrawal by Subject|1
7777603|NCT00634036|27035456|P2|Overall Study|Lost to Follow-up|1
7777604|NCT00634036|27035457|P1|Overall Study|Lost to Follow-up|1
7777605|NCT00634010|27035471|P2|Overall Study|Non-Compliant|1
7777606|NCT00634010|27035472|P1|Overall Study|Non-Compliant|1
7777607|NCT00634010|27035471|P2|Overall Study|Disease Progression|1
7777608|NCT00634010|27035472|P1|Overall Study|Disease Progression|1
7777609|NCT00634010|27035471|P2|Overall Study|Physician Decision|1
7777610|NCT00634010|27035472|P1|Overall Study|Physician Decision|1
7777611|NCT00634010|27035471|P2|Overall Study|Withdrawal by Subject|6
7777612|NCT00634010|27035472|P1|Overall Study|Withdrawal by Subject|5
7777613|NCT00634010|27035471|P2|Overall Study|Adverse Event|5
7777614|NCT00634010|27035472|P1|Overall Study|Adverse Event|2
7777615|NCT00633984|27035480|P2|Overall Study|Hospitalized|0
7777616|NCT00633984|27035481|P1|Overall Study|Hospitalized|1
7777617|NCT00633984|27035480|P2|Overall Study|Withdrawal by Subject|7
7777618|NCT00633984|27035481|P1|Overall Study|Withdrawal by Subject|8
7777619|NCT00633984|27035480|P2|Overall Study|Lost to Follow-up|6
7777620|NCT00633984|27035481|P1|Overall Study|Lost to Follow-up|0
7777621|NCT00633945|27035489|P1|Overall Study|Physician Decision|2
7777622|NCT00633932|27035505|P3|Overall Study|Moved Away|0
7777623|NCT00633932|27035506|P2|Overall Study|Moved Away|0
7777624|NCT00633932|27035507|P1|Overall Study|Moved Away|1
7777625|NCT00633932|27035505|P3|Overall Study|Doctor's judgement|0
7777626|NCT00633932|27035506|P2|Overall Study|Doctor's judgement|0
7777627|NCT00633932|27035507|P1|Overall Study|Doctor's judgement|1
7777628|NCT00633932|27035505|P3|Overall Study|Physician Decision|1
7777629|NCT00633932|27035506|P2|Overall Study|Physician Decision|0
7777630|NCT00633932|27035507|P1|Overall Study|Physician Decision|0
7777631|NCT00633932|27035505|P3|Overall Study|Protocol Violation|3
7777632|NCT00633932|27035506|P2|Overall Study|Protocol Violation|2
7777633|NCT00633932|27035507|P1|Overall Study|Protocol Violation|5
7777634|NCT00633932|27035505|P3|Overall Study|Lost to Follow-up|2
7777635|NCT00633932|27035506|P2|Overall Study|Lost to Follow-up|0
7777636|NCT00633932|27035507|P1|Overall Study|Lost to Follow-up|1
7777637|NCT00633932|27035505|P3|Overall Study|Withdrawal by Subject|1
7777638|NCT00633932|27035506|P2|Overall Study|Withdrawal by Subject|9
7777639|NCT00633932|27035507|P1|Overall Study|Withdrawal by Subject|3
7777640|NCT00633932|27035505|P3|Overall Study|Adverse Event|4
7777641|NCT00633932|27035506|P2|Overall Study|Adverse Event|3
7777642|NCT00633932|27035507|P1|Overall Study|Adverse Event|1
7777643|NCT00633893|27035538|P3|Overall Study|Other|31
7777644|NCT00633893|27035539|P2|Overall Study|Other|33
7777645|NCT00633893|27035540|P1|Overall Study|Other|28
7777646|NCT00633893|27035538|P3|Overall Study|Not meet/no longer meets criteria|4
7777647|NCT00633893|27035539|P2|Overall Study|Not meet/no longer meets criteria|6
7777648|NCT00633893|27035540|P1|Overall Study|Not meet/no longer meets criteria|4
7777649|NCT00633893|27035538|P3|Overall Study|Pregnancy|1
7777650|NCT00633893|27035539|P2|Overall Study|Pregnancy|1
7777651|NCT00633893|27035540|P1|Overall Study|Pregnancy|2
7777652|NCT00633893|27035538|P3|Overall Study|Poor/non-compliance|3
7777653|NCT00633893|27035539|P2|Overall Study|Poor/non-compliance|12
7777654|NCT00633893|27035540|P1|Overall Study|Poor/non-compliance|5
7777655|NCT00633893|27035538|P3|Overall Study|Lost to Follow-up|8
7777656|NCT00633893|27035539|P2|Overall Study|Lost to Follow-up|4
7777657|NCT00633893|27035540|P1|Overall Study|Lost to Follow-up|2
7777658|NCT00633893|27035538|P3|Overall Study|Withdrawal by Subject|6
7777659|NCT00633893|27035539|P2|Overall Study|Withdrawal by Subject|12
7777660|NCT00633893|27035540|P1|Overall Study|Withdrawal by Subject|7
7777661|NCT00633893|27035538|P3|Overall Study|Adverse Event|126
7777662|NCT00633893|27035539|P2|Overall Study|Adverse Event|58
7777663|NCT00633893|27035540|P1|Overall Study|Adverse Event|65
7777664|NCT00633893|27035538|P3|Overall Study|Death|9
7777665|NCT00633893|27035539|P2|Overall Study|Death|3
7777666|NCT00633893|27035540|P1|Overall Study|Death|1
7777667|NCT00633880|27035614|P3|Open Label Titration|Withdrawal by Subject|0
7777668|NCT00633880|27035615|P2|Open Label Titration|Withdrawal by Subject|0
7777669|NCT00633880|27035616|P1|Open Label Titration|Withdrawal by Subject|4
7777670|NCT00633880|27035614|P3|Open Label Titration|Physician Decision|0
7777671|NCT00633880|27035615|P2|Open Label Titration|Physician Decision|0
7777672|NCT00633880|27035616|P1|Open Label Titration|Physician Decision|1
7777673|NCT00633880|27035614|P3|Open Label Titration|Protocol Violation|0
7777674|NCT00633880|27035615|P2|Open Label Titration|Protocol Violation|0
7777675|NCT00633880|27035616|P1|Open Label Titration|Protocol Violation|6
7777676|NCT00633880|27035614|P3|Open Label Titration|Treatment Failure|0
7777677|NCT00633880|27035615|P2|Open Label Titration|Treatment Failure|0
7777678|NCT00633880|27035616|P1|Open Label Titration|Treatment Failure|55
7777679|NCT00633880|27035614|P3|Open Label Titration|Adverse Event|0
7777680|NCT00633880|27035615|P2|Open Label Titration|Adverse Event|0
7777681|NCT00633880|27035616|P1|Open Label Titration|Adverse Event|13
7777682|NCT00633880|27035614|P3|Open Label Titration|Lack of Efficacy|0
7777683|NCT00633880|27035615|P2|Open Label Titration|Lack of Efficacy|0
7777684|NCT00633880|27035616|P1|Open Label Titration|Lack of Efficacy|1
7777685|NCT00633750|27035652|P1|Overall Study|Withdrawal by Subject|3
7777686|NCT00633750|27035652|P1|Overall Study|Adverse Event|2
7777687|NCT00633594|27035661|P3|Overall Study|Disease Progression|1
7777688|NCT00633594|27035662|P2|Overall Study|Disease Progression|0
7777689|NCT00633594|27035663|P1|Overall Study|Disease Progression|0
7777690|NCT00633594|27035661|P3|Overall Study|Death|2
7777691|NCT00633594|27035662|P2|Overall Study|Death|1
7777692|NCT00633594|27035663|P1|Overall Study|Death|0
7777693|NCT00633594|27035661|P3|Overall Study|Adverse Event|7
7777694|NCT00633594|27035662|P2|Overall Study|Adverse Event|4
7777695|NCT00633594|27035663|P1|Overall Study|Adverse Event|0
7777696|NCT00633477|27035692|P2|Overall Study|Randomized but not treated|0
7777697|NCT00633477|27035693|P1|Overall Study|Randomized but not treated|1
7777698|NCT00633477|27035692|P2|Overall Study|Death|0
7777699|NCT00633477|27035693|P1|Overall Study|Death|1
7777700|NCT00633464|27035709|P2|Overall Study|Never Treated (Randomized in error)|1
7777701|NCT00633464|27035710|P1|Overall Study|Never Treated (Randomized in error)|0
7777702|NCT00633464|27035709|P2|Overall Study|Never Treated (Not met study criteria)|1
7777703|NCT00633464|27035710|P1|Overall Study|Never Treated (Not met study criteria)|0
7777704|NCT00633360|27035745|P2|Overall Study|Protocol Violation|1
7777705|NCT00633360|27035746|P1|Overall Study|Protocol Violation|0
7777706|NCT00633360|27035745|P2|Overall Study|Adverse Event|1
7777707|NCT00633360|27035746|P1|Overall Study|Adverse Event|3
7777708|NCT00633360|27035745|P2|Overall Study|Lost to Follow-up|1
7777709|NCT00633360|27035746|P1|Overall Study|Lost to Follow-up|1
7777710|NCT00633243|27035769|P2|Overall Study|Couldn't tolerate side-effects|1
7777711|NCT00633243|27035770|P1|Overall Study|Couldn't tolerate side-effects|1
7777712|NCT00633243|27035769|P2|Overall Study|Mental Health--Depression|1
7777713|NCT00633243|27035770|P1|Overall Study|Mental Health--Depression|0
7777714|NCT00633243|27035769|P2|Overall Study|Not comfortable with self-injecting|1
7777715|NCT00633243|27035770|P1|Overall Study|Not comfortable with self-injecting|0
7777716|NCT00633243|27035769|P2|Overall Study|Homeless--no refrigeration for meds|1
7777717|NCT00633243|27035770|P1|Overall Study|Homeless--no refrigeration for meds|0
7777718|NCT00633243|27035769|P2|Overall Study|incarceration|2
7777719|NCT00633243|27035770|P1|Overall Study|incarceration|0
7777720|NCT00633243|27035769|P2|Overall Study|Withdrawal by Subject|1
7777721|NCT00633243|27035770|P1|Overall Study|Withdrawal by Subject|0
7777722|NCT00633217|27035778|P2|Overall Study|Withdrew Consent|3
7777723|NCT00633217|27035779|P1|Overall Study|Withdrew Consent|3
7777724|NCT00633217|27035778|P2|Overall Study|Investigator Discretion|0
7777725|NCT00633217|27035779|P1|Overall Study|Investigator Discretion|2
7777726|NCT00633217|27035778|P2|Overall Study|Lost to Follow-up|2
7777727|NCT00633217|27035779|P1|Overall Study|Lost to Follow-up|2
7777728|NCT00633217|27035778|P2|Overall Study|Protocol Violation|7
7777729|NCT00633217|27035779|P1|Overall Study|Protocol Violation|3
7777730|NCT00633217|27035778|P2|Overall Study|Lack of Efficacy|2
7777731|NCT00633217|27035779|P1|Overall Study|Lack of Efficacy|0
7777732|NCT00633217|27035778|P2|Overall Study|Adverse Event|9
7777733|NCT00633217|27035779|P1|Overall Study|Adverse Event|5
7777734|NCT00633152|27035791|P2|Overall Study|Miscellaneous Other|2
7777735|NCT00633152|27035792|P1|Overall Study|Miscellaneous Other|3
7777736|NCT00633152|27035791|P2|Overall Study|Lost to Follow-up|1
7777737|NCT00633152|27035792|P1|Overall Study|Lost to Follow-up|4
7777738|NCT00633152|27035791|P2|Overall Study|Withdrawal by Subject|1
7777739|NCT00633152|27035792|P1|Overall Study|Withdrawal by Subject|1
7777740|NCT00633152|27035791|P2|Overall Study|Randomized, did not receive study drug|2
7777741|NCT00633152|27035792|P1|Overall Study|Randomized, did not receive study drug|5
7777742|NCT00633152|27035791|P2|Overall Study|Adverse Event|0
7777743|NCT00633152|27035792|P1|Overall Study|Adverse Event|1
7777744|NCT00633139|27035803|P3|Overall Study|Withdrawal by Subject|0
7777745|NCT00633139|27035804|P2|Overall Study|Withdrawal by Subject|1
7777746|NCT00633139|27035805|P1|Overall Study|Withdrawal by Subject|0
7777747|NCT00633139|27035803|P3|Overall Study|Non compliance|1
7777748|NCT00633139|27035804|P2|Overall Study|Non compliance|0
7777749|NCT00633139|27035805|P1|Overall Study|Non compliance|0
7777750|NCT00633126|27035819|P1|Overall Study|Did not receive full dose|1
7777751|NCT00633074|27035833|P2|Overall Study|Adverse Event|0
7777752|NCT00633074|27035834|P1|Overall Study|Adverse Event|1
7777753|NCT00633061|27035864|P2|Overall Study|Study closed|0
7777754|NCT00633061|27035865|P1|Overall Study|Study closed|86
7777755|NCT00633022|27035876|P3|Overall Study|Physician Decision|0
7777756|NCT00633022|27035877|P2|Overall Study|Physician Decision|1
7777757|NCT00633022|27035878|P1|Overall Study|Physician Decision|0
7777758|NCT00633022|27035876|P3|Overall Study|Adverse Event|5
7777759|NCT00633022|27035877|P2|Overall Study|Adverse Event|0
7777760|NCT00633022|27035878|P1|Overall Study|Adverse Event|1
7777761|NCT00632931|27035940|P3|Part 2|Withdrawal by Subject|3
7777762|NCT00632931|27035941|P2|Part 2|Withdrawal by Subject|0
7777763|NCT00632931|27035942|P1|Part 2|Withdrawal by Subject|0
7777764|NCT00632931|27035940|P3|Part 2|Lack of Efficacy|17
7777765|NCT00632931|27035941|P2|Part 2|Lack of Efficacy|0
7777766|NCT00632931|27035942|P1|Part 2|Lack of Efficacy|0
7777767|NCT00632931|27035940|P3|Part 2|Death|1
7777768|NCT00632931|27035941|P2|Part 2|Death|0
7777769|NCT00632931|27035942|P1|Part 2|Death|0
7777770|NCT00632931|27035940|P3|Part 2|Adverse Event|3
7777771|NCT00632931|27035941|P2|Part 2|Adverse Event|0
7777772|NCT00632931|27035942|P1|Part 2|Adverse Event|0
7777773|NCT00632931|27035940|P3|Part 1, Period 1|Withdrawal by Subject|0
7777774|NCT00632931|27035941|P2|Part 1, Period 1|Withdrawal by Subject|0
7777775|NCT00632931|27035942|P1|Part 1, Period 1|Withdrawal by Subject|1
7777776|NCT00632931|27035940|P3|Part 1, Period 1|Protocol Violation|0
7777777|NCT00632931|27035941|P2|Part 1, Period 1|Protocol Violation|0
7777778|NCT00632931|27035942|P1|Part 1, Period 1|Protocol Violation|1
7777779|NCT00632827|27035961|P1|Overall Study|Lost to Follow-up|1
7777780|NCT00632827|27035961|P1|Overall Study|Adverse Event|5
7777781|NCT00632827|27035961|P1|Overall Study|Death|2
7777782|NCT00632827|27035961|P1|Overall Study|Excluded after GVD (Not evaluable)|2
7777783|NCT00632749|27036019|P14|Overall Study|Reason other than those specified above|2
7777784|NCT00632749|27036020|P13|Overall Study|Reason other than those specified above|0
7777785|NCT00632749|27036021|P12|Overall Study|Reason other than those specified above|1
7777786|NCT00632749|27036022|P11|Overall Study|Reason other than those specified above|2
7777787|NCT00632749|27036023|P10|Overall Study|Reason other than those specified above|0
7777788|NCT00632749|27036024|P9|Overall Study|Reason other than those specified above|0
7777789|NCT00632749|27036025|P8|Overall Study|Reason other than those specified above|0
7777790|NCT00632749|27036026|P7|Overall Study|Reason other than those specified above|1
7777791|NCT00632749|27036027|P6|Overall Study|Reason other than those specified above|0
7777792|NCT00632749|27036028|P5|Overall Study|Reason other than those specified above|1
7777793|NCT00632749|27036029|P4|Overall Study|Reason other than those specified above|0
7777794|NCT00632749|27036030|P3|Overall Study|Reason other than those specified above|0
7777795|NCT00632749|27036031|P2|Overall Study|Reason other than those specified above|2
7777796|NCT00632749|27036032|P1|Overall Study|Reason other than those specified above|0
7777797|NCT00632749|27036019|P14|Overall Study|Refuse to continue medication|0
7777798|NCT00632749|27036020|P13|Overall Study|Refuse to continue medication|0
7777799|NCT00632749|27036021|P12|Overall Study|Refuse to continue medication|0
7777800|NCT00632749|27036022|P11|Overall Study|Refuse to continue medication|0
7777801|NCT00632749|27036023|P10|Overall Study|Refuse to continue medication|1
7777802|NCT00632749|27036024|P9|Overall Study|Refuse to continue medication|0
7777803|NCT00632749|27036025|P8|Overall Study|Refuse to continue medication|0
7777804|NCT00632749|27036026|P7|Overall Study|Refuse to continue medication|0
7777805|NCT00632749|27036027|P6|Overall Study|Refuse to continue medication|0
7777806|NCT00632749|27036028|P5|Overall Study|Refuse to continue medication|0
7777807|NCT00632749|27036029|P4|Overall Study|Refuse to continue medication|1
7777808|NCT00632749|27036030|P3|Overall Study|Refuse to continue medication|0
7777809|NCT00632749|27036031|P2|Overall Study|Refuse to continue medication|0
7777810|NCT00632749|27036032|P1|Overall Study|Refuse to continue medication|0
7777811|NCT00632749|27036019|P14|Overall Study|Other Adverse event|0
7777812|NCT00632749|27036020|P13|Overall Study|Other Adverse event|1
7777813|NCT00632749|27036021|P12|Overall Study|Other Adverse event|0
7777814|NCT00632749|27036022|P11|Overall Study|Other Adverse event|1
7777815|NCT00632749|27036023|P10|Overall Study|Other Adverse event|0
7777816|NCT00632749|27036024|P9|Overall Study|Other Adverse event|2
7777817|NCT00632749|27036025|P8|Overall Study|Other Adverse event|2
7777818|NCT00632749|27036026|P7|Overall Study|Other Adverse event|1
7777819|NCT00632749|27036027|P6|Overall Study|Other Adverse event|4
7777820|NCT00632749|27036028|P5|Overall Study|Other Adverse event|2
7777821|NCT00632749|27036029|P4|Overall Study|Other Adverse event|1
7777822|NCT00632749|27036030|P3|Overall Study|Other Adverse event|1
7777823|NCT00632749|27036031|P2|Overall Study|Other Adverse event|1
7777824|NCT00632749|27036032|P1|Overall Study|Other Adverse event|1
7777825|NCT00632749|27036019|P14|Overall Study|Progressive disease|4
7777826|NCT00632749|27036020|P13|Overall Study|Progressive disease|2
7777827|NCT00632749|27036021|P12|Overall Study|Progressive disease|3
7777828|NCT00632749|27036022|P11|Overall Study|Progressive disease|4
7777829|NCT00632749|27036023|P10|Overall Study|Progressive disease|2
7777830|NCT00632749|27036024|P9|Overall Study|Progressive disease|3
7777831|NCT00632749|27036025|P8|Overall Study|Progressive disease|2
7777832|NCT00632749|27036026|P7|Overall Study|Progressive disease|3
7777833|NCT00632749|27036027|P6|Overall Study|Progressive disease|4
7777834|NCT00632749|27036028|P5|Overall Study|Progressive disease|4
7777835|NCT00632749|27036029|P4|Overall Study|Progressive disease|2
7777836|NCT00632749|27036030|P3|Overall Study|Progressive disease|2
7777837|NCT00632749|27036031|P2|Overall Study|Progressive disease|2
7777838|NCT00632749|27036032|P1|Overall Study|Progressive disease|3
7777839|NCT00632736|27036326|P1|Overall Study|Other|16
7777840|NCT00632736|27036326|P1|Overall Study|Non-compliance|10
7777841|NCT00632736|27036326|P1|Overall Study|Sponsor terminated study|5
7777842|NCT00632736|27036326|P1|Overall Study|Lack of Efficacy|5
7777843|NCT00632736|27036326|P1|Overall Study|Withdrawal by Subject|99
7777844|NCT00632736|27036326|P1|Overall Study|Protocol Violation|14
7777845|NCT00632736|27036326|P1|Overall Study|Lost to Follow-up|15
7777846|NCT00632736|27036326|P1|Overall Study|Adverse Event|104
7777847|NCT00632541|27036361|P1|Overall Study|Adverse Event|7
7777848|NCT00632502|27036370|P2|Overall Study|Randomized not treated|0
7777849|NCT00632502|27036371|P1|Overall Study|Randomized not treated|3
7777850|NCT00632502|27036370|P2|Overall Study|Adverse Event|1
7777851|NCT00632502|27036371|P1|Overall Study|Adverse Event|0
7777852|NCT00632463|27036415|P3|Overall Study|Adverse Event|0
7777853|NCT00632463|27036416|P2|Overall Study|Adverse Event|1
7777854|NCT00632463|27036417|P1|Overall Study|Adverse Event|0
7777855|NCT00632424|27036434|P1|Overall Study|Study Drug Toxicity|1
7777856|NCT00632424|27036434|P1|Overall Study|Disease Progression|17
7777857|NCT00632359|27036465|P1|Overall Study|Withdrawal by Subject|2
7777858|NCT00632229|27036478|P2|Overall Study|Undisclosed reasons within the first wee|1
7777859|NCT00632229|27036479|P1|Overall Study|Undisclosed reasons within the first wee|0
7777860|NCT00632229|27036478|P2|Overall Study|Lack of Efficacy|2
7777861|NCT00632229|27036479|P1|Overall Study|Lack of Efficacy|0
7777862|NCT00632229|27036478|P2|Overall Study|Lost to Follow-up|3
7777863|NCT00632229|27036479|P1|Overall Study|Lost to Follow-up|0
7777864|NCT00632229|27036478|P2|Overall Study|Adverse Event|0
7777865|NCT00632229|27036479|P1|Overall Study|Adverse Event|6
7777866|NCT00632203|27036489|P2|Overall Study|Did not start study treatment|0
7777867|NCT00632203|27036490|P1|Overall Study|Did not start study treatment|1
7777868|NCT00632125|27036508|P1|Overall Study|Moved to other dialysis unit, etc.|102
7777869|NCT00632125|27036508|P1|Overall Study|Development of uncontrolled hypertension|5
7777870|NCT00632125|27036508|P1|Overall Study|Non-compliance|8
7777871|NCT00632125|27036508|P1|Overall Study|Need for systemic immunosuppressive medi|8
7777872|NCT00632125|27036508|P1|Overall Study|Renal transplantation|17
7777873|NCT00632125|27036508|P1|Overall Study|Adverse Event|36
7777874|NCT00632125|27036508|P1|Overall Study|Withdrawal by Subject|44
7777875|NCT00632125|27036508|P1|Overall Study|Death|82
7777876|NCT00632099|27036514|P2|Overall Study|Lost to Follow-up|3
7777877|NCT00632099|27036515|P1|Overall Study|Lost to Follow-up|3
7777878|NCT00632021|27036523|P2|Overall Study|Withdrawal/death|7
7777879|NCT00632021|27036524|P1|Overall Study|Withdrawal/death|4
7777880|NCT00631969|27036534|P2|Overall Study|No Drug Exposure|2
7777881|NCT00631969|27036535|P1|Overall Study|No Drug Exposure|2
7777882|NCT00631969|27036534|P2|Overall Study|Noncompliant With Study Medication|1
7777883|NCT00631969|27036535|P1|Overall Study|Noncompliant With Study Medication|0
7777884|NCT00631969|27036534|P2|Overall Study|Consent Withdrawn|7
7777885|NCT00631969|27036535|P1|Overall Study|Consent Withdrawn|5
7777886|NCT00631969|27036534|P2|Overall Study|Protocol Violation|1
7777887|NCT00631969|27036535|P1|Overall Study|Protocol Violation|1
7777888|NCT00631969|27036534|P2|Overall Study|Lost to Follow-up|1
7777889|NCT00631969|27036535|P1|Overall Study|Lost to Follow-up|2
7777890|NCT00631969|27036534|P2|Overall Study|Lack of Efficacy|8
7777891|NCT00631969|27036535|P1|Overall Study|Lack of Efficacy|2
7777892|NCT00631969|27036534|P2|Overall Study|Adverse Event|1
7777893|NCT00631969|27036535|P1|Overall Study|Adverse Event|3
7777894|NCT00631917|27036581|P2|Overall Study|Death|0
7777895|NCT00631917|27036582|P1|Overall Study|Death|1
7777896|NCT00631917|27036581|P2|Overall Study|Administrative problems|0
7777897|NCT00631917|27036582|P1|Overall Study|Administrative problems|2
7777898|NCT00631917|27036581|P2|Overall Study|Lost to Follow-up|7
7777899|NCT00631917|27036582|P1|Overall Study|Lost to Follow-up|7
7777900|NCT00631917|27036581|P2|Overall Study|Subject withdrew consent|33
7777901|NCT00631917|27036582|P1|Overall Study|Subject withdrew consent|25
7777902|NCT00631917|27036581|P2|Overall Study|Protocol deviation|5
7777903|NCT00631917|27036582|P1|Overall Study|Protocol deviation|6
7777904|NCT00631917|27036581|P2|Overall Study|No longer required study drug|1
7777905|NCT00631917|27036582|P1|Overall Study|No longer required study drug|0
7777906|NCT00631917|27036581|P2|Overall Study|Unsatisfactory therapeutic effect|14
7777907|NCT00631917|27036582|P1|Overall Study|Unsatisfactory therapeutic effect|8
7777908|NCT00631917|27036581|P2|Overall Study|Abnormal test procedure result(s)|2
7777909|NCT00631917|27036582|P1|Overall Study|Abnormal test procedure result(s)|3
7777910|NCT00631917|27036581|P2|Overall Study|Abnormal laboratory value(s)|1
7777911|NCT00631917|27036582|P1|Overall Study|Abnormal laboratory value(s)|2
7777912|NCT00631917|27036581|P2|Overall Study|Adverse Event|45
7777913|NCT00631917|27036582|P1|Overall Study|Adverse Event|34
7777914|NCT00631696|27036609|P2|Overall Study|Adverse Event|0
7777915|NCT00631696|27036610|P1|Overall Study|Adverse Event|5
7777916|NCT00631696|27036609|P2|Overall Study|Study terminated by sponsor|3
7777917|NCT00631696|27036610|P1|Overall Study|Study terminated by sponsor|3
7777918|NCT00631696|27036609|P2|Overall Study|Protocol Violation|9
7777919|NCT00631696|27036610|P1|Overall Study|Protocol Violation|9
7777920|NCT00631696|27036609|P2|Overall Study|Other|8
7777921|NCT00631696|27036610|P1|Overall Study|Other|8
7777922|NCT00631696|27036609|P2|Overall Study|Withdrawal by Subject|9
7777923|NCT00631696|27036610|P1|Overall Study|Withdrawal by Subject|2
7777924|NCT00631696|27036609|P2|Overall Study|Lost to Follow-up|10
7777925|NCT00631696|27036610|P1|Overall Study|Lost to Follow-up|7
7777926|NCT00631696|27036609|P2|Overall Study|Follow up after database release date|0
7777927|NCT00631696|27036610|P1|Overall Study|Follow up after database release date|1
7777928|NCT00631696|27036609|P2|Overall Study|Discontinued after database release date|0
7777929|NCT00631696|27036610|P1|Overall Study|Discontinued after database release date|1
7777930|NCT00631696|27036609|P2|Overall Study|Entered, not randomized to treatment|1
7777931|NCT00631696|27036610|P1|Overall Study|Entered, not randomized to treatment|1
7777932|NCT00631657|27036653|P3|7-Day Discontinuation Period|Other|0
7777933|NCT00631657|27036654|P2|7-Day Discontinuation Period|Other|0
7777934|NCT00631657|27036655|P1|7-Day Discontinuation Period|Other|1
7777935|NCT00631657|27036653|P3|7-Day Discontinuation Period|Not Treated|1
7777936|NCT00631657|27036654|P2|7-Day Discontinuation Period|Not Treated|1
7777937|NCT00631657|27036655|P1|7-Day Discontinuation Period|Not Treated|1
7777938|NCT00631657|27036653|P3|6-Month Treatment Period|Not Treated|1
7777939|NCT00631657|27036654|P2|6-Month Treatment Period|Not Treated|0
7777940|NCT00631657|27036655|P1|6-Month Treatment Period|Not Treated|2
7777941|NCT00631657|27036653|P3|6-Month Treatment Period|Other|4
7777942|NCT00631657|27036654|P2|6-Month Treatment Period|Other|0
7777943|NCT00631657|27036655|P1|6-Month Treatment Period|Other|16
7777944|NCT00631657|27036653|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
7777945|NCT00631657|27036654|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
7777946|NCT00631657|27036655|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
7777947|NCT00631657|27036653|P3|6-Month Treatment Period|Lost to Follow-up|2
7777948|NCT00631657|27036654|P2|6-Month Treatment Period|Lost to Follow-up|0
7777949|NCT00631657|27036655|P1|6-Month Treatment Period|Lost to Follow-up|7
7777950|NCT00631657|27036653|P3|6-Month Treatment Period|Lack of Efficacy|25
7777951|NCT00631657|27036654|P2|6-Month Treatment Period|Lack of Efficacy|0
7777952|NCT00631657|27036655|P1|6-Month Treatment Period|Lack of Efficacy|34
7777953|NCT00631657|27036653|P3|6-Month Treatment Period|Withdrawal by Subject|5
7777954|NCT00631657|27036654|P2|6-Month Treatment Period|Withdrawal by Subject|0
7777955|NCT00631657|27036655|P1|6-Month Treatment Period|Withdrawal by Subject|14
7777956|NCT00631657|27036653|P3|6-Month Treatment Period|Adverse Event|7
7777957|NCT00631657|27036654|P2|6-Month Treatment Period|Adverse Event|0
7777958|NCT00631657|27036655|P1|6-Month Treatment Period|Adverse Event|47
7777959|NCT00631540|27036704|P1|Overall Study|Core Lab Data Unavailable|3
7777960|NCT00631540|27036704|P1|Overall Study|Lost to Follow-up|2
7777961|NCT00631540|27036704|P1|Overall Study|Death|4
7777962|NCT00631540|27036704|P1|Overall Study|Withdrawal by Subject|5
7777963|NCT00631488|27036716|P3|Overall Study|Protocol Violation|1
7777964|NCT00631488|27036717|P2|Overall Study|Protocol Violation|0
7777965|NCT00631488|27036718|P1|Overall Study|Protocol Violation|0
7777966|NCT00631488|27036716|P3|Overall Study|Physician Decision|1
7777967|NCT00631488|27036717|P2|Overall Study|Physician Decision|0
7777968|NCT00631488|27036718|P1|Overall Study|Physician Decision|1
7777969|NCT00631488|27036716|P3|Overall Study|Lost to Follow-up|0
7777970|NCT00631488|27036717|P2|Overall Study|Lost to Follow-up|2
7777971|NCT00631488|27036718|P1|Overall Study|Lost to Follow-up|2
7777972|NCT00631488|27036716|P3|Overall Study|Adverse Event|0
7777973|NCT00631488|27036717|P2|Overall Study|Adverse Event|0
7777974|NCT00631488|27036718|P1|Overall Study|Adverse Event|1
7777975|NCT00631475|27036738|P1|Overall Study|Preparation for lung transplant|8
7777976|NCT00631475|27036738|P1|Overall Study|Withdrew consent|5
7777977|NCT00631475|27036738|P1|Overall Study|Adverse Event|14
7777978|NCT00631475|27036738|P1|Overall Study|Death|18
7777979|NCT00631410|27036759|P2|Overall Study|Surgery|0
7777980|NCT00631410|27036760|P1|Overall Study|Surgery|1
7777981|NCT00631410|27036759|P2|Overall Study|Objective Progression or Relapse|3
7777982|NCT00631410|27036760|P1|Overall Study|Objective Progression or Relapse|4
7777983|NCT00631410|27036759|P2|Overall Study|Adverse Event|3
7777984|NCT00631410|27036760|P1|Overall Study|Adverse Event|1
7777985|NCT00631371|27036779|P2|Overall Study|Death|239
7777986|NCT00631371|27036780|P1|Overall Study|Death|263
7777987|NCT00631371|27036779|P2|Overall Study|Discontinuation of study by Sponsor|76
7777988|NCT00631371|27036780|P1|Overall Study|Discontinuation of study by Sponsor|70
7777989|NCT00631371|27036779|P2|Overall Study|subject request|45
7777990|NCT00631371|27036780|P1|Overall Study|subject request|38
7777991|NCT00631371|27036779|P2|Overall Study|Other reason|12
7777992|NCT00631371|27036780|P1|Overall Study|Other reason|5
7777993|NCT00631371|27036779|P2|Overall Study|Lost to Follow-up|19
7777994|NCT00631371|27036780|P1|Overall Study|Lost to Follow-up|24
7777995|NCT00631189|27036823|P4|Treatment Phase|patient did not take pravastatin|0
7777996|NCT00631189|27036824|P3|Treatment Phase|patient did not take pravastatin|1
7777997|NCT00631189|27036825|P2|Treatment Phase|patient did not take pravastatin|0
7777998|NCT00631189|27036826|P1|Treatment Phase|patient did not take pravastatin|0
7777999|NCT00631189|27036823|P4|Treatment Phase|Pregnancy|0
7778000|NCT00631189|27036824|P3|Treatment Phase|Pregnancy|1
7778001|NCT00631189|27036825|P2|Treatment Phase|Pregnancy|0
7778002|NCT00631189|27036826|P1|Treatment Phase|Pregnancy|0
7778003|NCT00631189|27036823|P4|Treatment Phase|Lost to Follow-up|0
7778004|NCT00631189|27036824|P3|Treatment Phase|Lost to Follow-up|0
7778005|NCT00631189|27036825|P2|Treatment Phase|Lost to Follow-up|1
7778006|NCT00631189|27036826|P1|Treatment Phase|Lost to Follow-up|0
7778007|NCT00631189|27036823|P4|Treatment Phase|Adverse Event|4
7778008|NCT00631189|27036824|P3|Treatment Phase|Adverse Event|2
7778009|NCT00631189|27036825|P2|Treatment Phase|Adverse Event|3
7778010|NCT00631189|27036826|P1|Treatment Phase|Adverse Event|0
7778011|NCT00631189|27036823|P4|Treatment Phase|Protocol Violation|2
7778012|NCT00631189|27036824|P3|Treatment Phase|Protocol Violation|6
7778013|NCT00631189|27036825|P2|Treatment Phase|Protocol Violation|1
7778014|NCT00631189|27036826|P1|Treatment Phase|Protocol Violation|0
7778015|NCT00631189|27036823|P4|Treatment Phase|Withdrawal by Subject|1
7778016|NCT00631189|27036824|P3|Treatment Phase|Withdrawal by Subject|1
7778017|NCT00631189|27036825|P2|Treatment Phase|Withdrawal by Subject|2
7778018|NCT00631189|27036826|P1|Treatment Phase|Withdrawal by Subject|0
7778019|NCT00631189|27036823|P4|Initial Phase|Withdrawal by Subject|0
7778020|NCT00631189|27036824|P3|Initial Phase|Withdrawal by Subject|0
7778021|NCT00631189|27036825|P2|Initial Phase|Withdrawal by Subject|0
7778022|NCT00631189|27036826|P1|Initial Phase|Withdrawal by Subject|4
7778023|NCT00631189|27036823|P4|Initial Phase|Protocol Violation|0
7778024|NCT00631189|27036824|P3|Initial Phase|Protocol Violation|0
7778025|NCT00631189|27036825|P2|Initial Phase|Protocol Violation|0
7778026|NCT00631189|27036826|P1|Initial Phase|Protocol Violation|347
7778027|NCT00631163|27036868|P1|Number of Participants in Year 2|Abnormal laboratory value|1
7778028|NCT00631163|27036868|P1|Number of Participants in Year 2|Protocol Violation|1
7778029|NCT00631163|27036868|P1|Number of Participants in Year 2|Adverse Event|1
7778030|NCT00631163|27036868|P1|Number of Participants in Year 2|Withdrawal by Subject|2
7778031|NCT00631163|27036868|P1|Number of Participants in Year 1|Administrative problems|6
7778032|NCT00631163|27036868|P1|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
7778033|NCT00631163|27036868|P1|Number of Participants in Year 1|Lost to Follow-up|1
7778034|NCT00631163|27036868|P1|Number of Participants in Year 1|Death|6
7778035|NCT00631163|27036868|P1|Number of Participants in Year 1|Withdrawal by Subject|8
7778036|NCT00631163|27036868|P1|Number of Participants in Year 1|Adverse Event|12
7778037|NCT00631137|27036888|P2|Overall Study|Withdrawal by Subject|0
7778038|NCT00631137|27036889|P1|Overall Study|Withdrawal by Subject|1
7778039|NCT00631020|27036907|P1|Overall Study|Incarcerated|1
7778040|NCT00631020|27036907|P1|Overall Study|Lost to Follow-up|7
7778041|NCT00631007|27036922|P6|Overall Study|Other|0
7778042|NCT00631007|27036923|P5|Overall Study|Other|1
7778043|NCT00631007|27036924|P4|Overall Study|Other|0
7778044|NCT00631007|27036925|P3|Overall Study|Other|0
7778045|NCT00631007|27036926|P2|Overall Study|Other|1
7778046|NCT00631007|27036927|P1|Overall Study|Other|2
7778047|NCT00631007|27036922|P6|Overall Study|Withdrawal by Subject|3
7778048|NCT00631007|27036923|P5|Overall Study|Withdrawal by Subject|1
7778049|NCT00631007|27036924|P4|Overall Study|Withdrawal by Subject|2
7778050|NCT00631007|27036925|P3|Overall Study|Withdrawal by Subject|2
7778051|NCT00631007|27036926|P2|Overall Study|Withdrawal by Subject|5
7778052|NCT00631007|27036927|P1|Overall Study|Withdrawal by Subject|4
7778053|NCT00631007|27036922|P6|Overall Study|Persistent Hyperglycemia|5
7778054|NCT00631007|27036923|P5|Overall Study|Persistent Hyperglycemia|2
7778055|NCT00631007|27036924|P4|Overall Study|Persistent Hyperglycemia|1
7778056|NCT00631007|27036925|P3|Overall Study|Persistent Hyperglycemia|5
7778057|NCT00631007|27036926|P2|Overall Study|Persistent Hyperglycemia|2
7778058|NCT00631007|27036927|P1|Overall Study|Persistent Hyperglycemia|2
7778059|NCT00631007|27036922|P6|Overall Study|Physician Decision|2
7778060|NCT00631007|27036923|P5|Overall Study|Physician Decision|0
7778061|NCT00631007|27036924|P4|Overall Study|Physician Decision|0
7778062|NCT00631007|27036925|P3|Overall Study|Physician Decision|1
7778063|NCT00631007|27036926|P2|Overall Study|Physician Decision|0
7778064|NCT00631007|27036927|P1|Overall Study|Physician Decision|1
7778065|NCT00631007|27036922|P6|Overall Study|Lost to Follow-up|3
7778066|NCT00631007|27036923|P5|Overall Study|Lost to Follow-up|5
7778067|NCT00631007|27036924|P4|Overall Study|Lost to Follow-up|4
7778068|NCT00631007|27036925|P3|Overall Study|Lost to Follow-up|2
7778069|NCT00631007|27036926|P2|Overall Study|Lost to Follow-up|1
7778070|NCT00631007|27036927|P1|Overall Study|Lost to Follow-up|2
7778071|NCT00631007|27036922|P6|Overall Study|Adverse Event|2
7778072|NCT00631007|27036923|P5|Overall Study|Adverse Event|3
7778073|NCT00631007|27036924|P4|Overall Study|Adverse Event|2
7778074|NCT00631007|27036925|P3|Overall Study|Adverse Event|0
7778075|NCT00631007|27036926|P2|Overall Study|Adverse Event|2
7778076|NCT00631007|27036927|P1|Overall Study|Adverse Event|0
7778077|NCT00630994|27036947|P1|Overall Study|Other|1
7778078|NCT00630994|27036947|P1|Overall Study|Lack of Efficacy|1
7778079|NCT00630994|27036947|P1|Overall Study|Disease Progression|1
7778080|NCT00630994|27036947|P1|Overall Study|Adverse Event|1
7778081|NCT00630916|27036977|P1|Overall Study|Lack of Efficacy|3
7778082|NCT00630916|27036977|P1|Overall Study|Physician Decision|47
7778083|NCT00630916|27036977|P1|Overall Study|Protocol Violation|7
7778084|NCT00630916|27036977|P1|Overall Study|Withdrawal by Subject|30
7778085|NCT00630916|27036977|P1|Overall Study|Lost to Follow-up|5
7778086|NCT00630916|27036977|P1|Overall Study|Explant|8
7778087|NCT00630916|27036977|P1|Overall Study|Death|110
7778088|NCT00630877|27036987|P3|Overall Study|Personal reasons|1
7778089|NCT00630877|27036988|P2|Overall Study|Personal reasons|0
7778090|NCT00630877|27036989|P1|Overall Study|Personal reasons|0
7778091|NCT00630877|27036987|P3|Overall Study|Protocol violation|1
7778092|NCT00630877|27036988|P2|Overall Study|Protocol violation|0
7778093|NCT00630877|27036989|P1|Overall Study|Protocol violation|1
7778094|NCT00630877|27036987|P3|Overall Study|Noncompliance|1
7778095|NCT00630877|27036988|P2|Overall Study|Noncompliance|3
7778096|NCT00630877|27036989|P1|Overall Study|Noncompliance|2
7778097|NCT00630877|27036987|P3|Overall Study|Lost to Follow-up|0
7778098|NCT00630877|27036988|P2|Overall Study|Lost to Follow-up|0
7778099|NCT00630877|27036989|P1|Overall Study|Lost to Follow-up|2
7778100|NCT00630877|27036987|P3|Overall Study|Withdrawal by Subject|0
7778101|NCT00630877|27036988|P2|Overall Study|Withdrawal by Subject|4
7778102|NCT00630877|27036989|P1|Overall Study|Withdrawal by Subject|3
7778103|NCT00630877|27036987|P3|Overall Study|Adverse Event|7
7778104|NCT00630877|27036988|P2|Overall Study|Adverse Event|8
7778105|NCT00630877|27036989|P1|Overall Study|Adverse Event|11
7778106|NCT00630864|27037007|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
7778107|NCT00630864|27037007|P1|Part 1 (up to Week 6)|Adverse Event|1
7778108|NCT00630838|27037046|P2|Overall Study|Lost to Follow-up|1
7778109|NCT00630838|27037047|P1|Overall Study|Lost to Follow-up|0
7778110|NCT00630838|27037046|P2|Overall Study|Death|1
7778111|NCT00630838|27037047|P1|Overall Study|Death|0
7778112|NCT00630825|27037059|P4|Overall Study|Withdrawal by Subject|3
7778113|NCT00630825|27037060|P3|Overall Study|Withdrawal by Subject|2
7778114|NCT00630825|27037061|P2|Overall Study|Withdrawal by Subject|2
7778115|NCT00630825|27037062|P1|Overall Study|Withdrawal by Subject|2
7778116|NCT00630825|27037059|P4|Overall Study|Physician Decision|0
7778117|NCT00630825|27037060|P3|Overall Study|Physician Decision|0
7778118|NCT00630825|27037061|P2|Overall Study|Physician Decision|0
7778119|NCT00630825|27037062|P1|Overall Study|Physician Decision|1
7778120|NCT00630825|27037059|P4|Overall Study|Lost to Follow-up|1
7778121|NCT00630825|27037060|P3|Overall Study|Lost to Follow-up|1
7778122|NCT00630825|27037061|P2|Overall Study|Lost to Follow-up|1
7778123|NCT00630825|27037062|P1|Overall Study|Lost to Follow-up|1
7778124|NCT00630825|27037059|P4|Overall Study|Entry Criteria Not Met|1
7778125|NCT00630825|27037060|P3|Overall Study|Entry Criteria Not Met|2
7778126|NCT00630825|27037061|P2|Overall Study|Entry Criteria Not Met|0
7778127|NCT00630825|27037062|P1|Overall Study|Entry Criteria Not Met|1
7778128|NCT00630825|27037059|P4|Overall Study|Adverse Event|1
7778129|NCT00630825|27037060|P3|Overall Study|Adverse Event|3
7778130|NCT00630825|27037061|P2|Overall Study|Adverse Event|4
7778131|NCT00630825|27037062|P1|Overall Study|Adverse Event|4
7778132|NCT00630812|27037133|P2|Double Blind Treatment Period|Non-compliance|1
7778133|NCT00630812|27037134|P1|Double Blind Treatment Period|Non-compliance|0
7778134|NCT00630812|27037133|P2|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
7778135|NCT00630812|27037134|P1|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
7778136|NCT00630812|27037133|P2|Double Blind Treatment Period|Withdrawal by Subject|7
7778137|NCT00630812|27037134|P1|Double Blind Treatment Period|Withdrawal by Subject|13
7778138|NCT00630812|27037133|P2|Double Blind Treatment Period|Protocol Violation|0
7778139|NCT00630812|27037134|P1|Double Blind Treatment Period|Protocol Violation|1
7778140|NCT00630812|27037133|P2|Double Blind Treatment Period|Physician Decision|1
7778141|NCT00630812|27037134|P1|Double Blind Treatment Period|Physician Decision|2
7778142|NCT00630812|27037133|P2|Double Blind Treatment Period|Lost to Follow-up|0
7778143|NCT00630812|27037134|P1|Double Blind Treatment Period|Lost to Follow-up|1
7778144|NCT00630812|27037133|P2|Double Blind Treatment Period|Adverse Event|5
7778145|NCT00630812|27037134|P1|Double Blind Treatment Period|Adverse Event|13
7778146|NCT00630812|27037133|P2|Randomisation to First Dose|Protocol Violation|1
7778147|NCT00630812|27037134|P1|Randomisation to First Dose|Protocol Violation|4
7778148|NCT00630812|27037133|P2|Randomisation to First Dose|Lost to Follow-up|0
7778149|NCT00630812|27037134|P1|Randomisation to First Dose|Lost to Follow-up|1
7778150|NCT00630812|27037133|P2|Randomisation to First Dose|Withdrawal by Subject|3
7778151|NCT00630812|27037134|P1|Randomisation to First Dose|Withdrawal by Subject|2
7778152|NCT00630812|27037133|P2|Randomisation to First Dose|Adverse Event|1
7778153|NCT00630812|27037134|P1|Randomisation to First Dose|Adverse Event|1
7778154|NCT00630786|27037159|P3|Overall Study|Other|0
7778155|NCT00630786|27037160|P2|Overall Study|Other|0
7778156|NCT00630786|27037161|P1|Overall Study|Other|1
7778157|NCT00630786|27037159|P3|Overall Study|Lost to Follow-up|0
7778158|NCT00630786|27037160|P2|Overall Study|Lost to Follow-up|1
7778159|NCT00630786|27037161|P1|Overall Study|Lost to Follow-up|0
7778160|NCT00630786|27037159|P3|Overall Study|Withdrawal by Subject|1
7778161|NCT00630786|27037160|P2|Overall Study|Withdrawal by Subject|1
7778162|NCT00630786|27037161|P1|Overall Study|Withdrawal by Subject|0
7778163|NCT00630786|27037159|P3|Overall Study|Physician Decision|1
7778164|NCT00630786|27037160|P2|Overall Study|Physician Decision|0
7778165|NCT00630786|27037161|P1|Overall Study|Physician Decision|0
7778166|NCT00630747|27037180|P1|Overall Study|Returned to country of origin|1
7778167|NCT00630747|27037180|P1|Overall Study|Transferred to Study TKT031NPU|7
7778168|NCT00630747|27037180|P1|Overall Study|Death|1
7778169|NCT00630539|27037233|P4|Overall Study|Withdrawal by Subject|1
7778170|NCT00630539|27037234|P3|Overall Study|Withdrawal by Subject|0
7778171|NCT00630539|27037235|P2|Overall Study|Withdrawal by Subject|1
7778172|NCT00630539|27037236|P1|Overall Study|Withdrawal by Subject|0
7778173|NCT00630539|27037233|P4|Overall Study|Adverse Event|2
7778174|NCT00630539|27037234|P3|Overall Study|Adverse Event|1
7778175|NCT00630539|27037235|P2|Overall Study|Adverse Event|3
7778176|NCT00630539|27037236|P1|Overall Study|Adverse Event|1
7778177|NCT00630396|27037332|P1|Overall Study|Lost to Follow-up|3
7778178|NCT00630396|27037332|P1|Overall Study|Death|4
7778179|NCT00630344|27037338|P1|Overall Study|Other|1
7778180|NCT00630344|27037338|P1|Overall Study|Intercurrent Illness|1
7778181|NCT00630344|27037338|P1|Overall Study|Withdrawal by Subject|1
7778182|NCT00630344|27037338|P1|Overall Study|Physician Decision|9
7778183|NCT00630344|27037338|P1|Overall Study|Progressive Disease|19
7778184|NCT00630344|27037338|P1|Overall Study|Adverse Event|5
7778185|NCT00630331|27037350|P3|Overall Study|Protocol Violation|6
7778186|NCT00630331|27037351|P2|Overall Study|Protocol Violation|5
7778187|NCT00630331|27037352|P1|Overall Study|Protocol Violation|4
7778188|NCT00630331|27037350|P3|Overall Study|Unable to classify|3
7778189|NCT00630331|27037351|P2|Overall Study|Unable to classify|4
7778190|NCT00630331|27037352|P1|Overall Study|Unable to classify|9
7778191|NCT00630331|27037350|P3|Overall Study|Inappropriate enrollment|3
7778192|NCT00630331|27037351|P2|Overall Study|Inappropriate enrollment|6
7778193|NCT00630331|27037352|P1|Overall Study|Inappropriate enrollment|3
7778194|NCT00630331|27037350|P3|Overall Study|Lost to Follow-up|170
7778195|NCT00630331|27037351|P2|Overall Study|Lost to Follow-up|143
7778196|NCT00630331|27037352|P1|Overall Study|Lost to Follow-up|175
7778197|NCT00630331|27037350|P3|Overall Study|Withdrawal by Subject|5
7778198|NCT00630331|27037351|P2|Overall Study|Withdrawal by Subject|7
7778199|NCT00630331|27037352|P1|Overall Study|Withdrawal by Subject|12
7778200|NCT00630331|27037350|P3|Overall Study|Adverse Event|0
7778201|NCT00630331|27037351|P2|Overall Study|Adverse Event|0
7778202|NCT00630331|27037352|P1|Overall Study|Adverse Event|1
7778203|NCT00630331|27037350|P3|Overall Study|Death|1
7778204|NCT00630331|27037351|P2|Overall Study|Death|1
7778205|NCT00630331|27037352|P1|Overall Study|Death|2
7778206|NCT00630305|27037393|P1|Overall Study|Inability to insert contact lens|1
7778207|NCT00630305|27037393|P1|Overall Study|Withdrawal by Subject|1
7778208|NCT00630292|27037415|P1|Overall Study|Withdrawal by Subject|1
7778209|NCT00630058|27037446|P2|Overall Study|stopping criteria|2
7778210|NCT00630058|27037447|P1|Overall Study|stopping criteria|3
7778211|NCT00630058|27037446|P2|Overall Study|Withdrawal by Subject|1
7778212|NCT00630058|27037447|P1|Overall Study|Withdrawal by Subject|0
7778213|NCT00630058|27037446|P2|Overall Study|Adverse Event|1
7778214|NCT00630058|27037447|P1|Overall Study|Adverse Event|1
7778215|NCT00630032|27037465|P2|Overall Study|End of monitoring in US centers|11
7778216|NCT00630032|27037466|P1|Overall Study|End of monitoring in US centers|11
7778217|NCT00630032|27037465|P2|Overall Study|Disease progression|1
7778218|NCT00630032|27037466|P1|Overall Study|Disease progression|1
7778219|NCT00630032|27037465|P2|Overall Study|Patient has moved|1
7778220|NCT00630032|27037466|P1|Overall Study|Patient has moved|1
7778221|NCT00630032|27037465|P2|Overall Study|Protocol Violation|0
7778222|NCT00630032|27037466|P1|Overall Study|Protocol Violation|1
7778223|NCT00630032|27037465|P2|Overall Study|Lost to Follow-up|31
7778224|NCT00630032|27037466|P1|Overall Study|Lost to Follow-up|18
7778225|NCT00630032|27037465|P2|Overall Study|Withdrawal by Subject|2
7778226|NCT00630032|27037466|P1|Overall Study|Withdrawal by Subject|3
7778227|NCT00630032|27037465|P2|Overall Study|Death|49
7778228|NCT00630032|27037466|P1|Overall Study|Death|55
7778229|NCT00629798|27037495|P1|Overall Study|Not Treated|4
7778230|NCT00629772|27037503|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
7778231|NCT00629772|27037504|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
7778232|NCT00629772|27037503|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
7778233|NCT00629772|27037504|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
7778234|NCT00629707|27037524|P2|Overall Study|Physician Decision|1
7778235|NCT00629707|27037525|P1|Overall Study|Physician Decision|0
7778236|NCT00629707|27037524|P2|Overall Study|Withdrawal by Subject|1
7778237|NCT00629707|27037525|P1|Overall Study|Withdrawal by Subject|0
7778238|NCT00629265|27037545|P2|Overall Study|Unknown Reason|2
7778239|NCT00629265|27037546|P1|Overall Study|Unknown Reason|2
7778240|NCT00629265|27037545|P2|Overall Study|Unrelated Medical Complications|1
7778241|NCT00629265|27037546|P1|Overall Study|Unrelated Medical Complications|3
7778242|NCT00629265|27037545|P2|Overall Study|Needed Esophageal Dilation|1
7778243|NCT00629265|27037546|P1|Overall Study|Needed Esophageal Dilation|4
7778244|NCT00629265|27037545|P2|Overall Study|Other CA Requiring Treatment|3
7778245|NCT00629265|27037546|P1|Overall Study|Other CA Requiring Treatment|1
7778246|NCT00629265|27037545|P2|Overall Study|HNC Recurrence|0
7778247|NCT00629265|27037546|P1|Overall Study|HNC Recurrence|4
7778248|NCT00629265|27037545|P2|Overall Study|Adverse Event|0
7778249|NCT00629265|27037546|P1|Overall Study|Adverse Event|2
7778250|NCT00629265|27037545|P2|Overall Study|Death|0
7778251|NCT00629265|27037546|P1|Overall Study|Death|1
7778252|NCT00629265|27037545|P2|Overall Study|Withdrawal by Subject|8
7778253|NCT00629265|27037546|P1|Overall Study|Withdrawal by Subject|11
7778254|NCT00629265|27037545|P2|Overall Study|Lost to Follow-up|5
7778255|NCT00629265|27037546|P1|Overall Study|Lost to Follow-up|4
7778256|NCT00629239|27037556|P2|Overall Study|Physician Decision|0
7778257|NCT00629239|27037557|P1|Overall Study|Physician Decision|1
7778258|NCT00629239|27037556|P2|Overall Study|Adverse Event|4
7778259|NCT00629239|27037557|P1|Overall Study|Adverse Event|7
7778260|NCT00629083|27037610|P2|Overall Study|Refused to return for 12 month visit|0
7778261|NCT00629083|27037611|P1|Overall Study|Refused to return for 12 month visit|1
7778262|NCT00629083|27037610|P2|Overall Study|Moved out of country/state|1
7778263|NCT00629083|27037611|P1|Overall Study|Moved out of country/state|2
7778264|NCT00629083|27037610|P2|Overall Study|Lost to Follow-up|8
7778265|NCT00629083|27037611|P1|Overall Study|Lost to Follow-up|12
7778266|NCT00629083|27037610|P2|Overall Study|Withdrawal by Subject|2
7778267|NCT00629083|27037611|P1|Overall Study|Withdrawal by Subject|10
7778268|NCT00629083|27037610|P2|Overall Study|Lack of Efficacy|1
7778269|NCT00629083|27037611|P1|Overall Study|Lack of Efficacy|3
7778270|NCT00629083|27037610|P2|Overall Study|Adverse Event|2
7778271|NCT00629083|27037611|P1|Overall Study|Adverse Event|0
7778272|NCT00628927|27037642|P2|Overall Study|Equipment failure|0
7778273|NCT00628927|27037643|P1|Overall Study|Equipment failure|1
7778274|NCT00628927|27037642|P2|Overall Study|Lost to Follow-up|0
7778275|NCT00628927|27037643|P1|Overall Study|Lost to Follow-up|1
7778276|NCT00628927|27037642|P2|Overall Study|Problems performing blood draw|0
7778277|NCT00628927|27037643|P1|Overall Study|Problems performing blood draw|6
7778278|NCT00628862|27037688|P3|Overall Study|COPD Exacerbation|0
7778279|NCT00628862|27037689|P2|Overall Study|COPD Exacerbation|1
7778280|NCT00628862|27037690|P1|Overall Study|COPD Exacerbation|0
7778281|NCT00628862|27037688|P3|Overall Study|Protocol Violation|0
7778282|NCT00628862|27037689|P2|Overall Study|Protocol Violation|0
7778283|NCT00628862|27037690|P1|Overall Study|Protocol Violation|1
7778284|NCT00628862|27037688|P3|Overall Study|Lost to Follow-up|1
7778285|NCT00628862|27037689|P2|Overall Study|Lost to Follow-up|2
7778286|NCT00628862|27037690|P1|Overall Study|Lost to Follow-up|0
7778287|NCT00628862|27037688|P3|Overall Study|Withdrawal by Subject|11
7778288|NCT00628862|27037689|P2|Overall Study|Withdrawal by Subject|6
7778289|NCT00628862|27037690|P1|Overall Study|Withdrawal by Subject|4
7778290|NCT00628862|27037688|P3|Overall Study|Adverse Event|10
7778291|NCT00628862|27037689|P2|Overall Study|Adverse Event|8
7778292|NCT00628862|27037690|P1|Overall Study|Adverse Event|6
7778293|NCT00628758|27037736|P2|Overall Study|Treatment Failure|2
7778294|NCT00628758|27037737|P1|Overall Study|Treatment Failure|0
7778295|NCT00628758|27037736|P2|Overall Study|Investigator Moved|0
7778296|NCT00628758|27037737|P1|Overall Study|Investigator Moved|3
7778297|NCT00628758|27037736|P2|Overall Study|Pregnancy|2
7778298|NCT00628758|27037737|P1|Overall Study|Pregnancy|2
7778299|NCT00628758|27037736|P2|Overall Study|Lost to Follow-up|31
7778300|NCT00628758|27037737|P1|Overall Study|Lost to Follow-up|25
7778301|NCT00628758|27037736|P2|Overall Study|Protocol Violation|1
7778302|NCT00628758|27037737|P1|Overall Study|Protocol Violation|5
7778303|NCT00628758|27037736|P2|Overall Study|Death|0
7778304|NCT00628758|27037737|P1|Overall Study|Death|1
7778305|NCT00628758|27037736|P2|Overall Study|Withdrawal by Subject|3
7778306|NCT00628758|27037737|P1|Overall Study|Withdrawal by Subject|6
7778307|NCT00628758|27037736|P2|Overall Study|Adverse Event|3
7778308|NCT00628758|27037737|P1|Overall Study|Adverse Event|2
7778309|NCT00628446|27037781|P1|Overall Study|Protocol Violation|3
7778310|NCT00628446|27037781|P1|Overall Study|Withdrawal by Subject|1
7778311|NCT00628446|27037781|P1|Overall Study|Lost to Follow-up|3
7778312|NCT00628355|27037813|P2|Overall Study|Withdrawal by Subject|1
7778313|NCT00628355|27037814|P1|Overall Study|Withdrawal by Subject|1
7778314|NCT00628251|27037825|P3|Ongoing Initial Study Treatment at DCO|Other|2
7778315|NCT00628251|27037826|P2|Ongoing Initial Study Treatment at DCO|Other|0
7778316|NCT00628251|27037827|P1|Ongoing Initial Study Treatment at DCO|Other|1
7778317|NCT00628251|27037825|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
7778318|NCT00628251|27037826|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
7778319|NCT00628251|27037827|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
7778320|NCT00628251|27037825|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
7778321|NCT00628251|27037826|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
7778322|NCT00628251|27037827|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
7778323|NCT00628251|27037825|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
7778324|NCT00628251|27037826|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
7778325|NCT00628251|27037827|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
7778326|NCT00628251|27037825|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
7778327|NCT00628251|27037826|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
7778328|NCT00628251|27037827|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
7778329|NCT00628251|27037825|P3|Randomised Part|Withdrawal by Subject|1
7778330|NCT00628251|27037826|P2|Randomised Part|Withdrawal by Subject|0
7778331|NCT00628251|27037827|P1|Randomised Part|Withdrawal by Subject|0
7778332|NCT00628212|27037873|P4|Overall Study|Physician Decision|3
7778333|NCT00628212|27037874|P3|Overall Study|Physician Decision|2
7778334|NCT00628212|27037875|P2|Overall Study|Physician Decision|1
7778335|NCT00628212|27037876|P1|Overall Study|Physician Decision|1
7778336|NCT00628212|27037873|P4|Overall Study|Adverse Event|2
7778337|NCT00628212|27037874|P3|Overall Study|Adverse Event|1
7778338|NCT00628212|27037875|P2|Overall Study|Adverse Event|0
7778339|NCT00628212|27037876|P1|Overall Study|Adverse Event|2
7778340|NCT00628108|27037924|P2|Overall Study|Withdrawal by Subject|0
7778341|NCT00628108|27037925|P1|Overall Study|Withdrawal by Subject|1
7778342|NCT00628108|27037924|P2|Overall Study|Adverse Event|3
7778343|NCT00628108|27037925|P1|Overall Study|Adverse Event|0
7778344|NCT00628030|27037957|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
7778345|NCT00628030|27037958|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
7778346|NCT00628030|27037957|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
7778347|NCT00628030|27037958|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
7778348|NCT00628030|27037957|P2|Baseline to Post-Assessment|Lost to Follow-up|29
7778349|NCT00628030|27037958|P1|Baseline to Post-Assessment|Lost to Follow-up|28
7778350|NCT00627926|27037984|P3|Overall Study|Noncompliance/unspecified|17
7778351|NCT00627926|27037985|P2|Overall Study|Noncompliance/unspecified|23
7778352|NCT00627926|27037986|P1|Overall Study|Noncompliance/unspecified|8
7778353|NCT00627926|27037984|P3|Overall Study|Lack of Efficacy|38
7778354|NCT00627926|27037985|P2|Overall Study|Lack of Efficacy|40
7778355|NCT00627926|27037986|P1|Overall Study|Lack of Efficacy|118
7778356|NCT00627926|27037984|P3|Overall Study|Withdrawal by Subject|0
7778357|NCT00627926|27037985|P2|Overall Study|Withdrawal by Subject|1
7778358|NCT00627926|27037986|P1|Overall Study|Withdrawal by Subject|2
7778359|NCT00627926|27037984|P3|Overall Study|Lost to Follow-up|4
7778360|NCT00627926|27037985|P2|Overall Study|Lost to Follow-up|3
7778361|NCT00627926|27037986|P1|Overall Study|Lost to Follow-up|4
7778362|NCT00627926|27037984|P3|Overall Study|Death|0
7778363|NCT00627926|27037985|P2|Overall Study|Death|0
7778364|NCT00627926|27037986|P1|Overall Study|Death|1
7778365|NCT00627926|27037984|P3|Overall Study|Adverse Event|36
7778366|NCT00627926|27037985|P2|Overall Study|Adverse Event|37
7778367|NCT00627926|27037986|P1|Overall Study|Adverse Event|26
7778368|NCT00627705|27038038|P2|Overall Study|Lost to Follow-up|1
7778369|NCT00627705|27038039|P1|Overall Study|Lost to Follow-up|0
7778370|NCT00627705|27038038|P2|Overall Study|Withdrawal by Subject|2
7778371|NCT00627705|27038039|P1|Overall Study|Withdrawal by Subject|0
7778372|NCT00627705|27038038|P2|Overall Study|Adverse Event|0
7778373|NCT00627705|27038039|P1|Overall Study|Adverse Event|1
7778374|NCT00627705|27038038|P2|Overall Study|Unwilling to take the compound (taste)|3
7778375|NCT00627705|27038039|P1|Overall Study|Unwilling to take the compound (taste)|1
7778376|NCT00627523|27038090|P2|Overall Study|Other|0
7778377|NCT00627523|27038091|P1|Overall Study|Other|1
7778378|NCT00627523|27038090|P2|Overall Study|Withdrawal by Subject|2
7778379|NCT00627523|27038091|P1|Overall Study|Withdrawal by Subject|0
7778380|NCT00627523|27038090|P2|Overall Study|Lack of Efficacy|0
7778381|NCT00627523|27038091|P1|Overall Study|Lack of Efficacy|1
7778382|NCT00627497|27038119|P4|Overall Study|Lost to Follow-up|0
7778383|NCT00627497|27038120|P3|Overall Study|Lost to Follow-up|0
7778384|NCT00627497|27038121|P2|Overall Study|Lost to Follow-up|1
7778385|NCT00627497|27038122|P1|Overall Study|Lost to Follow-up|1
7778386|NCT00627458|27038183|P3|Overall Study|Lost to Follow-up|0
7778387|NCT00627458|27038184|P2|Overall Study|Lost to Follow-up|1
7778388|NCT00627458|27038185|P1|Overall Study|Lost to Follow-up|1
7778389|NCT00627458|27038183|P3|Overall Study|Withdrawal by Subject|5
7778390|NCT00627458|27038184|P2|Overall Study|Withdrawal by Subject|6
7778391|NCT00627458|27038185|P1|Overall Study|Withdrawal by Subject|2
7778392|NCT00627458|27038183|P3|Overall Study|Migrated from study area|1
7778393|NCT00627458|27038184|P2|Overall Study|Migrated from study area|0
7778394|NCT00627458|27038185|P1|Overall Study|Migrated from study area|1
7778395|NCT00627445|27038260|P2|Overall Study|Other|8
7778396|NCT00627445|27038261|P1|Overall Study|Other|6
7778397|NCT00627445|27038260|P2|Overall Study|Lack of Efficacy|1
7778398|NCT00627445|27038261|P1|Overall Study|Lack of Efficacy|0
7778399|NCT00627445|27038260|P2|Overall Study|Adverse Event|3
7778400|NCT00627445|27038261|P1|Overall Study|Adverse Event|3
7778401|NCT00627393|27038304|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
7778402|NCT00627393|27038305|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
7778403|NCT00627393|27038304|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
7778404|NCT00627393|27038305|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
7778405|NCT00627393|27038304|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
7778406|NCT00627393|27038305|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
7778407|NCT00627393|27038304|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
7778408|NCT00627393|27038305|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
7778409|NCT00627094|27038341|P2|Overall Study|Other reason|0
7778410|NCT00627094|27038342|P1|Overall Study|Other reason|1
7778411|NCT00627094|27038341|P2|Overall Study|ulcer healed|7
7778412|NCT00627094|27038342|P1|Overall Study|ulcer healed|1
7778413|NCT00627094|27038341|P2|Overall Study|Withdrawal by Subject|1
7778414|NCT00627094|27038342|P1|Overall Study|Withdrawal by Subject|1
7778415|NCT00627094|27038341|P2|Overall Study|Lost to Follow-up|0
7778416|NCT00627094|27038342|P1|Overall Study|Lost to Follow-up|1
7778417|NCT00627094|27038341|P2|Overall Study|Adverse Event|7
7778418|NCT00627094|27038342|P1|Overall Study|Adverse Event|8
7778419|NCT00627042|27038354|P1|Overall Study|Withdrawal by Subject|2
7778420|NCT00627016|27038366|P2|Overall Study|Pregnancy|0
7778421|NCT00627016|27038367|P1|Overall Study|Pregnancy|1
7778422|NCT00627016|27038366|P2|Overall Study|Placed on Excluded Drugs|0
7778423|NCT00627016|27038367|P1|Overall Study|Placed on Excluded Drugs|1
7778424|NCT00627016|27038366|P2|Overall Study|Lack of Efficacy|0
7778425|NCT00627016|27038367|P1|Overall Study|Lack of Efficacy|1
7778426|NCT00627016|27038366|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
7778427|NCT00627016|27038367|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
7778428|NCT00627016|27038366|P2|Overall Study|Withdrawal by Subject|1
7778429|NCT00627016|27038367|P1|Overall Study|Withdrawal by Subject|2
7778430|NCT00627016|27038366|P2|Overall Study|Lost to Follow-up|1
7778431|NCT00627016|27038367|P1|Overall Study|Lost to Follow-up|0
7778432|NCT00627016|27038366|P2|Overall Study|Protocol Violation|2
7778433|NCT00627016|27038367|P1|Overall Study|Protocol Violation|0
7778434|NCT00627016|27038366|P2|Overall Study|Adverse Event|1
7778435|NCT00627016|27038367|P1|Overall Study|Adverse Event|1
7778436|NCT00626925|27038379|P2|Overall Study|Time constraints|1
7778437|NCT00626925|27038380|P1|Overall Study|Time constraints|3
7778438|NCT00626925|27038379|P2|Overall Study|Lack of Efficacy|4
7778439|NCT00626925|27038380|P1|Overall Study|Lack of Efficacy|1
7778440|NCT00626925|27038379|P2|Overall Study|Adverse effect|2
7778441|NCT00626925|27038380|P1|Overall Study|Adverse effect|6
7778442|NCT00626925|27038379|P2|Overall Study|relapse|0
7778443|NCT00626925|27038380|P1|Overall Study|relapse|1
7778444|NCT00626925|27038379|P2|Overall Study|Lost to Follow-up|2
7778445|NCT00626925|27038380|P1|Overall Study|Lost to Follow-up|1
7778446|NCT00626821|27038454|P1|Overall Study|other/unknown reason|104
7778447|NCT00626821|27038454|P1|Overall Study|Product dysfunction|21
7778448|NCT00626821|27038454|P1|Overall Study|Physician Decision|9
7778449|NCT00626821|27038454|P1|Overall Study|Withdrawal by Subject|10
7778450|NCT00626821|27038454|P1|Overall Study|Protocol Violation|33
7778451|NCT00626821|27038454|P1|Overall Study|Adverse Event|44
7778452|NCT00626795|27038534|P3|Blinded Treatment|Missing reason for withdrawal|5
7778453|NCT00626795|27038535|P2|Blinded Treatment|Missing reason for withdrawal|3
7778454|NCT00626795|27038536|P1|Blinded Treatment|Missing reason for withdrawal|5
7778455|NCT00626795|27038534|P3|Blinded Treatment|Other reasons|2
7778456|NCT00626795|27038535|P2|Blinded Treatment|Other reasons|0
7778457|NCT00626795|27038536|P1|Blinded Treatment|Other reasons|2
7778458|NCT00626795|27038534|P3|Blinded Treatment|Withdrawal by Subject|0
7778459|NCT00626795|27038535|P2|Blinded Treatment|Withdrawal by Subject|1
7778460|NCT00626795|27038536|P1|Blinded Treatment|Withdrawal by Subject|1
7778461|NCT00626795|27038534|P3|Blinded Treatment|Protocol Violation|1
7778462|NCT00626795|27038535|P2|Blinded Treatment|Protocol Violation|1
7778463|NCT00626795|27038536|P1|Blinded Treatment|Protocol Violation|0
7778464|NCT00626795|27038534|P3|Blinded Treatment|Unacceptable adverse event|1
7778465|NCT00626795|27038535|P2|Blinded Treatment|Unacceptable adverse event|0
7778466|NCT00626795|27038536|P1|Blinded Treatment|Unacceptable adverse event|0
7778467|NCT00626795|27038534|P3|Blinded Treatment|Lack of Efficacy|0
7778468|NCT00626795|27038535|P2|Blinded Treatment|Lack of Efficacy|0
7778469|NCT00626795|27038536|P1|Blinded Treatment|Lack of Efficacy|2
7778470|NCT00626795|27038534|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
7778471|NCT00626795|27038535|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
7778472|NCT00626795|27038536|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
7778473|NCT00626639|27038587|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
7778474|NCT00626639|27038588|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
7778475|NCT00626561|27038634|P1|Overall Study|Disease Progression|2
7778476|NCT00626561|27038634|P1|Overall Study|Withdrawal by Subject|2
7778477|NCT00626548|27038640|P2|Overall Study|Other termination reason|613
7778478|NCT00626548|27038641|P1|Overall Study|Other termination reason|493
7778479|NCT00626548|27038640|P2|Overall Study|Lost to Follow-up|2
7778480|NCT00626548|27038641|P1|Overall Study|Lost to Follow-up|2
7778481|NCT00626548|27038640|P2|Overall Study|Protocol Violation|11
7778482|NCT00626548|27038641|P1|Overall Study|Protocol Violation|4
7778483|NCT00626548|27038640|P2|Overall Study|Withdrawal by Subject|46
7778484|NCT00626548|27038641|P1|Overall Study|Withdrawal by Subject|42
7778485|NCT00626548|27038640|P2|Overall Study|Adverse Event|44
7778486|NCT00626548|27038641|P1|Overall Study|Adverse Event|164
7778487|NCT00626522|27038655|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
7778488|NCT00626522|27038656|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
7778489|NCT00626522|27038657|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
7778490|NCT00626522|27038658|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
7778491|NCT00626522|27038659|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
7778492|NCT00626522|27038660|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
7778493|NCT00626522|27038655|P6|Overall Study|Inconsistent reason reported|0
7778494|NCT00626522|27038656|P5|Overall Study|Inconsistent reason reported|0
7778495|NCT00626522|27038657|P4|Overall Study|Inconsistent reason reported|0
7778496|NCT00626522|27038658|P3|Overall Study|Inconsistent reason reported|0
7778497|NCT00626522|27038659|P2|Overall Study|Inconsistent reason reported|0
7778498|NCT00626522|27038660|P1|Overall Study|Inconsistent reason reported|1
7778499|NCT00626522|27038655|P6|Overall Study|Lost to Follow-up|0
7778500|NCT00626522|27038656|P5|Overall Study|Lost to Follow-up|0
7778501|NCT00626522|27038657|P4|Overall Study|Lost to Follow-up|0
7778502|NCT00626522|27038658|P3|Overall Study|Lost to Follow-up|0
7778503|NCT00626522|27038659|P2|Overall Study|Lost to Follow-up|1
7778504|NCT00626522|27038660|P1|Overall Study|Lost to Follow-up|0
7778505|NCT00626522|27038655|P6|Overall Study|COPD exacerbation|0
7778506|NCT00626522|27038656|P5|Overall Study|COPD exacerbation|1
7778507|NCT00626522|27038657|P4|Overall Study|COPD exacerbation|1
7778508|NCT00626522|27038658|P3|Overall Study|COPD exacerbation|0
7778509|NCT00626522|27038659|P2|Overall Study|COPD exacerbation|0
7778510|NCT00626522|27038660|P1|Overall Study|COPD exacerbation|0
7778511|NCT00626522|27038655|P6|Overall Study|Withdrawal by Subject|1
7778512|NCT00626522|27038656|P5|Overall Study|Withdrawal by Subject|4
7778513|NCT00626522|27038657|P4|Overall Study|Withdrawal by Subject|0
7778514|NCT00626522|27038658|P3|Overall Study|Withdrawal by Subject|5
7778515|NCT00626522|27038659|P2|Overall Study|Withdrawal by Subject|5
7778516|NCT00626522|27038660|P1|Overall Study|Withdrawal by Subject|2
7778517|NCT00626522|27038655|P6|Overall Study|Adverse Event|1
7778518|NCT00626522|27038656|P5|Overall Study|Adverse Event|1
7778519|NCT00626522|27038657|P4|Overall Study|Adverse Event|0
7778520|NCT00626522|27038658|P3|Overall Study|Adverse Event|2
7778521|NCT00626522|27038659|P2|Overall Study|Adverse Event|1
7778522|NCT00626522|27038660|P1|Overall Study|Adverse Event|2
7778523|NCT00626522|27038655|P6|Overall Study|Protocol Violation|0
7778524|NCT00626522|27038656|P5|Overall Study|Protocol Violation|1
7778525|NCT00626522|27038657|P4|Overall Study|Protocol Violation|0
7778526|NCT00626522|27038658|P3|Overall Study|Protocol Violation|0
7778527|NCT00626522|27038659|P2|Overall Study|Protocol Violation|0
7778528|NCT00626522|27038660|P1|Overall Study|Protocol Violation|0
7778529|NCT00626405|27038723|P2|Overall Study|Withdrawal by Subject|1
7778530|NCT00626405|27038724|P1|Overall Study|Withdrawal by Subject|0
7778531|NCT00626405|27038723|P2|Overall Study|Deemed Ineligible|0
7778532|NCT00626405|27038724|P1|Overall Study|Deemed Ineligible|1
7778533|NCT00626392|27038740|P6|Coadministration Period|Other|1
7778534|NCT00626392|27038741|P5|Coadministration Period|Other|1
7778535|NCT00626392|27038742|P4|Coadministration Period|Other|1
7778536|NCT00626392|27038743|P3|Coadministration Period|Other|3
7778537|NCT00626392|27038744|P2|Coadministration Period|Other|2
7778538|NCT00626392|27038745|P1|Coadministration Period|Other|0
7778539|NCT00626392|27038740|P6|Coadministration Period|Protocol Violation|0
7778540|NCT00626392|27038741|P5|Coadministration Period|Protocol Violation|1
7778541|NCT00626392|27038742|P4|Coadministration Period|Protocol Violation|1
7778542|NCT00626392|27038743|P3|Coadministration Period|Protocol Violation|0
7778543|NCT00626392|27038744|P2|Coadministration Period|Protocol Violation|1
7778544|NCT00626392|27038745|P1|Coadministration Period|Protocol Violation|0
7778545|NCT00626392|27038740|P6|Coadministration Period|Withdrawal by Subject|1
7778546|NCT00626392|27038741|P5|Coadministration Period|Withdrawal by Subject|0
7778547|NCT00626392|27038742|P4|Coadministration Period|Withdrawal by Subject|1
7778548|NCT00626392|27038743|P3|Coadministration Period|Withdrawal by Subject|0
7778549|NCT00626392|27038744|P2|Coadministration Period|Withdrawal by Subject|1
7778550|NCT00626392|27038745|P1|Coadministration Period|Withdrawal by Subject|1
7778551|NCT00626392|27038740|P6|Coadministration Period|Adverse Event|4
7778552|NCT00626392|27038741|P5|Coadministration Period|Adverse Event|3
7778553|NCT00626392|27038742|P4|Coadministration Period|Adverse Event|4
7778554|NCT00626392|27038743|P3|Coadministration Period|Adverse Event|7
7778555|NCT00626392|27038744|P2|Coadministration Period|Adverse Event|1
7778556|NCT00626392|27038745|P1|Coadministration Period|Adverse Event|3
7778557|NCT00626392|27038740|P6|Run-in Period|Noncompliance|0
7778558|NCT00626392|27038741|P5|Run-in Period|Noncompliance|0
7778559|NCT00626392|27038742|P4|Run-in Period|Noncompliance|0
7778560|NCT00626392|27038743|P3|Run-in Period|Noncompliance|1
7778561|NCT00626392|27038744|P2|Run-in Period|Noncompliance|0
7778562|NCT00626392|27038745|P1|Run-in Period|Noncompliance|1
7778563|NCT00626392|27038740|P6|Run-in Period|Withdrawal by Subject|1
7778564|NCT00626392|27038741|P5|Run-in Period|Withdrawal by Subject|3
7778565|NCT00626392|27038742|P4|Run-in Period|Withdrawal by Subject|1
7778566|NCT00626392|27038743|P3|Run-in Period|Withdrawal by Subject|1
7778567|NCT00626392|27038744|P2|Run-in Period|Withdrawal by Subject|1
7778568|NCT00626392|27038745|P1|Run-in Period|Withdrawal by Subject|0
7778569|NCT00626392|27038740|P6|Run-in Period|Adverse Event|0
7778570|NCT00626392|27038741|P5|Run-in Period|Adverse Event|1
7778571|NCT00626392|27038742|P4|Run-in Period|Adverse Event|0
7778572|NCT00626392|27038743|P3|Run-in Period|Adverse Event|1
7778573|NCT00626392|27038744|P2|Run-in Period|Adverse Event|0
7778574|NCT00626392|27038745|P1|Run-in Period|Adverse Event|0
7778575|NCT00626327|27038773|P3|Overall Study|Protocol Violation|26
7778576|NCT00626327|27038774|P2|Overall Study|Protocol Violation|4
7778577|NCT00626327|27038775|P1|Overall Study|Protocol Violation|26
7778578|NCT00626327|27038773|P3|Overall Study|Administrative Reason|6
7778579|NCT00626327|27038774|P2|Overall Study|Administrative Reason|0
7778580|NCT00626327|27038775|P1|Overall Study|Administrative Reason|2
7778581|NCT00626327|27038773|P3|Overall Study|Inappropriate enrollment|3
7778582|NCT00626327|27038774|P2|Overall Study|Inappropriate enrollment|5
7778583|NCT00626327|27038775|P1|Overall Study|Inappropriate enrollment|4
7778584|NCT00626327|27038773|P3|Overall Study|Lost to Follow-up|23
7778585|NCT00626327|27038774|P2|Overall Study|Lost to Follow-up|21
7778586|NCT00626327|27038775|P1|Overall Study|Lost to Follow-up|24
7778587|NCT00626327|27038773|P3|Overall Study|Adverse Event|0
7778588|NCT00626327|27038774|P2|Overall Study|Adverse Event|0
7778589|NCT00626327|27038775|P1|Overall Study|Adverse Event|1
7778590|NCT00626327|27038773|P3|Overall Study|Withdrawal by Subject|30
7778591|NCT00626327|27038774|P2|Overall Study|Withdrawal by Subject|29
7778592|NCT00626327|27038775|P1|Overall Study|Withdrawal by Subject|21
7778593|NCT00626275|27038801|P8|Part B|Withdrawal by Subject|1
7778594|NCT00626275|27038802|P7|Part B|Withdrawal by Subject|0
7778595|NCT00626275|27038803|P6|Part B|Withdrawal by Subject|0
7778596|NCT00626275|27038804|P5|Part B|Withdrawal by Subject|0
7778597|NCT00626275|27038805|P4|Part B|Withdrawal by Subject|0
7778598|NCT00626275|27038806|P3|Part B|Withdrawal by Subject|0
7778599|NCT00626275|27038807|P2|Part B|Withdrawal by Subject|0
7778600|NCT00626275|27038808|P1|Part B|Withdrawal by Subject|0
7778601|NCT00626275|27038801|P8|Part B|Lost to Follow-up|0
7778602|NCT00626275|27038802|P7|Part B|Lost to Follow-up|1
7778603|NCT00626275|27038803|P6|Part B|Lost to Follow-up|0
7778604|NCT00626275|27038804|P5|Part B|Lost to Follow-up|0
7778605|NCT00626275|27038805|P4|Part B|Lost to Follow-up|0
7778606|NCT00626275|27038806|P3|Part B|Lost to Follow-up|0
7778607|NCT00626275|27038807|P2|Part B|Lost to Follow-up|0
7778608|NCT00626275|27038808|P1|Part B|Lost to Follow-up|0
7778609|NCT00626275|27038801|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
7778610|NCT00626275|27038802|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
7778611|NCT00626275|27038803|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
7778612|NCT00626275|27038804|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
7778613|NCT00626275|27038805|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
7778614|NCT00626275|27038806|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
7778615|NCT00626275|27038807|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
7778616|NCT00626275|27038808|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
7778617|NCT00626275|27038801|P8|Part A - Treatment Period 1|Adverse Event|0
7778618|NCT00626275|27038802|P7|Part A - Treatment Period 1|Adverse Event|0
7778619|NCT00626275|27038803|P6|Part A - Treatment Period 1|Adverse Event|0
7778620|NCT00626275|27038804|P5|Part A - Treatment Period 1|Adverse Event|0
7778621|NCT00626275|27038805|P4|Part A - Treatment Period 1|Adverse Event|0
7778622|NCT00626275|27038806|P3|Part A - Treatment Period 1|Adverse Event|0
7778623|NCT00626275|27038807|P2|Part A - Treatment Period 1|Adverse Event|0
7778624|NCT00626275|27038808|P1|Part A - Treatment Period 1|Adverse Event|1
7778625|NCT00626197|27038855|P3|Overall Study|Administrative reasons|55
7778626|NCT00626197|27038856|P2|Overall Study|Administrative reasons|19
7778627|NCT00626197|27038857|P1|Overall Study|Administrative reasons|15
7778628|NCT00626197|27038855|P3|Overall Study|Withdrawal by Subject|7
7778629|NCT00626197|27038856|P2|Overall Study|Withdrawal by Subject|17
7778630|NCT00626197|27038857|P1|Overall Study|Withdrawal by Subject|17
7778631|NCT00626197|27038855|P3|Overall Study|Adverse Event|2
7778632|NCT00626197|27038856|P2|Overall Study|Adverse Event|1
7778633|NCT00626197|27038857|P1|Overall Study|Adverse Event|1
7778634|NCT00626197|27038855|P3|Overall Study|Adverse event, serious fatal|6
7778635|NCT00626197|27038856|P2|Overall Study|Adverse event, serious fatal|6
7778636|NCT00626197|27038857|P1|Overall Study|Adverse event, serious fatal|3
7778637|NCT00626197|27038855|P3|Overall Study|Failure to return|6
7778638|NCT00626197|27038856|P2|Overall Study|Failure to return|5
7778639|NCT00626197|27038857|P1|Overall Study|Failure to return|6
7778640|NCT00626197|27038855|P3|Overall Study|Did not cooperate|1
7778641|NCT00626197|27038856|P2|Overall Study|Did not cooperate|6
7778642|NCT00626197|27038857|P1|Overall Study|Did not cooperate|2
7778643|NCT00626093|27038934|P1|Overall Study|One of the required devices not implante|6
7778644|NCT00626093|27038934|P1|Overall Study|Protocol Violation|1
7778645|NCT00626093|27038934|P1|Overall Study|Withdrawal by Subject|6
7778646|NCT00626093|27038934|P1|Overall Study|Physician Decision|4
7778647|NCT00626093|27038934|P1|Overall Study|Death|1
7778648|NCT00626093|27038934|P1|Overall Study|Lost to Follow-up|5
7778649|NCT00626028|27038941|P2|Overall Study|Inclusion/Exclusion Criteria|6
7778650|NCT00626028|27038942|P1|Overall Study|Inclusion/Exclusion Criteria|3
7778651|NCT00626028|27038941|P2|Overall Study|Physician Decision|1
7778652|NCT00626028|27038942|P1|Overall Study|Physician Decision|2
7778653|NCT00626028|27038941|P2|Overall Study|Device Failure|1
7778654|NCT00626028|27038942|P1|Overall Study|Device Failure|0
7778655|NCT00626028|27038941|P2|Overall Study|Adverse Event|1
7778656|NCT00626028|27038942|P1|Overall Study|Adverse Event|1
7778657|NCT00625872|27038966|P2|Overall Study|Randomized but not treated|1
7778658|NCT00625872|27038967|P1|Overall Study|Randomized but not treated|0
7778659|NCT00625872|27038966|P2|Overall Study|Terminated by sponsor|5
7778660|NCT00625872|27038967|P1|Overall Study|Terminated by sponsor|2
7778661|NCT00625872|27038966|P2|Overall Study|Does not meet inclusion criteria|0
7778662|NCT00625872|27038967|P1|Overall Study|Does not meet inclusion criteria|1
7778663|NCT00625872|27038966|P2|Overall Study|Withdrawal by Subject|0
7778664|NCT00625872|27038967|P1|Overall Study|Withdrawal by Subject|1
7778665|NCT00625846|27039081|P4|Overall Study|Withdrawal by Subject|2
7778666|NCT00625846|27039082|P3|Overall Study|Withdrawal by Subject|1
7778667|NCT00625846|27039083|P2|Overall Study|Withdrawal by Subject|0
7778668|NCT00625846|27039084|P1|Overall Study|Withdrawal by Subject|2
7778669|NCT00625820|27039110|P1|Overall Study|Withdrawal by Subject|1
7778670|NCT00625807|27039118|P2|Overall Study|schedule conflict|8
7778671|NCT00625807|27039119|P1|Overall Study|schedule conflict|2
7778672|NCT00625742|27039135|P1|Overall Study|Ineligible|1
7778673|NCT00625742|27039135|P1|Overall Study|Lost to Follow-up|4
7778674|NCT00625742|27039135|P1|Overall Study|Adverse Event|4
7778675|NCT00625742|27039135|P1|Overall Study|Withdrawal by Subject|1
7778676|NCT00625742|27039135|P1|Overall Study|Disease Progression|2
7778677|NCT00625586|27039154|P1|Overall Study|Adverse Event|1
7778678|NCT00625443|27039167|P3|Overall Study|Other|1
7778679|NCT00625443|27039168|P2|Overall Study|Other|1
7778680|NCT00625443|27039169|P1|Overall Study|Other|0
7778681|NCT00625443|27039167|P3|Overall Study|Physician Decision|2
7778682|NCT00625443|27039168|P2|Overall Study|Physician Decision|4
7778683|NCT00625443|27039169|P1|Overall Study|Physician Decision|0
7778684|NCT00625443|27039167|P3|Overall Study|Withdrawal by Subject|2
7778685|NCT00625443|27039168|P2|Overall Study|Withdrawal by Subject|1
7778686|NCT00625443|27039169|P1|Overall Study|Withdrawal by Subject|0
7778687|NCT00625443|27039167|P3|Overall Study|Platelet count increase >=500,000/mm3|0
7778688|NCT00625443|27039168|P2|Overall Study|Platelet count increase >=500,000/mm3|0
7778689|NCT00625443|27039169|P1|Overall Study|Platelet count increase >=500,000/mm3|1
7778690|NCT00625443|27039167|P3|Overall Study|Non-compliance with protocol|0
7778691|NCT00625443|27039168|P2|Overall Study|Non-compliance with protocol|1
7778692|NCT00625443|27039169|P1|Overall Study|Non-compliance with protocol|0
7778693|NCT00625443|27039167|P3|Overall Study|Adverse Event|0
7778694|NCT00625443|27039168|P2|Overall Study|Adverse Event|4
7778695|NCT00625443|27039169|P1|Overall Study|Adverse Event|1
7778696|NCT00625365|27039249|P1|Overall Study|VSD|1
7778697|NCT00625365|27039249|P1|Overall Study|No IV access|5
7778698|NCT00625365|27039249|P1|Overall Study|Withdrawal by Subject|1
7778699|NCT00625183|27039255|P1|Overall Study|Disease Progression|1
7778700|NCT00625131|27039266|P3|Overall Study|Withdrawal by Subject|5
7778701|NCT00625131|27039267|P2|Overall Study|Withdrawal by Subject|0
7778702|NCT00625131|27039268|P1|Overall Study|Withdrawal by Subject|1
7778703|NCT00625131|27039266|P3|Overall Study|Lost to Follow-up|0
7778704|NCT00625131|27039267|P2|Overall Study|Lost to Follow-up|2
7778705|NCT00625131|27039268|P1|Overall Study|Lost to Follow-up|3
7778706|NCT00624832|27039331|P4|Overall Study|Abnormal Laboratory Value|0
7778707|NCT00624832|27039332|P3|Overall Study|Abnormal Laboratory Value|0
7778708|NCT00624832|27039333|P2|Overall Study|Abnormal Laboratory Value|0
7778709|NCT00624832|27039334|P1|Overall Study|Abnormal Laboratory Value|2
7778710|NCT00624832|27039331|P4|Overall Study|Adverse Event|1
7778711|NCT00624832|27039332|P3|Overall Study|Adverse Event|0
7778712|NCT00624832|27039333|P2|Overall Study|Adverse Event|1
7778713|NCT00624832|27039334|P1|Overall Study|Adverse Event|0
7778714|NCT00624819|27039350|P4|Follow-up Period: Year 4|Lost to Follow-up|0
7778715|NCT00624819|27039351|P3|Follow-up Period: Year 4|Lost to Follow-up|0
7778716|NCT00624819|27039352|P2|Follow-up Period: Year 4|Lost to Follow-up|1
7778717|NCT00624819|27039353|P1|Follow-up Period: Year 4|Lost to Follow-up|1
7778718|NCT00624819|27039350|P4|Follow-up Period: Year 4|Parents decision|0
7778719|NCT00624819|27039351|P3|Follow-up Period: Year 4|Parents decision|1
7778720|NCT00624819|27039352|P2|Follow-up Period: Year 4|Parents decision|0
7778721|NCT00624819|27039353|P1|Follow-up Period: Year 4|Parents decision|0
7778722|NCT00624780|27039530|P6|Follow-up (Week 26)|Other|0
7778723|NCT00624780|27039531|P5|Follow-up (Week 26)|Other|0
7778724|NCT00624780|27039532|P4|Follow-up (Week 26)|Other|0
7778725|NCT00624780|27039533|P3|Follow-up (Week 26)|Other|0
7778726|NCT00624780|27039534|P2|Follow-up (Week 26)|Other|1
7778727|NCT00624780|27039535|P1|Follow-up (Week 26)|Other|1
7778728|NCT00624780|27039530|P6|Follow-up (Week 26)|Withdrawal by Subject|0
7778729|NCT00624780|27039531|P5|Follow-up (Week 26)|Withdrawal by Subject|0
7778730|NCT00624780|27039532|P4|Follow-up (Week 26)|Withdrawal by Subject|0
7778731|NCT00624780|27039533|P3|Follow-up (Week 26)|Withdrawal by Subject|0
7778732|NCT00624780|27039534|P2|Follow-up (Week 26)|Withdrawal by Subject|0
7778733|NCT00624780|27039535|P1|Follow-up (Week 26)|Withdrawal by Subject|1
7778734|NCT00624780|27039530|P6|Follow-up (Week 26)|Lost to Follow-up|0
7778735|NCT00624780|27039531|P5|Follow-up (Week 26)|Lost to Follow-up|1
7778736|NCT00624780|27039532|P4|Follow-up (Week 26)|Lost to Follow-up|0
7778737|NCT00624780|27039533|P3|Follow-up (Week 26)|Lost to Follow-up|1
7778738|NCT00624780|27039534|P2|Follow-up (Week 26)|Lost to Follow-up|0
7778739|NCT00624780|27039535|P1|Follow-up (Week 26)|Lost to Follow-up|0
7778740|NCT00624780|27039530|P6|Follow-up (Week 26)|Adverse Event|0
7778741|NCT00624780|27039531|P5|Follow-up (Week 26)|Adverse Event|1
7778742|NCT00624780|27039532|P4|Follow-up (Week 26)|Adverse Event|0
7778743|NCT00624780|27039533|P3|Follow-up (Week 26)|Adverse Event|0
7778744|NCT00624780|27039534|P2|Follow-up (Week 26)|Adverse Event|0
7778745|NCT00624780|27039535|P1|Follow-up (Week 26)|Adverse Event|0
7778746|NCT00624780|27039530|P6|Follow-up (Week 26)|Death|0
7778747|NCT00624780|27039531|P5|Follow-up (Week 26)|Death|0
7778748|NCT00624780|27039532|P4|Follow-up (Week 26)|Death|0
7778749|NCT00624780|27039533|P3|Follow-up (Week 26)|Death|1
7778750|NCT00624780|27039534|P2|Follow-up (Week 26)|Death|0
7778751|NCT00624780|27039535|P1|Follow-up (Week 26)|Death|0
7778752|NCT00624780|27039530|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7778753|NCT00624780|27039531|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7778754|NCT00624780|27039532|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7778755|NCT00624780|27039533|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
7778756|NCT00624780|27039534|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7778757|NCT00624780|27039535|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7778758|NCT00624780|27039530|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7778759|NCT00624780|27039531|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7778760|NCT00624780|27039532|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7778761|NCT00624780|27039533|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7778762|NCT00624780|27039534|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7778763|NCT00624780|27039535|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
7778764|NCT00624780|27039530|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
7778765|NCT00624780|27039531|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
7778766|NCT00624780|27039532|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
7778767|NCT00624780|27039533|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
7778768|NCT00624780|27039534|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
7778769|NCT00624780|27039535|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
7778770|NCT00624780|27039530|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
7778771|NCT00624780|27039531|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
7778772|NCT00624780|27039532|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
7778773|NCT00624780|27039533|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
7778774|NCT00624780|27039534|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
7778775|NCT00624780|27039535|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
7778776|NCT00624780|27039530|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7778777|NCT00624780|27039531|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
7778778|NCT00624780|27039532|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7778779|NCT00624780|27039533|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
7778780|NCT00624780|27039534|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7778781|NCT00624780|27039535|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7778782|NCT00624780|27039530|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7778783|NCT00624780|27039531|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7778784|NCT00624780|27039532|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7778785|NCT00624780|27039533|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7778786|NCT00624780|27039534|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7778787|NCT00624780|27039535|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7778788|NCT00624780|27039530|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7778789|NCT00624780|27039531|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7778790|NCT00624780|27039532|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7778791|NCT00624780|27039533|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7778792|NCT00624780|27039534|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
7778793|NCT00624780|27039535|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7778794|NCT00624780|27039530|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
7778795|NCT00624780|27039531|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
7778796|NCT00624780|27039532|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
7778797|NCT00624780|27039533|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7778798|NCT00624780|27039534|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
7778799|NCT00624780|27039535|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7778800|NCT00624780|27039530|P6|Treatment Optimization (Up to Week 12)|Other|0
7778801|NCT00624780|27039531|P5|Treatment Optimization (Up to Week 12)|Other|9
7778802|NCT00624780|27039532|P4|Treatment Optimization (Up to Week 12)|Other|2
7778803|NCT00624780|27039533|P3|Treatment Optimization (Up to Week 12)|Other|8
7778804|NCT00624780|27039534|P2|Treatment Optimization (Up to Week 12)|Other|4
7778805|NCT00624780|27039535|P1|Treatment Optimization (Up to Week 12)|Other|10
7778806|NCT00624780|27039530|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7778807|NCT00624780|27039531|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
7778808|NCT00624780|27039532|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7778809|NCT00624780|27039533|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
7778810|NCT00624780|27039534|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
7778811|NCT00624780|27039535|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
7778812|NCT00624780|27039530|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
7778813|NCT00624780|27039531|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
7778814|NCT00624780|27039532|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
7778815|NCT00624780|27039533|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
7778816|NCT00624780|27039534|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
7778817|NCT00624780|27039535|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
7778818|NCT00624780|27039530|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
7778819|NCT00624780|27039531|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
7778820|NCT00624780|27039532|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
7778821|NCT00624780|27039533|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
7778822|NCT00624780|27039534|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
7778823|NCT00624780|27039535|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
7778824|NCT00624780|27039530|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
7778825|NCT00624780|27039531|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
7778826|NCT00624780|27039532|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
7778827|NCT00624780|27039533|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
7778828|NCT00624780|27039534|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
7778829|NCT00624780|27039535|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
7778830|NCT00624585|27039726|P1|Overall Study|Adverse Event|3
7778831|NCT00624585|27039726|P1|Overall Study|Disease Progression|6
7778832|NCT00624585|27039726|P1|Overall Study|Death|3
7778833|NCT00624520|27039756|P2|Overall Study|Death|1
7778834|NCT00624520|27039757|P1|Overall Study|Death|0
7778835|NCT00624520|27039756|P2|Overall Study|Withdrawal by Subject|7
7778836|NCT00624520|27039757|P1|Overall Study|Withdrawal by Subject|12
7778837|NCT00624468|27039784|P4|Safety Follow-up (SFU) Period|Other|1
7778838|NCT00624468|27039785|P3|Safety Follow-up (SFU) Period|Other|1
7778839|NCT00624468|27039786|P2|Safety Follow-up (SFU) Period|Other|0
7778840|NCT00624468|27039787|P1|Safety Follow-up (SFU) Period|Other|0
7778841|NCT00624468|27039784|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
7778842|NCT00624468|27039785|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
7778843|NCT00624468|27039786|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7778844|NCT00624468|27039787|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7778845|NCT00624468|27039784|P4|Double-blind Period|Withdrew Prematurely|0
7778846|NCT00624468|27039785|P3|Double-blind Period|Withdrew Prematurely|0
7778847|NCT00624468|27039786|P2|Double-blind Period|Withdrew Prematurely|1
7778848|NCT00624468|27039787|P1|Double-blind Period|Withdrew Prematurely|1
7778849|NCT00624468|27039784|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
7778850|NCT00624468|27039785|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
7778851|NCT00624468|27039786|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
7778852|NCT00624468|27039787|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
7778853|NCT00624377|27039880|P1|Overall Study|Non-evaluable population|84
7778854|NCT00624377|27039880|P1|Overall Study|Other|91
7778855|NCT00624377|27039880|P1|Overall Study|Adverse Event|14
7778856|NCT00624377|27039880|P1|Overall Study|Withdrawal by Subject|100
7778857|NCT00624377|27039880|P1|Overall Study|Lost to Follow-up|355
7778858|NCT00624338|27039894|P3|Overall Study|Randomized but not treated|3
7778859|NCT00624338|27039895|P2|Overall Study|Randomized but not treated|1
7778860|NCT00624338|27039896|P1|Overall Study|Randomized but not treated|2
7778861|NCT00624338|27039894|P3|Overall Study|Other|9
7778862|NCT00624338|27039895|P2|Overall Study|Other|5
7778863|NCT00624338|27039896|P1|Overall Study|Other|15
7778864|NCT00624338|27039894|P3|Overall Study|Termination of 150 mg group by Sponsor|0
7778865|NCT00624338|27039895|P2|Overall Study|Termination of 150 mg group by Sponsor|55
7778866|NCT00624338|27039896|P1|Overall Study|Termination of 150 mg group by Sponsor|0
7778867|NCT00624338|27039894|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
7778868|NCT00624338|27039895|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
7778869|NCT00624338|27039896|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
7778870|NCT00624338|27039894|P3|Overall Study|Death|0
7778871|NCT00624338|27039895|P2|Overall Study|Death|2
7778872|NCT00624338|27039896|P1|Overall Study|Death|0
7778873|NCT00624338|27039894|P3|Overall Study|Protocol Violation|2
7778874|NCT00624338|27039895|P2|Overall Study|Protocol Violation|3
7778875|NCT00624338|27039896|P1|Overall Study|Protocol Violation|3
7778876|NCT00624338|27039894|P3|Overall Study|Lack of Efficacy|14
7778877|NCT00624338|27039895|P2|Overall Study|Lack of Efficacy|3
7778878|NCT00624338|27039896|P1|Overall Study|Lack of Efficacy|11
7778879|NCT00624338|27039894|P3|Overall Study|Lost to Follow-up|0
7778880|NCT00624338|27039895|P2|Overall Study|Lost to Follow-up|0
7778881|NCT00624338|27039896|P1|Overall Study|Lost to Follow-up|1
7778882|NCT00624338|27039894|P3|Overall Study|Adverse Event|18
7778883|NCT00624338|27039895|P2|Overall Study|Adverse Event|14
7778884|NCT00624338|27039896|P1|Overall Study|Adverse Event|14
7778885|NCT00624286|27039918|P2|Overall Study|Death|1
7778886|NCT00624286|27039919|P1|Overall Study|Death|0
7778887|NCT00624286|27039918|P2|Overall Study|Abnormal test procedure result(s)|1
7778888|NCT00624286|27039919|P1|Overall Study|Abnormal test procedure result(s)|0
7778889|NCT00624286|27039918|P2|Overall Study|Not stated|1
7778890|NCT00624286|27039919|P1|Overall Study|Not stated|0
7778891|NCT00624286|27039918|P2|Overall Study|Lack of Efficacy|6
7778892|NCT00624286|27039919|P1|Overall Study|Lack of Efficacy|1
7778893|NCT00624286|27039918|P2|Overall Study|Administrative problems|0
7778894|NCT00624286|27039919|P1|Overall Study|Administrative problems|3
7778895|NCT00624286|27039918|P2|Overall Study|Lost to Follow-up|2
7778896|NCT00624286|27039919|P1|Overall Study|Lost to Follow-up|3
7778897|NCT00624286|27039918|P2|Overall Study|Withdrawal by Subject|4
7778898|NCT00624286|27039919|P1|Overall Study|Withdrawal by Subject|5
7778899|NCT00624286|27039918|P2|Overall Study|Adverse Event|3
7778900|NCT00624286|27039919|P1|Overall Study|Adverse Event|6
7778901|NCT00624286|27039918|P2|Overall Study|Protocol Deviation|9
7778902|NCT00624286|27039919|P1|Overall Study|Protocol Deviation|7
7778903|NCT00624065|27039972|P2|Overall Study|Met protocol-defined stopping criteria|9
7778904|NCT00624065|27039973|P1|Overall Study|Met protocol-defined stopping criteria|4
7778905|NCT00624065|27039972|P2|Overall Study|Lack of Efficacy|3
7778906|NCT00624065|27039973|P1|Overall Study|Lack of Efficacy|0
7778907|NCT00624065|27039972|P2|Overall Study|Consent withdrawn|5
7778908|NCT00624065|27039973|P1|Overall Study|Consent withdrawn|6
7778909|NCT00624065|27039972|P2|Overall Study|Lost to Follow-up|1
7778910|NCT00624065|27039973|P1|Overall Study|Lost to Follow-up|4
7778911|NCT00624065|27039972|P2|Overall Study|Adverse Event|6
7778912|NCT00624065|27039973|P1|Overall Study|Adverse Event|5
7778913|NCT00624052|27039985|P4|Overall Study|Changed job/ran out if meds|0
7778914|NCT00624052|27039986|P3|Overall Study|Changed job/ran out if meds|0
7778915|NCT00624052|27039987|P2|Overall Study|Changed job/ran out if meds|2
7778916|NCT00624052|27039988|P1|Overall Study|Changed job/ran out if meds|0
7778917|NCT00624052|27039985|P4|Overall Study|Consent withdrawn|0
7778918|NCT00624052|27039986|P3|Overall Study|Consent withdrawn|1
7778919|NCT00624052|27039987|P2|Overall Study|Consent withdrawn|1
7778920|NCT00624052|27039988|P1|Overall Study|Consent withdrawn|3
7778921|NCT00624052|27039985|P4|Overall Study|Non compliant with the protocol|1
7778922|NCT00624052|27039986|P3|Overall Study|Non compliant with the protocol|1
7778923|NCT00624052|27039987|P2|Overall Study|Non compliant with the protocol|1
7778924|NCT00624052|27039988|P1|Overall Study|Non compliant with the protocol|2
7778925|NCT00624052|27039985|P4|Overall Study|Lost to Follow-up|0
7778926|NCT00624052|27039986|P3|Overall Study|Lost to Follow-up|1
7778927|NCT00624052|27039987|P2|Overall Study|Lost to Follow-up|3
7778928|NCT00624052|27039988|P1|Overall Study|Lost to Follow-up|2
7778929|NCT00624052|27039985|P4|Overall Study|Lack of Efficacy|0
7778930|NCT00624052|27039986|P3|Overall Study|Lack of Efficacy|0
7778931|NCT00624052|27039987|P2|Overall Study|Lack of Efficacy|1
7778932|NCT00624052|27039988|P1|Overall Study|Lack of Efficacy|1
7778933|NCT00624052|27039985|P4|Overall Study|Adverse Event|3
7778934|NCT00624052|27039986|P3|Overall Study|Adverse Event|0
7778935|NCT00624052|27039987|P2|Overall Study|Adverse Event|6
7778936|NCT00624052|27039988|P1|Overall Study|Adverse Event|7
7778937|NCT00623935|27040065|P1|Overall Study|Patient Declined Transplant|1
7778938|NCT00623935|27040065|P1|Overall Study|Death|1
7778939|NCT00623831|27040072|P2|Overall Study|Progressive Disease|1
7778940|NCT00623831|27040073|P1|Overall Study|Progressive Disease|0
7778941|NCT00623831|27040072|P2|Overall Study|Withdrawal by Subject|0
7778942|NCT00623831|27040073|P1|Overall Study|Withdrawal by Subject|1
7778943|NCT00623805|27040085|P2|Overall Study|Reason not Specified|6
7778944|NCT00623805|27040086|P1|Overall Study|Reason not Specified|3
7778945|NCT00623805|27040085|P2|Overall Study|Protocol Violation|1
7778946|NCT00623805|27040086|P1|Overall Study|Protocol Violation|1
7778947|NCT00623805|27040085|P2|Overall Study|Lost to Follow-up|2
7778948|NCT00623805|27040086|P1|Overall Study|Lost to Follow-up|2
7778949|NCT00623805|27040085|P2|Overall Study|Lack of Efficacy|7
7778950|NCT00623805|27040086|P1|Overall Study|Lack of Efficacy|3
7778951|NCT00623805|27040085|P2|Overall Study|Death|0
7778952|NCT00623805|27040086|P1|Overall Study|Death|2
7778953|NCT00623805|27040085|P2|Overall Study|Adverse Event|6
7778954|NCT00623805|27040086|P1|Overall Study|Adverse Event|9
7778955|NCT00623779|27040103|P3|Overall Study|Criteria from CSR|1
7778956|NCT00623779|27040104|P2|Overall Study|Criteria from CSR|0
7778957|NCT00623779|27040105|P1|Overall Study|Criteria from CSR|2
7778958|NCT00623779|27040103|P3|Overall Study|Adverse Event|0
7778959|NCT00623779|27040104|P2|Overall Study|Adverse Event|3
7778960|NCT00623779|27040105|P1|Overall Study|Adverse Event|1
7778961|NCT00623766|27040154|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
7778962|NCT00623766|27040155|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
7778963|NCT00623766|27040154|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
7778964|NCT00623766|27040155|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
7778965|NCT00623766|27040154|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
7778966|NCT00623766|27040155|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
7778967|NCT00623766|27040154|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
7778968|NCT00623766|27040155|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
7778969|NCT00623766|27040154|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
7778970|NCT00623766|27040155|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
7778971|NCT00623727|27040179|P2|Open Label Follow-up|Participant convenience|1
7778972|NCT00623727|27040180|P1|Open Label Follow-up|Participant convenience|0
7778973|NCT00623727|27040179|P2|Open Label Follow-up|Study termination|6
7778974|NCT00623727|27040180|P1|Open Label Follow-up|Study termination|0
7778975|NCT00623727|27040179|P2|Open Label Follow-up|Withdrawal by Subject|1
7778976|NCT00623727|27040180|P1|Open Label Follow-up|Withdrawal by Subject|0
7778977|NCT00623727|27040179|P2|Double Blind (DB)|Protocol Violation|2
7778978|NCT00623727|27040180|P1|Double Blind (DB)|Protocol Violation|2
7778979|NCT00623727|27040179|P2|Double Blind (DB)|Lost to Follow-up|1
7778980|NCT00623727|27040180|P1|Double Blind (DB)|Lost to Follow-up|1
7778981|NCT00623727|27040179|P2|Double Blind (DB)|Termination of the double-blind period|21
7778982|NCT00623727|27040180|P1|Double Blind (DB)|Termination of the double-blind period|22
7778983|NCT00623727|27040179|P2|Double Blind (DB)|Lack of Efficacy|2
7778984|NCT00623727|27040180|P1|Double Blind (DB)|Lack of Efficacy|2
7778985|NCT00623727|27040179|P2|Double Blind (DB)|Withdrawal by Subject|2
7778986|NCT00623727|27040180|P1|Double Blind (DB)|Withdrawal by Subject|8
7778987|NCT00623727|27040179|P2|Double Blind (DB)|Physician Decision|1
7778988|NCT00623727|27040180|P1|Double Blind (DB)|Physician Decision|0
7778989|NCT00623727|27040179|P2|Double Blind (DB)|Adverse Event|3
7778990|NCT00623727|27040180|P1|Double Blind (DB)|Adverse Event|1
7778991|NCT00623623|27040235|P2|Overall Study|Previous enrolment into this study|1
7778992|NCT00623623|27040236|P1|Overall Study|Previous enrolment into this study|1
7778993|NCT00623597|27040292|P2|Overall Study|Failed to return|0
7778994|NCT00623597|27040293|P1|Overall Study|Failed to return|1
7778995|NCT00623545|27040356|P1|Overall Study|Withdrawal by Subject|4
7778996|NCT00623545|27040356|P1|Overall Study|Adverse Event|6
7778997|NCT00623480|27040376|P2|Overall Study|Site closed by sponsor|1
7778998|NCT00623480|27040377|P1|Overall Study|Site closed by sponsor|0
7778999|NCT00623480|27040376|P2|Overall Study|Protocol Violation|1
7779000|NCT00623480|27040377|P1|Overall Study|Protocol Violation|0
7779001|NCT00623480|27040376|P2|Overall Study|Non-compliant with study medication|0
7779002|NCT00623480|27040377|P1|Overall Study|Non-compliant with study medication|4
7779003|NCT00623480|27040376|P2|Overall Study|Lack of Efficacy|0
7779004|NCT00623480|27040377|P1|Overall Study|Lack of Efficacy|1
7779005|NCT00623480|27040376|P2|Overall Study|Withdrawal by Subject|4
7779006|NCT00623480|27040377|P1|Overall Study|Withdrawal by Subject|2
7779007|NCT00623480|27040376|P2|Overall Study|Lost to Follow-up|1
7779008|NCT00623480|27040377|P1|Overall Study|Lost to Follow-up|0
7779009|NCT00623467|27040389|P1|Overall Study|Withdrawal by Subject|2
7779010|NCT00623467|27040389|P1|Overall Study|Protocol Violation|4
7779011|NCT00623467|27040389|P1|Overall Study|Lost to Follow-up|1
7779012|NCT00623428|27040459|P2|Follow-up Period|Death|1
7779013|NCT00623428|27040460|P1|Follow-up Period|Death|0
7779014|NCT00623428|27040459|P2|Follow-up Period|Reason not specified|1
7779015|NCT00623428|27040460|P1|Follow-up Period|Reason not specified|1
7779016|NCT00623428|27040459|P2|Follow-up Period|Did not cooperate|3
7779017|NCT00623428|27040460|P1|Follow-up Period|Did not cooperate|0
7779018|NCT00623428|27040459|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
7779019|NCT00623428|27040460|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
7779020|NCT00623428|27040459|P2|Follow-up Period|Patient withdrew consent|4
7779021|NCT00623428|27040460|P1|Follow-up Period|Patient withdrew consent|5
7779022|NCT00623428|27040459|P2|Follow-up Period|Failure to return|2
7779023|NCT00623428|27040460|P1|Follow-up Period|Failure to return|10
7779024|NCT00623428|27040459|P2|Follow-up Period|Relapse post-treatment|3
7779025|NCT00623428|27040460|P1|Follow-up Period|Relapse post-treatment|11
7779026|NCT00623428|27040459|P2|Treatment Period|Withdrawal by Subject|1
7779027|NCT00623428|27040460|P1|Treatment Period|Withdrawal by Subject|0
7779028|NCT00623428|27040459|P2|Treatment Period|Other|1
7779029|NCT00623428|27040460|P1|Treatment Period|Other|0
7779030|NCT00623428|27040459|P2|Treatment Period|Insufficient therapeutic response|2
7779031|NCT00623428|27040460|P1|Treatment Period|Insufficient therapeutic response|0
7779032|NCT00623428|27040459|P2|Treatment Period|Did not cooperate / refused treatment|13
7779033|NCT00623428|27040460|P1|Treatment Period|Did not cooperate / refused treatment|0
7779034|NCT00623428|27040459|P2|Treatment Period|Death|1
7779035|NCT00623428|27040460|P1|Treatment Period|Death|0
7779036|NCT00623428|27040459|P2|Treatment Period|Adverse event/intercurrent illness|9
7779037|NCT00623428|27040460|P1|Treatment Period|Adverse event/intercurrent illness|0
7779038|NCT00623363|27040480|P2|Overall Study|Adverse Event|2
7779039|NCT00623363|27040481|P1|Overall Study|Adverse Event|2
7779040|NCT00623233|27040512|P1|Overall Study|Withdrawal by Subject|3
7779041|NCT00623233|27040512|P1|Overall Study|Lost to Follow-up|1
7779042|NCT00623233|27040512|P1|Overall Study|Physician Decision|10
7779043|NCT00623233|27040512|P1|Overall Study|Adverse Event|10
7779044|NCT00623194|27040519|P1|Overall Study|Unclassified|1
7779045|NCT00623194|27040519|P1|Overall Study|Protocol Violation|3
7779046|NCT00623194|27040519|P1|Overall Study|Lack of Efficacy|1
7779047|NCT00623103|27040556|P2|Overall Study|Protocol deviation|1
7779048|NCT00623103|27040557|P1|Overall Study|Protocol deviation|2
7779049|NCT00623103|27040556|P2|Overall Study|Death|11
7779050|NCT00623103|27040557|P1|Overall Study|Death|11
7779051|NCT00623103|27040556|P2|Overall Study|Administrative problems|4
7779052|NCT00623103|27040557|P1|Overall Study|Administrative problems|2
7779053|NCT00623103|27040556|P2|Overall Study|Lost to Follow-up|1
7779054|NCT00623103|27040557|P1|Overall Study|Lost to Follow-up|4
7779055|NCT00623103|27040556|P2|Overall Study|Withdrawal by Subject|24
7779056|NCT00623103|27040557|P1|Overall Study|Withdrawal by Subject|18
7779057|NCT00623103|27040556|P2|Overall Study|Unsatisfactory therapeutic effect|12
7779058|NCT00623103|27040557|P1|Overall Study|Unsatisfactory therapeutic effect|4
7779059|NCT00623103|27040556|P2|Overall Study|Adverse Event|60
7779060|NCT00623103|27040557|P1|Overall Study|Adverse Event|70
7779061|NCT00622908|27040585|P2|Overall Study|Termination by study sponser|1
7779062|NCT00622908|27040586|P1|Overall Study|Termination by study sponser|0
7779063|NCT00622908|27040585|P2|Overall Study|Refusal|1
7779064|NCT00622908|27040586|P1|Overall Study|Refusal|0
7779065|NCT00622908|27040585|P2|Overall Study|Lost to Follow-up|0
7779066|NCT00622908|27040586|P1|Overall Study|Lost to Follow-up|1
7779067|NCT00622908|27040585|P2|Overall Study|Lack of Efficacy|7
7779068|NCT00622908|27040586|P1|Overall Study|Lack of Efficacy|1
7779069|NCT00622908|27040585|P2|Overall Study|Adverse Event|1
7779070|NCT00622908|27040586|P1|Overall Study|Adverse Event|0
7779071|NCT00622908|27040585|P2|Overall Study|Protocol Violation|0
7779072|NCT00622908|27040586|P1|Overall Study|Protocol Violation|1
7779073|NCT00622869|27040616|P3|Overall Study|Missing|1
7779074|NCT00622869|27040617|P2|Overall Study|Missing|1
7779075|NCT00622869|27040618|P1|Overall Study|Missing|0
7779076|NCT00622869|27040616|P3|Overall Study|Graft Loss|2
7779077|NCT00622869|27040617|P2|Overall Study|Graft Loss|3
7779078|NCT00622869|27040618|P1|Overall Study|Graft Loss|5
7779079|NCT00622869|27040616|P3|Overall Study|Lost to Follow-up|2
7779080|NCT00622869|27040617|P2|Overall Study|Lost to Follow-up|4
7779081|NCT00622869|27040618|P1|Overall Study|Lost to Follow-up|2
7779082|NCT00622869|27040616|P3|Overall Study|Death|10
7779083|NCT00622869|27040617|P2|Overall Study|Death|15
7779084|NCT00622869|27040618|P1|Overall Study|Death|12
7779085|NCT00622869|27040616|P3|Overall Study|Administrative Problems|13
7779086|NCT00622869|27040617|P2|Overall Study|Administrative Problems|17
7779087|NCT00622869|27040618|P1|Overall Study|Administrative Problems|11
7779088|NCT00622869|27040616|P3|Overall Study|Subject Withdrew Consent|11
7779089|NCT00622869|27040617|P2|Overall Study|Subject Withdrew Consent|17
7779090|NCT00622869|27040618|P1|Overall Study|Subject Withdrew Consent|13
7779091|NCT00622739|27040637|P2|Overall Study|Lost to Follow-up|1
7779092|NCT00622739|27040638|P1|Overall Study|Lost to Follow-up|0
7779093|NCT00622739|27040637|P2|Overall Study|Withdrawal by Subject|1
7779094|NCT00622739|27040638|P1|Overall Study|Withdrawal by Subject|0
7779095|NCT00622739|27040637|P2|Overall Study|Lack of Efficacy|2
7779096|NCT00622739|27040638|P1|Overall Study|Lack of Efficacy|0
7779097|NCT00622739|27040637|P2|Overall Study|Adverse Event|2
7779098|NCT00622739|27040638|P1|Overall Study|Adverse Event|1
7779099|NCT00622739|27040637|P2|Overall Study|Physician Decision|0
7779100|NCT00622739|27040638|P1|Overall Study|Physician Decision|1
7779101|NCT00622726|27040656|P2|August, 2010 to April, 2013|Death|5
7779102|NCT00622726|27040657|P1|August, 2010 to April, 2013|Death|1
7779103|NCT00622726|27040656|P2|March, 2008 to August, 2010|Death|2
7779104|NCT00622726|27040657|P1|March, 2008 to August, 2010|Death|5
7779105|NCT00622713|27040667|P1|Overall Study|Did not meet eligibility criteria|1
7779106|NCT00622713|27040667|P1|Overall Study|Subject no longer required study drug|1
7779107|NCT00622713|27040667|P1|Overall Study|Death|2
7779108|NCT00622713|27040667|P1|Overall Study|Lost to Follow-up|5
7779109|NCT00622713|27040667|P1|Overall Study|Withdrawal by Subject|11
7779110|NCT00622713|27040667|P1|Overall Study|Administrative problems|4
7779111|NCT00622713|27040667|P1|Overall Study|Adverse Event|35
7779112|NCT00622700|27040678|P7|Extension Treatment Period|Other than specified above|1
7779113|NCT00622700|27040679|P6|Extension Treatment Period|Other than specified above|1
7779114|NCT00622700|27040680|P5|Extension Treatment Period|Other than specified above|0
7779115|NCT00622700|27040681|P4|Extension Treatment Period|Other than specified above|0
7779116|NCT00622700|27040682|P3|Extension Treatment Period|Other than specified above|0
7779117|NCT00622700|27040683|P2|Extension Treatment Period|Other than specified above|0
7779118|NCT00622700|27040684|P1|Extension Treatment Period|Other than specified above|0
7779119|NCT00622700|27040678|P7|Extension Treatment Period|Missing|0
7779120|NCT00622700|27040679|P6|Extension Treatment Period|Missing|1
7779121|NCT00622700|27040680|P5|Extension Treatment Period|Missing|3
7779122|NCT00622700|27040681|P4|Extension Treatment Period|Missing|2
7779123|NCT00622700|27040682|P3|Extension Treatment Period|Missing|0
7779124|NCT00622700|27040683|P2|Extension Treatment Period|Missing|0
7779125|NCT00622700|27040684|P1|Extension Treatment Period|Missing|0
7779126|NCT00622700|27040678|P7|Extension Treatment Period|Withdrawal by Subject|10
7779127|NCT00622700|27040679|P6|Extension Treatment Period|Withdrawal by Subject|6
7779128|NCT00622700|27040680|P5|Extension Treatment Period|Withdrawal by Subject|16
7779129|NCT00622700|27040681|P4|Extension Treatment Period|Withdrawal by Subject|11
7779130|NCT00622700|27040682|P3|Extension Treatment Period|Withdrawal by Subject|0
7779131|NCT00622700|27040683|P2|Extension Treatment Period|Withdrawal by Subject|0
7779132|NCT00622700|27040684|P1|Extension Treatment Period|Withdrawal by Subject|0
7779133|NCT00622700|27040678|P7|Extension Treatment Period|Progressive Disease|2
7779134|NCT00622700|27040679|P6|Extension Treatment Period|Progressive Disease|0
7779135|NCT00622700|27040680|P5|Extension Treatment Period|Progressive Disease|2
7779136|NCT00622700|27040681|P4|Extension Treatment Period|Progressive Disease|1
7779137|NCT00622700|27040682|P3|Extension Treatment Period|Progressive Disease|0
7779138|NCT00622700|27040683|P2|Extension Treatment Period|Progressive Disease|0
7779139|NCT00622700|27040684|P1|Extension Treatment Period|Progressive Disease|0
7779140|NCT00622700|27040678|P7|Extension Treatment Period|Lost to Follow-up|0
7779141|NCT00622700|27040679|P6|Extension Treatment Period|Lost to Follow-up|0
7779142|NCT00622700|27040680|P5|Extension Treatment Period|Lost to Follow-up|1
7779143|NCT00622700|27040681|P4|Extension Treatment Period|Lost to Follow-up|0
7779144|NCT00622700|27040682|P3|Extension Treatment Period|Lost to Follow-up|0
7779145|NCT00622700|27040683|P2|Extension Treatment Period|Lost to Follow-up|0
7779146|NCT00622700|27040684|P1|Extension Treatment Period|Lost to Follow-up|0
7779147|NCT00622700|27040678|P7|Extension Treatment Period|Protocol Violation|0
7779148|NCT00622700|27040679|P6|Extension Treatment Period|Protocol Violation|2
7779149|NCT00622700|27040680|P5|Extension Treatment Period|Protocol Violation|0
7779150|NCT00622700|27040681|P4|Extension Treatment Period|Protocol Violation|0
7779151|NCT00622700|27040682|P3|Extension Treatment Period|Protocol Violation|0
7779152|NCT00622700|27040683|P2|Extension Treatment Period|Protocol Violation|0
7779153|NCT00622700|27040684|P1|Extension Treatment Period|Protocol Violation|0
7779154|NCT00622700|27040678|P7|Extension Treatment Period|Lack of Efficacy|9
7779155|NCT00622700|27040679|P6|Extension Treatment Period|Lack of Efficacy|1
7779156|NCT00622700|27040680|P5|Extension Treatment Period|Lack of Efficacy|8
7779157|NCT00622700|27040681|P4|Extension Treatment Period|Lack of Efficacy|2
7779158|NCT00622700|27040682|P3|Extension Treatment Period|Lack of Efficacy|0
7779159|NCT00622700|27040683|P2|Extension Treatment Period|Lack of Efficacy|0
7779160|NCT00622700|27040684|P1|Extension Treatment Period|Lack of Efficacy|0
7779161|NCT00622700|27040678|P7|Extension Treatment Period|Adverse Event|8
7779162|NCT00622700|27040679|P6|Extension Treatment Period|Adverse Event|6
7779163|NCT00622700|27040680|P5|Extension Treatment Period|Adverse Event|9
7779164|NCT00622700|27040681|P4|Extension Treatment Period|Adverse Event|5
7779165|NCT00622700|27040682|P3|Extension Treatment Period|Adverse Event|0
7779166|NCT00622700|27040683|P2|Extension Treatment Period|Adverse Event|0
7779167|NCT00622700|27040684|P1|Extension Treatment Period|Adverse Event|0
7779168|NCT00622700|27040678|P7|Core Treatment Period|Other than specified above|0
7779169|NCT00622700|27040679|P6|Core Treatment Period|Other than specified above|0
7779170|NCT00622700|27040680|P5|Core Treatment Period|Other than specified above|0
7779171|NCT00622700|27040681|P4|Core Treatment Period|Other than specified above|0
7779172|NCT00622700|27040682|P3|Core Treatment Period|Other than specified above|5
7779173|NCT00622700|27040683|P2|Core Treatment Period|Other than specified above|2
7779174|NCT00622700|27040684|P1|Core Treatment Period|Other than specified above|2
7779175|NCT00622700|27040678|P7|Core Treatment Period|Withdrawal by Subject|0
7779176|NCT00622700|27040679|P6|Core Treatment Period|Withdrawal by Subject|0
7779177|NCT00622700|27040680|P5|Core Treatment Period|Withdrawal by Subject|0
7779178|NCT00622700|27040681|P4|Core Treatment Period|Withdrawal by Subject|0
7779179|NCT00622700|27040682|P3|Core Treatment Period|Withdrawal by Subject|15
7779180|NCT00622700|27040683|P2|Core Treatment Period|Withdrawal by Subject|18
7779181|NCT00622700|27040684|P1|Core Treatment Period|Withdrawal by Subject|12
7779182|NCT00622700|27040678|P7|Core Treatment Period|Progressive Disease|0
7779183|NCT00622700|27040679|P6|Core Treatment Period|Progressive Disease|0
7779184|NCT00622700|27040680|P5|Core Treatment Period|Progressive Disease|0
7779185|NCT00622700|27040681|P4|Core Treatment Period|Progressive Disease|0
7779186|NCT00622700|27040682|P3|Core Treatment Period|Progressive Disease|0
7779187|NCT00622700|27040683|P2|Core Treatment Period|Progressive Disease|1
7779188|NCT00622700|27040684|P1|Core Treatment Period|Progressive Disease|3
7779189|NCT00622700|27040678|P7|Core Treatment Period|Death|0
7779190|NCT00622700|27040679|P6|Core Treatment Period|Death|0
7779191|NCT00622700|27040680|P5|Core Treatment Period|Death|0
7779192|NCT00622700|27040681|P4|Core Treatment Period|Death|0
7779193|NCT00622700|27040682|P3|Core Treatment Period|Death|0
7779194|NCT00622700|27040683|P2|Core Treatment Period|Death|0
7779195|NCT00622700|27040684|P1|Core Treatment Period|Death|1
7779196|NCT00622700|27040678|P7|Core Treatment Period|Lost to Follow-up|0
7779197|NCT00622700|27040679|P6|Core Treatment Period|Lost to Follow-up|0
7779198|NCT00622700|27040680|P5|Core Treatment Period|Lost to Follow-up|0
7779199|NCT00622700|27040681|P4|Core Treatment Period|Lost to Follow-up|0
7779200|NCT00622700|27040682|P3|Core Treatment Period|Lost to Follow-up|1
7779201|NCT00622700|27040683|P2|Core Treatment Period|Lost to Follow-up|1
7779202|NCT00622700|27040684|P1|Core Treatment Period|Lost to Follow-up|1
7779203|NCT00622700|27040678|P7|Core Treatment Period|Lack of Efficacy|0
7779204|NCT00622700|27040679|P6|Core Treatment Period|Lack of Efficacy|0
7779205|NCT00622700|27040680|P5|Core Treatment Period|Lack of Efficacy|0
7779206|NCT00622700|27040681|P4|Core Treatment Period|Lack of Efficacy|0
7779207|NCT00622700|27040682|P3|Core Treatment Period|Lack of Efficacy|12
7779208|NCT00622700|27040683|P2|Core Treatment Period|Lack of Efficacy|6
7779209|NCT00622700|27040684|P1|Core Treatment Period|Lack of Efficacy|19
7779210|NCT00622700|27040678|P7|Core Treatment Period|Adverse Event|0
7779211|NCT00622700|27040679|P6|Core Treatment Period|Adverse Event|0
7779212|NCT00622700|27040680|P5|Core Treatment Period|Adverse Event|0
7779213|NCT00622700|27040681|P4|Core Treatment Period|Adverse Event|0
7779214|NCT00622700|27040682|P3|Core Treatment Period|Adverse Event|18
7779215|NCT00622700|27040683|P2|Core Treatment Period|Adverse Event|25
7779216|NCT00622700|27040684|P1|Core Treatment Period|Adverse Event|18
7779217|NCT00622700|27040678|P7|Core Treatment Period|Randomized but Not Treated|0
7779218|NCT00622700|27040679|P6|Core Treatment Period|Randomized but Not Treated|0
7779219|NCT00622700|27040680|P5|Core Treatment Period|Randomized but Not Treated|0
7779220|NCT00622700|27040681|P4|Core Treatment Period|Randomized but Not Treated|0
7779221|NCT00622700|27040682|P3|Core Treatment Period|Randomized but Not Treated|2
7779222|NCT00622700|27040683|P2|Core Treatment Period|Randomized but Not Treated|2
7779223|NCT00622700|27040684|P1|Core Treatment Period|Randomized but Not Treated|0
7779224|NCT00622635|27040743|P6|Treatment Period 3|Withdrawal by Subject|0
7779225|NCT00622635|27040744|P5|Treatment Period 3|Withdrawal by Subject|0
7779226|NCT00622635|27040745|P4|Treatment Period 3|Withdrawal by Subject|1
7779227|NCT00622635|27040746|P3|Treatment Period 3|Withdrawal by Subject|0
7779228|NCT00622635|27040747|P2|Treatment Period 3|Withdrawal by Subject|0
7779229|NCT00622635|27040748|P1|Treatment Period 3|Withdrawal by Subject|0
7779230|NCT00622635|27040743|P6|Treatment Period 3|Adverse Event|0
7779231|NCT00622635|27040744|P5|Treatment Period 3|Adverse Event|0
7779232|NCT00622635|27040745|P4|Treatment Period 3|Adverse Event|2
7779233|NCT00622635|27040746|P3|Treatment Period 3|Adverse Event|0
7779234|NCT00622635|27040747|P2|Treatment Period 3|Adverse Event|0
7779235|NCT00622635|27040748|P1|Treatment Period 3|Adverse Event|0
7779236|NCT00622635|27040743|P6|Treatment Period 2|Adverse Event|0
7779237|NCT00622635|27040744|P5|Treatment Period 2|Adverse Event|0
7779238|NCT00622635|27040745|P4|Treatment Period 2|Adverse Event|0
7779239|NCT00622635|27040746|P3|Treatment Period 2|Adverse Event|0
7779240|NCT00622635|27040747|P2|Treatment Period 2|Adverse Event|0
7779241|NCT00622635|27040748|P1|Treatment Period 2|Adverse Event|1
7779242|NCT00622635|27040743|P6|Treatment Period 1|Abnormal test procedure result(s)|0
7779243|NCT00622635|27040744|P5|Treatment Period 1|Abnormal test procedure result(s)|1
7779244|NCT00622635|27040745|P4|Treatment Period 1|Abnormal test procedure result(s)|0
7779245|NCT00622635|27040746|P3|Treatment Period 1|Abnormal test procedure result(s)|0
7779246|NCT00622635|27040747|P2|Treatment Period 1|Abnormal test procedure result(s)|0
7779247|NCT00622635|27040748|P1|Treatment Period 1|Abnormal test procedure result(s)|0
7779248|NCT00622635|27040743|P6|Treatment Period 1|Withdrawal by Subject|0
7779249|NCT00622635|27040744|P5|Treatment Period 1|Withdrawal by Subject|0
7779250|NCT00622635|27040745|P4|Treatment Period 1|Withdrawal by Subject|0
7779251|NCT00622635|27040746|P3|Treatment Period 1|Withdrawal by Subject|0
7779252|NCT00622635|27040747|P2|Treatment Period 1|Withdrawal by Subject|1
7779253|NCT00622635|27040748|P1|Treatment Period 1|Withdrawal by Subject|0
7779254|NCT00622635|27040743|P6|Treatment Period 1|Adverse Event|0
7779255|NCT00622635|27040744|P5|Treatment Period 1|Adverse Event|0
7779256|NCT00622635|27040745|P4|Treatment Period 1|Adverse Event|0
7779257|NCT00622635|27040746|P3|Treatment Period 1|Adverse Event|1
7779258|NCT00622635|27040747|P2|Treatment Period 1|Adverse Event|0
7779259|NCT00622635|27040748|P1|Treatment Period 1|Adverse Event|0
7779260|NCT00622505|27040831|P2|Overall Study|Death|2
7779261|NCT00622505|27040832|P1|Overall Study|Death|2
7779262|NCT00622505|27040831|P2|Overall Study|Administrative Problems|4
7779263|NCT00622505|27040832|P1|Overall Study|Administrative Problems|2
7779264|NCT00622505|27040831|P2|Overall Study|Withdrawal by Subject|5
7779265|NCT00622505|27040832|P1|Overall Study|Withdrawal by Subject|12
7779266|NCT00622505|27040831|P2|Overall Study|Abnormal Test Procedure Result(s)|0
7779267|NCT00622505|27040832|P1|Overall Study|Abnormal Test Procedure Result(s)|1
7779268|NCT00622505|27040831|P2|Overall Study|Abnormal Laboratory Value(s)|5
7779269|NCT00622505|27040832|P1|Overall Study|Abnormal Laboratory Value(s)|3
7779270|NCT00622505|27040831|P2|Overall Study|Adverse Event|7
7779271|NCT00622505|27040832|P1|Overall Study|Adverse Event|9
7779272|NCT00622466|27040856|P1|Overall Study|Withdrawal by Subject|2
7779273|NCT00622466|27040856|P1|Overall Study|Adverse Event|1
7779274|NCT00622466|27040856|P1|Overall Study|Death|1
7779275|NCT00622440|27040869|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
7779276|NCT00622440|27040870|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
7779277|NCT00622440|27040869|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
7779278|NCT00622440|27040870|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
7779279|NCT00622440|27040869|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
7779280|NCT00622440|27040870|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
7779281|NCT00622440|27040869|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
7779282|NCT00622440|27040870|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
7779283|NCT00622401|27040896|P3|Overall Study|Disease progression prior to treatment|0
7779284|NCT00622401|27040897|P2|Overall Study|Disease progression prior to treatment|2
7779285|NCT00622401|27040898|P1|Overall Study|Disease progression prior to treatment|3
7779286|NCT00622388|27040905|P1|Overall Study|Insurance Expired|1
7779287|NCT00622388|27040905|P1|Overall Study|Withdrew Consent|1
7779288|NCT00622388|27040905|P1|Overall Study|Took Prohibited Medication|2
7779289|NCT00622388|27040905|P1|Overall Study|Received Alternate Anticancer Therapy|8
7779290|NCT00622388|27040905|P1|Overall Study|Death|3
7779291|NCT00622388|27040905|P1|Overall Study|Participant Refusal|1
7779292|NCT00622388|27040905|P1|Overall Study|Protocol Violation|3
7779293|NCT00622388|27040905|P1|Overall Study|Adverse Event|6
7779294|NCT00622388|27040905|P1|Overall Study|Disease Progression|47
7779295|NCT00622336|27040923|P1|Extension Phase|Other|9
7779296|NCT00622336|27040923|P1|Extension Phase|Lost to Follow-up|1
7779297|NCT00622336|27040923|P1|Extension Phase|Withdrawal by Subject|1
7779298|NCT00622336|27040923|P1|Extension Phase|Lack of therapeutic effect|2
7779299|NCT00622336|27040923|P1|Extension Phase|Progressive Disease|6
7779300|NCT00622336|27040923|P1|Extension Phase|Adverse Event|2
7779301|NCT00622336|27040923|P1|Treatment Phase|Lost to Follow-up|2
7779302|NCT00622336|27040923|P1|Treatment Phase|Withdrawal by Subject|13
7779303|NCT00622336|27040923|P1|Treatment Phase|Lack of therapeutic effect|13
7779304|NCT00622336|27040923|P1|Treatment Phase|Death|14
7779305|NCT00622336|27040923|P1|Treatment Phase|Other|40
7779306|NCT00622336|27040923|P1|Treatment Phase|Adverse Event|46
7779307|NCT00622336|27040923|P1|Treatment Phase|Progression of Disease|181
7779308|NCT00622284|27040934|P2|Overall Study|Other reason (not specified)|24
7779309|NCT00622284|27040935|P1|Overall Study|Other reason (not specified)|33
7779310|NCT00622284|27040934|P2|Overall Study|Withdrawal by Subject|24
7779311|NCT00622284|27040935|P1|Overall Study|Withdrawal by Subject|27
7779312|NCT00622284|27040934|P2|Overall Study|Lost to Follow-up|13
7779313|NCT00622284|27040935|P1|Overall Study|Lost to Follow-up|11
7779314|NCT00622284|27040934|P2|Overall Study|Protocol Violation|5
7779315|NCT00622284|27040935|P1|Overall Study|Protocol Violation|12
7779316|NCT00622284|27040934|P2|Overall Study|Adverse Event|90
7779317|NCT00622284|27040935|P1|Overall Study|Adverse Event|61
7779318|NCT00622284|27040934|P2|Overall Study|Lack of Efficacy|15
7779319|NCT00622284|27040935|P1|Overall Study|Lack of Efficacy|45
7779320|NCT00622180|27040997|P2|Overall Study|Lost to Follow-up|2
7779321|NCT00622180|27040998|P1|Overall Study|Lost to Follow-up|1
7779322|NCT00622167|27041004|P1|Overall Study|Did not meet angiographic criteria|20
7779323|NCT00621985|27041008|P1|Dexamethasone Admission|Adverse Event|1
7779324|NCT00621959|27041016|P2|Overall Study|Other|3
7779325|NCT00621959|27041017|P1|Overall Study|Other|1
7779326|NCT00621959|27041016|P2|Overall Study|Withdrawal by Subject|1
7779327|NCT00621959|27041017|P1|Overall Study|Withdrawal by Subject|1
7779328|NCT00621959|27041016|P2|Overall Study|Lost to Follow-up|2
7779329|NCT00621959|27041017|P1|Overall Study|Lost to Follow-up|0
7779330|NCT00621959|27041016|P2|Overall Study|Lack of Efficacy|1
7779331|NCT00621959|27041017|P1|Overall Study|Lack of Efficacy|1
7779332|NCT00621959|27041016|P2|Overall Study|Adverse Event|2
7779333|NCT00621959|27041017|P1|Overall Study|Adverse Event|4
7779334|NCT00621855|27041056|P5|Overall Study|Patients did not receive study drug|2
7779335|NCT00621855|27041057|P4|Overall Study|Patients did not receive study drug|4
7779336|NCT00621855|27041058|P3|Overall Study|Patients did not receive study drug|5
7779337|NCT00621855|27041059|P2|Overall Study|Patients did not receive study drug|3
7779338|NCT00621855|27041060|P1|Overall Study|Patients did not receive study drug|3
7779339|NCT00621855|27041056|P5|Overall Study|Other|4
7779340|NCT00621855|27041057|P4|Overall Study|Other|5
7779341|NCT00621855|27041058|P3|Overall Study|Other|6
7779342|NCT00621855|27041059|P2|Overall Study|Other|7
7779343|NCT00621855|27041060|P1|Overall Study|Other|9
7779344|NCT00621855|27041056|P5|Overall Study|Withdrawal by Subject|9
7779345|NCT00621855|27041057|P4|Overall Study|Withdrawal by Subject|13
7779346|NCT00621855|27041058|P3|Overall Study|Withdrawal by Subject|13
7779347|NCT00621855|27041059|P2|Overall Study|Withdrawal by Subject|11
7779348|NCT00621855|27041060|P1|Overall Study|Withdrawal by Subject|16
7779349|NCT00621855|27041056|P5|Overall Study|Protocol Violation|8
7779350|NCT00621855|27041057|P4|Overall Study|Protocol Violation|7
7779351|NCT00621855|27041058|P3|Overall Study|Protocol Violation|6
7779352|NCT00621855|27041059|P2|Overall Study|Protocol Violation|8
7779353|NCT00621855|27041060|P1|Overall Study|Protocol Violation|16
7779354|NCT00621855|27041056|P5|Overall Study|Lost to Follow-up|1
7779355|NCT00621855|27041057|P4|Overall Study|Lost to Follow-up|4
7779356|NCT00621855|27041058|P3|Overall Study|Lost to Follow-up|3
7779357|NCT00621855|27041059|P2|Overall Study|Lost to Follow-up|1
7779358|NCT00621855|27041060|P1|Overall Study|Lost to Follow-up|0
7779359|NCT00621855|27041056|P5|Overall Study|Adverse Event|31
7779360|NCT00621855|27041057|P4|Overall Study|Adverse Event|34
7779361|NCT00621855|27041058|P3|Overall Study|Adverse Event|48
7779362|NCT00621855|27041059|P2|Overall Study|Adverse Event|31
7779363|NCT00621855|27041060|P1|Overall Study|Adverse Event|32
7779364|NCT00621842|27041102|P1|Overall Study|Lack of Efficacy|2
7779365|NCT00621842|27041102|P1|Overall Study|Protocol Violation|4
7779366|NCT00621842|27041102|P1|Overall Study|Withdrawal by Subject|7
7779367|NCT00621842|27041102|P1|Overall Study|Adverse Event|6
7779368|NCT00621777|27041119|P2|Randomized Phase|Death|1
7779369|NCT00621777|27041120|P1|Randomized Phase|Death|0
7779370|NCT00621777|27041119|P2|Randomized Phase|administrative|3
7779371|NCT00621777|27041120|P1|Randomized Phase|administrative|0
7779372|NCT00621777|27041119|P2|Randomized Phase|Withdrawal by Subject|9
7779373|NCT00621777|27041120|P1|Randomized Phase|Withdrawal by Subject|1
7779374|NCT00621777|27041119|P2|Randomized Phase|Lost to Follow-up|3
7779375|NCT00621777|27041120|P1|Randomized Phase|Lost to Follow-up|3
7779376|NCT00621777|27041119|P2|Randomized Phase|Adverse Event|3
7779377|NCT00621777|27041120|P1|Randomized Phase|Adverse Event|3
7779378|NCT00621777|27041119|P2|Open Phase|Lost to Follow-up|0
7779379|NCT00621777|27041120|P1|Open Phase|Lost to Follow-up|10
7779380|NCT00621777|27041119|P2|Open Phase|administrative|0
7779381|NCT00621777|27041120|P1|Open Phase|administrative|13
7779382|NCT00621777|27041119|P2|Open Phase|Withdrawal by Subject|0
7779383|NCT00621777|27041120|P1|Open Phase|Withdrawal by Subject|17
7779384|NCT00621777|27041119|P2|Open Phase|Did not abstain during open phase|0
7779385|NCT00621777|27041120|P1|Open Phase|Did not abstain during open phase|56
7779386|NCT00621777|27041119|P2|Open Phase|Adverse Event|0
7779387|NCT00621777|27041120|P1|Open Phase|Adverse Event|20
7779388|NCT00621764|27041135|P4|Overall Study|Protocol Violation|1
7779389|NCT00621764|27041136|P3|Overall Study|Protocol Violation|0
7779390|NCT00621764|27041137|P2|Overall Study|Protocol Violation|0
7779391|NCT00621764|27041138|P1|Overall Study|Protocol Violation|0
7779392|NCT00621751|27041170|P2|Overall Study|Adverse Event|1
7779393|NCT00621751|27041171|P1|Overall Study|Adverse Event|0
7779394|NCT00621621|27041205|P2|Overall Study|Subjects were exited at EP study|0
7779395|NCT00621621|27041206|P1|Overall Study|Subjects were exited at EP study|30
7779396|NCT00621582|27041214|P1|Overall Study|issues not identified by investigators|18
7779397|NCT00621582|27041214|P1|Overall Study|Lost to Follow-up|24
7779398|NCT00621582|27041214|P1|Overall Study|Protocol Violation|57
7779399|NCT00621582|27041214|P1|Overall Study|Adverse Event|7
7779400|NCT00621543|27041221|P1|Overall Study|Lost to Follow-up|23
7779401|NCT00621517|27041245|P2|Overall Study|Adverse Event|0
7779402|NCT00621517|27041246|P1|Overall Study|Adverse Event|1
7779403|NCT00621517|27041245|P2|Overall Study|Withdrawal by Subject|4
7779404|NCT00621517|27041246|P1|Overall Study|Withdrawal by Subject|3
7779405|NCT00621517|27041245|P2|Overall Study|Lost to Follow-up|3
7779406|NCT00621517|27041246|P1|Overall Study|Lost to Follow-up|3
7779407|NCT00621504|27041258|P2|Overall Study|Death|6
7779408|NCT00621504|27041259|P1|Overall Study|Death|6
7779409|NCT00621504|27041258|P2|Overall Study|Other|0
7779410|NCT00621504|27041259|P1|Overall Study|Other|1
7779411|NCT00621504|27041258|P2|Overall Study|Lost to Follow-up|10
7779412|NCT00621504|27041259|P1|Overall Study|Lost to Follow-up|8
7779413|NCT00621504|27041258|P2|Overall Study|Withdrew consent|6
7779414|NCT00621504|27041259|P1|Overall Study|Withdrew consent|9
7779415|NCT00621504|27041258|P2|Overall Study|At the request of sponsor/investigator|0
7779416|NCT00621504|27041259|P1|Overall Study|At the request of sponsor/investigator|1
7779417|NCT00621504|27041258|P2|Overall Study|Adverse Event|3
7779418|NCT00621504|27041259|P1|Overall Study|Adverse Event|1
7779419|NCT00621322|27041293|P6|Overall Study|Migrated/moved from study area|2
7779420|NCT00621322|27041294|P5|Overall Study|Migrated/moved from study area|0
7779421|NCT00621322|27041295|P4|Overall Study|Migrated/moved from study area|1
7779422|NCT00621322|27041296|P3|Overall Study|Migrated/moved from study area|1
7779423|NCT00621322|27041297|P2|Overall Study|Migrated/moved from study area|0
7779424|NCT00621322|27041298|P1|Overall Study|Migrated/moved from study area|1
7779425|NCT00621322|27041293|P6|Overall Study|Withdrawal by Subject|2
7779426|NCT00621322|27041294|P5|Overall Study|Withdrawal by Subject|0
7779427|NCT00621322|27041295|P4|Overall Study|Withdrawal by Subject|1
7779428|NCT00621322|27041296|P3|Overall Study|Withdrawal by Subject|0
7779429|NCT00621322|27041297|P2|Overall Study|Withdrawal by Subject|0
7779430|NCT00621322|27041298|P1|Overall Study|Withdrawal by Subject|0
7779431|NCT00621322|27041293|P6|Overall Study|Physician Decision|0
7779432|NCT00621322|27041294|P5|Overall Study|Physician Decision|0
7779433|NCT00621322|27041295|P4|Overall Study|Physician Decision|1
7779434|NCT00621322|27041296|P3|Overall Study|Physician Decision|1
7779435|NCT00621322|27041297|P2|Overall Study|Physician Decision|0
7779436|NCT00621322|27041298|P1|Overall Study|Physician Decision|0
7779437|NCT00621322|27041293|P6|Overall Study|Lost to Follow-up|0
7779438|NCT00621322|27041294|P5|Overall Study|Lost to Follow-up|1
7779439|NCT00621322|27041295|P4|Overall Study|Lost to Follow-up|0
7779440|NCT00621322|27041296|P3|Overall Study|Lost to Follow-up|0
7779441|NCT00621322|27041297|P2|Overall Study|Lost to Follow-up|0
7779442|NCT00621322|27041298|P1|Overall Study|Lost to Follow-up|0
7779443|NCT00621309|27041378|P6|Overall Study|Withdrawal by Subject|1
7779444|NCT00621309|27041379|P5|Overall Study|Withdrawal by Subject|1
7779445|NCT00621309|27041380|P4|Overall Study|Withdrawal by Subject|1
7779446|NCT00621309|27041381|P3|Overall Study|Withdrawal by Subject|1
7779447|NCT00621309|27041382|P2|Overall Study|Withdrawal by Subject|0
7779448|NCT00621309|27041383|P1|Overall Study|Withdrawal by Subject|2
7779449|NCT00621296|27041389|P1|Overall Study|Stopping Criteria|3
7779450|NCT00621296|27041389|P1|Overall Study|Unmatch Criteria|1
7779451|NCT00621296|27041389|P1|Overall Study|Physician Decision|7
7779452|NCT00621296|27041389|P1|Overall Study|Lack of Efficacy|1
7779453|NCT00621296|27041389|P1|Overall Study|Adverse Event|2
7779454|NCT00621257|27041398|P5|Overall Study|Withdrawal by Subject|1
7779455|NCT00621257|27041399|P4|Overall Study|Withdrawal by Subject|1
7779456|NCT00621257|27041400|P3|Overall Study|Withdrawal by Subject|0
7779457|NCT00621257|27041401|P2|Overall Study|Withdrawal by Subject|0
7779458|NCT00621257|27041402|P1|Overall Study|Withdrawal by Subject|0
7779459|NCT00621257|27041398|P5|Overall Study|Physician Decision|1
7779460|NCT00621257|27041399|P4|Overall Study|Physician Decision|1
7779461|NCT00621257|27041400|P3|Overall Study|Physician Decision|0
7779462|NCT00621257|27041401|P2|Overall Study|Physician Decision|2
7779463|NCT00621257|27041402|P1|Overall Study|Physician Decision|0
7779464|NCT00621257|27041398|P5|Overall Study|Adverse Event|0
7779465|NCT00621257|27041399|P4|Overall Study|Adverse Event|0
7779466|NCT00621257|27041400|P3|Overall Study|Adverse Event|1
7779467|NCT00621257|27041401|P2|Overall Study|Adverse Event|1
7779468|NCT00621257|27041402|P1|Overall Study|Adverse Event|0
7779469|NCT00621257|27041398|P5|Overall Study|Lost to Follow-up|7
7779470|NCT00621257|27041399|P4|Overall Study|Lost to Follow-up|4
7779471|NCT00621257|27041400|P3|Overall Study|Lost to Follow-up|2
7779472|NCT00621257|27041401|P2|Overall Study|Lost to Follow-up|0
7779473|NCT00621257|27041402|P1|Overall Study|Lost to Follow-up|4
7779474|NCT00621244|27041418|P4|Overall Study|Administrative problems|2
7779475|NCT00621244|27041419|P3|Overall Study|Administrative problems|0
7779476|NCT00621244|27041420|P2|Overall Study|Administrative problems|1
7779477|NCT00621244|27041421|P1|Overall Study|Administrative problems|5
7779478|NCT00621244|27041418|P4|Overall Study|Adverse Event|2
7779479|NCT00621244|27041419|P3|Overall Study|Adverse Event|9
7779480|NCT00621244|27041420|P2|Overall Study|Adverse Event|7
7779481|NCT00621244|27041421|P1|Overall Study|Adverse Event|27
7779482|NCT00621244|27041418|P4|Overall Study|Death|1
7779483|NCT00621244|27041419|P3|Overall Study|Death|1
7779484|NCT00621244|27041420|P2|Overall Study|Death|3
7779485|NCT00621244|27041421|P1|Overall Study|Death|3
7779486|NCT00621244|27041418|P4|Overall Study|Disease progression|15
7779487|NCT00621244|27041419|P3|Overall Study|Disease progression|20
7779488|NCT00621244|27041420|P2|Overall Study|Disease progression|20
7779489|NCT00621244|27041421|P1|Overall Study|Disease progression|44
7779490|NCT00621244|27041418|P4|Overall Study|Withdrawal by Subject|3
7779491|NCT00621244|27041419|P3|Overall Study|Withdrawal by Subject|3
7779492|NCT00621244|27041420|P2|Overall Study|Withdrawal by Subject|3
7779493|NCT00621244|27041421|P1|Overall Study|Withdrawal by Subject|7
7779494|NCT00621192|27041525|P4|Overall Study|Final Assessments not Completed|1
7779495|NCT00621192|27041526|P3|Overall Study|Final Assessments not Completed|3
7779496|NCT00621192|27041527|P2|Overall Study|Final Assessments not Completed|0
7779497|NCT00621192|27041528|P1|Overall Study|Final Assessments not Completed|0
7779498|NCT00621192|27041525|P4|Overall Study|Death|0
7779499|NCT00621192|27041526|P3|Overall Study|Death|0
7779500|NCT00621192|27041527|P2|Overall Study|Death|5
7779501|NCT00621192|27041528|P1|Overall Study|Death|2
7779502|NCT00621192|27041525|P4|Overall Study|Adverse Event|1
7779503|NCT00621192|27041526|P3|Overall Study|Adverse Event|0
7779504|NCT00621192|27041527|P2|Overall Study|Adverse Event|1
7779505|NCT00621192|27041528|P1|Overall Study|Adverse Event|0
7779506|NCT00621192|27041525|P4|Overall Study|Protocol Violation|1
7779507|NCT00621192|27041526|P3|Overall Study|Protocol Violation|0
7779508|NCT00621192|27041527|P2|Overall Study|Protocol Violation|0
7779509|NCT00621192|27041528|P1|Overall Study|Protocol Violation|1
7779510|NCT00621192|27041525|P4|Overall Study|Physician Decision|0
7779511|NCT00621192|27041526|P3|Overall Study|Physician Decision|0
7779512|NCT00621192|27041527|P2|Overall Study|Physician Decision|3
7779513|NCT00621192|27041528|P1|Overall Study|Physician Decision|1
7779514|NCT00621192|27041525|P4|Overall Study|Withdrawal by Subject|0
7779515|NCT00621192|27041526|P3|Overall Study|Withdrawal by Subject|2
7779516|NCT00621192|27041527|P2|Overall Study|Withdrawal by Subject|0
7779517|NCT00621192|27041528|P1|Overall Study|Withdrawal by Subject|0
7779518|NCT00621153|27041569|P2|Overall Study|Withdrawal by Subject|5
7779519|NCT00621153|27041570|P1|Overall Study|Withdrawal by Subject|4
7779520|NCT00621153|27041569|P2|Overall Study|Lost to Follow-up|1
7779521|NCT00621153|27041570|P1|Overall Study|Lost to Follow-up|5
7779522|NCT00621153|27041569|P2|Overall Study|Adverse Event|2
7779523|NCT00621153|27041570|P1|Overall Study|Adverse Event|3
7779524|NCT00621153|27041569|P2|Overall Study|Safety Reason|7
7779525|NCT00621153|27041570|P1|Overall Study|Safety Reason|8
7779526|NCT00621140|27041578|P2|Overall Study|Other incl. lack of efficacy|5
7779527|NCT00621140|27041579|P1|Overall Study|Other incl. lack of efficacy|6
7779528|NCT00621140|27041578|P2|Overall Study|Withdrawal by Subject|6
7779529|NCT00621140|27041579|P1|Overall Study|Withdrawal by Subject|4
7779530|NCT00621140|27041578|P2|Overall Study|Lost to Follow-up|2
7779531|NCT00621140|27041579|P1|Overall Study|Lost to Follow-up|1
7779532|NCT00621140|27041578|P2|Overall Study|Adverse Event|5
7779533|NCT00621140|27041579|P1|Overall Study|Adverse Event|4
7779534|NCT00621023|27041626|P1|Overall Study|Follow up discontinued|1
7779535|NCT00621023|27041626|P1|Overall Study|Death|5
7779536|NCT00620854|27041643|P6|Washout 1|Withdrawal by Subject|0
7779537|NCT00620854|27041644|P5|Washout 1|Withdrawal by Subject|0
7779538|NCT00620854|27041645|P4|Washout 1|Withdrawal by Subject|1
7779539|NCT00620854|27041646|P3|Washout 1|Withdrawal by Subject|1
7779540|NCT00620854|27041647|P2|Washout 1|Withdrawal by Subject|0
7779541|NCT00620854|27041648|P1|Washout 1|Withdrawal by Subject|0
7779542|NCT00620815|27041679|P3|Overall Study|Protocol Violation|1
7779543|NCT00620815|27041680|P2|Overall Study|Protocol Violation|2
7779544|NCT00620815|27041681|P1|Overall Study|Protocol Violation|1
7779545|NCT00620815|27041679|P3|Overall Study|Inappropriate enrolment|1
7779546|NCT00620815|27041680|P2|Overall Study|Inappropriate enrolment|0
7779547|NCT00620815|27041681|P1|Overall Study|Inappropriate enrolment|0
7779548|NCT00620815|27041679|P3|Overall Study|Lost to Follow-up|3
7779549|NCT00620815|27041680|P2|Overall Study|Lost to Follow-up|6
7779550|NCT00620815|27041681|P1|Overall Study|Lost to Follow-up|1
7779551|NCT00620815|27041679|P3|Overall Study|Withdrawal by Subject|0
7779552|NCT00620815|27041680|P2|Overall Study|Withdrawal by Subject|2
7779553|NCT00620815|27041681|P1|Overall Study|Withdrawal by Subject|1
7779554|NCT00620815|27041679|P3|Overall Study|Adverse Event|2
7779555|NCT00620815|27041680|P2|Overall Study|Adverse Event|1
7779556|NCT00620815|27041681|P1|Overall Study|Adverse Event|1
7779557|NCT00620776|27041721|P2|Overall Study|Withdrawal by Subject|2
7779558|NCT00620776|27041722|P1|Overall Study|Withdrawal by Subject|3
7779559|NCT00620776|27041721|P2|Overall Study|Lost to Follow-up|5
7779560|NCT00620776|27041722|P1|Overall Study|Lost to Follow-up|2
7779561|NCT00620776|27041721|P2|Overall Study|Lack of Efficacy|1
7779562|NCT00620776|27041722|P1|Overall Study|Lack of Efficacy|2
7779563|NCT00620776|27041721|P2|Overall Study|Adverse Event|3
7779564|NCT00620776|27041722|P1|Overall Study|Adverse Event|2
7779565|NCT00620776|27041721|P2|Overall Study|Did not receive treatment|5
7779566|NCT00620776|27041722|P1|Overall Study|Did not receive treatment|3
7779567|NCT00620763|27041750|P2|Period: Second Intervention|Withdrawal by Subject|0
7779568|NCT00620763|27041751|P1|Period: Second Intervention|Withdrawal by Subject|1
7779569|NCT00620763|27041750|P2|Period: First Intervention|Protocol Violation|3
7779570|NCT00620763|27041751|P1|Period: First Intervention|Protocol Violation|0
7779571|NCT00620763|27041750|P2|Period: First Intervention|Withdrawal by Subject|2
7779572|NCT00620763|27041751|P1|Period: First Intervention|Withdrawal by Subject|0
7779573|NCT00620750|27041757|P1|Overall Study|Lost to Follow-up|25
7779574|NCT00620659|27041772|P6|Treatment Period 3|Withdrawal by Subject|0
7779575|NCT00620659|27041773|P5|Treatment Period 3|Withdrawal by Subject|0
7779576|NCT00620659|27041774|P4|Treatment Period 3|Withdrawal by Subject|1
7779577|NCT00620659|27041775|P3|Treatment Period 3|Withdrawal by Subject|0
7779578|NCT00620659|27041776|P2|Treatment Period 3|Withdrawal by Subject|0
7779579|NCT00620659|27041777|P1|Treatment Period 3|Withdrawal by Subject|0
7779580|NCT00620659|27041772|P6|Treatment Period 3|Adverse Event|0
7779581|NCT00620659|27041773|P5|Treatment Period 3|Adverse Event|0
7779582|NCT00620659|27041774|P4|Treatment Period 3|Adverse Event|0
7779583|NCT00620659|27041775|P3|Treatment Period 3|Adverse Event|0
7779584|NCT00620659|27041776|P2|Treatment Period 3|Adverse Event|2
7779585|NCT00620659|27041777|P1|Treatment Period 3|Adverse Event|0
7779586|NCT00620659|27041772|P6|Placebo Washout Period 2|Adverse Event|0
7779587|NCT00620659|27041773|P5|Placebo Washout Period 2|Adverse Event|0
7779588|NCT00620659|27041774|P4|Placebo Washout Period 2|Adverse Event|0
7779589|NCT00620659|27041775|P3|Placebo Washout Period 2|Adverse Event|0
7779590|NCT00620659|27041776|P2|Placebo Washout Period 2|Adverse Event|0
7779591|NCT00620659|27041777|P1|Placebo Washout Period 2|Adverse Event|2
7779592|NCT00620659|27041772|P6|Treatment Period 2|Withdrawal by Subject|0
7779593|NCT00620659|27041773|P5|Treatment Period 2|Withdrawal by Subject|3
7779594|NCT00620659|27041774|P4|Treatment Period 2|Withdrawal by Subject|0
7779595|NCT00620659|27041775|P3|Treatment Period 2|Withdrawal by Subject|1
7779596|NCT00620659|27041776|P2|Treatment Period 2|Withdrawal by Subject|0
7779597|NCT00620659|27041777|P1|Treatment Period 2|Withdrawal by Subject|0
7779598|NCT00620659|27041772|P6|Treatment Period 2|Adverse Event|0
7779599|NCT00620659|27041773|P5|Treatment Period 2|Adverse Event|2
7779600|NCT00620659|27041774|P4|Treatment Period 2|Adverse Event|0
7779601|NCT00620659|27041775|P3|Treatment Period 2|Adverse Event|0
7779602|NCT00620659|27041776|P2|Treatment Period 2|Adverse Event|3
7779603|NCT00620659|27041777|P1|Treatment Period 2|Adverse Event|0
7779604|NCT00620659|27041772|P6|Placebo Washout Period 1|Withdrawal by Subject|0
7779605|NCT00620659|27041773|P5|Placebo Washout Period 1|Withdrawal by Subject|0
7779606|NCT00620659|27041774|P4|Placebo Washout Period 1|Withdrawal by Subject|1
7779607|NCT00620659|27041775|P3|Placebo Washout Period 1|Withdrawal by Subject|0
7779608|NCT00620659|27041776|P2|Placebo Washout Period 1|Withdrawal by Subject|0
7779609|NCT00620659|27041777|P1|Placebo Washout Period 1|Withdrawal by Subject|0
7779610|NCT00620659|27041772|P6|Treatment Period 1|Withdrawal by Subject|0
7779611|NCT00620659|27041773|P5|Treatment Period 1|Withdrawal by Subject|1
7779612|NCT00620659|27041774|P4|Treatment Period 1|Withdrawal by Subject|0
7779613|NCT00620659|27041775|P3|Treatment Period 1|Withdrawal by Subject|1
7779614|NCT00620659|27041776|P2|Treatment Period 1|Withdrawal by Subject|0
7779615|NCT00620659|27041777|P1|Treatment Period 1|Withdrawal by Subject|1
7779616|NCT00620659|27041772|P6|Treatment Period 1|Protocol Violation|0
7779617|NCT00620659|27041773|P5|Treatment Period 1|Protocol Violation|0
7779618|NCT00620659|27041774|P4|Treatment Period 1|Protocol Violation|0
7779619|NCT00620659|27041775|P3|Treatment Period 1|Protocol Violation|0
7779620|NCT00620659|27041776|P2|Treatment Period 1|Protocol Violation|0
7779621|NCT00620659|27041777|P1|Treatment Period 1|Protocol Violation|1
7779622|NCT00620659|27041772|P6|Treatment Period 1|Adverse Event|0
7779623|NCT00620659|27041773|P5|Treatment Period 1|Adverse Event|0
7779624|NCT00620659|27041774|P4|Treatment Period 1|Adverse Event|3
7779625|NCT00620659|27041775|P3|Treatment Period 1|Adverse Event|0
7779626|NCT00620659|27041776|P2|Treatment Period 1|Adverse Event|0
7779627|NCT00620659|27041777|P1|Treatment Period 1|Adverse Event|1
7779628|NCT00620555|27041795|P1|Overall Study|Visit failure against planned|1
7779629|NCT00620555|27041795|P1|Overall Study|Choice of other treatment|1
7779630|NCT00620555|27041795|P1|Overall Study|Withdrawal by Subject|1
7779631|NCT00620555|27041795|P1|Overall Study|Lack of Efficacy|12
7779632|NCT00620555|27041795|P1|Overall Study|Protocol Violation|2
7779633|NCT00620555|27041795|P1|Overall Study|Adverse Event|4
7779634|NCT00620542|27041804|P4|Part B (2 Year Core Study)|IVUS not available|2
7779635|NCT00620542|27041805|P3|Part B (2 Year Core Study)|IVUS not available|3
7779636|NCT00620542|27041806|P2|Part B (2 Year Core Study)|IVUS not available|0
7779637|NCT00620542|27041807|P1|Part B (2 Year Core Study)|IVUS not available|0
7779638|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
7779639|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
7779640|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
7779641|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
7779642|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Safety reasons|3
7779643|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Safety reasons|2
7779644|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Safety reasons|0
7779645|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Safety reasons|0
7779646|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Protocol Violation|16
7779647|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Protocol Violation|13
7779648|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Protocol Violation|0
7779649|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Protocol Violation|0
7779650|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
7779651|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
7779652|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
7779653|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
7779654|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
7779655|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
7779656|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
7779657|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
7779658|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Protocol Violation|5
7779659|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Protocol Violation|3
7779660|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Protocol Violation|0
7779661|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Protocol Violation|0
7779662|NCT00620542|27041804|P4|Part B (2 Year Core Study)|Adverse Event|49
7779663|NCT00620542|27041805|P3|Part B (2 Year Core Study)|Adverse Event|46
7779664|NCT00620542|27041806|P2|Part B (2 Year Core Study)|Adverse Event|0
7779665|NCT00620542|27041807|P1|Part B (2 Year Core Study)|Adverse Event|0
7779666|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
7779667|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
7779668|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
7779669|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
7779670|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
7779671|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
7779672|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
7779673|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
7779674|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7779675|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7779676|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
7779677|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7779678|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
7779679|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
7779680|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
7779681|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
7779682|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
7779683|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
7779684|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
7779685|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
7779686|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7779687|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7779688|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
7779689|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
7779690|NCT00620542|27041804|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
7779691|NCT00620542|27041805|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
7779692|NCT00620542|27041806|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
7779693|NCT00620542|27041807|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
7779694|NCT00620464|27041872|P2|Overall Study|Used prohibited medication|0
7779695|NCT00620464|27041873|P1|Overall Study|Used prohibited medication|1
7779696|NCT00620464|27041872|P2|Overall Study|Personal|2
7779697|NCT00620464|27041873|P1|Overall Study|Personal|2
7779698|NCT00620464|27041872|P2|Overall Study|Planning Pregnancy|4
7779699|NCT00620464|27041873|P1|Overall Study|Planning Pregnancy|1
7779700|NCT00620464|27041872|P2|Overall Study|Lost to Follow-up|1
7779701|NCT00620464|27041873|P1|Overall Study|Lost to Follow-up|1
7779702|NCT00620464|27041872|P2|Overall Study|Adverse Event|17
7779703|NCT00620464|27041873|P1|Overall Study|Adverse Event|15
7779704|NCT00620373|27041892|P1|Overall Study|Unverified cancer status|33
7779705|NCT00620321|27041910|P2|Overall Study|Withdrawal by Subject|1
7779706|NCT00620321|27041911|P1|Overall Study|Withdrawal by Subject|1
7779707|NCT00620321|27041910|P2|Overall Study|Sponsor Decision|1
7779708|NCT00620321|27041911|P1|Overall Study|Sponsor Decision|0
7779709|NCT00620321|27041910|P2|Overall Study|Progressive Disease|5
7779710|NCT00620321|27041911|P1|Overall Study|Progressive Disease|5
7779711|NCT00620321|27041910|P2|Overall Study|Physician Decision|7
7779712|NCT00620321|27041911|P1|Overall Study|Physician Decision|0
7779713|NCT00620321|27041910|P2|Overall Study|Death|1
7779714|NCT00620321|27041911|P1|Overall Study|Death|1
7779715|NCT00620321|27041910|P2|Overall Study|Adverse Event|1
7779716|NCT00620321|27041911|P1|Overall Study|Adverse Event|1
7779717|NCT00620282|27041930|P3|Overall Study|Withdrawal by Subject|0
7779718|NCT00620282|27041931|P2|Overall Study|Withdrawal by Subject|1
7779719|NCT00620282|27041932|P1|Overall Study|Withdrawal by Subject|0
7779720|NCT00620282|27041930|P3|Overall Study|Arterial line unable to be placed|1
7779721|NCT00620282|27041931|P2|Overall Study|Arterial line unable to be placed|0
7779722|NCT00620282|27041932|P1|Overall Study|Arterial line unable to be placed|0
7779723|NCT00620282|27041930|P3|Overall Study|Adverse Event|0
7779724|NCT00620282|27041931|P2|Overall Study|Adverse Event|1
7779725|NCT00620282|27041932|P1|Overall Study|Adverse Event|0
7779726|NCT00620113|27042011|P4|Overall Study|Withdrawal by Subject|5
7779727|NCT00620113|27042012|P3|Overall Study|Withdrawal by Subject|3
7779728|NCT00620113|27042013|P2|Overall Study|Withdrawal by Subject|1
7779729|NCT00620113|27042014|P1|Overall Study|Withdrawal by Subject|5
7779730|NCT00620113|27042011|P4|Overall Study|Protocol Violation|0
7779731|NCT00620113|27042012|P3|Overall Study|Protocol Violation|0
7779732|NCT00620113|27042013|P2|Overall Study|Protocol Violation|1
7779733|NCT00620113|27042014|P1|Overall Study|Protocol Violation|2
7779734|NCT00620113|27042011|P4|Overall Study|Physician Decision|2
7779735|NCT00620113|27042012|P3|Overall Study|Physician Decision|0
7779736|NCT00620113|27042013|P2|Overall Study|Physician Decision|0
7779737|NCT00620113|27042014|P1|Overall Study|Physician Decision|1
7779738|NCT00620113|27042011|P4|Overall Study|Lack of Efficacy|2
7779739|NCT00620113|27042012|P3|Overall Study|Lack of Efficacy|0
7779740|NCT00620113|27042013|P2|Overall Study|Lack of Efficacy|3
7779741|NCT00620113|27042014|P1|Overall Study|Lack of Efficacy|2
7779742|NCT00620113|27042011|P4|Overall Study|Adverse Event|1
7779743|NCT00620113|27042012|P3|Overall Study|Adverse Event|2
7779744|NCT00620113|27042013|P2|Overall Study|Adverse Event|2
7779745|NCT00620113|27042014|P1|Overall Study|Adverse Event|3
7779746|NCT00620074|27042064|P1|Overall Study|Adverse Event|1
7779747|NCT00620035|27042087|P1|Overall Study|Other Reason|38
7779748|NCT00620035|27042087|P1|Overall Study|Withdrawal of Informed Consent|1
7779749|NCT00620035|27042087|P1|Overall Study|Adverse Event|106
7779750|NCT00620022|27042097|P2|Treatment Period 2|Adverse Event|2
7779751|NCT00620022|27042098|P1|Treatment Period 2|Adverse Event|2
7779752|NCT00620022|27042097|P2|Treatment Period 1|Subject withdrew consent|0
7779753|NCT00620022|27042098|P1|Treatment Period 1|Subject withdrew consent|1
7779754|NCT00620022|27042097|P2|Treatment Period 1|Adverse Event|6
7779755|NCT00620022|27042098|P1|Treatment Period 1|Adverse Event|4
7779756|NCT00619983|27042110|P4|Test Drug Alone|Failure of daily diary device|2
7779757|NCT00619983|27042111|P3|Test Drug Alone|Failure of daily diary device|2
7779758|NCT00619983|27042112|P2|Test Drug Alone|Failure of daily diary device|1
7779759|NCT00619983|27042113|P1|Test Drug Alone|Failure of daily diary device|1
7779760|NCT00619983|27042110|P4|Test Drug Alone|Withdrawal by Subject|1
7779761|NCT00619983|27042111|P3|Test Drug Alone|Withdrawal by Subject|0
7779762|NCT00619983|27042112|P2|Test Drug Alone|Withdrawal by Subject|0
7779763|NCT00619983|27042113|P1|Test Drug Alone|Withdrawal by Subject|1
7779764|NCT00619957|27042140|P2|Month 48 Open-Label|Withdrawal by Subject|9
7779765|NCT00619957|27042141|P1|Month 48 Open-Label|Withdrawal by Subject|6
7779766|NCT00619957|27042140|P2|Month 48 Open-Label|Lost to Follow-up|4
7779767|NCT00619957|27042141|P1|Month 48 Open-Label|Lost to Follow-up|2
7779768|NCT00619957|27042140|P2|Month 48 Open-Label|Adverse Event|4
7779769|NCT00619957|27042141|P1|Month 48 Open-Label|Adverse Event|4
7779770|NCT00619957|27042140|P2|Month 24 Double-Blind|Did not take any study medication|1
7779771|NCT00619957|27042141|P1|Month 24 Double-Blind|Did not take any study medication|0
7779772|NCT00619957|27042140|P2|Month 24 Double-Blind|Lost to Follow-up|0
7779773|NCT00619957|27042141|P1|Month 24 Double-Blind|Lost to Follow-up|1
7779774|NCT00619957|27042140|P2|Month 24 Double-Blind|Withdrawal by Subject|9
7779775|NCT00619957|27042141|P1|Month 24 Double-Blind|Withdrawal by Subject|7
7779776|NCT00619957|27042140|P2|Month 24 Double-Blind|Protocol Violation|0
7779777|NCT00619957|27042141|P1|Month 24 Double-Blind|Protocol Violation|1
7779778|NCT00619957|27042140|P2|Month 24 Double-Blind|Adverse Event|7
7779779|NCT00619957|27042141|P1|Month 24 Double-Blind|Adverse Event|9
7779780|NCT00619918|27042223|P2|Overall Study|Left before receiving first dose|8
7779781|NCT00619918|27042224|P1|Overall Study|Left before receiving first dose|5
7779782|NCT00619918|27042223|P2|Overall Study|Transfer to outside facility|3
7779783|NCT00619918|27042224|P1|Overall Study|Transfer to outside facility|3
7779784|NCT00619918|27042223|P2|Overall Study|Physician Decision|8
7779785|NCT00619918|27042224|P1|Overall Study|Physician Decision|8
7779786|NCT00619918|27042223|P2|Overall Study|Withdrawal by Subject|3
7779787|NCT00619918|27042224|P1|Overall Study|Withdrawal by Subject|4
7779788|NCT00619892|27042234|P2|Overall Study|Intercurrent illness|1
7779789|NCT00619892|27042235|P1|Overall Study|Intercurrent illness|0
7779790|NCT00619892|27042234|P2|Overall Study|Lost to Follow-up|1
7779791|NCT00619892|27042235|P1|Overall Study|Lost to Follow-up|0
7779792|NCT00619892|27042234|P2|Overall Study|Adverse Event|0
7779793|NCT00619892|27042235|P1|Overall Study|Adverse Event|3
7779794|NCT00619866|27042246|P5|Weeks 13 - 24|Lost to Follow-up|0
7779795|NCT00619866|27042247|P4|Weeks 13 - 24|Lost to Follow-up|0
7779796|NCT00619866|27042248|P3|Weeks 13 - 24|Lost to Follow-up|0
7779797|NCT00619866|27042249|P2|Weeks 13 - 24|Lost to Follow-up|3
7779798|NCT00619866|27042250|P1|Weeks 13 - 24|Lost to Follow-up|0
7779799|NCT00619866|27042246|P5|Weeks 13 - 24|Non-compliance|0
7779800|NCT00619866|27042247|P4|Weeks 13 - 24|Non-compliance|0
7779801|NCT00619866|27042248|P3|Weeks 13 - 24|Non-compliance|1
7779802|NCT00619866|27042249|P2|Weeks 13 - 24|Non-compliance|1
7779803|NCT00619866|27042250|P1|Weeks 13 - 24|Non-compliance|0
7779804|NCT00619866|27042246|P5|Weeks 13 - 24|Withdrawal by Subject|2
7779805|NCT00619866|27042247|P4|Weeks 13 - 24|Withdrawal by Subject|2
7779806|NCT00619866|27042248|P3|Weeks 13 - 24|Withdrawal by Subject|2
7779807|NCT00619866|27042249|P2|Weeks 13 - 24|Withdrawal by Subject|3
7779808|NCT00619866|27042250|P1|Weeks 13 - 24|Withdrawal by Subject|0
7779809|NCT00619866|27042246|P5|Weeks 13 - 24|Protocol Deviation|0
7779810|NCT00619866|27042247|P4|Weeks 13 - 24|Protocol Deviation|1
7779811|NCT00619866|27042248|P3|Weeks 13 - 24|Protocol Deviation|0
7779812|NCT00619866|27042249|P2|Weeks 13 - 24|Protocol Deviation|0
7779813|NCT00619866|27042250|P1|Weeks 13 - 24|Protocol Deviation|0
7779814|NCT00619866|27042246|P5|Weeks 13 - 24|Adverse Event|0
7779815|NCT00619866|27042247|P4|Weeks 13 - 24|Adverse Event|1
7779816|NCT00619866|27042248|P3|Weeks 13 - 24|Adverse Event|2
7779817|NCT00619866|27042249|P2|Weeks 13 - 24|Adverse Event|0
7779818|NCT00619866|27042250|P1|Weeks 13 - 24|Adverse Event|0
7779819|NCT00619866|27042246|P5|Weeks 1 - 12|Sponsor Decision|0
7779820|NCT00619866|27042247|P4|Weeks 1 - 12|Sponsor Decision|0
7779821|NCT00619866|27042248|P3|Weeks 1 - 12|Sponsor Decision|0
7779822|NCT00619866|27042249|P2|Weeks 1 - 12|Sponsor Decision|1
7779823|NCT00619866|27042250|P1|Weeks 1 - 12|Sponsor Decision|0
7779824|NCT00619866|27042246|P5|Weeks 1 - 12|Lost to Follow-up|0
7779825|NCT00619866|27042247|P4|Weeks 1 - 12|Lost to Follow-up|0
7779826|NCT00619866|27042248|P3|Weeks 1 - 12|Lost to Follow-up|2
7779827|NCT00619866|27042249|P2|Weeks 1 - 12|Lost to Follow-up|0
7779828|NCT00619866|27042250|P1|Weeks 1 - 12|Lost to Follow-up|4
7779829|NCT00619866|27042246|P5|Weeks 1 - 12|Lack of Efficacy|0
7779830|NCT00619866|27042247|P4|Weeks 1 - 12|Lack of Efficacy|0
7779831|NCT00619866|27042248|P3|Weeks 1 - 12|Lack of Efficacy|1
7779832|NCT00619866|27042249|P2|Weeks 1 - 12|Lack of Efficacy|2
7779833|NCT00619866|27042250|P1|Weeks 1 - 12|Lack of Efficacy|3
7779834|NCT00619866|27042246|P5|Weeks 1 - 12|Withdrawal by Subject|0
7779835|NCT00619866|27042247|P4|Weeks 1 - 12|Withdrawal by Subject|0
7779836|NCT00619866|27042248|P3|Weeks 1 - 12|Withdrawal by Subject|4
7779837|NCT00619866|27042249|P2|Weeks 1 - 12|Withdrawal by Subject|2
7779838|NCT00619866|27042250|P1|Weeks 1 - 12|Withdrawal by Subject|7
7779839|NCT00619866|27042246|P5|Weeks 1 - 12|Non-compliance|0
7779840|NCT00619866|27042247|P4|Weeks 1 - 12|Non-compliance|0
7779841|NCT00619866|27042248|P3|Weeks 1 - 12|Non-compliance|1
7779842|NCT00619866|27042249|P2|Weeks 1 - 12|Non-compliance|0
7779843|NCT00619866|27042250|P1|Weeks 1 - 12|Non-compliance|0
7779844|NCT00619866|27042246|P5|Weeks 1 - 12|Adverse Event|0
7779845|NCT00619866|27042247|P4|Weeks 1 - 12|Adverse Event|0
7779846|NCT00619866|27042248|P3|Weeks 1 - 12|Adverse Event|2
7779847|NCT00619866|27042249|P2|Weeks 1 - 12|Adverse Event|1
7779848|NCT00619866|27042250|P1|Weeks 1 - 12|Adverse Event|0
7779849|NCT00619827|27042337|P2|Overall Study|Withdrawal by Subject|2
7779850|NCT00619827|27042338|P1|Overall Study|Withdrawal by Subject|2
7779851|NCT00619827|27042337|P2|Overall Study|Adverse Event|2
7779852|NCT00619827|27042338|P1|Overall Study|Adverse Event|1
7779853|NCT00619801|27042346|P2|Overall Study|Loss of efficacy|1
7779854|NCT00619801|27042347|P1|Overall Study|Loss of efficacy|0
7779855|NCT00619801|27042346|P2|Overall Study|Withdrawal by Subject|1
7779856|NCT00619801|27042347|P1|Overall Study|Withdrawal by Subject|1
7779857|NCT00619801|27042346|P2|Overall Study|Lack of Efficacy|1
7779858|NCT00619801|27042347|P1|Overall Study|Lack of Efficacy|0
7779859|NCT00619645|27042404|P1|Overall Study|Adverse Event|1
7779860|NCT00619619|27042418|P8|Overall Study|Adverse Event|2
7779861|NCT00619619|27042419|P7|Overall Study|Adverse Event|0
7779862|NCT00619619|27042420|P6|Overall Study|Adverse Event|0
7779863|NCT00619619|27042421|P5|Overall Study|Adverse Event|2
7779864|NCT00619619|27042422|P4|Overall Study|Adverse Event|0
7779865|NCT00619619|27042423|P3|Overall Study|Adverse Event|0
7779866|NCT00619619|27042424|P2|Overall Study|Adverse Event|0
7779867|NCT00619619|27042425|P1|Overall Study|Adverse Event|0
7779868|NCT00619619|27042418|P8|Overall Study|Protocol Violation|1
7779869|NCT00619619|27042419|P7|Overall Study|Protocol Violation|1
7779870|NCT00619619|27042420|P6|Overall Study|Protocol Violation|0
7779871|NCT00619619|27042421|P5|Overall Study|Protocol Violation|0
7779872|NCT00619619|27042422|P4|Overall Study|Protocol Violation|1
7779873|NCT00619619|27042423|P3|Overall Study|Protocol Violation|0
7779874|NCT00619619|27042424|P2|Overall Study|Protocol Violation|0
7779875|NCT00619619|27042425|P1|Overall Study|Protocol Violation|0
7779876|NCT00619619|27042418|P8|Overall Study|Physician Decision|0
7779877|NCT00619619|27042419|P7|Overall Study|Physician Decision|0
7779878|NCT00619619|27042420|P6|Overall Study|Physician Decision|0
7779879|NCT00619619|27042421|P5|Overall Study|Physician Decision|0
7779880|NCT00619619|27042422|P4|Overall Study|Physician Decision|0
7779881|NCT00619619|27042423|P3|Overall Study|Physician Decision|1
7779882|NCT00619619|27042424|P2|Overall Study|Physician Decision|0
7779883|NCT00619619|27042425|P1|Overall Study|Physician Decision|0
7779884|NCT00619515|27042510|P1|Overall Study|Study Termination by IRB|73
7779885|NCT00619502|27042524|P2|Overall Study|Lost to Follow-up|10
7779886|NCT00619502|27042525|P1|Overall Study|Lost to Follow-up|8
7779887|NCT00619489|27042537|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
7779888|NCT00619489|27042538|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
7779889|NCT00619489|27042537|P2|Overall Study|Lack of Efficacy|11
7779890|NCT00619489|27042538|P1|Overall Study|Lack of Efficacy|0
7779891|NCT00619489|27042537|P2|Overall Study|Withdrawal by Subject|1
7779892|NCT00619489|27042538|P1|Overall Study|Withdrawal by Subject|1
7779893|NCT00619489|27042537|P2|Overall Study|Adverse Event|7
7779894|NCT00619489|27042538|P1|Overall Study|Adverse Event|0
7779895|NCT00619476|27042560|P4|Overall Study|Withdrawal by Subject|4
7779896|NCT00619476|27042561|P3|Overall Study|Withdrawal by Subject|5
7779897|NCT00619476|27042562|P2|Overall Study|Withdrawal by Subject|7
7779898|NCT00619476|27042563|P1|Overall Study|Withdrawal by Subject|5
7779899|NCT00619476|27042560|P4|Overall Study|Investigator Discretion|0
7779900|NCT00619476|27042561|P3|Overall Study|Investigator Discretion|2
7779901|NCT00619476|27042562|P2|Overall Study|Investigator Discretion|2
7779902|NCT00619476|27042563|P1|Overall Study|Investigator Discretion|2
7779903|NCT00619476|27042560|P4|Overall Study|Lost to Follow-up|1
7779904|NCT00619476|27042561|P3|Overall Study|Lost to Follow-up|0
7779905|NCT00619476|27042562|P2|Overall Study|Lost to Follow-up|2
7779906|NCT00619476|27042563|P1|Overall Study|Lost to Follow-up|1
7779907|NCT00619476|27042560|P4|Overall Study|Protocol Violation|9
7779908|NCT00619476|27042561|P3|Overall Study|Protocol Violation|4
7779909|NCT00619476|27042562|P2|Overall Study|Protocol Violation|4
7779910|NCT00619476|27042563|P1|Overall Study|Protocol Violation|5
7779911|NCT00619476|27042560|P4|Overall Study|Lack of Efficacy|4
7779912|NCT00619476|27042561|P3|Overall Study|Lack of Efficacy|1
7779913|NCT00619476|27042562|P2|Overall Study|Lack of Efficacy|1
7779914|NCT00619476|27042563|P1|Overall Study|Lack of Efficacy|6
7779915|NCT00619476|27042560|P4|Overall Study|Adverse Event|16
7779916|NCT00619476|27042561|P3|Overall Study|Adverse Event|12
7779917|NCT00619476|27042562|P2|Overall Study|Adverse Event|6
7779918|NCT00619476|27042563|P1|Overall Study|Adverse Event|12
7779919|NCT00619385|27042648|P3|Overall Study|Other|1
7779920|NCT00619385|27042649|P2|Overall Study|Other|2
7779921|NCT00619385|27042650|P1|Overall Study|Other|1
7779922|NCT00619385|27042648|P3|Overall Study|Adverse Event|3
7779923|NCT00619385|27042649|P2|Overall Study|Adverse Event|0
7779924|NCT00619385|27042650|P1|Overall Study|Adverse Event|0
7779925|NCT00619359|27042665|P2|Overall Study|Progressive Disease|1
7779926|NCT00619359|27042666|P1|Overall Study|Progressive Disease|3
7779927|NCT00619359|27042665|P2|Overall Study|Withdrawal by Subject|20
7779928|NCT00619359|27042666|P1|Overall Study|Withdrawal by Subject|19
7779929|NCT00619359|27042665|P2|Overall Study|Protocol Violation|1
7779930|NCT00619359|27042666|P1|Overall Study|Protocol Violation|1
7779931|NCT00619359|27042665|P2|Overall Study|Physician Decision|7
7779932|NCT00619359|27042666|P1|Overall Study|Physician Decision|0
7779933|NCT00619359|27042665|P2|Overall Study|Lost to Follow-up|16
7779934|NCT00619359|27042666|P1|Overall Study|Lost to Follow-up|12
7779935|NCT00619359|27042665|P2|Overall Study|Adverse Event|36
7779936|NCT00619359|27042666|P1|Overall Study|Adverse Event|32
7779937|NCT00619307|27042678|P2|Overall Study|MS attack plus steroids|1
7779938|NCT00619307|27042679|P1|Overall Study|MS attack plus steroids|0
7779939|NCT00619307|27042678|P2|Overall Study|Severe migraine|1
7779940|NCT00619307|27042679|P1|Overall Study|Severe migraine|0
7779941|NCT00619307|27042678|P2|Overall Study|Withdrew consent|0
7779942|NCT00619307|27042679|P1|Overall Study|Withdrew consent|1
7779943|NCT00619307|27042678|P2|Overall Study|Protocol Violation|0
7779944|NCT00619307|27042679|P1|Overall Study|Protocol Violation|3
7779945|NCT00619307|27042678|P2|Overall Study|Lost to Follow-up|1
7779946|NCT00619307|27042679|P1|Overall Study|Lost to Follow-up|0
7779947|NCT00619307|27042678|P2|Overall Study|Adverse Event|1
7779948|NCT00619307|27042679|P1|Overall Study|Adverse Event|0
7779949|NCT00619229|27042716|P2|Overall Study|Investigator planned Cataract Operation|0
7779950|NCT00619229|27042717|P1|Overall Study|Investigator planned Cataract Operation|1
7779951|NCT00619229|27042716|P2|Overall Study|Termination of the Study by the Sponsor|1
7779952|NCT00619229|27042717|P1|Overall Study|Termination of the Study by the Sponsor|1
7779953|NCT00619229|27042716|P2|Overall Study|Lost to Follow-up|0
7779954|NCT00619229|27042717|P1|Overall Study|Lost to Follow-up|1
7779955|NCT00619229|27042716|P2|Overall Study|Withdrawal by Subject|1
7779956|NCT00619229|27042717|P1|Overall Study|Withdrawal by Subject|1
7779957|NCT00619177|27042756|P1|Overall Study|Not specified reasons|6
7779958|NCT00619177|27042756|P1|Overall Study|Missing termination information|481
7779959|NCT00619177|27042756|P1|Overall Study|Lack of Efficacy|1
7779960|NCT00619177|27042756|P1|Overall Study|Lost to Follow-up|2
7779961|NCT00619177|27042756|P1|Overall Study|Adverse Event|18
7779962|NCT00619151|27042766|P2|Overall Study|Study terminated prior to followup|0
7779963|NCT00619151|27042767|P1|Overall Study|Study terminated prior to followup|1
7779964|NCT00619112|27042777|P2|Overall Study|Adverse Event|2
7779965|NCT00619112|27042778|P1|Overall Study|Adverse Event|1
7779966|NCT00619099|27042799|P2|Overall Study|Physician Decision|6
7779967|NCT00619099|27042800|P1|Overall Study|Physician Decision|9
7779968|NCT00619099|27042799|P2|Overall Study|Withdrawal by Subject|2
7779969|NCT00619099|27042800|P1|Overall Study|Withdrawal by Subject|10
7779970|NCT00619099|27042799|P2|Overall Study|Emergence of Clinically Significant Lab|2
7779971|NCT00619099|27042800|P1|Overall Study|Emergence of Clinically Significant Lab|1
7779972|NCT00619099|27042799|P2|Overall Study|Adverse Event|3
7779973|NCT00619099|27042800|P1|Overall Study|Adverse Event|4
7779974|NCT00619099|27042799|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
7779975|NCT00619099|27042800|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
7779976|NCT00619099|27042799|P2|Overall Study|Progressive Disease|5
7779977|NCT00619099|27042800|P1|Overall Study|Progressive Disease|7
7779978|NCT00618995|27042822|P4|Period 4|Adverse Event|0
7779979|NCT00618995|27042823|P3|Period 4|Adverse Event|0
7779980|NCT00618995|27042824|P2|Period 4|Adverse Event|0
7779981|NCT00618995|27042825|P1|Period 4|Adverse Event|1
7779982|NCT00618995|27042822|P4|Period 2|Protocol Violation|0
7779983|NCT00618995|27042823|P3|Period 2|Protocol Violation|1
7779984|NCT00618995|27042824|P2|Period 2|Protocol Violation|0
7779985|NCT00618995|27042825|P1|Period 2|Protocol Violation|0
7779986|NCT00618995|27042822|P4|Period 1|Protocol Violation|0
7779987|NCT00618995|27042823|P3|Period 1|Protocol Violation|1
7779988|NCT00618995|27042824|P2|Period 1|Protocol Violation|1
7779989|NCT00618995|27042825|P1|Period 1|Protocol Violation|0
7779990|NCT00618995|27042822|P4|Period 1|Adverse Event|0
7779991|NCT00618995|27042823|P3|Period 1|Adverse Event|1
7779992|NCT00618995|27042824|P2|Period 1|Adverse Event|0
7779993|NCT00618995|27042825|P1|Period 1|Adverse Event|0
7779994|NCT00618982|27042839|P1|Overall Study|ongoing, still treated with study med.|25
7779995|NCT00618982|27042839|P1|Overall Study|Protocol Violation|1
7779996|NCT00618982|27042839|P1|Overall Study|Withdrawal by Subject|1
7779997|NCT00618982|27042839|P1|Overall Study|Adverse Event|23
7779998|NCT00618956|27042862|P2|Overall Study|did not meet criteria, non-compliance|1
7779999|NCT00618956|27042863|P1|Overall Study|did not meet criteria, non-compliance|2
7780000|NCT00618956|27042862|P2|Overall Study|Protocol Violation|2
7780001|NCT00618956|27042863|P1|Overall Study|Protocol Violation|2
7780002|NCT00618956|27042862|P2|Overall Study|Lost to Follow-up|5
7780003|NCT00618956|27042863|P1|Overall Study|Lost to Follow-up|4
7780004|NCT00618956|27042862|P2|Overall Study|Withdrawal by Subject|7
7780005|NCT00618956|27042863|P1|Overall Study|Withdrawal by Subject|5
7780006|NCT00618956|27042862|P2|Overall Study|Lack of Efficacy|1
7780007|NCT00618956|27042863|P1|Overall Study|Lack of Efficacy|2
7780008|NCT00618956|27042862|P2|Overall Study|Adverse Event|34
7780009|NCT00618956|27042863|P1|Overall Study|Adverse Event|10
7780010|NCT00618826|27042888|P1|Overall Study|Adverse Event|1
7780011|NCT00618813|27042893|P1|Overall Study|Withdrawal by Subject|1
7780012|NCT00618813|27042893|P1|Overall Study|Physician Decision|2
7780013|NCT00618813|27042893|P1|Overall Study|Lack of Efficacy|1
7780014|NCT00618787|27042903|P2|Overall Study|Lost to Follow-up|0
7780015|NCT00618787|27042904|P1|Overall Study|Lost to Follow-up|1
7780016|NCT00618787|27042903|P2|Overall Study|Withdrawal by Subject|1
7780017|NCT00618787|27042904|P1|Overall Study|Withdrawal by Subject|2
7780018|NCT00618787|27042903|P2|Overall Study|Adverse Event|1
7780019|NCT00618787|27042904|P1|Overall Study|Adverse Event|0
7780020|NCT00618774|27042912|P2|Overall Study|Withdrawal by Subject|0
7780021|NCT00618774|27042913|P1|Overall Study|Withdrawal by Subject|1
7780022|NCT00618774|27042912|P2|Overall Study|Adverse Event|3
7780023|NCT00618774|27042913|P1|Overall Study|Adverse Event|5
7780024|NCT00618748|27042946|P3|Overall Study|Withdrawal by Subject|5
7780025|NCT00618748|27042947|P2|Overall Study|Withdrawal by Subject|1
7780026|NCT00618748|27042948|P1|Overall Study|Withdrawal by Subject|4
7780027|NCT00618748|27042946|P3|Overall Study|Physician Decision|1
7780028|NCT00618748|27042947|P2|Overall Study|Physician Decision|1
7780029|NCT00618748|27042948|P1|Overall Study|Physician Decision|3
7780030|NCT00618748|27042946|P3|Overall Study|Adverse Event|8
7780031|NCT00618748|27042947|P2|Overall Study|Adverse Event|3
7780032|NCT00618748|27042948|P1|Overall Study|Adverse Event|4
7780033|NCT00618722|27042993|P4|Overall Study|Miscellaneous Reasons|1
7780034|NCT00618722|27042994|P3|Overall Study|Miscellaneous Reasons|1
7780035|NCT00618722|27042995|P2|Overall Study|Miscellaneous Reasons|0
7780036|NCT00618722|27042996|P1|Overall Study|Miscellaneous Reasons|0
7780037|NCT00618722|27042993|P4|Overall Study|Lost to Follow-up|2
7780038|NCT00618722|27042994|P3|Overall Study|Lost to Follow-up|0
7780039|NCT00618722|27042995|P2|Overall Study|Lost to Follow-up|0
7780040|NCT00618722|27042996|P1|Overall Study|Lost to Follow-up|2
7780041|NCT00618722|27042993|P4|Overall Study|Inability to Complete Study Procedure|0
7780042|NCT00618722|27042994|P3|Overall Study|Inability to Complete Study Procedure|0
7780043|NCT00618722|27042995|P2|Overall Study|Inability to Complete Study Procedure|1
7780044|NCT00618722|27042996|P1|Overall Study|Inability to Complete Study Procedure|0
7780045|NCT00618722|27042993|P4|Overall Study|Patient Request|1
7780046|NCT00618722|27042994|P3|Overall Study|Patient Request|1
7780047|NCT00618722|27042995|P2|Overall Study|Patient Request|1
7780048|NCT00618722|27042996|P1|Overall Study|Patient Request|1
7780049|NCT00618722|27042993|P4|Overall Study|Refusal of Treatment|0
7780050|NCT00618722|27042994|P3|Overall Study|Refusal of Treatment|1
7780051|NCT00618722|27042995|P2|Overall Study|Refusal of Treatment|0
7780052|NCT00618722|27042996|P1|Overall Study|Refusal of Treatment|0
7780053|NCT00618618|27043034|P4|Overall Study|Death|0
7780054|NCT00618618|27043035|P3|Overall Study|Death|0
7780055|NCT00618618|27043036|P2|Overall Study|Death|1
7780056|NCT00618618|27043037|P1|Overall Study|Death|0
7780057|NCT00618618|27043034|P4|Overall Study|Did Not Meet Entry Criteria|0
7780058|NCT00618618|27043035|P3|Overall Study|Did Not Meet Entry Criteria|1
7780059|NCT00618618|27043036|P2|Overall Study|Did Not Meet Entry Criteria|0
7780060|NCT00618618|27043037|P1|Overall Study|Did Not Meet Entry Criteria|0
7780061|NCT00618618|27043034|P4|Overall Study|Non-compliance|0
7780062|NCT00618618|27043035|P3|Overall Study|Non-compliance|0
7780063|NCT00618618|27043036|P2|Overall Study|Non-compliance|1
7780064|NCT00618618|27043037|P1|Overall Study|Non-compliance|1
7780065|NCT00618618|27043034|P4|Overall Study|Lost to Follow-up|1
7780066|NCT00618618|27043035|P3|Overall Study|Lost to Follow-up|0
7780067|NCT00618618|27043036|P2|Overall Study|Lost to Follow-up|0
7780068|NCT00618618|27043037|P1|Overall Study|Lost to Follow-up|3
7780069|NCT00618618|27043034|P4|Overall Study|Inability to Complete Study Procedures|0
7780070|NCT00618618|27043035|P3|Overall Study|Inability to Complete Study Procedures|0
7780071|NCT00618618|27043036|P2|Overall Study|Inability to Complete Study Procedures|1
7780072|NCT00618618|27043037|P1|Overall Study|Inability to Complete Study Procedures|0
7780073|NCT00618618|27043034|P4|Overall Study|Patient Request|0
7780074|NCT00618618|27043035|P3|Overall Study|Patient Request|2
7780075|NCT00618618|27043036|P2|Overall Study|Patient Request|0
7780076|NCT00618618|27043037|P1|Overall Study|Patient Request|0
7780077|NCT00618514|27043096|P3|Overall Study|Lost to Follow-up|4
7780078|NCT00618514|27043097|P2|Overall Study|Lost to Follow-up|12
7780079|NCT00618514|27043098|P1|Overall Study|Lost to Follow-up|11
7780080|NCT00618449|27043118|P2|Overall Study|Lost to Follow-up|110
7780081|NCT00618449|27043119|P1|Overall Study|Lost to Follow-up|98
7780082|NCT00618410|27043138|P2|Washout Period (2 Weeks)|Physician Decision|1
7780083|NCT00618410|27043139|P1|Washout Period (2 Weeks)|Physician Decision|0
7780084|NCT00618371|27043155|P1|Overall Study|Withdrawal by Subject|2
7780085|NCT00618072|27043188|P3|Overall Study|Physician Decision|1
7780086|NCT00618072|27043189|P2|Overall Study|Physician Decision|1
7780087|NCT00618072|27043190|P1|Overall Study|Physician Decision|0
7780088|NCT00618072|27043188|P3|Overall Study|Lost to Follow-up|3
7780089|NCT00618072|27043189|P2|Overall Study|Lost to Follow-up|0
7780090|NCT00618072|27043190|P1|Overall Study|Lost to Follow-up|2
7780091|NCT00617929|27043246|P1|Overall Study|Physician Decision|1
7780092|NCT00617903|27043258|P2|Overall Study|noncompliance|1
7780093|NCT00617903|27043259|P1|Overall Study|noncompliance|0
7780094|NCT00617903|27043258|P2|Overall Study|Adverse Event|1
7780095|NCT00617903|27043259|P1|Overall Study|Adverse Event|0
7780096|NCT00617903|27043258|P2|Overall Study|Lack of Efficacy|1
7780097|NCT00617903|27043259|P1|Overall Study|Lack of Efficacy|0
7780098|NCT00617903|27043258|P2|Overall Study|Lost to Follow-up|1
7780099|NCT00617903|27043259|P1|Overall Study|Lost to Follow-up|1
7780100|NCT00617903|27043258|P2|Overall Study|Withdrawal by Subject|3
7780101|NCT00617903|27043259|P1|Overall Study|Withdrawal by Subject|2
7780102|NCT00617890|27043305|P4|Overall Study|Not treated|1
7780103|NCT00617890|27043306|P3|Overall Study|Not treated|1
7780104|NCT00617890|27043307|P2|Overall Study|Not treated|0
7780105|NCT00617890|27043308|P1|Overall Study|Not treated|1
7780106|NCT00617890|27043305|P4|Overall Study|Adverse Event|8
7780107|NCT00617890|27043306|P3|Overall Study|Adverse Event|3
7780108|NCT00617890|27043307|P2|Overall Study|Adverse Event|0
7780109|NCT00617890|27043308|P1|Overall Study|Adverse Event|1
7780110|NCT00617890|27043305|P4|Overall Study|Protocol Violation|0
7780111|NCT00617890|27043306|P3|Overall Study|Protocol Violation|0
7780112|NCT00617890|27043307|P2|Overall Study|Protocol Violation|1
7780113|NCT00617890|27043308|P1|Overall Study|Protocol Violation|2
7780114|NCT00617890|27043305|P4|Overall Study|Withdrawal by Subject|2
7780115|NCT00617890|27043306|P3|Overall Study|Withdrawal by Subject|0
7780116|NCT00617890|27043307|P2|Overall Study|Withdrawal by Subject|1
7780117|NCT00617890|27043308|P1|Overall Study|Withdrawal by Subject|4
7780118|NCT00617890|27043305|P4|Overall Study|Lost to Follow-up|2
7780119|NCT00617890|27043306|P3|Overall Study|Lost to Follow-up|1
7780120|NCT00617890|27043307|P2|Overall Study|Lost to Follow-up|0
7780121|NCT00617890|27043308|P1|Overall Study|Lost to Follow-up|0
7780122|NCT00617890|27043305|P4|Overall Study|Lack of Efficacy|97
7780123|NCT00617890|27043306|P3|Overall Study|Lack of Efficacy|30
7780124|NCT00617890|27043307|P2|Overall Study|Lack of Efficacy|26
7780125|NCT00617890|27043308|P1|Overall Study|Lack of Efficacy|23
7780126|NCT00617890|27043305|P4|Overall Study|Treatment ongoing at data cut-off|5
7780127|NCT00617890|27043306|P3|Overall Study|Treatment ongoing at data cut-off|0
7780128|NCT00617890|27043307|P2|Overall Study|Treatment ongoing at data cut-off|0
7780129|NCT00617890|27043308|P1|Overall Study|Treatment ongoing at data cut-off|0
7780130|NCT00617851|27043344|P4|Overall Study|Unable to classify|0
7780131|NCT00617851|27043345|P3|Overall Study|Unable to classify|1
7780132|NCT00617851|27043346|P2|Overall Study|Unable to classify|0
7780133|NCT00617851|27043347|P1|Overall Study|Unable to classify|1
7780134|NCT00617851|27043344|P4|Overall Study|Inappropriate Enrollment|1
7780135|NCT00617851|27043345|P3|Overall Study|Inappropriate Enrollment|1
7780136|NCT00617851|27043346|P2|Overall Study|Inappropriate Enrollment|4
7780137|NCT00617851|27043347|P1|Overall Study|Inappropriate Enrollment|5
7780138|NCT00617851|27043344|P4|Overall Study|Lost to Follow-up|19
7780139|NCT00617851|27043345|P3|Overall Study|Lost to Follow-up|31
7780140|NCT00617851|27043346|P2|Overall Study|Lost to Follow-up|29
7780141|NCT00617851|27043347|P1|Overall Study|Lost to Follow-up|27
7780142|NCT00617851|27043344|P4|Overall Study|Withdrawal by Subject|4
7780143|NCT00617851|27043345|P3|Overall Study|Withdrawal by Subject|12
7780144|NCT00617851|27043346|P2|Overall Study|Withdrawal by Subject|7
7780145|NCT00617851|27043347|P1|Overall Study|Withdrawal by Subject|14
7780146|NCT00617851|27043344|P4|Overall Study|Death|1
7780147|NCT00617851|27043345|P3|Overall Study|Death|0
7780148|NCT00617851|27043346|P2|Overall Study|Death|0
7780149|NCT00617851|27043347|P1|Overall Study|Death|0
7780150|NCT00617773|27043385|P1|Overall Study|Protocol Violation|1
7780151|NCT00617773|27043385|P1|Overall Study|Progressive disease|19
7780152|NCT00617773|27043385|P1|Overall Study|Death|1
7780153|NCT00617773|27043385|P1|Overall Study|Withdrawal by Subject|1
7780154|NCT00617773|27043385|P1|Overall Study|Lack of compliance with the protocol|1
7780155|NCT00617773|27043385|P1|Overall Study|Physician Decision|1
7780156|NCT00617734|27043402|P2|Overall Study|Lost to Follow-up|1
7780157|NCT00617734|27043403|P1|Overall Study|Lost to Follow-up|0
7780158|NCT00617734|27043402|P2|Overall Study|Found Ineligible After Randomization|4
7780159|NCT00617734|27043403|P1|Overall Study|Found Ineligible After Randomization|1
7780160|NCT00617734|27043402|P2|Overall Study|Protocol Violation|0
7780161|NCT00617734|27043403|P1|Overall Study|Protocol Violation|1
7780162|NCT00617734|27043402|P2|Overall Study|Adverse Event|1
7780163|NCT00617734|27043403|P1|Overall Study|Adverse Event|4
7780164|NCT00617734|27043402|P2|Overall Study|Withdrew Consent|0
7780165|NCT00617734|27043403|P1|Overall Study|Withdrew Consent|2
7780166|NCT00617708|27043424|P3|Overall Study|Not eligible|5
7780167|NCT00617708|27043425|P2|Overall Study|Not eligible|3
7780168|NCT00617708|27043426|P1|Overall Study|Not eligible|1
7780169|NCT00617708|27043424|P3|Overall Study|Not protocol specified|2
7780170|NCT00617708|27043425|P2|Overall Study|Not protocol specified|4
7780171|NCT00617708|27043426|P1|Overall Study|Not protocol specified|1
7780172|NCT00617708|27043424|P3|Overall Study|Progression/Relapse|36
7780173|NCT00617708|27043425|P2|Overall Study|Progression/Relapse|40
7780174|NCT00617708|27043426|P1|Overall Study|Progression/Relapse|7
7780175|NCT00617708|27043424|P3|Overall Study|Death|5
7780176|NCT00617708|27043425|P2|Overall Study|Death|6
7780177|NCT00617708|27043426|P1|Overall Study|Death|0
7780178|NCT00617708|27043424|P3|Overall Study|Withdrawal by Subject|7
7780179|NCT00617708|27043425|P2|Overall Study|Withdrawal by Subject|1
7780180|NCT00617708|27043426|P1|Overall Study|Withdrawal by Subject|1
7780181|NCT00617708|27043424|P3|Overall Study|Adverse Event|9
7780182|NCT00617708|27043425|P2|Overall Study|Adverse Event|6
7780183|NCT00617708|27043426|P1|Overall Study|Adverse Event|0
7780184|NCT00617669|27043443|P2|Overall Study|Patients randomized but not treated|3
7780185|NCT00617669|27043444|P1|Overall Study|Patients randomized but not treated|2
7780186|NCT00617669|27043443|P2|Overall Study|Reason not otherwise captured, eg; death|290
7780187|NCT00617669|27043444|P1|Overall Study|Reason not otherwise captured, eg; death|265
7780188|NCT00617669|27043443|P2|Overall Study|Protocol Violation|3
7780189|NCT00617669|27043444|P1|Overall Study|Protocol Violation|2
7780190|NCT00617669|27043443|P2|Overall Study|Adverse Event|76
7780191|NCT00617669|27043444|P1|Overall Study|Adverse Event|87
7780192|NCT00617669|27043443|P2|Overall Study|Lost to Follow-up|2
7780193|NCT00617669|27043444|P1|Overall Study|Lost to Follow-up|3
7780194|NCT00617669|27043443|P2|Overall Study|Withdrawal by Subject|77
7780195|NCT00617669|27043444|P1|Overall Study|Withdrawal by Subject|71
7780196|NCT00617604|27043466|P2|Overall Study|Randomized but Never Received Study Drug|3
7780197|NCT00617604|27043467|P1|Overall Study|Randomized but Never Received Study Drug|3
7780198|NCT00617604|27043466|P2|Overall Study|Withdrawal by Subject|6
7780199|NCT00617604|27043467|P1|Overall Study|Withdrawal by Subject|4
7780200|NCT00617604|27043466|P2|Overall Study|Miscellaneous Reasons|10
7780201|NCT00617604|27043467|P1|Overall Study|Miscellaneous Reasons|8
7780202|NCT00617604|27043466|P2|Overall Study|Lost to Follow-up|0
7780203|NCT00617604|27043467|P1|Overall Study|Lost to Follow-up|1
7780204|NCT00617604|27043466|P2|Overall Study|Death|1
7780205|NCT00617604|27043467|P1|Overall Study|Death|2
7780206|NCT00617591|27043511|P1|Overall Study|Withdrew consent during Maintenance|6
7780207|NCT00617591|27043511|P1|Overall Study|Withdrew consent during Induction|4
7780208|NCT00617461|27043527|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
7780209|NCT00617461|27043528|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
7780210|NCT00617461|27043527|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
7780211|NCT00617461|27043528|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
7780212|NCT00617461|27043527|P2|Second Treatment Intervention Period|Lack of Efficacy|3
7780213|NCT00617461|27043528|P1|Second Treatment Intervention Period|Lack of Efficacy|0
7780214|NCT00617461|27043527|P2|Second Treatment Intervention Period|Adverse Event|1
7780215|NCT00617461|27043528|P1|Second Treatment Intervention Period|Adverse Event|0
7780216|NCT00617461|27043527|P2|4-Day Crossover Period|Withdrawal by Subject|0
7780217|NCT00617461|27043528|P1|4-Day Crossover Period|Withdrawal by Subject|1
7780218|NCT00617461|27043527|P2|First Treatment Intervention Period|Withdrawal by Subject|0
7780219|NCT00617461|27043528|P1|First Treatment Intervention Period|Withdrawal by Subject|4
7780220|NCT00617461|27043527|P2|First Treatment Intervention Period|Investigator Discretion|1
7780221|NCT00617461|27043528|P1|First Treatment Intervention Period|Investigator Discretion|1
7780222|NCT00617461|27043527|P2|First Treatment Intervention Period|Lost to Follow-up|1
7780223|NCT00617461|27043528|P1|First Treatment Intervention Period|Lost to Follow-up|0
7780224|NCT00617461|27043527|P2|First Treatment Intervention Period|Protocol Violation|1
7780225|NCT00617461|27043528|P1|First Treatment Intervention Period|Protocol Violation|2
7780226|NCT00617461|27043527|P2|First Treatment Intervention Period|Lack of Efficacy|0
7780227|NCT00617461|27043528|P1|First Treatment Intervention Period|Lack of Efficacy|1
7780228|NCT00617461|27043527|P2|First Treatment Intervention Period|Adverse Event|0
7780229|NCT00617461|27043528|P1|First Treatment Intervention Period|Adverse Event|2
7780230|NCT00617409|27043584|P3|Overall Study|Alternative Therapy|0
7780231|NCT00617409|27043585|P2|Overall Study|Alternative Therapy|2
7780232|NCT00617409|27043586|P1|Overall Study|Alternative Therapy|1
7780233|NCT00617409|27043584|P3|Overall Study|Death|4
7780234|NCT00617409|27043585|P2|Overall Study|Death|5
7780235|NCT00617409|27043586|P1|Overall Study|Death|3
7780236|NCT00617409|27043584|P3|Overall Study|Disease Progression|18
7780237|NCT00617409|27043585|P2|Overall Study|Disease Progression|8
7780238|NCT00617409|27043586|P1|Overall Study|Disease Progression|8
7780239|NCT00617409|27043584|P3|Overall Study|Adverse Event|3
7780240|NCT00617409|27043585|P2|Overall Study|Adverse Event|2
7780241|NCT00617409|27043586|P1|Overall Study|Adverse Event|0
7780242|NCT00617409|27043584|P3|Overall Study|Withdrawal by Subject|2
7780243|NCT00617409|27043585|P2|Overall Study|Withdrawal by Subject|1
7780244|NCT00617409|27043586|P1|Overall Study|Withdrawal by Subject|4
7780245|NCT00617357|27043601|P1|Overall Study|Physician Decision|1
7780246|NCT00617357|27043601|P1|Overall Study|Withdrawal by Subject|1
7780247|NCT00617357|27043601|P1|Overall Study|insurance concerns|2
7780248|NCT00617357|27043601|P1|Overall Study|Death|5
7780249|NCT00617357|27043601|P1|Overall Study|Lost to Follow-up|7
7780250|NCT00617344|27043614|P3|Overall Study|Withdrawal by Subject|2
7780251|NCT00617344|27043615|P2|Overall Study|Withdrawal by Subject|9
7780252|NCT00617344|27043616|P1|Overall Study|Withdrawal by Subject|8
7780253|NCT00617344|27043614|P3|Overall Study|Lost to Follow-up|1
7780254|NCT00617344|27043615|P2|Overall Study|Lost to Follow-up|4
7780255|NCT00617344|27043616|P1|Overall Study|Lost to Follow-up|5
7780256|NCT00617344|27043614|P3|Overall Study|Protocol Violation|5
7780257|NCT00617344|27043615|P2|Overall Study|Protocol Violation|8
7780258|NCT00617344|27043616|P1|Overall Study|Protocol Violation|10
7780259|NCT00617344|27043614|P3|Overall Study|Other Adverse Event|0
7780260|NCT00617344|27043615|P2|Overall Study|Other Adverse Event|1
7780261|NCT00617344|27043616|P1|Overall Study|Other Adverse Event|1
7780262|NCT00617344|27043614|P3|Overall Study|Serious adverse event|0
7780263|NCT00617344|27043615|P2|Overall Study|Serious adverse event|0
7780264|NCT00617344|27043616|P1|Overall Study|Serious adverse event|1
7780265|NCT00617305|27043644|P3|Overall Study|Withdrawal by Subject|0
7780266|NCT00617305|27043645|P2|Overall Study|Withdrawal by Subject|0
7780267|NCT00617305|27043646|P1|Overall Study|Withdrawal by Subject|1
7780268|NCT00617305|27043644|P3|Overall Study|Protocol Violation|1
7780269|NCT00617305|27043645|P2|Overall Study|Protocol Violation|0
7780270|NCT00617305|27043646|P1|Overall Study|Protocol Violation|1
7780271|NCT00617305|27043644|P3|Overall Study|Physician Decision|0
7780272|NCT00617305|27043645|P2|Overall Study|Physician Decision|0
7780273|NCT00617305|27043646|P1|Overall Study|Physician Decision|1
7780274|NCT00617305|27043644|P3|Overall Study|Death|0
7780275|NCT00617305|27043645|P2|Overall Study|Death|0
7780276|NCT00617305|27043646|P1|Overall Study|Death|1
7780277|NCT00617305|27043644|P3|Overall Study|Adverse Event|0
7780278|NCT00617305|27043645|P2|Overall Study|Adverse Event|0
7780279|NCT00617305|27043646|P1|Overall Study|Adverse Event|4
7780280|NCT00617279|27043702|P2|Overall Study|Death|2
7780281|NCT00617279|27043703|P1|Overall Study|Death|1
7780282|NCT00617279|27043702|P2|Overall Study|Lost to Follow-up|0
7780283|NCT00617279|27043703|P1|Overall Study|Lost to Follow-up|1
7780284|NCT00617279|27043702|P2|Overall Study|Graft abandonment|0
7780285|NCT00617279|27043703|P1|Overall Study|Graft abandonment|2
7780286|NCT00617279|27043702|P2|Overall Study|Study terminated by Sponsor|15
7780287|NCT00617279|27043703|P1|Overall Study|Study terminated by Sponsor|10
7780288|NCT00617240|27043759|P2|Overall Study|Lack of Efficacy|0
7780289|NCT00617240|27043760|P1|Overall Study|Lack of Efficacy|1
7780290|NCT00617201|27043780|P2|Overall Study|Lost to Follow-up|13
7780291|NCT00617201|27043781|P1|Overall Study|Lost to Follow-up|9
7780292|NCT00617123|27043809|P2|Study Treatment Period|Noncompliance with Protocol|1
7780293|NCT00617123|27043810|P1|Study Treatment Period|Noncompliance with Protocol|0
7780294|NCT00617123|27043809|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
7780295|NCT00617123|27043810|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
7780296|NCT00617123|27043809|P2|Study Treatment Period|Adverse Event|3
7780297|NCT00617123|27043810|P1|Study Treatment Period|Adverse Event|7
7780298|NCT00617123|27043809|P2|Study Treatment Period|Withdrawal by Subject|12
7780299|NCT00617123|27043810|P1|Study Treatment Period|Withdrawal by Subject|8
7780300|NCT00617123|27043809|P2|Referral Screening Period|Adverse Event|1
7780301|NCT00617123|27043810|P1|Referral Screening Period|Adverse Event|0
7780302|NCT00617123|27043809|P2|Referral Screening Period|Did Not Wish To Continue|1
7780303|NCT00617123|27043810|P1|Referral Screening Period|Did Not Wish To Continue|3
7780304|NCT00617123|27043809|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
7780305|NCT00617123|27043810|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
7780306|NCT00617084|27043841|P2|Overall Study|Missed 12 Months visit|19
7780307|NCT00617084|27043842|P1|Overall Study|Missed 12 Months visit|16
7780308|NCT00617084|27043841|P2|Overall Study|Withdrawal by Subject|7
7780309|NCT00617084|27043842|P1|Overall Study|Withdrawal by Subject|5
7780310|NCT00616967|27043895|P3|Overall Study|Withdrawal by Subject|1
7780311|NCT00616967|27043896|P2|Overall Study|Withdrawal by Subject|0
7780312|NCT00616967|27043897|P1|Overall Study|Withdrawal by Subject|0
7780313|NCT00616941|27043922|P3|Overall Study|Vaccination Suspended|3
7780314|NCT00616941|27043923|P2|Overall Study|Vaccination Suspended|0
7780315|NCT00616941|27043924|P1|Overall Study|Vaccination Suspended|0
7780316|NCT00616941|27043922|P3|Overall Study|Unrelated Medical Illness/Complication|0
7780317|NCT00616941|27043923|P2|Overall Study|Unrelated Medical Illness/Complication|2
7780318|NCT00616941|27043924|P1|Overall Study|Unrelated Medical Illness/Complication|0
7780319|NCT00616941|27043922|P3|Overall Study|Subject Non-compliance|1
7780320|NCT00616941|27043923|P2|Overall Study|Subject Non-compliance|0
7780321|NCT00616941|27043924|P1|Overall Study|Subject Non-compliance|0
7780322|NCT00616941|27043922|P3|Overall Study|Adverse Event|1
7780323|NCT00616941|27043923|P2|Overall Study|Adverse Event|1
7780324|NCT00616941|27043924|P1|Overall Study|Adverse Event|0
7780325|NCT00616941|27043922|P3|Overall Study|Progressive Disease|1
7780326|NCT00616941|27043923|P2|Overall Study|Progressive Disease|2
7780327|NCT00616941|27043924|P1|Overall Study|Progressive Disease|1
7780328|NCT00616928|27043951|P4|Overall Study|Lost to Follow-up|0
7780329|NCT00616928|27043952|P3|Overall Study|Lost to Follow-up|0
7780330|NCT00616928|27043953|P2|Overall Study|Lost to Follow-up|7
7780331|NCT00616928|27043954|P1|Overall Study|Lost to Follow-up|5
7780332|NCT00616928|27043951|P4|Overall Study|Other|5
7780333|NCT00616928|27043952|P3|Overall Study|Other|15
7780334|NCT00616928|27043953|P2|Overall Study|Other|8
7780335|NCT00616928|27043954|P1|Overall Study|Other|51
7780336|NCT00616928|27043951|P4|Overall Study|Adverse Event|2
7780337|NCT00616928|27043952|P3|Overall Study|Adverse Event|2
7780338|NCT00616928|27043953|P2|Overall Study|Adverse Event|3
7780339|NCT00616928|27043954|P1|Overall Study|Adverse Event|6
7780340|NCT00616902|27044018|P2|Overall Study|Termination of study|6
7780341|NCT00616902|27044019|P1|Overall Study|Termination of study|6
7780342|NCT00616759|27044062|P2|Overall Study|Withdrawal by Subject|2
7780343|NCT00616759|27044063|P1|Overall Study|Withdrawal by Subject|1
7780344|NCT00616759|27044062|P2|Overall Study|Physician Decision|0
7780345|NCT00616759|27044063|P1|Overall Study|Physician Decision|2
7780346|NCT00616655|27044072|P3|Overall Study|Other|5
7780347|NCT00616655|27044073|P2|Overall Study|Other|6
7780348|NCT00616655|27044074|P1|Overall Study|Other|6
7780349|NCT00616655|27044072|P3|Overall Study|Does not meet in/ex criteria|2
7780350|NCT00616655|27044073|P2|Overall Study|Does not meet in/ex criteria|0
7780351|NCT00616655|27044074|P1|Overall Study|Does not meet in/ex criteria|0
7780352|NCT00616655|27044072|P3|Overall Study|Withdrawal by Subject|11
7780353|NCT00616655|27044073|P2|Overall Study|Withdrawal by Subject|7
7780354|NCT00616655|27044074|P1|Overall Study|Withdrawal by Subject|9
7780355|NCT00616655|27044072|P3|Overall Study|Protocol Violation|3
7780356|NCT00616655|27044073|P2|Overall Study|Protocol Violation|4
7780357|NCT00616655|27044074|P1|Overall Study|Protocol Violation|2
7780358|NCT00616655|27044072|P3|Overall Study|Lost to Follow-up|10
7780359|NCT00616655|27044073|P2|Overall Study|Lost to Follow-up|12
7780360|NCT00616655|27044074|P1|Overall Study|Lost to Follow-up|3
7780361|NCT00616655|27044072|P3|Overall Study|Lack of Efficacy|5
7780362|NCT00616655|27044073|P2|Overall Study|Lack of Efficacy|5
7780363|NCT00616655|27044074|P1|Overall Study|Lack of Efficacy|5
7780364|NCT00616655|27044072|P3|Overall Study|Adverse Event|12
7780365|NCT00616655|27044073|P2|Overall Study|Adverse Event|7
7780366|NCT00616655|27044074|P1|Overall Study|Adverse Event|10
7780367|NCT00616642|27044114|P2|Overall Study|Withdrawal by Subject|1
7780368|NCT00616642|27044115|P1|Overall Study|Withdrawal by Subject|0
7780369|NCT00616629|27044126|P5|Overall Study|AV-block|0
7780370|NCT00616629|27044127|P4|Overall Study|AV-block|0
7780371|NCT00616629|27044128|P3|Overall Study|AV-block|0
7780372|NCT00616629|27044129|P2|Overall Study|AV-block|0
7780373|NCT00616629|27044130|P1|Overall Study|AV-block|1
7780374|NCT00616629|27044126|P5|Overall Study|Protocol Violation|0
7780375|NCT00616629|27044127|P4|Overall Study|Protocol Violation|0
7780376|NCT00616629|27044128|P3|Overall Study|Protocol Violation|1
7780377|NCT00616629|27044129|P2|Overall Study|Protocol Violation|2
7780378|NCT00616629|27044130|P1|Overall Study|Protocol Violation|1
7780379|NCT00616603|27044175|P3|Overall Study|Physician Decision|2
7780380|NCT00616603|27044176|P2|Overall Study|Physician Decision|0
7780381|NCT00616603|27044177|P1|Overall Study|Physician Decision|2
7780382|NCT00616434|27044200|P2|Overall Study|Protocol deviation|1
7780383|NCT00616434|27044201|P1|Overall Study|Protocol deviation|0
7780384|NCT00616434|27044200|P2|Overall Study|Withdrawal by Subject|1
7780385|NCT00616434|27044201|P1|Overall Study|Withdrawal by Subject|1
7780386|NCT00616434|27044200|P2|Overall Study|Physician Decision|4
7780387|NCT00616434|27044201|P1|Overall Study|Physician Decision|0
7780388|NCT00616434|27044200|P2|Overall Study|Adverse Event|2
7780389|NCT00616434|27044201|P1|Overall Study|Adverse Event|5
7780390|NCT00616421|27044214|P3|Overall Study|Unable to classify|0
7780391|NCT00616421|27044215|P2|Overall Study|Unable to classify|0
7780392|NCT00616421|27044216|P1|Overall Study|Unable to classify|1
7780393|NCT00616421|27044214|P3|Overall Study|Protocol Violation|2
7780394|NCT00616421|27044215|P2|Overall Study|Protocol Violation|1
7780395|NCT00616421|27044216|P1|Overall Study|Protocol Violation|0
7780396|NCT00616421|27044214|P3|Overall Study|Administrative reason|0
7780397|NCT00616421|27044215|P2|Overall Study|Administrative reason|0
7780398|NCT00616421|27044216|P1|Overall Study|Administrative reason|1
7780399|NCT00616421|27044214|P3|Overall Study|Inappropriate enrollment|1
7780400|NCT00616421|27044215|P2|Overall Study|Inappropriate enrollment|0
7780401|NCT00616421|27044216|P1|Overall Study|Inappropriate enrollment|3
7780402|NCT00616421|27044214|P3|Overall Study|Lost to Follow-up|30
7780403|NCT00616421|27044215|P2|Overall Study|Lost to Follow-up|26
7780404|NCT00616421|27044216|P1|Overall Study|Lost to Follow-up|12
7780405|NCT00616421|27044214|P3|Overall Study|Withdrawal by Subject|8
7780406|NCT00616421|27044215|P2|Overall Study|Withdrawal by Subject|11
7780407|NCT00616421|27044216|P1|Overall Study|Withdrawal by Subject|9
7780408|NCT00616239|27044257|P1|Overall Study|Withdrawal by Subject|2
7780409|NCT00616018|27044287|P1|Overall Study|Protocol Violation|3
7780410|NCT00615992|27044292|P1|Overall Study|Protocol Violation|67
7780411|NCT00615914|27044318|P1|Overall Study|Irregularly enrolled patients|10
7780412|NCT00615914|27044318|P1|Overall Study|No treatment|2
7780413|NCT00615914|27044318|P1|Overall Study|No data was collected.|65
7780414|NCT00615914|27044318|P1|Overall Study|Physician Decision|4
7780415|NCT00615914|27044318|P1|Overall Study|Withdrawal by Subject|16
7780416|NCT00615914|27044318|P1|Overall Study|Lost to Follow-up|187
7780417|NCT00615914|27044318|P1|Overall Study|Lack of Efficacy|59
7780418|NCT00615914|27044318|P1|Overall Study|Death|20
7780419|NCT00615914|27044318|P1|Overall Study|Adverse Event|274
7780420|NCT00615901|27044325|P1|Overall Study|Adverse Event|7
7780421|NCT00615901|27044325|P1|Overall Study|Withdrawal by Subject|2
7780422|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7780423|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7780424|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7780425|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7780426|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
7780427|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Not reported|0
7780428|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Not reported|4
7780429|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Not reported|1
7780430|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Not reported|4
7780431|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Not reported|6
7780432|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Other|0
7780433|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Other|8
7780434|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Other|8
7780435|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Other|7
7780436|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Other|10
7780437|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
7780438|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
7780439|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
7780440|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
7780441|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
7780442|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
7780443|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
7780444|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
7780445|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
7780446|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
7780447|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
7780448|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
7780449|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
7780450|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
7780451|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
7780452|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
7780453|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
7780454|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
7780455|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
7780456|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
7780457|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
7780458|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
7780459|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
7780460|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
7780461|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
7780462|NCT00615836|27044333|P5|Extension Study (FE992026 CS31)|Adverse Event|0
7780463|NCT00615836|27044334|P4|Extension Study (FE992026 CS31)|Adverse Event|13
7780464|NCT00615836|27044335|P3|Extension Study (FE992026 CS31)|Adverse Event|15
7780465|NCT00615836|27044336|P2|Extension Study (FE992026 CS31)|Adverse Event|12
7780466|NCT00615836|27044337|P1|Extension Study (FE992026 CS31)|Adverse Event|7
7780467|NCT00615719|27044402|P1|Overall Study|Physician Decision|5
7780468|NCT00615550|27044416|P2|Overall Study|Lost to Follow-up|1
7780469|NCT00615550|27044417|P1|Overall Study|Lost to Follow-up|6
7780470|NCT00615459|27044440|P4|Period III|Unsatisfactory therapeutic effect|0
7780471|NCT00615459|27044441|P3|Period III|Unsatisfactory therapeutic effect|0
7780472|NCT00615459|27044442|P2|Period III|Unsatisfactory therapeutic effect|1
7780473|NCT00615459|27044443|P1|Period III|Unsatisfactory therapeutic effect|0
7780474|NCT00615459|27044440|P4|Period III|Administrative problems|0
7780475|NCT00615459|27044441|P3|Period III|Administrative problems|1
7780476|NCT00615459|27044442|P2|Period III|Administrative problems|1
7780477|NCT00615459|27044443|P1|Period III|Administrative problems|0
7780478|NCT00615459|27044440|P4|Period III|Adverse Event|0
7780479|NCT00615459|27044441|P3|Period III|Adverse Event|0
7780480|NCT00615459|27044442|P2|Period III|Adverse Event|1
7780481|NCT00615459|27044443|P1|Period III|Adverse Event|0
7780482|NCT00615459|27044440|P4|Period II|Lost to Follow-up|1
7780483|NCT00615459|27044441|P3|Period II|Lost to Follow-up|0
7780484|NCT00615459|27044442|P2|Period II|Lost to Follow-up|0
7780485|NCT00615459|27044443|P1|Period II|Lost to Follow-up|0
7780486|NCT00615459|27044440|P4|Period II|Adverse Event|0
7780487|NCT00615459|27044441|P3|Period II|Adverse Event|0
7780488|NCT00615459|27044442|P2|Period II|Adverse Event|0
7780489|NCT00615459|27044443|P1|Period II|Adverse Event|1
7780490|NCT00615459|27044440|P4|Period I|Abnormal test procedure results|0
7780491|NCT00615459|27044441|P3|Period I|Abnormal test procedure results|1
7780492|NCT00615459|27044442|P2|Period I|Abnormal test procedure results|1
7780493|NCT00615459|27044443|P1|Period I|Abnormal test procedure results|1
7780494|NCT00615459|27044440|P4|Period I|Subject withdrew consent|1
7780495|NCT00615459|27044441|P3|Period I|Subject withdrew consent|0
7780496|NCT00615459|27044442|P2|Period I|Subject withdrew consent|0
7780497|NCT00615459|27044443|P1|Period I|Subject withdrew consent|1
7780498|NCT00615459|27044440|P4|Period I|Adverse Event|0
7780499|NCT00615459|27044441|P3|Period I|Adverse Event|1
7780500|NCT00615459|27044442|P2|Period I|Adverse Event|0
7780501|NCT00615459|27044443|P1|Period I|Adverse Event|2
7780502|NCT00615290|27044489|P1|Overall Study|Other|2
7780503|NCT00615290|27044489|P1|Overall Study|Withdrawal by Subject|1
7780504|NCT00615290|27044489|P1|Overall Study|Lost to Follow-up|3
7780505|NCT00615290|27044489|P1|Overall Study|Adverse Event|2
7780506|NCT00615264|27044503|P2|Overall Study|Dermal Hypersensitivity|3
7780507|NCT00615264|27044504|P1|Overall Study|Dermal Hypersensitivity|0
7780508|NCT00615264|27044503|P2|Overall Study|Not defined|4
7780509|NCT00615264|27044504|P1|Overall Study|Not defined|7
7780510|NCT00615264|27044503|P2|Overall Study|Protocol Violation|7
7780511|NCT00615264|27044504|P1|Overall Study|Protocol Violation|11
7780512|NCT00615264|27044503|P2|Overall Study|Death|1
7780513|NCT00615264|27044504|P1|Overall Study|Death|1
7780514|NCT00615264|27044503|P2|Overall Study|Adverse Event|5
7780515|NCT00615264|27044504|P1|Overall Study|Adverse Event|8
7780516|NCT00615264|27044503|P2|Overall Study|Lost to Follow-up|13
7780517|NCT00615264|27044504|P1|Overall Study|Lost to Follow-up|6
7780518|NCT00615264|27044503|P2|Overall Study|Withdrawal by Subject|19
7780519|NCT00615264|27044504|P1|Overall Study|Withdrawal by Subject|17
7780520|NCT00615199|27044516|P4|Overall Study|Withdrawal by Subject|0
7780521|NCT00615199|27044517|P3|Overall Study|Withdrawal by Subject|0
7780522|NCT00615199|27044518|P2|Overall Study|Withdrawal by Subject|1
7780523|NCT00615199|27044519|P1|Overall Study|Withdrawal by Subject|2
7780524|NCT00615199|27044516|P4|Overall Study|Other|1
7780525|NCT00615199|27044517|P3|Overall Study|Other|0
7780526|NCT00615199|27044518|P2|Overall Study|Other|0
7780527|NCT00615199|27044519|P1|Overall Study|Other|0
7780528|NCT00615199|27044516|P4|Overall Study|Lost to Follow-up|0
7780529|NCT00615199|27044517|P3|Overall Study|Lost to Follow-up|0
7780530|NCT00615199|27044518|P2|Overall Study|Lost to Follow-up|0
7780531|NCT00615199|27044519|P1|Overall Study|Lost to Follow-up|1
7780532|NCT00615199|27044516|P4|Overall Study|Lack of Efficacy|1
7780533|NCT00615199|27044517|P3|Overall Study|Lack of Efficacy|0
7780534|NCT00615199|27044518|P2|Overall Study|Lack of Efficacy|0
7780535|NCT00615199|27044519|P1|Overall Study|Lack of Efficacy|2
7780536|NCT00615199|27044516|P4|Overall Study|Adverse Event|0
7780537|NCT00615199|27044517|P3|Overall Study|Adverse Event|1
7780538|NCT00615199|27044518|P2|Overall Study|Adverse Event|1
7780539|NCT00615199|27044519|P1|Overall Study|Adverse Event|3
7780540|NCT00615108|27044553|P1|Overall Study|Lost to Follow-up|15
7780541|NCT00615108|27044553|P1|Overall Study|Other|370
7780542|NCT00615108|27044553|P1|Overall Study|Adverse Event|122
7780543|NCT00615069|27044568|P1|Overall Study|Withdrawal by Subject|4
7780544|NCT00615069|27044568|P1|Overall Study|Physician Decision|2
7780545|NCT00615069|27044568|P1|Overall Study|Death|10
7780546|NCT00615056|27044577|P4|Overall Study|Randomized but not treated|0
7780547|NCT00615056|27044578|P3|Overall Study|Randomized but not treated|0
7780548|NCT00615056|27044579|P2|Overall Study|Randomized but not treated|0
7780549|NCT00615056|27044580|P1|Overall Study|Randomized but not treated|3
7780550|NCT00615056|27044577|P4|Overall Study|Discontinued by Sponsor|0
7780551|NCT00615056|27044578|P3|Overall Study|Discontinued by Sponsor|0
7780552|NCT00615056|27044579|P2|Overall Study|Discontinued by Sponsor|0
7780553|NCT00615056|27044580|P1|Overall Study|Discontinued by Sponsor|1
7780554|NCT00615056|27044577|P4|Overall Study|Withdrawal by Subject|0
7780555|NCT00615056|27044578|P3|Overall Study|Withdrawal by Subject|1
7780556|NCT00615056|27044579|P2|Overall Study|Withdrawal by Subject|1
7780557|NCT00615056|27044580|P1|Overall Study|Withdrawal by Subject|0
7780558|NCT00615056|27044577|P4|Overall Study|Objective progression or relapse|0
7780559|NCT00615056|27044578|P3|Overall Study|Objective progression or relapse|0
7780560|NCT00615056|27044579|P2|Overall Study|Objective progression or relapse|2
7780561|NCT00615056|27044580|P1|Overall Study|Objective progression or relapse|0
7780562|NCT00615056|27044577|P4|Overall Study|Other|7
7780563|NCT00615056|27044578|P3|Overall Study|Other|10
7780564|NCT00615056|27044579|P2|Overall Study|Other|15
7780565|NCT00615056|27044580|P1|Overall Study|Other|13
7780566|NCT00615056|27044577|P4|Overall Study|Lost to Follow-up|5
7780567|NCT00615056|27044578|P3|Overall Study|Lost to Follow-up|4
7780568|NCT00615056|27044579|P2|Overall Study|Lost to Follow-up|2
7780569|NCT00615056|27044580|P1|Overall Study|Lost to Follow-up|1
7780570|NCT00615056|27044577|P4|Overall Study|Death|23
7780571|NCT00615056|27044578|P3|Overall Study|Death|21
7780572|NCT00615056|27044579|P2|Overall Study|Death|31
7780573|NCT00615056|27044580|P1|Overall Study|Death|31
7780574|NCT00615030|27044610|P12|Period III|Administrative problems|0
7780575|NCT00615030|27044611|P11|Period III|Administrative problems|0
7780576|NCT00615030|27044612|P10|Period III|Administrative problems|0
7780577|NCT00615030|27044613|P9|Period III|Administrative problems|0
7780578|NCT00615030|27044614|P8|Period III|Administrative problems|0
7780579|NCT00615030|27044615|P7|Period III|Administrative problems|0
7780580|NCT00615030|27044616|P6|Period III|Administrative problems|0
7780581|NCT00615030|27044617|P5|Period III|Administrative problems|0
7780582|NCT00615030|27044618|P4|Period III|Administrative problems|1
7780583|NCT00615030|27044619|P3|Period III|Administrative problems|0
7780584|NCT00615030|27044620|P2|Period III|Administrative problems|0
7780585|NCT00615030|27044621|P1|Period III|Administrative problems|1
7780586|NCT00615030|27044610|P12|Period II|Subject withdrew consent|0
7780587|NCT00615030|27044611|P11|Period II|Subject withdrew consent|0
7780588|NCT00615030|27044612|P10|Period II|Subject withdrew consent|0
7780589|NCT00615030|27044613|P9|Period II|Subject withdrew consent|0
7780590|NCT00615030|27044614|P8|Period II|Subject withdrew consent|0
7780591|NCT00615030|27044615|P7|Period II|Subject withdrew consent|1
7780592|NCT00615030|27044616|P6|Period II|Subject withdrew consent|0
7780593|NCT00615030|27044617|P5|Period II|Subject withdrew consent|0
7780594|NCT00615030|27044618|P4|Period II|Subject withdrew consent|1
7780595|NCT00615030|27044619|P3|Period II|Subject withdrew consent|0
7780596|NCT00615030|27044620|P2|Period II|Subject withdrew consent|0
7780597|NCT00615030|27044621|P1|Period II|Subject withdrew consent|0
7780598|NCT00615030|27044610|P12|Period II|Adverse Event|0
7780599|NCT00615030|27044611|P11|Period II|Adverse Event|0
7780600|NCT00615030|27044612|P10|Period II|Adverse Event|0
7780601|NCT00615030|27044613|P9|Period II|Adverse Event|1
7780602|NCT00615030|27044614|P8|Period II|Adverse Event|0
7780603|NCT00615030|27044615|P7|Period II|Adverse Event|0
7780604|NCT00615030|27044616|P6|Period II|Adverse Event|0
7780605|NCT00615030|27044617|P5|Period II|Adverse Event|0
7780606|NCT00615030|27044618|P4|Period II|Adverse Event|0
7780607|NCT00615030|27044619|P3|Period II|Adverse Event|1
7780608|NCT00615030|27044620|P2|Period II|Adverse Event|0
7780609|NCT00615030|27044621|P1|Period II|Adverse Event|0
7780610|NCT00615030|27044610|P12|Period I|Abnormal laboratory value(s)|0
7780611|NCT00615030|27044611|P11|Period I|Abnormal laboratory value(s)|0
7780612|NCT00615030|27044612|P10|Period I|Abnormal laboratory value(s)|0
7780613|NCT00615030|27044613|P9|Period I|Abnormal laboratory value(s)|0
7780614|NCT00615030|27044614|P8|Period I|Abnormal laboratory value(s)|0
7780615|NCT00615030|27044615|P7|Period I|Abnormal laboratory value(s)|0
7780616|NCT00615030|27044616|P6|Period I|Abnormal laboratory value(s)|1
7780617|NCT00615030|27044617|P5|Period I|Abnormal laboratory value(s)|0
7780618|NCT00615030|27044618|P4|Period I|Abnormal laboratory value(s)|0
7780619|NCT00615030|27044619|P3|Period I|Abnormal laboratory value(s)|0
7780620|NCT00615030|27044620|P2|Period I|Abnormal laboratory value(s)|0
7780621|NCT00615030|27044621|P1|Period I|Abnormal laboratory value(s)|0
7780622|NCT00615030|27044610|P12|Period I|Subject withdrew consent|1
7780623|NCT00615030|27044611|P11|Period I|Subject withdrew consent|1
7780624|NCT00615030|27044612|P10|Period I|Subject withdrew consent|0
7780625|NCT00615030|27044613|P9|Period I|Subject withdrew consent|1
7780626|NCT00615030|27044614|P8|Period I|Subject withdrew consent|0
7780627|NCT00615030|27044615|P7|Period I|Subject withdrew consent|0
7780628|NCT00615030|27044616|P6|Period I|Subject withdrew consent|0
7780629|NCT00615030|27044617|P5|Period I|Subject withdrew consent|0
7780630|NCT00615030|27044618|P4|Period I|Subject withdrew consent|0
7780631|NCT00615030|27044619|P3|Period I|Subject withdrew consent|0
7780632|NCT00615030|27044620|P2|Period I|Subject withdrew consent|0
7780633|NCT00615030|27044621|P1|Period I|Subject withdrew consent|0
7780634|NCT00615030|27044610|P12|Period I|Protocol deviation|0
7780635|NCT00615030|27044611|P11|Period I|Protocol deviation|0
7780636|NCT00615030|27044612|P10|Period I|Protocol deviation|0
7780637|NCT00615030|27044613|P9|Period I|Protocol deviation|0
7780638|NCT00615030|27044614|P8|Period I|Protocol deviation|0
7780639|NCT00615030|27044615|P7|Period I|Protocol deviation|0
7780640|NCT00615030|27044616|P6|Period I|Protocol deviation|0
7780641|NCT00615030|27044617|P5|Period I|Protocol deviation|0
7780642|NCT00615030|27044618|P4|Period I|Protocol deviation|0
7780643|NCT00615030|27044619|P3|Period I|Protocol deviation|0
7780644|NCT00615030|27044620|P2|Period I|Protocol deviation|0
7780645|NCT00615030|27044621|P1|Period I|Protocol deviation|1
7780646|NCT00615030|27044610|P12|Period I|Administrative problem|0
7780647|NCT00615030|27044611|P11|Period I|Administrative problem|0
7780648|NCT00615030|27044612|P10|Period I|Administrative problem|0
7780649|NCT00615030|27044613|P9|Period I|Administrative problem|0
7780650|NCT00615030|27044614|P8|Period I|Administrative problem|0
7780651|NCT00615030|27044615|P7|Period I|Administrative problem|0
7780652|NCT00615030|27044616|P6|Period I|Administrative problem|0
7780653|NCT00615030|27044617|P5|Period I|Administrative problem|1
7780654|NCT00615030|27044618|P4|Period I|Administrative problem|0
7780655|NCT00615030|27044619|P3|Period I|Administrative problem|0
7780656|NCT00615030|27044620|P2|Period I|Administrative problem|0
7780657|NCT00615030|27044621|P1|Period I|Administrative problem|0
7780658|NCT00615017|27044641|P6|Overall Study|Physician discontinued drug|1
7780659|NCT00615017|27044642|P5|Overall Study|Physician discontinued drug|0
7780660|NCT00615017|27044643|P4|Overall Study|Physician discontinued drug|0
7780661|NCT00615017|27044644|P3|Overall Study|Physician discontinued drug|0
7780662|NCT00615017|27044645|P2|Overall Study|Physician discontinued drug|0
7780663|NCT00615017|27044646|P1|Overall Study|Physician discontinued drug|0
7780664|NCT00615017|27044641|P6|Overall Study|Transferred out of Intensive Care Unit|0
7780665|NCT00615017|27044642|P5|Overall Study|Transferred out of Intensive Care Unit|0
7780666|NCT00615017|27044643|P4|Overall Study|Transferred out of Intensive Care Unit|1
7780667|NCT00615017|27044644|P3|Overall Study|Transferred out of Intensive Care Unit|0
7780668|NCT00615017|27044645|P2|Overall Study|Transferred out of Intensive Care Unit|0
7780669|NCT00615017|27044646|P1|Overall Study|Transferred out of Intensive Care Unit|0
7780670|NCT00615017|27044641|P6|Overall Study|Sepsis resolved|0
7780671|NCT00615017|27044642|P5|Overall Study|Sepsis resolved|0
7780672|NCT00615017|27044643|P4|Overall Study|Sepsis resolved|0
7780673|NCT00615017|27044644|P3|Overall Study|Sepsis resolved|1
7780674|NCT00615017|27044645|P2|Overall Study|Sepsis resolved|0
7780675|NCT00615017|27044646|P1|Overall Study|Sepsis resolved|0
7780676|NCT00615017|27044641|P6|Overall Study|Death|1
7780677|NCT00615017|27044642|P5|Overall Study|Death|1
7780678|NCT00615017|27044643|P4|Overall Study|Death|0
7780679|NCT00615017|27044644|P3|Overall Study|Death|2
7780680|NCT00615017|27044645|P2|Overall Study|Death|0
7780681|NCT00615017|27044646|P1|Overall Study|Death|0
7780682|NCT00615017|27044641|P6|Overall Study|Adverse Event|1
7780683|NCT00615017|27044642|P5|Overall Study|Adverse Event|0
7780684|NCT00615017|27044643|P4|Overall Study|Adverse Event|0
7780685|NCT00615017|27044644|P3|Overall Study|Adverse Event|2
7780686|NCT00615017|27044645|P2|Overall Study|Adverse Event|1
7780687|NCT00615017|27044646|P1|Overall Study|Adverse Event|0
7780688|NCT00614991|27044804|P6|Overall Study|Adverse Event|0
7780689|NCT00614991|27044805|P5|Overall Study|Adverse Event|1
7780690|NCT00614991|27044806|P4|Overall Study|Adverse Event|0
7780691|NCT00614991|27044807|P3|Overall Study|Adverse Event|0
7780692|NCT00614991|27044808|P2|Overall Study|Adverse Event|3
7780693|NCT00614991|27044809|P1|Overall Study|Adverse Event|3
7780694|NCT00614939|27044843|P2|Overall Study|Hospitalized due to kidney transplant|0
7780695|NCT00614939|27044844|P1|Overall Study|Hospitalized due to kidney transplant|1
7780696|NCT00614939|27044843|P2|Overall Study|Poor/non-compliance|0
7780697|NCT00614939|27044844|P1|Overall Study|Poor/non-compliance|4
7780698|NCT00614939|27044843|P2|Overall Study|Death|3
7780699|NCT00614939|27044844|P1|Overall Study|Death|4
7780700|NCT00614939|27044843|P2|Overall Study|Incorrect enrollment|2
7780701|NCT00614939|27044844|P1|Overall Study|Incorrect enrollment|1
7780702|NCT00614939|27044843|P2|Overall Study|Adverse Event|5
7780703|NCT00614939|27044844|P1|Overall Study|Adverse Event|2
7780704|NCT00614939|27044843|P2|Overall Study|Study specific discontinuation criteris|16
7780705|NCT00614939|27044844|P1|Overall Study|Study specific discontinuation criteris|13
7780706|NCT00614939|27044843|P2|Overall Study|Withdrawal by Subject|17
7780707|NCT00614939|27044844|P1|Overall Study|Withdrawal by Subject|10
7780708|NCT00614926|27044878|P2|Overall Study|Adverse Event|0
7780709|NCT00614926|27044879|P1|Overall Study|Adverse Event|3
7780710|NCT00614926|27044878|P2|Overall Study|Burden of travel|0
7780711|NCT00614926|27044879|P1|Overall Study|Burden of travel|1
7780712|NCT00614874|27044892|P1|Overall Study|Withdrawal by Subject|1
7780713|NCT00614874|27044892|P1|Overall Study|Protocol Violation|1
7780714|NCT00614822|27044899|P1|Overall Study|Adverse Event|3
7780715|NCT00614744|27044908|P2|Overall Study|Incomplete for Behavior Issues|2
7780716|NCT00614744|27044909|P1|Overall Study|Incomplete for Behavior Issues|0
7780717|NCT00614744|27044908|P2|Overall Study|Lost to Follow-up|4
7780718|NCT00614744|27044909|P1|Overall Study|Lost to Follow-up|5
7780719|NCT00614614|27044935|P5|Booster Vaccination Phase|Other|1
7780720|NCT00614614|27044936|P4|Booster Vaccination Phase|Other|2
7780721|NCT00614614|27044937|P3|Booster Vaccination Phase|Other|3
7780722|NCT00614614|27044938|P2|Booster Vaccination Phase|Other|1
7780723|NCT00614614|27044939|P1|Booster Vaccination Phase|Other|0
7780724|NCT00614614|27044935|P5|Booster Vaccination Phase|Protocol Violation|0
7780725|NCT00614614|27044936|P4|Booster Vaccination Phase|Protocol Violation|3
7780726|NCT00614614|27044937|P3|Booster Vaccination Phase|Protocol Violation|2
7780727|NCT00614614|27044938|P2|Booster Vaccination Phase|Protocol Violation|0
7780728|NCT00614614|27044939|P1|Booster Vaccination Phase|Protocol Violation|0
7780729|NCT00614614|27044935|P5|Booster Vaccination Phase|Lost to Follow-up|8
7780730|NCT00614614|27044936|P4|Booster Vaccination Phase|Lost to Follow-up|10
7780731|NCT00614614|27044937|P3|Booster Vaccination Phase|Lost to Follow-up|17
7780732|NCT00614614|27044938|P2|Booster Vaccination Phase|Lost to Follow-up|5
7780733|NCT00614614|27044939|P1|Booster Vaccination Phase|Lost to Follow-up|0
7780734|NCT00614614|27044935|P5|Booster Vaccination Phase|Withdrawal by Subject|4
7780735|NCT00614614|27044936|P4|Booster Vaccination Phase|Withdrawal by Subject|3
7780736|NCT00614614|27044937|P3|Booster Vaccination Phase|Withdrawal by Subject|4
7780737|NCT00614614|27044938|P2|Booster Vaccination Phase|Withdrawal by Subject|0
7780738|NCT00614614|27044939|P1|Booster Vaccination Phase|Withdrawal by Subject|0
7780739|NCT00614614|27044935|P5|Booster Vaccination Phase|Adverse Event|0
7780740|NCT00614614|27044936|P4|Booster Vaccination Phase|Adverse Event|1
7780741|NCT00614614|27044937|P3|Booster Vaccination Phase|Adverse Event|1
7780742|NCT00614614|27044938|P2|Booster Vaccination Phase|Adverse Event|0
7780743|NCT00614614|27044939|P1|Booster Vaccination Phase|Adverse Event|0
7780744|NCT00614614|27044935|P5|Primary Vaccination Phase|Other|0
7780745|NCT00614614|27044936|P4|Primary Vaccination Phase|Other|0
7780746|NCT00614614|27044937|P3|Primary Vaccination Phase|Other|0
7780747|NCT00614614|27044938|P2|Primary Vaccination Phase|Other|0
7780748|NCT00614614|27044939|P1|Primary Vaccination Phase|Other|4
7780749|NCT00614614|27044935|P5|Primary Vaccination Phase|Protocol Violation|0
7780750|NCT00614614|27044936|P4|Primary Vaccination Phase|Protocol Violation|0
7780751|NCT00614614|27044937|P3|Primary Vaccination Phase|Protocol Violation|0
7780752|NCT00614614|27044938|P2|Primary Vaccination Phase|Protocol Violation|3
7780753|NCT00614614|27044939|P1|Primary Vaccination Phase|Protocol Violation|9
7780754|NCT00614614|27044935|P5|Primary Vaccination Phase|Lost to Follow-up|0
7780755|NCT00614614|27044936|P4|Primary Vaccination Phase|Lost to Follow-up|0
7780756|NCT00614614|27044937|P3|Primary Vaccination Phase|Lost to Follow-up|0
7780757|NCT00614614|27044938|P2|Primary Vaccination Phase|Lost to Follow-up|8
7780758|NCT00614614|27044939|P1|Primary Vaccination Phase|Lost to Follow-up|26
7780759|NCT00614614|27044935|P5|Primary Vaccination Phase|Withdrawal by Subject|0
7780760|NCT00614614|27044936|P4|Primary Vaccination Phase|Withdrawal by Subject|0
7780761|NCT00614614|27044937|P3|Primary Vaccination Phase|Withdrawal by Subject|0
7780762|NCT00614614|27044938|P2|Primary Vaccination Phase|Withdrawal by Subject|6
7780763|NCT00614614|27044939|P1|Primary Vaccination Phase|Withdrawal by Subject|45
7780764|NCT00614614|27044935|P5|Primary Vaccination Phase|Adverse Event|0
7780765|NCT00614614|27044936|P4|Primary Vaccination Phase|Adverse Event|0
7780766|NCT00614614|27044937|P3|Primary Vaccination Phase|Adverse Event|0
7780767|NCT00614614|27044938|P2|Primary Vaccination Phase|Adverse Event|0
7780768|NCT00614614|27044939|P1|Primary Vaccination Phase|Adverse Event|6
7780769|NCT00614575|27045062|P1|Overall Study|No treatment|1
7780770|NCT00614575|27045062|P1|Overall Study|Irregularly enrolled patients|23
7780771|NCT00614575|27045062|P1|Overall Study|No data were collected.|18
7780772|NCT00614575|27045062|P1|Overall Study|Physician Decision|2
7780773|NCT00614575|27045062|P1|Overall Study|Death|3
7780774|NCT00614575|27045062|P1|Overall Study|Withdrawal by Subject|6
7780775|NCT00614575|27045062|P1|Overall Study|Lack of Efficacy|14
7780776|NCT00614575|27045062|P1|Overall Study|Lost to Follow-up|55
7780777|NCT00614575|27045062|P1|Overall Study|Adverse Event|106
7780778|NCT00614523|27045073|P2|Overall Study|Administrative Decision|46
7780779|NCT00614523|27045074|P1|Overall Study|Administrative Decision|23
7780780|NCT00614523|27045073|P2|Overall Study|Disease Progression|8
7780781|NCT00614523|27045074|P1|Overall Study|Disease Progression|0
7780782|NCT00614523|27045073|P2|Overall Study|Ineligibility Determined|2
7780783|NCT00614523|27045074|P1|Overall Study|Ineligibility Determined|1
7780784|NCT00614523|27045073|P2|Overall Study|Other|11
7780785|NCT00614523|27045074|P1|Overall Study|Other|6
7780786|NCT00614523|27045073|P2|Overall Study|Withdrawal by Subject|22
7780787|NCT00614523|27045074|P1|Overall Study|Withdrawal by Subject|12
7780788|NCT00614523|27045073|P2|Overall Study|Protocol Violation|2
7780789|NCT00614523|27045074|P1|Overall Study|Protocol Violation|3
7780790|NCT00614523|27045073|P2|Overall Study|Lost to Follow-up|1
7780791|NCT00614523|27045074|P1|Overall Study|Lost to Follow-up|0
7780792|NCT00614523|27045073|P2|Overall Study|Lack of Efficacy|11
7780793|NCT00614523|27045074|P1|Overall Study|Lack of Efficacy|9
7780794|NCT00614523|27045073|P2|Overall Study|Death|8
7780795|NCT00614523|27045074|P1|Overall Study|Death|5
7780796|NCT00614523|27045073|P2|Overall Study|Adverse Event|20
7780797|NCT00614523|27045074|P1|Overall Study|Adverse Event|4
7780798|NCT00614393|27045139|P5|Overall Study|Not Treated|2
7780799|NCT00614393|27045140|P4|Overall Study|Not Treated|0
7780800|NCT00614393|27045141|P3|Overall Study|Not Treated|0
7780801|NCT00614393|27045142|P2|Overall Study|Not Treated|0
7780802|NCT00614393|27045143|P1|Overall Study|Not Treated|0
7780803|NCT00614393|27045139|P5|Overall Study|Other|2
7780804|NCT00614393|27045140|P4|Overall Study|Other|4
7780805|NCT00614393|27045141|P3|Overall Study|Other|0
7780806|NCT00614393|27045142|P2|Overall Study|Other|0
7780807|NCT00614393|27045143|P1|Overall Study|Other|4
7780808|NCT00614393|27045139|P5|Overall Study|Withdrawal by Subject|13
7780809|NCT00614393|27045140|P4|Overall Study|Withdrawal by Subject|16
7780810|NCT00614393|27045141|P3|Overall Study|Withdrawal by Subject|1
7780811|NCT00614393|27045142|P2|Overall Study|Withdrawal by Subject|1
7780812|NCT00614393|27045143|P1|Overall Study|Withdrawal by Subject|20
7780813|NCT00614393|27045139|P5|Overall Study|Terminated by Sponsor|1
7780814|NCT00614393|27045140|P4|Overall Study|Terminated by Sponsor|0
7780815|NCT00614393|27045141|P3|Overall Study|Terminated by Sponsor|0
7780816|NCT00614393|27045142|P2|Overall Study|Terminated by Sponsor|0
7780817|NCT00614393|27045143|P1|Overall Study|Terminated by Sponsor|0
7780818|NCT00614393|27045139|P5|Overall Study|Protocol Violation|0
7780819|NCT00614393|27045140|P4|Overall Study|Protocol Violation|0
7780820|NCT00614393|27045141|P3|Overall Study|Protocol Violation|0
7780821|NCT00614393|27045142|P2|Overall Study|Protocol Violation|0
7780822|NCT00614393|27045143|P1|Overall Study|Protocol Violation|1
7780823|NCT00614393|27045139|P5|Overall Study|Progressive Disease|130
7780824|NCT00614393|27045140|P4|Overall Study|Progressive Disease|138
7780825|NCT00614393|27045141|P3|Overall Study|Progressive Disease|5
7780826|NCT00614393|27045142|P2|Overall Study|Progressive Disease|5
7780827|NCT00614393|27045143|P1|Overall Study|Progressive Disease|118
7780828|NCT00614393|27045139|P5|Overall Study|Physician Decision|9
7780829|NCT00614393|27045140|P4|Overall Study|Physician Decision|8
7780830|NCT00614393|27045141|P3|Overall Study|Physician Decision|1
7780831|NCT00614393|27045142|P2|Overall Study|Physician Decision|0
7780832|NCT00614393|27045143|P1|Overall Study|Physician Decision|17
7780833|NCT00614393|27045139|P5|Overall Study|Lost to Follow-up|2
7780834|NCT00614393|27045140|P4|Overall Study|Lost to Follow-up|1
7780835|NCT00614393|27045141|P3|Overall Study|Lost to Follow-up|0
7780836|NCT00614393|27045142|P2|Overall Study|Lost to Follow-up|0
7780837|NCT00614393|27045143|P1|Overall Study|Lost to Follow-up|0
7780838|NCT00614393|27045139|P5|Overall Study|Adverse Event|21
7780839|NCT00614393|27045140|P4|Overall Study|Adverse Event|13
7780840|NCT00614393|27045141|P3|Overall Study|Adverse Event|3
7780841|NCT00614393|27045142|P2|Overall Study|Adverse Event|2
7780842|NCT00614393|27045143|P1|Overall Study|Adverse Event|20
7780843|NCT00614380|27045189|P4|Overall Study|Consent withdrawn|0
7780844|NCT00614380|27045190|P3|Overall Study|Consent withdrawn|0
7780845|NCT00614380|27045191|P2|Overall Study|Consent withdrawn|1
7780846|NCT00614380|27045192|P1|Overall Study|Consent withdrawn|3
7780847|NCT00614380|27045189|P4|Overall Study|Non compliant with the protocol|2
7780848|NCT00614380|27045190|P3|Overall Study|Non compliant with the protocol|1
7780849|NCT00614380|27045191|P2|Overall Study|Non compliant with the protocol|2
7780850|NCT00614380|27045192|P1|Overall Study|Non compliant with the protocol|12
7780851|NCT00614380|27045189|P4|Overall Study|Lost to Follow-up|0
7780852|NCT00614380|27045190|P3|Overall Study|Lost to Follow-up|0
7780853|NCT00614380|27045191|P2|Overall Study|Lost to Follow-up|1
7780854|NCT00614380|27045192|P1|Overall Study|Lost to Follow-up|6
7780855|NCT00614380|27045189|P4|Overall Study|Adverse Event|0
7780856|NCT00614380|27045190|P3|Overall Study|Adverse Event|0
7780857|NCT00614380|27045191|P2|Overall Study|Adverse Event|4
7780858|NCT00614380|27045192|P1|Overall Study|Adverse Event|14
7780859|NCT00614120|27045259|P4|Overall Study|Lost to Follow-up|4
7780860|NCT00614120|27045260|P3|Overall Study|Lost to Follow-up|3
7780861|NCT00614120|27045261|P2|Overall Study|Lost to Follow-up|2
7780862|NCT00614120|27045262|P1|Overall Study|Lost to Follow-up|1
7780863|NCT00614120|27045259|P4|Overall Study|Taken inhibition medication eg Prandin|1
7780864|NCT00614120|27045260|P3|Overall Study|Taken inhibition medication eg Prandin|1
7780865|NCT00614120|27045261|P2|Overall Study|Taken inhibition medication eg Prandin|0
7780866|NCT00614120|27045262|P1|Overall Study|Taken inhibition medication eg Prandin|0
7780867|NCT00614120|27045259|P4|Overall Study|Late syphilis, latent|0
7780868|NCT00614120|27045260|P3|Overall Study|Late syphilis, latent|0
7780869|NCT00614120|27045261|P2|Overall Study|Late syphilis, latent|0
7780870|NCT00614120|27045262|P1|Overall Study|Late syphilis, latent|1
7780871|NCT00614120|27045259|P4|Overall Study|Lack of trial product|0
7780872|NCT00614120|27045260|P3|Overall Study|Lack of trial product|2
7780873|NCT00614120|27045261|P2|Overall Study|Lack of trial product|3
7780874|NCT00614120|27045262|P1|Overall Study|Lack of trial product|3
7780875|NCT00614120|27045259|P4|Overall Study|Hypoglycaemia|1
7780876|NCT00614120|27045260|P3|Overall Study|Hypoglycaemia|0
7780877|NCT00614120|27045261|P2|Overall Study|Hypoglycaemia|0
7780878|NCT00614120|27045262|P1|Overall Study|Hypoglycaemia|0
7780879|NCT00614120|27045259|P4|Overall Study|hCG positive (not pregnant)|0
7780880|NCT00614120|27045260|P3|Overall Study|hCG positive (not pregnant)|1
7780881|NCT00614120|27045261|P2|Overall Study|hCG positive (not pregnant)|0
7780882|NCT00614120|27045262|P1|Overall Study|hCG positive (not pregnant)|0
7780883|NCT00614120|27045259|P4|Overall Study|Did not meet trial criteria|1
7780884|NCT00614120|27045260|P3|Overall Study|Did not meet trial criteria|1
7780885|NCT00614120|27045261|P2|Overall Study|Did not meet trial criteria|1
7780886|NCT00614120|27045262|P1|Overall Study|Did not meet trial criteria|0
7780887|NCT00614120|27045259|P4|Overall Study|Withdrawal by Subject|3
7780888|NCT00614120|27045260|P3|Overall Study|Withdrawal by Subject|16
7780889|NCT00614120|27045261|P2|Overall Study|Withdrawal by Subject|10
7780890|NCT00614120|27045262|P1|Overall Study|Withdrawal by Subject|9
7780891|NCT00614120|27045259|P4|Overall Study|Withdrawal criteria|0
7780892|NCT00614120|27045260|P3|Overall Study|Withdrawal criteria|0
7780893|NCT00614120|27045261|P2|Overall Study|Withdrawal criteria|0
7780894|NCT00614120|27045262|P1|Overall Study|Withdrawal criteria|1
7780895|NCT00614120|27045259|P4|Overall Study|Protocol Violation|1
7780896|NCT00614120|27045260|P3|Overall Study|Protocol Violation|3
7780897|NCT00614120|27045261|P2|Overall Study|Protocol Violation|5
7780898|NCT00614120|27045262|P1|Overall Study|Protocol Violation|2
7780899|NCT00614120|27045259|P4|Overall Study|Lack of Efficacy|2
7780900|NCT00614120|27045260|P3|Overall Study|Lack of Efficacy|2
7780901|NCT00614120|27045261|P2|Overall Study|Lack of Efficacy|3
7780902|NCT00614120|27045262|P1|Overall Study|Lack of Efficacy|3
7780903|NCT00614120|27045259|P4|Overall Study|Adverse Event|3
7780904|NCT00614120|27045260|P3|Overall Study|Adverse Event|30
7780905|NCT00614120|27045261|P2|Overall Study|Adverse Event|22
7780906|NCT00614120|27045262|P1|Overall Study|Adverse Event|9
7780907|NCT00614055|27045303|P3|Overall Study|Unclassified|2
7780908|NCT00614055|27045304|P2|Overall Study|Unclassified|4
7780909|NCT00614055|27045305|P1|Overall Study|Unclassified|1
7780910|NCT00614055|27045303|P3|Overall Study|Lack of Efficacy|2
7780911|NCT00614055|27045304|P2|Overall Study|Lack of Efficacy|0
7780912|NCT00614055|27045305|P1|Overall Study|Lack of Efficacy|0
7780913|NCT00614055|27045303|P3|Overall Study|Protocol Violation|1
7780914|NCT00614055|27045304|P2|Overall Study|Protocol Violation|2
7780915|NCT00614055|27045305|P1|Overall Study|Protocol Violation|2
7780916|NCT00614055|27045303|P3|Overall Study|Adverse Event|0
7780917|NCT00614055|27045304|P2|Overall Study|Adverse Event|0
7780918|NCT00614055|27045305|P1|Overall Study|Adverse Event|1
7780919|NCT00613951|27045352|P3|Overall Study|Unclassified|2
7780920|NCT00613951|27045353|P2|Overall Study|Unclassified|3
7780921|NCT00613951|27045354|P1|Overall Study|Unclassified|5
7780922|NCT00613951|27045352|P3|Overall Study|Protocol Violation|1
7780923|NCT00613951|27045353|P2|Overall Study|Protocol Violation|1
7780924|NCT00613951|27045354|P1|Overall Study|Protocol Violation|1
7780925|NCT00613951|27045352|P3|Overall Study|Lack of Efficacy|1
7780926|NCT00613951|27045353|P2|Overall Study|Lack of Efficacy|1
7780927|NCT00613951|27045354|P1|Overall Study|Lack of Efficacy|0
7780928|NCT00613951|27045352|P3|Overall Study|Adverse Event|1
7780929|NCT00613951|27045353|P2|Overall Study|Adverse Event|0
7780930|NCT00613951|27045354|P1|Overall Study|Adverse Event|1
7780931|NCT00613938|27045399|P4|Overall Study|Other|3
7780932|NCT00613938|27045400|P3|Overall Study|Other|1
7780933|NCT00613938|27045401|P2|Overall Study|Other|2
7780934|NCT00613938|27045402|P1|Overall Study|Other|1
7780935|NCT00613938|27045399|P4|Overall Study|Lack of Efficacy|9
7780936|NCT00613938|27045400|P3|Overall Study|Lack of Efficacy|5
7780937|NCT00613938|27045401|P2|Overall Study|Lack of Efficacy|18
7780938|NCT00613938|27045402|P1|Overall Study|Lack of Efficacy|16
7780939|NCT00613938|27045399|P4|Overall Study|Adverse Event|5
7780940|NCT00613938|27045400|P3|Overall Study|Adverse Event|8
7780941|NCT00613938|27045401|P2|Overall Study|Adverse Event|4
7780942|NCT00613938|27045402|P1|Overall Study|Adverse Event|1
7780943|NCT00613938|27045399|P4|Overall Study|Withdrawal by Subject|9
7780944|NCT00613938|27045400|P3|Overall Study|Withdrawal by Subject|9
7780945|NCT00613938|27045401|P2|Overall Study|Withdrawal by Subject|4
7780946|NCT00613938|27045402|P1|Overall Study|Withdrawal by Subject|2
7780947|NCT00613925|27045434|P2|Overall Study|1 did not tolerate outpatient biopsy|1
7780948|NCT00613925|27045435|P1|Overall Study|1 did not tolerate outpatient biopsy|0
7780949|NCT00613834|27045450|P2|Overall Study|Withdrawal by Subject|3
7780950|NCT00613834|27045451|P1|Overall Study|Withdrawal by Subject|0
7780951|NCT00613821|27045463|P2|Overall Study|Physician Decision|1
7780952|NCT00613821|27045464|P1|Overall Study|Physician Decision|1
7780953|NCT00613821|27045463|P2|Overall Study|Withdrawal by Subject|0
7780954|NCT00613821|27045464|P1|Overall Study|Withdrawal by Subject|1
7780955|NCT00613730|27045470|P1|Overall Study|Administrative decision|1
7780956|NCT00613730|27045470|P1|Overall Study|Disease progression|2
7780957|NCT00613626|27045479|P3|Overall Study|Ineligible|0
7780958|NCT00613626|27045480|P2|Overall Study|Ineligible|1
7780959|NCT00613626|27045481|P1|Overall Study|Ineligible|0
7780960|NCT00613574|27045497|P1|Overall Study|Other|1
7780961|NCT00613574|27045497|P1|Overall Study|Lost to Follow-up|2
7780962|NCT00613574|27045497|P1|Overall Study|Adverse Event|3
7780963|NCT00613509|27045509|P2|Cycle 1|Other administrative reason|1
7780964|NCT00613509|27045510|P1|Cycle 1|Other administrative reason|0
7780965|NCT00613509|27045509|P2|Cycle 1|Unacceptable Toxicity|0
7780966|NCT00613509|27045510|P1|Cycle 1|Unacceptable Toxicity|1
7780967|NCT00613509|27045509|P2|Cycle 1|Disease Progression|6
7780968|NCT00613509|27045510|P1|Cycle 1|Disease Progression|2
7780969|NCT00613509|27045509|P2|Cycle 1|Adverse Event|1
7780970|NCT00613509|27045510|P1|Cycle 1|Adverse Event|2
7780971|NCT00613366|27045556|P2|Overall Study|Withdrawal by Subject|2
7780972|NCT00613366|27045557|P1|Overall Study|Withdrawal by Subject|3
7780973|NCT00613327|27045565|P1|Overall Study|Other|47
7780974|NCT00613327|27045565|P1|Overall Study|Protocol Violation|2
7780975|NCT00613327|27045565|P1|Overall Study|Withdrawal by Subject|6
7780976|NCT00613327|27045565|P1|Overall Study|Lost to Follow-up|8
7780977|NCT00613327|27045565|P1|Overall Study|Adverse Event|38
7780978|NCT00613314|27045584|P1|Overall Study|Other reason not defined above|90
7780979|NCT00613314|27045584|P1|Overall Study|Lost to Follow-up|46
7780980|NCT00613314|27045584|P1|Overall Study|Protocol Violation|14
7780981|NCT00613314|27045584|P1|Overall Study|Adverse Event|5
7780982|NCT00613301|27045592|P1|Overall Study|Irregularly enrolled patients|12
7780983|NCT00613301|27045592|P1|Overall Study|No data was collected|53
7780984|NCT00613301|27045592|P1|Overall Study|Physician Decision|2
7780985|NCT00613301|27045592|P1|Overall Study|Lack of Efficacy|13
7780986|NCT00613301|27045592|P1|Overall Study|Death|6
7780987|NCT00613301|27045592|P1|Overall Study|Withdrawal by Subject|5
7780988|NCT00613301|27045592|P1|Overall Study|Lost to Follow-up|88
7780989|NCT00613301|27045592|P1|Overall Study|Adverse Event|49
7780990|NCT00613171|27045599|P1|Overall Study|Reason not Specified|4
7780991|NCT00613171|27045599|P1|Overall Study|Withdrawal by Subject|3
7780992|NCT00613171|27045599|P1|Overall Study|Adverse Event|7
7780993|NCT00613106|27045607|P2|Overall Study|misc|3
7780994|NCT00613106|27045608|P1|Overall Study|misc|4
7780995|NCT00613106|27045607|P2|Overall Study|Lost to Follow-up|2
7780996|NCT00613106|27045608|P1|Overall Study|Lost to Follow-up|7
7780997|NCT00613106|27045607|P2|Overall Study|Withdrawal by Subject|3
7780998|NCT00613106|27045608|P1|Overall Study|Withdrawal by Subject|6
7780999|NCT00613106|27045607|P2|Overall Study|Adverse Event|1
7781000|NCT00613106|27045608|P1|Overall Study|Adverse Event|3
7781001|NCT00613080|27045614|P1|Overall Study|Ineligible / no protocol treatment|11
7781002|NCT00613015|27045649|P6|Overall Study|Lost to Follow-up|3
7781003|NCT00613015|27045650|P5|Overall Study|Lost to Follow-up|2
7781004|NCT00613015|27045651|P4|Overall Study|Lost to Follow-up|3
7781005|NCT00613015|27045652|P3|Overall Study|Lost to Follow-up|3
7781006|NCT00613015|27045653|P2|Overall Study|Lost to Follow-up|1
7781007|NCT00613015|27045654|P1|Overall Study|Lost to Follow-up|0
7781008|NCT00612807|27045690|P2|Overall Study|Withdrawal by Subject|0
7781009|NCT00612807|27045691|P1|Overall Study|Withdrawal by Subject|2
7781010|NCT00612690|27045738|P2|Overall Study|Withdrawal by Site|0
7781011|NCT00612690|27045739|P1|Overall Study|Withdrawal by Site|11
7781012|NCT00612690|27045738|P2|Overall Study|Withdrawal by Subject|20
7781013|NCT00612690|27045739|P1|Overall Study|Withdrawal by Subject|32
7781014|NCT00612690|27045738|P2|Overall Study|Lost to Follow-up|98
7781015|NCT00612690|27045739|P1|Overall Study|Lost to Follow-up|72
7781016|NCT00612677|27045747|P1|Overall Study|study closed before treatment started|1
7781017|NCT00612586|27045755|P2|Overall Study|Randomized and Not Treated|1
7781018|NCT00612586|27045756|P1|Overall Study|Randomized and Not Treated|1
7781019|NCT00612586|27045755|P2|Overall Study|Progressive Disease|24
7781020|NCT00612586|27045756|P1|Overall Study|Progressive Disease|26
7781021|NCT00612586|27045755|P2|Overall Study|Sponsor Decision|1
7781022|NCT00612586|27045756|P1|Overall Study|Sponsor Decision|1
7781023|NCT00612586|27045755|P2|Overall Study|Physician Decision|2
7781024|NCT00612586|27045756|P1|Overall Study|Physician Decision|1
7781025|NCT00612586|27045755|P2|Overall Study|Withdrawal by Subject|9
7781026|NCT00612586|27045756|P1|Overall Study|Withdrawal by Subject|7
7781027|NCT00612586|27045755|P2|Overall Study|Entry Criteria Not Met|2
7781028|NCT00612586|27045756|P1|Overall Study|Entry Criteria Not Met|0
7781029|NCT00612586|27045755|P2|Overall Study|Death|0
7781030|NCT00612586|27045756|P1|Overall Study|Death|1
7781031|NCT00612586|27045755|P2|Overall Study|Adverse Event|2
7781032|NCT00612586|27045756|P1|Overall Study|Adverse Event|6
7781033|NCT00612534|27045832|P4|Overall Study|Other Reason|0
7781034|NCT00612534|27045833|P3|Overall Study|Other Reason|0
7781035|NCT00612534|27045834|P2|Overall Study|Other Reason|1
7781036|NCT00612534|27045835|P1|Overall Study|Other Reason|0
7781037|NCT00612534|27045832|P4|Overall Study|Lack of Efficacy|16
7781038|NCT00612534|27045833|P3|Overall Study|Lack of Efficacy|5
7781039|NCT00612534|27045834|P2|Overall Study|Lack of Efficacy|12
7781040|NCT00612534|27045835|P1|Overall Study|Lack of Efficacy|13
7781041|NCT00612534|27045832|P4|Overall Study|Adverse Event|1
7781042|NCT00612534|27045833|P3|Overall Study|Adverse Event|2
7781043|NCT00612534|27045834|P2|Overall Study|Adverse Event|4
7781044|NCT00612534|27045835|P1|Overall Study|Adverse Event|0
7781045|NCT00612508|27045847|P2|Overall Study|Withdrawal by Subject|4
7781046|NCT00612508|27045848|P1|Overall Study|Withdrawal by Subject|3
7781047|NCT00612456|27045859|P3|Overall Study|Withdrawal by Subject|0
7781048|NCT00612456|27045860|P2|Overall Study|Withdrawal by Subject|1
7781049|NCT00612456|27045861|P1|Overall Study|Withdrawal by Subject|0
7781050|NCT00612456|27045859|P3|Overall Study|Lack of Efficacy|0
7781051|NCT00612456|27045860|P2|Overall Study|Lack of Efficacy|1
7781052|NCT00612456|27045861|P1|Overall Study|Lack of Efficacy|1
7781053|NCT00612456|27045859|P3|Overall Study|Adverse Event|0
7781054|NCT00612456|27045860|P2|Overall Study|Adverse Event|0
7781055|NCT00612456|27045861|P1|Overall Study|Adverse Event|1
7781064|NCT00612313|27046045|P2|Overall Study|Lost to Follow-up|4
7781065|NCT00612313|27046046|P1|Overall Study|Lost to Follow-up|11
7781066|NCT00612313|27046045|P2|Overall Study|Withdrawal by Subject|9
7781067|NCT00612313|27046046|P1|Overall Study|Withdrawal by Subject|6
7781068|NCT00612105|27046088|P2|Period Title 3: 3-Week Taper Phase|Other|0
7781069|NCT00612105|27046089|P1|Period Title 3: 3-Week Taper Phase|Other|1
7781070|NCT00612105|27046088|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
7781071|NCT00612105|27046089|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
7781072|NCT00612105|27046088|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
7781073|NCT00612105|27046089|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
7781074|NCT00612105|27046088|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
7781075|NCT00612105|27046089|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
7781076|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Other|1
7781077|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Other|0
7781078|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
7781079|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
7781080|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
7781081|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
7781082|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
7781083|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
7781084|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
7781085|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
7781086|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
7781087|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
7781088|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
7781089|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
7781090|NCT00612105|27046088|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
7781091|NCT00612105|27046089|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
7781092|NCT00612066|27046139|P1|Overall Study|Adverse Event|1
7781093|NCT00612040|27046146|P3|Overall Study|Unclassified|5
7781094|NCT00612040|27046147|P2|Overall Study|Unclassified|2
7781095|NCT00612040|27046148|P1|Overall Study|Unclassified|2
7781096|NCT00612040|27046146|P3|Overall Study|Lack of Efficacy|0
7781097|NCT00612040|27046147|P2|Overall Study|Lack of Efficacy|1
7781098|NCT00612040|27046148|P1|Overall Study|Lack of Efficacy|2
7781099|NCT00612040|27046146|P3|Overall Study|Protocol Violation|1
7781100|NCT00612040|27046147|P2|Overall Study|Protocol Violation|2
7781101|NCT00612040|27046148|P1|Overall Study|Protocol Violation|1
7781102|NCT00612040|27046146|P3|Overall Study|Adverse Event|1
7781103|NCT00612040|27046147|P2|Overall Study|Adverse Event|2
7781104|NCT00612040|27046148|P1|Overall Study|Adverse Event|0
7781105|NCT00611975|27046194|P2|Overall Study|Pregnancy|1
7781106|NCT00611975|27046195|P1|Overall Study|Pregnancy|2
7781107|NCT00611975|27046194|P2|Overall Study|Withdrawal by Subject|7
7781108|NCT00611975|27046195|P1|Overall Study|Withdrawal by Subject|3
7781109|NCT00611923|27046223|P2|Overall Study|Withdrawal by Subject|2
7781110|NCT00611923|27046224|P1|Overall Study|Withdrawal by Subject|2
7781111|NCT00611884|27046269|P4|Overall Study|Unclassified|3
7781112|NCT00611884|27046270|P3|Overall Study|Unclassified|2
7781113|NCT00611884|27046271|P2|Overall Study|Unclassified|4
7781114|NCT00611884|27046272|P1|Overall Study|Unclassified|7
7781115|NCT00611884|27046269|P4|Overall Study|Lack of Efficacy|0
7781116|NCT00611884|27046270|P3|Overall Study|Lack of Efficacy|0
7781117|NCT00611884|27046271|P2|Overall Study|Lack of Efficacy|1
7781118|NCT00611884|27046272|P1|Overall Study|Lack of Efficacy|0
7781119|NCT00611884|27046269|P4|Overall Study|Non-Compliance|2
7781120|NCT00611884|27046270|P3|Overall Study|Non-Compliance|2
7781121|NCT00611884|27046271|P2|Overall Study|Non-Compliance|4
7781122|NCT00611884|27046272|P1|Overall Study|Non-Compliance|1
7781123|NCT00611884|27046269|P4|Overall Study|Adverse Event|1
7781124|NCT00611884|27046270|P3|Overall Study|Adverse Event|0
7781125|NCT00611884|27046271|P2|Overall Study|Adverse Event|0
7781126|NCT00611884|27046272|P1|Overall Study|Adverse Event|1
7781127|NCT00611858|27046326|P1|Overall Study|Withdrawal by Subject|2
7781128|NCT00611858|27046326|P1|Overall Study|Adverse Event|2
7781129|NCT00611806|27046338|P2|Overall Study|Lost to Follow-up|0
7781130|NCT00611806|27046339|P1|Overall Study|Lost to Follow-up|6
7781131|NCT00611806|27046338|P2|Overall Study|Adverse Event|1
7781132|NCT00611806|27046339|P1|Overall Study|Adverse Event|2
7781133|NCT00611806|27046338|P2|Overall Study|Withdrawal by Subject|2
7781134|NCT00611806|27046339|P1|Overall Study|Withdrawal by Subject|8
7781135|NCT00611767|27046353|P2|Overall Study|Physician Decision|0
7781136|NCT00611767|27046354|P1|Overall Study|Physician Decision|1
7781137|NCT00611767|27046353|P2|Overall Study|didn't like the medication|1
7781138|NCT00611767|27046354|P1|Overall Study|didn't like the medication|1
7781139|NCT00611767|27046353|P2|Overall Study|Thiopental not available|0
7781140|NCT00611767|27046354|P1|Overall Study|Thiopental not available|3
7781141|NCT00611767|27046353|P2|Overall Study|Withdrawal by Subject|1
7781142|NCT00611767|27046354|P1|Overall Study|Withdrawal by Subject|4
7781143|NCT00611715|27046516|P2|Overall Study|two patients are still on treatment|0
7781144|NCT00611715|27046517|P1|Overall Study|two patients are still on treatment|2
7781145|NCT00611715|27046516|P2|Overall Study|Death|0
7781146|NCT00611715|27046517|P1|Overall Study|Death|1
7781147|NCT00611715|27046516|P2|Overall Study|Adverse Event|1
7781148|NCT00611715|27046517|P1|Overall Study|Adverse Event|9
7781149|NCT00611715|27046516|P2|Overall Study|Withdrawal by Subject|1
7781150|NCT00611715|27046517|P1|Overall Study|Withdrawal by Subject|5
7781151|NCT00611715|27046516|P2|Overall Study|Disease Progression|4
7781152|NCT00611715|27046517|P1|Overall Study|Disease Progression|24
7781153|NCT00611559|27046537|P3|Overall Study|Protocol Violation|1
7781154|NCT00611559|27046538|P2|Overall Study|Protocol Violation|0
7781155|NCT00611559|27046539|P1|Overall Study|Protocol Violation|1
7781156|NCT00611559|27046537|P3|Overall Study|Lost to Follow-up|0
7781157|NCT00611559|27046538|P2|Overall Study|Lost to Follow-up|1
7781158|NCT00611559|27046539|P1|Overall Study|Lost to Follow-up|0
7781159|NCT00611533|27046598|P2|Second Intervention (6 Weeks)|Adverse Event|2
7781160|NCT00611533|27046599|P1|Second Intervention (6 Weeks)|Adverse Event|0
7781161|NCT00611533|27046598|P2|First Intervention (6 Weeks)|Adverse Event|1
7781162|NCT00611533|27046599|P1|First Intervention (6 Weeks)|Adverse Event|0
7781163|NCT00611533|27046598|P2|First Intervention (6 Weeks)|Never started study|1
7781164|NCT00611533|27046599|P1|First Intervention (6 Weeks)|Never started study|0
7781165|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
7781166|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
7781167|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
7781168|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
7781169|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
7781170|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
7781171|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
7781172|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
7781173|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
7781174|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
7781175|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
7781176|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
7781177|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
7781178|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
7781179|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
7781180|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
7781181|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
7781182|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
7781183|NCT00611455|27046633|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
7781184|NCT00611455|27046634|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
7781185|NCT00611455|27046635|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
7781186|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7781187|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
7781188|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7781189|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
7781190|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
7781191|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
7781192|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
7781193|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
7781194|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
7781195|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7781196|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
7781197|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7781198|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7781199|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
7781200|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7781201|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
7781202|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
7781203|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
7781204|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7781205|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
7781206|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7781207|NCT00611455|27046633|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
7781208|NCT00611455|27046634|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
7781209|NCT00611455|27046635|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
7781210|NCT00611455|27046633|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
7781211|NCT00611455|27046634|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
7781212|NCT00611455|27046635|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
7781213|NCT00611455|27046633|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
7781214|NCT00611455|27046634|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
7781215|NCT00611455|27046635|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
7781216|NCT00611455|27046633|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
7781217|NCT00611455|27046634|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
7781218|NCT00611455|27046635|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
7781219|NCT00611455|27046633|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
7781220|NCT00611455|27046634|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
7781221|NCT00611455|27046635|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
7781222|NCT00611455|27046633|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7781223|NCT00611455|27046634|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7781224|NCT00611455|27046635|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
7781225|NCT00611455|27046633|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
7781226|NCT00611455|27046634|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
7781227|NCT00611455|27046635|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
7781228|NCT00611247|27046815|P2|Overall Study|Lack of Efficacy|16
7781229|NCT00611247|27046816|P1|Overall Study|Lack of Efficacy|1
7781230|NCT00611247|27046815|P2|Overall Study|Death|5
7781231|NCT00611247|27046816|P1|Overall Study|Death|1
7781232|NCT00611130|27046828|P2|Overall Study|Death|0
7781233|NCT00611130|27046829|P1|Overall Study|Death|1
7781234|NCT00611130|27046828|P2|Overall Study|Adverse Event|0
7781235|NCT00611130|27046829|P1|Overall Study|Adverse Event|1
7781236|NCT00611130|27046828|P2|Overall Study|Administrative|1
7781237|NCT00611130|27046829|P1|Overall Study|Administrative|1
7781238|NCT00611130|27046828|P2|Overall Study|Incarceration|2
7781239|NCT00611130|27046829|P1|Overall Study|Incarceration|3
7781240|NCT00611130|27046828|P2|Overall Study|Other|4
7781241|NCT00611130|27046829|P1|Overall Study|Other|5
7781242|NCT00611130|27046828|P2|Overall Study|Withdrawal by Subject|5
7781243|NCT00611130|27046829|P1|Overall Study|Withdrawal by Subject|6
7781244|NCT00611130|27046828|P2|Overall Study|Protocol noncompliance|6
7781245|NCT00611130|27046829|P1|Overall Study|Protocol noncompliance|7
7781246|NCT00611130|27046828|P2|Overall Study|Lost to Follow-up|29
7781247|NCT00611130|27046829|P1|Overall Study|Lost to Follow-up|25
7781248|NCT00611026|27046839|P3|Double-blind Treatment Period|Other|18
7781249|NCT00611026|27046840|P2|Double-blind Treatment Period|Other|20
7781250|NCT00611026|27046841|P1|Double-blind Treatment Period|Other|13
7781251|NCT00611026|27046839|P3|Double-blind Treatment Period|Withdrawal by Subject|16
7781252|NCT00611026|27046840|P2|Double-blind Treatment Period|Withdrawal by Subject|19
7781253|NCT00611026|27046841|P1|Double-blind Treatment Period|Withdrawal by Subject|7
7781254|NCT00611026|27046839|P3|Double-blind Treatment Period|Lost to Follow-up|14
7781255|NCT00611026|27046840|P2|Double-blind Treatment Period|Lost to Follow-up|11
7781256|NCT00611026|27046841|P1|Double-blind Treatment Period|Lost to Follow-up|6
7781257|NCT00611026|27046839|P3|Double-blind Treatment Period|Lack of Efficacy|4
7781258|NCT00611026|27046840|P2|Double-blind Treatment Period|Lack of Efficacy|10
7781259|NCT00611026|27046841|P1|Double-blind Treatment Period|Lack of Efficacy|11
7781260|NCT00611026|27046839|P3|Double-blind Treatment Period|Adverse Event|46
7781261|NCT00611026|27046840|P2|Double-blind Treatment Period|Adverse Event|28
7781262|NCT00611026|27046841|P1|Double-blind Treatment Period|Adverse Event|9
7781263|NCT00611026|27046839|P3|Double-blind Treatment Period|Death|0
7781264|NCT00611026|27046840|P2|Double-blind Treatment Period|Death|0
7781265|NCT00611026|27046841|P1|Double-blind Treatment Period|Death|1
7781266|NCT00611026|27046839|P3|Randomized to Double-blind Treatment|Not treated|3
7781267|NCT00611026|27046840|P2|Randomized to Double-blind Treatment|Not treated|1
7781268|NCT00611026|27046841|P1|Randomized to Double-blind Treatment|Not treated|2
7781269|NCT00610935|27046916|P2|Overall Study|Sponsor Discontinuation|0
7781270|NCT00610935|27046917|P1|Overall Study|Sponsor Discontinuation|1
7781271|NCT00610935|27046916|P2|Overall Study|Withdrawal by Subject|2
7781272|NCT00610935|27046917|P1|Overall Study|Withdrawal by Subject|0
7781273|NCT00610935|27046916|P2|Overall Study|Lost to Follow-up|1
7781274|NCT00610935|27046917|P1|Overall Study|Lost to Follow-up|0
7781275|NCT00610857|27046929|P1|Overall Study|Not evaluable for response|2
7781276|NCT00610714|27046973|P2|Overall Study|Study completion at 120 PFS events|2
7781277|NCT00610714|27046974|P1|Overall Study|Study completion at 120 PFS events|2
7781278|NCT00610714|27046973|P2|Overall Study|Withdrawal by Subject|3
7781279|NCT00610714|27046974|P1|Overall Study|Withdrawal by Subject|9
7781280|NCT00610714|27046973|P2|Overall Study|Death|18
7781281|NCT00610714|27046974|P1|Overall Study|Death|12
7781282|NCT00610714|27046973|P2|Overall Study|Adverse Event|1
7781283|NCT00610714|27046974|P1|Overall Study|Adverse Event|3
7781284|NCT00610675|27047012|P1|Overall Study|Other reason (not specified)|25
7781285|NCT00610675|27047012|P1|Overall Study|Lost to Follow-up|31
7781286|NCT00610675|27047012|P1|Overall Study|Lack of Compliance|7
7781287|NCT00610675|27047012|P1|Overall Study|Reasons unrelated to trial|27
7781288|NCT00610675|27047012|P1|Overall Study|Withdrawal by Subject|28
7781289|NCT00610675|27047012|P1|Overall Study|Insufficient Effect|31
7781290|NCT00610675|27047012|P1|Overall Study|Adverse Event|67
7781291|NCT00610675|27047012|P1|Overall Study|Untreated|4
7781292|NCT00610649|27047034|P11|Overall Study|Withdrawal by Subject|0
7781293|NCT00610649|27047035|P10|Overall Study|Withdrawal by Subject|1
7781294|NCT00610649|27047036|P9|Overall Study|Withdrawal by Subject|0
7781295|NCT00610649|27047037|P8|Overall Study|Withdrawal by Subject|0
7781296|NCT00610649|27047038|P7|Overall Study|Withdrawal by Subject|0
7781297|NCT00610649|27047039|P6|Overall Study|Withdrawal by Subject|0
7781298|NCT00610649|27047040|P5|Overall Study|Withdrawal by Subject|0
7781299|NCT00610649|27047041|P4|Overall Study|Withdrawal by Subject|0
7781300|NCT00610649|27047042|P3|Overall Study|Withdrawal by Subject|0
7781301|NCT00610649|27047043|P2|Overall Study|Withdrawal by Subject|0
7781302|NCT00610649|27047044|P1|Overall Study|Withdrawal by Subject|0
7781303|NCT00610649|27047034|P11|Overall Study|Family Emergency|0
7781304|NCT00610649|27047035|P10|Overall Study|Family Emergency|0
7781305|NCT00610649|27047036|P9|Overall Study|Family Emergency|0
7781306|NCT00610649|27047037|P8|Overall Study|Family Emergency|0
7781307|NCT00610649|27047038|P7|Overall Study|Family Emergency|0
7781308|NCT00610649|27047039|P6|Overall Study|Family Emergency|0
7781309|NCT00610649|27047040|P5|Overall Study|Family Emergency|0
7781310|NCT00610649|27047041|P4|Overall Study|Family Emergency|0
7781311|NCT00610649|27047042|P3|Overall Study|Family Emergency|0
7781312|NCT00610649|27047043|P2|Overall Study|Family Emergency|1
7781313|NCT00610649|27047044|P1|Overall Study|Family Emergency|0
7781314|NCT00610649|27047034|P11|Overall Study|Adverse Event|1
7781315|NCT00610649|27047035|P10|Overall Study|Adverse Event|0
7781316|NCT00610649|27047036|P9|Overall Study|Adverse Event|0
7781317|NCT00610649|27047037|P8|Overall Study|Adverse Event|0
7781318|NCT00610649|27047038|P7|Overall Study|Adverse Event|0
7781319|NCT00610649|27047039|P6|Overall Study|Adverse Event|0
7781320|NCT00610649|27047040|P5|Overall Study|Adverse Event|0
7781321|NCT00610649|27047041|P4|Overall Study|Adverse Event|0
7781322|NCT00610649|27047042|P3|Overall Study|Adverse Event|0
7781323|NCT00610649|27047043|P2|Overall Study|Adverse Event|0
7781324|NCT00610649|27047044|P1|Overall Study|Adverse Event|1
7781325|NCT00610441|27047139|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7781326|NCT00610441|27047140|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7781327|NCT00610441|27047141|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7781328|NCT00610441|27047142|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
7781329|NCT00610441|27047139|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
7781330|NCT00610441|27047140|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
7781331|NCT00610441|27047141|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
7781332|NCT00610441|27047142|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
7781333|NCT00610441|27047139|P4|Treatment Period 2 - 3 Weeks|Other|1
7781334|NCT00610441|27047140|P3|Treatment Period 2 - 3 Weeks|Other|0
7781335|NCT00610441|27047141|P2|Treatment Period 2 - 3 Weeks|Other|1
7781336|NCT00610441|27047142|P1|Treatment Period 2 - 3 Weeks|Other|1
7781337|NCT00610441|27047139|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7781338|NCT00610441|27047140|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7781339|NCT00610441|27047141|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
7781340|NCT00610441|27047142|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7781341|NCT00610441|27047139|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
7781342|NCT00610441|27047140|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
7781343|NCT00610441|27047141|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
7781344|NCT00610441|27047142|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
7781345|NCT00610441|27047139|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7781346|NCT00610441|27047140|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7781347|NCT00610441|27047141|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
7781348|NCT00610441|27047142|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7781349|NCT00610441|27047139|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
7781350|NCT00610441|27047140|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7781351|NCT00610441|27047141|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7781352|NCT00610441|27047142|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7781353|NCT00610441|27047139|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7781354|NCT00610441|27047140|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
7781355|NCT00610441|27047141|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7781356|NCT00610441|27047142|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7781357|NCT00610441|27047139|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
7781358|NCT00610441|27047140|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
7781359|NCT00610441|27047141|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
7781360|NCT00610441|27047142|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
7781361|NCT00610363|27047251|P2|Overall Study|Other than specified above|1
7781362|NCT00610363|27047252|P1|Overall Study|Other than specified above|1
7781363|NCT00610363|27047251|P2|Overall Study|Withdrawal by Subject|0
7781364|NCT00610363|27047252|P1|Overall Study|Withdrawal by Subject|1
7781365|NCT00610363|27047251|P2|Overall Study|Lost to Follow-up|0
7781366|NCT00610363|27047252|P1|Overall Study|Lost to Follow-up|4
7781367|NCT00610363|27047251|P2|Overall Study|Lack of Efficacy|0
7781368|NCT00610363|27047252|P1|Overall Study|Lack of Efficacy|2
7781369|NCT00610363|27047251|P2|Overall Study|Adverse Event|1
7781370|NCT00610363|27047252|P1|Overall Study|Adverse Event|3
7781371|NCT00610363|27047251|P2|Overall Study|Non-compliance with protocol|1
7781372|NCT00610363|27047252|P1|Overall Study|Non-compliance with protocol|0
7781373|NCT00610207|27047277|P1|Overall Study|Lost to Follow-up|3
7781374|NCT00610168|27047284|P2|Overall Study|Withdrawal by Subject|0
7781375|NCT00610168|27047285|P1|Overall Study|Withdrawal by Subject|2
7781376|NCT00610155|27047304|P6|Period 3|Adverse Event|0
7781377|NCT00610155|27047305|P5|Period 3|Adverse Event|0
7781378|NCT00610155|27047306|P4|Period 3|Adverse Event|0
7781379|NCT00610155|27047307|P3|Period 3|Adverse Event|0
7781380|NCT00610155|27047308|P2|Period 3|Adverse Event|0
7781381|NCT00610155|27047309|P1|Period 3|Adverse Event|1
7781382|NCT00610155|27047304|P6|Period 1|Withdrawal by Subject|0
7781383|NCT00610155|27047305|P5|Period 1|Withdrawal by Subject|0
7781384|NCT00610155|27047306|P4|Period 1|Withdrawal by Subject|0
7781385|NCT00610155|27047307|P3|Period 1|Withdrawal by Subject|1
7781386|NCT00610155|27047308|P2|Period 1|Withdrawal by Subject|0
7781387|NCT00610155|27047309|P1|Period 1|Withdrawal by Subject|0
7781388|NCT00610129|27047356|P1|Overall Study|Not treated since patients ineligible|3
7781389|NCT00609986|27047366|P2|Overall Study|Did not receive transplant or treatment|3
7781390|NCT00609986|27047367|P1|Overall Study|Did not receive transplant or treatment|8
7781391|NCT00609973|27047381|P2|Overall Study|Withdrawal by Subject|1
7781392|NCT00609973|27047382|P1|Overall Study|Withdrawal by Subject|0
7781393|NCT00609973|27047381|P2|Overall Study|Lost to Follow-up|1
7781394|NCT00609973|27047382|P1|Overall Study|Lost to Follow-up|2
7781395|NCT00609973|27047381|P2|Overall Study|Protocol Violation|3
7781396|NCT00609973|27047382|P1|Overall Study|Protocol Violation|4
7781397|NCT00609973|27047381|P2|Overall Study|Adverse Event|1
7781398|NCT00609973|27047382|P1|Overall Study|Adverse Event|2
7781399|NCT00609947|27047390|P1|Overall Study|Death|1
7781400|NCT00609869|27047395|P1|Overall Study|Mantle cell: not evaluable|4
7781401|NCT00609869|27047395|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
7781402|NCT00609869|27047395|P1|Overall Study|Hepatitis B infection|1
7781403|NCT00609869|27047395|P1|Overall Study|Severe tumor flare reaction|1
7781404|NCT00609869|27047395|P1|Overall Study|Seizures|1
7781405|NCT00609869|27047395|P1|Overall Study|Withdrawal by Subject|1
7781406|NCT00609869|27047395|P1|Overall Study|Severe hematologic toxicity|1
7781407|NCT00609869|27047395|P1|Overall Study|Withdrawn, ischemic stroke|1
7781408|NCT00609765|27047414|P1|Overall Study|Study ended prior to 12 months|1
7781409|NCT00609674|27047428|P2|Overall Study|Withdrew consent|1
7781410|NCT00609674|27047429|P1|Overall Study|Withdrew consent|2
7781411|NCT00609674|27047428|P2|Overall Study|Lost to Follow-up|0
7781412|NCT00609674|27047429|P1|Overall Study|Lost to Follow-up|1
7781413|NCT00609674|27047428|P2|Overall Study|Protocol Violation|5
7781414|NCT00609674|27047429|P1|Overall Study|Protocol Violation|3
7781415|NCT00609674|27047428|P2|Overall Study|Adverse Event|1
7781416|NCT00609674|27047429|P1|Overall Study|Adverse Event|1
7781417|NCT00609622|27047465|P2|Overall Study|Global deterioration of health status|2
7781418|NCT00609622|27047466|P1|Overall Study|Global deterioration of health status|6
7781419|NCT00609622|27047465|P2|Overall Study|Other|14
7781420|NCT00609622|27047466|P1|Overall Study|Other|7
7781421|NCT00609622|27047465|P2|Overall Study|Study terminated by sponsor|3
7781422|NCT00609622|27047466|P1|Overall Study|Study terminated by sponsor|16
7781423|NCT00609622|27047465|P2|Overall Study|Objective progression or relapse|41
7781424|NCT00609622|27047466|P1|Overall Study|Objective progression or relapse|47
7781425|NCT00609622|27047465|P2|Overall Study|Protocol Violation|1
7781426|NCT00609622|27047466|P1|Overall Study|Protocol Violation|1
7781427|NCT00609622|27047465|P2|Overall Study|Death|4
7781428|NCT00609622|27047466|P1|Overall Study|Death|1
7781429|NCT00609622|27047465|P2|Overall Study|Withdrawal by Subject|20
7781430|NCT00609622|27047466|P1|Overall Study|Withdrawal by Subject|4
7781431|NCT00609622|27047465|P2|Overall Study|Adverse Event|10
7781432|NCT00609622|27047466|P1|Overall Study|Adverse Event|14
7781433|NCT00609609|27047488|P2|Overall Study|Progression|2
7781434|NCT00609609|27047489|P1|Overall Study|Progression|4
7781435|NCT00609609|27047488|P2|Overall Study|Withdrawal by Subject|0
7781436|NCT00609609|27047489|P1|Overall Study|Withdrawal by Subject|2
7781437|NCT00609518|27047501|P2|Overall Study|Death from Adverse Event|2
7781438|NCT00609518|27047502|P1|Overall Study|Death from Adverse Event|2
7781439|NCT00609518|27047501|P2|Overall Study|Physician Decision|3
7781440|NCT00609518|27047502|P1|Overall Study|Physician Decision|1
7781441|NCT00609518|27047501|P2|Overall Study|Lost to Follow-up|0
7781442|NCT00609518|27047502|P1|Overall Study|Lost to Follow-up|3
7781443|NCT00609518|27047501|P2|Overall Study|Withdrawal by Subject|3
7781444|NCT00609518|27047502|P1|Overall Study|Withdrawal by Subject|5
7781445|NCT00609518|27047501|P2|Overall Study|Death from Study Disease|32
7781446|NCT00609518|27047502|P1|Overall Study|Death from Study Disease|32
7781447|NCT00609492|27047517|P3|Overall Study|Lost to Follow-up|4
7781448|NCT00609492|27047518|P2|Overall Study|Lost to Follow-up|1
7781449|NCT00609492|27047519|P1|Overall Study|Lost to Follow-up|1
7781450|NCT00609492|27047517|P3|Overall Study|Withdrawal by Subject|3
7781451|NCT00609492|27047518|P2|Overall Study|Withdrawal by Subject|2
7781452|NCT00609492|27047519|P1|Overall Study|Withdrawal by Subject|0
7781453|NCT00609466|27047604|P3|Overall Study|Lack of Efficacy|2
7781454|NCT00609466|27047605|P2|Overall Study|Lack of Efficacy|2
7781455|NCT00609466|27047606|P1|Overall Study|Lack of Efficacy|0
7781456|NCT00609466|27047604|P3|Overall Study|Adverse Event|1
7781457|NCT00609466|27047605|P2|Overall Study|Adverse Event|3
7781458|NCT00609466|27047606|P1|Overall Study|Adverse Event|2
7781459|NCT00609466|27047604|P3|Overall Study|Withdrawal by Subject|1
7781460|NCT00609466|27047605|P2|Overall Study|Withdrawal by Subject|1
7781461|NCT00609466|27047606|P1|Overall Study|Withdrawal by Subject|0
7781462|NCT00609362|27047634|P2|Overall Study|Adverse Event|0
7781463|NCT00609362|27047635|P1|Overall Study|Adverse Event|1
7781464|NCT00609362|27047634|P2|Overall Study|Withdrawal by Subject|1
7781465|NCT00609362|27047635|P1|Overall Study|Withdrawal by Subject|2
7781466|NCT00609336|27047645|P1|Overall Study|LA or Met at Surgery|9
7781467|NCT00609336|27047645|P1|Overall Study|Death|1
7781468|NCT00609336|27047645|P1|Overall Study|Protocol Violation|3
7781469|NCT00609245|27047696|P1|Overall Study|Adverse Event|1
7781470|NCT00609167|27047704|P2|Overall Study|Stem Cell Transplant|6
7781471|NCT00609167|27047705|P1|Overall Study|Stem Cell Transplant|0
7781472|NCT00609167|27047704|P2|Overall Study|Disease Progression|0
7781473|NCT00609167|27047705|P1|Overall Study|Disease Progression|1
7781474|NCT00609167|27047704|P2|Overall Study|Adverse Event|1
7781475|NCT00609167|27047705|P1|Overall Study|Adverse Event|5
7781476|NCT00609167|27047704|P2|Overall Study|Lack of Efficacy|0
7781477|NCT00609167|27047705|P1|Overall Study|Lack of Efficacy|1
7781478|NCT00609167|27047704|P2|Overall Study|Withdrawal by Subject|0
7781479|NCT00609167|27047705|P1|Overall Study|Withdrawal by Subject|1
7781480|NCT00608985|27047736|P4|Overall Study|Lost to Follow-up|0
7781481|NCT00608985|27047737|P3|Overall Study|Lost to Follow-up|0
7781482|NCT00608985|27047738|P2|Overall Study|Lost to Follow-up|1
7781483|NCT00608985|27047739|P1|Overall Study|Lost to Follow-up|2
7781484|NCT00608985|27047736|P4|Overall Study|Withdrawal of Consent|1
7781485|NCT00608985|27047737|P3|Overall Study|Withdrawal of Consent|1
7781486|NCT00608985|27047738|P2|Overall Study|Withdrawal of Consent|1
7781487|NCT00608985|27047739|P1|Overall Study|Withdrawal of Consent|5
7781488|NCT00608985|27047736|P4|Overall Study|Administrative/Other|2
7781489|NCT00608985|27047737|P3|Overall Study|Administrative/Other|1
7781490|NCT00608985|27047738|P2|Overall Study|Administrative/Other|4
7781491|NCT00608985|27047739|P1|Overall Study|Administrative/Other|7
7781492|NCT00608985|27047736|P4|Overall Study|Adverse Event|6
7781493|NCT00608985|27047737|P3|Overall Study|Adverse Event|4
7781494|NCT00608985|27047738|P2|Overall Study|Adverse Event|7
7781495|NCT00608985|27047739|P1|Overall Study|Adverse Event|2
7781496|NCT00608959|27047771|P1|Part 1|Did not meet eligibility criteria|1
7781497|NCT00608907|27047784|P3|Overall Study|Progressive Disease|0
7781498|NCT00608907|27047785|P2|Overall Study|Progressive Disease|0
7781499|NCT00608907|27047786|P1|Overall Study|Progressive Disease|1
7781500|NCT00608907|27047784|P3|Overall Study|Withdrawal by Subject|0
7781501|NCT00608907|27047785|P2|Overall Study|Withdrawal by Subject|0
7781502|NCT00608907|27047786|P1|Overall Study|Withdrawal by Subject|4
7781503|NCT00608907|27047784|P3|Overall Study|Death|0
7781504|NCT00608907|27047785|P2|Overall Study|Death|0
7781505|NCT00608907|27047786|P1|Overall Study|Death|1
7781506|NCT00608907|27047784|P3|Overall Study|Adverse Event|1
7781507|NCT00608907|27047785|P2|Overall Study|Adverse Event|0
7781508|NCT00608907|27047786|P1|Overall Study|Adverse Event|6
7781509|NCT00608894|27047796|P2|Overall Study|Withdrawal by Subject|2
7781510|NCT00608894|27047797|P1|Overall Study|Withdrawal by Subject|0
7781511|NCT00608881|27047809|P2|Overall Study|Institutionalized|2
7781512|NCT00608881|27047810|P1|Overall Study|Institutionalized|1
7781513|NCT00608881|27047809|P2|Overall Study|Physician Decision|5
7781514|NCT00608881|27047810|P1|Overall Study|Physician Decision|5
7781515|NCT00608881|27047809|P2|Overall Study|Withdrawal by Subject|29
7781516|NCT00608881|27047810|P1|Overall Study|Withdrawal by Subject|18
7781517|NCT00608881|27047809|P2|Overall Study|Lost to Follow-up|14
7781518|NCT00608881|27047810|P1|Overall Study|Lost to Follow-up|28
7781519|NCT00608881|27047809|P2|Overall Study|Adverse Event|3
7781520|NCT00608881|27047810|P1|Overall Study|Adverse Event|5
7781521|NCT00608881|27047809|P2|Overall Study|Death|13
7781522|NCT00608881|27047810|P1|Overall Study|Death|22
7781523|NCT00608868|27047844|P1|Overall Study|Physician Decision|2
7781524|NCT00608868|27047844|P1|Overall Study|Adverse Event|1
7781525|NCT00608868|27047844|P1|Overall Study|Lost to Follow-up|2
7781526|NCT00608868|27047844|P1|Overall Study|Protocol Violation|3
7781527|NCT00608868|27047844|P1|Overall Study|Withdrawal by Subject|7
7781528|NCT00608842|27047855|P4|Overall Study|Lost to Follow-up|0
7781529|NCT00608842|27047856|P3|Overall Study|Lost to Follow-up|0
7781530|NCT00608842|27047857|P2|Overall Study|Lost to Follow-up|0
7781531|NCT00608842|27047858|P1|Overall Study|Lost to Follow-up|1
7781532|NCT00608842|27047855|P4|Overall Study|Participant's Request|1
7781533|NCT00608842|27047856|P3|Overall Study|Participant's Request|2
7781534|NCT00608842|27047857|P2|Overall Study|Participant's Request|1
7781535|NCT00608842|27047858|P1|Overall Study|Participant's Request|0
7781536|NCT00608829|27047892|P1|Overall Study|Subject refuses to follow up or return.|5
7781537|NCT00608829|27047892|P1|Overall Study|Withdrawal by Subject|4
7781538|NCT00608829|27047892|P1|Overall Study|Death|6
7781539|NCT00608582|27047918|P2|Overall Study|Early stage Design Change|3
7781540|NCT00608582|27047919|P1|Overall Study|Early stage Design Change|0
7781541|NCT00608582|27047918|P2|Overall Study|Illicit Drug Use|0
7781542|NCT00608582|27047919|P1|Overall Study|Illicit Drug Use|1
7781543|NCT00608582|27047918|P2|Overall Study|No Best Response in Phase 1 located|1
7781544|NCT00608582|27047919|P1|Overall Study|No Best Response in Phase 1 located|1
7781545|NCT00608582|27047918|P2|Overall Study|Lost to Follow-up|0
7781546|NCT00608582|27047919|P1|Overall Study|Lost to Follow-up|2
7781547|NCT00608569|27047929|P2|Overall Study|Unable to adhere with study requirements|1
7781548|NCT00608569|27047930|P1|Overall Study|Unable to adhere with study requirements|0
7781549|NCT00608569|27047929|P2|Overall Study|Adverse Event|0
7781550|NCT00608569|27047930|P1|Overall Study|Adverse Event|1
7781551|NCT00608569|27047929|P2|Overall Study|Withdrawal by Subject|0
7781552|NCT00608569|27047930|P1|Overall Study|Withdrawal by Subject|1
7781553|NCT00608569|27047929|P2|Overall Study|Lost to Follow-up|5
7781554|NCT00608569|27047930|P1|Overall Study|Lost to Follow-up|4
7781555|NCT00608569|27047929|P2|Overall Study|Death|3
7781556|NCT00608569|27047930|P1|Overall Study|Death|4
7781557|NCT00608543|27047950|P1|Overall Study|Adverse Event|4
7781558|NCT00608530|27047963|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7781559|NCT00608530|27047964|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
7781560|NCT00608530|27047965|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7781561|NCT00608530|27047966|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7781562|NCT00608530|27047963|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
7781563|NCT00608530|27047964|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
7781564|NCT00608530|27047965|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
7781565|NCT00608530|27047966|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
7781566|NCT00608530|27047963|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7781567|NCT00608530|27047964|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
7781568|NCT00608530|27047965|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7781569|NCT00608530|27047966|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7781570|NCT00608530|27047963|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
7781571|NCT00608530|27047964|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
7781572|NCT00608530|27047965|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
7781573|NCT00608530|27047966|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
7781574|NCT00608530|27047963|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
7781575|NCT00608530|27047964|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
7781576|NCT00608530|27047965|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
7781577|NCT00608530|27047966|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
7781578|NCT00608530|27047963|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
7781579|NCT00608530|27047964|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
7781580|NCT00608530|27047965|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
7781581|NCT00608530|27047966|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
7781582|NCT00608517|27047987|P3|Overall Study|Death|0
7781583|NCT00608517|27047988|P2|Overall Study|Death|0
7781584|NCT00608517|27047989|P1|Overall Study|Death|1
7781585|NCT00608426|27048169|P2|Overall Study|refused, health issues, wrong address|348
7781586|NCT00608426|27048170|P1|Overall Study|refused, health issues, wrong address|319
7781587|NCT00608426|27048169|P2|Overall Study|Lost to Follow-up|521
7781588|NCT00608426|27048170|P1|Overall Study|Lost to Follow-up|485
7781589|NCT00608426|27048169|P2|Overall Study|Death|36
7781590|NCT00608426|27048170|P1|Overall Study|Death|32
7781591|NCT00608322|27048182|P2|Overall Study|Death|1
7781592|NCT00608322|27048183|P1|Overall Study|Death|2
7781593|NCT00608244|27048189|P1|Overall Study|Low trough levels|1
7781594|NCT00608244|27048189|P1|Overall Study|Adverse Event|1
7781595|NCT00608205|27048200|P2|Overall Study|Patient non-compliant|1
7781596|NCT00608205|27048201|P1|Overall Study|Patient non-compliant|0
7781597|NCT00608205|27048200|P2|Overall Study|Adverse Event|2
7781598|NCT00608205|27048201|P1|Overall Study|Adverse Event|3
7781599|NCT00608023|27048385|P3|Overall Study|Unknown reason|0
7781600|NCT00608023|27048386|P2|Overall Study|Unknown reason|3
7781601|NCT00608023|27048387|P1|Overall Study|Unknown reason|0
7781602|NCT00608023|27048385|P3|Overall Study|Protocol Violation|1
7781603|NCT00608023|27048386|P2|Overall Study|Protocol Violation|3
7781604|NCT00608023|27048387|P1|Overall Study|Protocol Violation|1
7781605|NCT00608023|27048385|P3|Overall Study|Lost to Follow-up|1
7781606|NCT00608023|27048386|P2|Overall Study|Lost to Follow-up|2
7781607|NCT00608023|27048387|P1|Overall Study|Lost to Follow-up|2
7781608|NCT00608023|27048385|P3|Overall Study|Adverse Event|5
7781609|NCT00608023|27048386|P2|Overall Study|Adverse Event|4
7781610|NCT00608023|27048387|P1|Overall Study|Adverse Event|1
7781611|NCT00608023|27048385|P3|Overall Study|Withdrawal by Subject|7
7781612|NCT00608023|27048386|P2|Overall Study|Withdrawal by Subject|10
7781613|NCT00608023|27048387|P1|Overall Study|Withdrawal by Subject|8
7781614|NCT00607997|27048411|P4|Overall Study|Other without explanation|1
7781615|NCT00607997|27048412|P3|Overall Study|Other without explanation|4
7781616|NCT00607997|27048413|P2|Overall Study|Other without explanation|0
7781617|NCT00607997|27048414|P1|Overall Study|Other without explanation|2
7781618|NCT00607997|27048411|P4|Overall Study|Relapse, recurrent illness|0
7781619|NCT00607997|27048412|P3|Overall Study|Relapse, recurrent illness|2
7781620|NCT00607997|27048413|P2|Overall Study|Relapse, recurrent illness|0
7781621|NCT00607997|27048414|P1|Overall Study|Relapse, recurrent illness|4
7781622|NCT00607997|27048411|P4|Overall Study|Physician Decision|0
7781623|NCT00607997|27048412|P3|Overall Study|Physician Decision|0
7781624|NCT00607997|27048413|P2|Overall Study|Physician Decision|1
7781625|NCT00607997|27048414|P1|Overall Study|Physician Decision|4
7781626|NCT00607997|27048411|P4|Overall Study|Adverse Event|0
7781627|NCT00607997|27048412|P3|Overall Study|Adverse Event|2
7781628|NCT00607997|27048413|P2|Overall Study|Adverse Event|1
7781629|NCT00607997|27048414|P1|Overall Study|Adverse Event|3
7781630|NCT00607997|27048411|P4|Overall Study|Death|5
7781631|NCT00607997|27048412|P3|Overall Study|Death|2
7781632|NCT00607997|27048413|P2|Overall Study|Death|5
7781633|NCT00607997|27048414|P1|Overall Study|Death|8
7781634|NCT00607997|27048411|P4|Overall Study|Lack of Efficacy|10
7781635|NCT00607997|27048412|P3|Overall Study|Lack of Efficacy|14
7781636|NCT00607997|27048413|P2|Overall Study|Lack of Efficacy|20
7781637|NCT00607997|27048414|P1|Overall Study|Lack of Efficacy|6
7781638|NCT00607919|27048472|P2|Open-Label Phase|Parent/Caregiver Decision|2
7781639|NCT00607919|27048473|P1|Open-Label Phase|Parent/Caregiver Decision|1
7781640|NCT00607919|27048472|P2|Open-Label Phase|Withdrawal by Subject|2
7781641|NCT00607919|27048473|P1|Open-Label Phase|Withdrawal by Subject|2
7781642|NCT00607919|27048472|P2|Open-Label Phase|Protocol Violation|2
7781643|NCT00607919|27048473|P1|Open-Label Phase|Protocol Violation|2
7781644|NCT00607919|27048472|P2|Open-Label Phase|Lost to Follow-up|1
7781645|NCT00607919|27048473|P1|Open-Label Phase|Lost to Follow-up|4
7781646|NCT00607919|27048472|P2|Open-Label Phase|Adverse Event|5
7781647|NCT00607919|27048473|P1|Open-Label Phase|Adverse Event|1
7781648|NCT00607919|27048472|P2|Acute Phase|Withdrawal by Subject|3
7781649|NCT00607919|27048473|P1|Acute Phase|Withdrawal by Subject|3
7781650|NCT00607919|27048472|P2|Acute Phase|Protocol Violation|1
7781651|NCT00607919|27048473|P1|Acute Phase|Protocol Violation|5
7781652|NCT00607919|27048472|P2|Acute Phase|Parent/Caregiver Decision|4
7781653|NCT00607919|27048473|P1|Acute Phase|Parent/Caregiver Decision|6
7781654|NCT00607919|27048472|P2|Acute Phase|Lost to Follow-up|3
7781655|NCT00607919|27048473|P1|Acute Phase|Lost to Follow-up|9
7781656|NCT00607919|27048472|P2|Acute Phase|Lack of Efficacy|2
7781657|NCT00607919|27048473|P1|Acute Phase|Lack of Efficacy|1
7781658|NCT00607919|27048472|P2|Acute Phase|Entry Criteria Not Met|1
7781659|NCT00607919|27048473|P1|Acute Phase|Entry Criteria Not Met|1
7781660|NCT00607919|27048472|P2|Acute Phase|Adverse Event|2
7781661|NCT00607919|27048473|P1|Acute Phase|Adverse Event|9
7781662|NCT00607893|27048531|P2|Overall Study|Withdrew due to hypertensive urgency|1
7781663|NCT00607893|27048532|P1|Overall Study|Withdrew due to hypertensive urgency|1
7781664|NCT00607893|27048531|P2|Overall Study|Declined to be treated|0
7781665|NCT00607893|27048532|P1|Overall Study|Declined to be treated|1
7781666|NCT00607893|27048531|P2|Overall Study|withdrew could not tolerate CPAP|1
7781667|NCT00607893|27048532|P1|Overall Study|withdrew could not tolerate CPAP|0
7781668|NCT00607893|27048531|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
7781669|NCT00607893|27048532|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
7781670|NCT00607893|27048531|P2|Overall Study|withdrew due to loss of interest|1
7781671|NCT00607893|27048532|P1|Overall Study|withdrew due to loss of interest|0
7781672|NCT00607893|27048531|P2|Overall Study|Lost to Follow-up|0
7781673|NCT00607893|27048532|P1|Overall Study|Lost to Follow-up|4
7781674|NCT00607880|27048560|P2|Overall Study|Unable to place port due to occlusion|0
7781675|NCT00607880|27048561|P1|Overall Study|Unable to place port due to occlusion|1
7781676|NCT00607789|27048611|P2|Overall Study|Withdrawal by Subject|0
7781677|NCT00607789|27048612|P1|Overall Study|Withdrawal by Subject|1
7781678|NCT00607789|27048611|P2|Overall Study|Lost to Follow-up|5
7781679|NCT00607789|27048612|P1|Overall Study|Lost to Follow-up|0
7781680|NCT00607789|27048611|P2|Overall Study|Inadequate adherence|0
7781681|NCT00607789|27048612|P1|Overall Study|Inadequate adherence|3
7781682|NCT00607789|27048611|P2|Overall Study|Lack of Efficacy|1
7781683|NCT00607789|27048612|P1|Overall Study|Lack of Efficacy|0
7781684|NCT00607789|27048611|P2|Overall Study|Adverse Event|0
7781685|NCT00607789|27048612|P1|Overall Study|Adverse Event|3
7781686|NCT00607724|27048627|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7781687|NCT00607724|27048628|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7781688|NCT00607724|27048629|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7781689|NCT00607724|27048630|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
7781690|NCT00607724|27048631|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7781691|NCT00607724|27048632|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7781692|NCT00607724|27048633|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7781693|NCT00607724|27048627|P7|Stage 2: Expanded Cohort|Physician Decision|0
7781694|NCT00607724|27048628|P6|Stage 2: Expanded Cohort|Physician Decision|1
7781695|NCT00607724|27048629|P5|Stage 2: Expanded Cohort|Physician Decision|1
7781696|NCT00607724|27048630|P4|Stage 2: Expanded Cohort|Physician Decision|0
7781697|NCT00607724|27048631|P3|Stage 2: Expanded Cohort|Physician Decision|0
7781698|NCT00607724|27048632|P2|Stage 2: Expanded Cohort|Physician Decision|0
7781699|NCT00607724|27048633|P1|Stage 2: Expanded Cohort|Physician Decision|0
7781700|NCT00607724|27048627|P7|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
7781701|NCT00607724|27048628|P6|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
7781702|NCT00607724|27048629|P5|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
7781703|NCT00607724|27048630|P4|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
7781704|NCT00607724|27048631|P3|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7781705|NCT00607724|27048632|P2|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7781706|NCT00607724|27048633|P1|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7781707|NCT00607724|27048627|P7|Stage 2: Expanded Cohort|Adverse Event|1
7781708|NCT00607724|27048628|P6|Stage 2: Expanded Cohort|Adverse Event|0
7781709|NCT00607724|27048629|P5|Stage 2: Expanded Cohort|Adverse Event|0
7781710|NCT00607724|27048630|P4|Stage 2: Expanded Cohort|Adverse Event|0
7781711|NCT00607724|27048631|P3|Stage 2: Expanded Cohort|Adverse Event|0
7781712|NCT00607724|27048632|P2|Stage 2: Expanded Cohort|Adverse Event|0
7781713|NCT00607724|27048633|P1|Stage 2: Expanded Cohort|Adverse Event|0
7781714|NCT00607724|27048627|P7|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7781715|NCT00607724|27048628|P6|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7781716|NCT00607724|27048629|P5|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7781717|NCT00607724|27048630|P4|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7781718|NCT00607724|27048631|P3|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
7781719|NCT00607724|27048632|P2|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
7781720|NCT00607724|27048633|P1|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
7781721|NCT00607386|27048796|P1|Overall Study|Physician Decision|1
7781722|NCT00607373|27048811|P2|Follow-up Period|Withdrawal by Subject|3
7781723|NCT00607373|27048812|P1|Follow-up Period|Withdrawal by Subject|1
7781724|NCT00607373|27048811|P2|Follow-up Period|Protocol Violation|1
7781725|NCT00607373|27048812|P1|Follow-up Period|Protocol Violation|0
7781726|NCT00607373|27048811|P2|Follow-up Period|Other|1
7781727|NCT00607373|27048812|P1|Follow-up Period|Other|0
7781728|NCT00607373|27048811|P2|Treatment Period|Withdrawal by Subject|1
7781729|NCT00607373|27048812|P1|Treatment Period|Withdrawal by Subject|0
7781730|NCT00607373|27048811|P2|Treatment Period|Physician Decision|1
7781731|NCT00607373|27048812|P1|Treatment Period|Physician Decision|0
7781732|NCT00607373|27048811|P2|Treatment Period|Adverse Event|4
7781733|NCT00607373|27048812|P1|Treatment Period|Adverse Event|0
7781734|NCT00607087|27048914|P3|Period 3|Adverse Event|0
7781735|NCT00607087|27048915|P2|Period 3|Adverse Event|1
7781736|NCT00607087|27048916|P1|Period 3|Adverse Event|0
7781737|NCT00607087|27048914|P3|Period 3|Withdrawal by Subject|0
7781738|NCT00607087|27048915|P2|Period 3|Withdrawal by Subject|1
7781739|NCT00607087|27048916|P1|Period 3|Withdrawal by Subject|2
7781740|NCT00607087|27048914|P3|Period 2|Poor compliance to protocol|1
7781741|NCT00607087|27048915|P2|Period 2|Poor compliance to protocol|0
7781742|NCT00607087|27048916|P1|Period 2|Poor compliance to protocol|0
7781743|NCT00607087|27048914|P3|Period 2|Adverse Event|3
7781744|NCT00607087|27048915|P2|Period 2|Adverse Event|1
7781745|NCT00607087|27048916|P1|Period 2|Adverse Event|0
7781746|NCT00607087|27048914|P3|Period 2|Other reason|0
7781747|NCT00607087|27048915|P2|Period 2|Other reason|1
7781748|NCT00607087|27048916|P1|Period 2|Other reason|1
7781749|NCT00607087|27048914|P3|Period 2|Withdrawal by Subject|1
7781750|NCT00607087|27048915|P2|Period 2|Withdrawal by Subject|1
7781751|NCT00607087|27048916|P1|Period 2|Withdrawal by Subject|0
7781752|NCT00607087|27048914|P3|Period 1|Other reason|2
7781753|NCT00607087|27048915|P2|Period 1|Other reason|4
7781754|NCT00607087|27048916|P1|Period 1|Other reason|0
7781755|NCT00607087|27048914|P3|Period 1|Lost to Follow-up|0
7781756|NCT00607087|27048915|P2|Period 1|Lost to Follow-up|0
7781757|NCT00607087|27048916|P1|Period 1|Lost to Follow-up|1
7781758|NCT00607087|27048914|P3|Period 1|Poor compliance to protocol|0
7781759|NCT00607087|27048915|P2|Period 1|Poor compliance to protocol|0
7781760|NCT00607087|27048916|P1|Period 1|Poor compliance to protocol|1
7781761|NCT00607087|27048914|P3|Period 1|Adverse Event|0
7781762|NCT00607087|27048915|P2|Period 1|Adverse Event|0
7781763|NCT00607087|27048916|P1|Period 1|Adverse Event|3
7781764|NCT00607087|27048914|P3|Period 1|Withdrawal by Subject|3
7781765|NCT00607087|27048915|P2|Period 1|Withdrawal by Subject|2
7781766|NCT00607087|27048916|P1|Period 1|Withdrawal by Subject|7
7781767|NCT00607087|27048914|P3|Overall Study|Lost to Follow-up|0
7781768|NCT00607087|27048915|P2|Overall Study|Lost to Follow-up|0
7781769|NCT00607087|27048916|P1|Overall Study|Lost to Follow-up|1
7781770|NCT00607087|27048914|P3|Overall Study|Poor compliance to protocol|1
7781771|NCT00607087|27048915|P2|Overall Study|Poor compliance to protocol|0
7781772|NCT00607087|27048916|P1|Overall Study|Poor compliance to protocol|1
7781773|NCT00607087|27048914|P3|Overall Study|Other reason|2
7781774|NCT00607087|27048915|P2|Overall Study|Other reason|5
7781775|NCT00607087|27048916|P1|Overall Study|Other reason|1
7781776|NCT00607087|27048914|P3|Overall Study|Adverse Event|3
7781777|NCT00607087|27048915|P2|Overall Study|Adverse Event|2
7781778|NCT00607087|27048916|P1|Overall Study|Adverse Event|3
7781779|NCT00607087|27048914|P3|Overall Study|Withdrawal by Subject|4
7781780|NCT00607087|27048915|P2|Overall Study|Withdrawal by Subject|4
7781781|NCT00607087|27048916|P1|Overall Study|Withdrawal by Subject|9
7781782|NCT00607048|27048974|P6|Overall Study|Other|1
7781783|NCT00607048|27048975|P5|Overall Study|Other|0
7781784|NCT00607048|27048976|P4|Overall Study|Other|0
7781785|NCT00607048|27048977|P3|Overall Study|Other|0
7781786|NCT00607048|27048978|P2|Overall Study|Other|1
7781787|NCT00607048|27048979|P1|Overall Study|Other|1
7781788|NCT00607048|27048974|P6|Overall Study|Withdrawal by Subject|2
7781789|NCT00607048|27048975|P5|Overall Study|Withdrawal by Subject|0
7781790|NCT00607048|27048976|P4|Overall Study|Withdrawal by Subject|1
7781791|NCT00607048|27048977|P3|Overall Study|Withdrawal by Subject|0
7781792|NCT00607048|27048978|P2|Overall Study|Withdrawal by Subject|0
7781793|NCT00607048|27048979|P1|Overall Study|Withdrawal by Subject|0
7781794|NCT00607048|27048974|P6|Overall Study|Objective disease progression - relapse|2
7781795|NCT00607048|27048975|P5|Overall Study|Objective disease progression - relapse|2
7781796|NCT00607048|27048976|P4|Overall Study|Objective disease progression - relapse|2
7781797|NCT00607048|27048977|P3|Overall Study|Objective disease progression - relapse|4
7781798|NCT00607048|27048978|P2|Overall Study|Objective disease progression - relapse|2
7781799|NCT00607048|27048979|P1|Overall Study|Objective disease progression - relapse|1
7781800|NCT00607048|27048974|P6|Overall Study|Global deterioration of health|0
7781801|NCT00607048|27048975|P5|Overall Study|Global deterioration of health|0
7781802|NCT00607048|27048976|P4|Overall Study|Global deterioration of health|0
7781803|NCT00607048|27048977|P3|Overall Study|Global deterioration of health|0
7781804|NCT00607048|27048978|P2|Overall Study|Global deterioration of health|0
7781805|NCT00607048|27048979|P1|Overall Study|Global deterioration of health|1
7781806|NCT00607048|27048974|P6|Overall Study|Adverse Event|0
7781807|NCT00607048|27048975|P5|Overall Study|Adverse Event|4
7781808|NCT00607048|27048976|P4|Overall Study|Adverse Event|0
7781809|NCT00607048|27048977|P3|Overall Study|Adverse Event|0
7781810|NCT00607048|27048978|P2|Overall Study|Adverse Event|1
7781811|NCT00607048|27048979|P1|Overall Study|Adverse Event|0
7781812|NCT00607022|27049064|P3|Overall Study|Withdrawal by Subject|0
7781813|NCT00607022|27049065|P2|Overall Study|Withdrawal by Subject|0
7781814|NCT00607022|27049066|P1|Overall Study|Withdrawal by Subject|1
7781815|NCT00606931|27049083|P1|Overall Study|Withdrawal by Subject|3
7781816|NCT00606905|27049091|P2|Overall Study|Withdrew|5
7781817|NCT00606905|27049092|P1|Overall Study|Withdrew|5
7781818|NCT00606905|27049091|P2|Overall Study|Non-Index Pregnancy|4
7781819|NCT00606905|27049092|P1|Overall Study|Non-Index Pregnancy|1
7781820|NCT00606905|27049091|P2|Overall Study|No Pregnancy|6
7781821|NCT00606905|27049092|P1|Overall Study|No Pregnancy|9
7781822|NCT00606892|27049098|P2|First Intervention|Protocol Violation|4
7781823|NCT00606892|27049099|P1|First Intervention|Protocol Violation|1
7781824|NCT00606801|27049133|P2|Intervention|Protocol Violation|3
7781825|NCT00606801|27049134|P1|Intervention|Protocol Violation|3
7781826|NCT00606684|27049174|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
7781827|NCT00606684|27049175|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
7781828|NCT00606684|27049176|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
7781829|NCT00606684|27049177|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
7781830|NCT00606684|27049178|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
7781831|NCT00606684|27049179|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
7781832|NCT00606684|27049180|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
7781833|NCT00606684|27049174|P7|Double-Blind Treatment Period|Physician Decision|2
7781834|NCT00606684|27049175|P6|Double-Blind Treatment Period|Physician Decision|1
7781835|NCT00606684|27049176|P5|Double-Blind Treatment Period|Physician Decision|3
7781836|NCT00606684|27049177|P4|Double-Blind Treatment Period|Physician Decision|0
7781837|NCT00606684|27049178|P3|Double-Blind Treatment Period|Physician Decision|1
7781838|NCT00606684|27049179|P2|Double-Blind Treatment Period|Physician Decision|5
7781839|NCT00606684|27049180|P1|Double-Blind Treatment Period|Physician Decision|0
7781840|NCT00606684|27049174|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7781841|NCT00606684|27049175|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
7781842|NCT00606684|27049176|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
7781843|NCT00606684|27049177|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7781844|NCT00606684|27049178|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
7781845|NCT00606684|27049179|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7781846|NCT00606684|27049180|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
7781847|NCT00606684|27049174|P7|Double-Blind Treatment Period|Protocol Violation|4
7781848|NCT00606684|27049175|P6|Double-Blind Treatment Period|Protocol Violation|3
7781849|NCT00606684|27049176|P5|Double-Blind Treatment Period|Protocol Violation|0
7781850|NCT00606684|27049177|P4|Double-Blind Treatment Period|Protocol Violation|3
7781851|NCT00606684|27049178|P3|Double-Blind Treatment Period|Protocol Violation|5
7781852|NCT00606684|27049179|P2|Double-Blind Treatment Period|Protocol Violation|5
7781853|NCT00606684|27049180|P1|Double-Blind Treatment Period|Protocol Violation|0
7781854|NCT00606684|27049174|P7|Double-Blind Treatment Period|Lack of Efficacy|0
7781855|NCT00606684|27049175|P6|Double-Blind Treatment Period|Lack of Efficacy|0
7781856|NCT00606684|27049176|P5|Double-Blind Treatment Period|Lack of Efficacy|1
7781857|NCT00606684|27049177|P4|Double-Blind Treatment Period|Lack of Efficacy|0
7781858|NCT00606684|27049178|P3|Double-Blind Treatment Period|Lack of Efficacy|0
7781859|NCT00606684|27049179|P2|Double-Blind Treatment Period|Lack of Efficacy|1
7781860|NCT00606684|27049180|P1|Double-Blind Treatment Period|Lack of Efficacy|0
7781861|NCT00606684|27049174|P7|Double-Blind Treatment Period|Adverse Event|1
7781862|NCT00606684|27049175|P6|Double-Blind Treatment Period|Adverse Event|0
7781863|NCT00606684|27049176|P5|Double-Blind Treatment Period|Adverse Event|2
7781864|NCT00606684|27049177|P4|Double-Blind Treatment Period|Adverse Event|4
7781865|NCT00606684|27049178|P3|Double-Blind Treatment Period|Adverse Event|2
7781866|NCT00606684|27049179|P2|Double-Blind Treatment Period|Adverse Event|3
7781867|NCT00606684|27049180|P1|Double-Blind Treatment Period|Adverse Event|0
7781868|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7781869|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7781870|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7781871|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7781872|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7781873|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7781874|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
7781875|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Adverse Event|0
7781876|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Adverse Event|0
7781877|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Adverse Event|0
7781878|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Adverse Event|0
7781879|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Adverse Event|0
7781880|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Adverse Event|0
7781881|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Adverse Event|2
7781882|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7781883|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7781884|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7781885|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7781886|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7781887|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7781888|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
7781889|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7781890|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7781891|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7781892|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7781893|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7781894|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7781895|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
7781896|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Physician Decision|0
7781897|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Physician Decision|0
7781898|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Physician Decision|0
7781899|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Physician Decision|0
7781900|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Physician Decision|0
7781901|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Physician Decision|0
7781902|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Physician Decision|18
7781903|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7781904|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7781905|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7781906|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7781907|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7781908|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7781909|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
7781910|NCT00606684|27049174|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7781911|NCT00606684|27049175|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7781912|NCT00606684|27049176|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7781913|NCT00606684|27049177|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7781914|NCT00606684|27049178|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7781915|NCT00606684|27049179|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7781916|NCT00606684|27049180|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
7781917|NCT00606632|27049212|P1|Overall Study|Miscellaneous reasons|9
7781918|NCT00606632|27049212|P1|Overall Study|Withdrawal by Subject|13
7781919|NCT00606593|27049225|P10|Overall Study|Administrative/Other|0
7781920|NCT00606593|27049226|P9|Overall Study|Administrative/Other|0
7781921|NCT00606593|27049227|P8|Overall Study|Administrative/Other|0
7781922|NCT00606593|27049228|P7|Overall Study|Administrative/Other|0
7781923|NCT00606593|27049229|P6|Overall Study|Administrative/Other|0
7781924|NCT00606593|27049230|P5|Overall Study|Administrative/Other|0
7781925|NCT00606593|27049231|P4|Overall Study|Administrative/Other|0
7781926|NCT00606593|27049232|P3|Overall Study|Administrative/Other|1
7781927|NCT00606593|27049233|P2|Overall Study|Administrative/Other|0
7781928|NCT00606593|27049234|P1|Overall Study|Administrative/Other|0
7781929|NCT00606593|27049225|P10|Overall Study|Withdrawal of consent|0
7781930|NCT00606593|27049226|P9|Overall Study|Withdrawal of consent|0
7781931|NCT00606593|27049227|P8|Overall Study|Withdrawal of consent|0
7781932|NCT00606593|27049228|P7|Overall Study|Withdrawal of consent|0
7781933|NCT00606593|27049229|P6|Overall Study|Withdrawal of consent|0
7781934|NCT00606593|27049230|P5|Overall Study|Withdrawal of consent|0
7781935|NCT00606593|27049231|P4|Overall Study|Withdrawal of consent|0
7781936|NCT00606593|27049232|P3|Overall Study|Withdrawal of consent|1
7781937|NCT00606593|27049233|P2|Overall Study|Withdrawal of consent|0
7781938|NCT00606593|27049234|P1|Overall Study|Withdrawal of consent|1
7781939|NCT00606593|27049225|P10|Overall Study|Adverse Event|0
7781940|NCT00606593|27049226|P9|Overall Study|Adverse Event|1
7781941|NCT00606593|27049227|P8|Overall Study|Adverse Event|2
7781942|NCT00606593|27049228|P7|Overall Study|Adverse Event|1
7781943|NCT00606593|27049229|P6|Overall Study|Adverse Event|0
7781944|NCT00606593|27049230|P5|Overall Study|Adverse Event|1
7781945|NCT00606593|27049231|P4|Overall Study|Adverse Event|1
7781946|NCT00606593|27049232|P3|Overall Study|Adverse Event|0
7781947|NCT00606593|27049233|P2|Overall Study|Adverse Event|0
7781948|NCT00606593|27049234|P1|Overall Study|Adverse Event|0
7781949|NCT00606580|27049255|P3|Overall Study|Withdrawal by Subject|0
7781950|NCT00606580|27049256|P2|Overall Study|Withdrawal by Subject|1
7781951|NCT00606580|27049257|P1|Overall Study|Withdrawal by Subject|0
7781952|NCT00606580|27049255|P3|Overall Study|Withdrawal by investigator|6
7781953|NCT00606580|27049256|P2|Overall Study|Withdrawal by investigator|1
7781954|NCT00606580|27049257|P1|Overall Study|Withdrawal by investigator|0
7781955|NCT00606580|27049255|P3|Overall Study|Clinical failures|12
7781956|NCT00606580|27049256|P2|Overall Study|Clinical failures|0
7781957|NCT00606580|27049257|P1|Overall Study|Clinical failures|1
7781958|NCT00606580|27049255|P3|Overall Study|Lost to Follow-up|4
7781959|NCT00606580|27049256|P2|Overall Study|Lost to Follow-up|1
7781960|NCT00606580|27049257|P1|Overall Study|Lost to Follow-up|1
7781961|NCT00606502|27049323|P2|Treatment|Treatment ongoing at time of data cutoff|3
7781962|NCT00606502|27049324|P1|Treatment|Treatment ongoing at time of data cutoff|0
7781963|NCT00606502|27049323|P2|Randomization|Randomized but not treated|0
7781964|NCT00606502|27049324|P1|Randomization|Randomized but not treated|3
7781965|NCT00606320|27049345|P1|Overall Study|Progression to depressive phase|4
7781966|NCT00606320|27049345|P1|Overall Study|Withdrawal by Subject|10
7781967|NCT00606320|27049345|P1|Overall Study|Protocol Violation|8
7781968|NCT00606320|27049345|P1|Overall Study|Physician Decision|7
7781969|NCT00606320|27049345|P1|Overall Study|Lack of Efficacy|5
7781970|NCT00606320|27049345|P1|Overall Study|Adverse Event|3
7781971|NCT00606307|27049350|P1|Overall Study|QTc prolongation|1
7781972|NCT00606307|27049350|P1|Overall Study|Disease progression|6
7781973|NCT00606307|27049350|P1|Overall Study|Withdrawal by Subject|2
7781974|NCT00606307|27049350|P1|Overall Study|Adverse Event|2
7781975|NCT00606294|27049358|P2|Overall Study|Withdrawal by Subject|0
7781976|NCT00606294|27049359|P1|Overall Study|Withdrawal by Subject|36
7781977|NCT00606281|27049373|P2|Overall Study|Change of residence or other commitments|1
7781978|NCT00606281|27049374|P1|Overall Study|Change of residence or other commitments|1
7781979|NCT00606281|27049373|P2|Overall Study|Progression to depressive phase|1
7781980|NCT00606281|27049374|P1|Overall Study|Progression to depressive phase|1
7781981|NCT00606281|27049373|P2|Overall Study|Withdrawal by Subject|13
7781982|NCT00606281|27049374|P1|Overall Study|Withdrawal by Subject|11
7781983|NCT00606281|27049373|P2|Overall Study|Protocol Violation|3
7781984|NCT00606281|27049374|P1|Overall Study|Protocol Violation|3
7781985|NCT00606281|27049373|P2|Overall Study|Physician Decision|1
7781986|NCT00606281|27049374|P1|Overall Study|Physician Decision|0
7781987|NCT00606281|27049373|P2|Overall Study|Lack of Efficacy|35
7781988|NCT00606281|27049374|P1|Overall Study|Lack of Efficacy|28
7781989|NCT00606281|27049373|P2|Overall Study|Death|0
7781990|NCT00606281|27049374|P1|Overall Study|Death|1
7781991|NCT00606281|27049373|P2|Overall Study|Adverse Event|12
7781992|NCT00606281|27049374|P1|Overall Study|Adverse Event|11
7781993|NCT00606229|27049382|P1|Overall Study|change of residence or other commitments|2
7781994|NCT00606229|27049382|P1|Overall Study|does not meet inclusion criterion 1-3|4
7781995|NCT00606229|27049382|P1|Overall Study|Withdrawal by Subject|4
7781996|NCT00606229|27049382|P1|Overall Study|Lack of Efficacy|1
7781997|NCT00606229|27049382|P1|Overall Study|Adverse Event|11
7781998|NCT00606177|27049389|P2|Overall Study|Change of residence or other commitments|1
7781999|NCT00606177|27049390|P1|Overall Study|Change of residence or other commitments|1
7782000|NCT00606177|27049389|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
7782001|NCT00606177|27049390|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
7782002|NCT00606177|27049389|P2|Overall Study|Progression to depressive phase|1
7782003|NCT00606177|27049390|P1|Overall Study|Progression to depressive phase|6
7782004|NCT00606177|27049389|P2|Overall Study|Withdrawal by Subject|6
7782005|NCT00606177|27049390|P1|Overall Study|Withdrawal by Subject|5
7782006|NCT00606177|27049389|P2|Overall Study|Protocol Violation|4
7782007|NCT00606177|27049390|P1|Overall Study|Protocol Violation|1
7782008|NCT00606177|27049389|P2|Overall Study|Physician Decision|0
7782009|NCT00606177|27049390|P1|Overall Study|Physician Decision|1
7782010|NCT00606177|27049389|P2|Overall Study|Lack of Efficacy|7
7782011|NCT00606177|27049390|P1|Overall Study|Lack of Efficacy|3
7782012|NCT00606177|27049389|P2|Overall Study|Adverse Event|5
7782013|NCT00606177|27049390|P1|Overall Study|Adverse Event|9
7782014|NCT00606086|27049417|P2|Overall Study|Randomized, not treated|2
7782015|NCT00606086|27049418|P1|Overall Study|Randomized, not treated|1
7782016|NCT00606086|27049417|P2|Overall Study|Non-compliance|1
7782017|NCT00606086|27049418|P1|Overall Study|Non-compliance|0
7782018|NCT00606086|27049417|P2|Overall Study|Withdrawal by Subject|3
7782019|NCT00606086|27049418|P1|Overall Study|Withdrawal by Subject|5
7782020|NCT00606086|27049417|P2|Overall Study|Protocol Violation|0
7782021|NCT00606086|27049418|P1|Overall Study|Protocol Violation|1
7782022|NCT00606086|27049417|P2|Overall Study|Lost to Follow-up|8
7782023|NCT00606086|27049418|P1|Overall Study|Lost to Follow-up|4
7782024|NCT00606086|27049417|P2|Overall Study|Adverse Event|1
7782025|NCT00606086|27049418|P1|Overall Study|Adverse Event|1
7782026|NCT00606034|27049428|P1|Overall Study|incarceration|1
7782027|NCT00606021|27049436|P3|Maintenance Phase|Lost to Follow-up|2
7782028|NCT00606021|27049437|P2|Maintenance Phase|Lost to Follow-up|5
7782029|NCT00606021|27049438|P1|Maintenance Phase|Lost to Follow-up|0
7782030|NCT00606021|27049436|P3|Maintenance Phase|Physician Decision|0
7782031|NCT00606021|27049437|P2|Maintenance Phase|Physician Decision|1
7782032|NCT00606021|27049438|P1|Maintenance Phase|Physician Decision|0
7782033|NCT00606021|27049436|P3|Maintenance Phase|Death|15
7782034|NCT00606021|27049437|P2|Maintenance Phase|Death|17
7782035|NCT00606021|27049438|P1|Maintenance Phase|Death|0
7782036|NCT00606021|27049436|P3|Induction Phase|Lost to Follow-up|0
7782037|NCT00606021|27049437|P2|Induction Phase|Lost to Follow-up|0
7782038|NCT00606021|27049438|P1|Induction Phase|Lost to Follow-up|10
7782039|NCT00606021|27049436|P3|Induction Phase|Withdrawal by Subject|0
7782040|NCT00606021|27049437|P2|Induction Phase|Withdrawal by Subject|0
7782041|NCT00606021|27049438|P1|Induction Phase|Withdrawal by Subject|2
7782042|NCT00606021|27049436|P3|Induction Phase|Physician Decision|0
7782043|NCT00606021|27049437|P2|Induction Phase|Physician Decision|0
7782044|NCT00606021|27049438|P1|Induction Phase|Physician Decision|2
7782045|NCT00606021|27049436|P3|Induction Phase|Death|0
7782046|NCT00606021|27049437|P2|Induction Phase|Death|0
7782047|NCT00606021|27049438|P1|Induction Phase|Death|73
7782048|NCT00606008|27049456|P1|Overall Study|Withdrawal by Subject|4
7782049|NCT00606008|27049456|P1|Overall Study|Adverse Event|1
7782050|NCT00605917|27049470|P1|Overall Study|Protocol Violation|79
7782051|NCT00605865|27049522|P1|Overall Study|Protocol Violation|115
7782052|NCT00605839|27049564|P3|Overall Study|Protocol Violation|0
7782053|NCT00605839|27049565|P2|Overall Study|Protocol Violation|0
7782054|NCT00605839|27049566|P1|Overall Study|Protocol Violation|1
7782055|NCT00605813|27049589|P1|Overall Study|Protocol Violation|25
7782056|NCT00605722|27049602|P1|Overall Study|Failure to return|1
7782057|NCT00605722|27049602|P1|Overall Study|Insufficient therapeutic response|44
7782058|NCT00605722|27049602|P1|Overall Study|Adverse Event|6
7782059|NCT00605657|27049623|P1|Overall Study|Protocol Violation|1
7782060|NCT00605657|27049623|P1|Overall Study|Adverse Event|1
7782061|NCT00605566|27049649|P1|Overall Study|Poor compliance in run-in period|1
7782062|NCT00605566|27049649|P1|Overall Study|Clinical deterioration|1
7782063|NCT00605566|27049649|P1|Overall Study|Adverse Event|1
7782064|NCT00605540|27049657|P1|Overall Study|Lost to Follow-up|23
7782065|NCT00605540|27049657|P1|Overall Study|Death|15
7782066|NCT00605475|27049675|P10|Overall Study|Withdrawal by Subject|1
7782067|NCT00605475|27049676|P9|Overall Study|Withdrawal by Subject|0
7782068|NCT00605475|27049677|P8|Overall Study|Withdrawal by Subject|0
7782069|NCT00605475|27049678|P7|Overall Study|Withdrawal by Subject|0
7782070|NCT00605475|27049679|P6|Overall Study|Withdrawal by Subject|2
7782071|NCT00605475|27049680|P5|Overall Study|Withdrawal by Subject|0
7782072|NCT00605475|27049681|P4|Overall Study|Withdrawal by Subject|0
7782073|NCT00605475|27049682|P3|Overall Study|Withdrawal by Subject|0
7782074|NCT00605475|27049683|P2|Overall Study|Withdrawal by Subject|0
7782075|NCT00605475|27049684|P1|Overall Study|Withdrawal by Subject|0
7782076|NCT00605475|27049675|P10|Overall Study|Protocol Violation|0
7782077|NCT00605475|27049676|P9|Overall Study|Protocol Violation|0
7782078|NCT00605475|27049677|P8|Overall Study|Protocol Violation|0
7782079|NCT00605475|27049678|P7|Overall Study|Protocol Violation|0
7782080|NCT00605475|27049679|P6|Overall Study|Protocol Violation|0
7782081|NCT00605475|27049680|P5|Overall Study|Protocol Violation|1
7782082|NCT00605475|27049681|P4|Overall Study|Protocol Violation|0
7782083|NCT00605475|27049682|P3|Overall Study|Protocol Violation|0
7782084|NCT00605475|27049683|P2|Overall Study|Protocol Violation|0
7782085|NCT00605475|27049684|P1|Overall Study|Protocol Violation|0
7782086|NCT00605475|27049675|P10|Overall Study|Lost to Follow-up|1
7782087|NCT00605475|27049676|P9|Overall Study|Lost to Follow-up|1
7782088|NCT00605475|27049677|P8|Overall Study|Lost to Follow-up|0
7782089|NCT00605475|27049678|P7|Overall Study|Lost to Follow-up|0
7782090|NCT00605475|27049679|P6|Overall Study|Lost to Follow-up|0
7782091|NCT00605475|27049680|P5|Overall Study|Lost to Follow-up|0
7782092|NCT00605475|27049681|P4|Overall Study|Lost to Follow-up|0
7782093|NCT00605475|27049682|P3|Overall Study|Lost to Follow-up|0
7782094|NCT00605475|27049683|P2|Overall Study|Lost to Follow-up|0
7782095|NCT00605475|27049684|P1|Overall Study|Lost to Follow-up|0
7782096|NCT00605475|27049675|P10|Overall Study|Administrative problems|0
7782097|NCT00605475|27049676|P9|Overall Study|Administrative problems|0
7782098|NCT00605475|27049677|P8|Overall Study|Administrative problems|0
7782099|NCT00605475|27049678|P7|Overall Study|Administrative problems|1
7782100|NCT00605475|27049679|P6|Overall Study|Administrative problems|0
7782101|NCT00605475|27049680|P5|Overall Study|Administrative problems|0
7782102|NCT00605475|27049681|P4|Overall Study|Administrative problems|0
7782103|NCT00605475|27049682|P3|Overall Study|Administrative problems|0
7782104|NCT00605475|27049683|P2|Overall Study|Administrative problems|0
7782105|NCT00605475|27049684|P1|Overall Study|Administrative problems|0
7782106|NCT00605475|27049675|P10|Overall Study|Abnormal Laboratory Values|0
7782107|NCT00605475|27049676|P9|Overall Study|Abnormal Laboratory Values|1
7782108|NCT00605475|27049677|P8|Overall Study|Abnormal Laboratory Values|0
7782109|NCT00605475|27049678|P7|Overall Study|Abnormal Laboratory Values|0
7782110|NCT00605475|27049679|P6|Overall Study|Abnormal Laboratory Values|0
7782111|NCT00605475|27049680|P5|Overall Study|Abnormal Laboratory Values|0
7782112|NCT00605475|27049681|P4|Overall Study|Abnormal Laboratory Values|0
7782113|NCT00605475|27049682|P3|Overall Study|Abnormal Laboratory Values|0
7782114|NCT00605475|27049683|P2|Overall Study|Abnormal Laboratory Values|0
7782115|NCT00605475|27049684|P1|Overall Study|Abnormal Laboratory Values|0
7782116|NCT00605345|27049861|P2|Overall Study|Protocol Violation|2
7782117|NCT00605345|27049862|P1|Overall Study|Protocol Violation|0
7782118|NCT00605345|27049861|P2|Overall Study|Adverse Event|1
7782119|NCT00605345|27049862|P1|Overall Study|Adverse Event|0
7782120|NCT00605345|27049861|P2|Overall Study|Withdrawal by Subject|0
7782121|NCT00605345|27049862|P1|Overall Study|Withdrawal by Subject|1
7782122|NCT00605319|27049878|P1|Overall Study|Adverse Event|6
7782123|NCT00605306|27049890|P2|Overall Study|Adverse Event|1
7782124|NCT00605306|27049891|P1|Overall Study|Adverse Event|0
7782125|NCT00605293|27049905|P2|Overall Study|Principal Investigator Decision|1
7782126|NCT00605293|27049906|P1|Overall Study|Principal Investigator Decision|0
7782127|NCT00605293|27049905|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
7782128|NCT00605293|27049906|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
7782129|NCT00605293|27049905|P2|Overall Study|Incorrect Epoetin Beta Administration|0
7782130|NCT00605293|27049906|P1|Overall Study|Incorrect Epoetin Beta Administration|1
7782131|NCT00605293|27049905|P2|Overall Study|Renal Transplantation|1
7782132|NCT00605293|27049906|P1|Overall Study|Renal Transplantation|3
7782133|NCT00605293|27049905|P2|Overall Study|Blood Transfusion|1
7782134|NCT00605293|27049906|P1|Overall Study|Blood Transfusion|7
7782135|NCT00605293|27049905|P2|Overall Study|Holidays Dialysis Out|0
7782136|NCT00605293|27049906|P1|Overall Study|Holidays Dialysis Out|1
7782137|NCT00605293|27049905|P2|Overall Study|Adverse Event|0
7782138|NCT00605293|27049906|P1|Overall Study|Adverse Event|1
7782139|NCT00605293|27049905|P2|Overall Study|Insufficient Therapeutic Response|0
7782140|NCT00605293|27049906|P1|Overall Study|Insufficient Therapeutic Response|2
7782141|NCT00605293|27049905|P2|Overall Study|Death|1
7782142|NCT00605293|27049906|P1|Overall Study|Death|2
7782143|NCT00605280|27049926|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7782144|NCT00605280|27049927|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7782145|NCT00605280|27049928|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7782146|NCT00605280|27049929|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
7782147|NCT00605280|27049926|P4|Year 3 Extension|Other|0
7782148|NCT00605280|27049927|P3|Year 3 Extension|Other|0
7782149|NCT00605280|27049928|P2|Year 3 Extension|Other|0
7782150|NCT00605280|27049929|P1|Year 3 Extension|Other|2
7782151|NCT00605280|27049926|P4|Year 3 Extension|Withdrawal by Subject|5
7782152|NCT00605280|27049927|P3|Year 3 Extension|Withdrawal by Subject|0
7782153|NCT00605280|27049928|P2|Year 3 Extension|Withdrawal by Subject|0
7782154|NCT00605280|27049929|P1|Year 3 Extension|Withdrawal by Subject|2
7782155|NCT00605280|27049926|P4|Year 3 Extension|Physician Decision|2
7782156|NCT00605280|27049927|P3|Year 3 Extension|Physician Decision|0
7782157|NCT00605280|27049928|P2|Year 3 Extension|Physician Decision|0
7782158|NCT00605280|27049929|P1|Year 3 Extension|Physician Decision|0
7782159|NCT00605280|27049926|P4|Year 3 Extension|Adverse Event|2
7782160|NCT00605280|27049927|P3|Year 3 Extension|Adverse Event|0
7782161|NCT00605280|27049928|P2|Year 3 Extension|Adverse Event|0
7782162|NCT00605280|27049929|P1|Year 3 Extension|Adverse Event|2
7782163|NCT00605280|27049926|P4|Year 2|Lost to Follow-up or Patient non-comply|2
7782164|NCT00605280|27049927|P3|Year 2|Lost to Follow-up or Patient non-comply|0
7782165|NCT00605280|27049928|P2|Year 2|Lost to Follow-up or Patient non-comply|0
7782166|NCT00605280|27049929|P1|Year 2|Lost to Follow-up or Patient non-comply|4
7782167|NCT00605280|27049926|P4|Year 2|Other|1
7782168|NCT00605280|27049927|P3|Year 2|Other|0
7782169|NCT00605280|27049928|P2|Year 2|Other|0
7782170|NCT00605280|27049929|P1|Year 2|Other|1
7782171|NCT00605280|27049926|P4|Year 2|Withdrawal by Subject|4
7782172|NCT00605280|27049927|P3|Year 2|Withdrawal by Subject|0
7782173|NCT00605280|27049928|P2|Year 2|Withdrawal by Subject|0
7782174|NCT00605280|27049929|P1|Year 2|Withdrawal by Subject|4
7782175|NCT00605280|27049926|P4|Year 2|Physician Decision|11
7782176|NCT00605280|27049927|P3|Year 2|Physician Decision|4
7782177|NCT00605280|27049928|P2|Year 2|Physician Decision|6
7782178|NCT00605280|27049929|P1|Year 2|Physician Decision|11
7782179|NCT00605280|27049926|P4|Year 2|Adverse Event|4
7782180|NCT00605280|27049927|P3|Year 2|Adverse Event|2
7782181|NCT00605280|27049928|P2|Year 2|Adverse Event|0
7782182|NCT00605280|27049929|P1|Year 2|Adverse Event|4
7782183|NCT00605280|27049926|P4|Year 1|Lost to Follow-up or Patient non-comply|2
7782184|NCT00605280|27049927|P3|Year 1|Lost to Follow-up or Patient non-comply|0
7782185|NCT00605280|27049928|P2|Year 1|Lost to Follow-up or Patient non-comply|1
7782186|NCT00605280|27049929|P1|Year 1|Lost to Follow-up or Patient non-comply|5
7782187|NCT00605280|27049926|P4|Year 1|Other|1
7782188|NCT00605280|27049927|P3|Year 1|Other|0
7782189|NCT00605280|27049928|P2|Year 1|Other|1
7782190|NCT00605280|27049929|P1|Year 1|Other|2
7782191|NCT00605280|27049926|P4|Year 1|Withdrawal by Subject|4
7782192|NCT00605280|27049927|P3|Year 1|Withdrawal by Subject|0
7782193|NCT00605280|27049928|P2|Year 1|Withdrawal by Subject|4
7782194|NCT00605280|27049929|P1|Year 1|Withdrawal by Subject|2
7782195|NCT00605280|27049926|P4|Year 1|Physician Decision|6
7782196|NCT00605280|27049927|P3|Year 1|Physician Decision|0
7782197|NCT00605280|27049928|P2|Year 1|Physician Decision|4
7782198|NCT00605280|27049929|P1|Year 1|Physician Decision|7
7782199|NCT00605280|27049926|P4|Year 1|Adverse Event|5
7782200|NCT00605280|27049927|P3|Year 1|Adverse Event|1
7782201|NCT00605280|27049928|P2|Year 1|Adverse Event|1
7782202|NCT00605280|27049929|P1|Year 1|Adverse Event|3
7782203|NCT00605280|27049926|P4|Year 1|Protocol Violation|1
7782204|NCT00605280|27049927|P3|Year 1|Protocol Violation|0
7782205|NCT00605280|27049928|P2|Year 1|Protocol Violation|0
7782206|NCT00605280|27049929|P1|Year 1|Protocol Violation|0
7782207|NCT00605267|27049963|P2|Overall Study|Withdrawal by Subject|3
7782208|NCT00605267|27049964|P1|Overall Study|Withdrawal by Subject|2
7782209|NCT00605267|27049963|P2|Overall Study|Lack of Efficacy|5
7782210|NCT00605267|27049964|P1|Overall Study|Lack of Efficacy|1
7782211|NCT00605267|27049963|P2|Overall Study|Adverse Event|1
7782212|NCT00605267|27049964|P1|Overall Study|Adverse Event|0
7782213|NCT00605189|27050012|P3|Overall Study|Other|0
7782214|NCT00605189|27050013|P2|Overall Study|Other|2
7782215|NCT00605189|27050014|P1|Overall Study|Other|2
7782216|NCT00605189|27050012|P3|Overall Study|Adverse Event|0
7782217|NCT00605189|27050013|P2|Overall Study|Adverse Event|0
7782218|NCT00605189|27050014|P1|Overall Study|Adverse Event|1
7782219|NCT00605176|27050025|P3|Overall Study|Other (not due to AE)|0
7782220|NCT00605176|27050026|P2|Overall Study|Other (not due to AE)|1
7782221|NCT00605176|27050027|P1|Overall Study|Other (not due to AE)|1
7782222|NCT00605176|27050025|P3|Overall Study|Use of concomitant therapy|1
7782223|NCT00605176|27050026|P2|Overall Study|Use of concomitant therapy|0
7782224|NCT00605176|27050027|P1|Overall Study|Use of concomitant therapy|1
7782225|NCT00605176|27050025|P3|Overall Study|Non-complicance with study procedures|0
7782226|NCT00605176|27050026|P2|Overall Study|Non-complicance with study procedures|0
7782227|NCT00605176|27050027|P1|Overall Study|Non-complicance with study procedures|1
7782228|NCT00605176|27050025|P3|Overall Study|Lost to Follow-up|1
7782229|NCT00605176|27050026|P2|Overall Study|Lost to Follow-up|2
7782230|NCT00605176|27050027|P1|Overall Study|Lost to Follow-up|2
7782231|NCT00605176|27050025|P3|Overall Study|Withdrawal by Subject|4
7782232|NCT00605176|27050026|P2|Overall Study|Withdrawal by Subject|2
7782233|NCT00605176|27050027|P1|Overall Study|Withdrawal by Subject|4
7782234|NCT00605176|27050025|P3|Overall Study|Adverse Event|3
7782235|NCT00605176|27050026|P2|Overall Study|Adverse Event|1
7782236|NCT00605176|27050027|P1|Overall Study|Adverse Event|2
7782237|NCT00605085|27050051|P2|Overall Study|administrative reasons|8
7782238|NCT00605085|27050052|P1|Overall Study|administrative reasons|18
7782239|NCT00605085|27050051|P2|Overall Study|Lost to Follow-up|5
7782240|NCT00605085|27050052|P1|Overall Study|Lost to Follow-up|10
7782241|NCT00605085|27050051|P2|Overall Study|Protocol Violation|2
7782242|NCT00605085|27050052|P1|Overall Study|Protocol Violation|3
7782243|NCT00605085|27050051|P2|Overall Study|Pregnancy|0
7782244|NCT00605085|27050052|P1|Overall Study|Pregnancy|2
7782245|NCT00605085|27050051|P2|Overall Study|Adverse Event|5
7782246|NCT00605085|27050052|P1|Overall Study|Adverse Event|9
7782247|NCT00605085|27050051|P2|Overall Study|Withdrawal by Subject|5
7782248|NCT00605085|27050052|P1|Overall Study|Withdrawal by Subject|8
7782249|NCT00605033|27050085|P2|Overall Study|Protocol Violation|1
7782250|NCT00605033|27050086|P1|Overall Study|Protocol Violation|1
7782251|NCT00605033|27050085|P2|Overall Study|Withdrawal by Subject|4
7782252|NCT00605033|27050086|P1|Overall Study|Withdrawal by Subject|3
7782253|NCT00605033|27050085|P2|Overall Study|Lost to Follow-up|1
7782254|NCT00605033|27050086|P1|Overall Study|Lost to Follow-up|1
7782255|NCT00605033|27050085|P2|Overall Study|Adverse Event|2
7782256|NCT00605033|27050086|P1|Overall Study|Adverse Event|2
7782257|NCT00604825|27050130|P4|Overall Study|Exclusion criterion met|1
7782258|NCT00604825|27050131|P3|Overall Study|Exclusion criterion met|0
7782259|NCT00604825|27050132|P2|Overall Study|Exclusion criterion met|0
7782260|NCT00604825|27050133|P1|Overall Study|Exclusion criterion met|0
7782261|NCT00604825|27050130|P4|Overall Study|Physician Decision|1
7782262|NCT00604825|27050131|P3|Overall Study|Physician Decision|0
7782263|NCT00604825|27050132|P2|Overall Study|Physician Decision|0
7782264|NCT00604825|27050133|P1|Overall Study|Physician Decision|0
7782265|NCT00604825|27050130|P4|Overall Study|Did not meet eligibility criteria|0
7782266|NCT00604825|27050131|P3|Overall Study|Did not meet eligibility criteria|2
7782267|NCT00604825|27050132|P2|Overall Study|Did not meet eligibility criteria|0
7782268|NCT00604825|27050133|P1|Overall Study|Did not meet eligibility criteria|0
7782269|NCT00604825|27050130|P4|Overall Study|Lack of Efficacy|0
7782270|NCT00604825|27050131|P3|Overall Study|Lack of Efficacy|1
7782271|NCT00604825|27050132|P2|Overall Study|Lack of Efficacy|2
7782272|NCT00604825|27050133|P1|Overall Study|Lack of Efficacy|3
7782273|NCT00604825|27050130|P4|Overall Study|Withdrawal by Subject|5
7782274|NCT00604825|27050131|P3|Overall Study|Withdrawal by Subject|5
7782275|NCT00604825|27050132|P2|Overall Study|Withdrawal by Subject|3
7782276|NCT00604825|27050133|P1|Overall Study|Withdrawal by Subject|4
7782277|NCT00604825|27050130|P4|Overall Study|Protocol Violation|0
7782278|NCT00604825|27050131|P3|Overall Study|Protocol Violation|0
7782279|NCT00604825|27050132|P2|Overall Study|Protocol Violation|1
7782280|NCT00604825|27050133|P1|Overall Study|Protocol Violation|0
7782281|NCT00604825|27050130|P4|Overall Study|Lost to Follow-up|0
7782282|NCT00604825|27050131|P3|Overall Study|Lost to Follow-up|1
7782283|NCT00604825|27050132|P2|Overall Study|Lost to Follow-up|3
7782284|NCT00604825|27050133|P1|Overall Study|Lost to Follow-up|0
7782285|NCT00604825|27050130|P4|Overall Study|Adverse Event|4
7782286|NCT00604825|27050131|P3|Overall Study|Adverse Event|7
7782287|NCT00604825|27050132|P2|Overall Study|Adverse Event|6
7782288|NCT00604825|27050133|P1|Overall Study|Adverse Event|2
7782289|NCT00604786|27050361|P2|Overall Study|Lost to Follow-up|0
7782290|NCT00604786|27050362|P1|Overall Study|Lost to Follow-up|2
7782291|NCT00604721|27050368|P1|Overall Study|Withdrawal by Subject|1
7782292|NCT00604721|27050368|P1|Overall Study|Physician Decision|1
7782293|NCT00604708|27050376|P2|Overall Study|Adverse Event|6
7782294|NCT00604708|27050377|P1|Overall Study|Adverse Event|6
7782295|NCT00604708|27050376|P2|Overall Study|administrative reasons|11
7782296|NCT00604708|27050377|P1|Overall Study|administrative reasons|9
7782297|NCT00604708|27050376|P2|Overall Study|Lost to Follow-up|5
7782298|NCT00604708|27050377|P1|Overall Study|Lost to Follow-up|5
7782299|NCT00604708|27050376|P2|Overall Study|Protocol Violation|8
7782300|NCT00604708|27050377|P1|Overall Study|Protocol Violation|2
7782301|NCT00604708|27050376|P2|Overall Study|Withdrawal by Subject|10
7782302|NCT00604708|27050377|P1|Overall Study|Withdrawal by Subject|9
7782303|NCT00604695|27050387|P2|Overall Study|Did not receive first bolus.|4
7782304|NCT00604695|27050388|P1|Overall Study|Did not receive first bolus.|0
7782305|NCT00604669|27050410|P1|Overall Study|lack of information in chart|7
7782306|NCT00604565|27050416|P2|Overall Study|Study terminated|3
7782307|NCT00604565|27050417|P1|Overall Study|Study terminated|0
7782308|NCT00604500|27050436|P1|Overall Study|Did not meet protocol eligibility|1
7782309|NCT00604500|27050436|P1|Overall Study|Administrative|1
7782310|NCT00604500|27050436|P1|Overall Study|Withdrawal by Subject|4
7782311|NCT00604500|27050436|P1|Overall Study|Treatment Failure|1
7782312|NCT00604500|27050436|P1|Overall Study|Protocol Violation|2
7782313|NCT00604500|27050436|P1|Overall Study|Adverse Event|2
7782314|NCT00604383|27050450|P2|Overall Study|Physician Decision|3
7782315|NCT00604383|27050451|P1|Overall Study|Physician Decision|0
7782316|NCT00604383|27050450|P2|Overall Study|Adverse Event|9
7782317|NCT00604383|27050451|P1|Overall Study|Adverse Event|16
7782318|NCT00604383|27050450|P2|Overall Study|Death|22
7782319|NCT00604383|27050451|P1|Overall Study|Death|14
7782320|NCT00604383|27050450|P2|Overall Study|Lost to Follow-up|19
7782321|NCT00604383|27050451|P1|Overall Study|Lost to Follow-up|24
7782322|NCT00604383|27050450|P2|Overall Study|Withdrawal by Subject|31
7782323|NCT00604383|27050451|P1|Overall Study|Withdrawal by Subject|33
7782324|NCT00604279|27050467|P2|Overall Study|Other|4
7782325|NCT00604279|27050468|P1|Overall Study|Other|8
7782326|NCT00604279|27050467|P2|Overall Study|Adverse Event|5
7782327|NCT00604279|27050468|P1|Overall Study|Adverse Event|4
7782328|NCT00604279|27050467|P2|Overall Study|Withdrawal by Subject|5
7782329|NCT00604279|27050468|P1|Overall Study|Withdrawal by Subject|16
7782330|NCT00604279|27050467|P2|Overall Study|Protocol Violation|1
7782331|NCT00604279|27050468|P1|Overall Study|Protocol Violation|3
7782332|NCT00604279|27050467|P2|Overall Study|Pregnancy|0
7782333|NCT00604279|27050468|P1|Overall Study|Pregnancy|2
7782334|NCT00604279|27050467|P2|Overall Study|Lost to Follow-up|14
7782335|NCT00604279|27050468|P1|Overall Study|Lost to Follow-up|9
7782336|NCT00604279|27050467|P2|Overall Study|Lack of Efficacy|9
7782337|NCT00604279|27050468|P1|Overall Study|Lack of Efficacy|22
7782338|NCT00604214|27050484|P2|Day 91 to Day 180|Withdrawal by Subject|1
7782339|NCT00604214|27050485|P1|Day 91 to Day 180|Withdrawal by Subject|1
7782340|NCT00604214|27050484|P2|Day 91 to Day 180|Lost to Follow-up|8
7782341|NCT00604214|27050485|P1|Day 91 to Day 180|Lost to Follow-up|6
7782342|NCT00604214|27050484|P2|Day 91 to Day 180|Death|23
7782343|NCT00604214|27050485|P1|Day 91 to Day 180|Death|19
7782344|NCT00604214|27050484|P2|Day 29 to Day 90|Withdrawal by Subject|6
7782345|NCT00604214|27050485|P1|Day 29 to Day 90|Withdrawal by Subject|0
7782346|NCT00604214|27050484|P2|Day 29 to Day 90|Lost to Follow-up|6
7782347|NCT00604214|27050485|P1|Day 29 to Day 90|Lost to Follow-up|4
7782348|NCT00604214|27050484|P2|Day 29 to Day 90|Death|67
7782349|NCT00604214|27050485|P1|Day 29 to Day 90|Death|64
7782350|NCT00604214|27050484|P2|Baseline to Day 28|Withdrawal by Subject|7
7782351|NCT00604214|27050485|P1|Baseline to Day 28|Withdrawal by Subject|3
7782352|NCT00604214|27050484|P2|Baseline to Day 28|Lost to Follow-up|4
7782353|NCT00604214|27050485|P1|Baseline to Day 28|Lost to Follow-up|2
7782354|NCT00604214|27050484|P2|Baseline to Day 28|Death|202
7782355|NCT00604214|27050485|P1|Baseline to Day 28|Death|223
7782356|NCT00604188|27050533|P2|Overall Study|Did not receive study drug|1
7782357|NCT00604188|27050534|P1|Overall Study|Did not receive study drug|0
7782358|NCT00604188|27050533|P2|Overall Study|Non-compliance with protocol|4
7782359|NCT00604188|27050534|P1|Overall Study|Non-compliance with protocol|4
7782360|NCT00604188|27050533|P2|Overall Study|Withdrawal by Subject|1
7782361|NCT00604188|27050534|P1|Overall Study|Withdrawal by Subject|5
7782362|NCT00604188|27050533|P2|Overall Study|Lost to Follow-up|15
7782363|NCT00604188|27050534|P1|Overall Study|Lost to Follow-up|17
7782364|NCT00604188|27050533|P2|Overall Study|Adverse Event|4
7782365|NCT00604188|27050534|P1|Overall Study|Adverse Event|1
7782366|NCT00604175|27050557|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
7782367|NCT00604175|27050558|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
7782368|NCT00604175|27050559|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
7782369|NCT00604175|27050557|P3|Week 29 Through Week 72|Site closure|0
7782370|NCT00604175|27050558|P2|Week 29 Through Week 72|Site closure|1
7782371|NCT00604175|27050559|P1|Week 29 Through Week 72|Site closure|0
7782372|NCT00604175|27050557|P3|Week 29 Through Week 72|Lost to Follow-up|2
7782373|NCT00604175|27050558|P2|Week 29 Through Week 72|Lost to Follow-up|6
7782374|NCT00604175|27050559|P1|Week 29 Through Week 72|Lost to Follow-up|12
7782375|NCT00604175|27050557|P3|Week 29 Through Week 72|Death|1
7782376|NCT00604175|27050558|P2|Week 29 Through Week 72|Death|0
7782377|NCT00604175|27050559|P1|Week 29 Through Week 72|Death|0
7782378|NCT00604175|27050557|P3|Entry Through Week 28|Did not start intervention|1
7782379|NCT00604175|27050558|P2|Entry Through Week 28|Did not start intervention|0
7782380|NCT00604175|27050559|P1|Entry Through Week 28|Did not start intervention|2
7782381|NCT00604175|27050557|P3|Entry Through Week 28|Ineligible|0
7782382|NCT00604175|27050558|P2|Entry Through Week 28|Ineligible|0
7782383|NCT00604175|27050559|P1|Entry Through Week 28|Ineligible|1
7782384|NCT00604175|27050557|P3|Entry Through Week 28|Lost to Follow-up|0
7782385|NCT00604175|27050558|P2|Entry Through Week 28|Lost to Follow-up|3
7782386|NCT00604175|27050559|P1|Entry Through Week 28|Lost to Follow-up|4
7782387|NCT00604175|27050557|P3|Entry Through Week 28|Withdrawal by Subject|0
7782388|NCT00604175|27050558|P2|Entry Through Week 28|Withdrawal by Subject|0
7782389|NCT00604175|27050559|P1|Entry Through Week 28|Withdrawal by Subject|1
7782390|NCT00604175|27050557|P3|Entry Through Week 28|Death|0
7782391|NCT00604175|27050558|P2|Entry Through Week 28|Death|0
7782392|NCT00604175|27050559|P1|Entry Through Week 28|Death|2
7782393|NCT00604162|27050612|P1|Overall Study|Withdrawal by Subject|1
7782394|NCT00604162|27050612|P1|Overall Study|Physician Decision|3
7782395|NCT00603980|27050654|P1|Main Study|14th subject completed trial|1
7782396|NCT00603980|27050654|P1|Study Qualification|Inconsistent data reporting|13
7782397|NCT00603980|27050654|P1|Study Qualification|Protocol Violation|3
7782398|NCT00603941|27050773|P3|Overall Study|Withdrawal by Subject|0
7782399|NCT00603941|27050774|P2|Overall Study|Withdrawal by Subject|2
7782400|NCT00603941|27050775|P1|Overall Study|Withdrawal by Subject|0
7782401|NCT00603941|27050773|P3|Overall Study|Physician Decision|0
7782402|NCT00603941|27050774|P2|Overall Study|Physician Decision|1
7782403|NCT00603941|27050775|P1|Overall Study|Physician Decision|0
7782404|NCT00603941|27050773|P3|Overall Study|Adverse Event|1
7782405|NCT00603941|27050774|P2|Overall Study|Adverse Event|0
7782406|NCT00603941|27050775|P1|Overall Study|Adverse Event|1
7782407|NCT00603941|27050773|P3|Overall Study|Disease progression|1
7782408|NCT00603941|27050774|P2|Overall Study|Disease progression|7
7782409|NCT00603941|27050775|P1|Overall Study|Disease progression|6
7782410|NCT00603915|27050786|P1|Overall Study|Physician Decision|1
7782411|NCT00603837|27050816|P2|Overall Study|Physician Decision|0
7782412|NCT00603837|27050817|P1|Overall Study|Physician Decision|3
7782413|NCT00603798|27050826|P3|Overall Study|Not due to AE|4
7782414|NCT00603798|27050827|P2|Overall Study|Not due to AE|1
7782415|NCT00603798|27050828|P1|Overall Study|Not due to AE|1
7782416|NCT00603798|27050826|P3|Overall Study|Non-compliance with study procedures|0
7782417|NCT00603798|27050827|P2|Overall Study|Non-compliance with study procedures|1
7782418|NCT00603798|27050828|P1|Overall Study|Non-compliance with study procedures|0
7782419|NCT00603798|27050826|P3|Overall Study|Lost to Follow-up|1
7782420|NCT00603798|27050827|P2|Overall Study|Lost to Follow-up|0
7782421|NCT00603798|27050828|P1|Overall Study|Lost to Follow-up|1
7782422|NCT00603798|27050826|P3|Overall Study|Withdrawal by Subject|4
7782423|NCT00603798|27050827|P2|Overall Study|Withdrawal by Subject|3
7782424|NCT00603798|27050828|P1|Overall Study|Withdrawal by Subject|4
7782425|NCT00603798|27050826|P3|Overall Study|Adverse Event|1
7782426|NCT00603798|27050827|P2|Overall Study|Adverse Event|2
7782427|NCT00603798|27050828|P1|Overall Study|Adverse Event|4
7782428|NCT00603746|27050851|P6|Overall Study|Withdrawal by Subject|1
7782429|NCT00603746|27050852|P5|Overall Study|Withdrawal by Subject|3
7782430|NCT00603746|27050853|P4|Overall Study|Withdrawal by Subject|1
7782431|NCT00603746|27050854|P3|Overall Study|Withdrawal by Subject|0
7782432|NCT00603746|27050855|P2|Overall Study|Withdrawal by Subject|0
7782433|NCT00603746|27050856|P1|Overall Study|Withdrawal by Subject|1
7782434|NCT00603746|27050851|P6|Overall Study|Physician Decision|0
7782435|NCT00603746|27050852|P5|Overall Study|Physician Decision|1
7782436|NCT00603746|27050853|P4|Overall Study|Physician Decision|0
7782437|NCT00603746|27050854|P3|Overall Study|Physician Decision|0
7782438|NCT00603746|27050855|P2|Overall Study|Physician Decision|0
7782439|NCT00603746|27050856|P1|Overall Study|Physician Decision|1
7782440|NCT00603746|27050851|P6|Overall Study|Lost to Follow-up|0
7782441|NCT00603746|27050852|P5|Overall Study|Lost to Follow-up|0
7782442|NCT00603746|27050853|P4|Overall Study|Lost to Follow-up|0
7782443|NCT00603746|27050854|P3|Overall Study|Lost to Follow-up|1
7782444|NCT00603746|27050855|P2|Overall Study|Lost to Follow-up|1
7782445|NCT00603746|27050856|P1|Overall Study|Lost to Follow-up|0
7782446|NCT00603746|27050851|P6|Overall Study|Protocol Violation|0
7782447|NCT00603746|27050852|P5|Overall Study|Protocol Violation|1
7782448|NCT00603746|27050853|P4|Overall Study|Protocol Violation|0
7782449|NCT00603746|27050854|P3|Overall Study|Protocol Violation|1
7782450|NCT00603746|27050855|P2|Overall Study|Protocol Violation|3
7782451|NCT00603746|27050856|P1|Overall Study|Protocol Violation|0
7782452|NCT00603746|27050851|P6|Overall Study|Lack of Efficacy|8
7782453|NCT00603746|27050852|P5|Overall Study|Lack of Efficacy|12
7782454|NCT00603746|27050853|P4|Overall Study|Lack of Efficacy|11
7782455|NCT00603746|27050854|P3|Overall Study|Lack of Efficacy|6
7782456|NCT00603746|27050855|P2|Overall Study|Lack of Efficacy|11
7782457|NCT00603746|27050856|P1|Overall Study|Lack of Efficacy|34
7782458|NCT00603746|27050851|P6|Overall Study|Adverse Event|4
7782459|NCT00603746|27050852|P5|Overall Study|Adverse Event|0
7782460|NCT00603746|27050853|P4|Overall Study|Adverse Event|1
7782461|NCT00603746|27050854|P3|Overall Study|Adverse Event|0
7782462|NCT00603746|27050855|P2|Overall Study|Adverse Event|3
7782463|NCT00603746|27050856|P1|Overall Study|Adverse Event|2
7782464|NCT00603733|27051004|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
7782465|NCT00603733|27051005|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
7782466|NCT00603733|27051004|P2|Maintenance Phase ITT|Physician Decision|1
7782467|NCT00603733|27051005|P1|Maintenance Phase ITT|Physician Decision|0
7782468|NCT00603733|27051004|P2|Maintenance Phase ITT|Lack of Efficacy|2
7782469|NCT00603733|27051005|P1|Maintenance Phase ITT|Lack of Efficacy|2
7782470|NCT00603733|27051004|P2|Maintenance Phase ITT|Lost to Follow-up|1
7782471|NCT00603733|27051005|P1|Maintenance Phase ITT|Lost to Follow-up|0
7782472|NCT00603733|27051004|P2|Maintenance Phase ITT|Protocol Violation|1
7782473|NCT00603733|27051005|P1|Maintenance Phase ITT|Protocol Violation|1
7782474|NCT00603733|27051004|P2|Maintenance Phase ITT|Withdrawal by Subject|0
7782475|NCT00603733|27051005|P1|Maintenance Phase ITT|Withdrawal by Subject|1
7782476|NCT00603733|27051004|P2|Maintenance Phase ITT|Adverse Event|6
7782477|NCT00603733|27051005|P1|Maintenance Phase ITT|Adverse Event|3
7782478|NCT00603733|27051004|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
7782479|NCT00603733|27051005|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
7782480|NCT00603733|27051004|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
7782481|NCT00603733|27051005|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
7782482|NCT00603733|27051004|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
7782483|NCT00603733|27051005|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
7782484|NCT00603733|27051004|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
7782485|NCT00603733|27051005|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
7782486|NCT00603733|27051004|P2|Run-In Phase - 4 Weeks|Adverse Event|1
7782487|NCT00603733|27051005|P1|Run-In Phase - 4 Weeks|Adverse Event|2
7782488|NCT00603733|27051004|P2|Active Phase ITT|Subject moved, site closed|1
7782489|NCT00603733|27051005|P1|Active Phase ITT|Subject moved, site closed|1
7782490|NCT00603733|27051004|P2|Active Phase ITT|Lack of Efficacy|2
7782491|NCT00603733|27051005|P1|Active Phase ITT|Lack of Efficacy|1
7782492|NCT00603733|27051004|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
7782493|NCT00603733|27051005|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
7782494|NCT00603733|27051004|P2|Active Phase ITT|Lost to Follow-up|1
7782495|NCT00603733|27051005|P1|Active Phase ITT|Lost to Follow-up|0
7782496|NCT00603733|27051004|P2|Active Phase ITT|Withdrawal by Subject|3
7782497|NCT00603733|27051005|P1|Active Phase ITT|Withdrawal by Subject|0
7782498|NCT00603733|27051004|P2|Active Phase ITT|Adverse Event|7
7782499|NCT00603733|27051005|P1|Active Phase ITT|Adverse Event|8
7782500|NCT00603590|27051055|P2|Overall Study|Cardiovascular event|1
7782501|NCT00603590|27051056|P1|Overall Study|Cardiovascular event|0
7782502|NCT00603590|27051055|P2|Overall Study|Lost to Follow-up|4
7782503|NCT00603590|27051056|P1|Overall Study|Lost to Follow-up|8
7782504|NCT00603590|27051055|P2|Overall Study|Adverse Event|0
7782505|NCT00603590|27051056|P1|Overall Study|Adverse Event|2
7782506|NCT00603590|27051055|P2|Overall Study|Patient discontinued study drug|15
7782507|NCT00603590|27051056|P1|Overall Study|Patient discontinued study drug|22
7782508|NCT00603590|27051055|P2|Overall Study|Refused blood test|1
7782509|NCT00603590|27051056|P1|Overall Study|Refused blood test|5
7782510|NCT00603590|27051055|P2|Overall Study|Did not attend study clinic|30
7782511|NCT00603590|27051056|P1|Overall Study|Did not attend study clinic|39
7782512|NCT00603538|27051080|P3|Overall Study|Objective progression or relapse|0
7782513|NCT00603538|27051081|P2|Overall Study|Objective progression or relapse|0
7782514|NCT00603538|27051082|P1|Overall Study|Objective progression or relapse|3
7782515|NCT00603538|27051080|P3|Overall Study|Adverse Event|2
7782516|NCT00603538|27051081|P2|Overall Study|Adverse Event|4
7782517|NCT00603538|27051082|P1|Overall Study|Adverse Event|0
7782518|NCT00603525|27051122|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
7782519|NCT00603525|27051123|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
7782520|NCT00603525|27051124|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
7782521|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7782522|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
7782523|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7782524|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
7782525|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
7782526|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
7782527|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7782528|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
7782529|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7782530|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7782531|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
7782532|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7782533|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
7782534|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
7782535|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
7782536|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7782537|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
7782538|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7782539|NCT00603525|27051122|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
7782540|NCT00603525|27051123|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
7782541|NCT00603525|27051124|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
7782542|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
7782543|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
7782544|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
7782545|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
7782546|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
7782547|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
7782548|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
7782549|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
7782550|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
7782551|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
7782552|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
7782553|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
7782554|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
7782555|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
7782556|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
7782557|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7782558|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7782559|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
7782560|NCT00603525|27051122|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
7782561|NCT00603525|27051123|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
7782562|NCT00603525|27051124|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
7782563|NCT00603512|27051256|P5|Overall Study|Randomized but not treated|0
7782564|NCT00603512|27051257|P4|Overall Study|Randomized but not treated|2
7782565|NCT00603512|27051258|P3|Overall Study|Randomized but not treated|1
7782566|NCT00603512|27051259|P2|Overall Study|Randomized but not treated|1
7782567|NCT00603512|27051260|P1|Overall Study|Randomized but not treated|0
7782568|NCT00603512|27051256|P5|Overall Study|Withdrawal by Subject|1
7782569|NCT00603512|27051257|P4|Overall Study|Withdrawal by Subject|0
7782570|NCT00603512|27051258|P3|Overall Study|Withdrawal by Subject|0
7782571|NCT00603512|27051259|P2|Overall Study|Withdrawal by Subject|0
7782572|NCT00603512|27051260|P1|Overall Study|Withdrawal by Subject|0
7782573|NCT00603512|27051256|P5|Overall Study|Other|1
7782574|NCT00603512|27051257|P4|Overall Study|Other|1
7782575|NCT00603512|27051258|P3|Overall Study|Other|0
7782576|NCT00603512|27051259|P2|Overall Study|Other|1
7782577|NCT00603512|27051260|P1|Overall Study|Other|2
7782578|NCT00603512|27051256|P5|Overall Study|Lack of Efficacy|1
7782579|NCT00603512|27051257|P4|Overall Study|Lack of Efficacy|0
7782580|NCT00603512|27051258|P3|Overall Study|Lack of Efficacy|0
7782581|NCT00603512|27051259|P2|Overall Study|Lack of Efficacy|1
7782582|NCT00603512|27051260|P1|Overall Study|Lack of Efficacy|0
7782583|NCT00603512|27051256|P5|Overall Study|Adverse Event|2
7782584|NCT00603512|27051257|P4|Overall Study|Adverse Event|4
7782585|NCT00603512|27051258|P3|Overall Study|Adverse Event|4
7782586|NCT00603512|27051259|P2|Overall Study|Adverse Event|2
7782587|NCT00603512|27051260|P1|Overall Study|Adverse Event|0
7782588|NCT00603473|27051402|P1|Overall Study|Protocol Violation|1
7782589|NCT00603473|27051402|P1|Overall Study|Lack of Efficacy|4
7782590|NCT00603473|27051402|P1|Overall Study|Adverse Event|4
7782591|NCT00603447|27051415|P7|Overall Study|Withdrew Consent|1
7782592|NCT00603447|27051416|P6|Overall Study|Withdrew Consent|0
7782593|NCT00603447|27051417|P5|Overall Study|Withdrew Consent|1
7782594|NCT00603447|27051418|P4|Overall Study|Withdrew Consent|0
7782595|NCT00603447|27051419|P3|Overall Study|Withdrew Consent|0
7782596|NCT00603447|27051420|P2|Overall Study|Withdrew Consent|2
7782597|NCT00603447|27051421|P1|Overall Study|Withdrew Consent|0
7782598|NCT00603447|27051415|P7|Overall Study|Other|13
7782599|NCT00603447|27051416|P6|Overall Study|Other|0
7782600|NCT00603447|27051417|P5|Overall Study|Other|3
7782601|NCT00603447|27051418|P4|Overall Study|Other|0
7782602|NCT00603447|27051419|P3|Overall Study|Other|1
7782603|NCT00603447|27051420|P2|Overall Study|Other|0
7782604|NCT00603447|27051421|P1|Overall Study|Other|0
7782605|NCT00603447|27051415|P7|Overall Study|Adverse Event|10
7782606|NCT00603447|27051416|P6|Overall Study|Adverse Event|2
7782607|NCT00603447|27051417|P5|Overall Study|Adverse Event|1
7782608|NCT00603447|27051418|P4|Overall Study|Adverse Event|2
7782609|NCT00603447|27051419|P3|Overall Study|Adverse Event|1
7782610|NCT00603447|27051420|P2|Overall Study|Adverse Event|1
7782611|NCT00603447|27051421|P1|Overall Study|Adverse Event|0
7782612|NCT00603382|27051460|P6|Overall Study|Withdrawal by Subject|1
7782613|NCT00603382|27051461|P5|Overall Study|Withdrawal by Subject|0
7782614|NCT00603382|27051462|P4|Overall Study|Withdrawal by Subject|1
7782615|NCT00603382|27051463|P3|Overall Study|Withdrawal by Subject|1
7782616|NCT00603382|27051464|P2|Overall Study|Withdrawal by Subject|3
7782617|NCT00603382|27051465|P1|Overall Study|Withdrawal by Subject|3
7782618|NCT00603382|27051460|P6|Overall Study|Physician Decision|3
7782619|NCT00603382|27051461|P5|Overall Study|Physician Decision|1
7782620|NCT00603382|27051462|P4|Overall Study|Physician Decision|0
7782621|NCT00603382|27051463|P3|Overall Study|Physician Decision|2
7782622|NCT00603382|27051464|P2|Overall Study|Physician Decision|0
7782623|NCT00603382|27051465|P1|Overall Study|Physician Decision|0
7782624|NCT00603382|27051460|P6|Overall Study|Lost to Follow-up|1
7782625|NCT00603382|27051461|P5|Overall Study|Lost to Follow-up|0
7782626|NCT00603382|27051462|P4|Overall Study|Lost to Follow-up|1
7782627|NCT00603382|27051463|P3|Overall Study|Lost to Follow-up|1
7782628|NCT00603382|27051464|P2|Overall Study|Lost to Follow-up|1
7782629|NCT00603382|27051465|P1|Overall Study|Lost to Follow-up|0
7782630|NCT00603382|27051460|P6|Overall Study|Protocol Violation|0
7782631|NCT00603382|27051461|P5|Overall Study|Protocol Violation|1
7782632|NCT00603382|27051462|P4|Overall Study|Protocol Violation|2
7782633|NCT00603382|27051463|P3|Overall Study|Protocol Violation|1
7782634|NCT00603382|27051464|P2|Overall Study|Protocol Violation|0
7782635|NCT00603382|27051465|P1|Overall Study|Protocol Violation|1
7782636|NCT00603382|27051460|P6|Overall Study|Lack of Efficacy|11
7782637|NCT00603382|27051461|P5|Overall Study|Lack of Efficacy|6
7782638|NCT00603382|27051462|P4|Overall Study|Lack of Efficacy|6
7782639|NCT00603382|27051463|P3|Overall Study|Lack of Efficacy|3
7782640|NCT00603382|27051464|P2|Overall Study|Lack of Efficacy|9
7782641|NCT00603382|27051465|P1|Overall Study|Lack of Efficacy|14
7782642|NCT00603382|27051460|P6|Overall Study|Adverse Event|2
7782643|NCT00603382|27051461|P5|Overall Study|Adverse Event|1
7782644|NCT00603382|27051462|P4|Overall Study|Adverse Event|2
7782645|NCT00603382|27051463|P3|Overall Study|Adverse Event|1
7782646|NCT00603382|27051464|P2|Overall Study|Adverse Event|1
7782647|NCT00603382|27051465|P1|Overall Study|Adverse Event|0
7782648|NCT00603304|27051613|P2|Overall Study|Patient Decision|0
7782649|NCT00603304|27051614|P1|Overall Study|Patient Decision|2
7782650|NCT00603304|27051613|P2|Overall Study|Other|0
7782651|NCT00603304|27051614|P1|Overall Study|Other|2
7782652|NCT00603304|27051613|P2|Overall Study|Moved Away|2
7782653|NCT00603304|27051614|P1|Overall Study|Moved Away|0
7782654|NCT00603304|27051613|P2|Overall Study|Non-Compliant|1
7782655|NCT00603304|27051614|P1|Overall Study|Non-Compliant|0
7782656|NCT00603304|27051613|P2|Overall Study|Exclusionary Medication|3
7782657|NCT00603304|27051614|P1|Overall Study|Exclusionary Medication|2
7782658|NCT00603304|27051613|P2|Overall Study|Crossed Over to Open Label Therapy|3
7782659|NCT00603304|27051614|P1|Overall Study|Crossed Over to Open Label Therapy|3
7782660|NCT00603304|27051613|P2|Overall Study|Unacceptable Treatment Toxicity|8
7782661|NCT00603304|27051614|P1|Overall Study|Unacceptable Treatment Toxicity|5
7782662|NCT00603304|27051613|P2|Overall Study|Adverse Event|2
7782663|NCT00603304|27051614|P1|Overall Study|Adverse Event|4
7782664|NCT00603304|27051613|P2|Overall Study|Protocol Violation|0
7782665|NCT00603304|27051614|P1|Overall Study|Protocol Violation|1
7782666|NCT00603304|27051613|P2|Overall Study|Withdrawal by Subject|5
7782667|NCT00603304|27051614|P1|Overall Study|Withdrawal by Subject|8
7782668|NCT00603304|27051613|P2|Overall Study|Lost to Follow-up|7
7782669|NCT00603304|27051614|P1|Overall Study|Lost to Follow-up|5
7782670|NCT00603278|27051670|P6|Overall Study|Lost to Follow-up|0
7782671|NCT00603278|27051671|P5|Overall Study|Lost to Follow-up|1
7782672|NCT00603278|27051672|P4|Overall Study|Lost to Follow-up|0
7782673|NCT00603278|27051673|P3|Overall Study|Lost to Follow-up|0
7782674|NCT00603278|27051674|P2|Overall Study|Lost to Follow-up|0
7782675|NCT00603278|27051675|P1|Overall Study|Lost to Follow-up|1
7782676|NCT00603278|27051670|P6|Overall Study|Physician Decision|1
7782677|NCT00603278|27051671|P5|Overall Study|Physician Decision|2
7782678|NCT00603278|27051672|P4|Overall Study|Physician Decision|0
7782679|NCT00603278|27051673|P3|Overall Study|Physician Decision|0
7782680|NCT00603278|27051674|P2|Overall Study|Physician Decision|1
7782681|NCT00603278|27051675|P1|Overall Study|Physician Decision|0
7782682|NCT00603278|27051670|P6|Overall Study|Protocol Violation|1
7782683|NCT00603278|27051671|P5|Overall Study|Protocol Violation|0
7782684|NCT00603278|27051672|P4|Overall Study|Protocol Violation|1
7782685|NCT00603278|27051673|P3|Overall Study|Protocol Violation|1
7782686|NCT00603278|27051674|P2|Overall Study|Protocol Violation|0
7782687|NCT00603278|27051675|P1|Overall Study|Protocol Violation|3
7782688|NCT00603278|27051670|P6|Overall Study|Withdrawal by Subject|2
7782689|NCT00603278|27051671|P5|Overall Study|Withdrawal by Subject|1
7782690|NCT00603278|27051672|P4|Overall Study|Withdrawal by Subject|2
7782691|NCT00603278|27051673|P3|Overall Study|Withdrawal by Subject|1
7782692|NCT00603278|27051674|P2|Overall Study|Withdrawal by Subject|3
7782693|NCT00603278|27051675|P1|Overall Study|Withdrawal by Subject|2
7782694|NCT00603278|27051670|P6|Overall Study|Adverse Event|1
7782695|NCT00603278|27051671|P5|Overall Study|Adverse Event|2
7782696|NCT00603278|27051672|P4|Overall Study|Adverse Event|0
7782697|NCT00603278|27051673|P3|Overall Study|Adverse Event|1
7782698|NCT00603278|27051674|P2|Overall Study|Adverse Event|3
7782699|NCT00603278|27051675|P1|Overall Study|Adverse Event|0
7782700|NCT00603278|27051670|P6|Overall Study|Lack of Efficacy|14
7782701|NCT00603278|27051671|P5|Overall Study|Lack of Efficacy|7
7782702|NCT00603278|27051672|P4|Overall Study|Lack of Efficacy|8
7782703|NCT00603278|27051673|P3|Overall Study|Lack of Efficacy|11
7782704|NCT00603278|27051674|P2|Overall Study|Lack of Efficacy|10
7782705|NCT00603278|27051675|P1|Overall Study|Lack of Efficacy|35
7782706|NCT00603265|27051824|P3|Overall Study|Protocol Violation|0
7782707|NCT00603265|27051825|P2|Overall Study|Protocol Violation|0
7782708|NCT00603265|27051826|P1|Overall Study|Protocol Violation|1
7782709|NCT00603265|27051824|P3|Overall Study|Participant Left Country, No Responses|0
7782710|NCT00603265|27051825|P2|Overall Study|Participant Left Country, No Responses|1
7782711|NCT00603265|27051826|P1|Overall Study|Participant Left Country, No Responses|0
7782712|NCT00603265|27051824|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
7782713|NCT00603265|27051825|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
7782714|NCT00603265|27051826|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
7782715|NCT00603265|27051824|P3|Overall Study|Lost to Follow-up|0
7782716|NCT00603265|27051825|P2|Overall Study|Lost to Follow-up|1
7782717|NCT00603265|27051826|P1|Overall Study|Lost to Follow-up|0
7782718|NCT00603265|27051824|P3|Overall Study|Lack of Efficacy|3
7782719|NCT00603265|27051825|P2|Overall Study|Lack of Efficacy|0
7782720|NCT00603265|27051826|P1|Overall Study|Lack of Efficacy|3
7782721|NCT00603265|27051824|P3|Overall Study|Withdrawal by Subject|1
7782722|NCT00603265|27051825|P2|Overall Study|Withdrawal by Subject|2
7782723|NCT00603265|27051826|P1|Overall Study|Withdrawal by Subject|1
7782724|NCT00603265|27051824|P3|Overall Study|Adverse Event|1
7782725|NCT00603265|27051825|P2|Overall Study|Adverse Event|11
7782726|NCT00603265|27051826|P1|Overall Study|Adverse Event|2
7782727|NCT00603239|27051854|P2|Overall Study|Subject decision|1
7782728|NCT00603239|27051855|P1|Overall Study|Subject decision|2
7782729|NCT00603239|27051854|P2|Overall Study|Protocol Violation|0
7782730|NCT00603239|27051855|P1|Overall Study|Protocol Violation|2
7782731|NCT00603239|27051854|P2|Overall Study|Physician Decision|0
7782732|NCT00603239|27051855|P1|Overall Study|Physician Decision|2
7782733|NCT00603239|27051854|P2|Overall Study|Lost to Follow-up|1
7782734|NCT00603239|27051855|P1|Overall Study|Lost to Follow-up|2
7782735|NCT00603239|27051854|P2|Overall Study|Loss of glucose control|0
7782736|NCT00603239|27051855|P1|Overall Study|Loss of glucose control|3
7782737|NCT00603239|27051854|P2|Overall Study|Entry criteria not met|1
7782738|NCT00603239|27051855|P1|Overall Study|Entry criteria not met|0
7782739|NCT00603239|27051854|P2|Overall Study|Adverse Event|1
7782740|NCT00603239|27051855|P1|Overall Study|Adverse Event|4
7782741|NCT00602979|27051916|P5|Overall Study|Failed Intubation|0
7782742|NCT00602979|27051917|P4|Overall Study|Failed Intubation|1
7782743|NCT00602979|27051918|P3|Overall Study|Failed Intubation|0
7782744|NCT00602979|27051919|P2|Overall Study|Failed Intubation|1
7782745|NCT00602979|27051920|P1|Overall Study|Failed Intubation|0
7782746|NCT00602979|27051916|P5|Overall Study|Lost to Follow-up|3
7782747|NCT00602979|27051917|P4|Overall Study|Lost to Follow-up|2
7782748|NCT00602979|27051918|P3|Overall Study|Lost to Follow-up|3
7782749|NCT00602979|27051919|P2|Overall Study|Lost to Follow-up|2
7782750|NCT00602979|27051920|P1|Overall Study|Lost to Follow-up|3
7782751|NCT00602927|27051970|P2|Period 3: 13 Days|MRI data quality|2
7782752|NCT00602927|27051971|P1|Period 3: 13 Days|MRI data quality|2
7782753|NCT00602927|27051970|P2|Period 3: 13 Days|Protocol Violation|1
7782754|NCT00602927|27051971|P1|Period 3: 13 Days|Protocol Violation|0
7782755|NCT00602927|27051970|P2|Period 2: 14 Days|Protocol Violation|2
7782756|NCT00602927|27051971|P1|Period 2: 14 Days|Protocol Violation|0
7782757|NCT00602927|27051970|P2|Period 1: 13 Days|Claustrophobia|1
7782758|NCT00602927|27051971|P1|Period 1: 13 Days|Claustrophobia|0
7782759|NCT00602927|27051970|P2|Period 1: 13 Days|Time|0
7782760|NCT00602927|27051971|P1|Period 1: 13 Days|Time|1
7782761|NCT00602927|27051970|P2|Period 1: 13 Days|MRI scanner technical issue|0
7782762|NCT00602927|27051971|P1|Period 1: 13 Days|MRI scanner technical issue|1
7782763|NCT00602927|27051970|P2|Period 1: 13 Days|Protocol Violation|4
7782764|NCT00602927|27051971|P1|Period 1: 13 Days|Protocol Violation|2
7782765|NCT00602797|27051988|P1|Overall Study|Adverse Event|1
7782766|NCT00602667|27052006|P3|Overall Study|Progressive disease prior to therapy|1
7782767|NCT00602667|27052007|P2|Overall Study|Progressive disease prior to therapy|0
7782768|NCT00602667|27052008|P1|Overall Study|Progressive disease prior to therapy|0
7782769|NCT00602667|27052006|P3|Overall Study|Progressive disease|45
7782770|NCT00602667|27052007|P2|Overall Study|Progressive disease|48
7782771|NCT00602667|27052008|P1|Overall Study|Progressive disease|13
7782772|NCT00602667|27052006|P3|Overall Study|Physician Decision|8
7782773|NCT00602667|27052007|P2|Overall Study|Physician Decision|3
7782774|NCT00602667|27052008|P1|Overall Study|Physician Decision|2
7782775|NCT00602667|27052006|P3|Overall Study|Second malignancy|0
7782776|NCT00602667|27052007|P2|Overall Study|Second malignancy|1
7782777|NCT00602667|27052008|P1|Overall Study|Second malignancy|0
7782778|NCT00602667|27052006|P3|Overall Study|Excessive toxicity|0
7782779|NCT00602667|27052007|P2|Overall Study|Excessive toxicity|1
7782780|NCT00602667|27052008|P1|Overall Study|Excessive toxicity|1
7782781|NCT00602667|27052006|P3|Overall Study|Family request|6
7782782|NCT00602667|27052007|P2|Overall Study|Family request|25
7782783|NCT00602667|27052008|P1|Overall Study|Family request|3
7782784|NCT00602667|27052006|P3|Overall Study|Death|1
7782785|NCT00602667|27052007|P2|Overall Study|Death|1
7782786|NCT00602667|27052008|P1|Overall Study|Death|0
7782787|NCT00602667|27052006|P3|Overall Study|Still on Therapy|2
7782788|NCT00602667|27052007|P2|Overall Study|Still on Therapy|2
7782789|NCT00602667|27052008|P1|Overall Study|Still on Therapy|0
7782790|NCT00602641|27052187|P2|Overall Study|Other|1
7782791|NCT00602641|27052188|P1|Overall Study|Other|3
7782792|NCT00602641|27052187|P2|Overall Study|Administrative Closure|1
7782793|NCT00602641|27052188|P1|Overall Study|Administrative Closure|1
7782794|NCT00602641|27052187|P2|Overall Study|Physician Decision|4
7782795|NCT00602641|27052188|P1|Overall Study|Physician Decision|5
7782796|NCT00602641|27052187|P2|Overall Study|Other Complicating Disease|2
7782797|NCT00602641|27052188|P1|Overall Study|Other Complicating Disease|5
7782798|NCT00602641|27052187|P2|Overall Study|Alternative therapy|2
7782799|NCT00602641|27052188|P1|Overall Study|Alternative therapy|5
7782800|NCT00602641|27052187|P2|Overall Study|Withdrawal by Subject|12
7782801|NCT00602641|27052188|P1|Overall Study|Withdrawal by Subject|15
7782802|NCT00602641|27052187|P2|Overall Study|Death|5
7782803|NCT00602641|27052188|P1|Overall Study|Death|6
7782804|NCT00602641|27052187|P2|Overall Study|Disease progression|55
7782805|NCT00602641|27052188|P1|Overall Study|Disease progression|38
7782806|NCT00602641|27052187|P2|Overall Study|Adverse Event|53
7782807|NCT00602641|27052188|P1|Overall Study|Adverse Event|62
7782808|NCT00602641|27052187|P2|Overall Study|Still on treatment at time of analysis|15
7782809|NCT00602641|27052188|P1|Overall Study|Still on treatment at time of analysis|8
7782810|NCT00602641|27052187|P2|Overall Study|Never started protocol therapy|2
7782811|NCT00602641|27052188|P1|Overall Study|Never started protocol therapy|6
7782812|NCT00602537|27052202|P2|Follow Up Study Comparison|Withdrawal by Subject|2
7782813|NCT00602537|27052203|P1|Follow Up Study Comparison|Withdrawal by Subject|2
7782814|NCT00602537|27052202|P2|Follow Up Study Comparison|Lost to Follow-up|1
7782815|NCT00602537|27052203|P1|Follow Up Study Comparison|Lost to Follow-up|8
7782816|NCT00602537|27052202|P2|Follow Up Study Comparison|Adverse Event|0
7782817|NCT00602537|27052203|P1|Follow Up Study Comparison|Adverse Event|1
7782818|NCT00602537|27052202|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
7782819|NCT00602537|27052203|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
7782820|NCT00602537|27052202|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
7782821|NCT00602537|27052203|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
7782822|NCT00602537|27052202|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
7782823|NCT00602537|27052203|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
7782824|NCT00602537|27052202|P2|12 Week Double Blind Comparison|Adverse Event|5
7782825|NCT00602537|27052203|P1|12 Week Double Blind Comparison|Adverse Event|2
7782826|NCT00602472|27052213|P2|Overall Study|Other incl. lack of efficacy|2
7782827|NCT00602472|27052214|P1|Overall Study|Other incl. lack of efficacy|4
7782828|NCT00602472|27052213|P2|Overall Study|Withdrawal by Subject|14
7782829|NCT00602472|27052214|P1|Overall Study|Withdrawal by Subject|8
7782830|NCT00602472|27052213|P2|Overall Study|Protocol Violation|19
7782831|NCT00602472|27052214|P1|Overall Study|Protocol Violation|4
7782832|NCT00602472|27052213|P2|Overall Study|Adverse Event|23
7782833|NCT00602472|27052214|P1|Overall Study|Adverse Event|5
7782834|NCT00602420|27052279|P2|Overall Study|Adverse Event|0
7782835|NCT00602420|27052280|P1|Overall Study|Adverse Event|1
7782836|NCT00602420|27052279|P2|Overall Study|Withdrawal by Subject|17
7782837|NCT00602420|27052280|P1|Overall Study|Withdrawal by Subject|18
7782838|NCT00602420|27052279|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
7782839|NCT00602420|27052280|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
7782840|NCT00602420|27052279|P2|Overall Study|Death|4
7782841|NCT00602420|27052280|P1|Overall Study|Death|1
7782842|NCT00601900|27052388|P2|Overall Study|Withdrawal by Subject|3
7782843|NCT00601900|27052389|P1|Overall Study|Withdrawal by Subject|0
7782844|NCT00601835|27052413|P2|Overall Study|Relocate|2
7782845|NCT00601835|27052414|P1|Overall Study|Relocate|12
7782846|NCT00601835|27052413|P2|Overall Study|Adverse Event|1
7782847|NCT00601835|27052414|P1|Overall Study|Adverse Event|1
7782848|NCT00601835|27052413|P2|Overall Study|Lost to Follow-up|5
7782849|NCT00601835|27052414|P1|Overall Study|Lost to Follow-up|37
7782850|NCT00601835|27052413|P2|Overall Study|Physician Decision|0
7782851|NCT00601835|27052414|P1|Overall Study|Physician Decision|1
7782852|NCT00601835|27052413|P2|Overall Study|Withdrawal by Subject|6
7782853|NCT00601835|27052414|P1|Overall Study|Withdrawal by Subject|9
7782854|NCT00601705|27052503|P1|Overall Study|Withdrawal by Subject|1
7782855|NCT00601640|27052515|P3|Overall Study|change in eligibility status|1
7782856|NCT00601640|27052516|P2|Overall Study|change in eligibility status|1
7782857|NCT00601640|27052517|P1|Overall Study|change in eligibility status|0
7782858|NCT00601640|27052515|P3|Overall Study|intercurrent illness|0
7782859|NCT00601640|27052516|P2|Overall Study|intercurrent illness|0
7782860|NCT00601640|27052517|P1|Overall Study|intercurrent illness|1
7782861|NCT00601640|27052515|P3|Overall Study|Adverse Event|2
7782862|NCT00601640|27052516|P2|Overall Study|Adverse Event|4
7782863|NCT00601640|27052517|P1|Overall Study|Adverse Event|0
7782864|NCT00601640|27052515|P3|Overall Study|Death|0
7782865|NCT00601640|27052516|P2|Overall Study|Death|0
7782866|NCT00601640|27052517|P1|Overall Study|Death|1
7782867|NCT00601640|27052515|P3|Overall Study|Withdrawal by Subject|7
7782868|NCT00601640|27052516|P2|Overall Study|Withdrawal by Subject|0
7782869|NCT00601640|27052517|P1|Overall Study|Withdrawal by Subject|3
7782870|NCT00601523|27052542|P2|Overall Study|Other|1
7782871|NCT00601523|27052543|P1|Overall Study|Other|9
7782872|NCT00601523|27052542|P2|Overall Study|Withdrawal by Subject|9
7782873|NCT00601523|27052543|P1|Overall Study|Withdrawal by Subject|18
7782874|NCT00601523|27052542|P2|Overall Study|Lost to Follow-up|1
7782875|NCT00601523|27052543|P1|Overall Study|Lost to Follow-up|0
7782876|NCT00601523|27052542|P2|Overall Study|Protocol Violation|1
7782877|NCT00601523|27052543|P1|Overall Study|Protocol Violation|5
7782878|NCT00601523|27052542|P2|Overall Study|Lack of Efficacy|0
7782879|NCT00601523|27052543|P1|Overall Study|Lack of Efficacy|3
7782880|NCT00601523|27052542|P2|Overall Study|Adverse Event|14
7782881|NCT00601523|27052543|P1|Overall Study|Adverse Event|42
7782882|NCT00601484|27052577|P2|Overall Study|Randomized, but not treated|1
7782883|NCT00601484|27052578|P1|Overall Study|Randomized, but not treated|0
7782884|NCT00601484|27052577|P2|Overall Study|Withdrawal by Subject|1
7782885|NCT00601484|27052578|P1|Overall Study|Withdrawal by Subject|1
7782886|NCT00601484|27052577|P2|Overall Study|Lack of Efficacy|2
7782887|NCT00601484|27052578|P1|Overall Study|Lack of Efficacy|0
7782888|NCT00601484|27052577|P2|Overall Study|Lost to Follow-up|3
7782889|NCT00601484|27052578|P1|Overall Study|Lost to Follow-up|4
7782890|NCT00601484|27052577|P2|Overall Study|Adverse Event|1
7782891|NCT00601484|27052578|P1|Overall Study|Adverse Event|0
7782892|NCT00601458|27052675|P3|Overall Study|Early Termination|1
7782893|NCT00601458|27052676|P2|Overall Study|Early Termination|1
7782894|NCT00601458|27052677|P1|Overall Study|Early Termination|0
7782895|NCT00601458|27052675|P3|Overall Study|Protocol Violation|1
7782896|NCT00601458|27052676|P2|Overall Study|Protocol Violation|2
7782897|NCT00601458|27052677|P1|Overall Study|Protocol Violation|3
7782898|NCT00601458|27052675|P3|Overall Study|Incomplete Data|0
7782899|NCT00601458|27052676|P2|Overall Study|Incomplete Data|2
7782900|NCT00601458|27052677|P1|Overall Study|Incomplete Data|0
7782901|NCT00601458|27052675|P3|Overall Study|Dosing Error|0
7782902|NCT00601458|27052676|P2|Overall Study|Dosing Error|0
7782903|NCT00601458|27052677|P1|Overall Study|Dosing Error|1
7782904|NCT00601419|27052688|P1|Overall Study|Missed Visits|1
7782905|NCT00601419|27052688|P1|Overall Study|Lost to Follow-up|3
7782906|NCT00601354|27052718|P2|Overall Study|Lost to Follow-up|5
7782907|NCT00601354|27052719|P1|Overall Study|Lost to Follow-up|4
7782908|NCT00601250|27052731|P2|Overall Study|Other incl. lack of efficacy|9
7782909|NCT00601250|27052732|P1|Overall Study|Other incl. lack of efficacy|2
7782910|NCT00601250|27052731|P2|Overall Study|Withdrawal by Subject|13
7782911|NCT00601250|27052732|P1|Overall Study|Withdrawal by Subject|4
7782912|NCT00601250|27052731|P2|Overall Study|Lost to Follow-up|6
7782913|NCT00601250|27052732|P1|Overall Study|Lost to Follow-up|2
7782914|NCT00601250|27052731|P2|Overall Study|Protocol Violation|2
7782915|NCT00601250|27052732|P1|Overall Study|Protocol Violation|3
7782916|NCT00601250|27052731|P2|Overall Study|Adverse Event|9
7782917|NCT00601250|27052732|P1|Overall Study|Adverse Event|3
7782918|NCT00601172|27052768|P2|Overall Study|Did not meet continuation criteria|20
7782919|NCT00601172|27052769|P1|Overall Study|Did not meet continuation criteria|19
7782920|NCT00601172|27052768|P2|Overall Study|Withdrawal by Subject|27
7782921|NCT00601172|27052769|P1|Overall Study|Withdrawal by Subject|35
7782922|NCT00601172|27052768|P2|Overall Study|Physician Decision|28
7782923|NCT00601172|27052769|P1|Overall Study|Physician Decision|27
7782924|NCT00601172|27052768|P2|Overall Study|Lost to Follow-up|3
7782925|NCT00601172|27052769|P1|Overall Study|Lost to Follow-up|4
7782926|NCT00601172|27052768|P2|Overall Study|Protocol Violation|5
7782927|NCT00601172|27052769|P1|Overall Study|Protocol Violation|2
7782928|NCT00601172|27052768|P2|Overall Study|Lack of Efficacy|12
7782929|NCT00601172|27052769|P1|Overall Study|Lack of Efficacy|11
7782930|NCT00601172|27052768|P2|Overall Study|Adverse Event|32
7782931|NCT00601172|27052769|P1|Overall Study|Adverse Event|43
7782932|NCT00601107|27052826|P4|Overall Study|Undefined|0
7782933|NCT00601107|27052827|P3|Overall Study|Undefined|1
7782934|NCT00601107|27052828|P2|Overall Study|Undefined|0
7782935|NCT00601107|27052829|P1|Overall Study|Undefined|1
7782936|NCT00601107|27052826|P4|Overall Study|Worsening of Psoriasis|4
7782937|NCT00601107|27052827|P3|Overall Study|Worsening of Psoriasis|1
7782938|NCT00601107|27052828|P2|Overall Study|Worsening of Psoriasis|1
7782939|NCT00601107|27052829|P1|Overall Study|Worsening of Psoriasis|4
7782940|NCT00601107|27052826|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
7782941|NCT00601107|27052827|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7782942|NCT00601107|27052828|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7782943|NCT00601107|27052829|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7782944|NCT00601107|27052826|P4|Overall Study|Lost to Follow-up|3
7782945|NCT00601107|27052827|P3|Overall Study|Lost to Follow-up|0
7782946|NCT00601107|27052828|P2|Overall Study|Lost to Follow-up|3
7782947|NCT00601107|27052829|P1|Overall Study|Lost to Follow-up|3
7782948|NCT00601107|27052826|P4|Overall Study|Withdrawal by Subject|4
7782949|NCT00601107|27052827|P3|Overall Study|Withdrawal by Subject|7
7782950|NCT00601107|27052828|P2|Overall Study|Withdrawal by Subject|4
7782951|NCT00601107|27052829|P1|Overall Study|Withdrawal by Subject|5
7782952|NCT00601107|27052826|P4|Overall Study|Adverse Event|0
7782953|NCT00601107|27052827|P3|Overall Study|Adverse Event|3
7782954|NCT00601107|27052828|P2|Overall Study|Adverse Event|1
7782955|NCT00601107|27052829|P1|Overall Study|Adverse Event|0
7782956|NCT00600938|27052849|P4|Extension Study|Death|0
7782957|NCT00600938|27052850|P3|Extension Study|Death|0
7782958|NCT00600938|27052851|P2|Extension Study|Death|0
7782959|NCT00600938|27052852|P1|Extension Study|Death|1
7782960|NCT00600938|27052849|P4|Extension Study|Lost to Follow-up|0
7782961|NCT00600938|27052850|P3|Extension Study|Lost to Follow-up|2
7782962|NCT00600938|27052851|P2|Extension Study|Lost to Follow-up|1
7782963|NCT00600938|27052852|P1|Extension Study|Lost to Follow-up|1
7782964|NCT00600938|27052849|P4|Extension Study|Withdrawal by Subject|0
7782965|NCT00600938|27052850|P3|Extension Study|Withdrawal by Subject|3
7782966|NCT00600938|27052851|P2|Extension Study|Withdrawal by Subject|2
7782967|NCT00600938|27052852|P1|Extension Study|Withdrawal by Subject|2
7782968|NCT00600938|27052849|P4|Extension Study|Unsatisfactory therapeutic effect|0
7782969|NCT00600938|27052850|P3|Extension Study|Unsatisfactory therapeutic effect|1
7782970|NCT00600938|27052851|P2|Extension Study|Unsatisfactory therapeutic effect|1
7782971|NCT00600938|27052852|P1|Extension Study|Unsatisfactory therapeutic effect|4
7782972|NCT00600938|27052849|P4|Extension Study|Abnormal test procedure results|1
7782973|NCT00600938|27052850|P3|Extension Study|Abnormal test procedure results|1
7782974|NCT00600938|27052851|P2|Extension Study|Abnormal test procedure results|1
7782975|NCT00600938|27052852|P1|Extension Study|Abnormal test procedure results|0
7782976|NCT00600938|27052849|P4|Extension Study|Adverse Event|0
7782977|NCT00600938|27052850|P3|Extension Study|Adverse Event|2
7782978|NCT00600938|27052851|P2|Extension Study|Adverse Event|0
7782979|NCT00600938|27052852|P1|Extension Study|Adverse Event|1
7782980|NCT00600938|27052849|P4|Core Study|Protocol Violation|0
7782981|NCT00600938|27052850|P3|Core Study|Protocol Violation|0
7782982|NCT00600938|27052851|P2|Core Study|Protocol Violation|2
7782983|NCT00600938|27052852|P1|Core Study|Protocol Violation|1
7782984|NCT00600938|27052849|P4|Core Study|Death|0
7782985|NCT00600938|27052850|P3|Core Study|Death|0
7782986|NCT00600938|27052851|P2|Core Study|Death|1
7782987|NCT00600938|27052852|P1|Core Study|Death|1
7782988|NCT00600938|27052849|P4|Core Study|Lost to Follow-up|0
7782989|NCT00600938|27052850|P3|Core Study|Lost to Follow-up|0
7782990|NCT00600938|27052851|P2|Core Study|Lost to Follow-up|2
7782991|NCT00600938|27052852|P1|Core Study|Lost to Follow-up|3
7782992|NCT00600938|27052849|P4|Core Study|Patient withdrew consent|0
7782993|NCT00600938|27052850|P3|Core Study|Patient withdrew consent|0
7782994|NCT00600938|27052851|P2|Core Study|Patient withdrew consent|12
7782995|NCT00600938|27052852|P1|Core Study|Patient withdrew consent|7
7782996|NCT00600938|27052849|P4|Core Study|Unsatisfactory therapeutic effect|0
7782997|NCT00600938|27052850|P3|Core Study|Unsatisfactory therapeutic effect|0
7782998|NCT00600938|27052851|P2|Core Study|Unsatisfactory therapeutic effect|2
7782999|NCT00600938|27052852|P1|Core Study|Unsatisfactory therapeutic effect|1
7783000|NCT00600938|27052849|P4|Core Study|Abnormal test procedure result(s)|0
7783001|NCT00600938|27052850|P3|Core Study|Abnormal test procedure result(s)|0
7783002|NCT00600938|27052851|P2|Core Study|Abnormal test procedure result(s)|2
7783003|NCT00600938|27052852|P1|Core Study|Abnormal test procedure result(s)|3
7783004|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Death|0
7783005|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Death|1
7783006|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
7783007|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
7783008|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
7783009|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
7783010|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Administrative Problems|4
7783011|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Administrative Problems|4
7783012|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
7783013|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
7783014|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
7783015|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
7783016|NCT00600886|27052935|P2|Extension - After Crossover (CAS)|Adverse Event|1
7783017|NCT00600886|27052936|P1|Extension - After Crossover (CAS)|Adverse Event|19
7783018|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
7783019|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
7783020|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Death|1
7783021|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Death|1
7783022|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
7783023|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
7783024|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Adverse Event|1
7783025|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Adverse Event|4
7783026|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
7783027|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
7783028|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
7783029|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
7783030|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
7783031|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
7783032|NCT00600886|27052935|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
7783033|NCT00600886|27052936|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
7783034|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Death|1
7783035|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Death|0
7783036|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
7783037|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
7783038|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
7783039|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
7783040|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
7783041|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
7783042|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
7783043|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
7783044|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
7783045|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
7783046|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
7783047|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
7783048|NCT00600886|27052935|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
7783049|NCT00600886|27052936|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
7783050|NCT00600821|27053000|P2|Overall Study|Other|3
7783051|NCT00600821|27053001|P1|Overall Study|Other|2
7783052|NCT00600821|27053000|P2|Overall Study|Randomized but not treated|1
7783053|NCT00600821|27053001|P1|Overall Study|Randomized but not treated|0
7783054|NCT00600821|27053000|P2|Overall Study|Objective progression or relapse|1
7783055|NCT00600821|27053001|P1|Overall Study|Objective progression or relapse|0
7783056|NCT00600821|27053000|P2|Overall Study|Terminated by sponsor|6
7783057|NCT00600821|27053001|P1|Overall Study|Terminated by sponsor|8
7783058|NCT00600821|27053000|P2|Overall Study|Withdrawal by Subject|1
7783059|NCT00600821|27053001|P1|Overall Study|Withdrawal by Subject|1
7783060|NCT00600821|27053000|P2|Overall Study|Lost to Follow-up|2
7783061|NCT00600821|27053001|P1|Overall Study|Lost to Follow-up|2
7783062|NCT00600821|27053000|P2|Overall Study|Death|46
7783063|NCT00600821|27053001|P1|Overall Study|Death|45
7783064|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
7783065|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
7783066|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
7783067|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
7783068|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
7783069|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
7783070|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
7783071|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
7783072|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
7783073|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
7783074|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
7783075|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
7783076|NCT00600756|27053029|P2|Overall Study Analysis After 12 Months|Adverse Event|44
7783077|NCT00600756|27053030|P1|Overall Study Analysis After 12 Months|Adverse Event|53
7783078|NCT00600756|27053029|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
7783079|NCT00600756|27053030|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
7783080|NCT00600756|27053029|P2|Analysis After 6 Months|Lost to Follow-up|8
7783081|NCT00600756|27053030|P1|Analysis After 6 Months|Lost to Follow-up|10
7783082|NCT00600756|27053029|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
7783083|NCT00600756|27053030|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
7783084|NCT00600756|27053029|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
7783085|NCT00600756|27053030|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
7783086|NCT00600756|27053029|P2|Analysis After 6 Months|Incorrect Enrollment|21
7783087|NCT00600756|27053030|P1|Analysis After 6 Months|Incorrect Enrollment|12
7783088|NCT00600756|27053029|P2|Analysis After 6 Months|Withdrawal by Subject|30
7783089|NCT00600756|27053030|P1|Analysis After 6 Months|Withdrawal by Subject|38
7783090|NCT00600756|27053029|P2|Analysis After 6 Months|Adverse Event|33
7783091|NCT00600756|27053030|P1|Analysis After 6 Months|Adverse Event|43
7783092|NCT00600613|27053139|P1|Overall Study|Protocol Deviation|1
7783093|NCT00600353|27053145|P2|Overall Study|History of prepartive regimen|1
7783094|NCT00600353|27053146|P1|Overall Study|History of prepartive regimen|0
7783095|NCT00600353|27053145|P2|Overall Study|history of malignancy within 5 years|0
7783096|NCT00600353|27053146|P1|Overall Study|history of malignancy within 5 years|1
7783097|NCT00600171|27053209|P6|Overall Study|Lost to Follow-up|0
7783098|NCT00600171|27053210|P5|Overall Study|Lost to Follow-up|0
7783099|NCT00600171|27053211|P4|Overall Study|Lost to Follow-up|1
7783100|NCT00600171|27053212|P3|Overall Study|Lost to Follow-up|0
7783101|NCT00600171|27053213|P2|Overall Study|Lost to Follow-up|0
7783102|NCT00600171|27053214|P1|Overall Study|Lost to Follow-up|0
7783103|NCT00600171|27053209|P6|Overall Study|Physician Decision|2
7783104|NCT00600171|27053210|P5|Overall Study|Physician Decision|0
7783105|NCT00600171|27053211|P4|Overall Study|Physician Decision|1
7783106|NCT00600171|27053212|P3|Overall Study|Physician Decision|0
7783107|NCT00600171|27053213|P2|Overall Study|Physician Decision|1
7783108|NCT00600171|27053214|P1|Overall Study|Physician Decision|0
7783109|NCT00600171|27053209|P6|Overall Study|Withdrawal by Subject|1
7783110|NCT00600171|27053210|P5|Overall Study|Withdrawal by Subject|1
7783111|NCT00600171|27053211|P4|Overall Study|Withdrawal by Subject|1
7783112|NCT00600171|27053212|P3|Overall Study|Withdrawal by Subject|0
7783113|NCT00600171|27053213|P2|Overall Study|Withdrawal by Subject|0
7783114|NCT00600171|27053214|P1|Overall Study|Withdrawal by Subject|3
7783115|NCT00600171|27053209|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
7783116|NCT00600171|27053210|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
7783117|NCT00600171|27053211|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
7783118|NCT00600171|27053212|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
7783119|NCT00600171|27053213|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
7783120|NCT00600171|27053214|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
7783121|NCT00600171|27053209|P6|Overall Study|Protocol Violation|0
7783122|NCT00600171|27053210|P5|Overall Study|Protocol Violation|0
7783123|NCT00600171|27053211|P4|Overall Study|Protocol Violation|1
7783124|NCT00600171|27053212|P3|Overall Study|Protocol Violation|0
7783125|NCT00600171|27053213|P2|Overall Study|Protocol Violation|2
7783126|NCT00600171|27053214|P1|Overall Study|Protocol Violation|1
7783127|NCT00600171|27053209|P6|Overall Study|Lack of Efficacy|0
7783128|NCT00600171|27053210|P5|Overall Study|Lack of Efficacy|4
7783129|NCT00600171|27053211|P4|Overall Study|Lack of Efficacy|5
7783130|NCT00600171|27053212|P3|Overall Study|Lack of Efficacy|3
7783131|NCT00600171|27053213|P2|Overall Study|Lack of Efficacy|12
7783132|NCT00600171|27053214|P1|Overall Study|Lack of Efficacy|9
7783133|NCT00600171|27053209|P6|Overall Study|Adverse Event|0
7783134|NCT00600171|27053210|P5|Overall Study|Adverse Event|1
7783135|NCT00600171|27053211|P4|Overall Study|Adverse Event|0
7783136|NCT00600171|27053212|P3|Overall Study|Adverse Event|0
7783137|NCT00600171|27053213|P2|Overall Study|Adverse Event|1
7783138|NCT00600171|27053214|P1|Overall Study|Adverse Event|0
7783139|NCT00600119|27053288|P6|Follow-up Period|Other|0
7783140|NCT00600119|27053289|P5|Follow-up Period|Other|0
7783141|NCT00600119|27053290|P4|Follow-up Period|Other|0
7783142|NCT00600119|27053291|P3|Follow-up Period|Other|0
7783143|NCT00600119|27053292|P2|Follow-up Period|Other|0
7783144|NCT00600119|27053293|P1|Follow-up Period|Other|1
7783145|NCT00600119|27053288|P6|Follow-up Period|Adverse Event|1
7783146|NCT00600119|27053289|P5|Follow-up Period|Adverse Event|0
7783147|NCT00600119|27053290|P4|Follow-up Period|Adverse Event|0
7783148|NCT00600119|27053291|P3|Follow-up Period|Adverse Event|0
7783149|NCT00600119|27053292|P2|Follow-up Period|Adverse Event|0
7783150|NCT00600119|27053293|P1|Follow-up Period|Adverse Event|0
7783151|NCT00600119|27053288|P6|Double-blind Treatment Period|Adverse Event|10
7783152|NCT00600119|27053289|P5|Double-blind Treatment Period|Adverse Event|2
7783153|NCT00600119|27053290|P4|Double-blind Treatment Period|Adverse Event|1
7783154|NCT00600119|27053291|P3|Double-blind Treatment Period|Adverse Event|0
7783155|NCT00600119|27053292|P2|Double-blind Treatment Period|Adverse Event|1
7783156|NCT00600119|27053293|P1|Double-blind Treatment Period|Adverse Event|1
7783157|NCT00600119|27053288|P6|Double-blind Treatment Period|Lost to Follow-up|0
7783158|NCT00600119|27053289|P5|Double-blind Treatment Period|Lost to Follow-up|0
7783159|NCT00600119|27053290|P4|Double-blind Treatment Period|Lost to Follow-up|0
7783160|NCT00600119|27053291|P3|Double-blind Treatment Period|Lost to Follow-up|0
7783161|NCT00600119|27053292|P2|Double-blind Treatment Period|Lost to Follow-up|1
7783162|NCT00600119|27053293|P1|Double-blind Treatment Period|Lost to Follow-up|0
7783163|NCT00600119|27053288|P6|Double-blind Treatment Period|Physician Decision|0
7783164|NCT00600119|27053289|P5|Double-blind Treatment Period|Physician Decision|0
7783165|NCT00600119|27053290|P4|Double-blind Treatment Period|Physician Decision|0
7783166|NCT00600119|27053291|P3|Double-blind Treatment Period|Physician Decision|0
7783167|NCT00600119|27053292|P2|Double-blind Treatment Period|Physician Decision|0
7783168|NCT00600119|27053293|P1|Double-blind Treatment Period|Physician Decision|2
7783169|NCT00600119|27053288|P6|Double-blind Treatment Period|Sponsor Decision|0
7783170|NCT00600119|27053289|P5|Double-blind Treatment Period|Sponsor Decision|1
7783171|NCT00600119|27053290|P4|Double-blind Treatment Period|Sponsor Decision|0
7783172|NCT00600119|27053291|P3|Double-blind Treatment Period|Sponsor Decision|0
7783173|NCT00600119|27053292|P2|Double-blind Treatment Period|Sponsor Decision|1
7783174|NCT00600119|27053293|P1|Double-blind Treatment Period|Sponsor Decision|0
7783175|NCT00600119|27053288|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7783176|NCT00600119|27053289|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7783177|NCT00600119|27053290|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7783178|NCT00600119|27053291|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7783179|NCT00600119|27053292|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
7783180|NCT00600119|27053293|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7783181|NCT00600119|27053288|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7783182|NCT00600119|27053289|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
7783183|NCT00600119|27053290|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7783184|NCT00600119|27053291|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7783185|NCT00600119|27053292|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
7783186|NCT00600119|27053293|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7783187|NCT00600119|27053288|P6|Double-blind Treatment Period|Other|1
7783188|NCT00600119|27053289|P5|Double-blind Treatment Period|Other|2
7783189|NCT00600119|27053290|P4|Double-blind Treatment Period|Other|0
7783190|NCT00600119|27053291|P3|Double-blind Treatment Period|Other|0
7783191|NCT00600119|27053292|P2|Double-blind Treatment Period|Other|0
7783192|NCT00600119|27053293|P1|Double-blind Treatment Period|Other|0
7783193|NCT00600119|27053288|P6|Double-blind Treatment Period|Withdrawal by Subject|3
7783194|NCT00600119|27053289|P5|Double-blind Treatment Period|Withdrawal by Subject|0
7783195|NCT00600119|27053290|P4|Double-blind Treatment Period|Withdrawal by Subject|1
7783196|NCT00600119|27053291|P3|Double-blind Treatment Period|Withdrawal by Subject|0
7783197|NCT00600119|27053292|P2|Double-blind Treatment Period|Withdrawal by Subject|0
7783198|NCT00600119|27053293|P1|Double-blind Treatment Period|Withdrawal by Subject|2
7783199|NCT00600119|27053288|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7783200|NCT00600119|27053289|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7783201|NCT00600119|27053290|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7783202|NCT00600119|27053291|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7783203|NCT00600119|27053292|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
7783204|NCT00600119|27053293|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
7783205|NCT00600119|27053288|P6|Single-blind Placebo run-in Period|Adverse Event|1
7783206|NCT00600119|27053289|P5|Single-blind Placebo run-in Period|Adverse Event|0
7783207|NCT00600119|27053290|P4|Single-blind Placebo run-in Period|Adverse Event|1
7783208|NCT00600119|27053291|P3|Single-blind Placebo run-in Period|Adverse Event|0
7783209|NCT00600119|27053292|P2|Single-blind Placebo run-in Period|Adverse Event|0
7783210|NCT00600119|27053293|P1|Single-blind Placebo run-in Period|Adverse Event|0
7783211|NCT00600119|27053288|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
7783212|NCT00600119|27053289|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
7783213|NCT00600119|27053290|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
7783214|NCT00600119|27053291|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
7783215|NCT00600119|27053292|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
7783216|NCT00600119|27053293|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
7783217|NCT00600119|27053288|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
7783218|NCT00600119|27053289|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
7783219|NCT00600119|27053290|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
7783220|NCT00600119|27053291|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
7783221|NCT00600119|27053292|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
7783222|NCT00600119|27053293|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
7783223|NCT00600119|27053288|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7783224|NCT00600119|27053289|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7783225|NCT00600119|27053290|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7783226|NCT00600119|27053291|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
7783227|NCT00600119|27053292|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
7783228|NCT00600119|27053293|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7783229|NCT00600119|27053288|P6|Single-blind Placebo run-in Period|Other - Not specified|1
7783230|NCT00600119|27053289|P5|Single-blind Placebo run-in Period|Other - Not specified|1
7783231|NCT00600119|27053290|P4|Single-blind Placebo run-in Period|Other - Not specified|0
7783232|NCT00600119|27053291|P3|Single-blind Placebo run-in Period|Other - Not specified|0
7783233|NCT00600119|27053292|P2|Single-blind Placebo run-in Period|Other - Not specified|0
7783234|NCT00600119|27053293|P1|Single-blind Placebo run-in Period|Other - Not specified|1
7783235|NCT00600106|27053327|P2|Overall Study|Withdrawal by Subject|1
7783236|NCT00600106|27053328|P1|Overall Study|Withdrawal by Subject|1
7783237|NCT00600067|27053375|P2|Overall Study|Lack of Efficacy|0
7783238|NCT00600067|27053376|P1|Overall Study|Lack of Efficacy|1
7783239|NCT00600067|27053375|P2|Overall Study|protocol non-compliance|3
7783240|NCT00600067|27053376|P1|Overall Study|protocol non-compliance|0
7783241|NCT00600067|27053375|P2|Overall Study|Lost to Follow-up|3
7783242|NCT00600067|27053376|P1|Overall Study|Lost to Follow-up|2
7783243|NCT00600067|27053375|P2|Overall Study|Adverse Event|1
7783244|NCT00600067|27053376|P1|Overall Study|Adverse Event|0
7783245|NCT00600028|27053386|P2|Second Intervention (12 Weeks)|Adverse Event|2
7783246|NCT00600028|27053387|P1|Second Intervention (12 Weeks)|Adverse Event|0
7783247|NCT00600028|27053386|P2|First Intervention (12 Weeks)|Adverse Event|1
7783248|NCT00600028|27053387|P1|First Intervention (12 Weeks)|Adverse Event|0
7783249|NCT00600028|27053386|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
7783250|NCT00600028|27053387|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
7783251|NCT00599924|27053417|P7|Overall Study|Other|2
7783252|NCT00599924|27053418|P6|Overall Study|Other|0
7783253|NCT00599924|27053419|P5|Overall Study|Other|2
7783254|NCT00599924|27053420|P4|Overall Study|Other|1
7783255|NCT00599924|27053421|P3|Overall Study|Other|0
7783256|NCT00599924|27053422|P2|Overall Study|Other|0
7783257|NCT00599924|27053423|P1|Overall Study|Other|0
7783258|NCT00599924|27053417|P7|Overall Study|Withdrawal by Subject|0
7783259|NCT00599924|27053418|P6|Overall Study|Withdrawal by Subject|0
7783260|NCT00599924|27053419|P5|Overall Study|Withdrawal by Subject|1
7783261|NCT00599924|27053420|P4|Overall Study|Withdrawal by Subject|0
7783262|NCT00599924|27053421|P3|Overall Study|Withdrawal by Subject|1
7783263|NCT00599924|27053422|P2|Overall Study|Withdrawal by Subject|0
7783264|NCT00599924|27053423|P1|Overall Study|Withdrawal by Subject|0
7783265|NCT00599924|27053417|P7|Overall Study|Protocol Violation|0
7783266|NCT00599924|27053418|P6|Overall Study|Protocol Violation|0
7783267|NCT00599924|27053419|P5|Overall Study|Protocol Violation|0
7783268|NCT00599924|27053420|P4|Overall Study|Protocol Violation|1
7783269|NCT00599924|27053421|P3|Overall Study|Protocol Violation|0
7783270|NCT00599924|27053422|P2|Overall Study|Protocol Violation|0
7783271|NCT00599924|27053423|P1|Overall Study|Protocol Violation|0
7783272|NCT00599924|27053417|P7|Overall Study|Death|1
7783273|NCT00599924|27053418|P6|Overall Study|Death|2
7783274|NCT00599924|27053419|P5|Overall Study|Death|0
7783275|NCT00599924|27053420|P4|Overall Study|Death|2
7783276|NCT00599924|27053421|P3|Overall Study|Death|0
7783277|NCT00599924|27053422|P2|Overall Study|Death|0
7783278|NCT00599924|27053423|P1|Overall Study|Death|0
7783279|NCT00599924|27053417|P7|Overall Study|Adverse Event|2
7783280|NCT00599924|27053418|P6|Overall Study|Adverse Event|0
7783281|NCT00599924|27053419|P5|Overall Study|Adverse Event|0
7783282|NCT00599924|27053420|P4|Overall Study|Adverse Event|2
7783283|NCT00599924|27053421|P3|Overall Study|Adverse Event|0
7783284|NCT00599924|27053422|P2|Overall Study|Adverse Event|0
7783285|NCT00599924|27053423|P1|Overall Study|Adverse Event|0
7783286|NCT00599924|27053417|P7|Overall Study|Lack of Efficacy|0
7783287|NCT00599924|27053418|P6|Overall Study|Lack of Efficacy|2
7783288|NCT00599924|27053419|P5|Overall Study|Lack of Efficacy|3
7783289|NCT00599924|27053420|P4|Overall Study|Lack of Efficacy|2
7783290|NCT00599924|27053421|P3|Overall Study|Lack of Efficacy|1
7783291|NCT00599924|27053422|P2|Overall Study|Lack of Efficacy|5
7783292|NCT00599924|27053423|P1|Overall Study|Lack of Efficacy|3
7783293|NCT00599755|27053527|P1|Overall Study|No data available|1
7783294|NCT00599755|27053527|P1|Overall Study|Other Reason|2
7783295|NCT00599755|27053527|P1|Overall Study|Progression of Disease|3
7783296|NCT00599755|27053527|P1|Overall Study|Withdrawal by Subject|2
7783297|NCT00599755|27053527|P1|Overall Study|Adverse Event|11
7783298|NCT00599638|27053540|P4|Second Intervention Period (2 Weeks)|Protocol Violation|0
7783299|NCT00599638|27053541|P3|Second Intervention Period (2 Weeks)|Protocol Violation|0
7783300|NCT00599638|27053542|P2|Second Intervention Period (2 Weeks)|Protocol Violation|0
7783301|NCT00599638|27053543|P1|Second Intervention Period (2 Weeks)|Protocol Violation|1
7783302|NCT00599638|27053540|P4|Washout Period (2 Weeks)|Protocol Violation|0
7783303|NCT00599638|27053541|P3|Washout Period (2 Weeks)|Protocol Violation|0
7783304|NCT00599638|27053542|P2|Washout Period (2 Weeks)|Protocol Violation|1
7783305|NCT00599638|27053543|P1|Washout Period (2 Weeks)|Protocol Violation|0
7783306|NCT00599638|27053540|P4|Washout Period (2 Weeks)|Lost to Follow-up|1
7783307|NCT00599638|27053541|P3|Washout Period (2 Weeks)|Lost to Follow-up|0
7783308|NCT00599638|27053542|P2|Washout Period (2 Weeks)|Lost to Follow-up|0
7783309|NCT00599638|27053543|P1|Washout Period (2 Weeks)|Lost to Follow-up|0
7783310|NCT00599638|27053540|P4|Washout Period (2 Weeks)|Adverse Event|1
7783311|NCT00599638|27053541|P3|Washout Period (2 Weeks)|Adverse Event|0
7783312|NCT00599638|27053542|P2|Washout Period (2 Weeks)|Adverse Event|0
7783313|NCT00599638|27053543|P1|Washout Period (2 Weeks)|Adverse Event|0
7783314|NCT00599638|27053540|P4|Washout Period (2 Weeks)|Withdrawal by Subject|1
7783315|NCT00599638|27053541|P3|Washout Period (2 Weeks)|Withdrawal by Subject|0
7783316|NCT00599638|27053542|P2|Washout Period (2 Weeks)|Withdrawal by Subject|0
7783317|NCT00599638|27053543|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
7783318|NCT00599638|27053540|P4|First Intervention Period (2 Weeks)|Randomized but not Treated|1
7783319|NCT00599638|27053541|P3|First Intervention Period (2 Weeks)|Randomized but not Treated|0
7783320|NCT00599638|27053542|P2|First Intervention Period (2 Weeks)|Randomized but not Treated|1
7783321|NCT00599638|27053543|P1|First Intervention Period (2 Weeks)|Randomized but not Treated|0
7783322|NCT00599638|27053540|P4|First Intervention Period (2 Weeks)|Protocol Violation|1
7783323|NCT00599638|27053541|P3|First Intervention Period (2 Weeks)|Protocol Violation|0
7783324|NCT00599638|27053542|P2|First Intervention Period (2 Weeks)|Protocol Violation|1
7783325|NCT00599638|27053543|P1|First Intervention Period (2 Weeks)|Protocol Violation|0
7783326|NCT00599638|27053540|P4|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
7783327|NCT00599638|27053541|P3|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
7783328|NCT00599638|27053542|P2|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
7783329|NCT00599638|27053543|P1|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
7783330|NCT00599638|27053540|P4|First Intervention Period (2 Weeks)|Adverse Event|2
7783331|NCT00599638|27053541|P3|First Intervention Period (2 Weeks)|Adverse Event|3
7783332|NCT00599638|27053542|P2|First Intervention Period (2 Weeks)|Adverse Event|0
7783333|NCT00599638|27053543|P1|First Intervention Period (2 Weeks)|Adverse Event|1
7783334|NCT00599521|27053577|P2|Overall Study|Pregnancy|2
7783335|NCT00599521|27053578|P1|Overall Study|Pregnancy|0
7783336|NCT00599521|27053577|P2|Overall Study|Lost to Follow-up|23
7783337|NCT00599521|27053578|P1|Overall Study|Lost to Follow-up|23
7783338|NCT00599521|27053577|P2|Overall Study|Protocol Violation|1
7783339|NCT00599521|27053578|P1|Overall Study|Protocol Violation|1
7783340|NCT00599521|27053577|P2|Overall Study|Withdrawal by Subject|34
7783341|NCT00599521|27053578|P1|Overall Study|Withdrawal by Subject|28
7783342|NCT00599521|27053577|P2|Overall Study|Adverse Event|1
7783343|NCT00599521|27053578|P1|Overall Study|Adverse Event|4
7783344|NCT00599521|27053577|P2|Overall Study|Lack of Efficacy|8
7783345|NCT00599521|27053578|P1|Overall Study|Lack of Efficacy|4
7783346|NCT00599339|27053592|P1|Overall Study|Study Termination Status Unknown|12
7783347|NCT00599339|27053592|P1|Overall Study|No valid data consent|36
7783348|NCT00599339|27053592|P1|Overall Study|Lost to Follow-up|221
7783349|NCT00599339|27053592|P1|Overall Study|Other Reason|179
7783350|NCT00599339|27053592|P1|Overall Study|Withdrawal by Subject|137
7783351|NCT00599339|27053592|P1|Overall Study|Adverse Event|79
7783352|NCT00599326|27053694|P1|Overall Study|Noncompliant|1
7783353|NCT00599326|27053694|P1|Overall Study|Lost to Follow-up|1
7783354|NCT00599313|27053699|P1|Overall Study|Ineligible|1
7783355|NCT00599313|27053699|P1|Overall Study|Patient Request|4
7783356|NCT00599313|27053699|P1|Overall Study|Disease Progression|12
7783357|NCT00599313|27053699|P1|Overall Study|Adverse Event|19
7783358|NCT00599196|27053741|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
7783359|NCT00599196|27053741|P1|Overall Study|Other: Patient Stopped Due To Moving|1
7783360|NCT00599196|27053741|P1|Overall Study|Other: Pt Moved To Australia|1
7783361|NCT00599196|27053741|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
7783362|NCT00599196|27053741|P1|Overall Study|Other: Spouse Withdrew Consent|1
7783363|NCT00599196|27053741|P1|Overall Study|Other: Patient Leaving For Israel|1
7783364|NCT00599196|27053741|P1|Overall Study|Lost to Follow-up|17
7783365|NCT00599196|27053741|P1|Overall Study|Study ended per sponsor|197
7783366|NCT00599196|27053741|P1|Overall Study|Subject withdrew consent|43
7783367|NCT00599196|27053741|P1|Overall Study|Unsatisfactory compliance of subject|3
7783368|NCT00599196|27053741|P1|Overall Study|Adverse Event|93
7783369|NCT00599196|27053741|P1|Overall Study|Lack of Efficacy|22
7783370|NCT00599027|27053772|P2|Overall Study|Treatment Failure|1
7783371|NCT00599027|27053773|P1|Overall Study|Treatment Failure|0
7783372|NCT00599027|27053772|P2|Overall Study|Adverse Event|1
7783373|NCT00599027|27053773|P1|Overall Study|Adverse Event|0
7783374|NCT00599027|27053772|P2|Overall Study|Withdrawal by Subject|1
7783375|NCT00599027|27053773|P1|Overall Study|Withdrawal by Subject|1
7783376|NCT00598975|27053786|P2|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
7783377|NCT00598975|27053787|P1|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
7783378|NCT00598975|27053786|P2|Overall Study|Disease progression|3
7783379|NCT00598975|27053787|P1|Overall Study|Disease progression|8
7783380|NCT00598975|27053786|P2|Overall Study|Withdrawal of consent|1
7783381|NCT00598975|27053787|P1|Overall Study|Withdrawal of consent|0
7783382|NCT00598975|27053786|P2|Overall Study|Withdrawal by Subject|1
7783383|NCT00598975|27053787|P1|Overall Study|Withdrawal by Subject|1
7783384|NCT00598975|27053786|P2|Overall Study|Brain metastases|0
7783385|NCT00598975|27053787|P1|Overall Study|Brain metastases|1
7783386|NCT00598975|27053786|P2|Overall Study|Adverse Event|1
7783387|NCT00598975|27053787|P1|Overall Study|Adverse Event|1
7783388|NCT00598871|27053803|P2|Overall Study|Adverse Event|1
7783389|NCT00598871|27053804|P1|Overall Study|Adverse Event|0
7783390|NCT00598832|27053814|P2|Overall Study|Non compliance|0
7783391|NCT00598832|27053815|P1|Overall Study|Non compliance|1
7783392|NCT00598832|27053814|P2|Overall Study|Physician Decision|4
7783393|NCT00598832|27053815|P1|Overall Study|Physician Decision|1
7783394|NCT00598832|27053814|P2|Overall Study|Pregnancy|2
7783395|NCT00598832|27053815|P1|Overall Study|Pregnancy|2
7783396|NCT00598832|27053814|P2|Overall Study|Lost to Follow-up|29
7783397|NCT00598832|27053815|P1|Overall Study|Lost to Follow-up|24
7783398|NCT00598832|27053814|P2|Overall Study|Protocol Violation|2
7783399|NCT00598832|27053815|P1|Overall Study|Protocol Violation|0
7783400|NCT00598832|27053814|P2|Overall Study|Withdrawal by Subject|36
7783401|NCT00598832|27053815|P1|Overall Study|Withdrawal by Subject|25
7783402|NCT00598832|27053814|P2|Overall Study|Adverse Event|2
7783403|NCT00598832|27053815|P1|Overall Study|Adverse Event|6
7783404|NCT00598832|27053814|P2|Overall Study|Lack of Efficacy|7
7783405|NCT00598832|27053815|P1|Overall Study|Lack of Efficacy|3
7783406|NCT00598702|27053868|P8|Overall Study|Dose limiting toxicity|0
7783407|NCT00598702|27053869|P7|Overall Study|Dose limiting toxicity|0
7783408|NCT00598702|27053870|P6|Overall Study|Dose limiting toxicity|1
7783409|NCT00598702|27053871|P5|Overall Study|Dose limiting toxicity|1
7783410|NCT00598702|27053872|P4|Overall Study|Dose limiting toxicity|1
7783411|NCT00598702|27053873|P3|Overall Study|Dose limiting toxicity|0
7783412|NCT00598702|27053874|P2|Overall Study|Dose limiting toxicity|0
7783413|NCT00598702|27053875|P1|Overall Study|Dose limiting toxicity|0
7783414|NCT00598702|27053868|P8|Overall Study|Physician Decision|0
7783415|NCT00598702|27053869|P7|Overall Study|Physician Decision|0
7783416|NCT00598702|27053870|P6|Overall Study|Physician Decision|0
7783417|NCT00598702|27053871|P5|Overall Study|Physician Decision|1
7783418|NCT00598702|27053872|P4|Overall Study|Physician Decision|0
7783419|NCT00598702|27053873|P3|Overall Study|Physician Decision|0
7783420|NCT00598702|27053874|P2|Overall Study|Physician Decision|0
7783421|NCT00598702|27053875|P1|Overall Study|Physician Decision|0
7783422|NCT00598702|27053868|P8|Overall Study|Withdrawal by Subject|0
7783423|NCT00598702|27053869|P7|Overall Study|Withdrawal by Subject|0
7783424|NCT00598702|27053870|P6|Overall Study|Withdrawal by Subject|0
7783425|NCT00598702|27053871|P5|Overall Study|Withdrawal by Subject|1
7783426|NCT00598702|27053872|P4|Overall Study|Withdrawal by Subject|1
7783427|NCT00598702|27053873|P3|Overall Study|Withdrawal by Subject|0
7783428|NCT00598702|27053874|P2|Overall Study|Withdrawal by Subject|0
7783429|NCT00598702|27053875|P1|Overall Study|Withdrawal by Subject|0
7783430|NCT00598702|27053868|P8|Overall Study|Adverse Event|0
7783431|NCT00598702|27053869|P7|Overall Study|Adverse Event|0
7783432|NCT00598702|27053870|P6|Overall Study|Adverse Event|0
7783433|NCT00598702|27053871|P5|Overall Study|Adverse Event|0
7783434|NCT00598702|27053872|P4|Overall Study|Adverse Event|1
7783435|NCT00598702|27053873|P3|Overall Study|Adverse Event|0
7783436|NCT00598702|27053874|P2|Overall Study|Adverse Event|0
7783437|NCT00598702|27053875|P1|Overall Study|Adverse Event|0
7783438|NCT00598702|27053868|P8|Overall Study|Early discharge from hospital|0
7783439|NCT00598702|27053869|P7|Overall Study|Early discharge from hospital|1
7783440|NCT00598702|27053870|P6|Overall Study|Early discharge from hospital|10
7783441|NCT00598702|27053871|P5|Overall Study|Early discharge from hospital|0
7783442|NCT00598702|27053872|P4|Overall Study|Early discharge from hospital|5
7783443|NCT00598702|27053873|P3|Overall Study|Early discharge from hospital|2
7783444|NCT00598702|27053874|P2|Overall Study|Early discharge from hospital|0
7783445|NCT00598702|27053875|P1|Overall Study|Early discharge from hospital|0
7783446|NCT00598702|27053868|P8|Overall Study|Other|0
7783447|NCT00598702|27053869|P7|Overall Study|Other|0
7783448|NCT00598702|27053870|P6|Overall Study|Other|1
7783449|NCT00598702|27053871|P5|Overall Study|Other|0
7783450|NCT00598702|27053872|P4|Overall Study|Other|0
7783451|NCT00598702|27053873|P3|Overall Study|Other|0
7783452|NCT00598702|27053874|P2|Overall Study|Other|2
7783453|NCT00598702|27053875|P1|Overall Study|Other|0
7783454|NCT00598650|27053951|P1|Overall Study|Physician Decision|2
7783455|NCT00598650|27053951|P1|Overall Study|Prohibited Concomitant Medication|2
7783456|NCT00598650|27053951|P1|Overall Study|Not eligible|1
7783457|NCT00598650|27053951|P1|Overall Study|No treatment for 3 weeks|1
7783458|NCT00598650|27053951|P1|Overall Study|Adverse Event|18
7783459|NCT00598650|27053951|P1|Overall Study|Withdrawal by Subject|3
7783460|NCT00598585|27053960|P2|Overall Study|Lost to Follow-up|0
7783461|NCT00598585|27053961|P1|Overall Study|Lost to Follow-up|1
7783462|NCT00598559|27053970|P3|Overall Study|Subject unable/unwilling to attend visit|0
7783463|NCT00598559|27053971|P2|Overall Study|Subject unable/unwilling to attend visit|7
7783464|NCT00598559|27053972|P1|Overall Study|Subject unable/unwilling to attend visit|4
7783465|NCT00598559|27053970|P3|Overall Study|Early discharge from hospital|3
7783466|NCT00598559|27053971|P2|Overall Study|Early discharge from hospital|12
7783467|NCT00598559|27053972|P1|Overall Study|Early discharge from hospital|9
7783468|NCT00598559|27053970|P3|Overall Study|Protocol Non-compliance|0
7783469|NCT00598559|27053971|P2|Overall Study|Protocol Non-compliance|0
7783470|NCT00598559|27053972|P1|Overall Study|Protocol Non-compliance|1
7783471|NCT00598559|27053970|P3|Overall Study|Withdrawal by Subject|0
7783472|NCT00598559|27053971|P2|Overall Study|Withdrawal by Subject|2
7783473|NCT00598559|27053972|P1|Overall Study|Withdrawal by Subject|2
7783474|NCT00598559|27053970|P3|Overall Study|Adverse Event|0
7783475|NCT00598559|27053971|P2|Overall Study|Adverse Event|7
7783476|NCT00598559|27053972|P1|Overall Study|Adverse Event|11
7783477|NCT00598481|27053996|P1|Treatment|Physician Decision|1
7783478|NCT00598442|27054006|P3|Overall Study|Started dialysis|0
7783479|NCT00598442|27054007|P2|Overall Study|Started dialysis|0
7783480|NCT00598442|27054008|P1|Overall Study|Started dialysis|1
7783481|NCT00598442|27054006|P3|Overall Study|Site closed by sponsor|1
7783482|NCT00598442|27054007|P2|Overall Study|Site closed by sponsor|2
7783483|NCT00598442|27054008|P1|Overall Study|Site closed by sponsor|5
7783484|NCT00598442|27054006|P3|Overall Study|Renal transplant|1
7783485|NCT00598442|27054007|P2|Overall Study|Renal transplant|0
7783486|NCT00598442|27054008|P1|Overall Study|Renal transplant|0
7783487|NCT00598442|27054006|P3|Overall Study|Relocation|0
7783488|NCT00598442|27054007|P2|Overall Study|Relocation|4
7783489|NCT00598442|27054008|P1|Overall Study|Relocation|1
7783490|NCT00598442|27054006|P3|Overall Study|Noncompliance|1
7783491|NCT00598442|27054007|P2|Overall Study|Noncompliance|2
7783492|NCT00598442|27054008|P1|Overall Study|Noncompliance|0
7783493|NCT00598442|27054006|P3|Overall Study|Withdrawal by Subject|6
7783494|NCT00598442|27054007|P2|Overall Study|Withdrawal by Subject|16
7783495|NCT00598442|27054008|P1|Overall Study|Withdrawal by Subject|8
7783496|NCT00598442|27054006|P3|Overall Study|Physician Decision|1
7783497|NCT00598442|27054007|P2|Overall Study|Physician Decision|1
7783498|NCT00598442|27054008|P1|Overall Study|Physician Decision|2
7783499|NCT00598442|27054006|P3|Overall Study|Lost to Follow-up|3
7783500|NCT00598442|27054007|P2|Overall Study|Lost to Follow-up|3
7783501|NCT00598442|27054008|P1|Overall Study|Lost to Follow-up|4
7783502|NCT00598442|27054006|P3|Overall Study|Death|11
7783503|NCT00598442|27054007|P2|Overall Study|Death|11
7783504|NCT00598442|27054008|P1|Overall Study|Death|19
7783505|NCT00598442|27054006|P3|Overall Study|Adverse Event|0
7783506|NCT00598442|27054007|P2|Overall Study|Adverse Event|0
7783507|NCT00598442|27054008|P1|Overall Study|Adverse Event|3
7783508|NCT00598273|27054025|P3|Overall Study|Started dialysis|5
7783509|NCT00598273|27054026|P2|Overall Study|Started dialysis|4
7783510|NCT00598273|27054027|P1|Overall Study|Started dialysis|6
7783511|NCT00598273|27054025|P3|Overall Study|Site elected to close|0
7783512|NCT00598273|27054026|P2|Overall Study|Site elected to close|0
7783513|NCT00598273|27054027|P1|Overall Study|Site elected to close|1
7783514|NCT00598273|27054025|P3|Overall Study|Renal transplant|1
7783515|NCT00598273|27054026|P2|Overall Study|Renal transplant|0
7783516|NCT00598273|27054027|P1|Overall Study|Renal transplant|1
7783517|NCT00598273|27054025|P3|Overall Study|Relocation|4
7783518|NCT00598273|27054026|P2|Overall Study|Relocation|2
7783519|NCT00598273|27054027|P1|Overall Study|Relocation|0
7783520|NCT00598273|27054025|P3|Overall Study|Noncompliance|3
7783521|NCT00598273|27054026|P2|Overall Study|Noncompliance|2
7783522|NCT00598273|27054027|P1|Overall Study|Noncompliance|3
7783523|NCT00598273|27054025|P3|Overall Study|Withdrawal by Subject|10
7783524|NCT00598273|27054026|P2|Overall Study|Withdrawal by Subject|10
7783525|NCT00598273|27054027|P1|Overall Study|Withdrawal by Subject|12
7783526|NCT00598273|27054025|P3|Overall Study|Physician Decision|1
7783527|NCT00598273|27054026|P2|Overall Study|Physician Decision|0
7783528|NCT00598273|27054027|P1|Overall Study|Physician Decision|0
7783529|NCT00598273|27054025|P3|Overall Study|Lost to Follow-up|5
7783530|NCT00598273|27054026|P2|Overall Study|Lost to Follow-up|3
7783531|NCT00598273|27054027|P1|Overall Study|Lost to Follow-up|8
7783532|NCT00598273|27054025|P3|Overall Study|Death|8
7783533|NCT00598273|27054026|P2|Overall Study|Death|12
7783534|NCT00598273|27054027|P1|Overall Study|Death|6
7783535|NCT00598273|27054025|P3|Overall Study|Adverse Event|2
7783536|NCT00598273|27054026|P2|Overall Study|Adverse Event|5
7783537|NCT00598273|27054027|P1|Overall Study|Adverse Event|4
7783538|NCT00598078|27054041|P2|Period 2 (Day 2)|Adverse Event|0
7783539|NCT00598078|27054042|P1|Period 2 (Day 2)|Adverse Event|1
7783540|NCT00597766|27054185|P3|Follow-up 2, Week 8|Lost to Follow-up|1
7783541|NCT00597766|27054186|P2|Follow-up 2, Week 8|Lost to Follow-up|0
7783542|NCT00597766|27054187|P1|Follow-up 2, Week 8|Lost to Follow-up|0
7783543|NCT00597766|27054185|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
7783544|NCT00597766|27054186|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
7783545|NCT00597766|27054187|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
7783546|NCT00597753|27054206|P2|Overall Study|Site elected to close|4
7783547|NCT00597753|27054207|P1|Overall Study|Site elected to close|2
7783548|NCT00597753|27054206|P2|Overall Study|Site closed by sponsor|7
7783549|NCT00597753|27054207|P1|Overall Study|Site closed by sponsor|19
7783550|NCT00597753|27054206|P2|Overall Study|Renal transplant|3
7783551|NCT00597753|27054207|P1|Overall Study|Renal transplant|10
7783552|NCT00597753|27054206|P2|Overall Study|Relocation|6
7783553|NCT00597753|27054207|P1|Overall Study|Relocation|17
7783554|NCT00597753|27054206|P2|Overall Study|Noncompliance|1
7783555|NCT00597753|27054207|P1|Overall Study|Noncompliance|2
7783556|NCT00597753|27054206|P2|Overall Study|Never dosed|0
7783557|NCT00597753|27054207|P1|Overall Study|Never dosed|2
7783558|NCT00597753|27054206|P2|Overall Study|Discontinued Dialysis|1
7783559|NCT00597753|27054207|P1|Overall Study|Discontinued Dialysis|0
7783560|NCT00597753|27054206|P2|Overall Study|Withdrawal by Subject|12
7783561|NCT00597753|27054207|P1|Overall Study|Withdrawal by Subject|35
7783562|NCT00597753|27054206|P2|Overall Study|Pregnancy|0
7783563|NCT00597753|27054207|P1|Overall Study|Pregnancy|1
7783564|NCT00597753|27054206|P2|Overall Study|Physician Decision|1
7783565|NCT00597753|27054207|P1|Overall Study|Physician Decision|5
7783566|NCT00597753|27054206|P2|Overall Study|Lost to Follow-up|3
7783567|NCT00597753|27054207|P1|Overall Study|Lost to Follow-up|10
7783568|NCT00597753|27054206|P2|Overall Study|Lack of Efficacy|0
7783569|NCT00597753|27054207|P1|Overall Study|Lack of Efficacy|2
7783570|NCT00597753|27054206|P2|Overall Study|Death|29
7783571|NCT00597753|27054207|P1|Overall Study|Death|55
7783572|NCT00597753|27054206|P2|Overall Study|Adverse Event|2
7783573|NCT00597753|27054207|P1|Overall Study|Adverse Event|6
7783574|NCT00597714|27054241|P3|Overall Study|Recipient death|10
7783575|NCT00597714|27054242|P2|Overall Study|Recipient death|0
7783576|NCT00597714|27054243|P1|Overall Study|Recipient death|0
7783577|NCT00597714|27054241|P3|Overall Study|Death|0
7783578|NCT00597714|27054242|P2|Overall Study|Death|46
7783579|NCT00597714|27054243|P1|Overall Study|Death|56
7783580|NCT00597701|27054255|P2|Overall Study|Did not start intervention (pharmacy er)|2
7783581|NCT00597701|27054256|P1|Overall Study|Did not start intervention (pharmacy er)|0
7783582|NCT00597701|27054255|P2|Overall Study|Physician Decision|0
7783583|NCT00597701|27054256|P1|Overall Study|Physician Decision|2
7783584|NCT00597701|27054255|P2|Overall Study|Death|1
7783585|NCT00597701|27054256|P1|Overall Study|Death|0
7783586|NCT00597701|27054255|P2|Overall Study|Withdrawal by Subject|5
7783587|NCT00597701|27054256|P1|Overall Study|Withdrawal by Subject|5
7783588|NCT00597584|27054278|P2|Overall Study|Renal transplant|7
7783589|NCT00597584|27054279|P1|Overall Study|Renal transplant|9
7783590|NCT00597584|27054278|P2|Overall Study|Relocation|6
7783591|NCT00597584|27054279|P1|Overall Study|Relocation|8
7783592|NCT00597584|27054278|P2|Overall Study|Never dosed|0
7783593|NCT00597584|27054279|P1|Overall Study|Never dosed|1
7783594|NCT00597584|27054278|P2|Overall Study|Lost ability to consent|1
7783595|NCT00597584|27054279|P1|Overall Study|Lost ability to consent|1
7783596|NCT00597584|27054278|P2|Overall Study|Discontinued Dialysis|1
7783597|NCT00597584|27054279|P1|Overall Study|Discontinued Dialysis|0
7783598|NCT00597584|27054278|P2|Overall Study|Withdrawal by Subject|12
7783599|NCT00597584|27054279|P1|Overall Study|Withdrawal by Subject|44
7783600|NCT00597584|27054278|P2|Overall Study|Pregnancy|0
7783601|NCT00597584|27054279|P1|Overall Study|Pregnancy|2
7783602|NCT00597584|27054278|P2|Overall Study|Physician Decision|0
7783603|NCT00597584|27054279|P1|Overall Study|Physician Decision|3
7783604|NCT00597584|27054278|P2|Overall Study|Lost to Follow-up|4
7783605|NCT00597584|27054279|P1|Overall Study|Lost to Follow-up|2
7783606|NCT00597584|27054278|P2|Overall Study|Lack of Efficacy|0
7783607|NCT00597584|27054279|P1|Overall Study|Lack of Efficacy|1
7783608|NCT00597584|27054278|P2|Overall Study|Death|30
7783609|NCT00597584|27054279|P1|Overall Study|Death|53
7783610|NCT00597584|27054278|P2|Overall Study|Adverse Event|2
7783611|NCT00597584|27054279|P1|Overall Study|Adverse Event|4
7783612|NCT00597519|27054304|P1|Overall Study|Death|1
7783613|NCT00597506|27054308|P1|Overall Study|Subject is being followed for survival|1
7783614|NCT00597376|27054358|P2|Overall Study|Adverse Event|1
7783615|NCT00597376|27054359|P1|Overall Study|Adverse Event|4
7783616|NCT00597376|27054358|P2|Overall Study|Withdrawal by Subject|3
7783617|NCT00597376|27054359|P1|Overall Study|Withdrawal by Subject|4
7783618|NCT00597207|27054405|P2|Overall Study|Lost to Follow-up|7
7783619|NCT00597207|27054406|P1|Overall Study|Lost to Follow-up|5
7783620|NCT00597116|27054414|P2|Overall Study|Progressive disease|6
7783621|NCT00597116|27054415|P1|Overall Study|Progressive disease|11
7783622|NCT00597116|27054414|P2|Overall Study|Lost to Follow-up|0
7783623|NCT00597116|27054415|P1|Overall Study|Lost to Follow-up|1
7783624|NCT00597116|27054414|P2|Overall Study|Death|1
7783625|NCT00597116|27054415|P1|Overall Study|Death|0
7783626|NCT00597116|27054414|P2|Overall Study|Physician Decision|1
7783627|NCT00597116|27054415|P1|Overall Study|Physician Decision|0
7783628|NCT00597116|27054414|P2|Overall Study|Withdrawal by Subject|2
7783629|NCT00597116|27054415|P1|Overall Study|Withdrawal by Subject|0
7783630|NCT00597116|27054414|P2|Overall Study|Adverse Event|1
7783631|NCT00597116|27054415|P1|Overall Study|Adverse Event|2
7783632|NCT00597012|27054441|P2|Overall Study|Lost to Follow-up|2
7783633|NCT00597012|27054442|P1|Overall Study|Lost to Follow-up|0
7783634|NCT00597012|27054441|P2|Overall Study|Ineligible|0
7783635|NCT00597012|27054442|P1|Overall Study|Ineligible|2
7783636|NCT00597012|27054441|P2|Overall Study|Withdrawal by Subject|4
7783637|NCT00597012|27054442|P1|Overall Study|Withdrawal by Subject|7
7783638|NCT00597012|27054441|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
7783639|NCT00597012|27054442|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
7783640|NCT00597012|27054441|P2|Overall Study|Death|1
7783641|NCT00597012|27054442|P1|Overall Study|Death|1
7783642|NCT00596960|27054458|P2|Overall Study|No alcohol use data|1
7783643|NCT00596960|27054459|P1|Overall Study|No alcohol use data|0
7783644|NCT00596960|27054458|P2|Overall Study|Protocol Violation|1
7783645|NCT00596960|27054459|P1|Overall Study|Protocol Violation|0
7783646|NCT00596960|27054458|P2|Overall Study|Physician Decision|0
7783647|NCT00596960|27054459|P1|Overall Study|Physician Decision|1
7783648|NCT00596960|27054458|P2|Overall Study|Incarcerated|0
7783649|NCT00596960|27054459|P1|Overall Study|Incarcerated|2
7783650|NCT00596960|27054458|P2|Overall Study|Withdrawal by Subject|0
7783651|NCT00596960|27054459|P1|Overall Study|Withdrawal by Subject|1
7783652|NCT00596960|27054458|P2|Overall Study|Lost to Follow-up|5
7783653|NCT00596960|27054459|P1|Overall Study|Lost to Follow-up|6
7783654|NCT00596960|27054458|P2|Overall Study|Death|2
7783655|NCT00596960|27054459|P1|Overall Study|Death|1
7783656|NCT00596947|27054471|P2|Overall Study|Lost to Follow-up|0
7783657|NCT00596947|27054472|P1|Overall Study|Lost to Follow-up|1
7783658|NCT00596947|27054471|P2|Overall Study|study halted due to low enrollment|3
7783659|NCT00596947|27054472|P1|Overall Study|study halted due to low enrollment|5
7783660|NCT00596934|27054512|P1|Overall Study|Withdrawal by Subject|1
7783661|NCT00596934|27054512|P1|Overall Study|Protocol Violation|1
7783662|NCT00596830|27054525|P2|Overall Study|Randomized but not treated|7
7783663|NCT00596830|27054526|P1|Overall Study|Randomized but not treated|3
7783664|NCT00596830|27054525|P2|Overall Study|Follow-up was discontinued|0
7783665|NCT00596830|27054526|P1|Overall Study|Follow-up was discontinued|1
7783666|NCT00596830|27054525|P2|Overall Study|Study terminated by sponsor|62
7783667|NCT00596830|27054526|P1|Overall Study|Study terminated by sponsor|51
7783668|NCT00596830|27054525|P2|Overall Study|Withdrawal by Subject|12
7783669|NCT00596830|27054526|P1|Overall Study|Withdrawal by Subject|22
7783670|NCT00596830|27054525|P2|Overall Study|Lost to Follow-up|11
7783671|NCT00596830|27054526|P1|Overall Study|Lost to Follow-up|7
7783672|NCT00596830|27054525|P2|Overall Study|Death|247
7783673|NCT00596830|27054526|P1|Overall Study|Death|258
7783674|NCT00596817|27054552|P2|Double-blind Period|Other Reasons|18
7783675|NCT00596817|27054553|P1|Double-blind Period|Other Reasons|10
7783676|NCT00596817|27054552|P2|Double-blind Period|Lost to Follow-up|2
7783677|NCT00596817|27054553|P1|Double-blind Period|Lost to Follow-up|0
7783678|NCT00596817|27054552|P2|Double-blind Period|Withdrawal of Consent|3
7783679|NCT00596817|27054553|P1|Double-blind Period|Withdrawal of Consent|7
7783680|NCT00596817|27054552|P2|Double-blind Period|Protocol Violation|8
7783681|NCT00596817|27054553|P1|Double-blind Period|Protocol Violation|11
7783682|NCT00596817|27054552|P2|Double-blind Period|Non-compliance With Study Product|4
7783683|NCT00596817|27054553|P1|Double-blind Period|Non-compliance With Study Product|3
7783684|NCT00596817|27054552|P2|Double-blind Period|Lack of Efficacy|28
7783685|NCT00596817|27054553|P1|Double-blind Period|Lack of Efficacy|52
7783686|NCT00596817|27054552|P2|Double-blind Period|Adverse Event|16
7783687|NCT00596817|27054553|P1|Double-blind Period|Adverse Event|5
7783688|NCT00596817|27054552|P2|Open-label Period to Double-blind Period|Other Reasons|14
7783689|NCT00596817|27054553|P1|Open-label Period to Double-blind Period|Other Reasons|0
7783690|NCT00596817|27054552|P2|Open-label Period to Double-blind Period|Not Eligible|49
7783691|NCT00596817|27054553|P1|Open-label Period to Double-blind Period|Not Eligible|0
7783692|NCT00596817|27054552|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
7783693|NCT00596817|27054553|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
7783694|NCT00596817|27054552|P2|Open-label Period to Double-blind Period|Adverse Event|5
7783695|NCT00596817|27054553|P1|Open-label Period to Double-blind Period|Adverse Event|0
7783696|NCT00596817|27054552|P2|Open-label Period|Other Reasons|65
7783697|NCT00596817|27054553|P1|Open-label Period|Other Reasons|0
7783698|NCT00596817|27054552|P2|Open-label Period|Lack of Efficacy|33
7783699|NCT00596817|27054553|P1|Open-label Period|Lack of Efficacy|0
7783700|NCT00596817|27054552|P2|Open-label Period|Adverse Event|49
7783701|NCT00596817|27054553|P1|Open-label Period|Adverse Event|0
7783702|NCT00596752|27054578|P2|Overall Study|Protocol Violation|0
7783703|NCT00596752|27054579|P1|Overall Study|Protocol Violation|1
7783704|NCT00596752|27054578|P2|Overall Study|Lack of Efficacy|7
7783705|NCT00596752|27054579|P1|Overall Study|Lack of Efficacy|4
7783706|NCT00596752|27054578|P2|Overall Study|Unsatisfactory Compliance|6
7783707|NCT00596752|27054579|P1|Overall Study|Unsatisfactory Compliance|9
7783708|NCT00596752|27054578|P2|Overall Study|Withdrawal by Subject|9
7783709|NCT00596752|27054579|P1|Overall Study|Withdrawal by Subject|12
7783710|NCT00596752|27054578|P2|Overall Study|Lost to Follow-up|38
7783711|NCT00596752|27054579|P1|Overall Study|Lost to Follow-up|22
7783712|NCT00596752|27054578|P2|Overall Study|Adverse Event|34
7783713|NCT00596752|27054579|P1|Overall Study|Adverse Event|34
7783714|NCT00596752|27054578|P2|Overall Study|Other Reason|49
7783715|NCT00596752|27054579|P1|Overall Study|Other Reason|44
7783716|NCT00596687|27054609|P2|Overall Study|cancelled surgery|1
7783717|NCT00596687|27054610|P1|Overall Study|cancelled surgery|1
7783718|NCT00596687|27054609|P2|Overall Study|Withdrawal by Subject|1
7783719|NCT00596687|27054610|P1|Overall Study|Withdrawal by Subject|3
7783720|NCT00596687|27054609|P2|Overall Study|continuous insulin infusion during TPN|1
7783721|NCT00596687|27054610|P1|Overall Study|continuous insulin infusion during TPN|2
7783722|NCT00596687|27054609|P2|Overall Study|< 24 hours of insulin treatment|6
7783723|NCT00596687|27054610|P1|Overall Study|< 24 hours of insulin treatment|8
7783724|NCT00596635|27054621|P3|Overall Study|Could not provide urine specimen|2
7783725|NCT00596635|27054622|P2|Overall Study|Could not provide urine specimen|2
7783726|NCT00596635|27054623|P1|Overall Study|Could not provide urine specimen|1
7783727|NCT00596635|27054621|P3|Overall Study|Hip fracture|3
7783728|NCT00596635|27054622|P2|Overall Study|Hip fracture|3
7783729|NCT00596635|27054623|P1|Overall Study|Hip fracture|2
7783730|NCT00596635|27054621|P3|Overall Study|Treatment for symptomatic UTI|3
7783731|NCT00596635|27054622|P2|Overall Study|Treatment for symptomatic UTI|6
7783732|NCT00596635|27054623|P1|Overall Study|Treatment for symptomatic UTI|4
7783733|NCT00596635|27054621|P3|Overall Study|Lost to Follow-up|0
7783734|NCT00596635|27054622|P2|Overall Study|Lost to Follow-up|2
7783735|NCT00596635|27054623|P1|Overall Study|Lost to Follow-up|0
7783736|NCT00596466|27054649|P1|Overall Study|Enrolled, not treated|2
7783737|NCT00596466|27054649|P1|Overall Study|Unpecified|2
7783738|NCT00596466|27054649|P1|Overall Study|Protocol Violation|2
7783739|NCT00596466|27054649|P1|Overall Study|Withdrawal by Subject|2
7783740|NCT00596466|27054649|P1|Overall Study|Adverse Event|4
7783741|NCT00596466|27054649|P1|Overall Study|Lack of Efficacy|5
7783742|NCT00596427|27054679|P2|Overall Study|Protocol Violation|0
7783743|NCT00596427|27054680|P1|Overall Study|Protocol Violation|1
7783744|NCT00596427|27054679|P2|Overall Study|Increased Fasting Triacylglycerol level|0
7783745|NCT00596427|27054680|P1|Overall Study|Increased Fasting Triacylglycerol level|1
7783746|NCT00596427|27054679|P2|Overall Study|Withdrawal by Subject|2
7783747|NCT00596427|27054680|P1|Overall Study|Withdrawal by Subject|2
7783748|NCT00596362|27054708|P1|Overall Study|Progressive Disease|1
7783749|NCT00596011|27054744|P2|Overall Study|Adverse Event|7
7783750|NCT00596011|27054745|P1|Overall Study|Adverse Event|11
7783751|NCT00596011|27054744|P2|Overall Study|Withdrawal by Subject|3
7783752|NCT00596011|27054745|P1|Overall Study|Withdrawal by Subject|2
7783753|NCT00595959|27054761|P1|Overall Study|Lost to Follow-up|1
7783754|NCT00595959|27054761|P1|Overall Study|Withdrawal by Subject|1
7783755|NCT00595920|27054795|P1|Overall Study|The OLTERMS study was discontinued by th|116
7783756|NCT00595868|27054806|P2|Overall Study|Lost to Follow-up|50
7783757|NCT00595868|27054807|P1|Overall Study|Lost to Follow-up|45
7783758|NCT00595764|27054830|P2|Overall Study|Withdrawal by Subject|0
7783759|NCT00595764|27054831|P1|Overall Study|Withdrawal by Subject|4
7783760|NCT00595764|27054830|P2|Overall Study|Missed 3 PM visits|7
7783761|NCT00595764|27054831|P1|Overall Study|Missed 3 PM visits|1
7783762|NCT00595764|27054830|P2|Overall Study|Missed Medication >1 week|17
7783763|NCT00595764|27054831|P1|Overall Study|Missed Medication >1 week|10
7783764|NCT00595764|27054830|P2|Overall Study|Protocol Violation|19
7783765|NCT00595764|27054831|P1|Overall Study|Protocol Violation|24
7783766|NCT00595621|27054847|P2|Randomization and Study|Withdrawal by Subject|1
7783767|NCT00595621|27054848|P1|Randomization and Study|Withdrawal by Subject|0
7783768|NCT00595621|27054847|P2|Randomization and Study|Adverse Event|0
7783769|NCT00595621|27054848|P1|Randomization and Study|Adverse Event|2
7783770|NCT00595621|27054847|P2|Open Label Run in|Withdrawal by Subject|0
7783771|NCT00595621|27054848|P1|Open Label Run in|Withdrawal by Subject|1
7783772|NCT00595621|27054847|P2|Open Label Run in|Physician Decision|0
7783773|NCT00595621|27054848|P1|Open Label Run in|Physician Decision|1
7783774|NCT00595621|27054847|P2|Open Label Run in|Adverse Event|0
7783775|NCT00595621|27054848|P1|Open Label Run in|Adverse Event|1
7783776|NCT00595582|27054865|P1|Overall Study|Physician Decision|5
7783777|NCT00595582|27054865|P1|Overall Study|Adverse Event|2
7783778|NCT00595582|27054865|P1|Overall Study|Lost to Follow-up|1
7783779|NCT00595582|27054865|P1|Overall Study|Pilot study that PI terminated|2
7783780|NCT00595517|27054891|P1|Overall Study|No intention to attend regularly|1
7783781|NCT00595517|27054891|P1|Overall Study|usage of prohibited treatment|1
7783782|NCT00595517|27054891|P1|Overall Study|Recurrence of ulcer|5
7783783|NCT00595517|27054891|P1|Overall Study|Protocol Violation|2
7783784|NCT00595517|27054891|P1|Overall Study|Withdrawal by Subject|4
7783785|NCT00595517|27054891|P1|Overall Study|Adverse Event|6
7783786|NCT00595504|27054900|P2|Overall Study|Physician Decision|0
7783787|NCT00595504|27054901|P1|Overall Study|Physician Decision|1
7783788|NCT00595504|27054900|P2|Overall Study|Withdrawal by Subject|3
7783789|NCT00595504|27054901|P1|Overall Study|Withdrawal by Subject|1
7783790|NCT00595478|27054913|P2|36-week Follow-up Period|Withdrawal by Subject|4
7783791|NCT00595478|27054914|P1|36-week Follow-up Period|Withdrawal by Subject|4
7783792|NCT00595478|27054913|P2|36-week Follow-up Period|Lost to Follow-up|4
7783793|NCT00595478|27054914|P1|36-week Follow-up Period|Lost to Follow-up|5
7783794|NCT00595465|27054925|P3|Overall Study|administrative reason|1
7783795|NCT00595465|27054926|P2|Overall Study|administrative reason|0
7783796|NCT00595465|27054927|P1|Overall Study|administrative reason|0
7783797|NCT00595465|27054925|P3|Overall Study|Lost to Follow-up|2
7783798|NCT00595465|27054926|P2|Overall Study|Lost to Follow-up|0
7783799|NCT00595465|27054927|P1|Overall Study|Lost to Follow-up|0
7783800|NCT00595465|27054925|P3|Overall Study|Protocol Violation|0
7783801|NCT00595465|27054926|P2|Overall Study|Protocol Violation|1
7783802|NCT00595465|27054927|P1|Overall Study|Protocol Violation|2
7783803|NCT00595465|27054925|P3|Overall Study|Pregnancy|1
7783804|NCT00595465|27054926|P2|Overall Study|Pregnancy|0
7783805|NCT00595465|27054927|P1|Overall Study|Pregnancy|0
7783806|NCT00595465|27054925|P3|Overall Study|Adverse Event|3
7783807|NCT00595465|27054926|P2|Overall Study|Adverse Event|3
7783808|NCT00595465|27054927|P1|Overall Study|Adverse Event|4
7783809|NCT00595413|27054939|P4|Overall Study|Other|0
7783810|NCT00595413|27054940|P3|Overall Study|Other|5
7783811|NCT00595413|27054941|P2|Overall Study|Other|1
7783812|NCT00595413|27054942|P1|Overall Study|Other|5
7783813|NCT00595413|27054939|P4|Overall Study|Death|0
7783814|NCT00595413|27054940|P3|Overall Study|Death|1
7783815|NCT00595413|27054941|P2|Overall Study|Death|0
7783816|NCT00595413|27054942|P1|Overall Study|Death|0
7783817|NCT00595413|27054939|P4|Overall Study|Lost to Follow-up|3
7783818|NCT00595413|27054940|P3|Overall Study|Lost to Follow-up|1
7783819|NCT00595413|27054941|P2|Overall Study|Lost to Follow-up|2
7783820|NCT00595413|27054942|P1|Overall Study|Lost to Follow-up|2
7783821|NCT00595413|27054939|P4|Overall Study|Adverse Event|1
7783822|NCT00595413|27054940|P3|Overall Study|Adverse Event|1
7783823|NCT00595413|27054941|P2|Overall Study|Adverse Event|2
7783824|NCT00595413|27054942|P1|Overall Study|Adverse Event|0
7783825|NCT00595335|27054983|P2|Six Months to Twelve Months|Disease Progression|0
7783826|NCT00595335|27054984|P1|Six Months to Twelve Months|Disease Progression|1
7783827|NCT00595335|27054983|P2|Six Months to Twelve Months|Withdrawal by Subject|1
7783828|NCT00595335|27054984|P1|Six Months to Twelve Months|Withdrawal by Subject|0
7783829|NCT00595335|27054983|P2|Baseline to Six Months|Adverse Event|0
7783830|NCT00595335|27054984|P1|Baseline to Six Months|Adverse Event|1
7783831|NCT00595335|27054983|P2|Baseline to Six Months|Disease Progression|1
7783832|NCT00595335|27054984|P1|Baseline to Six Months|Disease Progression|1
7783833|NCT00595335|27054983|P2|Baseline to Six Months|Withdrawal by Subject|1
7783834|NCT00595335|27054984|P1|Baseline to Six Months|Withdrawal by Subject|0
7783835|NCT00595309|27055004|P1|Overall Study|personal reason|1
7783836|NCT00595309|27055004|P1|Overall Study|acute infection after V0|1
7783837|NCT00595309|27055004|P1|Overall Study|planned vaccination against yellow fever|1
7783838|NCT00595309|27055004|P1|Overall Study|Lost to Follow-up|1
7783839|NCT00595127|27055053|P1|Overall Study|joined another trial|1
7783840|NCT00595127|27055053|P1|Overall Study|Relapsed|3
7783841|NCT00595127|27055053|P1|Overall Study|Death|6
7783842|NCT00595075|27055099|P2|Overall Study|Withdrawal by Subject|0
7783843|NCT00595075|27055100|P1|Overall Study|Withdrawal by Subject|1
7783844|NCT00594958|27055132|P3|Overall Study|administrative|2
7783845|NCT00594958|27055133|P2|Overall Study|administrative|0
7783846|NCT00594958|27055134|P1|Overall Study|administrative|3
7783847|NCT00594958|27055132|P3|Overall Study|Lost to Follow-up|3
7783848|NCT00594958|27055133|P2|Overall Study|Lost to Follow-up|0
7783849|NCT00594958|27055134|P1|Overall Study|Lost to Follow-up|5
7783850|NCT00594958|27055132|P3|Overall Study|Protocol Violation|2
7783851|NCT00594958|27055133|P2|Overall Study|Protocol Violation|0
7783852|NCT00594958|27055134|P1|Overall Study|Protocol Violation|1
7783853|NCT00594958|27055132|P3|Overall Study|Pregnancy|0
7783854|NCT00594958|27055133|P2|Overall Study|Pregnancy|2
7783855|NCT00594958|27055134|P1|Overall Study|Pregnancy|0
7783856|NCT00594958|27055132|P3|Overall Study|Adverse Event|2
7783857|NCT00594958|27055133|P2|Overall Study|Adverse Event|1
7783858|NCT00594958|27055134|P1|Overall Study|Adverse Event|4
7783859|NCT00594958|27055132|P3|Overall Study|Withdrawal by Subject|1
7783860|NCT00594958|27055133|P2|Overall Study|Withdrawal by Subject|0
7783861|NCT00594958|27055134|P1|Overall Study|Withdrawal by Subject|1
7783862|NCT00594932|27055155|P2|Final 3 Months|Withdrawal by Subject|3
7783863|NCT00594932|27055156|P1|Final 3 Months|Withdrawal by Subject|4
7783864|NCT00594932|27055155|P2|First 3 Months|Withdrawal by Subject|3
7783865|NCT00594932|27055156|P1|First 3 Months|Withdrawal by Subject|1
7783866|NCT00594906|27055168|P2|Overall Study|Death|1
7783867|NCT00594906|27055169|P1|Overall Study|Death|0
7783868|NCT00594906|27055168|P2|Overall Study|Physician Decision|1
7783869|NCT00594906|27055169|P1|Overall Study|Physician Decision|0
7783870|NCT00594906|27055168|P2|Overall Study|Physician Decision|0
7783871|NCT00594906|27055169|P1|Overall Study|Physician Decision|1
7783872|NCT00594880|27055177|P2|Overall Study|Lost to Follow-up|0
7783873|NCT00594880|27055178|P1|Overall Study|Lost to Follow-up|1
7783874|NCT00594880|27055177|P2|Overall Study|Withdrawal by Subject|1
7783875|NCT00594880|27055178|P1|Overall Study|Withdrawal by Subject|1
7783876|NCT00594854|27055190|P2|Overall Study|Study terminated|10
7783877|NCT00594854|27055191|P1|Overall Study|Study terminated|7
7783878|NCT00594815|27055201|P1|Overall Study|Toxicity|4
7783879|NCT00594815|27055201|P1|Overall Study|Withdrawal by Subject|2
7783880|NCT00594815|27055201|P1|Overall Study|Never Treated|3
7783881|NCT00594659|27055226|P3|Overall Study|Lost to Follow-up|7
7783882|NCT00594659|27055227|P2|Overall Study|Lost to Follow-up|9
7783883|NCT00594659|27055228|P1|Overall Study|Lost to Follow-up|13
7783884|NCT00594646|27055239|P1|Overall Study|Lost to Follow-up|15
7783885|NCT00594646|27055239|P1|Overall Study|Withdrawal by Subject|1
7783886|NCT00594568|27055247|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
7783887|NCT00594568|27055248|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
7783888|NCT00594568|27055249|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
7783889|NCT00594568|27055247|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
7783890|NCT00594568|27055248|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
7783891|NCT00594568|27055249|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
7783892|NCT00594568|27055247|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
7783893|NCT00594568|27055248|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
7783894|NCT00594568|27055249|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
7783895|NCT00594568|27055247|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
7783896|NCT00594568|27055248|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
7783897|NCT00594568|27055249|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
7783898|NCT00594568|27055247|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
7783899|NCT00594568|27055248|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
7783900|NCT00594568|27055249|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
7783901|NCT00594568|27055247|P3|Safety Follow Up (SFU)-Optional|Death|0
7783902|NCT00594568|27055248|P2|Safety Follow Up (SFU)-Optional|Death|1
7783903|NCT00594568|27055249|P1|Safety Follow Up (SFU)-Optional|Death|0
7783904|NCT00594568|27055247|P3|Delayed Start|Sponsor Decision|59
7783905|NCT00594568|27055248|P2|Delayed Start|Sponsor Decision|66
7783906|NCT00594568|27055249|P1|Delayed Start|Sponsor Decision|77
7783907|NCT00594568|27055247|P3|Delayed Start|Caregiver Decision|2
7783908|NCT00594568|27055248|P2|Delayed Start|Caregiver Decision|6
7783909|NCT00594568|27055249|P1|Delayed Start|Caregiver Decision|5
7783910|NCT00594568|27055247|P3|Delayed Start|Lost to Follow-up|1
7783911|NCT00594568|27055248|P2|Delayed Start|Lost to Follow-up|0
7783912|NCT00594568|27055249|P1|Delayed Start|Lost to Follow-up|0
7783913|NCT00594568|27055247|P3|Delayed Start|Physician Decision|1
7783914|NCT00594568|27055248|P2|Delayed Start|Physician Decision|0
7783915|NCT00594568|27055249|P1|Delayed Start|Physician Decision|0
7783916|NCT00594568|27055247|P3|Delayed Start|Withdrawal by Subject|0
7783917|NCT00594568|27055248|P2|Delayed Start|Withdrawal by Subject|3
7783918|NCT00594568|27055249|P1|Delayed Start|Withdrawal by Subject|4
7783919|NCT00594568|27055247|P3|Delayed Start|Adverse Event|2
7783920|NCT00594568|27055248|P2|Delayed Start|Adverse Event|2
7783921|NCT00594568|27055249|P1|Delayed Start|Adverse Event|12
7783922|NCT00594568|27055247|P3|Delayed Start|Death|1
7783923|NCT00594568|27055248|P2|Delayed Start|Death|0
7783924|NCT00594568|27055249|P1|Delayed Start|Death|0
7783925|NCT00594568|27055247|P3|Initial Treatment|Entry criteria exclusion|1
7783926|NCT00594568|27055248|P2|Initial Treatment|Entry criteria exclusion|1
7783927|NCT00594568|27055249|P1|Initial Treatment|Entry criteria exclusion|0
7783928|NCT00594568|27055247|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
7783929|NCT00594568|27055248|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
7783930|NCT00594568|27055249|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
7783931|NCT00594568|27055247|P3|Initial Treatment|Caregiver decision|36
7783932|NCT00594568|27055248|P2|Initial Treatment|Caregiver decision|36
7783933|NCT00594568|27055249|P1|Initial Treatment|Caregiver decision|21
7783934|NCT00594568|27055247|P3|Initial Treatment|Sponsor decision|147
7783935|NCT00594568|27055248|P2|Initial Treatment|Sponsor decision|142
7783936|NCT00594568|27055249|P1|Initial Treatment|Sponsor decision|193
7783937|NCT00594568|27055247|P3|Initial Treatment|Withdrawal by Subject|46
7783938|NCT00594568|27055248|P2|Initial Treatment|Withdrawal by Subject|31
7783939|NCT00594568|27055249|P1|Initial Treatment|Withdrawal by Subject|25
7783940|NCT00594568|27055247|P3|Initial Treatment|Protocol Violation|5
7783941|NCT00594568|27055248|P2|Initial Treatment|Protocol Violation|2
7783942|NCT00594568|27055249|P1|Initial Treatment|Protocol Violation|2
7783943|NCT00594568|27055247|P3|Initial Treatment|Physician Decision|4
7783944|NCT00594568|27055248|P2|Initial Treatment|Physician Decision|2
7783945|NCT00594568|27055249|P1|Initial Treatment|Physician Decision|3
7783946|NCT00594568|27055247|P3|Initial Treatment|Lost to Follow-up|4
7783947|NCT00594568|27055248|P2|Initial Treatment|Lost to Follow-up|1
7783948|NCT00594568|27055249|P1|Initial Treatment|Lost to Follow-up|4
7783949|NCT00594568|27055247|P3|Initial Treatment|Death|15
7783950|NCT00594568|27055248|P2|Initial Treatment|Death|11
7783951|NCT00594568|27055249|P1|Initial Treatment|Death|6
7783952|NCT00594568|27055247|P3|Initial Treatment|Adverse Event|144
7783953|NCT00594568|27055248|P2|Initial Treatment|Adverse Event|121
7783954|NCT00594568|27055249|P1|Initial Treatment|Adverse Event|51
7783955|NCT00594516|27055337|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
7783956|NCT00594516|27055338|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
7783957|NCT00594516|27055339|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
7783958|NCT00594516|27055337|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
7783959|NCT00594516|27055338|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
7783960|NCT00594516|27055339|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
7783961|NCT00594516|27055337|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
7783962|NCT00594516|27055338|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
7783963|NCT00594516|27055339|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
7783964|NCT00594516|27055337|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
7783965|NCT00594516|27055338|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
7783966|NCT00594516|27055339|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
7783967|NCT00594516|27055337|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
7783968|NCT00594516|27055338|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
7783969|NCT00594516|27055339|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
7783970|NCT00594516|27055337|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
7783971|NCT00594516|27055338|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
7783972|NCT00594516|27055339|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
7783973|NCT00594516|27055337|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
7783974|NCT00594516|27055338|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
7783975|NCT00594516|27055339|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
7783976|NCT00594516|27055337|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
7783977|NCT00594516|27055338|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
7783978|NCT00594516|27055339|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
7783979|NCT00594516|27055337|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
7783980|NCT00594516|27055338|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
7783981|NCT00594516|27055339|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
7783982|NCT00594464|27055347|P1|Overall Study|Delay in operation|2
7783983|NCT00594464|27055347|P1|Overall Study|Withdrawal by Subject|1
7783984|NCT00594399|27055476|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
7783985|NCT00594399|27055477|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
7783986|NCT00594399|27055478|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
7783987|NCT00594399|27055476|P3|Rerandomization Arm 1 Only|Death|0
7783988|NCT00594399|27055477|P2|Rerandomization Arm 1 Only|Death|1
7783989|NCT00594399|27055478|P1|Rerandomization Arm 1 Only|Death|2
7783990|NCT00594399|27055476|P3|Initial 3 Month Counseling|Family illness|0
7783991|NCT00594399|27055477|P2|Initial 3 Month Counseling|Family illness|0
7783992|NCT00594399|27055478|P1|Initial 3 Month Counseling|Family illness|1
7783993|NCT00594399|27055476|P3|Initial 3 Month Counseling|Moved|0
7783994|NCT00594399|27055477|P2|Initial 3 Month Counseling|Moved|0
7783995|NCT00594399|27055478|P1|Initial 3 Month Counseling|Moved|1
7783996|NCT00594399|27055476|P3|Initial 3 Month Counseling|Pain|0
7783997|NCT00594399|27055477|P2|Initial 3 Month Counseling|Pain|0
7783998|NCT00594399|27055478|P1|Initial 3 Month Counseling|Pain|2
7783999|NCT00594399|27055476|P3|Initial 3 Month Counseling|Too busy|0
7784000|NCT00594399|27055477|P2|Initial 3 Month Counseling|Too busy|1
7784001|NCT00594399|27055478|P1|Initial 3 Month Counseling|Too busy|7
7784002|NCT00594399|27055476|P3|Initial 3 Month Counseling|Personal issues|0
7784003|NCT00594399|27055477|P2|Initial 3 Month Counseling|Personal issues|0
7784004|NCT00594399|27055478|P1|Initial 3 Month Counseling|Personal issues|2
7784005|NCT00594399|27055476|P3|Initial 3 Month Counseling|Lack of Interest|0
7784006|NCT00594399|27055477|P2|Initial 3 Month Counseling|Lack of Interest|3
7784007|NCT00594399|27055478|P1|Initial 3 Month Counseling|Lack of Interest|3
7784008|NCT00594399|27055476|P3|Initial 3 Month Counseling|Not ready to exercise|0
7784009|NCT00594399|27055477|P2|Initial 3 Month Counseling|Not ready to exercise|0
7784010|NCT00594399|27055478|P1|Initial 3 Month Counseling|Not ready to exercise|1
7784011|NCT00594386|27055500|P1|Overall Study|Other: Loss of drivers license|1
7784012|NCT00594386|27055500|P1|Overall Study|Other: Patient wants prescription Neupro|1
7784013|NCT00594386|27055500|P1|Overall Study|Other: Site terminated participation|1
7784014|NCT00594386|27055500|P1|Overall Study|Other: Sponsor closure of study|1
7784015|NCT00594386|27055500|P1|Overall Study|Other: Study terminated per investigator|2
7784016|NCT00594386|27055500|P1|Overall Study|Other: Subject admitted to nursing home|1
7784017|NCT00594386|27055500|P1|Overall Study|Other: Subject moved to Seattle|1
7784018|NCT00594386|27055500|P1|Overall Study|Other: Patient went off patch (hospital)|1
7784019|NCT00594386|27055500|P1|Overall Study|Lost to Follow-up|6
7784020|NCT00594386|27055500|P1|Overall Study|Study ended per sponsor|115
7784021|NCT00594386|27055500|P1|Overall Study|Subject withdrew consent|35
7784022|NCT00594386|27055500|P1|Overall Study|Unsatisfactory compliance of subject|11
7784023|NCT00594386|27055500|P1|Overall Study|Adverse Event|68
7784024|NCT00594386|27055500|P1|Overall Study|Lack of Efficacy|12
7784025|NCT00594386|27055500|P1|Overall Study|Major protocol violation|2
7784026|NCT00594204|27055533|P2|Overall Study|Randomized but not treated|1
7784027|NCT00594204|27055534|P1|Overall Study|Randomized but not treated|4
7784028|NCT00594204|27055533|P2|Overall Study|Lack of Efficacy|4
7784029|NCT00594204|27055534|P1|Overall Study|Lack of Efficacy|3
7784030|NCT00594204|27055533|P2|Overall Study|Other|3
7784031|NCT00594204|27055534|P1|Overall Study|Other|4
7784032|NCT00594204|27055533|P2|Overall Study|Withdrawal by Subject|29
7784033|NCT00594204|27055534|P1|Overall Study|Withdrawal by Subject|23
7784034|NCT00594204|27055533|P2|Overall Study|Lost to Follow-up|5
7784035|NCT00594204|27055534|P1|Overall Study|Lost to Follow-up|9
7784036|NCT00594204|27055533|P2|Overall Study|Adverse Event|3
7784037|NCT00594204|27055534|P1|Overall Study|Adverse Event|15
7784038|NCT00594178|27055544|P1|Overall Study|Physician Decision|5
7784039|NCT00594165|27055549|P1|Overall Study|Other: Site terminated participation|2
7784040|NCT00594165|27055549|P1|Overall Study|Other: Subject enrolled in other trial|1
7784041|NCT00594165|27055549|P1|Overall Study|Other: House bound; can't get to clinic|1
7784042|NCT00594165|27055549|P1|Overall Study|Other: Brain surgery controlled symptoms|1
7784043|NCT00594165|27055549|P1|Overall Study|Other: Subject moving|3
7784044|NCT00594165|27055549|P1|Overall Study|Other: PI discretion|5
7784045|NCT00594165|27055549|P1|Overall Study|Lost to Follow-up|4
7784046|NCT00594165|27055549|P1|Overall Study|Study ended per sponsor|102
7784047|NCT00594165|27055549|P1|Overall Study|Subject withdrew consent|27
7784048|NCT00594165|27055549|P1|Overall Study|Unsatisfactory compliance of subject|6
7784049|NCT00594165|27055549|P1|Overall Study|Adverse Event|52
7784050|NCT00594165|27055549|P1|Overall Study|Lack of Efficacy|12
7784051|NCT00594165|27055549|P1|Overall Study|Major protocol violation|1
7784052|NCT00594100|27055555|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
7784053|NCT00594100|27055555|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
7784054|NCT00594100|27055555|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
7784055|NCT00594100|27055555|P1|Procedure|Technical Failure|9
7784056|NCT00594035|27055571|P2|Overall Study|Subject couldn't return due to job|1
7784057|NCT00594035|27055572|P1|Overall Study|Subject couldn't return due to job|0
7784058|NCT00594035|27055571|P2|Overall Study|Subject transferred to nursing home|1
7784059|NCT00594035|27055572|P1|Overall Study|Subject transferred to nursing home|0
7784060|NCT00594035|27055571|P2|Overall Study|Withdrawal by Subject|0
7784061|NCT00594035|27055572|P1|Overall Study|Withdrawal by Subject|1
7784062|NCT00594035|27055571|P2|Overall Study|Lost to Follow-up|1
7784063|NCT00594035|27055572|P1|Overall Study|Lost to Follow-up|1
7784064|NCT00593957|27055602|P3|Overall Study|Physician Decision|2
7784065|NCT00593957|27055603|P2|Overall Study|Physician Decision|1
7784066|NCT00593957|27055604|P1|Overall Study|Physician Decision|0
7784067|NCT00593918|27055628|P2|Overall Study|Withdrawal by Subject|24
7784068|NCT00593918|27055629|P1|Overall Study|Withdrawal by Subject|5
7784069|NCT00593840|27055642|P1|Overall Study|Withdrawal by Subject|1
7784070|NCT00593827|27055654|P2|Overall Study|On Active Treatment/Pending|2
7784071|NCT00593827|27055655|P1|Overall Study|On Active Treatment/Pending|0
7784072|NCT00593814|27055679|P2|Overall Study|Physician Decision|0
7784073|NCT00593814|27055680|P1|Overall Study|Physician Decision|3
7784074|NCT00593814|27055679|P2|Overall Study|Lost to Follow-up|0
7784075|NCT00593814|27055680|P1|Overall Study|Lost to Follow-up|7
7784076|NCT00593814|27055679|P2|Overall Study|Withdrawal by Subject|0
7784077|NCT00593814|27055680|P1|Overall Study|Withdrawal by Subject|7
7784078|NCT00593814|27055679|P2|Overall Study|Death|0
7784079|NCT00593814|27055680|P1|Overall Study|Death|7
7784080|NCT00593736|27055692|P4|Treatment Period and Placebo Run-out|Various|0
7784081|NCT00593736|27055693|P3|Treatment Period and Placebo Run-out|Various|1
7784082|NCT00593736|27055694|P2|Treatment Period and Placebo Run-out|Various|1
7784083|NCT00593736|27055695|P1|Treatment Period and Placebo Run-out|Various|1
7784084|NCT00593736|27055692|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
7784085|NCT00593736|27055693|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
7784086|NCT00593736|27055694|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
7784087|NCT00593736|27055695|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
7784088|NCT00593736|27055692|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
7784089|NCT00593736|27055693|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
7784090|NCT00593736|27055694|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
7784091|NCT00593736|27055695|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
7784092|NCT00593736|27055692|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
7784093|NCT00593736|27055693|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
7784094|NCT00593736|27055694|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
7784095|NCT00593736|27055695|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
7784096|NCT00593736|27055692|P4|Screening Period and Placebo Run-in|Various|25
7784097|NCT00593736|27055693|P3|Screening Period and Placebo Run-in|Various|0
7784098|NCT00593736|27055694|P2|Screening Period and Placebo Run-in|Various|0
7784099|NCT00593736|27055695|P1|Screening Period and Placebo Run-in|Various|0
7784100|NCT00593736|27055692|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
7784101|NCT00593736|27055693|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7784102|NCT00593736|27055694|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7784103|NCT00593736|27055695|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7784104|NCT00593736|27055692|P4|Screening Period and Placebo Run-in|Study Termination|15
7784105|NCT00593736|27055693|P3|Screening Period and Placebo Run-in|Study Termination|0
7784106|NCT00593736|27055694|P2|Screening Period and Placebo Run-in|Study Termination|0
7784107|NCT00593736|27055695|P1|Screening Period and Placebo Run-in|Study Termination|0
7784108|NCT00593736|27055692|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
7784109|NCT00593736|27055693|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7784110|NCT00593736|27055694|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7784111|NCT00593736|27055695|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7784112|NCT00593736|27055692|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
7784113|NCT00593736|27055693|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
7784114|NCT00593736|27055694|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
7784115|NCT00593736|27055695|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
7784116|NCT00593736|27055692|P4|Screening Period and Placebo Run-in|Adverse Event|3
7784117|NCT00593736|27055693|P3|Screening Period and Placebo Run-in|Adverse Event|0
7784118|NCT00593736|27055694|P2|Screening Period and Placebo Run-in|Adverse Event|0
7784119|NCT00593736|27055695|P1|Screening Period and Placebo Run-in|Adverse Event|0
7784120|NCT00593684|27055943|P2|Overall Study|Death|1
7784121|NCT00593684|27055944|P1|Overall Study|Death|2
7784122|NCT00593606|27055970|P1|Overall Study|Screen Failure|3
7784123|NCT00593606|27055970|P1|Overall Study|Run-In Failure|5
7784124|NCT00593606|27055970|P1|Overall Study|Lost to Follow-up|2
7784125|NCT00593606|27055970|P1|Overall Study|Protocol Violation|3
7784126|NCT00593606|27055970|P1|Overall Study|Withdrawal by Subject|1
7784127|NCT00593606|27055970|P1|Overall Study|Adverse Event|13
7784128|NCT00593554|27056068|P2|Overall Study|Disease Progression|2
7784129|NCT00593554|27056069|P1|Overall Study|Disease Progression|1
7784130|NCT00593554|27056068|P2|Overall Study|Withdrawal by Subject|0
7784131|NCT00593554|27056069|P1|Overall Study|Withdrawal by Subject|1
7784132|NCT00593554|27056068|P2|Overall Study|Physician Decision|1
7784133|NCT00593554|27056069|P1|Overall Study|Physician Decision|0
7784134|NCT00593554|27056068|P2|Overall Study|Death|2
7784135|NCT00593554|27056069|P1|Overall Study|Death|1
7784136|NCT00593489|27056089|P2|Allocation|did not attend workshop; allocation not|1
7784137|NCT00593489|27056090|P1|Allocation|did not attend workshop; allocation not|2
7784138|NCT00593385|27056193|P1|Overall Study|Withdrawal by Subject|9
7784139|NCT00593385|27056193|P1|Overall Study|Lost to Follow-up|17
7784140|NCT00593385|27056193|P1|Overall Study|Death|14
7784141|NCT00593333|27056254|P2|Overall Study|Lost to Follow-up|11
7784142|NCT00593333|27056255|P1|Overall Study|Lost to Follow-up|10
7784143|NCT00593112|27056278|P2|Overall Study|Withdrawal by Subject|0
7784144|NCT00593112|27056279|P1|Overall Study|Withdrawal by Subject|5
7784145|NCT00593112|27056278|P2|Overall Study|Unreadable Scan|0
7784146|NCT00593112|27056279|P1|Overall Study|Unreadable Scan|1
7784147|NCT00593112|27056278|P2|Overall Study|Abnormal Scan|0
7784148|NCT00593112|27056279|P1|Overall Study|Abnormal Scan|1
7784149|NCT00593112|27056278|P2|Overall Study|Scan Anxiety|0
7784150|NCT00593112|27056279|P1|Overall Study|Scan Anxiety|3
7784151|NCT00592904|27056306|P4|Overall Study|Other|0
7784152|NCT00592904|27056307|P3|Overall Study|Other|0
7784153|NCT00592904|27056308|P2|Overall Study|Other|3
7784154|NCT00592904|27056309|P1|Overall Study|Other|3
7784155|NCT00592904|27056306|P4|Overall Study|Physician Decision|0
7784156|NCT00592904|27056307|P3|Overall Study|Physician Decision|1
7784157|NCT00592904|27056308|P2|Overall Study|Physician Decision|3
7784158|NCT00592904|27056309|P1|Overall Study|Physician Decision|0
7784159|NCT00592904|27056306|P4|Overall Study|Lack of Efficacy|3
7784160|NCT00592904|27056307|P3|Overall Study|Lack of Efficacy|2
7784161|NCT00592904|27056308|P2|Overall Study|Lack of Efficacy|7
7784162|NCT00592904|27056309|P1|Overall Study|Lack of Efficacy|2
7784163|NCT00592904|27056306|P4|Overall Study|Withdrawal by Subject|2
7784164|NCT00592904|27056307|P3|Overall Study|Withdrawal by Subject|1
7784165|NCT00592904|27056308|P2|Overall Study|Withdrawal by Subject|16
7784166|NCT00592904|27056309|P1|Overall Study|Withdrawal by Subject|4
7784167|NCT00592904|27056306|P4|Overall Study|Protocol Violation|1
7784168|NCT00592904|27056307|P3|Overall Study|Protocol Violation|0
7784169|NCT00592904|27056308|P2|Overall Study|Protocol Violation|1
7784170|NCT00592904|27056309|P1|Overall Study|Protocol Violation|1
7784171|NCT00592904|27056306|P4|Overall Study|Adverse Event|5
7784172|NCT00592904|27056307|P3|Overall Study|Adverse Event|13
7784173|NCT00592904|27056308|P2|Overall Study|Adverse Event|25
7784174|NCT00592904|27056309|P1|Overall Study|Adverse Event|15
7784175|NCT00592852|27056335|P1|Overall Study|Withdrawal by Subject|1
7784176|NCT00592852|27056335|P1|Overall Study|Found ineligible|1
7784177|NCT00592852|27056335|P1|Overall Study|Adverse Event|3
7784178|NCT00592852|27056335|P1|Overall Study|Non-compliance|1
7784179|NCT00592839|27056343|P3|Overall Study|Lost to Follow-up|1
7784180|NCT00592839|27056344|P2|Overall Study|Lost to Follow-up|1
7784181|NCT00592839|27056345|P1|Overall Study|Lost to Follow-up|0
7784182|NCT00592839|27056343|P3|Overall Study|Adverse Event|0
7784183|NCT00592839|27056344|P2|Overall Study|Adverse Event|1
7784184|NCT00592839|27056345|P1|Overall Study|Adverse Event|0
7784185|NCT00592839|27056343|P3|Overall Study|Protocol Violation|2
7784186|NCT00592839|27056344|P2|Overall Study|Protocol Violation|1
7784187|NCT00592839|27056345|P1|Overall Study|Protocol Violation|1
7784188|NCT00592839|27056343|P3|Overall Study|Withdrawal by Subject|3
7784189|NCT00592839|27056344|P2|Overall Study|Withdrawal by Subject|1
7784190|NCT00592839|27056345|P1|Overall Study|Withdrawal by Subject|1
7784191|NCT00592774|27056373|P5|Overall Study|Other|2
7784192|NCT00592774|27056374|P4|Overall Study|Other|0
7784193|NCT00592774|27056375|P3|Overall Study|Other|1
7784194|NCT00592774|27056376|P2|Overall Study|Other|1
7784195|NCT00592774|27056377|P1|Overall Study|Other|0
7784196|NCT00592774|27056373|P5|Overall Study|Physician Decision|1
7784197|NCT00592774|27056374|P4|Overall Study|Physician Decision|0
7784198|NCT00592774|27056375|P3|Overall Study|Physician Decision|1
7784199|NCT00592774|27056376|P2|Overall Study|Physician Decision|1
7784200|NCT00592774|27056377|P1|Overall Study|Physician Decision|0
7784201|NCT00592774|27056373|P5|Overall Study|Lack of Efficacy|2
7784202|NCT00592774|27056374|P4|Overall Study|Lack of Efficacy|0
7784203|NCT00592774|27056375|P3|Overall Study|Lack of Efficacy|0
7784204|NCT00592774|27056376|P2|Overall Study|Lack of Efficacy|3
7784205|NCT00592774|27056377|P1|Overall Study|Lack of Efficacy|3
7784206|NCT00592774|27056373|P5|Overall Study|Withdrawal by Subject|0
7784207|NCT00592774|27056374|P4|Overall Study|Withdrawal by Subject|0
7784208|NCT00592774|27056375|P3|Overall Study|Withdrawal by Subject|0
7784209|NCT00592774|27056376|P2|Overall Study|Withdrawal by Subject|7
7784210|NCT00592774|27056377|P1|Overall Study|Withdrawal by Subject|3
7784211|NCT00592774|27056373|P5|Overall Study|Protocol Violation|1
7784212|NCT00592774|27056374|P4|Overall Study|Protocol Violation|0
7784213|NCT00592774|27056375|P3|Overall Study|Protocol Violation|0
7784214|NCT00592774|27056376|P2|Overall Study|Protocol Violation|1
7784215|NCT00592774|27056377|P1|Overall Study|Protocol Violation|0
7784216|NCT00592774|27056373|P5|Overall Study|Adverse Event|8
7784217|NCT00592774|27056374|P4|Overall Study|Adverse Event|14
7784218|NCT00592774|27056375|P3|Overall Study|Adverse Event|2
7784219|NCT00592774|27056376|P2|Overall Study|Adverse Event|19
7784220|NCT00592774|27056377|P1|Overall Study|Adverse Event|5
7784221|NCT00592683|27056449|P2|Overall Study|Lost to Follow-up|1
7784222|NCT00592683|27056450|P1|Overall Study|Lost to Follow-up|0
7784223|NCT00592683|27056449|P2|Overall Study|Other|0
7784224|NCT00592683|27056450|P1|Overall Study|Other|1
7784225|NCT00592683|27056449|P2|Overall Study|Study drug expired|0
7784226|NCT00592683|27056450|P1|Overall Study|Study drug expired|1
7784227|NCT00592683|27056449|P2|Overall Study|Protocol Violation|0
7784228|NCT00592683|27056450|P1|Overall Study|Protocol Violation|1
7784229|NCT00592683|27056449|P2|Overall Study|Adverse Event|2
7784230|NCT00592683|27056450|P1|Overall Study|Adverse Event|0
7784231|NCT00592683|27056449|P2|Overall Study|Withdrawal by Subject|0
7784232|NCT00592683|27056450|P1|Overall Study|Withdrawal by Subject|1
7784233|NCT00592683|27056449|P2|Overall Study|Found ineligible|1
7784234|NCT00592683|27056450|P1|Overall Study|Found ineligible|0
7784235|NCT00592631|27056460|P2|Overall Study|Lost to Follow-up|2
7784236|NCT00592631|27056461|P1|Overall Study|Lost to Follow-up|0
7784237|NCT00592553|27056470|P3|Overall Study|Protocol Noncompliance|0
7784238|NCT00592553|27056471|P2|Overall Study|Protocol Noncompliance|0
7784239|NCT00592553|27056472|P1|Overall Study|Protocol Noncompliance|1
7784240|NCT00592384|27056589|P2|Overall Study|Withdrawal by Subject|6
7784241|NCT00592384|27056590|P1|Overall Study|Withdrawal by Subject|5
7784242|NCT00592358|27056598|P1|Overall Study|Inability to swallow pills|1
7784243|NCT00592358|27056598|P1|Overall Study|Lack of Efficacy|2
7784244|NCT00592358|27056598|P1|Overall Study|Adverse Event|1
7784245|NCT00592358|27056598|P1|Overall Study|Withdrawal by Subject|2
7784246|NCT00592319|27056605|P2|Overall Study|Lost to Follow-up|3
7784247|NCT00592319|27056606|P1|Overall Study|Lost to Follow-up|0
7784248|NCT00592072|27056681|P2|Wash Out Period|Lost to Follow-up|1
7784249|NCT00592072|27056682|P1|Wash Out Period|Lost to Follow-up|1
7784250|NCT00592007|27056704|P1|Overall Study|patient ineligible (out of lab range)|1
7784251|NCT00592007|27056704|P1|Overall Study|Withdrawal by Subject|1
7784252|NCT00591864|27056716|P1|Overall Study|Incomplete Imaging|5
7784253|NCT00591851|27056722|P1|Overall Study|Progressive Disease|1
7784254|NCT00591851|27056722|P1|Overall Study|Adverse Event|2
7784255|NCT00591851|27056722|P1|Overall Study|Withdrawal by Subject|3
7784256|NCT00591838|27056731|P5|Overall Study|Withdrawal by Subject|0
7784257|NCT00591838|27056732|P4|Overall Study|Withdrawal by Subject|1
7784258|NCT00591838|27056733|P3|Overall Study|Withdrawal by Subject|0
7784259|NCT00591838|27056734|P2|Overall Study|Withdrawal by Subject|0
7784260|NCT00591838|27056735|P1|Overall Study|Withdrawal by Subject|0
7784261|NCT00591786|27056799|P10|Overall Study|Withdrawal of Informed Consent|0
7784262|NCT00591786|27056800|P9|Overall Study|Withdrawal of Informed Consent|0
7784263|NCT00591786|27056801|P8|Overall Study|Withdrawal of Informed Consent|0
7784264|NCT00591786|27056802|P7|Overall Study|Withdrawal of Informed Consent|0
7784265|NCT00591786|27056803|P6|Overall Study|Withdrawal of Informed Consent|0
7784266|NCT00591786|27056804|P5|Overall Study|Withdrawal of Informed Consent|0
7784267|NCT00591786|27056805|P4|Overall Study|Withdrawal of Informed Consent|0
7784268|NCT00591786|27056806|P3|Overall Study|Withdrawal of Informed Consent|1
7784269|NCT00591786|27056807|P2|Overall Study|Withdrawal of Informed Consent|0
7784270|NCT00591786|27056808|P1|Overall Study|Withdrawal of Informed Consent|0
7784271|NCT00591773|27056853|P3|Overall Study|Other|4
7784272|NCT00591773|27056854|P2|Overall Study|Other|1
7784273|NCT00591773|27056855|P1|Overall Study|Other|1
7784274|NCT00591773|27056853|P3|Overall Study|Lack of Efficacy|2
7784275|NCT00591773|27056854|P2|Overall Study|Lack of Efficacy|2
7784276|NCT00591773|27056855|P1|Overall Study|Lack of Efficacy|1
7784277|NCT00591773|27056853|P3|Overall Study|Withdrawal by Subject|3
7784278|NCT00591773|27056854|P2|Overall Study|Withdrawal by Subject|5
7784279|NCT00591773|27056855|P1|Overall Study|Withdrawal by Subject|2
7784280|NCT00591773|27056853|P3|Overall Study|Lost to Follow-up|1
7784281|NCT00591773|27056854|P2|Overall Study|Lost to Follow-up|4
7784282|NCT00591773|27056855|P1|Overall Study|Lost to Follow-up|1
7784283|NCT00591773|27056853|P3|Overall Study|Protocol Violation|0
7784284|NCT00591773|27056854|P2|Overall Study|Protocol Violation|3
7784285|NCT00591773|27056855|P1|Overall Study|Protocol Violation|2
7784286|NCT00591773|27056853|P3|Overall Study|Adverse Event|6
7784287|NCT00591773|27056854|P2|Overall Study|Adverse Event|9
7784288|NCT00591773|27056855|P1|Overall Study|Adverse Event|9
7784289|NCT00591734|27056914|P1|Overall Study|Intercurrent Illness|8
7784290|NCT00591734|27056914|P1|Overall Study|Physician Decision|5
7784291|NCT00591734|27056914|P1|Overall Study|Adverse Event|5
7784292|NCT00591734|27056914|P1|Overall Study|Lack of Efficacy|35
7784293|NCT00591721|27056920|P2|Overall Study|Intervention not received|8
7784294|NCT00591721|27056921|P1|Overall Study|Intervention not received|10
7784295|NCT00591721|27056920|P2|Overall Study|Lost to Follow-up|4
7784296|NCT00591721|27056921|P1|Overall Study|Lost to Follow-up|1
7784297|NCT00591721|27056920|P2|Overall Study|Withdrawal by Subject|10
7784298|NCT00591721|27056921|P1|Overall Study|Withdrawal by Subject|10
7784299|NCT00591630|27056931|P4|Overall Study|Death|0
7784300|NCT00591630|27056932|P3|Overall Study|Death|1
7784301|NCT00591630|27056933|P2|Overall Study|Death|0
7784302|NCT00591630|27056934|P1|Overall Study|Death|0
7784303|NCT00591591|27056946|P2|Overall Study|Lack of Efficacy|2
7784304|NCT00591591|27056947|P1|Overall Study|Lack of Efficacy|10
7784305|NCT00591591|27056946|P2|Overall Study|Withdrawal by Subject|37
7784306|NCT00591591|27056947|P1|Overall Study|Withdrawal by Subject|1
7784307|NCT00591578|27056964|P3|Open-Label Extension Phase|Other|0
7784308|NCT00591578|27056965|P2|Open-Label Extension Phase|Other|0
7784309|NCT00591578|27056966|P1|Open-Label Extension Phase|Other|1
7784310|NCT00591578|27056964|P3|Open-Label Extension Phase|Withdrawal by Subject|0
7784311|NCT00591578|27056965|P2|Open-Label Extension Phase|Withdrawal by Subject|1
7784312|NCT00591578|27056966|P1|Open-Label Extension Phase|Withdrawal by Subject|1
7784313|NCT00591578|27056964|P3|Open-Label Extension Phase|Lost to Follow-up|0
7784314|NCT00591578|27056965|P2|Open-Label Extension Phase|Lost to Follow-up|4
7784315|NCT00591578|27056966|P1|Open-Label Extension Phase|Lost to Follow-up|1
7784316|NCT00591578|27056964|P3|Open-Label Extension Phase|Adverse Event|0
7784317|NCT00591578|27056965|P2|Open-Label Extension Phase|Adverse Event|5
7784318|NCT00591578|27056966|P1|Open-Label Extension Phase|Adverse Event|3
7784319|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Other|4
7784320|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Other|9
7784321|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Other|4
7784322|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
7784323|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
7784324|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
7784325|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Pregnancy|0
7784326|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Pregnancy|0
7784327|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Pregnancy|1
7784328|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
7784329|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
7784330|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
7784331|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
7784332|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
7784333|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
7784334|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Protocol Violation|3
7784335|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Protocol Violation|2
7784336|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Protocol Violation|3
7784337|NCT00591578|27056964|P3|Double-Blind Treatment Phase|Adverse Event|19
7784338|NCT00591578|27056965|P2|Double-Blind Treatment Phase|Adverse Event|26
7784339|NCT00591578|27056966|P1|Double-Blind Treatment Phase|Adverse Event|20
7784340|NCT00591565|27057017|P1|Overall Study|lost follow up, withdrawn|5
7784341|NCT00591409|27057031|P10|Overall Study|Not Treated|1
7784342|NCT00591409|27057032|P9|Overall Study|Not Treated|0
7784343|NCT00591409|27057033|P8|Overall Study|Not Treated|0
7784344|NCT00591409|27057034|P7|Overall Study|Not Treated|0
7784345|NCT00591409|27057035|P6|Overall Study|Not Treated|0
7784346|NCT00591409|27057036|P5|Overall Study|Not Treated|1
7784347|NCT00591409|27057037|P4|Overall Study|Not Treated|0
7784348|NCT00591409|27057038|P3|Overall Study|Not Treated|0
7784349|NCT00591409|27057039|P2|Overall Study|Not Treated|0
7784350|NCT00591409|27057040|P1|Overall Study|Not Treated|0
7784351|NCT00591370|27057082|P1|Overall Study|Not Treated|2
7784352|NCT00591344|27057090|P2|Overall Study|Did not want to come off medication|1
7784353|NCT00591344|27057091|P1|Overall Study|Did not want to come off medication|0
7784354|NCT00591344|27057090|P2|Overall Study|Lost to Follow-up|1
7784355|NCT00591344|27057091|P1|Overall Study|Lost to Follow-up|0
7784356|NCT00591344|27057090|P2|Overall Study|Death|1
7784357|NCT00591344|27057091|P1|Overall Study|Death|0
7784358|NCT00591344|27057090|P2|Overall Study|Underwent DBS|2
7784359|NCT00591344|27057091|P1|Overall Study|Underwent DBS|2
7784360|NCT00591344|27057090|P2|Overall Study|Medical complications|3
7784361|NCT00591344|27057091|P1|Overall Study|Medical complications|1
7784362|NCT00591344|27057090|P2|Overall Study|Moved out of state|0
7784363|NCT00591344|27057091|P1|Overall Study|Moved out of state|1
7784364|NCT00591344|27057090|P2|Overall Study|Transportation issues|0
7784365|NCT00591344|27057091|P1|Overall Study|Transportation issues|1
7784366|NCT00591266|27057117|P3|Overall Study|Other|5
7784367|NCT00591266|27057118|P2|Overall Study|Other|4
7784368|NCT00591266|27057119|P1|Overall Study|Other|1
7784369|NCT00591266|27057117|P3|Overall Study|Lack of Efficacy|0
7784370|NCT00591266|27057118|P2|Overall Study|Lack of Efficacy|2
7784371|NCT00591266|27057119|P1|Overall Study|Lack of Efficacy|0
7784372|NCT00591266|27057117|P3|Overall Study|Withdrawal by Subject|5
7784373|NCT00591266|27057118|P2|Overall Study|Withdrawal by Subject|2
7784374|NCT00591266|27057119|P1|Overall Study|Withdrawal by Subject|6
7784375|NCT00591266|27057117|P3|Overall Study|Protocol Violation|1
7784376|NCT00591266|27057118|P2|Overall Study|Protocol Violation|0
7784377|NCT00591266|27057119|P1|Overall Study|Protocol Violation|0
7784378|NCT00591266|27057117|P3|Overall Study|Lost to Follow-up|0
7784379|NCT00591266|27057118|P2|Overall Study|Lost to Follow-up|1
7784380|NCT00591266|27057119|P1|Overall Study|Lost to Follow-up|0
7784381|NCT00591266|27057117|P3|Overall Study|Adverse Event|3
7784382|NCT00591266|27057118|P2|Overall Study|Adverse Event|2
7784383|NCT00591266|27057119|P1|Overall Study|Adverse Event|2
7784384|NCT00591253|27057172|P3|Overall Study|Other|3
7784385|NCT00591253|27057173|P2|Overall Study|Other|5
7784386|NCT00591253|27057174|P1|Overall Study|Other|5
7784387|NCT00591253|27057172|P3|Overall Study|Lack of Efficacy|3
7784388|NCT00591253|27057173|P2|Overall Study|Lack of Efficacy|0
7784389|NCT00591253|27057174|P1|Overall Study|Lack of Efficacy|1
7784390|NCT00591253|27057172|P3|Overall Study|Withdrawal by Subject|6
7784391|NCT00591253|27057173|P2|Overall Study|Withdrawal by Subject|7
7784392|NCT00591253|27057174|P1|Overall Study|Withdrawal by Subject|1
7784393|NCT00591253|27057172|P3|Overall Study|Lost to Follow-up|0
7784394|NCT00591253|27057173|P2|Overall Study|Lost to Follow-up|4
7784395|NCT00591253|27057174|P1|Overall Study|Lost to Follow-up|2
7784396|NCT00591253|27057172|P3|Overall Study|Protocol Violation|2
7784397|NCT00591253|27057173|P2|Overall Study|Protocol Violation|2
7784398|NCT00591253|27057174|P1|Overall Study|Protocol Violation|2
7784399|NCT00591253|27057172|P3|Overall Study|Adverse Event|1
7784400|NCT00591253|27057173|P2|Overall Study|Adverse Event|3
7784401|NCT00591253|27057174|P1|Overall Study|Adverse Event|3
7784402|NCT00591214|27057242|P1|Overall Study|Withdrawal by Subject|1
7784403|NCT00591214|27057242|P1|Overall Study|Physician Decision|7
7784404|NCT00591149|27057251|P1|Overall Study|Withdrawal by Subject|1
7784405|NCT00591149|27057251|P1|Overall Study|Adverse Event|4
7784406|NCT00591006|27057272|P24|Overall Study|Adverse Event|0
7784407|NCT00591006|27057273|P23|Overall Study|Adverse Event|1
7784408|NCT00591006|27057274|P22|Overall Study|Adverse Event|0
7784409|NCT00591006|27057275|P21|Overall Study|Adverse Event|0
7784410|NCT00591006|27057276|P20|Overall Study|Adverse Event|0
7784411|NCT00591006|27057277|P19|Overall Study|Adverse Event|0
7784412|NCT00591006|27057278|P18|Overall Study|Adverse Event|0
7784413|NCT00591006|27057279|P17|Overall Study|Adverse Event|0
7784414|NCT00591006|27057280|P16|Overall Study|Adverse Event|0
7784415|NCT00591006|27057281|P15|Overall Study|Adverse Event|0
7784416|NCT00591006|27057282|P14|Overall Study|Adverse Event|0
7784417|NCT00591006|27057283|P13|Overall Study|Adverse Event|0
7784418|NCT00591006|27057284|P12|Overall Study|Adverse Event|0
7784419|NCT00591006|27057285|P11|Overall Study|Adverse Event|0
7784420|NCT00591006|27057286|P10|Overall Study|Adverse Event|0
7784421|NCT00591006|27057287|P9|Overall Study|Adverse Event|0
7784422|NCT00591006|27057288|P8|Overall Study|Adverse Event|0
7784423|NCT00591006|27057289|P7|Overall Study|Adverse Event|0
7784424|NCT00591006|27057290|P6|Overall Study|Adverse Event|0
7784425|NCT00591006|27057291|P5|Overall Study|Adverse Event|0
7784426|NCT00591006|27057292|P4|Overall Study|Adverse Event|0
7784427|NCT00591006|27057293|P3|Overall Study|Adverse Event|0
7784428|NCT00591006|27057294|P2|Overall Study|Adverse Event|0
7784429|NCT00591006|27057295|P1|Overall Study|Adverse Event|0
7784430|NCT00591006|27057272|P24|Overall Study|Withdrawal by Subject|1
7784431|NCT00591006|27057273|P23|Overall Study|Withdrawal by Subject|0
7784432|NCT00591006|27057274|P22|Overall Study|Withdrawal by Subject|0
7784433|NCT00591006|27057275|P21|Overall Study|Withdrawal by Subject|0
7784434|NCT00591006|27057276|P20|Overall Study|Withdrawal by Subject|0
7784435|NCT00591006|27057277|P19|Overall Study|Withdrawal by Subject|0
7784436|NCT00591006|27057278|P18|Overall Study|Withdrawal by Subject|0
7784437|NCT00591006|27057279|P17|Overall Study|Withdrawal by Subject|0
7784438|NCT00591006|27057280|P16|Overall Study|Withdrawal by Subject|1
7784439|NCT00591006|27057281|P15|Overall Study|Withdrawal by Subject|0
7784440|NCT00591006|27057282|P14|Overall Study|Withdrawal by Subject|0
7784441|NCT00591006|27057283|P13|Overall Study|Withdrawal by Subject|0
7784442|NCT00591006|27057284|P12|Overall Study|Withdrawal by Subject|0
7784443|NCT00591006|27057285|P11|Overall Study|Withdrawal by Subject|0
7784444|NCT00591006|27057286|P10|Overall Study|Withdrawal by Subject|0
7784445|NCT00591006|27057287|P9|Overall Study|Withdrawal by Subject|0
7784446|NCT00591006|27057288|P8|Overall Study|Withdrawal by Subject|0
7784447|NCT00591006|27057289|P7|Overall Study|Withdrawal by Subject|0
7784448|NCT00591006|27057290|P6|Overall Study|Withdrawal by Subject|0
7784449|NCT00591006|27057291|P5|Overall Study|Withdrawal by Subject|0
7784450|NCT00591006|27057292|P4|Overall Study|Withdrawal by Subject|0
7784451|NCT00591006|27057293|P3|Overall Study|Withdrawal by Subject|0
7784452|NCT00591006|27057294|P2|Overall Study|Withdrawal by Subject|0
7784453|NCT00591006|27057295|P1|Overall Study|Withdrawal by Subject|0
7784454|NCT00590980|27057313|P1|Overall Study|Did not meet all inclusion criteria|10
7784455|NCT00590967|27057319|P2|Overall Study|Did not receive chemo per protocol|0
7784456|NCT00590967|27057320|P1|Overall Study|Did not receive chemo per protocol|1
7784457|NCT00590967|27057319|P2|Overall Study|Did not sign consent form|1
7784458|NCT00590967|27057320|P1|Overall Study|Did not sign consent form|0
7784459|NCT00590967|27057319|P2|Overall Study|Non-compliant|2
7784460|NCT00590967|27057320|P1|Overall Study|Non-compliant|0
7784461|NCT00590967|27057319|P2|Overall Study|Poor performance status|1
7784462|NCT00590967|27057320|P1|Overall Study|Poor performance status|0
7784463|NCT00590967|27057319|P2|Overall Study|Ineligible|0
7784464|NCT00590967|27057320|P1|Overall Study|Ineligible|1
7784465|NCT00590967|27057319|P2|Overall Study|Withdrawal by Subject|1
7784466|NCT00590967|27057320|P1|Overall Study|Withdrawal by Subject|1
7784467|NCT00590954|27057332|P1|Overall Study|Inevaluable|2
7784468|NCT00590902|27057338|P1|Overall Study|Death|1
7784469|NCT00590824|27057371|P4|Overall Study|Adverse Event|1
7784470|NCT00590824|27057372|P3|Overall Study|Adverse Event|0
7784471|NCT00590824|27057373|P2|Overall Study|Adverse Event|0
7784472|NCT00590824|27057374|P1|Overall Study|Adverse Event|0
7784473|NCT00590824|27057371|P4|Overall Study|Disease could not be resected|0
7784474|NCT00590824|27057372|P3|Overall Study|Disease could not be resected|1
7784475|NCT00590824|27057373|P2|Overall Study|Disease could not be resected|2
7784476|NCT00590824|27057374|P1|Overall Study|Disease could not be resected|0
7784477|NCT00590759|27057400|P1|Overall Study|Lost to Follow-up|28
7784478|NCT00590759|27057400|P1|Overall Study|Death|52
7784479|NCT00590720|27057407|P2|Overall Study|Withdrawal by Subject|1
7784480|NCT00590720|27057408|P1|Overall Study|Withdrawal by Subject|0
7784481|NCT00590720|27057407|P2|Overall Study|Lost to Follow-up|0
7784482|NCT00590720|27057408|P1|Overall Study|Lost to Follow-up|1
7784483|NCT00590681|27057467|P1|Overall Study|disease progression|1
7784484|NCT00590681|27057467|P1|Overall Study|Lost to Follow-up|1
7784485|NCT00590681|27057467|P1|Overall Study|Death|3
7784486|NCT00590681|27057467|P1|Overall Study|Adverse Event|8
7784487|NCT00590681|27057467|P1|Overall Study|Withdrawal by Subject|7
7784488|NCT00590590|27057479|P3|Overall Study|Did not complete study|0
7784489|NCT00590590|27057480|P2|Overall Study|Did not complete study|1
7784490|NCT00590590|27057481|P1|Overall Study|Did not complete study|0
7784491|NCT00590590|27057479|P3|Overall Study|Did not complete due to study closure|1
7784492|NCT00590590|27057480|P2|Overall Study|Did not complete due to study closure|1
7784493|NCT00590590|27057481|P1|Overall Study|Did not complete due to study closure|1
7784494|NCT00590590|27057479|P3|Overall Study|Withdrawal by Subject|1
7784495|NCT00590590|27057480|P2|Overall Study|Withdrawal by Subject|1
7784496|NCT00590590|27057481|P1|Overall Study|Withdrawal by Subject|0
7784497|NCT00590590|27057479|P3|Overall Study|Lost to Follow-up|2
7784498|NCT00590590|27057480|P2|Overall Study|Lost to Follow-up|1
7784499|NCT00590590|27057481|P1|Overall Study|Lost to Follow-up|4
7784500|NCT00590590|27057479|P3|Overall Study|Protocol Violation|2
7784501|NCT00590590|27057480|P2|Overall Study|Protocol Violation|0
7784502|NCT00590590|27057481|P1|Overall Study|Protocol Violation|0
7784503|NCT00590590|27057479|P3|Overall Study|Adverse Event|0
7784504|NCT00590590|27057480|P2|Overall Study|Adverse Event|0
7784505|NCT00590590|27057481|P1|Overall Study|Adverse Event|1
7784506|NCT00590590|27057479|P3|Overall Study|Lack of Efficacy|0
7784507|NCT00590590|27057480|P2|Overall Study|Lack of Efficacy|2
7784508|NCT00590590|27057481|P1|Overall Study|Lack of Efficacy|1
7784509|NCT00590577|27057508|P4|Overall Study|Various reasons|2
7784510|NCT00590577|27057509|P3|Overall Study|Various reasons|1
7784511|NCT00590577|27057510|P2|Overall Study|Various reasons|3
7784512|NCT00590577|27057511|P1|Overall Study|Various reasons|1
7784513|NCT00590577|27057508|P4|Overall Study|Pregnancy|0
7784514|NCT00590577|27057509|P3|Overall Study|Pregnancy|0
7784515|NCT00590577|27057510|P2|Overall Study|Pregnancy|1
7784516|NCT00590577|27057511|P1|Overall Study|Pregnancy|0
7784517|NCT00590577|27057508|P4|Overall Study|Lost to Follow-up|9
7784518|NCT00590577|27057509|P3|Overall Study|Lost to Follow-up|6
7784519|NCT00590577|27057510|P2|Overall Study|Lost to Follow-up|6
7784520|NCT00590577|27057511|P1|Overall Study|Lost to Follow-up|12
7784521|NCT00590577|27057508|P4|Overall Study|Adverse Event|11
7784522|NCT00590577|27057509|P3|Overall Study|Adverse Event|13
7784523|NCT00590577|27057510|P2|Overall Study|Adverse Event|10
7784524|NCT00590577|27057511|P1|Overall Study|Adverse Event|10
7784525|NCT00590577|27057508|P4|Overall Study|Withdrawal by Subject|26
7784526|NCT00590577|27057509|P3|Overall Study|Withdrawal by Subject|30
7784527|NCT00590577|27057510|P2|Overall Study|Withdrawal by Subject|28
7784528|NCT00590577|27057511|P1|Overall Study|Withdrawal by Subject|23
7784529|NCT00590577|27057508|P4|Overall Study|Lack of Efficacy|45
7784530|NCT00590577|27057509|P3|Overall Study|Lack of Efficacy|23
7784531|NCT00590577|27057510|P2|Overall Study|Lack of Efficacy|28
7784532|NCT00590577|27057511|P1|Overall Study|Lack of Efficacy|31
7784533|NCT00590564|27057529|P1|Overall Study|Patient Non-compliance|6
7784534|NCT00590564|27057529|P1|Overall Study|Patient Found to be Ineligible|1
7784535|NCT00590564|27057529|P1|Overall Study|Protocol Violation|1
7784536|NCT00590564|27057529|P1|Overall Study|Lost to Follow-up|6
7784537|NCT00590564|27057529|P1|Overall Study|Withdrawal by Subject|4
7784538|NCT00590538|27057533|P1|Overall Study|Study terminated before completed|2
7784539|NCT00590317|27057579|P2|Overall Study|Lack of Efficacy|5
7784540|NCT00590317|27057580|P1|Overall Study|Lack of Efficacy|1
7784541|NCT00590135|27057610|P1|Overall Study|Primary endpoint measure not obtainable|59
7784542|NCT00590044|27057620|P2|Overall Study|Protocol Violation|0
7784543|NCT00590044|27057621|P1|Overall Study|Protocol Violation|1
7784544|NCT00590044|27057620|P2|Overall Study|wrong insulin arm assigned|0
7784545|NCT00590044|27057621|P1|Overall Study|wrong insulin arm assigned|1
7784546|NCT00590044|27057620|P2|Overall Study|Withdrawal by Subject|2
7784547|NCT00590044|27057621|P1|Overall Study|Withdrawal by Subject|2
7784548|NCT00590031|27057633|P1|Overall Study|Admin Hold|1
7784549|NCT00590031|27057633|P1|Overall Study|Metastatic Disease|1
7784550|NCT00590031|27057633|P1|Overall Study|Withdrawal by Subject|1
7784551|NCT00590031|27057633|P1|Overall Study|Adverse Event|3
7784552|NCT00589979|27057660|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
7784553|NCT00589979|27057661|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
7784554|NCT00589979|27057662|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
7784555|NCT00589979|27057660|P3|Double-Blind Treatment Period 3|Protocol Violation|0
7784556|NCT00589979|27057661|P2|Double-Blind Treatment Period 3|Protocol Violation|1
7784557|NCT00589979|27057662|P1|Double-Blind Treatment Period 3|Protocol Violation|0
7784558|NCT00589979|27057660|P3|Double-Blind Treatment Period 2|Other|1
7784559|NCT00589979|27057661|P2|Double-Blind Treatment Period 2|Other|0
7784560|NCT00589979|27057662|P1|Double-Blind Treatment Period 2|Other|0
7784561|NCT00589979|27057660|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
7784562|NCT00589979|27057661|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7784563|NCT00589979|27057662|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7784564|NCT00589979|27057660|P3|Double-Blind Treatment Period 2|Adverse Event|0
7784565|NCT00589979|27057661|P2|Double-Blind Treatment Period 2|Adverse Event|1
7784566|NCT00589979|27057662|P1|Double-Blind Treatment Period 2|Adverse Event|0
7784567|NCT00589979|27057660|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
7784568|NCT00589979|27057661|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7784569|NCT00589979|27057662|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7784570|NCT00589979|27057660|P3|Double-Blind Treatment Period 1|Protocol Violation|1
7784571|NCT00589979|27057661|P2|Double-Blind Treatment Period 1|Protocol Violation|1
7784572|NCT00589979|27057662|P1|Double-Blind Treatment Period 1|Protocol Violation|0
7784573|NCT00589979|27057660|P3|Double-Blind Treatment Period 1|Adverse Event|0
7784574|NCT00589979|27057661|P2|Double-Blind Treatment Period 1|Adverse Event|1
7784575|NCT00589979|27057662|P1|Double-Blind Treatment Period 1|Adverse Event|0
7784576|NCT00589979|27057660|P3|Run-In Period|Informed Consent Withdrawn|0
7784577|NCT00589979|27057661|P2|Run-In Period|Informed Consent Withdrawn|0
7784578|NCT00589979|27057662|P1|Run-In Period|Informed Consent Withdrawn|4
7784579|NCT00589979|27057660|P3|Run-In Period|Withdrawal by Subject|0
7784580|NCT00589979|27057661|P2|Run-In Period|Withdrawal by Subject|0
7784581|NCT00589979|27057662|P1|Run-In Period|Withdrawal by Subject|10
7784582|NCT00589979|27057660|P3|Run-In Period|Did not qualify for randomization|0
7784583|NCT00589979|27057661|P2|Run-In Period|Did not qualify for randomization|0
7784584|NCT00589979|27057662|P1|Run-In Period|Did not qualify for randomization|54
7784585|NCT00589979|27057660|P3|Run-In Period|Protocol Violation|0
7784586|NCT00589979|27057661|P2|Run-In Period|Protocol Violation|0
7784587|NCT00589979|27057662|P1|Run-In Period|Protocol Violation|3
7784588|NCT00589979|27057660|P3|Run-In Period|Adverse Event|0
7784589|NCT00589979|27057661|P2|Run-In Period|Adverse Event|0
7784590|NCT00589979|27057662|P1|Run-In Period|Adverse Event|5
7784591|NCT00589914|27057701|P2|Overall Study|Other|17
7784592|NCT00589914|27057702|P1|Overall Study|Other|22
7784593|NCT00589914|27057701|P2|Overall Study|Withdrawal by Subject|49
7784594|NCT00589914|27057702|P1|Overall Study|Withdrawal by Subject|55
7784595|NCT00589914|27057701|P2|Overall Study|Pregnancy|0
7784596|NCT00589914|27057702|P1|Overall Study|Pregnancy|1
7784597|NCT00589914|27057701|P2|Overall Study|Lost to Follow-up|18
7784598|NCT00589914|27057702|P1|Overall Study|Lost to Follow-up|11
7784599|NCT00589914|27057701|P2|Overall Study|Lack of Efficacy|43
7784600|NCT00589914|27057702|P1|Overall Study|Lack of Efficacy|40
7784601|NCT00589914|27057701|P2|Overall Study|Death|0
7784602|NCT00589914|27057702|P1|Overall Study|Death|2
7784603|NCT00589914|27057701|P2|Overall Study|Adverse Event|10
7784604|NCT00589914|27057702|P1|Overall Study|Adverse Event|19
7784605|NCT00589797|27057758|P2|Overall Study|Non-Randomized Training Subjects|6
7784606|NCT00589797|27057759|P1|Overall Study|Non-Randomized Training Subjects|46
7784607|NCT00589797|27057758|P2|Overall Study|Withdrawal by Subject|5
7784608|NCT00589797|27057759|P1|Overall Study|Withdrawal by Subject|6
7784609|NCT00589797|27057758|P2|Overall Study|Physician Decision|3
7784610|NCT00589797|27057759|P1|Overall Study|Physician Decision|8
7784611|NCT00589797|27057758|P2|Overall Study|Lost to Follow-up|9
7784612|NCT00589797|27057759|P1|Overall Study|Lost to Follow-up|12
7784613|NCT00589797|27057758|P2|Overall Study|Death|0
7784614|NCT00589797|27057759|P1|Overall Study|Death|1
7784615|NCT00589784|27057783|P2|Overall Study|Adverse Event|4
7784616|NCT00589784|27057784|P1|Overall Study|Adverse Event|0
7784617|NCT00589784|27057783|P2|Overall Study|Patient inevaluable|0
7784618|NCT00589784|27057784|P1|Overall Study|Patient inevaluable|1
7784619|NCT00589784|27057783|P2|Overall Study|Withdrawal by Subject|6
7784620|NCT00589784|27057784|P1|Overall Study|Withdrawal by Subject|0
7784621|NCT00589693|27057791|P2|Overall Study|Protocol Violation|1
7784622|NCT00589693|27057792|P1|Overall Study|Protocol Violation|1
7784623|NCT00589693|27057791|P2|Overall Study|Physician Decision|1
7784624|NCT00589693|27057792|P1|Overall Study|Physician Decision|0
7784625|NCT00589693|27057791|P2|Overall Study|Lost to Follow-up|0
7784626|NCT00589693|27057792|P1|Overall Study|Lost to Follow-up|1
7784627|NCT00589693|27057791|P2|Overall Study|Lack of Efficacy|1
7784628|NCT00589693|27057792|P1|Overall Study|Lack of Efficacy|0
7784629|NCT00589693|27057791|P2|Overall Study|Death|16
7784630|NCT00589693|27057792|P1|Overall Study|Death|26
7784631|NCT00589693|27057791|P2|Overall Study|Adverse Event|4
7784632|NCT00589693|27057792|P1|Overall Study|Adverse Event|4
7784633|NCT00589693|27057791|P2|Overall Study|randomized in error|6
7784634|NCT00589693|27057792|P1|Overall Study|randomized in error|12
7784635|NCT00589667|27057806|P1|Overall Study|Withdrawal by Subject|1
7784636|NCT00589667|27057806|P1|Overall Study|Adverse Event|2
7784637|NCT00589628|27057813|P2|Overall Study|Lost to Follow-up|1
7784638|NCT00589628|27057814|P1|Overall Study|Lost to Follow-up|0
7784639|NCT00589602|27057820|P1|Overall Study|Did not collect enough CD34+ cells|1
7784640|NCT00589472|27057855|P1|Overall Study|Adverse Event|1
7784641|NCT00589303|27057878|P2|Overall Study|Withdrawal by Subject|1
7784642|NCT00589303|27057879|P1|Overall Study|Withdrawal by Subject|2
7784643|NCT00589290|27057885|P1|Overall Study|Withdrawal by Subject|1
7784644|NCT00589121|27057908|P2|Overall Study|No protocol treatment received|1
7784645|NCT00589121|27057909|P1|Overall Study|No protocol treatment received|0
7784646|NCT00589121|27057908|P2|Overall Study|Protocol Violation|6
7784647|NCT00589121|27057909|P1|Overall Study|Protocol Violation|2
7784648|NCT00589108|27057931|P3|Overall Study|Death|4
7784649|NCT00589108|27057932|P2|Overall Study|Death|3
7784650|NCT00589108|27057933|P1|Overall Study|Death|3
7784651|NCT00589108|27057931|P3|Overall Study|Lost to Follow-up|1
7784652|NCT00589108|27057932|P2|Overall Study|Lost to Follow-up|1
7784653|NCT00589108|27057933|P1|Overall Study|Lost to Follow-up|1
7784654|NCT00588952|27057969|P2|Overall Study|Withdrawal by Subject|5
7784655|NCT00588952|27057970|P1|Overall Study|Withdrawal by Subject|3
7784656|NCT00588952|27057969|P2|Overall Study|Adverse Event|2
7784657|NCT00588952|27057970|P1|Overall Study|Adverse Event|0
7784658|NCT00588861|27057998|P2|10 Years|Incomplete due to study termination|114
7784659|NCT00588861|27057999|P1|10 Years|Incomplete due to study termination|107
7784660|NCT00588861|27057998|P2|8 Years|Patients did not return for follow-up|114
7784661|NCT00588861|27057999|P1|8 Years|Patients did not return for follow-up|105
7784662|NCT00588861|27057998|P2|6 Years|Patients did not return for follow-up|109
7784663|NCT00588861|27057999|P1|6 Years|Patients did not return for follow-up|104
7784664|NCT00588861|27057998|P2|4 Years|Patients did not return for follow-up|103
7784665|NCT00588861|27057999|P1|4 Years|Patients did not return for follow-up|91
7784666|NCT00588861|27057998|P2|2 Years|Patients did not return for follow-up|87
7784667|NCT00588861|27057999|P1|2 Years|Patients did not return for follow-up|92
7784668|NCT00588861|27057998|P2|1 Year|Patients did not return for follow-up|82
7784669|NCT00588861|27057999|P1|1 Year|Patients did not return for follow-up|89
7784670|NCT00588861|27057998|P2|6 Months|Patients did not return for follow-up|73
7784671|NCT00588861|27057999|P1|6 Months|Patients did not return for follow-up|98
7784672|NCT00588861|27057998|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
7784673|NCT00588861|27057999|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
7784674|NCT00588848|27058009|P2|Overall Study|Physician Decision|3
7784675|NCT00588848|27058010|P1|Overall Study|Physician Decision|0
7784676|NCT00588822|27058020|P1|Overall Study|progression of disease|8
7784697|NCT00588731|27058053|P2|Overall Study|Withdrawal by Subject|2
7784698|NCT00588731|27058054|P1|Overall Study|Withdrawal by Subject|3
7784699|NCT00588692|27058064|P2|Overall Study|Death|0
7784700|NCT00588692|27058065|P1|Overall Study|Death|1
7784701|NCT00588692|27058064|P2|Overall Study|Cancer|0
7784702|NCT00588692|27058065|P1|Overall Study|Cancer|1
7784703|NCT00588692|27058064|P2|Overall Study|Severe Peptic Ulcer Disease|0
7784704|NCT00588692|27058065|P1|Overall Study|Severe Peptic Ulcer Disease|1
7784705|NCT00588692|27058064|P2|Overall Study|Hip Surgery|1
7784706|NCT00588692|27058065|P1|Overall Study|Hip Surgery|0
7784707|NCT00588692|27058064|P2|Overall Study|Withdrawal by Subject|2
7784708|NCT00588692|27058065|P1|Overall Study|Withdrawal by Subject|4
7784709|NCT00588666|27058101|P1|Overall Study|Adverse Event|4
7784710|NCT00588640|27058106|P1|Overall Study|Ineligible Patient|1
7784711|NCT00588640|27058106|P1|Overall Study|Physician Decision|1
7784712|NCT00588445|27058125|P1|Overall Study|Not Treated|10
7784713|NCT00588445|27058125|P1|Overall Study|Disease Progression|1
7784714|NCT00588445|27058125|P1|Overall Study|Withdrawal by Subject|3
7784715|NCT00588445|27058125|P1|Overall Study|Protocol Violation|1
7784716|NCT00588354|27058149|P2|Baseline to 4 Weeks|Lost to Follow-up|1
7784717|NCT00588354|27058150|P1|Baseline to 4 Weeks|Lost to Follow-up|0
7784718|NCT00588354|27058149|P2|Baseline to 2 Weeks|Lack of Efficacy|0
7784719|NCT00588354|27058150|P1|Baseline to 2 Weeks|Lack of Efficacy|1
7784720|NCT00588354|27058149|P2|Baseline to 2 Weeks|Adverse Event|0
7784721|NCT00588354|27058150|P1|Baseline to 2 Weeks|Adverse Event|1
7784722|NCT00588341|27058170|P1|Overall Study|Patient ineligible|1
7784723|NCT00588341|27058170|P1|Overall Study|Not treated due to metastatic disease|1
7784724|NCT00588341|27058170|P1|Overall Study|Withdrawal by Subject|3
7784725|NCT00588237|27058174|P1|Overall Study|Patien not treated|1
7784726|NCT00588237|27058174|P1|Overall Study|Evaluable for toxicity only|3
7784727|NCT00588146|27058197|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
7784728|NCT00588146|27058198|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
7784729|NCT00588094|27058204|P1|Overall Study|Progression of Disease|2
7784730|NCT00588094|27058204|P1|Overall Study|Adverse Event|3
7784731|NCT00587990|27058211|P3|Overall Study|Death|1
7784732|NCT00587990|27058212|P2|Overall Study|Death|0
7784733|NCT00587990|27058213|P1|Overall Study|Death|0
7784734|NCT00587964|27058256|P1|Overall Study|Progression of Disease|4
7784735|NCT00587964|27058256|P1|Overall Study|Patient did not receive intervention|5
7784736|NCT00587964|27058256|P1|Overall Study|Patient found to be ineligible|1
7784737|NCT00587964|27058256|P1|Overall Study|Lost to Follow-up|1
7784738|NCT00587964|27058256|P1|Overall Study|Withdrawal by Subject|1
7784739|NCT00587860|27058262|P2|Overall Study|Withdrawal by Subject|3
7784740|NCT00587860|27058263|P1|Overall Study|Withdrawal by Subject|3
7784741|NCT00587860|27058262|P2|Overall Study|Lost to Follow-up|2
7784742|NCT00587860|27058263|P1|Overall Study|Lost to Follow-up|2
7784743|NCT00587847|27058283|P1|Overall Study|Adverse Event|2
7784744|NCT00587847|27058283|P1|Overall Study|Lack of Efficacy|5
7784745|NCT00587795|27058306|P2|Overall Study|Withdrawal by Subject|0
7784746|NCT00587795|27058307|P1|Overall Study|Withdrawal by Subject|1
7784747|NCT00587639|27058361|P1|Overall Study|Withdrawal by Subject|1
7784748|NCT00587587|27058368|P2|Overall Study|Lost to Follow-up|1
7784749|NCT00587587|27058369|P1|Overall Study|Lost to Follow-up|6
7784750|NCT00587457|27058423|P3|Overall Study|Development of neutralizing Abs|1
7784751|NCT00587457|27058424|P2|Overall Study|Development of neutralizing Abs|0
7784752|NCT00587457|27058425|P1|Overall Study|Development of neutralizing Abs|0
7784753|NCT00587457|27058423|P3|Overall Study|Undefined|1
7784754|NCT00587457|27058424|P2|Overall Study|Undefined|0
7784755|NCT00587457|27058425|P1|Overall Study|Undefined|0
7784756|NCT00587457|27058423|P3|Overall Study|Initiation of alternative therapy|0
7784757|NCT00587457|27058424|P2|Overall Study|Initiation of alternative therapy|1
7784758|NCT00587457|27058425|P1|Overall Study|Initiation of alternative therapy|0
7784759|NCT00587457|27058423|P3|Overall Study|Disease progression|2
7784760|NCT00587457|27058424|P2|Overall Study|Disease progression|0
7784761|NCT00587457|27058425|P1|Overall Study|Disease progression|2
7784762|NCT00587457|27058423|P3|Overall Study|Adverse Event|1
7784763|NCT00587457|27058424|P2|Overall Study|Adverse Event|2
7784764|NCT00587457|27058425|P1|Overall Study|Adverse Event|1
7784765|NCT00587431|27058462|P2|Overall Study|Withdrawal by Subject|1
7784766|NCT00587431|27058463|P1|Overall Study|Withdrawal by Subject|0
7784767|NCT00587431|27058462|P2|Overall Study|Adverse Event|0
7784768|NCT00587431|27058463|P1|Overall Study|Adverse Event|1
7784769|NCT00587288|27058474|P2|Overall Study|Protocol Violation|0
7784770|NCT00587288|27058475|P1|Overall Study|Protocol Violation|1
7784771|NCT00587288|27058474|P2|Overall Study|Lack of Efficacy|8
7784772|NCT00587288|27058475|P1|Overall Study|Lack of Efficacy|2
7784773|NCT00587288|27058474|P2|Overall Study|Adverse Event|1
7784774|NCT00587288|27058475|P1|Overall Study|Adverse Event|0
7784775|NCT00587223|27058493|P1|Overall Study|Adverse Event|1
7784776|NCT00587171|27058510|P2|Overall Study|Lost to Follow-up|1
7784777|NCT00587171|27058511|P1|Overall Study|Lost to Follow-up|1
7784778|NCT00587158|27058541|P2|Overall Study|Subject did not want to take study med|1
7784779|NCT00587158|27058542|P1|Overall Study|Subject did not want to take study med|0
7784780|NCT00587158|27058541|P2|Overall Study|Death|1
7784781|NCT00587158|27058542|P1|Overall Study|Death|0
7784782|NCT00587158|27058541|P2|Overall Study|Lost to Follow-up|2
7784783|NCT00587158|27058542|P1|Overall Study|Lost to Follow-up|1
7784784|NCT00587158|27058541|P2|Overall Study|Physician Decision|1
7784785|NCT00587158|27058542|P1|Overall Study|Physician Decision|0
7784786|NCT00587158|27058541|P2|Overall Study|Did not want to do 24 hr urine collect.|3
7784787|NCT00587158|27058542|P1|Overall Study|Did not want to do 24 hr urine collect.|4
7784788|NCT00587054|27058595|P1|Overall Study|Patient not treated|9
7784789|NCT00586924|27058621|P6|Overall Study|Other|6
7784790|NCT00586924|27058622|P5|Overall Study|Other|1
7784791|NCT00586924|27058623|P4|Overall Study|Other|1
7784792|NCT00586924|27058624|P3|Overall Study|Other|1
7784793|NCT00586924|27058625|P2|Overall Study|Other|0
7784794|NCT00586924|27058626|P1|Overall Study|Other|1
7784795|NCT00586924|27058621|P6|Overall Study|Complete response|2
7784796|NCT00586924|27058622|P5|Overall Study|Complete response|2
7784797|NCT00586924|27058623|P4|Overall Study|Complete response|0
7784798|NCT00586924|27058624|P3|Overall Study|Complete response|0
7784799|NCT00586924|27058625|P2|Overall Study|Complete response|1
7784800|NCT00586924|27058626|P1|Overall Study|Complete response|0
7784801|NCT00586924|27058621|P6|Overall Study|Development of neutralizing antibodies|22
7784802|NCT00586924|27058622|P5|Overall Study|Development of neutralizing antibodies|0
7784803|NCT00586924|27058623|P4|Overall Study|Development of neutralizing antibodies|0
7784804|NCT00586924|27058624|P3|Overall Study|Development of neutralizing antibodies|2
7784805|NCT00586924|27058625|P2|Overall Study|Development of neutralizing antibodies|2
7784806|NCT00586924|27058626|P1|Overall Study|Development of neutralizing antibodies|2
7784807|NCT00586924|27058621|P6|Overall Study|Disease progression|0
7784808|NCT00586924|27058622|P5|Overall Study|Disease progression|1
7784809|NCT00586924|27058623|P4|Overall Study|Disease progression|1
7784810|NCT00586924|27058624|P3|Overall Study|Disease progression|0
7784811|NCT00586924|27058625|P2|Overall Study|Disease progression|0
7784812|NCT00586924|27058626|P1|Overall Study|Disease progression|0
7784813|NCT00586924|27058621|P6|Overall Study|Initiation of alternative cancer therapy|1
7784814|NCT00586924|27058622|P5|Overall Study|Initiation of alternative cancer therapy|0
7784815|NCT00586924|27058623|P4|Overall Study|Initiation of alternative cancer therapy|0
7784816|NCT00586924|27058624|P3|Overall Study|Initiation of alternative cancer therapy|0
7784817|NCT00586924|27058625|P2|Overall Study|Initiation of alternative cancer therapy|0
7784818|NCT00586924|27058626|P1|Overall Study|Initiation of alternative cancer therapy|0
7784819|NCT00586924|27058621|P6|Overall Study|Adverse event/serious adverse event|2
7784820|NCT00586924|27058622|P5|Overall Study|Adverse event/serious adverse event|0
7784821|NCT00586924|27058623|P4|Overall Study|Adverse event/serious adverse event|1
7784822|NCT00586924|27058624|P3|Overall Study|Adverse event/serious adverse event|0
7784823|NCT00586924|27058625|P2|Overall Study|Adverse event/serious adverse event|0
7784824|NCT00586924|27058626|P1|Overall Study|Adverse event/serious adverse event|0
7784825|NCT00586898|27058826|P1|Overall Study|Evaluable for Toxicity Only|5
7784826|NCT00586898|27058826|P1|Overall Study|Patiemt Non-compliance|1
7784827|NCT00586898|27058826|P1|Overall Study|Adverse Event|1
7784828|NCT00586846|27058830|P1|Overall Study|Evaluable for Toxicity Only|4
7784829|NCT00586846|27058830|P1|Overall Study|Death|1
7784830|NCT00586846|27058830|P1|Overall Study|Physician Decision|1
7784831|NCT00586820|27058836|P2|Overall Study|Unsuccessful PCI|0
7784832|NCT00586820|27058837|P1|Overall Study|Unsuccessful PCI|1
7784833|NCT00586703|27058868|P1|Overall Study|Death|12
7784834|NCT00586690|27058875|P2|Overall Study|Lab can't accommodate|0
7784835|NCT00586690|27058876|P1|Overall Study|Lab can't accommodate|1
7784836|NCT00586690|27058875|P2|Overall Study|Lack of Efficacy|0
7784837|NCT00586690|27058876|P1|Overall Study|Lack of Efficacy|2
7784838|NCT00586690|27058875|P2|Overall Study|Adverse Event|0
7784839|NCT00586690|27058876|P1|Overall Study|Adverse Event|1
7784840|NCT00586690|27058875|P2|Overall Study|Disease Progression|0
7784841|NCT00586690|27058876|P1|Overall Study|Disease Progression|10
7784842|NCT00586690|27058875|P2|Overall Study|Death|0
7784843|NCT00586690|27058876|P1|Overall Study|Death|2
7784844|NCT00586664|27058886|P3|Overall Study|Exclusion criteria met|0
7784845|NCT00586664|27058887|P2|Overall Study|Exclusion criteria met|0
7784846|NCT00586664|27058888|P1|Overall Study|Exclusion criteria met|2
7784847|NCT00586664|27058886|P3|Overall Study|Withdrawal by Subject|1
7784848|NCT00586664|27058887|P2|Overall Study|Withdrawal by Subject|7
7784849|NCT00586664|27058888|P1|Overall Study|Withdrawal by Subject|3
7784850|NCT00586625|27058934|P2|Overall Study|Subject unable to return for visit|0
7784851|NCT00586625|27058935|P1|Overall Study|Subject unable to return for visit|2
7784852|NCT00586625|27058934|P2|Overall Study|Subject non-compliance|1
7784853|NCT00586625|27058935|P1|Overall Study|Subject non-compliance|0
7784854|NCT00586625|27058934|P2|Overall Study|Withdrawal by Subject|10
7784855|NCT00586625|27058935|P1|Overall Study|Withdrawal by Subject|32
7784856|NCT00586625|27058934|P2|Overall Study|Protocol Violation|0
7784857|NCT00586625|27058935|P1|Overall Study|Protocol Violation|3
7784858|NCT00586625|27058934|P2|Overall Study|Adverse Event|6
7784859|NCT00586625|27058935|P1|Overall Study|Adverse Event|6
7784860|NCT00586612|27058943|P2|Booster Phase|Lost to Follow-up|1
7784861|NCT00586612|27058944|P1|Booster Phase|Lost to Follow-up|3
7784862|NCT00586612|27058943|P2|Primary Phase|Withdrawal by Subject|2
7784863|NCT00586612|27058944|P1|Primary Phase|Withdrawal by Subject|0
7784864|NCT00586612|27058943|P2|Primary Phase|Lost to Follow-up|1
7784865|NCT00586612|27058944|P1|Primary Phase|Lost to Follow-up|0
7784866|NCT00586612|27058943|P2|Primary Phase|Protocol Violation|0
7784867|NCT00586612|27058944|P1|Primary Phase|Protocol Violation|1
7784868|NCT00586521|27059014|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
7784869|NCT00586508|27059023|P2|Overall Study|Withdrawal by Subject|0
7784870|NCT00586508|27059024|P1|Overall Study|Withdrawal by Subject|4
7784871|NCT00586508|27059023|P2|Overall Study|Adverse Event|4
7784872|NCT00586508|27059024|P1|Overall Study|Adverse Event|12
7784873|NCT00586508|27059023|P2|Overall Study|Death|1
7784874|NCT00586508|27059024|P1|Overall Study|Death|0
7784875|NCT00586508|27059023|P2|Overall Study|Progressive disease|8
7784876|NCT00586508|27059024|P1|Overall Study|Progressive disease|52
7784877|NCT00586495|27059040|P1|Follow-up|Switch to commercial drug|10
7784878|NCT00586495|27059040|P1|Follow-up|Protocol driven decision point|37
7784879|NCT00586495|27059040|P1|Follow-up|Withdrawal by Subject|4
7784880|NCT00586495|27059040|P1|Follow-up|Lost to Follow-up|1
7784881|NCT00586495|27059040|P1|Follow-up|Death|40
7784882|NCT00586495|27059040|P1|Treatment Period|Switch to commercial drug|10
7784883|NCT00586495|27059040|P1|Treatment Period|Disease progression, recurrence/relapse|71
7784884|NCT00586495|27059040|P1|Treatment Period|Withdrawal by Subject|1
7784885|NCT00586495|27059040|P1|Treatment Period|Protocol Violation|1
7784886|NCT00586495|27059040|P1|Treatment Period|Death|1
7784887|NCT00586495|27059040|P1|Treatment Period|Adverse Event|11
7784888|NCT00586469|27059069|P2|Overall Study|Adverse Event|1
7784889|NCT00586469|27059070|P1|Overall Study|Adverse Event|0
7784890|NCT00586339|27059097|P3|Overall Study|Lost to Follow-up|1
7784891|NCT00586339|27059098|P2|Overall Study|Lost to Follow-up|2
7784892|NCT00586339|27059099|P1|Overall Study|Lost to Follow-up|3
7784893|NCT00586339|27059097|P3|Overall Study|Migrated/moved from study area|4
7784894|NCT00586339|27059098|P2|Overall Study|Migrated/moved from study area|2
7784895|NCT00586339|27059099|P1|Overall Study|Migrated/moved from study area|3
7784896|NCT00586339|27059097|P3|Overall Study|Withdrawal by Subject|1
7784897|NCT00586339|27059098|P2|Overall Study|Withdrawal by Subject|3
7784898|NCT00586339|27059099|P1|Overall Study|Withdrawal by Subject|1
7784899|NCT00586326|27059200|P1|Treated Through 5-yr Follow Up-Treated|Other|2
7784900|NCT00586326|27059200|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
7784901|NCT00586326|27059200|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
7784902|NCT00586326|27059200|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
7784903|NCT00586326|27059200|P1|Treated Through 5-yr Follow Up-Treated|Death|2
7784904|NCT00586326|27059200|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
7784905|NCT00586326|27059200|P1|Device Placed toTreatment-ITT|Physician Decision|1
7784906|NCT00586326|27059200|P1|Device Placed toTreatment-ITT|Positive Margins|3
7784907|NCT00586326|27059200|P1|Device Placed toTreatment-ITT|Microinvasion|1
7784908|NCT00586326|27059200|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
7784909|NCT00586326|27059200|P1|Device Placed toTreatment-ITT|Skin Distance|7
7784910|NCT00586326|27059200|P1|Enrollment to Device Placement-Enrolled|Other|1
7784911|NCT00586326|27059200|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
7784912|NCT00586326|27059200|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
7784913|NCT00586326|27059200|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
7784914|NCT00586326|27059200|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
7784915|NCT00586326|27059200|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
7784916|NCT00586313|27059211|P1|Overall Study|Lack of Efficacy|2
7784917|NCT00586157|27059264|P2|Second Intervention|Adverse Event|1
7784918|NCT00586157|27059265|P1|Second Intervention|Adverse Event|0
7784919|NCT00586157|27059264|P2|Second Intervention|Worsening behavior|0
7784920|NCT00586157|27059265|P1|Second Intervention|Worsening behavior|1
7784921|NCT00586157|27059264|P2|Second Intervention|Withdrawal by Subject|0
7784922|NCT00586157|27059265|P1|Second Intervention|Withdrawal by Subject|1
7784923|NCT00586157|27059264|P2|First Intervention|Worsening behavior|0
7784924|NCT00586157|27059265|P1|First Intervention|Worsening behavior|1
7784925|NCT00586105|27059275|P1|Overall Study|Reason not reported|1
7784926|NCT00586105|27059275|P1|Overall Study|Switched to commercial drug|9
7784927|NCT00586105|27059275|P1|Overall Study|Disease progression|19
7784928|NCT00586105|27059275|P1|Overall Study|Withdrawal by Subject|3
7784929|NCT00586105|27059275|P1|Overall Study|Protocol Violation|1
7784930|NCT00586105|27059275|P1|Overall Study|Death|2
7784931|NCT00586105|27059275|P1|Overall Study|Adverse Event|4
7784932|NCT00586066|27059290|P2|Overall Study|Withdrawal of consent|2
7784933|NCT00586066|27059291|P1|Overall Study|Withdrawal of consent|4
7784934|NCT00586066|27059290|P2|Overall Study|Physician Decision|0
7784935|NCT00586066|27059291|P1|Overall Study|Physician Decision|1
7784936|NCT00586066|27059290|P2|Overall Study|Adverse Event|2
7784937|NCT00586066|27059291|P1|Overall Study|Adverse Event|2
7784938|NCT00586066|27059290|P2|Overall Study|Lack of Efficacy|3
7784939|NCT00586066|27059291|P1|Overall Study|Lack of Efficacy|5
7784940|NCT00586066|27059290|P2|Overall Study|Lost to Follow-up|3
7784941|NCT00586066|27059291|P1|Overall Study|Lost to Follow-up|6
7784942|NCT00585975|27059348|P2|Overall Study|Enrollment met/over-enrolled|9
7784943|NCT00585975|27059349|P1|Overall Study|Enrollment met/over-enrolled|10
7784944|NCT00585975|27059348|P2|Overall Study|Lost to Follow-up|1
7784945|NCT00585975|27059349|P1|Overall Study|Lost to Follow-up|2
7784946|NCT00585975|27059348|P2|Overall Study|Withdrawal by Subject|3
7784947|NCT00585975|27059349|P1|Overall Study|Withdrawal by Subject|3
7784948|NCT00585923|27059359|P2|Overall Study|Physician decided not to continue|33
7784949|NCT00585923|27059360|P1|Overall Study|Physician decided not to continue|31
7784950|NCT00585689|27059412|P1|Overall Study|Death|1
7784951|NCT00585689|27059412|P1|Overall Study|Patient had unresectable disease|1
7784952|NCT00585689|27059412|P1|Overall Study|Patient Declined Surgery|1
7784953|NCT00585689|27059412|P1|Overall Study|Adverse Event|1
7784954|NCT00585689|27059412|P1|Overall Study|Received different ABI-007 schedule|3
7784955|NCT00585585|27059471|P1|Overall Study|Adverse Event|1
7784956|NCT00585546|27059475|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
7784957|NCT00585546|27059475|P1|Clenbuterol Treatment - up to 12 Months|Death|1
7784958|NCT00585533|27059489|P1|Overall Study|objective or symptomatic progression|9
7784959|NCT00585468|27059498|P2|First Intervention|Withdrawal by Subject|1
7784960|NCT00585468|27059499|P1|First Intervention|Withdrawal by Subject|1
7784961|NCT00585351|27059531|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7784962|NCT00585351|27059532|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7784963|NCT00585351|27059533|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
7784964|NCT00585351|27059534|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
7784965|NCT00585351|27059535|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7784966|NCT00585351|27059536|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7784967|NCT00585351|27059537|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7784968|NCT00585351|27059538|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7784969|NCT00585351|27059531|P8|Enrollment Period (Intervention)|Death|0
7784970|NCT00585351|27059532|P7|Enrollment Period (Intervention)|Death|1
7784971|NCT00585351|27059533|P6|Enrollment Period (Intervention)|Death|0
7784972|NCT00585351|27059534|P5|Enrollment Period (Intervention)|Death|1
7784973|NCT00585351|27059535|P4|Enrollment Period (Intervention)|Death|0
7784974|NCT00585351|27059536|P3|Enrollment Period (Intervention)|Death|0
7784975|NCT00585351|27059537|P2|Enrollment Period (Intervention)|Death|0
7784976|NCT00585351|27059538|P1|Enrollment Period (Intervention)|Death|0
7784977|NCT00585351|27059531|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
7784978|NCT00585351|27059532|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
7784979|NCT00585351|27059533|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
7784980|NCT00585351|27059534|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
7784981|NCT00585351|27059535|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
7784982|NCT00585351|27059536|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
7784983|NCT00585351|27059537|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
7784984|NCT00585351|27059538|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
7784985|NCT00585351|27059531|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7784986|NCT00585351|27059532|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7784987|NCT00585351|27059533|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7784988|NCT00585351|27059534|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7784989|NCT00585351|27059535|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7784990|NCT00585351|27059536|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7784991|NCT00585351|27059537|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
7784992|NCT00585351|27059538|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
7784993|NCT00585351|27059531|P8|Notification Period (Informed Consent)|No study medication on flight|0
7784994|NCT00585351|27059532|P7|Notification Period (Informed Consent)|No study medication on flight|0
7784995|NCT00585351|27059533|P6|Notification Period (Informed Consent)|No study medication on flight|0
7784996|NCT00585351|27059534|P5|Notification Period (Informed Consent)|No study medication on flight|0
7784997|NCT00585351|27059535|P4|Notification Period (Informed Consent)|No study medication on flight|0
7784998|NCT00585351|27059536|P3|Notification Period (Informed Consent)|No study medication on flight|0
7784999|NCT00585351|27059537|P2|Notification Period (Informed Consent)|No study medication on flight|1
7785000|NCT00585351|27059538|P1|Notification Period (Informed Consent)|No study medication on flight|0
7785001|NCT00585351|27059531|P8|Notification Period (Informed Consent)|Flight aborted|0
7785002|NCT00585351|27059532|P7|Notification Period (Informed Consent)|Flight aborted|0
7785003|NCT00585351|27059533|P6|Notification Period (Informed Consent)|Flight aborted|0
7785004|NCT00585351|27059534|P5|Notification Period (Informed Consent)|Flight aborted|0
7785005|NCT00585351|27059535|P4|Notification Period (Informed Consent)|Flight aborted|0
7785006|NCT00585351|27059536|P3|Notification Period (Informed Consent)|Flight aborted|0
7785007|NCT00585351|27059537|P2|Notification Period (Informed Consent)|Flight aborted|1
7785008|NCT00585351|27059538|P1|Notification Period (Informed Consent)|Flight aborted|2
7785009|NCT00585351|27059531|P8|Notification Period (Informed Consent)|Physician Decision|0
7785010|NCT00585351|27059532|P7|Notification Period (Informed Consent)|Physician Decision|0
7785011|NCT00585351|27059533|P6|Notification Period (Informed Consent)|Physician Decision|0
7785012|NCT00585351|27059534|P5|Notification Period (Informed Consent)|Physician Decision|0
7785013|NCT00585351|27059535|P4|Notification Period (Informed Consent)|Physician Decision|0
7785014|NCT00585351|27059536|P3|Notification Period (Informed Consent)|Physician Decision|0
7785015|NCT00585351|27059537|P2|Notification Period (Informed Consent)|Physician Decision|2
7785016|NCT00585351|27059538|P1|Notification Period (Informed Consent)|Physician Decision|0
7785017|NCT00585325|27059554|P2|Overall Study|Withdrawal by Subject|1
7785018|NCT00585325|27059555|P1|Overall Study|Withdrawal by Subject|1
7785019|NCT00585312|27059563|P2|Overall Study|Study terminated by the sponsor|31
7785020|NCT00585312|27059564|P1|Overall Study|Study terminated by the sponsor|34
7785021|NCT00585312|27059563|P2|Overall Study|Withdrawal by Subject|1
7785022|NCT00585312|27059564|P1|Overall Study|Withdrawal by Subject|5
7785023|NCT00585312|27059563|P2|Overall Study|Reason not specified|0
7785024|NCT00585312|27059564|P1|Overall Study|Reason not specified|2
7785025|NCT00585312|27059563|P2|Overall Study|Lost to Follow-up|1
7785026|NCT00585312|27059564|P1|Overall Study|Lost to Follow-up|1
7785027|NCT00585312|27059563|P2|Overall Study|Lack of Efficacy|11
7785028|NCT00585312|27059564|P1|Overall Study|Lack of Efficacy|6
7785029|NCT00585312|27059563|P2|Overall Study|Adverse Event|0
7785030|NCT00585312|27059564|P1|Overall Study|Adverse Event|3
7785031|NCT00585286|27059576|P1|Overall Study|Lost to Follow-up|1
7785032|NCT00585221|27059592|P1|Overall Study|Protocol Violation|8
7785033|NCT00585195|27059618|P21|Overall Study|Withdrawn Due to Pregnancy|0
7785034|NCT00585195|27059619|P20|Overall Study|Withdrawn Due to Pregnancy|0
7785035|NCT00585195|27059620|P19|Overall Study|Withdrawn Due to Pregnancy|0
7785036|NCT00585195|27059621|P18|Overall Study|Withdrawn Due to Pregnancy|0
7785037|NCT00585195|27059622|P17|Overall Study|Withdrawn Due to Pregnancy|0
7785038|NCT00585195|27059623|P16|Overall Study|Withdrawn Due to Pregnancy|0
7785039|NCT00585195|27059624|P15|Overall Study|Withdrawn Due to Pregnancy|1
7785040|NCT00585195|27059625|P14|Overall Study|Withdrawn Due to Pregnancy|0
7785041|NCT00585195|27059626|P13|Overall Study|Withdrawn Due to Pregnancy|0
7785042|NCT00585195|27059627|P12|Overall Study|Withdrawn Due to Pregnancy|0
7785043|NCT00585195|27059628|P11|Overall Study|Withdrawn Due to Pregnancy|0
7785044|NCT00585195|27059629|P10|Overall Study|Withdrawn Due to Pregnancy|0
7785045|NCT00585195|27059630|P9|Overall Study|Withdrawn Due to Pregnancy|0
7785046|NCT00585195|27059631|P8|Overall Study|Withdrawn Due to Pregnancy|0
7785047|NCT00585195|27059632|P7|Overall Study|Withdrawn Due to Pregnancy|0
7785048|NCT00585195|27059633|P6|Overall Study|Withdrawn Due to Pregnancy|0
7785049|NCT00585195|27059634|P5|Overall Study|Withdrawn Due to Pregnancy|0
7785050|NCT00585195|27059635|P4|Overall Study|Withdrawn Due to Pregnancy|0
7785051|NCT00585195|27059636|P3|Overall Study|Withdrawn Due to Pregnancy|0
7785052|NCT00585195|27059637|P2|Overall Study|Withdrawn Due to Pregnancy|0
7785053|NCT00585195|27059638|P1|Overall Study|Withdrawn Due to Pregnancy|0
7785054|NCT00585195|27059618|P21|Overall Study|Ongoing|0
7785055|NCT00585195|27059619|P20|Overall Study|Ongoing|0
7785056|NCT00585195|27059620|P19|Overall Study|Ongoing|0
7785057|NCT00585195|27059621|P18|Overall Study|Ongoing|0
7785058|NCT00585195|27059622|P17|Overall Study|Ongoing|0
7785059|NCT00585195|27059623|P16|Overall Study|Ongoing|0
7785060|NCT00585195|27059624|P15|Overall Study|Ongoing|0
7785061|NCT00585195|27059625|P14|Overall Study|Ongoing|0
7785062|NCT00585195|27059626|P13|Overall Study|Ongoing|2
7785063|NCT00585195|27059627|P12|Overall Study|Ongoing|0
7785064|NCT00585195|27059628|P11|Overall Study|Ongoing|0
7785065|NCT00585195|27059629|P10|Overall Study|Ongoing|0
7785066|NCT00585195|27059630|P9|Overall Study|Ongoing|0
7785067|NCT00585195|27059631|P8|Overall Study|Ongoing|0
7785068|NCT00585195|27059632|P7|Overall Study|Ongoing|0
7785069|NCT00585195|27059633|P6|Overall Study|Ongoing|0
7785070|NCT00585195|27059634|P5|Overall Study|Ongoing|0
7785071|NCT00585195|27059635|P4|Overall Study|Ongoing|0
7785072|NCT00585195|27059636|P3|Overall Study|Ongoing|0
7785073|NCT00585195|27059637|P2|Overall Study|Ongoing|0
7785074|NCT00585195|27059638|P1|Overall Study|Ongoing|0
7785075|NCT00585195|27059618|P21|Overall Study|Lost to Follow-up|0
7785076|NCT00585195|27059619|P20|Overall Study|Lost to Follow-up|0
7785077|NCT00585195|27059620|P19|Overall Study|Lost to Follow-up|0
7785078|NCT00585195|27059621|P18|Overall Study|Lost to Follow-up|2
7785079|NCT00585195|27059622|P17|Overall Study|Lost to Follow-up|0
7785080|NCT00585195|27059623|P16|Overall Study|Lost to Follow-up|0
7785081|NCT00585195|27059624|P15|Overall Study|Lost to Follow-up|0
7785082|NCT00585195|27059625|P14|Overall Study|Lost to Follow-up|0
7785083|NCT00585195|27059626|P13|Overall Study|Lost to Follow-up|1
7785084|NCT00585195|27059627|P12|Overall Study|Lost to Follow-up|0
7785085|NCT00585195|27059628|P11|Overall Study|Lost to Follow-up|0
7785086|NCT00585195|27059629|P10|Overall Study|Lost to Follow-up|0
7785087|NCT00585195|27059630|P9|Overall Study|Lost to Follow-up|0
7785088|NCT00585195|27059631|P8|Overall Study|Lost to Follow-up|0
7785089|NCT00585195|27059632|P7|Overall Study|Lost to Follow-up|0
7785090|NCT00585195|27059633|P6|Overall Study|Lost to Follow-up|0
7785091|NCT00585195|27059634|P5|Overall Study|Lost to Follow-up|0
7785092|NCT00585195|27059635|P4|Overall Study|Lost to Follow-up|0
7785093|NCT00585195|27059636|P3|Overall Study|Lost to Follow-up|0
7785094|NCT00585195|27059637|P2|Overall Study|Lost to Follow-up|0
7785095|NCT00585195|27059638|P1|Overall Study|Lost to Follow-up|0
7785096|NCT00585195|27059618|P21|Overall Study|Death|1
7785097|NCT00585195|27059619|P20|Overall Study|Death|0
7785098|NCT00585195|27059620|P19|Overall Study|Death|0
7785099|NCT00585195|27059621|P18|Overall Study|Death|0
7785100|NCT00585195|27059622|P17|Overall Study|Death|11
7785101|NCT00585195|27059623|P16|Overall Study|Death|2
7785102|NCT00585195|27059624|P15|Overall Study|Death|8
7785103|NCT00585195|27059625|P14|Overall Study|Death|2
7785104|NCT00585195|27059626|P13|Overall Study|Death|7
7785105|NCT00585195|27059627|P12|Overall Study|Death|1
7785106|NCT00585195|27059628|P11|Overall Study|Death|1
7785107|NCT00585195|27059629|P10|Overall Study|Death|0
7785108|NCT00585195|27059630|P9|Overall Study|Death|1
7785109|NCT00585195|27059631|P8|Overall Study|Death|0
7785110|NCT00585195|27059632|P7|Overall Study|Death|0
7785111|NCT00585195|27059633|P6|Overall Study|Death|0
7785112|NCT00585195|27059634|P5|Overall Study|Death|0
7785113|NCT00585195|27059635|P4|Overall Study|Death|0
7785114|NCT00585195|27059636|P3|Overall Study|Death|0
7785115|NCT00585195|27059637|P2|Overall Study|Death|0
7785116|NCT00585195|27059638|P1|Overall Study|Death|0
7785117|NCT00585195|27059618|P21|Overall Study|Randomized not treated|2
7785118|NCT00585195|27059619|P20|Overall Study|Randomized not treated|0
7785119|NCT00585195|27059620|P19|Overall Study|Randomized not treated|3
7785120|NCT00585195|27059621|P18|Overall Study|Randomized not treated|1
7785121|NCT00585195|27059622|P17|Overall Study|Randomized not treated|0
7785122|NCT00585195|27059623|P16|Overall Study|Randomized not treated|1
7785123|NCT00585195|27059624|P15|Overall Study|Randomized not treated|0
7785124|NCT00585195|27059625|P14|Overall Study|Randomized not treated|0
7785125|NCT00585195|27059626|P13|Overall Study|Randomized not treated|0
7785126|NCT00585195|27059627|P12|Overall Study|Randomized not treated|0
7785127|NCT00585195|27059628|P11|Overall Study|Randomized not treated|2
7785128|NCT00585195|27059629|P10|Overall Study|Randomized not treated|0
7785129|NCT00585195|27059630|P9|Overall Study|Randomized not treated|0
7785130|NCT00585195|27059631|P8|Overall Study|Randomized not treated|0
7785131|NCT00585195|27059632|P7|Overall Study|Randomized not treated|1
7785132|NCT00585195|27059633|P6|Overall Study|Randomized not treated|0
7785133|NCT00585195|27059634|P5|Overall Study|Randomized not treated|1
7785134|NCT00585195|27059635|P4|Overall Study|Randomized not treated|0
7785135|NCT00585195|27059636|P3|Overall Study|Randomized not treated|1
7785136|NCT00585195|27059637|P2|Overall Study|Randomized not treated|0
7785137|NCT00585195|27059638|P1|Overall Study|Randomized not treated|0
7785138|NCT00585195|27059618|P21|Overall Study|Other|2
7785139|NCT00585195|27059619|P20|Overall Study|Other|4
7785140|NCT00585195|27059620|P19|Overall Study|Other|10
7785141|NCT00585195|27059621|P18|Overall Study|Other|12
7785142|NCT00585195|27059622|P17|Overall Study|Other|28
7785143|NCT00585195|27059623|P16|Overall Study|Other|3
7785144|NCT00585195|27059624|P15|Overall Study|Other|11
7785145|NCT00585195|27059625|P14|Overall Study|Other|7
7785146|NCT00585195|27059626|P13|Overall Study|Other|23
7785147|NCT00585195|27059627|P12|Overall Study|Other|19
7785148|NCT00585195|27059628|P11|Overall Study|Other|0
7785149|NCT00585195|27059629|P10|Overall Study|Other|1
7785150|NCT00585195|27059630|P9|Overall Study|Other|2
7785151|NCT00585195|27059631|P8|Overall Study|Other|0
7785152|NCT00585195|27059632|P7|Overall Study|Other|0
7785153|NCT00585195|27059633|P6|Overall Study|Other|1
7785154|NCT00585195|27059634|P5|Overall Study|Other|0
7785155|NCT00585195|27059635|P4|Overall Study|Other|1
7785156|NCT00585195|27059636|P3|Overall Study|Other|1
7785157|NCT00585195|27059637|P2|Overall Study|Other|1
7785158|NCT00585195|27059638|P1|Overall Study|Other|0
7785159|NCT00585195|27059618|P21|Overall Study|Withdrawal by Subject|0
7785160|NCT00585195|27059619|P20|Overall Study|Withdrawal by Subject|2
7785161|NCT00585195|27059620|P19|Overall Study|Withdrawal by Subject|2
7785162|NCT00585195|27059621|P18|Overall Study|Withdrawal by Subject|1
7785163|NCT00585195|27059622|P17|Overall Study|Withdrawal by Subject|7
7785164|NCT00585195|27059623|P16|Overall Study|Withdrawal by Subject|0
7785165|NCT00585195|27059624|P15|Overall Study|Withdrawal by Subject|3
7785166|NCT00585195|27059625|P14|Overall Study|Withdrawal by Subject|0
7785167|NCT00585195|27059626|P13|Overall Study|Withdrawal by Subject|15
7785168|NCT00585195|27059627|P12|Overall Study|Withdrawal by Subject|8
7785169|NCT00585195|27059628|P11|Overall Study|Withdrawal by Subject|3
7785170|NCT00585195|27059629|P10|Overall Study|Withdrawal by Subject|0
7785171|NCT00585195|27059630|P9|Overall Study|Withdrawal by Subject|0
7785172|NCT00585195|27059631|P8|Overall Study|Withdrawal by Subject|1
7785173|NCT00585195|27059632|P7|Overall Study|Withdrawal by Subject|0
7785174|NCT00585195|27059633|P6|Overall Study|Withdrawal by Subject|0
7785175|NCT00585195|27059634|P5|Overall Study|Withdrawal by Subject|0
7785176|NCT00585195|27059635|P4|Overall Study|Withdrawal by Subject|2
7785177|NCT00585195|27059636|P3|Overall Study|Withdrawal by Subject|2
7785178|NCT00585195|27059637|P2|Overall Study|Withdrawal by Subject|1
7785179|NCT00585195|27059638|P1|Overall Study|Withdrawal by Subject|1
7785180|NCT00585195|27059618|P21|Overall Study|Progressive Disease|8
7785181|NCT00585195|27059619|P20|Overall Study|Progressive Disease|9
7785182|NCT00585195|27059620|P19|Overall Study|Progressive Disease|4
7785183|NCT00585195|27059621|P18|Overall Study|Progressive Disease|42
7785184|NCT00585195|27059622|P17|Overall Study|Progressive Disease|94
7785185|NCT00585195|27059623|P16|Overall Study|Progressive Disease|12
7785186|NCT00585195|27059624|P15|Overall Study|Progressive Disease|21
7785187|NCT00585195|27059625|P14|Overall Study|Progressive Disease|26
7785188|NCT00585195|27059626|P13|Overall Study|Progressive Disease|29
7785189|NCT00585195|27059627|P12|Overall Study|Progressive Disease|25
7785190|NCT00585195|27059628|P11|Overall Study|Progressive Disease|2
7785191|NCT00585195|27059629|P10|Overall Study|Progressive Disease|5
7785192|NCT00585195|27059630|P9|Overall Study|Progressive Disease|0
7785193|NCT00585195|27059631|P8|Overall Study|Progressive Disease|3
7785194|NCT00585195|27059632|P7|Overall Study|Progressive Disease|6
7785195|NCT00585195|27059633|P6|Overall Study|Progressive Disease|4
7785196|NCT00585195|27059634|P5|Overall Study|Progressive Disease|6
7785197|NCT00585195|27059635|P4|Overall Study|Progressive Disease|4
7785198|NCT00585195|27059636|P3|Overall Study|Progressive Disease|5
7785199|NCT00585195|27059637|P2|Overall Study|Progressive Disease|2
7785200|NCT00585195|27059638|P1|Overall Study|Progressive Disease|2
7785201|NCT00585195|27059618|P21|Overall Study|Adverse Event|1
7785202|NCT00585195|27059619|P20|Overall Study|Adverse Event|3
7785203|NCT00585195|27059620|P19|Overall Study|Adverse Event|2
7785204|NCT00585195|27059621|P18|Overall Study|Adverse Event|9
7785205|NCT00585195|27059622|P17|Overall Study|Adverse Event|14
7785206|NCT00585195|27059623|P16|Overall Study|Adverse Event|1
7785207|NCT00585195|27059624|P15|Overall Study|Adverse Event|4
7785208|NCT00585195|27059625|P14|Overall Study|Adverse Event|6
7785209|NCT00585195|27059626|P13|Overall Study|Adverse Event|8
7785210|NCT00585195|27059627|P12|Overall Study|Adverse Event|0
7785211|NCT00585195|27059628|P11|Overall Study|Adverse Event|3
7785212|NCT00585195|27059629|P10|Overall Study|Adverse Event|0
7785213|NCT00585195|27059630|P9|Overall Study|Adverse Event|0
7785214|NCT00585195|27059631|P8|Overall Study|Adverse Event|1
7785215|NCT00585195|27059632|P7|Overall Study|Adverse Event|0
7785216|NCT00585195|27059633|P6|Overall Study|Adverse Event|1
7785217|NCT00585195|27059634|P5|Overall Study|Adverse Event|2
7785218|NCT00585195|27059635|P4|Overall Study|Adverse Event|0
7785219|NCT00585195|27059636|P3|Overall Study|Adverse Event|0
7785220|NCT00585195|27059637|P2|Overall Study|Adverse Event|0
7785221|NCT00585195|27059638|P1|Overall Study|Adverse Event|0
7785222|NCT00585169|27059954|P1|Overall Study|Withdrawal by Subject|1
7785223|NCT00585078|27059964|P1|Overall Study|Death|1
7785224|NCT00585078|27059964|P1|Overall Study|Adverse Event|10
7785225|NCT00585078|27059964|P1|Overall Study|Disease Progression|24
7785226|NCT00585078|27059964|P1|Overall Study|Poor performance status|1
7785227|NCT00585078|27059964|P1|Overall Study|Withdrawal by Subject|4
7785228|NCT00585052|27059971|P1|Overall Study|Withdrawal by Subject|1
7785229|NCT00585039|27059978|P2|Overall Study|medication spilled|0
7785230|NCT00585039|27059979|P1|Overall Study|medication spilled|2
7785231|NCT00584987|27060008|P4|Overall Study|Adverse Event|1
7785232|NCT00584987|27060009|P3|Overall Study|Adverse Event|0
7785233|NCT00584987|27060010|P2|Overall Study|Adverse Event|0
7785234|NCT00584987|27060011|P1|Overall Study|Adverse Event|0
7785235|NCT00584987|27060008|P4|Overall Study|Protocol Violation|0
7785236|NCT00584987|27060009|P3|Overall Study|Protocol Violation|1
7785237|NCT00584987|27060010|P2|Overall Study|Protocol Violation|1
7785238|NCT00584987|27060011|P1|Overall Study|Protocol Violation|1
7785239|NCT00584909|27060063|P1|Overall Study|Adverse Event|4
7785240|NCT00584870|27060071|P3|Overall Study|Randomized but not treated|2
7785241|NCT00584870|27060072|P2|Overall Study|Randomized but not treated|1
7785242|NCT00584870|27060073|P1|Overall Study|Randomized but not treated|0
7785243|NCT00584870|27060071|P3|Overall Study|Other|0
7785244|NCT00584870|27060072|P2|Overall Study|Other|0
7785245|NCT00584870|27060073|P1|Overall Study|Other|2
7785246|NCT00584870|27060071|P3|Overall Study|Did not met entrance criteria|0
7785247|NCT00584870|27060072|P2|Overall Study|Did not met entrance criteria|0
7785248|NCT00584870|27060073|P1|Overall Study|Did not met entrance criteria|1
7785249|NCT00584870|27060071|P3|Overall Study|Protocol Violation|2
7785250|NCT00584870|27060072|P2|Overall Study|Protocol Violation|1
7785251|NCT00584870|27060073|P1|Overall Study|Protocol Violation|1
7785252|NCT00584870|27060071|P3|Overall Study|Withdrawal by Subject|3
7785253|NCT00584870|27060072|P2|Overall Study|Withdrawal by Subject|5
7785254|NCT00584870|27060073|P1|Overall Study|Withdrawal by Subject|10
7785255|NCT00584870|27060071|P3|Overall Study|Lack of Efficacy|8
7785256|NCT00584870|27060072|P2|Overall Study|Lack of Efficacy|14
7785257|NCT00584870|27060073|P1|Overall Study|Lack of Efficacy|7
7785258|NCT00584870|27060071|P3|Overall Study|Lost to Follow-up|1
7785259|NCT00584870|27060072|P2|Overall Study|Lost to Follow-up|1
7785260|NCT00584870|27060073|P1|Overall Study|Lost to Follow-up|4
7785261|NCT00584870|27060071|P3|Overall Study|Adverse Event|2
7785262|NCT00584870|27060072|P2|Overall Study|Adverse Event|3
7785263|NCT00584870|27060073|P1|Overall Study|Adverse Event|4
7785264|NCT00584844|27060147|P1|Overall Study|Screen Failure|20
7785265|NCT00584844|27060147|P1|Overall Study|Withdrawal by Subject|59
7785266|NCT00584805|27060197|P1|Overall Study|Screen failures|2
7785267|NCT00584805|27060197|P1|Overall Study|Lost to follow up|3
7785268|NCT00584805|27060197|P1|Overall Study|Non-compliance|1
7785269|NCT00584805|27060197|P1|Overall Study|Withdrawal by Subject|18
7785270|NCT00584805|27060197|P1|Overall Study|Relocation|36
7785271|NCT00584805|27060197|P1|Overall Study|No longer at risk of exposure|39
7785272|NCT00584740|27060210|P2|Overall Study|Lost to Follow-up|1
7785273|NCT00584740|27060211|P1|Overall Study|Lost to Follow-up|0
7785274|NCT00584740|27060210|P2|Overall Study|Withdrawal by Subject|2
7785275|NCT00584740|27060211|P1|Overall Study|Withdrawal by Subject|3
7785276|NCT00584740|27060210|P2|Overall Study|Lack of Efficacy|2
7785277|NCT00584740|27060211|P1|Overall Study|Lack of Efficacy|8
7785278|NCT00584740|27060210|P2|Overall Study|Adverse Event|1
7785279|NCT00584740|27060211|P1|Overall Study|Adverse Event|1
7785280|NCT00584727|27060229|P6|Third Intervention|Protocol Violation|2
7785281|NCT00584727|27060230|P5|Third Intervention|Protocol Violation|4
7785282|NCT00584727|27060231|P4|Third Intervention|Protocol Violation|0
7785283|NCT00584727|27060232|P3|Third Intervention|Protocol Violation|1
7785284|NCT00584727|27060233|P2|Third Intervention|Protocol Violation|0
7785285|NCT00584727|27060234|P1|Third Intervention|Protocol Violation|0
7785286|NCT00584727|27060229|P6|First Intervention|Discontinuation|0
7785287|NCT00584727|27060230|P5|First Intervention|Discontinuation|0
7785288|NCT00584727|27060231|P4|First Intervention|Discontinuation|0
7785289|NCT00584727|27060232|P3|First Intervention|Discontinuation|1
7785290|NCT00584727|27060233|P2|First Intervention|Discontinuation|0
7785291|NCT00584727|27060234|P1|First Intervention|Discontinuation|0
7785292|NCT00584454|27060272|P1|Overall Study|Clinical Hold|2
7785293|NCT00584454|27060272|P1|Overall Study|Relocation|1
7785294|NCT00584454|27060272|P1|Overall Study|Adverse Event|1
7785295|NCT00584415|27060276|P1|Overall Study|Adverse Event|7
7785296|NCT00584194|27060299|P1|Overall Study|Other|135
7785297|NCT00584012|27060312|P1|Overall Study|Withdrawal by Subject|1
7785298|NCT00583947|27060318|P2|Cross-over Period|Other|1
7785299|NCT00583947|27060319|P1|Cross-over Period|Other|1
7785300|NCT00583947|27060318|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
7785301|NCT00583947|27060319|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
7785302|NCT00583947|27060318|P2|Cross-over Period|Withdrawal by Subject|0
7785303|NCT00583947|27060319|P1|Cross-over Period|Withdrawal by Subject|2
7785304|NCT00583947|27060318|P2|Cross-over Period|Adverse Event|0
7785305|NCT00583947|27060319|P1|Cross-over Period|Adverse Event|2
7785306|NCT00583791|27060440|P1|Overall Study|Death|6
7785307|NCT00583791|27060440|P1|Overall Study|Other|67
7785308|NCT00583596|27060495|P1|Overall Study|Outside f-up window|26
7785309|NCT00583596|27060495|P1|Overall Study|Not consented|15
7785310|NCT00583596|27060495|P1|Overall Study|Data not complete|1
7785311|NCT00583596|27060495|P1|Overall Study|Lost to Follow-up|94
7785312|NCT00583596|27060495|P1|Overall Study|Withdrawal by Subject|6
7785313|NCT00583596|27060495|P1|Overall Study|Death|2
7785314|NCT00583596|27060495|P1|Overall Study|Excluded due to Hurricane Katrina|30
7785315|NCT00583596|27060495|P1|Overall Study|Lost to Follow-up|110
7785316|NCT00583557|27060500|P1|Overall Study|Did not receive belimumab in LBRA99|2
7785317|NCT00583557|27060500|P1|Overall Study|Other|5
7785318|NCT00583557|27060500|P1|Overall Study|Lack of Compliance|5
7785319|NCT00583557|27060500|P1|Overall Study|Lack of Efficacy|31
7785320|NCT00583557|27060500|P1|Overall Study|Adverse Event|9
7785321|NCT00583557|27060500|P1|Overall Study|Withdrawal by Subject|18
7785322|NCT00583453|27060531|P2|Overall Study|discontinued intervention|2
7785323|NCT00583453|27060532|P1|Overall Study|discontinued intervention|0
7785324|NCT00583362|27060569|P1|Overall Study|Withdrawal by Subject|57
7785325|NCT00583362|27060569|P1|Overall Study|Protocol Violation|2
7785326|NCT00583362|27060569|P1|Overall Study|Physician Decision|19
7785327|NCT00583362|27060569|P1|Overall Study|Sponsor request due to missed doses|1
7785328|NCT00583362|27060569|P1|Overall Study|Behavioral problems and non-compliance|1
7785329|NCT00583362|27060569|P1|Overall Study|Misunderstanding of protocol|1
7785330|NCT00583362|27060569|P1|Overall Study|Missed visits due to staff changes|1
7785331|NCT00583362|27060569|P1|Overall Study|Subject moved out of the country/state|2
7785332|NCT00583362|27060569|P1|Overall Study|Subject not dosed in LBSL99|1
7785333|NCT00583362|27060569|P1|Overall Study|Current site closed|7
7785334|NCT00583362|27060569|P1|Overall Study|Miscommunication of visit window|5
7785335|NCT00583362|27060569|P1|Overall Study|Pregnancy|7
7785336|NCT00583362|27060569|P1|Overall Study|Non-compliance with study drug|28
7785337|NCT00583362|27060569|P1|Overall Study|Lost to Follow-up|4
7785338|NCT00583362|27060569|P1|Overall Study|Lack of Efficacy|22
7785339|NCT00583362|27060569|P1|Overall Study|Adverse Event|44
7785340|NCT00583219|27060593|P1|Phase 2|Withdrawal by Subject|1
7785341|NCT00583115|27060610|P1|Overall Study|Death|1
7785342|NCT00583102|27060615|P1|Overall Study|Adverse Event|3
7785343|NCT00582972|27060643|P1|Overall Study|Protocol Violation|2
7785344|NCT00582933|27060652|P1|Overall Study|Physician Decision|3
7785345|NCT00582907|27060656|P4|2nd Course|Lack of Efficacy|0
7785346|NCT00582907|27060657|P3|2nd Course|Lack of Efficacy|0
7785347|NCT00582907|27060658|P2|2nd Course|Lack of Efficacy|0
7785348|NCT00582907|27060659|P1|2nd Course|Lack of Efficacy|1
7785349|NCT00582907|27060656|P4|1st Course|Lost to Follow-up|1
7785350|NCT00582907|27060657|P3|1st Course|Lost to Follow-up|0
7785351|NCT00582907|27060658|P2|1st Course|Lost to Follow-up|0
7785352|NCT00582907|27060659|P1|1st Course|Lost to Follow-up|0
7785353|NCT00582907|27060656|P4|1st Course|Withdrawal by Subject|0
7785354|NCT00582907|27060657|P3|1st Course|Withdrawal by Subject|0
7785355|NCT00582907|27060658|P2|1st Course|Withdrawal by Subject|0
7785356|NCT00582907|27060659|P1|1st Course|Withdrawal by Subject|1
7785357|NCT00582816|27060698|P1|Overall Study|Engraftment Failure|3
7785358|NCT00582790|27060708|P1|Overall Study|Rapid progression of disease|1
7785359|NCT00582738|27060717|P2|Overall Study|Withdrawal by Subject|3
7785360|NCT00582738|27060718|P1|Overall Study|Withdrawal by Subject|0
7785361|NCT00582738|27060717|P2|Overall Study|Protocol Violation|1
7785362|NCT00582738|27060718|P1|Overall Study|Protocol Violation|1
7785363|NCT00582738|27060717|P2|Overall Study|Other|0
7785364|NCT00582738|27060718|P1|Overall Study|Other|1
7785365|NCT00582738|27060717|P2|Overall Study|Graft Lost|1
7785366|NCT00582738|27060718|P1|Overall Study|Graft Lost|0
7785367|NCT00582738|27060717|P2|Overall Study|Adverse Event|5
7785368|NCT00582738|27060718|P1|Overall Study|Adverse Event|0
7785369|NCT00582738|27060717|P2|Overall Study|Administrative Problems|8
7785370|NCT00582738|27060718|P1|Overall Study|Administrative Problems|7
7785371|NCT00582712|27060742|P1|Overall Study|Complicating disease requiring treatment|1
7785372|NCT00582712|27060742|P1|Overall Study|Withdrawal by Subject|1
7785373|NCT00582712|27060742|P1|Overall Study|Lack of Efficacy|1
7785374|NCT00582712|27060742|P1|Overall Study|Adverse Event|1
7785375|NCT00582608|27060757|P1|Overall Study|Lack of accrual|4
7785376|NCT00582608|27060757|P1|Overall Study|Patient Ineligible|1
7785377|NCT00582608|27060757|P1|Overall Study|Not Treated|7
7785378|NCT00582556|27060764|P3|Overall Study|Physician Decision|1
7785379|NCT00582556|27060765|P2|Overall Study|Physician Decision|0
7785380|NCT00582556|27060766|P1|Overall Study|Physician Decision|0
7785381|NCT00582556|27060764|P3|Overall Study|Withdrawal by Subject|1
7785382|NCT00582556|27060765|P2|Overall Study|Withdrawal by Subject|1
7785383|NCT00582556|27060766|P1|Overall Study|Withdrawal by Subject|0
7785384|NCT00582491|27060794|P2|Overall Study|Withdrawal by Subject|0
7785385|NCT00582491|27060795|P1|Overall Study|Withdrawal by Subject|1
7785386|NCT00582426|27060819|P2|Overall Study|Use of illicit drugs|0
7785387|NCT00582426|27060820|P1|Overall Study|Use of illicit drugs|1
7785388|NCT00582426|27060819|P2|Overall Study|Disease Progression|2
7785389|NCT00582426|27060820|P1|Overall Study|Disease Progression|2
7785390|NCT00582426|27060819|P2|Overall Study|Withdrawal by Subject|2
7785391|NCT00582426|27060820|P1|Overall Study|Withdrawal by Subject|3
7785392|NCT00582426|27060819|P2|Overall Study|Death|3
7785393|NCT00582426|27060820|P1|Overall Study|Death|4
7785394|NCT00582426|27060819|P2|Overall Study|Protocol Violation|2
7785395|NCT00582426|27060820|P1|Overall Study|Protocol Violation|6
7785396|NCT00582426|27060819|P2|Overall Study|Adverse Event|2
7785397|NCT00582426|27060820|P1|Overall Study|Adverse Event|4
7785398|NCT00582426|27060819|P2|Overall Study|Lost to Follow-up|2
7785399|NCT00582426|27060820|P1|Overall Study|Lost to Follow-up|0
7785400|NCT00582309|27060867|P3|Overall Study|Protocol Violation|2
7785401|NCT00582309|27060868|P2|Overall Study|Protocol Violation|0
7785402|NCT00582309|27060869|P1|Overall Study|Protocol Violation|0
7785403|NCT00582166|27060882|P1|Overall Study|Ineligible pathology|1
7785404|NCT00582166|27060882|P1|Overall Study|Death|1
7785405|NCT00582114|27060892|P2|Overall Study|Stopped by data safety monitoring board|20
7785406|NCT00582114|27060893|P1|Overall Study|Stopped by data safety monitoring board|19
7785407|NCT00582114|27060892|P2|Overall Study|Physician Decision|6
7785408|NCT00582114|27060893|P1|Overall Study|Physician Decision|0
7785409|NCT00582114|27060892|P2|Overall Study|Adverse Event|1
7785410|NCT00582114|27060893|P1|Overall Study|Adverse Event|1
7785411|NCT00582114|27060892|P2|Overall Study|Withdrawal by Subject|16
7785412|NCT00582114|27060893|P1|Overall Study|Withdrawal by Subject|8
7785413|NCT00582114|27060892|P2|Overall Study|Lost to Follow-up|6
7785414|NCT00582114|27060893|P1|Overall Study|Lost to Follow-up|7
7785415|NCT00582114|27060892|P2|Overall Study|Kidney Transplant|1
7785416|NCT00582114|27060893|P1|Overall Study|Kidney Transplant|3
7785417|NCT00582114|27060892|P2|Overall Study|Death|4
7785418|NCT00582114|27060893|P1|Overall Study|Death|4
7785419|NCT00582036|27060908|P2|Overall Study|Withdrawal by Subject|1
7785420|NCT00582036|27060909|P1|Overall Study|Withdrawal by Subject|0
7785421|NCT00582010|27060917|P2|Overall Study|Death|1
7785422|NCT00582010|27060918|P1|Overall Study|Death|0
7785423|NCT00581945|27060947|P2|Overall Study|Death|0
7785424|NCT00581945|27060948|P1|Overall Study|Death|1
7785425|NCT00581945|27060947|P2|Overall Study|Withdrawal by Subject|6
7785426|NCT00581945|27060948|P1|Overall Study|Withdrawal by Subject|2
7785427|NCT00581945|27060947|P2|Overall Study|Unsatisfactory therapeutic effect|0
7785428|NCT00581945|27060948|P1|Overall Study|Unsatisfactory therapeutic effect|2
7785429|NCT00581945|27060947|P2|Overall Study|Adverse Event|4
7785430|NCT00581945|27060948|P1|Overall Study|Adverse Event|4
7785431|NCT00581919|27060964|P1|Overall Study|Withdrawal by Subject|1
7785432|NCT00581919|27060964|P1|Overall Study|Started Non-Protocol Therapy|2
7785433|NCT00581919|27060964|P1|Overall Study|Other Complicating Disease|1
7785434|NCT00581919|27060964|P1|Overall Study|Physician Decision|1
7785435|NCT00581919|27060964|P1|Overall Study|Disease Progression|10
7785436|NCT00581919|27060964|P1|Overall Study|Death|1
7785437|NCT00581919|27060964|P1|Overall Study|Adverse Event|8
7785438|NCT00581893|27060970|P2|Second Intervention (1 Month)|Lost to Follow-up|2
7785439|NCT00581893|27060971|P1|Second Intervention (1 Month)|Lost to Follow-up|3
7785440|NCT00581828|27060990|P1|Overall Study|Protocol Violation|1
7785441|NCT00581776|27060994|P1|Overall Study|Disease progression or no response|3
7785442|NCT00581555|27061012|P2|Overall Study|Other reasons|4
7785443|NCT00581555|27061013|P1|Overall Study|Other reasons|16
7785444|NCT00581555|27061012|P2|Overall Study|Lost to Follow-up|2
7785445|NCT00581555|27061013|P1|Overall Study|Lost to Follow-up|2
7785446|NCT00581555|27061012|P2|Overall Study|Withdrawal by Subject|9
7785447|NCT00581555|27061013|P1|Overall Study|Withdrawal by Subject|18
7785448|NCT00581555|27061012|P2|Overall Study|Physician Decision|2
7785449|NCT00581555|27061013|P1|Overall Study|Physician Decision|3
7785450|NCT00581555|27061012|P2|Overall Study|Adverse Event|3
7785451|NCT00581555|27061013|P1|Overall Study|Adverse Event|4
7785452|NCT00581542|27061037|P2|Overall Study|Lost to Follow-up|21
7785453|NCT00581542|27061038|P1|Overall Study|Lost to Follow-up|9
7785454|NCT00581542|27061037|P2|Overall Study|they met an exclusion criteria|2
7785455|NCT00581542|27061038|P1|Overall Study|they met an exclusion criteria|2
7785456|NCT00581360|27061092|P1|Overall Study|Withdrawal by Subject|1
7785457|NCT00581308|27061111|P1|Month 12|Other|1
7785458|NCT00581308|27061111|P1|Month 12|Device Removed|1
7785459|NCT00581308|27061111|P1|Month 12|Withdrawal by Subject|3
7785460|NCT00581308|27061111|P1|Month 12|Lost to Follow-up|14
7785461|NCT00581308|27061111|P1|Month 12|Death|1
7785462|NCT00581308|27061111|P1|Month 6|Withdrawal by Subject|2
7785463|NCT00581308|27061111|P1|Month 6|Lost to Follow-up|1
7785464|NCT00581308|27061111|P1|Month 1|Uknown|1
7785465|NCT00581308|27061111|P1|Month 1|Device Removed|2
7785466|NCT00581308|27061111|P1|Month 1|Withdrawal by Subject|2
7785467|NCT00581308|27061111|P1|Month 1|Lost to Follow-up|3
7785468|NCT00581308|27061111|P1|Pre Discharge|Device Removed|1
7785469|NCT00581308|27061111|P1|Pre Discharge|Lost to Follow-up|1
7785470|NCT00581113|27061142|P2|Overall Study|Withdrawal by Subject|1
7785471|NCT00581113|27061143|P1|Overall Study|Withdrawal by Subject|0
7785472|NCT00581100|27061153|P2|Overall Study|Other|0
7785473|NCT00581100|27061154|P1|Overall Study|Other|3
7785474|NCT00581100|27061153|P2|Overall Study|Withdrawal by Subject|4
7785475|NCT00581100|27061154|P1|Overall Study|Withdrawal by Subject|1
7785476|NCT00581100|27061153|P2|Overall Study|Adverse Event|1
7785477|NCT00581100|27061154|P1|Overall Study|Adverse Event|2
7785478|NCT00581100|27061153|P2|Overall Study|Death|0
7785479|NCT00581100|27061154|P1|Overall Study|Death|1
7785480|NCT00580983|27061207|P1|Overall Study|Did not complete 12 mon post RT studies|7
7785481|NCT00580970|27061214|P1|Treatment (Lovastatin)|Death|1
7785482|NCT00580970|27061214|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
7785483|NCT00580970|27061214|P1|Treatment (Lovastatin)|Physician Decision|4
7785484|NCT00580970|27061214|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
7785485|NCT00580970|27061214|P1|Treatment (Lovastatin)|Non-compliance|6
7785486|NCT00580970|27061214|P1|Pre-treatment|Non-compliance|1
7785487|NCT00580866|27061229|P2|Overall Study|Lost to Follow-up|2
7785488|NCT00580866|27061230|P1|Overall Study|Lost to Follow-up|2
7785489|NCT00580840|27061254|P4|Double-Blind|Other: Forbidden Medication|0
7785490|NCT00580840|27061255|P3|Double-Blind|Other: Forbidden Medication|1
7785491|NCT00580840|27061256|P2|Double-Blind|Other: Forbidden Medication|0
7785492|NCT00580840|27061257|P1|Double-Blind|Other: Forbidden Medication|0
7785493|NCT00580840|27061254|P4|Double-Blind|Other: Discontinued Methotrexate|0
7785494|NCT00580840|27061255|P3|Double-Blind|Other: Discontinued Methotrexate|0
7785495|NCT00580840|27061256|P2|Double-Blind|Other: Discontinued Methotrexate|1
7785496|NCT00580840|27061257|P1|Double-Blind|Other: Discontinued Methotrexate|0
7785497|NCT00580840|27061254|P4|Double-Blind|Withdrawal by Subject|2
7785498|NCT00580840|27061255|P3|Double-Blind|Withdrawal by Subject|2
7785499|NCT00580840|27061256|P2|Double-Blind|Withdrawal by Subject|1
7785500|NCT00580840|27061257|P1|Double-Blind|Withdrawal by Subject|0
7785501|NCT00580840|27061254|P4|Double-Blind|Lost to Follow-up|2
7785502|NCT00580840|27061255|P3|Double-Blind|Lost to Follow-up|0
7785503|NCT00580840|27061256|P2|Double-Blind|Lost to Follow-up|1
7785504|NCT00580840|27061257|P1|Double-Blind|Lost to Follow-up|0
7785505|NCT00580840|27061254|P4|Double-Blind|Loss of Efficacy|10
7785506|NCT00580840|27061255|P3|Double-Blind|Loss of Efficacy|2
7785507|NCT00580840|27061256|P2|Double-Blind|Loss of Efficacy|1
7785508|NCT00580840|27061257|P1|Double-Blind|Loss of Efficacy|0
7785509|NCT00580840|27061254|P4|Double-Blind|Adverse Event|1
7785510|NCT00580840|27061255|P3|Double-Blind|Adverse Event|4
7785511|NCT00580840|27061256|P2|Double-Blind|Adverse Event|3
7785512|NCT00580840|27061257|P1|Double-Blind|Adverse Event|0
7785513|NCT00580840|27061254|P4|Run-in|Other: Exclusionary Lab Value|0
7785514|NCT00580840|27061255|P3|Run-in|Other: Exclusionary Lab Value|0
7785515|NCT00580840|27061256|P2|Run-in|Other: Exclusionary Lab Value|0
7785516|NCT00580840|27061257|P1|Run-in|Other: Exclusionary Lab Value|1
7785517|NCT00580840|27061254|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
7785518|NCT00580840|27061255|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
7785519|NCT00580840|27061256|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
7785520|NCT00580840|27061257|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
7785521|NCT00580840|27061254|P4|Run-in|Other: Per Sponsor Request|0
7785522|NCT00580840|27061255|P3|Run-in|Other: Per Sponsor Request|0
7785523|NCT00580840|27061256|P2|Run-in|Other: Per Sponsor Request|0
7785524|NCT00580840|27061257|P1|Run-in|Other: Per Sponsor Request|2
7785525|NCT00580840|27061254|P4|Run-in|Withdrawal by Subject|0
7785526|NCT00580840|27061255|P3|Run-in|Withdrawal by Subject|0
7785527|NCT00580840|27061256|P2|Run-in|Withdrawal by Subject|0
7785528|NCT00580840|27061257|P1|Run-in|Withdrawal by Subject|5
7785529|NCT00580840|27061254|P4|Run-in|Lost to Follow-up|0
7785530|NCT00580840|27061255|P3|Run-in|Lost to Follow-up|0
7785531|NCT00580840|27061256|P2|Run-in|Lost to Follow-up|0
7785532|NCT00580840|27061257|P1|Run-in|Lost to Follow-up|4
7785533|NCT00580840|27061254|P4|Run-in|Loss of Efficacy|0
7785534|NCT00580840|27061255|P3|Run-in|Loss of Efficacy|0
7785535|NCT00580840|27061256|P2|Run-in|Loss of Efficacy|0
7785536|NCT00580840|27061257|P1|Run-in|Loss of Efficacy|1
7785537|NCT00580840|27061254|P4|Run-in|Lack of Efficacy|0
7785538|NCT00580840|27061255|P3|Run-in|Lack of Efficacy|0
7785539|NCT00580840|27061256|P2|Run-in|Lack of Efficacy|0
7785540|NCT00580840|27061257|P1|Run-in|Lack of Efficacy|93
7785541|NCT00580840|27061254|P4|Run-in|Adverse Event|0
7785542|NCT00580840|27061255|P3|Run-in|Adverse Event|0
7785543|NCT00580840|27061256|P2|Run-in|Adverse Event|0
7785544|NCT00580840|27061257|P1|Run-in|Adverse Event|17
7785545|NCT00580801|27061365|P3|Overall Study|Travel|0
7785546|NCT00580801|27061366|P2|Overall Study|Travel|0
7785547|NCT00580801|27061367|P1|Overall Study|Travel|1
7785548|NCT00580801|27061365|P3|Overall Study|Participant non-compliant|1
7785549|NCT00580801|27061366|P2|Overall Study|Participant non-compliant|0
7785550|NCT00580801|27061367|P1|Overall Study|Participant non-compliant|0
7785551|NCT00580801|27061365|P3|Overall Study|Reached a virologic endpoint|2
7785552|NCT00580801|27061366|P2|Overall Study|Reached a virologic endpoint|1
7785553|NCT00580801|27061367|P1|Overall Study|Reached a virologic endpoint|0
7785554|NCT00580801|27061365|P3|Overall Study|Lost to Follow-up|0
7785555|NCT00580801|27061366|P2|Overall Study|Lost to Follow-up|0
7785556|NCT00580801|27061367|P1|Overall Study|Lost to Follow-up|2
7785557|NCT00580801|27061365|P3|Overall Study|Adverse Event|0
7785558|NCT00580801|27061366|P2|Overall Study|Adverse Event|0
7785559|NCT00580801|27061367|P1|Overall Study|Adverse Event|2
7785560|NCT00580801|27061365|P3|Overall Study|Physician Decision|0
7785561|NCT00580801|27061366|P2|Overall Study|Physician Decision|0
7785562|NCT00580801|27061367|P1|Overall Study|Physician Decision|1
7785563|NCT00580788|27061406|P4|Overall Study|Adverse Event|1
7785564|NCT00580788|27061407|P3|Overall Study|Adverse Event|0
7785565|NCT00580788|27061408|P2|Overall Study|Adverse Event|0
7785566|NCT00580788|27061409|P1|Overall Study|Adverse Event|0
7785567|NCT00580723|27061467|P1|Overall Study|Lost to Follow-up|5
7785568|NCT00580723|27061467|P1|Overall Study|Did not want to participate in extension|3
7785569|NCT00580606|27061510|P2|Open Label (OL)|Needed Prohibited Medication|1
7785570|NCT00580606|27061511|P1|Open Label (OL)|Needed Prohibited Medication|0
7785571|NCT00580606|27061510|P2|Open Label (OL)|Physician Decision|1
7785572|NCT00580606|27061511|P1|Open Label (OL)|Physician Decision|1
7785573|NCT00580606|27061510|P2|Open Label (OL)|Non-compliance|0
7785574|NCT00580606|27061511|P1|Open Label (OL)|Non-compliance|2
7785575|NCT00580606|27061510|P2|Open Label (OL)|Pregnancy|1
7785576|NCT00580606|27061511|P1|Open Label (OL)|Pregnancy|0
7785577|NCT00580606|27061510|P2|Open Label (OL)|Lost to Follow-up|1
7785578|NCT00580606|27061511|P1|Open Label (OL)|Lost to Follow-up|0
7785579|NCT00580606|27061510|P2|Open Label (OL)|Dosing Symptoms|1
7785580|NCT00580606|27061511|P1|Open Label (OL)|Dosing Symptoms|0
7785581|NCT00580606|27061510|P2|Open Label (OL)|Withdrawal by Subject|6
7785582|NCT00580606|27061511|P1|Open Label (OL)|Withdrawal by Subject|4
7785583|NCT00580606|27061510|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
7785584|NCT00580606|27061511|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
7785585|NCT00580047|27061592|P3|Overall Study|Withdrawal by Subject|0
7785586|NCT00580047|27061593|P2|Overall Study|Withdrawal by Subject|0
7785587|NCT00580047|27061594|P1|Overall Study|Withdrawal by Subject|1
7785588|NCT00580047|27061592|P3|Overall Study|Withdrawal by Subject|2
7785589|NCT00580047|27061593|P2|Overall Study|Withdrawal by Subject|1
7785590|NCT00580047|27061594|P1|Overall Study|Withdrawal by Subject|1
7785591|NCT00580047|27061592|P3|Overall Study|Lost to Follow-up|0
7785592|NCT00580047|27061593|P2|Overall Study|Lost to Follow-up|1
7785593|NCT00580047|27061594|P1|Overall Study|Lost to Follow-up|1
7785594|NCT00580034|27061605|P2|Overall Study|Toxicity|0
7785595|NCT00580034|27061606|P1|Overall Study|Toxicity|10
7785596|NCT00579982|27061612|P1|Overall Study|Protocol Violation|4
7785597|NCT00579982|27061612|P1|Overall Study|Adverse Event|4
7785598|NCT00579826|27061646|P2|Overall Study|Withdrawal by Subject|3
7785599|NCT00579826|27061647|P1|Overall Study|Withdrawal by Subject|5
7785600|NCT00579670|27061681|P5|Overall Study|Withdrawal by Subject|0
7785601|NCT00579670|27061682|P4|Overall Study|Withdrawal by Subject|0
7785602|NCT00579670|27061683|P3|Overall Study|Withdrawal by Subject|1
7785603|NCT00579670|27061684|P2|Overall Study|Withdrawal by Subject|0
7785604|NCT00579670|27061685|P1|Overall Study|Withdrawal by Subject|0
7785605|NCT00579670|27061681|P5|Overall Study|Other|0
7785606|NCT00579670|27061682|P4|Overall Study|Other|2
7785607|NCT00579670|27061683|P3|Overall Study|Other|1
7785608|NCT00579670|27061684|P2|Overall Study|Other|0
7785609|NCT00579670|27061685|P1|Overall Study|Other|0
7785610|NCT00579670|27061681|P5|Overall Study|Lost to Follow-up|0
7785611|NCT00579670|27061682|P4|Overall Study|Lost to Follow-up|4
7785612|NCT00579670|27061683|P3|Overall Study|Lost to Follow-up|0
7785613|NCT00579670|27061684|P2|Overall Study|Lost to Follow-up|1
7785614|NCT00579670|27061685|P1|Overall Study|Lost to Follow-up|0
7785615|NCT00579670|27061681|P5|Overall Study|Lack of Efficacy|0
7785616|NCT00579670|27061682|P4|Overall Study|Lack of Efficacy|14
7785617|NCT00579670|27061683|P3|Overall Study|Lack of Efficacy|1
7785618|NCT00579670|27061684|P2|Overall Study|Lack of Efficacy|0
7785619|NCT00579670|27061685|P1|Overall Study|Lack of Efficacy|0
7785620|NCT00579670|27061681|P5|Overall Study|Adverse Event|0
7785621|NCT00579670|27061682|P4|Overall Study|Adverse Event|2
7785622|NCT00579670|27061683|P3|Overall Study|Adverse Event|1
7785623|NCT00579670|27061684|P2|Overall Study|Adverse Event|0
7785624|NCT00579670|27061685|P1|Overall Study|Adverse Event|1
7785625|NCT00579670|27061681|P5|Overall Study|Death|0
7785626|NCT00579670|27061682|P4|Overall Study|Death|0
7785627|NCT00579670|27061683|P3|Overall Study|Death|0
7785628|NCT00579670|27061684|P2|Overall Study|Death|0
7785629|NCT00579670|27061685|P1|Overall Study|Death|1
7785630|NCT00579553|27061899|P2|Overall Study|Lost to Follow-up|13
7785631|NCT00579553|27061900|P1|Overall Study|Lost to Follow-up|16
7785632|NCT00579527|27061912|P1|Overall Study|Death|4
7785633|NCT00579501|27061924|P1|Overall Study|Radiation therapy before surgery|1
7785634|NCT00579501|27061924|P1|Overall Study|Secondary lesion|1
7785635|NCT00579501|27061924|P1|Overall Study|toxicity|1
7785636|NCT00579501|27061924|P1|Overall Study|End of neoadjuvant therapy|25
7785637|NCT00579501|27061924|P1|Overall Study|Death|1
7785638|NCT00579345|27061952|P8|Overall Study|Death|0
7785639|NCT00579345|27061953|P7|Overall Study|Death|0
7785640|NCT00579345|27061954|P6|Overall Study|Death|0
7785641|NCT00579345|27061955|P5|Overall Study|Death|0
7785642|NCT00579345|27061956|P4|Overall Study|Death|1
7785643|NCT00579345|27061957|P3|Overall Study|Death|1
7785644|NCT00579345|27061958|P2|Overall Study|Death|1
7785645|NCT00579345|27061959|P1|Overall Study|Death|1
7785646|NCT00579345|27061952|P8|Overall Study|Protocol Violation|1
7785647|NCT00579345|27061953|P7|Overall Study|Protocol Violation|0
7785648|NCT00579345|27061954|P6|Overall Study|Protocol Violation|0
7785649|NCT00579345|27061955|P5|Overall Study|Protocol Violation|0
7785650|NCT00579345|27061956|P4|Overall Study|Protocol Violation|0
7785651|NCT00579345|27061957|P3|Overall Study|Protocol Violation|0
7785652|NCT00579345|27061958|P2|Overall Study|Protocol Violation|0
7785653|NCT00579345|27061959|P1|Overall Study|Protocol Violation|1
7785654|NCT00579345|27061952|P8|Overall Study|Adverse Event|0
7785655|NCT00579345|27061953|P7|Overall Study|Adverse Event|0
7785656|NCT00579345|27061954|P6|Overall Study|Adverse Event|0
7785657|NCT00579345|27061955|P5|Overall Study|Adverse Event|0
7785658|NCT00579345|27061956|P4|Overall Study|Adverse Event|0
7785659|NCT00579345|27061957|P3|Overall Study|Adverse Event|1
7785660|NCT00579345|27061958|P2|Overall Study|Adverse Event|0
7785661|NCT00579345|27061959|P1|Overall Study|Adverse Event|0
7785662|NCT00579345|27061952|P8|Overall Study|Lost to Follow-up|0
7785663|NCT00579345|27061953|P7|Overall Study|Lost to Follow-up|0
7785664|NCT00579345|27061954|P6|Overall Study|Lost to Follow-up|0
7785665|NCT00579345|27061955|P5|Overall Study|Lost to Follow-up|0
7785666|NCT00579345|27061956|P4|Overall Study|Lost to Follow-up|0
7785667|NCT00579345|27061957|P3|Overall Study|Lost to Follow-up|0
7785668|NCT00579345|27061958|P2|Overall Study|Lost to Follow-up|0
7785669|NCT00579345|27061959|P1|Overall Study|Lost to Follow-up|1
7785670|NCT00579345|27061952|P8|Overall Study|Withdrawal by Subject|1
7785671|NCT00579345|27061953|P7|Overall Study|Withdrawal by Subject|0
7785672|NCT00579345|27061954|P6|Overall Study|Withdrawal by Subject|0
7785673|NCT00579345|27061955|P5|Overall Study|Withdrawal by Subject|0
7785674|NCT00579345|27061956|P4|Overall Study|Withdrawal by Subject|0
7785675|NCT00579345|27061957|P3|Overall Study|Withdrawal by Subject|0
7785676|NCT00579345|27061958|P2|Overall Study|Withdrawal by Subject|0
7785677|NCT00579345|27061959|P1|Overall Study|Withdrawal by Subject|2
7785678|NCT00579254|27062034|P1|Overall Study|Discontinued when study terminated|73
7785679|NCT00579254|27062034|P1|Overall Study|Lost to Follow-up|39
7785680|NCT00579098|27062058|P2|Overall Study|AF returned after ablation|2
7785681|NCT00579098|27062059|P1|Overall Study|AF returned after ablation|3
7785682|NCT00579098|27062058|P2|Overall Study|Withdrawal by Subject|3
7785683|NCT00579098|27062059|P1|Overall Study|Withdrawal by Subject|2
7785684|NCT00579098|27062058|P2|Overall Study|Adverse Event|3
7785685|NCT00579098|27062059|P1|Overall Study|Adverse Event|2
7785686|NCT00579098|27062058|P2|Overall Study|Lost to Follow-up|0
7785687|NCT00579098|27062059|P1|Overall Study|Lost to Follow-up|2
7785688|NCT00579059|27062075|P2|Overall Study|Study Canceled at 1 Year|10
7785689|NCT00579059|27062076|P1|Overall Study|Study Canceled at 1 Year|21
7785690|NCT00578942|27062150|P1|Overall Study|Lost to Follow-up|1
7785691|NCT00578877|27062189|P2|Overall Study|did not provide follow-up data|17
7785692|NCT00578877|27062190|P1|Overall Study|did not provide follow-up data|12
7785693|NCT00578877|27062189|P2|Overall Study|early discontinue|101
7785694|NCT00578877|27062190|P1|Overall Study|early discontinue|61
7785695|NCT00578877|27062189|P2|Overall Study|Lost to Follow-up|10
7785696|NCT00578877|27062190|P1|Overall Study|Lost to Follow-up|8
7785697|NCT00578864|27062198|P2|Overall Study|Death|0
7785698|NCT00578864|27062199|P1|Overall Study|Death|1
7785699|NCT00578812|27062215|P2|Overall Study|Not treated|7
7785700|NCT00578812|27062216|P1|Overall Study|Not treated|6
7785701|NCT00578786|27062255|P3|Overall Study|Qualified but Not Enrolled in Extension|0
7785702|NCT00578786|27062256|P2|Overall Study|Qualified but Not Enrolled in Extension|3
7785703|NCT00578786|27062257|P1|Overall Study|Qualified but Not Enrolled in Extension|0
7785704|NCT00578786|27062255|P3|Overall Study|Not Otherwise Specified|1
7785705|NCT00578786|27062256|P2|Overall Study|Not Otherwise Specified|4
7785706|NCT00578786|27062257|P1|Overall Study|Not Otherwise Specified|0
7785707|NCT00578786|27062255|P3|Overall Study|Pregnancy|0
7785708|NCT00578786|27062256|P2|Overall Study|Pregnancy|1
7785709|NCT00578786|27062257|P1|Overall Study|Pregnancy|0
7785710|NCT00578786|27062255|P3|Overall Study|Lost to Follow-up|0
7785711|NCT00578786|27062256|P2|Overall Study|Lost to Follow-up|4
7785712|NCT00578786|27062257|P1|Overall Study|Lost to Follow-up|0
7785713|NCT00578786|27062255|P3|Overall Study|Sponsor Decision|1
7785714|NCT00578786|27062256|P2|Overall Study|Sponsor Decision|0
7785715|NCT00578786|27062257|P1|Overall Study|Sponsor Decision|0
7785716|NCT00578786|27062255|P3|Overall Study|Physician Decision|1
7785717|NCT00578786|27062256|P2|Overall Study|Physician Decision|0
7785718|NCT00578786|27062257|P1|Overall Study|Physician Decision|1
7785719|NCT00578786|27062255|P3|Overall Study|Protocol Violation|1
7785720|NCT00578786|27062256|P2|Overall Study|Protocol Violation|3
7785721|NCT00578786|27062257|P1|Overall Study|Protocol Violation|0
7785722|NCT00578786|27062255|P3|Overall Study|Withdrawal by Subject|5
7785723|NCT00578786|27062256|P2|Overall Study|Withdrawal by Subject|8
7785724|NCT00578786|27062257|P1|Overall Study|Withdrawal by Subject|7
7785725|NCT00578786|27062255|P3|Overall Study|Early Escape from Prior Study|2
7785726|NCT00578786|27062256|P2|Overall Study|Early Escape from Prior Study|1
7785727|NCT00578786|27062257|P1|Overall Study|Early Escape from Prior Study|2
7785728|NCT00578786|27062255|P3|Overall Study|Lack of Efficacy|2
7785729|NCT00578786|27062256|P2|Overall Study|Lack of Efficacy|5
7785730|NCT00578786|27062257|P1|Overall Study|Lack of Efficacy|2
7785731|NCT00578786|27062255|P3|Overall Study|Adverse Event|17
7785732|NCT00578786|27062256|P2|Overall Study|Adverse Event|37
7785733|NCT00578786|27062257|P1|Overall Study|Adverse Event|27
7785734|NCT00578643|27062358|P1|Overall Study|Lost to Follow-up|1
7785735|NCT00578643|27062358|P1|Overall Study|Death|1
7785736|NCT00578565|27062374|P1|Overall Study|Adverse Event|3
7785737|NCT00578448|27062404|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
7785738|NCT00578448|27062404|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
7785739|NCT00578448|27062404|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
7785740|NCT00578448|27062404|P1|Day 1 up to 3 Years of Planned Study|Death|1
7785741|NCT00578344|27062455|P1|Overall Study|Graft failure|1
7785742|NCT00578344|27062455|P1|Overall Study|Insurance problems|1
7785743|NCT00578318|27062474|P2|Overall Study|Physician Decision|0
7785744|NCT00578318|27062475|P1|Overall Study|Physician Decision|1
7785745|NCT00578318|27062474|P2|Overall Study|Lost to Follow-up|0
7785746|NCT00578318|27062475|P1|Overall Study|Lost to Follow-up|2
7785747|NCT00578292|27062545|P1|Overall Study|Graft failure|2
7785748|NCT00578292|27062545|P1|Overall Study|Death|1
7785749|NCT00578227|27062569|P3|Overall Study|Withdrawal by Subject|3
7785750|NCT00578227|27062570|P2|Overall Study|Withdrawal by Subject|1
7785751|NCT00578227|27062571|P1|Overall Study|Withdrawal by Subject|5
7785752|NCT00578227|27062569|P3|Overall Study|Lost to Follow-up|1
7785753|NCT00578227|27062570|P2|Overall Study|Lost to Follow-up|1
7785754|NCT00578227|27062571|P1|Overall Study|Lost to Follow-up|0
7785755|NCT00578175|27062696|P3|Overall Study|Other reasons|23
7785756|NCT00578175|27062697|P2|Overall Study|Other reasons|42
7785757|NCT00578175|27062698|P1|Overall Study|Other reasons|70
7785758|NCT00578175|27062696|P3|Overall Study|Adverse Event|1
7785759|NCT00578175|27062697|P2|Overall Study|Adverse Event|1
7785760|NCT00578175|27062698|P1|Overall Study|Adverse Event|0
7785761|NCT00578136|27062777|P2|Overall Study|Not given intervention|1
7785762|NCT00578136|27062778|P1|Overall Study|Not given intervention|1
7785763|NCT00577993|27062796|P3|Overall Study|Uninsured|0
7785764|NCT00577993|27062797|P2|Overall Study|Uninsured|0
7785765|NCT00577993|27062798|P1|Overall Study|Uninsured|1
7785766|NCT00577993|27062796|P3|Overall Study|Conversion|0
7785767|NCT00577993|27062797|P2|Overall Study|Conversion|5
7785768|NCT00577993|27062798|P1|Overall Study|Conversion|2
7785769|NCT00577993|27062796|P3|Overall Study|Withdrawal by Subject|2
7785770|NCT00577993|27062797|P2|Overall Study|Withdrawal by Subject|0
7785771|NCT00577993|27062798|P1|Overall Study|Withdrawal by Subject|1
7785772|NCT00577993|27062796|P3|Overall Study|Protocol Violation|0
7785773|NCT00577993|27062797|P2|Overall Study|Protocol Violation|3
7785774|NCT00577993|27062798|P1|Overall Study|Protocol Violation|2
7785775|NCT00577993|27062796|P3|Overall Study|Lack of Efficacy|0
7785776|NCT00577993|27062797|P2|Overall Study|Lack of Efficacy|1
7785777|NCT00577993|27062798|P1|Overall Study|Lack of Efficacy|0
7785778|NCT00577993|27062796|P3|Overall Study|Death|1
7785779|NCT00577993|27062797|P2|Overall Study|Death|1
7785780|NCT00577993|27062798|P1|Overall Study|Death|0
7785781|NCT00577993|27062796|P3|Overall Study|Adverse Event|0
7785782|NCT00577993|27062797|P2|Overall Study|Adverse Event|0
7785783|NCT00577993|27062798|P1|Overall Study|Adverse Event|1
7785784|NCT00577889|27062809|P3|Overall Study|Withdrawal by Subject|0
7785785|NCT00577889|27062810|P2|Overall Study|Withdrawal by Subject|0
7785786|NCT00577889|27062811|P1|Overall Study|Withdrawal by Subject|1
7785787|NCT00577863|27062830|P2|Overall Study|Did Not Receive at Least One Injection|1
7785788|NCT00577863|27062831|P1|Overall Study|Did Not Receive at Least One Injection|0
7785789|NCT00577863|27062830|P2|Overall Study|Sponsor Decision|7
7785790|NCT00577863|27062831|P1|Overall Study|Sponsor Decision|2
7785791|NCT00577863|27062830|P2|Overall Study|Withdrawal by Subject|2
7785792|NCT00577863|27062831|P1|Overall Study|Withdrawal by Subject|0
7785793|NCT00577863|27062830|P2|Overall Study|Entry Criteria Exclusion|0
7785794|NCT00577863|27062831|P1|Overall Study|Entry Criteria Exclusion|1
7785795|NCT00577863|27062830|P2|Overall Study|Lost to Follow-up|2
7785796|NCT00577863|27062831|P1|Overall Study|Lost to Follow-up|2
7785797|NCT00577863|27062830|P2|Overall Study|Death|0
7785798|NCT00577863|27062831|P1|Overall Study|Death|1
7785799|NCT00577863|27062830|P2|Overall Study|Adverse Event|2
7785800|NCT00577863|27062831|P1|Overall Study|Adverse Event|4
7785801|NCT00577824|27062873|P3|Overall Study|Protocol Violation|0
7785802|NCT00577824|27062874|P2|Overall Study|Protocol Violation|1
7785803|NCT00577824|27062875|P1|Overall Study|Protocol Violation|1
7785804|NCT00577824|27062873|P3|Overall Study|Patient decision|1
7785805|NCT00577824|27062874|P2|Overall Study|Patient decision|1
7785806|NCT00577824|27062875|P1|Overall Study|Patient decision|0
7785807|NCT00577824|27062873|P3|Overall Study|Adverse Event|1
7785808|NCT00577824|27062874|P2|Overall Study|Adverse Event|18
7785809|NCT00577824|27062875|P1|Overall Study|Adverse Event|6
7785810|NCT00577772|27062933|P2|Overall Study|Lost to Follow-up|1
7785811|NCT00577772|27062934|P1|Overall Study|Lost to Follow-up|0
7785812|NCT00577720|27062944|P4|Overall Study|Withdrawal by Subject|2
7785813|NCT00577720|27062945|P3|Overall Study|Withdrawal by Subject|0
7785814|NCT00577720|27062946|P2|Overall Study|Withdrawal by Subject|0
7785815|NCT00577720|27062947|P1|Overall Study|Withdrawal by Subject|2
7785816|NCT00577720|27062944|P4|Overall Study|Protocol Violation|1
7785817|NCT00577720|27062945|P3|Overall Study|Protocol Violation|0
7785818|NCT00577720|27062946|P2|Overall Study|Protocol Violation|0
7785819|NCT00577720|27062947|P1|Overall Study|Protocol Violation|0
7785820|NCT00577720|27062944|P4|Overall Study|Lost to Follow-up|0
7785821|NCT00577720|27062945|P3|Overall Study|Lost to Follow-up|1
7785822|NCT00577720|27062946|P2|Overall Study|Lost to Follow-up|0
7785823|NCT00577720|27062947|P1|Overall Study|Lost to Follow-up|0
7785824|NCT00577720|27062944|P4|Overall Study|Adverse Event|4
7785825|NCT00577720|27062945|P3|Overall Study|Adverse Event|0
7785826|NCT00577720|27062946|P2|Overall Study|Adverse Event|1
7785827|NCT00577720|27062947|P1|Overall Study|Adverse Event|2
7785828|NCT00577707|27062965|P1|Overall Study|Withdrawal by Subject|3
7785829|NCT00577655|27062973|P2|Overall Study|Lost to Follow-up|1
7785830|NCT00577655|27062974|P1|Overall Study|Lost to Follow-up|1
7785831|NCT00577655|27062973|P2|Overall Study|Protocol Violation|1
7785832|NCT00577655|27062974|P1|Overall Study|Protocol Violation|0
7785833|NCT00577655|27062973|P2|Overall Study|Patient Request|2
7785834|NCT00577655|27062974|P1|Overall Study|Patient Request|0
7785835|NCT00577642|27063012|P1|Overall Study|Clinical Disease Progression|1
7785836|NCT00577629|27063016|P1|Long Term Follow-Up|Physician Decision|1
7785837|NCT00577629|27063016|P1|Long Term Follow-Up|Withdrawal by Subject|4
7785838|NCT00577629|27063016|P1|Long Term Follow-Up|Lost to Follow-up|5
7785839|NCT00577629|27063016|P1|Long Term Follow-Up|Death|15
7785840|NCT00577629|27063016|P1|Treatment Period|Death|1
7785841|NCT00577473|27063043|P2|Overall Study|Lack of Efficacy|7
7785842|NCT00577473|27063044|P1|Overall Study|Lack of Efficacy|8
7785843|NCT00577473|27063043|P2|Overall Study|Physician Decision|2
7785844|NCT00577473|27063044|P1|Overall Study|Physician Decision|2
7785845|NCT00577473|27063043|P2|Overall Study|Withdrawal by Subject|6
7785846|NCT00577473|27063044|P1|Overall Study|Withdrawal by Subject|2
7785847|NCT00577473|27063043|P2|Overall Study|Adverse Event|5
7785848|NCT00577473|27063044|P1|Overall Study|Adverse Event|8
7785849|NCT00577473|27063043|P2|Overall Study|Protocol Violation|4
7785850|NCT00577473|27063044|P1|Overall Study|Protocol Violation|1
7785851|NCT00577460|27063075|P3|Overall Study|Other|2
7785852|NCT00577460|27063076|P2|Overall Study|Other|3
7785853|NCT00577460|27063077|P1|Overall Study|Other|0
7785854|NCT00577460|27063075|P3|Overall Study|Withdrawal by Subject|6
7785855|NCT00577460|27063076|P2|Overall Study|Withdrawal by Subject|5
7785856|NCT00577460|27063077|P1|Overall Study|Withdrawal by Subject|5
7785857|NCT00577460|27063075|P3|Overall Study|Lost to Follow-up|4
7785858|NCT00577460|27063076|P2|Overall Study|Lost to Follow-up|3
7785859|NCT00577460|27063077|P1|Overall Study|Lost to Follow-up|0
7785860|NCT00577460|27063075|P3|Overall Study|Protocol Violation|1
7785861|NCT00577460|27063076|P2|Overall Study|Protocol Violation|1
7785862|NCT00577460|27063077|P1|Overall Study|Protocol Violation|0
7785863|NCT00577460|27063075|P3|Overall Study|Adverse Event|14
7785864|NCT00577460|27063076|P2|Overall Study|Adverse Event|7
7785865|NCT00577460|27063077|P1|Overall Study|Adverse Event|11
7785866|NCT00577408|27063186|P2|Overall Study|Psychiatric hospitalization|1
7785867|NCT00577408|27063187|P1|Overall Study|Psychiatric hospitalization|0
7785868|NCT00577408|27063186|P2|Overall Study|Death|1
7785869|NCT00577408|27063187|P1|Overall Study|Death|0
7785870|NCT00577408|27063186|P2|Overall Study|Scheduling Issues|3
7785871|NCT00577408|27063187|P1|Overall Study|Scheduling Issues|0
7785872|NCT00577408|27063186|P2|Overall Study|Moved out of state|1
7785873|NCT00577408|27063187|P1|Overall Study|Moved out of state|0
7785874|NCT00577408|27063186|P2|Overall Study|Refused Oral Naltrexone|1
7785875|NCT00577408|27063187|P1|Overall Study|Refused Oral Naltrexone|0
7785876|NCT00577408|27063186|P2|Overall Study|Non-compliance with study meds|3
7785877|NCT00577408|27063187|P1|Overall Study|Non-compliance with study meds|0
7785878|NCT00577408|27063186|P2|Overall Study|Continued opioid use|2
7785879|NCT00577408|27063187|P1|Overall Study|Continued opioid use|3
7785880|NCT00577408|27063186|P2|Overall Study|Stopped attending study visits|11
7785881|NCT00577408|27063187|P1|Overall Study|Stopped attending study visits|9
7785882|NCT00577395|27063195|P2|Overall Study|Study was terminated early by Sponsor|6
7785883|NCT00577395|27063196|P1|Overall Study|Study was terminated early by Sponsor|7
7785884|NCT00577382|27063206|P2|Overall Study|Lost to Follow-up|2
7785885|NCT00577382|27063207|P1|Overall Study|Lost to Follow-up|2
7785886|NCT00577382|27063206|P2|Overall Study|Death|1
7785887|NCT00577382|27063207|P1|Overall Study|Death|1
7785888|NCT00577382|27063206|P2|Overall Study|Intercurrent Illness|2
7785889|NCT00577382|27063207|P1|Overall Study|Intercurrent Illness|1
7785890|NCT00577382|27063206|P2|Overall Study|Progressive Disease|19
7785891|NCT00577382|27063207|P1|Overall Study|Progressive Disease|17
7785892|NCT00577382|27063206|P2|Overall Study|Withdrawal by Subject|1
7785893|NCT00577382|27063207|P1|Overall Study|Withdrawal by Subject|0
7785894|NCT00577382|27063206|P2|Overall Study|Adverse Event|6
7785895|NCT00577382|27063207|P1|Overall Study|Adverse Event|0
7785896|NCT00577317|27063225|P2|Overall Study|Study Terminated|2
7785897|NCT00577317|27063226|P1|Overall Study|Study Terminated|0
7785898|NCT00577122|27063359|P2|Overall Study|Alternative Therapy|1
7785899|NCT00577122|27063360|P1|Overall Study|Alternative Therapy|0
7785900|NCT00577122|27063359|P2|Overall Study|Prog, refract disease during active trt|5
7785901|NCT00577122|27063360|P1|Overall Study|Prog, refract disease during active trt|8
7785902|NCT00577122|27063359|P2|Overall Study|Progression, relapse during active trt|8
7785903|NCT00577122|27063360|P1|Overall Study|Progression, relapse during active trt|6
7785904|NCT00577122|27063359|P2|Overall Study|Adverse Event|2
7785905|NCT00577122|27063360|P1|Overall Study|Adverse Event|0
7785906|NCT00577096|27063374|P2|Short Term Participation|Death|1
7785907|NCT00577096|27063375|P1|Short Term Participation|Death|1
7785908|NCT00577096|27063374|P2|Short Term Participation|Withdrawal by Subject|5
7785909|NCT00577096|27063375|P1|Short Term Participation|Withdrawal by Subject|3
7785910|NCT00577096|27063374|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
7785911|NCT00577096|27063375|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
7785912|NCT00577031|27063414|P1|Overall Study|Death|6
7785913|NCT00577031|27063414|P1|Overall Study|Medical decision|14
7785914|NCT00577031|27063414|P1|Overall Study|Need for surgery|17
7785915|NCT00577031|27063414|P1|Overall Study|Participant non-compliance|5
7785916|NCT00577031|27063414|P1|Overall Study|Participant withdrew consent|13
7785917|NCT00577031|27063414|P1|Overall Study|Protocol Violation|5
7785918|NCT00577031|27063414|P1|Overall Study|Progression of disease|93
7785919|NCT00577031|27063414|P1|Overall Study|Adverse Event|52
7785920|NCT00577005|27063435|P2|Overall Study|Withdrawal by Subject|1
7785921|NCT00577005|27063436|P1|Overall Study|Withdrawal by Subject|2
7785922|NCT00577005|27063435|P2|Overall Study|Lost to Follow-up|2
7785923|NCT00577005|27063436|P1|Overall Study|Lost to Follow-up|3
7785924|NCT00576927|27063450|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
7785925|NCT00576927|27063450|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
7785926|NCT00576927|27063450|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
7785927|NCT00576927|27063450|P1|Sleep Hygiene Behavioral Intervention|Death|1
7785928|NCT00576927|27063450|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
7785929|NCT00576927|27063450|P1|Baseline|Withdrawal by Subject|3
7785930|NCT00576927|27063450|P1|Baseline|Medication Change by PCP of subject|1
7785931|NCT00576927|27063450|P1|Baseline|Physician Decision|9
7785932|NCT00576927|27063450|P1|Clinical Assessment|Physician Decision|1
7785933|NCT00576927|27063450|P1|Clinical Assessment|Withdrawal by Subject|10
7785934|NCT00576927|27063450|P1|Clinical Assessment|Death|1
7785935|NCT00576927|27063450|P1|Clinical Assessment|Lack of Efficacy|24
7785936|NCT00576901|27063462|P1|Overall Study|Protocol Violation|1
7785937|NCT00576901|27063462|P1|Overall Study|Disease course|1
7785938|NCT00576901|27063462|P1|Overall Study|Withdrawal by Subject|1
7785939|NCT00576836|27063470|P2|Overall Study|Physician Decision|1
7785940|NCT00576836|27063471|P1|Overall Study|Physician Decision|0
7785941|NCT00576836|27063470|P2|Overall Study|Death|1
7785942|NCT00576836|27063471|P1|Overall Study|Death|0
7785943|NCT00576823|27063486|P3|40-week Safety Extension Phase|Lack of Efficacy|0
7785944|NCT00576823|27063487|P2|40-week Safety Extension Phase|Lack of Efficacy|0
7785945|NCT00576823|27063488|P1|40-week Safety Extension Phase|Lack of Efficacy|1
7785946|NCT00576823|27063486|P3|12-week Efficacy Phase|Parent's schedule issue|0
7785947|NCT00576823|27063487|P2|12-week Efficacy Phase|Parent's schedule issue|0
7785948|NCT00576823|27063488|P1|12-week Efficacy Phase|Parent's schedule issue|1
7785949|NCT00576758|27063504|P2|Follow-up Period|Withdrew consent|1
7785950|NCT00576758|27063505|P1|Follow-up Period|Withdrew consent|2
7785951|NCT00576758|27063504|P2|Follow-up Period|Insufficient therapeutic response|5
7785952|NCT00576758|27063505|P1|Follow-up Period|Insufficient therapeutic response|16
7785953|NCT00576758|27063504|P2|Follow-up Period|Death|3
7785954|NCT00576758|27063505|P1|Follow-up Period|Death|3
7785955|NCT00576758|27063504|P2|Follow-up Period|Administrative/Other|8
7785956|NCT00576758|27063505|P1|Follow-up Period|Administrative/Other|6
7785957|NCT00576758|27063504|P2|Extension Treatment Period|Administrative/Other|1
7785958|NCT00576758|27063505|P1|Extension Treatment Period|Administrative/Other|3
7785959|NCT00576758|27063504|P2|Extension Treatment Period|Insufficient therapeutic response|33
7785960|NCT00576758|27063505|P1|Extension Treatment Period|Insufficient therapeutic response|30
7785961|NCT00576758|27063504|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
7785962|NCT00576758|27063505|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
7785963|NCT00576758|27063504|P2|Extension Treatment Period|Death|1
7785964|NCT00576758|27063505|P1|Extension Treatment Period|Death|1
7785965|NCT00576758|27063504|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
7785966|NCT00576758|27063505|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
7785967|NCT00576758|27063504|P2|Induction Treatment Period|Withdrew consent|0
7785968|NCT00576758|27063505|P1|Induction Treatment Period|Withdrew consent|1
7785969|NCT00576758|27063504|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
7785970|NCT00576758|27063505|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
7785971|NCT00576758|27063504|P2|Induction Treatment Period|Death|0
7785972|NCT00576758|27063505|P1|Induction Treatment Period|Death|1
7785973|NCT00576758|27063504|P2|Induction Treatment Period|Violation of selection criteria at entry|1
7785974|NCT00576758|27063505|P1|Induction Treatment Period|Violation of selection criteria at entry|1
7785975|NCT00576758|27063504|P2|Induction Treatment Period|Insufficient therapeutic response|0
7785976|NCT00576758|27063505|P1|Induction Treatment Period|Insufficient therapeutic response|2
7785977|NCT00576758|27063504|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
7785978|NCT00576758|27063505|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
7785979|NCT00576732|27063551|P6|OPEN LABEL|Protocol Violation|0
7785980|NCT00576732|27063552|P5|OPEN LABEL|Protocol Violation|1
7785981|NCT00576732|27063553|P4|OPEN LABEL|Protocol Violation|2
7785982|NCT00576732|27063554|P3|OPEN LABEL|Protocol Violation|0
7785983|NCT00576732|27063555|P2|OPEN LABEL|Protocol Violation|0
7785984|NCT00576732|27063556|P1|OPEN LABEL|Protocol Violation|0
7785985|NCT00576732|27063551|P6|OPEN LABEL|Lack of Efficacy|3
7785986|NCT00576732|27063552|P5|OPEN LABEL|Lack of Efficacy|2
7785987|NCT00576732|27063553|P4|OPEN LABEL|Lack of Efficacy|2
7785988|NCT00576732|27063554|P3|OPEN LABEL|Lack of Efficacy|0
7785989|NCT00576732|27063555|P2|OPEN LABEL|Lack of Efficacy|0
7785990|NCT00576732|27063556|P1|OPEN LABEL|Lack of Efficacy|0
7785991|NCT00576732|27063551|P6|OPEN LABEL|OTHER|2
7785992|NCT00576732|27063552|P5|OPEN LABEL|OTHER|0
7785993|NCT00576732|27063553|P4|OPEN LABEL|OTHER|0
7785994|NCT00576732|27063554|P3|OPEN LABEL|OTHER|0
7785995|NCT00576732|27063555|P2|OPEN LABEL|OTHER|0
7785996|NCT00576732|27063556|P1|OPEN LABEL|OTHER|0
7785997|NCT00576732|27063551|P6|OPEN LABEL|Withdrawal by Subject|1
7785998|NCT00576732|27063552|P5|OPEN LABEL|Withdrawal by Subject|0
7785999|NCT00576732|27063553|P4|OPEN LABEL|Withdrawal by Subject|1
7786000|NCT00576732|27063554|P3|OPEN LABEL|Withdrawal by Subject|0
7786001|NCT00576732|27063555|P2|OPEN LABEL|Withdrawal by Subject|0
7786002|NCT00576732|27063556|P1|OPEN LABEL|Withdrawal by Subject|0
7786003|NCT00576732|27063551|P6|OPEN LABEL|Lost to Follow-up|1
7786004|NCT00576732|27063552|P5|OPEN LABEL|Lost to Follow-up|1
7786005|NCT00576732|27063553|P4|OPEN LABEL|Lost to Follow-up|2
7786006|NCT00576732|27063554|P3|OPEN LABEL|Lost to Follow-up|0
7786007|NCT00576732|27063555|P2|OPEN LABEL|Lost to Follow-up|0
7786008|NCT00576732|27063556|P1|OPEN LABEL|Lost to Follow-up|0
7786009|NCT00576732|27063551|P6|OPEN LABEL|Adverse Event|1
7786010|NCT00576732|27063552|P5|OPEN LABEL|Adverse Event|0
7786011|NCT00576732|27063553|P4|OPEN LABEL|Adverse Event|4
7786012|NCT00576732|27063554|P3|OPEN LABEL|Adverse Event|0
7786013|NCT00576732|27063555|P2|OPEN LABEL|Adverse Event|0
7786014|NCT00576732|27063556|P1|OPEN LABEL|Adverse Event|0
7786015|NCT00576732|27063551|P6|DOUBLE BLIND|Protocol Violation|0
7786016|NCT00576732|27063552|P5|DOUBLE BLIND|Protocol Violation|0
7786017|NCT00576732|27063553|P4|DOUBLE BLIND|Protocol Violation|0
7786018|NCT00576732|27063554|P3|DOUBLE BLIND|Protocol Violation|0
7786019|NCT00576732|27063555|P2|DOUBLE BLIND|Protocol Violation|0
7786020|NCT00576732|27063556|P1|DOUBLE BLIND|Protocol Violation|1
7786021|NCT00576732|27063551|P6|DOUBLE BLIND|Lack of Efficacy|0
7786022|NCT00576732|27063552|P5|DOUBLE BLIND|Lack of Efficacy|0
7786023|NCT00576732|27063553|P4|DOUBLE BLIND|Lack of Efficacy|0
7786024|NCT00576732|27063554|P3|DOUBLE BLIND|Lack of Efficacy|0
7786025|NCT00576732|27063555|P2|DOUBLE BLIND|Lack of Efficacy|1
7786026|NCT00576732|27063556|P1|DOUBLE BLIND|Lack of Efficacy|6
7786027|NCT00576732|27063551|P6|DOUBLE BLIND|OTHER|0
7786028|NCT00576732|27063552|P5|DOUBLE BLIND|OTHER|0
7786029|NCT00576732|27063553|P4|DOUBLE BLIND|OTHER|0
7786030|NCT00576732|27063554|P3|DOUBLE BLIND|OTHER|1
7786031|NCT00576732|27063555|P2|DOUBLE BLIND|OTHER|2
7786032|NCT00576732|27063556|P1|DOUBLE BLIND|OTHER|0
7786033|NCT00576732|27063551|P6|DOUBLE BLIND|Withdrawal by Subject|0
7786034|NCT00576732|27063552|P5|DOUBLE BLIND|Withdrawal by Subject|0
7786035|NCT00576732|27063553|P4|DOUBLE BLIND|Withdrawal by Subject|0
7786036|NCT00576732|27063554|P3|DOUBLE BLIND|Withdrawal by Subject|3
7786037|NCT00576732|27063555|P2|DOUBLE BLIND|Withdrawal by Subject|1
7786038|NCT00576732|27063556|P1|DOUBLE BLIND|Withdrawal by Subject|1
7786039|NCT00576732|27063551|P6|DOUBLE BLIND|Lost to Follow-up|0
7786040|NCT00576732|27063552|P5|DOUBLE BLIND|Lost to Follow-up|0
7786041|NCT00576732|27063553|P4|DOUBLE BLIND|Lost to Follow-up|0
7786042|NCT00576732|27063554|P3|DOUBLE BLIND|Lost to Follow-up|1
7786043|NCT00576732|27063555|P2|DOUBLE BLIND|Lost to Follow-up|1
7786044|NCT00576732|27063556|P1|DOUBLE BLIND|Lost to Follow-up|0
7786045|NCT00576732|27063551|P6|DOUBLE BLIND|Adverse Event|0
7786046|NCT00576732|27063552|P5|DOUBLE BLIND|Adverse Event|0
7786047|NCT00576732|27063553|P4|DOUBLE BLIND|Adverse Event|0
7786048|NCT00576732|27063554|P3|DOUBLE BLIND|Adverse Event|1
7786049|NCT00576732|27063555|P2|DOUBLE BLIND|Adverse Event|0
7786050|NCT00576732|27063556|P1|DOUBLE BLIND|Adverse Event|0
7786051|NCT00576693|27063588|P2|Overall Study|Withdrawal by Subject|13
7786052|NCT00576693|27063589|P1|Overall Study|Withdrawal by Subject|3
7786053|NCT00576693|27063588|P2|Overall Study|Lost to Follow-up|11
7786054|NCT00576693|27063589|P1|Overall Study|Lost to Follow-up|7
7786055|NCT00576628|27063601|P1|Overall Study|Dialysis|15
7786056|NCT00576628|27063601|P1|Overall Study|Transplantation|1
7786057|NCT00576628|27063601|P1|Overall Study|The patient move into other town|1
7786058|NCT00576628|27063601|P1|Overall Study|Progression of Renal Failure|1
7786059|NCT00576628|27063601|P1|Overall Study|Progression of Kidney Disease|1
7786060|NCT00576628|27063601|P1|Overall Study|RBC transfusion|1
7786061|NCT00576628|27063601|P1|Overall Study|Pregnancy|1
7786062|NCT00576628|27063601|P1|Overall Study|Refused Treatment|8
7786063|NCT00576628|27063601|P1|Overall Study|Failure to return|1
7786064|NCT00576628|27063601|P1|Overall Study|Death|2
7786065|NCT00576628|27063601|P1|Overall Study|Adverse Event|11
7786066|NCT00576576|27063621|P1|Overall Study|Protocol Violation|1
7786067|NCT00576576|27063621|P1|Overall Study|Lost to Follow-up|6
7786068|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
7786069|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
7786070|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
7786071|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
7786072|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
7786073|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
7786074|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
7786075|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
7786076|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
7786077|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
7786078|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
7786079|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
7786080|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
7786081|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
7786082|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
7786083|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Medical reasons|6
7786084|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Medical reasons|0
7786085|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Medical reasons|0
7786086|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Medical reasons|0
7786087|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Medical reasons|0
7786088|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Medical reasons|0
7786089|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Medical reasons|0
7786090|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Medical reasons|0
7786091|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Medical reasons|0
7786092|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Medical reasons|0
7786093|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Medical reasons|0
7786094|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Medical reasons|0
7786095|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Medical reasons|0
7786096|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Medical reasons|0
7786097|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Medical reasons|0
7786098|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
7786099|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786100|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786101|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786102|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786103|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786104|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786105|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786106|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786107|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786108|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786109|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786110|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786111|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786112|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
7786113|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Side effects|8
7786114|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Side effects|0
7786115|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Side effects|0
7786116|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Side effects|0
7786117|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Side effects|0
7786118|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Side effects|0
7786119|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Side effects|0
7786120|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Side effects|0
7786121|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Side effects|0
7786122|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Side effects|0
7786123|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Side effects|0
7786124|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Side effects|0
7786125|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Side effects|0
7786126|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Side effects|0
7786127|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Side effects|0
7786128|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Insufficient data|0
7786129|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Insufficient data|4
7786130|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Insufficient data|0
7786131|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Insufficient data|0
7786132|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Insufficient data|0
7786133|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Insufficient data|0
7786134|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Insufficient data|0
7786135|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Insufficient data|0
7786136|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Insufficient data|0
7786137|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Insufficient data|0
7786138|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Insufficient data|0
7786139|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Insufficient data|0
7786140|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Insufficient data|0
7786141|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Insufficient data|0
7786142|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Insufficient data|0
7786143|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Declined to participate|0
7786144|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Declined to participate|7
7786145|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Declined to participate|0
7786146|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Declined to participate|0
7786147|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Declined to participate|0
7786148|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Declined to participate|0
7786149|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Declined to participate|0
7786150|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Declined to participate|0
7786151|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Declined to participate|0
7786152|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Declined to participate|0
7786153|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Declined to participate|0
7786154|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Declined to participate|0
7786155|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Declined to participate|0
7786156|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Declined to participate|0
7786157|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Declined to participate|0
7786158|NCT00576472|27063655|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
7786159|NCT00576472|27063656|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
7786160|NCT00576472|27063657|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
7786161|NCT00576472|27063658|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
7786162|NCT00576472|27063659|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
7786163|NCT00576472|27063660|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
7786164|NCT00576472|27063661|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
7786165|NCT00576472|27063662|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
7786166|NCT00576472|27063663|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
7786167|NCT00576472|27063664|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
7786168|NCT00576472|27063665|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
7786169|NCT00576472|27063666|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
7786170|NCT00576472|27063667|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
7786171|NCT00576472|27063668|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
7786172|NCT00576472|27063669|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
7786173|NCT00576472|27063655|P15|MPH Cross Over Phase|Did not complete cross over phase|0
7786174|NCT00576472|27063656|P14|MPH Cross Over Phase|Did not complete cross over phase|0
7786175|NCT00576472|27063657|P13|MPH Cross Over Phase|Did not complete cross over phase|0
7786176|NCT00576472|27063658|P12|MPH Cross Over Phase|Did not complete cross over phase|1
7786177|NCT00576472|27063659|P11|MPH Cross Over Phase|Did not complete cross over phase|1
7786178|NCT00576472|27063660|P10|MPH Cross Over Phase|Did not complete cross over phase|0
7786179|NCT00576472|27063661|P9|MPH Cross Over Phase|Did not complete cross over phase|2
7786180|NCT00576472|27063662|P8|MPH Cross Over Phase|Did not complete cross over phase|0
7786181|NCT00576472|27063663|P7|MPH Cross Over Phase|Did not complete cross over phase|0
7786182|NCT00576472|27063664|P6|MPH Cross Over Phase|Did not complete cross over phase|0
7786183|NCT00576472|27063665|P5|MPH Cross Over Phase|Did not complete cross over phase|0
7786184|NCT00576472|27063666|P4|MPH Cross Over Phase|Did not complete cross over phase|0
7786185|NCT00576472|27063667|P3|MPH Cross Over Phase|Did not complete cross over phase|0
7786186|NCT00576472|27063668|P2|MPH Cross Over Phase|Did not complete cross over phase|0
7786187|NCT00576472|27063669|P1|MPH Cross Over Phase|Did not complete cross over phase|0
7786188|NCT00576472|27063655|P15|MPH Cross Over Phase|Physician Decision|0
7786189|NCT00576472|27063656|P14|MPH Cross Over Phase|Physician Decision|0
7786190|NCT00576472|27063657|P13|MPH Cross Over Phase|Physician Decision|0
7786191|NCT00576472|27063658|P12|MPH Cross Over Phase|Physician Decision|0
7786192|NCT00576472|27063659|P11|MPH Cross Over Phase|Physician Decision|0
7786193|NCT00576472|27063660|P10|MPH Cross Over Phase|Physician Decision|0
7786194|NCT00576472|27063661|P9|MPH Cross Over Phase|Physician Decision|0
7786195|NCT00576472|27063662|P8|MPH Cross Over Phase|Physician Decision|0
7786196|NCT00576472|27063663|P7|MPH Cross Over Phase|Physician Decision|4
7786197|NCT00576472|27063664|P6|MPH Cross Over Phase|Physician Decision|0
7786198|NCT00576472|27063665|P5|MPH Cross Over Phase|Physician Decision|0
7786199|NCT00576472|27063666|P4|MPH Cross Over Phase|Physician Decision|0
7786200|NCT00576472|27063667|P3|MPH Cross Over Phase|Physician Decision|0
7786201|NCT00576472|27063668|P2|MPH Cross Over Phase|Physician Decision|0
7786202|NCT00576472|27063669|P1|MPH Cross Over Phase|Physician Decision|0
7786203|NCT00576472|27063655|P15|MPH Cross Over Phase|Ineligible due to disease|0
7786204|NCT00576472|27063656|P14|MPH Cross Over Phase|Ineligible due to disease|0
7786205|NCT00576472|27063657|P13|MPH Cross Over Phase|Ineligible due to disease|0
7786206|NCT00576472|27063658|P12|MPH Cross Over Phase|Ineligible due to disease|0
7786207|NCT00576472|27063659|P11|MPH Cross Over Phase|Ineligible due to disease|0
7786208|NCT00576472|27063660|P10|MPH Cross Over Phase|Ineligible due to disease|0
7786209|NCT00576472|27063661|P9|MPH Cross Over Phase|Ineligible due to disease|0
7786210|NCT00576472|27063662|P8|MPH Cross Over Phase|Ineligible due to disease|0
7786211|NCT00576472|27063663|P7|MPH Cross Over Phase|Ineligible due to disease|2
7786212|NCT00576472|27063664|P6|MPH Cross Over Phase|Ineligible due to disease|0
7786213|NCT00576472|27063665|P5|MPH Cross Over Phase|Ineligible due to disease|0
7786214|NCT00576472|27063666|P4|MPH Cross Over Phase|Ineligible due to disease|0
7786215|NCT00576472|27063667|P3|MPH Cross Over Phase|Ineligible due to disease|0
7786216|NCT00576472|27063668|P2|MPH Cross Over Phase|Ineligible due to disease|0
7786217|NCT00576472|27063669|P1|MPH Cross Over Phase|Ineligible due to disease|0
7786218|NCT00576472|27063655|P15|MPH Cross Over Phase|Withdrawal by Subject|0
7786219|NCT00576472|27063656|P14|MPH Cross Over Phase|Withdrawal by Subject|0
7786220|NCT00576472|27063657|P13|MPH Cross Over Phase|Withdrawal by Subject|0
7786221|NCT00576472|27063658|P12|MPH Cross Over Phase|Withdrawal by Subject|0
7786222|NCT00576472|27063659|P11|MPH Cross Over Phase|Withdrawal by Subject|0
7786223|NCT00576472|27063660|P10|MPH Cross Over Phase|Withdrawal by Subject|0
7786224|NCT00576472|27063661|P9|MPH Cross Over Phase|Withdrawal by Subject|0
7786225|NCT00576472|27063662|P8|MPH Cross Over Phase|Withdrawal by Subject|0
7786226|NCT00576472|27063663|P7|MPH Cross Over Phase|Withdrawal by Subject|6
7786227|NCT00576472|27063664|P6|MPH Cross Over Phase|Withdrawal by Subject|0
7786228|NCT00576472|27063665|P5|MPH Cross Over Phase|Withdrawal by Subject|0
7786229|NCT00576472|27063666|P4|MPH Cross Over Phase|Withdrawal by Subject|0
7786230|NCT00576472|27063667|P3|MPH Cross Over Phase|Withdrawal by Subject|0
7786231|NCT00576472|27063668|P2|MPH Cross Over Phase|Withdrawal by Subject|0
7786232|NCT00576472|27063669|P1|MPH Cross Over Phase|Withdrawal by Subject|0
7786233|NCT00576472|27063655|P15|MPH In-Lab Phase|Psychiatric exclusion|0
7786234|NCT00576472|27063656|P14|MPH In-Lab Phase|Psychiatric exclusion|0
7786235|NCT00576472|27063657|P13|MPH In-Lab Phase|Psychiatric exclusion|0
7786236|NCT00576472|27063658|P12|MPH In-Lab Phase|Psychiatric exclusion|0
7786237|NCT00576472|27063659|P11|MPH In-Lab Phase|Psychiatric exclusion|0
7786238|NCT00576472|27063660|P10|MPH In-Lab Phase|Psychiatric exclusion|0
7786239|NCT00576472|27063661|P9|MPH In-Lab Phase|Psychiatric exclusion|0
7786240|NCT00576472|27063662|P8|MPH In-Lab Phase|Psychiatric exclusion|0
7786241|NCT00576472|27063663|P7|MPH In-Lab Phase|Psychiatric exclusion|0
7786242|NCT00576472|27063664|P6|MPH In-Lab Phase|Psychiatric exclusion|0
7786243|NCT00576472|27063665|P5|MPH In-Lab Phase|Psychiatric exclusion|0
7786244|NCT00576472|27063666|P4|MPH In-Lab Phase|Psychiatric exclusion|10
7786245|NCT00576472|27063667|P3|MPH In-Lab Phase|Psychiatric exclusion|0
7786246|NCT00576472|27063668|P2|MPH In-Lab Phase|Psychiatric exclusion|0
7786247|NCT00576472|27063669|P1|MPH In-Lab Phase|Psychiatric exclusion|0
7786248|NCT00576472|27063655|P15|MPH In-Lab Phase|No attention/academic problems|0
7786249|NCT00576472|27063656|P14|MPH In-Lab Phase|No attention/academic problems|0
7786250|NCT00576472|27063657|P13|MPH In-Lab Phase|No attention/academic problems|0
7786251|NCT00576472|27063658|P12|MPH In-Lab Phase|No attention/academic problems|0
7786252|NCT00576472|27063659|P11|MPH In-Lab Phase|No attention/academic problems|0
7786253|NCT00576472|27063660|P10|MPH In-Lab Phase|No attention/academic problems|0
7786254|NCT00576472|27063661|P9|MPH In-Lab Phase|No attention/academic problems|0
7786255|NCT00576472|27063662|P8|MPH In-Lab Phase|No attention/academic problems|0
7786256|NCT00576472|27063663|P7|MPH In-Lab Phase|No attention/academic problems|0
7786257|NCT00576472|27063664|P6|MPH In-Lab Phase|No attention/academic problems|0
7786258|NCT00576472|27063665|P5|MPH In-Lab Phase|No attention/academic problems|0
7786259|NCT00576472|27063666|P4|MPH In-Lab Phase|No attention/academic problems|245
7786260|NCT00576472|27063667|P3|MPH In-Lab Phase|No attention/academic problems|0
7786261|NCT00576472|27063668|P2|MPH In-Lab Phase|No attention/academic problems|0
7786262|NCT00576472|27063669|P1|MPH In-Lab Phase|No attention/academic problems|0
7786263|NCT00576472|27063655|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786264|NCT00576472|27063656|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786265|NCT00576472|27063657|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786266|NCT00576472|27063658|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786267|NCT00576472|27063659|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786268|NCT00576472|27063660|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786269|NCT00576472|27063661|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786270|NCT00576472|27063662|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786271|NCT00576472|27063663|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786272|NCT00576472|27063664|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786273|NCT00576472|27063665|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786274|NCT00576472|27063666|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
7786275|NCT00576472|27063667|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786276|NCT00576472|27063668|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786277|NCT00576472|27063669|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7786278|NCT00576472|27063655|P15|MPH In-Lab Phase|Lost to Follow-up|0
7786279|NCT00576472|27063656|P14|MPH In-Lab Phase|Lost to Follow-up|0
7786280|NCT00576472|27063657|P13|MPH In-Lab Phase|Lost to Follow-up|0
7786281|NCT00576472|27063658|P12|MPH In-Lab Phase|Lost to Follow-up|0
7786282|NCT00576472|27063659|P11|MPH In-Lab Phase|Lost to Follow-up|0
7786283|NCT00576472|27063660|P10|MPH In-Lab Phase|Lost to Follow-up|0
7786284|NCT00576472|27063661|P9|MPH In-Lab Phase|Lost to Follow-up|0
7786285|NCT00576472|27063662|P8|MPH In-Lab Phase|Lost to Follow-up|0
7786286|NCT00576472|27063663|P7|MPH In-Lab Phase|Lost to Follow-up|0
7786287|NCT00576472|27063664|P6|MPH In-Lab Phase|Lost to Follow-up|0
7786288|NCT00576472|27063665|P5|MPH In-Lab Phase|Lost to Follow-up|0
7786289|NCT00576472|27063666|P4|MPH In-Lab Phase|Lost to Follow-up|1
7786290|NCT00576472|27063667|P3|MPH In-Lab Phase|Lost to Follow-up|0
7786291|NCT00576472|27063668|P2|MPH In-Lab Phase|Lost to Follow-up|0
7786292|NCT00576472|27063669|P1|MPH In-Lab Phase|Lost to Follow-up|0
7786293|NCT00576472|27063655|P15|MPH In-Lab Phase|Declined participation in medication pha|0
7786294|NCT00576472|27063656|P14|MPH In-Lab Phase|Declined participation in medication pha|0
7786295|NCT00576472|27063657|P13|MPH In-Lab Phase|Declined participation in medication pha|0
7786296|NCT00576472|27063658|P12|MPH In-Lab Phase|Declined participation in medication pha|0
7786297|NCT00576472|27063659|P11|MPH In-Lab Phase|Declined participation in medication pha|0
7786298|NCT00576472|27063660|P10|MPH In-Lab Phase|Declined participation in medication pha|0
7786299|NCT00576472|27063661|P9|MPH In-Lab Phase|Declined participation in medication pha|0
7786300|NCT00576472|27063662|P8|MPH In-Lab Phase|Declined participation in medication pha|0
7786301|NCT00576472|27063663|P7|MPH In-Lab Phase|Declined participation in medication pha|0
7786302|NCT00576472|27063664|P6|MPH In-Lab Phase|Declined participation in medication pha|0
7786303|NCT00576472|27063665|P5|MPH In-Lab Phase|Declined participation in medication pha|0
7786304|NCT00576472|27063666|P4|MPH In-Lab Phase|Declined participation in medication pha|75
7786305|NCT00576472|27063667|P3|MPH In-Lab Phase|Declined participation in medication pha|0
7786306|NCT00576472|27063668|P2|MPH In-Lab Phase|Declined participation in medication pha|0
7786307|NCT00576472|27063669|P1|MPH In-Lab Phase|Declined participation in medication pha|0
7786308|NCT00576420|27063762|P3|Overall Study|Death|1
7786309|NCT00576420|27063763|P2|Overall Study|Death|0
7786310|NCT00576420|27063764|P1|Overall Study|Death|0
7786311|NCT00576407|27063929|P1|Overall Study|Physician Decision|1
7786312|NCT00576407|27063929|P1|Overall Study|Death|7
7786313|NCT00576381|27063941|P1|Overall Study|Adverse Event|4
7786314|NCT00576381|27063941|P1|Overall Study|Reoperation|3
7786315|NCT00576316|27063945|P1|Overall Study|Protocol Violation|9
7786316|NCT00576316|27063945|P1|Overall Study|Withdrawal by Subject|2
7786317|NCT00576316|27063945|P1|Overall Study|Adverse Event|9
7786318|NCT00576303|27063950|P1|Long Term Safety Period|Early withdrawal|16
7786319|NCT00576303|27063950|P1|Efficacy Evaluation Period|Early withdrawal|5
7786320|NCT00576303|27063950|P1|Dose Titration Period|Early withdrawal|17
7786321|NCT00576199|27063968|P1|Overall Study|Reason Unspecified|2
7786322|NCT00576199|27063968|P1|Overall Study|Refused Treatment|2
7786323|NCT00576199|27063968|P1|Overall Study|Insufficient Therapeutic Response|14
7786324|NCT00576199|27063968|P1|Overall Study|Adverse Event|12
7786325|NCT00576056|27063981|P1|Overall Study|Physician Decision|1
7786326|NCT00576056|27063981|P1|Overall Study|did not meet eligibility criteria|8
7786327|NCT00576056|27063981|P1|Overall Study|Withdrawal by Subject|2
7786328|NCT00576056|27063981|P1|Overall Study|Lack of Efficacy|1
7786329|NCT00576056|27063981|P1|Overall Study|Death|1
7786330|NCT00576056|27063981|P1|Overall Study|Adverse Event|1
7786331|NCT00575666|27063997|P2|Overall Study|Physician Decision|1
7786332|NCT00575666|27063998|P1|Overall Study|Physician Decision|1
7786333|NCT00575666|27063997|P2|Overall Study|Withdrawal by Subject|2
7786334|NCT00575666|27063998|P1|Overall Study|Withdrawal by Subject|3
7786335|NCT00575588|27064038|P2|Overall Study|Impossible to determine HbA1c|1
7786336|NCT00575588|27064039|P1|Overall Study|Impossible to determine HbA1c|0
7786337|NCT00575588|27064038|P2|Overall Study|Patient moved|3
7786338|NCT00575588|27064039|P1|Overall Study|Patient moved|1
7786339|NCT00575588|27064038|P2|Overall Study|Elevated triglyceride|0
7786340|NCT00575588|27064039|P1|Overall Study|Elevated triglyceride|1
7786341|NCT00575588|27064038|P2|Overall Study|Safety reasons|1
7786342|NCT00575588|27064039|P1|Overall Study|Safety reasons|2
7786343|NCT00575588|27064038|P2|Overall Study|Severe non-compliance to protocol|7
7786344|NCT00575588|27064039|P1|Overall Study|Severe non-compliance to protocol|5
7786345|NCT00575588|27064038|P2|Overall Study|Study specific discontinuation criteria|218
7786346|NCT00575588|27064039|P1|Overall Study|Study specific discontinuation criteria|203
7786347|NCT00575588|27064038|P2|Overall Study|Incorrect enrollment|4
7786348|NCT00575588|27064039|P1|Overall Study|Incorrect enrollment|8
7786349|NCT00575588|27064038|P2|Overall Study|Death|2
7786350|NCT00575588|27064039|P1|Overall Study|Death|4
7786351|NCT00575588|27064038|P2|Overall Study|Lost to Follow-up|3
7786352|NCT00575588|27064039|P1|Overall Study|Lost to Follow-up|1
7786353|NCT00575588|27064038|P2|Overall Study|Withdrawal by Subject|31
7786354|NCT00575588|27064039|P1|Overall Study|Withdrawal by Subject|27
7786355|NCT00575588|27064038|P2|Overall Study|Adverse Event|13
7786356|NCT00575588|27064039|P1|Overall Study|Adverse Event|11
7786357|NCT00575510|27064062|P3|Overall Study|Pregnancy|1
7786358|NCT00575510|27064063|P2|Overall Study|Pregnancy|0
7786359|NCT00575510|27064064|P1|Overall Study|Pregnancy|0
7786360|NCT00575510|27064062|P3|Overall Study|Clinic Called Patient|7
7786361|NCT00575510|27064063|P2|Overall Study|Clinic Called Patient|7
7786362|NCT00575510|27064064|P1|Overall Study|Clinic Called Patient|7
7786363|NCT00575510|27064062|P3|Overall Study|Withdrawal by Subject|0
7786364|NCT00575510|27064063|P2|Overall Study|Withdrawal by Subject|0
7786365|NCT00575510|27064064|P1|Overall Study|Withdrawal by Subject|1
7786366|NCT00575510|27064062|P3|Overall Study|Lost to Follow-up|9
7786367|NCT00575510|27064063|P2|Overall Study|Lost to Follow-up|6
7786368|NCT00575510|27064064|P1|Overall Study|Lost to Follow-up|4
7786369|NCT00575380|27064077|P2|Overall Study|Various|2
7786370|NCT00575380|27064078|P1|Overall Study|Various|0
7786371|NCT00575380|27064077|P2|Overall Study|Adverse Event|1
7786372|NCT00575380|27064078|P1|Overall Study|Adverse Event|0
7786373|NCT00575380|27064077|P2|Overall Study|Withdrawal by Subject|0
7786374|NCT00575380|27064078|P1|Overall Study|Withdrawal by Subject|1
7786375|NCT00575328|27064097|P2|Overall Study|Lost to Follow-up|1
7786376|NCT00575328|27064098|P1|Overall Study|Lost to Follow-up|2
7786377|NCT00575328|27064097|P2|Overall Study|Adverse Event|1
7786378|NCT00575328|27064098|P1|Overall Study|Adverse Event|1
7786379|NCT00575094|27064231|P1|Overall Study|Withdrawal by Subject|1
7786380|NCT00575094|27064231|P1|Overall Study|Adverse Event|2
7786381|NCT00575042|27064235|P1|Overall Study|Lost to Follow-up|1
7786382|NCT00575042|27064235|P1|Overall Study|Adverse Event|2
7786383|NCT00574951|27064286|P1|Overall Study|Ineligible - improper prior treatment|1
7786384|NCT00574912|27064294|P1|Overall Study|Physician Decision|2
7786385|NCT00574912|27064294|P1|Overall Study|scheduling conflicts|3
7786386|NCT00574912|27064294|P1|Overall Study|Could not place IV lines.|3
7786387|NCT00574873|27064308|P2|Overall Study|Extension Study|0
7786388|NCT00574873|27064309|P1|Overall Study|Extension Study|126
7786389|NCT00574873|27064308|P2|Overall Study|Blank, site closed per local regulations|2
7786390|NCT00574873|27064309|P1|Overall Study|Blank, site closed per local regulations|2
7786391|NCT00574873|27064308|P2|Overall Study|Discontinuation of study by sponsor|199
7786392|NCT00574873|27064309|P1|Overall Study|Discontinuation of study by sponsor|5
7786393|NCT00574873|27064308|P2|Overall Study|Other|4
7786394|NCT00574873|27064309|P1|Overall Study|Other|40
7786395|NCT00574873|27064308|P2|Overall Study|Lost to Follow-up|5
7786396|NCT00574873|27064309|P1|Overall Study|Lost to Follow-up|14
7786397|NCT00574873|27064308|P2|Overall Study|Death|14
7786398|NCT00574873|27064309|P1|Overall Study|Death|15
7786399|NCT00574873|27064308|P2|Overall Study|Investigator request|8
7786400|NCT00574873|27064309|P1|Overall Study|Investigator request|18
7786401|NCT00574873|27064308|P2|Overall Study|Withdrawal by Subject|19
7786402|NCT00574873|27064309|P1|Overall Study|Withdrawal by Subject|18
7786403|NCT00574847|27064327|P2|Overall Study|Did not receive medication (declined)|5
7786404|NCT00574847|27064328|P1|Overall Study|Did not receive medication (declined)|2
7786405|NCT00574847|27064327|P2|Overall Study|Physician Decision|0
7786406|NCT00574847|27064328|P1|Overall Study|Physician Decision|1
7786407|NCT00574847|27064327|P2|Overall Study|Withdrawal by Subject|2
7786408|NCT00574847|27064328|P1|Overall Study|Withdrawal by Subject|2
7786409|NCT00574847|27064327|P2|Overall Study|Death|0
7786410|NCT00574847|27064328|P1|Overall Study|Death|1
7786411|NCT00574847|27064327|P2|Overall Study|Adverse Event|0
7786412|NCT00574847|27064328|P1|Overall Study|Adverse Event|2
7786413|NCT00574795|27064373|P1|Toddler Dose|Withdrawal by Subject|1
7786414|NCT00574795|27064373|P1|After Infant Series|Adverse Event|2
7786415|NCT00574795|27064373|P1|After Infant Series|Withdrawal by Subject|1
7786416|NCT00574795|27064373|P1|Infant Series|Adverse Event|1
7786417|NCT00574795|27064373|P1|Infant Series|Protocol Violation|2
7786418|NCT00574795|27064373|P1|Infant Series|Withdrawal by Subject|2
7786419|NCT00574405|27064474|P2|Overall Study|Withdrawal by Subject|2
7786420|NCT00574405|27064475|P1|Overall Study|Withdrawal by Subject|3
7786421|NCT00574288|27064495|P7|Overall Study|Other|0
7786422|NCT00574288|27064496|P6|Overall Study|Other|0
7786423|NCT00574288|27064497|P5|Overall Study|Other|0
7786424|NCT00574288|27064498|P4|Overall Study|Other|0
7786425|NCT00574288|27064499|P3|Overall Study|Other|0
7786426|NCT00574288|27064500|P2|Overall Study|Other|1
7786427|NCT00574288|27064501|P1|Overall Study|Other|1
7786428|NCT00574288|27064495|P7|Overall Study|Progressive Disease|0
7786429|NCT00574288|27064496|P6|Overall Study|Progressive Disease|0
7786430|NCT00574288|27064497|P5|Overall Study|Progressive Disease|1
7786431|NCT00574288|27064498|P4|Overall Study|Progressive Disease|2
7786432|NCT00574288|27064499|P3|Overall Study|Progressive Disease|3
7786433|NCT00574288|27064500|P2|Overall Study|Progressive Disease|2
7786434|NCT00574288|27064501|P1|Overall Study|Progressive Disease|17
7786435|NCT00574288|27064495|P7|Overall Study|Study Terminated By Sponsor|5
7786436|NCT00574288|27064496|P6|Overall Study|Study Terminated By Sponsor|0
7786437|NCT00574288|27064497|P5|Overall Study|Study Terminated By Sponsor|0
7786438|NCT00574288|27064498|P4|Overall Study|Study Terminated By Sponsor|0
7786439|NCT00574288|27064499|P3|Overall Study|Study Terminated By Sponsor|0
7786440|NCT00574288|27064500|P2|Overall Study|Study Terminated By Sponsor|0
7786441|NCT00574288|27064501|P1|Overall Study|Study Terminated By Sponsor|0
7786442|NCT00574288|27064495|P7|Overall Study|Lost to Follow-up|2
7786443|NCT00574288|27064496|P6|Overall Study|Lost to Follow-up|1
7786444|NCT00574288|27064497|P5|Overall Study|Lost to Follow-up|0
7786445|NCT00574288|27064498|P4|Overall Study|Lost to Follow-up|0
7786446|NCT00574288|27064499|P3|Overall Study|Lost to Follow-up|0
7786447|NCT00574288|27064500|P2|Overall Study|Lost to Follow-up|0
7786448|NCT00574288|27064501|P1|Overall Study|Lost to Follow-up|0
7786449|NCT00574288|27064495|P7|Overall Study|Death|21
7786450|NCT00574288|27064496|P6|Overall Study|Death|25
7786451|NCT00574288|27064497|P5|Overall Study|Death|0
7786452|NCT00574288|27064498|P4|Overall Study|Death|0
7786453|NCT00574288|27064499|P3|Overall Study|Death|0
7786454|NCT00574288|27064500|P2|Overall Study|Death|0
7786455|NCT00574288|27064501|P1|Overall Study|Death|0
7786456|NCT00574288|27064495|P7|Overall Study|Adverse Event|0
7786457|NCT00574288|27064496|P6|Overall Study|Adverse Event|0
7786458|NCT00574288|27064497|P5|Overall Study|Adverse Event|1
7786459|NCT00574288|27064498|P4|Overall Study|Adverse Event|0
7786460|NCT00574288|27064499|P3|Overall Study|Adverse Event|0
7786461|NCT00574288|27064500|P2|Overall Study|Adverse Event|0
7786462|NCT00574288|27064501|P1|Overall Study|Adverse Event|2
7786463|NCT00574275|27064539|P2|Overall Study|Operation for curative intent|1
7786464|NCT00574275|27064540|P1|Overall Study|Operation for curative intent|0
7786465|NCT00574275|27064539|P2|Overall Study|Insurance change|1
7786466|NCT00574275|27064540|P1|Overall Study|Insurance change|0
7786467|NCT00574275|27064539|P2|Overall Study|Patient and Investigator decision|1
7786468|NCT00574275|27064540|P1|Overall Study|Patient and Investigator decision|0
7786469|NCT00574275|27064539|P2|Overall Study|Protocol Violation|1
7786470|NCT00574275|27064540|P1|Overall Study|Protocol Violation|0
7786471|NCT00574275|27064539|P2|Overall Study|Physician Decision|1
7786472|NCT00574275|27064540|P1|Overall Study|Physician Decision|1
7786473|NCT00574275|27064539|P2|Overall Study|Error calculating tumor measurement|0
7786474|NCT00574275|27064540|P1|Overall Study|Error calculating tumor measurement|1
7786475|NCT00574275|27064539|P2|Overall Study|Withdrawal by Subject|17
7786476|NCT00574275|27064540|P1|Overall Study|Withdrawal by Subject|15
7786477|NCT00574275|27064539|P2|Overall Study|Study stopped based on DMC decision|23
7786478|NCT00574275|27064540|P1|Overall Study|Study stopped based on DMC decision|62
7786479|NCT00574275|27064539|P2|Overall Study|Lost to Follow-up|1
7786480|NCT00574275|27064540|P1|Overall Study|Lost to Follow-up|2
7786481|NCT00574275|27064539|P2|Overall Study|Disease progression|146
7786482|NCT00574275|27064540|P1|Overall Study|Disease progression|160
7786483|NCT00574275|27064539|P2|Overall Study|Adverse Event|76
7786484|NCT00574275|27064540|P1|Overall Study|Adverse Event|32
7786485|NCT00574275|27064539|P2|Overall Study|Randomized but not treated|3
7786486|NCT00574275|27064540|P1|Overall Study|Randomized but not treated|2
7786487|NCT00574249|27064558|P2|Overall Study|PPD test taken twice|1
7786488|NCT00574249|27064559|P1|Overall Study|PPD test taken twice|0
7786489|NCT00574249|27064558|P2|Overall Study|Excluded by company|1
7786490|NCT00574249|27064559|P1|Overall Study|Excluded by company|0
7786491|NCT00574249|27064558|P2|Overall Study|Pregnancy|0
7786492|NCT00574249|27064559|P1|Overall Study|Pregnancy|1
7786493|NCT00574249|27064558|P2|Overall Study|Physician Decision|0
7786494|NCT00574249|27064559|P1|Overall Study|Physician Decision|1
7786495|NCT00574249|27064558|P2|Overall Study|Withdrawal by Subject|0
7786496|NCT00574249|27064559|P1|Overall Study|Withdrawal by Subject|3
7786497|NCT00574249|27064558|P2|Overall Study|History of carcinoma|0
7786498|NCT00574249|27064559|P1|Overall Study|History of carcinoma|1
7786499|NCT00574249|27064558|P2|Overall Study|Protocol Violation|2
7786500|NCT00574249|27064559|P1|Overall Study|Protocol Violation|5
7786501|NCT00574249|27064558|P2|Overall Study|Lost to Follow-up|3
7786502|NCT00574249|27064559|P1|Overall Study|Lost to Follow-up|4
7786503|NCT00574249|27064558|P2|Overall Study|Lack of Efficacy|3
7786504|NCT00574249|27064559|P1|Overall Study|Lack of Efficacy|5
7786505|NCT00574249|27064558|P2|Overall Study|Adverse Event|18
7786506|NCT00574249|27064559|P1|Overall Study|Adverse Event|6
7786507|NCT00574145|27064615|P2|Overall Study|Withdrawal by Subject|1
7786508|NCT00574145|27064616|P1|Overall Study|Withdrawal by Subject|2
7786509|NCT00574119|27064626|P1|Overall Study|Physician Decision|1
7786510|NCT00574119|27064626|P1|Overall Study|Withdrawal by Subject|1
7786511|NCT00574119|27064626|P1|Overall Study|Protocol Violation|1
7786512|NCT00574119|27064626|P1|Overall Study|Adverse Event|1
7786513|NCT00574080|27064640|P2|Overall Study|Death|10
7786514|NCT00574080|27064641|P1|Overall Study|Death|10
7786515|NCT00573937|27064710|P2|Overall Study|Study Terminated|1
7786516|NCT00573937|27064711|P1|Overall Study|Study Terminated|0
7786517|NCT00573859|27064725|P1|Smoking Versus Abstinence|Scheduling conflicts|12
7786518|NCT00573859|27064725|P1|Medication Versus Placebo|Scheduling conflicts|12
7786519|NCT00573833|27064731|P1|Overall Study|Not Treated|2
7786520|NCT00573794|27064738|P1|Overall Study|Other|46
7786521|NCT00573794|27064738|P1|Overall Study|Lack of Efficacy|94
7786522|NCT00573794|27064738|P1|Overall Study|Protocol Violation|6
7786523|NCT00573794|27064738|P1|Overall Study|Lost to Follow-up|13
7786524|NCT00573794|27064738|P1|Overall Study|Withdrew Consent|90
7786525|NCT00573794|27064738|P1|Overall Study|Adverse Event|81
7786526|NCT00573768|27064769|P3|Overall Study|Lost to Follow-up|1
7786527|NCT00573768|27064770|P2|Overall Study|Lost to Follow-up|0
7786528|NCT00573768|27064771|P1|Overall Study|Lost to Follow-up|0
7786529|NCT00573768|27064769|P3|Overall Study|Withdrawal by Subject|0
7786530|NCT00573768|27064770|P2|Overall Study|Withdrawal by Subject|1
7786531|NCT00573768|27064771|P1|Overall Study|Withdrawal by Subject|0
7786532|NCT00573768|27064769|P3|Overall Study|Protocol Violation|1
7786533|NCT00573768|27064770|P2|Overall Study|Protocol Violation|0
7786534|NCT00573768|27064771|P1|Overall Study|Protocol Violation|1
7786535|NCT00573768|27064769|P3|Overall Study|Adverse Event|2
7786536|NCT00573768|27064770|P2|Overall Study|Adverse Event|1
7786537|NCT00573768|27064771|P1|Overall Study|Adverse Event|1
7786538|NCT00573755|27064781|P2|Overall Study|Still receiving treatment|0
7786539|NCT00573755|27064782|P1|Overall Study|Still receiving treatment|1
7786540|NCT00573534|27064798|P1|Overall Study|oppositional behavior|3
7786541|NCT00573469|27064839|P3|Overall Study|Other|3
7786542|NCT00573469|27064840|P2|Overall Study|Other|1
7786543|NCT00573469|27064841|P1|Overall Study|Other|5
7786544|NCT00573469|27064839|P3|Overall Study|Withdrawal by Subject|0
7786545|NCT00573469|27064840|P2|Overall Study|Withdrawal by Subject|2
7786546|NCT00573469|27064841|P1|Overall Study|Withdrawal by Subject|0
7786547|NCT00573469|27064839|P3|Overall Study|Adverse Event|1
7786548|NCT00573469|27064840|P2|Overall Study|Adverse Event|1
7786549|NCT00573469|27064841|P1|Overall Study|Adverse Event|1
7786550|NCT00573443|27064864|P3|Open-Label Extension Phase|Other|0
7786551|NCT00573443|27064865|P2|Open-Label Extension Phase|Other|0
7786552|NCT00573443|27064866|P1|Open-Label Extension Phase|Other|2
7786553|NCT00573443|27064864|P3|Open-Label Extension Phase|Protocol Violation|0
7786554|NCT00573443|27064865|P2|Open-Label Extension Phase|Protocol Violation|0
7786555|NCT00573443|27064866|P1|Open-Label Extension Phase|Protocol Violation|2
7786556|NCT00573443|27064864|P3|Open-Label Extension Phase|Withdrawal by Subject|0
7786557|NCT00573443|27064865|P2|Open-Label Extension Phase|Withdrawal by Subject|0
7786558|NCT00573443|27064866|P1|Open-Label Extension Phase|Withdrawal by Subject|3
7786559|NCT00573443|27064864|P3|Open-Label Extension Phase|Serious Adverse Event|0
7786560|NCT00573443|27064865|P2|Open-Label Extension Phase|Serious Adverse Event|0
7786561|NCT00573443|27064866|P1|Open-Label Extension Phase|Serious Adverse Event|5
7786562|NCT00573443|27064864|P3|Open-Label Extension Phase|Adverse Event|0
7786563|NCT00573443|27064865|P2|Open-Label Extension Phase|Adverse Event|0
7786564|NCT00573443|27064866|P1|Open-Label Extension Phase|Adverse Event|3
7786565|NCT00573443|27064864|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
7786566|NCT00573443|27064865|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
7786567|NCT00573443|27064866|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
7786568|NCT00573443|27064864|P3|Open-Label Extension Phase|Lost to Follow-up|0
7786569|NCT00573443|27064865|P2|Open-Label Extension Phase|Lost to Follow-up|0
7786570|NCT00573443|27064866|P1|Open-Label Extension Phase|Lost to Follow-up|1
7786571|NCT00573443|27064864|P3|Double-Blind Phase|Other|3
7786572|NCT00573443|27064865|P2|Double-Blind Phase|Other|2
7786573|NCT00573443|27064866|P1|Double-Blind Phase|Other|0
7786574|NCT00573443|27064864|P3|Double-Blind Phase|Protocol Violation|1
7786575|NCT00573443|27064865|P2|Double-Blind Phase|Protocol Violation|2
7786576|NCT00573443|27064866|P1|Double-Blind Phase|Protocol Violation|0
7786577|NCT00573443|27064864|P3|Double-Blind Phase|Withdrawal by Subject|7
7786578|NCT00573443|27064865|P2|Double-Blind Phase|Withdrawal by Subject|2
7786579|NCT00573443|27064866|P1|Double-Blind Phase|Withdrawal by Subject|2
7786580|NCT00573443|27064864|P3|Double-Blind Phase|Medication refusal due to AE|0
7786581|NCT00573443|27064865|P2|Double-Blind Phase|Medication refusal due to AE|2
7786582|NCT00573443|27064866|P1|Double-Blind Phase|Medication refusal due to AE|2
7786583|NCT00573443|27064864|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
7786584|NCT00573443|27064865|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
7786585|NCT00573443|27064866|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
7786586|NCT00573443|27064864|P3|Double-Blind Phase|Adverse Event|0
7786587|NCT00573443|27064865|P2|Double-Blind Phase|Adverse Event|5
7786588|NCT00573443|27064866|P1|Double-Blind Phase|Adverse Event|1
7786589|NCT00573443|27064864|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
7786590|NCT00573443|27064865|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
7786591|NCT00573443|27064866|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
7786592|NCT00573443|27064864|P3|Double-Blind Phase|Lost to Follow-up|2
7786593|NCT00573443|27064865|P2|Double-Blind Phase|Lost to Follow-up|3
7786594|NCT00573443|27064866|P1|Double-Blind Phase|Lost to Follow-up|1
7786595|NCT00573430|27064896|P3|Overall Study|Eligibility criteria not fulfilled|3
7786596|NCT00573430|27064897|P2|Overall Study|Eligibility criteria not fulfilled|0
7786597|NCT00573430|27064898|P1|Overall Study|Eligibility criteria not fulfilled|0
7786598|NCT00573430|27064896|P3|Overall Study|Protocol Violation|1
7786599|NCT00573430|27064897|P2|Overall Study|Protocol Violation|1
7786600|NCT00573430|27064898|P1|Overall Study|Protocol Violation|0
7786601|NCT00573430|27064896|P3|Overall Study|Withdrawal by Subject|1
7786602|NCT00573430|27064897|P2|Overall Study|Withdrawal by Subject|0
7786603|NCT00573430|27064898|P1|Overall Study|Withdrawal by Subject|1
7786604|NCT00573430|27064896|P3|Overall Study|Adverse Event|2
7786605|NCT00573430|27064897|P2|Overall Study|Adverse Event|0
7786606|NCT00573430|27064898|P1|Overall Study|Adverse Event|0
7786607|NCT00573430|27064896|P3|Overall Study|Incorrect enrollment of randomization|3
7786608|NCT00573430|27064897|P2|Overall Study|Incorrect enrollment of randomization|4
7786609|NCT00573430|27064898|P1|Overall Study|Incorrect enrollment of randomization|0
7786610|NCT00573391|27064920|P2|Overall Study|Death|0
7786611|NCT00573391|27064921|P1|Overall Study|Death|1
7786612|NCT00573391|27064920|P2|Overall Study|study stopped|2
7786613|NCT00573391|27064921|P1|Overall Study|study stopped|2
7786614|NCT00573313|27064931|P4|Overall Study|Protocol Violation|0
7786615|NCT00573313|27064932|P3|Overall Study|Protocol Violation|6
7786616|NCT00573313|27064933|P2|Overall Study|Protocol Violation|0
7786617|NCT00573313|27064934|P1|Overall Study|Protocol Violation|5
7786618|NCT00573248|27064984|P2|Overall Study|scheduling conflicts|11
7786619|NCT00573248|27064985|P1|Overall Study|scheduling conflicts|15
7786620|NCT00573183|27064999|P2|Overall Study|Other|2
7786621|NCT00573183|27065000|P1|Overall Study|Other|5
7786622|NCT00573183|27064999|P2|Overall Study|Incarceration|8
7786623|NCT00573183|27065000|P1|Overall Study|Incarceration|5
7786624|NCT00573183|27064999|P2|Overall Study|Adverse Event|0
7786625|NCT00573183|27065000|P1|Overall Study|Adverse Event|2
7786626|NCT00573183|27064999|P2|Overall Study|Death|1
7786627|NCT00573183|27065000|P1|Overall Study|Death|0
7786628|NCT00573183|27064999|P2|Overall Study|Withdrawal by Subject|2
7786629|NCT00573183|27065000|P1|Overall Study|Withdrawal by Subject|8
7786630|NCT00573183|27064999|P2|Overall Study|Lost to Follow-up|50
7786631|NCT00573183|27065000|P1|Overall Study|Lost to Follow-up|52
7786632|NCT00573170|27065008|P6|Third Treatment Period|Lost to Follow-up|2
7786633|NCT00573170|27065009|P5|Third Treatment Period|Lost to Follow-up|0
7786634|NCT00573170|27065010|P4|Third Treatment Period|Lost to Follow-up|0
7786635|NCT00573170|27065011|P3|Third Treatment Period|Lost to Follow-up|0
7786636|NCT00573170|27065012|P2|Third Treatment Period|Lost to Follow-up|0
7786637|NCT00573170|27065013|P1|Third Treatment Period|Lost to Follow-up|0
7786638|NCT00573170|27065008|P6|Third Treatment Period|Withdrawal by Subject|0
7786639|NCT00573170|27065009|P5|Third Treatment Period|Withdrawal by Subject|0
7786640|NCT00573170|27065010|P4|Third Treatment Period|Withdrawal by Subject|0
7786641|NCT00573170|27065011|P3|Third Treatment Period|Withdrawal by Subject|0
7786642|NCT00573170|27065012|P2|Third Treatment Period|Withdrawal by Subject|0
7786643|NCT00573170|27065013|P1|Third Treatment Period|Withdrawal by Subject|1
7786644|NCT00573170|27065008|P6|Second Washout Period|Other|2
7786645|NCT00573170|27065009|P5|Second Washout Period|Other|6
7786646|NCT00573170|27065010|P4|Second Washout Period|Other|4
7786647|NCT00573170|27065011|P3|Second Washout Period|Other|1
7786648|NCT00573170|27065012|P2|Second Washout Period|Other|2
7786649|NCT00573170|27065013|P1|Second Washout Period|Other|1
7786650|NCT00573170|27065008|P6|Second Washout Period|Lost to Follow-up|0
7786651|NCT00573170|27065009|P5|Second Washout Period|Lost to Follow-up|0
7786652|NCT00573170|27065010|P4|Second Washout Period|Lost to Follow-up|1
7786653|NCT00573170|27065011|P3|Second Washout Period|Lost to Follow-up|0
7786654|NCT00573170|27065012|P2|Second Washout Period|Lost to Follow-up|0
7786655|NCT00573170|27065013|P1|Second Washout Period|Lost to Follow-up|0
7786656|NCT00573170|27065008|P6|Second Washout Period|Withdrawal by Subject|0
7786657|NCT00573170|27065009|P5|Second Washout Period|Withdrawal by Subject|1
7786658|NCT00573170|27065010|P4|Second Washout Period|Withdrawal by Subject|0
7786659|NCT00573170|27065011|P3|Second Washout Period|Withdrawal by Subject|2
7786660|NCT00573170|27065012|P2|Second Washout Period|Withdrawal by Subject|1
7786661|NCT00573170|27065013|P1|Second Washout Period|Withdrawal by Subject|1
7786662|NCT00573170|27065008|P6|Second Washout Period|Protocol Violation|0
7786663|NCT00573170|27065009|P5|Second Washout Period|Protocol Violation|0
7786664|NCT00573170|27065010|P4|Second Washout Period|Protocol Violation|0
7786665|NCT00573170|27065011|P3|Second Washout Period|Protocol Violation|1
7786666|NCT00573170|27065012|P2|Second Washout Period|Protocol Violation|1
7786667|NCT00573170|27065013|P1|Second Washout Period|Protocol Violation|2
7786668|NCT00573170|27065008|P6|Second Washout Period|Adverse Event|0
7786669|NCT00573170|27065009|P5|Second Washout Period|Adverse Event|1
7786670|NCT00573170|27065010|P4|Second Washout Period|Adverse Event|0
7786671|NCT00573170|27065011|P3|Second Washout Period|Adverse Event|0
7786672|NCT00573170|27065012|P2|Second Washout Period|Adverse Event|0
7786673|NCT00573170|27065013|P1|Second Washout Period|Adverse Event|1
7786674|NCT00573170|27065008|P6|First Washout Period|Other|0
7786675|NCT00573170|27065009|P5|First Washout Period|Other|0
7786676|NCT00573170|27065010|P4|First Washout Period|Other|1
7786677|NCT00573170|27065011|P3|First Washout Period|Other|1
7786678|NCT00573170|27065012|P2|First Washout Period|Other|0
7786679|NCT00573170|27065013|P1|First Washout Period|Other|4
7786680|NCT00573170|27065008|P6|First Washout Period|Withdrawal by Subject|3
7786681|NCT00573170|27065009|P5|First Washout Period|Withdrawal by Subject|3
7786682|NCT00573170|27065010|P4|First Washout Period|Withdrawal by Subject|2
7786683|NCT00573170|27065011|P3|First Washout Period|Withdrawal by Subject|0
7786684|NCT00573170|27065012|P2|First Washout Period|Withdrawal by Subject|0
7786685|NCT00573170|27065013|P1|First Washout Period|Withdrawal by Subject|2
7786686|NCT00573170|27065008|P6|First Washout Period|Lost to Follow-up|2
7786687|NCT00573170|27065009|P5|First Washout Period|Lost to Follow-up|0
7786688|NCT00573170|27065010|P4|First Washout Period|Lost to Follow-up|2
7786689|NCT00573170|27065011|P3|First Washout Period|Lost to Follow-up|0
7786690|NCT00573170|27065012|P2|First Washout Period|Lost to Follow-up|1
7786691|NCT00573170|27065013|P1|First Washout Period|Lost to Follow-up|1
7786692|NCT00573170|27065008|P6|First Washout Period|Lack of Efficacy|1
7786693|NCT00573170|27065009|P5|First Washout Period|Lack of Efficacy|0
7786694|NCT00573170|27065010|P4|First Washout Period|Lack of Efficacy|0
7786695|NCT00573170|27065011|P3|First Washout Period|Lack of Efficacy|0
7786696|NCT00573170|27065012|P2|First Washout Period|Lack of Efficacy|0
7786697|NCT00573170|27065013|P1|First Washout Period|Lack of Efficacy|0
7786698|NCT00573170|27065008|P6|First Washout Period|Adverse Event|1
7786699|NCT00573170|27065009|P5|First Washout Period|Adverse Event|0
7786700|NCT00573170|27065010|P4|First Washout Period|Adverse Event|0
7786701|NCT00573170|27065011|P3|First Washout Period|Adverse Event|0
7786702|NCT00573170|27065012|P2|First Washout Period|Adverse Event|1
7786703|NCT00573170|27065013|P1|First Washout Period|Adverse Event|1
7786704|NCT00573170|27065008|P6|First Treatment Period|Did Not Treat Attack 1|0
7786705|NCT00573170|27065009|P5|First Treatment Period|Did Not Treat Attack 1|1
7786706|NCT00573170|27065010|P4|First Treatment Period|Did Not Treat Attack 1|0
7786707|NCT00573170|27065011|P3|First Treatment Period|Did Not Treat Attack 1|0
7786708|NCT00573170|27065012|P2|First Treatment Period|Did Not Treat Attack 1|0
7786709|NCT00573170|27065013|P1|First Treatment Period|Did Not Treat Attack 1|0
7786710|NCT00573157|27065089|P2|Overall Study|Other|1
7786711|NCT00573157|27065090|P1|Overall Study|Other|1
7786712|NCT00573157|27065089|P2|Overall Study|Adverse Event|1
7786713|NCT00573157|27065090|P1|Overall Study|Adverse Event|3
7786714|NCT00573144|27065102|P2|Overall Study|Withdrawal by Subject|3
7786715|NCT00573144|27065103|P1|Overall Study|Withdrawal by Subject|2
7786716|NCT00573131|27065115|P2|Overall Study|Withdrawal by Subject|8
7786717|NCT00573131|27065116|P1|Overall Study|Withdrawal by Subject|10
7786718|NCT00573066|27065122|P1|Overall Study|Postoperative bleeding|1
7786719|NCT00573066|27065122|P1|Overall Study|IV malfunction|1
7786720|NCT00573066|27065122|P1|Overall Study|Exclusion criteria|18
7786721|NCT00572910|27065166|P11|Overall Study|Withdrawal by Subject|1
7786722|NCT00572910|27065167|P10|Overall Study|Withdrawal by Subject|2
7786723|NCT00572910|27065168|P9|Overall Study|Withdrawal by Subject|2
7786724|NCT00572910|27065169|P8|Overall Study|Withdrawal by Subject|2
7786725|NCT00572910|27065170|P7|Overall Study|Withdrawal by Subject|0
7786726|NCT00572910|27065171|P6|Overall Study|Withdrawal by Subject|3
7786727|NCT00572910|27065172|P5|Overall Study|Withdrawal by Subject|1
7786728|NCT00572910|27065173|P4|Overall Study|Withdrawal by Subject|0
7786729|NCT00572910|27065174|P3|Overall Study|Withdrawal by Subject|1
7786730|NCT00572910|27065175|P2|Overall Study|Withdrawal by Subject|0
7786731|NCT00572910|27065176|P1|Overall Study|Withdrawal by Subject|3
7786732|NCT00572910|27065166|P11|Overall Study|Lost to Follow-up|0
7786733|NCT00572910|27065167|P10|Overall Study|Lost to Follow-up|1
7786734|NCT00572910|27065168|P9|Overall Study|Lost to Follow-up|0
7786735|NCT00572910|27065169|P8|Overall Study|Lost to Follow-up|0
7786736|NCT00572910|27065170|P7|Overall Study|Lost to Follow-up|0
7786737|NCT00572910|27065171|P6|Overall Study|Lost to Follow-up|0
7786738|NCT00572910|27065172|P5|Overall Study|Lost to Follow-up|1
7786739|NCT00572910|27065173|P4|Overall Study|Lost to Follow-up|2
7786740|NCT00572910|27065174|P3|Overall Study|Lost to Follow-up|1
7786741|NCT00572910|27065175|P2|Overall Study|Lost to Follow-up|1
7786742|NCT00572910|27065176|P1|Overall Study|Lost to Follow-up|0
7786743|NCT00572910|27065166|P11|Overall Study|Adverse Event|2
7786744|NCT00572910|27065167|P10|Overall Study|Adverse Event|3
7786745|NCT00572910|27065168|P9|Overall Study|Adverse Event|1
7786746|NCT00572910|27065169|P8|Overall Study|Adverse Event|2
7786747|NCT00572910|27065170|P7|Overall Study|Adverse Event|4
7786748|NCT00572910|27065171|P6|Overall Study|Adverse Event|0
7786749|NCT00572910|27065172|P5|Overall Study|Adverse Event|0
7786750|NCT00572910|27065173|P4|Overall Study|Adverse Event|2
7786751|NCT00572910|27065174|P3|Overall Study|Adverse Event|0
7786752|NCT00572910|27065175|P2|Overall Study|Adverse Event|2
7786753|NCT00572910|27065176|P1|Overall Study|Adverse Event|1
7786754|NCT00572832|27065243|P2|Overall Study|Pregnancy|1
7786755|NCT00572832|27065244|P1|Overall Study|Pregnancy|0
7786756|NCT00572832|27065243|P2|Overall Study|Lost to Follow-up|11
7786757|NCT00572832|27065244|P1|Overall Study|Lost to Follow-up|0
7786758|NCT00572728|27065250|P1|Overall Study|Pathology missing|1
7786759|NCT00572728|27065250|P1|Overall Study|FLT2 after second chemotherapy initiated|7
7786760|NCT00572728|27065250|P1|Overall Study|Second chemotherapy not initiated|1
7786761|NCT00572728|27065250|P1|Overall Study|FLT2 not completed|5
7786762|NCT00572728|27065250|P1|Overall Study|First Chemotherapy not initiated|2
7786763|NCT00572728|27065250|P1|Overall Study|FLT1 not completed|4
7786764|NCT00572728|27065250|P1|Overall Study|Offstudy due to complicating disease|1
7786765|NCT00572728|27065250|P1|Overall Study|Enrolled under Amendment 4|5
7786766|NCT00572728|27065250|P1|Overall Study|Ineligible|3
7786767|NCT00572728|27065250|P1|Overall Study|Withdrawal by Subject|10
7786768|NCT00572624|27065264|P2|Overall Study|Health issues unrelated to the study|0
7786769|NCT00572624|27065265|P1|Overall Study|Health issues unrelated to the study|1
7786770|NCT00572624|27065264|P2|Overall Study|Problem with vascular access|0
7786771|NCT00572624|27065265|P1|Overall Study|Problem with vascular access|1
7786772|NCT00572624|27065264|P2|Overall Study|Refused to do the stress test|0
7786773|NCT00572624|27065265|P1|Overall Study|Refused to do the stress test|1
7786774|NCT00572624|27065264|P2|Overall Study|Admitted to being a smoker|0
7786775|NCT00572624|27065265|P1|Overall Study|Admitted to being a smoker|1
7786776|NCT00572624|27065264|P2|Overall Study|Started a new job-- no time for study|0
7786777|NCT00572624|27065265|P1|Overall Study|Started a new job-- no time for study|1
7786778|NCT00572624|27065264|P2|Overall Study|Medication change|0
7786779|NCT00572624|27065265|P1|Overall Study|Medication change|1
7786780|NCT00572624|27065264|P2|Overall Study|Wanted to do a different diet program|0
7786781|NCT00572624|27065265|P1|Overall Study|Wanted to do a different diet program|1
7786782|NCT00572624|27065264|P2|Overall Study|Lost to Follow-up|4
7786783|NCT00572624|27065265|P1|Overall Study|Lost to Follow-up|10
7786784|NCT00572572|27065293|P2|Overall Study|Withdrawal by Subject|6
7786785|NCT00572572|27065294|P1|Overall Study|Withdrawal by Subject|3
7786786|NCT00572533|27065312|P2|Overall Study|Transfer out of Facility|1
7786787|NCT00572533|27065313|P1|Overall Study|Transfer out of Facility|0
7786788|NCT00572533|27065312|P2|Overall Study|Social Issues|0
7786789|NCT00572533|27065313|P1|Overall Study|Social Issues|1
7786790|NCT00572533|27065312|P2|Overall Study|Received Kidney Transplant|1
7786791|NCT00572533|27065313|P1|Overall Study|Received Kidney Transplant|2
7786792|NCT00572533|27065312|P2|Overall Study|Death|1
7786793|NCT00572533|27065313|P1|Overall Study|Death|4
7786794|NCT00572455|27065358|P14|Stage II (28 Days)|Randomized, but not treated|1
7786795|NCT00572455|27065359|P13|Stage II (28 Days)|Randomized, but not treated|0
7786796|NCT00572455|27065360|P12|Stage II (28 Days)|Randomized, but not treated|0
7786797|NCT00572455|27065361|P11|Stage II (28 Days)|Randomized, but not treated|0
7786798|NCT00572455|27065362|P10|Stage II (28 Days)|Randomized, but not treated|0
7786799|NCT00572455|27065363|P9|Stage II (28 Days)|Randomized, but not treated|0
7786800|NCT00572455|27065364|P8|Stage II (28 Days)|Randomized, but not treated|0
7786801|NCT00572455|27065365|P7|Stage II (28 Days)|Randomized, but not treated|0
7786802|NCT00572455|27065366|P6|Stage II (28 Days)|Randomized, but not treated|0
7786803|NCT00572455|27065367|P5|Stage II (28 Days)|Randomized, but not treated|0
7786804|NCT00572455|27065368|P4|Stage II (28 Days)|Randomized, but not treated|0
7786805|NCT00572455|27065369|P3|Stage II (28 Days)|Randomized, but not treated|0
7786806|NCT00572455|27065370|P2|Stage II (28 Days)|Randomized, but not treated|0
7786807|NCT00572455|27065371|P1|Stage II (28 Days)|Randomized, but not treated|0
7786808|NCT00572455|27065358|P14|Stage II (28 Days)|Other|0
7786809|NCT00572455|27065359|P13|Stage II (28 Days)|Other|0
7786810|NCT00572455|27065360|P12|Stage II (28 Days)|Other|0
7786811|NCT00572455|27065361|P11|Stage II (28 Days)|Other|0
7786812|NCT00572455|27065362|P10|Stage II (28 Days)|Other|0
7786813|NCT00572455|27065363|P9|Stage II (28 Days)|Other|1
7786814|NCT00572455|27065364|P8|Stage II (28 Days)|Other|0
7786815|NCT00572455|27065365|P7|Stage II (28 Days)|Other|0
7786816|NCT00572455|27065366|P6|Stage II (28 Days)|Other|0
7786817|NCT00572455|27065367|P5|Stage II (28 Days)|Other|0
7786818|NCT00572455|27065368|P4|Stage II (28 Days)|Other|0
7786819|NCT00572455|27065369|P3|Stage II (28 Days)|Other|0
7786820|NCT00572455|27065370|P2|Stage II (28 Days)|Other|0
7786821|NCT00572455|27065371|P1|Stage II (28 Days)|Other|0
7786822|NCT00572455|27065358|P14|Stage II (28 Days)|Withdrawal by Subject|0
7786823|NCT00572455|27065359|P13|Stage II (28 Days)|Withdrawal by Subject|0
7786824|NCT00572455|27065360|P12|Stage II (28 Days)|Withdrawal by Subject|0
7786825|NCT00572455|27065361|P11|Stage II (28 Days)|Withdrawal by Subject|2
7786826|NCT00572455|27065362|P10|Stage II (28 Days)|Withdrawal by Subject|0
7786827|NCT00572455|27065363|P9|Stage II (28 Days)|Withdrawal by Subject|0
7786828|NCT00572455|27065364|P8|Stage II (28 Days)|Withdrawal by Subject|1
7786829|NCT00572455|27065365|P7|Stage II (28 Days)|Withdrawal by Subject|0
7786830|NCT00572455|27065366|P6|Stage II (28 Days)|Withdrawal by Subject|0
7786831|NCT00572455|27065367|P5|Stage II (28 Days)|Withdrawal by Subject|0
7786832|NCT00572455|27065368|P4|Stage II (28 Days)|Withdrawal by Subject|0
7786833|NCT00572455|27065369|P3|Stage II (28 Days)|Withdrawal by Subject|0
7786834|NCT00572455|27065370|P2|Stage II (28 Days)|Withdrawal by Subject|0
7786835|NCT00572455|27065371|P1|Stage II (28 Days)|Withdrawal by Subject|0
7786836|NCT00572455|27065358|P14|Stage II (28 Days)|Death|0
7786837|NCT00572455|27065359|P13|Stage II (28 Days)|Death|0
7786838|NCT00572455|27065360|P12|Stage II (28 Days)|Death|0
7786839|NCT00572455|27065361|P11|Stage II (28 Days)|Death|0
7786840|NCT00572455|27065362|P10|Stage II (28 Days)|Death|0
7786841|NCT00572455|27065363|P9|Stage II (28 Days)|Death|1
7786842|NCT00572455|27065364|P8|Stage II (28 Days)|Death|0
7786843|NCT00572455|27065365|P7|Stage II (28 Days)|Death|0
7786844|NCT00572455|27065366|P6|Stage II (28 Days)|Death|0
7786845|NCT00572455|27065367|P5|Stage II (28 Days)|Death|0
7786846|NCT00572455|27065368|P4|Stage II (28 Days)|Death|0
7786847|NCT00572455|27065369|P3|Stage II (28 Days)|Death|0
7786848|NCT00572455|27065370|P2|Stage II (28 Days)|Death|0
7786849|NCT00572455|27065371|P1|Stage II (28 Days)|Death|0
7786850|NCT00572455|27065358|P14|Stage II (28 Days)|Adverse Event|1
7786851|NCT00572455|27065359|P13|Stage II (28 Days)|Adverse Event|5
7786852|NCT00572455|27065360|P12|Stage II (28 Days)|Adverse Event|4
7786853|NCT00572455|27065361|P11|Stage II (28 Days)|Adverse Event|3
7786854|NCT00572455|27065362|P10|Stage II (28 Days)|Adverse Event|3
7786855|NCT00572455|27065363|P9|Stage II (28 Days)|Adverse Event|1
7786856|NCT00572455|27065364|P8|Stage II (28 Days)|Adverse Event|0
7786857|NCT00572455|27065365|P7|Stage II (28 Days)|Adverse Event|0
7786858|NCT00572455|27065366|P6|Stage II (28 Days)|Adverse Event|0
7786859|NCT00572455|27065367|P5|Stage II (28 Days)|Adverse Event|0
7786860|NCT00572455|27065368|P4|Stage II (28 Days)|Adverse Event|0
7786861|NCT00572455|27065369|P3|Stage II (28 Days)|Adverse Event|0
7786862|NCT00572455|27065370|P2|Stage II (28 Days)|Adverse Event|0
7786863|NCT00572455|27065371|P1|Stage II (28 Days)|Adverse Event|0
7786864|NCT00572455|27065358|P14|Stage I (14 Days)|Other|0
7786865|NCT00572455|27065359|P13|Stage I (14 Days)|Other|0
7786866|NCT00572455|27065360|P12|Stage I (14 Days)|Other|0
7786867|NCT00572455|27065361|P11|Stage I (14 Days)|Other|0
7786868|NCT00572455|27065362|P10|Stage I (14 Days)|Other|0
7786869|NCT00572455|27065363|P9|Stage I (14 Days)|Other|0
7786870|NCT00572455|27065364|P8|Stage I (14 Days)|Other|0
7786871|NCT00572455|27065365|P7|Stage I (14 Days)|Other|0
7786872|NCT00572455|27065366|P6|Stage I (14 Days)|Other|0
7786873|NCT00572455|27065367|P5|Stage I (14 Days)|Other|1
7786874|NCT00572455|27065368|P4|Stage I (14 Days)|Other|0
7786875|NCT00572455|27065369|P3|Stage I (14 Days)|Other|0
7786876|NCT00572455|27065370|P2|Stage I (14 Days)|Other|0
7786877|NCT00572455|27065371|P1|Stage I (14 Days)|Other|0
7786878|NCT00572455|27065358|P14|Stage I (14 Days)|Adverse Event|0
7786879|NCT00572455|27065359|P13|Stage I (14 Days)|Adverse Event|0
7786880|NCT00572455|27065360|P12|Stage I (14 Days)|Adverse Event|0
7786881|NCT00572455|27065361|P11|Stage I (14 Days)|Adverse Event|0
7786882|NCT00572455|27065362|P10|Stage I (14 Days)|Adverse Event|0
7786883|NCT00572455|27065363|P9|Stage I (14 Days)|Adverse Event|0
7786884|NCT00572455|27065364|P8|Stage I (14 Days)|Adverse Event|0
7786885|NCT00572455|27065365|P7|Stage I (14 Days)|Adverse Event|0
7786886|NCT00572455|27065366|P6|Stage I (14 Days)|Adverse Event|3
7786887|NCT00572455|27065367|P5|Stage I (14 Days)|Adverse Event|0
7786888|NCT00572455|27065368|P4|Stage I (14 Days)|Adverse Event|0
7786889|NCT00572455|27065369|P3|Stage I (14 Days)|Adverse Event|0
7786890|NCT00572455|27065370|P2|Stage I (14 Days)|Adverse Event|0
7786891|NCT00572455|27065371|P1|Stage I (14 Days)|Adverse Event|0
7786892|NCT00572195|27065470|P1|Overall Study|Lost to Follow-up|5
7786893|NCT00572195|27065470|P1|Overall Study|Adverse Event|4
7786894|NCT00572195|27065470|P1|Overall Study|Death|9
7786895|NCT00572195|27065470|P1|Overall Study|Withdrawal by Subject|50
7786896|NCT00572156|27065482|P4|Overall Study|Sponsor Decision|19
7786897|NCT00572156|27065483|P3|Overall Study|Sponsor Decision|17
7786898|NCT00572156|27065484|P2|Overall Study|Sponsor Decision|16
7786899|NCT00572156|27065485|P1|Overall Study|Sponsor Decision|20
7786900|NCT00572156|27065482|P4|Overall Study|Patient/Parent Decision|3
7786901|NCT00572156|27065483|P3|Overall Study|Patient/Parent Decision|4
7786902|NCT00572156|27065484|P2|Overall Study|Patient/Parent Decision|6
7786903|NCT00572156|27065485|P1|Overall Study|Patient/Parent Decision|1
7786904|NCT00572156|27065482|P4|Overall Study|Protocol Violation|2
7786905|NCT00572156|27065483|P3|Overall Study|Protocol Violation|0
7786906|NCT00572156|27065484|P2|Overall Study|Protocol Violation|2
7786907|NCT00572156|27065485|P1|Overall Study|Protocol Violation|1
7786908|NCT00572156|27065482|P4|Overall Study|Lost to Follow-up|0
7786909|NCT00572156|27065483|P3|Overall Study|Lost to Follow-up|1
7786910|NCT00572156|27065484|P2|Overall Study|Lost to Follow-up|1
7786911|NCT00572156|27065485|P1|Overall Study|Lost to Follow-up|1
7786912|NCT00572156|27065482|P4|Overall Study|Adverse Event|1
7786913|NCT00572156|27065483|P3|Overall Study|Adverse Event|5
7786914|NCT00572156|27065484|P2|Overall Study|Adverse Event|1
7786915|NCT00572156|27065485|P1|Overall Study|Adverse Event|3
7786916|NCT00572039|27065556|P2|Overall Study|Ill|1
7786917|NCT00572039|27065557|P1|Overall Study|Ill|5
7786918|NCT00572039|27065556|P2|Overall Study|Death|3
7786919|NCT00572039|27065557|P1|Overall Study|Death|2
7786920|NCT00572039|27065556|P2|Overall Study|Withdrawal by Subject|6
7786921|NCT00572039|27065557|P1|Overall Study|Withdrawal by Subject|9
7786922|NCT00571948|27065589|P2|Overall Study|Parent were afraid of blood colection|5
7786923|NCT00571948|27065590|P1|Overall Study|Parent were afraid of blood colection|2
7786924|NCT00571948|27065589|P2|Overall Study|infant refused study meal|4
7786925|NCT00571948|27065590|P1|Overall Study|infant refused study meal|3
7786926|NCT00571948|27065589|P2|Overall Study|Protocol Violation|3
7786927|NCT00571948|27065590|P1|Overall Study|Protocol Violation|3
7786928|NCT00571948|27065589|P2|Overall Study|Withdrawal by Subject|2
7786929|NCT00571948|27065590|P1|Overall Study|Withdrawal by Subject|1
7786930|NCT00571948|27065589|P2|Overall Study|Lost to Follow-up|0
7786931|NCT00571948|27065590|P1|Overall Study|Lost to Follow-up|2
7786932|NCT00571922|27065598|P2|Overall Study|Completion unknown|36
7786933|NCT00571922|27065599|P1|Overall Study|Completion unknown|36
7786934|NCT00571701|27065609|P2|Second Intervention 12 Months|Withdrawal by Subject|0
7786935|NCT00571701|27065610|P1|Second Intervention 12 Months|Withdrawal by Subject|3
7786936|NCT00571701|27065609|P2|Second Intervention 12 Months|Adverse Event|1
7786937|NCT00571701|27065610|P1|Second Intervention 12 Months|Adverse Event|0
7786938|NCT00571701|27065609|P2|First Intervention 12 Months|Death|0
7786939|NCT00571701|27065610|P1|First Intervention 12 Months|Death|1
7786940|NCT00571701|27065609|P2|First Intervention 12 Months|Withdrawal by Subject|1
7786941|NCT00571701|27065610|P1|First Intervention 12 Months|Withdrawal by Subject|2
7786942|NCT00571688|27065636|P2|Overall Study|subject moved out of the area|0
7786943|NCT00571688|27065637|P1|Overall Study|subject moved out of the area|1
7786944|NCT00571688|27065636|P2|Overall Study|subject did not tolerate Consta|0
7786945|NCT00571688|27065637|P1|Overall Study|subject did not tolerate Consta|1
7786946|NCT00571688|27065636|P2|Overall Study|Lost to Follow-up|6
7786947|NCT00571688|27065637|P1|Overall Study|Lost to Follow-up|3
7786948|NCT00571662|27065643|P1|Overall Study|Adverse Event|5
7786949|NCT00571662|27065643|P1|Overall Study|psychiatric instability|1
7786950|NCT00571662|27065643|P1|Overall Study|Withdrawal by Subject|2
7786951|NCT00571649|27065654|P2|Follow-up Period|Protocol Violation|12
7786952|NCT00571649|27065655|P1|Follow-up Period|Protocol Violation|5
7786953|NCT00571649|27065654|P2|Follow-up Period|Patient convenience|121
7786954|NCT00571649|27065655|P1|Follow-up Period|Patient convenience|136
7786955|NCT00571649|27065654|P2|Follow-up Period|Lost to Follow-up|92
7786956|NCT00571649|27065655|P1|Follow-up Period|Lost to Follow-up|95
7786957|NCT00571649|27065654|P2|Follow-up Period|Physician Decision|13
7786958|NCT00571649|27065655|P1|Follow-up Period|Physician Decision|7
7786959|NCT00571649|27065654|P2|Follow-up Period|Death|133
7786960|NCT00571649|27065655|P1|Follow-up Period|Death|132
7786961|NCT00571649|27065654|P2|Follow-up Period|Withdrawal by Subject|115
7786962|NCT00571649|27065655|P1|Follow-up Period|Withdrawal by Subject|119
7786963|NCT00571649|27065654|P2|Follow-up Period|Clinical endpoint reached|2
7786964|NCT00571649|27065655|P1|Follow-up Period|Clinical endpoint reached|5
7786965|NCT00571649|27065654|P2|Follow-up Period|Adverse Event|40
7786966|NCT00571649|27065655|P1|Follow-up Period|Adverse Event|46
7786967|NCT00571649|27065654|P2|Treatment Period|Technical problems|5
7786968|NCT00571649|27065655|P1|Treatment Period|Technical problems|3
7786969|NCT00571649|27065654|P2|Treatment Period|Protocol Violation|92
7786970|NCT00571649|27065655|P1|Treatment Period|Protocol Violation|90
7786971|NCT00571649|27065654|P2|Treatment Period|Patient convenience|13
7786972|NCT00571649|27065655|P1|Treatment Period|Patient convenience|11
7786973|NCT00571649|27065654|P2|Treatment Period|Non-compliant with study medication|89
7786974|NCT00571649|27065655|P1|Treatment Period|Non-compliant with study medication|88
7786975|NCT00571649|27065654|P2|Treatment Period|Lost to Follow-up|41
7786976|NCT00571649|27065655|P1|Treatment Period|Lost to Follow-up|43
7786977|NCT00571649|27065654|P2|Treatment Period|Physician Decision|9
7786978|NCT00571649|27065655|P1|Treatment Period|Physician Decision|8
7786979|NCT00571649|27065654|P2|Treatment Period|Death|59
7786980|NCT00571649|27065655|P1|Treatment Period|Death|76
7786981|NCT00571649|27065654|P2|Treatment Period|Withdrawal by Subject|255
7786982|NCT00571649|27065655|P1|Treatment Period|Withdrawal by Subject|285
7786983|NCT00571649|27065654|P2|Treatment Period|Clinical endpoint reached|56
7786984|NCT00571649|27065655|P1|Treatment Period|Clinical endpoint reached|50
7786985|NCT00571649|27065654|P2|Treatment Period|Adverse Event|385
7786986|NCT00571649|27065655|P1|Treatment Period|Adverse Event|438
7786987|NCT00571519|27065694|P7|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7786988|NCT00571519|27065695|P6|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7786989|NCT00571519|27065696|P5|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7786990|NCT00571519|27065697|P4|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7786991|NCT00571519|27065698|P3|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
7786992|NCT00571519|27065699|P2|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7786993|NCT00571519|27065700|P1|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7786994|NCT00571519|27065694|P7|Overall Study|Termination of study by Sponsor|22
7786995|NCT00571519|27065695|P6|Overall Study|Termination of study by Sponsor|9
7786996|NCT00571519|27065696|P5|Overall Study|Termination of study by Sponsor|8
7786997|NCT00571519|27065697|P4|Overall Study|Termination of study by Sponsor|24
7786998|NCT00571519|27065698|P3|Overall Study|Termination of study by Sponsor|10
7786999|NCT00571519|27065699|P2|Overall Study|Termination of study by Sponsor|7
7787000|NCT00571519|27065700|P1|Overall Study|Termination of study by Sponsor|2
7787001|NCT00571519|27065694|P7|Overall Study|Therapeutic failure/lack of efficacy|0
7787002|NCT00571519|27065695|P6|Overall Study|Therapeutic failure/lack of efficacy|0
7787003|NCT00571519|27065696|P5|Overall Study|Therapeutic failure/lack of efficacy|0
7787004|NCT00571519|27065697|P4|Overall Study|Therapeutic failure/lack of efficacy|0
7787005|NCT00571519|27065698|P3|Overall Study|Therapeutic failure/lack of efficacy|0
7787006|NCT00571519|27065699|P2|Overall Study|Therapeutic failure/lack of efficacy|1
7787007|NCT00571519|27065700|P1|Overall Study|Therapeutic failure/lack of efficacy|0
7787008|NCT00571519|27065694|P7|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7787009|NCT00571519|27065695|P6|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7787010|NCT00571519|27065696|P5|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7787011|NCT00571519|27065697|P4|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7787012|NCT00571519|27065698|P3|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7787013|NCT00571519|27065699|P2|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7787014|NCT00571519|27065700|P1|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7787015|NCT00571519|27065694|P7|Overall Study|Subject withdrew consent|2
7787016|NCT00571519|27065695|P6|Overall Study|Subject withdrew consent|1
7787017|NCT00571519|27065696|P5|Overall Study|Subject withdrew consent|1
7787018|NCT00571519|27065697|P4|Overall Study|Subject withdrew consent|2
7787019|NCT00571519|27065698|P3|Overall Study|Subject withdrew consent|0
7787020|NCT00571519|27065699|P2|Overall Study|Subject withdrew consent|1
7787021|NCT00571519|27065700|P1|Overall Study|Subject withdrew consent|0
7787022|NCT00571103|27065891|P1|Overall Study|Lost to Follow-up|1
7787023|NCT00571103|27065891|P1|Overall Study|Withdrawal by Subject|1
7787024|NCT00571064|27065896|P1|Overall Study|Other|2
7787025|NCT00571064|27065896|P1|Overall Study|Withdrawal by Subject|2
7787026|NCT00571064|27065896|P1|Overall Study|Protocol Violation|4
7787027|NCT00571064|27065896|P1|Overall Study|Adverse Event|13
7787028|NCT00571038|27065911|P2|Overall Study|Moved out of state|2
7787029|NCT00571038|27065912|P1|Overall Study|Moved out of state|2
7787030|NCT00571038|27065911|P2|Overall Study|Withdrawal by Subject|3
7787031|NCT00571038|27065912|P1|Overall Study|Withdrawal by Subject|1
7787032|NCT00571038|27065911|P2|Overall Study|Death|5
7787033|NCT00571038|27065912|P1|Overall Study|Death|7
7787034|NCT00571038|27065911|P2|Overall Study|Lost to Follow-up|4
7787035|NCT00571038|27065912|P1|Overall Study|Lost to Follow-up|1
7787036|NCT00570921|27065967|P1|Overall Study|Physician Decision|1
7787037|NCT00570921|27065967|P1|Overall Study|Protocol Violation|1
7787038|NCT00570908|27065973|P1|Overall Study|Withdrawal by Subject|2
7787039|NCT00570908|27065973|P1|Overall Study|Adverse Event|5
7787040|NCT00570778|27065977|P4|Overall Study|Subject no longer requires study drug|0
7787041|NCT00570778|27065978|P3|Overall Study|Subject no longer requires study drug|0
7787042|NCT00570778|27065979|P2|Overall Study|Subject no longer requires study drug|1
7787043|NCT00570778|27065980|P1|Overall Study|Subject no longer requires study drug|0
7787044|NCT00570778|27065977|P4|Overall Study|Lost to Follow-up|0
7787045|NCT00570778|27065978|P3|Overall Study|Lost to Follow-up|1
7787046|NCT00570778|27065979|P2|Overall Study|Lost to Follow-up|0
7787047|NCT00570778|27065980|P1|Overall Study|Lost to Follow-up|0
7787048|NCT00570778|27065977|P4|Overall Study|Unsatisfactory therapeutic effect|0
7787049|NCT00570778|27065978|P3|Overall Study|Unsatisfactory therapeutic effect|0
7787050|NCT00570778|27065979|P2|Overall Study|Unsatisfactory therapeutic effect|0
7787051|NCT00570778|27065980|P1|Overall Study|Unsatisfactory therapeutic effect|1
7787052|NCT00570778|27065977|P4|Overall Study|Abnormal test procedure|0
7787053|NCT00570778|27065978|P3|Overall Study|Abnormal test procedure|0
7787054|NCT00570778|27065979|P2|Overall Study|Abnormal test procedure|0
7787055|NCT00570778|27065980|P1|Overall Study|Abnormal test procedure|1
7787056|NCT00570778|27065977|P4|Overall Study|Subject withdrew consent|1
7787057|NCT00570778|27065978|P3|Overall Study|Subject withdrew consent|0
7787058|NCT00570778|27065979|P2|Overall Study|Subject withdrew consent|1
7787059|NCT00570778|27065980|P1|Overall Study|Subject withdrew consent|0
7787060|NCT00570778|27065977|P4|Overall Study|Adverse Event|1
7787061|NCT00570778|27065978|P3|Overall Study|Adverse Event|4
7787062|NCT00570778|27065979|P2|Overall Study|Adverse Event|1
7787063|NCT00570778|27065980|P1|Overall Study|Adverse Event|0
7787064|NCT00570778|27065977|P4|Overall Study|Protocol deviation|2
7787065|NCT00570778|27065978|P3|Overall Study|Protocol deviation|2
7787066|NCT00570778|27065979|P2|Overall Study|Protocol deviation|1
7787067|NCT00570778|27065980|P1|Overall Study|Protocol deviation|2
7787068|NCT00570765|27066001|P4|LTSE Phase|Physician Decision|4
7787069|NCT00570765|27066002|P3|LTSE Phase|Physician Decision|0
7787070|NCT00570765|27066003|P2|LTSE Phase|Physician Decision|0
7787071|NCT00570765|27066004|P1|LTSE Phase|Physician Decision|0
7787072|NCT00570765|27066001|P4|LTSE Phase|Adverse Event|7
7787073|NCT00570765|27066002|P3|LTSE Phase|Adverse Event|0
7787074|NCT00570765|27066003|P2|LTSE Phase|Adverse Event|0
7787075|NCT00570765|27066004|P1|LTSE Phase|Adverse Event|0
7787076|NCT00570765|27066001|P4|LTSE Phase|Withdrawal by Subject|1
7787077|NCT00570765|27066002|P3|LTSE Phase|Withdrawal by Subject|0
7787078|NCT00570765|27066003|P2|LTSE Phase|Withdrawal by Subject|0
7787079|NCT00570765|27066004|P1|LTSE Phase|Withdrawal by Subject|0
7787080|NCT00570765|27066001|P4|DB Phase|Did Not Receive Study Drug|0
7787081|NCT00570765|27066002|P3|DB Phase|Did Not Receive Study Drug|1
7787082|NCT00570765|27066003|P2|DB Phase|Did Not Receive Study Drug|0
7787083|NCT00570765|27066004|P1|DB Phase|Did Not Receive Study Drug|0
7787084|NCT00570765|27066001|P4|DB Phase|Adverse Event|0
7787085|NCT00570765|27066002|P3|DB Phase|Adverse Event|0
7787086|NCT00570765|27066003|P2|DB Phase|Adverse Event|6
7787087|NCT00570765|27066004|P1|DB Phase|Adverse Event|3
7787088|NCT00570765|27066001|P4|DB Phase|Protocol Violation|0
7787089|NCT00570765|27066002|P3|DB Phase|Protocol Violation|0
7787090|NCT00570765|27066003|P2|DB Phase|Protocol Violation|1
7787091|NCT00570765|27066004|P1|DB Phase|Protocol Violation|0
7787092|NCT00570765|27066001|P4|DB Phase|Withdrawal by Subject|0
7787093|NCT00570765|27066002|P3|DB Phase|Withdrawal by Subject|0
7787094|NCT00570765|27066003|P2|DB Phase|Withdrawal by Subject|0
7787095|NCT00570765|27066004|P1|DB Phase|Withdrawal by Subject|1
7787096|NCT00570739|27066039|P4|Overall Study|Other|3
7787097|NCT00570739|27066040|P3|Overall Study|Other|5
7787098|NCT00570739|27066041|P2|Overall Study|Other|2
7787099|NCT00570739|27066042|P1|Overall Study|Other|0
7787100|NCT00570739|27066039|P4|Overall Study|Met discontinuation criteria|1
7787101|NCT00570739|27066040|P3|Overall Study|Met discontinuation criteria|1
7787102|NCT00570739|27066041|P2|Overall Study|Met discontinuation criteria|0
7787103|NCT00570739|27066042|P1|Overall Study|Met discontinuation criteria|1
7787104|NCT00570739|27066039|P4|Overall Study|Required restricted medication|0
7787105|NCT00570739|27066040|P3|Overall Study|Required restricted medication|1
7787106|NCT00570739|27066041|P2|Overall Study|Required restricted medication|0
7787107|NCT00570739|27066042|P1|Overall Study|Required restricted medication|0
7787108|NCT00570739|27066039|P4|Overall Study|Withdrawal by Subject|5
7787109|NCT00570739|27066040|P3|Overall Study|Withdrawal by Subject|3
7787110|NCT00570739|27066041|P2|Overall Study|Withdrawal by Subject|7
7787111|NCT00570739|27066042|P1|Overall Study|Withdrawal by Subject|7
7787112|NCT00570739|27066039|P4|Overall Study|Physician Decision|0
7787113|NCT00570739|27066040|P3|Overall Study|Physician Decision|0
7787114|NCT00570739|27066041|P2|Overall Study|Physician Decision|1
7787115|NCT00570739|27066042|P1|Overall Study|Physician Decision|1
7787116|NCT00570739|27066039|P4|Overall Study|Lost to Follow-up|1
7787117|NCT00570739|27066040|P3|Overall Study|Lost to Follow-up|4
7787118|NCT00570739|27066041|P2|Overall Study|Lost to Follow-up|5
7787119|NCT00570739|27066042|P1|Overall Study|Lost to Follow-up|4
7787120|NCT00570739|27066039|P4|Overall Study|Adverse Event|2
7787121|NCT00570739|27066040|P3|Overall Study|Adverse Event|2
7787122|NCT00570739|27066041|P2|Overall Study|Adverse Event|6
7787123|NCT00570739|27066042|P1|Overall Study|Adverse Event|8
7787124|NCT00570713|27066194|P2|Overall Study|Discontinuation of Study by the Sponsor|7
7787125|NCT00570713|27066195|P1|Overall Study|Discontinuation of Study by the Sponsor|10
7787126|NCT00570713|27066194|P2|Overall Study|Withdrawal by Subject|3
7787127|NCT00570713|27066195|P1|Overall Study|Withdrawal by Subject|3
7787128|NCT00570713|27066194|P2|Overall Study|Physician Decision|2
7787129|NCT00570713|27066195|P1|Overall Study|Physician Decision|2
7787130|NCT00570713|27066194|P2|Overall Study|Lack of Efficacy|49
7787131|NCT00570713|27066195|P1|Overall Study|Lack of Efficacy|40
7787132|NCT00570713|27066194|P2|Overall Study|Death|7
7787133|NCT00570713|27066195|P1|Overall Study|Death|7
7787134|NCT00570713|27066194|P2|Overall Study|Adverse Event|9
7787135|NCT00570713|27066195|P1|Overall Study|Adverse Event|16
7787136|NCT00570687|27066213|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787137|NCT00570687|27066214|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787138|NCT00570687|27066215|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787139|NCT00570687|27066216|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
7787140|NCT00570687|27066217|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787141|NCT00570687|27066218|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787142|NCT00570687|27066219|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787143|NCT00570687|27066220|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787144|NCT00570687|27066221|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787145|NCT00570687|27066222|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787146|NCT00570687|27066213|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787147|NCT00570687|27066214|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
7787148|NCT00570687|27066215|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787149|NCT00570687|27066216|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787150|NCT00570687|27066217|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787151|NCT00570687|27066218|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787152|NCT00570687|27066219|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787153|NCT00570687|27066220|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787154|NCT00570687|27066221|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787155|NCT00570687|27066222|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787156|NCT00570687|27066213|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7787157|NCT00570687|27066214|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
7787158|NCT00570687|27066215|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7787159|NCT00570687|27066216|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
7787160|NCT00570687|27066217|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7787161|NCT00570687|27066218|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7787162|NCT00570687|27066219|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787163|NCT00570687|27066220|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787164|NCT00570687|27066221|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787165|NCT00570687|27066222|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7787166|NCT00570674|27066248|P7|Overall Study|Withdrawal by Subject|0
7787167|NCT00570674|27066249|P6|Overall Study|Withdrawal by Subject|0
7787168|NCT00570674|27066250|P5|Overall Study|Withdrawal by Subject|0
7787169|NCT00570674|27066251|P4|Overall Study|Withdrawal by Subject|0
7787170|NCT00570674|27066252|P3|Overall Study|Withdrawal by Subject|1
7787171|NCT00570674|27066253|P2|Overall Study|Withdrawal by Subject|0
7787172|NCT00570674|27066254|P1|Overall Study|Withdrawal by Subject|0
7787173|NCT00570661|27066271|P1|Overall Study|Adverse Event|1
7787174|NCT00570661|27066271|P1|Overall Study|Unmet criterion of sufficient therapeutic response|1
7787175|NCT00570661|27066271|P1|Overall Study|Disease worsening|5
7787176|NCT00570505|27066320|P1|Overall Study|Other loss to follow-up|4
7787177|NCT00570505|27066320|P1|Overall Study|Lost to Follow-up|23
7787178|NCT00570505|27066320|P1|Overall Study|Withdrawal by Subject|7
7787179|NCT00570505|27066320|P1|Overall Study|Adverse Event|7
7787180|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
7787181|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
7787182|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
7787183|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
7787184|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
7787185|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
7787186|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Physician Decision|4
7787187|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Physician Decision|2
7787188|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Physician Decision|0
7787189|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Adverse Event|5
7787190|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Adverse Event|5
7787191|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Adverse Event|0
7787192|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
7787193|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
7787194|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
7787195|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Protocol Violation|15
7787196|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Protocol Violation|12
7787197|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Protocol Violation|0
7787198|NCT00570492|27066333|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
7787199|NCT00570492|27066334|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
7787200|NCT00570492|27066335|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
7787201|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
7787202|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
7787203|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
7787204|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Adverse Event|0
7787205|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Adverse Event|0
7787206|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Adverse Event|1
7787207|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
7787208|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
7787209|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
7787210|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Protocol Violation|0
7787211|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Protocol Violation|0
7787212|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Protocol Violation|15
7787213|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
7787214|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
7787215|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
7787216|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
7787217|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
7787218|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
7787219|NCT00570492|27066333|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
7787220|NCT00570492|27066334|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
7787305|NCT00569582|27066773|P1|Overall Study|Withdrawal by Subject|5
7787221|NCT00570492|27066335|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
7787222|NCT00570401|27066373|P1|Overall Study|Adverse Event|2
7787223|NCT00570323|27066407|P2|Complete Study After Start|Physician Decision|0
7787224|NCT00570323|27066408|P1|Complete Study After Start|Physician Decision|1
7787225|NCT00570323|27066407|P2|Complete Study After Start|Withdrawal by Subject|0
7787226|NCT00570323|27066408|P1|Complete Study After Start|Withdrawal by Subject|2
7787227|NCT00570323|27066407|P2|Complete Study After Start|Lost to Follow-up|1
7787228|NCT00570323|27066408|P1|Complete Study After Start|Lost to Follow-up|0
7787229|NCT00570323|27066407|P2|Started Treatment After Randomization|Physician Decision|0
7787230|NCT00570323|27066408|P1|Started Treatment After Randomization|Physician Decision|1
7787231|NCT00570323|27066407|P2|Started Treatment After Randomization|Protocol Violation|0
7787232|NCT00570323|27066408|P1|Started Treatment After Randomization|Protocol Violation|1
7787233|NCT00570323|27066407|P2|Started Treatment After Randomization|Withdrawal by Subject|1
7787234|NCT00570323|27066408|P1|Started Treatment After Randomization|Withdrawal by Subject|0
7787235|NCT00570310|27066420|P2|Overall Study|Lack of Efficacy|4
7787236|NCT00570310|27066421|P1|Overall Study|Lack of Efficacy|1
7787237|NCT00570310|27066420|P2|Overall Study|Adverse Event|2
7787238|NCT00570310|27066421|P1|Overall Study|Adverse Event|1
7787239|NCT00570232|27066440|P1|Overall Study|discontinued due to noncompliance|2
7787240|NCT00570232|27066440|P1|Overall Study|discontinued due to recurrence|8
7787241|NCT00570232|27066440|P1|Overall Study|discontinued due to medical condition|3
7787242|NCT00570232|27066440|P1|Overall Study|Adverse Event|10
7787243|NCT00570141|27066446|P1|Overall Study|Lost to Follow-up|1
7787244|NCT00570141|27066446|P1|Overall Study|Missed visits|1
7787245|NCT00570141|27066446|P1|Overall Study|Adverse Event|1
7787246|NCT00570128|27066453|P2|Overall Study|Withdrawal by Subject|0
7787247|NCT00570128|27066454|P1|Overall Study|Withdrawal by Subject|2
7787248|NCT00570128|27066453|P2|Overall Study|Lost to Follow-up|0
7787249|NCT00570128|27066454|P1|Overall Study|Lost to Follow-up|1
7787250|NCT00570128|27066453|P2|Overall Study|Adverse Event|0
7787251|NCT00570128|27066454|P1|Overall Study|Adverse Event|1
7787252|NCT00570063|27066477|P2|Overall Study|Sponsor's Decision|3
7787253|NCT00570063|27066478|P1|Overall Study|Sponsor's Decision|7
7787254|NCT00570063|27066477|P2|Overall Study|Withdrawal by Subject|3
7787255|NCT00570063|27066478|P1|Overall Study|Withdrawal by Subject|4
7787256|NCT00570063|27066477|P2|Overall Study|Lack of Efficacy|1
7787257|NCT00570063|27066478|P1|Overall Study|Lack of Efficacy|0
7787258|NCT00570063|27066477|P2|Overall Study|Adverse Event|1
7787259|NCT00570063|27066478|P1|Overall Study|Adverse Event|4
7787260|NCT00570037|27066544|P2|Overall Study|Could not reach for 6-8 week contact|69
7787261|NCT00570037|27066545|P1|Overall Study|Could not reach for 6-8 week contact|44
7787262|NCT00569946|27066555|P1|Overall Study|Global Deterioration of Health Status|1
7787263|NCT00569946|27066555|P1|Overall Study|Objective Progression or Relapse|42
7787264|NCT00569946|27066555|P1|Overall Study|Adverse Event|16
7787265|NCT00569803|27066587|P8|Overall Study|Withdrawal by Subject|1
7787266|NCT00569803|27066588|P7|Overall Study|Withdrawal by Subject|0
7787267|NCT00569803|27066589|P6|Overall Study|Withdrawal by Subject|0
7787268|NCT00569803|27066590|P5|Overall Study|Withdrawal by Subject|0
7787269|NCT00569803|27066591|P4|Overall Study|Withdrawal by Subject|0
7787270|NCT00569803|27066592|P3|Overall Study|Withdrawal by Subject|0
7787271|NCT00569803|27066593|P2|Overall Study|Withdrawal by Subject|0
7787272|NCT00569803|27066594|P1|Overall Study|Withdrawal by Subject|0
7787273|NCT00569803|27066587|P8|Overall Study|injection syringe leaked during dosing|0
7787274|NCT00569803|27066588|P7|Overall Study|injection syringe leaked during dosing|0
7787275|NCT00569803|27066589|P6|Overall Study|injection syringe leaked during dosing|0
7787276|NCT00569803|27066590|P5|Overall Study|injection syringe leaked during dosing|0
7787277|NCT00569803|27066591|P4|Overall Study|injection syringe leaked during dosing|1
7787278|NCT00569803|27066592|P3|Overall Study|injection syringe leaked during dosing|0
7787279|NCT00569803|27066593|P2|Overall Study|injection syringe leaked during dosing|0
7787280|NCT00569803|27066594|P1|Overall Study|injection syringe leaked during dosing|0
7787281|NCT00569803|27066587|P8|Overall Study|Lost to Follow-up|0
7787282|NCT00569803|27066588|P7|Overall Study|Lost to Follow-up|0
7787283|NCT00569803|27066589|P6|Overall Study|Lost to Follow-up|0
7787284|NCT00569803|27066590|P5|Overall Study|Lost to Follow-up|0
7787285|NCT00569803|27066591|P4|Overall Study|Lost to Follow-up|0
7787286|NCT00569803|27066592|P3|Overall Study|Lost to Follow-up|0
7787287|NCT00569803|27066593|P2|Overall Study|Lost to Follow-up|0
7787288|NCT00569803|27066594|P1|Overall Study|Lost to Follow-up|1
7787289|NCT00569777|27066721|P2|Overall Study|pregnant|0
7787290|NCT00569777|27066722|P1|Overall Study|pregnant|1
7787291|NCT00569777|27066721|P2|Overall Study|did not meet exclusion criteria|2
7787292|NCT00569777|27066722|P1|Overall Study|did not meet exclusion criteria|1
7787293|NCT00569777|27066721|P2|Overall Study|scheduled eye surgery|1
7787294|NCT00569777|27066722|P1|Overall Study|scheduled eye surgery|0
7787295|NCT00569777|27066721|P2|Overall Study|Lost to Follow-up|0
7787296|NCT00569777|27066722|P1|Overall Study|Lost to Follow-up|1
7787297|NCT00569777|27066721|P2|Overall Study|Adverse Event|0
7787298|NCT00569777|27066722|P1|Overall Study|Adverse Event|3
7787299|NCT00569777|27066721|P2|Overall Study|Withdrawal by Subject|0
7787300|NCT00569777|27066722|P1|Overall Study|Withdrawal by Subject|4
7787301|NCT00569582|27066773|P1|Overall Study|Subject was non-compliant.|1
7787302|NCT00569582|27066773|P1|Overall Study|Subject was too ill to travel.|1
7787303|NCT00569582|27066773|P1|Overall Study|Adverse Event|7
7787304|NCT00569582|27066773|P1|Overall Study|Death|2
7787306|NCT00569374|27066789|P1|Overall Study|Withdrawal by Subject|4
7787307|NCT00569270|27066808|P2|Period: First Intervention|Protocol Violation|1
7787308|NCT00569270|27066809|P1|Period: First Intervention|Protocol Violation|0
7787309|NCT00569231|27066844|P1|Overall Study|Non-compliance|2
7787310|NCT00569231|27066844|P1|Overall Study|Car accident injury|1
7787311|NCT00569231|27066844|P1|Overall Study|Withdrawal by Subject|1
7787312|NCT00569231|27066844|P1|Overall Study|Airfare expense|2
7787313|NCT00569231|27066844|P1|Overall Study|Study unrelated surgery|1
7787314|NCT00569166|27066882|P3|Overall Study|Lost to Follow-up|1
7787315|NCT00569166|27066883|P2|Overall Study|Lost to Follow-up|1
7787316|NCT00569166|27066884|P1|Overall Study|Lost to Follow-up|2
7787317|NCT00569166|27066882|P3|Overall Study|Withdrawal by Subject|3
7787318|NCT00569166|27066883|P2|Overall Study|Withdrawal by Subject|5
7787319|NCT00569166|27066884|P1|Overall Study|Withdrawal by Subject|7
7787320|NCT00569127|27066918|P2|Overall Study|Still on Treatment|3
7787321|NCT00569127|27066919|P1|Overall Study|Still on Treatment|7
7787322|NCT00569127|27066918|P2|Overall Study|Not Eligible|11
7787323|NCT00569127|27066919|P1|Overall Study|Not Eligible|14
7787324|NCT00569127|27066918|P2|Overall Study|Lost to Follow-up|3
7787325|NCT00569127|27066919|P1|Overall Study|Lost to Follow-up|0
7787326|NCT00569127|27066918|P2|Overall Study|Other|19
7787327|NCT00569127|27066919|P1|Overall Study|Other|20
7787328|NCT00569127|27066918|P2|Overall Study|Death|3
7787329|NCT00569127|27066919|P1|Overall Study|Death|4
7787330|NCT00569127|27066918|P2|Overall Study|Progression|100
7787331|NCT00569127|27066919|P1|Overall Study|Progression|99
7787332|NCT00569127|27066918|P2|Overall Study|Withdrawal by Subject|27
7787333|NCT00569127|27066919|P1|Overall Study|Withdrawal by Subject|13
7787334|NCT00569127|27066918|P2|Overall Study|Adverse Event|47
7787335|NCT00569127|27066919|P1|Overall Study|Adverse Event|57
7787336|NCT00568958|27066954|P2|Follow-Up|Adverse Event|0
7787337|NCT00568958|27066955|P1|Follow-Up|Adverse Event|1
7787338|NCT00568958|27066954|P2|Follow-Up|Family Emergency|0
7787339|NCT00568958|27066955|P1|Follow-Up|Family Emergency|1
7787340|NCT00568958|27066954|P2|Follow-Up|Physician Decision|1
7787341|NCT00568958|27066955|P1|Follow-Up|Physician Decision|1
7787342|NCT00568958|27066954|P2|Follow-Up|Withdrawal by Subject|6
7787343|NCT00568958|27066955|P1|Follow-Up|Withdrawal by Subject|6
7787344|NCT00568958|27066954|P2|Allocation|Physician Decision|0
7787345|NCT00568958|27066955|P1|Allocation|Physician Decision|2
7787346|NCT00568958|27066954|P2|Allocation|Withdrawal by Subject|3
7787347|NCT00568958|27066955|P1|Allocation|Withdrawal by Subject|7
7787348|NCT00568776|27067002|P4|Overall Study|Miscellaeneous|4
7787349|NCT00568776|27067003|P3|Overall Study|Miscellaeneous|1
7787350|NCT00568776|27067004|P2|Overall Study|Miscellaeneous|3
7787351|NCT00568776|27067005|P1|Overall Study|Miscellaeneous|3
7787352|NCT00568776|27067002|P4|Overall Study|Sponsor Decision|42
7787353|NCT00568776|27067003|P3|Overall Study|Sponsor Decision|41
7787354|NCT00568776|27067004|P2|Overall Study|Sponsor Decision|2
7787355|NCT00568776|27067005|P1|Overall Study|Sponsor Decision|2
7787356|NCT00568776|27067002|P4|Overall Study|Loss of Caregiver|2
7787357|NCT00568776|27067003|P3|Overall Study|Loss of Caregiver|1
7787358|NCT00568776|27067004|P2|Overall Study|Loss of Caregiver|2
7787359|NCT00568776|27067005|P1|Overall Study|Loss of Caregiver|0
7787360|NCT00568776|27067002|P4|Overall Study|Withdrawal by Subject|7
7787361|NCT00568776|27067003|P3|Overall Study|Withdrawal by Subject|13
7787362|NCT00568776|27067004|P2|Overall Study|Withdrawal by Subject|15
7787363|NCT00568776|27067005|P1|Overall Study|Withdrawal by Subject|13
7787364|NCT00568776|27067002|P4|Overall Study|Protocol Violation|1
7787365|NCT00568776|27067003|P3|Overall Study|Protocol Violation|1
7787366|NCT00568776|27067004|P2|Overall Study|Protocol Violation|0
7787367|NCT00568776|27067005|P1|Overall Study|Protocol Violation|1
7787368|NCT00568776|27067002|P4|Overall Study|Lost to Follow-up|1
7787369|NCT00568776|27067003|P3|Overall Study|Lost to Follow-up|1
7787370|NCT00568776|27067004|P2|Overall Study|Lost to Follow-up|1
7787371|NCT00568776|27067005|P1|Overall Study|Lost to Follow-up|1
7787372|NCT00568776|27067002|P4|Overall Study|Lack of Efficacy|4
7787373|NCT00568776|27067003|P3|Overall Study|Lack of Efficacy|2
7787374|NCT00568776|27067004|P2|Overall Study|Lack of Efficacy|2
7787375|NCT00568776|27067005|P1|Overall Study|Lack of Efficacy|2
7787376|NCT00568776|27067002|P4|Overall Study|Physician Decision|0
7787377|NCT00568776|27067003|P3|Overall Study|Physician Decision|0
7787378|NCT00568776|27067004|P2|Overall Study|Physician Decision|2
7787379|NCT00568776|27067005|P1|Overall Study|Physician Decision|0
7787380|NCT00568776|27067002|P4|Overall Study|Death|3
7787381|NCT00568776|27067003|P3|Overall Study|Death|4
7787382|NCT00568776|27067004|P2|Overall Study|Death|1
7787383|NCT00568776|27067005|P1|Overall Study|Death|0
7787384|NCT00568776|27067002|P4|Overall Study|Adverse Event|8
7787385|NCT00568776|27067003|P3|Overall Study|Adverse Event|10
7787386|NCT00568776|27067004|P2|Overall Study|Adverse Event|8
7787387|NCT00568776|27067005|P1|Overall Study|Adverse Event|8
7787388|NCT00568685|27067054|P3|Overall Study|Protocol Violation|0
7787389|NCT00568685|27067055|P2|Overall Study|Protocol Violation|0
7787390|NCT00568685|27067056|P1|Overall Study|Protocol Violation|1
7787391|NCT00568685|27067054|P3|Overall Study|Withdrawal by Subject|2
7787392|NCT00568685|27067055|P2|Overall Study|Withdrawal by Subject|2
7787393|NCT00568685|27067056|P1|Overall Study|Withdrawal by Subject|7
7787394|NCT00568685|27067054|P3|Overall Study|Adverse Event|3
7787395|NCT00568685|27067055|P2|Overall Study|Adverse Event|3
7787396|NCT00568685|27067056|P1|Overall Study|Adverse Event|2
7787397|NCT00568555|27067113|P2|Overall Study|Withdrawal by Subject|1
7787398|NCT00568555|27067114|P1|Overall Study|Withdrawal by Subject|1
7787399|NCT00568451|27067132|P4|Overall Study|Disease Progression|7
7787400|NCT00568451|27067133|P3|Overall Study|Disease Progression|2
7787401|NCT00568451|27067134|P2|Overall Study|Disease Progression|0
7787402|NCT00568451|27067135|P1|Overall Study|Disease Progression|0
7787403|NCT00568399|27067151|P1|Overall Study|Withdrawal by Subject|8
7787404|NCT00568399|27067151|P1|Overall Study|Adverse Event|5
7787405|NCT00568399|27067151|P1|Overall Study|Death|2
7787406|NCT00568334|27067166|P2|Overall Study|Lost to Follow-up|0
7787407|NCT00568334|27067167|P1|Overall Study|Lost to Follow-up|1
7787408|NCT00568334|27067166|P2|Overall Study|Withdrawal by Subject|1
7787409|NCT00568334|27067167|P1|Overall Study|Withdrawal by Subject|0
7787410|NCT00568321|27067194|P3|Overall Study|Randomized, not treated|1
7787411|NCT00568321|27067195|P2|Overall Study|Randomized, not treated|0
7787412|NCT00568321|27067196|P1|Overall Study|Randomized, not treated|2
7787413|NCT00568321|27067194|P3|Overall Study|Protocol Violation|1
7787414|NCT00568321|27067195|P2|Overall Study|Protocol Violation|0
7787415|NCT00568321|27067196|P1|Overall Study|Protocol Violation|0
7787416|NCT00568321|27067194|P3|Overall Study|Withdrawal by Subject|0
7787417|NCT00568321|27067195|P2|Overall Study|Withdrawal by Subject|0
7787418|NCT00568321|27067196|P1|Overall Study|Withdrawal by Subject|2
7787419|NCT00568321|27067194|P3|Overall Study|Lost to Follow-up|1
7787420|NCT00568321|27067195|P2|Overall Study|Lost to Follow-up|0
7787421|NCT00568321|27067196|P1|Overall Study|Lost to Follow-up|0
7787422|NCT00568321|27067194|P3|Overall Study|Lack of Efficacy|6
7787423|NCT00568321|27067195|P2|Overall Study|Lack of Efficacy|5
7787424|NCT00568321|27067196|P1|Overall Study|Lack of Efficacy|8
7787425|NCT00568321|27067194|P3|Overall Study|Adverse Event|0
7787426|NCT00568321|27067195|P2|Overall Study|Adverse Event|0
7787427|NCT00568321|27067196|P1|Overall Study|Adverse Event|1
7787428|NCT00568178|27067298|P6|Open Label Extension|Withdrawal by Subject|4
7787429|NCT00568178|27067299|P5|Open Label Extension|Withdrawal by Subject|4
7787430|NCT00568178|27067300|P4|Open Label Extension|Withdrawal by Subject|0
7787431|NCT00568178|27067301|P3|Open Label Extension|Withdrawal by Subject|0
7787432|NCT00568178|27067302|P2|Open Label Extension|Withdrawal by Subject|0
7787433|NCT00568178|27067303|P1|Open Label Extension|Withdrawal by Subject|0
7787434|NCT00568178|27067298|P6|Open Label Extension|Termination of Trial|47
7787435|NCT00568178|27067299|P5|Open Label Extension|Termination of Trial|45
7787436|NCT00568178|27067300|P4|Open Label Extension|Termination of Trial|0
7787437|NCT00568178|27067301|P3|Open Label Extension|Termination of Trial|0
7787438|NCT00568178|27067302|P2|Open Label Extension|Termination of Trial|0
7787439|NCT00568178|27067303|P1|Open Label Extension|Termination of Trial|0
7787440|NCT00568178|27067298|P6|Open Label Extension|Progressive Disease|1
7787441|NCT00568178|27067299|P5|Open Label Extension|Progressive Disease|3
7787442|NCT00568178|27067300|P4|Open Label Extension|Progressive Disease|0
7787443|NCT00568178|27067301|P3|Open Label Extension|Progressive Disease|0
7787444|NCT00568178|27067302|P2|Open Label Extension|Progressive Disease|0
7787445|NCT00568178|27067303|P1|Open Label Extension|Progressive Disease|0
7787446|NCT00568178|27067298|P6|Open Label Extension|Pregnancy|1
7787447|NCT00568178|27067299|P5|Open Label Extension|Pregnancy|0
7787448|NCT00568178|27067300|P4|Open Label Extension|Pregnancy|0
7787449|NCT00568178|27067301|P3|Open Label Extension|Pregnancy|0
7787450|NCT00568178|27067302|P2|Open Label Extension|Pregnancy|0
7787451|NCT00568178|27067303|P1|Open Label Extension|Pregnancy|0
7787452|NCT00568178|27067298|P6|Open Label Extension|Physician Decision|8
7787453|NCT00568178|27067299|P5|Open Label Extension|Physician Decision|9
7787454|NCT00568178|27067300|P4|Open Label Extension|Physician Decision|0
7787455|NCT00568178|27067301|P3|Open Label Extension|Physician Decision|0
7787456|NCT00568178|27067302|P2|Open Label Extension|Physician Decision|0
7787457|NCT00568178|27067303|P1|Open Label Extension|Physician Decision|0
7787458|NCT00568178|27067298|P6|Open Label Extension|Lost to Follow-up|11
7787459|NCT00568178|27067299|P5|Open Label Extension|Lost to Follow-up|6
7787460|NCT00568178|27067300|P4|Open Label Extension|Lost to Follow-up|0
7787461|NCT00568178|27067301|P3|Open Label Extension|Lost to Follow-up|0
7787462|NCT00568178|27067302|P2|Open Label Extension|Lost to Follow-up|0
7787463|NCT00568178|27067303|P1|Open Label Extension|Lost to Follow-up|0
7787464|NCT00568178|27067298|P6|Open Label Extension|Protocol Violation|0
7787465|NCT00568178|27067299|P5|Open Label Extension|Protocol Violation|1
7787466|NCT00568178|27067300|P4|Open Label Extension|Protocol Violation|0
7787467|NCT00568178|27067301|P3|Open Label Extension|Protocol Violation|0
7787468|NCT00568178|27067302|P2|Open Label Extension|Protocol Violation|0
7787469|NCT00568178|27067303|P1|Open Label Extension|Protocol Violation|0
7787470|NCT00568178|27067298|P6|Open Label Extension|Adverse Event|8
7787471|NCT00568178|27067299|P5|Open Label Extension|Adverse Event|11
7787472|NCT00568178|27067300|P4|Open Label Extension|Adverse Event|0
7787473|NCT00568178|27067301|P3|Open Label Extension|Adverse Event|0
7787474|NCT00568178|27067302|P2|Open Label Extension|Adverse Event|0
7787475|NCT00568178|27067303|P1|Open Label Extension|Adverse Event|0
7787476|NCT00568178|27067298|P6|Double Blind Base Study|Progressive Disease|0
7787477|NCT00568178|27067299|P5|Double Blind Base Study|Progressive Disease|0
7787478|NCT00568178|27067300|P4|Double Blind Base Study|Progressive Disease|1
7787479|NCT00568178|27067301|P3|Double Blind Base Study|Progressive Disease|0
7787480|NCT00568178|27067302|P2|Double Blind Base Study|Progressive Disease|0
7787481|NCT00568178|27067303|P1|Double Blind Base Study|Progressive Disease|0
7787482|NCT00568178|27067298|P6|Double Blind Base Study|Withdrawal by Subject|0
7787483|NCT00568178|27067299|P5|Double Blind Base Study|Withdrawal by Subject|0
7787484|NCT00568178|27067300|P4|Double Blind Base Study|Withdrawal by Subject|0
7787485|NCT00568178|27067301|P3|Double Blind Base Study|Withdrawal by Subject|0
7787486|NCT00568178|27067302|P2|Double Blind Base Study|Withdrawal by Subject|1
7787487|NCT00568178|27067303|P1|Double Blind Base Study|Withdrawal by Subject|1
7787488|NCT00568178|27067298|P6|Double Blind Base Study|Protocol Violation|0
7787489|NCT00568178|27067299|P5|Double Blind Base Study|Protocol Violation|0
7787490|NCT00568178|27067300|P4|Double Blind Base Study|Protocol Violation|0
7787491|NCT00568178|27067301|P3|Double Blind Base Study|Protocol Violation|0
7787492|NCT00568178|27067302|P2|Double Blind Base Study|Protocol Violation|2
7787493|NCT00568178|27067303|P1|Double Blind Base Study|Protocol Violation|3
7787494|NCT00568178|27067298|P6|Double Blind Base Study|Physician Decision|0
7787495|NCT00568178|27067299|P5|Double Blind Base Study|Physician Decision|0
7787496|NCT00568178|27067300|P4|Double Blind Base Study|Physician Decision|1
7787497|NCT00568178|27067301|P3|Double Blind Base Study|Physician Decision|0
7787498|NCT00568178|27067302|P2|Double Blind Base Study|Physician Decision|1
7787499|NCT00568178|27067303|P1|Double Blind Base Study|Physician Decision|1
7787500|NCT00568178|27067298|P6|Double Blind Base Study|Lost to Follow-up|0
7787501|NCT00568178|27067299|P5|Double Blind Base Study|Lost to Follow-up|0
7787502|NCT00568178|27067300|P4|Double Blind Base Study|Lost to Follow-up|1
7787503|NCT00568178|27067301|P3|Double Blind Base Study|Lost to Follow-up|0
7787504|NCT00568178|27067302|P2|Double Blind Base Study|Lost to Follow-up|0
7787505|NCT00568178|27067303|P1|Double Blind Base Study|Lost to Follow-up|1
7787506|NCT00568178|27067298|P6|Double Blind Base Study|Adverse Event|0
7787507|NCT00568178|27067299|P5|Double Blind Base Study|Adverse Event|0
7787508|NCT00568178|27067300|P4|Double Blind Base Study|Adverse Event|2
7787509|NCT00568178|27067301|P3|Double Blind Base Study|Adverse Event|1
7787510|NCT00568178|27067302|P2|Double Blind Base Study|Adverse Event|2
7787511|NCT00568178|27067303|P1|Double Blind Base Study|Adverse Event|0
7787512|NCT00568126|27067321|P2|Overall Study|Physician Decision|2
7787513|NCT00568126|27067322|P1|Overall Study|Physician Decision|2
7787514|NCT00568126|27067321|P2|Overall Study|Lack of Efficacy|1
7787515|NCT00568126|27067322|P1|Overall Study|Lack of Efficacy|0
7787516|NCT00568126|27067321|P2|Overall Study|Lost to Follow-up|3
7787517|NCT00568126|27067322|P1|Overall Study|Lost to Follow-up|4
7787518|NCT00568126|27067321|P2|Overall Study|Withdrawal by Subject|3
7787519|NCT00568126|27067322|P1|Overall Study|Withdrawal by Subject|2
7787520|NCT00568126|27067321|P2|Overall Study|Adverse Event|0
7787521|NCT00568126|27067322|P1|Overall Study|Adverse Event|3
7787522|NCT00568061|27067347|P2|Overall Study|Adverse Event|1
7787523|NCT00568061|27067348|P1|Overall Study|Adverse Event|0
7787524|NCT00568061|27067347|P2|Overall Study|Inclusion / exclusion criteria|1
7787525|NCT00568061|27067348|P1|Overall Study|Inclusion / exclusion criteria|5
7787526|NCT00567996|27067411|P3|Overall Study|Patient's inability to use the device|0
7787527|NCT00567996|27067412|P2|Overall Study|Patient's inability to use the device|1
7787528|NCT00567996|27067413|P1|Overall Study|Patient's inability to use the device|0
7787529|NCT00567996|27067411|P3|Overall Study|Death|2
7787530|NCT00567996|27067412|P2|Overall Study|Death|0
7787531|NCT00567996|27067413|P1|Overall Study|Death|1
7787532|NCT00567996|27067411|P3|Overall Study|Administrative problems|0
7787533|NCT00567996|27067412|P2|Overall Study|Administrative problems|1
7787534|NCT00567996|27067413|P1|Overall Study|Administrative problems|1
7787535|NCT00567996|27067411|P3|Overall Study|Unsatisfactory therapeutic effect|15
7787536|NCT00567996|27067412|P2|Overall Study|Unsatisfactory therapeutic effect|2
7787537|NCT00567996|27067413|P1|Overall Study|Unsatisfactory therapeutic effect|1
7787538|NCT00567996|27067411|P3|Overall Study|Lost to Follow-up|2
7787539|NCT00567996|27067412|P2|Overall Study|Lost to Follow-up|5
7787540|NCT00567996|27067413|P1|Overall Study|Lost to Follow-up|2
7787541|NCT00567996|27067411|P3|Overall Study|Abnormal test procedure result(s)|1
7787542|NCT00567996|27067412|P2|Overall Study|Abnormal test procedure result(s)|1
7787543|NCT00567996|27067413|P1|Overall Study|Abnormal test procedure result(s)|2
7787544|NCT00567996|27067411|P3|Overall Study|Abnormal Lab value(s)|2
7787545|NCT00567996|27067412|P2|Overall Study|Abnormal Lab value(s)|1
7787546|NCT00567996|27067413|P1|Overall Study|Abnormal Lab value(s)|2
7787547|NCT00567996|27067411|P3|Overall Study|Withdrawal by Subject|22
7787548|NCT00567996|27067412|P2|Overall Study|Withdrawal by Subject|12
7787549|NCT00567996|27067413|P1|Overall Study|Withdrawal by Subject|8
7787550|NCT00567996|27067411|P3|Overall Study|Protocol Deviation|13
7787551|NCT00567996|27067412|P2|Overall Study|Protocol Deviation|11
7787552|NCT00567996|27067413|P1|Overall Study|Protocol Deviation|9
7787553|NCT00567996|27067411|P3|Overall Study|Adverse Event|13
7787554|NCT00567996|27067412|P2|Overall Study|Adverse Event|16
7787555|NCT00567996|27067413|P1|Overall Study|Adverse Event|18
7787556|NCT00567892|27067429|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
7787557|NCT00567892|27067430|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7787558|NCT00567892|27067431|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7787559|NCT00567892|27067432|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7787560|NCT00567892|27067429|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
7787561|NCT00567892|27067430|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
7787562|NCT00567892|27067431|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7787563|NCT00567892|27067432|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7787564|NCT00567879|27067450|P6|Overall Study|Disease progression|3
7787565|NCT00567879|27067451|P5|Overall Study|Disease progression|11
7787566|NCT00567879|27067452|P4|Overall Study|Disease progression|5
7787567|NCT00567879|27067453|P3|Overall Study|Disease progression|15
7787568|NCT00567879|27067454|P2|Overall Study|Disease progression|7
7787569|NCT00567879|27067455|P1|Overall Study|Disease progression|5
7787570|NCT00567879|27067450|P6|Overall Study|New cancer therapy|0
7787571|NCT00567879|27067451|P5|Overall Study|New cancer therapy|0
7787572|NCT00567879|27067452|P4|Overall Study|New cancer therapy|0
7787573|NCT00567879|27067453|P3|Overall Study|New cancer therapy|1
7787574|NCT00567879|27067454|P2|Overall Study|New cancer therapy|0
7787575|NCT00567879|27067455|P1|Overall Study|New cancer therapy|0
7787576|NCT00567879|27067450|P6|Overall Study|Withdrawal by Subject|0
7787577|NCT00567879|27067451|P5|Overall Study|Withdrawal by Subject|0
7787578|NCT00567879|27067452|P4|Overall Study|Withdrawal by Subject|1
7787579|NCT00567879|27067453|P3|Overall Study|Withdrawal by Subject|3
7787580|NCT00567879|27067454|P2|Overall Study|Withdrawal by Subject|0
7787581|NCT00567879|27067455|P1|Overall Study|Withdrawal by Subject|0
7787582|NCT00567879|27067450|P6|Overall Study|Abnormal test procedure(s)|0
7787583|NCT00567879|27067451|P5|Overall Study|Abnormal test procedure(s)|0
7787584|NCT00567879|27067452|P4|Overall Study|Abnormal test procedure(s)|0
7787585|NCT00567879|27067453|P3|Overall Study|Abnormal test procedure(s)|1
7787586|NCT00567879|27067454|P2|Overall Study|Abnormal test procedure(s)|0
7787587|NCT00567879|27067455|P1|Overall Study|Abnormal test procedure(s)|0
7787588|NCT00567879|27067450|P6|Overall Study|Adverse Event|0
7787589|NCT00567879|27067451|P5|Overall Study|Adverse Event|1
7787590|NCT00567879|27067452|P4|Overall Study|Adverse Event|0
7787591|NCT00567879|27067453|P3|Overall Study|Adverse Event|1
7787592|NCT00567879|27067454|P2|Overall Study|Adverse Event|0
7787593|NCT00567879|27067455|P1|Overall Study|Adverse Event|2
7787594|NCT00567593|27067522|P1|Overall Study|Physician Decision|1
7787595|NCT00567593|27067522|P1|Overall Study|Adverse Event|1
7787596|NCT00567580|27067529|P3|Overall Study|Protocol Violation|24
7787597|NCT00567580|27067530|P2|Overall Study|Protocol Violation|24
7787598|NCT00567580|27067531|P1|Overall Study|Protocol Violation|28
7787599|NCT00567567|27067566|P3|Overall Study|Unable adequate stem cell for transplant|2
7787600|NCT00567567|27067567|P2|Overall Study|Unable adequate stem cell for transplant|0
7787601|NCT00567567|27067568|P1|Overall Study|Unable adequate stem cell for transplant|0
7787602|NCT00567567|27067566|P3|Overall Study|Enrolled another COG therapeutic study|0
7787603|NCT00567567|27067567|P2|Overall Study|Enrolled another COG therapeutic study|80
7787604|NCT00567567|27067568|P1|Overall Study|Enrolled another COG therapeutic study|99
7787605|NCT00567567|27067566|P3|Overall Study|Refusal by patient/parent/guardian|122
7787606|NCT00567567|27067567|P2|Overall Study|Refusal by patient/parent/guardian|16
7787607|NCT00567567|27067568|P1|Overall Study|Refusal by patient/parent/guardian|9
7787608|NCT00567567|27067566|P3|Overall Study|Ineligible|9
7787609|NCT00567567|27067567|P2|Overall Study|Ineligible|0
7787610|NCT00567567|27067568|P1|Overall Study|Ineligible|4
7787611|NCT00567567|27067566|P3|Overall Study|Withdrawal by Subject|2
7787612|NCT00567567|27067567|P2|Overall Study|Withdrawal by Subject|0
7787613|NCT00567567|27067568|P1|Overall Study|Withdrawal by Subject|0
7787614|NCT00567567|27067566|P3|Overall Study|Physician Decision|84
7787615|NCT00567567|27067567|P2|Overall Study|Physician Decision|18
7787616|NCT00567567|27067568|P1|Overall Study|Physician Decision|16
7787617|NCT00567567|27067566|P3|Overall Study|Lost to Follow-up|1
7787618|NCT00567567|27067567|P2|Overall Study|Lost to Follow-up|0
7787619|NCT00567567|27067568|P1|Overall Study|Lost to Follow-up|0
7787620|NCT00567567|27067566|P3|Overall Study|Lack of Efficacy|48
7787621|NCT00567567|27067567|P2|Overall Study|Lack of Efficacy|17
7787622|NCT00567567|27067568|P1|Overall Study|Lack of Efficacy|16
7787623|NCT00567567|27067566|P3|Overall Study|Death|5
7787624|NCT00567567|27067567|P2|Overall Study|Death|1
7787625|NCT00567567|27067568|P1|Overall Study|Death|8
7787626|NCT00567567|27067566|P3|Overall Study|Adverse Event|5
7787627|NCT00567567|27067567|P2|Overall Study|Adverse Event|2
7787628|NCT00567567|27067568|P1|Overall Study|Adverse Event|0
7787629|NCT00567541|27067616|P2|Overall Study|Adverse Event|1
7787630|NCT00567541|27067617|P1|Overall Study|Adverse Event|0
7787631|NCT00567502|27067627|P4|Overall Study|Never Initiated Treatment|72
7787632|NCT00567502|27067628|P3|Overall Study|Never Initiated Treatment|0
7787633|NCT00567502|27067629|P2|Overall Study|Never Initiated Treatment|0
7787634|NCT00567502|27067630|P1|Overall Study|Never Initiated Treatment|0
7787635|NCT00567502|27067627|P4|Overall Study|Sponsor request|1
7787636|NCT00567502|27067628|P3|Overall Study|Sponsor request|30
7787637|NCT00567502|27067629|P2|Overall Study|Sponsor request|0
7787638|NCT00567502|27067630|P1|Overall Study|Sponsor request|9
7787639|NCT00567502|27067627|P4|Overall Study|Participant request|1
7787640|NCT00567502|27067628|P3|Overall Study|Participant request|33
7787641|NCT00567502|27067629|P2|Overall Study|Participant request|1
7787642|NCT00567502|27067630|P1|Overall Study|Participant request|12
7787643|NCT00567502|27067627|P4|Overall Study|Other|6
7787644|NCT00567502|27067628|P3|Overall Study|Other|134
7787645|NCT00567502|27067629|P2|Overall Study|Other|2
7787646|NCT00567502|27067630|P1|Overall Study|Other|64
7787647|NCT00567502|27067627|P4|Overall Study|Death|5
7787648|NCT00567502|27067628|P3|Overall Study|Death|360
7787649|NCT00567502|27067629|P2|Overall Study|Death|16
7787650|NCT00567502|27067630|P1|Overall Study|Death|65
7787651|NCT00567502|27067627|P4|Overall Study|Lost to Follow-up|2
7787652|NCT00567502|27067628|P3|Overall Study|Lost to Follow-up|351
7787653|NCT00567502|27067629|P2|Overall Study|Lost to Follow-up|14
7787654|NCT00567502|27067630|P1|Overall Study|Lost to Follow-up|91
7787655|NCT00567489|27067667|P2|Overall Study|Other|0
7787656|NCT00567489|27067668|P1|Overall Study|Other|1
7787657|NCT00567489|27067667|P2|Overall Study|Renal Transplantation|3
7787658|NCT00567489|27067668|P1|Overall Study|Renal Transplantation|0
7787659|NCT00567489|27067667|P2|Overall Study|Withdrawal by Subject|2
7787660|NCT00567489|27067668|P1|Overall Study|Withdrawal by Subject|0
7787661|NCT00567489|27067667|P2|Overall Study|Physician Decision|4
7787662|NCT00567489|27067668|P1|Overall Study|Physician Decision|0
7787663|NCT00567489|27067667|P2|Overall Study|Adverse Event|14
7787664|NCT00567489|27067668|P1|Overall Study|Adverse Event|6
7787665|NCT00567476|27067718|P2|Overall Study|Non-adherence to protocol|1
7787666|NCT00567476|27067719|P1|Overall Study|Non-adherence to protocol|0
7787667|NCT00567476|27067718|P2|Overall Study|Medical Decision|1
7787668|NCT00567476|27067719|P1|Overall Study|Medical Decision|0
7787669|NCT00567476|27067718|P2|Overall Study|Administrative issues|0
7787670|NCT00567476|27067719|P1|Overall Study|Administrative issues|1
7787671|NCT00567476|27067718|P2|Overall Study|Lost to Follow-up|1
7787672|NCT00567476|27067719|P1|Overall Study|Lost to Follow-up|0
7787673|NCT00567476|27067718|P2|Overall Study|Protocol Violation|1
7787674|NCT00567476|27067719|P1|Overall Study|Protocol Violation|4
7787675|NCT00567476|27067718|P2|Overall Study|Pregnancy|0
7787676|NCT00567476|27067719|P1|Overall Study|Pregnancy|1
7787677|NCT00567476|27067718|P2|Overall Study|Adverse Event|0
7787678|NCT00567476|27067719|P1|Overall Study|Adverse Event|2
7787679|NCT00567398|27067745|P2|Overall Study|Other|0
7787680|NCT00567398|27067746|P1|Overall Study|Other|1
7787681|NCT00567398|27067745|P2|Overall Study|Renal Transplantation|3
7787682|NCT00567398|27067746|P1|Overall Study|Renal Transplantation|0
7787683|NCT00567398|27067745|P2|Overall Study|Withdrawal by Subject|2
7787684|NCT00567398|27067746|P1|Overall Study|Withdrawal by Subject|0
7787685|NCT00567398|27067745|P2|Overall Study|Physician Decision|4
7787686|NCT00567398|27067746|P1|Overall Study|Physician Decision|0
7787687|NCT00567398|27067745|P2|Overall Study|Adverse Event|14
7787688|NCT00567398|27067746|P1|Overall Study|Adverse Event|6
7787689|NCT00567359|27067794|P1|Overall Study|Withdrawal by Subject|1
7787690|NCT00567268|27067819|P1|Overall Study|"Safety Evaluation Not Assessable"|1
7787691|NCT00567268|27067819|P1|Overall Study|No Drug Administration|4
7787692|NCT00567268|27067819|P1|Overall Study|No Visit After First Day of Treatment|2
7787693|NCT00567268|27067819|P1|Overall Study|Lost to Follow-up|36
7787694|NCT00567268|27067819|P1|Overall Study|Protocol Violation|7
7787695|NCT00567255|27067870|P2|Overall Study|Drug noncompliance,moved,other|15
7787696|NCT00567255|27067871|P1|Overall Study|Drug noncompliance,moved,other|25
7787697|NCT00567255|27067870|P2|Overall Study|Pregnancy|0
7787698|NCT00567255|27067871|P1|Overall Study|Pregnancy|6
7787699|NCT00567255|27067870|P2|Overall Study|Protocol Violation|8
7787700|NCT00567255|27067871|P1|Overall Study|Protocol Violation|20
7787701|NCT00567255|27067870|P2|Overall Study|Lack of Efficacy|33
7787702|NCT00567255|27067871|P1|Overall Study|Lack of Efficacy|19
7787703|NCT00567255|27067870|P2|Overall Study|Withdrawal by Subject|56
7787704|NCT00567255|27067871|P1|Overall Study|Withdrawal by Subject|75
7787705|NCT00567255|27067870|P2|Overall Study|Lost to Follow-up|48
7787706|NCT00567255|27067871|P1|Overall Study|Lost to Follow-up|77
7787707|NCT00567255|27067870|P2|Overall Study|Adverse Event|68
7787708|NCT00567255|27067871|P1|Overall Study|Adverse Event|241
7787709|NCT00567190|27067934|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
7787710|NCT00567190|27067935|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
7787711|NCT00567190|27067934|P2|Overall Study|Death|280
7787712|NCT00567190|27067935|P1|Overall Study|Death|235
7787713|NCT00567164|27067986|P3|Overall Study|Missing|0
7787714|NCT00567164|27067987|P2|Overall Study|Missing|0
7787715|NCT00567164|27067988|P1|Overall Study|Missing|1
7787716|NCT00567164|27067986|P3|Overall Study|Primary Reason coded as 'Other'|16
7787717|NCT00567164|27067987|P2|Overall Study|Primary Reason coded as 'Other'|8
7787718|NCT00567164|27067988|P1|Overall Study|Primary Reason coded as 'Other'|37
7787719|NCT00567164|27067986|P3|Overall Study|Pregnancy|6
7787720|NCT00567164|27067987|P2|Overall Study|Pregnancy|4
7787721|NCT00567164|27067988|P1|Overall Study|Pregnancy|20
7787722|NCT00567164|27067986|P3|Overall Study|Lost to Follow-up|21
7787723|NCT00567164|27067987|P2|Overall Study|Lost to Follow-up|23
7787724|NCT00567164|27067988|P1|Overall Study|Lost to Follow-up|202
7787725|NCT00567164|27067986|P3|Overall Study|Death|1
7787726|NCT00567164|27067987|P2|Overall Study|Death|0
7787727|NCT00567164|27067988|P1|Overall Study|Death|0
7787728|NCT00567164|27067986|P3|Overall Study|Adverse Event|9
7787729|NCT00567164|27067987|P2|Overall Study|Adverse Event|13
7787730|NCT00567164|27067988|P1|Overall Study|Adverse Event|92
7787731|NCT00567164|27067986|P3|Overall Study|Protocol Violation|2
7787732|NCT00567164|27067987|P2|Overall Study|Protocol Violation|4
7787733|NCT00567164|27067988|P1|Overall Study|Protocol Violation|23
7787734|NCT00567164|27067986|P3|Overall Study|Withdrawal by Subject|17
7787735|NCT00567164|27067987|P2|Overall Study|Withdrawal by Subject|21
7787736|NCT00567164|27067988|P1|Overall Study|Withdrawal by Subject|171
7787737|NCT00567112|27068060|P3|Washout Period 3 (3 Days)|Protocol Violation|0
7787738|NCT00567112|27068061|P2|Washout Period 3 (3 Days)|Protocol Violation|0
7787739|NCT00567112|27068062|P1|Washout Period 3 (3 Days)|Protocol Violation|1
7787740|NCT00567112|27068060|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
7787741|NCT00567112|27068061|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
7787742|NCT00567112|27068062|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
7787827|NCT00566527|27068323|P2|Overall Study|Physician Decision|8
7787743|NCT00567112|27068060|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
7787744|NCT00567112|27068061|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
7787745|NCT00567112|27068062|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
7787746|NCT00566995|27068093|P1|Overall Study|Withdrew consent|3
7787747|NCT00566995|27068093|P1|Overall Study|Toxicity|4
7787748|NCT00566982|27068108|P2|Overall Study|Other-family problems & doctor's request|2
7787749|NCT00566982|27068109|P1|Overall Study|Other-family problems & doctor's request|0
7787750|NCT00566982|27068108|P2|Overall Study|Lost to Follow-up|1
7787751|NCT00566982|27068109|P1|Overall Study|Lost to Follow-up|0
7787752|NCT00566982|27068108|P2|Overall Study|Protocol Violation|4
7787753|NCT00566982|27068109|P1|Overall Study|Protocol Violation|1
7787754|NCT00566982|27068108|P2|Overall Study|Withdrawal by Subject|14
7787755|NCT00566982|27068109|P1|Overall Study|Withdrawal by Subject|1
7787756|NCT00566982|27068108|P2|Overall Study|Adverse Event|48
7787757|NCT00566982|27068109|P1|Overall Study|Adverse Event|6
7787758|NCT00566852|27068174|P2|Overall Study|Missing reason not reported|20
7787759|NCT00566852|27068175|P1|Overall Study|Missing reason not reported|16
7787760|NCT00566852|27068174|P2|Overall Study|Missing reason not specified|2
7787761|NCT00566852|27068175|P1|Overall Study|Missing reason not specified|1
7787762|NCT00566852|27068174|P2|Overall Study|Not tested due to disability|12
7787763|NCT00566852|27068175|P1|Overall Study|Not tested due to disability|6
7787764|NCT00566852|27068174|P2|Overall Study|Patient refusal|37
7787765|NCT00566852|27068175|P1|Overall Study|Patient refusal|37
7787766|NCT00566852|27068174|P2|Overall Study|Withdrawal by Subject|25
7787767|NCT00566852|27068175|P1|Overall Study|Withdrawal by Subject|30
7787768|NCT00566852|27068174|P2|Overall Study|Death|78
7787769|NCT00566852|27068175|P1|Overall Study|Death|95
7787770|NCT00566852|27068174|P2|Overall Study|Protocol Violation|24
7787771|NCT00566852|27068175|P1|Overall Study|Protocol Violation|22
7787772|NCT00566735|27068206|P2|Overall Study|Switched into a manic episode|1
7787773|NCT00566735|27068207|P1|Overall Study|Switched into a manic episode|0
7787774|NCT00566735|27068206|P2|Overall Study|Refused neuropsychological testing|5
7787775|NCT00566735|27068207|P1|Overall Study|Refused neuropsychological testing|2
7787776|NCT00566735|27068206|P2|Overall Study|Withdrawal by Subject|1
7787777|NCT00566735|27068207|P1|Overall Study|Withdrawal by Subject|0
7787778|NCT00566722|27068220|P3|Overall Study|Noncompliant with drug administration|1
7787779|NCT00566722|27068221|P2|Overall Study|Noncompliant with drug administration|0
7787780|NCT00566722|27068222|P1|Overall Study|Noncompliant with drug administration|0
7787781|NCT00566722|27068220|P3|Overall Study|Serious adverse event|0
7787782|NCT00566722|27068221|P2|Overall Study|Serious adverse event|1
7787783|NCT00566722|27068222|P1|Overall Study|Serious adverse event|0
7787784|NCT00566722|27068220|P3|Overall Study|Did not meet exclusion criteria|2
7787785|NCT00566722|27068221|P2|Overall Study|Did not meet exclusion criteria|0
7787786|NCT00566722|27068222|P1|Overall Study|Did not meet exclusion criteria|0
7787787|NCT00566722|27068220|P3|Overall Study|Lack of Efficacy|4
7787788|NCT00566722|27068221|P2|Overall Study|Lack of Efficacy|2
7787789|NCT00566722|27068222|P1|Overall Study|Lack of Efficacy|1
7787790|NCT00566722|27068220|P3|Overall Study|Lost to Follow-up|1
7787791|NCT00566722|27068221|P2|Overall Study|Lost to Follow-up|1
7787792|NCT00566722|27068222|P1|Overall Study|Lost to Follow-up|1
7787793|NCT00566722|27068220|P3|Overall Study|Withdrawal by Subject|1
7787794|NCT00566722|27068221|P2|Overall Study|Withdrawal by Subject|0
7787795|NCT00566722|27068222|P1|Overall Study|Withdrawal by Subject|0
7787796|NCT00566722|27068220|P3|Overall Study|Adverse Event|0
7787797|NCT00566722|27068221|P2|Overall Study|Adverse Event|1
7787798|NCT00566722|27068222|P1|Overall Study|Adverse Event|0
7787799|NCT00566709|27068268|P2|Overall Study|Protocol Violation|0
7787800|NCT00566709|27068269|P1|Overall Study|Protocol Violation|5
7787801|NCT00566696|27068285|P1|Overall Study|Non-Patient Donors|37
7787802|NCT00566696|27068285|P1|Overall Study|Physician Decision|1
7787803|NCT00566696|27068285|P1|Overall Study|Health Status Change|1
7787804|NCT00566696|27068285|P1|Overall Study|Muromonab not available|1
7787805|NCT00566696|27068285|P1|Overall Study|Met Exclusion Criteria|2
7787806|NCT00566631|27068295|P1|Part 2: Extension Phase|Other|5
7787807|NCT00566631|27068295|P1|Part 2: Extension Phase|Death|1
7787808|NCT00566631|27068295|P1|Part 2: Extension Phase|Lost to Follow-up|6
7787809|NCT00566631|27068295|P1|Part 2: Extension Phase|Adverse Event|11
7787810|NCT00566631|27068295|P1|Part 2: Extension Phase|Withdrawal by Subject|34
7787811|NCT00566631|27068295|P1|Part 2: Extension Phase|Lack of Efficacy|25
7787812|NCT00566631|27068295|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
7787813|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
7787814|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
7787815|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
7787816|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
7787817|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Adverse Event|9
7787818|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Physician Decision|1
7787819|NCT00566631|27068295|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
7787820|NCT00566527|27068322|P3|Overall Study|Withdrawal by Subject|43
7787821|NCT00566527|27068323|P2|Overall Study|Withdrawal by Subject|43
7787822|NCT00566527|27068324|P1|Overall Study|Withdrawal by Subject|6
7787823|NCT00566527|27068322|P3|Overall Study|Lost to Follow-up|4
7787824|NCT00566527|27068323|P2|Overall Study|Lost to Follow-up|4
7787825|NCT00566527|27068324|P1|Overall Study|Lost to Follow-up|3
7787826|NCT00566527|27068322|P3|Overall Study|Physician Decision|20
7787828|NCT00566527|27068324|P1|Overall Study|Physician Decision|3
7787829|NCT00566527|27068322|P3|Overall Study|Adverse Event|1
7787830|NCT00566527|27068323|P2|Overall Study|Adverse Event|0
7787831|NCT00566527|27068324|P1|Overall Study|Adverse Event|2
7787832|NCT00566527|27068322|P3|Overall Study|Reason not provided|10
7787833|NCT00566527|27068323|P2|Overall Study|Reason not provided|11
7787834|NCT00566527|27068324|P1|Overall Study|Reason not provided|3
7787835|NCT00566254|27068385|P2|Overall Study|Other|2
7787836|NCT00566254|27068386|P1|Overall Study|Other|0
7787837|NCT00566254|27068385|P2|Overall Study|Lack of Efficacy|6
7787838|NCT00566254|27068386|P1|Overall Study|Lack of Efficacy|5
7787839|NCT00566254|27068385|P2|Overall Study|Withdrawal by Subject|2
7787840|NCT00566254|27068386|P1|Overall Study|Withdrawal by Subject|1
7787841|NCT00566254|27068385|P2|Overall Study|Protocol Violation|3
7787842|NCT00566254|27068386|P1|Overall Study|Protocol Violation|1
7787843|NCT00566254|27068385|P2|Overall Study|Adverse Event|1
7787844|NCT00566254|27068386|P1|Overall Study|Adverse Event|3
7787845|NCT00566228|27068400|P2|Overall Study|progressed before infusion could occur|1
7787846|NCT00566228|27068401|P1|Overall Study|progressed before infusion could occur|0
7787847|NCT00566228|27068400|P2|Overall Study|Unable to collect sufficient CD34 cells|2
7787848|NCT00566228|27068401|P1|Overall Study|Unable to collect sufficient CD34 cells|3
7787849|NCT00566228|27068400|P2|Overall Study|Attempt to mobilize stem cells failed|2
7787850|NCT00566228|27068401|P1|Overall Study|Attempt to mobilize stem cells failed|2
7787851|NCT00566228|27068400|P2|Overall Study|Withdrawal by Subject|0
7787852|NCT00566228|27068401|P1|Overall Study|Withdrawal by Subject|1
7787853|NCT00566111|27068434|P2|Overall Study|Adverse Event|2
7787854|NCT00566111|27068435|P1|Overall Study|Adverse Event|0
7787855|NCT00566098|27068449|P1|Administration of ASCT+MILs|Lack of Efficacy|8
7787856|NCT00566098|27068449|P1|Administration of ASCT+MILs|Death|10
7787857|NCT00566098|27068449|P1|Generation of MILs Product|Relapsed|1
7787858|NCT00566098|27068449|P1|Collection of MILs|Relapsed|1
7787859|NCT00566098|27068449|P1|Collection of MILs|Withdrawal by Subject|1
7787860|NCT00566020|27068459|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
7787861|NCT00566020|27068460|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
7787862|NCT00566020|27068459|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
7787863|NCT00566020|27068460|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
7787864|NCT00566020|27068459|P2|46-week Long-term Administration Phase|Physician Decision|7
7787865|NCT00566020|27068460|P1|46-week Long-term Administration Phase|Physician Decision|0
7787866|NCT00566020|27068459|P2|46-week Long-term Administration Phase|Adverse Event|7
7787867|NCT00566020|27068460|P1|46-week Long-term Administration Phase|Adverse Event|0
7787868|NCT00566020|27068459|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
7787869|NCT00566020|27068460|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
7787870|NCT00566020|27068459|P2|6-week Dosage Adjustment Phase|Adverse Event|0
7787871|NCT00566020|27068460|P1|6-week Dosage Adjustment Phase|Adverse Event|5
7787888|NCT00565812|27068598|P3|Overall Study|Physician Decision|0
7787889|NCT00565812|27068599|P2|Overall Study|Physician Decision|0
7787890|NCT00565812|27068600|P1|Overall Study|Physician Decision|2
7787891|NCT00565812|27068598|P3|Overall Study|Follow-up Visit Not Completed|1
7787892|NCT00565812|27068599|P2|Overall Study|Follow-up Visit Not Completed|0
7787893|NCT00565812|27068600|P1|Overall Study|Follow-up Visit Not Completed|2
7787894|NCT00565812|27068598|P3|Overall Study|Low Compliance|1
7787895|NCT00565812|27068599|P2|Overall Study|Low Compliance|0
7787896|NCT00565812|27068600|P1|Overall Study|Low Compliance|1
7787897|NCT00565812|27068598|P3|Overall Study|Surgical Intervention|2
7787898|NCT00565812|27068599|P2|Overall Study|Surgical Intervention|1
7787899|NCT00565812|27068600|P1|Overall Study|Surgical Intervention|0
7787900|NCT00565812|27068598|P3|Overall Study|Research Site Closure|8
7787901|NCT00565812|27068599|P2|Overall Study|Research Site Closure|1
7787902|NCT00565812|27068600|P1|Overall Study|Research Site Closure|6
7787903|NCT00565812|27068598|P3|Overall Study|Domestic Reasons|3
7787904|NCT00565812|27068599|P2|Overall Study|Domestic Reasons|1
7787905|NCT00565812|27068600|P1|Overall Study|Domestic Reasons|7
7787906|NCT00565812|27068598|P3|Overall Study|Sponsor Decision|1
7787907|NCT00565812|27068599|P2|Overall Study|Sponsor Decision|5
7787908|NCT00565812|27068600|P1|Overall Study|Sponsor Decision|1
7787909|NCT00565812|27068598|P3|Overall Study|Relocated Out of Area|9
7787910|NCT00565812|27068599|P2|Overall Study|Relocated Out of Area|8
7787911|NCT00565812|27068600|P1|Overall Study|Relocated Out of Area|5
7787912|NCT00565812|27068598|P3|Overall Study|Jury Duty|0
7787913|NCT00565812|27068599|P2|Overall Study|Jury Duty|0
7787914|NCT00565812|27068600|P1|Overall Study|Jury Duty|1
7787915|NCT00565812|27068598|P3|Overall Study|Adverse Event|40
7787916|NCT00565812|27068599|P2|Overall Study|Adverse Event|54
7787917|NCT00565812|27068600|P1|Overall Study|Adverse Event|41
7787918|NCT00565812|27068598|P3|Overall Study|Protocol Violation|4
7787919|NCT00565812|27068599|P2|Overall Study|Protocol Violation|6
7787920|NCT00565812|27068600|P1|Overall Study|Protocol Violation|2
7787921|NCT00565812|27068598|P3|Overall Study|Work Schedule|1
7787922|NCT00565812|27068599|P2|Overall Study|Work Schedule|3
7787923|NCT00565812|27068600|P1|Overall Study|Work Schedule|5
7787924|NCT00565812|27068598|P3|Overall Study|Withdrawal by Subject|48
7787925|NCT00565812|27068599|P2|Overall Study|Withdrawal by Subject|47
7787926|NCT00565812|27068600|P1|Overall Study|Withdrawal by Subject|58
7787927|NCT00565812|27068598|P3|Overall Study|Lost to Follow-up|8
7787928|NCT00565812|27068599|P2|Overall Study|Lost to Follow-up|8
7787929|NCT00565812|27068600|P1|Overall Study|Lost to Follow-up|10
7787930|NCT00565812|27068598|P3|Overall Study|Did not Meet Entrance Criteria|1
7787931|NCT00565812|27068599|P2|Overall Study|Did not Meet Entrance Criteria|0
7787932|NCT00565812|27068600|P1|Overall Study|Did not Meet Entrance Criteria|1
7787933|NCT00565812|27068598|P3|Overall Study|Death|3
7787934|NCT00565812|27068599|P2|Overall Study|Death|1
7787935|NCT00565812|27068600|P1|Overall Study|Death|2
7787936|NCT00565773|27068737|P1|Overall Study|Physician Decision|1
7787937|NCT00565773|27068737|P1|Overall Study|Withdrawal by Subject|1
7787938|NCT00565747|27068749|P2|Overall Study|No embryo transfer|73
7787939|NCT00565747|27068750|P1|Overall Study|No embryo transfer|67
7787940|NCT00565721|27068760|P1|Overall Study|Other reasons|6
7787941|NCT00565721|27068760|P1|Overall Study|Physician Decision|2
7787942|NCT00565721|27068760|P1|Overall Study|Technical Problems|1
7787943|NCT00565721|27068760|P1|Overall Study|Lost to Follow-up|6
7787944|NCT00565721|27068760|P1|Overall Study|Screen Failure|2
7787945|NCT00565617|27068809|P1|Overall Study|Withdrawal by Subject|1
7787946|NCT00565604|27068813|P1|Overall Study|Lost to Follow-up|2
7787947|NCT00565604|27068813|P1|Overall Study|Failure to treat|2
7787948|NCT00565448|27068859|P2|Overall Study|Withdrawal by Subject|0
7787949|NCT00565448|27068860|P1|Overall Study|Withdrawal by Subject|1
7787950|NCT00565448|27068859|P2|Overall Study|Disease progression|0
7787951|NCT00565448|27068860|P1|Overall Study|Disease progression|1
7787952|NCT00565448|27068859|P2|Overall Study|Adverse Event|2
7787953|NCT00565448|27068860|P1|Overall Study|Adverse Event|1
7787954|NCT00565409|27068871|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
7787955|NCT00565409|27068872|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
7787956|NCT00565409|27068873|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
7787957|NCT00565409|27068874|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
7787958|NCT00565409|27068871|P4|Period 2 Double-Blind|Other|9
7787959|NCT00565409|27068872|P3|Period 2 Double-Blind|Other|5
7787960|NCT00565409|27068873|P2|Period 2 Double-Blind|Other|4
7787961|NCT00565409|27068874|P1|Period 2 Double-Blind|Other|0
7787962|NCT00565409|27068871|P4|Period 2 Double-Blind|Lost to Follow-up|0
7787963|NCT00565409|27068872|P3|Period 2 Double-Blind|Lost to Follow-up|1
7787964|NCT00565409|27068873|P2|Period 2 Double-Blind|Lost to Follow-up|0
7787965|NCT00565409|27068874|P1|Period 2 Double-Blind|Lost to Follow-up|0
7787966|NCT00565409|27068871|P4|Period 2 Double-Blind|Protocol Violation|2
7787967|NCT00565409|27068872|P3|Period 2 Double-Blind|Protocol Violation|6
7787968|NCT00565409|27068873|P2|Period 2 Double-Blind|Protocol Violation|4
7787969|NCT00565409|27068874|P1|Period 2 Double-Blind|Protocol Violation|0
7787970|NCT00565409|27068871|P4|Period 2 Double-Blind|Death|0
7787971|NCT00565409|27068872|P3|Period 2 Double-Blind|Death|0
7787972|NCT00565409|27068873|P2|Period 2 Double-Blind|Death|2
7787973|NCT00565409|27068874|P1|Period 2 Double-Blind|Death|0
7787974|NCT00565409|27068871|P4|Period 2 Double-Blind|Adverse Event|5
7787975|NCT00565409|27068872|P3|Period 2 Double-Blind|Adverse Event|4
7787976|NCT00565409|27068873|P2|Period 2 Double-Blind|Adverse Event|7
7787977|NCT00565409|27068874|P1|Period 2 Double-Blind|Adverse Event|0
7787978|NCT00565409|27068871|P4|After Period 1, Prior to Period 2|did not meet criteria|0
7787979|NCT00565409|27068872|P3|After Period 1, Prior to Period 2|did not meet criteria|0
7787980|NCT00565409|27068873|P2|After Period 1, Prior to Period 2|did not meet criteria|0
7787981|NCT00565409|27068874|P1|After Period 1, Prior to Period 2|did not meet criteria|152
7787982|NCT00565409|27068871|P4|Period 1 Open Label|no conclusion of participation record|0
7787983|NCT00565409|27068872|P3|Period 1 Open Label|no conclusion of participation record|0
7787984|NCT00565409|27068873|P2|Period 1 Open Label|no conclusion of participation record|0
7787985|NCT00565409|27068874|P1|Period 1 Open Label|no conclusion of participation record|1
7787986|NCT00565409|27068871|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7787987|NCT00565409|27068872|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7787988|NCT00565409|27068873|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7787989|NCT00565409|27068874|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
7787990|NCT00565409|27068871|P4|Period 1 Open Label|Protocol Violation|0
7787991|NCT00565409|27068872|P3|Period 1 Open Label|Protocol Violation|0
7787992|NCT00565409|27068873|P2|Period 1 Open Label|Protocol Violation|0
7787993|NCT00565409|27068874|P1|Period 1 Open Label|Protocol Violation|14
7787994|NCT00565409|27068871|P4|Period 1 Open Label|Other|0
7787995|NCT00565409|27068872|P3|Period 1 Open Label|Other|0
7787996|NCT00565409|27068873|P2|Period 1 Open Label|Other|0
7787997|NCT00565409|27068874|P1|Period 1 Open Label|Other|21
7787998|NCT00565409|27068871|P4|Period 1 Open Label|Lost to Follow-up|0
7787999|NCT00565409|27068872|P3|Period 1 Open Label|Lost to Follow-up|0
7788000|NCT00565409|27068873|P2|Period 1 Open Label|Lost to Follow-up|0
7788001|NCT00565409|27068874|P1|Period 1 Open Label|Lost to Follow-up|1
7788002|NCT00565409|27068871|P4|Period 1 Open Label|Death|0
7788003|NCT00565409|27068872|P3|Period 1 Open Label|Death|0
7788004|NCT00565409|27068873|P2|Period 1 Open Label|Death|0
7788005|NCT00565409|27068874|P1|Period 1 Open Label|Death|2
7788006|NCT00565409|27068871|P4|Period 1 Open Label|Adverse Event|0
7788007|NCT00565409|27068872|P3|Period 1 Open Label|Adverse Event|0
7788008|NCT00565409|27068873|P2|Period 1 Open Label|Adverse Event|0
7788009|NCT00565409|27068874|P1|Period 1 Open Label|Adverse Event|17
7788010|NCT00565136|27069010|P1|Overall Study|Protocol Violation|1
7788011|NCT00565136|27069010|P1|Overall Study|Withdrawal by Subject|1
7788012|NCT00565136|27069010|P1|Overall Study|Lost to Follow-up|1
7788013|NCT00565058|27069051|P2|Overall Study|Adverse Event|0
7788014|NCT00565058|27069052|P1|Overall Study|Adverse Event|1
7788015|NCT00564902|27069099|P3|Overall Study|Death|0
7788016|NCT00564902|27069100|P2|Overall Study|Death|1
7788017|NCT00564902|27069101|P1|Overall Study|Death|1
7788018|NCT00564902|27069099|P3|Overall Study|Withdrawal by Subject|4
7788019|NCT00564902|27069100|P2|Overall Study|Withdrawal by Subject|3
7788020|NCT00564902|27069101|P1|Overall Study|Withdrawal by Subject|0
7788021|NCT00564889|27069133|P1|Overall Study|Other, not specified|4
7788022|NCT00564889|27069133|P1|Overall Study|Disease progression|3
7788023|NCT00564889|27069133|P1|Overall Study|Alternative treatment|3
7788024|NCT00564889|27069133|P1|Overall Study|Adverse Event|12
7788025|NCT00564889|27069133|P1|Overall Study|Death|7
7788026|NCT00564850|27069148|P1|Overall Study|Protocol Violation|2
7788027|NCT00564733|27069166|P1|Overall Study|Ineligible|5
7788028|NCT00564733|27069166|P1|Overall Study|Withdrawal by Subject|4
7788029|NCT00564629|27069200|P2|Overall Study|Vomited within 2 hours of receiving drug|9
7788030|NCT00564629|27069201|P1|Overall Study|Vomited within 2 hours of receiving drug|15
7788031|NCT00564486|27069226|P4|Overall Study|Lost to Follow-up|2
7788032|NCT00564486|27069227|P3|Overall Study|Lost to Follow-up|2
7788033|NCT00564486|27069228|P2|Overall Study|Lost to Follow-up|0
7788034|NCT00564486|27069229|P1|Overall Study|Lost to Follow-up|3
7788035|NCT00564486|27069226|P4|Overall Study|Subject refused to have blood drawn|0
7788036|NCT00564486|27069227|P3|Overall Study|Subject refused to have blood drawn|1
7788037|NCT00564486|27069228|P2|Overall Study|Subject refused to have blood drawn|0
7788038|NCT00564486|27069229|P1|Overall Study|Subject refused to have blood drawn|0
7788039|NCT00564486|27069226|P4|Overall Study|Withdrawal by Subject|5
7788040|NCT00564486|27069227|P3|Overall Study|Withdrawal by Subject|0
7788041|NCT00564486|27069228|P2|Overall Study|Withdrawal by Subject|0
7788042|NCT00564486|27069229|P1|Overall Study|Withdrawal by Subject|4
7788043|NCT00564486|27069226|P4|Overall Study|Adverse Event|0
7788044|NCT00564486|27069227|P3|Overall Study|Adverse Event|0
7788045|NCT00564486|27069228|P2|Overall Study|Adverse Event|1
7788046|NCT00564486|27069229|P1|Overall Study|Adverse Event|0
7788047|NCT00564395|27069278|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
7788048|NCT00564395|27069279|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
7788049|NCT00564395|27069278|P2|First Intervention (10 Days)|Withdrawal by Subject|0
7788050|NCT00564395|27069279|P1|First Intervention (10 Days)|Withdrawal by Subject|1
7788051|NCT00564278|27069287|P2|Overall Study|Withdrawal by Subject|7
7788052|NCT00564278|27069288|P1|Overall Study|Withdrawal by Subject|11
7788053|NCT00564278|27069287|P2|Overall Study|Physician Decision|2
7788054|NCT00564278|27069288|P1|Overall Study|Physician Decision|1
7788055|NCT00564278|27069287|P2|Overall Study|Lost to Follow-up|33
7788056|NCT00564278|27069288|P1|Overall Study|Lost to Follow-up|35
7788057|NCT00564070|27069310|P2|Overall Study|Worsening depression, referred to care|0
7788058|NCT00564070|27069311|P1|Overall Study|Worsening depression, referred to care|3
7788059|NCT00564070|27069310|P2|Overall Study|Lost to Follow-up|7
7788060|NCT00564070|27069311|P1|Overall Study|Lost to Follow-up|9
7788061|NCT00564018|27069338|P3|Overall Study|Withdrawal by Subject|1
7788062|NCT00564018|27069339|P2|Overall Study|Withdrawal by Subject|3
7788063|NCT00564018|27069340|P1|Overall Study|Withdrawal by Subject|2
7788064|NCT00563797|27069353|P2|Overall Study|Lost to Follow-up|2
7788065|NCT00563797|27069354|P1|Overall Study|Lost to Follow-up|7
7788066|NCT00563784|27069366|P1|Overall Study|Screen Failures|20
7788067|NCT00563784|27069366|P1|Overall Study|Withdrawal by Subject|2
7788068|NCT00563706|27069380|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
7788069|NCT00563706|27069381|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
7788070|NCT00563706|27069382|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788071|NCT00563706|27069383|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788072|NCT00563706|27069384|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788073|NCT00563706|27069385|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788074|NCT00563706|27069386|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788075|NCT00563706|27069387|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788076|NCT00563706|27069388|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
7788077|NCT00563706|27069380|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788078|NCT00563706|27069381|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
7788079|NCT00563706|27069382|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788080|NCT00563706|27069383|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788081|NCT00563706|27069384|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788082|NCT00563706|27069385|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788083|NCT00563706|27069386|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788084|NCT00563706|27069387|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7788085|NCT00563706|27069388|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
7788086|NCT00563706|27069380|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7788087|NCT00563706|27069381|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
7788088|NCT00563706|27069382|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
7788089|NCT00563706|27069383|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7788090|NCT00563706|27069384|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
7788091|NCT00563706|27069385|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
7788092|NCT00563706|27069386|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
7788093|NCT00563706|27069387|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7788094|NCT00563706|27069388|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
7788095|NCT00563706|27069380|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7788096|NCT00563706|27069381|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
7788097|NCT00563706|27069382|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7788098|NCT00563706|27069383|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7788099|NCT00563706|27069384|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7788100|NCT00563706|27069385|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
7788101|NCT00563706|27069386|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7788102|NCT00563706|27069387|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7788103|NCT00563706|27069388|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7788104|NCT00563706|27069380|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
7788105|NCT00563706|27069381|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7788106|NCT00563706|27069382|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7788107|NCT00563706|27069383|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7788108|NCT00563706|27069384|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7788109|NCT00563706|27069385|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7788110|NCT00563706|27069386|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7788111|NCT00563706|27069387|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7788112|NCT00563706|27069388|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
7788113|NCT00563381|27069506|P2|Overall Study|Individual different reasons|34
7788114|NCT00563381|27069507|P1|Overall Study|Individual different reasons|24
7788115|NCT00563381|27069506|P2|Overall Study|Lack of Efficacy|24
7788116|NCT00563381|27069507|P1|Overall Study|Lack of Efficacy|32
7788117|NCT00563381|27069506|P2|Overall Study|Withdrawal by Subject|209
7788118|NCT00563381|27069507|P1|Overall Study|Withdrawal by Subject|192
7788119|NCT00563381|27069506|P2|Overall Study|Lost to Follow-up|15
7788120|NCT00563381|27069507|P1|Overall Study|Lost to Follow-up|7
7788121|NCT00563381|27069506|P2|Overall Study|Protocol Violation|74
7788122|NCT00563381|27069507|P1|Overall Study|Protocol Violation|66
7788123|NCT00563381|27069506|P2|Overall Study|Adverse Event|292
7788124|NCT00563381|27069507|P1|Overall Study|Adverse Event|264
7788125|NCT00563368|27069580|P7|Overall Study|Other|0
7788126|NCT00563368|27069581|P6|Overall Study|Other|4
7788127|NCT00563368|27069582|P5|Overall Study|Other|4
7788128|NCT00563368|27069583|P4|Overall Study|Other|4
7788129|NCT00563368|27069584|P3|Overall Study|Other|3
7788130|NCT00563368|27069585|P2|Overall Study|Other|5
7788131|NCT00563368|27069586|P1|Overall Study|Other|5
7788132|NCT00563368|27069580|P7|Overall Study|requirement for restricted medication|0
7788133|NCT00563368|27069581|P6|Overall Study|requirement for restricted medication|0
7788134|NCT00563368|27069582|P5|Overall Study|requirement for restricted medication|0
7788135|NCT00563368|27069583|P4|Overall Study|requirement for restricted medication|0
7788136|NCT00563368|27069584|P3|Overall Study|requirement for restricted medication|2
7788137|NCT00563368|27069585|P2|Overall Study|requirement for restricted medication|0
7788138|NCT00563368|27069586|P1|Overall Study|requirement for restricted medication|0
7788139|NCT00563368|27069580|P7|Overall Study|Pregnancy|0
7788140|NCT00563368|27069581|P6|Overall Study|Pregnancy|2
7788141|NCT00563368|27069582|P5|Overall Study|Pregnancy|1
7788142|NCT00563368|27069583|P4|Overall Study|Pregnancy|2
7788143|NCT00563368|27069584|P3|Overall Study|Pregnancy|1
7788144|NCT00563368|27069585|P2|Overall Study|Pregnancy|0
7788145|NCT00563368|27069586|P1|Overall Study|Pregnancy|1
7788146|NCT00563368|27069580|P7|Overall Study|protocol non-compliance|3
7788147|NCT00563368|27069581|P6|Overall Study|protocol non-compliance|1
7788148|NCT00563368|27069582|P5|Overall Study|protocol non-compliance|0
7788149|NCT00563368|27069583|P4|Overall Study|protocol non-compliance|1
7788150|NCT00563368|27069584|P3|Overall Study|protocol non-compliance|2
7788151|NCT00563368|27069585|P2|Overall Study|protocol non-compliance|1
7788152|NCT00563368|27069586|P1|Overall Study|protocol non-compliance|1
7788153|NCT00563368|27069580|P7|Overall Study|Withdrawal by Subject|4
7788154|NCT00563368|27069581|P6|Overall Study|Withdrawal by Subject|5
7788155|NCT00563368|27069582|P5|Overall Study|Withdrawal by Subject|8
7788156|NCT00563368|27069583|P4|Overall Study|Withdrawal by Subject|7
7788157|NCT00563368|27069584|P3|Overall Study|Withdrawal by Subject|5
7788158|NCT00563368|27069585|P2|Overall Study|Withdrawal by Subject|6
7788159|NCT00563368|27069586|P1|Overall Study|Withdrawal by Subject|11
7788160|NCT00563368|27069580|P7|Overall Study|Adverse Event|17
7788161|NCT00563368|27069581|P6|Overall Study|Adverse Event|10
7788162|NCT00563368|27069582|P5|Overall Study|Adverse Event|6
7788163|NCT00563368|27069583|P4|Overall Study|Adverse Event|9
7788164|NCT00563368|27069584|P3|Overall Study|Adverse Event|5
7788165|NCT00563368|27069585|P2|Overall Study|Adverse Event|4
7788166|NCT00563368|27069586|P1|Overall Study|Adverse Event|3
7788167|NCT00563368|27069580|P7|Overall Study|Lost to Follow-up|9
7788168|NCT00563368|27069581|P6|Overall Study|Lost to Follow-up|8
7788169|NCT00563368|27069582|P5|Overall Study|Lost to Follow-up|9
7788170|NCT00563368|27069583|P4|Overall Study|Lost to Follow-up|6
7788171|NCT00563368|27069584|P3|Overall Study|Lost to Follow-up|12
7788172|NCT00563368|27069585|P2|Overall Study|Lost to Follow-up|14
7788173|NCT00563368|27069586|P1|Overall Study|Lost to Follow-up|14
7788174|NCT00563316|27069609|P1|Overall Study|Other|1
7788175|NCT00563316|27069609|P1|Overall Study|On-going in study as of 16 July 2009.|5
7788176|NCT00563316|27069609|P1|Overall Study|Death|1
7788177|NCT00563316|27069609|P1|Overall Study|Lost to Follow-up|2
7788178|NCT00563316|27069609|P1|Overall Study|Physician Decision|1
7788179|NCT00563316|27069609|P1|Overall Study|Adverse Event|2
7788180|NCT00563186|27069634|P2|Overall Study|Incomplete data|1
7788181|NCT00563186|27069635|P1|Overall Study|Incomplete data|1
7788182|NCT00563186|27069634|P2|Overall Study|LOS<48 hours|74
7788183|NCT00563186|27069635|P1|Overall Study|LOS<48 hours|97
7788184|NCT00562978|27069646|P2|Overall Study|Patient had imaging dose only|11
7788185|NCT00562978|27069647|P1|Overall Study|Patient had imaging dose only|1
7788186|NCT00562965|27069661|P2|Overall Study|Other|1
7788187|NCT00562965|27069662|P1|Overall Study|Other|0
7788188|NCT00562965|27069661|P2|Overall Study|Lost to Follow-up|0
7788189|NCT00562965|27069662|P1|Overall Study|Lost to Follow-up|1
7788190|NCT00562965|27069661|P2|Overall Study|Death|4
7788191|NCT00562965|27069662|P1|Overall Study|Death|2
7788192|NCT00562965|27069661|P2|Overall Study|Withdrawal by Subject|1
7788193|NCT00562965|27069662|P1|Overall Study|Withdrawal by Subject|0
7788194|NCT00562861|27069683|P2|Overall Study|Lost to Follow-up|3
7788195|NCT00562861|27069684|P1|Overall Study|Lost to Follow-up|7
7788196|NCT00562861|27069683|P2|Overall Study|noncompliance, moved|2
7788197|NCT00562861|27069684|P1|Overall Study|noncompliance, moved|7
7788198|NCT00562861|27069683|P2|Overall Study|Lack of Efficacy|5
7788199|NCT00562861|27069684|P1|Overall Study|Lack of Efficacy|5
7788200|NCT00562861|27069683|P2|Overall Study|Adverse Event|1
7788201|NCT00562861|27069684|P1|Overall Study|Adverse Event|1
7788202|NCT00562718|27069690|P1|Overall Study|not stated|1
7788203|NCT00562718|27069690|P1|Overall Study|Lack of Efficacy|2
7788204|NCT00562718|27069690|P1|Overall Study|Adverse Event|4
7788205|NCT00562718|27069690|P1|Overall Study|Withdrawal by Subject|3
7788206|NCT00562718|27069690|P1|Overall Study|Death|1
7788207|NCT00562627|27069699|P3|Overall Study|Protocol Violation|1
7788208|NCT00562627|27069700|P2|Overall Study|Protocol Violation|1
7788209|NCT00562627|27069701|P1|Overall Study|Protocol Violation|1
7788210|NCT00562588|27069717|P2|Overall Study|Other|2
7788211|NCT00562588|27069718|P1|Overall Study|Other|0
7788212|NCT00562588|27069717|P2|Overall Study|Withdrawal by Subject|9
7788213|NCT00562588|27069718|P1|Overall Study|Withdrawal by Subject|10
7788214|NCT00562588|27069717|P2|Overall Study|Lost to Follow-up|4
7788215|NCT00562588|27069718|P1|Overall Study|Lost to Follow-up|12
7788216|NCT00562588|27069717|P2|Overall Study|Protocol Violation|26
7788217|NCT00562588|27069718|P1|Overall Study|Protocol Violation|30
7788218|NCT00562588|27069717|P2|Overall Study|Adverse Event|58
7788219|NCT00562588|27069718|P1|Overall Study|Adverse Event|40
7788220|NCT00562484|27069748|P2|Overall Study|Reason not provided or not specified|12
7788221|NCT00562484|27069749|P1|Overall Study|Reason not provided or not specified|25
7788222|NCT00562484|27069748|P2|Overall Study|Lost to Follow-up|71
7788223|NCT00562484|27069749|P1|Overall Study|Lost to Follow-up|132
7788224|NCT00562484|27069748|P2|Overall Study|Moved away from the study area|9
7788225|NCT00562484|27069749|P1|Overall Study|Moved away from the study area|20
7788226|NCT00562484|27069748|P2|Overall Study|Withdrawal by Subject|9
7788227|NCT00562484|27069749|P1|Overall Study|Withdrawal by Subject|12
7788228|NCT00562484|27069748|P2|Overall Study|Protocol Violation|2
7788229|NCT00562484|27069749|P1|Overall Study|Protocol Violation|11
7788230|NCT00562484|27069748|P2|Overall Study|Adverse Event|1
7788231|NCT00562484|27069749|P1|Overall Study|Adverse Event|6
7788232|NCT00562354|27069781|P2|Overall Study|Lost to Follow-up|1
7788233|NCT00562354|27069782|P1|Overall Study|Lost to Follow-up|0
7788234|NCT00562354|27069781|P2|Overall Study|Physician Decision|1
7788235|NCT00562354|27069782|P1|Overall Study|Physician Decision|0
7788236|NCT00562302|27069848|P2|Overall Study|Not stated|4
7788237|NCT00562302|27069849|P1|Overall Study|Not stated|1
7788238|NCT00562302|27069848|P2|Overall Study|Lung resection prior to study completion|7
7788239|NCT00562302|27069849|P1|Overall Study|Lung resection prior to study completion|7
7788240|NCT00562302|27069848|P2|Overall Study|Death|2
7788241|NCT00562302|27069849|P1|Overall Study|Death|1
7788242|NCT00562302|27069848|P2|Overall Study|Withdrawal by Subject|8
7788243|NCT00562302|27069849|P1|Overall Study|Withdrawal by Subject|7
7788244|NCT00562302|27069848|P2|Overall Study|Non-compliance|2
7788245|NCT00562302|27069849|P1|Overall Study|Non-compliance|1
7788246|NCT00562302|27069848|P2|Overall Study|Adverse Event|6
7788247|NCT00562302|27069849|P1|Overall Study|Adverse Event|0
7788248|NCT00562302|27069848|P2|Overall Study|Lost to Follow-up|3
7788249|NCT00562302|27069849|P1|Overall Study|Lost to Follow-up|3
7788250|NCT00562159|27069871|P2|Overall Study|Did not meet protocol eligibility|1
7788251|NCT00562159|27069872|P1|Overall Study|Did not meet protocol eligibility|1
7788252|NCT00562159|27069871|P2|Overall Study|Protocol Violation|12
7788253|NCT00562159|27069872|P1|Overall Study|Protocol Violation|12
7788254|NCT00562159|27069871|P2|Overall Study|Withdrawal by Subject|8
7788255|NCT00562159|27069872|P1|Overall Study|Withdrawal by Subject|9
7788256|NCT00562159|27069871|P2|Overall Study|Lost to Follow-up|4
7788257|NCT00562159|27069872|P1|Overall Study|Lost to Follow-up|5
7788258|NCT00562159|27069871|P2|Overall Study|Adverse Event|8
7788259|NCT00562159|27069872|P1|Overall Study|Adverse Event|11
7788260|NCT00562120|27069884|P4|First Intervention Period|Randomized but not Treated|0
7788261|NCT00562120|27069885|P3|First Intervention Period|Randomized but not Treated|0
7788262|NCT00562120|27069886|P2|First Intervention Period|Randomized but not Treated|0
7788263|NCT00562120|27069887|P1|First Intervention Period|Randomized but not Treated|1
7788264|NCT00562120|27069884|P4|First Intervention Period|Adverse Event|0
7788265|NCT00562120|27069885|P3|First Intervention Period|Adverse Event|0
7788266|NCT00562120|27069886|P2|First Intervention Period|Adverse Event|0
7788267|NCT00562120|27069887|P1|First Intervention Period|Adverse Event|1
7788268|NCT00562094|27069919|P1|Overall Study|Lost to Follow-up|62
7788269|NCT00561977|27069934|P3|Overall Study|Pregnancy|1
7788270|NCT00561977|27069935|P2|Overall Study|Pregnancy|1
7788271|NCT00561977|27069936|P1|Overall Study|Pregnancy|0
7788272|NCT00561977|27069934|P3|Overall Study|Withdrawal by Subject|1
7788273|NCT00561977|27069935|P2|Overall Study|Withdrawal by Subject|2
7788274|NCT00561977|27069936|P1|Overall Study|Withdrawal by Subject|0
7788275|NCT00561951|27069962|P3|Overall Study|Adverse Event Occured Before Treatment|1
7788276|NCT00561951|27069963|P2|Overall Study|Adverse Event Occured Before Treatment|2
7788277|NCT00561951|27069964|P1|Overall Study|Adverse Event Occured Before Treatment|1
7788278|NCT00561951|27069962|P3|Overall Study|Meet Withdrawal Criterion|1
7788279|NCT00561951|27069963|P2|Overall Study|Meet Withdrawal Criterion|1
7788280|NCT00561951|27069964|P1|Overall Study|Meet Withdrawal Criterion|0
7788281|NCT00561951|27069962|P3|Overall Study|Pregnancy|0
7788282|NCT00561951|27069963|P2|Overall Study|Pregnancy|1
7788283|NCT00561951|27069964|P1|Overall Study|Pregnancy|0
7788284|NCT00561951|27069962|P3|Overall Study|Physician Decision|0
7788285|NCT00561951|27069963|P2|Overall Study|Physician Decision|0
7788286|NCT00561951|27069964|P1|Overall Study|Physician Decision|1
7788287|NCT00561951|27069962|P3|Overall Study|Protocol Violation|4
7788288|NCT00561951|27069963|P2|Overall Study|Protocol Violation|3
7788289|NCT00561951|27069964|P1|Overall Study|Protocol Violation|4
7788290|NCT00561951|27069962|P3|Overall Study|Withdrawal by Subject|10
7788291|NCT00561951|27069963|P2|Overall Study|Withdrawal by Subject|9
7788292|NCT00561951|27069964|P1|Overall Study|Withdrawal by Subject|10
7788293|NCT00561951|27069962|P3|Overall Study|Lost to Follow-up|0
7788294|NCT00561951|27069963|P2|Overall Study|Lost to Follow-up|1
7788295|NCT00561951|27069964|P1|Overall Study|Lost to Follow-up|1
7788296|NCT00561951|27069962|P3|Overall Study|Lack of Efficacy|2
7788297|NCT00561951|27069963|P2|Overall Study|Lack of Efficacy|3
7788298|NCT00561951|27069964|P1|Overall Study|Lack of Efficacy|5
7788299|NCT00561951|27069962|P3|Overall Study|Adverse Event|14
7788300|NCT00561951|27069963|P2|Overall Study|Adverse Event|14
7788301|NCT00561951|27069964|P1|Overall Study|Adverse Event|11
7788302|NCT00561925|27070020|P5|Open-Label Extension Period|Declined entry into extension period|50
7788303|NCT00561925|27070021|P4|Open-Label Extension Period|Declined entry into extension period|43
7788304|NCT00561925|27070022|P3|Open-Label Extension Period|Declined entry into extension period|0
7788305|NCT00561925|27070023|P2|Open-Label Extension Period|Declined entry into extension period|0
7788306|NCT00561925|27070024|P1|Open-Label Extension Period|Declined entry into extension period|0
7788307|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Other|0
7788308|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Other|0
7788309|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Other|11
7788310|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Other|8
7788311|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Other|0
7788312|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
7788313|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
7788314|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
7788315|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
7788316|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
7788317|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Death|0
7788318|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Death|0
7788319|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Death|3
7788320|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Death|6
7788321|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Death|0
7788322|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Pregnancy|0
7788323|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Pregnancy|0
7788324|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Pregnancy|9
7788325|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Pregnancy|1
7788326|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Pregnancy|0
7788327|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7788328|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7788329|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
7788330|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
7788331|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7788332|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7788333|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7788334|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
7788335|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
7788336|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7788337|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7788338|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7788339|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
7788340|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
7788341|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7788342|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
7788343|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
7788344|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
7788345|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
7788346|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
7788347|NCT00561925|27070020|P5|144-week Double-blind, Double-dummy|Adverse Event|0
7788348|NCT00561925|27070021|P4|144-week Double-blind, Double-dummy|Adverse Event|0
7788349|NCT00561925|27070022|P3|144-week Double-blind, Double-dummy|Adverse Event|43
7788350|NCT00561925|27070023|P2|144-week Double-blind, Double-dummy|Adverse Event|48
7788351|NCT00561925|27070024|P1|144-week Double-blind, Double-dummy|Adverse Event|0
7788352|NCT00561925|27070020|P5|14 Day Lead-In Period|Other|0
7788353|NCT00561925|27070021|P4|14 Day Lead-In Period|Other|0
7788354|NCT00561925|27070022|P3|14 Day Lead-In Period|Other|0
7788355|NCT00561925|27070023|P2|14 Day Lead-In Period|Other|0
7788356|NCT00561925|27070024|P1|14 Day Lead-In Period|Other|5
7788357|NCT00561925|27070020|P5|14 Day Lead-In Period|Withdrawal by Subject|0
7788358|NCT00561925|27070021|P4|14 Day Lead-In Period|Withdrawal by Subject|0
7788359|NCT00561925|27070022|P3|14 Day Lead-In Period|Withdrawal by Subject|0
7788360|NCT00561925|27070023|P2|14 Day Lead-In Period|Withdrawal by Subject|0
7788361|NCT00561925|27070024|P1|14 Day Lead-In Period|Withdrawal by Subject|4
7788362|NCT00561925|27070020|P5|14 Day Lead-In Period|Lost to Follow-up|0
7788363|NCT00561925|27070021|P4|14 Day Lead-In Period|Lost to Follow-up|0
7788364|NCT00561925|27070022|P3|14 Day Lead-In Period|Lost to Follow-up|0
7788365|NCT00561925|27070023|P2|14 Day Lead-In Period|Lost to Follow-up|0
7788366|NCT00561925|27070024|P1|14 Day Lead-In Period|Lost to Follow-up|4
7788367|NCT00561925|27070020|P5|14 Day Lead-In Period|In/Exclusion criteria|0
7788368|NCT00561925|27070021|P4|14 Day Lead-In Period|In/Exclusion criteria|0
7788369|NCT00561925|27070022|P3|14 Day Lead-In Period|In/Exclusion criteria|0
7788370|NCT00561925|27070023|P2|14 Day Lead-In Period|In/Exclusion criteria|0
7788371|NCT00561925|27070024|P1|14 Day Lead-In Period|In/Exclusion criteria|4
7788372|NCT00561925|27070020|P5|14 Day Lead-In Period|Adverse Event|0
7788373|NCT00561925|27070021|P4|14 Day Lead-In Period|Adverse Event|0
7788374|NCT00561925|27070022|P3|14 Day Lead-In Period|Adverse Event|0
7788375|NCT00561925|27070023|P2|14 Day Lead-In Period|Adverse Event|0
7788376|NCT00561925|27070024|P1|14 Day Lead-In Period|Adverse Event|38
7788377|NCT00561912|27070073|P1|Overall Study|ineligible|1
7788378|NCT00561821|27070085|P4|Overall Study|Adverse Event|1
7788379|NCT00561821|27070086|P3|Overall Study|Adverse Event|1
7788380|NCT00561821|27070087|P2|Overall Study|Adverse Event|3
7788381|NCT00561821|27070088|P1|Overall Study|Adverse Event|2
7788382|NCT00561821|27070085|P4|Overall Study|Other (reason not specified)|0
7788383|NCT00561821|27070086|P3|Overall Study|Other (reason not specified)|0
7788384|NCT00561821|27070087|P2|Overall Study|Other (reason not specified)|1
7788385|NCT00561821|27070088|P1|Overall Study|Other (reason not specified)|1
7788386|NCT00561821|27070085|P4|Overall Study|Reasons not related to trial|0
7788387|NCT00561821|27070086|P3|Overall Study|Reasons not related to trial|0
7788388|NCT00561821|27070087|P2|Overall Study|Reasons not related to trial|1
7788389|NCT00561821|27070088|P1|Overall Study|Reasons not related to trial|2
7788390|NCT00561821|27070085|P4|Overall Study|Withdrawal by Subject|2
7788391|NCT00561821|27070086|P3|Overall Study|Withdrawal by Subject|0
7788392|NCT00561821|27070087|P2|Overall Study|Withdrawal by Subject|1
7788393|NCT00561821|27070088|P1|Overall Study|Withdrawal by Subject|0
7788394|NCT00561821|27070085|P4|Overall Study|Not treated|0
7788395|NCT00561821|27070086|P3|Overall Study|Not treated|1
7788396|NCT00561821|27070087|P2|Overall Study|Not treated|0
7788397|NCT00561821|27070088|P1|Overall Study|Not treated|0
7788398|NCT00561795|27070164|P4|Overall Study|Physician Decision|0
7788399|NCT00561795|27070165|P3|Overall Study|Physician Decision|0
7788400|NCT00561795|27070166|P2|Overall Study|Physician Decision|0
7788401|NCT00561795|27070167|P1|Overall Study|Physician Decision|1
7788402|NCT00561795|27070164|P4|Overall Study|Study Closed/Terminated|0
7788403|NCT00561795|27070165|P3|Overall Study|Study Closed/Terminated|0
7788404|NCT00561795|27070166|P2|Overall Study|Study Closed/Terminated|3
7788405|NCT00561795|27070167|P1|Overall Study|Study Closed/Terminated|0
7788406|NCT00561795|27070164|P4|Overall Study|Adverse Event|0
7788407|NCT00561795|27070165|P3|Overall Study|Adverse Event|0
7788408|NCT00561795|27070166|P2|Overall Study|Adverse Event|3
7788409|NCT00561795|27070167|P1|Overall Study|Adverse Event|3
7788410|NCT00561730|27070187|P1|Overall Study|Not specified reasons|1
7788411|NCT00561730|27070187|P1|Overall Study|Lost to Follow-up|5
7788412|NCT00561730|27070187|P1|Overall Study|Handling of the drug|1
7788413|NCT00561730|27070187|P1|Overall Study|Adverse Event|2
7788414|NCT00561678|27070203|P2|Overall Study|anesthesia provider refusal|0
7788415|NCT00561678|27070204|P1|Overall Study|anesthesia provider refusal|1
7788416|NCT00561678|27070203|P2|Overall Study|surgery rescheduled to different site|2
7788417|NCT00561678|27070204|P1|Overall Study|surgery rescheduled to different site|2
7788418|NCT00561678|27070203|P2|Overall Study|surgery cancelled|1
7788419|NCT00561678|27070204|P1|Overall Study|surgery cancelled|1
7788420|NCT00561678|27070203|P2|Overall Study|Withdrawal by Subject|3
7788421|NCT00561678|27070204|P1|Overall Study|Withdrawal by Subject|4
7788422|NCT00561652|27070222|P2|Overall Study|Withdrawal by Subject|1
7788423|NCT00561652|27070223|P1|Overall Study|Withdrawal by Subject|0
7788424|NCT00561574|27070306|P2|Overall Study|Other|7
7788425|NCT00561574|27070307|P1|Overall Study|Other|5
7788426|NCT00561574|27070306|P2|Overall Study|Lost to Follow-up|0
7788427|NCT00561574|27070307|P1|Overall Study|Lost to Follow-up|1
7788428|NCT00561574|27070306|P2|Overall Study|Reason Unrelated to Trial|2
7788429|NCT00561574|27070307|P1|Overall Study|Reason Unrelated to Trial|6
7788430|NCT00561574|27070306|P2|Overall Study|Withdrawal by Subject|4
7788431|NCT00561574|27070307|P1|Overall Study|Withdrawal by Subject|4
7788432|NCT00561574|27070306|P2|Overall Study|Lack of Efficacy|21
7788433|NCT00561574|27070307|P1|Overall Study|Lack of Efficacy|11
7788434|NCT00561574|27070306|P2|Overall Study|Adverse Event|24
7788435|NCT00561574|27070307|P1|Overall Study|Adverse Event|21
7788436|NCT00561470|27070333|P2|Overall Study|Ongoing Treatment|14
7788437|NCT00561470|27070334|P1|Overall Study|Ongoing Treatment|11
7788438|NCT00561470|27070333|P2|Overall Study|Planning surgery|1
7788439|NCT00561470|27070334|P1|Overall Study|Planning surgery|1
7788440|NCT00561470|27070333|P2|Overall Study|Missed visit window|4
7788441|NCT00561470|27070334|P1|Overall Study|Missed visit window|1
7788442|NCT00561470|27070333|P2|Overall Study|Randomized but not treated|5
7788443|NCT00561470|27070334|P1|Overall Study|Randomized but not treated|5
7788444|NCT00561470|27070333|P2|Overall Study|Unauthorized procedure|1
7788445|NCT00561470|27070334|P1|Overall Study|Unauthorized procedure|3
7788446|NCT00561470|27070333|P2|Overall Study|Metastatic surgery|12
7788447|NCT00561470|27070334|P1|Overall Study|Metastatic surgery|10
7788448|NCT00561470|27070333|P2|Overall Study|Subject request|77
7788449|NCT00561470|27070334|P1|Overall Study|Subject request|43
7788450|NCT00561470|27070333|P2|Overall Study|Consent Withdrawn|6
7788451|NCT00561470|27070334|P1|Overall Study|Consent Withdrawn|2
7788452|NCT00561470|27070333|P2|Overall Study|Physician Decision|20
7788453|NCT00561470|27070334|P1|Overall Study|Physician Decision|21
7788454|NCT00561470|27070333|P2|Overall Study|Lost to Follow-up|0
7788455|NCT00561470|27070334|P1|Overall Study|Lost to Follow-up|2
7788456|NCT00561470|27070333|P2|Overall Study|poor compliance to protocol|4
7788457|NCT00561470|27070334|P1|Overall Study|poor compliance to protocol|4
7788458|NCT00561470|27070333|P2|Overall Study|Disease progression|305
7788459|NCT00561470|27070334|P1|Overall Study|Disease progression|437
7788460|NCT00561470|27070333|P2|Overall Study|Adverse Event|163
7788461|NCT00561470|27070334|P1|Overall Study|Adverse Event|74
7788462|NCT00561392|27070370|P1|Overall Study|Administrative problems|4
7788463|NCT00561392|27070370|P1|Overall Study|Withdrawal by Subject|8
7788464|NCT00561392|27070370|P1|Overall Study|Protocol Violation|1
7788465|NCT00561392|27070370|P1|Overall Study|Lack of Efficacy|2
7788466|NCT00561392|27070370|P1|Overall Study|Adverse Event|38
7788467|NCT00561353|27070392|P10|Overall Study|Withdrawal by Subject|0
7788468|NCT00561353|27070393|P9|Overall Study|Withdrawal by Subject|0
7788469|NCT00561353|27070394|P8|Overall Study|Withdrawal by Subject|0
7788470|NCT00561353|27070395|P7|Overall Study|Withdrawal by Subject|0
7788471|NCT00561353|27070396|P6|Overall Study|Withdrawal by Subject|0
7788472|NCT00561353|27070397|P5|Overall Study|Withdrawal by Subject|0
7788473|NCT00561353|27070398|P4|Overall Study|Withdrawal by Subject|0
7788474|NCT00561353|27070399|P3|Overall Study|Withdrawal by Subject|0
7788475|NCT00561353|27070400|P2|Overall Study|Withdrawal by Subject|2
7788476|NCT00561353|27070401|P1|Overall Study|Withdrawal by Subject|0
7788477|NCT00561353|27070392|P10|Overall Study|Lost to Follow-up|0
7788478|NCT00561353|27070393|P9|Overall Study|Lost to Follow-up|0
7788479|NCT00561353|27070394|P8|Overall Study|Lost to Follow-up|0
7788480|NCT00561353|27070395|P7|Overall Study|Lost to Follow-up|0
7788481|NCT00561353|27070396|P6|Overall Study|Lost to Follow-up|0
7788482|NCT00561353|27070397|P5|Overall Study|Lost to Follow-up|0
7788483|NCT00561353|27070398|P4|Overall Study|Lost to Follow-up|0
7788484|NCT00561353|27070399|P3|Overall Study|Lost to Follow-up|1
7788485|NCT00561353|27070400|P2|Overall Study|Lost to Follow-up|0
7788486|NCT00561353|27070401|P1|Overall Study|Lost to Follow-up|2
7788487|NCT00561353|27070392|P10|Overall Study|Adverse Event|1
7788488|NCT00561353|27070393|P9|Overall Study|Adverse Event|0
7788489|NCT00561353|27070394|P8|Overall Study|Adverse Event|0
7788490|NCT00561353|27070395|P7|Overall Study|Adverse Event|1
7788491|NCT00561353|27070396|P6|Overall Study|Adverse Event|0
7788492|NCT00561353|27070397|P5|Overall Study|Adverse Event|0
7788493|NCT00561353|27070398|P4|Overall Study|Adverse Event|2
7788494|NCT00561353|27070399|P3|Overall Study|Adverse Event|0
7788495|NCT00561353|27070400|P2|Overall Study|Adverse Event|0
7788496|NCT00561353|27070401|P1|Overall Study|Adverse Event|0
7788497|NCT00561353|27070392|P10|Overall Study|Other|0
7788498|NCT00561353|27070393|P9|Overall Study|Other|0
7788499|NCT00561353|27070394|P8|Overall Study|Other|0
7788500|NCT00561353|27070395|P7|Overall Study|Other|0
7788501|NCT00561353|27070396|P6|Overall Study|Other|2
7788502|NCT00561353|27070397|P5|Overall Study|Other|0
7788503|NCT00561353|27070398|P4|Overall Study|Other|0
7788504|NCT00561353|27070399|P3|Overall Study|Other|1
7788505|NCT00561353|27070400|P2|Overall Study|Other|0
7788506|NCT00561353|27070401|P1|Overall Study|Other|1
7788507|NCT00561353|27070392|P10|Overall Study|Subject ineligible to continue the trial|1
7788508|NCT00561353|27070393|P9|Overall Study|Subject ineligible to continue the trial|2
7788509|NCT00561353|27070394|P8|Overall Study|Subject ineligible to continue the trial|0
7788510|NCT00561353|27070395|P7|Overall Study|Subject ineligible to continue the trial|1
7788511|NCT00561353|27070396|P6|Overall Study|Subject ineligible to continue the trial|1
7788512|NCT00561353|27070397|P5|Overall Study|Subject ineligible to continue the trial|0
7788513|NCT00561353|27070398|P4|Overall Study|Subject ineligible to continue the trial|0
7788514|NCT00561353|27070399|P3|Overall Study|Subject ineligible to continue the trial|0
7788515|NCT00561353|27070400|P2|Overall Study|Subject ineligible to continue the trial|0
7788516|NCT00561353|27070401|P1|Overall Study|Subject ineligible to continue the trial|0
7788517|NCT00561353|27070392|P10|Overall Study|Subject reached a virologic endpoint|0
7788518|NCT00561353|27070393|P9|Overall Study|Subject reached a virologic endpoint|5
7788519|NCT00561353|27070394|P8|Overall Study|Subject reached a virologic endpoint|4
7788520|NCT00561353|27070395|P7|Overall Study|Subject reached a virologic endpoint|4
7788521|NCT00561353|27070396|P6|Overall Study|Subject reached a virologic endpoint|3
7788522|NCT00561353|27070397|P5|Overall Study|Subject reached a virologic endpoint|1
7788523|NCT00561353|27070398|P4|Overall Study|Subject reached a virologic endpoint|4
7788524|NCT00561353|27070399|P3|Overall Study|Subject reached a virologic endpoint|1
7788525|NCT00561353|27070400|P2|Overall Study|Subject reached a virologic endpoint|1
7788526|NCT00561353|27070401|P1|Overall Study|Subject reached a virologic endpoint|2
7788527|NCT00561340|27070556|P2|Overall Study|refused to drink pediasure|0
7788528|NCT00561340|27070557|P1|Overall Study|refused to drink pediasure|6
7788529|NCT00561080|27070577|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
7788530|NCT00561080|27070578|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
7788531|NCT00561080|27070579|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
7788532|NCT00561080|27070577|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
7788533|NCT00561080|27070578|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
7788534|NCT00561080|27070579|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
7788535|NCT00561080|27070577|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
7788536|NCT00561080|27070578|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
7788537|NCT00561080|27070579|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
7788538|NCT00561080|27070577|P3|12-month Post Last Dose Follow-up|Adverse Event|1
7788539|NCT00561080|27070578|P2|12-month Post Last Dose Follow-up|Adverse Event|3
7788540|NCT00561080|27070579|P1|12-month Post Last Dose Follow-up|Adverse Event|3
7788541|NCT00561080|27070577|P3|Vaccination Period (up to Month 4)|Other|1
7788542|NCT00561080|27070578|P2|Vaccination Period (up to Month 4)|Other|2
7788543|NCT00561080|27070579|P1|Vaccination Period (up to Month 4)|Other|0
7788544|NCT00561080|27070577|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
7788545|NCT00561080|27070578|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
7788546|NCT00561080|27070579|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
7788547|NCT00561080|27070577|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
7788548|NCT00561080|27070578|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
7788549|NCT00561080|27070579|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
7788550|NCT00561080|27070577|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
7788551|NCT00561080|27070578|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
7788552|NCT00561080|27070579|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
7788553|NCT00561080|27070577|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
7788554|NCT00561080|27070578|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
7788555|NCT00561080|27070579|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
7788556|NCT00561080|27070577|P3|Vaccination Period (up to Month 4)|Adverse Event|6
7788557|NCT00561080|27070578|P2|Vaccination Period (up to Month 4)|Adverse Event|4
7788558|NCT00561080|27070579|P1|Vaccination Period (up to Month 4)|Adverse Event|0
7788559|NCT00561015|27070656|P6|Overall Study|Participant non-compliance|0
7788560|NCT00561015|27070657|P5|Overall Study|Participant non-compliance|0
7788561|NCT00561015|27070658|P4|Overall Study|Participant non-compliance|0
7788562|NCT00561015|27070659|P3|Overall Study|Participant non-compliance|0
7788563|NCT00561015|27070660|P2|Overall Study|Participant non-compliance|0
7788564|NCT00561015|27070661|P1|Overall Study|Participant non-compliance|2
7788565|NCT00561015|27070656|P6|Overall Study|Lost to Follow-up|3
7788566|NCT00561015|27070657|P5|Overall Study|Lost to Follow-up|0
7788567|NCT00561015|27070658|P4|Overall Study|Lost to Follow-up|1
7788568|NCT00561015|27070659|P3|Overall Study|Lost to Follow-up|0
7788569|NCT00561015|27070660|P2|Overall Study|Lost to Follow-up|0
7788570|NCT00561015|27070661|P1|Overall Study|Lost to Follow-up|2
7788571|NCT00561015|27070656|P6|Overall Study|Adverse Event|0
7788572|NCT00561015|27070657|P5|Overall Study|Adverse Event|1
7788573|NCT00561015|27070658|P4|Overall Study|Adverse Event|0
7788574|NCT00561015|27070659|P3|Overall Study|Adverse Event|0
7788575|NCT00561015|27070660|P2|Overall Study|Adverse Event|0
7788576|NCT00561015|27070661|P1|Overall Study|Adverse Event|0
7788577|NCT00560950|27070752|P2|Overall Study|Lost to Follow-up|0
7788578|NCT00560950|27070753|P1|Overall Study|Lost to Follow-up|1
7788579|NCT00560937|27070791|P2|Overall Study|Physician Decision|1
7788580|NCT00560937|27070792|P1|Overall Study|Physician Decision|1
7788581|NCT00560937|27070791|P2|Overall Study|Withdrawal by Subject|1
7788582|NCT00560937|27070792|P1|Overall Study|Withdrawal by Subject|0
7788583|NCT00560885|27070808|P1|Overall Study|Withdrawal by Subject|1
7788584|NCT00560885|27070808|P1|Overall Study|Death|7
7788585|NCT00560833|27070833|P5|Overall Study|Never received drug|1
7788586|NCT00560833|27070834|P4|Overall Study|Never received drug|0
7788587|NCT00560833|27070835|P3|Overall Study|Never received drug|0
7788588|NCT00560833|27070836|P2|Overall Study|Never received drug|1
7788589|NCT00560833|27070837|P1|Overall Study|Never received drug|0
7788590|NCT00560833|27070833|P5|Overall Study|Other|0
7788591|NCT00560833|27070834|P4|Overall Study|Other|0
7788592|NCT00560833|27070835|P3|Overall Study|Other|3
7788593|NCT00560833|27070836|P2|Overall Study|Other|1
7788594|NCT00560833|27070837|P1|Overall Study|Other|1
7788595|NCT00560833|27070833|P5|Overall Study|Participant uncooperative|2
7788596|NCT00560833|27070834|P4|Overall Study|Participant uncooperative|4
7788597|NCT00560833|27070835|P3|Overall Study|Participant uncooperative|4
7788598|NCT00560833|27070836|P2|Overall Study|Participant uncooperative|5
7788599|NCT00560833|27070837|P1|Overall Study|Participant uncooperative|5
7788600|NCT00560833|27070833|P5|Overall Study|Lack of Efficacy|4
7788601|NCT00560833|27070834|P4|Overall Study|Lack of Efficacy|4
7788602|NCT00560833|27070835|P3|Overall Study|Lack of Efficacy|6
7788603|NCT00560833|27070836|P2|Overall Study|Lack of Efficacy|9
7788604|NCT00560833|27070837|P1|Overall Study|Lack of Efficacy|22
7788605|NCT00560833|27070833|P5|Overall Study|Lost to Follow-up|0
7788606|NCT00560833|27070834|P4|Overall Study|Lost to Follow-up|0
7788607|NCT00560833|27070835|P3|Overall Study|Lost to Follow-up|1
7788608|NCT00560833|27070836|P2|Overall Study|Lost to Follow-up|0
7788609|NCT00560833|27070837|P1|Overall Study|Lost to Follow-up|0
7788610|NCT00560833|27070833|P5|Overall Study|Adverse Event|35
7788611|NCT00560833|27070834|P4|Overall Study|Adverse Event|23
7788612|NCT00560833|27070835|P3|Overall Study|Adverse Event|25
7788613|NCT00560833|27070836|P2|Overall Study|Adverse Event|10
7788614|NCT00560833|27070837|P1|Overall Study|Adverse Event|16
7788615|NCT00560794|27070869|P1|Overall Study|Received Bone Marrow Transplant|6
7788616|NCT00560794|27070869|P1|Overall Study|Hematological Relapse|1
7788617|NCT00560794|27070869|P1|Overall Study|Minimal Residual Disease Relapse|1
7788618|NCT00560794|27070869|P1|Overall Study|Patient was not Compliant|1
7788619|NCT00560794|27070869|P1|Overall Study|Adverse Event|2
7788620|NCT00560755|27070886|P1|Overall Study|Physician Decision|2
7788621|NCT00560755|27070886|P1|Overall Study|Adverse Event|8
7788622|NCT00560755|27070886|P1|Overall Study|Lost to Follow-up|9
7788623|NCT00560755|27070886|P1|Overall Study|Withdrawal by Subject|26
7788624|NCT00560755|27070886|P1|Overall Study|Protocol Violation|15
7788625|NCT00560703|27070907|P2|Overall Study|non-compliance|1
7788626|NCT00560703|27070908|P1|Overall Study|non-compliance|0
7788627|NCT00560703|27070907|P2|Overall Study|Withdrawal by Subject|1
7788628|NCT00560703|27070908|P1|Overall Study|Withdrawal by Subject|0
7788629|NCT00560703|27070907|P2|Overall Study|Protocol Violation|2
7788630|NCT00560703|27070908|P1|Overall Study|Protocol Violation|0
7788631|NCT00560703|27070907|P2|Overall Study|Adverse Event|2
7788632|NCT00560703|27070908|P1|Overall Study|Adverse Event|0
7788633|NCT00560573|27070931|P6|Overall Study|Enrolled, not treated|0
7788634|NCT00560573|27070932|P5|Overall Study|Enrolled, not treated|1
7788635|NCT00560573|27070933|P4|Overall Study|Enrolled, not treated|0
7788636|NCT00560573|27070934|P3|Overall Study|Enrolled, not treated|0
7788637|NCT00560573|27070935|P2|Overall Study|Enrolled, not treated|0
7788638|NCT00560573|27070936|P1|Overall Study|Enrolled, not treated|0
7788639|NCT00560573|27070931|P6|Overall Study|Other|3
7788640|NCT00560573|27070932|P5|Overall Study|Other|3
7788641|NCT00560573|27070933|P4|Overall Study|Other|3
7788642|NCT00560573|27070934|P3|Overall Study|Other|2
7788643|NCT00560573|27070935|P2|Overall Study|Other|2
7788644|NCT00560573|27070936|P1|Overall Study|Other|2
7788645|NCT00560573|27070931|P6|Overall Study|Withdrawal by Subject|0
7788646|NCT00560573|27070932|P5|Overall Study|Withdrawal by Subject|1
7788647|NCT00560573|27070933|P4|Overall Study|Withdrawal by Subject|1
7788648|NCT00560573|27070934|P3|Overall Study|Withdrawal by Subject|0
7788649|NCT00560573|27070935|P2|Overall Study|Withdrawal by Subject|0
7788650|NCT00560573|27070936|P1|Overall Study|Withdrawal by Subject|0
7788651|NCT00560573|27070931|P6|Overall Study|Lost to Follow-up|0
7788652|NCT00560573|27070932|P5|Overall Study|Lost to Follow-up|1
7788653|NCT00560573|27070933|P4|Overall Study|Lost to Follow-up|1
7788654|NCT00560573|27070934|P3|Overall Study|Lost to Follow-up|0
7788655|NCT00560573|27070935|P2|Overall Study|Lost to Follow-up|0
7788656|NCT00560573|27070936|P1|Overall Study|Lost to Follow-up|0
7788657|NCT00560573|27070931|P6|Overall Study|Death|10
7788658|NCT00560573|27070932|P5|Overall Study|Death|1
7788659|NCT00560573|27070933|P4|Overall Study|Death|5
7788660|NCT00560573|27070934|P3|Overall Study|Death|4
7788661|NCT00560573|27070935|P2|Overall Study|Death|1
7788662|NCT00560573|27070936|P1|Overall Study|Death|4
7788663|NCT00560508|27071013|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
7788664|NCT00560508|27071014|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
7788665|NCT00560508|27071013|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
7788666|NCT00560508|27071014|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
7788667|NCT00560508|27071013|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
7788668|NCT00560508|27071014|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
7788669|NCT00560508|27071013|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
7788670|NCT00560508|27071014|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
7788671|NCT00560508|27071013|P2|12 Week Double-blind Period|Withdrawal by Subject|1
7788672|NCT00560508|27071014|P1|12 Week Double-blind Period|Withdrawal by Subject|1
7788673|NCT00560508|27071013|P2|12 Week Double-blind Period|Protocol Violation|0
7788674|NCT00560508|27071014|P1|12 Week Double-blind Period|Protocol Violation|1
7788675|NCT00560508|27071013|P2|12 Week Double-blind Period|Adverse Event|2
7788676|NCT00560508|27071014|P1|12 Week Double-blind Period|Adverse Event|3
7788677|NCT00560417|27071073|P2|Overall Study|Withdrawal by Subject|3
7788678|NCT00560417|27071074|P1|Overall Study|Withdrawal by Subject|3
7788679|NCT00560417|27071073|P2|Overall Study|Sponsor Decision|0
7788680|NCT00560417|27071074|P1|Overall Study|Sponsor Decision|2
7788681|NCT00560417|27071073|P2|Overall Study|Protocol Violation|5
7788682|NCT00560417|27071074|P1|Overall Study|Protocol Violation|6
7788683|NCT00560417|27071073|P2|Overall Study|Physician Decision|6
7788684|NCT00560417|27071074|P1|Overall Study|Physician Decision|2
7788685|NCT00560417|27071073|P2|Overall Study|Lost to Follow-up|1
7788686|NCT00560417|27071074|P1|Overall Study|Lost to Follow-up|0
7788687|NCT00560417|27071073|P2|Overall Study|Entry Criteria Not Met|0
7788688|NCT00560417|27071074|P1|Overall Study|Entry Criteria Not Met|1
7788689|NCT00560417|27071073|P2|Overall Study|Adverse Event|2
7788690|NCT00560417|27071074|P1|Overall Study|Adverse Event|3
7788691|NCT00560404|27071102|P2|Overall Study|Other withdrawal reason|5
7788692|NCT00560404|27071103|P1|Overall Study|Other withdrawal reason|13
7788693|NCT00560404|27071102|P2|Overall Study|Failure to return|2
7788694|NCT00560404|27071103|P1|Overall Study|Failure to return|1
7788695|NCT00560404|27071102|P2|Overall Study|Withdrew Consent|0
7788696|NCT00560404|27071103|P1|Overall Study|Withdrew Consent|4
7788697|NCT00560404|27071102|P2|Overall Study|Administrative Reasons|1
7788698|NCT00560404|27071103|P1|Overall Study|Administrative Reasons|1
7788699|NCT00560404|27071102|P2|Overall Study|Protocol Violation|7
7788700|NCT00560404|27071103|P1|Overall Study|Protocol Violation|12
7788701|NCT00560404|27071102|P2|Overall Study|Death|3
7788702|NCT00560404|27071103|P1|Overall Study|Death|3
7788703|NCT00560404|27071102|P2|Overall Study|Adverse Event|3
7788704|NCT00560404|27071103|P1|Overall Study|Adverse Event|2
7788705|NCT00560391|27071150|P5|Overall Study|Still on treatment|2
7788706|NCT00560391|27071151|P4|Overall Study|Still on treatment|1
7788707|NCT00560391|27071152|P3|Overall Study|Still on treatment|0
7788708|NCT00560391|27071153|P2|Overall Study|Still on treatment|0
7788709|NCT00560391|27071154|P1|Overall Study|Still on treatment|0
7788710|NCT00560352|27071210|P3|Overall Study|Maximum clinical benefit|0
7788711|NCT00560352|27071211|P2|Overall Study|Maximum clinical benefit|0
7788712|NCT00560352|27071212|P1|Overall Study|Maximum clinical benefit|1
7788713|NCT00560352|27071210|P3|Overall Study|Withdrawal by Subject|1
7788714|NCT00560352|27071211|P2|Overall Study|Withdrawal by Subject|1
7788715|NCT00560352|27071212|P1|Overall Study|Withdrawal by Subject|1
7788716|NCT00560352|27071210|P3|Overall Study|Disease progression|1
7788717|NCT00560352|27071211|P2|Overall Study|Disease progression|1
7788718|NCT00560352|27071212|P1|Overall Study|Disease progression|0
7788719|NCT00560352|27071210|P3|Overall Study|Study drug toxicity|1
7788720|NCT00560352|27071211|P2|Overall Study|Study drug toxicity|0
7788721|NCT00560352|27071212|P1|Overall Study|Study drug toxicity|3
7788722|NCT00560352|27071210|P3|Overall Study|Adverse event unrelated to study drug|1
7788723|NCT00560352|27071211|P2|Overall Study|Adverse event unrelated to study drug|1
7788724|NCT00560352|27071212|P1|Overall Study|Adverse event unrelated to study drug|2
7788725|NCT00560313|27071229|P1|Overall Study|Protocol Violation|1
7788726|NCT00560313|27071229|P1|Overall Study|Lost to Follow-up|1
7788727|NCT00560313|27071229|P1|Overall Study|Withdrawal by Subject|2
7788728|NCT00560313|27071229|P1|Overall Study|Adverse Events or Death|2
7788729|NCT00560235|27071256|P3|Phase 2|Ongoing at Date of Cut-Off|1
7788730|NCT00560235|27071257|P2|Phase 2|Ongoing at Date of Cut-Off|0
7788731|NCT00560235|27071258|P1|Phase 2|Ongoing at Date of Cut-Off|0
7788732|NCT00560235|27071256|P3|Phase 2|Discontinued|96
7788733|NCT00560235|27071257|P2|Phase 2|Discontinued|0
7788734|NCT00560235|27071258|P1|Phase 2|Discontinued|0
7788735|NCT00560235|27071256|P3|Phase 1B|Discontinued|0
7788736|NCT00560235|27071257|P2|Phase 1B|Discontinued|19
7788737|NCT00560235|27071258|P1|Phase 1B|Discontinued|0
7788738|NCT00560235|27071256|P3|Phase 1|Discontinued|0
7788739|NCT00560235|27071257|P2|Phase 1|Discontinued|0
7788740|NCT00560235|27071258|P1|Phase 1|Discontinued|8
7788741|NCT00560105|27071289|P2|Overall Study|musculoskeletal chest discomfort with us|2
7788742|NCT00560105|27071290|P1|Overall Study|musculoskeletal chest discomfort with us|1
7788743|NCT00560066|27071304|P2|Overall Study|Missing primary reason|2
7788744|NCT00560066|27071305|P1|Overall Study|Missing primary reason|0
7788745|NCT00560066|27071304|P2|Overall Study|Administrative reason|5
7788746|NCT00560066|27071305|P1|Overall Study|Administrative reason|0
7788747|NCT00560066|27071304|P2|Overall Study|Protocol Violation|1
7788748|NCT00560066|27071305|P1|Overall Study|Protocol Violation|0
7788749|NCT00560066|27071304|P2|Overall Study|Lost to Follow-up|10
7788750|NCT00560066|27071305|P1|Overall Study|Lost to Follow-up|4
7788751|NCT00560066|27071304|P2|Overall Study|Withdrawal by Subject|3
7788752|NCT00560066|27071305|P1|Overall Study|Withdrawal by Subject|0
7788753|NCT00560066|27071304|P2|Overall Study|Death|1
7788754|NCT00560066|27071305|P1|Overall Study|Death|2
7788755|NCT00559988|27071337|P2|Overall Study|ICD device explanted|17
7788756|NCT00559988|27071338|P1|Overall Study|ICD device explanted|10
7788757|NCT00559988|27071337|P2|Overall Study|Lost to Follow-up|56
7788758|NCT00559988|27071338|P1|Overall Study|Lost to Follow-up|42
7788759|NCT00559988|27071337|P2|Overall Study|Withdrawal by Subject|139
7788760|NCT00559988|27071338|P1|Overall Study|Withdrawal by Subject|152
7788761|NCT00559988|27071337|P2|Overall Study|Death|140
7788762|NCT00559988|27071338|P1|Overall Study|Death|147
7788763|NCT00559962|27071368|P8|Overall Study|Inclusion/exclusion criteria not met|0
7788764|NCT00559962|27071369|P7|Overall Study|Inclusion/exclusion criteria not met|1
7788765|NCT00559962|27071370|P6|Overall Study|Inclusion/exclusion criteria not met|0
7788766|NCT00559962|27071371|P5|Overall Study|Inclusion/exclusion criteria not met|0
7788767|NCT00559962|27071372|P4|Overall Study|Inclusion/exclusion criteria not met|0
7788768|NCT00559962|27071373|P3|Overall Study|Inclusion/exclusion criteria not met|0
7788769|NCT00559962|27071374|P2|Overall Study|Inclusion/exclusion criteria not met|0
7788770|NCT00559962|27071375|P1|Overall Study|Inclusion/exclusion criteria not met|0
7788771|NCT00559962|27071368|P8|Overall Study|Withdrawal by Subject|2
7788772|NCT00559962|27071369|P7|Overall Study|Withdrawal by Subject|0
7788773|NCT00559962|27071370|P6|Overall Study|Withdrawal by Subject|1
7788774|NCT00559962|27071371|P5|Overall Study|Withdrawal by Subject|3
7788775|NCT00559962|27071372|P4|Overall Study|Withdrawal by Subject|0
7788776|NCT00559962|27071373|P3|Overall Study|Withdrawal by Subject|2
7788777|NCT00559962|27071374|P2|Overall Study|Withdrawal by Subject|1
7788778|NCT00559962|27071375|P1|Overall Study|Withdrawal by Subject|1
7788779|NCT00559962|27071368|P8|Overall Study|Lost to Follow-up|0
7788780|NCT00559962|27071369|P7|Overall Study|Lost to Follow-up|0
7788781|NCT00559962|27071370|P6|Overall Study|Lost to Follow-up|0
7788782|NCT00559962|27071371|P5|Overall Study|Lost to Follow-up|0
7788783|NCT00559962|27071372|P4|Overall Study|Lost to Follow-up|0
7788784|NCT00559962|27071373|P3|Overall Study|Lost to Follow-up|0
7788785|NCT00559962|27071374|P2|Overall Study|Lost to Follow-up|1
7788786|NCT00559962|27071375|P1|Overall Study|Lost to Follow-up|0
7788787|NCT00559962|27071368|P8|Overall Study|Adverse Event|2
7788788|NCT00559962|27071369|P7|Overall Study|Adverse Event|4
7788789|NCT00559962|27071370|P6|Overall Study|Adverse Event|4
7788790|NCT00559962|27071371|P5|Overall Study|Adverse Event|11
7788791|NCT00559962|27071372|P4|Overall Study|Adverse Event|5
7788792|NCT00559962|27071373|P3|Overall Study|Adverse Event|8
7788793|NCT00559962|27071374|P2|Overall Study|Adverse Event|7
7788794|NCT00559962|27071375|P1|Overall Study|Adverse Event|1
7788795|NCT00559949|27071395|P1|Overall Study|No disease evaluation per protocol|1
7788796|NCT00559949|27071395|P1|Overall Study|Withdrawal by Subject|4
7788797|NCT00559949|27071395|P1|Overall Study|Adverse Event|1
7788798|NCT00559949|27071395|P1|Overall Study|Progressive Disease during cycle 1|1
7788799|NCT00559845|27071411|P1|Overall Study|Premature Surgery-Investigator Decision|1
7788800|NCT00559845|27071411|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
7788801|NCT00559845|27071411|P1|Overall Study|Adverse Event|3
7788802|NCT00559845|27071411|P1|Overall Study|Disease Progression|1
7788803|NCT00559845|27071411|P1|Overall Study|Withdrew Consent|1
7788804|NCT00559754|27071420|P1|Overall Study|Withdrawal by Subject|2
7788805|NCT00559754|27071420|P1|Overall Study|Investigator criteria|2
7788806|NCT00559754|27071420|P1|Overall Study|Protocol Violation|1
7788807|NCT00559754|27071420|P1|Overall Study|Adverse Event|5
7788808|NCT00559754|27071420|P1|Overall Study|Disease progression|1
7788809|NCT00559637|27071444|P1|Overall Study|Inclusion or exclusion criteria violated|2
7788810|NCT00559637|27071444|P1|Overall Study|Change of home|1
7788811|NCT00559637|27071444|P1|Overall Study|Change of center|1
7788812|NCT00559637|27071444|P1|Overall Study|Delayed administration of C.E.R.A|1
7788813|NCT00559637|27071444|P1|Overall Study|Participation in another study|1
7788814|NCT00559637|27071444|P1|Overall Study|Suspected lung cancer|1
7788815|NCT00559637|27071444|P1|Overall Study|Started requiring dialysis after month 7|2
7788816|NCT00559637|27071444|P1|Overall Study|Insufficient response|3
7788817|NCT00559637|27071444|P1|Overall Study|Failure to return|6
7788818|NCT00559637|27071444|P1|Overall Study|Withdrawal criteria fulfilled|4
7788819|NCT00559637|27071444|P1|Overall Study|Protocol Violation|6
7788820|NCT00559637|27071444|P1|Overall Study|Withdrawal by Subject|4
7788821|NCT00559637|27071444|P1|Overall Study|Adverse Event|22
7788822|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
7788823|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
7788824|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|non-specified|0
7788825|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|non-specified|71
7788826|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
7788827|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
7788828|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
7788829|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
7788830|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
7788831|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
7788832|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Death|0
7788833|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Death|20
7788834|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
7788835|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
7788836|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
7788837|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
7788838|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
7788839|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
7788840|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
7788841|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
7788842|NCT00559585|27071457|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
7788843|NCT00559585|27071458|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
7788844|NCT00559585|27071457|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
7788845|NCT00559585|27071458|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
7788846|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
7788847|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
7788848|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Investigator Decision|1
7788849|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Investigator Decision|0
7788850|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
7788851|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
7788852|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
7788853|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
7788854|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Early Discontinuation|1
7788855|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Early Discontinuation|0
7788856|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
7788857|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
7788858|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
7788859|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
7788860|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Missed Doses|1
7788861|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Missed Doses|0
7788862|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
7788863|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
7788864|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
7788865|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
7788866|NCT00559585|27071457|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
7788867|NCT00559585|27071458|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
7788868|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Death|1
7788869|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Death|1
7788870|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
7788871|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
7788872|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
7788873|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
7788874|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
7788875|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
7788876|NCT00559585|27071457|P2|Double Blind ST Period Main Study|Adverse Event|25
7788877|NCT00559585|27071458|P1|Double Blind ST Period Main Study|Adverse Event|17
7788878|NCT00559507|27071518|P1|Overall Study|Not treated, patient ineligible|3
7788879|NCT00559377|27071537|P1|Overall Study|Withdrawal by Subject|9
7788880|NCT00559364|27071547|P2|Overall Study|Inclusion/exclusion criteria failure|0
7788881|NCT00559364|27071548|P1|Overall Study|Inclusion/exclusion criteria failure|1
7788882|NCT00559273|27071560|P2|Evaluation Period (8 Weeks)|Physician Decision|1
7788883|NCT00559273|27071561|P1|Evaluation Period (8 Weeks)|Physician Decision|0
7788884|NCT00559273|27071560|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
7788885|NCT00559273|27071561|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
7788886|NCT00559273|27071560|P2|Evaluation Period (8 Weeks)|Adverse Event|1
7788887|NCT00559273|27071561|P1|Evaluation Period (8 Weeks)|Adverse Event|0
7788888|NCT00559273|27071560|P2|Evaluation Period (8 Weeks)|Death|3
7788889|NCT00559273|27071561|P1|Evaluation Period (8 Weeks)|Death|1
7788890|NCT00559273|27071560|P2|Correction Period (20 Weeks)|Did not received study treatment|0
7788891|NCT00559273|27071561|P1|Correction Period (20 Weeks)|Did not received study treatment|2
7788892|NCT00559273|27071560|P2|Correction Period (20 Weeks)|Participant treated by another center|1
7788893|NCT00559273|27071561|P1|Correction Period (20 Weeks)|Participant treated by another center|0
7788894|NCT00559273|27071560|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
7788895|NCT00559273|27071561|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
7788896|NCT00559273|27071560|P2|Correction Period (20 Weeks)|Adverse Event|1
7788897|NCT00559273|27071561|P1|Correction Period (20 Weeks)|Adverse Event|2
7788898|NCT00559273|27071560|P2|Correction Period (20 Weeks)|Death|4
7788899|NCT00559273|27071561|P1|Correction Period (20 Weeks)|Death|3
7788900|NCT00559104|27071583|P2|Overall Study|Lack of Efficacy|0
7788901|NCT00559104|27071584|P1|Overall Study|Lack of Efficacy|9
7788902|NCT00558896|27071605|P7|Overall Study|Continues on treatment|6
7788903|NCT00558896|27071606|P6|Overall Study|Continues on treatment|25
7788904|NCT00558896|27071607|P5|Overall Study|Continues on treatment|9
7788905|NCT00558896|27071608|P4|Overall Study|Continues on treatment|1
7788906|NCT00558896|27071609|P3|Overall Study|Continues on treatment|0
7788907|NCT00558896|27071610|P2|Overall Study|Continues on treatment|1
7788908|NCT00558896|27071611|P1|Overall Study|Continues on treatment|10
7788909|NCT00558896|27071605|P7|Overall Study|Physician discretion|3
7788910|NCT00558896|27071606|P6|Overall Study|Physician discretion|3
7788911|NCT00558896|27071607|P5|Overall Study|Physician discretion|1
7788912|NCT00558896|27071608|P4|Overall Study|Physician discretion|2
7788913|NCT00558896|27071609|P3|Overall Study|Physician discretion|1
7788914|NCT00558896|27071610|P2|Overall Study|Physician discretion|2
7788915|NCT00558896|27071611|P1|Overall Study|Physician discretion|3
7788916|NCT00558896|27071605|P7|Overall Study|Alternative Treatment|1
7788917|NCT00558896|27071606|P6|Overall Study|Alternative Treatment|7
7788918|NCT00558896|27071607|P5|Overall Study|Alternative Treatment|6
7788919|NCT00558896|27071608|P4|Overall Study|Alternative Treatment|2
7788920|NCT00558896|27071609|P3|Overall Study|Alternative Treatment|0
7788921|NCT00558896|27071610|P2|Overall Study|Alternative Treatment|2
7788922|NCT00558896|27071611|P1|Overall Study|Alternative Treatment|2
7788923|NCT00558896|27071605|P7|Overall Study|Withdrawal by Subject|5
7788924|NCT00558896|27071606|P6|Overall Study|Withdrawal by Subject|5
7788925|NCT00558896|27071607|P5|Overall Study|Withdrawal by Subject|1
7788926|NCT00558896|27071608|P4|Overall Study|Withdrawal by Subject|1
7788927|NCT00558896|27071609|P3|Overall Study|Withdrawal by Subject|1
7788928|NCT00558896|27071610|P2|Overall Study|Withdrawal by Subject|1
7788929|NCT00558896|27071611|P1|Overall Study|Withdrawal by Subject|2
7788930|NCT00558896|27071605|P7|Overall Study|Death|6
7788931|NCT00558896|27071606|P6|Overall Study|Death|2
7788932|NCT00558896|27071607|P5|Overall Study|Death|2
7788933|NCT00558896|27071608|P4|Overall Study|Death|3
7788934|NCT00558896|27071609|P3|Overall Study|Death|2
7788935|NCT00558896|27071610|P2|Overall Study|Death|0
7788936|NCT00558896|27071611|P1|Overall Study|Death|3
7788937|NCT00558896|27071605|P7|Overall Study|Adverse Event|3
7788938|NCT00558896|27071606|P6|Overall Study|Adverse Event|10
7788939|NCT00558896|27071607|P5|Overall Study|Adverse Event|4
7788940|NCT00558896|27071608|P4|Overall Study|Adverse Event|3
7788941|NCT00558896|27071609|P3|Overall Study|Adverse Event|1
7788942|NCT00558896|27071610|P2|Overall Study|Adverse Event|1
7788943|NCT00558896|27071611|P1|Overall Study|Adverse Event|1
7788944|NCT00558831|27071713|P1|Overall Study|Lost to Follow-up|1
7788945|NCT00558753|27071770|P2|Overall Study|Lost to Follow-up|7
7788946|NCT00558753|27071771|P1|Overall Study|Lost to Follow-up|5
7788947|NCT00558701|27071783|P2|Overall Study|Protocol Deviations|4
7788948|NCT00558701|27071784|P1|Overall Study|Protocol Deviations|1
7788949|NCT00558636|27071792|P2|Follow-up|Premature termination of the study|7
7788950|NCT00558636|27071793|P1|Follow-up|Premature termination of the study|12
7788951|NCT00558636|27071792|P2|Treatment|Disease progression|5
7788952|NCT00558636|27071793|P1|Treatment|Disease progression|1
7788953|NCT00558636|27071792|P2|Treatment|Premature termination of the study|37
7788954|NCT00558636|27071793|P1|Treatment|Premature termination of the study|35
7788955|NCT00558636|27071792|P2|Treatment|Withdrawal by Subject|0
7788956|NCT00558636|27071793|P1|Treatment|Withdrawal by Subject|2
7788957|NCT00558636|27071792|P2|Treatment|Adverse Event|2
7788958|NCT00558636|27071793|P1|Treatment|Adverse Event|9
7788959|NCT00558558|27071893|P1|Overall Study|Lack of Efficacy|4
7788960|NCT00558558|27071893|P1|Overall Study|Withdrawal by Subject|1
7788961|NCT00558558|27071893|P1|Overall Study|Unable to swallow|1
7788962|NCT00558519|27071897|P1|Overall Study|Never received treatment|1
7788963|NCT00558519|27071897|P1|Overall Study|Insufficient data|1
7788964|NCT00558519|27071897|P1|Overall Study|Ineligible|1
7788965|NCT00558519|27071897|P1|Overall Study|Ph+|20
7788966|NCT00558467|27071907|P2|Overall Study|Patient moving out of state|1
7788967|NCT00558467|27071908|P1|Overall Study|Patient moving out of state|0
7788968|NCT00558467|27071907|P2|Overall Study|Lack of Efficacy|1
7788969|NCT00558467|27071908|P1|Overall Study|Lack of Efficacy|0
7788970|NCT00558467|27071907|P2|Overall Study|Adverse Event|2
7788971|NCT00558467|27071908|P1|Overall Study|Adverse Event|1
7788972|NCT00558428|27071968|P4|Overall Study|Other|1
7788973|NCT00558428|27071969|P3|Overall Study|Other|0
7788974|NCT00558428|27071970|P2|Overall Study|Other|0
7788975|NCT00558428|27071971|P1|Overall Study|Other|3
7788976|NCT00558428|27071968|P4|Overall Study|Consent withdrawn|1
7788977|NCT00558428|27071969|P3|Overall Study|Consent withdrawn|0
7788978|NCT00558428|27071970|P2|Overall Study|Consent withdrawn|1
7788979|NCT00558428|27071971|P1|Overall Study|Consent withdrawn|2
7788980|NCT00558428|27071968|P4|Overall Study|Non compliant with protocol|3
7788981|NCT00558428|27071969|P3|Overall Study|Non compliant with protocol|0
7788982|NCT00558428|27071970|P2|Overall Study|Non compliant with protocol|0
7788983|NCT00558428|27071971|P1|Overall Study|Non compliant with protocol|1
7788984|NCT00558428|27071968|P4|Overall Study|Lack of Efficacy|2
7788985|NCT00558428|27071969|P3|Overall Study|Lack of Efficacy|1
7788986|NCT00558428|27071970|P2|Overall Study|Lack of Efficacy|0
7788987|NCT00558428|27071971|P1|Overall Study|Lack of Efficacy|0
7788988|NCT00558428|27071968|P4|Overall Study|Lost to Follow-up|0
7788989|NCT00558428|27071969|P3|Overall Study|Lost to Follow-up|0
7788990|NCT00558428|27071970|P2|Overall Study|Lost to Follow-up|1
7788991|NCT00558428|27071971|P1|Overall Study|Lost to Follow-up|0
7788992|NCT00558428|27071968|P4|Overall Study|Adverse Event|4
7788993|NCT00558428|27071969|P3|Overall Study|Adverse Event|3
7788994|NCT00558428|27071970|P2|Overall Study|Adverse Event|22
7788995|NCT00558428|27071971|P1|Overall Study|Adverse Event|6
7788996|NCT00558363|27072011|P2|Overall Study|Hospitalized; Unable to Continue|1
7788997|NCT00558363|27072012|P1|Overall Study|Hospitalized; Unable to Continue|0
7788998|NCT00558363|27072011|P2|Overall Study|Randomized in Error|2
7788999|NCT00558363|27072012|P1|Overall Study|Randomized in Error|1
7789000|NCT00558363|27072011|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
7789001|NCT00558363|27072012|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
7789002|NCT00558363|27072011|P2|Overall Study|Lost to Follow-up|1
7789003|NCT00558363|27072012|P1|Overall Study|Lost to Follow-up|0
7789004|NCT00558363|27072011|P2|Overall Study|Protocol Violation|1
7789005|NCT00558363|27072012|P1|Overall Study|Protocol Violation|2
7789006|NCT00558363|27072011|P2|Overall Study|Lack of Efficacy|2
7789007|NCT00558363|27072012|P1|Overall Study|Lack of Efficacy|2
7789008|NCT00558363|27072011|P2|Overall Study|Adverse Event|5
7789009|NCT00558363|27072012|P1|Overall Study|Adverse Event|5
7789010|NCT00558363|27072011|P2|Overall Study|Withdrawal by Subject|4
7789011|NCT00558363|27072012|P1|Overall Study|Withdrawal by Subject|11
7789012|NCT00558363|27072011|P2|Overall Study|Physician Decision|4
7789013|NCT00558363|27072012|P1|Overall Study|Physician Decision|18
7789014|NCT00558285|27072067|P5|Overall Study|Protocol deviation|0
7789015|NCT00558285|27072068|P4|Overall Study|Protocol deviation|1
7789016|NCT00558285|27072069|P3|Overall Study|Protocol deviation|0
7789017|NCT00558285|27072070|P2|Overall Study|Protocol deviation|1
7789018|NCT00558285|27072071|P1|Overall Study|Protocol deviation|1
7789019|NCT00558285|27072067|P5|Overall Study|Administrative problems|1
7789020|NCT00558285|27072068|P4|Overall Study|Administrative problems|1
7789021|NCT00558285|27072069|P3|Overall Study|Administrative problems|0
7789022|NCT00558285|27072070|P2|Overall Study|Administrative problems|0
7789023|NCT00558285|27072071|P1|Overall Study|Administrative problems|0
7789024|NCT00558285|27072067|P5|Overall Study|Lost to Follow-up|0
7789025|NCT00558285|27072068|P4|Overall Study|Lost to Follow-up|0
7789026|NCT00558285|27072069|P3|Overall Study|Lost to Follow-up|0
7789027|NCT00558285|27072070|P2|Overall Study|Lost to Follow-up|1
7789028|NCT00558285|27072071|P1|Overall Study|Lost to Follow-up|1
7789029|NCT00558285|27072067|P5|Overall Study|Subject withdrew consent|1
7789030|NCT00558285|27072068|P4|Overall Study|Subject withdrew consent|1
7789031|NCT00558285|27072069|P3|Overall Study|Subject withdrew consent|1
7789032|NCT00558285|27072070|P2|Overall Study|Subject withdrew consent|0
7789033|NCT00558285|27072071|P1|Overall Study|Subject withdrew consent|2
7789034|NCT00558285|27072067|P5|Overall Study|Abnormal test procedure result(s)|0
7789035|NCT00558285|27072068|P4|Overall Study|Abnormal test procedure result(s)|0
7789036|NCT00558285|27072069|P3|Overall Study|Abnormal test procedure result(s)|0
7789037|NCT00558285|27072070|P2|Overall Study|Abnormal test procedure result(s)|0
7789038|NCT00558285|27072071|P1|Overall Study|Abnormal test procedure result(s)|1
7789039|NCT00558285|27072067|P5|Overall Study|Adverse Event|2
7789040|NCT00558285|27072068|P4|Overall Study|Adverse Event|1
7789041|NCT00558285|27072069|P3|Overall Study|Adverse Event|4
7789042|NCT00558285|27072070|P2|Overall Study|Adverse Event|1
7789043|NCT00558285|27072071|P1|Overall Study|Adverse Event|1
7789044|NCT00558272|27072115|P2|Overall Study|Withdrawal by Subject|1
7789045|NCT00558272|27072116|P1|Overall Study|Withdrawal by Subject|0
7789046|NCT00558272|27072115|P2|Overall Study|Incorrectly enrolled|0
7789047|NCT00558272|27072116|P1|Overall Study|Incorrectly enrolled|1
7789048|NCT00558272|27072115|P2|Overall Study|AZ study team decision|1
7789049|NCT00558272|27072116|P1|Overall Study|AZ study team decision|0
7789050|NCT00558272|27072115|P2|Overall Study|Dev. of study specific discon. criteria|0
7789051|NCT00558272|27072116|P1|Overall Study|Dev. of study specific discon. criteria|1
7789052|NCT00558272|27072115|P2|Overall Study|Death|0
7789053|NCT00558272|27072116|P1|Overall Study|Death|1
7789054|NCT00558272|27072115|P2|Overall Study|Adverse Event|0
7789055|NCT00558272|27072116|P1|Overall Study|Adverse Event|10
7789056|NCT00558259|27072156|P2|Overall Study|Withdrawal by Subject|13
7789057|NCT00558259|27072157|P1|Overall Study|Withdrawal by Subject|12
7789058|NCT00558259|27072156|P2|Overall Study|Protocol Violation|5
7789059|NCT00558259|27072157|P1|Overall Study|Protocol Violation|9
7789060|NCT00558259|27072156|P2|Overall Study|Adverse Event|81
7789061|NCT00558259|27072157|P1|Overall Study|Adverse Event|50
7789062|NCT00558103|27072197|P6|Monotherapy Extension Phase|Disease Progression|8
7789063|NCT00558103|27072198|P5|Monotherapy Extension Phase|Disease Progression|0
7789064|NCT00558103|27072199|P4|Monotherapy Extension Phase|Disease Progression|0
7789065|NCT00558103|27072200|P3|Monotherapy Extension Phase|Disease Progression|0
7789066|NCT00558103|27072201|P2|Monotherapy Extension Phase|Disease Progression|0
7789067|NCT00558103|27072202|P1|Monotherapy Extension Phase|Disease Progression|0
7789068|NCT00558103|27072197|P6|Monotherapy Extension Phase|Protocol Violation|1
7789069|NCT00558103|27072198|P5|Monotherapy Extension Phase|Protocol Violation|0
7789070|NCT00558103|27072199|P4|Monotherapy Extension Phase|Protocol Violation|0
7789071|NCT00558103|27072200|P3|Monotherapy Extension Phase|Protocol Violation|0
7789072|NCT00558103|27072201|P2|Monotherapy Extension Phase|Protocol Violation|0
7789073|NCT00558103|27072202|P1|Monotherapy Extension Phase|Protocol Violation|0
7789074|NCT00558103|27072197|P6|Randomized Treatment Phase|Adverse Event|0
7789075|NCT00558103|27072198|P5|Randomized Treatment Phase|Adverse Event|1
7789076|NCT00558103|27072199|P4|Randomized Treatment Phase|Adverse Event|1
7789077|NCT00558103|27072200|P3|Randomized Treatment Phase|Adverse Event|0
7789078|NCT00558103|27072201|P2|Randomized Treatment Phase|Adverse Event|0
7789079|NCT00558103|27072202|P1|Randomized Treatment Phase|Adverse Event|0
7789080|NCT00558103|27072197|P6|Randomized Treatment Phase|Disease Progression|0
7789081|NCT00558103|27072198|P5|Randomized Treatment Phase|Disease Progression|0
7789082|NCT00558103|27072199|P4|Randomized Treatment Phase|Disease Progression|0
7789083|NCT00558103|27072200|P3|Randomized Treatment Phase|Disease Progression|1
7789084|NCT00558103|27072201|P2|Randomized Treatment Phase|Disease Progression|0
7789085|NCT00558103|27072202|P1|Randomized Treatment Phase|Disease Progression|1
7789086|NCT00558103|27072197|P6|Randomized Treatment Phase|Withdrawal by Subject|0
7789087|NCT00558103|27072198|P5|Randomized Treatment Phase|Withdrawal by Subject|1
7789088|NCT00558103|27072199|P4|Randomized Treatment Phase|Withdrawal by Subject|0
7789089|NCT00558103|27072200|P3|Randomized Treatment Phase|Withdrawal by Subject|0
7789090|NCT00558103|27072201|P2|Randomized Treatment Phase|Withdrawal by Subject|2
7789091|NCT00558103|27072202|P1|Randomized Treatment Phase|Withdrawal by Subject|2
7789092|NCT00558103|27072197|P6|Randomized Treatment Phase|Lost to Follow-up|0
7789093|NCT00558103|27072198|P5|Randomized Treatment Phase|Lost to Follow-up|3
7789094|NCT00558103|27072199|P4|Randomized Treatment Phase|Lost to Follow-up|1
7789095|NCT00558103|27072200|P3|Randomized Treatment Phase|Lost to Follow-up|2
7789096|NCT00558103|27072201|P2|Randomized Treatment Phase|Lost to Follow-up|2
7789097|NCT00558103|27072202|P1|Randomized Treatment Phase|Lost to Follow-up|2
7789098|NCT00558064|27072232|P2|Overall Study|No visit within allowance period|0
7789099|NCT00558064|27072233|P1|Overall Study|No visit within allowance period|1
7789100|NCT00558064|27072232|P2|Overall Study|Withdrawal by Subject|1
7789101|NCT00558064|27072233|P1|Overall Study|Withdrawal by Subject|0
7789102|NCT00558064|27072232|P2|Overall Study|Lost to Follow-up|1
7789103|NCT00558064|27072233|P1|Overall Study|Lost to Follow-up|0
7789104|NCT00558064|27072232|P2|Overall Study|Protocol Violation|0
7789105|NCT00558064|27072233|P1|Overall Study|Protocol Violation|1
7789106|NCT00558064|27072232|P2|Overall Study|Lack of Efficacy|1
7789107|NCT00558064|27072233|P1|Overall Study|Lack of Efficacy|0
7789108|NCT00558064|27072232|P2|Overall Study|Adverse Event|2
7789109|NCT00558064|27072233|P1|Overall Study|Adverse Event|3
7789110|NCT00558025|27072255|P2|Overall Study|Protocol Violation|0
7789111|NCT00558025|27072256|P1|Overall Study|Protocol Violation|1
7789112|NCT00558025|27072255|P2|Overall Study|Withdrawal by Subject|2
7789113|NCT00558025|27072256|P1|Overall Study|Withdrawal by Subject|2
7789114|NCT00558025|27072255|P2|Overall Study|Adverse Event|1
7789115|NCT00558025|27072256|P1|Overall Study|Adverse Event|1
7789116|NCT00557856|27072312|P9|Part 2: Exploratory Phase|global deterioration of health status|1
7789117|NCT00557856|27072313|P8|Part 2: Exploratory Phase|global deterioration of health status|0
7789118|NCT00557856|27072314|P7|Part 2: Exploratory Phase|global deterioration of health status|0
7789119|NCT00557856|27072315|P6|Part 2: Exploratory Phase|global deterioration of health status|0
7789120|NCT00557856|27072316|P5|Part 2: Exploratory Phase|global deterioration of health status|0
7789121|NCT00557856|27072317|P4|Part 2: Exploratory Phase|global deterioration of health status|0
7789122|NCT00557856|27072318|P3|Part 2: Exploratory Phase|global deterioration of health status|0
7789123|NCT00557856|27072319|P2|Part 2: Exploratory Phase|global deterioration of health status|0
7789124|NCT00557856|27072320|P1|Part 2: Exploratory Phase|global deterioration of health status|0
7789125|NCT00557856|27072312|P9|Part 2: Exploratory Phase|Death|2
7789126|NCT00557856|27072313|P8|Part 2: Exploratory Phase|Death|0
7789127|NCT00557856|27072314|P7|Part 2: Exploratory Phase|Death|0
7789128|NCT00557856|27072315|P6|Part 2: Exploratory Phase|Death|0
7789129|NCT00557856|27072316|P5|Part 2: Exploratory Phase|Death|0
7789130|NCT00557856|27072317|P4|Part 2: Exploratory Phase|Death|0
7789131|NCT00557856|27072318|P3|Part 2: Exploratory Phase|Death|0
7789132|NCT00557856|27072319|P2|Part 2: Exploratory Phase|Death|0
7789133|NCT00557856|27072320|P1|Part 2: Exploratory Phase|Death|0
7789134|NCT00557856|27072312|P9|Part 2: Exploratory Phase|Other|1
7789135|NCT00557856|27072313|P8|Part 2: Exploratory Phase|Other|0
7789136|NCT00557856|27072314|P7|Part 2: Exploratory Phase|Other|0
7789137|NCT00557856|27072315|P6|Part 2: Exploratory Phase|Other|0
7789138|NCT00557856|27072316|P5|Part 2: Exploratory Phase|Other|0
7789139|NCT00557856|27072317|P4|Part 2: Exploratory Phase|Other|0
7789140|NCT00557856|27072318|P3|Part 2: Exploratory Phase|Other|0
7789141|NCT00557856|27072319|P2|Part 2: Exploratory Phase|Other|0
7789142|NCT00557856|27072320|P1|Part 2: Exploratory Phase|Other|0
7789143|NCT00557856|27072312|P9|Part 2: Exploratory Phase|Adverse Event|4
7789144|NCT00557856|27072313|P8|Part 2: Exploratory Phase|Adverse Event|0
7789145|NCT00557856|27072314|P7|Part 2: Exploratory Phase|Adverse Event|0
7789146|NCT00557856|27072315|P6|Part 2: Exploratory Phase|Adverse Event|0
7789147|NCT00557856|27072316|P5|Part 2: Exploratory Phase|Adverse Event|0
7789148|NCT00557856|27072317|P4|Part 2: Exploratory Phase|Adverse Event|0
7789149|NCT00557856|27072318|P3|Part 2: Exploratory Phase|Adverse Event|0
7789150|NCT00557856|27072319|P2|Part 2: Exploratory Phase|Adverse Event|0
7789151|NCT00557856|27072320|P1|Part 2: Exploratory Phase|Adverse Event|0
7789152|NCT00557856|27072312|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
7789153|NCT00557856|27072313|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789154|NCT00557856|27072314|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789155|NCT00557856|27072315|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789156|NCT00557856|27072316|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789157|NCT00557856|27072317|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789158|NCT00557856|27072318|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789159|NCT00557856|27072319|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789160|NCT00557856|27072320|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
7789161|NCT00557856|27072312|P9|Part 2: Exploratory Phase|objective progression or relapse|15
7789162|NCT00557856|27072313|P8|Part 2: Exploratory Phase|objective progression or relapse|0
7789163|NCT00557856|27072314|P7|Part 2: Exploratory Phase|objective progression or relapse|0
7789164|NCT00557856|27072315|P6|Part 2: Exploratory Phase|objective progression or relapse|0
7789165|NCT00557856|27072316|P5|Part 2: Exploratory Phase|objective progression or relapse|0
7789166|NCT00557856|27072317|P4|Part 2: Exploratory Phase|objective progression or relapse|0
7789167|NCT00557856|27072318|P3|Part 2: Exploratory Phase|objective progression or relapse|0
7789168|NCT00557856|27072319|P2|Part 2: Exploratory Phase|objective progression or relapse|0
7789169|NCT00557856|27072320|P1|Part 2: Exploratory Phase|objective progression or relapse|0
7789170|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
7789171|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
7789172|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
7789173|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
7789174|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
7789175|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
7789176|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
7789177|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
7789178|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
7789179|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789180|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789181|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
7789182|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
7789183|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789184|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789185|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789186|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789187|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
7789188|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|Death|0
7789189|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|Death|0
7789190|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|Death|0
7789191|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|Death|1
7789192|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|Death|0
7789193|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|Death|0
7789194|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|Death|0
7789195|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|Death|0
7789196|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|Death|0
7789197|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|Other|0
7789198|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|Other|1
7789199|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|Other|0
7789200|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|Other|0
7789201|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|Other|0
7789202|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|Other|1
7789203|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|Other|1
7789204|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|Other|0
7789205|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|Other|0
7789206|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|Adverse Event|0
7789207|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|Adverse Event|2
7789208|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|Adverse Event|1
7789209|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|Adverse Event|3
7789210|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|Adverse Event|1
7789211|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|Adverse Event|1
7789212|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|Adverse Event|1
7789213|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|Adverse Event|0
7789214|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|Adverse Event|1
7789215|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789216|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789217|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789218|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789219|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789220|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789221|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
7789222|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7789223|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
7789224|NCT00557856|27072312|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
7789225|NCT00557856|27072313|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
7789226|NCT00557856|27072314|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
7789227|NCT00557856|27072315|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
7789228|NCT00557856|27072316|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
7789229|NCT00557856|27072317|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
7789230|NCT00557856|27072318|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
7789231|NCT00557856|27072319|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
7789232|NCT00557856|27072320|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
7789233|NCT00557830|27072519|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
7789234|NCT00557830|27072520|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
7789235|NCT00557830|27072521|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
7789236|NCT00557830|27072519|P3|Screening Treatment Phase|Adverse Event|0
7789237|NCT00557830|27072520|P2|Screening Treatment Phase|Adverse Event|0
7789238|NCT00557830|27072521|P1|Screening Treatment Phase|Adverse Event|2
7789239|NCT00557830|27072519|P3|Screening Treatment Phase|Withdrawal by Subject|0
7789240|NCT00557830|27072520|P2|Screening Treatment Phase|Withdrawal by Subject|0
7789241|NCT00557830|27072521|P1|Screening Treatment Phase|Withdrawal by Subject|1
7789242|NCT00557622|27072543|P2|12-Week Treatment Phase|Lost to Follow-up|1
7789243|NCT00557622|27072544|P1|12-Week Treatment Phase|Lost to Follow-up|0
7789244|NCT00557622|27072543|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
7789245|NCT00557622|27072544|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
7789246|NCT00557622|27072543|P2|4-Week Run-in Phase|Withdrawal by Subject|0
7789247|NCT00557622|27072544|P1|4-Week Run-in Phase|Withdrawal by Subject|1
7789248|NCT00557505|27072573|P9|Overall Study|Withdrawal by Subject|1
7789249|NCT00557505|27072574|P8|Overall Study|Withdrawal by Subject|0
7789250|NCT00557505|27072575|P7|Overall Study|Withdrawal by Subject|0
7789251|NCT00557505|27072576|P6|Overall Study|Withdrawal by Subject|0
7789252|NCT00557505|27072577|P5|Overall Study|Withdrawal by Subject|0
7789253|NCT00557505|27072578|P4|Overall Study|Withdrawal by Subject|1
7789254|NCT00557505|27072579|P3|Overall Study|Withdrawal by Subject|0
7789255|NCT00557505|27072580|P2|Overall Study|Withdrawal by Subject|0
7789256|NCT00557505|27072581|P1|Overall Study|Withdrawal by Subject|0
7789257|NCT00557505|27072573|P9|Overall Study|Objective progression or relapse|15
7789258|NCT00557505|27072574|P8|Overall Study|Objective progression or relapse|5
7789259|NCT00557505|27072575|P7|Overall Study|Objective progression or relapse|2
7789260|NCT00557505|27072576|P6|Overall Study|Objective progression or relapse|3
7789261|NCT00557505|27072577|P5|Overall Study|Objective progression or relapse|2
7789262|NCT00557505|27072578|P4|Overall Study|Objective progression or relapse|2
7789263|NCT00557505|27072579|P3|Overall Study|Objective progression or relapse|3
7789264|NCT00557505|27072580|P2|Overall Study|Objective progression or relapse|3
7789265|NCT00557505|27072581|P1|Overall Study|Objective progression or relapse|2
7789266|NCT00557505|27072573|P9|Overall Study|Global deterioration of health|0
7789267|NCT00557505|27072574|P8|Overall Study|Global deterioration of health|0
7789268|NCT00557505|27072575|P7|Overall Study|Global deterioration of health|0
7789269|NCT00557505|27072576|P6|Overall Study|Global deterioration of health|0
7789270|NCT00557505|27072577|P5|Overall Study|Global deterioration of health|0
7789271|NCT00557505|27072578|P4|Overall Study|Global deterioration of health|0
7789272|NCT00557505|27072579|P3|Overall Study|Global deterioration of health|0
7789273|NCT00557505|27072580|P2|Overall Study|Global deterioration of health|0
7789274|NCT00557505|27072581|P1|Overall Study|Global deterioration of health|1
7789275|NCT00557505|27072573|P9|Overall Study|Adverse Event|0
7789276|NCT00557505|27072574|P8|Overall Study|Adverse Event|0
7789277|NCT00557505|27072575|P7|Overall Study|Adverse Event|1
7789278|NCT00557505|27072576|P6|Overall Study|Adverse Event|0
7789279|NCT00557505|27072577|P5|Overall Study|Adverse Event|0
7789280|NCT00557505|27072578|P4|Overall Study|Adverse Event|0
7789281|NCT00557505|27072579|P3|Overall Study|Adverse Event|1
7789282|NCT00557505|27072580|P2|Overall Study|Adverse Event|0
7789283|NCT00557505|27072581|P1|Overall Study|Adverse Event|0
7789284|NCT00557505|27072573|P9|Overall Study|Death|1
7789285|NCT00557505|27072574|P8|Overall Study|Death|0
7789286|NCT00557505|27072575|P7|Overall Study|Death|0
7789287|NCT00557505|27072576|P6|Overall Study|Death|0
7789288|NCT00557505|27072577|P5|Overall Study|Death|0
7789289|NCT00557505|27072578|P4|Overall Study|Death|0
7789290|NCT00557505|27072579|P3|Overall Study|Death|0
7789291|NCT00557505|27072580|P2|Overall Study|Death|0
7789292|NCT00557505|27072581|P1|Overall Study|Death|0
7789293|NCT00557492|27072745|P1|Overall Study|Change in health insurance|1
7789294|NCT00557466|27072763|P6|Overall Study|Lost to Follow-up|0
7789295|NCT00557466|27072764|P5|Overall Study|Lost to Follow-up|0
7789296|NCT00557466|27072765|P4|Overall Study|Lost to Follow-up|1
7789297|NCT00557466|27072766|P3|Overall Study|Lost to Follow-up|0
7789298|NCT00557466|27072767|P2|Overall Study|Lost to Follow-up|0
7789299|NCT00557466|27072768|P1|Overall Study|Lost to Follow-up|0
7789300|NCT00557466|27072763|P6|Overall Study|Abnormal test procedure results|0
7789301|NCT00557466|27072764|P5|Overall Study|Abnormal test procedure results|0
7789302|NCT00557466|27072765|P4|Overall Study|Abnormal test procedure results|0
7789303|NCT00557466|27072766|P3|Overall Study|Abnormal test procedure results|1
7789304|NCT00557466|27072767|P2|Overall Study|Abnormal test procedure results|0
7789305|NCT00557466|27072768|P1|Overall Study|Abnormal test procedure results|0
7789306|NCT00557466|27072763|P6|Overall Study|Administrative problems|0
7789307|NCT00557466|27072764|P5|Overall Study|Administrative problems|0
7789308|NCT00557466|27072765|P4|Overall Study|Administrative problems|0
7789309|NCT00557466|27072766|P3|Overall Study|Administrative problems|1
7789310|NCT00557466|27072767|P2|Overall Study|Administrative problems|1
7789311|NCT00557466|27072768|P1|Overall Study|Administrative problems|0
7789312|NCT00557466|27072763|P6|Overall Study|Subject withdrew consent|2
7789313|NCT00557466|27072764|P5|Overall Study|Subject withdrew consent|1
7789314|NCT00557466|27072765|P4|Overall Study|Subject withdrew consent|0
7789315|NCT00557466|27072766|P3|Overall Study|Subject withdrew consent|0
7789316|NCT00557466|27072767|P2|Overall Study|Subject withdrew consent|0
7789317|NCT00557466|27072768|P1|Overall Study|Subject withdrew consent|0
7789318|NCT00557466|27072763|P6|Overall Study|Protocol deviation|0
7789319|NCT00557466|27072764|P5|Overall Study|Protocol deviation|0
7789320|NCT00557466|27072765|P4|Overall Study|Protocol deviation|2
7789321|NCT00557466|27072766|P3|Overall Study|Protocol deviation|0
7789322|NCT00557466|27072767|P2|Overall Study|Protocol deviation|1
7789323|NCT00557466|27072768|P1|Overall Study|Protocol deviation|0
7789324|NCT00557466|27072763|P6|Overall Study|Abnormal laboratory value(s)|0
7789325|NCT00557466|27072764|P5|Overall Study|Abnormal laboratory value(s)|0
7789326|NCT00557466|27072765|P4|Overall Study|Abnormal laboratory value(s)|0
7789327|NCT00557466|27072766|P3|Overall Study|Abnormal laboratory value(s)|0
7789328|NCT00557466|27072767|P2|Overall Study|Abnormal laboratory value(s)|2
7789329|NCT00557466|27072768|P1|Overall Study|Abnormal laboratory value(s)|1
7789330|NCT00557466|27072763|P6|Overall Study|Adverse Event|4
7789331|NCT00557466|27072764|P5|Overall Study|Adverse Event|2
7789332|NCT00557466|27072765|P4|Overall Study|Adverse Event|1
7789333|NCT00557466|27072766|P3|Overall Study|Adverse Event|4
7789334|NCT00557466|27072767|P2|Overall Study|Adverse Event|1
7789335|NCT00557466|27072768|P1|Overall Study|Adverse Event|3
7789336|NCT00557440|27072821|P3|Treatment Period 1|Adverse Event|1
7789337|NCT00557440|27072822|P2|Treatment Period 1|Adverse Event|0
7789338|NCT00557440|27072823|P1|Treatment Period 1|Adverse Event|0
7789339|NCT00557323|27072877|P1|Overall Study|Administrative change|2
7789340|NCT00557323|27072877|P1|Overall Study|Withdrawal by Subject|2
7789341|NCT00557323|27072877|P1|Overall Study|Death|3
7789342|NCT00557310|27072882|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
7789343|NCT00557310|27072882|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
7789344|NCT00557310|27072882|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
7789345|NCT00557310|27072882|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
7789346|NCT00557310|27072882|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
7789347|NCT00557310|27072882|P1|Main Study (0 - 18 Months)|Adverse Event|4
7789348|NCT00557245|27072928|P3|Overall Study|Ineligible|2
7789349|NCT00557245|27072929|P2|Overall Study|Ineligible|4
7789350|NCT00557245|27072930|P1|Overall Study|Ineligible|5
7789351|NCT00557245|27072928|P3|Overall Study|Lost to Follow-up|10
7789352|NCT00557245|27072929|P2|Overall Study|Lost to Follow-up|8
7789353|NCT00557245|27072930|P1|Overall Study|Lost to Follow-up|7
7789354|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
7789355|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
7789356|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
7789357|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
7789358|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
7789359|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
7789360|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7789361|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7789362|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7789363|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
7789364|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7789365|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7789366|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7789367|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7789368|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7789369|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
7789370|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7789371|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7789372|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Relapse|20
7789373|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Relapse|1
7789374|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Relapse|3
7789375|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Relapse|16
7789376|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Relapse|5
7789377|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Relapse|0
7789378|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
7789379|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7789380|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7789381|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7789382|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
7789383|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7789384|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
7789385|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
7789386|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
7789387|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
7789388|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
7789389|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
7789390|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Death|2
7789391|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Death|2
7789392|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Death|0
7789393|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Death|2
7789394|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Death|0
7789395|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Death|0
7789396|NCT00557193|27072968|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
7789397|NCT00557193|27072969|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
7789398|NCT00557193|27072970|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
7789399|NCT00557193|27072971|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
7789400|NCT00557193|27072972|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
7789401|NCT00557193|27072973|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
7789402|NCT00557193|27072968|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
7789403|NCT00557193|27072969|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
7789404|NCT00557193|27072970|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
7789405|NCT00557193|27072971|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
7789406|NCT00557193|27072972|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
7789407|NCT00557193|27072973|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
7789408|NCT00557193|27072968|P6|Induction|Inevaluable for post Induction|0
7789409|NCT00557193|27072969|P5|Induction|Inevaluable for post Induction|0
7789410|NCT00557193|27072970|P4|Induction|Inevaluable for post Induction|0
7789411|NCT00557193|27072971|P3|Induction|Inevaluable for post Induction|0
7789412|NCT00557193|27072972|P2|Induction|Inevaluable for post Induction|0
7789413|NCT00557193|27072973|P1|Induction|Inevaluable for post Induction|2
7789414|NCT00557193|27072968|P6|Induction|Ineligible|0
7789415|NCT00557193|27072969|P5|Induction|Ineligible|0
7789416|NCT00557193|27072970|P4|Induction|Ineligible|0
7789417|NCT00557193|27072971|P3|Induction|Ineligible|0
7789418|NCT00557193|27072972|P2|Induction|Ineligible|0
7789419|NCT00557193|27072973|P1|Induction|Ineligible|8
7789420|NCT00557193|27072968|P6|Induction|Refusal of Further Protocol Therapy|0
7789421|NCT00557193|27072969|P5|Induction|Refusal of Further Protocol Therapy|0
7789422|NCT00557193|27072970|P4|Induction|Refusal of Further Protocol Therapy|0
7789423|NCT00557193|27072971|P3|Induction|Refusal of Further Protocol Therapy|0
7789424|NCT00557193|27072972|P2|Induction|Refusal of Further Protocol Therapy|0
7789425|NCT00557193|27072973|P1|Induction|Refusal of Further Protocol Therapy|2
7789426|NCT00557193|27072968|P6|Induction|Withdrawal by Subject|0
7789427|NCT00557193|27072969|P5|Induction|Withdrawal by Subject|0
7789428|NCT00557193|27072970|P4|Induction|Withdrawal by Subject|0
7789429|NCT00557193|27072971|P3|Induction|Withdrawal by Subject|0
7789430|NCT00557193|27072972|P2|Induction|Withdrawal by Subject|0
7789431|NCT00557193|27072973|P1|Induction|Withdrawal by Subject|1
7789432|NCT00557193|27072968|P6|Induction|Physician Decision|0
7789433|NCT00557193|27072969|P5|Induction|Physician Decision|0
7789434|NCT00557193|27072970|P4|Induction|Physician Decision|0
7789435|NCT00557193|27072971|P3|Induction|Physician Decision|0
7789436|NCT00557193|27072972|P2|Induction|Physician Decision|0
7789437|NCT00557193|27072973|P1|Induction|Physician Decision|3
7789438|NCT00557193|27072968|P6|Induction|Death|0
7789439|NCT00557193|27072969|P5|Induction|Death|0
7789440|NCT00557193|27072970|P4|Induction|Death|0
7789441|NCT00557193|27072971|P3|Induction|Death|0
7789442|NCT00557193|27072972|P2|Induction|Death|0
7789443|NCT00557193|27072973|P1|Induction|Death|6
7789444|NCT00557193|27072968|P6|Induction|Adverse Event|0
7789445|NCT00557193|27072969|P5|Induction|Adverse Event|0
7789446|NCT00557193|27072970|P4|Induction|Adverse Event|0
7789447|NCT00557193|27072971|P3|Induction|Adverse Event|0
7789448|NCT00557193|27072972|P2|Induction|Adverse Event|0
7789449|NCT00557193|27072973|P1|Induction|Adverse Event|2
7789450|NCT00557076|27073013|P2|Overall Study|Unblinding|1
7789451|NCT00557076|27073014|P1|Overall Study|Unblinding|0
7789452|NCT00556998|27073022|P1|Voriconazole Oral|Intolerant of oral treatment|1
7789453|NCT00556998|27073022|P1|Voriconazole Oral|Adverse Event|1
7789454|NCT00556998|27073022|P1|Voriconazole Intravenous (IV)|Other|4
7789455|NCT00556998|27073022|P1|Voriconazole Intravenous (IV)|Adverse Event|1
7789456|NCT00556933|27073057|P4|CNI Withdrawal vs. Minimization|Death|1
7789457|NCT00556933|27073058|P3|CNI Withdrawal vs. Minimization|Death|0
7789458|NCT00556933|27073059|P2|CNI Withdrawal vs. Minimization|Death|0
7789459|NCT00556933|27073060|P1|CNI Withdrawal vs. Minimization|Death|0
7789460|NCT00556933|27073057|P4|CNI Withdrawal vs. Minimization|Graft loss|0
7789461|NCT00556933|27073058|P3|CNI Withdrawal vs. Minimization|Graft loss|2
7789462|NCT00556933|27073059|P2|CNI Withdrawal vs. Minimization|Graft loss|1
7789463|NCT00556933|27073060|P1|CNI Withdrawal vs. Minimization|Graft loss|0
7789464|NCT00556933|27073057|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
7789465|NCT00556933|27073058|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
7789466|NCT00556933|27073059|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
7789467|NCT00556933|27073060|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
7789468|NCT00556933|27073057|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
7789469|NCT00556933|27073058|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
7789470|NCT00556933|27073059|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
7789471|NCT00556933|27073060|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
7789472|NCT00556933|27073057|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
7789473|NCT00556933|27073058|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
7789474|NCT00556933|27073059|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
7789475|NCT00556933|27073060|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
7789476|NCT00556933|27073057|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7789477|NCT00556933|27073058|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7789478|NCT00556933|27073059|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
7789479|NCT00556933|27073060|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7789480|NCT00556933|27073057|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7789481|NCT00556933|27073058|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7789482|NCT00556933|27073059|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
7789483|NCT00556933|27073060|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7789484|NCT00556933|27073057|P4|Single vs. Divided-dose rATG Induction|Death|0
7789485|NCT00556933|27073058|P3|Single vs. Divided-dose rATG Induction|Death|0
7789486|NCT00556933|27073059|P2|Single vs. Divided-dose rATG Induction|Death|1
7789487|NCT00556933|27073060|P1|Single vs. Divided-dose rATG Induction|Death|0
7789488|NCT00556933|27073057|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7789489|NCT00556933|27073058|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7789490|NCT00556933|27073059|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7789491|NCT00556933|27073060|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
7789492|NCT00556933|27073057|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7789493|NCT00556933|27073058|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
7789494|NCT00556933|27073059|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7789495|NCT00556933|27073060|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7789496|NCT00556933|27073057|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
7789497|NCT00556933|27073058|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
7789498|NCT00556933|27073059|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
7789499|NCT00556933|27073060|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
7789500|NCT00556894|27073117|P3|Overall Study|Withdrawal by Subject|1
7789501|NCT00556894|27073118|P2|Overall Study|Withdrawal by Subject|1
7789502|NCT00556894|27073119|P1|Overall Study|Withdrawal by Subject|1
7789503|NCT00556894|27073117|P3|Overall Study|Change in therapy|2
7789504|NCT00556894|27073118|P2|Overall Study|Change in therapy|1
7789505|NCT00556894|27073119|P1|Overall Study|Change in therapy|2
7789506|NCT00556894|27073117|P3|Overall Study|regulatory decision in Bulgaria|13
7789507|NCT00556894|27073118|P2|Overall Study|regulatory decision in Bulgaria|14
7789508|NCT00556894|27073119|P1|Overall Study|regulatory decision in Bulgaria|10
7789509|NCT00556894|27073117|P3|Overall Study|Death|0
7789510|NCT00556894|27073118|P2|Overall Study|Death|0
7789511|NCT00556894|27073119|P1|Overall Study|Death|1
7789512|NCT00556894|27073117|P3|Overall Study|Adverse Event|3
7789513|NCT00556894|27073118|P2|Overall Study|Adverse Event|3
7789514|NCT00556894|27073119|P1|Overall Study|Adverse Event|2
7789515|NCT00556712|27073148|P2|Overall Study|Ongoing at Data Cutoff|66
7789516|NCT00556712|27073149|P1|Overall Study|Ongoing at Data Cutoff|32
7789517|NCT00556712|27073148|P2|Overall Study|Other|2
7789518|NCT00556712|27073149|P1|Overall Study|Other|2
7789519|NCT00556712|27073148|P2|Overall Study|Failure to Return|3
7789520|NCT00556712|27073149|P1|Overall Study|Failure to Return|2
7789521|NCT00556712|27073148|P2|Overall Study|Refused Treatment|16
7789522|NCT00556712|27073149|P1|Overall Study|Refused Treatment|17
7789523|NCT00556712|27073148|P2|Overall Study|Protocol Violation|2
7789524|NCT00556712|27073149|P1|Overall Study|Protocol Violation|3
7789525|NCT00556712|27073148|P2|Overall Study|Progressive Disease|320
7789526|NCT00556712|27073149|P1|Overall Study|Progressive Disease|383
7789527|NCT00556712|27073148|P2|Overall Study|Death|10
7789528|NCT00556712|27073149|P1|Overall Study|Death|5
7789529|NCT00556712|27073148|P2|Overall Study|Adverse Event|19
7789530|NCT00556712|27073149|P1|Overall Study|Adverse Event|7
7789531|NCT00556673|27073227|P2|Overall Study|Protocol deviation|2
7789532|NCT00556673|27073228|P1|Overall Study|Protocol deviation|3
7789533|NCT00556439|27073364|P4|After Week 12 (Randomized Study Period)|Severe infection|0
7789534|NCT00556439|27073365|P3|After Week 12 (Randomized Study Period)|Severe infection|0
7789535|NCT00556439|27073366|P2|After Week 12 (Randomized Study Period)|Severe infection|0
7789536|NCT00556439|27073367|P1|After Week 12 (Randomized Study Period)|Severe infection|1
7789537|NCT00556439|27073364|P4|After Week 12 (Randomized Study Period)|Malignancy|1
7789538|NCT00556439|27073365|P3|After Week 12 (Randomized Study Period)|Malignancy|0
7789539|NCT00556439|27073366|P2|After Week 12 (Randomized Study Period)|Malignancy|1
7789540|NCT00556439|27073367|P1|After Week 12 (Randomized Study Period)|Malignancy|0
7789541|NCT00556439|27073364|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
7789542|NCT00556439|27073365|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
7789543|NCT00556439|27073366|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
7789544|NCT00556439|27073367|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
7789545|NCT00556439|27073364|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
7789546|NCT00556439|27073365|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
7789547|NCT00556439|27073366|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
7789548|NCT00556439|27073367|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
7789549|NCT00556439|27073364|P4|Study Entry to Week 12|Malignancy|0
7789550|NCT00556439|27073365|P3|Study Entry to Week 12|Malignancy|1
7789551|NCT00556439|27073366|P2|Study Entry to Week 12|Malignancy|0
7789552|NCT00556439|27073367|P1|Study Entry to Week 12|Malignancy|0
7789553|NCT00556439|27073364|P4|Study Entry to Week 12|Recurrent infection|0
7789554|NCT00556439|27073365|P3|Study Entry to Week 12|Recurrent infection|0
7789555|NCT00556439|27073366|P2|Study Entry to Week 12|Recurrent infection|0
7789556|NCT00556439|27073367|P1|Study Entry to Week 12|Recurrent infection|1
7789557|NCT00556439|27073364|P4|Study Entry to Week 12|Withdrawal by Subject|0
7789558|NCT00556439|27073365|P3|Study Entry to Week 12|Withdrawal by Subject|1
7789559|NCT00556439|27073366|P2|Study Entry to Week 12|Withdrawal by Subject|0
7789560|NCT00556439|27073367|P1|Study Entry to Week 12|Withdrawal by Subject|1
7789561|NCT00556439|27073364|P4|Study Entry to Week 12|Physician Decision|0
7789562|NCT00556439|27073365|P3|Study Entry to Week 12|Physician Decision|0
7789563|NCT00556439|27073366|P2|Study Entry to Week 12|Physician Decision|0
7789564|NCT00556439|27073367|P1|Study Entry to Week 12|Physician Decision|1
7789565|NCT00556439|27073364|P4|Study Entry to Week 12|Lack of Efficacy|0
7789566|NCT00556439|27073365|P3|Study Entry to Week 12|Lack of Efficacy|6
7789567|NCT00556439|27073366|P2|Study Entry to Week 12|Lack of Efficacy|0
7789568|NCT00556439|27073367|P1|Study Entry to Week 12|Lack of Efficacy|5
7789569|NCT00556426|27073377|P1|Overall Study|Death|6
7789570|NCT00556426|27073377|P1|Overall Study|Withdrawal by Subject|3
7789571|NCT00556374|27073399|P2|Overall Study|Lost to Follow-up|5
7789572|NCT00556374|27073400|P1|Overall Study|Lost to Follow-up|7
7789573|NCT00556374|27073399|P2|Overall Study|Death|43
7789574|NCT00556374|27073400|P1|Overall Study|Death|50
7789575|NCT00556374|27073399|P2|Overall Study|Withdrawal by Subject|172
7789576|NCT00556374|27073400|P1|Overall Study|Withdrawal by Subject|190
7789577|NCT00556322|27073420|P2|Overall Study|Death|14
7789578|NCT00556322|27073421|P1|Overall Study|Death|20
7789579|NCT00556322|27073420|P2|Overall Study|Ongoing at data cutoff|5
7789580|NCT00556322|27073421|P1|Overall Study|Ongoing at data cutoff|3
7789581|NCT00556322|27073420|P2|Overall Study|Protocol Violation|1
7789582|NCT00556322|27073421|P1|Overall Study|Protocol Violation|5
7789583|NCT00556322|27073420|P2|Overall Study|Withdrawal by Subject|7
7789584|NCT00556322|27073421|P1|Overall Study|Withdrawal by Subject|19
7789585|NCT00556322|27073420|P2|Overall Study|Lost to Follow-up|3
7789586|NCT00556322|27073421|P1|Overall Study|Lost to Follow-up|5
7789587|NCT00556322|27073420|P2|Overall Study|Other|1
7789588|NCT00556322|27073421|P1|Overall Study|Other|4
7789589|NCT00556322|27073420|P2|Overall Study|Adverse Event|4
7789590|NCT00556322|27073421|P1|Overall Study|Adverse Event|7
7789591|NCT00556322|27073420|P2|Overall Study|Insufficient therapeutic response|168
7789592|NCT00556322|27073421|P1|Overall Study|Insufficient therapeutic response|158
7789593|NCT00556166|27073469|P1|Overall Study|Withdrawal by Subject|1
7789594|NCT00556075|27073482|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
7789595|NCT00556075|27073483|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
7789596|NCT00556075|27073484|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
7789597|NCT00556075|27073482|P3|Overall Study|Personal issues|0
7789598|NCT00556075|27073483|P2|Overall Study|Personal issues|1
7789599|NCT00556075|27073484|P1|Overall Study|Personal issues|4
7789600|NCT00556075|27073482|P3|Overall Study|Adverse Event|0
7789601|NCT00556075|27073483|P2|Overall Study|Adverse Event|2
7789602|NCT00556075|27073484|P1|Overall Study|Adverse Event|1
7789603|NCT00556075|27073482|P3|Overall Study|Not eligible|2
7789604|NCT00556075|27073483|P2|Overall Study|Not eligible|1
7789605|NCT00556075|27073484|P1|Overall Study|Not eligible|1
7789606|NCT00556075|27073482|P3|Overall Study|Protocol Violation|3
7789607|NCT00556075|27073483|P2|Overall Study|Protocol Violation|1
7789608|NCT00556075|27073484|P1|Overall Study|Protocol Violation|1
7789609|NCT00556075|27073482|P3|Overall Study|Withdrawal by Subject|0
7789610|NCT00556075|27073483|P2|Overall Study|Withdrawal by Subject|3
7789611|NCT00556075|27073484|P1|Overall Study|Withdrawal by Subject|3
7789612|NCT00556075|27073482|P3|Overall Study|Lost to Follow-up|3
7789613|NCT00556075|27073483|P2|Overall Study|Lost to Follow-up|0
7789614|NCT00556075|27073484|P1|Overall Study|Lost to Follow-up|3
7789615|NCT00555971|27073535|P2|Overall Study|Adverse Event|1
7789616|NCT00555971|27073536|P1|Overall Study|Adverse Event|1
7789617|NCT00555906|27073547|P5|Phase 2|Randomized but not Treated|2
7789618|NCT00555906|27073548|P4|Phase 2|Randomized but not Treated|0
7789619|NCT00555906|27073549|P3|Phase 2|Randomized but not Treated|0
7789620|NCT00555906|27073550|P2|Phase 2|Randomized but not Treated|0
7789621|NCT00555906|27073551|P1|Phase 2|Randomized but not Treated|0
7789622|NCT00555906|27073547|P5|Phase 2|Other|6
7789623|NCT00555906|27073548|P4|Phase 2|Other|0
7789624|NCT00555906|27073549|P3|Phase 2|Other|0
7789625|NCT00555906|27073550|P2|Phase 2|Other|0
7789626|NCT00555906|27073551|P1|Phase 2|Other|0
7789627|NCT00555906|27073547|P5|Phase 2|Withdrawal by Subject|2
7789628|NCT00555906|27073548|P4|Phase 2|Withdrawal by Subject|0
7789629|NCT00555906|27073549|P3|Phase 2|Withdrawal by Subject|0
7789630|NCT00555906|27073550|P2|Phase 2|Withdrawal by Subject|0
7789631|NCT00555906|27073551|P1|Phase 2|Withdrawal by Subject|0
7789632|NCT00555906|27073547|P5|Phase 2|Objective Progression or Relapse|16
7789633|NCT00555906|27073548|P4|Phase 2|Objective Progression or Relapse|0
7789634|NCT00555906|27073549|P3|Phase 2|Objective Progression or Relapse|0
7789635|NCT00555906|27073550|P2|Phase 2|Objective Progression or Relapse|0
7789636|NCT00555906|27073551|P1|Phase 2|Objective Progression or Relapse|0
7789637|NCT00555906|27073547|P5|Phase 2|Global Deterioration of Health Status|2
7789638|NCT00555906|27073548|P4|Phase 2|Global Deterioration of Health Status|0
7789639|NCT00555906|27073549|P3|Phase 2|Global Deterioration of Health Status|0
7789640|NCT00555906|27073550|P2|Phase 2|Global Deterioration of Health Status|0
7789641|NCT00555906|27073551|P1|Phase 2|Global Deterioration of Health Status|0
7789642|NCT00555906|27073547|P5|Phase 2|Adverse Event|4
7789643|NCT00555906|27073548|P4|Phase 2|Adverse Event|0
7789644|NCT00555906|27073549|P3|Phase 2|Adverse Event|0
7789645|NCT00555906|27073550|P2|Phase 2|Adverse Event|0
7789646|NCT00555906|27073551|P1|Phase 2|Adverse Event|0
7789647|NCT00555906|27073547|P5|Phase 1|Withdrawal by Subject|0
7789648|NCT00555906|27073548|P4|Phase 1|Withdrawal by Subject|1
7789649|NCT00555906|27073549|P3|Phase 1|Withdrawal by Subject|0
7789650|NCT00555906|27073550|P2|Phase 1|Withdrawal by Subject|0
7789651|NCT00555906|27073551|P1|Phase 1|Withdrawal by Subject|0
7789652|NCT00555906|27073547|P5|Phase 1|Adverse Event|0
7789653|NCT00555906|27073548|P4|Phase 1|Adverse Event|2
7789654|NCT00555906|27073549|P3|Phase 1|Adverse Event|3
7789655|NCT00555906|27073550|P2|Phase 1|Adverse Event|0
7789656|NCT00555906|27073551|P1|Phase 1|Adverse Event|0
7789657|NCT00555906|27073547|P5|Phase 1|Global Deterioration of Health Status|0
7789658|NCT00555906|27073548|P4|Phase 1|Global Deterioration of Health Status|1
7789659|NCT00555906|27073549|P3|Phase 1|Global Deterioration of Health Status|1
7789660|NCT00555906|27073550|P2|Phase 1|Global Deterioration of Health Status|1
7789661|NCT00555906|27073551|P1|Phase 1|Global Deterioration of Health Status|0
7789662|NCT00555906|27073547|P5|Phase 1|Objective Progression or Relapse|0
7789663|NCT00555906|27073548|P4|Phase 1|Objective Progression or Relapse|1
7789664|NCT00555906|27073549|P3|Phase 1|Objective Progression or Relapse|3
7789665|NCT00555906|27073550|P2|Phase 1|Objective Progression or Relapse|5
7789666|NCT00555906|27073551|P1|Phase 1|Objective Progression or Relapse|3
7789667|NCT00555672|27073673|P2|Overall Study|Participant refused|0
7789668|NCT00555672|27073674|P1|Overall Study|Participant refused|2
7789669|NCT00555672|27073673|P2|Overall Study|Other|1
7789670|NCT00555672|27073674|P1|Overall Study|Other|3
7789671|NCT00555672|27073673|P2|Overall Study|Objective progression or relapse|5
7789672|NCT00555672|27073674|P1|Overall Study|Objective progression or relapse|11
7789673|NCT00555672|27073673|P2|Overall Study|Adverse Event|2
7789674|NCT00555672|27073674|P1|Overall Study|Adverse Event|8
7789675|NCT00555672|27073673|P2|Overall Study|Death|2
7789676|NCT00555672|27073674|P1|Overall Study|Death|0
7789677|NCT00555620|27073699|P6|Overall Study|Other|3
7789678|NCT00555620|27073700|P5|Overall Study|Other|0
7789679|NCT00555620|27073701|P4|Overall Study|Other|1
7789680|NCT00555620|27073702|P3|Overall Study|Other|0
7789681|NCT00555620|27073703|P2|Overall Study|Other|0
7789682|NCT00555620|27073704|P1|Overall Study|Other|0
7789683|NCT00555620|27073699|P6|Overall Study|Participant refused treatment|1
7789684|NCT00555620|27073700|P5|Overall Study|Participant refused treatment|0
7789685|NCT00555620|27073701|P4|Overall Study|Participant refused treatment|0
7789686|NCT00555620|27073702|P3|Overall Study|Participant refused treatment|1
7789687|NCT00555620|27073703|P2|Overall Study|Participant refused treatment|1
7789688|NCT00555620|27073704|P1|Overall Study|Participant refused treatment|0
7789689|NCT00555620|27073699|P6|Overall Study|Objective progression or relapse|16
7789690|NCT00555620|27073700|P5|Overall Study|Objective progression or relapse|3
7789691|NCT00555620|27073701|P4|Overall Study|Objective progression or relapse|17
7789692|NCT00555620|27073702|P3|Overall Study|Objective progression or relapse|12
7789693|NCT00555620|27073703|P2|Overall Study|Objective progression or relapse|5
7789694|NCT00555620|27073704|P1|Overall Study|Objective progression or relapse|6
7789695|NCT00555620|27073699|P6|Overall Study|Adverse Event|1
7789696|NCT00555620|27073700|P5|Overall Study|Adverse Event|0
7789697|NCT00555620|27073701|P4|Overall Study|Adverse Event|5
7789698|NCT00555620|27073702|P3|Overall Study|Adverse Event|1
7789699|NCT00555620|27073703|P2|Overall Study|Adverse Event|0
7789700|NCT00555620|27073704|P1|Overall Study|Adverse Event|0
7789701|NCT00555620|27073699|P6|Overall Study|Study terminated by sponsor|0
7789702|NCT00555620|27073700|P5|Overall Study|Study terminated by sponsor|0
7789703|NCT00555620|27073701|P4|Overall Study|Study terminated by sponsor|0
7789704|NCT00555620|27073702|P3|Overall Study|Study terminated by sponsor|1
7789705|NCT00555620|27073703|P2|Overall Study|Study terminated by sponsor|0
7789706|NCT00555620|27073704|P1|Overall Study|Study terminated by sponsor|0
7789707|NCT00555620|27073699|P6|Overall Study|Death|1
7789708|NCT00555620|27073700|P5|Overall Study|Death|0
7789709|NCT00555620|27073701|P4|Overall Study|Death|0
7789710|NCT00555620|27073702|P3|Overall Study|Death|0
7789711|NCT00555620|27073703|P2|Overall Study|Death|1
7789712|NCT00555620|27073704|P1|Overall Study|Death|0
7789713|NCT00555568|27073828|P3|Overall Study|Lost to Follow-up|16
7789714|NCT00555568|27073829|P2|Overall Study|Lost to Follow-up|16
7789715|NCT00555568|27073830|P1|Overall Study|Lost to Follow-up|26
7789716|NCT00555477|27073852|P2|Overall Study|Physician Decision|2
7789717|NCT00555477|27073853|P1|Overall Study|Physician Decision|1
7789718|NCT00555477|27073852|P2|Overall Study|Withdrawal by Subject|2
7789719|NCT00555477|27073853|P1|Overall Study|Withdrawal by Subject|1
7789720|NCT00555477|27073852|P2|Overall Study|Adverse Event|9
7789721|NCT00555477|27073853|P1|Overall Study|Adverse Event|0
7789722|NCT00555438|27073869|P1|Between 10 Days and 30 Days Postoperativ|Death|5
7789723|NCT00555438|27073869|P1|10 Days Post-operative|Death|4
7789724|NCT00555425|27073879|P2|Overall Study|Became pregnant and transferred care|1
7789725|NCT00555425|27073880|P1|Overall Study|Became pregnant and transferred care|0
7789726|NCT00555425|27073879|P2|Overall Study|Met criteria for protective transfer|3
7789727|NCT00555425|27073880|P1|Overall Study|Met criteria for protective transfer|16
7789728|NCT00555425|27073879|P2|Overall Study|Missed 3 physician management visits|0
7789729|NCT00555425|27073880|P1|Overall Study|Missed 3 physician management visits|1
7789730|NCT00555425|27073879|P2|Overall Study|Missed Medication > 1 wk|15
7789731|NCT00555425|27073880|P1|Overall Study|Missed Medication > 1 wk|34
7789732|NCT00555321|27073916|P5|Long-term Extension Phase|Other Reason|0
7789733|NCT00555321|27073917|P4|Long-term Extension Phase|Other Reason|0
7789734|NCT00555321|27073918|P3|Long-term Extension Phase|Other Reason|2
7789735|NCT00555321|27073919|P2|Long-term Extension Phase|Other Reason|0
7789736|NCT00555321|27073920|P1|Long-term Extension Phase|Other Reason|1
7789737|NCT00555321|27073916|P5|Long-term Extension Phase|Participant did not meet study criteria|1
7789738|NCT00555321|27073917|P4|Long-term Extension Phase|Participant did not meet study criteria|0
7789739|NCT00555321|27073918|P3|Long-term Extension Phase|Participant did not meet study criteria|0
7789740|NCT00555321|27073919|P2|Long-term Extension Phase|Participant did not meet study criteria|0
7789741|NCT00555321|27073920|P1|Long-term Extension Phase|Participant did not meet study criteria|0
7789742|NCT00555321|27073916|P5|Long-term Extension Phase|Death|0
7789743|NCT00555321|27073917|P4|Long-term Extension Phase|Death|3
7789744|NCT00555321|27073918|P3|Long-term Extension Phase|Death|0
7789745|NCT00555321|27073919|P2|Long-term Extension Phase|Death|0
7789746|NCT00555321|27073920|P1|Long-term Extension Phase|Death|2
7789747|NCT00555321|27073916|P5|Long-term Extension Phase|Administrative reason by sponsor|23
7789748|NCT00555321|27073917|P4|Long-term Extension Phase|Administrative reason by sponsor|31
7789749|NCT00555321|27073918|P3|Long-term Extension Phase|Administrative reason by sponsor|18
7789750|NCT00555321|27073919|P2|Long-term Extension Phase|Administrative reason by sponsor|21
7789751|NCT00555321|27073920|P1|Long-term Extension Phase|Administrative reason by sponsor|23
7789752|NCT00555321|27073916|P5|Long-term Extension Phase|Withdrawal by Subject|2
7789753|NCT00555321|27073917|P4|Long-term Extension Phase|Withdrawal by Subject|3
7789754|NCT00555321|27073918|P3|Long-term Extension Phase|Withdrawal by Subject|2
7789755|NCT00555321|27073919|P2|Long-term Extension Phase|Withdrawal by Subject|1
7789756|NCT00555321|27073920|P1|Long-term Extension Phase|Withdrawal by Subject|2
7789757|NCT00555321|27073916|P5|Long-term Extension Phase|Adverse Event|0
7789758|NCT00555321|27073917|P4|Long-term Extension Phase|Adverse Event|1
7789759|NCT00555321|27073918|P3|Long-term Extension Phase|Adverse Event|2
7789760|NCT00555321|27073919|P2|Long-term Extension Phase|Adverse Event|5
7789761|NCT00555321|27073920|P1|Long-term Extension Phase|Adverse Event|2
7789762|NCT00555321|27073916|P5|Treatment Phase up to 12-months|Never treated|4
7789763|NCT00555321|27073917|P4|Treatment Phase up to 12-months|Never treated|0
7789764|NCT00555321|27073918|P3|Treatment Phase up to 12-months|Never treated|1
7789765|NCT00555321|27073919|P2|Treatment Phase up to 12-months|Never treated|3
7789766|NCT00555321|27073920|P1|Treatment Phase up to 12-months|Never treated|2
7789767|NCT00555321|27073916|P5|Treatment Phase up to 12-months|Other Reason|0
7789768|NCT00555321|27073917|P4|Treatment Phase up to 12-months|Other Reason|0
7789769|NCT00555321|27073918|P3|Treatment Phase up to 12-months|Other Reason|2
7789770|NCT00555321|27073919|P2|Treatment Phase up to 12-months|Other Reason|3
7789771|NCT00555321|27073920|P1|Treatment Phase up to 12-months|Other Reason|1
7789772|NCT00555321|27073916|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
7789773|NCT00555321|27073917|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
7789774|NCT00555321|27073918|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
7789775|NCT00555321|27073919|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
7789776|NCT00555321|27073920|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
7789777|NCT00555321|27073916|P5|Treatment Phase up to 12-months|Death|0
7789778|NCT00555321|27073917|P4|Treatment Phase up to 12-months|Death|0
7789779|NCT00555321|27073918|P3|Treatment Phase up to 12-months|Death|4
7789780|NCT00555321|27073919|P2|Treatment Phase up to 12-months|Death|1
7789781|NCT00555321|27073920|P1|Treatment Phase up to 12-months|Death|2
7789782|NCT00555321|27073916|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
7789783|NCT00555321|27073917|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
7789784|NCT00555321|27073918|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
7789785|NCT00555321|27073919|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
7789786|NCT00555321|27073920|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
7789787|NCT00555321|27073916|P5|Treatment Phase up to 12-months|Adverse Event|18
7789788|NCT00555321|27073917|P4|Treatment Phase up to 12-months|Adverse Event|7
7789789|NCT00555321|27073918|P3|Treatment Phase up to 12-months|Adverse Event|11
7789790|NCT00555321|27073919|P2|Treatment Phase up to 12-months|Adverse Event|7
7789791|NCT00555321|27073920|P1|Treatment Phase up to 12-months|Adverse Event|6
7789792|NCT00555217|27074224|P2|Overall Study|close out sites|17
7789793|NCT00555217|27074225|P1|Overall Study|close out sites|21
7789794|NCT00555217|27074224|P2|Overall Study|Lost to Follow-up|20
7789795|NCT00555217|27074225|P1|Overall Study|Lost to Follow-up|19
7789796|NCT00555217|27074224|P2|Overall Study|Withdrawal by Subject|31
7789797|NCT00555217|27074225|P1|Overall Study|Withdrawal by Subject|35
7789798|NCT00555061|27074262|P1|Overall Study|Participant enrolled, but never treated|1
7789799|NCT00555061|27074262|P1|Overall Study|Withdrawal by Subject|2
7789800|NCT00555061|27074262|P1|Overall Study|Lost to Follow-up|2
7789801|NCT00555061|27074262|P1|Overall Study|Protocol Violation|1
7789802|NCT00555061|27074262|P1|Overall Study|Adverse Event|3
7789803|NCT00555009|27074281|P2|Overall Study|Terminated by Sponsor|5
7789804|NCT00555009|27074282|P1|Overall Study|Terminated by Sponsor|2
7789805|NCT00555009|27074281|P2|Overall Study|Withdrawal by Subject|1
7789806|NCT00555009|27074282|P1|Overall Study|Withdrawal by Subject|0
7789807|NCT00554840|27074362|P2|Overall Study|Physician Decision|1
7789808|NCT00554840|27074363|P1|Overall Study|Physician Decision|0
7789809|NCT00554801|27074381|P2|Overall Study|Withdrawal by Subject|0
7789810|NCT00554801|27074382|P1|Overall Study|Withdrawal by Subject|14
7789811|NCT00554801|27074381|P2|Overall Study|left area before completion|0
7789812|NCT00554801|27074382|P1|Overall Study|left area before completion|5
7789813|NCT00554788|27074393|P3|Overall Study|Ineligible|1
7789814|NCT00554788|27074394|P2|Overall Study|Ineligible|0
7789815|NCT00554788|27074395|P1|Overall Study|Ineligible|2
7789816|NCT00554788|27074393|P3|Overall Study|Progressive disease|3
7789817|NCT00554788|27074394|P2|Overall Study|Progressive disease|0
7789818|NCT00554788|27074395|P1|Overall Study|Progressive disease|0
7789819|NCT00554788|27074393|P3|Overall Study|Refusal of further protocol therapy|1
7789820|NCT00554788|27074394|P2|Overall Study|Refusal of further protocol therapy|1
7789821|NCT00554788|27074395|P1|Overall Study|Refusal of further protocol therapy|0
7789822|NCT00554788|27074393|P3|Overall Study|Withdrawal by Subject|1
7789823|NCT00554788|27074394|P2|Overall Study|Withdrawal by Subject|0
7789824|NCT00554788|27074395|P1|Overall Study|Withdrawal by Subject|0
7789825|NCT00554788|27074393|P3|Overall Study|Physician Decision|3
7789826|NCT00554788|27074394|P2|Overall Study|Physician Decision|1
7789827|NCT00554788|27074395|P1|Overall Study|Physician Decision|1
7789828|NCT00554788|27074393|P3|Overall Study|Lost to Follow-up|3
7789829|NCT00554788|27074394|P2|Overall Study|Lost to Follow-up|3
7789830|NCT00554788|27074395|P1|Overall Study|Lost to Follow-up|4
7789831|NCT00554788|27074393|P3|Overall Study|Adverse Event|2
7789832|NCT00554788|27074394|P2|Overall Study|Adverse Event|1
7789833|NCT00554788|27074395|P1|Overall Study|Adverse Event|0
7789834|NCT00554619|27074427|P1|Overall Study|Liver Function Test Abnormality|1
7789835|NCT00554619|27074427|P1|Overall Study|Physician Decision|1
7789836|NCT00554619|27074427|P1|Overall Study|Adverse Event|1
7789837|NCT00554606|27074439|P1|Overall Study|Protocol deviation|2
7789838|NCT00554606|27074439|P1|Overall Study|Death|1
7789839|NCT00554606|27074439|P1|Overall Study|Administrative problems|60
7789840|NCT00554606|27074439|P1|Overall Study|Lost to Follow-up|2
7789841|NCT00554606|27074439|P1|Overall Study|Subject withdrew consent|2
7789842|NCT00554606|27074439|P1|Overall Study|Unsatisfactory therapeutic effect|14
7789843|NCT00554606|27074439|P1|Overall Study|Abnormal laboratory values|1
7789844|NCT00554606|27074439|P1|Overall Study|Adverse Event|3
7789845|NCT00554515|27074468|P1|Overall Study|Misc|15
7789846|NCT00554515|27074468|P1|Overall Study|Other|1
7789847|NCT00554515|27074468|P1|Overall Study|Achieved Stable Disease|7
7789848|NCT00554515|27074468|P1|Overall Study|Death|2
7789849|NCT00554515|27074468|P1|Overall Study|Adverse Event|9
7789850|NCT00554515|27074468|P1|Overall Study|Withdrawal by Subject|11
7789851|NCT00554515|27074468|P1|Overall Study|Physician Decision|18
7789852|NCT00554515|27074468|P1|Overall Study|Disease progression|52
7789853|NCT00554515|27074468|P1|Overall Study|Withdrawal by Subject|3
7789854|NCT00554229|27074531|P2|Overall Study|Randomised but no treatment received|0
7789855|NCT00554229|27074532|P1|Overall Study|Randomised but no treatment received|1
7789856|NCT00554229|27074531|P2|Overall Study|Reason not otherwise captured, eg; death|140
7789857|NCT00554229|27074532|P1|Overall Study|Reason not otherwise captured, eg; death|119
7789858|NCT00554229|27074531|P2|Overall Study|Protocol Violation|3
7789859|NCT00554229|27074532|P1|Overall Study|Protocol Violation|3
7789860|NCT00554229|27074531|P2|Overall Study|Adverse Event|39
7789861|NCT00554229|27074532|P1|Overall Study|Adverse Event|71
7789862|NCT00554229|27074531|P2|Overall Study|Withdrawal by Subject|37
7789863|NCT00554229|27074532|P1|Overall Study|Withdrawal by Subject|29
7789864|NCT00554229|27074531|P2|Overall Study|Lost to Follow-up|6
7789865|NCT00554229|27074532|P1|Overall Study|Lost to Follow-up|3
7789866|NCT00554216|27074557|P3|Overall Study|Lack of Efficacy|0
7789867|NCT00554216|27074558|P2|Overall Study|Lack of Efficacy|3
7789868|NCT00554216|27074559|P1|Overall Study|Lack of Efficacy|15
7789869|NCT00554216|27074557|P3|Overall Study|Other|10
7789870|NCT00554216|27074558|P2|Overall Study|Other|7
7789871|NCT00554216|27074559|P1|Overall Study|Other|12
7789872|NCT00554216|27074557|P3|Overall Study|Restricted med|1
7789873|NCT00554216|27074558|P2|Overall Study|Restricted med|1
7789874|NCT00554216|27074559|P1|Overall Study|Restricted med|3
7789875|NCT00554216|27074557|P3|Overall Study|Pregnancy|14
7789876|NCT00554216|27074558|P2|Overall Study|Pregnancy|1
7789877|NCT00554216|27074559|P1|Overall Study|Pregnancy|2
7789878|NCT00554216|27074557|P3|Overall Study|Non compliance|5
7789879|NCT00554216|27074558|P2|Overall Study|Non compliance|4
7789880|NCT00554216|27074559|P1|Overall Study|Non compliance|10
7789881|NCT00554216|27074557|P3|Overall Study|Withdrawal by Subject|43
7789882|NCT00554216|27074558|P2|Overall Study|Withdrawal by Subject|31
7789883|NCT00554216|27074559|P1|Overall Study|Withdrawal by Subject|92
7789884|NCT00554216|27074557|P3|Overall Study|Adverse Event|36
7789885|NCT00554216|27074558|P2|Overall Study|Adverse Event|16
7789886|NCT00554216|27074559|P1|Overall Study|Adverse Event|16
7789887|NCT00554216|27074557|P3|Overall Study|Lost to Follow-up|63
7789888|NCT00554216|27074558|P2|Overall Study|Lost to Follow-up|31
7789889|NCT00554216|27074559|P1|Overall Study|Lost to Follow-up|92
7789890|NCT00554190|27074570|P1|Overall Study|Termination forms not completed|10
7789891|NCT00554099|27074579|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
7789892|NCT00554099|27074580|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
7789893|NCT00554099|27074581|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
7789894|NCT00554099|27074579|P3|Non-Treatment Phase (9 Months)|Relapse|1
7789895|NCT00554099|27074580|P2|Non-Treatment Phase (9 Months)|Relapse|1
7789896|NCT00554099|27074581|P1|Non-Treatment Phase (9 Months)|Relapse|2
7789897|NCT00554099|27074579|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
7789898|NCT00554099|27074580|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
7789899|NCT00554099|27074581|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
7789900|NCT00554099|27074579|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
7789901|NCT00554099|27074580|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
7789902|NCT00554099|27074581|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
7789903|NCT00554099|27074579|P3|Treatment Period (12 Weeks)|Protocol Violation|2
7789904|NCT00554099|27074580|P2|Treatment Period (12 Weeks)|Protocol Violation|0
7789905|NCT00554099|27074581|P1|Treatment Period (12 Weeks)|Protocol Violation|0
7789906|NCT00554099|27074579|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
7789907|NCT00554099|27074580|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
7789908|NCT00554099|27074581|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
7789909|NCT00554099|27074579|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
7789910|NCT00554099|27074580|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
7789911|NCT00554099|27074581|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
7789912|NCT00554099|27074579|P3|Treatment Period (12 Weeks)|Physician Decision|0
7789913|NCT00554099|27074580|P2|Treatment Period (12 Weeks)|Physician Decision|0
7789914|NCT00554099|27074581|P1|Treatment Period (12 Weeks)|Physician Decision|3
7789915|NCT00554099|27074579|P3|Treatment Period (12 Weeks)|Adverse Event|1
7789916|NCT00554099|27074580|P2|Treatment Period (12 Weeks)|Adverse Event|5
7789917|NCT00554099|27074581|P1|Treatment Period (12 Weeks)|Adverse Event|3
7789918|NCT00553787|27074636|P3|Overall Study|Other|13
7789919|NCT00553787|27074637|P2|Overall Study|Other|10
7789920|NCT00553787|27074638|P1|Overall Study|Other|18
7789921|NCT00553787|27074636|P3|Overall Study|Requirement for restricted medication|5
7789922|NCT00553787|27074637|P2|Overall Study|Requirement for restricted medication|7
7789923|NCT00553787|27074638|P1|Overall Study|Requirement for restricted medication|8
7789924|NCT00553787|27074636|P3|Overall Study|non compliance|11
7789925|NCT00553787|27074637|P2|Overall Study|non compliance|0
7789926|NCT00553787|27074638|P1|Overall Study|non compliance|4
7789927|NCT00553787|27074636|P3|Overall Study|Pregnancy|2
7789928|NCT00553787|27074637|P2|Overall Study|Pregnancy|1
7789929|NCT00553787|27074638|P1|Overall Study|Pregnancy|0
7789930|NCT00553787|27074636|P3|Overall Study|Lack of Efficacy|3
7789931|NCT00553787|27074637|P2|Overall Study|Lack of Efficacy|1
7789932|NCT00553787|27074638|P1|Overall Study|Lack of Efficacy|31
7789933|NCT00553787|27074636|P3|Overall Study|Withdrawal by Subject|83
7789934|NCT00553787|27074637|P2|Overall Study|Withdrawal by Subject|40
7789935|NCT00553787|27074638|P1|Overall Study|Withdrawal by Subject|151
7789936|NCT00553787|27074636|P3|Overall Study|Lost to Follow-up|78
7789937|NCT00553787|27074637|P2|Overall Study|Lost to Follow-up|44
7789938|NCT00553787|27074638|P1|Overall Study|Lost to Follow-up|132
7789939|NCT00553787|27074636|P3|Overall Study|Adverse Event|67
7789940|NCT00553787|27074637|P2|Overall Study|Adverse Event|21
7789941|NCT00553787|27074638|P1|Overall Study|Adverse Event|34
7789942|NCT00553696|27074670|P4|Overall Study|Withdrawal by Subject|0
7789943|NCT00553696|27074671|P3|Overall Study|Withdrawal by Subject|0
7789944|NCT00553696|27074672|P2|Overall Study|Withdrawal by Subject|1
7789945|NCT00553696|27074673|P1|Overall Study|Withdrawal by Subject|0
7789946|NCT00553696|27074670|P4|Overall Study|Objective progression or relapse|0
7789947|NCT00553696|27074671|P3|Overall Study|Objective progression or relapse|6
7789948|NCT00553696|27074672|P2|Overall Study|Objective progression or relapse|9
7789949|NCT00553696|27074673|P1|Overall Study|Objective progression or relapse|2
7789950|NCT00553696|27074670|P4|Overall Study|Global deterioration of health status|0
7789951|NCT00553696|27074671|P3|Overall Study|Global deterioration of health status|0
7789952|NCT00553696|27074672|P2|Overall Study|Global deterioration of health status|2
7789953|NCT00553696|27074673|P1|Overall Study|Global deterioration of health status|0
7789954|NCT00553696|27074670|P4|Overall Study|Adverse Event|1
7789955|NCT00553696|27074671|P3|Overall Study|Adverse Event|0
7789956|NCT00553696|27074672|P2|Overall Study|Adverse Event|4
7789957|NCT00553696|27074673|P1|Overall Study|Adverse Event|2
7789958|NCT00553644|27074711|P1|Overall Study|Alternative therapy|6
7789959|NCT00553644|27074711|P1|Overall Study|Physician Decision|1
7789960|NCT00553644|27074711|P1|Overall Study|Withdrawal by Subject|4
7789961|NCT00553644|27074711|P1|Overall Study|Adverse Event|17
7789962|NCT00553631|27074720|P2|Overall Study|Lost to Follow-up|0
7789963|NCT00553631|27074721|P1|Overall Study|Lost to Follow-up|1
7789964|NCT00553631|27074720|P2|Overall Study|Withdrawal by Subject|1
7789965|NCT00553631|27074721|P1|Overall Study|Withdrawal by Subject|0
7789966|NCT00553605|27074743|P2|Overall Study|Randomized but not treated|0
7789967|NCT00553605|27074744|P1|Overall Study|Randomized but not treated|2
7789968|NCT00553605|27074743|P2|Overall Study|Did not receive full dose|0
7789969|NCT00553605|27074744|P1|Overall Study|Did not receive full dose|1
7789970|NCT00553605|27074743|P2|Overall Study|Did not meet entrance criteria|3
7789971|NCT00553605|27074744|P1|Overall Study|Did not meet entrance criteria|1
7789972|NCT00553540|27074770|P2|Overall Study|discharged after first visit|5
7789973|NCT00553540|27074771|P1|Overall Study|discharged after first visit|2
7789974|NCT00553514|27074782|P5|Overall Study|Other|1
7789975|NCT00553514|27074783|P4|Overall Study|Other|0
7789976|NCT00553514|27074784|P3|Overall Study|Other|0
7789977|NCT00553514|27074785|P2|Overall Study|Other|1
7789978|NCT00553514|27074786|P1|Overall Study|Other|1
7789979|NCT00553514|27074782|P5|Overall Study|Risk of multiple pregnancy|0
7789980|NCT00553514|27074783|P4|Overall Study|Risk of multiple pregnancy|1
7789981|NCT00553514|27074784|P3|Overall Study|Risk of multiple pregnancy|0
7789982|NCT00553514|27074785|P2|Overall Study|Risk of multiple pregnancy|2
7789983|NCT00553514|27074786|P1|Overall Study|Risk of multiple pregnancy|0
7789984|NCT00553514|27074782|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
7789985|NCT00553514|27074783|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
7789986|NCT00553514|27074784|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
7789987|NCT00553514|27074785|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
7789988|NCT00553514|27074786|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
7789989|NCT00553514|27074782|P5|Overall Study|Lack of ovarian response|6
7789990|NCT00553514|27074783|P4|Overall Study|Lack of ovarian response|5
7789991|NCT00553514|27074784|P3|Overall Study|Lack of ovarian response|5
7789992|NCT00553514|27074785|P2|Overall Study|Lack of ovarian response|5
7789993|NCT00553514|27074786|P1|Overall Study|Lack of ovarian response|4
7789994|NCT00553514|27074782|P5|Overall Study|Protocol deviation|0
7789995|NCT00553514|27074783|P4|Overall Study|Protocol deviation|1
7789996|NCT00553514|27074784|P3|Overall Study|Protocol deviation|0
7789997|NCT00553514|27074785|P2|Overall Study|Protocol deviation|0
7789998|NCT00553514|27074786|P1|Overall Study|Protocol deviation|0
7789999|NCT00553501|27074823|P1|Overall Study|Progression|1
7790000|NCT00553501|27074823|P1|Overall Study|Death|1
7790001|NCT00553501|27074823|P1|Overall Study|Adverse Event|2
7790002|NCT00553475|27074832|P3|Overall Study|Due to moving|0
7790003|NCT00553475|27074833|P2|Overall Study|Due to moving|1
7790004|NCT00553475|27074834|P1|Overall Study|Due to moving|0
7790005|NCT00553475|27074832|P3|Overall Study|Physician Decision|0
7790006|NCT00553475|27074833|P2|Overall Study|Physician Decision|0
7790007|NCT00553475|27074834|P1|Overall Study|Physician Decision|1
7790008|NCT00553475|27074832|P3|Overall Study|Withdrawal by Subject|0
7790009|NCT00553475|27074833|P2|Overall Study|Withdrawal by Subject|1
7790010|NCT00553475|27074834|P1|Overall Study|Withdrawal by Subject|1
7790011|NCT00553475|27074832|P3|Overall Study|Lack of Efficacy|0
7790012|NCT00553475|27074833|P2|Overall Study|Lack of Efficacy|1
7790013|NCT00553475|27074834|P1|Overall Study|Lack of Efficacy|7
7790014|NCT00553475|27074832|P3|Overall Study|Adverse Event|13
7790015|NCT00553475|27074833|P2|Overall Study|Adverse Event|17
7790016|NCT00553475|27074834|P1|Overall Study|Adverse Event|7
7790017|NCT00553462|27074956|P1|Overall Study|Physician Decision|1
7790018|NCT00553462|27074956|P1|Overall Study|Withdrawal by Subject|5
7790019|NCT00553462|27074956|P1|Overall Study|Progression|4
7790020|NCT00553462|27074956|P1|Overall Study|Adverse Event|4
7790021|NCT00553436|27074962|P1|Overall Study|Conversion to another procedure|1
7790022|NCT00553358|27074986|P3|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7790023|NCT00553358|27074987|P2|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7790024|NCT00553358|27074988|P1|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7790025|NCT00553358|27074986|P3|Overall Study|Died after clinical follow-up ended|0
7790026|NCT00553358|27074987|P2|Overall Study|Died after clinical follow-up ended|2
7790027|NCT00553358|27074988|P1|Overall Study|Died after clinical follow-up ended|1
7790028|NCT00553358|27074986|P3|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
7790029|NCT00553358|27074987|P2|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
7790030|NCT00553358|27074988|P1|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
7790031|NCT00553358|27074986|P3|Overall Study|Died during clinical follow-up|32
7790032|NCT00553358|27074987|P2|Overall Study|Died during clinical follow-up|29
7790033|NCT00553358|27074988|P1|Overall Study|Died during clinical follow-up|25
7790034|NCT00553358|27074986|P3|Overall Study|Withdrew completely|34
7790035|NCT00553358|27074987|P2|Overall Study|Withdrew completely|33
7790036|NCT00553358|27074988|P1|Overall Study|Withdrew completely|23
7790037|NCT00553358|27074986|P3|Overall Study|Lost to Follow-up|18
7790038|NCT00553358|27074987|P2|Overall Study|Lost to Follow-up|26
7790039|NCT00553358|27074988|P1|Overall Study|Lost to Follow-up|22
7790040|NCT00553358|27074986|P3|Overall Study|Randomized but did not receive treatment|1
7790041|NCT00553358|27074987|P2|Overall Study|Randomized but did not receive treatment|3
7790042|NCT00553358|27074988|P1|Overall Study|Randomized but did not receive treatment|3
7790043|NCT00553332|27075059|P1|Overall Study|ineligible, incorrect diagnosis|1
7790044|NCT00553319|27075071|P3|Overall Study|moved|1
7790045|NCT00553319|27075072|P2|Overall Study|moved|0
7790046|NCT00553319|27075073|P1|Overall Study|moved|1
7790047|NCT00553319|27075071|P3|Overall Study|incarceration|0
7790048|NCT00553319|27075072|P2|Overall Study|incarceration|0
7790049|NCT00553319|27075073|P1|Overall Study|incarceration|1
7790050|NCT00553319|27075071|P3|Overall Study|non-compliance|2
7790051|NCT00553319|27075072|P2|Overall Study|non-compliance|0
7790052|NCT00553319|27075073|P1|Overall Study|non-compliance|0
7790053|NCT00553319|27075071|P3|Overall Study|wanted treatment elsewhere|1
7790054|NCT00553319|27075072|P2|Overall Study|wanted treatment elsewhere|1
7790055|NCT00553319|27075073|P1|Overall Study|wanted treatment elsewhere|2
7790056|NCT00553319|27075071|P3|Overall Study|Lost to Follow-up|5
7790057|NCT00553319|27075072|P2|Overall Study|Lost to Follow-up|9
7790058|NCT00553319|27075073|P1|Overall Study|Lost to Follow-up|10
7790059|NCT00553280|27075084|P1|Overall Study|Physician Decision|1
7790060|NCT00553280|27075084|P1|Overall Study|Withdrawal by Subject|3
7790061|NCT00553280|27075084|P1|Overall Study|Lack of Efficacy|3
7790062|NCT00553280|27075084|P1|Overall Study|Adverse Event|19
7790063|NCT00553267|27075096|P3|Overall Study|Specified category|1
7790064|NCT00553267|27075097|P2|Overall Study|Specified category|2
7790065|NCT00553267|27075098|P1|Overall Study|Specified category|1
7790066|NCT00553267|27075096|P3|Overall Study|Consent withdrawn|1
7790067|NCT00553267|27075097|P2|Overall Study|Consent withdrawn|3
7790068|NCT00553267|27075098|P1|Overall Study|Consent withdrawn|2
7790069|NCT00553267|27075096|P3|Overall Study|Lost to Follow-up|1
7790070|NCT00553267|27075097|P2|Overall Study|Lost to Follow-up|0
7790071|NCT00553267|27075098|P1|Overall Study|Lost to Follow-up|0
7790072|NCT00553267|27075096|P3|Overall Study|Non compliant with protocol|2
7790073|NCT00553267|27075097|P2|Overall Study|Non compliant with protocol|3
7790074|NCT00553267|27075098|P1|Overall Study|Non compliant with protocol|3
7790075|NCT00553267|27075096|P3|Overall Study|Adverse Event|5
7790076|NCT00553267|27075097|P2|Overall Study|Adverse Event|10
7790077|NCT00553267|27075098|P1|Overall Study|Adverse Event|8
7790078|NCT00553254|27075135|P3|Overall Study|Other|13
7790079|NCT00553254|27075136|P2|Overall Study|Other|0
7790080|NCT00553254|27075137|P1|Overall Study|Other|1
7790081|NCT00553254|27075135|P3|Overall Study|Study terminated by Sponsor|1
7790082|NCT00553254|27075136|P2|Overall Study|Study terminated by Sponsor|0
7790083|NCT00553254|27075137|P1|Overall Study|Study terminated by Sponsor|0
7790084|NCT00553254|27075135|P3|Overall Study|Withdrawal by Subject|2
7790085|NCT00553254|27075136|P2|Overall Study|Withdrawal by Subject|0
7790086|NCT00553254|27075137|P1|Overall Study|Withdrawal by Subject|2
7790087|NCT00553254|27075135|P3|Overall Study|Lost to Follow-up|2
7790088|NCT00553254|27075136|P2|Overall Study|Lost to Follow-up|0
7790089|NCT00553254|27075137|P1|Overall Study|Lost to Follow-up|0
7790090|NCT00553254|27075135|P3|Overall Study|Death|25
7790091|NCT00553254|27075136|P2|Overall Study|Death|6
7790092|NCT00553254|27075137|P1|Overall Study|Death|3
7790093|NCT00553202|27075179|P1|Overall Study|Fails to meet organ function|6
7790094|NCT00553202|27075179|P1|Overall Study|No donor identified|16
7790095|NCT00553202|27075179|P1|Overall Study|Withdrawal by Subject|1
7790096|NCT00553202|27075179|P1|Overall Study|Physician Decision|28
7790097|NCT00553202|27075179|P1|Overall Study|Lost to Follow-up|1
7790098|NCT00553202|27075179|P1|Overall Study|Death|16
7790099|NCT00553150|27075206|P4|Overall Study|Ineligible|1
7790100|NCT00553150|27075207|P3|Overall Study|Ineligible|0
7790101|NCT00553150|27075208|P2|Overall Study|Ineligible|0
7790102|NCT00553150|27075209|P1|Overall Study|Ineligible|0
7790103|NCT00553150|27075206|P4|Overall Study|Protocol Violation|1
7790104|NCT00553150|27075207|P3|Overall Study|Protocol Violation|0
7790105|NCT00553150|27075208|P2|Overall Study|Protocol Violation|0
7790106|NCT00553150|27075209|P1|Overall Study|Protocol Violation|0
7790107|NCT00553150|27075206|P4|Overall Study|Withdrawal by Subject|2
7790108|NCT00553150|27075207|P3|Overall Study|Withdrawal by Subject|0
7790109|NCT00553150|27075208|P2|Overall Study|Withdrawal by Subject|0
7790110|NCT00553150|27075209|P1|Overall Study|Withdrawal by Subject|0
7790111|NCT00553059|27075237|P2|Overall Study|Drug supply not available|1
7790112|NCT00553059|27075238|P1|Overall Study|Drug supply not available|0
7790113|NCT00553059|27075237|P2|Overall Study|Deemed ineligible|1
7790114|NCT00553059|27075238|P1|Overall Study|Deemed ineligible|1
7790115|NCT00552929|27075266|P10|Overall Study|Not Eligible|0
7790116|NCT00552929|27075267|P9|Overall Study|Not Eligible|0
7790117|NCT00552929|27075268|P8|Overall Study|Not Eligible|0
7790118|NCT00552929|27075269|P7|Overall Study|Not Eligible|0
7790119|NCT00552929|27075270|P6|Overall Study|Not Eligible|1
7790120|NCT00552929|27075271|P5|Overall Study|Not Eligible|0
7790121|NCT00552929|27075272|P4|Overall Study|Not Eligible|0
7790122|NCT00552929|27075273|P3|Overall Study|Not Eligible|0
7790123|NCT00552929|27075274|P2|Overall Study|Not Eligible|0
7790124|NCT00552929|27075275|P1|Overall Study|Not Eligible|0
7790125|NCT00552929|27075266|P10|Overall Study|Lost to Follow-up|0
7790126|NCT00552929|27075267|P9|Overall Study|Lost to Follow-up|1
7790127|NCT00552929|27075268|P8|Overall Study|Lost to Follow-up|0
7790128|NCT00552929|27075269|P7|Overall Study|Lost to Follow-up|0
7790129|NCT00552929|27075270|P6|Overall Study|Lost to Follow-up|0
7790130|NCT00552929|27075271|P5|Overall Study|Lost to Follow-up|0
7790131|NCT00552929|27075272|P4|Overall Study|Lost to Follow-up|0
7790132|NCT00552929|27075273|P3|Overall Study|Lost to Follow-up|0
7790133|NCT00552929|27075274|P2|Overall Study|Lost to Follow-up|0
7790134|NCT00552929|27075275|P1|Overall Study|Lost to Follow-up|0
7790135|NCT00552760|27075346|P2|Overall Study|Medication Change|0
7790136|NCT00552760|27075347|P1|Overall Study|Medication Change|1
7790137|NCT00552760|27075346|P2|Overall Study|Withdrawal by Subject|0
7790138|NCT00552760|27075347|P1|Overall Study|Withdrawal by Subject|3
7790139|NCT00552760|27075346|P2|Overall Study|Medical Condition|1
7790140|NCT00552760|27075347|P1|Overall Study|Medical Condition|1
7790141|NCT00552760|27075346|P2|Overall Study|Non-compliance|1
7790142|NCT00552760|27075347|P1|Overall Study|Non-compliance|1
7790143|NCT00552760|27075346|P2|Overall Study|Lost to Follow-up|1
7790144|NCT00552760|27075347|P1|Overall Study|Lost to Follow-up|1
7790145|NCT00552760|27075346|P2|Overall Study|Protocol Violation|1
7790146|NCT00552760|27075347|P1|Overall Study|Protocol Violation|0
7790147|NCT00552760|27075346|P2|Overall Study|Relapsed- Mixed Event|5
7790148|NCT00552760|27075347|P1|Overall Study|Relapsed- Mixed Event|3
7790149|NCT00552760|27075346|P2|Overall Study|Relapse- Manic Event|3
7790150|NCT00552760|27075347|P1|Overall Study|Relapse- Manic Event|3
7790151|NCT00552760|27075346|P2|Overall Study|Relapsed- Depressed Event|16
7790152|NCT00552760|27075347|P1|Overall Study|Relapsed- Depressed Event|10
7790153|NCT00552760|27075346|P2|Overall Study|Adverse Event|5
7790154|NCT00552760|27075347|P1|Overall Study|Adverse Event|3
7790155|NCT00552669|27075374|P2|Overall Study|Death|7
7790156|NCT00552669|27075375|P1|Overall Study|Death|3
7790157|NCT00552617|27075395|P10|Overall Study|Lost to Follow-up|0
7790158|NCT00552617|27075396|P9|Overall Study|Lost to Follow-up|2
7790159|NCT00552617|27075397|P8|Overall Study|Lost to Follow-up|0
7790160|NCT00552617|27075398|P7|Overall Study|Lost to Follow-up|0
7790161|NCT00552617|27075399|P6|Overall Study|Lost to Follow-up|2
7790162|NCT00552617|27075400|P5|Overall Study|Lost to Follow-up|0
7790163|NCT00552617|27075401|P4|Overall Study|Lost to Follow-up|1
7790164|NCT00552617|27075402|P3|Overall Study|Lost to Follow-up|0
7790165|NCT00552617|27075403|P2|Overall Study|Lost to Follow-up|0
7790166|NCT00552617|27075404|P1|Overall Study|Lost to Follow-up|0
7790167|NCT00552617|27075395|P10|Overall Study|Not Treated|1
7790168|NCT00552617|27075396|P9|Overall Study|Not Treated|0
7790169|NCT00552617|27075397|P8|Overall Study|Not Treated|0
7790170|NCT00552617|27075398|P7|Overall Study|Not Treated|0
7790171|NCT00552617|27075399|P6|Overall Study|Not Treated|0
7790172|NCT00552617|27075400|P5|Overall Study|Not Treated|0
7790173|NCT00552617|27075401|P4|Overall Study|Not Treated|0
7790174|NCT00552617|27075402|P3|Overall Study|Not Treated|1
7790175|NCT00552617|27075403|P2|Overall Study|Not Treated|0
7790176|NCT00552617|27075404|P1|Overall Study|Not Treated|0
7790177|NCT00552578|27075448|P2|Overall Study|Lost to Follow-up|1
7790178|NCT00552578|27075449|P1|Overall Study|Lost to Follow-up|1
7790179|NCT00552513|27075461|P2|Overall Study|Lost to Follow-up|1
7790180|NCT00552513|27075462|P1|Overall Study|Lost to Follow-up|5
7790181|NCT00552396|27075507|P7|Overall Study|protocol withdrawal criteria|9
7790182|NCT00552396|27075508|P6|Overall Study|protocol withdrawal criteria|3
7790183|NCT00552396|27075509|P5|Overall Study|protocol withdrawal criteria|3
7790184|NCT00552396|27075510|P4|Overall Study|protocol withdrawal criteria|6
7790185|NCT00552396|27075511|P3|Overall Study|protocol withdrawal criteria|3
7790186|NCT00552396|27075512|P2|Overall Study|protocol withdrawal criteria|3
7790187|NCT00552396|27075513|P1|Overall Study|protocol withdrawal criteria|3
7790188|NCT00552344|27075550|P1|Overall Study|Other Reason|22
7790189|NCT00552344|27075550|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
7790190|NCT00552344|27075550|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
7790191|NCT00552344|27075550|P1|Overall Study|AE, non-serious non-fatal|38
7790192|NCT00552344|27075550|P1|Overall Study|SAE, non-fatal|6
7790193|NCT00552344|27075550|P1|Overall Study|Withdrawal by Subject|48
7790194|NCT00552344|27075550|P1|Overall Study|Lost to Follow-up|8
7790195|NCT00552344|27075550|P1|Overall Study|Loss of efficacy|75
7790196|NCT00552344|27075550|P1|Overall Study|Lack of Efficacy|55
7790197|NCT00552305|27075559|P1|Overall Study|Other: Subject went to rehab|1
7790198|NCT00552305|27075559|P1|Overall Study|Other: Subject incarcerated|1
7790199|NCT00552305|27075559|P1|Overall Study|Other: Subject moved from area|2
7790200|NCT00552305|27075559|P1|Overall Study|Other: Health problems, not drug related|1
7790201|NCT00552305|27075559|P1|Overall Study|Other: Subject became pregnant|1
7790202|NCT00552305|27075559|P1|Overall Study|Other: Subject underwent surgery|4
7790203|NCT00552305|27075559|P1|Overall Study|Other: Unable to attend visits|1
7790204|NCT00552305|27075559|P1|Overall Study|Other: Personal problems|1
7790205|NCT00552305|27075559|P1|Overall Study|Other: Site closed|4
7790206|NCT00552305|27075559|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
7790207|NCT00552305|27075559|P1|Overall Study|AE/Other: prohibited drug required|1
7790208|NCT00552305|27075559|P1|Overall Study|Poor compliance/lost to follow-up|1
7790209|NCT00552305|27075559|P1|Overall Study|Unsatisfactory compliance|11
7790210|NCT00552305|27075559|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
7790211|NCT00552305|27075559|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
7790212|NCT00552305|27075559|P1|Overall Study|Lack of efficacy/withdrew consent|1
7790213|NCT00552305|27075559|P1|Overall Study|Withdrawal by Subject|44
7790214|NCT00552305|27075559|P1|Overall Study|Protocol Violation|3
7790215|NCT00552305|27075559|P1|Overall Study|Lost to Follow-up|4
7790216|NCT00552305|27075559|P1|Overall Study|Lack of Efficacy|120
7790217|NCT00552305|27075559|P1|Overall Study|Adverse Event|43
7790218|NCT00552279|27075569|P2|Overall Study|Other|1
7790219|NCT00552279|27075570|P1|Overall Study|Other|1
7790220|NCT00552279|27075569|P2|Overall Study|Lost to Follow-up|0
7790221|NCT00552279|27075570|P1|Overall Study|Lost to Follow-up|1
7790222|NCT00552279|27075569|P2|Overall Study|Withdrawal by Subject|1
7790223|NCT00552279|27075570|P1|Overall Study|Withdrawal by Subject|12
7790224|NCT00552279|27075569|P2|Overall Study|Adverse Event|1
7790225|NCT00552279|27075570|P1|Overall Study|Adverse Event|0
7790226|NCT00552240|27075596|P2|Overall Study|Other|0
7790227|NCT00552240|27075597|P1|Overall Study|Other|1
7790228|NCT00552240|27075596|P2|Overall Study|Lack of Efficacy|0
7790229|NCT00552240|27075597|P1|Overall Study|Lack of Efficacy|6
7790230|NCT00552240|27075596|P2|Overall Study|Withdrawal by Subject|2
7790231|NCT00552240|27075597|P1|Overall Study|Withdrawal by Subject|2
7790232|NCT00552240|27075596|P2|Overall Study|Lost to Follow-up|6
7790233|NCT00552240|27075597|P1|Overall Study|Lost to Follow-up|5
7790234|NCT00552240|27075596|P2|Overall Study|Protocol Violation|1
7790235|NCT00552240|27075597|P1|Overall Study|Protocol Violation|1
7790236|NCT00552240|27075596|P2|Overall Study|Adverse Event|9
7790237|NCT00552240|27075597|P1|Overall Study|Adverse Event|9
7790238|NCT00552188|27075699|P2|Overall Study|Subject returned to home country|1
7790239|NCT00552188|27075700|P1|Overall Study|Subject returned to home country|0
7790240|NCT00552188|27075699|P2|Overall Study|Withdrawal of consent|1
7790241|NCT00552188|27075700|P1|Overall Study|Withdrawal of consent|0
7790242|NCT00552188|27075699|P2|Overall Study|Lost to Follow-up|1
7790243|NCT00552188|27075700|P1|Overall Study|Lost to Follow-up|2
7790244|NCT00552188|27075699|P2|Overall Study|Adverse Event|2
7790245|NCT00552188|27075700|P1|Overall Study|Adverse Event|0
7790246|NCT00552175|27075711|P3|Overall Study|Reason Not Specified|1
7790247|NCT00552175|27075712|P2|Overall Study|Reason Not Specified|1
7790248|NCT00552175|27075713|P1|Overall Study|Reason Not Specified|3
7790249|NCT00552175|27075711|P3|Overall Study|Entry Criteria Not Met|0
7790250|NCT00552175|27075712|P2|Overall Study|Entry Criteria Not Met|1
7790251|NCT00552175|27075713|P1|Overall Study|Entry Criteria Not Met|1
7790252|NCT00552175|27075711|P3|Overall Study|Lost to Follow-up|1
7790253|NCT00552175|27075712|P2|Overall Study|Lost to Follow-up|0
7790254|NCT00552175|27075713|P1|Overall Study|Lost to Follow-up|0
7790255|NCT00552175|27075711|P3|Overall Study|Withdrawal by Subject|1
7790256|NCT00552175|27075712|P2|Overall Study|Withdrawal by Subject|2
7790257|NCT00552175|27075713|P1|Overall Study|Withdrawal by Subject|2
7790258|NCT00552175|27075711|P3|Overall Study|Adverse Event|10
7790259|NCT00552175|27075712|P2|Overall Study|Adverse Event|9
7790260|NCT00552175|27075713|P1|Overall Study|Adverse Event|9
7790261|NCT00552175|27075711|P3|Overall Study|Lack of Efficacy|1
7790262|NCT00552175|27075712|P2|Overall Study|Lack of Efficacy|0
7790263|NCT00552175|27075713|P1|Overall Study|Lack of Efficacy|2
7790264|NCT00552110|27075753|P5|Overall Study|Nonserious Adverse Event (AE)|0
7790265|NCT00552110|27075754|P4|Overall Study|Nonserious Adverse Event (AE)|1
7790266|NCT00552110|27075755|P3|Overall Study|Nonserious Adverse Event (AE)|0
7790267|NCT00552110|27075756|P2|Overall Study|Nonserious Adverse Event (AE)|0
7790268|NCT00552110|27075757|P1|Overall Study|Nonserious Adverse Event (AE)|1
7790269|NCT00552110|27075753|P5|Overall Study|Increased Blood Pressure at Visit 2|0
7790270|NCT00552110|27075754|P4|Overall Study|Increased Blood Pressure at Visit 2|1
7790271|NCT00552110|27075755|P3|Overall Study|Increased Blood Pressure at Visit 2|0
7790272|NCT00552110|27075756|P2|Overall Study|Increased Blood Pressure at Visit 2|0
7790273|NCT00552110|27075757|P1|Overall Study|Increased Blood Pressure at Visit 2|0
7790274|NCT00552110|27075753|P5|Overall Study|Delay of Study due to Relabeling|0
7790275|NCT00552110|27075754|P4|Overall Study|Delay of Study due to Relabeling|1
7790276|NCT00552110|27075755|P3|Overall Study|Delay of Study due to Relabeling|0
7790277|NCT00552110|27075756|P2|Overall Study|Delay of Study due to Relabeling|0
7790278|NCT00552110|27075757|P1|Overall Study|Delay of Study due to Relabeling|0
7790279|NCT00552110|27075753|P5|Overall Study|Use of Prohibited Medication|0
7790280|NCT00552110|27075754|P4|Overall Study|Use of Prohibited Medication|0
7790281|NCT00552110|27075755|P3|Overall Study|Use of Prohibited Medication|0
7790282|NCT00552110|27075756|P2|Overall Study|Use of Prohibited Medication|1
7790283|NCT00552110|27075757|P1|Overall Study|Use of Prohibited Medication|1
7790284|NCT00552110|27075753|P5|Overall Study|Withdrawn per Sponsor|1
7790285|NCT00552110|27075754|P4|Overall Study|Withdrawn per Sponsor|0
7790286|NCT00552110|27075755|P3|Overall Study|Withdrawn per Sponsor|0
7790287|NCT00552110|27075756|P2|Overall Study|Withdrawn per Sponsor|1
7790288|NCT00552110|27075757|P1|Overall Study|Withdrawn per Sponsor|0
7790289|NCT00552110|27075753|P5|Overall Study|Failed to Comply With Study Requirements|1
7790290|NCT00552110|27075754|P4|Overall Study|Failed to Comply With Study Requirements|0
7790291|NCT00552110|27075755|P3|Overall Study|Failed to Comply With Study Requirements|1
7790292|NCT00552110|27075756|P2|Overall Study|Failed to Comply With Study Requirements|1
7790293|NCT00552110|27075757|P1|Overall Study|Failed to Comply With Study Requirements|1
7790294|NCT00552110|27075753|P5|Overall Study|Lost to Follow-up|1
7790295|NCT00552110|27075754|P4|Overall Study|Lost to Follow-up|1
7790296|NCT00552110|27075755|P3|Overall Study|Lost to Follow-up|0
7790297|NCT00552110|27075756|P2|Overall Study|Lost to Follow-up|0
7790298|NCT00552110|27075757|P1|Overall Study|Lost to Follow-up|0
7790299|NCT00552110|27075753|P5|Overall Study|Withdrawal by Subject|2
7790300|NCT00552110|27075754|P4|Overall Study|Withdrawal by Subject|3
7790301|NCT00552110|27075755|P3|Overall Study|Withdrawal by Subject|0
7790302|NCT00552110|27075756|P2|Overall Study|Withdrawal by Subject|2
7790303|NCT00552110|27075757|P1|Overall Study|Withdrawal by Subject|0
7790304|NCT00552110|27075753|P5|Overall Study|Lack of Efficacy|4
7790305|NCT00552110|27075754|P4|Overall Study|Lack of Efficacy|1
7790306|NCT00552110|27075755|P3|Overall Study|Lack of Efficacy|0
7790307|NCT00552110|27075756|P2|Overall Study|Lack of Efficacy|0
7790308|NCT00552110|27075757|P1|Overall Study|Lack of Efficacy|1
7790309|NCT00552110|27075753|P5|Overall Study|Serious or Life-Threatening AE|0
7790310|NCT00552110|27075754|P4|Overall Study|Serious or Life-Threatening AE|0
7790311|NCT00552110|27075755|P3|Overall Study|Serious or Life-Threatening AE|1
7790312|NCT00552110|27075756|P2|Overall Study|Serious or Life-Threatening AE|0
7790313|NCT00552110|27075757|P1|Overall Study|Serious or Life-Threatening AE|0
7790314|NCT00552084|27075776|P2|Overall Study|change in anti-arrythmic drug|1
7790315|NCT00552084|27075777|P1|Overall Study|change in anti-arrythmic drug|1
7790316|NCT00552084|27075776|P2|Overall Study|Protocol Violation|0
7790317|NCT00552084|27075777|P1|Overall Study|Protocol Violation|1
7790318|NCT00552084|27075776|P2|Overall Study|Withdrawal by Subject|5
7790319|NCT00552084|27075777|P1|Overall Study|Withdrawal by Subject|4
7790320|NCT00552084|27075776|P2|Overall Study|Adverse Event|3
7790321|NCT00552084|27075777|P1|Overall Study|Adverse Event|2
7790322|NCT00552071|27075785|P2|Overall Study|Withdrawal by Subject|1
7790323|NCT00552071|27075786|P1|Overall Study|Withdrawal by Subject|0
7790324|NCT00552071|27075785|P2|Overall Study|Death|1
7790325|NCT00552071|27075786|P1|Overall Study|Death|0
7790326|NCT00552071|27075785|P2|Overall Study|Pregnancy|0
7790327|NCT00552071|27075786|P1|Overall Study|Pregnancy|1
7790328|NCT00552071|27075785|P2|Overall Study|Physician Decision|0
7790329|NCT00552071|27075786|P1|Overall Study|Physician Decision|1
7790330|NCT00552071|27075785|P2|Overall Study|Lack of Efficacy|0
7790331|NCT00552071|27075786|P1|Overall Study|Lack of Efficacy|1
7790332|NCT00552071|27075785|P2|Overall Study|Adverse Event|0
7790333|NCT00552071|27075786|P1|Overall Study|Adverse Event|1
7790334|NCT00552058|27075796|P2|Overall Study|Other: Early Roll Over|0
7790335|NCT00552058|27075797|P1|Overall Study|Other: Early Roll Over|1
7790336|NCT00552058|27075796|P2|Overall Study|Other: Sponsors Decision|1
7790337|NCT00552058|27075797|P1|Overall Study|Other: Sponsors Decision|0
7790338|NCT00552058|27075796|P2|Overall Study|Other: Randomized in error|1
7790339|NCT00552058|27075797|P1|Overall Study|Other: Randomized in error|0
7790340|NCT00552058|27075796|P2|Overall Study|Other: Positive Stool Result|1
7790341|NCT00552058|27075797|P1|Overall Study|Other: Positive Stool Result|0
7790342|NCT00552058|27075796|P2|Overall Study|Other: Low CDAI score, entry violation|1
7790343|NCT00552058|27075797|P1|Overall Study|Other: Low CDAI score, entry violation|0
7790344|NCT00552058|27075796|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
7790345|NCT00552058|27075797|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
7790346|NCT00552058|27075796|P2|Overall Study|Other: Non Compliance|2
7790347|NCT00552058|27075797|P1|Overall Study|Other: Non Compliance|1
7790348|NCT00552058|27075796|P2|Overall Study|Other: Protocol Violation|1
7790349|NCT00552058|27075797|P1|Overall Study|Other: Protocol Violation|0
7790350|NCT00552058|27075796|P2|Overall Study|Withdrawal by Subject|4
7790351|NCT00552058|27075797|P1|Overall Study|Withdrawal by Subject|4
7790352|NCT00552058|27075796|P2|Overall Study|Lost to Follow-up|0
7790353|NCT00552058|27075797|P1|Overall Study|Lost to Follow-up|1
7790354|NCT00552058|27075796|P2|Overall Study|Lack of Efficacy|5
7790355|NCT00552058|27075797|P1|Overall Study|Lack of Efficacy|1
7790356|NCT00552058|27075796|P2|Overall Study|Adverse Event|7
7790357|NCT00552058|27075797|P1|Overall Study|Adverse Event|8
7790358|NCT00552032|27075837|P2|Overall Study|Lost to Follow-up|5
7790359|NCT00552032|27075838|P1|Overall Study|Lost to Follow-up|8
7790360|NCT00552032|27075837|P2|Overall Study|Protocol Violation|12
7790361|NCT00552032|27075838|P1|Overall Study|Protocol Violation|7
7790362|NCT00552032|27075837|P2|Overall Study|Withdrawal by Subject|2
7790363|NCT00552032|27075838|P1|Overall Study|Withdrawal by Subject|2
7790364|NCT00551759|27075882|P1|Overall Study|Ineligible|1
7790365|NCT00551759|27075882|P1|Overall Study|Death|5
7790366|NCT00551759|27075882|P1|Overall Study|Adverse Event|7
7790367|NCT00551642|27075923|P2|Treatment Period|Withdrawal by Subject|1
7790368|NCT00551642|27075924|P1|Treatment Period|Withdrawal by Subject|2
7790369|NCT00551642|27075923|P2|Treatment Period|Adverse Event|12
7790370|NCT00551642|27075924|P1|Treatment Period|Adverse Event|15
7790371|NCT00551642|27075923|P2|Treatment Period|Inclusion/Exclusion criteria|4
7790372|NCT00551642|27075924|P1|Treatment Period|Inclusion/Exclusion criteria|4
7790373|NCT00551642|27075923|P2|Treatment Period|Death|31
7790374|NCT00551642|27075924|P1|Treatment Period|Death|33
7790375|NCT00551642|27075923|P2|Treatment Period|Physician Decision|1
7790376|NCT00551642|27075924|P1|Treatment Period|Physician Decision|0
7790377|NCT00551642|27075923|P2|Treatment Period|Delivery device failure|3
7790378|NCT00551642|27075924|P1|Treatment Period|Delivery device failure|1
7790379|NCT00551642|27075923|P2|Treatment Period|Protocol Deviation|11
7790380|NCT00551642|27075924|P1|Treatment Period|Protocol Deviation|6
7790381|NCT00551525|27075934|P1|Overall Study|Protocol Violation|5
7790382|NCT00551460|27075943|P1|Overall Study|Not analyzable (did not start treatment)|4
7790383|NCT00551460|27075943|P1|Overall Study|Ineligible|4
7790384|NCT00551460|27075943|P1|Overall Study|Death|7
7790385|NCT00551460|27075943|P1|Overall Study|Physician Decision|1
7790386|NCT00551460|27075943|P1|Overall Study|Withdrawal by Subject|1
7790387|NCT00551460|27075943|P1|Overall Study|Adverse Event|1
7790388|NCT00551421|27075949|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
7790389|NCT00551369|27075956|P1|Overall Study|Not treated per protocol and re|1
7790390|NCT00551369|27075956|P1|Overall Study|Withdrawal by Subject|1
7790391|NCT00551369|27075956|P1|Overall Study|Protocol Violation|5
7790392|NCT00551291|27075965|P1|Overall Study|Physician Decision|1
7790393|NCT00551213|27075973|P2|Overall Study|Not Treated|2
7790394|NCT00551213|27075974|P1|Overall Study|Not Treated|1
7790395|NCT00551213|27075973|P2|Overall Study|Withdrawal by Subject|0
7790396|NCT00551213|27075974|P1|Overall Study|Withdrawal by Subject|2
7790397|NCT00551213|27075973|P2|Overall Study|Progressive Disease|12
7790398|NCT00551213|27075974|P1|Overall Study|Progressive Disease|41
7790399|NCT00551213|27075973|P2|Overall Study|Adverse Event|3
7790400|NCT00551213|27075974|P1|Overall Study|Adverse Event|6
7790401|NCT00551161|27076018|P1|Overall Study|Withdrawal by Subject|1
7790402|NCT00551135|27076026|P4|Overall Study|Withdrawal by Subject|1
7790403|NCT00551135|27076027|P3|Overall Study|Withdrawal by Subject|3
7790404|NCT00551135|27076028|P2|Overall Study|Withdrawal by Subject|0
7790405|NCT00551135|27076029|P1|Overall Study|Withdrawal by Subject|1
7790406|NCT00551135|27076026|P4|Overall Study|Other|2
7790407|NCT00551135|27076027|P3|Overall Study|Other|1
7790408|NCT00551135|27076028|P2|Overall Study|Other|2
7790409|NCT00551135|27076029|P1|Overall Study|Other|3
7790410|NCT00551135|27076026|P4|Overall Study|Lost to Follow-up|1
7790411|NCT00551135|27076027|P3|Overall Study|Lost to Follow-up|0
7790412|NCT00551135|27076028|P2|Overall Study|Lost to Follow-up|0
7790413|NCT00551135|27076029|P1|Overall Study|Lost to Follow-up|0
7790414|NCT00551135|27076026|P4|Overall Study|Adverse Event|1
7790415|NCT00551135|27076027|P3|Overall Study|Adverse Event|1
7790416|NCT00551135|27076028|P2|Overall Study|Adverse Event|0
7790417|NCT00551135|27076029|P1|Overall Study|Adverse Event|1
7790418|NCT00551031|27076158|P5|Overall Study|Did not receive vaccine|0
7790419|NCT00551031|27076159|P4|Overall Study|Did not receive vaccine|0
7790420|NCT00551031|27076160|P3|Overall Study|Did not receive vaccine|0
7790421|NCT00551031|27076161|P2|Overall Study|Did not receive vaccine|2
7790422|NCT00551031|27076162|P1|Overall Study|Did not receive vaccine|1
7790423|NCT00551031|27076158|P5|Overall Study|Serious Adverse Event|0
7790424|NCT00551031|27076159|P4|Overall Study|Serious Adverse Event|0
7790425|NCT00551031|27076160|P3|Overall Study|Serious Adverse Event|1
7790426|NCT00551031|27076161|P2|Overall Study|Serious Adverse Event|2
7790427|NCT00551031|27076162|P1|Overall Study|Serious Adverse Event|0
7790428|NCT00551031|27076158|P5|Overall Study|Withdrawal by Subject|0
7790429|NCT00551031|27076159|P4|Overall Study|Withdrawal by Subject|2
7790430|NCT00551031|27076160|P3|Overall Study|Withdrawal by Subject|1
7790431|NCT00551031|27076161|P2|Overall Study|Withdrawal by Subject|4
7790432|NCT00551031|27076162|P1|Overall Study|Withdrawal by Subject|0
7790433|NCT00551031|27076158|P5|Overall Study|Lost to Follow-up|1
7790434|NCT00551031|27076159|P4|Overall Study|Lost to Follow-up|1
7790435|NCT00551031|27076160|P3|Overall Study|Lost to Follow-up|0
7790436|NCT00551031|27076161|P2|Overall Study|Lost to Follow-up|1
7790437|NCT00551031|27076162|P1|Overall Study|Lost to Follow-up|0
7790438|NCT00551031|27076158|P5|Overall Study|Protocol Violation|0
7790439|NCT00551031|27076159|P4|Overall Study|Protocol Violation|0
7790440|NCT00551031|27076160|P3|Overall Study|Protocol Violation|0
7790441|NCT00551031|27076161|P2|Overall Study|Protocol Violation|1
7790442|NCT00551031|27076162|P1|Overall Study|Protocol Violation|1
7790443|NCT00551031|27076158|P5|Overall Study|Adverse Event|0
7790444|NCT00551031|27076159|P4|Overall Study|Adverse Event|0
7790445|NCT00551031|27076160|P3|Overall Study|Adverse Event|0
7790446|NCT00551031|27076161|P2|Overall Study|Adverse Event|1
7790447|NCT00551031|27076162|P1|Overall Study|Adverse Event|0
7790448|NCT00550953|27076191|P2|Overall Study|Not able to visit the site|3
7790449|NCT00550953|27076192|P1|Overall Study|Not able to visit the site|2
7790450|NCT00550953|27076191|P2|Overall Study|Adverse Event|3
7790451|NCT00550953|27076192|P1|Overall Study|Adverse Event|4
7790452|NCT00550836|27076239|P2|Overall Study|Withdrawal by Subject|9
7790453|NCT00550836|27076240|P1|Overall Study|Withdrawal by Subject|3
7790454|NCT00550771|27076256|P2|Overall Study|Protocol Violation|5
7790455|NCT00550771|27076257|P1|Overall Study|Protocol Violation|4
7790456|NCT00550771|27076256|P2|Overall Study|Withdrawal by Subject|1
7790457|NCT00550771|27076257|P1|Overall Study|Withdrawal by Subject|0
7790458|NCT00550771|27076256|P2|Overall Study|Physician Decision|0
7790459|NCT00550771|27076257|P1|Overall Study|Physician Decision|2
7790460|NCT00550771|27076256|P2|Overall Study|Discontinued for study-related reasons|1
7790461|NCT00550771|27076257|P1|Overall Study|Discontinued for study-related reasons|0
7790462|NCT00550771|27076256|P2|Overall Study|Adverse Event|3
7790463|NCT00550771|27076257|P1|Overall Study|Adverse Event|11
7790464|NCT00550745|27076271|P2|Overall Study|Screen failure|0
7790465|NCT00550745|27076272|P1|Overall Study|Screen failure|1
7790466|NCT00550745|27076271|P2|Overall Study|Withdrawal by Subject|10
7790467|NCT00550745|27076272|P1|Overall Study|Withdrawal by Subject|17
7790468|NCT00550745|27076271|P2|Overall Study|Protocol Violation|2
7790469|NCT00550745|27076272|P1|Overall Study|Protocol Violation|4
7790470|NCT00550745|27076271|P2|Overall Study|Physician Decision|2
7790471|NCT00550745|27076272|P1|Overall Study|Physician Decision|0
7790472|NCT00550745|27076271|P2|Overall Study|Lost to Follow-up|30
7790473|NCT00550745|27076272|P1|Overall Study|Lost to Follow-up|45
7790474|NCT00550745|27076271|P2|Overall Study|Death|16
7790475|NCT00550745|27076272|P1|Overall Study|Death|20
7790476|NCT00550732|27076280|P1|Overall Study|Adverse Event|1
7790477|NCT00550732|27076280|P1|Overall Study|Palliative care|1
7790478|NCT00550732|27076280|P1|Overall Study|Lost to Follow-up|1
7790479|NCT00550732|27076280|P1|Overall Study|Physician Decision|2
7790480|NCT00550732|27076280|P1|Overall Study|Withdrawal by Subject|2
7790481|NCT00550732|27076280|P1|Overall Study|Death|4
7790482|NCT00550680|27076291|P1|Overall Study|Screen Failure|6
7790483|NCT00550680|27076291|P1|Overall Study|Refused Treatment|19
7790484|NCT00550680|27076291|P1|Overall Study|Protocol Violation|7
7790485|NCT00550680|27076291|P1|Overall Study|Other|10
7790486|NCT00550680|27076291|P1|Overall Study|Lack of Efficacy|1
7790487|NCT00550680|27076291|P1|Overall Study|Lost to Follow-up|3
7790488|NCT00550680|27076291|P1|Overall Study|Early Improvement|1
7790489|NCT00550680|27076291|P1|Overall Study|Death|3
7790490|NCT00550680|27076291|P1|Overall Study|Adverse Event|5
7790491|NCT00550680|27076291|P1|Overall Study|Administrative Reasons|1
7790492|NCT00550615|27076312|P4|Overall Study|Not evaluable|7
7790493|NCT00550615|27076313|P3|Overall Study|Not evaluable|2
7790494|NCT00550615|27076314|P2|Overall Study|Not evaluable|0
7790495|NCT00550615|27076315|P1|Overall Study|Not evaluable|0
7790496|NCT00550615|27076312|P4|Overall Study|Withdrawal by Subject|3
7790497|NCT00550615|27076313|P3|Overall Study|Withdrawal by Subject|2
7790498|NCT00550615|27076314|P2|Overall Study|Withdrawal by Subject|0
7790499|NCT00550615|27076315|P1|Overall Study|Withdrawal by Subject|0
7790500|NCT00550550|27076334|P2|Overall Study|Randomized But Not Treated|0
7790501|NCT00550550|27076335|P1|Overall Study|Randomized But Not Treated|1
7790502|NCT00550550|27076334|P2|Overall Study|Did Not Meet Protocol Eligibility|1
7790503|NCT00550550|27076335|P1|Overall Study|Did Not Meet Protocol Eligibility|1
7790504|NCT00550550|27076334|P2|Overall Study|Protocol Violation|14
7790505|NCT00550550|27076335|P1|Overall Study|Protocol Violation|5
7790506|NCT00550550|27076334|P2|Overall Study|Withdrawal by Subject|8
7790507|NCT00550550|27076335|P1|Overall Study|Withdrawal by Subject|10
7790508|NCT00550550|27076334|P2|Overall Study|Lost to Follow-up|0
7790509|NCT00550550|27076335|P1|Overall Study|Lost to Follow-up|4
7790510|NCT00550550|27076334|P2|Overall Study|Treatment Failure|1
7790511|NCT00550550|27076335|P1|Overall Study|Treatment Failure|0
7790512|NCT00550550|27076334|P2|Overall Study|Adverse Event|5
7790513|NCT00550550|27076335|P1|Overall Study|Adverse Event|13
7790514|NCT00550537|27076347|P1|Overall Study|Treated closer to home|4
7790515|NCT00550537|27076347|P1|Overall Study|Declining performance status|2
7790516|NCT00550537|27076347|P1|Overall Study|Other complicating ilness|3
7790517|NCT00550537|27076347|P1|Overall Study|Change in treatment plan|4
7790518|NCT00550537|27076347|P1|Overall Study|Withdrawal by Subject|7
7790519|NCT00550537|27076347|P1|Overall Study|Disease progression before|46
7790520|NCT00550537|27076347|P1|Overall Study|Adverse Event|20
7790521|NCT00550537|27076347|P1|Overall Study|Death|18
7790522|NCT00550459|27076364|P2|Overall Study|Withdrawal by Subject|1
7790523|NCT00550459|27076365|P1|Overall Study|Withdrawal by Subject|1
7790524|NCT00550459|27076364|P2|Overall Study|Adverse Event|2
7790525|NCT00550459|27076365|P1|Overall Study|Adverse Event|0
7790526|NCT00550446|27076434|P11|Post Week 12|Other|0
7790527|NCT00550446|27076435|P10|Post Week 12|Other|1
7790528|NCT00550446|27076436|P9|Post Week 12|Other|1
7790529|NCT00550446|27076437|P8|Post Week 12|Other|0
7790530|NCT00550446|27076438|P7|Post Week 12|Other|1
7790531|NCT00550446|27076439|P6|Post Week 12|Other|0
7790532|NCT00550446|27076440|P5|Post Week 12|Other|0
7790533|NCT00550446|27076441|P4|Post Week 12|Other|1
7790534|NCT00550446|27076442|P3|Post Week 12|Other|0
7790535|NCT00550446|27076443|P2|Post Week 12|Other|1
7790536|NCT00550446|27076444|P1|Post Week 12|Other|1
7790537|NCT00550446|27076434|P11|Post Week 12|Withdrawal by Subject|0
7790538|NCT00550446|27076435|P10|Post Week 12|Withdrawal by Subject|0
7790539|NCT00550446|27076436|P9|Post Week 12|Withdrawal by Subject|0
7790540|NCT00550446|27076437|P8|Post Week 12|Withdrawal by Subject|0
7790541|NCT00550446|27076438|P7|Post Week 12|Withdrawal by Subject|0
7790542|NCT00550446|27076439|P6|Post Week 12|Withdrawal by Subject|0
7790543|NCT00550446|27076440|P5|Post Week 12|Withdrawal by Subject|1
7790544|NCT00550446|27076441|P4|Post Week 12|Withdrawal by Subject|0
7790545|NCT00550446|27076442|P3|Post Week 12|Withdrawal by Subject|0
7790546|NCT00550446|27076443|P2|Post Week 12|Withdrawal by Subject|0
7790547|NCT00550446|27076444|P1|Post Week 12|Withdrawal by Subject|0
7790548|NCT00550446|27076434|P11|Post Week 12|Lost to Follow-up|0
7790549|NCT00550446|27076435|P10|Post Week 12|Lost to Follow-up|0
7790550|NCT00550446|27076436|P9|Post Week 12|Lost to Follow-up|0
7790551|NCT00550446|27076437|P8|Post Week 12|Lost to Follow-up|0
7790552|NCT00550446|27076438|P7|Post Week 12|Lost to Follow-up|1
7790553|NCT00550446|27076439|P6|Post Week 12|Lost to Follow-up|0
7790554|NCT00550446|27076440|P5|Post Week 12|Lost to Follow-up|0
7790555|NCT00550446|27076441|P4|Post Week 12|Lost to Follow-up|1
7790556|NCT00550446|27076442|P3|Post Week 12|Lost to Follow-up|1
7790557|NCT00550446|27076443|P2|Post Week 12|Lost to Follow-up|0
7790558|NCT00550446|27076444|P1|Post Week 12|Lost to Follow-up|0
7790559|NCT00550446|27076434|P11|Post Week 12|Lack of Efficacy|1
7790560|NCT00550446|27076435|P10|Post Week 12|Lack of Efficacy|2
7790561|NCT00550446|27076436|P9|Post Week 12|Lack of Efficacy|1
7790562|NCT00550446|27076437|P8|Post Week 12|Lack of Efficacy|1
7790563|NCT00550446|27076438|P7|Post Week 12|Lack of Efficacy|0
7790564|NCT00550446|27076439|P6|Post Week 12|Lack of Efficacy|0
7790565|NCT00550446|27076440|P5|Post Week 12|Lack of Efficacy|0
7790566|NCT00550446|27076441|P4|Post Week 12|Lack of Efficacy|0
7790567|NCT00550446|27076442|P3|Post Week 12|Lack of Efficacy|1
7790568|NCT00550446|27076443|P2|Post Week 12|Lack of Efficacy|0
7790569|NCT00550446|27076444|P1|Post Week 12|Lack of Efficacy|0
7790570|NCT00550446|27076434|P11|Post Week 12|Adverse Event|0
7790571|NCT00550446|27076435|P10|Post Week 12|Adverse Event|4
7790572|NCT00550446|27076436|P9|Post Week 12|Adverse Event|0
7790573|NCT00550446|27076437|P8|Post Week 12|Adverse Event|0
7790574|NCT00550446|27076438|P7|Post Week 12|Adverse Event|0
7790575|NCT00550446|27076439|P6|Post Week 12|Adverse Event|1
7790576|NCT00550446|27076440|P5|Post Week 12|Adverse Event|1
7790577|NCT00550446|27076441|P4|Post Week 12|Adverse Event|1
7790578|NCT00550446|27076442|P3|Post Week 12|Adverse Event|1
7790579|NCT00550446|27076443|P2|Post Week 12|Adverse Event|1
7790580|NCT00550446|27076444|P1|Post Week 12|Adverse Event|2
7790581|NCT00550446|27076434|P11|Up To Week 12|Randomized not treated|0
7790582|NCT00550446|27076435|P10|Up To Week 12|Randomized not treated|0
7790583|NCT00550446|27076436|P9|Up To Week 12|Randomized not treated|0
7790584|NCT00550446|27076437|P8|Up To Week 12|Randomized not treated|0
7790585|NCT00550446|27076438|P7|Up To Week 12|Randomized not treated|0
7790586|NCT00550446|27076439|P6|Up To Week 12|Randomized not treated|0
7790587|NCT00550446|27076440|P5|Up To Week 12|Randomized not treated|0
7790588|NCT00550446|27076441|P4|Up To Week 12|Randomized not treated|0
7790589|NCT00550446|27076442|P3|Up To Week 12|Randomized not treated|1
7790590|NCT00550446|27076443|P2|Up To Week 12|Randomized not treated|1
7790591|NCT00550446|27076444|P1|Up To Week 12|Randomized not treated|0
7790592|NCT00550446|27076434|P11|Up To Week 12|Other|0
7790593|NCT00550446|27076435|P10|Up To Week 12|Other|0
7790594|NCT00550446|27076436|P9|Up To Week 12|Other|0
7790595|NCT00550446|27076437|P8|Up To Week 12|Other|0
7790596|NCT00550446|27076438|P7|Up To Week 12|Other|4
7790597|NCT00550446|27076439|P6|Up To Week 12|Other|1
7790598|NCT00550446|27076440|P5|Up To Week 12|Other|0
7790599|NCT00550446|27076441|P4|Up To Week 12|Other|0
7790600|NCT00550446|27076442|P3|Up To Week 12|Other|0
7790601|NCT00550446|27076443|P2|Up To Week 12|Other|0
7790602|NCT00550446|27076444|P1|Up To Week 12|Other|3
7790603|NCT00550446|27076434|P11|Up To Week 12|Withdrawal by Subject|0
7790604|NCT00550446|27076435|P10|Up To Week 12|Withdrawal by Subject|0
7790605|NCT00550446|27076436|P9|Up To Week 12|Withdrawal by Subject|0
7790606|NCT00550446|27076437|P8|Up To Week 12|Withdrawal by Subject|0
7790607|NCT00550446|27076438|P7|Up To Week 12|Withdrawal by Subject|3
7790608|NCT00550446|27076439|P6|Up To Week 12|Withdrawal by Subject|1
7790609|NCT00550446|27076440|P5|Up To Week 12|Withdrawal by Subject|0
7790610|NCT00550446|27076441|P4|Up To Week 12|Withdrawal by Subject|2
7790611|NCT00550446|27076442|P3|Up To Week 12|Withdrawal by Subject|3
7790612|NCT00550446|27076443|P2|Up To Week 12|Withdrawal by Subject|0
7790613|NCT00550446|27076444|P1|Up To Week 12|Withdrawal by Subject|2
7790614|NCT00550446|27076434|P11|Up To Week 12|Lost to Follow-up|0
7790615|NCT00550446|27076435|P10|Up To Week 12|Lost to Follow-up|0
7790616|NCT00550446|27076436|P9|Up To Week 12|Lost to Follow-up|0
7790617|NCT00550446|27076437|P8|Up To Week 12|Lost to Follow-up|0
7790618|NCT00550446|27076438|P7|Up To Week 12|Lost to Follow-up|2
7790619|NCT00550446|27076439|P6|Up To Week 12|Lost to Follow-up|1
7790620|NCT00550446|27076440|P5|Up To Week 12|Lost to Follow-up|1
7790621|NCT00550446|27076441|P4|Up To Week 12|Lost to Follow-up|0
7790622|NCT00550446|27076442|P3|Up To Week 12|Lost to Follow-up|0
7790623|NCT00550446|27076443|P2|Up To Week 12|Lost to Follow-up|1
7790624|NCT00550446|27076444|P1|Up To Week 12|Lost to Follow-up|0
7790625|NCT00550446|27076434|P11|Up To Week 12|Lack of Efficacy|0
7790626|NCT00550446|27076435|P10|Up To Week 12|Lack of Efficacy|0
7790627|NCT00550446|27076436|P9|Up To Week 12|Lack of Efficacy|0
7790628|NCT00550446|27076437|P8|Up To Week 12|Lack of Efficacy|0
7790629|NCT00550446|27076438|P7|Up To Week 12|Lack of Efficacy|3
7790630|NCT00550446|27076439|P6|Up To Week 12|Lack of Efficacy|3
7790631|NCT00550446|27076440|P5|Up To Week 12|Lack of Efficacy|0
7790632|NCT00550446|27076441|P4|Up To Week 12|Lack of Efficacy|1
7790633|NCT00550446|27076442|P3|Up To Week 12|Lack of Efficacy|0
7790634|NCT00550446|27076443|P2|Up To Week 12|Lack of Efficacy|1
7790635|NCT00550446|27076444|P1|Up To Week 12|Lack of Efficacy|3
7790636|NCT00550446|27076434|P11|Up To Week 12|Adverse Event|0
7790637|NCT00550446|27076435|P10|Up To Week 12|Adverse Event|0
7790638|NCT00550446|27076436|P9|Up To Week 12|Adverse Event|0
7790639|NCT00550446|27076437|P8|Up To Week 12|Adverse Event|0
7790640|NCT00550446|27076438|P7|Up To Week 12|Adverse Event|1
7790641|NCT00550446|27076439|P6|Up To Week 12|Adverse Event|2
7790642|NCT00550446|27076440|P5|Up To Week 12|Adverse Event|2
7790643|NCT00550446|27076441|P4|Up To Week 12|Adverse Event|0
7790644|NCT00550446|27076442|P3|Up To Week 12|Adverse Event|0
7790645|NCT00550446|27076443|P2|Up To Week 12|Adverse Event|2
7790646|NCT00550446|27076444|P1|Up To Week 12|Adverse Event|2
7790647|NCT00550420|27076876|P1|Overall Study|Prohibited medicine|1
7790648|NCT00550420|27076876|P1|Overall Study|Exclusion criteria|1
7790649|NCT00550420|27076876|P1|Overall Study|Out of Electrocardiogram criteria|1
7790650|NCT00550420|27076876|P1|Overall Study|Caregiver's decision to withdraw|1
7790651|NCT00550420|27076876|P1|Overall Study|Unethical stop of enrollment|2
7790652|NCT00550420|27076876|P1|Overall Study|Lack of curative effect|1
7790653|NCT00550420|27076876|P1|Overall Study|Investigators opinion|1
7790654|NCT00550420|27076876|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
7790655|NCT00550420|27076876|P1|Overall Study|Missing|2
7790656|NCT00550420|27076876|P1|Overall Study|Still in study at termination|206
7790657|NCT00550420|27076876|P1|Overall Study|Withdrawal by Subject|30
7790658|NCT00550420|27076876|P1|Overall Study|Protocol Violation|11
7790659|NCT00550420|27076876|P1|Overall Study|Lost to Follow-up|8
7790660|NCT00550420|27076876|P1|Overall Study|Adverse Event|28
7790661|NCT00550407|27076899|P3|26-Week Randomized Phase|Withdrawal by Subject|3
7790662|NCT00550407|27076900|P2|26-Week Randomized Phase|Withdrawal by Subject|1
7790663|NCT00550407|27076901|P1|26-Week Randomized Phase|Withdrawal by Subject|0
7790664|NCT00550407|27076899|P3|26-Week Randomized Phase|Investigator Discretion|0
7790665|NCT00550407|27076900|P2|26-Week Randomized Phase|Investigator Discretion|1
7790666|NCT00550407|27076901|P1|26-Week Randomized Phase|Investigator Discretion|0
7790667|NCT00550407|27076899|P3|26-Week Randomized Phase|Lack of Efficacy|19
7790668|NCT00550407|27076900|P2|26-Week Randomized Phase|Lack of Efficacy|36
7790669|NCT00550407|27076901|P1|26-Week Randomized Phase|Lack of Efficacy|0
7790670|NCT00550407|27076899|P3|26-Week Randomized Phase|Adverse Event|2
7790671|NCT00550407|27076900|P2|26-Week Randomized Phase|Adverse Event|5
7790672|NCT00550407|27076901|P1|26-Week Randomized Phase|Adverse Event|0
7790673|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
7790674|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
7790675|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
7790676|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
7790677|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
7790678|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
7790679|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
7790680|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
7790681|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
7790682|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
7790683|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
7790684|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
7790685|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
7790686|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
7790687|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
7790688|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
7790689|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
7790690|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
7790691|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
7790692|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
7790693|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
7790694|NCT00550407|27076899|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
7790695|NCT00550407|27076900|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
7790696|NCT00550407|27076901|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
7790697|NCT00550238|27076973|P1|Overall Study|Sponsor decision|55
7790698|NCT00550238|27076973|P1|Overall Study|Lost to Follow-up|13
7790699|NCT00550238|27076973|P1|Overall Study|Patient noncompliance|25
7790700|NCT00550238|27076973|P1|Overall Study|Physician Decision|31
7790701|NCT00550238|27076973|P1|Overall Study|Withdrawal by Subject|167
7790702|NCT00550238|27076973|P1|Overall Study|Disease progression|46
7790703|NCT00550238|27076973|P1|Overall Study|Death|34
7790704|NCT00550238|27076973|P1|Overall Study|Adverse Event|88
7790705|NCT00550173|27076980|P3|Overall Study|Lost to Follow-up|3
7790706|NCT00550173|27076981|P2|Overall Study|Lost to Follow-up|4
7790707|NCT00550173|27076982|P1|Overall Study|Lost to Follow-up|4
7790708|NCT00550173|27076980|P3|Overall Study|Sponsor Decision|1
7790709|NCT00550173|27076981|P2|Overall Study|Sponsor Decision|7
7790710|NCT00550173|27076982|P1|Overall Study|Sponsor Decision|13
7790711|NCT00550173|27076980|P3|Overall Study|Withdrawal by Subject|17
7790712|NCT00550173|27076981|P2|Overall Study|Withdrawal by Subject|12
7790713|NCT00550173|27076982|P1|Overall Study|Withdrawal by Subject|9
7790714|NCT00550173|27076980|P3|Overall Study|Physician Decision|2
7790715|NCT00550173|27076981|P2|Overall Study|Physician Decision|2
7790716|NCT00550173|27076982|P1|Overall Study|Physician Decision|1
7790717|NCT00550173|27076980|P3|Overall Study|Death|50
7790718|NCT00550173|27076981|P2|Overall Study|Death|38
7790719|NCT00550173|27076982|P1|Overall Study|Death|45
7790720|NCT00550147|27077011|P1|Quetiapine Addition Treatment Period|Moved out of state|1
7790721|NCT00550147|27077011|P1|Quetiapine Addition Treatment Period|Noncompliance|2
7790722|NCT00550147|27077011|P1|Quetiapine Addition Treatment Period|Adverse Event|3
7790723|NCT00550147|27077011|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
7790724|NCT00550147|27077011|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
7790725|NCT00550043|27077034|P5|Overall Study|Other Reasons- Unspecified|0
7790726|NCT00550043|27077035|P4|Overall Study|Other Reasons- Unspecified|1
7790727|NCT00550043|27077036|P3|Overall Study|Other Reasons- Unspecified|0
7790728|NCT00550043|27077037|P2|Overall Study|Other Reasons- Unspecified|1
7790729|NCT00550043|27077038|P1|Overall Study|Other Reasons- Unspecified|0
7790730|NCT00550043|27077034|P5|Overall Study|Subject Withdrew Consent|0
7790731|NCT00550043|27077035|P4|Overall Study|Subject Withdrew Consent|0
7790732|NCT00550043|27077036|P3|Overall Study|Subject Withdrew Consent|1
7790733|NCT00550043|27077037|P2|Overall Study|Subject Withdrew Consent|2
7790734|NCT00550043|27077038|P1|Overall Study|Subject Withdrew Consent|0
7790735|NCT00550043|27077034|P5|Overall Study|Adverse Event|1
7790736|NCT00550043|27077035|P4|Overall Study|Adverse Event|1
7790737|NCT00550043|27077036|P3|Overall Study|Adverse Event|0
7790738|NCT00550043|27077037|P2|Overall Study|Adverse Event|0
7790739|NCT00550043|27077038|P1|Overall Study|Adverse Event|0
7790740|NCT00549939|27077093|P3|40-week Open Label Treatment Period|Other|4
7790741|NCT00549939|27077094|P2|40-week Open Label Treatment Period|Other|1
7790742|NCT00549939|27077095|P1|40-week Open Label Treatment Period|Other|0
7790743|NCT00549939|27077093|P3|40-week Open Label Treatment Period|Protocol Violation|0
7790744|NCT00549939|27077094|P2|40-week Open Label Treatment Period|Protocol Violation|1
7790745|NCT00549939|27077095|P1|40-week Open Label Treatment Period|Protocol Violation|0
7790746|NCT00549939|27077093|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
7790747|NCT00549939|27077094|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
7790748|NCT00549939|27077095|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
7790749|NCT00549939|27077093|P3|40-week Open Label Treatment Period|Adverse Event|1
7790750|NCT00549939|27077094|P2|40-week Open Label Treatment Period|Adverse Event|2
7790751|NCT00549939|27077095|P1|40-week Open Label Treatment Period|Adverse Event|0
7790752|NCT00549939|27077093|P3|12-week Double Blind Treatment Period|Too many blood draws|0
7790753|NCT00549939|27077094|P2|12-week Double Blind Treatment Period|Too many blood draws|1
7790754|NCT00549939|27077095|P1|12-week Double Blind Treatment Period|Too many blood draws|0
7790755|NCT00549939|27077093|P3|12-week Double Blind Treatment Period|Adverse Event|2
7790756|NCT00549939|27077094|P2|12-week Double Blind Treatment Period|Adverse Event|1
7790757|NCT00549939|27077095|P1|12-week Double Blind Treatment Period|Adverse Event|1
7790758|NCT00549900|27077122|P1|Overall Study|Adverse Event|1
7790759|NCT00549770|27077178|P8|Overall Study|Adverse Event|4
7790760|NCT00549770|27077179|P7|Overall Study|Adverse Event|5
7790761|NCT00549770|27077180|P6|Overall Study|Adverse Event|0
7790762|NCT00549770|27077181|P5|Overall Study|Adverse Event|1
7790763|NCT00549770|27077182|P4|Overall Study|Adverse Event|2
7790764|NCT00549770|27077183|P3|Overall Study|Adverse Event|1
7790765|NCT00549770|27077184|P2|Overall Study|Adverse Event|3
7790766|NCT00549770|27077185|P1|Overall Study|Adverse Event|1
7790767|NCT00549770|27077178|P8|Overall Study|Abnormal laboratory values|0
7790768|NCT00549770|27077179|P7|Overall Study|Abnormal laboratory values|0
7790769|NCT00549770|27077180|P6|Overall Study|Abnormal laboratory values|1
7790770|NCT00549770|27077181|P5|Overall Study|Abnormal laboratory values|0
7790771|NCT00549770|27077182|P4|Overall Study|Abnormal laboratory values|0
7790772|NCT00549770|27077183|P3|Overall Study|Abnormal laboratory values|0
7790773|NCT00549770|27077184|P2|Overall Study|Abnormal laboratory values|0
7790774|NCT00549770|27077185|P1|Overall Study|Abnormal laboratory values|0
7790775|NCT00549770|27077178|P8|Overall Study|Abnormal test procedure results|1
7790776|NCT00549770|27077179|P7|Overall Study|Abnormal test procedure results|1
7790777|NCT00549770|27077180|P6|Overall Study|Abnormal test procedure results|1
7790778|NCT00549770|27077181|P5|Overall Study|Abnormal test procedure results|0
7790779|NCT00549770|27077182|P4|Overall Study|Abnormal test procedure results|2
7790780|NCT00549770|27077183|P3|Overall Study|Abnormal test procedure results|0
7790781|NCT00549770|27077184|P2|Overall Study|Abnormal test procedure results|0
7790782|NCT00549770|27077185|P1|Overall Study|Abnormal test procedure results|0
7790783|NCT00549770|27077178|P8|Overall Study|Lack of Efficacy|8
7790784|NCT00549770|27077179|P7|Overall Study|Lack of Efficacy|3
7790785|NCT00549770|27077180|P6|Overall Study|Lack of Efficacy|1
7790786|NCT00549770|27077181|P5|Overall Study|Lack of Efficacy|5
7790787|NCT00549770|27077182|P4|Overall Study|Lack of Efficacy|3
7790788|NCT00549770|27077183|P3|Overall Study|Lack of Efficacy|2
7790789|NCT00549770|27077184|P2|Overall Study|Lack of Efficacy|0
7790790|NCT00549770|27077185|P1|Overall Study|Lack of Efficacy|1
7790791|NCT00549770|27077178|P8|Overall Study|Withdrawal by Subject|9
7790792|NCT00549770|27077179|P7|Overall Study|Withdrawal by Subject|4
7790793|NCT00549770|27077180|P6|Overall Study|Withdrawal by Subject|6
7790794|NCT00549770|27077181|P5|Overall Study|Withdrawal by Subject|6
7790795|NCT00549770|27077182|P4|Overall Study|Withdrawal by Subject|5
7790796|NCT00549770|27077183|P3|Overall Study|Withdrawal by Subject|4
7790797|NCT00549770|27077184|P2|Overall Study|Withdrawal by Subject|6
7790798|NCT00549770|27077185|P1|Overall Study|Withdrawal by Subject|4
7790799|NCT00549770|27077178|P8|Overall Study|Lost to Follow-up|0
7790800|NCT00549770|27077179|P7|Overall Study|Lost to Follow-up|0
7790801|NCT00549770|27077180|P6|Overall Study|Lost to Follow-up|2
7790802|NCT00549770|27077181|P5|Overall Study|Lost to Follow-up|3
7790803|NCT00549770|27077182|P4|Overall Study|Lost to Follow-up|2
7790804|NCT00549770|27077183|P3|Overall Study|Lost to Follow-up|2
7790805|NCT00549770|27077184|P2|Overall Study|Lost to Follow-up|0
7790806|NCT00549770|27077185|P1|Overall Study|Lost to Follow-up|0
7790807|NCT00549770|27077178|P8|Overall Study|Administrative problems|1
7790808|NCT00549770|27077179|P7|Overall Study|Administrative problems|0
7790809|NCT00549770|27077180|P6|Overall Study|Administrative problems|0
7790810|NCT00549770|27077181|P5|Overall Study|Administrative problems|0
7790811|NCT00549770|27077182|P4|Overall Study|Administrative problems|0
7790812|NCT00549770|27077183|P3|Overall Study|Administrative problems|0
7790813|NCT00549770|27077184|P2|Overall Study|Administrative problems|1
7790814|NCT00549770|27077185|P1|Overall Study|Administrative problems|0
7790815|NCT00549770|27077178|P8|Overall Study|Protocol deviation|2
7790816|NCT00549770|27077179|P7|Overall Study|Protocol deviation|1
7790817|NCT00549770|27077180|P6|Overall Study|Protocol deviation|2
7790818|NCT00549770|27077181|P5|Overall Study|Protocol deviation|2
7790819|NCT00549770|27077182|P4|Overall Study|Protocol deviation|2
7790820|NCT00549770|27077183|P3|Overall Study|Protocol deviation|1
7790821|NCT00549770|27077184|P2|Overall Study|Protocol deviation|1
7790822|NCT00549770|27077185|P1|Overall Study|Protocol deviation|1
7790823|NCT00549757|27077269|P2|Extension Period (in Average 9 Months)|Patient's request|436
7790824|NCT00549757|27077270|P1|Extension Period (in Average 9 Months)|Patient's request|421
7790825|NCT00549757|27077269|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
7790826|NCT00549757|27077270|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
7790827|NCT00549757|27077269|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
7790828|NCT00549757|27077270|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
7790829|NCT00549757|27077269|P2|Extension Period (in Average 9 Months)|Death|136
7790830|NCT00549757|27077270|P1|Extension Period (in Average 9 Months)|Death|143
7790831|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
7790832|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
7790833|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
7790834|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
7790835|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
7790836|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
7790837|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Death|200
7790838|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Death|188
7790839|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
7790840|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
7790841|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
7790842|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
7790843|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
7790844|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
7790845|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
7790846|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
7790847|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
7790848|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
7790849|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
7790850|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
7790851|NCT00549757|27077269|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
7790852|NCT00549757|27077270|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
7790853|NCT00549718|27077332|P4|Overall Study|Administrative|1
7790854|NCT00549718|27077333|P3|Overall Study|Administrative|2
7790855|NCT00549718|27077334|P2|Overall Study|Administrative|2
7790856|NCT00549718|27077335|P1|Overall Study|Administrative|2
7790857|NCT00549718|27077332|P4|Overall Study|Withdrawal by Subject|13
7790858|NCT00549718|27077333|P3|Overall Study|Withdrawal by Subject|12
7790859|NCT00549718|27077334|P2|Overall Study|Withdrawal by Subject|18
7790860|NCT00549718|27077335|P1|Overall Study|Withdrawal by Subject|9
7790861|NCT00549718|27077332|P4|Overall Study|Lost to Follow-up|6
7790862|NCT00549718|27077333|P3|Overall Study|Lost to Follow-up|0
7790863|NCT00549718|27077334|P2|Overall Study|Lost to Follow-up|2
7790864|NCT00549718|27077335|P1|Overall Study|Lost to Follow-up|4
7790865|NCT00549718|27077332|P4|Overall Study|Adverse Event|3
7790866|NCT00549718|27077333|P3|Overall Study|Adverse Event|7
7790867|NCT00549718|27077334|P2|Overall Study|Adverse Event|8
7790868|NCT00549718|27077335|P1|Overall Study|Adverse Event|6
7790869|NCT00549718|27077332|P4|Overall Study|Insufficient clinical response|32
7790870|NCT00549718|27077333|P3|Overall Study|Insufficient clinical response|18
7790871|NCT00549718|27077334|P2|Overall Study|Insufficient clinical response|7
7790872|NCT00549718|27077335|P1|Overall Study|Insufficient clinical response|20
7790873|NCT00549640|27077351|P2|Overall Study|Lost to Follow-up|4
7790874|NCT00549640|27077352|P1|Overall Study|Lost to Follow-up|7
7790875|NCT00549640|27077351|P2|Overall Study|Adverse Event|0
7790876|NCT00549640|27077352|P1|Overall Study|Adverse Event|5
7790877|NCT00549640|27077351|P2|Overall Study|Withdrawal by Subject|12
7790878|NCT00549640|27077352|P1|Overall Study|Withdrawal by Subject|6
7790879|NCT00549601|27077365|P3|Received Study Drug|Withdrawal by Subject|1
7790880|NCT00549601|27077366|P2|Received Study Drug|Withdrawal by Subject|0
7790881|NCT00549601|27077367|P1|Received Study Drug|Withdrawal by Subject|2
7790882|NCT00549601|27077365|P3|Received Study Drug|Protocol Violation|1
7790883|NCT00549601|27077366|P2|Received Study Drug|Protocol Violation|4
7790884|NCT00549601|27077367|P1|Received Study Drug|Protocol Violation|3
7790885|NCT00549601|27077365|P3|Received Study Drug|Lost to Follow-up|1
7790886|NCT00549601|27077366|P2|Received Study Drug|Lost to Follow-up|1
7790887|NCT00549601|27077367|P1|Received Study Drug|Lost to Follow-up|0
7790888|NCT00549601|27077365|P3|Received Study Drug|Death|0
7790889|NCT00549601|27077366|P2|Received Study Drug|Death|1
7790890|NCT00549601|27077367|P1|Received Study Drug|Death|0
7790891|NCT00549601|27077365|P3|Received Study Drug|Adverse Event|1
7790892|NCT00549601|27077366|P2|Received Study Drug|Adverse Event|5
7790893|NCT00549601|27077367|P1|Received Study Drug|Adverse Event|2
7790894|NCT00549601|27077365|P3|Randomized|Withdrawal by Subject|1
7790895|NCT00549601|27077366|P2|Randomized|Withdrawal by Subject|1
7790896|NCT00549601|27077367|P1|Randomized|Withdrawal by Subject|0
7790897|NCT00549601|27077365|P3|Randomized|Protocol Violation|1
7790898|NCT00549601|27077366|P2|Randomized|Protocol Violation|0
7790899|NCT00549601|27077367|P1|Randomized|Protocol Violation|0
7790900|NCT00549562|27077389|P1|Overall Study|Lack of Efficacy|1
7790901|NCT00549562|27077389|P1|Overall Study|Adverse Event|1
7790902|NCT00549549|27077401|P4|Overall Study|Randomized but not treated|1
7790903|NCT00549549|27077402|P3|Overall Study|Randomized but not treated|1
7790904|NCT00549549|27077403|P2|Overall Study|Randomized but not treated|0
7790905|NCT00549549|27077404|P1|Overall Study|Randomized but not treated|0
7790906|NCT00549549|27077401|P4|Overall Study|Other|11
7790907|NCT00549549|27077402|P3|Overall Study|Other|9
7790908|NCT00549549|27077403|P2|Overall Study|Other|9
7790909|NCT00549549|27077404|P1|Overall Study|Other|9
7790910|NCT00549549|27077401|P4|Overall Study|Withdrawal by Subject|0
7790911|NCT00549549|27077402|P3|Overall Study|Withdrawal by Subject|1
7790912|NCT00549549|27077403|P2|Overall Study|Withdrawal by Subject|4
7790913|NCT00549549|27077404|P1|Overall Study|Withdrawal by Subject|0
7790914|NCT00549549|27077401|P4|Overall Study|Lost to Follow-up|2
7790915|NCT00549549|27077402|P3|Overall Study|Lost to Follow-up|1
7790916|NCT00549549|27077403|P2|Overall Study|Lost to Follow-up|0
7790917|NCT00549549|27077404|P1|Overall Study|Lost to Follow-up|1
7790918|NCT00549549|27077401|P4|Overall Study|Lack of Efficacy|2
7790919|NCT00549549|27077402|P3|Overall Study|Lack of Efficacy|4
7790920|NCT00549549|27077403|P2|Overall Study|Lack of Efficacy|6
7790921|NCT00549549|27077404|P1|Overall Study|Lack of Efficacy|9
7790922|NCT00549549|27077401|P4|Overall Study|Adverse Event|9
7790923|NCT00549549|27077402|P3|Overall Study|Adverse Event|1
7790924|NCT00549549|27077403|P2|Overall Study|Adverse Event|3
7790925|NCT00549549|27077404|P1|Overall Study|Adverse Event|5
7790926|NCT00549445|27077472|P2|Overall Study|Sputum & Blood Samples Not Available|17
7790927|NCT00549445|27077473|P1|Overall Study|Sputum & Blood Samples Not Available|15
7790928|NCT00549328|27077492|P1|Overall Study|Use of Prohibited Medication|1
7790929|NCT00549328|27077492|P1|Overall Study|Death|1
7790930|NCT00549328|27077492|P1|Overall Study|Disease Progression|10
7790931|NCT00549328|27077492|P1|Overall Study|Adverse Event|2
7790932|NCT00549302|27077503|P3|Open-Label|Withdrawal by Subject|6
7790933|NCT00549302|27077504|P2|Open-Label|Withdrawal by Subject|0
7790934|NCT00549302|27077505|P1|Open-Label|Withdrawal by Subject|0
7790935|NCT00549302|27077503|P3|Open-Label|New drug pulmonary atrial hypertension|2
7790936|NCT00549302|27077504|P2|Open-Label|New drug pulmonary atrial hypertension|0
7790937|NCT00549302|27077505|P1|Open-Label|New drug pulmonary atrial hypertension|0
7790938|NCT00549302|27077503|P3|Open-Label|Other|3
7790939|NCT00549302|27077504|P2|Open-Label|Other|0
7790940|NCT00549302|27077505|P1|Open-Label|Other|0
7790941|NCT00549302|27077503|P3|Open-Label|Lost to Follow-up|2
7790942|NCT00549302|27077504|P2|Open-Label|Lost to Follow-up|0
7790943|NCT00549302|27077505|P1|Open-Label|Lost to Follow-up|0
7790944|NCT00549302|27077503|P3|Open-Label|Investigator Decision|5
7790945|NCT00549302|27077504|P2|Open-Label|Investigator Decision|0
7790946|NCT00549302|27077505|P1|Open-Label|Investigator Decision|0
7790947|NCT00549302|27077503|P3|Open-Label|Death|40
7790948|NCT00549302|27077504|P2|Open-Label|Death|0
7790949|NCT00549302|27077505|P1|Open-Label|Death|0
7790950|NCT00549302|27077503|P3|Open-Label|Adverse Event|11
7790951|NCT00549302|27077504|P2|Open-Label|Adverse Event|0
7790952|NCT00549302|27077505|P1|Open-Label|Adverse Event|0
7790953|NCT00549302|27077503|P3|Double-Blind|New condition or starts new therapy|0
7790954|NCT00549302|27077504|P2|Double-Blind|New condition or starts new therapy|2
7790955|NCT00549302|27077505|P1|Double-Blind|New condition or starts new therapy|0
7790956|NCT00549302|27077503|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
7790957|NCT00549302|27077504|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
7790958|NCT00549302|27077505|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
7790959|NCT00549302|27077503|P3|Double-Blind|Lost to Follow-up|0
7790960|NCT00549302|27077504|P2|Double-Blind|Lost to Follow-up|2
7790961|NCT00549302|27077505|P1|Double-Blind|Lost to Follow-up|1
7790962|NCT00549302|27077503|P3|Double-Blind|Sponsor Decision|0
7790963|NCT00549302|27077504|P2|Double-Blind|Sponsor Decision|1
7790964|NCT00549302|27077505|P1|Double-Blind|Sponsor Decision|0
7790965|NCT00549302|27077503|P3|Double-Blind|Investigator Decision|0
7790966|NCT00549302|27077504|P2|Double-Blind|Investigator Decision|5
7790967|NCT00549302|27077505|P1|Double-Blind|Investigator Decision|1
7790968|NCT00549302|27077503|P3|Double-Blind|Withdrawal by Subject|0
7790969|NCT00549302|27077504|P2|Double-Blind|Withdrawal by Subject|8
7790970|NCT00549302|27077505|P1|Double-Blind|Withdrawal by Subject|3
7790971|NCT00549302|27077503|P3|Double-Blind|Adverse Event|0
7790972|NCT00549302|27077504|P2|Double-Blind|Adverse Event|16
7790973|NCT00549302|27077505|P1|Double-Blind|Adverse Event|3
7790974|NCT00549302|27077503|P3|Double-Blind|Death|0
7790975|NCT00549302|27077504|P2|Double-Blind|Death|9
7790976|NCT00549302|27077505|P1|Double-Blind|Death|2
7790977|NCT00549198|27077517|P2|Overall Study|Not Exposed to Study Drug|4
7790978|NCT00549198|27077518|P1|Overall Study|Not Exposed to Study Drug|3
7790979|NCT00549198|27077517|P2|Overall Study|Pregnancy|3
7790980|NCT00549198|27077518|P1|Overall Study|Pregnancy|0
7790981|NCT00549198|27077517|P2|Overall Study|No scan facilities|2
7790982|NCT00549198|27077518|P1|Overall Study|No scan facilities|0
7790983|NCT00549198|27077517|P2|Overall Study|Participant overweight, no scan possible|0
7790984|NCT00549198|27077518|P1|Overall Study|Participant overweight, no scan possible|1
7790985|NCT00549198|27077517|P2|Overall Study|Participant planning pregnancy|0
7790986|NCT00549198|27077518|P1|Overall Study|Participant planning pregnancy|1
7790987|NCT00549198|27077517|P2|Overall Study|Prohibited Medication|2
7790988|NCT00549198|27077518|P1|Overall Study|Prohibited Medication|1
7790989|NCT00549198|27077517|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
7790990|NCT00549198|27077518|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
7790991|NCT00549198|27077517|P2|Overall Study|Participant not able to perform Week 96|0
7790992|NCT00549198|27077518|P1|Overall Study|Participant not able to perform Week 96|1
7790993|NCT00549198|27077517|P2|Overall Study|Participant Moved|0
7790994|NCT00549198|27077518|P1|Overall Study|Participant Moved|2
7790995|NCT00549198|27077517|P2|Overall Study|Disease Progression|0
7790996|NCT00549198|27077518|P1|Overall Study|Disease Progression|1
7790997|NCT00549198|27077517|P2|Overall Study|Withdrawal by Subject|7
7790998|NCT00549198|27077518|P1|Overall Study|Withdrawal by Subject|7
7790999|NCT00549198|27077517|P2|Overall Study|Investigator Decision|3
7791000|NCT00549198|27077518|P1|Overall Study|Investigator Decision|4
7791001|NCT00549198|27077517|P2|Overall Study|Protocol Violation|2
7791002|NCT00549198|27077518|P1|Overall Study|Protocol Violation|7
7791003|NCT00549198|27077517|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
7791004|NCT00549198|27077518|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
7791005|NCT00549198|27077517|P2|Overall Study|Lost to Follow-up|8
7791006|NCT00549198|27077518|P1|Overall Study|Lost to Follow-up|7
7791007|NCT00549198|27077517|P2|Overall Study|Non-compliance|4
7791008|NCT00549198|27077518|P1|Overall Study|Non-compliance|2
7791009|NCT00549198|27077517|P2|Overall Study|Protocol-defined Virological Failure|0
7791010|NCT00549198|27077518|P1|Overall Study|Protocol-defined Virological Failure|7
7791011|NCT00549198|27077517|P2|Overall Study|Insufficient Viral Load Response|2
7791012|NCT00549198|27077518|P1|Overall Study|Insufficient Viral Load Response|4
7791013|NCT00549198|27077517|P2|Overall Study|Adverse Event|26
7791014|NCT00549198|27077518|P1|Overall Study|Adverse Event|28
7791015|NCT00549055|27077655|P1|Overall Study|Very low visual acuity (VA)|1
7791016|NCT00549055|27077655|P1|Overall Study|Choroidal neovascularization|1
7791017|NCT00549055|27077655|P1|Overall Study|Growth choroidal neovascularisation|1
7791018|NCT00549055|27077655|P1|Overall Study|Vitreous hemorrhage|1
7791019|NCT00549055|27077655|P1|Overall Study|Active choroidal neovascula increased|1
7791020|NCT00549055|27077655|P1|Overall Study|Decrease of size|1
7791021|NCT00549055|27077655|P1|Overall Study|Progression to fibrosis|2
7791022|NCT00549055|27077655|P1|Overall Study|Stabilization|5
7791023|NCT00549055|27077655|P1|Overall Study|Lack of Efficacy|18
7791024|NCT00549055|27077655|P1|Overall Study|Adverse Event|4
7791025|NCT00548847|27077699|P1|Overall Study|Disease progression|7
7791026|NCT00548808|27077706|P2|Overall Study|Sponsor Decision|1
7791027|NCT00548808|27077707|P1|Overall Study|Sponsor Decision|1
7791028|NCT00548808|27077706|P2|Overall Study|Lack of Efficacy|0
7791029|NCT00548808|27077707|P1|Overall Study|Lack of Efficacy|2
7791030|NCT00548808|27077706|P2|Overall Study|Entry Criteria Not Met|2
7791031|NCT00548808|27077707|P1|Overall Study|Entry Criteria Not Met|2
7791032|NCT00548808|27077706|P2|Overall Study|Death|0
7791033|NCT00548808|27077707|P1|Overall Study|Death|2
7791034|NCT00548808|27077706|P2|Overall Study|Adverse Event|5
7791035|NCT00548808|27077707|P1|Overall Study|Adverse Event|4
7791036|NCT00548808|27077706|P2|Overall Study|Physician Decision|3
7791037|NCT00548808|27077707|P1|Overall Study|Physician Decision|6
7791038|NCT00548808|27077706|P2|Overall Study|Withdrawal by Subject|4
7791039|NCT00548808|27077707|P1|Overall Study|Withdrawal by Subject|8
7791040|NCT00548808|27077706|P2|Overall Study|Protocol Violation|8
7791041|NCT00548808|27077707|P1|Overall Study|Protocol Violation|8
7791042|NCT00548808|27077706|P2|Overall Study|Lost to Follow-up|3
7791043|NCT00548808|27077707|P1|Overall Study|Lost to Follow-up|9
7791044|NCT00548717|27077731|P2|Overall Study|Alternative treatment for GVHD|0
7791045|NCT00548717|27077732|P1|Overall Study|Alternative treatment for GVHD|1
7791046|NCT00548717|27077731|P2|Overall Study|Relapse|0
7791047|NCT00548717|27077732|P1|Overall Study|Relapse|3
7791048|NCT00548717|27077731|P2|Overall Study|Death|2
7791049|NCT00548717|27077732|P1|Overall Study|Death|5
7791050|NCT00548548|27077776|P2|Overall Study|Lost to Follow-up|18
7791051|NCT00548548|27077777|P1|Overall Study|Lost to Follow-up|17
7791052|NCT00548548|27077776|P2|Overall Study|Death|348
7791053|NCT00548548|27077777|P1|Overall Study|Death|345
7791054|NCT00548405|27077820|P3|Overall Study|Randomized but not treated|0
7791055|NCT00548405|27077821|P2|Overall Study|Randomized but not treated|0
7791056|NCT00548405|27077822|P1|Overall Study|Randomized but not treated|1
7791057|NCT00548405|27077820|P3|Overall Study|Sponsor decision|0
7791058|NCT00548405|27077821|P2|Overall Study|Sponsor decision|0
7791059|NCT00548405|27077822|P1|Overall Study|Sponsor decision|1
7791060|NCT00548405|27077820|P3|Overall Study|Death|1
7791061|NCT00548405|27077821|P2|Overall Study|Death|1
7791062|NCT00548405|27077822|P1|Overall Study|Death|0
7791063|NCT00548405|27077820|P3|Overall Study|Lost to Follow-up|2
7791064|NCT00548405|27077821|P2|Overall Study|Lost to Follow-up|1
7791065|NCT00548405|27077822|P1|Overall Study|Lost to Follow-up|1
7791066|NCT00548405|27077820|P3|Overall Study|Withdrawal by Subject|5
7791067|NCT00548405|27077821|P2|Overall Study|Withdrawal by Subject|12
7791068|NCT00548405|27077822|P1|Overall Study|Withdrawal by Subject|36
7791069|NCT00548405|27077820|P3|Overall Study|Protocol Violation|0
7791070|NCT00548405|27077821|P2|Overall Study|Protocol Violation|0
7791071|NCT00548405|27077822|P1|Overall Study|Protocol Violation|1
7791072|NCT00548405|27077820|P3|Overall Study|Pregnancy|0
7791073|NCT00548405|27077821|P2|Overall Study|Pregnancy|0
7791074|NCT00548405|27077822|P1|Overall Study|Pregnancy|1
7791075|NCT00548405|27077820|P3|Overall Study|Physician Decision|1
7791076|NCT00548405|27077821|P2|Overall Study|Physician Decision|4
7791077|NCT00548405|27077822|P1|Overall Study|Physician Decision|3
7791078|NCT00548405|27077820|P3|Overall Study|Lack of Efficacy|0
7791079|NCT00548405|27077821|P2|Overall Study|Lack of Efficacy|0
7791080|NCT00548405|27077822|P1|Overall Study|Lack of Efficacy|6
7791081|NCT00548405|27077820|P3|Overall Study|Adverse Event|0
7791082|NCT00548405|27077821|P2|Overall Study|Adverse Event|2
7791083|NCT00548405|27077822|P1|Overall Study|Adverse Event|6
7791084|NCT00548340|27077843|P3|Overall Study|Other|1
7791085|NCT00548340|27077844|P2|Overall Study|Other|1
7791086|NCT00548340|27077845|P1|Overall Study|Other|1
7791087|NCT00548340|27077843|P3|Overall Study|Withdrawal by Subject|3
7791088|NCT00548340|27077844|P2|Overall Study|Withdrawal by Subject|4
7791089|NCT00548340|27077845|P1|Overall Study|Withdrawal by Subject|2
7791090|NCT00548340|27077843|P3|Overall Study|Lost to Follow-up|0
7791091|NCT00548340|27077844|P2|Overall Study|Lost to Follow-up|1
7791092|NCT00548340|27077845|P1|Overall Study|Lost to Follow-up|1
7791093|NCT00548340|27077843|P3|Overall Study|Adverse Event|2
7791094|NCT00548340|27077844|P2|Overall Study|Adverse Event|2
7791095|NCT00548340|27077845|P1|Overall Study|Adverse Event|2
7791096|NCT00548340|27077843|P3|Overall Study|Protocol Violation|3
7791097|NCT00548340|27077844|P2|Overall Study|Protocol Violation|3
7791098|NCT00548340|27077845|P1|Overall Study|Protocol Violation|2
7791099|NCT00548327|27077864|P2|Overall Study|Adverse Event|1
7791100|NCT00548327|27077865|P1|Overall Study|Adverse Event|0
7791101|NCT00548262|27077883|P1|Overall Study|Withdrawal by Subject|1
7791102|NCT00548262|27077883|P1|Overall Study|Other|3
7791103|NCT00548262|27077883|P1|Overall Study|Lost to Follow-up|1
7791104|NCT00548262|27077883|P1|Overall Study|Lack of Efficacy|4
7791105|NCT00548262|27077883|P1|Overall Study|Adverse Event|2
7791106|NCT00548262|27077883|P1|Overall Study|Death|21
7791107|NCT00548249|27077913|P5|Overall Study|Sponsor's request|0
7791108|NCT00548249|27077914|P4|Overall Study|Sponsor's request|1
7791109|NCT00548249|27077915|P3|Overall Study|Sponsor's request|0
7791110|NCT00548249|27077916|P2|Overall Study|Sponsor's request|0
7791111|NCT00548249|27077917|P1|Overall Study|Sponsor's request|0
7791112|NCT00548249|27077913|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
7791113|NCT00548249|27077914|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7791114|NCT00548249|27077915|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7791115|NCT00548249|27077916|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
7791116|NCT00548249|27077917|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7791117|NCT00548249|27077913|P5|Overall Study|Withdrawal by Subject|0
7791118|NCT00548249|27077914|P4|Overall Study|Withdrawal by Subject|0
7791119|NCT00548249|27077915|P3|Overall Study|Withdrawal by Subject|0
7791120|NCT00548249|27077916|P2|Overall Study|Withdrawal by Subject|0
7791121|NCT00548249|27077917|P1|Overall Study|Withdrawal by Subject|2
7791122|NCT00548249|27077913|P5|Overall Study|Prolonged hospitalization|0
7791123|NCT00548249|27077914|P4|Overall Study|Prolonged hospitalization|1
7791124|NCT00548249|27077915|P3|Overall Study|Prolonged hospitalization|2
7791125|NCT00548249|27077916|P2|Overall Study|Prolonged hospitalization|0
7791126|NCT00548249|27077917|P1|Overall Study|Prolonged hospitalization|0
7791127|NCT00548249|27077913|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
7791128|NCT00548249|27077914|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7791129|NCT00548249|27077915|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7791130|NCT00548249|27077916|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7791131|NCT00548249|27077917|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7791132|NCT00548249|27077913|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
7791133|NCT00548249|27077914|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
7791134|NCT00548249|27077915|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
7791135|NCT00548249|27077916|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
7791136|NCT00548249|27077917|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
7791137|NCT00548249|27077913|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
7791138|NCT00548249|27077914|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
7791139|NCT00548249|27077915|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
7791140|NCT00548249|27077916|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
7791141|NCT00548249|27077917|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
7791142|NCT00548249|27077913|P5|Overall Study|Adverse Event|1
7791143|NCT00548249|27077914|P4|Overall Study|Adverse Event|1
7791144|NCT00548249|27077915|P3|Overall Study|Adverse Event|0
7791145|NCT00548249|27077916|P2|Overall Study|Adverse Event|2
7791146|NCT00548249|27077917|P1|Overall Study|Adverse Event|2
7791147|NCT00548249|27077913|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
7791148|NCT00548249|27077914|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
7791149|NCT00548249|27077915|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
7791150|NCT00548249|27077916|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
7791151|NCT00548249|27077917|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
7791152|NCT00548249|27077913|P5|Overall Study|Miscellaneous|2
7791153|NCT00548249|27077914|P4|Overall Study|Miscellaneous|0
7791154|NCT00548249|27077915|P3|Overall Study|Miscellaneous|2
7791155|NCT00548249|27077916|P2|Overall Study|Miscellaneous|3
7791156|NCT00548249|27077917|P1|Overall Study|Miscellaneous|2
7791157|NCT00548249|27077913|P5|Overall Study|Protocol Violation|3
7791158|NCT00548249|27077914|P4|Overall Study|Protocol Violation|0
7791159|NCT00548249|27077915|P3|Overall Study|Protocol Violation|4
7791160|NCT00548249|27077916|P2|Overall Study|Protocol Violation|1
7791161|NCT00548249|27077917|P1|Overall Study|Protocol Violation|1
7791162|NCT00548249|27077913|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
7791163|NCT00548249|27077914|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
7791164|NCT00548249|27077915|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
7791165|NCT00548249|27077916|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
7791166|NCT00548249|27077917|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
7791167|NCT00548249|27077913|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7791168|NCT00548249|27077914|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
7791169|NCT00548249|27077915|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7791170|NCT00548249|27077916|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7791171|NCT00548249|27077917|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
7791172|NCT00548184|27077965|P1|Overall Study|Found Her2 negative|1
7791173|NCT00548184|27077965|P1|Overall Study|took other drug|1
7791174|NCT00548184|27077965|P1|Overall Study|Adverse Event|3
7791175|NCT00548145|27078013|P2|Overall Study|Physician Decision|1
7791176|NCT00548145|27078014|P1|Overall Study|Physician Decision|1
7791177|NCT00548145|27078013|P2|Overall Study|Withdrawal by Subject|2
7791178|NCT00548145|27078014|P1|Overall Study|Withdrawal by Subject|0
7791179|NCT00548145|27078013|P2|Overall Study|Death|1
7791180|NCT00548145|27078014|P1|Overall Study|Death|0
7791181|NCT00548093|27078033|P2|Overall Study|Completed post-treatment follow-up|0
7791182|NCT00548093|27078034|P1|Overall Study|Completed post-treatment follow-up|1
7791183|NCT00548093|27078033|P2|Overall Study|Withdrawal by Subject|0
7791184|NCT00548093|27078034|P1|Overall Study|Withdrawal by Subject|1
7791185|NCT00548093|27078033|P2|Overall Study|Other|1
7791186|NCT00548093|27078034|P1|Overall Study|Other|11
7791187|NCT00548093|27078033|P2|Overall Study|Objective progression or relapse|1
7791188|NCT00548093|27078034|P1|Overall Study|Objective progression or relapse|1
7791189|NCT00548093|27078033|P2|Overall Study|Lost to Follow-up|1
7791190|NCT00548093|27078034|P1|Overall Study|Lost to Follow-up|3
7791191|NCT00548093|27078033|P2|Overall Study|Death|13
7791192|NCT00548093|27078034|P1|Overall Study|Death|33
7791193|NCT00547911|27078072|P6|Overall Study|Adverse Event|0
7791194|NCT00547911|27078073|P5|Overall Study|Adverse Event|0
7791195|NCT00547911|27078074|P4|Overall Study|Adverse Event|1
7791196|NCT00547911|27078075|P3|Overall Study|Adverse Event|0
7791197|NCT00547911|27078076|P2|Overall Study|Adverse Event|0
7791198|NCT00547911|27078077|P1|Overall Study|Adverse Event|0
7791199|NCT00547703|27078131|P2|Overall Study|Lost to Follow-up|0
7791200|NCT00547703|27078132|P1|Overall Study|Lost to Follow-up|1
7791201|NCT00547534|27078178|P1|Overall Study|Disease Progression|4
7791202|NCT00547534|27078178|P1|Overall Study|Adverse Event|7
7791203|NCT00547521|27078186|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
7791204|NCT00547521|27078187|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
7791205|NCT00547521|27078186|P2|Long Term Extension (LTE) Study|Other|2
7791206|NCT00547521|27078187|P1|Long Term Extension (LTE) Study|Other|0
7791207|NCT00547521|27078186|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
7791208|NCT00547521|27078187|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
7791209|NCT00547521|27078186|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
7791210|NCT00547521|27078187|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
7791211|NCT00547521|27078186|P2|Long Term Extension (LTE) Study|Adverse Event|9
7791212|NCT00547521|27078187|P1|Long Term Extension (LTE) Study|Adverse Event|0
7791213|NCT00547521|27078186|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
7791214|NCT00547521|27078187|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
7791215|NCT00547521|27078186|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
7791216|NCT00547521|27078187|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
7791217|NCT00547521|27078186|P2|Short Term Study (4 Months)|Withdrawal of consent|1
7791218|NCT00547521|27078187|P1|Short Term Study (4 Months)|Withdrawal of consent|0
7791219|NCT00547521|27078186|P2|Short Term Study (4 Months)|Lack of Efficacy|2
7791220|NCT00547521|27078187|P1|Short Term Study (4 Months)|Lack of Efficacy|0
7791221|NCT00547521|27078186|P2|Short Term Study (4 Months)|Adverse Event|0
7791222|NCT00547521|27078187|P1|Short Term Study (4 Months)|Adverse Event|1
7791223|NCT00547378|27078264|P3|All Implanted Cohort|Other reasons|1
7791224|NCT00547378|27078265|P2|All Implanted Cohort|Other reasons|0
7791225|NCT00547378|27078266|P1|All Implanted Cohort|Other reasons|1
7791226|NCT00547378|27078264|P3|All Implanted Cohort|Site closure|1
7791227|NCT00547378|27078265|P2|All Implanted Cohort|Site closure|0
7791228|NCT00547378|27078266|P1|All Implanted Cohort|Site closure|2
7791229|NCT00547378|27078264|P3|All Implanted Cohort|Physician Decision|6
7791230|NCT00547378|27078265|P2|All Implanted Cohort|Physician Decision|2
7791231|NCT00547378|27078266|P1|All Implanted Cohort|Physician Decision|0
7791232|NCT00547378|27078264|P3|All Implanted Cohort|Death|4
7791233|NCT00547378|27078265|P2|All Implanted Cohort|Death|1
7791234|NCT00547378|27078266|P1|All Implanted Cohort|Death|3
7791235|NCT00547378|27078264|P3|All Implanted Cohort|Lost to Follow-up|14
7791236|NCT00547378|27078265|P2|All Implanted Cohort|Lost to Follow-up|1
7791237|NCT00547378|27078266|P1|All Implanted Cohort|Lost to Follow-up|0
7791238|NCT00547378|27078264|P3|All Implanted Cohort|Adverse Event|17
7791239|NCT00547378|27078265|P2|All Implanted Cohort|Adverse Event|10
7791240|NCT00547378|27078266|P1|All Implanted Cohort|Adverse Event|4
7791241|NCT00547378|27078264|P3|All Implanted Cohort|Withdrawal by Subject|27
7791242|NCT00547378|27078265|P2|All Implanted Cohort|Withdrawal by Subject|4
7791243|NCT00547378|27078266|P1|All Implanted Cohort|Withdrawal by Subject|5
7791244|NCT00547378|27078264|P3|Randomized Cohort|Other reasons|0
7791245|NCT00547378|27078265|P2|Randomized Cohort|Other reasons|0
7791246|NCT00547378|27078266|P1|Randomized Cohort|Other reasons|2
7791247|NCT00547378|27078264|P3|Randomized Cohort|Adverse Event|0
7791248|NCT00547378|27078265|P2|Randomized Cohort|Adverse Event|0
7791249|NCT00547378|27078266|P1|Randomized Cohort|Adverse Event|1
7791250|NCT00547378|27078264|P3|Randomized Cohort|Lost to Follow-up|0
7791251|NCT00547378|27078265|P2|Randomized Cohort|Lost to Follow-up|0
7791252|NCT00547378|27078266|P1|Randomized Cohort|Lost to Follow-up|1
7791253|NCT00547378|27078264|P3|Randomized Cohort|Death|0
7791254|NCT00547378|27078265|P2|Randomized Cohort|Death|1
7791255|NCT00547378|27078266|P1|Randomized Cohort|Death|0
7791256|NCT00547378|27078264|P3|Randomized Cohort|Withdrawal by Subject|0
7791257|NCT00547378|27078265|P2|Randomized Cohort|Withdrawal by Subject|5
7791258|NCT00547378|27078266|P1|Randomized Cohort|Withdrawal by Subject|7
7791259|NCT00547365|27078276|P1|Overall Study|death (not related to study)|4
7791260|NCT00547365|27078276|P1|Overall Study|Protocol Violation|2
7791261|NCT00547365|27078276|P1|Overall Study|Lost to Follow-up|1
7791262|NCT00547365|27078276|P1|Overall Study|Physician Decision|1
7791263|NCT00547300|27078283|P2|Overall Study|Did not Meet Entry Criteria|2
7791264|NCT00547300|27078284|P1|Overall Study|Did not Meet Entry Criteria|0
7791265|NCT00547300|27078283|P2|Overall Study|Study was Administratively Terminated|24
7791266|NCT00547300|27078284|P1|Overall Study|Study was Administratively Terminated|25
7791267|NCT00547248|27078298|P4|Overall Study|Withdrawal by Subject|1
7791268|NCT00547248|27078299|P3|Overall Study|Withdrawal by Subject|7
7791269|NCT00547248|27078300|P2|Overall Study|Withdrawal by Subject|0
7791270|NCT00547248|27078301|P1|Overall Study|Withdrawal by Subject|0
7791271|NCT00547248|27078298|P4|Overall Study|Migrated/moved from study area|0
7791272|NCT00547248|27078299|P3|Overall Study|Migrated/moved from study area|2
7791273|NCT00547248|27078300|P2|Overall Study|Migrated/moved from study area|0
7791274|NCT00547248|27078301|P1|Overall Study|Migrated/moved from study area|0
7791275|NCT00547248|27078298|P4|Overall Study|Protocol Violation|1
7791276|NCT00547248|27078299|P3|Overall Study|Protocol Violation|1
7791277|NCT00547248|27078300|P2|Overall Study|Protocol Violation|0
7791278|NCT00547248|27078301|P1|Overall Study|Protocol Violation|0
7791279|NCT00547157|27078419|P2|Overall Study|Lost to Follow-up|2
7791280|NCT00547157|27078420|P1|Overall Study|Lost to Follow-up|4
7791281|NCT00547157|27078419|P2|Overall Study|Administrative decision|2
7791282|NCT00547157|27078420|P1|Overall Study|Administrative decision|3
7791283|NCT00547157|27078419|P2|Overall Study|Withdrawal by Subject|1
7791284|NCT00547157|27078420|P1|Overall Study|Withdrawal by Subject|3
7791285|NCT00547157|27078419|P2|Overall Study|Death|18
7791286|NCT00547157|27078420|P1|Overall Study|Death|38
7791287|NCT00547157|27078419|P2|Overall Study|Other|0
7791288|NCT00547157|27078420|P1|Overall Study|Other|1
7791289|NCT00547118|27078438|P2|Overall Study|Study suspended|8
7791290|NCT00547118|27078439|P1|Overall Study|Study suspended|7
7791291|NCT00547118|27078438|P2|Overall Study|Did not qualify prior to starting drug|1
7791292|NCT00547118|27078439|P1|Overall Study|Did not qualify prior to starting drug|1
7791293|NCT00546910|27078483|P2|Overall Study|Withdrawal by Subject|0
7791294|NCT00546910|27078484|P1|Overall Study|Withdrawal by Subject|2
7791295|NCT00546910|27078483|P2|Overall Study|Physician Decision|1
7791296|NCT00546910|27078484|P1|Overall Study|Physician Decision|0
7791297|NCT00546910|27078483|P2|Overall Study|Lack of Efficacy|7
7791298|NCT00546910|27078484|P1|Overall Study|Lack of Efficacy|5
7791299|NCT00546910|27078483|P2|Overall Study|Adverse Event|3
7791300|NCT00546910|27078484|P1|Overall Study|Adverse Event|2
7791301|NCT00546871|27078550|P2|Study Extension Period|Withdrawal by Subject|1
7791302|NCT00546871|27078551|P1|Study Extension Period|Withdrawal by Subject|0
7791303|NCT00546871|27078550|P2|Study Extension Period|Protocol Violation|0
7791304|NCT00546871|27078551|P1|Study Extension Period|Protocol Violation|1
7791305|NCT00546871|27078550|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
7791306|NCT00546871|27078551|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
7791307|NCT00546871|27078550|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
7791308|NCT00546871|27078551|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
7791309|NCT00546871|27078550|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
7791310|NCT00546871|27078551|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
7791311|NCT00546819|27078656|P2|Overall Study|Withdrawal by Subject|2
7791312|NCT00546819|27078657|P1|Overall Study|Withdrawal by Subject|4
7791313|NCT00546819|27078656|P2|Overall Study|Lost to Follow-up|1
7791314|NCT00546819|27078657|P1|Overall Study|Lost to Follow-up|2
7791315|NCT00546819|27078656|P2|Overall Study|Adverse Event|3
7791316|NCT00546819|27078657|P1|Overall Study|Adverse Event|2
7791317|NCT00546754|27078669|P2|Overall Study|Missing|7
7791318|NCT00546754|27078670|P1|Overall Study|Missing|14
7791319|NCT00546754|27078669|P2|Overall Study|Patient's Decision|1
7791320|NCT00546754|27078670|P1|Overall Study|Patient's Decision|0
7791321|NCT00546754|27078669|P2|Overall Study|Elevated Creatinine and Potassium levels|1
7791322|NCT00546754|27078670|P1|Overall Study|Elevated Creatinine and Potassium levels|0
7791323|NCT00546754|27078669|P2|Overall Study|Missing Cooperation|0
7791324|NCT00546754|27078670|P1|Overall Study|Missing Cooperation|1
7791325|NCT00546754|27078669|P2|Overall Study|Suicide|0
7791326|NCT00546754|27078670|P1|Overall Study|Suicide|1
7791327|NCT00546754|27078669|P2|Overall Study|Hip Replacement|0
7791328|NCT00546754|27078670|P1|Overall Study|Hip Replacement|1
7791329|NCT00546754|27078669|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
7791330|NCT00546754|27078670|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
7791331|NCT00546754|27078669|P2|Overall Study|Dyspnea|0
7791332|NCT00546754|27078670|P1|Overall Study|Dyspnea|1
7791333|NCT00546754|27078669|P2|Overall Study|Withdrawal by Subject|7
7791334|NCT00546754|27078670|P1|Overall Study|Withdrawal by Subject|6
7791335|NCT00546754|27078669|P2|Overall Study|Protocol Violation|0
7791336|NCT00546754|27078670|P1|Overall Study|Protocol Violation|3
7791337|NCT00546754|27078669|P2|Overall Study|Lost to Follow-up|15
7791338|NCT00546754|27078670|P1|Overall Study|Lost to Follow-up|9
7791339|NCT00546754|27078669|P2|Overall Study|Lack of Efficacy|1
7791340|NCT00546754|27078670|P1|Overall Study|Lack of Efficacy|1
7791341|NCT00546754|27078669|P2|Overall Study|Adverse Event|16
7791342|NCT00546754|27078670|P1|Overall Study|Adverse Event|11
7791343|NCT00546754|27078669|P2|Overall Study|Serious Adverse Event|1
7791344|NCT00546754|27078670|P1|Overall Study|Serious Adverse Event|1
7791345|NCT00546715|27078713|P4|Overall Study|Withdrawal by Subject|0
7791346|NCT00546715|27078714|P3|Overall Study|Withdrawal by Subject|0
7791347|NCT00546715|27078715|P2|Overall Study|Withdrawal by Subject|1
7791348|NCT00546715|27078716|P1|Overall Study|Withdrawal by Subject|0
7791349|NCT00546637|27078771|P2|Overall Study|Randomized, but not treated|1
7791350|NCT00546637|27078772|P1|Overall Study|Randomized, but not treated|3
7791351|NCT00546637|27078771|P2|Overall Study|Withdrawal by Subject|9
7791352|NCT00546637|27078772|P1|Overall Study|Withdrawal by Subject|7
7791353|NCT00546637|27078771|P2|Overall Study|Other|12
7791354|NCT00546637|27078772|P1|Overall Study|Other|10
7791355|NCT00546637|27078771|P2|Overall Study|Lost to Follow-up|2
7791356|NCT00546637|27078772|P1|Overall Study|Lost to Follow-up|2
7791357|NCT00546637|27078771|P2|Overall Study|Lack of Efficacy|5
7791358|NCT00546637|27078772|P1|Overall Study|Lack of Efficacy|5
7791359|NCT00546637|27078771|P2|Overall Study|Adverse Event|20
7791360|NCT00546637|27078772|P1|Overall Study|Adverse Event|46
7791361|NCT00546572|27078846|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
7791362|NCT00546572|27078847|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
7791363|NCT00546572|27078846|P2|Vax 2 / Year 1|Adverse Event|0
7791364|NCT00546572|27078847|P1|Vax 2 / Year 1|Adverse Event|1
7791365|NCT00546572|27078846|P2|Vax 2 / Year 1|Other|1
7791366|NCT00546572|27078847|P1|Vax 2 / Year 1|Other|1
7791367|NCT00546572|27078846|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
7791368|NCT00546572|27078847|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
7791369|NCT00546572|27078846|P2|Vax 1 / Year 0|Lost to Follow-up|1
7791370|NCT00546572|27078847|P1|Vax 1 / Year 0|Lost to Follow-up|0
7791371|NCT00546572|27078846|P2|Vax 1 / Year 0|Adverse Event|1
7791372|NCT00546572|27078847|P1|Vax 1 / Year 0|Adverse Event|0
7791373|NCT00546572|27078846|P2|Vax 1 / Year 0|Death|2
7791374|NCT00546572|27078847|P1|Vax 1 / Year 0|Death|2
7791375|NCT00546572|27078846|P2|Vax 1 / Year 0|Protocol Violation|4
7791376|NCT00546572|27078847|P1|Vax 1 / Year 0|Protocol Violation|3
7791377|NCT00546572|27078846|P2|Vax 1 / Year 0|Withdrawal by Subject|2
7791378|NCT00546572|27078847|P1|Vax 1 / Year 0|Withdrawal by Subject|3
7791379|NCT00546572|27078846|P2|Vax 1 / Year 0|Randomized, not treated|1
7791380|NCT00546572|27078847|P1|Vax 1 / Year 0|Randomized, not treated|1
7791381|NCT00546481|27078891|P3|Maintenance Phase (CERA)|Other Reason|1
7791382|NCT00546481|27078892|P2|Maintenance Phase (CERA)|Other Reason|0
7791383|NCT00546481|27078893|P1|Maintenance Phase (CERA)|Other Reason|0
7791384|NCT00546481|27078891|P3|Maintenance Phase (CERA)|Kidney transplantation|1
7791385|NCT00546481|27078892|P2|Maintenance Phase (CERA)|Kidney transplantation|0
7791386|NCT00546481|27078893|P1|Maintenance Phase (CERA)|Kidney transplantation|0
7791387|NCT00546481|27078891|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
7791388|NCT00546481|27078892|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
7791389|NCT00546481|27078893|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
7791390|NCT00546481|27078891|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
7791391|NCT00546481|27078892|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
7791392|NCT00546481|27078893|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
7791393|NCT00546481|27078891|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
7791394|NCT00546481|27078892|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
7791395|NCT00546481|27078893|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
7791396|NCT00546481|27078891|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
7791397|NCT00546481|27078892|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
7791398|NCT00546481|27078893|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
7791399|NCT00546481|27078891|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
7791400|NCT00546481|27078892|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
7791401|NCT00546481|27078893|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
7791402|NCT00546481|27078891|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
7791403|NCT00546481|27078892|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
7791404|NCT00546481|27078893|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
7791405|NCT00546481|27078891|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
7791406|NCT00546481|27078892|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
7791407|NCT00546481|27078893|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
7791408|NCT00546377|27078942|P1|Overall Study|Adverse Event|6
7791409|NCT00546377|27078942|P1|Overall Study|Deemed ineligible|1
7791410|NCT00546364|27078950|P3|Overall Study|Sponsor decision|1
7791411|NCT00546364|27078951|P2|Overall Study|Sponsor decision|0
7791412|NCT00546364|27078952|P1|Overall Study|Sponsor decision|0
7791413|NCT00546364|27078950|P3|Overall Study|Physician Decision|1
7791414|NCT00546364|27078951|P2|Overall Study|Physician Decision|0
7791415|NCT00546364|27078952|P1|Overall Study|Physician Decision|0
7791416|NCT00546364|27078950|P3|Overall Study|Target lesions resected|0
7791417|NCT00546364|27078951|P2|Overall Study|Target lesions resected|0
7791418|NCT00546364|27078952|P1|Overall Study|Target lesions resected|1
7791419|NCT00546364|27078950|P3|Overall Study|Palliative treatment|1
7791420|NCT00546364|27078951|P2|Overall Study|Palliative treatment|0
7791421|NCT00546364|27078952|P1|Overall Study|Palliative treatment|1
7791422|NCT00546364|27078950|P3|Overall Study|Mixed response|0
7791423|NCT00546364|27078951|P2|Overall Study|Mixed response|0
7791424|NCT00546364|27078952|P1|Overall Study|Mixed response|1
7791425|NCT00546364|27078950|P3|Overall Study|Prior taxotere|0
7791426|NCT00546364|27078951|P2|Overall Study|Prior taxotere|0
7791427|NCT00546364|27078952|P1|Overall Study|Prior taxotere|1
7791428|NCT00546364|27078950|P3|Overall Study|Withdrawal by Subject|3
7791429|NCT00546364|27078951|P2|Overall Study|Withdrawal by Subject|6
7791430|NCT00546364|27078952|P1|Overall Study|Withdrawal by Subject|5
7791431|NCT00546364|27078950|P3|Overall Study|No longer meets study criteria|0
7791432|NCT00546364|27078951|P2|Overall Study|No longer meets study criteria|1
7791433|NCT00546364|27078952|P1|Overall Study|No longer meets study criteria|1
7791434|NCT00546364|27078950|P3|Overall Study|Poor compliance/noncompliance|1
7791435|NCT00546364|27078951|P2|Overall Study|Poor compliance/noncompliance|0
7791436|NCT00546364|27078952|P1|Overall Study|Poor compliance/noncompliance|0
7791437|NCT00546364|27078950|P3|Overall Study|Administrative reason by sponsor|0
7791438|NCT00546364|27078951|P2|Overall Study|Administrative reason by sponsor|0
7791439|NCT00546364|27078952|P1|Overall Study|Administrative reason by sponsor|1
7791440|NCT00546364|27078950|P3|Overall Study|Completed and off treatment|2
7791441|NCT00546364|27078951|P2|Overall Study|Completed and off treatment|0
7791442|NCT00546364|27078952|P1|Overall Study|Completed and off treatment|1
7791443|NCT00546364|27078950|P3|Overall Study|Disease progression|8
7791444|NCT00546364|27078951|P2|Overall Study|Disease progression|11
7791445|NCT00546364|27078952|P1|Overall Study|Disease progression|5
7791446|NCT00546351|27078987|P1|Overall Study|Other reasons for premature termination|17
7791447|NCT00546351|27078987|P1|Overall Study|Unsatisfactory compliance|9
7791448|NCT00546351|27078987|P1|Overall Study|Protocol Deviation|1
7791449|NCT00546351|27078987|P1|Overall Study|Lost to Follow-up|9
7791450|NCT00546351|27078987|P1|Overall Study|Withdrawal by Subject|109
7791451|NCT00546351|27078987|P1|Overall Study|Lack of Efficacy|15
7791452|NCT00546351|27078987|P1|Overall Study|Adverse Event|76
7791453|NCT00546260|27079033|P2|Overall Study|Drug not given pre diagnostic angiogr|2
7791454|NCT00546260|27079034|P1|Overall Study|Drug not given pre diagnostic angiogr|8
7791455|NCT00546117|27079056|P2|Overall Study|Inability to schedule follow-up visit|0
7791456|NCT00546117|27079057|P1|Overall Study|Inability to schedule follow-up visit|1
7791457|NCT00546117|27079056|P2|Overall Study|Withdrawal by Subject|0
7791458|NCT00546117|27079057|P1|Overall Study|Withdrawal by Subject|3
7791459|NCT00546078|27079082|P2|Overall Study|Other reason|1
7791460|NCT00546078|27079083|P1|Overall Study|Other reason|1
7791461|NCT00546078|27079082|P2|Overall Study|Withdrawal by Subject|3
7791462|NCT00546078|27079083|P1|Overall Study|Withdrawal by Subject|2
7791463|NCT00546078|27079082|P2|Overall Study|Lost to Follow-up|3
7791464|NCT00546078|27079083|P1|Overall Study|Lost to Follow-up|1
7791465|NCT00546052|27079121|P1|Overall Study|Non Compliance|7
7791466|NCT00546052|27079121|P1|Overall Study|Withdrawal by Subject|20
7791467|NCT00546052|27079121|P1|Overall Study|Protocol Violation|9
7791468|NCT00546052|27079121|P1|Overall Study|Lost to Follow-up|144
7791469|NCT00546052|27079121|P1|Overall Study|Adverse Event|47
7791470|NCT00546000|27079139|P1|Overall Study|Baseline HPA Axis Supression|2
7791471|NCT00546000|27079139|P1|Overall Study|Lost to Follow-up|1
7791472|NCT00546000|27079139|P1|Overall Study|Adverse Event|1
7791473|NCT00545948|27079164|P3|Overall Study|Not Treated|7
7791474|NCT00545948|27079165|P2|Overall Study|Not Treated|1
7791475|NCT00545948|27079166|P1|Overall Study|Not Treated|1
7791476|NCT00545844|27079176|P1|Overall Study|Withdrawal by Subject|2
7791477|NCT00545844|27079176|P1|Overall Study|Protocol Violation|1
7791478|NCT00545844|27079176|P1|Overall Study|Lost to Follow-up|9
7791479|NCT00545818|27079192|P2|Overall Study|Lost to Follow-up|6
7791480|NCT00545818|27079193|P1|Overall Study|Lost to Follow-up|1
7791481|NCT00545818|27079192|P2|Overall Study|Adverse Event|1
7791482|NCT00545818|27079193|P1|Overall Study|Adverse Event|1
7791483|NCT00545818|27079192|P2|Overall Study|Protocol Violation|0
7791484|NCT00545818|27079193|P1|Overall Study|Protocol Violation|1
7791485|NCT00545792|27079207|P1|Overall Study|Withdrawal by Subject|1
7791486|NCT00545779|27079212|P1|Overall Study|Failure to return|3
7791487|NCT00545779|27079212|P1|Overall Study|Adverse Event/intercurrent illness|5
7791488|NCT00545779|27079212|P1|Overall Study|Withdrawal by Subject|20
7791489|NCT00545779|27079212|P1|Overall Study|Did not cooperate|7
7791490|NCT00545779|27079212|P1|Overall Study|Other protocol violation|1
7791491|NCT00545779|27079212|P1|Overall Study|Violation of selection criteria at entry|8
7791492|NCT00545753|27079232|P3|Overall Study|Protocol Violation|4
7791493|NCT00545753|27079233|P2|Overall Study|Protocol Violation|1
7791494|NCT00545753|27079234|P1|Overall Study|Protocol Violation|3
7791495|NCT00545753|27079232|P3|Overall Study|Lost to Follow-up|12
7791496|NCT00545753|27079233|P2|Overall Study|Lost to Follow-up|3
7791497|NCT00545753|27079234|P1|Overall Study|Lost to Follow-up|13
7791498|NCT00545753|27079232|P3|Overall Study|Withdrawal by Subject|10
7791499|NCT00545753|27079233|P2|Overall Study|Withdrawal by Subject|1
7791500|NCT00545753|27079234|P1|Overall Study|Withdrawal by Subject|0
7791501|NCT00545740|27079247|P4|Overall Study|Husband against study|0
7791502|NCT00545740|27079248|P3|Overall Study|Husband against study|1
7791503|NCT00545740|27079249|P2|Overall Study|Husband against study|0
7791504|NCT00545740|27079250|P1|Overall Study|Husband against study|0
7791505|NCT00545740|27079247|P4|Overall Study|Patient difficulties|0
7791506|NCT00545740|27079248|P3|Overall Study|Patient difficulties|0
7791507|NCT00545740|27079249|P2|Overall Study|Patient difficulties|1
7791508|NCT00545740|27079250|P1|Overall Study|Patient difficulties|0
7791509|NCT00545740|27079247|P4|Overall Study|Non-adherence to visits|0
7791510|NCT00545740|27079248|P3|Overall Study|Non-adherence to visits|0
7791511|NCT00545740|27079249|P2|Overall Study|Non-adherence to visits|1
7791512|NCT00545740|27079250|P1|Overall Study|Non-adherence to visits|0
7791513|NCT00545740|27079247|P4|Overall Study|Lack of time|0
7791514|NCT00545740|27079248|P3|Overall Study|Lack of time|0
7791515|NCT00545740|27079249|P2|Overall Study|Lack of time|1
7791516|NCT00545740|27079250|P1|Overall Study|Lack of time|0
7791517|NCT00545740|27079247|P4|Overall Study|Sponsor decision|0
7791518|NCT00545740|27079248|P3|Overall Study|Sponsor decision|0
7791519|NCT00545740|27079249|P2|Overall Study|Sponsor decision|1
7791520|NCT00545740|27079250|P1|Overall Study|Sponsor decision|0
7791521|NCT00545740|27079247|P4|Overall Study|Accepted only monthly telephone calls|0
7791522|NCT00545740|27079248|P3|Overall Study|Accepted only monthly telephone calls|0
7791523|NCT00545740|27079249|P2|Overall Study|Accepted only monthly telephone calls|0
7791524|NCT00545740|27079250|P1|Overall Study|Accepted only monthly telephone calls|1
7791525|NCT00545740|27079247|P4|Overall Study|Physician Decision|0
7791526|NCT00545740|27079248|P3|Overall Study|Physician Decision|3
7791527|NCT00545740|27079249|P2|Overall Study|Physician Decision|0
7791528|NCT00545740|27079250|P1|Overall Study|Physician Decision|0
7791529|NCT00545740|27079247|P4|Overall Study|Missed visit|0
7791530|NCT00545740|27079248|P3|Overall Study|Missed visit|0
7791531|NCT00545740|27079249|P2|Overall Study|Missed visit|0
7791532|NCT00545740|27079250|P1|Overall Study|Missed visit|1
7791533|NCT00545740|27079247|P4|Overall Study|Site closure|0
7791534|NCT00545740|27079248|P3|Overall Study|Site closure|0
7791535|NCT00545740|27079249|P2|Overall Study|Site closure|0
7791536|NCT00545740|27079250|P1|Overall Study|Site closure|1
7791537|NCT00545740|27079247|P4|Overall Study|Suspected Diverticulitis Recurrence|1
7791538|NCT00545740|27079248|P3|Overall Study|Suspected Diverticulitis Recurrence|1
7791539|NCT00545740|27079249|P2|Overall Study|Suspected Diverticulitis Recurrence|1
7791540|NCT00545740|27079250|P1|Overall Study|Suspected Diverticulitis Recurrence|1
7791541|NCT00545740|27079247|P4|Overall Study|Diverticulitis attack|1
7791542|NCT00545740|27079248|P3|Overall Study|Diverticulitis attack|1
7791543|NCT00545740|27079249|P2|Overall Study|Diverticulitis attack|0
7791544|NCT00545740|27079250|P1|Overall Study|Diverticulitis attack|0
7791545|NCT00545740|27079247|P4|Overall Study|Moved|0
7791546|NCT00545740|27079248|P3|Overall Study|Moved|1
7791547|NCT00545740|27079249|P2|Overall Study|Moved|0
7791548|NCT00545740|27079250|P1|Overall Study|Moved|2
7791549|NCT00545740|27079247|P4|Overall Study|Non-compliance|0
7791550|NCT00545740|27079248|P3|Overall Study|Non-compliance|1
7791551|NCT00545740|27079249|P2|Overall Study|Non-compliance|2
7791552|NCT00545740|27079250|P1|Overall Study|Non-compliance|0
7791553|NCT00545740|27079247|P4|Overall Study|Protocol Violation|0
7791554|NCT00545740|27079248|P3|Overall Study|Protocol Violation|1
7791555|NCT00545740|27079249|P2|Overall Study|Protocol Violation|3
7791556|NCT00545740|27079250|P1|Overall Study|Protocol Violation|1
7791557|NCT00545740|27079247|P4|Overall Study|Lost to Follow-up|6
7791558|NCT00545740|27079248|P3|Overall Study|Lost to Follow-up|5
7791559|NCT00545740|27079249|P2|Overall Study|Lost to Follow-up|5
7791560|NCT00545740|27079250|P1|Overall Study|Lost to Follow-up|7
7791561|NCT00545740|27079247|P4|Overall Study|Adverse Event|9
7791562|NCT00545740|27079248|P3|Overall Study|Adverse Event|19
7791563|NCT00545740|27079249|P2|Overall Study|Adverse Event|18
7791564|NCT00545740|27079250|P1|Overall Study|Adverse Event|10
7791565|NCT00545740|27079247|P4|Overall Study|Withdrawal by Subject|18
7791566|NCT00545740|27079248|P3|Overall Study|Withdrawal by Subject|16
7791567|NCT00545740|27079249|P2|Overall Study|Withdrawal by Subject|15
7791568|NCT00545740|27079250|P1|Overall Study|Withdrawal by Subject|17
7791569|NCT00545740|27079247|P4|Overall Study|Lack of Efficacy|36
7791570|NCT00545740|27079248|P3|Overall Study|Lack of Efficacy|47
7791571|NCT00545740|27079249|P2|Overall Study|Lack of Efficacy|35
7791572|NCT00545740|27079250|P1|Overall Study|Lack of Efficacy|34
7791573|NCT00545714|27079284|P1|Maintenance Phase (36 Months)|Death|2
7791574|NCT00545714|27079284|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
7791575|NCT00545714|27079284|P1|Maintenance Phase (36 Months)|Protocol Violation|1
7791576|NCT00545714|27079284|P1|Maintenance Phase (36 Months)|Physician Decision|1
7791577|NCT00545714|27079284|P1|Maintenance Phase (36 Months)|Disease Progression|9
7791578|NCT00545714|27079284|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
7791579|NCT00545714|27079284|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
7791580|NCT00545714|27079284|P1|Induction Phase (6 Months)|Disease Progression|1
7791581|NCT00545714|27079284|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
7791582|NCT00545714|27079284|P1|Induction Phase (6 Months)|Physician Decision|3
7791583|NCT00545688|27079305|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
7791584|NCT00545688|27079306|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
7791585|NCT00545688|27079307|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
7791586|NCT00545688|27079308|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
7791587|NCT00545688|27079305|P4|Follow-Up Period|Unspecified Reason|8
7791588|NCT00545688|27079306|P3|Follow-Up Period|Unspecified Reason|6
7791589|NCT00545688|27079307|P2|Follow-Up Period|Unspecified Reason|5
7791590|NCT00545688|27079308|P1|Follow-Up Period|Unspecified Reason|2
7791591|NCT00545688|27079305|P4|Follow-Up Period|Lost to Follow-up|1
7791592|NCT00545688|27079306|P3|Follow-Up Period|Lost to Follow-up|3
7791593|NCT00545688|27079307|P2|Follow-Up Period|Lost to Follow-up|3
7791594|NCT00545688|27079308|P1|Follow-Up Period|Lost to Follow-up|3
7791595|NCT00545688|27079305|P4|Follow-Up Period|Refused Treatment|2
7791596|NCT00545688|27079306|P3|Follow-Up Period|Refused Treatment|0
7791597|NCT00545688|27079307|P2|Follow-Up Period|Refused Treatment|2
7791598|NCT00545688|27079308|P1|Follow-Up Period|Refused Treatment|6
7791599|NCT00545688|27079305|P4|Follow-Up Period|Disease Progression|9
7791600|NCT00545688|27079306|P3|Follow-Up Period|Disease Progression|9
7791601|NCT00545688|27079307|P2|Follow-Up Period|Disease Progression|5
7791602|NCT00545688|27079308|P1|Follow-Up Period|Disease Progression|6
7791603|NCT00545688|27079305|P4|Follow-Up Period|Death|6
7791604|NCT00545688|27079306|P3|Follow-Up Period|Death|2
7791605|NCT00545688|27079307|P2|Follow-Up Period|Death|2
7791606|NCT00545688|27079308|P1|Follow-Up Period|Death|4
7791607|NCT00545688|27079305|P4|Adjuvant Treatment Period|Unknown Reason|0
7791608|NCT00545688|27079306|P3|Adjuvant Treatment Period|Unknown Reason|0
7791609|NCT00545688|27079307|P2|Adjuvant Treatment Period|Unknown Reason|1
7791610|NCT00545688|27079308|P1|Adjuvant Treatment Period|Unknown Reason|0
7791611|NCT00545688|27079305|P4|Adjuvant Treatment Period|Adverse Event|2
7791612|NCT00545688|27079306|P3|Adjuvant Treatment Period|Adverse Event|2
7791613|NCT00545688|27079307|P2|Adjuvant Treatment Period|Adverse Event|3
7791614|NCT00545688|27079308|P1|Adjuvant Treatment Period|Adverse Event|0
7791615|NCT00545688|27079305|P4|Adjuvant Treatment Period|Lost to Follow-up|0
7791616|NCT00545688|27079306|P3|Adjuvant Treatment Period|Lost to Follow-up|1
7791617|NCT00545688|27079307|P2|Adjuvant Treatment Period|Lost to Follow-up|0
7791618|NCT00545688|27079308|P1|Adjuvant Treatment Period|Lost to Follow-up|1
7791619|NCT00545688|27079305|P4|Adjuvant Treatment Period|Refused Treatment|5
7791620|NCT00545688|27079306|P3|Adjuvant Treatment Period|Refused Treatment|1
7791621|NCT00545688|27079307|P2|Adjuvant Treatment Period|Refused Treatment|1
7791622|NCT00545688|27079308|P1|Adjuvant Treatment Period|Refused Treatment|1
7791623|NCT00545688|27079305|P4|Adjuvant Treatment Period|Disease Progression|7
7791624|NCT00545688|27079306|P3|Adjuvant Treatment Period|Disease Progression|0
7791625|NCT00545688|27079307|P2|Adjuvant Treatment Period|Disease Progression|3
7791626|NCT00545688|27079308|P1|Adjuvant Treatment Period|Disease Progression|3
7791627|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
7791628|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
7791629|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
7791630|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
7791631|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
7791632|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
7791633|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
7791634|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
7791635|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
7791636|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
7791637|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
7791638|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
7791639|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Death|0
7791640|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Death|0
7791641|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Death|1
7791642|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Death|0
7791643|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7791644|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7791645|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7791646|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
7791647|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
7791648|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
7791649|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
7791650|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
7791651|NCT00545688|27079305|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
7791652|NCT00545688|27079306|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
7791653|NCT00545688|27079307|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
7791654|NCT00545688|27079308|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
7791655|NCT00545584|27079407|P3|Overall Study|Two or more reasons for discontinuation|8
7791656|NCT00545584|27079408|P2|Overall Study|Two or more reasons for discontinuation|19
7791657|NCT00545584|27079409|P1|Overall Study|Two or more reasons for discontinuation|17
7791658|NCT00545584|27079407|P3|Overall Study|Only one reason for discontinuation|48
7791659|NCT00545584|27079408|P2|Overall Study|Only one reason for discontinuation|61
7791660|NCT00545584|27079409|P1|Overall Study|Only one reason for discontinuation|62
7791661|NCT00545571|27079420|P1|Overall Study|Kidney Transplantation|3
7791662|NCT00545571|27079420|P1|Overall Study|Early Termination of Study|24
7791663|NCT00545571|27079420|P1|Overall Study|Transfusion|12
7791664|NCT00545571|27079420|P1|Overall Study|Screen Failure|16
7791665|NCT00545571|27079420|P1|Overall Study|Refused Treatment|1
7791666|NCT00545571|27079420|P1|Overall Study|Protocol Violation|2
7791667|NCT00545571|27079420|P1|Overall Study|Lack of Efficacy|1
7791668|NCT00545571|27079420|P1|Overall Study|Death|5
7791669|NCT00545571|27079420|P1|Overall Study|Adverse Event|2
7791670|NCT00545571|27079420|P1|Overall Study|Administrative Reasons|1
7791671|NCT00545532|27079435|P2|Overall Study|Death|1
7791672|NCT00545532|27079436|P1|Overall Study|Death|0
7791673|NCT00545532|27079435|P2|Overall Study|Lost to Follow-up|6
7791674|NCT00545532|27079436|P1|Overall Study|Lost to Follow-up|5
7791675|NCT00545532|27079435|P2|Overall Study|Withdrawal by Subject|3
7791676|NCT00545532|27079436|P1|Overall Study|Withdrawal by Subject|1
7791677|NCT00545441|27079527|P2|Overall Study|Patients were not treated|3
7791678|NCT00545441|27079528|P1|Overall Study|Patients were not treated|1
7791679|NCT00545441|27079527|P2|Overall Study|Persistence or recurrence of fistula|2
7791680|NCT00545441|27079528|P1|Overall Study|Persistence or recurrence of fistula|5
7791681|NCT00545441|27079527|P2|Overall Study|Withdrawal by Subject|1
7791682|NCT00545441|27079528|P1|Overall Study|Withdrawal by Subject|1
7791683|NCT00545441|27079527|P2|Overall Study|Technical failure|1
7791684|NCT00545441|27079528|P1|Overall Study|Technical failure|0
7791685|NCT00545441|27079527|P2|Overall Study|Lost to Follow-up|5
7791686|NCT00545441|27079528|P1|Overall Study|Lost to Follow-up|9
7791687|NCT00545441|27079527|P2|Overall Study|Fistula draining at 6 months|4
7791688|NCT00545441|27079528|P1|Overall Study|Fistula draining at 6 months|2
7791689|NCT00545402|27079536|P2|Overall Study|Reason not specified|1
7791690|NCT00545402|27079537|P1|Overall Study|Reason not specified|1
7791691|NCT00545402|27079536|P2|Overall Study|Protocol Violation|0
7791692|NCT00545402|27079537|P1|Overall Study|Protocol Violation|1
7791693|NCT00545402|27079536|P2|Overall Study|Withdrawal by Subject|1
7791694|NCT00545402|27079537|P1|Overall Study|Withdrawal by Subject|0
7791695|NCT00545402|27079536|P2|Overall Study|Graft loss|4
7791696|NCT00545402|27079537|P1|Overall Study|Graft loss|2
7791697|NCT00545402|27079536|P2|Overall Study|Death|7
7791698|NCT00545402|27079537|P1|Overall Study|Death|5
7791699|NCT00545402|27079536|P2|Overall Study|Use of unauthorized immunosuppressant|7
7791700|NCT00545402|27079537|P1|Overall Study|Use of unauthorized immunosuppressant|8
7791701|NCT00545402|27079536|P2|Overall Study|Discontinuation of treatment|9
7791702|NCT00545402|27079537|P1|Overall Study|Discontinuation of treatment|17
7791703|NCT00545363|27079555|P2|Overall Study|Other|1
7791704|NCT00545363|27079556|P1|Overall Study|Other|1
7791705|NCT00545363|27079555|P2|Overall Study|Lost to Follow-up|0
7791706|NCT00545363|27079556|P1|Overall Study|Lost to Follow-up|2
7791707|NCT00545363|27079555|P2|Overall Study|Did not meet entry criteria|1
7791708|NCT00545363|27079556|P1|Overall Study|Did not meet entry criteria|1
7791709|NCT00545363|27079555|P2|Overall Study|Non-compliance|1
7791710|NCT00545363|27079556|P1|Overall Study|Non-compliance|3
7791711|NCT00545363|27079555|P2|Overall Study|Withdrawal by Subject|5
7791712|NCT00545363|27079556|P1|Overall Study|Withdrawal by Subject|6
7791713|NCT00545363|27079555|P2|Overall Study|Adverse Event|7
7791714|NCT00545363|27079556|P1|Overall Study|Adverse Event|6
7791715|NCT00545298|27079571|P3|Overall Study|Issues with Standard of Care|1
7791716|NCT00545298|27079572|P2|Overall Study|Issues with Standard of Care|0
7791717|NCT00545298|27079573|P1|Overall Study|Issues with Standard of Care|2
7791718|NCT00545272|27079590|P6|Overall Study|Lost to Follow-up|0
7791719|NCT00545272|27079591|P5|Overall Study|Lost to Follow-up|1
7791720|NCT00545272|27079592|P4|Overall Study|Lost to Follow-up|0
7791721|NCT00545272|27079593|P3|Overall Study|Lost to Follow-up|0
7791722|NCT00545272|27079594|P2|Overall Study|Lost to Follow-up|0
7791723|NCT00545272|27079595|P1|Overall Study|Lost to Follow-up|0
7791724|NCT00545272|27079590|P6|Overall Study|Abnormal test procedure result(s)|0
7791725|NCT00545272|27079591|P5|Overall Study|Abnormal test procedure result(s)|1
7791726|NCT00545272|27079592|P4|Overall Study|Abnormal test procedure result(s)|0
7791727|NCT00545272|27079593|P3|Overall Study|Abnormal test procedure result(s)|0
7791728|NCT00545272|27079594|P2|Overall Study|Abnormal test procedure result(s)|0
7791729|NCT00545272|27079595|P1|Overall Study|Abnormal test procedure result(s)|0
7791730|NCT00545272|27079590|P6|Overall Study|Abnormal laboratory value(s)|1
7791731|NCT00545272|27079591|P5|Overall Study|Abnormal laboratory value(s)|0
7791732|NCT00545272|27079592|P4|Overall Study|Abnormal laboratory value(s)|0
7791733|NCT00545272|27079593|P3|Overall Study|Abnormal laboratory value(s)|0
7791734|NCT00545272|27079594|P2|Overall Study|Abnormal laboratory value(s)|0
7791735|NCT00545272|27079595|P1|Overall Study|Abnormal laboratory value(s)|0
7791736|NCT00545272|27079590|P6|Overall Study|Adverse Event|1
7791737|NCT00545272|27079591|P5|Overall Study|Adverse Event|0
7791738|NCT00545272|27079592|P4|Overall Study|Adverse Event|0
7791739|NCT00545272|27079593|P3|Overall Study|Adverse Event|1
7791740|NCT00545272|27079594|P2|Overall Study|Adverse Event|0
7791741|NCT00545272|27079595|P1|Overall Study|Adverse Event|0
7791742|NCT00545272|27079590|P6|Overall Study|Protocol deviation|1
7791743|NCT00545272|27079591|P5|Overall Study|Protocol deviation|0
7791744|NCT00545272|27079592|P4|Overall Study|Protocol deviation|1
7791745|NCT00545272|27079593|P3|Overall Study|Protocol deviation|0
7791746|NCT00545272|27079594|P2|Overall Study|Protocol deviation|1
7791747|NCT00545272|27079595|P1|Overall Study|Protocol deviation|0
7791748|NCT00545233|27079647|P2|Overall Study|Physician Decision|1
7791749|NCT00545233|27079648|P1|Overall Study|Physician Decision|2
7791750|NCT00545233|27079647|P2|Overall Study|Insufficient response|15
7791751|NCT00545233|27079648|P1|Overall Study|Insufficient response|14
7791752|NCT00545233|27079647|P2|Overall Study|Failure to Return|6
7791753|NCT00545233|27079648|P1|Overall Study|Failure to Return|4
7791754|NCT00545233|27079647|P2|Overall Study|Refused Treatment|7
7791755|NCT00545233|27079648|P1|Overall Study|Refused Treatment|9
7791756|NCT00545233|27079647|P2|Overall Study|Protocol Violation|0
7791757|NCT00545233|27079648|P1|Overall Study|Protocol Violation|2
7791758|NCT00545233|27079647|P2|Overall Study|Violation of Selection Criteria at Entry|1
7791759|NCT00545233|27079648|P1|Overall Study|Violation of Selection Criteria at Entry|5
7791760|NCT00545233|27079647|P2|Overall Study|Adverse Event|5
7791761|NCT00545233|27079648|P1|Overall Study|Adverse Event|10
7791762|NCT00545168|27079707|P3|Overall Study|Visit for Day 21 was not done in error|2
7791763|NCT00545168|27079708|P2|Overall Study|Visit for Day 21 was not done in error|0
7791764|NCT00545168|27079709|P1|Overall Study|Visit for Day 21 was not done in error|1
7791765|NCT00545168|27079707|P3|Overall Study|Protocol Violation|1
7791766|NCT00545168|27079708|P2|Overall Study|Protocol Violation|0
7791767|NCT00545168|27079709|P1|Overall Study|Protocol Violation|1
7791768|NCT00545168|27079707|P3|Overall Study|Withdrawal by Subject|13
7791769|NCT00545168|27079708|P2|Overall Study|Withdrawal by Subject|0
7791770|NCT00545168|27079709|P1|Overall Study|Withdrawal by Subject|9
7791771|NCT00545168|27079707|P3|Overall Study|Lost to Follow-up|5
7791772|NCT00545168|27079708|P2|Overall Study|Lost to Follow-up|5
7791773|NCT00545168|27079709|P1|Overall Study|Lost to Follow-up|5
7791774|NCT00545129|27079733|P2|Overall Study|Other|3
7791775|NCT00545129|27079734|P1|Overall Study|Other|3
7791776|NCT00545129|27079733|P2|Overall Study|Rollover to Study A4091029 (NCT00830180)|14
7791777|NCT00545129|27079734|P1|Overall Study|Rollover to Study A4091029 (NCT00830180)|9
7791778|NCT00545129|27079733|P2|Overall Study|Adverse Event|1
7791779|NCT00545129|27079734|P1|Overall Study|Adverse Event|1
7791780|NCT00545129|27079733|P2|Overall Study|Death|1
7791781|NCT00545129|27079734|P1|Overall Study|Death|2
7791782|NCT00545129|27079733|P2|Overall Study|Lack of Efficacy|5
7791783|NCT00545129|27079734|P1|Overall Study|Lack of Efficacy|2
7791784|NCT00545103|27079805|P4|Overall Study|Death|0
7791785|NCT00545103|27079806|P3|Overall Study|Death|0
7791786|NCT00545103|27079807|P2|Overall Study|Death|1
7791787|NCT00545103|27079808|P1|Overall Study|Death|0
7791788|NCT00545103|27079805|P4|Overall Study|Subject met endpoint under protocol v. 1|0
7791789|NCT00545103|27079806|P3|Overall Study|Subject met endpoint under protocol v. 1|1
7791790|NCT00545103|27079807|P2|Overall Study|Subject met endpoint under protocol v. 1|0
7791791|NCT00545103|27079808|P1|Overall Study|Subject met endpoint under protocol v. 1|0
7791792|NCT00545103|27079805|P4|Overall Study|Does not want to take study drug anymore|0
7791793|NCT00545103|27079806|P3|Overall Study|Does not want to take study drug anymore|1
7791794|NCT00545103|27079807|P2|Overall Study|Does not want to take study drug anymore|0
7791795|NCT00545103|27079808|P1|Overall Study|Does not want to take study drug anymore|1
7791796|NCT00545103|27079805|P4|Overall Study|Use of prohibited medication|0
7791797|NCT00545103|27079806|P3|Overall Study|Use of prohibited medication|1
7791798|NCT00545103|27079807|P2|Overall Study|Use of prohibited medication|0
7791799|NCT00545103|27079808|P1|Overall Study|Use of prohibited medication|0
7791800|NCT00545103|27079805|P4|Overall Study|Subject moved|0
7791801|NCT00545103|27079806|P3|Overall Study|Subject moved|0
7791802|NCT00545103|27079807|P2|Overall Study|Subject moved|1
7791803|NCT00545103|27079808|P1|Overall Study|Subject moved|0
7791804|NCT00545103|27079805|P4|Overall Study|Investigator decision|0
7791805|NCT00545103|27079806|P3|Overall Study|Investigator decision|1
7791806|NCT00545103|27079807|P2|Overall Study|Investigator decision|0
7791807|NCT00545103|27079808|P1|Overall Study|Investigator decision|0
7791808|NCT00545103|27079805|P4|Overall Study|Noncompliance|0
7791809|NCT00545103|27079806|P3|Overall Study|Noncompliance|0
7791810|NCT00545103|27079807|P2|Overall Study|Noncompliance|1
7791811|NCT00545103|27079808|P1|Overall Study|Noncompliance|0
7791812|NCT00545103|27079805|P4|Overall Study|Subject's decision|0
7791813|NCT00545103|27079806|P3|Overall Study|Subject's decision|0
7791814|NCT00545103|27079807|P2|Overall Study|Subject's decision|0
7791815|NCT00545103|27079808|P1|Overall Study|Subject's decision|1
7791816|NCT00545103|27079805|P4|Overall Study|Personal reasons|0
7791817|NCT00545103|27079806|P3|Overall Study|Personal reasons|0
7791818|NCT00545103|27079807|P2|Overall Study|Personal reasons|0
7791819|NCT00545103|27079808|P1|Overall Study|Personal reasons|1
7791820|NCT00545103|27079805|P4|Overall Study|Diverticulitis crisis|1
7791821|NCT00545103|27079806|P3|Overall Study|Diverticulitis crisis|0
7791822|NCT00545103|27079807|P2|Overall Study|Diverticulitis crisis|0
7791823|NCT00545103|27079808|P1|Overall Study|Diverticulitis crisis|0
7791824|NCT00545103|27079805|P4|Overall Study|Wish to start a family|1
7791825|NCT00545103|27079806|P3|Overall Study|Wish to start a family|0
7791826|NCT00545103|27079807|P2|Overall Study|Wish to start a family|0
7791827|NCT00545103|27079808|P1|Overall Study|Wish to start a family|0
7791828|NCT00545103|27079805|P4|Overall Study|Investigational product not taken|1
7791829|NCT00545103|27079806|P3|Overall Study|Investigational product not taken|0
7791830|NCT00545103|27079807|P2|Overall Study|Investigational product not taken|0
7791831|NCT00545103|27079808|P1|Overall Study|Investigational product not taken|1
7791832|NCT00545103|27079805|P4|Overall Study|Difficult to open package|1
7791833|NCT00545103|27079806|P3|Overall Study|Difficult to open package|0
7791834|NCT00545103|27079807|P2|Overall Study|Difficult to open package|0
7791835|NCT00545103|27079808|P1|Overall Study|Difficult to open package|0
7791836|NCT00545103|27079805|P4|Overall Study|Suspected recurrence of diverticulitis|3
7791837|NCT00545103|27079806|P3|Overall Study|Suspected recurrence of diverticulitis|0
7791838|NCT00545103|27079807|P2|Overall Study|Suspected recurrence of diverticulitis|0
7791839|NCT00545103|27079808|P1|Overall Study|Suspected recurrence of diverticulitis|1
7791840|NCT00545103|27079805|P4|Overall Study|Protocol Violation|0
7791841|NCT00545103|27079806|P3|Overall Study|Protocol Violation|3
7791842|NCT00545103|27079807|P2|Overall Study|Protocol Violation|2
7791843|NCT00545103|27079808|P1|Overall Study|Protocol Violation|1
7791844|NCT00545103|27079805|P4|Overall Study|Lost to Follow-up|4
7791845|NCT00545103|27079806|P3|Overall Study|Lost to Follow-up|3
7791846|NCT00545103|27079807|P2|Overall Study|Lost to Follow-up|6
7791847|NCT00545103|27079808|P1|Overall Study|Lost to Follow-up|4
7791848|NCT00545103|27079805|P4|Overall Study|Adverse Event|10
7791849|NCT00545103|27079806|P3|Overall Study|Adverse Event|17
7791850|NCT00545103|27079807|P2|Overall Study|Adverse Event|12
7791851|NCT00545103|27079808|P1|Overall Study|Adverse Event|11
7791852|NCT00545103|27079805|P4|Overall Study|Withdrawal by Subject|22
7791853|NCT00545103|27079806|P3|Overall Study|Withdrawal by Subject|18
7791854|NCT00545103|27079807|P2|Overall Study|Withdrawal by Subject|10
7791855|NCT00545103|27079808|P1|Overall Study|Withdrawal by Subject|6
7791856|NCT00545103|27079805|P4|Overall Study|Lack of Efficacy|27
7791857|NCT00545103|27079806|P3|Overall Study|Lack of Efficacy|31
7791858|NCT00545103|27079807|P2|Overall Study|Lack of Efficacy|45
7791859|NCT00545103|27079808|P1|Overall Study|Lack of Efficacy|48
7791860|NCT00545077|27079844|P2|Overall Study|Death|8
7791861|NCT00545077|27079845|P1|Overall Study|Death|0
7791862|NCT00545077|27079844|P2|Overall Study|Adverse Event|31
7791863|NCT00545077|27079845|P1|Overall Study|Adverse Event|0
7791864|NCT00545077|27079844|P2|Overall Study|Protocol Violation|0
7791865|NCT00545077|27079845|P1|Overall Study|Protocol Violation|1
7791866|NCT00545077|27079844|P2|Overall Study|Lost to Follow-up|0
7791867|NCT00545077|27079845|P1|Overall Study|Lost to Follow-up|2
7791868|NCT00545077|27079844|P2|Overall Study|Physician Decision|3
7791869|NCT00545077|27079845|P1|Overall Study|Physician Decision|6
7791870|NCT00545077|27079844|P2|Overall Study|Withdrawal by Subject|14
7791871|NCT00545077|27079845|P1|Overall Study|Withdrawal by Subject|3
7791872|NCT00545077|27079844|P2|Overall Study|Disease Progression|98
7791873|NCT00545077|27079845|P1|Overall Study|Disease Progression|131
7791874|NCT00545077|27079844|P2|Overall Study|Treatment not received|1
7791875|NCT00545077|27079845|P1|Overall Study|Treatment not received|5
7791876|NCT00545064|27079861|P1|Overall Study|inclement weather|1
7791877|NCT00545064|27079861|P1|Overall Study|cancel all appointments, no rebooking|1
7791878|NCT00545064|27079861|P1|Overall Study|did not complete course of treatment|1
7791879|NCT00545064|27079861|P1|Overall Study|Withdrawal by Subject|2
7791880|NCT00545064|27079861|P1|Overall Study|Lost to Follow-up|3
7791881|NCT00545051|27079872|P2|Overall Study|Administrative reasons|1
7791882|NCT00545051|27079873|P1|Overall Study|Administrative reasons|0
7791883|NCT00545051|27079872|P2|Overall Study|Withdrawal by Subject|1
7791884|NCT00545051|27079873|P1|Overall Study|Withdrawal by Subject|0
7791885|NCT00545051|27079872|P2|Overall Study|Protocol Violation|0
7791886|NCT00545051|27079873|P1|Overall Study|Protocol Violation|1
7791887|NCT00545051|27079872|P2|Overall Study|Violation of inclusion/exclusion|2
7791888|NCT00545051|27079873|P1|Overall Study|Violation of inclusion/exclusion|0
7791889|NCT00545051|27079872|P2|Overall Study|Death|0
7791890|NCT00545051|27079873|P1|Overall Study|Death|1
7791891|NCT00545051|27079872|P2|Overall Study|Adverse Event|3
7791892|NCT00545051|27079873|P1|Overall Study|Adverse Event|7
7791893|NCT00544882|27079917|P3|Cycle 3: Follow-up|Pregnancy|0
7791894|NCT00544882|27079918|P2|Cycle 3: Follow-up|Pregnancy|1
7791895|NCT00544882|27079919|P1|Cycle 3: Follow-up|Pregnancy|0
7791896|NCT00544882|27079917|P3|Cycle 3: Follow-up|Noncompliance|0
7791897|NCT00544882|27079918|P2|Cycle 3: Follow-up|Noncompliance|1
7791898|NCT00544882|27079919|P1|Cycle 3: Follow-up|Noncompliance|0
7791899|NCT00544882|27079917|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
7791900|NCT00544882|27079918|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
7791901|NCT00544882|27079919|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
7791902|NCT00544882|27079917|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
7791903|NCT00544882|27079918|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
7791904|NCT00544882|27079919|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
7791905|NCT00544882|27079917|P3|Cycle 1: Run-in Cycle|Adverse Event|0
7791906|NCT00544882|27079918|P2|Cycle 1: Run-in Cycle|Adverse Event|0
7791907|NCT00544882|27079919|P1|Cycle 1: Run-in Cycle|Adverse Event|1
7791908|NCT00544882|27079917|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
7791909|NCT00544882|27079918|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
7791910|NCT00544882|27079919|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
7791911|NCT00544869|27079944|P3|Overall Study|Physician Decision|0
7791912|NCT00544869|27079945|P2|Overall Study|Physician Decision|0
7791913|NCT00544869|27079946|P1|Overall Study|Physician Decision|2
7791914|NCT00544869|27079944|P3|Overall Study|Lack of Efficacy|0
7791915|NCT00544869|27079945|P2|Overall Study|Lack of Efficacy|1
7791916|NCT00544869|27079946|P1|Overall Study|Lack of Efficacy|1
7791917|NCT00544869|27079944|P3|Overall Study|Adverse Event|0
7791918|NCT00544869|27079945|P2|Overall Study|Adverse Event|1
7791919|NCT00544869|27079946|P1|Overall Study|Adverse Event|6
7791920|NCT00544869|27079944|P3|Overall Study|Rsolution of congenitive symptoms|0
7791921|NCT00544869|27079945|P2|Overall Study|Rsolution of congenitive symptoms|0
7791922|NCT00544869|27079946|P1|Overall Study|Rsolution of congenitive symptoms|3
7791923|NCT00544817|27079954|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
7791924|NCT00544817|27079954|P1|Follow-up Systemic Therapy|Physician Decision|3
7791925|NCT00544817|27079954|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
7791926|NCT00544817|27079954|P1|No Treatment Interval|Adverse Event|1
7791927|NCT00544817|27079954|P1|No Treatment Interval|Physician Decision|3
7791928|NCT00544817|27079954|P1|No Treatment Interval|Lack of Efficacy|8
7791929|NCT00544817|27079954|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
7791930|NCT00544817|27079954|P1|Combined Modality|Adverse Event|2
7791931|NCT00544817|27079954|P1|Combined Modality|Worsening Neurologic Symptoms|2
7791932|NCT00544817|27079954|P1|Combined Modality|Lack of Efficacy|2
7791933|NCT00544648|27080003|P2|Overall Study|progression of disease|0
7791934|NCT00544648|27080004|P1|Overall Study|progression of disease|1
7791935|NCT00544648|27080003|P2|Overall Study|Adverse Event|1
7791936|NCT00544648|27080004|P1|Overall Study|Adverse Event|1
7791937|NCT00544648|27080003|P2|Overall Study|Withdrawal by Subject|0
7791938|NCT00544648|27080004|P1|Overall Study|Withdrawal by Subject|1
7791939|NCT00544557|27080018|P1|Overall Study|Other|98
7791940|NCT00544557|27080018|P1|Overall Study|Lack of Efficacy|196
7791941|NCT00544557|27080018|P1|Overall Study|Adverse Event|140
7791942|NCT00544544|27080049|P1|Overall Study|Lost to Follow-up|1
7791943|NCT00544544|27080049|P1|Overall Study|Adverse Event|1
7791944|NCT00544544|27080049|P1|Overall Study|Withdrawal by Subject|1
7791945|NCT00544440|27080056|P1|Overall Study|Other|5
7791946|NCT00544440|27080056|P1|Overall Study|Progressive Disease|47
7791947|NCT00544440|27080056|P1|Overall Study|Subject Non-compliance|1
7791948|NCT00544440|27080056|P1|Overall Study|Withdrawal by Subject|2
7791949|NCT00544440|27080056|P1|Overall Study|Adverse Event|1
7791950|NCT00544440|27080056|P1|Overall Study|Other|1
7791951|NCT00544167|27080063|P1|Overall Study|Physician Decision|8
7791952|NCT00544167|27080063|P1|Overall Study|Adverse Event|21
7791953|NCT00543985|27080089|P1|Overall Study|Withdrawal by Subject|4
7791954|NCT00543855|27080100|P4|Overall Study|Protocol Violation|0
7791955|NCT00543855|27080101|P3|Overall Study|Protocol Violation|0
7791956|NCT00543855|27080102|P2|Overall Study|Protocol Violation|0
7791957|NCT00543855|27080103|P1|Overall Study|Protocol Violation|1
7791958|NCT00543855|27080100|P4|Overall Study|Withdrawal by Subject|0
7791959|NCT00543855|27080101|P3|Overall Study|Withdrawal by Subject|2
7791960|NCT00543855|27080102|P2|Overall Study|Withdrawal by Subject|1
7791961|NCT00543855|27080103|P1|Overall Study|Withdrawal by Subject|0
7791962|NCT00543855|27080100|P4|Overall Study|Lost to Follow-up|0
7791963|NCT00543855|27080101|P3|Overall Study|Lost to Follow-up|1
7791964|NCT00543855|27080102|P2|Overall Study|Lost to Follow-up|0
7791965|NCT00543855|27080103|P1|Overall Study|Lost to Follow-up|0
7791966|NCT00543855|27080100|P4|Overall Study|Adverse Event|4
7791967|NCT00543855|27080101|P3|Overall Study|Adverse Event|3
7791968|NCT00543855|27080102|P2|Overall Study|Adverse Event|1
7791969|NCT00543855|27080103|P1|Overall Study|Adverse Event|3
7791970|NCT00543803|27080125|P1|Overall Study|Other|86
7791971|NCT00543803|27080125|P1|Overall Study|Lost to Follow-up|20
7791972|NCT00543803|27080125|P1|Overall Study|Lack of Efficacy|22
7791973|NCT00543803|27080125|P1|Overall Study|Adverse Event|14
7791974|NCT00543725|27080159|P2|Overall Study|Other|3
7791975|NCT00543725|27080160|P1|Overall Study|Other|3
7791976|NCT00543725|27080159|P2|Overall Study|Lost to Follow-up|11
7791977|NCT00543725|27080160|P1|Overall Study|Lost to Follow-up|15
7791978|NCT00543725|27080159|P2|Overall Study|Withdrawal by Subject|13
7791979|NCT00543725|27080160|P1|Overall Study|Withdrawal by Subject|4
7791980|NCT00543725|27080159|P2|Overall Study|Protocol Violation|1
7791981|NCT00543725|27080160|P1|Overall Study|Protocol Violation|0
7791982|NCT00543725|27080159|P2|Overall Study|Subject Reached A Virologic Endpoint|14
7791983|NCT00543725|27080160|P1|Overall Study|Subject Reached A Virologic Endpoint|22
7791984|NCT00543725|27080159|P2|Overall Study|Subject Ineligible To Continue The Trial|0
7791985|NCT00543725|27080160|P1|Overall Study|Subject Ineligible To Continue The Trial|2
7791986|NCT00543725|27080159|P2|Overall Study|Subject Non-Compliant|4
7791987|NCT00543725|27080160|P1|Overall Study|Subject Non-Compliant|4
7791988|NCT00543725|27080159|P2|Overall Study|Sponsor's Decision|1
7791989|NCT00543725|27080160|P1|Overall Study|Sponsor's Decision|0
7791990|NCT00543725|27080159|P2|Overall Study|Adverse Event|27
7791991|NCT00543725|27080160|P1|Overall Study|Adverse Event|18
7791992|NCT00543569|27080186|P4|Overall Study|Randomized but never received study drug|3
7791993|NCT00543569|27080187|P3|Overall Study|Randomized but never received study drug|5
7791994|NCT00543569|27080188|P2|Overall Study|Randomized but never received study drug|3
7791995|NCT00543569|27080189|P1|Overall Study|Randomized but never received study drug|3
7791996|NCT00543569|27080186|P4|Overall Study|Miscellaneous Reasons|4
7791997|NCT00543569|27080187|P3|Overall Study|Miscellaneous Reasons|11
7791998|NCT00543569|27080188|P2|Overall Study|Miscellaneous Reasons|3
7791999|NCT00543569|27080189|P1|Overall Study|Miscellaneous Reasons|7
7792000|NCT00543569|27080186|P4|Overall Study|Lost to Follow-up|1
7792001|NCT00543569|27080187|P3|Overall Study|Lost to Follow-up|1
7792002|NCT00543569|27080188|P2|Overall Study|Lost to Follow-up|0
7792003|NCT00543569|27080189|P1|Overall Study|Lost to Follow-up|0
7792004|NCT00543569|27080186|P4|Overall Study|Death|1
7792005|NCT00543569|27080187|P3|Overall Study|Death|3
7792006|NCT00543569|27080188|P2|Overall Study|Death|2
7792007|NCT00543569|27080189|P1|Overall Study|Death|2
7792008|NCT00543543|27080295|P4|Extension Study|Withdrawal by Subject|120
7792009|NCT00543543|27080296|P3|Extension Study|Withdrawal by Subject|0
7792010|NCT00543543|27080297|P2|Extension Study|Withdrawal by Subject|0
7792011|NCT00543543|27080298|P1|Extension Study|Withdrawal by Subject|0
7792012|NCT00543543|27080295|P4|Extension Study|Protocol Violation|11
7792013|NCT00543543|27080296|P3|Extension Study|Protocol Violation|0
7792014|NCT00543543|27080297|P2|Extension Study|Protocol Violation|0
7792015|NCT00543543|27080298|P1|Extension Study|Protocol Violation|0
7792016|NCT00543543|27080295|P4|Extension Study|Pregnancy|6
7792017|NCT00543543|27080296|P3|Extension Study|Pregnancy|0
7792018|NCT00543543|27080297|P2|Extension Study|Pregnancy|0
7792019|NCT00543543|27080298|P1|Extension Study|Pregnancy|0
7792020|NCT00543543|27080295|P4|Extension Study|Physician Decision|7
7792021|NCT00543543|27080296|P3|Extension Study|Physician Decision|0
7792022|NCT00543543|27080297|P2|Extension Study|Physician Decision|0
7792023|NCT00543543|27080298|P1|Extension Study|Physician Decision|0
7792024|NCT00543543|27080295|P4|Extension Study|Lost to Follow-up|77
7792025|NCT00543543|27080296|P3|Extension Study|Lost to Follow-up|0
7792026|NCT00543543|27080297|P2|Extension Study|Lost to Follow-up|0
7792027|NCT00543543|27080298|P1|Extension Study|Lost to Follow-up|0
7792028|NCT00543543|27080295|P4|Extension Study|Adverse Event|5
7792029|NCT00543543|27080296|P3|Extension Study|Adverse Event|0
7792030|NCT00543543|27080297|P2|Extension Study|Adverse Event|0
7792031|NCT00543543|27080298|P1|Extension Study|Adverse Event|0
7792032|NCT00543543|27080295|P4|Base Study|Withdrawal by Subject|503
7792033|NCT00543543|27080296|P3|Base Study|Withdrawal by Subject|5
7792034|NCT00543543|27080297|P2|Base Study|Withdrawal by Subject|482
7792035|NCT00543543|27080298|P1|Base Study|Withdrawal by Subject|7
7792036|NCT00543543|27080295|P4|Base Study|Protocol Violation|6
7792037|NCT00543543|27080296|P3|Base Study|Protocol Violation|0
7792038|NCT00543543|27080297|P2|Base Study|Protocol Violation|6
7792039|NCT00543543|27080298|P1|Base Study|Protocol Violation|0
7792040|NCT00543543|27080295|P4|Base Study|Physician Decision|7
7792041|NCT00543543|27080296|P3|Base Study|Physician Decision|0
7792042|NCT00543543|27080297|P2|Base Study|Physician Decision|4
7792043|NCT00543543|27080298|P1|Base Study|Physician Decision|0
7792044|NCT00543543|27080295|P4|Base Study|Lost to Follow-up|701
7792045|NCT00543543|27080296|P3|Base Study|Lost to Follow-up|9
7792046|NCT00543543|27080297|P2|Base Study|Lost to Follow-up|749
7792047|NCT00543543|27080298|P1|Base Study|Lost to Follow-up|12
7792048|NCT00543543|27080295|P4|Base Study|Adverse Event|5
7792049|NCT00543543|27080296|P3|Base Study|Adverse Event|0
7792050|NCT00543543|27080297|P2|Base Study|Adverse Event|11
7792051|NCT00543543|27080298|P1|Base Study|Adverse Event|1
7792052|NCT00543439|27080342|P3|Period 2|Adverse Event|1
7792053|NCT00543439|27080343|P2|Period 2|Adverse Event|1
7792054|NCT00543439|27080344|P1|Period 2|Adverse Event|0
7792055|NCT00543439|27080342|P3|Period 2|Protocol Violation|1
7792056|NCT00543439|27080343|P2|Period 2|Protocol Violation|0
7792057|NCT00543439|27080344|P1|Period 2|Protocol Violation|1
7792058|NCT00543439|27080342|P3|Period 1|Physician Decision|1
7792059|NCT00543439|27080343|P2|Period 1|Physician Decision|0
7792060|NCT00543439|27080344|P1|Period 1|Physician Decision|0
7792061|NCT00543439|27080342|P3|Period 1|Withdrawal by Subject|0
7792062|NCT00543439|27080343|P2|Period 1|Withdrawal by Subject|1
7792063|NCT00543439|27080344|P1|Period 1|Withdrawal by Subject|1
7792064|NCT00543439|27080342|P3|Period 1|Adverse Event|1
7792065|NCT00543439|27080343|P2|Period 1|Adverse Event|2
7792066|NCT00543439|27080344|P1|Period 1|Adverse Event|0
7792067|NCT00543387|27080413|P11|Crossover Participants|Study Terminated by Sponsor|1
7792068|NCT00543387|27080414|P10|Crossover Participants|Study Terminated by Sponsor|0
7792069|NCT00543387|27080415|P9|Crossover Participants|Study Terminated by Sponsor|0
7792070|NCT00543387|27080416|P8|Crossover Participants|Study Terminated by Sponsor|0
7792071|NCT00543387|27080417|P7|Crossover Participants|Study Terminated by Sponsor|0
7792072|NCT00543387|27080418|P6|Crossover Participants|Study Terminated by Sponsor|0
7792073|NCT00543387|27080419|P5|Crossover Participants|Study Terminated by Sponsor|0
7792074|NCT00543387|27080420|P4|Crossover Participants|Study Terminated by Sponsor|0
7792075|NCT00543387|27080421|P3|Crossover Participants|Study Terminated by Sponsor|0
7792076|NCT00543387|27080422|P2|Crossover Participants|Study Terminated by Sponsor|0
7792077|NCT00543387|27080423|P1|Crossover Participants|Study Terminated by Sponsor|0
7792078|NCT00543387|27080413|P11|Crossover Participants|Progressive Disease|2
7792079|NCT00543387|27080414|P10|Crossover Participants|Progressive Disease|1
7792080|NCT00543387|27080415|P9|Crossover Participants|Progressive Disease|0
7792081|NCT00543387|27080416|P8|Crossover Participants|Progressive Disease|0
7792082|NCT00543387|27080417|P7|Crossover Participants|Progressive Disease|0
7792083|NCT00543387|27080418|P6|Crossover Participants|Progressive Disease|0
7792084|NCT00543387|27080419|P5|Crossover Participants|Progressive Disease|0
7792085|NCT00543387|27080420|P4|Crossover Participants|Progressive Disease|0
7792086|NCT00543387|27080421|P3|Crossover Participants|Progressive Disease|0
7792087|NCT00543387|27080422|P2|Crossover Participants|Progressive Disease|0
7792088|NCT00543387|27080423|P1|Crossover Participants|Progressive Disease|0
7792089|NCT00543387|27080413|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
7792090|NCT00543387|27080414|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
7792091|NCT00543387|27080415|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
7792092|NCT00543387|27080416|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
7792093|NCT00543387|27080417|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
7792094|NCT00543387|27080418|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
7792095|NCT00543387|27080419|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
7792096|NCT00543387|27080420|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
7792097|NCT00543387|27080421|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
7792098|NCT00543387|27080422|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
7792099|NCT00543387|27080423|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
7792100|NCT00543387|27080413|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
7792101|NCT00543387|27080414|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
7792102|NCT00543387|27080415|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
7792103|NCT00543387|27080416|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
7792104|NCT00543387|27080417|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
7792105|NCT00543387|27080418|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
7792106|NCT00543387|27080419|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
7792107|NCT00543387|27080420|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
7792108|NCT00543387|27080421|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
7792109|NCT00543387|27080422|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
7792110|NCT00543387|27080423|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
7792111|NCT00543387|27080413|P11|Panel 1 + Panel 2|Physician Decision|0
7792112|NCT00543387|27080414|P10|Panel 1 + Panel 2|Physician Decision|0
7792113|NCT00543387|27080415|P9|Panel 1 + Panel 2|Physician Decision|0
7792114|NCT00543387|27080416|P8|Panel 1 + Panel 2|Physician Decision|1
7792115|NCT00543387|27080417|P7|Panel 1 + Panel 2|Physician Decision|0
7792116|NCT00543387|27080418|P6|Panel 1 + Panel 2|Physician Decision|0
7792117|NCT00543387|27080419|P5|Panel 1 + Panel 2|Physician Decision|0
7792118|NCT00543387|27080420|P4|Panel 1 + Panel 2|Physician Decision|0
7792119|NCT00543387|27080421|P3|Panel 1 + Panel 2|Physician Decision|1
7792120|NCT00543387|27080422|P2|Panel 1 + Panel 2|Physician Decision|0
7792121|NCT00543387|27080423|P1|Panel 1 + Panel 2|Physician Decision|0
7792122|NCT00543387|27080413|P11|Panel 1 + Panel 2|Adverse Event|0
7792123|NCT00543387|27080414|P10|Panel 1 + Panel 2|Adverse Event|0
7792124|NCT00543387|27080415|P9|Panel 1 + Panel 2|Adverse Event|1
7792125|NCT00543387|27080416|P8|Panel 1 + Panel 2|Adverse Event|1
7792126|NCT00543387|27080417|P7|Panel 1 + Panel 2|Adverse Event|0
7792127|NCT00543387|27080418|P6|Panel 1 + Panel 2|Adverse Event|0
7792128|NCT00543387|27080419|P5|Panel 1 + Panel 2|Adverse Event|0
7792129|NCT00543387|27080420|P4|Panel 1 + Panel 2|Adverse Event|0
7792130|NCT00543387|27080421|P3|Panel 1 + Panel 2|Adverse Event|0
7792131|NCT00543387|27080422|P2|Panel 1 + Panel 2|Adverse Event|1
7792132|NCT00543387|27080423|P1|Panel 1 + Panel 2|Adverse Event|0
7792133|NCT00543309|27080461|P3|Overall Study|Physician Decision|0
7792134|NCT00543309|27080462|P2|Overall Study|Physician Decision|1
7792135|NCT00543309|27080463|P1|Overall Study|Physician Decision|0
7792136|NCT00543296|27080513|P1|Overall Study|Physician Decision|7
7792137|NCT00543140|27080520|P1|Overall Study|Conversion to different procedure|1
7792138|NCT00543140|27080520|P1|Overall Study|Subject moved|1
7792139|NCT00543140|27080520|P1|Overall Study|Death|1
7792140|NCT00543140|27080520|P1|Overall Study|SAE leading to explant of SAGB|3
7792141|NCT00543140|27080520|P1|Overall Study|Insufficient weight loss|10
7792142|NCT00543140|27080520|P1|Overall Study|Protocol Violation|10
7792143|NCT00543140|27080520|P1|Overall Study|Withdrawal by Subject|13
7792144|NCT00543140|27080520|P1|Overall Study|Lost to Follow-up|33
7792145|NCT00543062|27080558|P4|Overall Study|Protocol Violation|0
7792146|NCT00543062|27080559|P3|Overall Study|Protocol Violation|0
7792147|NCT00543062|27080560|P2|Overall Study|Protocol Violation|0
7792148|NCT00543062|27080561|P1|Overall Study|Protocol Violation|1
7792149|NCT00543062|27080558|P4|Overall Study|Adverse Event|1
7792150|NCT00543062|27080559|P3|Overall Study|Adverse Event|1
7792151|NCT00543062|27080560|P2|Overall Study|Adverse Event|1
7792152|NCT00543062|27080561|P1|Overall Study|Adverse Event|0
7792153|NCT00543062|27080558|P4|Overall Study|Withdrawal by Subject|0
7792154|NCT00543062|27080559|P3|Overall Study|Withdrawal by Subject|2
7792155|NCT00543062|27080560|P2|Overall Study|Withdrawal by Subject|0
7792156|NCT00543062|27080561|P1|Overall Study|Withdrawal by Subject|1
7792157|NCT00542997|27080583|P1|Efficacy Period|Adverse Event|3
7792158|NCT00542997|27080583|P1|Wash in / Wash Out Period|Adverse Event|3
7792159|NCT00542997|27080583|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
7792160|NCT00542919|27080606|P3|Overall Study|Lost to Follow-up|1
7792161|NCT00542919|27080607|P2|Overall Study|Lost to Follow-up|0
7792162|NCT00542919|27080608|P1|Overall Study|Lost to Follow-up|2
7792163|NCT00542919|27080606|P3|Overall Study|Sponsor Decision|0
7792164|NCT00542919|27080607|P2|Overall Study|Sponsor Decision|0
7792165|NCT00542919|27080608|P1|Overall Study|Sponsor Decision|1
7792166|NCT00542919|27080606|P3|Overall Study|Physician Decision|1
7792167|NCT00542919|27080607|P2|Overall Study|Physician Decision|2
7792168|NCT00542919|27080608|P1|Overall Study|Physician Decision|2
7792169|NCT00542919|27080606|P3|Overall Study|Withdrawal by Subject|3
7792170|NCT00542919|27080607|P2|Overall Study|Withdrawal by Subject|0
7792171|NCT00542919|27080608|P1|Overall Study|Withdrawal by Subject|1
7792172|NCT00542919|27080606|P3|Overall Study|Adverse Event|1
7792173|NCT00542919|27080607|P2|Overall Study|Adverse Event|5
7792174|NCT00542919|27080608|P1|Overall Study|Adverse Event|1
7792175|NCT00542880|27080653|P2|Period 3|Adverse Event|2
7792176|NCT00542880|27080654|P1|Period 3|Adverse Event|0
7792177|NCT00542880|27080653|P2|Period 2|Other|1
7792178|NCT00542880|27080654|P1|Period 2|Other|0
7792179|NCT00542880|27080653|P2|Period 2|Severe non-compliance|1
7792180|NCT00542880|27080654|P1|Period 2|Severe non-compliance|0
7792181|NCT00542880|27080653|P2|Period 2|Discontinuation criteria|0
7792182|NCT00542880|27080654|P1|Period 2|Discontinuation criteria|2
7792183|NCT00542880|27080653|P2|Period 2|Eligibility not fulfilled|1
7792184|NCT00542880|27080654|P1|Period 2|Eligibility not fulfilled|0
7792185|NCT00542880|27080653|P2|Period 2|Adverse Event|7
7792186|NCT00542880|27080654|P1|Period 2|Adverse Event|5
7792187|NCT00542880|27080653|P2|Period 1|Protocol Violation|1
7792188|NCT00542880|27080654|P1|Period 1|Protocol Violation|0
7792189|NCT00542880|27080653|P2|Period 1|Withdrawal by Subject|1
7792190|NCT00542880|27080654|P1|Period 1|Withdrawal by Subject|1
7792191|NCT00542880|27080653|P2|Period 1|Development of study-specific criteria|2
7792192|NCT00542880|27080654|P1|Period 1|Development of study-specific criteria|1
7792193|NCT00542880|27080653|P2|Period 1|Adverse Event|2
7792194|NCT00542880|27080654|P1|Period 1|Adverse Event|2
7792195|NCT00542880|27080653|P2|Period 1|Eligibility criteria not fulfilled|6
7792196|NCT00542880|27080654|P1|Period 1|Eligibility criteria not fulfilled|2
7792197|NCT00542828|27080690|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
7792198|NCT00542828|27080690|P1|Overall Study|Study Prematurely Discontinued|7
7792199|NCT00542828|27080690|P1|Overall Study|Need for Prohibited Treatment|3
7792200|NCT00542828|27080690|P1|Overall Study|Physician Decision|1
7792201|NCT00542815|27080708|P3|Overall Study|Other reasons|10
7792202|NCT00542815|27080709|P2|Overall Study|Other reasons|10
7792203|NCT00542815|27080710|P1|Overall Study|Other reasons|24
7792204|NCT00542815|27080708|P3|Overall Study|Withdrawal by Subject|8
7792205|NCT00542815|27080709|P2|Overall Study|Withdrawal by Subject|5
7792206|NCT00542815|27080710|P1|Overall Study|Withdrawal by Subject|41
7792207|NCT00542815|27080708|P3|Overall Study|Protocol Violation|2
7792208|NCT00542815|27080709|P2|Overall Study|Protocol Violation|1
7792209|NCT00542815|27080710|P1|Overall Study|Protocol Violation|1
7792210|NCT00542815|27080708|P3|Overall Study|Physician Decision|0
7792211|NCT00542815|27080709|P2|Overall Study|Physician Decision|1
7792212|NCT00542815|27080710|P1|Overall Study|Physician Decision|2
7792213|NCT00542815|27080708|P3|Overall Study|Lack of Efficacy|0
7792214|NCT00542815|27080709|P2|Overall Study|Lack of Efficacy|2
7792215|NCT00542815|27080710|P1|Overall Study|Lack of Efficacy|9
7792216|NCT00542815|27080708|P3|Overall Study|Death|3
7792217|NCT00542815|27080709|P2|Overall Study|Death|7
7792218|NCT00542815|27080710|P1|Overall Study|Death|10
7792219|NCT00542815|27080708|P3|Overall Study|Adverse Event|9
7792220|NCT00542815|27080709|P2|Overall Study|Adverse Event|6
7792221|NCT00542815|27080710|P1|Overall Study|Adverse Event|19
7792222|NCT00542789|27080723|P2|Overall Study|Recurrence of Gastric Ulcer|57
7792223|NCT00542789|27080724|P1|Overall Study|Recurrence of Gastric Ulcer|8
7792224|NCT00542789|27080723|P2|Overall Study|Protocol Violation|1
7792225|NCT00542789|27080724|P1|Overall Study|Protocol Violation|8
7792226|NCT00542789|27080723|P2|Overall Study|Withdrawal by Subject|3
7792227|NCT00542789|27080724|P1|Overall Study|Withdrawal by Subject|7
7792228|NCT00542789|27080723|P2|Overall Study|Adverse Event|17
7792229|NCT00542789|27080724|P1|Overall Study|Adverse Event|18
7792230|NCT00542425|27080824|P5|Extended 24 Weeks of Treatment|Other|1
7792231|NCT00542425|27080825|P4|Extended 24 Weeks of Treatment|Other|0
7792232|NCT00542425|27080826|P3|Extended 24 Weeks of Treatment|Other|0
7792233|NCT00542425|27080827|P2|Extended 24 Weeks of Treatment|Other|1
7792234|NCT00542425|27080828|P1|Extended 24 Weeks of Treatment|Other|1
7792235|NCT00542425|27080824|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
7792236|NCT00542425|27080825|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
7792237|NCT00542425|27080826|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
7792238|NCT00542425|27080827|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
7792239|NCT00542425|27080828|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
7792240|NCT00542425|27080824|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
7792241|NCT00542425|27080825|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
7792242|NCT00542425|27080826|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
7792243|NCT00542425|27080827|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
7792244|NCT00542425|27080828|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
7792245|NCT00542425|27080824|P5|Extended 24 Weeks of Treatment|Adverse Event|0
7792246|NCT00542425|27080825|P4|Extended 24 Weeks of Treatment|Adverse Event|1
7792247|NCT00542425|27080826|P3|Extended 24 Weeks of Treatment|Adverse Event|1
7792248|NCT00542425|27080827|P2|Extended 24 Weeks of Treatment|Adverse Event|0
7792249|NCT00542425|27080828|P1|Extended 24 Weeks of Treatment|Adverse Event|0
7792250|NCT00542425|27080824|P5|Initial 24 Weeks|Other|0
7792251|NCT00542425|27080825|P4|Initial 24 Weeks|Other|0
7792252|NCT00542425|27080826|P3|Initial 24 Weeks|Other|1
7792253|NCT00542425|27080827|P2|Initial 24 Weeks|Other|2
7792254|NCT00542425|27080828|P1|Initial 24 Weeks|Other|0
7792255|NCT00542425|27080824|P5|Initial 24 Weeks|Refusal of treatment|1
7792256|NCT00542425|27080825|P4|Initial 24 Weeks|Refusal of treatment|4
7792257|NCT00542425|27080826|P3|Initial 24 Weeks|Refusal of treatment|1
7792258|NCT00542425|27080827|P2|Initial 24 Weeks|Refusal of treatment|2
7792259|NCT00542425|27080828|P1|Initial 24 Weeks|Refusal of treatment|2
7792260|NCT00542425|27080824|P5|Initial 24 Weeks|Protocol Violation|0
7792261|NCT00542425|27080825|P4|Initial 24 Weeks|Protocol Violation|1
7792262|NCT00542425|27080826|P3|Initial 24 Weeks|Protocol Violation|0
7792263|NCT00542425|27080827|P2|Initial 24 Weeks|Protocol Violation|0
7792264|NCT00542425|27080828|P1|Initial 24 Weeks|Protocol Violation|0
7792265|NCT00542425|27080824|P5|Initial 24 Weeks|Non-compliance|1
7792266|NCT00542425|27080825|P4|Initial 24 Weeks|Non-compliance|1
7792267|NCT00542425|27080826|P3|Initial 24 Weeks|Non-compliance|0
7792268|NCT00542425|27080827|P2|Initial 24 Weeks|Non-compliance|0
7792269|NCT00542425|27080828|P1|Initial 24 Weeks|Non-compliance|0
7792270|NCT00542425|27080824|P5|Initial 24 Weeks|Lost to Follow-up|0
7792271|NCT00542425|27080825|P4|Initial 24 Weeks|Lost to Follow-up|0
7792272|NCT00542425|27080826|P3|Initial 24 Weeks|Lost to Follow-up|1
7792273|NCT00542425|27080827|P2|Initial 24 Weeks|Lost to Follow-up|2
7792274|NCT00542425|27080828|P1|Initial 24 Weeks|Lost to Follow-up|2
7792275|NCT00542425|27080824|P5|Initial 24 Weeks|Inability to complete procedures|2
7792276|NCT00542425|27080825|P4|Initial 24 Weeks|Inability to complete procedures|1
7792277|NCT00542425|27080826|P3|Initial 24 Weeks|Inability to complete procedures|2
7792278|NCT00542425|27080827|P2|Initial 24 Weeks|Inability to complete procedures|3
7792279|NCT00542425|27080828|P1|Initial 24 Weeks|Inability to complete procedures|0
7792280|NCT00542425|27080824|P5|Initial 24 Weeks|Adverse Event|2
7792281|NCT00542425|27080825|P4|Initial 24 Weeks|Adverse Event|3
7792282|NCT00542425|27080826|P3|Initial 24 Weeks|Adverse Event|1
7792283|NCT00542425|27080827|P2|Initial 24 Weeks|Adverse Event|1
7792284|NCT00542425|27080828|P1|Initial 24 Weeks|Adverse Event|0
7792285|NCT00542425|27080824|P5|Initial 24 Weeks|Administrative reasons|0
7792286|NCT00542425|27080825|P4|Initial 24 Weeks|Administrative reasons|1
7792287|NCT00542425|27080826|P3|Initial 24 Weeks|Administrative reasons|1
7792288|NCT00542425|27080827|P2|Initial 24 Weeks|Administrative reasons|0
7792289|NCT00542425|27080828|P1|Initial 24 Weeks|Administrative reasons|0
7792290|NCT00542386|27080866|P6|Overall Study|Other Reasons|2
7792291|NCT00542386|27080867|P5|Overall Study|Other Reasons|4
7792292|NCT00542386|27080868|P4|Overall Study|Other Reasons|3
7792293|NCT00542386|27080869|P3|Overall Study|Other Reasons|4
7792294|NCT00542386|27080870|P2|Overall Study|Other Reasons|1
7792295|NCT00542386|27080871|P1|Overall Study|Other Reasons|4
7792296|NCT00542386|27080866|P6|Overall Study|Withdrawal by Subject|7
7792297|NCT00542386|27080867|P5|Overall Study|Withdrawal by Subject|15
7792298|NCT00542386|27080868|P4|Overall Study|Withdrawal by Subject|11
7792299|NCT00542386|27080869|P3|Overall Study|Withdrawal by Subject|10
7792300|NCT00542386|27080870|P2|Overall Study|Withdrawal by Subject|8
7792301|NCT00542386|27080871|P1|Overall Study|Withdrawal by Subject|5
7792302|NCT00542386|27080866|P6|Overall Study|Protocol Violation|4
7792303|NCT00542386|27080867|P5|Overall Study|Protocol Violation|0
7792304|NCT00542386|27080868|P4|Overall Study|Protocol Violation|0
7792305|NCT00542386|27080869|P3|Overall Study|Protocol Violation|1
7792306|NCT00542386|27080870|P2|Overall Study|Protocol Violation|0
7792307|NCT00542386|27080871|P1|Overall Study|Protocol Violation|0
7792308|NCT00542386|27080866|P6|Overall Study|Physician Decision|0
7792309|NCT00542386|27080867|P5|Overall Study|Physician Decision|0
7792310|NCT00542386|27080868|P4|Overall Study|Physician Decision|1
7792311|NCT00542386|27080869|P3|Overall Study|Physician Decision|0
7792312|NCT00542386|27080870|P2|Overall Study|Physician Decision|0
7792313|NCT00542386|27080871|P1|Overall Study|Physician Decision|1
7792314|NCT00542386|27080866|P6|Overall Study|Lack of Efficacy|31
7792315|NCT00542386|27080867|P5|Overall Study|Lack of Efficacy|7
7792316|NCT00542386|27080868|P4|Overall Study|Lack of Efficacy|13
7792317|NCT00542386|27080869|P3|Overall Study|Lack of Efficacy|10
7792318|NCT00542386|27080870|P2|Overall Study|Lack of Efficacy|12
7792319|NCT00542386|27080871|P1|Overall Study|Lack of Efficacy|32
7792320|NCT00542386|27080866|P6|Overall Study|Death|2
7792321|NCT00542386|27080867|P5|Overall Study|Death|1
7792322|NCT00542386|27080868|P4|Overall Study|Death|2
7792323|NCT00542386|27080869|P3|Overall Study|Death|1
7792324|NCT00542386|27080870|P2|Overall Study|Death|0
7792325|NCT00542386|27080871|P1|Overall Study|Death|0
7792326|NCT00542386|27080866|P6|Overall Study|Adverse Event|4
7792327|NCT00542386|27080867|P5|Overall Study|Adverse Event|13
7792328|NCT00542386|27080868|P4|Overall Study|Adverse Event|8
7792329|NCT00542386|27080869|P3|Overall Study|Adverse Event|7
7792330|NCT00542386|27080870|P2|Overall Study|Adverse Event|7
7792331|NCT00542386|27080871|P1|Overall Study|Adverse Event|1
7792332|NCT00542321|27080893|P2|Overall Study|Death|1
7792333|NCT00542321|27080894|P1|Overall Study|Death|0
7792334|NCT00542269|27080916|P3|Overall Study|Administrative problems|1
7792335|NCT00542269|27080917|P2|Overall Study|Administrative problems|1
7792336|NCT00542269|27080918|P1|Overall Study|Administrative problems|1
7792337|NCT00542269|27080916|P3|Overall Study|Withdrawal by Subject|0
7792338|NCT00542269|27080917|P2|Overall Study|Withdrawal by Subject|0
7792339|NCT00542269|27080918|P1|Overall Study|Withdrawal by Subject|1
7792340|NCT00542269|27080916|P3|Overall Study|Protocol Violation|0
7792341|NCT00542269|27080917|P2|Overall Study|Protocol Violation|1
7792342|NCT00542269|27080918|P1|Overall Study|Protocol Violation|1
7792343|NCT00542269|27080916|P3|Overall Study|Adverse Event|5
7792344|NCT00542269|27080917|P2|Overall Study|Adverse Event|4
7792345|NCT00542269|27080918|P1|Overall Study|Adverse Event|10
7792346|NCT00542191|27080947|P1|Overall Study|Death|3
7792347|NCT00542178|27080957|P8|Overall Study|did not complete year 4 follow-up|85
7792348|NCT00542178|27080958|P7|Overall Study|did not complete year 4 follow-up|87
7792349|NCT00542178|27080959|P6|Overall Study|did not complete year 4 follow-up|89
7792350|NCT00542178|27080960|P5|Overall Study|did not complete year 4 follow-up|64
7792351|NCT00542178|27080961|P4|Overall Study|did not complete year 4 follow-up|62
7792352|NCT00542178|27080962|P3|Overall Study|did not complete year 4 follow-up|74
7792353|NCT00542178|27080963|P2|Overall Study|did not complete year 4 follow-up|80
7792354|NCT00542178|27080964|P1|Overall Study|did not complete year 4 follow-up|75
7792355|NCT00541970|27081000|P4|Month 60|Protocol Violation|72
7792356|NCT00541970|27081001|P3|Month 60|Protocol Violation|82
7792357|NCT00541970|27081002|P2|Month 60|Protocol Violation|77
7792358|NCT00541970|27081003|P1|Month 60|Protocol Violation|78
7792359|NCT00541970|27081000|P4|Month 48|Lost to Follow-up|73
7792360|NCT00541970|27081001|P3|Month 48|Lost to Follow-up|68
7792361|NCT00541970|27081002|P2|Month 48|Lost to Follow-up|68
7792362|NCT00541970|27081003|P1|Month 48|Lost to Follow-up|66
7792363|NCT00541970|27081000|P4|Month 48|Other|0
7792364|NCT00541970|27081001|P3|Month 48|Other|1
7792365|NCT00541970|27081002|P2|Month 48|Other|1
7792366|NCT00541970|27081003|P1|Month 48|Other|3
7792367|NCT00541970|27081000|P4|Month 48|Withdrawal by Subject|2
7792368|NCT00541970|27081001|P3|Month 48|Withdrawal by Subject|4
7792369|NCT00541970|27081002|P2|Month 48|Withdrawal by Subject|4
7792370|NCT00541970|27081003|P1|Month 48|Withdrawal by Subject|2
7792371|NCT00541970|27081000|P4|Month 36|Protocol Violation|60
7792372|NCT00541970|27081001|P3|Month 36|Protocol Violation|66
7792373|NCT00541970|27081002|P2|Month 36|Protocol Violation|66
7792374|NCT00541970|27081003|P1|Month 36|Protocol Violation|61
7792375|NCT00541970|27081000|P4|Month 24|Protocol Violation|21
7792376|NCT00541970|27081001|P3|Month 24|Protocol Violation|31
7792377|NCT00541970|27081002|P2|Month 24|Protocol Violation|31
7792378|NCT00541970|27081003|P1|Month 24|Protocol Violation|29
7792379|NCT00541970|27081000|P4|Month 24|Adverse Event|1
7792380|NCT00541970|27081001|P3|Month 24|Adverse Event|1
7792381|NCT00541970|27081002|P2|Month 24|Adverse Event|1
7792382|NCT00541970|27081003|P1|Month 24|Adverse Event|0
7792383|NCT00541970|27081000|P4|Month 18|Protocol Violation|16
7792384|NCT00541970|27081001|P3|Month 18|Protocol Violation|24
7792385|NCT00541970|27081002|P2|Month 18|Protocol Violation|23
7792386|NCT00541970|27081003|P1|Month 18|Protocol Violation|14
7792387|NCT00541970|27081000|P4|Month 18|Adverse Event|1
7792388|NCT00541970|27081001|P3|Month 18|Adverse Event|1
7792389|NCT00541970|27081002|P2|Month 18|Adverse Event|1
7792390|NCT00541970|27081003|P1|Month 18|Adverse Event|0
7792391|NCT00541970|27081000|P4|Month 12|Protocol Violation|15
7792392|NCT00541970|27081001|P3|Month 12|Protocol Violation|20
7792393|NCT00541970|27081002|P2|Month 12|Protocol Violation|21
7792394|NCT00541970|27081003|P1|Month 12|Protocol Violation|12
7792395|NCT00541970|27081000|P4|Month 12|Adverse Event|1
7792396|NCT00541970|27081001|P3|Month 12|Adverse Event|1
7792397|NCT00541970|27081002|P2|Month 12|Adverse Event|1
7792398|NCT00541970|27081003|P1|Month 12|Adverse Event|0
7792399|NCT00541970|27081000|P4|Month 7|Protocol Violation|5
7792400|NCT00541970|27081001|P3|Month 7|Protocol Violation|11
7792401|NCT00541970|27081002|P2|Month 7|Protocol Violation|13
7792402|NCT00541970|27081003|P1|Month 7|Protocol Violation|9
7792403|NCT00541931|27081154|P2|Overall Study|Transportation Issue|1
7792404|NCT00541931|27081155|P1|Overall Study|Transportation Issue|0
7792405|NCT00541931|27081154|P2|Overall Study|Withdrawal by Subject|0
7792406|NCT00541931|27081155|P1|Overall Study|Withdrawal by Subject|1
7792407|NCT00541931|27081154|P2|Overall Study|Lost to Follow-up|3
7792408|NCT00541931|27081155|P1|Overall Study|Lost to Follow-up|3
7792409|NCT00541931|27081154|P2|Overall Study|Adverse Event|0
7792410|NCT00541931|27081155|P1|Overall Study|Adverse Event|1
7792411|NCT00541866|27081168|P5|Overall Study|Physician Decision|0
7792412|NCT00541866|27081169|P4|Overall Study|Physician Decision|1
7792413|NCT00541866|27081170|P3|Overall Study|Physician Decision|2
7792414|NCT00541866|27081171|P2|Overall Study|Physician Decision|0
7792415|NCT00541866|27081172|P1|Overall Study|Physician Decision|0
7792416|NCT00541866|27081168|P5|Overall Study|Not Reported or Other|1
7792417|NCT00541866|27081169|P4|Overall Study|Not Reported or Other|3
7792418|NCT00541866|27081170|P3|Overall Study|Not Reported or Other|3
7792419|NCT00541866|27081171|P2|Overall Study|Not Reported or Other|3
7792420|NCT00541866|27081172|P1|Overall Study|Not Reported or Other|11
7792421|NCT00541866|27081168|P5|Overall Study|Lack of Efficacy|14
7792422|NCT00541866|27081169|P4|Overall Study|Lack of Efficacy|12
7792423|NCT00541866|27081170|P3|Overall Study|Lack of Efficacy|10
7792424|NCT00541866|27081171|P2|Overall Study|Lack of Efficacy|15
7792425|NCT00541866|27081172|P1|Overall Study|Lack of Efficacy|19
7792426|NCT00541866|27081168|P5|Overall Study|Death|0
7792427|NCT00541866|27081169|P4|Overall Study|Death|0
7792428|NCT00541866|27081170|P3|Overall Study|Death|0
7792429|NCT00541866|27081171|P2|Overall Study|Death|0
7792430|NCT00541866|27081172|P1|Overall Study|Death|1
7792431|NCT00541866|27081168|P5|Overall Study|Adverse Event|0
7792432|NCT00541866|27081169|P4|Overall Study|Adverse Event|0
7792433|NCT00541866|27081170|P3|Overall Study|Adverse Event|0
7792434|NCT00541866|27081171|P2|Overall Study|Adverse Event|0
7792435|NCT00541866|27081172|P1|Overall Study|Adverse Event|3
7792436|NCT00541775|27081213|P3|Overall Study|Withdrawal by Subject and Other|2
7792437|NCT00541775|27081214|P2|Overall Study|Withdrawal by Subject and Other|0
7792438|NCT00541775|27081215|P1|Overall Study|Withdrawal by Subject and Other|5
7792439|NCT00541775|27081213|P3|Overall Study|Protocol Violation|0
7792440|NCT00541775|27081214|P2|Overall Study|Protocol Violation|0
7792441|NCT00541775|27081215|P1|Overall Study|Protocol Violation|1
7792442|NCT00541775|27081213|P3|Overall Study|Lost to Follow-up|2
7792443|NCT00541775|27081214|P2|Overall Study|Lost to Follow-up|0
7792444|NCT00541775|27081215|P1|Overall Study|Lost to Follow-up|0
7792445|NCT00541775|27081213|P3|Overall Study|Lack of Efficacy|3
7792446|NCT00541775|27081214|P2|Overall Study|Lack of Efficacy|0
7792447|NCT00541775|27081215|P1|Overall Study|Lack of Efficacy|0
7792448|NCT00541775|27081213|P3|Overall Study|Adverse Event|1
7792449|NCT00541775|27081214|P2|Overall Study|Adverse Event|2
7792450|NCT00541775|27081215|P1|Overall Study|Adverse Event|3
7792451|NCT00541658|27081241|P3|Overall Study|Took No Study Drug|0
7792452|NCT00541658|27081242|P2|Overall Study|Took No Study Drug|0
7792453|NCT00541658|27081243|P1|Overall Study|Took No Study Drug|1
7792454|NCT00541658|27081241|P3|Overall Study|Withdrawal by Subject|32
7792455|NCT00541658|27081242|P2|Overall Study|Withdrawal by Subject|32
7792456|NCT00541658|27081243|P1|Overall Study|Withdrawal by Subject|28
7792457|NCT00541658|27081241|P3|Overall Study|Protocol Violation|1
7792458|NCT00541658|27081242|P2|Overall Study|Protocol Violation|1
7792459|NCT00541658|27081243|P1|Overall Study|Protocol Violation|0
7792460|NCT00541658|27081241|P3|Overall Study|Lost to Follow-up|6
7792461|NCT00541658|27081242|P2|Overall Study|Lost to Follow-up|3
7792462|NCT00541658|27081243|P1|Overall Study|Lost to Follow-up|3
7792463|NCT00541658|27081241|P3|Overall Study|Physician Decision|4
7792464|NCT00541658|27081242|P2|Overall Study|Physician Decision|0
7792465|NCT00541658|27081243|P1|Overall Study|Physician Decision|0
7792466|NCT00541658|27081241|P3|Overall Study|Adverse Event|25
7792467|NCT00541658|27081242|P2|Overall Study|Adverse Event|37
7792468|NCT00541658|27081243|P1|Overall Study|Adverse Event|28
7792469|NCT00541450|27081406|P2|Phase B|Withdrawal by Subject|6
7792470|NCT00541450|27081407|P1|Phase B|Withdrawal by Subject|8
7792471|NCT00541450|27081406|P2|Phase B|Protocol Violation|3
7792472|NCT00541450|27081407|P1|Phase B|Protocol Violation|3
7792473|NCT00541450|27081406|P2|Phase B|Pregnancy|1
7792474|NCT00541450|27081407|P1|Phase B|Pregnancy|0
7792475|NCT00541450|27081406|P2|Phase B|Physician Decision|2
7792476|NCT00541450|27081407|P1|Phase B|Physician Decision|4
7792477|NCT00541450|27081406|P2|Phase B|Lost to Follow-up|4
7792478|NCT00541450|27081407|P1|Phase B|Lost to Follow-up|6
7792479|NCT00541450|27081406|P2|Phase B|Hyperglycemia|9
7792480|NCT00541450|27081407|P1|Phase B|Hyperglycemia|10
7792481|NCT00541450|27081406|P2|Phase B|Adverse Event|6
7792482|NCT00541450|27081407|P1|Phase B|Adverse Event|6
7792483|NCT00541450|27081406|P2|Phase A|Withdrawal by Subject|7
7792484|NCT00541450|27081407|P1|Phase A|Withdrawal by Subject|7
7792485|NCT00541450|27081406|P2|Phase A|Protocol Violation|3
7792486|NCT00541450|27081407|P1|Phase A|Protocol Violation|2
7792487|NCT00541450|27081406|P2|Phase A|Physician Decision|0
7792488|NCT00541450|27081407|P1|Phase A|Physician Decision|2
7792489|NCT00541450|27081406|P2|Phase A|Lost to Follow-up|4
7792490|NCT00541450|27081407|P1|Phase A|Lost to Follow-up|6
7792491|NCT00541450|27081406|P2|Phase A|Hyperglycemia|1
7792492|NCT00541450|27081407|P1|Phase A|Hyperglycemia|0
7792493|NCT00541450|27081406|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
7792494|NCT00541450|27081407|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
7792495|NCT00541450|27081406|P2|Phase A|Adverse Event|0
7792496|NCT00541450|27081407|P1|Phase A|Adverse Event|3
7792497|NCT00541346|27081425|P1|Follow-up|Adverse Event|1
7792498|NCT00541307|27081439|P1|Overall Study|Surgical Bypass|5
7792499|NCT00541307|27081439|P1|Overall Study|Subject returned early (outside window)|1
7792500|NCT00541307|27081439|P1|Overall Study|Lost to Follow-up|4
7792501|NCT00541307|27081439|P1|Overall Study|Withdrawal by Subject|6
7792502|NCT00541307|27081439|P1|Overall Study|Physician Decision|3
7792503|NCT00541307|27081439|P1|Overall Study|Death|5
7792504|NCT00541229|27081464|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7792505|NCT00541229|27081465|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7792506|NCT00541229|27081466|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7792507|NCT00541229|27081467|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
7792508|NCT00541229|27081468|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7792509|NCT00541229|27081469|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7792510|NCT00541229|27081464|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
7792511|NCT00541229|27081465|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7792512|NCT00541229|27081466|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7792513|NCT00541229|27081467|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7792514|NCT00541229|27081468|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7792515|NCT00541229|27081469|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7792516|NCT00541229|27081464|P6|Treatment Period III (Week 11)|Adverse Event|0
7792517|NCT00541229|27081465|P5|Treatment Period III (Week 11)|Adverse Event|1
7792518|NCT00541229|27081466|P4|Treatment Period III (Week 11)|Adverse Event|0
7792519|NCT00541229|27081467|P3|Treatment Period III (Week 11)|Adverse Event|0
7792520|NCT00541229|27081468|P2|Treatment Period III (Week 11)|Adverse Event|0
7792521|NCT00541229|27081469|P1|Treatment Period III (Week 11)|Adverse Event|0
7792522|NCT00541229|27081464|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7792523|NCT00541229|27081465|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7792524|NCT00541229|27081466|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
7792525|NCT00541229|27081467|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
7792526|NCT00541229|27081468|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
7792527|NCT00541229|27081469|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7792528|NCT00541229|27081464|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7792529|NCT00541229|27081465|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
7792530|NCT00541229|27081466|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7792531|NCT00541229|27081467|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7792532|NCT00541229|27081468|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7792533|NCT00541229|27081469|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7792534|NCT00541229|27081464|P6|Washout Period II (Week 7-10)|Protocol Violation|0
7792535|NCT00541229|27081465|P5|Washout Period II (Week 7-10)|Protocol Violation|0
7792536|NCT00541229|27081466|P4|Washout Period II (Week 7-10)|Protocol Violation|0
7792537|NCT00541229|27081467|P3|Washout Period II (Week 7-10)|Protocol Violation|0
7792538|NCT00541229|27081468|P2|Washout Period II (Week 7-10)|Protocol Violation|0
7792539|NCT00541229|27081469|P1|Washout Period II (Week 7-10)|Protocol Violation|1
7792540|NCT00541229|27081464|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
7792541|NCT00541229|27081465|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7792542|NCT00541229|27081466|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7792543|NCT00541229|27081467|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7792544|NCT00541229|27081468|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7792545|NCT00541229|27081469|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
7792546|NCT00541229|27081464|P6|Treatment Period II (Week 6)|Protocol Violation|1
7792547|NCT00541229|27081465|P5|Treatment Period II (Week 6)|Protocol Violation|1
7792548|NCT00541229|27081466|P4|Treatment Period II (Week 6)|Protocol Violation|0
7792549|NCT00541229|27081467|P3|Treatment Period II (Week 6)|Protocol Violation|0
7792550|NCT00541229|27081468|P2|Treatment Period II (Week 6)|Protocol Violation|0
7792551|NCT00541229|27081469|P1|Treatment Period II (Week 6)|Protocol Violation|0
7792552|NCT00541229|27081464|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
7792553|NCT00541229|27081465|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
7792554|NCT00541229|27081466|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7792555|NCT00541229|27081467|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7792556|NCT00541229|27081468|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
7792557|NCT00541229|27081469|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7792558|NCT00541229|27081464|P6|Washout Period I (Week 2-5)|Protocol Violation|1
7792559|NCT00541229|27081465|P5|Washout Period I (Week 2-5)|Protocol Violation|0
7792560|NCT00541229|27081466|P4|Washout Period I (Week 2-5)|Protocol Violation|0
7792561|NCT00541229|27081467|P3|Washout Period I (Week 2-5)|Protocol Violation|0
7792562|NCT00541229|27081468|P2|Washout Period I (Week 2-5)|Protocol Violation|0
7792563|NCT00541229|27081469|P1|Washout Period I (Week 2-5)|Protocol Violation|0
7792564|NCT00541229|27081464|P6|Washout Period I (Week 2-5)|Physician Decision|0
7792565|NCT00541229|27081465|P5|Washout Period I (Week 2-5)|Physician Decision|0
7792566|NCT00541229|27081466|P4|Washout Period I (Week 2-5)|Physician Decision|1
7792567|NCT00541229|27081467|P3|Washout Period I (Week 2-5)|Physician Decision|0
7792568|NCT00541229|27081468|P2|Washout Period I (Week 2-5)|Physician Decision|0
7792569|NCT00541229|27081469|P1|Washout Period I (Week 2-5)|Physician Decision|0
7792570|NCT00541229|27081464|P6|Washout Period I (Week 2-5)|Adverse Event|0
7792571|NCT00541229|27081465|P5|Washout Period I (Week 2-5)|Adverse Event|0
7792572|NCT00541229|27081466|P4|Washout Period I (Week 2-5)|Adverse Event|0
7792573|NCT00541229|27081467|P3|Washout Period I (Week 2-5)|Adverse Event|1
7792574|NCT00541229|27081468|P2|Washout Period I (Week 2-5)|Adverse Event|0
7792575|NCT00541229|27081469|P1|Washout Period I (Week 2-5)|Adverse Event|1
7792576|NCT00541229|27081464|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7792577|NCT00541229|27081465|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7792578|NCT00541229|27081466|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
7792579|NCT00541229|27081467|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
7792580|NCT00541229|27081468|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
7792581|NCT00541229|27081469|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7792582|NCT00541229|27081464|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
7792583|NCT00541229|27081465|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7792584|NCT00541229|27081466|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7792585|NCT00541229|27081467|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7792586|NCT00541229|27081468|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7792587|NCT00541229|27081469|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7792588|NCT00541229|27081464|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
7792589|NCT00541229|27081465|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
7792590|NCT00541229|27081466|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
7792591|NCT00541229|27081467|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
7792592|NCT00541229|27081468|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
7792593|NCT00541229|27081469|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
7792594|NCT00541229|27081464|P6|Treatment Period I (Week 1)|Physician Decision|0
7792595|NCT00541229|27081465|P5|Treatment Period I (Week 1)|Physician Decision|0
7792596|NCT00541229|27081466|P4|Treatment Period I (Week 1)|Physician Decision|0
7792597|NCT00541229|27081467|P3|Treatment Period I (Week 1)|Physician Decision|1
7792598|NCT00541229|27081468|P2|Treatment Period I (Week 1)|Physician Decision|0
7792599|NCT00541229|27081469|P1|Treatment Period I (Week 1)|Physician Decision|0
7792600|NCT00541099|27081488|P1|Overall Study|Ineligible|3
7792601|NCT00541034|27081496|P1|Overall Study|Non-Compliance|3
7792602|NCT00540644|27081545|P2|Overall Study|Noncomplilance|0
7792603|NCT00540644|27081546|P1|Overall Study|Noncomplilance|1
7792604|NCT00540644|27081545|P2|Overall Study|Withdrawal by Subject|2
7792605|NCT00540644|27081546|P1|Overall Study|Withdrawal by Subject|2
7792606|NCT00540644|27081545|P2|Overall Study|Physician Decision|5
7792607|NCT00540644|27081546|P1|Overall Study|Physician Decision|0
7792608|NCT00540644|27081545|P2|Overall Study|Disease Progression|1
7792609|NCT00540644|27081546|P1|Overall Study|Disease Progression|3
7792610|NCT00540644|27081545|P2|Overall Study|Adverse Event|1
7792611|NCT00540644|27081546|P1|Overall Study|Adverse Event|3
7792612|NCT00540592|27081566|P10|Overall Study|Withdrawal by Subject|0
7792613|NCT00540592|27081567|P9|Overall Study|Withdrawal by Subject|0
7792614|NCT00540592|27081568|P8|Overall Study|Withdrawal by Subject|0
7792615|NCT00540592|27081569|P7|Overall Study|Withdrawal by Subject|0
7792616|NCT00540592|27081570|P6|Overall Study|Withdrawal by Subject|0
7792617|NCT00540592|27081571|P5|Overall Study|Withdrawal by Subject|0
7792618|NCT00540592|27081572|P4|Overall Study|Withdrawal by Subject|1
7792619|NCT00540592|27081573|P3|Overall Study|Withdrawal by Subject|1
7792620|NCT00540592|27081574|P2|Overall Study|Withdrawal by Subject|0
7792621|NCT00540592|27081575|P1|Overall Study|Withdrawal by Subject|0
7792622|NCT00540592|27081566|P10|Overall Study|Lost to Follow-up|0
7792623|NCT00540592|27081567|P9|Overall Study|Lost to Follow-up|0
7792624|NCT00540592|27081568|P8|Overall Study|Lost to Follow-up|0
7792625|NCT00540592|27081569|P7|Overall Study|Lost to Follow-up|0
7792626|NCT00540592|27081570|P6|Overall Study|Lost to Follow-up|0
7792627|NCT00540592|27081571|P5|Overall Study|Lost to Follow-up|0
7792628|NCT00540592|27081572|P4|Overall Study|Lost to Follow-up|0
7792629|NCT00540592|27081573|P3|Overall Study|Lost to Follow-up|0
7792630|NCT00540592|27081574|P2|Overall Study|Lost to Follow-up|0
7792631|NCT00540592|27081575|P1|Overall Study|Lost to Follow-up|2
7792632|NCT00540592|27081566|P10|Overall Study|Adverse Event|2
7792633|NCT00540592|27081567|P9|Overall Study|Adverse Event|1
7792634|NCT00540592|27081568|P8|Overall Study|Adverse Event|1
7792635|NCT00540592|27081569|P7|Overall Study|Adverse Event|0
7792636|NCT00540592|27081570|P6|Overall Study|Adverse Event|0
7792637|NCT00540592|27081571|P5|Overall Study|Adverse Event|1
7792638|NCT00540592|27081572|P4|Overall Study|Adverse Event|0
7792639|NCT00540592|27081573|P3|Overall Study|Adverse Event|0
7792640|NCT00540592|27081574|P2|Overall Study|Adverse Event|1
7792641|NCT00540592|27081575|P1|Overall Study|Adverse Event|0
7792642|NCT00540514|27081814|P2|Overall Study|Paclitaxel not available|2
7792643|NCT00540514|27081815|P1|Overall Study|Paclitaxel not available|0
7792644|NCT00540514|27081814|P2|Overall Study|Excluded prior to treatment|7
7792645|NCT00540514|27081815|P1|Overall Study|Excluded prior to treatment|7
7792646|NCT00540514|27081814|P2|Overall Study|Withdrawal by Subject|67
7792647|NCT00540514|27081815|P1|Overall Study|Withdrawal by Subject|65
7792648|NCT00540514|27081814|P2|Overall Study|Lost to Follow-up|1
7792649|NCT00540514|27081815|P1|Overall Study|Lost to Follow-up|1
7792650|NCT00540514|27081814|P2|Overall Study|Protocol Deviation|4
7792651|NCT00540514|27081815|P1|Overall Study|Protocol Deviation|3
7792652|NCT00540514|27081814|P2|Overall Study|Physician Decision|99
7792653|NCT00540514|27081815|P1|Overall Study|Physician Decision|86
7792654|NCT00540514|27081814|P2|Overall Study|Adverse Event|24
7792655|NCT00540514|27081815|P1|Overall Study|Adverse Event|20
7792656|NCT00540514|27081814|P2|Overall Study|Unacceptable Toxicity|62
7792657|NCT00540514|27081815|P1|Overall Study|Unacceptable Toxicity|61
7792658|NCT00540514|27081814|P2|Overall Study|Still on treatment|0
7792659|NCT00540514|27081815|P1|Overall Study|Still on treatment|3
7792660|NCT00540449|27081847|P2|Overall Study|Other|4
7792661|NCT00540449|27081848|P1|Overall Study|Other|1
7792662|NCT00540449|27081847|P2|Overall Study|Withdrawal by Subject|10
7792663|NCT00540449|27081848|P1|Overall Study|Withdrawal by Subject|10
7792664|NCT00540449|27081847|P2|Overall Study|Subject Reached A Virologic Endpoint|8
7792665|NCT00540449|27081848|P1|Overall Study|Subject Reached A Virologic Endpoint|32
7792666|NCT00540449|27081847|P2|Overall Study|Subject Non-Compliant|5
7792667|NCT00540449|27081848|P1|Overall Study|Subject Non-Compliant|7
7792668|NCT00540449|27081847|P2|Overall Study|Lost to Follow-up|17
7792669|NCT00540449|27081848|P1|Overall Study|Lost to Follow-up|19
7792670|NCT00540449|27081847|P2|Overall Study|Subject Ineligible To Continue The Trial|1
7792671|NCT00540449|27081848|P1|Overall Study|Subject Ineligible To Continue The Trial|2
7792672|NCT00540449|27081847|P2|Overall Study|Sponsor's Decision|1
7792673|NCT00540449|27081848|P1|Overall Study|Sponsor's Decision|1
7792674|NCT00540449|27081847|P2|Overall Study|Adverse Event|32
7792675|NCT00540449|27081848|P1|Overall Study|Adverse Event|12
7792676|NCT00540436|27081870|P1|Second 12-Week Treatment Period|Adverse Event|1
7792677|NCT00540436|27081870|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
7792678|NCT00540436|27081870|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
7792679|NCT00540436|27081870|P1|First 12-Week Treatment Period|Adverse Event|1
7792680|NCT00540423|27081885|P3|Open-Label Treatment Period|Lack of Efficacy|2
7792681|NCT00540423|27081886|P2|Open-Label Treatment Period|Lack of Efficacy|0
7792682|NCT00540423|27081887|P1|Open-Label Treatment Period|Lack of Efficacy|0
7792683|NCT00540423|27081885|P3|Double-Blind Treatment Period|Adverse Event|0
7792684|NCT00540423|27081886|P2|Double-Blind Treatment Period|Adverse Event|1
7792685|NCT00540423|27081887|P1|Double-Blind Treatment Period|Adverse Event|0
7792686|NCT00540293|27081937|P1|Overall Study|Protocol violation, & subject schedule|12
7792687|NCT00540293|27081937|P1|Overall Study|Withdrawal by Subject|6
7792688|NCT00540293|27081937|P1|Overall Study|Adverse event not related to study drug|7
7792689|NCT00540293|27081937|P1|Overall Study|Adverse event related to study drug|10
7792690|NCT00540228|27081985|P5|Overall Study|Lost to Follow-up|0
7792691|NCT00540228|27081986|P4|Overall Study|Lost to Follow-up|0
7792692|NCT00540228|27081987|P3|Overall Study|Lost to Follow-up|0
7792693|NCT00540228|27081988|P2|Overall Study|Lost to Follow-up|1
7792694|NCT00540228|27081989|P1|Overall Study|Lost to Follow-up|1
7792695|NCT00540228|27081985|P5|Overall Study|Adverse Event|0
7792696|NCT00540228|27081986|P4|Overall Study|Adverse Event|0
7792697|NCT00540228|27081987|P3|Overall Study|Adverse Event|0
7792698|NCT00540228|27081988|P2|Overall Study|Adverse Event|0
7792699|NCT00540228|27081989|P1|Overall Study|Adverse Event|2
7792700|NCT00540124|27082059|P3|Overall Study|Withdrawal by Subject|0
7792701|NCT00540124|27082060|P2|Overall Study|Withdrawal by Subject|1
7792702|NCT00540124|27082061|P1|Overall Study|Withdrawal by Subject|1
7792703|NCT00540124|27082059|P3|Overall Study|Lack of Efficacy|0
7792704|NCT00540124|27082060|P2|Overall Study|Lack of Efficacy|0
7792705|NCT00540124|27082061|P1|Overall Study|Lack of Efficacy|1
7792706|NCT00540124|27082059|P3|Overall Study|Entry Criteria Not Met|0
7792707|NCT00540124|27082060|P2|Overall Study|Entry Criteria Not Met|0
7792708|NCT00540124|27082061|P1|Overall Study|Entry Criteria Not Met|2
7792709|NCT00540124|27082059|P3|Overall Study|Adverse Event|1
7792710|NCT00540124|27082060|P2|Overall Study|Adverse Event|2
7792711|NCT00540124|27082061|P1|Overall Study|Adverse Event|0
7792712|NCT00540046|27082107|P2|Overall Study|Lost to Follow-up|23
7792713|NCT00540046|27082108|P1|Overall Study|Lost to Follow-up|33
7792714|NCT00539994|27082144|P3|Overall Study|Physician Decision|1
7792715|NCT00539994|27082145|P2|Overall Study|Physician Decision|0
7792716|NCT00539994|27082146|P1|Overall Study|Physician Decision|0
7792717|NCT00539994|27082144|P3|Overall Study|Withdrawal by Subject|1
7792718|NCT00539994|27082145|P2|Overall Study|Withdrawal by Subject|0
7792719|NCT00539994|27082146|P1|Overall Study|Withdrawal by Subject|1
7792720|NCT00539994|27082144|P3|Overall Study|Lost to Follow-up|0
7792721|NCT00539994|27082145|P2|Overall Study|Lost to Follow-up|1
7792722|NCT00539994|27082146|P1|Overall Study|Lost to Follow-up|2
7792723|NCT00539981|27082185|P2|Overall Study|Other reason-unspecified|13
7792724|NCT00539981|27082186|P1|Overall Study|Other reason-unspecified|9
7792725|NCT00539981|27082185|P2|Overall Study|Death|1
7792726|NCT00539981|27082186|P1|Overall Study|Death|1
7792727|NCT00539981|27082185|P2|Overall Study|Withdrew consent|14
7792728|NCT00539981|27082186|P1|Overall Study|Withdrew consent|22
7792729|NCT00539981|27082185|P2|Overall Study|Lost to Follow-up|251
7792730|NCT00539981|27082186|P1|Overall Study|Lost to Follow-up|260
7792731|NCT00539981|27082185|P2|Overall Study|Adverse events (AE)|3
7792732|NCT00539981|27082186|P1|Overall Study|Adverse events (AE)|3
7792733|NCT00539864|27082216|P2|Overall Study|Withdrawal by Subject|1
7792734|NCT00539864|27082217|P1|Overall Study|Withdrawal by Subject|1
7792735|NCT00539864|27082216|P2|Overall Study|Lost to Follow-up|1
7792736|NCT00539864|27082217|P1|Overall Study|Lost to Follow-up|0
7792737|NCT00539838|27082232|P3|Overall Study|Administrative|8
7792738|NCT00539838|27082233|P2|Overall Study|Administrative|0
7792739|NCT00539838|27082234|P1|Overall Study|Administrative|4
7792740|NCT00539838|27082232|P3|Overall Study|Did not cooperate|1
7792741|NCT00539838|27082233|P2|Overall Study|Did not cooperate|0
7792742|NCT00539838|27082234|P1|Overall Study|Did not cooperate|1
7792743|NCT00539838|27082232|P3|Overall Study|Death|0
7792744|NCT00539838|27082233|P2|Overall Study|Death|2
7792745|NCT00539838|27082234|P1|Overall Study|Death|0
7792746|NCT00539838|27082232|P3|Overall Study|Withdrawal by Subject|0
7792747|NCT00539838|27082233|P2|Overall Study|Withdrawal by Subject|4
7792748|NCT00539838|27082234|P1|Overall Study|Withdrawal by Subject|0
7792749|NCT00539838|27082232|P3|Overall Study|Fail to return|0
7792750|NCT00539838|27082233|P2|Overall Study|Fail to return|0
7792751|NCT00539838|27082234|P1|Overall Study|Fail to return|2
7792752|NCT00539734|27082284|P1|Overall Study|Protocol Violation|1
7792753|NCT00539591|27082310|P3|Overall Study|Disease progression|3
7792754|NCT00539591|27082311|P2|Overall Study|Disease progression|2
7792755|NCT00539591|27082312|P1|Overall Study|Disease progression|2
7792756|NCT00539591|27082310|P3|Overall Study|Toxicity|0
7792757|NCT00539591|27082311|P2|Overall Study|Toxicity|0
7792758|NCT00539591|27082312|P1|Overall Study|Toxicity|3
7792759|NCT00539513|27082464|P2|Overall Study|Lost to Follow-up|1
7792760|NCT00539513|27082465|P1|Overall Study|Lost to Follow-up|0
7792761|NCT00539513|27082464|P2|Overall Study|Withdrawal by Subject|1
7792762|NCT00539513|27082465|P1|Overall Study|Withdrawal by Subject|2
7792763|NCT00539500|27082477|P1|Overall Study|Lost to Follow-up|2
7792764|NCT00539500|27082477|P1|Overall Study|Disease Progression|1
7792765|NCT00539305|27082485|P2|Overall Study|Withdrawal by Subject|1
7792766|NCT00539305|27082486|P1|Overall Study|Withdrawal by Subject|0
7792767|NCT00539305|27082485|P2|Overall Study|Substance Use|1
7792768|NCT00539305|27082486|P1|Overall Study|Substance Use|0
7792769|NCT00539305|27082485|P2|Overall Study|Adverse Event|0
7792770|NCT00539305|27082486|P1|Overall Study|Adverse Event|1
7792771|NCT00539279|27082500|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
7792772|NCT00539279|27082501|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
7792773|NCT00539279|27082500|P2|Post-Treatment Assessment|Lost to Follow-up|9
7792774|NCT00539279|27082501|P1|Post-Treatment Assessment|Lost to Follow-up|12
7792775|NCT00539279|27082500|P2|Treatment|Death|0
7792776|NCT00539279|27082501|P1|Treatment|Death|1
7792777|NCT00539279|27082500|P2|Treatment|Withdrawal by Subject|8
7792778|NCT00539279|27082501|P1|Treatment|Withdrawal by Subject|10
7792779|NCT00539240|27082527|P3|Overall Study|Adverse Event|10
7792780|NCT00539240|27082528|P2|Overall Study|Adverse Event|1
7792781|NCT00539240|27082529|P1|Overall Study|Adverse Event|3
7792782|NCT00539240|27082527|P3|Overall Study|Lost to Follow-up|1
7792783|NCT00539240|27082528|P2|Overall Study|Lost to Follow-up|3
7792784|NCT00539240|27082529|P1|Overall Study|Lost to Follow-up|2
7792785|NCT00539240|27082527|P3|Overall Study|Protocol Violation|4
7792786|NCT00539240|27082528|P2|Overall Study|Protocol Violation|1
7792787|NCT00539240|27082529|P1|Overall Study|Protocol Violation|1
7792788|NCT00539240|27082527|P3|Overall Study|Withdrawal by Subject|0
7792789|NCT00539240|27082528|P2|Overall Study|Withdrawal by Subject|2
7792790|NCT00539240|27082529|P1|Overall Study|Withdrawal by Subject|0
7792791|NCT00539188|27082548|P2|Overall Study|Lost to Follow-up|1
7792792|NCT00539188|27082549|P1|Overall Study|Lost to Follow-up|2
7792793|NCT00539188|27082548|P2|Overall Study|Withdrawal by Subject|0
7792794|NCT00539188|27082549|P1|Overall Study|Withdrawal by Subject|1
7792795|NCT00539032|27082572|P2|Overall Study|Withdrawal by Subject|1
7792796|NCT00539032|27082573|P1|Overall Study|Withdrawal by Subject|2
7792797|NCT00539006|27082587|P4|Treatment Period 2|Other|0
7792798|NCT00539006|27082588|P3|Treatment Period 2|Other|0
7792799|NCT00539006|27082589|P2|Treatment Period 2|Other|1
7792800|NCT00539006|27082590|P1|Treatment Period 2|Other|0
7792801|NCT00539006|27082587|P4|Treatment Period 2|Protocol Violation|0
7792802|NCT00539006|27082588|P3|Treatment Period 2|Protocol Violation|0
7792803|NCT00539006|27082589|P2|Treatment Period 2|Protocol Violation|0
7792804|NCT00539006|27082590|P1|Treatment Period 2|Protocol Violation|1
7792805|NCT00539006|27082587|P4|Washout|Other|3
7792806|NCT00539006|27082588|P3|Washout|Other|2
7792807|NCT00539006|27082589|P2|Washout|Other|1
7792808|NCT00539006|27082590|P1|Washout|Other|1
7792809|NCT00539006|27082587|P4|Washout|Failed to meet continuation criteria|6
7792810|NCT00539006|27082588|P3|Washout|Failed to meet continuation criteria|14
7792811|NCT00539006|27082589|P2|Washout|Failed to meet continuation criteria|5
7792812|NCT00539006|27082590|P1|Washout|Failed to meet continuation criteria|16
7792813|NCT00539006|27082587|P4|Washout|Withdrawal by Subject|0
7792814|NCT00539006|27082588|P3|Washout|Withdrawal by Subject|0
7792815|NCT00539006|27082589|P2|Washout|Withdrawal by Subject|2
7792816|NCT00539006|27082590|P1|Washout|Withdrawal by Subject|0
7792817|NCT00539006|27082587|P4|Washout|Protocol Violation|0
7792818|NCT00539006|27082588|P3|Washout|Protocol Violation|0
7792819|NCT00539006|27082589|P2|Washout|Protocol Violation|1
7792820|NCT00539006|27082590|P1|Washout|Protocol Violation|1
7792821|NCT00539006|27082587|P4|Washout|Adverse Event|0
7792822|NCT00539006|27082588|P3|Washout|Adverse Event|0
7792823|NCT00539006|27082589|P2|Washout|Adverse Event|1
7792824|NCT00539006|27082590|P1|Washout|Adverse Event|2
7792825|NCT00539006|27082587|P4|Treatment Period 1|Lack of Efficacy|1
7792826|NCT00539006|27082588|P3|Treatment Period 1|Lack of Efficacy|0
7792827|NCT00539006|27082589|P2|Treatment Period 1|Lack of Efficacy|0
7792828|NCT00539006|27082590|P1|Treatment Period 1|Lack of Efficacy|0
7792829|NCT00539006|27082587|P4|Treatment Period 1|Protocol Violation|0
7792830|NCT00539006|27082588|P3|Treatment Period 1|Protocol Violation|1
7792831|NCT00539006|27082589|P2|Treatment Period 1|Protocol Violation|0
7792832|NCT00539006|27082590|P1|Treatment Period 1|Protocol Violation|0
7792833|NCT00539006|27082587|P4|Treatment Period 1|Lost to Follow-up|0
7792834|NCT00539006|27082588|P3|Treatment Period 1|Lost to Follow-up|1
7792835|NCT00539006|27082589|P2|Treatment Period 1|Lost to Follow-up|0
7792836|NCT00539006|27082590|P1|Treatment Period 1|Lost to Follow-up|0
7792837|NCT00539006|27082587|P4|Pre-treatment|Other|0
7792838|NCT00539006|27082588|P3|Pre-treatment|Other|0
7792839|NCT00539006|27082589|P2|Pre-treatment|Other|1
7792840|NCT00539006|27082590|P1|Pre-treatment|Other|0
7792841|NCT00538902|27082635|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
7792842|NCT00538902|27082636|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
7792843|NCT00538902|27082637|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
7792844|NCT00538902|27082635|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
7792845|NCT00538902|27082636|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
7792846|NCT00538902|27082637|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
7792847|NCT00538902|27082635|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
7792848|NCT00538902|27082636|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
7792849|NCT00538902|27082637|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
7792850|NCT00538902|27082635|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
7792851|NCT00538902|27082636|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
7792852|NCT00538902|27082637|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
7792853|NCT00538902|27082635|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7792854|NCT00538902|27082636|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7792855|NCT00538902|27082637|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7792856|NCT00538902|27082635|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
7792857|NCT00538902|27082636|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
7792858|NCT00538902|27082637|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
7792859|NCT00538902|27082635|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
7792860|NCT00538902|27082636|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
7792861|NCT00538902|27082637|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
7792862|NCT00538902|27082635|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
7792863|NCT00538902|27082636|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
7792864|NCT00538902|27082637|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
7792865|NCT00538785|27082698|P2|Overall Study|Lost to Follow-up|0
7792866|NCT00538785|27082699|P1|Overall Study|Lost to Follow-up|1
7792867|NCT00538785|27082698|P2|Overall Study|Withdrawal of consent|7
7792868|NCT00538785|27082699|P1|Overall Study|Withdrawal of consent|9
7792869|NCT00538785|27082698|P2|Overall Study|Death|10
7792870|NCT00538785|27082699|P1|Overall Study|Death|9
7792871|NCT00538733|27082741|P1|Overall Study|still on therapy|1
7792872|NCT00538733|27082741|P1|Overall Study|declined to participate|2
7792873|NCT00538733|27082741|P1|Overall Study|Death|1
7792874|NCT00538733|27082741|P1|Overall Study|Adverse Event|8
7792875|NCT00538681|27082753|P4|Overall Study|Investigator Decision|1
7792876|NCT00538681|27082754|P3|Overall Study|Investigator Decision|0
7792877|NCT00538681|27082755|P2|Overall Study|Investigator Decision|0
7792878|NCT00538681|27082756|P1|Overall Study|Investigator Decision|0
7792879|NCT00538681|27082753|P4|Overall Study|Death|1
7792880|NCT00538681|27082754|P3|Overall Study|Death|1
7792881|NCT00538681|27082755|P2|Overall Study|Death|0
7792882|NCT00538681|27082756|P1|Overall Study|Death|0
7792883|NCT00538681|27082753|P4|Overall Study|Adverse Event|0
7792884|NCT00538681|27082754|P3|Overall Study|Adverse Event|1
7792885|NCT00538681|27082755|P2|Overall Study|Adverse Event|1
7792886|NCT00538681|27082756|P1|Overall Study|Adverse Event|1
7792887|NCT00538681|27082753|P4|Overall Study|Sponsor Decision|9
7792888|NCT00538681|27082754|P3|Overall Study|Sponsor Decision|8
7792889|NCT00538681|27082755|P2|Overall Study|Sponsor Decision|3
7792890|NCT00538681|27082756|P1|Overall Study|Sponsor Decision|1
7792891|NCT00538681|27082753|P4|Overall Study|Progressive Disease|0
7792892|NCT00538681|27082754|P3|Overall Study|Progressive Disease|1
7792893|NCT00538681|27082755|P2|Overall Study|Progressive Disease|0
7792894|NCT00538681|27082756|P1|Overall Study|Progressive Disease|7
7792895|NCT00538629|27082822|P1|Overall Study|Subject's untimely distrust of medicine|1
7792896|NCT00538629|27082822|P1|Overall Study|Lost to Follow-up|6
7792897|NCT00538629|27082822|P1|Overall Study|Lack of Efficacy|12
7792898|NCT00538629|27082822|P1|Overall Study|Adverse Event|2
7792899|NCT00538629|27082822|P1|Overall Study|At subject's request|1
7792900|NCT00538590|27082878|P2|Overall Study|Death|0
7792901|NCT00538590|27082879|P1|Overall Study|Death|1
7792902|NCT00538473|27082917|P2|Overall Study|Adverse Event|0
7792903|NCT00538473|27082918|P1|Overall Study|Adverse Event|1
7792904|NCT00538291|27082998|P1|Overall Study|Withdrawal by Subject|1
7792905|NCT00538291|27082998|P1|Overall Study|Adverse Event|2
7792906|NCT00537979|27083056|P2|Overall Study|Heart failure|1
7792907|NCT00537979|27083057|P1|Overall Study|Heart failure|0
7792908|NCT00537979|27083056|P2|Overall Study|Kidney transplant|3
7792909|NCT00537979|27083057|P1|Overall Study|Kidney transplant|0
7792910|NCT00537979|27083056|P2|Overall Study|Death|3
7792911|NCT00537979|27083057|P1|Overall Study|Death|0
7792912|NCT00537979|27083056|P2|Overall Study|Non-compliance with treatment/procedure|2
7792913|NCT00537979|27083057|P1|Overall Study|Non-compliance with treatment/procedure|2
7792914|NCT00537979|27083056|P2|Overall Study|Lack of Efficacy|1
7792915|NCT00537979|27083057|P1|Overall Study|Lack of Efficacy|0
7792916|NCT00537979|27083056|P2|Overall Study|Lost to Follow-up|4
7792917|NCT00537979|27083057|P1|Overall Study|Lost to Follow-up|1
7792918|NCT00537979|27083056|P2|Overall Study|Withdrawal by Subject|4
7792919|NCT00537979|27083057|P1|Overall Study|Withdrawal by Subject|1
7792920|NCT00537979|27083056|P2|Overall Study|Adverse Event|2
7792921|NCT00537979|27083057|P1|Overall Study|Adverse Event|2
7792922|NCT00537940|27083073|P2|Overall Study|Other|12
7792923|NCT00537940|27083074|P1|Overall Study|Other|10
7792924|NCT00537940|27083073|P2|Overall Study|Study terminated by sponsor|3
7792925|NCT00537940|27083074|P1|Overall Study|Study terminated by sponsor|2
7792926|NCT00537940|27083073|P2|Overall Study|Pregnancy|1
7792927|NCT00537940|27083074|P1|Overall Study|Pregnancy|1
7792928|NCT00537940|27083073|P2|Overall Study|Protocol Violation|4
7792929|NCT00537940|27083074|P1|Overall Study|Protocol Violation|6
7792930|NCT00537940|27083073|P2|Overall Study|Withdrawal by Subject|95
7792931|NCT00537940|27083074|P1|Overall Study|Withdrawal by Subject|113
7792932|NCT00537940|27083073|P2|Overall Study|Lost to Follow-up|29
7792933|NCT00537940|27083074|P1|Overall Study|Lost to Follow-up|23
7792934|NCT00537940|27083073|P2|Overall Study|Lack of Efficacy|16
7792935|NCT00537940|27083074|P1|Overall Study|Lack of Efficacy|8
7792936|NCT00537940|27083073|P2|Overall Study|Adverse Event|19
7792937|NCT00537940|27083074|P1|Overall Study|Adverse Event|20
7792938|NCT00537823|27083098|P2|Overall Study|Adverse Event|0
7792939|NCT00537823|27083099|P1|Overall Study|Adverse Event|2
7792940|NCT00537810|27083125|P4|Overall Study|Medically withdrawn|1
7792941|NCT00537810|27083126|P3|Overall Study|Medically withdrawn|0
7792942|NCT00537810|27083127|P2|Overall Study|Medically withdrawn|2
7792943|NCT00537810|27083128|P1|Overall Study|Medically withdrawn|2
7792944|NCT00537810|27083125|P4|Overall Study|Withdrawal by Subject|3
7792945|NCT00537810|27083126|P3|Overall Study|Withdrawal by Subject|4
7792946|NCT00537810|27083127|P2|Overall Study|Withdrawal by Subject|11
7792947|NCT00537810|27083128|P1|Overall Study|Withdrawal by Subject|4
7792948|NCT00537771|27083144|P2|Overall Study|Severe Non-Compliance to Protocol|2
7792949|NCT00537771|27083145|P1|Overall Study|Severe Non-Compliance to Protocol|4
7792950|NCT00537771|27083144|P2|Overall Study|Protocol Violation|6
7792951|NCT00537771|27083145|P1|Overall Study|Protocol Violation|2
7792952|NCT00537771|27083144|P2|Overall Study|Lost to Follow-up|15
7792953|NCT00537771|27083145|P1|Overall Study|Lost to Follow-up|9
7792954|NCT00537771|27083144|P2|Overall Study|Adverse Event|15
7792955|NCT00537771|27083145|P1|Overall Study|Adverse Event|8
7792956|NCT00537771|27083144|P2|Overall Study|Withdrawal by Subject|23
7792957|NCT00537771|27083145|P1|Overall Study|Withdrawal by Subject|6
7792958|NCT00537745|27083155|P1|Overall Study|Subject unable to provide Interlock info|1
7792959|NCT00537745|27083155|P1|Overall Study|Withdrawal by Subject|2
7792960|NCT00537745|27083155|P1|Overall Study|Did not meet eligibility criteria|2
7792961|NCT00537485|27083237|P2|Overall Study|Physician Decision|0
7792962|NCT00537485|27083238|P1|Overall Study|Physician Decision|1
7792963|NCT00537485|27083237|P2|Overall Study|Withdrawal by Subject|3
7792964|NCT00537485|27083238|P1|Overall Study|Withdrawal by Subject|1
7792965|NCT00537485|27083237|P2|Overall Study|Withdrawal by Subject|2
7792966|NCT00537485|27083238|P1|Overall Study|Withdrawal by Subject|3
7792967|NCT00537485|27083237|P2|Overall Study|Adverse Event|5
7792968|NCT00537485|27083238|P1|Overall Study|Adverse Event|10
7792969|NCT00537394|27083321|P3|2nd Year of Follow-up|Clinic site closure|0
7792970|NCT00537394|27083322|P2|2nd Year of Follow-up|Clinic site closure|0
7792971|NCT00537394|27083323|P1|2nd Year of Follow-up|Clinic site closure|1
7792972|NCT00537394|27083321|P3|2nd Year of Follow-up|Lost to Follow-up|2
7792973|NCT00537394|27083322|P2|2nd Year of Follow-up|Lost to Follow-up|7
7792974|NCT00537394|27083323|P1|2nd Year of Follow-up|Lost to Follow-up|6
7792975|NCT00537394|27083321|P3|2nd Year of Follow-up|Withdrawal by Subject|2
7792976|NCT00537394|27083322|P2|2nd Year of Follow-up|Withdrawal by Subject|1
7792977|NCT00537394|27083323|P1|2nd Year of Follow-up|Withdrawal by Subject|0
7792978|NCT00537394|27083321|P3|2nd Year of Follow-up|Death|2
7792979|NCT00537394|27083322|P2|2nd Year of Follow-up|Death|1
7792980|NCT00537394|27083323|P1|2nd Year of Follow-up|Death|4
7792981|NCT00537394|27083321|P3|First Year of Follow-up|Lost to Follow-up|1
7792982|NCT00537394|27083322|P2|First Year of Follow-up|Lost to Follow-up|5
7792983|NCT00537394|27083323|P1|First Year of Follow-up|Lost to Follow-up|1
7792984|NCT00537394|27083321|P3|First Year of Follow-up|Withdrawal by Subject|1
7792985|NCT00537394|27083322|P2|First Year of Follow-up|Withdrawal by Subject|6
7792986|NCT00537394|27083323|P1|First Year of Follow-up|Withdrawal by Subject|3
7792987|NCT00537394|27083321|P3|First Year of Follow-up|Severe debilitation|1
7792988|NCT00537394|27083322|P2|First Year of Follow-up|Severe debilitation|0
7792989|NCT00537394|27083323|P1|First Year of Follow-up|Severe debilitation|1
7792990|NCT00537394|27083321|P3|First Year of Follow-up|Death|0
7792991|NCT00537394|27083322|P2|First Year of Follow-up|Death|0
7792992|NCT00537394|27083323|P1|First Year of Follow-up|Death|7
7792993|NCT00537381|27083359|P2|Overall Study|Other|3
7792994|NCT00537381|27083360|P1|Overall Study|Other|5
7792995|NCT00537381|27083359|P2|Overall Study|Sponsor decision|9
7792996|NCT00537381|27083360|P1|Overall Study|Sponsor decision|14
7792997|NCT00537381|27083359|P2|Overall Study|Disease Progression|18
7792998|NCT00537381|27083360|P1|Overall Study|Disease Progression|9
7792999|NCT00537381|27083359|P2|Overall Study|Physician Decision|6
7793000|NCT00537381|27083360|P1|Overall Study|Physician Decision|7
7793001|NCT00537381|27083359|P2|Overall Study|Withdrawal by Subject|14
7793002|NCT00537381|27083360|P1|Overall Study|Withdrawal by Subject|5
7793003|NCT00537381|27083359|P2|Overall Study|Death|3
7793004|NCT00537381|27083360|P1|Overall Study|Death|3
7793005|NCT00537381|27083359|P2|Overall Study|Adverse Event|9
7793006|NCT00537381|27083360|P1|Overall Study|Adverse Event|13
7793007|NCT00537329|27083380|P1|Overall Study|Other|1
7793008|NCT00537329|27083380|P1|Overall Study|Withdrawal by Subject|4
7793009|NCT00537329|27083380|P1|Overall Study|Lost to Follow-up|6
7793010|NCT00537329|27083380|P1|Overall Study|Lack of Efficacy|2
7793011|NCT00537329|27083380|P1|Overall Study|Adverse Event|3
7793012|NCT00537329|27083380|P1|Overall Study|Death|10
7793013|NCT00537316|27083400|P7|Part 2|Administrative|1
7793014|NCT00537316|27083401|P6|Part 2|Administrative|4
7793015|NCT00537316|27083402|P5|Part 2|Administrative|1
7793016|NCT00537316|27083403|P4|Part 2|Administrative|3
7793017|NCT00537316|27083404|P3|Part 2|Administrative|24
7793018|NCT00537316|27083405|P2|Part 2|Administrative|8
7793019|NCT00537316|27083406|P1|Part 2|Administrative|16
7793020|NCT00537316|27083400|P7|Part 2|Withdrawal by Subject|0
7793021|NCT00537316|27083401|P6|Part 2|Withdrawal by Subject|0
7793022|NCT00537316|27083402|P5|Part 2|Withdrawal by Subject|0
7793023|NCT00537316|27083403|P4|Part 2|Withdrawal by Subject|0
7793024|NCT00537316|27083404|P3|Part 2|Withdrawal by Subject|4
7793025|NCT00537316|27083405|P2|Part 2|Withdrawal by Subject|1
7793026|NCT00537316|27083406|P1|Part 2|Withdrawal by Subject|5
7793027|NCT00537316|27083400|P7|Part 2|Lost to Follow-up|0
7793028|NCT00537316|27083401|P6|Part 2|Lost to Follow-up|0
7793029|NCT00537316|27083402|P5|Part 2|Lost to Follow-up|0
7793030|NCT00537316|27083403|P4|Part 2|Lost to Follow-up|0
7793031|NCT00537316|27083404|P3|Part 2|Lost to Follow-up|2
7793032|NCT00537316|27083405|P2|Part 2|Lost to Follow-up|0
7793033|NCT00537316|27083406|P1|Part 2|Lost to Follow-up|1
7793034|NCT00537316|27083400|P7|Part 2|Adverse Event|0
7793035|NCT00537316|27083401|P6|Part 2|Adverse Event|0
7793036|NCT00537316|27083402|P5|Part 2|Adverse Event|0
7793037|NCT00537316|27083403|P4|Part 2|Adverse Event|0
7793038|NCT00537316|27083404|P3|Part 2|Adverse Event|2
7793039|NCT00537316|27083405|P2|Part 2|Adverse Event|0
7793040|NCT00537316|27083406|P1|Part 2|Adverse Event|4
7793041|NCT00537316|27083400|P7|Part 2|Never entered follow-up|1
7793042|NCT00537316|27083401|P6|Part 2|Never entered follow-up|0
7793043|NCT00537316|27083402|P5|Part 2|Never entered follow-up|0
7793044|NCT00537316|27083403|P4|Part 2|Never entered follow-up|0
7793045|NCT00537316|27083404|P3|Part 2|Never entered follow-up|0
7793046|NCT00537316|27083405|P2|Part 2|Never entered follow-up|0
7793047|NCT00537316|27083406|P1|Part 2|Never entered follow-up|0
7793048|NCT00537316|27083400|P7|Part 1|Administrative|0
7793049|NCT00537316|27083401|P6|Part 1|Administrative|0
7793050|NCT00537316|27083402|P5|Part 1|Administrative|0
7793051|NCT00537316|27083403|P4|Part 1|Administrative|0
7793052|NCT00537316|27083404|P3|Part 1|Administrative|2
7793053|NCT00537316|27083405|P2|Part 1|Administrative|0
7793054|NCT00537316|27083406|P1|Part 1|Administrative|0
7793055|NCT00537316|27083400|P7|Part 1|Did not meet protocol eligibility|0
7793056|NCT00537316|27083401|P6|Part 1|Did not meet protocol eligibility|0
7793057|NCT00537316|27083402|P5|Part 1|Did not meet protocol eligibility|0
7793058|NCT00537316|27083403|P4|Part 1|Did not meet protocol eligibility|0
7793059|NCT00537316|27083404|P3|Part 1|Did not meet protocol eligibility|2
7793060|NCT00537316|27083405|P2|Part 1|Did not meet protocol eligibility|3
7793061|NCT00537316|27083406|P1|Part 1|Did not meet protocol eligibility|1
7793062|NCT00537316|27083400|P7|Part 1|Protocol Violation|0
7793063|NCT00537316|27083401|P6|Part 1|Protocol Violation|0
7793064|NCT00537316|27083402|P5|Part 1|Protocol Violation|0
7793065|NCT00537316|27083403|P4|Part 1|Protocol Violation|0
7793066|NCT00537316|27083404|P3|Part 1|Protocol Violation|1
7793067|NCT00537316|27083405|P2|Part 1|Protocol Violation|5
7793068|NCT00537316|27083406|P1|Part 1|Protocol Violation|1
7793069|NCT00537316|27083400|P7|Part 1|Withdrawal by Subject|0
7793070|NCT00537316|27083401|P6|Part 1|Withdrawal by Subject|0
7793071|NCT00537316|27083402|P5|Part 1|Withdrawal by Subject|0
7793072|NCT00537316|27083403|P4|Part 1|Withdrawal by Subject|0
7793073|NCT00537316|27083404|P3|Part 1|Withdrawal by Subject|4
7793074|NCT00537316|27083405|P2|Part 1|Withdrawal by Subject|8
7793075|NCT00537316|27083406|P1|Part 1|Withdrawal by Subject|3
7793076|NCT00537316|27083400|P7|Part 1|Lost to Follow-up|0
7793077|NCT00537316|27083401|P6|Part 1|Lost to Follow-up|0
7793078|NCT00537316|27083402|P5|Part 1|Lost to Follow-up|0
7793079|NCT00537316|27083403|P4|Part 1|Lost to Follow-up|0
7793080|NCT00537316|27083404|P3|Part 1|Lost to Follow-up|0
7793081|NCT00537316|27083405|P2|Part 1|Lost to Follow-up|0
7793082|NCT00537316|27083406|P1|Part 1|Lost to Follow-up|1
7793083|NCT00537316|27083400|P7|Part 1|Protocol defined clinical event|0
7793084|NCT00537316|27083401|P6|Part 1|Protocol defined clinical event|0
7793085|NCT00537316|27083402|P5|Part 1|Protocol defined clinical event|0
7793086|NCT00537316|27083403|P4|Part 1|Protocol defined clinical event|0
7793087|NCT00537316|27083404|P3|Part 1|Protocol defined clinical event|0
7793088|NCT00537316|27083405|P2|Part 1|Protocol defined clinical event|0
7793089|NCT00537316|27083406|P1|Part 1|Protocol defined clinical event|1
7793090|NCT00537316|27083400|P7|Part 1|Adverse Event|0
7793091|NCT00537316|27083401|P6|Part 1|Adverse Event|0
7793092|NCT00537316|27083402|P5|Part 1|Adverse Event|0
7793093|NCT00537316|27083403|P4|Part 1|Adverse Event|0
7793094|NCT00537316|27083404|P3|Part 1|Adverse Event|8
7793095|NCT00537316|27083405|P2|Part 1|Adverse Event|11
7793096|NCT00537316|27083406|P1|Part 1|Adverse Event|7
7793097|NCT00537303|27083433|P2|Overall Study|Unclassified|7
7793098|NCT00537303|27083434|P1|Overall Study|Unclassified|8
7793099|NCT00537303|27083433|P2|Overall Study|Withdrawal criteria|3
7793100|NCT00537303|27083434|P1|Overall Study|Withdrawal criteria|3
7793101|NCT00537303|27083433|P2|Overall Study|Protocol Violation|4
7793102|NCT00537303|27083434|P1|Overall Study|Protocol Violation|8
7793103|NCT00537303|27083433|P2|Overall Study|Lack of Efficacy|7
7793104|NCT00537303|27083434|P1|Overall Study|Lack of Efficacy|6
7793105|NCT00537303|27083433|P2|Overall Study|Adverse Event|4
7793106|NCT00537303|27083434|P1|Overall Study|Adverse Event|1
7793107|NCT00537277|27083455|P1|Overall Study|Non-compliance with trial procedures|15
7793108|NCT00537277|27083455|P1|Overall Study|Inability to tolerate trial medication|4
7793109|NCT00537277|27083455|P1|Overall Study|Unclassified|4
7793110|NCT00537277|27083455|P1|Overall Study|Protocol Violation|11
7793111|NCT00537277|27083455|P1|Overall Study|Lost to Follow-up|12
7793112|NCT00537277|27083455|P1|Overall Study|Lack of Efficacy|2
7793113|NCT00537277|27083455|P1|Overall Study|Adverse Event|1
7793114|NCT00537238|27083466|P2|Overall Study|Other|52
7793115|NCT00537238|27083467|P1|Overall Study|Other|44
7793116|NCT00537238|27083466|P2|Overall Study|Does not meet entrance criteria|2
7793117|NCT00537238|27083467|P1|Overall Study|Does not meet entrance criteria|0
7793118|NCT00537238|27083466|P2|Overall Study|Protocol Violation|19
7793119|NCT00537238|27083467|P1|Overall Study|Protocol Violation|15
7793120|NCT00537238|27083466|P2|Overall Study|Withdrawal by Subject|47
7793121|NCT00537238|27083467|P1|Overall Study|Withdrawal by Subject|51
7793122|NCT00537238|27083466|P2|Overall Study|Lost to Follow-up|8
7793123|NCT00537238|27083467|P1|Overall Study|Lost to Follow-up|12
7793124|NCT00537238|27083466|P2|Overall Study|Lack of Efficacy|21
7793125|NCT00537238|27083467|P1|Overall Study|Lack of Efficacy|20
7793126|NCT00537238|27083466|P2|Overall Study|Adverse Event|22
7793127|NCT00537238|27083467|P1|Overall Study|Adverse Event|31
7793128|NCT00537238|27083466|P2|Overall Study|Death|2
7793129|NCT00537238|27083467|P1|Overall Study|Death|1
7793130|NCT00537199|27083487|P1|Overall Study|Study Terminated|1
7793131|NCT00537095|27083493|P2|Overall Study|Incorrect enrolment|1
7793132|NCT00537095|27083494|P1|Overall Study|Incorrect enrolment|0
7793133|NCT00537095|27083493|P2|Overall Study|subjective disease progression|1
7793134|NCT00537095|27083494|P1|Overall Study|subjective disease progression|0
7793135|NCT00537095|27083493|P2|Overall Study|Withdrawal by Subject|2
7793136|NCT00537095|27083494|P1|Overall Study|Withdrawal by Subject|2
7793137|NCT00537095|27083493|P2|Overall Study|Death|1
7793138|NCT00537095|27083494|P1|Overall Study|Death|3
7793139|NCT00537095|27083493|P2|Overall Study|disease progression|48
7793140|NCT00537095|27083494|P1|Overall Study|disease progression|21
7793141|NCT00537095|27083493|P2|Overall Study|Adverse Event|4
7793142|NCT00537095|27083494|P1|Overall Study|Adverse Event|24
7793143|NCT00537095|27083493|P2|Overall Study|surgery|0
7793144|NCT00537095|27083494|P1|Overall Study|surgery|1
7793145|NCT00537082|27083509|P3|Overall Study|Discontinued before initiating treatment|0
7793146|NCT00537082|27083510|P2|Overall Study|Discontinued before initiating treatment|0
7793147|NCT00537082|27083511|P1|Overall Study|Discontinued before initiating treatment|3
7793148|NCT00537082|27083509|P3|Overall Study|Withdrawal by Subject|0
7793149|NCT00537082|27083510|P2|Overall Study|Withdrawal by Subject|1
7793150|NCT00537082|27083511|P1|Overall Study|Withdrawal by Subject|0
7793151|NCT00537082|27083509|P3|Overall Study|Lack of Efficacy|2
7793152|NCT00537082|27083510|P2|Overall Study|Lack of Efficacy|0
7793153|NCT00537082|27083511|P1|Overall Study|Lack of Efficacy|0
7793154|NCT00537082|27083509|P3|Overall Study|Protocol Violation|1
7793155|NCT00537082|27083510|P2|Overall Study|Protocol Violation|2
7793156|NCT00537082|27083511|P1|Overall Study|Protocol Violation|0
7793157|NCT00537082|27083509|P3|Overall Study|Adverse Event|3
7793158|NCT00537082|27083510|P2|Overall Study|Adverse Event|6
7793159|NCT00537082|27083511|P1|Overall Study|Adverse Event|6
7793160|NCT00537056|27083528|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
7793161|NCT00537030|27083540|P1|Overall Study|Inevaluable|2
7793162|NCT00537030|27083540|P1|Overall Study|Ineligible|2
7793163|NCT00537030|27083540|P1|Overall Study|Disease progression/ relapse during Tx|1
7793164|NCT00537030|27083540|P1|Overall Study|≥ Grade 2 allergy|7
7793165|NCT00537030|27083540|P1|Overall Study|Withdrawal by Subject|2
7793166|NCT00537030|27083540|P1|Overall Study|Physician Decision|2
7793167|NCT00537017|27083547|P1|Follow-up Phase|Withdrawal by Subject|9
7793168|NCT00537017|27083547|P1|Treatment Phase|Protocol Violation|2
7793169|NCT00537017|27083547|P1|Treatment Phase|Withdrawal by Subject|13
7793170|NCT00537017|27083547|P1|Treatment Phase|Adverse Event|19
7793171|NCT00536991|27083558|P1|Overall Study|patient ineligible|2
7793172|NCT00536991|27083558|P1|Overall Study|Physician Decision|1
7793173|NCT00536991|27083558|P1|Overall Study|Withdrawal by Subject|10
7793174|NCT00536978|27083565|P1|Overall Study|Not eligible for Adback Infusion|22
7793175|NCT00536939|27083569|P2|Overall Study|Other Complicating Disease|0
7793176|NCT00536939|27083570|P1|Overall Study|Other Complicating Disease|1
7793177|NCT00536939|27083569|P2|Overall Study|Withdrawal by Subject|0
7793178|NCT00536939|27083570|P1|Overall Study|Withdrawal by Subject|1
7793179|NCT00536874|27083601|P1|Overall Study|Withdrawal by Subject|1
7793180|NCT00536874|27083601|P1|Overall Study|Death|2
7793181|NCT00536874|27083601|P1|Overall Study|Adverse Event|1
7793182|NCT00536809|27083611|P1|Phase II|Referred for surgical resection|1
7793183|NCT00536809|27083611|P1|Phase II|Adverse Event|1
7793184|NCT00536744|27083634|P2|Overall Study|PI tried alternative treatment|3
7793185|NCT00536744|27083635|P1|Overall Study|PI tried alternative treatment|1
7793186|NCT00536744|27083634|P2|Overall Study|Withdrawal by Subject|8
7793187|NCT00536744|27083635|P1|Overall Study|Withdrawal by Subject|7
7793188|NCT00536744|27083634|P2|Overall Study|Lost to Follow-up|5
7793189|NCT00536744|27083635|P1|Overall Study|Lost to Follow-up|3
7793190|NCT00536744|27083634|P2|Overall Study|Physician Decision|1
7793191|NCT00536744|27083635|P1|Overall Study|Physician Decision|3
7793192|NCT00536744|27083634|P2|Overall Study|Death|1
7793193|NCT00536744|27083635|P1|Overall Study|Death|2
7793194|NCT00536744|27083634|P2|Overall Study|Adverse Event|10
7793195|NCT00536744|27083635|P1|Overall Study|Adverse Event|13
7793196|NCT00536731|27083644|P3|Overall Study|Other|0
7793197|NCT00536731|27083645|P2|Overall Study|Other|1
7793198|NCT00536731|27083646|P1|Overall Study|Other|1
7793199|NCT00536731|27083644|P3|Overall Study|Safety reasons|1
7793200|NCT00536731|27083645|P2|Overall Study|Safety reasons|0
7793201|NCT00536731|27083646|P1|Overall Study|Safety reasons|0
7793202|NCT00536731|27083644|P3|Overall Study|Intake of prohibited conc. medication|1
7793203|NCT00536731|27083645|P2|Overall Study|Intake of prohibited conc. medication|0
7793204|NCT00536731|27083646|P1|Overall Study|Intake of prohibited conc. medication|0
7793205|NCT00536731|27083644|P3|Overall Study|Withdrawal by Subject|0
7793206|NCT00536731|27083645|P2|Overall Study|Withdrawal by Subject|2
7793207|NCT00536731|27083646|P1|Overall Study|Withdrawal by Subject|0
7793208|NCT00536731|27083644|P3|Overall Study|Adverse Event|3
7793209|NCT00536731|27083645|P2|Overall Study|Adverse Event|2
7793210|NCT00536731|27083646|P1|Overall Study|Adverse Event|3
7793211|NCT00536575|27083726|P1|Overall Study|Death|1
7793212|NCT00536575|27083726|P1|Overall Study|Withdrawal by Subject|1
7793213|NCT00536510|27083732|P2|Overall Study|Patient Discontinued for Other Reasons|2
7793214|NCT00536510|27083733|P1|Overall Study|Patient Discontinued for Other Reasons|2
7793215|NCT00536510|27083732|P2|Overall Study|Laboratory Adverse Event|1
7793216|NCT00536510|27083733|P1|Overall Study|Laboratory Adverse Event|2
7793217|NCT00536510|27083732|P2|Overall Study|Flushing with Product|0
7793218|NCT00536510|27083733|P1|Overall Study|Flushing with Product|20
7793219|NCT00536510|27083732|P2|Overall Study|Withdrawal by Subject|9
7793220|NCT00536510|27083733|P1|Overall Study|Withdrawal by Subject|16
7793221|NCT00536510|27083732|P2|Overall Study|Protocol Violation|5
7793222|NCT00536510|27083733|P1|Overall Study|Protocol Violation|4
7793223|NCT00536510|27083732|P2|Overall Study|Lost to Follow-up|8
7793224|NCT00536510|27083733|P1|Overall Study|Lost to Follow-up|11
7793225|NCT00536510|27083732|P2|Overall Study|Adverse Event|4
7793226|NCT00536510|27083733|P1|Overall Study|Adverse Event|27
7793227|NCT00536484|27083743|P2|Overall Study|Other|0
7793228|NCT00536484|27083744|P1|Overall Study|Other|4
7793229|NCT00536484|27083743|P2|Overall Study|Lack of Efficacy|5
7793230|NCT00536484|27083744|P1|Overall Study|Lack of Efficacy|16
7793231|NCT00536484|27083743|P2|Overall Study|Lost to Follow-up|6
7793232|NCT00536484|27083744|P1|Overall Study|Lost to Follow-up|8
7793233|NCT00536484|27083743|P2|Overall Study|Withdrawal by Subject|11
7793234|NCT00536484|27083744|P1|Overall Study|Withdrawal by Subject|11
7793235|NCT00536484|27083743|P2|Overall Study|Adverse Event|34
7793236|NCT00536484|27083744|P1|Overall Study|Adverse Event|21
7793237|NCT00536471|27083778|P4|Overall Study|Sponsor Decision|2
7793238|NCT00536471|27083779|P3|Overall Study|Sponsor Decision|3
7793239|NCT00536471|27083780|P2|Overall Study|Sponsor Decision|1
7793240|NCT00536471|27083781|P1|Overall Study|Sponsor Decision|0
7793241|NCT00536471|27083778|P4|Overall Study|Death|2
7793242|NCT00536471|27083779|P3|Overall Study|Death|1
7793243|NCT00536471|27083780|P2|Overall Study|Death|0
7793244|NCT00536471|27083781|P1|Overall Study|Death|0
7793245|NCT00536471|27083778|P4|Overall Study|Physician Decision|2
7793246|NCT00536471|27083779|P3|Overall Study|Physician Decision|3
7793247|NCT00536471|27083780|P2|Overall Study|Physician Decision|1
7793248|NCT00536471|27083781|P1|Overall Study|Physician Decision|11
7793249|NCT00536471|27083778|P4|Overall Study|Protocol Violation|3
7793250|NCT00536471|27083779|P3|Overall Study|Protocol Violation|2
7793251|NCT00536471|27083780|P2|Overall Study|Protocol Violation|1
7793252|NCT00536471|27083781|P1|Overall Study|Protocol Violation|8
7793253|NCT00536471|27083778|P4|Overall Study|Lack of Efficacy|9
7793254|NCT00536471|27083779|P3|Overall Study|Lack of Efficacy|11
7793255|NCT00536471|27083780|P2|Overall Study|Lack of Efficacy|18
7793256|NCT00536471|27083781|P1|Overall Study|Lack of Efficacy|17
7793257|NCT00536471|27083778|P4|Overall Study|Withdrawal by Subject|21
7793258|NCT00536471|27083779|P3|Overall Study|Withdrawal by Subject|43
7793259|NCT00536471|27083780|P2|Overall Study|Withdrawal by Subject|24
7793260|NCT00536471|27083781|P1|Overall Study|Withdrawal by Subject|40
7793261|NCT00536471|27083778|P4|Overall Study|Adverse Event|13
7793262|NCT00536471|27083779|P3|Overall Study|Adverse Event|28
7793263|NCT00536471|27083780|P2|Overall Study|Adverse Event|16
7793264|NCT00536471|27083781|P1|Overall Study|Adverse Event|32
7793265|NCT00536471|27083778|P4|Overall Study|Lost to Follow-up|22
7793266|NCT00536471|27083779|P3|Overall Study|Lost to Follow-up|48
7793267|NCT00536471|27083780|P2|Overall Study|Lost to Follow-up|23
7793268|NCT00536471|27083781|P1|Overall Study|Lost to Follow-up|48
7793269|NCT00536380|27084026|P3|Overall Study|Administrative|1
7793270|NCT00536380|27084027|P2|Overall Study|Administrative|0
7793271|NCT00536380|27084028|P1|Overall Study|Administrative|0
7793272|NCT00536380|27084026|P3|Overall Study|Did not meet protocol eligibility|1
7793273|NCT00536380|27084027|P2|Overall Study|Did not meet protocol eligibility|0
7793274|NCT00536380|27084028|P1|Overall Study|Did not meet protocol eligibility|0
7793275|NCT00536380|27084026|P3|Overall Study|Noncompliance with protocol|2
7793276|NCT00536380|27084027|P2|Overall Study|Noncompliance with protocol|2
7793277|NCT00536380|27084028|P1|Overall Study|Noncompliance with protocol|3
7793278|NCT00536380|27084026|P3|Overall Study|Withdrawal related to study drug|2
7793279|NCT00536380|27084027|P2|Overall Study|Withdrawal related to study drug|5
7793280|NCT00536380|27084028|P1|Overall Study|Withdrawal related to study drug|7
7793281|NCT00536380|27084026|P3|Overall Study|Withdrawal unrelated to study drug|1
7793282|NCT00536380|27084027|P2|Overall Study|Withdrawal unrelated to study drug|0
7793283|NCT00536380|27084028|P1|Overall Study|Withdrawal unrelated to study drug|2
7793284|NCT00536380|27084026|P3|Overall Study|Lost to Follow-up|1
7793285|NCT00536380|27084027|P2|Overall Study|Lost to Follow-up|0
7793286|NCT00536380|27084028|P1|Overall Study|Lost to Follow-up|0
7793287|NCT00536380|27084026|P3|Overall Study|Adverse Event|2
7793288|NCT00536380|27084027|P2|Overall Study|Adverse Event|2
7793289|NCT00536380|27084028|P1|Overall Study|Adverse Event|0
7793290|NCT00536263|27084052|P3|Overall Study|Did not meet protocol eligibility|2
7793291|NCT00536263|27084053|P2|Overall Study|Did not meet protocol eligibility|2
7793292|NCT00536263|27084054|P1|Overall Study|Did not meet protocol eligibility|1
7793293|NCT00536263|27084052|P3|Overall Study|Noncompliance with protocol|1
7793294|NCT00536263|27084053|P2|Overall Study|Noncompliance with protocol|0
7793295|NCT00536263|27084054|P1|Overall Study|Noncompliance with protocol|0
7793296|NCT00536263|27084052|P3|Overall Study|Subject withdrew - treatment related|2
7793297|NCT00536263|27084053|P2|Overall Study|Subject withdrew - treatment related|3
7793298|NCT00536263|27084054|P1|Overall Study|Subject withdrew - treatment related|0
7793299|NCT00536263|27084052|P3|Overall Study|Subject withdrew - not treatment related|5
7793300|NCT00536263|27084053|P2|Overall Study|Subject withdrew - not treatment related|0
7793301|NCT00536263|27084054|P1|Overall Study|Subject withdrew - not treatment related|2
7793302|NCT00536263|27084052|P3|Overall Study|Lost to Follow-up|4
7793303|NCT00536263|27084053|P2|Overall Study|Lost to Follow-up|4
7793304|NCT00536263|27084054|P1|Overall Study|Lost to Follow-up|3
7793305|NCT00536263|27084052|P3|Overall Study|Adverse Event|7
7793306|NCT00536263|27084053|P2|Overall Study|Adverse Event|5
7793307|NCT00536263|27084054|P1|Overall Study|Adverse Event|5
7793308|NCT00536198|27084094|P2|Overall Study|Protocol Violation|1
7793309|NCT00536198|27084095|P1|Overall Study|Protocol Violation|0
7793310|NCT00536198|27084094|P2|Overall Study|Pregnancy|1
7793311|NCT00536198|27084095|P1|Overall Study|Pregnancy|1
7793312|NCT00536198|27084094|P2|Overall Study|Rescue|9
7793313|NCT00536198|27084095|P1|Overall Study|Rescue|3
7793314|NCT00536198|27084094|P2|Overall Study|Adverse Event|2
7793315|NCT00536198|27084095|P1|Overall Study|Adverse Event|2
7793316|NCT00536198|27084094|P2|Overall Study|Withdrawal by Subject|12
7793317|NCT00536198|27084095|P1|Overall Study|Withdrawal by Subject|16
7793318|NCT00536198|27084094|P2|Overall Study|Lost to Follow-up|14
7793319|NCT00536198|27084095|P1|Overall Study|Lost to Follow-up|15
7793320|NCT00536120|27084134|P2|Overall Study|Missed Study Visit|1
7793321|NCT00536120|27084135|P1|Overall Study|Missed Study Visit|0
7793322|NCT00536120|27084134|P2|Overall Study|Steroid Use|2
7793323|NCT00536120|27084135|P1|Overall Study|Steroid Use|0
7793324|NCT00536120|27084134|P2|Overall Study|Sponsor Decision Due to Lab Values|0
7793325|NCT00536120|27084135|P1|Overall Study|Sponsor Decision Due to Lab Values|1
7793326|NCT00536120|27084134|P2|Overall Study|Non-compliance|0
7793327|NCT00536120|27084135|P1|Overall Study|Non-compliance|1
7793328|NCT00536120|27084134|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
7793329|NCT00536120|27084135|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
7793330|NCT00536120|27084134|P2|Overall Study|Lost to Follow-up|0
7793331|NCT00536120|27084135|P1|Overall Study|Lost to Follow-up|1
7793332|NCT00536107|27084149|P2|Overall Study|Study Termination|4
7793333|NCT00536107|27084150|P1|Overall Study|Study Termination|2
7793334|NCT00536107|27084149|P2|Overall Study|Withdrawal by Subject|1
7793335|NCT00536107|27084150|P1|Overall Study|Withdrawal by Subject|0
7793336|NCT00536107|27084149|P2|Overall Study|Incorrect enrolment|0
7793337|NCT00536107|27084150|P1|Overall Study|Incorrect enrolment|1
7793338|NCT00536107|27084149|P2|Overall Study|Death|1
7793339|NCT00536107|27084150|P1|Overall Study|Death|5
7793340|NCT00535847|27084215|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
7793341|NCT00535847|27084216|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
7793342|NCT00535847|27084217|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
7793343|NCT00535847|27084215|P3|Overall Study|Non compliance|0
7793344|NCT00535847|27084216|P2|Overall Study|Non compliance|1
7793345|NCT00535847|27084217|P1|Overall Study|Non compliance|1
7793346|NCT00535847|27084215|P3|Overall Study|Adverse Event|2
7793347|NCT00535847|27084216|P2|Overall Study|Adverse Event|3
7793348|NCT00535847|27084217|P1|Overall Study|Adverse Event|5
7793349|NCT00535730|27084452|P2|Overall Study|Withdrawal by Subject|4
7793350|NCT00535730|27084453|P1|Overall Study|Withdrawal by Subject|0
7793351|NCT00535730|27084452|P2|Overall Study|Protocol Violation|0
7793352|NCT00535730|27084453|P1|Overall Study|Protocol Violation|1
7793353|NCT00535730|27084452|P2|Overall Study|Physician Decision|1
7793354|NCT00535730|27084453|P1|Overall Study|Physician Decision|0
7793355|NCT00535730|27084452|P2|Overall Study|Lost to Follow-up|1
7793356|NCT00535730|27084453|P1|Overall Study|Lost to Follow-up|0
7793357|NCT00535730|27084452|P2|Overall Study|Adverse Event|1
7793358|NCT00535730|27084453|P1|Overall Study|Adverse Event|1
7793359|NCT00535626|27084474|P1|Overall Study|Unable to return|2
7793360|NCT00535626|27084474|P1|Overall Study|Subject terminated|31
7793361|NCT00535626|27084474|P1|Overall Study|Removal/revision of study component|8
7793362|NCT00535626|27084474|P1|Overall Study|Withdrawal by Subject|20
7793363|NCT00535626|27084474|P1|Overall Study|Lost to Follow-up|29
7793364|NCT00535626|27084474|P1|Overall Study|Death|15
7793365|NCT00535496|27084514|P4|Overall Study|Not treated with sugammadex|0
7793366|NCT00535496|27084515|P3|Overall Study|Not treated with sugammadex|0
7793367|NCT00535496|27084516|P2|Overall Study|Not treated with sugammadex|1
7793368|NCT00535496|27084517|P1|Overall Study|Not treated with sugammadex|0
7793369|NCT00535496|27084514|P4|Overall Study|Lost to Follow-up|0
7793370|NCT00535496|27084515|P3|Overall Study|Lost to Follow-up|0
7793371|NCT00535496|27084516|P2|Overall Study|Lost to Follow-up|1
7793372|NCT00535496|27084517|P1|Overall Study|Lost to Follow-up|0
7793373|NCT00535405|27084537|P5|Overall Study|Withdrawal by Subject|8
7793374|NCT00535405|27084538|P4|Overall Study|Withdrawal by Subject|10
7793375|NCT00535405|27084539|P3|Overall Study|Withdrawal by Subject|10
7793376|NCT00535405|27084540|P2|Overall Study|Withdrawal by Subject|11
7793377|NCT00535405|27084541|P1|Overall Study|Withdrawal by Subject|5
7793378|NCT00535405|27084537|P5|Overall Study|Protocol Violation|0
7793379|NCT00535405|27084538|P4|Overall Study|Protocol Violation|1
7793380|NCT00535405|27084539|P3|Overall Study|Protocol Violation|2
7793381|NCT00535405|27084540|P2|Overall Study|Protocol Violation|2
7793382|NCT00535405|27084541|P1|Overall Study|Protocol Violation|2
7793383|NCT00535405|27084537|P5|Overall Study|Physician Decision|1
7793384|NCT00535405|27084538|P4|Overall Study|Physician Decision|1
7793385|NCT00535405|27084539|P3|Overall Study|Physician Decision|0
7793386|NCT00535405|27084540|P2|Overall Study|Physician Decision|2
7793387|NCT00535405|27084541|P1|Overall Study|Physician Decision|3
7793388|NCT00535405|27084537|P5|Overall Study|Lost to Follow-up|1
7793389|NCT00535405|27084538|P4|Overall Study|Lost to Follow-up|2
7793390|NCT00535405|27084539|P3|Overall Study|Lost to Follow-up|3
7793391|NCT00535405|27084540|P2|Overall Study|Lost to Follow-up|3
7793392|NCT00535405|27084541|P1|Overall Study|Lost to Follow-up|1
7793393|NCT00535405|27084537|P5|Overall Study|Adverse Event|6
7793394|NCT00535405|27084538|P4|Overall Study|Adverse Event|8
7793395|NCT00535405|27084539|P3|Overall Study|Adverse Event|3
7793396|NCT00535405|27084540|P2|Overall Study|Adverse Event|8
7793397|NCT00535405|27084541|P1|Overall Study|Adverse Event|6
7793398|NCT00535288|27084602|P5|Overall Study|Other|1
7793399|NCT00535288|27084603|P4|Overall Study|Other|2
7793400|NCT00535288|27084604|P3|Overall Study|Other|1
7793401|NCT00535288|27084605|P2|Overall Study|Other|1
7793402|NCT00535288|27084606|P1|Overall Study|Other|2
7793403|NCT00535288|27084602|P5|Overall Study|Unwilling to cooperate|4
7793404|NCT00535288|27084603|P4|Overall Study|Unwilling to cooperate|3
7793405|NCT00535288|27084604|P3|Overall Study|Unwilling to cooperate|3
7793406|NCT00535288|27084605|P2|Overall Study|Unwilling to cooperate|6
7793407|NCT00535288|27084606|P1|Overall Study|Unwilling to cooperate|6
7793408|NCT00535288|27084602|P5|Overall Study|Lack of Efficacy|7
7793409|NCT00535288|27084603|P4|Overall Study|Lack of Efficacy|4
7793410|NCT00535288|27084604|P3|Overall Study|Lack of Efficacy|4
7793411|NCT00535288|27084605|P2|Overall Study|Lack of Efficacy|3
7793412|NCT00535288|27084606|P1|Overall Study|Lack of Efficacy|26
7793413|NCT00535288|27084602|P5|Overall Study|Lost to Follow-up|0
7793414|NCT00535288|27084603|P4|Overall Study|Lost to Follow-up|0
7793415|NCT00535288|27084604|P3|Overall Study|Lost to Follow-up|0
7793416|NCT00535288|27084605|P2|Overall Study|Lost to Follow-up|3
7793417|NCT00535288|27084606|P1|Overall Study|Lost to Follow-up|0
7793418|NCT00535288|27084602|P5|Overall Study|Adverse Event|30
7793419|NCT00535288|27084603|P4|Overall Study|Adverse Event|20
7793420|NCT00535288|27084604|P3|Overall Study|Adverse Event|25
7793421|NCT00535288|27084605|P2|Overall Study|Adverse Event|19
7793422|NCT00535288|27084606|P1|Overall Study|Adverse Event|20
7793423|NCT00535262|27084683|P1|Overall Study|No funding|3
7793424|NCT00535236|27084697|P10|Overall Study|Withdrawal by Subject|2
7793425|NCT00535236|27084698|P9|Overall Study|Withdrawal by Subject|4
7793426|NCT00535236|27084699|P8|Overall Study|Withdrawal by Subject|0
7793427|NCT00535236|27084700|P7|Overall Study|Withdrawal by Subject|5
7793428|NCT00535236|27084701|P6|Overall Study|Withdrawal by Subject|1
7793429|NCT00535236|27084702|P5|Overall Study|Withdrawal by Subject|6
7793430|NCT00535236|27084703|P4|Overall Study|Withdrawal by Subject|1
7793431|NCT00535236|27084704|P3|Overall Study|Withdrawal by Subject|2
7793432|NCT00535236|27084705|P2|Overall Study|Withdrawal by Subject|0
7793433|NCT00535236|27084706|P1|Overall Study|Withdrawal by Subject|3
7793434|NCT00535236|27084697|P10|Overall Study|Protocol Violation|0
7793435|NCT00535236|27084698|P9|Overall Study|Protocol Violation|1
7793436|NCT00535236|27084699|P8|Overall Study|Protocol Violation|0
7793437|NCT00535236|27084700|P7|Overall Study|Protocol Violation|0
7793438|NCT00535236|27084701|P6|Overall Study|Protocol Violation|0
7793439|NCT00535236|27084702|P5|Overall Study|Protocol Violation|0
7793440|NCT00535236|27084703|P4|Overall Study|Protocol Violation|0
7793441|NCT00535236|27084704|P3|Overall Study|Protocol Violation|1
7793442|NCT00535236|27084705|P2|Overall Study|Protocol Violation|0
7793443|NCT00535236|27084706|P1|Overall Study|Protocol Violation|2
7793444|NCT00535236|27084697|P10|Overall Study|Physician Decision|0
7793445|NCT00535236|27084698|P9|Overall Study|Physician Decision|0
7793446|NCT00535236|27084699|P8|Overall Study|Physician Decision|0
7793447|NCT00535236|27084700|P7|Overall Study|Physician Decision|1
7793448|NCT00535236|27084701|P6|Overall Study|Physician Decision|0
7793449|NCT00535236|27084702|P5|Overall Study|Physician Decision|1
7793450|NCT00535236|27084703|P4|Overall Study|Physician Decision|0
7793451|NCT00535236|27084704|P3|Overall Study|Physician Decision|0
7793452|NCT00535236|27084705|P2|Overall Study|Physician Decision|0
7793453|NCT00535236|27084706|P1|Overall Study|Physician Decision|0
7793454|NCT00535236|27084697|P10|Overall Study|Lost to Follow-up|1
7793455|NCT00535236|27084698|P9|Overall Study|Lost to Follow-up|6
7793456|NCT00535236|27084699|P8|Overall Study|Lost to Follow-up|0
7793457|NCT00535236|27084700|P7|Overall Study|Lost to Follow-up|0
7793458|NCT00535236|27084701|P6|Overall Study|Lost to Follow-up|0
7793459|NCT00535236|27084702|P5|Overall Study|Lost to Follow-up|2
7793460|NCT00535236|27084703|P4|Overall Study|Lost to Follow-up|0
7793461|NCT00535236|27084704|P3|Overall Study|Lost to Follow-up|0
7793462|NCT00535236|27084705|P2|Overall Study|Lost to Follow-up|2
7793463|NCT00535236|27084706|P1|Overall Study|Lost to Follow-up|1
7793464|NCT00535236|27084697|P10|Overall Study|Adverse Event|1
7793465|NCT00535236|27084698|P9|Overall Study|Adverse Event|2
7793466|NCT00535236|27084699|P8|Overall Study|Adverse Event|1
7793467|NCT00535236|27084700|P7|Overall Study|Adverse Event|5
7793468|NCT00535236|27084701|P6|Overall Study|Adverse Event|0
7793469|NCT00535236|27084702|P5|Overall Study|Adverse Event|3
7793470|NCT00535236|27084703|P4|Overall Study|Adverse Event|3
7793471|NCT00535236|27084704|P3|Overall Study|Adverse Event|9
7793472|NCT00535236|27084705|P2|Overall Study|Adverse Event|0
7793473|NCT00535236|27084706|P1|Overall Study|Adverse Event|1
7793474|NCT00535223|27084766|P2|Overall Study|Withdrawal by Subject|1
7793475|NCT00535223|27084767|P1|Overall Study|Withdrawal by Subject|4
7793476|NCT00535145|27084775|P1|Phase II|Subject non-compliance|2
7793477|NCT00535145|27084775|P1|Phase II|Withdrawal by Subject|5
7793478|NCT00535145|27084775|P1|Phase II|Lost to Follow-up|5
7793479|NCT00535145|27084775|P1|Phase II|Lack of Efficacy|1
7793480|NCT00535145|27084775|P1|Phase II|Adverse Event|2
7793481|NCT00535145|27084775|P1|Phase I|(diagnosis)|3
7793482|NCT00535145|27084775|P1|Phase I|(PI decision)|1
7793483|NCT00535145|27084775|P1|Phase I|(protocol violation)|1
7793484|NCT00535145|27084775|P1|Phase I|(eligibility)|8
7793485|NCT00535145|27084775|P1|Phase I|Withdrawal by Subject|6
7793486|NCT00535145|27084775|P1|Phase I|Lost to Follow-up|7
7793487|NCT00535145|27084775|P1|Phase I|Adverse Event|3
7793488|NCT00535132|27084787|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
7793489|NCT00535132|27084788|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
7793490|NCT00535132|27084787|P2|Safety Analysis Set|Did Not Receive Study Medication|2
7793491|NCT00535132|27084788|P1|Safety Analysis Set|Did Not Receive Study Medication|2
7793492|NCT00534976|27084869|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
7793493|NCT00534976|27084870|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
7793494|NCT00534976|27084869|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
7793495|NCT00534976|27084870|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
7793496|NCT00534976|27084869|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
7793497|NCT00534976|27084870|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
7793498|NCT00534638|27084950|P2|Overall Study|Other|902
7793499|NCT00534638|27084951|P1|Overall Study|Other|1685
7793500|NCT00534638|27084950|P2|Overall Study|Lost to follow-up, complete vaccination|10757
7793501|NCT00534638|27084951|P1|Overall Study|Lost to follow-up, complete vaccination|4707
7793502|NCT00534638|27084950|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
7793503|NCT00534638|27084951|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
7793504|NCT00534638|27084950|P2|Overall Study|Migrated/moved from study area|11
7793505|NCT00534638|27084951|P1|Overall Study|Migrated/moved from study area|13
7793506|NCT00534638|27084950|P2|Overall Study|Withdrawal by Subject|4
7793507|NCT00534638|27084951|P1|Overall Study|Withdrawal by Subject|3
7793508|NCT00534599|27084989|P2|Overall Study|Other|0
7793509|NCT00534599|27084990|P1|Overall Study|Other|7
7793510|NCT00534599|27084989|P2|Overall Study|Withdrawal by Subject|6
7793511|NCT00534599|27084990|P1|Overall Study|Withdrawal by Subject|4
7793512|NCT00534599|27084989|P2|Overall Study|Lost to Follow-up|14
7793513|NCT00534599|27084990|P1|Overall Study|Lost to Follow-up|11
7793514|NCT00534599|27084989|P2|Overall Study|Protocol Violation|3
7793515|NCT00534599|27084990|P1|Overall Study|Protocol Violation|1
7793516|NCT00534599|27084989|P2|Overall Study|Generalized anxiety disorder worsened|1
7793517|NCT00534599|27084990|P1|Overall Study|Generalized anxiety disorder worsened|0
7793518|NCT00534599|27084989|P2|Overall Study|Lack of Efficacy|1
7793519|NCT00534599|27084990|P1|Overall Study|Lack of Efficacy|0
7793520|NCT00534599|27084989|P2|Overall Study|Developed study-specific d/c criteria|0
7793521|NCT00534599|27084990|P1|Overall Study|Developed study-specific d/c criteria|5
7793522|NCT00534599|27084989|P2|Overall Study|Mis-randomization|2
7793523|NCT00534599|27084990|P1|Overall Study|Mis-randomization|2
7793524|NCT00534599|27084989|P2|Overall Study|Incorrect enrollment|1
7793525|NCT00534599|27084990|P1|Overall Study|Incorrect enrollment|2
7793526|NCT00534599|27084989|P2|Overall Study|Adverse Event|4
7793527|NCT00534599|27084990|P1|Overall Study|Adverse Event|25
7793528|NCT00534495|27085026|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
7793529|NCT00534495|27085027|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
7793530|NCT00534495|27085028|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
7793531|NCT00534495|27085026|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
7793532|NCT00534495|27085027|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
7793533|NCT00534495|27085028|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
7793534|NCT00534495|27085026|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
7793535|NCT00534495|27085027|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
7793536|NCT00534495|27085028|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
7793537|NCT00534495|27085026|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
7793538|NCT00534495|27085027|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
7793539|NCT00534495|27085028|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
7793540|NCT00534495|27085026|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
7793541|NCT00534495|27085027|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
7793542|NCT00534495|27085028|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
7793543|NCT00534495|27085026|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
7793544|NCT00534495|27085027|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
7793545|NCT00534495|27085028|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
7793546|NCT00534495|27085026|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
7793547|NCT00534495|27085027|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
7793548|NCT00534495|27085028|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
7793549|NCT00534495|27085026|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
7793550|NCT00534495|27085027|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
7793551|NCT00534495|27085028|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
7793552|NCT00534495|27085026|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
7793553|NCT00534495|27085027|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
7793554|NCT00534495|27085028|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
7793555|NCT00534404|27085066|P3|Overall Study|Lost to Follow-up|201
7793556|NCT00534404|27085067|P2|Overall Study|Lost to Follow-up|138
7793557|NCT00534404|27085068|P1|Overall Study|Lost to Follow-up|170
7793558|NCT00534404|27085066|P3|Overall Study|Removed by study staff|1
7793559|NCT00534404|27085067|P2|Overall Study|Removed by study staff|3
7793560|NCT00534404|27085068|P1|Overall Study|Removed by study staff|2
7793561|NCT00534404|27085066|P3|Overall Study|Withdrawal by Subject|38
7793562|NCT00534404|27085067|P2|Overall Study|Withdrawal by Subject|2
7793563|NCT00534404|27085068|P1|Overall Study|Withdrawal by Subject|8
7793564|NCT00534404|27085066|P3|Overall Study|Death|2
7793565|NCT00534404|27085067|P2|Overall Study|Death|0
7793566|NCT00534404|27085068|P1|Overall Study|Death|0
7793567|NCT00534352|27085099|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
7793568|NCT00534352|27085099|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
7793569|NCT00534352|27085099|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
7793570|NCT00534352|27085099|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
7793571|NCT00534352|27085099|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
7793572|NCT00534352|27085099|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
7793573|NCT00534313|27085143|P4|Long-term Period|Other|2
7793574|NCT00534313|27085144|P3|Long-term Period|Other|2
7793575|NCT00534313|27085145|P2|Long-term Period|Other|2
7793576|NCT00534313|27085146|P1|Long-term Period|Other|1
7793577|NCT00534313|27085143|P4|Long-term Period|Administrative reason by sponsor|18
7793578|NCT00534313|27085144|P3|Long-term Period|Administrative reason by sponsor|26
7793579|NCT00534313|27085145|P2|Long-term Period|Administrative reason by sponsor|15
7793580|NCT00534313|27085146|P1|Long-term Period|Administrative reason by sponsor|17
7793581|NCT00534313|27085143|P4|Long-term Period|Poor compliance/noncompliance|0
7793582|NCT00534313|27085144|P3|Long-term Period|Poor compliance/noncompliance|1
7793583|NCT00534313|27085145|P2|Long-term Period|Poor compliance/noncompliance|1
7793584|NCT00534313|27085146|P1|Long-term Period|Poor compliance/noncompliance|0
7793585|NCT00534313|27085143|P4|Long-term Period|No longer meets study criteria|0
7793586|NCT00534313|27085144|P3|Long-term Period|No longer meets study criteria|0
7793587|NCT00534313|27085145|P2|Long-term Period|No longer meets study criteria|1
7793588|NCT00534313|27085146|P1|Long-term Period|No longer meets study criteria|0
7793589|NCT00534313|27085143|P4|Long-term Period|Withdrawal by Subject|0
7793590|NCT00534313|27085144|P3|Long-term Period|Withdrawal by Subject|0
7793591|NCT00534313|27085145|P2|Long-term Period|Withdrawal by Subject|2
7793592|NCT00534313|27085146|P1|Long-term Period|Withdrawal by Subject|2
7793593|NCT00534313|27085143|P4|Long-term Period|Lost to Follow-up|0
7793594|NCT00534313|27085144|P3|Long-term Period|Lost to Follow-up|0
7793595|NCT00534313|27085145|P2|Long-term Period|Lost to Follow-up|2
7793596|NCT00534313|27085146|P1|Long-term Period|Lost to Follow-up|1
7793597|NCT00534313|27085143|P4|Long-term Period|Lack of Efficacy|12
7793598|NCT00534313|27085144|P3|Long-term Period|Lack of Efficacy|14
7793599|NCT00534313|27085145|P2|Long-term Period|Lack of Efficacy|10
7793600|NCT00534313|27085146|P1|Long-term Period|Lack of Efficacy|14
7793601|NCT00534313|27085143|P4|Long-term Period|Adverse Event|1
7793602|NCT00534313|27085144|P3|Long-term Period|Adverse Event|0
7793603|NCT00534313|27085145|P2|Long-term Period|Adverse Event|1
7793604|NCT00534313|27085146|P1|Long-term Period|Adverse Event|2
7793605|NCT00534313|27085143|P4|Short-term Period|Pregnancy|0
7793606|NCT00534313|27085144|P3|Short-term Period|Pregnancy|1
7793607|NCT00534313|27085145|P2|Short-term Period|Pregnancy|0
7793608|NCT00534313|27085146|P1|Short-term Period|Pregnancy|0
7793609|NCT00534313|27085143|P4|Short-term Period|Participant withdrew consent|2
7793610|NCT00534313|27085144|P3|Short-term Period|Participant withdrew consent|0
7793611|NCT00534313|27085145|P2|Short-term Period|Participant withdrew consent|0
7793612|NCT00534313|27085146|P1|Short-term Period|Participant withdrew consent|2
7793613|NCT00534313|27085143|P4|Short-term Period|Participant not meeting study criteria|1
7793614|NCT00534313|27085144|P3|Short-term Period|Participant not meeting study criteria|0
7793615|NCT00534313|27085145|P2|Short-term Period|Participant not meeting study criteria|0
7793616|NCT00534313|27085146|P1|Short-term Period|Participant not meeting study criteria|0
7793617|NCT00534313|27085143|P4|Short-term Period|Lack of Efficacy|3
7793618|NCT00534313|27085144|P3|Short-term Period|Lack of Efficacy|0
7793619|NCT00534313|27085145|P2|Short-term Period|Lack of Efficacy|4
7793620|NCT00534313|27085146|P1|Short-term Period|Lack of Efficacy|3
7793621|NCT00534313|27085143|P4|Short-term Period|Adverse Event|3
7793622|NCT00534313|27085144|P3|Short-term Period|Adverse Event|1
7793623|NCT00534313|27085145|P2|Short-term Period|Adverse Event|2
7793624|NCT00534313|27085146|P1|Short-term Period|Adverse Event|1
7793625|NCT00534248|27085241|P2|Overall Study|Withdrawal by Subject|255
7793626|NCT00534248|27085242|P1|Overall Study|Withdrawal by Subject|263
7793627|NCT00534248|27085241|P2|Overall Study|Protocol Violation|4
7793628|NCT00534248|27085242|P1|Overall Study|Protocol Violation|3
7793629|NCT00534248|27085241|P2|Overall Study|Physician Decision|7
7793630|NCT00534248|27085242|P1|Overall Study|Physician Decision|10
7793631|NCT00534248|27085241|P2|Overall Study|Other protocol specified criteria|3
7793632|NCT00534248|27085242|P1|Overall Study|Other protocol specified criteria|13
7793633|NCT00534248|27085241|P2|Overall Study|Lost to Follow-up|375
7793634|NCT00534248|27085242|P1|Overall Study|Lost to Follow-up|353
7793635|NCT00534248|27085241|P2|Overall Study|Adverse Event|29
7793636|NCT00534248|27085242|P1|Overall Study|Adverse Event|19
7793637|NCT00534105|27085412|P2|Overall Study|Lost to Follow-up|39
7793638|NCT00534105|27085413|P1|Overall Study|Lost to Follow-up|23
7793639|NCT00534092|27085427|P2|Overall Study|personal reasons/family concerns|0
7793640|NCT00534092|27085428|P1|Overall Study|personal reasons/family concerns|1
7793641|NCT00534092|27085427|P2|Overall Study|Lost to Follow-up|0
7793642|NCT00534092|27085428|P1|Overall Study|Lost to Follow-up|1
7793643|NCT00533949|27085466|P4|Overall Study|Withdrawal by Subject|1
7793644|NCT00533949|27085467|P3|Overall Study|Withdrawal by Subject|1
7793645|NCT00533949|27085468|P2|Overall Study|Withdrawal by Subject|2
7793646|NCT00533949|27085469|P1|Overall Study|Withdrawal by Subject|3
7793647|NCT00533949|27085466|P4|Overall Study|Protocol Violation|9
7793648|NCT00533949|27085467|P3|Overall Study|Protocol Violation|9
7793649|NCT00533949|27085468|P2|Overall Study|Protocol Violation|12
7793650|NCT00533949|27085469|P1|Overall Study|Protocol Violation|12
7793651|NCT00533897|27085523|P8|Long Term Extension (LTE)|Other|6
7793652|NCT00533897|27085524|P7|Long Term Extension (LTE)|Other|1
7793653|NCT00533897|27085525|P6|Long Term Extension (LTE)|Other|0
7793654|NCT00533897|27085526|P5|Long Term Extension (LTE)|Other|0
7793655|NCT00533897|27085527|P4|Long Term Extension (LTE)|Other|0
7793656|NCT00533897|27085528|P3|Long Term Extension (LTE)|Other|0
7793657|NCT00533897|27085529|P2|Long Term Extension (LTE)|Other|0
7793658|NCT00533897|27085530|P1|Long Term Extension (LTE)|Other|0
7793659|NCT00533897|27085523|P8|Long Term Extension (LTE)|Lost to Follow-up|1
7793660|NCT00533897|27085524|P7|Long Term Extension (LTE)|Lost to Follow-up|1
7793661|NCT00533897|27085525|P6|Long Term Extension (LTE)|Lost to Follow-up|0
7793662|NCT00533897|27085526|P5|Long Term Extension (LTE)|Lost to Follow-up|0
7793663|NCT00533897|27085527|P4|Long Term Extension (LTE)|Lost to Follow-up|0
7793664|NCT00533897|27085528|P3|Long Term Extension (LTE)|Lost to Follow-up|0
7793665|NCT00533897|27085529|P2|Long Term Extension (LTE)|Lost to Follow-up|0
7793666|NCT00533897|27085530|P1|Long Term Extension (LTE)|Lost to Follow-up|0
7793667|NCT00533897|27085523|P8|Long Term Extension (LTE)|Pregnancy|2
7793668|NCT00533897|27085524|P7|Long Term Extension (LTE)|Pregnancy|0
7793669|NCT00533897|27085525|P6|Long Term Extension (LTE)|Pregnancy|0
7793670|NCT00533897|27085526|P5|Long Term Extension (LTE)|Pregnancy|0
7793671|NCT00533897|27085527|P4|Long Term Extension (LTE)|Pregnancy|0
7793672|NCT00533897|27085528|P3|Long Term Extension (LTE)|Pregnancy|0
7793673|NCT00533897|27085529|P2|Long Term Extension (LTE)|Pregnancy|0
7793674|NCT00533897|27085530|P1|Long Term Extension (LTE)|Pregnancy|0
7793675|NCT00533897|27085523|P8|Long Term Extension (LTE)|Adverse Event|5
7793676|NCT00533897|27085524|P7|Long Term Extension (LTE)|Adverse Event|2
7793677|NCT00533897|27085525|P6|Long Term Extension (LTE)|Adverse Event|0
7793678|NCT00533897|27085526|P5|Long Term Extension (LTE)|Adverse Event|0
7793679|NCT00533897|27085527|P4|Long Term Extension (LTE)|Adverse Event|0
7793680|NCT00533897|27085528|P3|Long Term Extension (LTE)|Adverse Event|0
7793681|NCT00533897|27085529|P2|Long Term Extension (LTE)|Adverse Event|0
7793682|NCT00533897|27085530|P1|Long Term Extension (LTE)|Adverse Event|0
7793683|NCT00533897|27085523|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
7793684|NCT00533897|27085524|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
7793685|NCT00533897|27085525|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
7793686|NCT00533897|27085526|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
7793687|NCT00533897|27085527|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
7793688|NCT00533897|27085528|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
7793689|NCT00533897|27085529|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
7793690|NCT00533897|27085530|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
7793691|NCT00533897|27085523|P8|Long Term Extension (LTE)|Lack of Efficacy|3
7793692|NCT00533897|27085524|P7|Long Term Extension (LTE)|Lack of Efficacy|5
7793693|NCT00533897|27085525|P6|Long Term Extension (LTE)|Lack of Efficacy|0
7793694|NCT00533897|27085526|P5|Long Term Extension (LTE)|Lack of Efficacy|0
7793695|NCT00533897|27085527|P4|Long Term Extension (LTE)|Lack of Efficacy|0
7793696|NCT00533897|27085528|P3|Long Term Extension (LTE)|Lack of Efficacy|0
7793697|NCT00533897|27085529|P2|Long Term Extension (LTE)|Lack of Efficacy|0
7793698|NCT00533897|27085530|P1|Long Term Extension (LTE)|Lack of Efficacy|0
7793699|NCT00533897|27085523|P8|Long Term Extension (LTE)|Death|3
7793700|NCT00533897|27085524|P7|Long Term Extension (LTE)|Death|1
7793701|NCT00533897|27085525|P6|Long Term Extension (LTE)|Death|0
7793702|NCT00533897|27085526|P5|Long Term Extension (LTE)|Death|0
7793703|NCT00533897|27085527|P4|Long Term Extension (LTE)|Death|0
7793704|NCT00533897|27085528|P3|Long Term Extension (LTE)|Death|0
7793705|NCT00533897|27085529|P2|Long Term Extension (LTE)|Death|0
7793706|NCT00533897|27085530|P1|Long Term Extension (LTE)|Death|0
7793707|NCT00533897|27085523|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
7793708|NCT00533897|27085524|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
7793709|NCT00533897|27085525|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
7793710|NCT00533897|27085526|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
7793711|NCT00533897|27085527|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
7793712|NCT00533897|27085528|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
7793713|NCT00533897|27085529|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
7793714|NCT00533897|27085530|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
7793715|NCT00533897|27085523|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793716|NCT00533897|27085524|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793717|NCT00533897|27085525|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
7793718|NCT00533897|27085526|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793719|NCT00533897|27085527|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793720|NCT00533897|27085528|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793721|NCT00533897|27085529|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793722|NCT00533897|27085530|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7793723|NCT00533897|27085523|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793724|NCT00533897|27085524|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793725|NCT00533897|27085525|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
7793726|NCT00533897|27085526|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793727|NCT00533897|27085527|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793728|NCT00533897|27085528|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793729|NCT00533897|27085529|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793730|NCT00533897|27085530|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7793731|NCT00533897|27085523|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793732|NCT00533897|27085524|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793733|NCT00533897|27085525|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793734|NCT00533897|27085526|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793735|NCT00533897|27085527|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793736|NCT00533897|27085528|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
7793737|NCT00533897|27085529|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793738|NCT00533897|27085530|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7793739|NCT00533897|27085523|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7793740|NCT00533897|27085524|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7793741|NCT00533897|27085525|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7793742|NCT00533897|27085526|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7793743|NCT00533897|27085527|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7793744|NCT00533897|27085528|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
7793745|NCT00533897|27085529|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
7793746|NCT00533897|27085530|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7793747|NCT00533897|27085523|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793748|NCT00533897|27085524|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793749|NCT00533897|27085525|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793750|NCT00533897|27085526|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793751|NCT00533897|27085527|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793752|NCT00533897|27085528|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793753|NCT00533897|27085529|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7793754|NCT00533897|27085530|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
7793755|NCT00533897|27085523|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
7793756|NCT00533897|27085524|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
7793757|NCT00533897|27085525|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
7793758|NCT00533897|27085526|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
7793759|NCT00533897|27085527|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
7793760|NCT00533897|27085528|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
7793761|NCT00533897|27085529|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
7793762|NCT00533897|27085530|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
7793763|NCT00533897|27085523|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793764|NCT00533897|27085524|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793765|NCT00533897|27085525|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793766|NCT00533897|27085526|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793767|NCT00533897|27085527|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793768|NCT00533897|27085528|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793769|NCT00533897|27085529|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7793770|NCT00533897|27085530|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
7793771|NCT00533897|27085523|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
7793772|NCT00533897|27085524|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
7793773|NCT00533897|27085525|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
7793774|NCT00533897|27085526|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
7793775|NCT00533897|27085527|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
7793776|NCT00533897|27085528|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
7793777|NCT00533897|27085529|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
7793778|NCT00533897|27085530|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
7793779|NCT00533897|27085523|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793780|NCT00533897|27085524|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793781|NCT00533897|27085525|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793782|NCT00533897|27085526|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793783|NCT00533897|27085527|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793784|NCT00533897|27085528|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793785|NCT00533897|27085529|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7793786|NCT00533897|27085530|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
7793787|NCT00533897|27085523|P8|Lead-in (LI) Period 1|Adverse Event|0
7793788|NCT00533897|27085524|P7|Lead-in (LI) Period 1|Adverse Event|0
7793789|NCT00533897|27085525|P6|Lead-in (LI) Period 1|Adverse Event|0
7793790|NCT00533897|27085526|P5|Lead-in (LI) Period 1|Adverse Event|0
7793791|NCT00533897|27085527|P4|Lead-in (LI) Period 1|Adverse Event|0
7793792|NCT00533897|27085528|P3|Lead-in (LI) Period 1|Adverse Event|0
7793793|NCT00533897|27085529|P2|Lead-in (LI) Period 1|Adverse Event|0
7793794|NCT00533897|27085530|P1|Lead-in (LI) Period 1|Adverse Event|1
7793795|NCT00533845|27085670|P2|Overall Study|Physician Decision|0
7793796|NCT00533845|27085671|P1|Overall Study|Physician Decision|1
7793797|NCT00533702|27085679|P2|Overall Study|Found ineligible after randomization|1
7793798|NCT00533702|27085680|P1|Overall Study|Found ineligible after randomization|2
7793799|NCT00533702|27085679|P2|Overall Study|Withdrawal by Subject|1
7793800|NCT00533702|27085680|P1|Overall Study|Withdrawal by Subject|3
7793801|NCT00533507|27085711|P1|Overall Study|Withdrawal by Subject|1
7793802|NCT00533429|27085745|P2|Overall Study|Symptomatic deterioration|2
7793803|NCT00533429|27085746|P1|Overall Study|Symptomatic deterioration|1
7793804|NCT00533429|27085745|P2|Overall Study|Progressive Disease|13
7793805|NCT00533429|27085746|P1|Overall Study|Progressive Disease|12
7793806|NCT00533429|27085745|P2|Overall Study|Withdrawal by Subject|0
7793807|NCT00533429|27085746|P1|Overall Study|Withdrawal by Subject|2
7793808|NCT00533429|27085745|P2|Overall Study|Death|0
7793809|NCT00533429|27085746|P1|Overall Study|Death|1
7793810|NCT00533429|27085745|P2|Overall Study|Adverse Event|1
7793811|NCT00533429|27085746|P1|Overall Study|Adverse Event|3
7793812|NCT00533273|27085775|P2|Open-label|Withdrawal by Subject|0
7793813|NCT00533273|27085776|P1|Open-label|Withdrawal by Subject|6
7793814|NCT00533273|27085775|P2|Double-blind|Withdrew consent|2
7793815|NCT00533273|27085776|P1|Double-blind|Withdrew consent|0
7793816|NCT00532948|27085827|P3|Overall Study|Failure to return|0
7793817|NCT00532948|27085828|P2|Overall Study|Failure to return|1
7793818|NCT00532948|27085829|P1|Overall Study|Failure to return|0
7793819|NCT00532948|27085827|P3|Overall Study|Violation of selection criteria at entry|0
7793820|NCT00532948|27085828|P2|Overall Study|Violation of selection criteria at entry|1
7793821|NCT00532948|27085829|P1|Overall Study|Violation of selection criteria at entry|0
7793822|NCT00532948|27085827|P3|Overall Study|Death|4
7793823|NCT00532948|27085828|P2|Overall Study|Death|3
7793824|NCT00532948|27085829|P1|Overall Study|Death|3
7793825|NCT00532948|27085827|P3|Overall Study|Protocol Violation|0
7793826|NCT00532948|27085828|P2|Overall Study|Protocol Violation|0
7793827|NCT00532948|27085829|P1|Overall Study|Protocol Violation|1
7793828|NCT00532935|27085861|P2|Overall Study|Protocol Specific Criteria|15
7793829|NCT00532935|27085862|P1|Overall Study|Protocol Specific Criteria|11
7793830|NCT00532935|27085861|P2|Overall Study|Withdrawal by Subject|9
7793831|NCT00532935|27085862|P1|Overall Study|Withdrawal by Subject|10
7793832|NCT00532935|27085861|P2|Overall Study|Protocol Violation|2
7793833|NCT00532935|27085862|P1|Overall Study|Protocol Violation|4
7793834|NCT00532935|27085861|P2|Overall Study|Pregnancy|0
7793835|NCT00532935|27085862|P1|Overall Study|Pregnancy|1
7793836|NCT00532935|27085861|P2|Overall Study|Physician Decision|5
7793837|NCT00532935|27085862|P1|Overall Study|Physician Decision|4
7793838|NCT00532935|27085861|P2|Overall Study|Lost to Follow-up|6
7793839|NCT00532935|27085862|P1|Overall Study|Lost to Follow-up|10
7793840|NCT00532935|27085861|P2|Overall Study|Lack of Efficacy|3
7793841|NCT00532935|27085862|P1|Overall Study|Lack of Efficacy|0
7793842|NCT00532935|27085861|P2|Overall Study|Adverse Event|12
7793843|NCT00532935|27085862|P1|Overall Study|Adverse Event|11
7793844|NCT00532883|27085880|P4|Overall Study|Early Study Termination|4
7793845|NCT00532883|27085881|P3|Overall Study|Early Study Termination|1
7793846|NCT00532883|27085882|P2|Overall Study|Early Study Termination|4
7793847|NCT00532883|27085883|P1|Overall Study|Early Study Termination|4
7793848|NCT00532883|27085880|P4|Overall Study|Subject was Nonadherent|0
7793849|NCT00532883|27085881|P3|Overall Study|Subject was Nonadherent|1
7793850|NCT00532883|27085882|P2|Overall Study|Subject was Nonadherent|1
7793851|NCT00532883|27085883|P1|Overall Study|Subject was Nonadherent|0
7793852|NCT00532883|27085880|P4|Overall Study|Withdrawal by Subject|0
7793853|NCT00532883|27085881|P3|Overall Study|Withdrawal by Subject|1
7793854|NCT00532883|27085882|P2|Overall Study|Withdrawal by Subject|1
7793855|NCT00532883|27085883|P1|Overall Study|Withdrawal by Subject|0
7793856|NCT00532883|27085880|P4|Overall Study|Lost to Follow-up|0
7793857|NCT00532883|27085881|P3|Overall Study|Lost to Follow-up|1
7793858|NCT00532883|27085882|P2|Overall Study|Lost to Follow-up|1
7793859|NCT00532883|27085883|P1|Overall Study|Lost to Follow-up|1
7793860|NCT00532883|27085880|P4|Overall Study|Adverse Event|1
7793861|NCT00532883|27085881|P3|Overall Study|Adverse Event|0
7793862|NCT00532883|27085882|P2|Overall Study|Adverse Event|0
7793863|NCT00532883|27085883|P1|Overall Study|Adverse Event|1
7793864|NCT00532844|27085895|P2|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
7793865|NCT00532844|27085896|P1|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
7793866|NCT00532844|27085895|P2|Treatment Period - Day 15 to Day 28|Adverse Event|0
7793867|NCT00532844|27085896|P1|Treatment Period - Day 15 to Day 28|Adverse Event|1
7793868|NCT00532844|27085895|P2|Treatment Period - Day 15 to Day 28|Personal reasons|0
7793869|NCT00532844|27085896|P1|Treatment Period - Day 15 to Day 28|Personal reasons|1
7793870|NCT00532844|27085895|P2|Treatment Period - Day 15 to Day 28|Pregnancy|0
7793871|NCT00532844|27085896|P1|Treatment Period - Day 15 to Day 28|Pregnancy|1
7793872|NCT00532844|27085895|P2|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
7793873|NCT00532844|27085896|P1|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
7793874|NCT00532779|27085926|P3|Overall Study|Drug noncompliance, moved, other|29
7793875|NCT00532779|27085927|P2|Overall Study|Drug noncompliance, moved, other|23
7793876|NCT00532779|27085928|P1|Overall Study|Drug noncompliance, moved, other|14
7793877|NCT00532779|27085926|P3|Overall Study|Death|0
7793878|NCT00532779|27085927|P2|Overall Study|Death|1
7793879|NCT00532779|27085928|P1|Overall Study|Death|0
7793880|NCT00532779|27085926|P3|Overall Study|Pregnancy|3
7793881|NCT00532779|27085927|P2|Overall Study|Pregnancy|5
7793882|NCT00532779|27085928|P1|Overall Study|Pregnancy|2
7793883|NCT00532779|27085926|P3|Overall Study|Protocol Violation|7
7793884|NCT00532779|27085927|P2|Overall Study|Protocol Violation|9
7793885|NCT00532779|27085928|P1|Overall Study|Protocol Violation|5
7793886|NCT00532779|27085926|P3|Overall Study|Lack of Efficacy|40
7793887|NCT00532779|27085927|P2|Overall Study|Lack of Efficacy|12
7793888|NCT00532779|27085928|P1|Overall Study|Lack of Efficacy|12
7793889|NCT00532779|27085926|P3|Overall Study|Withdrawal by Subject|90
7793890|NCT00532779|27085927|P2|Overall Study|Withdrawal by Subject|60
7793891|NCT00532779|27085928|P1|Overall Study|Withdrawal by Subject|63
7793892|NCT00532779|27085926|P3|Overall Study|Lost to Follow-up|66
7793893|NCT00532779|27085927|P2|Overall Study|Lost to Follow-up|65
7793894|NCT00532779|27085928|P1|Overall Study|Lost to Follow-up|76
7793895|NCT00532779|27085926|P3|Overall Study|Adverse Event|56
7793896|NCT00532779|27085927|P2|Overall Study|Adverse Event|112
7793897|NCT00532779|27085928|P1|Overall Study|Adverse Event|122
7793898|NCT00532493|27085989|P2|Overall Study|Contraindicative Medication|0
7793899|NCT00532493|27085990|P1|Overall Study|Contraindicative Medication|1
7793900|NCT00532493|27085989|P2|Overall Study|Subject Moved Away|1
7793901|NCT00532493|27085990|P1|Overall Study|Subject Moved Away|3
7793902|NCT00532493|27085989|P2|Overall Study|Protocol Deviation|0
7793903|NCT00532493|27085990|P1|Overall Study|Protocol Deviation|1
7793904|NCT00532493|27085989|P2|Overall Study|Adverse Event|5
7793905|NCT00532493|27085990|P1|Overall Study|Adverse Event|6
7793906|NCT00532493|27085989|P2|Overall Study|Physician Decision|6
7793907|NCT00532493|27085990|P1|Overall Study|Physician Decision|1
7793908|NCT00532493|27085989|P2|Overall Study|Withdrawal by Subject|9
7793909|NCT00532493|27085990|P1|Overall Study|Withdrawal by Subject|7
7793910|NCT00532493|27085989|P2|Overall Study|Lost to Follow-up|7
7793911|NCT00532493|27085990|P1|Overall Study|Lost to Follow-up|10
7793912|NCT00532493|27085989|P2|Overall Study|Death|1
7793913|NCT00532493|27085990|P1|Overall Study|Death|1
7793914|NCT00532441|27086024|P2|Overall Study|Death|0
7793915|NCT00532441|27086025|P1|Overall Study|Death|1
7793916|NCT00532298|27086040|P6|Overall Study|Lost to Follow-up|1
7793917|NCT00532298|27086041|P5|Overall Study|Lost to Follow-up|0
7793918|NCT00532298|27086042|P4|Overall Study|Lost to Follow-up|0
7793919|NCT00532298|27086043|P3|Overall Study|Lost to Follow-up|1
7793920|NCT00532298|27086044|P2|Overall Study|Lost to Follow-up|1
7793921|NCT00532298|27086045|P1|Overall Study|Lost to Follow-up|1
7793922|NCT00532298|27086040|P6|Overall Study|Adverse Event|1
7793923|NCT00532298|27086041|P5|Overall Study|Adverse Event|1
7793924|NCT00532298|27086042|P4|Overall Study|Adverse Event|0
7793925|NCT00532298|27086043|P3|Overall Study|Adverse Event|0
7793926|NCT00532298|27086044|P2|Overall Study|Adverse Event|0
7793927|NCT00532298|27086045|P1|Overall Study|Adverse Event|1
7793928|NCT00532259|27086125|P1|Overall Study|Protocol Violation|1
7793929|NCT00532259|27086125|P1|Overall Study|Physician Decision|3
7793930|NCT00532259|27086125|P1|Overall Study|Lost to Follow-up|3
7793931|NCT00532259|27086125|P1|Overall Study|Lack of Efficacy|21
7793932|NCT00532259|27086125|P1|Overall Study|Death|1
7793933|NCT00532259|27086125|P1|Overall Study|Adverse Event|1
7793934|NCT00532259|27086125|P1|Overall Study|Withdrawal by Subject|2
7793935|NCT00532155|27086132|P2|Overall Study|Did not receive study medication|6
7793936|NCT00532155|27086133|P1|Overall Study|Did not receive study medication|2
7793937|NCT00532155|27086132|P2|Overall Study|Study termination stop further treatment|0
7793938|NCT00532155|27086133|P1|Overall Study|Study termination stop further treatment|4
7793939|NCT00532155|27086132|P2|Overall Study|Study terminated by sponsor|0
7793940|NCT00532155|27086133|P1|Overall Study|Study terminated by sponsor|1
7793941|NCT00532155|27086132|P2|Overall Study|Study stopped|0
7793942|NCT00532155|27086133|P1|Overall Study|Study stopped|1
7793943|NCT00532155|27086132|P2|Overall Study|Had brain metastasis, was mis-randomized|0
7793944|NCT00532155|27086133|P1|Overall Study|Had brain metastasis, was mis-randomized|1
7793945|NCT00532155|27086132|P2|Overall Study|Progressive disease (by incorrect scan)|1
7793946|NCT00532155|27086133|P1|Overall Study|Progressive disease (by incorrect scan)|0
7793947|NCT00532155|27086132|P2|Overall Study|Promotor ended study|0
7793948|NCT00532155|27086133|P1|Overall Study|Promotor ended study|1
7793949|NCT00532155|27086132|P2|Overall Study|Occurence of a secondary cancer|1
7793950|NCT00532155|27086133|P1|Overall Study|Occurence of a secondary cancer|0
7793951|NCT00532155|27086132|P2|Overall Study|Occurence of a second cancer|1
7793952|NCT00532155|27086133|P1|Overall Study|Occurence of a second cancer|0
7793953|NCT00532155|27086132|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
7793954|NCT00532155|27086133|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
7793955|NCT00532155|27086132|P2|Overall Study|Moved|0
7793956|NCT00532155|27086133|P1|Overall Study|Moved|1
7793957|NCT00532155|27086132|P2|Overall Study|Consent withdrawn|7
7793958|NCT00532155|27086133|P1|Overall Study|Consent withdrawn|5
7793959|NCT00532155|27086132|P2|Overall Study|Withdrawal by Subject|44
7793960|NCT00532155|27086133|P1|Overall Study|Withdrawal by Subject|23
7793961|NCT00532155|27086132|P2|Overall Study|Physician Decision|15
7793962|NCT00532155|27086133|P1|Overall Study|Physician Decision|16
7793963|NCT00532155|27086132|P2|Overall Study|Lost to Follow-up|0
7793964|NCT00532155|27086133|P1|Overall Study|Lost to Follow-up|2
7793965|NCT00532155|27086132|P2|Overall Study|Protocol Violation|3
7793966|NCT00532155|27086133|P1|Overall Study|Protocol Violation|1
7793967|NCT00532155|27086132|P2|Overall Study|Lack of Efficacy|255
7793968|NCT00532155|27086133|P1|Overall Study|Lack of Efficacy|332
7793969|NCT00532155|27086132|P2|Overall Study|Adverse Event|123
7793970|NCT00532155|27086133|P1|Overall Study|Adverse Event|66
7793971|NCT00532129|27086147|P1|Follow-up Period|Other|6
7793972|NCT00532129|27086147|P1|Follow-up Period|Lost to Follow-up|1
7793973|NCT00532129|27086147|P1|Follow-up Period|Disease progression|57
7793974|NCT00532129|27086147|P1|Follow-up Period|Adverse event/Serious adverse event|1
7793975|NCT00532129|27086147|P1|Treatment Period|Other|5
7793976|NCT00532129|27086147|P1|Treatment Period|Protocol Violation|1
7793977|NCT00532129|27086147|P1|Treatment Period|Disease progression|3
7793978|NCT00532129|27086147|P1|Treatment Period|Physician Decision|15
7793979|NCT00532129|27086147|P1|Treatment Period|Adverse event/Serious adverse event|25
7793980|NCT00531960|27086167|P2|Overall Study|Other|10
7793981|NCT00531960|27086168|P1|Overall Study|Other|4
7793982|NCT00531960|27086167|P2|Overall Study|Refused Treatment|6
7793983|NCT00531960|27086168|P1|Overall Study|Refused Treatment|5
7793984|NCT00531960|27086167|P2|Overall Study|Violation of Selection Criteria|0
7793985|NCT00531960|27086168|P1|Overall Study|Violation of Selection Criteria|2
7793986|NCT00531960|27086167|P2|Overall Study|Lack of Efficacy|41
7793987|NCT00531960|27086168|P1|Overall Study|Lack of Efficacy|42
7793988|NCT00531960|27086167|P2|Overall Study|Death|2
7793989|NCT00531960|27086168|P1|Overall Study|Death|3
7793990|NCT00531960|27086167|P2|Overall Study|Adverse Event|4
7793991|NCT00531960|27086168|P1|Overall Study|Adverse Event|5
7793992|NCT00531947|27086186|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
7793993|NCT00531947|27086187|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
7793994|NCT00531947|27086186|P2|Overall Study|Non-Compliance|7
7793995|NCT00531947|27086187|P1|Overall Study|Non-Compliance|4
7793996|NCT00531947|27086186|P2|Overall Study|Protocol Violation|1
7793997|NCT00531947|27086187|P1|Overall Study|Protocol Violation|2
7793998|NCT00531947|27086186|P2|Overall Study|Withdrawal by Subject|19
7793999|NCT00531947|27086187|P1|Overall Study|Withdrawal by Subject|14
7794000|NCT00531947|27086186|P2|Overall Study|Lost to Follow-up|9
7794001|NCT00531947|27086187|P1|Overall Study|Lost to Follow-up|12
7794002|NCT00531947|27086186|P2|Overall Study|Adverse Event|10
7794003|NCT00531947|27086187|P1|Overall Study|Adverse Event|5
7794004|NCT00531934|27086231|P2|Overall Study|Other|2
7794005|NCT00531934|27086232|P1|Overall Study|Other|2
7794006|NCT00531934|27086231|P2|Overall Study|Withdrawal by Subject|1
7794007|NCT00531934|27086232|P1|Overall Study|Withdrawal by Subject|1
7794008|NCT00531934|27086231|P2|Overall Study|Death|10
7794009|NCT00531934|27086232|P1|Overall Study|Death|7
7794010|NCT00531934|27086231|P2|Overall Study|Progression|42
7794011|NCT00531934|27086232|P1|Overall Study|Progression|52
7794012|NCT00531934|27086231|P2|Overall Study|Adverse Event|8
7794013|NCT00531934|27086232|P1|Overall Study|Adverse Event|4
7794014|NCT00531752|27086360|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
7794015|NCT00531752|27086361|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
7794016|NCT00531752|27086362|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
7794017|NCT00531752|27086363|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
7794018|NCT00531752|27086360|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
7794019|NCT00531752|27086361|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
7794020|NCT00531752|27086362|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
7794021|NCT00531752|27086363|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
7794022|NCT00531752|27086360|P4|Second Double-blind Intervention Period|Other|0
7794023|NCT00531752|27086361|P3|Second Double-blind Intervention Period|Other|0
7794024|NCT00531752|27086362|P2|Second Double-blind Intervention Period|Other|1
7794025|NCT00531752|27086363|P1|Second Double-blind Intervention Period|Other|1
7794026|NCT00531752|27086360|P4|Second Double-blind Intervention Period|Adverse Event|0
7794027|NCT00531752|27086361|P3|Second Double-blind Intervention Period|Adverse Event|0
7794028|NCT00531752|27086362|P2|Second Double-blind Intervention Period|Adverse Event|1
7794029|NCT00531752|27086363|P1|Second Double-blind Intervention Period|Adverse Event|1
7794030|NCT00531752|27086360|P4|First Double-blind Intervention Period|Randomized but not treated|0
7794031|NCT00531752|27086361|P3|First Double-blind Intervention Period|Randomized but not treated|0
7794032|NCT00531752|27086362|P2|First Double-blind Intervention Period|Randomized but not treated|0
7794033|NCT00531752|27086363|P1|First Double-blind Intervention Period|Randomized but not treated|1
7794034|NCT00531752|27086360|P4|First Double-blind Intervention Period|Lost to Follow-up|1
7794035|NCT00531752|27086361|P3|First Double-blind Intervention Period|Lost to Follow-up|1
7794036|NCT00531752|27086362|P2|First Double-blind Intervention Period|Lost to Follow-up|0
7794037|NCT00531752|27086363|P1|First Double-blind Intervention Period|Lost to Follow-up|0
7794038|NCT00531752|27086360|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
7794039|NCT00531752|27086361|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
7794040|NCT00531752|27086362|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
7794041|NCT00531752|27086363|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
7794042|NCT00531752|27086360|P4|First Double-blind Intervention Period|Other|0
7794043|NCT00531752|27086361|P3|First Double-blind Intervention Period|Other|4
7794044|NCT00531752|27086362|P2|First Double-blind Intervention Period|Other|4
7794045|NCT00531752|27086363|P1|First Double-blind Intervention Period|Other|1
7794046|NCT00531752|27086360|P4|First Double-blind Intervention Period|Adverse Event|1
7794047|NCT00531752|27086361|P3|First Double-blind Intervention Period|Adverse Event|1
7794048|NCT00531752|27086362|P2|First Double-blind Intervention Period|Adverse Event|0
7794049|NCT00531752|27086363|P1|First Double-blind Intervention Period|Adverse Event|2
7794050|NCT00531479|27086474|P2|Overall Study|Did not receive treatment|3
7794051|NCT00531479|27086475|P1|Overall Study|Did not receive treatment|2
7794052|NCT00531479|27086474|P2|Overall Study|Withdrawal by Subject|6
7794053|NCT00531479|27086475|P1|Overall Study|Withdrawal by Subject|6
7794054|NCT00531479|27086474|P2|Overall Study|Other|1
7794055|NCT00531479|27086475|P1|Overall Study|Other|0
7794056|NCT00531479|27086474|P2|Overall Study|Lost to Follow-up|2
7794057|NCT00531479|27086475|P1|Overall Study|Lost to Follow-up|0
7794058|NCT00531479|27086474|P2|Overall Study|Death|71
7794059|NCT00531479|27086475|P1|Overall Study|Death|68
7794060|NCT00531427|27086506|P2|Overall Study|Administrative|9
7794061|NCT00531427|27086507|P1|Overall Study|Administrative|4
7794062|NCT00531427|27086506|P2|Overall Study|Lack of Efficacy|39
7794063|NCT00531427|27086507|P1|Overall Study|Lack of Efficacy|14
7794064|NCT00531427|27086506|P2|Overall Study|Lost to Follow-up|3
7794065|NCT00531427|27086507|P1|Overall Study|Lost to Follow-up|4
7794066|NCT00531427|27086506|P2|Overall Study|Adverse Event|30
7794067|NCT00531427|27086507|P1|Overall Study|Adverse Event|44
7794068|NCT00531427|27086506|P2|Overall Study|Withdrawal by Subject|13
7794069|NCT00531427|27086507|P1|Overall Study|Withdrawal by Subject|7
7794070|NCT00531284|27086535|P17|Overall Study|Other|0
7794071|NCT00531284|27086536|P16|Overall Study|Other|0
7794072|NCT00531284|27086537|P15|Overall Study|Other|1
7794073|NCT00531284|27086538|P14|Overall Study|Other|0
7794074|NCT00531284|27086539|P13|Overall Study|Other|0
7794075|NCT00531284|27086540|P12|Overall Study|Other|2
7794076|NCT00531284|27086541|P11|Overall Study|Other|0
7794077|NCT00531284|27086542|P10|Overall Study|Other|1
7794078|NCT00531284|27086543|P9|Overall Study|Other|2
7794079|NCT00531284|27086544|P8|Overall Study|Other|0
7794080|NCT00531284|27086545|P7|Overall Study|Other|0
7794081|NCT00531284|27086546|P6|Overall Study|Other|1
7794082|NCT00531284|27086547|P5|Overall Study|Other|2
7794083|NCT00531284|27086548|P4|Overall Study|Other|10
7794084|NCT00531284|27086549|P3|Overall Study|Other|0
7794085|NCT00531284|27086550|P2|Overall Study|Other|0
7794086|NCT00531284|27086551|P1|Overall Study|Other|1
7794087|NCT00531284|27086535|P17|Overall Study|Withdrawal by Subject|1
7794088|NCT00531284|27086536|P16|Overall Study|Withdrawal by Subject|1
7794089|NCT00531284|27086537|P15|Overall Study|Withdrawal by Subject|0
7794090|NCT00531284|27086538|P14|Overall Study|Withdrawal by Subject|1
7794091|NCT00531284|27086539|P13|Overall Study|Withdrawal by Subject|0
7794092|NCT00531284|27086540|P12|Overall Study|Withdrawal by Subject|3
7794093|NCT00531284|27086541|P11|Overall Study|Withdrawal by Subject|0
7794094|NCT00531284|27086542|P10|Overall Study|Withdrawal by Subject|0
7794095|NCT00531284|27086543|P9|Overall Study|Withdrawal by Subject|0
7794096|NCT00531284|27086544|P8|Overall Study|Withdrawal by Subject|0
7794097|NCT00531284|27086545|P7|Overall Study|Withdrawal by Subject|0
7794098|NCT00531284|27086546|P6|Overall Study|Withdrawal by Subject|0
7794099|NCT00531284|27086547|P5|Overall Study|Withdrawal by Subject|0
7794100|NCT00531284|27086548|P4|Overall Study|Withdrawal by Subject|4
7794101|NCT00531284|27086549|P3|Overall Study|Withdrawal by Subject|0
7794102|NCT00531284|27086550|P2|Overall Study|Withdrawal by Subject|0
7794103|NCT00531284|27086551|P1|Overall Study|Withdrawal by Subject|1
7794104|NCT00531284|27086535|P17|Overall Study|Adverse Event|2
7794105|NCT00531284|27086536|P16|Overall Study|Adverse Event|0
7794106|NCT00531284|27086537|P15|Overall Study|Adverse Event|1
7794107|NCT00531284|27086538|P14|Overall Study|Adverse Event|1
7794108|NCT00531284|27086539|P13|Overall Study|Adverse Event|0
7794109|NCT00531284|27086540|P12|Overall Study|Adverse Event|5
7794110|NCT00531284|27086541|P11|Overall Study|Adverse Event|0
7794111|NCT00531284|27086542|P10|Overall Study|Adverse Event|0
7794112|NCT00531284|27086543|P9|Overall Study|Adverse Event|3
7794113|NCT00531284|27086544|P8|Overall Study|Adverse Event|2
7794114|NCT00531284|27086545|P7|Overall Study|Adverse Event|3
7794115|NCT00531284|27086546|P6|Overall Study|Adverse Event|2
7794116|NCT00531284|27086547|P5|Overall Study|Adverse Event|0
7794117|NCT00531284|27086548|P4|Overall Study|Adverse Event|7
7794118|NCT00531284|27086549|P3|Overall Study|Adverse Event|1
7794119|NCT00531284|27086550|P2|Overall Study|Adverse Event|1
7794120|NCT00531284|27086551|P1|Overall Study|Adverse Event|0
7794121|NCT00531284|27086535|P17|Overall Study|Progressive Disease|5
7794122|NCT00531284|27086536|P16|Overall Study|Progressive Disease|11
7794123|NCT00531284|27086537|P15|Overall Study|Progressive Disease|2
7794124|NCT00531284|27086538|P14|Overall Study|Progressive Disease|1
7794125|NCT00531284|27086539|P13|Overall Study|Progressive Disease|2
7794126|NCT00531284|27086540|P12|Overall Study|Progressive Disease|14
7794127|NCT00531284|27086541|P11|Overall Study|Progressive Disease|3
7794128|NCT00531284|27086542|P10|Overall Study|Progressive Disease|3
7794129|NCT00531284|27086543|P9|Overall Study|Progressive Disease|6
7794130|NCT00531284|27086544|P8|Overall Study|Progressive Disease|8
7794131|NCT00531284|27086545|P7|Overall Study|Progressive Disease|3
7794132|NCT00531284|27086546|P6|Overall Study|Progressive Disease|4
7794133|NCT00531284|27086547|P5|Overall Study|Progressive Disease|4
7794134|NCT00531284|27086548|P4|Overall Study|Progressive Disease|42
7794135|NCT00531284|27086549|P3|Overall Study|Progressive Disease|5
7794136|NCT00531284|27086550|P2|Overall Study|Progressive Disease|3
7794137|NCT00531284|27086551|P1|Overall Study|Progressive Disease|1
7794138|NCT00531206|27086701|P1|Overall Study|including non-related adverse events|8
7794139|NCT00531206|27086701|P1|Overall Study|Lost to Follow-up|5
7794140|NCT00531206|27086701|P1|Overall Study|Lack of Efficacy|2
7794141|NCT00531206|27086701|P1|Overall Study|Adverse Event related|5
7794142|NCT00531050|27086731|P6|Part 2: Period 3|Abnormal test procedure|1
7794143|NCT00531050|27086732|P5|Part 2: Period 3|Abnormal test procedure|0
7794144|NCT00531050|27086733|P4|Part 2: Period 3|Abnormal test procedure|0
7794145|NCT00531050|27086734|P3|Part 2: Period 3|Abnormal test procedure|0
7794146|NCT00531050|27086735|P2|Part 2: Period 3|Abnormal test procedure|0
7794147|NCT00531050|27086736|P1|Part 2: Period 3|Abnormal test procedure|1
7794148|NCT00531050|27086731|P6|Part 2: Period 1|Adverse Event|1
7794149|NCT00531050|27086732|P5|Part 2: Period 1|Adverse Event|0
7794150|NCT00531050|27086733|P4|Part 2: Period 1|Adverse Event|0
7794151|NCT00531050|27086734|P3|Part 2: Period 1|Adverse Event|0
7794152|NCT00531050|27086735|P2|Part 2: Period 1|Adverse Event|0
7794153|NCT00531050|27086736|P1|Part 2: Period 1|Adverse Event|0
7794154|NCT00531050|27086731|P6|Part 1: Period 3|Adverse Event|0
7794155|NCT00531050|27086732|P5|Part 1: Period 3|Adverse Event|0
7794156|NCT00531050|27086733|P4|Part 1: Period 3|Adverse Event|0
7794157|NCT00531050|27086734|P3|Part 1: Period 3|Adverse Event|0
7794158|NCT00531050|27086735|P2|Part 1: Period 3|Adverse Event|0
7794159|NCT00531050|27086736|P1|Part 1: Period 3|Adverse Event|1
7794160|NCT00531050|27086731|P6|Part 1: Period 1|Protocol Deviation|0
7794161|NCT00531050|27086732|P5|Part 1: Period 1|Protocol Deviation|0
7794162|NCT00531050|27086733|P4|Part 1: Period 1|Protocol Deviation|1
7794163|NCT00531050|27086734|P3|Part 1: Period 1|Protocol Deviation|0
7794164|NCT00531050|27086735|P2|Part 1: Period 1|Protocol Deviation|0
7794165|NCT00531050|27086736|P1|Part 1: Period 1|Protocol Deviation|0
7794166|NCT00531050|27086731|P6|Part 1: Period 1|Adverse Event|0
7794167|NCT00531050|27086732|P5|Part 1: Period 1|Adverse Event|0
7794168|NCT00531050|27086733|P4|Part 1: Period 1|Adverse Event|0
7794169|NCT00531050|27086734|P3|Part 1: Period 1|Adverse Event|0
7794170|NCT00531050|27086735|P2|Part 1: Period 1|Adverse Event|1
7794171|NCT00531050|27086736|P1|Part 1: Period 1|Adverse Event|0
7794172|NCT00531011|27086765|P2|Overall Study|Physician Decision|3
7794173|NCT00531011|27086766|P1|Overall Study|Physician Decision|0
7794174|NCT00531011|27086765|P2|Overall Study|Lost to Follow-up|0
7794175|NCT00531011|27086766|P1|Overall Study|Lost to Follow-up|1
7794176|NCT00531011|27086765|P2|Overall Study|Death|0
7794177|NCT00531011|27086766|P1|Overall Study|Death|1
7794178|NCT00531011|27086765|P2|Overall Study|Withdrawal by Subject|4
7794179|NCT00531011|27086766|P1|Overall Study|Withdrawal by Subject|2
7794180|NCT00530946|27086812|P4|Overall Study|Noncompliance|0
7794181|NCT00530946|27086813|P3|Overall Study|Noncompliance|0
7794182|NCT00530946|27086814|P2|Overall Study|Noncompliance|0
7794183|NCT00530946|27086815|P1|Overall Study|Noncompliance|1
7794184|NCT00530946|27086812|P4|Overall Study|Protocol Violation|1
7794185|NCT00530946|27086813|P3|Overall Study|Protocol Violation|0
7794186|NCT00530946|27086814|P2|Overall Study|Protocol Violation|0
7794187|NCT00530946|27086815|P1|Overall Study|Protocol Violation|0
7794188|NCT00530946|27086812|P4|Overall Study|Adverse Event|1
7794189|NCT00530946|27086813|P3|Overall Study|Adverse Event|1
7794190|NCT00530946|27086814|P2|Overall Study|Adverse Event|2
7794191|NCT00530946|27086815|P1|Overall Study|Adverse Event|1
7794192|NCT00530920|27086868|P3|Overall Study|Withdrawal by Subject|1
7794193|NCT00530920|27086869|P2|Overall Study|Withdrawal by Subject|0
7794194|NCT00530920|27086870|P1|Overall Study|Withdrawal by Subject|0
7794195|NCT00530920|27086868|P3|Overall Study|Adverse Event|3
7794196|NCT00530920|27086869|P2|Overall Study|Adverse Event|0
7794197|NCT00530920|27086870|P1|Overall Study|Adverse Event|0
7794198|NCT00530920|27086868|P3|Overall Study|Randomized but not treated|0
7794199|NCT00530920|27086869|P2|Overall Study|Randomized but not treated|2
7794200|NCT00530920|27086870|P1|Overall Study|Randomized but not treated|0
7794201|NCT00530894|27086930|P4|Overall Study|Alive and censored prior to 1 year|0
7794202|NCT00530894|27086931|P3|Overall Study|Alive and censored prior to 1 year|0
7794203|NCT00530894|27086932|P2|Overall Study|Alive and censored prior to 1 year|0
7794204|NCT00530894|27086933|P1|Overall Study|Alive and censored prior to 1 year|2
7794205|NCT00530894|27086930|P4|Overall Study|Withdrawal by Subject|5
7794206|NCT00530894|27086931|P3|Overall Study|Withdrawal by Subject|0
7794207|NCT00530894|27086932|P2|Overall Study|Withdrawal by Subject|23
7794208|NCT00530894|27086933|P1|Overall Study|Withdrawal by Subject|1
7794209|NCT00530894|27086930|P4|Overall Study|Lost to Follow-up|0
7794210|NCT00530894|27086931|P3|Overall Study|Lost to Follow-up|0
7794211|NCT00530894|27086932|P2|Overall Study|Lost to Follow-up|3
7794212|NCT00530894|27086933|P1|Overall Study|Lost to Follow-up|1
7794213|NCT00530894|27086930|P4|Overall Study|Death|89
7794214|NCT00530894|27086931|P3|Overall Study|Death|55
7794215|NCT00530894|27086932|P2|Overall Study|Death|89
7794216|NCT00530894|27086933|P1|Overall Study|Death|84
7794217|NCT00530855|27086961|P1|Overall Study|Other reason for premature termination|17
7794218|NCT00530855|27086961|P1|Overall Study|Lost to Follow-up|9
7794219|NCT00530855|27086961|P1|Overall Study|Unsatisfactory compliance of subject|11
7794220|NCT00530855|27086961|P1|Overall Study|Protocol Violation|3
7794221|NCT00530855|27086961|P1|Overall Study|Non Fatal Non Serious AE|12
7794222|NCT00530855|27086961|P1|Overall Study|Non Fatal Serious AE|7
7794223|NCT00530855|27086961|P1|Overall Study|Fatal Serious AE|3
7794224|NCT00530855|27086961|P1|Overall Study|Withdrawal by Subject|30
7794225|NCT00530855|27086961|P1|Overall Study|Lack of Efficacy|20
7794226|NCT00530842|27086970|P2|Period 2|Individual different reasons|0
7794227|NCT00530842|27086971|P1|Period 2|Individual different reasons|2
7794228|NCT00530842|27086970|P2|Period 2|Withdrawal by Subject|2
7794229|NCT00530842|27086971|P1|Period 2|Withdrawal by Subject|1
7794230|NCT00530842|27086970|P2|Period 2|Protocol Violation|0
7794231|NCT00530842|27086971|P1|Period 2|Protocol Violation|1
7794232|NCT00530842|27086970|P2|Period 2|Lost to Follow-up|4
7794233|NCT00530842|27086971|P1|Period 2|Lost to Follow-up|0
7794234|NCT00530842|27086970|P2|Period 2|Lack of Efficacy|0
7794235|NCT00530842|27086971|P1|Period 2|Lack of Efficacy|1
7794236|NCT00530842|27086970|P2|Period 2|Adverse Event|3
7794237|NCT00530842|27086971|P1|Period 2|Adverse Event|3
7794238|NCT00530842|27086970|P2|Period 1|Individual different reasons|3
7794239|NCT00530842|27086971|P1|Period 1|Individual different reasons|2
7794240|NCT00530842|27086970|P2|Period 1|Withdrawal by Subject|3
7794241|NCT00530842|27086971|P1|Period 1|Withdrawal by Subject|2
7794242|NCT00530842|27086970|P2|Period 1|Protocol Violation|1
7794243|NCT00530842|27086971|P1|Period 1|Protocol Violation|2
7794244|NCT00530842|27086970|P2|Period 1|Lack of Efficacy|1
7794245|NCT00530842|27086971|P1|Period 1|Lack of Efficacy|1
7794246|NCT00530842|27086970|P2|Period 1|Adverse Event|3
7794247|NCT00530842|27086971|P1|Period 1|Adverse Event|7
7794248|NCT00530842|27086970|P2|Overall Study|Individual different reasons|3
7794249|NCT00530842|27086971|P1|Overall Study|Individual different reasons|4
7794250|NCT00530842|27086970|P2|Overall Study|Withdrawal by Subject|5
7794251|NCT00530842|27086971|P1|Overall Study|Withdrawal by Subject|4
7794252|NCT00530842|27086970|P2|Overall Study|Protocol Violation|2
7794253|NCT00530842|27086971|P1|Overall Study|Protocol Violation|3
7794254|NCT00530842|27086970|P2|Overall Study|Lost to Follow-up|4
7794255|NCT00530842|27086971|P1|Overall Study|Lost to Follow-up|0
7794256|NCT00530842|27086970|P2|Overall Study|Lack of Efficacy|1
7794257|NCT00530842|27086971|P1|Overall Study|Lack of Efficacy|2
7794258|NCT00530842|27086970|P2|Overall Study|Adverse Event|6
7794259|NCT00530842|27086971|P1|Overall Study|Adverse Event|10
7794260|NCT00530816|27087098|P3|Overall Study|Withdrawal by Subject|6
7794261|NCT00530816|27087099|P2|Overall Study|Withdrawal by Subject|2
7794262|NCT00530816|27087100|P1|Overall Study|Withdrawal by Subject|1
7794263|NCT00530816|27087098|P3|Overall Study|Other|4
7794264|NCT00530816|27087099|P2|Overall Study|Other|3
7794265|NCT00530816|27087100|P1|Overall Study|Other|3
7794266|NCT00530816|27087098|P3|Overall Study|Adverse Event|7
7794267|NCT00530816|27087099|P2|Overall Study|Adverse Event|13
7794268|NCT00530816|27087100|P1|Overall Study|Adverse Event|6
7794269|NCT00530816|27087098|P3|Overall Study|Progressive Disease|24
7794270|NCT00530816|27087099|P2|Overall Study|Progressive Disease|24
7794271|NCT00530816|27087100|P1|Overall Study|Progressive Disease|16
7794272|NCT00530790|27087143|P1|Overall Study|Physician Decision|1
7794273|NCT00530790|27087143|P1|Overall Study|Withdrawal by Subject|2
7794274|NCT00530790|27087143|P1|Overall Study|Adverse Event|2
7794275|NCT00530777|27087165|P2|Overall Study|Unable to adhere to visit schedule|1
7794276|NCT00530777|27087166|P1|Overall Study|Unable to adhere to visit schedule|5
7794277|NCT00530777|27087165|P2|Overall Study|Withdrawal by Subject|1
7794278|NCT00530777|27087166|P1|Overall Study|Withdrawal by Subject|0
7794279|NCT00530777|27087165|P2|Overall Study|Physician Decision|0
7794280|NCT00530777|27087166|P1|Overall Study|Physician Decision|1
7794281|NCT00530777|27087165|P2|Overall Study|Death|2
7794282|NCT00530777|27087166|P1|Overall Study|Death|1
7794283|NCT00530777|27087165|P2|Overall Study|Lost to Follow-up|1
7794284|NCT00530777|27087166|P1|Overall Study|Lost to Follow-up|0
7794285|NCT00530712|27087223|P1|12 Month Follow-up Visit|Death|9
7794286|NCT00530712|27087223|P1|12 Month Follow-up Visit|Lost to Follow-up|7
7794287|NCT00530712|27087223|P1|12 Month Follow-up Visit|Missed Visit|3
7794288|NCT00530712|27087223|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
7794289|NCT00530712|27087223|P1|6 Month Follow-up Visit|Death|2
7794290|NCT00530712|27087223|P1|6 Month Follow-up Visit|Lost to Follow-up|3
7794291|NCT00530712|27087223|P1|6 Month Follow-up Visit|Missed Visit|3
7794292|NCT00530712|27087223|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
7794293|NCT00530712|27087223|P1|30 Day Follow-up Visit|Missed Visit|5
7794294|NCT00530712|27087223|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
7794295|NCT00530621|27087246|P2|Overall Study|Not Treated Due to PD Prior to Dosing|0
7794296|NCT00530621|27087247|P1|Overall Study|Not Treated Due to PD Prior to Dosing|1
7794297|NCT00530621|27087246|P2|Overall Study|Death|6
7794298|NCT00530621|27087247|P1|Overall Study|Death|3
7794299|NCT00530621|27087246|P2|Overall Study|Subject Decision|7
7794300|NCT00530621|27087247|P1|Overall Study|Subject Decision|4
7794301|NCT00530621|27087246|P2|Overall Study|Sponsor Decision|15
7794302|NCT00530621|27087247|P1|Overall Study|Sponsor Decision|12
7794303|NCT00530621|27087246|P2|Overall Study|Progressive Disease (PD)|40
7794304|NCT00530621|27087247|P1|Overall Study|Progressive Disease (PD)|47
7794305|NCT00530621|27087246|P2|Overall Study|Physician Decision|4
7794306|NCT00530621|27087247|P1|Overall Study|Physician Decision|2
7794307|NCT00530621|27087246|P2|Overall Study|Adverse Event|8
7794308|NCT00530621|27087247|P1|Overall Study|Adverse Event|11
7794309|NCT00530504|27087268|P1|Overall Study|Exited study due to other reasons|33
7794310|NCT00530504|27087268|P1|Overall Study|Withdrawal by Subject|39
7794311|NCT00530504|27087268|P1|Overall Study|Lost to Follow-up|26
7794312|NCT00530504|27087268|P1|Overall Study|Death|54
7794313|NCT00530439|27087274|P2|Overall Study|Severe malformation/abortion|3
7794314|NCT00530439|27087275|P1|Overall Study|Severe malformation/abortion|0
7794315|NCT00530439|27087274|P2|Overall Study|Twin pregnancy|2
7794316|NCT00530439|27087275|P1|Overall Study|Twin pregnancy|0
7794317|NCT00530439|27087274|P2|Overall Study|Misclassification|0
7794318|NCT00530439|27087275|P1|Overall Study|Misclassification|2
7794319|NCT00530439|27087274|P2|Overall Study|Missed abortion|4
7794320|NCT00530439|27087275|P1|Overall Study|Missed abortion|1
7794321|NCT00530439|27087274|P2|Overall Study|Withdraw|14
7794322|NCT00530439|27087275|P1|Overall Study|Withdraw|18
7794323|NCT00530439|27087274|P2|Overall Study|GDM|3
7794324|NCT00530439|27087275|P1|Overall Study|GDM|9
7794325|NCT00530348|27087283|P2|Overall Study|Noncompliance with inclusion criterion 3|1
7794326|NCT00530348|27087284|P1|Overall Study|Noncompliance with inclusion criterion 3|0
7794327|NCT00530348|27087283|P2|Overall Study|Randomised in error|0
7794328|NCT00530348|27087284|P1|Overall Study|Randomised in error|1
7794329|NCT00530348|27087283|P2|Overall Study|Withdrawal by Subject|12
7794330|NCT00530348|27087284|P1|Overall Study|Withdrawal by Subject|12
7794331|NCT00530348|27087283|P2|Overall Study|Pregnancy|0
7794332|NCT00530348|27087284|P1|Overall Study|Pregnancy|1
7794333|NCT00530348|27087283|P2|Overall Study|Physician Decision|2
7794334|NCT00530348|27087284|P1|Overall Study|Physician Decision|1
7794335|NCT00530348|27087283|P2|Overall Study|Lost to Follow-up|2
7794336|NCT00530348|27087284|P1|Overall Study|Lost to Follow-up|0
7794337|NCT00530348|27087283|P2|Overall Study|Lack of Efficacy|0
7794338|NCT00530348|27087284|P1|Overall Study|Lack of Efficacy|2
7794339|NCT00530348|27087283|P2|Overall Study|Death|1
7794340|NCT00530348|27087284|P1|Overall Study|Death|0
7794341|NCT00530348|27087283|P2|Overall Study|Adverse Event|1
7794342|NCT00530348|27087284|P1|Overall Study|Adverse Event|5
7794343|NCT00530335|27087300|P1|Overall Study|Physician Decision|1
7794344|NCT00530335|27087300|P1|Overall Study|Withdrawal by Subject|1
7794345|NCT00530335|27087300|P1|Overall Study|Protocol Violation|1
7794346|NCT00530335|27087300|P1|Overall Study|Adverse Event|3
7794347|NCT00530270|27087317|P2|Overall Study|Protocol Violation|0
7794348|NCT00530270|27087318|P1|Overall Study|Protocol Violation|1
7794349|NCT00530257|27087332|P1|Overall Study|Lost to Follow-up|1
7794350|NCT00530218|27087360|P1|Overall Study|Death|12
7794351|NCT00530218|27087360|P1|Overall Study|CMV Not Detected|13
7794352|NCT00530088|27087367|P1|Overall Study|Other Not Specified|2
7794353|NCT00530088|27087367|P1|Overall Study|Physician Decision|4
7794354|NCT00530088|27087367|P1|Overall Study|Disease Progression|4
7794355|NCT00530075|27087372|P1|Overall Study|Withdrawal by Subject|1
7794356|NCT00530075|27087372|P1|Overall Study|Protocol Violation|1
7794357|NCT00530075|27087372|P1|Overall Study|Lack of Efficacy|3
7794358|NCT00530075|27087372|P1|Overall Study|Death|1
7794359|NCT00530075|27087372|P1|Overall Study|Adverse Event|1
7794360|NCT00530023|27087385|P2|Overall Study|Withdrawal by Subject|1
7794361|NCT00530023|27087386|P1|Overall Study|Withdrawal by Subject|0
7794362|NCT00529958|27087403|P3|5-Year Follow-up|Withdrawal by Subject|0
7794363|NCT00529958|27087404|P2|5-Year Follow-up|Withdrawal by Subject|0
7794364|NCT00529958|27087405|P1|5-Year Follow-up|Withdrawal by Subject|1
7794365|NCT00529958|27087403|P3|5-Year Follow-up|Lost to Follow-up|1
7794366|NCT00529958|27087404|P2|5-Year Follow-up|Lost to Follow-up|3
7794367|NCT00529958|27087405|P1|5-Year Follow-up|Lost to Follow-up|2
7794368|NCT00529958|27087403|P3|2-Year Follow-up|Withdrawal by Subject|0
7794369|NCT00529958|27087404|P2|2-Year Follow-up|Withdrawal by Subject|0
7794370|NCT00529958|27087405|P1|2-Year Follow-up|Withdrawal by Subject|3
7794371|NCT00529958|27087403|P3|2-Year Follow-up|Lost to Follow-up|2
7794372|NCT00529958|27087404|P2|2-Year Follow-up|Lost to Follow-up|2
7794373|NCT00529958|27087405|P1|2-Year Follow-up|Lost to Follow-up|1
7794374|NCT00529802|27087446|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
7794375|NCT00529802|27087446|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
7794376|NCT00529802|27087446|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
7794377|NCT00529802|27087446|P1|Evaluable for Primary Endpoint|Death|1
7794378|NCT00529802|27087446|P1|Evaluable for Primary Endpoint|Adverse Event|2
7794379|NCT00529802|27087446|P1|Evaluable for Primary Endpoint|Worsening performance status|2
7794380|NCT00529802|27087446|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
7794381|NCT00529789|27087452|P1|Study Period IV|Lost to Follow-up|3
7794382|NCT00529789|27087452|P1|Study Period IV|Lack of Efficacy|1
7794383|NCT00529789|27087452|P1|Study Period IV|Adverse Event|1
7794384|NCT00529789|27087452|P1|Study Period IV|Parent/Caregiver Decision|1
7794385|NCT00529789|27087452|P1|Study Period II/III|Lost to Follow-up|3
7794386|NCT00529789|27087452|P1|Study Period II/III|Physician Decision|3
7794387|NCT00529789|27087452|P1|Study Period II/III|Protocol Violation|3
7794388|NCT00529789|27087452|P1|Study Period II/III|Withdrawal by Subject|1
7794389|NCT00529789|27087452|P1|Study Period II/III|Lack of Efficacy|2
7794390|NCT00529789|27087452|P1|Study Period II/III|Adverse Event|3
7794391|NCT00529789|27087452|P1|Study Period II/III|Parent/Caregiver Decision|9
7794392|NCT00529763|27087477|P3|Overall Study|Patient Withdrew Consent|2
7794393|NCT00529763|27087478|P2|Overall Study|Patient Withdrew Consent|3
7794394|NCT00529763|27087479|P1|Overall Study|Patient Withdrew Consent|2
7794395|NCT00529763|27087477|P3|Overall Study|Study Drug Toxicity|1
7794396|NCT00529763|27087478|P2|Overall Study|Study Drug Toxicity|6
7794397|NCT00529763|27087479|P1|Overall Study|Study Drug Toxicity|1
7794398|NCT00529763|27087477|P3|Overall Study|Stem Cell Transplant|0
7794399|NCT00529763|27087478|P2|Overall Study|Stem Cell Transplant|3
7794400|NCT00529763|27087479|P1|Overall Study|Stem Cell Transplant|0
7794401|NCT00529763|27087477|P3|Overall Study|Lost to Follow-up|1
7794402|NCT00529763|27087478|P2|Overall Study|Lost to Follow-up|1
7794403|NCT00529763|27087479|P1|Overall Study|Lost to Follow-up|0
7794404|NCT00529763|27087477|P3|Overall Study|Disease Progression|1
7794405|NCT00529763|27087478|P2|Overall Study|Disease Progression|16
7794406|NCT00529763|27087479|P1|Overall Study|Disease Progression|6
7794407|NCT00529763|27087477|P3|Overall Study|Death|1
7794408|NCT00529763|27087478|P2|Overall Study|Death|1
7794409|NCT00529763|27087479|P1|Overall Study|Death|0
7794410|NCT00529763|27087477|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
7794411|NCT00529763|27087478|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
7794412|NCT00529763|27087479|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
7794413|NCT00529659|27087517|P2|Overall Study|Withdrawal by Subject|6
7794414|NCT00529659|27087518|P1|Overall Study|Withdrawal by Subject|1
7794415|NCT00529659|27087517|P2|Overall Study|Protocol Violation|6
7794416|NCT00529659|27087518|P1|Overall Study|Protocol Violation|2
7794417|NCT00529659|27087517|P2|Overall Study|Physician Decision|2
7794418|NCT00529659|27087518|P1|Overall Study|Physician Decision|0
7794419|NCT00529659|27087517|P2|Overall Study|Lost to Follow-up|2
7794420|NCT00529659|27087518|P1|Overall Study|Lost to Follow-up|0
7794421|NCT00529659|27087517|P2|Overall Study|Adverse Event|7
7794422|NCT00529659|27087518|P1|Overall Study|Adverse Event|8
7794423|NCT00529633|27087536|P2|Overall Study|Withdrawal by Subject|1
7794424|NCT00529633|27087537|P1|Overall Study|Withdrawal by Subject|1
7794425|NCT00529568|27087549|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
7794426|NCT00529568|27087550|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
7794427|NCT00529568|27087551|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
7794428|NCT00529568|27087549|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
7794429|NCT00529568|27087550|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
7794430|NCT00529568|27087551|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
7794431|NCT00529568|27087549|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
7794432|NCT00529568|27087550|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
7794433|NCT00529568|27087551|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
7794434|NCT00529568|27087549|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
7794435|NCT00529568|27087550|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
7794436|NCT00529568|27087551|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
7794437|NCT00529568|27087549|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
7794438|NCT00529568|27087550|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
7794439|NCT00529568|27087551|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
7794440|NCT00529568|27087549|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
7794441|NCT00529568|27087550|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
7794442|NCT00529568|27087551|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
7794443|NCT00529568|27087549|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
7794444|NCT00529568|27087550|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
7794445|NCT00529568|27087551|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
7794446|NCT00529568|27087549|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
7794447|NCT00529568|27087550|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
7794448|NCT00529568|27087551|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
7794449|NCT00529568|27087549|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
7794450|NCT00529568|27087550|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
7794451|NCT00529568|27087551|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
7794452|NCT00529568|27087549|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
7794453|NCT00529568|27087550|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
7794454|NCT00529568|27087551|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
7794455|NCT00529568|27087549|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
7794456|NCT00529568|27087550|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
7794457|NCT00529568|27087551|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
7794458|NCT00529542|27087614|P2|Overall Study|Lost to Follow-up|1
7794459|NCT00529542|27087615|P1|Overall Study|Lost to Follow-up|0
7794460|NCT00529542|27087614|P2|Overall Study|Withdrawal by Subject|0
7794461|NCT00529542|27087615|P1|Overall Study|Withdrawal by Subject|1
7794462|NCT00529529|27087658|P3|Overall Study|Administrative problems|3
7794463|NCT00529529|27087659|P2|Overall Study|Administrative problems|0
7794464|NCT00529529|27087660|P1|Overall Study|Administrative problems|1
7794465|NCT00529529|27087658|P3|Overall Study|Abnormal test procedure result(s)|0
7794466|NCT00529529|27087659|P2|Overall Study|Abnormal test procedure result(s)|0
7794467|NCT00529529|27087660|P1|Overall Study|Abnormal test procedure result(s)|1
7794468|NCT00529529|27087658|P3|Overall Study|Death|0
7794469|NCT00529529|27087659|P2|Overall Study|Death|0
7794470|NCT00529529|27087660|P1|Overall Study|Death|2
7794471|NCT00529529|27087658|P3|Overall Study|Unsatisfactory therapeutic effect|2
7794472|NCT00529529|27087659|P2|Overall Study|Unsatisfactory therapeutic effect|2
7794473|NCT00529529|27087660|P1|Overall Study|Unsatisfactory therapeutic effect|2
7794474|NCT00529529|27087658|P3|Overall Study|Lost to Follow-up|1
7794475|NCT00529529|27087659|P2|Overall Study|Lost to Follow-up|3
7794476|NCT00529529|27087660|P1|Overall Study|Lost to Follow-up|5
7794477|NCT00529529|27087658|P3|Overall Study|Protocol deviation|5
7794478|NCT00529529|27087659|P2|Overall Study|Protocol deviation|12
7794479|NCT00529529|27087660|P1|Overall Study|Protocol deviation|8
7794480|NCT00529529|27087658|P3|Overall Study|Subject withdrew consent|12
7794481|NCT00529529|27087659|P2|Overall Study|Subject withdrew consent|9
7794482|NCT00529529|27087660|P1|Overall Study|Subject withdrew consent|12
7794483|NCT00529529|27087658|P3|Overall Study|Adverse Event|8
7794484|NCT00529529|27087659|P2|Overall Study|Adverse Event|17
7794485|NCT00529529|27087660|P1|Overall Study|Adverse Event|12
7794486|NCT00529516|27087719|P3|Overall Study|Lost to Follow-up|1
7794487|NCT00529516|27087720|P2|Overall Study|Lost to Follow-up|0
7794488|NCT00529516|27087721|P1|Overall Study|Lost to Follow-up|0
7794489|NCT00529516|27087719|P3|Overall Study|Withdrawal by Subject|0
7794490|NCT00529516|27087720|P2|Overall Study|Withdrawal by Subject|1
7794491|NCT00529516|27087721|P1|Overall Study|Withdrawal by Subject|1
7794492|NCT00529516|27087719|P3|Overall Study|Adverse Event|0
7794493|NCT00529516|27087720|P2|Overall Study|Adverse Event|1
7794494|NCT00529516|27087721|P1|Overall Study|Adverse Event|2
7794495|NCT00529451|27087806|P4|Overall Study|Administrative problems|2
7794496|NCT00529451|27087807|P3|Overall Study|Administrative problems|0
7794497|NCT00529451|27087808|P2|Overall Study|Administrative problems|1
7794498|NCT00529451|27087809|P1|Overall Study|Administrative problems|1
7794499|NCT00529451|27087806|P4|Overall Study|Protocol deviation|1
7794500|NCT00529451|27087807|P3|Overall Study|Protocol deviation|4
7794501|NCT00529451|27087808|P2|Overall Study|Protocol deviation|1
7794502|NCT00529451|27087809|P1|Overall Study|Protocol deviation|1
7794503|NCT00529451|27087806|P4|Overall Study|Lost to Follow-up|4
7794504|NCT00529451|27087807|P3|Overall Study|Lost to Follow-up|4
7794505|NCT00529451|27087808|P2|Overall Study|Lost to Follow-up|7
7794506|NCT00529451|27087809|P1|Overall Study|Lost to Follow-up|4
7794507|NCT00529451|27087806|P4|Overall Study|Unsatisfactory therapeutic response|4
7794508|NCT00529451|27087807|P3|Overall Study|Unsatisfactory therapeutic response|5
7794509|NCT00529451|27087808|P2|Overall Study|Unsatisfactory therapeutic response|2
7794510|NCT00529451|27087809|P1|Overall Study|Unsatisfactory therapeutic response|6
7794511|NCT00529451|27087806|P4|Overall Study|Adverse Event|8
7794512|NCT00529451|27087807|P3|Overall Study|Adverse Event|14
7794513|NCT00529451|27087808|P2|Overall Study|Adverse Event|16
7794514|NCT00529451|27087809|P1|Overall Study|Adverse Event|9
7794515|NCT00529451|27087806|P4|Overall Study|Subject withdrew consent|12
7794516|NCT00529451|27087807|P3|Overall Study|Subject withdrew consent|13
7794517|NCT00529451|27087808|P2|Overall Study|Subject withdrew consent|21
7794518|NCT00529451|27087809|P1|Overall Study|Subject withdrew consent|16
7794519|NCT00529399|27087836|P3|Overall Study|Non-compliant|0
7794520|NCT00529399|27087837|P2|Overall Study|Non-compliant|1
7794521|NCT00529399|27087838|P1|Overall Study|Non-compliant|0
7794522|NCT00529399|27087836|P3|Overall Study|Withdrawal by Subject|1
7794523|NCT00529399|27087837|P2|Overall Study|Withdrawal by Subject|0
7794524|NCT00529399|27087838|P1|Overall Study|Withdrawal by Subject|1
7794525|NCT00529399|27087836|P3|Overall Study|Lost to Follow-up|1
7794526|NCT00529399|27087837|P2|Overall Study|Lost to Follow-up|0
7794527|NCT00529399|27087838|P1|Overall Study|Lost to Follow-up|1
7794528|NCT00529386|27087846|P1|Overall Study|Lost to Follow-up|1
7794529|NCT00529373|27087852|P2|Second Extension Study|Status Missing|5
7794530|NCT00529373|27087853|P1|Second Extension Study|Status Missing|5
7794531|NCT00529373|27087852|P2|Second Extension Study|Withdrawal by Subject|75
7794532|NCT00529373|27087853|P1|Second Extension Study|Withdrawal by Subject|97
7794533|NCT00529373|27087852|P2|Second Extension Study|Protocol Violation|1
7794534|NCT00529373|27087853|P1|Second Extension Study|Protocol Violation|2
7794535|NCT00529373|27087852|P2|Second Extension Study|Physician Decision|26
7794536|NCT00529373|27087853|P1|Second Extension Study|Physician Decision|63
7794537|NCT00529373|27087852|P2|Second Extension Study|Other|12
7794538|NCT00529373|27087853|P1|Second Extension Study|Other|7
7794539|NCT00529373|27087852|P2|Second Extension Study|Lost to Follow-up|12
7794540|NCT00529373|27087853|P1|Second Extension Study|Lost to Follow-up|18
7794541|NCT00529373|27087852|P2|Second Extension Study|Lack of Efficacy|15
7794542|NCT00529373|27087853|P1|Second Extension Study|Lack of Efficacy|7
7794543|NCT00529373|27087852|P2|Second Extension Study|Adverse Event|51
7794544|NCT00529373|27087853|P1|Second Extension Study|Adverse Event|101
7794545|NCT00529373|27087852|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
7794546|NCT00529373|27087853|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
7794547|NCT00529373|27087852|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
7794548|NCT00529373|27087853|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
7794549|NCT00529373|27087852|P2|First Extension Study|Discontinued after 5 years completion|346
7794550|NCT00529373|27087853|P1|First Extension Study|Discontinued after 5 years completion|208
7794551|NCT00529373|27087852|P2|First Extension Study|Disposition record non-existing|1
7794552|NCT00529373|27087853|P1|First Extension Study|Disposition record non-existing|0
7794553|NCT00529373|27087852|P2|First Extension Study|Withdrawal by Subject|287
7794554|NCT00529373|27087853|P1|First Extension Study|Withdrawal by Subject|296
7794555|NCT00529373|27087852|P2|First Extension Study|Protocol Violation|13
7794556|NCT00529373|27087853|P1|First Extension Study|Protocol Violation|16
7794557|NCT00529373|27087852|P2|First Extension Study|Physician Decision|45
7794558|NCT00529373|27087853|P1|First Extension Study|Physician Decision|50
7794559|NCT00529373|27087852|P2|First Extension Study|Other|47
7794560|NCT00529373|27087853|P1|First Extension Study|Other|27
7794561|NCT00529373|27087852|P2|First Extension Study|Lost to Follow-up|37
7794562|NCT00529373|27087853|P1|First Extension Study|Lost to Follow-up|41
7794563|NCT00529373|27087852|P2|First Extension Study|Lack of Efficacy|427
7794564|NCT00529373|27087853|P1|First Extension Study|Lack of Efficacy|65
7794565|NCT00529373|27087852|P2|First Extension Study|Adverse Event|142
7794566|NCT00529373|27087853|P1|First Extension Study|Adverse Event|162
7794567|NCT00529373|27087852|P2|Base Study|Did not continue into Extension|2238
7794568|NCT00529373|27087853|P1|Base Study|Did not continue into Extension|1795
7794569|NCT00529373|27087852|P2|Base Study|Withdrawal by Subject|967
7794570|NCT00529373|27087853|P1|Base Study|Withdrawal by Subject|1062
7794571|NCT00529373|27087852|P2|Base Study|Protocol Violation|38
7794572|NCT00529373|27087853|P1|Base Study|Protocol Violation|48
7794573|NCT00529373|27087852|P2|Base Study|Physician Decision|52
7794574|NCT00529373|27087853|P1|Base Study|Physician Decision|60
7794575|NCT00529373|27087852|P2|Base Study|Other Protocol Specified Criteria|20
7794576|NCT00529373|27087853|P1|Base Study|Other Protocol Specified Criteria|19
7794577|NCT00529373|27087852|P2|Base Study|Lost to Follow-up|208
7794578|NCT00529373|27087853|P1|Base Study|Lost to Follow-up|221
7794579|NCT00529373|27087852|P2|Base Study|Lack of Efficacy|75
7794580|NCT00529373|27087853|P1|Base Study|Lack of Efficacy|16
7794581|NCT00529373|27087852|P2|Base Study|Adverse Event|470
7794582|NCT00529373|27087853|P1|Base Study|Adverse Event|525
7794583|NCT00529308|27088047|P2|Overall Study|Withdrawal by Subject|1
7794584|NCT00529308|27088048|P1|Overall Study|Withdrawal by Subject|1
7794585|NCT00529243|27088077|P1|Overall Study|Relocated|1
7794586|NCT00529243|27088077|P1|Overall Study|Death|1
7794587|NCT00529243|27088077|P1|Overall Study|Adverse Event|1
7794588|NCT00529217|27088082|P1|Overall Study|Unable to adhere to study schedule|2
7794589|NCT00529217|27088082|P1|Overall Study|Lack of Efficacy|2
7794590|NCT00529152|27088118|P1|Overall Study|Lost to Follow-up|1
7794591|NCT00529152|27088118|P1|Overall Study|Withdrawal by Subject|2
7794592|NCT00529152|27088118|P1|Overall Study|Adverse Event|2
7794593|NCT00529100|27088142|P2|Overall Study|Participant Ineligibility|1
7794594|NCT00529100|27088143|P1|Overall Study|Participant Ineligibility|0
7794595|NCT00529100|27088142|P2|Overall Study|Withdrawal by Subject|1
7794596|NCT00529100|27088143|P1|Overall Study|Withdrawal by Subject|0
7794597|NCT00529100|27088142|P2|Overall Study|Progressive Disease|1
7794598|NCT00529100|27088143|P1|Overall Study|Progressive Disease|0
7794599|NCT00529100|27088142|P2|Overall Study|Protocol Violation|1
7794600|NCT00529100|27088143|P1|Overall Study|Protocol Violation|0
7794601|NCT00529100|27088142|P2|Overall Study|Adverse Event|5
7794602|NCT00529100|27088143|P1|Overall Study|Adverse Event|0
7794603|NCT00529087|27088160|P3|Overall Study|Protocol deviation|2
7794604|NCT00529087|27088161|P2|Overall Study|Protocol deviation|1
7794605|NCT00529087|27088162|P1|Overall Study|Protocol deviation|1
7794606|NCT00529087|27088160|P3|Overall Study|Withdrawal by Subject|3
7794607|NCT00529087|27088161|P2|Overall Study|Withdrawal by Subject|3
7794608|NCT00529087|27088162|P1|Overall Study|Withdrawal by Subject|3
7794609|NCT00529087|27088160|P3|Overall Study|Protocol Violation|6
7794610|NCT00529087|27088161|P2|Overall Study|Protocol Violation|7
7794611|NCT00529087|27088162|P1|Overall Study|Protocol Violation|8
7794612|NCT00529087|27088160|P3|Overall Study|Lost to Follow-up|1
7794613|NCT00529087|27088161|P2|Overall Study|Lost to Follow-up|4
7794614|NCT00529087|27088162|P1|Overall Study|Lost to Follow-up|6
7794615|NCT00529087|27088160|P3|Overall Study|Adverse Event|4
7794616|NCT00529087|27088161|P2|Overall Study|Adverse Event|13
7794617|NCT00529087|27088162|P1|Overall Study|Adverse Event|10
7794618|NCT00529035|27088226|P1|Overall Study|Withdrawal by Subject|1
7794619|NCT00528996|27088242|P5|Overall Study|Adverse Event|18
7794620|NCT00528996|27088243|P4|Overall Study|Adverse Event|29
7794621|NCT00528996|27088244|P3|Overall Study|Adverse Event|18
7794622|NCT00528996|27088245|P2|Overall Study|Adverse Event|13
7794623|NCT00528996|27088246|P1|Overall Study|Adverse Event|32
7794624|NCT00528996|27088242|P5|Overall Study|Lack of Efficacy|3
7794625|NCT00528996|27088243|P4|Overall Study|Lack of Efficacy|3
7794626|NCT00528996|27088244|P3|Overall Study|Lack of Efficacy|1
7794627|NCT00528996|27088245|P2|Overall Study|Lack of Efficacy|2
7794628|NCT00528996|27088246|P1|Overall Study|Lack of Efficacy|7
7794629|NCT00528996|27088242|P5|Overall Study|Protocol Violation|2
7794630|NCT00528996|27088243|P4|Overall Study|Protocol Violation|3
7794631|NCT00528996|27088244|P3|Overall Study|Protocol Violation|3
7794632|NCT00528996|27088245|P2|Overall Study|Protocol Violation|2
7794633|NCT00528996|27088246|P1|Overall Study|Protocol Violation|1
7794634|NCT00528996|27088242|P5|Overall Study|Lost to Follow-up|3
7794635|NCT00528996|27088243|P4|Overall Study|Lost to Follow-up|1
7794636|NCT00528996|27088244|P3|Overall Study|Lost to Follow-up|4
7794637|NCT00528996|27088245|P2|Overall Study|Lost to Follow-up|0
7794638|NCT00528996|27088246|P1|Overall Study|Lost to Follow-up|2
7794639|NCT00528996|27088242|P5|Overall Study|Refused continue medication|6
7794640|NCT00528996|27088243|P4|Overall Study|Refused continue medication|3
7794641|NCT00528996|27088244|P3|Overall Study|Refused continue medication|3
7794642|NCT00528996|27088245|P2|Overall Study|Refused continue medication|0
7794643|NCT00528996|27088246|P1|Overall Study|Refused continue medication|16
7794644|NCT00528996|27088242|P5|Overall Study|Other reasons than listing|5
7794645|NCT00528996|27088243|P4|Overall Study|Other reasons than listing|11
7794646|NCT00528996|27088244|P3|Overall Study|Other reasons than listing|14
7794647|NCT00528996|27088245|P2|Overall Study|Other reasons than listing|7
7794648|NCT00528996|27088246|P1|Overall Study|Other reasons than listing|6
7794649|NCT00528970|27088411|P3|Overall Study|Randomized but not treated|1
7794650|NCT00528970|27088412|P2|Overall Study|Randomized but not treated|0
7794651|NCT00528970|27088413|P1|Overall Study|Randomized but not treated|0
7794652|NCT00528970|27088411|P3|Overall Study|Withdrawal by Subject|5
7794653|NCT00528970|27088412|P2|Overall Study|Withdrawal by Subject|3
7794654|NCT00528970|27088413|P1|Overall Study|Withdrawal by Subject|4
7794655|NCT00528970|27088411|P3|Overall Study|Lack of Efficacy|1
7794656|NCT00528970|27088412|P2|Overall Study|Lack of Efficacy|0
7794657|NCT00528970|27088413|P1|Overall Study|Lack of Efficacy|0
7794658|NCT00528970|27088411|P3|Overall Study|Protocol Violation|4
7794659|NCT00528970|27088412|P2|Overall Study|Protocol Violation|1
7794660|NCT00528970|27088413|P1|Overall Study|Protocol Violation|2
7794661|NCT00528970|27088411|P3|Overall Study|Other than specified|3
7794662|NCT00528970|27088412|P2|Overall Study|Other than specified|3
7794663|NCT00528970|27088413|P1|Overall Study|Other than specified|2
7794664|NCT00528970|27088411|P3|Overall Study|Lost to Follow-up|1
7794665|NCT00528970|27088412|P2|Overall Study|Lost to Follow-up|0
7794666|NCT00528970|27088413|P1|Overall Study|Lost to Follow-up|0
7794667|NCT00528970|27088411|P3|Overall Study|Adverse Event|5
7794668|NCT00528970|27088412|P2|Overall Study|Adverse Event|8
7794669|NCT00528970|27088413|P1|Overall Study|Adverse Event|6
7794670|NCT00528957|27088432|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
7794671|NCT00528957|27088433|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
7794672|NCT00528957|27088432|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
7794673|NCT00528957|27088433|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
7794674|NCT00528957|27088432|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
7794675|NCT00528957|27088433|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
7794676|NCT00528957|27088432|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
7794677|NCT00528957|27088433|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
7794678|NCT00528957|27088432|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
7794679|NCT00528957|27088433|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
7794680|NCT00528957|27088432|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
7794681|NCT00528957|27088433|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
7794682|NCT00528957|27088432|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7794683|NCT00528957|27088433|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7794684|NCT00528957|27088432|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
7794685|NCT00528957|27088433|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
7794686|NCT00528957|27088432|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
7794687|NCT00528957|27088433|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
7794688|NCT00528957|27088432|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
7794689|NCT00528957|27088433|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
7794690|NCT00528957|27088432|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
7794691|NCT00528957|27088433|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
7794692|NCT00528957|27088432|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
7794693|NCT00528957|27088433|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
7794694|NCT00528957|27088432|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
7794695|NCT00528957|27088433|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
7794696|NCT00528957|27088432|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
7794697|NCT00528957|27088433|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
7794698|NCT00528957|27088432|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
7794699|NCT00528957|27088433|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
7794700|NCT00528957|27088432|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
7794701|NCT00528957|27088433|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
7794702|NCT00528931|27088574|P1|Overall Study|Lost to Follow-up|1
7794703|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
7794704|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7794705|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7794706|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7794707|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7794708|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7794709|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7794710|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
7794711|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
7794712|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
7794713|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
7794714|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
7794715|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
7794716|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
7794717|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
7794718|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
7794719|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Death|0
7794720|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Death|0
7794721|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Death|1
7794722|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Death|0
7794723|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7794724|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
7794725|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
7794726|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7794727|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
7794728|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
7794729|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
7794730|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
7794731|NCT00528879|27088586|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
7794732|NCT00528879|27088587|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
7794733|NCT00528879|27088588|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
7794734|NCT00528879|27088589|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
7794735|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Other|1
7794736|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Other|1
7794737|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Other|0
7794738|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Other|0
7794739|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7794740|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
7794741|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7794742|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7794743|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
7794744|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7794745|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
7794746|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
7794747|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7794748|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
7794749|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7794750|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7794751|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
7794752|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7794753|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7794754|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
7794755|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
7794756|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
7794757|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
7794758|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
7794759|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7794760|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
7794761|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7794762|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7794763|NCT00528879|27088586|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
7794764|NCT00528879|27088587|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
7794765|NCT00528879|27088588|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
7794766|NCT00528879|27088589|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
7794767|NCT00528866|27088655|P1|Overall Study|Protocol Violation|6
7794768|NCT00528840|27088668|P1|Overall Study|Other|2
7794769|NCT00528840|27088668|P1|Overall Study|Administrative Reasons|1
7794770|NCT00528840|27088668|P1|Overall Study|Death|2
7794771|NCT00528840|27088668|P1|Overall Study|Withdrawal by Subject|17
7794772|NCT00528840|27088668|P1|Overall Study|Adverse Event|1
7794773|NCT00528840|27088668|P1|Overall Study|Lost to Follow-up|10
7794774|NCT00528801|27088682|P2|Overall Study|Administrative Reasons|1
7794775|NCT00528801|27088683|P1|Overall Study|Administrative Reasons|0
7794776|NCT00528801|27088682|P2|Overall Study|Lost to Follow-up|4
7794777|NCT00528801|27088683|P1|Overall Study|Lost to Follow-up|15
7794778|NCT00528801|27088682|P2|Overall Study|Protocol Violation|5
7794779|NCT00528801|27088683|P1|Overall Study|Protocol Violation|11
7794780|NCT00528801|27088682|P2|Overall Study|Withdrawal by Subject|1
7794781|NCT00528801|27088683|P1|Overall Study|Withdrawal by Subject|1
7794782|NCT00528775|27088697|P1|Overall Study|Other not specified|1
7794783|NCT00528645|27088705|P1|Overall Study|Adverse Event|3
7794784|NCT00528606|27088714|P2|Overall Study|Other|0
7794785|NCT00528606|27088715|P1|Overall Study|Other|2
7794786|NCT00528606|27088714|P2|Overall Study|Adverse Event|0
7794787|NCT00528606|27088715|P1|Overall Study|Adverse Event|3
7794788|NCT00528606|27088714|P2|Overall Study|Lost to Follow-up|1
7794789|NCT00528606|27088715|P1|Overall Study|Lost to Follow-up|4
7794790|NCT00528606|27088714|P2|Overall Study|Withdrew consent|3
7794791|NCT00528606|27088715|P1|Overall Study|Withdrew consent|4
7794792|NCT00528567|27088748|P2|Overall Study|Administrative/Other|75
7794793|NCT00528567|27088749|P1|Overall Study|Administrative/Other|22
7794794|NCT00528567|27088748|P2|Overall Study|Other Protocol Violation|21
7794795|NCT00528567|27088749|P1|Overall Study|Other Protocol Violation|5
7794796|NCT00528567|27088748|P2|Overall Study|Failure to Return|4
7794797|NCT00528567|27088749|P1|Overall Study|Failure to Return|1
7794798|NCT00528567|27088748|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
7794799|NCT00528567|27088749|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
7794800|NCT00528567|27088748|P2|Overall Study|Withdrew Consent|55
7794801|NCT00528567|27088749|P1|Overall Study|Withdrew Consent|59
7794802|NCT00528567|27088748|P2|Overall Study|Violation Criteria at Entry|17
7794803|NCT00528567|27088749|P1|Overall Study|Violation Criteria at Entry|3
7794804|NCT00528567|27088748|P2|Overall Study|Adverse Event/Intermittent Illness|29
7794805|NCT00528567|27088749|P1|Overall Study|Adverse Event/Intermittent Illness|255
7794806|NCT00528567|27088748|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
7794807|NCT00528567|27088749|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
7794808|NCT00528567|27088748|P2|Overall Study|Death|5
7794809|NCT00528567|27088749|P1|Overall Study|Death|4
7794810|NCT00528528|27088816|P4|Overall Study|Ongoing participant|0
7794811|NCT00528528|27088817|P3|Overall Study|Ongoing participant|1
7794812|NCT00528528|27088818|P2|Overall Study|Ongoing participant|0
7794813|NCT00528528|27088819|P1|Overall Study|Ongoing participant|0
7794814|NCT00528528|27088816|P4|Overall Study|Withdrawal by Subject|1
7794815|NCT00528528|27088817|P3|Overall Study|Withdrawal by Subject|1
7794816|NCT00528528|27088818|P2|Overall Study|Withdrawal by Subject|2
7794817|NCT00528528|27088819|P1|Overall Study|Withdrawal by Subject|3
7794818|NCT00528528|27088816|P4|Overall Study|Other|0
7794819|NCT00528528|27088817|P3|Overall Study|Other|0
7794820|NCT00528528|27088818|P2|Overall Study|Other|1
7794821|NCT00528528|27088819|P1|Overall Study|Other|0
7794822|NCT00528528|27088816|P4|Overall Study|Ineligible to continue the trial|1
7794823|NCT00528528|27088817|P3|Overall Study|Ineligible to continue the trial|0
7794824|NCT00528528|27088818|P2|Overall Study|Ineligible to continue the trial|0
7794825|NCT00528528|27088819|P1|Overall Study|Ineligible to continue the trial|0
7794826|NCT00528528|27088816|P4|Overall Study|Lost to Follow-up|1
7794827|NCT00528528|27088817|P3|Overall Study|Lost to Follow-up|1
7794828|NCT00528528|27088818|P2|Overall Study|Lost to Follow-up|0
7794829|NCT00528528|27088819|P1|Overall Study|Lost to Follow-up|0
7794830|NCT00528424|27088863|P1|Overall Study|Other|12
7794831|NCT00528424|27088863|P1|Overall Study|Administrative reason|2
7794832|NCT00528424|27088863|P1|Overall Study|Withdrew consent|2
7794833|NCT00528424|27088863|P1|Overall Study|Lost to Follow-up|13
7794834|NCT00528411|27088878|P3|Overall Study|Prior commitment medication|0
7794835|NCT00528411|27088879|P2|Overall Study|Prior commitment medication|1
7794836|NCT00528411|27088880|P1|Overall Study|Prior commitment medication|0
7794837|NCT00528411|27088878|P3|Overall Study|Severe non-compliance to protocol|0
7794838|NCT00528411|27088879|P2|Overall Study|Severe non-compliance to protocol|1
7794839|NCT00528411|27088880|P1|Overall Study|Severe non-compliance to protocol|0
7794840|NCT00528411|27088878|P3|Overall Study|Incorrect Enrolment|0
7794841|NCT00528411|27088879|P2|Overall Study|Incorrect Enrolment|1
7794842|NCT00528411|27088880|P1|Overall Study|Incorrect Enrolment|1
7794843|NCT00528411|27088878|P3|Overall Study|Adverse Event|1
7794844|NCT00528411|27088879|P2|Overall Study|Adverse Event|0
7794845|NCT00528411|27088880|P1|Overall Study|Adverse Event|4
7794846|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
7794847|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
7794848|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
7794849|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
7794850|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
7794851|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
7794852|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
7794853|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
7794854|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
7794855|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7794856|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7794857|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7794858|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7794859|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7794860|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7794861|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7794862|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7794863|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7794864|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794865|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794866|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794867|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
7794868|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
7794869|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794870|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794871|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794872|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7794873|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7794874|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7794875|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7794876|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7794877|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7794878|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7794879|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7794880|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7794881|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7794882|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7794883|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
7794884|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
7794885|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
7794886|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
7794887|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7794888|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7794889|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
7794890|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
7794891|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
7794892|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
7794893|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
7794894|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
7794895|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
7794896|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
7794897|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
7794898|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7794899|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7794900|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7794901|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7794902|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
7794903|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
7794904|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
7794905|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7794906|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
7794907|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
7794908|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
7794909|NCT00528372|27089017|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
7794910|NCT00528372|27089018|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
7794911|NCT00528372|27089019|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
7794912|NCT00528372|27089020|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7794913|NCT00528372|27089021|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7794914|NCT00528372|27089022|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7794915|NCT00528372|27089023|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
7794916|NCT00528372|27089024|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
7794917|NCT00528372|27089025|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
7794918|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
7794919|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
7794920|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
7794921|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
7794922|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
7794923|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
7794924|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
7794925|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
7794926|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
7794927|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7794928|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7794929|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7794930|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7794931|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7794932|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7794933|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7794934|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7794935|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7794936|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794937|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794938|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794939|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
7794940|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794941|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
7794942|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794943|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794944|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7794945|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
7794946|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7794947|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7794948|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7794949|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7794950|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7794951|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7794952|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
7794953|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
7794954|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
7794955|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
7794956|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
7794957|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
7794958|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
7794959|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
7794960|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
7794961|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
7794962|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
7794963|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7794964|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7794965|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
7794966|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
7794967|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7794968|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
7794969|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
7794970|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
7794971|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7794972|NCT00528372|27089017|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794973|NCT00528372|27089018|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794974|NCT00528372|27089019|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794975|NCT00528372|27089020|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794976|NCT00528372|27089021|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794977|NCT00528372|27089022|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794978|NCT00528372|27089023|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794979|NCT00528372|27089024|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7794980|NCT00528372|27089025|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
7794981|NCT00528112|27089157|P2|Extension Phase|Protocol Violation|2
7794982|NCT00528112|27089158|P1|Extension Phase|Protocol Violation|0
7794983|NCT00528112|27089157|P2|Extension Phase|Adverse Event|36
7794984|NCT00528112|27089158|P1|Extension Phase|Adverse Event|0
7794985|NCT00528112|27089157|P2|Extension Phase|Death|1
7794986|NCT00528112|27089158|P1|Extension Phase|Death|0
7794987|NCT00528112|27089157|P2|Extension Phase|Lost to Follow-up|12
7794988|NCT00528112|27089158|P1|Extension Phase|Lost to Follow-up|0
7794989|NCT00528112|27089157|P2|Extension Phase|Pregnancy|3
7794990|NCT00528112|27089158|P1|Extension Phase|Pregnancy|0
7794991|NCT00528112|27089157|P2|Extension Phase|Other reasons|100
7794992|NCT00528112|27089158|P1|Extension Phase|Other reasons|0
7794993|NCT00528112|27089157|P2|Extension Phase|Withdrawal by Subject|3
7794994|NCT00528112|27089158|P1|Extension Phase|Withdrawal by Subject|0
7794995|NCT00528112|27089157|P2|Treatment up to 3 Years|Other reasons|186
7794996|NCT00528112|27089158|P1|Treatment up to 3 Years|Other reasons|186
7794997|NCT00528112|27089157|P2|Treatment up to 3 Years|Pregnancy|10
7794998|NCT00528112|27089158|P1|Treatment up to 3 Years|Pregnancy|9
7794999|NCT00528112|27089157|P2|Treatment up to 3 Years|Lost to Follow-up|61
7795000|NCT00528112|27089158|P1|Treatment up to 3 Years|Lost to Follow-up|63
7795001|NCT00528112|27089157|P2|Treatment up to 3 Years|Death|1
7795002|NCT00528112|27089158|P1|Treatment up to 3 Years|Death|0
7795003|NCT00528112|27089157|P2|Treatment up to 3 Years|Protocol Violation|16
7795004|NCT00528112|27089158|P1|Treatment up to 3 Years|Protocol Violation|16
7795005|NCT00528112|27089157|P2|Treatment up to 3 Years|Withdrawal by Subject|31
7795006|NCT00528112|27089158|P1|Treatment up to 3 Years|Withdrawal by Subject|26
7795007|NCT00528112|27089157|P2|Treatment up to 3 Years|Adverse Event|278
7795008|NCT00528112|27089158|P1|Treatment up to 3 Years|Adverse Event|313
7795009|NCT00528021|27089216|P4|Overall Study|Lack of Efficacy|9
7795010|NCT00528021|27089217|P3|Overall Study|Lack of Efficacy|7
7795011|NCT00528021|27089218|P2|Overall Study|Lack of Efficacy|13
7795012|NCT00528021|27089219|P1|Overall Study|Lack of Efficacy|17
7795013|NCT00527982|27089231|P2|Overall Study|Physician Decision|0
7795014|NCT00527982|27089232|P1|Overall Study|Physician Decision|1
7795015|NCT00527904|27089273|P1|Overall Study|misc|22
7795016|NCT00527904|27089273|P1|Overall Study|Lost to Follow-up|8
7795017|NCT00527904|27089273|P1|Overall Study|Withdrawal by Subject|21
7795018|NCT00527904|27089273|P1|Overall Study|Adverse Event|45
7795019|NCT00527826|27089292|P2|Overall Study|Participant moved away|1
7795020|NCT00527826|27089293|P1|Overall Study|Participant moved away|0
7795021|NCT00527826|27089292|P2|Overall Study|Additional Intake of Viani forte|1
7795022|NCT00527826|27089293|P1|Overall Study|Additional Intake of Viani forte|0
7795023|NCT00527826|27089292|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
7795024|NCT00527826|27089293|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
7795025|NCT00527826|27089292|P2|Overall Study|Inclusion Criteria Not Met|3
7795026|NCT00527826|27089293|P1|Overall Study|Inclusion Criteria Not Met|3
7795027|NCT00527826|27089292|P2|Overall Study|Withdrawal by Subject|8
7795028|NCT00527826|27089293|P1|Overall Study|Withdrawal by Subject|5
7795029|NCT00527826|27089292|P2|Overall Study|Lost to Follow-up|2
7795030|NCT00527826|27089293|P1|Overall Study|Lost to Follow-up|3
7795031|NCT00527826|27089292|P2|Overall Study|Adverse Event|10
7795032|NCT00527826|27089293|P1|Overall Study|Adverse Event|10
7795033|NCT00527787|27089342|P2|Overall Study|misc|2
7795034|NCT00527787|27089343|P1|Overall Study|misc|5
7795035|NCT00527787|27089342|P2|Overall Study|Duodenal Ulcer|10
7795036|NCT00527787|27089343|P1|Overall Study|Duodenal Ulcer|1
7795037|NCT00527787|27089342|P2|Overall Study|Lost to Follow-up|2
7795038|NCT00527787|27089343|P1|Overall Study|Lost to Follow-up|5
7795039|NCT00527787|27089342|P2|Overall Study|Withdrawal by Subject|25
7795040|NCT00527787|27089343|P1|Overall Study|Withdrawal by Subject|13
7795041|NCT00527787|27089342|P2|Overall Study|Adverse Event|24
7795042|NCT00527787|27089343|P1|Overall Study|Adverse Event|14
7795043|NCT00527748|27089365|P1|Overall Study|Other|3
7795044|NCT00527735|27089372|P3|Overall Study|Completed treatment during maintenance|1
7795045|NCT00527735|27089373|P2|Overall Study|Completed treatment during maintenance|2
7795046|NCT00527735|27089374|P1|Overall Study|Completed treatment during maintenance|2
7795047|NCT00527735|27089372|P3|Overall Study|Poor compliance or noncompliance|1
7795048|NCT00527735|27089373|P2|Overall Study|Poor compliance or noncompliance|1
7795049|NCT00527735|27089374|P1|Overall Study|Poor compliance or noncompliance|0
7795050|NCT00527735|27089372|P3|Overall Study|Lost to Follow-up|3
7795051|NCT00527735|27089373|P2|Overall Study|Lost to Follow-up|0
7795052|NCT00527735|27089374|P1|Overall Study|Lost to Follow-up|0
7795053|NCT00527735|27089372|P3|Overall Study|No longer met study criteria|1
7795054|NCT00527735|27089373|P2|Overall Study|No longer met study criteria|2
7795055|NCT00527735|27089374|P1|Overall Study|No longer met study criteria|2
7795056|NCT00527735|27089372|P3|Overall Study|Withdrawal by Subject|3
7795057|NCT00527735|27089373|P2|Overall Study|Withdrawal by Subject|4
7795058|NCT00527735|27089374|P1|Overall Study|Withdrawal by Subject|5
7795059|NCT00527735|27089372|P3|Overall Study|Not identified|5
7795060|NCT00527735|27089373|P2|Overall Study|Not identified|5
7795061|NCT00527735|27089374|P1|Overall Study|Not identified|5
7795062|NCT00527735|27089372|P3|Overall Study|Adverse Event|7
7795063|NCT00527735|27089373|P2|Overall Study|Adverse Event|6
7795064|NCT00527735|27089374|P1|Overall Study|Adverse Event|10
7795065|NCT00527735|27089372|P3|Overall Study|Completed treatment in treatment phase|18
7795066|NCT00527735|27089373|P2|Overall Study|Completed treatment in treatment phase|13
7795067|NCT00527735|27089374|P1|Overall Study|Completed treatment in treatment phase|14
7795068|NCT00527735|27089372|P3|Overall Study|Death|15
7795069|NCT00527735|27089373|P2|Overall Study|Death|13
7795070|NCT00527735|27089374|P1|Overall Study|Death|23
7795071|NCT00527735|27089372|P3|Overall Study|Disease progression|53
7795072|NCT00527735|27089373|P2|Overall Study|Disease progression|61
7795073|NCT00527735|27089374|P1|Overall Study|Disease progression|47
7795074|NCT00527618|27089460|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
7795075|NCT00527618|27089461|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
7795076|NCT00527618|27089460|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
7795077|NCT00527618|27089461|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
7795078|NCT00527618|27089460|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
7795079|NCT00527618|27089461|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
7795080|NCT00527618|27089460|P2|Week 13-14 (Washout)|Lost to Follow-up|0
7795081|NCT00527618|27089461|P1|Week 13-14 (Washout)|Lost to Follow-up|1
7795082|NCT00527618|27089460|P2|Week 1-12 (First Intervention)|Adverse Event|1
7795083|NCT00527618|27089461|P1|Week 1-12 (First Intervention)|Adverse Event|0
7795084|NCT00527618|27089460|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
7795085|NCT00527618|27089461|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
7795086|NCT00527605|27089476|P2|Overall Study|Protocol Violation|2
7795087|NCT00527605|27089477|P1|Overall Study|Protocol Violation|1
7795088|NCT00527605|27089476|P2|Overall Study|Lost to Follow-up|2
7795089|NCT00527605|27089477|P1|Overall Study|Lost to Follow-up|6
7795090|NCT00527605|27089476|P2|Overall Study|Withdrawal by Subject|7
7795091|NCT00527605|27089477|P1|Overall Study|Withdrawal by Subject|3
7795092|NCT00527605|27089476|P2|Overall Study|Adverse Event|0
7795093|NCT00527605|27089477|P1|Overall Study|Adverse Event|3
7795094|NCT00527514|27089528|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
7795095|NCT00527514|27089528|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
7795096|NCT00527514|27089528|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
7795097|NCT00527514|27089528|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
7795098|NCT00527514|27089528|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
7795099|NCT00527514|27089528|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
7795100|NCT00527514|27089528|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
7795101|NCT00527488|27089544|P4|Overall Study|Withdrawn prior to dosing|0
7795102|NCT00527488|27089545|P3|Overall Study|Withdrawn prior to dosing|1
7795103|NCT00527488|27089546|P2|Overall Study|Withdrawn prior to dosing|1
7795104|NCT00527488|27089547|P1|Overall Study|Withdrawn prior to dosing|0
7795105|NCT00527423|27089630|P1|Overall Study|Death|9
7795106|NCT00527423|27089630|P1|Overall Study|OTHER|4
7795107|NCT00527423|27089630|P1|Overall Study|Lost to Follow-up|4
7795108|NCT00527423|27089630|P1|Overall Study|Withdrawal by Subject|10
7795109|NCT00527423|27089630|P1|Overall Study|Physician Decision|4
7795110|NCT00527423|27089630|P1|Overall Study|Adverse Event|5
7795111|NCT00527423|27089630|P1|Overall Study|Protocol Violation|1
7795112|NCT00527397|27089636|P1|Overall Study|Study terminated by sponsor|13
7795113|NCT00527397|27089636|P1|Overall Study|Withdrawal by Subject|6
7795114|NCT00527397|27089636|P1|Overall Study|Protocol Violation|1
7795115|NCT00527397|27089636|P1|Overall Study|Lack of Efficacy|1
7795116|NCT00527397|27089636|P1|Overall Study|Adverse Event|3
7795117|NCT00527332|27089662|P2|Overall Study|Withdrew consent|1
7795118|NCT00527332|27089663|P1|Overall Study|Withdrew consent|5
7795119|NCT00527332|27089662|P2|Overall Study|Protocol Violation|8
7795120|NCT00527332|27089663|P1|Overall Study|Protocol Violation|4
7795121|NCT00527319|27089672|P3|Overall Study|Adverse Event|1
7795122|NCT00527319|27089673|P2|Overall Study|Adverse Event|0
7795123|NCT00527319|27089674|P1|Overall Study|Adverse Event|0
7795124|NCT00527319|27089672|P3|Overall Study|Intercurrent Medical Illness|3
7795125|NCT00527319|27089673|P2|Overall Study|Intercurrent Medical Illness|1
7795126|NCT00527319|27089674|P1|Overall Study|Intercurrent Medical Illness|0
7795127|NCT00527319|27089672|P3|Overall Study|Death|1
7795128|NCT00527319|27089673|P2|Overall Study|Death|3
7795129|NCT00527319|27089674|P1|Overall Study|Death|0
7795130|NCT00527319|27089672|P3|Overall Study|Lost to Follow-up|0
7795131|NCT00527319|27089673|P2|Overall Study|Lost to Follow-up|0
7795132|NCT00527319|27089674|P1|Overall Study|Lost to Follow-up|1
7795133|NCT00527319|27089672|P3|Overall Study|Withdrawal by Subject|1
7795134|NCT00527319|27089673|P2|Overall Study|Withdrawal by Subject|0
7795135|NCT00527319|27089674|P1|Overall Study|Withdrawal by Subject|5
7795136|NCT00527111|27089704|P2|Overall Study|Other|2
7795137|NCT00527111|27089705|P1|Overall Study|Other|2
7795138|NCT00527111|27089704|P2|Overall Study|Patient Request|5
7795139|NCT00527111|27089705|P1|Overall Study|Patient Request|2
7795140|NCT00527111|27089704|P2|Overall Study|Investigator Request|1
7795141|NCT00527111|27089705|P1|Overall Study|Investigator Request|2
7795142|NCT00527111|27089704|P2|Overall Study|Death|1
7795143|NCT00527111|27089705|P1|Overall Study|Death|0
7795144|NCT00527111|27089704|P2|Overall Study|Adverse Event|13
7795145|NCT00527111|27089705|P1|Overall Study|Adverse Event|14
7795146|NCT00527072|27089727|P1|Overall Study|Withdrawal by Subject|7
7795147|NCT00527072|27089727|P1|Overall Study|Protocol Violation|2
7795148|NCT00527072|27089727|P1|Overall Study|Lost to Follow-up|3
7795149|NCT00527072|27089727|P1|Overall Study|Lack of Efficacy|11
7795150|NCT00527072|27089727|P1|Overall Study|Adverse Event|13
7795151|NCT00526994|27089736|P3|Overall Study|incarcerated, impaired, incomplete|3
7795152|NCT00526994|27089737|P2|Overall Study|incarcerated, impaired, incomplete|3
7795153|NCT00526994|27089738|P1|Overall Study|incarcerated, impaired, incomplete|4
7795154|NCT00526994|27089736|P3|Overall Study|Withdrawal by Subject|5
7795155|NCT00526994|27089737|P2|Overall Study|Withdrawal by Subject|7
7795156|NCT00526994|27089738|P1|Overall Study|Withdrawal by Subject|2
7795157|NCT00526994|27089736|P3|Overall Study|Death|3
7795158|NCT00526994|27089737|P2|Overall Study|Death|3
7795159|NCT00526994|27089738|P1|Overall Study|Death|4
7795160|NCT00526994|27089736|P3|Overall Study|Lost to Follow-up|96
7795161|NCT00526994|27089737|P2|Overall Study|Lost to Follow-up|108
7795162|NCT00526994|27089738|P1|Overall Study|Lost to Follow-up|98
7795163|NCT00526890|27089755|P1|Overall Study|Adverse Event|2
7795164|NCT00526799|27089767|P2|Overall Study|Intercurrent Complicating Disease|1
7795165|NCT00526799|27089768|P1|Overall Study|Intercurrent Complicating Disease|0
7795166|NCT00526799|27089767|P2|Overall Study|Withdrawal by Subject|0
7795167|NCT00526799|27089768|P1|Overall Study|Withdrawal by Subject|1
7795168|NCT00526669|27089776|P2|Combined Treatment Phase|Death|2
7795169|NCT00526669|27089777|P1|Combined Treatment Phase|Death|0
7795170|NCT00526669|27089776|P2|Combined Treatment Phase|Sponsor Terminated Study|2
7795171|NCT00526669|27089777|P1|Combined Treatment Phase|Sponsor Terminated Study|0
7795172|NCT00526669|27089776|P2|Combined Treatment Phase|Withdrawal by Subject|2
7795173|NCT00526669|27089777|P1|Combined Treatment Phase|Withdrawal by Subject|0
7795174|NCT00526669|27089776|P2|Combined Treatment Phase|Lost to Follow-up|2
7795175|NCT00526669|27089777|P1|Combined Treatment Phase|Lost to Follow-up|0
7795176|NCT00526656|27089806|P1|Overall Study|Refused surgery|1
7795177|NCT00526656|27089806|P1|Overall Study|Death|1
7795178|NCT00526630|27089812|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
7795179|NCT00526630|27089813|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
7795180|NCT00526630|27089812|P2|First Intervention Period - 12 Weeks|Withdrawn|3
7795181|NCT00526630|27089813|P1|First Intervention Period - 12 Weeks|Withdrawn|0
7795182|NCT00526331|27089925|P1|Overall Study|Sponsor Termination|55
7795183|NCT00526227|27089933|P1|Overall Study|Death|1
7795184|NCT00526227|27089933|P1|Overall Study|Device not implanted|1
7795185|NCT00526162|27089946|P1|Overall Study|Device not implanted|3
7795186|NCT00526110|27089979|P2|Overall Study|Poor Tolerance|5
7795187|NCT00526110|27089980|P1|Overall Study|Poor Tolerance|0
7795188|NCT00526110|27089979|P2|Overall Study|Withdrawal by Subject|2
7795189|NCT00526110|27089980|P1|Overall Study|Withdrawal by Subject|0
7795190|NCT00526110|27089979|P2|Overall Study|Maximal Response|6
7795191|NCT00526110|27089980|P1|Overall Study|Maximal Response|0
7795192|NCT00526110|27089979|P2|Overall Study|Disease Progression|19
7795193|NCT00526110|27089980|P1|Overall Study|Disease Progression|0
7795194|NCT00526110|27089979|P2|Overall Study|Adverse Event|9
7795195|NCT00526110|27089980|P1|Overall Study|Adverse Event|2
7795196|NCT00526097|27089989|P2|Overall Study|Other|1
7795197|NCT00526097|27089990|P1|Overall Study|Other|2
7795198|NCT00526097|27089989|P2|Overall Study|Withdrawal by Subject|1
7795199|NCT00526097|27089990|P1|Overall Study|Withdrawal by Subject|3
7795200|NCT00526097|27089989|P2|Overall Study|Protocol Violation|10
7795201|NCT00526097|27089990|P1|Overall Study|Protocol Violation|4
7795202|NCT00526097|27089989|P2|Overall Study|Adverse Event|44
7795203|NCT00526097|27089990|P1|Overall Study|Adverse Event|6
7795204|NCT00526071|27090166|P1|Overall Study|Lack of Response to Study Drug|4
7795205|NCT00526071|27090166|P1|Overall Study|Withdrawal by Subject|1
7795206|NCT00526071|27090166|P1|Overall Study|Adverse Event|1
7795207|NCT00525915|27090192|P2|Overall Study|Unrelated illness|0
7795208|NCT00525915|27090193|P1|Overall Study|Unrelated illness|1
7795209|NCT00525915|27090192|P2|Overall Study|Refused Surgery|2
7795210|NCT00525915|27090193|P1|Overall Study|Refused Surgery|1
7795211|NCT00525915|27090192|P2|Overall Study|Withdrawal by Subject|0
7795212|NCT00525915|27090193|P1|Overall Study|Withdrawal by Subject|1
7795213|NCT00525915|27090192|P2|Overall Study|Disease Progression|6
7795214|NCT00525915|27090193|P1|Overall Study|Disease Progression|5
7795215|NCT00525915|27090192|P2|Overall Study|Non-Compliance|1
7795216|NCT00525915|27090193|P1|Overall Study|Non-Compliance|0
7795217|NCT00525902|27090199|P1|Overall Study|Lack of Efficacy|1
7795218|NCT00525824|27090223|P4|Overall Study|Other|1
7795219|NCT00525824|27090224|P3|Overall Study|Other|3
7795220|NCT00525824|27090225|P2|Overall Study|Other|3
7795221|NCT00525824|27090226|P1|Overall Study|Other|1
7795222|NCT00525824|27090223|P4|Overall Study|Safety reasons|0
7795223|NCT00525824|27090224|P3|Overall Study|Safety reasons|1
7795224|NCT00525824|27090225|P2|Overall Study|Safety reasons|0
7795225|NCT00525824|27090226|P1|Overall Study|Safety reasons|1
7795226|NCT00525824|27090223|P4|Overall Study|Severe non-compliance|1
7795227|NCT00525824|27090224|P3|Overall Study|Severe non-compliance|1
7795228|NCT00525824|27090225|P2|Overall Study|Severe non-compliance|1
7795229|NCT00525824|27090226|P1|Overall Study|Severe non-compliance|0
7795230|NCT00525824|27090223|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
7795231|NCT00525824|27090224|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
7795232|NCT00525824|27090225|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
7795233|NCT00525824|27090226|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
7795234|NCT00525824|27090223|P4|Overall Study|Lost to Follow-up|0
7795235|NCT00525824|27090224|P3|Overall Study|Lost to Follow-up|4
7795236|NCT00525824|27090225|P2|Overall Study|Lost to Follow-up|2
7795237|NCT00525824|27090226|P1|Overall Study|Lost to Follow-up|4
7795238|NCT00525824|27090223|P4|Overall Study|Withdrawal by Subject|4
7795239|NCT00525824|27090224|P3|Overall Study|Withdrawal by Subject|3
7795240|NCT00525824|27090225|P2|Overall Study|Withdrawal by Subject|9
7795241|NCT00525824|27090226|P1|Overall Study|Withdrawal by Subject|5
7795242|NCT00525824|27090223|P4|Overall Study|Adverse Event|7
7795243|NCT00525824|27090224|P3|Overall Study|Adverse Event|6
7795244|NCT00525824|27090225|P2|Overall Study|Adverse Event|11
7795245|NCT00525824|27090226|P1|Overall Study|Adverse Event|7
7795246|NCT00525785|27090299|P1|Overall Study|Physician Decision|1
7795247|NCT00525785|27090299|P1|Overall Study|Lack of Efficacy|1
7795248|NCT00525785|27090299|P1|Overall Study|Withdrawal by Subject|1
7795249|NCT00525590|27090323|P1|Overall Study|Other|13
7795250|NCT00525590|27090323|P1|Overall Study|Death|9
7795251|NCT00525590|27090323|P1|Overall Study|Lost to Follow-up|1
7795252|NCT00525590|27090323|P1|Overall Study|Withdrawal by Subject|16
7795253|NCT00525590|27090323|P1|Overall Study|Physician Decision|3
7795254|NCT00525590|27090323|P1|Overall Study|Adverse Event|3
7795255|NCT00525512|27090351|P4|Open-Label Phase|Other reason (not specified)|5
7795256|NCT00525512|27090352|P3|Open-Label Phase|Other reason (not specified)|4
7795257|NCT00525512|27090353|P2|Open-Label Phase|Other reason (not specified)|0
7795258|NCT00525512|27090354|P1|Open-Label Phase|Other reason (not specified)|0
7795259|NCT00525512|27090351|P4|Open-Label Phase|Lost to Follow-up|0
7795260|NCT00525512|27090352|P3|Open-Label Phase|Lost to Follow-up|1
7795261|NCT00525512|27090353|P2|Open-Label Phase|Lost to Follow-up|0
7795262|NCT00525512|27090354|P1|Open-Label Phase|Lost to Follow-up|0
7795263|NCT00525512|27090351|P4|Open-Label Phase|Adverse Event|0
7795264|NCT00525512|27090352|P3|Open-Label Phase|Adverse Event|1
7795265|NCT00525512|27090353|P2|Open-Label Phase|Adverse Event|0
7795266|NCT00525512|27090354|P1|Open-Label Phase|Adverse Event|0
7795267|NCT00525512|27090351|P4|Double-Blind Phase|Other reason (not specified)|0
7795268|NCT00525512|27090352|P3|Double-Blind Phase|Other reason (not specified)|0
7795269|NCT00525512|27090353|P2|Double-Blind Phase|Other reason (not specified)|13
7795270|NCT00525512|27090354|P1|Double-Blind Phase|Other reason (not specified)|12
7795271|NCT00525512|27090351|P4|Double-Blind Phase|Lack of Efficacy|0
7795272|NCT00525512|27090352|P3|Double-Blind Phase|Lack of Efficacy|0
7795273|NCT00525512|27090353|P2|Double-Blind Phase|Lack of Efficacy|5
7795274|NCT00525512|27090354|P1|Double-Blind Phase|Lack of Efficacy|13
7795275|NCT00525512|27090351|P4|Double-Blind Phase|Withdrawal by Subject|0
7795276|NCT00525512|27090352|P3|Double-Blind Phase|Withdrawal by Subject|0
7795277|NCT00525512|27090353|P2|Double-Blind Phase|Withdrawal by Subject|12
7795278|NCT00525512|27090354|P1|Double-Blind Phase|Withdrawal by Subject|17
7795279|NCT00525512|27090351|P4|Double-Blind Phase|Lost to Follow-up|0
7795280|NCT00525512|27090352|P3|Double-Blind Phase|Lost to Follow-up|0
7795281|NCT00525512|27090353|P2|Double-Blind Phase|Lost to Follow-up|7
7795282|NCT00525512|27090354|P1|Double-Blind Phase|Lost to Follow-up|3
7795283|NCT00525512|27090351|P4|Double-Blind Phase|Protocol Violation|0
7795284|NCT00525512|27090352|P3|Double-Blind Phase|Protocol Violation|0
7795285|NCT00525512|27090353|P2|Double-Blind Phase|Protocol Violation|1
7795286|NCT00525512|27090354|P1|Double-Blind Phase|Protocol Violation|3
7795287|NCT00525512|27090351|P4|Double-Blind Phase|Adverse Event|0
7795288|NCT00525512|27090352|P3|Double-Blind Phase|Adverse Event|0
7795289|NCT00525512|27090353|P2|Double-Blind Phase|Adverse Event|28
7795290|NCT00525512|27090354|P1|Double-Blind Phase|Adverse Event|48
7795291|NCT00525499|27090496|P4|Overall Study|Protocol Violation|0
7795292|NCT00525499|27090497|P3|Overall Study|Protocol Violation|1
7795293|NCT00525499|27090498|P2|Overall Study|Protocol Violation|1
7795294|NCT00525499|27090499|P1|Overall Study|Protocol Violation|0
7795295|NCT00525499|27090496|P4|Overall Study|Withdrawal by Subject|2
7795296|NCT00525499|27090497|P3|Overall Study|Withdrawal by Subject|5
7795297|NCT00525499|27090498|P2|Overall Study|Withdrawal by Subject|1
7795298|NCT00525499|27090499|P1|Overall Study|Withdrawal by Subject|5
7795299|NCT00525499|27090496|P4|Overall Study|Adverse Event|1
7795300|NCT00525499|27090497|P3|Overall Study|Adverse Event|0
7795301|NCT00525499|27090498|P2|Overall Study|Adverse Event|1
7795302|NCT00525499|27090499|P1|Overall Study|Adverse Event|0
7795303|NCT00525499|27090496|P4|Overall Study|Lost to Follow-up|4
7795304|NCT00525499|27090497|P3|Overall Study|Lost to Follow-up|1
7795305|NCT00525499|27090498|P2|Overall Study|Lost to Follow-up|4
7795306|NCT00525499|27090499|P1|Overall Study|Lost to Follow-up|2
7795307|NCT00525265|27090526|P2|Overall Study|Protocol Violation|0
7795308|NCT00525265|27090527|P1|Overall Study|Protocol Violation|1
7795309|NCT00525161|27090584|P1|Overall Study|Adverse Event|1
7795310|NCT00525148|27090594|P4|Overall Study|Other than stated|3
7795311|NCT00525148|27090595|P3|Overall Study|Other than stated|0
7795312|NCT00525148|27090596|P2|Overall Study|Other than stated|1
7795313|NCT00525148|27090597|P1|Overall Study|Other than stated|2
7795314|NCT00525148|27090594|P4|Overall Study|Refused continuation of study medication|1
7795315|NCT00525148|27090595|P3|Overall Study|Refused continuation of study medication|0
7795316|NCT00525148|27090596|P2|Overall Study|Refused continuation of study medication|2
7795317|NCT00525148|27090597|P1|Overall Study|Refused continuation of study medication|0
7795318|NCT00525148|27090594|P4|Overall Study|Progressive disease|49
7795319|NCT00525148|27090595|P3|Overall Study|Progressive disease|6
7795320|NCT00525148|27090596|P2|Overall Study|Progressive disease|30
7795321|NCT00525148|27090597|P1|Overall Study|Progressive disease|18
7795322|NCT00525148|27090594|P4|Overall Study|Other Adverse Event|8
7795323|NCT00525148|27090595|P3|Overall Study|Other Adverse Event|1
7795324|NCT00525148|27090596|P2|Overall Study|Other Adverse Event|5
7795325|NCT00525148|27090597|P1|Overall Study|Other Adverse Event|3
7795326|NCT00525044|27090638|P2|Overall Study|Lost to Follow-up|1
7795327|NCT00525044|27090639|P1|Overall Study|Lost to Follow-up|0
7795328|NCT00525031|27090655|P2|Overall Study|Disease Progression|1
7795329|NCT00525031|27090656|P1|Overall Study|Disease Progression|1
7795330|NCT00524771|27090670|P2|Overall Study|Protocol Violation|585
7795331|NCT00524771|27090671|P1|Overall Study|Protocol Violation|220
7795332|NCT00524745|27090685|P4|Overall Study|subject withdrawal or lost to follow up|22
7795333|NCT00524745|27090686|P3|Overall Study|subject withdrawal or lost to follow up|29
7795334|NCT00524745|27090687|P2|Overall Study|subject withdrawal or lost to follow up|13
7795335|NCT00524745|27090688|P1|Overall Study|subject withdrawal or lost to follow up|34
7795336|NCT00524680|27090714|P4|Overall Study|Withdrawal by Subject|1
7795337|NCT00524680|27090715|P3|Overall Study|Withdrawal by Subject|1
7795338|NCT00524680|27090716|P2|Overall Study|Withdrawal by Subject|0
7795339|NCT00524680|27090717|P1|Overall Study|Withdrawal by Subject|1
7795340|NCT00524680|27090714|P4|Overall Study|Other|3
7795341|NCT00524680|27090715|P3|Overall Study|Other|2
7795342|NCT00524680|27090716|P2|Overall Study|Other|1
7795343|NCT00524680|27090717|P1|Overall Study|Other|0
7795344|NCT00524680|27090714|P4|Overall Study|Adverse Event|1
7795345|NCT00524680|27090715|P3|Overall Study|Adverse Event|0
7795346|NCT00524680|27090716|P2|Overall Study|Adverse Event|0
7795347|NCT00524680|27090717|P1|Overall Study|Adverse Event|2
7795348|NCT00524680|27090714|P4|Overall Study|progression|1
7795349|NCT00524680|27090715|P3|Overall Study|progression|0
7795350|NCT00524680|27090716|P2|Overall Study|progression|0
7795351|NCT00524680|27090717|P1|Overall Study|progression|0
7795352|NCT00524589|27090739|P1|Overall Study|Disease Progression|16
7795353|NCT00524589|27090739|P1|Overall Study|Withdrawal by Subject|2
7795354|NCT00524485|27090790|P1|Overall Study|Withdrawal by Subject|5
7795355|NCT00524459|27090819|P1|Overall Study|Other|1
7795356|NCT00524459|27090819|P1|Overall Study|Withdrawal by Subject|1
7795357|NCT00524420|27090829|P2|Overall Study|Lack of Efficacy|0
7795358|NCT00524420|27090830|P1|Overall Study|Lack of Efficacy|1
7795359|NCT00524368|27090848|P2|Overall Study|Other|2
7795360|NCT00524368|27090849|P1|Overall Study|Other|3
7795361|NCT00524368|27090848|P2|Overall Study|Ineligible to Continue the study|5
7795362|NCT00524368|27090849|P1|Overall Study|Ineligible to Continue the study|2
7795363|NCT00524368|27090848|P2|Overall Study|Sponsor's Decision|0
7795364|NCT00524368|27090849|P1|Overall Study|Sponsor's Decision|2
7795365|NCT00524368|27090848|P2|Overall Study|Reached a Virologic Endpoint|2
7795366|NCT00524368|27090849|P1|Overall Study|Reached a Virologic Endpoint|3
7795367|NCT00524368|27090848|P2|Overall Study|Non-compliant|9
7795368|NCT00524368|27090849|P1|Overall Study|Non-compliant|8
7795369|NCT00524368|27090848|P2|Overall Study|Withdrawal by Subject|5
7795370|NCT00524368|27090849|P1|Overall Study|Withdrawal by Subject|4
7795371|NCT00524368|27090848|P2|Overall Study|Lost to Follow-up|13
7795372|NCT00524368|27090849|P1|Overall Study|Lost to Follow-up|9
7795373|NCT00524368|27090848|P2|Overall Study|Adverse Event|12
7795374|NCT00524368|27090849|P1|Overall Study|Adverse Event|10
7795375|NCT00524316|27090883|P1|Overall Study|Disease Progression|7
7795376|NCT00524316|27090883|P1|Overall Study|Adverse Event|7
7795377|NCT00524316|27090883|P1|Overall Study|Withdrawal by Subject|2
7795378|NCT00524303|27090895|P3|Overall Study|Completed 5 years|1
7795379|NCT00524303|27090896|P2|Overall Study|Completed 5 years|0
7795380|NCT00524303|27090897|P1|Overall Study|Completed 5 years|0
7795381|NCT00524303|27090895|P3|Overall Study|Physician Decision|1
7795382|NCT00524303|27090896|P2|Overall Study|Physician Decision|0
7795383|NCT00524303|27090897|P1|Overall Study|Physician Decision|0
7795384|NCT00524303|27090895|P3|Overall Study|Sponsor Request|1
7795385|NCT00524303|27090896|P2|Overall Study|Sponsor Request|0
7795386|NCT00524303|27090897|P1|Overall Study|Sponsor Request|0
7795387|NCT00524303|27090895|P3|Overall Study|Disease Recurrence|0
7795388|NCT00524303|27090896|P2|Overall Study|Disease Recurrence|1
7795389|NCT00524303|27090897|P1|Overall Study|Disease Recurrence|0
7795390|NCT00524303|27090895|P3|Overall Study|Disease Progression|1
7795391|NCT00524303|27090896|P2|Overall Study|Disease Progression|4
7795392|NCT00524303|27090897|P1|Overall Study|Disease Progression|0
7795393|NCT00524303|27090895|P3|Overall Study|Worsening Peripheral Neuropathy|0
7795394|NCT00524303|27090896|P2|Overall Study|Worsening Peripheral Neuropathy|0
7795395|NCT00524303|27090897|P1|Overall Study|Worsening Peripheral Neuropathy|1
7795396|NCT00524303|27090895|P3|Overall Study|Did not Complete Study Dosing|0
7795397|NCT00524303|27090896|P2|Overall Study|Did not Complete Study Dosing|0
7795398|NCT00524303|27090897|P1|Overall Study|Did not Complete Study Dosing|1
7795399|NCT00524303|27090895|P3|Overall Study|Adverse Event|3
7795400|NCT00524303|27090896|P2|Overall Study|Adverse Event|2
7795401|NCT00524303|27090897|P1|Overall Study|Adverse Event|1
7795402|NCT00524303|27090895|P3|Overall Study|Death|3
7795403|NCT00524303|27090896|P2|Overall Study|Death|2
7795404|NCT00524303|27090897|P1|Overall Study|Death|0
7795405|NCT00524303|27090895|P3|Overall Study|Withdrawal by Subject|4
7795406|NCT00524303|27090896|P2|Overall Study|Withdrawal by Subject|0
7795407|NCT00524303|27090897|P1|Overall Study|Withdrawal by Subject|3
7795408|NCT00524303|27090895|P3|Overall Study|Protocol Violation|1
7795409|NCT00524303|27090896|P2|Overall Study|Protocol Violation|1
7795410|NCT00524303|27090897|P1|Overall Study|Protocol Violation|0
7795411|NCT00524303|27090895|P3|Overall Study|Lost to Follow-up|3
7795412|NCT00524303|27090896|P2|Overall Study|Lost to Follow-up|0
7795413|NCT00524303|27090897|P1|Overall Study|Lost to Follow-up|6
7795414|NCT00524173|27090949|P2|Overall Study|Had not reached endpoint at study close|1
7795415|NCT00524173|27090950|P1|Overall Study|Had not reached endpoint at study close|4
7795416|NCT00524173|27090949|P2|Overall Study|Death|0
7795417|NCT00524173|27090950|P1|Overall Study|Death|1
7795418|NCT00524173|27090949|P2|Overall Study|Lost to Follow-up|1
7795419|NCT00524173|27090950|P1|Overall Study|Lost to Follow-up|0
7795420|NCT00524134|27090962|P1|Overall Study|Physician Decision|1
7795421|NCT00524134|27090962|P1|Overall Study|Withdrawal by Subject|1
7795422|NCT00524121|27090969|P1|Overall Study|Not treated (changed mind)|1
7795423|NCT00524121|27090969|P1|Overall Study|Not treated (became ineligible)|4
7795424|NCT00524121|27090969|P1|Overall Study|Death|1
7795425|NCT00524121|27090969|P1|Overall Study|Other|1
7795426|NCT00524121|27090969|P1|Overall Study|Patient refused|2
7795427|NCT00524121|27090969|P1|Overall Study|Adverse Event|4
7795428|NCT00524121|27090969|P1|Overall Study|Disease progression|6
7795429|NCT00524043|27090989|P3|Overall Study|Various (eg, incarceration)|0
7795430|NCT00524043|27090990|P2|Overall Study|Various (eg, incarceration)|1
7795431|NCT00524043|27090991|P1|Overall Study|Various (eg, incarceration)|2
7795432|NCT00524043|27090989|P3|Overall Study|Lost to Follow-up|3
7795433|NCT00524043|27090990|P2|Overall Study|Lost to Follow-up|5
7795434|NCT00524043|27090991|P1|Overall Study|Lost to Follow-up|3
7795435|NCT00524043|27090989|P3|Overall Study|Adverse Event|7
7795436|NCT00524043|27090990|P2|Overall Study|Adverse Event|2
7795437|NCT00524043|27090991|P1|Overall Study|Adverse Event|5
7795438|NCT00524043|27090989|P3|Overall Study|Withdrawal by Subject|7
7795439|NCT00524043|27090990|P2|Overall Study|Withdrawal by Subject|7
7795440|NCT00524043|27090991|P1|Overall Study|Withdrawal by Subject|5
7795441|NCT00524043|27090989|P3|Overall Study|Lack of Efficacy|14
7795442|NCT00524043|27090990|P2|Overall Study|Lack of Efficacy|13
7795443|NCT00524043|27090991|P1|Overall Study|Lack of Efficacy|15
7795444|NCT00524030|27091013|P2|Overall Study|Death|1
7795445|NCT00524030|27091014|P1|Overall Study|Death|0
7795446|NCT00524030|27091013|P2|Overall Study|Adverse Event|21
7795447|NCT00524030|27091014|P1|Overall Study|Adverse Event|3
7795448|NCT00524030|27091013|P2|Overall Study|Pregnancy|0
7795449|NCT00524030|27091014|P1|Overall Study|Pregnancy|1
7795450|NCT00524030|27091013|P2|Overall Study|Protocol Violation|1
7795451|NCT00524030|27091014|P1|Overall Study|Protocol Violation|0
7795452|NCT00524030|27091013|P2|Overall Study|Noncompliance/Investigator discretion|2
7795453|NCT00524030|27091014|P1|Overall Study|Noncompliance/Investigator discretion|0
7795454|NCT00524030|27091013|P2|Overall Study|Withdrawal by Subject|8
7795455|NCT00524030|27091014|P1|Overall Study|Withdrawal by Subject|3
7795456|NCT00524030|27091013|P2|Overall Study|Lost to Follow-up|2
7795457|NCT00524030|27091014|P1|Overall Study|Lost to Follow-up|0
7795458|NCT00524030|27091013|P2|Overall Study|Lack of Efficacy|24
7795459|NCT00524030|27091014|P1|Overall Study|Lack of Efficacy|10
7795460|NCT00523991|27091053|P2|Overall Study|Other reason (not specified)|0
7795461|NCT00523991|27091054|P1|Overall Study|Other reason (not specified)|3
7795462|NCT00523991|27091053|P2|Overall Study|Withdrawal by Subject|17
7795463|NCT00523991|27091054|P1|Overall Study|Withdrawal by Subject|7
7795464|NCT00523991|27091053|P2|Overall Study|Lost to Follow-up|1
7795465|NCT00523991|27091054|P1|Overall Study|Lost to Follow-up|4
7795466|NCT00523991|27091053|P2|Overall Study|Protocol Violation|4
7795467|NCT00523991|27091054|P1|Overall Study|Protocol Violation|1
7795468|NCT00523991|27091053|P2|Overall Study|Adverse Event|5
7795469|NCT00523991|27091054|P1|Overall Study|Adverse Event|6
7795470|NCT00523978|27091334|P2|Overall Study|Death|0
7795471|NCT00523978|27091335|P1|Overall Study|Death|1
7795472|NCT00523978|27091334|P2|Overall Study|Screen Failures|1
7795473|NCT00523978|27091335|P1|Overall Study|Screen Failures|5
7795474|NCT00523978|27091334|P2|Overall Study|Withdrawal by Subject|7
7795475|NCT00523978|27091335|P1|Overall Study|Withdrawal by Subject|3
7795476|NCT00523848|27091357|P1|Overall Study|Other, unspecified|4
7795477|NCT00523848|27091357|P1|Overall Study|Disease Progression|5
7795478|NCT00523848|27091357|P1|Overall Study|NOT TREATED (Became ineligible)|2
7795479|NCT00523848|27091357|P1|Overall Study|Withdrawal by Subject|2
7795480|NCT00523848|27091357|P1|Overall Study|Adverse Event|11
7795481|NCT00523744|27091367|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
7795482|NCT00523744|27091367|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
7795483|NCT00523744|27091367|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
7795484|NCT00523744|27091367|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
7795485|NCT00523744|27091367|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
7795486|NCT00523744|27091367|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
7795487|NCT00523718|27091386|P2|Overall Study|Protocol Violation|0
7795488|NCT00523718|27091387|P1|Overall Study|Protocol Violation|2
7795489|NCT00523718|27091386|P2|Overall Study|Withdrawal by Subject|0
7795490|NCT00523718|27091387|P1|Overall Study|Withdrawal by Subject|1
7795491|NCT00523705|27091401|P2|Overall Study|No time for study.|1
7795492|NCT00523705|27091402|P1|Overall Study|No time for study.|0
7795493|NCT00523640|27091414|P1|Overall Study|Death|1
7795494|NCT00523549|27091431|P2|Overall Study|Lost to Follow-up|5
7795495|NCT00523549|27091432|P1|Overall Study|Lost to Follow-up|3
7795496|NCT00523549|27091431|P2|Overall Study|Patient withdrew consent|6
7795497|NCT00523549|27091432|P1|Overall Study|Patient withdrew consent|7
7795498|NCT00523549|27091431|P2|Overall Study|Protocol Deviation|1
7795499|NCT00523549|27091432|P1|Overall Study|Protocol Deviation|3
7795500|NCT00523549|27091431|P2|Overall Study|Unsatisfactory therapeutic effect|1
7795501|NCT00523549|27091432|P1|Overall Study|Unsatisfactory therapeutic effect|0
7795502|NCT00523549|27091431|P2|Overall Study|Adverse Event|3
7795503|NCT00523549|27091432|P1|Overall Study|Adverse Event|6
7795504|NCT00523419|27091450|P1|Overall Study|Death due to Adverse Event|2
7795505|NCT00523419|27091450|P1|Overall Study|Death due to Study Disease|4
7795506|NCT00523419|27091450|P1|Overall Study|Progressive Disease|22
7795507|NCT00523419|27091450|P1|Overall Study|Physician Decision|2
7795508|NCT00523419|27091450|P1|Overall Study|Withdrawal by Subject|1
7795509|NCT00523419|27091450|P1|Overall Study|Adverse Event|1
7795510|NCT00523367|27091460|P1|Overall Study|4 Withdrawn by PI|4
7795511|NCT00523367|27091460|P1|Overall Study|19 screen failures|19
7795512|NCT00523341|27091466|P2|Overall Study|Disease Progression|0
7795513|NCT00523341|27091467|P1|Overall Study|Disease Progression|1
7795514|NCT00523341|27091466|P2|Overall Study|Ineligibility Determined|4
7795515|NCT00523341|27091467|P1|Overall Study|Ineligibility Determined|3
7795516|NCT00523341|27091466|P2|Overall Study|Protocol Deviation|5
7795517|NCT00523341|27091467|P1|Overall Study|Protocol Deviation|6
7795518|NCT00523341|27091466|P2|Overall Study|Requirement for Alternative Therapy|14
7795519|NCT00523341|27091467|P1|Overall Study|Requirement for Alternative Therapy|4
7795520|NCT00523341|27091466|P2|Overall Study|Physician Decision|13
7795521|NCT00523341|27091467|P1|Overall Study|Physician Decision|14
7795522|NCT00523341|27091466|P2|Overall Study|Non-compliance|13
7795523|NCT00523341|27091467|P1|Overall Study|Non-compliance|20
7795524|NCT00523341|27091466|P2|Overall Study|Lost to Follow-up|61
7795525|NCT00523341|27091467|P1|Overall Study|Lost to Follow-up|73
7795526|NCT00523341|27091466|P2|Overall Study|Death|110
7795527|NCT00523341|27091467|P1|Overall Study|Death|101
7795528|NCT00523341|27091466|P2|Overall Study|Adverse Event|155
7795529|NCT00523341|27091467|P1|Overall Study|Adverse Event|122
7795530|NCT00523341|27091466|P2|Overall Study|Other|198
7795531|NCT00523341|27091467|P1|Overall Study|Other|181
7795532|NCT00523341|27091466|P2|Overall Study|Withdrawal by Subject|427
7795533|NCT00523341|27091467|P1|Overall Study|Withdrawal by Subject|399
7795534|NCT00522951|27091584|P2|Period 2|residual contrast medium|1
7795535|NCT00522951|27091585|P1|Period 2|residual contrast medium|1
7795536|NCT00522951|27091584|P2|Period 2|Withdrawal by Subject|0
7795537|NCT00522951|27091585|P1|Period 2|Withdrawal by Subject|1
7795538|NCT00522951|27091584|P2|Washout Period|Death|1
7795539|NCT00522951|27091585|P1|Washout Period|Death|0
7795540|NCT00522951|27091584|P2|Washout Period|Adverse Event|1
7795541|NCT00522951|27091585|P1|Washout Period|Adverse Event|0
7795542|NCT00522951|27091584|P2|Period 1|body motion|1
7795543|NCT00522951|27091585|P1|Period 1|body motion|0
7795544|NCT00522873|27091640|P2|Overall Study|Never Received Medication|0
7795545|NCT00522873|27091641|P1|Overall Study|Never Received Medication|1
7795546|NCT00522873|27091640|P2|Overall Study|Medication Errors|1
7795547|NCT00522873|27091641|P1|Overall Study|Medication Errors|1
7795548|NCT00522873|27091640|P2|Overall Study|Personal Reasons|1
7795549|NCT00522873|27091641|P1|Overall Study|Personal Reasons|8
7795550|NCT00522873|27091640|P2|Overall Study|Lost to Follow-up|3
7795551|NCT00522873|27091641|P1|Overall Study|Lost to Follow-up|11
7795552|NCT00522873|27091640|P2|Overall Study|Protocol Violation|4
7795553|NCT00522873|27091641|P1|Overall Study|Protocol Violation|14
7795554|NCT00522873|27091640|P2|Overall Study|Withdrawal by Subject|9
7795555|NCT00522873|27091641|P1|Overall Study|Withdrawal by Subject|20
7795556|NCT00522873|27091640|P2|Overall Study|Adverse Event|26
7795557|NCT00522873|27091641|P1|Overall Study|Adverse Event|41
7795558|NCT00522626|27091654|P1|Overall Study|Lost to Follow-up|7
7795559|NCT00522548|27091660|P2|Overall Study|Withdrawal by Subject|2
7795560|NCT00522548|27091661|P1|Overall Study|Withdrawal by Subject|0
7795561|NCT00522548|27091660|P2|Overall Study|Adverse Event|2
7795562|NCT00522548|27091661|P1|Overall Study|Adverse Event|2
7795563|NCT00522457|27091689|P1|Overall Study|Adverse Event|2
7795564|NCT00522457|27091689|P1|Overall Study|Due to disease progression|16
7795565|NCT00522431|27091695|P1|Overall Study|Other/unknown|1
7795566|NCT00522431|27091695|P1|Overall Study|Subject non-compliance|1
7795567|NCT00522431|27091695|P1|Overall Study|Withdrawal by Subject|2
7795568|NCT00522431|27091695|P1|Overall Study|Protocol Violation|2
7795569|NCT00522431|27091695|P1|Overall Study|Adverse Event|5
7795570|NCT00522418|27091702|P2|Overall Study|Lack of Efficacy|1
7795571|NCT00522418|27091703|P1|Overall Study|Lack of Efficacy|0
7795572|NCT00522418|27091702|P2|Overall Study|Consent Withdraw|2
7795573|NCT00522418|27091703|P1|Overall Study|Consent Withdraw|1
7795574|NCT00522418|27091702|P2|Overall Study|Reason Not Specified|1
7795575|NCT00522418|27091703|P1|Overall Study|Reason Not Specified|3
7795576|NCT00522418|27091702|P2|Overall Study|Noncompliance|2
7795577|NCT00522418|27091703|P1|Overall Study|Noncompliance|2
7795578|NCT00522418|27091702|P2|Overall Study|Early Study Termination|47
7795579|NCT00522418|27091703|P1|Overall Study|Early Study Termination|46
7795580|NCT00522418|27091702|P2|Overall Study|Local IRB Consent Violation|5
7795581|NCT00522418|27091703|P1|Overall Study|Local IRB Consent Violation|5
7795582|NCT00522392|27091751|P2|Overall Study|Non-compliance|1
7795583|NCT00522392|27091752|P1|Overall Study|Non-compliance|0
7795584|NCT00522392|27091751|P2|Overall Study|Physician Decision|1
7795585|NCT00522392|27091752|P1|Overall Study|Physician Decision|0
7795586|NCT00522392|27091751|P2|Overall Study|Withdrawal by Subject|1
7795587|NCT00522392|27091752|P1|Overall Study|Withdrawal by Subject|1
7795588|NCT00522392|27091751|P2|Overall Study|Adverse Event|7
7795589|NCT00522392|27091752|P1|Overall Study|Adverse Event|7
7795590|NCT00522392|27091751|P2|Overall Study|Disease progression|3
7795591|NCT00522392|27091752|P1|Overall Study|Disease progression|0
7795592|NCT00522379|27091769|P5|Overall Study|Subject Withdrawal|0
7795593|NCT00522379|27091770|P4|Overall Study|Subject Withdrawal|1
7795594|NCT00522379|27091771|P3|Overall Study|Subject Withdrawal|0
7795595|NCT00522379|27091772|P2|Overall Study|Subject Withdrawal|0
7795596|NCT00522379|27091773|P1|Overall Study|Subject Withdrawal|0
7795597|NCT00522379|27091769|P5|Overall Study|Site Closed|0
7795598|NCT00522379|27091770|P4|Overall Study|Site Closed|1
7795599|NCT00522379|27091771|P3|Overall Study|Site Closed|0
7795600|NCT00522379|27091772|P2|Overall Study|Site Closed|0
7795601|NCT00522379|27091773|P1|Overall Study|Site Closed|0
7795602|NCT00522379|27091769|P5|Overall Study|Family Problem|0
7795603|NCT00522379|27091770|P4|Overall Study|Family Problem|0
7795604|NCT00522379|27091771|P3|Overall Study|Family Problem|1
7795605|NCT00522379|27091772|P2|Overall Study|Family Problem|0
7795606|NCT00522379|27091773|P1|Overall Study|Family Problem|0
7795607|NCT00522379|27091769|P5|Overall Study|Sponsor Request|0
7795608|NCT00522379|27091770|P4|Overall Study|Sponsor Request|0
7795609|NCT00522379|27091771|P3|Overall Study|Sponsor Request|0
7795610|NCT00522379|27091772|P2|Overall Study|Sponsor Request|1
7795611|NCT00522379|27091773|P1|Overall Study|Sponsor Request|0
7795612|NCT00522379|27091769|P5|Overall Study|Subject Moved|0
7795613|NCT00522379|27091770|P4|Overall Study|Subject Moved|0
7795614|NCT00522379|27091771|P3|Overall Study|Subject Moved|0
7795615|NCT00522379|27091772|P2|Overall Study|Subject Moved|1
7795616|NCT00522379|27091773|P1|Overall Study|Subject Moved|1
7795617|NCT00522379|27091769|P5|Overall Study|Dispensing error|0
7795618|NCT00522379|27091770|P4|Overall Study|Dispensing error|1
7795619|NCT00522379|27091771|P3|Overall Study|Dispensing error|0
7795620|NCT00522379|27091772|P2|Overall Study|Dispensing error|0
7795621|NCT00522379|27091773|P1|Overall Study|Dispensing error|1
7795622|NCT00522379|27091769|P5|Overall Study|Randomization error|1
7795623|NCT00522379|27091770|P4|Overall Study|Randomization error|0
7795624|NCT00522379|27091771|P3|Overall Study|Randomization error|0
7795625|NCT00522379|27091772|P2|Overall Study|Randomization error|0
7795626|NCT00522379|27091773|P1|Overall Study|Randomization error|0
7795627|NCT00522379|27091769|P5|Overall Study|Lost to Follow-up|2
7795628|NCT00522379|27091770|P4|Overall Study|Lost to Follow-up|2
7795629|NCT00522379|27091771|P3|Overall Study|Lost to Follow-up|4
7795630|NCT00522379|27091772|P2|Overall Study|Lost to Follow-up|0
7795631|NCT00522379|27091773|P1|Overall Study|Lost to Follow-up|1
7795632|NCT00522379|27091769|P5|Overall Study|Unsatisfactory Subject Compliance|0
7795633|NCT00522379|27091770|P4|Overall Study|Unsatisfactory Subject Compliance|0
7795634|NCT00522379|27091771|P3|Overall Study|Unsatisfactory Subject Compliance|0
7795635|NCT00522379|27091772|P2|Overall Study|Unsatisfactory Subject Compliance|2
7795636|NCT00522379|27091773|P1|Overall Study|Unsatisfactory Subject Compliance|1
7795637|NCT00522379|27091769|P5|Overall Study|Protocol Violation|0
7795638|NCT00522379|27091770|P4|Overall Study|Protocol Violation|0
7795639|NCT00522379|27091771|P3|Overall Study|Protocol Violation|2
7795640|NCT00522379|27091772|P2|Overall Study|Protocol Violation|1
7795641|NCT00522379|27091773|P1|Overall Study|Protocol Violation|1
7795642|NCT00522379|27091769|P5|Overall Study|Withdrawal by Subject|0
7795643|NCT00522379|27091770|P4|Overall Study|Withdrawal by Subject|2
7795644|NCT00522379|27091771|P3|Overall Study|Withdrawal by Subject|1
7795645|NCT00522379|27091772|P2|Overall Study|Withdrawal by Subject|3
7795646|NCT00522379|27091773|P1|Overall Study|Withdrawal by Subject|2
7795647|NCT00522379|27091769|P5|Overall Study|Lack of Efficacy|7
7795648|NCT00522379|27091770|P4|Overall Study|Lack of Efficacy|2
7795649|NCT00522379|27091771|P3|Overall Study|Lack of Efficacy|2
7795650|NCT00522379|27091772|P2|Overall Study|Lack of Efficacy|0
7795651|NCT00522379|27091773|P1|Overall Study|Lack of Efficacy|3
7795652|NCT00522379|27091769|P5|Overall Study|Adverse Event|17
7795653|NCT00522379|27091770|P4|Overall Study|Adverse Event|5
7795654|NCT00522379|27091771|P3|Overall Study|Adverse Event|12
7795655|NCT00522379|27091772|P2|Overall Study|Adverse Event|15
7795656|NCT00522379|27091773|P1|Overall Study|Adverse Event|12
7795657|NCT00522301|27091875|P1|Overall Study|Adverse Event|5
7795658|NCT00522301|27091875|P1|Overall Study|Withdrawal by Subject|1
7795659|NCT00522275|27091879|P1|Overall Study|Other: Subject had surgery for epilepsy|2
7795660|NCT00522275|27091879|P1|Overall Study|Other: Subject ran out of medication|1
7795661|NCT00522275|27091879|P1|Overall Study|Other: Sponsor request|2
7795662|NCT00522275|27091879|P1|Overall Study|Other: Travel to / from site difficulty|3
7795663|NCT00522275|27091879|P1|Overall Study|Other: Site / clinic closed|4
7795664|NCT00522275|27091879|P1|Overall Study|Other: Subject arrested|1
7795665|NCT00522275|27091879|P1|Overall Study|Other: Subject relocated|2
7795666|NCT00522275|27091879|P1|Overall Study|Other: Subject is pregnant|2
7795667|NCT00522275|27091879|P1|Overall Study|Other: Subject wants to become pregnant|2
7795668|NCT00522275|27091879|P1|Overall Study|Lost to Follow-up|8
7795669|NCT00522275|27091879|P1|Overall Study|Unsatisfactory compliance|11
7795670|NCT00522275|27091879|P1|Overall Study|Protocol deviation|1
7795671|NCT00522275|27091879|P1|Overall Study|Subject withdrew consent|16
7795672|NCT00522275|27091879|P1|Overall Study|Lack of Efficacy|80
7795673|NCT00522275|27091879|P1|Overall Study|Adverse Event|35
7795674|NCT00522041|27091900|P2|Overall Study|Did not receive treatment|1
7795675|NCT00522041|27091901|P1|Overall Study|Did not receive treatment|0
7795676|NCT00522041|27091900|P2|Overall Study|Voluntary withdrawal|4
7795677|NCT00522041|27091901|P1|Overall Study|Voluntary withdrawal|5
7795678|NCT00522041|27091900|P2|Overall Study|Lost to Follow-up|4
7795679|NCT00522041|27091901|P1|Overall Study|Lost to Follow-up|1
7795680|NCT00522041|27091900|P2|Overall Study|Protocol Violation|0
7795681|NCT00522041|27091901|P1|Overall Study|Protocol Violation|2
7795682|NCT00522041|27091900|P2|Overall Study|Adverse Event|3
7795683|NCT00522041|27091901|P1|Overall Study|Adverse Event|9
7795684|NCT00521599|27091960|P3|Overall Study|Did not meet protocol eligibility|1
7795685|NCT00521599|27091961|P2|Overall Study|Did not meet protocol eligibility|2
7795686|NCT00521599|27091962|P1|Overall Study|Did not meet protocol eligibility|2
7795687|NCT00521599|27091960|P3|Overall Study|Protocol Violation|2
7795688|NCT00521599|27091961|P2|Overall Study|Protocol Violation|4
7795689|NCT00521599|27091962|P1|Overall Study|Protocol Violation|2
7795690|NCT00521599|27091960|P3|Overall Study|Withdrawal by subject treatment related|2
7795691|NCT00521599|27091961|P2|Overall Study|Withdrawal by subject treatment related|1
7795692|NCT00521599|27091962|P1|Overall Study|Withdrawal by subject treatment related|3
7795693|NCT00521599|27091960|P3|Overall Study|Withdrawal by Subject|1
7795694|NCT00521599|27091961|P2|Overall Study|Withdrawal by Subject|5
7795695|NCT00521599|27091962|P1|Overall Study|Withdrawal by Subject|3
7795696|NCT00521599|27091960|P3|Overall Study|Lost to Follow-up|2
7795697|NCT00521599|27091961|P2|Overall Study|Lost to Follow-up|1
7795698|NCT00521599|27091962|P1|Overall Study|Lost to Follow-up|2
7795699|NCT00521599|27091960|P3|Overall Study|Treatment Failure|22
7795700|NCT00521599|27091961|P2|Overall Study|Treatment Failure|9
7795701|NCT00521599|27091962|P1|Overall Study|Treatment Failure|8
7795702|NCT00521599|27091960|P3|Overall Study|Adverse Event|6
7795703|NCT00521599|27091961|P2|Overall Study|Adverse Event|7
7795704|NCT00521599|27091962|P1|Overall Study|Adverse Event|5
7795705|NCT00521586|27091973|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
7795706|NCT00521586|27091974|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
7795707|NCT00521586|27091973|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
7795708|NCT00521586|27091974|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
7795709|NCT00521586|27091973|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
7795710|NCT00521586|27091974|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
7795711|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
7795712|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
7795713|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
7795714|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
7795715|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
7795716|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
7795717|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
7795718|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
7795719|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
7795720|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
7795721|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
7795722|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
7795723|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
7795724|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
7795725|NCT00521586|27091973|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
7795726|NCT00521586|27091974|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
7795727|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Failed to return|1
7795728|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Failed to return|0
7795729|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Death|0
7795730|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Death|1
7795731|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Adverse Event|1
7795732|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Adverse Event|0
7795733|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Investigator request|0
7795734|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Investigator request|2
7795735|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Other, unspecified|1
7795736|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Other, unspecified|3
7795737|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Protocol Violation|5
7795738|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Protocol Violation|2
7795739|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
7795740|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
7795741|NCT00521586|27091973|P2|Initial Vaccination (Year 0)|Subject request|11
7795742|NCT00521586|27091974|P1|Initial Vaccination (Year 0)|Subject request|8
7795743|NCT00521404|27092047|P1|Overall Study|Other|7
7795744|NCT00521404|27092047|P1|Overall Study|Noncompliance or lack of cooperation|1
7795745|NCT00521404|27092047|P1|Overall Study|Withdrawal of consent|3
7795746|NCT00521404|27092047|P1|Overall Study|Investigator decision|5
7795747|NCT00521404|27092047|P1|Overall Study|Disease Progression|33
7795748|NCT00521404|27092047|P1|Overall Study|Adverse Event|13
7795749|NCT00521365|27092056|P1|Overall Study|Usage of not allowed drugs|6
7795750|NCT00521365|27092056|P1|Overall Study|Drug compliance|3
7795751|NCT00521365|27092056|P1|Overall Study|Protocol deviation|2
7795752|NCT00521365|27092056|P1|Overall Study|Lost to Follow-up|6
7795753|NCT00521365|27092056|P1|Overall Study|Adverse Event|3
7795754|NCT00521339|27092086|P3|Treatment Extension Phase|Death|1
7795755|NCT00521339|27092087|P2|Treatment Extension Phase|Death|0
7795756|NCT00521339|27092088|P1|Treatment Extension Phase|Death|0
7795757|NCT00521339|27092086|P3|Treatment Extension Phase|Withdrawal by Subject|2
7795758|NCT00521339|27092087|P2|Treatment Extension Phase|Withdrawal by Subject|0
7795759|NCT00521339|27092088|P1|Treatment Extension Phase|Withdrawal by Subject|0
7795760|NCT00521339|27092086|P3|Treatment Phase|Protocol Violation|0
7795761|NCT00521339|27092087|P2|Treatment Phase|Protocol Violation|0
7795762|NCT00521339|27092088|P1|Treatment Phase|Protocol Violation|1
7795763|NCT00521339|27092086|P3|Treatment Phase|Lost to Follow-up|0
7795764|NCT00521339|27092087|P2|Treatment Phase|Lost to Follow-up|0
7795765|NCT00521339|27092088|P1|Treatment Phase|Lost to Follow-up|1
7795766|NCT00521339|27092086|P3|Treatment Phase|Withdrawal by Subject|0
7795767|NCT00521339|27092087|P2|Treatment Phase|Withdrawal by Subject|0
7795768|NCT00521339|27092088|P1|Treatment Phase|Withdrawal by Subject|3
7795769|NCT00521339|27092086|P3|Treatment Phase|Lack of Efficacy|0
7795770|NCT00521339|27092087|P2|Treatment Phase|Lack of Efficacy|0
7795771|NCT00521339|27092088|P1|Treatment Phase|Lack of Efficacy|3
7795772|NCT00521339|27092086|P3|Treatment Phase|Intolerability to study drug|0
7795773|NCT00521339|27092087|P2|Treatment Phase|Intolerability to study drug|0
7795774|NCT00521339|27092088|P1|Treatment Phase|Intolerability to study drug|2
7795775|NCT00521339|27092086|P3|Treatment Phase|Adverse Event|0
7795776|NCT00521339|27092087|P2|Treatment Phase|Adverse Event|0
7795777|NCT00521339|27092088|P1|Treatment Phase|Adverse Event|2
7795778|NCT00521144|27092156|P5|Overall Study|Progressive Disease|6
7795779|NCT00521144|27092157|P4|Overall Study|Progressive Disease|0
7795780|NCT00521144|27092158|P3|Overall Study|Progressive Disease|2
7795781|NCT00521144|27092159|P2|Overall Study|Progressive Disease|2
7795782|NCT00521144|27092160|P1|Overall Study|Progressive Disease|4
7795783|NCT00521144|27092156|P5|Overall Study|Adverse Event|1
7795784|NCT00521144|27092157|P4|Overall Study|Adverse Event|0
7795785|NCT00521144|27092158|P3|Overall Study|Adverse Event|0
7795786|NCT00521144|27092159|P2|Overall Study|Adverse Event|1
7795787|NCT00521144|27092160|P1|Overall Study|Adverse Event|0
7795788|NCT00521144|27092156|P5|Overall Study|Not Treated|0
7795789|NCT00521144|27092157|P4|Overall Study|Not Treated|1
7795790|NCT00521144|27092158|P3|Overall Study|Not Treated|0
7795791|NCT00521144|27092159|P2|Overall Study|Not Treated|0
7795792|NCT00521144|27092160|P1|Overall Study|Not Treated|0
7795793|NCT00521079|27092174|P2|Overall Study|Withdrawal by Subject|3
7795794|NCT00521079|27092175|P1|Overall Study|Withdrawal by Subject|5
7795795|NCT00521079|27092174|P2|Overall Study|Lost to Follow-up|1
7795796|NCT00521079|27092175|P1|Overall Study|Lost to Follow-up|2
7795797|NCT00521079|27092174|P2|Overall Study|Adverse Event|1
7795798|NCT00521079|27092175|P1|Overall Study|Adverse Event|7
7795799|NCT00521053|27092185|P1|Observation Phase|Physician Decision|1
7795800|NCT00521053|27092185|P1|Observation Phase|Other non-study melanoma treatment|1
7795801|NCT00521053|27092185|P1|Observation Phase|Adverse Event|1
7795802|NCT00521053|27092185|P1|Observation Phase|Death|2
7795803|NCT00521053|27092185|P1|Observation Phase|Additional PV-10 via alternate protocol|8
7795804|NCT00521053|27092185|P1|Observation Phase|Disease Progression|55
7795805|NCT00521014|27092195|P1|Overall Study|Inevaluable, not treated|1
7795806|NCT00521001|27092199|P1|Overall Study|Ineligible|1
7795807|NCT00520975|27092208|P2|Overall Study|Not start protocol therapy|2
7795808|NCT00520975|27092209|P1|Overall Study|Not start protocol therapy|1
7795809|NCT00520975|27092208|P2|Overall Study|Other reasons|2
7795810|NCT00520975|27092209|P1|Overall Study|Other reasons|4
7795811|NCT00520975|27092208|P2|Overall Study|Other therapy|4
7795812|NCT00520975|27092209|P1|Overall Study|Other therapy|2
7795813|NCT00520975|27092208|P2|Overall Study|Withdrawal by Subject|5
7795814|NCT00520975|27092209|P1|Overall Study|Withdrawal by Subject|3
7795815|NCT00520975|27092208|P2|Overall Study|Death|2
7795816|NCT00520975|27092209|P1|Overall Study|Death|0
7795817|NCT00520975|27092208|P2|Overall Study|Adverse Event|10
7795818|NCT00520975|27092209|P1|Overall Study|Adverse Event|7
7795819|NCT00520975|27092208|P2|Overall Study|Disease progression|23
7795820|NCT00520975|27092209|P1|Overall Study|Disease progression|31
7795821|NCT00520936|27092241|P8|Overall Study|Protocol Violation|0
7795822|NCT00520936|27092242|P7|Overall Study|Protocol Violation|1
7795823|NCT00520936|27092243|P6|Overall Study|Protocol Violation|0
7795824|NCT00520936|27092244|P5|Overall Study|Protocol Violation|1
7795825|NCT00520936|27092245|P4|Overall Study|Protocol Violation|0
7795826|NCT00520936|27092246|P3|Overall Study|Protocol Violation|1
7795827|NCT00520936|27092247|P2|Overall Study|Protocol Violation|1
7795828|NCT00520936|27092248|P1|Overall Study|Protocol Violation|0
7795829|NCT00520936|27092241|P8|Overall Study|Death|0
7795830|NCT00520936|27092242|P7|Overall Study|Death|1
7795831|NCT00520936|27092243|P6|Overall Study|Death|0
7795832|NCT00520936|27092244|P5|Overall Study|Death|0
7795833|NCT00520936|27092245|P4|Overall Study|Death|0
7795834|NCT00520936|27092246|P3|Overall Study|Death|0
7795835|NCT00520936|27092247|P2|Overall Study|Death|0
7795836|NCT00520936|27092248|P1|Overall Study|Death|0
7795837|NCT00520936|27092241|P8|Overall Study|Toxicity Requiring Removal from Study|0
7795838|NCT00520936|27092242|P7|Overall Study|Toxicity Requiring Removal from Study|2
7795839|NCT00520936|27092243|P6|Overall Study|Toxicity Requiring Removal from Study|0
7795840|NCT00520936|27092244|P5|Overall Study|Toxicity Requiring Removal from Study|0
7795841|NCT00520936|27092245|P4|Overall Study|Toxicity Requiring Removal from Study|0
7795842|NCT00520936|27092246|P3|Overall Study|Toxicity Requiring Removal from Study|0
7795843|NCT00520936|27092247|P2|Overall Study|Toxicity Requiring Removal from Study|1
7795844|NCT00520936|27092248|P1|Overall Study|Toxicity Requiring Removal from Study|0
7795845|NCT00520936|27092241|P8|Overall Study|Withdrawal by Subject|1
7795846|NCT00520936|27092242|P7|Overall Study|Withdrawal by Subject|0
7795847|NCT00520936|27092243|P6|Overall Study|Withdrawal by Subject|0
7795848|NCT00520936|27092244|P5|Overall Study|Withdrawal by Subject|0
7795849|NCT00520936|27092245|P4|Overall Study|Withdrawal by Subject|0
7795850|NCT00520936|27092246|P3|Overall Study|Withdrawal by Subject|0
7795851|NCT00520936|27092247|P2|Overall Study|Withdrawal by Subject|0
7795852|NCT00520936|27092248|P1|Overall Study|Withdrawal by Subject|0
7795853|NCT00520936|27092241|P8|Overall Study|Physician Decision|0
7795854|NCT00520936|27092242|P7|Overall Study|Physician Decision|0
7795855|NCT00520936|27092243|P6|Overall Study|Physician Decision|0
7795856|NCT00520936|27092244|P5|Overall Study|Physician Decision|0
7795857|NCT00520936|27092245|P4|Overall Study|Physician Decision|0
7795858|NCT00520936|27092246|P3|Overall Study|Physician Decision|1
7795859|NCT00520936|27092247|P2|Overall Study|Physician Decision|2
7795860|NCT00520936|27092248|P1|Overall Study|Physician Decision|0
7795861|NCT00520845|27092303|P1|Overall Study|Alternative Therapy|1
7795862|NCT00520845|27092303|P1|Overall Study|Withdrawal by Subject|1
7795863|NCT00520845|27092303|P1|Overall Study|Disease Progression, relapse|13
7795864|NCT00520845|27092303|P1|Overall Study|Adverse Event|4
7795865|NCT00520845|27092303|P1|Overall Study|Death|3
7795866|NCT00520767|27092311|P1|Overall Study|Death|2
7795867|NCT00520741|27092317|P2|Overall Study|Other reasons for premature termination|6
7795868|NCT00520741|27092318|P1|Overall Study|Other reasons for premature termination|0
7795869|NCT00520741|27092317|P2|Overall Study|Lost to Follow-up|4
7795870|NCT00520741|27092318|P1|Overall Study|Lost to Follow-up|4
7795871|NCT00520741|27092317|P2|Overall Study|Unsatisfactory compliance of subject|3
7795872|NCT00520741|27092318|P1|Overall Study|Unsatisfactory compliance of subject|4
7795873|NCT00520741|27092317|P2|Overall Study|Protocol Violation|15
7795874|NCT00520741|27092318|P1|Overall Study|Protocol Violation|2
7795875|NCT00520741|27092317|P2|Overall Study|Withdrawal by Subject|11
7795876|NCT00520741|27092318|P1|Overall Study|Withdrawal by Subject|0
7795877|NCT00520741|27092317|P2|Overall Study|Lack of Efficacy|30
7795878|NCT00520741|27092318|P1|Overall Study|Lack of Efficacy|11
7795879|NCT00520741|27092317|P2|Overall Study|Adverse Event|56
7795880|NCT00520741|27092318|P1|Overall Study|Adverse Event|16
7795881|NCT00520676|27092336|P2|Overall Study|Withdrawal by Subject|11
7795882|NCT00520676|27092337|P1|Overall Study|Withdrawal by Subject|7
7795883|NCT00520676|27092336|P2|Overall Study|Physician Decision|1
7795884|NCT00520676|27092337|P1|Overall Study|Physician Decision|4
7795885|NCT00520676|27092336|P2|Overall Study|Lost to Follow-up|10
7795886|NCT00520676|27092337|P1|Overall Study|Lost to Follow-up|6
7795887|NCT00520676|27092336|P2|Overall Study|Death|81
7795888|NCT00520676|27092337|P1|Overall Study|Death|84
7795889|NCT00520572|27092363|P6|Overall Study|Did not receive Treatment|0
7795890|NCT00520572|27092364|P5|Overall Study|Did not receive Treatment|0
7795891|NCT00520572|27092365|P4|Overall Study|Did not receive Treatment|0
7795892|NCT00520572|27092366|P3|Overall Study|Did not receive Treatment|1
7795893|NCT00520572|27092367|P2|Overall Study|Did not receive Treatment|0
7795894|NCT00520572|27092368|P1|Overall Study|Did not receive Treatment|1
7795895|NCT00520572|27092363|P6|Overall Study|Long break in taking Medication|0
7795896|NCT00520572|27092364|P5|Overall Study|Long break in taking Medication|0
7795897|NCT00520572|27092365|P4|Overall Study|Long break in taking Medication|1
7795898|NCT00520572|27092366|P3|Overall Study|Long break in taking Medication|0
7795899|NCT00520572|27092367|P2|Overall Study|Long break in taking Medication|0
7795900|NCT00520572|27092368|P1|Overall Study|Long break in taking Medication|0
7795901|NCT00520572|27092363|P6|Overall Study|Oral corticotherapy for acute urticaria|0
7795902|NCT00520572|27092364|P5|Overall Study|Oral corticotherapy for acute urticaria|0
7795903|NCT00520572|27092365|P4|Overall Study|Oral corticotherapy for acute urticaria|0
7795904|NCT00520572|27092366|P3|Overall Study|Oral corticotherapy for acute urticaria|0
7795905|NCT00520572|27092367|P2|Overall Study|Oral corticotherapy for acute urticaria|1
7795906|NCT00520572|27092368|P1|Overall Study|Oral corticotherapy for acute urticaria|0
7795907|NCT00520572|27092363|P6|Overall Study|Incorrect enrollment|0
7795908|NCT00520572|27092364|P5|Overall Study|Incorrect enrollment|1
7795909|NCT00520572|27092365|P4|Overall Study|Incorrect enrollment|0
7795910|NCT00520572|27092366|P3|Overall Study|Incorrect enrollment|1
7795911|NCT00520572|27092367|P2|Overall Study|Incorrect enrollment|0
7795912|NCT00520572|27092368|P1|Overall Study|Incorrect enrollment|1
7795913|NCT00520572|27092363|P6|Overall Study|Lost to Follow-up|0
7795914|NCT00520572|27092364|P5|Overall Study|Lost to Follow-up|1
7795915|NCT00520572|27092365|P4|Overall Study|Lost to Follow-up|0
7795916|NCT00520572|27092366|P3|Overall Study|Lost to Follow-up|0
7795917|NCT00520572|27092367|P2|Overall Study|Lost to Follow-up|0
7795918|NCT00520572|27092368|P1|Overall Study|Lost to Follow-up|0
7795919|NCT00520572|27092363|P6|Overall Study|Lack of Efficacy|0
7795920|NCT00520572|27092364|P5|Overall Study|Lack of Efficacy|1
7795921|NCT00520572|27092365|P4|Overall Study|Lack of Efficacy|2
7795922|NCT00520572|27092366|P3|Overall Study|Lack of Efficacy|1
7795923|NCT00520572|27092367|P2|Overall Study|Lack of Efficacy|1
7795924|NCT00520572|27092368|P1|Overall Study|Lack of Efficacy|1
7795925|NCT00520572|27092363|P6|Overall Study|Protocol Violation|0
7795926|NCT00520572|27092364|P5|Overall Study|Protocol Violation|0
7795927|NCT00520572|27092365|P4|Overall Study|Protocol Violation|0
7795928|NCT00520572|27092366|P3|Overall Study|Protocol Violation|1
7795929|NCT00520572|27092367|P2|Overall Study|Protocol Violation|0
7795930|NCT00520572|27092368|P1|Overall Study|Protocol Violation|0
7795931|NCT00520572|27092363|P6|Overall Study|Withdrawal by Subject|0
7795932|NCT00520572|27092364|P5|Overall Study|Withdrawal by Subject|2
7795933|NCT00520572|27092365|P4|Overall Study|Withdrawal by Subject|2
7795934|NCT00520572|27092366|P3|Overall Study|Withdrawal by Subject|5
7795935|NCT00520572|27092367|P2|Overall Study|Withdrawal by Subject|9
7795936|NCT00520572|27092368|P1|Overall Study|Withdrawal by Subject|0
7795937|NCT00520572|27092363|P6|Overall Study|Adverse Event|2
7795938|NCT00520572|27092364|P5|Overall Study|Adverse Event|7
7795939|NCT00520572|27092365|P4|Overall Study|Adverse Event|9
7795940|NCT00520572|27092366|P3|Overall Study|Adverse Event|6
7795941|NCT00520572|27092367|P2|Overall Study|Adverse Event|3
7795942|NCT00520572|27092368|P1|Overall Study|Adverse Event|9
7795943|NCT00520546|27092406|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
7795944|NCT00520546|27092406|P1|Overall Study|Withdrawal by Subject|1
7795945|NCT00520533|27092421|P1|Overall Study|Physician Decision|1
7795946|NCT00520533|27092421|P1|Overall Study|Withdrawal by Subject|1
7795947|NCT00520533|27092421|P1|Overall Study|Suspension of the study for safety reasons|1
7795948|NCT00520533|27092421|P1|Overall Study|Death|1
7795949|NCT00520494|27092437|P1|Overall Study|Withdrawal by Subject|1
7795950|NCT00520481|27092462|P2|Overall Study|Withdrawal by Subject|0
7795951|NCT00520481|27092463|P1|Overall Study|Withdrawal by Subject|3
7795952|NCT00520481|27092462|P2|Overall Study|Adverse Event|1
7795953|NCT00520481|27092463|P1|Overall Study|Adverse Event|4
7795954|NCT00520403|27092487|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
7795955|NCT00520403|27092487|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
7795956|NCT00520403|27092487|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
7795957|NCT00520403|27092487|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
7795958|NCT00520403|27092487|P1|Bevacizumab + IFN/Vinblastine|Death|2
7795959|NCT00520403|27092487|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
7795960|NCT00520403|27092487|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
7795961|NCT00520403|27092487|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
7795962|NCT00520351|27092496|P2|First Intervention|Withdrawal by Subject|1
7795963|NCT00520351|27092497|P1|First Intervention|Withdrawal by Subject|1
7795964|NCT00520299|27092512|P3|Overall Study|Progressive disease|4
7795965|NCT00520299|27092513|P2|Overall Study|Progressive disease|3
7795966|NCT00520299|27092514|P1|Overall Study|Progressive disease|0
7795967|NCT00520299|27092512|P3|Overall Study|Withdrawal by Subject|2
7795968|NCT00520299|27092513|P2|Overall Study|Withdrawal by Subject|0
7795969|NCT00520299|27092514|P1|Overall Study|Withdrawal by Subject|0
7795970|NCT00520130|27092569|P2|Overall Study|Physician Decision|1
7795971|NCT00520130|27092570|P1|Overall Study|Physician Decision|1
7795972|NCT00520130|27092569|P2|Overall Study|Disease progression on study|0
7795973|NCT00520130|27092570|P1|Overall Study|Disease progression on study|4
7795974|NCT00520039|27092612|P2|Overall Study|Exclusion criteria met at first visit|5
7795975|NCT00520039|27092613|P1|Overall Study|Exclusion criteria met at first visit|7
7795976|NCT00520013|27092626|P3|Overall Study|Physician Decision|3
7795977|NCT00520013|27092627|P2|Overall Study|Physician Decision|0
7795978|NCT00520013|27092628|P1|Overall Study|Physician Decision|0
7795979|NCT00520013|27092626|P3|Overall Study|Death|0
7795980|NCT00520013|27092627|P2|Overall Study|Death|1
7795981|NCT00520013|27092628|P1|Overall Study|Death|0
7795982|NCT00520013|27092626|P3|Overall Study|Clinical Progression|0
7795983|NCT00520013|27092627|P2|Overall Study|Clinical Progression|1
7795984|NCT00520013|27092628|P1|Overall Study|Clinical Progression|3
7795985|NCT00520013|27092626|P3|Overall Study|Progressive Disease|0
7795986|NCT00520013|27092627|P2|Overall Study|Progressive Disease|3
7795987|NCT00520013|27092628|P1|Overall Study|Progressive Disease|7
7795988|NCT00520013|27092626|P3|Overall Study|Adverse Event|7
7795989|NCT00520013|27092627|P2|Overall Study|Adverse Event|10
7795990|NCT00520013|27092628|P1|Overall Study|Adverse Event|2
7795991|NCT00520013|27092626|P3|Overall Study|Withdrawal by Subject|1
7795992|NCT00520013|27092627|P2|Overall Study|Withdrawal by Subject|0
7795993|NCT00520013|27092628|P1|Overall Study|Withdrawal by Subject|0
7795994|NCT00519896|27092638|P1|Overall Study|Adverse Event|1
7795995|NCT00519896|27092638|P1|Overall Study|Protocol Violation|1
7795996|NCT00519831|27092644|P1|Overall Study|Adverse Event|3
7795997|NCT00519779|27092661|P2|Overall Study|Withdrawal by Subject|1
7795998|NCT00519779|27092662|P1|Overall Study|Withdrawal by Subject|0
7795999|NCT00519649|27092678|P1|Overall Study|Withdrawal by Subject|1
7796000|NCT00519636|27092691|P4|Post Study Period|Subject randomized in error|1
7796001|NCT00519636|27092692|P3|Post Study Period|Subject randomized in error|0
7796002|NCT00519636|27092693|P2|Post Study Period|Subject randomized in error|0
7796003|NCT00519636|27092694|P1|Post Study Period|Subject randomized in error|0
7796004|NCT00519636|27092691|P4|Treatment Period 2|Subject misrandomized|1
7796005|NCT00519636|27092692|P3|Treatment Period 2|Subject misrandomized|0
7796006|NCT00519636|27092693|P2|Treatment Period 2|Subject misrandomized|0
7796007|NCT00519636|27092694|P1|Treatment Period 2|Subject misrandomized|0
7796008|NCT00519636|27092691|P4|Treatment Period 2|Per doctors request|0
7796009|NCT00519636|27092692|P3|Treatment Period 2|Per doctors request|1
7796010|NCT00519636|27092693|P2|Treatment Period 2|Per doctors request|0
7796011|NCT00519636|27092694|P1|Treatment Period 2|Per doctors request|0
7796012|NCT00519636|27092691|P4|Treatment Period 2|Subject randomized in error|0
7796013|NCT00519636|27092692|P3|Treatment Period 2|Subject randomized in error|0
7796014|NCT00519636|27092693|P2|Treatment Period 2|Subject randomized in error|1
7796015|NCT00519636|27092694|P1|Treatment Period 2|Subject randomized in error|0
7796016|NCT00519636|27092691|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
7796017|NCT00519636|27092692|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
7796018|NCT00519636|27092693|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
7796019|NCT00519636|27092694|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
7796020|NCT00519636|27092691|P4|Washout Period|Prohibited medications|0
7796021|NCT00519636|27092692|P3|Washout Period|Prohibited medications|1
7796022|NCT00519636|27092693|P2|Washout Period|Prohibited medications|0
7796023|NCT00519636|27092694|P1|Washout Period|Prohibited medications|0
7796024|NCT00519636|27092691|P4|Washout Period|Subject randomized in error|0
7796025|NCT00519636|27092692|P3|Washout Period|Subject randomized in error|1
7796026|NCT00519636|27092693|P2|Washout Period|Subject randomized in error|0
7796027|NCT00519636|27092694|P1|Washout Period|Subject randomized in error|0
7796028|NCT00519636|27092691|P4|Washout Period|Per doctors request|0
7796029|NCT00519636|27092692|P3|Washout Period|Per doctors request|0
7796030|NCT00519636|27092693|P2|Washout Period|Per doctors request|1
7796031|NCT00519636|27092694|P1|Washout Period|Per doctors request|0
7796032|NCT00519636|27092691|P4|Washout Period|Non-compliant|0
7796033|NCT00519636|27092692|P3|Washout Period|Non-compliant|0
7796034|NCT00519636|27092693|P2|Washout Period|Non-compliant|1
7796035|NCT00519636|27092694|P1|Washout Period|Non-compliant|0
7796036|NCT00519636|27092691|P4|Washout Period|Participating in study at another site|0
7796037|NCT00519636|27092692|P3|Washout Period|Participating in study at another site|0
7796038|NCT00519636|27092693|P2|Washout Period|Participating in study at another site|0
7796039|NCT00519636|27092694|P1|Washout Period|Participating in study at another site|1
7796040|NCT00519636|27092691|P4|Washout Period|Out of pollen area > 48 hours|0
7796041|NCT00519636|27092692|P3|Washout Period|Out of pollen area > 48 hours|0
7796042|NCT00519636|27092693|P2|Washout Period|Out of pollen area > 48 hours|0
7796043|NCT00519636|27092694|P1|Washout Period|Out of pollen area > 48 hours|1
7796044|NCT00519636|27092691|P4|Washout Period|Failed to meet continuation criteria|3
7796045|NCT00519636|27092692|P3|Washout Period|Failed to meet continuation criteria|9
7796046|NCT00519636|27092693|P2|Washout Period|Failed to meet continuation criteria|11
7796047|NCT00519636|27092694|P1|Washout Period|Failed to meet continuation criteria|14
7796048|NCT00519636|27092691|P4|Washout Period|Withdrawal by Subject|0
7796049|NCT00519636|27092692|P3|Washout Period|Withdrawal by Subject|1
7796050|NCT00519636|27092693|P2|Washout Period|Withdrawal by Subject|0
7796051|NCT00519636|27092694|P1|Washout Period|Withdrawal by Subject|1
7796052|NCT00519636|27092691|P4|Washout Period|Protocol Violation|2
7796053|NCT00519636|27092692|P3|Washout Period|Protocol Violation|1
7796054|NCT00519636|27092693|P2|Washout Period|Protocol Violation|0
7796055|NCT00519636|27092694|P1|Washout Period|Protocol Violation|0
7796056|NCT00519636|27092691|P4|Washout Period|Lost to Follow-up|0
7796057|NCT00519636|27092692|P3|Washout Period|Lost to Follow-up|0
7796058|NCT00519636|27092693|P2|Washout Period|Lost to Follow-up|0
7796059|NCT00519636|27092694|P1|Washout Period|Lost to Follow-up|1
7796060|NCT00519636|27092691|P4|Washout Period|Adverse Event|0
7796061|NCT00519636|27092692|P3|Washout Period|Adverse Event|1
7796062|NCT00519636|27092693|P2|Washout Period|Adverse Event|1
7796063|NCT00519636|27092694|P1|Washout Period|Adverse Event|2
7796064|NCT00519636|27092691|P4|Treatment Period 1|Sponsor request due to missed visit|0
7796065|NCT00519636|27092692|P3|Treatment Period 1|Sponsor request due to missed visit|0
7796066|NCT00519636|27092693|P2|Treatment Period 1|Sponsor request due to missed visit|0
7796067|NCT00519636|27092694|P1|Treatment Period 1|Sponsor request due to missed visit|1
7796068|NCT00519636|27092691|P4|Treatment Period 1|Adverse Event|0
7796069|NCT00519636|27092692|P3|Treatment Period 1|Adverse Event|1
7796070|NCT00519636|27092693|P2|Treatment Period 1|Adverse Event|0
7796071|NCT00519636|27092694|P1|Treatment Period 1|Adverse Event|1
7796072|NCT00519623|27092724|P1|Overall Study|Adverse Event|1
7796073|NCT00519532|27092758|P1|Overall Study|Lost to Follow-up|2
7796074|NCT00519532|27092758|P1|Overall Study|Withdrawal by Subject|5
7796075|NCT00519532|27092758|P1|Overall Study|Adverse Event|11
7796076|NCT00519428|27092768|P3|Overall Study|unstated|2
7796077|NCT00519428|27092769|P2|Overall Study|unstated|3
7796078|NCT00519428|27092770|P1|Overall Study|unstated|1
7796079|NCT00519428|27092768|P3|Overall Study|Withdrawal by Subject|7
7796080|NCT00519428|27092769|P2|Overall Study|Withdrawal by Subject|3
7796081|NCT00519428|27092770|P1|Overall Study|Withdrawal by Subject|8
7796082|NCT00519428|27092768|P3|Overall Study|Lost to Follow-up|6
7796083|NCT00519428|27092769|P2|Overall Study|Lost to Follow-up|7
7796084|NCT00519428|27092770|P1|Overall Study|Lost to Follow-up|7
7796085|NCT00519428|27092768|P3|Overall Study|Adverse Event|10
7796086|NCT00519428|27092769|P2|Overall Study|Adverse Event|2
7796087|NCT00519428|27092770|P1|Overall Study|Adverse Event|5
7796088|NCT00519376|27092790|P16|Treatment Period 4|Lost to Follow-up|0
7796089|NCT00519376|27092791|P15|Treatment Period 4|Lost to Follow-up|0
7796090|NCT00519376|27092792|P14|Treatment Period 4|Lost to Follow-up|0
7796091|NCT00519376|27092793|P13|Treatment Period 4|Lost to Follow-up|0
7796092|NCT00519376|27092794|P12|Treatment Period 4|Lost to Follow-up|0
7796093|NCT00519376|27092795|P11|Treatment Period 4|Lost to Follow-up|0
7796094|NCT00519376|27092796|P10|Treatment Period 4|Lost to Follow-up|0
7796095|NCT00519376|27092797|P9|Treatment Period 4|Lost to Follow-up|0
7796096|NCT00519376|27092798|P8|Treatment Period 4|Lost to Follow-up|0
7796097|NCT00519376|27092799|P7|Treatment Period 4|Lost to Follow-up|0
7796098|NCT00519376|27092800|P6|Treatment Period 4|Lost to Follow-up|0
7796099|NCT00519376|27092801|P5|Treatment Period 4|Lost to Follow-up|0
7796100|NCT00519376|27092802|P4|Treatment Period 4|Lost to Follow-up|0
7796101|NCT00519376|27092803|P3|Treatment Period 4|Lost to Follow-up|1
7796102|NCT00519376|27092804|P2|Treatment Period 4|Lost to Follow-up|0
7796103|NCT00519376|27092805|P1|Treatment Period 4|Lost to Follow-up|0
7796104|NCT00519376|27092790|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796105|NCT00519376|27092791|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796106|NCT00519376|27092792|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796107|NCT00519376|27092793|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
7796108|NCT00519376|27092794|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796109|NCT00519376|27092795|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796110|NCT00519376|27092796|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796111|NCT00519376|27092797|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796112|NCT00519376|27092798|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796113|NCT00519376|27092799|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796114|NCT00519376|27092800|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796115|NCT00519376|27092801|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796116|NCT00519376|27092802|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796117|NCT00519376|27092803|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796118|NCT00519376|27092804|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796119|NCT00519376|27092805|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7796120|NCT00519285|27092929|P2|Overall Study|Treatment ongoing|2
7796121|NCT00519285|27092930|P1|Overall Study|Treatment ongoing|1
7796122|NCT00519285|27092929|P2|Overall Study|Not treated|7
7796123|NCT00519285|27092930|P1|Overall Study|Not treated|8
7796124|NCT00519285|27092929|P2|Overall Study|Reason unspecified|8
7796125|NCT00519285|27092930|P1|Overall Study|Reason unspecified|5
7796126|NCT00519285|27092929|P2|Overall Study|Poor compliance to protocol|7
7796127|NCT00519285|27092930|P1|Overall Study|Poor compliance to protocol|5
7796128|NCT00519285|27092929|P2|Overall Study|Consent withdrawn|5
7796129|NCT00519285|27092930|P1|Overall Study|Consent withdrawn|4
7796130|NCT00519285|27092929|P2|Overall Study|Participant's request|84
7796131|NCT00519285|27092930|P1|Overall Study|Participant's request|53
7796132|NCT00519285|27092929|P2|Overall Study|Physician Decision|47
7796133|NCT00519285|27092930|P1|Overall Study|Physician Decision|75
7796134|NCT00519285|27092929|P2|Overall Study|Disease progression|186
7796135|NCT00519285|27092930|P1|Overall Study|Disease progression|334
7796136|NCT00519285|27092929|P2|Overall Study|Adverse Event|266
7796137|NCT00519285|27092930|P1|Overall Study|Adverse Event|127
7796138|NCT00519194|27092956|P1|Overall Study|Lost to Follow-up|3
7796139|NCT00519194|27092956|P1|Overall Study|Death|9
7796140|NCT00519194|27092956|P1|Overall Study|Withdrawal by Subject|9
7796141|NCT00519077|27092971|P1|Overall Study|Other|2
7796142|NCT00519077|27092971|P1|Overall Study|Death|6
7796143|NCT00518986|27092978|P2|Overall Study|Non-Specific|1
7796144|NCT00518986|27092979|P1|Overall Study|Non-Specific|2
7796145|NCT00518986|27092978|P2|Overall Study|Withdrawal by Subject|4
7796146|NCT00518986|27092979|P1|Overall Study|Withdrawal by Subject|4
7796147|NCT00518986|27092978|P2|Overall Study|Protocol Violation|7
7796148|NCT00518986|27092979|P1|Overall Study|Protocol Violation|5
7796149|NCT00518986|27092978|P2|Overall Study|Physician Decision|3
7796150|NCT00518986|27092979|P1|Overall Study|Physician Decision|0
7796151|NCT00518986|27092978|P2|Overall Study|Lost to Follow-up|2
7796152|NCT00518986|27092979|P1|Overall Study|Lost to Follow-up|3
7796153|NCT00518986|27092978|P2|Overall Study|Lack of Efficacy|2
7796154|NCT00518986|27092979|P1|Overall Study|Lack of Efficacy|0
7796155|NCT00518986|27092978|P2|Overall Study|Adverse Event|7
7796156|NCT00518986|27092979|P1|Overall Study|Adverse Event|12
7796157|NCT00518973|27093105|P2|Overall Study|Withdrawal by Subject|2
7796158|NCT00518973|27093106|P1|Overall Study|Withdrawal by Subject|3
7796159|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
7796160|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
7796161|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Subject decision|0
7796162|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Subject decision|2
7796163|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
7796164|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
7796165|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
7796166|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
7796167|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Creatine increased|0
7796168|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Creatine increased|1
7796169|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Change in treatment|1
7796170|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Change in treatment|1
7796171|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
7796172|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
7796173|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
7796174|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
7796175|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
7796176|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
7796177|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
7796178|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
7796179|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
7796180|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
7796181|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
7796182|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
7796183|NCT00518882|27093122|P2|Open-Label Extension, Week 26-78|Adverse Event|9
7796184|NCT00518882|27093123|P1|Open-Label Extension, Week 26-78|Adverse Event|3
7796185|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Mutual consent|1
7796186|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Mutual consent|0
7796187|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
7796188|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
7796189|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
7796190|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
7796191|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Loss of trust|1
7796192|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Loss of trust|0
7796193|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
7796194|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
7796195|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Subject decision|1
7796196|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Subject decision|1
7796197|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Lost to follow up|1
7796198|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Lost to follow up|2
7796199|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
7796200|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
7796201|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Protocol Violation|3
7796202|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Protocol Violation|4
7796203|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
7796204|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
7796205|NCT00518882|27093122|P2|Double-Blind, Week 0-26|Adverse Event|31
7796206|NCT00518882|27093123|P1|Double-Blind, Week 0-26|Adverse Event|23
7796207|NCT00518687|27093304|P2|Overall Study|Withdrawal by Subject|110
7796208|NCT00518687|27093305|P1|Overall Study|Withdrawal by Subject|110
7796209|NCT00518687|27093304|P2|Overall Study|Study terminated by sponsor|918
7796210|NCT00518687|27093305|P1|Overall Study|Study terminated by sponsor|930
7796211|NCT00518687|27093304|P2|Overall Study|Protocol Violation|10
7796212|NCT00518687|27093305|P1|Overall Study|Protocol Violation|8
7796213|NCT00518687|27093304|P2|Overall Study|Progressive disease|2
7796214|NCT00518687|27093305|P1|Overall Study|Progressive disease|2
7796215|NCT00518687|27093304|P2|Overall Study|Physician Decision|48
7796216|NCT00518687|27093305|P1|Overall Study|Physician Decision|42
7796217|NCT00518687|27093304|P2|Overall Study|Lost to Follow-up|155
7796218|NCT00518687|27093305|P1|Overall Study|Lost to Follow-up|144
7796219|NCT00518687|27093304|P2|Overall Study|Adverse Event|177
7796220|NCT00518687|27093305|P1|Overall Study|Adverse Event|201
7796221|NCT00518622|27093325|P8|Overall Study|Study medication taken incorrectly|0
7796222|NCT00518622|27093326|P7|Overall Study|Study medication taken incorrectly|0
7796223|NCT00518622|27093327|P6|Overall Study|Study medication taken incorrectly|0
7796224|NCT00518622|27093328|P5|Overall Study|Study medication taken incorrectly|0
7796225|NCT00518622|27093329|P4|Overall Study|Study medication taken incorrectly|0
7796226|NCT00518622|27093330|P3|Overall Study|Study medication taken incorrectly|0
7796227|NCT00518622|27093331|P2|Overall Study|Study medication taken incorrectly|1
7796228|NCT00518622|27093332|P1|Overall Study|Study medication taken incorrectly|0
7796229|NCT00518622|27093325|P8|Overall Study|Lost to Follow-up|0
7796230|NCT00518622|27093326|P7|Overall Study|Lost to Follow-up|0
7796231|NCT00518622|27093327|P6|Overall Study|Lost to Follow-up|0
7796232|NCT00518622|27093328|P5|Overall Study|Lost to Follow-up|0
7796233|NCT00518622|27093329|P4|Overall Study|Lost to Follow-up|0
7796234|NCT00518622|27093330|P3|Overall Study|Lost to Follow-up|1
7796235|NCT00518622|27093331|P2|Overall Study|Lost to Follow-up|0
7796236|NCT00518622|27093332|P1|Overall Study|Lost to Follow-up|0
7796237|NCT00518531|27093360|P2|Treatment Period 2|Non-compliance|2
7796238|NCT00518531|27093361|P1|Treatment Period 2|Non-compliance|1
7796239|NCT00518531|27093360|P2|Treatment Period 2|Protocol-specified criteria|1
7796240|NCT00518531|27093361|P1|Treatment Period 2|Protocol-specified criteria|0
7796241|NCT00518531|27093360|P2|Treatment Period 2|Adverse Event|7
7796242|NCT00518531|27093361|P1|Treatment Period 2|Adverse Event|1
7796243|NCT00518531|27093360|P2|Treatment Period 2|Complete out of scheduled visit window|2
7796244|NCT00518531|27093361|P1|Treatment Period 2|Complete out of scheduled visit window|1
7796245|NCT00518531|27093360|P2|Treatment Period 2|Withdrawal by Subject|8
7796246|NCT00518531|27093361|P1|Treatment Period 2|Withdrawal by Subject|0
7796247|NCT00518531|27093360|P2|Treatment Period 1|Early crossover|3
7796248|NCT00518531|27093361|P1|Treatment Period 1|Early crossover|1
7796249|NCT00518531|27093360|P2|Treatment Period 1|Withdrawal by Subject|6
7796250|NCT00518531|27093361|P1|Treatment Period 1|Withdrawal by Subject|4
7796251|NCT00518531|27093360|P2|Treatment Period 1|Protocol Violation|0
7796252|NCT00518531|27093361|P1|Treatment Period 1|Protocol Violation|2
7796253|NCT00518531|27093360|P2|Treatment Period 1|Physician Decision|0
7796254|NCT00518531|27093361|P1|Treatment Period 1|Physician Decision|1
7796255|NCT00518531|27093360|P2|Treatment Period 1|Lost to Follow-up|3
7796256|NCT00518531|27093361|P1|Treatment Period 1|Lost to Follow-up|5
7796257|NCT00518531|27093360|P2|Treatment Period 1|Adverse Event|0
7796258|NCT00518531|27093361|P1|Treatment Period 1|Adverse Event|5
7796259|NCT00518336|27093406|P2|Year 9|Personal reasons|0
7796260|NCT00518336|27093407|P1|Year 9|Personal reasons|1
7796261|NCT00518336|27093406|P2|Year 9|Lost to Follow-up|0
7796262|NCT00518336|27093407|P1|Year 9|Lost to Follow-up|3
7796263|NCT00518336|27093406|P2|Year 9|Migrated/moved from study area|1
7796264|NCT00518336|27093407|P1|Year 9|Migrated/moved from study area|1
7796265|NCT00518336|27093406|P2|Year 8|Could not attend in time|1
7796266|NCT00518336|27093407|P1|Year 8|Could not attend in time|0
7796267|NCT00518336|27093406|P2|Year 8|Lost to Follow-up|1
7796268|NCT00518336|27093407|P1|Year 8|Lost to Follow-up|1
7796269|NCT00518336|27093406|P2|Year 7|Could not attend in time|3
7796270|NCT00518336|27093407|P1|Year 7|Could not attend in time|0
7796271|NCT00518336|27093406|P2|Year 7|Lost to Follow-up|0
7796272|NCT00518336|27093407|P1|Year 7|Lost to Follow-up|2
7796273|NCT00518323|27093573|P4|Overall Study|Prohibited medication and others|0
7796274|NCT00518323|27093574|P3|Overall Study|Prohibited medication and others|1
7796275|NCT00518323|27093575|P2|Overall Study|Prohibited medication and others|1
7796276|NCT00518323|27093576|P1|Overall Study|Prohibited medication and others|3
7796277|NCT00518323|27093573|P4|Overall Study|Adverse Event|0
7796278|NCT00518323|27093574|P3|Overall Study|Adverse Event|1
7796279|NCT00518323|27093575|P2|Overall Study|Adverse Event|1
7796280|NCT00518323|27093576|P1|Overall Study|Adverse Event|1
7796281|NCT00518323|27093573|P4|Overall Study|Lost to Follow-up|3
7796282|NCT00518323|27093574|P3|Overall Study|Lost to Follow-up|1
7796283|NCT00518323|27093575|P2|Overall Study|Lost to Follow-up|2
7796284|NCT00518323|27093576|P1|Overall Study|Lost to Follow-up|0
7796285|NCT00518323|27093573|P4|Overall Study|Withdrawal by Subject|2
7796286|NCT00518323|27093574|P3|Overall Study|Withdrawal by Subject|4
7796287|NCT00518323|27093575|P2|Overall Study|Withdrawal by Subject|2
7796288|NCT00518323|27093576|P1|Overall Study|Withdrawal by Subject|1
7796289|NCT00518323|27093573|P4|Overall Study|Lack of Efficacy|20
7796290|NCT00518323|27093574|P3|Overall Study|Lack of Efficacy|4
7796291|NCT00518323|27093575|P2|Overall Study|Lack of Efficacy|2
7796292|NCT00518323|27093576|P1|Overall Study|Lack of Efficacy|14
7796293|NCT00518284|27093606|P4|Overall Study|Study Termination|2
7796294|NCT00518284|27093607|P3|Overall Study|Study Termination|1
7796295|NCT00518284|27093608|P2|Overall Study|Study Termination|2
7796296|NCT00518284|27093609|P1|Overall Study|Study Termination|0
7796297|NCT00518284|27093606|P4|Overall Study|Adverse Event|0
7796298|NCT00518284|27093607|P3|Overall Study|Adverse Event|0
7796299|NCT00518284|27093608|P2|Overall Study|Adverse Event|1
7796300|NCT00518284|27093609|P1|Overall Study|Adverse Event|0
7796301|NCT00518206|27093665|P2|Overall Study|Completion Status Unknown|0
7796302|NCT00518206|27093666|P1|Overall Study|Completion Status Unknown|1
7796303|NCT00518206|27093665|P2|Overall Study|Reason Unknown|0
7796304|NCT00518206|27093666|P1|Overall Study|Reason Unknown|1
7796305|NCT00518206|27093665|P2|Overall Study|Drug Supply Issue|0
7796306|NCT00518206|27093666|P1|Overall Study|Drug Supply Issue|1
7796307|NCT00518206|27093665|P2|Overall Study|Withdrawal by Subject|0
7796308|NCT00518206|27093666|P1|Overall Study|Withdrawal by Subject|2
7796309|NCT00518206|27093665|P2|Overall Study|Disease Progression Requiring Therapy|6
7796310|NCT00518206|27093666|P1|Overall Study|Disease Progression Requiring Therapy|6
7796311|NCT00518180|27093683|P3|Overall Study|Adverse Event|0
7796312|NCT00518180|27093684|P2|Overall Study|Adverse Event|0
7796313|NCT00518180|27093685|P1|Overall Study|Adverse Event|1
7796314|NCT00518180|27093683|P3|Overall Study|Unable to classify|0
7796315|NCT00518180|27093684|P2|Overall Study|Unable to classify|2
7796316|NCT00518180|27093685|P1|Overall Study|Unable to classify|0
7796317|NCT00518180|27093683|P3|Overall Study|Protocol Violation|4
7796318|NCT00518180|27093684|P2|Overall Study|Protocol Violation|7
7796319|NCT00518180|27093685|P1|Overall Study|Protocol Violation|5
7796320|NCT00518180|27093683|P3|Overall Study|Administrative reason|2
7796321|NCT00518180|27093684|P2|Overall Study|Administrative reason|2
7796322|NCT00518180|27093685|P1|Overall Study|Administrative reason|0
7796323|NCT00518180|27093683|P3|Overall Study|Lost to Follow-up|34
7796324|NCT00518180|27093684|P2|Overall Study|Lost to Follow-up|28
7796325|NCT00518180|27093685|P1|Overall Study|Lost to Follow-up|30
7796326|NCT00518180|27093683|P3|Overall Study|Withdrawal by Subject|42
7796327|NCT00518180|27093684|P2|Overall Study|Withdrawal by Subject|30
7796328|NCT00518180|27093685|P1|Overall Study|Withdrawal by Subject|29
7796329|NCT00518115|27093741|P10|Overall Study|Moved Out of State|1
7796330|NCT00518115|27093742|P9|Overall Study|Moved Out of State|0
7796331|NCT00518115|27093743|P8|Overall Study|Moved Out of State|0
7796332|NCT00518115|27093744|P7|Overall Study|Moved Out of State|0
7796333|NCT00518115|27093745|P6|Overall Study|Moved Out of State|0
7796334|NCT00518115|27093746|P5|Overall Study|Moved Out of State|0
7796335|NCT00518115|27093747|P4|Overall Study|Moved Out of State|0
7796336|NCT00518115|27093748|P3|Overall Study|Moved Out of State|0
7796337|NCT00518115|27093749|P2|Overall Study|Moved Out of State|0
7796338|NCT00518115|27093750|P1|Overall Study|Moved Out of State|0
7796339|NCT00518115|27093741|P10|Overall Study|Withdrew Consent|0
7796340|NCT00518115|27093742|P9|Overall Study|Withdrew Consent|0
7796341|NCT00518115|27093743|P8|Overall Study|Withdrew Consent|0
7796342|NCT00518115|27093744|P7|Overall Study|Withdrew Consent|0
7796343|NCT00518115|27093745|P6|Overall Study|Withdrew Consent|1
7796344|NCT00518115|27093746|P5|Overall Study|Withdrew Consent|0
7796345|NCT00518115|27093747|P4|Overall Study|Withdrew Consent|0
7796346|NCT00518115|27093748|P3|Overall Study|Withdrew Consent|0
7796347|NCT00518115|27093749|P2|Overall Study|Withdrew Consent|0
7796348|NCT00518115|27093750|P1|Overall Study|Withdrew Consent|0
7796349|NCT00518115|27093741|P10|Overall Study|Family Emergency; Had to Go to England|0
7796350|NCT00518115|27093742|P9|Overall Study|Family Emergency; Had to Go to England|0
7796351|NCT00518115|27093743|P8|Overall Study|Family Emergency; Had to Go to England|0
7796352|NCT00518115|27093744|P7|Overall Study|Family Emergency; Had to Go to England|0
7796353|NCT00518115|27093745|P6|Overall Study|Family Emergency; Had to Go to England|0
7796354|NCT00518115|27093746|P5|Overall Study|Family Emergency; Had to Go to England|1
7796355|NCT00518115|27093747|P4|Overall Study|Family Emergency; Had to Go to England|0
7796356|NCT00518115|27093748|P3|Overall Study|Family Emergency; Had to Go to England|0
7796357|NCT00518115|27093749|P2|Overall Study|Family Emergency; Had to Go to England|0
7796358|NCT00518115|27093750|P1|Overall Study|Family Emergency; Had to Go to England|0
7796359|NCT00518115|27093741|P10|Overall Study|Violation of Exclusion Criteria|0
7796360|NCT00518115|27093742|P9|Overall Study|Violation of Exclusion Criteria|0
7796361|NCT00518115|27093743|P8|Overall Study|Violation of Exclusion Criteria|0
7796362|NCT00518115|27093744|P7|Overall Study|Violation of Exclusion Criteria|1
7796363|NCT00518115|27093745|P6|Overall Study|Violation of Exclusion Criteria|0
7796364|NCT00518115|27093746|P5|Overall Study|Violation of Exclusion Criteria|0
7796365|NCT00518115|27093747|P4|Overall Study|Violation of Exclusion Criteria|1
7796366|NCT00518115|27093748|P3|Overall Study|Violation of Exclusion Criteria|0
7796367|NCT00518115|27093749|P2|Overall Study|Violation of Exclusion Criteria|0
7796368|NCT00518115|27093750|P1|Overall Study|Violation of Exclusion Criteria|0
7796369|NCT00518115|27093741|P10|Overall Study|Wrong Monotherapy Administered|0
7796370|NCT00518115|27093742|P9|Overall Study|Wrong Monotherapy Administered|0
7796371|NCT00518115|27093743|P8|Overall Study|Wrong Monotherapy Administered|0
7796372|NCT00518115|27093744|P7|Overall Study|Wrong Monotherapy Administered|1
7796373|NCT00518115|27093745|P6|Overall Study|Wrong Monotherapy Administered|0
7796374|NCT00518115|27093746|P5|Overall Study|Wrong Monotherapy Administered|0
7796375|NCT00518115|27093747|P4|Overall Study|Wrong Monotherapy Administered|0
7796376|NCT00518115|27093748|P3|Overall Study|Wrong Monotherapy Administered|1
7796377|NCT00518115|27093749|P2|Overall Study|Wrong Monotherapy Administered|0
7796378|NCT00518115|27093750|P1|Overall Study|Wrong Monotherapy Administered|0
7796379|NCT00518115|27093741|P10|Overall Study|Different Monotherapy Diabetic Drug|0
7796380|NCT00518115|27093742|P9|Overall Study|Different Monotherapy Diabetic Drug|1
7796381|NCT00518115|27093743|P8|Overall Study|Different Monotherapy Diabetic Drug|0
7796382|NCT00518115|27093744|P7|Overall Study|Different Monotherapy Diabetic Drug|0
7796383|NCT00518115|27093745|P6|Overall Study|Different Monotherapy Diabetic Drug|0
7796384|NCT00518115|27093746|P5|Overall Study|Different Monotherapy Diabetic Drug|0
7796385|NCT00518115|27093747|P4|Overall Study|Different Monotherapy Diabetic Drug|0
7796386|NCT00518115|27093748|P3|Overall Study|Different Monotherapy Diabetic Drug|1
7796387|NCT00518115|27093749|P2|Overall Study|Different Monotherapy Diabetic Drug|0
7796388|NCT00518115|27093750|P1|Overall Study|Different Monotherapy Diabetic Drug|0
7796389|NCT00518115|27093741|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796390|NCT00518115|27093742|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796391|NCT00518115|27093743|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796392|NCT00518115|27093744|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796393|NCT00518115|27093745|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796394|NCT00518115|27093746|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796395|NCT00518115|27093747|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796396|NCT00518115|27093748|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796397|NCT00518115|27093749|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
7796398|NCT00518115|27093750|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
7796399|NCT00518115|27093741|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
7796400|NCT00518115|27093742|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
7796401|NCT00518115|27093743|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
7796402|NCT00518115|27093744|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
7796403|NCT00518115|27093745|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
7796404|NCT00518115|27093746|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
7796405|NCT00518115|27093747|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
7796406|NCT00518115|27093748|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
7796407|NCT00518115|27093749|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
7796408|NCT00518115|27093750|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
7796409|NCT00518115|27093741|P10|Overall Study|Non-Compliance|1
7796410|NCT00518115|27093742|P9|Overall Study|Non-Compliance|0
7796411|NCT00518115|27093743|P8|Overall Study|Non-Compliance|1
7796412|NCT00518115|27093744|P7|Overall Study|Non-Compliance|1
7796413|NCT00518115|27093745|P6|Overall Study|Non-Compliance|1
7796414|NCT00518115|27093746|P5|Overall Study|Non-Compliance|1
7796415|NCT00518115|27093747|P4|Overall Study|Non-Compliance|0
7796416|NCT00518115|27093748|P3|Overall Study|Non-Compliance|1
7796417|NCT00518115|27093749|P2|Overall Study|Non-Compliance|0
7796418|NCT00518115|27093750|P1|Overall Study|Non-Compliance|1
7796419|NCT00518115|27093741|P10|Overall Study|Lack of Efficacy|0
7796420|NCT00518115|27093742|P9|Overall Study|Lack of Efficacy|0
7796421|NCT00518115|27093743|P8|Overall Study|Lack of Efficacy|1
7796422|NCT00518115|27093744|P7|Overall Study|Lack of Efficacy|0
7796423|NCT00518115|27093745|P6|Overall Study|Lack of Efficacy|0
7796424|NCT00518115|27093746|P5|Overall Study|Lack of Efficacy|0
7796425|NCT00518115|27093747|P4|Overall Study|Lack of Efficacy|1
7796426|NCT00518115|27093748|P3|Overall Study|Lack of Efficacy|1
7796427|NCT00518115|27093749|P2|Overall Study|Lack of Efficacy|0
7796428|NCT00518115|27093750|P1|Overall Study|Lack of Efficacy|1
7796429|NCT00518115|27093741|P10|Overall Study|Withdrawal by Subject|3
7796430|NCT00518115|27093742|P9|Overall Study|Withdrawal by Subject|1
7796431|NCT00518115|27093743|P8|Overall Study|Withdrawal by Subject|2
7796432|NCT00518115|27093744|P7|Overall Study|Withdrawal by Subject|0
7796433|NCT00518115|27093745|P6|Overall Study|Withdrawal by Subject|1
7796434|NCT00518115|27093746|P5|Overall Study|Withdrawal by Subject|2
7796435|NCT00518115|27093747|P4|Overall Study|Withdrawal by Subject|0
7796436|NCT00518115|27093748|P3|Overall Study|Withdrawal by Subject|5
7796437|NCT00518115|27093749|P2|Overall Study|Withdrawal by Subject|1
7796438|NCT00518115|27093750|P1|Overall Study|Withdrawal by Subject|1
7796439|NCT00518115|27093741|P10|Overall Study|Protocol Violation|0
7796440|NCT00518115|27093742|P9|Overall Study|Protocol Violation|0
7796441|NCT00518115|27093743|P8|Overall Study|Protocol Violation|0
7796442|NCT00518115|27093744|P7|Overall Study|Protocol Violation|0
7796443|NCT00518115|27093745|P6|Overall Study|Protocol Violation|0
7796444|NCT00518115|27093746|P5|Overall Study|Protocol Violation|0
7796445|NCT00518115|27093747|P4|Overall Study|Protocol Violation|0
7796446|NCT00518115|27093748|P3|Overall Study|Protocol Violation|1
7796447|NCT00518115|27093749|P2|Overall Study|Protocol Violation|3
7796448|NCT00518115|27093750|P1|Overall Study|Protocol Violation|1
7796449|NCT00518115|27093741|P10|Overall Study|Lost to Follow-up|1
7796450|NCT00518115|27093742|P9|Overall Study|Lost to Follow-up|1
7796451|NCT00518115|27093743|P8|Overall Study|Lost to Follow-up|1
7796452|NCT00518115|27093744|P7|Overall Study|Lost to Follow-up|0
7796453|NCT00518115|27093745|P6|Overall Study|Lost to Follow-up|3
7796454|NCT00518115|27093746|P5|Overall Study|Lost to Follow-up|1
7796455|NCT00518115|27093747|P4|Overall Study|Lost to Follow-up|3
7796456|NCT00518115|27093748|P3|Overall Study|Lost to Follow-up|2
7796457|NCT00518115|27093749|P2|Overall Study|Lost to Follow-up|0
7796458|NCT00518115|27093750|P1|Overall Study|Lost to Follow-up|0
7796459|NCT00518115|27093741|P10|Overall Study|Adverse Event|9
7796460|NCT00518115|27093742|P9|Overall Study|Adverse Event|2
7796461|NCT00518115|27093743|P8|Overall Study|Adverse Event|10
7796462|NCT00518115|27093744|P7|Overall Study|Adverse Event|5
7796463|NCT00518115|27093745|P6|Overall Study|Adverse Event|5
7796464|NCT00518115|27093746|P5|Overall Study|Adverse Event|5
7796465|NCT00518115|27093747|P4|Overall Study|Adverse Event|6
7796466|NCT00518115|27093748|P3|Overall Study|Adverse Event|5
7796467|NCT00518115|27093749|P2|Overall Study|Adverse Event|1
7796468|NCT00518115|27093750|P1|Overall Study|Adverse Event|6
7796469|NCT00518011|27093925|P2|Overall Study|Withdrawal by Subject|0
7796470|NCT00518011|27093926|P1|Overall Study|Withdrawal by Subject|1
7796471|NCT00518011|27093925|P2|Overall Study|Other Reasons|2
7796472|NCT00518011|27093926|P1|Overall Study|Other Reasons|3
7796473|NCT00518011|27093925|P2|Overall Study|Disease Progression|2
7796474|NCT00518011|27093926|P1|Overall Study|Disease Progression|2
7796475|NCT00518011|27093925|P2|Overall Study|Adverse Event|3
7796476|NCT00518011|27093926|P1|Overall Study|Adverse Event|2
7796477|NCT00518011|27093925|P2|Overall Study|Death|1
7796478|NCT00518011|27093926|P1|Overall Study|Death|1
7796479|NCT00517933|27093948|P2|Period 2|Underwent lung transplant|2
7796480|NCT00517933|27093949|P1|Period 2|Underwent lung transplant|0
7796481|NCT00517933|27093948|P2|Period 2|Withdrawal by Subject|3
7796482|NCT00517933|27093949|P1|Period 2|Withdrawal by Subject|1
7796483|NCT00517933|27093948|P2|Period 2|Physician Decision|0
7796484|NCT00517933|27093949|P1|Period 2|Physician Decision|1
7796485|NCT00517933|27093948|P2|Period 2|Adverse Event|4
7796486|NCT00517933|27093949|P1|Period 2|Adverse Event|2
7796487|NCT00517933|27093948|P2|Period 2|Death|4
7796488|NCT00517933|27093949|P1|Period 2|Death|2
7796489|NCT00517933|27093948|P2|Period 1|Underwent lung transplant|1
7796490|NCT00517933|27093949|P1|Period 1|Underwent lung transplant|0
7796491|NCT00517933|27093948|P2|Period 1|Lost to Follow-up|0
7796492|NCT00517933|27093949|P1|Period 1|Lost to Follow-up|2
7796493|NCT00517933|27093948|P2|Period 1|Adverse Event|4
7796494|NCT00517933|27093949|P1|Period 1|Adverse Event|4
7796495|NCT00517933|27093948|P2|Period 1|Death|1
7796496|NCT00517933|27093949|P1|Period 1|Death|2
7796497|NCT00517881|27094013|P1|Overall Study|Renal transplantation|2
7796498|NCT00517881|27094013|P1|Overall Study|Adverse Event|1
7796499|NCT00517881|27094013|P1|Overall Study|Protocol Violation|2
7796500|NCT00517829|27094025|P2|Overall Study|Other|1
7796501|NCT00517829|27094026|P1|Overall Study|Other|3
7796502|NCT00517829|27094025|P2|Overall Study|Investigator Request|3
7796503|NCT00517829|27094026|P1|Overall Study|Investigator Request|5
7796504|NCT00517829|27094025|P2|Overall Study|Patient Request|5
7796505|NCT00517829|27094026|P1|Overall Study|Patient Request|6
7796506|NCT00517829|27094025|P2|Overall Study|Disease Progression|32
7796507|NCT00517829|27094026|P1|Overall Study|Disease Progression|39
7796508|NCT00517829|27094025|P2|Overall Study|Adverse Event|34
7796509|NCT00517829|27094026|P1|Overall Study|Adverse Event|22
7796510|NCT00517751|27094040|P1|Overall Study|Missing|3
7796511|NCT00517751|27094040|P1|Overall Study|Patient not due for visit|76
7796512|NCT00517751|27094040|P1|Overall Study|patient not over due|6
7796513|NCT00517751|27094040|P1|Overall Study|Lost to Follow-up|4
7796514|NCT00517751|27094040|P1|Overall Study|Withdrawal by Subject|37
7796515|NCT00517751|27094040|P1|Overall Study|Death|3
7796516|NCT00517699|27094063|P1|Overall Study|Study terminated by Sponsor|2
7796517|NCT00517699|27094063|P1|Overall Study|Administrative error|1
7796518|NCT00517699|27094063|P1|Overall Study|Lack of Efficacy|1
7796519|NCT00517699|27094063|P1|Overall Study|Withdrawal by Subject|1
7796520|NCT00517634|27094071|P6|Second Treatment Period|Withdrawal by Subject|0
7796521|NCT00517634|27094072|P5|Second Treatment Period|Withdrawal by Subject|1
7796522|NCT00517634|27094073|P4|Second Treatment Period|Withdrawal by Subject|0
7796523|NCT00517634|27094074|P3|Second Treatment Period|Withdrawal by Subject|0
7796524|NCT00517634|27094075|P2|Second Treatment Period|Withdrawal by Subject|0
7796525|NCT00517634|27094076|P1|Second Treatment Period|Withdrawal by Subject|0
7796526|NCT00517413|27094178|P1|Overall Study|Other-Reasons|23
7796527|NCT00517413|27094178|P1|Overall Study|Failure to return|1
7796528|NCT00517413|27094178|P1|Overall Study|Withdrawal by Subject|2
7796529|NCT00517413|27094178|P1|Overall Study|Protocol Violation|15
7796530|NCT00517413|27094178|P1|Overall Study|Death|13
7796531|NCT00517413|27094178|P1|Overall Study|Adverse Event|7
7796532|NCT00517361|27094199|P1|Overall Study|The study was terminated|5
7796533|NCT00517361|27094199|P1|Overall Study|Death|6
7796534|NCT00517296|27094208|P2|Overall Study|Withdrawal by Subject|0
7796535|NCT00517296|27094209|P1|Overall Study|Withdrawal by Subject|1
7796536|NCT00517192|27094221|P2|Overall Study|Early termination of the trial|18
7796537|NCT00517192|27094222|P1|Overall Study|Early termination of the trial|16
7796538|NCT00517192|27094221|P2|Overall Study|Withdrawal by Subject|0
7796539|NCT00517192|27094222|P1|Overall Study|Withdrawal by Subject|1
7796540|NCT00517192|27094221|P2|Overall Study|Lost to Follow-up|1
7796541|NCT00517192|27094222|P1|Overall Study|Lost to Follow-up|1
7796542|NCT00517192|27094221|P2|Overall Study|Adverse Event|1
7796543|NCT00517192|27094222|P1|Overall Study|Adverse Event|1
7796544|NCT00516906|27094329|P2|Overall Study|Final Dressing Removal Data not captured|2
7796545|NCT00516906|27094330|P1|Overall Study|Final Dressing Removal Data not captured|6
7796546|NCT00516893|27094340|P1|Overall Study|Received Medication From Another Study|1
7796547|NCT00516893|27094340|P1|Overall Study|Pregnancy|1
7796548|NCT00516893|27094340|P1|Overall Study|Relocated|1
7796549|NCT00516893|27094340|P1|Overall Study|Persistent Antibodies per Protocol|6
7796550|NCT00516893|27094340|P1|Overall Study|Death|1
7796551|NCT00516893|27094340|P1|Overall Study|Noncompliance|2
7796552|NCT00516893|27094340|P1|Overall Study|Withdrawal by Subject|2
7796553|NCT00516893|27094340|P1|Overall Study|Adverse Event|3
7796554|NCT00516893|27094340|P1|Overall Study|Lost to Follow-up|4
7796555|NCT00516737|27094349|P2|Overall Study|Lack of Qualifying Event|6
7796556|NCT00516737|27094350|P1|Overall Study|Lack of Qualifying Event|9
7796557|NCT00516737|27094349|P2|Overall Study|Withdrawal by Subject|1
7796558|NCT00516737|27094350|P1|Overall Study|Withdrawal by Subject|0
7796559|NCT00516737|27094349|P2|Overall Study|Physician Decision|1
7796560|NCT00516737|27094350|P1|Overall Study|Physician Decision|0
7796561|NCT00516737|27094349|P2|Overall Study|Lost to Follow-up|0
7796562|NCT00516737|27094350|P1|Overall Study|Lost to Follow-up|2
7796563|NCT00516386|27094389|P1|Overall Study|Lost to Follow-up|2
7796564|NCT00516386|27094389|P1|Overall Study|not interested in the study|4
7796565|NCT00516321|27094396|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
7796566|NCT00516321|27094397|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
7796567|NCT00516321|27094398|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
7796568|NCT00516321|27094396|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
7796569|NCT00516321|27094397|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
7796570|NCT00516321|27094398|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
7796571|NCT00516321|27094396|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
7796572|NCT00516321|27094397|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
7796573|NCT00516321|27094398|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
7796574|NCT00516321|27094396|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
7796575|NCT00516321|27094397|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
7796576|NCT00516321|27094398|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
7796577|NCT00516321|27094396|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
7796578|NCT00516321|27094397|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
7796579|NCT00516321|27094398|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
7796580|NCT00516321|27094396|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
7796581|NCT00516321|27094397|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
7796582|NCT00516321|27094398|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
7796583|NCT00516321|27094396|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
7796584|NCT00516321|27094397|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
7796585|NCT00516321|27094398|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
7796586|NCT00516321|27094396|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
7796587|NCT00516321|27094397|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
7796588|NCT00516321|27094398|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
7796589|NCT00516321|27094396|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
7796590|NCT00516321|27094397|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
7796591|NCT00516321|27094398|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
7796592|NCT00516321|27094396|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
7796593|NCT00516321|27094397|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
7796594|NCT00516321|27094398|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
7796595|NCT00516321|27094396|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
7796596|NCT00516321|27094397|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
7796597|NCT00516321|27094398|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
7796598|NCT00516295|27094449|P3|Overall Study|Ineligible|0
7796599|NCT00516295|27094450|P2|Overall Study|Ineligible|0
7796600|NCT00516295|27094451|P1|Overall Study|Ineligible|1
7796601|NCT00516295|27094449|P3|Overall Study|Lack of Efficacy|0
7796602|NCT00516295|27094450|P2|Overall Study|Lack of Efficacy|0
7796603|NCT00516295|27094451|P1|Overall Study|Lack of Efficacy|2
7796604|NCT00516269|27094464|P2|Overall Study|Protocol Violation|1
7796605|NCT00516269|27094465|P1|Overall Study|Protocol Violation|0
7796606|NCT00516269|27094464|P2|Overall Study|Lost to Follow-up|1
7796607|NCT00516269|27094465|P1|Overall Study|Lost to Follow-up|0
7796608|NCT00516269|27094464|P2|Overall Study|Adverse Event|1
7796609|NCT00516269|27094465|P1|Overall Study|Adverse Event|2
7796610|NCT00516139|27094486|P1|Overall Study|Lack of Efficacy|1
7796611|NCT00516139|27094486|P1|Overall Study|Withdrawal by Subject|8
7796612|NCT00516139|27094486|P1|Overall Study|Protocol Violation|1
7796613|NCT00516139|27094486|P1|Overall Study|Lost to Follow-up|1
7796614|NCT00516139|27094486|P1|Overall Study|Adverse Event|27
7796615|NCT00516074|27094517|P2|Overall Study|Loss of Glucose Control|0
7796616|NCT00516074|27094518|P1|Overall Study|Loss of Glucose Control|2
7796617|NCT00516074|27094517|P2|Overall Study|Subject Decision|2
7796618|NCT00516074|27094518|P1|Overall Study|Subject Decision|4
7796619|NCT00516074|27094517|P2|Overall Study|Adverse Event|1
7796620|NCT00516074|27094518|P1|Overall Study|Adverse Event|0
7796621|NCT00516048|27094536|P3|Overall Study|Subject Decision|0
7796622|NCT00516048|27094537|P2|Overall Study|Subject Decision|2
7796623|NCT00516048|27094538|P1|Overall Study|Subject Decision|0
7796624|NCT00516048|27094536|P3|Overall Study|Death|1
7796625|NCT00516048|27094537|P2|Overall Study|Death|0
7796626|NCT00516048|27094538|P1|Overall Study|Death|0
7796627|NCT00515827|27094573|P2|Second Intervention (12 Weeks)|Consent withdraw|0
7796628|NCT00515827|27094574|P1|Second Intervention (12 Weeks)|Consent withdraw|1
7796629|NCT00515827|27094573|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
7796630|NCT00515827|27094574|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
7796631|NCT00515671|27094632|P2|Overall Study|incarcerated|2
7796632|NCT00515671|27094633|P1|Overall Study|incarcerated|1
7796633|NCT00515671|27094632|P2|Overall Study|Withdrawal by Subject|5
7796634|NCT00515671|27094633|P1|Overall Study|Withdrawal by Subject|3
7796635|NCT00515671|27094632|P2|Overall Study|Lost to Follow-up|10
7796636|NCT00515671|27094633|P1|Overall Study|Lost to Follow-up|13
7796637|NCT00515619|27094641|P1|Overall Study|Other: Subject interested in other AED|1
7796638|NCT00515619|27094641|P1|Overall Study|Other: Drug available on license|1
7796639|NCT00515619|27094641|P1|Overall Study|Other: Request from sponsor|1
7796640|NCT00515619|27094641|P1|Overall Study|Other: Subject became pregnant|1
7796641|NCT00515619|27094641|P1|Overall Study|Other: Investigator decision|1
7796730|NCT00515086|27095172|P3|Overall Study|Lost to Follow-up|0
7796642|NCT00515619|27094641|P1|Overall Study|Other: Subject moved to another country|1
7796643|NCT00515619|27094641|P1|Overall Study|Other: Subject required surgery|1
7796644|NCT00515619|27094641|P1|Overall Study|Other: Subject cannot attend visits|2
7796645|NCT00515619|27094641|P1|Overall Study|Other: Site discontinuing trials|2
7796646|NCT00515619|27094641|P1|Overall Study|Unsatisfactory compliance|6
7796647|NCT00515619|27094641|P1|Overall Study|Lost to Follow-up|4
7796648|NCT00515619|27094641|P1|Overall Study|Protocol Violation|3
7796649|NCT00515619|27094641|P1|Overall Study|Withdrawal by Subject|66
7796650|NCT00515619|27094641|P1|Overall Study|Lack of Efficacy|92
7796651|NCT00515619|27094641|P1|Overall Study|Adverse Event|34
7796652|NCT00515541|27094653|P4|Overall Study|Withdrawal by Subject|2
7796653|NCT00515541|27094654|P3|Overall Study|Withdrawal by Subject|0
7796654|NCT00515541|27094655|P2|Overall Study|Withdrawal by Subject|2
7796655|NCT00515541|27094656|P1|Overall Study|Withdrawal by Subject|0
7796656|NCT00515541|27094653|P4|Overall Study|No show for appointments|2
7796657|NCT00515541|27094654|P3|Overall Study|No show for appointments|0
7796658|NCT00515541|27094655|P2|Overall Study|No show for appointments|1
7796659|NCT00515541|27094656|P1|Overall Study|No show for appointments|0
7796660|NCT00515541|27094653|P4|Overall Study|Physician Decision|1
7796661|NCT00515541|27094654|P3|Overall Study|Physician Decision|0
7796662|NCT00515541|27094655|P2|Overall Study|Physician Decision|2
7796663|NCT00515541|27094656|P1|Overall Study|Physician Decision|0
7796664|NCT00515502|27094687|P12|Treatment Period 2|Adverse Event|0
7796665|NCT00515502|27094688|P11|Treatment Period 2|Adverse Event|0
7796666|NCT00515502|27094689|P10|Treatment Period 2|Adverse Event|0
7796667|NCT00515502|27094690|P9|Treatment Period 2|Adverse Event|0
7796668|NCT00515502|27094691|P8|Treatment Period 2|Adverse Event|0
7796669|NCT00515502|27094692|P7|Treatment Period 2|Adverse Event|0
7796670|NCT00515502|27094693|P6|Treatment Period 2|Adverse Event|0
7796671|NCT00515502|27094694|P5|Treatment Period 2|Adverse Event|0
7796672|NCT00515502|27094695|P4|Treatment Period 2|Adverse Event|0
7796673|NCT00515502|27094696|P3|Treatment Period 2|Adverse Event|0
7796674|NCT00515502|27094697|P2|Treatment Period 2|Adverse Event|1
7796675|NCT00515502|27094698|P1|Treatment Period 2|Adverse Event|0
7796676|NCT00515502|27094687|P12|Treatment Period 1|Adverse Event|1
7796677|NCT00515502|27094688|P11|Treatment Period 1|Adverse Event|0
7796678|NCT00515502|27094689|P10|Treatment Period 1|Adverse Event|0
7796679|NCT00515502|27094690|P9|Treatment Period 1|Adverse Event|1
7796680|NCT00515502|27094691|P8|Treatment Period 1|Adverse Event|0
7796681|NCT00515502|27094692|P7|Treatment Period 1|Adverse Event|1
7796682|NCT00515502|27094693|P6|Treatment Period 1|Adverse Event|0
7796683|NCT00515502|27094694|P5|Treatment Period 1|Adverse Event|0
7796684|NCT00515502|27094695|P4|Treatment Period 1|Adverse Event|0
7796685|NCT00515502|27094696|P3|Treatment Period 1|Adverse Event|0
7796686|NCT00515502|27094697|P2|Treatment Period 1|Adverse Event|0
7796687|NCT00515502|27094698|P1|Treatment Period 1|Adverse Event|0
7796688|NCT00515463|27094858|P2|Overall Study|Other|1
7796689|NCT00515463|27094859|P1|Overall Study|Other|0
7796690|NCT00515463|27094858|P2|Overall Study|Lost to Follow-up|5
7796691|NCT00515463|27094859|P1|Overall Study|Lost to Follow-up|6
7796692|NCT00515463|27094858|P2|Overall Study|Withdrawal by Subject|4
7796693|NCT00515463|27094859|P1|Overall Study|Withdrawal by Subject|3
7796694|NCT00515463|27094858|P2|Overall Study|Adverse Event|2
7796695|NCT00515463|27094859|P1|Overall Study|Adverse Event|1
7796696|NCT00515463|27094858|P2|Overall Study|Physician Decision|2
7796697|NCT00515463|27094859|P1|Overall Study|Physician Decision|4
7796698|NCT00515294|27095058|P4|Overall Study|Caffeine amount inaccurate|0
7796699|NCT00515294|27095059|P3|Overall Study|Caffeine amount inaccurate|7
7796700|NCT00515294|27095060|P2|Overall Study|Caffeine amount inaccurate|0
7796701|NCT00515294|27095061|P1|Overall Study|Caffeine amount inaccurate|5
7796702|NCT00515294|27095058|P4|Overall Study|Driver simulator problems|3
7796703|NCT00515294|27095059|P3|Overall Study|Driver simulator problems|1
7796704|NCT00515294|27095060|P2|Overall Study|Driver simulator problems|1
7796705|NCT00515294|27095061|P1|Overall Study|Driver simulator problems|1
7796706|NCT00515294|27095058|P4|Overall Study|Lost to Follow-up|1
7796707|NCT00515294|27095059|P3|Overall Study|Lost to Follow-up|3
7796708|NCT00515294|27095060|P2|Overall Study|Lost to Follow-up|2
7796709|NCT00515294|27095061|P1|Overall Study|Lost to Follow-up|3
7796710|NCT00515216|27095075|P1|Overall Study|Withdrawal by Subject|1
7796711|NCT00515112|27095137|P2|Overall Study|The study was terminated|2
7796712|NCT00515112|27095138|P1|Overall Study|The study was terminated|3
7796713|NCT00515112|27095137|P2|Overall Study|Death|1
7796714|NCT00515112|27095138|P1|Overall Study|Death|0
7796715|NCT00515099|27095148|P2|Overall Study|IRB Recommendation|0
7796716|NCT00515099|27095149|P1|Overall Study|IRB Recommendation|1
7796717|NCT00515099|27095148|P2|Overall Study|Withdrawal by Subject|0
7796718|NCT00515099|27095149|P1|Overall Study|Withdrawal by Subject|2
7796719|NCT00515099|27095148|P2|Overall Study|Lost to Follow-up|4
7796720|NCT00515099|27095149|P1|Overall Study|Lost to Follow-up|0
7796721|NCT00515086|27095171|P4|Overall Study|Death|0
7796722|NCT00515086|27095172|P3|Overall Study|Death|0
7796723|NCT00515086|27095173|P2|Overall Study|Death|0
7796724|NCT00515086|27095174|P1|Overall Study|Death|2
7796725|NCT00515086|27095171|P4|Overall Study|Study drug no longer required|0
7796726|NCT00515086|27095172|P3|Overall Study|Study drug no longer required|0
7796727|NCT00515086|27095173|P2|Overall Study|Study drug no longer required|1
7796728|NCT00515086|27095174|P1|Overall Study|Study drug no longer required|0
7796729|NCT00515086|27095171|P4|Overall Study|Lost to Follow-up|0
7796731|NCT00515086|27095173|P2|Overall Study|Lost to Follow-up|0
7796732|NCT00515086|27095174|P1|Overall Study|Lost to Follow-up|1
7796733|NCT00515086|27095171|P4|Overall Study|Unsatisfactory therapeutic effect|2
7796734|NCT00515086|27095172|P3|Overall Study|Unsatisfactory therapeutic effect|3
7796735|NCT00515086|27095173|P2|Overall Study|Unsatisfactory therapeutic effect|3
7796736|NCT00515086|27095174|P1|Overall Study|Unsatisfactory therapeutic effect|18
7796737|NCT00515086|27095171|P4|Overall Study|Withdrawal by Subject|1
7796738|NCT00515086|27095172|P3|Overall Study|Withdrawal by Subject|0
7796739|NCT00515086|27095173|P2|Overall Study|Withdrawal by Subject|0
7796740|NCT00515086|27095174|P1|Overall Study|Withdrawal by Subject|1
7796741|NCT00515086|27095171|P4|Overall Study|Administrative|0
7796742|NCT00515086|27095172|P3|Overall Study|Administrative|0
7796743|NCT00515086|27095173|P2|Overall Study|Administrative|1
7796744|NCT00515086|27095174|P1|Overall Study|Administrative|1
7796745|NCT00515086|27095171|P4|Overall Study|Adverse Event|3
7796746|NCT00515086|27095172|P3|Overall Study|Adverse Event|2
7796747|NCT00515086|27095173|P2|Overall Study|Adverse Event|1
7796748|NCT00515086|27095174|P1|Overall Study|Adverse Event|1
7796749|NCT00515073|27095201|P1|Overall Study|Physician Decision|1
7796750|NCT00515073|27095201|P1|Overall Study|Withdrawal by Subject|1
7796751|NCT00515034|27095209|P4|Overall Study|Other|1
7796752|NCT00515034|27095210|P3|Overall Study|Other|2
7796753|NCT00515034|27095211|P2|Overall Study|Other|0
7796754|NCT00515034|27095212|P1|Overall Study|Other|1
7796755|NCT00515034|27095209|P4|Overall Study|Physician Decision|1
7796756|NCT00515034|27095210|P3|Overall Study|Physician Decision|1
7796757|NCT00515034|27095211|P2|Overall Study|Physician Decision|0
7796758|NCT00515034|27095212|P1|Overall Study|Physician Decision|0
7796759|NCT00515034|27095209|P4|Overall Study|Withdrawal by Subject|0
7796760|NCT00515034|27095210|P3|Overall Study|Withdrawal by Subject|3
7796761|NCT00515034|27095211|P2|Overall Study|Withdrawal by Subject|0
7796762|NCT00515034|27095212|P1|Overall Study|Withdrawal by Subject|1
7796763|NCT00515034|27095209|P4|Overall Study|Death|3
7796764|NCT00515034|27095210|P3|Overall Study|Death|1
7796765|NCT00515034|27095211|P2|Overall Study|Death|2
7796766|NCT00515034|27095212|P1|Overall Study|Death|4
7796767|NCT00515034|27095209|P4|Overall Study|Adverse Event|0
7796768|NCT00515034|27095210|P3|Overall Study|Adverse Event|1
7796769|NCT00515034|27095211|P2|Overall Study|Adverse Event|0
7796770|NCT00515034|27095212|P1|Overall Study|Adverse Event|2
7796771|NCT00515008|27095243|P2|Overall Study|Scheduling conflict|0
7796772|NCT00515008|27095244|P1|Overall Study|Scheduling conflict|1
7796773|NCT00515008|27095243|P2|Overall Study|Left the Boston Area|1
7796774|NCT00515008|27095244|P1|Overall Study|Left the Boston Area|1
7796775|NCT00515008|27095243|P2|Overall Study|Declined|3
7796776|NCT00515008|27095244|P1|Overall Study|Declined|0
7796777|NCT00515008|27095243|P2|Overall Study|Lost to Follow-up|0
7796778|NCT00515008|27095244|P1|Overall Study|Lost to Follow-up|1
7796779|NCT00514943|27095268|P2|Stage 2|Other than stated above|2
7796780|NCT00514943|27095269|P1|Stage 2|Other than stated above|0
7796781|NCT00514943|27095268|P2|Stage 2|Patient refused to continue study meds|0
7796782|NCT00514943|27095269|P1|Stage 2|Patient refused to continue study meds|2
7796783|NCT00514943|27095268|P2|Stage 2|Other Adverse Event|10
7796784|NCT00514943|27095269|P1|Stage 2|Other Adverse Event|3
7796785|NCT00514943|27095268|P2|Stage 2|Progressive disease|24
7796786|NCT00514943|27095269|P1|Stage 2|Progressive disease|27
7796787|NCT00514943|27095268|P2|Stage 1|Other than stated above|7
7796788|NCT00514943|27095269|P1|Stage 1|Other than stated above|1
7796789|NCT00514943|27095268|P2|Stage 1|Patient refused to continue study meds|3
7796790|NCT00514943|27095269|P1|Stage 1|Patient refused to continue study meds|8
7796791|NCT00514943|27095268|P2|Stage 1|Not treated|2
7796792|NCT00514943|27095269|P1|Stage 1|Not treated|1
7796793|NCT00514943|27095268|P2|Stage 1|Other Adverse Event|6
7796794|NCT00514943|27095269|P1|Stage 1|Other Adverse Event|16
7796795|NCT00514943|27095268|P2|Stage 1|Progressive disease|8
7796796|NCT00514943|27095269|P1|Stage 1|Progressive disease|4
7796797|NCT00514917|27095327|P2|Overall Study|Undefined|5
7796798|NCT00514917|27095328|P1|Overall Study|Undefined|11
7796799|NCT00514917|27095327|P2|Overall Study|Discontinued due to study closure|81
7796800|NCT00514917|27095328|P1|Overall Study|Discontinued due to study closure|88
7796801|NCT00514917|27095327|P2|Overall Study|Withdrawal by Subject|16
7796802|NCT00514917|27095328|P1|Overall Study|Withdrawal by Subject|18
7796803|NCT00514917|27095327|P2|Overall Study|Lost to Follow-up|3
7796804|NCT00514917|27095328|P1|Overall Study|Lost to Follow-up|4
7796805|NCT00514917|27095327|P2|Overall Study|Protocol Violation|0
7796806|NCT00514917|27095328|P1|Overall Study|Protocol Violation|1
7796807|NCT00514917|27095327|P2|Overall Study|Death|10
7796808|NCT00514917|27095328|P1|Overall Study|Death|4
7796809|NCT00514904|27095356|P2|Overall Study|Lost to Follow-up|3
7796810|NCT00514904|27095357|P1|Overall Study|Lost to Follow-up|21
7796811|NCT00514904|27095356|P2|Overall Study|Withdrawal by Subject|2
7796812|NCT00514904|27095357|P1|Overall Study|Withdrawal by Subject|3
7796813|NCT00514813|27095422|P4|Overall Study|Death|2
7796814|NCT00514813|27095423|P3|Overall Study|Death|3
7796815|NCT00514813|27095424|P2|Overall Study|Death|2
7796816|NCT00514813|27095425|P1|Overall Study|Death|0
7796817|NCT00514813|27095422|P4|Overall Study|Kidney transplant|0
7796818|NCT00514813|27095423|P3|Overall Study|Kidney transplant|2
7796819|NCT00514813|27095424|P2|Overall Study|Kidney transplant|6
7796820|NCT00514813|27095425|P1|Overall Study|Kidney transplant|0
7796821|NCT00514813|27095422|P4|Overall Study|Lack of Efficacy|0
7796822|NCT00514813|27095423|P3|Overall Study|Lack of Efficacy|0
7796823|NCT00514813|27095424|P2|Overall Study|Lack of Efficacy|1
7796824|NCT00514813|27095425|P1|Overall Study|Lack of Efficacy|0
7796825|NCT00514813|27095422|P4|Overall Study|Withdrawal by Subject|0
7796826|NCT00514813|27095423|P3|Overall Study|Withdrawal by Subject|0
7796827|NCT00514813|27095424|P2|Overall Study|Withdrawal by Subject|1
7796828|NCT00514813|27095425|P1|Overall Study|Withdrawal by Subject|0
7796829|NCT00514813|27095422|P4|Overall Study|Protocol Violation|0
7796830|NCT00514813|27095423|P3|Overall Study|Protocol Violation|0
7796831|NCT00514813|27095424|P2|Overall Study|Protocol Violation|0
7796832|NCT00514813|27095425|P1|Overall Study|Protocol Violation|1
7796833|NCT00514813|27095422|P4|Overall Study|Adverse Event|0
7796834|NCT00514813|27095423|P3|Overall Study|Adverse Event|2
7796835|NCT00514813|27095424|P2|Overall Study|Adverse Event|2
7796836|NCT00514813|27095425|P1|Overall Study|Adverse Event|0
7796837|NCT00514813|27095422|P4|Overall Study|Study terminated|2
7796838|NCT00514813|27095423|P3|Overall Study|Study terminated|40
7796839|NCT00514813|27095424|P2|Overall Study|Study terminated|74
7796840|NCT00514813|27095425|P1|Overall Study|Study terminated|14
7796841|NCT00514735|27095445|P2|Overall Study|Lost to Follow-up|1
7796842|NCT00514735|27095446|P1|Overall Study|Lost to Follow-up|0
7796843|NCT00514735|27095445|P2|Overall Study|Death|0
7796844|NCT00514735|27095446|P1|Overall Study|Death|1
7796845|NCT00514735|27095445|P2|Overall Study|Withdrawal by Subject|5
7796846|NCT00514735|27095446|P1|Overall Study|Withdrawal by Subject|13
7796847|NCT00514683|27095482|P5|Overall Study|Reason other than listed above|1
7796848|NCT00514683|27095483|P4|Overall Study|Reason other than listed above|0
7796849|NCT00514683|27095484|P3|Overall Study|Reason other than listed above|2
7796850|NCT00514683|27095485|P2|Overall Study|Reason other than listed above|1
7796851|NCT00514683|27095486|P1|Overall Study|Reason other than listed above|0
7796852|NCT00514683|27095482|P5|Overall Study|Withdrawal by Subject|4
7796853|NCT00514683|27095483|P4|Overall Study|Withdrawal by Subject|0
7796854|NCT00514683|27095484|P3|Overall Study|Withdrawal by Subject|1
7796855|NCT00514683|27095485|P2|Overall Study|Withdrawal by Subject|2
7796856|NCT00514683|27095486|P1|Overall Study|Withdrawal by Subject|2
7796857|NCT00514683|27095482|P5|Overall Study|Protocol Violation|0
7796858|NCT00514683|27095483|P4|Overall Study|Protocol Violation|1
7796859|NCT00514683|27095484|P3|Overall Study|Protocol Violation|0
7796860|NCT00514683|27095485|P2|Overall Study|Protocol Violation|1
7796861|NCT00514683|27095486|P1|Overall Study|Protocol Violation|1
7796862|NCT00514683|27095482|P5|Overall Study|Adverse Event|27
7796863|NCT00514683|27095483|P4|Overall Study|Adverse Event|13
7796864|NCT00514683|27095484|P3|Overall Study|Adverse Event|15
7796865|NCT00514683|27095485|P2|Overall Study|Adverse Event|20
7796866|NCT00514683|27095486|P1|Overall Study|Adverse Event|21
7796867|NCT00514683|27095482|P5|Overall Study|Not treated|1
7796868|NCT00514683|27095483|P4|Overall Study|Not treated|0
7796869|NCT00514683|27095484|P3|Overall Study|Not treated|0
7796870|NCT00514683|27095485|P2|Overall Study|Not treated|1
7796871|NCT00514683|27095486|P1|Overall Study|Not treated|2
7796872|NCT00514540|27095682|P1|Second-Line|Physician/Patient Decision|31
7796873|NCT00514540|27095682|P1|First-Line Chemo|Protocol Violation|7
7796874|NCT00514540|27095682|P1|First-Line Chemo|Withdrawal by Subject|1
7796875|NCT00514514|27095693|P3|Extension - 4 Years|Adverse Event|3
7796876|NCT00514514|27095694|P2|Extension - 4 Years|Adverse Event|6
7796877|NCT00514514|27095695|P1|Extension - 4 Years|Adverse Event|9
7796878|NCT00514514|27095693|P3|Extension - 4 Years|Death|6
7796879|NCT00514514|27095694|P2|Extension - 4 Years|Death|3
7796880|NCT00514514|27095695|P1|Extension - 4 Years|Death|8
7796881|NCT00514514|27095693|P3|Extension - 4 Years|Administrative problems|1
7796882|NCT00514514|27095694|P2|Extension - 4 Years|Administrative problems|1
7796883|NCT00514514|27095695|P1|Extension - 4 Years|Administrative problems|3
7796884|NCT00514514|27095693|P3|Extension - 4 Years|Lost to Follow-up|9
7796885|NCT00514514|27095694|P2|Extension - 4 Years|Lost to Follow-up|10
7796886|NCT00514514|27095695|P1|Extension - 4 Years|Lost to Follow-up|12
7796887|NCT00514514|27095693|P3|Extension - 4 Years|Withdrawal by Subject|2
7796888|NCT00514514|27095694|P2|Extension - 4 Years|Withdrawal by Subject|2
7796889|NCT00514514|27095695|P1|Extension - 4 Years|Withdrawal by Subject|5
7796890|NCT00514514|27095693|P3|Randomized - 9 Month|Adverse Event|27
7796891|NCT00514514|27095694|P2|Randomized - 9 Month|Adverse Event|44
7796892|NCT00514514|27095695|P1|Randomized - 9 Month|Adverse Event|25
7796893|NCT00514514|27095693|P3|Randomized - 9 Month|Abnormal laboratory values|1
7796894|NCT00514514|27095694|P2|Randomized - 9 Month|Abnormal laboratory values|3
7796895|NCT00514514|27095695|P1|Randomized - 9 Month|Abnormal laboratory values|0
7796896|NCT00514514|27095693|P3|Randomized - 9 Month|Lack of Efficacy|1
7796897|NCT00514514|27095694|P2|Randomized - 9 Month|Lack of Efficacy|3
7796898|NCT00514514|27095695|P1|Randomized - 9 Month|Lack of Efficacy|2
7796899|NCT00514514|27095693|P3|Randomized - 9 Month|Protocol Violation|0
7796900|NCT00514514|27095694|P2|Randomized - 9 Month|Protocol Violation|1
7796901|NCT00514514|27095695|P1|Randomized - 9 Month|Protocol Violation|1
7796902|NCT00514514|27095693|P3|Randomized - 9 Month|Withdrawal by Subject|5
7796903|NCT00514514|27095694|P2|Randomized - 9 Month|Withdrawal by Subject|7
7796904|NCT00514514|27095695|P1|Randomized - 9 Month|Withdrawal by Subject|7
7796905|NCT00514514|27095693|P3|Randomized - 9 Month|Administrative problems|2
7796906|NCT00514514|27095694|P2|Randomized - 9 Month|Administrative problems|1
7796907|NCT00514514|27095695|P1|Randomized - 9 Month|Administrative problems|1
7796908|NCT00514514|27095693|P3|Randomized - 9 Month|Death|2
7796909|NCT00514514|27095694|P2|Randomized - 9 Month|Death|2
7796910|NCT00514514|27095695|P1|Randomized - 9 Month|Death|3
7796911|NCT00514514|27095693|P3|Pre-phase|Withdrawal by Subject|0
7796912|NCT00514514|27095694|P2|Pre-phase|Withdrawal by Subject|0
7796913|NCT00514514|27095695|P1|Pre-phase|Withdrawal by Subject|66
7796914|NCT00514514|27095693|P3|Pre-phase|Adverse Event|0
7796915|NCT00514514|27095694|P2|Pre-phase|Adverse Event|0
7796916|NCT00514514|27095695|P1|Pre-phase|Adverse Event|137
7796917|NCT00514514|27095693|P3|Pre-phase|Lack of Efficacy|0
7796918|NCT00514514|27095694|P2|Pre-phase|Lack of Efficacy|0
7796919|NCT00514514|27095695|P1|Pre-phase|Lack of Efficacy|35
7796920|NCT00514514|27095693|P3|Pre-phase|abnormal lab values|0
7796921|NCT00514514|27095694|P2|Pre-phase|abnormal lab values|0
7796922|NCT00514514|27095695|P1|Pre-phase|abnormal lab values|23
7796923|NCT00514514|27095693|P3|Pre-phase|Lost to Follow-up|0
7796924|NCT00514514|27095694|P2|Pre-phase|Lost to Follow-up|0
7796925|NCT00514514|27095695|P1|Pre-phase|Lost to Follow-up|2
7796926|NCT00514514|27095693|P3|Pre-phase|abnormal test procedure results|0
7796927|NCT00514514|27095694|P2|Pre-phase|abnormal test procedure results|0
7796928|NCT00514514|27095695|P1|Pre-phase|abnormal test procedure results|15
7796929|NCT00514514|27095693|P3|Pre-phase|condition no longer requires study drug|0
7796930|NCT00514514|27095694|P2|Pre-phase|condition no longer requires study drug|0
7796931|NCT00514514|27095695|P1|Pre-phase|condition no longer requires study drug|7
7796932|NCT00514514|27095693|P3|Pre-phase|Protocol Violation|0
7796933|NCT00514514|27095694|P2|Pre-phase|Protocol Violation|0
7796934|NCT00514514|27095695|P1|Pre-phase|Protocol Violation|6
7796935|NCT00514514|27095693|P3|Pre-phase|administrative problems|0
7796936|NCT00514514|27095694|P2|Pre-phase|administrative problems|0
7796937|NCT00514514|27095695|P1|Pre-phase|administrative problems|2
7796938|NCT00514514|27095693|P3|Pre-phase|Death|0
7796939|NCT00514514|27095694|P2|Pre-phase|Death|0
7796940|NCT00514514|27095695|P1|Pre-phase|Death|10
7796941|NCT00514449|27095747|P2|Overall Study|Lost to Follow-up|0
7796942|NCT00514449|27095748|P1|Overall Study|Lost to Follow-up|1
7796943|NCT00514449|27095747|P2|Overall Study|Protocol Violation|2
7796944|NCT00514449|27095748|P1|Overall Study|Protocol Violation|1
7796945|NCT00514449|27095747|P2|Overall Study|Withdrawal by Subject|2
7796946|NCT00514449|27095748|P1|Overall Study|Withdrawal by Subject|1
7796947|NCT00514046|27095781|P9|Overall Study|Disease progression on study|0
7796948|NCT00514046|27095782|P8|Overall Study|Disease progression on study|0
7796949|NCT00514046|27095783|P7|Overall Study|Disease progression on study|0
7796950|NCT00514046|27095784|P6|Overall Study|Disease progression on study|1
7796951|NCT00514046|27095785|P5|Overall Study|Disease progression on study|0
7796952|NCT00514046|27095786|P4|Overall Study|Disease progression on study|0
7796953|NCT00514046|27095787|P3|Overall Study|Disease progression on study|2
7796954|NCT00514046|27095788|P2|Overall Study|Disease progression on study|0
7796955|NCT00514046|27095789|P1|Overall Study|Disease progression on study|0
7796956|NCT00514046|27095781|P9|Overall Study|Getting vandetanib via the REMS program|1
7796957|NCT00514046|27095782|P8|Overall Study|Getting vandetanib via the REMS program|1
7796958|NCT00514046|27095783|P7|Overall Study|Getting vandetanib via the REMS program|0
7796959|NCT00514046|27095784|P6|Overall Study|Getting vandetanib via the REMS program|0
7796960|NCT00514046|27095785|P5|Overall Study|Getting vandetanib via the REMS program|0
7796961|NCT00514046|27095786|P4|Overall Study|Getting vandetanib via the REMS program|0
7796962|NCT00514046|27095787|P3|Overall Study|Getting vandetanib via the REMS program|0
7796963|NCT00514046|27095788|P2|Overall Study|Getting vandetanib via the REMS program|0
7796964|NCT00514046|27095789|P1|Overall Study|Getting vandetanib via the REMS program|1
7796965|NCT00514046|27095781|P9|Overall Study|transferred to another protocol|0
7796966|NCT00514046|27095782|P8|Overall Study|transferred to another protocol|0
7796967|NCT00514046|27095783|P7|Overall Study|transferred to another protocol|0
7796968|NCT00514046|27095784|P6|Overall Study|transferred to another protocol|0
7796969|NCT00514046|27095785|P5|Overall Study|transferred to another protocol|1
7796970|NCT00514046|27095786|P4|Overall Study|transferred to another protocol|0
7796971|NCT00514046|27095787|P3|Overall Study|transferred to another protocol|3
7796972|NCT00514046|27095788|P2|Overall Study|transferred to another protocol|1
7796973|NCT00514046|27095789|P1|Overall Study|transferred to another protocol|2
7796974|NCT00514020|27095831|P1|Overall Study|"patients moved to the no tx group"|6
7796975|NCT00514020|27095831|P1|Overall Study|patient went to radiation treatment|1
7796976|NCT00514020|27095831|P1|Overall Study|other complicating disease|2
7796977|NCT00514020|27095831|P1|Overall Study|disease progression|9
7796978|NCT00514020|27095831|P1|Overall Study|Physician Decision|1
7796979|NCT00514020|27095831|P1|Overall Study|Withdrawal by Subject|3
7796980|NCT00514020|27095831|P1|Overall Study|Adverse Event|6
7796981|NCT00513708|27095885|P3|Overall Study|Lost to Follow-up|4
7796982|NCT00513708|27095886|P2|Overall Study|Lost to Follow-up|4
7796983|NCT00513708|27095887|P1|Overall Study|Lost to Follow-up|4
7796984|NCT00513695|27095901|P1|Overall Study|Progression prior to surgery|3
7796985|NCT00513695|27095901|P1|Overall Study|Discontinued therapy|2
7796986|NCT00513682|27095910|P1|Washout Phase|Adverse Event|2
7796987|NCT00513604|27095940|P5|Overall Study|Death during treatment|0
7796988|NCT00513604|27095941|P4|Overall Study|Death during treatment|0
7796989|NCT00513604|27095942|P3|Overall Study|Death during treatment|2
7796990|NCT00513604|27095943|P2|Overall Study|Death during treatment|3
7796991|NCT00513604|27095944|P1|Overall Study|Death during treatment|0
7796992|NCT00513604|27095940|P5|Overall Study|Not treated|0
7796993|NCT00513604|27095941|P4|Overall Study|Not treated|0
7796994|NCT00513604|27095942|P3|Overall Study|Not treated|1
7796995|NCT00513604|27095943|P2|Overall Study|Not treated|0
7796996|NCT00513604|27095944|P1|Overall Study|Not treated|2
7796997|NCT00513500|27095978|P2|Overall Study|Hospitalized|14
7796998|NCT00513500|27095979|P1|Overall Study|Hospitalized|4
7796999|NCT00513500|27095978|P2|Overall Study|Death|1
7797000|NCT00513500|27095979|P1|Overall Study|Death|2
7797001|NCT00513500|27095978|P2|Overall Study|Lost to Follow-up|39
7797002|NCT00513500|27095979|P1|Overall Study|Lost to Follow-up|35
7797003|NCT00513474|27095991|P2|Overall Study|Participant Withdrew Consent|0
7797004|NCT00513474|27095992|P1|Overall Study|Participant Withdrew Consent|1
7797005|NCT00513474|27095991|P2|Overall Study|Death|9
7797006|NCT00513474|27095992|P1|Overall Study|Death|6
7797007|NCT00513409|27096048|P2|Overall Study|Visit 3 not done|2
7797008|NCT00513409|27096049|P1|Overall Study|Visit 3 not done|1
7797009|NCT00513409|27096048|P2|Overall Study|Physician Decision|0
7797010|NCT00513409|27096049|P1|Overall Study|Physician Decision|1
7797011|NCT00513409|27096048|P2|Overall Study|Lost to Follow-up|1
7797012|NCT00513409|27096049|P1|Overall Study|Lost to Follow-up|0
7797013|NCT00513409|27096048|P2|Overall Study|Withdrawal by Subject|2
7797014|NCT00513409|27096049|P1|Overall Study|Withdrawal by Subject|0
7797015|NCT00513409|27096048|P2|Overall Study|Adverse Event|1
7797016|NCT00513409|27096049|P1|Overall Study|Adverse Event|0
7797017|NCT00513357|27096105|P2|Overall Study|Disease Progression|1
7797018|NCT00513357|27096106|P1|Overall Study|Disease Progression|2
7797019|NCT00513357|27096105|P2|Overall Study|Withdrawal by Subject|4
7797020|NCT00513357|27096106|P1|Overall Study|Withdrawal by Subject|5
7797021|NCT00513357|27096105|P2|Overall Study|Death|0
7797022|NCT00513357|27096106|P1|Overall Study|Death|2
7797023|NCT00513357|27096105|P2|Overall Study|Adverse Event|2
7797024|NCT00513357|27096106|P1|Overall Study|Adverse Event|4
7797025|NCT00513357|27096105|P2|Overall Study|did not receive allocated placebo|3
7797026|NCT00513357|27096106|P1|Overall Study|did not receive allocated placebo|2
7797027|NCT00513305|27096125|P2|Overall Study|Sponsor Decision|2
7797028|NCT00513305|27096126|P1|Overall Study|Sponsor Decision|0
7797029|NCT00513305|27096125|P2|Overall Study|Persistent hypocellularity|1
7797030|NCT00513305|27096126|P1|Overall Study|Persistent hypocellularity|0
7797031|NCT00513305|27096125|P2|Overall Study|Physician Decision|0
7797032|NCT00513305|27096126|P1|Overall Study|Physician Decision|1
7797033|NCT00513305|27096125|P2|Overall Study|Hematologic counts did not recover|0
7797034|NCT00513305|27096126|P1|Overall Study|Hematologic counts did not recover|1
7797035|NCT00513305|27096125|P2|Overall Study|Eligible for stem cell transplant|0
7797036|NCT00513305|27096126|P1|Overall Study|Eligible for stem cell transplant|1
7797037|NCT00513305|27096125|P2|Overall Study|Disease progression|5
7797038|NCT00513305|27096126|P1|Overall Study|Disease progression|8
7797039|NCT00513305|27096125|P2|Overall Study|Withdrawal by Subject|2
7797040|NCT00513305|27096126|P1|Overall Study|Withdrawal by Subject|1
7797041|NCT00513305|27096125|P2|Overall Study|Lack of Efficacy|13
7797042|NCT00513305|27096126|P1|Overall Study|Lack of Efficacy|8
7797043|NCT00513305|27096125|P2|Overall Study|Death (through Consolidation Treatment)|2
7797044|NCT00513305|27096126|P1|Overall Study|Death (through Consolidation Treatment)|2
7797045|NCT00513305|27096125|P2|Overall Study|Adverse Event|2
7797046|NCT00513305|27096126|P1|Overall Study|Adverse Event|6
7797047|NCT00513240|27096169|P2|Overall Study|Withdrawal by Subject|4
7797048|NCT00513240|27096170|P1|Overall Study|Withdrawal by Subject|7
7797049|NCT00513240|27096169|P2|Overall Study|Death|3
7797050|NCT00513240|27096170|P1|Overall Study|Death|3
7797051|NCT00513240|27096169|P2|Overall Study|Did not have intended surgery|0
7797052|NCT00513240|27096170|P1|Overall Study|Did not have intended surgery|3
7797053|NCT00513071|27096183|P1|Overall Study|Physician Decision|3
7797054|NCT00513071|27096183|P1|Overall Study|Withdrawal by Subject|1
7797055|NCT00513071|27096183|P1|Overall Study|Adverse Event|1
7797056|NCT00513019|27096195|P2|Overall Study|Withdrawal by Subject|5
7797057|NCT00513019|27096196|P1|Overall Study|Withdrawal by Subject|4
7797058|NCT00513019|27096195|P2|Overall Study|Adverse Event|0
7797059|NCT00513019|27096196|P1|Overall Study|Adverse Event|1
7797060|NCT00512902|27096202|P1|Overall Study|Lost to Follow-up|1
7797061|NCT00512902|27096202|P1|Overall Study|Adverse Event|7
7797062|NCT00512798|27096217|P2|Overall Study|Withdrawal by Subject|0
7797063|NCT00512798|27096218|P1|Overall Study|Withdrawal by Subject|3
7797064|NCT00512798|27096217|P2|Overall Study|Progression of disease|20
7797065|NCT00512798|27096218|P1|Overall Study|Progression of disease|14
7797066|NCT00512798|27096217|P2|Overall Study|Adverse Event|4
7797067|NCT00512798|27096218|P1|Overall Study|Adverse Event|2
7797068|NCT00512798|27096217|P2|Overall Study|Death|3
7797069|NCT00512798|27096218|P1|Overall Study|Death|0
7797070|NCT00512707|27096229|P2|Overall Study|Unable to tolerate the smell of the gel|0
7797071|NCT00512707|27096230|P1|Overall Study|Unable to tolerate the smell of the gel|1
7797072|NCT00512707|27096229|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
7797073|NCT00512707|27096230|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
7797074|NCT00512707|27096229|P2|Overall Study|Developed skin irritation|1
7797075|NCT00512707|27096230|P1|Overall Study|Developed skin irritation|2
7797076|NCT00512707|27096229|P2|Overall Study|Lost to Follow-up|11
7797077|NCT00512707|27096230|P1|Overall Study|Lost to Follow-up|5
7797078|NCT00512252|27096280|P3|Overall Study|Death|1
7797079|NCT00512252|27096281|P2|Overall Study|Death|0
7797080|NCT00512252|27096282|P1|Overall Study|Death|0
7797081|NCT00512252|27096280|P3|Overall Study|Protocol Violation|1
7797082|NCT00512252|27096281|P2|Overall Study|Protocol Violation|0
7797083|NCT00512252|27096282|P1|Overall Study|Protocol Violation|0
7797084|NCT00512252|27096280|P3|Overall Study|Lost to Follow-up|1
7797085|NCT00512252|27096281|P2|Overall Study|Lost to Follow-up|0
7797086|NCT00512252|27096282|P1|Overall Study|Lost to Follow-up|0
7797087|NCT00512148|27096310|P1|Primay Study Period|Withdrawal by Subject|1
7797088|NCT00512135|27096316|P1|Overall Study|Other|22
7797089|NCT00512135|27096316|P1|Overall Study|Lost to Follow-up|27
7797090|NCT00512135|27096316|P1|Overall Study|Withdrawal by Subject|22
7797091|NCT00512135|27096316|P1|Overall Study|Adverse Event|6
7797092|NCT00512135|27096316|P1|Overall Study|Lack of Efficacy|2
7797093|NCT00512135|27096316|P1|Overall Study|Not Treated|5
7797094|NCT00512096|27096328|P1|Overall Study|Lack of Efficacy|3
7797095|NCT00512096|27096328|P1|Overall Study|Withdrawal by Subject|2
7797096|NCT00512096|27096328|P1|Overall Study|Adverse Event|2
7797097|NCT00511901|27096356|P2|Overall Study|Withdrawal by Subject|3
7797098|NCT00511901|27096357|P1|Overall Study|Withdrawal by Subject|1
7797099|NCT00511875|27096379|P2|Overall Study|Missing variables|0
7797100|NCT00511875|27096380|P1|Overall Study|Missing variables|1
7797101|NCT00511875|27096379|P2|Overall Study|Lost to Follow-up|0
7797102|NCT00511875|27096380|P1|Overall Study|Lost to Follow-up|4
7797103|NCT00511836|27096420|P2|Double-blind Period|Lost to Follow-up|0
7797104|NCT00511836|27096421|P1|Double-blind Period|Lost to Follow-up|1
7797105|NCT00511810|27096438|P2|Overall Study|Refused second scn|1
7797106|NCT00511810|27096439|P1|Overall Study|Refused second scn|0
7797107|NCT00511810|27096438|P2|Overall Study|Lack of Efficacy|2
7797108|NCT00511810|27096439|P1|Overall Study|Lack of Efficacy|0
7797109|NCT00511810|27096438|P2|Overall Study|Lost to Follow-up|2
7797110|NCT00511810|27096439|P1|Overall Study|Lost to Follow-up|1
7797111|NCT00511797|27096449|P4|Overall Study|Other (moving etc)|2
7797112|NCT00511797|27096450|P3|Overall Study|Other (moving etc)|1
7797113|NCT00511797|27096451|P2|Overall Study|Other (moving etc)|0
7797114|NCT00511797|27096452|P1|Overall Study|Other (moving etc)|1
7797115|NCT00511797|27096449|P4|Overall Study|Partially missing diary|0
7797116|NCT00511797|27096450|P3|Overall Study|Partially missing diary|1
7797117|NCT00511797|27096451|P2|Overall Study|Partially missing diary|0
7797118|NCT00511797|27096452|P1|Overall Study|Partially missing diary|0
7797119|NCT00511797|27096449|P4|Overall Study|Study drug not taken|1
7797120|NCT00511797|27096450|P3|Overall Study|Study drug not taken|0
7797121|NCT00511797|27096451|P2|Overall Study|Study drug not taken|1
7797122|NCT00511797|27096452|P1|Overall Study|Study drug not taken|0
7797123|NCT00511797|27096449|P4|Overall Study|Never dispensed|3
7797124|NCT00511797|27096450|P3|Overall Study|Never dispensed|1
7797125|NCT00511797|27096451|P2|Overall Study|Never dispensed|0
7797126|NCT00511797|27096452|P1|Overall Study|Never dispensed|1
7797127|NCT00511797|27096449|P4|Overall Study|Withdrawal by Subject|2
7797128|NCT00511797|27096450|P3|Overall Study|Withdrawal by Subject|4
7797129|NCT00511797|27096451|P2|Overall Study|Withdrawal by Subject|3
7797130|NCT00511797|27096452|P1|Overall Study|Withdrawal by Subject|3
7797131|NCT00511797|27096449|P4|Overall Study|Protocol Violation|3
7797132|NCT00511797|27096450|P3|Overall Study|Protocol Violation|2
7797133|NCT00511797|27096451|P2|Overall Study|Protocol Violation|2
7797134|NCT00511797|27096452|P1|Overall Study|Protocol Violation|0
7797135|NCT00511797|27096449|P4|Overall Study|Pregnancy|1
7797136|NCT00511797|27096450|P3|Overall Study|Pregnancy|0
7797137|NCT00511797|27096451|P2|Overall Study|Pregnancy|0
7797138|NCT00511797|27096452|P1|Overall Study|Pregnancy|0
7797139|NCT00511797|27096449|P4|Overall Study|Lost to Follow-up|1
7797140|NCT00511797|27096450|P3|Overall Study|Lost to Follow-up|0
7797141|NCT00511797|27096451|P2|Overall Study|Lost to Follow-up|0
7797142|NCT00511797|27096452|P1|Overall Study|Lost to Follow-up|1
7797143|NCT00511797|27096449|P4|Overall Study|Adverse Event|2
7797144|NCT00511797|27096450|P3|Overall Study|Adverse Event|2
7797145|NCT00511797|27096451|P2|Overall Study|Adverse Event|2
7797146|NCT00511797|27096452|P1|Overall Study|Adverse Event|1
7797147|NCT00511667|27096571|P2|Overall Study|Other|1
7797148|NCT00511667|27096572|P1|Overall Study|Other|2
7797149|NCT00511667|27096571|P2|Overall Study|Site terminated|1
7797150|NCT00511667|27096572|P1|Overall Study|Site terminated|6
7797151|NCT00511667|27096571|P2|Overall Study|Withdrawal by Subject|0
7797152|NCT00511667|27096572|P1|Overall Study|Withdrawal by Subject|2
7797153|NCT00511667|27096571|P2|Overall Study|Protocol Violation|1
7797154|NCT00511667|27096572|P1|Overall Study|Protocol Violation|1
7797155|NCT00511667|27096571|P2|Overall Study|Adverse Event|0
7797156|NCT00511667|27096572|P1|Overall Study|Adverse Event|1
7797157|NCT00511472|27096607|P2|Overall Study|Not reported|2
7797158|NCT00511472|27096608|P1|Overall Study|Not reported|2
7797159|NCT00511472|27096607|P2|Overall Study|Laboratory Adverse Event|2
7797160|NCT00511472|27096608|P1|Overall Study|Laboratory Adverse Event|0
7797161|NCT00511472|27096607|P2|Overall Study|Clinical Adverse Event|2
7797162|NCT00511472|27096608|P1|Overall Study|Clinical Adverse Event|1
7797163|NCT00511433|27096627|P2|Overall Study|Other Reason|1
7797164|NCT00511433|27096628|P1|Overall Study|Other Reason|1
7797165|NCT00511433|27096627|P2|Overall Study|Adverse Event|0
7797166|NCT00511433|27096628|P1|Overall Study|Adverse Event|5
7797167|NCT00511355|27096668|P2|Overall Study|Other reason pre-treatment|1
7797168|NCT00511355|27096669|P1|Overall Study|Other reason pre-treatment|0
7797169|NCT00511355|27096668|P2|Overall Study|Withdrawal of informed consent|1
7797170|NCT00511355|27096669|P1|Overall Study|Withdrawal of informed consent|0
7797171|NCT00511355|27096668|P2|Overall Study|Pre-treatment (serious) adverse event|1
7797172|NCT00511355|27096669|P1|Overall Study|Pre-treatment (serious) adverse event|0
7797173|NCT00511355|27096668|P2|Overall Study|Other Reason|1
7797174|NCT00511355|27096669|P1|Overall Study|Other Reason|0
7797175|NCT00511355|27096668|P2|Overall Study|Lost to Follow-up|1
7797176|NCT00511355|27096669|P1|Overall Study|Lost to Follow-up|2
7797177|NCT00511355|27096668|P2|Overall Study|Pregnancy Wish|0
7797178|NCT00511355|27096669|P1|Overall Study|Pregnancy Wish|1
7797179|NCT00511355|27096668|P2|Overall Study|Adverse Event|4
7797180|NCT00511355|27096669|P1|Overall Study|Adverse Event|4
7797181|NCT00511342|27096769|P2|Overall Study|Other Reason|2
7797182|NCT00511342|27096770|P1|Overall Study|Other Reason|2
7797183|NCT00511342|27096769|P2|Overall Study|Lost to Follow-up|5
7797184|NCT00511342|27096770|P1|Overall Study|Lost to Follow-up|1
7797185|NCT00511342|27096769|P2|Overall Study|Pregnancy wish|1
7797186|NCT00511342|27096770|P1|Overall Study|Pregnancy wish|0
7797187|NCT00511342|27096769|P2|Overall Study|Pregnancy|1
7797188|NCT00511342|27096770|P1|Overall Study|Pregnancy|0
7797189|NCT00511342|27096769|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
7797190|NCT00511342|27096770|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
7797191|NCT00511342|27096769|P2|Overall Study|Unacceptable vaginal bleeding|1
7797192|NCT00511342|27096770|P1|Overall Study|Unacceptable vaginal bleeding|2
7797193|NCT00511238|27096801|P2|Overall Study|various reasons|14
7797194|NCT00511238|27096802|P1|Overall Study|various reasons|4
7797195|NCT00511238|27096801|P2|Overall Study|Progressive Disease|157
7797196|NCT00511238|27096802|P1|Overall Study|Progressive Disease|23
7797197|NCT00511238|27096801|P2|Overall Study|Withdrawal by Subject|22
7797198|NCT00511238|27096802|P1|Overall Study|Withdrawal by Subject|2
7797199|NCT00511238|27096801|P2|Overall Study|Adverse Event|33
7797200|NCT00511238|27096802|P1|Overall Study|Adverse Event|13
7797201|NCT00511199|27096821|P2|Overall Study|Other Reason|37
7797202|NCT00511199|27096822|P1|Overall Study|Other Reason|78
7797203|NCT00511199|27096821|P2|Overall Study|Lost to Follow-up|17
7797204|NCT00511199|27096822|P1|Overall Study|Lost to Follow-up|40
7797205|NCT00511199|27096821|P2|Overall Study|Pregnancy Wish|8
7797206|NCT00511199|27096822|P1|Overall Study|Pregnancy Wish|16
7797207|NCT00511199|27096821|P2|Overall Study|Pregnancy|3
7797208|NCT00511199|27096822|P1|Overall Study|Pregnancy|6
7797209|NCT00511199|27096821|P2|Overall Study|Withdrawal of Informed Consent|4
7797210|NCT00511199|27096822|P1|Overall Study|Withdrawal of Informed Consent|19
7797211|NCT00511199|27096821|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
7797212|NCT00511199|27096822|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
7797213|NCT00511199|27096821|P2|Overall Study|Unacceptable Vaginal Bleeding|4
7797214|NCT00511199|27096822|P1|Overall Study|Unacceptable Vaginal Bleeding|63
7797215|NCT00511147|27096851|P1|Overall Study|Required platelet transfusion|1
7797216|NCT00511147|27096851|P1|Overall Study|Disease progression|5
7797217|NCT00511147|27096851|P1|Overall Study|Withdrawal by Subject|1
7797218|NCT00511134|27096860|P2|Overall Study|Withdrawal by Subject|2
7797219|NCT00511134|27096861|P1|Overall Study|Withdrawal by Subject|0
7797220|NCT00511108|27096873|P4|Overall Study|Withdrawal by Subject|2
7797221|NCT00511108|27096874|P3|Overall Study|Withdrawal by Subject|3
7797222|NCT00511108|27096875|P2|Overall Study|Withdrawal by Subject|0
7797223|NCT00511108|27096876|P1|Overall Study|Withdrawal by Subject|4
7797224|NCT00511108|27096873|P4|Overall Study|Physician Decision|1
7797225|NCT00511108|27096874|P3|Overall Study|Physician Decision|0
7797226|NCT00511108|27096875|P2|Overall Study|Physician Decision|0
7797227|NCT00511108|27096876|P1|Overall Study|Physician Decision|0
7797228|NCT00511108|27096873|P4|Overall Study|Lost to Follow-up|0
7797229|NCT00511108|27096874|P3|Overall Study|Lost to Follow-up|1
7797230|NCT00511108|27096875|P2|Overall Study|Lost to Follow-up|2
7797231|NCT00511108|27096876|P1|Overall Study|Lost to Follow-up|0
7797232|NCT00511108|27096873|P4|Overall Study|Adverse Event|2
7797233|NCT00511108|27096874|P3|Overall Study|Adverse Event|1
7797234|NCT00511108|27096875|P2|Overall Study|Adverse Event|0
7797235|NCT00511108|27096876|P1|Overall Study|Adverse Event|2
7797236|NCT00511004|27096907|P3|Overall Study|Lost to Follow-up|4
7797237|NCT00511004|27096908|P2|Overall Study|Lost to Follow-up|0
7797238|NCT00511004|27096909|P1|Overall Study|Lost to Follow-up|0
7797239|NCT00510952|27096928|P2|Overall Study|Did Not Receive Study Drug|0
7797240|NCT00510952|27096929|P1|Overall Study|Did Not Receive Study Drug|2
7797241|NCT00510952|27096928|P2|Overall Study|Withdrawal by Subject|7
7797242|NCT00510952|27096929|P1|Overall Study|Withdrawal by Subject|6
7797243|NCT00510952|27096928|P2|Overall Study|Sponsor Decision|0
7797244|NCT00510952|27096929|P1|Overall Study|Sponsor Decision|1
7797245|NCT00510952|27096928|P2|Overall Study|Protocol Violation|4
7797246|NCT00510952|27096929|P1|Overall Study|Protocol Violation|7
7797247|NCT00510952|27096928|P2|Overall Study|Physician Decision|1
7797248|NCT00510952|27096929|P1|Overall Study|Physician Decision|1
7797249|NCT00510952|27096928|P2|Overall Study|Lost to Follow-up|3
7797250|NCT00510952|27096929|P1|Overall Study|Lost to Follow-up|5
7797251|NCT00510952|27096928|P2|Overall Study|Entry Criteria Not Met|1
7797252|NCT00510952|27096929|P1|Overall Study|Entry Criteria Not Met|3
7797253|NCT00510952|27096928|P2|Overall Study|Adverse Event|0
7797254|NCT00510952|27096929|P1|Overall Study|Adverse Event|1
7797255|NCT00510887|27096955|P1|Overall Study|Lost to Follow-up|1
7797256|NCT00510874|27096971|P7|Overall Study|Lost to Follow-up|1
7797257|NCT00510874|27096972|P6|Overall Study|Lost to Follow-up|0
7797258|NCT00510874|27096973|P5|Overall Study|Lost to Follow-up|4
7797259|NCT00510874|27096974|P4|Overall Study|Lost to Follow-up|3
7797260|NCT00510874|27096975|P3|Overall Study|Lost to Follow-up|1
7797261|NCT00510874|27096976|P2|Overall Study|Lost to Follow-up|3
7797262|NCT00510874|27096977|P1|Overall Study|Lost to Follow-up|2
7797263|NCT00510874|27096971|P7|Overall Study|Withdrawal by Subject|0
7797264|NCT00510874|27096972|P6|Overall Study|Withdrawal by Subject|0
7797265|NCT00510874|27096973|P5|Overall Study|Withdrawal by Subject|3
7797266|NCT00510874|27096974|P4|Overall Study|Withdrawal by Subject|0
7797267|NCT00510874|27096975|P3|Overall Study|Withdrawal by Subject|0
7797268|NCT00510874|27096976|P2|Overall Study|Withdrawal by Subject|1
7797269|NCT00510874|27096977|P1|Overall Study|Withdrawal by Subject|1
7797270|NCT00510835|27097080|P3|Overall Study|Withdrawal by Subject|2
7797271|NCT00510835|27097081|P2|Overall Study|Withdrawal by Subject|2
7797272|NCT00510835|27097082|P1|Overall Study|Withdrawal by Subject|6
7797273|NCT00510783|27097108|P2|Overall Study|Protocol Violation|1
7797274|NCT00510783|27097109|P1|Overall Study|Protocol Violation|0
7797275|NCT00510783|27097108|P2|Overall Study|Withdrawal by Subject|3
7797276|NCT00510783|27097109|P1|Overall Study|Withdrawal by Subject|2
7797277|NCT00510783|27097108|P2|Overall Study|Lost to Follow-up|25
7797278|NCT00510783|27097109|P1|Overall Study|Lost to Follow-up|29
7797279|NCT00510718|27097126|P2|Multiple Dose Period: 12 Weeks|Other|1
7797280|NCT00510718|27097127|P1|Multiple Dose Period: 12 Weeks|Other|1
7797281|NCT00510718|27097126|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
7797282|NCT00510718|27097127|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
7797283|NCT00510718|27097126|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
7797284|NCT00510718|27097127|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
7797285|NCT00510718|27097126|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
7797286|NCT00510718|27097127|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
7797287|NCT00510718|27097126|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
7797288|NCT00510718|27097127|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
7797289|NCT00510718|27097126|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
7797290|NCT00510718|27097127|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
7797291|NCT00510692|27097253|P2|Overall Study|Withdrawal by Subject|0
7797292|NCT00510692|27097254|P1|Overall Study|Withdrawal by Subject|1
7797293|NCT00510692|27097253|P2|Overall Study|Adverse Event|3
7797294|NCT00510692|27097254|P1|Overall Study|Adverse Event|1
7797295|NCT00510653|27097268|P1|Overall Study|Monetary|3
7797296|NCT00510653|27097268|P1|Overall Study|Withdrawal by Subject|8
7797297|NCT00510510|27097275|P3|Overall Study|Protocol Violation|4
7797298|NCT00510510|27097276|P2|Overall Study|Protocol Violation|3
7797299|NCT00510510|27097277|P1|Overall Study|Protocol Violation|0
7797300|NCT00510510|27097275|P3|Overall Study|Lost to Follow-up|1
7797301|NCT00510510|27097276|P2|Overall Study|Lost to Follow-up|0
7797302|NCT00510510|27097277|P1|Overall Study|Lost to Follow-up|0
7797303|NCT00510510|27097275|P3|Overall Study|Withdrawal by Subject|3
7797304|NCT00510510|27097276|P2|Overall Study|Withdrawal by Subject|2
7797305|NCT00510510|27097277|P1|Overall Study|Withdrawal by Subject|1
7797306|NCT00510510|27097275|P3|Overall Study|Subjects no longer requires study drug|2
7797307|NCT00510510|27097276|P2|Overall Study|Subjects no longer requires study drug|0
7797308|NCT00510510|27097277|P1|Overall Study|Subjects no longer requires study drug|0
7797309|NCT00510510|27097275|P3|Overall Study|Lack of Efficacy|1
7797310|NCT00510510|27097276|P2|Overall Study|Lack of Efficacy|1
7797311|NCT00510510|27097277|P1|Overall Study|Lack of Efficacy|0
7797312|NCT00510510|27097275|P3|Overall Study|Adverse Event|6
7797313|NCT00510510|27097276|P2|Overall Study|Adverse Event|3
7797314|NCT00510510|27097277|P1|Overall Study|Adverse Event|4
7797315|NCT00510484|27097295|P2|Wash-out Period|Adverse Event|1
7797316|NCT00510484|27097296|P1|Wash-out Period|Adverse Event|0
7797317|NCT00510458|27097316|P1|Overall Study|Revision|2
7797318|NCT00510458|27097316|P1|Overall Study|Withdrawal by Subject|3
7797319|NCT00510458|27097316|P1|Overall Study|Lost to Follow-up|6
7797320|NCT00510458|27097316|P1|Overall Study|Terminated|14
7797321|NCT00510458|27097316|P1|Overall Study|Death|1
7797322|NCT00510458|27097316|P1|Overall Study|5 year not evaluable/missed|21
7797323|NCT00510289|27097329|P1|Overall Study|Progressed prior to starting drug|2
7797324|NCT00510289|27097329|P1|Overall Study|Lost to Follow-up|1
7797325|NCT00510289|27097329|P1|Overall Study|Refused bone marrow biopsy|2
7797326|NCT00510289|27097329|P1|Overall Study|Withdrawal by Subject|7
7797327|NCT00510276|27097339|P2|Extension Open-Label Phase|Subject Decision|9
7797328|NCT00510276|27097340|P1|Extension Open-Label Phase|Subject Decision|7
7797329|NCT00510276|27097339|P2|Extension Open-Label Phase|Sponsor Decision|0
7797330|NCT00510276|27097340|P1|Extension Open-Label Phase|Sponsor Decision|1
7797331|NCT00510276|27097339|P2|Extension Open-Label Phase|Protocol Violation|1
7797332|NCT00510276|27097340|P1|Extension Open-Label Phase|Protocol Violation|0
7797333|NCT00510276|27097339|P2|Extension Open-Label Phase|Physician Decision|3
7797334|NCT00510276|27097340|P1|Extension Open-Label Phase|Physician Decision|2
7797335|NCT00510276|27097339|P2|Extension Open-Label Phase|Lost to Follow-up|10
7797336|NCT00510276|27097340|P1|Extension Open-Label Phase|Lost to Follow-up|12
7797337|NCT00510276|27097339|P2|Extension Open-Label Phase|Lack of Efficacy|7
7797338|NCT00510276|27097340|P1|Extension Open-Label Phase|Lack of Efficacy|2
7797339|NCT00510276|27097339|P2|Extension Open-Label Phase|Adverse Event|18
7797340|NCT00510276|27097340|P1|Extension Open-Label Phase|Adverse Event|9
7797341|NCT00510276|27097339|P2|Acute Double-Blind Phase|Subject Decision|28
7797342|NCT00510276|27097340|P1|Acute Double-Blind Phase|Subject Decision|26
7797343|NCT00510276|27097339|P2|Acute Double-Blind Phase|Sponsor Decision|1
7797344|NCT00510276|27097340|P1|Acute Double-Blind Phase|Sponsor Decision|2
7797345|NCT00510276|27097339|P2|Acute Double-Blind Phase|Protocol Violation|3
7797346|NCT00510276|27097340|P1|Acute Double-Blind Phase|Protocol Violation|4
7797347|NCT00510276|27097339|P2|Acute Double-Blind Phase|Physician Decision|3
7797348|NCT00510276|27097340|P1|Acute Double-Blind Phase|Physician Decision|0
7797349|NCT00510276|27097339|P2|Acute Double-Blind Phase|Lost to Follow-up|49
7797350|NCT00510276|27097340|P1|Acute Double-Blind Phase|Lost to Follow-up|48
7797351|NCT00510276|27097339|P2|Acute Double-Blind Phase|Lack of Efficacy|4
7797352|NCT00510276|27097340|P1|Acute Double-Blind Phase|Lack of Efficacy|3
7797353|NCT00510276|27097339|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
7797354|NCT00510276|27097340|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
7797355|NCT00510276|27097339|P2|Acute Double-Blind Phase|Adverse Event|6
7797356|NCT00510276|27097340|P1|Acute Double-Blind Phase|Adverse Event|21
7797357|NCT00510198|27097434|P2|Overall Study|Withdrawal by Subject|4
7797358|NCT00510198|27097435|P1|Overall Study|Withdrawal by Subject|5
7797359|NCT00510146|27097449|P2|Open-Label Treatment|Sponsor Decision|0
7797360|NCT00510146|27097450|P1|Open-Label Treatment|Sponsor Decision|2
7797361|NCT00510146|27097449|P2|Open-Label Treatment|Clinical Relapse|1
7797362|NCT00510146|27097450|P1|Open-Label Treatment|Clinical Relapse|1
7797363|NCT00510146|27097449|P2|Open-Label Treatment|Withdrawal by Subject|12
7797364|NCT00510146|27097450|P1|Open-Label Treatment|Withdrawal by Subject|24
7797365|NCT00510146|27097449|P2|Open-Label Treatment|Protocol Violation|2
7797366|NCT00510146|27097450|P1|Open-Label Treatment|Protocol Violation|4
7797367|NCT00510146|27097449|P2|Open-Label Treatment|Physician Decision|1
7797368|NCT00510146|27097450|P1|Open-Label Treatment|Physician Decision|3
7797369|NCT00510146|27097449|P2|Open-Label Treatment|Lost to Follow-up|1
7797370|NCT00510146|27097450|P1|Open-Label Treatment|Lost to Follow-up|10
7797371|NCT00510146|27097449|P2|Open-Label Treatment|Lack of Efficacy|0
7797372|NCT00510146|27097450|P1|Open-Label Treatment|Lack of Efficacy|4
7797373|NCT00510146|27097449|P2|Open-Label Treatment|Death|1
7797374|NCT00510146|27097450|P1|Open-Label Treatment|Death|1
7797375|NCT00510146|27097449|P2|Open-Label Treatment|Adverse Event|8
7797376|NCT00510146|27097450|P1|Open-Label Treatment|Adverse Event|22
7797377|NCT00510146|27097449|P2|Double-Blind Treatment|Entry Criteria Not Met|0
7797378|NCT00510146|27097450|P1|Double-Blind Treatment|Entry Criteria Not Met|3
7797379|NCT00510146|27097449|P2|Double-Blind Treatment|Clinical Relapse|1
7797380|NCT00510146|27097450|P1|Double-Blind Treatment|Clinical Relapse|0
7797381|NCT00510146|27097449|P2|Double-Blind Treatment|Withdrawal by Subject|13
7797382|NCT00510146|27097450|P1|Double-Blind Treatment|Withdrawal by Subject|27
7797383|NCT00510146|27097449|P2|Double-Blind Treatment|Protocol Violation|2
7797384|NCT00510146|27097450|P1|Double-Blind Treatment|Protocol Violation|1
7797385|NCT00510146|27097449|P2|Double-Blind Treatment|Physician Decision|0
7797386|NCT00510146|27097450|P1|Double-Blind Treatment|Physician Decision|6
7797387|NCT00510146|27097449|P2|Double-Blind Treatment|Lost to Follow-up|7
7797388|NCT00510146|27097450|P1|Double-Blind Treatment|Lost to Follow-up|3
7797389|NCT00510146|27097449|P2|Double-Blind Treatment|Lack of Efficacy|13
7797390|NCT00510146|27097450|P1|Double-Blind Treatment|Lack of Efficacy|6
7797391|NCT00510146|27097449|P2|Double-Blind Treatment|Adverse Event|13
7797392|NCT00510146|27097450|P1|Double-Blind Treatment|Adverse Event|30
7797393|NCT00510068|27097539|P2|Open-label Period|Abnormal laboratory value (s)|0
7797394|NCT00510068|27097540|P1|Open-label Period|Abnormal laboratory value (s)|1
7797395|NCT00510068|27097539|P2|Open-label Period|Protocol Violation|0
7797396|NCT00510068|27097540|P1|Open-label Period|Protocol Violation|2
7797397|NCT00510068|27097539|P2|Open-label Period|New cancer therapy|0
7797398|NCT00510068|27097540|P1|Open-label Period|New cancer therapy|7
7797399|NCT00510068|27097539|P2|Open-label Period|Death|0
7797400|NCT00510068|27097540|P1|Open-label Period|Death|7
7797401|NCT00510068|27097539|P2|Open-label Period|Administrative problems|0
7797402|NCT00510068|27097540|P1|Open-label Period|Administrative problems|17
7797403|NCT00510068|27097539|P2|Open-label Period|Withdrawal by Subject|0
7797404|NCT00510068|27097540|P1|Open-label Period|Withdrawal by Subject|21
7797405|NCT00510068|27097539|P2|Open-label Period|Adverse Event|0
7797406|NCT00510068|27097540|P1|Open-label Period|Adverse Event|46
7797407|NCT00510068|27097539|P2|Open-label Period|Disease Progression|0
7797408|NCT00510068|27097540|P1|Open-label Period|Disease Progression|124
7797409|NCT00510068|27097539|P2|Double-blind Period|Protocol Violation|0
7797410|NCT00510068|27097540|P1|Double-blind Period|Protocol Violation|6
7797411|NCT00510068|27097539|P2|Double-blind Period|Lost to Follow-up|0
7797412|NCT00510068|27097540|P1|Double-blind Period|Lost to Follow-up|1
7797413|NCT00510068|27097539|P2|Double-blind Period|Abnormal test result (s)|0
7797414|NCT00510068|27097540|P1|Double-blind Period|Abnormal test result (s)|1
7797415|NCT00510068|27097539|P2|Double-blind Period|Death|3
7797416|NCT00510068|27097540|P1|Double-blind Period|Death|4
7797417|NCT00510068|27097539|P2|Double-blind Period|Withdrawal by Subject|6
7797418|NCT00510068|27097540|P1|Double-blind Period|Withdrawal by Subject|8
7797419|NCT00510068|27097539|P2|Double-blind Period|Adverse Event|7
7797420|NCT00510068|27097540|P1|Double-blind Period|Adverse Event|37
7797421|NCT00510068|27097539|P2|Double-blind Period|Final primary analysis|18
7797422|NCT00510068|27097540|P1|Double-blind Period|Final primary analysis|52
7797423|NCT00510068|27097539|P2|Double-blind Period|Disease progression|169
7797424|NCT00510068|27097540|P1|Double-blind Period|Disease progression|98
7797425|NCT00509925|27097581|P2|Overall Study|Personal reasons|1
7797426|NCT00509925|27097582|P1|Overall Study|Personal reasons|0
7797427|NCT00509899|27097630|P8|Overall Study|Lack of Efficacy|0
7797428|NCT00509899|27097631|P7|Overall Study|Lack of Efficacy|0
7797429|NCT00509899|27097632|P6|Overall Study|Lack of Efficacy|1
7797430|NCT00509899|27097633|P5|Overall Study|Lack of Efficacy|0
7797431|NCT00509899|27097634|P4|Overall Study|Lack of Efficacy|0
7797432|NCT00509899|27097635|P3|Overall Study|Lack of Efficacy|2
7797433|NCT00509899|27097636|P2|Overall Study|Lack of Efficacy|0
7797434|NCT00509899|27097637|P1|Overall Study|Lack of Efficacy|1
7797435|NCT00509899|27097630|P8|Overall Study|Death|1
7797436|NCT00509899|27097631|P7|Overall Study|Death|1
7797437|NCT00509899|27097632|P6|Overall Study|Death|1
7797438|NCT00509899|27097633|P5|Overall Study|Death|1
7797439|NCT00509899|27097634|P4|Overall Study|Death|0
7797440|NCT00509899|27097635|P3|Overall Study|Death|3
7797441|NCT00509899|27097636|P2|Overall Study|Death|2
7797442|NCT00509899|27097637|P1|Overall Study|Death|2
7797443|NCT00509899|27097630|P8|Overall Study|Intercurrent Illness|0
7797444|NCT00509899|27097631|P7|Overall Study|Intercurrent Illness|0
7797445|NCT00509899|27097632|P6|Overall Study|Intercurrent Illness|1
7797446|NCT00509899|27097633|P5|Overall Study|Intercurrent Illness|0
7797447|NCT00509899|27097634|P4|Overall Study|Intercurrent Illness|1
7797448|NCT00509899|27097635|P3|Overall Study|Intercurrent Illness|0
7797449|NCT00509899|27097636|P2|Overall Study|Intercurrent Illness|0
7797450|NCT00509899|27097637|P1|Overall Study|Intercurrent Illness|1
7797451|NCT00509899|27097630|P8|Overall Study|Physician Decision|0
7797452|NCT00509899|27097631|P7|Overall Study|Physician Decision|0
7797453|NCT00509899|27097632|P6|Overall Study|Physician Decision|4
7797454|NCT00509899|27097633|P5|Overall Study|Physician Decision|1
7797455|NCT00509899|27097634|P4|Overall Study|Physician Decision|0
7797456|NCT00509899|27097635|P3|Overall Study|Physician Decision|7
7797457|NCT00509899|27097636|P2|Overall Study|Physician Decision|2
7797458|NCT00509899|27097637|P1|Overall Study|Physician Decision|4
7797459|NCT00509899|27097630|P8|Overall Study|Withdrawal by Subject|0
7797460|NCT00509899|27097631|P7|Overall Study|Withdrawal by Subject|0
7797461|NCT00509899|27097632|P6|Overall Study|Withdrawal by Subject|2
7797462|NCT00509899|27097633|P5|Overall Study|Withdrawal by Subject|3
7797463|NCT00509899|27097634|P4|Overall Study|Withdrawal by Subject|0
7797464|NCT00509899|27097635|P3|Overall Study|Withdrawal by Subject|3
7797465|NCT00509899|27097636|P2|Overall Study|Withdrawal by Subject|2
7797466|NCT00509899|27097637|P1|Overall Study|Withdrawal by Subject|6
7797467|NCT00509899|27097630|P8|Overall Study|Unacceptable Toxicity|0
7797468|NCT00509899|27097631|P7|Overall Study|Unacceptable Toxicity|0
7797469|NCT00509899|27097632|P6|Overall Study|Unacceptable Toxicity|0
7797470|NCT00509899|27097633|P5|Overall Study|Unacceptable Toxicity|0
7797471|NCT00509899|27097634|P4|Overall Study|Unacceptable Toxicity|2
7797472|NCT00509899|27097635|P3|Overall Study|Unacceptable Toxicity|0
7797473|NCT00509899|27097636|P2|Overall Study|Unacceptable Toxicity|0
7797474|NCT00509899|27097637|P1|Overall Study|Unacceptable Toxicity|1
7797475|NCT00509899|27097630|P8|Overall Study|Progressive disease|0
7797476|NCT00509899|27097631|P7|Overall Study|Progressive disease|0
7797477|NCT00509899|27097632|P6|Overall Study|Progressive disease|1
7797478|NCT00509899|27097633|P5|Overall Study|Progressive disease|0
7797479|NCT00509899|27097634|P4|Overall Study|Progressive disease|1
7797480|NCT00509899|27097635|P3|Overall Study|Progressive disease|5
7797481|NCT00509899|27097636|P2|Overall Study|Progressive disease|3
7797482|NCT00509899|27097637|P1|Overall Study|Progressive disease|1
7797483|NCT00509821|27097694|P2|Study Period 1 (Induction)|Progressive Disease|1
7797484|NCT00509821|27097695|P1|Study Period 1 (Induction)|Progressive Disease|0
7797485|NCT00509821|27097694|P2|Study Period 1 (Induction)|Adverse Event|2
7797486|NCT00509821|27097695|P1|Study Period 1 (Induction)|Adverse Event|0
7797487|NCT00509821|27097694|P2|Study Period 1 (Induction)|Death|1
7797488|NCT00509821|27097695|P1|Study Period 1 (Induction)|Death|0
7797489|NCT00509795|27097713|P4|Overall Study|Withdrawal by Subject|8
7797490|NCT00509795|27097714|P3|Overall Study|Withdrawal by Subject|7
7797491|NCT00509795|27097715|P2|Overall Study|Withdrawal by Subject|5
7797492|NCT00509795|27097716|P1|Overall Study|Withdrawal by Subject|10
7797493|NCT00509795|27097713|P4|Overall Study|Protocol Violation|1
7797494|NCT00509795|27097714|P3|Overall Study|Protocol Violation|3
7797495|NCT00509795|27097715|P2|Overall Study|Protocol Violation|0
7797496|NCT00509795|27097716|P1|Overall Study|Protocol Violation|3
7797497|NCT00509795|27097713|P4|Overall Study|OTHER|1
7797498|NCT00509795|27097714|P3|Overall Study|OTHER|4
7797499|NCT00509795|27097715|P2|Overall Study|OTHER|0
7797500|NCT00509795|27097716|P1|Overall Study|OTHER|1
7797501|NCT00509795|27097713|P4|Overall Study|Lost to Follow-up|4
7797502|NCT00509795|27097714|P3|Overall Study|Lost to Follow-up|4
7797503|NCT00509795|27097715|P2|Overall Study|Lost to Follow-up|2
7797504|NCT00509795|27097716|P1|Overall Study|Lost to Follow-up|1
7797505|NCT00509795|27097713|P4|Overall Study|Lack of Efficacy|2
7797506|NCT00509795|27097714|P3|Overall Study|Lack of Efficacy|2
7797507|NCT00509795|27097715|P2|Overall Study|Lack of Efficacy|0
7797508|NCT00509795|27097716|P1|Overall Study|Lack of Efficacy|0
7797509|NCT00509795|27097713|P4|Overall Study|Death|7
7797510|NCT00509795|27097714|P3|Overall Study|Death|2
7797511|NCT00509795|27097715|P2|Overall Study|Death|1
7797512|NCT00509795|27097716|P1|Overall Study|Death|3
7797513|NCT00509795|27097713|P4|Overall Study|Adverse Event|4
7797514|NCT00509795|27097714|P3|Overall Study|Adverse Event|5
7797515|NCT00509795|27097715|P2|Overall Study|Adverse Event|3
7797516|NCT00509795|27097716|P1|Overall Study|Adverse Event|4
7797517|NCT00509769|27097747|P1|Overall Study|Use of prohibited therapies during study|1
7797518|NCT00509769|27097747|P1|Overall Study|Physician Decision|8
7797519|NCT00509769|27097747|P1|Overall Study|Patient's decision|1
7797520|NCT00509769|27097747|P1|Overall Study|Adverse Event|4
7797521|NCT00509769|27097747|P1|Overall Study|Progressive disease|77
7797522|NCT00509600|27097766|P1|Overall Study|Adverse Event|1
7797523|NCT00509366|27097845|P5|Overall Study|Not Treated (Screen Failure)|0
7797524|NCT00509366|27097846|P4|Overall Study|Not Treated (Screen Failure)|0
7797525|NCT00509366|27097847|P3|Overall Study|Not Treated (Screen Failure)|1
7797526|NCT00509366|27097848|P2|Overall Study|Not Treated (Screen Failure)|1
7797527|NCT00509366|27097849|P1|Overall Study|Not Treated (Screen Failure)|1
7797528|NCT00509262|27097873|P2|Overall Study|Withdrawal by Subject|11
7797529|NCT00509262|27097874|P1|Overall Study|Withdrawal by Subject|24
7797530|NCT00509262|27097873|P2|Overall Study|Protocol Violation|2
7797531|NCT00509262|27097874|P1|Overall Study|Protocol Violation|2
7797532|NCT00509262|27097873|P2|Overall Study|Physician Decision|3
7797533|NCT00509262|27097874|P1|Overall Study|Physician Decision|1
7797534|NCT00509262|27097873|P2|Overall Study|Lost to Follow-up|6
7797535|NCT00509262|27097874|P1|Overall Study|Lost to Follow-up|1
7797536|NCT00509262|27097873|P2|Overall Study|Lack of Efficacy|0
7797537|NCT00509262|27097874|P1|Overall Study|Lack of Efficacy|1
7797538|NCT00509262|27097873|P2|Overall Study|Other|2
7797539|NCT00509262|27097874|P1|Overall Study|Other|2
7797540|NCT00509262|27097873|P2|Overall Study|Adverse Event|18
7797541|NCT00509262|27097874|P1|Overall Study|Adverse Event|16
7797542|NCT00509236|27097892|P2|Overall Study|Scheduled Kidney Transplant|0
7797543|NCT00509236|27097893|P1|Overall Study|Scheduled Kidney Transplant|1
7797544|NCT00509236|27097892|P2|Overall Study|Excluded Medication|1
7797545|NCT00509236|27097893|P1|Overall Study|Excluded Medication|1
7797546|NCT00509236|27097892|P2|Overall Study|Protocol Violation|0
7797547|NCT00509236|27097893|P1|Overall Study|Protocol Violation|3
7797548|NCT00509236|27097892|P2|Overall Study|Withdrawal by Subject|10
7797549|NCT00509236|27097893|P1|Overall Study|Withdrawal by Subject|5
7797550|NCT00509236|27097892|P2|Overall Study|Adverse Event|9
7797551|NCT00509236|27097893|P1|Overall Study|Adverse Event|7
7797552|NCT00509223|27097908|P2|Overall Study|Did not meet revised inclusion criteria|62
7797553|NCT00509223|27097909|P1|Overall Study|Did not meet revised inclusion criteria|56
7797554|NCT00509223|27097908|P2|Overall Study|Including: subject change of address|2
7797555|NCT00509223|27097909|P1|Overall Study|Including: subject change of address|5
7797556|NCT00509223|27097908|P2|Overall Study|Withdrawal by Subject|6
7797557|NCT00509223|27097909|P1|Overall Study|Withdrawal by Subject|25
7797558|NCT00509223|27097908|P2|Overall Study|Adverse Event|1
7797559|NCT00509223|27097909|P1|Overall Study|Adverse Event|1
7797560|NCT00509223|27097908|P2|Overall Study|Lost to Follow-up|1
7797561|NCT00509223|27097909|P1|Overall Study|Lost to Follow-up|1
7797562|NCT00509106|27097941|P2|Overall Study|Death|6
7797563|NCT00509106|27097942|P1|Overall Study|Death|6
7797564|NCT00509106|27097941|P2|Overall Study|Other|0
7797565|NCT00509106|27097942|P1|Overall Study|Other|1
7797566|NCT00509106|27097941|P2|Overall Study|Lost to Follow-up|10
7797567|NCT00509106|27097942|P1|Overall Study|Lost to Follow-up|16
7797568|NCT00509106|27097941|P2|Overall Study|Withdrew consent|8
7797569|NCT00509106|27097942|P1|Overall Study|Withdrew consent|4
7797570|NCT00509106|27097941|P2|Overall Study|At the request of sponsor/investigator|2
7797571|NCT00509106|27097942|P1|Overall Study|At the request of sponsor/investigator|1
7797572|NCT00509106|27097941|P2|Overall Study|Noncompliance|1
7797573|NCT00509106|27097942|P1|Overall Study|Noncompliance|0
7797574|NCT00509106|27097941|P2|Overall Study|Adverse Event|2
7797575|NCT00509106|27097942|P1|Overall Study|Adverse Event|3
7797576|NCT00509093|27097948|P1|Overall Study|Physician Decision|1
7797577|NCT00509093|27097948|P1|Overall Study|Withdrawal by Subject|3
7797578|NCT00509093|27097948|P1|Overall Study|Transformed into MDS|1
7797579|NCT00509093|27097948|P1|Overall Study|Disease Progression|9
7797580|NCT00509093|27097948|P1|Overall Study|Adverse Event|10
7797581|NCT00509067|27097958|P2|Overall Study|Protocol Violation|3
7797582|NCT00509067|27097959|P1|Overall Study|Protocol Violation|0
7797583|NCT00509067|27097958|P2|Overall Study|Adverse Event|1
7797584|NCT00509067|27097959|P1|Overall Study|Adverse Event|3
7797585|NCT00509067|27097958|P2|Overall Study|Lost to Follow-up|1
7797586|NCT00509067|27097959|P1|Overall Study|Lost to Follow-up|1
7797587|NCT00509028|27097978|P2|Overall Study|Non-compliance|1
7797588|NCT00509028|27097979|P1|Overall Study|Non-compliance|2
7797589|NCT00509028|27097978|P2|Overall Study|Protocol Violation|2
7797590|NCT00509028|27097979|P1|Overall Study|Protocol Violation|4
7797591|NCT00509028|27097978|P2|Overall Study|Lost to Follow-up|1
7797592|NCT00509028|27097979|P1|Overall Study|Lost to Follow-up|0
7797593|NCT00509028|27097978|P2|Overall Study|Withdrawal by Subject|3
7797594|NCT00509028|27097979|P1|Overall Study|Withdrawal by Subject|4
7797595|NCT00509028|27097978|P2|Overall Study|Adverse Event|0
7797596|NCT00509028|27097979|P1|Overall Study|Adverse Event|2
7797597|NCT00508924|27098019|P4|Overall Study|Protocol Violation|1
7797598|NCT00508924|27098020|P3|Overall Study|Protocol Violation|1
7797599|NCT00508924|27098021|P2|Overall Study|Protocol Violation|0
7797600|NCT00508924|27098022|P1|Overall Study|Protocol Violation|0
7797601|NCT00508872|27098036|P1|Overall Study|Physician Decision|1
7797602|NCT00508872|27098036|P1|Overall Study|Lost to Follow-up|1
7797603|NCT00508820|27098042|P2|Overall Study|Protocol-specified Criteria|12
7797604|NCT00508820|27098043|P1|Overall Study|Protocol-specified Criteria|3
7797605|NCT00508820|27098042|P2|Overall Study|Requirement for alternative therapy|15
7797606|NCT00508820|27098043|P1|Overall Study|Requirement for alternative therapy|7
7797607|NCT00508820|27098042|P2|Overall Study|Noncompliance|0
7797608|NCT00508820|27098043|P1|Overall Study|Noncompliance|1
7797609|NCT00508820|27098042|P2|Overall Study|Other|2
7797610|NCT00508820|27098043|P1|Overall Study|Other|11
7797611|NCT00508820|27098042|P2|Overall Study|Withdrawal by Subject|12
7797612|NCT00508820|27098043|P1|Overall Study|Withdrawal by Subject|10
7797613|NCT00508820|27098042|P2|Overall Study|Protocol Violation|0
7797614|NCT00508820|27098043|P1|Overall Study|Protocol Violation|2
7797615|NCT00508820|27098042|P2|Overall Study|Pregnancy|2
7797616|NCT00508820|27098043|P1|Overall Study|Pregnancy|0
7797617|NCT00508820|27098042|P2|Overall Study|Physician Decision|2
7797618|NCT00508820|27098043|P1|Overall Study|Physician Decision|8
7797619|NCT00508820|27098042|P2|Overall Study|Lost to Follow-up|1
7797620|NCT00508820|27098043|P1|Overall Study|Lost to Follow-up|1
7797621|NCT00508820|27098042|P2|Overall Study|Death|8
7797622|NCT00508820|27098043|P1|Overall Study|Death|6
7797623|NCT00508820|27098042|P2|Overall Study|Adverse Event|10
7797624|NCT00508820|27098043|P1|Overall Study|Adverse Event|6
7797625|NCT00508755|27098053|P1|Overall Study|Withdrawal by Subject|1
7797626|NCT00508742|27098061|P2|Period 3: Toddler Dose|Other|4
7797627|NCT00508742|27098062|P1|Period 3: Toddler Dose|Other|5
7797628|NCT00508742|27098061|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
7797629|NCT00508742|27098062|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
7797630|NCT00508742|27098061|P2|Period 3: Toddler Dose|Lost to Follow-up|3
7797631|NCT00508742|27098062|P1|Period 3: Toddler Dose|Lost to Follow-up|2
7797632|NCT00508742|27098061|P2|Period 3: Toddler Dose|Adverse Event|0
7797633|NCT00508742|27098062|P1|Period 3: Toddler Dose|Adverse Event|1
7797634|NCT00508742|27098061|P2|Period 2: After Infant Series|Other|1
7797635|NCT00508742|27098062|P1|Period 2: After Infant Series|Other|2
7797636|NCT00508742|27098061|P2|Period 2: After Infant Series|Failed to Return|0
7797637|NCT00508742|27098062|P1|Period 2: After Infant Series|Failed to Return|1
7797638|NCT00508742|27098061|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
7797639|NCT00508742|27098062|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
7797640|NCT00508742|27098061|P2|Period 2: After Infant Series|Protocol Violation|0
7797641|NCT00508742|27098062|P1|Period 2: After Infant Series|Protocol Violation|1
7797642|NCT00508742|27098061|P2|Period 2: After Infant Series|Lost to Follow-up|1
7797643|NCT00508742|27098062|P1|Period 2: After Infant Series|Lost to Follow-up|1
7797644|NCT00508742|27098061|P2|Period 2: After Infant Series|Adverse Event|6
7797645|NCT00508742|27098062|P1|Period 2: After Infant Series|Adverse Event|2
7797646|NCT00508742|27098061|P2|Period 1: Infant Series|Other|1
7797647|NCT00508742|27098062|P1|Period 1: Infant Series|Other|4
7797648|NCT00508742|27098061|P2|Period 1: Infant Series|Physician Decision|0
7797649|NCT00508742|27098062|P1|Period 1: Infant Series|Physician Decision|1
7797650|NCT00508742|27098061|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
7797651|NCT00508742|27098062|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
7797652|NCT00508742|27098061|P2|Period 1: Infant Series|Protocol Violation|0
7797653|NCT00508742|27098062|P1|Period 1: Infant Series|Protocol Violation|1
7797654|NCT00508742|27098061|P2|Period 1: Infant Series|Adverse Event|4
7797655|NCT00508742|27098062|P1|Period 1: Infant Series|Adverse Event|5
7797656|NCT00508651|27098087|P2|Overall Study|Withdrawal by Subject|1
7797657|NCT00508651|27098088|P1|Overall Study|Withdrawal by Subject|1
7797658|NCT00508651|27098087|P2|Overall Study|Lost to Follow-up|1
7797659|NCT00508651|27098088|P1|Overall Study|Lost to Follow-up|3
7797660|NCT00508482|27098169|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
7797661|NCT00508482|27098170|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
7797662|NCT00508482|27098171|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
7797663|NCT00508482|27098169|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
7797664|NCT00508482|27098170|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
7797665|NCT00508482|27098171|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
7797666|NCT00508482|27098169|P3|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
7797667|NCT00508482|27098170|P2|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
7797668|NCT00508482|27098171|P1|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
7797669|NCT00508404|27098215|P1|Overall Study|Other - Not Specified|3
7797670|NCT00508404|27098215|P1|Overall Study|Lost to Follow-up|2
7797671|NCT00508404|27098215|P1|Overall Study|Protocol-specified Criteria|2
7797672|NCT00508404|27098215|P1|Overall Study|Withdrawal by Subject|3
7797673|NCT00508404|27098215|P1|Overall Study|Physician Decision|2
7797674|NCT00508404|27098215|P1|Overall Study|Death|16
7797675|NCT00508404|27098215|P1|Overall Study|Adverse Event|2
7797676|NCT00508404|27098215|P1|Overall Study|Ongoing at Data Cut-off|12
7797677|NCT00508391|27098242|P2|Second Treatment|Withdrawal by Subject|0
7797678|NCT00508391|27098243|P1|Second Treatment|Withdrawal by Subject|2
7797679|NCT00508391|27098242|P2|First Treatment|Withdrawal by Subject|3
7797680|NCT00508391|27098243|P1|First Treatment|Withdrawal by Subject|6
7797681|NCT00508274|27098263|P1|Overall Study|Missing|3
7797682|NCT00508274|27098263|P1|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
7797683|NCT00508274|27098263|P1|Overall Study|Withdrawal by Subject|1
7797684|NCT00508274|27098263|P1|Overall Study|Disease progression|32
7797685|NCT00508274|27098263|P1|Overall Study|Death|7
7797686|NCT00508274|27098263|P1|Overall Study|Adverse Event|5
7797687|NCT00508261|27098277|P4|Overall Study|Lost to Follow-up|1
7797688|NCT00508261|27098278|P3|Overall Study|Lost to Follow-up|1
7797689|NCT00508261|27098279|P2|Overall Study|Lost to Follow-up|1
7797690|NCT00508261|27098280|P1|Overall Study|Lost to Follow-up|0
7797691|NCT00508261|27098277|P4|Overall Study|Migrated/ moved from study area|0
7797692|NCT00508261|27098278|P3|Overall Study|Migrated/ moved from study area|0
7797693|NCT00508261|27098279|P2|Overall Study|Migrated/ moved from study area|1
7797694|NCT00508261|27098280|P1|Overall Study|Migrated/ moved from study area|0
7797695|NCT00508261|27098277|P4|Overall Study|Withdrawal by Subject|0
7797696|NCT00508261|27098278|P3|Overall Study|Withdrawal by Subject|4
7797697|NCT00508261|27098279|P2|Overall Study|Withdrawal by Subject|4
7797698|NCT00508261|27098280|P1|Overall Study|Withdrawal by Subject|3
7797699|NCT00508261|27098277|P4|Overall Study|Serious Adverse Event|0
7797700|NCT00508261|27098278|P3|Overall Study|Serious Adverse Event|0
7797701|NCT00508261|27098279|P2|Overall Study|Serious Adverse Event|1
7797702|NCT00508261|27098280|P1|Overall Study|Serious Adverse Event|0
7797703|NCT00508261|27098277|P4|Overall Study|Other|0
7797704|NCT00508261|27098278|P3|Overall Study|Other|1
7797705|NCT00508261|27098279|P2|Overall Study|Other|1
7797706|NCT00508261|27098280|P1|Overall Study|Other|0
7797707|NCT00508157|27098420|P2|Overall Study|Other known cause|1
7797708|NCT00508157|27098421|P1|Overall Study|Other known cause|0
7797709|NCT00508157|27098420|P2|Overall Study|Subject no longer met study criteria|1
7797710|NCT00508157|27098421|P1|Overall Study|Subject no longer met study criteria|0
7797711|NCT00508157|27098420|P2|Overall Study|Lost to Follow-up|0
7797712|NCT00508157|27098421|P1|Overall Study|Lost to Follow-up|1
7797713|NCT00508157|27098420|P2|Overall Study|Subject Withdrew Consent|0
7797714|NCT00508157|27098421|P1|Overall Study|Subject Withdrew Consent|1
7797715|NCT00508157|27098420|P2|Overall Study|Adverse Event|1
7797716|NCT00508157|27098421|P1|Overall Study|Adverse Event|0
7797717|NCT00508144|27098443|P1|Overall Study|Death|5
7797718|NCT00508144|27098443|P1|Overall Study|Not eligible|6
7797719|NCT00508027|27098482|P1|Dose Level 2|Withdrawal by Subject|2
7797720|NCT00508027|27098482|P1|Dose Level 2|Lost to Follow-up|2
7797721|NCT00508027|27098482|P1|Dose Level 1|Physician Decision|2
7797722|NCT00508027|27098482|P1|Dose Level 1|Withdrawal by Subject|2
7797723|NCT00508027|27098482|P1|Dose Level 1|Lost to Follow-up|4
7797724|NCT00508001|27098523|P3|Overall Study|Withdrawal by Subject|1
7797725|NCT00508001|27098524|P2|Overall Study|Withdrawal by Subject|4
7797726|NCT00508001|27098525|P1|Overall Study|Withdrawal by Subject|4
7797727|NCT00508001|27098523|P3|Overall Study|Death|1
7797728|NCT00508001|27098524|P2|Overall Study|Death|1
7797729|NCT00508001|27098525|P1|Overall Study|Death|0
7797730|NCT00508001|27098523|P3|Overall Study|condition under investigation worsened|1
7797731|NCT00508001|27098524|P2|Overall Study|condition under investigation worsened|7
7797732|NCT00508001|27098525|P1|Overall Study|condition under investigation worsened|13
7797733|NCT00508001|27098523|P3|Overall Study|Adverse Event|4
7797734|NCT00508001|27098524|P2|Overall Study|Adverse Event|0
7797735|NCT00508001|27098525|P1|Overall Study|Adverse Event|2
7797736|NCT00507819|27098542|P2|Washout (6 Weeks)|Withdrawal by Subject|0
7797737|NCT00507819|27098543|P1|Washout (6 Weeks)|Withdrawal by Subject|1
7797738|NCT00507728|27098562|P3|From 3 Months to 6 Months|Lost to Follow-up|9
7797739|NCT00507728|27098563|P2|From 3 Months to 6 Months|Lost to Follow-up|10
7797740|NCT00507728|27098564|P1|From 3 Months to 6 Months|Lost to Follow-up|6
7797741|NCT00507728|27098562|P3|Randomization to Month 3|Lost to Follow-up|20
7797742|NCT00507728|27098563|P2|Randomization to Month 3|Lost to Follow-up|14
7797743|NCT00507728|27098564|P1|Randomization to Month 3|Lost to Follow-up|15
7797744|NCT00507689|27098635|P2|Randomized Period|Withdrawal by Subject|1
7797745|NCT00507689|27098636|P1|Randomized Period|Withdrawal by Subject|0
7797746|NCT00507689|27098635|P2|Randomized Period|Adverse Event|1
7797747|NCT00507689|27098636|P1|Randomized Period|Adverse Event|1
7797748|NCT00507689|27098635|P2|Pre-Randomization Period|Withdrawal by Subject|0
7797749|NCT00507689|27098636|P1|Pre-Randomization Period|Withdrawal by Subject|1
7797750|NCT00507689|27098635|P2|Pre-Randomization Period|Physician Decision|0
7797751|NCT00507689|27098636|P1|Pre-Randomization Period|Physician Decision|1
7797752|NCT00507689|27098635|P2|Pre-Randomization Period|Adverse Event|0
7797753|NCT00507689|27098636|P1|Pre-Randomization Period|Adverse Event|1
7797754|NCT00507546|27098668|P2|Overall Study|Physician Decision|1
7797755|NCT00507546|27098669|P1|Overall Study|Physician Decision|0
7797756|NCT00507546|27098668|P2|Overall Study|Protocol Violation|0
7797757|NCT00507546|27098669|P1|Overall Study|Protocol Violation|1
7797758|NCT00507546|27098668|P2|Overall Study|Withdrawal by Subject|0
7797759|NCT00507546|27098669|P1|Overall Study|Withdrawal by Subject|1
7797760|NCT00507507|27098679|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
7797761|NCT00507507|27098680|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
7797762|NCT00507507|27098679|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
7797763|NCT00507507|27098680|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
7797764|NCT00507507|27098679|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
7797765|NCT00507507|27098680|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
7797766|NCT00507507|27098679|P2|Treatment Period|Withdrawal by Subject|47
7797767|NCT00507507|27098680|P1|Treatment Period|Withdrawal by Subject|46
7797768|NCT00507507|27098679|P2|Treatment Period|Adverse Event|1
7797769|NCT00507507|27098680|P1|Treatment Period|Adverse Event|1
7797770|NCT00507507|27098679|P2|Treatment Period|Protocol Violation|2
7797771|NCT00507507|27098680|P1|Treatment Period|Protocol Violation|1
7797772|NCT00507507|27098679|P2|Treatment Period|Physician Decision|1
7797773|NCT00507507|27098680|P1|Treatment Period|Physician Decision|4
7797774|NCT00507507|27098679|P2|Treatment Period|Lost to Follow-up|2
7797775|NCT00507507|27098680|P1|Treatment Period|Lost to Follow-up|0
7797776|NCT00507455|27098715|P3|Overall Study|Other - miscellaneous reason|1
7797777|NCT00507455|27098716|P2|Overall Study|Other - miscellaneous reason|0
7797778|NCT00507455|27098717|P1|Overall Study|Other - miscellaneous reason|1
7797779|NCT00507455|27098715|P3|Overall Study|Lack of Efficacy|0
7797780|NCT00507455|27098716|P2|Overall Study|Lack of Efficacy|1
7797781|NCT00507455|27098717|P1|Overall Study|Lack of Efficacy|0
7797782|NCT00507455|27098715|P3|Overall Study|Lost to Follow-up|2
7797783|NCT00507455|27098716|P2|Overall Study|Lost to Follow-up|0
7797784|NCT00507455|27098717|P1|Overall Study|Lost to Follow-up|2
7797785|NCT00507455|27098715|P3|Overall Study|Protocol Violation|1
7797786|NCT00507455|27098716|P2|Overall Study|Protocol Violation|1
7797787|NCT00507455|27098717|P1|Overall Study|Protocol Violation|4
7797788|NCT00507455|27098715|P3|Overall Study|Withdrawal by Subject|2
7797789|NCT00507455|27098716|P2|Overall Study|Withdrawal by Subject|1
7797790|NCT00507455|27098717|P1|Overall Study|Withdrawal by Subject|2
7797791|NCT00507455|27098715|P3|Overall Study|Adverse Event|6
7797792|NCT00507455|27098716|P2|Overall Study|Adverse Event|3
7797793|NCT00507455|27098717|P1|Overall Study|Adverse Event|3
7797794|NCT00507442|27098780|P4|Overall Study|Other|2
7797795|NCT00507442|27098781|P3|Overall Study|Other|2
7797796|NCT00507442|27098782|P2|Overall Study|Other|5
7797797|NCT00507442|27098783|P1|Overall Study|Other|2
7797798|NCT00507442|27098780|P4|Overall Study|Withdrawal by Subject|1
7797799|NCT00507442|27098781|P3|Overall Study|Withdrawal by Subject|2
7797800|NCT00507442|27098782|P2|Overall Study|Withdrawal by Subject|4
7797801|NCT00507442|27098783|P1|Overall Study|Withdrawal by Subject|4
7797802|NCT00507442|27098780|P4|Overall Study|Progressive Disease|0
7797803|NCT00507442|27098781|P3|Overall Study|Progressive Disease|2
7797804|NCT00507442|27098782|P2|Overall Study|Progressive Disease|4
7797805|NCT00507442|27098783|P1|Overall Study|Progressive Disease|2
7797806|NCT00507442|27098780|P4|Overall Study|Physician Decision|1
7797807|NCT00507442|27098781|P3|Overall Study|Physician Decision|4
7797808|NCT00507442|27098782|P2|Overall Study|Physician Decision|2
7797809|NCT00507442|27098783|P1|Overall Study|Physician Decision|0
7797810|NCT00507442|27098780|P4|Overall Study|Lost to Follow-up|0
7797811|NCT00507442|27098781|P3|Overall Study|Lost to Follow-up|1
7797812|NCT00507442|27098782|P2|Overall Study|Lost to Follow-up|0
7797813|NCT00507442|27098783|P1|Overall Study|Lost to Follow-up|0
7797814|NCT00507442|27098780|P4|Overall Study|Protocol Violation|0
7797815|NCT00507442|27098781|P3|Overall Study|Protocol Violation|0
7797816|NCT00507442|27098782|P2|Overall Study|Protocol Violation|1
7797817|NCT00507442|27098783|P1|Overall Study|Protocol Violation|0
7797818|NCT00507442|27098780|P4|Overall Study|Adverse Event|1
7797819|NCT00507442|27098781|P3|Overall Study|Adverse Event|4
7797820|NCT00507442|27098782|P2|Overall Study|Adverse Event|11
7797821|NCT00507442|27098783|P1|Overall Study|Adverse Event|8
7797822|NCT00507429|27098835|P2|Maintenance Phase|Progressive Disease|0
7797823|NCT00507429|27098836|P1|Maintenance Phase|Progressive Disease|14
7797824|NCT00507429|27098835|P2|Treatment Phase|Other|3
7797825|NCT00507429|27098836|P1|Treatment Phase|Other|6
7797826|NCT00507429|27098835|P2|Treatment Phase|Physician Decision|2
7797827|NCT00507429|27098836|P1|Treatment Phase|Physician Decision|4
7797828|NCT00507429|27098835|P2|Treatment Phase|Withdrawal by Subject|3
7797829|NCT00507429|27098836|P1|Treatment Phase|Withdrawal by Subject|3
7797830|NCT00507429|27098835|P2|Treatment Phase|Adverse Event|5
7797831|NCT00507429|27098836|P1|Treatment Phase|Adverse Event|12
7797832|NCT00507429|27098835|P2|Treatment Phase|Disease Progression|5
7797833|NCT00507429|27098836|P1|Treatment Phase|Disease Progression|12
7797834|NCT00507416|27098847|P3|Overall Study|Did not Receive Study Treatment|4
7797835|NCT00507416|27098848|P2|Overall Study|Did not Receive Study Treatment|9
7797836|NCT00507416|27098849|P1|Overall Study|Did not Receive Study Treatment|3
7797837|NCT00507416|27098847|P3|Overall Study|Other|13
7797838|NCT00507416|27098848|P2|Overall Study|Other|16
7797839|NCT00507416|27098849|P1|Overall Study|Other|11
7797840|NCT00507416|27098847|P3|Overall Study|Patient declined further treatment|11
7797841|NCT00507416|27098848|P2|Overall Study|Patient declined further treatment|14
7797842|NCT00507416|27098849|P1|Overall Study|Patient declined further treatment|18
7797843|NCT00507416|27098847|P3|Overall Study|Progressive Disease|13
7797844|NCT00507416|27098848|P2|Overall Study|Progressive Disease|10
7797845|NCT00507416|27098849|P1|Overall Study|Progressive Disease|20
7797846|NCT00507416|27098847|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
7797847|NCT00507416|27098848|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
7797848|NCT00507416|27098849|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
7797849|NCT00507416|27098847|P3|Overall Study|Protocol Violation|0
7797850|NCT00507416|27098848|P2|Overall Study|Protocol Violation|2
7797851|NCT00507416|27098849|P1|Overall Study|Protocol Violation|1
7797852|NCT00507416|27098847|P3|Overall Study|Adverse Event|65
7797853|NCT00507416|27098848|P2|Overall Study|Adverse Event|67
7797854|NCT00507416|27098849|P1|Overall Study|Adverse Event|58
7797855|NCT00507130|27098891|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7797856|NCT00507130|27098892|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7797857|NCT00507130|27098893|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7797858|NCT00507130|27098894|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
7797859|NCT00507130|27098891|P4|Overall Study|Lost to Follow-up|1
7797860|NCT00507130|27098892|P3|Overall Study|Lost to Follow-up|1
7797861|NCT00507130|27098893|P2|Overall Study|Lost to Follow-up|0
7797862|NCT00507130|27098894|P1|Overall Study|Lost to Follow-up|0
7797863|NCT00506948|27098936|P1|Overall Study|Physician Decision|1
7797864|NCT00506948|27098936|P1|Overall Study|Adverse Event|5
7797865|NCT00506948|27098936|P1|Overall Study|Death|4
7797866|NCT00506922|27098945|P5|Overall Study|Withdrawal by Subject|1
7797867|NCT00506922|27098946|P4|Overall Study|Withdrawal by Subject|0
7797868|NCT00506922|27098947|P3|Overall Study|Withdrawal by Subject|0
7797869|NCT00506922|27098948|P2|Overall Study|Withdrawal by Subject|0
7797870|NCT00506922|27098949|P1|Overall Study|Withdrawal by Subject|0
7797871|NCT00506922|27098945|P5|Overall Study|Physician Decision|0
7797872|NCT00506922|27098946|P4|Overall Study|Physician Decision|2
7797873|NCT00506922|27098947|P3|Overall Study|Physician Decision|0
7797874|NCT00506922|27098948|P2|Overall Study|Physician Decision|0
7797875|NCT00506922|27098949|P1|Overall Study|Physician Decision|0
7797876|NCT00506883|27098976|P3|Overall Study|Other|1
7797877|NCT00506883|27098977|P2|Overall Study|Other|1
7797878|NCT00506883|27098978|P1|Overall Study|Other|5
7797879|NCT00506883|27098976|P3|Overall Study|Lack of Efficacy|1
7797880|NCT00506883|27098977|P2|Overall Study|Lack of Efficacy|1
7797881|NCT00506883|27098978|P1|Overall Study|Lack of Efficacy|0
7797882|NCT00506883|27098976|P3|Overall Study|Withdrawal by Subject|1
7797883|NCT00506883|27098977|P2|Overall Study|Withdrawal by Subject|0
7797884|NCT00506883|27098978|P1|Overall Study|Withdrawal by Subject|1
7797885|NCT00506883|27098976|P3|Overall Study|Lost to Follow-up|1
7797886|NCT00506883|27098977|P2|Overall Study|Lost to Follow-up|1
7797887|NCT00506883|27098978|P1|Overall Study|Lost to Follow-up|1
7797888|NCT00506831|27098991|P1|Overall Study|Withdrawal by Subject|1
7797889|NCT00506831|27098991|P1|Overall Study|Death|1
7797890|NCT00506779|27099004|P4|Overall Study|Adverse Event|1
7797891|NCT00506779|27099005|P3|Overall Study|Adverse Event|1
7797892|NCT00506779|27099006|P2|Overall Study|Adverse Event|1
7797893|NCT00506779|27099007|P1|Overall Study|Adverse Event|0
7797894|NCT00506779|27099004|P4|Overall Study|Withdrawal by Subject|0
7797895|NCT00506779|27099005|P3|Overall Study|Withdrawal by Subject|1
7797896|NCT00506779|27099006|P2|Overall Study|Withdrawal by Subject|0
7797897|NCT00506779|27099007|P1|Overall Study|Withdrawal by Subject|1
7797898|NCT00506753|27099022|P2|Overall Study|Lost to Follow-up|15
7797899|NCT00506753|27099023|P1|Overall Study|Lost to Follow-up|21
7797900|NCT00506662|27099061|P2|Overall Study|Not recorded|6
7797901|NCT00506662|27099062|P1|Overall Study|Not recorded|4
7797902|NCT00506662|27099061|P2|Overall Study|Trial terminated|16
7797903|NCT00506662|27099062|P1|Overall Study|Trial terminated|10
7797904|NCT00506662|27099061|P2|Overall Study|Protocol Violation|4
7797905|NCT00506662|27099062|P1|Overall Study|Protocol Violation|2
7797906|NCT00506662|27099061|P2|Overall Study|Lack of Efficacy|0
7797907|NCT00506662|27099062|P1|Overall Study|Lack of Efficacy|1
7797908|NCT00506662|27099061|P2|Overall Study|Adverse Event|2
7797909|NCT00506662|27099062|P1|Overall Study|Adverse Event|0
7797910|NCT00506519|27099099|P3|Overall Study|Adverse Event|0
7797911|NCT00506519|27099100|P2|Overall Study|Adverse Event|0
7797912|NCT00506519|27099101|P1|Overall Study|Adverse Event|1
7797913|NCT00506519|27099099|P3|Overall Study|Death|0
7797914|NCT00506519|27099100|P2|Overall Study|Death|6
7797915|NCT00506519|27099101|P1|Overall Study|Death|4
7797916|NCT00506493|27099142|P1|Overall Study|Withdrawal by Subject|5
7797917|NCT00506493|27099142|P1|Overall Study|Death|6
7797918|NCT00506454|27099151|P2|Overall Study|Withdrawal by Subject|1
7797919|NCT00506454|27099152|P1|Overall Study|Withdrawal by Subject|1
7797920|NCT00506441|27099158|P2|Period 2; Double-blind Period|Other Reason|1
7797921|NCT00506441|27099159|P1|Period 2; Double-blind Period|Other Reason|1
7797922|NCT00506441|27099158|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
7797923|NCT00506441|27099159|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
7797924|NCT00506441|27099158|P2|Period 2; Double-blind Period|Physician Decision|1
7797925|NCT00506441|27099159|P1|Period 2; Double-blind Period|Physician Decision|1
7797926|NCT00506441|27099158|P2|Period 2; Double-blind Period|Lack of Efficacy|2
7797927|NCT00506441|27099159|P1|Period 2; Double-blind Period|Lack of Efficacy|0
7797928|NCT00506441|27099158|P2|Period 2; Double-blind Period|Adverse Event|1
7797929|NCT00506441|27099159|P1|Period 2; Double-blind Period|Adverse Event|0
7797930|NCT00506441|27099158|P2|Period 1; Open-label Period|Other Reasons|0
7797931|NCT00506441|27099159|P1|Period 1; Open-label Period|Other Reasons|13
7797932|NCT00506441|27099158|P2|Period 1; Open-label Period|Withdrawal by Subject|0
7797933|NCT00506441|27099159|P1|Period 1; Open-label Period|Withdrawal by Subject|13
7797934|NCT00506441|27099158|P2|Period 1; Open-label Period|Protocol Violation|0
7797935|NCT00506441|27099159|P1|Period 1; Open-label Period|Protocol Violation|9
7797936|NCT00506441|27099158|P2|Period 1; Open-label Period|Physician Decision|0
7797937|NCT00506441|27099159|P1|Period 1; Open-label Period|Physician Decision|5
7797938|NCT00506441|27099158|P2|Period 1; Open-label Period|Lost to Follow-up|0
7797939|NCT00506441|27099159|P1|Period 1; Open-label Period|Lost to Follow-up|2
7797940|NCT00506441|27099158|P2|Period 1; Open-label Period|Lack of Efficacy|0
7797941|NCT00506441|27099159|P1|Period 1; Open-label Period|Lack of Efficacy|13
7797942|NCT00506441|27099158|P2|Period 1; Open-label Period|Adverse Event|0
7797943|NCT00506441|27099159|P1|Period 1; Open-label Period|Adverse Event|21
7797944|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
7797945|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
7797946|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
7797947|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
7797948|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
7797949|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7797950|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7797951|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7797952|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
7797953|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7797954|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7797955|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7797956|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
7797957|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7797958|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7797959|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7797960|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
7797961|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7797962|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7797963|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7797964|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
7797965|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7797966|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7797967|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7797968|NCT00506415|27099167|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
7797969|NCT00506415|27099168|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7797970|NCT00506415|27099169|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7797971|NCT00506415|27099170|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7797972|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7797973|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
7797974|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7797975|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7797976|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
7797977|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
7797978|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
7797979|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
7797980|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
7797981|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
7797982|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
7797983|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
7797984|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
7797985|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
7797986|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
7797987|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
7797988|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
7797989|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
7797990|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
7797991|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
7797992|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
7797993|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
7797994|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
7797995|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
7797996|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Death|0
7797997|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Death|3
7797998|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Death|5
7797999|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Death|0
7798000|NCT00506415|27099167|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
7798001|NCT00506415|27099168|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
7798002|NCT00506415|27099169|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
7798003|NCT00506415|27099170|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
7798004|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7798005|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7798006|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7798007|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
7798008|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
7798009|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
7798010|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
7798011|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
7798012|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7798013|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7798014|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7798015|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
7798016|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7798017|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7798018|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7798019|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
7798020|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7798021|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7798022|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7798023|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
7798024|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7798025|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7798026|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7798027|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
7798028|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7798029|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7798030|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7798031|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
7798032|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7798033|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7798034|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7798035|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
7798036|NCT00506415|27099167|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7798037|NCT00506415|27099168|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7798038|NCT00506415|27099169|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7798039|NCT00506415|27099170|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
7798040|NCT00506389|27099195|P3|In-treatment Period|Randomized but not treated|1
7798041|NCT00506389|27099196|P2|In-treatment Period|Randomized but not treated|1
7798042|NCT00506389|27099197|P1|In-treatment Period|Randomized but not treated|4
7798043|NCT00506389|27099195|P3|In-treatment Period|Adverse Event|2
7798044|NCT00506389|27099196|P2|In-treatment Period|Adverse Event|5
7798045|NCT00506389|27099197|P1|In-treatment Period|Adverse Event|11
7798046|NCT00506389|27099195|P3|In-treatment Period|Lack of Efficacy|0
7798047|NCT00506389|27099196|P2|In-treatment Period|Lack of Efficacy|2
7798048|NCT00506389|27099197|P1|In-treatment Period|Lack of Efficacy|0
7798049|NCT00506389|27099195|P3|In-treatment Period|Withdrawal by Subject|4
7798050|NCT00506389|27099196|P2|In-treatment Period|Withdrawal by Subject|3
7798051|NCT00506389|27099197|P1|In-treatment Period|Withdrawal by Subject|3
7798052|NCT00506389|27099195|P3|In-treatment Period|Reasons not related to trial|0
7798053|NCT00506389|27099196|P2|In-treatment Period|Reasons not related to trial|1
7798054|NCT00506389|27099197|P1|In-treatment Period|Reasons not related to trial|4
7798055|NCT00506389|27099195|P3|In-treatment Period|Lack of compliance|0
7798056|NCT00506389|27099196|P2|In-treatment Period|Lack of compliance|0
7798057|NCT00506389|27099197|P1|In-treatment Period|Lack of compliance|1
7798058|NCT00506389|27099195|P3|In-treatment Period|Lost to Follow-up|1
7798059|NCT00506389|27099196|P2|In-treatment Period|Lost to Follow-up|0
7798060|NCT00506389|27099197|P1|In-treatment Period|Lost to Follow-up|0
7798061|NCT00506389|27099195|P3|In-treatment Period|Other|4
7798062|NCT00506389|27099196|P2|In-treatment Period|Other|3
7798063|NCT00506389|27099197|P1|In-treatment Period|Other|3
7798064|NCT00506350|27099223|P9|Overall Study|Other|2
7798065|NCT00506350|27099224|P8|Overall Study|Other|2
7798066|NCT00506350|27099225|P7|Overall Study|Other|0
7798067|NCT00506350|27099226|P6|Overall Study|Other|0
7798068|NCT00506350|27099227|P5|Overall Study|Other|3
7798069|NCT00506350|27099228|P4|Overall Study|Other|0
7798070|NCT00506350|27099229|P3|Overall Study|Other|3
7798071|NCT00506350|27099230|P2|Overall Study|Other|1
7798072|NCT00506350|27099231|P1|Overall Study|Other|1
7798073|NCT00506350|27099223|P9|Overall Study|Medical Reason|0
7798074|NCT00506350|27099224|P8|Overall Study|Medical Reason|0
7798075|NCT00506350|27099225|P7|Overall Study|Medical Reason|0
7798076|NCT00506350|27099226|P6|Overall Study|Medical Reason|0
7798077|NCT00506350|27099227|P5|Overall Study|Medical Reason|1
7798078|NCT00506350|27099228|P4|Overall Study|Medical Reason|0
7798079|NCT00506350|27099229|P3|Overall Study|Medical Reason|0
7798080|NCT00506350|27099230|P2|Overall Study|Medical Reason|0
7798081|NCT00506350|27099231|P1|Overall Study|Medical Reason|0
7798082|NCT00506350|27099223|P9|Overall Study|Lost to Follow-up|2
7798083|NCT00506350|27099224|P8|Overall Study|Lost to Follow-up|0
7798084|NCT00506350|27099225|P7|Overall Study|Lost to Follow-up|0
7798085|NCT00506350|27099226|P6|Overall Study|Lost to Follow-up|1
7798086|NCT00506350|27099227|P5|Overall Study|Lost to Follow-up|2
7798087|NCT00506350|27099228|P4|Overall Study|Lost to Follow-up|1
7798088|NCT00506350|27099229|P3|Overall Study|Lost to Follow-up|1
7798089|NCT00506350|27099230|P2|Overall Study|Lost to Follow-up|1
7798090|NCT00506350|27099231|P1|Overall Study|Lost to Follow-up|1
7798091|NCT00506350|27099223|P9|Overall Study|Withdrawal by Subject|0
7798092|NCT00506350|27099224|P8|Overall Study|Withdrawal by Subject|2
7798093|NCT00506350|27099225|P7|Overall Study|Withdrawal by Subject|1
7798094|NCT00506350|27099226|P6|Overall Study|Withdrawal by Subject|1
7798095|NCT00506350|27099227|P5|Overall Study|Withdrawal by Subject|4
7798096|NCT00506350|27099228|P4|Overall Study|Withdrawal by Subject|1
7798097|NCT00506350|27099229|P3|Overall Study|Withdrawal by Subject|1
7798098|NCT00506350|27099230|P2|Overall Study|Withdrawal by Subject|1
7798099|NCT00506350|27099231|P1|Overall Study|Withdrawal by Subject|0
7798100|NCT00506350|27099223|P9|Overall Study|Protocol Violation|0
7798101|NCT00506350|27099224|P8|Overall Study|Protocol Violation|0
7798102|NCT00506350|27099225|P7|Overall Study|Protocol Violation|1
7798103|NCT00506350|27099226|P6|Overall Study|Protocol Violation|0
7798104|NCT00506350|27099227|P5|Overall Study|Protocol Violation|0
7798105|NCT00506350|27099228|P4|Overall Study|Protocol Violation|0
7798106|NCT00506350|27099229|P3|Overall Study|Protocol Violation|1
7798107|NCT00506350|27099230|P2|Overall Study|Protocol Violation|0
7798108|NCT00506350|27099231|P1|Overall Study|Protocol Violation|0
7798109|NCT00506350|27099223|P9|Overall Study|Adverse Event|1
7798110|NCT00506350|27099224|P8|Overall Study|Adverse Event|1
7798111|NCT00506350|27099225|P7|Overall Study|Adverse Event|0
7798112|NCT00506350|27099226|P6|Overall Study|Adverse Event|0
7798113|NCT00506350|27099227|P5|Overall Study|Adverse Event|0
7798114|NCT00506350|27099228|P4|Overall Study|Adverse Event|0
7798115|NCT00506350|27099229|P3|Overall Study|Adverse Event|0
7798116|NCT00506350|27099230|P2|Overall Study|Adverse Event|0
7798117|NCT00506350|27099231|P1|Overall Study|Adverse Event|0
7798118|NCT00506350|27099223|P9|Overall Study|Serious Adverse Event|0
7798119|NCT00506350|27099224|P8|Overall Study|Serious Adverse Event|0
7798120|NCT00506350|27099225|P7|Overall Study|Serious Adverse Event|0
7798121|NCT00506350|27099226|P6|Overall Study|Serious Adverse Event|0
7798122|NCT00506350|27099227|P5|Overall Study|Serious Adverse Event|0
7798123|NCT00506350|27099228|P4|Overall Study|Serious Adverse Event|0
7798124|NCT00506350|27099229|P3|Overall Study|Serious Adverse Event|0
7798125|NCT00506350|27099230|P2|Overall Study|Serious Adverse Event|0
7798126|NCT00506350|27099231|P1|Overall Study|Serious Adverse Event|1
7798127|NCT00506285|27099378|P2|6-month Open Label Phase|Withdrawal by Subject|5
7798128|NCT00506285|27099379|P1|6-month Open Label Phase|Withdrawal by Subject|9
7798129|NCT00506285|27099378|P2|6-month Open Label Phase|Lost to Follow-up|7
7798130|NCT00506285|27099379|P1|6-month Open Label Phase|Lost to Follow-up|1
7798131|NCT00506285|27099378|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
7798132|NCT00506285|27099379|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
7798133|NCT00506285|27099378|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
7798134|NCT00506285|27099379|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
7798135|NCT00506285|27099378|P2|3 Week Screening Phase|Withdrawal by Subject|10
7798136|NCT00506285|27099379|P1|3 Week Screening Phase|Withdrawal by Subject|17
7798137|NCT00506142|27099394|P2|Overall Study|New health condition|0
7798138|NCT00506142|27099395|P1|Overall Study|New health condition|1
7798139|NCT00506142|27099394|P2|Overall Study|Physician Decision|0
7798140|NCT00506142|27099395|P1|Overall Study|Physician Decision|1
7798141|NCT00506142|27099394|P2|Overall Study|Withdrawal by Subject|5
7798142|NCT00506142|27099395|P1|Overall Study|Withdrawal by Subject|4
7798143|NCT00506142|27099394|P2|Overall Study|Lack of Efficacy|7
7798144|NCT00506142|27099395|P1|Overall Study|Lack of Efficacy|21
7798145|NCT00506142|27099394|P2|Overall Study|Adverse Event|7
7798146|NCT00506142|27099395|P1|Overall Study|Adverse Event|8
7798147|NCT00506129|27099401|P1|Overall Study|Death|7
7798148|NCT00506129|27099401|P1|Overall Study|Disease Progression/Relapse|15
7798149|NCT00506077|27099408|P2|Treatment Period 2|Withdrawal by Subject|0
7798150|NCT00506077|27099409|P1|Treatment Period 2|Withdrawal by Subject|1
7798151|NCT00506077|27099408|P2|Treatment Period 2|Adverse Event|1
7798152|NCT00506077|27099409|P1|Treatment Period 2|Adverse Event|0
7798153|NCT00506077|27099408|P2|Treatment Period 1|Withdrawal by Subject|0
7798154|NCT00506077|27099409|P1|Treatment Period 1|Withdrawal by Subject|2
7798155|NCT00506077|27099408|P2|Treatment Period 1|Lost to Follow-up|2
7798156|NCT00506077|27099409|P1|Treatment Period 1|Lost to Follow-up|0
7798157|NCT00506077|27099408|P2|Treatment Period 1|Adverse Event|1
7798158|NCT00506077|27099409|P1|Treatment Period 1|Adverse Event|2
7798159|NCT00505934|27099451|P1|Overall Study|Other: IV dose needed to be changed|1
7798160|NCT00505934|27099451|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
7798161|NCT00505934|27099451|P1|Overall Study|Adverse Event|1
7798162|NCT00505921|27099457|P1|Overall Study|Failed to Mobilize|8
7798163|NCT00505921|27099457|P1|Overall Study|Ineligible|1
7798164|NCT00505778|27099474|P2|Overall Study|Took No Study Drug|2
7798165|NCT00505778|27099475|P1|Overall Study|Took No Study Drug|2
7798166|NCT00505778|27099474|P2|Overall Study|Relapse|65
7798167|NCT00505778|27099475|P1|Overall Study|Relapse|65
7798168|NCT00505778|27099474|P2|Overall Study|Withdrawal by Subject|14
7798169|NCT00505778|27099475|P1|Overall Study|Withdrawal by Subject|29
7798170|NCT00505778|27099474|P2|Overall Study|Protocol Violation|9
7798171|NCT00505778|27099475|P1|Overall Study|Protocol Violation|7
7798172|NCT00505778|27099474|P2|Overall Study|Unable to Meet Protocol Criteria|1
7798173|NCT00505778|27099475|P1|Overall Study|Unable to Meet Protocol Criteria|4
7798174|NCT00505778|27099474|P2|Overall Study|Lost to Follow-up|23
7798175|NCT00505778|27099475|P1|Overall Study|Lost to Follow-up|17
7798176|NCT00505778|27099474|P2|Overall Study|Physician Decision|14
7798177|NCT00505778|27099475|P1|Overall Study|Physician Decision|8
7798178|NCT00505778|27099474|P2|Overall Study|Adverse Event|7
7798179|NCT00505778|27099475|P1|Overall Study|Adverse Event|2
7798180|NCT00505765|27099494|P3|Overall Study|Noncompliance|3
7798181|NCT00505765|27099495|P2|Overall Study|Noncompliance|1
7798182|NCT00505765|27099496|P1|Overall Study|Noncompliance|0
7798183|NCT00505765|27099494|P3|Overall Study|Adverse Event|0
7798184|NCT00505765|27099495|P2|Overall Study|Adverse Event|2
7798185|NCT00505765|27099496|P1|Overall Study|Adverse Event|1
7798186|NCT00505765|27099494|P3|Overall Study|Withdrawal by Subject|0
7798187|NCT00505765|27099495|P2|Overall Study|Withdrawal by Subject|0
7798188|NCT00505765|27099496|P1|Overall Study|Withdrawal by Subject|1
7798189|NCT00505752|27099523|P4|Overall Study|Other|2
7798190|NCT00505752|27099524|P3|Overall Study|Other|1
7798191|NCT00505752|27099525|P2|Overall Study|Other|2
7798192|NCT00505752|27099526|P1|Overall Study|Other|1
7798193|NCT00505752|27099523|P4|Overall Study|All embryos/blastocysts discarded|1
7798194|NCT00505752|27099524|P3|Overall Study|All embryos/blastocysts discarded|1
7798195|NCT00505752|27099525|P2|Overall Study|All embryos/blastocysts discarded|0
7798196|NCT00505752|27099526|P1|Overall Study|All embryos/blastocysts discarded|0
7798197|NCT00505752|27099523|P4|Overall Study|No Fertilization|1
7798198|NCT00505752|27099524|P3|Overall Study|No Fertilization|2
7798199|NCT00505752|27099525|P2|Overall Study|No Fertilization|1
7798200|NCT00505752|27099526|P1|Overall Study|No Fertilization|1
7798201|NCT00505752|27099523|P4|Overall Study|No oocytes retrieved|1
7798202|NCT00505752|27099524|P3|Overall Study|No oocytes retrieved|0
7798203|NCT00505752|27099525|P2|Overall Study|No oocytes retrieved|2
7798204|NCT00505752|27099526|P1|Overall Study|No oocytes retrieved|0
7798205|NCT00505752|27099523|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
7798206|NCT00505752|27099524|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
7798207|NCT00505752|27099525|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
7798208|NCT00505752|27099526|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
7798209|NCT00505752|27099523|P4|Overall Study|Lack of ovarian response|0
7798210|NCT00505752|27099524|P3|Overall Study|Lack of ovarian response|0
7798211|NCT00505752|27099525|P2|Overall Study|Lack of ovarian response|3
7798212|NCT00505752|27099526|P1|Overall Study|Lack of ovarian response|1
7798213|NCT00505752|27099523|P4|Overall Study|Lost to Follow-up|0
7798214|NCT00505752|27099524|P3|Overall Study|Lost to Follow-up|0
7798215|NCT00505752|27099525|P2|Overall Study|Lost to Follow-up|0
7798216|NCT00505752|27099526|P1|Overall Study|Lost to Follow-up|1
7798217|NCT00505752|27099523|P4|Overall Study|Adverse Event|0
7798218|NCT00505752|27099524|P3|Overall Study|Adverse Event|1
7798219|NCT00505752|27099525|P2|Overall Study|Adverse Event|0
7798220|NCT00505752|27099526|P1|Overall Study|Adverse Event|1
7798221|NCT00505687|27099540|P1|Overall Study|Other: As Per Sponsor|8
7798222|NCT00505687|27099540|P1|Overall Study|Other: Disease Progression|1
7798223|NCT00505687|27099540|P1|Overall Study|Other: Neupro Given In Hospital|1
7798224|NCT00505687|27099540|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
7798225|NCT00505687|27099540|P1|Overall Study|Other: Prolonged Hospitalization|1
7798226|NCT00505687|27099540|P1|Overall Study|Other: Scheduled DBS Surgery|1
7798227|NCT00505687|27099540|P1|Overall Study|Other: Underwent Implantation Of DBS|1
7798228|NCT00505687|27099540|P1|Overall Study|Lost to Follow-up|1
7798229|NCT00505687|27099540|P1|Overall Study|Subject withdrew consent|15
7798230|NCT00505687|27099540|P1|Overall Study|Adverse Event|48
7798231|NCT00505687|27099540|P1|Overall Study|Lack of Efficacy|15
7798232|NCT00505687|27099540|P1|Overall Study|Important protocol violation|2
7798233|NCT00505661|27099546|P1|Overall Study|Not Eligible|4
7798234|NCT00505622|27099557|P3|Overall Study|Study termination by sponsor|90
7798235|NCT00505622|27099558|P2|Overall Study|Study termination by sponsor|98
7798236|NCT00505622|27099559|P1|Overall Study|Study termination by sponsor|115
7798237|NCT00505622|27099557|P3|Overall Study|Withdrawal by Subject|2
7798238|NCT00505622|27099558|P2|Overall Study|Withdrawal by Subject|3
7798239|NCT00505622|27099559|P1|Overall Study|Withdrawal by Subject|0
7798240|NCT00505622|27099557|P3|Overall Study|Protocol Violation|0
7798241|NCT00505622|27099558|P2|Overall Study|Protocol Violation|1
7798242|NCT00505622|27099559|P1|Overall Study|Protocol Violation|1
7798243|NCT00505622|27099557|P3|Overall Study|Adverse Event|4
7798244|NCT00505622|27099558|P2|Overall Study|Adverse Event|6
7798245|NCT00505622|27099559|P1|Overall Study|Adverse Event|5
7798246|NCT00505414|27099584|P5|Maintenance Phase|underlying disease and therapy required|0
7798247|NCT00505414|27099585|P4|Maintenance Phase|underlying disease and therapy required|0
7798248|NCT00505414|27099586|P3|Maintenance Phase|underlying disease and therapy required|2
7798249|NCT00505414|27099587|P2|Maintenance Phase|underlying disease and therapy required|2
7798250|NCT00505414|27099588|P1|Maintenance Phase|underlying disease and therapy required|0
7798251|NCT00505414|27099584|P5|Maintenance Phase|Withdrawal by Subject|0
7798252|NCT00505414|27099585|P4|Maintenance Phase|Withdrawal by Subject|0
7798253|NCT00505414|27099586|P3|Maintenance Phase|Withdrawal by Subject|1
7798254|NCT00505414|27099587|P2|Maintenance Phase|Withdrawal by Subject|0
7798255|NCT00505414|27099588|P1|Maintenance Phase|Withdrawal by Subject|0
7798256|NCT00505414|27099584|P5|Maintenance Phase|Lack of Efficacy|0
7798257|NCT00505414|27099585|P4|Maintenance Phase|Lack of Efficacy|0
7798258|NCT00505414|27099586|P3|Maintenance Phase|Lack of Efficacy|1
7798259|NCT00505414|27099587|P2|Maintenance Phase|Lack of Efficacy|1
7798260|NCT00505414|27099588|P1|Maintenance Phase|Lack of Efficacy|2
7798261|NCT00505414|27099584|P5|Maintenance Phase|Death|0
7798262|NCT00505414|27099585|P4|Maintenance Phase|Death|0
7798263|NCT00505414|27099586|P3|Maintenance Phase|Death|1
7798264|NCT00505414|27099587|P2|Maintenance Phase|Death|0
7798265|NCT00505414|27099588|P1|Maintenance Phase|Death|2
7798266|NCT00505414|27099584|P5|Maintenance Phase|Adverse Event|0
7798267|NCT00505414|27099585|P4|Maintenance Phase|Adverse Event|0
7798268|NCT00505414|27099586|P3|Maintenance Phase|Adverse Event|3
7798269|NCT00505414|27099587|P2|Maintenance Phase|Adverse Event|2
7798270|NCT00505414|27099588|P1|Maintenance Phase|Adverse Event|2
7798271|NCT00505414|27099584|P5|Titration Phase|Underlying disease and therapy required|3
7798272|NCT00505414|27099585|P4|Titration Phase|Underlying disease and therapy required|7
7798273|NCT00505414|27099586|P3|Titration Phase|Underlying disease and therapy required|0
7798274|NCT00505414|27099587|P2|Titration Phase|Underlying disease and therapy required|0
7798275|NCT00505414|27099588|P1|Titration Phase|Underlying disease and therapy required|0
7798276|NCT00505414|27099584|P5|Titration Phase|Withdrawal by Subject|4
7798277|NCT00505414|27099585|P4|Titration Phase|Withdrawal by Subject|3
7798278|NCT00505414|27099586|P3|Titration Phase|Withdrawal by Subject|0
7798279|NCT00505414|27099587|P2|Titration Phase|Withdrawal by Subject|0
7798280|NCT00505414|27099588|P1|Titration Phase|Withdrawal by Subject|0
7798281|NCT00505414|27099584|P5|Titration Phase|Protocol Violation|1
7798282|NCT00505414|27099585|P4|Titration Phase|Protocol Violation|0
7798283|NCT00505414|27099586|P3|Titration Phase|Protocol Violation|0
7798284|NCT00505414|27099587|P2|Titration Phase|Protocol Violation|0
7798285|NCT00505414|27099588|P1|Titration Phase|Protocol Violation|0
7798286|NCT00505414|27099584|P5|Titration Phase|Lack of Efficacy|1
7798287|NCT00505414|27099585|P4|Titration Phase|Lack of Efficacy|10
7798288|NCT00505414|27099586|P3|Titration Phase|Lack of Efficacy|0
7798289|NCT00505414|27099587|P2|Titration Phase|Lack of Efficacy|0
7798290|NCT00505414|27099588|P1|Titration Phase|Lack of Efficacy|0
7798291|NCT00505414|27099584|P5|Titration Phase|Death|0
7798292|NCT00505414|27099585|P4|Titration Phase|Death|2
7798293|NCT00505414|27099586|P3|Titration Phase|Death|0
7798294|NCT00505414|27099587|P2|Titration Phase|Death|0
7798295|NCT00505414|27099588|P1|Titration Phase|Death|0
7798296|NCT00505414|27099584|P5|Titration Phase|Adverse Event|3
7798297|NCT00505414|27099585|P4|Titration Phase|Adverse Event|8
7798298|NCT00505414|27099586|P3|Titration Phase|Adverse Event|0
7798299|NCT00505414|27099587|P2|Titration Phase|Adverse Event|0
7798300|NCT00505414|27099588|P1|Titration Phase|Adverse Event|0
7798301|NCT00505375|27099605|P2|Overall Study|Travel issues|1
7798302|NCT00505375|27099606|P1|Overall Study|Travel issues|0
7798303|NCT00505375|27099605|P2|Overall Study|Pregnancy|0
7798304|NCT00505375|27099606|P1|Overall Study|Pregnancy|1
7798305|NCT00505375|27099605|P2|Overall Study|Lost to Follow-up|2
7798306|NCT00505375|27099606|P1|Overall Study|Lost to Follow-up|0
7798307|NCT00505375|27099605|P2|Overall Study|Withdrawal by Subject|2
7798308|NCT00505375|27099606|P1|Overall Study|Withdrawal by Subject|2
7798309|NCT00505375|27099605|P2|Overall Study|Death|0
7798310|NCT00505375|27099606|P1|Overall Study|Death|1
7798311|NCT00505284|27099628|P5|Overall Study|Other|4
7798312|NCT00505284|27099629|P4|Overall Study|Other|4
7798313|NCT00505284|27099630|P3|Overall Study|Other|0
7798314|NCT00505284|27099631|P2|Overall Study|Other|0
7798315|NCT00505284|27099632|P1|Overall Study|Other|5
7798316|NCT00505284|27099628|P5|Overall Study|Physician Decision|0
7798317|NCT00505284|27099629|P4|Overall Study|Physician Decision|0
7798318|NCT00505284|27099630|P3|Overall Study|Physician Decision|0
7798319|NCT00505284|27099631|P2|Overall Study|Physician Decision|1
7798320|NCT00505284|27099632|P1|Overall Study|Physician Decision|0
7798321|NCT00505284|27099628|P5|Overall Study|Lack of Efficacy|1
7798322|NCT00505284|27099629|P4|Overall Study|Lack of Efficacy|1
7798323|NCT00505284|27099630|P3|Overall Study|Lack of Efficacy|1
7798324|NCT00505284|27099631|P2|Overall Study|Lack of Efficacy|1
7798325|NCT00505284|27099632|P1|Overall Study|Lack of Efficacy|0
7798326|NCT00505284|27099628|P5|Overall Study|Withdrawal by Subject|6
7798327|NCT00505284|27099629|P4|Overall Study|Withdrawal by Subject|0
7798328|NCT00505284|27099630|P3|Overall Study|Withdrawal by Subject|1
7798329|NCT00505284|27099631|P2|Overall Study|Withdrawal by Subject|6
7798330|NCT00505284|27099632|P1|Overall Study|Withdrawal by Subject|2
7798331|NCT00505284|27099628|P5|Overall Study|Protocol Violation|0
7798332|NCT00505284|27099629|P4|Overall Study|Protocol Violation|0
7798333|NCT00505284|27099630|P3|Overall Study|Protocol Violation|1
7798334|NCT00505284|27099631|P2|Overall Study|Protocol Violation|1
7798335|NCT00505284|27099632|P1|Overall Study|Protocol Violation|0
7798336|NCT00505284|27099628|P5|Overall Study|Adverse Event|22
7798337|NCT00505284|27099629|P4|Overall Study|Adverse Event|14
7798338|NCT00505284|27099630|P3|Overall Study|Adverse Event|9
7798339|NCT00505284|27099631|P2|Overall Study|Adverse Event|7
7798340|NCT00505284|27099632|P1|Overall Study|Adverse Event|3
7798341|NCT00505076|27099702|P3|Overall Study|Withdrawal by Subject|2
7798342|NCT00505076|27099703|P2|Overall Study|Withdrawal by Subject|1
7798343|NCT00505076|27099704|P1|Overall Study|Withdrawal by Subject|0
7798344|NCT00505076|27099702|P3|Overall Study|Protocol Violation|2
7798345|NCT00505076|27099703|P2|Overall Study|Protocol Violation|1
7798346|NCT00505076|27099704|P1|Overall Study|Protocol Violation|2
7798347|NCT00505076|27099702|P3|Overall Study|Adverse Event|1
7798348|NCT00505076|27099703|P2|Overall Study|Adverse Event|0
7798349|NCT00505076|27099704|P1|Overall Study|Adverse Event|1
7798350|NCT00504894|27099725|P3|Overall Study|poor subject data|0
7798351|NCT00504894|27099726|P2|Overall Study|poor subject data|0
7798352|NCT00504894|27099727|P1|Overall Study|poor subject data|2
7798353|NCT00504894|27099725|P3|Overall Study|Infusion technical problems|0
7798354|NCT00504894|27099726|P2|Overall Study|Infusion technical problems|1
7798355|NCT00504894|27099727|P1|Overall Study|Infusion technical problems|0
7798356|NCT00504894|27099725|P3|Overall Study|Withdrawal by Subject|0
7798357|NCT00504894|27099726|P2|Overall Study|Withdrawal by Subject|1
7798358|NCT00504894|27099727|P1|Overall Study|Withdrawal by Subject|0
7798359|NCT00504894|27099725|P3|Overall Study|fMRI technical problems|0
7798360|NCT00504894|27099726|P2|Overall Study|fMRI technical problems|1
7798361|NCT00504894|27099727|P1|Overall Study|fMRI technical problems|1
7798362|NCT00504881|27099740|P2|Overall Study|AE of unknown type|0
7798363|NCT00504881|27099741|P1|Overall Study|AE of unknown type|1
7798364|NCT00504881|27099740|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
7798365|NCT00504881|27099741|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7798366|NCT00504881|27099740|P2|Overall Study|AE, non-serious non-fatal|14
7798367|NCT00504881|27099741|P1|Overall Study|AE, non-serious non-fatal|4
7798368|NCT00504881|27099740|P2|Overall Study|SAE, non-fatal|6
7798369|NCT00504881|27099741|P1|Overall Study|SAE, non-fatal|2
7798370|NCT00504881|27099740|P2|Overall Study|AE, serious fatal|1
7798371|NCT00504881|27099741|P1|Overall Study|AE, serious fatal|0
7798372|NCT00504881|27099740|P2|Overall Study|Safety Visit not performed|1
7798373|NCT00504881|27099741|P1|Overall Study|Safety Visit not performed|0
7798374|NCT00504881|27099740|P2|Overall Study|No Birth Control|1
7798375|NCT00504881|27099741|P1|Overall Study|No Birth Control|0
7798376|NCT00504881|27099740|P2|Overall Study|Non-Compliance|0
7798377|NCT00504881|27099741|P1|Overall Study|Non-Compliance|1
7798378|NCT00504881|27099740|P2|Overall Study|Withdrawal by Subject|4
7798379|NCT00504881|27099741|P1|Overall Study|Withdrawal by Subject|1
7798380|NCT00504881|27099740|P2|Overall Study|Lost to Follow-up|2
7798381|NCT00504881|27099741|P1|Overall Study|Lost to Follow-up|0
7798382|NCT00504881|27099740|P2|Overall Study|Lack of Efficacy|5
7798383|NCT00504881|27099741|P1|Overall Study|Lack of Efficacy|1
7798384|NCT00504829|27099794|P3|Overall Study|Protocol Violation|10
7798385|NCT00504829|27099795|P2|Overall Study|Protocol Violation|4
7798386|NCT00504829|27099796|P1|Overall Study|Protocol Violation|6
7798387|NCT00504777|27099805|P1|Overall Study|Adverse Event|1
7798388|NCT00504725|27099818|P2|Overall Study|Protocol Violation|0
7798389|NCT00504725|27099819|P1|Overall Study|Protocol Violation|1
7798390|NCT00504595|27099842|P4|Overall Study|Other|0
7798391|NCT00504595|27099843|P3|Overall Study|Other|2
7798392|NCT00504595|27099844|P2|Overall Study|Other|0
7798393|NCT00504595|27099845|P1|Overall Study|Other|0
7798394|NCT00504595|27099842|P4|Overall Study|Lack of Efficacy|0
7798395|NCT00504595|27099843|P3|Overall Study|Lack of Efficacy|0
7798396|NCT00504595|27099844|P2|Overall Study|Lack of Efficacy|0
7798397|NCT00504595|27099845|P1|Overall Study|Lack of Efficacy|1
7798398|NCT00504556|27099862|P5|Overall Study|not in safety analysis set|1
7798399|NCT00504556|27099863|P4|Overall Study|not in safety analysis set|0
7798400|NCT00504556|27099864|P3|Overall Study|not in safety analysis set|1
7798401|NCT00504556|27099865|P2|Overall Study|not in safety analysis set|1
7798402|NCT00504556|27099866|P1|Overall Study|not in safety analysis set|0
7798403|NCT00504556|27099862|P5|Overall Study|Other|0
7798404|NCT00504556|27099863|P4|Overall Study|Other|3
7798405|NCT00504556|27099864|P3|Overall Study|Other|2
7798406|NCT00504556|27099865|P2|Overall Study|Other|2
7798407|NCT00504556|27099866|P1|Overall Study|Other|2
7798408|NCT00504556|27099862|P5|Overall Study|data monitor committee decision|0
7798409|NCT00504556|27099863|P4|Overall Study|data monitor committee decision|100
7798410|NCT00504556|27099864|P3|Overall Study|data monitor committee decision|0
7798411|NCT00504556|27099865|P2|Overall Study|data monitor committee decision|0
7798412|NCT00504556|27099866|P1|Overall Study|data monitor committee decision|0
7798413|NCT00504556|27099862|P5|Overall Study|did not meet entry criteria|0
7798414|NCT00504556|27099863|P4|Overall Study|did not meet entry criteria|1
7798415|NCT00504556|27099864|P3|Overall Study|did not meet entry criteria|1
7798416|NCT00504556|27099865|P2|Overall Study|did not meet entry criteria|0
7798417|NCT00504556|27099866|P1|Overall Study|did not meet entry criteria|2
7798418|NCT00504556|27099862|P5|Overall Study|administrative reasons|2
7798419|NCT00504556|27099863|P4|Overall Study|administrative reasons|1
7798420|NCT00504556|27099864|P3|Overall Study|administrative reasons|2
7798421|NCT00504556|27099865|P2|Overall Study|administrative reasons|2
7798422|NCT00504556|27099866|P1|Overall Study|administrative reasons|0
7798423|NCT00504556|27099862|P5|Overall Study|Withdrawal by Subject|12
7798424|NCT00504556|27099863|P4|Overall Study|Withdrawal by Subject|8
7798425|NCT00504556|27099864|P3|Overall Study|Withdrawal by Subject|7
7798426|NCT00504556|27099865|P2|Overall Study|Withdrawal by Subject|16
7798427|NCT00504556|27099866|P1|Overall Study|Withdrawal by Subject|16
7798428|NCT00504556|27099862|P5|Overall Study|Lost to Follow-up|1
7798429|NCT00504556|27099863|P4|Overall Study|Lost to Follow-up|1
7798430|NCT00504556|27099864|P3|Overall Study|Lost to Follow-up|1
7798431|NCT00504556|27099865|P2|Overall Study|Lost to Follow-up|0
7798432|NCT00504556|27099866|P1|Overall Study|Lost to Follow-up|0
7798433|NCT00504556|27099862|P5|Overall Study|Protocol Violation|2
7798434|NCT00504556|27099863|P4|Overall Study|Protocol Violation|1
7798435|NCT00504556|27099864|P3|Overall Study|Protocol Violation|2
7798436|NCT00504556|27099865|P2|Overall Study|Protocol Violation|3
7798437|NCT00504556|27099866|P1|Overall Study|Protocol Violation|1
7798438|NCT00504556|27099862|P5|Overall Study|Death|2
7798439|NCT00504556|27099863|P4|Overall Study|Death|0
7798440|NCT00504556|27099864|P3|Overall Study|Death|1
7798441|NCT00504556|27099865|P2|Overall Study|Death|3
7798442|NCT00504556|27099866|P1|Overall Study|Death|3
7798443|NCT00504556|27099862|P5|Overall Study|Adverse Event|5
7798444|NCT00504556|27099863|P4|Overall Study|Adverse Event|13
7798445|NCT00504556|27099864|P3|Overall Study|Adverse Event|14
7798446|NCT00504556|27099865|P2|Overall Study|Adverse Event|11
7798447|NCT00504556|27099866|P1|Overall Study|Adverse Event|11
7798448|NCT00504426|27099934|P4|Overall Study|Withdrawal by Subject|0
7798449|NCT00504426|27099935|P3|Overall Study|Withdrawal by Subject|0
7798450|NCT00504426|27099936|P2|Overall Study|Withdrawal by Subject|0
7798451|NCT00504426|27099937|P1|Overall Study|Withdrawal by Subject|2
7798452|NCT00504426|27099934|P4|Overall Study|Protocol Violation|0
7798453|NCT00504426|27099935|P3|Overall Study|Protocol Violation|2
7798454|NCT00504426|27099936|P2|Overall Study|Protocol Violation|1
7798455|NCT00504426|27099937|P1|Overall Study|Protocol Violation|1
7798456|NCT00504426|27099934|P4|Overall Study|Adverse Event|0
7798457|NCT00504426|27099935|P3|Overall Study|Adverse Event|2
7798458|NCT00504426|27099936|P2|Overall Study|Adverse Event|0
7798459|NCT00504426|27099937|P1|Overall Study|Adverse Event|0
7798460|NCT00504348|27099951|P1|Overall Study|Physician Decision|1
7798461|NCT00504348|27099951|P1|Overall Study|Lack of Efficacy|4
7798462|NCT00504348|27099951|P1|Overall Study|Adverse Event|3
7798463|NCT00504309|27099962|P6|Overall Study|Withdrawal by Subject|0
7798464|NCT00504309|27099963|P5|Overall Study|Withdrawal by Subject|0
7798465|NCT00504309|27099964|P4|Overall Study|Withdrawal by Subject|0
7798466|NCT00504309|27099965|P3|Overall Study|Withdrawal by Subject|1
7798467|NCT00504309|27099966|P2|Overall Study|Withdrawal by Subject|0
7798468|NCT00504309|27099967|P1|Overall Study|Withdrawal by Subject|0
7798469|NCT00504309|27099962|P6|Overall Study|Death|0
7798470|NCT00504309|27099963|P5|Overall Study|Death|1
7798471|NCT00504309|27099964|P4|Overall Study|Death|0
7798472|NCT00504309|27099965|P3|Overall Study|Death|0
7798473|NCT00504309|27099966|P2|Overall Study|Death|0
7798474|NCT00504309|27099967|P1|Overall Study|Death|0
7798475|NCT00504257|27100005|P1|Overall Study|ineligible histology|2
7798476|NCT00504257|27100005|P1|Overall Study|Withdrawal by Subject|2
7798477|NCT00504231|27100017|P4|Overall Study|Discrepant chart documentation re route|0
7798478|NCT00504231|27100018|P3|Overall Study|Discrepant chart documentation re route|1
7798479|NCT00504231|27100019|P2|Overall Study|Discrepant chart documentation re route|0
7798480|NCT00504231|27100020|P1|Overall Study|Discrepant chart documentation re route|0
7798481|NCT00504166|27100040|P2|Overall Study|Lost to Follow-up|3
7798482|NCT00504166|27100041|P1|Overall Study|Lost to Follow-up|1
7798483|NCT00504166|27100040|P2|Overall Study|Physician Decision|1
7798484|NCT00504166|27100041|P1|Overall Study|Physician Decision|1
7798485|NCT00504166|27100040|P2|Overall Study|Withdrawal by Subject|6
7798486|NCT00504166|27100041|P1|Overall Study|Withdrawal by Subject|3
7798487|NCT00504166|27100040|P2|Overall Study|Adverse Event|4
7798488|NCT00504166|27100041|P1|Overall Study|Adverse Event|1
7798489|NCT00504153|27100047|P1|Overall Study|Death|1
7798490|NCT00504153|27100047|P1|Overall Study|Adverse Event|4
7798491|NCT00504153|27100047|P1|Overall Study|Withdrawal by Subject|1
7798492|NCT00504075|27100055|P1|Overall Study|Required other therapeutic intervention|1
7798493|NCT00504075|27100055|P1|Overall Study|Withdrawal by Subject|1
7798494|NCT00504075|27100055|P1|Overall Study|Lost to Follow-up|5
7798495|NCT00504075|27100055|P1|Overall Study|Adverse Event|1
7798496|NCT00503997|27100065|P1|Overall Study|Withdrawal by Subject|1
7798497|NCT00503997|27100065|P1|Overall Study|Death|1
7798498|NCT00503997|27100065|P1|Overall Study|Adverse Event|5
7798499|NCT00503997|27100065|P1|Overall Study|disease progression|1
7798500|NCT00503984|27100071|P6|Overall Study|Death|0
7798501|NCT00503984|27100072|P5|Overall Study|Death|1
7798502|NCT00503984|27100073|P4|Overall Study|Death|0
7798503|NCT00503984|27100074|P3|Overall Study|Death|0
7798504|NCT00503984|27100075|P2|Overall Study|Death|0
7798505|NCT00503984|27100076|P1|Overall Study|Death|0
7798506|NCT00503984|27100071|P6|Overall Study|Adverse Event|0
7798507|NCT00503984|27100072|P5|Overall Study|Adverse Event|0
7798508|NCT00503984|27100073|P4|Overall Study|Adverse Event|0
7798509|NCT00503984|27100074|P3|Overall Study|Adverse Event|0
7798510|NCT00503984|27100075|P2|Overall Study|Adverse Event|1
7798511|NCT00503984|27100076|P1|Overall Study|Adverse Event|0
7798512|NCT00503984|27100071|P6|Overall Study|Protocol Violation|0
7798513|NCT00503984|27100072|P5|Overall Study|Protocol Violation|0
7798514|NCT00503984|27100073|P4|Overall Study|Protocol Violation|0
7798515|NCT00503984|27100074|P3|Overall Study|Protocol Violation|0
7798516|NCT00503984|27100075|P2|Overall Study|Protocol Violation|1
7798517|NCT00503984|27100076|P1|Overall Study|Protocol Violation|0
7798518|NCT00503906|27100102|P1|Overall Study|Withdrawal by Subject|1
7798519|NCT00503867|27100124|P1|Overall Study|Adverse Event|1
7798520|NCT00503867|27100124|P1|Overall Study|Lost to Follow-up|1
7798521|NCT00503841|27100132|P1|Overall Study|All screen failures|44
7798522|NCT00503776|27100143|P4|Overall Study|Physician Decision|1
7798523|NCT00503776|27100144|P3|Overall Study|Physician Decision|1
7798524|NCT00503776|27100145|P2|Overall Study|Physician Decision|0
7798525|NCT00503776|27100146|P1|Overall Study|Physician Decision|0
7798526|NCT00503776|27100143|P4|Overall Study|Withdrawal by Subject|1
7798527|NCT00503776|27100144|P3|Overall Study|Withdrawal by Subject|1
7798528|NCT00503776|27100145|P2|Overall Study|Withdrawal by Subject|0
7798529|NCT00503776|27100146|P1|Overall Study|Withdrawal by Subject|1
7798530|NCT00503698|27100179|P2|Overall Study|Not exposed to trial drug|6
7798531|NCT00503698|27100180|P1|Overall Study|Not exposed to trial drug|11
7798532|NCT00503698|27100179|P2|Overall Study|Unclassified|32
7798533|NCT00503698|27100180|P1|Overall Study|Unclassified|48
7798534|NCT00503698|27100179|P2|Overall Study|Critically ill|0
7798535|NCT00503698|27100180|P1|Overall Study|Critically ill|2
7798536|NCT00503698|27100179|P2|Overall Study|Move to nonparticipating dialysis center|1
7798537|NCT00503698|27100180|P1|Overall Study|Move to nonparticipating dialysis center|2
7798538|NCT00503698|27100179|P2|Overall Study|Switch to peritoneal or home dialysis|2
7798539|NCT00503698|27100180|P1|Overall Study|Switch to peritoneal or home dialysis|2
7798540|NCT00503698|27100179|P2|Overall Study|Any condition in exclusion criteria|6
7798541|NCT00503698|27100180|P1|Overall Study|Any condition in exclusion criteria|4
7798542|NCT00503698|27100179|P2|Overall Study|Pregnancy/intention to become pregnant|0
7798543|NCT00503698|27100180|P1|Overall Study|Pregnancy/intention to become pregnant|1
7798544|NCT00503698|27100179|P2|Overall Study|End hemodialysis due to renal transplant|4
7798545|NCT00503698|27100180|P1|Overall Study|End hemodialysis due to renal transplant|10
7798546|NCT00503698|27100179|P2|Overall Study|Trial terminated|253
7798547|NCT00503698|27100180|P1|Overall Study|Trial terminated|216
7798548|NCT00503698|27100179|P2|Overall Study|Lack of Efficacy|4
7798549|NCT00503698|27100180|P1|Overall Study|Lack of Efficacy|3
7798550|NCT00503698|27100179|P2|Overall Study|Death|0
7798551|NCT00503698|27100180|P1|Overall Study|Death|1
7798552|NCT00503698|27100179|P2|Overall Study|Adverse Event|41
7798553|NCT00503698|27100180|P1|Overall Study|Adverse Event|52
7798554|NCT00503698|27100179|P2|Overall Study|Protocol Violation|6
7798555|NCT00503698|27100180|P1|Overall Study|Protocol Violation|5
7798556|NCT00503685|27100197|P3|Overall Study|Eligibility Criteria Not Met|0
7798557|NCT00503685|27100198|P2|Overall Study|Eligibility Criteria Not Met|1
7798558|NCT00503685|27100199|P1|Overall Study|Eligibility Criteria Not Met|0
7798559|NCT00503685|27100197|P3|Overall Study|Protocol Violation|0
7798560|NCT00503685|27100198|P2|Overall Study|Protocol Violation|1
7798561|NCT00503685|27100199|P1|Overall Study|Protocol Violation|0
7798562|NCT00503685|27100197|P3|Overall Study|Withdrawal by Subject|0
7798563|NCT00503685|27100198|P2|Overall Study|Withdrawal by Subject|1
7798564|NCT00503685|27100199|P1|Overall Study|Withdrawal by Subject|0
7798565|NCT00503685|27100197|P3|Overall Study|Adverse Event|2
7798566|NCT00503685|27100198|P2|Overall Study|Adverse Event|0
7798567|NCT00503685|27100199|P1|Overall Study|Adverse Event|0
7798568|NCT00503581|27100244|P3|Overall Study|Study closed|2
7798569|NCT00503581|27100245|P2|Overall Study|Study closed|4
7798570|NCT00503581|27100246|P1|Overall Study|Study closed|3
7798571|NCT00503425|27100257|P1|Overall Study|Missing Data/Unknown|4
7798572|NCT00503425|27100257|P1|Overall Study|Death|3
7798573|NCT00503425|27100257|P1|Overall Study|Lost to Follow-up|3
7798574|NCT00503425|27100257|P1|Overall Study|Withdrawal by Subject|8
7798575|NCT00503425|27100257|P1|Overall Study|Lack of Efficacy|25
7798576|NCT00503425|27100257|P1|Overall Study|Adverse Event|5
7798577|NCT00503425|27100257|P1|Overall Study|Participant files lost|6
7798578|NCT00503399|27100267|P2|Overall Study|Lost to Follow-up|2
7798579|NCT00503399|27100268|P1|Overall Study|Lost to Follow-up|0
7798580|NCT00503399|27100267|P2|Overall Study|Adverse Event|3
7798581|NCT00503399|27100268|P1|Overall Study|Adverse Event|0
7798582|NCT00503399|27100267|P2|Overall Study|Withdrawal by Subject|2
7798583|NCT00503399|27100268|P1|Overall Study|Withdrawal by Subject|4
7798584|NCT00503399|27100267|P2|Overall Study|Protocol Violation|0
7798585|NCT00503399|27100268|P1|Overall Study|Protocol Violation|1
7798586|NCT00503399|27100267|P2|Overall Study|Death|1
7798587|NCT00503399|27100268|P1|Overall Study|Death|2
7798588|NCT00503308|27100292|P2|Overall Study|Protocol Violation|1
7798589|NCT00503308|27100293|P1|Overall Study|Protocol Violation|2
7798590|NCT00503139|27100299|P1|Overall Study|Protocol Violation|4
7798591|NCT00503139|27100299|P1|Overall Study|Case Report Forms were not collected|4
7798592|NCT00503009|27100347|P3|Overall Study|Physician Decision|1
7798593|NCT00503009|27100348|P2|Overall Study|Physician Decision|1
7798594|NCT00503009|27100349|P1|Overall Study|Physician Decision|0
7798595|NCT00503009|27100347|P3|Overall Study|Withdrawal by Subject|1
7798596|NCT00503009|27100348|P2|Overall Study|Withdrawal by Subject|1
7798597|NCT00503009|27100349|P1|Overall Study|Withdrawal by Subject|0
7798598|NCT00503009|27100347|P3|Overall Study|Protocol Violation|1
7798599|NCT00503009|27100348|P2|Overall Study|Protocol Violation|0
7798600|NCT00503009|27100349|P1|Overall Study|Protocol Violation|1
7798601|NCT00502996|27100366|P1|Overall Study|Adverse Event|2
7798602|NCT00502996|27100366|P1|Overall Study|Withdrawal Informed Consent|6
7798603|NCT00502996|27100366|P1|Overall Study|Treatment failure|25
7798604|NCT00502996|27100366|P1|Overall Study|Protocol Violation|2
7798605|NCT00502996|27100366|P1|Overall Study|Lost to Follow-up|9
7798606|NCT00502840|27100434|P1|Overall Study|Other|20
7798607|NCT00502840|27100434|P1|Overall Study|Administrative problems|1
7798608|NCT00502840|27100434|P1|Overall Study|Lost to Follow-up|6
7798609|NCT00502840|27100434|P1|Overall Study|Withdrawal by Subject|5
7798610|NCT00502840|27100434|P1|Overall Study|Protocol Violation|4
7798611|NCT00502840|27100434|P1|Overall Study|Lack of Efficacy|11
7798612|NCT00502840|27100434|P1|Overall Study|Additional or changed therapy|48
7798613|NCT00502840|27100434|P1|Overall Study|Adverse Event|5
7798614|NCT00502801|27100462|P1|End of Therapy to Test of Cure|OTHER|2
7798615|NCT00502801|27100462|P1|End of Therapy to Test of Cure|Death|3
7798616|NCT00502801|27100462|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
7798617|NCT00502801|27100462|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
7798618|NCT00502801|27100462|P1|Treatment Period|OTHER|30
7798619|NCT00502801|27100462|P1|Treatment Period|Death|14
7798620|NCT00502801|27100462|P1|Treatment Period|Adverse Event|7
7798621|NCT00502801|27100462|P1|Treatment Period|Withdrawal by Subject|3
7798622|NCT00502775|27100470|P3|Overall Study|Subject took disallowed drug|1
7798623|NCT00502775|27100471|P2|Overall Study|Subject took disallowed drug|0
7798624|NCT00502775|27100472|P1|Overall Study|Subject took disallowed drug|0
7798625|NCT00502775|27100470|P3|Overall Study|Subject in jail|0
7798626|NCT00502775|27100471|P2|Overall Study|Subject in jail|1
7798627|NCT00502775|27100472|P1|Overall Study|Subject in jail|0
7798628|NCT00502775|27100470|P3|Overall Study|Declining pollen counts|1
7798629|NCT00502775|27100471|P2|Overall Study|Declining pollen counts|1
7798630|NCT00502775|27100472|P1|Overall Study|Declining pollen counts|0
7798631|NCT00502775|27100470|P3|Overall Study|Outside pollen area more than 48 hours|0
7798632|NCT00502775|27100471|P2|Overall Study|Outside pollen area more than 48 hours|1
7798633|NCT00502775|27100472|P1|Overall Study|Outside pollen area more than 48 hours|0
7798634|NCT00502775|27100470|P3|Overall Study|Non-compliance|2
7798635|NCT00502775|27100471|P2|Overall Study|Non-compliance|2
7798636|NCT00502775|27100472|P1|Overall Study|Non-compliance|0
7798637|NCT00502775|27100470|P3|Overall Study|Randomized in error|1
7798638|NCT00502775|27100471|P2|Overall Study|Randomized in error|1
7798639|NCT00502775|27100472|P1|Overall Study|Randomized in error|0
7798640|NCT00502775|27100470|P3|Overall Study|Logpad compliance <80%|0
7798641|NCT00502775|27100471|P2|Overall Study|Logpad compliance <80%|0
7798642|NCT00502775|27100472|P1|Overall Study|Logpad compliance <80%|1
7798643|NCT00502775|27100470|P3|Overall Study|Subject unable to swallow capsule|1
7798644|NCT00502775|27100471|P2|Overall Study|Subject unable to swallow capsule|0
7798645|NCT00502775|27100472|P1|Overall Study|Subject unable to swallow capsule|1
7798646|NCT00502775|27100470|P3|Overall Study|Non-compliance with eDiary|1
7798647|NCT00502775|27100471|P2|Overall Study|Non-compliance with eDiary|1
7798648|NCT00502775|27100472|P1|Overall Study|Non-compliance with eDiary|4
7798649|NCT00502775|27100470|P3|Overall Study|Sponsor Terminated Study|1
7798650|NCT00502775|27100471|P2|Overall Study|Sponsor Terminated Study|0
7798651|NCT00502775|27100472|P1|Overall Study|Sponsor Terminated Study|1
7798652|NCT00502775|27100470|P3|Overall Study|Withdrawal by Subject|2
7798653|NCT00502775|27100471|P2|Overall Study|Withdrawal by Subject|1
7798654|NCT00502775|27100472|P1|Overall Study|Withdrawal by Subject|1
7798655|NCT00502775|27100470|P3|Overall Study|Protocol Violation|2
7798656|NCT00502775|27100471|P2|Overall Study|Protocol Violation|5
7798657|NCT00502775|27100472|P1|Overall Study|Protocol Violation|1
7798658|NCT00502775|27100470|P3|Overall Study|Adverse Event|1
7798659|NCT00502775|27100471|P2|Overall Study|Adverse Event|2
7798660|NCT00502775|27100472|P1|Overall Study|Adverse Event|1
7798661|NCT00502697|27100515|P2|Overall Study|did not meet assignment criteria|2
7798662|NCT00502697|27100516|P1|Overall Study|did not meet assignment criteria|4
7798663|NCT00502697|27100515|P2|Overall Study|found not to meet eligibility criteria|4
7798664|NCT00502697|27100516|P1|Overall Study|found not to meet eligibility criteria|3
7798665|NCT00502697|27100515|P2|Overall Study|disenrolled due to pregnancy loss|5
7798666|NCT00502697|27100516|P1|Overall Study|disenrolled due to pregnancy loss|3
7798667|NCT00502697|27100515|P2|Overall Study|Withdrawal by Subject|1
7798668|NCT00502697|27100516|P1|Overall Study|Withdrawal by Subject|3
7798669|NCT00502671|27100524|P1|Overall Study|Adverse Event|19
7798670|NCT00502671|27100524|P1|Overall Study|Protocol Violation|16
7798671|NCT00502671|27100524|P1|Overall Study|Lost to Follow-up|7
7798672|NCT00502671|27100524|P1|Overall Study|Personal Reasons|22
7798673|NCT00502671|27100524|P1|Overall Study|Disease Progression|13
7798674|NCT00502593|27100541|P12|Overall Study|Lost to Follow-up|0
7798675|NCT00502593|27100542|P11|Overall Study|Lost to Follow-up|1
7798676|NCT00502593|27100543|P10|Overall Study|Lost to Follow-up|0
7798677|NCT00502593|27100544|P9|Overall Study|Lost to Follow-up|3
7798678|NCT00502593|27100545|P8|Overall Study|Lost to Follow-up|0
7798679|NCT00502593|27100546|P7|Overall Study|Lost to Follow-up|0
7798680|NCT00502593|27100547|P6|Overall Study|Lost to Follow-up|0
7798681|NCT00502593|27100548|P5|Overall Study|Lost to Follow-up|0
7798682|NCT00502593|27100549|P4|Overall Study|Lost to Follow-up|1
7798683|NCT00502593|27100550|P3|Overall Study|Lost to Follow-up|1
7798684|NCT00502593|27100551|P2|Overall Study|Lost to Follow-up|1
7798685|NCT00502593|27100552|P1|Overall Study|Lost to Follow-up|2
7798686|NCT00502593|27100541|P12|Overall Study|Withdrawal by Subject|0
7798687|NCT00502593|27100542|P11|Overall Study|Withdrawal by Subject|1
7798688|NCT00502593|27100543|P10|Overall Study|Withdrawal by Subject|0
7798689|NCT00502593|27100544|P9|Overall Study|Withdrawal by Subject|3
7798690|NCT00502593|27100545|P8|Overall Study|Withdrawal by Subject|0
7798691|NCT00502593|27100546|P7|Overall Study|Withdrawal by Subject|3
7798692|NCT00502593|27100547|P6|Overall Study|Withdrawal by Subject|0
7798693|NCT00502593|27100548|P5|Overall Study|Withdrawal by Subject|2
7798694|NCT00502593|27100549|P4|Overall Study|Withdrawal by Subject|2
7798695|NCT00502593|27100550|P3|Overall Study|Withdrawal by Subject|6
7798696|NCT00502593|27100551|P2|Overall Study|Withdrawal by Subject|0
7798697|NCT00502593|27100552|P1|Overall Study|Withdrawal by Subject|0
7798698|NCT00502593|27100541|P12|Overall Study|Withdrawn unspecified reason|0
7798699|NCT00502593|27100542|P11|Overall Study|Withdrawn unspecified reason|0
7798700|NCT00502593|27100543|P10|Overall Study|Withdrawn unspecified reason|0
7798701|NCT00502593|27100544|P9|Overall Study|Withdrawn unspecified reason|0
7798702|NCT00502593|27100545|P8|Overall Study|Withdrawn unspecified reason|0
7798703|NCT00502593|27100546|P7|Overall Study|Withdrawn unspecified reason|2
7798704|NCT00502593|27100547|P6|Overall Study|Withdrawn unspecified reason|0
7798705|NCT00502593|27100548|P5|Overall Study|Withdrawn unspecified reason|2
7798706|NCT00502593|27100549|P4|Overall Study|Withdrawn unspecified reason|1
7798707|NCT00502593|27100550|P3|Overall Study|Withdrawn unspecified reason|3
7798708|NCT00502593|27100551|P2|Overall Study|Withdrawn unspecified reason|1
7798709|NCT00502593|27100552|P1|Overall Study|Withdrawn unspecified reason|1
7798710|NCT00502320|27101068|P2|Overall Study|Adverse Event|5
7798711|NCT00502320|27101069|P1|Overall Study|Adverse Event|3
7798712|NCT00502320|27101068|P2|Overall Study|Screen Failure|1
7798713|NCT00502320|27101069|P1|Overall Study|Screen Failure|0
7798714|NCT00502320|27101068|P2|Overall Study|No longer met criteria|0
7798715|NCT00502320|27101069|P1|Overall Study|No longer met criteria|1
7798716|NCT00502320|27101068|P2|Overall Study|Withdrew Consent|0
7798717|NCT00502320|27101069|P1|Overall Study|Withdrew Consent|1
7798718|NCT00502320|27101068|P2|Overall Study|Lost to Follow-up|1
7798719|NCT00502320|27101069|P1|Overall Study|Lost to Follow-up|1
7798720|NCT00502307|27101079|P3|Maintenance Period|Discontinued due to other reasons|0
7798721|NCT00502307|27101080|P2|Maintenance Period|Discontinued due to other reasons|0
7798722|NCT00502307|27101081|P1|Maintenance Period|Discontinued due to other reasons|68
7798723|NCT00502307|27101079|P3|Maintenance Period|Progressive disease|0
7798724|NCT00502307|27101080|P2|Maintenance Period|Progressive disease|0
7798725|NCT00502307|27101081|P1|Maintenance Period|Progressive disease|80
7798726|NCT00502307|27101079|P3|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
7798727|NCT00502307|27101080|P2|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
7798728|NCT00502307|27101081|P1|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
7798729|NCT00502307|27101079|P3|Double-Blind Period (12 Weeks)|Progressive disease|2
7798730|NCT00502307|27101080|P2|Double-Blind Period (12 Weeks)|Progressive disease|23
7798731|NCT00502307|27101081|P1|Double-Blind Period (12 Weeks)|Progressive disease|0
7798732|NCT00502307|27101079|P3|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
7798733|NCT00502307|27101080|P2|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
7798734|NCT00502307|27101081|P1|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
7798735|NCT00502307|27101079|P3|Open Label Period (16 Weeks)|Progressive disease|0
7798736|NCT00502307|27101080|P2|Open Label Period (16 Weeks)|Progressive disease|0
7798737|NCT00502307|27101081|P1|Open Label Period (16 Weeks)|Progressive disease|50
7798738|NCT00502242|27101108|P2|Overall Study|Withdrawal by Subject|7
7798739|NCT00502242|27101109|P1|Overall Study|Withdrawal by Subject|6
7798740|NCT00502242|27101108|P2|Overall Study|Protocol Violation|1
7798741|NCT00502242|27101109|P1|Overall Study|Protocol Violation|3
7798742|NCT00502242|27101108|P2|Overall Study|Other - Unspecified|14
7798743|NCT00502242|27101109|P1|Overall Study|Other - Unspecified|8
7798744|NCT00502242|27101108|P2|Overall Study|Physician Decision|3
7798745|NCT00502242|27101109|P1|Overall Study|Physician Decision|2
7798746|NCT00502242|27101108|P2|Overall Study|Adverse Event|20
7798747|NCT00502242|27101109|P1|Overall Study|Adverse Event|31
7798748|NCT00502242|27101108|P2|Overall Study|Lack of Efficacy|11
7798749|NCT00502242|27101109|P1|Overall Study|Lack of Efficacy|1
7798750|NCT00502203|27101173|P1|Overall Study|Inevaluable|1
7798751|NCT00501969|27101182|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
7798752|NCT00501969|27101182|P1|Overall Study|Other: Admin Request from the Sponsor|3
7798753|NCT00501969|27101182|P1|Overall Study|Other: As Required by Local EC|2
7798754|NCT00501969|27101182|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
7798755|NCT00501969|27101182|P1|Overall Study|Other: Pat Pending Surgery for PD|1
7798756|NCT00501969|27101182|P1|Overall Study|Other: Patient is Going to Have DBS|1
7798757|NCT00501969|27101182|P1|Overall Study|Other: Patients + Investigator Agreement|1
7798758|NCT00501969|27101182|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
7798759|NCT00501969|27101182|P1|Overall Study|Other: Sponsor Stopped Study|12
7798760|NCT00501969|27101182|P1|Overall Study|Other: Sponsor Termination at Site|1
7798761|NCT00501969|27101182|P1|Overall Study|Other: Sponsors Request|10
7798762|NCT00501969|27101182|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
7798763|NCT00501969|27101182|P1|Overall Study|Lost to Follow-up|4
7798764|NCT00501969|27101182|P1|Overall Study|Subject withdrew consent|51
7798765|NCT00501969|27101182|P1|Overall Study|Unsatisfactory compliance of subject|7
7798766|NCT00501969|27101182|P1|Overall Study|Adverse Event|76
7798767|NCT00501969|27101182|P1|Overall Study|Lack of Efficacy|29
7798768|NCT00501969|27101182|P1|Overall Study|Major Protocol Violation|4
7798769|NCT00501852|27101214|P1|Overall Study|Withdrawal by Subject|2
7798770|NCT00501852|27101214|P1|Overall Study|Adverse Event|3
7798771|NCT00501644|27101234|P1|Overall Study|Withdrawal by Subject|1
7798772|NCT00501644|27101234|P1|Overall Study|Adverse Event|4
7798773|NCT00501540|27101263|P1|Overall Study|Death|5
7798774|NCT00501293|27101275|P2|Maintenance Period|Application site reaction|0
7798775|NCT00501293|27101276|P1|Maintenance Period|Application site reaction|1
7798776|NCT00501293|27101275|P2|Maintenance Period|Would not wear patch|0
7798777|NCT00501293|27101276|P1|Maintenance Period|Would not wear patch|1
7798778|NCT00501293|27101275|P2|Maintenance Period|Went into rehabilitation|0
7798779|NCT00501293|27101276|P1|Maintenance Period|Went into rehabilitation|1
7798780|NCT00501293|27101275|P2|Maintenance Period|Noncompliant with study medication|0
7798781|NCT00501293|27101276|P1|Maintenance Period|Noncompliant with study medication|5
7798782|NCT00501293|27101275|P2|Maintenance Period|Lack of Efficacy|1
7798783|NCT00501293|27101276|P1|Maintenance Period|Lack of Efficacy|4
7798784|NCT00501293|27101275|P2|Maintenance Period|Protocol Violation|1
7798785|NCT00501293|27101276|P1|Maintenance Period|Protocol Violation|2
7798786|NCT00501293|27101275|P2|Maintenance Period|Adverse Event|6
7798787|NCT00501293|27101276|P1|Maintenance Period|Adverse Event|6
7798788|NCT00501293|27101275|P2|Maintenance Period|Lost to Follow-up|7
7798789|NCT00501293|27101276|P1|Maintenance Period|Lost to Follow-up|12
7798790|NCT00501293|27101275|P2|Maintenance Period|Withdrawal by Subject|13
7798791|NCT00501293|27101276|P1|Maintenance Period|Withdrawal by Subject|14
7798792|NCT00501293|27101275|P2|Optimization Period|Enrolled in error|0
7798793|NCT00501293|27101276|P1|Optimization Period|Enrolled in error|1
7798794|NCT00501228|27101303|P1|Overall Study|Withdrawal by Subject|1
7798795|NCT00501085|27101307|P1|Overall Study|Other loss to follow-up|32
7798796|NCT00501085|27101307|P1|Overall Study|Study closed by sponsor|109
7798797|NCT00501085|27101307|P1|Overall Study|Non-Compliance|24
7798798|NCT00501085|27101307|P1|Overall Study|Adverse Event|4
7798799|NCT00501085|27101307|P1|Overall Study|Explantation Surgery|26
7798800|NCT00501085|27101307|P1|Overall Study|Revision Surgery|7
7798801|NCT00501085|27101307|P1|Overall Study|Subject Decision|1
7798802|NCT00501085|27101307|P1|Overall Study|Withdrawal by Subject|34
7798803|NCT00501085|27101307|P1|Overall Study|Lost to Follow-up|195
7798804|NCT00501059|27101317|P2|Overall Study|Not treated|17
7798805|NCT00501059|27101318|P1|Overall Study|Not treated|25
7798806|NCT00501059|27101317|P2|Overall Study|Lost to Follow-up|198
7798807|NCT00501059|27101318|P1|Overall Study|Lost to Follow-up|210
7798808|NCT00501059|27101317|P2|Overall Study|Adverse Event|122
7798809|NCT00501059|27101318|P1|Overall Study|Adverse Event|129
7798810|NCT00501059|27101317|P2|Overall Study|Reason not given|1
7798811|NCT00501059|27101318|P1|Overall Study|Reason not given|3
7798812|NCT00501059|27101317|P2|Overall Study|Non-compliant with study treatment|16
7798813|NCT00501059|27101318|P1|Overall Study|Non-compliant with study treatment|23
7798814|NCT00501059|27101317|P2|Overall Study|Consent withdrawn by subject|873
7798815|NCT00501059|27101318|P1|Overall Study|Consent withdrawn by subject|817
7798816|NCT00501059|27101317|P2|Overall Study|Insufficient therapeutic effect|5
7798817|NCT00501059|27101318|P1|Overall Study|Insufficient therapeutic effect|4
7798818|NCT00501059|27101317|P2|Overall Study|Clinical endpoint reached|123
7798819|NCT00501059|27101318|P1|Overall Study|Clinical endpoint reached|110
7798820|NCT00501059|27101317|P2|Overall Study|Missing end-of-study page|92
7798821|NCT00501059|27101318|P1|Overall Study|Missing end-of-study page|91
7798822|NCT00501059|27101317|P2|Overall Study|Other|239
7798823|NCT00501059|27101318|P1|Overall Study|Other|236
7798824|NCT00501059|27101317|P2|Overall Study|Death|137
7798825|NCT00501059|27101318|P1|Overall Study|Death|140
7798826|NCT00501059|27101317|P2|Overall Study|Protocol Violation|69
7798827|NCT00501059|27101318|P1|Overall Study|Protocol Violation|80
7798828|NCT00501046|27101342|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
7798829|NCT00501046|27101343|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
7798830|NCT00501046|27101342|P2|Overall Study|Withdrawal by Subject|83
7798831|NCT00501046|27101343|P1|Overall Study|Withdrawal by Subject|84
7798832|NCT00501046|27101342|P2|Overall Study|Protocol Violation|1
7798833|NCT00501046|27101343|P1|Overall Study|Protocol Violation|2
7798834|NCT00501046|27101342|P2|Overall Study|Pregnancy|3
7798835|NCT00501046|27101343|P1|Overall Study|Pregnancy|0
7798836|NCT00501046|27101342|P2|Overall Study|Physician Decision|2
7798837|NCT00501046|27101343|P1|Overall Study|Physician Decision|7
7798838|NCT00501046|27101342|P2|Overall Study|Lost to Follow-up|13
7798839|NCT00501046|27101343|P1|Overall Study|Lost to Follow-up|14
7798840|NCT00501046|27101342|P2|Overall Study|Death|30
7798841|NCT00501046|27101343|P1|Overall Study|Death|23
7798842|NCT00501046|27101342|P2|Overall Study|Adverse Event|25
7798843|NCT00501046|27101343|P1|Overall Study|Adverse Event|21
7798844|NCT00501007|27101349|P2|Overall Study|Inclusion criteria not met.|25
7798845|NCT00501007|27101350|P1|Overall Study|Inclusion criteria not met.|29
7798846|NCT00500903|27101359|P3|Overall Study|Reason Not Specified|2
7798847|NCT00500903|27101360|P2|Overall Study|Reason Not Specified|0
7798848|NCT00500903|27101361|P1|Overall Study|Reason Not Specified|10
7798849|NCT00500903|27101359|P3|Overall Study|Symptomatic Deterioration|0
7798850|NCT00500903|27101360|P2|Overall Study|Symptomatic Deterioration|0
7798851|NCT00500903|27101361|P1|Overall Study|Symptomatic Deterioration|2
7798852|NCT00500903|27101359|P3|Overall Study|Patient Declined Further Treatment|3
7798853|NCT00500903|27101360|P2|Overall Study|Patient Declined Further Treatment|0
7798854|NCT00500903|27101361|P1|Overall Study|Patient Declined Further Treatment|0
7798855|NCT00500903|27101359|P3|Overall Study|Progressive Disease|15
7798856|NCT00500903|27101360|P2|Overall Study|Progressive Disease|2
7798857|NCT00500903|27101361|P1|Overall Study|Progressive Disease|41
7798858|NCT00500903|27101359|P3|Overall Study|Unsatisfactory Therapeutic Response|0
7798859|NCT00500903|27101360|P2|Overall Study|Unsatisfactory Therapeutic Response|0
7798860|NCT00500903|27101361|P1|Overall Study|Unsatisfactory Therapeutic Response|2
7798861|NCT00500903|27101359|P3|Overall Study|Occurrence of Adverse Event(s)|0
7798862|NCT00500903|27101360|P2|Overall Study|Occurrence of Adverse Event(s)|0
7798863|NCT00500903|27101361|P1|Overall Study|Occurrence of Adverse Event(s)|10
7798864|NCT00500760|27101557|P2|Overall Study|Other|2
7798865|NCT00500760|27101558|P1|Overall Study|Other|1
7798866|NCT00500760|27101557|P2|Overall Study|Lost to Follow-up|0
7798867|NCT00500760|27101558|P1|Overall Study|Lost to Follow-up|3
7798868|NCT00500760|27101557|P2|Overall Study|Administrative decision|0
7798869|NCT00500760|27101558|P1|Overall Study|Administrative decision|2
7798870|NCT00500760|27101557|P2|Overall Study|Withdrawal by Subject|7
7798871|NCT00500760|27101558|P1|Overall Study|Withdrawal by Subject|5
7798872|NCT00500760|27101557|P2|Overall Study|Death|15
7798873|NCT00500760|27101558|P1|Overall Study|Death|32
7798874|NCT00500682|27101578|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
7798875|NCT00500682|27101579|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
7798876|NCT00500682|27101578|P2|Overall Study|Withdrawal by Subject|74
7798877|NCT00500682|27101579|P1|Overall Study|Withdrawal by Subject|80
7798878|NCT00500682|27101578|P2|Overall Study|Protocol Violation|3
7798879|NCT00500682|27101579|P1|Overall Study|Protocol Violation|1
7798880|NCT00500682|27101578|P2|Overall Study|Pregnancy|0
7798881|NCT00500682|27101579|P1|Overall Study|Pregnancy|2
7798882|NCT00500682|27101578|P2|Overall Study|Physician Decision|10
7798883|NCT00500682|27101579|P1|Overall Study|Physician Decision|6
7798884|NCT00500682|27101578|P2|Overall Study|Lost to Follow-up|11
7798885|NCT00500682|27101579|P1|Overall Study|Lost to Follow-up|11
7798886|NCT00500682|27101578|P2|Overall Study|Death|16
7798887|NCT00500682|27101579|P1|Overall Study|Death|25
7798888|NCT00500682|27101578|P2|Overall Study|Adverse Event|29
7798889|NCT00500682|27101579|P1|Overall Study|Adverse Event|37
7798890|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Missing|3
7798891|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
7798892|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Death|1
7798893|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Administrative problems|1
7798894|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
7798895|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
7798896|NCT00500539|27101613|P1|Follow-up Period (16 Weeks)|Adverse Event|1
7798897|NCT00500539|27101613|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
7798898|NCT00500539|27101613|P1|Treatment Period (24 Weeks)|Administrative problems|2
7798899|NCT00500539|27101613|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
7798900|NCT00500539|27101613|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
7798901|NCT00500539|27101613|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
7798902|NCT00500539|27101613|P1|Treatment Period (24 Weeks)|Adverse Event|4
7798903|NCT00500370|27101639|P2|Overall Study|Subject Decision|17
7798904|NCT00500370|27101640|P1|Overall Study|Subject Decision|10
7798905|NCT00500370|27101639|P2|Overall Study|Sponsor Decision|0
7798906|NCT00500370|27101640|P1|Overall Study|Sponsor Decision|2
7798907|NCT00500370|27101639|P2|Overall Study|Protocol Violation|4
7798908|NCT00500370|27101640|P1|Overall Study|Protocol Violation|2
7798909|NCT00500370|27101639|P2|Overall Study|Lost to Follow-up|10
7798910|NCT00500370|27101640|P1|Overall Study|Lost to Follow-up|10
7798911|NCT00500370|27101639|P2|Overall Study|Adverse Event|3
7798912|NCT00500370|27101640|P1|Overall Study|Adverse Event|9
7798913|NCT00500357|27101676|P1|Overall Study|Death|1
7798914|NCT00500331|27101702|P7|Overall Study|Protocol violated|0
7798915|NCT00500331|27101703|P6|Overall Study|Protocol violated|0
7798916|NCT00500331|27101704|P5|Overall Study|Protocol violated|0
7798917|NCT00500331|27101705|P4|Overall Study|Protocol violated|1
7798918|NCT00500331|27101706|P3|Overall Study|Protocol violated|0
7798919|NCT00500331|27101707|P2|Overall Study|Protocol violated|0
7798920|NCT00500331|27101708|P1|Overall Study|Protocol violated|0
7798921|NCT00500331|27101702|P7|Overall Study|State ban of biological samples export|0
7798922|NCT00500331|27101703|P6|Overall Study|State ban of biological samples export|0
7798923|NCT00500331|27101704|P5|Overall Study|State ban of biological samples export|0
7798924|NCT00500331|27101705|P4|Overall Study|State ban of biological samples export|1
7798925|NCT00500331|27101706|P3|Overall Study|State ban of biological samples export|0
7798926|NCT00500331|27101707|P2|Overall Study|State ban of biological samples export|0
7798927|NCT00500331|27101708|P1|Overall Study|State ban of biological samples export|0
7798928|NCT00500331|27101702|P7|Overall Study|Diabetologist nurse in the study|0
7798929|NCT00500331|27101703|P6|Overall Study|Diabetologist nurse in the study|0
7798930|NCT00500331|27101704|P5|Overall Study|Diabetologist nurse in the study|0
7798931|NCT00500331|27101705|P4|Overall Study|Diabetologist nurse in the study|0
7798932|NCT00500331|27101706|P3|Overall Study|Diabetologist nurse in the study|1
7798933|NCT00500331|27101707|P2|Overall Study|Diabetologist nurse in the study|0
7798934|NCT00500331|27101708|P1|Overall Study|Diabetologist nurse in the study|0
7798935|NCT00500331|27101702|P7|Overall Study|Participant was randomized by mistake|0
7798936|NCT00500331|27101703|P6|Overall Study|Participant was randomized by mistake|0
7798937|NCT00500331|27101704|P5|Overall Study|Participant was randomized by mistake|0
7798938|NCT00500331|27101705|P4|Overall Study|Participant was randomized by mistake|0
7798939|NCT00500331|27101706|P3|Overall Study|Participant was randomized by mistake|0
7798940|NCT00500331|27101707|P2|Overall Study|Participant was randomized by mistake|0
7798941|NCT00500331|27101708|P1|Overall Study|Participant was randomized by mistake|1
7798942|NCT00500331|27101702|P7|Overall Study|Sponsor decided to withdraw participant|0
7798943|NCT00500331|27101703|P6|Overall Study|Sponsor decided to withdraw participant|0
7798944|NCT00500331|27101704|P5|Overall Study|Sponsor decided to withdraw participant|0
7798945|NCT00500331|27101705|P4|Overall Study|Sponsor decided to withdraw participant|0
7798946|NCT00500331|27101706|P3|Overall Study|Sponsor decided to withdraw participant|0
7798947|NCT00500331|27101707|P2|Overall Study|Sponsor decided to withdraw participant|0
7798948|NCT00500331|27101708|P1|Overall Study|Sponsor decided to withdraw participant|1
7798949|NCT00500331|27101702|P7|Overall Study|Exclusion citeria not met on Visit 4|0
7798950|NCT00500331|27101703|P6|Overall Study|Exclusion citeria not met on Visit 4|0
7798951|NCT00500331|27101704|P5|Overall Study|Exclusion citeria not met on Visit 4|0
7798952|NCT00500331|27101705|P4|Overall Study|Exclusion citeria not met on Visit 4|0
7798953|NCT00500331|27101706|P3|Overall Study|Exclusion citeria not met on Visit 4|0
7798954|NCT00500331|27101707|P2|Overall Study|Exclusion citeria not met on Visit 4|0
7798955|NCT00500331|27101708|P1|Overall Study|Exclusion citeria not met on Visit 4|1
7798956|NCT00500331|27101702|P7|Overall Study|Didn't return for continuation of study|0
7798957|NCT00500331|27101703|P6|Overall Study|Didn't return for continuation of study|0
7798958|NCT00500331|27101704|P5|Overall Study|Didn't return for continuation of study|0
7798959|NCT00500331|27101705|P4|Overall Study|Didn't return for continuation of study|0
7798960|NCT00500331|27101706|P3|Overall Study|Didn't return for continuation of study|0
7798961|NCT00500331|27101707|P2|Overall Study|Didn't return for continuation of study|0
7798962|NCT00500331|27101708|P1|Overall Study|Didn't return for continuation of study|1
7798963|NCT00500331|27101702|P7|Overall Study|Increased serum creatinine from Baseline|0
7798964|NCT00500331|27101703|P6|Overall Study|Increased serum creatinine from Baseline|1
7798965|NCT00500331|27101704|P5|Overall Study|Increased serum creatinine from Baseline|0
7798966|NCT00500331|27101705|P4|Overall Study|Increased serum creatinine from Baseline|0
7798967|NCT00500331|27101706|P3|Overall Study|Increased serum creatinine from Baseline|0
7798968|NCT00500331|27101707|P2|Overall Study|Increased serum creatinine from Baseline|0
7798969|NCT00500331|27101708|P1|Overall Study|Increased serum creatinine from Baseline|0
7798970|NCT00500331|27101702|P7|Overall Study|Liver function test abnormality|0
7798971|NCT00500331|27101703|P6|Overall Study|Liver function test abnormality|0
7798972|NCT00500331|27101704|P5|Overall Study|Liver function test abnormality|0
7798973|NCT00500331|27101705|P4|Overall Study|Liver function test abnormality|0
7798974|NCT00500331|27101706|P3|Overall Study|Liver function test abnormality|1
7798975|NCT00500331|27101707|P2|Overall Study|Liver function test abnormality|0
7798976|NCT00500331|27101708|P1|Overall Study|Liver function test abnormality|0
7798977|NCT00500331|27101702|P7|Overall Study|Lack of Efficacy|0
7798978|NCT00500331|27101703|P6|Overall Study|Lack of Efficacy|0
7798979|NCT00500331|27101704|P5|Overall Study|Lack of Efficacy|0
7798980|NCT00500331|27101705|P4|Overall Study|Lack of Efficacy|0
7798981|NCT00500331|27101706|P3|Overall Study|Lack of Efficacy|0
7798982|NCT00500331|27101707|P2|Overall Study|Lack of Efficacy|1
7798983|NCT00500331|27101708|P1|Overall Study|Lack of Efficacy|3
7798984|NCT00500331|27101702|P7|Overall Study|Withdrawal by Subject|1
7798985|NCT00500331|27101703|P6|Overall Study|Withdrawal by Subject|1
7798986|NCT00500331|27101704|P5|Overall Study|Withdrawal by Subject|0
7798987|NCT00500331|27101705|P4|Overall Study|Withdrawal by Subject|5
7798988|NCT00500331|27101706|P3|Overall Study|Withdrawal by Subject|1
7798989|NCT00500331|27101707|P2|Overall Study|Withdrawal by Subject|0
7798990|NCT00500331|27101708|P1|Overall Study|Withdrawal by Subject|4
7798991|NCT00500331|27101702|P7|Overall Study|Protocol Violation|1
7798992|NCT00500331|27101703|P6|Overall Study|Protocol Violation|1
7798993|NCT00500331|27101704|P5|Overall Study|Protocol Violation|1
7798994|NCT00500331|27101705|P4|Overall Study|Protocol Violation|0
7798995|NCT00500331|27101706|P3|Overall Study|Protocol Violation|1
7798996|NCT00500331|27101707|P2|Overall Study|Protocol Violation|1
7798997|NCT00500331|27101708|P1|Overall Study|Protocol Violation|3
7798998|NCT00500331|27101702|P7|Overall Study|Lost to Follow-up|0
7798999|NCT00500331|27101703|P6|Overall Study|Lost to Follow-up|0
7799000|NCT00500331|27101704|P5|Overall Study|Lost to Follow-up|1
7799001|NCT00500331|27101705|P4|Overall Study|Lost to Follow-up|2
7799002|NCT00500331|27101706|P3|Overall Study|Lost to Follow-up|1
7799003|NCT00500331|27101707|P2|Overall Study|Lost to Follow-up|1
7799004|NCT00500331|27101708|P1|Overall Study|Lost to Follow-up|1
7799005|NCT00500331|27101702|P7|Overall Study|Adverse Event|0
7799006|NCT00500331|27101703|P6|Overall Study|Adverse Event|2
7799007|NCT00500331|27101704|P5|Overall Study|Adverse Event|2
7799008|NCT00500331|27101705|P4|Overall Study|Adverse Event|1
7799009|NCT00500331|27101706|P3|Overall Study|Adverse Event|0
7799010|NCT00500331|27101707|P2|Overall Study|Adverse Event|2
7799011|NCT00500331|27101708|P1|Overall Study|Adverse Event|0
7799012|NCT00500318|27101845|P2|Overall Study|Other Reason|1
7799013|NCT00500318|27101846|P1|Overall Study|Other Reason|0
7799014|NCT00500318|27101845|P2|Overall Study|Lack of Efficacy|3
7799015|NCT00500318|27101846|P1|Overall Study|Lack of Efficacy|0
7799016|NCT00500318|27101845|P2|Overall Study|Withdrawal by Subject|2
7799017|NCT00500318|27101846|P1|Overall Study|Withdrawal by Subject|1
7799018|NCT00500318|27101845|P2|Overall Study|Protocol Violation|3
7799019|NCT00500318|27101846|P1|Overall Study|Protocol Violation|1
7799020|NCT00500318|27101845|P2|Overall Study|Adverse Event|8
7799021|NCT00500318|27101846|P1|Overall Study|Adverse Event|3
7799022|NCT00500292|27101863|P3|Overall Study|Other|4
7799023|NCT00500292|27101864|P2|Overall Study|Other|1
7799024|NCT00500292|27101865|P1|Overall Study|Other|1
7799025|NCT00500292|27101863|P3|Overall Study|Withdrawal by Subject|0
7799026|NCT00500292|27101864|P2|Overall Study|Withdrawal by Subject|1
7799027|NCT00500292|27101865|P1|Overall Study|Withdrawal by Subject|0
7799028|NCT00500292|27101863|P3|Overall Study|Condition under investigation worsened|19
7799029|NCT00500292|27101864|P2|Overall Study|Condition under investigation worsened|23
7799030|NCT00500292|27101865|P1|Overall Study|Condition under investigation worsened|21
7799031|NCT00500292|27101863|P3|Overall Study|Adverse Event|4
7799032|NCT00500292|27101864|P2|Overall Study|Adverse Event|6
7799033|NCT00500292|27101865|P1|Overall Study|Adverse Event|3
7799034|NCT00500149|27101886|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
7799035|NCT00500149|27101887|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
7799036|NCT00500149|27101886|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
7799037|NCT00500149|27101887|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
7799038|NCT00500149|27101886|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
7799039|NCT00500149|27101887|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
7799040|NCT00500149|27101886|P2|First Intervention (Cross-over Phase)|Adverse Event|1
7799041|NCT00500149|27101887|P1|First Intervention (Cross-over Phase)|Adverse Event|0
7799042|NCT00500149|27101886|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
7799043|NCT00500149|27101887|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
7799044|NCT00500149|27101886|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
7799045|NCT00500149|27101887|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
7799046|NCT00500149|27101886|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
7799047|NCT00500149|27101887|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
7799048|NCT00500110|27101895|P1|Overall Study|Withdrawal by Subject|3
7799049|NCT00500071|27101899|P1|30-day Safety Follow-up|Lost to Follow-up|17
7799050|NCT00500071|27101899|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
7799051|NCT00500071|27101899|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
7799052|NCT00500071|27101899|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
7799053|NCT00500071|27101899|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
7799054|NCT00500071|27101899|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
7799055|NCT00500071|27101899|P1|Screening and Washout Phase|Protocol Violation|1
7799056|NCT00499889|27101922|P1|Overall Study|Infection prior to treatment|1
7799057|NCT00499863|27101930|P2|Overall Study|Lost to Follow-up|1
7799058|NCT00499863|27101931|P1|Overall Study|Lost to Follow-up|1
7799059|NCT00499863|27101930|P2|Overall Study|Sponsor decision|2
7799060|NCT00499863|27101931|P1|Overall Study|Sponsor decision|2
7799061|NCT00499863|27101930|P2|Overall Study|Adverse Event|2
7799062|NCT00499863|27101931|P1|Overall Study|Adverse Event|8
7799063|NCT00499863|27101930|P2|Overall Study|Withdrawal by Subject|4
7799064|NCT00499863|27101931|P1|Overall Study|Withdrawal by Subject|6
7799065|NCT00499863|27101930|P2|Overall Study|Protocol Violation|7
7799066|NCT00499863|27101931|P1|Overall Study|Protocol Violation|12
7799067|NCT00499863|27101930|P2|Overall Study|Lack of Efficacy|27
7799068|NCT00499863|27101931|P1|Overall Study|Lack of Efficacy|21
7799069|NCT00500266|27101959|P1|Overall Study|Assigned, not treated|4
7799070|NCT00500266|27101959|P1|Overall Study|Withdrawal by Subject|3
7799071|NCT00500266|27101959|P1|Overall Study|Lost to Follow-up|3
7799072|NCT00500266|27101959|P1|Overall Study|Death|3
7799073|NCT00499746|27101966|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
7799074|NCT00499746|27101966|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
7799075|NCT00499746|27101966|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
7799076|NCT00499746|27101966|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
7799077|NCT00499694|27102035|P1|Overall Study|Patient never received treatment.|1
7799078|NCT00499681|27102044|P2|Overall Study|disease progression|1
7799079|NCT00499681|27102045|P1|Overall Study|disease progression|0
7799080|NCT00499681|27102044|P2|Overall Study|toxicity|1
7799081|NCT00499681|27102045|P1|Overall Study|toxicity|0
7799082|NCT00499616|27102072|P4|Overall Study|Patient/Parent Refusal|0
7799083|NCT00499616|27102073|P3|Overall Study|Patient/Parent Refusal|3
7799084|NCT00499616|27102074|P2|Overall Study|Patient/Parent Refusal|5
7799085|NCT00499616|27102075|P1|Overall Study|Patient/Parent Refusal|1
7799086|NCT00499616|27102072|P4|Overall Study|Not evaluable|41
7799087|NCT00499616|27102073|P3|Overall Study|Not evaluable|0
7799088|NCT00499616|27102074|P2|Overall Study|Not evaluable|0
7799089|NCT00499616|27102075|P1|Overall Study|Not evaluable|0
7799090|NCT00499616|27102072|P4|Overall Study|Ineligible|15
7799091|NCT00499616|27102073|P3|Overall Study|Ineligible|0
7799092|NCT00499616|27102074|P2|Overall Study|Ineligible|2
7799093|NCT00499616|27102075|P1|Overall Study|Ineligible|1
7799094|NCT00499616|27102072|P4|Overall Study|Withdrawal by Subject|0
7799095|NCT00499616|27102073|P3|Overall Study|Withdrawal by Subject|1
7799096|NCT00499616|27102074|P2|Overall Study|Withdrawal by Subject|0
7799097|NCT00499616|27102075|P1|Overall Study|Withdrawal by Subject|1
7799098|NCT00499616|27102072|P4|Overall Study|Physician Decision|0
7799099|NCT00499616|27102073|P3|Overall Study|Physician Decision|9
7799100|NCT00499616|27102074|P2|Overall Study|Physician Decision|16
7799101|NCT00499616|27102075|P1|Overall Study|Physician Decision|6
7799102|NCT00499616|27102072|P4|Overall Study|Lost to Follow-up|0
7799103|NCT00499616|27102073|P3|Overall Study|Lost to Follow-up|1
7799104|NCT00499616|27102074|P2|Overall Study|Lost to Follow-up|0
7799105|NCT00499616|27102075|P1|Overall Study|Lost to Follow-up|0
7799106|NCT00499616|27102072|P4|Overall Study|Lack of Efficacy|0
7799107|NCT00499616|27102073|P3|Overall Study|Lack of Efficacy|19
7799108|NCT00499616|27102074|P2|Overall Study|Lack of Efficacy|0
7799109|NCT00499616|27102075|P1|Overall Study|Lack of Efficacy|5
7799110|NCT00499616|27102072|P4|Overall Study|Death|1
7799111|NCT00499616|27102073|P3|Overall Study|Death|3
7799112|NCT00499616|27102074|P2|Overall Study|Death|5
7799113|NCT00499616|27102075|P1|Overall Study|Death|1
7799114|NCT00499603|27102120|P2|Overall Study|Adverse Event|1
7799115|NCT00499603|27102121|P1|Overall Study|Adverse Event|0
7799116|NCT00499590|27102134|P3|Overall Study|Not treated|1
7799117|NCT00499590|27102135|P2|Overall Study|Not treated|0
7799118|NCT00499590|27102136|P1|Overall Study|Not treated|1
7799119|NCT00499590|27102134|P3|Overall Study|Study Terminated|112
7799120|NCT00499590|27102135|P2|Overall Study|Study Terminated|112
7799121|NCT00499590|27102136|P1|Overall Study|Study Terminated|112
7799122|NCT00499486|27102147|P1|Overall Study|Withdrawal by Subject|16
7799123|NCT00499460|27102174|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
7799124|NCT00499460|27102175|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
7799125|NCT00499460|27102174|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
7799126|NCT00499460|27102175|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
7799127|NCT00499460|27102174|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
7799128|NCT00499460|27102175|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
7799129|NCT00499369|27102208|P5|Overall Study|Ineligible|0
7799130|NCT00499369|27102209|P4|Overall Study|Ineligible|1
7799131|NCT00499369|27102210|P3|Overall Study|Ineligible|1
7799132|NCT00499369|27102211|P2|Overall Study|Ineligible|2
7799133|NCT00499369|27102212|P1|Overall Study|Ineligible|2
7799134|NCT00499369|27102208|P5|Overall Study|Not protocol specified|0
7799135|NCT00499369|27102209|P4|Overall Study|Not protocol specified|1
7799136|NCT00499369|27102210|P3|Overall Study|Not protocol specified|3
7799137|NCT00499369|27102211|P2|Overall Study|Not protocol specified|0
7799138|NCT00499369|27102212|P1|Overall Study|Not protocol specified|2
7799139|NCT00499369|27102208|P5|Overall Study|Death|0
7799140|NCT00499369|27102209|P4|Overall Study|Death|0
7799141|NCT00499369|27102210|P3|Overall Study|Death|0
7799142|NCT00499369|27102211|P2|Overall Study|Death|1
7799143|NCT00499369|27102212|P1|Overall Study|Death|0
7799144|NCT00499369|27102208|P5|Overall Study|Progression|10
7799145|NCT00499369|27102209|P4|Overall Study|Progression|6
7799146|NCT00499369|27102210|P3|Overall Study|Progression|9
7799147|NCT00499369|27102211|P2|Overall Study|Progression|12
7799148|NCT00499369|27102212|P1|Overall Study|Progression|10
7799149|NCT00499369|27102208|P5|Overall Study|Withdrawal by Subject|0
7799150|NCT00499369|27102209|P4|Overall Study|Withdrawal by Subject|0
7799151|NCT00499369|27102210|P3|Overall Study|Withdrawal by Subject|1
7799152|NCT00499369|27102211|P2|Overall Study|Withdrawal by Subject|1
7799153|NCT00499369|27102212|P1|Overall Study|Withdrawal by Subject|0
7799154|NCT00499369|27102208|P5|Overall Study|Adverse Event|2
7799155|NCT00499369|27102209|P4|Overall Study|Adverse Event|1
7799156|NCT00499369|27102210|P3|Overall Study|Adverse Event|3
7799157|NCT00499369|27102211|P2|Overall Study|Adverse Event|2
7799158|NCT00499369|27102212|P1|Overall Study|Adverse Event|2
7799159|NCT00499252|27102248|P1|Overall Study|<no further label>|3
7799160|NCT00499252|27102248|P1|Overall Study|Ineligible|4
7799161|NCT00499252|27102248|P1|Overall Study|Refused further treatment|2
7799162|NCT00499252|27102248|P1|Overall Study|Adverse Event|3
7799163|NCT00499174|27102260|P2|Overall Study|Physician Decision|9
7799164|NCT00499174|27102261|P1|Overall Study|Physician Decision|78
7799165|NCT00499122|27102269|P1|Overall Study|Withdrawal by Subject|2
7799166|NCT00499083|27102312|P1|Overall Study|Not evaluable|3
7799167|NCT00499031|27102319|P1|Overall Study|Never treated|1
7799168|NCT00499031|27102319|P1|Overall Study|Required test not done|1
7799169|NCT00499031|27102319|P1|Overall Study|Improper pre-protocol treatment|1
7799170|NCT00498797|27102342|P2|Overall Study|Other|1
7799171|NCT00498797|27102343|P1|Overall Study|Other|3
7799172|NCT00498797|27102342|P2|Overall Study|Condition under investigation worsened|21
7799173|NCT00498797|27102343|P1|Overall Study|Condition under investigation worsened|19
7799174|NCT00498797|27102342|P2|Overall Study|Adverse Event|5
7799175|NCT00498797|27102343|P1|Overall Study|Adverse Event|12
7799176|NCT00498797|27102342|P2|Overall Study|Withdrawal by Subject|2
7799177|NCT00498797|27102343|P1|Overall Study|Withdrawal by Subject|4
7799178|NCT00498602|27102427|P7|Overall Study|Other|0
7799179|NCT00498602|27102428|P6|Overall Study|Other|3
7799180|NCT00498602|27102429|P5|Overall Study|Other|0
7799181|NCT00498602|27102430|P4|Overall Study|Other|0
7799182|NCT00498602|27102431|P3|Overall Study|Other|1
7799183|NCT00498602|27102432|P2|Overall Study|Other|3
7799184|NCT00498602|27102433|P1|Overall Study|Other|2
7799185|NCT00498602|27102427|P7|Overall Study|Subject Request|1
7799186|NCT00498602|27102428|P6|Overall Study|Subject Request|4
7799187|NCT00498602|27102429|P5|Overall Study|Subject Request|1
7799188|NCT00498602|27102430|P4|Overall Study|Subject Request|1
7799189|NCT00498602|27102431|P3|Overall Study|Subject Request|1
7799190|NCT00498602|27102432|P2|Overall Study|Subject Request|0
7799191|NCT00498602|27102433|P1|Overall Study|Subject Request|3
7799192|NCT00498602|27102427|P7|Overall Study|Investigator Request|0
7799193|NCT00498602|27102428|P6|Overall Study|Investigator Request|0
7799194|NCT00498602|27102429|P5|Overall Study|Investigator Request|0
7799195|NCT00498602|27102430|P4|Overall Study|Investigator Request|0
7799196|NCT00498602|27102431|P3|Overall Study|Investigator Request|1
7799197|NCT00498602|27102432|P2|Overall Study|Investigator Request|0
7799198|NCT00498602|27102433|P1|Overall Study|Investigator Request|0
7799199|NCT00498602|27102427|P7|Overall Study|Caregiver Request|0
7799200|NCT00498602|27102428|P6|Overall Study|Caregiver Request|2
7799201|NCT00498602|27102429|P5|Overall Study|Caregiver Request|1
7799202|NCT00498602|27102430|P4|Overall Study|Caregiver Request|0
7799203|NCT00498602|27102431|P3|Overall Study|Caregiver Request|2
7799204|NCT00498602|27102432|P2|Overall Study|Caregiver Request|2
7799205|NCT00498602|27102433|P1|Overall Study|Caregiver Request|2
7799206|NCT00498602|27102427|P7|Overall Study|AE not related to Study Drug|1
7799207|NCT00498602|27102428|P6|Overall Study|AE not related to Study Drug|2
7799208|NCT00498602|27102429|P5|Overall Study|AE not related to Study Drug|2
7799209|NCT00498602|27102430|P4|Overall Study|AE not related to Study Drug|0
7799210|NCT00498602|27102431|P3|Overall Study|AE not related to Study Drug|0
7799211|NCT00498602|27102432|P2|Overall Study|AE not related to Study Drug|3
7799212|NCT00498602|27102433|P1|Overall Study|AE not related to Study Drug|1
7799213|NCT00498602|27102427|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
7799214|NCT00498602|27102428|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
7799215|NCT00498602|27102429|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
7799216|NCT00498602|27102430|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
7799217|NCT00498602|27102431|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
7799218|NCT00498602|27102432|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
7799219|NCT00498602|27102433|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
7799220|NCT00498602|27102427|P7|Overall Study|Lost to Follow-up|0
7799221|NCT00498602|27102428|P6|Overall Study|Lost to Follow-up|0
7799222|NCT00498602|27102429|P5|Overall Study|Lost to Follow-up|0
7799223|NCT00498602|27102430|P4|Overall Study|Lost to Follow-up|2
7799224|NCT00498602|27102431|P3|Overall Study|Lost to Follow-up|0
7799225|NCT00498602|27102432|P2|Overall Study|Lost to Follow-up|2
7799226|NCT00498602|27102433|P1|Overall Study|Lost to Follow-up|0
7799227|NCT00498602|27102427|P7|Overall Study|Lack of Efficacy|0
7799228|NCT00498602|27102428|P6|Overall Study|Lack of Efficacy|0
7799229|NCT00498602|27102429|P5|Overall Study|Lack of Efficacy|0
7799230|NCT00498602|27102430|P4|Overall Study|Lack of Efficacy|0
7799231|NCT00498602|27102431|P3|Overall Study|Lack of Efficacy|0
7799232|NCT00498602|27102432|P2|Overall Study|Lack of Efficacy|0
7799233|NCT00498602|27102433|P1|Overall Study|Lack of Efficacy|1
7799234|NCT00498602|27102427|P7|Overall Study|Death|0
7799235|NCT00498602|27102428|P6|Overall Study|Death|1
7799236|NCT00498602|27102429|P5|Overall Study|Death|0
7799237|NCT00498602|27102430|P4|Overall Study|Death|0
7799238|NCT00498602|27102431|P3|Overall Study|Death|0
7799239|NCT00498602|27102432|P2|Overall Study|Death|0
7799240|NCT00498602|27102433|P1|Overall Study|Death|0
7799241|NCT00498485|27102481|P2|Overall Study|Adverse Event|5
7799242|NCT00498485|27102482|P1|Overall Study|Adverse Event|1
7799243|NCT00498433|27102493|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
7799244|NCT00498433|27102494|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
7799245|NCT00498433|27102495|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
7799246|NCT00498433|27102493|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
7799247|NCT00498433|27102494|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
7799248|NCT00498433|27102495|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
7799249|NCT00498433|27102493|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
7799250|NCT00498433|27102494|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
7799251|NCT00498433|27102495|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
7799252|NCT00498433|27102493|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
7799253|NCT00498433|27102494|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
7799254|NCT00498433|27102495|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
7799255|NCT00498368|27102540|P2|Overall Study|Withdrawal by Subject|2
7799256|NCT00498368|27102541|P1|Overall Study|Withdrawal by Subject|3
7799257|NCT00498355|27102553|P1|Overall Study|Lost to Follow-up|1
7799258|NCT00498186|27102561|P1|Overall Study|Other|10
7799259|NCT00498186|27102561|P1|Overall Study|Lost to Follow-up|3
7799260|NCT00498186|27102561|P1|Overall Study|Withdrawal by Subject|18
7799261|NCT00498186|27102561|P1|Overall Study|Unsatisfactory compliance of subject|12
7799262|NCT00498186|27102561|P1|Overall Study|Adverse Event|89
7799263|NCT00498186|27102561|P1|Overall Study|Lack of Efficacy|31
7799264|NCT00498186|27102561|P1|Overall Study|Protocol Violation|10
7799265|NCT00498173|27102568|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
7799266|NCT00498173|27102569|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
7799267|NCT00498173|27102570|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
7799268|NCT00497874|27102600|P2|Overall Study|Unable to schedule|24
7799269|NCT00497874|27102601|P1|Overall Study|Unable to schedule|37
7799270|NCT00497874|27102600|P2|Overall Study|Unable to contact|67
7799271|NCT00497874|27102601|P1|Overall Study|Unable to contact|52
7799272|NCT00497874|27102600|P2|Overall Study|Death|4
7799273|NCT00497874|27102601|P1|Overall Study|Death|2
7799274|NCT00497874|27102600|P2|Overall Study|Illness|4
7799275|NCT00497874|27102601|P1|Overall Study|Illness|8
7799276|NCT00497874|27102600|P2|Overall Study|Withdrawal by Subject|17
7799277|NCT00497874|27102601|P1|Overall Study|Withdrawal by Subject|48
7799278|NCT00497796|27102619|P2|Overall Study|Not applicable (randomized not treated)|4
7799279|NCT00497796|27102620|P1|Overall Study|Not applicable (randomized not treated)|0
7799280|NCT00497796|27102619|P2|Overall Study|Lost to Follow-up|1
7799281|NCT00497796|27102620|P1|Overall Study|Lost to Follow-up|0
7799282|NCT00497796|27102619|P2|Overall Study|Investigator/sponsor discretion|34
7799283|NCT00497796|27102620|P1|Overall Study|Investigator/sponsor discretion|31
7799284|NCT00497796|27102619|P2|Overall Study|Consent withdrawn|3
7799285|NCT00497796|27102620|P1|Overall Study|Consent withdrawn|10
7799286|NCT00497796|27102619|P2|Overall Study|CMV infection or disease treatment|4
7799287|NCT00497796|27102620|P1|Overall Study|CMV infection or disease treatment|30
7799288|NCT00497796|27102619|P2|Overall Study|Adverse event (related)|4
7799289|NCT00497796|27102620|P1|Overall Study|Adverse event (related)|5
7799290|NCT00497796|27102619|P2|Overall Study|Adverse event (not related)|9
7799291|NCT00497796|27102620|P1|Overall Study|Adverse event (not related)|9
7799292|NCT00497198|27102718|P2|Overall Study|Withdrawal by Subject|1
7799293|NCT00497198|27102719|P1|Overall Study|Withdrawal by Subject|0
7799294|NCT00497198|27102718|P2|Overall Study|Physician Decision|2
7799295|NCT00497198|27102719|P1|Overall Study|Physician Decision|1
7799296|NCT00497198|27102718|P2|Overall Study|Adverse Event|2
7799297|NCT00497198|27102719|P1|Overall Study|Adverse Event|4
7799298|NCT00497146|27102735|P2|Long-term Follow-up Period|Other|1
7799299|NCT00497146|27102736|P1|Long-term Follow-up Period|Other|0
7799300|NCT00497146|27102735|P2|Long-term Follow-up Period|Lost to Follow-up|1
7799301|NCT00497146|27102736|P1|Long-term Follow-up Period|Lost to Follow-up|5
7799302|NCT00497146|27102735|P2|Long-term Follow-up Period|Withdrawal by Subject|2
7799303|NCT00497146|27102736|P1|Long-term Follow-up Period|Withdrawal by Subject|8
7799304|NCT00497146|27102735|P2|Long-term Follow-up Period|Adverse Event|2
7799305|NCT00497146|27102736|P1|Long-term Follow-up Period|Adverse Event|2
7799306|NCT00497146|27102735|P2|Treatment Period|Other Reason|3
7799307|NCT00497146|27102736|P1|Treatment Period|Other Reason|2
7799308|NCT00497146|27102735|P2|Treatment Period|Unable to dose reduce per protocol|1
7799309|NCT00497146|27102736|P1|Treatment Period|Unable to dose reduce per protocol|4
7799310|NCT00497146|27102735|P2|Treatment Period|Change in RAAS inhibitor therapy|2
7799311|NCT00497146|27102736|P1|Treatment Period|Change in RAAS inhibitor therapy|5
7799312|NCT00497146|27102735|P2|Treatment Period|Required dialysis|1
7799313|NCT00497146|27102736|P1|Treatment Period|Required dialysis|4
7799314|NCT00497146|27102735|P2|Treatment Period|Lost to Follow-up|3
7799315|NCT00497146|27102736|P1|Treatment Period|Lost to Follow-up|1
7799316|NCT00497146|27102735|P2|Treatment Period|Withdrawal by Subject|9
7799317|NCT00497146|27102736|P1|Treatment Period|Withdrawal by Subject|5
7799318|NCT00497146|27102735|P2|Treatment Period|Adverse Event|2
7799319|NCT00497146|27102736|P1|Treatment Period|Adverse Event|6
7799320|NCT00496964|27102804|P2|Overall Study|Withdrawal by Subject|1
7799321|NCT00496964|27102805|P1|Overall Study|Withdrawal by Subject|0
7799322|NCT00496873|27102823|P1|Overall Study|Withdrawal by Subject|3
7799323|NCT00496873|27102823|P1|Overall Study|Death|2
7799324|NCT00496873|27102823|P1|Overall Study|Ineligible|2
7799325|NCT00496834|27102856|P2|Overall Study|Blood Pressure control failure|1
7799326|NCT00496834|27102857|P1|Overall Study|Blood Pressure control failure|2
7799327|NCT00496834|27102856|P2|Overall Study|Lost to Follow-up|0
7799328|NCT00496834|27102857|P1|Overall Study|Lost to Follow-up|2
7799329|NCT00496834|27102856|P2|Overall Study|IP administration violation|0
7799330|NCT00496834|27102857|P1|Overall Study|IP administration violation|2
7799331|NCT00496834|27102856|P2|Overall Study|Adverse Event|3
7799332|NCT00496834|27102857|P1|Overall Study|Adverse Event|5
7799333|NCT00496834|27102856|P2|Overall Study|Inclusion/exclusion criteria not met|2
7799334|NCT00496834|27102857|P1|Overall Study|Inclusion/exclusion criteria not met|3
7799335|NCT00496834|27102856|P2|Overall Study|Contraindicated medication administered|1
7799336|NCT00496834|27102857|P1|Overall Study|Contraindicated medication administered|0
7799337|NCT00496834|27102856|P2|Overall Study|Withdrawal by Subject|6
7799338|NCT00496834|27102857|P1|Overall Study|Withdrawal by Subject|4
7799339|NCT00496782|27102876|P2|Overall Study|Protocol Violation|2
7799340|NCT00496782|27102877|P1|Overall Study|Protocol Violation|1
7799341|NCT00496769|27102911|P3|Open Label|>=1 reason assigned per patient|1011
7799342|NCT00496769|27102912|P2|Open Label|>=1 reason assigned per patient|0
7799343|NCT00496769|27102913|P1|Open Label|>=1 reason assigned per patient|0
7799344|NCT00496769|27102911|P3|Double Blind|>=1 reason assigned per patient|0
7799345|NCT00496769|27102912|P2|Double Blind|>=1 reason assigned per patient|649
7799346|NCT00496769|27102913|P1|Double Blind|>=1 reason assigned per patient|558
7799347|NCT00496730|27102943|P2|Overall Study|Withdrawal by Subject|2
7799348|NCT00496730|27102944|P1|Overall Study|Withdrawal by Subject|2
7799349|NCT00496730|27102943|P2|Overall Study|Lost to Follow-up|3
7799350|NCT00496730|27102944|P1|Overall Study|Lost to Follow-up|4
7799351|NCT00496626|27102956|P2|Overall Study|Relocated|1
7799352|NCT00496626|27102957|P1|Overall Study|Relocated|0
7799353|NCT00496626|27102956|P2|Overall Study|Withdrawal by Subject|4
7799354|NCT00496626|27102957|P1|Overall Study|Withdrawal by Subject|5
7799355|NCT00496626|27102956|P2|Overall Study|Protocol Violation|0
7799356|NCT00496626|27102957|P1|Overall Study|Protocol Violation|1
7799357|NCT00496626|27102956|P2|Overall Study|Lost to Follow-up|1
7799358|NCT00496626|27102957|P1|Overall Study|Lost to Follow-up|0
7799359|NCT00496587|27102969|P1|Overall Study|Complications unrelated|2
7799360|NCT00496587|27102969|P1|Overall Study|Death|1
7799361|NCT00496587|27102969|P1|Overall Study|Withdrawal by Subject|2
7799362|NCT00496587|27102969|P1|Overall Study|Progressive Disease|24
7799363|NCT00496587|27102969|P1|Overall Study|Adverse Event|2
7799364|NCT00496483|27102975|P1|Overall Study|Lack of Efficacy|1
7799365|NCT00496483|27102975|P1|Overall Study|Adverse Event|2
7799366|NCT00496483|27102975|P1|Overall Study|Not dosed|9
7799367|NCT00496470|27102992|P2|Overall Study|Other reason|2
7799368|NCT00496470|27102993|P1|Overall Study|Other reason|0
7799369|NCT00496470|27102992|P2|Overall Study|Incorrectly enrolled|5
7799370|NCT00496470|27102993|P1|Overall Study|Incorrectly enrolled|13
7799371|NCT00496470|27102992|P2|Overall Study|Withdrawal by Subject|12
7799372|NCT00496470|27102993|P1|Overall Study|Withdrawal by Subject|5
7799373|NCT00496470|27102992|P2|Overall Study|Adverse Event|10
7799374|NCT00496470|27102993|P1|Overall Study|Adverse Event|8
7799375|NCT00496366|27103079|P1|Overall Study|Death|1
7799376|NCT00496197|27103110|P1|Overall Study|Protocol Violation|8
7799377|NCT00496197|27103110|P1|Overall Study|Other|14
7799378|NCT00496197|27103110|P1|Overall Study|Pathogen not isolated baseline specimen|4
7799379|NCT00496197|27103110|P1|Overall Study|Withdrawal by Subject|11
7799380|NCT00496197|27103110|P1|Overall Study|Lost to Follow-up|11
7799381|NCT00496197|27103110|P1|Overall Study|Insufficient bacteriological response|10
7799382|NCT00496197|27103110|P1|Overall Study|Insufficient clinical response|3
7799383|NCT00496197|27103110|P1|Overall Study|Does not meet entrance criteria|5
7799384|NCT00496197|27103110|P1|Overall Study|Adverse Event|13
7799385|NCT00496197|27103110|P1|Overall Study|Discontinued study due to death|43
7799386|NCT00496080|27103137|P1|Overall Study|Physician Decision|6
7799387|NCT00496080|27103137|P1|Overall Study|Withdrawal by Subject|5
7799388|NCT00496080|27103137|P1|Overall Study|Surgical re-intervention|7
7799389|NCT00496080|27103137|P1|Overall Study|Lost to Follow-up|9
7799390|NCT00496054|27103147|P1|Overall Study|Lost to Follow-up|7
7799391|NCT00496054|27103147|P1|Overall Study|Adverse Event|1
7799392|NCT00496015|27103179|P5|Overall Study|Other|0
7799393|NCT00496015|27103180|P4|Overall Study|Other|1
7799394|NCT00496015|27103181|P3|Overall Study|Other|0
7799395|NCT00496015|27103182|P2|Overall Study|Other|0
7799396|NCT00496015|27103183|P1|Overall Study|Other|1
7799397|NCT00495820|27103307|P2|Overall Study|Adverse Event|1
7799398|NCT00495820|27103308|P1|Overall Study|Adverse Event|1
7799399|NCT00495794|27103320|P2|Overall Study|Pharmacist did not activate patient|0
7799400|NCT00495794|27103321|P1|Overall Study|Pharmacist did not activate patient|522
7799401|NCT00495755|27103331|P1|Overall Study|Adverse Event|3
7799402|NCT00495677|27103352|P7|Stage 1 (25 Days)|Adverse Event|0
7799403|NCT00495677|27103353|P6|Stage 1 (25 Days)|Adverse Event|0
7799404|NCT00495677|27103354|P5|Stage 1 (25 Days)|Adverse Event|0
7799405|NCT00495677|27103355|P4|Stage 1 (25 Days)|Adverse Event|0
7799406|NCT00495677|27103356|P3|Stage 1 (25 Days)|Adverse Event|1
7799407|NCT00495677|27103357|P2|Stage 1 (25 Days)|Adverse Event|0
7799408|NCT00495677|27103358|P1|Stage 1 (25 Days)|Adverse Event|0
7799409|NCT00495625|27103413|P1|Overall Study|Did not complete at least 1 42 day cycle|10
7799410|NCT00495612|27103424|P2|Overall Study|Subject's Decision to Withdraw|0
7799411|NCT00495612|27103425|P1|Overall Study|Subject's Decision to Withdraw|3
7799412|NCT00495612|27103424|P2|Overall Study|Lost to Follow-up|0
7799413|NCT00495612|27103425|P1|Overall Study|Lost to Follow-up|1
7799414|NCT00495586|27103443|P2|Overall Study|Withdrawal by Subject|4
7799415|NCT00495586|27103444|P1|Overall Study|Withdrawal by Subject|4
7799416|NCT00495521|27103454|P2|Overall Study|Physician Decision|1
7799417|NCT00495521|27103455|P1|Overall Study|Physician Decision|0
7799418|NCT00495495|27103485|P1|Overall Study|Protocol Violation|99
7799419|NCT00495469|27103505|P7|Overall Study|ST depression at randomisation in ECG|0
7799420|NCT00495469|27103506|P6|Overall Study|ST depression at randomisation in ECG|0
7799421|NCT00495469|27103507|P5|Overall Study|ST depression at randomisation in ECG|0
7799422|NCT00495469|27103508|P4|Overall Study|ST depression at randomisation in ECG|0
7799423|NCT00495469|27103509|P3|Overall Study|ST depression at randomisation in ECG|0
7799424|NCT00495469|27103510|P2|Overall Study|ST depression at randomisation in ECG|1
7799425|NCT00495469|27103511|P1|Overall Study|ST depression at randomisation in ECG|0
7799426|NCT00495469|27103505|P7|Overall Study|Liver function test abnormality|0
7799427|NCT00495469|27103506|P6|Overall Study|Liver function test abnormality|0
7799428|NCT00495469|27103507|P5|Overall Study|Liver function test abnormality|0
7799429|NCT00495469|27103508|P4|Overall Study|Liver function test abnormality|0
7799430|NCT00495469|27103509|P3|Overall Study|Liver function test abnormality|0
7799431|NCT00495469|27103510|P2|Overall Study|Liver function test abnormality|1
7799432|NCT00495469|27103511|P1|Overall Study|Liver function test abnormality|0
7799433|NCT00495469|27103505|P7|Overall Study|Lack of Efficacy|1
7799434|NCT00495469|27103506|P6|Overall Study|Lack of Efficacy|0
7799435|NCT00495469|27103507|P5|Overall Study|Lack of Efficacy|0
7799436|NCT00495469|27103508|P4|Overall Study|Lack of Efficacy|0
7799437|NCT00495469|27103509|P3|Overall Study|Lack of Efficacy|0
7799438|NCT00495469|27103510|P2|Overall Study|Lack of Efficacy|0
7799439|NCT00495469|27103511|P1|Overall Study|Lack of Efficacy|0
7799440|NCT00495469|27103505|P7|Overall Study|Withdrawal by Subject|3
7799441|NCT00495469|27103506|P6|Overall Study|Withdrawal by Subject|2
7799442|NCT00495469|27103507|P5|Overall Study|Withdrawal by Subject|3
7799443|NCT00495469|27103508|P4|Overall Study|Withdrawal by Subject|3
7799444|NCT00495469|27103509|P3|Overall Study|Withdrawal by Subject|1
7799445|NCT00495469|27103510|P2|Overall Study|Withdrawal by Subject|3
7799446|NCT00495469|27103511|P1|Overall Study|Withdrawal by Subject|5
7799447|NCT00495469|27103505|P7|Overall Study|Protocol Violation|0
7799448|NCT00495469|27103506|P6|Overall Study|Protocol Violation|2
7799449|NCT00495469|27103507|P5|Overall Study|Protocol Violation|1
7799450|NCT00495469|27103508|P4|Overall Study|Protocol Violation|0
7799451|NCT00495469|27103509|P3|Overall Study|Protocol Violation|0
7799452|NCT00495469|27103510|P2|Overall Study|Protocol Violation|0
7799453|NCT00495469|27103511|P1|Overall Study|Protocol Violation|0
7799454|NCT00495469|27103505|P7|Overall Study|Lost to Follow-up|0
7799455|NCT00495469|27103506|P6|Overall Study|Lost to Follow-up|0
7799456|NCT00495469|27103507|P5|Overall Study|Lost to Follow-up|0
7799457|NCT00495469|27103508|P4|Overall Study|Lost to Follow-up|1
7799458|NCT00495469|27103509|P3|Overall Study|Lost to Follow-up|3
7799459|NCT00495469|27103510|P2|Overall Study|Lost to Follow-up|1
7799460|NCT00495469|27103511|P1|Overall Study|Lost to Follow-up|1
7799461|NCT00495469|27103505|P7|Overall Study|Adverse Event|1
7799462|NCT00495469|27103506|P6|Overall Study|Adverse Event|1
7799463|NCT00495469|27103507|P5|Overall Study|Adverse Event|1
7799464|NCT00495469|27103508|P4|Overall Study|Adverse Event|0
7799465|NCT00495469|27103509|P3|Overall Study|Adverse Event|3
7799466|NCT00495469|27103510|P2|Overall Study|Adverse Event|1
7799467|NCT00495469|27103511|P1|Overall Study|Adverse Event|0
7799468|NCT00495391|27103655|P2|Overall Study|Withdrawal by Subject|3
7799469|NCT00495391|27103656|P1|Overall Study|Withdrawal by Subject|2
7799470|NCT00495391|27103655|P2|Overall Study|Lack of Efficacy|18
7799471|NCT00495391|27103656|P1|Overall Study|Lack of Efficacy|34
7799472|NCT00495170|27103679|P1|Overall Study|Inappropriate staging|8
7799473|NCT00495170|27103679|P1|Overall Study|Withdrawal by Subject|3
7799474|NCT00495170|27103679|P1|Overall Study|Lost to Follow-up|9
7799475|NCT00495131|27103698|P2|Overall Study|Withdrawal by Subject|0
7799476|NCT00495131|27103699|P1|Overall Study|Withdrawal by Subject|1
7799477|NCT00495131|27103698|P2|Overall Study|Lost to Follow-up|2
7799478|NCT00495131|27103699|P1|Overall Study|Lost to Follow-up|0
7799479|NCT00495131|27103698|P2|Overall Study|Lack of Efficacy|2
7799480|NCT00495131|27103699|P1|Overall Study|Lack of Efficacy|0
7799481|NCT00495131|27103698|P2|Overall Study|Adverse Event|2
7799482|NCT00495131|27103699|P1|Overall Study|Adverse Event|6
7799483|NCT00495040|27103716|P1|Overall Study|Withdrawal by Subject|3
7799484|NCT00494871|27103731|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
7799485|NCT00494871|27103732|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
7799486|NCT00494871|27103731|P2|Follow-up (FU) Period|Withdrawal by Subject|5
7799487|NCT00494871|27103732|P1|Follow-up (FU) Period|Withdrawal by Subject|5
7799488|NCT00494871|27103731|P2|Follow-up (FU) Period|Protocol Violation|0
7799489|NCT00494871|27103732|P1|Follow-up (FU) Period|Protocol Violation|1
7799490|NCT00494871|27103731|P2|Follow-up (FU) Period|Physician Decision|1
7799491|NCT00494871|27103732|P1|Follow-up (FU) Period|Physician Decision|0
7799492|NCT00494871|27103731|P2|Follow-up (FU) Period|Lost to Follow-up|2
7799493|NCT00494871|27103732|P1|Follow-up (FU) Period|Lost to Follow-up|6
7799494|NCT00494871|27103731|P2|Follow-up (FU) Period|Death|12
7799495|NCT00494871|27103732|P1|Follow-up (FU) Period|Death|13
7799496|NCT00494871|27103731|P2|Follow-up (FU) Period|Adverse Event|1
7799497|NCT00494871|27103732|P1|Follow-up (FU) Period|Adverse Event|1
7799498|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
7799499|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
7799500|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
7799501|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
7799502|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
7799503|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
7799504|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
7799505|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
7799506|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
7799507|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
7799508|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
7799509|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
7799510|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
7799511|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
7799512|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
7799513|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
7799514|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Physician Decision|13
7799515|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Physician Decision|4
7799516|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Death|3
7799517|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Death|8
7799518|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
7799519|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
7799520|NCT00494871|27103731|P2|Double-blind (DB) Treatment Period|Adverse Event|70
7799521|NCT00494871|27103732|P1|Double-blind (DB) Treatment Period|Adverse Event|73
7799522|NCT00494780|27103773|P2|Overall Study|Insurance Issues|1
7799523|NCT00494780|27103774|P1|Overall Study|Insurance Issues|0
7799524|NCT00494780|27103773|P2|Overall Study|Residual Tumour Mass|1
7799525|NCT00494780|27103774|P1|Overall Study|Residual Tumour Mass|0
7799526|NCT00494780|27103773|P2|Overall Study|Non-compliance|0
7799527|NCT00494780|27103774|P1|Overall Study|Non-compliance|1
7799528|NCT00494780|27103773|P2|Overall Study|New Treatment|2
7799529|NCT00494780|27103774|P1|Overall Study|New Treatment|2
7799530|NCT00494780|27103773|P2|Overall Study|Progression of Study Disease|8
7799531|NCT00494780|27103774|P1|Overall Study|Progression of Study Disease|7
7799532|NCT00494780|27103773|P2|Overall Study|Withdrew before Dosed|1
7799533|NCT00494780|27103774|P1|Overall Study|Withdrew before Dosed|0
7799534|NCT00494780|27103773|P2|Overall Study|Adverse Event|0
7799535|NCT00494780|27103774|P1|Overall Study|Adverse Event|1
7799536|NCT00494676|27103812|P2|Second Intervention|Withdrawal by Subject|1
7799537|NCT00494676|27103813|P1|Second Intervention|Withdrawal by Subject|1
7799538|NCT00494676|27103812|P2|First Intervention|Withdrawal by Subject|3
7799539|NCT00494676|27103813|P1|First Intervention|Withdrawal by Subject|1
7799540|NCT00494676|27103812|P2|Allocation|Withdrawal by Subject|4
7799541|NCT00494676|27103813|P1|Allocation|Withdrawal by Subject|2
7799542|NCT00494507|27103828|P4|Open-Label Phase|Worsening Disease|2
7799543|NCT00494507|27103829|P3|Open-Label Phase|Worsening Disease|0
7799544|NCT00494507|27103830|P2|Open-Label Phase|Worsening Disease|0
7799545|NCT00494507|27103831|P1|Open-Label Phase|Worsening Disease|0
7799546|NCT00494507|27103828|P4|Open-Label Phase|Adverse Event|3
7799547|NCT00494507|27103829|P3|Open-Label Phase|Adverse Event|5
7799548|NCT00494507|27103830|P2|Open-Label Phase|Adverse Event|1
7799549|NCT00494507|27103831|P1|Open-Label Phase|Adverse Event|0
7799550|NCT00494507|27103828|P4|Double-Blind Phase|Negative DNA test|1
7799551|NCT00494507|27103829|P3|Double-Blind Phase|Negative DNA test|0
7799552|NCT00494507|27103830|P2|Double-Blind Phase|Negative DNA test|0
7799553|NCT00494507|27103831|P1|Double-Blind Phase|Negative DNA test|0
7799554|NCT00494507|27103828|P4|Double-Blind Phase|Subject Non-compliance|0
7799555|NCT00494507|27103829|P3|Double-Blind Phase|Subject Non-compliance|1
7799556|NCT00494507|27103830|P2|Double-Blind Phase|Subject Non-compliance|0
7799557|NCT00494507|27103831|P1|Double-Blind Phase|Subject Non-compliance|0
7799558|NCT00494507|27103828|P4|Double-Blind Phase|Withdrawal by Subject|0
7799559|NCT00494507|27103829|P3|Double-Blind Phase|Withdrawal by Subject|0
7799560|NCT00494507|27103830|P2|Double-Blind Phase|Withdrawal by Subject|0
7799561|NCT00494507|27103831|P1|Double-Blind Phase|Withdrawal by Subject|1
7799562|NCT00494507|27103828|P4|Double-Blind Phase|Adverse Event|0
7799563|NCT00494507|27103829|P3|Double-Blind Phase|Adverse Event|1
7799564|NCT00494507|27103830|P2|Double-Blind Phase|Adverse Event|0
7799565|NCT00494507|27103831|P1|Double-Blind Phase|Adverse Event|2
7799566|NCT00494481|27103898|P2|Overall Study|Never received IP|0
7799567|NCT00494481|27103899|P1|Overall Study|Never received IP|2
7799568|NCT00494481|27103898|P2|Overall Study|Other|0
7799569|NCT00494481|27103899|P1|Overall Study|Other|1
7799570|NCT00494481|27103898|P2|Overall Study|Adverse Event|11
7799571|NCT00494481|27103899|P1|Overall Study|Adverse Event|15
7799572|NCT00494481|27103898|P2|Overall Study|Condition under investigation worsened|13
7799573|NCT00494481|27103899|P1|Overall Study|Condition under investigation worsened|11
7799574|NCT00494442|27103907|P2|Overall Study|Intercurrent illness|1
7799575|NCT00494442|27103908|P1|Overall Study|Intercurrent illness|0
7799576|NCT00494442|27103907|P2|Overall Study|Non-compliance|1
7799577|NCT00494442|27103908|P1|Overall Study|Non-compliance|0
7799578|NCT00494442|27103907|P2|Overall Study|Physician Decision|1
7799579|NCT00494442|27103908|P1|Overall Study|Physician Decision|0
7799580|NCT00494442|27103907|P2|Overall Study|Adverse Event|2
7799581|NCT00494442|27103908|P1|Overall Study|Adverse Event|0
7799582|NCT00494442|27103907|P2|Overall Study|Lack of Efficacy|10
7799583|NCT00494442|27103908|P1|Overall Study|Lack of Efficacy|16
7799584|NCT00494442|27103907|P2|Overall Study|Death|1
7799585|NCT00494442|27103908|P1|Overall Study|Death|1
7799586|NCT00494299|27103924|P2|Overall Study|Protocol Driven Decision Point|22
7799587|NCT00494299|27103925|P1|Overall Study|Protocol Driven Decision Point|11
7799588|NCT00494299|27103924|P2|Overall Study|Site Closed by Sponsor|0
7799589|NCT00494299|27103925|P1|Overall Study|Site Closed by Sponsor|6
7799590|NCT00494299|27103924|P2|Overall Study|Participant Did Not Take Study Drug|2
7799591|NCT00494299|27103925|P1|Overall Study|Participant Did Not Take Study Drug|0
7799592|NCT00494299|27103924|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
7799593|NCT00494299|27103925|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
7799594|NCT00494299|27103924|P2|Overall Study|Withdrawal by Subject|3
7799595|NCT00494299|27103925|P1|Overall Study|Withdrawal by Subject|8
7799596|NCT00494299|27103924|P2|Overall Study|Protocol Violation|2
7799597|NCT00494299|27103925|P1|Overall Study|Protocol Violation|1
7799598|NCT00494299|27103924|P2|Overall Study|Physician Decision|2
7799599|NCT00494299|27103925|P1|Overall Study|Physician Decision|0
7799600|NCT00494299|27103924|P2|Overall Study|Lost to Follow-up|0
7799601|NCT00494299|27103925|P1|Overall Study|Lost to Follow-up|1
7799602|NCT00494299|27103924|P2|Overall Study|Adverse Event|13
7799603|NCT00494299|27103925|P1|Overall Study|Adverse Event|93
7799604|NCT00494234|27103937|P2|Overall Study|Death|1
7799605|NCT00494234|27103938|P1|Overall Study|Death|2
7799606|NCT00494234|27103937|P2|Overall Study|Withdrawal by Subject|0
7799607|NCT00494234|27103938|P1|Overall Study|Withdrawal by Subject|1
7799608|NCT00494234|27103937|P2|Overall Study|Lack of Efficacy|9
7799609|NCT00494234|27103938|P1|Overall Study|Lack of Efficacy|12
7799610|NCT00494221|27103957|P3|Overall Study|Withdrawal by Subject|0
7799611|NCT00494221|27103958|P2|Overall Study|Withdrawal by Subject|2
7799612|NCT00494221|27103959|P1|Overall Study|Withdrawal by Subject|1
7799613|NCT00494221|27103957|P3|Overall Study|Death|14
7799614|NCT00494221|27103958|P2|Overall Study|Death|9
7799615|NCT00494221|27103959|P1|Overall Study|Death|15
7799616|NCT00494091|27104000|P2|Overall Study|Withdrawal by Subject|7
7799617|NCT00494091|27104001|P1|Overall Study|Withdrawal by Subject|0
7799618|NCT00494091|27104000|P2|Overall Study|Other|11
7799619|NCT00494091|27104001|P1|Overall Study|Other|1
7799620|NCT00494091|27104000|P2|Overall Study|Lost to Follow-up|4
7799621|NCT00494091|27104001|P1|Overall Study|Lost to Follow-up|0
7799622|NCT00494091|27104000|P2|Overall Study|Death|54
7799623|NCT00494091|27104001|P1|Overall Study|Death|5
7799624|NCT00494026|27104023|P1|Overall Study|Sponsor Decision|4
7799625|NCT00494013|27104033|P2|Overall Study|Sponsor Decision|1
7799626|NCT00494013|27104034|P1|Overall Study|Sponsor Decision|0
7799627|NCT00494013|27104033|P2|Overall Study|Withdrawal by Subject|14
7799628|NCT00494013|27104034|P1|Overall Study|Withdrawal by Subject|13
7799629|NCT00494013|27104033|P2|Overall Study|Protocol Violation|5
7799630|NCT00494013|27104034|P1|Overall Study|Protocol Violation|8
7799631|NCT00494013|27104033|P2|Overall Study|Physician Decision|5
7799632|NCT00494013|27104034|P1|Overall Study|Physician Decision|3
7799633|NCT00494013|27104033|P2|Overall Study|Lost to Follow-up|6
7799634|NCT00494013|27104034|P1|Overall Study|Lost to Follow-up|5
7799635|NCT00494013|27104033|P2|Overall Study|Entry Criteria Not Met|4
7799636|NCT00494013|27104034|P1|Overall Study|Entry Criteria Not Met|1
7799637|NCT00494013|27104033|P2|Overall Study|Adverse Event|1
7799638|NCT00494013|27104034|P1|Overall Study|Adverse Event|0
7799639|NCT00493974|27104064|P2|Overall Study|Lost to Follow-up|6
7799640|NCT00493974|27104065|P1|Overall Study|Lost to Follow-up|4
7799641|NCT00493974|27104064|P2|Overall Study|Withdrawal by Subject|6
7799642|NCT00493974|27104065|P1|Overall Study|Withdrawal by Subject|8
7799643|NCT00493974|27104064|P2|Overall Study|Death|2
7799644|NCT00493974|27104065|P1|Overall Study|Death|1
7799645|NCT00493779|27104092|P1|Overall Study|Logistical issue at site|1
7799646|NCT00493649|27104099|P1|Overall Study|Other|13
7799647|NCT00493649|27104099|P1|Overall Study|Lost to Follow-up|1
7799648|NCT00493649|27104099|P1|Overall Study|Disease Progression|1
7799649|NCT00493649|27104099|P1|Overall Study|Investigator Request|2
7799650|NCT00493649|27104099|P1|Overall Study|Patient Request|21
7799651|NCT00493649|27104099|P1|Overall Study|Adverse Event|44
7799652|NCT00493636|27104112|P2|Overall Study|Mis-randomization|1
7799653|NCT00493636|27104113|P1|Overall Study|Mis-randomization|1
7799654|NCT00493636|27104112|P2|Overall Study|Disease progression/recurrence/relapse|1
7799655|NCT00493636|27104113|P1|Overall Study|Disease progression/recurrence/relapse|0
7799656|NCT00493636|27104112|P2|Overall Study|Withdrawal by Subject|0
7799657|NCT00493636|27104113|P1|Overall Study|Withdrawal by Subject|1
7799658|NCT00493467|27104127|P1|Overall Study|Death|1
7799659|NCT00493454|27104132|P1|Overall Study|Withdrawal by Subject|1
7799660|NCT00493311|27104138|P2|Overall Study|Need for rescue medication|2
7799661|NCT00493311|27104139|P1|Overall Study|Need for rescue medication|2
7799662|NCT00493285|27104159|P6|Overall Study|Lost to Follow-up|0
7799663|NCT00493285|27104160|P5|Overall Study|Lost to Follow-up|1
7799664|NCT00493285|27104161|P4|Overall Study|Lost to Follow-up|0
7799665|NCT00493285|27104162|P3|Overall Study|Lost to Follow-up|0
7799666|NCT00493285|27104163|P2|Overall Study|Lost to Follow-up|0
7799667|NCT00493285|27104164|P1|Overall Study|Lost to Follow-up|0
7799668|NCT00493246|27104396|P8|Overall Study|Lost to Follow-up|0
7799669|NCT00493246|27104397|P7|Overall Study|Lost to Follow-up|1
7799670|NCT00493246|27104398|P6|Overall Study|Lost to Follow-up|0
7799671|NCT00493246|27104399|P5|Overall Study|Lost to Follow-up|0
7799672|NCT00493246|27104400|P4|Overall Study|Lost to Follow-up|0
7799673|NCT00493246|27104401|P3|Overall Study|Lost to Follow-up|0
7799674|NCT00493246|27104402|P2|Overall Study|Lost to Follow-up|0
7799675|NCT00493246|27104403|P1|Overall Study|Lost to Follow-up|0
7799676|NCT00493246|27104396|P8|Overall Study|No access to draw blood|0
7799677|NCT00493246|27104397|P7|Overall Study|No access to draw blood|0
7799678|NCT00493246|27104398|P6|Overall Study|No access to draw blood|1
7799679|NCT00493246|27104399|P5|Overall Study|No access to draw blood|0
7799680|NCT00493246|27104400|P4|Overall Study|No access to draw blood|0
7799681|NCT00493246|27104401|P3|Overall Study|No access to draw blood|0
7799682|NCT00493246|27104402|P2|Overall Study|No access to draw blood|0
7799683|NCT00493246|27104403|P1|Overall Study|No access to draw blood|0
7799684|NCT00493246|27104396|P8|Overall Study|Withdrawal by Subject|0
7799685|NCT00493246|27104397|P7|Overall Study|Withdrawal by Subject|0
7799686|NCT00493246|27104398|P6|Overall Study|Withdrawal by Subject|0
7799687|NCT00493246|27104399|P5|Overall Study|Withdrawal by Subject|1
7799688|NCT00493246|27104400|P4|Overall Study|Withdrawal by Subject|0
7799689|NCT00493246|27104401|P3|Overall Study|Withdrawal by Subject|0
7799690|NCT00493246|27104402|P2|Overall Study|Withdrawal by Subject|0
7799691|NCT00493246|27104403|P1|Overall Study|Withdrawal by Subject|0
7799692|NCT00493220|27104467|P6|Third Intervention|Withdrawal by Subject|0
7799693|NCT00493220|27104468|P5|Third Intervention|Withdrawal by Subject|0
7799694|NCT00493220|27104469|P4|Third Intervention|Withdrawal by Subject|0
7799695|NCT00493220|27104470|P3|Third Intervention|Withdrawal by Subject|0
7799696|NCT00493220|27104471|P2|Third Intervention|Withdrawal by Subject|0
7799697|NCT00493220|27104472|P1|Third Intervention|Withdrawal by Subject|1
7799698|NCT00493038|27104500|P2|Follow-up|Lost to Follow-up|0
7799699|NCT00493038|27104501|P1|Follow-up|Lost to Follow-up|1
7799700|NCT00493038|27104500|P2|Treatment|Other|1
7799701|NCT00493038|27104501|P1|Treatment|Other|0
7799702|NCT00493038|27104500|P2|Treatment|Withdrawal by Subject|12
7799703|NCT00493038|27104501|P1|Treatment|Withdrawal by Subject|11
7799704|NCT00493038|27104500|P2|Treatment|Lost to Follow-up|3
7799705|NCT00493038|27104501|P1|Treatment|Lost to Follow-up|5
7799706|NCT00493038|27104500|P2|Treatment|Adverse Event|4
7799707|NCT00493038|27104501|P1|Treatment|Adverse Event|8
7799708|NCT00493025|27104515|P1|Overall Study|Physician Decision|19
7799709|NCT00493012|27104526|P2|Overall Study|Lost to Follow-up|17
7799710|NCT00493012|27104527|P1|Overall Study|Lost to Follow-up|18
7799711|NCT00492921|27104570|P3|Overall Study|Death|1
7799712|NCT00492921|27104571|P2|Overall Study|Death|0
7799713|NCT00492921|27104572|P1|Overall Study|Death|1
7799714|NCT00492856|27104583|P4|Post-consolidation|Observation Arm|0
7799715|NCT00492856|27104584|P3|Post-consolidation|Observation Arm|27
7799716|NCT00492856|27104585|P2|Post-consolidation|Observation Arm|0
7799717|NCT00492856|27104586|P1|Post-consolidation|Observation Arm|0
7799718|NCT00492856|27104583|P4|Post-consolidation|Lost to Follow-up|0
7799719|NCT00492856|27104584|P3|Post-consolidation|Lost to Follow-up|0
7799720|NCT00492856|27104585|P2|Post-consolidation|Lost to Follow-up|2
7799721|NCT00492856|27104586|P1|Post-consolidation|Lost to Follow-up|0
7799722|NCT00492856|27104583|P4|Post-consolidation|Not protocol specified|0
7799723|NCT00492856|27104584|P3|Post-consolidation|Not protocol specified|0
7799724|NCT00492856|27104585|P2|Post-consolidation|Not protocol specified|1
7799725|NCT00492856|27104586|P1|Post-consolidation|Not protocol specified|0
7799726|NCT00492856|27104583|P4|Post-consolidation|Death|0
7799727|NCT00492856|27104584|P3|Post-consolidation|Death|0
7799728|NCT00492856|27104585|P2|Post-consolidation|Death|1
7799729|NCT00492856|27104586|P1|Post-consolidation|Death|0
7799730|NCT00492856|27104583|P4|Post-consolidation|Withdrawal by Subject|0
7799731|NCT00492856|27104584|P3|Post-consolidation|Withdrawal by Subject|0
7799732|NCT00492856|27104585|P2|Post-consolidation|Withdrawal by Subject|4
7799733|NCT00492856|27104586|P1|Post-consolidation|Withdrawal by Subject|0
7799734|NCT00492856|27104583|P4|Post-consolidation|Adverse Event|1
7799735|NCT00492856|27104584|P3|Post-consolidation|Adverse Event|0
7799736|NCT00492856|27104585|P2|Post-consolidation|Adverse Event|4
7799737|NCT00492856|27104586|P1|Post-consolidation|Adverse Event|0
7799738|NCT00492856|27104583|P4|Consolidation|Lost to Follow-up|0
7799739|NCT00492856|27104584|P3|Consolidation|Lost to Follow-up|0
7799740|NCT00492856|27104585|P2|Consolidation|Lost to Follow-up|0
7799741|NCT00492856|27104586|P1|Consolidation|Lost to Follow-up|1
7799742|NCT00492856|27104583|P4|Consolidation|Not protocol specified|0
7799743|NCT00492856|27104584|P3|Consolidation|Not protocol specified|0
7799744|NCT00492856|27104585|P2|Consolidation|Not protocol specified|0
7799745|NCT00492856|27104586|P1|Consolidation|Not protocol specified|2
7799746|NCT00492856|27104583|P4|Consolidation|Adverse Event|0
7799747|NCT00492856|27104584|P3|Consolidation|Adverse Event|0
7799748|NCT00492856|27104585|P2|Consolidation|Adverse Event|0
7799749|NCT00492856|27104586|P1|Consolidation|Adverse Event|6
7799750|NCT00492856|27104583|P4|Induction|Death|0
7799751|NCT00492856|27104584|P3|Induction|Death|0
7799752|NCT00492856|27104585|P2|Induction|Death|0
7799753|NCT00492856|27104586|P1|Induction|Death|3
7799754|NCT00492856|27104583|P4|Induction|Withdrawal by Subject|0
7799755|NCT00492856|27104584|P3|Induction|Withdrawal by Subject|0
7799756|NCT00492856|27104585|P2|Induction|Withdrawal by Subject|0
7799757|NCT00492856|27104586|P1|Induction|Withdrawal by Subject|1
7799758|NCT00492856|27104583|P4|Induction|Adverse Event|0
7799759|NCT00492856|27104584|P3|Induction|Adverse Event|0
7799760|NCT00492856|27104585|P2|Induction|Adverse Event|0
7799761|NCT00492856|27104586|P1|Induction|Adverse Event|2
7799762|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7799763|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7799764|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7799765|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
7799766|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7799767|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7799768|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
7799769|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7799770|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
7799771|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7799772|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7799773|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7799774|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
7799775|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
7799776|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
7799777|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
7799778|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
7799779|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
7799780|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
7799781|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
7799782|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
7799783|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
7799784|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
7799785|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
7799786|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Death|1
7799787|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Death|45
7799788|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Death|5
7799789|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Death|75
7799790|NCT00492752|27104600|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
7799791|NCT00492752|27104601|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
7799792|NCT00492752|27104602|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
7799793|NCT00492752|27104603|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
7799794|NCT00492752|27104600|P4|Double Blind Treatment|Protocol Violation|0
7799795|NCT00492752|27104601|P3|Double Blind Treatment|Protocol Violation|1
7799796|NCT00492752|27104602|P2|Double Blind Treatment|Protocol Violation|0
7799797|NCT00492752|27104603|P1|Double Blind Treatment|Protocol Violation|0
7799798|NCT00492752|27104600|P4|Double Blind Treatment|Adverse Event|0
7799799|NCT00492752|27104601|P3|Double Blind Treatment|Adverse Event|0
7799800|NCT00492752|27104602|P2|Double Blind Treatment|Adverse Event|0
7799801|NCT00492752|27104603|P1|Double Blind Treatment|Adverse Event|1
7799802|NCT00492752|27104600|P4|Double Blind Treatment|Death|0
7799803|NCT00492752|27104601|P3|Double Blind Treatment|Death|2
7799804|NCT00492752|27104602|P2|Double Blind Treatment|Death|0
7799805|NCT00492752|27104603|P1|Double Blind Treatment|Death|13
7799806|NCT00492726|27104638|P2|Overall Study|Non compliant with study medication|3
7799807|NCT00492726|27104639|P1|Overall Study|Non compliant with study medication|0
7799808|NCT00492726|27104638|P2|Overall Study|Withdrawal by Subject|3
7799809|NCT00492726|27104639|P1|Overall Study|Withdrawal by Subject|6
7799810|NCT00492726|27104638|P2|Overall Study|Physician Decision|1
7799811|NCT00492726|27104639|P1|Overall Study|Physician Decision|0
7799812|NCT00492726|27104638|P2|Overall Study|Lost to Follow-up|19
7799813|NCT00492726|27104639|P1|Overall Study|Lost to Follow-up|27
7799814|NCT00492726|27104638|P2|Overall Study|Lack of Efficacy|2
7799815|NCT00492726|27104639|P1|Overall Study|Lack of Efficacy|0
7799816|NCT00492726|27104638|P2|Overall Study|Death|2
7799817|NCT00492726|27104639|P1|Overall Study|Death|7
7799818|NCT00492726|27104638|P2|Overall Study|Adverse Event|6
7799819|NCT00492726|27104639|P1|Overall Study|Adverse Event|10
7799820|NCT00492648|27104665|P2|Month 30 (109671 Study)|Protocol Violation|1
7799821|NCT00492648|27104666|P1|Month 30 (109671 Study)|Protocol Violation|0
7799822|NCT00492557|27104713|P2|Overall Study|Lost to Follow-up|1
7799823|NCT00492557|27104714|P1|Overall Study|Lost to Follow-up|0
7799824|NCT00492557|27104713|P2|Overall Study|Failed to return|0
7799825|NCT00492557|27104714|P1|Overall Study|Failed to return|1
7799826|NCT00492557|27104713|P2|Overall Study|Adverse Event|0
7799827|NCT00492557|27104714|P1|Overall Study|Adverse Event|1
7799828|NCT00492557|27104713|P2|Overall Study|Death|1
7799829|NCT00492557|27104714|P1|Overall Study|Death|1
7799830|NCT00492557|27104713|P2|Overall Study|Other|2
7799831|NCT00492557|27104714|P1|Overall Study|Other|2
7799832|NCT00492557|27104713|P2|Overall Study|Protocol Violation|8
7799833|NCT00492557|27104714|P1|Overall Study|Protocol Violation|7
7799834|NCT00492557|27104713|P2|Overall Study|Subject request|11
7799835|NCT00492557|27104714|P1|Overall Study|Subject request|12
7799836|NCT00492531|27104744|P2|Overall Study|Withdrawn(More than one reason selected)|23
7799837|NCT00492531|27104745|P1|Overall Study|Withdrawn(More than one reason selected)|22
7799838|NCT00492297|27104818|P1|Survival Only Follow-up|Study terminated by sponsor|12
7799839|NCT00492297|27104818|P1|Survival Only Follow-up|Lack of Efficacy|1
7799840|NCT00492297|27104818|P1|Survival Only Follow-up|Death|46
7799841|NCT00492297|27104818|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
7799842|NCT00492297|27104818|P1|Active Follow-up 30(+4) Days Duration|Death|17
7799843|NCT00492297|27104818|P1|Treatment|Study terminated by sponsor|3
7799844|NCT00492297|27104818|P1|Treatment|Death|2
7799845|NCT00492284|27104836|P4|Overall Study|Withdrawal by Subject|2
7799846|NCT00492284|27104837|P3|Overall Study|Withdrawal by Subject|0
7799847|NCT00492284|27104838|P2|Overall Study|Withdrawal by Subject|0
7799848|NCT00492284|27104839|P1|Overall Study|Withdrawal by Subject|1
7799849|NCT00492284|27104836|P4|Overall Study|Death|5
7799850|NCT00492284|27104837|P3|Overall Study|Death|2
7799851|NCT00492284|27104838|P2|Overall Study|Death|3
7799852|NCT00492284|27104839|P1|Overall Study|Death|0
7799853|NCT00492284|27104836|P4|Overall Study|Lost to Follow-up|1
7799854|NCT00492284|27104837|P3|Overall Study|Lost to Follow-up|3
7799855|NCT00492284|27104838|P2|Overall Study|Lost to Follow-up|0
7799856|NCT00492284|27104839|P1|Overall Study|Lost to Follow-up|0
7799857|NCT00492284|27104836|P4|Overall Study|Adverse Event|2
7799858|NCT00492284|27104837|P3|Overall Study|Adverse Event|1
7799859|NCT00492284|27104838|P2|Overall Study|Adverse Event|1
7799860|NCT00492284|27104839|P1|Overall Study|Adverse Event|0
7799861|NCT00492232|27104883|P2|Open-Label Treatment|Withdrawal by Subject|0
7799862|NCT00492232|27104884|P1|Open-Label Treatment|Withdrawal by Subject|1
7799863|NCT00492232|27104883|P2|Double-Blind Treatment|Randomized not treated|0
7799864|NCT00492232|27104884|P1|Double-Blind Treatment|Randomized not treated|1
7799865|NCT00492232|27104883|P2|Double-Blind Treatment|Other|5
7799866|NCT00492232|27104884|P1|Double-Blind Treatment|Other|6
7799867|NCT00492232|27104883|P2|Double-Blind Treatment|Lack of Efficacy|0
7799868|NCT00492232|27104884|P1|Double-Blind Treatment|Lack of Efficacy|1
7799869|NCT00492232|27104883|P2|Double-Blind Treatment|Withdrawal by Subject|8
7799870|NCT00492232|27104884|P1|Double-Blind Treatment|Withdrawal by Subject|4
7799871|NCT00492232|27104883|P2|Double-Blind Treatment|Lost to Follow-up|3
7799872|NCT00492232|27104884|P1|Double-Blind Treatment|Lost to Follow-up|2
7799873|NCT00492232|27104883|P2|Double-Blind Treatment|Protocol Violation|7
7799874|NCT00492232|27104884|P1|Double-Blind Treatment|Protocol Violation|3
7799875|NCT00492232|27104883|P2|Double-Blind Treatment|Adverse Event|2
7799876|NCT00492232|27104884|P1|Double-Blind Treatment|Adverse Event|1
7799877|NCT00492232|27104883|P2|Placebo Run-in|Missing|2
7799878|NCT00492232|27104884|P1|Placebo Run-in|Missing|0
7799879|NCT00492232|27104883|P2|Placebo Run-in|Other|6
7799880|NCT00492232|27104884|P1|Placebo Run-in|Other|0
7799881|NCT00492232|27104883|P2|Placebo Run-in|Entrance criteria not met|45
7799882|NCT00492232|27104884|P1|Placebo Run-in|Entrance criteria not met|0
7799883|NCT00492232|27104883|P2|Placebo Run-in|Pregnancy|1
7799884|NCT00492232|27104884|P1|Placebo Run-in|Pregnancy|0
7799885|NCT00492232|27104883|P2|Placebo Run-in|Withdrawal by Subject|8
7799886|NCT00492232|27104884|P1|Placebo Run-in|Withdrawal by Subject|0
7799887|NCT00492232|27104883|P2|Placebo Run-in|Lost to Follow-up|3
7799888|NCT00492232|27104884|P1|Placebo Run-in|Lost to Follow-up|0
7799889|NCT00492232|27104883|P2|Placebo Run-in|Protocol Violation|3
7799890|NCT00492232|27104884|P1|Placebo Run-in|Protocol Violation|0
7799891|NCT00492232|27104883|P2|Placebo Run-in|Adverse Event|2
7799892|NCT00492232|27104884|P1|Placebo Run-in|Adverse Event|0
7799893|NCT00492115|27104925|P2|Overall Study|Withdrawal by Subject|4
7799894|NCT00492115|27104926|P1|Overall Study|Withdrawal by Subject|3
7799895|NCT00492063|27104947|P4|Overall Study|Protocol Violation|1
7799896|NCT00492063|27104948|P3|Overall Study|Protocol Violation|0
7799897|NCT00492063|27104949|P2|Overall Study|Protocol Violation|0
7799898|NCT00492063|27104950|P1|Overall Study|Protocol Violation|0
7799899|NCT00492063|27104947|P4|Overall Study|Lost to Follow-up|3
7799900|NCT00492063|27104948|P3|Overall Study|Lost to Follow-up|5
7799901|NCT00492063|27104949|P2|Overall Study|Lost to Follow-up|11
7799902|NCT00492063|27104950|P1|Overall Study|Lost to Follow-up|6
7799903|NCT00492063|27104947|P4|Overall Study|Withdrawal by Subject|4
7799904|NCT00492063|27104948|P3|Overall Study|Withdrawal by Subject|5
7799905|NCT00492063|27104949|P2|Overall Study|Withdrawal by Subject|3
7799906|NCT00492063|27104950|P1|Overall Study|Withdrawal by Subject|4
7799907|NCT00492063|27104947|P4|Overall Study|Death|2
7799908|NCT00492063|27104948|P3|Overall Study|Death|1
7799909|NCT00492063|27104949|P2|Overall Study|Death|0
7799910|NCT00492063|27104950|P1|Overall Study|Death|0
7799911|NCT00492024|27104974|P2|Follow up|Lost to Follow-up|1
7799912|NCT00492024|27104975|P1|Follow up|Lost to Follow-up|1
7799913|NCT00492024|27104974|P2|Follow up|Lack of Efficacy|1
7799914|NCT00492024|27104975|P1|Follow up|Lack of Efficacy|0
7799915|NCT00492024|27104974|P2|Treatment|Withdrawal by Subject|0
7799916|NCT00492024|27104975|P1|Treatment|Withdrawal by Subject|2
7799917|NCT00492024|27104974|P2|Treatment|Lost to Follow-up|1
7799918|NCT00492024|27104975|P1|Treatment|Lost to Follow-up|3
7799919|NCT00492024|27104974|P2|Treatment|Lack of Efficacy|20
7799920|NCT00492024|27104975|P1|Treatment|Lack of Efficacy|21
7799921|NCT00492024|27104974|P2|Treatment|Adverse Event|1
7799922|NCT00492024|27104975|P1|Treatment|Adverse Event|3
7799923|NCT00491894|27104991|P1|Overall Study|Other-Intake of prohibited medication|1
7799924|NCT00491894|27104991|P1|Overall Study|Protocol Violation|2
7799925|NCT00491894|27104991|P1|Overall Study|Physician Decision|2
7799926|NCT00491894|27104991|P1|Overall Study|Other-Failed to meet any criteria|2
7799927|NCT00491894|27104991|P1|Overall Study|Lack of Efficacy|2
7799928|NCT00491894|27104991|P1|Overall Study|Lost to Follow-up|3
7799929|NCT00491894|27104991|P1|Overall Study|Death|3
7799930|NCT00491894|27104991|P1|Overall Study|Withdrawal by Subject|5
7799931|NCT00491894|27104991|P1|Overall Study|Adverse Event|14
7799932|NCT00491764|27105018|P6|Overall Study|Administrative|0
7799933|NCT00491764|27105019|P5|Overall Study|Administrative|0
7799934|NCT00491764|27105020|P4|Overall Study|Administrative|1
7799935|NCT00491764|27105021|P3|Overall Study|Administrative|2
7799936|NCT00491764|27105022|P2|Overall Study|Administrative|0
7799937|NCT00491764|27105023|P1|Overall Study|Administrative|1
7799938|NCT00491764|27105018|P6|Overall Study|Did not Meet Protocol Eligibility|1
7799939|NCT00491764|27105019|P5|Overall Study|Did not Meet Protocol Eligibility|1
7799940|NCT00491764|27105020|P4|Overall Study|Did not Meet Protocol Eligibility|0
7799941|NCT00491764|27105021|P3|Overall Study|Did not Meet Protocol Eligibility|1
7799942|NCT00491764|27105022|P2|Overall Study|Did not Meet Protocol Eligibility|1
7799943|NCT00491764|27105023|P1|Overall Study|Did not Meet Protocol Eligibility|0
7799944|NCT00491764|27105018|P6|Overall Study|Non Compliance with the Protocol|0
7799945|NCT00491764|27105019|P5|Overall Study|Non Compliance with the Protocol|0
7799946|NCT00491764|27105020|P4|Overall Study|Non Compliance with the Protocol|0
7799947|NCT00491764|27105021|P3|Overall Study|Non Compliance with the Protocol|0
7799948|NCT00491764|27105022|P2|Overall Study|Non Compliance with the Protocol|0
7799949|NCT00491764|27105023|P1|Overall Study|Non Compliance with the Protocol|1
7799950|NCT00491764|27105018|P6|Overall Study|Withdrawal by Subject|4
7799951|NCT00491764|27105019|P5|Overall Study|Withdrawal by Subject|2
7799952|NCT00491764|27105020|P4|Overall Study|Withdrawal by Subject|2
7799953|NCT00491764|27105021|P3|Overall Study|Withdrawal by Subject|1
7799954|NCT00491764|27105022|P2|Overall Study|Withdrawal by Subject|3
7799955|NCT00491764|27105023|P1|Overall Study|Withdrawal by Subject|2
7799956|NCT00491764|27105018|P6|Overall Study|Lost to Follow-up|3
7799957|NCT00491764|27105019|P5|Overall Study|Lost to Follow-up|0
7799958|NCT00491764|27105020|P4|Overall Study|Lost to Follow-up|1
7799959|NCT00491764|27105021|P3|Overall Study|Lost to Follow-up|0
7799960|NCT00491764|27105022|P2|Overall Study|Lost to Follow-up|1
7799961|NCT00491764|27105023|P1|Overall Study|Lost to Follow-up|0
7799962|NCT00491764|27105018|P6|Overall Study|Adverse Event|1
7799963|NCT00491764|27105019|P5|Overall Study|Adverse Event|0
7799964|NCT00491764|27105020|P4|Overall Study|Adverse Event|4
7799965|NCT00491764|27105021|P3|Overall Study|Adverse Event|4
7799966|NCT00491764|27105022|P2|Overall Study|Adverse Event|2
7799967|NCT00491764|27105023|P1|Overall Study|Adverse Event|1
7799968|NCT00491608|27105071|P1|Overall Study|Withdrawal by Subject|1
7799969|NCT00491608|27105071|P1|Overall Study|Death|2
7799970|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
7799971|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
7799972|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
7799973|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
7799974|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
7799975|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
7799976|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
7799977|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
7799978|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
7799979|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
7799980|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
7799981|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
7799982|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
7799983|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
7799984|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
7799985|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
7799986|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
7799987|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
7799988|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
7799989|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
7799990|NCT00491556|27105082|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
7799991|NCT00491556|27105083|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
7799992|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
7799993|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
7799994|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
7799995|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
7799996|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
7799997|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
7799998|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
7799999|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
7800000|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
7800001|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
7800002|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
7800003|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
7800004|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
7800005|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
7800006|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
7800007|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
7800008|NCT00491556|27105082|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
7800009|NCT00491556|27105083|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
7800010|NCT00491530|27105142|P3|Overall Study|Use of Prohibited Medication|1
7800011|NCT00491530|27105143|P2|Overall Study|Use of Prohibited Medication|0
7800012|NCT00491530|27105144|P1|Overall Study|Use of Prohibited Medication|0
7800013|NCT00491530|27105142|P3|Overall Study|Patient Request|0
7800014|NCT00491530|27105143|P2|Overall Study|Patient Request|1
7800015|NCT00491530|27105144|P1|Overall Study|Patient Request|0
7800016|NCT00491530|27105142|P3|Overall Study|Investigator Discretion|0
7800017|NCT00491530|27105143|P2|Overall Study|Investigator Discretion|1
7800018|NCT00491530|27105144|P1|Overall Study|Investigator Discretion|0
7800019|NCT00491530|27105142|P3|Overall Study|Lack of Efficacy|0
7800020|NCT00491530|27105143|P2|Overall Study|Lack of Efficacy|1
7800021|NCT00491530|27105144|P1|Overall Study|Lack of Efficacy|0
7800022|NCT00491530|27105142|P3|Overall Study|Lost to Follow-up|2
7800023|NCT00491530|27105143|P2|Overall Study|Lost to Follow-up|2
7800024|NCT00491530|27105144|P1|Overall Study|Lost to Follow-up|3
7800025|NCT00491530|27105142|P3|Overall Study|Withdrawal by Subject|0
7800026|NCT00491530|27105143|P2|Overall Study|Withdrawal by Subject|0
7800027|NCT00491530|27105144|P1|Overall Study|Withdrawal by Subject|3
7800028|NCT00491530|27105142|P3|Overall Study|Adverse Event|2
7800029|NCT00491530|27105143|P2|Overall Study|Adverse Event|1
7800030|NCT00491530|27105144|P1|Overall Study|Adverse Event|6
7800031|NCT00491504|27105174|P4|Overall Study|Protocol Violation|2
7800032|NCT00491504|27105175|P3|Overall Study|Protocol Violation|3
7800033|NCT00491504|27105176|P2|Overall Study|Protocol Violation|0
7800034|NCT00491504|27105177|P1|Overall Study|Protocol Violation|0
7800035|NCT00491504|27105174|P4|Overall Study|Withdrawal by Subject|2
7800036|NCT00491504|27105175|P3|Overall Study|Withdrawal by Subject|1
7800037|NCT00491504|27105176|P2|Overall Study|Withdrawal by Subject|0
7800038|NCT00491504|27105177|P1|Overall Study|Withdrawal by Subject|0
7800039|NCT00491504|27105174|P4|Overall Study|Adverse Event|0
7800040|NCT00491504|27105175|P3|Overall Study|Adverse Event|0
7800041|NCT00491504|27105176|P2|Overall Study|Adverse Event|1
7800042|NCT00491504|27105177|P1|Overall Study|Adverse Event|0
7800043|NCT00491400|27105206|P2|Overall Study|Withdrawal by Subject|4
7800044|NCT00491400|27105207|P1|Overall Study|Withdrawal by Subject|5
7800045|NCT00491387|27105215|P1|Overall Study|study terminated|20
7800046|NCT00491322|27105230|P2|Overall Study|Pregnancy|1
7800047|NCT00491322|27105231|P1|Overall Study|Pregnancy|0
7800048|NCT00491322|27105230|P2|Overall Study|Protocol Violation|0
7800049|NCT00491322|27105231|P1|Overall Study|Protocol Violation|1
7800050|NCT00491179|27105250|P2|Overall Study|Withdrawal by Subject|1
7800051|NCT00491179|27105251|P1|Overall Study|Withdrawal by Subject|2
7800052|NCT00491179|27105250|P2|Overall Study|Adverse Event|1
7800053|NCT00491179|27105251|P1|Overall Study|Adverse Event|5
7800054|NCT00491075|27105259|P1|Overall Study|Physician Decision|1
7800055|NCT00491075|27105259|P1|Overall Study|Withdrawal by Subject|1
7800056|NCT00490971|27105265|P5|Maintenance|Other|3
7800057|NCT00490971|27105266|P4|Maintenance|Other|9
7800058|NCT00490971|27105267|P3|Maintenance|Other|11
7800059|NCT00490971|27105268|P2|Maintenance|Other|0
7800060|NCT00490971|27105269|P1|Maintenance|Other|0
7800061|NCT00490971|27105265|P5|Maintenance|Withdrawal by Subject|18
7800062|NCT00490971|27105266|P4|Maintenance|Withdrawal by Subject|28
7800063|NCT00490971|27105267|P3|Maintenance|Withdrawal by Subject|26
7800064|NCT00490971|27105268|P2|Maintenance|Withdrawal by Subject|0
7800065|NCT00490971|27105269|P1|Maintenance|Withdrawal by Subject|0
7800066|NCT00490971|27105265|P5|Maintenance|Protocol Violation|1
7800067|NCT00490971|27105266|P4|Maintenance|Protocol Violation|1
7800068|NCT00490971|27105267|P3|Maintenance|Protocol Violation|4
7800069|NCT00490971|27105268|P2|Maintenance|Protocol Violation|0
7800070|NCT00490971|27105269|P1|Maintenance|Protocol Violation|0
7800071|NCT00490971|27105265|P5|Maintenance|Pregnancy|0
7800072|NCT00490971|27105266|P4|Maintenance|Pregnancy|0
7800073|NCT00490971|27105267|P3|Maintenance|Pregnancy|1
7800074|NCT00490971|27105268|P2|Maintenance|Pregnancy|0
7800075|NCT00490971|27105269|P1|Maintenance|Pregnancy|0
7800076|NCT00490971|27105265|P5|Maintenance|Lost to Follow-up|10
7800077|NCT00490971|27105266|P4|Maintenance|Lost to Follow-up|8
7800078|NCT00490971|27105267|P3|Maintenance|Lost to Follow-up|5
7800079|NCT00490971|27105268|P2|Maintenance|Lost to Follow-up|0
7800080|NCT00490971|27105269|P1|Maintenance|Lost to Follow-up|0
7800081|NCT00490971|27105265|P5|Maintenance|Death|0
7800082|NCT00490971|27105266|P4|Maintenance|Death|2
7800083|NCT00490971|27105267|P3|Maintenance|Death|0
7800084|NCT00490971|27105268|P2|Maintenance|Death|0
7800085|NCT00490971|27105269|P1|Maintenance|Death|0
7800086|NCT00490971|27105265|P5|Maintenance|Adverse Event|7
7800087|NCT00490971|27105266|P4|Maintenance|Adverse Event|5
7800088|NCT00490971|27105267|P3|Maintenance|Adverse Event|4
7800089|NCT00490971|27105268|P2|Maintenance|Adverse Event|0
7800090|NCT00490971|27105269|P1|Maintenance|Adverse Event|0
7800091|NCT00490971|27105265|P5|Acute/Continuation|Other|0
7800092|NCT00490971|27105266|P4|Acute/Continuation|Other|0
7800093|NCT00490971|27105267|P3|Acute/Continuation|Other|0
7800094|NCT00490971|27105268|P2|Acute/Continuation|Other|4
7800095|NCT00490971|27105269|P1|Acute/Continuation|Other|11
7800096|NCT00490971|27105265|P5|Acute/Continuation|Withdrawal by Subject|0
7800097|NCT00490971|27105266|P4|Acute/Continuation|Withdrawal by Subject|0
7800098|NCT00490971|27105267|P3|Acute/Continuation|Withdrawal by Subject|0
7800099|NCT00490971|27105268|P2|Acute/Continuation|Withdrawal by Subject|24
7800100|NCT00490971|27105269|P1|Acute/Continuation|Withdrawal by Subject|92
7800101|NCT00490971|27105265|P5|Acute/Continuation|Protocol Violation|0
7800102|NCT00490971|27105266|P4|Acute/Continuation|Protocol Violation|0
7800103|NCT00490971|27105267|P3|Acute/Continuation|Protocol Violation|0
7800104|NCT00490971|27105268|P2|Acute/Continuation|Protocol Violation|2
7800105|NCT00490971|27105269|P1|Acute/Continuation|Protocol Violation|10
7800106|NCT00490971|27105265|P5|Acute/Continuation|Lost to Follow-up|0
7800107|NCT00490971|27105266|P4|Acute/Continuation|Lost to Follow-up|0
7800108|NCT00490971|27105267|P3|Acute/Continuation|Lost to Follow-up|0
7800109|NCT00490971|27105268|P2|Acute/Continuation|Lost to Follow-up|7
7800110|NCT00490971|27105269|P1|Acute/Continuation|Lost to Follow-up|23
7800111|NCT00490971|27105265|P5|Acute/Continuation|Lack of Efficacy|0
7800112|NCT00490971|27105266|P4|Acute/Continuation|Lack of Efficacy|0
7800113|NCT00490971|27105267|P3|Acute/Continuation|Lack of Efficacy|0
7800114|NCT00490971|27105268|P2|Acute/Continuation|Lack of Efficacy|12
7800115|NCT00490971|27105269|P1|Acute/Continuation|Lack of Efficacy|106
7800116|NCT00490971|27105265|P5|Acute/Continuation|Death|0
7800117|NCT00490971|27105266|P4|Acute/Continuation|Death|0
7800118|NCT00490971|27105267|P3|Acute/Continuation|Death|0
7800119|NCT00490971|27105268|P2|Acute/Continuation|Death|0
7800120|NCT00490971|27105269|P1|Acute/Continuation|Death|2
7800121|NCT00490971|27105265|P5|Acute/Continuation|Adverse Event|0
7800122|NCT00490971|27105266|P4|Acute/Continuation|Adverse Event|0
7800123|NCT00490971|27105267|P3|Acute/Continuation|Adverse Event|0
7800124|NCT00490971|27105268|P2|Acute/Continuation|Adverse Event|13
7800125|NCT00490971|27105269|P1|Acute/Continuation|Adverse Event|62
7800126|NCT00490945|27105316|P5|Overall Study|Adverse Event|0
7800127|NCT00490945|27105317|P4|Overall Study|Adverse Event|0
7800128|NCT00490945|27105318|P3|Overall Study|Adverse Event|0
7800129|NCT00490945|27105319|P2|Overall Study|Adverse Event|1
7800130|NCT00490945|27105320|P1|Overall Study|Adverse Event|0
7800131|NCT00490919|27105356|P3|Double-blind Phase|Administrative|6
7800132|NCT00490919|27105357|P2|Double-blind Phase|Administrative|6
7800133|NCT00490919|27105358|P1|Double-blind Phase|Administrative|0
7800134|NCT00490919|27105356|P3|Double-blind Phase|Lack of Efficacy|36
7800135|NCT00490919|27105357|P2|Double-blind Phase|Lack of Efficacy|22
7800136|NCT00490919|27105358|P1|Double-blind Phase|Lack of Efficacy|0
7800137|NCT00490919|27105356|P3|Double-blind Phase|Lost to Follow-up|11
7800138|NCT00490919|27105357|P2|Double-blind Phase|Lost to Follow-up|8
7800139|NCT00490919|27105358|P1|Double-blind Phase|Lost to Follow-up|0
7800140|NCT00490919|27105356|P3|Double-blind Phase|Withdrawal by Subject|11
7800141|NCT00490919|27105357|P2|Double-blind Phase|Withdrawal by Subject|10
7800142|NCT00490919|27105358|P1|Double-blind Phase|Withdrawal by Subject|0
7800143|NCT00490919|27105356|P3|Double-blind Phase|Adverse Event|20
7800144|NCT00490919|27105357|P2|Double-blind Phase|Adverse Event|40
7800145|NCT00490919|27105358|P1|Double-blind Phase|Adverse Event|0
7800146|NCT00490919|27105356|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
7800147|NCT00490919|27105357|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
7800148|NCT00490919|27105358|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
7800149|NCT00490919|27105356|P3|Open-label Run-in Period|Administrative|0
7800150|NCT00490919|27105357|P2|Open-label Run-in Period|Administrative|0
7800151|NCT00490919|27105358|P1|Open-label Run-in Period|Administrative|40
7800152|NCT00490919|27105356|P3|Open-label Run-in Period|Lack of Efficacy|0
7800153|NCT00490919|27105357|P2|Open-label Run-in Period|Lack of Efficacy|0
7800154|NCT00490919|27105358|P1|Open-label Run-in Period|Lack of Efficacy|143
7800155|NCT00490919|27105356|P3|Open-label Run-in Period|Lost to Follow-up|0
7800156|NCT00490919|27105357|P2|Open-label Run-in Period|Lost to Follow-up|0
7800157|NCT00490919|27105358|P1|Open-label Run-in Period|Lost to Follow-up|21
7800158|NCT00490919|27105356|P3|Open-label Run-in Period|Withdrawal by Subject|0
7800159|NCT00490919|27105357|P2|Open-label Run-in Period|Withdrawal by Subject|0
7800160|NCT00490919|27105358|P1|Open-label Run-in Period|Withdrawal by Subject|37
7800161|NCT00490919|27105356|P3|Open-label Run-in Period|Adverse Event|0
7800162|NCT00490919|27105357|P2|Open-label Run-in Period|Adverse Event|0
7800163|NCT00490919|27105358|P1|Open-label Run-in Period|Adverse Event|239
7800164|NCT00490841|27105369|P1|Overall Study|30 day f/u, only non-study stent used|3
7800165|NCT00490841|27105369|P1|Overall Study|Lost to Follow-up|1
7800166|NCT00490841|27105369|P1|Overall Study|Withdrawal by Subject|4
7800167|NCT00490841|27105369|P1|Overall Study|Death|5
7800168|NCT00490815|27105391|P2|Overall Study|Death|3
7800169|NCT00490815|27105392|P1|Overall Study|Death|1
7800170|NCT00490815|27105391|P2|Overall Study|Lost to Follow-up|3
7800171|NCT00490815|27105392|P1|Overall Study|Lost to Follow-up|1
7800172|NCT00490815|27105391|P2|Overall Study|Withdrawal by Subject|0
7800173|NCT00490815|27105392|P1|Overall Study|Withdrawal by Subject|4
7800174|NCT00490815|27105391|P2|Overall Study|Adverse Event|3
7800175|NCT00490815|27105392|P1|Overall Study|Adverse Event|2
7800176|NCT00490776|27105417|P1|Overall Study|Disease Progression|5
7800177|NCT00490776|27105417|P1|Overall Study|New Cancer Therapy|1
7800178|NCT00490776|27105417|P1|Overall Study|Death|1
7800179|NCT00490776|27105417|P1|Overall Study|Administrative Problems|1
7800180|NCT00490776|27105417|P1|Overall Study|Withdrawal by Subject|1
7800181|NCT00490724|27105431|P3|Period II|Treatment Discontinuation|3
7800182|NCT00490724|27105432|P2|Period II|Treatment Discontinuation|1
7800183|NCT00490724|27105433|P1|Period II|Treatment Discontinuation|3
7800184|NCT00490724|27105431|P3|Period I|Physician Decision|1
7800185|NCT00490724|27105432|P2|Period I|Physician Decision|0
7800186|NCT00490724|27105433|P1|Period I|Physician Decision|0
7800187|NCT00490698|27105498|P1|Overall Study|Physician Decision|2
7800188|NCT00490698|27105498|P1|Overall Study|Disease Progression|7
7800189|NCT00490698|27105498|P1|Overall Study|Withdrawal by Subject|1
7800190|NCT00490646|27105504|P2|Overall Study|Never Treated (withdrew consent)|1
7800191|NCT00490646|27105505|P1|Overall Study|Never Treated (withdrew consent)|0
7800192|NCT00490646|27105504|P2|Overall Study|Never Treated (had an adverse event)|0
7800193|NCT00490646|27105505|P1|Overall Study|Never Treated (had an adverse event)|1
7800194|NCT00490646|27105504|P2|Overall Study|Still on trastuzumab monotherapy|1
7800195|NCT00490646|27105505|P1|Overall Study|Still on trastuzumab monotherapy|1
7800196|NCT00490568|27105525|P1|Overall Study|Participant withdrawal due to surgery|1
7800197|NCT00490568|27105525|P1|Overall Study|Participant died|1
7800198|NCT00490568|27105525|P1|Overall Study|Efficacy related|3
7800199|NCT00490568|27105525|P1|Overall Study|Non-Compliance|7
7800200|NCT00490568|27105525|P1|Overall Study|Investigator decision|3
7800201|NCT00490568|27105525|P1|Overall Study|Unmet inclusion-exclusion criteria|5
7800202|NCT00490568|27105525|P1|Overall Study|Disease progression|4
7800203|NCT00490568|27105525|P1|Overall Study|Legal representative withdrew consent|1
7800204|NCT00490568|27105525|P1|Overall Study|Participant refused follow-up|9
7800205|NCT00490568|27105525|P1|Overall Study|Abnormal ECG|25
7800206|NCT00490568|27105525|P1|Overall Study|Caregiver related|20
7800207|NCT00490568|27105525|P1|Overall Study|Exclusion criteria met|1
7800208|NCT00490568|27105525|P1|Overall Study|Other|1
7800209|NCT00490568|27105525|P1|Overall Study|Still in the study at termination|974
7800210|NCT00490568|27105525|P1|Overall Study|Withdrawal by Subject|135
7800211|NCT00490568|27105525|P1|Overall Study|Protocol Violation|45
7800212|NCT00490568|27105525|P1|Overall Study|Lost to Follow-up|13
7800213|NCT00490568|27105525|P1|Overall Study|Adverse Event|116
7800214|NCT00490555|27105549|P4|Overall Study|noncompliant with drug administration|0
7800215|NCT00490555|27105550|P3|Overall Study|noncompliant with drug administration|2
7800216|NCT00490555|27105551|P2|Overall Study|noncompliant with drug administration|0
7800217|NCT00490555|27105552|P1|Overall Study|noncompliant with drug administration|0
7800218|NCT00490542|27105580|P2|Overall Study|Lack of Efficacy|1
7800219|NCT00490542|27105581|P1|Overall Study|Lack of Efficacy|1
7800220|NCT00490542|27105580|P2|Overall Study|Adverse Event|3
7800221|NCT00490542|27105581|P1|Overall Study|Adverse Event|3
7800222|NCT00490542|27105580|P2|Overall Study|Lost to Follow-up|0
7800223|NCT00490542|27105581|P1|Overall Study|Lost to Follow-up|3
7800224|NCT00490529|27105587|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
7800225|NCT00490529|27105587|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
7800226|NCT00490529|27105587|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
7800227|NCT00490529|27105587|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
7800228|NCT00490529|27105587|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
7800229|NCT00490529|27105587|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
7800230|NCT00490490|27105595|P1|Completed Assessment for TTP|Lost to Follow-up|2
7800231|NCT00490490|27105595|P1|Completed Assessment for TTP|Withdrawal by Subject|1
7800232|NCT00490451|27105612|P2|Overall Study|Progressive Disease|34
7800233|NCT00490451|27105613|P1|Overall Study|Progressive Disease|53
7800234|NCT00490451|27105612|P2|Overall Study|Protocol Violation|0
7800235|NCT00490451|27105613|P1|Overall Study|Protocol Violation|1
7800236|NCT00490451|27105612|P2|Overall Study|Investigator Decision|0
7800237|NCT00490451|27105613|P1|Overall Study|Investigator Decision|1
7800238|NCT00490451|27105612|P2|Overall Study|Withdrawal by Subject|0
7800239|NCT00490451|27105613|P1|Overall Study|Withdrawal by Subject|2
7800240|NCT00490451|27105612|P2|Overall Study|Death|1
7800241|NCT00490451|27105613|P1|Overall Study|Death|3
7800242|NCT00490451|27105612|P2|Overall Study|Adverse Event|3
7800243|NCT00490451|27105613|P1|Overall Study|Adverse Event|3
7800244|NCT00490282|27105633|P1|Overall Study|Withdrawal by Subject|3
7800245|NCT00490139|27105661|P4|Overall Study|Participant Withdrew Consent|116
7800246|NCT00490139|27105662|P3|Overall Study|Participant Withdrew Consent|208
7800247|NCT00490139|27105663|P2|Overall Study|Participant Withdrew Consent|110
7800248|NCT00490139|27105664|P1|Overall Study|Participant Withdrew Consent|146
7800249|NCT00490139|27105661|P4|Overall Study|Lost to Follow-up|56
7800250|NCT00490139|27105662|P3|Overall Study|Lost to Follow-up|58
7800251|NCT00490139|27105663|P2|Overall Study|Lost to Follow-up|46
7800252|NCT00490139|27105664|P1|Overall Study|Lost to Follow-up|56
7800253|NCT00490139|27105661|P4|Overall Study|Death|135
7800254|NCT00490139|27105662|P3|Overall Study|Death|168
7800255|NCT00490139|27105663|P2|Overall Study|Death|119
7800256|NCT00490139|27105664|P1|Overall Study|Death|106
7800257|NCT00490061|27105699|P1|Overall Study|Physician Decision|1
7800258|NCT00490035|27105708|P4|Overall Study|AE of unknown type|0
7800259|NCT00490035|27105709|P3|Overall Study|AE of unknown type|2
7800260|NCT00490035|27105710|P2|Overall Study|AE of unknown type|0
7800261|NCT00490035|27105711|P1|Overall Study|AE of unknown type|0
7800262|NCT00490035|27105708|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
7800263|NCT00490035|27105709|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
7800264|NCT00490035|27105710|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
7800265|NCT00490035|27105711|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
7800266|NCT00490035|27105708|P4|Overall Study|AE, serious fatal|0
7800267|NCT00490035|27105709|P3|Overall Study|AE, serious fatal|0
7800268|NCT00490035|27105710|P2|Overall Study|AE, serious fatal|0
7800269|NCT00490035|27105711|P1|Overall Study|AE, serious fatal|1
7800270|NCT00490035|27105708|P4|Overall Study|Other reason|1
7800271|NCT00490035|27105709|P3|Overall Study|Other reason|3
7800272|NCT00490035|27105710|P2|Overall Study|Other reason|1
7800273|NCT00490035|27105711|P1|Overall Study|Other reason|0
7800274|NCT00490035|27105708|P4|Overall Study|Withdrawal by Subject|0
7800275|NCT00490035|27105709|P3|Overall Study|Withdrawal by Subject|1
7800276|NCT00490035|27105710|P2|Overall Study|Withdrawal by Subject|1
7800277|NCT00490035|27105711|P1|Overall Study|Withdrawal by Subject|2
7800278|NCT00490035|27105708|P4|Overall Study|Lost to Follow-up|0
7800279|NCT00490035|27105709|P3|Overall Study|Lost to Follow-up|1
7800280|NCT00490035|27105710|P2|Overall Study|Lost to Follow-up|0
7800281|NCT00490035|27105711|P1|Overall Study|Lost to Follow-up|2
7800282|NCT00490035|27105708|P4|Overall Study|AE, non-serious non-fatal|5
7800283|NCT00490035|27105709|P3|Overall Study|AE, non-serious non-fatal|4
7800284|NCT00490035|27105710|P2|Overall Study|AE, non-serious non-fatal|4
7800285|NCT00490035|27105711|P1|Overall Study|AE, non-serious non-fatal|3
7800286|NCT00490022|27105811|P2|Overall Study|Subject failed to disclose concommitant|1
7800287|NCT00490022|27105812|P1|Overall Study|Subject failed to disclose concommitant|0
7800288|NCT00490022|27105811|P2|Overall Study|Withdrawal by Subject|0
7800289|NCT00490022|27105812|P1|Overall Study|Withdrawal by Subject|1
7800290|NCT00490022|27105811|P2|Overall Study|Adverse Event|2
7800291|NCT00490022|27105812|P1|Overall Study|Adverse Event|0
7800292|NCT00489970|27105829|P3|Persistence Year 9|Other|2
7800293|NCT00489970|27105830|P2|Persistence Year 9|Other|0
7800294|NCT00489970|27105831|P1|Persistence Year 9|Other|1
7800295|NCT00489970|27105829|P3|Persistence Year 9|Lost to Follow-up|3
7800296|NCT00489970|27105830|P2|Persistence Year 9|Lost to Follow-up|2
7800297|NCT00489970|27105831|P1|Persistence Year 9|Lost to Follow-up|2
7800298|NCT00489918|27105935|P5|Overall Study|Physician Decision|0
7800299|NCT00489918|27105936|P4|Overall Study|Physician Decision|0
7800300|NCT00489918|27105937|P3|Overall Study|Physician Decision|1
7800301|NCT00489918|27105938|P2|Overall Study|Physician Decision|0
7800302|NCT00489918|27105939|P1|Overall Study|Physician Decision|0
7800303|NCT00489918|27105935|P5|Overall Study|Lost to Follow-up|0
7800304|NCT00489918|27105936|P4|Overall Study|Lost to Follow-up|1
7800305|NCT00489918|27105937|P3|Overall Study|Lost to Follow-up|1
7800306|NCT00489918|27105938|P2|Overall Study|Lost to Follow-up|0
7800307|NCT00489918|27105939|P1|Overall Study|Lost to Follow-up|0
7800308|NCT00489918|27105935|P5|Overall Study|Adverse Event|0
7800309|NCT00489918|27105936|P4|Overall Study|Adverse Event|0
7800310|NCT00489918|27105937|P3|Overall Study|Adverse Event|1
7800311|NCT00489918|27105938|P2|Overall Study|Adverse Event|1
7800312|NCT00489918|27105939|P1|Overall Study|Adverse Event|0
7800313|NCT00489918|27105935|P5|Overall Study|Withdrawal by Subject|1
7800314|NCT00489918|27105936|P4|Overall Study|Withdrawal by Subject|0
7800315|NCT00489918|27105937|P3|Overall Study|Withdrawal by Subject|1
7800316|NCT00489918|27105938|P2|Overall Study|Withdrawal by Subject|1
7800317|NCT00489918|27105939|P1|Overall Study|Withdrawal by Subject|2
7800318|NCT00489853|27105988|P3|Treatment Period 3|Study specific discontinuation criteria|0
7800319|NCT00489853|27105989|P2|Treatment Period 3|Study specific discontinuation criteria|1
7800320|NCT00489853|27105990|P1|Treatment Period 3|Study specific discontinuation criteria|0
7800321|NCT00489853|27105988|P3|Wash-out Period 2|Study specific discontinuation criteria|2
7800322|NCT00489853|27105989|P2|Wash-out Period 2|Study specific discontinuation criteria|2
7800323|NCT00489853|27105990|P1|Wash-out Period 2|Study specific discontinuation criteria|3
7800324|NCT00489853|27105988|P3|Wash-out Period 2|Adverse Event|0
7800325|NCT00489853|27105989|P2|Wash-out Period 2|Adverse Event|1
7800326|NCT00489853|27105990|P1|Wash-out Period 2|Adverse Event|1
7800327|NCT00489853|27105988|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
7800328|NCT00489853|27105989|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
7800329|NCT00489853|27105990|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
7800330|NCT00489853|27105988|P3|Wash-out Period 1|Protocol Violation|1
7800331|NCT00489853|27105989|P2|Wash-out Period 1|Protocol Violation|1
7800332|NCT00489853|27105990|P1|Wash-out Period 1|Protocol Violation|0
7800333|NCT00489853|27105988|P3|Wash-out Period 1|Adverse Event|1
7800334|NCT00489853|27105989|P2|Wash-out Period 1|Adverse Event|1
7800335|NCT00489853|27105990|P1|Wash-out Period 1|Adverse Event|0
7800336|NCT00489853|27105988|P3|Wash-out Period 1|Withdrawal by Subject|0
7800337|NCT00489853|27105989|P2|Wash-out Period 1|Withdrawal by Subject|0
7800338|NCT00489853|27105990|P1|Wash-out Period 1|Withdrawal by Subject|1
7800339|NCT00489827|27106087|P2|Overall Study|Intraoperative exclusion criteria|1
7800340|NCT00489827|27106088|P1|Overall Study|Intraoperative exclusion criteria|1
7800341|NCT00489827|27106087|P2|Overall Study|Intraoperative exclusion criteria|1
7800342|NCT00489827|27106088|P1|Overall Study|Intraoperative exclusion criteria|1
7800343|NCT00489736|27106112|P2|Overall Study|Not coded/ Not pre-specified|8
7800344|NCT00489736|27106113|P1|Overall Study|Not coded/ Not pre-specified|5
7800345|NCT00489736|27106112|P2|Overall Study|Poor compliance|2
7800346|NCT00489736|27106113|P1|Overall Study|Poor compliance|6
7800347|NCT00489736|27106112|P2|Overall Study|Adverse Event|45
7800348|NCT00489736|27106113|P1|Overall Study|Adverse Event|32
7800349|NCT00489736|27106112|P2|Overall Study|Lack of Efficacy|14
7800350|NCT00489736|27106113|P1|Overall Study|Lack of Efficacy|53
7800351|NCT00489554|27106123|P1|Overall Study|Lost to Follow-up|1
7800352|NCT00489554|27106123|P1|Overall Study|Withdrawal by Subject|1
7800353|NCT00489554|27106123|P1|Overall Study|Adverse Event|2
7800354|NCT00489541|27106143|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
7800355|NCT00489541|27106144|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
7800356|NCT00489541|27106143|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
7800357|NCT00489541|27106144|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
7800358|NCT00489541|27106143|P2|12-Month Clinical Follow-up|Death|2
7800359|NCT00489541|27106144|P1|12-Month Clinical Follow-up|Death|3
7800360|NCT00489541|27106143|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
7800361|NCT00489541|27106144|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
7800362|NCT00489541|27106143|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
7800363|NCT00489541|27106144|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
7800364|NCT00489541|27106143|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
7800365|NCT00489541|27106144|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
7800366|NCT00489489|27106155|P3|Overall Study|Other than above|0
7800367|NCT00489489|27106156|P2|Overall Study|Other than above|1
7800368|NCT00489489|27106157|P1|Overall Study|Other than above|0
7800369|NCT00489489|27106155|P3|Overall Study|Participant did not wish to continue|0
7800370|NCT00489489|27106156|P2|Overall Study|Participant did not wish to continue|1
7800371|NCT00489489|27106157|P1|Overall Study|Participant did not wish to continue|1
7800372|NCT00489489|27106155|P3|Overall Study|Progressive disease|0
7800373|NCT00489489|27106156|P2|Overall Study|Progressive disease|1
7800374|NCT00489489|27106157|P1|Overall Study|Progressive disease|0
7800375|NCT00489489|27106155|P3|Overall Study|Protocol Violation|1
7800376|NCT00489489|27106156|P2|Overall Study|Protocol Violation|0
7800377|NCT00489489|27106157|P1|Overall Study|Protocol Violation|1
7800378|NCT00489489|27106155|P3|Overall Study|Adverse Event|1
7800379|NCT00489489|27106156|P2|Overall Study|Adverse Event|1
7800380|NCT00489489|27106157|P1|Overall Study|Adverse Event|1
7800381|NCT00489489|27106155|P3|Overall Study|Not treated due to protocol violation|1
7800382|NCT00489489|27106156|P2|Overall Study|Not treated due to protocol violation|1
7800383|NCT00489489|27106157|P1|Overall Study|Not treated due to protocol violation|0
7800384|NCT00489476|27106189|P4|Overall Study|Lost to Follow-up|0
7800385|NCT00489476|27106190|P3|Overall Study|Lost to Follow-up|0
7800386|NCT00489476|27106191|P2|Overall Study|Lost to Follow-up|1
7800387|NCT00489476|27106192|P1|Overall Study|Lost to Follow-up|0
7800388|NCT00489424|27106213|P3|Overall Study|Administrative problems|1
7800389|NCT00489424|27106214|P2|Overall Study|Administrative problems|2
7800390|NCT00489424|27106215|P1|Overall Study|Administrative problems|0
7800391|NCT00489424|27106213|P3|Overall Study|Lack of Efficacy|0
7800392|NCT00489424|27106214|P2|Overall Study|Lack of Efficacy|0
7800393|NCT00489424|27106215|P1|Overall Study|Lack of Efficacy|1
7800394|NCT00489424|27106213|P3|Overall Study|Adverse Event|4
7800395|NCT00489424|27106214|P2|Overall Study|Adverse Event|3
7800396|NCT00489424|27106215|P1|Overall Study|Adverse Event|3
7800397|NCT00489411|27106246|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
7800398|NCT00489411|27106247|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
7800399|NCT00489411|27106246|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
7800400|NCT00489411|27106247|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
7800401|NCT00489411|27106246|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
7800402|NCT00489411|27106247|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
7800403|NCT00489411|27106246|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
7800404|NCT00489411|27106247|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
7800405|NCT00489411|27106246|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
7800406|NCT00489411|27106247|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
7800407|NCT00489359|27106261|P2|Overall Study|Adverse Event|16
7800408|NCT00489359|27106262|P1|Overall Study|Adverse Event|0
7800409|NCT00489359|27106261|P2|Overall Study|Withdrawal by Subject|5
7800410|NCT00489359|27106262|P1|Overall Study|Withdrawal by Subject|1
7800411|NCT00489359|27106261|P2|Overall Study|Lost to Follow-up|0
7800412|NCT00489359|27106262|P1|Overall Study|Lost to Follow-up|1
7800413|NCT00489359|27106261|P2|Overall Study|Progressive Disease|6
7800414|NCT00489359|27106262|P1|Overall Study|Progressive Disease|5
7800415|NCT00489359|27106261|P2|Overall Study|Death|2
7800416|NCT00489359|27106262|P1|Overall Study|Death|0
7800417|NCT00489255|27106338|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
7800418|NCT00489255|27106339|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
7800419|NCT00489255|27106338|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
7800420|NCT00489255|27106339|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
7800421|NCT00489255|27106338|P2|Period 3: Days 57 to 84|Adverse Event|3
7800422|NCT00489255|27106339|P1|Period 3: Days 57 to 84|Adverse Event|3
7800423|NCT00489255|27106338|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
7800424|NCT00489255|27106339|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
7800425|NCT00489255|27106338|P2|Period 2: Days 29 to 56|Adverse Event|1
7800426|NCT00489255|27106339|P1|Period 2: Days 29 to 56|Adverse Event|3
7800427|NCT00489255|27106338|P2|Period 1: Days 1 to 28|Noncompliance|0
7800428|NCT00489255|27106339|P1|Period 1: Days 1 to 28|Noncompliance|2
7800429|NCT00489255|27106338|P2|Period 1: Days 1 to 28|Physician Decision|4
7800430|NCT00489255|27106339|P1|Period 1: Days 1 to 28|Physician Decision|1
7800431|NCT00489255|27106338|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
7800432|NCT00489255|27106339|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
7800433|NCT00489255|27106338|P2|Period 1: Days 1 to 28|Adverse Event|8
7800434|NCT00489255|27106339|P1|Period 1: Days 1 to 28|Adverse Event|21
7800435|NCT00489255|27106338|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
7800436|NCT00489255|27106339|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
7800437|NCT00489216|27106387|P1|Overall Study|Adverse Event|1
7800438|NCT00488982|27106404|P3|Course 1|Adverse Event|6
7800439|NCT00488982|27106405|P2|Course 1|Adverse Event|0
7800440|NCT00488982|27106406|P1|Course 1|Adverse Event|0
7800441|NCT00488982|27106404|P3|Course 1|nonprotocol therapy|2
7800442|NCT00488982|27106405|P2|Course 1|nonprotocol therapy|2
7800443|NCT00488982|27106406|P1|Course 1|nonprotocol therapy|0
7800444|NCT00488982|27106404|P3|Course 1|Withdrawal by Subject|2
7800445|NCT00488982|27106405|P2|Course 1|Withdrawal by Subject|8
7800446|NCT00488982|27106406|P1|Course 1|Withdrawal by Subject|0
7800447|NCT00488982|27106404|P3|Course 1|Physician Decision|4
7800448|NCT00488982|27106405|P2|Course 1|Physician Decision|2
7800449|NCT00488982|27106406|P1|Course 1|Physician Decision|0
7800450|NCT00488826|27106429|P3|Overall Study|Protocol Deviations|1
7800451|NCT00488826|27106430|P2|Overall Study|Protocol Deviations|1
7800452|NCT00488826|27106431|P1|Overall Study|Protocol Deviations|2
7800453|NCT00488826|27106429|P3|Overall Study|Lost to Follow-up|0
7800454|NCT00488826|27106430|P2|Overall Study|Lost to Follow-up|1
7800455|NCT00488826|27106431|P1|Overall Study|Lost to Follow-up|5
7800456|NCT00488826|27106429|P3|Overall Study|Adverse Event|4
7800457|NCT00488826|27106430|P2|Overall Study|Adverse Event|15
7800458|NCT00488826|27106431|P1|Overall Study|Adverse Event|9
7800459|NCT00488826|27106429|P3|Overall Study|Protocol Violation|2
7800460|NCT00488826|27106430|P2|Overall Study|Protocol Violation|0
7800461|NCT00488826|27106431|P1|Overall Study|Protocol Violation|0
7800462|NCT00488826|27106429|P3|Overall Study|Withdrawal by Subject|19
7800463|NCT00488826|27106430|P2|Overall Study|Withdrawal by Subject|35
7800464|NCT00488826|27106431|P1|Overall Study|Withdrawal by Subject|40
7800465|NCT00488774|27106446|P4|Overall Study|Lost to Follow-up|1
7800466|NCT00488774|27106447|P3|Overall Study|Lost to Follow-up|1
7800467|NCT00488774|27106448|P2|Overall Study|Lost to Follow-up|0
7800468|NCT00488774|27106449|P1|Overall Study|Lost to Follow-up|0
7800469|NCT00488774|27106446|P4|Overall Study|Other|2
7800470|NCT00488774|27106447|P3|Overall Study|Other|2
7800471|NCT00488774|27106448|P2|Overall Study|Other|3
7800472|NCT00488774|27106449|P1|Overall Study|Other|6
7800473|NCT00488774|27106446|P4|Overall Study|Withdrawal of consent|0
7800474|NCT00488774|27106447|P3|Overall Study|Withdrawal of consent|2
7800475|NCT00488774|27106448|P2|Overall Study|Withdrawal of consent|2
7800476|NCT00488774|27106449|P1|Overall Study|Withdrawal of consent|2
7800477|NCT00488683|27106466|P3|Overall Study|Unable to Classify|0
7800478|NCT00488683|27106467|P2|Overall Study|Unable to Classify|0
7800479|NCT00488683|27106468|P1|Overall Study|Unable to Classify|1
7800480|NCT00488683|27106466|P3|Overall Study|Protocol Violation|0
7800481|NCT00488683|27106467|P2|Overall Study|Protocol Violation|1
7800482|NCT00488683|27106468|P1|Overall Study|Protocol Violation|5
7800483|NCT00488683|27106466|P3|Overall Study|Lost to Follow-up|0
7800484|NCT00488683|27106467|P2|Overall Study|Lost to Follow-up|3
7800485|NCT00488683|27106468|P1|Overall Study|Lost to Follow-up|5
7800486|NCT00488683|27106466|P3|Overall Study|Withdrawal by Subject|2
7800487|NCT00488683|27106467|P2|Overall Study|Withdrawal by Subject|2
7800488|NCT00488683|27106468|P1|Overall Study|Withdrawal by Subject|1
7800489|NCT00488644|27106527|P1|Overall Study|Not Evaluable|1
7800490|NCT00488644|27106527|P1|Overall Study|Not Eligible|1
7800491|NCT00488631|27106537|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800492|NCT00488631|27106538|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
7800493|NCT00488631|27106539|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
7800494|NCT00488631|27106540|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
7800495|NCT00488631|27106541|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800496|NCT00488631|27106542|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800497|NCT00488631|27106543|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800498|NCT00488631|27106544|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800499|NCT00488631|27106545|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800500|NCT00488631|27106546|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7800501|NCT00488631|27106537|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800502|NCT00488631|27106538|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
7800503|NCT00488631|27106539|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800504|NCT00488631|27106540|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
7800505|NCT00488631|27106541|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800506|NCT00488631|27106542|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800507|NCT00488631|27106543|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800508|NCT00488631|27106544|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800509|NCT00488631|27106545|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800510|NCT00488631|27106546|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7800511|NCT00488631|27106537|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
7800512|NCT00488631|27106538|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
7800513|NCT00488631|27106539|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
7800514|NCT00488631|27106540|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
7800515|NCT00488631|27106541|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7800516|NCT00488631|27106542|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7800517|NCT00488631|27106543|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7800518|NCT00488631|27106544|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7800519|NCT00488631|27106545|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7800520|NCT00488631|27106546|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7800521|NCT00488631|27106537|P10|Open Label Study Extension (Week 54-228)|Death|0
7800522|NCT00488631|27106538|P9|Open Label Study Extension (Week 54-228)|Death|1
7800523|NCT00488631|27106539|P8|Open Label Study Extension (Week 54-228)|Death|0
7800524|NCT00488631|27106540|P7|Open Label Study Extension (Week 54-228)|Death|0
7800525|NCT00488631|27106541|P6|Open Label Study Extension (Week 54-228)|Death|0
7800526|NCT00488631|27106542|P5|Open Label Study Extension (Week 54-228)|Death|0
7800527|NCT00488631|27106543|P4|Open Label Study Extension (Week 54-228)|Death|0
7800528|NCT00488631|27106544|P3|Open Label Study Extension (Week 54-228)|Death|0
7800529|NCT00488631|27106545|P2|Open Label Study Extension (Week 54-228)|Death|0
7800530|NCT00488631|27106546|P1|Open Label Study Extension (Week 54-228)|Death|0
7800531|NCT00488631|27106537|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800532|NCT00488631|27106538|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
7800533|NCT00488631|27106539|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
7800534|NCT00488631|27106540|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
7800535|NCT00488631|27106541|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800536|NCT00488631|27106542|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800537|NCT00488631|27106543|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800538|NCT00488631|27106544|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800539|NCT00488631|27106545|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800540|NCT00488631|27106546|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
7800541|NCT00488631|27106537|P10|Double Blind Period (Week 0-54)|Other|0
7800542|NCT00488631|27106538|P9|Double Blind Period (Week 0-54)|Other|0
7800543|NCT00488631|27106539|P8|Double Blind Period (Week 0-54)|Other|0
7800544|NCT00488631|27106540|P7|Double Blind Period (Week 0-54)|Other|0
7800545|NCT00488631|27106541|P6|Double Blind Period (Week 0-54)|Other|34
7800546|NCT00488631|27106542|P5|Double Blind Period (Week 0-54)|Other|14
7800547|NCT00488631|27106543|P4|Double Blind Period (Week 0-54)|Other|11
7800548|NCT00488631|27106544|P3|Double Blind Period (Week 0-54)|Other|10
7800549|NCT00488631|27106545|P2|Double Blind Period (Week 0-54)|Other|12
7800550|NCT00488631|27106546|P1|Double Blind Period (Week 0-54)|Other|6
7800551|NCT00488631|27106537|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7800552|NCT00488631|27106538|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7800553|NCT00488631|27106539|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7800554|NCT00488631|27106540|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7800555|NCT00488631|27106541|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
7800556|NCT00488631|27106542|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
7800557|NCT00488631|27106543|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7800558|NCT00488631|27106544|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
7800559|NCT00488631|27106545|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
7800560|NCT00488631|27106546|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
7800561|NCT00488631|27106537|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7800562|NCT00488631|27106538|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7800563|NCT00488631|27106539|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7800564|NCT00488631|27106540|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7800565|NCT00488631|27106541|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
7800566|NCT00488631|27106542|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
7800567|NCT00488631|27106543|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
7800568|NCT00488631|27106544|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
7800569|NCT00488631|27106545|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
7800570|NCT00488631|27106546|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
7800571|NCT00488631|27106537|P10|Double Blind Period (Week 0-54)|Death|0
7800572|NCT00488631|27106538|P9|Double Blind Period (Week 0-54)|Death|0
7800573|NCT00488631|27106539|P8|Double Blind Period (Week 0-54)|Death|0
7800574|NCT00488631|27106540|P7|Double Blind Period (Week 0-54)|Death|0
7800575|NCT00488631|27106541|P6|Double Blind Period (Week 0-54)|Death|1
7800576|NCT00488631|27106542|P5|Double Blind Period (Week 0-54)|Death|0
7800577|NCT00488631|27106543|P4|Double Blind Period (Week 0-54)|Death|0
7800578|NCT00488631|27106544|P3|Double Blind Period (Week 0-54)|Death|0
7800579|NCT00488631|27106545|P2|Double Blind Period (Week 0-54)|Death|0
7800580|NCT00488631|27106546|P1|Double Blind Period (Week 0-54)|Death|0
7800581|NCT00488631|27106537|P10|Double Blind Period (Week 0-54)|Adverse Event|0
7800582|NCT00488631|27106538|P9|Double Blind Period (Week 0-54)|Adverse Event|0
7800583|NCT00488631|27106539|P8|Double Blind Period (Week 0-54)|Adverse Event|0
7800584|NCT00488631|27106540|P7|Double Blind Period (Week 0-54)|Adverse Event|0
7800585|NCT00488631|27106541|P6|Double Blind Period (Week 0-54)|Adverse Event|50
7800586|NCT00488631|27106542|P5|Double Blind Period (Week 0-54)|Adverse Event|30
7800587|NCT00488631|27106543|P4|Double Blind Period (Week 0-54)|Adverse Event|12
7800588|NCT00488631|27106544|P3|Double Blind Period (Week 0-54)|Adverse Event|12
7800589|NCT00488631|27106545|P2|Double Blind Period (Week 0-54)|Adverse Event|12
7800590|NCT00488631|27106546|P1|Double Blind Period (Week 0-54)|Adverse Event|17
7800591|NCT00488618|27106583|P2|Overall Study|Lost to Follow-up|0
7800592|NCT00488618|27106584|P1|Overall Study|Lost to Follow-up|1
7800593|NCT00488618|27106583|P2|Overall Study|Withdrawal of Consent|13
7800594|NCT00488618|27106584|P1|Overall Study|Withdrawal of Consent|15
7800595|NCT00488618|27106583|P2|Overall Study|Protocol Violation|2
7800596|NCT00488618|27106584|P1|Overall Study|Protocol Violation|0
7800597|NCT00488618|27106583|P2|Overall Study|Insufficient Therapeutic Response|11
7800598|NCT00488618|27106584|P1|Overall Study|Insufficient Therapeutic Response|18
7800599|NCT00488618|27106583|P2|Overall Study|Adverse Event|17
7800600|NCT00488618|27106584|P1|Overall Study|Adverse Event|13
7800601|NCT00488592|27106592|P1|Overall Study|Enrolled but not treated|1
7800602|NCT00488592|27106592|P1|Overall Study|Disease progression|1
7800603|NCT00488592|27106592|P1|Overall Study|Withdrawal by Subject|1
7800604|NCT00488514|27106597|P1|Overall Study|Increased use of concomitant medication|1
7800605|NCT00488514|27106597|P1|Overall Study|Increase in number of migraines|2
7800606|NCT00488514|27106597|P1|Overall Study|Participant had too few migraines|5
7800607|NCT00488514|27106597|P1|Overall Study|Investigator decision|1
7800608|NCT00488514|27106597|P1|Overall Study|Withdrawn per medical monitor decision|2
7800609|NCT00488514|27106597|P1|Overall Study|Postive drug screen|1
7800610|NCT00488514|27106597|P1|Overall Study|Did not meet criteria for treatment|30
7800611|NCT00488514|27106597|P1|Overall Study|Lack of Efficacy|28
7800612|NCT00488514|27106597|P1|Overall Study|Withdrawal by Subject|106
7800613|NCT00488514|27106597|P1|Overall Study|Protocol Violation|32
7800614|NCT00488514|27106597|P1|Overall Study|Lost to Follow-up|44
7800615|NCT00488514|27106597|P1|Overall Study|Adverse Event|41
7800616|NCT00488475|27106685|P1|Overall Study|Other|1754
7800617|NCT00488345|27106714|P3|Overall Study|Parent/legal guardian request|1
7800618|NCT00488345|27106715|P2|Overall Study|Parent/legal guardian request|1
7800619|NCT00488345|27106716|P1|Overall Study|Parent/legal guardian request|0
7800620|NCT00488345|27106714|P3|Overall Study|Surgical team recommendation|0
7800621|NCT00488345|27106715|P2|Overall Study|Surgical team recommendation|1
7800622|NCT00488345|27106716|P1|Overall Study|Surgical team recommendation|0
7800623|NCT00488345|27106714|P3|Overall Study|Institutional Review Board review|1
7800624|NCT00488345|27106715|P2|Overall Study|Institutional Review Board review|0
7800625|NCT00488345|27106716|P1|Overall Study|Institutional Review Board review|0
7800626|NCT00488345|27106714|P3|Overall Study|Unable to administer antibiotics at home|0
7800627|NCT00488345|27106715|P2|Overall Study|Unable to administer antibiotics at home|1
7800628|NCT00488345|27106716|P1|Overall Study|Unable to administer antibiotics at home|0
7800629|NCT00488345|27106714|P3|Overall Study|Adverse Event|1
7800630|NCT00488345|27106715|P2|Overall Study|Adverse Event|1
7800631|NCT00488345|27106716|P1|Overall Study|Adverse Event|0
7800632|NCT00488319|27106742|P3|Overall Study|Other reasons for withdrawal|12
7800633|NCT00488319|27106743|P2|Overall Study|Other reasons for withdrawal|4
7800634|NCT00488319|27106744|P1|Overall Study|Other reasons for withdrawal|0
7800635|NCT00488319|27106742|P3|Overall Study|Withdrawal by Subject|44
7800636|NCT00488319|27106743|P2|Overall Study|Withdrawal by Subject|20
7800637|NCT00488319|27106744|P1|Overall Study|Withdrawal by Subject|5
7800638|NCT00488319|27106742|P3|Overall Study|Lost to Follow-up|16
7800639|NCT00488319|27106743|P2|Overall Study|Lost to Follow-up|5
7800640|NCT00488319|27106744|P1|Overall Study|Lost to Follow-up|3
7800641|NCT00488319|27106742|P3|Overall Study|Lack of Efficacy|27
7800642|NCT00488319|27106743|P2|Overall Study|Lack of Efficacy|12
7800643|NCT00488319|27106744|P1|Overall Study|Lack of Efficacy|6
7800644|NCT00488319|27106742|P3|Overall Study|Adverse Event|23
7800645|NCT00488319|27106743|P2|Overall Study|Adverse Event|2
7800646|NCT00488319|27106744|P1|Overall Study|Adverse Event|1
7800647|NCT00488293|27106831|P2|Overall Study|Misrandomization/Other Unspecified|1
7800648|NCT00488293|27106832|P1|Overall Study|Misrandomization/Other Unspecified|1
7800649|NCT00488293|27106831|P2|Overall Study|Death|1
7800650|NCT00488293|27106832|P1|Overall Study|Death|2
7800651|NCT00488293|27106831|P2|Overall Study|Withdrawal by Subject|3
7800652|NCT00488293|27106832|P1|Overall Study|Withdrawal by Subject|5
7800653|NCT00488293|27106831|P2|Overall Study|Lost to Follow-up|25
7800654|NCT00488293|27106832|P1|Overall Study|Lost to Follow-up|28
7800655|NCT00488033|27106877|P2|Overall Study|Withdrawal by Subject|0
7800656|NCT00488033|27106878|P1|Overall Study|Withdrawal by Subject|1
7800657|NCT00487981|27106894|P1|Overall Study|Hypothyroidism diagnosis|1
7800658|NCT00487942|27106902|P4|Overall Study|Withdrawal by Subject|0
7800659|NCT00487942|27106903|P3|Overall Study|Withdrawal by Subject|2
7800660|NCT00487942|27106904|P2|Overall Study|Withdrawal by Subject|1
7800661|NCT00487942|27106905|P1|Overall Study|Withdrawal by Subject|0
7800662|NCT00487942|27106902|P4|Overall Study|Protocol Violation|0
7800663|NCT00487942|27106903|P3|Overall Study|Protocol Violation|0
7800664|NCT00487942|27106904|P2|Overall Study|Protocol Violation|1
7800665|NCT00487942|27106905|P1|Overall Study|Protocol Violation|1
7800666|NCT00487942|27106902|P4|Overall Study|Lost to Follow-up|1
7800667|NCT00487942|27106903|P3|Overall Study|Lost to Follow-up|0
7800668|NCT00487942|27106904|P2|Overall Study|Lost to Follow-up|0
7800669|NCT00487942|27106905|P1|Overall Study|Lost to Follow-up|1
7800670|NCT00487942|27106902|P4|Overall Study|Adverse Event|1
7800671|NCT00487942|27106903|P3|Overall Study|Adverse Event|1
7800672|NCT00487942|27106904|P2|Overall Study|Adverse Event|1
7800673|NCT00487942|27106905|P1|Overall Study|Adverse Event|1
7800674|NCT00487825|27107289|P2|Overall Study|Other|2
7800675|NCT00487825|27107290|P1|Overall Study|Other|3
7800676|NCT00487825|27107289|P2|Overall Study|Lack of Efficacy|1
7800677|NCT00487825|27107290|P1|Overall Study|Lack of Efficacy|1
7800678|NCT00487825|27107289|P2|Overall Study|Adverse Event|2
7800679|NCT00487825|27107290|P1|Overall Study|Adverse Event|2
7800680|NCT00487747|27107302|P1|Overall Study|Lack of Efficacy|1
7800681|NCT00487747|27107302|P1|Overall Study|Lost to Follow-up|9
7800682|NCT00487747|27107302|P1|Overall Study|Adverse Event|1
7800683|NCT00487695|27107319|P2|Second Procedure|Withdrawal by Subject|2
7800684|NCT00487695|27107320|P1|Second Procedure|Withdrawal by Subject|1
7800685|NCT00487695|27107319|P2|Second Procedure|active wheezing|1
7800686|NCT00487695|27107320|P1|Second Procedure|active wheezing|0
7800687|NCT00487695|27107319|P2|First Procedure|esophageal stricture found (excl crit)|0
7800688|NCT00487695|27107320|P1|First Procedure|esophageal stricture found (excl crit)|1
7800689|NCT00487695|27107319|P2|First Procedure|active wheezing (did not have procedure)|0
7800690|NCT00487695|27107320|P1|First Procedure|active wheezing (did not have procedure)|1
7800691|NCT00487695|27107319|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
7800692|NCT00487695|27107320|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
7800693|NCT00487578|27107348|P2|Overall Study|Lost to Follow-up|1
7800694|NCT00487578|27107349|P1|Overall Study|Lost to Follow-up|0
7800695|NCT00487578|27107348|P2|Overall Study|Lack of Efficacy|1
7800696|NCT00487578|27107349|P1|Overall Study|Lack of Efficacy|0
7800697|NCT00487578|27107348|P2|Overall Study|Adverse Event|2
7800698|NCT00487578|27107349|P1|Overall Study|Adverse Event|1
7800699|NCT00487552|27107369|P1|Overall Study|Stent not placed|1
7800700|NCT00487552|27107369|P1|Overall Study|Death due to progressive malignancy|2
7800701|NCT00487552|27107369|P1|Overall Study|Unsuccessful magnet placements|3
7800702|NCT00487539|27107378|P4|Overall Study|Other|2
7800703|NCT00487539|27107379|P3|Overall Study|Other|2
7800704|NCT00487539|27107380|P2|Overall Study|Other|1
7800705|NCT00487539|27107381|P1|Overall Study|Other|3
7800706|NCT00487539|27107378|P4|Overall Study|Unsatisfactory therapeutic effect|1
7800707|NCT00487539|27107379|P3|Overall Study|Unsatisfactory therapeutic effect|0
7800708|NCT00487539|27107380|P2|Overall Study|Unsatisfactory therapeutic effect|0
7800709|NCT00487539|27107381|P1|Overall Study|Unsatisfactory therapeutic effect|1
7800710|NCT00487539|27107378|P4|Overall Study|Adverse Event|1
7800711|NCT00487539|27107379|P3|Overall Study|Adverse Event|1
7800712|NCT00487539|27107380|P2|Overall Study|Adverse Event|2
7800713|NCT00487539|27107381|P1|Overall Study|Adverse Event|3
7800714|NCT00487435|27107415|P1|Overall Study|Other|83
7800715|NCT00487435|27107415|P1|Overall Study|Study Medication Non-Compliant|32
7800716|NCT00487435|27107415|P1|Overall Study|Resolution Of Pain|1
7800717|NCT00487435|27107415|P1|Overall Study|Withdrawal by Subject|132
7800718|NCT00487435|27107415|P1|Overall Study|Pregnancy|2
7800719|NCT00487435|27107415|P1|Overall Study|Lost to Follow-up|54
7800720|NCT00487435|27107415|P1|Overall Study|Lack of Efficacy|33
7800721|NCT00487435|27107415|P1|Overall Study|Death|2
7800722|NCT00487435|27107415|P1|Overall Study|Adverse Event|146
7800723|NCT00487279|27107431|P2|Overall Study|Withdrawal by Subject|2
7800724|NCT00487279|27107432|P1|Overall Study|Withdrawal by Subject|0
7800725|NCT00487279|27107431|P2|Overall Study|Death|0
7800726|NCT00487279|27107432|P1|Overall Study|Death|1
7800727|NCT00487240|27107442|P2|Overall Study|Physician Decision|0
7800728|NCT00487240|27107443|P1|Overall Study|Physician Decision|2
7800729|NCT00487240|27107442|P2|Overall Study|Sponsor Decision|1
7800730|NCT00487240|27107443|P1|Overall Study|Sponsor Decision|2
7800731|NCT00487240|27107442|P2|Overall Study|Entry Criteria Not Met|4
7800732|NCT00487240|27107443|P1|Overall Study|Entry Criteria Not Met|3
7800733|NCT00487240|27107442|P2|Overall Study|Protocol Violation|5
7800734|NCT00487240|27107443|P1|Overall Study|Protocol Violation|5
7800735|NCT00487240|27107442|P2|Overall Study|Adverse Event|4
7800736|NCT00487240|27107443|P1|Overall Study|Adverse Event|0
7800737|NCT00487240|27107442|P2|Overall Study|Lost to Follow-up|6
7800738|NCT00487240|27107443|P1|Overall Study|Lost to Follow-up|7
7800739|NCT00487240|27107442|P2|Overall Study|Withdrawal by Subject|6
7800740|NCT00487240|27107443|P1|Overall Study|Withdrawal by Subject|12
7800741|NCT00487188|27107471|P3|Maintenance Phase|Administrative|1
7800742|NCT00487188|27107472|P2|Maintenance Phase|Administrative|0
7800743|NCT00487188|27107473|P1|Maintenance Phase|Administrative|0
7800744|NCT00487188|27107471|P3|Maintenance Phase|Lost to Follow-up|0
7800745|NCT00487188|27107472|P2|Maintenance Phase|Lost to Follow-up|0
7800746|NCT00487188|27107473|P1|Maintenance Phase|Lost to Follow-up|1
7800747|NCT00487188|27107471|P3|Maintenance Phase|Death|0
7800748|NCT00487188|27107472|P2|Maintenance Phase|Death|0
7800749|NCT00487188|27107473|P1|Maintenance Phase|Death|1
7800750|NCT00487188|27107471|P3|Maintenance Phase|Adverse Event|0
7800751|NCT00487188|27107472|P2|Maintenance Phase|Adverse Event|0
7800752|NCT00487188|27107473|P1|Maintenance Phase|Adverse Event|1
7800753|NCT00487188|27107471|P3|Induction Phase|Administrative|0
7800754|NCT00487188|27107472|P2|Induction Phase|Administrative|1
7800755|NCT00487188|27107473|P1|Induction Phase|Administrative|0
7800756|NCT00487188|27107471|P3|Induction Phase|Lost to Follow-up|0
7800757|NCT00487188|27107472|P2|Induction Phase|Lost to Follow-up|2
7800758|NCT00487188|27107473|P1|Induction Phase|Lost to Follow-up|2
7800759|NCT00487188|27107471|P3|Induction Phase|Refused Treatment|0
7800760|NCT00487188|27107472|P2|Induction Phase|Refused Treatment|2
7800761|NCT00487188|27107473|P1|Induction Phase|Refused Treatment|1
7800762|NCT00487188|27107471|P3|Induction Phase|Protocol Violation|0
7800763|NCT00487188|27107472|P2|Induction Phase|Protocol Violation|0
7800764|NCT00487188|27107473|P1|Induction Phase|Protocol Violation|1
7800765|NCT00487188|27107471|P3|Induction Phase|Lack of Efficacy|0
7800766|NCT00487188|27107472|P2|Induction Phase|Lack of Efficacy|1
7800767|NCT00487188|27107473|P1|Induction Phase|Lack of Efficacy|0
7800768|NCT00487188|27107471|P3|Induction Phase|Adverse Event|0
7800769|NCT00487188|27107472|P2|Induction Phase|Adverse Event|0
7800770|NCT00487188|27107473|P1|Induction Phase|Adverse Event|5
7800771|NCT00487188|27107471|P3|Induction Phase|Abnormality of Laboratory Test|0
7800772|NCT00487188|27107472|P2|Induction Phase|Abnormality of Laboratory Test|1
7800773|NCT00487188|27107473|P1|Induction Phase|Abnormality of Laboratory Test|0
7800774|NCT00487162|27107512|P2|Overall Study|Withdrawal by Subject|3
7800775|NCT00487162|27107513|P1|Overall Study|Withdrawal by Subject|2
7800776|NCT00487162|27107512|P2|Overall Study|Physician Decision|1
7800777|NCT00487162|27107513|P1|Overall Study|Physician Decision|0
7800778|NCT00487162|27107512|P2|Overall Study|Adverse Event|1
7800779|NCT00487162|27107513|P1|Overall Study|Adverse Event|0
7800780|NCT00487084|27107524|P3|Overall Study|Did not receive intervention|5
7800781|NCT00487084|27107525|P2|Overall Study|Did not receive intervention|3
7800782|NCT00487084|27107526|P1|Overall Study|Did not receive intervention|4
7800783|NCT00486954|27107547|P5|Randomized Part|Sponsor Terminated Study|13
7800784|NCT00486954|27107548|P4|Randomized Part|Sponsor Terminated Study|19
7800785|NCT00486954|27107549|P3|Randomized Part|Sponsor Terminated Study|0
7800786|NCT00486954|27107550|P2|Randomized Part|Sponsor Terminated Study|0
7800787|NCT00486954|27107551|P1|Randomized Part|Sponsor Terminated Study|0
7800788|NCT00486954|27107547|P5|Randomized Part|Withdrawal by Subject|0
7800789|NCT00486954|27107548|P4|Randomized Part|Withdrawal by Subject|1
7800790|NCT00486954|27107549|P3|Randomized Part|Withdrawal by Subject|0
7800791|NCT00486954|27107550|P2|Randomized Part|Withdrawal by Subject|0
7800792|NCT00486954|27107551|P1|Randomized Part|Withdrawal by Subject|0
7800793|NCT00486954|27107547|P5|Randomized Part|Lost to Follow-up|1
7800794|NCT00486954|27107548|P4|Randomized Part|Lost to Follow-up|0
7800795|NCT00486954|27107549|P3|Randomized Part|Lost to Follow-up|0
7800796|NCT00486954|27107550|P2|Randomized Part|Lost to Follow-up|0
7800797|NCT00486954|27107551|P1|Randomized Part|Lost to Follow-up|0
7800798|NCT00486954|27107547|P5|Pilot Part|Disease Progression|0
7800799|NCT00486954|27107548|P4|Pilot Part|Disease Progression|0
7800800|NCT00486954|27107549|P3|Pilot Part|Disease Progression|1
7800801|NCT00486954|27107550|P2|Pilot Part|Disease Progression|0
7800802|NCT00486954|27107551|P1|Pilot Part|Disease Progression|2
7800803|NCT00486954|27107547|P5|Pilot Part|Adverse Event|0
7800804|NCT00486954|27107548|P4|Pilot Part|Adverse Event|0
7800805|NCT00486954|27107549|P3|Pilot Part|Adverse Event|5
7800806|NCT00486954|27107550|P2|Pilot Part|Adverse Event|0
7800807|NCT00486954|27107551|P1|Pilot Part|Adverse Event|4
7800808|NCT00486902|27107649|P2|Overall Study|No toradol due to hemmorhage or allergy|1
7800809|NCT00486902|27107650|P1|Overall Study|No toradol due to hemmorhage or allergy|3
7800810|NCT00486902|27107649|P2|Overall Study|Did not meet inclusion criteria|0
7800811|NCT00486902|27107650|P1|Overall Study|Did not meet inclusion criteria|1
7800812|NCT00486902|27107649|P2|Overall Study|spinal anesthetic protocal violation|1
7800813|NCT00486902|27107650|P1|Overall Study|spinal anesthetic protocal violation|1
7800814|NCT00486902|27107649|P2|Overall Study|decision for postpartum tubal ligation|1
7800815|NCT00486902|27107650|P1|Overall Study|decision for postpartum tubal ligation|3
7800816|NCT00486902|27107649|P2|Overall Study|Withdrawal by Subject|2
7800817|NCT00486902|27107650|P1|Overall Study|Withdrawal by Subject|1
7800818|NCT00486837|27107717|P2|Overall Study|No sputum, devise issues, exacerbation|4
7800819|NCT00486837|27107718|P1|Overall Study|No sputum, devise issues, exacerbation|3
7800820|NCT00486837|27107717|P2|Overall Study|Protocol Violation|2
7800821|NCT00486837|27107718|P1|Overall Study|Protocol Violation|4
7800822|NCT00486837|27107717|P2|Overall Study|Adverse Event|1
7800823|NCT00486837|27107718|P1|Overall Study|Adverse Event|1
7800824|NCT00486837|27107717|P2|Overall Study|Withdrawal by Subject|0
7800825|NCT00486837|27107718|P1|Overall Study|Withdrawal by Subject|1
7800826|NCT00486811|27107758|P3|Overall Study|All other|7
7800827|NCT00486811|27107759|P2|Overall Study|All other|11
7800828|NCT00486811|27107760|P1|Overall Study|All other|18
7800829|NCT00486811|27107758|P3|Overall Study|Study drug non-compliant|3
7800830|NCT00486811|27107759|P2|Overall Study|Study drug non-compliant|6
7800831|NCT00486811|27107760|P1|Overall Study|Study drug non-compliant|5
7800832|NCT00486811|27107758|P3|Overall Study|Withdrawal by Subject|58
7800833|NCT00486811|27107759|P2|Overall Study|Withdrawal by Subject|44
7800834|NCT00486811|27107760|P1|Overall Study|Withdrawal by Subject|33
7800835|NCT00486811|27107758|P3|Overall Study|Lost to Follow-up|4
7800836|NCT00486811|27107759|P2|Overall Study|Lost to Follow-up|6
7800837|NCT00486811|27107760|P1|Overall Study|Lost to Follow-up|4
7800838|NCT00486811|27107758|P3|Overall Study|Lack of Efficacy|7
7800839|NCT00486811|27107759|P2|Overall Study|Lack of Efficacy|14
7800840|NCT00486811|27107760|P1|Overall Study|Lack of Efficacy|34
7800841|NCT00486811|27107758|P3|Overall Study|Adverse Event|135
7800842|NCT00486811|27107759|P2|Overall Study|Adverse Event|60
7800843|NCT00486811|27107760|P1|Overall Study|Adverse Event|28
7800844|NCT00486759|27107803|P2|Safety Follow-up|Adverse event/intercurrent illness|0
7800845|NCT00486759|27107804|P1|Safety Follow-up|Adverse event/intercurrent illness|4
7800846|NCT00486759|27107803|P2|Safety Follow-up|Refused treatment/did not cooperate|4
7800847|NCT00486759|27107804|P1|Safety Follow-up|Refused treatment/did not cooperate|6
7800848|NCT00486759|27107803|P2|Safety Follow-up|Administrative/not specified|6
7800849|NCT00486759|27107804|P1|Safety Follow-up|Administrative/not specified|8
7800850|NCT00486759|27107803|P2|Safety Follow-up|Failure to return|6
7800851|NCT00486759|27107804|P1|Safety Follow-up|Failure to return|9
7800852|NCT00486759|27107803|P2|Safety Follow-up|Withdrew consent|23
7800853|NCT00486759|27107804|P1|Safety Follow-up|Withdrew consent|32
7800854|NCT00486759|27107803|P2|Safety Follow-up|Death|29
7800855|NCT00486759|27107804|P1|Safety Follow-up|Death|40
7800856|NCT00486759|27107803|P2|Safety Follow-up|Insufficient therapeutic response|50
7800857|NCT00486759|27107804|P1|Safety Follow-up|Insufficient therapeutic response|40
7800858|NCT00486759|27107803|P2|Treatment|Failure to return|1
7800859|NCT00486759|27107804|P1|Treatment|Failure to return|1
7800860|NCT00486759|27107803|P2|Treatment|Other protocol violation|5
7800861|NCT00486759|27107804|P1|Treatment|Other protocol violation|1
7800862|NCT00486759|27107803|P2|Treatment|Violation of selection criteria at entry|3
7800863|NCT00486759|27107804|P1|Treatment|Violation of selection criteria at entry|3
7800864|NCT00486759|27107803|P2|Treatment|Refused treatment|7
7800865|NCT00486759|27107804|P1|Treatment|Refused treatment|10
7800866|NCT00486759|27107803|P2|Treatment|Administrative/reason not specified|21
7800867|NCT00486759|27107804|P1|Treatment|Administrative/reason not specified|17
7800868|NCT00486759|27107803|P2|Treatment|Withdrew consent|12
7800869|NCT00486759|27107804|P1|Treatment|Withdrew consent|15
7800870|NCT00486759|27107803|P2|Treatment|Death|10
7800871|NCT00486759|27107804|P1|Treatment|Death|17
7800872|NCT00486759|27107803|P2|Treatment|Insufficient therapeutic response|39
7800873|NCT00486759|27107804|P1|Treatment|Insufficient therapeutic response|37
7800874|NCT00486759|27107803|P2|Treatment|Adverse event/intercurrent illness|39
7800875|NCT00486759|27107804|P1|Treatment|Adverse event/intercurrent illness|86
7800876|NCT00486720|27107816|P2|Overall Study|Progressive Disease|1
7800877|NCT00486720|27107817|P1|Overall Study|Progressive Disease|0
7800878|NCT00486720|27107816|P2|Overall Study|Withdrawal by Subject|1
7800879|NCT00486720|27107817|P1|Overall Study|Withdrawal by Subject|3
7800880|NCT00486720|27107816|P2|Overall Study|Protocol Violation|0
7800881|NCT00486720|27107817|P1|Overall Study|Protocol Violation|1
7800882|NCT00486720|27107816|P2|Overall Study|Physician Decision|2
7800883|NCT00486720|27107817|P1|Overall Study|Physician Decision|1
7800884|NCT00486720|27107816|P2|Overall Study|Lack of Efficacy|6
7800885|NCT00486720|27107817|P1|Overall Study|Lack of Efficacy|4
7800886|NCT00486720|27107816|P2|Overall Study|Adverse Event|2
7800887|NCT00486720|27107817|P1|Overall Study|Adverse Event|1
7800888|NCT00486603|27107852|P5|Overall Study|Physician Decision|0
7800889|NCT00486603|27107853|P4|Overall Study|Physician Decision|0
7800890|NCT00486603|27107854|P3|Overall Study|Physician Decision|0
7800891|NCT00486603|27107855|P2|Overall Study|Physician Decision|1
7800892|NCT00486603|27107856|P1|Overall Study|Physician Decision|0
7800893|NCT00486603|27107852|P5|Overall Study|Withdrawal by Subject|0
7800894|NCT00486603|27107853|P4|Overall Study|Withdrawal by Subject|0
7800895|NCT00486603|27107854|P3|Overall Study|Withdrawal by Subject|0
7800896|NCT00486603|27107855|P2|Overall Study|Withdrawal by Subject|0
7800897|NCT00486603|27107856|P1|Overall Study|Withdrawal by Subject|1
7800898|NCT00486434|27107904|P2|Overall Study|Personal reasons|6
7800899|NCT00486434|27107905|P1|Overall Study|Personal reasons|5
7800900|NCT00486434|27107904|P2|Overall Study|Death|2
7800901|NCT00486434|27107905|P1|Overall Study|Death|1
7800902|NCT00486434|27107904|P2|Overall Study|Lost to Follow-up|3
7800903|NCT00486434|27107905|P1|Overall Study|Lost to Follow-up|2
7800904|NCT00486434|27107904|P2|Overall Study|Lack of Efficacy|19
7800905|NCT00486434|27107905|P1|Overall Study|Lack of Efficacy|12
7800906|NCT00486434|27107904|P2|Overall Study|Protocol Violation|21
7800907|NCT00486434|27107905|P1|Overall Study|Protocol Violation|22
7800908|NCT00486434|27107904|P2|Overall Study|Adverse Event|44
7800909|NCT00486434|27107905|P1|Overall Study|Adverse Event|118
7800910|NCT00486434|27107904|P2|Overall Study|Withdrawal by Subject|39
7800911|NCT00486434|27107905|P1|Overall Study|Withdrawal by Subject|34
7800912|NCT00486330|27107924|P1|Overall Study|Adverse Event|2
7800913|NCT00486291|27107930|P2|Overall Study|requirement for restricted medication|3
7800914|NCT00486291|27107931|P1|Overall Study|requirement for restricted medication|0
7800915|NCT00486291|27107930|P2|Overall Study|protocol non-compliance|15
7800916|NCT00486291|27107931|P1|Overall Study|protocol non-compliance|10
7800917|NCT00486291|27107930|P2|Overall Study|Lost to Follow-up|7
7800918|NCT00486291|27107931|P1|Overall Study|Lost to Follow-up|3
7800919|NCT00486291|27107930|P2|Overall Study|Adverse Event|4
7800920|NCT00486291|27107931|P1|Overall Study|Adverse Event|3
7800921|NCT00486278|27107939|P1|Overall Study|Physician Decision|2
7800922|NCT00486278|27107939|P1|Overall Study|Withdrawal by Subject|2
7800923|NCT00486278|27107939|P1|Overall Study|Adverse Event|5
7800924|NCT00486265|27108073|P1|Overall Study|Lack of Efficacy|8
7800925|NCT00486265|27108073|P1|Overall Study|Adverse Event|1
7800926|NCT00486252|27108077|P1|Overall Study|Other|18
7800927|NCT00486252|27108077|P1|Overall Study|Lost to Follow-up|24
7800928|NCT00486252|27108077|P1|Overall Study|Lack of Efficacy|9
7800929|NCT00486252|27108077|P1|Overall Study|Adverse Event|7
7800930|NCT00486226|27108092|P1|Overall Study|Lost to Follow-up|8
7800931|NCT00486226|27108092|P1|Overall Study|Withdrawal by Subject|1
7800932|NCT00486226|27108092|P1|Overall Study|Adverse Event|1
7800933|NCT00486226|27108092|P1|Overall Study|Death|3
7800934|NCT00486044|27108102|P2|Overall Study|Lost to Follow-up|1
7800935|NCT00486044|27108103|P1|Overall Study|Lost to Follow-up|0
7800936|NCT00486044|27108102|P2|Overall Study|Adverse Event|1
7800937|NCT00486044|27108103|P1|Overall Study|Adverse Event|0
7800938|NCT00486044|27108102|P2|Overall Study|Withdrawal by Subject|1
7800939|NCT00486044|27108103|P1|Overall Study|Withdrawal by Subject|2
7800940|NCT00485758|27108197|P2|Overall Study|Study Terminated by Sponsor|0
7800941|NCT00485758|27108198|P1|Overall Study|Study Terminated by Sponsor|3
7800942|NCT00485758|27108197|P2|Overall Study|Withdrawal by Subject|27
7800943|NCT00485758|27108198|P1|Overall Study|Withdrawal by Subject|32
7800944|NCT00485758|27108197|P2|Overall Study|Protocol Violation|2
7800945|NCT00485758|27108198|P1|Overall Study|Protocol Violation|11
7800946|NCT00485758|27108197|P2|Overall Study|Physician Decision|3
7800947|NCT00485758|27108198|P1|Overall Study|Physician Decision|3
7800948|NCT00485758|27108197|P2|Overall Study|Lost to Follow-up|1
7800949|NCT00485758|27108198|P1|Overall Study|Lost to Follow-up|5
7800950|NCT00485758|27108197|P2|Overall Study|Death|1
7800951|NCT00485758|27108198|P1|Overall Study|Death|0
7800952|NCT00485758|27108197|P2|Overall Study|Adverse Event|31
7800953|NCT00485758|27108198|P1|Overall Study|Adverse Event|102
7800954|NCT00485732|27108210|P2|Overall Study|Lost to Follow-up|2
7800955|NCT00485732|27108211|P1|Overall Study|Lost to Follow-up|2
7800956|NCT00485732|27108210|P2|Overall Study|Withdrawal by Subject|4
7800957|NCT00485732|27108211|P1|Overall Study|Withdrawal by Subject|5
7800958|NCT00485732|27108210|P2|Overall Study|Protocol Violation|3
7800959|NCT00485732|27108211|P1|Overall Study|Protocol Violation|1
7800960|NCT00485589|27108246|P3|Overall Study|Adverse Event|10
7800961|NCT00485589|27108247|P2|Overall Study|Adverse Event|3
7800962|NCT00485589|27108248|P1|Overall Study|Adverse Event|3
7800963|NCT00485589|27108246|P3|Overall Study|Withdrawal by Subject|2
7800964|NCT00485589|27108247|P2|Overall Study|Withdrawal by Subject|2
7800965|NCT00485589|27108248|P1|Overall Study|Withdrawal by Subject|3
7800966|NCT00485589|27108246|P3|Overall Study|Refused treatment/did not cooperate|2
7800967|NCT00485589|27108247|P2|Overall Study|Refused treatment/did not cooperate|0
7800968|NCT00485589|27108248|P1|Overall Study|Refused treatment/did not cooperate|1
7800969|NCT00485589|27108246|P3|Overall Study|Insufficient therapeutic response|1
7800970|NCT00485589|27108247|P2|Overall Study|Insufficient therapeutic response|3
7800971|NCT00485589|27108248|P1|Overall Study|Insufficient therapeutic response|10
7800972|NCT00485589|27108246|P3|Overall Study|Administrative/Other|1
7800973|NCT00485589|27108247|P2|Overall Study|Administrative/Other|2
7800974|NCT00485589|27108248|P1|Overall Study|Administrative/Other|1
7800975|NCT00485589|27108246|P3|Overall Study|Violation of selection criteria at entry|1
7800976|NCT00485589|27108247|P2|Overall Study|Violation of selection criteria at entry|3
7800977|NCT00485589|27108248|P1|Overall Study|Violation of selection criteria at entry|0
7800978|NCT00485589|27108246|P3|Overall Study|Protocol Violation|0
7800979|NCT00485589|27108247|P2|Overall Study|Protocol Violation|0
7800980|NCT00485589|27108248|P1|Overall Study|Protocol Violation|1
7800981|NCT00485589|27108246|P3|Overall Study|Failure to return|1
7800982|NCT00485589|27108247|P2|Overall Study|Failure to return|5
7800983|NCT00485589|27108248|P1|Overall Study|Failure to return|6
7800984|NCT00485589|27108246|P3|Overall Study|Death|0
7800985|NCT00485589|27108247|P2|Overall Study|Death|2
7800986|NCT00485589|27108248|P1|Overall Study|Death|2
7800987|NCT00485472|27108280|P2|Overall Study|Lost to Follow-up|1
7800988|NCT00485472|27108281|P1|Overall Study|Lost to Follow-up|0
7800989|NCT00485472|27108280|P2|Overall Study|Other|1
7800990|NCT00485472|27108281|P1|Overall Study|Other|2
7800991|NCT00485472|27108280|P2|Overall Study|Protocol Violation|1
7800992|NCT00485472|27108281|P1|Overall Study|Protocol Violation|0
7800993|NCT00485472|27108280|P2|Overall Study|Withdrawal by Subject|0
7800994|NCT00485472|27108281|P1|Overall Study|Withdrawal by Subject|1
7800995|NCT00485472|27108280|P2|Overall Study|Lack of Efficacy|4
7800996|NCT00485472|27108281|P1|Overall Study|Lack of Efficacy|5
7800997|NCT00485472|27108280|P2|Overall Study|Adverse Event|5
7800998|NCT00485472|27108281|P1|Overall Study|Adverse Event|8
7800999|NCT00485303|27108318|P1|Overall Study|Treatment ongoing at cutoff date|2
7801000|NCT00485303|27108318|P1|Overall Study|Initiation of new anti-cancer treatment|2
7801001|NCT00485303|27108318|P1|Overall Study|Other|3
7801002|NCT00485303|27108318|P1|Overall Study|Progressive Disease|44
7801003|NCT00485303|27108318|P1|Overall Study|Adverse Event|5
7801004|NCT00485264|27108336|P6|Overall Study|Other Reason|0
7801005|NCT00485264|27108337|P5|Overall Study|Other Reason|0
7801006|NCT00485264|27108338|P4|Overall Study|Other Reason|0
7801007|NCT00485264|27108339|P3|Overall Study|Other Reason|0
7801008|NCT00485264|27108340|P2|Overall Study|Other Reason|0
7801009|NCT00485264|27108341|P1|Overall Study|Other Reason|3
7801010|NCT00485264|27108336|P6|Overall Study|Lost to Follow-up|1
7801011|NCT00485264|27108337|P5|Overall Study|Lost to Follow-up|0
7801012|NCT00485264|27108338|P4|Overall Study|Lost to Follow-up|0
7801013|NCT00485264|27108339|P3|Overall Study|Lost to Follow-up|1
7801014|NCT00485264|27108340|P2|Overall Study|Lost to Follow-up|1
7801015|NCT00485264|27108341|P1|Overall Study|Lost to Follow-up|2
7801016|NCT00485264|27108336|P6|Overall Study|Non-Compliant|0
7801017|NCT00485264|27108337|P5|Overall Study|Non-Compliant|1
7801018|NCT00485264|27108338|P4|Overall Study|Non-Compliant|0
7801019|NCT00485264|27108339|P3|Overall Study|Non-Compliant|1
7801020|NCT00485264|27108340|P2|Overall Study|Non-Compliant|2
7801021|NCT00485264|27108341|P1|Overall Study|Non-Compliant|17
7801022|NCT00485264|27108336|P6|Overall Study|Not Able to Attend Clinic|2
7801023|NCT00485264|27108337|P5|Overall Study|Not Able to Attend Clinic|1
7801024|NCT00485264|27108338|P4|Overall Study|Not Able to Attend Clinic|1
7801025|NCT00485264|27108339|P3|Overall Study|Not Able to Attend Clinic|0
7801026|NCT00485264|27108340|P2|Overall Study|Not Able to Attend Clinic|0
7801027|NCT00485264|27108341|P1|Overall Study|Not Able to Attend Clinic|5
7801028|NCT00485264|27108336|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
7801029|NCT00485264|27108337|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
7801030|NCT00485264|27108338|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
7801031|NCT00485264|27108339|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
7801032|NCT00485264|27108340|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
7801033|NCT00485264|27108341|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
7801034|NCT00485264|27108336|P6|Overall Study|Physician Decision|0
7801035|NCT00485264|27108337|P5|Overall Study|Physician Decision|0
7801036|NCT00485264|27108338|P4|Overall Study|Physician Decision|0
7801037|NCT00485264|27108339|P3|Overall Study|Physician Decision|0
7801038|NCT00485264|27108340|P2|Overall Study|Physician Decision|2
7801039|NCT00485264|27108341|P1|Overall Study|Physician Decision|0
7801040|NCT00485264|27108336|P6|Overall Study|Guardian Consent Withdrawn|0
7801041|NCT00485264|27108337|P5|Overall Study|Guardian Consent Withdrawn|1
7801042|NCT00485264|27108338|P4|Overall Study|Guardian Consent Withdrawn|0
7801043|NCT00485264|27108339|P3|Overall Study|Guardian Consent Withdrawn|0
7801044|NCT00485264|27108340|P2|Overall Study|Guardian Consent Withdrawn|0
7801045|NCT00485264|27108341|P1|Overall Study|Guardian Consent Withdrawn|1
7801046|NCT00485264|27108336|P6|Overall Study|Lack of Efficacy|0
7801047|NCT00485264|27108337|P5|Overall Study|Lack of Efficacy|0
7801048|NCT00485264|27108338|P4|Overall Study|Lack of Efficacy|0
7801049|NCT00485264|27108339|P3|Overall Study|Lack of Efficacy|0
7801050|NCT00485264|27108340|P2|Overall Study|Lack of Efficacy|1
7801051|NCT00485264|27108341|P1|Overall Study|Lack of Efficacy|0
7801052|NCT00485264|27108336|P6|Overall Study|Number/Volume/Timing of Study Meds|0
7801053|NCT00485264|27108337|P5|Overall Study|Number/Volume/Timing of Study Meds|0
7801054|NCT00485264|27108338|P4|Overall Study|Number/Volume/Timing of Study Meds|0
7801055|NCT00485264|27108339|P3|Overall Study|Number/Volume/Timing of Study Meds|1
7801056|NCT00485264|27108340|P2|Overall Study|Number/Volume/Timing of Study Meds|1
7801057|NCT00485264|27108341|P1|Overall Study|Number/Volume/Timing of Study Meds|2
7801058|NCT00485264|27108336|P6|Overall Study|Disallowed Medication|1
7801059|NCT00485264|27108337|P5|Overall Study|Disallowed Medication|0
7801060|NCT00485264|27108338|P4|Overall Study|Disallowed Medication|0
7801061|NCT00485264|27108339|P3|Overall Study|Disallowed Medication|0
7801062|NCT00485264|27108340|P2|Overall Study|Disallowed Medication|0
7801063|NCT00485264|27108341|P1|Overall Study|Disallowed Medication|0
7801064|NCT00485264|27108336|P6|Overall Study|Pregnancy|0
7801065|NCT00485264|27108337|P5|Overall Study|Pregnancy|0
7801066|NCT00485264|27108338|P4|Overall Study|Pregnancy|0
7801067|NCT00485264|27108339|P3|Overall Study|Pregnancy|0
7801068|NCT00485264|27108340|P2|Overall Study|Pregnancy|0
7801069|NCT00485264|27108341|P1|Overall Study|Pregnancy|4
7801070|NCT00485264|27108336|P6|Overall Study|Adverse Event|3
7801071|NCT00485264|27108337|P5|Overall Study|Adverse Event|1
7801072|NCT00485264|27108338|P4|Overall Study|Adverse Event|3
7801073|NCT00485264|27108339|P3|Overall Study|Adverse Event|2
7801074|NCT00485264|27108340|P2|Overall Study|Adverse Event|0
7801075|NCT00485264|27108341|P1|Overall Study|Adverse Event|1
7801076|NCT00485264|27108336|P6|Overall Study|Death|0
7801077|NCT00485264|27108337|P5|Overall Study|Death|1
7801078|NCT00485264|27108338|P4|Overall Study|Death|0
7801079|NCT00485264|27108339|P3|Overall Study|Death|0
7801080|NCT00485264|27108340|P2|Overall Study|Death|0
7801081|NCT00485264|27108341|P1|Overall Study|Death|1
7801082|NCT00485264|27108336|P6|Overall Study|Enrolled But Not Given Treatment|0
7801083|NCT00485264|27108337|P5|Overall Study|Enrolled But Not Given Treatment|1
7801084|NCT00485264|27108338|P4|Overall Study|Enrolled But Not Given Treatment|0
7801085|NCT00485264|27108339|P3|Overall Study|Enrolled But Not Given Treatment|0
7801086|NCT00485264|27108340|P2|Overall Study|Enrolled But Not Given Treatment|0
7801087|NCT00485264|27108341|P1|Overall Study|Enrolled But Not Given Treatment|0
7801088|NCT00485173|27108429|P2|Overall Study|Lost to Follow-up|61
7801089|NCT00485173|27108430|P1|Overall Study|Lost to Follow-up|32
7801090|NCT00485173|27108429|P2|Overall Study|Death|3
7801091|NCT00485173|27108430|P1|Overall Study|Death|4
7801092|NCT00485134|27108478|P8|Overall Study|Pregnancy|0
7801093|NCT00485134|27108479|P7|Overall Study|Pregnancy|1
7801094|NCT00485134|27108480|P6|Overall Study|Pregnancy|0
7801095|NCT00485134|27108481|P5|Overall Study|Pregnancy|0
7801096|NCT00485134|27108482|P4|Overall Study|Pregnancy|0
7801097|NCT00485134|27108483|P3|Overall Study|Pregnancy|0
7801098|NCT00485134|27108484|P2|Overall Study|Pregnancy|0
7801099|NCT00485134|27108485|P1|Overall Study|Pregnancy|0
7801100|NCT00485134|27108478|P8|Overall Study|Unable to comply with study schedule|1
7801101|NCT00485134|27108479|P7|Overall Study|Unable to comply with study schedule|0
7801102|NCT00485134|27108480|P6|Overall Study|Unable to comply with study schedule|0
7801103|NCT00485134|27108481|P5|Overall Study|Unable to comply with study schedule|0
7801104|NCT00485134|27108482|P4|Overall Study|Unable to comply with study schedule|0
7801105|NCT00485134|27108483|P3|Overall Study|Unable to comply with study schedule|0
7801106|NCT00485134|27108484|P2|Overall Study|Unable to comply with study schedule|0
7801107|NCT00485134|27108485|P1|Overall Study|Unable to comply with study schedule|0
7801108|NCT00485134|27108478|P8|Overall Study|Non-compliance|0
7801109|NCT00485134|27108479|P7|Overall Study|Non-compliance|2
7801110|NCT00485134|27108480|P6|Overall Study|Non-compliance|2
7801111|NCT00485134|27108481|P5|Overall Study|Non-compliance|1
7801112|NCT00485134|27108482|P4|Overall Study|Non-compliance|0
7801113|NCT00485134|27108483|P3|Overall Study|Non-compliance|0
7801114|NCT00485134|27108484|P2|Overall Study|Non-compliance|0
7801115|NCT00485134|27108485|P1|Overall Study|Non-compliance|0
7801116|NCT00485134|27108478|P8|Overall Study|Positive drug test|0
7801117|NCT00485134|27108479|P7|Overall Study|Positive drug test|0
7801118|NCT00485134|27108480|P6|Overall Study|Positive drug test|1
7801119|NCT00485134|27108481|P5|Overall Study|Positive drug test|2
7801120|NCT00485134|27108482|P4|Overall Study|Positive drug test|0
7801121|NCT00485134|27108483|P3|Overall Study|Positive drug test|0
7801122|NCT00485134|27108484|P2|Overall Study|Positive drug test|0
7801123|NCT00485134|27108485|P1|Overall Study|Positive drug test|0
7801124|NCT00485134|27108478|P8|Overall Study|Withdrew for adverse event|0
7801125|NCT00485134|27108479|P7|Overall Study|Withdrew for adverse event|0
7801126|NCT00485134|27108480|P6|Overall Study|Withdrew for adverse event|0
7801127|NCT00485134|27108481|P5|Overall Study|Withdrew for adverse event|0
7801128|NCT00485134|27108482|P4|Overall Study|Withdrew for adverse event|0
7801129|NCT00485134|27108483|P3|Overall Study|Withdrew for adverse event|1
7801130|NCT00485134|27108484|P2|Overall Study|Withdrew for adverse event|0
7801131|NCT00485134|27108485|P1|Overall Study|Withdrew for adverse event|0
7801132|NCT00485134|27108478|P8|Overall Study|Change in health status|0
7801133|NCT00485134|27108479|P7|Overall Study|Change in health status|0
7801134|NCT00485134|27108480|P6|Overall Study|Change in health status|1
7801135|NCT00485134|27108481|P5|Overall Study|Change in health status|0
7801136|NCT00485134|27108482|P4|Overall Study|Change in health status|1
7801137|NCT00485134|27108483|P3|Overall Study|Change in health status|2
7801138|NCT00485134|27108484|P2|Overall Study|Change in health status|1
7801139|NCT00485134|27108485|P1|Overall Study|Change in health status|0
7801140|NCT00485134|27108478|P8|Overall Study|Withdrawal by Subject|0
7801141|NCT00485134|27108479|P7|Overall Study|Withdrawal by Subject|0
7801142|NCT00485134|27108480|P6|Overall Study|Withdrawal by Subject|0
7801143|NCT00485134|27108481|P5|Overall Study|Withdrawal by Subject|0
7801144|NCT00485134|27108482|P4|Overall Study|Withdrawal by Subject|0
7801145|NCT00485134|27108483|P3|Overall Study|Withdrawal by Subject|0
7801146|NCT00485134|27108484|P2|Overall Study|Withdrawal by Subject|1
7801147|NCT00485134|27108485|P1|Overall Study|Withdrawal by Subject|0
7801148|NCT00485134|27108478|P8|Overall Study|Lost to Follow-up|0
7801149|NCT00485134|27108479|P7|Overall Study|Lost to Follow-up|0
7801150|NCT00485134|27108480|P6|Overall Study|Lost to Follow-up|0
7801151|NCT00485134|27108481|P5|Overall Study|Lost to Follow-up|0
7801152|NCT00485134|27108482|P4|Overall Study|Lost to Follow-up|0
7801153|NCT00485134|27108483|P3|Overall Study|Lost to Follow-up|0
7801154|NCT00485134|27108484|P2|Overall Study|Lost to Follow-up|0
7801155|NCT00485134|27108485|P1|Overall Study|Lost to Follow-up|1
7801156|NCT00485069|27108507|P2|Overall Study|Withdrawal by Subject|6
7801157|NCT00485069|27108508|P1|Overall Study|Withdrawal by Subject|6
7801158|NCT00485069|27108507|P2|Overall Study|Protocol Violation|1
7801159|NCT00485069|27108508|P1|Overall Study|Protocol Violation|0
7801160|NCT00485069|27108507|P2|Overall Study|Lack of Efficacy|1
7801161|NCT00485069|27108508|P1|Overall Study|Lack of Efficacy|2
7801162|NCT00485069|27108507|P2|Overall Study|Adverse Event|4
7801163|NCT00485069|27108508|P1|Overall Study|Adverse Event|10
7801164|NCT00484939|27108553|P2|Overall Study|Reason Not Specified|6
7801165|NCT00484939|27108554|P1|Overall Study|Reason Not Specified|11
7801166|NCT00484939|27108553|P2|Overall Study|Screen Failure|2
7801167|NCT00484939|27108554|P1|Overall Study|Screen Failure|2
7801168|NCT00484939|27108553|P2|Overall Study|Disease progression|88
7801169|NCT00484939|27108554|P1|Overall Study|Disease progression|67
7801170|NCT00484939|27108553|P2|Overall Study|Discretion of Investigator or Sponsor|3
7801171|NCT00484939|27108554|P1|Overall Study|Discretion of Investigator or Sponsor|7
7801172|NCT00484939|27108553|P2|Overall Study|Lost to Follow-up|3
7801173|NCT00484939|27108554|P1|Overall Study|Lost to Follow-up|0
7801174|NCT00484939|27108553|P2|Overall Study|Protocol Violation|3
7801175|NCT00484939|27108554|P1|Overall Study|Protocol Violation|3
7801176|NCT00484939|27108553|P2|Overall Study|Patient Withdrew Consent|10
7801177|NCT00484939|27108554|P1|Overall Study|Patient Withdrew Consent|19
7801178|NCT00484939|27108553|P2|Overall Study|Adverse Event|12
7801179|NCT00484939|27108554|P1|Overall Study|Adverse Event|22
7801180|NCT00484939|27108553|P2|Overall Study|Death|13
7801181|NCT00484939|27108554|P1|Overall Study|Death|9
7801182|NCT00484679|27108633|P1|Overall Study|Withdrawal by Subject|3
7801183|NCT00484419|27108640|P3|Overall Study|sponsor decision, randomized in error|2
7801184|NCT00484419|27108641|P2|Overall Study|sponsor decision, randomized in error|0
7801185|NCT00484419|27108642|P1|Overall Study|sponsor decision, randomized in error|0
7801186|NCT00484419|27108640|P3|Overall Study|subject relocated|0
7801187|NCT00484419|27108641|P2|Overall Study|subject relocated|1
7801188|NCT00484419|27108642|P1|Overall Study|subject relocated|0
7801189|NCT00484419|27108640|P3|Overall Study|subject unable to receive medication|0
7801190|NCT00484419|27108641|P2|Overall Study|subject unable to receive medication|0
7801191|NCT00484419|27108642|P1|Overall Study|subject unable to receive medication|1
7801192|NCT00484419|27108640|P3|Overall Study|Physician Decision|1
7801193|NCT00484419|27108641|P2|Overall Study|Physician Decision|1
7801194|NCT00484419|27108642|P1|Overall Study|Physician Decision|1
7801195|NCT00484419|27108640|P3|Overall Study|required restricted medication|1
7801196|NCT00484419|27108641|P2|Overall Study|required restricted medication|0
7801197|NCT00484419|27108642|P1|Overall Study|required restricted medication|1
7801198|NCT00484419|27108640|P3|Overall Study|subject met discontinuation criteria|4
7801199|NCT00484419|27108641|P2|Overall Study|subject met discontinuation criteria|2
7801200|NCT00484419|27108642|P1|Overall Study|subject met discontinuation criteria|2
7801201|NCT00484419|27108640|P3|Overall Study|Withdrawal by Subject|1
7801202|NCT00484419|27108641|P2|Overall Study|Withdrawal by Subject|1
7801203|NCT00484419|27108642|P1|Overall Study|Withdrawal by Subject|3
7801204|NCT00484419|27108640|P3|Overall Study|Lost to Follow-up|2
7801205|NCT00484419|27108641|P2|Overall Study|Lost to Follow-up|0
7801206|NCT00484419|27108642|P1|Overall Study|Lost to Follow-up|1
7801207|NCT00484419|27108640|P3|Overall Study|Adverse Event|0
7801208|NCT00484419|27108641|P2|Overall Study|Adverse Event|0
7801209|NCT00484419|27108642|P1|Overall Study|Adverse Event|3
7801210|NCT00484315|27108726|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
7801211|NCT00484315|27108727|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
7801212|NCT00484315|27108726|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
7801213|NCT00484315|27108727|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
7801214|NCT00484315|27108726|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
7801215|NCT00484315|27108727|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
7801216|NCT00484315|27108726|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
7801217|NCT00484315|27108727|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
7801218|NCT00484315|27108726|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
7801219|NCT00484315|27108727|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
7801220|NCT00484315|27108726|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
7801221|NCT00484315|27108727|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
7801222|NCT00484315|27108726|P2|12-Month Clinical Follow-up|Death|2
7801223|NCT00484315|27108727|P1|12-Month Clinical Follow-up|Death|6
7801224|NCT00484289|27108738|P3|Post Marketing Phase|Adverse Event|0
7801225|NCT00484289|27108739|P2|Post Marketing Phase|Adverse Event|1
7801226|NCT00484289|27108740|P1|Post Marketing Phase|Adverse Event|0
7801227|NCT00484289|27108738|P3|Long Term Phase|Other Reason|1
7801228|NCT00484289|27108739|P2|Long Term Phase|Other Reason|5
7801229|NCT00484289|27108740|P1|Long Term Phase|Other Reason|0
7801230|NCT00484289|27108738|P3|Long Term Phase|Inadequate response|4
7801231|NCT00484289|27108739|P2|Long Term Phase|Inadequate response|7
7801232|NCT00484289|27108740|P1|Long Term Phase|Inadequate response|2
7801233|NCT00484289|27108738|P3|Long Term Phase|Withdrawal by Subject|6
7801234|NCT00484289|27108739|P2|Long Term Phase|Withdrawal by Subject|7
7801235|NCT00484289|27108740|P1|Long Term Phase|Withdrawal by Subject|0
7801236|NCT00484289|27108738|P3|Long Term Phase|Adverse Event|5
7801237|NCT00484289|27108739|P2|Long Term Phase|Adverse Event|17
7801238|NCT00484289|27108740|P1|Long Term Phase|Adverse Event|1
7801239|NCT00484198|27108816|P4|Overall Study|Other|28
7801240|NCT00484198|27108817|P3|Overall Study|Other|31
7801241|NCT00484198|27108818|P2|Overall Study|Other|10
7801242|NCT00484198|27108819|P1|Overall Study|Other|7
7801243|NCT00484198|27108816|P4|Overall Study|Protocol Violation|8
7801244|NCT00484198|27108817|P3|Overall Study|Protocol Violation|6
7801245|NCT00484198|27108818|P2|Overall Study|Protocol Violation|5
7801246|NCT00484198|27108819|P1|Overall Study|Protocol Violation|0
7801247|NCT00484198|27108816|P4|Overall Study|Adverse Event|31
7801248|NCT00484198|27108817|P3|Overall Study|Adverse Event|32
7801249|NCT00484198|27108818|P2|Overall Study|Adverse Event|11
7801250|NCT00484198|27108819|P1|Overall Study|Adverse Event|3
7801251|NCT00484198|27108816|P4|Overall Study|Therapeutic failure/ lack of efficacy|8
7801252|NCT00484198|27108817|P3|Overall Study|Therapeutic failure/ lack of efficacy|6
7801253|NCT00484198|27108818|P2|Overall Study|Therapeutic failure/ lack of efficacy|2
7801254|NCT00484198|27108819|P1|Overall Study|Therapeutic failure/ lack of efficacy|3
7801255|NCT00484198|27108816|P4|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
7801256|NCT00484198|27108817|P3|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
7801257|NCT00484198|27108818|P2|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
7801258|NCT00484198|27108819|P1|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
7801259|NCT00484198|27108816|P4|Overall Study|Participant Withdrew Consent|59
7801260|NCT00484198|27108817|P3|Overall Study|Participant Withdrew Consent|47
7801261|NCT00484198|27108818|P2|Overall Study|Participant Withdrew Consent|21
7801262|NCT00484198|27108819|P1|Overall Study|Participant Withdrew Consent|12
7801263|NCT00484185|27108917|P1|Overall Study|Death|2
7801264|NCT00484185|27108917|P1|Overall Study|Randomized but not treated|5
7801265|NCT00484185|27108917|P1|Overall Study|Other|20
7801266|NCT00484185|27108917|P1|Overall Study|Lost to Follow-up|44
7801267|NCT00484159|27108939|P3|Overall Study|Lost to Follow-up|0
7801268|NCT00484159|27108940|P2|Overall Study|Lost to Follow-up|1
7801269|NCT00484159|27108941|P1|Overall Study|Lost to Follow-up|1
7801270|NCT00484094|27108952|P1|Overall Study|Other|3
7801271|NCT00484094|27108952|P1|Overall Study|Discontinued|39
7801272|NCT00483938|27108968|P7|Overall Study|Other|32
7801273|NCT00483938|27108969|P6|Overall Study|Other|4
7801274|NCT00483938|27108970|P5|Overall Study|Other|0
7801275|NCT00483938|27108971|P4|Overall Study|Other|4
7801276|NCT00483938|27108972|P3|Overall Study|Other|0
7801277|NCT00483938|27108973|P2|Overall Study|Other|9
7801278|NCT00483938|27108974|P1|Overall Study|Other|3
7801279|NCT00483938|27108968|P7|Overall Study|Death|0
7801280|NCT00483938|27108969|P6|Overall Study|Death|0
7801281|NCT00483938|27108970|P5|Overall Study|Death|0
7801282|NCT00483938|27108971|P4|Overall Study|Death|0
7801283|NCT00483938|27108972|P3|Overall Study|Death|0
7801284|NCT00483938|27108973|P2|Overall Study|Death|2
7801285|NCT00483938|27108974|P1|Overall Study|Death|0
7801286|NCT00483938|27108968|P7|Overall Study|Lost to Follow-up|3
7801287|NCT00483938|27108969|P6|Overall Study|Lost to Follow-up|1
7801288|NCT00483938|27108970|P5|Overall Study|Lost to Follow-up|1
7801289|NCT00483938|27108971|P4|Overall Study|Lost to Follow-up|2
7801290|NCT00483938|27108972|P3|Overall Study|Lost to Follow-up|0
7801291|NCT00483938|27108973|P2|Overall Study|Lost to Follow-up|2
7801292|NCT00483938|27108974|P1|Overall Study|Lost to Follow-up|1
7801293|NCT00483938|27108968|P7|Overall Study|Withdrawal by Subject|2
7801294|NCT00483938|27108969|P6|Overall Study|Withdrawal by Subject|3
7801295|NCT00483938|27108970|P5|Overall Study|Withdrawal by Subject|1
7801296|NCT00483938|27108971|P4|Overall Study|Withdrawal by Subject|0
7801297|NCT00483938|27108972|P3|Overall Study|Withdrawal by Subject|0
7801298|NCT00483938|27108973|P2|Overall Study|Withdrawal by Subject|6
7801299|NCT00483938|27108974|P1|Overall Study|Withdrawal by Subject|1
7801300|NCT00483938|27108968|P7|Overall Study|Protocol Violation|3
7801301|NCT00483938|27108969|P6|Overall Study|Protocol Violation|0
7801302|NCT00483938|27108970|P5|Overall Study|Protocol Violation|0
7801303|NCT00483938|27108971|P4|Overall Study|Protocol Violation|0
7801304|NCT00483938|27108972|P3|Overall Study|Protocol Violation|0
7801305|NCT00483938|27108973|P2|Overall Study|Protocol Violation|0
7801306|NCT00483938|27108974|P1|Overall Study|Protocol Violation|0
7801307|NCT00483756|27108998|P3|Overall Study|Randomized, Not Treated|4
7801308|NCT00483756|27108999|P2|Overall Study|Randomized, Not Treated|4
7801309|NCT00483756|27109000|P1|Overall Study|Randomized, Not Treated|1
7801310|NCT00483756|27108998|P3|Overall Study|Other|3
7801311|NCT00483756|27108999|P2|Overall Study|Other|4
7801312|NCT00483756|27109000|P1|Overall Study|Other|2
7801313|NCT00483756|27108998|P3|Overall Study|Withdrawal by Subject|4
7801314|NCT00483756|27108999|P2|Overall Study|Withdrawal by Subject|3
7801315|NCT00483756|27109000|P1|Overall Study|Withdrawal by Subject|5
7801316|NCT00483756|27108998|P3|Overall Study|Lost to Follow-up|0
7801317|NCT00483756|27108999|P2|Overall Study|Lost to Follow-up|1
7801318|NCT00483756|27109000|P1|Overall Study|Lost to Follow-up|3
7801319|NCT00483756|27108998|P3|Overall Study|Lack of Efficacy|0
7801320|NCT00483756|27108999|P2|Overall Study|Lack of Efficacy|0
7801321|NCT00483756|27109000|P1|Overall Study|Lack of Efficacy|1
7801322|NCT00483756|27108998|P3|Overall Study|Adverse Event|40
7801323|NCT00483756|27108999|P2|Overall Study|Adverse Event|38
7801324|NCT00483756|27109000|P1|Overall Study|Adverse Event|19
7801325|NCT00483756|27108998|P3|Overall Study|Death|1
7801326|NCT00483756|27108999|P2|Overall Study|Death|0
7801327|NCT00483756|27109000|P1|Overall Study|Death|2
7801328|NCT00483717|27109064|P2|Overall Study|Withdrawal by Subject|0
7801329|NCT00483717|27109065|P1|Overall Study|Withdrawal by Subject|1
7801330|NCT00483717|27109064|P2|Overall Study|Lost to Follow-up|0
7801331|NCT00483717|27109065|P1|Overall Study|Lost to Follow-up|1
7801332|NCT00483717|27109064|P2|Overall Study|No treatment for migraine|13
7801333|NCT00483717|27109065|P1|Overall Study|No treatment for migraine|16
7801334|NCT00483717|27109064|P2|Overall Study|Time of dosing missing|1
7801335|NCT00483717|27109065|P1|Overall Study|Time of dosing missing|1
7801336|NCT00483717|27109064|P2|Overall Study|Protocol Violation|7
7801337|NCT00483717|27109065|P1|Overall Study|Protocol Violation|5
7801338|NCT00483704|27109088|P3|Treatment|Physician Decision|4
7801339|NCT00483704|27109089|P2|Treatment|Physician Decision|1
7801340|NCT00483704|27109090|P1|Treatment|Physician Decision|0
7801341|NCT00483704|27109088|P3|Treatment|Pregnancy|0
7801342|NCT00483704|27109089|P2|Treatment|Pregnancy|1
7801343|NCT00483704|27109090|P1|Treatment|Pregnancy|0
7801344|NCT00483704|27109088|P3|Treatment|Lack of Efficacy|1
7801345|NCT00483704|27109089|P2|Treatment|Lack of Efficacy|1
7801346|NCT00483704|27109090|P1|Treatment|Lack of Efficacy|1
7801347|NCT00483704|27109088|P3|Treatment|Lost to Follow-up|5
7801348|NCT00483704|27109089|P2|Treatment|Lost to Follow-up|7
7801349|NCT00483704|27109090|P1|Treatment|Lost to Follow-up|2
7801350|NCT00483704|27109088|P3|Treatment|Protocol Violation|5
7801351|NCT00483704|27109089|P2|Treatment|Protocol Violation|3
7801352|NCT00483704|27109090|P1|Treatment|Protocol Violation|6
7801353|NCT00483704|27109088|P3|Treatment|Withdrawal by Subject|21
7801354|NCT00483704|27109089|P2|Treatment|Withdrawal by Subject|12
7801355|NCT00483704|27109090|P1|Treatment|Withdrawal by Subject|16
7801356|NCT00483704|27109088|P3|Treatment|Adverse Event|4
7801357|NCT00483704|27109089|P2|Treatment|Adverse Event|5
7801358|NCT00483704|27109090|P1|Treatment|Adverse Event|3
7801359|NCT00483704|27109088|P3|Treatment|Lack of qualifying migraines|116
7801360|NCT00483704|27109089|P2|Treatment|Lack of qualifying migraines|99
7801361|NCT00483704|27109090|P1|Treatment|Lack of qualifying migraines|101
7801362|NCT00483704|27109088|P3|Randomization|Lack of qualifying migraines|31
7801363|NCT00483704|27109089|P2|Randomization|Lack of qualifying migraines|25
7801364|NCT00483704|27109090|P1|Randomization|Lack of qualifying migraines|21
7801365|NCT00483704|27109088|P3|Randomization|Progressive disease|1
7801366|NCT00483704|27109089|P2|Randomization|Progressive disease|0
7801367|NCT00483704|27109090|P1|Randomization|Progressive disease|0
7801368|NCT00483704|27109088|P3|Randomization|Physician Decision|0
7801369|NCT00483704|27109089|P2|Randomization|Physician Decision|4
7801370|NCT00483704|27109090|P1|Randomization|Physician Decision|2
7801371|NCT00483704|27109088|P3|Randomization|Pregnancy|0
7801372|NCT00483704|27109089|P2|Randomization|Pregnancy|0
7801373|NCT00483704|27109090|P1|Randomization|Pregnancy|1
7801374|NCT00483704|27109088|P3|Randomization|Lost to Follow-up|19
7801375|NCT00483704|27109089|P2|Randomization|Lost to Follow-up|14
7801376|NCT00483704|27109090|P1|Randomization|Lost to Follow-up|14
7801377|NCT00483704|27109088|P3|Randomization|Protocol Violation|22
7801378|NCT00483704|27109089|P2|Randomization|Protocol Violation|25
7801379|NCT00483704|27109090|P1|Randomization|Protocol Violation|14
7801380|NCT00483704|27109088|P3|Randomization|Withdrawal by Subject|18
7801381|NCT00483704|27109089|P2|Randomization|Withdrawal by Subject|28
7801382|NCT00483704|27109090|P1|Randomization|Withdrawal by Subject|19
7801383|NCT00483652|27109136|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
7801384|NCT00483652|27109137|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
7801385|NCT00483652|27109136|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
7801386|NCT00483652|27109137|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
7801387|NCT00483652|27109136|P2|Double-blind Treatment Period|Adverse Event|4
7801388|NCT00483652|27109137|P1|Double-blind Treatment Period|Adverse Event|3
7801389|NCT00483652|27109136|P2|Double-blind Treatment Period|Protocol Violation|1
7801390|NCT00483652|27109137|P1|Double-blind Treatment Period|Protocol Violation|2
7801391|NCT00483574|27109147|P2|Overall Study|Withdrawal by Subject|0
7801392|NCT00483574|27109148|P1|Overall Study|Withdrawal by Subject|52
7801393|NCT00483574|27109147|P2|Overall Study|Lost to Follow-up|4
7801394|NCT00483574|27109148|P1|Overall Study|Lost to Follow-up|16
7801395|NCT00483574|27109147|P2|Overall Study|Protocol Violation|9
7801396|NCT00483574|27109148|P1|Overall Study|Protocol Violation|28
7801397|NCT00483574|27109147|P2|Overall Study|Adverse Event|0
7801398|NCT00483574|27109148|P1|Overall Study|Adverse Event|6
7801399|NCT00483548|27109163|P2|Overall Study|Withdrawal by Subject|2
7801400|NCT00483548|27109164|P1|Overall Study|Withdrawal by Subject|5
7801401|NCT00483548|27109163|P2|Overall Study|Lost to Follow-up|4
7801402|NCT00483548|27109164|P1|Overall Study|Lost to Follow-up|3
7801403|NCT00483548|27109163|P2|Overall Study|Non-compliance with medication|0
7801404|NCT00483548|27109164|P1|Overall Study|Non-compliance with medication|2
7801405|NCT00483548|27109163|P2|Overall Study|Unable to comply with protocol schedule|0
7801406|NCT00483548|27109164|P1|Overall Study|Unable to comply with protocol schedule|1
7801407|NCT00483548|27109163|P2|Overall Study|Protocol required discontinuation|6
7801408|NCT00483548|27109164|P1|Overall Study|Protocol required discontinuation|6
7801409|NCT00483548|27109163|P2|Overall Study|Pregnancy|0
7801410|NCT00483548|27109164|P1|Overall Study|Pregnancy|1
7801411|NCT00483548|27109163|P2|Overall Study|Protocol Violation|7
7801412|NCT00483548|27109164|P1|Overall Study|Protocol Violation|11
7801413|NCT00483548|27109163|P2|Overall Study|Lack of Efficacy|8
7801414|NCT00483548|27109164|P1|Overall Study|Lack of Efficacy|4
7801415|NCT00483548|27109163|P2|Overall Study|Laboratory abnormality|2
7801416|NCT00483548|27109164|P1|Overall Study|Laboratory abnormality|1
7801417|NCT00483548|27109163|P2|Overall Study|Adverse Event|14
7801418|NCT00483548|27109164|P1|Overall Study|Adverse Event|25
7801419|NCT00483548|27109163|P2|Overall Study|Randomized; not treated with study drug|3
7801420|NCT00483548|27109164|P1|Overall Study|Randomized; not treated with study drug|1
7801421|NCT00483405|27109222|P1|Overall Study|Other complicating disease|1
7801422|NCT00483405|27109222|P1|Overall Study|Withdrawal by Subject|2
7801423|NCT00483405|27109222|P1|Overall Study|Death|3
7801424|NCT00483405|27109222|P1|Overall Study|Lack of Efficacy|14
7801425|NCT00483405|27109222|P1|Overall Study|Adverse Event|8
7801426|NCT00483379|27109231|P2|Treatment Period|Withdrawal by Subject|0
7801427|NCT00483379|27109232|P1|Treatment Period|Withdrawal by Subject|1
7801428|NCT00483379|27109231|P2|Treatment Period|Adverse Event|0
7801429|NCT00483379|27109232|P1|Treatment Period|Adverse Event|1
7801430|NCT00483327|27109268|P1|Overall Study|Patient Non Compliance|2
7801431|NCT00483327|27109268|P1|Overall Study|Lost to Follow-up|4
7801432|NCT00483327|27109268|P1|Overall Study|Withdrawal by Subject|3
7801433|NCT00483327|27109268|P1|Overall Study|Adverse Event|1
7801434|NCT00483184|27109300|P3|Overall Study|Protocol Violation|1
7801435|NCT00483184|27109301|P2|Overall Study|Protocol Violation|0
7801436|NCT00483184|27109302|P1|Overall Study|Protocol Violation|1
7801437|NCT00483184|27109300|P3|Overall Study|Adverse Event|2
7801438|NCT00483184|27109301|P2|Overall Study|Adverse Event|2
7801439|NCT00483184|27109302|P1|Overall Study|Adverse Event|1
7801440|NCT00483184|27109300|P3|Overall Study|Lost to Follow-up|0
7801441|NCT00483184|27109301|P2|Overall Study|Lost to Follow-up|0
7801442|NCT00483184|27109302|P1|Overall Study|Lost to Follow-up|1
7801443|NCT00483184|27109300|P3|Overall Study|Withdrawal by Subject|0
7801444|NCT00483184|27109301|P2|Overall Study|Withdrawal by Subject|2
7801445|NCT00483184|27109302|P1|Overall Study|Withdrawal by Subject|2
7801446|NCT00483119|27109312|P2|Overall Study|Physician Decision|0
7801447|NCT00483119|27109313|P1|Overall Study|Physician Decision|1
7801448|NCT00483119|27109312|P2|Overall Study|Adverse Event|1
7801449|NCT00483119|27109313|P1|Overall Study|Adverse Event|0
7801450|NCT00483041|27109327|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
7801451|NCT00483041|27109328|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
7801452|NCT00483002|27109358|P1|Overall Study|Other|967
7801453|NCT00483002|27109358|P1|Overall Study|Other|2
7801454|NCT00483002|27109358|P1|Overall Study|Lost to Follow-up|962
7801455|NCT00483002|27109358|P1|Overall Study|Lack of Efficacy|555
7801456|NCT00483002|27109358|P1|Overall Study|Adverse Event|68
7801457|NCT00482729|27109383|P2|Overall Study|Withdrawal by Subject|69
7801458|NCT00482729|27109384|P1|Overall Study|Withdrawal by Subject|67
7801459|NCT00482729|27109383|P2|Overall Study|Protocol Violation|18
7801460|NCT00482729|27109384|P1|Overall Study|Protocol Violation|10
7801461|NCT00482729|27109383|P2|Overall Study|Pregnancy|2
7801462|NCT00482729|27109384|P1|Overall Study|Pregnancy|4
7801463|NCT00482729|27109383|P2|Overall Study|Physician Decision|7
7801464|NCT00482729|27109384|P1|Overall Study|Physician Decision|10
7801465|NCT00482729|27109383|P2|Overall Study|Lost to Follow-up|66
7801466|NCT00482729|27109384|P1|Overall Study|Lost to Follow-up|86
7801467|NCT00482729|27109383|P2|Overall Study|Lack of Efficacy|16
7801468|NCT00482729|27109384|P1|Overall Study|Lack of Efficacy|4
7801469|NCT00482729|27109383|P2|Overall Study|Hyperglycemia Criteria|5
7801470|NCT00482729|27109384|P1|Overall Study|Hyperglycemia Criteria|7
7801471|NCT00482729|27109383|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
7801472|NCT00482729|27109384|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
7801473|NCT00482729|27109383|P2|Overall Study|Adverse Event|33
7801474|NCT00482729|27109384|P1|Overall Study|Adverse Event|29
7801475|NCT00482703|27109400|P2|Overall Study|Poor compliance|0
7801476|NCT00482703|27109401|P1|Overall Study|Poor compliance|1
7801477|NCT00482612|27109472|P4|Follow-up Period|Reasons not related to trial|3
7801478|NCT00482612|27109473|P3|Follow-up Period|Reasons not related to trial|1
7801479|NCT00482612|27109474|P2|Follow-up Period|Reasons not related to trial|0
7801480|NCT00482612|27109475|P1|Follow-up Period|Reasons not related to trial|1
7801481|NCT00482612|27109472|P4|Follow-up Period|Withdrawal by Subject|2
7801482|NCT00482612|27109473|P3|Follow-up Period|Withdrawal by Subject|7
7801483|NCT00482612|27109474|P2|Follow-up Period|Withdrawal by Subject|5
7801484|NCT00482612|27109475|P1|Follow-up Period|Withdrawal by Subject|3
7801485|NCT00482612|27109472|P4|Follow-up Period|Lack of Efficacy|0
7801486|NCT00482612|27109473|P3|Follow-up Period|Lack of Efficacy|1
7801487|NCT00482612|27109474|P2|Follow-up Period|Lack of Efficacy|0
7801488|NCT00482612|27109475|P1|Follow-up Period|Lack of Efficacy|2
7801489|NCT00482612|27109472|P4|Follow-up Period|Adverse Event|0
7801490|NCT00482612|27109473|P3|Follow-up Period|Adverse Event|9
7801491|NCT00482612|27109474|P2|Follow-up Period|Adverse Event|7
7801492|NCT00482612|27109475|P1|Follow-up Period|Adverse Event|4
7801493|NCT00482612|27109472|P4|Follow-up Period|Lost to Follow-up|1
7801494|NCT00482612|27109473|P3|Follow-up Period|Lost to Follow-up|2
7801495|NCT00482612|27109474|P2|Follow-up Period|Lost to Follow-up|4
7801496|NCT00482612|27109475|P1|Follow-up Period|Lost to Follow-up|0
7801497|NCT00482612|27109472|P4|Follow-up Period|Lack of compliance|0
7801498|NCT00482612|27109473|P3|Follow-up Period|Lack of compliance|1
7801499|NCT00482612|27109474|P2|Follow-up Period|Lack of compliance|0
7801500|NCT00482612|27109475|P1|Follow-up Period|Lack of compliance|0
7801501|NCT00482612|27109472|P4|Follow-up Period|Other|2
7801502|NCT00482612|27109473|P3|Follow-up Period|Other|1
7801503|NCT00482612|27109474|P2|Follow-up Period|Other|2
7801504|NCT00482612|27109475|P1|Follow-up Period|Other|4
7801505|NCT00482612|27109472|P4|In-treatment Period|No study medication administered|0
7801506|NCT00482612|27109473|P3|In-treatment Period|No study medication administered|1
7801507|NCT00482612|27109474|P2|In-treatment Period|No study medication administered|0
7801508|NCT00482612|27109475|P1|In-treatment Period|No study medication administered|0
7801509|NCT00482391|27109524|P1|Overall Study|Death|1
7801510|NCT00482391|27109524|P1|Overall Study|Adverse Event|1
7801511|NCT00482391|27109524|P1|Overall Study|Withdrawal by Subject|1
7801512|NCT00482274|27109529|P1|Overall Study|Adverse Event|1
7801513|NCT00482170|27109539|P2|Overall Study|Unspecified reason|2
7801514|NCT00482170|27109540|P1|Overall Study|Unspecified reason|0
7801515|NCT00482170|27109539|P2|Overall Study|Lost to Follow-up|0
7801516|NCT00482170|27109540|P1|Overall Study|Lost to Follow-up|2
7801517|NCT00482170|27109539|P2|Overall Study|Protocol Violation|3
7801518|NCT00482170|27109540|P1|Overall Study|Protocol Violation|2
7801519|NCT00482170|27109539|P2|Overall Study|Withdrawal by Subject|1
7801520|NCT00482170|27109540|P1|Overall Study|Withdrawal by Subject|6
7801521|NCT00482170|27109539|P2|Overall Study|Adverse Event|14
7801522|NCT00482170|27109540|P1|Overall Study|Adverse Event|5
7801523|NCT00482053|27109658|P1|Inter-treatment Period|Disease progression|1
7801524|NCT00482014|27109672|P4|Overall Study|Sponsor Decision|1
7801525|NCT00482014|27109673|P3|Overall Study|Sponsor Decision|1
7801526|NCT00482014|27109674|P2|Overall Study|Sponsor Decision|2
7801527|NCT00482014|27109675|P1|Overall Study|Sponsor Decision|1
7801528|NCT00482014|27109672|P4|Overall Study|Lack of Efficacy|6
7801529|NCT00482014|27109673|P3|Overall Study|Lack of Efficacy|4
7801530|NCT00482014|27109674|P2|Overall Study|Lack of Efficacy|0
7801531|NCT00482014|27109675|P1|Overall Study|Lack of Efficacy|1
7801532|NCT00482014|27109672|P4|Overall Study|Death|4
7801533|NCT00482014|27109673|P3|Overall Study|Death|1
7801534|NCT00482014|27109674|P2|Overall Study|Death|2
7801535|NCT00482014|27109675|P1|Overall Study|Death|1
7801536|NCT00482014|27109672|P4|Overall Study|Adverse Event|8
7801537|NCT00482014|27109673|P3|Overall Study|Adverse Event|2
7801538|NCT00482014|27109674|P2|Overall Study|Adverse Event|0
7801539|NCT00482014|27109675|P1|Overall Study|Adverse Event|3
7801540|NCT00482014|27109672|P4|Overall Study|Withdrawal by Subject|4
7801541|NCT00482014|27109673|P3|Overall Study|Withdrawal by Subject|3
7801542|NCT00482014|27109674|P2|Overall Study|Withdrawal by Subject|2
7801543|NCT00482014|27109675|P1|Overall Study|Withdrawal by Subject|1
7801544|NCT00482001|27109699|P2|Overall Study|Protocol Violation|1
7801545|NCT00482001|27109700|P1|Overall Study|Protocol Violation|1
7801546|NCT00481988|27109720|P2|Overall Study|Withdrawal by Subject|1
7801547|NCT00481988|27109721|P1|Overall Study|Withdrawal by Subject|1
7801548|NCT00481871|27109734|P5|Overall Study|Progressive Disease - pt withdrew|0
7801549|NCT00481871|27109735|P4|Overall Study|Progressive Disease - pt withdrew|0
7801550|NCT00481871|27109736|P3|Overall Study|Progressive Disease - pt withdrew|1
7801551|NCT00481871|27109737|P2|Overall Study|Progressive Disease - pt withdrew|0
7801552|NCT00481871|27109738|P1|Overall Study|Progressive Disease - pt withdrew|0
7801553|NCT00481832|27109763|P1|Inter-transplant Period|Lack of allogeneic donor|5
7801554|NCT00481832|27109763|P1|Inter-transplant Period|Disease relapse|11
7801555|NCT00481832|27109763|P1|Inter-transplant Period|Physician Decision|4
7801556|NCT00481832|27109763|P1|Inter-transplant Period|Death|3
7801557|NCT00481832|27109763|P1|Inter-transplant Period|Adverse Event|4
7801558|NCT00481832|27109763|P1|Enrollment|Unable to collect enough stem cells|2
7801559|NCT00481832|27109763|P1|Enrollment|Physician Decision|8
7801560|NCT00481767|27109778|P2|Overall Study|Lost to Follow-up|10
7801561|NCT00481767|27109779|P1|Overall Study|Lost to Follow-up|16
7801562|NCT00481767|27109778|P2|Overall Study|Withdrawal by Subject|11
7801563|NCT00481767|27109779|P1|Overall Study|Withdrawal by Subject|16
7801564|NCT00481676|27109813|P2|Overall Study|Administrative problem|0
7801565|NCT00481676|27109814|P1|Overall Study|Administrative problem|1
7801566|NCT00481676|27109813|P2|Overall Study|Unsatisfactory therapeutic effect|4
7801567|NCT00481676|27109814|P1|Overall Study|Unsatisfactory therapeutic effect|1
7801568|NCT00481676|27109813|P2|Overall Study|Adverse Event|1
7801569|NCT00481676|27109814|P1|Overall Study|Adverse Event|0
7801570|NCT00481247|27109866|P2|Overall Study|Did not receive treatment|2
7801571|NCT00481247|27109867|P1|Overall Study|Did not receive treatment|1
7801572|NCT00481247|27109866|P2|Overall Study|Varied|15
7801573|NCT00481247|27109867|P1|Overall Study|Varied|6
7801574|NCT00481247|27109866|P2|Overall Study|Administrative reason by sponsor|162
7801575|NCT00481247|27109867|P1|Overall Study|Administrative reason by sponsor|157
7801576|NCT00481247|27109866|P2|Overall Study|Poor compliance/noncompliance|7
7801577|NCT00481247|27109867|P1|Overall Study|Poor compliance/noncompliance|1
7801578|NCT00481247|27109866|P2|Overall Study|Lost to Follow-up|2
7801579|NCT00481247|27109867|P1|Overall Study|Lost to Follow-up|1
7801580|NCT00481247|27109866|P2|Overall Study|Pregnancy|1
7801581|NCT00481247|27109867|P1|Overall Study|Pregnancy|2
7801582|NCT00481247|27109866|P2|Overall Study|Withdrawal by Subject|13
7801583|NCT00481247|27109867|P1|Overall Study|Withdrawal by Subject|8
7801584|NCT00481247|27109866|P2|Overall Study|AE unrelated to study drug|4
7801585|NCT00481247|27109867|P1|Overall Study|AE unrelated to study drug|13
7801586|NCT00481247|27109866|P2|Overall Study|Treatment failure|14
7801587|NCT00481247|27109867|P1|Overall Study|Treatment failure|10
7801588|NCT00481247|27109866|P2|Overall Study|Intolerance|17
7801589|NCT00481247|27109867|P1|Overall Study|Intolerance|42
7801590|NCT00481247|27109866|P2|Overall Study|Disease progression|22
7801591|NCT00481247|27109867|P1|Overall Study|Disease progression|18
7801592|NCT00481247|27109866|P2|Overall Study|Death|1
7801593|NCT00481247|27109867|P1|Overall Study|Death|0
7801594|NCT00481195|27109891|P2|Overall Study|Miscellaneous|2
7801595|NCT00481195|27109892|P1|Overall Study|Miscellaneous|2
7801596|NCT00481195|27109891|P2|Overall Study|Withdrawal by Subject|9
7801597|NCT00481195|27109892|P1|Overall Study|Withdrawal by Subject|3
7801598|NCT00481195|27109891|P2|Overall Study|Protocol Violation|7
7801599|NCT00481195|27109892|P1|Overall Study|Protocol Violation|10
7801600|NCT00481195|27109891|P2|Overall Study|Physician Decision|1
7801601|NCT00481195|27109892|P1|Overall Study|Physician Decision|3
7801602|NCT00481195|27109891|P2|Overall Study|Lost to Follow-up|6
7801603|NCT00481195|27109892|P1|Overall Study|Lost to Follow-up|4
7801604|NCT00481195|27109891|P2|Overall Study|Lack of Efficacy|3
7801605|NCT00481195|27109892|P1|Overall Study|Lack of Efficacy|1
7801606|NCT00481195|27109891|P2|Overall Study|Adverse Event|11
7801607|NCT00481195|27109892|P1|Overall Study|Adverse Event|16
7801608|NCT00481078|27109978|P2|Overall Study|Brain metastasis|1
7801609|NCT00481078|27109979|P1|Overall Study|Brain metastasis|0
7801610|NCT00481078|27109978|P2|Overall Study|Received other treatment|1
7801611|NCT00481078|27109979|P1|Overall Study|Received other treatment|2
7801612|NCT00481078|27109978|P2|Overall Study|Information not available|0
7801613|NCT00481078|27109979|P1|Overall Study|Information not available|1
7801614|NCT00481078|27109978|P2|Overall Study|Withdrawal by Subject|1
7801615|NCT00481078|27109979|P1|Overall Study|Withdrawal by Subject|7
7801616|NCT00481078|27109978|P2|Overall Study|Intercurrent illness|0
7801617|NCT00481078|27109979|P1|Overall Study|Intercurrent illness|1
7801618|NCT00481078|27109978|P2|Overall Study|Death|3
7801619|NCT00481078|27109979|P1|Overall Study|Death|5
7801620|NCT00481078|27109978|P2|Overall Study|Adverse Event|3
7801621|NCT00481078|27109979|P1|Overall Study|Adverse Event|15
7801622|NCT00481078|27109978|P2|Overall Study|Progression of disease|11
7801623|NCT00481078|27109979|P1|Overall Study|Progression of disease|11
7801624|NCT00481065|27109997|P8|Overall Study|Unable to classify|0
7801625|NCT00481065|27109998|P7|Overall Study|Unable to classify|0
7801626|NCT00481065|27109999|P6|Overall Study|Unable to classify|0
7801627|NCT00481065|27110000|P5|Overall Study|Unable to classify|1
7801628|NCT00481065|27110001|P4|Overall Study|Unable to classify|0
7801629|NCT00481065|27110002|P3|Overall Study|Unable to classify|2
7801630|NCT00481065|27110003|P2|Overall Study|Unable to classify|1
7801631|NCT00481065|27110004|P1|Overall Study|Unable to classify|0
7801632|NCT00481065|27109997|P8|Overall Study|Protocol Violation|2
7801633|NCT00481065|27109998|P7|Overall Study|Protocol Violation|3
7801634|NCT00481065|27109999|P6|Overall Study|Protocol Violation|6
7801635|NCT00481065|27110000|P5|Overall Study|Protocol Violation|2
7801636|NCT00481065|27110001|P4|Overall Study|Protocol Violation|1
7801637|NCT00481065|27110002|P3|Overall Study|Protocol Violation|1
7801638|NCT00481065|27110003|P2|Overall Study|Protocol Violation|1
7801639|NCT00481065|27110004|P1|Overall Study|Protocol Violation|2
7801640|NCT00481065|27109997|P8|Overall Study|Administrative reason|0
7801641|NCT00481065|27109998|P7|Overall Study|Administrative reason|1
7801642|NCT00481065|27109999|P6|Overall Study|Administrative reason|2
7801643|NCT00481065|27110000|P5|Overall Study|Administrative reason|0
7801644|NCT00481065|27110001|P4|Overall Study|Administrative reason|0
7801645|NCT00481065|27110002|P3|Overall Study|Administrative reason|0
7801646|NCT00481065|27110003|P2|Overall Study|Administrative reason|0
7801647|NCT00481065|27110004|P1|Overall Study|Administrative reason|0
7801648|NCT00481065|27109997|P8|Overall Study|Inappropriate enrollment|1
7801649|NCT00481065|27109998|P7|Overall Study|Inappropriate enrollment|0
7801650|NCT00481065|27109999|P6|Overall Study|Inappropriate enrollment|1
7801651|NCT00481065|27110000|P5|Overall Study|Inappropriate enrollment|2
7801652|NCT00481065|27110001|P4|Overall Study|Inappropriate enrollment|0
7801653|NCT00481065|27110002|P3|Overall Study|Inappropriate enrollment|2
7801654|NCT00481065|27110003|P2|Overall Study|Inappropriate enrollment|0
7801655|NCT00481065|27110004|P1|Overall Study|Inappropriate enrollment|4
7801656|NCT00481065|27109997|P8|Overall Study|Lost to Follow-up|5
7801657|NCT00481065|27109998|P7|Overall Study|Lost to Follow-up|2
7801658|NCT00481065|27109999|P6|Overall Study|Lost to Follow-up|3
7801659|NCT00481065|27110000|P5|Overall Study|Lost to Follow-up|3
7801660|NCT00481065|27110001|P4|Overall Study|Lost to Follow-up|3
7801661|NCT00481065|27110002|P3|Overall Study|Lost to Follow-up|4
7801662|NCT00481065|27110003|P2|Overall Study|Lost to Follow-up|2
7801663|NCT00481065|27110004|P1|Overall Study|Lost to Follow-up|4
7801664|NCT00481065|27109997|P8|Overall Study|Withdrawal by Subject|10
7801665|NCT00481065|27109998|P7|Overall Study|Withdrawal by Subject|9
7801666|NCT00481065|27109999|P6|Overall Study|Withdrawal by Subject|12
7801667|NCT00481065|27110000|P5|Overall Study|Withdrawal by Subject|13
7801668|NCT00481065|27110001|P4|Overall Study|Withdrawal by Subject|11
7801669|NCT00481065|27110002|P3|Overall Study|Withdrawal by Subject|7
7801670|NCT00481065|27110003|P2|Overall Study|Withdrawal by Subject|12
7801671|NCT00481065|27110004|P1|Overall Study|Withdrawal by Subject|11
7801672|NCT00481065|27109997|P8|Overall Study|Adverse event or death|1
7801673|NCT00481065|27109998|P7|Overall Study|Adverse event or death|1
7801674|NCT00481065|27109999|P6|Overall Study|Adverse event or death|0
7801675|NCT00481065|27110000|P5|Overall Study|Adverse event or death|2
7801676|NCT00481065|27110001|P4|Overall Study|Adverse event or death|0
7801677|NCT00481065|27110002|P3|Overall Study|Adverse event or death|3
7801678|NCT00481065|27110003|P2|Overall Study|Adverse event or death|1
7801679|NCT00481065|27110004|P1|Overall Study|Adverse event or death|1
7801680|NCT00480857|27110094|P1|Overall Study|Lack of Efficacy|2
7801681|NCT00480779|27110104|P2|Overall Study|Job and Health-related|3
7801682|NCT00480779|27110105|P1|Overall Study|Job and Health-related|0
7801683|NCT00480779|27110104|P2|Overall Study|Other|0
7801684|NCT00480779|27110105|P1|Overall Study|Other|2
7801685|NCT00480636|27110142|P1|Overall Study|Lost to follow-up; subsequently died|1
7801686|NCT00480636|27110142|P1|Overall Study|Other|2
7801687|NCT00480636|27110142|P1|Overall Study|Lost to Follow-up|4
7801688|NCT00480636|27110142|P1|Overall Study|Death|12
7801689|NCT00480532|27110154|P4|Overall Study|Protocol Violation|0
7801690|NCT00480532|27110155|P3|Overall Study|Protocol Violation|1
7801691|NCT00480532|27110156|P2|Overall Study|Protocol Violation|0
7801692|NCT00480532|27110157|P1|Overall Study|Protocol Violation|0
7801693|NCT00480532|27110154|P4|Overall Study|Withdrawal by Subject|1
7801694|NCT00480532|27110155|P3|Overall Study|Withdrawal by Subject|3
7801695|NCT00480532|27110156|P2|Overall Study|Withdrawal by Subject|4
7801696|NCT00480532|27110157|P1|Overall Study|Withdrawal by Subject|2
7801697|NCT00480493|27110177|P2|Overall Study|moved|7
7801698|NCT00480493|27110178|P1|Overall Study|moved|2
7801699|NCT00480441|27110190|P3|Randomization|Lost to Follow-up|2
7801700|NCT00480441|27110191|P2|Randomization|Lost to Follow-up|7
7801701|NCT00480441|27110192|P1|Randomization|Lost to Follow-up|0
7801702|NCT00480441|27110190|P3|Baseline Functional MRI|physical contraindication|0
7801703|NCT00480441|27110191|P2|Baseline Functional MRI|physical contraindication|0
7801704|NCT00480441|27110192|P1|Baseline Functional MRI|physical contraindication|4
7801705|NCT00480441|27110190|P3|Baseline Functional MRI|Lost to Follow-up|0
7801706|NCT00480441|27110191|P2|Baseline Functional MRI|Lost to Follow-up|0
7801707|NCT00480441|27110192|P1|Baseline Functional MRI|Lost to Follow-up|4
7801708|NCT00480441|27110190|P3|Baseline Functional MRI|Functional MRI data not usable|0
7801709|NCT00480441|27110191|P2|Baseline Functional MRI|Functional MRI data not usable|0
7801710|NCT00480441|27110192|P1|Baseline Functional MRI|Functional MRI data not usable|4
7801711|NCT00480441|27110190|P3|Screening|Not Eligible|0
7801712|NCT00480441|27110191|P2|Screening|Not Eligible|0
7801713|NCT00480441|27110192|P1|Screening|Not Eligible|37
7801714|NCT00480324|27110201|P2|Overall Study|Subject's mother pregnant|1
7801715|NCT00480324|27110202|P1|Overall Study|Subject's mother pregnant|0
7801716|NCT00480324|27110201|P2|Overall Study|Lost to Follow-up|8
7801717|NCT00480324|27110202|P1|Overall Study|Lost to Follow-up|17
7801718|NCT00480324|27110201|P2|Overall Study|Withdrawal by Subject|5
7801719|NCT00480324|27110202|P1|Overall Study|Withdrawal by Subject|14
7801720|NCT00480324|27110201|P2|Overall Study|Protocol Violation|1
7801721|NCT00480324|27110202|P1|Overall Study|Protocol Violation|0
7801722|NCT00480324|27110201|P2|Overall Study|Adverse Event|1
7801723|NCT00480324|27110202|P1|Overall Study|Adverse Event|1
7801724|NCT00480077|27110230|P2|Overall Study|early exit|11
7801725|NCT00480077|27110231|P1|Overall Study|early exit|12
7801726|NCT00480077|27110230|P2|Overall Study|Death|15
7801727|NCT00480077|27110231|P1|Overall Study|Death|19
7801728|NCT00480025|27110239|P2|Overall Study|SAE including intercurrent illness|42
7801729|NCT00480025|27110240|P1|Overall Study|SAE including intercurrent illness|76
7801730|NCT00480025|27110239|P2|Overall Study|Other|29
7801731|NCT00480025|27110240|P1|Overall Study|Other|70
7801732|NCT00480025|27110239|P2|Overall Study|Adverse Event|12
7801733|NCT00480025|27110240|P1|Overall Study|Adverse Event|44
7801734|NCT00480025|27110239|P2|Overall Study|Disease Progression / Recurrence|224
7801735|NCT00480025|27110240|P1|Overall Study|Disease Progression / Recurrence|449
7801736|NCT00480025|27110239|P2|Overall Study|Patients remaining ongoing at Data Lock|55
7801737|NCT00480025|27110240|P1|Overall Study|Patients remaining ongoing at Data Lock|101
7801738|NCT00480025|27110239|P2|Overall Study|Protocol Violation|7
7801739|NCT00480025|27110240|P1|Overall Study|Protocol Violation|12
7801740|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7801741|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
7801742|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7801743|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7801744|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7801745|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
7801746|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7801747|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7801748|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
7801749|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
7801750|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
7801751|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
7801752|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Other|2
7801753|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Other|2
7801754|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Other|0
7801755|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Other|5
7801756|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7801757|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7801758|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
7801759|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7801760|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
7801761|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
7801762|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
7801763|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
7801764|NCT00479882|27110312|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
7801765|NCT00479882|27110313|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
7801766|NCT00479882|27110314|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
7801767|NCT00479882|27110315|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
7801768|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
7801769|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
7801770|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
7801771|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
7801772|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
7801773|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
7801774|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
7801775|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
7801776|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
7801777|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
7801778|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
7801779|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
7801780|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
7801781|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
7801782|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
7801783|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
7801784|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
7801785|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
7801786|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
7801787|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
7801788|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7801789|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7801790|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7801791|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
7801792|NCT00479882|27110312|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
7801793|NCT00479882|27110313|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
7801794|NCT00479882|27110314|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
7801795|NCT00479882|27110315|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
7801796|NCT00479856|27110445|P1|Overall Study|Physician Decision|1
7801797|NCT00479856|27110445|P1|Overall Study|Withdrawal by Subject|1
7801798|NCT00479856|27110445|P1|Overall Study|Adverse Event|1
7801799|NCT00479765|27110454|P1|Overall Study|study terminated|4
7801800|NCT00479713|27110460|P2|Overall Study|Withdrawal by Subject|1
7801801|NCT00479713|27110461|P1|Overall Study|Withdrawal by Subject|4
7801802|NCT00479713|27110460|P2|Overall Study|Protocol Violation|1
7801803|NCT00479713|27110461|P1|Overall Study|Protocol Violation|0
7801804|NCT00479713|27110460|P2|Overall Study|Lost to Follow-up|1
7801805|NCT00479713|27110461|P1|Overall Study|Lost to Follow-up|0
7801806|NCT00479713|27110460|P2|Overall Study|Death|0
7801807|NCT00479713|27110461|P1|Overall Study|Death|1
7801808|NCT00479713|27110460|P2|Overall Study|Adverse Event|6
7801809|NCT00479713|27110461|P1|Overall Study|Adverse Event|8
7801810|NCT00479687|27110487|P3|Ph 2: Open Label, Single (Supartz) Arm|Death|1
7801811|NCT00479687|27110488|P2|Ph 2: Open Label, Single (Supartz) Arm|Death|0
7801812|NCT00479687|27110489|P1|Ph 2: Open Label, Single (Supartz) Arm|Death|0
7801813|NCT00479687|27110487|P3|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
7801814|NCT00479687|27110488|P2|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
7801815|NCT00479687|27110489|P1|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
7801816|NCT00479687|27110487|P3|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
7801817|NCT00479687|27110488|P2|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
7801818|NCT00479687|27110489|P1|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
7801819|NCT00479687|27110487|P3|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
7801820|NCT00479687|27110488|P2|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
7801821|NCT00479687|27110489|P1|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
7801822|NCT00479687|27110487|P3|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
7801823|NCT00479687|27110488|P2|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
7801824|NCT00479687|27110489|P1|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
7801825|NCT00479687|27110487|P3|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
7801826|NCT00479687|27110488|P2|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
7801827|NCT00479687|27110489|P1|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
7801828|NCT00479687|27110487|P3|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
7801829|NCT00479687|27110488|P2|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
7801830|NCT00479687|27110489|P1|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
7801831|NCT00479687|27110487|P3|Ph 1: Blinded, Randomized, Controlled|Death|0
7801832|NCT00479687|27110488|P2|Ph 1: Blinded, Randomized, Controlled|Death|1
7801833|NCT00479687|27110489|P1|Ph 1: Blinded, Randomized, Controlled|Death|0
7801834|NCT00479687|27110487|P3|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
7801835|NCT00479687|27110488|P2|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
7801836|NCT00479687|27110489|P1|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
7801837|NCT00479674|27110496|P1|Overall Study|none provided|3
7801838|NCT00479674|27110496|P1|Overall Study|Physician Decision|14
7801839|NCT00479674|27110496|P1|Overall Study|Withdrawal by Subject|6
7801840|NCT00479674|27110496|P1|Overall Study|Adverse Event|18
7801841|NCT00479557|27110511|P7|Overall Study|Other|0
7801842|NCT00479557|27110512|P6|Overall Study|Other|3
7801843|NCT00479557|27110513|P5|Overall Study|Other|0
7801844|NCT00479557|27110514|P4|Overall Study|Other|0
7801845|NCT00479557|27110515|P3|Overall Study|Other|1
7801846|NCT00479557|27110516|P2|Overall Study|Other|3
7801847|NCT00479557|27110517|P1|Overall Study|Other|2
7801848|NCT00479557|27110511|P7|Overall Study|Subject Request|1
7801849|NCT00479557|27110512|P6|Overall Study|Subject Request|4
7801850|NCT00479557|27110513|P5|Overall Study|Subject Request|1
7801851|NCT00479557|27110514|P4|Overall Study|Subject Request|1
7801852|NCT00479557|27110515|P3|Overall Study|Subject Request|1
7801853|NCT00479557|27110516|P2|Overall Study|Subject Request|0
7801854|NCT00479557|27110517|P1|Overall Study|Subject Request|3
7801855|NCT00479557|27110511|P7|Overall Study|Investigator Request|0
7801856|NCT00479557|27110512|P6|Overall Study|Investigator Request|0
7801857|NCT00479557|27110513|P5|Overall Study|Investigator Request|0
7801858|NCT00479557|27110514|P4|Overall Study|Investigator Request|0
7801859|NCT00479557|27110515|P3|Overall Study|Investigator Request|1
7801860|NCT00479557|27110516|P2|Overall Study|Investigator Request|0
7801861|NCT00479557|27110517|P1|Overall Study|Investigator Request|0
7801862|NCT00479557|27110511|P7|Overall Study|Caregiver Request|0
7801863|NCT00479557|27110512|P6|Overall Study|Caregiver Request|2
7801864|NCT00479557|27110513|P5|Overall Study|Caregiver Request|1
7801865|NCT00479557|27110514|P4|Overall Study|Caregiver Request|0
7801866|NCT00479557|27110515|P3|Overall Study|Caregiver Request|2
7801867|NCT00479557|27110516|P2|Overall Study|Caregiver Request|2
7801868|NCT00479557|27110517|P1|Overall Study|Caregiver Request|2
7801869|NCT00479557|27110511|P7|Overall Study|AE not related to Study Drug|1
7801870|NCT00479557|27110512|P6|Overall Study|AE not related to Study Drug|2
7801871|NCT00479557|27110513|P5|Overall Study|AE not related to Study Drug|2
7801872|NCT00479557|27110514|P4|Overall Study|AE not related to Study Drug|0
7801873|NCT00479557|27110515|P3|Overall Study|AE not related to Study Drug|0
7801874|NCT00479557|27110516|P2|Overall Study|AE not related to Study Drug|3
7801875|NCT00479557|27110517|P1|Overall Study|AE not related to Study Drug|1
7801876|NCT00479557|27110511|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
7801877|NCT00479557|27110512|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
7801878|NCT00479557|27110513|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
7801879|NCT00479557|27110514|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
7801880|NCT00479557|27110515|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
7801881|NCT00479557|27110516|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
7801882|NCT00479557|27110517|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
7801883|NCT00479557|27110511|P7|Overall Study|Lost to Follow-up|0
7801884|NCT00479557|27110512|P6|Overall Study|Lost to Follow-up|0
7801885|NCT00479557|27110513|P5|Overall Study|Lost to Follow-up|0
7801886|NCT00479557|27110514|P4|Overall Study|Lost to Follow-up|2
7801887|NCT00479557|27110515|P3|Overall Study|Lost to Follow-up|0
7801888|NCT00479557|27110516|P2|Overall Study|Lost to Follow-up|2
7801889|NCT00479557|27110517|P1|Overall Study|Lost to Follow-up|0
7801890|NCT00479557|27110511|P7|Overall Study|Lack of Efficacy|0
7801891|NCT00479557|27110512|P6|Overall Study|Lack of Efficacy|0
7801892|NCT00479557|27110513|P5|Overall Study|Lack of Efficacy|0
7801893|NCT00479557|27110514|P4|Overall Study|Lack of Efficacy|0
7801894|NCT00479557|27110515|P3|Overall Study|Lack of Efficacy|0
7801895|NCT00479557|27110516|P2|Overall Study|Lack of Efficacy|0
7801896|NCT00479557|27110517|P1|Overall Study|Lack of Efficacy|1
7801897|NCT00479557|27110511|P7|Overall Study|Death|0
7801898|NCT00479557|27110512|P6|Overall Study|Death|1
7801899|NCT00479557|27110513|P5|Overall Study|Death|0
7801900|NCT00479557|27110514|P4|Overall Study|Death|0
7801901|NCT00479557|27110515|P3|Overall Study|Death|0
7801902|NCT00479557|27110516|P2|Overall Study|Death|0
7801903|NCT00479557|27110517|P1|Overall Study|Death|0
7801904|NCT00479466|27110560|P6|Overall Study|Withdrawal by Subject|1
7801905|NCT00479466|27110561|P5|Overall Study|Withdrawal by Subject|3
7801906|NCT00479466|27110562|P4|Overall Study|Withdrawal by Subject|2
7801907|NCT00479466|27110563|P3|Overall Study|Withdrawal by Subject|0
7801908|NCT00479466|27110564|P2|Overall Study|Withdrawal by Subject|5
7801909|NCT00479466|27110565|P1|Overall Study|Withdrawal by Subject|3
7801910|NCT00479466|27110560|P6|Overall Study|Protocol Violation|0
7801911|NCT00479466|27110561|P5|Overall Study|Protocol Violation|0
7801912|NCT00479466|27110562|P4|Overall Study|Protocol Violation|0
7801913|NCT00479466|27110563|P3|Overall Study|Protocol Violation|0
7801914|NCT00479466|27110564|P2|Overall Study|Protocol Violation|0
7801915|NCT00479466|27110565|P1|Overall Study|Protocol Violation|1
7801916|NCT00479466|27110560|P6|Overall Study|Pregnancy|0
7801917|NCT00479466|27110561|P5|Overall Study|Pregnancy|1
7801918|NCT00479466|27110562|P4|Overall Study|Pregnancy|0
7801919|NCT00479466|27110563|P3|Overall Study|Pregnancy|0
7801920|NCT00479466|27110564|P2|Overall Study|Pregnancy|0
7801921|NCT00479466|27110565|P1|Overall Study|Pregnancy|0
7801922|NCT00479466|27110560|P6|Overall Study|Physician Decision|0
7801923|NCT00479466|27110561|P5|Overall Study|Physician Decision|0
7801924|NCT00479466|27110562|P4|Overall Study|Physician Decision|0
7801925|NCT00479466|27110563|P3|Overall Study|Physician Decision|1
7801926|NCT00479466|27110564|P2|Overall Study|Physician Decision|1
7801927|NCT00479466|27110565|P1|Overall Study|Physician Decision|2
7801928|NCT00479466|27110560|P6|Overall Study|Lost to Follow-up|2
7801929|NCT00479466|27110561|P5|Overall Study|Lost to Follow-up|2
7801930|NCT00479466|27110562|P4|Overall Study|Lost to Follow-up|0
7801931|NCT00479466|27110563|P3|Overall Study|Lost to Follow-up|1
7801932|NCT00479466|27110564|P2|Overall Study|Lost to Follow-up|1
7801933|NCT00479466|27110565|P1|Overall Study|Lost to Follow-up|0
7801934|NCT00479466|27110560|P6|Overall Study|Lack of Efficacy|0
7801935|NCT00479466|27110561|P5|Overall Study|Lack of Efficacy|0
7801936|NCT00479466|27110562|P4|Overall Study|Lack of Efficacy|0
7801937|NCT00479466|27110563|P3|Overall Study|Lack of Efficacy|1
7801938|NCT00479466|27110564|P2|Overall Study|Lack of Efficacy|0
7801939|NCT00479466|27110565|P1|Overall Study|Lack of Efficacy|2
7801940|NCT00479466|27110560|P6|Overall Study|Hyperglycemia|1
7801941|NCT00479466|27110561|P5|Overall Study|Hyperglycemia|0
7801942|NCT00479466|27110562|P4|Overall Study|Hyperglycemia|0
7801943|NCT00479466|27110563|P3|Overall Study|Hyperglycemia|0
7801944|NCT00479466|27110564|P2|Overall Study|Hyperglycemia|0
7801945|NCT00479466|27110565|P1|Overall Study|Hyperglycemia|0
7801946|NCT00479466|27110560|P6|Overall Study|Adverse Event|0
7801947|NCT00479466|27110561|P5|Overall Study|Adverse Event|2
7801948|NCT00479466|27110562|P4|Overall Study|Adverse Event|1
7801949|NCT00479466|27110563|P3|Overall Study|Adverse Event|0
7801950|NCT00479466|27110564|P2|Overall Study|Adverse Event|1
7801951|NCT00479466|27110565|P1|Overall Study|Adverse Event|5
7801952|NCT00479401|27110594|P3|Overall Study|Exclusion criteria, relocation|0
7801953|NCT00479401|27110595|P2|Overall Study|Exclusion criteria, relocation|3
7801954|NCT00479401|27110596|P1|Overall Study|Exclusion criteria, relocation|4
7801955|NCT00479401|27110594|P3|Overall Study|Withdrawal by Subject|2
7801956|NCT00479401|27110595|P2|Overall Study|Withdrawal by Subject|10
7801957|NCT00479401|27110596|P1|Overall Study|Withdrawal by Subject|16
7801958|NCT00479401|27110594|P3|Overall Study|Lost to Follow-up|1
7801959|NCT00479401|27110595|P2|Overall Study|Lost to Follow-up|1
7801960|NCT00479401|27110596|P1|Overall Study|Lost to Follow-up|1
7801961|NCT00479401|27110594|P3|Overall Study|Protocol Violation|1
7801962|NCT00479401|27110595|P2|Overall Study|Protocol Violation|1
7801963|NCT00479401|27110596|P1|Overall Study|Protocol Violation|2
7801964|NCT00479401|27110594|P3|Overall Study|Lack of Efficacy|4
7801965|NCT00479401|27110595|P2|Overall Study|Lack of Efficacy|2
7801966|NCT00479401|27110596|P1|Overall Study|Lack of Efficacy|2
7801967|NCT00479401|27110594|P3|Overall Study|Adverse Event|4
7801968|NCT00479401|27110595|P2|Overall Study|Adverse Event|20
7801969|NCT00479401|27110596|P1|Overall Study|Adverse Event|24
7801970|NCT00479388|27110651|P2|Overall Study|Withdrawal by Subject|17
7801971|NCT00479388|27110652|P1|Overall Study|Withdrawal by Subject|32
7801972|NCT00479388|27110651|P2|Overall Study|Protocol Violation|9
7801973|NCT00479388|27110652|P1|Overall Study|Protocol Violation|10
7801974|NCT00479388|27110651|P2|Overall Study|Lost to Follow-up|2
7801975|NCT00479388|27110652|P1|Overall Study|Lost to Follow-up|0
7801976|NCT00479388|27110651|P2|Overall Study|Adverse Event|45
7801977|NCT00479388|27110652|P1|Overall Study|Adverse Event|90
7801978|NCT00479336|27110666|P4|Overall Study|Resolution of all hepatic edema findings|0
7801979|NCT00479336|27110667|P3|Overall Study|Resolution of all hepatic edema findings|0
7801980|NCT00479336|27110668|P2|Overall Study|Resolution of all hepatic edema findings|1
7801981|NCT00479336|27110669|P1|Overall Study|Resolution of all hepatic edema findings|1
7801982|NCT00479336|27110666|P4|Overall Study|Physician Decision|2
7801983|NCT00479336|27110667|P3|Overall Study|Physician Decision|0
7801984|NCT00479336|27110668|P2|Overall Study|Physician Decision|1
7801985|NCT00479336|27110669|P1|Overall Study|Physician Decision|0
7801986|NCT00479336|27110666|P4|Overall Study|Withdrawal by Subject|0
7801987|NCT00479336|27110667|P3|Overall Study|Withdrawal by Subject|0
7801988|NCT00479336|27110668|P2|Overall Study|Withdrawal by Subject|2
7801989|NCT00479336|27110669|P1|Overall Study|Withdrawal by Subject|1
7801990|NCT00479336|27110666|P4|Overall Study|Protocol Violation|0
7801991|NCT00479336|27110667|P3|Overall Study|Protocol Violation|0
7801992|NCT00479336|27110668|P2|Overall Study|Protocol Violation|1
7801993|NCT00479336|27110669|P1|Overall Study|Protocol Violation|0
7801994|NCT00479336|27110666|P4|Overall Study|Lack of Efficacy|0
7801995|NCT00479336|27110667|P3|Overall Study|Lack of Efficacy|0
7801996|NCT00479336|27110668|P2|Overall Study|Lack of Efficacy|0
7801997|NCT00479336|27110669|P1|Overall Study|Lack of Efficacy|1
7801998|NCT00479336|27110666|P4|Overall Study|Adverse Event|3
7801999|NCT00479336|27110667|P3|Overall Study|Adverse Event|1
7802000|NCT00479336|27110668|P2|Overall Study|Adverse Event|1
7802001|NCT00479336|27110669|P1|Overall Study|Adverse Event|1
7802002|NCT00479232|27110692|P6|Overall Study|Withdrew Consent|3
7802003|NCT00479232|27110693|P5|Overall Study|Withdrew Consent|1
7802004|NCT00479232|27110694|P4|Overall Study|Withdrew Consent|0
7802005|NCT00479232|27110695|P3|Overall Study|Withdrew Consent|6
7802006|NCT00479232|27110696|P2|Overall Study|Withdrew Consent|2
7802007|NCT00479232|27110697|P1|Overall Study|Withdrew Consent|0
7802008|NCT00479232|27110692|P6|Overall Study|Progressive Disease|12
7802009|NCT00479232|27110693|P5|Overall Study|Progressive Disease|3
7802010|NCT00479232|27110694|P4|Overall Study|Progressive Disease|3
7802011|NCT00479232|27110695|P3|Overall Study|Progressive Disease|12
7802012|NCT00479232|27110696|P2|Overall Study|Progressive Disease|1
7802013|NCT00479232|27110697|P1|Overall Study|Progressive Disease|3
7802014|NCT00479232|27110692|P6|Overall Study|Physician Decision|1
7802015|NCT00479232|27110693|P5|Overall Study|Physician Decision|0
7802016|NCT00479232|27110694|P4|Overall Study|Physician Decision|0
7802017|NCT00479232|27110695|P3|Overall Study|Physician Decision|2
7802018|NCT00479232|27110696|P2|Overall Study|Physician Decision|0
7802019|NCT00479232|27110697|P1|Overall Study|Physician Decision|0
7802020|NCT00479232|27110692|P6|Overall Study|Lack of Efficacy|4
7802021|NCT00479232|27110693|P5|Overall Study|Lack of Efficacy|0
7802022|NCT00479232|27110694|P4|Overall Study|Lack of Efficacy|0
7802023|NCT00479232|27110695|P3|Overall Study|Lack of Efficacy|2
7802024|NCT00479232|27110696|P2|Overall Study|Lack of Efficacy|0
7802025|NCT00479232|27110697|P1|Overall Study|Lack of Efficacy|0
7802026|NCT00479232|27110692|P6|Overall Study|Deviation from Protocol|0
7802027|NCT00479232|27110693|P5|Overall Study|Deviation from Protocol|0
7802028|NCT00479232|27110694|P4|Overall Study|Deviation from Protocol|0
7802029|NCT00479232|27110695|P3|Overall Study|Deviation from Protocol|1
7802030|NCT00479232|27110696|P2|Overall Study|Deviation from Protocol|0
7802031|NCT00479232|27110697|P1|Overall Study|Deviation from Protocol|0
7802032|NCT00479232|27110692|P6|Overall Study|Adverse Event|10
7802033|NCT00479232|27110693|P5|Overall Study|Adverse Event|0
7802034|NCT00479232|27110694|P4|Overall Study|Adverse Event|0
7802035|NCT00479232|27110695|P3|Overall Study|Adverse Event|5
7802036|NCT00479232|27110696|P2|Overall Study|Adverse Event|0
7802037|NCT00479232|27110697|P1|Overall Study|Adverse Event|0
7802038|NCT00478933|27110759|P1|Overall Study|Inadequate data available|53
7802039|NCT00478933|27110759|P1|Overall Study|Informed consent not verified|3
7802040|NCT00478933|27110759|P1|Overall Study|Protocol Violation|22
7802041|NCT00478881|27110785|P2|Overall Study|Non-Compliance with Study Medication|2
7802042|NCT00478881|27110786|P1|Overall Study|Non-Compliance with Study Medication|0
7802043|NCT00478881|27110785|P2|Overall Study|Withdrawal by Subject|2
7802044|NCT00478881|27110786|P1|Overall Study|Withdrawal by Subject|6
7802045|NCT00478881|27110785|P2|Overall Study|Protocol Violation|2
7802046|NCT00478881|27110786|P1|Overall Study|Protocol Violation|2
7802047|NCT00478881|27110785|P2|Overall Study|Lost to Follow-up|1
7802048|NCT00478881|27110786|P1|Overall Study|Lost to Follow-up|0
7802049|NCT00478881|27110785|P2|Overall Study|Lack of Efficacy|3
7802050|NCT00478881|27110786|P1|Overall Study|Lack of Efficacy|0
7802051|NCT00478881|27110785|P2|Overall Study|Adverse Event|12
7802052|NCT00478881|27110786|P1|Overall Study|Adverse Event|31
7802053|NCT00478777|27110810|P1|Overall Study|Not treated with lenalidomide|6
7802054|NCT00478777|27110810|P1|Overall Study|End of therapy|2
7802055|NCT00478777|27110810|P1|Overall Study|Lymphocytes infusion|1
7802056|NCT00478777|27110810|P1|Overall Study|Lack of compliance|1
7802057|NCT00478777|27110810|P1|Overall Study|Intolerance of therapy|1
7802058|NCT00478777|27110810|P1|Overall Study|Physician Decision|1
7802059|NCT00478777|27110810|P1|Overall Study|Lost to Follow-up|3
7802060|NCT00478777|27110810|P1|Overall Study|Protocol Violation|3
7802061|NCT00478777|27110810|P1|Overall Study|Death|3
7802062|NCT00478777|27110810|P1|Overall Study|Withdrawal by Subject|4
7802063|NCT00478777|27110810|P1|Overall Study|Lack of Efficacy|23
7802064|NCT00478777|27110810|P1|Overall Study|Adverse Event|29
7802065|NCT00478673|27110817|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
7802066|NCT00478673|27110817|P1|12-Months Post-Procedure|Missed Visit|25
7802067|NCT00478673|27110817|P1|12-Months Post-Procedure|Withdrawal by Subject|6
7802068|NCT00478673|27110817|P1|12-Months Post-Procedure|Lost to Follow-up|4
7802069|NCT00478673|27110817|P1|12-Months Post-Procedure|Death|23
7802070|NCT00478673|27110817|P1|30-Days Post-Procedure|Missed Visit|7
7802071|NCT00478673|27110817|P1|30-Days Post-Procedure|Withdrawal by Subject|1
7802072|NCT00478673|27110817|P1|30-Days Post-Procedure|Death|2
7802073|NCT00478647|27110822|P1|Overall Study|Withdrawal by Subject|1
7802074|NCT00478647|27110822|P1|Overall Study|Adverse Event|1
7802075|NCT00478608|27110830|P1|Overall Study|Protocol Violation|3
7802076|NCT00478608|27110830|P1|Overall Study|Withdrawal by Subject|2
7802077|NCT00478608|27110830|P1|Overall Study|Serious Adverse Event|14
7802078|NCT00478608|27110830|P1|Overall Study|Adverse Event|1
7802079|NCT00478426|27110863|P1|Overall Study|Withdrawal by Subject|1
7802080|NCT00478257|27110888|P2|Overall Study|Withdrawal by Subject|3
7802081|NCT00478257|27110889|P1|Overall Study|Withdrawal by Subject|8
7802082|NCT00478244|27110895|P1|Overall Study|Did not receive transplant|1
7802083|NCT00478231|27110908|P1|Overall Study|Randomized, not treated|3
7802084|NCT00478231|27110908|P1|Overall Study|Adverse Event|5
7802085|NCT00478231|27110908|P1|Overall Study|Other|9
7802086|NCT00478231|27110908|P1|Overall Study|Withdrawal by Subject|6
7802087|NCT00478231|27110908|P1|Overall Study|Lost to Follow-up|7
7802088|NCT00478231|27110908|P1|Overall Study|Lack of Efficacy|47
7802089|NCT00478231|27110908|P1|Overall Study|Death|7
7802090|NCT00478205|27110944|P2|Overall Study|Other|12
7802091|NCT00478205|27110945|P1|Overall Study|Other|24
7802092|NCT00478205|27110944|P2|Overall Study|Lack of Efficacy|0
7802093|NCT00478205|27110945|P1|Overall Study|Lack of Efficacy|1
7802094|NCT00478205|27110944|P2|Overall Study|Withdrawal by Subject|22
7802095|NCT00478205|27110945|P1|Overall Study|Withdrawal by Subject|61
7802096|NCT00478205|27110944|P2|Overall Study|Request of Investigator or Sponsor|5
7802097|NCT00478205|27110945|P1|Overall Study|Request of Investigator or Sponsor|4
7802098|NCT00478205|27110944|P2|Overall Study|Protocol Violation|5
7802099|NCT00478205|27110945|P1|Overall Study|Protocol Violation|15
7802100|NCT00478205|27110944|P2|Overall Study|Medication Non-compliance|4
7802101|NCT00478205|27110945|P1|Overall Study|Medication Non-compliance|9
7802102|NCT00478205|27110944|P2|Overall Study|Adverse Event|39
7802103|NCT00478205|27110945|P1|Overall Study|Adverse Event|182
7802104|NCT00478140|27110989|P1|Overall Study|Clinical Disease Progression|1
7802105|NCT00478023|27111021|P5|Overall Study|Lack of pain, Technical difficulties|3
7802106|NCT00478023|27111022|P4|Overall Study|Lack of pain, Technical difficulties|6
7802107|NCT00478023|27111023|P3|Overall Study|Lack of pain, Technical difficulties|5
7802108|NCT00478023|27111024|P2|Overall Study|Lack of pain, Technical difficulties|3
7802109|NCT00478023|27111025|P1|Overall Study|Lack of pain, Technical difficulties|7
7802110|NCT00478023|27111021|P5|Overall Study|Withdrawal by Subject|5
7802111|NCT00478023|27111022|P4|Overall Study|Withdrawal by Subject|4
7802112|NCT00478023|27111023|P3|Overall Study|Withdrawal by Subject|2
7802113|NCT00478023|27111024|P2|Overall Study|Withdrawal by Subject|3
7802114|NCT00478023|27111025|P1|Overall Study|Withdrawal by Subject|2
7802115|NCT00478023|27111021|P5|Overall Study|Lost to Follow-up|0
7802116|NCT00478023|27111022|P4|Overall Study|Lost to Follow-up|1
7802117|NCT00478023|27111023|P3|Overall Study|Lost to Follow-up|1
7802118|NCT00478023|27111024|P2|Overall Study|Lost to Follow-up|1
7802119|NCT00478023|27111025|P1|Overall Study|Lost to Follow-up|3
7802120|NCT00478023|27111021|P5|Overall Study|Lack of Efficacy|41
7802121|NCT00478023|27111022|P4|Overall Study|Lack of Efficacy|5
7802122|NCT00478023|27111023|P3|Overall Study|Lack of Efficacy|4
7802123|NCT00478023|27111024|P2|Overall Study|Lack of Efficacy|10
7802124|NCT00478023|27111025|P1|Overall Study|Lack of Efficacy|11
7802125|NCT00478023|27111021|P5|Overall Study|Death|0
7802126|NCT00478023|27111022|P4|Overall Study|Death|0
7802127|NCT00478023|27111023|P3|Overall Study|Death|0
7802128|NCT00478023|27111024|P2|Overall Study|Death|0
7802129|NCT00478023|27111025|P1|Overall Study|Death|1
7802130|NCT00478023|27111021|P5|Overall Study|Adverse Event|6
7802131|NCT00478023|27111022|P4|Overall Study|Adverse Event|14
7802132|NCT00478023|27111023|P3|Overall Study|Adverse Event|8
7802133|NCT00478023|27111024|P2|Overall Study|Adverse Event|7
7802134|NCT00478023|27111025|P1|Overall Study|Adverse Event|11
7802135|NCT00477971|27111044|P2|Overall Study|Alternative treatment|1
7802136|NCT00477971|27111045|P1|Overall Study|Alternative treatment|3
7802137|NCT00477971|27111044|P2|Overall Study|Death|4
7802138|NCT00477971|27111045|P1|Overall Study|Death|2
7802139|NCT00477971|27111044|P2|Overall Study|Adverse Event|0
7802140|NCT00477971|27111045|P1|Overall Study|Adverse Event|3
7802141|NCT00477971|27111044|P2|Overall Study|Withdrawal by Subject|1
7802142|NCT00477971|27111045|P1|Overall Study|Withdrawal by Subject|3
7802143|NCT00477971|27111044|P2|Overall Study|Disease progression|0
7802144|NCT00477971|27111045|P1|Overall Study|Disease progression|6
7802145|NCT00477750|27111057|P1|Overall Study|Currently Receiving Treatment|11
7802146|NCT00477672|27111073|P3|Overall Study|Discretion of Sponsor|0
7802147|NCT00477672|27111074|P2|Overall Study|Discretion of Sponsor|2
7802148|NCT00477672|27111075|P1|Overall Study|Discretion of Sponsor|1
7802149|NCT00477672|27111073|P3|Overall Study|Consent withdrawn|10
7802150|NCT00477672|27111074|P2|Overall Study|Consent withdrawn|5
7802151|NCT00477672|27111075|P1|Overall Study|Consent withdrawn|2
7802152|NCT00477672|27111073|P3|Overall Study|Protocol noncompliance|0
7802153|NCT00477672|27111074|P2|Overall Study|Protocol noncompliance|2
7802154|NCT00477672|27111075|P1|Overall Study|Protocol noncompliance|0
7802155|NCT00477672|27111073|P3|Overall Study|Physician Decision|0
7802156|NCT00477672|27111074|P2|Overall Study|Physician Decision|0
7802157|NCT00477672|27111075|P1|Overall Study|Physician Decision|1
7802158|NCT00477672|27111073|P3|Overall Study|Disease progression|0
7802159|NCT00477672|27111074|P2|Overall Study|Disease progression|1
7802160|NCT00477672|27111075|P1|Overall Study|Disease progression|0
7802161|NCT00477672|27111073|P3|Overall Study|Death|0
7802162|NCT00477672|27111074|P2|Overall Study|Death|1
7802163|NCT00477672|27111075|P1|Overall Study|Death|0
7802164|NCT00477672|27111073|P3|Overall Study|Adverse Event|6
7802165|NCT00477672|27111074|P2|Overall Study|Adverse Event|5
7802166|NCT00477672|27111075|P1|Overall Study|Adverse Event|3
7802167|NCT00477633|27111086|P1|Overall Study|Various (Moving, Enrollment closed)|75
7802168|NCT00477633|27111086|P1|Overall Study|Protocol Violation|25
7802169|NCT00477633|27111086|P1|Overall Study|Withdrawal by Subject|149
7802170|NCT00477633|27111086|P1|Overall Study|Lost to Follow-up|271
7802171|NCT00477633|27111086|P1|Overall Study|Pregnancy|23
7802172|NCT00477633|27111086|P1|Overall Study|Adverse Event|143
7802173|NCT00477633|27111086|P1|Overall Study|Did not receive treatment|23
7802174|NCT00477607|27111094|P2|Overall Study|Lost to Follow-up|7
7802175|NCT00477607|27111095|P1|Overall Study|Lost to Follow-up|7
7802176|NCT00477594|27111107|P2|Follow-up Period|Other|0
7802177|NCT00477594|27111108|P1|Follow-up Period|Other|1
7802178|NCT00477594|27111107|P2|Follow-up Period|Withdrawal by Subject|1
7802179|NCT00477594|27111108|P1|Follow-up Period|Withdrawal by Subject|2
7802180|NCT00477594|27111107|P2|Year 3|Withdrawal by Subject|0
7802181|NCT00477594|27111108|P1|Year 3|Withdrawal by Subject|1
7802182|NCT00477594|27111107|P2|Year 3|Adverse Event|0
7802183|NCT00477594|27111108|P1|Year 3|Adverse Event|1
7802184|NCT00477594|27111107|P2|Year 1 and Year 2|Other|0
7802185|NCT00477594|27111108|P1|Year 1 and Year 2|Other|1
7802186|NCT00477594|27111107|P2|Year 1 and Year 2|Withdrawal by Subject|1
7802187|NCT00477594|27111108|P1|Year 1 and Year 2|Withdrawal by Subject|2
7802188|NCT00477594|27111107|P2|Year 1 and Year 2|Physician Decision|1
7802189|NCT00477594|27111108|P1|Year 1 and Year 2|Physician Decision|2
7802190|NCT00477594|27111107|P2|Year 1 and Year 2|Adverse Event|2
7802191|NCT00477594|27111108|P1|Year 1 and Year 2|Adverse Event|4
7802192|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
7802193|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
7802194|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
7802195|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
7802196|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
7802197|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
7802198|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
7802199|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
7802200|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
7802201|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7802202|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
7802203|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7802204|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7802205|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
7802206|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
7802207|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
7802208|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
7802209|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
7802210|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802211|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802212|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802213|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802214|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802215|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802216|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802217|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
7802218|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7802219|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7802220|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7802221|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7802222|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7802223|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7802224|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7802225|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7802226|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7802227|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7802228|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7802229|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7802230|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
7802231|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7802232|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
7802233|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7802234|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
7802235|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
7802236|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7802237|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
7802238|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7802239|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7802240|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7802241|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7802242|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7802243|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
7802244|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
7802245|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
7802246|NCT00477490|27111169|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
7802247|NCT00477490|27111170|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
7802248|NCT00477490|27111171|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
7802249|NCT00477490|27111172|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
7802250|NCT00477490|27111173|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
7802251|NCT00477490|27111174|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
7802252|NCT00477490|27111175|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
7802253|NCT00477490|27111176|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
7802254|NCT00477490|27111177|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
7802255|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Not Reported|0
7802256|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Not Reported|0
7802257|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Not Reported|0
7802258|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Not Reported|0
7802259|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Not Reported|1
7802260|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Not Reported|0
7802261|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Not Reported|3
7802262|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Not Reported|2
7802263|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Not Reported|1
7802264|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Other, not specified|0
7802265|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Other, not specified|0
7802266|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Other, not specified|0
7802267|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Other, not specified|0
7802268|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Other, not specified|1
7802269|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Other, not specified|1
7802270|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Other, not specified|0
7802271|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Other, not specified|4
7802272|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Other, not specified|2
7802273|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
7802274|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
7802275|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
7802276|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
7802277|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
7802278|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
7802279|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
7802280|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
7802281|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
7802282|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7802283|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7802284|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7802285|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7802286|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
7802287|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
7802288|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
7802289|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
7802290|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
7802291|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Protocol Violation|0
7802292|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Protocol Violation|0
7802293|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Protocol Violation|0
7802294|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Protocol Violation|0
7802295|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Protocol Violation|1
7802296|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Protocol Violation|0
7802297|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Protocol Violation|0
7802298|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Protocol Violation|0
7802299|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Protocol Violation|2
7802300|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7802301|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7802302|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7802303|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7802304|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
7802305|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
7802306|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7802307|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7802308|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
7802309|NCT00477490|27111169|P9|Part I: 4 Week Efficacy|Adverse Event|0
7802310|NCT00477490|27111170|P8|Part I: 4 Week Efficacy|Adverse Event|0
7802311|NCT00477490|27111171|P7|Part I: 4 Week Efficacy|Adverse Event|0
7802312|NCT00477490|27111172|P6|Part I: 4 Week Efficacy|Adverse Event|0
7802313|NCT00477490|27111173|P5|Part I: 4 Week Efficacy|Adverse Event|6
7802314|NCT00477490|27111174|P4|Part I: 4 Week Efficacy|Adverse Event|5
7802315|NCT00477490|27111175|P3|Part I: 4 Week Efficacy|Adverse Event|0
7802316|NCT00477490|27111176|P2|Part I: 4 Week Efficacy|Adverse Event|4
7802317|NCT00477490|27111177|P1|Part I: 4 Week Efficacy|Adverse Event|1
7802318|NCT00477464|27111261|P1|Overall Study|Completion of protocol-defined follow-up|14
7802319|NCT00477464|27111261|P1|Overall Study|Death|36
7802320|NCT00477464|27111261|P1|Overall Study|Lost to Follow-up|1
7802321|NCT00477386|27111305|P2|Overall Study|Withdrawal by Subject|0
7802322|NCT00477386|27111306|P1|Overall Study|Withdrawal by Subject|1
7802323|NCT00477386|27111305|P2|Overall Study|Physician Decision|0
7802324|NCT00477386|27111306|P1|Overall Study|Physician Decision|1
7802325|NCT00477386|27111305|P2|Overall Study|Other|2
7802326|NCT00477386|27111306|P1|Overall Study|Other|1
7802327|NCT00477386|27111305|P2|Overall Study|Disease progression, refractory|3
7802328|NCT00477386|27111306|P1|Overall Study|Disease progression, refractory|1
7802329|NCT00477386|27111305|P2|Overall Study|Disease progression, relapse|4
7802330|NCT00477386|27111306|P1|Overall Study|Disease progression, relapse|3
7802331|NCT00477386|27111305|P2|Overall Study|Adverse Event|8
7802332|NCT00477386|27111306|P1|Overall Study|Adverse Event|4
7802333|NCT00477334|27111316|P2|Overall Study|Protocol Violation|1
7802334|NCT00477334|27111317|P1|Overall Study|Protocol Violation|7
7802335|NCT00477334|27111316|P2|Overall Study|Administrative Problems|15
7802336|NCT00477334|27111317|P1|Overall Study|Administrative Problems|39
7802337|NCT00477334|27111316|P2|Overall Study|Lost to Follow-up|4
7802338|NCT00477334|27111317|P1|Overall Study|Lost to Follow-up|15
7802339|NCT00477334|27111316|P2|Overall Study|Withdrawal by Subject|1
7802340|NCT00477334|27111317|P1|Overall Study|Withdrawal by Subject|2
7802341|NCT00477334|27111316|P2|Overall Study|Adverse Event|2
7802342|NCT00477334|27111317|P1|Overall Study|Adverse Event|1
7802343|NCT00477334|27111316|P2|Overall Study|Discontinued prior to taking study drug|53
7802344|NCT00477334|27111317|P1|Overall Study|Discontinued prior to taking study drug|106
7802345|NCT00477295|27111343|P2|Overall Study|Other|3
7802346|NCT00477295|27111344|P1|Overall Study|Other|4
7802347|NCT00477295|27111343|P2|Overall Study|Lost to Follow-up|11
7802348|NCT00477295|27111344|P1|Overall Study|Lost to Follow-up|21
7802349|NCT00477295|27111343|P2|Overall Study|Physician Decision|5
7802350|NCT00477295|27111344|P1|Overall Study|Physician Decision|4
7802351|NCT00477295|27111343|P2|Overall Study|Protocol Violation|8
7802352|NCT00477295|27111344|P1|Overall Study|Protocol Violation|3
7802353|NCT00477295|27111343|P2|Overall Study|Lack of Efficacy|23
7802354|NCT00477295|27111344|P1|Overall Study|Lack of Efficacy|23
7802355|NCT00477295|27111343|P2|Overall Study|Withdrawal by Subject|24
7802356|NCT00477295|27111344|P1|Overall Study|Withdrawal by Subject|35
7802357|NCT00477295|27111343|P2|Overall Study|Adverse Event|35
7802358|NCT00477295|27111344|P1|Overall Study|Adverse Event|31
7802359|NCT00477269|27111372|P3|Open Label Extension|Death|4
7802360|NCT00477269|27111373|P2|Open Label Extension|Death|0
7802361|NCT00477269|27111374|P1|Open Label Extension|Death|0
7802362|NCT00477269|27111372|P3|Open Label Extension|Adminiatrative problems|2
7802363|NCT00477269|27111373|P2|Open Label Extension|Adminiatrative problems|0
7802364|NCT00477269|27111374|P1|Open Label Extension|Adminiatrative problems|0
7802365|NCT00477269|27111372|P3|Open Label Extension|unsatisfactory therapeutic effects|2
7802366|NCT00477269|27111373|P2|Open Label Extension|unsatisfactory therapeutic effects|0
7802367|NCT00477269|27111374|P1|Open Label Extension|unsatisfactory therapeutic effects|0
7802368|NCT00477269|27111372|P3|Open Label Extension|Abnormal laboratory values|1
7802369|NCT00477269|27111373|P2|Open Label Extension|Abnormal laboratory values|0
7802370|NCT00477269|27111374|P1|Open Label Extension|Abnormal laboratory values|0
7802371|NCT00477269|27111372|P3|Open Label Extension|Adverse Event|4
7802372|NCT00477269|27111373|P2|Open Label Extension|Adverse Event|0
7802373|NCT00477269|27111374|P1|Open Label Extension|Adverse Event|0
7802374|NCT00477269|27111372|P3|Core Study|Withdrawn Consent|0
7802375|NCT00477269|27111373|P2|Core Study|Withdrawn Consent|1
7802376|NCT00477269|27111374|P1|Core Study|Withdrawn Consent|0
7802377|NCT00477269|27111372|P3|Core Study|Death|0
7802378|NCT00477269|27111373|P2|Core Study|Death|3
7802379|NCT00477269|27111374|P1|Core Study|Death|3
7802380|NCT00477269|27111372|P3|Core Study|Adverse Event|0
7802381|NCT00477269|27111373|P2|Core Study|Adverse Event|4
7802382|NCT00477269|27111374|P1|Core Study|Adverse Event|6
7802383|NCT00477165|27111453|P2|Overall Study|Adverse Event|2
7802384|NCT00477165|27111454|P1|Overall Study|Adverse Event|7
7802385|NCT00477152|27111466|P1|Overall Study|Adverse Event|1
7802386|NCT00477152|27111466|P1|Overall Study|Parent withdrew consent|2
7802387|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Early termination of the study|578
7802388|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Early termination of the study|0
7802389|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Early termination of the study|0
7802390|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Early termination of the study|0
7802391|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
7802392|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7802393|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7802394|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7802395|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
7802396|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
7802397|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
7802398|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
7802399|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
7802400|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
7802401|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
7802402|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
7802403|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Death|7
7802404|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Death|0
7802405|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Death|0
7802406|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Death|0
7802407|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Adverse Event|8
7802408|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Adverse Event|0
7802409|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Adverse Event|0
7802410|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Adverse Event|0
7802411|NCT00476996|27111482|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
7802412|NCT00476996|27111483|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
7802413|NCT00476996|27111484|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
7802414|NCT00476996|27111485|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
7802415|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
7802416|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
7802417|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
7802418|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
7802419|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Death|0
7802420|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Death|1
7802421|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Death|1
7802422|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Death|2
7802423|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
7802424|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
7802425|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
7802426|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
7802427|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
7802428|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
7802429|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
7802430|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
7802431|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7802432|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7802433|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
7802434|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7802435|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
7802436|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
7802437|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
7802438|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
7802439|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
7802440|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
7802441|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
7802442|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
7802443|NCT00476996|27111482|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
7802444|NCT00476996|27111483|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
7802445|NCT00476996|27111484|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
7802446|NCT00476996|27111485|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
7802447|NCT00476957|27111517|P2|Overall Study|Lost to Follow-up|193
7802448|NCT00476957|27111518|P1|Overall Study|Lost to Follow-up|176
7802449|NCT00476593|27111582|P4|Overall Study|Lost to Follow-up|22
7802450|NCT00476593|27111583|P3|Overall Study|Lost to Follow-up|8
7802451|NCT00476593|27111584|P2|Overall Study|Lost to Follow-up|2
7802452|NCT00476593|27111585|P1|Overall Study|Lost to Follow-up|10
7802453|NCT00476476|27111597|P2|Overall Study|Progressive Disease|17
7802454|NCT00476476|27111598|P1|Overall Study|Progressive Disease|0
7802455|NCT00476476|27111597|P2|Overall Study|Adverse Event|7
7802456|NCT00476476|27111598|P1|Overall Study|Adverse Event|2
7802457|NCT00476229|27111616|P1|Overall Study|Progressive shortness of breath|1
7802458|NCT00476151|27111622|P2|Overall Study|Physician Decision|2
7802459|NCT00476151|27111623|P1|Overall Study|Physician Decision|0
7802460|NCT00476151|27111622|P2|Overall Study|Withdrawal by Subject|0
7802461|NCT00476151|27111623|P1|Overall Study|Withdrawal by Subject|2
7802462|NCT00476151|27111622|P2|Overall Study|Protocol Violation|3
7802463|NCT00476151|27111623|P1|Overall Study|Protocol Violation|1
7802464|NCT00476151|27111622|P2|Overall Study|Adverse Event|2
7802465|NCT00476151|27111623|P1|Overall Study|Adverse Event|0
7802466|NCT00476086|27111629|P1|Overall Study|Progressive Disease|4
7802467|NCT00476086|27111629|P1|Overall Study|Alternative therapy|1
7802468|NCT00476047|27111635|P1|Overall Study|Lost to Follow-up|1
7802469|NCT00476008|27111661|P2|Overall Study|Death|0
7802470|NCT00476008|27111662|P1|Overall Study|Death|1
7802471|NCT00476008|27111661|P2|Overall Study|Withdrawal by Subject|1
7802472|NCT00476008|27111662|P1|Overall Study|Withdrawal by Subject|0
7802473|NCT00476008|27111661|P2|Overall Study|Physician Decision: Medication Noncompli|1
7802474|NCT00476008|27111662|P1|Overall Study|Physician Decision: Medication Noncompli|2
7802475|NCT00476008|27111661|P2|Overall Study|Placebo concerns|2
7802476|NCT00476008|27111662|P1|Overall Study|Placebo concerns|2
7802477|NCT00476008|27111661|P2|Overall Study|Adverse Event|4
7802478|NCT00476008|27111662|P1|Overall Study|Adverse Event|4
7802479|NCT00475982|27111688|P2|Overall Study|surgery rescheduled|3
7802480|NCT00475982|27111689|P1|Overall Study|surgery rescheduled|7
7802481|NCT00475865|27111737|P3|Overall Study|Other than above|0
7802482|NCT00475865|27111738|P2|Overall Study|Other than above|1
7802483|NCT00475865|27111739|P1|Overall Study|Other than above|0
7802484|NCT00475865|27111737|P3|Overall Study|Participant did not wish to continue|0
7802485|NCT00475865|27111738|P2|Overall Study|Participant did not wish to continue|0
7802486|NCT00475865|27111739|P1|Overall Study|Participant did not wish to continue|1
7802487|NCT00475865|27111737|P3|Overall Study|Progressive disease|2
7802488|NCT00475865|27111738|P2|Overall Study|Progressive disease|1
7802489|NCT00475865|27111739|P1|Overall Study|Progressive disease|0
7802490|NCT00475865|27111737|P3|Overall Study|Lack of Efficacy|0
7802491|NCT00475865|27111738|P2|Overall Study|Lack of Efficacy|0
7802492|NCT00475865|27111739|P1|Overall Study|Lack of Efficacy|1
7802493|NCT00475865|27111737|P3|Overall Study|Adverse Event|4
7802494|NCT00475865|27111738|P2|Overall Study|Adverse Event|3
7802495|NCT00475865|27111739|P1|Overall Study|Adverse Event|0
7802496|NCT00475852|27111769|P2|Overall Study|Lost to Follow-up|68
7802497|NCT00475852|27111770|P1|Overall Study|Lost to Follow-up|54
7802498|NCT00475852|27111769|P2|Overall Study|Withdrawal by Subject|24
7802499|NCT00475852|27111770|P1|Overall Study|Withdrawal by Subject|19
7802500|NCT00475852|27111769|P2|Overall Study|Death|456
7802501|NCT00475852|27111770|P1|Overall Study|Death|444
7802502|NCT00475735|27111821|P6|Treatment Period 2|Withdrawal by Subject|0
7802503|NCT00475735|27111822|P5|Treatment Period 2|Withdrawal by Subject|1
7802504|NCT00475735|27111823|P4|Treatment Period 2|Withdrawal by Subject|0
7802505|NCT00475735|27111824|P3|Treatment Period 2|Withdrawal by Subject|0
7802506|NCT00475735|27111825|P2|Treatment Period 2|Withdrawal by Subject|0
7802507|NCT00475735|27111826|P1|Treatment Period 2|Withdrawal by Subject|0
7802508|NCT00475735|27111821|P6|Treatment Period 2|Lack of Efficacy|1
7802509|NCT00475735|27111822|P5|Treatment Period 2|Lack of Efficacy|0
7802510|NCT00475735|27111823|P4|Treatment Period 2|Lack of Efficacy|0
7802511|NCT00475735|27111824|P3|Treatment Period 2|Lack of Efficacy|0
7802512|NCT00475735|27111825|P2|Treatment Period 2|Lack of Efficacy|0
7802513|NCT00475735|27111826|P1|Treatment Period 2|Lack of Efficacy|0
7802514|NCT00475735|27111821|P6|Treatment Period 2|Adverse Event|0
7802515|NCT00475735|27111822|P5|Treatment Period 2|Adverse Event|0
7802516|NCT00475735|27111823|P4|Treatment Period 2|Adverse Event|2
7802517|NCT00475735|27111824|P3|Treatment Period 2|Adverse Event|0
7802518|NCT00475735|27111825|P2|Treatment Period 2|Adverse Event|1
7802519|NCT00475735|27111826|P1|Treatment Period 2|Adverse Event|0
7802520|NCT00475735|27111821|P6|Treatment Washout|Protocol Violation|0
7802521|NCT00475735|27111822|P5|Treatment Washout|Protocol Violation|0
7802522|NCT00475735|27111823|P4|Treatment Washout|Protocol Violation|0
7802523|NCT00475735|27111824|P3|Treatment Washout|Protocol Violation|0
7802524|NCT00475735|27111825|P2|Treatment Washout|Protocol Violation|1
7802525|NCT00475735|27111826|P1|Treatment Washout|Protocol Violation|0
7802526|NCT00475735|27111821|P6|Treatment Washout|Lost to Follow-up|0
7802527|NCT00475735|27111822|P5|Treatment Washout|Lost to Follow-up|0
7802528|NCT00475735|27111823|P4|Treatment Washout|Lost to Follow-up|0
7802529|NCT00475735|27111824|P3|Treatment Washout|Lost to Follow-up|0
7802530|NCT00475735|27111825|P2|Treatment Washout|Lost to Follow-up|1
7802531|NCT00475735|27111826|P1|Treatment Washout|Lost to Follow-up|0
7802532|NCT00475735|27111821|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
7802533|NCT00475735|27111822|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
7802534|NCT00475735|27111823|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
7802535|NCT00475735|27111824|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
7802536|NCT00475735|27111825|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
7802537|NCT00475735|27111826|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
7802538|NCT00475735|27111821|P6|Treatment Period 1|DC due to AE but continuing|2
7802539|NCT00475735|27111822|P5|Treatment Period 1|DC due to AE but continuing|2
7802540|NCT00475735|27111823|P4|Treatment Period 1|DC due to AE but continuing|1
7802541|NCT00475735|27111824|P3|Treatment Period 1|DC due to AE but continuing|0
7802542|NCT00475735|27111825|P2|Treatment Period 1|DC due to AE but continuing|0
7802543|NCT00475735|27111826|P1|Treatment Period 1|DC due to AE but continuing|0
7802544|NCT00475735|27111821|P6|Treatment Period 1|Withdrawal by Subject|0
7802545|NCT00475735|27111822|P5|Treatment Period 1|Withdrawal by Subject|0
7802546|NCT00475735|27111823|P4|Treatment Period 1|Withdrawal by Subject|0
7802547|NCT00475735|27111824|P3|Treatment Period 1|Withdrawal by Subject|0
7802548|NCT00475735|27111825|P2|Treatment Period 1|Withdrawal by Subject|1
7802549|NCT00475735|27111826|P1|Treatment Period 1|Withdrawal by Subject|1
7802550|NCT00475735|27111821|P6|Treatment Period 1|Protocol Violation|0
7802551|NCT00475735|27111822|P5|Treatment Period 1|Protocol Violation|0
7802552|NCT00475735|27111823|P4|Treatment Period 1|Protocol Violation|1
7802553|NCT00475735|27111824|P3|Treatment Period 1|Protocol Violation|0
7802554|NCT00475735|27111825|P2|Treatment Period 1|Protocol Violation|0
7802555|NCT00475735|27111826|P1|Treatment Period 1|Protocol Violation|0
7802556|NCT00475735|27111821|P6|Treatment Period 1|Lost to Follow-up|1
7802557|NCT00475735|27111822|P5|Treatment Period 1|Lost to Follow-up|0
7802558|NCT00475735|27111823|P4|Treatment Period 1|Lost to Follow-up|0
7802559|NCT00475735|27111824|P3|Treatment Period 1|Lost to Follow-up|0
7802560|NCT00475735|27111825|P2|Treatment Period 1|Lost to Follow-up|0
7802561|NCT00475735|27111826|P1|Treatment Period 1|Lost to Follow-up|0
7802562|NCT00475735|27111821|P6|Treatment Period 1|Lack of Efficacy|0
7802563|NCT00475735|27111822|P5|Treatment Period 1|Lack of Efficacy|0
7802564|NCT00475735|27111823|P4|Treatment Period 1|Lack of Efficacy|0
7802565|NCT00475735|27111824|P3|Treatment Period 1|Lack of Efficacy|0
7802566|NCT00475735|27111825|P2|Treatment Period 1|Lack of Efficacy|0
7802567|NCT00475735|27111826|P1|Treatment Period 1|Lack of Efficacy|1
7802568|NCT00475735|27111821|P6|Treatment Period 1|Adverse Event|0
7802569|NCT00475735|27111822|P5|Treatment Period 1|Adverse Event|0
7802570|NCT00475735|27111823|P4|Treatment Period 1|Adverse Event|0
7802571|NCT00475735|27111824|P3|Treatment Period 1|Adverse Event|0
7802572|NCT00475735|27111825|P2|Treatment Period 1|Adverse Event|0
7802573|NCT00475735|27111826|P1|Treatment Period 1|Adverse Event|2
7802574|NCT00475722|27111839|P2|Overall Study|Protocol Violation|0
7802575|NCT00475722|27111840|P1|Overall Study|Protocol Violation|3
7802576|NCT00475722|27111839|P2|Overall Study|Withdrawal by Subject|12
7802577|NCT00475722|27111840|P1|Overall Study|Withdrawal by Subject|12
7802578|NCT00475709|27111846|P1|Overall Study|Lost to Follow-up|21
7802579|NCT00475709|27111846|P1|Overall Study|Device Explant|6
7802580|NCT00475709|27111846|P1|Overall Study|Death|41
7802581|NCT00475709|27111846|P1|Overall Study|Did not meet eligibility criteria|8
7802582|NCT00475670|27111854|P2|Overall Study|Other|3
7802583|NCT00475670|27111855|P1|Overall Study|Other|0
7802584|NCT00475670|27111854|P2|Overall Study|Failure to Return|1
7802585|NCT00475670|27111855|P1|Overall Study|Failure to Return|0
7802586|NCT00475670|27111854|P2|Overall Study|Refused treatment|2
7802587|NCT00475670|27111855|P1|Overall Study|Refused treatment|0
7802588|NCT00475670|27111854|P2|Overall Study|Lack of Efficacy|34
7802589|NCT00475670|27111855|P1|Overall Study|Lack of Efficacy|3
7802590|NCT00475670|27111854|P2|Overall Study|Death|1
7802591|NCT00475670|27111855|P1|Overall Study|Death|0
7802592|NCT00475657|27111879|P1|Overall Study|Sponsor's Decision|3
7802593|NCT00475657|27111879|P1|Overall Study|Death|1
7802594|NCT00475644|27111887|P1|Overall Study|Protocol Violation|13
7802595|NCT00475423|27111952|P1|Overall Study|Lost to Follow-up|7
7802596|NCT00475423|27111952|P1|Overall Study|Reason not specified|1
7802597|NCT00475423|27111952|P1|Overall Study|Death|1
7802598|NCT00475423|27111952|P1|Overall Study|Lack of Efficacy|8
7802599|NCT00475423|27111952|P1|Overall Study|Withdrawal by Subject|6
7802600|NCT00475423|27111952|P1|Overall Study|Adverse Event|4
7802601|NCT00475423|27111952|P1|Overall Study|Protocol Violation|5
7802602|NCT00475306|27111998|P4|Overall Study|Protocol Violation|1
7802603|NCT00475306|27111999|P3|Overall Study|Protocol Violation|0
7802604|NCT00475306|27112000|P2|Overall Study|Protocol Violation|1
7802605|NCT00475306|27112001|P1|Overall Study|Protocol Violation|1
7802606|NCT00475228|27112032|P2|Overall Study|Lost to Follow-up|17
7802607|NCT00475228|27112033|P1|Overall Study|Lost to Follow-up|17
7802608|NCT00475176|27112072|P1|Overall Study|Protocol Violation|1
7802609|NCT00475176|27112072|P1|Overall Study|Withdrawal by Subject|1
7802610|NCT00475176|27112072|P1|Overall Study|Adverse Event|2
7802611|NCT00475033|27112112|P2|Toddler Dose|Lost to Follow-up|0
7802612|NCT00475033|27112113|P1|Toddler Dose|Lost to Follow-up|1
7802613|NCT00475033|27112112|P2|Toddler Dose|Failed to return|0
7802614|NCT00475033|27112113|P1|Toddler Dose|Failed to return|1
7802615|NCT00475033|27112112|P2|Toddler Dose|Parent or legal guardian request|0
7802616|NCT00475033|27112113|P1|Toddler Dose|Parent or legal guardian request|2
7802617|NCT00475033|27112112|P2|After the Infant Series|Other|1
7802618|NCT00475033|27112113|P1|After the Infant Series|Other|0
7802619|NCT00475033|27112112|P2|After the Infant Series|Lost to Follow-up|0
7802620|NCT00475033|27112113|P1|After the Infant Series|Lost to Follow-up|1
7802621|NCT00475033|27112112|P2|After the Infant Series|Protocol Violation|0
7802622|NCT00475033|27112113|P1|After the Infant Series|Protocol Violation|1
7802623|NCT00475033|27112112|P2|After the Infant Series|Failed to return|1
7802624|NCT00475033|27112113|P1|After the Infant Series|Failed to return|2
7802625|NCT00475033|27112112|P2|After the Infant Series|Parent or legal guardian request|2
7802626|NCT00475033|27112113|P1|After the Infant Series|Parent or legal guardian request|2
7802627|NCT00475033|27112112|P2|After the Infant Series|Adverse Event|4
7802628|NCT00475033|27112113|P1|After the Infant Series|Adverse Event|0
7802629|NCT00475033|27112112|P2|Infant Series|Adverse Event|2
7802630|NCT00475033|27112113|P1|Infant Series|Adverse Event|0
7802631|NCT00475033|27112112|P2|Infant Series|Lost to Follow-up|0
7802632|NCT00475033|27112113|P1|Infant Series|Lost to Follow-up|2
7802633|NCT00475033|27112112|P2|Infant Series|Protocol Violation|2
7802634|NCT00475033|27112113|P1|Infant Series|Protocol Violation|1
7802635|NCT00475033|27112112|P2|Infant Series|Parent or legal guardian request|5
7802636|NCT00475033|27112113|P1|Infant Series|Parent or legal guardian request|1
7802637|NCT00475033|27112112|P2|Infant Series|Failed to return|4
7802638|NCT00475033|27112113|P1|Infant Series|Failed to return|3
7802639|NCT00475020|27112161|P1|Overall Study|Donor not able to donate the last minute|1
7802640|NCT00475020|27112161|P1|Overall Study|Insurance Denial|1
7802641|NCT00475020|27112161|P1|Overall Study|Physician Decision|3
7802642|NCT00474994|27112166|P1|Overall Study|Patient found to be ineligible|1
7802643|NCT00474994|27112166|P1|Overall Study|Patient evaluable for toxicity only|3
7802644|NCT00474994|27112166|P1|Overall Study|Patient Not treated|1
7802645|NCT00474968|27112172|P2|Overall Study|Sample not collected|1
7802646|NCT00474968|27112173|P1|Overall Study|Sample not collected|1
7802647|NCT00474968|27112172|P2|Overall Study|Protocol Violation|8
7802648|NCT00474968|27112173|P1|Overall Study|Protocol Violation|9
7802649|NCT00474968|27112172|P2|Overall Study|Withdrawal by Subject|7
7802650|NCT00474968|27112173|P1|Overall Study|Withdrawal by Subject|8
7802651|NCT00474955|27112183|P1|Overall Study|Personal reasons|5
7802652|NCT00474955|27112183|P1|Overall Study|Drug unavailability|1
7802653|NCT00474955|27112183|P1|Overall Study|Adverse Event|2
7802654|NCT00474929|27112199|P5|Overall Study|Physician Decision|0
7802655|NCT00474929|27112200|P4|Overall Study|Physician Decision|2
7802656|NCT00474929|27112201|P3|Overall Study|Physician Decision|1
7802657|NCT00474929|27112202|P2|Overall Study|Physician Decision|0
7802658|NCT00474929|27112203|P1|Overall Study|Physician Decision|0
7802659|NCT00474929|27112199|P5|Overall Study|Unrelated medical condition|0
7802660|NCT00474929|27112200|P4|Overall Study|Unrelated medical condition|0
7802661|NCT00474929|27112201|P3|Overall Study|Unrelated medical condition|1
7802662|NCT00474929|27112202|P2|Overall Study|Unrelated medical condition|0
7802663|NCT00474929|27112203|P1|Overall Study|Unrelated medical condition|0
7802664|NCT00474929|27112199|P5|Overall Study|Withdrawal by Subject|0
7802665|NCT00474929|27112200|P4|Overall Study|Withdrawal by Subject|0
7802666|NCT00474929|27112201|P3|Overall Study|Withdrawal by Subject|0
7802667|NCT00474929|27112202|P2|Overall Study|Withdrawal by Subject|1
7802668|NCT00474929|27112203|P1|Overall Study|Withdrawal by Subject|0
7802669|NCT00474903|27112220|P3|Overall Study|Protocol Violation|2
7802670|NCT00474903|27112221|P2|Overall Study|Protocol Violation|5
7802671|NCT00474903|27112222|P1|Overall Study|Protocol Violation|1
7802672|NCT00474812|27112244|P1|Overall Study|No Initiation of treatment|2
7802673|NCT00474812|27112244|P1|Overall Study|Withdrawal by Subject|5
7802674|NCT00474786|27112254|P2|Overall Study|Other|0
7802675|NCT00474786|27112255|P1|Overall Study|Other|5
7802676|NCT00474786|27112254|P2|Overall Study|Withdrawal by Subject|15
7802677|NCT00474786|27112255|P1|Overall Study|Withdrawal by Subject|15
7802678|NCT00474786|27112254|P2|Overall Study|Protocol Violation|0
7802679|NCT00474786|27112255|P1|Overall Study|Protocol Violation|2
7802680|NCT00474786|27112254|P2|Overall Study|Lost to Follow-up|7
7802681|NCT00474786|27112255|P1|Overall Study|Lost to Follow-up|4
7802682|NCT00474786|27112254|P2|Overall Study|Discontinuation of Study by Sponsor|59
7802683|NCT00474786|27112255|P1|Overall Study|Discontinuation of Study by Sponsor|42
7802684|NCT00474786|27112254|P2|Overall Study|Death|170
7802685|NCT00474786|27112255|P1|Overall Study|Death|189
7802686|NCT00474786|27112254|P2|Overall Study|Investigator Request|1
7802687|NCT00474786|27112255|P1|Overall Study|Investigator Request|2
7802688|NCT00474786|27112254|P2|Overall Study|Not Meeting Study Criteria|1
7802689|NCT00474786|27112255|P1|Overall Study|Not Meeting Study Criteria|0
7802690|NCT00474760|27112280|P7|Overall Study|Terminated by sponsor|2
7802691|NCT00474760|27112281|P6|Overall Study|Terminated by sponsor|0
7802692|NCT00474760|27112282|P5|Overall Study|Terminated by sponsor|0
7802693|NCT00474760|27112283|P4|Overall Study|Terminated by sponsor|0
7802694|NCT00474760|27112284|P3|Overall Study|Terminated by sponsor|0
7802695|NCT00474760|27112285|P2|Overall Study|Terminated by sponsor|0
7802696|NCT00474760|27112286|P1|Overall Study|Terminated by sponsor|0
7802697|NCT00474760|27112280|P7|Overall Study|Progressive disease|7
7802698|NCT00474760|27112281|P6|Overall Study|Progressive disease|20
7802699|NCT00474760|27112282|P5|Overall Study|Progressive disease|8
7802700|NCT00474760|27112283|P4|Overall Study|Progressive disease|2
7802701|NCT00474760|27112284|P3|Overall Study|Progressive disease|3
7802702|NCT00474760|27112285|P2|Overall Study|Progressive disease|2
7802703|NCT00474760|27112286|P1|Overall Study|Progressive disease|3
7802704|NCT00474760|27112280|P7|Overall Study|Other|0
7802705|NCT00474760|27112281|P6|Overall Study|Other|0
7802706|NCT00474760|27112282|P5|Overall Study|Other|1
7802707|NCT00474760|27112283|P4|Overall Study|Other|0
7802708|NCT00474760|27112284|P3|Overall Study|Other|0
7802709|NCT00474760|27112285|P2|Overall Study|Other|1
7802710|NCT00474760|27112286|P1|Overall Study|Other|0
7802711|NCT00474760|27112280|P7|Overall Study|Withdrawal by Subject|1
7802712|NCT00474760|27112281|P6|Overall Study|Withdrawal by Subject|1
7802713|NCT00474760|27112282|P5|Overall Study|Withdrawal by Subject|0
7802714|NCT00474760|27112283|P4|Overall Study|Withdrawal by Subject|1
7802715|NCT00474760|27112284|P3|Overall Study|Withdrawal by Subject|0
7802716|NCT00474760|27112285|P2|Overall Study|Withdrawal by Subject|0
7802717|NCT00474760|27112286|P1|Overall Study|Withdrawal by Subject|0
7802718|NCT00474760|27112280|P7|Overall Study|Laboratory abnormality|0
7802719|NCT00474760|27112281|P6|Overall Study|Laboratory abnormality|1
7802720|NCT00474760|27112282|P5|Overall Study|Laboratory abnormality|0
7802721|NCT00474760|27112283|P4|Overall Study|Laboratory abnormality|0
7802722|NCT00474760|27112284|P3|Overall Study|Laboratory abnormality|0
7802723|NCT00474760|27112285|P2|Overall Study|Laboratory abnormality|0
7802724|NCT00474760|27112286|P1|Overall Study|Laboratory abnormality|0
7802725|NCT00474760|27112280|P7|Overall Study|Adverse Event|0
7802726|NCT00474760|27112281|P6|Overall Study|Adverse Event|7
7802727|NCT00474760|27112282|P5|Overall Study|Adverse Event|1
7802728|NCT00474760|27112283|P4|Overall Study|Adverse Event|0
7802729|NCT00474760|27112284|P3|Overall Study|Adverse Event|0
7802730|NCT00474760|27112285|P2|Overall Study|Adverse Event|0
7802731|NCT00474760|27112286|P1|Overall Study|Adverse Event|0
7802732|NCT00474760|27112280|P7|Overall Study|Death|0
7802733|NCT00474760|27112281|P6|Overall Study|Death|0
7802734|NCT00474760|27112282|P5|Overall Study|Death|2
7802735|NCT00474760|27112283|P4|Overall Study|Death|0
7802736|NCT00474760|27112284|P3|Overall Study|Death|0
7802737|NCT00474760|27112285|P2|Overall Study|Death|0
7802738|NCT00474760|27112286|P1|Overall Study|Death|0
7802739|NCT00474708|27112393|P2|Overall Study|Physician Decision|6
7802740|NCT00474708|27112394|P1|Overall Study|Physician Decision|9
7802741|NCT00474708|27112393|P2|Overall Study|Lost to Follow-up|9
7802742|NCT00474708|27112394|P1|Overall Study|Lost to Follow-up|18
7802743|NCT00474708|27112393|P2|Overall Study|Lack of compliance|4
7802744|NCT00474708|27112394|P1|Overall Study|Lack of compliance|12
7802745|NCT00474708|27112393|P2|Overall Study|Withdrawal by Subject|0
7802746|NCT00474708|27112394|P1|Overall Study|Withdrawal by Subject|7
7802747|NCT00474708|27112393|P2|Overall Study|Suicide ideation/behavior|1
7802748|NCT00474708|27112394|P1|Overall Study|Suicide ideation/behavior|0
7802749|NCT00474708|27112393|P2|Overall Study|Lack of Efficacy|5
7802750|NCT00474708|27112394|P1|Overall Study|Lack of Efficacy|11
7802751|NCT00474630|27112404|P2|Overall Study|Drug noncompliance, other|4
7802752|NCT00474630|27112405|P1|Overall Study|Drug noncompliance, other|11
7802753|NCT00474630|27112404|P2|Overall Study|Lack of Efficacy|6
7802754|NCT00474630|27112405|P1|Overall Study|Lack of Efficacy|5
7802755|NCT00474630|27112404|P2|Overall Study|Protocol Violation|4
7802756|NCT00474630|27112405|P1|Overall Study|Protocol Violation|3
7802757|NCT00474630|27112404|P2|Overall Study|Withdrawal by Subject|15
7802758|NCT00474630|27112405|P1|Overall Study|Withdrawal by Subject|21
7802759|NCT00474630|27112404|P2|Overall Study|Lost to Follow-up|15
7802760|NCT00474630|27112405|P1|Overall Study|Lost to Follow-up|22
7802761|NCT00474630|27112404|P2|Overall Study|Adverse Event|26
7802762|NCT00474630|27112405|P1|Overall Study|Adverse Event|98
7802763|NCT00474539|27112498|P2|Toddler Dose|Protocol Violation|0
7802764|NCT00474539|27112499|P1|Toddler Dose|Protocol Violation|1
7802765|NCT00474539|27112498|P2|After Infant Series|Withdrawal by Subject|0
7802766|NCT00474539|27112499|P1|After Infant Series|Withdrawal by Subject|1
7802767|NCT00474539|27112498|P2|After Infant Series|Lost to Follow-up|0
7802768|NCT00474539|27112499|P1|After Infant Series|Lost to Follow-up|3
7802769|NCT00474539|27112498|P2|Infant Series|Protocol Violation|1
7802770|NCT00474539|27112499|P1|Infant Series|Protocol Violation|0
7802771|NCT00474539|27112498|P2|Infant Series|Lost to Follow-up|1
7802772|NCT00474539|27112499|P1|Infant Series|Lost to Follow-up|2
7802773|NCT00474539|27112498|P2|Infant Series|Randomization error|0
7802774|NCT00474539|27112499|P1|Infant Series|Randomization error|5
7802775|NCT00474539|27112498|P2|Infant Series|Withdrawal by Subject|4
7802776|NCT00474539|27112499|P1|Infant Series|Withdrawal by Subject|3
7802777|NCT00474526|27112564|P17|Overall Study|Withdrawal by Subject|1
7802778|NCT00474526|27112565|P16|Overall Study|Withdrawal by Subject|1
7802779|NCT00474526|27112566|P15|Overall Study|Withdrawal by Subject|22
7802780|NCT00474526|27112567|P14|Overall Study|Withdrawal by Subject|37
7802781|NCT00474526|27112568|P13|Overall Study|Withdrawal by Subject|4
7802782|NCT00474526|27112569|P12|Overall Study|Withdrawal by Subject|4
7802783|NCT00474526|27112570|P11|Overall Study|Withdrawal by Subject|5
7802784|NCT00474526|27112571|P10|Overall Study|Withdrawal by Subject|13
7802785|NCT00474526|27112572|P9|Overall Study|Withdrawal by Subject|4
7802786|NCT00474526|27112573|P8|Overall Study|Withdrawal by Subject|4
7802787|NCT00474526|27112574|P7|Overall Study|Withdrawal by Subject|12
7802788|NCT00474526|27112575|P6|Overall Study|Withdrawal by Subject|6
7802789|NCT00474526|27112576|P5|Overall Study|Withdrawal by Subject|38
7802790|NCT00474526|27112577|P4|Overall Study|Withdrawal by Subject|52
7802791|NCT00474526|27112578|P3|Overall Study|Withdrawal by Subject|21
7802792|NCT00474526|27112579|P2|Overall Study|Withdrawal by Subject|24
7802793|NCT00474526|27112580|P1|Overall Study|Withdrawal by Subject|9
7802794|NCT00474526|27112564|P17|Overall Study|UNABLE TO CLASSIFY|1
7802795|NCT00474526|27112565|P16|Overall Study|UNABLE TO CLASSIFY|6
7802796|NCT00474526|27112566|P15|Overall Study|UNABLE TO CLASSIFY|12
7802797|NCT00474526|27112567|P14|Overall Study|UNABLE TO CLASSIFY|20
7802798|NCT00474526|27112568|P13|Overall Study|UNABLE TO CLASSIFY|0
7802799|NCT00474526|27112569|P12|Overall Study|UNABLE TO CLASSIFY|0
7802800|NCT00474526|27112570|P11|Overall Study|UNABLE TO CLASSIFY|0
7802801|NCT00474526|27112571|P10|Overall Study|UNABLE TO CLASSIFY|3
7802802|NCT00474526|27112572|P9|Overall Study|UNABLE TO CLASSIFY|0
7802803|NCT00474526|27112573|P8|Overall Study|UNABLE TO CLASSIFY|1
7802804|NCT00474526|27112574|P7|Overall Study|UNABLE TO CLASSIFY|0
7802805|NCT00474526|27112575|P6|Overall Study|UNABLE TO CLASSIFY|2
7802806|NCT00474526|27112576|P5|Overall Study|UNABLE TO CLASSIFY|3
7802807|NCT00474526|27112577|P4|Overall Study|UNABLE TO CLASSIFY|1
7802808|NCT00474526|27112578|P3|Overall Study|UNABLE TO CLASSIFY|0
7802809|NCT00474526|27112579|P2|Overall Study|UNABLE TO CLASSIFY|0
7802810|NCT00474526|27112580|P1|Overall Study|UNABLE TO CLASSIFY|1
7802811|NCT00474526|27112564|P17|Overall Study|Protocol Violation|2
7802812|NCT00474526|27112565|P16|Overall Study|Protocol Violation|6
7802813|NCT00474526|27112566|P15|Overall Study|Protocol Violation|9
7802814|NCT00474526|27112567|P14|Overall Study|Protocol Violation|19
7802815|NCT00474526|27112568|P13|Overall Study|Protocol Violation|4
7802816|NCT00474526|27112569|P12|Overall Study|Protocol Violation|2
7802817|NCT00474526|27112570|P11|Overall Study|Protocol Violation|2
7802818|NCT00474526|27112571|P10|Overall Study|Protocol Violation|4
7802819|NCT00474526|27112572|P9|Overall Study|Protocol Violation|0
7802820|NCT00474526|27112573|P8|Overall Study|Protocol Violation|0
7802821|NCT00474526|27112574|P7|Overall Study|Protocol Violation|3
7802822|NCT00474526|27112575|P6|Overall Study|Protocol Violation|1
7802823|NCT00474526|27112576|P5|Overall Study|Protocol Violation|3
7802824|NCT00474526|27112577|P4|Overall Study|Protocol Violation|12
7802825|NCT00474526|27112578|P3|Overall Study|Protocol Violation|4
7802826|NCT00474526|27112579|P2|Overall Study|Protocol Violation|6
7802827|NCT00474526|27112580|P1|Overall Study|Protocol Violation|2
7802828|NCT00474526|27112564|P17|Overall Study|Lost to Follow-up|5
7802829|NCT00474526|27112565|P16|Overall Study|Lost to Follow-up|4
7802830|NCT00474526|27112566|P15|Overall Study|Lost to Follow-up|29
7802831|NCT00474526|27112567|P14|Overall Study|Lost to Follow-up|74
7802832|NCT00474526|27112568|P13|Overall Study|Lost to Follow-up|6
7802833|NCT00474526|27112569|P12|Overall Study|Lost to Follow-up|4
7802834|NCT00474526|27112570|P11|Overall Study|Lost to Follow-up|2
7802835|NCT00474526|27112571|P10|Overall Study|Lost to Follow-up|6
7802836|NCT00474526|27112572|P9|Overall Study|Lost to Follow-up|0
7802837|NCT00474526|27112573|P8|Overall Study|Lost to Follow-up|1
7802838|NCT00474526|27112574|P7|Overall Study|Lost to Follow-up|8
7802839|NCT00474526|27112575|P6|Overall Study|Lost to Follow-up|5
7802840|NCT00474526|27112576|P5|Overall Study|Lost to Follow-up|11
7802841|NCT00474526|27112577|P4|Overall Study|Lost to Follow-up|29
7802842|NCT00474526|27112578|P3|Overall Study|Lost to Follow-up|13
7802843|NCT00474526|27112579|P2|Overall Study|Lost to Follow-up|6
7802844|NCT00474526|27112580|P1|Overall Study|Lost to Follow-up|8
7802845|NCT00474526|27112564|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802846|NCT00474526|27112565|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802847|NCT00474526|27112566|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
7802848|NCT00474526|27112567|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
7802849|NCT00474526|27112568|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802850|NCT00474526|27112569|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802851|NCT00474526|27112570|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802852|NCT00474526|27112571|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802853|NCT00474526|27112572|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802854|NCT00474526|27112573|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802855|NCT00474526|27112574|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802856|NCT00474526|27112575|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802857|NCT00474526|27112576|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
7802858|NCT00474526|27112577|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
7802859|NCT00474526|27112578|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802860|NCT00474526|27112579|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
7802861|NCT00474526|27112580|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
7802862|NCT00474526|27112564|P17|Overall Study|Death|0
7802863|NCT00474526|27112565|P16|Overall Study|Death|0
7802864|NCT00474526|27112566|P15|Overall Study|Death|0
7802865|NCT00474526|27112567|P14|Overall Study|Death|3
7802866|NCT00474526|27112568|P13|Overall Study|Death|0
7802867|NCT00474526|27112569|P12|Overall Study|Death|0
7802868|NCT00474526|27112570|P11|Overall Study|Death|0
7802869|NCT00474526|27112571|P10|Overall Study|Death|0
7802870|NCT00474526|27112572|P9|Overall Study|Death|0
7802871|NCT00474526|27112573|P8|Overall Study|Death|0
7802872|NCT00474526|27112574|P7|Overall Study|Death|0
7802873|NCT00474526|27112575|P6|Overall Study|Death|0
7802874|NCT00474526|27112576|P5|Overall Study|Death|0
7802875|NCT00474526|27112577|P4|Overall Study|Death|0
7802876|NCT00474526|27112578|P3|Overall Study|Death|0
7802877|NCT00474526|27112579|P2|Overall Study|Death|0
7802878|NCT00474526|27112580|P1|Overall Study|Death|0
7802879|NCT00474526|27112564|P17|Overall Study|Adverse Event|0
7802880|NCT00474526|27112565|P16|Overall Study|Adverse Event|1
7802881|NCT00474526|27112566|P15|Overall Study|Adverse Event|1
7802882|NCT00474526|27112567|P14|Overall Study|Adverse Event|0
7802883|NCT00474526|27112568|P13|Overall Study|Adverse Event|0
7802884|NCT00474526|27112569|P12|Overall Study|Adverse Event|0
7802885|NCT00474526|27112570|P11|Overall Study|Adverse Event|0
7802886|NCT00474526|27112571|P10|Overall Study|Adverse Event|0
7802887|NCT00474526|27112572|P9|Overall Study|Adverse Event|0
7802888|NCT00474526|27112573|P8|Overall Study|Adverse Event|0
7802889|NCT00474526|27112574|P7|Overall Study|Adverse Event|1
7802890|NCT00474526|27112575|P6|Overall Study|Adverse Event|1
7802891|NCT00474526|27112576|P5|Overall Study|Adverse Event|2
7802892|NCT00474526|27112577|P4|Overall Study|Adverse Event|4
7802893|NCT00474526|27112578|P3|Overall Study|Adverse Event|2
7802894|NCT00474526|27112579|P2|Overall Study|Adverse Event|0
7802895|NCT00474526|27112580|P1|Overall Study|Adverse Event|2
7802896|NCT00474526|27112564|P17|Overall Study|ADMINISTRATIVE REASON|0
7802897|NCT00474526|27112565|P16|Overall Study|ADMINISTRATIVE REASON|0
7802898|NCT00474526|27112566|P15|Overall Study|ADMINISTRATIVE REASON|2
7802899|NCT00474526|27112567|P14|Overall Study|ADMINISTRATIVE REASON|1
7802900|NCT00474526|27112568|P13|Overall Study|ADMINISTRATIVE REASON|1
7802901|NCT00474526|27112569|P12|Overall Study|ADMINISTRATIVE REASON|1
7802902|NCT00474526|27112570|P11|Overall Study|ADMINISTRATIVE REASON|1
7802903|NCT00474526|27112571|P10|Overall Study|ADMINISTRATIVE REASON|1
7802904|NCT00474526|27112572|P9|Overall Study|ADMINISTRATIVE REASON|2
7802905|NCT00474526|27112573|P8|Overall Study|ADMINISTRATIVE REASON|0
7802906|NCT00474526|27112574|P7|Overall Study|ADMINISTRATIVE REASON|1
7802907|NCT00474526|27112575|P6|Overall Study|ADMINISTRATIVE REASON|1
7802908|NCT00474526|27112576|P5|Overall Study|ADMINISTRATIVE REASON|9
7802909|NCT00474526|27112577|P4|Overall Study|ADMINISTRATIVE REASON|20
7802910|NCT00474526|27112578|P3|Overall Study|ADMINISTRATIVE REASON|9
7802911|NCT00474526|27112579|P2|Overall Study|ADMINISTRATIVE REASON|9
7802912|NCT00474526|27112580|P1|Overall Study|ADMINISTRATIVE REASON|11
7802913|NCT00474487|27112745|P4|Overall Study|Death|0
7802914|NCT00474487|27112746|P3|Overall Study|Death|0
7802915|NCT00474487|27112747|P2|Overall Study|Death|1
7802916|NCT00474487|27112748|P1|Overall Study|Death|0
7802917|NCT00474487|27112745|P4|Overall Study|Inappropriate enrollment|0
7802918|NCT00474487|27112746|P3|Overall Study|Inappropriate enrollment|7
7802919|NCT00474487|27112747|P2|Overall Study|Inappropriate enrollment|0
7802920|NCT00474487|27112748|P1|Overall Study|Inappropriate enrollment|4
7802921|NCT00474487|27112745|P4|Overall Study|Lost to Follow-up|0
7802922|NCT00474487|27112746|P3|Overall Study|Lost to Follow-up|7
7802923|NCT00474487|27112747|P2|Overall Study|Lost to Follow-up|1
7802924|NCT00474487|27112748|P1|Overall Study|Lost to Follow-up|20
7802925|NCT00474487|27112745|P4|Overall Study|Withdrawal by Subject|0
7802926|NCT00474487|27112746|P3|Overall Study|Withdrawal by Subject|0
7802927|NCT00474487|27112747|P2|Overall Study|Withdrawal by Subject|0
7802928|NCT00474487|27112748|P1|Overall Study|Withdrawal by Subject|6
7802929|NCT00474383|27112768|P2|Extension|Progressive Disease|5
7802930|NCT00474383|27112769|P1|Extension|Progressive Disease|0
7802931|NCT00474383|27112768|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
7802932|NCT00474383|27112769|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
7802933|NCT00474383|27112768|P2|Main Study|Other|0
7802934|NCT00474383|27112769|P1|Main Study|Other|1
7802935|NCT00474383|27112768|P2|Main Study|Progressive Disease|0
7802936|NCT00474383|27112769|P1|Main Study|Progressive Disease|23
7802937|NCT00474383|27112768|P2|Main Study|Symptomatic Deterioration|0
7802938|NCT00474383|27112769|P1|Main Study|Symptomatic Deterioration|1
7802939|NCT00474383|27112768|P2|Main Study|Adverse Event|0
7802940|NCT00474383|27112769|P1|Main Study|Adverse Event|11
7802941|NCT00474266|27112784|P4|Overall Study|Withdrawal by Subject|7
7802942|NCT00474266|27112785|P3|Overall Study|Withdrawal by Subject|4
7802943|NCT00474266|27112786|P2|Overall Study|Withdrawal by Subject|20
7802944|NCT00474266|27112787|P1|Overall Study|Withdrawal by Subject|7
7802945|NCT00474253|27112891|P2|Overall Study|Discharged prior to study completion|1
7802946|NCT00474253|27112892|P1|Overall Study|Discharged prior to study completion|0
7802947|NCT00474253|27112891|P2|Overall Study|Lost to Follow-up|0
7802948|NCT00474253|27112892|P1|Overall Study|Lost to Follow-up|1
7802949|NCT00474253|27112891|P2|Overall Study|Withdrew due to surgery-related issues|3
7802950|NCT00474253|27112892|P1|Overall Study|Withdrew due to surgery-related issues|0
7802951|NCT00474253|27112891|P2|Overall Study|Withdrew consent|0
7802952|NCT00474253|27112892|P1|Overall Study|Withdrew consent|2
7802953|NCT00474240|27112916|P6|Overall Study|Removed due to lab value|1
7802954|NCT00474240|27112917|P5|Overall Study|Removed due to lab value|0
7802955|NCT00474240|27112918|P4|Overall Study|Removed due to lab value|0
7802956|NCT00474240|27112919|P3|Overall Study|Removed due to lab value|0
7802957|NCT00474240|27112920|P2|Overall Study|Removed due to lab value|0
7802958|NCT00474240|27112921|P1|Overall Study|Removed due to lab value|0
7802959|NCT00474240|27112916|P6|Overall Study|Adverse Event|16
7802960|NCT00474240|27112917|P5|Overall Study|Adverse Event|5
7802961|NCT00474240|27112918|P4|Overall Study|Adverse Event|14
7802962|NCT00474240|27112919|P3|Overall Study|Adverse Event|9
7802963|NCT00474240|27112920|P2|Overall Study|Adverse Event|0
7802964|NCT00474240|27112921|P1|Overall Study|Adverse Event|0
7802965|NCT00474240|27112916|P6|Overall Study|Withdrawal by Subject|1
7802966|NCT00474240|27112917|P5|Overall Study|Withdrawal by Subject|3
7802967|NCT00474240|27112918|P4|Overall Study|Withdrawal by Subject|2
7802968|NCT00474240|27112919|P3|Overall Study|Withdrawal by Subject|0
7802969|NCT00474240|27112920|P2|Overall Study|Withdrawal by Subject|1
7802970|NCT00474240|27112921|P1|Overall Study|Withdrawal by Subject|1
7802971|NCT00474188|27112946|P1|Overall Study|Study discontinued by sponsor|5
7802972|NCT00474188|27112946|P1|Overall Study|Withdrawal by Subject|1
7802973|NCT00474175|27112956|P3|Overall Study|Administrative|0
7802974|NCT00474175|27112957|P2|Overall Study|Administrative|1
7802975|NCT00474175|27112958|P1|Overall Study|Administrative|0
7802976|NCT00474175|27112956|P3|Overall Study|Protocol Violation|1
7802977|NCT00474175|27112957|P2|Overall Study|Protocol Violation|2
7802978|NCT00474175|27112958|P1|Overall Study|Protocol Violation|0
7802979|NCT00474175|27112956|P3|Overall Study|Ineligible|1
7802980|NCT00474175|27112957|P2|Overall Study|Ineligible|3
7802981|NCT00474175|27112958|P1|Overall Study|Ineligible|1
7802982|NCT00474175|27112956|P3|Overall Study|Withdrawal by Subject|1
7802983|NCT00474175|27112957|P2|Overall Study|Withdrawal by Subject|1
7802984|NCT00474175|27112958|P1|Overall Study|Withdrawal by Subject|0
7802985|NCT00474175|27112956|P3|Overall Study|Lack of Efficacy|1
7802986|NCT00474175|27112957|P2|Overall Study|Lack of Efficacy|0
7802987|NCT00474175|27112958|P1|Overall Study|Lack of Efficacy|0
7802988|NCT00474058|27113022|P2|Overall Study|Other|0
7802989|NCT00474058|27113023|P1|Overall Study|Other|2
7802990|NCT00474058|27113022|P2|Overall Study|Withdrawal by Subject|7
7802991|NCT00474058|27113023|P1|Overall Study|Withdrawal by Subject|11
7802992|NCT00474058|27113022|P2|Overall Study|Lack of Efficacy|4
7802993|NCT00474058|27113023|P1|Overall Study|Lack of Efficacy|0
7802994|NCT00474058|27113022|P2|Overall Study|Adverse Event|6
7802995|NCT00474058|27113023|P1|Overall Study|Adverse Event|11
7802996|NCT00474045|27113037|P2|Overall Study|Withdrawal criteria|50
7802997|NCT00474045|27113038|P1|Overall Study|Withdrawal criteria|60
7802998|NCT00474045|27113037|P2|Overall Study|Withdrawal by Subject|18
7802999|NCT00474045|27113038|P1|Overall Study|Withdrawal by Subject|16
7803000|NCT00474045|27113037|P2|Overall Study|Protocol Violation|12
7803001|NCT00474045|27113038|P1|Overall Study|Protocol Violation|10
7803002|NCT00474045|27113037|P2|Overall Study|Lost to Follow-up|1
7803003|NCT00474045|27113038|P1|Overall Study|Lost to Follow-up|1
7803004|NCT00474045|27113037|P2|Overall Study|Lack of Efficacy|9
7803005|NCT00474045|27113038|P1|Overall Study|Lack of Efficacy|0
7803006|NCT00474045|27113037|P2|Overall Study|Unclassified|3
7803007|NCT00474045|27113038|P1|Overall Study|Unclassified|1
7803008|NCT00474045|27113037|P2|Overall Study|Adverse Event|8
7803009|NCT00474045|27113038|P1|Overall Study|Adverse Event|18
7803010|NCT00473889|27113138|P2|Overall Study|Withdrawal by Subject|0
7803011|NCT00473889|27113139|P1|Overall Study|Withdrawal by Subject|5
7803012|NCT00473889|27113138|P2|Overall Study|Trial Terminated|6
7803013|NCT00473889|27113139|P1|Overall Study|Trial Terminated|3
7803014|NCT00473889|27113138|P2|Overall Study|Physician Decision|5
7803015|NCT00473889|27113139|P1|Overall Study|Physician Decision|10
7803016|NCT00473889|27113138|P2|Overall Study|Lost to Follow-up|1
7803017|NCT00473889|27113139|P1|Overall Study|Lost to Follow-up|2
7803018|NCT00473889|27113138|P2|Overall Study|Lack of Efficacy|29
7803019|NCT00473889|27113139|P1|Overall Study|Lack of Efficacy|28
7803020|NCT00473889|27113138|P2|Overall Study|Protocol Violation|2
7803021|NCT00473889|27113139|P1|Overall Study|Protocol Violation|4
7803022|NCT00473889|27113138|P2|Overall Study|Adverse Event|17
7803023|NCT00473889|27113139|P1|Overall Study|Adverse Event|30
7803024|NCT00473889|27113138|P2|Overall Study|Did not receive study medication|4
7803025|NCT00473889|27113139|P1|Overall Study|Did not receive study medication|1
7803026|NCT00473876|27113151|P2|Overall Study|Lost to Follow-up|1
7803027|NCT00473876|27113152|P1|Overall Study|Lost to Follow-up|3
7803028|NCT00473824|27113171|P2|Overall Study|Withdrawal by physician|0
7803029|NCT00473824|27113172|P1|Overall Study|Withdrawal by physician|1
7803030|NCT00473824|27113171|P2|Overall Study|Lost to Follow-up|0
7803031|NCT00473824|27113172|P1|Overall Study|Lost to Follow-up|1
7803032|NCT00473824|27113171|P2|Overall Study|Death|0
7803033|NCT00473824|27113172|P1|Overall Study|Death|1
7803034|NCT00473824|27113171|P2|Overall Study|Adverse Event|0
7803035|NCT00473824|27113172|P1|Overall Study|Adverse Event|1
7803036|NCT00473824|27113171|P2|Overall Study|Virologic Breakthrough|0
7803037|NCT00473824|27113172|P1|Overall Study|Virologic Breakthrough|1
7803038|NCT00473746|27113183|P5|Period 2 (Phase 2)|Reason not specified|3
7803039|NCT00473746|27113184|P4|Period 2 (Phase 2)|Reason not specified|0
7803040|NCT00473746|27113185|P3|Period 2 (Phase 2)|Reason not specified|0
7803041|NCT00473746|27113186|P2|Period 2 (Phase 2)|Reason not specified|0
7803042|NCT00473746|27113187|P1|Period 2 (Phase 2)|Reason not specified|0
7803043|NCT00473746|27113183|P5|Period 2 (Phase 2)|Progressive Disease|20
7803044|NCT00473746|27113184|P4|Period 2 (Phase 2)|Progressive Disease|0
7803045|NCT00473746|27113185|P3|Period 2 (Phase 2)|Progressive Disease|0
7803046|NCT00473746|27113186|P2|Period 2 (Phase 2)|Progressive Disease|0
7803047|NCT00473746|27113187|P1|Period 2 (Phase 2)|Progressive Disease|0
7803048|NCT00473746|27113183|P5|Period 2 (Phase 2)|Death|1
7803049|NCT00473746|27113184|P4|Period 2 (Phase 2)|Death|0
7803050|NCT00473746|27113185|P3|Period 2 (Phase 2)|Death|0
7803051|NCT00473746|27113186|P2|Period 2 (Phase 2)|Death|0
7803052|NCT00473746|27113187|P1|Period 2 (Phase 2)|Death|0
7803053|NCT00473746|27113183|P5|Period 2 (Phase 2)|Adverse Event|3
7803054|NCT00473746|27113184|P4|Period 2 (Phase 2)|Adverse Event|0
7803055|NCT00473746|27113185|P3|Period 2 (Phase 2)|Adverse Event|0
7803056|NCT00473746|27113186|P2|Period 2 (Phase 2)|Adverse Event|0
7803057|NCT00473746|27113187|P1|Period 2 (Phase 2)|Adverse Event|0
7803058|NCT00473746|27113183|P5|Period 1 (Phase 1)|Reason not specified|0
7803059|NCT00473746|27113184|P4|Period 1 (Phase 1)|Reason not specified|0
7803060|NCT00473746|27113185|P3|Period 1 (Phase 1)|Reason not specified|0
7803061|NCT00473746|27113186|P2|Period 1 (Phase 1)|Reason not specified|1
7803062|NCT00473746|27113187|P1|Period 1 (Phase 1)|Reason not specified|0
7803063|NCT00473746|27113183|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
7803064|NCT00473746|27113184|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
7803065|NCT00473746|27113185|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
7803066|NCT00473746|27113186|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
7803067|NCT00473746|27113187|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
7803068|NCT00473746|27113183|P5|Period 1 (Phase 1)|Progressive Disease|0
7803069|NCT00473746|27113184|P4|Period 1 (Phase 1)|Progressive Disease|10
7803070|NCT00473746|27113185|P3|Period 1 (Phase 1)|Progressive Disease|6
7803071|NCT00473746|27113186|P2|Period 1 (Phase 1)|Progressive Disease|6
7803072|NCT00473746|27113187|P1|Period 1 (Phase 1)|Progressive Disease|5
7803073|NCT00473746|27113183|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
7803074|NCT00473746|27113184|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
7803075|NCT00473746|27113185|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
7803076|NCT00473746|27113186|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
7803077|NCT00473746|27113187|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
7803078|NCT00473746|27113183|P5|Period 1 (Phase 1)|Adverse Event|0
7803079|NCT00473746|27113184|P4|Period 1 (Phase 1)|Adverse Event|0
7803080|NCT00473746|27113185|P3|Period 1 (Phase 1)|Adverse Event|0
7803081|NCT00473746|27113186|P2|Period 1 (Phase 1)|Adverse Event|0
7803082|NCT00473746|27113187|P1|Period 1 (Phase 1)|Adverse Event|1
7803083|NCT00473694|27113236|P4|Overall Study|Lost to Follow-up|1
7803084|NCT00473694|27113237|P3|Overall Study|Lost to Follow-up|0
7803085|NCT00473694|27113238|P2|Overall Study|Lost to Follow-up|0
7803086|NCT00473694|27113239|P1|Overall Study|Lost to Follow-up|0
7803087|NCT00473694|27113236|P4|Overall Study|Participants did not receive treatment|6
7803088|NCT00473694|27113237|P3|Overall Study|Participants did not receive treatment|5
7803089|NCT00473694|27113238|P2|Overall Study|Participants did not receive treatment|3
7803090|NCT00473694|27113239|P1|Overall Study|Participants did not receive treatment|11
7803091|NCT00473694|27113236|P4|Overall Study|Adverse Event|0
7803092|NCT00473694|27113237|P3|Overall Study|Adverse Event|0
7803093|NCT00473694|27113238|P2|Overall Study|Adverse Event|1
7803094|NCT00473694|27113239|P1|Overall Study|Adverse Event|0
7803095|NCT00473668|27113280|P3|Overall Study|Other|4
7803096|NCT00473668|27113281|P2|Overall Study|Other|3
7803097|NCT00473668|27113282|P1|Overall Study|Other|2
7803098|NCT00473668|27113280|P3|Overall Study|Lost to Follow-up|6
7803099|NCT00473668|27113281|P2|Overall Study|Lost to Follow-up|4
7803100|NCT00473668|27113282|P1|Overall Study|Lost to Follow-up|0
7803101|NCT00473668|27113280|P3|Overall Study|Migrated/moved from study area|0
7803102|NCT00473668|27113281|P2|Overall Study|Migrated/moved from study area|2
7803103|NCT00473668|27113282|P1|Overall Study|Migrated/moved from study area|3
7803104|NCT00473668|27113280|P3|Overall Study|Withdrawal by Subject|0
7803105|NCT00473668|27113281|P2|Overall Study|Withdrawal by Subject|2
7803106|NCT00473668|27113282|P1|Overall Study|Withdrawal by Subject|0
7803107|NCT00473655|27113335|P3|Overall Study|Lost to Follow-up|8
7803108|NCT00473655|27113336|P2|Overall Study|Lost to Follow-up|5
7803109|NCT00473655|27113337|P1|Overall Study|Lost to Follow-up|9
7803110|NCT00473590|27113398|P2|Overall Study|Other|1
7803111|NCT00473590|27113399|P1|Overall Study|Other|0
7803112|NCT00473590|27113398|P2|Overall Study|Withdrawal by Subject|3
7803113|NCT00473590|27113399|P1|Overall Study|Withdrawal by Subject|5
7803114|NCT00473590|27113398|P2|Overall Study|Physician Decision|4
7803115|NCT00473590|27113399|P1|Overall Study|Physician Decision|2
7803116|NCT00473590|27113398|P2|Overall Study|Non-protocol-specified therapy|5
7803117|NCT00473590|27113399|P1|Overall Study|Non-protocol-specified therapy|7
7803118|NCT00473590|27113398|P2|Overall Study|Progression not resulting in death|20
7803119|NCT00473590|27113399|P1|Overall Study|Progression not resulting in death|24
7803120|NCT00473590|27113398|P2|Overall Study|Death|2
7803121|NCT00473590|27113399|P1|Overall Study|Death|4
7803122|NCT00473590|27113398|P2|Overall Study|Adverse Event|3
7803123|NCT00473590|27113399|P1|Overall Study|Adverse Event|3
7803124|NCT00473564|27113415|P1|Overall Study|robot surgery aborted in OR|23
7803125|NCT00473512|27113425|P5|Period 2 (Phase 2)|Other|0
7803126|NCT00473512|27113426|P4|Period 2 (Phase 2)|Other|3
7803127|NCT00473512|27113427|P3|Period 2 (Phase 2)|Other|0
7803128|NCT00473512|27113428|P2|Period 2 (Phase 2)|Other|0
7803129|NCT00473512|27113429|P1|Period 2 (Phase 2)|Other|1
7803130|NCT00473512|27113425|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
7803131|NCT00473512|27113426|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
7803132|NCT00473512|27113427|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
7803133|NCT00473512|27113428|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
7803134|NCT00473512|27113429|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
7803135|NCT00473512|27113425|P5|Period 2 (Phase 2)|Disease Progression|1
7803136|NCT00473512|27113426|P4|Period 2 (Phase 2)|Disease Progression|17
7803137|NCT00473512|27113427|P3|Period 2 (Phase 2)|Disease Progression|2
7803138|NCT00473512|27113428|P2|Period 2 (Phase 2)|Disease Progression|2
7803139|NCT00473512|27113429|P1|Period 2 (Phase 2)|Disease Progression|0
7803140|NCT00473512|27113425|P5|Period 2 (Phase 2)|Death|1
7803141|NCT00473512|27113426|P4|Period 2 (Phase 2)|Death|1
7803142|NCT00473512|27113427|P3|Period 2 (Phase 2)|Death|0
7803143|NCT00473512|27113428|P2|Period 2 (Phase 2)|Death|0
7803144|NCT00473512|27113429|P1|Period 2 (Phase 2)|Death|0
7803145|NCT00473512|27113425|P5|Period 2 (Phase 2)|Adverse Event|0
7803146|NCT00473512|27113426|P4|Period 2 (Phase 2)|Adverse Event|1
7803147|NCT00473512|27113427|P3|Period 2 (Phase 2)|Adverse Event|0
7803148|NCT00473512|27113428|P2|Period 2 (Phase 2)|Adverse Event|0
7803149|NCT00473512|27113429|P1|Period 2 (Phase 2)|Adverse Event|0
7803150|NCT00473512|27113425|P5|Period 1 (Phase 1)|Other|0
7803151|NCT00473512|27113426|P4|Period 1 (Phase 1)|Other|1
7803152|NCT00473512|27113427|P3|Period 1 (Phase 1)|Other|0
7803153|NCT00473512|27113428|P2|Period 1 (Phase 1)|Other|0
7803154|NCT00473512|27113429|P1|Period 1 (Phase 1)|Other|0
7803155|NCT00473512|27113425|P5|Period 1 (Phase 1)|Disease Progression|1
7803156|NCT00473512|27113426|P4|Period 1 (Phase 1)|Disease Progression|10
7803157|NCT00473512|27113427|P3|Period 1 (Phase 1)|Disease Progression|0
7803158|NCT00473512|27113428|P2|Period 1 (Phase 1)|Disease Progression|1
7803159|NCT00473512|27113429|P1|Period 1 (Phase 1)|Disease Progression|1
7803160|NCT00473512|27113425|P5|Period 1 (Phase 1)|Death|0
7803161|NCT00473512|27113426|P4|Period 1 (Phase 1)|Death|1
7803162|NCT00473512|27113427|P3|Period 1 (Phase 1)|Death|0
7803163|NCT00473512|27113428|P2|Period 1 (Phase 1)|Death|0
7803164|NCT00473512|27113429|P1|Period 1 (Phase 1)|Death|0
7803165|NCT00473512|27113425|P5|Period 1 (Phase 1)|Adverse Event|0
7803166|NCT00473512|27113426|P4|Period 1 (Phase 1)|Adverse Event|5
7803167|NCT00473512|27113427|P3|Period 1 (Phase 1)|Adverse Event|0
7803168|NCT00473512|27113428|P2|Period 1 (Phase 1)|Adverse Event|0
7803169|NCT00473512|27113429|P1|Period 1 (Phase 1)|Adverse Event|0
7803170|NCT00473434|27113487|P1|Overall Study|No longer required|1
7803171|NCT00473434|27113487|P1|Overall Study|Switching to trial medication|1
7803172|NCT00473434|27113487|P1|Overall Study|Ceased in favor of Paliperidone|1
7803173|NCT00473434|27113487|P1|Overall Study|Reason not specified|6
7803174|NCT00473434|27113487|P1|Overall Study|Safety evaluation|1
7803175|NCT00473434|27113487|P1|Overall Study|Patient was selling medication to others|1
7803176|NCT00473434|27113487|P1|Overall Study|Adverse Event|3
7803177|NCT00473434|27113487|P1|Overall Study|Lack of Efficacy|3
7803178|NCT00473434|27113487|P1|Overall Study|Compliance|3
7803179|NCT00473434|27113487|P1|Overall Study|Withdrawal by Subject|9
7803180|NCT00473434|27113487|P1|Overall Study|Physician Decision|3
7803181|NCT00473382|27113552|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
7803182|NCT00473382|27113553|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
7803183|NCT00473382|27113554|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
7803184|NCT00473382|27113552|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
7803185|NCT00473382|27113553|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
7803186|NCT00473382|27113554|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
7803187|NCT00473382|27113552|P3|Open-label Extension Through Month 60|Subject's Decision|6
7803188|NCT00473382|27113553|P2|Open-label Extension Through Month 60|Subject's Decision|1
7803189|NCT00473382|27113554|P1|Open-label Extension Through Month 60|Subject's Decision|7
7803190|NCT00473382|27113552|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
7803191|NCT00473382|27113553|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
7803192|NCT00473382|27113554|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
7803193|NCT00473382|27113552|P3|Open-label Extension Through Month 60|Death|4
7803194|NCT00473382|27113553|P2|Open-label Extension Through Month 60|Death|7
7803195|NCT00473382|27113554|P1|Open-label Extension Through Month 60|Death|1
7803196|NCT00473382|27113552|P3|Open-label Extension Through Month 60|Adverse Event|2
7803197|NCT00473382|27113553|P2|Open-label Extension Through Month 60|Adverse Event|0
7803198|NCT00473382|27113554|P1|Open-label Extension Through Month 60|Adverse Event|0
7803199|NCT00473382|27113552|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
7803200|NCT00473382|27113553|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
7803201|NCT00473382|27113554|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
7803202|NCT00473382|27113552|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
7803203|NCT00473382|27113553|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
7803204|NCT00473382|27113554|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
7803205|NCT00473382|27113552|P3|Open-label Extension Through Month 48|Subject's Decision|6
7803206|NCT00473382|27113553|P2|Open-label Extension Through Month 48|Subject's Decision|1
7803207|NCT00473382|27113554|P1|Open-label Extension Through Month 48|Subject's Decision|5
7803208|NCT00473382|27113552|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
7803209|NCT00473382|27113553|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
7803210|NCT00473382|27113554|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
7803211|NCT00473382|27113552|P3|Open-label Extension Through Month 48|Death|3
7803212|NCT00473382|27113553|P2|Open-label Extension Through Month 48|Death|3
7803213|NCT00473382|27113554|P1|Open-label Extension Through Month 48|Death|1
7803214|NCT00473382|27113552|P3|Open-label Extension Through Month 48|Adverse Event|1
7803215|NCT00473382|27113553|P2|Open-label Extension Through Month 48|Adverse Event|0
7803216|NCT00473382|27113554|P1|Open-label Extension Through Month 48|Adverse Event|0
7803217|NCT00473382|27113552|P3|Core Study|Subject's decision|10
7803218|NCT00473382|27113553|P2|Core Study|Subject's decision|11
7803219|NCT00473382|27113554|P1|Core Study|Subject's decision|12
7803220|NCT00473382|27113552|P3|Core Study|Subject needed other treatment|2
7803221|NCT00473382|27113553|P2|Core Study|Subject needed other treatment|3
7803222|NCT00473382|27113554|P1|Core Study|Subject needed other treatment|1
7803223|NCT00473382|27113552|P3|Core Study|Subject non-compliance|1
7803224|NCT00473382|27113553|P2|Core Study|Subject non-compliance|2
7803225|NCT00473382|27113554|P1|Core Study|Subject non-compliance|5
7803226|NCT00473382|27113552|P3|Core Study|Physician Decision|2
7803227|NCT00473382|27113553|P2|Core Study|Physician Decision|2
7803228|NCT00473382|27113554|P1|Core Study|Physician Decision|1
7803229|NCT00473382|27113552|P3|Core Study|Lost to Follow-up|3
7803230|NCT00473382|27113553|P2|Core Study|Lost to Follow-up|3
7803231|NCT00473382|27113554|P1|Core Study|Lost to Follow-up|3
7803232|NCT00473382|27113552|P3|Core Study|Death|10
7803233|NCT00473382|27113553|P2|Core Study|Death|5
7803234|NCT00473382|27113554|P1|Core Study|Death|3
7803235|NCT00473382|27113552|P3|Core Study|Adverse Event|1
7803236|NCT00473382|27113553|P2|Core Study|Adverse Event|1
7803237|NCT00473382|27113554|P1|Core Study|Adverse Event|3
7803238|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
7803239|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
7803240|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
7803241|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
7803242|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
7803243|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
7803244|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
7803245|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
7803246|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
7803247|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Subject's Decision|4
7803248|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Subject's Decision|3
7803249|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Subject's Decision|1
7803250|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Physician's Decision|3
7803251|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Physician's Decision|1
7803252|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Physician's Decision|2
7803253|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
7803254|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
7803255|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
7803256|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Death|1
7803257|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Death|2
7803258|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Death|2
7803259|NCT00473330|27113612|P3|Open-label Extension Through Month 60|Adverse Event|2
7803260|NCT00473330|27113613|P2|Open-label Extension Through Month 60|Adverse Event|0
7803261|NCT00473330|27113614|P1|Open-label Extension Through Month 60|Adverse Event|0
7803262|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
7803263|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
7803264|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
7803265|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
7803266|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
7803267|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
7803268|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
7803269|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
7803270|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
7803271|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Subject's Decision|3
7803272|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Subject's Decision|3
7803273|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Subject's Decision|1
7803274|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Physician's Decision|3
7803275|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Physician's Decision|1
7803276|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Physician's Decision|2
7803277|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
7803278|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
7803279|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
7803280|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Death|0
7803281|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Death|0
7803282|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Death|2
7803283|NCT00473330|27113612|P3|Open-label Extension Through Month 48|Adverse Event|2
7803284|NCT00473330|27113613|P2|Open-label Extension Through Month 48|Adverse Event|0
7803285|NCT00473330|27113614|P1|Open-label Extension Through Month 48|Adverse Event|0
7803286|NCT00473330|27113612|P3|Core Study|Subject's Decision|19
7803287|NCT00473330|27113613|P2|Core Study|Subject's Decision|8
7803288|NCT00473330|27113614|P1|Core Study|Subject's Decision|9
7803289|NCT00473330|27113612|P3|Core Study|Subject Required Other Therapy|3
7803290|NCT00473330|27113613|P2|Core Study|Subject Required Other Therapy|1
7803291|NCT00473330|27113614|P1|Core Study|Subject Required Other Therapy|0
7803292|NCT00473330|27113612|P3|Core Study|Subject Non-compliance|1
7803293|NCT00473330|27113613|P2|Core Study|Subject Non-compliance|2
7803294|NCT00473330|27113614|P1|Core Study|Subject Non-compliance|1
7803295|NCT00473330|27113612|P3|Core Study|Physician Decision|3
7803296|NCT00473330|27113613|P2|Core Study|Physician Decision|1
7803297|NCT00473330|27113614|P1|Core Study|Physician Decision|2
7803298|NCT00473330|27113612|P3|Core Study|Lost to Follow-up|10
7803299|NCT00473330|27113613|P2|Core Study|Lost to Follow-up|5
7803300|NCT00473330|27113614|P1|Core Study|Lost to Follow-up|5
7803301|NCT00473330|27113612|P3|Core Study|Death|4
7803302|NCT00473330|27113613|P2|Core Study|Death|4
7803303|NCT00473330|27113614|P1|Core Study|Death|6
7803304|NCT00473330|27113612|P3|Core Study|Adverse Event|1
7803305|NCT00473330|27113613|P2|Core Study|Adverse Event|4
7803306|NCT00473330|27113614|P1|Core Study|Adverse Event|4
7803307|NCT00473265|27113669|P1|Overall Study|Off treatment early|15
7803308|NCT00473265|27113669|P1|Overall Study|Unrelated adverse event|5
7803309|NCT00473083|27113681|P3|Overall Study|Adverse Event|0
7803310|NCT00473083|27113682|P2|Overall Study|Adverse Event|0
7803311|NCT00473083|27113683|P1|Overall Study|Adverse Event|1
7803312|NCT00472641|27113758|P1|Overall Study|Lost to Follow-up|1
7803313|NCT00472641|27113758|P1|Overall Study|Adverse Event|3
7803314|NCT00472641|27113758|P1|Overall Study|Lack of Efficacy|3
7803315|NCT00472446|27113778|P4|Overall Study|Questionnaires not returned|4
7803316|NCT00472446|27113779|P3|Overall Study|Questionnaires not returned|6
7803317|NCT00472446|27113780|P2|Overall Study|Questionnaires not returned|6
7803318|NCT00472446|27113781|P1|Overall Study|Questionnaires not returned|5
7803319|NCT00472446|27113778|P4|Overall Study|Reintervention|1
7803320|NCT00472446|27113779|P3|Overall Study|Reintervention|1
7803321|NCT00472446|27113780|P2|Overall Study|Reintervention|0
7803322|NCT00472446|27113781|P1|Overall Study|Reintervention|0
7803323|NCT00472446|27113778|P4|Overall Study|Protocol Violation|1
7803324|NCT00472446|27113779|P3|Overall Study|Protocol Violation|0
7803325|NCT00472446|27113780|P2|Overall Study|Protocol Violation|0
7803326|NCT00472446|27113781|P1|Overall Study|Protocol Violation|0
7803327|NCT00472420|27113811|P1|Follow-up Period|Protocol Violation|1
7803328|NCT00472420|27113811|P1|Follow-up Period|Lost to Follow-up|2
7803329|NCT00472420|27113811|P1|Follow-up Period|Physician Decision|9
7803330|NCT00472420|27113811|P1|Follow-up Period|Death|5
7803331|NCT00472420|27113811|P1|Induction Treatment Period|Death|3
7803332|NCT00472420|27113811|P1|Induction Treatment Period|Non-compliance|1
7803333|NCT00472420|27113811|P1|Induction Treatment Period|Adverse Event|3
7803334|NCT00472420|27113811|P1|Induction Treatment Period|Physician Decision|9
7803335|NCT00472303|27113819|P3|Maintenance Phase|Other|0
7803336|NCT00472303|27113820|P2|Maintenance Phase|Other|1
7803337|NCT00472303|27113821|P1|Maintenance Phase|Other|1
7803338|NCT00472303|27113819|P3|Maintenance Phase|Resolution of pain|1
7803339|NCT00472303|27113820|P2|Maintenance Phase|Resolution of pain|0
7803340|NCT00472303|27113821|P1|Maintenance Phase|Resolution of pain|0
7803341|NCT00472303|27113819|P3|Maintenance Phase|Trial medication non-compliant|1
7803342|NCT00472303|27113820|P2|Maintenance Phase|Trial medication non-compliant|0
7803343|NCT00472303|27113821|P1|Maintenance Phase|Trial medication non-compliant|0
7803344|NCT00472303|27113819|P3|Maintenance Phase|Withdrawal by Subject|3
7803345|NCT00472303|27113820|P2|Maintenance Phase|Withdrawal by Subject|7
7803346|NCT00472303|27113821|P1|Maintenance Phase|Withdrawal by Subject|6
7803347|NCT00472303|27113819|P3|Maintenance Phase|Lack of Efficacy|4
7803348|NCT00472303|27113820|P2|Maintenance Phase|Lack of Efficacy|2
7803349|NCT00472303|27113821|P1|Maintenance Phase|Lack of Efficacy|2
7803350|NCT00472303|27113819|P3|Maintenance Phase|Death|2
7803351|NCT00472303|27113820|P2|Maintenance Phase|Death|0
7803352|NCT00472303|27113821|P1|Maintenance Phase|Death|3
7803353|NCT00472303|27113819|P3|Maintenance Phase|Adverse Event|6
7803354|NCT00472303|27113820|P2|Maintenance Phase|Adverse Event|6
7803355|NCT00472303|27113821|P1|Maintenance Phase|Adverse Event|5
7803356|NCT00472303|27113819|P3|Discontinuations After Titration Phase|Other|0
7803357|NCT00472303|27113820|P2|Discontinuations After Titration Phase|Other|0
7803358|NCT00472303|27113821|P1|Discontinuations After Titration Phase|Other|5
7803359|NCT00472303|27113819|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
7803360|NCT00472303|27113820|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
7803361|NCT00472303|27113821|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
7803362|NCT00472303|27113819|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
7803363|NCT00472303|27113820|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
7803364|NCT00472303|27113821|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
7803365|NCT00472303|27113819|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
7803366|NCT00472303|27113820|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
7803367|NCT00472303|27113821|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
7803368|NCT00472303|27113819|P3|Discontinuations After Titration Phase|Adverse Event|0
7803369|NCT00472303|27113820|P2|Discontinuations After Titration Phase|Adverse Event|0
7803370|NCT00472303|27113821|P1|Discontinuations After Titration Phase|Adverse Event|6
7803371|NCT00472303|27113819|P3|Titration Phase|Other|0
7803372|NCT00472303|27113820|P2|Titration Phase|Other|1
7803373|NCT00472303|27113821|P1|Titration Phase|Other|3
7803374|NCT00472303|27113819|P3|Titration Phase|Trial Medication non-compliant|0
7803375|NCT00472303|27113820|P2|Titration Phase|Trial Medication non-compliant|1
7803376|NCT00472303|27113821|P1|Titration Phase|Trial Medication non-compliant|4
7803377|NCT00472303|27113819|P3|Titration Phase|Withdrawal by Subject|0
7803378|NCT00472303|27113820|P2|Titration Phase|Withdrawal by Subject|13
7803379|NCT00472303|27113821|P1|Titration Phase|Withdrawal by Subject|16
7803380|NCT00472303|27113819|P3|Titration Phase|Lack of Efficacy|0
7803381|NCT00472303|27113820|P2|Titration Phase|Lack of Efficacy|0
7803382|NCT00472303|27113821|P1|Titration Phase|Lack of Efficacy|10
7803383|NCT00472303|27113819|P3|Titration Phase|Death|0
7803384|NCT00472303|27113820|P2|Titration Phase|Death|2
7803385|NCT00472303|27113821|P1|Titration Phase|Death|4
7803386|NCT00472303|27113819|P3|Titration Phase|Adverse Event|0
7803387|NCT00472303|27113820|P2|Titration Phase|Adverse Event|12
7803388|NCT00472303|27113821|P1|Titration Phase|Adverse Event|22
7803389|NCT00472290|27113884|P1|Overall Study|Requirement for alternative therapy|7
7803390|NCT00472290|27113884|P1|Overall Study|Adverse Event|6
7803391|NCT00472290|27113884|P1|Overall Study|Withdrawal by Subject|5
7803392|NCT00472290|27113884|P1|Overall Study|Disease Progression|4
7803393|NCT00472290|27113884|P1|Overall Study|Lack of Efficacy|1
7803394|NCT00472290|27113884|P1|Overall Study|Lost to Follow-up|1
7803395|NCT00472290|27113884|P1|Overall Study|Death|3
7803396|NCT00472290|27113884|P1|Overall Study|Administrative Decision|37
7803397|NCT00472290|27113884|P1|Overall Study|Protocol Specified Criteria|7
7803398|NCT00472290|27113884|P1|Overall Study|Progression of Therapy-Related MDS|1
7803399|NCT00472199|27113896|P2|Overall Study|patient was asymptomatic|0
7803400|NCT00472199|27113897|P1|Overall Study|patient was asymptomatic|1
7803401|NCT00472199|27113896|P2|Overall Study|personal reason|1
7803402|NCT00472199|27113897|P1|Overall Study|personal reason|0
7803403|NCT00472199|27113896|P2|Overall Study|Withdrawal by Subject|5
7803404|NCT00472199|27113897|P1|Overall Study|Withdrawal by Subject|6
7803405|NCT00472199|27113896|P2|Overall Study|Protocol Violation|2
7803406|NCT00472199|27113897|P1|Overall Study|Protocol Violation|3
7803407|NCT00472199|27113896|P2|Overall Study|Lost to Follow-up|4
7803408|NCT00472199|27113897|P1|Overall Study|Lost to Follow-up|2
7803409|NCT00472199|27113896|P2|Overall Study|Lack of Efficacy|25
7803410|NCT00472199|27113897|P1|Overall Study|Lack of Efficacy|4
7803411|NCT00472199|27113896|P2|Overall Study|Adverse Event|23
7803412|NCT00472199|27113897|P1|Overall Study|Adverse Event|19
7803413|NCT00472082|27113963|P1|Overall Study|Study prematurely terminated|5
7803414|NCT00472030|27113985|P2|Overall Study|Physician Decision|0
7803415|NCT00472030|27113986|P1|Overall Study|Physician Decision|1
7803416|NCT00471887|27114002|P1|Overall Study|Adverse Event|9
7803417|NCT00471822|27114011|P1|Overall Study|Protocol Violation|2
7803418|NCT00471718|27114019|P1|Overall Study|Withdrawal by Subject|1
7803419|NCT00471718|27114019|P1|Overall Study|disease progression|22
7803420|NCT00471718|27114019|P1|Overall Study|other complicating disease|1
7803421|NCT00471718|27114019|P1|Overall Study|Adverse Event|3
7803422|NCT00471536|27114047|P1|Overall Study|Withdrawal by Subject|1
7803423|NCT00471497|27114059|P3|Extension Phase|Protocol Violation|0
7803424|NCT00471497|27114060|P2|Extension Phase|Protocol Violation|2
7803425|NCT00471497|27114061|P1|Extension Phase|Protocol Violation|2
7803426|NCT00471497|27114059|P3|Extension Phase|Disease progression|0
7803427|NCT00471497|27114060|P2|Extension Phase|Disease progression|0
7803428|NCT00471497|27114061|P1|Extension Phase|Disease progression|2
7803429|NCT00471497|27114059|P3|Extension Phase|Death|0
7803430|NCT00471497|27114060|P2|Extension Phase|Death|0
7803431|NCT00471497|27114061|P1|Extension Phase|Death|1
7803432|NCT00471497|27114059|P3|Extension Phase|Lost to Follow-up|0
7803433|NCT00471497|27114060|P2|Extension Phase|Lost to Follow-up|0
7803434|NCT00471497|27114061|P1|Extension Phase|Lost to Follow-up|2
7803435|NCT00471497|27114059|P3|Extension Phase|Withdrawal by Subject|0
7803436|NCT00471497|27114060|P2|Extension Phase|Withdrawal by Subject|1
7803437|NCT00471497|27114061|P1|Extension Phase|Withdrawal by Subject|3
7803438|NCT00471497|27114059|P3|Extension Phase|Unsatisfactory therapeutic effect|0
7803439|NCT00471497|27114060|P2|Extension Phase|Unsatisfactory therapeutic effect|6
7803440|NCT00471497|27114061|P1|Extension Phase|Unsatisfactory therapeutic effect|8
7803441|NCT00471497|27114059|P3|Extension Phase|Adverse Event|1
7803442|NCT00471497|27114060|P2|Extension Phase|Adverse Event|5
7803443|NCT00471497|27114061|P1|Extension Phase|Adverse Event|9
7803444|NCT00471497|27114059|P3|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
7803445|NCT00471497|27114060|P2|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
7803446|NCT00471497|27114061|P1|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
7803447|NCT00471497|27114059|P3|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
7803448|NCT00471497|27114060|P2|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
7803449|NCT00471497|27114061|P1|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
7803450|NCT00471497|27114059|P3|Core Treatment Phase|Adverse Event|89
7803451|NCT00471497|27114060|P2|Core Treatment Phase|Adverse Event|53
7803452|NCT00471497|27114061|P1|Core Treatment Phase|Adverse Event|43
7803453|NCT00471497|27114059|P3|Core Treatment Phase|Administrative problems|12
7803454|NCT00471497|27114060|P2|Core Treatment Phase|Administrative problems|14
7803455|NCT00471497|27114061|P1|Core Treatment Phase|Administrative problems|14
7803456|NCT00471497|27114059|P3|Core Treatment Phase|Sub optimal response or treat. failure|13
7803457|NCT00471497|27114060|P2|Core Treatment Phase|Sub optimal response or treat. failure|11
7803458|NCT00471497|27114061|P1|Core Treatment Phase|Sub optimal response or treat. failure|19
7803459|NCT00471497|27114059|P3|Core Treatment Phase|Protocol Violation|11
7803460|NCT00471497|27114060|P2|Core Treatment Phase|Protocol Violation|15
7803461|NCT00471497|27114061|P1|Core Treatment Phase|Protocol Violation|6
7803462|NCT00471497|27114059|P3|Core Treatment Phase|Disease Progression|4
7803463|NCT00471497|27114060|P2|Core Treatment Phase|Disease Progression|2
7803464|NCT00471497|27114061|P1|Core Treatment Phase|Disease Progression|10
7803465|NCT00471497|27114059|P3|Core Treatment Phase|Death|3
7803466|NCT00471497|27114060|P2|Core Treatment Phase|Death|9
7803467|NCT00471497|27114061|P1|Core Treatment Phase|Death|3
7803468|NCT00471497|27114059|P3|Core Treatment Phase|Lost to Follow-up|3
7803469|NCT00471497|27114060|P2|Core Treatment Phase|Lost to Follow-up|6
7803470|NCT00471497|27114061|P1|Core Treatment Phase|Lost to Follow-up|6
7803471|NCT00471497|27114059|P3|Core Treatment Phase|Withdrawal by Subject|34
7803472|NCT00471497|27114060|P2|Core Treatment Phase|Withdrawal by Subject|29
7803473|NCT00471497|27114061|P1|Core Treatment Phase|Withdrawal by Subject|31
7803474|NCT00471497|27114059|P3|Core Treatment Phase|Condition no longer requires study drug|0
7803475|NCT00471497|27114060|P2|Core Treatment Phase|Condition no longer requires study drug|1
7803476|NCT00471497|27114061|P1|Core Treatment Phase|Condition no longer requires study drug|0
7803477|NCT00471497|27114059|P3|Core Treatment Phase|Abnormal Test Procedures|1
7803478|NCT00471497|27114060|P2|Core Treatment Phase|Abnormal Test Procedures|0
7803479|NCT00471497|27114061|P1|Core Treatment Phase|Abnormal Test Procedures|1
7803480|NCT00471497|27114059|P3|Core Treatment Phase|Abnormal Laboratory Values|9
7803481|NCT00471497|27114060|P2|Core Treatment Phase|Abnormal Laboratory Values|9
7803482|NCT00471497|27114061|P1|Core Treatment Phase|Abnormal Laboratory Values|3
7803483|NCT00471445|27114157|P2|Overall Study|Protocol Violation|1
7803484|NCT00471445|27114158|P1|Overall Study|Protocol Violation|0
7803485|NCT00471445|27114157|P2|Overall Study|Ineligible|0
7803486|NCT00471445|27114158|P1|Overall Study|Ineligible|1
7803487|NCT00471445|27114157|P2|Overall Study|Withdrawal by Subject|1
7803488|NCT00471445|27114158|P1|Overall Study|Withdrawal by Subject|1
7803489|NCT00471354|27114171|P1|Overall Study|Patient/Caregiver Decision|12
7803490|NCT00471354|27114171|P1|Overall Study|Lack of Efficacy|5
7803491|NCT00471354|27114171|P1|Overall Study|Lost to Follow-up|3
7803492|NCT00471354|27114171|P1|Overall Study|Sponsor Decision|1
7803493|NCT00471354|27114171|P1|Overall Study|Physician Decision|4
7803494|NCT00471354|27114171|P1|Overall Study|Withdrawal by Subject|1
7803495|NCT00471354|27114171|P1|Overall Study|Protocol Violation|12
7803496|NCT00471354|27114171|P1|Overall Study|Adverse Event|13
7803497|NCT00471354|27114171|P1|Overall Study|Protocol Entry Criteria Not Met|1
7803498|NCT00471328|27114183|P2|Extension Phase|Administrative Problem|0
7803499|NCT00471328|27114184|P1|Extension Phase|Administrative Problem|1
7803500|NCT00471328|27114183|P2|Extension Phase|New cancer Therapy|0
7803501|NCT00471328|27114184|P1|Extension Phase|New cancer Therapy|1
7803502|NCT00471328|27114183|P2|Extension Phase|Disease Progression|44
7803503|NCT00471328|27114184|P1|Extension Phase|Disease Progression|32
7803504|NCT00471328|27114183|P2|Extension Phase|Treatment duration as per protocol|1
7803505|NCT00471328|27114184|P1|Extension Phase|Treatment duration as per protocol|0
7803506|NCT00471328|27114183|P2|Extension Phase|Protocol Deviation|1
7803507|NCT00471328|27114184|P1|Extension Phase|Protocol Deviation|3
7803508|NCT00471328|27114183|P2|Extension Phase|Death|7
7803509|NCT00471328|27114184|P1|Extension Phase|Death|1
7803510|NCT00471328|27114183|P2|Extension Phase|Withdrawal by Subject|2
7803511|NCT00471328|27114184|P1|Extension Phase|Withdrawal by Subject|0
7803512|NCT00471328|27114183|P2|Extension Phase|Adverse Event|12
7803513|NCT00471328|27114184|P1|Extension Phase|Adverse Event|3
7803514|NCT00471328|27114183|P2|Core Phase|Protocol Deviation|1
7803515|NCT00471328|27114184|P1|Core Phase|Protocol Deviation|0
7803516|NCT00471328|27114183|P2|Core Phase|Administrative Problem|1
7803517|NCT00471328|27114184|P1|Core Phase|Administrative Problem|0
7803518|NCT00471328|27114183|P2|Core Phase|Disease Progression|53
7803519|NCT00471328|27114184|P1|Core Phase|Disease Progression|78
7803520|NCT00471328|27114183|P2|Core Phase|Abnormal laboratory value|0
7803521|NCT00471328|27114184|P1|Core Phase|Abnormal laboratory value|1
7803522|NCT00471328|27114183|P2|Core Phase|Withdrawal by Subject|2
7803523|NCT00471328|27114184|P1|Core Phase|Withdrawal by Subject|2
7803524|NCT00471328|27114183|P2|Core Phase|Death|4
7803525|NCT00471328|27114184|P1|Core Phase|Death|8
7803526|NCT00471328|27114183|P2|Core Phase|Adverse Event|6
7803527|NCT00471328|27114184|P1|Core Phase|Adverse Event|18
7803528|NCT00471315|27114203|P1|Overall Study|Withdrawal by Subject|1
7803529|NCT00471315|27114203|P1|Overall Study|Adverse Event|7
7803530|NCT00471276|27114208|P1|Overall Study|Refused treatment|6
7803531|NCT00471276|27114208|P1|Overall Study|Other|3
7803532|NCT00471276|27114208|P1|Overall Study|Global deterioration of health status|1
7803533|NCT00471276|27114208|P1|Overall Study|Objective progression or relapse|54
7803534|NCT00471276|27114208|P1|Overall Study|Protocol Violation|1
7803535|NCT00471276|27114208|P1|Overall Study|Adverse Event|16
7803536|NCT00471276|27114208|P1|Overall Study|Death|2
7803537|NCT00471237|27114238|P7|Overall Study|Participant's decision|0
7803538|NCT00471237|27114239|P6|Overall Study|Participant's decision|1
7803539|NCT00471237|27114240|P5|Overall Study|Participant's decision|0
7803540|NCT00471237|27114241|P4|Overall Study|Participant's decision|0
7803541|NCT00471237|27114242|P3|Overall Study|Participant's decision|0
7803542|NCT00471237|27114243|P2|Overall Study|Participant's decision|0
7803543|NCT00471237|27114244|P1|Overall Study|Participant's decision|0
7803544|NCT00471237|27114238|P7|Overall Study|Participant shifted residence|0
7803545|NCT00471237|27114239|P6|Overall Study|Participant shifted residence|0
7803546|NCT00471237|27114240|P5|Overall Study|Participant shifted residence|1
7803547|NCT00471237|27114241|P4|Overall Study|Participant shifted residence|0
7803548|NCT00471237|27114242|P3|Overall Study|Participant shifted residence|0
7803549|NCT00471237|27114243|P2|Overall Study|Participant shifted residence|0
7803550|NCT00471237|27114244|P1|Overall Study|Participant shifted residence|0
7803551|NCT00471237|27114238|P7|Overall Study|Administration of prohibited medicine|0
7803552|NCT00471237|27114239|P6|Overall Study|Administration of prohibited medicine|0
7803553|NCT00471237|27114240|P5|Overall Study|Administration of prohibited medicine|1
7803554|NCT00471237|27114241|P4|Overall Study|Administration of prohibited medicine|0
7803555|NCT00471237|27114242|P3|Overall Study|Administration of prohibited medicine|0
7803556|NCT00471237|27114243|P2|Overall Study|Administration of prohibited medicine|0
7803557|NCT00471237|27114244|P1|Overall Study|Administration of prohibited medicine|0
7803558|NCT00471237|27114238|P7|Overall Study|Participant lost medication|0
7803559|NCT00471237|27114239|P6|Overall Study|Participant lost medication|0
7803560|NCT00471237|27114240|P5|Overall Study|Participant lost medication|1
7803561|NCT00471237|27114241|P4|Overall Study|Participant lost medication|0
7803562|NCT00471237|27114242|P3|Overall Study|Participant lost medication|0
7803563|NCT00471237|27114243|P2|Overall Study|Participant lost medication|0
7803564|NCT00471237|27114244|P1|Overall Study|Participant lost medication|0
7803565|NCT00471237|27114238|P7|Overall Study|High parathyroid hormone|0
7803566|NCT00471237|27114239|P6|Overall Study|High parathyroid hormone|0
7803567|NCT00471237|27114240|P5|Overall Study|High parathyroid hormone|0
7803568|NCT00471237|27114241|P4|Overall Study|High parathyroid hormone|0
7803569|NCT00471237|27114242|P3|Overall Study|High parathyroid hormone|1
7803570|NCT00471237|27114243|P2|Overall Study|High parathyroid hormone|0
7803571|NCT00471237|27114244|P1|Overall Study|High parathyroid hormone|0
7803572|NCT00471237|27114238|P7|Overall Study|Participant planned to travel to abraod|0
7803573|NCT00471237|27114239|P6|Overall Study|Participant planned to travel to abraod|1
7803574|NCT00471237|27114240|P5|Overall Study|Participant planned to travel to abraod|0
7803575|NCT00471237|27114241|P4|Overall Study|Participant planned to travel to abraod|0
7803576|NCT00471237|27114242|P3|Overall Study|Participant planned to travel to abraod|0
7803577|NCT00471237|27114243|P2|Overall Study|Participant planned to travel to abraod|0
7803578|NCT00471237|27114244|P1|Overall Study|Participant planned to travel to abraod|1
7803579|NCT00471237|27114238|P7|Overall Study|Early stopping due to non-efficacy|0
7803580|NCT00471237|27114239|P6|Overall Study|Early stopping due to non-efficacy|0
7803581|NCT00471237|27114240|P5|Overall Study|Early stopping due to non-efficacy|1
7803582|NCT00471237|27114241|P4|Overall Study|Early stopping due to non-efficacy|0
7803583|NCT00471237|27114242|P3|Overall Study|Early stopping due to non-efficacy|0
7803584|NCT00471237|27114243|P2|Overall Study|Early stopping due to non-efficacy|0
7803585|NCT00471237|27114244|P1|Overall Study|Early stopping due to non-efficacy|1
7803586|NCT00471237|27114238|P7|Overall Study|Met serum creatinine withdrawal criteria|0
7803587|NCT00471237|27114239|P6|Overall Study|Met serum creatinine withdrawal criteria|0
7803588|NCT00471237|27114240|P5|Overall Study|Met serum creatinine withdrawal criteria|0
7803589|NCT00471237|27114241|P4|Overall Study|Met serum creatinine withdrawal criteria|2
7803590|NCT00471237|27114242|P3|Overall Study|Met serum creatinine withdrawal criteria|2
7803591|NCT00471237|27114243|P2|Overall Study|Met serum creatinine withdrawal criteria|0
7803592|NCT00471237|27114244|P1|Overall Study|Met serum creatinine withdrawal criteria|1
7803593|NCT00471237|27114238|P7|Overall Study|Non-compliance|0
7803594|NCT00471237|27114239|P6|Overall Study|Non-compliance|0
7803595|NCT00471237|27114240|P5|Overall Study|Non-compliance|0
7803596|NCT00471237|27114241|P4|Overall Study|Non-compliance|1
7803597|NCT00471237|27114242|P3|Overall Study|Non-compliance|0
7803598|NCT00471237|27114243|P2|Overall Study|Non-compliance|1
7803599|NCT00471237|27114244|P1|Overall Study|Non-compliance|0
7803600|NCT00471237|27114238|P7|Overall Study|Sponsor terminated study|0
7803601|NCT00471237|27114239|P6|Overall Study|Sponsor terminated study|24
7803602|NCT00471237|27114240|P5|Overall Study|Sponsor terminated study|18
7803603|NCT00471237|27114241|P4|Overall Study|Sponsor terminated study|22
7803604|NCT00471237|27114242|P3|Overall Study|Sponsor terminated study|19
7803605|NCT00471237|27114243|P2|Overall Study|Sponsor terminated study|23
7803606|NCT00471237|27114244|P1|Overall Study|Sponsor terminated study|20
7803607|NCT00471237|27114238|P7|Overall Study|Withdrawal by Subject|2
7803608|NCT00471237|27114239|P6|Overall Study|Withdrawal by Subject|4
7803609|NCT00471237|27114240|P5|Overall Study|Withdrawal by Subject|7
7803610|NCT00471237|27114241|P4|Overall Study|Withdrawal by Subject|8
7803611|NCT00471237|27114242|P3|Overall Study|Withdrawal by Subject|5
7803612|NCT00471237|27114243|P2|Overall Study|Withdrawal by Subject|6
7803613|NCT00471237|27114244|P1|Overall Study|Withdrawal by Subject|8
7803614|NCT00471237|27114238|P7|Overall Study|Protocol Violation|1
7803615|NCT00471237|27114239|P6|Overall Study|Protocol Violation|4
7803616|NCT00471237|27114240|P5|Overall Study|Protocol Violation|2
7803617|NCT00471237|27114241|P4|Overall Study|Protocol Violation|2
7803618|NCT00471237|27114242|P3|Overall Study|Protocol Violation|3
7803619|NCT00471237|27114243|P2|Overall Study|Protocol Violation|6
7803620|NCT00471237|27114244|P1|Overall Study|Protocol Violation|3
7803621|NCT00471237|27114238|P7|Overall Study|Lost to Follow-up|0
7803622|NCT00471237|27114239|P6|Overall Study|Lost to Follow-up|0
7803623|NCT00471237|27114240|P5|Overall Study|Lost to Follow-up|3
7803624|NCT00471237|27114241|P4|Overall Study|Lost to Follow-up|2
7803625|NCT00471237|27114242|P3|Overall Study|Lost to Follow-up|0
7803626|NCT00471237|27114243|P2|Overall Study|Lost to Follow-up|1
7803627|NCT00471237|27114244|P1|Overall Study|Lost to Follow-up|1
7803628|NCT00471237|27114238|P7|Overall Study|Adverse Event|0
7803629|NCT00471237|27114239|P6|Overall Study|Adverse Event|5
7803630|NCT00471237|27114240|P5|Overall Study|Adverse Event|7
7803631|NCT00471237|27114241|P4|Overall Study|Adverse Event|8
7803632|NCT00471237|27114242|P3|Overall Study|Adverse Event|4
7803633|NCT00471237|27114243|P2|Overall Study|Adverse Event|5
7803634|NCT00471237|27114244|P1|Overall Study|Adverse Event|6
7803635|NCT00471146|27114394|P2|Overall Study|Other|5
7803636|NCT00471146|27114395|P1|Overall Study|Other|4
7803637|NCT00471146|27114394|P2|Overall Study|Randomized but not treated|8
7803638|NCT00471146|27114395|P1|Overall Study|Randomized but not treated|9
7803639|NCT00471146|27114394|P2|Overall Study|Global deterioration of health status|14
7803640|NCT00471146|27114395|P1|Overall Study|Global deterioration of health status|12
7803641|NCT00471146|27114394|P2|Overall Study|Objective progression or relapse|87
7803642|NCT00471146|27114395|P1|Overall Study|Objective progression or relapse|84
7803643|NCT00471146|27114394|P2|Overall Study|Protocol Violation|2
7803644|NCT00471146|27114395|P1|Overall Study|Protocol Violation|2
7803645|NCT00471146|27114394|P2|Overall Study|Lost to Follow-up|2
7803646|NCT00471146|27114395|P1|Overall Study|Lost to Follow-up|4
7803647|NCT00471146|27114394|P2|Overall Study|Death|12
7803648|NCT00471146|27114395|P1|Overall Study|Death|11
7803649|NCT00471146|27114394|P2|Overall Study|Withdrawal by Subject|11
7803650|NCT00471146|27114395|P1|Overall Study|Withdrawal by Subject|14
7803651|NCT00471146|27114394|P2|Overall Study|Adverse Event|33
7803652|NCT00471146|27114395|P1|Overall Study|Adverse Event|32
7803653|NCT00471107|27114420|P3|Overall Study|Technical problems/data loss|3
7803654|NCT00471107|27114421|P2|Overall Study|Technical problems/data loss|1
7803655|NCT00471107|27114422|P1|Overall Study|Technical problems/data loss|3
7803656|NCT00471081|27114432|P2|Extended Safety Follow-Up|Missing confirmed|1
7803657|NCT00471081|27114433|P1|Extended Safety Follow-Up|Missing confirmed|0
7803658|NCT00471081|27114432|P2|Extended Safety Follow-Up|Lost to Follow-up|8
7803659|NCT00471081|27114433|P1|Extended Safety Follow-Up|Lost to Follow-up|1
7803660|NCT00471081|27114432|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
7803661|NCT00471081|27114433|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
7803662|NCT00471081|27114432|P2|Active Phase|Lost health plan/insurance|8
7803663|NCT00471081|27114433|P1|Active Phase|Lost health plan/insurance|1
7803664|NCT00471081|27114432|P2|Active Phase|Lost to Follow-up|1
7803665|NCT00471081|27114433|P1|Active Phase|Lost to Follow-up|0
7803666|NCT00471081|27114432|P2|Active Phase|Withdrawal by Subject|3
7803667|NCT00471081|27114433|P1|Active Phase|Withdrawal by Subject|0
7803668|NCT00471081|27114432|P2|Active Phase|Protocol Violation|1
7803669|NCT00471081|27114433|P1|Active Phase|Protocol Violation|1
7803670|NCT00470847|27114479|P1|Overall Study|Pt still receiving treatment|1
7803671|NCT00470834|27114492|P2|Extension Period (24 Months)|Disease Progression|1
7803672|NCT00470834|27114493|P1|Extension Period (24 Months)|Disease Progression|0
7803673|NCT00470834|27114492|P2|Extension Period (24 Months)|Non-compliance|1
7803674|NCT00470834|27114493|P1|Extension Period (24 Months)|Non-compliance|0
7803675|NCT00470834|27114492|P2|Extension Period (24 Months)|Lost to Follow-up|1
7803676|NCT00470834|27114493|P1|Extension Period (24 Months)|Lost to Follow-up|0
7803677|NCT00470834|27114492|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
7803678|NCT00470834|27114493|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
7803679|NCT00470834|27114492|P2|Extension Period (24 Months)|Physician Decision|3
7803680|NCT00470834|27114493|P1|Extension Period (24 Months)|Physician Decision|4
7803681|NCT00470834|27114492|P2|Extension Period (24 Months)|Withdrawal by Subject|5
7803682|NCT00470834|27114493|P1|Extension Period (24 Months)|Withdrawal by Subject|2
7803683|NCT00470834|27114492|P2|Extension Period (24 Months)|Adverse Event|4
7803684|NCT00470834|27114493|P1|Extension Period (24 Months)|Adverse Event|3
7803685|NCT00470834|27114492|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
7803686|NCT00470834|27114493|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
7803687|NCT00470834|27114492|P2|Treatment Period (18 Months)|Lack of Efficacy|0
7803688|NCT00470834|27114493|P1|Treatment Period (18 Months)|Lack of Efficacy|1
7803689|NCT00470834|27114492|P2|Treatment Period (18 Months)|Non-compliance|0
7803690|NCT00470834|27114493|P1|Treatment Period (18 Months)|Non-compliance|1
7803691|NCT00470834|27114492|P2|Treatment Period (18 Months)|Lost to Follow-up|0
7803692|NCT00470834|27114493|P1|Treatment Period (18 Months)|Lost to Follow-up|1
7803693|NCT00470834|27114492|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
7803694|NCT00470834|27114493|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
7803695|NCT00470834|27114492|P2|Treatment Period (18 Months)|Protocol Violation|1
7803696|NCT00470834|27114493|P1|Treatment Period (18 Months)|Protocol Violation|3
7803697|NCT00470834|27114492|P2|Treatment Period (18 Months)|Physician Decision|4
7803698|NCT00470834|27114493|P1|Treatment Period (18 Months)|Physician Decision|4
7803699|NCT00470834|27114492|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
7803700|NCT00470834|27114493|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
7803701|NCT00470834|27114492|P2|Treatment Period (18 Months)|Adverse Event|6
7803702|NCT00470834|27114493|P1|Treatment Period (18 Months)|Adverse Event|7
7803703|NCT00470834|27114492|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
7803704|NCT00470834|27114493|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
7803705|NCT00470626|27114511|P1|Overall Study|Withdrawal by Subject|7
7803706|NCT00470626|27114511|P1|Overall Study|Lost to Follow-up|10
7803707|NCT00470535|27114559|P1|Overall Study|Other|2
7803708|NCT00470535|27114559|P1|Overall Study|Death|1
7803709|NCT00470535|27114559|P1|Overall Study|Adverse Event|1
7803710|NCT00470535|27114559|P1|Overall Study|Withdrawal by Subject|1
7803711|NCT00470535|27114559|P1|Overall Study|Disease Progression|13
7803712|NCT00470470|27114568|P1|Overall Study|Not treated|1
7803713|NCT00470470|27114568|P1|Overall Study|Death|2
7803714|NCT00470470|27114568|P1|Overall Study|Adverse Event|2
7803715|NCT00470418|27114575|P2|Overall Study|Withdrawal by Subject|0
7803716|NCT00470418|27114576|P1|Overall Study|Withdrawal by Subject|1
7803717|NCT00470366|27114597|P1|Overall Study|Poor compliance|1
7803718|NCT00470366|27114597|P1|Overall Study|Adverse Event|3
7803719|NCT00470275|27114609|P1|Overall Study|Withdrawal by Subject|2
7803720|NCT00470275|27114609|P1|Overall Study|Lack of Efficacy|7
7803721|NCT00470275|27114609|P1|Overall Study|Death|1
7803722|NCT00470262|27114615|P2|Overall Study|Withdrawal by Subject|0
7803723|NCT00470262|27114616|P1|Overall Study|Withdrawal by Subject|2
7803724|NCT00470184|27114624|P1|Overall Study|recurrence|1
7803725|NCT00470184|27114624|P1|Overall Study|other|5
7803726|NCT00470184|27114624|P1|Overall Study|Withdrawal by Subject|4
7803727|NCT00470184|27114624|P1|Overall Study|Adverse Event|3
7803728|NCT00470184|27114624|P1|Overall Study|disease Progression|4
7803729|NCT00470184|27114624|P1|Overall Study|Not treated (other)|1
7803730|NCT00470184|27114624|P1|Overall Study|Not Treated(became ineligible)|4
7803731|NCT00470158|27114636|P5|Overall Study|Protocol Violation|0
7803732|NCT00470158|27114637|P4|Overall Study|Protocol Violation|0
7803733|NCT00470158|27114638|P3|Overall Study|Protocol Violation|0
7803734|NCT00470158|27114639|P2|Overall Study|Protocol Violation|0
7803735|NCT00470158|27114640|P1|Overall Study|Protocol Violation|1
7803736|NCT00470158|27114636|P5|Overall Study|Lost to Follow-up|4
7803737|NCT00470158|27114637|P4|Overall Study|Lost to Follow-up|5
7803738|NCT00470158|27114638|P3|Overall Study|Lost to Follow-up|8
7803739|NCT00470158|27114639|P2|Overall Study|Lost to Follow-up|8
7803740|NCT00470158|27114640|P1|Overall Study|Lost to Follow-up|7
7803741|NCT00470158|27114636|P5|Overall Study|Death|2
7803742|NCT00470158|27114637|P4|Overall Study|Death|0
7803743|NCT00470158|27114638|P3|Overall Study|Death|0
7803744|NCT00470158|27114639|P2|Overall Study|Death|0
7803745|NCT00470158|27114640|P1|Overall Study|Death|0
7803746|NCT00470093|27114673|P1|Overall Study|Adverse Event|2
7803747|NCT00470067|27114680|P1|Overall Study|Disease Progression|6
7803748|NCT00470067|27114680|P1|Overall Study|Death|1
7803749|NCT00470054|27114684|P1|Overall Study|Ineligible|1
7803750|NCT00469898|27114700|P1|Overall Study|Decreased performance status|1
7803751|NCT00469898|27114700|P1|Overall Study|Disease progression|9
7803752|NCT00469898|27114700|P1|Overall Study|Death|4
7803753|NCT00469898|27114700|P1|Overall Study|Withdrawal by Subject|4
7803754|NCT00469898|27114700|P1|Overall Study|Adverse Event|7
7803755|NCT00469859|27114709|P2|Overall Study|Inevaluable|2
7803756|NCT00469859|27114710|P1|Overall Study|Inevaluable|0
7803757|NCT00469833|27114718|P1|Overall Study|No IV access|2
7803758|NCT00469612|27114730|P2|Overall Study|Study terminated before data collected|0
7803759|NCT00469612|27114731|P1|Overall Study|Study terminated before data collected|2
7803760|NCT00469456|27114758|P2|Overall Study|Withdrawal by Subject|1
7803761|NCT00469456|27114759|P1|Overall Study|Withdrawal by Subject|4
7803762|NCT00469456|27114758|P2|Overall Study|Protocol Violation|0
7803763|NCT00469456|27114759|P1|Overall Study|Protocol Violation|1
7803764|NCT00469456|27114758|P2|Overall Study|Adverse Event|3
7803765|NCT00469456|27114759|P1|Overall Study|Adverse Event|4
7803766|NCT00469209|27114788|P3|Overall Study|Adverse Event|1
7803767|NCT00469209|27114789|P2|Overall Study|Adverse Event|0
7803768|NCT00469209|27114790|P1|Overall Study|Adverse Event|1
7803769|NCT00469144|27114800|P2|Overall Study|Progressive Disease|0
7803770|NCT00469144|27114801|P1|Overall Study|Progressive Disease|1
7803771|NCT00469144|27114800|P2|Overall Study|No Response|5
7803772|NCT00469144|27114801|P1|Overall Study|No Response|5
7803773|NCT00469144|27114800|P2|Overall Study|Death|1
7803774|NCT00469144|27114801|P1|Overall Study|Death|0
7803775|NCT00469092|27114813|P2|Overall Study|Use of Corticosteroid|0
7803776|NCT00469092|27114814|P1|Overall Study|Use of Corticosteroid|1
7803777|NCT00469092|27114813|P2|Overall Study|Abnormal lab value|0
7803778|NCT00469092|27114814|P1|Overall Study|Abnormal lab value|1
7803779|NCT00469092|27114813|P2|Overall Study|Hypoglycaemic Episodes|1
7803780|NCT00469092|27114814|P1|Overall Study|Hypoglycaemic Episodes|1
7803781|NCT00469092|27114813|P2|Overall Study|Use of lipid lowering drug|0
7803782|NCT00469092|27114814|P1|Overall Study|Use of lipid lowering drug|1
7803783|NCT00469092|27114813|P2|Overall Study|Contraindication metformin/glimepiride|0
7803784|NCT00469092|27114814|P1|Overall Study|Contraindication metformin/glimepiride|1
7803785|NCT00469092|27114813|P2|Overall Study|Incorrectly Randomised|3
7803786|NCT00469092|27114814|P1|Overall Study|Incorrectly Randomised|4
7803787|NCT00469092|27114813|P2|Overall Study|Withdrawal Criteria|4
7803788|NCT00469092|27114814|P1|Overall Study|Withdrawal Criteria|3
7803789|NCT00469092|27114813|P2|Overall Study|Withdrawal by Subject|4
7803790|NCT00469092|27114814|P1|Overall Study|Withdrawal by Subject|4
7803791|NCT00469092|27114813|P2|Overall Study|Protocol Violation|3
7803792|NCT00469092|27114814|P1|Overall Study|Protocol Violation|3
7803793|NCT00469092|27114813|P2|Overall Study|Lost to Follow-up|2
7803794|NCT00469092|27114814|P1|Overall Study|Lost to Follow-up|1
7803795|NCT00469092|27114813|P2|Overall Study|Lack of Efficacy|0
7803796|NCT00469092|27114814|P1|Overall Study|Lack of Efficacy|1
7803797|NCT00469092|27114813|P2|Overall Study|Adverse Event|4
7803798|NCT00469092|27114814|P1|Overall Study|Adverse Event|5
7803799|NCT00469079|27114833|P3|Overall Study|Ineligible|0
7803800|NCT00469079|27114834|P2|Overall Study|Ineligible|1
7803801|NCT00469079|27114835|P1|Overall Study|Ineligible|0
7803802|NCT00469079|27114833|P3|Overall Study|Withdrawal by Subject|2
7803803|NCT00469079|27114834|P2|Overall Study|Withdrawal by Subject|2
7803804|NCT00469079|27114835|P1|Overall Study|Withdrawal by Subject|1
7803805|NCT00469079|27114833|P3|Overall Study|Lost to Follow-up|10
7803806|NCT00469079|27114834|P2|Overall Study|Lost to Follow-up|8
7803807|NCT00469079|27114835|P1|Overall Study|Lost to Follow-up|4
7803808|NCT00469079|27114833|P3|Overall Study|Adverse Event|2
7803809|NCT00469079|27114834|P2|Overall Study|Adverse Event|3
7803810|NCT00469079|27114835|P1|Overall Study|Adverse Event|1
7803811|NCT00469079|27114833|P3|Overall Study|Lack of Efficacy|5
7803812|NCT00469079|27114834|P2|Overall Study|Lack of Efficacy|8
7803813|NCT00469079|27114835|P1|Overall Study|Lack of Efficacy|3
7803814|NCT00469014|27114856|P4|Adaptive Randomization|Death|0
7803815|NCT00469014|27114857|P3|Adaptive Randomization|Death|1
7803816|NCT00469014|27114858|P2|Adaptive Randomization|Death|0
7803817|NCT00469014|27114859|P1|Adaptive Randomization|Death|0
7803818|NCT00469014|27114856|P4|Adaptive Randomization|No Response|0
7803819|NCT00469014|27114857|P3|Adaptive Randomization|No Response|0
7803820|NCT00469014|27114858|P2|Adaptive Randomization|No Response|1
7803821|NCT00469014|27114859|P1|Adaptive Randomization|No Response|0
7803822|NCT00469014|27114856|P4|Adaptive Randomization|Not Evaluable|1
7803823|NCT00469014|27114857|P3|Adaptive Randomization|Not Evaluable|0
7803824|NCT00469014|27114858|P2|Adaptive Randomization|Not Evaluable|0
7803825|NCT00469014|27114859|P1|Adaptive Randomization|Not Evaluable|1
7803826|NCT00469014|27114856|P4|Initial Phase Randomization|No Response|1
7803827|NCT00469014|27114857|P3|Initial Phase Randomization|No Response|0
7803828|NCT00469014|27114858|P2|Initial Phase Randomization|No Response|0
7803829|NCT00469014|27114859|P1|Initial Phase Randomization|No Response|1
7803830|NCT00469014|27114856|P4|Initial Phase Randomization|Disease Progression|0
7803831|NCT00469014|27114857|P3|Initial Phase Randomization|Disease Progression|1
7803832|NCT00469014|27114858|P2|Initial Phase Randomization|Disease Progression|1
7803833|NCT00469014|27114859|P1|Initial Phase Randomization|Disease Progression|0
7803834|NCT00468910|27114871|P2|Overall Study|Medical Contraindication|1
7803835|NCT00468910|27114872|P1|Overall Study|Medical Contraindication|0
7803836|NCT00468910|27114871|P2|Overall Study|Withdrawal by Subject|1
7803837|NCT00468910|27114872|P1|Overall Study|Withdrawal by Subject|2
7803838|NCT00468910|27114871|P2|Overall Study|Lost to Follow-up|1
7803839|NCT00468910|27114872|P1|Overall Study|Lost to Follow-up|2
7803840|NCT00468858|27114891|P3|Overall Study|Other|1
7803841|NCT00468858|27114892|P2|Overall Study|Other|0
7803842|NCT00468858|27114893|P1|Overall Study|Other|0
7803843|NCT00468858|27114891|P3|Overall Study|Lost to Follow-up|5
7803844|NCT00468858|27114892|P2|Overall Study|Lost to Follow-up|2
7803845|NCT00468858|27114893|P1|Overall Study|Lost to Follow-up|1
7803846|NCT00468858|27114891|P3|Overall Study|Relocation|3
7803847|NCT00468858|27114892|P2|Overall Study|Relocation|3
7803848|NCT00468858|27114893|P1|Overall Study|Relocation|1
7803849|NCT00468858|27114891|P3|Overall Study|Withdrawal by Subject|5
7803850|NCT00468858|27114892|P2|Overall Study|Withdrawal by Subject|4
7803851|NCT00468858|27114893|P1|Overall Study|Withdrawal by Subject|7
7803852|NCT00468858|27114891|P3|Overall Study|Adverse Event|0
7803853|NCT00468858|27114892|P2|Overall Study|Adverse Event|1
7803854|NCT00468858|27114893|P1|Overall Study|Adverse Event|0
7803855|NCT00468845|27115014|P3|Overall Study|Randomized, not treated|2
7803856|NCT00468845|27115015|P2|Overall Study|Randomized, not treated|4
7803857|NCT00468845|27115016|P1|Overall Study|Randomized, not treated|1
7803858|NCT00468845|27115014|P3|Overall Study|No longer willing to participate|10
7803859|NCT00468845|27115015|P2|Overall Study|No longer willing to participate|6
7803860|NCT00468845|27115016|P1|Overall Study|No longer willing to participate|5
7803861|NCT00468845|27115014|P3|Overall Study|Other|5
7803862|NCT00468845|27115015|P2|Overall Study|Other|9
7803863|NCT00468845|27115016|P1|Overall Study|Other|4
7803864|NCT00468845|27115014|P3|Overall Study|Lost to Follow-up|2
7803865|NCT00468845|27115015|P2|Overall Study|Lost to Follow-up|1
7803866|NCT00468845|27115016|P1|Overall Study|Lost to Follow-up|2
7803867|NCT00468845|27115014|P3|Overall Study|Adverse Event|11
7803868|NCT00468845|27115015|P2|Overall Study|Adverse Event|14
7803869|NCT00468845|27115016|P1|Overall Study|Adverse Event|9
7803870|NCT00468819|27115153|P3|Overall Study|Drop-outs (Treatment never received)|0
7803871|NCT00468819|27115154|P2|Overall Study|Drop-outs (Treatment never received)|0
7803872|NCT00468819|27115155|P1|Overall Study|Drop-outs (Treatment never received)|2
7803873|NCT00468819|27115153|P3|Overall Study|Lost to Follow-up|1
7803874|NCT00468819|27115154|P2|Overall Study|Lost to Follow-up|0
7803875|NCT00468819|27115155|P1|Overall Study|Lost to Follow-up|0
7803876|NCT00468819|27115153|P3|Overall Study|Withdrawal by Subject|1
7803877|NCT00468819|27115154|P2|Overall Study|Withdrawal by Subject|0
7803878|NCT00468819|27115155|P1|Overall Study|Withdrawal by Subject|4
7803879|NCT00468728|27115235|P2|Follow-up|mITT failure|31
7803880|NCT00468728|27115236|P1|Follow-up|mITT failure|34
7803881|NCT00468728|27115235|P2|Treatment|criteria for mITT population|11
7803882|NCT00468728|27115236|P1|Treatment|criteria for mITT population|4
7803883|NCT00468676|27115248|P2|Overall Study|Death|1
7803884|NCT00468676|27115249|P1|Overall Study|Death|2
7803885|NCT00468676|27115248|P2|Overall Study|Lost to Follow-up|11
7803886|NCT00468676|27115249|P1|Overall Study|Lost to Follow-up|14
7803887|NCT00468650|27115266|P1|Overall Study|Protocol Violation|1
7803888|NCT00468650|27115266|P1|Overall Study|Withdrawal by Subject|2
7803889|NCT00468650|27115266|P1|Overall Study|Lost to Follow-up|4
7803890|NCT00468585|27115314|P4|Overall Study|Withdrawal by Subject|1
7803891|NCT00468585|27115315|P3|Overall Study|Withdrawal by Subject|2
7803892|NCT00468585|27115316|P2|Overall Study|Withdrawal by Subject|0
7803893|NCT00468585|27115317|P1|Overall Study|Withdrawal by Subject|0
7803894|NCT00468585|27115314|P4|Overall Study|Adverse Event|0
7803895|NCT00468585|27115315|P3|Overall Study|Adverse Event|1
7803896|NCT00468585|27115316|P2|Overall Study|Adverse Event|0
7803897|NCT00468585|27115317|P1|Overall Study|Adverse Event|0
7803898|NCT00468585|27115314|P4|Overall Study|Patient found to be ineligible|0
7803899|NCT00468585|27115315|P3|Overall Study|Patient found to be ineligible|1
7803900|NCT00468585|27115316|P2|Overall Study|Patient found to be ineligible|0
7803901|NCT00468585|27115317|P1|Overall Study|Patient found to be ineligible|0
7803902|NCT00468585|27115314|P4|Overall Study|Patient not treated|0
7803903|NCT00468585|27115315|P3|Overall Study|Patient not treated|1
7803904|NCT00468585|27115316|P2|Overall Study|Patient not treated|0
7803905|NCT00468585|27115317|P1|Overall Study|Patient not treated|1
7803906|NCT00468559|27115329|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
7803907|NCT00468559|27115330|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
7803908|NCT00468559|27115331|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
7803909|NCT00468559|27115329|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
7803910|NCT00468559|27115330|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
7803995|NCT00468286|27115519|P2|Overall Study|Adverse Event|6
7803911|NCT00468559|27115331|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
7803912|NCT00468559|27115329|P3|Open-label Treatment Phase|Withdrawal by Subject|0
7803913|NCT00468559|27115330|P2|Open-label Treatment Phase|Withdrawal by Subject|0
7803914|NCT00468559|27115331|P1|Open-label Treatment Phase|Withdrawal by Subject|4
7803915|NCT00468559|27115329|P3|Open-label Treatment Phase|Lack of Efficacy|0
7803916|NCT00468559|27115330|P2|Open-label Treatment Phase|Lack of Efficacy|0
7803917|NCT00468559|27115331|P1|Open-label Treatment Phase|Lack of Efficacy|9
7803918|NCT00468559|27115329|P3|Open-label Treatment Phase|Adverse Event|0
7803919|NCT00468559|27115330|P2|Open-label Treatment Phase|Adverse Event|0
7803920|NCT00468559|27115331|P1|Open-label Treatment Phase|Adverse Event|5
7803921|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Other|14
7803922|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Other|17
7803923|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
7803924|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
7803925|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Failure to return|2
7803926|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Failure to return|1
7803927|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Refused treatment|7
7803928|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Refused treatment|4
7803929|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
7803930|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
7803931|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
7803932|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
7803933|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Death|0
7803934|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Death|1
7803935|NCT00468546|27115359|P2|Week 24 to Week 104 Analysis|Adverse Event|5
7803936|NCT00468546|27115360|P1|Week 24 to Week 104 Analysis|Adverse Event|2
7803937|NCT00468546|27115359|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
7803938|NCT00468546|27115360|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
7803939|NCT00468546|27115359|P2|Week 24 Analysis|Went onto rescue therapy|0
7803940|NCT00468546|27115360|P1|Week 24 Analysis|Went onto rescue therapy|1
7803941|NCT00468546|27115359|P2|Week 24 Analysis|Due to clinical hold|0
7803942|NCT00468546|27115360|P1|Week 24 Analysis|Due to clinical hold|1
7803943|NCT00468546|27115359|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
7803944|NCT00468546|27115360|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
7803945|NCT00468546|27115359|P2|Week 24 Analysis|Rescue therapy|0
7803946|NCT00468546|27115360|P1|Week 24 Analysis|Rescue therapy|2
7803947|NCT00468546|27115359|P2|Week 24 Analysis|Failure to return|4
7803948|NCT00468546|27115360|P1|Week 24 Analysis|Failure to return|3
7803949|NCT00468546|27115359|P2|Week 24 Analysis|Adverse Event|8
7803950|NCT00468546|27115360|P1|Week 24 Analysis|Adverse Event|1
7803951|NCT00468546|27115359|P2|Week 24 Analysis|Refused treatment|5
7803952|NCT00468546|27115360|P1|Week 24 Analysis|Refused treatment|5
7803953|NCT00468546|27115359|P2|Week 24 Analysis|Lack of Efficacy|37
7803954|NCT00468546|27115360|P1|Week 24 Analysis|Lack of Efficacy|83
7803955|NCT00468481|27115390|P2|Overall Study|Other|0
7803956|NCT00468481|27115391|P1|Overall Study|Other|6
7803957|NCT00468481|27115390|P2|Overall Study|Non-Compliance|0
7803958|NCT00468481|27115391|P1|Overall Study|Non-Compliance|5
7803959|NCT00468481|27115390|P2|Overall Study|Moved out of area|1
7803960|NCT00468481|27115391|P1|Overall Study|Moved out of area|4
7803961|NCT00468481|27115390|P2|Overall Study|Egg Donor|0
7803962|NCT00468481|27115391|P1|Overall Study|Egg Donor|1
7803963|NCT00468481|27115390|P2|Overall Study|Prohibited Medication|1
7803964|NCT00468481|27115391|P1|Overall Study|Prohibited Medication|1
7803965|NCT00468481|27115390|P2|Overall Study|susp/diag malignant/premalignant disease|0
7803966|NCT00468481|27115391|P1|Overall Study|susp/diag malignant/premalignant disease|1
7803967|NCT00468481|27115390|P2|Overall Study|Withdrawal by Subject|3
7803968|NCT00468481|27115391|P1|Overall Study|Withdrawal by Subject|12
7803969|NCT00468481|27115390|P2|Overall Study|Protocol Violation|8
7803970|NCT00468481|27115391|P1|Overall Study|Protocol Violation|18
7803971|NCT00468481|27115390|P2|Overall Study|Pregnancy|0
7803972|NCT00468481|27115391|P1|Overall Study|Pregnancy|2
7803973|NCT00468481|27115390|P2|Overall Study|Lost to Follow-up|8
7803974|NCT00468481|27115391|P1|Overall Study|Lost to Follow-up|25
7803975|NCT00468481|27115390|P2|Overall Study|Adverse Event|3
7803976|NCT00468481|27115391|P1|Overall Study|Adverse Event|13
7803977|NCT00468312|27115491|P2|Overall Study|Did not meet protocol eligibility|1
7803978|NCT00468312|27115492|P1|Overall Study|Did not meet protocol eligibility|0
7803979|NCT00468312|27115491|P2|Overall Study|Protocol Violation|1
7803980|NCT00468312|27115492|P1|Overall Study|Protocol Violation|2
7803981|NCT00468312|27115491|P2|Overall Study|Withdrawal by Subject|1
7803982|NCT00468312|27115492|P1|Overall Study|Withdrawal by Subject|0
7803983|NCT00468312|27115491|P2|Overall Study|Lack of Efficacy|1
7803984|NCT00468312|27115492|P1|Overall Study|Lack of Efficacy|0
7803985|NCT00468312|27115491|P2|Overall Study|Adverse Event|1
7803986|NCT00468312|27115492|P1|Overall Study|Adverse Event|2
7803987|NCT00468299|27115508|P2|Overall Study|Withdrawal by Subject|1
7803988|NCT00468299|27115509|P1|Overall Study|Withdrawal by Subject|0
7803989|NCT00468286|27115519|P2|Overall Study|Physician Decision|1
7803990|NCT00468286|27115520|P1|Overall Study|Physician Decision|0
7803991|NCT00468286|27115519|P2|Overall Study|Withdrawal by Subject|3
7803992|NCT00468286|27115520|P1|Overall Study|Withdrawal by Subject|4
7803993|NCT00468286|27115519|P2|Overall Study|Protocol Violation|2
7803994|NCT00468286|27115520|P1|Overall Study|Protocol Violation|2
7803996|NCT00468286|27115520|P1|Overall Study|Adverse Event|1
7803997|NCT00468169|27115552|P2|Overall Study|Withdrawal by Subject|0
7803998|NCT00468169|27115553|P1|Overall Study|Withdrawal by Subject|1
7803999|NCT00468143|27115569|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
7804000|NCT00468143|27115570|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
7804001|NCT00468143|27115569|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
7804002|NCT00468143|27115570|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
7804003|NCT00468104|27115584|P2|Second Intervention|discarded for malposition of chest tube|2
7804004|NCT00468104|27115585|P1|Second Intervention|discarded for malposition of chest tube|0
7804005|NCT00468104|27115584|P2|Second Intervention|Withdrawal by Subject|2
7804006|NCT00468104|27115585|P1|Second Intervention|Withdrawal by Subject|5
7804007|NCT00468104|27115584|P2|First Intervention|trapped lung|0
7804008|NCT00468104|27115585|P1|First Intervention|trapped lung|1
7804009|NCT00468104|27115584|P2|First Intervention|associated prolonged pneumothorax|0
7804010|NCT00468104|27115585|P1|First Intervention|associated prolonged pneumothorax|1
7804011|NCT00468104|27115584|P2|First Intervention|large lung mass with minimal effusion|0
7804012|NCT00468104|27115585|P1|First Intervention|large lung mass with minimal effusion|1
7804013|NCT00468104|27115584|P2|First Intervention|malposition/blocked chest tube tube|0
7804014|NCT00468104|27115585|P1|First Intervention|malposition/blocked chest tube tube|2
7804015|NCT00468104|27115584|P2|First Intervention|died within 3 weeks|0
7804016|NCT00468104|27115585|P1|First Intervention|died within 3 weeks|1
7804017|NCT00468104|27115584|P2|First Intervention|bleeding at chest tube site--first dose|0
7804018|NCT00468104|27115585|P1|First Intervention|bleeding at chest tube site--first dose|1
7804019|NCT00468104|27115584|P2|First Intervention|Protocol Violation|1
7804020|NCT00468104|27115585|P1|First Intervention|Protocol Violation|2
7804021|NCT00468052|27115602|P2|Overall Study|Protocol Violation|8
7804022|NCT00468052|27115603|P1|Overall Study|Protocol Violation|7
7804023|NCT00467961|27115621|P1|Overall Study|Disease Progression|2
7804024|NCT00467961|27115621|P1|Overall Study|Technical Failures|5
7804025|NCT00467896|27115625|P1|Overall Study|Patient had no improvement|1
7804026|NCT00467896|27115625|P1|Overall Study|Started inhaled Remodulin|1
7804027|NCT00467896|27115625|P1|Overall Study|Started intravenous prostacyclin|1
7804028|NCT00467896|27115625|P1|Overall Study|Mainly used Prodose not I-neb® device|1
7804029|NCT00467896|27115625|P1|Overall Study|Patient weaned off iloprost|1
7804030|NCT00467896|27115625|P1|Overall Study|Patient had atrial septostomy|1
7804031|NCT00467896|27115625|P1|Overall Study|Patient received transplant|2
7804032|NCT00467896|27115625|P1|Overall Study|Changed therapy|2
7804033|NCT00467896|27115625|P1|Overall Study|Non-compliance|3
7804034|NCT00467896|27115625|P1|Overall Study|Serious Adverse Event|13
7804035|NCT00467896|27115625|P1|Overall Study|Adverse Event|7
7804036|NCT00467896|27115625|P1|Overall Study|Consent Withdrawal|18
7804037|NCT00467870|27115651|P6|Overall Study|Other/Unknown|0
7804038|NCT00467870|27115652|P5|Overall Study|Other/Unknown|4
7804039|NCT00467870|27115653|P4|Overall Study|Other/Unknown|5
7804040|NCT00467870|27115654|P3|Overall Study|Other/Unknown|1
7804041|NCT00467870|27115655|P2|Overall Study|Other/Unknown|5
7804042|NCT00467870|27115656|P1|Overall Study|Other/Unknown|8
7804043|NCT00467870|27115651|P6|Overall Study|Subject Non-compliance|0
7804044|NCT00467870|27115652|P5|Overall Study|Subject Non-compliance|5
7804045|NCT00467870|27115653|P4|Overall Study|Subject Non-compliance|1
7804046|NCT00467870|27115654|P3|Overall Study|Subject Non-compliance|0
7804047|NCT00467870|27115655|P2|Overall Study|Subject Non-compliance|4
7804048|NCT00467870|27115656|P1|Overall Study|Subject Non-compliance|3
7804049|NCT00467870|27115651|P6|Overall Study|Lost to Follow-up|0
7804050|NCT00467870|27115652|P5|Overall Study|Lost to Follow-up|3
7804051|NCT00467870|27115653|P4|Overall Study|Lost to Follow-up|1
7804052|NCT00467870|27115654|P3|Overall Study|Lost to Follow-up|1
7804053|NCT00467870|27115655|P2|Overall Study|Lost to Follow-up|3
7804054|NCT00467870|27115656|P1|Overall Study|Lost to Follow-up|5
7804055|NCT00467870|27115651|P6|Overall Study|Withdrawal by Subject|1
7804056|NCT00467870|27115652|P5|Overall Study|Withdrawal by Subject|10
7804057|NCT00467870|27115653|P4|Overall Study|Withdrawal by Subject|9
7804058|NCT00467870|27115654|P3|Overall Study|Withdrawal by Subject|0
7804059|NCT00467870|27115655|P2|Overall Study|Withdrawal by Subject|21
7804060|NCT00467870|27115656|P1|Overall Study|Withdrawal by Subject|14
7804061|NCT00467870|27115651|P6|Overall Study|Protocol Violation|0
7804062|NCT00467870|27115652|P5|Overall Study|Protocol Violation|0
7804063|NCT00467870|27115653|P4|Overall Study|Protocol Violation|2
7804064|NCT00467870|27115654|P3|Overall Study|Protocol Violation|1
7804065|NCT00467870|27115655|P2|Overall Study|Protocol Violation|1
7804066|NCT00467870|27115656|P1|Overall Study|Protocol Violation|2
7804067|NCT00467870|27115651|P6|Overall Study|Adverse Event|1
7804068|NCT00467870|27115652|P5|Overall Study|Adverse Event|15
7804069|NCT00467870|27115653|P4|Overall Study|Adverse Event|15
7804070|NCT00467870|27115654|P3|Overall Study|Adverse Event|1
7804071|NCT00467870|27115655|P2|Overall Study|Adverse Event|9
7804072|NCT00467870|27115656|P1|Overall Study|Adverse Event|13
7804073|NCT00467857|27115699|P2|Overall Study|Discontinuation reason missing|3
7804074|NCT00467857|27115700|P1|Overall Study|Discontinuation reason missing|0
7804075|NCT00467857|27115699|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
7804076|NCT00467857|27115700|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
7804077|NCT00467857|27115699|P2|Overall Study|Emergency care required|1
7804078|NCT00467857|27115700|P1|Overall Study|Emergency care required|0
7804079|NCT00467857|27115699|P2|Overall Study|Discharged from court service|1
7804080|NCT00467857|27115700|P1|Overall Study|Discharged from court service|0
7804081|NCT00467857|27115699|P2|Overall Study|Death|1
7804082|NCT00467857|27115700|P1|Overall Study|Death|0
7804083|NCT00467857|27115699|P2|Overall Study|Withdrew consent|0
7804084|NCT00467857|27115700|P1|Overall Study|Withdrew consent|2
7804085|NCT00467857|27115699|P2|Overall Study|Adverse Event|0
7804086|NCT00467857|27115700|P1|Overall Study|Adverse Event|1
7804087|NCT00467831|27115748|P1|Overall Study|Withdrawal by Subject|1
7804088|NCT00467831|27115748|P1|Overall Study|Death|2
7804089|NCT00467818|27115754|P2|Overall Study|Lost to Follow-up|2
7804090|NCT00467818|27115755|P1|Overall Study|Lost to Follow-up|2
7804091|NCT00467818|27115754|P2|Overall Study|Adverse Event|0
7804092|NCT00467818|27115755|P1|Overall Study|Adverse Event|1
7804093|NCT00467779|27115784|P15|Stage 3|Unspecified Reason|5
7804094|NCT00467779|27115785|P14|Stage 3|Unspecified Reason|0
7804095|NCT00467779|27115786|P13|Stage 3|Unspecified Reason|0
7804096|NCT00467779|27115787|P12|Stage 3|Unspecified Reason|0
7804097|NCT00467779|27115788|P11|Stage 3|Unspecified Reason|0
7804098|NCT00467779|27115789|P10|Stage 3|Unspecified Reason|0
7804099|NCT00467779|27115790|P9|Stage 3|Unspecified Reason|0
7804100|NCT00467779|27115791|P8|Stage 3|Unspecified Reason|0
7804101|NCT00467779|27115792|P7|Stage 3|Unspecified Reason|0
7804102|NCT00467779|27115793|P6|Stage 3|Unspecified Reason|0
7804103|NCT00467779|27115794|P5|Stage 3|Unspecified Reason|0
7804104|NCT00467779|27115795|P4|Stage 3|Unspecified Reason|0
7804105|NCT00467779|27115796|P3|Stage 3|Unspecified Reason|0
7804106|NCT00467779|27115797|P2|Stage 3|Unspecified Reason|0
7804107|NCT00467779|27115798|P1|Stage 3|Unspecified Reason|0
7804108|NCT00467779|27115784|P15|Stage 3|Disease Progression|9
7804109|NCT00467779|27115785|P14|Stage 3|Disease Progression|0
7804110|NCT00467779|27115786|P13|Stage 3|Disease Progression|0
7804111|NCT00467779|27115787|P12|Stage 3|Disease Progression|0
7804112|NCT00467779|27115788|P11|Stage 3|Disease Progression|0
7804113|NCT00467779|27115789|P10|Stage 3|Disease Progression|0
7804114|NCT00467779|27115790|P9|Stage 3|Disease Progression|0
7804115|NCT00467779|27115791|P8|Stage 3|Disease Progression|0
7804116|NCT00467779|27115792|P7|Stage 3|Disease Progression|0
7804117|NCT00467779|27115793|P6|Stage 3|Disease Progression|0
7804118|NCT00467779|27115794|P5|Stage 3|Disease Progression|0
7804119|NCT00467779|27115795|P4|Stage 3|Disease Progression|0
7804120|NCT00467779|27115796|P3|Stage 3|Disease Progression|0
7804121|NCT00467779|27115797|P2|Stage 3|Disease Progression|0
7804122|NCT00467779|27115798|P1|Stage 3|Disease Progression|0
7804123|NCT00467779|27115784|P15|Stage 3|Death|1
7804124|NCT00467779|27115785|P14|Stage 3|Death|0
7804125|NCT00467779|27115786|P13|Stage 3|Death|0
7804126|NCT00467779|27115787|P12|Stage 3|Death|0
7804127|NCT00467779|27115788|P11|Stage 3|Death|0
7804128|NCT00467779|27115789|P10|Stage 3|Death|0
7804129|NCT00467779|27115790|P9|Stage 3|Death|0
7804130|NCT00467779|27115791|P8|Stage 3|Death|0
7804131|NCT00467779|27115792|P7|Stage 3|Death|0
7804132|NCT00467779|27115793|P6|Stage 3|Death|0
7804133|NCT00467779|27115794|P5|Stage 3|Death|0
7804134|NCT00467779|27115795|P4|Stage 3|Death|0
7804135|NCT00467779|27115796|P3|Stage 3|Death|0
7804136|NCT00467779|27115797|P2|Stage 3|Death|0
7804137|NCT00467779|27115798|P1|Stage 3|Death|0
7804138|NCT00467779|27115784|P15|Stage 3|Adverse Event|2
7804139|NCT00467779|27115785|P14|Stage 3|Adverse Event|0
7804140|NCT00467779|27115786|P13|Stage 3|Adverse Event|0
7804141|NCT00467779|27115787|P12|Stage 3|Adverse Event|0
7804142|NCT00467779|27115788|P11|Stage 3|Adverse Event|0
7804143|NCT00467779|27115789|P10|Stage 3|Adverse Event|0
7804144|NCT00467779|27115790|P9|Stage 3|Adverse Event|0
7804145|NCT00467779|27115791|P8|Stage 3|Adverse Event|0
7804146|NCT00467779|27115792|P7|Stage 3|Adverse Event|0
7804147|NCT00467779|27115793|P6|Stage 3|Adverse Event|0
7804148|NCT00467779|27115794|P5|Stage 3|Adverse Event|0
7804149|NCT00467779|27115795|P4|Stage 3|Adverse Event|0
7804150|NCT00467779|27115796|P3|Stage 3|Adverse Event|0
7804151|NCT00467779|27115797|P2|Stage 3|Adverse Event|0
7804152|NCT00467779|27115798|P1|Stage 3|Adverse Event|0
7804153|NCT00467779|27115784|P15|Stage 2A|Withdrawal by Subject|0
7804154|NCT00467779|27115785|P14|Stage 2A|Withdrawal by Subject|1
7804155|NCT00467779|27115786|P13|Stage 2A|Withdrawal by Subject|0
7804156|NCT00467779|27115787|P12|Stage 2A|Withdrawal by Subject|0
7804157|NCT00467779|27115788|P11|Stage 2A|Withdrawal by Subject|0
7804158|NCT00467779|27115789|P10|Stage 2A|Withdrawal by Subject|0
7804159|NCT00467779|27115790|P9|Stage 2A|Withdrawal by Subject|0
7804160|NCT00467779|27115791|P8|Stage 2A|Withdrawal by Subject|0
7804161|NCT00467779|27115792|P7|Stage 2A|Withdrawal by Subject|0
7804162|NCT00467779|27115793|P6|Stage 2A|Withdrawal by Subject|0
7804163|NCT00467779|27115794|P5|Stage 2A|Withdrawal by Subject|0
7804164|NCT00467779|27115795|P4|Stage 2A|Withdrawal by Subject|0
7804165|NCT00467779|27115796|P3|Stage 2A|Withdrawal by Subject|0
7804166|NCT00467779|27115797|P2|Stage 2A|Withdrawal by Subject|0
7804167|NCT00467779|27115798|P1|Stage 2A|Withdrawal by Subject|0
7804168|NCT00467779|27115784|P15|Stage 2A|Unspecified Reason|0
7804169|NCT00467779|27115785|P14|Stage 2A|Unspecified Reason|7
7804170|NCT00467779|27115786|P13|Stage 2A|Unspecified Reason|0
7804171|NCT00467779|27115787|P12|Stage 2A|Unspecified Reason|0
7804172|NCT00467779|27115788|P11|Stage 2A|Unspecified Reason|0
7804173|NCT00467779|27115789|P10|Stage 2A|Unspecified Reason|0
7804174|NCT00467779|27115790|P9|Stage 2A|Unspecified Reason|0
7804175|NCT00467779|27115791|P8|Stage 2A|Unspecified Reason|0
7804176|NCT00467779|27115792|P7|Stage 2A|Unspecified Reason|0
7804177|NCT00467779|27115793|P6|Stage 2A|Unspecified Reason|0
7804178|NCT00467779|27115794|P5|Stage 2A|Unspecified Reason|0
7804179|NCT00467779|27115795|P4|Stage 2A|Unspecified Reason|0
7804180|NCT00467779|27115796|P3|Stage 2A|Unspecified Reason|0
7804181|NCT00467779|27115797|P2|Stage 2A|Unspecified Reason|0
7804182|NCT00467779|27115798|P1|Stage 2A|Unspecified Reason|0
7804183|NCT00467779|27115784|P15|Stage 2A|Disease Progression|0
7804184|NCT00467779|27115785|P14|Stage 2A|Disease Progression|10
7804185|NCT00467779|27115786|P13|Stage 2A|Disease Progression|0
7804186|NCT00467779|27115787|P12|Stage 2A|Disease Progression|0
7804187|NCT00467779|27115788|P11|Stage 2A|Disease Progression|0
7804188|NCT00467779|27115789|P10|Stage 2A|Disease Progression|0
7804189|NCT00467779|27115790|P9|Stage 2A|Disease Progression|0
7804190|NCT00467779|27115791|P8|Stage 2A|Disease Progression|0
7804191|NCT00467779|27115792|P7|Stage 2A|Disease Progression|0
7804192|NCT00467779|27115793|P6|Stage 2A|Disease Progression|0
7804193|NCT00467779|27115794|P5|Stage 2A|Disease Progression|0
7804194|NCT00467779|27115795|P4|Stage 2A|Disease Progression|0
7804195|NCT00467779|27115796|P3|Stage 2A|Disease Progression|0
7804196|NCT00467779|27115797|P2|Stage 2A|Disease Progression|0
7804197|NCT00467779|27115798|P1|Stage 2A|Disease Progression|0
7804198|NCT00467779|27115784|P15|Stage 2A|Death|0
7804199|NCT00467779|27115785|P14|Stage 2A|Death|1
7804200|NCT00467779|27115786|P13|Stage 2A|Death|0
7804201|NCT00467779|27115787|P12|Stage 2A|Death|0
7804202|NCT00467779|27115788|P11|Stage 2A|Death|0
7804203|NCT00467779|27115789|P10|Stage 2A|Death|0
7804204|NCT00467779|27115790|P9|Stage 2A|Death|0
7804205|NCT00467779|27115791|P8|Stage 2A|Death|0
7804206|NCT00467779|27115792|P7|Stage 2A|Death|0
7804207|NCT00467779|27115793|P6|Stage 2A|Death|0
7804208|NCT00467779|27115794|P5|Stage 2A|Death|0
7804209|NCT00467779|27115795|P4|Stage 2A|Death|0
7804210|NCT00467779|27115796|P3|Stage 2A|Death|0
7804211|NCT00467779|27115797|P2|Stage 2A|Death|0
7804212|NCT00467779|27115798|P1|Stage 2A|Death|0
7804213|NCT00467779|27115784|P15|Stage 2A|Adverse Event|0
7804214|NCT00467779|27115785|P14|Stage 2A|Adverse Event|2
7804215|NCT00467779|27115786|P13|Stage 2A|Adverse Event|0
7804216|NCT00467779|27115787|P12|Stage 2A|Adverse Event|0
7804217|NCT00467779|27115788|P11|Stage 2A|Adverse Event|0
7804218|NCT00467779|27115789|P10|Stage 2A|Adverse Event|0
7804219|NCT00467779|27115790|P9|Stage 2A|Adverse Event|0
7804220|NCT00467779|27115791|P8|Stage 2A|Adverse Event|0
7804221|NCT00467779|27115792|P7|Stage 2A|Adverse Event|0
7804222|NCT00467779|27115793|P6|Stage 2A|Adverse Event|0
7804223|NCT00467779|27115794|P5|Stage 2A|Adverse Event|0
7804224|NCT00467779|27115795|P4|Stage 2A|Adverse Event|0
7804225|NCT00467779|27115796|P3|Stage 2A|Adverse Event|0
7804226|NCT00467779|27115797|P2|Stage 2A|Adverse Event|0
7804227|NCT00467779|27115798|P1|Stage 2A|Adverse Event|0
7804228|NCT00467779|27115784|P15|Stage 2|Unspecified Reason|0
7804229|NCT00467779|27115785|P14|Stage 2|Unspecified Reason|0
7804230|NCT00467779|27115786|P13|Stage 2|Unspecified Reason|0
7804231|NCT00467779|27115787|P12|Stage 2|Unspecified Reason|0
7804232|NCT00467779|27115788|P11|Stage 2|Unspecified Reason|0
7804233|NCT00467779|27115789|P10|Stage 2|Unspecified Reason|0
7804234|NCT00467779|27115790|P9|Stage 2|Unspecified Reason|3
7804235|NCT00467779|27115791|P8|Stage 2|Unspecified Reason|0
7804236|NCT00467779|27115792|P7|Stage 2|Unspecified Reason|0
7804237|NCT00467779|27115793|P6|Stage 2|Unspecified Reason|0
7804238|NCT00467779|27115794|P5|Stage 2|Unspecified Reason|0
7804239|NCT00467779|27115795|P4|Stage 2|Unspecified Reason|0
7804240|NCT00467779|27115796|P3|Stage 2|Unspecified Reason|0
7804241|NCT00467779|27115797|P2|Stage 2|Unspecified Reason|0
7804242|NCT00467779|27115798|P1|Stage 2|Unspecified Reason|0
7804243|NCT00467779|27115784|P15|Stage 2|Disease Progression|0
7804244|NCT00467779|27115785|P14|Stage 2|Disease Progression|0
7804245|NCT00467779|27115786|P13|Stage 2|Disease Progression|0
7804246|NCT00467779|27115787|P12|Stage 2|Disease Progression|0
7804247|NCT00467779|27115788|P11|Stage 2|Disease Progression|0
7804248|NCT00467779|27115789|P10|Stage 2|Disease Progression|0
7804249|NCT00467779|27115790|P9|Stage 2|Disease Progression|16
7804250|NCT00467779|27115791|P8|Stage 2|Disease Progression|0
7804251|NCT00467779|27115792|P7|Stage 2|Disease Progression|0
7804252|NCT00467779|27115793|P6|Stage 2|Disease Progression|0
7804253|NCT00467779|27115794|P5|Stage 2|Disease Progression|0
7804254|NCT00467779|27115795|P4|Stage 2|Disease Progression|0
7804255|NCT00467779|27115796|P3|Stage 2|Disease Progression|0
7804256|NCT00467779|27115797|P2|Stage 2|Disease Progression|0
7804257|NCT00467779|27115798|P1|Stage 2|Disease Progression|0
7804258|NCT00467779|27115784|P15|Stage 2|Death|0
7804259|NCT00467779|27115785|P14|Stage 2|Death|0
7804260|NCT00467779|27115786|P13|Stage 2|Death|0
7804261|NCT00467779|27115787|P12|Stage 2|Death|0
7804262|NCT00467779|27115788|P11|Stage 2|Death|0
7804263|NCT00467779|27115789|P10|Stage 2|Death|0
7804264|NCT00467779|27115790|P9|Stage 2|Death|1
7804265|NCT00467779|27115791|P8|Stage 2|Death|0
7804266|NCT00467779|27115792|P7|Stage 2|Death|0
7804267|NCT00467779|27115793|P6|Stage 2|Death|0
7804268|NCT00467779|27115794|P5|Stage 2|Death|0
7804269|NCT00467779|27115795|P4|Stage 2|Death|0
7804270|NCT00467779|27115796|P3|Stage 2|Death|0
7804271|NCT00467779|27115797|P2|Stage 2|Death|0
7804272|NCT00467779|27115798|P1|Stage 2|Death|0
7804273|NCT00467779|27115784|P15|Stage 2|Adverse Event|0
7804274|NCT00467779|27115785|P14|Stage 2|Adverse Event|0
7804275|NCT00467779|27115786|P13|Stage 2|Adverse Event|0
7804276|NCT00467779|27115787|P12|Stage 2|Adverse Event|0
7804277|NCT00467779|27115788|P11|Stage 2|Adverse Event|0
7804278|NCT00467779|27115789|P10|Stage 2|Adverse Event|0
7804279|NCT00467779|27115790|P9|Stage 2|Adverse Event|1
7804280|NCT00467779|27115791|P8|Stage 2|Adverse Event|0
7804281|NCT00467779|27115792|P7|Stage 2|Adverse Event|0
7804282|NCT00467779|27115793|P6|Stage 2|Adverse Event|0
7804283|NCT00467779|27115794|P5|Stage 2|Adverse Event|0
7804284|NCT00467779|27115795|P4|Stage 2|Adverse Event|0
7804285|NCT00467779|27115796|P3|Stage 2|Adverse Event|0
7804286|NCT00467779|27115797|P2|Stage 2|Adverse Event|0
7804287|NCT00467779|27115798|P1|Stage 2|Adverse Event|0
7804288|NCT00467779|27115784|P15|Stage 1A|Unspecified Reason|0
7804289|NCT00467779|27115785|P14|Stage 1A|Unspecified Reason|0
7804290|NCT00467779|27115786|P13|Stage 1A|Unspecified Reason|1
7804291|NCT00467779|27115787|P12|Stage 1A|Unspecified Reason|1
7804292|NCT00467779|27115788|P11|Stage 1A|Unspecified Reason|0
7804293|NCT00467779|27115789|P10|Stage 1A|Unspecified Reason|0
7804294|NCT00467779|27115790|P9|Stage 1A|Unspecified Reason|0
7804295|NCT00467779|27115791|P8|Stage 1A|Unspecified Reason|0
7804296|NCT00467779|27115792|P7|Stage 1A|Unspecified Reason|0
7804297|NCT00467779|27115793|P6|Stage 1A|Unspecified Reason|0
7804298|NCT00467779|27115794|P5|Stage 1A|Unspecified Reason|0
7804299|NCT00467779|27115795|P4|Stage 1A|Unspecified Reason|0
7804300|NCT00467779|27115796|P3|Stage 1A|Unspecified Reason|0
7804301|NCT00467779|27115797|P2|Stage 1A|Unspecified Reason|0
7804302|NCT00467779|27115798|P1|Stage 1A|Unspecified Reason|0
7804303|NCT00467779|27115784|P15|Stage 1A|Withdrawal by Subject|0
7804304|NCT00467779|27115785|P14|Stage 1A|Withdrawal by Subject|0
7804305|NCT00467779|27115786|P13|Stage 1A|Withdrawal by Subject|1
7804306|NCT00467779|27115787|P12|Stage 1A|Withdrawal by Subject|1
7804307|NCT00467779|27115788|P11|Stage 1A|Withdrawal by Subject|1
7804308|NCT00467779|27115789|P10|Stage 1A|Withdrawal by Subject|0
7804309|NCT00467779|27115790|P9|Stage 1A|Withdrawal by Subject|0
7804310|NCT00467779|27115791|P8|Stage 1A|Withdrawal by Subject|0
7804311|NCT00467779|27115792|P7|Stage 1A|Withdrawal by Subject|0
7804312|NCT00467779|27115793|P6|Stage 1A|Withdrawal by Subject|0
7804313|NCT00467779|27115794|P5|Stage 1A|Withdrawal by Subject|0
7804314|NCT00467779|27115795|P4|Stage 1A|Withdrawal by Subject|0
7804315|NCT00467779|27115796|P3|Stage 1A|Withdrawal by Subject|0
7804316|NCT00467779|27115797|P2|Stage 1A|Withdrawal by Subject|0
7804317|NCT00467779|27115798|P1|Stage 1A|Withdrawal by Subject|0
7804318|NCT00467779|27115784|P15|Stage 1A|Physician Decision|0
7804319|NCT00467779|27115785|P14|Stage 1A|Physician Decision|0
7804320|NCT00467779|27115786|P13|Stage 1A|Physician Decision|0
7804321|NCT00467779|27115787|P12|Stage 1A|Physician Decision|0
7804322|NCT00467779|27115788|P11|Stage 1A|Physician Decision|0
7804323|NCT00467779|27115789|P10|Stage 1A|Physician Decision|1
7804324|NCT00467779|27115790|P9|Stage 1A|Physician Decision|0
7804325|NCT00467779|27115791|P8|Stage 1A|Physician Decision|0
7804326|NCT00467779|27115792|P7|Stage 1A|Physician Decision|0
7804327|NCT00467779|27115793|P6|Stage 1A|Physician Decision|0
7804328|NCT00467779|27115794|P5|Stage 1A|Physician Decision|0
7804329|NCT00467779|27115795|P4|Stage 1A|Physician Decision|0
7804330|NCT00467779|27115796|P3|Stage 1A|Physician Decision|0
7804331|NCT00467779|27115797|P2|Stage 1A|Physician Decision|0
7804332|NCT00467779|27115798|P1|Stage 1A|Physician Decision|0
7804333|NCT00467779|27115784|P15|Stage 1A|Disease Progression|0
7804334|NCT00467779|27115785|P14|Stage 1A|Disease Progression|0
7804335|NCT00467779|27115786|P13|Stage 1A|Disease Progression|2
7804336|NCT00467779|27115787|P12|Stage 1A|Disease Progression|5
7804337|NCT00467779|27115788|P11|Stage 1A|Disease Progression|2
7804338|NCT00467779|27115789|P10|Stage 1A|Disease Progression|2
7804339|NCT00467779|27115790|P9|Stage 1A|Disease Progression|0
7804340|NCT00467779|27115791|P8|Stage 1A|Disease Progression|0
7804341|NCT00467779|27115792|P7|Stage 1A|Disease Progression|0
7804342|NCT00467779|27115793|P6|Stage 1A|Disease Progression|0
7804343|NCT00467779|27115794|P5|Stage 1A|Disease Progression|0
7804344|NCT00467779|27115795|P4|Stage 1A|Disease Progression|0
7804345|NCT00467779|27115796|P3|Stage 1A|Disease Progression|0
7804346|NCT00467779|27115797|P2|Stage 1A|Disease Progression|0
7804347|NCT00467779|27115798|P1|Stage 1A|Disease Progression|0
7804348|NCT00467779|27115784|P15|Stage 1A|Death|0
7804349|NCT00467779|27115785|P14|Stage 1A|Death|0
7804350|NCT00467779|27115786|P13|Stage 1A|Death|1
7804351|NCT00467779|27115787|P12|Stage 1A|Death|1
7804352|NCT00467779|27115788|P11|Stage 1A|Death|0
7804353|NCT00467779|27115789|P10|Stage 1A|Death|0
7804354|NCT00467779|27115790|P9|Stage 1A|Death|0
7804355|NCT00467779|27115791|P8|Stage 1A|Death|0
7804356|NCT00467779|27115792|P7|Stage 1A|Death|0
7804357|NCT00467779|27115793|P6|Stage 1A|Death|0
7804358|NCT00467779|27115794|P5|Stage 1A|Death|0
7804359|NCT00467779|27115795|P4|Stage 1A|Death|0
7804360|NCT00467779|27115796|P3|Stage 1A|Death|0
7804361|NCT00467779|27115797|P2|Stage 1A|Death|0
7804362|NCT00467779|27115798|P1|Stage 1A|Death|0
7804363|NCT00467779|27115784|P15|Stage 1A|Adverse Event|0
7804364|NCT00467779|27115785|P14|Stage 1A|Adverse Event|0
7804365|NCT00467779|27115786|P13|Stage 1A|Adverse Event|1
7804366|NCT00467779|27115787|P12|Stage 1A|Adverse Event|0
7804367|NCT00467779|27115788|P11|Stage 1A|Adverse Event|0
7804368|NCT00467779|27115789|P10|Stage 1A|Adverse Event|0
7804369|NCT00467779|27115790|P9|Stage 1A|Adverse Event|0
7804370|NCT00467779|27115791|P8|Stage 1A|Adverse Event|0
7804371|NCT00467779|27115792|P7|Stage 1A|Adverse Event|0
7804372|NCT00467779|27115793|P6|Stage 1A|Adverse Event|0
7804373|NCT00467779|27115794|P5|Stage 1A|Adverse Event|0
7804374|NCT00467779|27115795|P4|Stage 1A|Adverse Event|0
7804375|NCT00467779|27115796|P3|Stage 1A|Adverse Event|0
7804376|NCT00467779|27115797|P2|Stage 1A|Adverse Event|0
7804377|NCT00467779|27115798|P1|Stage 1A|Adverse Event|0
7804378|NCT00467779|27115784|P15|Stage 1|Withdrawal by Subject|0
7804379|NCT00467779|27115785|P14|Stage 1|Withdrawal by Subject|0
7804380|NCT00467779|27115786|P13|Stage 1|Withdrawal by Subject|0
7804381|NCT00467779|27115787|P12|Stage 1|Withdrawal by Subject|0
7804382|NCT00467779|27115788|P11|Stage 1|Withdrawal by Subject|0
7804383|NCT00467779|27115789|P10|Stage 1|Withdrawal by Subject|0
7804384|NCT00467779|27115790|P9|Stage 1|Withdrawal by Subject|0
7804385|NCT00467779|27115791|P8|Stage 1|Withdrawal by Subject|1
7804386|NCT00467779|27115792|P7|Stage 1|Withdrawal by Subject|1
7804387|NCT00467779|27115793|P6|Stage 1|Withdrawal by Subject|0
7804388|NCT00467779|27115794|P5|Stage 1|Withdrawal by Subject|0
7804389|NCT00467779|27115795|P4|Stage 1|Withdrawal by Subject|0
7804390|NCT00467779|27115796|P3|Stage 1|Withdrawal by Subject|0
7804391|NCT00467779|27115797|P2|Stage 1|Withdrawal by Subject|0
7804392|NCT00467779|27115798|P1|Stage 1|Withdrawal by Subject|0
7804393|NCT00467779|27115784|P15|Stage 1|Physician Decision|0
7804394|NCT00467779|27115785|P14|Stage 1|Physician Decision|0
7804395|NCT00467779|27115786|P13|Stage 1|Physician Decision|0
7804396|NCT00467779|27115787|P12|Stage 1|Physician Decision|0
7804397|NCT00467779|27115788|P11|Stage 1|Physician Decision|0
7804398|NCT00467779|27115789|P10|Stage 1|Physician Decision|0
7804399|NCT00467779|27115790|P9|Stage 1|Physician Decision|0
7804400|NCT00467779|27115791|P8|Stage 1|Physician Decision|0
7804401|NCT00467779|27115792|P7|Stage 1|Physician Decision|0
7804402|NCT00467779|27115793|P6|Stage 1|Physician Decision|0
7804403|NCT00467779|27115794|P5|Stage 1|Physician Decision|0
7804404|NCT00467779|27115795|P4|Stage 1|Physician Decision|0
7804405|NCT00467779|27115796|P3|Stage 1|Physician Decision|0
7804406|NCT00467779|27115797|P2|Stage 1|Physician Decision|1
7804407|NCT00467779|27115798|P1|Stage 1|Physician Decision|0
7804408|NCT00467779|27115784|P15|Stage 1|Unspecified Reason|0
7804409|NCT00467779|27115785|P14|Stage 1|Unspecified Reason|0
7804410|NCT00467779|27115786|P13|Stage 1|Unspecified Reason|0
7804411|NCT00467779|27115787|P12|Stage 1|Unspecified Reason|0
7804412|NCT00467779|27115788|P11|Stage 1|Unspecified Reason|0
7804413|NCT00467779|27115789|P10|Stage 1|Unspecified Reason|0
7804414|NCT00467779|27115790|P9|Stage 1|Unspecified Reason|0
7804415|NCT00467779|27115791|P8|Stage 1|Unspecified Reason|0
7804416|NCT00467779|27115792|P7|Stage 1|Unspecified Reason|0
7804417|NCT00467779|27115793|P6|Stage 1|Unspecified Reason|2
7804418|NCT00467779|27115794|P5|Stage 1|Unspecified Reason|1
7804419|NCT00467779|27115795|P4|Stage 1|Unspecified Reason|0
7804420|NCT00467779|27115796|P3|Stage 1|Unspecified Reason|1
7804421|NCT00467779|27115797|P2|Stage 1|Unspecified Reason|0
7804422|NCT00467779|27115798|P1|Stage 1|Unspecified Reason|1
7804423|NCT00467779|27115784|P15|Stage 1|Disease Progression|0
7804424|NCT00467779|27115785|P14|Stage 1|Disease Progression|0
7804425|NCT00467779|27115786|P13|Stage 1|Disease Progression|0
7804426|NCT00467779|27115787|P12|Stage 1|Disease Progression|0
7804427|NCT00467779|27115788|P11|Stage 1|Disease Progression|0
7804428|NCT00467779|27115789|P10|Stage 1|Disease Progression|0
7804429|NCT00467779|27115790|P9|Stage 1|Disease Progression|0
7804430|NCT00467779|27115791|P8|Stage 1|Disease Progression|5
7804431|NCT00467779|27115792|P7|Stage 1|Disease Progression|4
7804432|NCT00467779|27115793|P6|Stage 1|Disease Progression|2
7804433|NCT00467779|27115794|P5|Stage 1|Disease Progression|2
7804434|NCT00467779|27115795|P4|Stage 1|Disease Progression|3
7804435|NCT00467779|27115796|P3|Stage 1|Disease Progression|2
7804436|NCT00467779|27115797|P2|Stage 1|Disease Progression|2
7804437|NCT00467779|27115798|P1|Stage 1|Disease Progression|2
7804438|NCT00467779|27115784|P15|Stage 1|Adverse Event|0
7804439|NCT00467779|27115785|P14|Stage 1|Adverse Event|0
7804440|NCT00467779|27115786|P13|Stage 1|Adverse Event|0
7804441|NCT00467779|27115787|P12|Stage 1|Adverse Event|0
7804442|NCT00467779|27115788|P11|Stage 1|Adverse Event|0
7804443|NCT00467779|27115789|P10|Stage 1|Adverse Event|0
7804444|NCT00467779|27115790|P9|Stage 1|Adverse Event|0
7804445|NCT00467779|27115791|P8|Stage 1|Adverse Event|1
7804446|NCT00467779|27115792|P7|Stage 1|Adverse Event|2
7804447|NCT00467779|27115793|P6|Stage 1|Adverse Event|1
7804448|NCT00467779|27115794|P5|Stage 1|Adverse Event|0
7804449|NCT00467779|27115795|P4|Stage 1|Adverse Event|0
7804450|NCT00467779|27115796|P3|Stage 1|Adverse Event|0
7804451|NCT00467779|27115797|P2|Stage 1|Adverse Event|0
7804452|NCT00467779|27115798|P1|Stage 1|Adverse Event|1
7804453|NCT00467753|27115972|P2|Overall Study|Adverse Event|0
7804454|NCT00467753|27115973|P1|Overall Study|Adverse Event|2
7804455|NCT00467753|27115972|P2|Overall Study|Lost to Follow-up|2
7804456|NCT00467753|27115973|P1|Overall Study|Lost to Follow-up|1
7804457|NCT00467740|27115990|P5|Overall Study|Lack of Efficacy|0
7804458|NCT00467740|27115991|P4|Overall Study|Lack of Efficacy|0
7804459|NCT00467740|27115992|P3|Overall Study|Lack of Efficacy|0
7804460|NCT00467740|27115993|P2|Overall Study|Lack of Efficacy|1
7804461|NCT00467740|27115994|P1|Overall Study|Lack of Efficacy|0
7804462|NCT00467740|27115990|P5|Overall Study|Withdrawal by Subject|0
7804463|NCT00467740|27115991|P4|Overall Study|Withdrawal by Subject|1
7804464|NCT00467740|27115992|P3|Overall Study|Withdrawal by Subject|0
7804465|NCT00467740|27115993|P2|Overall Study|Withdrawal by Subject|1
7804466|NCT00467740|27115994|P1|Overall Study|Withdrawal by Subject|1
7804467|NCT00467740|27115990|P5|Overall Study|Lost to Follow-up|0
7804468|NCT00467740|27115991|P4|Overall Study|Lost to Follow-up|0
7804469|NCT00467740|27115992|P3|Overall Study|Lost to Follow-up|0
7804470|NCT00467740|27115993|P2|Overall Study|Lost to Follow-up|1
7804471|NCT00467740|27115994|P1|Overall Study|Lost to Follow-up|0
7804472|NCT00467740|27115990|P5|Overall Study|Protocol Violation|0
7804473|NCT00467740|27115991|P4|Overall Study|Protocol Violation|0
7804474|NCT00467740|27115992|P3|Overall Study|Protocol Violation|1
7804475|NCT00467740|27115993|P2|Overall Study|Protocol Violation|0
7804476|NCT00467740|27115994|P1|Overall Study|Protocol Violation|0
7804477|NCT00467740|27115990|P5|Overall Study|Adverse Event|0
7804478|NCT00467740|27115991|P4|Overall Study|Adverse Event|0
7804479|NCT00467740|27115992|P3|Overall Study|Adverse Event|1
7804480|NCT00467740|27115993|P2|Overall Study|Adverse Event|0
7804481|NCT00467740|27115994|P1|Overall Study|Adverse Event|0
7804482|NCT00467649|27116183|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
7804483|NCT00467649|27116184|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7804484|NCT00467649|27116185|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7804485|NCT00467649|27116186|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7804486|NCT00467649|27116187|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7804487|NCT00467649|27116188|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7804488|NCT00467649|27116183|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7804489|NCT00467649|27116184|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7804490|NCT00467649|27116185|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
7804491|NCT00467649|27116186|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7804492|NCT00467649|27116187|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7804493|NCT00467649|27116188|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7804494|NCT00467649|27116183|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7804495|NCT00467649|27116184|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7804496|NCT00467649|27116185|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
7804497|NCT00467649|27116186|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7804498|NCT00467649|27116187|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7804499|NCT00467649|27116188|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7804500|NCT00467649|27116183|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7804501|NCT00467649|27116184|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7804502|NCT00467649|27116185|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7804503|NCT00467649|27116186|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7804504|NCT00467649|27116187|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
7804505|NCT00467649|27116188|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
7804506|NCT00467649|27116183|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
7804507|NCT00467649|27116184|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
7804508|NCT00467649|27116185|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
7804509|NCT00467649|27116186|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
7804510|NCT00467649|27116187|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
7804511|NCT00467649|27116188|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
7804512|NCT00467649|27116183|P6|Phase 1 (Randomized Population)|Investigator Decision|0
7804513|NCT00467649|27116184|P5|Phase 1 (Randomized Population)|Investigator Decision|0
7804514|NCT00467649|27116185|P4|Phase 1 (Randomized Population)|Investigator Decision|0
7804515|NCT00467649|27116186|P3|Phase 1 (Randomized Population)|Investigator Decision|0
7804516|NCT00467649|27116187|P2|Phase 1 (Randomized Population)|Investigator Decision|0
7804517|NCT00467649|27116188|P1|Phase 1 (Randomized Population)|Investigator Decision|1
7804518|NCT00467649|27116183|P6|Phase 1 (Randomized Population)|Adverse Event|0
7804519|NCT00467649|27116184|P5|Phase 1 (Randomized Population)|Adverse Event|0
7804520|NCT00467649|27116185|P4|Phase 1 (Randomized Population)|Adverse Event|0
7804521|NCT00467649|27116186|P3|Phase 1 (Randomized Population)|Adverse Event|0
7804522|NCT00467649|27116187|P2|Phase 1 (Randomized Population)|Adverse Event|0
7804523|NCT00467649|27116188|P1|Phase 1 (Randomized Population)|Adverse Event|2
7804524|NCT00467610|27116228|P1|Overall Study|Withdrawal by Subject|1
7804525|NCT00467597|27116239|P2|Overall Study|Withdrawal by Subject|0
7804526|NCT00467597|27116240|P1|Overall Study|Withdrawal by Subject|2
7804527|NCT00467584|27116253|P3|Overall Study|Withdrawal by Subject|1
7804528|NCT00467584|27116254|P2|Overall Study|Withdrawal by Subject|5
7804529|NCT00467584|27116255|P1|Overall Study|Withdrawal by Subject|4
7804530|NCT00467558|27116265|P2|Overall Study|Lost to Follow-up|0
7804531|NCT00467558|27116266|P1|Overall Study|Lost to Follow-up|2
7804532|NCT00467519|27116276|P2|Overall Study|Withdrawal by Subject|10
7804533|NCT00467519|27116277|P1|Overall Study|Withdrawal by Subject|4
7804534|NCT00467519|27116276|P2|Overall Study|Lost to Follow-up|9
7804535|NCT00467519|27116277|P1|Overall Study|Lost to Follow-up|2
7804536|NCT00467519|27116276|P2|Overall Study|Protocol Violation|4
7804537|NCT00467519|27116277|P1|Overall Study|Protocol Violation|8
7804538|NCT00467363|27116306|P2|Overall Study|Lost to Follow-up|70
7804539|NCT00467363|27116307|P1|Overall Study|Lost to Follow-up|80
7804540|NCT00467285|27116363|P2|Overall Study|Lost to Follow-up|4
7804541|NCT00467285|27116364|P1|Overall Study|Lost to Follow-up|4
7804542|NCT00467272|27116382|P1|Overall Study|Thrombophlebitis|1
7804543|NCT00467272|27116382|P1|Overall Study|Pneumonia|2
7804544|NCT00467259|27116393|P2|Overall Study|Site Closed|1
7804545|NCT00467259|27116394|P1|Overall Study|Site Closed|2
7804546|NCT00467259|27116393|P2|Overall Study|Lost to Follow-up|34
7804547|NCT00467259|27116394|P1|Overall Study|Lost to Follow-up|14
7804548|NCT00467259|27116393|P2|Overall Study|Physician Decision|2
7804549|NCT00467259|27116394|P1|Overall Study|Physician Decision|0
7804550|NCT00467259|27116393|P2|Overall Study|Withdrawal by Subject|108
7804551|NCT00467259|27116394|P1|Overall Study|Withdrawal by Subject|34
7804552|NCT00467259|27116393|P2|Overall Study|Protocol Violation|7
7804553|NCT00467259|27116394|P1|Overall Study|Protocol Violation|1
7804554|NCT00467259|27116393|P2|Overall Study|Adverse Event|90
7804555|NCT00467259|27116394|P1|Overall Study|Adverse Event|24
7804556|NCT00467051|27116411|P1|Overall Study|Adverse Event|2
7804557|NCT00466947|27116438|P2|Study End Analysis Period|Other - Unconformity in team's treatment|1
7804558|NCT00466947|27116439|P1|Study End Analysis Period|Other - Unconformity in team's treatment|0
7804559|NCT00466947|27116438|P2|Study End Analysis Period|Other - Subject without a legal guardian|0
7804560|NCT00466947|27116439|P1|Study End Analysis Period|Other - Subject without a legal guardian|1
7804561|NCT00466947|27116438|P2|Study End Analysis Period|Other - Forbidden vaccination|10
7804562|NCT00466947|27116439|P1|Study End Analysis Period|Other - Forbidden vaccination|21
7804563|NCT00466947|27116438|P2|Study End Analysis Period|Withdrawal by Subject|1267
7804564|NCT00466947|27116439|P1|Study End Analysis Period|Withdrawal by Subject|1264
7804565|NCT00466947|27116438|P2|Study End Analysis Period|Protocol Violation|17
7804566|NCT00466947|27116439|P1|Study End Analysis Period|Protocol Violation|9
7804567|NCT00466947|27116438|P2|Study End Analysis Period|Physician Decision|29
7804568|NCT00466947|27116439|P1|Study End Analysis Period|Physician Decision|29
7804569|NCT00466947|27116438|P2|Study End Analysis Period|Lost to Follow-up|1167
7804570|NCT00466947|27116439|P1|Study End Analysis Period|Lost to Follow-up|1137
7804571|NCT00466947|27116438|P2|Study End Analysis Period|Adverse Event|43
7804572|NCT00466947|27116439|P1|Study End Analysis Period|Adverse Event|35
7804573|NCT00466947|27116438|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
7804574|NCT00466947|27116439|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
7804575|NCT00466921|27116561|P1|Follow up for a Minimum of 1 Year|Death|6
7804576|NCT00466921|27116561|P1|Completed 4 Cycles/Reached 1st Response|Other|1
7804577|NCT00466921|27116561|P1|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
7804578|NCT00466921|27116561|P1|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
7804579|NCT00466921|27116561|P1|First 3 Cycles of Treatment|Withdrawal by Subject|5
7804580|NCT00466921|27116561|P1|First 3 Cycles of Treatment|Adverse Event|2
7804581|NCT00466726|27116637|P1|Overall Study|Not evaluable for response|14
7804582|NCT00466687|27116643|P1|Overall Study|Disease progression|29
7804583|NCT00466687|27116643|P1|Overall Study|Withdrawal by Subject|1
7804584|NCT00466687|27116643|P1|Overall Study|Other complicating illness|3
7804585|NCT00466687|27116643|P1|Overall Study|Adverse Event|1
7804586|NCT00466505|27116675|P1|Overall Study|Adverse Event|4
7804587|NCT00466505|27116675|P1|Overall Study|disease progression|13
7804588|NCT00466440|27116690|P3|Overall Study|Sponsor decision|1
7804589|NCT00466440|27116691|P2|Overall Study|Sponsor decision|0
7804590|NCT00466440|27116692|P1|Overall Study|Sponsor decision|0
7804591|NCT00466440|27116690|P3|Overall Study|Withdrawal by Subject|0
7804592|NCT00466440|27116691|P2|Overall Study|Withdrawal by Subject|1
7804593|NCT00466440|27116692|P1|Overall Study|Withdrawal by Subject|0
7804594|NCT00466440|27116690|P3|Overall Study|Protocol entry criteria not met|4
7804595|NCT00466440|27116691|P2|Overall Study|Protocol entry criteria not met|0
7804596|NCT00466440|27116692|P1|Overall Study|Protocol entry criteria not met|0
7804597|NCT00466440|27116690|P3|Overall Study|Physician Decision|2
7804598|NCT00466440|27116691|P2|Overall Study|Physician Decision|1
7804599|NCT00466440|27116692|P1|Overall Study|Physician Decision|0
7804600|NCT00466440|27116690|P3|Overall Study|Lost to Follow-up|0
7804601|NCT00466440|27116691|P2|Overall Study|Lost to Follow-up|1
7804602|NCT00466440|27116692|P1|Overall Study|Lost to Follow-up|0
7804603|NCT00466440|27116690|P3|Overall Study|Progressive disease|4
7804604|NCT00466440|27116691|P2|Overall Study|Progressive disease|5
7804605|NCT00466440|27116692|P1|Overall Study|Progressive disease|13
7804606|NCT00466440|27116690|P3|Overall Study|Death|0
7804607|NCT00466440|27116691|P2|Overall Study|Death|1
7804608|NCT00466440|27116692|P1|Overall Study|Death|1
7804609|NCT00466440|27116690|P3|Overall Study|Adverse Event|1
7804610|NCT00466440|27116691|P2|Overall Study|Adverse Event|3
7804611|NCT00466440|27116692|P1|Overall Study|Adverse Event|0
7804612|NCT00466193|27116767|P2|Overall Study|Patient refused Visit 4 procedures|0
7804613|NCT00466193|27116768|P1|Overall Study|Patient refused Visit 4 procedures|1
7804614|NCT00466193|27116767|P2|Overall Study|Withdrawal by Subject|2
7804615|NCT00466193|27116768|P1|Overall Study|Withdrawal by Subject|7
7804616|NCT00466193|27116767|P2|Overall Study|Protocol Violation|1
7804617|NCT00466193|27116768|P1|Overall Study|Protocol Violation|1
7804618|NCT00466193|27116767|P2|Overall Study|Physician Decision|0
7804619|NCT00466193|27116768|P1|Overall Study|Physician Decision|1
7804620|NCT00466193|27116767|P2|Overall Study|Lost to Follow-up|4
7804621|NCT00466193|27116768|P1|Overall Study|Lost to Follow-up|2
7804622|NCT00466193|27116767|P2|Overall Study|Adverse Event|1
7804623|NCT00466193|27116768|P1|Overall Study|Adverse Event|0
7804624|NCT00466167|27116795|P3|Overall Study|Not treated|0
7804625|NCT00466167|27116796|P2|Overall Study|Not treated|0
7804626|NCT00466167|27116797|P1|Overall Study|Not treated|1
7804627|NCT00466167|27116795|P3|Overall Study|patient did not meet inclusion criteria|1
7804628|NCT00466167|27116796|P2|Overall Study|patient did not meet inclusion criteria|0
7804629|NCT00466167|27116797|P1|Overall Study|patient did not meet inclusion criteria|1
7804630|NCT00466167|27116795|P3|Overall Study|Withdrawal by Subject|6
7804631|NCT00466167|27116796|P2|Overall Study|Withdrawal by Subject|1
7804632|NCT00466167|27116797|P1|Overall Study|Withdrawal by Subject|4
7804633|NCT00466167|27116795|P3|Overall Study|Lost to Follow-up|2
7804634|NCT00466167|27116796|P2|Overall Study|Lost to Follow-up|2
7804635|NCT00466167|27116797|P1|Overall Study|Lost to Follow-up|3
7804636|NCT00466167|27116795|P3|Overall Study|Protocol Violation|2
7804637|NCT00466167|27116796|P2|Overall Study|Protocol Violation|1
7804638|NCT00466167|27116797|P1|Overall Study|Protocol Violation|1
7804639|NCT00466167|27116795|P3|Overall Study|Lack of Efficacy|3
7804640|NCT00466167|27116796|P2|Overall Study|Lack of Efficacy|0
7804641|NCT00466167|27116797|P1|Overall Study|Lack of Efficacy|2
7804642|NCT00466167|27116795|P3|Overall Study|Adverse Event|7
7804643|NCT00466167|27116796|P2|Overall Study|Adverse Event|8
7804644|NCT00466167|27116797|P1|Overall Study|Adverse Event|8
7804645|NCT00465985|27116858|P2|Part III - Open-label Treatment Period|Adverse Event|0
7804646|NCT00465985|27116859|P1|Part III - Open-label Treatment Period|Adverse Event|1
7804647|NCT00465985|27116858|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
7804648|NCT00465985|27116859|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
7804649|NCT00465985|27116858|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
7804650|NCT00465985|27116859|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
7804651|NCT00465985|27116858|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
7804652|NCT00465985|27116859|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
7804653|NCT00465972|27116882|P2|Overall Study|Withdrawal by Subject|1
7804654|NCT00465972|27116883|P1|Overall Study|Withdrawal by Subject|2
7804655|NCT00465894|27116893|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
7804656|NCT00465894|27116894|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
7804657|NCT00465894|27116893|P2|Treatment For 12 Weeks|Family Issues|1
7804658|NCT00465894|27116894|P1|Treatment For 12 Weeks|Family Issues|1
7804659|NCT00465894|27116893|P2|Treatment For 12 Weeks|Lost to Follow-up|1
7804660|NCT00465894|27116894|P1|Treatment For 12 Weeks|Lost to Follow-up|4
7804661|NCT00465816|27116927|P3|Overall Study|Lost to Follow-up|2
7804662|NCT00465816|27116928|P2|Overall Study|Lost to Follow-up|0
7804663|NCT00465816|27116929|P1|Overall Study|Lost to Follow-up|0
7804664|NCT00465738|27116992|P2|Overall Study|Other|5
7804665|NCT00465738|27116993|P1|Overall Study|Other|2
7804666|NCT00465738|27116992|P2|Overall Study|Withdrawal by Subject|0
7804667|NCT00465738|27116993|P1|Overall Study|Withdrawal by Subject|2
7804668|NCT00465738|27116992|P2|Overall Study|Adverse Event|1
7804669|NCT00465738|27116993|P1|Overall Study|Adverse Event|0
7804670|NCT00465738|27116992|P2|Overall Study|Lost to Follow-up|0
7804671|NCT00465738|27116993|P1|Overall Study|Lost to Follow-up|2
7804672|NCT00465647|27117087|P4|Overall Study|"The other reasons included loss of IV"|2
7804673|NCT00465647|27117088|P3|Overall Study|"The other reasons included loss of IV"|3
7804674|NCT00465647|27117089|P2|Overall Study|"The other reasons included loss of IV"|4
7804675|NCT00465647|27117090|P1|Overall Study|"The other reasons included loss of IV"|8
7804676|NCT00465647|27117087|P4|Overall Study|Withdrawal by Subject|7
7804677|NCT00465647|27117088|P3|Overall Study|Withdrawal by Subject|2
7804678|NCT00465647|27117089|P2|Overall Study|Withdrawal by Subject|2
7804679|NCT00465647|27117090|P1|Overall Study|Withdrawal by Subject|1
7804680|NCT00465647|27117087|P4|Overall Study|Adverse Event|2
7804681|NCT00465647|27117088|P3|Overall Study|Adverse Event|3
7804682|NCT00465647|27117089|P2|Overall Study|Adverse Event|0
7804683|NCT00465647|27117090|P1|Overall Study|Adverse Event|2
7804684|NCT00465647|27117087|P4|Overall Study|Administrative|2
7804685|NCT00465647|27117088|P3|Overall Study|Administrative|3
7804686|NCT00465647|27117089|P2|Overall Study|Administrative|2
7804687|NCT00465647|27117090|P1|Overall Study|Administrative|2
7804688|NCT00465569|27117138|P2|Overall Study|persistent eczema during dose escalation|0
7804689|NCT00465569|27117139|P1|Overall Study|persistent eczema during dose escalation|1
7804690|NCT00465361|27117162|P1|Baseline Assessment|Personal Issues/Scheduling|4
7804691|NCT00465270|27117168|P2|Overall Study|Investigator request|4
7804692|NCT00465270|27117169|P1|Overall Study|Investigator request|3
7804693|NCT00465270|27117168|P2|Overall Study|Lost to Follow-up|67
7804694|NCT00465270|27117169|P1|Overall Study|Lost to Follow-up|60
7804695|NCT00465270|27117168|P2|Overall Study|Withdrawal by Subject|78
7804696|NCT00465270|27117169|P1|Overall Study|Withdrawal by Subject|34
7804697|NCT00465270|27117168|P2|Overall Study|Death|11
7804698|NCT00465270|27117169|P1|Overall Study|Death|7
7804699|NCT00465179|27117178|P1|Overall Study|Progression of Disease|47
7804700|NCT00465179|27117178|P1|Overall Study|Withdrawal by Subject|2
7804701|NCT00465179|27117178|P1|Overall Study|Adverse Event|4
7804702|NCT00465101|27117184|P1|Overall Study|Withdrew consent prior to procedure|3
7804703|NCT00465101|27117184|P1|Overall Study|Physician Decision|1
7804704|NCT00465101|27117184|P1|Overall Study|Withdrawal by Subject|25
7804705|NCT00465101|27117184|P1|Overall Study|Death|3
7804706|NCT00465101|27117184|P1|Overall Study|Unable to obtain IRB approval|1
7804707|NCT00465101|27117184|P1|Overall Study|Site closed due to IRB expiration|1
7804708|NCT00465101|27117184|P1|Overall Study|Patient postponed procedure|1
7804709|NCT00465101|27117184|P1|Overall Study|Pt. Insurance not accepted at center|2
7804710|NCT00465101|27117184|P1|Overall Study|Other|6
7804711|NCT00465101|27117184|P1|Overall Study|Lost to Follow-up|5
7804712|NCT00465101|27117184|P1|Overall Study|Did not meet study criteria|4
7804713|NCT00465101|27117184|P1|Overall Study|Change in health precluded follow up|4
7804714|NCT00465101|27117184|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
7804715|NCT00464945|27117254|P2|Toddler Dose|Lost to Follow-up|1
7804716|NCT00464945|27117255|P1|Toddler Dose|Lost to Follow-up|0
7804717|NCT00464945|27117254|P2|After Infant Series|Withdrawal by Subject|2
7804718|NCT00464945|27117255|P1|After Infant Series|Withdrawal by Subject|0
7804719|NCT00464945|27117254|P2|Infant Series|Lost to Follow-up|0
7804720|NCT00464945|27117255|P1|Infant Series|Lost to Follow-up|1
7804721|NCT00464945|27117254|P2|Infant Series|Protocol Violation|0
7804722|NCT00464945|27117255|P1|Infant Series|Protocol Violation|1
7804723|NCT00464945|27117254|P2|Infant Series|Withdrawal by parent/guardian request|1
7804724|NCT00464945|27117255|P1|Infant Series|Withdrawal by parent/guardian request|2
7804725|NCT00464815|27117285|P2|Overall Study|Withdrawal by Subject|3
7804726|NCT00464815|27117286|P1|Overall Study|Withdrawal by Subject|6
7804727|NCT00464737|27117319|P3|Overall Study|Other: Subject's disability per sponsor|1
7804728|NCT00464737|27117320|P2|Overall Study|Other: Subject's disability per sponsor|0
7804729|NCT00464737|27117321|P1|Overall Study|Other: Subject's disability per sponsor|0
7804730|NCT00464737|27117319|P3|Overall Study|Other: Personal family reasons|1
7804731|NCT00464737|27117320|P2|Overall Study|Other: Personal family reasons|0
7804732|NCT00464737|27117321|P1|Overall Study|Other: Personal family reasons|0
7804733|NCT00464737|27117319|P3|Overall Study|Other: Study demands too great|0
7804734|NCT00464737|27117320|P2|Overall Study|Other: Study demands too great|1
7804735|NCT00464737|27117321|P1|Overall Study|Other: Study demands too great|0
7804736|NCT00464737|27117319|P3|Overall Study|Other: Subject left town; family illness|0
7804737|NCT00464737|27117320|P2|Overall Study|Other: Subject left town; family illness|0
7804738|NCT00464737|27117321|P1|Overall Study|Other: Subject left town; family illness|1
7804739|NCT00464737|27117319|P3|Overall Study|Other: Subject's schedule doesn't permit|0
7804740|NCT00464737|27117320|P2|Overall Study|Other: Subject's schedule doesn't permit|0
7804741|NCT00464737|27117321|P1|Overall Study|Other: Subject's schedule doesn't permit|1
7804742|NCT00464737|27117319|P3|Overall Study|Lost to Follow-up|5
7804743|NCT00464737|27117320|P2|Overall Study|Lost to Follow-up|2
7804744|NCT00464737|27117321|P1|Overall Study|Lost to Follow-up|5
7804745|NCT00464737|27117319|P3|Overall Study|Non-compliance|1
7804746|NCT00464737|27117320|P2|Overall Study|Non-compliance|1
7804747|NCT00464737|27117321|P1|Overall Study|Non-compliance|0
7804748|NCT00464737|27117319|P3|Overall Study|Protocol Violation|5
7804749|NCT00464737|27117320|P2|Overall Study|Protocol Violation|1
7804750|NCT00464737|27117321|P1|Overall Study|Protocol Violation|1
7804751|NCT00464737|27117319|P3|Overall Study|Withdrawal by Subject|5
7804752|NCT00464737|27117320|P2|Overall Study|Withdrawal by Subject|3
7804753|NCT00464737|27117321|P1|Overall Study|Withdrawal by Subject|5
7804754|NCT00464737|27117319|P3|Overall Study|Lack of Efficacy|4
7804755|NCT00464737|27117320|P2|Overall Study|Lack of Efficacy|7
7804756|NCT00464737|27117321|P1|Overall Study|Lack of Efficacy|7
7804757|NCT00464737|27117319|P3|Overall Study|Adverse Event|33
7804758|NCT00464737|27117320|P2|Overall Study|Adverse Event|17
7804759|NCT00464737|27117321|P1|Overall Study|Adverse Event|12
7804760|NCT00464672|27117401|P6|Overall Study|Lost to Follow-up|0
7804761|NCT00464672|27117402|P5|Overall Study|Lost to Follow-up|1
7804762|NCT00464672|27117403|P4|Overall Study|Lost to Follow-up|0
7804763|NCT00464672|27117404|P3|Overall Study|Lost to Follow-up|0
7804764|NCT00464672|27117405|P2|Overall Study|Lost to Follow-up|10
7804765|NCT00464672|27117406|P1|Overall Study|Lost to Follow-up|25
7804766|NCT00464672|27117401|P6|Overall Study|withdrawal of consent|4
7804767|NCT00464672|27117402|P5|Overall Study|withdrawal of consent|9
7804768|NCT00464672|27117403|P4|Overall Study|withdrawal of consent|1
7804769|NCT00464672|27117404|P3|Overall Study|withdrawal of consent|0
7804770|NCT00464672|27117405|P2|Overall Study|withdrawal of consent|0
7804771|NCT00464672|27117406|P1|Overall Study|withdrawal of consent|0
7804772|NCT00464620|27117497|P3|Overall Study|Use of prohibited concomitant medication|2
7804773|NCT00464620|27117498|P2|Overall Study|Use of prohibited concomitant medication|0
7804774|NCT00464620|27117499|P1|Overall Study|Use of prohibited concomitant medication|0
7804775|NCT00464620|27117497|P3|Overall Study|Ineligible sarcoma subtype|2
7804776|NCT00464620|27117498|P2|Overall Study|Ineligible sarcoma subtype|2
7804777|NCT00464620|27117499|P1|Overall Study|Ineligible sarcoma subtype|0
7804778|NCT00464620|27117497|P3|Overall Study|Withdrawal by Subject|3
7804779|NCT00464620|27117498|P2|Overall Study|Withdrawal by Subject|0
7804780|NCT00464620|27117499|P1|Overall Study|Withdrawal by Subject|1
7804781|NCT00464620|27117497|P3|Overall Study|Physician Decision|0
7804782|NCT00464620|27117498|P2|Overall Study|Physician Decision|0
7804783|NCT00464620|27117499|P1|Overall Study|Physician Decision|1
7804784|NCT00464568|27117526|P1|Overall Study|Adverse Event|2
7804785|NCT00464542|27117599|P1|Pre-treatment|Withdrawal by Subject|2
7804786|NCT00464490|27117606|P2|Overall Study|Physician Decision|11
7804787|NCT00464490|27117607|P1|Overall Study|Physician Decision|11
7804788|NCT00464334|27117654|P11|Overall Study|Withdrawal by Subject|0
7804789|NCT00464334|27117655|P10|Overall Study|Withdrawal by Subject|0
7804790|NCT00464334|27117656|P9|Overall Study|Withdrawal by Subject|3
7804791|NCT00464334|27117657|P8|Overall Study|Withdrawal by Subject|1
7804792|NCT00464334|27117658|P7|Overall Study|Withdrawal by Subject|2
7804793|NCT00464334|27117659|P6|Overall Study|Withdrawal by Subject|2
7804794|NCT00464334|27117660|P5|Overall Study|Withdrawal by Subject|2
7804795|NCT00464334|27117661|P4|Overall Study|Withdrawal by Subject|2
7804796|NCT00464334|27117662|P3|Overall Study|Withdrawal by Subject|4
7804797|NCT00464334|27117663|P2|Overall Study|Withdrawal by Subject|7
7804798|NCT00464334|27117664|P1|Overall Study|Withdrawal by Subject|1
7804799|NCT00464334|27117654|P11|Overall Study|Study Terminated by Sponsor|0
7804800|NCT00464334|27117655|P10|Overall Study|Study Terminated by Sponsor|0
7804801|NCT00464334|27117656|P9|Overall Study|Study Terminated by Sponsor|0
7804802|NCT00464334|27117657|P8|Overall Study|Study Terminated by Sponsor|0
7804803|NCT00464334|27117658|P7|Overall Study|Study Terminated by Sponsor|0
7804804|NCT00464334|27117659|P6|Overall Study|Study Terminated by Sponsor|0
7804805|NCT00464334|27117660|P5|Overall Study|Study Terminated by Sponsor|0
7804806|NCT00464334|27117661|P4|Overall Study|Study Terminated by Sponsor|1
7804807|NCT00464334|27117662|P3|Overall Study|Study Terminated by Sponsor|0
7804808|NCT00464334|27117663|P2|Overall Study|Study Terminated by Sponsor|0
7804809|NCT00464334|27117664|P1|Overall Study|Study Terminated by Sponsor|0
7804810|NCT00464334|27117654|P11|Overall Study|Progressive Disease|0
7804811|NCT00464334|27117655|P10|Overall Study|Progressive Disease|0
7804812|NCT00464334|27117656|P9|Overall Study|Progressive Disease|1
7804813|NCT00464334|27117657|P8|Overall Study|Progressive Disease|0
7804814|NCT00464334|27117658|P7|Overall Study|Progressive Disease|0
7804815|NCT00464334|27117659|P6|Overall Study|Progressive Disease|1
7804816|NCT00464334|27117660|P5|Overall Study|Progressive Disease|0
7804817|NCT00464334|27117661|P4|Overall Study|Progressive Disease|0
7804818|NCT00464334|27117662|P3|Overall Study|Progressive Disease|0
7804819|NCT00464334|27117663|P2|Overall Study|Progressive Disease|0
7804820|NCT00464334|27117664|P1|Overall Study|Progressive Disease|0
7804821|NCT00464334|27117654|P11|Overall Study|Lost to Follow-up|2
7804822|NCT00464334|27117655|P10|Overall Study|Lost to Follow-up|0
7804823|NCT00464334|27117656|P9|Overall Study|Lost to Follow-up|0
7804824|NCT00464334|27117657|P8|Overall Study|Lost to Follow-up|0
7804825|NCT00464334|27117658|P7|Overall Study|Lost to Follow-up|1
7804826|NCT00464334|27117659|P6|Overall Study|Lost to Follow-up|0
7804827|NCT00464334|27117660|P5|Overall Study|Lost to Follow-up|1
7804828|NCT00464334|27117661|P4|Overall Study|Lost to Follow-up|0
7804829|NCT00464334|27117662|P3|Overall Study|Lost to Follow-up|1
7804830|NCT00464334|27117663|P2|Overall Study|Lost to Follow-up|0
7804831|NCT00464334|27117664|P1|Overall Study|Lost to Follow-up|0
7804832|NCT00464334|27117654|P11|Overall Study|Lack of Efficacy|0
7804833|NCT00464334|27117655|P10|Overall Study|Lack of Efficacy|0
7804834|NCT00464334|27117656|P9|Overall Study|Lack of Efficacy|0
7804835|NCT00464334|27117657|P8|Overall Study|Lack of Efficacy|0
7804836|NCT00464334|27117658|P7|Overall Study|Lack of Efficacy|0
7804837|NCT00464334|27117659|P6|Overall Study|Lack of Efficacy|0
7804838|NCT00464334|27117660|P5|Overall Study|Lack of Efficacy|0
7804839|NCT00464334|27117661|P4|Overall Study|Lack of Efficacy|0
7804840|NCT00464334|27117662|P3|Overall Study|Lack of Efficacy|0
7804841|NCT00464334|27117663|P2|Overall Study|Lack of Efficacy|1
7804842|NCT00464334|27117664|P1|Overall Study|Lack of Efficacy|0
7804843|NCT00464334|27117654|P11|Overall Study|Adverse Event|2
7804844|NCT00464334|27117655|P10|Overall Study|Adverse Event|1
7804845|NCT00464334|27117656|P9|Overall Study|Adverse Event|2
7804846|NCT00464334|27117657|P8|Overall Study|Adverse Event|0
7804847|NCT00464334|27117658|P7|Overall Study|Adverse Event|0
7804848|NCT00464334|27117659|P6|Overall Study|Adverse Event|1
7804849|NCT00464334|27117660|P5|Overall Study|Adverse Event|1
7804850|NCT00464334|27117661|P4|Overall Study|Adverse Event|1
7804851|NCT00464334|27117662|P3|Overall Study|Adverse Event|0
7804852|NCT00464334|27117663|P2|Overall Study|Adverse Event|0
7804853|NCT00464334|27117664|P1|Overall Study|Adverse Event|0
7804854|NCT00464308|27117724|P3|Overall Study|Physician Decision|0
7804855|NCT00464308|27117725|P2|Overall Study|Physician Decision|0
7804856|NCT00464308|27117726|P1|Overall Study|Physician Decision|1
7804857|NCT00464308|27117724|P3|Overall Study|Patient discontinued and other reasons|23
7804858|NCT00464308|27117725|P2|Overall Study|Patient discontinued and other reasons|17
7804859|NCT00464308|27117726|P1|Overall Study|Patient discontinued and other reasons|17
7804860|NCT00464308|27117724|P3|Overall Study|Lost to Follow-up|20
7804861|NCT00464308|27117725|P2|Overall Study|Lost to Follow-up|19
7804862|NCT00464308|27117726|P1|Overall Study|Lost to Follow-up|29
7804863|NCT00464308|27117724|P3|Overall Study|Adverse Event|16
7804864|NCT00464308|27117725|P2|Overall Study|Adverse Event|27
7804865|NCT00464308|27117726|P1|Overall Study|Adverse Event|22
7804866|NCT00464269|27117756|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7804867|NCT00464269|27117757|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7804868|NCT00464269|27117758|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7804869|NCT00464269|27117759|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7804870|NCT00464269|27117756|P4|Overall Study|AE, non-serious non-fatal|4
7804871|NCT00464269|27117757|P3|Overall Study|AE, non-serious non-fatal|3
7804872|NCT00464269|27117758|P2|Overall Study|AE, non-serious non-fatal|8
7804873|NCT00464269|27117759|P1|Overall Study|AE, non-serious non-fatal|2
7804874|NCT00464269|27117756|P4|Overall Study|SAE, non-fatal|1
7804875|NCT00464269|27117757|P3|Overall Study|SAE, non-fatal|0
7804876|NCT00464269|27117758|P2|Overall Study|SAE, non-fatal|0
7804877|NCT00464269|27117759|P1|Overall Study|SAE, non-fatal|0
7804878|NCT00464269|27117756|P4|Overall Study|AE, serious fatal|1
7804879|NCT00464269|27117757|P3|Overall Study|AE, serious fatal|1
7804880|NCT00464269|27117758|P2|Overall Study|AE, serious fatal|0
7804881|NCT00464269|27117759|P1|Overall Study|AE, serious fatal|0
7804882|NCT00464269|27117756|P4|Overall Study|Other reason|1
7804883|NCT00464269|27117757|P3|Overall Study|Other reason|1
7804884|NCT00464269|27117758|P2|Overall Study|Other reason|3
7804885|NCT00464269|27117759|P1|Overall Study|Other reason|3
7804886|NCT00464269|27117756|P4|Overall Study|Withdrawal by Subject|1
7804887|NCT00464269|27117757|P3|Overall Study|Withdrawal by Subject|1
7804888|NCT00464269|27117758|P2|Overall Study|Withdrawal by Subject|2
7804889|NCT00464269|27117759|P1|Overall Study|Withdrawal by Subject|0
7804890|NCT00464269|27117756|P4|Overall Study|Lost to Follow-up|1
7804891|NCT00464269|27117757|P3|Overall Study|Lost to Follow-up|0
7804892|NCT00464269|27117758|P2|Overall Study|Lost to Follow-up|4
7804893|NCT00464269|27117759|P1|Overall Study|Lost to Follow-up|0
7804894|NCT00464269|27117756|P4|Overall Study|Lack of Efficacy|0
7804895|NCT00464269|27117757|P3|Overall Study|Lack of Efficacy|0
7804896|NCT00464269|27117758|P2|Overall Study|Lack of Efficacy|0
7804897|NCT00464269|27117759|P1|Overall Study|Lack of Efficacy|1
7804898|NCT00464087|27117897|P3|Overall Study|No PCI per inclusion criteria|29
7804899|NCT00464087|27117898|P2|Overall Study|No PCI per inclusion criteria|0
7804900|NCT00464087|27117899|P1|Overall Study|No PCI per inclusion criteria|0
7804901|NCT00463866|27117917|P2|Overall Study|Other|22
7804902|NCT00463866|27117918|P1|Overall Study|Other|22
7804903|NCT00463866|27117917|P2|Overall Study|Mis-Randomization of subject|1
7804904|NCT00463866|27117918|P1|Overall Study|Mis-Randomization of subject|0
7804905|NCT00463866|27117917|P2|Overall Study|Safety Reason|3
7804906|NCT00463866|27117918|P1|Overall Study|Safety Reason|1
7804907|NCT00463866|27117917|P2|Overall Study|Severe Non-Compliance to Protocol|21
7804908|NCT00463866|27117918|P1|Overall Study|Severe Non-Compliance to Protocol|25
7804909|NCT00463866|27117917|P2|Overall Study|Incorrect Enrolment|66
7804910|NCT00463866|27117918|P1|Overall Study|Incorrect Enrolment|64
7804911|NCT00463866|27117917|P2|Overall Study|Lost to Follow-up|55
7804912|NCT00463866|27117918|P1|Overall Study|Lost to Follow-up|46
7804913|NCT00463866|27117917|P2|Overall Study|Withdrawal by Subject|79
7804914|NCT00463866|27117918|P1|Overall Study|Withdrawal by Subject|81
7804915|NCT00463866|27117917|P2|Overall Study|Adverse Event|93
7804916|NCT00463866|27117918|P1|Overall Study|Adverse Event|70
7804917|NCT00463840|27117938|P1|Overall Study|Adverse Event|3
7804918|NCT00463840|27117938|P1|Overall Study|Withdrawal by Subject|2
7804919|NCT00463840|27117938|P1|Overall Study|Disease progression|7
7804920|NCT00463801|27117943|P1|Overall Study|No longer require therapy|1
7804921|NCT00463801|27117943|P1|Overall Study|Lost to Follow-up|5
7804922|NCT00463801|27117943|P1|Overall Study|Adverse Event|4
7804923|NCT00463801|27117943|P1|Overall Study|Lack of Efficacy|2
7804924|NCT00463801|27117943|P1|Overall Study|Protocol Violation|1
7804925|NCT00463788|27117949|P2|Overall Study|Randomized but not treated|1
7804926|NCT00463788|27117950|P1|Overall Study|Randomized but not treated|1
7804927|NCT00463788|27117949|P2|Overall Study|Other|0
7804928|NCT00463788|27117950|P1|Overall Study|Other|3
7804929|NCT00463788|27117949|P2|Overall Study|Protocol Violation|1
7804930|NCT00463788|27117950|P1|Overall Study|Protocol Violation|0
7804931|NCT00463788|27117949|P2|Overall Study|Lost to Follow-up|0
7804932|NCT00463788|27117950|P1|Overall Study|Lost to Follow-up|1
7804933|NCT00463788|27117949|P2|Overall Study|Symptomatic Deterioration|3
7804934|NCT00463788|27117950|P1|Overall Study|Symptomatic Deterioration|2
7804935|NCT00463788|27117949|P2|Overall Study|Death|3
7804936|NCT00463788|27117950|P1|Overall Study|Death|4
7804937|NCT00463788|27117949|P2|Overall Study|Withdrawal by Subject|2
7804938|NCT00463788|27117950|P1|Overall Study|Withdrawal by Subject|6
7804939|NCT00463788|27117949|P2|Overall Study|Adverse Event|2
7804940|NCT00463788|27117950|P1|Overall Study|Adverse Event|6
7804941|NCT00463788|27117949|P2|Overall Study|Progressive Disease|42
7804942|NCT00463788|27117950|P1|Overall Study|Progressive Disease|86
7804943|NCT00463684|27117965|P1|Overall Study|Lost to Follow-up|3
7804944|NCT00463684|27117965|P1|Overall Study|Withdrawal by Subject|1
7804945|NCT00463606|27117983|P3|Overall Study|Protocol Violation|1
7804946|NCT00463606|27117984|P2|Overall Study|Protocol Violation|0
7804947|NCT00463606|27117985|P1|Overall Study|Protocol Violation|0
7804948|NCT00463606|27117983|P3|Overall Study|Participation in another ABT-335 trial|0
7804949|NCT00463606|27117984|P2|Overall Study|Participation in another ABT-335 trial|0
7804950|NCT00463606|27117985|P1|Overall Study|Participation in another ABT-335 trial|1
7804951|NCT00463606|27117983|P3|Overall Study|Patient randomized in error|0
7804952|NCT00463606|27117984|P2|Overall Study|Patient randomized in error|0
7804953|NCT00463606|27117985|P1|Overall Study|Patient randomized in error|1
7804954|NCT00463606|27117983|P3|Overall Study|Coordinator error|0
7804955|NCT00463606|27117984|P2|Overall Study|Coordinator error|0
7804956|NCT00463606|27117985|P1|Overall Study|Coordinator error|1
7804957|NCT00463606|27117983|P3|Overall Study|Exclusion criteria violation|0
7804958|NCT00463606|27117984|P2|Overall Study|Exclusion criteria violation|0
7804959|NCT00463606|27117985|P1|Overall Study|Exclusion criteria violation|2
7804960|NCT00463606|27117983|P3|Overall Study|Sponsor request|0
7804961|NCT00463606|27117984|P2|Overall Study|Sponsor request|1
7804962|NCT00463606|27117985|P1|Overall Study|Sponsor request|0
7804963|NCT00463606|27117983|P3|Overall Study|Physician Decision|0
7804964|NCT00463606|27117984|P2|Overall Study|Physician Decision|1
7804965|NCT00463606|27117985|P1|Overall Study|Physician Decision|0
7804966|NCT00463606|27117983|P3|Overall Study|Subject moved out of town|0
7804967|NCT00463606|27117984|P2|Overall Study|Subject moved out of town|0
7804968|NCT00463606|27117985|P1|Overall Study|Subject moved out of town|1
7804969|NCT00463606|27117983|P3|Overall Study|Subject noncompliance|0
7804970|NCT00463606|27117984|P2|Overall Study|Subject noncompliance|1
7804971|NCT00463606|27117985|P1|Overall Study|Subject noncompliance|1
7804972|NCT00463606|27117983|P3|Overall Study|Lost to Follow-up|3
7804973|NCT00463606|27117984|P2|Overall Study|Lost to Follow-up|2
7804974|NCT00463606|27117985|P1|Overall Study|Lost to Follow-up|2
7804975|NCT00463606|27117983|P3|Overall Study|Withdrawal by Subject|5
7804976|NCT00463606|27117984|P2|Overall Study|Withdrawal by Subject|11
7804977|NCT00463606|27117985|P1|Overall Study|Withdrawal by Subject|11
7804978|NCT00463606|27117983|P3|Overall Study|Adverse Event|11
7804979|NCT00463606|27117984|P2|Overall Study|Adverse Event|18
7804980|NCT00463606|27117985|P1|Overall Study|Adverse Event|21
7804981|NCT00463580|27118010|P2|Overall Study|Medical/psychiatric complications|2
7804982|NCT00463580|27118011|P1|Overall Study|Medical/psychiatric complications|0
7804983|NCT00463580|27118010|P2|Overall Study|Schedule conflict|0
7804984|NCT00463580|27118011|P1|Overall Study|Schedule conflict|2
7804985|NCT00463580|27118010|P2|Overall Study|Lost to Follow-up|0
7804986|NCT00463580|27118011|P1|Overall Study|Lost to Follow-up|1
7804987|NCT00463567|27118044|P7|Overall Study|Death|0
7804988|NCT00463567|27118045|P6|Overall Study|Death|0
7804989|NCT00463567|27118046|P5|Overall Study|Death|0
7804990|NCT00463567|27118047|P4|Overall Study|Death|0
7804991|NCT00463567|27118048|P3|Overall Study|Death|2
7804992|NCT00463567|27118049|P2|Overall Study|Death|0
7804993|NCT00463567|27118050|P1|Overall Study|Death|1
7804994|NCT00463567|27118044|P7|Overall Study|Abnormal test procedure result(s)|0
7804995|NCT00463567|27118045|P6|Overall Study|Abnormal test procedure result(s)|2
7804996|NCT00463567|27118046|P5|Overall Study|Abnormal test procedure result(s)|0
7804997|NCT00463567|27118047|P4|Overall Study|Abnormal test procedure result(s)|2
7804998|NCT00463567|27118048|P3|Overall Study|Abnormal test procedure result(s)|6
7804999|NCT00463567|27118049|P2|Overall Study|Abnormal test procedure result(s)|1
7805000|NCT00463567|27118050|P1|Overall Study|Abnormal test procedure result(s)|1
7805001|NCT00463567|27118044|P7|Overall Study|Abnormal lab value(s)|0
7805002|NCT00463567|27118045|P6|Overall Study|Abnormal lab value(s)|0
7805003|NCT00463567|27118046|P5|Overall Study|Abnormal lab value(s)|1
7805004|NCT00463567|27118047|P4|Overall Study|Abnormal lab value(s)|1
7805005|NCT00463567|27118048|P3|Overall Study|Abnormal lab value(s)|2
7805006|NCT00463567|27118049|P2|Overall Study|Abnormal lab value(s)|1
7805007|NCT00463567|27118050|P1|Overall Study|Abnormal lab value(s)|1
7805008|NCT00463567|27118044|P7|Overall Study|Lack of Efficacy|1
7805009|NCT00463567|27118045|P6|Overall Study|Lack of Efficacy|0
7805010|NCT00463567|27118046|P5|Overall Study|Lack of Efficacy|1
7805011|NCT00463567|27118047|P4|Overall Study|Lack of Efficacy|17
7805012|NCT00463567|27118048|P3|Overall Study|Lack of Efficacy|9
7805013|NCT00463567|27118049|P2|Overall Study|Lack of Efficacy|9
7805014|NCT00463567|27118050|P1|Overall Study|Lack of Efficacy|4
7805015|NCT00463567|27118044|P7|Overall Study|Administrative problems|2
7805016|NCT00463567|27118045|P6|Overall Study|Administrative problems|2
7805017|NCT00463567|27118046|P5|Overall Study|Administrative problems|3
7805018|NCT00463567|27118047|P4|Overall Study|Administrative problems|9
7805019|NCT00463567|27118048|P3|Overall Study|Administrative problems|6
7805020|NCT00463567|27118049|P2|Overall Study|Administrative problems|3
7805021|NCT00463567|27118050|P1|Overall Study|Administrative problems|5
7805022|NCT00463567|27118044|P7|Overall Study|Lost to Follow-up|1
7805023|NCT00463567|27118045|P6|Overall Study|Lost to Follow-up|1
7805024|NCT00463567|27118046|P5|Overall Study|Lost to Follow-up|1
7805025|NCT00463567|27118047|P4|Overall Study|Lost to Follow-up|8
7805026|NCT00463567|27118048|P3|Overall Study|Lost to Follow-up|13
7805027|NCT00463567|27118049|P2|Overall Study|Lost to Follow-up|6
7805028|NCT00463567|27118050|P1|Overall Study|Lost to Follow-up|12
7805029|NCT00463567|27118044|P7|Overall Study|Protocol Deviation|2
7805030|NCT00463567|27118045|P6|Overall Study|Protocol Deviation|1
7805031|NCT00463567|27118046|P5|Overall Study|Protocol Deviation|1
7805032|NCT00463567|27118047|P4|Overall Study|Protocol Deviation|11
7805033|NCT00463567|27118048|P3|Overall Study|Protocol Deviation|14
7805034|NCT00463567|27118049|P2|Overall Study|Protocol Deviation|9
7805035|NCT00463567|27118050|P1|Overall Study|Protocol Deviation|13
7805036|NCT00463567|27118044|P7|Overall Study|Withdrawal by Subject|1
7805037|NCT00463567|27118045|P6|Overall Study|Withdrawal by Subject|5
7805038|NCT00463567|27118046|P5|Overall Study|Withdrawal by Subject|6
7805039|NCT00463567|27118047|P4|Overall Study|Withdrawal by Subject|37
7805040|NCT00463567|27118048|P3|Overall Study|Withdrawal by Subject|20
7805041|NCT00463567|27118049|P2|Overall Study|Withdrawal by Subject|22
7805042|NCT00463567|27118050|P1|Overall Study|Withdrawal by Subject|29
7805043|NCT00463567|27118044|P7|Overall Study|Adverse Event|4
7805044|NCT00463567|27118045|P6|Overall Study|Adverse Event|10
7805045|NCT00463567|27118046|P5|Overall Study|Adverse Event|10
7805046|NCT00463567|27118047|P4|Overall Study|Adverse Event|46
7805047|NCT00463567|27118048|P3|Overall Study|Adverse Event|17
7805048|NCT00463567|27118049|P2|Overall Study|Adverse Event|26
7805049|NCT00463567|27118050|P1|Overall Study|Adverse Event|29
7805050|NCT00463476|27118083|P2|Overall Study|Lost to Follow-up|1
7805051|NCT00463476|27118084|P1|Overall Study|Lost to Follow-up|1
7805052|NCT00463476|27118083|P2|Overall Study|Withdrawal by Subject|2
7805053|NCT00463476|27118084|P1|Overall Study|Withdrawal by Subject|1
7805054|NCT00463385|27118173|P4|Overall Study|1 participant received commercial drug|0
7805055|NCT00463385|27118174|P3|Overall Study|1 participant received commercial drug|0
7805056|NCT00463385|27118175|P2|Overall Study|1 participant received commercial drug|1
7805057|NCT00463385|27118176|P1|Overall Study|1 participant received commercial drug|0
7805058|NCT00463385|27118173|P4|Overall Study|Missing|2
7805059|NCT00463385|27118174|P3|Overall Study|Missing|0
7805060|NCT00463385|27118175|P2|Overall Study|Missing|0
7805061|NCT00463385|27118176|P1|Overall Study|Missing|2
7805062|NCT00463385|27118173|P4|Overall Study|Death|0
7805063|NCT00463385|27118174|P3|Overall Study|Death|2
7805064|NCT00463385|27118175|P2|Overall Study|Death|1
7805065|NCT00463385|27118176|P1|Overall Study|Death|2
7805066|NCT00463385|27118173|P4|Overall Study|Lost to Follow-up|1
7805067|NCT00463385|27118174|P3|Overall Study|Lost to Follow-up|0
7805068|NCT00463385|27118175|P2|Overall Study|Lost to Follow-up|0
7805069|NCT00463385|27118176|P1|Overall Study|Lost to Follow-up|0
7805070|NCT00463385|27118173|P4|Overall Study|Withdrawal by Subject|4
7805071|NCT00463385|27118174|P3|Overall Study|Withdrawal by Subject|3
7805072|NCT00463385|27118175|P2|Overall Study|Withdrawal by Subject|3
7805073|NCT00463385|27118176|P1|Overall Study|Withdrawal by Subject|3
7805074|NCT00463385|27118173|P4|Overall Study|Lack of Efficacy|9
7805075|NCT00463385|27118174|P3|Overall Study|Lack of Efficacy|7
7805076|NCT00463385|27118175|P2|Overall Study|Lack of Efficacy|6
7805077|NCT00463385|27118176|P1|Overall Study|Lack of Efficacy|6
7805078|NCT00463385|27118173|P4|Overall Study|Adverse Event|2
7805079|NCT00463385|27118174|P3|Overall Study|Adverse Event|4
7805080|NCT00463385|27118175|P2|Overall Study|Adverse Event|8
7805081|NCT00463385|27118176|P1|Overall Study|Adverse Event|5
7805082|NCT00463385|27118173|P4|Overall Study|Other|4
7805083|NCT00463385|27118174|P3|Overall Study|Other|6
7805084|NCT00463385|27118175|P2|Overall Study|Other|3
7805085|NCT00463385|27118176|P1|Overall Study|Other|4
7805086|NCT00463346|27118228|P2|Overall Study|Withdrawal by Subject|3
7805087|NCT00463346|27118229|P1|Overall Study|Withdrawal by Subject|3
7805088|NCT00463229|27118239|P2|Overall Study|Death|3
7805089|NCT00463229|27118240|P1|Overall Study|Death|4
7805090|NCT00463229|27118239|P2|Overall Study|Lost to Follow-up|7
7805091|NCT00463229|27118240|P1|Overall Study|Lost to Follow-up|5
7805092|NCT00463151|27118262|P4|Overall Study|Withdrawal by Subject|1
7805093|NCT00463151|27118263|P3|Overall Study|Withdrawal by Subject|0
7805094|NCT00463151|27118264|P2|Overall Study|Withdrawal by Subject|0
7805095|NCT00463151|27118265|P1|Overall Study|Withdrawal by Subject|0
7805096|NCT00463151|27118262|P4|Overall Study|Protocol Violation|1
7805097|NCT00463151|27118263|P3|Overall Study|Protocol Violation|0
7805098|NCT00463151|27118264|P2|Overall Study|Protocol Violation|0
7805099|NCT00463151|27118265|P1|Overall Study|Protocol Violation|0
7805100|NCT00463151|27118262|P4|Overall Study|Lack of Efficacy|5
7805101|NCT00463151|27118263|P3|Overall Study|Lack of Efficacy|2
7805102|NCT00463151|27118264|P2|Overall Study|Lack of Efficacy|5
7805103|NCT00463151|27118265|P1|Overall Study|Lack of Efficacy|2
7805104|NCT00463151|27118262|P4|Overall Study|Adverse Event|0
7805105|NCT00463151|27118263|P3|Overall Study|Adverse Event|1
7805106|NCT00463151|27118264|P2|Overall Study|Adverse Event|0
7805107|NCT00463151|27118265|P1|Overall Study|Adverse Event|0
7805108|NCT00463060|27118293|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
7805109|NCT00463060|27118293|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
7805110|NCT00463047|27118307|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
7805111|NCT00463047|27118308|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
7805112|NCT00463047|27118307|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
7805113|NCT00463047|27118308|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7805114|NCT00463047|27118307|P2|Double-Blind Treatment Period 2|Adverse Event|1
7805115|NCT00463047|27118308|P1|Double-Blind Treatment Period 2|Adverse Event|0
7805116|NCT00463047|27118307|P2|Double-Blind Treatment Period 1|Other|0
7805117|NCT00463047|27118308|P1|Double-Blind Treatment Period 1|Other|1
7805118|NCT00463047|27118307|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
7805119|NCT00463047|27118308|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
7805120|NCT00463047|27118307|P2|Double-Blind Treatment Period 1|Protocol Violation|2
7805121|NCT00463047|27118308|P1|Double-Blind Treatment Period 1|Protocol Violation|1
7805122|NCT00463047|27118307|P2|Double-Blind Treatment Period 1|Adverse Event|2
7805123|NCT00463047|27118308|P1|Double-Blind Treatment Period 1|Adverse Event|0
7805124|NCT00463047|27118307|P2|Titration Period 2|Other|2
7805125|NCT00463047|27118308|P1|Titration Period 2|Other|3
7805126|NCT00463047|27118307|P2|Titration Period 2|Non-compliance procedures|1
7805127|NCT00463047|27118308|P1|Titration Period 2|Non-compliance procedures|4
7805128|NCT00463047|27118307|P2|Titration Period 2|Non-compliance study medication|2
7805129|NCT00463047|27118308|P1|Titration Period 2|Non-compliance study medication|4
7805130|NCT00463047|27118307|P2|Titration Period 2|Lost to Follow-up|2
7805131|NCT00463047|27118308|P1|Titration Period 2|Lost to Follow-up|1
7805132|NCT00463047|27118307|P2|Titration Period 2|Protocol Violation|3
7805133|NCT00463047|27118308|P1|Titration Period 2|Protocol Violation|2
7805134|NCT00463047|27118307|P2|Titration Period 2|Withdrawal by Subject|0
7805135|NCT00463047|27118308|P1|Titration Period 2|Withdrawal by Subject|1
7805136|NCT00463047|27118307|P2|Titration Period 2|Lack of Efficacy|4
7805137|NCT00463047|27118308|P1|Titration Period 2|Lack of Efficacy|6
7805138|NCT00463047|27118307|P2|Titration Period 2|Adverse Event|9
7805139|NCT00463047|27118308|P1|Titration Period 2|Adverse Event|9
7805140|NCT00463047|27118307|P2|Titration Period 1|Other|2
7805141|NCT00463047|27118308|P1|Titration Period 1|Other|0
7805142|NCT00463047|27118307|P2|Titration Period 1|Non-compliance procedures|10
7805143|NCT00463047|27118308|P1|Titration Period 1|Non-compliance procedures|4
7805144|NCT00463047|27118307|P2|Titration Period 1|Withdrawal by Subject|5
7805145|NCT00463047|27118308|P1|Titration Period 1|Withdrawal by Subject|3
7805146|NCT00463047|27118307|P2|Titration Period 1|Protocol Violation|5
7805147|NCT00463047|27118308|P1|Titration Period 1|Protocol Violation|5
7805148|NCT00463047|27118307|P2|Titration Period 1|Non-compliance with study medication|5
7805149|NCT00463047|27118308|P1|Titration Period 1|Non-compliance with study medication|3
7805150|NCT00463047|27118307|P2|Titration Period 1|Lost to Follow-up|0
7805151|NCT00463047|27118308|P1|Titration Period 1|Lost to Follow-up|2
7805152|NCT00463047|27118307|P2|Titration Period 1|Lack of Efficacy|4
7805153|NCT00463047|27118308|P1|Titration Period 1|Lack of Efficacy|10
7805154|NCT00463047|27118307|P2|Titration Period 1|Adverse Event|8
7805155|NCT00463047|27118308|P1|Titration Period 1|Adverse Event|10
7805156|NCT00462982|27118393|P1|Overall Study|Patient Not Treated|2
7805157|NCT00462982|27118393|P1|Overall Study|Adverse Event|1
7805158|NCT00462943|27118400|P3|Overall Study|Withdrawal by Subject|0
7805159|NCT00462943|27118401|P2|Overall Study|Withdrawal by Subject|1
7805160|NCT00462943|27118402|P1|Overall Study|Withdrawal by Subject|0
7805161|NCT00462943|27118400|P3|Overall Study|Physician Decision|0
7805162|NCT00462943|27118401|P2|Overall Study|Physician Decision|0
7805163|NCT00462943|27118402|P1|Overall Study|Physician Decision|1
7805164|NCT00462943|27118400|P3|Overall Study|Transplant - not specified|1
7805165|NCT00462943|27118401|P2|Overall Study|Transplant - not specified|0
7805166|NCT00462943|27118402|P1|Overall Study|Transplant - not specified|1
7805167|NCT00462943|27118400|P3|Overall Study|Required Lymphocyte Infusion|0
7805168|NCT00462943|27118401|P2|Overall Study|Required Lymphocyte Infusion|0
7805169|NCT00462943|27118402|P1|Overall Study|Required Lymphocyte Infusion|1
7805170|NCT00462943|27118400|P3|Overall Study|Bone Marrow Transplant|0
7805171|NCT00462943|27118401|P2|Overall Study|Bone Marrow Transplant|0
7805172|NCT00462943|27118402|P1|Overall Study|Bone Marrow Transplant|1
7805173|NCT00462943|27118400|P3|Overall Study|Stem Cell Transplant|0
7805174|NCT00462943|27118401|P2|Overall Study|Stem Cell Transplant|1
7805175|NCT00462943|27118402|P1|Overall Study|Stem Cell Transplant|1
7805176|NCT00462943|27118400|P3|Overall Study|Death|7
7805177|NCT00462943|27118401|P2|Overall Study|Death|2
7805178|NCT00462943|27118402|P1|Overall Study|Death|5
7805179|NCT00462943|27118400|P3|Overall Study|Disease Progression|9
7805180|NCT00462943|27118401|P2|Overall Study|Disease Progression|15
7805181|NCT00462943|27118402|P1|Overall Study|Disease Progression|15
7805182|NCT00462943|27118400|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
7805183|NCT00462943|27118401|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
7805184|NCT00462943|27118402|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
7805185|NCT00462943|27118400|P3|Overall Study|Protocol Violation|0
7805186|NCT00462943|27118401|P2|Overall Study|Protocol Violation|0
7805187|NCT00462943|27118402|P1|Overall Study|Protocol Violation|1
7805188|NCT00462943|27118400|P3|Overall Study|Adverse Event|1
7805189|NCT00462943|27118401|P2|Overall Study|Adverse Event|4
7805190|NCT00462943|27118402|P1|Overall Study|Adverse Event|6
7805191|NCT00462943|27118400|P3|Overall Study|Failure to achieve a response|1
7805192|NCT00462943|27118401|P2|Overall Study|Failure to achieve a response|5
7805193|NCT00462943|27118402|P1|Overall Study|Failure to achieve a response|5
7805194|NCT00462904|27118494|P1|Overall Study|Lost to Follow-up|1
7805195|NCT00462865|27118499|P1|Overall Study|Adverse Event|1
7805196|NCT00462826|27118519|P1|Overall Study|Never treated|1
7805197|NCT00462826|27118519|P1|Overall Study|Ineligible - wrong primary|2
7805198|NCT00462826|27118519|P1|Overall Study|Ineligible - wrong cell type|1
7805199|NCT00462826|27118519|P1|Overall Study|Ineligible - second primary|1
7805200|NCT00462761|27118532|P1|Overall Study|Other|1
7805201|NCT00462761|27118532|P1|Overall Study|Death|12
7805202|NCT00462761|27118532|P1|Overall Study|Disease progression|43
7805203|NCT00462761|27118532|P1|Overall Study|Physician Decision|5
7805204|NCT00462761|27118532|P1|Overall Study|Withdrawal by Subject|9
7805205|NCT00462761|27118532|P1|Overall Study|Adverse Event|6
7805206|NCT00462748|27118607|P3|Overall Study|Discontinued after 41 days Rx|0
7805207|NCT00462748|27118608|P2|Overall Study|Discontinued after 41 days Rx|0
7805208|NCT00462748|27118609|P1|Overall Study|Discontinued after 41 days Rx|1
7805209|NCT00462748|27118607|P3|Overall Study|Lost to Follow-up|1
7805210|NCT00462748|27118608|P2|Overall Study|Lost to Follow-up|1
7805211|NCT00462748|27118609|P1|Overall Study|Lost to Follow-up|1
7805212|NCT00462748|27118607|P3|Overall Study|Withdrew consent|0
7805213|NCT00462748|27118608|P2|Overall Study|Withdrew consent|3
7805214|NCT00462748|27118609|P1|Overall Study|Withdrew consent|3
7805215|NCT00462748|27118607|P3|Overall Study|Protocol Violation|1
7805216|NCT00462748|27118608|P2|Overall Study|Protocol Violation|2
7805217|NCT00462748|27118609|P1|Overall Study|Protocol Violation|0
7805218|NCT00462748|27118607|P3|Overall Study|Adverse Event|9
7805219|NCT00462748|27118608|P2|Overall Study|Adverse Event|5
7805220|NCT00462748|27118609|P1|Overall Study|Adverse Event|7
7805221|NCT00462709|27118662|P1|Overall Study|Withdrew to start treatment with Cetor|1
7805222|NCT00462709|27118662|P1|Overall Study|Physician Decision|1
7805223|NCT00462709|27118662|P1|Overall Study|Logistical reasons|2
7805224|NCT00462709|27118662|P1|Overall Study|Death|2
7805225|NCT00462709|27118662|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
7805226|NCT00462709|27118662|P1|Overall Study|Withdrawal by Subject|8
7805227|NCT00462709|27118662|P1|Overall Study|Lost to Follow-up|10
7805228|NCT00462709|27118662|P1|Overall Study|Transitioned to commercial C1INH-nf|40
7805229|NCT00462670|27118671|P2|Overall Study|Resolution of signs and symptoms|2
7805230|NCT00462670|27118672|P1|Overall Study|Resolution of signs and symptoms|0
7805231|NCT00462670|27118671|P2|Overall Study|Protocol Violation|0
7805232|NCT00462670|27118672|P1|Overall Study|Protocol Violation|1
7805233|NCT00462670|27118671|P2|Overall Study|Lack of Efficacy|0
7805234|NCT00462670|27118672|P1|Overall Study|Lack of Efficacy|1
7805235|NCT00462670|27118671|P2|Overall Study|Adverse Event|5
7805236|NCT00462670|27118672|P1|Overall Study|Adverse Event|3
7805237|NCT00462501|27118709|P1|Overall Study|Adverse Event|2
7805238|NCT00462501|27118709|P1|Overall Study|Not treated|3
7805239|NCT00462488|27118715|P2|Overall Study|Lack of Efficacy|17
7805240|NCT00462488|27118716|P1|Overall Study|Lack of Efficacy|19
7805241|NCT00462488|27118715|P2|Overall Study|Protocol Violation|0
7805242|NCT00462488|27118716|P1|Overall Study|Protocol Violation|1
7805243|NCT00462462|27118724|P2|Overall Study|Physician Decision|1
7805244|NCT00462462|27118725|P1|Overall Study|Physician Decision|0
7805245|NCT00462384|27118753|P1|Overall Study|Other|4
7805246|NCT00462384|27118753|P1|Overall Study|Withdrawal by Subject|1
7805247|NCT00462384|27118753|P1|Overall Study|Death|2
7805248|NCT00462384|27118753|P1|Overall Study|Adverse Event|2
7805249|NCT00462345|27118761|P1|Overall Study|Did not complete second course|1
7805250|NCT00462345|27118761|P1|Overall Study|Withdrawal by Subject|2
7805251|NCT00462306|27118796|P2|Overall Study|insufficient data|13
7805252|NCT00462306|27118797|P1|Overall Study|insufficient data|0
7805253|NCT00461981|27118936|P2|Overall Study|Withdrawal by Subject|3
7805254|NCT00461981|27118937|P1|Overall Study|Withdrawal by Subject|2
7805255|NCT00461981|27118936|P2|Overall Study|Lost to Follow-up|6
7805256|NCT00461981|27118937|P1|Overall Study|Lost to Follow-up|9
7805257|NCT00461812|27119053|P1|Overall Study|study terminated|10
7805258|NCT00461786|27119058|P1|Overall Study|Inevaluable (Never Treated)|1
7805259|NCT00461786|27119058|P1|Overall Study|Entry Criteria Not Met|2
7805260|NCT00461708|27119122|P2|Overall Study|Death|1
7805261|NCT00461708|27119123|P1|Overall Study|Death|8
7805262|NCT00461708|27119122|P2|Overall Study|Other|4
7805263|NCT00461708|27119123|P1|Overall Study|Other|4
7805264|NCT00461708|27119122|P2|Overall Study|Withdrawal by Subject|2
7805265|NCT00461708|27119123|P1|Overall Study|Withdrawal by Subject|8
7805266|NCT00461708|27119122|P2|Overall Study|Physician Decision|4
7805267|NCT00461708|27119123|P1|Overall Study|Physician Decision|10
7805268|NCT00461708|27119122|P2|Overall Study|Lack of Efficacy|20
7805269|NCT00461708|27119123|P1|Overall Study|Lack of Efficacy|68
7805270|NCT00461708|27119122|P2|Overall Study|Adverse Event|7
7805271|NCT00461708|27119123|P1|Overall Study|Adverse Event|17
7805272|NCT00461682|27119149|P1|Overall Study|Protocol Violation|1
7805273|NCT00461630|27119177|P2|Overall Study|Lost to Follow-up|95
7805274|NCT00461630|27119178|P1|Overall Study|Lost to Follow-up|108
7805275|NCT00461630|27119177|P2|Overall Study|Death|732
7805276|NCT00461630|27119178|P1|Overall Study|Death|798
7805277|NCT00461552|27119217|P2|Overall Study|Drug Dispensing error|2
7805278|NCT00461552|27119218|P1|Overall Study|Drug Dispensing error|0
7805279|NCT00461500|27119241|P2|Overall Study|Lost to Follow-up|2
7805280|NCT00461500|27119242|P1|Overall Study|Lost to Follow-up|2
7805281|NCT00461500|27119241|P2|Overall Study|No Longer Willing to Take Part in Study|0
7805282|NCT00461500|27119242|P1|Overall Study|No Longer Willing to Take Part in Study|1
7805283|NCT00461500|27119241|P2|Overall Study|Drug Treatment Misuse|0
7805284|NCT00461500|27119242|P1|Overall Study|Drug Treatment Misuse|1
7805285|NCT00461500|27119241|P2|Overall Study|Study Stopped|2
7805286|NCT00461500|27119242|P1|Overall Study|Study Stopped|1
7805287|NCT00461500|27119241|P2|Overall Study|Expired Drug Treatment|1
7805288|NCT00461500|27119242|P1|Overall Study|Expired Drug Treatment|1
7805289|NCT00461500|27119241|P2|Overall Study|Lack of Efficacy|1
7805290|NCT00461500|27119242|P1|Overall Study|Lack of Efficacy|0
7805291|NCT00461500|27119241|P2|Overall Study|Adverse Event|0
7805292|NCT00461500|27119242|P1|Overall Study|Adverse Event|1
7805293|NCT00461305|27119285|P2|Continued Treatment|Other (missing drug etc)|0
7805294|NCT00461305|27119286|P1|Continued Treatment|Other (missing drug etc)|2
7805295|NCT00461305|27119285|P2|Continued Treatment|Partially missing diary|0
7805296|NCT00461305|27119286|P1|Continued Treatment|Partially missing diary|2
7805297|NCT00461305|27119285|P2|Continued Treatment|Withdrawal by Subject|0
7805298|NCT00461305|27119286|P1|Continued Treatment|Withdrawal by Subject|48
7805299|NCT00461305|27119285|P2|Continued Treatment|Protocol Violation|0
7805300|NCT00461305|27119286|P1|Continued Treatment|Protocol Violation|13
7805301|NCT00461305|27119285|P2|Continued Treatment|Lost to Follow-up|0
7805302|NCT00461305|27119286|P1|Continued Treatment|Lost to Follow-up|4
7805303|NCT00461305|27119285|P2|Continued Treatment|Adverse Event|0
7805304|NCT00461305|27119286|P1|Continued Treatment|Adverse Event|26
7805305|NCT00461305|27119285|P2|Treatment|Other (missing drug etc)|0
7805306|NCT00461305|27119286|P1|Treatment|Other (missing drug etc)|2
7805307|NCT00461305|27119285|P2|Treatment|Partially missing diary|0
7805308|NCT00461305|27119286|P1|Treatment|Partially missing diary|2
7805309|NCT00461305|27119285|P2|Treatment|Study drug not taken|0
7805310|NCT00461305|27119286|P1|Treatment|Study drug not taken|1
7805311|NCT00461305|27119285|P2|Treatment|Never dispensed|0
7805312|NCT00461305|27119286|P1|Treatment|Never dispensed|5
7805313|NCT00461305|27119285|P2|Treatment|Withdrawal by Subject|2
7805314|NCT00461305|27119286|P1|Treatment|Withdrawal by Subject|48
7805315|NCT00461305|27119285|P2|Treatment|Protocol Violation|2
7805316|NCT00461305|27119286|P1|Treatment|Protocol Violation|13
7805317|NCT00461305|27119285|P2|Treatment|Lost to Follow-up|2
7805318|NCT00461305|27119286|P1|Treatment|Lost to Follow-up|4
7805319|NCT00461305|27119285|P2|Treatment|Adverse Event|3
7805320|NCT00461305|27119286|P1|Treatment|Adverse Event|26
7805321|NCT00461253|27119370|P2|Overall Study|administrative|7773
7805322|NCT00461253|27119371|P1|Overall Study|administrative|773
7805323|NCT00461253|27119370|P2|Overall Study|no response|11789
7805324|NCT00461253|27119371|P1|Overall Study|no response|2609
7805325|NCT00461253|27119370|P2|Overall Study|Protocol Violation|236
7805326|NCT00461253|27119371|P1|Overall Study|Protocol Violation|613
7805327|NCT00461253|27119370|P2|Overall Study|Death|0
7805328|NCT00461253|27119371|P1|Overall Study|Death|985
7805329|NCT00461175|27119379|P2|Overall Study|Protocol Violation|365
7805330|NCT00461175|27119380|P1|Overall Study|Protocol Violation|522
7805331|NCT00461123|27119390|P2|Overall Study|Withdrawal by Subject|3
7805332|NCT00461123|27119391|P1|Overall Study|Withdrawal by Subject|1
7805333|NCT00461123|27119390|P2|Overall Study|Protocol Violation|2
7805334|NCT00461123|27119391|P1|Overall Study|Protocol Violation|3
7805335|NCT00461123|27119390|P2|Overall Study|Lost to Follow-up|1
7805336|NCT00461123|27119391|P1|Overall Study|Lost to Follow-up|1
7805337|NCT00461123|27119390|P2|Overall Study|Adverse Event|0
7805338|NCT00461123|27119391|P1|Overall Study|Adverse Event|1
7805339|NCT00461032|27119436|P2|Overall Study|Other|5
7805340|NCT00461032|27119437|P1|Overall Study|Other|7
7805341|NCT00461032|27119436|P2|Overall Study|Patient Moved or Relocated|1
7805342|NCT00461032|27119437|P1|Overall Study|Patient Moved or Relocated|2
7805343|NCT00461032|27119436|P2|Overall Study|Withdrawal by Subject|15
7805344|NCT00461032|27119437|P1|Overall Study|Withdrawal by Subject|7
7805345|NCT00461032|27119436|P2|Overall Study|Protocol Violation|4
7805346|NCT00461032|27119437|P1|Overall Study|Protocol Violation|4
7805347|NCT00461032|27119436|P2|Overall Study|Lost to Follow-up|12
7805348|NCT00461032|27119437|P1|Overall Study|Lost to Follow-up|7
7805349|NCT00461032|27119436|P2|Overall Study|Lack of Efficacy|1
7805350|NCT00461032|27119437|P1|Overall Study|Lack of Efficacy|5
7805351|NCT00461032|27119436|P2|Overall Study|Adverse Event|6
7805352|NCT00461032|27119437|P1|Overall Study|Adverse Event|5
7805353|NCT00460811|27119463|P5|Overall Study|Lost to Follow-up|6
7805354|NCT00460811|27119464|P4|Overall Study|Lost to Follow-up|3
7805355|NCT00460811|27119465|P3|Overall Study|Lost to Follow-up|5
7805356|NCT00460811|27119466|P2|Overall Study|Lost to Follow-up|2
7805357|NCT00460811|27119467|P1|Overall Study|Lost to Follow-up|3
7805358|NCT00460811|27119463|P5|Overall Study|Physician Decision|0
7805359|NCT00460811|27119464|P4|Overall Study|Physician Decision|0
7805360|NCT00460811|27119465|P3|Overall Study|Physician Decision|0
7805361|NCT00460811|27119466|P2|Overall Study|Physician Decision|0
7805362|NCT00460811|27119467|P1|Overall Study|Physician Decision|1
7805363|NCT00460811|27119463|P5|Overall Study|Withdrawal by Subject|11
7805364|NCT00460811|27119464|P4|Overall Study|Withdrawal by Subject|3
7805365|NCT00460811|27119465|P3|Overall Study|Withdrawal by Subject|6
7805366|NCT00460811|27119466|P2|Overall Study|Withdrawal by Subject|7
7805367|NCT00460811|27119467|P1|Overall Study|Withdrawal by Subject|7
7805368|NCT00460811|27119463|P5|Overall Study|Noncompliance|1
7805369|NCT00460811|27119464|P4|Overall Study|Noncompliance|2
7805370|NCT00460811|27119465|P3|Overall Study|Noncompliance|0
7805371|NCT00460811|27119466|P2|Overall Study|Noncompliance|0
7805372|NCT00460811|27119467|P1|Overall Study|Noncompliance|1
7805373|NCT00460811|27119463|P5|Overall Study|Adverse Event|2
7805374|NCT00460811|27119464|P4|Overall Study|Adverse Event|10
7805375|NCT00460811|27119465|P3|Overall Study|Adverse Event|3
7805376|NCT00460811|27119466|P2|Overall Study|Adverse Event|6
7805377|NCT00460811|27119467|P1|Overall Study|Adverse Event|4
7805378|NCT00460798|27119509|P1|Overall Study|Missing/Incomplete Dosing Information|27
7805379|NCT00460798|27119509|P1|Overall Study|Ongoing at Date of Cut-Off|82
7805380|NCT00460798|27119509|P1|Overall Study|Other|27
7805381|NCT00460798|27119509|P1|Overall Study|Progressive Disease|99
7805382|NCT00460798|27119509|P1|Overall Study|Lost to Follow-up|19
7805383|NCT00460798|27119509|P1|Overall Study|Adverse Event|27
7805384|NCT00460798|27119509|P1|Overall Study|Death|59
7805385|NCT00460746|27119517|P1|Overall Study|Lost to Follow-up|1
7805386|NCT00460746|27119517|P1|Overall Study|Adverse Event|1
7805387|NCT00460655|27119532|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
7805388|NCT00460655|27119533|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7805389|NCT00460655|27119534|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7805390|NCT00460655|27119535|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7805391|NCT00460655|27119532|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
7805392|NCT00460655|27119533|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
7805393|NCT00460655|27119534|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805394|NCT00460655|27119535|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805395|NCT00460655|27119532|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
7805396|NCT00460655|27119533|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
7805397|NCT00460655|27119534|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
7805398|NCT00460655|27119535|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
7805399|NCT00460655|27119532|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7805400|NCT00460655|27119533|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7805401|NCT00460655|27119534|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
7805402|NCT00460655|27119535|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7805403|NCT00460655|27119532|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805404|NCT00460655|27119533|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805405|NCT00460655|27119534|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805406|NCT00460655|27119535|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
7805407|NCT00460655|27119532|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805408|NCT00460655|27119533|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805409|NCT00460655|27119534|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805410|NCT00460655|27119535|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
7805411|NCT00460603|27119579|P12|Phase 2|Randomized, but not treated|0
7805412|NCT00460603|27119580|P11|Phase 2|Randomized, but not treated|0
7805413|NCT00460603|27119581|P10|Phase 2|Randomized, but not treated|3
7805414|NCT00460603|27119582|P9|Phase 2|Randomized, but not treated|0
7805415|NCT00460603|27119583|P8|Phase 2|Randomized, but not treated|0
7805416|NCT00460603|27119584|P7|Phase 2|Randomized, but not treated|0
7805417|NCT00460603|27119585|P6|Phase 2|Randomized, but not treated|0
7805418|NCT00460603|27119586|P5|Phase 2|Randomized, but not treated|0
7805419|NCT00460603|27119587|P4|Phase 2|Randomized, but not treated|0
7805420|NCT00460603|27119588|P3|Phase 2|Randomized, but not treated|0
7805421|NCT00460603|27119589|P2|Phase 2|Randomized, but not treated|0
7805422|NCT00460603|27119590|P1|Phase 2|Randomized, but not treated|0
7805423|NCT00460603|27119579|P12|Phase 2|Withdrawal by Subject|5
7805424|NCT00460603|27119580|P11|Phase 2|Withdrawal by Subject|4
7805425|NCT00460603|27119581|P10|Phase 2|Withdrawal by Subject|5
7805426|NCT00460603|27119582|P9|Phase 2|Withdrawal by Subject|0
7805427|NCT00460603|27119583|P8|Phase 2|Withdrawal by Subject|0
7805428|NCT00460603|27119584|P7|Phase 2|Withdrawal by Subject|0
7805429|NCT00460603|27119585|P6|Phase 2|Withdrawal by Subject|0
7805430|NCT00460603|27119586|P5|Phase 2|Withdrawal by Subject|0
7805431|NCT00460603|27119587|P4|Phase 2|Withdrawal by Subject|0
7805432|NCT00460603|27119588|P3|Phase 2|Withdrawal by Subject|0
7805433|NCT00460603|27119589|P2|Phase 2|Withdrawal by Subject|0
7805434|NCT00460603|27119590|P1|Phase 2|Withdrawal by Subject|0
7805435|NCT00460603|27119579|P12|Phase 2|Global Deterioration of Health Status|0
7805436|NCT00460603|27119580|P11|Phase 2|Global Deterioration of Health Status|1
7805437|NCT00460603|27119581|P10|Phase 2|Global Deterioration of Health Status|0
7805438|NCT00460603|27119582|P9|Phase 2|Global Deterioration of Health Status|0
7805439|NCT00460603|27119583|P8|Phase 2|Global Deterioration of Health Status|0
7805440|NCT00460603|27119584|P7|Phase 2|Global Deterioration of Health Status|0
7805441|NCT00460603|27119585|P6|Phase 2|Global Deterioration of Health Status|0
7805442|NCT00460603|27119586|P5|Phase 2|Global Deterioration of Health Status|0
7805443|NCT00460603|27119587|P4|Phase 2|Global Deterioration of Health Status|0
7805444|NCT00460603|27119588|P3|Phase 2|Global Deterioration of Health Status|0
7805445|NCT00460603|27119589|P2|Phase 2|Global Deterioration of Health Status|0
7805446|NCT00460603|27119590|P1|Phase 2|Global Deterioration of Health Status|0
7805447|NCT00460603|27119579|P12|Phase 2|Objective Progression or Relapse|17
7805448|NCT00460603|27119580|P11|Phase 2|Objective Progression or Relapse|10
7805449|NCT00460603|27119581|P10|Phase 2|Objective Progression or Relapse|9
7805450|NCT00460603|27119582|P9|Phase 2|Objective Progression or Relapse|0
7805451|NCT00460603|27119583|P8|Phase 2|Objective Progression or Relapse|0
7805452|NCT00460603|27119584|P7|Phase 2|Objective Progression or Relapse|0
7805453|NCT00460603|27119585|P6|Phase 2|Objective Progression or Relapse|0
7805454|NCT00460603|27119586|P5|Phase 2|Objective Progression or Relapse|0
7805455|NCT00460603|27119587|P4|Phase 2|Objective Progression or Relapse|0
7805456|NCT00460603|27119588|P3|Phase 2|Objective Progression or Relapse|0
7805457|NCT00460603|27119589|P2|Phase 2|Objective Progression or Relapse|0
7805458|NCT00460603|27119590|P1|Phase 2|Objective Progression or Relapse|0
7805459|NCT00460603|27119579|P12|Phase 2|Other|7
7805460|NCT00460603|27119580|P11|Phase 2|Other|16
7805461|NCT00460603|27119581|P10|Phase 2|Other|6
7805462|NCT00460603|27119582|P9|Phase 2|Other|0
7805463|NCT00460603|27119583|P8|Phase 2|Other|0
7805464|NCT00460603|27119584|P7|Phase 2|Other|0
7805465|NCT00460603|27119585|P6|Phase 2|Other|0
7805466|NCT00460603|27119586|P5|Phase 2|Other|0
7805467|NCT00460603|27119587|P4|Phase 2|Other|0
7805468|NCT00460603|27119588|P3|Phase 2|Other|0
7805469|NCT00460603|27119589|P2|Phase 2|Other|0
7805470|NCT00460603|27119590|P1|Phase 2|Other|0
7805471|NCT00460603|27119579|P12|Phase 2|Lost to Follow-up|0
7805472|NCT00460603|27119580|P11|Phase 2|Lost to Follow-up|0
7805473|NCT00460603|27119581|P10|Phase 2|Lost to Follow-up|1
7805474|NCT00460603|27119582|P9|Phase 2|Lost to Follow-up|0
7805475|NCT00460603|27119583|P8|Phase 2|Lost to Follow-up|0
7805476|NCT00460603|27119584|P7|Phase 2|Lost to Follow-up|0
7805477|NCT00460603|27119585|P6|Phase 2|Lost to Follow-up|0
7805478|NCT00460603|27119586|P5|Phase 2|Lost to Follow-up|0
7805479|NCT00460603|27119587|P4|Phase 2|Lost to Follow-up|0
7805480|NCT00460603|27119588|P3|Phase 2|Lost to Follow-up|0
7805481|NCT00460603|27119589|P2|Phase 2|Lost to Follow-up|0
7805482|NCT00460603|27119590|P1|Phase 2|Lost to Follow-up|0
7805483|NCT00460603|27119579|P12|Phase 2|Protocol Violation|0
7805484|NCT00460603|27119580|P11|Phase 2|Protocol Violation|1
7805485|NCT00460603|27119581|P10|Phase 2|Protocol Violation|1
7805486|NCT00460603|27119582|P9|Phase 2|Protocol Violation|0
7805487|NCT00460603|27119583|P8|Phase 2|Protocol Violation|0
7805488|NCT00460603|27119584|P7|Phase 2|Protocol Violation|0
7805489|NCT00460603|27119585|P6|Phase 2|Protocol Violation|0
7805490|NCT00460603|27119586|P5|Phase 2|Protocol Violation|0
7805491|NCT00460603|27119587|P4|Phase 2|Protocol Violation|0
7805492|NCT00460603|27119588|P3|Phase 2|Protocol Violation|0
7805493|NCT00460603|27119589|P2|Phase 2|Protocol Violation|0
7805494|NCT00460603|27119590|P1|Phase 2|Protocol Violation|0
7805495|NCT00460603|27119579|P12|Phase 2|Death|2
7805496|NCT00460603|27119580|P11|Phase 2|Death|2
7805497|NCT00460603|27119581|P10|Phase 2|Death|4
7805498|NCT00460603|27119582|P9|Phase 2|Death|0
7805499|NCT00460603|27119583|P8|Phase 2|Death|0
7805500|NCT00460603|27119584|P7|Phase 2|Death|0
7805501|NCT00460603|27119585|P6|Phase 2|Death|0
7805502|NCT00460603|27119586|P5|Phase 2|Death|0
7805503|NCT00460603|27119587|P4|Phase 2|Death|0
7805504|NCT00460603|27119588|P3|Phase 2|Death|0
7805505|NCT00460603|27119589|P2|Phase 2|Death|0
7805506|NCT00460603|27119590|P1|Phase 2|Death|0
7805507|NCT00460603|27119579|P12|Phase 2|Adverse Event|10
7805508|NCT00460603|27119580|P11|Phase 2|Adverse Event|9
7805509|NCT00460603|27119581|P10|Phase 2|Adverse Event|12
7805510|NCT00460603|27119582|P9|Phase 2|Adverse Event|0
7805511|NCT00460603|27119583|P8|Phase 2|Adverse Event|0
7805512|NCT00460603|27119584|P7|Phase 2|Adverse Event|0
7805513|NCT00460603|27119585|P6|Phase 2|Adverse Event|0
7805514|NCT00460603|27119586|P5|Phase 2|Adverse Event|0
7805515|NCT00460603|27119587|P4|Phase 2|Adverse Event|0
7805516|NCT00460603|27119588|P3|Phase 2|Adverse Event|0
7805517|NCT00460603|27119589|P2|Phase 2|Adverse Event|0
7805518|NCT00460603|27119590|P1|Phase 2|Adverse Event|0
7805519|NCT00460603|27119579|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805520|NCT00460603|27119580|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805521|NCT00460603|27119581|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
7805522|NCT00460603|27119582|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805523|NCT00460603|27119583|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805524|NCT00460603|27119584|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805525|NCT00460603|27119585|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805526|NCT00460603|27119586|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805527|NCT00460603|27119587|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805528|NCT00460603|27119588|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805529|NCT00460603|27119589|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805530|NCT00460603|27119590|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7805531|NCT00460603|27119579|P12|Phase 1|Other|0
7805532|NCT00460603|27119580|P11|Phase 1|Other|0
7805533|NCT00460603|27119581|P10|Phase 1|Other|0
7805534|NCT00460603|27119582|P9|Phase 1|Other|0
7805535|NCT00460603|27119583|P8|Phase 1|Other|1
7805536|NCT00460603|27119584|P7|Phase 1|Other|0
7805537|NCT00460603|27119585|P6|Phase 1|Other|2
7805538|NCT00460603|27119586|P5|Phase 1|Other|1
7805539|NCT00460603|27119587|P4|Phase 1|Other|1
7805540|NCT00460603|27119588|P3|Phase 1|Other|1
7805541|NCT00460603|27119589|P2|Phase 1|Other|3
7805542|NCT00460603|27119590|P1|Phase 1|Other|0
7805543|NCT00460603|27119579|P12|Phase 1|Withdrawal by Subject|0
7805544|NCT00460603|27119580|P11|Phase 1|Withdrawal by Subject|0
7805545|NCT00460603|27119581|P10|Phase 1|Withdrawal by Subject|0
7805546|NCT00460603|27119582|P9|Phase 1|Withdrawal by Subject|2
7805547|NCT00460603|27119583|P8|Phase 1|Withdrawal by Subject|0
7805548|NCT00460603|27119584|P7|Phase 1|Withdrawal by Subject|1
7805549|NCT00460603|27119585|P6|Phase 1|Withdrawal by Subject|0
7805550|NCT00460603|27119586|P5|Phase 1|Withdrawal by Subject|3
7805551|NCT00460603|27119587|P4|Phase 1|Withdrawal by Subject|1
7805552|NCT00460603|27119588|P3|Phase 1|Withdrawal by Subject|1
7805553|NCT00460603|27119589|P2|Phase 1|Withdrawal by Subject|2
7805554|NCT00460603|27119590|P1|Phase 1|Withdrawal by Subject|1
7805555|NCT00460603|27119579|P12|Phase 1|Lack of Efficacy|0
7805556|NCT00460603|27119580|P11|Phase 1|Lack of Efficacy|0
7805557|NCT00460603|27119581|P10|Phase 1|Lack of Efficacy|0
7805558|NCT00460603|27119582|P9|Phase 1|Lack of Efficacy|11
7805559|NCT00460603|27119583|P8|Phase 1|Lack of Efficacy|2
7805560|NCT00460603|27119584|P7|Phase 1|Lack of Efficacy|2
7805561|NCT00460603|27119585|P6|Phase 1|Lack of Efficacy|2
7805562|NCT00460603|27119586|P5|Phase 1|Lack of Efficacy|2
7805563|NCT00460603|27119587|P4|Phase 1|Lack of Efficacy|2
7805564|NCT00460603|27119588|P3|Phase 1|Lack of Efficacy|1
7805565|NCT00460603|27119589|P2|Phase 1|Lack of Efficacy|0
7805566|NCT00460603|27119590|P1|Phase 1|Lack of Efficacy|1
7805567|NCT00460603|27119579|P12|Phase 1|Adverse Event|0
7805568|NCT00460603|27119580|P11|Phase 1|Adverse Event|0
7805569|NCT00460603|27119581|P10|Phase 1|Adverse Event|0
7805570|NCT00460603|27119582|P9|Phase 1|Adverse Event|4
7805571|NCT00460603|27119583|P8|Phase 1|Adverse Event|0
7805572|NCT00460603|27119584|P7|Phase 1|Adverse Event|3
7805573|NCT00460603|27119585|P6|Phase 1|Adverse Event|0
7805574|NCT00460603|27119586|P5|Phase 1|Adverse Event|0
7805575|NCT00460603|27119587|P4|Phase 1|Adverse Event|2
7805576|NCT00460603|27119588|P3|Phase 1|Adverse Event|1
7805577|NCT00460603|27119589|P2|Phase 1|Adverse Event|1
7805578|NCT00460603|27119590|P1|Phase 1|Adverse Event|3
7805579|NCT00460603|27119579|P12|Phase 1|Death|0
7805580|NCT00460603|27119580|P11|Phase 1|Death|0
7805581|NCT00460603|27119581|P10|Phase 1|Death|0
7805582|NCT00460603|27119582|P9|Phase 1|Death|1
7805583|NCT00460603|27119583|P8|Phase 1|Death|0
7805584|NCT00460603|27119584|P7|Phase 1|Death|0
7805585|NCT00460603|27119585|P6|Phase 1|Death|0
7805586|NCT00460603|27119586|P5|Phase 1|Death|0
7805587|NCT00460603|27119587|P4|Phase 1|Death|2
7805588|NCT00460603|27119588|P3|Phase 1|Death|0
7805589|NCT00460603|27119589|P2|Phase 1|Death|0
7805590|NCT00460603|27119590|P1|Phase 1|Death|1
7805591|NCT00460577|27119684|P2|Overall Study|Protocol Violation|6
7805592|NCT00460577|27119685|P1|Overall Study|Protocol Violation|2
7805593|NCT00460564|27119703|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805594|NCT00460564|27119704|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805595|NCT00460564|27119705|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805596|NCT00460564|27119706|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
7805597|NCT00460564|27119707|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805598|NCT00460564|27119708|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805599|NCT00460564|27119709|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805600|NCT00460564|27119710|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7805601|NCT00460564|27119703|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805602|NCT00460564|27119704|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805603|NCT00460564|27119705|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
7805604|NCT00460564|27119706|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
7805605|NCT00460564|27119707|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805606|NCT00460564|27119708|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805607|NCT00460564|27119709|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805608|NCT00460564|27119710|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7805609|NCT00460564|27119703|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
7805610|NCT00460564|27119704|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
7805611|NCT00460564|27119705|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
7805612|NCT00460564|27119706|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
7805613|NCT00460564|27119707|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
7805614|NCT00460564|27119708|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
7805615|NCT00460564|27119709|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
7805616|NCT00460564|27119710|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
7805617|NCT00460564|27119703|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805618|NCT00460564|27119704|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805619|NCT00460564|27119705|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805620|NCT00460564|27119706|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805621|NCT00460564|27119707|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805622|NCT00460564|27119708|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805623|NCT00460564|27119709|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7805624|NCT00460564|27119710|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
7805625|NCT00460564|27119703|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805626|NCT00460564|27119704|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805627|NCT00460564|27119705|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805628|NCT00460564|27119706|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805629|NCT00460564|27119707|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805630|NCT00460564|27119708|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
7805631|NCT00460564|27119709|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
7805632|NCT00460564|27119710|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
7805633|NCT00460434|27119854|P2|Overall Study|Lost to Follow-up|7
7805634|NCT00460434|27119855|P1|Overall Study|Lost to Follow-up|3
7805635|NCT00460408|27119934|P4|Overall Study|Other|0
7805636|NCT00460408|27119935|P3|Overall Study|Other|0
7805637|NCT00460408|27119936|P2|Overall Study|Other|2
7805638|NCT00460408|27119937|P1|Overall Study|Other|12
7805639|NCT00460408|27119934|P4|Overall Study|Insufficient clinical response|0
7805640|NCT00460408|27119935|P3|Overall Study|Insufficient clinical response|5
7805641|NCT00460408|27119936|P2|Overall Study|Insufficient clinical response|1
7805642|NCT00460408|27119937|P1|Overall Study|Insufficient clinical response|5
7805643|NCT00460408|27119934|P4|Overall Study|Withdrawal by Subject|0
7805644|NCT00460408|27119935|P3|Overall Study|Withdrawal by Subject|0
7805645|NCT00460408|27119936|P2|Overall Study|Withdrawal by Subject|0
7805646|NCT00460408|27119937|P1|Overall Study|Withdrawal by Subject|31
7805647|NCT00460408|27119934|P4|Overall Study|Lost to Follow-up|0
7805648|NCT00460408|27119935|P3|Overall Study|Lost to Follow-up|1
7805649|NCT00460408|27119936|P2|Overall Study|Lost to Follow-up|0
7805650|NCT00460408|27119937|P1|Overall Study|Lost to Follow-up|11
7805651|NCT00460408|27119934|P4|Overall Study|Death|0
7805652|NCT00460408|27119935|P3|Overall Study|Death|0
7805653|NCT00460408|27119936|P2|Overall Study|Death|0
7805654|NCT00460408|27119937|P1|Overall Study|Death|7
7805655|NCT00460408|27119934|P4|Overall Study|Adverse Event|0
7805656|NCT00460408|27119935|P3|Overall Study|Adverse Event|0
7805657|NCT00460408|27119936|P2|Overall Study|Adverse Event|0
7805658|NCT00460408|27119937|P1|Overall Study|Adverse Event|1
7805659|NCT00460265|27119974|P2|Overall Study|Ongoing|47
7805660|NCT00460265|27119975|P1|Overall Study|Ongoing|60
7805661|NCT00460265|27119974|P2|Overall Study|Withdrawal by Subject|25
7805662|NCT00460265|27119975|P1|Overall Study|Withdrawal by Subject|10
7805663|NCT00460265|27119974|P2|Overall Study|Physician Decision|2
7805664|NCT00460265|27119975|P1|Overall Study|Physician Decision|1
7805665|NCT00460265|27119974|P2|Overall Study|Lost to Follow-up|15
7805666|NCT00460265|27119975|P1|Overall Study|Lost to Follow-up|14
7805667|NCT00460239|27119991|P9|Overall Study|Withdrawal by Subject|0
7805668|NCT00460239|27119992|P8|Overall Study|Withdrawal by Subject|0
7805669|NCT00460239|27119993|P7|Overall Study|Withdrawal by Subject|0
7805670|NCT00460239|27119994|P6|Overall Study|Withdrawal by Subject|1
7805671|NCT00460239|27119995|P5|Overall Study|Withdrawal by Subject|0
7805672|NCT00460239|27119996|P4|Overall Study|Withdrawal by Subject|0
7805673|NCT00460239|27119997|P3|Overall Study|Withdrawal by Subject|0
7805674|NCT00460239|27119998|P2|Overall Study|Withdrawal by Subject|0
7805675|NCT00460239|27119999|P1|Overall Study|Withdrawal by Subject|0
7805676|NCT00460239|27119991|P9|Overall Study|Physician Decision|0
7805677|NCT00460239|27119992|P8|Overall Study|Physician Decision|0
7805678|NCT00460239|27119993|P7|Overall Study|Physician Decision|0
7805679|NCT00460239|27119994|P6|Overall Study|Physician Decision|2
7805680|NCT00460239|27119995|P5|Overall Study|Physician Decision|0
7805681|NCT00460239|27119996|P4|Overall Study|Physician Decision|0
7805682|NCT00460239|27119997|P3|Overall Study|Physician Decision|0
7805683|NCT00460239|27119998|P2|Overall Study|Physician Decision|1
7805684|NCT00460239|27119999|P1|Overall Study|Physician Decision|0
7805685|NCT00460109|27120068|P1|Overall Study|Death|1
7805686|NCT00460031|27120076|P1|Overall Study|Death|1
7805687|NCT00460031|27120076|P1|Overall Study|Withdrawal by Subject|5
7805688|NCT00460031|27120076|P1|Overall Study|Adverse Event|5
7805689|NCT00459979|27120084|P1|Overall Study|Protocol Violation|1
7805690|NCT00459979|27120084|P1|Overall Study|Withdrawal by Subject|1
7805691|NCT00459953|27120096|P2|Overall Study|not analyzed-household member in study|1
7805692|NCT00459953|27120097|P1|Overall Study|not analyzed-household member in study|1
7805693|NCT00459875|27120103|P1|Overall Study|Adverse Event|2
7805694|NCT00459875|27120103|P1|Overall Study|Ineligible participant|1
7805695|NCT00459706|27120139|P2|Overall Study|Other|1
7805696|NCT00459706|27120140|P1|Overall Study|Other|0
7805697|NCT00459706|27120139|P2|Overall Study|Failed to Return|0
7805698|NCT00459706|27120140|P1|Overall Study|Failed to Return|1
7805699|NCT00459706|27120139|P2|Overall Study|Protocol Violation|1
7805700|NCT00459706|27120140|P1|Overall Study|Protocol Violation|2
7805701|NCT00459706|27120139|P2|Overall Study|Discontinuation of Study by Sponsor|0
7805702|NCT00459706|27120140|P1|Overall Study|Discontinuation of Study by Sponsor|1
7805703|NCT00459706|27120139|P2|Overall Study|Physician Decision|0
7805704|NCT00459706|27120140|P1|Overall Study|Physician Decision|2
7805705|NCT00459706|27120139|P2|Overall Study|Withdrawal by Subject|6
7805706|NCT00459706|27120140|P1|Overall Study|Withdrawal by Subject|1
7805707|NCT00459706|27120139|P2|Overall Study|Adverse Event|13
7805708|NCT00459706|27120140|P1|Overall Study|Adverse Event|19
7805709|NCT00459667|27120283|P3|Overall Study|No treatment administered|1
7805710|NCT00459667|27120284|P2|Overall Study|No treatment administered|3
7805711|NCT00459667|27120285|P1|Overall Study|No treatment administered|6
7805712|NCT00459667|27120283|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
7805713|NCT00459667|27120284|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
7805714|NCT00459667|27120285|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
7805715|NCT00459667|27120283|P3|Overall Study|Other disease modifying treatment|1
7805716|NCT00459667|27120284|P2|Overall Study|Other disease modifying treatment|2
7805717|NCT00459667|27120285|P1|Overall Study|Other disease modifying treatment|1
7805718|NCT00459667|27120283|P3|Overall Study|Withdrawal by Subject|5
7805719|NCT00459667|27120284|P2|Overall Study|Withdrawal by Subject|5
7805720|NCT00459667|27120285|P1|Overall Study|Withdrawal by Subject|3
7805721|NCT00459667|27120283|P3|Overall Study|Protocol Violation|0
7805722|NCT00459667|27120284|P2|Overall Study|Protocol Violation|0
7805723|NCT00459667|27120285|P1|Overall Study|Protocol Violation|1
7805724|NCT00459667|27120283|P3|Overall Study|Pregnancy|1
7805725|NCT00459667|27120284|P2|Overall Study|Pregnancy|1
7805726|NCT00459667|27120285|P1|Overall Study|Pregnancy|1
7805727|NCT00459667|27120283|P3|Overall Study|Lost to Follow-up|3
7805728|NCT00459667|27120284|P2|Overall Study|Lost to Follow-up|9
7805729|NCT00459667|27120285|P1|Overall Study|Lost to Follow-up|5
7805730|NCT00459667|27120283|P3|Overall Study|Adverse Event|8
7805731|NCT00459667|27120284|P2|Overall Study|Adverse Event|12
7805732|NCT00459667|27120285|P1|Overall Study|Adverse Event|9
7805733|NCT00459537|27120307|P2|Overall Study|Missing|0
7805734|NCT00459537|27120308|P1|Overall Study|Missing|1
7805735|NCT00459537|27120307|P2|Overall Study|Protocol Violation|3
7805736|NCT00459537|27120308|P1|Overall Study|Protocol Violation|4
7805737|NCT00459537|27120307|P2|Overall Study|Administrative problems|0
7805738|NCT00459537|27120308|P1|Overall Study|Administrative problems|3
7805739|NCT00459537|27120307|P2|Overall Study|Lost to Follow-up|30
7805740|NCT00459537|27120308|P1|Overall Study|Lost to Follow-up|27
7805741|NCT00459537|27120307|P2|Overall Study|Withdrawal by Subject|26
7805742|NCT00459537|27120308|P1|Overall Study|Withdrawal by Subject|20
7805743|NCT00459537|27120307|P2|Overall Study|Lack of Efficacy|11
7805744|NCT00459537|27120308|P1|Overall Study|Lack of Efficacy|10
7805745|NCT00459537|27120307|P2|Overall Study|Adverse Event|6
7805746|NCT00459537|27120308|P1|Overall Study|Adverse Event|1
7805747|NCT00459355|27120343|P2|Overall Study|Subject no longer met inc criteria|18
7805748|NCT00459355|27120344|P1|Overall Study|Subject no longer met inc criteria|20
7805749|NCT00459342|27120356|P1|Overall Study|Not eligible|1
7805750|NCT00459316|27120369|P3|Step 3|Withdrawal by Subject|1
7805751|NCT00459316|27120370|P2|Step 3|Withdrawal by Subject|0
7805752|NCT00459316|27120371|P1|Step 3|Withdrawal by Subject|3
7805753|NCT00459316|27120369|P3|Steps 1 & 2|Lost to Follow-up|2
7805754|NCT00459316|27120370|P2|Steps 1 & 2|Lost to Follow-up|0
7805755|NCT00459316|27120371|P1|Steps 1 & 2|Lost to Follow-up|5
7805756|NCT00459316|27120369|P3|Steps 1 & 2|Not willing to adhere to regulations|0
7805757|NCT00459316|27120370|P2|Steps 1 & 2|Not willing to adhere to regulations|0
7805758|NCT00459316|27120371|P1|Steps 1 & 2|Not willing to adhere to regulations|1
7805759|NCT00459316|27120369|P3|Steps 1 & 2|Withdrawal by Subject|0
7805760|NCT00459316|27120370|P2|Steps 1 & 2|Withdrawal by Subject|1
7805761|NCT00459316|27120371|P1|Steps 1 & 2|Withdrawal by Subject|6
7805762|NCT00459316|27120369|P3|Steps 1 & 2|Not able to get to clinic|0
7805763|NCT00459316|27120370|P2|Steps 1 & 2|Not able to get to clinic|4
7805764|NCT00459316|27120371|P1|Steps 1 & 2|Not able to get to clinic|7
7805765|NCT00459316|27120369|P3|Steps 1 & 2|Death|0
7805766|NCT00459316|27120370|P2|Steps 1 & 2|Death|1
7805767|NCT00459316|27120371|P1|Steps 1 & 2|Death|1
7805768|NCT00459316|27120369|P3|Steps 1 & 2|Other eligibility failure|0
7805769|NCT00459316|27120370|P2|Steps 1 & 2|Other eligibility failure|1
7805770|NCT00459316|27120371|P1|Steps 1 & 2|Other eligibility failure|1
7805771|NCT00459290|27120436|P1|Overall Study|Ineligible|2
7805772|NCT00459290|27120436|P1|Overall Study|Adverse Event|3
7805773|NCT00459186|27120451|P1|PET Imaging and Assessment|Adverse Event|3
7805774|NCT00459186|27120451|P1|Single Agent RAD001|Withdrawal by Subject|1
7805775|NCT00459134|27120458|P2|Overall Study|Multiple Reasons|3
7805776|NCT00459134|27120459|P1|Overall Study|Multiple Reasons|2
7805777|NCT00459134|27120458|P2|Overall Study|Progression|0
7805778|NCT00459134|27120459|P1|Overall Study|Progression|1
7805779|NCT00459134|27120458|P2|Overall Study|Toxicity|5
7805780|NCT00459134|27120459|P1|Overall Study|Toxicity|4
7805781|NCT00459134|27120458|P2|Overall Study|Surgery|2
7805782|NCT00459134|27120459|P1|Overall Study|Surgery|1
7805783|NCT00459134|27120458|P2|Overall Study|Lost to Follow-up|7
7805784|NCT00459134|27120459|P1|Overall Study|Lost to Follow-up|6
7805785|NCT00459134|27120458|P2|Overall Study|Withdrawal by Subject|7
7805786|NCT00459134|27120459|P1|Overall Study|Withdrawal by Subject|8
7805787|NCT00459134|27120458|P2|Overall Study|Physician Decision|1
7805788|NCT00459134|27120459|P1|Overall Study|Physician Decision|1
7805789|NCT00459108|27120475|P1|Overall Study|Progression|1
7805790|NCT00459108|27120475|P1|Overall Study|Death|2
7805791|NCT00459108|27120475|P1|Overall Study|Adverse Event|3
7805792|NCT00459108|27120475|P1|Overall Study|Withdrawal by Subject|5
7805793|NCT00459056|27120485|P2|First Intervention (First Three Months)|Lost to Follow-up|1
7805794|NCT00459056|27120486|P1|First Intervention (First Three Months)|Lost to Follow-up|1
7805795|NCT00459043|27120494|P2|Overall Study|Withdrawal by Subject|0
7805796|NCT00459043|27120495|P1|Overall Study|Withdrawal by Subject|1
7805797|NCT00458783|27120524|P2|Overall Study|Protocol Violation|1220
7805798|NCT00458783|27120525|P1|Overall Study|Protocol Violation|1228
7805799|NCT00458705|27120555|P1|Overall Study|Not Treated|1
7805800|NCT00458705|27120555|P1|Overall Study|Adverse Event|4
7805801|NCT00458536|27120559|P1|Overall Study|Progressive disease during treatment|2
7805802|NCT00458536|27120559|P1|Overall Study|Withdrawal by Subject|1
7805803|NCT00458536|27120559|P1|Overall Study|Ineligible due to toxicity|1
7805804|NCT00458536|27120559|P1|Overall Study|Patient did not have surgery|1
7805805|NCT00458536|27120559|P1|Overall Study|Did not have renal cell carcinoma|2
7805806|NCT00458536|27120559|P1|Overall Study|No measurable disease after surgery|2
7805807|NCT00458536|27120559|P1|Overall Study|Unable to make vaccine|3
7805808|NCT00458536|27120559|P1|Overall Study|Disease progression prior to treatment|7
7805809|NCT00458484|27120570|P7|Overall Study|Not eligible b/c prior radiation history|0
7805810|NCT00458484|27120571|P6|Overall Study|Not eligible b/c prior radiation history|1
7805811|NCT00458484|27120572|P5|Overall Study|Not eligible b/c prior radiation history|0
7805812|NCT00458484|27120573|P4|Overall Study|Not eligible b/c prior radiation history|0
7805813|NCT00458484|27120574|P3|Overall Study|Not eligible b/c prior radiation history|0
7805814|NCT00458484|27120575|P2|Overall Study|Not eligible b/c prior radiation history|0
7805815|NCT00458484|27120576|P1|Overall Study|Not eligible b/c prior radiation history|0
7805816|NCT00458393|27120642|P2|Overall Study|Sites marked other on the form.|20
7805817|NCT00458393|27120643|P1|Overall Study|Sites marked other on the form.|19
7805818|NCT00458393|27120642|P2|Overall Study|Lost to Follow-up|92
7805819|NCT00458393|27120643|P1|Overall Study|Lost to Follow-up|115
7805820|NCT00458393|27120642|P2|Overall Study|Relocated|81
7805821|NCT00458393|27120643|P1|Overall Study|Relocated|77
7805822|NCT00458393|27120642|P2|Overall Study|Physician Decision|22
7805823|NCT00458393|27120643|P1|Overall Study|Physician Decision|31
7805824|NCT00458393|27120642|P2|Overall Study|Withdrawal by Subject|80
7805825|NCT00458393|27120643|P1|Overall Study|Withdrawal by Subject|67
7805826|NCT00458341|27120691|P2|Cycle 1|Adverse Event|0
7805827|NCT00458341|27120692|P1|Cycle 1|Adverse Event|1
7805828|NCT00458302|27120732|P2|Overall Study|Other|2
7805829|NCT00458302|27120733|P1|Overall Study|Other|4
7805830|NCT00458302|27120732|P2|Overall Study|Lost to Follow-up|0
7805831|NCT00458302|27120733|P1|Overall Study|Lost to Follow-up|2
7805832|NCT00458302|27120732|P2|Overall Study|Study Termination By Sponsor|0
7805833|NCT00458302|27120733|P1|Overall Study|Study Termination By Sponsor|1
7805834|NCT00458302|27120732|P2|Overall Study|Inc/Exc Criteria Not Met|1
7805835|NCT00458302|27120733|P1|Overall Study|Inc/Exc Criteria Not Met|1
7805836|NCT00458302|27120732|P2|Overall Study|Withdrawal by Subject|4
7805837|NCT00458302|27120733|P1|Overall Study|Withdrawal by Subject|6
7805838|NCT00458302|27120732|P2|Overall Study|Protocol Violation|2
7805839|NCT00458302|27120733|P1|Overall Study|Protocol Violation|0
7805840|NCT00458302|27120732|P2|Overall Study|Pregnancy|1
7805841|NCT00458302|27120733|P1|Overall Study|Pregnancy|2
7805842|NCT00458302|27120732|P2|Overall Study|Adverse Event|14
7805843|NCT00458302|27120733|P1|Overall Study|Adverse Event|4
7805844|NCT00458211|27120778|P1|Overall Study|Protocol Violation|2
7805845|NCT00458211|27120778|P1|Overall Study|Withdrawal by Subject|2
7805846|NCT00458211|27120778|P1|Overall Study|Lack of Efficacy|12
7805847|NCT00457821|27120828|P8|Part 2|Withdrawal by Subject|1
7805848|NCT00457821|27120829|P7|Part 2|Withdrawal by Subject|0
7805849|NCT00457821|27120830|P6|Part 2|Withdrawal by Subject|0
7805850|NCT00457821|27120831|P5|Part 2|Withdrawal by Subject|0
7805851|NCT00457821|27120832|P4|Part 2|Withdrawal by Subject|0
7805852|NCT00457821|27120833|P3|Part 2|Withdrawal by Subject|0
7805853|NCT00457821|27120834|P2|Part 2|Withdrawal by Subject|0
7805854|NCT00457821|27120835|P1|Part 2|Withdrawal by Subject|0
7805855|NCT00457743|27120874|P3|Overall Study|Lack of Efficacy|3
7805856|NCT00457743|27120875|P2|Overall Study|Lack of Efficacy|23
7805857|NCT00457743|27120876|P1|Overall Study|Lack of Efficacy|3
7805858|NCT00457743|27120874|P3|Overall Study|Adverse Event|0
7805859|NCT00457743|27120875|P2|Overall Study|Adverse Event|4
7805860|NCT00457743|27120876|P1|Overall Study|Adverse Event|0
7805861|NCT00457691|27120933|P2|Overall Study|Disease progression, study terminated|196
7805862|NCT00457691|27120934|P1|Overall Study|Disease progression, study terminated|180
7805863|NCT00457691|27120933|P2|Overall Study|Subject refused (reason other than AE)|19
7805864|NCT00457691|27120934|P1|Overall Study|Subject refused (reason other than AE)|14
7805865|NCT00457691|27120933|P2|Overall Study|Study terminated by Sponsor|1
7805866|NCT00457691|27120934|P1|Overall Study|Study terminated by Sponsor|1
7805867|NCT00457691|27120933|P2|Overall Study|Lost to Follow-up|14
7805868|NCT00457691|27120934|P1|Overall Study|Lost to Follow-up|23
7805869|NCT00457691|27120933|P2|Overall Study|Protocol Violation|3
7805870|NCT00457691|27120934|P1|Overall Study|Protocol Violation|1
7805871|NCT00457691|27120933|P2|Overall Study|Death|148
7805872|NCT00457691|27120934|P1|Overall Study|Death|163
7805873|NCT00457691|27120933|P2|Overall Study|Adverse Event|1
7805874|NCT00457691|27120934|P1|Overall Study|Adverse Event|4
7805875|NCT00457665|27120956|P2|24 Months|Abnormal liver function tests|5
7805876|NCT00457665|27120957|P1|24 Months|Abnormal liver function tests|1
7805877|NCT00457665|27120956|P2|24 Months|Lipodystrophy|1
7805878|NCT00457665|27120957|P1|24 Months|Lipodystrophy|1
7805879|NCT00457665|27120956|P2|24 Months|Withdrawal by Subject|2
7805880|NCT00457665|27120957|P1|24 Months|Withdrawal by Subject|3
7805881|NCT00457665|27120956|P2|12 Months|Abnormal Liver function tests|5
7805882|NCT00457665|27120957|P1|12 Months|Abnormal Liver function tests|0
7805883|NCT00457665|27120956|P2|12 Months|Withdrawal by Subject|2
7805884|NCT00457665|27120957|P1|12 Months|Withdrawal by Subject|0
7805885|NCT00457665|27120956|P2|12 Months|Lipodystrophy|0
7805886|NCT00457665|27120957|P1|12 Months|Lipodystrophy|2
7805887|NCT00457665|27120956|P2|12 Months|High HIV viral load|1
7805888|NCT00457665|27120957|P1|12 Months|High HIV viral load|5
7805889|NCT00457665|27120956|P2|12 Months|Drug allergy|1
7805890|NCT00457665|27120957|P1|12 Months|Drug allergy|1
7805891|NCT00457639|27120963|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
7805892|NCT00457639|27120964|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
7805893|NCT00457639|27120963|P2|Intervention 1 (6 Months)|unrelated illness|2
7805894|NCT00457639|27120964|P1|Intervention 1 (6 Months)|unrelated illness|0
7805895|NCT00457639|27120963|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
7805896|NCT00457639|27120964|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
7805897|NCT00457626|27120972|P1|Overall Study|Participant's Condition No Longer Requires Study Drug|1
7805898|NCT00457626|27120972|P1|Overall Study|Administrative Problems|2
7805899|NCT00457626|27120972|P1|Overall Study|Adverse Event|3
7805900|NCT00457418|27120978|P1|Post PK Maintenance|Lost to Follow-up|1
7805901|NCT00457418|27120978|P1|Post PK Maintenance|Withdrawal by Subject|11
7805902|NCT00457418|27120978|P1|Post PK Maintenance|Progression of Disease|6
7805903|NCT00457418|27120978|P1|Post PK Maintenance|Adverse Event|10
7805904|NCT00457418|27120978|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
7805905|NCT00457418|27120978|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
7805906|NCT00457418|27120978|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
7805907|NCT00457392|27120990|P2|Overall Study|Randomized, Not Treated|3
7805908|NCT00457392|27120991|P1|Overall Study|Randomized, Not Treated|7
7805909|NCT00457392|27120990|P2|Overall Study|Study Terminated by Sponsor|4
7805910|NCT00457392|27120991|P1|Overall Study|Study Terminated by Sponsor|1
7805911|NCT00457392|27120990|P2|Overall Study|Other|4
7805912|NCT00457392|27120991|P1|Overall Study|Other|7
7805913|NCT00457392|27120990|P2|Overall Study|Protocol Violation|3
7805914|NCT00457392|27120991|P1|Overall Study|Protocol Violation|4
7805915|NCT00457392|27120990|P2|Overall Study|Lost to Follow-up|7
7805916|NCT00457392|27120991|P1|Overall Study|Lost to Follow-up|6
7805917|NCT00457392|27120990|P2|Overall Study|Withdrawal by Subject|8
7805918|NCT00457392|27120991|P1|Overall Study|Withdrawal by Subject|14
7805919|NCT00457392|27120990|P2|Overall Study|Global Deterioration of Health Status|8
7805920|NCT00457392|27120991|P1|Overall Study|Global Deterioration of Health Status|22
7805921|NCT00457392|27120990|P2|Overall Study|Adverse Event|41
7805922|NCT00457392|27120991|P1|Overall Study|Adverse Event|84
7805923|NCT00457392|27120990|P2|Overall Study|Death|106
7805924|NCT00457392|27120991|P1|Overall Study|Death|106
7805925|NCT00457392|27120990|P2|Overall Study|Objective Progression or Relapse|296
7805926|NCT00457392|27120991|P1|Overall Study|Objective Progression or Relapse|229
7805927|NCT00457301|27121018|P2|Overall Study|Death|7
7805928|NCT00457301|27121019|P1|Overall Study|Death|5
7805929|NCT00457301|27121018|P2|Overall Study|Censored out of the study|14
7805930|NCT00457301|27121019|P1|Overall Study|Censored out of the study|15
7805931|NCT00457301|27121018|P2|Overall Study|Withdrawal by Subject|3
7805932|NCT00457301|27121019|P1|Overall Study|Withdrawal by Subject|3
7805933|NCT00457249|27121033|P2|Overall Study|Serious Adverse Events|0
7805934|NCT00457249|27121034|P1|Overall Study|Serious Adverse Events|2
7805935|NCT00457249|27121033|P2|Overall Study|Withdrawal by Subject|1
7805936|NCT00457249|27121034|P1|Overall Study|Withdrawal by Subject|3
7805937|NCT00457249|27121033|P2|Overall Study|Protocol Violation|1
7805938|NCT00457249|27121034|P1|Overall Study|Protocol Violation|4
7805939|NCT00457249|27121033|P2|Overall Study|Lost to Follow-up|0
7805940|NCT00457249|27121034|P1|Overall Study|Lost to Follow-up|3
7805941|NCT00457015|27121073|P2|Overall Study|Left study site against medical advice|1
7805942|NCT00457015|27121074|P1|Overall Study|Left study site against medical advice|0
7805943|NCT00457002|27121090|P2|Overall Study|treated for 1 day; missing status/reason|0
7805944|NCT00457002|27121091|P1|Overall Study|treated for 1 day; missing status/reason|1
7805945|NCT00457002|27121090|P2|Overall Study|non-specified|38
7805946|NCT00457002|27121091|P1|Overall Study|non-specified|29
7805947|NCT00457002|27121090|P2|Overall Study|Administrative reason by Sponsor|0
7805948|NCT00457002|27121091|P1|Overall Study|Administrative reason by Sponsor|1
7805949|NCT00457002|27121090|P2|Overall Study|No longer met criteria|37
7805950|NCT00457002|27121091|P1|Overall Study|No longer met criteria|41
7805951|NCT00457002|27121090|P2|Overall Study|Poor/Non-compliance|33
7805952|NCT00457002|27121091|P1|Overall Study|Poor/Non-compliance|46
7805953|NCT00457002|27121090|P2|Overall Study|Lost to Follow-up|71
7805954|NCT00457002|27121091|P1|Overall Study|Lost to Follow-up|72
7805955|NCT00457002|27121090|P2|Overall Study|Withdrawal by Subject|271
7805956|NCT00457002|27121091|P1|Overall Study|Withdrawal by Subject|299
7805957|NCT00457002|27121090|P2|Overall Study|Adverse Event|260
7805958|NCT00457002|27121091|P1|Overall Study|Adverse Event|284
7805959|NCT00457002|27121090|P2|Overall Study|Death|47
7805960|NCT00457002|27121091|P1|Overall Study|Death|40
7805961|NCT00456846|27121196|P2|Overall Study|Other|2
7805962|NCT00456846|27121197|P1|Overall Study|Other|0
7805963|NCT00456846|27121196|P2|Overall Study|Participant Discretion|5
7805964|NCT00456846|27121197|P1|Overall Study|Participant Discretion|1
7805965|NCT00456846|27121196|P2|Overall Study|Protocol Deviation|0
7805966|NCT00456846|27121197|P1|Overall Study|Protocol Deviation|2
7805967|NCT00456846|27121196|P2|Overall Study|Physician Decision|6
7805968|NCT00456846|27121197|P1|Overall Study|Physician Decision|11
7805969|NCT00456846|27121196|P2|Overall Study|Adverse Event|15
7805970|NCT00456846|27121197|P1|Overall Study|Adverse Event|2
7805971|NCT00456755|27121238|P2|Overall Study|Lost to Follow-up|1
7805972|NCT00456755|27121239|P1|Overall Study|Lost to Follow-up|2
7805973|NCT00456612|27121253|P1|Overall Study|Withdrawal by Subject|3
7805974|NCT00456599|27121258|P1|Overall Study|Withdrawal by Subject|2
7805975|NCT00456599|27121258|P1|Overall Study|Non-compliance|1
7805976|NCT00456521|27121281|P2|Overall Study|Drug non-compliance, moved, other|11
7805977|NCT00456521|27121282|P1|Overall Study|Drug non-compliance, moved, other|26
7805978|NCT00456521|27121281|P2|Overall Study|Pregnancy|1
7805979|NCT00456521|27121282|P1|Overall Study|Pregnancy|1
7805980|NCT00456521|27121281|P2|Overall Study|Protocol Violation|0
7805981|NCT00456521|27121282|P1|Overall Study|Protocol Violation|4
7805982|NCT00456521|27121281|P2|Overall Study|Lack of Efficacy|6
7805983|NCT00456521|27121282|P1|Overall Study|Lack of Efficacy|3
7805984|NCT00456521|27121281|P2|Overall Study|Lost to Follow-up|17
7805985|NCT00456521|27121282|P1|Overall Study|Lost to Follow-up|22
7805986|NCT00456521|27121281|P2|Overall Study|Withdrawal by Subject|24
7805987|NCT00456521|27121282|P1|Overall Study|Withdrawal by Subject|43
7805988|NCT00456521|27121281|P2|Overall Study|Adverse Event|25
7805989|NCT00456521|27121282|P1|Overall Study|Adverse Event|150
7805990|NCT00456495|27121328|P1|Overall Study|Physician Decision|2
7805991|NCT00456365|27121335|P2|Overall Study|oncologic diagnosis|1
7805992|NCT00456365|27121336|P1|Overall Study|oncologic diagnosis|1
7805993|NCT00456365|27121335|P2|Overall Study|Pregnancy|1
7805994|NCT00456365|27121336|P1|Overall Study|Pregnancy|1
7805995|NCT00456365|27121335|P2|Overall Study|Withdrawal by Subject|7
7805996|NCT00456365|27121336|P1|Overall Study|Withdrawal by Subject|4
7805997|NCT00456365|27121335|P2|Overall Study|Lost to Follow-up|3
7805998|NCT00456365|27121336|P1|Overall Study|Lost to Follow-up|1
7805999|NCT00456300|27121348|P2|Overall Study|Adverse Event|0
7806000|NCT00456300|27121349|P1|Overall Study|Adverse Event|1
7806001|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Other|0
7806002|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Other|0
7806003|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Other|1
7806004|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Other|0
7806005|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Other|1
7806006|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7806007|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7806008|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
7806009|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
7806010|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7806011|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
7806012|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
7806013|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
7806014|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
7806015|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
7806016|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7806017|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7806018|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
7806019|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
7806020|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7806021|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7806022|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7806023|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
7806024|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
7806025|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7806026|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7806027|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7806028|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
7806029|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
7806030|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7806031|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7806032|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7806033|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7806034|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7806035|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
7806036|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7806037|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7806038|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7806039|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
7806040|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
7806041|NCT00456092|27121373|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
7806042|NCT00456092|27121374|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
7806043|NCT00456092|27121375|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
7806044|NCT00456092|27121376|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
7806045|NCT00456092|27121377|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
7806046|NCT00456092|27121373|P5|Extension Phase|Other|1
7806047|NCT00456092|27121374|P4|Extension Phase|Other|1
7806048|NCT00456092|27121375|P3|Extension Phase|Other|0
7806049|NCT00456092|27121376|P2|Extension Phase|Other|0
7806050|NCT00456092|27121377|P1|Extension Phase|Other|2
7806051|NCT00456092|27121373|P5|Extension Phase|Lost to Follow-up|1
7806052|NCT00456092|27121374|P4|Extension Phase|Lost to Follow-up|0
7806053|NCT00456092|27121375|P3|Extension Phase|Lost to Follow-up|0
7806054|NCT00456092|27121376|P2|Extension Phase|Lost to Follow-up|1
7806055|NCT00456092|27121377|P1|Extension Phase|Lost to Follow-up|1
7806056|NCT00456092|27121373|P5|Extension Phase|Withdrew Consent|0
7806057|NCT00456092|27121374|P4|Extension Phase|Withdrew Consent|0
7806058|NCT00456092|27121375|P3|Extension Phase|Withdrew Consent|0
7806059|NCT00456092|27121376|P2|Extension Phase|Withdrew Consent|0
7806060|NCT00456092|27121377|P1|Extension Phase|Withdrew Consent|2
7806061|NCT00456092|27121373|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
7806062|NCT00456092|27121374|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
7806063|NCT00456092|27121375|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
7806064|NCT00456092|27121376|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
7806065|NCT00456092|27121377|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
7806066|NCT00456092|27121373|P5|Extension Phase|Flare of Psoriatic Arthritis|1
7806067|NCT00456092|27121374|P4|Extension Phase|Flare of Psoriatic Arthritis|0
7806068|NCT00456092|27121375|P3|Extension Phase|Flare of Psoriatic Arthritis|0
7806069|NCT00456092|27121376|P2|Extension Phase|Flare of Psoriatic Arthritis|0
7806070|NCT00456092|27121377|P1|Extension Phase|Flare of Psoriatic Arthritis|1
7806071|NCT00456092|27121373|P5|Extension Phase|Grade 2 or Greater AE|2
7806072|NCT00456092|27121374|P4|Extension Phase|Grade 2 or Greater AE|0
7806073|NCT00456092|27121375|P3|Extension Phase|Grade 2 or Greater AE|0
7806074|NCT00456092|27121376|P2|Extension Phase|Grade 2 or Greater AE|2
7806075|NCT00456092|27121377|P1|Extension Phase|Grade 2 or Greater AE|2
7806076|NCT00455923|27121559|P2|Overall Study|Other|1
7806077|NCT00455923|27121560|P1|Overall Study|Other|3
7806078|NCT00455923|27121559|P2|Overall Study|Pregnancy|2
7806079|NCT00455923|27121560|P1|Overall Study|Pregnancy|0
7806080|NCT00455858|27121576|P1|Overall Study|Withdrawal|1
7806081|NCT00455858|27121576|P1|Overall Study|Well controlled FPG without insulin|1
7806082|NCT00455858|27121576|P1|Overall Study|Lack of Efficacy|1
7806083|NCT00455858|27121576|P1|Overall Study|Protocol Violation|1
7806084|NCT00455858|27121576|P1|Overall Study|Lost to Follow-up|2
7806085|NCT00455741|27121586|P2|Overall Study|Physician Decision|1
7806086|NCT00455741|27121587|P1|Overall Study|Physician Decision|0
7806087|NCT00455533|27121683|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
7806088|NCT00455533|27121684|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
7806089|NCT00455533|27121685|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
7806090|NCT00455533|27121683|P3|Period Two: Randomized Period|Study Drug Toxicity|0
7806091|NCT00455533|27121684|P2|Period Two: Randomized Period|Study Drug Toxicity|2
7806092|NCT00455533|27121685|P1|Period Two: Randomized Period|Study Drug Toxicity|0
7806093|NCT00455533|27121683|P3|Period Two: Randomized Period|Other - need reasons|0
7806094|NCT00455533|27121684|P2|Period Two: Randomized Period|Other - need reasons|1
7806095|NCT00455533|27121685|P1|Period Two: Randomized Period|Other - need reasons|0
7806096|NCT00455533|27121683|P3|Period Two: Randomized Period|Lost to Follow-up|1
7806097|NCT00455533|27121684|P2|Period Two: Randomized Period|Lost to Follow-up|0
7806098|NCT00455533|27121685|P1|Period Two: Randomized Period|Lost to Follow-up|0
7806099|NCT00455533|27121683|P3|Period Two: Randomized Period|Disease Progression|1
7806100|NCT00455533|27121684|P2|Period Two: Randomized Period|Disease Progression|1
7806101|NCT00455533|27121685|P1|Period Two: Randomized Period|Disease Progression|0
7806102|NCT00455533|27121683|P3|Period Two: Randomized Period|Death|3
7806103|NCT00455533|27121684|P2|Period Two: Randomized Period|Death|0
7806104|NCT00455533|27121685|P1|Period Two: Randomized Period|Death|0
7806105|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
7806106|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
7806107|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
7806108|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
7806109|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
7806110|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
7806111|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
7806112|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
7806113|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
7806114|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
7806115|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
7806116|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
7806117|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
7806118|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
7806119|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
7806120|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Not Reported|0
7806121|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Not Reported|0
7806122|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Not Reported|1
7806123|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
7806124|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
7806125|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
7806126|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Disease Progression|0
7806127|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Disease Progression|0
7806128|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Disease Progression|5
7806129|NCT00455533|27121683|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
7806130|NCT00455533|27121684|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
7806131|NCT00455533|27121685|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
7806132|NCT00455520|27121734|P2|Double Blind Tapentadol ER vs Placebo|All other|6
7806133|NCT00455520|27121735|P1|Double Blind Tapentadol ER vs Placebo|All other|4
7806134|NCT00455520|27121734|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
7806135|NCT00455520|27121735|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
7806136|NCT00455520|27121734|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
7806137|NCT00455520|27121735|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
7806138|NCT00455520|27121734|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
7806139|NCT00455520|27121735|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
7806140|NCT00455520|27121734|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
7806141|NCT00455520|27121735|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
7806142|NCT00455520|27121734|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
7806143|NCT00455520|27121735|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
7806144|NCT00455520|27121734|P2|Open Label Tapentadol Extended Release|All other|0
7806145|NCT00455520|27121735|P1|Open Label Tapentadol Extended Release|All other|33
7806146|NCT00455520|27121734|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
7806147|NCT00455520|27121735|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
7806148|NCT00455520|27121734|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
7806149|NCT00455520|27121735|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
7806150|NCT00455520|27121734|P2|Open Label Tapentadol Extended Release|Adverse Event|0
7806151|NCT00455520|27121735|P1|Open Label Tapentadol Extended Release|Adverse Event|100
7806152|NCT00455520|27121734|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
7806153|NCT00455520|27121735|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
7806154|NCT00455520|27121734|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
7806155|NCT00455520|27121735|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
7806156|NCT00455455|27121751|P2|Washout|Withdrawal by Subject|0
7806157|NCT00455455|27121752|P1|Washout|Withdrawal by Subject|1
7806158|NCT00455455|27121751|P2|Washout|Withdrawal by Subject|1
7806159|NCT00455455|27121752|P1|Washout|Withdrawal by Subject|0
7806160|NCT00455429|27121772|P4|Overall Study|Other|1
7806161|NCT00455429|27121773|P3|Overall Study|Other|0
7806162|NCT00455429|27121774|P2|Overall Study|Other|2
7806163|NCT00455429|27121775|P1|Overall Study|Other|0
7806164|NCT00455429|27121772|P4|Overall Study|Non-compliance|1
7806165|NCT00455429|27121773|P3|Overall Study|Non-compliance|0
7806166|NCT00455429|27121774|P2|Overall Study|Non-compliance|0
7806167|NCT00455429|27121775|P1|Overall Study|Non-compliance|0
7806168|NCT00455429|27121772|P4|Overall Study|Personal Reason|0
7806169|NCT00455429|27121773|P3|Overall Study|Personal Reason|0
7806170|NCT00455429|27121774|P2|Overall Study|Personal Reason|0
7806171|NCT00455429|27121775|P1|Overall Study|Personal Reason|1
7806172|NCT00455429|27121772|P4|Overall Study|Randomly assigned but not treated|2
7806173|NCT00455429|27121773|P3|Overall Study|Randomly assigned but not treated|0
7806174|NCT00455429|27121774|P2|Overall Study|Randomly assigned but not treated|0
7806175|NCT00455429|27121775|P1|Overall Study|Randomly assigned but not treated|0
7806176|NCT00455429|27121772|P4|Overall Study|Adverse Event|3
7806177|NCT00455429|27121773|P3|Overall Study|Adverse Event|0
7806178|NCT00455429|27121774|P2|Overall Study|Adverse Event|1
7806179|NCT00455429|27121775|P1|Overall Study|Adverse Event|0
7806180|NCT00455429|27121772|P4|Overall Study|Lack of Efficacy|1
7806181|NCT00455429|27121773|P3|Overall Study|Lack of Efficacy|0
7806182|NCT00455429|27121774|P2|Overall Study|Lack of Efficacy|1
7806183|NCT00455429|27121775|P1|Overall Study|Lack of Efficacy|0
7806184|NCT00455429|27121772|P4|Overall Study|Withdrawal by Subject|0
7806185|NCT00455429|27121773|P3|Overall Study|Withdrawal by Subject|1
7806186|NCT00455429|27121774|P2|Overall Study|Withdrawal by Subject|1
7806187|NCT00455429|27121775|P1|Overall Study|Withdrawal by Subject|0
7806188|NCT00455429|27121772|P4|Overall Study|Lost to Follow-up|3
7806189|NCT00455429|27121773|P3|Overall Study|Lost to Follow-up|0
7806190|NCT00455429|27121774|P2|Overall Study|Lost to Follow-up|0
7806191|NCT00455429|27121775|P1|Overall Study|Lost to Follow-up|1
7806192|NCT00455429|27121772|P4|Overall Study|Study Terminated by Sponsor|3
7806193|NCT00455429|27121773|P3|Overall Study|Study Terminated by Sponsor|0
7806194|NCT00455429|27121774|P2|Overall Study|Study Terminated by Sponsor|0
7806195|NCT00455429|27121775|P1|Overall Study|Study Terminated by Sponsor|0
7806196|NCT00455403|27121834|P2|Overall Study|Protocol Violation|2
7806197|NCT00455403|27121835|P1|Overall Study|Protocol Violation|0
7806198|NCT00455403|27121834|P2|Overall Study|Withdrawal by Subject|3
7806199|NCT00455403|27121835|P1|Overall Study|Withdrawal by Subject|1
7806200|NCT00455403|27121834|P2|Overall Study|Lost to Follow-up|1
7806201|NCT00455403|27121835|P1|Overall Study|Lost to Follow-up|2
7806202|NCT00455312|27121843|P2|Overall Study|Death|1
7806203|NCT00455312|27121844|P1|Overall Study|Death|0
7806204|NCT00455195|27121870|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
7806205|NCT00455195|27121871|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
7806206|NCT00455195|27121870|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
7806207|NCT00455195|27121871|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
7806208|NCT00455195|27121870|P2|Double-blind Study AGLU02704|Death|0
7806209|NCT00455195|27121871|P1|Double-blind Study AGLU02704|Death|1
7806210|NCT00455195|27121870|P2|Double-blind Study AGLU02704|Adverse Event|1
7806211|NCT00455195|27121871|P1|Double-blind Study AGLU02704|Adverse Event|2
7806212|NCT00455143|27121885|P1|Overall Study|Surgical time, staff not available|1
7806213|NCT00455143|27121885|P1|Overall Study|No longer met Inclusion Criteria|1
7806214|NCT00455143|27121885|P1|Overall Study|Staff was not avail to follow patient|2
7806215|NCT00455143|27121885|P1|Overall Study|Withdrawal by Subject|1
7806216|NCT00455143|27121885|P1|Overall Study|Physician Decision|1
7806217|NCT00455013|27121909|P3|Long Term Extension (LTE)|non-specified|1
7806218|NCT00455013|27121910|P2|Long Term Extension (LTE)|non-specified|0
7806219|NCT00455013|27121911|P1|Long Term Extension (LTE)|non-specified|0
7806220|NCT00455013|27121909|P3|Long Term Extension (LTE)|Poor non-compliance|0
7806221|NCT00455013|27121910|P2|Long Term Extension (LTE)|Poor non-compliance|1
7806222|NCT00455013|27121911|P1|Long Term Extension (LTE)|Poor non-compliance|0
7806223|NCT00455013|27121909|P3|Long Term Extension (LTE)|Subject Request or refused|3
7806224|NCT00455013|27121910|P2|Long Term Extension (LTE)|Subject Request or refused|0
7806225|NCT00455013|27121911|P1|Long Term Extension (LTE)|Subject Request or refused|0
7806226|NCT00455013|27121909|P3|Long Term Extension (LTE)|No longer met criteria|1
7806227|NCT00455013|27121910|P2|Long Term Extension (LTE)|No longer met criteria|0
7806228|NCT00455013|27121911|P1|Long Term Extension (LTE)|No longer met criteria|0
7806229|NCT00455013|27121909|P3|Long Term Extension (LTE)|Death|0
7806230|NCT00455013|27121910|P2|Long Term Extension (LTE)|Death|1
7806231|NCT00455013|27121911|P1|Long Term Extension (LTE)|Death|1
7806232|NCT00455013|27121909|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
7806233|NCT00455013|27121910|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
7806234|NCT00455013|27121911|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
7806235|NCT00455013|27121909|P3|Long Term Extension (LTE)|Adverse Event|1
7806236|NCT00455013|27121910|P2|Long Term Extension (LTE)|Adverse Event|1
7806237|NCT00455013|27121911|P1|Long Term Extension (LTE)|Adverse Event|0
7806238|NCT00455013|27121909|P3|Short Term Period|Other|1
7806239|NCT00455013|27121910|P2|Short Term Period|Other|0
7806240|NCT00455013|27121911|P1|Short Term Period|Other|0
7806241|NCT00455013|27121909|P3|Short Term Period|Lack of Efficacy|0
7806242|NCT00455013|27121910|P2|Short Term Period|Lack of Efficacy|0
7806243|NCT00455013|27121911|P1|Short Term Period|Lack of Efficacy|4
7806244|NCT00455013|27121909|P3|Short Term Period|Withdrawal by Subject|1
7806245|NCT00455013|27121910|P2|Short Term Period|Withdrawal by Subject|0
7806246|NCT00455013|27121911|P1|Short Term Period|Withdrawal by Subject|0
7806247|NCT00455013|27121909|P3|Short Term Period|Adverse Event|0
7806248|NCT00455013|27121910|P2|Short Term Period|Adverse Event|5
7806249|NCT00455013|27121911|P1|Short Term Period|Adverse Event|2
7806250|NCT00454987|27121979|P3|Booster Period (NCT00258700)|Lost to Follow-up|0
7806251|NCT00454987|27121980|P2|Booster Period (NCT00258700)|Lost to Follow-up|0
7806252|NCT00454987|27121981|P1|Booster Period (NCT00258700)|Lost to Follow-up|1
7806253|NCT00454987|27121979|P3|Booster Period (NCT00258700)|Withdrawal by Subject|0
7806254|NCT00454987|27121980|P2|Booster Period (NCT00258700)|Withdrawal by Subject|1
7806255|NCT00454987|27121981|P1|Booster Period (NCT00258700)|Withdrawal by Subject|0
7806256|NCT00454987|27121979|P3|Booster Period (NCT00258700)|Adverse Event|0
7806257|NCT00454987|27121980|P2|Booster Period (NCT00258700)|Adverse Event|0
7806258|NCT00454987|27121981|P1|Booster Period (NCT00258700)|Adverse Event|1
7806259|NCT00454909|27122055|P3|Overall Study|Others|0
7806260|NCT00454909|27122056|P2|Overall Study|Others|0
7806261|NCT00454909|27122057|P1|Overall Study|Others|1
7806262|NCT00454909|27122055|P3|Overall Study|Lost to follow-up (complete vaccination)|1
7806263|NCT00454909|27122056|P2|Overall Study|Lost to follow-up (complete vaccination)|3
7806264|NCT00454909|27122057|P1|Overall Study|Lost to follow-up (complete vaccination)|5
7806265|NCT00454909|27122055|P3|Overall Study|Migrated/moved from study area|1
7806266|NCT00454909|27122056|P2|Overall Study|Migrated/moved from study area|0
7806267|NCT00454909|27122057|P1|Overall Study|Migrated/moved from study area|0
7806268|NCT00454909|27122055|P3|Overall Study|Withdrawal by Subject|0
7806269|NCT00454909|27122056|P2|Overall Study|Withdrawal by Subject|0
7806270|NCT00454909|27122057|P1|Overall Study|Withdrawal by Subject|1
7806271|NCT00454857|27122095|P1|Overall Study|Reason unknown|1
7806272|NCT00454857|27122095|P1|Overall Study|Other|11
7806273|NCT00454857|27122095|P1|Overall Study|Death|5
7806274|NCT00454857|27122095|P1|Overall Study|Noncompliance|6
7806275|NCT00454857|27122095|P1|Overall Study|Lost to Follow-up|16
7806276|NCT00454857|27122095|P1|Overall Study|Withdrawal by Subject|15
7806277|NCT00454818|27122120|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
7806278|NCT00454818|27122121|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7806279|NCT00454818|27122122|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
7806280|NCT00454818|27122123|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7806281|NCT00454818|27122124|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7806282|NCT00454818|27122120|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
7806283|NCT00454818|27122121|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
7806284|NCT00454818|27122122|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
7806285|NCT00454818|27122123|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
7806286|NCT00454818|27122124|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
7806287|NCT00454818|27122120|P5|Phase 2: Randomized Double-blind|Death|1
7806288|NCT00454818|27122121|P4|Phase 2: Randomized Double-blind|Death|0
7806289|NCT00454818|27122122|P3|Phase 2: Randomized Double-blind|Death|0
7806290|NCT00454818|27122123|P2|Phase 2: Randomized Double-blind|Death|1
7806291|NCT00454818|27122124|P1|Phase 2: Randomized Double-blind|Death|0
7806292|NCT00454818|27122120|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7806293|NCT00454818|27122121|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
7806294|NCT00454818|27122122|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7806295|NCT00454818|27122123|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
7806296|NCT00454818|27122124|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7806297|NCT00454818|27122120|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7806298|NCT00454818|27122121|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
7806299|NCT00454818|27122122|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
7806300|NCT00454818|27122123|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7806301|NCT00454818|27122124|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7806302|NCT00454818|27122120|P5|Phase I: Open-label Dose-escalation|Death|0
7806303|NCT00454818|27122121|P4|Phase I: Open-label Dose-escalation|Death|0
7806304|NCT00454818|27122122|P3|Phase I: Open-label Dose-escalation|Death|0
7806305|NCT00454818|27122123|P2|Phase I: Open-label Dose-escalation|Death|1
7806306|NCT00454818|27122124|P1|Phase I: Open-label Dose-escalation|Death|0
7806307|NCT00454818|27122120|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
7806308|NCT00454818|27122121|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
7806309|NCT00454818|27122122|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
7806310|NCT00454818|27122123|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
7806311|NCT00454818|27122124|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
7806312|NCT00454805|27122203|P2|Overall Study|In order to begin radiotherapy|0
7806313|NCT00454805|27122204|P1|Overall Study|In order to begin radiotherapy|1
7806314|NCT00454805|27122203|P2|Overall Study|Disease progression|19
7806315|NCT00454805|27122204|P1|Overall Study|Disease progression|16
7806316|NCT00454805|27122203|P2|Overall Study|Death|2
7806317|NCT00454805|27122204|P1|Overall Study|Death|0
7806318|NCT00454805|27122203|P2|Overall Study|Withdrawal by Subject|2
7806319|NCT00454805|27122204|P1|Overall Study|Withdrawal by Subject|9
7806320|NCT00454779|27122220|P2|Second-line Treatment Phase|Ongoing|1
7806321|NCT00454779|27122221|P1|Second-line Treatment Phase|Ongoing|0
7806322|NCT00454779|27122220|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
7806323|NCT00454779|27122221|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
7806324|NCT00454779|27122220|P2|Second-line Treatment Phase|Withdrawal by Subject|1
7806325|NCT00454779|27122221|P1|Second-line Treatment Phase|Withdrawal by Subject|0
7806326|NCT00454779|27122220|P2|First-line Treatment Phase|Ongoing|0
7806327|NCT00454779|27122221|P1|First-line Treatment Phase|Ongoing|1
7806328|NCT00454779|27122220|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
7806329|NCT00454779|27122221|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
7806330|NCT00454779|27122220|P2|First-line Treatment Phase|Protocol Violation|1
7806331|NCT00454779|27122221|P1|First-line Treatment Phase|Protocol Violation|0
7806332|NCT00454779|27122220|P2|First-line Treatment Phase|Lost to Follow-up|0
7806333|NCT00454779|27122221|P1|First-line Treatment Phase|Lost to Follow-up|1
7806334|NCT00454779|27122220|P2|First-line Treatment Phase|Withdrawal by Subject|4
7806335|NCT00454779|27122221|P1|First-line Treatment Phase|Withdrawal by Subject|2
7806336|NCT00454779|27122220|P2|First-line Treatment Phase|Lack of Efficacy|2
7806337|NCT00454779|27122221|P1|First-line Treatment Phase|Lack of Efficacy|0
7806338|NCT00454649|27122259|P10|Overall Study|Withdrawal by Subject|0
7806339|NCT00454649|27122260|P9|Overall Study|Withdrawal by Subject|1
7806340|NCT00454649|27122261|P8|Overall Study|Withdrawal by Subject|2
7806341|NCT00454649|27122262|P7|Overall Study|Withdrawal by Subject|0
7806342|NCT00454649|27122263|P6|Overall Study|Withdrawal by Subject|1
7806343|NCT00454649|27122264|P5|Overall Study|Withdrawal by Subject|0
7806344|NCT00454649|27122265|P4|Overall Study|Withdrawal by Subject|0
7806345|NCT00454649|27122266|P3|Overall Study|Withdrawal by Subject|0
7806346|NCT00454649|27122267|P2|Overall Study|Withdrawal by Subject|0
7806347|NCT00454649|27122268|P1|Overall Study|Withdrawal by Subject|0
7806348|NCT00454649|27122259|P10|Overall Study|Other|1
7806349|NCT00454649|27122260|P9|Overall Study|Other|3
7806350|NCT00454649|27122261|P8|Overall Study|Other|0
7806351|NCT00454649|27122262|P7|Overall Study|Other|0
7806352|NCT00454649|27122263|P6|Overall Study|Other|0
7806353|NCT00454649|27122264|P5|Overall Study|Other|0
7806354|NCT00454649|27122265|P4|Overall Study|Other|3
7806355|NCT00454649|27122266|P3|Overall Study|Other|5
7806356|NCT00454649|27122267|P2|Overall Study|Other|1
7806357|NCT00454649|27122268|P1|Overall Study|Other|1
7806358|NCT00454649|27122259|P10|Overall Study|Lost to Follow-up|0
7806359|NCT00454649|27122260|P9|Overall Study|Lost to Follow-up|0
7806360|NCT00454649|27122261|P8|Overall Study|Lost to Follow-up|0
7806361|NCT00454649|27122262|P7|Overall Study|Lost to Follow-up|1
7806362|NCT00454649|27122263|P6|Overall Study|Lost to Follow-up|0
7806363|NCT00454649|27122264|P5|Overall Study|Lost to Follow-up|0
7806364|NCT00454649|27122265|P4|Overall Study|Lost to Follow-up|0
7806365|NCT00454649|27122266|P3|Overall Study|Lost to Follow-up|1
7806366|NCT00454649|27122267|P2|Overall Study|Lost to Follow-up|0
7806367|NCT00454649|27122268|P1|Overall Study|Lost to Follow-up|0
7806368|NCT00454649|27122259|P10|Overall Study|Adverse Event|2
7806369|NCT00454649|27122260|P9|Overall Study|Adverse Event|6
7806370|NCT00454649|27122261|P8|Overall Study|Adverse Event|4
7806371|NCT00454649|27122262|P7|Overall Study|Adverse Event|3
7806372|NCT00454649|27122263|P6|Overall Study|Adverse Event|2
7806373|NCT00454649|27122264|P5|Overall Study|Adverse Event|1
7806374|NCT00454649|27122265|P4|Overall Study|Adverse Event|0
7806375|NCT00454649|27122266|P3|Overall Study|Adverse Event|3
7806376|NCT00454649|27122267|P2|Overall Study|Adverse Event|1
7806377|NCT00454649|27122268|P1|Overall Study|Adverse Event|0
7806378|NCT00454649|27122259|P10|Overall Study|Lack of Efficacy|2
7806379|NCT00454649|27122260|P9|Overall Study|Lack of Efficacy|10
7806380|NCT00454649|27122261|P8|Overall Study|Lack of Efficacy|13
7806381|NCT00454649|27122262|P7|Overall Study|Lack of Efficacy|5
7806382|NCT00454649|27122263|P6|Overall Study|Lack of Efficacy|4
7806383|NCT00454649|27122264|P5|Overall Study|Lack of Efficacy|0
7806384|NCT00454649|27122265|P4|Overall Study|Lack of Efficacy|3
7806385|NCT00454649|27122266|P3|Overall Study|Lack of Efficacy|10
7806386|NCT00454649|27122267|P2|Overall Study|Lack of Efficacy|2
7806387|NCT00454649|27122268|P1|Overall Study|Lack of Efficacy|2
7806388|NCT00454636|27122397|P4|Overall Study|Lost to Follow-up|0
7806389|NCT00454636|27122398|P3|Overall Study|Lost to Follow-up|0
7806390|NCT00454636|27122399|P2|Overall Study|Lost to Follow-up|1
7806391|NCT00454636|27122400|P1|Overall Study|Lost to Follow-up|0
7806392|NCT00454636|27122397|P4|Overall Study|Patient refusal|2
7806393|NCT00454636|27122398|P3|Overall Study|Patient refusal|3
7806394|NCT00454636|27122399|P2|Overall Study|Patient refusal|1
7806395|NCT00454636|27122400|P1|Overall Study|Patient refusal|1
7806396|NCT00454636|27122397|P4|Overall Study|Death|1
7806397|NCT00454636|27122398|P3|Overall Study|Death|1
7806398|NCT00454636|27122399|P2|Overall Study|Death|1
7806399|NCT00454636|27122400|P1|Overall Study|Death|6
7806400|NCT00454636|27122397|P4|Overall Study|Protocol Violation|3
7806401|NCT00454636|27122398|P3|Overall Study|Protocol Violation|3
7806402|NCT00454636|27122399|P2|Overall Study|Protocol Violation|2
7806403|NCT00454636|27122400|P1|Overall Study|Protocol Violation|3
7806404|NCT00454636|27122397|P4|Overall Study|Disease Progression|11
7806405|NCT00454636|27122398|P3|Overall Study|Disease Progression|4
7806406|NCT00454636|27122399|P2|Overall Study|Disease Progression|12
7806407|NCT00454636|27122400|P1|Overall Study|Disease Progression|11
7806408|NCT00454636|27122397|P4|Overall Study|Adverse Event|15
7806409|NCT00454636|27122398|P3|Overall Study|Adverse Event|9
7806410|NCT00454636|27122399|P2|Overall Study|Adverse Event|6
7806411|NCT00454636|27122400|P1|Overall Study|Adverse Event|10
7806412|NCT00454584|27122433|P6|After Controlled Period|Other|17
7806413|NCT00454584|27122434|P5|After Controlled Period|Other|5
7806414|NCT00454584|27122435|P4|After Controlled Period|Other|13
7806415|NCT00454584|27122436|P3|After Controlled Period|Other|0
7806416|NCT00454584|27122437|P2|After Controlled Period|Other|0
7806417|NCT00454584|27122438|P1|After Controlled Period|Other|0
7806418|NCT00454584|27122433|P6|After Controlled Period|Other|0
7806419|NCT00454584|27122434|P5|After Controlled Period|Other|0
7806420|NCT00454584|27122435|P4|After Controlled Period|Other|1
7806421|NCT00454584|27122436|P3|After Controlled Period|Other|0
7806422|NCT00454584|27122437|P2|After Controlled Period|Other|0
7806423|NCT00454584|27122438|P1|After Controlled Period|Other|0
7806424|NCT00454584|27122433|P6|After Controlled Period|Lost to Follow-up|6
7806425|NCT00454584|27122434|P5|After Controlled Period|Lost to Follow-up|4
7806426|NCT00454584|27122435|P4|After Controlled Period|Lost to Follow-up|2
7806427|NCT00454584|27122436|P3|After Controlled Period|Lost to Follow-up|0
7806428|NCT00454584|27122437|P2|After Controlled Period|Lost to Follow-up|0
7806429|NCT00454584|27122438|P1|After Controlled Period|Lost to Follow-up|0
7806430|NCT00454584|27122433|P6|After Controlled Period|Lack of Efficacy|0
7806431|NCT00454584|27122434|P5|After Controlled Period|Lack of Efficacy|0
7806432|NCT00454584|27122435|P4|After Controlled Period|Lack of Efficacy|1
7806433|NCT00454584|27122436|P3|After Controlled Period|Lack of Efficacy|0
7806434|NCT00454584|27122437|P2|After Controlled Period|Lack of Efficacy|0
7806435|NCT00454584|27122438|P1|After Controlled Period|Lack of Efficacy|0
7806436|NCT00454584|27122433|P6|After Controlled Period|Adverse Event|9
7806437|NCT00454584|27122434|P5|After Controlled Period|Adverse Event|3
7806438|NCT00454584|27122435|P4|After Controlled Period|Adverse Event|9
7806439|NCT00454584|27122436|P3|After Controlled Period|Adverse Event|0
7806440|NCT00454584|27122437|P2|After Controlled Period|Adverse Event|0
7806441|NCT00454584|27122438|P1|After Controlled Period|Adverse Event|0
7806442|NCT00454584|27122433|P6|Controlled Period|Other|0
7806443|NCT00454584|27122434|P5|Controlled Period|Other|0
7806444|NCT00454584|27122435|P4|Controlled Period|Other|0
7806445|NCT00454584|27122436|P3|Controlled Period|Other|2
7806446|NCT00454584|27122437|P2|Controlled Period|Other|4
7806447|NCT00454584|27122438|P1|Controlled Period|Other|5
7806448|NCT00454584|27122433|P6|Controlled Period|Lost to Follow-up|0
7806449|NCT00454584|27122434|P5|Controlled Period|Lost to Follow-up|0
7806450|NCT00454584|27122435|P4|Controlled Period|Lost to Follow-up|0
7806451|NCT00454584|27122436|P3|Controlled Period|Lost to Follow-up|2
7806452|NCT00454584|27122437|P2|Controlled Period|Lost to Follow-up|2
7806453|NCT00454584|27122438|P1|Controlled Period|Lost to Follow-up|1
7806454|NCT00454584|27122433|P6|Controlled Period|Adverse Event|0
7806455|NCT00454584|27122434|P5|Controlled Period|Adverse Event|0
7806456|NCT00454584|27122435|P4|Controlled Period|Adverse Event|0
7806457|NCT00454584|27122436|P3|Controlled Period|Adverse Event|1
7806458|NCT00454584|27122437|P2|Controlled Period|Adverse Event|2
7806459|NCT00454584|27122438|P1|Controlled Period|Adverse Event|5
7806460|NCT00454571|27122460|P2|Overall Study|Withdrawal by Subject|5
7806461|NCT00454571|27122461|P1|Overall Study|Withdrawal by Subject|10
7806462|NCT00454571|27122460|P2|Overall Study|Protocol Violation|0
7806463|NCT00454571|27122461|P1|Overall Study|Protocol Violation|1
7806464|NCT00454571|27122460|P2|Overall Study|Physician Decision|1
7806465|NCT00454571|27122461|P1|Overall Study|Physician Decision|0
7806466|NCT00454571|27122460|P2|Overall Study|Adverse Event|0
7806467|NCT00454571|27122461|P1|Overall Study|Adverse Event|2
7806468|NCT00454363|27122496|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
7806469|NCT00454363|27122497|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
7806470|NCT00454363|27122496|P2|Overall Study|Adverse Event|2
7806471|NCT00454363|27122497|P1|Overall Study|Adverse Event|1
7806472|NCT00454246|27122526|P3|Overall Study|Early termination of study|9
7806473|NCT00454246|27122527|P2|Overall Study|Early termination of study|26
7806474|NCT00454246|27122528|P1|Overall Study|Early termination of study|62
7806475|NCT00454246|27122526|P3|Overall Study|Failure to return|0
7806476|NCT00454246|27122527|P2|Overall Study|Failure to return|0
7806477|NCT00454246|27122528|P1|Overall Study|Failure to return|1
7806478|NCT00454246|27122526|P3|Overall Study|Refused Treatment|0
7806479|NCT00454246|27122527|P2|Overall Study|Refused Treatment|1
7806480|NCT00454246|27122528|P1|Overall Study|Refused Treatment|1
7806481|NCT00454246|27122526|P3|Overall Study|Protocol Violation|0
7806482|NCT00454246|27122527|P2|Overall Study|Protocol Violation|0
7806483|NCT00454246|27122528|P1|Overall Study|Protocol Violation|1
7806484|NCT00454246|27122526|P3|Overall Study|Violation of selection criteria at entry|0
7806485|NCT00454246|27122527|P2|Overall Study|Violation of selection criteria at entry|0
7806486|NCT00454246|27122528|P1|Overall Study|Violation of selection criteria at entry|6
7806487|NCT00454246|27122526|P3|Overall Study|Adverse Event|0
7806488|NCT00454246|27122527|P2|Overall Study|Adverse Event|2
7806489|NCT00454246|27122528|P1|Overall Study|Adverse Event|2
7806490|NCT00454207|27122544|P2|Overall Study|Protocol Violation|1
7806491|NCT00454207|27122545|P1|Overall Study|Protocol Violation|0
7806492|NCT00454207|27122544|P2|Overall Study|Lack of Efficacy|0
7806493|NCT00454207|27122545|P1|Overall Study|Lack of Efficacy|1
7806494|NCT00454207|27122544|P2|Overall Study|Adverse Event|1
7806495|NCT00454207|27122545|P1|Overall Study|Adverse Event|3
7806496|NCT00454194|27122590|P2|Overall Study|Other Unspecified Reason|2
7806497|NCT00454194|27122591|P1|Overall Study|Other Unspecified Reason|2
7806498|NCT00454194|27122590|P2|Overall Study|Other Medical Problems|2
7806499|NCT00454194|27122591|P1|Overall Study|Other Medical Problems|1
7806500|NCT00454194|27122590|P2|Overall Study|Withdrawal by Subject|8
7806501|NCT00454194|27122591|P1|Overall Study|Withdrawal by Subject|12
7806502|NCT00454194|27122590|P2|Overall Study|Adverse Event|2
7806503|NCT00454194|27122591|P1|Overall Study|Adverse Event|7
7806504|NCT00454181|27122609|P2|Overall Study|Withdrawal by Subject|0
7806505|NCT00454181|27122610|P1|Overall Study|Withdrawal by Subject|2
7806506|NCT00454181|27122609|P2|Overall Study|Protocol Violation|1
7806507|NCT00454181|27122610|P1|Overall Study|Protocol Violation|1
7806508|NCT00454181|27122609|P2|Overall Study|Lost to Follow-up|1
7806509|NCT00454181|27122610|P1|Overall Study|Lost to Follow-up|11
7806510|NCT00454181|27122609|P2|Overall Study|Adverse Event|1
7806511|NCT00454181|27122610|P1|Overall Study|Adverse Event|1
7806512|NCT00454142|27122626|P1|Overall Study|Withdrawal by Subject|1
7806513|NCT00454116|27122644|P3|Overall Study|Other|0
7806514|NCT00454116|27122645|P2|Overall Study|Other|2
7806515|NCT00454116|27122646|P1|Overall Study|Other|2
7806516|NCT00454116|27122644|P3|Overall Study|Withdrawal by Subject|1
7806517|NCT00454116|27122645|P2|Overall Study|Withdrawal by Subject|3
7806518|NCT00454116|27122646|P1|Overall Study|Withdrawal by Subject|3
7806519|NCT00454116|27122644|P3|Overall Study|Condition under investigation worsened|18
7806520|NCT00454116|27122645|P2|Overall Study|Condition under investigation worsened|13
7806521|NCT00454116|27122646|P1|Overall Study|Condition under investigation worsened|17
7806522|NCT00454116|27122644|P3|Overall Study|Adverse Event|9
7806523|NCT00454116|27122645|P2|Overall Study|Adverse Event|11
7806524|NCT00454116|27122646|P1|Overall Study|Adverse Event|5
7806525|NCT00454051|27122656|P2|Overall Study|Protocol Violation|1
7806526|NCT00454051|27122657|P1|Overall Study|Protocol Violation|1
7806527|NCT00454051|27122656|P2|Overall Study|Withdrawal by Subject|0
7806528|NCT00454051|27122657|P1|Overall Study|Withdrawal by Subject|1
7806529|NCT00454051|27122656|P2|Overall Study|Adverse Event|2
7806530|NCT00454051|27122657|P1|Overall Study|Adverse Event|1
7806531|NCT00453999|27122690|P3|Overall Study|Subject Request|0
7806532|NCT00453999|27122691|P2|Overall Study|Subject Request|1
7806533|NCT00453999|27122692|P1|Overall Study|Subject Request|2
7806534|NCT00453999|27122690|P3|Overall Study|Withdrawal by Subject|1
7806535|NCT00453999|27122691|P2|Overall Study|Withdrawal by Subject|1
7806536|NCT00453999|27122692|P1|Overall Study|Withdrawal by Subject|2
7806537|NCT00453999|27122690|P3|Overall Study|Lost to Follow-up|1
7806538|NCT00453999|27122691|P2|Overall Study|Lost to Follow-up|1
7806539|NCT00453999|27122692|P1|Overall Study|Lost to Follow-up|0
7806540|NCT00453999|27122690|P3|Overall Study|Adverse Event|1
7806541|NCT00453999|27122691|P2|Overall Study|Adverse Event|2
7806542|NCT00453999|27122692|P1|Overall Study|Adverse Event|1
7806543|NCT00453986|27122720|P5|Overall Study|Lost to Follow-up|0
7806544|NCT00453986|27122721|P4|Overall Study|Lost to Follow-up|2
7806545|NCT00453986|27122722|P3|Overall Study|Lost to Follow-up|6
7806546|NCT00453986|27122723|P2|Overall Study|Lost to Follow-up|5
7806547|NCT00453986|27122724|P1|Overall Study|Lost to Follow-up|6
7806548|NCT00453973|27122817|P2|Overall Study|Sponsor Decision to Terminate Study|30
7806549|NCT00453973|27122818|P1|Overall Study|Sponsor Decision to Terminate Study|35
7806550|NCT00453973|27122817|P2|Overall Study|Site closed by sponsor|0
7806551|NCT00453973|27122818|P1|Overall Study|Site closed by sponsor|3
7806552|NCT00453973|27122817|P2|Overall Study|Renal transplant|1
7806553|NCT00453973|27122818|P1|Overall Study|Renal transplant|1
7806554|NCT00453973|27122817|P2|Overall Study|Relocation|0
7806555|NCT00453973|27122818|P1|Overall Study|Relocation|1
7806556|NCT00453973|27122817|P2|Overall Study|PI Decision|2
7806557|NCT00453973|27122818|P1|Overall Study|PI Decision|0
7806558|NCT00453973|27122817|P2|Overall Study|Withdrawal by Subject|6
7806559|NCT00453973|27122818|P1|Overall Study|Withdrawal by Subject|7
7806560|NCT00453973|27122817|P2|Overall Study|Adverse Event|9
7806561|NCT00453973|27122818|P1|Overall Study|Adverse Event|4
7806562|NCT00453921|27122828|P4|Overall Study|Lost to Follow-up|0
7806563|NCT00453921|27122829|P3|Overall Study|Lost to Follow-up|1
7806564|NCT00453921|27122830|P2|Overall Study|Lost to Follow-up|0
7806565|NCT00453921|27122831|P1|Overall Study|Lost to Follow-up|0
7806566|NCT00453921|27122828|P4|Overall Study|Withdrawal by Subject|1
7806567|NCT00453921|27122829|P3|Overall Study|Withdrawal by Subject|1
7806568|NCT00453921|27122830|P2|Overall Study|Withdrawal by Subject|1
7806569|NCT00453921|27122831|P1|Overall Study|Withdrawal by Subject|1
7806570|NCT00453362|27122978|P1|Overall Study|Screening Failure|14
7806571|NCT00453362|27122978|P1|Overall Study|Progression of disease|56
7806572|NCT00453362|27122978|P1|Overall Study|Withdrawal by Subject|3
7806573|NCT00453362|27122978|P1|Overall Study|Physician Decision|2
7806574|NCT00453362|27122978|P1|Overall Study|Death|7
7806575|NCT00453362|27122978|P1|Overall Study|Adverse Event|5
7806576|NCT00453349|27123004|P2|Completed Study|Lost to follow up after study treatment|11
7806577|NCT00453349|27123005|P1|Completed Study|Lost to follow up after study treatment|2
7806578|NCT00453349|27123004|P2|Completed Study|Withdrawal by Subject|5
7806579|NCT00453349|27123005|P1|Completed Study|Withdrawal by Subject|3
7806580|NCT00453349|27123004|P2|Completed Study|Protocol Violation|1
7806581|NCT00453349|27123005|P1|Completed Study|Protocol Violation|1
7806582|NCT00453349|27123004|P2|Completed Study|Lost to Follow-up|5
7806583|NCT00453349|27123005|P1|Completed Study|Lost to Follow-up|7
7806584|NCT00453349|27123004|P2|Completed Study|Lack of Efficacy|1
7806585|NCT00453349|27123005|P1|Completed Study|Lack of Efficacy|2
7806586|NCT00453349|27123004|P2|Completed Study|Adverse Event|11
7806587|NCT00453349|27123005|P1|Completed Study|Adverse Event|12
7806588|NCT00453349|27123004|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
7806589|NCT00453349|27123005|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
7806590|NCT00453349|27123004|P2|Randomized|Withdrawal by Subject|5
7806591|NCT00453349|27123005|P1|Randomized|Withdrawal by Subject|3
7806592|NCT00453349|27123004|P2|Randomized|Protocol Violation|1
7806593|NCT00453349|27123005|P1|Randomized|Protocol Violation|1
7806594|NCT00453349|27123004|P2|Randomized|Lost to Follow-up|5
7806595|NCT00453349|27123005|P1|Randomized|Lost to Follow-up|7
7806596|NCT00453349|27123004|P2|Randomized|Lack of Efficacy|1
7806597|NCT00453349|27123005|P1|Randomized|Lack of Efficacy|2
7806598|NCT00453349|27123004|P2|Randomized|Adverse Event|11
7806599|NCT00453349|27123005|P1|Randomized|Adverse Event|12
7806600|NCT00453310|27123036|P1|Overall Study|Progression of Disease|10
7806601|NCT00453206|27123040|P1|Overall Study|Death|1
7806602|NCT00453180|27123050|P2|Overall Study|Adverse Event|2
7806603|NCT00453180|27123051|P1|Overall Study|Adverse Event|1
7806604|NCT00453180|27123050|P2|Overall Study|Lost to Follow-up|1
7806605|NCT00453180|27123051|P1|Overall Study|Lost to Follow-up|2
7806606|NCT00453154|27123070|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
7806607|NCT00453154|27123071|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
7806608|NCT00453154|27123072|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
7806609|NCT00453154|27123073|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
7806610|NCT00453154|27123070|P4|Double BIind Maintenance|Medical Issues|1
7806611|NCT00453154|27123071|P3|Double BIind Maintenance|Medical Issues|3
7806612|NCT00453154|27123072|P2|Double BIind Maintenance|Medical Issues|0
7806613|NCT00453154|27123073|P1|Double BIind Maintenance|Medical Issues|0
7806614|NCT00453154|27123070|P4|Double BIind Maintenance|Progression|26
7806615|NCT00453154|27123071|P3|Double BIind Maintenance|Progression|29
7806616|NCT00453154|27123072|P2|Double BIind Maintenance|Progression|0
7806617|NCT00453154|27123073|P1|Double BIind Maintenance|Progression|0
7806618|NCT00453154|27123070|P4|Double BIind Maintenance|Withdrawal by Subject|4
7806619|NCT00453154|27123071|P3|Double BIind Maintenance|Withdrawal by Subject|4
7806620|NCT00453154|27123072|P2|Double BIind Maintenance|Withdrawal by Subject|0
7806621|NCT00453154|27123073|P1|Double BIind Maintenance|Withdrawal by Subject|0
7806622|NCT00453154|27123070|P4|Double BIind Maintenance|Death|1
7806623|NCT00453154|27123071|P3|Double BIind Maintenance|Death|2
7806624|NCT00453154|27123072|P2|Double BIind Maintenance|Death|0
7806625|NCT00453154|27123073|P1|Double BIind Maintenance|Death|0
7806626|NCT00453154|27123070|P4|Double BIind Maintenance|Adverse Event|12
7806627|NCT00453154|27123071|P3|Double BIind Maintenance|Adverse Event|3
7806628|NCT00453154|27123072|P2|Double BIind Maintenance|Adverse Event|0
7806629|NCT00453154|27123073|P1|Double BIind Maintenance|Adverse Event|0
7806630|NCT00453102|27123086|P1|Overall Study|Withdrawal by Subject|2
7806631|NCT00453063|27123097|P2|Overall Study|Protocol Violation|0
7806632|NCT00453063|27123098|P1|Overall Study|Protocol Violation|1
7806633|NCT00453063|27123097|P2|Overall Study|Withdrawal by Subject|1
7806634|NCT00453063|27123098|P1|Overall Study|Withdrawal by Subject|1
7806635|NCT00453063|27123097|P2|Overall Study|Adverse Event|2
7806636|NCT00453063|27123098|P1|Overall Study|Adverse Event|1
7806637|NCT00452790|27123118|P2|Toddler Dose|Parent/legal guardian request|1
7806638|NCT00452790|27123119|P1|Toddler Dose|Parent/legal guardian request|0
7806639|NCT00452790|27123118|P2|Toddler Dose|Failed to return|1
7806640|NCT00452790|27123119|P1|Toddler Dose|Failed to return|0
7806641|NCT00452790|27123118|P2|After Infant Series|Other reasons|0
7806642|NCT00452790|27123119|P1|After Infant Series|Other reasons|1
7806643|NCT00452790|27123118|P2|After Infant Series|Failed to return|0
7806644|NCT00452790|27123119|P1|After Infant Series|Failed to return|1
7806645|NCT00452790|27123118|P2|After Infant Series|Lost to Follow-up|0
7806646|NCT00452790|27123119|P1|After Infant Series|Lost to Follow-up|4
7806647|NCT00452790|27123118|P2|After Infant Series|Parent/legal guardian request|3
7806648|NCT00452790|27123119|P1|After Infant Series|Parent/legal guardian request|1
7806649|NCT00452790|27123118|P2|After Infant Series|Adverse Event|1
7806650|NCT00452790|27123119|P1|After Infant Series|Adverse Event|4
7806651|NCT00452790|27123118|P2|After Infant Series|Investigator request|10
7806652|NCT00452790|27123119|P1|After Infant Series|Investigator request|10
7806653|NCT00452790|27123118|P2|Infant Series|Death|1
7806654|NCT00452790|27123119|P1|Infant Series|Death|0
7806655|NCT00452790|27123118|P2|Infant Series|Investigator request|1
7806656|NCT00452790|27123119|P1|Infant Series|Investigator request|0
7806657|NCT00452790|27123118|P2|Infant Series|Other reasons|2
7806658|NCT00452790|27123119|P1|Infant Series|Other reasons|1
7806659|NCT00452790|27123118|P2|Infant Series|Adverse Event|2
7806660|NCT00452790|27123119|P1|Infant Series|Adverse Event|1
7806661|NCT00452790|27123118|P2|Infant Series|Lost to Follow-up|2
7806662|NCT00452790|27123119|P1|Infant Series|Lost to Follow-up|2
7806663|NCT00452790|27123118|P2|Infant Series|Protocol Violation|3
7806664|NCT00452790|27123119|P1|Infant Series|Protocol Violation|1
7806665|NCT00452790|27123118|P2|Infant Series|Failed to return|1
7806666|NCT00452790|27123119|P1|Infant Series|Failed to return|4
7806667|NCT00452790|27123118|P2|Infant Series|Parent/legal guardian request|6
7806668|NCT00452790|27123119|P1|Infant Series|Parent/legal guardian request|8
7806669|NCT00452790|27123118|P2|Infant Series|Clinical hold - consent withdrawn|123
7806670|NCT00452790|27123119|P1|Infant Series|Clinical hold - consent withdrawn|118
7806671|NCT00452699|27123155|P2|Overall Study|Other|7
7806672|NCT00452699|27123156|P1|Overall Study|Other|12
7806673|NCT00452699|27123155|P2|Overall Study|Withdrawal by Subject|25
7806674|NCT00452699|27123156|P1|Overall Study|Withdrawal by Subject|26
7806675|NCT00452699|27123155|P2|Overall Study|Protocol Violation|25
7806676|NCT00452699|27123156|P1|Overall Study|Protocol Violation|21
7806677|NCT00452699|27123155|P2|Overall Study|Lost to Follow-up|9
7806678|NCT00452699|27123156|P1|Overall Study|Lost to Follow-up|6
7806679|NCT00452699|27123155|P2|Overall Study|Lack of Efficacy|4
7806680|NCT00452699|27123156|P1|Overall Study|Lack of Efficacy|6
7806681|NCT00452699|27123155|P2|Overall Study|Adverse Event|3
7806682|NCT00452699|27123156|P1|Overall Study|Adverse Event|10
7806683|NCT00452673|27123172|P5|Dose Expansion Period|Other|2
7806684|NCT00452673|27123173|P4|Dose Expansion Period|Other|0
7806685|NCT00452673|27123174|P3|Dose Expansion Period|Other|0
7806686|NCT00452673|27123175|P2|Dose Expansion Period|Other|0
7806687|NCT00452673|27123176|P1|Dose Expansion Period|Other|0
7806688|NCT00452673|27123172|P5|Dose Expansion Period|Disease Progression|19
7806689|NCT00452673|27123173|P4|Dose Expansion Period|Disease Progression|0
7806690|NCT00452673|27123174|P3|Dose Expansion Period|Disease Progression|0
7806691|NCT00452673|27123175|P2|Dose Expansion Period|Disease Progression|0
7806692|NCT00452673|27123176|P1|Dose Expansion Period|Disease Progression|0
7806693|NCT00452673|27123172|P5|Dose Escalation Period|Withdrawal by Subject|0
7806694|NCT00452673|27123173|P4|Dose Escalation Period|Withdrawal by Subject|1
7806695|NCT00452673|27123174|P3|Dose Escalation Period|Withdrawal by Subject|0
7806696|NCT00452673|27123175|P2|Dose Escalation Period|Withdrawal by Subject|0
7806697|NCT00452673|27123176|P1|Dose Escalation Period|Withdrawal by Subject|0
7806698|NCT00452673|27123172|P5|Dose Escalation Period|Adverse Event|0
7806699|NCT00452673|27123173|P4|Dose Escalation Period|Adverse Event|1
7806700|NCT00452673|27123174|P3|Dose Escalation Period|Adverse Event|0
7806701|NCT00452673|27123175|P2|Dose Escalation Period|Adverse Event|0
7806702|NCT00452673|27123176|P1|Dose Escalation Period|Adverse Event|0
7806703|NCT00452673|27123172|P5|Dose Escalation Period|Other|0
7806704|NCT00452673|27123173|P4|Dose Escalation Period|Other|0
7806705|NCT00452673|27123174|P3|Dose Escalation Period|Other|1
7806706|NCT00452673|27123175|P2|Dose Escalation Period|Other|0
7806707|NCT00452673|27123176|P1|Dose Escalation Period|Other|0
7806708|NCT00452673|27123172|P5|Dose Escalation Period|study drug toxicity|0
7806709|NCT00452673|27123173|P4|Dose Escalation Period|study drug toxicity|1
7806710|NCT00452673|27123174|P3|Dose Escalation Period|study drug toxicity|3
7806711|NCT00452673|27123175|P2|Dose Escalation Period|study drug toxicity|3
7806712|NCT00452673|27123176|P1|Dose Escalation Period|study drug toxicity|1
7806713|NCT00452673|27123172|P5|Dose Escalation Period|Disease Progression|0
7806714|NCT00452673|27123173|P4|Dose Escalation Period|Disease Progression|6
7806715|NCT00452673|27123174|P3|Dose Escalation Period|Disease Progression|2
7806716|NCT00452673|27123175|P2|Dose Escalation Period|Disease Progression|6
7806717|NCT00452673|27123176|P1|Dose Escalation Period|Disease Progression|6
7806718|NCT00452530|27123223|P2|Overall Study|Other|11
7806719|NCT00452530|27123224|P1|Overall Study|Other|7
7806720|NCT00452530|27123223|P2|Overall Study|No longer met study criteria|22
7806721|NCT00452530|27123224|P1|Overall Study|No longer met study criteria|18
7806722|NCT00452530|27123223|P2|Overall Study|Poor compliance/noncompliance|2
7806723|NCT00452530|27123224|P1|Overall Study|Poor compliance/noncompliance|1
7806724|NCT00452530|27123223|P2|Overall Study|Lost to Follow-up|0
7806725|NCT00452530|27123224|P1|Overall Study|Lost to Follow-up|1
7806726|NCT00452530|27123223|P2|Overall Study|Withdrawal by Subject|57
7806727|NCT00452530|27123224|P1|Overall Study|Withdrawal by Subject|68
7806728|NCT00452530|27123223|P2|Overall Study|Adverse Event|44
7806729|NCT00452530|27123224|P1|Overall Study|Adverse Event|40
7806730|NCT00452530|27123223|P2|Overall Study|Death|0
7806731|NCT00452530|27123224|P1|Overall Study|Death|1
7806732|NCT00452452|27123245|P3|Overall Study|Lost to Follow-up|0
7806733|NCT00452452|27123246|P2|Overall Study|Lost to Follow-up|0
7806734|NCT00452452|27123247|P1|Overall Study|Lost to Follow-up|1
7806735|NCT00452452|27123245|P3|Overall Study|Withdrawal by Subject|0
7806736|NCT00452452|27123246|P2|Overall Study|Withdrawal by Subject|0
7806737|NCT00452452|27123247|P1|Overall Study|Withdrawal by Subject|1
7806738|NCT00452452|27123245|P3|Overall Study|Protocol Violation|1
7806739|NCT00452452|27123246|P2|Overall Study|Protocol Violation|0
7806740|NCT00452452|27123247|P1|Overall Study|Protocol Violation|0
7806741|NCT00452439|27123272|P2|Overall Study|Fracture|0
7806742|NCT00452439|27123273|P1|Overall Study|Fracture|1
7806743|NCT00452439|27123272|P2|Overall Study|Relapse|0
7806744|NCT00452439|27123273|P1|Overall Study|Relapse|3
7806745|NCT00452439|27123272|P2|Overall Study|Failed to achieve complete response|0
7806746|NCT00452439|27123273|P1|Overall Study|Failed to achieve complete response|2
7806747|NCT00452439|27123272|P2|Overall Study|Too Ill to Continue|1
7806748|NCT00452439|27123273|P1|Overall Study|Too Ill to Continue|0
7806749|NCT00452439|27123272|P2|Overall Study|Bone Marrow Transplant|1
7806750|NCT00452439|27123273|P1|Overall Study|Bone Marrow Transplant|0
7806751|NCT00452439|27123272|P2|Overall Study|Death|1
7806752|NCT00452439|27123273|P1|Overall Study|Death|3
7806753|NCT00452439|27123272|P2|Overall Study|Refused Treatment|3
7806754|NCT00452439|27123273|P1|Overall Study|Refused Treatment|4
7806755|NCT00452439|27123272|P2|Overall Study|Lost to Follow-up|1
7806756|NCT00452439|27123273|P1|Overall Study|Lost to Follow-up|1
7806757|NCT00452413|27123301|P3|Overall Study|On treatment|3
7806758|NCT00452413|27123302|P2|Overall Study|On treatment|0
7806759|NCT00452413|27123303|P1|Overall Study|On treatment|0
7806760|NCT00452413|27123301|P3|Overall Study|Death due to adverse event (AE)|1
7806761|NCT00452413|27123302|P2|Overall Study|Death due to adverse event (AE)|0
7806762|NCT00452413|27123303|P1|Overall Study|Death due to adverse event (AE)|0
7806763|NCT00452413|27123301|P3|Overall Study|Death due to study disease|2
7806764|NCT00452413|27123302|P2|Overall Study|Death due to study disease|0
7806765|NCT00452413|27123303|P1|Overall Study|Death due to study disease|0
7806766|NCT00452413|27123301|P3|Overall Study|Physician Decision|4
7806767|NCT00452413|27123302|P2|Overall Study|Physician Decision|0
7806768|NCT00452413|27123303|P1|Overall Study|Physician Decision|0
7806769|NCT00452413|27123301|P3|Overall Study|Adverse Event|5
7806770|NCT00452413|27123302|P2|Overall Study|Adverse Event|0
7806771|NCT00452413|27123303|P1|Overall Study|Adverse Event|0
7806772|NCT00452413|27123301|P3|Overall Study|Withdrawal by Subject|4
7806773|NCT00452413|27123302|P2|Overall Study|Withdrawal by Subject|1
7806774|NCT00452413|27123303|P1|Overall Study|Withdrawal by Subject|0
7806775|NCT00452413|27123301|P3|Overall Study|Progressive Disease|30
7806776|NCT00452413|27123302|P2|Overall Study|Progressive Disease|11
7806777|NCT00452413|27123303|P1|Overall Study|Progressive Disease|4
7806778|NCT00452400|27123327|P5|Overall Study|Other reasons not listed above|1
7806779|NCT00452400|27123328|P4|Overall Study|Other reasons not listed above|1
7806780|NCT00452400|27123329|P3|Overall Study|Other reasons not listed above|0
7806781|NCT00452400|27123330|P2|Overall Study|Other reasons not listed above|0
7806782|NCT00452400|27123331|P1|Overall Study|Other reasons not listed above|0
7806783|NCT00452400|27123327|P5|Overall Study|Lack of Efficacy|0
7806784|NCT00452400|27123328|P4|Overall Study|Lack of Efficacy|0
7806785|NCT00452400|27123329|P3|Overall Study|Lack of Efficacy|0
7806786|NCT00452400|27123330|P2|Overall Study|Lack of Efficacy|0
7806787|NCT00452400|27123331|P1|Overall Study|Lack of Efficacy|2
7806788|NCT00452400|27123327|P5|Overall Study|Withdrawal by Subject|0
7806789|NCT00452400|27123328|P4|Overall Study|Withdrawal by Subject|0
7806790|NCT00452400|27123329|P3|Overall Study|Withdrawal by Subject|1
7806791|NCT00452400|27123330|P2|Overall Study|Withdrawal by Subject|0
7806792|NCT00452400|27123331|P1|Overall Study|Withdrawal by Subject|1
7806793|NCT00452400|27123327|P5|Overall Study|Lost to Follow-up|0
7806794|NCT00452400|27123328|P4|Overall Study|Lost to Follow-up|0
7806795|NCT00452400|27123329|P3|Overall Study|Lost to Follow-up|0
7806796|NCT00452400|27123330|P2|Overall Study|Lost to Follow-up|0
7806797|NCT00452400|27123331|P1|Overall Study|Lost to Follow-up|1
7806798|NCT00452400|27123327|P5|Overall Study|Protocol Violation|0
7806799|NCT00452400|27123328|P4|Overall Study|Protocol Violation|0
7806800|NCT00452400|27123329|P3|Overall Study|Protocol Violation|1
7806801|NCT00452400|27123330|P2|Overall Study|Protocol Violation|0
7806802|NCT00452400|27123331|P1|Overall Study|Protocol Violation|0
7806803|NCT00452400|27123327|P5|Overall Study|Adverse Event|2
7806804|NCT00452400|27123328|P4|Overall Study|Adverse Event|0
7806805|NCT00452400|27123329|P3|Overall Study|Adverse Event|5
7806806|NCT00452400|27123330|P2|Overall Study|Adverse Event|1
7806807|NCT00452400|27123331|P1|Overall Study|Adverse Event|1
7806808|NCT00452361|27123518|P2|Overall Study|Premature termination|9
7806809|NCT00452361|27123519|P1|Overall Study|Premature termination|13
7806810|NCT00452361|27123518|P2|Overall Study|Withdrawal by Subject|1
7806811|NCT00452361|27123519|P1|Overall Study|Withdrawal by Subject|0
7806812|NCT00452361|27123518|P2|Overall Study|Adverse Event|0
7806813|NCT00452361|27123519|P1|Overall Study|Adverse Event|8
7806814|NCT00452348|27123563|P2|Overall Study|Other|9
7806815|NCT00452348|27123564|P1|Overall Study|Other|9
7806816|NCT00452348|27123563|P2|Overall Study|Withdrawal by Subject|21
7806817|NCT00452348|27123564|P1|Overall Study|Withdrawal by Subject|18
7806818|NCT00452348|27123563|P2|Overall Study|Protocol Violation|28
7806819|NCT00452348|27123564|P1|Overall Study|Protocol Violation|22
7806820|NCT00452348|27123563|P2|Overall Study|Lost to Follow-up|8
7806821|NCT00452348|27123564|P1|Overall Study|Lost to Follow-up|14
7806822|NCT00452348|27123563|P2|Overall Study|Lack of Efficacy|9
7806823|NCT00452348|27123564|P1|Overall Study|Lack of Efficacy|10
7806824|NCT00452348|27123563|P2|Overall Study|Adverse Event|9
7806825|NCT00452348|27123564|P1|Overall Study|Adverse Event|6
7806826|NCT00452114|27123618|P2|Overall Study|Physician Decision|3
7806827|NCT00452114|27123619|P1|Overall Study|Physician Decision|3
7806828|NCT00451958|27123635|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
7806829|NCT00451958|27123636|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
7806830|NCT00451958|27123637|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
7806831|NCT00451958|27123638|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
7806832|NCT00451958|27123639|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
7806833|NCT00451958|27123635|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
7806834|NCT00451958|27123636|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
7806835|NCT00451958|27123637|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
7806836|NCT00451958|27123638|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
7806837|NCT00451958|27123639|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
7806838|NCT00451958|27123635|P5|CS21A (NCT00451958)|Physician Decision|0
7806839|NCT00451958|27123636|P4|CS21A (NCT00451958)|Physician Decision|4
7806840|NCT00451958|27123637|P3|CS21A (NCT00451958)|Physician Decision|4
7806841|NCT00451958|27123638|P2|CS21A (NCT00451958)|Physician Decision|4
7806842|NCT00451958|27123639|P1|CS21A (NCT00451958)|Physician Decision|2
7806843|NCT00451958|27123635|P5|CS21A (NCT00451958)|Protocol Violation|0
7806844|NCT00451958|27123636|P4|CS21A (NCT00451958)|Protocol Violation|0
7806845|NCT00451958|27123637|P3|CS21A (NCT00451958)|Protocol Violation|2
7806846|NCT00451958|27123638|P2|CS21A (NCT00451958)|Protocol Violation|3
7806847|NCT00451958|27123639|P1|CS21A (NCT00451958)|Protocol Violation|1
7806848|NCT00451958|27123635|P5|CS21A (NCT00451958)|Lost to Follow-up|0
7806849|NCT00451958|27123636|P4|CS21A (NCT00451958)|Lost to Follow-up|1
7806850|NCT00451958|27123637|P3|CS21A (NCT00451958)|Lost to Follow-up|1
7806851|NCT00451958|27123638|P2|CS21A (NCT00451958)|Lost to Follow-up|5
7806852|NCT00451958|27123639|P1|CS21A (NCT00451958)|Lost to Follow-up|6
7806853|NCT00451958|27123635|P5|CS21A (NCT00451958)|Adverse Event|0
7806854|NCT00451958|27123636|P4|CS21A (NCT00451958)|Adverse Event|17
7806855|NCT00451958|27123637|P3|CS21A (NCT00451958)|Adverse Event|14
7806856|NCT00451958|27123638|P2|CS21A (NCT00451958)|Adverse Event|34
7806857|NCT00451958|27123639|P1|CS21A (NCT00451958)|Adverse Event|21
7806858|NCT00451906|27123669|P1|Overall Study|Did not complete final visit|4
7806859|NCT00451906|27123669|P1|Overall Study|Other Reasons|121
7806860|NCT00451906|27123669|P1|Overall Study|Termination of the study|108
7806861|NCT00451906|27123669|P1|Overall Study|Progressive disease|1328
7806862|NCT00451906|27123669|P1|Overall Study|Protocol Violation|21
7806863|NCT00451906|27123669|P1|Overall Study|Withdrawal by Subject|111
7806864|NCT00451906|27123669|P1|Overall Study|Lost to Follow-up|31
7806865|NCT00451906|27123669|P1|Overall Study|Adverse Event|515
7806866|NCT00451555|27123697|P2|Overall Study|Physician Decision|1
7806867|NCT00451555|27123698|P1|Overall Study|Physician Decision|2
7806868|NCT00451555|27123697|P2|Overall Study|Withdrawal by Subject|0
7806869|NCT00451555|27123698|P1|Overall Study|Withdrawal by Subject|6
7806870|NCT00451555|27123697|P2|Overall Study|Adverse Event|1
7806871|NCT00451555|27123698|P1|Overall Study|Adverse Event|3
7806872|NCT00451555|27123697|P2|Overall Study|Protocol Violation|2
7806873|NCT00451555|27123698|P1|Overall Study|Protocol Violation|2
7806874|NCT00451451|27123732|P4|Overall Study|Other Reasons for Not Completing Study|14
7806875|NCT00451451|27123733|P3|Overall Study|Other Reasons for Not Completing Study|17
7806876|NCT00451451|27123734|P2|Overall Study|Other Reasons for Not Completing Study|30
7806877|NCT00451451|27123735|P1|Overall Study|Other Reasons for Not Completing Study|34
7806878|NCT00451451|27123732|P4|Overall Study|Death|1
7806879|NCT00451451|27123733|P3|Overall Study|Death|0
7806880|NCT00451451|27123734|P2|Overall Study|Death|0
7806881|NCT00451451|27123735|P1|Overall Study|Death|1
7806882|NCT00451451|27123732|P4|Overall Study|Subject Non-Compliance|3
7806883|NCT00451451|27123733|P3|Overall Study|Subject Non-Compliance|3
7806884|NCT00451451|27123734|P2|Overall Study|Subject Non-Compliance|4
7806885|NCT00451451|27123735|P1|Overall Study|Subject Non-Compliance|8
7806886|NCT00451451|27123732|P4|Overall Study|Investigator Decision|2
7806887|NCT00451451|27123733|P3|Overall Study|Investigator Decision|1
7806888|NCT00451451|27123734|P2|Overall Study|Investigator Decision|2
7806889|NCT00451451|27123735|P1|Overall Study|Investigator Decision|6
7806890|NCT00451451|27123732|P4|Overall Study|Consent Withdrawn|17
7806891|NCT00451451|27123733|P3|Overall Study|Consent Withdrawn|17
7806892|NCT00451451|27123734|P2|Overall Study|Consent Withdrawn|9
7806893|NCT00451451|27123735|P1|Overall Study|Consent Withdrawn|14
7806894|NCT00451451|27123732|P4|Overall Study|Lost to Follow-up|11
7806895|NCT00451451|27123733|P3|Overall Study|Lost to Follow-up|8
7806896|NCT00451451|27123734|P2|Overall Study|Lost to Follow-up|9
7806897|NCT00451451|27123735|P1|Overall Study|Lost to Follow-up|11
7806898|NCT00451451|27123732|P4|Overall Study|Adverse Event|10
7806899|NCT00451451|27123733|P3|Overall Study|Adverse Event|26
7806900|NCT00451451|27123734|P2|Overall Study|Adverse Event|21
7806901|NCT00451451|27123735|P1|Overall Study|Adverse Event|11
7806902|NCT00451321|27123770|P8|Overall Study|Sponsor decision to amend protocol|3
7806903|NCT00451321|27123771|P7|Overall Study|Sponsor decision to amend protocol|1
7806904|NCT00451321|27123772|P6|Overall Study|Sponsor decision to amend protocol|1
7806905|NCT00451321|27123773|P5|Overall Study|Sponsor decision to amend protocol|0
7806906|NCT00451321|27123774|P4|Overall Study|Sponsor decision to amend protocol|0
7806907|NCT00451321|27123775|P3|Overall Study|Sponsor decision to amend protocol|0
7806908|NCT00451321|27123776|P2|Overall Study|Sponsor decision to amend protocol|0
7806909|NCT00451321|27123777|P1|Overall Study|Sponsor decision to amend protocol|0
7806910|NCT00451321|27123770|P8|Overall Study|Study closed/terminated|3
7806911|NCT00451321|27123771|P7|Overall Study|Study closed/terminated|5
7806912|NCT00451321|27123772|P6|Overall Study|Study closed/terminated|7
7806913|NCT00451321|27123773|P5|Overall Study|Study closed/terminated|7
7806914|NCT00451321|27123774|P4|Overall Study|Study closed/terminated|5
7806915|NCT00451321|27123775|P3|Overall Study|Study closed/terminated|17
7806916|NCT00451321|27123776|P2|Overall Study|Study closed/terminated|1
7806917|NCT00451321|27123777|P1|Overall Study|Study closed/terminated|1
7806918|NCT00451321|27123770|P8|Overall Study|Withdrawal by Subject|0
7806919|NCT00451321|27123771|P7|Overall Study|Withdrawal by Subject|0
7806920|NCT00451321|27123772|P6|Overall Study|Withdrawal by Subject|0
7806921|NCT00451321|27123773|P5|Overall Study|Withdrawal by Subject|0
7806922|NCT00451321|27123774|P4|Overall Study|Withdrawal by Subject|4
7806923|NCT00451321|27123775|P3|Overall Study|Withdrawal by Subject|0
7806924|NCT00451321|27123776|P2|Overall Study|Withdrawal by Subject|1
7806925|NCT00451321|27123777|P1|Overall Study|Withdrawal by Subject|3
7806926|NCT00451321|27123770|P8|Overall Study|Lost to Follow-up|0
7806927|NCT00451321|27123771|P7|Overall Study|Lost to Follow-up|0
7806928|NCT00451321|27123772|P6|Overall Study|Lost to Follow-up|1
7806929|NCT00451321|27123773|P5|Overall Study|Lost to Follow-up|0
7806930|NCT00451321|27123774|P4|Overall Study|Lost to Follow-up|3
7806931|NCT00451321|27123775|P3|Overall Study|Lost to Follow-up|1
7806932|NCT00451321|27123776|P2|Overall Study|Lost to Follow-up|3
7806933|NCT00451321|27123777|P1|Overall Study|Lost to Follow-up|3
7806934|NCT00451282|27123949|P2|Overall Study|Lost to Follow-up|5
7806935|NCT00451282|27123950|P1|Overall Study|Lost to Follow-up|6
7806936|NCT00451217|27123966|P4|Overall Study|Not Treated|4
7806937|NCT00451217|27123967|P3|Overall Study|Not Treated|3
7806938|NCT00451217|27123968|P2|Overall Study|Not Treated|1
7806939|NCT00451217|27123969|P1|Overall Study|Not Treated|1
7806940|NCT00451217|27123966|P4|Overall Study|Withdrawal by Subject|0
7806941|NCT00451217|27123967|P3|Overall Study|Withdrawal by Subject|0
7806942|NCT00451217|27123968|P2|Overall Study|Withdrawal by Subject|0
7806943|NCT00451217|27123969|P1|Overall Study|Withdrawal by Subject|1
7806944|NCT00451217|27123966|P4|Overall Study|Lost to Follow-up|1
7806945|NCT00451217|27123967|P3|Overall Study|Lost to Follow-up|1
7806946|NCT00451217|27123968|P2|Overall Study|Lost to Follow-up|1
7806947|NCT00451217|27123969|P1|Overall Study|Lost to Follow-up|0
7806948|NCT00451204|27123997|P2|Overall Study|Other|2
7806949|NCT00451204|27123998|P1|Overall Study|Other|1
7806950|NCT00451204|27123997|P2|Overall Study|Patient refusal|4
7806951|NCT00451204|27123998|P1|Overall Study|Patient refusal|8
7806952|NCT00451204|27123997|P2|Overall Study|Protocol Violation|0
7806953|NCT00451204|27123998|P1|Overall Study|Protocol Violation|1
7806954|NCT00451204|27123997|P2|Overall Study|Lost to Follow-up|4
7806955|NCT00451204|27123998|P1|Overall Study|Lost to Follow-up|4
7806956|NCT00451204|27123997|P2|Overall Study|Lack of Efficacy|4
7806957|NCT00451204|27123998|P1|Overall Study|Lack of Efficacy|4
7806958|NCT00451204|27123997|P2|Overall Study|Adverse Event|6
7806959|NCT00451204|27123998|P1|Overall Study|Adverse Event|4
7806960|NCT00451191|27124016|P2|Overall Study|withdrawal or received alternate tx|11
7806961|NCT00451191|27124017|P1|Overall Study|withdrawal or received alternate tx|15
7806962|NCT00451178|27124025|P2|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
7806963|NCT00451178|27124026|P1|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
7806964|NCT00451178|27124025|P2|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
7806965|NCT00451178|27124026|P1|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
7806966|NCT00451178|27124025|P2|Maintenance Therapy (up to 3 Years)|PD|0
7806967|NCT00451178|27124026|P1|Maintenance Therapy (up to 3 Years)|PD|10
7806968|NCT00451178|27124025|P2|Maintenance Therapy (up to 3 Years)|Death|0
7806969|NCT00451178|27124026|P1|Maintenance Therapy (up to 3 Years)|Death|1
7806970|NCT00451178|27124025|P2|Maintenance Therapy (up to 3 Years)|Physician Decision|0
7806971|NCT00451178|27124026|P1|Maintenance Therapy (up to 3 Years)|Physician Decision|1
7806972|NCT00451178|27124025|P2|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
7806973|NCT00451178|27124026|P1|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
7806974|NCT00451178|27124025|P2|Maintenance Therapy (up to 3 Years)|Adverse Event|0
7806975|NCT00451178|27124026|P1|Maintenance Therapy (up to 3 Years)|Adverse Event|4
7806976|NCT00451178|27124025|P2|Prior to Maintenance Therapy|PD|0
7806977|NCT00451178|27124026|P1|Prior to Maintenance Therapy|PD|2
7806978|NCT00451178|27124025|P2|Prior to Maintenance Therapy|Physician Decision|0
7806979|NCT00451178|27124026|P1|Prior to Maintenance Therapy|Physician Decision|2
7806980|NCT00451178|27124025|P2|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
7806981|NCT00451178|27124026|P1|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
7806982|NCT00451178|27124025|P2|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
7806983|NCT00451178|27124026|P1|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
7806984|NCT00451178|27124025|P2|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
7806985|NCT00451178|27124026|P1|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
7806986|NCT00451178|27124025|P2|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
7806987|NCT00451178|27124026|P1|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
7806988|NCT00451178|27124025|P2|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
7806989|NCT00451178|27124026|P1|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
7806990|NCT00451178|27124025|P2|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
7806991|NCT00451178|27124026|P1|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
7806992|NCT00451035|27124061|P1|Overall Study|New anti-neoplastic therapy|3
7806993|NCT00451035|27124061|P1|Overall Study|Death|3
7806994|NCT00451035|27124061|P1|Overall Study|Disease progression|11
7806995|NCT00450866|27124090|P2|Overall Study|Physician Decision|0
7806996|NCT00450866|27124091|P1|Overall Study|Physician Decision|1
7806997|NCT00450866|27124090|P2|Overall Study|Death|0
7806998|NCT00450866|27124091|P1|Overall Study|Death|1
7806999|NCT00450866|27124090|P2|Overall Study|Withdrawal by Subject|2
7807000|NCT00450866|27124091|P1|Overall Study|Withdrawal by Subject|5
7807001|NCT00450866|27124090|P2|Overall Study|Adverse Event|1
7807002|NCT00450866|27124091|P1|Overall Study|Adverse Event|0
7807003|NCT00450814|27124111|P11|Overall Study|Patient withdrawal prior to treatment|0
7807004|NCT00450814|27124112|P10|Overall Study|Patient withdrawal prior to treatment|1
7807005|NCT00450814|27124113|P9|Overall Study|Patient withdrawal prior to treatment|0
7807006|NCT00450814|27124114|P8|Overall Study|Patient withdrawal prior to treatment|0
7807007|NCT00450814|27124115|P7|Overall Study|Patient withdrawal prior to treatment|0
7807008|NCT00450814|27124116|P6|Overall Study|Patient withdrawal prior to treatment|0
7807009|NCT00450814|27124117|P5|Overall Study|Patient withdrawal prior to treatment|0
7807010|NCT00450814|27124118|P4|Overall Study|Patient withdrawal prior to treatment|0
7807011|NCT00450814|27124119|P3|Overall Study|Patient withdrawal prior to treatment|0
7807012|NCT00450814|27124120|P2|Overall Study|Patient withdrawal prior to treatment|0
7807013|NCT00450814|27124121|P1|Overall Study|Patient withdrawal prior to treatment|0
7807014|NCT00450814|27124111|P11|Overall Study|Failed to complete the initial therapy|0
7807015|NCT00450814|27124112|P10|Overall Study|Failed to complete the initial therapy|0
7807016|NCT00450814|27124113|P9|Overall Study|Failed to complete the initial therapy|0
7807017|NCT00450814|27124114|P8|Overall Study|Failed to complete the initial therapy|0
7807018|NCT00450814|27124115|P7|Overall Study|Failed to complete the initial therapy|0
7807019|NCT00450814|27124116|P6|Overall Study|Failed to complete the initial therapy|1
7807020|NCT00450814|27124117|P5|Overall Study|Failed to complete the initial therapy|1
7807021|NCT00450814|27124118|P4|Overall Study|Failed to complete the initial therapy|1
7807022|NCT00450814|27124119|P3|Overall Study|Failed to complete the initial therapy|0
7807023|NCT00450814|27124120|P2|Overall Study|Failed to complete the initial therapy|0
7807024|NCT00450814|27124121|P1|Overall Study|Failed to complete the initial therapy|0
7807025|NCT00450801|27124155|P1|Overall Study|Death|1
7807026|NCT00450749|27124169|P3|Overall Study|Noncompliant|0
7807027|NCT00450749|27124170|P2|Overall Study|Noncompliant|1
7807028|NCT00450749|27124171|P1|Overall Study|Noncompliant|0
7807029|NCT00450749|27124169|P3|Overall Study|Withdrawal by Subject|2
7807030|NCT00450749|27124170|P2|Overall Study|Withdrawal by Subject|0
7807031|NCT00450749|27124171|P1|Overall Study|Withdrawal by Subject|0
7807032|NCT00450723|27124209|P1|Overall Study|Physician Decision|5
7807033|NCT00450658|27124217|P2|Overall Study|misc|10
7807034|NCT00450658|27124218|P1|Overall Study|misc|21
7807035|NCT00450658|27124217|P2|Overall Study|UGI ulcer|34
7807036|NCT00450658|27124218|P1|Overall Study|UGI ulcer|33
7807037|NCT00450658|27124217|P2|Overall Study|Lost to Follow-up|5
7807038|NCT00450658|27124218|P1|Overall Study|Lost to Follow-up|22
7807039|NCT00450658|27124217|P2|Overall Study|Withdrawal by Subject|26
7807040|NCT00450658|27124218|P1|Overall Study|Withdrawal by Subject|43
7807041|NCT00450658|27124217|P2|Overall Study|Adverse Event|15
7807042|NCT00450658|27124218|P1|Overall Study|Adverse Event|24
7807043|NCT00450619|27124232|P2|Overall Study|Adverse Event|0
7807044|NCT00450619|27124233|P1|Overall Study|Adverse Event|1
7807045|NCT00450619|27124232|P2|Overall Study|did not progress; refused further trmt|1
7807046|NCT00450619|27124233|P1|Overall Study|did not progress; refused further trmt|1
7807047|NCT00450619|27124232|P2|Overall Study|refused treatment after randomization|0
7807048|NCT00450619|27124233|P1|Overall Study|refused treatment after randomization|2
7807049|NCT00450580|27124259|P2|Overall Study|Withdrawal due to pregnancy|1
7807050|NCT00450580|27124260|P1|Overall Study|Withdrawal due to pregnancy|0
7807051|NCT00450580|27124259|P2|Overall Study|Patient could not swallow Norvir|0
7807052|NCT00450580|27124260|P1|Overall Study|Patient could not swallow Norvir|1
7807053|NCT00450580|27124259|P2|Overall Study|Patient went to Brazil|0
7807054|NCT00450580|27124260|P1|Overall Study|Patient went to Brazil|1
7807055|NCT00450580|27124259|P2|Overall Study|Could not comply with scheduled visits|0
7807056|NCT00450580|27124260|P1|Overall Study|Could not comply with scheduled visits|1
7807057|NCT00450580|27124259|P2|Overall Study|Protocol-defined virologic failure|0
7807058|NCT00450580|27124260|P1|Overall Study|Protocol-defined virologic failure|1
7807059|NCT00450580|27124259|P2|Overall Study|Protocol Violation|1
7807060|NCT00450580|27124260|P1|Overall Study|Protocol Violation|1
7807061|NCT00450580|27124259|P2|Overall Study|Withdrawal by Subject|2
7807062|NCT00450580|27124260|P1|Overall Study|Withdrawal by Subject|2
7807063|NCT00450580|27124259|P2|Overall Study|Lost to Follow-up|5
7807064|NCT00450580|27124260|P1|Overall Study|Lost to Follow-up|4
7807065|NCT00450580|27124259|P2|Overall Study|Adverse Event|7
7807066|NCT00450580|27124260|P1|Overall Study|Adverse Event|5
7807067|NCT00450450|27124297|P2|Overall Study|Missing Data|0
7807068|NCT00450450|27124298|P1|Overall Study|Missing Data|2
7807069|NCT00450450|27124297|P2|Overall Study|Relapse|0
7807070|NCT00450450|27124298|P1|Overall Study|Relapse|2
7807071|NCT00450450|27124297|P2|Overall Study|Death|3
7807072|NCT00450450|27124298|P1|Overall Study|Death|1
7807073|NCT00450437|27124322|P4|Overall Study|Unable to Classify|0
7807074|NCT00450437|27124323|P3|Overall Study|Unable to Classify|1
7807075|NCT00450437|27124324|P2|Overall Study|Unable to Classify|0
7807076|NCT00450437|27124325|P1|Overall Study|Unable to Classify|1
7807077|NCT00450437|27124322|P4|Overall Study|Administrative reason|0
7807078|NCT00450437|27124323|P3|Overall Study|Administrative reason|1
7807079|NCT00450437|27124324|P2|Overall Study|Administrative reason|0
7807080|NCT00450437|27124325|P1|Overall Study|Administrative reason|0
7807081|NCT00450437|27124322|P4|Overall Study|Inappropriate enrollment|0
7807082|NCT00450437|27124323|P3|Overall Study|Inappropriate enrollment|3
7807083|NCT00450437|27124324|P2|Overall Study|Inappropriate enrollment|1
7807084|NCT00450437|27124325|P1|Overall Study|Inappropriate enrollment|4
7807085|NCT00450437|27124322|P4|Overall Study|Protocol Violation|1
7807086|NCT00450437|27124323|P3|Overall Study|Protocol Violation|0
7807087|NCT00450437|27124324|P2|Overall Study|Protocol Violation|1
7807088|NCT00450437|27124325|P1|Overall Study|Protocol Violation|0
7807089|NCT00450437|27124322|P4|Overall Study|Lost to Follow-up|9
7807090|NCT00450437|27124323|P3|Overall Study|Lost to Follow-up|19
7807091|NCT00450437|27124324|P2|Overall Study|Lost to Follow-up|12
7807092|NCT00450437|27124325|P1|Overall Study|Lost to Follow-up|31
7807093|NCT00450437|27124322|P4|Overall Study|Withdrawal by Subject|1
7807094|NCT00450437|27124323|P3|Overall Study|Withdrawal by Subject|0
7807095|NCT00450437|27124324|P2|Overall Study|Withdrawal by Subject|2
7807096|NCT00450437|27124325|P1|Overall Study|Withdrawal by Subject|10
7807097|NCT00450411|27124356|P1|Overall Study|No protocol treatment|2
7807098|NCT00450411|27124356|P1|Overall Study|Protocol Violation|6
7807099|NCT00450385|27124367|P1|Overall Study|Other|3
7807100|NCT00450385|27124367|P1|Overall Study|Physician Decision|1
7807101|NCT00450385|27124367|P1|Overall Study|Adverse Event|1
7807102|NCT00450385|27124367|P1|Overall Study|Lack of Efficacy|2
7807103|NCT00450385|27124367|P1|Overall Study|Withdrawal by Subject|2
7807104|NCT00450385|27124367|P1|Overall Study|Protocol Violation|1
7807105|NCT00450385|27124367|P1|Overall Study|Death|3
7807106|NCT00450372|27124376|P1|Overall Study|Physician Decision|1
7807107|NCT00450333|27124389|P4|Overall Study|Death|2
7807108|NCT00450333|27124390|P3|Overall Study|Death|2
7807109|NCT00450333|27124391|P2|Overall Study|Death|2
7807110|NCT00450333|27124392|P1|Overall Study|Death|3
7807111|NCT00450333|27124389|P4|Overall Study|Kidney transplant|3
7807112|NCT00450333|27124390|P3|Overall Study|Kidney transplant|1
7807113|NCT00450333|27124391|P2|Overall Study|Kidney transplant|0
7807114|NCT00450333|27124392|P1|Overall Study|Kidney transplant|1
7807115|NCT00450333|27124389|P4|Overall Study|Withdrawal by Subject|0
7807116|NCT00450333|27124390|P3|Overall Study|Withdrawal by Subject|3
7807117|NCT00450333|27124391|P2|Overall Study|Withdrawal by Subject|0
7807118|NCT00450333|27124392|P1|Overall Study|Withdrawal by Subject|1
7807119|NCT00450333|27124389|P4|Overall Study|Protocol Violation|0
7807120|NCT00450333|27124390|P3|Overall Study|Protocol Violation|1
7807121|NCT00450333|27124391|P2|Overall Study|Protocol Violation|0
7807122|NCT00450333|27124392|P1|Overall Study|Protocol Violation|1
7807123|NCT00450333|27124389|P4|Overall Study|Adverse Event|2
7807124|NCT00450333|27124390|P3|Overall Study|Adverse Event|2
7807125|NCT00450333|27124391|P2|Overall Study|Adverse Event|7
7807126|NCT00450333|27124392|P1|Overall Study|Adverse Event|1
7807127|NCT00450333|27124389|P4|Overall Study|Study terminated|21
7807128|NCT00450333|27124390|P3|Overall Study|Study terminated|16
7807129|NCT00450333|27124391|P2|Overall Study|Study terminated|54
7807130|NCT00450333|27124392|P1|Overall Study|Study terminated|47
7807131|NCT00450255|27124415|P1|Overall Study|Prior RFA ablation of liver|1
7807132|NCT00450216|27124440|P2|Overall Study|misc|20
7807133|NCT00450216|27124441|P1|Overall Study|misc|21
7807134|NCT00450216|27124440|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
7807135|NCT00450216|27124441|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
7807136|NCT00450216|27124440|P2|Overall Study|Lost to Follow-up|9
7807137|NCT00450216|27124441|P1|Overall Study|Lost to Follow-up|16
7807138|NCT00450216|27124440|P2|Overall Study|Withdrawal by Subject|26
7807139|NCT00450216|27124441|P1|Overall Study|Withdrawal by Subject|48
7807140|NCT00450216|27124440|P2|Overall Study|Adverse Event|23
7807141|NCT00450216|27124441|P1|Overall Study|Adverse Event|38
7807142|NCT00450190|27124453|P1|Overall Study|Withdrawal by Subject|2
7807143|NCT00450177|27124463|P2|Overall Study|Withdrawal by Primary Team|1
7807144|NCT00450177|27124464|P1|Overall Study|Withdrawal by Primary Team|1
7807145|NCT00450177|27124463|P2|Overall Study|Withdrawal by Subject|6
7807146|NCT00450177|27124464|P1|Overall Study|Withdrawal by Subject|1
7807147|NCT00450177|27124463|P2|Overall Study|Adverse Event|4
7807148|NCT00450177|27124464|P1|Overall Study|Adverse Event|7
7807149|NCT00450112|27124490|P2|Overall Study|Others|3
7807150|NCT00450112|27124491|P1|Overall Study|Others|2
7807151|NCT00450112|27124490|P2|Overall Study|Lost to Follow-up|1
7807152|NCT00450112|27124491|P1|Overall Study|Lost to Follow-up|2
7807153|NCT00450112|27124490|P2|Overall Study|Withdrawal by Subject|1
7807154|NCT00450112|27124491|P1|Overall Study|Withdrawal by Subject|4
7807155|NCT00450112|27124490|P2|Overall Study|Other Treatment Required|1
7807156|NCT00450112|27124491|P1|Overall Study|Other Treatment Required|5
7807157|NCT00449956|27124529|P3|Overall Study|Physician Decision|1
7807158|NCT00449956|27124530|P2|Overall Study|Physician Decision|1
7807159|NCT00449956|27124531|P1|Overall Study|Physician Decision|2
7807160|NCT00449956|27124529|P3|Overall Study|Withdrawal by Subject|0
7807161|NCT00449956|27124530|P2|Overall Study|Withdrawal by Subject|1
7807162|NCT00449956|27124531|P1|Overall Study|Withdrawal by Subject|0
7807163|NCT00449956|27124529|P3|Overall Study|Protocol Violation|1
7807164|NCT00449956|27124530|P2|Overall Study|Protocol Violation|1
7807165|NCT00449956|27124531|P1|Overall Study|Protocol Violation|1
7807166|NCT00449956|27124529|P3|Overall Study|Lack of Efficacy|1
7807167|NCT00449956|27124530|P2|Overall Study|Lack of Efficacy|0
7807168|NCT00449956|27124531|P1|Overall Study|Lack of Efficacy|0
7807169|NCT00449956|27124529|P3|Overall Study|Adverse Event|6
7807170|NCT00449956|27124530|P2|Overall Study|Adverse Event|1
7807171|NCT00449956|27124531|P1|Overall Study|Adverse Event|7
7807172|NCT00449930|27124547|P2|Overall Study|Glycemic discontinuation criteria|1
7807173|NCT00449930|27124548|P1|Overall Study|Glycemic discontinuation criteria|1
7807174|NCT00449930|27124547|P2|Overall Study|Withdrawal by Subject|23
7807175|NCT00449930|27124548|P1|Overall Study|Withdrawal by Subject|16
7807176|NCT00449930|27124547|P2|Overall Study|Protocol Violation|15
7807177|NCT00449930|27124548|P1|Overall Study|Protocol Violation|14
7807178|NCT00449930|27124547|P2|Overall Study|Physician Decision|2
7807179|NCT00449930|27124548|P1|Overall Study|Physician Decision|1
7807180|NCT00449930|27124547|P2|Overall Study|Lost to Follow-up|14
7807181|NCT00449930|27124548|P1|Overall Study|Lost to Follow-up|9
7807182|NCT00449930|27124547|P2|Overall Study|Lack of Efficacy|1
7807183|NCT00449930|27124548|P1|Overall Study|Lack of Efficacy|10
7807184|NCT00449930|27124547|P2|Overall Study|Trial Terminated ( Site Closed)|0
7807185|NCT00449930|27124548|P1|Overall Study|Trial Terminated ( Site Closed)|1
7807186|NCT00449930|27124547|P2|Overall Study|Adverse Event|19
7807187|NCT00449930|27124548|P1|Overall Study|Adverse Event|9
7807188|NCT00449865|27124564|P2|Overall Study|Study was stopped|328
7807189|NCT00449865|27124565|P1|Overall Study|Study was stopped|324
7807190|NCT00449865|27124564|P2|Overall Study|Protocol Violation|7
7807191|NCT00449865|27124565|P1|Overall Study|Protocol Violation|8
7807192|NCT00449865|27124564|P2|Overall Study|Death|40
7807193|NCT00449865|27124565|P1|Overall Study|Death|31
7807194|NCT00449865|27124564|P2|Overall Study|Physician Decision|12
7807195|NCT00449865|27124565|P1|Overall Study|Physician Decision|13
7807196|NCT00449865|27124564|P2|Overall Study|Lost to Follow-up|37
7807197|NCT00449865|27124565|P1|Overall Study|Lost to Follow-up|36
7807198|NCT00449865|27124564|P2|Overall Study|Withdrawal by Subject|110
7807199|NCT00449865|27124565|P1|Overall Study|Withdrawal by Subject|110
7807200|NCT00449787|27124573|P2|Overall Study|Did not require medication|92
7807201|NCT00449787|27124574|P1|Overall Study|Did not require medication|95
7807202|NCT00449787|27124573|P2|Overall Study|Lost to Follow-up|8
7807203|NCT00449787|27124574|P1|Overall Study|Lost to Follow-up|10
7807204|NCT00449761|27124584|P1|Overall Study|New cancer therapy|1
7807205|NCT00449761|27124584|P1|Overall Study|Death|5
7807206|NCT00449761|27124584|P1|Overall Study|Disease progression|12
7807207|NCT00449696|27124610|P2|Overall Study|Others|0
7807208|NCT00449696|27124611|P1|Overall Study|Others|7
7807209|NCT00449696|27124610|P2|Overall Study|Lost to Follow-up|3
7807210|NCT00449696|27124611|P1|Overall Study|Lost to Follow-up|2
7807211|NCT00449696|27124610|P2|Overall Study|Withdrawal by Subject|5
7807212|NCT00449696|27124611|P1|Overall Study|Withdrawal by Subject|5
7807213|NCT00449696|27124610|P2|Overall Study|Other Treatment Required|1
7807214|NCT00449696|27124611|P1|Overall Study|Other Treatment Required|6
7807215|NCT00449670|27124635|P2|Booster Phase (Study no.109873)|Other|2
7807216|NCT00449670|27124636|P1|Booster Phase (Study no.109873)|Other|0
7807217|NCT00449670|27124635|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
7807218|NCT00449670|27124636|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
7807219|NCT00449670|27124635|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
7807220|NCT00449670|27124636|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
7807221|NCT00449670|27124635|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
7807222|NCT00449670|27124636|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
7807223|NCT00449670|27124635|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
7807224|NCT00449670|27124636|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
7807225|NCT00449670|27124635|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
7807226|NCT00449670|27124636|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
7807227|NCT00449644|27124749|P4|Overall Study|Rolled-over to treatment with TMC207|1
7807228|NCT00449644|27124750|P3|Overall Study|Rolled-over to treatment with TMC207|0
7807229|NCT00449644|27124751|P2|Overall Study|Rolled-over to treatment with TMC207|0
7807230|NCT00449644|27124752|P1|Overall Study|Rolled-over to treatment with TMC207|0
7807231|NCT00449644|27124749|P4|Overall Study|Other|0
7807232|NCT00449644|27124750|P3|Overall Study|Other|1
7807233|NCT00449644|27124751|P2|Overall Study|Other|4
7807234|NCT00449644|27124752|P1|Overall Study|Other|1
7807235|NCT00449644|27124749|P4|Overall Study|Inclusion/exclusion criteria not met|6
7807236|NCT00449644|27124750|P3|Overall Study|Inclusion/exclusion criteria not met|2
7807237|NCT00449644|27124751|P2|Overall Study|Inclusion/exclusion criteria not met|0
7807238|NCT00449644|27124752|P1|Overall Study|Inclusion/exclusion criteria not met|0
7807239|NCT00449644|27124749|P4|Overall Study|Withdrawal by Subject|7
7807240|NCT00449644|27124750|P3|Overall Study|Withdrawal by Subject|6
7807241|NCT00449644|27124751|P2|Overall Study|Withdrawal by Subject|4
7807242|NCT00449644|27124752|P1|Overall Study|Withdrawal by Subject|3
7807243|NCT00449644|27124749|P4|Overall Study|Protocol Violation|7
7807244|NCT00449644|27124750|P3|Overall Study|Protocol Violation|3
7807245|NCT00449644|27124751|P2|Overall Study|Protocol Violation|4
7807246|NCT00449644|27124752|P1|Overall Study|Protocol Violation|4
7807247|NCT00449644|27124749|P4|Overall Study|Pregnancy|2
7807248|NCT00449644|27124750|P3|Overall Study|Pregnancy|3
7807249|NCT00449644|27124751|P2|Overall Study|Pregnancy|0
7807250|NCT00449644|27124752|P1|Overall Study|Pregnancy|0
7807251|NCT00449644|27124749|P4|Overall Study|Lost to Follow-up|3
7807252|NCT00449644|27124750|P3|Overall Study|Lost to Follow-up|5
7807253|NCT00449644|27124751|P2|Overall Study|Lost to Follow-up|1
7807254|NCT00449644|27124752|P1|Overall Study|Lost to Follow-up|1
7807255|NCT00449644|27124749|P4|Overall Study|Death|1
7807256|NCT00449644|27124750|P3|Overall Study|Death|6
7807257|NCT00449644|27124751|P2|Overall Study|Death|0
7807258|NCT00449644|27124752|P1|Overall Study|Death|1
7807259|NCT00449644|27124749|P4|Overall Study|Adverse Event|5
7807260|NCT00449644|27124750|P3|Overall Study|Adverse Event|3
7807261|NCT00449644|27124751|P2|Overall Study|Adverse Event|0
7807262|NCT00449644|27124752|P1|Overall Study|Adverse Event|0
7807263|NCT00449540|27124772|P3|Treatment Phase|did not experience or treat migraine|17
7807264|NCT00449540|27124773|P2|Treatment Phase|did not experience or treat migraine|20
7807265|NCT00449540|27124774|P1|Treatment Phase|did not experience or treat migraine|0
7807266|NCT00449540|27124772|P3|Pretreatment Phase|No migraine experienced|0
7807267|NCT00449540|27124773|P2|Pretreatment Phase|No migraine experienced|0
7807268|NCT00449540|27124774|P1|Pretreatment Phase|No migraine experienced|66
7807269|NCT00449176|27124791|P3|Overall Study|all other|20
7807270|NCT00449176|27124792|P2|Overall Study|all other|19
7807271|NCT00449176|27124793|P1|Overall Study|all other|22
7807272|NCT00449176|27124791|P3|Overall Study|Study drug non-compliant|11
7807273|NCT00449176|27124792|P2|Overall Study|Study drug non-compliant|11
7807274|NCT00449176|27124793|P1|Overall Study|Study drug non-compliant|14
7807275|NCT00449176|27124791|P3|Overall Study|Lack of Efficacy|50
7807276|NCT00449176|27124792|P2|Overall Study|Lack of Efficacy|7
7807277|NCT00449176|27124793|P1|Overall Study|Lack of Efficacy|13
7807278|NCT00449176|27124791|P3|Overall Study|Adverse Event|15
7807279|NCT00449176|27124792|P2|Overall Study|Adverse Event|107
7807280|NCT00449176|27124793|P1|Overall Study|Adverse Event|51
7807281|NCT00449176|27124791|P3|Overall Study|Lost to Follow-up|12
7807282|NCT00449176|27124792|P2|Overall Study|Lost to Follow-up|8
7807283|NCT00449176|27124793|P1|Overall Study|Lost to Follow-up|13
7807284|NCT00449176|27124791|P3|Overall Study|Withdrawal by Subject|59
7807285|NCT00449176|27124792|P2|Overall Study|Withdrawal by Subject|43
7807286|NCT00449176|27124793|P1|Overall Study|Withdrawal by Subject|39
7807287|NCT00449163|27124819|P1|Overall Study|Physician Decision|3
7807288|NCT00449150|27124829|P3|Overall Study|Protocol Violation|1
7807289|NCT00449150|27124830|P2|Overall Study|Protocol Violation|2
7807290|NCT00449150|27124831|P1|Overall Study|Protocol Violation|1
7807291|NCT00449150|27124829|P3|Overall Study|Withdrawal by Subject|21
7807292|NCT00449150|27124830|P2|Overall Study|Withdrawal by Subject|18
7807293|NCT00449150|27124831|P1|Overall Study|Withdrawal by Subject|17
7807294|NCT00449150|27124829|P3|Overall Study|Other|14
7807295|NCT00449150|27124830|P2|Overall Study|Other|13
7807296|NCT00449150|27124831|P1|Overall Study|Other|16
7807297|NCT00449150|27124829|P3|Overall Study|Lack of Efficacy|2
7807298|NCT00449150|27124830|P2|Overall Study|Lack of Efficacy|2
7807299|NCT00449150|27124831|P1|Overall Study|Lack of Efficacy|1
7807300|NCT00449150|27124829|P3|Overall Study|Adverse Event|9
7807301|NCT00449150|27124830|P2|Overall Study|Adverse Event|18
7807302|NCT00449150|27124831|P1|Overall Study|Adverse Event|11
7807303|NCT00449072|27124844|P2|Overall Study|Relocation|2
7807304|NCT00449072|27124845|P1|Overall Study|Relocation|3
7807305|NCT00449072|27124844|P2|Overall Study|Sponsor decision|3
7807306|NCT00449072|27124845|P1|Overall Study|Sponsor decision|1
7807307|NCT00449072|27124844|P2|Overall Study|Non-compliance|5
7807308|NCT00449072|27124845|P1|Overall Study|Non-compliance|2
7807309|NCT00449072|27124844|P2|Overall Study|Excluded medication|2
7807310|NCT00449072|27124845|P1|Overall Study|Excluded medication|0
7807311|NCT00449072|27124844|P2|Overall Study|Not treated|1
7807312|NCT00449072|27124845|P1|Overall Study|Not treated|0
7807313|NCT00449072|27124844|P2|Overall Study|Physician Decision|0
7807314|NCT00449072|27124845|P1|Overall Study|Physician Decision|1
7807315|NCT00449072|27124844|P2|Overall Study|Lack of Efficacy|1
7807316|NCT00449072|27124845|P1|Overall Study|Lack of Efficacy|1
7807317|NCT00449072|27124844|P2|Overall Study|Withdrawal by Subject|8
7807318|NCT00449072|27124845|P1|Overall Study|Withdrawal by Subject|11
7807319|NCT00449072|27124844|P2|Overall Study|Lost to Follow-up|7
7807320|NCT00449072|27124845|P1|Overall Study|Lost to Follow-up|5
7807321|NCT00449072|27124844|P2|Overall Study|Protocol Violation|12
7807322|NCT00449072|27124845|P1|Overall Study|Protocol Violation|14
7807323|NCT00449072|27124844|P2|Overall Study|Adverse Event|1
7807324|NCT00449072|27124845|P1|Overall Study|Adverse Event|3
7807325|NCT00449033|27124882|P2|Follow-up Period|Reason Missing|113
7807326|NCT00449033|27124883|P1|Follow-up Period|Reason Missing|120
7807327|NCT00449033|27124882|P2|Follow-up Period|Lost to Follow-up|10
7807328|NCT00449033|27124883|P1|Follow-up Period|Lost to Follow-up|6
7807329|NCT00449033|27124882|P2|Follow-up Period|Death|311
7807330|NCT00449033|27124883|P1|Follow-up Period|Death|299
7807331|NCT00449033|27124882|P2|Treatment Period|Treatment Ongoing|4
7807332|NCT00449033|27124883|P1|Treatment Period|Treatment Ongoing|6
7807333|NCT00449033|27124882|P2|Treatment Period|Reason Missing|4
7807334|NCT00449033|27124883|P1|Treatment Period|Reason Missing|0
7807335|NCT00449033|27124882|P2|Treatment Period|Second Malignancy|1
7807336|NCT00449033|27124883|P1|Treatment Period|Second Malignancy|0
7807337|NCT00449033|27124882|P2|Treatment Period|Non-compliance|8
7807338|NCT00449033|27124883|P1|Treatment Period|Non-compliance|7
7807339|NCT00449033|27124882|P2|Treatment Period|Amended Protocol Criteria|18
7807340|NCT00449033|27124883|P1|Treatment Period|Amended Protocol Criteria|22
7807341|NCT00449033|27124882|P2|Treatment Period|Consent Withdrawn|20
7807342|NCT00449033|27124883|P1|Treatment Period|Consent Withdrawn|36
7807343|NCT00449033|27124882|P2|Treatment Period|Disease Progression|288
7807344|NCT00449033|27124883|P1|Treatment Period|Disease Progression|231
7807345|NCT00449033|27124882|P2|Treatment Period|Protocol Violation|7
7807346|NCT00449033|27124883|P1|Treatment Period|Protocol Violation|8
7807347|NCT00449033|27124882|P2|Treatment Period|Physician Decision|5
7807348|NCT00449033|27124883|P1|Treatment Period|Physician Decision|4
7807349|NCT00449033|27124882|P2|Treatment Period|Lost to Follow-up|2
7807350|NCT00449033|27124883|P1|Treatment Period|Lost to Follow-up|0
7807351|NCT00449033|27124882|P2|Treatment Period|Death|12
7807352|NCT00449033|27124883|P1|Treatment Period|Death|21
7807353|NCT00449033|27124882|P2|Treatment Period|Adverse Event|83
7807354|NCT00449033|27124883|P1|Treatment Period|Adverse Event|117
7807355|NCT00448916|27124932|P4|Overall Study|Protocol Violation|1
7807356|NCT00448916|27124933|P3|Overall Study|Protocol Violation|0
7807357|NCT00448916|27124934|P2|Overall Study|Protocol Violation|0
7807358|NCT00448916|27124935|P1|Overall Study|Protocol Violation|0
7807359|NCT00448916|27124932|P4|Overall Study|Lost to Follow-up|1
7807360|NCT00448916|27124933|P3|Overall Study|Lost to Follow-up|0
7807361|NCT00448916|27124934|P2|Overall Study|Lost to Follow-up|1
7807362|NCT00448916|27124935|P1|Overall Study|Lost to Follow-up|0
7807363|NCT00448916|27124932|P4|Overall Study|Other|0
7807364|NCT00448916|27124933|P3|Overall Study|Other|0
7807365|NCT00448916|27124934|P2|Overall Study|Other|0
7807366|NCT00448916|27124935|P1|Overall Study|Other|1
7807367|NCT00448916|27124932|P4|Overall Study|Withdrawal by Subject|1
7807368|NCT00448916|27124933|P3|Overall Study|Withdrawal by Subject|1
7807369|NCT00448916|27124934|P2|Overall Study|Withdrawal by Subject|3
7807370|NCT00448916|27124935|P1|Overall Study|Withdrawal by Subject|3
7807371|NCT00448916|27124932|P4|Overall Study|Lack of Efficacy|1
7807372|NCT00448916|27124933|P3|Overall Study|Lack of Efficacy|2
7807373|NCT00448916|27124934|P2|Overall Study|Lack of Efficacy|0
7807374|NCT00448916|27124935|P1|Overall Study|Lack of Efficacy|1
7807375|NCT00448916|27124932|P4|Overall Study|Adverse Event|2
7807376|NCT00448916|27124933|P3|Overall Study|Adverse Event|3
7807377|NCT00448916|27124934|P2|Overall Study|Adverse Event|2
7807378|NCT00448916|27124935|P1|Overall Study|Adverse Event|2
7807379|NCT00448864|27125009|P3|Overall Study|Protocol Violation|0
7807380|NCT00448864|27125010|P2|Overall Study|Protocol Violation|2
7807381|NCT00448864|27125011|P1|Overall Study|Protocol Violation|0
7807382|NCT00448864|27125009|P3|Overall Study|Withdrawal by Subject|0
7807383|NCT00448864|27125010|P2|Overall Study|Withdrawal by Subject|2
7807384|NCT00448864|27125011|P1|Overall Study|Withdrawal by Subject|0
7807385|NCT00448864|27125009|P3|Overall Study|Physician Decision|1
7807386|NCT00448864|27125010|P2|Overall Study|Physician Decision|0
7807387|NCT00448864|27125011|P1|Overall Study|Physician Decision|1
7807388|NCT00448864|27125009|P3|Overall Study|Lost to Follow-up|0
7807389|NCT00448864|27125010|P2|Overall Study|Lost to Follow-up|1
7807390|NCT00448864|27125011|P1|Overall Study|Lost to Follow-up|3
7807391|NCT00448864|27125009|P3|Overall Study|Death|0
7807392|NCT00448864|27125010|P2|Overall Study|Death|0
7807393|NCT00448864|27125011|P1|Overall Study|Death|1
7807394|NCT00448812|27125029|P2|Year 5|Missed visit but remained in study|0
7807395|NCT00448812|27125030|P1|Year 5|Missed visit but remained in study|1
7807396|NCT00448812|27125029|P2|Year 3|Missed visit but remained in study|0
7807397|NCT00448812|27125030|P1|Year 3|Missed visit but remained in study|2
7807398|NCT00448812|27125029|P2|Year 3|Lost to Follow-up|0
7807399|NCT00448812|27125030|P1|Year 3|Lost to Follow-up|1
7807400|NCT00448812|27125029|P2|Year 3|Withdrawal by Subject|3
7807401|NCT00448812|27125030|P1|Year 3|Withdrawal by Subject|1
7807402|NCT00448812|27125029|P2|Year 2|Missed visit but remained in study|1
7807403|NCT00448812|27125030|P1|Year 2|Missed visit but remained in study|4
7807404|NCT00448760|27125072|P1|Overall Study|Death|3
7807405|NCT00448747|27125081|P2|Overall Study|collapsed veins|0
7807406|NCT00448747|27125082|P1|Overall Study|collapsed veins|1
7807407|NCT00448708|27125100|P2|Overall Study|not listed|2
7807408|NCT00448708|27125101|P1|Overall Study|not listed|0
7807409|NCT00448708|27125100|P2|Overall Study|Lost to Follow-up|8
7807410|NCT00448708|27125101|P1|Overall Study|Lost to Follow-up|6
7807411|NCT00448708|27125100|P2|Overall Study|Withdrawal by Subject|4
7807412|NCT00448708|27125101|P1|Overall Study|Withdrawal by Subject|8
7807413|NCT00448708|27125100|P2|Overall Study|Death|17
7807414|NCT00448708|27125101|P1|Overall Study|Death|21
7807415|NCT00448669|27125117|P2|Overall Study|Never started drug|7
7807416|NCT00448669|27125118|P1|Overall Study|Never started drug|9
7807417|NCT00448669|27125117|P2|Overall Study|HIV-infected at enrollment|2
7807418|NCT00448669|27125118|P1|Overall Study|HIV-infected at enrollment|1
7807419|NCT00448669|27125117|P2|Overall Study|Had other reasons|6
7807420|NCT00448669|27125118|P1|Overall Study|Had other reasons|5
7807421|NCT00448669|27125117|P2|Overall Study|Death|4
7807422|NCT00448669|27125118|P1|Overall Study|Death|2
7807423|NCT00448669|27125117|P2|Overall Study|Were withdrawn by investigator|6
7807424|NCT00448669|27125118|P1|Overall Study|Were withdrawn by investigator|10
7807425|NCT00448669|27125117|P2|Overall Study|Relocated|36
7807426|NCT00448669|27125118|P1|Overall Study|Relocated|49
7807427|NCT00448669|27125117|P2|Overall Study|Withdrawal by Subject|74
7807428|NCT00448669|27125118|P1|Overall Study|Withdrawal by Subject|90
7807429|NCT00448669|27125117|P2|Overall Study|Lost to Follow-up|63
7807430|NCT00448669|27125118|P1|Overall Study|Lost to Follow-up|52
7807431|NCT00448591|27125179|P1|Overall Study|Termination of Study|70
7807432|NCT00448591|27125179|P1|Overall Study|Other|154
7807433|NCT00448591|27125179|P1|Overall Study|Treatment Regimen Completed|70
7807434|NCT00448591|27125179|P1|Overall Study|Lost to Follow-up|19
7807435|NCT00448591|27125179|P1|Overall Study|Protocol Violation|41
7807436|NCT00448591|27125179|P1|Overall Study|Adverse Event|382
7807437|NCT00448591|27125179|P1|Overall Study|Progressive Disease|1382
7807438|NCT00448591|27125179|P1|Overall Study|Withdrawal by Subject|178
7807439|NCT00448539|27125190|P2|Overall Study|Lost to Follow-up|3
7807440|NCT00448539|27125191|P1|Overall Study|Lost to Follow-up|1
7807441|NCT00448539|27125190|P2|Overall Study|Change of meds|3
7807442|NCT00448539|27125191|P1|Overall Study|Change of meds|2
7807443|NCT00448539|27125190|P2|Overall Study|Miscellaneous|1
7807444|NCT00448539|27125191|P1|Overall Study|Miscellaneous|2
7807445|NCT00448539|27125190|P2|Overall Study|Lack of Efficacy|40
7807446|NCT00448539|27125191|P1|Overall Study|Lack of Efficacy|27
7807447|NCT00448539|27125190|P2|Overall Study|Adverse Event|26
7807448|NCT00448539|27125191|P1|Overall Study|Adverse Event|9
7807449|NCT00448539|27125190|P2|Overall Study|Diary non-compliance|0
7807450|NCT00448539|27125191|P1|Overall Study|Diary non-compliance|1
7807451|NCT00448539|27125190|P2|Overall Study|Withdrawal by Subject|24
7807452|NCT00448539|27125191|P1|Overall Study|Withdrawal by Subject|20
7807453|NCT00448539|27125190|P2|Overall Study|Request of the investigator or sponsor|54
7807454|NCT00448539|27125191|P1|Overall Study|Request of the investigator or sponsor|67
7807455|NCT00448539|27125190|P2|Overall Study|Protocol Violation|0
7807456|NCT00448539|27125191|P1|Overall Study|Protocol Violation|1
7807457|NCT00448539|27125190|P2|Overall Study|Medication non-compliance|1
7807458|NCT00448539|27125191|P1|Overall Study|Medication non-compliance|4
7807459|NCT00448448|27125199|P2|Overall Study|Signed consent lost|1
7807460|NCT00448448|27125200|P1|Overall Study|Signed consent lost|0
7807461|NCT00448448|27125199|P2|Overall Study|Wrong diagnosis (n=3) or other|1
7807462|NCT00448448|27125200|P1|Overall Study|Wrong diagnosis (n=3) or other|2
7807463|NCT00448448|27125199|P2|Overall Study|Lost to Follow-up|1
7807464|NCT00448448|27125200|P1|Overall Study|Lost to Follow-up|2
7807465|NCT00448448|27125199|P2|Overall Study|On protocol when study ended|36
7807466|NCT00448448|27125200|P1|Overall Study|On protocol when study ended|83
7807467|NCT00448448|27125199|P2|Overall Study|Withdrawal by Subject|2
7807468|NCT00448448|27125200|P1|Overall Study|Withdrawal by Subject|13
7807469|NCT00448435|27125206|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
7807470|NCT00448435|27125207|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
7807471|NCT00448344|27125258|P2|Overall Study|Physician Decision|2
7807472|NCT00448344|27125259|P1|Overall Study|Physician Decision|1
7807473|NCT00448344|27125258|P2|Overall Study|Death|4
7807474|NCT00448344|27125259|P1|Overall Study|Death|3
7807475|NCT00448344|27125258|P2|Overall Study|Withdrawal by Subject|8
7807476|NCT00448344|27125259|P1|Overall Study|Withdrawal by Subject|6
7807477|NCT00448344|27125258|P2|Overall Study|Lost to Follow-up|22
7807478|NCT00448344|27125259|P1|Overall Study|Lost to Follow-up|20
7807479|NCT00448279|27125269|P2|Overall Study|Protocol Violation|1
7807480|NCT00448279|27125270|P1|Overall Study|Protocol Violation|0
7807481|NCT00448279|27125269|P2|Overall Study|Other|4
7807482|NCT00448279|27125270|P1|Overall Study|Other|6
7807483|NCT00448279|27125269|P2|Overall Study|Withdrawal by Subject|3
7807484|NCT00448279|27125270|P1|Overall Study|Withdrawal by Subject|4
7807485|NCT00448279|27125269|P2|Overall Study|Disease progression|18
7807486|NCT00448279|27125270|P1|Overall Study|Disease progression|16
7807487|NCT00448279|27125269|P2|Overall Study|Adverse Event|1
7807488|NCT00448279|27125270|P1|Overall Study|Adverse Event|1
7807489|NCT00448279|27125269|P2|Overall Study|Lost to Follow-up|2
7807490|NCT00448279|27125270|P1|Overall Study|Lost to Follow-up|2
7807491|NCT00448136|27125333|P2|Overall Study|Investigator's decision (progression)|0
7807492|NCT00448136|27125334|P1|Overall Study|Investigator's decision (progression)|1
7807493|NCT00448136|27125333|P2|Overall Study|Death|8
7807494|NCT00448136|27125334|P1|Overall Study|Death|3
7807495|NCT00448123|27125372|P2|Overall Study|Physician Decision|6
7807496|NCT00448123|27125373|P1|Overall Study|Physician Decision|6
7807497|NCT00448123|27125372|P2|Overall Study|Lost to Follow-up|6
7807498|NCT00448123|27125373|P1|Overall Study|Lost to Follow-up|9
7807499|NCT00448019|27125383|P1|Overall Study|Insurance Issues|1
7807500|NCT00448019|27125383|P1|Overall Study|Death|2
7807501|NCT00448019|27125383|P1|Overall Study|Disease progression|1
7807502|NCT00448019|27125383|P1|Overall Study|Withdrawal by Subject|3
7807503|NCT00447902|27125391|P2|Overall Study|Lack of Efficacy|1
7807504|NCT00447902|27125392|P1|Overall Study|Lack of Efficacy|2
7807505|NCT00447902|27125391|P2|Overall Study|included patients who discontinued|1
7807506|NCT00447902|27125392|P1|Overall Study|included patients who discontinued|1
7807507|NCT00447902|27125391|P2|Overall Study|Withdrawal by Subject|1
7807508|NCT00447902|27125392|P1|Overall Study|Withdrawal by Subject|0
7807509|NCT00447902|27125391|P2|Overall Study|Protocol Violation|0
7807510|NCT00447902|27125392|P1|Overall Study|Protocol Violation|1
7807511|NCT00447902|27125391|P2|Overall Study|Adverse Event|3
7807512|NCT00447902|27125392|P1|Overall Study|Adverse Event|0
7807513|NCT00447876|27125434|P2|Overall Study|Deterioration of symptomology|0
7807514|NCT00447876|27125435|P1|Overall Study|Deterioration of symptomology|1
7807515|NCT00447876|27125434|P2|Overall Study|Lost to Follow-up|0
7807516|NCT00447876|27125435|P1|Overall Study|Lost to Follow-up|1
7807517|NCT00447876|27125434|P2|Overall Study|Withdrawal by Subject|4
7807518|NCT00447876|27125435|P1|Overall Study|Withdrawal by Subject|1
7807519|NCT00447772|27125465|P1|Overall Study|Premature re-injection required|1
7807520|NCT00447772|27125465|P1|Overall Study|Chemotherapy for lung cancer|1
7807521|NCT00447772|27125465|P1|Overall Study|Incomplete documentation at visit 1|1
7807522|NCT00447772|27125465|P1|Overall Study|Patient relocated|1
7807523|NCT00447772|27125465|P1|Overall Study|Adverse Event|1
7807524|NCT00447772|27125465|P1|Overall Study|Unable to attend all study visits|2
7807525|NCT00447772|27125465|P1|Overall Study|Withdrawal by Subject|1
7807526|NCT00447772|27125465|P1|Overall Study|Lost to Follow-up|9
7807527|NCT00447772|27125465|P1|Overall Study|Discontinuation of drug therapy|1
7807528|NCT00447772|27125465|P1|Overall Study|Insufficient compliance|6
7807529|NCT00447772|27125465|P1|Overall Study|Lack of Efficacy|3
7807530|NCT00447694|27125485|P1|Overall Study|Withdrawal by Subject|2
7807531|NCT00447694|27125485|P1|Overall Study|Abnormal test procedure result|1
7807532|NCT00447694|27125485|P1|Overall Study|Abnormal laboratory value|1
7807533|NCT00447694|27125485|P1|Overall Study|Adverse Event|2
7807534|NCT00447603|27125492|P3|Filter Period|Study terminated by Sponsor|10
7807535|NCT00447603|27125493|P2|Filter Period|Study terminated by Sponsor|1
7807536|NCT00447603|27125494|P1|Filter Period|Study terminated by Sponsor|0
7807537|NCT00447603|27125492|P3|Filter Period|Screen Failure|4
7807538|NCT00447603|27125493|P2|Filter Period|Screen Failure|3
7807539|NCT00447603|27125494|P1|Filter Period|Screen Failure|0
7807540|NCT00447603|27125492|P3|Filter Period|Adverse Event|1
7807541|NCT00447603|27125493|P2|Filter Period|Adverse Event|0
7807542|NCT00447603|27125494|P1|Filter Period|Adverse Event|0
7807543|NCT00447603|27125492|P3|Screening|Study Terminated by Sponsor|0
7807544|NCT00447603|27125493|P2|Screening|Study Terminated by Sponsor|0
7807545|NCT00447603|27125494|P1|Screening|Study Terminated by Sponsor|15
7807546|NCT00447603|27125492|P3|Screening|Screen Failure|0
7807547|NCT00447603|27125493|P2|Screening|Screen Failure|0
7807548|NCT00447603|27125494|P1|Screening|Screen Failure|4
7807549|NCT00447603|27125492|P3|Screening|Protocol Violation|0
7807550|NCT00447603|27125493|P2|Screening|Protocol Violation|0
7807551|NCT00447603|27125494|P1|Screening|Protocol Violation|1
7807552|NCT00447603|27125492|P3|Screening|Withdrawal by Subject|0
7807553|NCT00447603|27125493|P2|Screening|Withdrawal by Subject|0
7807554|NCT00447603|27125494|P1|Screening|Withdrawal by Subject|1
7807555|NCT00447590|27125514|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
7807556|NCT00447590|27125514|P1|Overall Study|Lost to Follow-up|24
7807557|NCT00447590|27125514|P1|Overall Study|Withdrawal by Subject|26
7807558|NCT00447499|27125523|P1|Overall Study|Physician Decision|1
7807559|NCT00447499|27125523|P1|Overall Study|Sponsor Decision|1
7807560|NCT00447499|27125523|P1|Overall Study|Patient Decision|4
7807561|NCT00447499|27125523|P1|Overall Study|Adverse Event|1
7807562|NCT00447421|27125533|P1|Overall Study|Sponsor Decision|2
7807563|NCT00447421|27125533|P1|Overall Study|Adverse Event|3
7807564|NCT00447421|27125533|P1|Overall Study|Lack of Efficacy|1
7807565|NCT00447382|27125545|P2|Overall Study|Unclassified|5
7807566|NCT00447382|27125546|P1|Overall Study|Unclassified|2
7807567|NCT00447382|27125545|P2|Overall Study|Protocol Violation|0
7807568|NCT00447382|27125546|P1|Overall Study|Protocol Violation|2
7807569|NCT00447382|27125545|P2|Overall Study|Lack of Efficacy|0
7807570|NCT00447382|27125546|P1|Overall Study|Lack of Efficacy|1
7807571|NCT00447382|27125545|P2|Overall Study|Adverse Event|1
7807572|NCT00447382|27125546|P1|Overall Study|Adverse Event|1
7807573|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
7807574|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
7807575|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
7807576|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
7807577|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
7807578|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
7807579|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
7807580|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
7807581|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
7807582|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
7807583|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
7807584|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
7807585|NCT00447278|27125607|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
7807586|NCT00447278|27125608|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
7807587|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
7807588|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
7807589|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
7807590|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
7807591|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Physician Decision|1
7807592|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Physician Decision|4
7807593|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
7807594|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
7807595|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Protocol Violation|7
7807596|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Protocol Violation|10
7807597|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
7807598|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
7807599|NCT00447278|27125607|P2|Period II (6 Month Open-Label)|Adverse Event|3
7807600|NCT00447278|27125608|P1|Period II (6 Month Open-Label)|Adverse Event|7
7807601|NCT00447265|27125629|P2|Overall Study|Physician Decision|0
7807602|NCT00447265|27125630|P1|Overall Study|Physician Decision|1
7807603|NCT00447226|27125643|P2|Double-blind Phase|Disease Progression|3
7807604|NCT00447226|27125644|P1|Double-blind Phase|Disease Progression|4
7807605|NCT00447226|27125643|P2|12-Week Open-label Phase|Physician Decision|1
7807606|NCT00447226|27125644|P1|12-Week Open-label Phase|Physician Decision|0
7807607|NCT00447226|27125643|P2|12-Week Open-label Phase|Disease Progression|20
7807608|NCT00447226|27125644|P1|12-Week Open-label Phase|Disease Progression|0
7807609|NCT00447226|27125643|P2|12-Week Open-label Phase|Protocol Violation|1
7807610|NCT00447226|27125644|P1|12-Week Open-label Phase|Protocol Violation|0
7807611|NCT00447226|27125643|P2|12-Week Open-label Phase|Adverse Event|3
7807612|NCT00447226|27125644|P1|12-Week Open-label Phase|Adverse Event|0
7807613|NCT00447057|27125687|P4|Overall Study|Death, study drug related|0
7807614|NCT00447057|27125688|P3|Overall Study|Death, study drug related|0
7807615|NCT00447057|27125689|P2|Overall Study|Death, study drug related|1
7807616|NCT00447057|27125690|P1|Overall Study|Death, study drug related|0
7807617|NCT00447057|27125687|P4|Overall Study|Death due to adverse event|2
7807618|NCT00447057|27125688|P3|Overall Study|Death due to adverse event|1
7807619|NCT00447057|27125689|P2|Overall Study|Death due to adverse event|0
7807620|NCT00447057|27125690|P1|Overall Study|Death due to adverse event|0
7807621|NCT00447057|27125687|P4|Overall Study|Progressive disease|18
7807622|NCT00447057|27125688|P3|Overall Study|Progressive disease|13
7807623|NCT00447057|27125689|P2|Overall Study|Progressive disease|43
7807624|NCT00447057|27125690|P1|Overall Study|Progressive disease|58
7807625|NCT00447057|27125687|P4|Overall Study|Sponsor decision|0
7807626|NCT00447057|27125688|P3|Overall Study|Sponsor decision|0
7807627|NCT00447057|27125689|P2|Overall Study|Sponsor decision|1
7807628|NCT00447057|27125690|P1|Overall Study|Sponsor decision|1
7807629|NCT00447057|27125687|P4|Overall Study|Physician Decision|1
7807630|NCT00447057|27125688|P3|Overall Study|Physician Decision|3
7807631|NCT00447057|27125689|P2|Overall Study|Physician Decision|6
7807632|NCT00447057|27125690|P1|Overall Study|Physician Decision|9
7807633|NCT00447057|27125687|P4|Overall Study|Withdrawal by Subject|1
7807634|NCT00447057|27125688|P3|Overall Study|Withdrawal by Subject|1
7807635|NCT00447057|27125689|P2|Overall Study|Withdrawal by Subject|5
7807636|NCT00447057|27125690|P1|Overall Study|Withdrawal by Subject|4
7807637|NCT00447057|27125687|P4|Overall Study|Protocol Violation|0
7807638|NCT00447057|27125688|P3|Overall Study|Protocol Violation|0
7807639|NCT00447057|27125689|P2|Overall Study|Protocol Violation|1
7807640|NCT00447057|27125690|P1|Overall Study|Protocol Violation|0
7807641|NCT00447057|27125687|P4|Overall Study|Entry criteria not met|0
7807642|NCT00447057|27125688|P3|Overall Study|Entry criteria not met|0
7807643|NCT00447057|27125689|P2|Overall Study|Entry criteria not met|1
7807644|NCT00447057|27125690|P1|Overall Study|Entry criteria not met|1
7807645|NCT00447057|27125687|P4|Overall Study|Lost to Follow-up|0
7807646|NCT00447057|27125688|P3|Overall Study|Lost to Follow-up|0
7807647|NCT00447057|27125689|P2|Overall Study|Lost to Follow-up|1
7807648|NCT00447057|27125690|P1|Overall Study|Lost to Follow-up|0
7807649|NCT00447057|27125687|P4|Overall Study|Death due to study disease|1
7807650|NCT00447057|27125688|P3|Overall Study|Death due to study disease|1
7807651|NCT00447057|27125689|P2|Overall Study|Death due to study disease|4
7807652|NCT00447057|27125690|P1|Overall Study|Death due to study disease|6
7807653|NCT00447057|27125687|P4|Overall Study|Adverse Event|3
7807654|NCT00447057|27125688|P3|Overall Study|Adverse Event|0
7807655|NCT00447057|27125689|P2|Overall Study|Adverse Event|10
7807656|NCT00447057|27125690|P1|Overall Study|Adverse Event|4
7807657|NCT00447005|27125708|P1|Overall Study|Lack of Efficacy|11
7807658|NCT00447005|27125708|P1|Overall Study|Adverse Event|1
7807659|NCT00446992|27125722|P1|Overall Study|Lost to Follow-up|5
7807660|NCT00446992|27125722|P1|Overall Study|Adverse Event|11
7807661|NCT00446966|27125736|P2|Overall Study|Lost to Follow-up|7
7807662|NCT00446966|27125737|P1|Overall Study|Lost to Follow-up|10
7807663|NCT00446849|27125743|P1|Maintenance Phase|concomitant medication use|1
7807664|NCT00446849|27125743|P1|Maintenance Phase|hydrocodone use|1
7807665|NCT00446849|27125743|P1|Maintenance Phase|study closure|1
7807666|NCT00446849|27125743|P1|Maintenance Phase|antibiotic use|1
7807667|NCT00446849|27125743|P1|Maintenance Phase|prohibited medication use|2
7807668|NCT00446849|27125743|P1|Maintenance Phase|noncompliance|2
7807669|NCT00446849|27125743|P1|Maintenance Phase|Pregnancy|1
7807670|NCT00446849|27125743|P1|Maintenance Phase|Lost to Follow-up|3
7807671|NCT00446849|27125743|P1|Maintenance Phase|Consent withdrawn|5
7807672|NCT00446849|27125743|P1|Maintenance Phase|Adverse Event|6
7807673|NCT00446849|27125743|P1|Maintenance Phase|Protocol Violation|7
7807674|NCT00446849|27125743|P1|Maintenance Phase|Lack of Efficacy|40
7807675|NCT00446849|27125743|P1|Acute Phase|noncompliance|1
7807676|NCT00446849|27125743|P1|Acute Phase|Physician Decision|1
7807677|NCT00446849|27125743|P1|Acute Phase|Lost to Follow-up|2
7807678|NCT00446849|27125743|P1|Acute Phase|Consent withdrawn|4
7807679|NCT00446849|27125743|P1|Acute Phase|Protocol Violation|10
7807680|NCT00446849|27125743|P1|Acute Phase|Lack of Efficacy|64
7807681|NCT00446797|27125755|P2|Overall Study|did not meet entrance criteria|1
7807682|NCT00446797|27125756|P1|Overall Study|did not meet entrance criteria|0
7807683|NCT00446797|27125755|P2|Overall Study|subject entered at another site|1
7807684|NCT00446797|27125756|P1|Overall Study|subject entered at another site|0
7807685|NCT00446797|27125755|P2|Overall Study|Protocol Violation|3
7807686|NCT00446797|27125756|P1|Overall Study|Protocol Violation|1
7807687|NCT00446797|27125755|P2|Overall Study|Withdrawal by Subject|2
7807688|NCT00446797|27125756|P1|Overall Study|Withdrawal by Subject|2
7807689|NCT00446797|27125755|P2|Overall Study|Lost to Follow-up|3
7807690|NCT00446797|27125756|P1|Overall Study|Lost to Follow-up|5
7807691|NCT00446797|27125755|P2|Overall Study|Lack of Efficacy|2
7807692|NCT00446797|27125756|P1|Overall Study|Lack of Efficacy|0
7807693|NCT00446654|27125802|P2|Overall Study|Adverse Event|0
7807694|NCT00446654|27125803|P1|Overall Study|Adverse Event|1
7807695|NCT00446654|27125802|P2|Overall Study|Withdrawal by Subject|0
7807696|NCT00446654|27125803|P1|Overall Study|Withdrawal by Subject|1
7807697|NCT00446641|27125811|P2|Overall Study|Lost to Follow-up|1
7807698|NCT00446641|27125812|P1|Overall Study|Lost to Follow-up|1
7807699|NCT00446641|27125811|P2|Overall Study|poor compliance|6
7807700|NCT00446641|27125812|P1|Overall Study|poor compliance|8
7807701|NCT00446641|27125811|P2|Overall Study|Withdrawal by Subject|3
7807702|NCT00446641|27125812|P1|Overall Study|Withdrawal by Subject|8
7807703|NCT00446563|27125832|P2|Overall Study|Administrative problems|1
7807704|NCT00446563|27125833|P1|Overall Study|Administrative problems|0
7807705|NCT00446563|27125832|P2|Overall Study|Withdrawal by Subject|1
7807706|NCT00446563|27125833|P1|Overall Study|Withdrawal by Subject|2
7807707|NCT00446563|27125832|P2|Overall Study|Unsatisfactory therapeutic effect|3
7807708|NCT00446563|27125833|P1|Overall Study|Unsatisfactory therapeutic effect|0
7807709|NCT00446563|27125832|P2|Overall Study|Abnormal test procedure result(s)|0
7807710|NCT00446563|27125833|P1|Overall Study|Abnormal test procedure result(s)|1
7807711|NCT00446563|27125832|P2|Overall Study|Abnormal laboratory value(s)|1
7807712|NCT00446563|27125833|P1|Overall Study|Abnormal laboratory value(s)|0
7807713|NCT00446563|27125832|P2|Overall Study|Adverse Event|3
7807714|NCT00446563|27125833|P1|Overall Study|Adverse Event|4
7807715|NCT00446550|27125869|P2|Overall Study|Adverse Event|0
7807716|NCT00446550|27125870|P1|Overall Study|Adverse Event|1
7807717|NCT00446511|27125882|P4|Overall Study|Administrative Problems|1
7807718|NCT00446511|27125883|P3|Overall Study|Administrative Problems|4
7807719|NCT00446511|27125884|P2|Overall Study|Administrative Problems|0
7807720|NCT00446511|27125885|P1|Overall Study|Administrative Problems|3
7807721|NCT00446511|27125882|P4|Overall Study|Withdrawal by Subject|3
7807722|NCT00446511|27125883|P3|Overall Study|Withdrawal by Subject|0
7807723|NCT00446511|27125884|P2|Overall Study|Withdrawal by Subject|0
7807724|NCT00446511|27125885|P1|Overall Study|Withdrawal by Subject|0
7807725|NCT00446511|27125882|P4|Overall Study|Protocol Violation|1
7807726|NCT00446511|27125883|P3|Overall Study|Protocol Violation|0
7807727|NCT00446511|27125884|P2|Overall Study|Protocol Violation|0
7807728|NCT00446511|27125885|P1|Overall Study|Protocol Violation|0
7807729|NCT00446511|27125882|P4|Overall Study|Adverse Event|1
7807730|NCT00446511|27125883|P3|Overall Study|Adverse Event|3
7807731|NCT00446511|27125884|P2|Overall Study|Adverse Event|2
7807732|NCT00446511|27125885|P1|Overall Study|Adverse Event|7
7807733|NCT00446459|27125909|P1|12 Months|14 subjects to MMF + Rituximab Study|14
7807734|NCT00446459|27125909|P1|12 Months|Protocol Violation|4
7807735|NCT00446459|27125909|P1|8 Months|Protocol Violation|12
7807736|NCT00446446|27125917|P1|Overall Study|On Treatment at Time of Data Cut-off|1
7807737|NCT00446446|27125917|P1|Overall Study|Adverse Event|1
7807738|NCT00446446|27125917|P1|Overall Study|Disease Progession|2
7807739|NCT00446446|27125917|P1|Overall Study|Other|4
7807740|NCT00446446|27125917|P1|Overall Study|Withdrawal by Subject|6
7807741|NCT00446446|27125917|P1|Overall Study|Death|10
7807742|NCT00446251|27125941|P1|Overall Study|Lost to Follow-up|1
7807743|NCT00446251|27125941|P1|Overall Study|Rituximab Infusion Reaction|2
7807744|NCT00446251|27125941|P1|Overall Study|On-study Transplants|2
7807745|NCT00446199|27125951|P4|Overall Study|Move|0
7807746|NCT00446199|27125952|P3|Overall Study|Move|0
7807747|NCT00446199|27125953|P2|Overall Study|Move|1
7807748|NCT00446199|27125954|P1|Overall Study|Move|0
7807749|NCT00446199|27125951|P4|Overall Study|In-/Exclusion criterion violated|1
7807750|NCT00446199|27125952|P3|Overall Study|In-/Exclusion criterion violated|2
7807751|NCT00446199|27125953|P2|Overall Study|In-/Exclusion criterion violated|1
7807752|NCT00446199|27125954|P1|Overall Study|In-/Exclusion criterion violated|2
7807753|NCT00446199|27125951|P4|Overall Study|Lost interest in study participation|0
7807754|NCT00446199|27125952|P3|Overall Study|Lost interest in study participation|0
7807755|NCT00446199|27125953|P2|Overall Study|Lost interest in study participation|1
7807756|NCT00446199|27125954|P1|Overall Study|Lost interest in study participation|0
7807757|NCT00446199|27125951|P4|Overall Study|Hormone fear|1
7807758|NCT00446199|27125952|P3|Overall Study|Hormone fear|0
7807759|NCT00446199|27125953|P2|Overall Study|Hormone fear|0
7807760|NCT00446199|27125954|P1|Overall Study|Hormone fear|0
7807761|NCT00446199|27125951|P4|Overall Study|Non-compliant with visit schedule|2
7807762|NCT00446199|27125952|P3|Overall Study|Non-compliant with visit schedule|1
7807763|NCT00446199|27125953|P2|Overall Study|Non-compliant with visit schedule|1
7807764|NCT00446199|27125954|P1|Overall Study|Non-compliant with visit schedule|1
7807765|NCT00446199|27125951|P4|Overall Study|Non-compliant with study drug|0
7807766|NCT00446199|27125952|P3|Overall Study|Non-compliant with study drug|5
7807767|NCT00446199|27125953|P2|Overall Study|Non-compliant with study drug|0
7807768|NCT00446199|27125954|P1|Overall Study|Non-compliant with study drug|1
7807769|NCT00446199|27125951|P4|Overall Study|Lack of Efficacy|1
7807770|NCT00446199|27125952|P3|Overall Study|Lack of Efficacy|0
7807771|NCT00446199|27125953|P2|Overall Study|Lack of Efficacy|0
7807772|NCT00446199|27125954|P1|Overall Study|Lack of Efficacy|1
7807773|NCT00446199|27125951|P4|Overall Study|Randomization in Error|1
7807774|NCT00446199|27125952|P3|Overall Study|Randomization in Error|1
7807775|NCT00446199|27125953|P2|Overall Study|Randomization in Error|0
7807776|NCT00446199|27125954|P1|Overall Study|Randomization in Error|2
7807777|NCT00446199|27125951|P4|Overall Study|Site termination|1
7807778|NCT00446199|27125952|P3|Overall Study|Site termination|0
7807779|NCT00446199|27125953|P2|Overall Study|Site termination|0
7807780|NCT00446199|27125954|P1|Overall Study|Site termination|2
7807781|NCT00446199|27125951|P4|Overall Study|Withdrawal by Subject|10
7807782|NCT00446199|27125952|P3|Overall Study|Withdrawal by Subject|9
7807783|NCT00446199|27125953|P2|Overall Study|Withdrawal by Subject|5
7807784|NCT00446199|27125954|P1|Overall Study|Withdrawal by Subject|2
7807785|NCT00446199|27125951|P4|Overall Study|Protocol Violation|3
7807786|NCT00446199|27125952|P3|Overall Study|Protocol Violation|1
7807787|NCT00446199|27125953|P2|Overall Study|Protocol Violation|2
7807788|NCT00446199|27125954|P1|Overall Study|Protocol Violation|1
7807789|NCT00446199|27125951|P4|Overall Study|Lost to Follow-up|6
7807790|NCT00446199|27125952|P3|Overall Study|Lost to Follow-up|2
7807791|NCT00446199|27125953|P2|Overall Study|Lost to Follow-up|5
7807792|NCT00446199|27125954|P1|Overall Study|Lost to Follow-up|4
7807793|NCT00446199|27125951|P4|Overall Study|Adverse Event|4
7807794|NCT00446199|27125952|P3|Overall Study|Adverse Event|6
7807795|NCT00446199|27125953|P2|Overall Study|Adverse Event|4
7807796|NCT00446199|27125954|P1|Overall Study|Adverse Event|7
7807797|NCT00446134|27126047|P4|Overall Study|Reason Not Completed|2
7807798|NCT00446134|27126048|P3|Overall Study|Reason Not Completed|1
7807799|NCT00446134|27126049|P2|Overall Study|Reason Not Completed|0
7807800|NCT00446134|27126050|P1|Overall Study|Reason Not Completed|3
7807801|NCT00446134|27126047|P4|Overall Study|Adverse Event-Diarrhea|0
7807802|NCT00446134|27126048|P3|Overall Study|Adverse Event-Diarrhea|2
7807803|NCT00446134|27126049|P2|Overall Study|Adverse Event-Diarrhea|1
7807804|NCT00446134|27126050|P1|Overall Study|Adverse Event-Diarrhea|1
7807805|NCT00446134|27126047|P4|Overall Study|Physician Decision|2
7807806|NCT00446134|27126048|P3|Overall Study|Physician Decision|0
7807807|NCT00446134|27126049|P2|Overall Study|Physician Decision|0
7807808|NCT00446134|27126050|P1|Overall Study|Physician Decision|0
7807809|NCT00446134|27126047|P4|Overall Study|Withdrawal by Subject|3
7807810|NCT00446134|27126048|P3|Overall Study|Withdrawal by Subject|1
7807811|NCT00446134|27126049|P2|Overall Study|Withdrawal by Subject|3
7807812|NCT00446134|27126050|P1|Overall Study|Withdrawal by Subject|3
7807813|NCT00446134|27126047|P4|Overall Study|Lost to Follow-up|1
7807814|NCT00446134|27126048|P3|Overall Study|Lost to Follow-up|1
7807815|NCT00446134|27126049|P2|Overall Study|Lost to Follow-up|3
7807816|NCT00446134|27126050|P1|Overall Study|Lost to Follow-up|1
7807817|NCT00446134|27126047|P4|Overall Study|Protocol Violation|0
7807818|NCT00446134|27126048|P3|Overall Study|Protocol Violation|1
7807819|NCT00446134|27126049|P2|Overall Study|Protocol Violation|2
7807820|NCT00446134|27126050|P1|Overall Study|Protocol Violation|0
7807821|NCT00446134|27126047|P4|Overall Study|Lack of Efficacy|19
7807822|NCT00446134|27126048|P3|Overall Study|Lack of Efficacy|24
7807823|NCT00446134|27126049|P2|Overall Study|Lack of Efficacy|19
7807824|NCT00446134|27126050|P1|Overall Study|Lack of Efficacy|19
7807825|NCT00446134|27126047|P4|Overall Study|Adverse Event|18
7807826|NCT00446134|27126048|P3|Overall Study|Adverse Event|13
7807827|NCT00446134|27126049|P2|Overall Study|Adverse Event|17
7807828|NCT00446134|27126050|P1|Overall Study|Adverse Event|7
7807829|NCT00446095|27126077|P5|Phase I (28 Days)|Lack of Efficacy|3
7807830|NCT00446095|27126078|P4|Phase I (28 Days)|Lack of Efficacy|0
7807831|NCT00446095|27126079|P3|Phase I (28 Days)|Lack of Efficacy|0
7807832|NCT00446095|27126080|P2|Phase I (28 Days)|Lack of Efficacy|0
7807833|NCT00446095|27126081|P1|Phase I (28 Days)|Lack of Efficacy|0
7807834|NCT00446095|27126077|P5|Phase I (28 Days)|Adverse Event|0
7807835|NCT00446095|27126078|P4|Phase I (28 Days)|Adverse Event|1
7807836|NCT00446095|27126079|P3|Phase I (28 Days)|Adverse Event|0
7807837|NCT00446095|27126080|P2|Phase I (28 Days)|Adverse Event|0
7807838|NCT00446095|27126081|P1|Phase I (28 Days)|Adverse Event|0
7807839|NCT00446095|27126077|P5|Phase II (8 Weeks)|Ongoing|0
7807840|NCT00446095|27126078|P4|Phase II (8 Weeks)|Ongoing|0
7807841|NCT00446095|27126079|P3|Phase II (8 Weeks)|Ongoing|1
7807842|NCT00446095|27126080|P2|Phase II (8 Weeks)|Ongoing|0
7807843|NCT00446095|27126081|P1|Phase II (8 Weeks)|Ongoing|0
7807844|NCT00446095|27126077|P5|Phase II (8 Weeks)|Lack of Efficacy|0
7807845|NCT00446095|27126078|P4|Phase II (8 Weeks)|Lack of Efficacy|0
7807846|NCT00446095|27126079|P3|Phase II (8 Weeks)|Lack of Efficacy|1
7807847|NCT00446095|27126080|P2|Phase II (8 Weeks)|Lack of Efficacy|2
7807848|NCT00446095|27126081|P1|Phase II (8 Weeks)|Lack of Efficacy|9
7807849|NCT00446095|27126077|P5|Phase II (8 Weeks)|Physician Decision|0
7807850|NCT00446095|27126078|P4|Phase II (8 Weeks)|Physician Decision|0
7807851|NCT00446095|27126079|P3|Phase II (8 Weeks)|Physician Decision|0
7807852|NCT00446095|27126080|P2|Phase II (8 Weeks)|Physician Decision|0
7807853|NCT00446095|27126081|P1|Phase II (8 Weeks)|Physician Decision|1
7807854|NCT00446095|27126077|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
7807855|NCT00446095|27126078|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
7807856|NCT00446095|27126079|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
7807857|NCT00446095|27126080|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
7807858|NCT00446095|27126081|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
7807859|NCT00446095|27126077|P5|Phase II (8 Weeks)|Adverse Event|0
7807860|NCT00446095|27126078|P4|Phase II (8 Weeks)|Adverse Event|0
7807861|NCT00446095|27126079|P3|Phase II (8 Weeks)|Adverse Event|1
7807862|NCT00446095|27126080|P2|Phase II (8 Weeks)|Adverse Event|1
7807863|NCT00446095|27126081|P1|Phase II (8 Weeks)|Adverse Event|0
7807864|NCT00446095|27126077|P5|Phase II (8 Weeks)|Lost to Follow-up|0
7807865|NCT00446095|27126078|P4|Phase II (8 Weeks)|Lost to Follow-up|0
7807866|NCT00446095|27126079|P3|Phase II (8 Weeks)|Lost to Follow-up|0
7807867|NCT00446095|27126080|P2|Phase II (8 Weeks)|Lost to Follow-up|0
7807868|NCT00446095|27126081|P1|Phase II (8 Weeks)|Lost to Follow-up|1
7807869|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
7807870|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
7807871|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
7807872|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
7807873|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
7807874|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
7807875|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
7807876|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
7807877|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
7807878|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
7807879|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
7807880|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
7807881|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
7807882|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
7807883|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Death|2
7807884|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Death|2
7807885|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
7807886|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
7807887|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
7807888|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
7807889|NCT00446030|27126104|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
7807890|NCT00446030|27126105|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
7807891|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
7807892|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
7807893|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
7807894|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
7807895|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
7807896|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
7807897|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
7807898|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
7807899|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
7807987|NCT00445601|27126344|P1|Overall Study|TURBT Complication|12
7807900|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
7807901|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
7807902|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
7807903|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
7807904|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
7807905|NCT00446030|27126104|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
7807906|NCT00446030|27126105|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
7807907|NCT00445978|27126113|P1|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
7807908|NCT00445978|27126113|P1|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
7807909|NCT00445978|27126113|P1|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
7807910|NCT00445978|27126113|P1|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
7807911|NCT00445978|27126113|P1|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
7807912|NCT00445978|27126113|P1|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
7807913|NCT00445978|27126113|P1|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
7807914|NCT00445978|27126113|P1|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
7807915|NCT00445978|27126113|P1|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
7807916|NCT00445939|27126130|P4|Period B - Week 4 - Week 8|Adverse Event|1
7807917|NCT00445939|27126131|P3|Period B - Week 4 - Week 8|Adverse Event|0
7807918|NCT00445939|27126132|P2|Period B - Week 4 - Week 8|Adverse Event|0
7807919|NCT00445939|27126133|P1|Period B - Week 4 - Week 8|Adverse Event|2
7807920|NCT00445939|27126130|P4|Period A - Week 0 - Week 4|Adverse Event|0
7807921|NCT00445939|27126131|P3|Period A - Week 0 - Week 4|Adverse Event|0
7807922|NCT00445939|27126132|P2|Period A - Week 0 - Week 4|Adverse Event|2
7807923|NCT00445939|27126133|P1|Period A - Week 0 - Week 4|Adverse Event|1
7807924|NCT00445848|27126181|P1|Overall Study|Other-Not protocol specified|5
7807925|NCT00445848|27126181|P1|Overall Study|Progression|62
7807926|NCT00445848|27126181|P1|Overall Study|Withdrawal by Subject|4
7807927|NCT00445848|27126181|P1|Overall Study|Adverse Event|14
7807928|NCT00445770|27126191|P3|Overall Study|Other|6
7807929|NCT00445770|27126192|P2|Overall Study|Other|5
7807930|NCT00445770|27126193|P1|Overall Study|Other|6
7807931|NCT00445770|27126191|P3|Overall Study|Lost to Follow-up|0
7807932|NCT00445770|27126192|P2|Overall Study|Lost to Follow-up|2
7807933|NCT00445770|27126193|P1|Overall Study|Lost to Follow-up|0
7807934|NCT00445770|27126191|P3|Overall Study|Lack of Efficacy|6
7807935|NCT00445770|27126192|P2|Overall Study|Lack of Efficacy|13
7807936|NCT00445770|27126193|P1|Overall Study|Lack of Efficacy|38
7807937|NCT00445770|27126191|P3|Overall Study|Adverse Event|19
7807938|NCT00445770|27126192|P2|Overall Study|Adverse Event|15
7807939|NCT00445770|27126193|P1|Overall Study|Adverse Event|9
7807940|NCT00445692|27126294|P1|Overall Study|Lack of Efficacy|5
7807941|NCT00445692|27126294|P1|Overall Study|Adverse Event|11
7807942|NCT00445679|27126304|P4|Overall Study|Lack of Efficacy|0
7807943|NCT00445679|27126305|P3|Overall Study|Lack of Efficacy|2
7807944|NCT00445679|27126306|P2|Overall Study|Lack of Efficacy|6
7807945|NCT00445679|27126307|P1|Overall Study|Lack of Efficacy|2
7807946|NCT00445679|27126304|P4|Overall Study|Withdrawal by Subject|18
7807947|NCT00445679|27126305|P3|Overall Study|Withdrawal by Subject|20
7807948|NCT00445679|27126306|P2|Overall Study|Withdrawal by Subject|14
7807949|NCT00445679|27126307|P1|Overall Study|Withdrawal by Subject|8
7807950|NCT00445679|27126304|P4|Overall Study|Protocol Violation|1
7807951|NCT00445679|27126305|P3|Overall Study|Protocol Violation|3
7807952|NCT00445679|27126306|P2|Overall Study|Protocol Violation|3
7807953|NCT00445679|27126307|P1|Overall Study|Protocol Violation|2
7807954|NCT00445679|27126304|P4|Overall Study|Withdrawal of Informed Consent|0
7807955|NCT00445679|27126305|P3|Overall Study|Withdrawal of Informed Consent|1
7807956|NCT00445679|27126306|P2|Overall Study|Withdrawal of Informed Consent|0
7807957|NCT00445679|27126307|P1|Overall Study|Withdrawal of Informed Consent|0
7807958|NCT00445679|27126304|P4|Overall Study|Compliance|2
7807959|NCT00445679|27126305|P3|Overall Study|Compliance|1
7807960|NCT00445679|27126306|P2|Overall Study|Compliance|2
7807961|NCT00445679|27126307|P1|Overall Study|Compliance|3
7807962|NCT00445679|27126304|P4|Overall Study|Lost to Follow-up|5
7807963|NCT00445679|27126305|P3|Overall Study|Lost to Follow-up|6
7807964|NCT00445679|27126306|P2|Overall Study|Lost to Follow-up|6
7807965|NCT00445679|27126307|P1|Overall Study|Lost to Follow-up|10
7807966|NCT00445679|27126304|P4|Overall Study|Physician Decision|0
7807967|NCT00445679|27126305|P3|Overall Study|Physician Decision|1
7807968|NCT00445679|27126306|P2|Overall Study|Physician Decision|0
7807969|NCT00445679|27126307|P1|Overall Study|Physician Decision|0
7807970|NCT00445679|27126304|P4|Overall Study|Failed to return|2
7807971|NCT00445679|27126305|P3|Overall Study|Failed to return|2
7807972|NCT00445679|27126306|P2|Overall Study|Failed to return|3
7807973|NCT00445679|27126307|P1|Overall Study|Failed to return|1
7807974|NCT00445679|27126304|P4|Overall Study|Adverse Event|19
7807975|NCT00445679|27126305|P3|Overall Study|Adverse Event|30
7807976|NCT00445679|27126306|P2|Overall Study|Adverse Event|12
7807977|NCT00445679|27126307|P1|Overall Study|Adverse Event|22
7807978|NCT00445601|27126343|P2|Overall Study|Death prior to TURBT|1
7807979|NCT00445601|27126344|P1|Overall Study|Death prior to TURBT|0
7807980|NCT00445601|27126343|P2|Overall Study|Adverse Event|0
7807981|NCT00445601|27126344|P1|Overall Study|Adverse Event|2
7807982|NCT00445601|27126343|P2|Overall Study|Drug Delivery Issue|2
7807983|NCT00445601|27126344|P1|Overall Study|Drug Delivery Issue|2
7807984|NCT00445601|27126343|P2|Overall Study|Incorrect Disease Status|6
7807985|NCT00445601|27126344|P1|Overall Study|Incorrect Disease Status|6
7807986|NCT00445601|27126343|P2|Overall Study|TURBT Complication|8
7807988|NCT00445601|27126343|P2|Overall Study|Withdrawal by Subject|11
7807989|NCT00445601|27126344|P1|Overall Study|Withdrawal by Subject|11
7807990|NCT00445549|27126361|P1|Overall Study|progressive disease|12
7807991|NCT00445458|27126385|P4|Overall Study|Surgery|0
7807992|NCT00445458|27126386|P3|Overall Study|Surgery|1
7807993|NCT00445458|27126387|P2|Overall Study|Surgery|0
7807994|NCT00445458|27126388|P1|Overall Study|Surgery|0
7807995|NCT00445458|27126385|P4|Overall Study|Physician Decision|1
7807996|NCT00445458|27126386|P3|Overall Study|Physician Decision|1
7807997|NCT00445458|27126387|P2|Overall Study|Physician Decision|0
7807998|NCT00445458|27126388|P1|Overall Study|Physician Decision|0
7807999|NCT00445458|27126385|P4|Overall Study|Death|0
7808000|NCT00445458|27126386|P3|Overall Study|Death|2
7808001|NCT00445458|27126387|P2|Overall Study|Death|1
7808002|NCT00445458|27126388|P1|Overall Study|Death|0
7808003|NCT00445458|27126385|P4|Overall Study|Adverse Event|0
7808004|NCT00445458|27126386|P3|Overall Study|Adverse Event|3
7808005|NCT00445458|27126387|P2|Overall Study|Adverse Event|0
7808006|NCT00445458|27126388|P1|Overall Study|Adverse Event|0
7808007|NCT00445458|27126385|P4|Overall Study|Withdrawal by Subject|0
7808008|NCT00445458|27126386|P3|Overall Study|Withdrawal by Subject|7
7808009|NCT00445458|27126387|P2|Overall Study|Withdrawal by Subject|0
7808010|NCT00445458|27126388|P1|Overall Study|Withdrawal by Subject|0
7808011|NCT00445458|27126385|P4|Overall Study|Disease Progression|27
7808012|NCT00445458|27126386|P3|Overall Study|Disease Progression|54
7808013|NCT00445458|27126387|P2|Overall Study|Disease Progression|4
7808014|NCT00445458|27126388|P1|Overall Study|Disease Progression|3
7808015|NCT00445432|27126406|P4|148 Weeks of Adalimumab Treatment|Other|9
7808016|NCT00445432|27126407|P3|148 Weeks of Adalimumab Treatment|Other|0
7808017|NCT00445432|27126408|P2|148 Weeks of Adalimumab Treatment|Other|0
7808018|NCT00445432|27126409|P1|148 Weeks of Adalimumab Treatment|Other|0
7808019|NCT00445432|27126406|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
7808020|NCT00445432|27126407|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7808021|NCT00445432|27126408|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7808022|NCT00445432|27126409|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7808023|NCT00445432|27126406|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
7808024|NCT00445432|27126407|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
7808025|NCT00445432|27126408|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
7808026|NCT00445432|27126409|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
7808027|NCT00445432|27126406|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
7808028|NCT00445432|27126407|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
7808029|NCT00445432|27126408|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
7808030|NCT00445432|27126409|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
7808031|NCT00445432|27126406|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
7808032|NCT00445432|27126407|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
7808033|NCT00445432|27126408|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
7808034|NCT00445432|27126409|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
7808035|NCT00445432|27126406|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7808036|NCT00445432|27126407|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
7808037|NCT00445432|27126408|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7808038|NCT00445432|27126409|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7808039|NCT00445432|27126406|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
7808040|NCT00445432|27126407|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
7808041|NCT00445432|27126408|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
7808042|NCT00445432|27126409|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
7808043|NCT00445341|27126442|P1|Overall Study|taken off treatment too early|1
7808044|NCT00445341|27126442|P1|Overall Study|refused further treatment|1
7808045|NCT00445328|27126449|P2|Overall Study|Protocol Violation|0
7808046|NCT00445328|27126450|P1|Overall Study|Protocol Violation|1
7808047|NCT00445328|27126449|P2|Overall Study|Withdrawal by Subject|0
7808048|NCT00445328|27126450|P1|Overall Study|Withdrawal by Subject|2
7808049|NCT00445328|27126449|P2|Overall Study|Other|2
7808050|NCT00445328|27126450|P1|Overall Study|Other|0
7808051|NCT00445328|27126449|P2|Overall Study|Adverse Event|3
7808052|NCT00445328|27126450|P1|Overall Study|Adverse Event|0
7808053|NCT00445328|27126449|P2|Overall Study|Death|1
7808054|NCT00445328|27126450|P1|Overall Study|Death|0
7808055|NCT00445224|27126611|P2|Specific Exercises|Withdrawal by Subject|0
7808056|NCT00445224|27126612|P1|Specific Exercises|Withdrawal by Subject|1
7808057|NCT00445224|27126611|P2|Specific Exercises|Withdrawal by Subject|3
7808058|NCT00445224|27126612|P1|Specific Exercises|Withdrawal by Subject|3
7808059|NCT00445146|27126639|P1|Overall Study|Pregnancy|1
7808060|NCT00445146|27126639|P1|Overall Study|Protocol Violation|4
7808061|NCT00445146|27126639|P1|Overall Study|Death|9
7808062|NCT00445146|27126639|P1|Overall Study|Lost to Follow-up|13
7808063|NCT00445146|27126639|P1|Overall Study|Adverse Event|13
7808064|NCT00445146|27126639|P1|Overall Study|Investigator's Discretion|22
7808065|NCT00445146|27126639|P1|Overall Study|Lack of Efficacy|28
7808066|NCT00445146|27126639|P1|Overall Study|Withdrew Consent|29
7808067|NCT00445068|27126658|P1|Overall Study|Death|1
7808068|NCT00445068|27126658|P1|Overall Study|Withdrawal by Subject|2
7808069|NCT00445068|27126658|P1|Overall Study|Abnormal laboratory value|2
7808070|NCT00445068|27126658|P1|Overall Study|Adverse Event|5
7808071|NCT00445068|27126658|P1|Overall Study|Disease progression|26
7808072|NCT00445003|27126676|P3|Overall Study|Dropped|2
7808073|NCT00445003|27126677|P2|Overall Study|Dropped|3
7808074|NCT00445003|27126678|P1|Overall Study|Dropped|1
7808075|NCT00445003|27126676|P3|Overall Study|Missed Visit|1
7808076|NCT00445003|27126677|P2|Overall Study|Missed Visit|5
7808077|NCT00445003|27126678|P1|Overall Study|Missed Visit|3
7808078|NCT00445003|27126676|P3|Overall Study|Death|1
7808079|NCT00445003|27126677|P2|Overall Study|Death|2
7808080|NCT00445003|27126678|P1|Overall Study|Death|1
7808081|NCT00444951|27126716|P3|Overall Study|Withdrawal by Subject|3
7808082|NCT00444951|27126717|P2|Overall Study|Withdrawal by Subject|5
7808083|NCT00444951|27126718|P1|Overall Study|Withdrawal by Subject|4
7808084|NCT00444951|27126716|P3|Overall Study|Lost to Follow-up|0
7808085|NCT00444951|27126717|P2|Overall Study|Lost to Follow-up|1
7808086|NCT00444951|27126718|P1|Overall Study|Lost to Follow-up|1
7808087|NCT00444925|27126735|P3|Double-blind Treatment Period|Other|12
7808088|NCT00444925|27126736|P2|Double-blind Treatment Period|Other|7
7808089|NCT00444925|27126737|P1|Double-blind Treatment Period|Other|7
7808090|NCT00444925|27126735|P3|Double-blind Treatment Period|Withdrawal by Subject|7
7808091|NCT00444925|27126736|P2|Double-blind Treatment Period|Withdrawal by Subject|8
7808092|NCT00444925|27126737|P1|Double-blind Treatment Period|Withdrawal by Subject|6
7808093|NCT00444925|27126735|P3|Double-blind Treatment Period|Lost to Follow-up|5
7808094|NCT00444925|27126736|P2|Double-blind Treatment Period|Lost to Follow-up|8
7808095|NCT00444925|27126737|P1|Double-blind Treatment Period|Lost to Follow-up|4
7808096|NCT00444925|27126735|P3|Double-blind Treatment Period|Lack of Efficacy|13
7808097|NCT00444925|27126736|P2|Double-blind Treatment Period|Lack of Efficacy|5
7808098|NCT00444925|27126737|P1|Double-blind Treatment Period|Lack of Efficacy|5
7808099|NCT00444925|27126735|P3|Double-blind Treatment Period|Adverse Event|44
7808100|NCT00444925|27126736|P2|Double-blind Treatment Period|Adverse Event|28
7808101|NCT00444925|27126737|P1|Double-blind Treatment Period|Adverse Event|6
7808102|NCT00444925|27126735|P3|Double-blind Treatment Period|Death|0
7808103|NCT00444925|27126736|P2|Double-blind Treatment Period|Death|0
7808104|NCT00444925|27126737|P1|Double-blind Treatment Period|Death|2
7808105|NCT00444925|27126735|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
7808106|NCT00444925|27126736|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
7808107|NCT00444925|27126737|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
7808108|NCT00444912|27126801|P2|Overall Study|Participant Failed Mobilization|0
7808109|NCT00444912|27126802|P1|Overall Study|Participant Failed Mobilization|1
7808110|NCT00444912|27126801|P2|Overall Study|Lost to Follow-up|0
7808111|NCT00444912|27126802|P1|Overall Study|Lost to Follow-up|1
7808112|NCT00444912|27126801|P2|Overall Study|Death|2
7808113|NCT00444912|27126802|P1|Overall Study|Death|1
7808114|NCT00444795|27126843|P1|Overall Study|Treated Prior to the Contract Date|2
7808115|NCT00444795|27126843|P1|Overall Study|Not Treated|1
7808116|NCT00444678|27126848|P1|Overall Study|Withdrawal by Subject|2
7808117|NCT00444678|27126848|P1|Overall Study|Physician Decision|3
7808118|NCT00444678|27126848|P1|Overall Study|Death|3
7808119|NCT00444678|27126848|P1|Overall Study|Disease Progression|12
7808120|NCT00444678|27126848|P1|Overall Study|Toxicity|11
7808121|NCT00444626|27126855|P1|Initial Treatment Period|Lost to Follow-up|9
7808122|NCT00444626|27126855|P1|Initial Treatment Period|Adverse Event|1
7808123|NCT00444626|27126855|P1|Initial Treatment Period|Withdrawal by Subject|2
7808124|NCT00444600|27126885|P4|Overall Study|Missed visit|1
7808125|NCT00444600|27126886|P3|Overall Study|Missed visit|0
7808126|NCT00444600|27126887|P2|Overall Study|Missed visit|0
7808127|NCT00444600|27126888|P1|Overall Study|Missed visit|1
7808128|NCT00444600|27126885|P4|Overall Study|Dropped|7
7808129|NCT00444600|27126886|P3|Overall Study|Dropped|7
7808130|NCT00444600|27126887|P2|Overall Study|Dropped|11
7808131|NCT00444600|27126888|P1|Overall Study|Dropped|11
7808132|NCT00444600|27126885|P4|Overall Study|Death|2
7808133|NCT00444600|27126886|P3|Overall Study|Death|3
7808134|NCT00444600|27126887|P2|Overall Study|Death|5
7808135|NCT00444600|27126888|P1|Overall Study|Death|7
7808136|NCT00444587|27126980|P2|Overall Study|Missing|5
7808137|NCT00444587|27126981|P1|Overall Study|Missing|0
7808138|NCT00444587|27126980|P2|Overall Study|Protocol Violation|0
7808139|NCT00444587|27126981|P1|Overall Study|Protocol Violation|1
7808140|NCT00444587|27126980|P2|Overall Study|Investigator decision|0
7808141|NCT00444587|27126981|P1|Overall Study|Investigator decision|3
7808142|NCT00444587|27126980|P2|Overall Study|Refused treatment/did not cooperate|1
7808143|NCT00444587|27126981|P1|Overall Study|Refused treatment/did not cooperate|4
7808144|NCT00444587|27126980|P2|Overall Study|Progression of the disease|8
7808145|NCT00444587|27126981|P1|Overall Study|Progression of the disease|73
7808146|NCT00444587|27126980|P2|Overall Study|Death|1
7808147|NCT00444587|27126981|P1|Overall Study|Death|2
7808152|NCT00444457|27127017|P4|Toddler Dose|Protocol Violation|1
7808153|NCT00444457|27127018|P3|Toddler Dose|Protocol Violation|0
7808154|NCT00444457|27127019|P2|Toddler Dose|Protocol Violation|0
7808155|NCT00444457|27127020|P1|Toddler Dose|Protocol Violation|1
7808156|NCT00444457|27127017|P4|Toddler Dose|Parent or legal guardian request|1
7808157|NCT00444457|27127018|P3|Toddler Dose|Parent or legal guardian request|2
7808158|NCT00444457|27127019|P2|Toddler Dose|Parent or legal guardian request|3
7808159|NCT00444457|27127020|P1|Toddler Dose|Parent or legal guardian request|0
7808160|NCT00444457|27127017|P4|Toddler Dose|Failed to return|3
7808161|NCT00444457|27127018|P3|Toddler Dose|Failed to return|1
7808162|NCT00444457|27127019|P2|Toddler Dose|Failed to return|2
7808163|NCT00444457|27127020|P1|Toddler Dose|Failed to return|2
7808164|NCT00444457|27127017|P4|Toddler Dose|Lost to Follow-up|3
7808165|NCT00444457|27127018|P3|Toddler Dose|Lost to Follow-up|1
7808166|NCT00444457|27127019|P2|Toddler Dose|Lost to Follow-up|1
7808167|NCT00444457|27127020|P1|Toddler Dose|Lost to Follow-up|4
7808168|NCT00444457|27127017|P4|After Infant Series|Other|0
7808169|NCT00444457|27127018|P3|After Infant Series|Other|0
7808170|NCT00444457|27127019|P2|After Infant Series|Other|1
7808171|NCT00444457|27127020|P1|After Infant Series|Other|0
7808172|NCT00444457|27127017|P4|After Infant Series|Investigator request|1
7808173|NCT00444457|27127018|P3|After Infant Series|Investigator request|0
7808174|NCT00444457|27127019|P2|After Infant Series|Investigator request|0
7808175|NCT00444457|27127020|P1|After Infant Series|Investigator request|0
7808176|NCT00444457|27127017|P4|After Infant Series|Adverse Event|0
7808177|NCT00444457|27127018|P3|After Infant Series|Adverse Event|0
7808178|NCT00444457|27127019|P2|After Infant Series|Adverse Event|2
7808179|NCT00444457|27127020|P1|After Infant Series|Adverse Event|2
7808180|NCT00444457|27127017|P4|After Infant Series|Protocol Violation|2
7808181|NCT00444457|27127018|P3|After Infant Series|Protocol Violation|2
7808182|NCT00444457|27127019|P2|After Infant Series|Protocol Violation|4
7808183|NCT00444457|27127020|P1|After Infant Series|Protocol Violation|2
7808184|NCT00444457|27127017|P4|After Infant Series|Lost to Follow-up|2
7808185|NCT00444457|27127018|P3|After Infant Series|Lost to Follow-up|5
7808186|NCT00444457|27127019|P2|After Infant Series|Lost to Follow-up|5
7808187|NCT00444457|27127020|P1|After Infant Series|Lost to Follow-up|5
7808188|NCT00444457|27127017|P4|After Infant Series|Failed to return|1
7808189|NCT00444457|27127018|P3|After Infant Series|Failed to return|5
7808190|NCT00444457|27127019|P2|After Infant Series|Failed to return|6
7808191|NCT00444457|27127020|P1|After Infant Series|Failed to return|7
7808192|NCT00444457|27127017|P4|After Infant Series|Parent or legal guardian request|3
7808193|NCT00444457|27127018|P3|After Infant Series|Parent or legal guardian request|6
7808194|NCT00444457|27127019|P2|After Infant Series|Parent or legal guardian request|11
7808195|NCT00444457|27127020|P1|After Infant Series|Parent or legal guardian request|4
7808196|NCT00444457|27127017|P4|After Infant Series|Other|1
7808197|NCT00444457|27127018|P3|After Infant Series|Other|1
7808198|NCT00444457|27127019|P2|After Infant Series|Other|1
7808199|NCT00444457|27127020|P1|After Infant Series|Other|0
7808200|NCT00444457|27127017|P4|Infant Series|Death|1
7808201|NCT00444457|27127018|P3|Infant Series|Death|1
7808202|NCT00444457|27127019|P2|Infant Series|Death|1
7808203|NCT00444457|27127020|P1|Infant Series|Death|0
7808204|NCT00444457|27127017|P4|Infant Series|Adverse Event|0
7808205|NCT00444457|27127018|P3|Infant Series|Adverse Event|2
7808206|NCT00444457|27127019|P2|Infant Series|Adverse Event|2
7808207|NCT00444457|27127020|P1|Infant Series|Adverse Event|1
7808208|NCT00444457|27127017|P4|Infant Series|Other|0
7808209|NCT00444457|27127018|P3|Infant Series|Other|4
7808210|NCT00444457|27127019|P2|Infant Series|Other|2
7808211|NCT00444457|27127020|P1|Infant Series|Other|0
7808212|NCT00444457|27127017|P4|Infant Series|Investigator request|2
7808213|NCT00444457|27127018|P3|Infant Series|Investigator request|3
7808214|NCT00444457|27127019|P2|Infant Series|Investigator request|3
7808215|NCT00444457|27127020|P1|Infant Series|Investigator request|4
7808216|NCT00444457|27127017|P4|Infant Series|Failed to return|2
7808217|NCT00444457|27127018|P3|Infant Series|Failed to return|4
7808218|NCT00444457|27127019|P2|Infant Series|Failed to return|4
7808219|NCT00444457|27127020|P1|Infant Series|Failed to return|5
7808220|NCT00444457|27127017|P4|Infant Series|Protocol Violation|3
7808221|NCT00444457|27127018|P3|Infant Series|Protocol Violation|6
7808222|NCT00444457|27127019|P2|Infant Series|Protocol Violation|8
7808223|NCT00444457|27127020|P1|Infant Series|Protocol Violation|16
7808224|NCT00444457|27127017|P4|Infant Series|Lost to Follow-up|6
7808225|NCT00444457|27127018|P3|Infant Series|Lost to Follow-up|7
7808226|NCT00444457|27127019|P2|Infant Series|Lost to Follow-up|11
7808227|NCT00444457|27127020|P1|Infant Series|Lost to Follow-up|10
7808228|NCT00444457|27127017|P4|Infant Series|Parent or legal guardian request|14
7808229|NCT00444457|27127018|P3|Infant Series|Parent or legal guardian request|34
7808230|NCT00444457|27127019|P2|Infant Series|Parent or legal guardian request|29
7808231|NCT00444457|27127020|P1|Infant Series|Parent or legal guardian request|18
7808232|NCT00444457|27127017|P4|Infant Series|Other|0
7808233|NCT00444457|27127018|P3|Infant Series|Other|0
7808234|NCT00444457|27127019|P2|Infant Series|Other|1
7808235|NCT00444457|27127020|P1|Infant Series|Other|0
7808236|NCT00444275|27127085|P5|Maintenance Treatment Phase|Ineffectiveness|14
7808237|NCT00444275|27127086|P4|Maintenance Treatment Phase|Ineffectiveness|3
7808238|NCT00444275|27127087|P3|Maintenance Treatment Phase|Ineffectiveness|5
7808239|NCT00444275|27127088|P2|Maintenance Treatment Phase|Ineffectiveness|0
7808240|NCT00444275|27127089|P1|Maintenance Treatment Phase|Ineffectiveness|0
7808241|NCT00444275|27127085|P5|Maintenance Treatment Phase|Protocol Violation|87
7808242|NCT00444275|27127086|P4|Maintenance Treatment Phase|Protocol Violation|88
7808243|NCT00444275|27127087|P3|Maintenance Treatment Phase|Protocol Violation|103
7808244|NCT00444275|27127088|P2|Maintenance Treatment Phase|Protocol Violation|0
7808245|NCT00444275|27127089|P1|Maintenance Treatment Phase|Protocol Violation|0
7808246|NCT00444275|27127085|P5|Maintenance Treatment Phase|Patient's wish|20
7808247|NCT00444275|27127086|P4|Maintenance Treatment Phase|Patient's wish|9
7808248|NCT00444275|27127087|P3|Maintenance Treatment Phase|Patient's wish|19
7808249|NCT00444275|27127088|P2|Maintenance Treatment Phase|Patient's wish|0
7808250|NCT00444275|27127089|P1|Maintenance Treatment Phase|Patient's wish|0
7808251|NCT00444275|27127085|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
7808252|NCT00444275|27127086|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
7808253|NCT00444275|27127087|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
7808254|NCT00444275|27127088|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
7808255|NCT00444275|27127089|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
7808256|NCT00444275|27127085|P5|Maintenance Treatment Phase|Adverse Event|13
7808257|NCT00444275|27127086|P4|Maintenance Treatment Phase|Adverse Event|2
7808258|NCT00444275|27127087|P3|Maintenance Treatment Phase|Adverse Event|3
7808259|NCT00444275|27127088|P2|Maintenance Treatment Phase|Adverse Event|0
7808260|NCT00444275|27127089|P1|Maintenance Treatment Phase|Adverse Event|0
7808261|NCT00444275|27127085|P5|Maintenance Treatment Phase|Lost to Follow-up|10
7808262|NCT00444275|27127086|P4|Maintenance Treatment Phase|Lost to Follow-up|14
7808263|NCT00444275|27127087|P3|Maintenance Treatment Phase|Lost to Follow-up|8
7808264|NCT00444275|27127088|P2|Maintenance Treatment Phase|Lost to Follow-up|0
7808265|NCT00444275|27127089|P1|Maintenance Treatment Phase|Lost to Follow-up|0
7808266|NCT00444275|27127085|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
7808267|NCT00444275|27127086|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
7808268|NCT00444275|27127087|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
7808269|NCT00444275|27127088|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
7808270|NCT00444275|27127089|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
7808271|NCT00444145|27127139|P1|Overall Study|Screen Failures|5
7808272|NCT00444145|27127139|P1|Overall Study|non-compliant|11
7808273|NCT00444145|27127139|P1|Overall Study|Lost to Follow-up|1
7808274|NCT00444145|27127139|P1|Overall Study|Withdrawal by Subject|2
7808275|NCT00444106|27127146|P3|Overall Study|Abnormal Test Procedure Results|1
7808276|NCT00444106|27127147|P2|Overall Study|Abnormal Test Procedure Results|0
7808277|NCT00444106|27127148|P1|Overall Study|Abnormal Test Procedure Results|0
7808278|NCT00444106|27127146|P3|Overall Study|Lost to Follow-up|0
7808279|NCT00444106|27127147|P2|Overall Study|Lost to Follow-up|1
7808280|NCT00444106|27127148|P1|Overall Study|Lost to Follow-up|2
7808281|NCT00444067|27127180|P2|Overall Study|Lost to Follow-up|1
7808282|NCT00444067|27127181|P1|Overall Study|Lost to Follow-up|0
7808283|NCT00443898|27127244|P4|Overall Study|Death|0
7808284|NCT00443898|27127245|P3|Overall Study|Death|0
7808285|NCT00443898|27127246|P2|Overall Study|Death|1
7808286|NCT00443898|27127247|P1|Overall Study|Death|0
7808287|NCT00443898|27127244|P4|Overall Study|Lost to Follow-up|10
7808288|NCT00443898|27127245|P3|Overall Study|Lost to Follow-up|14
7808289|NCT00443898|27127246|P2|Overall Study|Lost to Follow-up|10
7808290|NCT00443898|27127247|P1|Overall Study|Lost to Follow-up|10
7808291|NCT00443898|27127244|P4|Overall Study|Withdrawal by Subject|6
7808292|NCT00443898|27127245|P3|Overall Study|Withdrawal by Subject|10
7808293|NCT00443898|27127246|P2|Overall Study|Withdrawal by Subject|10
7808294|NCT00443898|27127247|P1|Overall Study|Withdrawal by Subject|11
7808295|NCT00443898|27127244|P4|Overall Study|Protocol Violation|0
7808296|NCT00443898|27127245|P3|Overall Study|Protocol Violation|1
7808297|NCT00443898|27127246|P2|Overall Study|Protocol Violation|1
7808298|NCT00443898|27127247|P1|Overall Study|Protocol Violation|1
7808299|NCT00443898|27127244|P4|Overall Study|Lack of Efficacy|1
7808300|NCT00443898|27127245|P3|Overall Study|Lack of Efficacy|3
7808301|NCT00443898|27127246|P2|Overall Study|Lack of Efficacy|3
7808302|NCT00443898|27127247|P1|Overall Study|Lack of Efficacy|2
7808303|NCT00443898|27127244|P4|Overall Study|Adverse Event|1
7808304|NCT00443898|27127245|P3|Overall Study|Adverse Event|1
7808305|NCT00443898|27127246|P2|Overall Study|Adverse Event|0
7808306|NCT00443898|27127247|P1|Overall Study|Adverse Event|0
7808307|NCT00443872|27127269|P1|Overall Study|Adverse Event|8
7808308|NCT00443872|27127269|P1|Overall Study|Lost to Follow-up|2
7808309|NCT00443872|27127269|P1|Overall Study|Protocol Violation|7
7808310|NCT00443846|27127284|P2|Overall Study|Lost to Follow-up|2
7808311|NCT00443846|27127285|P1|Overall Study|Lost to Follow-up|1
7808312|NCT00443846|27127284|P2|Overall Study|Personal reason|3
7808313|NCT00443846|27127285|P1|Overall Study|Personal reason|8
7808314|NCT00443846|27127284|P2|Overall Study|Adverse Event|1
7808315|NCT00443846|27127285|P1|Overall Study|Adverse Event|0
7808316|NCT00443846|27127284|P2|Overall Study|Not vaccinated, no blood sample drawn|0
7808317|NCT00443846|27127285|P1|Overall Study|Not vaccinated, no blood sample drawn|1
7808318|NCT00443846|27127284|P2|Overall Study|Withdrawn due to intercurrent disease|0
7808319|NCT00443846|27127285|P1|Overall Study|Withdrawn due to intercurrent disease|1
7808320|NCT00443820|27127295|P4|Overall Study|Death|0
7808321|NCT00443820|27127296|P3|Overall Study|Death|1
7808322|NCT00443820|27127297|P2|Overall Study|Death|0
7808323|NCT00443820|27127298|P1|Overall Study|Death|0
7808324|NCT00443820|27127295|P4|Overall Study|Administrative problems|1
7808325|NCT00443820|27127296|P3|Overall Study|Administrative problems|0
7808326|NCT00443820|27127297|P2|Overall Study|Administrative problems|0
7808327|NCT00443820|27127298|P1|Overall Study|Administrative problems|0
7808328|NCT00443820|27127295|P4|Overall Study|Lost to Follow-up|5
7808329|NCT00443820|27127296|P3|Overall Study|Lost to Follow-up|6
7808330|NCT00443820|27127297|P2|Overall Study|Lost to Follow-up|8
7808331|NCT00443820|27127298|P1|Overall Study|Lost to Follow-up|9
7808332|NCT00443820|27127295|P4|Overall Study|Withdrawal by Subject|9
7808333|NCT00443820|27127296|P3|Overall Study|Withdrawal by Subject|8
7808334|NCT00443820|27127297|P2|Overall Study|Withdrawal by Subject|7
7808335|NCT00443820|27127298|P1|Overall Study|Withdrawal by Subject|6
7808336|NCT00443820|27127295|P4|Overall Study|Protocol Violation|1
7808337|NCT00443820|27127296|P3|Overall Study|Protocol Violation|2
7808338|NCT00443820|27127297|P2|Overall Study|Protocol Violation|1
7808339|NCT00443820|27127298|P1|Overall Study|Protocol Violation|2
7808340|NCT00443820|27127295|P4|Overall Study|Lack of Efficacy|1
7808341|NCT00443820|27127296|P3|Overall Study|Lack of Efficacy|1
7808342|NCT00443820|27127297|P2|Overall Study|Lack of Efficacy|2
7808343|NCT00443820|27127298|P1|Overall Study|Lack of Efficacy|3
7808344|NCT00443820|27127295|P4|Overall Study|Adverse Event|0
7808345|NCT00443820|27127296|P3|Overall Study|Adverse Event|0
7808346|NCT00443820|27127297|P2|Overall Study|Adverse Event|1
7808347|NCT00443820|27127298|P1|Overall Study|Adverse Event|1
7808348|NCT00443781|27127320|P1|Overall Study|PD/FAD not done|1
7808349|NCT00443781|27127320|P1|Overall Study|Insurance not covered|2
7808350|NCT00443781|27127320|P1|Overall Study|Investigator terminated participation|1
7808351|NCT00443781|27127320|P1|Overall Study|Unable to comply with study follow up|2
7808352|NCT00443781|27127320|P1|Overall Study|Withdrawal by Subject|6
7808353|NCT00443781|27127320|P1|Overall Study|Protocol Violation|1
7808354|NCT00443781|27127320|P1|Overall Study|Physician Decision|2
7808355|NCT00443781|27127320|P1|Overall Study|Lost to Follow-up|10
7808356|NCT00443755|27127326|P2|Overall Study|Withdrawal by Subject|1
7808357|NCT00443755|27127327|P1|Overall Study|Withdrawal by Subject|2
7808358|NCT00443729|27127361|P2|Overall Study|Withdrawal by Subject|1
7808359|NCT00443729|27127362|P1|Overall Study|Withdrawal by Subject|3
7808360|NCT00443729|27127361|P2|Overall Study|Protocol Violation|1
7808361|NCT00443729|27127362|P1|Overall Study|Protocol Violation|1
7808362|NCT00443729|27127361|P2|Overall Study|Physician Decision|1
7808363|NCT00443729|27127362|P1|Overall Study|Physician Decision|2
7808364|NCT00443729|27127361|P2|Overall Study|Lost to Follow-up|1
7808365|NCT00443729|27127362|P1|Overall Study|Lost to Follow-up|0
7808366|NCT00443729|27127361|P2|Overall Study|Lack of Efficacy|2
7808367|NCT00443729|27127362|P1|Overall Study|Lack of Efficacy|4
7808368|NCT00443729|27127361|P2|Overall Study|Never Treated|1
7808369|NCT00443729|27127362|P1|Overall Study|Never Treated|0
7808370|NCT00443703|27127410|P2|Overall Study|Progressive Disease|0
7808371|NCT00443703|27127411|P1|Overall Study|Progressive Disease|1
7808372|NCT00443703|27127410|P2|Overall Study|Withdrawal by Subject|6
7808373|NCT00443703|27127411|P1|Overall Study|Withdrawal by Subject|9
7808374|NCT00443703|27127410|P2|Overall Study|Protocol Violation|1
7808375|NCT00443703|27127411|P1|Overall Study|Protocol Violation|1
7808376|NCT00443703|27127410|P2|Overall Study|Physician Decision|2
7808377|NCT00443703|27127411|P1|Overall Study|Physician Decision|4
7808378|NCT00443703|27127410|P2|Overall Study|Lost to Follow-up|4
7808379|NCT00443703|27127411|P1|Overall Study|Lost to Follow-up|0
7808380|NCT00443703|27127410|P2|Overall Study|Lack of Efficacy|1
7808381|NCT00443703|27127411|P1|Overall Study|Lack of Efficacy|3
7808382|NCT00443703|27127410|P2|Overall Study|Adverse Event|3
7808383|NCT00443703|27127411|P1|Overall Study|Adverse Event|7
7808384|NCT00443703|27127410|P2|Overall Study|Never Treated|1
7808385|NCT00443703|27127411|P1|Overall Study|Never Treated|3
7808386|NCT00443651|27127463|P2|Overall Study|Pregnancy|1
7808387|NCT00443651|27127464|P1|Overall Study|Pregnancy|0
7808388|NCT00443651|27127463|P2|Overall Study|Physician Decision|4
7808389|NCT00443651|27127464|P1|Overall Study|Physician Decision|13
7808390|NCT00443651|27127463|P2|Overall Study|Patient's/Guardian's Decision|30
7808391|NCT00443651|27127464|P1|Overall Study|Patient's/Guardian's Decision|58
7808392|NCT00443651|27127463|P2|Overall Study|Lost to Follow-up|12
7808393|NCT00443651|27127464|P1|Overall Study|Lost to Follow-up|18
7808394|NCT00443651|27127463|P2|Overall Study|Adverse Event|6
7808395|NCT00443651|27127464|P1|Overall Study|Adverse Event|5
7808396|NCT00443651|27127463|P2|Overall Study|Death|5
7808397|NCT00443651|27127464|P1|Overall Study|Death|1
7808398|NCT00443599|27127484|P2|Overall Study|Cardiopulmonary bypass canceled|1
7808399|NCT00443599|27127485|P1|Overall Study|Cardiopulmonary bypass canceled|3
7808400|NCT00443599|27127484|P2|Overall Study|Death|1
7808401|NCT00443599|27127485|P1|Overall Study|Death|1
7808402|NCT00443599|27127484|P2|Overall Study|Physician Decision|1
7808403|NCT00443599|27127485|P1|Overall Study|Physician Decision|2
7808404|NCT00443560|27127519|P2|Overall Study|Multiple pregnancies or fetal demise|4
7808405|NCT00443560|27127520|P1|Overall Study|Multiple pregnancies or fetal demise|2
7808406|NCT00443560|27127519|P2|Overall Study|No intrathecal dose|26
7808407|NCT00443560|27127520|P1|Overall Study|No intrathecal dose|58
7808408|NCT00443534|27127555|P1|Overall Study|Enrolled, Not Treated|1
7808409|NCT00443534|27127555|P1|Overall Study|Other|10
7808410|NCT00443534|27127555|P1|Overall Study|Study Terminated by Sponsor|12
7808411|NCT00443534|27127555|P1|Overall Study|Withdrawal by Subject|8
7808412|NCT00443534|27127555|P1|Overall Study|Death|9
7808413|NCT00443534|27127555|P1|Overall Study|Adverse Event|16
7808414|NCT00443534|27127555|P1|Overall Study|Lack of Efficacy|67
7808415|NCT00443456|27127562|P1|Overall Study|Withdrawal by Subject|1
7808416|NCT00443456|27127562|P1|Overall Study|Move|1
7808417|NCT00443456|27127562|P1|Overall Study|Adverse Event|16
7808418|NCT00443430|27127597|P2|Overall Study|Adverse Event|1
7808419|NCT00443430|27127598|P1|Overall Study|Adverse Event|1
7808420|NCT00443430|27127597|P2|Overall Study|Lack of Efficacy|3
7808421|NCT00443430|27127598|P1|Overall Study|Lack of Efficacy|3
7808422|NCT00443261|27127612|P1|Overall Study|Death|1
7808423|NCT00443209|27127618|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
7808424|NCT00443209|27127619|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
7808425|NCT00443209|27127618|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
7808426|NCT00443209|27127619|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
7808427|NCT00443209|27127618|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
7808428|NCT00443209|27127619|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
7808429|NCT00443209|27127618|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
7808430|NCT00443209|27127619|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
7808431|NCT00443209|27127618|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
7808432|NCT00443209|27127619|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
7808433|NCT00443209|27127618|P2|Months 13 to 18 Treatment Period|Adverse Event|0
7808434|NCT00443209|27127619|P1|Months 13 to 18 Treatment Period|Adverse Event|1
7808435|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Not Treated|43
7808436|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Not Treated|71
7808437|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Missing|1
7808438|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Missing|2
7808439|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
7808440|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
7808441|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
7808442|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
7808443|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Pregnancy|4
7808444|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Pregnancy|3
7808445|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Physician Decision|4
7808446|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Physician Decision|8
7808447|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
7808448|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
7808449|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
7808450|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
7808451|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
7808452|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
7808453|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
7808454|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
7808455|NCT00443209|27127618|P2|Months 1 to 12 Treatment Period|Adverse Event|11
7808456|NCT00443209|27127619|P1|Months 1 to 12 Treatment Period|Adverse Event|22
7808457|NCT00443118|27127636|P3|Overall Study|Withdrawal by Subject|0
7808458|NCT00443118|27127637|P2|Overall Study|Withdrawal by Subject|0
7808459|NCT00443118|27127638|P1|Overall Study|Withdrawal by Subject|1
7808460|NCT00443118|27127636|P3|Overall Study|unknown primary outcome|0
7808461|NCT00443118|27127637|P2|Overall Study|unknown primary outcome|1
7808462|NCT00443118|27127638|P1|Overall Study|unknown primary outcome|3
7808463|NCT00443079|27127687|P2|Overall Study|Lost to Follow-up|1
7808464|NCT00443079|27127688|P1|Overall Study|Lost to Follow-up|0
7808465|NCT00443053|27127698|P2|Overall Study|Physician Decision|4
7808466|NCT00443053|27127699|P1|Overall Study|Physician Decision|0
7808467|NCT00443053|27127698|P2|Overall Study|Other|4
7808468|NCT00443053|27127699|P1|Overall Study|Other|3
7808469|NCT00443053|27127698|P2|Overall Study|Noncompliance|1
7808470|NCT00443053|27127699|P1|Overall Study|Noncompliance|2
7808471|NCT00443053|27127698|P2|Overall Study|Did Not Meet Eligibility Criteria|0
7808472|NCT00443053|27127699|P1|Overall Study|Did Not Meet Eligibility Criteria|1
7808473|NCT00443053|27127698|P2|Overall Study|Lost to Follow-up|5
7808474|NCT00443053|27127699|P1|Overall Study|Lost to Follow-up|4
7808475|NCT00443053|27127698|P2|Overall Study|Withdrawal by Subject|18
7808476|NCT00443053|27127699|P1|Overall Study|Withdrawal by Subject|9
7808477|NCT00443053|27127698|P2|Overall Study|Adverse Event|1
7808478|NCT00443053|27127699|P1|Overall Study|Adverse Event|2
7808479|NCT00443040|27127720|P3|Overall Study|Converted to an open laparotomy|1
7808480|NCT00443040|27127721|P2|Overall Study|Converted to an open laparotomy|0
7808481|NCT00443040|27127722|P1|Overall Study|Converted to an open laparotomy|3
7808482|NCT00443040|27127720|P3|Overall Study|Withdrawal by Subject|0
7808483|NCT00443040|27127721|P2|Overall Study|Withdrawal by Subject|0
7808484|NCT00443040|27127722|P1|Overall Study|Withdrawal by Subject|1
7808485|NCT00442962|27127730|P1|Overall Study|Lost to Follow-up|7
7808486|NCT00442962|27127730|P1|Overall Study|Pregnancy|1
7808487|NCT00442936|27127748|P4|Overall Study|Protocol Violation|1
7808488|NCT00442936|27127749|P3|Overall Study|Protocol Violation|1
7808489|NCT00442936|27127750|P2|Overall Study|Protocol Violation|0
7808490|NCT00442936|27127751|P1|Overall Study|Protocol Violation|1
7808491|NCT00442897|27127799|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
7808492|NCT00442897|27127800|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
7808493|NCT00442897|27127799|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
7808494|NCT00442897|27127800|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
7808495|NCT00442897|27127799|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7808496|NCT00442897|27127800|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7808497|NCT00442897|27127799|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
7808498|NCT00442897|27127800|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
7808499|NCT00442897|27127799|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
7808500|NCT00442897|27127800|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
7808501|NCT00442897|27127799|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
7808502|NCT00442897|27127800|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
7808503|NCT00442897|27127799|P2|Base Study (12 Week Follow-up)|Death|1
7808504|NCT00442897|27127800|P1|Base Study (12 Week Follow-up)|Death|0
7808505|NCT00442897|27127799|P2|Base Study (12 Week Follow-up)|Adverse Event|0
7808506|NCT00442897|27127800|P1|Base Study (12 Week Follow-up)|Adverse Event|1
7808507|NCT00442702|27127818|P2|Evaluation Period|Site closure|1
7808508|NCT00442702|27127819|P1|Evaluation Period|Site closure|0
7808509|NCT00442702|27127818|P2|Evaluation Period|Failure to return|0
7808510|NCT00442702|27127819|P1|Evaluation Period|Failure to return|1
7808511|NCT00442702|27127818|P2|Evaluation Period|Renal transplant|1
7808512|NCT00442702|27127819|P1|Evaluation Period|Renal transplant|0
7808513|NCT00442702|27127818|P2|Evaluation Period|Refused treatment|1
7808514|NCT00442702|27127819|P1|Evaluation Period|Refused treatment|1
7808515|NCT00442702|27127818|P2|Evaluation Period|Insufficient Therapeutic Response|0
7808516|NCT00442702|27127819|P1|Evaluation Period|Insufficient Therapeutic Response|1
7808517|NCT00442702|27127818|P2|Evaluation Period|Death|1
7808518|NCT00442702|27127819|P1|Evaluation Period|Death|1
7808519|NCT00442702|27127818|P2|Evaluation Period|Adverse Event|0
7808520|NCT00442702|27127819|P1|Evaluation Period|Adverse Event|1
7808521|NCT00442702|27127818|P2|Titration Period|Hospitalized in another hospital|0
7808522|NCT00442702|27127819|P1|Titration Period|Hospitalized in another hospital|1
7808523|NCT00442702|27127818|P2|Titration Period|Failure to return|0
7808524|NCT00442702|27127819|P1|Titration Period|Failure to return|1
7808525|NCT00442702|27127818|P2|Titration Period|Refused Treatment|1
7808526|NCT00442702|27127819|P1|Titration Period|Refused Treatment|4
7808527|NCT00442702|27127818|P2|Titration Period|Insufficient Therapeutic Response|0
7808528|NCT00442702|27127819|P1|Titration Period|Insufficient Therapeutic Response|1
7808529|NCT00442702|27127818|P2|Titration Period|Death|2
7808530|NCT00442702|27127819|P1|Titration Period|Death|3
7808531|NCT00442702|27127818|P2|Titration Period|Adverse Event|0
7808532|NCT00442702|27127819|P1|Titration Period|Adverse Event|2
7808533|NCT00442598|27127884|P3|Overall Study|Death|0
7808534|NCT00442598|27127885|P2|Overall Study|Death|1
7808535|NCT00442598|27127886|P1|Overall Study|Death|0
7808536|NCT00442598|27127884|P3|Overall Study|Reduced creatinine clearance|0
7808537|NCT00442598|27127885|P2|Overall Study|Reduced creatinine clearance|0
7808538|NCT00442598|27127886|P1|Overall Study|Reduced creatinine clearance|1
7808539|NCT00442598|27127884|P3|Overall Study|CA125 progression|0
7808540|NCT00442598|27127885|P2|Overall Study|CA125 progression|1
7808541|NCT00442598|27127886|P1|Overall Study|CA125 progression|0
7808542|NCT00442598|27127884|P3|Overall Study|Clinical deterioration|0
7808543|NCT00442598|27127885|P2|Overall Study|Clinical deterioration|2
7808544|NCT00442598|27127886|P1|Overall Study|Clinical deterioration|1
7808545|NCT00442598|27127884|P3|Overall Study|Tumor progression|0
7808546|NCT00442598|27127885|P2|Overall Study|Tumor progression|4
7808547|NCT00442598|27127886|P1|Overall Study|Tumor progression|3
7808548|NCT00442598|27127884|P3|Overall Study|Adverse Event|0
7808549|NCT00442598|27127885|P2|Overall Study|Adverse Event|0
7808550|NCT00442598|27127886|P1|Overall Study|Adverse Event|1
7808551|NCT00442572|27127904|P2|Overall Study|Withdrawal by Subject|1
7808552|NCT00442572|27127905|P1|Overall Study|Withdrawal by Subject|0
7808553|NCT00442572|27127904|P2|Overall Study|Lost to Follow-up|1
7808554|NCT00442572|27127905|P1|Overall Study|Lost to Follow-up|0
7808555|NCT00442572|27127904|P2|Overall Study|Relapse|1
7808556|NCT00442572|27127905|P1|Overall Study|Relapse|8
7808557|NCT00442559|27127945|P2|Overall Study|Withdrawal by Subject|0
7808558|NCT00442559|27127946|P1|Overall Study|Withdrawal by Subject|1
7808559|NCT00442559|27127945|P2|Overall Study|Protocol Violation|1
7808560|NCT00442559|27127946|P1|Overall Study|Protocol Violation|1
7808561|NCT00442559|27127945|P2|Overall Study|Lost to Follow-up|34
7808562|NCT00442559|27127946|P1|Overall Study|Lost to Follow-up|32
7808563|NCT00442546|27127961|P3|Overall Study|Randomized But Not Treated|6
7808564|NCT00442546|27127962|P2|Overall Study|Randomized But Not Treated|4
7808565|NCT00442546|27127963|P1|Overall Study|Randomized But Not Treated|5
7808566|NCT00442546|27127961|P3|Overall Study|Withdrawal by Subject|7
7808567|NCT00442546|27127962|P2|Overall Study|Withdrawal by Subject|5
7808568|NCT00442546|27127963|P1|Overall Study|Withdrawal by Subject|5
7808569|NCT00442546|27127961|P3|Overall Study|Other|6
7808570|NCT00442546|27127962|P2|Overall Study|Other|9
7808571|NCT00442546|27127963|P1|Overall Study|Other|4
7808572|NCT00442546|27127961|P3|Overall Study|Lost to Follow-up|1
7808573|NCT00442546|27127962|P2|Overall Study|Lost to Follow-up|2
7808574|NCT00442546|27127963|P1|Overall Study|Lost to Follow-up|1
7808575|NCT00442546|27127961|P3|Overall Study|Adverse Event|13
7808576|NCT00442546|27127962|P2|Overall Study|Adverse Event|17
7808577|NCT00442546|27127963|P1|Overall Study|Adverse Event|11
7808578|NCT00442468|27128092|P1|Overall Study|Did not complete all study procedures|88
7808579|NCT00442468|27128092|P1|Overall Study|Withdrawal by Subject|91
7808580|NCT00442468|27128092|P1|Overall Study|Adverse Event|4
7808581|NCT00442416|27128122|P2|Overall Study|Administrative/Other|33
7808582|NCT00442416|27128123|P1|Overall Study|Administrative/Other|27
7808583|NCT00442416|27128122|P2|Overall Study|Withdrew consent|2
7808584|NCT00442416|27128123|P1|Overall Study|Withdrew consent|1
7808585|NCT00442416|27128122|P2|Overall Study|Protocol Violation|3
7808586|NCT00442416|27128123|P1|Overall Study|Protocol Violation|2
7808587|NCT00442416|27128122|P2|Overall Study|Lack of Efficacy|0
7808588|NCT00442416|27128123|P1|Overall Study|Lack of Efficacy|2
7808589|NCT00442416|27128122|P2|Overall Study|Death|0
7808590|NCT00442416|27128123|P1|Overall Study|Death|1
7808591|NCT00442416|27128122|P2|Overall Study|Adverse Event|1
7808592|NCT00442416|27128123|P1|Overall Study|Adverse Event|4
7808593|NCT00442351|27128162|P2|Overall Study|Other|1
7808594|NCT00442351|27128163|P1|Overall Study|Other|0
7808595|NCT00442351|27128162|P2|Overall Study|Did not meet protocol eligibility|0
7808596|NCT00442351|27128163|P1|Overall Study|Did not meet protocol eligibility|1
7808597|NCT00442351|27128162|P2|Overall Study|Administrative|5
7808598|NCT00442351|27128163|P1|Overall Study|Administrative|6
7808599|NCT00442286|27128185|P2|Overall Study|Patient Injury|0
7808600|NCT00442286|27128186|P1|Overall Study|Patient Injury|1
7808601|NCT00442286|27128185|P2|Overall Study|System explanted|0
7808602|NCT00442286|27128186|P1|Overall Study|System explanted|1
7808603|NCT00442286|27128185|P2|Overall Study|Withdrawal by Subject|0
7808604|NCT00442286|27128186|P1|Overall Study|Withdrawal by Subject|2
7808605|NCT00442286|27128185|P2|Overall Study|Lost to Follow-up|0
7808606|NCT00442286|27128186|P1|Overall Study|Lost to Follow-up|1
7808607|NCT00442286|27128185|P2|Overall Study|Death|2
7808608|NCT00442286|27128186|P1|Overall Study|Death|2
7808609|NCT00442117|27128252|P2|Overall Study|Met Withdrawal Criteria|1
7808610|NCT00442117|27128253|P1|Overall Study|Met Withdrawal Criteria|2
7808611|NCT00442117|27128252|P2|Overall Study|Non compliance with protocol|5
7808612|NCT00442117|27128253|P1|Overall Study|Non compliance with protocol|3
7808613|NCT00442117|27128252|P2|Overall Study|Major Deviation|20
7808614|NCT00442117|27128253|P1|Overall Study|Major Deviation|25
7808615|NCT00442117|27128252|P2|Overall Study|Withdrawal by Subject|2
7808616|NCT00442117|27128253|P1|Overall Study|Withdrawal by Subject|2
7808617|NCT00442117|27128252|P2|Overall Study|Lost to Follow-up|2
7808618|NCT00442117|27128253|P1|Overall Study|Lost to Follow-up|1
7808619|NCT00442117|27128252|P2|Overall Study|Lack of Efficacy|6
7808620|NCT00442117|27128253|P1|Overall Study|Lack of Efficacy|2
7808621|NCT00442117|27128252|P2|Overall Study|Adverse Event|2
7808622|NCT00442117|27128253|P1|Overall Study|Adverse Event|3
7808623|NCT00441974|27128284|P1|Overall Study|Protocol Violation|7
7808624|NCT00441974|27128284|P1|Overall Study|Lost to Follow-up|80
7808625|NCT00441974|27128284|P1|Overall Study|Consent Withdrawn|35
7808626|NCT00441974|27128284|P1|Overall Study|Adverse Event|6
7808627|NCT00441792|27128331|P2|Overall Study|Lost to Follow-up|2
7808628|NCT00441792|27128332|P1|Overall Study|Lost to Follow-up|0
7808629|NCT00441727|27128372|P3|Overall Study|Various reason specified|5
7808630|NCT00441727|27128373|P2|Overall Study|Various reason specified|8
7808631|NCT00441727|27128374|P1|Overall Study|Various reason specified|6
7808632|NCT00441727|27128372|P3|Overall Study|Safety Reasons|3
7808633|NCT00441727|27128373|P2|Overall Study|Safety Reasons|1
7808634|NCT00441727|27128374|P1|Overall Study|Safety Reasons|3
7808635|NCT00441727|27128372|P3|Overall Study|Lost to Follow-up|5
7808636|NCT00441727|27128373|P2|Overall Study|Lost to Follow-up|6
7808637|NCT00441727|27128374|P1|Overall Study|Lost to Follow-up|5
7808638|NCT00441727|27128372|P3|Overall Study|Withdrawal by Subject|47
7808639|NCT00441727|27128373|P2|Overall Study|Withdrawal by Subject|34
7808640|NCT00441727|27128374|P1|Overall Study|Withdrawal by Subject|40
7808641|NCT00441727|27128372|P3|Overall Study|Lack of Efficacy|48
7808642|NCT00441727|27128373|P2|Overall Study|Lack of Efficacy|8
7808643|NCT00441727|27128374|P1|Overall Study|Lack of Efficacy|7
7808644|NCT00441727|27128372|P3|Overall Study|Adverse Event|28
7808645|NCT00441727|27128373|P2|Overall Study|Adverse Event|33
7808646|NCT00441727|27128374|P1|Overall Study|Adverse Event|26
7808647|NCT00441727|27128372|P3|Overall Study|Protocol Violation|32
7808648|NCT00441727|27128373|P2|Overall Study|Protocol Violation|28
7808649|NCT00441727|27128374|P1|Overall Study|Protocol Violation|19
7808650|NCT00441701|27128407|P10|Overall Study|Withdrawal by Subject|0
7808651|NCT00441701|27128408|P9|Overall Study|Withdrawal by Subject|0
7808652|NCT00441701|27128409|P8|Overall Study|Withdrawal by Subject|0
7808653|NCT00441701|27128410|P7|Overall Study|Withdrawal by Subject|0
7808654|NCT00441701|27128411|P6|Overall Study|Withdrawal by Subject|0
7808655|NCT00441701|27128412|P5|Overall Study|Withdrawal by Subject|0
7808656|NCT00441701|27128413|P4|Overall Study|Withdrawal by Subject|1
7808657|NCT00441701|27128414|P3|Overall Study|Withdrawal by Subject|1
7808658|NCT00441701|27128415|P2|Overall Study|Withdrawal by Subject|2
7808659|NCT00441701|27128416|P1|Overall Study|Withdrawal by Subject|0
7808660|NCT00441701|27128407|P10|Overall Study|Lack of Efficacy|0
7808661|NCT00441701|27128408|P9|Overall Study|Lack of Efficacy|0
7808662|NCT00441701|27128409|P8|Overall Study|Lack of Efficacy|0
7808663|NCT00441701|27128410|P7|Overall Study|Lack of Efficacy|0
7808664|NCT00441701|27128411|P6|Overall Study|Lack of Efficacy|1
7808665|NCT00441701|27128412|P5|Overall Study|Lack of Efficacy|0
7808666|NCT00441701|27128413|P4|Overall Study|Lack of Efficacy|2
7808667|NCT00441701|27128414|P3|Overall Study|Lack of Efficacy|2
7808668|NCT00441701|27128415|P2|Overall Study|Lack of Efficacy|0
7808669|NCT00441701|27128416|P1|Overall Study|Lack of Efficacy|2
7808670|NCT00441701|27128407|P10|Overall Study|Adverse Event|0
7808671|NCT00441701|27128408|P9|Overall Study|Adverse Event|0
7808672|NCT00441701|27128409|P8|Overall Study|Adverse Event|0
7808673|NCT00441701|27128410|P7|Overall Study|Adverse Event|0
7808674|NCT00441701|27128411|P6|Overall Study|Adverse Event|2
7808675|NCT00441701|27128412|P5|Overall Study|Adverse Event|2
7808676|NCT00441701|27128413|P4|Overall Study|Adverse Event|0
7808677|NCT00441701|27128414|P3|Overall Study|Adverse Event|1
7808678|NCT00441701|27128415|P2|Overall Study|Adverse Event|2
7808679|NCT00441701|27128416|P1|Overall Study|Adverse Event|3
7808680|NCT00441584|27128498|P1|Overall Study|Failure to meet eligibility criteria|3
7808681|NCT00441584|27128498|P1|Overall Study|Lost to Follow-up|4
7808682|NCT00441584|27128498|P1|Overall Study|Protocol Violation|5
7808683|NCT00441584|27128498|P1|Overall Study|Adverse Event|6
7808684|NCT00441584|27128498|P1|Overall Study|Withdrawal by Subject|8
7808685|NCT00441584|27128498|P1|Overall Study|Lack of Efficacy|79
7808686|NCT00441545|27128506|P2|Second Intervention|Subject moved|1
7808687|NCT00441545|27128507|P1|Second Intervention|Subject moved|0
7808688|NCT00441545|27128506|P2|Second Intervention|Subject exceeded safety criteria|0
7808689|NCT00441545|27128507|P1|Second Intervention|Subject exceeded safety criteria|1
7808690|NCT00441545|27128506|P2|Second Intervention|Lack of Efficacy|1
7808691|NCT00441545|27128507|P1|Second Intervention|Lack of Efficacy|0
7808692|NCT00441545|27128506|P2|Second Intervention|Kidney Transplant|1
7808693|NCT00441545|27128507|P1|Second Intervention|Kidney Transplant|1
7808694|NCT00441545|27128506|P2|Second Intervention|Withdrawal by Subject|1
7808695|NCT00441545|27128507|P1|Second Intervention|Withdrawal by Subject|1
7808696|NCT00441545|27128506|P2|Second Intervention|Protocol Violation|1
7808697|NCT00441545|27128507|P1|Second Intervention|Protocol Violation|4
7808698|NCT00441545|27128506|P2|Second Intervention|Adverse Event|2
7808699|NCT00441545|27128507|P1|Second Intervention|Adverse Event|5
7808700|NCT00441545|27128506|P2|First Intervention|Sponsor's request|0
7808701|NCT00441545|27128507|P1|First Intervention|Sponsor's request|1
7808702|NCT00441545|27128506|P2|First Intervention|Site error|0
7808703|NCT00441545|27128507|P1|First Intervention|Site error|1
7808704|NCT00441545|27128506|P2|First Intervention|Extended hospitalization|0
7808705|NCT00441545|27128507|P1|First Intervention|Extended hospitalization|1
7808706|NCT00441545|27128506|P2|First Intervention|Subject met an exclusionary criteria|0
7808707|NCT00441545|27128507|P1|First Intervention|Subject met an exclusionary criteria|1
7808708|NCT00441545|27128506|P2|First Intervention|Subject exceeded safety criteria|1
7808709|NCT00441545|27128507|P1|First Intervention|Subject exceeded safety criteria|0
7808710|NCT00441545|27128506|P2|First Intervention|Lack of Efficacy|0
7808711|NCT00441545|27128507|P1|First Intervention|Lack of Efficacy|2
7808712|NCT00441545|27128506|P2|First Intervention|Kidney transplant|1
7808713|NCT00441545|27128507|P1|First Intervention|Kidney transplant|1
7808714|NCT00441545|27128506|P2|First Intervention|Withdrawal by Subject|3
7808715|NCT00441545|27128507|P1|First Intervention|Withdrawal by Subject|3
7808716|NCT00441545|27128506|P2|First Intervention|Protocol Violation|2
7808717|NCT00441545|27128507|P1|First Intervention|Protocol Violation|2
7808718|NCT00441545|27128506|P2|First Intervention|Adverse Event|5
7808719|NCT00441545|27128507|P1|First Intervention|Adverse Event|6
7808720|NCT00441480|27128521|P2|Overall Study|Withdrawal by Subject|3
7808721|NCT00441480|27128522|P1|Overall Study|Withdrawal by Subject|2
7808722|NCT00441480|27128521|P2|Overall Study|Protocol Violation|1
7808723|NCT00441480|27128522|P1|Overall Study|Protocol Violation|1
7808724|NCT00441467|27128554|P1|Overall Study|Progressive disease|9
7808725|NCT00441467|27128554|P1|Overall Study|Withdrawal by Subject|3
7808726|NCT00441467|27128554|P1|Overall Study|Adverse Event|6
7808727|NCT00441441|27128562|P2|Overall Study|Other|3
7808728|NCT00441441|27128563|P1|Overall Study|Other|3
7808729|NCT00441441|27128562|P2|Overall Study|Withdrawal by Subject|2
7808730|NCT00441441|27128563|P1|Overall Study|Withdrawal by Subject|1
7808731|NCT00441441|27128562|P2|Overall Study|Exacerbation of asthma|2
7808732|NCT00441441|27128563|P1|Overall Study|Exacerbation of asthma|1
7808733|NCT00441441|27128562|P2|Overall Study|Protocol Violation|6
7808734|NCT00441441|27128563|P1|Overall Study|Protocol Violation|4
7808735|NCT00441441|27128562|P2|Overall Study|Adverse Event|1
7808736|NCT00441441|27128563|P1|Overall Study|Adverse Event|2
7808737|NCT00441363|27128623|P2|Overall Study|Other|0
7808738|NCT00441363|27128624|P1|Overall Study|Other|2
7808739|NCT00441363|27128623|P2|Overall Study|Lost to Follow-up|2
7808740|NCT00441363|27128624|P1|Overall Study|Lost to Follow-up|2
7808741|NCT00441363|27128623|P2|Overall Study|Physician Decision|7
7808742|NCT00441363|27128624|P1|Overall Study|Physician Decision|6
7808743|NCT00441363|27128623|P2|Overall Study|Withdrawal by Subject|4
7808744|NCT00441363|27128624|P1|Overall Study|Withdrawal by Subject|3
7808745|NCT00441363|27128623|P2|Overall Study|Adverse Event|2
7808746|NCT00441363|27128624|P1|Overall Study|Adverse Event|4
7808747|NCT00441337|27128663|P4|Overall Study|Did not meet inclusion criteria|0
7808748|NCT00441337|27128664|P3|Overall Study|Did not meet inclusion criteria|1
7808749|NCT00441337|27128665|P2|Overall Study|Did not meet inclusion criteria|0
7808750|NCT00441337|27128666|P1|Overall Study|Did not meet inclusion criteria|0
7808751|NCT00441337|27128663|P4|Overall Study|Sponsor Decision|2
7808752|NCT00441337|27128664|P3|Overall Study|Sponsor Decision|1
7808753|NCT00441337|27128665|P2|Overall Study|Sponsor Decision|0
7808754|NCT00441337|27128666|P1|Overall Study|Sponsor Decision|0
7808755|NCT00441337|27128663|P4|Overall Study|Lost to Follow-up|1
7808756|NCT00441337|27128664|P3|Overall Study|Lost to Follow-up|0
7808757|NCT00441337|27128665|P2|Overall Study|Lost to Follow-up|0
7808758|NCT00441337|27128666|P1|Overall Study|Lost to Follow-up|0
7808759|NCT00441337|27128663|P4|Overall Study|Disease Progression|18
7808760|NCT00441337|27128664|P3|Overall Study|Disease Progression|4
7808761|NCT00441337|27128665|P2|Overall Study|Disease Progression|6
7808762|NCT00441337|27128666|P1|Overall Study|Disease Progression|6
7808763|NCT00441272|27128779|P2|Overall Study|Study terminated prior to enrollment|25
7808764|NCT00441272|27128780|P1|Overall Study|Study terminated prior to enrollment|25
7808765|NCT00441168|27128807|P2|Follow-up Period|Other|3
7808766|NCT00441168|27128808|P1|Follow-up Period|Other|1
7808767|NCT00441168|27128807|P2|Follow-up Period|Withdrawal by Subject|0
7808768|NCT00441168|27128808|P1|Follow-up Period|Withdrawal by Subject|3
7808769|NCT00441168|27128807|P2|Follow-up Period|Lost to Follow-up|6
7808770|NCT00441168|27128808|P1|Follow-up Period|Lost to Follow-up|5
7808771|NCT00441168|27128807|P2|Follow-up Period|Death|0
7808772|NCT00441168|27128808|P1|Follow-up Period|Death|3
7808773|NCT00441168|27128807|P2|Treatment Period|refractory disease|0
7808774|NCT00441168|27128808|P1|Treatment Period|refractory disease|1
7808775|NCT00441168|27128807|P2|Treatment Period|qualified for stem-cell transplantation|0
7808776|NCT00441168|27128808|P1|Treatment Period|qualified for stem-cell transplantation|3
7808777|NCT00441168|27128807|P2|Treatment Period|Withdrawal by Subject|0
7808778|NCT00441168|27128808|P1|Treatment Period|Withdrawal by Subject|3
7808779|NCT00441168|27128807|P2|Treatment Period|Lost to Follow-up|1
7808780|NCT00441168|27128808|P1|Treatment Period|Lost to Follow-up|0
7808781|NCT00441168|27128807|P2|Treatment Period|Protocol Violation|1
7808782|NCT00441168|27128808|P1|Treatment Period|Protocol Violation|0
7808783|NCT00441168|27128807|P2|Treatment Period|Progressive Disease|2
7808784|NCT00441168|27128808|P1|Treatment Period|Progressive Disease|0
7808785|NCT00441168|27128807|P2|Treatment Period|Adverse Event|2
7808786|NCT00441168|27128808|P1|Treatment Period|Adverse Event|1
7808787|NCT00441168|27128807|P2|Treatment Period|Death|0
7808788|NCT00441168|27128808|P1|Treatment Period|Death|3
7808789|NCT00441142|27128822|P4|Overall Study|Death|1
7808790|NCT00441142|27128823|P3|Overall Study|Death|0
7808791|NCT00441142|27128824|P2|Overall Study|Death|0
7808792|NCT00441142|27128825|P1|Overall Study|Death|0
7808793|NCT00441142|27128822|P4|Overall Study|Physician Decision|1
7808794|NCT00441142|27128823|P3|Overall Study|Physician Decision|0
7808795|NCT00441142|27128824|P2|Overall Study|Physician Decision|1
7808796|NCT00441142|27128825|P1|Overall Study|Physician Decision|0
7808797|NCT00441142|27128822|P4|Overall Study|Patient still receiving active study tx|2
7808798|NCT00441142|27128823|P3|Overall Study|Patient still receiving active study tx|0
7808799|NCT00441142|27128824|P2|Overall Study|Patient still receiving active study tx|0
7808800|NCT00441142|27128825|P1|Overall Study|Patient still receiving active study tx|1
7808801|NCT00441142|27128822|P4|Overall Study|Withdrawal by Subject|10
7808802|NCT00441142|27128823|P3|Overall Study|Withdrawal by Subject|2
7808803|NCT00441142|27128824|P2|Overall Study|Withdrawal by Subject|0
7808804|NCT00441142|27128825|P1|Overall Study|Withdrawal by Subject|0
7808805|NCT00441142|27128822|P4|Overall Study|Lack of Efficacy|32
7808806|NCT00441142|27128823|P3|Overall Study|Lack of Efficacy|17
7808807|NCT00441142|27128824|P2|Overall Study|Lack of Efficacy|3
7808808|NCT00441142|27128825|P1|Overall Study|Lack of Efficacy|3
7808809|NCT00441142|27128822|P4|Overall Study|Adverse Event|22
7808810|NCT00441142|27128823|P3|Overall Study|Adverse Event|3
7808811|NCT00441142|27128824|P2|Overall Study|Adverse Event|3
7808812|NCT00441142|27128825|P1|Overall Study|Adverse Event|2
7808813|NCT00441129|27128847|P2|Overall Study|Withdrawal by Subject|14
7808814|NCT00441129|27128848|P1|Overall Study|Withdrawal by Subject|6
7808815|NCT00441116|27128860|P2|Overall Study|Did not meet Eligibility Criteria|1
7808816|NCT00441116|27128861|P1|Overall Study|Did not meet Eligibility Criteria|1
7808817|NCT00441116|27128860|P2|Overall Study|Withdrawal by Subject|0
7808818|NCT00441116|27128861|P1|Overall Study|Withdrawal by Subject|1
7808819|NCT00441116|27128860|P2|Overall Study|Adverse Event|1
7808820|NCT00441116|27128861|P1|Overall Study|Adverse Event|1
7808821|NCT00441103|27128929|P2|Overall Study|Participant decided to stop|1
7808822|NCT00441103|27128930|P1|Overall Study|Participant decided to stop|0
7808823|NCT00441103|27128929|P2|Overall Study|Participant's reason|1
7808824|NCT00441103|27128930|P1|Overall Study|Participant's reason|0
7808825|NCT00441103|27128929|P2|Overall Study|Participant decided to withdraw|0
7808826|NCT00441103|27128930|P1|Overall Study|Participant decided to withdraw|1
7808827|NCT00441103|27128929|P2|Overall Study|Non-compliant|1
7808828|NCT00441103|27128930|P1|Overall Study|Non-compliant|0
7808829|NCT00441103|27128929|P2|Overall Study|Inclusion criteria absent|0
7808830|NCT00441103|27128930|P1|Overall Study|Inclusion criteria absent|1
7808831|NCT00441103|27128929|P2|Overall Study|Participant refused MRI|0
7808832|NCT00441103|27128930|P1|Overall Study|Participant refused MRI|1
7808833|NCT00441103|27128929|P2|Overall Study|Participant unable to use Rebiject II|0
7808834|NCT00441103|27128930|P1|Overall Study|Participant unable to use Rebiject II|1
7808835|NCT00441103|27128929|P2|Overall Study|Protocol Violation|0
7808836|NCT00441103|27128930|P1|Overall Study|Protocol Violation|1
7808837|NCT00441103|27128929|P2|Overall Study|Lost to Follow-up|0
7808838|NCT00441103|27128930|P1|Overall Study|Lost to Follow-up|1
7808839|NCT00441103|27128929|P2|Overall Study|Disease Progression|0
7808840|NCT00441103|27128930|P1|Overall Study|Disease Progression|2
7808841|NCT00441103|27128929|P2|Overall Study|Death|0
7808842|NCT00441103|27128930|P1|Overall Study|Death|1
7808843|NCT00441103|27128929|P2|Overall Study|Adverse Event|1
7808844|NCT00441103|27128930|P1|Overall Study|Adverse Event|2
7808845|NCT00441090|27128946|P5|Overall Study|Lack of Efficacy|0
7808846|NCT00441090|27128947|P4|Overall Study|Lack of Efficacy|0
7808847|NCT00441090|27128948|P3|Overall Study|Lack of Efficacy|0
7808848|NCT00441090|27128949|P2|Overall Study|Lack of Efficacy|0
7808849|NCT00441090|27128950|P1|Overall Study|Lack of Efficacy|1
7808850|NCT00441090|27128946|P5|Overall Study|Withdrawal by Subject|0
7808851|NCT00441090|27128947|P4|Overall Study|Withdrawal by Subject|0
7808852|NCT00441090|27128948|P3|Overall Study|Withdrawal by Subject|1
7808853|NCT00441090|27128949|P2|Overall Study|Withdrawal by Subject|0
7808854|NCT00441090|27128950|P1|Overall Study|Withdrawal by Subject|1
7808855|NCT00441090|27128946|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
7808856|NCT00441090|27128947|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
7808857|NCT00441090|27128948|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
7808858|NCT00441090|27128949|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
7808859|NCT00441090|27128950|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
7808860|NCT00441090|27128946|P5|Overall Study|Adverse Event|0
7808861|NCT00441090|27128947|P4|Overall Study|Adverse Event|0
7808862|NCT00441090|27128948|P3|Overall Study|Adverse Event|1
7808863|NCT00441090|27128949|P2|Overall Study|Adverse Event|1
7808864|NCT00441090|27128950|P1|Overall Study|Adverse Event|0
7808865|NCT00441064|27128994|P2|Overall Study|Patient withdrew consent|2
7808866|NCT00441064|27128995|P1|Overall Study|Patient withdrew consent|5
7808867|NCT00441064|27128994|P2|Overall Study|Protocol Deviation|2
7808868|NCT00441064|27128995|P1|Overall Study|Protocol Deviation|3
7808869|NCT00441064|27128994|P2|Overall Study|Unsatisfactory therapeutic effect|0
7808870|NCT00441064|27128995|P1|Overall Study|Unsatisfactory therapeutic effect|1
7808871|NCT00441064|27128994|P2|Overall Study|Abnormal test procedure results|1
7808872|NCT00441064|27128995|P1|Overall Study|Abnormal test procedure results|0
7808873|NCT00441064|27128994|P2|Overall Study|Abnormal laboratory values|2
7808874|NCT00441064|27128995|P1|Overall Study|Abnormal laboratory values|0
7808875|NCT00441064|27128994|P2|Overall Study|Adverse Event|0
7808876|NCT00441064|27128995|P1|Overall Study|Adverse Event|1
7808877|NCT00441012|27129007|P2|Overall Study|Subject Randomized but Not Vaccinated|0
7808878|NCT00441012|27129008|P1|Overall Study|Subject Randomized but Not Vaccinated|1
7808879|NCT00441012|27129007|P2|Overall Study|Withdrawal by Subject|0
7808880|NCT00441012|27129008|P1|Overall Study|Withdrawal by Subject|4
7808881|NCT00441012|27129007|P2|Overall Study|Protocol Violation|9
7808882|NCT00441012|27129008|P1|Overall Study|Protocol Violation|10
7808883|NCT00441012|27129007|P2|Overall Study|Lost to Follow-up|3
7808884|NCT00441012|27129008|P1|Overall Study|Lost to Follow-up|3
7808885|NCT00441012|27129007|P2|Overall Study|Adverse Event|1
7808886|NCT00441012|27129008|P1|Overall Study|Adverse Event|0
7808887|NCT00440999|27129024|P2|Overall Study|Subj left hosp without inform staff|1
7808888|NCT00440999|27129025|P1|Overall Study|Subj left hosp without inform staff|0
7808889|NCT00440999|27129024|P2|Overall Study|P. falciparum malaria|14
7808890|NCT00440999|27129025|P1|Overall Study|P. falciparum malaria|5
7808891|NCT00440999|27129024|P2|Overall Study|Mixed infection at entry|0
7808892|NCT00440999|27129025|P1|Overall Study|Mixed infection at entry|1
7808893|NCT00440999|27129024|P2|Overall Study|Subjets missed the visit|0
7808894|NCT00440999|27129025|P1|Overall Study|Subjets missed the visit|1
7808895|NCT00440999|27129024|P2|Overall Study|Withdrawal by Subject|5
7808896|NCT00440999|27129025|P1|Overall Study|Withdrawal by Subject|2
7808897|NCT00440999|27129024|P2|Overall Study|Protocol Violation|0
7808898|NCT00440999|27129025|P1|Overall Study|Protocol Violation|1
7808899|NCT00440999|27129024|P2|Overall Study|Lost to Follow-up|12
7808900|NCT00440999|27129025|P1|Overall Study|Lost to Follow-up|19
7808901|NCT00440999|27129024|P2|Overall Study|Lack of Efficacy|7
7808902|NCT00440999|27129025|P1|Overall Study|Lack of Efficacy|6
7808903|NCT00440999|27129024|P2|Overall Study|Adverse Event|2
7808904|NCT00440999|27129025|P1|Overall Study|Adverse Event|0
7808905|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
7808906|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7808907|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7808908|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7808909|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7808910|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Physician Decision|1
7808911|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Physician Decision|0
7808912|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Physician Decision|0
7808913|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Physician Decision|0
7808914|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Physician Decision|0
7808915|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Other|0
7808916|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Other|1
7808917|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Other|0
7808918|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Other|0
7808919|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Other|0
7808920|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
7808921|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
7808922|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7808923|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7808924|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7808925|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Sponsor Request|1
7808926|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Sponsor Request|1
7808927|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Sponsor Request|0
7808928|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Sponsor Request|0
7808929|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Sponsor Request|0
7808930|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Participant Moved|1
7808931|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Participant Moved|1
7808932|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Participant Moved|0
7808933|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Participant Moved|0
7808934|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Participant Moved|0
7808935|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Pregnancy|0
7808936|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Pregnancy|3
7808937|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Pregnancy|0
7808938|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Pregnancy|0
7808939|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Pregnancy|0
7808940|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
7808941|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
7808942|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7808943|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7808944|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7808945|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Protocol Violation|0
7808946|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Protocol Violation|1
7808947|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Protocol Violation|0
7808948|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Protocol Violation|0
7808949|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Protocol Violation|0
7808950|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
7808951|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
7808952|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
7808953|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
7808954|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
7808955|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Non-compliance|1
7808956|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Non-compliance|1
7808957|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Non-compliance|0
7808958|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Non-compliance|0
7808959|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Non-compliance|0
7808960|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
7808961|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
7808962|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7808963|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7808964|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7808965|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
7808966|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
7808967|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7808968|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7808969|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7808970|NCT00440947|27129047|P5|Optional 60-Week Extension Phase|Adverse Event|3
7808971|NCT00440947|27129048|P4|Optional 60-Week Extension Phase|Adverse Event|1
7808972|NCT00440947|27129049|P3|Optional 60-Week Extension Phase|Adverse Event|0
7808973|NCT00440947|27129050|P2|Optional 60-Week Extension Phase|Adverse Event|0
7808974|NCT00440947|27129051|P1|Optional 60-Week Extension Phase|Adverse Event|0
7808975|NCT00440947|27129047|P5|48-Week Randomization Phase|Physician Decision|0
7808976|NCT00440947|27129048|P4|48-Week Randomization Phase|Physician Decision|0
7808977|NCT00440947|27129049|P3|48-Week Randomization Phase|Physician Decision|0
7808978|NCT00440947|27129050|P2|48-Week Randomization Phase|Physician Decision|2
7808979|NCT00440947|27129051|P1|48-Week Randomization Phase|Physician Decision|0
7808980|NCT00440947|27129047|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
7808981|NCT00440947|27129048|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
7808982|NCT00440947|27129049|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
7808983|NCT00440947|27129050|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
7808984|NCT00440947|27129051|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
7808985|NCT00440947|27129047|P5|48-Week Randomization Phase|Incarceration|0
7808986|NCT00440947|27129048|P4|48-Week Randomization Phase|Incarceration|0
7808987|NCT00440947|27129049|P3|48-Week Randomization Phase|Incarceration|0
7808988|NCT00440947|27129050|P2|48-Week Randomization Phase|Incarceration|3
7808989|NCT00440947|27129051|P1|48-Week Randomization Phase|Incarceration|0
7808990|NCT00440947|27129047|P5|48-Week Randomization Phase|Pregnancy|0
7808991|NCT00440947|27129048|P4|48-Week Randomization Phase|Pregnancy|0
7808992|NCT00440947|27129049|P3|48-Week Randomization Phase|Pregnancy|1
7808993|NCT00440947|27129050|P2|48-Week Randomization Phase|Pregnancy|0
7808994|NCT00440947|27129051|P1|48-Week Randomization Phase|Pregnancy|0
7808995|NCT00440947|27129047|P5|48-Week Randomization Phase|Withdrawal by Subject|0
7808996|NCT00440947|27129048|P4|48-Week Randomization Phase|Withdrawal by Subject|0
7808997|NCT00440947|27129049|P3|48-Week Randomization Phase|Withdrawal by Subject|4
7808998|NCT00440947|27129050|P2|48-Week Randomization Phase|Withdrawal by Subject|2
7808999|NCT00440947|27129051|P1|48-Week Randomization Phase|Withdrawal by Subject|0
7809000|NCT00440947|27129047|P5|48-Week Randomization Phase|Protocol Violation|0
7809001|NCT00440947|27129048|P4|48-Week Randomization Phase|Protocol Violation|0
7809002|NCT00440947|27129049|P3|48-Week Randomization Phase|Protocol Violation|1
7809003|NCT00440947|27129050|P2|48-Week Randomization Phase|Protocol Violation|0
7809004|NCT00440947|27129051|P1|48-Week Randomization Phase|Protocol Violation|0
7809005|NCT00440947|27129047|P5|48-Week Randomization Phase|Lost to Follow-up|0
7809006|NCT00440947|27129048|P4|48-Week Randomization Phase|Lost to Follow-up|0
7809007|NCT00440947|27129049|P3|48-Week Randomization Phase|Lost to Follow-up|8
7809008|NCT00440947|27129050|P2|48-Week Randomization Phase|Lost to Follow-up|2
7809009|NCT00440947|27129051|P1|48-Week Randomization Phase|Lost to Follow-up|0
7809010|NCT00440947|27129047|P5|48-Week Randomization Phase|Non-compliance|0
7809011|NCT00440947|27129048|P4|48-Week Randomization Phase|Non-compliance|0
7809012|NCT00440947|27129049|P3|48-Week Randomization Phase|Non-compliance|4
7809013|NCT00440947|27129050|P2|48-Week Randomization Phase|Non-compliance|3
7809014|NCT00440947|27129051|P1|48-Week Randomization Phase|Non-compliance|0
7809015|NCT00440947|27129047|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7809016|NCT00440947|27129048|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7809017|NCT00440947|27129049|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
7809018|NCT00440947|27129050|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
7809019|NCT00440947|27129051|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7809020|NCT00440947|27129047|P5|48-Week Randomization Phase|Adverse Event|0
7809021|NCT00440947|27129048|P4|48-Week Randomization Phase|Adverse Event|0
7809022|NCT00440947|27129049|P3|48-Week Randomization Phase|Adverse Event|5
7809023|NCT00440947|27129050|P2|48-Week Randomization Phase|Adverse Event|2
7809024|NCT00440947|27129051|P1|48-Week Randomization Phase|Adverse Event|0
7809025|NCT00440947|27129047|P5|36-Week Induction Phase|Pregnancy|0
7809026|NCT00440947|27129048|P4|36-Week Induction Phase|Pregnancy|0
7809027|NCT00440947|27129049|P3|36-Week Induction Phase|Pregnancy|0
7809028|NCT00440947|27129050|P2|36-Week Induction Phase|Pregnancy|0
7809029|NCT00440947|27129051|P1|36-Week Induction Phase|Pregnancy|1
7809030|NCT00440947|27129047|P5|36-Week Induction Phase|Incarceration|0
7809031|NCT00440947|27129048|P4|36-Week Induction Phase|Incarceration|0
7809032|NCT00440947|27129049|P3|36-Week Induction Phase|Incarceration|0
7809033|NCT00440947|27129050|P2|36-Week Induction Phase|Incarceration|0
7809034|NCT00440947|27129051|P1|36-Week Induction Phase|Incarceration|3
7809035|NCT00440947|27129047|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7809036|NCT00440947|27129048|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7809037|NCT00440947|27129049|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7809038|NCT00440947|27129050|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7809039|NCT00440947|27129051|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
7809040|NCT00440947|27129047|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7809041|NCT00440947|27129048|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7809042|NCT00440947|27129049|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7809043|NCT00440947|27129050|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7809044|NCT00440947|27129051|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
7809045|NCT00440947|27129047|P5|36-Week Induction Phase|Took Exclusionary Medications|0
7809046|NCT00440947|27129048|P4|36-Week Induction Phase|Took Exclusionary Medications|0
7809047|NCT00440947|27129049|P3|36-Week Induction Phase|Took Exclusionary Medications|0
7809048|NCT00440947|27129050|P2|36-Week Induction Phase|Took Exclusionary Medications|0
7809049|NCT00440947|27129051|P1|36-Week Induction Phase|Took Exclusionary Medications|1
7809050|NCT00440947|27129047|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7809051|NCT00440947|27129048|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7809052|NCT00440947|27129049|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7809053|NCT00440947|27129050|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7809054|NCT00440947|27129051|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
7809055|NCT00440947|27129047|P5|36-Week Induction Phase|Withdrawal by Subject|0
7809056|NCT00440947|27129048|P4|36-Week Induction Phase|Withdrawal by Subject|0
7809057|NCT00440947|27129049|P3|36-Week Induction Phase|Withdrawal by Subject|0
7809058|NCT00440947|27129050|P2|36-Week Induction Phase|Withdrawal by Subject|0
7809059|NCT00440947|27129051|P1|36-Week Induction Phase|Withdrawal by Subject|7
7809060|NCT00440947|27129047|P5|36-Week Induction Phase|Lost to Follow-up|0
7809061|NCT00440947|27129048|P4|36-Week Induction Phase|Lost to Follow-up|0
7809062|NCT00440947|27129049|P3|36-Week Induction Phase|Lost to Follow-up|0
7809063|NCT00440947|27129050|P2|36-Week Induction Phase|Lost to Follow-up|0
7809064|NCT00440947|27129051|P1|36-Week Induction Phase|Lost to Follow-up|16
7809065|NCT00440947|27129047|P5|36-Week Induction Phase|Non-compliance|0
7809066|NCT00440947|27129048|P4|36-Week Induction Phase|Non-compliance|0
7809067|NCT00440947|27129049|P3|36-Week Induction Phase|Non-compliance|0
7809068|NCT00440947|27129050|P2|36-Week Induction Phase|Non-compliance|0
7809069|NCT00440947|27129051|P1|36-Week Induction Phase|Non-compliance|10
7809070|NCT00440947|27129047|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7809071|NCT00440947|27129048|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7809072|NCT00440947|27129049|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7809073|NCT00440947|27129050|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7809074|NCT00440947|27129051|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
7809075|NCT00440947|27129047|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
7809076|NCT00440947|27129048|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
7809077|NCT00440947|27129049|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
7809078|NCT00440947|27129050|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
7809079|NCT00440947|27129051|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
7809080|NCT00440947|27129047|P5|36-Week Induction Phase|Adverse Event|0
7809081|NCT00440947|27129048|P4|36-Week Induction Phase|Adverse Event|0
7809082|NCT00440947|27129049|P3|36-Week Induction Phase|Adverse Event|0
7809083|NCT00440947|27129050|P2|36-Week Induction Phase|Adverse Event|0
7809084|NCT00440947|27129051|P1|36-Week Induction Phase|Adverse Event|16
7809085|NCT00440726|27129146|P3|Phase 2|Adverse Event|1
7809086|NCT00440726|27129147|P2|Phase 2|Adverse Event|0
7809087|NCT00440726|27129148|P1|Phase 2|Adverse Event|0
7809088|NCT00440726|27129146|P3|Phase 2|Death|1
7809089|NCT00440726|27129147|P2|Phase 2|Death|0
7809090|NCT00440726|27129148|P1|Phase 2|Death|0
7809091|NCT00440726|27129146|P3|Phase 1|Physician Decision|0
7809092|NCT00440726|27129147|P2|Phase 1|Physician Decision|0
7809093|NCT00440726|27129148|P1|Phase 1|Physician Decision|1
7809094|NCT00440726|27129146|P3|Phase 1|Dose-Limiting Toxicity|0
7809095|NCT00440726|27129147|P2|Phase 1|Dose-Limiting Toxicity|1
7809096|NCT00440726|27129148|P1|Phase 1|Dose-Limiting Toxicity|0
7809097|NCT00440700|27129162|P3|Overall Study|Withdrawal by Subject|4
7809098|NCT00440700|27129163|P2|Overall Study|Withdrawal by Subject|8
7809099|NCT00440700|27129164|P1|Overall Study|Withdrawal by Subject|8
7809100|NCT00440557|27129198|P3|Overall Study|Patient had surgery|0
7809101|NCT00440557|27129199|P2|Overall Study|Patient had surgery|0
7809102|NCT00440557|27129200|P1|Overall Study|Patient had surgery|1
7809103|NCT00440557|27129198|P3|Overall Study|Patient transferred to nursing home|0
7809104|NCT00440557|27129199|P2|Overall Study|Patient transferred to nursing home|1
7809105|NCT00440557|27129200|P1|Overall Study|Patient transferred to nursing home|0
7809106|NCT00440557|27129198|P3|Overall Study|Principal Investigator's office closed|4
7809107|NCT00440557|27129199|P2|Overall Study|Principal Investigator's office closed|6
7809108|NCT00440557|27129200|P1|Overall Study|Principal Investigator's office closed|3
7809109|NCT00440557|27129198|P3|Overall Study|Patient moved|1
7809110|NCT00440557|27129199|P2|Overall Study|Patient moved|2
7809111|NCT00440557|27129200|P1|Overall Study|Patient moved|1
7809112|NCT00440557|27129198|P3|Overall Study|Principal Investigator decision|1
7809113|NCT00440557|27129199|P2|Overall Study|Principal Investigator decision|3
7809114|NCT00440557|27129200|P1|Overall Study|Principal Investigator decision|0
7809115|NCT00440557|27129198|P3|Overall Study|Began Dialysis|4
7809116|NCT00440557|27129199|P2|Overall Study|Began Dialysis|1
7809117|NCT00440557|27129200|P1|Overall Study|Began Dialysis|4
7809118|NCT00440557|27129198|P3|Overall Study|Death|3
7809119|NCT00440557|27129199|P2|Overall Study|Death|6
7809120|NCT00440557|27129200|P1|Overall Study|Death|2
7809121|NCT00440557|27129198|P3|Overall Study|Adverse Event|5
7809122|NCT00440557|27129199|P2|Overall Study|Adverse Event|3
7809123|NCT00440557|27129200|P1|Overall Study|Adverse Event|3
7809124|NCT00440557|27129198|P3|Overall Study|Lost to Follow-up|6
7809125|NCT00440557|27129199|P2|Overall Study|Lost to Follow-up|2
7809126|NCT00440557|27129200|P1|Overall Study|Lost to Follow-up|1
7809127|NCT00440557|27129198|P3|Overall Study|Withdrawal by Subject|11
7809128|NCT00440557|27129199|P2|Overall Study|Withdrawal by Subject|5
7809129|NCT00440557|27129200|P1|Overall Study|Withdrawal by Subject|10
7809130|NCT00440531|27129232|P3|Overall Study|see pre-assignment details|0
7809131|NCT00440531|27129233|P2|Overall Study|see pre-assignment details|0
7809132|NCT00440531|27129234|P1|Overall Study|see pre-assignment details|2
7809133|NCT00440531|27129232|P3|Overall Study|Lost to Follow-up|5
7809134|NCT00440531|27129233|P2|Overall Study|Lost to Follow-up|3
7809135|NCT00440531|27129234|P1|Overall Study|Lost to Follow-up|4
7809136|NCT00440531|27129232|P3|Overall Study|Protocol Violation|0
7809137|NCT00440531|27129233|P2|Overall Study|Protocol Violation|2
7809138|NCT00440531|27129234|P1|Overall Study|Protocol Violation|1
7809139|NCT00440531|27129232|P3|Overall Study|Withdrawal by Subject|0
7809140|NCT00440531|27129233|P2|Overall Study|Withdrawal by Subject|0
7809141|NCT00440531|27129234|P1|Overall Study|Withdrawal by Subject|2
7809142|NCT00440531|27129232|P3|Overall Study|Adverse Event|2
7809143|NCT00440531|27129233|P2|Overall Study|Adverse Event|0
7809144|NCT00440531|27129234|P1|Overall Study|Adverse Event|1
7809145|NCT00440518|27129251|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
7809146|NCT00440518|27129252|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
7809147|NCT00440518|27129253|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
7809148|NCT00440518|27129251|P3|Maintenance and Safety Follow-up Periods|Other|2
7809149|NCT00440518|27129252|P2|Maintenance and Safety Follow-up Periods|Other|0
7809150|NCT00440518|27129253|P1|Maintenance and Safety Follow-up Periods|Other|0
7809151|NCT00440518|27129251|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
7809152|NCT00440518|27129252|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
7809153|NCT00440518|27129253|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
7809154|NCT00440518|27129251|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
7809155|NCT00440518|27129252|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
7809156|NCT00440518|27129253|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
7809157|NCT00440518|27129251|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
7809158|NCT00440518|27129252|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
7809159|NCT00440518|27129253|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
7809160|NCT00440518|27129251|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
7809161|NCT00440518|27129252|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
7809162|NCT00440518|27129253|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
7809163|NCT00440518|27129251|P3|Randomized /Titration Period|Adverse Event|0
7809164|NCT00440518|27129252|P2|Randomized /Titration Period|Adverse Event|3
7809165|NCT00440518|27129253|P1|Randomized /Titration Period|Adverse Event|2
7809166|NCT00440518|27129251|P3|Randomized /Titration Period|Lost to Follow-up|1
7809167|NCT00440518|27129252|P2|Randomized /Titration Period|Lost to Follow-up|2
7809168|NCT00440518|27129253|P1|Randomized /Titration Period|Lost to Follow-up|2
7809169|NCT00440518|27129251|P3|Randomized /Titration Period|Other|0
7809170|NCT00440518|27129252|P2|Randomized /Titration Period|Other|0
7809171|NCT00440518|27129253|P1|Randomized /Titration Period|Other|1
7809172|NCT00440518|27129251|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
7809173|NCT00440518|27129252|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
7809174|NCT00440518|27129253|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
7809175|NCT00440518|27129251|P3|Randomized /Titration Period|Protocol Deviation|0
7809176|NCT00440518|27129252|P2|Randomized /Titration Period|Protocol Deviation|0
7809177|NCT00440518|27129253|P1|Randomized /Titration Period|Protocol Deviation|1
7809178|NCT00440518|27129251|P3|Randomized /Titration Period|Subject Withdrew Consent|0
7809179|NCT00440518|27129252|P2|Randomized /Titration Period|Subject Withdrew Consent|1
7809180|NCT00440518|27129253|P1|Randomized /Titration Period|Subject Withdrew Consent|4
7809181|NCT00440518|27129251|P3|Randomized /Titration Period|Lack of Efficacy|1
7809182|NCT00440518|27129252|P2|Randomized /Titration Period|Lack of Efficacy|0
7809183|NCT00440518|27129253|P1|Randomized /Titration Period|Lack of Efficacy|1
7809184|NCT00440466|27129298|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
7809185|NCT00440466|27129299|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
7809186|NCT00440466|27129300|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
7809187|NCT00440466|27129298|P3|Overall Study|Began Dialysis|1
7809188|NCT00440466|27129299|P2|Overall Study|Began Dialysis|0
7809189|NCT00440466|27129300|P1|Overall Study|Began Dialysis|0
7809190|NCT00440466|27129298|P3|Overall Study|Withdrawal by Subject|9
7809191|NCT00440466|27129299|P2|Overall Study|Withdrawal by Subject|5
7809192|NCT00440466|27129300|P1|Overall Study|Withdrawal by Subject|2
7809193|NCT00440466|27129298|P3|Overall Study|Protocol Violation|4
7809194|NCT00440466|27129299|P2|Overall Study|Protocol Violation|0
7809195|NCT00440466|27129300|P1|Overall Study|Protocol Violation|2
7809196|NCT00440466|27129298|P3|Overall Study|Physician Decision|1
7809197|NCT00440466|27129299|P2|Overall Study|Physician Decision|0
7809198|NCT00440466|27129300|P1|Overall Study|Physician Decision|2
7809199|NCT00440466|27129298|P3|Overall Study|Lost to Follow-up|2
7809200|NCT00440466|27129299|P2|Overall Study|Lost to Follow-up|0
7809201|NCT00440466|27129300|P1|Overall Study|Lost to Follow-up|1
7809202|NCT00440466|27129298|P3|Overall Study|Adverse Event|11
7809203|NCT00440466|27129299|P2|Overall Study|Adverse Event|4
7809204|NCT00440466|27129300|P1|Overall Study|Adverse Event|3
7809205|NCT00440466|27129298|P3|Overall Study|Death|9
7809206|NCT00440466|27129299|P2|Overall Study|Death|2
7809207|NCT00440466|27129300|P1|Overall Study|Death|3
7809208|NCT00440401|27129334|P2|Overall Study|Other|5
7809209|NCT00440401|27129335|P1|Overall Study|Other|2
7809210|NCT00440401|27129334|P2|Overall Study|Adverse Event|1
7809211|NCT00440401|27129335|P1|Overall Study|Adverse Event|2
7809212|NCT00440310|27129345|P2|Overall Study|Status Unknown|3
7809213|NCT00440310|27129346|P1|Overall Study|Status Unknown|1
7809214|NCT00440310|27129345|P2|Overall Study|Other|0
7809215|NCT00440310|27129346|P1|Overall Study|Other|1
7809216|NCT00440310|27129345|P2|Overall Study|No Reply at EOS|7
7809217|NCT00440310|27129346|P1|Overall Study|No Reply at EOS|7
7809218|NCT00440310|27129345|P2|Overall Study|Withdrawal by Subject|14
7809219|NCT00440310|27129346|P1|Overall Study|Withdrawal by Subject|15
7809220|NCT00440310|27129345|P2|Overall Study|Protocol Violation|1
7809221|NCT00440310|27129346|P1|Overall Study|Protocol Violation|0
7809222|NCT00440310|27129345|P2|Overall Study|Lost to Follow-up|5
7809223|NCT00440310|27129346|P1|Overall Study|Lost to Follow-up|4
7809224|NCT00440297|27129354|P2|Overall Study|Randomized by mistake|0
7809225|NCT00440297|27129355|P1|Overall Study|Randomized by mistake|1
7809226|NCT00440297|27129354|P2|Overall Study|Withdrawal by Subject|6
7809227|NCT00440297|27129355|P1|Overall Study|Withdrawal by Subject|1
7809228|NCT00440297|27129354|P2|Overall Study|Protocol Violation|7
7809229|NCT00440297|27129355|P1|Overall Study|Protocol Violation|11
7809230|NCT00440297|27129354|P2|Overall Study|Physician Decision|0
7809231|NCT00440297|27129355|P1|Overall Study|Physician Decision|1
7809232|NCT00440297|27129354|P2|Overall Study|Lost to Follow-up|0
7809233|NCT00440297|27129355|P1|Overall Study|Lost to Follow-up|1
7809234|NCT00440297|27129354|P2|Overall Study|Adverse Event|5
7809235|NCT00440297|27129355|P1|Overall Study|Adverse Event|8
7809236|NCT00440271|27129371|P2|Overall Study|Other|0
7809237|NCT00440271|27129372|P1|Overall Study|Other|2
7809238|NCT00440271|27129371|P2|Overall Study|Due to closure of trial|10
7809239|NCT00440271|27129372|P1|Overall Study|Due to closure of trial|8
7809240|NCT00440271|27129371|P2|Overall Study|Lack of Efficacy|1
7809241|NCT00440271|27129372|P1|Overall Study|Lack of Efficacy|0
7809242|NCT00440271|27129371|P2|Overall Study|Withdrawal by Subject|2
7809243|NCT00440271|27129372|P1|Overall Study|Withdrawal by Subject|0
7809244|NCT00440271|27129371|P2|Overall Study|Lost to Follow-up|0
7809245|NCT00440271|27129372|P1|Overall Study|Lost to Follow-up|1
7809246|NCT00440271|27129371|P2|Overall Study|Adverse Event|1
7809247|NCT00440271|27129372|P1|Overall Study|Adverse Event|0
7809248|NCT00440271|27129371|P2|Overall Study|Protocol Violation|1
7809249|NCT00440271|27129372|P1|Overall Study|Protocol Violation|1
7809250|NCT00440232|27129406|P2|Overall Study|Onset of headache within 4 hours of fast|2
7809251|NCT00440232|27129407|P1|Overall Study|Onset of headache within 4 hours of fast|2
7809252|NCT00440232|27129406|P2|Overall Study|Unable to treat within allowed time|1
7809253|NCT00440232|27129407|P1|Overall Study|Unable to treat within allowed time|0
7809254|NCT00440232|27129406|P2|Overall Study|Lost to Follow-up|1
7809255|NCT00440232|27129407|P1|Overall Study|Lost to Follow-up|1
7809256|NCT00440193|27129417|P2|Observational Period|Participant convenience|0
7809257|NCT00440193|27129418|P1|Observational Period|Participant convenience|2
7809258|NCT00440193|27129417|P2|Observational Period|Clinical endpoint reached|0
7809259|NCT00440193|27129418|P1|Observational Period|Clinical endpoint reached|1
7809260|NCT00440193|27129417|P2|Observational Period|Physician Decision|0
7809261|NCT00440193|27129418|P1|Observational Period|Physician Decision|1
7809262|NCT00440193|27129417|P2|Observational Period|Withdrawal by Subject|8
7809263|NCT00440193|27129418|P1|Observational Period|Withdrawal by Subject|11
7809264|NCT00440193|27129417|P2|Observational Period|Protocol Violation|0
7809265|NCT00440193|27129418|P1|Observational Period|Protocol Violation|1
7809266|NCT00440193|27129417|P2|Observational Period|Lost to Follow-up|8
7809267|NCT00440193|27129418|P1|Observational Period|Lost to Follow-up|12
7809268|NCT00440193|27129417|P2|Observational Period|Death|20
7809269|NCT00440193|27129418|P1|Observational Period|Death|15
7809270|NCT00440193|27129417|P2|Observational Period|Adverse Event|2
7809271|NCT00440193|27129418|P1|Observational Period|Adverse Event|2
7809272|NCT00440193|27129417|P2|Treatment Period|Site closed by investigator|2
7809273|NCT00440193|27129418|P1|Treatment Period|Site closed by investigator|0
7809274|NCT00440193|27129417|P2|Treatment Period|Participant did not receive treatment|13
7809275|NCT00440193|27129418|P1|Treatment Period|Participant did not receive treatment|7
7809276|NCT00440193|27129417|P2|Treatment Period|Participant convenience|2
7809277|NCT00440193|27129418|P1|Treatment Period|Participant convenience|5
7809278|NCT00440193|27129417|P2|Treatment Period|Technical problems|1
7809279|NCT00440193|27129418|P1|Treatment Period|Technical problems|1
7809280|NCT00440193|27129417|P2|Treatment Period|Switch to commercial drug|2
7809281|NCT00440193|27129418|P1|Treatment Period|Switch to commercial drug|0
7809282|NCT00440193|27129417|P2|Treatment Period|Protocol driven decision point|2
7809283|NCT00440193|27129418|P1|Treatment Period|Protocol driven decision point|2
7809284|NCT00440193|27129417|P2|Treatment Period|Study terminated by sponsor|94
7809285|NCT00440193|27129418|P1|Treatment Period|Study terminated by sponsor|102
7809286|NCT00440193|27129417|P2|Treatment Period|Clinical endpoint reached|25
7809287|NCT00440193|27129418|P1|Treatment Period|Clinical endpoint reached|28
7809288|NCT00440193|27129417|P2|Treatment Period|Withdrawal by Subject|77
7809289|NCT00440193|27129418|P1|Treatment Period|Withdrawal by Subject|36
7809290|NCT00440193|27129417|P2|Treatment Period|Protocol Violation|19
7809291|NCT00440193|27129418|P1|Treatment Period|Protocol Violation|16
7809292|NCT00440193|27129417|P2|Treatment Period|Physician Decision|6
7809293|NCT00440193|27129418|P1|Treatment Period|Physician Decision|3
7809294|NCT00440193|27129417|P2|Treatment Period|Lost to Follow-up|18
7809295|NCT00440193|27129418|P1|Treatment Period|Lost to Follow-up|12
7809296|NCT00440193|27129417|P2|Treatment Period|Lack of Efficacy|1
7809297|NCT00440193|27129418|P1|Treatment Period|Lack of Efficacy|0
7809298|NCT00440193|27129417|P2|Treatment Period|Death|22
7809299|NCT00440193|27129418|P1|Treatment Period|Death|19
7809300|NCT00440193|27129417|P2|Treatment Period|Adverse Event|67
7809301|NCT00440193|27129418|P1|Treatment Period|Adverse Event|74
7809302|NCT00440115|27129464|P3|Overall Study|Incarceration|1
7809303|NCT00440115|27129465|P2|Overall Study|Incarceration|2
7809304|NCT00440115|27129466|P1|Overall Study|Incarceration|0
7809305|NCT00440115|27129464|P3|Overall Study|Death|5
7809306|NCT00440115|27129465|P2|Overall Study|Death|9
7809307|NCT00440115|27129466|P1|Overall Study|Death|7
7809308|NCT00440037|27129495|P1|Overall Study|Administrative decision|3
7809309|NCT00440037|27129495|P1|Overall Study|Withdrawal by Subject|6
7809310|NCT00440011|27129505|P2|Overall Study|Withdrawal by Subject|0
7809311|NCT00440011|27129506|P1|Overall Study|Withdrawal by Subject|1
7809312|NCT00440011|27129505|P2|Overall Study|Protocol Violation|1
7809313|NCT00440011|27129506|P1|Overall Study|Protocol Violation|1
7809314|NCT00440011|27129505|P2|Overall Study|Lost to Follow-up|2
7809315|NCT00440011|27129506|P1|Overall Study|Lost to Follow-up|0
7809316|NCT00440011|27129505|P2|Overall Study|Adverse Event|0
7809317|NCT00440011|27129506|P1|Overall Study|Adverse Event|2
7809318|NCT00439777|27129533|P2|Observational Period|Technical problems|1
7809319|NCT00439777|27129534|P1|Observational Period|Technical problems|0
7809320|NCT00439777|27129533|P2|Observational Period|Lack of Efficacy|0
7809321|NCT00439777|27129534|P1|Observational Period|Lack of Efficacy|1
7809322|NCT00439777|27129533|P2|Observational Period|Protocol driven decision point|1
7809323|NCT00439777|27129534|P1|Observational Period|Protocol driven decision point|0
7809324|NCT00439777|27129533|P2|Observational Period|Study terminated by sponsor|1
7809325|NCT00439777|27129534|P1|Observational Period|Study terminated by sponsor|3
7809326|NCT00439777|27129533|P2|Observational Period|Death|20
7809327|NCT00439777|27129534|P1|Observational Period|Death|27
7809328|NCT00439777|27129533|P2|Observational Period|Lost to Follow-up|11
7809329|NCT00439777|27129534|P1|Observational Period|Lost to Follow-up|1
7809330|NCT00439777|27129533|P2|Observational Period|Withdrawal by Subject|5
7809331|NCT00439777|27129534|P1|Observational Period|Withdrawal by Subject|9
7809332|NCT00439777|27129533|P2|Observational Period|Protocol Violation|2
7809333|NCT00439777|27129534|P1|Observational Period|Protocol Violation|0
7809334|NCT00439777|27129533|P2|Treatment Period|Participant convenience|8
7809335|NCT00439777|27129534|P1|Treatment Period|Participant convenience|12
7809336|NCT00439777|27129533|P2|Treatment Period|Technical problems|1
7809337|NCT00439777|27129534|P1|Treatment Period|Technical problems|3
7809338|NCT00439777|27129533|P2|Treatment Period|Clinical endpoint reached|13
7809339|NCT00439777|27129534|P1|Treatment Period|Clinical endpoint reached|26
7809340|NCT00439777|27129533|P2|Treatment Period|Physician Decision|18
7809341|NCT00439777|27129534|P1|Treatment Period|Physician Decision|7
7809342|NCT00439777|27129533|P2|Treatment Period|Protocol driven decision point|3
7809343|NCT00439777|27129534|P1|Treatment Period|Protocol driven decision point|1
7809344|NCT00439777|27129533|P2|Treatment Period|Lost to Follow-up|10
7809345|NCT00439777|27129534|P1|Treatment Period|Lost to Follow-up|8
7809346|NCT00439777|27129533|P2|Treatment Period|Lack of Efficacy|4
7809347|NCT00439777|27129534|P1|Treatment Period|Lack of Efficacy|1
7809348|NCT00439777|27129533|P2|Treatment Period|Withdrawal by Subject|118
7809349|NCT00439777|27129534|P1|Treatment Period|Withdrawal by Subject|66
7809350|NCT00439777|27129533|P2|Treatment Period|Protocol Violation|30
7809351|NCT00439777|27129534|P1|Treatment Period|Protocol Violation|23
7809352|NCT00439777|27129533|P2|Treatment Period|Adverse Event|92
7809353|NCT00439777|27129534|P1|Treatment Period|Adverse Event|111
7809354|NCT00439777|27129533|P2|Treatment Period|Did not take study treatment|8
7809355|NCT00439777|27129534|P1|Treatment Period|Did not take study treatment|7
7809356|NCT00439777|27129533|P2|Treatment Period|Site closed by investigator|1
7809357|NCT00439777|27129534|P1|Treatment Period|Site closed by investigator|0
7809358|NCT00439777|27129533|P2|Treatment Period|Study terminated by sponsor|132
7809359|NCT00439777|27129534|P1|Treatment Period|Study terminated by sponsor|125
7809360|NCT00439777|27129533|P2|Treatment Period|Death|21
7809361|NCT00439777|27129534|P1|Treatment Period|Death|29
7809362|NCT00439738|27129572|P2|Overall Study|Abnormal Lab Values|0
7809363|NCT00439738|27129573|P1|Overall Study|Abnormal Lab Values|1
7809364|NCT00439738|27129572|P2|Overall Study|Lack of Efficacy|2
7809365|NCT00439738|27129573|P1|Overall Study|Lack of Efficacy|2
7809366|NCT00439738|27129572|P2|Overall Study|Protocol Violation|3
7809367|NCT00439738|27129573|P1|Overall Study|Protocol Violation|6
7809368|NCT00439738|27129572|P2|Overall Study|Lost to Follow-up|6
7809369|NCT00439738|27129573|P1|Overall Study|Lost to Follow-up|5
7809370|NCT00439738|27129572|P2|Overall Study|Adverse Event|4
7809371|NCT00439738|27129573|P1|Overall Study|Adverse Event|6
7809372|NCT00439738|27129572|P2|Overall Study|Withdrawal by Subject|13
7809373|NCT00439738|27129573|P1|Overall Study|Withdrawal by Subject|16
7809374|NCT00439725|27129591|P2|Observational Period|Participant convenience|0
7809375|NCT00439725|27129592|P1|Observational Period|Participant convenience|1
7809376|NCT00439725|27129591|P2|Observational Period|Technical problems|0
7809377|NCT00439725|27129592|P1|Observational Period|Technical problems|1
7809378|NCT00439725|27129591|P2|Observational Period|Clinical endpoint reached|1
7809379|NCT00439725|27129592|P1|Observational Period|Clinical endpoint reached|3
7809380|NCT00439725|27129591|P2|Observational Period|Study termination by sponsor|1
7809381|NCT00439725|27129592|P1|Observational Period|Study termination by sponsor|1
7809382|NCT00439725|27129591|P2|Observational Period|Death|2
7809383|NCT00439725|27129592|P1|Observational Period|Death|0
7809384|NCT00439725|27129591|P2|Observational Period|Lost to Follow-up|1
7809385|NCT00439725|27129592|P1|Observational Period|Lost to Follow-up|0
7809386|NCT00439725|27129591|P2|Observational Period|Withdrawal by Subject|2
7809387|NCT00439725|27129592|P1|Observational Period|Withdrawal by Subject|2
7809388|NCT00439725|27129591|P2|Treatment Period|Participant did not receive treatment|4
7809389|NCT00439725|27129592|P1|Treatment Period|Participant did not receive treatment|4
7809390|NCT00439725|27129591|P2|Treatment Period|Death|1
7809391|NCT00439725|27129592|P1|Treatment Period|Death|1
7809392|NCT00439725|27129591|P2|Treatment Period|Protocol driven decision point|1
7809393|NCT00439725|27129592|P1|Treatment Period|Protocol driven decision point|1
7809394|NCT00439725|27129591|P2|Treatment Period|Participant convenience|0
7809395|NCT00439725|27129592|P1|Treatment Period|Participant convenience|1
7809396|NCT00439725|27129591|P2|Treatment Period|Lost to Follow-up|1
7809397|NCT00439725|27129592|P1|Treatment Period|Lost to Follow-up|1
7809398|NCT00439725|27129591|P2|Treatment Period|Technical problems|0
7809399|NCT00439725|27129592|P1|Treatment Period|Technical problems|1
7809400|NCT00439725|27129591|P2|Treatment Period|Clinical endpoint reached|50
7809401|NCT00439725|27129592|P1|Treatment Period|Clinical endpoint reached|6
7809402|NCT00439725|27129591|P2|Treatment Period|Protocol Violation|1
7809403|NCT00439725|27129592|P1|Treatment Period|Protocol Violation|2
7809404|NCT00439725|27129591|P2|Treatment Period|Physician Decision|1
7809405|NCT00439725|27129592|P1|Treatment Period|Physician Decision|1
7809406|NCT00439725|27129591|P2|Treatment Period|Adverse Event|18
7809407|NCT00439725|27129592|P1|Treatment Period|Adverse Event|39
7809408|NCT00439725|27129591|P2|Treatment Period|Site closed by investigator|2
7809409|NCT00439725|27129592|P1|Treatment Period|Site closed by investigator|1
7809410|NCT00439725|27129591|P2|Treatment Period|Study terminated by sponsor|148
7809411|NCT00439725|27129592|P1|Treatment Period|Study terminated by sponsor|156
7809412|NCT00439725|27129591|P2|Treatment Period|Withdrawal by Subject|19
7809413|NCT00439725|27129592|P1|Treatment Period|Withdrawal by Subject|22
7809414|NCT00439647|27129643|P2|Overall Study|Lack of Efficacy|4
7809415|NCT00439647|27129644|P1|Overall Study|Lack of Efficacy|0
7809416|NCT00439647|27129643|P2|Overall Study|Protocol Violation|4
7809417|NCT00439647|27129644|P1|Overall Study|Protocol Violation|3
7809418|NCT00439647|27129643|P2|Overall Study|Lost to Follow-up|12
7809419|NCT00439647|27129644|P1|Overall Study|Lost to Follow-up|4
7809420|NCT00439647|27129643|P2|Overall Study|Adverse Event|11
7809421|NCT00439647|27129644|P1|Overall Study|Adverse Event|11
7809422|NCT00439647|27129643|P2|Overall Study|Death|18
7809423|NCT00439647|27129644|P1|Overall Study|Death|15
7809424|NCT00439647|27129643|P2|Overall Study|Withdrawal by Subject|22
7809425|NCT00439647|27129644|P1|Overall Study|Withdrawal by Subject|25
7809426|NCT00439569|27129681|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
7809427|NCT00439569|27129681|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
7809428|NCT00439569|27129681|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
7809429|NCT00439556|27129695|P3|Overall Study|Patient was taken off study for non-comp|0
7809430|NCT00439556|27129696|P2|Overall Study|Patient was taken off study for non-comp|1
7809431|NCT00439556|27129697|P1|Overall Study|Patient was taken off study for non-comp|0
7809432|NCT00439517|27129710|P2|Overall Study|Subject in survival follow-up|0
7809433|NCT00439517|27129711|P1|Overall Study|Subject in survival follow-up|1
7809434|NCT00439517|27129710|P2|Overall Study|Subject on treatment|0
7809435|NCT00439517|27129711|P1|Overall Study|Subject on treatment|1
7809436|NCT00439309|27129850|P2|Follow-Up|Late response by subject|1
7809437|NCT00439309|27129851|P1|Follow-Up|Late response by subject|0
7809438|NCT00439309|27129850|P2|Follow-Up|Withdrawal by Subject|1
7809439|NCT00439309|27129851|P1|Follow-Up|Withdrawal by Subject|0
7809440|NCT00439309|27129850|P2|Follow-Up|Lost to Follow-up|0
7809441|NCT00439309|27129851|P1|Follow-Up|Lost to Follow-up|2
7809442|NCT00439309|27129850|P2|Follow-Up|Death|0
7809443|NCT00439309|27129851|P1|Follow-Up|Death|1
7809444|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7809445|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
7809446|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7809447|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7809448|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7809449|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7809450|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
7809451|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7809452|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7809453|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7809454|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7809455|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
7809456|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7809457|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7809458|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7809459|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
7809460|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
7809461|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
7809462|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
7809463|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
7809464|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7809465|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
7809466|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7809467|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7809468|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7809469|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
7809470|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
7809471|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
7809472|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
7809473|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
7809474|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7809475|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
7809476|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7809477|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7809478|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7809479|NCT00439270|27129883|P5|Phase 2 (51.6 Months)|Disease progression|0
7809480|NCT00439270|27129884|P4|Phase 2 (51.6 Months)|Disease progression|18
7809481|NCT00439270|27129885|P3|Phase 2 (51.6 Months)|Disease progression|0
7809482|NCT00439270|27129886|P2|Phase 2 (51.6 Months)|Disease progression|0
7809483|NCT00439270|27129887|P1|Phase 2 (51.6 Months)|Disease progression|0
7809484|NCT00439270|27129883|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
7809485|NCT00439270|27129884|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
7809486|NCT00439270|27129885|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
7809487|NCT00439270|27129886|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
7809488|NCT00439270|27129887|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
7809489|NCT00439270|27129883|P5|Phase 1 (18.1 Months)|Disease progression|3
7809490|NCT00439270|27129884|P4|Phase 1 (18.1 Months)|Disease progression|0
7809491|NCT00439270|27129885|P3|Phase 1 (18.1 Months)|Disease progression|3
7809492|NCT00439270|27129886|P2|Phase 1 (18.1 Months)|Disease progression|2
7809493|NCT00439270|27129887|P1|Phase 1 (18.1 Months)|Disease progression|3
7809494|NCT00439244|27129929|P3|Overall Study|Administrative problems|0
7809495|NCT00439244|27129930|P2|Overall Study|Administrative problems|0
7809496|NCT00439244|27129931|P1|Overall Study|Administrative problems|1
7809497|NCT00439244|27129929|P3|Overall Study|Protocol Violation|0
7809498|NCT00439244|27129930|P2|Overall Study|Protocol Violation|1
7809499|NCT00439244|27129931|P1|Overall Study|Protocol Violation|0
7809500|NCT00439244|27129929|P3|Overall Study|Death|0
7809501|NCT00439244|27129930|P2|Overall Study|Death|1
7809502|NCT00439244|27129931|P1|Overall Study|Death|0
7809503|NCT00439244|27129929|P3|Overall Study|Lost to Follow-up|2
7809504|NCT00439244|27129930|P2|Overall Study|Lost to Follow-up|1
7809505|NCT00439244|27129931|P1|Overall Study|Lost to Follow-up|2
7809506|NCT00439244|27129929|P3|Overall Study|Withdrawal by Subject|2
7809507|NCT00439244|27129930|P2|Overall Study|Withdrawal by Subject|1
7809508|NCT00439244|27129931|P1|Overall Study|Withdrawal by Subject|3
7809509|NCT00439244|27129929|P3|Overall Study|Adverse Event|3
7809510|NCT00439244|27129930|P2|Overall Study|Adverse Event|2
7809511|NCT00439244|27129931|P1|Overall Study|Adverse Event|5
7809512|NCT00439231|27129951|P1|Overall Study|Lack of Efficacy|28
7809513|NCT00439218|27129955|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
7809514|NCT00439179|27129970|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7809515|NCT00439179|27129971|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7809516|NCT00439179|27129972|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
7809517|NCT00439179|27129973|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7809518|NCT00439140|27129990|P3|Treatment Cycle 2|Lost to Follow-up|0
7809519|NCT00439140|27129991|P2|Treatment Cycle 2|Lost to Follow-up|1
7809520|NCT00439140|27129992|P1|Treatment Cycle 2|Lost to Follow-up|1
7809521|NCT00439140|27129990|P3|Treatment Cycle 2|Withdrawal by Subject|0
7809522|NCT00439140|27129991|P2|Treatment Cycle 2|Withdrawal by Subject|0
7809523|NCT00439140|27129992|P1|Treatment Cycle 2|Withdrawal by Subject|1
7809524|NCT00439140|27129990|P3|Treatment Cycle 1|Withdrawal by Subject|0
7809525|NCT00439140|27129991|P2|Treatment Cycle 1|Withdrawal by Subject|1
7809526|NCT00439140|27129992|P1|Treatment Cycle 1|Withdrawal by Subject|0
7809527|NCT00439140|27129990|P3|Treatment Cycle 1|Personal reasons|0
7809528|NCT00439140|27129991|P2|Treatment Cycle 1|Personal reasons|2
7809529|NCT00439140|27129992|P1|Treatment Cycle 1|Personal reasons|0
7809530|NCT00439140|27129990|P3|Treatment Cycle 1|Lost to Follow-up|1
7809531|NCT00439140|27129991|P2|Treatment Cycle 1|Lost to Follow-up|1
7809532|NCT00439140|27129992|P1|Treatment Cycle 1|Lost to Follow-up|1
7809533|NCT00438815|27130075|P1|Overall Study|Death|1
7809534|NCT00438815|27130075|P1|Overall Study|Withdrawal by Subject|6
7809535|NCT00438815|27130075|P1|Overall Study|Lost to Follow-up|6
7809536|NCT00438815|27130075|P1|Overall Study|Transitioned to commercial C1INH-nf|6
7809537|NCT00438815|27130075|P1|Overall Study|Noncompliance with protocol requirements|9
7809538|NCT00438815|27130075|P1|Overall Study|3-month follow-up no longer required|12
7809539|NCT00438815|27130075|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
7809540|NCT00438672|27130125|P2|Overall Study|Lost to Follow-up|9
7809541|NCT00438672|27130126|P1|Overall Study|Lost to Follow-up|7
7809542|NCT00438659|27130136|P2|Overall Study|Cancel|2
7809543|NCT00438659|27130137|P1|Overall Study|Cancel|5
7809544|NCT00438659|27130136|P2|Overall Study|Discontinued Mometasone/Placebo|2
7809545|NCT00438659|27130137|P1|Overall Study|Discontinued Mometasone/Placebo|1
7809546|NCT00438633|27130161|P2|Overall Study|Lost to Follow-up|17
7809547|NCT00438633|27130162|P1|Overall Study|Lost to Follow-up|15
7809548|NCT00438633|27130161|P2|Overall Study|Withdrawal by Subject|0
7809549|NCT00438633|27130162|P1|Overall Study|Withdrawal by Subject|1
7809550|NCT00438464|27130193|P2|Overall Study|Incomplete data submission|2
7809551|NCT00438464|27130194|P1|Overall Study|Incomplete data submission|0
7809552|NCT00438464|27130193|P2|Overall Study|Terminated Early|5
7809553|NCT00438464|27130194|P1|Overall Study|Terminated Early|14
7809554|NCT00438399|27130295|P6|Overall Study|Patien stopped study at visit 4 by error|0
7809555|NCT00438399|27130296|P5|Overall Study|Patien stopped study at visit 4 by error|0
7809556|NCT00438399|27130297|P4|Overall Study|Patien stopped study at visit 4 by error|0
7809557|NCT00438399|27130298|P3|Overall Study|Patien stopped study at visit 4 by error|0
7809558|NCT00438399|27130299|P2|Overall Study|Patien stopped study at visit 4 by error|0
7809559|NCT00438399|27130300|P1|Overall Study|Patien stopped study at visit 4 by error|1
7809560|NCT00438399|27130295|P6|Overall Study|Pregnancy|1
7809561|NCT00438399|27130296|P5|Overall Study|Pregnancy|0
7809562|NCT00438399|27130297|P4|Overall Study|Pregnancy|0
7809563|NCT00438399|27130298|P3|Overall Study|Pregnancy|0
7809564|NCT00438399|27130299|P2|Overall Study|Pregnancy|0
7809565|NCT00438399|27130300|P1|Overall Study|Pregnancy|0
7809566|NCT00438399|27130295|P6|Overall Study|Subje stopped study|0
7809567|NCT00438399|27130296|P5|Overall Study|Subje stopped study|0
7809568|NCT00438399|27130297|P4|Overall Study|Subje stopped study|0
7809569|NCT00438399|27130298|P3|Overall Study|Subje stopped study|1
7809570|NCT00438399|27130299|P2|Overall Study|Subje stopped study|0
7809571|NCT00438399|27130300|P1|Overall Study|Subje stopped study|0
7809572|NCT00438399|27130295|P6|Overall Study|Protocol Violation|1
7809573|NCT00438399|27130296|P5|Overall Study|Protocol Violation|0
7809574|NCT00438399|27130297|P4|Overall Study|Protocol Violation|0
7809575|NCT00438399|27130298|P3|Overall Study|Protocol Violation|1
7809576|NCT00438399|27130299|P2|Overall Study|Protocol Violation|0
7809577|NCT00438399|27130300|P1|Overall Study|Protocol Violation|0
7809578|NCT00438399|27130295|P6|Overall Study|Withdrawal by Subject|2
7809579|NCT00438399|27130296|P5|Overall Study|Withdrawal by Subject|2
7809580|NCT00438399|27130297|P4|Overall Study|Withdrawal by Subject|2
7809581|NCT00438399|27130298|P3|Overall Study|Withdrawal by Subject|3
7809582|NCT00438399|27130299|P2|Overall Study|Withdrawal by Subject|6
7809583|NCT00438399|27130300|P1|Overall Study|Withdrawal by Subject|5
7809584|NCT00438399|27130295|P6|Overall Study|Adverse Event|1
7809585|NCT00438399|27130296|P5|Overall Study|Adverse Event|0
7809586|NCT00438399|27130297|P4|Overall Study|Adverse Event|1
7809587|NCT00438399|27130298|P3|Overall Study|Adverse Event|1
7809588|NCT00438399|27130299|P2|Overall Study|Adverse Event|0
7809589|NCT00438399|27130300|P1|Overall Study|Adverse Event|0
7809590|NCT00438399|27130295|P6|Overall Study|Lost to Follow-up|1
7809591|NCT00438399|27130296|P5|Overall Study|Lost to Follow-up|1
7809592|NCT00438399|27130297|P4|Overall Study|Lost to Follow-up|1
7809593|NCT00438399|27130298|P3|Overall Study|Lost to Follow-up|1
7809594|NCT00438399|27130299|P2|Overall Study|Lost to Follow-up|2
7809595|NCT00438399|27130300|P1|Overall Study|Lost to Follow-up|2
7809596|NCT00438360|27130311|P2|Overall Study|Other|15
7809597|NCT00438360|27130312|P1|Overall Study|Other|24
7809598|NCT00438360|27130311|P2|Overall Study|Lack of Efficacy|27
7809599|NCT00438360|27130312|P1|Overall Study|Lack of Efficacy|42
7809600|NCT00438360|27130311|P2|Overall Study|Adverse Event|1
7809601|NCT00438360|27130312|P1|Overall Study|Adverse Event|6
7809602|NCT00438256|27130326|P4|Overall Study|Excluded final Diagnosis|2
7809603|NCT00438256|27130327|P3|Overall Study|Excluded final Diagnosis|0
7809604|NCT00438256|27130328|P2|Overall Study|Excluded final Diagnosis|0
7809605|NCT00438256|27130329|P1|Overall Study|Excluded final Diagnosis|0
7809606|NCT00438256|27130326|P4|Overall Study|Ineligible for Resection|7
7809607|NCT00438256|27130327|P3|Overall Study|Ineligible for Resection|1
7809608|NCT00438256|27130328|P2|Overall Study|Ineligible for Resection|1
7809609|NCT00438256|27130329|P1|Overall Study|Ineligible for Resection|2
7809610|NCT00437983|27130379|P2|Overall Study|Withdrawal by Subject|6
7809611|NCT00437983|27130380|P1|Overall Study|Withdrawal by Subject|5
7809612|NCT00437983|27130379|P2|Overall Study|Protocol Violation|1
7809613|NCT00437983|27130380|P1|Overall Study|Protocol Violation|2
7809614|NCT00437983|27130379|P2|Overall Study|Adverse Event|6
7809615|NCT00437983|27130380|P1|Overall Study|Adverse Event|6
7809616|NCT00437658|27130393|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
7809617|NCT00437658|27130394|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
7809618|NCT00437658|27130395|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
7809619|NCT00437658|27130393|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
7809620|NCT00437658|27130394|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
7809621|NCT00437658|27130395|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
7809622|NCT00437658|27130393|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
7809623|NCT00437658|27130394|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
7809624|NCT00437658|27130395|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
7809625|NCT00437658|27130393|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
7809626|NCT00437658|27130394|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
7809627|NCT00437658|27130395|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
7809628|NCT00437658|27130393|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
7809629|NCT00437658|27130394|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
7809630|NCT00437658|27130395|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
7809631|NCT00437658|27130393|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
7809632|NCT00437658|27130394|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
7809633|NCT00437658|27130395|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
7809634|NCT00437658|27130393|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
7809635|NCT00437658|27130394|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
7809636|NCT00437658|27130395|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
7809637|NCT00437658|27130393|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
7809638|NCT00437658|27130394|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
7809639|NCT00437658|27130395|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
7809640|NCT00437658|27130393|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
7809641|NCT00437658|27130394|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
7809642|NCT00437658|27130395|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
7809643|NCT00437658|27130393|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7809644|NCT00437658|27130394|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7809645|NCT00437658|27130395|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
7809646|NCT00437658|27130393|P3|Treatment Period (24 Weeks)|Non-compliance|4
7809647|NCT00437658|27130394|P2|Treatment Period (24 Weeks)|Non-compliance|1
7809648|NCT00437658|27130395|P1|Treatment Period (24 Weeks)|Non-compliance|1
7809649|NCT00437658|27130393|P3|Treatment Period (24 Weeks)|Adverse Event|14
7809650|NCT00437658|27130394|P2|Treatment Period (24 Weeks)|Adverse Event|7
7809651|NCT00437658|27130395|P1|Treatment Period (24 Weeks)|Adverse Event|4
7809652|NCT00437645|27130489|P2|Overall Study|Condition no longer requires study drug|1
7809653|NCT00437645|27130490|P1|Overall Study|Condition no longer requires study drug|1
7809654|NCT00437645|27130489|P2|Overall Study|Lack of Efficacy|1
7809655|NCT00437645|27130490|P1|Overall Study|Lack of Efficacy|2
7809656|NCT00437645|27130489|P2|Overall Study|Administrative problems|1
7809657|NCT00437645|27130490|P1|Overall Study|Administrative problems|2
7809658|NCT00437645|27130489|P2|Overall Study|Lost to Follow-up|3
7809659|NCT00437645|27130490|P1|Overall Study|Lost to Follow-up|2
7809660|NCT00437645|27130489|P2|Overall Study|Protocol Violation|3
7809661|NCT00437645|27130490|P1|Overall Study|Protocol Violation|3
7809662|NCT00437645|27130489|P2|Overall Study|Withdrawal by Subject|22
7809663|NCT00437645|27130490|P1|Overall Study|Withdrawal by Subject|10
7809664|NCT00437645|27130489|P2|Overall Study|Adverse Event|84
7809665|NCT00437645|27130490|P1|Overall Study|Adverse Event|15
7809666|NCT00437489|27130506|P2|Overall Study|Lost to Follow-up|1
7809667|NCT00437489|27130507|P1|Overall Study|Lost to Follow-up|0
7809668|NCT00437489|27130506|P2|Overall Study|Study terminated by sponsor|21
7809669|NCT00437489|27130507|P1|Overall Study|Study terminated by sponsor|23
7809670|NCT00437294|27130526|P2|Overall Study|Entry criteria not met|1
7809671|NCT00437294|27130527|P1|Overall Study|Entry criteria not met|1
7809672|NCT00437294|27130526|P2|Overall Study|Protocol Violation|1
7809673|NCT00437294|27130527|P1|Overall Study|Protocol Violation|0
7809674|NCT00437294|27130526|P2|Overall Study|Sponsor Decision|9
7809675|NCT00437294|27130527|P1|Overall Study|Sponsor Decision|8
7809676|NCT00437294|27130526|P2|Overall Study|Progressive Disease|23
7809677|NCT00437294|27130527|P1|Overall Study|Progressive Disease|19
7809678|NCT00437294|27130526|P2|Overall Study|Withdrawal by Subject|0
7809679|NCT00437294|27130527|P1|Overall Study|Withdrawal by Subject|5
7809680|NCT00437294|27130526|P2|Overall Study|Physician Decision|3
7809681|NCT00437294|27130527|P1|Overall Study|Physician Decision|0
7809682|NCT00437294|27130526|P2|Overall Study|Death|2
7809683|NCT00437294|27130527|P1|Overall Study|Death|5
7809684|NCT00437294|27130526|P2|Overall Study|Adverse Event|4
7809685|NCT00437294|27130527|P1|Overall Study|Adverse Event|5
7809686|NCT00437281|27130568|P20|Overall Study|Lost to Follow-up|1
7809687|NCT00437281|27130569|P19|Overall Study|Lost to Follow-up|0
7809688|NCT00437281|27130570|P18|Overall Study|Lost to Follow-up|0
7809689|NCT00437281|27130571|P17|Overall Study|Lost to Follow-up|0
7809690|NCT00437281|27130572|P16|Overall Study|Lost to Follow-up|0
7809691|NCT00437281|27130573|P15|Overall Study|Lost to Follow-up|0
7809692|NCT00437281|27130574|P14|Overall Study|Lost to Follow-up|0
7809693|NCT00437281|27130575|P13|Overall Study|Lost to Follow-up|0
7809694|NCT00437281|27130576|P12|Overall Study|Lost to Follow-up|0
7809695|NCT00437281|27130577|P11|Overall Study|Lost to Follow-up|0
7809696|NCT00437281|27130578|P10|Overall Study|Lost to Follow-up|0
7809697|NCT00437281|27130579|P9|Overall Study|Lost to Follow-up|0
7809698|NCT00437281|27130580|P8|Overall Study|Lost to Follow-up|0
7809699|NCT00437281|27130581|P7|Overall Study|Lost to Follow-up|0
7809700|NCT00437281|27130582|P6|Overall Study|Lost to Follow-up|0
7809701|NCT00437281|27130583|P5|Overall Study|Lost to Follow-up|0
7809702|NCT00437281|27130584|P4|Overall Study|Lost to Follow-up|0
7809703|NCT00437281|27130585|P3|Overall Study|Lost to Follow-up|0
7809704|NCT00437281|27130586|P2|Overall Study|Lost to Follow-up|0
7809705|NCT00437281|27130587|P1|Overall Study|Lost to Follow-up|0
7809706|NCT00437281|27130568|P20|Overall Study|Adverse Event|0
7809707|NCT00437281|27130569|P19|Overall Study|Adverse Event|1
7809708|NCT00437281|27130570|P18|Overall Study|Adverse Event|0
7809709|NCT00437281|27130571|P17|Overall Study|Adverse Event|0
7809710|NCT00437281|27130572|P16|Overall Study|Adverse Event|0
7809711|NCT00437281|27130573|P15|Overall Study|Adverse Event|1
7809712|NCT00437281|27130574|P14|Overall Study|Adverse Event|1
7809713|NCT00437281|27130575|P13|Overall Study|Adverse Event|0
7809714|NCT00437281|27130576|P12|Overall Study|Adverse Event|0
7809715|NCT00437281|27130577|P11|Overall Study|Adverse Event|0
7809716|NCT00437281|27130578|P10|Overall Study|Adverse Event|1
7809717|NCT00437281|27130579|P9|Overall Study|Adverse Event|0
7809718|NCT00437281|27130580|P8|Overall Study|Adverse Event|0
7809719|NCT00437281|27130581|P7|Overall Study|Adverse Event|0
7809720|NCT00437281|27130582|P6|Overall Study|Adverse Event|1
7809721|NCT00437281|27130583|P5|Overall Study|Adverse Event|0
7809722|NCT00437281|27130584|P4|Overall Study|Adverse Event|1
7809723|NCT00437281|27130585|P3|Overall Study|Adverse Event|0
7809724|NCT00437281|27130586|P2|Overall Study|Adverse Event|0
7809725|NCT00437281|27130587|P1|Overall Study|Adverse Event|0
7809726|NCT00437268|27130883|P2|Overall Study|Death|1
7809727|NCT00437268|27130884|P1|Overall Study|Death|0
7809728|NCT00437268|27130883|P2|Overall Study|Physician Decision|0
7809729|NCT00437268|27130884|P1|Overall Study|Physician Decision|1
7809730|NCT00437268|27130883|P2|Overall Study|Progressive disease|9
7809731|NCT00437268|27130884|P1|Overall Study|Progressive disease|9
7809732|NCT00437268|27130883|P2|Overall Study|Withdrawal by Subject|2
7809733|NCT00437268|27130884|P1|Overall Study|Withdrawal by Subject|2
7809734|NCT00437268|27130883|P2|Overall Study|Adverse Event|1
7809735|NCT00437268|27130884|P1|Overall Study|Adverse Event|1
7809736|NCT00437203|27130910|P10|Overall Study|Other|0
7809737|NCT00437203|27130911|P9|Overall Study|Other|0
7809738|NCT00437203|27130912|P8|Overall Study|Other|0
7809739|NCT00437203|27130913|P7|Overall Study|Other|1
7809740|NCT00437203|27130914|P6|Overall Study|Other|0
7809741|NCT00437203|27130915|P5|Overall Study|Other|0
7809742|NCT00437203|27130916|P4|Overall Study|Other|0
7809743|NCT00437203|27130917|P3|Overall Study|Other|0
7809744|NCT00437203|27130918|P2|Overall Study|Other|1
7809745|NCT00437203|27130919|P1|Overall Study|Other|0
7809746|NCT00437203|27130910|P10|Overall Study|Objective progression or relapse|2
7809747|NCT00437203|27130911|P9|Overall Study|Objective progression or relapse|2
7809748|NCT00437203|27130912|P8|Overall Study|Objective progression or relapse|1
7809749|NCT00437203|27130913|P7|Overall Study|Objective progression or relapse|6
7809750|NCT00437203|27130914|P6|Overall Study|Objective progression or relapse|3
7809751|NCT00437203|27130915|P5|Overall Study|Objective progression or relapse|3
7809752|NCT00437203|27130916|P4|Overall Study|Objective progression or relapse|3
7809753|NCT00437203|27130917|P3|Overall Study|Objective progression or relapse|2
7809754|NCT00437203|27130918|P2|Overall Study|Objective progression or relapse|6
7809755|NCT00437203|27130919|P1|Overall Study|Objective progression or relapse|5
7809756|NCT00437203|27130910|P10|Overall Study|Study terminated by sponsor|0
7809757|NCT00437203|27130911|P9|Overall Study|Study terminated by sponsor|1
7809758|NCT00437203|27130912|P8|Overall Study|Study terminated by sponsor|0
7809759|NCT00437203|27130913|P7|Overall Study|Study terminated by sponsor|0
7809760|NCT00437203|27130914|P6|Overall Study|Study terminated by sponsor|0
7809761|NCT00437203|27130915|P5|Overall Study|Study terminated by sponsor|0
7809762|NCT00437203|27130916|P4|Overall Study|Study terminated by sponsor|0
7809763|NCT00437203|27130917|P3|Overall Study|Study terminated by sponsor|0
7809764|NCT00437203|27130918|P2|Overall Study|Study terminated by sponsor|0
7809765|NCT00437203|27130919|P1|Overall Study|Study terminated by sponsor|0
7809766|NCT00437203|27130910|P10|Overall Study|Adverse Event|1
7809767|NCT00437203|27130911|P9|Overall Study|Adverse Event|0
7809768|NCT00437203|27130912|P8|Overall Study|Adverse Event|1
7809769|NCT00437203|27130913|P7|Overall Study|Adverse Event|0
7809770|NCT00437203|27130914|P6|Overall Study|Adverse Event|0
7809771|NCT00437203|27130915|P5|Overall Study|Adverse Event|0
7809772|NCT00437203|27130916|P4|Overall Study|Adverse Event|0
7809773|NCT00437203|27130917|P3|Overall Study|Adverse Event|0
7809774|NCT00437203|27130918|P2|Overall Study|Adverse Event|1
7809775|NCT00437203|27130919|P1|Overall Study|Adverse Event|1
7809776|NCT00437203|27130910|P10|Overall Study|Death|1
7809777|NCT00437203|27130911|P9|Overall Study|Death|0
7809778|NCT00437203|27130912|P8|Overall Study|Death|1
7809779|NCT00437203|27130913|P7|Overall Study|Death|0
7809780|NCT00437203|27130914|P6|Overall Study|Death|0
7809781|NCT00437203|27130915|P5|Overall Study|Death|0
7809782|NCT00437203|27130916|P4|Overall Study|Death|0
7809783|NCT00437203|27130917|P3|Overall Study|Death|1
7809784|NCT00437203|27130918|P2|Overall Study|Death|0
7809785|NCT00437203|27130919|P1|Overall Study|Death|0
7809786|NCT00437125|27131023|P1|Overall Study|Physician Decision|1
7809787|NCT00437125|27131023|P1|Overall Study|Withdrawal by Caregiver|2
7809788|NCT00437125|27131023|P1|Overall Study|Withdrawal by Subject|13
7809789|NCT00437125|27131023|P1|Overall Study|Lost to Follow-up|1
7809790|NCT00437125|27131023|P1|Overall Study|Lack of Efficacy|1
7809791|NCT00437125|27131023|P1|Overall Study|Clinical Relapse|1
7809792|NCT00437125|27131023|P1|Overall Study|Death|1
7809793|NCT00437125|27131023|P1|Overall Study|Adverse Event|12
7809794|NCT00437073|27131044|P2|Overall Study|Physician Decision|1
7809795|NCT00437073|27131045|P1|Overall Study|Physician Decision|0
7809796|NCT00437073|27131044|P2|Overall Study|Sponsor Terminated Study|0
7809797|NCT00437073|27131045|P1|Overall Study|Sponsor Terminated Study|1
7809798|NCT00437034|27131073|P1|Overall Study|Disease progression during treatment|5
7809799|NCT00437034|27131073|P1|Overall Study|Adverse Event|1
7809800|NCT00436982|27131086|P2|Overall Study|no RSA data|2
7809801|NCT00436982|27131087|P1|Overall Study|no RSA data|1
7809802|NCT00436982|27131086|P2|Overall Study|Did not receive allocated intervention|1
7809803|NCT00436982|27131087|P1|Overall Study|Did not receive allocated intervention|0
7809804|NCT00436982|27131086|P2|Overall Study|Withdrawal by Subject|1
7809805|NCT00436982|27131087|P1|Overall Study|Withdrawal by Subject|3
7809806|NCT00436956|27131158|P2|Overall Study|Not evaluable|0
7809807|NCT00436956|27131159|P1|Overall Study|Not evaluable|1
7809808|NCT00436917|27131173|P1|Overall Study|Personal conflicts of patient|1
7809809|NCT00436917|27131173|P1|Overall Study|Increased creatinine|1
7809810|NCT00436917|27131173|P1|Overall Study|Treatment for polymyalgia rheumatic|1
7809811|NCT00436917|27131173|P1|Overall Study|Lost to Follow-up|1
7809812|NCT00436917|27131173|P1|Overall Study|Death|1
7809813|NCT00436917|27131173|P1|Overall Study|Physician Decision|1
7809814|NCT00436917|27131173|P1|Overall Study|Adverse Event|2
7809815|NCT00436917|27131173|P1|Overall Study|Withdrawal by Subject|13
7809816|NCT00436852|27131199|P2|Overall Study|Ineligible|0
7809817|NCT00436852|27131200|P1|Overall Study|Ineligible|1
7809818|NCT00436852|27131199|P2|Overall Study|Withdrawal by Subject|4
7809819|NCT00436852|27131200|P1|Overall Study|Withdrawal by Subject|2
7809820|NCT00436852|27131199|P2|Overall Study|Lack of Efficacy|7
7809821|NCT00436852|27131200|P1|Overall Study|Lack of Efficacy|9
7809822|NCT00436852|27131199|P2|Overall Study|Death|34
7809823|NCT00436852|27131200|P1|Overall Study|Death|23
7809824|NCT00436826|27131219|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
7809825|NCT00436826|27131220|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
7809826|NCT00436826|27131221|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7809827|NCT00436826|27131222|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7809828|NCT00436826|27131223|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7809829|NCT00436826|27131224|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7809830|NCT00436826|27131219|P6|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7809831|NCT00436826|27131220|P5|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7809832|NCT00436826|27131221|P4|Ext. Period (With Cladribine Treatment)|Other un-specified|25
7809833|NCT00436826|27131222|P3|Ext. Period (With Cladribine Treatment)|Other un-specified|46
7809834|NCT00436826|27131223|P2|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7809835|NCT00436826|27131224|P1|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7809836|NCT00436826|27131219|P6|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7809837|NCT00436826|27131220|P5|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7809838|NCT00436826|27131221|P4|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
7809839|NCT00436826|27131222|P3|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7809840|NCT00436826|27131223|P2|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7809841|NCT00436826|27131224|P1|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7809842|NCT00436826|27131219|P6|Double Blind Period (DBP)|Other|0
7809843|NCT00436826|27131220|P5|Double Blind Period (DBP)|Other|0
7809844|NCT00436826|27131221|P4|Double Blind Period (DBP)|Other|0
7809845|NCT00436826|27131222|P3|Double Blind Period (DBP)|Other|0
7809846|NCT00436826|27131223|P2|Double Blind Period (DBP)|Other|11
7809847|NCT00436826|27131224|P1|Double Blind Period (DBP)|Other|10
7809848|NCT00436826|27131219|P6|Double Blind Period (DBP)|Protocol Violation|0
7809849|NCT00436826|27131220|P5|Double Blind Period (DBP)|Protocol Violation|0
7809850|NCT00436826|27131221|P4|Double Blind Period (DBP)|Protocol Violation|0
7809851|NCT00436826|27131222|P3|Double Blind Period (DBP)|Protocol Violation|0
7809852|NCT00436826|27131223|P2|Double Blind Period (DBP)|Protocol Violation|0
7809853|NCT00436826|27131224|P1|Double Blind Period (DBP)|Protocol Violation|1
7809854|NCT00436826|27131219|P6|Double Blind Period (DBP)|Adverse Event|0
7809855|NCT00436826|27131220|P5|Double Blind Period (DBP)|Adverse Event|0
7809856|NCT00436826|27131221|P4|Double Blind Period (DBP)|Adverse Event|0
7809857|NCT00436826|27131222|P3|Double Blind Period (DBP)|Adverse Event|0
7809858|NCT00436826|27131223|P2|Double Blind Period (DBP)|Adverse Event|0
7809859|NCT00436826|27131224|P1|Double Blind Period (DBP)|Adverse Event|2
7809860|NCT00436748|27131322|P2|Overall Study|Other|0
7809861|NCT00436748|27131323|P1|Overall Study|Other|3
7809862|NCT00436748|27131322|P2|Overall Study|Protocol-specified Criteria|4
7809863|NCT00436748|27131323|P1|Overall Study|Protocol-specified Criteria|5
7809864|NCT00436748|27131322|P2|Overall Study|Lost to Follow-up|1
7809865|NCT00436748|27131323|P1|Overall Study|Lost to Follow-up|0
7809866|NCT00436748|27131322|P2|Overall Study|Administrative Decision|0
7809867|NCT00436748|27131323|P1|Overall Study|Administrative Decision|1
7809868|NCT00436748|27131322|P2|Overall Study|Consent Withdrawn|4
7809869|NCT00436748|27131323|P1|Overall Study|Consent Withdrawn|1
7809870|NCT00436748|27131322|P2|Overall Study|Adverse Event|2
7809871|NCT00436748|27131323|P1|Overall Study|Adverse Event|0
7809872|NCT00436748|27131322|P2|Overall Study|Ineligibility Determined|1
7809873|NCT00436748|27131323|P1|Overall Study|Ineligibility Determined|1
7809874|NCT00436644|27131357|P1|Overall Study|Death|1
7809875|NCT00436644|27131357|P1|Overall Study|Adverse Event|2
7809876|NCT00436618|27131367|P3|Overall Study|Still on treatment|7
7809877|NCT00436618|27131368|P2|Overall Study|Still on treatment|2
7809878|NCT00436618|27131369|P1|Overall Study|Still on treatment|1
7809879|NCT00436618|27131367|P3|Overall Study|New Primary or Other Reasons|12
7809880|NCT00436618|27131368|P2|Overall Study|New Primary or Other Reasons|2
7809881|NCT00436618|27131369|P1|Overall Study|New Primary or Other Reasons|6
7809882|NCT00436618|27131367|P3|Overall Study|Death|3
7809883|NCT00436618|27131368|P2|Overall Study|Death|2
7809884|NCT00436618|27131369|P1|Overall Study|Death|4
7809885|NCT00436618|27131367|P3|Overall Study|Other Medical Problems|7
7809886|NCT00436618|27131368|P2|Overall Study|Other Medical Problems|1
7809887|NCT00436618|27131369|P1|Overall Study|Other Medical Problems|3
7809888|NCT00436618|27131367|P3|Overall Study|Alternate Treatment|12
7809889|NCT00436618|27131368|P2|Overall Study|Alternate Treatment|4
7809890|NCT00436618|27131369|P1|Overall Study|Alternate Treatment|3
7809891|NCT00436618|27131367|P3|Overall Study|Adverse Event|9
7809892|NCT00436618|27131368|P2|Overall Study|Adverse Event|8
7809893|NCT00436618|27131369|P1|Overall Study|Adverse Event|8
7809894|NCT00436618|27131367|P3|Overall Study|Withdrawal by Subject|11
7809895|NCT00436618|27131368|P2|Overall Study|Withdrawal by Subject|8
7809896|NCT00436618|27131369|P1|Overall Study|Withdrawal by Subject|5
7809897|NCT00436605|27131386|P1|Overall Study|Protocol Violation|3
7809898|NCT00436566|27131391|P1|Overall Study|Protocol Violation|1
7809899|NCT00436566|27131391|P1|Overall Study|Withdrawal by Subject|2
7809900|NCT00436553|27131398|P3|Overall Study|Withdrawal by Subject|3
7809901|NCT00436553|27131399|P2|Overall Study|Withdrawal by Subject|6
7809902|NCT00436553|27131400|P1|Overall Study|Withdrawal by Subject|5
7809903|NCT00436553|27131398|P3|Overall Study|Protocol Violation|0
7809904|NCT00436553|27131399|P2|Overall Study|Protocol Violation|0
7809905|NCT00436553|27131400|P1|Overall Study|Protocol Violation|1
7809906|NCT00436553|27131398|P3|Overall Study|Lost to Follow-up|0
7809907|NCT00436553|27131399|P2|Overall Study|Lost to Follow-up|2
7809908|NCT00436553|27131400|P1|Overall Study|Lost to Follow-up|0
7809909|NCT00436553|27131398|P3|Overall Study|Death|3
7809910|NCT00436553|27131399|P2|Overall Study|Death|1
7809911|NCT00436553|27131400|P1|Overall Study|Death|3
7809912|NCT00436553|27131398|P3|Overall Study|Adverse Event|4
7809913|NCT00436553|27131399|P2|Overall Study|Adverse Event|3
7809914|NCT00436553|27131400|P1|Overall Study|Adverse Event|4
7809915|NCT00436501|27131421|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
7809916|NCT00436501|27131422|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
7809917|NCT00436501|27131421|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
7809918|NCT00436501|27131422|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
7809919|NCT00436436|27131458|P1|Overall Study|Death|6
7809920|NCT00436436|27131458|P1|Overall Study|Adverse Event|2
7809921|NCT00436436|27131458|P1|Overall Study|Progression|4
7809922|NCT00436345|27131469|P2|Overall Study|ICU resident beyond follow-up period|0
7809923|NCT00436345|27131470|P1|Overall Study|ICU resident beyond follow-up period|3
7809924|NCT00436332|27131523|P1|Overall Study|Never Received Treatment|3
7809925|NCT00436332|27131523|P1|Overall Study|Ineligible|2
7809926|NCT00436332|27131523|P1|Overall Study|Not Protocol Specified|6
7809927|NCT00436332|27131523|P1|Overall Study|Death|2
7809928|NCT00436332|27131523|P1|Overall Study|Progression|59
7809929|NCT00436332|27131523|P1|Overall Study|Withdrawal by Subject|2
7809930|NCT00436332|27131523|P1|Overall Study|Adverse Event|9
7809931|NCT00436280|27131530|P1|Period 3: Maintenance|Progressive Disease|12
7809932|NCT00436280|27131530|P1|Period 3: Maintenance|Adverse Event|6
7809933|NCT00436280|27131530|P1|Period 2: Consolidation|Death|1
7809934|NCT00436280|27131530|P1|Period 2: Consolidation|Withdrawal by Subject|2
7809935|NCT00436280|27131530|P1|Period 2: Consolidation|Physician Decision|2
7809936|NCT00436280|27131530|P1|Period 2: Consolidation|Stable Disease|1
7809937|NCT00436280|27131530|P1|Period 2: Consolidation|Progressive Disease|10
7809938|NCT00436280|27131530|P1|Period 2: Consolidation|Adverse Event|1
7809939|NCT00436280|27131530|P1|Period 1: Induction|Death|1
7809940|NCT00436280|27131530|P1|Period 1: Induction|Withdrawal by Subject|1
7809941|NCT00436280|27131530|P1|Period 1: Induction|Stable Disease|6
7809942|NCT00436280|27131530|P1|Period 1: Induction|Progressive Disease|12
7809943|NCT00436280|27131530|P1|Period 1: Induction|Adverse Event|8
7809944|NCT00436215|27131544|P1|Overall Study|Small bowel obstruction|1
7809945|NCT00436215|27131544|P1|Overall Study|Refused further treatment|3
7809946|NCT00436163|27131550|P1|Overall Study|Adverse Event|1
7809947|NCT00436163|27131550|P1|Overall Study|Lost to Follow-up|2
7809948|NCT00436007|27131598|P3|Overall Study|Other|1
7809949|NCT00436007|27131599|P2|Overall Study|Other|0
7809950|NCT00436007|27131600|P1|Overall Study|Other|0
7809951|NCT00436007|27131598|P3|Overall Study|Death|3
7809952|NCT00436007|27131599|P2|Overall Study|Death|1
7809953|NCT00436007|27131600|P1|Overall Study|Death|0
7809954|NCT00436007|27131598|P3|Overall Study|Physician Decision|2
7809955|NCT00436007|27131599|P2|Overall Study|Physician Decision|0
7809956|NCT00436007|27131600|P1|Overall Study|Physician Decision|0
7809957|NCT00436007|27131598|P3|Overall Study|Lost to Follow-up|13
7809958|NCT00436007|27131599|P2|Overall Study|Lost to Follow-up|10
7809959|NCT00436007|27131600|P1|Overall Study|Lost to Follow-up|14
7809960|NCT00436007|27131598|P3|Overall Study|Withdrawal by Subject|4
7809961|NCT00436007|27131599|P2|Overall Study|Withdrawal by Subject|3
7809962|NCT00436007|27131600|P1|Overall Study|Withdrawal by Subject|5
7809963|NCT00435994|27131648|P3|Overall Study|Lost to Follow-up|0
7809964|NCT00435994|27131649|P2|Overall Study|Lost to Follow-up|0
7809965|NCT00435994|27131650|P1|Overall Study|Lost to Follow-up|7
7809966|NCT00435942|27131661|P2|Overall Study|Other|1
7809967|NCT00435942|27131662|P1|Overall Study|Other|0
7809968|NCT00435942|27131661|P2|Overall Study|Technical Failure|0
7809969|NCT00435942|27131662|P1|Overall Study|Technical Failure|3
7809970|NCT00435942|27131661|P2|Overall Study|Conversion to Open Repair|0
7809971|NCT00435942|27131662|P1|Overall Study|Conversion to Open Repair|1
7809972|NCT00435942|27131661|P2|Overall Study|Lost to Follow-up|16
7809973|NCT00435942|27131662|P1|Overall Study|Lost to Follow-up|0
7809974|NCT00435942|27131661|P2|Overall Study|Withdrawal by Subject|0
7809975|NCT00435942|27131662|P1|Overall Study|Withdrawal by Subject|2
7809976|NCT00435942|27131661|P2|Overall Study|Death|10
7809977|NCT00435942|27131662|P1|Overall Study|Death|17
7809978|NCT00435825|27131702|P4|Overall Study|Did not complete full follow-up period|5
7809979|NCT00435825|27131703|P3|Overall Study|Did not complete full follow-up period|4
7809980|NCT00435825|27131704|P2|Overall Study|Did not complete full follow-up period|6
7809981|NCT00435825|27131705|P1|Overall Study|Did not complete full follow-up period|6
7809982|NCT00435825|27131702|P4|Overall Study|Did not enter follow-up|3
7809983|NCT00435825|27131703|P3|Overall Study|Did not enter follow-up|1
7809984|NCT00435825|27131704|P2|Overall Study|Did not enter follow-up|4
7809985|NCT00435825|27131705|P1|Overall Study|Did not enter follow-up|0
7809986|NCT00435825|27131702|P4|Overall Study|Did not receive study drug|0
7809987|NCT00435825|27131703|P3|Overall Study|Did not receive study drug|2
7809988|NCT00435825|27131704|P2|Overall Study|Did not receive study drug|0
7809989|NCT00435825|27131705|P1|Overall Study|Did not receive study drug|1
7809990|NCT00435825|27131702|P4|Overall Study|Failure to return|0
7809991|NCT00435825|27131703|P3|Overall Study|Failure to return|4
7809992|NCT00435825|27131704|P2|Overall Study|Failure to return|0
7809993|NCT00435825|27131705|P1|Overall Study|Failure to return|5
7809994|NCT00435825|27131702|P4|Overall Study|Refused treatment|5
7809995|NCT00435825|27131703|P3|Overall Study|Refused treatment|0
7809996|NCT00435825|27131704|P2|Overall Study|Refused treatment|0
7809997|NCT00435825|27131705|P1|Overall Study|Refused treatment|2
7809998|NCT00435825|27131702|P4|Overall Study|Other Protocol Violation|0
7809999|NCT00435825|27131703|P3|Overall Study|Other Protocol Violation|0
7810000|NCT00435825|27131704|P2|Overall Study|Other Protocol Violation|0
7810001|NCT00435825|27131705|P1|Overall Study|Other Protocol Violation|1
7810002|NCT00435825|27131702|P4|Overall Study|Insufficient Therapeutic Response|3
7810003|NCT00435825|27131703|P3|Overall Study|Insufficient Therapeutic Response|0
7810004|NCT00435825|27131704|P2|Overall Study|Insufficient Therapeutic Response|1
7810005|NCT00435825|27131705|P1|Overall Study|Insufficient Therapeutic Response|3
7810006|NCT00435825|27131702|P4|Overall Study|Abnormality of Laboratory Test|0
7810007|NCT00435825|27131703|P3|Overall Study|Abnormality of Laboratory Test|0
7810008|NCT00435825|27131704|P2|Overall Study|Abnormality of Laboratory Test|1
7810009|NCT00435825|27131705|P1|Overall Study|Abnormality of Laboratory Test|0
7810010|NCT00435487|27131828|P2|Overall Study|Received Drug in Other Treatment Group|1
7810011|NCT00435487|27131829|P1|Overall Study|Received Drug in Other Treatment Group|0
7810012|NCT00435487|27131828|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
7810013|NCT00435487|27131829|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
7810014|NCT00435487|27131828|P2|Overall Study|Withdrawal by Subject|1
7810015|NCT00435487|27131829|P1|Overall Study|Withdrawal by Subject|2
7810016|NCT00435487|27131828|P2|Overall Study|Other|2
7810017|NCT00435487|27131829|P1|Overall Study|Other|5
7810018|NCT00435487|27131828|P2|Overall Study|Lost to Follow-up|2
7810019|NCT00435487|27131829|P1|Overall Study|Lost to Follow-up|2
7810020|NCT00435487|27131828|P2|Overall Study|Adverse Event|3
7810021|NCT00435487|27131829|P1|Overall Study|Adverse Event|0
7810022|NCT00435487|27131828|P2|Overall Study|Death|4
7810023|NCT00435487|27131829|P1|Overall Study|Death|3
7810024|NCT00435461|27131848|P3|Overall Study|Lost to Follow-up|2
7810025|NCT00435461|27131849|P2|Overall Study|Lost to Follow-up|1
7810026|NCT00435461|27131850|P1|Overall Study|Lost to Follow-up|1
7810027|NCT00435461|27131848|P3|Overall Study|Non-Compliance of diary|1
7810028|NCT00435461|27131849|P2|Overall Study|Non-Compliance of diary|0
7810029|NCT00435461|27131850|P1|Overall Study|Non-Compliance of diary|2
7810030|NCT00435461|27131848|P3|Overall Study|Adverse Event|6
7810031|NCT00435461|27131849|P2|Overall Study|Adverse Event|2
7810032|NCT00435461|27131850|P1|Overall Study|Adverse Event|1
7810033|NCT00435461|27131848|P3|Overall Study|Noncompliance with study requirements|1
7810034|NCT00435461|27131849|P2|Overall Study|Noncompliance with study requirements|1
7810035|NCT00435461|27131850|P1|Overall Study|Noncompliance with study requirements|1
7810036|NCT00435461|27131848|P3|Overall Study|Participant ended study one day early|0
7810037|NCT00435461|27131849|P2|Overall Study|Participant ended study one day early|0
7810038|NCT00435461|27131850|P1|Overall Study|Participant ended study one day early|1
7810039|NCT00435461|27131848|P3|Overall Study|Participant moved eDiary,studymedication|0
7810040|NCT00435461|27131849|P2|Overall Study|Participant moved eDiary,studymedication|0
7810041|NCT00435461|27131850|P1|Overall Study|Participant moved eDiary,studymedication|1
7810042|NCT00435461|27131848|P3|Overall Study|Pregnancy|0
7810043|NCT00435461|27131849|P2|Overall Study|Pregnancy|0
7810044|NCT00435461|27131850|P1|Overall Study|Pregnancy|2
7810045|NCT00435461|27131848|P3|Overall Study|Participant could not swallow capsule|1
7810046|NCT00435461|27131849|P2|Overall Study|Participant could not swallow capsule|0
7810047|NCT00435461|27131850|P1|Overall Study|Participant could not swallow capsule|0
7810048|NCT00435461|27131848|P3|Overall Study|Participant could not tolerate symptoms|1
7810049|NCT00435461|27131849|P2|Overall Study|Participant could not tolerate symptoms|0
7810050|NCT00435461|27131850|P1|Overall Study|Participant could not tolerate symptoms|0
7810051|NCT00435461|27131848|P3|Overall Study|Randomized in error|0
7810052|NCT00435461|27131849|P2|Overall Study|Randomized in error|0
7810053|NCT00435461|27131850|P1|Overall Study|Randomized in error|1
7810054|NCT00435461|27131848|P3|Overall Study|Withdrawal by Subject|2
7810055|NCT00435461|27131849|P2|Overall Study|Withdrawal by Subject|0
7810056|NCT00435461|27131850|P1|Overall Study|Withdrawal by Subject|1
7810057|NCT00435461|27131848|P3|Overall Study|Lack of Efficacy|0
7810058|NCT00435461|27131849|P2|Overall Study|Lack of Efficacy|1
7810059|NCT00435461|27131850|P1|Overall Study|Lack of Efficacy|2
7810060|NCT00435461|27131848|P3|Overall Study|In error, two study medications switched|0
7810061|NCT00435461|27131849|P2|Overall Study|In error, two study medications switched|0
7810062|NCT00435461|27131850|P1|Overall Study|In error, two study medications switched|1
7810063|NCT00435461|27131848|P3|Overall Study|Compliance less than 80 percent|0
7810064|NCT00435461|27131849|P2|Overall Study|Compliance less than 80 percent|0
7810065|NCT00435461|27131850|P1|Overall Study|Compliance less than 80 percent|1
7810066|NCT00435461|27131848|P3|Overall Study|Participant randomized(inadequate score)|0
7810067|NCT00435461|27131849|P2|Overall Study|Participant randomized(inadequate score)|0
7810068|NCT00435461|27131850|P1|Overall Study|Participant randomized(inadequate score)|1
7810069|NCT00435461|27131848|P3|Overall Study|Protocol Violation|10
7810070|NCT00435461|27131849|P2|Overall Study|Protocol Violation|9
7810071|NCT00435461|27131850|P1|Overall Study|Protocol Violation|6
7810072|NCT00435461|27131848|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
7810073|NCT00435461|27131849|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
7810074|NCT00435461|27131850|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
7810075|NCT00435409|27131887|P3|Overall Study|Sponsor decision|0
7810076|NCT00435409|27131888|P2|Overall Study|Sponsor decision|3
7810077|NCT00435409|27131889|P1|Overall Study|Sponsor decision|0
7810078|NCT00435409|27131887|P3|Overall Study|Adverse Event|8
7810079|NCT00435409|27131888|P2|Overall Study|Adverse Event|0
7810080|NCT00435409|27131889|P1|Overall Study|Adverse Event|0
7810081|NCT00435409|27131887|P3|Overall Study|Other|1
7810082|NCT00435409|27131888|P2|Overall Study|Other|30
7810083|NCT00435409|27131889|P1|Overall Study|Other|45
7810084|NCT00435409|27131887|P3|Overall Study|Withdrawal by Subject|1
7810085|NCT00435409|27131888|P2|Overall Study|Withdrawal by Subject|7
7810086|NCT00435409|27131889|P1|Overall Study|Withdrawal by Subject|8
7810087|NCT00435409|27131887|P3|Overall Study|Global deterioration of health status|4
7810088|NCT00435409|27131888|P2|Overall Study|Global deterioration of health status|0
7810089|NCT00435409|27131889|P1|Overall Study|Global deterioration of health status|0
7810090|NCT00435409|27131887|P3|Overall Study|Objective progression or relapse|58
7810091|NCT00435409|27131888|P2|Overall Study|Objective progression or relapse|93
7810092|NCT00435409|27131889|P1|Overall Study|Objective progression or relapse|158
7810093|NCT00435409|27131887|P3|Overall Study|Death|6
7810094|NCT00435409|27131888|P2|Overall Study|Death|6
7810095|NCT00435409|27131889|P1|Overall Study|Death|8
7810096|NCT00435409|27131887|P3|Overall Study|Lost to Follow-up|0
7810097|NCT00435409|27131888|P2|Overall Study|Lost to Follow-up|2
7810098|NCT00435409|27131889|P1|Overall Study|Lost to Follow-up|1
7810099|NCT00435409|27131887|P3|Overall Study|Protocol Violation|0
7810100|NCT00435409|27131888|P2|Overall Study|Protocol Violation|2
7810101|NCT00435409|27131889|P1|Overall Study|Protocol Violation|1
7810102|NCT00435370|27131911|P2|Overall Study|Antipsychotic medication changed|2
7810103|NCT00435370|27131912|P1|Overall Study|Antipsychotic medication changed|4
7810104|NCT00435370|27131911|P2|Overall Study|Withdrawal by Subject|10
7810105|NCT00435370|27131912|P1|Overall Study|Withdrawal by Subject|10
7810106|NCT00435370|27131911|P2|Overall Study|Adverse Event|8
7810107|NCT00435370|27131912|P1|Overall Study|Adverse Event|8
7810108|NCT00435188|27131968|P2|Overall Study|Lost to Follow-up|6
7810109|NCT00435188|27131969|P1|Overall Study|Lost to Follow-up|5
7810110|NCT00435188|27131968|P2|Overall Study|Withdrawal by Subject|11
7810111|NCT00435188|27131969|P1|Overall Study|Withdrawal by Subject|16
7810112|NCT00435188|27131968|P2|Overall Study|Death|6
7810113|NCT00435188|27131969|P1|Overall Study|Death|1
7810114|NCT00435162|27132012|P6|Period 2 (2 Weeks)|Adverse Event|0
7810115|NCT00435162|27132013|P5|Period 2 (2 Weeks)|Adverse Event|0
7810116|NCT00435162|27132014|P4|Period 2 (2 Weeks)|Adverse Event|0
7810117|NCT00435162|27132015|P3|Period 2 (2 Weeks)|Adverse Event|0
7810118|NCT00435162|27132016|P2|Period 2 (2 Weeks)|Adverse Event|1
7810119|NCT00435162|27132017|P1|Period 2 (2 Weeks)|Adverse Event|0
7810120|NCT00435045|27132037|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
7810121|NCT00435045|27132038|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
7810122|NCT00435045|27132037|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
7810123|NCT00435045|27132038|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
7810124|NCT00435045|27132037|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
7810125|NCT00435045|27132038|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
7810126|NCT00435045|27132037|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
7810127|NCT00435045|27132038|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
7810128|NCT00435045|27132037|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
7810129|NCT00435045|27132038|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
7810130|NCT00435045|27132037|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
7810131|NCT00435045|27132038|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
7810132|NCT00435045|27132037|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
7810133|NCT00435045|27132038|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
7810134|NCT00435045|27132037|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
7810135|NCT00435045|27132038|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
7810136|NCT00435045|27132037|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
7810137|NCT00435045|27132038|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
7810138|NCT00435045|27132037|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
7810139|NCT00435045|27132038|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
7810140|NCT00435045|27132037|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
7810141|NCT00435045|27132038|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
7810142|NCT00435019|27132094|P2|Overall Study|Personal reasons for withdrawal|7
7810143|NCT00435019|27132095|P1|Overall Study|Personal reasons for withdrawal|8
7810144|NCT00435019|27132094|P2|Overall Study|Protocol Violation|1
7810145|NCT00435019|27132095|P1|Overall Study|Protocol Violation|3
7810146|NCT00435019|27132094|P2|Overall Study|Lack of Efficacy|2
7810147|NCT00435019|27132095|P1|Overall Study|Lack of Efficacy|1
7810148|NCT00435019|27132094|P2|Overall Study|Adverse Event|0
7810149|NCT00435019|27132095|P1|Overall Study|Adverse Event|1
7810150|NCT00434967|27132136|P4|Overall Study|Patient Disposition Challenges|3
7810151|NCT00434967|27132137|P3|Overall Study|Patient Disposition Challenges|0
7810152|NCT00434967|27132138|P2|Overall Study|Patient Disposition Challenges|0
7810153|NCT00434967|27132139|P1|Overall Study|Patient Disposition Challenges|2
7810154|NCT00434967|27132136|P4|Overall Study|Physician Decision|0
7810155|NCT00434967|27132137|P3|Overall Study|Physician Decision|1
7810156|NCT00434967|27132138|P2|Overall Study|Physician Decision|1
7810157|NCT00434967|27132139|P1|Overall Study|Physician Decision|1
7810158|NCT00434967|27132136|P4|Overall Study|Protocol Violation|1
7810159|NCT00434967|27132137|P3|Overall Study|Protocol Violation|0
7810160|NCT00434967|27132138|P2|Overall Study|Protocol Violation|1
7810161|NCT00434967|27132139|P1|Overall Study|Protocol Violation|0
7810162|NCT00434967|27132136|P4|Overall Study|Randomized in error|1
7810163|NCT00434967|27132137|P3|Overall Study|Randomized in error|0
7810164|NCT00434967|27132138|P2|Overall Study|Randomized in error|0
7810165|NCT00434967|27132139|P1|Overall Study|Randomized in error|0
7810166|NCT00434967|27132136|P4|Overall Study|Withdrawal by Subject|6
7810167|NCT00434967|27132137|P3|Overall Study|Withdrawal by Subject|4
7810168|NCT00434967|27132138|P2|Overall Study|Withdrawal by Subject|2
7810169|NCT00434967|27132139|P1|Overall Study|Withdrawal by Subject|2
7810170|NCT00434967|27132136|P4|Overall Study|Lost to Follow-up|0
7810171|NCT00434967|27132137|P3|Overall Study|Lost to Follow-up|1
7810172|NCT00434967|27132138|P2|Overall Study|Lost to Follow-up|0
7810173|NCT00434967|27132139|P1|Overall Study|Lost to Follow-up|0
7810174|NCT00434967|27132136|P4|Overall Study|Adverse Event|3
7810175|NCT00434967|27132137|P3|Overall Study|Adverse Event|3
7810176|NCT00434967|27132138|P2|Overall Study|Adverse Event|4
7810177|NCT00434967|27132139|P1|Overall Study|Adverse Event|2
7810178|NCT00434954|27132159|P2|Overall Study|Subject decision|22
7810179|NCT00434954|27132160|P1|Overall Study|Subject decision|8
7810180|NCT00434954|27132159|P2|Overall Study|Sponsor decision|0
7810181|NCT00434954|27132160|P1|Overall Study|Sponsor decision|1
7810182|NCT00434954|27132159|P2|Overall Study|Protocol Violation|27
7810183|NCT00434954|27132160|P1|Overall Study|Protocol Violation|36
7810184|NCT00434954|27132159|P2|Overall Study|Physician Decision|3
7810185|NCT00434954|27132160|P1|Overall Study|Physician Decision|6
7810186|NCT00434954|27132159|P2|Overall Study|Lost to Follow-up|1
7810187|NCT00434954|27132160|P1|Overall Study|Lost to Follow-up|0
7810188|NCT00434954|27132159|P2|Overall Study|Entry criteria not met|16
7810189|NCT00434954|27132160|P1|Overall Study|Entry criteria not met|14
7810190|NCT00434954|27132159|P2|Overall Study|Adverse Event|2
7810191|NCT00434954|27132160|P1|Overall Study|Adverse Event|17
7810192|NCT00434876|27132190|P2|Overall Study|Lost to Follow-up|1
7810193|NCT00434876|27132191|P1|Overall Study|Lost to Follow-up|1
7810194|NCT00434759|27132205|P2|Overall Study|family affairs|0
7810195|NCT00434759|27132206|P1|Overall Study|family affairs|2
7810196|NCT00434759|27132205|P2|Overall Study|Withdrawal by Subject|1
7810197|NCT00434759|27132206|P1|Overall Study|Withdrawal by Subject|17
7810198|NCT00434759|27132205|P2|Overall Study|Lack of Efficacy|4
7810199|NCT00434759|27132206|P1|Overall Study|Lack of Efficacy|5
7810200|NCT00434642|27132222|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
7810201|NCT00434642|27132223|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
7810202|NCT00434642|27132222|P2|Open-label Treatment Phase|Adverse Event|5
7810203|NCT00434642|27132223|P1|Open-label Treatment Phase|Adverse Event|0
7810204|NCT00434642|27132222|P2|Blinded Treatment Phase|Did not Receive Treatment|1
7810205|NCT00434642|27132223|P1|Blinded Treatment Phase|Did not Receive Treatment|4
7810206|NCT00434642|27132222|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
7810207|NCT00434642|27132223|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
7810208|NCT00434642|27132222|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
7810209|NCT00434642|27132223|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
7810210|NCT00434642|27132222|P2|Blinded Treatment Phase|Physician Decision|27
7810211|NCT00434642|27132223|P1|Blinded Treatment Phase|Physician Decision|19
7810212|NCT00434642|27132222|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
7810213|NCT00434642|27132223|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
7810214|NCT00434642|27132222|P2|Blinded Treatment Phase|Clinical Disease Progression|5
7810215|NCT00434642|27132223|P1|Blinded Treatment Phase|Clinical Disease Progression|4
7810216|NCT00434642|27132222|P2|Blinded Treatment Phase|Adverse Event|58
7810217|NCT00434642|27132223|P1|Blinded Treatment Phase|Adverse Event|12
7810218|NCT00434590|27132241|P2|Overall Study|Administrative problems|5
7810219|NCT00434590|27132242|P1|Overall Study|Administrative problems|5
7810220|NCT00434577|27132253|P5|Months 0-3|Withdrawal by Subject|1
7810221|NCT00434577|27132254|P4|Months 0-3|Withdrawal by Subject|1
7810222|NCT00434577|27132255|P3|Months 0-3|Withdrawal by Subject|1
7810223|NCT00434577|27132256|P2|Months 0-3|Withdrawal by Subject|1
7810224|NCT00434577|27132257|P1|Months 0-3|Withdrawal by Subject|2
7810225|NCT00434577|27132253|P5|Months 0-3|Protocol Violation|0
7810226|NCT00434577|27132254|P4|Months 0-3|Protocol Violation|0
7810227|NCT00434577|27132255|P3|Months 0-3|Protocol Violation|1
7810228|NCT00434577|27132256|P2|Months 0-3|Protocol Violation|0
7810229|NCT00434577|27132257|P1|Months 0-3|Protocol Violation|1
7810230|NCT00434577|27132253|P5|Months 0-3|Lost to Follow-up|2
7810231|NCT00434577|27132254|P4|Months 0-3|Lost to Follow-up|0
7810232|NCT00434577|27132255|P3|Months 0-3|Lost to Follow-up|0
7810233|NCT00434577|27132256|P2|Months 0-3|Lost to Follow-up|0
7810234|NCT00434577|27132257|P1|Months 0-3|Lost to Follow-up|0
7810235|NCT00434577|27132253|P5|Months 0-3|Adverse Event|0
7810236|NCT00434577|27132254|P4|Months 0-3|Adverse Event|0
7810237|NCT00434577|27132255|P3|Months 0-3|Adverse Event|1
7810238|NCT00434577|27132256|P2|Months 0-3|Adverse Event|1
7810239|NCT00434577|27132257|P1|Months 0-3|Adverse Event|0
7810240|NCT00434577|27132253|P5|Months 0-3|Serious Adverse Event|0
7810241|NCT00434577|27132254|P4|Months 0-3|Serious Adverse Event|0
7810242|NCT00434577|27132255|P3|Months 0-3|Serious Adverse Event|1
7810243|NCT00434577|27132256|P2|Months 0-3|Serious Adverse Event|0
7810244|NCT00434577|27132257|P1|Months 0-3|Serious Adverse Event|0
7810245|NCT00434512|27132435|P6|Overall Study|Other|0
7810246|NCT00434512|27132436|P5|Overall Study|Other|0
7810247|NCT00434512|27132437|P4|Overall Study|Other|0
7810248|NCT00434512|27132438|P3|Overall Study|Other|0
7810249|NCT00434512|27132439|P2|Overall Study|Other|1
7810250|NCT00434512|27132440|P1|Overall Study|Other|0
7810251|NCT00434512|27132435|P6|Overall Study|Migrated/moved from study area|1
7810252|NCT00434512|27132436|P5|Overall Study|Migrated/moved from study area|1
7810253|NCT00434512|27132437|P4|Overall Study|Migrated/moved from study area|1
7810254|NCT00434512|27132438|P3|Overall Study|Migrated/moved from study area|0
7810255|NCT00434512|27132439|P2|Overall Study|Migrated/moved from study area|0
7810256|NCT00434512|27132440|P1|Overall Study|Migrated/moved from study area|0
7810257|NCT00434421|27132554|P1|Overall Study|Non-compliance with study treatment|1
7810258|NCT00434421|27132554|P1|Overall Study|Withdrawal by Subject|1
7810259|NCT00434330|27132582|P6|Overall Study|Subject Not Compliant With Study|0
7810260|NCT00434330|27132583|P5|Overall Study|Subject Not Compliant With Study|0
7810261|NCT00434330|27132584|P4|Overall Study|Subject Not Compliant With Study|0
7810262|NCT00434330|27132585|P3|Overall Study|Subject Not Compliant With Study|1
7810263|NCT00434330|27132586|P2|Overall Study|Subject Not Compliant With Study|0
7810264|NCT00434330|27132587|P1|Overall Study|Subject Not Compliant With Study|0
7810265|NCT00434330|27132582|P6|Overall Study|Renal transplant|0
7810266|NCT00434330|27132583|P5|Overall Study|Renal transplant|0
7810267|NCT00434330|27132584|P4|Overall Study|Renal transplant|1
7810268|NCT00434330|27132585|P3|Overall Study|Renal transplant|0
7810269|NCT00434330|27132586|P2|Overall Study|Renal transplant|0
7810270|NCT00434330|27132587|P1|Overall Study|Renal transplant|0
7810271|NCT00434330|27132582|P6|Overall Study|Withdrawal by Subject|0
7810272|NCT00434330|27132583|P5|Overall Study|Withdrawal by Subject|0
7810273|NCT00434330|27132584|P4|Overall Study|Withdrawal by Subject|1
7810274|NCT00434330|27132585|P3|Overall Study|Withdrawal by Subject|1
7810275|NCT00434330|27132586|P2|Overall Study|Withdrawal by Subject|0
7810276|NCT00434330|27132587|P1|Overall Study|Withdrawal by Subject|0
7810277|NCT00434330|27132582|P6|Overall Study|Death|1
7810278|NCT00434330|27132583|P5|Overall Study|Death|1
7810279|NCT00434330|27132584|P4|Overall Study|Death|0
7810280|NCT00434330|27132585|P3|Overall Study|Death|0
7810281|NCT00434330|27132586|P2|Overall Study|Death|0
7810282|NCT00434330|27132587|P1|Overall Study|Death|1
7810283|NCT00434330|27132582|P6|Overall Study|Adverse Event|0
7810284|NCT00434330|27132583|P5|Overall Study|Adverse Event|0
7810285|NCT00434330|27132584|P4|Overall Study|Adverse Event|0
7810286|NCT00434330|27132585|P3|Overall Study|Adverse Event|1
7810287|NCT00434330|27132586|P2|Overall Study|Adverse Event|0
7810288|NCT00434330|27132587|P1|Overall Study|Adverse Event|0
7810289|NCT00434304|27132619|P1|Overall Study|Withdrawal by Subject|4
7810290|NCT00434304|27132619|P1|Overall Study|Lack of Efficacy|2
7810291|NCT00434304|27132619|P1|Overall Study|Adverse Event|14
7810292|NCT00434252|27132668|P2|Overall Study|Withdrawal by Subject|7
7810293|NCT00434252|27132669|P1|Overall Study|Withdrawal by Subject|3
7810294|NCT00434252|27132668|P2|Overall Study|Physician Decision|8
7810295|NCT00434252|27132669|P1|Overall Study|Physician Decision|4
7810296|NCT00434252|27132668|P2|Overall Study|Lost to Follow-up|1
7810297|NCT00434252|27132669|P1|Overall Study|Lost to Follow-up|0
7810298|NCT00434252|27132668|P2|Overall Study|Death|2
7810299|NCT00434252|27132669|P1|Overall Study|Death|1
7810300|NCT00434252|27132668|P2|Overall Study|Adverse Event|13
7810301|NCT00434252|27132669|P1|Overall Study|Adverse Event|6
7810302|NCT00434252|27132668|P2|Overall Study|Lack of Efficacy|100
7810303|NCT00434252|27132669|P1|Overall Study|Lack of Efficacy|50
7810304|NCT00434213|27132703|P1|Overall Study|Non-compliant to study schedule|1
7810305|NCT00434213|27132703|P1|Overall Study|Application site reaction|1
7810306|NCT00434213|27132703|P1|Overall Study|Unable to comply with study visit window|2
7810307|NCT00434213|27132703|P1|Overall Study|Protocol Violation|3
7810308|NCT00434213|27132703|P1|Overall Study|Withdrawal by Subject|7
7810309|NCT00434213|27132703|P1|Overall Study|Lost to Follow-up|14
7810310|NCT00434213|27132703|P1|Overall Study|Lack of Efficacy|9
7810311|NCT00434213|27132703|P1|Overall Study|Adverse Event|12
7810312|NCT00434161|27132711|P3|Overall Study|Logistical error study assessments|3
7810313|NCT00434161|27132712|P2|Overall Study|Logistical error study assessments|0
7810314|NCT00434161|27132713|P1|Overall Study|Logistical error study assessments|1
7810315|NCT00434161|27132711|P3|Overall Study|Withdrawal by Subject|3
7810316|NCT00434161|27132712|P2|Overall Study|Withdrawal by Subject|0
7810317|NCT00434161|27132713|P1|Overall Study|Withdrawal by Subject|2
7810318|NCT00434161|27132711|P3|Overall Study|Non-Compliance|0
7810319|NCT00434161|27132712|P2|Overall Study|Non-Compliance|1
7810320|NCT00434161|27132713|P1|Overall Study|Non-Compliance|1
7810321|NCT00434161|27132711|P3|Overall Study|Death|1
7810322|NCT00434161|27132712|P2|Overall Study|Death|0
7810323|NCT00434161|27132713|P1|Overall Study|Death|1
7810324|NCT00434161|27132711|P3|Overall Study|Lost to Follow-up|0
7810325|NCT00434161|27132712|P2|Overall Study|Lost to Follow-up|1
7810326|NCT00434161|27132713|P1|Overall Study|Lost to Follow-up|0
7810327|NCT00434161|27132711|P3|Overall Study|Adverse Event|4
7810328|NCT00434161|27132712|P2|Overall Study|Adverse Event|1
7810329|NCT00434161|27132713|P1|Overall Study|Adverse Event|5
7810330|NCT00434148|27132757|P2|Overall Study|Abnormal test procedure result|1
7810331|NCT00434148|27132758|P1|Overall Study|Abnormal test procedure result|0
7810332|NCT00434148|27132757|P2|Overall Study|Condition no longer requires study drug|0
7810333|NCT00434148|27132758|P1|Overall Study|Condition no longer requires study drug|1
7810334|NCT00434148|27132757|P2|Overall Study|Lost to Follow-up|1
7810335|NCT00434148|27132758|P1|Overall Study|Lost to Follow-up|0
7810336|NCT00434148|27132757|P2|Overall Study|Administrative problems|10
7810337|NCT00434148|27132758|P1|Overall Study|Administrative problems|6
7810338|NCT00434148|27132757|P2|Overall Study|Protocol Violation|0
7810339|NCT00434148|27132758|P1|Overall Study|Protocol Violation|4
7810340|NCT00434148|27132757|P2|Overall Study|Withdrawal by Subject|15
7810341|NCT00434148|27132758|P1|Overall Study|Withdrawal by Subject|15
7810342|NCT00434148|27132757|P2|Overall Study|Lack of Efficacy|28
7810343|NCT00434148|27132758|P1|Overall Study|Lack of Efficacy|25
7810344|NCT00434148|27132757|P2|Overall Study|Adverse Event|18
7810345|NCT00434148|27132758|P1|Overall Study|Adverse Event|18
7810346|NCT00434122|27132794|P2|Overall Study|Travelling of subject.|0
7810347|NCT00434122|27132795|P1|Overall Study|Travelling of subject.|1
7810348|NCT00434122|27132794|P2|Overall Study|Low follicular response.|2
7810349|NCT00434122|27132795|P1|Overall Study|Low follicular response.|1
7810350|NCT00434122|27132794|P2|Overall Study|Large follicle size|2
7810351|NCT00434122|27132795|P1|Overall Study|Large follicle size|2
7810352|NCT00434122|27132794|P2|Overall Study|Personal reasons|1
7810353|NCT00434122|27132795|P1|Overall Study|Personal reasons|1
7810354|NCT00434122|27132794|P2|Overall Study|loss of subject contact|1
7810355|NCT00434122|27132795|P1|Overall Study|loss of subject contact|1
7810356|NCT00434122|27132794|P2|Overall Study|Non-compliance with protocol|1
7810357|NCT00434122|27132795|P1|Overall Study|Non-compliance with protocol|0
7810358|NCT00434109|27132804|P1|Overall Study|had embolism, did not receive sunitinib|3
7810359|NCT00434109|27132804|P1|Overall Study|Protocol Violation|1
7810360|NCT00434109|27132804|P1|Overall Study|Adverse Event|5
7810361|NCT00434109|27132804|P1|Overall Study|Physician Decision|9
7810362|NCT00434057|27132813|P1|Overall Study|Withdrawal by Subject|1
7810363|NCT00433966|27132851|P4|Stent Intervention/Randomization|Lost to Follow-up|47
7810364|NCT00433966|27132852|P3|Stent Intervention/Randomization|Lost to Follow-up|113
7810365|NCT00433966|27132853|P2|Stent Intervention/Randomization|Lost to Follow-up|0
7810366|NCT00433966|27132854|P1|Stent Intervention/Randomization|Lost to Follow-up|0
7810367|NCT00433966|27132851|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
7810368|NCT00433966|27132852|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
7810369|NCT00433966|27132853|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
7810370|NCT00433966|27132854|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
7810371|NCT00433966|27132851|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
7810372|NCT00433966|27132852|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
7810373|NCT00433966|27132853|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
7810374|NCT00433966|27132854|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
7810375|NCT00433966|27132851|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
7810376|NCT00433966|27132852|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
7810377|NCT00433966|27132853|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
7810378|NCT00433966|27132854|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
7810379|NCT00433966|27132851|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
7810380|NCT00433966|27132852|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
7810381|NCT00433966|27132853|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
7810382|NCT00433966|27132854|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
7810383|NCT00433914|27132876|P2|Overall Study|Lost to Follow-up|1
7810384|NCT00433914|27132877|P1|Overall Study|Lost to Follow-up|0
7810385|NCT00433914|27132876|P2|Overall Study|Withdrawal by Subject|2
7810386|NCT00433914|27132877|P1|Overall Study|Withdrawal by Subject|0
7810387|NCT00433836|27132897|P2|Overall Study|Abnormal laboratory values|1
7810388|NCT00433836|27132898|P1|Overall Study|Abnormal laboratory values|0
7810389|NCT00433836|27132897|P2|Overall Study|Condition no longer requires study drug|1
7810390|NCT00433836|27132898|P1|Overall Study|Condition no longer requires study drug|0
7810391|NCT00433836|27132897|P2|Overall Study|Protocol Violation|2
7810392|NCT00433836|27132898|P1|Overall Study|Protocol Violation|0
7810393|NCT00433836|27132897|P2|Overall Study|Unsatisfactory therapeutic effect|1
7810394|NCT00433836|27132898|P1|Overall Study|Unsatisfactory therapeutic effect|1
7810395|NCT00433836|27132897|P2|Overall Study|Withdrawal by Subject|1
7810396|NCT00433836|27132898|P1|Overall Study|Withdrawal by Subject|2
7810397|NCT00433836|27132897|P2|Overall Study|Lost to Follow-up|0
7810398|NCT00433836|27132898|P1|Overall Study|Lost to Follow-up|3
7810399|NCT00433836|27132897|P2|Overall Study|Adverse Event|0
7810400|NCT00433836|27132898|P1|Overall Study|Adverse Event|7
7810401|NCT00433771|27132910|P1|Overall Study|Failure to deploy stent|1
7810402|NCT00433771|27132910|P1|Overall Study|Death|2
7810403|NCT00433771|27132910|P1|Overall Study|Treated and later found to be ineligible|2
7810404|NCT00433771|27132910|P1|Overall Study|screen fail|14
7810405|NCT00433654|27132933|P2|Overall Study|Withdrawal by Subject|2
7810406|NCT00433654|27132934|P1|Overall Study|Withdrawal by Subject|1
7810407|NCT00433654|27132933|P2|Overall Study|Subject not yet due for visit|0
7810408|NCT00433654|27132934|P1|Overall Study|Subject not yet due for visit|4
7810409|NCT00433654|27132933|P2|Overall Study|Missed visit|3
7810410|NCT00433654|27132934|P1|Overall Study|Missed visit|6
7810411|NCT00433654|27132933|P2|Overall Study|Death|0
7810412|NCT00433654|27132934|P1|Overall Study|Death|4
7810413|NCT00433537|27132980|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
7810414|NCT00433537|27132981|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
7810415|NCT00433537|27132982|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
7810416|NCT00433537|27132980|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
7810417|NCT00433537|27132981|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
7810418|NCT00433537|27132982|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
7810419|NCT00433537|27132980|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
7810420|NCT00433537|27132981|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
7810421|NCT00433537|27132982|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
7810422|NCT00433537|27132980|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
7810423|NCT00433537|27132981|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
7810424|NCT00433537|27132982|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
7810425|NCT00433537|27132980|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
7810426|NCT00433537|27132981|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
7810427|NCT00433537|27132982|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
7810428|NCT00433537|27132980|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
7810429|NCT00433537|27132981|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
7810430|NCT00433537|27132982|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
7810431|NCT00433537|27132980|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
7810432|NCT00433537|27132981|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
7810433|NCT00433537|27132982|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
7810434|NCT00433537|27132980|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
7810435|NCT00433537|27132981|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
7810436|NCT00433537|27132982|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
7810437|NCT00433537|27132980|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
7810438|NCT00433537|27132981|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
7810439|NCT00433537|27132982|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
7810440|NCT00433511|27132994|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
7810441|NCT00433511|27132995|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
7810442|NCT00433511|27132996|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
7810443|NCT00433511|27132994|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
7810444|NCT00433511|27132995|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
7810445|NCT00433511|27132996|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
7810446|NCT00433511|27132994|P3|Step 2 (Arm D)|Suspected recurrence|1
7810447|NCT00433511|27132995|P2|Step 2 (Arm D)|Suspected recurrence|0
7810448|NCT00433511|27132996|P1|Step 2 (Arm D)|Suspected recurrence|0
7810449|NCT00433511|27132994|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
7810450|NCT00433511|27132995|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
7810451|NCT00433511|27132996|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
7810452|NCT00433511|27132994|P3|Step 2 (Arm D)|Other complicating disease|3
7810453|NCT00433511|27132995|P2|Step 2 (Arm D)|Other complicating disease|0
7810454|NCT00433511|27132996|P1|Step 2 (Arm D)|Other complicating disease|0
7810455|NCT00433511|27132994|P3|Step 2 (Arm D)|Disease progression, relapse|7
7810456|NCT00433511|27132995|P2|Step 2 (Arm D)|Disease progression, relapse|0
7810457|NCT00433511|27132996|P1|Step 2 (Arm D)|Disease progression, relapse|0
7810458|NCT00433511|27132994|P3|Step 2 (Arm D)|Physician Decision|9
7810459|NCT00433511|27132995|P2|Step 2 (Arm D)|Physician Decision|0
7810460|NCT00433511|27132996|P1|Step 2 (Arm D)|Physician Decision|0
7810461|NCT00433511|27132994|P3|Step 2 (Arm D)|Never started protocol therapy|148
7810462|NCT00433511|27132995|P2|Step 2 (Arm D)|Never started protocol therapy|0
7810463|NCT00433511|27132996|P1|Step 2 (Arm D)|Never started protocol therapy|0
7810464|NCT00433511|27132994|P3|Step 2 (Arm D)|Withdrawal by Subject|181
7810465|NCT00433511|27132995|P2|Step 2 (Arm D)|Withdrawal by Subject|0
7810466|NCT00433511|27132996|P1|Step 2 (Arm D)|Withdrawal by Subject|0
7810467|NCT00433511|27132994|P3|Step 2 (Arm D)|Adverse Event|135
7810468|NCT00433511|27132995|P2|Step 2 (Arm D)|Adverse Event|0
7810469|NCT00433511|27132996|P1|Step 2 (Arm D)|Adverse Event|0
7810470|NCT00433511|27132994|P3|Step 1|Patient moved|1
7810471|NCT00433511|27132995|P2|Step 1|Patient moved|0
7810472|NCT00433511|27132996|P1|Step 1|Patient moved|0
7810473|NCT00433511|27132994|P3|Step 1|Insurance/drug distribution issues|2
7810474|NCT00433511|27132995|P2|Step 1|Insurance/drug distribution issues|1
7810475|NCT00433511|27132996|P1|Step 1|Insurance/drug distribution issues|0
7810476|NCT00433511|27132994|P3|Step 1|Suspected recurrence|0
7810477|NCT00433511|27132995|P2|Step 1|Suspected recurrence|1
7810478|NCT00433511|27132996|P1|Step 1|Suspected recurrence|0
7810479|NCT00433511|27132994|P3|Step 1|Non-breast cancer surgery/wound issues|1
7810480|NCT00433511|27132995|P2|Step 1|Non-breast cancer surgery/wound issues|4
7810481|NCT00433511|27132996|P1|Step 1|Non-breast cancer surgery/wound issues|0
7810482|NCT00433511|27132994|P3|Step 1|Other complicating disease|3
7810483|NCT00433511|27132995|P2|Step 1|Other complicating disease|6
7810484|NCT00433511|27132996|P1|Step 1|Other complicating disease|2
7810485|NCT00433511|27132994|P3|Step 1|Disease progression, relapse|3
7810486|NCT00433511|27132995|P2|Step 1|Disease progression, relapse|3
7810487|NCT00433511|27132996|P1|Step 1|Disease progression, relapse|5
7810488|NCT00433511|27132994|P3|Step 1|Alternative therapy|3
7810489|NCT00433511|27132995|P2|Step 1|Alternative therapy|1
7810490|NCT00433511|27132996|P1|Step 1|Alternative therapy|2
7810491|NCT00433511|27132994|P3|Step 1|Never started protocol therapy|66
7810492|NCT00433511|27132995|P2|Step 1|Never started protocol therapy|64
7810493|NCT00433511|27132996|P1|Step 1|Never started protocol therapy|28
7810494|NCT00433511|27132994|P3|Step 1|Physician Decision|3
7810495|NCT00433511|27132995|P2|Step 1|Physician Decision|4
7810496|NCT00433511|27132996|P1|Step 1|Physician Decision|1
7810497|NCT00433511|27132994|P3|Step 1|Death|1
7810498|NCT00433511|27132995|P2|Step 1|Death|1
7810499|NCT00433511|27132996|P1|Step 1|Death|3
7810500|NCT00433511|27132994|P3|Step 1|Withdrawal by Subject|154
7810501|NCT00433511|27132995|P2|Step 1|Withdrawal by Subject|143
7810502|NCT00433511|27132996|P1|Step 1|Withdrawal by Subject|45
7810503|NCT00433511|27132994|P3|Step 1|Adverse Event|153
7810504|NCT00433511|27132995|P2|Step 1|Adverse Event|157
7810505|NCT00433511|27132996|P1|Step 1|Adverse Event|50
7810506|NCT00433446|27133010|P1|Overall Study|Ineligible|9
7810507|NCT00433446|27133010|P1|Overall Study|Other - Not Protocol specified|3
7810508|NCT00433446|27133010|P1|Overall Study|Progression|44
7810509|NCT00433446|27133010|P1|Overall Study|Refusal Unrelated to Adverse Event|1
7810510|NCT00433446|27133010|P1|Overall Study|Adverse Event|4
7810511|NCT00433381|27133020|P2|Overall Study|Ineligible / no protocol treatment|3
7810512|NCT00433381|27133021|P1|Overall Study|Ineligible / no protocol treatment|3
7810513|NCT00433329|27133040|P1|Overall Study|Physician Decision|1
7810514|NCT00433329|27133040|P1|Overall Study|Lost to Follow-up|1
7810515|NCT00433329|27133040|P1|Overall Study|Moved out of state|1
7810516|NCT00433329|27133040|P1|Overall Study|Discontinued sildenafil|2
7810517|NCT00433329|27133040|P1|Overall Study|Withdrew consent|3
7810518|NCT00433329|27133040|P1|Overall Study|Death|4
7810519|NCT00433329|27133040|P1|Overall Study|Adverse Event|9
7810520|NCT00433290|27133046|P2|Overall Study|Lost to Follow-up|0
7810521|NCT00433290|27133047|P1|Overall Study|Lost to Follow-up|1
7810522|NCT00433290|27133046|P2|Overall Study|Entry Criteria Not Met|1
7810523|NCT00433290|27133047|P1|Overall Study|Entry Criteria Not Met|0
7810524|NCT00433290|27133046|P2|Overall Study|Physician Decision|0
7810525|NCT00433290|27133047|P1|Overall Study|Physician Decision|2
7810526|NCT00433290|27133046|P2|Overall Study|Protocol Violation|2
7810527|NCT00433290|27133047|P1|Overall Study|Protocol Violation|3
7810528|NCT00433290|27133046|P2|Overall Study|Withdrawal by Subject|2
7810529|NCT00433290|27133047|P1|Overall Study|Withdrawal by Subject|4
7810530|NCT00433290|27133046|P2|Overall Study|Lack of Efficacy|5
7810531|NCT00433290|27133047|P1|Overall Study|Lack of Efficacy|1
7810532|NCT00433290|27133046|P2|Overall Study|Adverse Event|7
7810533|NCT00433290|27133047|P1|Overall Study|Adverse Event|24
7810534|NCT00433199|27133116|P2|Open-Label Period|Administrative|1
7810535|NCT00433199|27133117|P1|Open-Label Period|Administrative|0
7810536|NCT00433199|27133116|P2|Open-Label Period|Protocol Violation|2
7810537|NCT00433199|27133117|P1|Open-Label Period|Protocol Violation|0
7810538|NCT00433199|27133116|P2|Open-Label Period|Withdrawal by Subject|7
7810539|NCT00433199|27133117|P1|Open-Label Period|Withdrawal by Subject|0
7810540|NCT00433199|27133116|P2|Open-Label Period|Lost to Follow-up|3
7810541|NCT00433199|27133117|P1|Open-Label Period|Lost to Follow-up|0
7810542|NCT00433199|27133116|P2|Open-Label Period|Lack of Efficacy|2
7810543|NCT00433199|27133117|P1|Open-Label Period|Lack of Efficacy|0
7810544|NCT00433199|27133116|P2|Open-Label Period|Adverse Event|19
7810545|NCT00433199|27133117|P1|Open-Label Period|Adverse Event|0
7810546|NCT00433199|27133116|P2|Double-Blind Period|Administrative|5
7810547|NCT00433199|27133117|P1|Double-Blind Period|Administrative|1
7810548|NCT00433199|27133116|P2|Double-Blind Period|Protocol Violation|10
7810549|NCT00433199|27133117|P1|Double-Blind Period|Protocol Violation|1
7810550|NCT00433199|27133116|P2|Double-Blind Period|Withdrawal by Subject|19
7810551|NCT00433199|27133117|P1|Double-Blind Period|Withdrawal by Subject|8
7810552|NCT00433199|27133116|P2|Double-Blind Period|Lost to Follow-up|5
7810553|NCT00433199|27133117|P1|Double-Blind Period|Lost to Follow-up|2
7810554|NCT00433199|27133116|P2|Double-Blind Period|Lack of Efficacy|2
7810555|NCT00433199|27133117|P1|Double-Blind Period|Lack of Efficacy|0
7810556|NCT00433199|27133116|P2|Double-Blind Period|Adverse Event|25
7810557|NCT00433199|27133117|P1|Double-Blind Period|Adverse Event|0
7810558|NCT00433160|27133137|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
7810559|NCT00433160|27133138|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
7810560|NCT00433160|27133137|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
7810561|NCT00433160|27133138|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
7810562|NCT00433160|27133137|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
7810563|NCT00433160|27133138|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
7810564|NCT00433160|27133137|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
7810565|NCT00433160|27133138|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
7810566|NCT00433160|27133137|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
7810567|NCT00433160|27133138|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
7810568|NCT00433160|27133137|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
7810569|NCT00433160|27133138|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
7810570|NCT00433160|27133137|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
7810571|NCT00433160|27133138|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
7810572|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
7810573|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
7810574|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
7810575|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
7810576|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
7810577|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
7810578|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
7810579|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
7810580|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
7810581|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
7810582|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
7810583|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
7810584|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7810585|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7810586|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Death|0
7810587|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Death|0
7810588|NCT00433160|27133137|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
7810589|NCT00433160|27133138|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
7810590|NCT00433147|27133190|P4|Overall Study|Adverse Event|0
7810591|NCT00433147|27133191|P3|Overall Study|Adverse Event|0
7810592|NCT00433147|27133192|P2|Overall Study|Adverse Event|1
7810593|NCT00433147|27133193|P1|Overall Study|Adverse Event|0
7810594|NCT00433017|27133209|P2|Overall Study|Subject no longer requires study drug|1
7810595|NCT00433017|27133210|P1|Overall Study|Subject no longer requires study drug|1
7810596|NCT00433017|27133209|P2|Overall Study|Death|2
7810597|NCT00433017|27133210|P1|Overall Study|Death|2
7810598|NCT00433017|27133209|P2|Overall Study|Protocol Violation|0
7810599|NCT00433017|27133210|P1|Overall Study|Protocol Violation|1
7810600|NCT00433017|27133209|P2|Overall Study|Administrative problems|86
7810601|NCT00433017|27133210|P1|Overall Study|Administrative problems|80
7810602|NCT00433017|27133209|P2|Overall Study|Lost to Follow-up|4
7810603|NCT00433017|27133210|P1|Overall Study|Lost to Follow-up|3
7810604|NCT00433017|27133209|P2|Overall Study|Withdrawal by Subject|5
7810605|NCT00433017|27133210|P1|Overall Study|Withdrawal by Subject|4
7810606|NCT00433017|27133209|P2|Overall Study|Adverse Event|3
7810607|NCT00433017|27133210|P1|Overall Study|Adverse Event|5
7810608|NCT00433004|27133226|P2|Overall Study|Lost to Follow-up|7
7810609|NCT00433004|27133227|P1|Overall Study|Lost to Follow-up|5
7810610|NCT00432991|27133239|P2|Overall Study|Protocol Violation|12
7810611|NCT00432991|27133240|P1|Overall Study|Protocol Violation|7
7810612|NCT00432965|27133252|P2|Overall Study|Incomplete Data|3
7810613|NCT00432965|27133253|P1|Overall Study|Incomplete Data|4
7810614|NCT00432965|27133252|P2|Overall Study|Exclusionary Methods|2
7810615|NCT00432965|27133253|P1|Overall Study|Exclusionary Methods|1
7810616|NCT00432965|27133252|P2|Overall Study|Death|4
7810617|NCT00432965|27133253|P1|Overall Study|Death|3
7810618|NCT00432965|27133252|P2|Overall Study|Adverse Event|19
7810619|NCT00432965|27133253|P1|Overall Study|Adverse Event|22
7810620|NCT00432965|27133252|P2|Overall Study|Non-compliance|0
7810621|NCT00432965|27133253|P1|Overall Study|Non-compliance|7
7810622|NCT00432965|27133252|P2|Overall Study|Lack of Efficacy|13
7810623|NCT00432965|27133253|P1|Overall Study|Lack of Efficacy|8
7810624|NCT00432965|27133252|P2|Overall Study|Physician Decision|13
7810625|NCT00432965|27133253|P1|Overall Study|Physician Decision|14
7810626|NCT00432965|27133252|P2|Overall Study|Withdrawal by Subject|13
7810627|NCT00432965|27133253|P1|Overall Study|Withdrawal by Subject|13
7810628|NCT00432965|27133252|P2|Overall Study|Lost to Follow-up|19
7810629|NCT00432965|27133253|P1|Overall Study|Lost to Follow-up|22
7810630|NCT00432835|27133261|P2|Overall Study|Adverse event: lead dislodgement.|7
7810631|NCT00432835|27133262|P1|Overall Study|Adverse event: lead dislodgement.|6
7810632|NCT00432809|27133275|P3|1 Year Follow-up|Withdrawal by Subject|1
7810633|NCT00432809|27133276|P2|1 Year Follow-up|Withdrawal by Subject|0
7810634|NCT00432809|27133277|P1|1 Year Follow-up|Withdrawal by Subject|7
7810635|NCT00432809|27133275|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
7810636|NCT00432809|27133276|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
7810637|NCT00432809|27133277|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
7810638|NCT00432744|27133350|P2|Months 7 - 12|Too disabled to score|1
7810639|NCT00432744|27133351|P1|Months 7 - 12|Too disabled to score|0
7810640|NCT00432744|27133350|P2|Months 7 - 12|Withdrawal by Subject|0
7810641|NCT00432744|27133351|P1|Months 7 - 12|Withdrawal by Subject|1
7810642|NCT00432744|27133350|P2|Months 0-6|Too disabled to score|0
7810643|NCT00432744|27133351|P1|Months 0-6|Too disabled to score|1
7810644|NCT00432744|27133350|P2|Months 0-6|Withdrawal by Subject|4
7810645|NCT00432744|27133351|P1|Months 0-6|Withdrawal by Subject|4
7810646|NCT00432679|27133363|P2|Overall Study|Withdrawal by Subject|2
7810647|NCT00432679|27133364|P1|Overall Study|Withdrawal by Subject|3
7810648|NCT00432679|27133363|P2|Overall Study|Adverse Event|1
7810649|NCT00432679|27133364|P1|Overall Study|Adverse Event|2
7810650|NCT00432666|27133388|P2|Open-Label Extension Period|Physician Decision|0
7810651|NCT00432666|27133389|P1|Open-Label Extension Period|Physician Decision|3
7810652|NCT00432666|27133388|P2|Open-Label Extension Period|Consent withdrawn|0
7810653|NCT00432666|27133389|P1|Open-Label Extension Period|Consent withdrawn|10
7810654|NCT00432666|27133388|P2|Open-Label Extension Period|Adverse Event|0
7810655|NCT00432666|27133389|P1|Open-Label Extension Period|Adverse Event|5
7810656|NCT00432666|27133388|P2|Open-Label Extension Period|Lack of Efficacy|0
7810657|NCT00432666|27133389|P1|Open-Label Extension Period|Lack of Efficacy|6
7810658|NCT00432666|27133388|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
7810659|NCT00432666|27133389|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
7810660|NCT00432666|27133388|P2|Main Period|Consent Withdrawn|0
7810661|NCT00432666|27133389|P1|Main Period|Consent Withdrawn|1
7810662|NCT00432666|27133388|P2|Main Period|Adverse Event|1
7810663|NCT00432666|27133389|P1|Main Period|Adverse Event|1
7810664|NCT00432562|27133562|P2|Overall Study|Death|0
7810665|NCT00432562|27133563|P1|Overall Study|Death|3
7810666|NCT00432380|27133615|P3|Overall Study|Adverse Event|0
7810667|NCT00432380|27133616|P2|Overall Study|Adverse Event|0
7810668|NCT00432380|27133617|P1|Overall Study|Adverse Event|1
7810669|NCT00432380|27133615|P3|Overall Study|Migrated/moved from study area|1
7810670|NCT00432380|27133616|P2|Overall Study|Migrated/moved from study area|4
7810671|NCT00432380|27133617|P1|Overall Study|Migrated/moved from study area|3
7810672|NCT00432276|27133670|P2|Overall Study|Other|3
7810673|NCT00432276|27133671|P1|Overall Study|Other|2
7810674|NCT00432276|27133670|P2|Overall Study|Physician Decision|8
7810675|NCT00432276|27133671|P1|Overall Study|Physician Decision|6
7810676|NCT00432276|27133670|P2|Overall Study|Withdrawal by Subject|20
7810677|NCT00432276|27133671|P1|Overall Study|Withdrawal by Subject|25
7810678|NCT00432276|27133670|P2|Overall Study|Lost to Follow-up|2
7810679|NCT00432276|27133671|P1|Overall Study|Lost to Follow-up|6
7810680|NCT00432276|27133670|P2|Overall Study|Protocol Violation|20
7810681|NCT00432276|27133671|P1|Overall Study|Protocol Violation|25
7810682|NCT00432276|27133670|P2|Overall Study|Adverse Event|16
7810683|NCT00432276|27133671|P1|Overall Study|Adverse Event|13
7810684|NCT00432276|27133670|P2|Overall Study|Hyperglycemic Rescue|87
7810685|NCT00432276|27133671|P1|Overall Study|Hyperglycemic Rescue|44
7810686|NCT00432237|27133761|P4|Overall Study|Lack of Qualifying Event|84
7810687|NCT00432237|27133762|P3|Overall Study|Lack of Qualifying Event|69
7810688|NCT00432237|27133763|P2|Overall Study|Lack of Qualifying Event|71
7810689|NCT00432237|27133764|P1|Overall Study|Lack of Qualifying Event|38
7810690|NCT00432237|27133761|P4|Overall Study|Withdrawal by Subject|11
7810691|NCT00432237|27133762|P3|Overall Study|Withdrawal by Subject|9
7810692|NCT00432237|27133763|P2|Overall Study|Withdrawal by Subject|6
7810693|NCT00432237|27133764|P1|Overall Study|Withdrawal by Subject|5
7810694|NCT00432237|27133761|P4|Overall Study|Protocol Violation|8
7810695|NCT00432237|27133762|P3|Overall Study|Protocol Violation|11
7810696|NCT00432237|27133763|P2|Overall Study|Protocol Violation|10
7810697|NCT00432237|27133764|P1|Overall Study|Protocol Violation|13
7810698|NCT00432237|27133761|P4|Overall Study|Pregnancy|0
7810699|NCT00432237|27133762|P3|Overall Study|Pregnancy|0
7810700|NCT00432237|27133763|P2|Overall Study|Pregnancy|1
7810701|NCT00432237|27133764|P1|Overall Study|Pregnancy|0
7810702|NCT00432237|27133761|P4|Overall Study|Physician Decision|1
7810703|NCT00432237|27133762|P3|Overall Study|Physician Decision|2
7810704|NCT00432237|27133763|P2|Overall Study|Physician Decision|3
7810705|NCT00432237|27133764|P1|Overall Study|Physician Decision|1
7810706|NCT00432237|27133761|P4|Overall Study|Lost to Follow-up|18
7810707|NCT00432237|27133762|P3|Overall Study|Lost to Follow-up|18
7810708|NCT00432237|27133763|P2|Overall Study|Lost to Follow-up|10
7810709|NCT00432237|27133764|P1|Overall Study|Lost to Follow-up|10
7810710|NCT00432237|27133761|P4|Overall Study|Lack of Efficacy|1
7810711|NCT00432237|27133762|P3|Overall Study|Lack of Efficacy|0
7810712|NCT00432237|27133763|P2|Overall Study|Lack of Efficacy|0
7810713|NCT00432237|27133764|P1|Overall Study|Lack of Efficacy|0
7810714|NCT00432237|27133761|P4|Overall Study|Adverse Event|1
7810715|NCT00432237|27133762|P3|Overall Study|Adverse Event|0
7810716|NCT00432237|27133763|P2|Overall Study|Adverse Event|0
7810717|NCT00432237|27133764|P1|Overall Study|Adverse Event|0
7810718|NCT00432172|27133806|P4|Overall Study|No treatment received|1
7810719|NCT00432172|27133807|P3|Overall Study|No treatment received|0
7810720|NCT00432172|27133808|P2|Overall Study|No treatment received|2
7810721|NCT00432172|27133809|P1|Overall Study|No treatment received|2
7810722|NCT00432172|27133806|P4|Overall Study|Withdrawal by Subject|2
7810723|NCT00432172|27133807|P3|Overall Study|Withdrawal by Subject|0
7810724|NCT00432172|27133808|P2|Overall Study|Withdrawal by Subject|1
7810725|NCT00432172|27133809|P1|Overall Study|Withdrawal by Subject|0
7810726|NCT00432172|27133806|P4|Overall Study|Disease progression|1
7810727|NCT00432172|27133807|P3|Overall Study|Disease progression|5
7810728|NCT00432172|27133808|P2|Overall Study|Disease progression|2
7810729|NCT00432172|27133809|P1|Overall Study|Disease progression|0
7810730|NCT00432172|27133806|P4|Overall Study|Adverse Event|3
7810731|NCT00432172|27133807|P3|Overall Study|Adverse Event|4
7810732|NCT00432172|27133808|P2|Overall Study|Adverse Event|2
7810733|NCT00432172|27133809|P1|Overall Study|Adverse Event|4
7810734|NCT00432172|27133806|P4|Overall Study|Physician Decision|0
7810735|NCT00432172|27133807|P3|Overall Study|Physician Decision|2
7810736|NCT00432172|27133808|P2|Overall Study|Physician Decision|0
7810737|NCT00432172|27133809|P1|Overall Study|Physician Decision|0
7810738|NCT00432159|27133834|P5|Overall Study|Missing NDI and/or neuro. assessment|7
7810739|NCT00432159|27133835|P4|Overall Study|Missing NDI and/or neuro. assessment|3
7810740|NCT00432159|27133836|P3|Overall Study|Missing NDI and/or neuro. assessment|1
7810741|NCT00432159|27133837|P2|Overall Study|Missing NDI and/or neuro. assessment|24
7810742|NCT00432159|27133838|P1|Overall Study|Missing NDI and/or neuro. assessment|13
7810743|NCT00432159|27133834|P5|Overall Study|Failure|3
7810744|NCT00432159|27133835|P4|Overall Study|Failure|2
7810745|NCT00432159|27133836|P3|Overall Study|Failure|3
7810746|NCT00432159|27133837|P2|Overall Study|Failure|5
7810747|NCT00432159|27133838|P1|Overall Study|Failure|9
7810748|NCT00432159|27133834|P5|Overall Study|Death|0
7810749|NCT00432159|27133835|P4|Overall Study|Death|0
7810750|NCT00432159|27133836|P3|Overall Study|Death|0
7810751|NCT00432159|27133837|P2|Overall Study|Death|1
7810752|NCT00432159|27133838|P1|Overall Study|Death|0
7810753|NCT00432042|27133945|P3|Overall Study|Lost to Follow-up|0
7810754|NCT00432042|27133946|P2|Overall Study|Lost to Follow-up|1
7810755|NCT00432042|27133947|P1|Overall Study|Lost to Follow-up|5
7810756|NCT00432042|27133945|P3|Overall Study|Withdrawal by Subject|2
7810757|NCT00432042|27133946|P2|Overall Study|Withdrawal by Subject|0
7810758|NCT00432042|27133947|P1|Overall Study|Withdrawal by Subject|0
7810759|NCT00432042|27133945|P3|Overall Study|Protocol Violation|0
7810760|NCT00432042|27133946|P2|Overall Study|Protocol Violation|0
7810761|NCT00432042|27133947|P1|Overall Study|Protocol Violation|2
7810762|NCT00431964|27133960|P2|Overall Study|Due to Unstable Health|1
7810763|NCT00431964|27133961|P1|Overall Study|Due to Unstable Health|0
7810764|NCT00431964|27133960|P2|Overall Study|Parental Consent Withdrawn|2
7810765|NCT00431964|27133961|P1|Overall Study|Parental Consent Withdrawn|0
7810766|NCT00431964|27133960|P2|Overall Study|Withdrawal by Subject|1
7810767|NCT00431964|27133961|P1|Overall Study|Withdrawal by Subject|2
7810768|NCT00431964|27133960|P2|Overall Study|Physician Decision|2
7810769|NCT00431964|27133961|P1|Overall Study|Physician Decision|2
7810770|NCT00431964|27133960|P2|Overall Study|Lost to Follow-up|2
7810771|NCT00431964|27133961|P1|Overall Study|Lost to Follow-up|1
7810772|NCT00431964|27133960|P2|Overall Study|Adverse Event|0
7810773|NCT00431964|27133961|P1|Overall Study|Adverse Event|1
7810774|NCT00431951|27133971|P4|Overall Study|Adverse Event|0
7810775|NCT00431951|27133972|P3|Overall Study|Adverse Event|1
7810776|NCT00431951|27133973|P2|Overall Study|Adverse Event|0
7810777|NCT00431951|27133974|P1|Overall Study|Adverse Event|0
7810778|NCT00431951|27133971|P4|Overall Study|Withdrawal by Subject|0
7810779|NCT00431951|27133972|P3|Overall Study|Withdrawal by Subject|0
7810780|NCT00431951|27133973|P2|Overall Study|Withdrawal by Subject|1
7810781|NCT00431951|27133974|P1|Overall Study|Withdrawal by Subject|0
7810782|NCT00431951|27133971|P4|Overall Study|Lost to Follow-up|0
7810783|NCT00431951|27133972|P3|Overall Study|Lost to Follow-up|0
7810784|NCT00431951|27133973|P2|Overall Study|Lost to Follow-up|1
7810785|NCT00431951|27133974|P1|Overall Study|Lost to Follow-up|0
7810786|NCT00431951|27133971|P4|Overall Study|Inability to follow study procedures|2
7810787|NCT00431951|27133972|P3|Overall Study|Inability to follow study procedures|1
7810788|NCT00431951|27133973|P2|Overall Study|Inability to follow study procedures|0
7810789|NCT00431951|27133974|P1|Overall Study|Inability to follow study procedures|1
7810790|NCT00431847|27134036|P5|Overall Study|Protocol Violation|1
7810791|NCT00431847|27134037|P4|Overall Study|Protocol Violation|0
7810792|NCT00431847|27134038|P3|Overall Study|Protocol Violation|0
7810793|NCT00431847|27134039|P2|Overall Study|Protocol Violation|0
7810794|NCT00431847|27134040|P1|Overall Study|Protocol Violation|0
7810795|NCT00431847|27134036|P5|Overall Study|completion of less than two study visits|0
7810796|NCT00431847|27134037|P4|Overall Study|completion of less than two study visits|14
7810797|NCT00431847|27134038|P3|Overall Study|completion of less than two study visits|4
7810798|NCT00431847|27134039|P2|Overall Study|completion of less than two study visits|3
7810799|NCT00431847|27134040|P1|Overall Study|completion of less than two study visits|6
7810800|NCT00431834|27134114|P1|Overall Study|Lost to Follow-up|1
7810801|NCT00431834|27134114|P1|Overall Study|Missed Endpoint Visit|2
7810802|NCT00431834|27134114|P1|Overall Study|Death|3
7810803|NCT00431834|27134114|P1|Overall Study|Withdrawal by Subject|7
7810804|NCT00431496|27134130|P1|Overall Study|Protocol-specified criteria|5
7810805|NCT00431496|27134130|P1|Overall Study|Withdrawal by Subject|2
7810806|NCT00431496|27134130|P1|Overall Study|Lost to Follow-up|1
7810807|NCT00431496|27134130|P1|Overall Study|Adverse Event|3
7810808|NCT00431444|27134141|P2|Overall Study|Administrative Problems|1
7810809|NCT00431444|27134142|P1|Overall Study|Administrative Problems|0
7810810|NCT00431444|27134141|P2|Overall Study|Lost to Follow-up|0
7810811|NCT00431444|27134142|P1|Overall Study|Lost to Follow-up|1
7810812|NCT00431444|27134141|P2|Overall Study|Withdrawal by Subject|1
7810813|NCT00431444|27134142|P1|Overall Study|Withdrawal by Subject|1
7810814|NCT00431444|27134141|P2|Overall Study|Adverse Event|1
7810815|NCT00431444|27134142|P1|Overall Study|Adverse Event|2
7810816|NCT00431444|27134141|P2|Overall Study|Protocol Violation|4
7810817|NCT00431444|27134142|P1|Overall Study|Protocol Violation|1
7810818|NCT00431067|27134182|P1|Overall Study|Non-compliance,lost to follow-up|2
7810819|NCT00431067|27134182|P1|Overall Study|Progressive disease|30
7810820|NCT00431067|27134182|P1|Overall Study|Other Adverse Event|9
7810821|NCT00430989|27134207|P2|Overall Study|Not eligible|6
7810822|NCT00430989|27134208|P1|Overall Study|Not eligible|13
7810823|NCT00430989|27134207|P2|Overall Study|Protocol Violation|37
7810824|NCT00430989|27134208|P1|Overall Study|Protocol Violation|30
7810825|NCT00430989|27134207|P2|Overall Study|Withdrawal by Subject|14
7810826|NCT00430989|27134208|P1|Overall Study|Withdrawal by Subject|15
7810827|NCT00430989|27134207|P2|Overall Study|Lost to Follow-up|3
7810828|NCT00430989|27134208|P1|Overall Study|Lost to Follow-up|2
7810829|NCT00430950|27134228|P2|Overall Study|concomitant medication,etc.|7
7810830|NCT00430950|27134229|P1|Overall Study|concomitant medication,etc.|5
7810831|NCT00430950|27134228|P2|Overall Study|Withdrawal by Subject|0
7810832|NCT00430950|27134229|P1|Overall Study|Withdrawal by Subject|1
7810833|NCT00430950|27134228|P2|Overall Study|Adverse Event|6
7810834|NCT00430950|27134229|P1|Overall Study|Adverse Event|7
7810835|NCT00430937|27134243|P2|Overall Study|Unable to classify|1
7810836|NCT00430937|27134244|P1|Overall Study|Unable to classify|0
7810837|NCT00430937|27134243|P2|Overall Study|Protocol discontinuation criteria met|2
7810838|NCT00430937|27134244|P1|Overall Study|Protocol discontinuation criteria met|1
7810839|NCT00430937|27134243|P2|Overall Study|Administrative reasons|0
7810840|NCT00430937|27134244|P1|Overall Study|Administrative reasons|1
7810841|NCT00430937|27134243|P2|Overall Study|Inappropriate enrollment|1
7810842|NCT00430937|27134244|P1|Overall Study|Inappropriate enrollment|2
7810843|NCT00430937|27134243|P2|Overall Study|Lack of Efficacy|5
7810844|NCT00430937|27134244|P1|Overall Study|Lack of Efficacy|6
7810845|NCT00430937|27134243|P2|Overall Study|Protocol Violation|2
7810846|NCT00430937|27134244|P1|Overall Study|Protocol Violation|3
7810847|NCT00430937|27134243|P2|Overall Study|Withdrawal by Subject|2
7810848|NCT00430937|27134244|P1|Overall Study|Withdrawal by Subject|5
7810849|NCT00430937|27134243|P2|Overall Study|Lost to Follow-up|6
7810850|NCT00430937|27134244|P1|Overall Study|Lost to Follow-up|6
7810851|NCT00430937|27134243|P2|Overall Study|Death|1
7810852|NCT00430937|27134244|P1|Overall Study|Death|0
7810853|NCT00430937|27134243|P2|Overall Study|Adverse Event|8
7810854|NCT00430937|27134244|P1|Overall Study|Adverse Event|3
7810855|NCT00430781|27134255|P3|End-of-Study Analysis; 28 July 2011|Other|0
7810856|NCT00430781|27134256|P2|End-of-Study Analysis; 28 July 2011|Other|1
7810857|NCT00430781|27134257|P1|End-of-Study Analysis; 28 July 2011|Other|4
7810858|NCT00430781|27134255|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
7810859|NCT00430781|27134256|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
7810860|NCT00430781|27134257|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
7810861|NCT00430781|27134255|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
7810862|NCT00430781|27134256|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
7810863|NCT00430781|27134257|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
7810864|NCT00430781|27134255|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
7810865|NCT00430781|27134256|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
7810866|NCT00430781|27134257|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
7810867|NCT00430781|27134255|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
7811030|NCT00430521|27134518|P4|Overall Study|Protocol Violation|0
7810868|NCT00430781|27134256|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
7810869|NCT00430781|27134257|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
7810870|NCT00430781|27134255|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
7810871|NCT00430781|27134256|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
7810872|NCT00430781|27134257|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
7810873|NCT00430781|27134255|P3|Final Analysis; 31 July 2008|Ongoing|32
7810874|NCT00430781|27134256|P2|Final Analysis; 31 July 2008|Ongoing|29
7810875|NCT00430781|27134257|P1|Final Analysis; 31 July 2008|Ongoing|0
7810876|NCT00430781|27134255|P3|Final Analysis; 31 July 2008|Other|0
7810877|NCT00430781|27134256|P2|Final Analysis; 31 July 2008|Other|1
7810878|NCT00430781|27134257|P1|Final Analysis; 31 July 2008|Other|0
7810879|NCT00430781|27134255|P3|Final Analysis; 31 July 2008|Physician Decision|6
7810880|NCT00430781|27134256|P2|Final Analysis; 31 July 2008|Physician Decision|6
7810881|NCT00430781|27134257|P1|Final Analysis; 31 July 2008|Physician Decision|0
7810882|NCT00430781|27134255|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
7810883|NCT00430781|27134256|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
7810884|NCT00430781|27134257|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
7810885|NCT00430781|27134255|P3|Final Analysis; 31 July 2008|Protocol Violation|0
7810886|NCT00430781|27134256|P2|Final Analysis; 31 July 2008|Protocol Violation|1
7810887|NCT00430781|27134257|P1|Final Analysis; 31 July 2008|Protocol Violation|0
7810888|NCT00430781|27134255|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
7810889|NCT00430781|27134256|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
7810890|NCT00430781|27134257|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
7810891|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Ongoing|25
7810892|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Ongoing|20
7810893|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Ongoing|23
7810894|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Physician Decision|3
7810895|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Physician Decision|3
7810896|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Physician Decision|2
7810897|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
7810898|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
7810899|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
7810900|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Death|0
7810901|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Death|1
7810902|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Death|0
7810903|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Disease Progression|22
7810904|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Disease Progression|30
7810905|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Disease Progression|16
7810906|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
7810907|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
7810908|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
7810909|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
7810910|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
7810911|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
7810912|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
7810913|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
7810914|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
7810915|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
7810916|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
7810917|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
7810918|NCT00430781|27134255|P3|Interim Analysis; 11 February 2008|Adverse Event|7
7810919|NCT00430781|27134256|P2|Interim Analysis; 11 February 2008|Adverse Event|3
7810920|NCT00430781|27134257|P1|Interim Analysis; 11 February 2008|Adverse Event|10
7810921|NCT00430755|27134299|P1|Overall Study|Withdrawal by Subject|53
7810922|NCT00430716|27134306|P3|Open Label Phase|Study terminated by sponsor|4
7810923|NCT00430716|27134307|P2|Open Label Phase|Study terminated by sponsor|5
7810924|NCT00430716|27134308|P1|Open Label Phase|Study terminated by sponsor|4
7810925|NCT00430716|27134306|P3|Open Label Phase|Protocol Violation|0
7810926|NCT00430716|27134307|P2|Open Label Phase|Protocol Violation|0
7810927|NCT00430716|27134308|P1|Open Label Phase|Protocol Violation|1
7810928|NCT00430716|27134306|P3|Open Label Phase|Other|1
7810929|NCT00430716|27134307|P2|Open Label Phase|Other|1
7810930|NCT00430716|27134308|P1|Open Label Phase|Other|3
7810931|NCT00430716|27134306|P3|Open Label Phase|No longer willing to participate|1
7810932|NCT00430716|27134307|P2|Open Label Phase|No longer willing to participate|1
7810933|NCT00430716|27134308|P1|Open Label Phase|No longer willing to participate|0
7810934|NCT00430716|27134306|P3|Open Label Phase|Lost to Follow-up|1
7810935|NCT00430716|27134307|P2|Open Label Phase|Lost to Follow-up|0
7810936|NCT00430716|27134308|P1|Open Label Phase|Lost to Follow-up|1
7810937|NCT00430716|27134306|P3|Double Blind Phase|Not treated|0
7810938|NCT00430716|27134307|P2|Double Blind Phase|Not treated|0
7810939|NCT00430716|27134308|P1|Double Blind Phase|Not treated|1
7810940|NCT00430716|27134306|P3|Double Blind Phase|Adverse Event|3
7810941|NCT00430716|27134307|P2|Double Blind Phase|Adverse Event|1
7810942|NCT00430716|27134308|P1|Double Blind Phase|Adverse Event|1
7810943|NCT00430716|27134306|P3|Double Blind Phase|Study terminated by sponsor|2
7810944|NCT00430716|27134307|P2|Double Blind Phase|Study terminated by sponsor|1
7810945|NCT00430716|27134308|P1|Double Blind Phase|Study terminated by sponsor|1
7810946|NCT00430716|27134306|P3|Double Blind Phase|Other|0
7810947|NCT00430716|27134307|P2|Double Blind Phase|Other|2
7810948|NCT00430716|27134308|P1|Double Blind Phase|Other|0
7810949|NCT00430716|27134306|P3|Double Blind Phase|No longer willing to participate|1
7810950|NCT00430716|27134307|P2|Double Blind Phase|No longer willing to participate|1
7810951|NCT00430716|27134308|P1|Double Blind Phase|No longer willing to participate|2
7810952|NCT00430716|27134306|P3|Double Blind Phase|Death|0
7810953|NCT00430716|27134307|P2|Double Blind Phase|Death|0
7810954|NCT00430716|27134308|P1|Double Blind Phase|Death|1
7810955|NCT00430677|27134340|P3|Long-term Extension Period|Poor compliance/noncompliance|0
7810956|NCT00430677|27134341|P2|Long-term Extension Period|Poor compliance/noncompliance|0
7810957|NCT00430677|27134342|P1|Long-term Extension Period|Poor compliance/noncompliance|1
7810958|NCT00430677|27134340|P3|Long-term Extension Period|Other|1
7810959|NCT00430677|27134341|P2|Long-term Extension Period|Other|1
7810960|NCT00430677|27134342|P1|Long-term Extension Period|Other|2
7810961|NCT00430677|27134340|P3|Long-term Extension Period|Administrative reason by sponsor|46
7810962|NCT00430677|27134341|P2|Long-term Extension Period|Administrative reason by sponsor|49
7810963|NCT00430677|27134342|P1|Long-term Extension Period|Administrative reason by sponsor|41
7810964|NCT00430677|27134340|P3|Long-term Extension Period|Pregnancy|0
7810965|NCT00430677|27134341|P2|Long-term Extension Period|Pregnancy|1
7810966|NCT00430677|27134342|P1|Long-term Extension Period|Pregnancy|1
7810967|NCT00430677|27134340|P3|Long-term Extension Period|Withdrawal by Subject|2
7810968|NCT00430677|27134341|P2|Long-term Extension Period|Withdrawal by Subject|1
7810969|NCT00430677|27134342|P1|Long-term Extension Period|Withdrawal by Subject|5
7810970|NCT00430677|27134340|P3|Long-term Extension Period|Lost to Follow-up|1
7810971|NCT00430677|27134341|P2|Long-term Extension Period|Lost to Follow-up|1
7810972|NCT00430677|27134342|P1|Long-term Extension Period|Lost to Follow-up|1
7810973|NCT00430677|27134340|P3|Long-term Extension Period|Lack of Efficacy|8
7810974|NCT00430677|27134341|P2|Long-term Extension Period|Lack of Efficacy|3
7810975|NCT00430677|27134342|P1|Long-term Extension Period|Lack of Efficacy|5
7810976|NCT00430677|27134340|P3|Long-term Extension Period|Adverse Event|5
7810977|NCT00430677|27134341|P2|Long-term Extension Period|Adverse Event|2
7810978|NCT00430677|27134342|P1|Long-term Extension Period|Adverse Event|3
7810979|NCT00430677|27134340|P3|Long-term Extension Period|Death|0
7810980|NCT00430677|27134341|P2|Long-term Extension Period|Death|0
7810981|NCT00430677|27134342|P1|Long-term Extension Period|Death|1
7810982|NCT00430677|27134340|P3|Short-term Period|Pregnancy|0
7810983|NCT00430677|27134341|P2|Short-term Period|Pregnancy|2
7810984|NCT00430677|27134342|P1|Short-term Period|Pregnancy|0
7810985|NCT00430677|27134340|P3|Short-term Period|Poor compliance/ noncompliance|0
7810986|NCT00430677|27134341|P2|Short-term Period|Poor compliance/ noncompliance|1
7810987|NCT00430677|27134342|P1|Short-term Period|Poor compliance/ noncompliance|0
7810988|NCT00430677|27134340|P3|Short-term Period|Participant no longer met study criteria|2
7810989|NCT00430677|27134341|P2|Short-term Period|Participant no longer met study criteria|1
7810990|NCT00430677|27134342|P1|Short-term Period|Participant no longer met study criteria|1
7810991|NCT00430677|27134340|P3|Short-term Period|Withdrawal by Subject|2
7810992|NCT00430677|27134341|P2|Short-term Period|Withdrawal by Subject|1
7810993|NCT00430677|27134342|P1|Short-term Period|Withdrawal by Subject|1
7810994|NCT00430677|27134340|P3|Short-term Period|Lack of Efficacy|4
7810995|NCT00430677|27134341|P2|Short-term Period|Lack of Efficacy|6
7810996|NCT00430677|27134342|P1|Short-term Period|Lack of Efficacy|5
7810997|NCT00430677|27134340|P3|Short-term Period|Adverse Event|9
7810998|NCT00430677|27134341|P2|Short-term Period|Adverse Event|13
7810999|NCT00430677|27134342|P1|Short-term Period|Adverse Event|15
7811000|NCT00430677|27134340|P3|Short-term Period|Death|5
7811001|NCT00430677|27134341|P2|Short-term Period|Death|1
7811002|NCT00430677|27134342|P1|Short-term Period|Death|1
7811003|NCT00430638|27134465|P2|Overall Study|Other|2
7811004|NCT00430638|27134466|P1|Overall Study|Other|2
7811005|NCT00430638|27134465|P2|Overall Study|Non-compliant|1
7811006|NCT00430638|27134466|P1|Overall Study|Non-compliant|2
7811007|NCT00430638|27134465|P2|Overall Study|Withdrawal by Subject|6
7811008|NCT00430638|27134466|P1|Overall Study|Withdrawal by Subject|4
7811009|NCT00430638|27134465|P2|Overall Study|Protocol Violation|4
7811010|NCT00430638|27134466|P1|Overall Study|Protocol Violation|6
7811011|NCT00430638|27134465|P2|Overall Study|Lost to Follow-up|7
7811012|NCT00430638|27134466|P1|Overall Study|Lost to Follow-up|1
7811013|NCT00430638|27134465|P2|Overall Study|Uncontrolled blood pressure|13
7811014|NCT00430638|27134466|P1|Overall Study|Uncontrolled blood pressure|48
7811015|NCT00430638|27134465|P2|Overall Study|Adverse Event|15
7811016|NCT00430638|27134466|P1|Overall Study|Adverse Event|15
7811017|NCT00430573|27134501|P1|Overall Study|Withdrawal by Subject|5
7811018|NCT00430521|27134514|P8|Overall Study|Withdrawal by Subject|2
7811019|NCT00430521|27134515|P7|Overall Study|Withdrawal by Subject|0
7811020|NCT00430521|27134516|P6|Overall Study|Withdrawal by Subject|0
7811021|NCT00430521|27134517|P5|Overall Study|Withdrawal by Subject|0
7811022|NCT00430521|27134518|P4|Overall Study|Withdrawal by Subject|3
7811023|NCT00430521|27134519|P3|Overall Study|Withdrawal by Subject|0
7811024|NCT00430521|27134520|P2|Overall Study|Withdrawal by Subject|1
7811025|NCT00430521|27134521|P1|Overall Study|Withdrawal by Subject|3
7811026|NCT00430521|27134514|P8|Overall Study|Protocol Violation|0
7811027|NCT00430521|27134515|P7|Overall Study|Protocol Violation|0
7811028|NCT00430521|27134516|P6|Overall Study|Protocol Violation|0
7811029|NCT00430521|27134517|P5|Overall Study|Protocol Violation|0
7811031|NCT00430521|27134519|P3|Overall Study|Protocol Violation|0
7811032|NCT00430521|27134520|P2|Overall Study|Protocol Violation|0
7811033|NCT00430521|27134521|P1|Overall Study|Protocol Violation|1
7811034|NCT00430521|27134514|P8|Overall Study|Vaccine Expired|0
7811035|NCT00430521|27134515|P7|Overall Study|Vaccine Expired|0
7811036|NCT00430521|27134516|P6|Overall Study|Vaccine Expired|1
7811037|NCT00430521|27134517|P5|Overall Study|Vaccine Expired|0
7811038|NCT00430521|27134518|P4|Overall Study|Vaccine Expired|0
7811039|NCT00430521|27134519|P3|Overall Study|Vaccine Expired|0
7811040|NCT00430521|27134520|P2|Overall Study|Vaccine Expired|0
7811041|NCT00430521|27134521|P1|Overall Study|Vaccine Expired|0
7811042|NCT00430521|27134514|P8|Overall Study|Pregnancy|0
7811043|NCT00430521|27134515|P7|Overall Study|Pregnancy|1
7811044|NCT00430521|27134516|P6|Overall Study|Pregnancy|0
7811045|NCT00430521|27134517|P5|Overall Study|Pregnancy|0
7811046|NCT00430521|27134518|P4|Overall Study|Pregnancy|0
7811047|NCT00430521|27134519|P3|Overall Study|Pregnancy|0
7811048|NCT00430521|27134520|P2|Overall Study|Pregnancy|0
7811049|NCT00430521|27134521|P1|Overall Study|Pregnancy|0
7811050|NCT00430521|27134514|P8|Overall Study|Lost to Follow-up|10
7811051|NCT00430521|27134515|P7|Overall Study|Lost to Follow-up|8
7811052|NCT00430521|27134516|P6|Overall Study|Lost to Follow-up|2
7811053|NCT00430521|27134517|P5|Overall Study|Lost to Follow-up|5
7811054|NCT00430521|27134518|P4|Overall Study|Lost to Follow-up|5
7811055|NCT00430521|27134519|P3|Overall Study|Lost to Follow-up|3
7811056|NCT00430521|27134520|P2|Overall Study|Lost to Follow-up|8
7811057|NCT00430521|27134521|P1|Overall Study|Lost to Follow-up|7
7811058|NCT00430521|27134514|P8|Overall Study|Adverse Event|0
7811059|NCT00430521|27134515|P7|Overall Study|Adverse Event|1
7811060|NCT00430521|27134516|P6|Overall Study|Adverse Event|2
7811061|NCT00430521|27134517|P5|Overall Study|Adverse Event|0
7811062|NCT00430521|27134518|P4|Overall Study|Adverse Event|0
7811063|NCT00430521|27134519|P3|Overall Study|Adverse Event|0
7811064|NCT00430521|27134520|P2|Overall Study|Adverse Event|0
7811065|NCT00430521|27134521|P1|Overall Study|Adverse Event|0
7811066|NCT00430508|27134763|P4|Overall Study|Other|0
7811067|NCT00430508|27134764|P3|Overall Study|Other|3
7811068|NCT00430508|27134765|P2|Overall Study|Other|1
7811069|NCT00430508|27134766|P1|Overall Study|Other|1
7811070|NCT00430508|27134763|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
7811071|NCT00430508|27134764|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
7811072|NCT00430508|27134765|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
7811073|NCT00430508|27134766|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
7811074|NCT00430508|27134763|P4|Overall Study|responder at visit 4|0
7811075|NCT00430508|27134764|P3|Overall Study|responder at visit 4|2
7811076|NCT00430508|27134765|P2|Overall Study|responder at visit 4|0
7811077|NCT00430508|27134766|P1|Overall Study|responder at visit 4|0
7811078|NCT00430508|27134763|P4|Overall Study|Withdrawal by Subject|1
7811079|NCT00430508|27134764|P3|Overall Study|Withdrawal by Subject|1
7811080|NCT00430508|27134765|P2|Overall Study|Withdrawal by Subject|1
7811081|NCT00430508|27134766|P1|Overall Study|Withdrawal by Subject|0
7811082|NCT00430508|27134763|P4|Overall Study|Adverse Event|3
7811083|NCT00430508|27134764|P3|Overall Study|Adverse Event|5
7811084|NCT00430508|27134765|P2|Overall Study|Adverse Event|3
7811085|NCT00430508|27134766|P1|Overall Study|Adverse Event|2
7811086|NCT00430495|27134804|P4|Overall Study|Randomized but not Treated|0
7811087|NCT00430495|27134805|P3|Overall Study|Randomized but not Treated|0
7811088|NCT00430495|27134806|P2|Overall Study|Randomized but not Treated|0
7811089|NCT00430495|27134807|P1|Overall Study|Randomized but not Treated|2
7811090|NCT00430495|27134804|P4|Overall Study|Other|4
7811091|NCT00430495|27134805|P3|Overall Study|Other|5
7811092|NCT00430495|27134806|P2|Overall Study|Other|2
7811093|NCT00430495|27134807|P1|Overall Study|Other|8
7811094|NCT00430495|27134804|P4|Overall Study|Disease Progression|0
7811095|NCT00430495|27134805|P3|Overall Study|Disease Progression|0
7811096|NCT00430495|27134806|P2|Overall Study|Disease Progression|1
7811097|NCT00430495|27134807|P1|Overall Study|Disease Progression|1
7811098|NCT00430495|27134804|P4|Overall Study|Protocol Violation|0
7811099|NCT00430495|27134805|P3|Overall Study|Protocol Violation|1
7811100|NCT00430495|27134806|P2|Overall Study|Protocol Violation|0
7811101|NCT00430495|27134807|P1|Overall Study|Protocol Violation|1
7811102|NCT00430495|27134804|P4|Overall Study|Lost to Follow-up|0
7811103|NCT00430495|27134805|P3|Overall Study|Lost to Follow-up|4
7811104|NCT00430495|27134806|P2|Overall Study|Lost to Follow-up|1
7811105|NCT00430495|27134807|P1|Overall Study|Lost to Follow-up|0
7811106|NCT00430495|27134804|P4|Overall Study|Death|0
7811107|NCT00430495|27134805|P3|Overall Study|Death|1
7811108|NCT00430495|27134806|P2|Overall Study|Death|0
7811109|NCT00430495|27134807|P1|Overall Study|Death|0
7811110|NCT00430495|27134804|P4|Overall Study|Adverse Event|0
7811111|NCT00430495|27134805|P3|Overall Study|Adverse Event|2
7811112|NCT00430495|27134806|P2|Overall Study|Adverse Event|3
7811113|NCT00430495|27134807|P1|Overall Study|Adverse Event|2
7811114|NCT00430482|27134847|P2|Completed Treatment|Insufficient Treatment|11
7811115|NCT00430482|27134848|P1|Completed Treatment|Insufficient Treatment|7
7811116|NCT00430352|27134856|P1|Overall Study|Other|48
7811117|NCT00430352|27134856|P1|Overall Study|Death|5
7811118|NCT00430352|27134856|P1|Overall Study|Adverse Event|16
7811119|NCT00430352|27134856|P1|Overall Study|Withdrawal by Subject|11
7811120|NCT00430352|27134856|P1|Overall Study|Disease progression|58
7811121|NCT00430300|27134874|P4|Overall Study|Other|1
7811122|NCT00430300|27134875|P3|Overall Study|Other|0
7811123|NCT00430300|27134876|P2|Overall Study|Other|0
7811124|NCT00430300|27134877|P1|Overall Study|Other|0
7811125|NCT00430300|27134874|P4|Overall Study|Laboratory abnormality|0
7811126|NCT00430300|27134875|P3|Overall Study|Laboratory abnormality|0
7811127|NCT00430300|27134876|P2|Overall Study|Laboratory abnormality|0
7811128|NCT00430300|27134877|P1|Overall Study|Laboratory abnormality|1
7811129|NCT00430300|27134874|P4|Overall Study|Withdrawal by Subject|0
7811130|NCT00430300|27134875|P3|Overall Study|Withdrawal by Subject|5
7811131|NCT00430300|27134876|P2|Overall Study|Withdrawal by Subject|0
7811132|NCT00430300|27134877|P1|Overall Study|Withdrawal by Subject|1
7811133|NCT00430300|27134874|P4|Overall Study|Adverse Event|1
7811134|NCT00430300|27134875|P3|Overall Study|Adverse Event|1
7811135|NCT00430300|27134876|P2|Overall Study|Adverse Event|2
7811136|NCT00430300|27134877|P1|Overall Study|Adverse Event|0
7811137|NCT00430248|27134982|P3|Overall Study|Reason Not Specified|11
7811138|NCT00430248|27134983|P2|Overall Study|Reason Not Specified|8
7811139|NCT00430248|27134984|P1|Overall Study|Reason Not Specified|8
7811140|NCT00430248|27134982|P3|Overall Study|Gout Flare|2
7811141|NCT00430248|27134983|P2|Overall Study|Gout Flare|7
7811142|NCT00430248|27134984|P1|Overall Study|Gout Flare|3
7811143|NCT00430248|27134982|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7811144|NCT00430248|27134983|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7811145|NCT00430248|27134984|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7811146|NCT00430248|27134982|P3|Overall Study|Withdrawal by Subject|16
7811147|NCT00430248|27134983|P2|Overall Study|Withdrawal by Subject|20
7811148|NCT00430248|27134984|P1|Overall Study|Withdrawal by Subject|14
7811149|NCT00430248|27134982|P3|Overall Study|Therapeutic Failure|1
7811150|NCT00430248|27134983|P2|Overall Study|Therapeutic Failure|1
7811151|NCT00430248|27134984|P1|Overall Study|Therapeutic Failure|1
7811152|NCT00430248|27134982|P3|Overall Study|Lost to Follow-up|28
7811153|NCT00430248|27134983|P2|Overall Study|Lost to Follow-up|33
7811154|NCT00430248|27134984|P1|Overall Study|Lost to Follow-up|28
7811155|NCT00430248|27134982|P3|Overall Study|Personal Reasons|9
7811156|NCT00430248|27134983|P2|Overall Study|Personal Reasons|24
7811157|NCT00430248|27134984|P1|Overall Study|Personal Reasons|12
7811158|NCT00430248|27134982|P3|Overall Study|Protocol Violation|4
7811159|NCT00430248|27134983|P2|Overall Study|Protocol Violation|2
7811160|NCT00430248|27134984|P1|Overall Study|Protocol Violation|10
7811161|NCT00430248|27134982|P3|Overall Study|Adverse Event|64
7811162|NCT00430248|27134983|P2|Overall Study|Adverse Event|61
7811163|NCT00430248|27134984|P1|Overall Study|Adverse Event|49
7811164|NCT00430092|27135052|P3|Overall Study|Withdrawal by Subject|1
7811165|NCT00430092|27135053|P2|Overall Study|Withdrawal by Subject|1
7811166|NCT00430092|27135054|P1|Overall Study|Withdrawal by Subject|0
7811167|NCT00430092|27135052|P3|Overall Study|Protocol Violation|1
7811168|NCT00430092|27135053|P2|Overall Study|Protocol Violation|1
7811169|NCT00430092|27135054|P1|Overall Study|Protocol Violation|0
7811170|NCT00430092|27135052|P3|Overall Study|Lost to Follow-up|0
7811171|NCT00430092|27135053|P2|Overall Study|Lost to Follow-up|0
7811172|NCT00430092|27135054|P1|Overall Study|Lost to Follow-up|1
7811173|NCT00430092|27135052|P3|Overall Study|Lack of Efficacy|54
7811174|NCT00430092|27135053|P2|Overall Study|Lack of Efficacy|2
7811175|NCT00430092|27135054|P1|Overall Study|Lack of Efficacy|5
7811176|NCT00430092|27135052|P3|Overall Study|Adverse Event|1
7811177|NCT00430092|27135053|P2|Overall Study|Adverse Event|0
7811178|NCT00430092|27135054|P1|Overall Study|Adverse Event|0
7811179|NCT00430027|27135059|P1|Overall Study|Study terminated|8
7811180|NCT00429923|27135076|P3|Overall Study|Early Termination|0
7811181|NCT00429923|27135077|P2|Overall Study|Early Termination|1
7811182|NCT00429923|27135078|P1|Overall Study|Early Termination|0
7811183|NCT00429923|27135076|P3|Overall Study|Withdrew Consent|1
7811184|NCT00429923|27135077|P2|Overall Study|Withdrew Consent|0
7811185|NCT00429923|27135078|P1|Overall Study|Withdrew Consent|1
7811186|NCT00429923|27135076|P3|Overall Study|Lost to Follow-up|2
7811187|NCT00429923|27135077|P2|Overall Study|Lost to Follow-up|0
7811188|NCT00429923|27135078|P1|Overall Study|Lost to Follow-up|0
7811189|NCT00429923|27135076|P3|Overall Study|Lack of Efficacy|33
7811190|NCT00429923|27135077|P2|Overall Study|Lack of Efficacy|1
7811191|NCT00429923|27135078|P1|Overall Study|Lack of Efficacy|4
7811192|NCT00429923|27135076|P3|Overall Study|Adverse Event|3
7811193|NCT00429923|27135077|P2|Overall Study|Adverse Event|2
7811194|NCT00429923|27135078|P1|Overall Study|Adverse Event|0
7811195|NCT00429858|27135083|P1|Overall Study|Study Termination|1
7811196|NCT00429858|27135083|P1|Overall Study|Withdrawal by Subject|1
7811197|NCT00429793|27135094|P1|Overall Study|Non-measurable|1
7811198|NCT00429793|27135094|P1|Overall Study|Never treated|1
7811199|NCT00429793|27135094|P1|Overall Study|Required test not done|1
7811200|NCT00429793|27135094|P1|Overall Study|Improper pre-protocol treatment|3
7811201|NCT00429663|27135121|P2|Overall Study|Death|0
7811202|NCT00429663|27135122|P1|Overall Study|Death|4
7811203|NCT00429663|27135121|P2|Overall Study|Withdrawal by Subject|5
7811204|NCT00429663|27135122|P1|Overall Study|Withdrawal by Subject|2
7811205|NCT00429663|27135121|P2|Overall Study|Physician Decision|3
7811206|NCT00429663|27135122|P1|Overall Study|Physician Decision|6
7811207|NCT00429663|27135121|P2|Overall Study|Lost to Follow-up|31
7811208|NCT00429663|27135122|P1|Overall Study|Lost to Follow-up|24
7811209|NCT00429572|27135136|P1|Overall Study|Disease progression|1
7811210|NCT00429494|27135148|P1|Overall Study|Death|6
7811211|NCT00429494|27135148|P1|Overall Study|Withdrawal by Subject|9
7811212|NCT00429416|27135152|P1|Overall Study|Death|1
7811213|NCT00429364|27135171|P2|Overall Study|Pregnancy|1
7811214|NCT00429364|27135172|P1|Overall Study|Pregnancy|0
7811215|NCT00429364|27135171|P2|Overall Study|Underwent aortic root surgery|18
7811216|NCT00429364|27135172|P1|Overall Study|Underwent aortic root surgery|10
7811217|NCT00429364|27135171|P2|Overall Study|Death|1
7811218|NCT00429364|27135172|P1|Overall Study|Death|0
7811219|NCT00429364|27135171|P2|Overall Study|Lost to Follow-up|6
7811220|NCT00429364|27135172|P1|Overall Study|Lost to Follow-up|7
7811221|NCT00429364|27135171|P2|Overall Study|Physician Decision|2
7811222|NCT00429364|27135172|P1|Overall Study|Physician Decision|4
7811223|NCT00429364|27135171|P2|Overall Study|Withdrawal by Subject|5
7811224|NCT00429364|27135172|P1|Overall Study|Withdrawal by Subject|11
7811225|NCT00429299|27135231|P3|Overall Study|Withdrawal by Subject|3
7811226|NCT00429299|27135232|P2|Overall Study|Withdrawal by Subject|1
7811227|NCT00429299|27135233|P1|Overall Study|Withdrawal by Subject|0
7811228|NCT00429299|27135231|P3|Overall Study|Protocol Violation|0
7811229|NCT00429299|27135232|P2|Overall Study|Protocol Violation|0
7811230|NCT00429299|27135233|P1|Overall Study|Protocol Violation|1
7811231|NCT00429299|27135231|P3|Overall Study|Adverse Event|1
7811232|NCT00429299|27135232|P2|Overall Study|Adverse Event|5
7811233|NCT00429299|27135233|P1|Overall Study|Adverse Event|2
7811234|NCT00429299|27135231|P3|Overall Study|Disease Progression|0
7811235|NCT00429299|27135232|P2|Overall Study|Disease Progression|1
7811236|NCT00429299|27135233|P1|Overall Study|Disease Progression|1
7811237|NCT00429273|27135265|P3|Overall Study|Adverse Event|2
7811238|NCT00429273|27135266|P2|Overall Study|Adverse Event|1
7811239|NCT00429273|27135267|P1|Overall Study|Adverse Event|1
7811240|NCT00429273|27135265|P3|Overall Study|Physician Decision|5
7811241|NCT00429273|27135266|P2|Overall Study|Physician Decision|5
7811242|NCT00429273|27135267|P1|Overall Study|Physician Decision|6
7811243|NCT00429273|27135265|P3|Overall Study|Lost to Follow-up|2
7811244|NCT00429273|27135266|P2|Overall Study|Lost to Follow-up|2
7811245|NCT00429273|27135267|P1|Overall Study|Lost to Follow-up|1
7811246|NCT00429182|27135275|P1|Overall Study|Not eligible|5
7811247|NCT00429182|27135275|P1|Overall Study|Not evaluable, Disease Progression|2
7811248|NCT00429169|27135282|P2|Overall Study|Ineligibility discovered after entry|1
7811249|NCT00429169|27135283|P1|Overall Study|Ineligibility discovered after entry|2
7811250|NCT00429169|27135282|P2|Overall Study|Lost to Follow-up|1
7811251|NCT00429169|27135283|P1|Overall Study|Lost to Follow-up|0
7811252|NCT00429104|27135303|P1|Overall Study|Protocol Violation|1
7811253|NCT00429026|27135308|P1|Overall Study|Inevaluable for response.|40
7811254|NCT00428948|27135335|P2|Overall Study|Protocol Deviation|1
7811255|NCT00428948|27135336|P1|Overall Study|Protocol Deviation|1
7811256|NCT00428948|27135335|P2|Overall Study|Subject Withdrew Consent|30
7811257|NCT00428948|27135336|P1|Overall Study|Subject Withdrew Consent|50
7811258|NCT00428948|27135335|P2|Overall Study|Investigator Withdrew Subject|4
7811259|NCT00428948|27135336|P1|Overall Study|Investigator Withdrew Subject|3
7811260|NCT00428948|27135335|P2|Overall Study|Subject Met Withdrawal Criteria|0
7811261|NCT00428948|27135336|P1|Overall Study|Subject Met Withdrawal Criteria|4
7811262|NCT00428948|27135335|P2|Overall Study|Adverse Event|24
7811263|NCT00428948|27135336|P1|Overall Study|Adverse Event|148
7811264|NCT00428948|27135335|P2|Overall Study|Lost to Follow-up|8
7811265|NCT00428948|27135336|P1|Overall Study|Lost to Follow-up|15
7811266|NCT00428844|27135364|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
7811267|NCT00428844|27135365|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
7811268|NCT00428844|27135366|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
7811269|NCT00428844|27135364|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
7811270|NCT00428844|27135365|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
7811271|NCT00428844|27135366|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
7811272|NCT00428844|27135364|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
7811273|NCT00428844|27135365|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
7811274|NCT00428844|27135366|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
7811275|NCT00428844|27135364|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
7811276|NCT00428844|27135365|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
7811277|NCT00428844|27135366|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
7811278|NCT00428844|27135364|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
7811279|NCT00428844|27135365|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
7811280|NCT00428844|27135366|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
7811281|NCT00428844|27135364|P3|Completed Study Drug Treatment|Randomized Not Treated|1
7811282|NCT00428844|27135365|P2|Completed Study Drug Treatment|Randomized Not Treated|0
7811283|NCT00428844|27135366|P1|Completed Study Drug Treatment|Randomized Not Treated|0
7811284|NCT00428844|27135364|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
7811285|NCT00428844|27135365|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
7811286|NCT00428844|27135366|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
7811287|NCT00428844|27135364|P3|Completed Study Drug Treatment|Protocol Violation|1
7811288|NCT00428844|27135365|P2|Completed Study Drug Treatment|Protocol Violation|1
7811289|NCT00428844|27135366|P1|Completed Study Drug Treatment|Protocol Violation|0
7811290|NCT00428844|27135364|P3|Completed Study Drug Treatment|Adverse Event|4
7811291|NCT00428844|27135365|P2|Completed Study Drug Treatment|Adverse Event|4
7811292|NCT00428844|27135366|P1|Completed Study Drug Treatment|Adverse Event|2
7811293|NCT00428792|27135389|P2|Overall Study|Lost to Follow-up|1
7811294|NCT00428792|27135390|P1|Overall Study|Lost to Follow-up|0
7811295|NCT00428792|27135389|P2|Overall Study|Lack of Efficacy|3
7811296|NCT00428792|27135390|P1|Overall Study|Lack of Efficacy|1
7811297|NCT00428714|27135416|P2|Overall Study|Death due to other then PD|0
7811298|NCT00428714|27135417|P1|Overall Study|Death due to other then PD|1
7811299|NCT00428714|27135416|P2|Overall Study|Death due to Progressive Disease (PD)|0
7811300|NCT00428714|27135417|P1|Overall Study|Death due to Progressive Disease (PD)|1
7811301|NCT00428714|27135416|P2|Overall Study|Physician Decision|1
7811302|NCT00428714|27135417|P1|Overall Study|Physician Decision|1
7811303|NCT00428714|27135416|P2|Overall Study|Adverse Event|2
7811304|NCT00428714|27135417|P1|Overall Study|Adverse Event|0
7811305|NCT00428714|27135416|P2|Overall Study|Withdrawal by Subject|3
7811306|NCT00428714|27135417|P1|Overall Study|Withdrawal by Subject|0
7811307|NCT00428714|27135416|P2|Overall Study|Progressive Disease|36
7811308|NCT00428714|27135417|P1|Overall Study|Progressive Disease|28
7811309|NCT00428610|27135436|P3|Overall Study|Withdrawal by Subject|0
7811310|NCT00428610|27135437|P2|Overall Study|Withdrawal by Subject|0
7811311|NCT00428610|27135438|P1|Overall Study|Withdrawal by Subject|4
7811312|NCT00428610|27135436|P3|Overall Study|Progressive Disease|22
7811313|NCT00428610|27135437|P2|Overall Study|Progressive Disease|14
7811314|NCT00428610|27135438|P1|Overall Study|Progressive Disease|42
7811315|NCT00428610|27135436|P3|Overall Study|Investigator Decision|1
7811316|NCT00428610|27135437|P2|Overall Study|Investigator Decision|1
7811317|NCT00428610|27135438|P1|Overall Study|Investigator Decision|2
7811318|NCT00428610|27135436|P3|Overall Study|Adverse Event|2
7811319|NCT00428610|27135437|P2|Overall Study|Adverse Event|3
7811320|NCT00428610|27135438|P1|Overall Study|Adverse Event|2
7811321|NCT00428610|27135436|P3|Overall Study|Death Due to Progressive Disease|2
7811322|NCT00428610|27135437|P2|Overall Study|Death Due to Progressive Disease|0
7811323|NCT00428610|27135438|P1|Overall Study|Death Due to Progressive Disease|0
7811324|NCT00428610|27135436|P3|Overall Study|Death Due to Adverse Event|5
7811325|NCT00428610|27135437|P2|Overall Study|Death Due to Adverse Event|0
7811326|NCT00428610|27135438|P1|Overall Study|Death Due to Adverse Event|3
7811327|NCT00428597|27135472|P2|Overall Study|Death|3
7811328|NCT00428597|27135473|P1|Overall Study|Death|1
7811329|NCT00428597|27135472|P2|Overall Study|Pregnancy|0
7811330|NCT00428597|27135473|P1|Overall Study|Pregnancy|1
7811331|NCT00428597|27135472|P2|Overall Study|Lost to Follow-up|1
7811332|NCT00428597|27135473|P1|Overall Study|Lost to Follow-up|0
7811333|NCT00428597|27135472|P2|Overall Study|Other|1
7811334|NCT00428597|27135473|P1|Overall Study|Other|1
7811335|NCT00428597|27135472|P2|Overall Study|Withdrawal by Subject|1
7811336|NCT00428597|27135473|P1|Overall Study|Withdrawal by Subject|2
7811337|NCT00428597|27135472|P2|Overall Study|Protocol Violation|1
7811338|NCT00428597|27135473|P1|Overall Study|Protocol Violation|2
7811339|NCT00428597|27135472|P2|Overall Study|Global Deterioration of Health Status|5
7811340|NCT00428597|27135473|P1|Overall Study|Global Deterioration of Health Status|1
7811341|NCT00428597|27135472|P2|Overall Study|Adverse Event|7
7811342|NCT00428597|27135473|P1|Overall Study|Adverse Event|15
7811343|NCT00428597|27135472|P2|Overall Study|Study Terminated by Sponsor|16
7811344|NCT00428597|27135473|P1|Overall Study|Study Terminated by Sponsor|41
7811345|NCT00428597|27135472|P2|Overall Study|Objective Progression or Relapse|47
7811346|NCT00428597|27135473|P1|Overall Study|Objective Progression or Relapse|19
7811347|NCT00428597|27135472|P2|Overall Study|Randomized but not treated|3
7811348|NCT00428597|27135473|P1|Overall Study|Randomized but not treated|3
7811349|NCT00428441|27135540|P1|Overall Study|Lost to Follow-up|1
7811350|NCT00428389|27135546|P2|Extension Phase|Administrative problems|1
7811351|NCT00428389|27135547|P1|Extension Phase|Administrative problems|1
7811352|NCT00428389|27135546|P2|Extension Phase|Protocol Violation|2
7811353|NCT00428389|27135547|P1|Extension Phase|Protocol Violation|3
7811354|NCT00428389|27135546|P2|Extension Phase|Death|0
7811355|NCT00428389|27135547|P1|Extension Phase|Death|1
7811356|NCT00428389|27135546|P2|Extension Phase|Lost to Follow-up|3
7811357|NCT00428389|27135547|P1|Extension Phase|Lost to Follow-up|0
7811358|NCT00428389|27135546|P2|Extension Phase|Withdrawal by Subject|6
7811359|NCT00428389|27135547|P1|Extension Phase|Withdrawal by Subject|6
7811360|NCT00428389|27135546|P2|Extension Phase|Lack of Efficacy|3
7811361|NCT00428389|27135547|P1|Extension Phase|Lack of Efficacy|4
7811362|NCT00428389|27135546|P2|Extension Phase|Adverse Event|11
7811363|NCT00428389|27135547|P1|Extension Phase|Adverse Event|17
7811364|NCT00428389|27135546|P2|Core Phase|Protocol deviation|2
7811365|NCT00428389|27135547|P1|Core Phase|Protocol deviation|0
7811366|NCT00428389|27135546|P2|Core Phase|Withdrawal by Subject|4
7811367|NCT00428389|27135547|P1|Core Phase|Withdrawal by Subject|3
7811368|NCT00428389|27135546|P2|Core Phase|Abnormal test procedure result(s)|1
7811369|NCT00428389|27135547|P1|Core Phase|Abnormal test procedure result(s)|0
7811370|NCT00428389|27135546|P2|Core Phase|Lack of Efficacy|0
7811371|NCT00428389|27135547|P1|Core Phase|Lack of Efficacy|2
7811372|NCT00428389|27135546|P2|Core Phase|Adverse Event|4
7811373|NCT00428389|27135547|P1|Core Phase|Adverse Event|6
7811374|NCT00428246|27135581|P3|Overall Study|Adverse Event|0
7811375|NCT00428246|27135582|P2|Overall Study|Adverse Event|0
7811376|NCT00428246|27135583|P1|Overall Study|Adverse Event|1
7811377|NCT00428246|27135581|P3|Overall Study|Withdrawal by Subject|1
7811378|NCT00428246|27135582|P2|Overall Study|Withdrawal by Subject|0
7811379|NCT00428246|27135583|P1|Overall Study|Withdrawal by Subject|0
7811380|NCT00428220|27135591|P1|Overall Study|Other|23
7811381|NCT00428220|27135591|P1|Overall Study|Adverse Event|51
7811382|NCT00428220|27135591|P1|Overall Study|Participant refused continued treatment|7
7811383|NCT00428220|27135591|P1|Overall Study|Objective progression or relapse|123
7811384|NCT00428220|27135591|P1|Overall Study|Lost to Follow-up|4
7811385|NCT00428220|27135591|P1|Overall Study|Global deterioration of health status|7
7811386|NCT00428220|27135591|P1|Overall Study|Participant died|8
7811387|NCT00428116|27135616|P2|Overall Study|Lost to Follow-up|0
7811388|NCT00428116|27135617|P1|Overall Study|Lost to Follow-up|1
7811389|NCT00428116|27135616|P2|Overall Study|Withdrawal by Subject|0
7811390|NCT00428116|27135617|P1|Overall Study|Withdrawal by Subject|1
7811391|NCT00428116|27135616|P2|Overall Study|Death|0
7811392|NCT00428116|27135617|P1|Overall Study|Death|1
7811393|NCT00428090|27135629|P4|Overall Study|Raised Creatinine Value|1
7811394|NCT00428090|27135630|P3|Overall Study|Raised Creatinine Value|0
7811395|NCT00428090|27135631|P2|Overall Study|Raised Creatinine Value|0
7811396|NCT00428090|27135632|P1|Overall Study|Raised Creatinine Value|0
7811397|NCT00428090|27135629|P4|Overall Study|Excluded for heart insufficiency|0
7811398|NCT00428090|27135630|P3|Overall Study|Excluded for heart insufficiency|1
7811399|NCT00428090|27135631|P2|Overall Study|Excluded for heart insufficiency|0
7811400|NCT00428090|27135632|P1|Overall Study|Excluded for heart insufficiency|0
7811401|NCT00428090|27135629|P4|Overall Study|Serious adverse event|0
7811402|NCT00428090|27135630|P3|Overall Study|Serious adverse event|1
7811403|NCT00428090|27135631|P2|Overall Study|Serious adverse event|0
7811404|NCT00428090|27135632|P1|Overall Study|Serious adverse event|0
7811405|NCT00428090|27135629|P4|Overall Study|Deterioration of cognitive status|0
7811406|NCT00428090|27135630|P3|Overall Study|Deterioration of cognitive status|1
7811407|NCT00428090|27135631|P2|Overall Study|Deterioration of cognitive status|0
7811408|NCT00428090|27135632|P1|Overall Study|Deterioration of cognitive status|0
7811409|NCT00428090|27135629|P4|Overall Study|High MMSE scores|0
7811410|NCT00428090|27135630|P3|Overall Study|High MMSE scores|1
7811411|NCT00428090|27135631|P2|Overall Study|High MMSE scores|0
7811412|NCT00428090|27135632|P1|Overall Study|High MMSE scores|0
7811413|NCT00428090|27135629|P4|Overall Study|Insufficient AD documentation|0
7811414|NCT00428090|27135630|P3|Overall Study|Insufficient AD documentation|1
7811415|NCT00428090|27135631|P2|Overall Study|Insufficient AD documentation|0
7811416|NCT00428090|27135632|P1|Overall Study|Insufficient AD documentation|0
7811417|NCT00428090|27135629|P4|Overall Study|Excluded for concerning QTc value|0
7811418|NCT00428090|27135630|P3|Overall Study|Excluded for concerning QTc value|1
7811419|NCT00428090|27135631|P2|Overall Study|Excluded for concerning QTc value|0
7811420|NCT00428090|27135632|P1|Overall Study|Excluded for concerning QTc value|0
7811421|NCT00428090|27135629|P4|Overall Study|Worsening of AD|0
7811422|NCT00428090|27135630|P3|Overall Study|Worsening of AD|1
7811423|NCT00428090|27135631|P2|Overall Study|Worsening of AD|0
7811424|NCT00428090|27135632|P1|Overall Study|Worsening of AD|0
7811425|NCT00428090|27135629|P4|Overall Study|Mental status of par. was|0
7811426|NCT00428090|27135630|P3|Overall Study|Mental status of par. was|0
7811427|NCT00428090|27135631|P2|Overall Study|Mental status of par. was|1
7811428|NCT00428090|27135632|P1|Overall Study|Mental status of par. was|0
7811429|NCT00428090|27135629|P4|Overall Study|Medical monitor terminated par.|0
7811430|NCT00428090|27135630|P3|Overall Study|Medical monitor terminated par.|0
7811431|NCT00428090|27135631|P2|Overall Study|Medical monitor terminated par.|1
7811432|NCT00428090|27135632|P1|Overall Study|Medical monitor terminated par.|0
7811433|NCT00428090|27135629|P4|Overall Study|Visit 7 exceed the visit window|0
7811434|NCT00428090|27135630|P3|Overall Study|Visit 7 exceed the visit window|0
7811435|NCT00428090|27135631|P2|Overall Study|Visit 7 exceed the visit window|1
7811436|NCT00428090|27135632|P1|Overall Study|Visit 7 exceed the visit window|0
7811437|NCT00428090|27135629|P4|Overall Study|Death of par.|0
7811438|NCT00428090|27135630|P3|Overall Study|Death of par.|1
7811439|NCT00428090|27135631|P2|Overall Study|Death of par.|0
7811440|NCT00428090|27135632|P1|Overall Study|Death of par.|1
7811441|NCT00428090|27135629|P4|Overall Study|Prohibited medication used for SAE|0
7811442|NCT00428090|27135630|P3|Overall Study|Prohibited medication used for SAE|0
7811443|NCT00428090|27135631|P2|Overall Study|Prohibited medication used for SAE|0
7811444|NCT00428090|27135632|P1|Overall Study|Prohibited medication used for SAE|1
7811445|NCT00428090|27135629|P4|Overall Study|Follow-Up visit not possible|0
7811446|NCT00428090|27135630|P3|Overall Study|Follow-Up visit not possible|0
7811447|NCT00428090|27135631|P2|Overall Study|Follow-Up visit not possible|0
7811448|NCT00428090|27135632|P1|Overall Study|Follow-Up visit not possible|1
7811449|NCT00428090|27135629|P4|Overall Study|Par. did not returned to visit|1
7811450|NCT00428090|27135630|P3|Overall Study|Par. did not returned to visit|0
7811451|NCT00428090|27135631|P2|Overall Study|Par. did not returned to visit|0
7811452|NCT00428090|27135632|P1|Overall Study|Par. did not returned to visit|1
7811453|NCT00428090|27135629|P4|Overall Study|Non-compliance|3
7811454|NCT00428090|27135630|P3|Overall Study|Non-compliance|1
7811455|NCT00428090|27135631|P2|Overall Study|Non-compliance|0
7811456|NCT00428090|27135632|P1|Overall Study|Non-compliance|4
7811457|NCT00428090|27135629|P4|Overall Study|Sponsor terminated study|0
7811458|NCT00428090|27135630|P3|Overall Study|Sponsor terminated study|0
7811459|NCT00428090|27135631|P2|Overall Study|Sponsor terminated study|1
7811460|NCT00428090|27135632|P1|Overall Study|Sponsor terminated study|0
7811461|NCT00428090|27135629|P4|Overall Study|Withdrawal by Subject|5
7811462|NCT00428090|27135630|P3|Overall Study|Withdrawal by Subject|15
7811463|NCT00428090|27135631|P2|Overall Study|Withdrawal by Subject|12
7811464|NCT00428090|27135632|P1|Overall Study|Withdrawal by Subject|10
7811465|NCT00428090|27135629|P4|Overall Study|Protocol Violation|3
7811466|NCT00428090|27135630|P3|Overall Study|Protocol Violation|3
7811467|NCT00428090|27135631|P2|Overall Study|Protocol Violation|1
7811468|NCT00428090|27135632|P1|Overall Study|Protocol Violation|3
7811469|NCT00428090|27135629|P4|Overall Study|Lost to Follow-up|4
7811470|NCT00428090|27135630|P3|Overall Study|Lost to Follow-up|1
7811471|NCT00428090|27135631|P2|Overall Study|Lost to Follow-up|6
7811472|NCT00428090|27135632|P1|Overall Study|Lost to Follow-up|3
7811473|NCT00428090|27135629|P4|Overall Study|Adverse Event|11
7811474|NCT00428090|27135630|P3|Overall Study|Adverse Event|10
7811475|NCT00428090|27135631|P2|Overall Study|Adverse Event|8
7811476|NCT00428090|27135632|P1|Overall Study|Adverse Event|10
7811477|NCT00427999|27135750|P1|Overall Study|Death|1
7811478|NCT00427999|27135750|P1|Overall Study|Withdrawal by Subject|9
7811479|NCT00427999|27135750|P1|Overall Study|Protocol Violation|2
7811480|NCT00427999|27135750|P1|Overall Study|Unsatisfactory therapeutic effect|13
7811481|NCT00427999|27135750|P1|Overall Study|Abnormal laboratory values|1
7811482|NCT00427999|27135750|P1|Overall Study|Adverse Event|6
7811483|NCT00427960|27135768|P2|Overall Study|Other|1
7811484|NCT00427960|27135769|P1|Overall Study|Other|0
7811485|NCT00427960|27135768|P2|Overall Study|Withdrawal by Subject|3
7811486|NCT00427960|27135769|P1|Overall Study|Withdrawal by Subject|0
7811487|NCT00427960|27135768|P2|Overall Study|Adverse Event|0
7811488|NCT00427960|27135769|P1|Overall Study|Adverse Event|2
7811489|NCT00427934|27135807|P4|Overall Study|Withdrawal by Subject|3
7811490|NCT00427934|27135808|P3|Overall Study|Withdrawal by Subject|1
7811491|NCT00427934|27135809|P2|Overall Study|Withdrawal by Subject|0
7811492|NCT00427934|27135810|P1|Overall Study|Withdrawal by Subject|0
7811493|NCT00427934|27135807|P4|Overall Study|Other|5
7811494|NCT00427934|27135808|P3|Overall Study|Other|11
7811495|NCT00427934|27135809|P2|Overall Study|Other|0
7811496|NCT00427934|27135810|P1|Overall Study|Other|0
7811497|NCT00427934|27135807|P4|Overall Study|Randomized But Did Not Receive Treatment|1
7811498|NCT00427934|27135808|P3|Overall Study|Randomized But Did Not Receive Treatment|1
7811499|NCT00427934|27135809|P2|Overall Study|Randomized But Did Not Receive Treatment|0
7811500|NCT00427934|27135810|P1|Overall Study|Randomized But Did Not Receive Treatment|0
7811501|NCT00427934|27135807|P4|Overall Study|Lack of Efficacy|2
7811502|NCT00427934|27135808|P3|Overall Study|Lack of Efficacy|5
7811503|NCT00427934|27135809|P2|Overall Study|Lack of Efficacy|0
7811504|NCT00427934|27135810|P1|Overall Study|Lack of Efficacy|0
7811505|NCT00427934|27135807|P4|Overall Study|Adverse Event|4
7811506|NCT00427934|27135808|P3|Overall Study|Adverse Event|5
7811507|NCT00427934|27135809|P2|Overall Study|Adverse Event|0
7811508|NCT00427934|27135810|P1|Overall Study|Adverse Event|1
7811509|NCT00427921|27135878|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
7811510|NCT00427921|27135878|P1|Overall Study|Adverse Event + Withdrawn from Study|1
7811511|NCT00427921|27135878|P1|Overall Study|Adverse Event + Lost Response|1
7811512|NCT00427921|27135878|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
7811513|NCT00427921|27135878|P1|Overall Study|Adverse Event + Worsening of CD|1
7811514|NCT00427921|27135878|P1|Overall Study|Adverse Event + No Response|1
7811515|NCT00427921|27135878|P1|Overall Study|Adverse Event + Withdrew Consent|1
7811516|NCT00427921|27135878|P1|Overall Study|Adverse Event + Hospitalization|1
7811517|NCT00427921|27135878|P1|Overall Study|Other reason not specified|10
7811518|NCT00427921|27135878|P1|Overall Study|Lost to Follow-up|2
7811519|NCT00427921|27135878|P1|Overall Study|Withdrawal by Subject|4
7811520|NCT00427921|27135878|P1|Overall Study|Adverse Event|26
7811521|NCT00427908|27135901|P4|Primary Phase|Adverse Event|0
7811522|NCT00427908|27135902|P3|Primary Phase|Adverse Event|0
7811523|NCT00427908|27135903|P2|Primary Phase|Adverse Event|1
7811524|NCT00427908|27135904|P1|Primary Phase|Adverse Event|0
7811525|NCT00427908|27135901|P4|Primary Phase|Withdrawal by Subject|0
7811526|NCT00427908|27135902|P3|Primary Phase|Withdrawal by Subject|1
7811527|NCT00427908|27135903|P2|Primary Phase|Withdrawal by Subject|2
7811528|NCT00427908|27135904|P1|Primary Phase|Withdrawal by Subject|1
7811529|NCT00427908|27135901|P4|Primary Phase|Lost to Follow-up|0
7811530|NCT00427908|27135902|P3|Primary Phase|Lost to Follow-up|2
7811531|NCT00427908|27135903|P2|Primary Phase|Lost to Follow-up|0
7811532|NCT00427908|27135904|P1|Primary Phase|Lost to Follow-up|4
7811533|NCT00427895|27136104|P8|Vax 2/Year 3 to 4|Failed to Return|0
7811534|NCT00427895|27136105|P7|Vax 2/Year 3 to 4|Failed to Return|0
7811535|NCT00427895|27136106|P6|Vax 2/Year 3 to 4|Failed to Return|0
7811536|NCT00427895|27136107|P5|Vax 2/Year 3 to 4|Failed to Return|1
7811537|NCT00427895|27136108|P4|Vax 2/Year 3 to 4|Failed to Return|0
7811538|NCT00427895|27136109|P3|Vax 2/Year 3 to 4|Failed to Return|0
7811539|NCT00427895|27136110|P2|Vax 2/Year 3 to 4|Failed to Return|0
7811540|NCT00427895|27136111|P1|Vax 2/Year 3 to 4|Failed to Return|0
7811541|NCT00427895|27136104|P8|Vax 2/Year 3 to 4|Protocol Violation|1
7811542|NCT00427895|27136105|P7|Vax 2/Year 3 to 4|Protocol Violation|0
7811543|NCT00427895|27136106|P6|Vax 2/Year 3 to 4|Protocol Violation|0
7811544|NCT00427895|27136107|P5|Vax 2/Year 3 to 4|Protocol Violation|0
7811545|NCT00427895|27136108|P4|Vax 2/Year 3 to 4|Protocol Violation|0
7811546|NCT00427895|27136109|P3|Vax 2/Year 3 to 4|Protocol Violation|0
7811547|NCT00427895|27136110|P2|Vax 2/Year 3 to 4|Protocol Violation|0
7811548|NCT00427895|27136111|P1|Vax 2/Year 3 to 4|Protocol Violation|0
7811549|NCT00427895|27136104|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
7811550|NCT00427895|27136105|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811551|NCT00427895|27136106|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811552|NCT00427895|27136107|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811553|NCT00427895|27136108|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811554|NCT00427895|27136109|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811555|NCT00427895|27136110|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811556|NCT00427895|27136111|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
7811557|NCT00427895|27136104|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7811558|NCT00427895|27136105|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7811559|NCT00427895|27136106|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7811560|NCT00427895|27136107|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7811561|NCT00427895|27136108|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
7811562|NCT00427895|27136109|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
7811563|NCT00427895|27136110|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
7811564|NCT00427895|27136111|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
7811565|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Other|0
7811566|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Other|0
7811567|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Other|0
7811568|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Other|0
7811569|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Other|2
7811570|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Other|0
7811571|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Other|0
7811572|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Other|0
7811573|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
7811574|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
7811575|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
7811576|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
7811577|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
7811578|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
7811579|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
7811580|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
7811581|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Death|0
7811582|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Death|0
7811583|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Death|0
7811584|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Death|0
7811585|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Death|0
7811586|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Death|0
7811587|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Death|0
7811588|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Death|1
7811589|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
7811590|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
7811591|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
7811592|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
7811593|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
7811594|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
7811595|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
7811596|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
7811597|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7811598|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7811599|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7811600|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7811601|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
7811602|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
7811603|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
7811604|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
7811605|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
7811606|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
7811607|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
7811608|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
7811609|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
7811610|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
7811611|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
7811612|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
7811613|NCT00427895|27136104|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7811614|NCT00427895|27136105|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7811615|NCT00427895|27136106|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7811616|NCT00427895|27136107|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7811617|NCT00427895|27136108|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
7811618|NCT00427895|27136109|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
7811619|NCT00427895|27136110|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
7811620|NCT00427895|27136111|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7811621|NCT00427895|27136104|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811622|NCT00427895|27136105|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811623|NCT00427895|27136106|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811624|NCT00427895|27136107|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811625|NCT00427895|27136108|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
7811626|NCT00427895|27136109|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811627|NCT00427895|27136110|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811628|NCT00427895|27136111|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7811629|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
7811630|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
7811631|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
7811632|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
7811633|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
7811634|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
7811635|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
7811636|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
7811637|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7811638|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7811639|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7811640|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7811641|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
7811642|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
7811643|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
7811644|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
7811645|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811646|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811647|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811648|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811649|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
7811650|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811651|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811652|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7811653|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7811654|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7811655|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7811656|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7811657|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
7811658|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
7811659|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
7811660|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
7811661|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7811662|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7811663|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7811664|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7811665|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7811666|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7811667|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
7811668|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
7811669|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7811670|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7811671|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7811672|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7811673|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
7811674|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
7811675|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7811676|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
7811677|NCT00427895|27136104|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7811678|NCT00427895|27136105|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7811679|NCT00427895|27136106|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7811680|NCT00427895|27136107|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7811681|NCT00427895|27136108|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
7811682|NCT00427895|27136109|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
7811683|NCT00427895|27136110|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
7811684|NCT00427895|27136111|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7811685|NCT00427778|27136186|P2|First Intervention (4 Weeks)|anxious about using ring|0
7811686|NCT00427778|27136187|P1|First Intervention (4 Weeks)|anxious about using ring|1
7811687|NCT00427778|27136186|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
7811688|NCT00427778|27136187|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
7811689|NCT00427778|27136186|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
7811690|NCT00427778|27136187|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
7811691|NCT00427778|27136186|P2|First Intervention (4 Weeks)|no longer interested|0
7811692|NCT00427778|27136187|P1|First Intervention (4 Weeks)|no longer interested|1
7811693|NCT00427700|27136212|P2|Overall Study|Pregnancy|2
7811694|NCT00427700|27136213|P1|Overall Study|Pregnancy|0
7811695|NCT00427700|27136212|P2|Overall Study|no induction of menses|4
7811696|NCT00427700|27136213|P1|Overall Study|no induction of menses|1
7811697|NCT00427700|27136212|P2|Overall Study|Lost to Follow-up|5
7811698|NCT00427700|27136213|P1|Overall Study|Lost to Follow-up|2
7811699|NCT00427648|27136229|P2|Overall Study|Adverse Event|1
7811700|NCT00427648|27136230|P1|Overall Study|Adverse Event|0
7811701|NCT00427648|27136229|P2|Overall Study|Protocol Violation|2
7811702|NCT00427648|27136230|P1|Overall Study|Protocol Violation|1
7811703|NCT00427635|27136250|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
7811704|NCT00427635|27136251|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
7811705|NCT00427635|27136250|P2|Treatment Phase|Withdrawal by Subject|0
7811706|NCT00427635|27136251|P1|Treatment Phase|Withdrawal by Subject|1
7811707|NCT00427349|27136283|P1|Overall Study|Never started therapy|1
7811708|NCT00427349|27136283|P1|Overall Study|Ineligible|1
7811709|NCT00427349|27136283|P1|Overall Study|Other|2
7811710|NCT00427349|27136283|P1|Overall Study|Alternative therapy|1
7811711|NCT00427349|27136283|P1|Overall Study|Withdrawal by Subject|3
7811712|NCT00427349|27136283|P1|Overall Study|Death|1
7811713|NCT00427349|27136283|P1|Overall Study|Adverse Event|14
7811714|NCT00427349|27136283|P1|Overall Study|Lack of Efficacy|23
7811715|NCT00427011|27136340|P1|Overall Study|Other|12
7811716|NCT00427011|27136340|P1|Overall Study|Lack of Efficacy|2
7811717|NCT00427011|27136340|P1|Overall Study|Withdrawal by Subject|1
7811718|NCT00427011|27136340|P1|Overall Study|Adverse Event|10
7811719|NCT00426842|27136355|P1|Overall Study|Lost to Follow-up|1
7811720|NCT00426764|27136361|P1|Overall Study|Other Reasons (Miscellaneous)|10
7811721|NCT00426764|27136361|P1|Overall Study|Death|1
7811722|NCT00426764|27136361|P1|Overall Study|Other|1
7811723|NCT00426764|27136361|P1|Overall Study|Adverse Event|24
7811724|NCT00426764|27136361|P1|Overall Study|Progressive Disease|83
7811725|NCT00426764|27136361|P1|Overall Study|Compassionate Use|1
7811726|NCT00426764|27136361|P1|Overall Study|Physician Decision|6
7811727|NCT00426764|27136361|P1|Overall Study|Withdrawal by Subject|4
7811728|NCT00426764|27136361|P1|Overall Study|Protocol Violation|1
7811729|NCT00426751|27136378|P2|Overall Study|Other Reasons|12
7811730|NCT00426751|27136379|P1|Overall Study|Other Reasons|7
7811731|NCT00426751|27136378|P2|Overall Study|Consent Withdrawn|1
7811732|NCT00426751|27136379|P1|Overall Study|Consent Withdrawn|0
7811733|NCT00426751|27136378|P2|Overall Study|Lost to Follow-up|6
7811734|NCT00426751|27136379|P1|Overall Study|Lost to Follow-up|7
7811735|NCT00426751|27136378|P2|Overall Study|Adverse Event|1
7811736|NCT00426751|27136379|P1|Overall Study|Adverse Event|8
7811737|NCT00426660|27136423|P1|Overall Study|Enrolled Not Treated|15
7811738|NCT00426660|27136423|P1|Overall Study|Protocol Violation|1
7811739|NCT00426660|27136423|P1|Overall Study|Withdrawal by Subject|18
7811740|NCT00426660|27136423|P1|Overall Study|Other|23
7811741|NCT00426660|27136423|P1|Overall Study|Lost to Follow-up|15
7811742|NCT00426660|27136423|P1|Overall Study|Insufficient Clinical Response|22
7811743|NCT00426660|27136423|P1|Overall Study|Adverse Event|23
7811744|NCT00426660|27136423|P1|Overall Study|Death|14
7811745|NCT00426556|27136454|P4|Phase II - Extension Phase|Adverse Event|2
7811746|NCT00426556|27136455|P3|Phase II - Extension Phase|Adverse Event|0
7811747|NCT00426556|27136456|P2|Phase II - Extension Phase|Adverse Event|0
7811748|NCT00426556|27136457|P1|Phase II - Extension Phase|Adverse Event|0
7811749|NCT00426556|27136454|P4|Phase II - Extension Phase|Disease Progression|21
7811750|NCT00426556|27136455|P3|Phase II - Extension Phase|Disease Progression|0
7811751|NCT00426556|27136456|P2|Phase II - Extension Phase|Disease Progression|0
7811752|NCT00426556|27136457|P1|Phase II - Extension Phase|Disease Progression|0
7811753|NCT00426556|27136454|P4|Phase II - Core Phase|Adverse Event|8
7811754|NCT00426556|27136455|P3|Phase II - Core Phase|Adverse Event|0
7811755|NCT00426556|27136456|P2|Phase II - Core Phase|Adverse Event|0
7811756|NCT00426556|27136457|P1|Phase II - Core Phase|Adverse Event|0
7811757|NCT00426556|27136454|P4|Phase II - Core Phase|Disease Progression|16
7811758|NCT00426556|27136455|P3|Phase II - Core Phase|Disease Progression|0
7811759|NCT00426556|27136456|P2|Phase II - Core Phase|Disease Progression|0
7811760|NCT00426556|27136457|P1|Phase II - Core Phase|Disease Progression|0
7811761|NCT00426556|27136454|P4|Phase II - Core Phase|Withdrawal by Subject|3
7811762|NCT00426556|27136455|P3|Phase II - Core Phase|Withdrawal by Subject|0
7811763|NCT00426556|27136456|P2|Phase II - Core Phase|Withdrawal by Subject|0
7811764|NCT00426556|27136457|P1|Phase II - Core Phase|Withdrawal by Subject|0
7811765|NCT00426556|27136454|P4|Phase I - Extension Phase|Disease Progression|0
7811766|NCT00426556|27136455|P3|Phase I - Extension Phase|Disease Progression|6
7811767|NCT00426556|27136456|P2|Phase I - Extension Phase|Disease Progression|5
7811768|NCT00426556|27136457|P1|Phase I - Extension Phase|Disease Progression|5
7811769|NCT00426556|27136454|P4|Phase I - Extension Phase|Adverse Event|0
7811770|NCT00426556|27136455|P3|Phase I - Extension Phase|Adverse Event|1
7811771|NCT00426556|27136456|P2|Phase I - Extension Phase|Adverse Event|1
7811772|NCT00426556|27136457|P1|Phase I - Extension Phase|Adverse Event|0
7811773|NCT00426556|27136454|P4|Phase I - Core Phase|Death|0
7811774|NCT00426556|27136455|P3|Phase I - Core Phase|Death|0
7811775|NCT00426556|27136456|P2|Phase I - Core Phase|Death|1
7811776|NCT00426556|27136457|P1|Phase I - Core Phase|Death|0
7811777|NCT00426556|27136454|P4|Phase I - Core Phase|Adverse Event|0
7811778|NCT00426556|27136455|P3|Phase I - Core Phase|Adverse Event|1
7811779|NCT00426556|27136456|P2|Phase I - Core Phase|Adverse Event|3
7811780|NCT00426556|27136457|P1|Phase I - Core Phase|Adverse Event|1
7811781|NCT00426556|27136454|P4|Phase I - Core Phase|Disease Progression|0
7811782|NCT00426556|27136455|P3|Phase I - Core Phase|Disease Progression|2
7811783|NCT00426556|27136456|P2|Phase I - Core Phase|Disease Progression|6
7811784|NCT00426556|27136457|P1|Phase I - Core Phase|Disease Progression|0
7811785|NCT00426361|27136527|P3|Overall Study|Withdrawal by Subject|0
7811786|NCT00426361|27136528|P2|Overall Study|Withdrawal by Subject|3
7811787|NCT00426361|27136529|P1|Overall Study|Withdrawal by Subject|1
7811788|NCT00426361|27136527|P3|Overall Study|Lost to Follow-up|5
7811789|NCT00426361|27136528|P2|Overall Study|Lost to Follow-up|2
7811790|NCT00426361|27136529|P1|Overall Study|Lost to Follow-up|3
7811791|NCT00426270|27136596|P1|Overall Study|Adverse Event|5
7811792|NCT00426270|27136596|P1|Overall Study|Incorrectly Enrolled in the Study|1
7811793|NCT00426231|27136606|P2|Overall Study|Withdrawal by Subject|12
7811794|NCT00426231|27136607|P1|Overall Study|Withdrawal by Subject|9
7811795|NCT00426127|27136630|P1|Overall Study|Removed due to disease progression|1
7811796|NCT00426127|27136630|P1|Overall Study|Adverse Event|1
7811797|NCT00425945|27136638|P2|Overall Study|Moved from area|1
7811798|NCT00425945|27136639|P1|Overall Study|Moved from area|0
7811799|NCT00425945|27136638|P2|Overall Study|Began cancer treatments|0
7811800|NCT00425945|27136639|P1|Overall Study|Began cancer treatments|1
7811801|NCT00425945|27136638|P2|Overall Study|Began hypertension medication|0
7811802|NCT00425945|27136639|P1|Overall Study|Began hypertension medication|1
7811803|NCT00425945|27136638|P2|Overall Study|Lost to Follow-up|2
7811804|NCT00425945|27136639|P1|Overall Study|Lost to Follow-up|0
7811805|NCT00425945|27136638|P2|Overall Study|Inconvenience|2
7811806|NCT00425945|27136639|P1|Overall Study|Inconvenience|0
7811807|NCT00425945|27136638|P2|Overall Study|Concern about Supplement|0
7811808|NCT00425945|27136639|P1|Overall Study|Concern about Supplement|2
7811809|NCT00425854|27136677|P2|Overall Study|Other Adverse Event|2
7811810|NCT00425854|27136678|P1|Overall Study|Other Adverse Event|2
7811811|NCT00425854|27136677|P2|Overall Study|Dose reduction toxicity AE|7
7811812|NCT00425854|27136678|P1|Overall Study|Dose reduction toxicity AE|8
7811813|NCT00425854|27136677|P2|Overall Study|Progressive Disease|12
7811814|NCT00425854|27136678|P1|Overall Study|Progressive Disease|19
7811815|NCT00425750|27136711|P1|Overall Study|Progression of disease|18
7811816|NCT00425750|27136711|P1|Overall Study|Adverse Event|3
7811817|NCT00425750|27136711|P1|Overall Study|Withdrawal by Subject|3
7811818|NCT00425750|27136711|P1|Overall Study|Death|1
7811819|NCT00425698|27136719|P2|Overall Study|Withdrawal by Subject|1
7811820|NCT00425698|27136720|P1|Overall Study|Withdrawal by Subject|0
7811821|NCT00425698|27136719|P2|Overall Study|Adverse Event|1
7811822|NCT00425698|27136720|P1|Overall Study|Adverse Event|3
7811823|NCT00425607|27136735|P1|Overall Study|Withdrawal by Subject|1
7811824|NCT00425607|27136735|P1|Overall Study|Death|1
7811825|NCT00425555|27136741|P2|Overall Study|Protocol Violation|0
7811826|NCT00425555|27136742|P1|Overall Study|Protocol Violation|1
7811827|NCT00425555|27136741|P2|Overall Study|Adverse Event|15
7811828|NCT00425555|27136742|P1|Overall Study|Adverse Event|25
7811829|NCT00425555|27136741|P2|Overall Study|Disease progression|33
7811830|NCT00425555|27136742|P1|Overall Study|Disease progression|36
7811831|NCT00425555|27136741|P2|Overall Study|New cancer therapy|1
7811832|NCT00425555|27136742|P1|Overall Study|New cancer therapy|2
7811833|NCT00425555|27136741|P2|Overall Study|Death|2
7811834|NCT00425555|27136742|P1|Overall Study|Death|1
7811835|NCT00425555|27136741|P2|Overall Study|Administrative problems|0
7811836|NCT00425555|27136742|P1|Overall Study|Administrative problems|3
7811837|NCT00425555|27136741|P2|Overall Study|Lost to Follow-up|1
7811838|NCT00425555|27136742|P1|Overall Study|Lost to Follow-up|0
7811839|NCT00425555|27136741|P2|Overall Study|Withdrawal by Subject|8
7811840|NCT00425555|27136742|P1|Overall Study|Withdrawal by Subject|11
7811841|NCT00425503|27136772|P1|Overall Study|Protocol Violation|1
7811842|NCT00425503|27136772|P1|Overall Study|Adverse Event|2
7811843|NCT00425438|27136784|P2|Overall Study|Termination by Sponsor|27
7811844|NCT00425438|27136785|P1|Overall Study|Termination by Sponsor|25
7811845|NCT00425373|27136819|P9|Overall Study|Lack of Efficacy|5
7811846|NCT00425373|27136820|P8|Overall Study|Lack of Efficacy|0
7811847|NCT00425373|27136821|P7|Overall Study|Lack of Efficacy|3
7811848|NCT00425373|27136822|P6|Overall Study|Lack of Efficacy|3
7811849|NCT00425373|27136823|P5|Overall Study|Lack of Efficacy|1
7811850|NCT00425373|27136824|P4|Overall Study|Lack of Efficacy|0
7811851|NCT00425373|27136825|P3|Overall Study|Lack of Efficacy|0
7811852|NCT00425373|27136826|P2|Overall Study|Lack of Efficacy|0
7811853|NCT00425373|27136827|P1|Overall Study|Lack of Efficacy|0
7811854|NCT00425373|27136819|P9|Overall Study|Withdrawal by Subject|2
7811855|NCT00425373|27136820|P8|Overall Study|Withdrawal by Subject|2
7811856|NCT00425373|27136821|P7|Overall Study|Withdrawal by Subject|2
7811857|NCT00425373|27136822|P6|Overall Study|Withdrawal by Subject|0
7811858|NCT00425373|27136823|P5|Overall Study|Withdrawal by Subject|4
7811859|NCT00425373|27136824|P4|Overall Study|Withdrawal by Subject|1
7811860|NCT00425373|27136825|P3|Overall Study|Withdrawal by Subject|2
7811861|NCT00425373|27136826|P2|Overall Study|Withdrawal by Subject|0
7811862|NCT00425373|27136827|P1|Overall Study|Withdrawal by Subject|2
7811863|NCT00425373|27136819|P9|Overall Study|Protocol Violation|3
7811864|NCT00425373|27136820|P8|Overall Study|Protocol Violation|5
7811865|NCT00425373|27136821|P7|Overall Study|Protocol Violation|0
7811866|NCT00425373|27136822|P6|Overall Study|Protocol Violation|0
7811867|NCT00425373|27136823|P5|Overall Study|Protocol Violation|0
7811868|NCT00425373|27136824|P4|Overall Study|Protocol Violation|0
7811869|NCT00425373|27136825|P3|Overall Study|Protocol Violation|1
7811870|NCT00425373|27136826|P2|Overall Study|Protocol Violation|0
7811871|NCT00425373|27136827|P1|Overall Study|Protocol Violation|1
7811872|NCT00425373|27136819|P9|Overall Study|Lost to Follow-up|0
7811873|NCT00425373|27136820|P8|Overall Study|Lost to Follow-up|0
7811874|NCT00425373|27136821|P7|Overall Study|Lost to Follow-up|0
7811875|NCT00425373|27136822|P6|Overall Study|Lost to Follow-up|0
7811876|NCT00425373|27136823|P5|Overall Study|Lost to Follow-up|1
7811877|NCT00425373|27136824|P4|Overall Study|Lost to Follow-up|0
7811878|NCT00425373|27136825|P3|Overall Study|Lost to Follow-up|0
7811879|NCT00425373|27136826|P2|Overall Study|Lost to Follow-up|1
7811880|NCT00425373|27136827|P1|Overall Study|Lost to Follow-up|0
7811881|NCT00425373|27136819|P9|Overall Study|Adverse Event|8
7811882|NCT00425373|27136820|P8|Overall Study|Adverse Event|3
7811883|NCT00425373|27136821|P7|Overall Study|Adverse Event|2
7811884|NCT00425373|27136822|P6|Overall Study|Adverse Event|6
7811885|NCT00425373|27136823|P5|Overall Study|Adverse Event|4
7811886|NCT00425373|27136824|P4|Overall Study|Adverse Event|1
7811887|NCT00425373|27136825|P3|Overall Study|Adverse Event|0
7811888|NCT00425373|27136826|P2|Overall Study|Adverse Event|2
7811889|NCT00425373|27136827|P1|Overall Study|Adverse Event|2
7811890|NCT00425308|27136885|P2|Overall Study|Death|0
7811891|NCT00425308|27136886|P1|Overall Study|Death|1
7811892|NCT00425308|27136885|P2|Overall Study|Withdrawal by Subject|0
7811893|NCT00425308|27136886|P1|Overall Study|Withdrawal by Subject|1
7811894|NCT00425308|27136885|P2|Overall Study|Adverse Event|1
7811895|NCT00425308|27136886|P1|Overall Study|Adverse Event|2
7811896|NCT00425269|27136916|P2|Overall Study|moved or medical reason|4
7811897|NCT00425269|27136917|P1|Overall Study|moved or medical reason|5
7811898|NCT00425269|27136916|P2|Overall Study|Lost to Follow-up|9
7811899|NCT00425269|27136917|P1|Overall Study|Lost to Follow-up|9
7811900|NCT00425269|27136916|P2|Overall Study|Pregnancy|7
7811901|NCT00425269|27136917|P1|Overall Study|Pregnancy|5
7811902|NCT00425113|27136995|P2|Overall Study|Withdrawal by Subject|0
7811903|NCT00425113|27136996|P1|Overall Study|Withdrawal by Subject|1
7811904|NCT00425113|27136995|P2|Overall Study|missing study drug more than 14 days|1
7811905|NCT00425113|27136996|P1|Overall Study|missing study drug more than 14 days|0
7811906|NCT00425113|27136995|P2|Overall Study|diagnosis of abdominal TB|1
7811907|NCT00425113|27136996|P1|Overall Study|diagnosis of abdominal TB|0
7811908|NCT00425113|27136995|P2|Overall Study|uncontrolled diabetes mellitus|0
7811909|NCT00425113|27136996|P1|Overall Study|uncontrolled diabetes mellitus|1
7811910|NCT00425100|27137004|P1|Overall Study|Withdrawal by Subject|7
7811911|NCT00425100|27137004|P1|Overall Study|Protocol Violation|4
7811912|NCT00425100|27137004|P1|Overall Study|Lost to Follow-up|2
7811913|NCT00425100|27137004|P1|Overall Study|Lack of Efficacy|4
7811914|NCT00425100|27137004|P1|Overall Study|Adverse Event|36
7811915|NCT00425061|27137048|P7|Overall Study|Other|1
7811916|NCT00425061|27137049|P6|Overall Study|Other|0
7811917|NCT00425061|27137050|P5|Overall Study|Other|3
7811918|NCT00425061|27137051|P4|Overall Study|Other|0
7811919|NCT00425061|27137052|P3|Overall Study|Other|0
7811920|NCT00425061|27137053|P2|Overall Study|Other|0
7811921|NCT00425061|27137054|P1|Overall Study|Other|0
7811922|NCT00425061|27137048|P7|Overall Study|Physician Decision|0
7811923|NCT00425061|27137049|P6|Overall Study|Physician Decision|0
7811924|NCT00425061|27137050|P5|Overall Study|Physician Decision|1
7811925|NCT00425061|27137051|P4|Overall Study|Physician Decision|0
7811926|NCT00425061|27137052|P3|Overall Study|Physician Decision|0
7811927|NCT00425061|27137053|P2|Overall Study|Physician Decision|0
7811928|NCT00425061|27137054|P1|Overall Study|Physician Decision|0
7811929|NCT00425061|27137048|P7|Overall Study|Sponsor's request|15
7811930|NCT00425061|27137049|P6|Overall Study|Sponsor's request|4
7811931|NCT00425061|27137050|P5|Overall Study|Sponsor's request|19
7811932|NCT00425061|27137051|P4|Overall Study|Sponsor's request|0
7811933|NCT00425061|27137052|P3|Overall Study|Sponsor's request|0
7811934|NCT00425061|27137053|P2|Overall Study|Sponsor's request|0
7811935|NCT00425061|27137054|P1|Overall Study|Sponsor's request|0
7811936|NCT00425061|27137048|P7|Overall Study|Withdrawal by Subject|3
7811937|NCT00425061|27137049|P6|Overall Study|Withdrawal by Subject|0
7811938|NCT00425061|27137050|P5|Overall Study|Withdrawal by Subject|1
7811939|NCT00425061|27137051|P4|Overall Study|Withdrawal by Subject|0
7811940|NCT00425061|27137052|P3|Overall Study|Withdrawal by Subject|0
7811941|NCT00425061|27137053|P2|Overall Study|Withdrawal by Subject|1
7811942|NCT00425061|27137054|P1|Overall Study|Withdrawal by Subject|0
7811943|NCT00425061|27137048|P7|Overall Study|Protocol Violation|0
7811944|NCT00425061|27137049|P6|Overall Study|Protocol Violation|0
7811945|NCT00425061|27137050|P5|Overall Study|Protocol Violation|0
7811946|NCT00425061|27137051|P4|Overall Study|Protocol Violation|0
7811947|NCT00425061|27137052|P3|Overall Study|Protocol Violation|0
7811948|NCT00425061|27137053|P2|Overall Study|Protocol Violation|0
7811949|NCT00425061|27137054|P1|Overall Study|Protocol Violation|1
7811950|NCT00425061|27137048|P7|Overall Study|Lost to Follow-up|0
7811951|NCT00425061|27137049|P6|Overall Study|Lost to Follow-up|0
7811952|NCT00425061|27137050|P5|Overall Study|Lost to Follow-up|0
7811953|NCT00425061|27137051|P4|Overall Study|Lost to Follow-up|0
7811954|NCT00425061|27137052|P3|Overall Study|Lost to Follow-up|0
7811955|NCT00425061|27137053|P2|Overall Study|Lost to Follow-up|1
7811956|NCT00425061|27137054|P1|Overall Study|Lost to Follow-up|0
7811957|NCT00425061|27137048|P7|Overall Study|Adverse Event|0
7811958|NCT00425061|27137049|P6|Overall Study|Adverse Event|0
7811959|NCT00425061|27137050|P5|Overall Study|Adverse Event|2
7811960|NCT00425061|27137051|P4|Overall Study|Adverse Event|2
7811961|NCT00425061|27137052|P3|Overall Study|Adverse Event|0
7811962|NCT00425061|27137053|P2|Overall Study|Adverse Event|0
7811963|NCT00425061|27137054|P1|Overall Study|Adverse Event|1
7811964|NCT00424827|27137178|P1|Overall Study|Adverse Event|1
7811965|NCT00424775|27137186|P2|Overall Study|Lack of Efficacy|0
7811966|NCT00424775|27137187|P1|Overall Study|Lack of Efficacy|1
7811967|NCT00424775|27137186|P2|Overall Study|Adverse Event|0
7811968|NCT00424775|27137187|P1|Overall Study|Adverse Event|2
7811969|NCT00424762|27137197|P2|Overall Study|Lost to Follow-up|3
7811970|NCT00424762|27137198|P1|Overall Study|Lost to Follow-up|2
7811971|NCT00424762|27137197|P2|Overall Study|Withdrawal by Subject|19
7811972|NCT00424762|27137198|P1|Overall Study|Withdrawal by Subject|18
7811973|NCT00424749|27137208|P1|Overall Study|Withdrawal by Subject|1
7811974|NCT00424645|27137215|P2|Overall Study|Death|0
7811975|NCT00424645|27137216|P1|Overall Study|Death|1
7811976|NCT00424632|27137224|P10|Overall Study|Other|0
7811977|NCT00424632|27137225|P9|Overall Study|Other|1
7811978|NCT00424632|27137226|P8|Overall Study|Other|0
7811979|NCT00424632|27137227|P7|Overall Study|Other|0
7811980|NCT00424632|27137228|P6|Overall Study|Other|0
7811981|NCT00424632|27137229|P5|Overall Study|Other|0
7811982|NCT00424632|27137230|P4|Overall Study|Other|1
7811983|NCT00424632|27137231|P3|Overall Study|Other|0
7811984|NCT00424632|27137232|P2|Overall Study|Other|0
7811985|NCT00424632|27137233|P1|Overall Study|Other|0
7811986|NCT00424632|27137224|P10|Overall Study|Objective progression or relapse|4
7811987|NCT00424632|27137225|P9|Overall Study|Objective progression or relapse|12
7811988|NCT00424632|27137226|P8|Overall Study|Objective progression or relapse|3
7811989|NCT00424632|27137227|P7|Overall Study|Objective progression or relapse|7
7811990|NCT00424632|27137228|P6|Overall Study|Objective progression or relapse|13
7811991|NCT00424632|27137229|P5|Overall Study|Objective progression or relapse|2
7811992|NCT00424632|27137230|P4|Overall Study|Objective progression or relapse|2
7811993|NCT00424632|27137231|P3|Overall Study|Objective progression or relapse|1
7811994|NCT00424632|27137232|P2|Overall Study|Objective progression or relapse|1
7811995|NCT00424632|27137233|P1|Overall Study|Objective progression or relapse|1
7811996|NCT00424632|27137224|P10|Overall Study|Global deterioration of health status|0
7811997|NCT00424632|27137225|P9|Overall Study|Global deterioration of health status|0
7811998|NCT00424632|27137226|P8|Overall Study|Global deterioration of health status|0
7811999|NCT00424632|27137227|P7|Overall Study|Global deterioration of health status|0
7812000|NCT00424632|27137228|P6|Overall Study|Global deterioration of health status|0
7812001|NCT00424632|27137229|P5|Overall Study|Global deterioration of health status|1
7812002|NCT00424632|27137230|P4|Overall Study|Global deterioration of health status|1
7812003|NCT00424632|27137231|P3|Overall Study|Global deterioration of health status|0
7812004|NCT00424632|27137232|P2|Overall Study|Global deterioration of health status|0
7812005|NCT00424632|27137233|P1|Overall Study|Global deterioration of health status|0
7812006|NCT00424632|27137224|P10|Overall Study|Adverse Event|2
7812007|NCT00424632|27137225|P9|Overall Study|Adverse Event|3
7812008|NCT00424632|27137226|P8|Overall Study|Adverse Event|0
7812009|NCT00424632|27137227|P7|Overall Study|Adverse Event|0
7812010|NCT00424632|27137228|P6|Overall Study|Adverse Event|0
7812011|NCT00424632|27137229|P5|Overall Study|Adverse Event|0
7812012|NCT00424632|27137230|P4|Overall Study|Adverse Event|0
7812013|NCT00424632|27137231|P3|Overall Study|Adverse Event|0
7812014|NCT00424632|27137232|P2|Overall Study|Adverse Event|0
7812015|NCT00424632|27137233|P1|Overall Study|Adverse Event|0
7812016|NCT00424632|27137224|P10|Overall Study|Death|0
7812017|NCT00424632|27137225|P9|Overall Study|Death|0
7812018|NCT00424632|27137226|P8|Overall Study|Death|0
7812019|NCT00424632|27137227|P7|Overall Study|Death|0
7812020|NCT00424632|27137228|P6|Overall Study|Death|2
7812021|NCT00424632|27137229|P5|Overall Study|Death|0
7812022|NCT00424632|27137230|P4|Overall Study|Death|0
7812023|NCT00424632|27137231|P3|Overall Study|Death|0
7812024|NCT00424632|27137232|P2|Overall Study|Death|0
7812025|NCT00424632|27137233|P1|Overall Study|Death|0
7812026|NCT00424593|27137403|P2|Dose-Blind Extension Period|Physician Decision|0
7812027|NCT00424593|27137404|P1|Dose-Blind Extension Period|Physician Decision|3
7812028|NCT00424593|27137403|P2|Dose-Blind Extension Period|Lost to Follow-up|0
7812029|NCT00424593|27137404|P1|Dose-Blind Extension Period|Lost to Follow-up|6
7812030|NCT00424593|27137403|P2|Dose-Blind Extension Period|Protocol Violation|0
7812031|NCT00424593|27137404|P1|Dose-Blind Extension Period|Protocol Violation|9
7812032|NCT00424593|27137403|P2|Dose-Blind Extension Period|Lack of Efficacy|0
7812033|NCT00424593|27137404|P1|Dose-Blind Extension Period|Lack of Efficacy|9
7812034|NCT00424593|27137403|P2|Dose-Blind Extension Period|Adverse Event|0
7812035|NCT00424593|27137404|P1|Dose-Blind Extension Period|Adverse Event|18
7812036|NCT00424593|27137403|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
7812037|NCT00424593|27137404|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
7812038|NCT00424593|27137403|P2|Acute Double-Blind Period|Lack of Efficacy|1
7812039|NCT00424593|27137404|P1|Acute Double-Blind Period|Lack of Efficacy|0
7812040|NCT00424593|27137403|P2|Acute Double-Blind Period|Lost to Follow-up|1
7812041|NCT00424593|27137404|P1|Acute Double-Blind Period|Lost to Follow-up|1
7812042|NCT00424593|27137403|P2|Acute Double-Blind Period|Physician Decision|2
7812043|NCT00424593|27137404|P1|Acute Double-Blind Period|Physician Decision|1
7812044|NCT00424593|27137403|P2|Acute Double-Blind Period|Protocol Violation|2
7812045|NCT00424593|27137404|P1|Acute Double-Blind Period|Protocol Violation|2
7812046|NCT00424593|27137403|P2|Acute Double-Blind Period|Withdrawal by Subject|10
7812047|NCT00424593|27137404|P1|Acute Double-Blind Period|Withdrawal by Subject|11
7812048|NCT00424593|27137403|P2|Acute Double-Blind Period|Adverse Event|7
7812049|NCT00424593|27137404|P1|Acute Double-Blind Period|Adverse Event|16
7812050|NCT00424528|27137468|P3|Overall Study|noncompliance with study requirements|2
7812051|NCT00424528|27137469|P2|Overall Study|noncompliance with study requirements|1
7812052|NCT00424528|27137470|P1|Overall Study|noncompliance with study requirements|2
7812053|NCT00424528|27137468|P3|Overall Study|Lost to Follow-up|0
7812054|NCT00424528|27137469|P2|Overall Study|Lost to Follow-up|1
7812055|NCT00424528|27137470|P1|Overall Study|Lost to Follow-up|0
7812056|NCT00424528|27137468|P3|Overall Study|Protocol Violation|0
7812057|NCT00424528|27137469|P2|Overall Study|Protocol Violation|1
7812058|NCT00424528|27137470|P1|Overall Study|Protocol Violation|1
7812059|NCT00424528|27137468|P3|Overall Study|Adverse Event|2
7812060|NCT00424528|27137469|P2|Overall Study|Adverse Event|1
7812061|NCT00424528|27137470|P1|Overall Study|Adverse Event|2
7812062|NCT00424515|27137525|P2|Overall Study|Withdrawal by Subject|0
7812063|NCT00424515|27137526|P1|Overall Study|Withdrawal by Subject|1
7812064|NCT00424515|27137525|P2|Overall Study|Intercurrent Illness|1
7812065|NCT00424515|27137526|P1|Overall Study|Intercurrent Illness|0
7812066|NCT00424515|27137525|P2|Overall Study|Adverse Event|1
7812067|NCT00424515|27137526|P1|Overall Study|Adverse Event|0
7812068|NCT00424515|27137525|P2|Overall Study|Progressive Disease|11
7812069|NCT00424515|27137526|P1|Overall Study|Progressive Disease|10
7812070|NCT00424489|27137545|P1|Overall Study|Death|3
7812071|NCT00424476|27137552|P3|Overall Study|Other|9
7812072|NCT00424476|27137553|P2|Overall Study|Other|3
7812073|NCT00424476|27137554|P1|Overall Study|Other|4
7812074|NCT00424476|27137552|P3|Overall Study|Physician Decision|3
7812075|NCT00424476|27137553|P2|Overall Study|Physician Decision|2
7812076|NCT00424476|27137554|P1|Overall Study|Physician Decision|3
7812077|NCT00424476|27137552|P3|Overall Study|Protocol Violation|3
7812078|NCT00424476|27137553|P2|Overall Study|Protocol Violation|2
7812079|NCT00424476|27137554|P1|Overall Study|Protocol Violation|7
7812080|NCT00424476|27137552|P3|Overall Study|Lost to Follow-up|3
7812081|NCT00424476|27137553|P2|Overall Study|Lost to Follow-up|6
7812082|NCT00424476|27137554|P1|Overall Study|Lost to Follow-up|4
7812083|NCT00424476|27137552|P3|Overall Study|Lack of Compliance|1
7812084|NCT00424476|27137553|P2|Overall Study|Lack of Compliance|1
7812085|NCT00424476|27137554|P1|Overall Study|Lack of Compliance|1
7812086|NCT00424476|27137552|P3|Overall Study|Lack of Efficacy|12
7812087|NCT00424476|27137553|P2|Overall Study|Lack of Efficacy|12
7812088|NCT00424476|27137554|P1|Overall Study|Lack of Efficacy|16
7812089|NCT00424476|27137552|P3|Overall Study|Adverse Event|15
7812090|NCT00424476|27137553|P2|Overall Study|Adverse Event|16
7812091|NCT00424476|27137554|P1|Overall Study|Adverse Event|19
7812092|NCT00424476|27137552|P3|Overall Study|Withdrawal by Subject|3
7812093|NCT00424476|27137553|P2|Overall Study|Withdrawal by Subject|6
7812094|NCT00424476|27137554|P1|Overall Study|Withdrawal by Subject|7
7812095|NCT00424463|27137580|P3|Overall Study|Patient's convenience|1
7812096|NCT00424463|27137581|P2|Overall Study|Patient's convenience|0
7812097|NCT00424463|27137582|P1|Overall Study|Patient's convenience|0
7812098|NCT00424463|27137580|P3|Overall Study|Tracheotomy due to worsening of ALS|6
7812099|NCT00424463|27137581|P2|Overall Study|Tracheotomy due to worsening of ALS|7
7812100|NCT00424463|27137582|P1|Overall Study|Tracheotomy due to worsening of ALS|1
7812101|NCT00424463|27137580|P3|Overall Study|Withdrawal by Subject|5
7812102|NCT00424463|27137581|P2|Overall Study|Withdrawal by Subject|2
7812103|NCT00424463|27137582|P1|Overall Study|Withdrawal by Subject|4
7812104|NCT00424463|27137580|P3|Overall Study|Physician Decision|2
7812105|NCT00424463|27137581|P2|Overall Study|Physician Decision|2
7812106|NCT00424463|27137582|P1|Overall Study|Physician Decision|0
7812107|NCT00424463|27137580|P3|Overall Study|Adverse Event|2
7812108|NCT00424463|27137581|P2|Overall Study|Adverse Event|3
7812109|NCT00424463|27137582|P1|Overall Study|Adverse Event|2
7812110|NCT00424398|27137611|P3|Overall Study|Subject met exclusion criteria|0
7812111|NCT00424398|27137612|P2|Overall Study|Subject met exclusion criteria|0
7812112|NCT00424398|27137613|P1|Overall Study|Subject met exclusion criteria|1
7812113|NCT00424398|27137611|P3|Overall Study|Withdrawal by Subject|0
7812114|NCT00424398|27137612|P2|Overall Study|Withdrawal by Subject|1
7812115|NCT00424398|27137613|P1|Overall Study|Withdrawal by Subject|2
7812116|NCT00424385|27137657|P1|Cohort 1|Withdrawal by Subject|1
7812117|NCT00424385|27137657|P1|Cohort 0|Physician Decision|1
7812118|NCT00424385|27137657|P1|Cohort 0|Withdrawal by Subject|5
7812119|NCT00424372|27137664|P1|Overall Study|Health deterioration|1
7812120|NCT00424372|27137664|P1|Overall Study|Protocol Violation|1
7812121|NCT00424372|27137664|P1|Overall Study|Withdrawal by Subject|4
7812122|NCT00424372|27137664|P1|Overall Study|Lack of Efficacy|6
7812123|NCT00424372|27137664|P1|Overall Study|Adverse Event|18
7812124|NCT00424372|27137664|P1|Overall Study|Death|1
7812125|NCT00424346|27137677|P4|Extension Phase|Protocol Violation|0
7812126|NCT00424346|27137678|P3|Extension Phase|Protocol Violation|1
7812127|NCT00424346|27137679|P2|Extension Phase|Protocol Violation|1
7812128|NCT00424346|27137680|P1|Extension Phase|Protocol Violation|0
7812129|NCT00424346|27137677|P4|Extension Phase|Death|1
7812130|NCT00424346|27137678|P3|Extension Phase|Death|0
7812131|NCT00424346|27137679|P2|Extension Phase|Death|0
7812132|NCT00424346|27137680|P1|Extension Phase|Death|0
7812133|NCT00424346|27137677|P4|Extension Phase|Administrative Problems|35
7812134|NCT00424346|27137678|P3|Extension Phase|Administrative Problems|32
7812135|NCT00424346|27137679|P2|Extension Phase|Administrative Problems|69
7812136|NCT00424346|27137680|P1|Extension Phase|Administrative Problems|0
7812137|NCT00424346|27137677|P4|Extension Phase|Lost to Follow-up|0
7812138|NCT00424346|27137678|P3|Extension Phase|Lost to Follow-up|0
7812139|NCT00424346|27137679|P2|Extension Phase|Lost to Follow-up|2
7812140|NCT00424346|27137680|P1|Extension Phase|Lost to Follow-up|0
7812141|NCT00424346|27137677|P4|Extension Phase|Withdrawal by Subject|4
7812142|NCT00424346|27137678|P3|Extension Phase|Withdrawal by Subject|3
7812143|NCT00424346|27137679|P2|Extension Phase|Withdrawal by Subject|5
7812144|NCT00424346|27137680|P1|Extension Phase|Withdrawal by Subject|0
7812145|NCT00424346|27137677|P4|Extension Phase|Lack of Efficacy|11
7812146|NCT00424346|27137678|P3|Extension Phase|Lack of Efficacy|14
7812147|NCT00424346|27137679|P2|Extension Phase|Lack of Efficacy|16
7812148|NCT00424346|27137680|P1|Extension Phase|Lack of Efficacy|0
7812149|NCT00424346|27137677|P4|Extension Phase|Adverse Event|4
7812150|NCT00424346|27137678|P3|Extension Phase|Adverse Event|5
7812151|NCT00424346|27137679|P2|Extension Phase|Adverse Event|9
7812152|NCT00424346|27137680|P1|Extension Phase|Adverse Event|0
7812153|NCT00424346|27137677|P4|Core Study|Protocol Violation|0
7812154|NCT00424346|27137678|P3|Core Study|Protocol Violation|2
7812155|NCT00424346|27137679|P2|Core Study|Protocol Violation|0
7812156|NCT00424346|27137680|P1|Core Study|Protocol Violation|0
7812157|NCT00424346|27137677|P4|Core Study|Administrative Problems|0
7812158|NCT00424346|27137678|P3|Core Study|Administrative Problems|1
7812159|NCT00424346|27137679|P2|Core Study|Administrative Problems|0
7812160|NCT00424346|27137680|P1|Core Study|Administrative Problems|1
7812161|NCT00424346|27137677|P4|Core Study|Lost to Follow-up|0
7812162|NCT00424346|27137678|P3|Core Study|Lost to Follow-up|0
7812163|NCT00424346|27137679|P2|Core Study|Lost to Follow-up|1
7812164|NCT00424346|27137680|P1|Core Study|Lost to Follow-up|1
7812165|NCT00424346|27137677|P4|Core Study|Withdrawal by Subject|2
7812166|NCT00424346|27137678|P3|Core Study|Withdrawal by Subject|0
7812167|NCT00424346|27137679|P2|Core Study|Withdrawal by Subject|0
7812168|NCT00424346|27137680|P1|Core Study|Withdrawal by Subject|1
7812169|NCT00424346|27137677|P4|Core Study|Lack of Efficacy|4
7812170|NCT00424346|27137678|P3|Core Study|Lack of Efficacy|0
7812171|NCT00424346|27137679|P2|Core Study|Lack of Efficacy|3
7812172|NCT00424346|27137680|P1|Core Study|Lack of Efficacy|1
7812173|NCT00424346|27137677|P4|Core Study|Abnormal Laboratory Values|0
7812174|NCT00424346|27137678|P3|Core Study|Abnormal Laboratory Values|0
7812175|NCT00424346|27137679|P2|Core Study|Abnormal Laboratory Values|1
7812176|NCT00424346|27137680|P1|Core Study|Abnormal Laboratory Values|0
7812177|NCT00424346|27137677|P4|Core Study|Adverse Event|1
7812178|NCT00424346|27137678|P3|Core Study|Adverse Event|1
7812179|NCT00424346|27137679|P2|Core Study|Adverse Event|3
7812180|NCT00424346|27137680|P1|Core Study|Adverse Event|5
7812181|NCT00424294|27137795|P2|Overall Study|Randomized but not Treated|0
7812182|NCT00424294|27137796|P1|Overall Study|Randomized but not Treated|1
7812183|NCT00424294|27137795|P2|Overall Study|Other|2
7812184|NCT00424294|27137796|P1|Overall Study|Other|0
7812185|NCT00424294|27137795|P2|Overall Study|Withdrawal by Subject|2
7812186|NCT00424294|27137796|P1|Overall Study|Withdrawal by Subject|1
7812187|NCT00424294|27137795|P2|Overall Study|Lack of Efficacy|1
7812188|NCT00424294|27137796|P1|Overall Study|Lack of Efficacy|2
7812189|NCT00424294|27137795|P2|Overall Study|Adverse Event|10
7812190|NCT00424294|27137796|P1|Overall Study|Adverse Event|4
7812191|NCT00424255|27137863|P2|Overall Study|Sponsor Terminated Study|167
7812192|NCT00424255|27137864|P1|Overall Study|Sponsor Terminated Study|161
7812193|NCT00424255|27137863|P2|Overall Study|Disease Progression|2
7812194|NCT00424255|27137864|P1|Overall Study|Disease Progression|0
7812195|NCT00424255|27137863|P2|Overall Study|Fatigue|0
7812196|NCT00424255|27137864|P1|Overall Study|Fatigue|1
7812197|NCT00424255|27137863|P2|Overall Study|Non-compliance by Participants|0
7812198|NCT00424255|27137864|P1|Overall Study|Non-compliance by Participants|1
7812199|NCT00424255|27137863|P2|Overall Study|Cognitive Disturbance|0
7812200|NCT00424255|27137864|P1|Overall Study|Cognitive Disturbance|1
7812201|NCT00424255|27137863|P2|Overall Study|Physician Decision|7
7812202|NCT00424255|27137864|P1|Overall Study|Physician Decision|3
7812203|NCT00424255|27137863|P2|Overall Study|Withdrawal by Subject|38
7812204|NCT00424255|27137864|P1|Overall Study|Withdrawal by Subject|34
7812205|NCT00424255|27137863|P2|Overall Study|Protocol Violation|1
7812206|NCT00424255|27137864|P1|Overall Study|Protocol Violation|0
7812207|NCT00424255|27137863|P2|Overall Study|Lost to Follow-up|20
7812208|NCT00424255|27137864|P1|Overall Study|Lost to Follow-up|26
7812209|NCT00424255|27137863|P2|Overall Study|Death|111
7812210|NCT00424255|27137864|P1|Overall Study|Death|115
7812211|NCT00424190|27137912|P2|Overall Study|Other|21
7812212|NCT00424190|27137913|P1|Overall Study|Other|15
7812213|NCT00424190|27137912|P2|Overall Study|Diagnosis of osteomyelitis|1
7812214|NCT00424190|27137913|P1|Overall Study|Diagnosis of osteomyelitis|0
7812215|NCT00424190|27137912|P2|Overall Study|Request of sponsor or investigator|2
7812216|NCT00424190|27137913|P1|Overall Study|Request of sponsor or investigator|0
7812217|NCT00424190|27137912|P2|Overall Study|Noncompliance|2
7812218|NCT00424190|27137913|P1|Overall Study|Noncompliance|1
7812219|NCT00424190|27137912|P2|Overall Study|Death|0
7812220|NCT00424190|27137913|P1|Overall Study|Death|3
7812221|NCT00424190|27137912|P2|Overall Study|Withdrew consent|4
7812222|NCT00424190|27137913|P1|Overall Study|Withdrew consent|3
7812223|NCT00424177|27137919|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
7812224|NCT00424177|27137919|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
7812225|NCT00424177|27137919|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
7812226|NCT00424177|27137919|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
7812227|NCT00424177|27137919|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
7812228|NCT00424177|27137919|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
7812229|NCT00424177|27137919|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
7812230|NCT00424177|27137919|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
7812231|NCT00424177|27137919|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
7812232|NCT00424177|27137919|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
7812233|NCT00424047|27137948|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
7812234|NCT00424047|27137949|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
7812235|NCT00424047|27137948|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
7812236|NCT00424047|27137949|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
7812237|NCT00424047|27137948|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
7812238|NCT00424047|27137949|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
7812239|NCT00424047|27137948|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
7812240|NCT00424047|27137949|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
7812241|NCT00424047|27137948|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
7812242|NCT00424047|27137949|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
7812243|NCT00424047|27137948|P2|On Study at Time of Unblinding|Other|4
7812244|NCT00424047|27137949|P1|On Study at Time of Unblinding|Other|5
7812245|NCT00424047|27137948|P2|On Study at Time of Unblinding|Death|11
7812246|NCT00424047|27137949|P1|On Study at Time of Unblinding|Death|11
7812247|NCT00424047|27137948|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
7812248|NCT00424047|27137949|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
7812249|NCT00424047|27137948|P2|On Study at Time of Unblinding|Lack of Efficacy|3
7812250|NCT00424047|27137949|P1|On Study at Time of Unblinding|Lack of Efficacy|1
7812251|NCT00424047|27137948|P2|On Study at Time of Unblinding|Progression of disease|128
7812252|NCT00424047|27137949|P1|On Study at Time of Unblinding|Progression of disease|92
7812253|NCT00424047|27137948|P2|On Study at Time of Unblinding|Adverse Event|12
7812254|NCT00424047|27137949|P1|On Study at Time of Unblinding|Adverse Event|22
7812255|NCT00424047|27137948|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
7812256|NCT00424047|27137949|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
7812257|NCT00424047|27137948|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
7812258|NCT00424047|27137949|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
7812259|NCT00424047|27137948|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
7812260|NCT00424047|27137949|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
7812261|NCT00424047|27137948|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
7812262|NCT00424047|27137949|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
7812263|NCT00424047|27137948|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
7812264|NCT00424047|27137949|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
7812265|NCT00424047|27137948|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
7812266|NCT00424047|27137949|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
7812267|NCT00424021|27137981|P4|AMB-220-E Study Period|Physician Decision|1
7812268|NCT00424021|27137982|P3|AMB-220-E Study Period|Physician Decision|0
7812269|NCT00424021|27137983|P2|AMB-220-E Study Period|Physician Decision|0
7812270|NCT00424021|27137984|P1|AMB-220-E Study Period|Physician Decision|0
7812271|NCT00424021|27137981|P4|AMB-220-E Study Period|Lost to Follow-up|1
7812272|NCT00424021|27137982|P3|AMB-220-E Study Period|Lost to Follow-up|1
7812273|NCT00424021|27137983|P2|AMB-220-E Study Period|Lost to Follow-up|1
7812274|NCT00424021|27137984|P1|AMB-220-E Study Period|Lost to Follow-up|0
7812275|NCT00424021|27137981|P4|AMB-220-E Study Period|Death|1
7812276|NCT00424021|27137982|P3|AMB-220-E Study Period|Death|1
7812277|NCT00424021|27137983|P2|AMB-220-E Study Period|Death|0
7812278|NCT00424021|27137984|P1|AMB-220-E Study Period|Death|0
7812279|NCT00424021|27137981|P4|AMB-220-E Study Period|Adverse Event|7
7812280|NCT00424021|27137982|P3|AMB-220-E Study Period|Adverse Event|3
7812281|NCT00424021|27137983|P2|AMB-220-E Study Period|Adverse Event|1
7812282|NCT00424021|27137984|P1|AMB-220-E Study Period|Adverse Event|1
7812283|NCT00424021|27137981|P4|NCT00046319 Study Period|Lost to Follow-up|0
7812284|NCT00424021|27137982|P3|NCT00046319 Study Period|Lost to Follow-up|0
7812285|NCT00424021|27137983|P2|NCT00046319 Study Period|Lost to Follow-up|1
7812286|NCT00424021|27137984|P1|NCT00046319 Study Period|Lost to Follow-up|0
7812287|NCT00424021|27137981|P4|NCT00046319 Study Period|Sponsor discretion|0
7812288|NCT00424021|27137982|P3|NCT00046319 Study Period|Sponsor discretion|0
7812289|NCT00424021|27137983|P2|NCT00046319 Study Period|Sponsor discretion|1
7812290|NCT00424021|27137984|P1|NCT00046319 Study Period|Sponsor discretion|0
7812291|NCT00424021|27137981|P4|NCT00046319 Study Period|Withdrawal by Subject|0
7812292|NCT00424021|27137982|P3|NCT00046319 Study Period|Withdrawal by Subject|0
7812293|NCT00424021|27137983|P2|NCT00046319 Study Period|Withdrawal by Subject|1
7812294|NCT00424021|27137984|P1|NCT00046319 Study Period|Withdrawal by Subject|0
7812295|NCT00424021|27137981|P4|NCT00046319 Study Period|Adverse Event|1
7812296|NCT00424021|27137982|P3|NCT00046319 Study Period|Adverse Event|1
7812297|NCT00424021|27137983|P2|NCT00046319 Study Period|Adverse Event|0
7812298|NCT00424021|27137984|P1|NCT00046319 Study Period|Adverse Event|1
7812299|NCT00424008|27138027|P2|Overall Study|Administrative|257
7812300|NCT00424008|27138028|P1|Overall Study|Administrative|266
7812301|NCT00424008|27138027|P2|Overall Study|Did not meet protocol eligibility|21
7812302|NCT00424008|27138028|P1|Overall Study|Did not meet protocol eligibility|16
7812303|NCT00424008|27138027|P2|Overall Study|Noncompliance with protocol|7
7812304|NCT00424008|27138028|P1|Overall Study|Noncompliance with protocol|13
7812305|NCT00424008|27138027|P2|Overall Study|Withdrawal by Subject|8
7812306|NCT00424008|27138028|P1|Overall Study|Withdrawal by Subject|5
7812307|NCT00424008|27138027|P2|Overall Study|Lost to Follow-up|2
7812308|NCT00424008|27138028|P1|Overall Study|Lost to Follow-up|1
7812309|NCT00424008|27138027|P2|Overall Study|Lack of Efficacy|34
7812310|NCT00424008|27138028|P1|Overall Study|Lack of Efficacy|40
7812311|NCT00424008|27138027|P2|Overall Study|Adverse Event|6
7812312|NCT00424008|27138028|P1|Overall Study|Adverse Event|8
7812313|NCT00423943|27138043|P2|Overall Study|Withdrawal by Subject|1
7812314|NCT00423943|27138044|P1|Overall Study|Withdrawal by Subject|3
7812315|NCT00423930|27138058|P1|Overall Study|Withdrawal by Subject|2
7812316|NCT00423917|27138063|P1|Overall Study|Ineligible|1
7812317|NCT00423917|27138063|P1|Overall Study|Cancel|2
7812318|NCT00423891|27138076|P3|Post-Dosing Follow Up|Lost to Follow-up|0
7812319|NCT00423891|27138077|P2|Post-Dosing Follow Up|Lost to Follow-up|0
7812320|NCT00423891|27138078|P1|Post-Dosing Follow Up|Lost to Follow-up|2
7812321|NCT00423891|27138076|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
7812322|NCT00423891|27138077|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
7812323|NCT00423891|27138078|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
7812324|NCT00423891|27138076|P3|Treatment|Lost to Follow-up|0
7812325|NCT00423891|27138077|P2|Treatment|Lost to Follow-up|0
7812326|NCT00423891|27138078|P1|Treatment|Lost to Follow-up|1
7812327|NCT00423891|27138076|P3|Treatment|Withdrawal by Subject|0
7812328|NCT00423891|27138077|P2|Treatment|Withdrawal by Subject|0
7812329|NCT00423891|27138078|P1|Treatment|Withdrawal by Subject|1
7812330|NCT00423891|27138076|P3|Enrolled|No longer met criteria|1
7812331|NCT00423891|27138077|P2|Enrolled|No longer met criteria|2
7812332|NCT00423891|27138078|P1|Enrolled|No longer met criteria|11
7812333|NCT00423891|27138076|P3|Enrolled|Lost to Follow-up|1
7812334|NCT00423891|27138077|P2|Enrolled|Lost to Follow-up|0
7812335|NCT00423891|27138078|P1|Enrolled|Lost to Follow-up|0
7812336|NCT00423891|27138076|P3|Enrolled|Withdrawal by Subject|1
7812337|NCT00423891|27138077|P2|Enrolled|Withdrawal by Subject|0
7812338|NCT00423891|27138078|P1|Enrolled|Withdrawal by Subject|0
7812339|NCT00423852|27138156|P1|Overall Study|Removed pior to the high-dose portion|3
7812340|NCT00423813|27138164|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
7812341|NCT00423813|27138165|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
7812342|NCT00423813|27138166|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
7812343|NCT00423813|27138164|P3|Overall Study|Will start exclusionary medications|0
7812344|NCT00423813|27138165|P2|Overall Study|Will start exclusionary medications|1
7812345|NCT00423813|27138166|P1|Overall Study|Will start exclusionary medications|0
7812346|NCT00423813|27138164|P3|Overall Study|Subject started night shift work|0
7812347|NCT00423813|27138165|P2|Overall Study|Subject started night shift work|0
7812348|NCT00423813|27138166|P1|Overall Study|Subject started night shift work|1
7812349|NCT00423813|27138164|P3|Overall Study|Pregnancy|1
7812350|NCT00423813|27138165|P2|Overall Study|Pregnancy|0
7812351|NCT00423813|27138166|P1|Overall Study|Pregnancy|0
7812352|NCT00423813|27138164|P3|Overall Study|Protocol Violation|4
7812353|NCT00423813|27138165|P2|Overall Study|Protocol Violation|4
7812354|NCT00423813|27138166|P1|Overall Study|Protocol Violation|9
7812355|NCT00423813|27138164|P3|Overall Study|Sponsor Decision|0
7812356|NCT00423813|27138165|P2|Overall Study|Sponsor Decision|1
7812357|NCT00423813|27138166|P1|Overall Study|Sponsor Decision|0
7812358|NCT00423813|27138164|P3|Overall Study|Physician Decision|0
7812359|NCT00423813|27138165|P2|Overall Study|Physician Decision|0
7812360|NCT00423813|27138166|P1|Overall Study|Physician Decision|2
7812361|NCT00423813|27138164|P3|Overall Study|Lack of Efficacy|19
7812362|NCT00423813|27138165|P2|Overall Study|Lack of Efficacy|18
7812363|NCT00423813|27138166|P1|Overall Study|Lack of Efficacy|23
7812364|NCT00423813|27138164|P3|Overall Study|Lost to Follow-up|4
7812365|NCT00423813|27138165|P2|Overall Study|Lost to Follow-up|4
7812366|NCT00423813|27138166|P1|Overall Study|Lost to Follow-up|5
7812367|NCT00423813|27138164|P3|Overall Study|Withdrawal by Subject|5
7812368|NCT00423813|27138165|P2|Overall Study|Withdrawal by Subject|8
7812369|NCT00423813|27138166|P1|Overall Study|Withdrawal by Subject|6
7812370|NCT00423813|27138164|P3|Overall Study|Adverse Event|40
7812371|NCT00423813|27138165|P2|Overall Study|Adverse Event|30
7812372|NCT00423813|27138166|P1|Overall Study|Adverse Event|11
7812373|NCT00423800|27138176|P2|Overall Study|Protocol Violation|1
7812374|NCT00423800|27138177|P1|Overall Study|Protocol Violation|0
7812375|NCT00423735|27138189|P3|Overall Study|Ineligible / No protocol treatment|0
7812376|NCT00423735|27138190|P2|Overall Study|Ineligible / No protocol treatment|6
7812377|NCT00423735|27138191|P1|Overall Study|Ineligible / No protocol treatment|8
7812378|NCT00423722|27138214|P2|Overall Study|Withdrawal by Subject|2
7812379|NCT00423722|27138215|P1|Overall Study|Withdrawal by Subject|4
7812380|NCT00423722|27138214|P2|Overall Study|Unable to complete questionnaires|4
7812381|NCT00423722|27138215|P1|Overall Study|Unable to complete questionnaires|4
7812382|NCT00423722|27138214|P2|Overall Study|Declined to participate|3
7812383|NCT00423722|27138215|P1|Overall Study|Declined to participate|2
7812384|NCT00423722|27138214|P2|Overall Study|Death|4
7812385|NCT00423722|27138215|P1|Overall Study|Death|4
7812386|NCT00423670|27138257|P8|Follow-up Period|Non-compliance with protocol|2
7812387|NCT00423670|27138258|P7|Follow-up Period|Non-compliance with protocol|3
7812388|NCT00423670|27138259|P6|Follow-up Period|Non-compliance with protocol|0
7812389|NCT00423670|27138260|P5|Follow-up Period|Non-compliance with protocol|0
7812390|NCT00423670|27138261|P4|Follow-up Period|Non-compliance with protocol|1
7812391|NCT00423670|27138262|P3|Follow-up Period|Non-compliance with protocol|1
7812392|NCT00423670|27138263|P2|Follow-up Period|Non-compliance with protocol|0
7812393|NCT00423670|27138264|P1|Follow-up Period|Non-compliance with protocol|2
7812394|NCT00423670|27138257|P8|Follow-up Period|Subject withdrew (not treatment related)|1
7812395|NCT00423670|27138258|P7|Follow-up Period|Subject withdrew (not treatment related)|1
7812396|NCT00423670|27138259|P6|Follow-up Period|Subject withdrew (not treatment related)|0
7812397|NCT00423670|27138260|P5|Follow-up Period|Subject withdrew (not treatment related)|1
7812398|NCT00423670|27138261|P4|Follow-up Period|Subject withdrew (not treatment related)|1
7812399|NCT00423670|27138262|P3|Follow-up Period|Subject withdrew (not treatment related)|2
7812400|NCT00423670|27138263|P2|Follow-up Period|Subject withdrew (not treatment related)|4
7812401|NCT00423670|27138264|P1|Follow-up Period|Subject withdrew (not treatment related)|1
7812402|NCT00423670|27138257|P8|Follow-up Period|Lost to Follow-up|0
7812403|NCT00423670|27138258|P7|Follow-up Period|Lost to Follow-up|5
7812404|NCT00423670|27138259|P6|Follow-up Period|Lost to Follow-up|0
7812405|NCT00423670|27138260|P5|Follow-up Period|Lost to Follow-up|1
7812406|NCT00423670|27138261|P4|Follow-up Period|Lost to Follow-up|3
7812407|NCT00423670|27138262|P3|Follow-up Period|Lost to Follow-up|8
7812408|NCT00423670|27138263|P2|Follow-up Period|Lost to Follow-up|12
7812409|NCT00423670|27138264|P1|Follow-up Period|Lost to Follow-up|0
7812410|NCT00423670|27138257|P8|Treatment Period|Non-compliance with protocol|2
7812411|NCT00423670|27138258|P7|Treatment Period|Non-compliance with protocol|2
7812412|NCT00423670|27138259|P6|Treatment Period|Non-compliance with protocol|0
7812413|NCT00423670|27138260|P5|Treatment Period|Non-compliance with protocol|2
7812414|NCT00423670|27138261|P4|Treatment Period|Non-compliance with protocol|3
7812415|NCT00423670|27138262|P3|Treatment Period|Non-compliance with protocol|1
7812416|NCT00423670|27138263|P2|Treatment Period|Non-compliance with protocol|1
7812417|NCT00423670|27138264|P1|Treatment Period|Non-compliance with protocol|3
7812418|NCT00423670|27138257|P8|Treatment Period|Investigator decision|1
7812419|NCT00423670|27138258|P7|Treatment Period|Investigator decision|0
7812420|NCT00423670|27138259|P6|Treatment Period|Investigator decision|0
7812421|NCT00423670|27138260|P5|Treatment Period|Investigator decision|0
7812422|NCT00423670|27138261|P4|Treatment Period|Investigator decision|0
7812423|NCT00423670|27138262|P3|Treatment Period|Investigator decision|0
7812424|NCT00423670|27138263|P2|Treatment Period|Investigator decision|0
7812425|NCT00423670|27138264|P1|Treatment Period|Investigator decision|0
7812426|NCT00423670|27138257|P8|Treatment Period|Subject withdrew (not treatment related)|0
7812427|NCT00423670|27138258|P7|Treatment Period|Subject withdrew (not treatment related)|3
7812428|NCT00423670|27138259|P6|Treatment Period|Subject withdrew (not treatment related)|0
7812429|NCT00423670|27138260|P5|Treatment Period|Subject withdrew (not treatment related)|5
7812430|NCT00423670|27138261|P4|Treatment Period|Subject withdrew (not treatment related)|4
7812431|NCT00423670|27138262|P3|Treatment Period|Subject withdrew (not treatment related)|4
7812432|NCT00423670|27138263|P2|Treatment Period|Subject withdrew (not treatment related)|9
7812433|NCT00423670|27138264|P1|Treatment Period|Subject withdrew (not treatment related)|3
7812434|NCT00423670|27138257|P8|Treatment Period|Lost to Follow-up|1
7812435|NCT00423670|27138258|P7|Treatment Period|Lost to Follow-up|3
7812436|NCT00423670|27138259|P6|Treatment Period|Lost to Follow-up|0
7812437|NCT00423670|27138260|P5|Treatment Period|Lost to Follow-up|6
7812438|NCT00423670|27138261|P4|Treatment Period|Lost to Follow-up|1
7812439|NCT00423670|27138262|P3|Treatment Period|Lost to Follow-up|3
7812440|NCT00423670|27138263|P2|Treatment Period|Lost to Follow-up|1
7812441|NCT00423670|27138264|P1|Treatment Period|Lost to Follow-up|2
7812442|NCT00423670|27138257|P8|Treatment Period|Protocol-defined clinical event|15
7812443|NCT00423670|27138258|P7|Treatment Period|Protocol-defined clinical event|16
7812444|NCT00423670|27138259|P6|Treatment Period|Protocol-defined clinical event|4
7812445|NCT00423670|27138260|P5|Treatment Period|Protocol-defined clinical event|5
7812446|NCT00423670|27138261|P4|Treatment Period|Protocol-defined clinical event|12
7812447|NCT00423670|27138262|P3|Treatment Period|Protocol-defined clinical event|4
7812448|NCT00423670|27138263|P2|Treatment Period|Protocol-defined clinical event|7
7812449|NCT00423670|27138264|P1|Treatment Period|Protocol-defined clinical event|0
7812450|NCT00423670|27138257|P8|Treatment Period|Adverse Event|2
7812451|NCT00423670|27138258|P7|Treatment Period|Adverse Event|7
7812452|NCT00423670|27138259|P6|Treatment Period|Adverse Event|4
7812453|NCT00423670|27138260|P5|Treatment Period|Adverse Event|9
7812454|NCT00423670|27138261|P4|Treatment Period|Adverse Event|20
7812455|NCT00423670|27138262|P3|Treatment Period|Adverse Event|15
7812456|NCT00423670|27138263|P2|Treatment Period|Adverse Event|12
7812457|NCT00423670|27138264|P1|Treatment Period|Adverse Event|8
7812458|NCT00423670|27138257|P8|Treatment Period|Switched to Arm 8 at TW 24|0
7812459|NCT00423670|27138258|P7|Treatment Period|Switched to Arm 8 at TW 24|0
7812460|NCT00423670|27138259|P6|Treatment Period|Switched to Arm 8 at TW 24|0
7812461|NCT00423670|27138260|P5|Treatment Period|Switched to Arm 8 at TW 24|0
7812462|NCT00423670|27138261|P4|Treatment Period|Switched to Arm 8 at TW 24|0
7812463|NCT00423670|27138262|P3|Treatment Period|Switched to Arm 8 at TW 24|0
7812464|NCT00423670|27138263|P2|Treatment Period|Switched to Arm 8 at TW 24|0
7812465|NCT00423670|27138264|P1|Treatment Period|Switched to Arm 8 at TW 24|36
7812466|NCT00423657|27138322|P2|Overall Study|Request of sponsor/investigator|0
7812467|NCT00423657|27138323|P1|Overall Study|Request of sponsor/investigator|1
7812468|NCT00423657|27138322|P2|Overall Study|Other|16
7812469|NCT00423657|27138323|P1|Overall Study|Other|15
7812470|NCT00423657|27138322|P2|Overall Study|Non-compliance|1
7812471|NCT00423657|27138323|P1|Overall Study|Non-compliance|0
7812472|NCT00423657|27138322|P2|Overall Study|Withdrew consent|8
7812473|NCT00423657|27138323|P1|Overall Study|Withdrew consent|10
7812474|NCT00423605|27138329|P1|Overall Study|Not one of the pre-specified options|5
7812475|NCT00423605|27138329|P1|Overall Study|Protocol Violation|7
7812476|NCT00423605|27138329|P1|Overall Study|Physician Decision|8
7812477|NCT00423605|27138329|P1|Overall Study|Sponsor Decision|3
7812478|NCT00423605|27138329|P1|Overall Study|Lack of Efficacy|38
7812479|NCT00423605|27138329|P1|Overall Study|Lost to Follow-up|15
7812480|NCT00423605|27138329|P1|Overall Study|Withdrawal by Subject|36
7812481|NCT00423605|27138329|P1|Overall Study|Adverse Event|129
7812482|NCT00423592|27138333|P1|Overall Study|Adverse Event (post Week 12)|5
7812483|NCT00423592|27138333|P1|Overall Study|Adverse Event (through Week 12)|2
7812484|NCT00423579|27138354|P2|Overall Study|Diagnosis of diabetes|1
7812485|NCT00423579|27138355|P1|Overall Study|Diagnosis of diabetes|0
7812486|NCT00423579|27138354|P2|Overall Study|Protocol Violation|3
7812487|NCT00423579|27138355|P1|Overall Study|Protocol Violation|1
7812488|NCT00423579|27138354|P2|Overall Study|Lost to Follow-up|0
7812489|NCT00423579|27138355|P1|Overall Study|Lost to Follow-up|3
7812490|NCT00423488|27138363|P2|Overall Study|No post baseline data|0
7812491|NCT00423488|27138364|P1|Overall Study|No post baseline data|3
7812492|NCT00423488|27138363|P2|Overall Study|No evidence of study drug intake|1
7812493|NCT00423488|27138364|P1|Overall Study|No evidence of study drug intake|2
7812494|NCT00423449|27138370|P5|Overall Study|Protocol Violation|0
7812495|NCT00423449|27138371|P4|Overall Study|Protocol Violation|1
7812496|NCT00423449|27138372|P3|Overall Study|Protocol Violation|2
7812497|NCT00423449|27138373|P2|Overall Study|Protocol Violation|0
7812498|NCT00423449|27138374|P1|Overall Study|Protocol Violation|0
7812499|NCT00423449|27138370|P5|Overall Study|Other|0
7812500|NCT00423449|27138371|P4|Overall Study|Other|1
7812501|NCT00423449|27138372|P3|Overall Study|Other|0
7812502|NCT00423449|27138373|P2|Overall Study|Other|0
7812503|NCT00423449|27138374|P1|Overall Study|Other|0
7812504|NCT00423449|27138370|P5|Overall Study|Laboratory Adverse Event|0
7812505|NCT00423449|27138371|P4|Overall Study|Laboratory Adverse Event|0
7812506|NCT00423449|27138372|P3|Overall Study|Laboratory Adverse Event|2
7812507|NCT00423449|27138373|P2|Overall Study|Laboratory Adverse Event|1
7812508|NCT00423449|27138374|P1|Overall Study|Laboratory Adverse Event|0
7812509|NCT00423449|27138370|P5|Overall Study|Progressive Disease|4
7812510|NCT00423449|27138371|P4|Overall Study|Progressive Disease|11
7812511|NCT00423449|27138372|P3|Overall Study|Progressive Disease|8
7812512|NCT00423449|27138373|P2|Overall Study|Progressive Disease|3
7812513|NCT00423449|27138374|P1|Overall Study|Progressive Disease|1
7812514|NCT00423449|27138370|P5|Overall Study|Death|1
7812515|NCT00423449|27138371|P4|Overall Study|Death|1
7812516|NCT00423449|27138372|P3|Overall Study|Death|2
7812517|NCT00423449|27138373|P2|Overall Study|Death|0
7812518|NCT00423449|27138374|P1|Overall Study|Death|1
7812519|NCT00423449|27138370|P5|Overall Study|Clinical Adverse Event|2
7812520|NCT00423449|27138371|P4|Overall Study|Clinical Adverse Event|8
7812521|NCT00423449|27138372|P3|Overall Study|Clinical Adverse Event|1
7812522|NCT00423449|27138373|P2|Overall Study|Clinical Adverse Event|0
7812523|NCT00423449|27138374|P1|Overall Study|Clinical Adverse Event|1
7812524|NCT00423332|27138421|P2|Overall Study|Unblinded before 12 weeks|3
7812525|NCT00423332|27138422|P1|Overall Study|Unblinded before 12 weeks|1
7812526|NCT00423332|27138421|P2|Overall Study|Progressive at Week 6|1
7812527|NCT00423332|27138422|P1|Overall Study|Progressive at Week 6|0
7812528|NCT00423332|27138421|P2|Overall Study|Condition under investigation worsened|1
7812529|NCT00423332|27138422|P1|Overall Study|Condition under investigation worsened|1
7812530|NCT00423332|27138421|P2|Overall Study|Withdrawal by Subject|0
7812531|NCT00423332|27138422|P1|Overall Study|Withdrawal by Subject|1
7812532|NCT00423332|27138421|P2|Overall Study|Adverse Event|2
7812533|NCT00423332|27138422|P1|Overall Study|Adverse Event|6
7812534|NCT00423319|27138441|P2|Overall Study|Other|22
7812535|NCT00423319|27138442|P1|Overall Study|Other|23
7812536|NCT00423319|27138441|P2|Overall Study|No longer meets study criteria|15
7812537|NCT00423319|27138442|P1|Overall Study|No longer meets study criteria|15
7812538|NCT00423319|27138441|P2|Overall Study|Poor compliance or noncompliance|1
7812539|NCT00423319|27138442|P1|Overall Study|Poor compliance or noncompliance|1
7812540|NCT00423319|27138441|P2|Overall Study|Lost to Follow-up|3
7812541|NCT00423319|27138442|P1|Overall Study|Lost to Follow-up|4
7812542|NCT00423319|27138441|P2|Overall Study|Withdrawal by Subject|99
7812543|NCT00423319|27138442|P1|Overall Study|Withdrawal by Subject|86
7812544|NCT00423319|27138441|P2|Overall Study|Adverse Event|112
7812545|NCT00423319|27138442|P1|Overall Study|Adverse Event|93
7812546|NCT00423319|27138441|P2|Overall Study|Death|0
7812547|NCT00423319|27138442|P1|Overall Study|Death|2
7812548|NCT00423293|27138474|P1|Overall Study|Ineligible / No protocol treatment|11
7812549|NCT00423267|27138491|P2|Period A|Administrative|0
7812550|NCT00423267|27138492|P1|Period A|Administrative|1
7812551|NCT00423267|27138491|P2|Period A|Non-compliance with protocol|0
7812552|NCT00423267|27138492|P1|Period A|Non-compliance with protocol|1
7812553|NCT00423267|27138491|P2|Period A|Withdrawal by Subject|1
7812554|NCT00423267|27138492|P1|Period A|Withdrawal by Subject|0
7812555|NCT00423189|27138512|P3|Overall Study|Death|0
7812556|NCT00423189|27138513|P2|Overall Study|Death|1
7812557|NCT00423189|27138514|P1|Overall Study|Death|0
7812558|NCT00423176|27138536|P2|Overall Study|Did not meet protocol eligibility|4
7812559|NCT00423176|27138537|P1|Overall Study|Did not meet protocol eligibility|2
7812560|NCT00423176|27138536|P2|Overall Study|Protocol Violation|3
7812561|NCT00423176|27138537|P1|Overall Study|Protocol Violation|1
7812562|NCT00423176|27138536|P2|Overall Study|Withdrawal by Subject|3
7812563|NCT00423176|27138537|P1|Overall Study|Withdrawal by Subject|4
7812564|NCT00423176|27138536|P2|Overall Study|Lost to Follow-up|7
7812565|NCT00423176|27138537|P1|Overall Study|Lost to Follow-up|4
7812566|NCT00423176|27138536|P2|Overall Study|Treatment Failure|6
7812567|NCT00423176|27138537|P1|Overall Study|Treatment Failure|1
7812568|NCT00423176|27138536|P2|Overall Study|Adverse Event|6
7812569|NCT00423176|27138537|P1|Overall Study|Adverse Event|4
7812570|NCT00423150|27138545|P1|Overall Study|Administrative|4
7812571|NCT00423150|27138545|P1|Overall Study|Non-compliance with protocol|1
7812572|NCT00423150|27138545|P1|Overall Study|Withdrawal by Subject|1
7812573|NCT00423150|27138545|P1|Overall Study|Progression of disease being studied|69
7812574|NCT00423150|27138545|P1|Overall Study|Adverse Event|11
7812575|NCT00423098|27138551|P2|Overall Study|Death|0
7812576|NCT00423098|27138552|P1|Overall Study|Death|2
7812577|NCT00423098|27138551|P2|Overall Study|Administrative problems|1
7812578|NCT00423098|27138552|P1|Overall Study|Administrative problems|0
7812579|NCT00423098|27138551|P2|Overall Study|Unsatisfactory therapeutic effect|1
7812580|NCT00423098|27138552|P1|Overall Study|Unsatisfactory therapeutic effect|0
7812581|NCT00423098|27138551|P2|Overall Study|Adverse Event|2
7812582|NCT00423098|27138552|P1|Overall Study|Adverse Event|1
7812583|NCT00423085|27138579|P4|52-Week Open-Label Extension Phase|Death|2
7812584|NCT00423085|27138580|P3|52-Week Open-Label Extension Phase|Death|0
7812585|NCT00423085|27138581|P2|52-Week Open-Label Extension Phase|Death|0
7812586|NCT00423085|27138582|P1|52-Week Open-Label Extension Phase|Death|0
7812587|NCT00423085|27138579|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
7812588|NCT00423085|27138580|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
7812589|NCT00423085|27138581|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
7812590|NCT00423085|27138582|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
7812591|NCT00423085|27138579|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
7812592|NCT00423085|27138580|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7812593|NCT00423085|27138581|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7812594|NCT00423085|27138582|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7812595|NCT00423085|27138579|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
7812596|NCT00423085|27138580|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7812597|NCT00423085|27138581|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7812598|NCT00423085|27138582|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7812599|NCT00423085|27138579|P4|52-Week Open-Label Extension Phase|Adverse Event|97
7812600|NCT00423085|27138580|P3|52-Week Open-Label Extension Phase|Adverse Event|0
7812601|NCT00423085|27138581|P2|52-Week Open-Label Extension Phase|Adverse Event|0
7812602|NCT00423085|27138582|P1|52-Week Open-Label Extension Phase|Adverse Event|0
7812603|NCT00423085|27138579|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7812604|NCT00423085|27138580|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7812605|NCT00423085|27138581|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7812606|NCT00423085|27138582|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
7812607|NCT00423085|27138579|P4|24-Week Double-Blind Treatment Phase|Death|0
7812608|NCT00423085|27138580|P3|24-Week Double-Blind Treatment Phase|Death|0
7812609|NCT00423085|27138581|P2|24-Week Double-Blind Treatment Phase|Death|1
7812610|NCT00423085|27138582|P1|24-Week Double-Blind Treatment Phase|Death|1
7812611|NCT00423085|27138579|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
7812612|NCT00423085|27138580|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
7812613|NCT00423085|27138581|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
7812614|NCT00423085|27138582|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
7812615|NCT00423085|27138579|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7812616|NCT00423085|27138580|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
7812617|NCT00423085|27138581|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
7812618|NCT00423085|27138582|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
7812619|NCT00423085|27138579|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
7812620|NCT00423085|27138580|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
7812621|NCT00423085|27138581|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
7812622|NCT00423085|27138582|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
7812623|NCT00423085|27138579|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
7812624|NCT00423085|27138580|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
7812625|NCT00423085|27138581|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
7812626|NCT00423085|27138582|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
7812627|NCT00423046|27138611|P2|Overall Study|Other|345
7812628|NCT00423046|27138612|P1|Overall Study|Other|340
7812629|NCT00422942|27138678|P1|Overall Study|Study terminated by Sponsor|3
7812630|NCT00422903|27138697|P2|Overall Study|Informed Consent Withdrawn|2
7812631|NCT00422903|27138698|P1|Overall Study|Informed Consent Withdrawn|1
7812632|NCT00422903|27138697|P2|Overall Study|Adverse Event|2
7812633|NCT00422903|27138698|P1|Overall Study|Adverse Event|0
7812634|NCT00422903|27138697|P2|Overall Study|Disease Progression|1
7812635|NCT00422903|27138698|P1|Overall Study|Disease Progression|3
7812636|NCT00422799|27138747|P1|Overall Study|Adverse Event|7
7812637|NCT00422799|27138747|P1|Overall Study|Withdrawal by Subject|6
7812638|NCT00422734|27138756|P2|Overall Study|Partner Decision|3
7812639|NCT00422734|27138757|P1|Overall Study|Partner Decision|0
7812640|NCT00422734|27138756|P2|Overall Study|Adverse Event|3
7812641|NCT00422734|27138757|P1|Overall Study|Adverse Event|0
7812642|NCT00422734|27138756|P2|Overall Study|Withdrawal by Subject|8
7812643|NCT00422734|27138757|P1|Overall Study|Withdrawal by Subject|12
7812644|NCT00422734|27138756|P2|Overall Study|Protocol Violation|6
7812645|NCT00422734|27138757|P1|Overall Study|Protocol Violation|1
7812646|NCT00422734|27138756|P2|Overall Study|Physician Decision|1
7812647|NCT00422734|27138757|P1|Overall Study|Physician Decision|1
7812648|NCT00422669|27138803|P3|Overall Study|The study was terminated early.|7
7812649|NCT00422669|27138804|P2|Overall Study|The study was terminated early.|100
7812650|NCT00422669|27138805|P1|Overall Study|The study was terminated early.|98
7812651|NCT00422591|27138833|P1|Overall Study|Withdrawal by Subject|2
7812652|NCT00422591|27138833|P1|Overall Study|Physician Decision|4
7812653|NCT00422513|27138841|P2|Overall Study|Death|7
7812654|NCT00422513|27138842|P1|Overall Study|Death|3
7812655|NCT00422513|27138841|P2|Overall Study|Adverse Event|4
7812656|NCT00422513|27138842|P1|Overall Study|Adverse Event|4
7812657|NCT00422513|27138841|P2|Overall Study|early termination of the study|80
7812658|NCT00422513|27138842|P1|Overall Study|early termination of the study|67
7812659|NCT00422513|27138841|P2|Overall Study|Withdrawal by Subject|1
7812660|NCT00422513|27138842|P1|Overall Study|Withdrawal by Subject|2
7812661|NCT00422513|27138841|P2|Overall Study|Refused Treatment|2
7812662|NCT00422513|27138842|P1|Overall Study|Refused Treatment|4
7812663|NCT00422513|27138841|P2|Overall Study|Protocol Violation|7
7812664|NCT00422513|27138842|P1|Overall Study|Protocol Violation|23
7812665|NCT00422513|27138841|P2|Overall Study|Lack of Efficacy|5
7812666|NCT00422513|27138842|P1|Overall Study|Lack of Efficacy|4
7812667|NCT00422461|27138858|P4|Overall Study|Randomized but not treated|0
7812668|NCT00422461|27138859|P3|Overall Study|Randomized but not treated|0
7812669|NCT00422461|27138860|P2|Overall Study|Randomized but not treated|1
7812670|NCT00422461|27138861|P1|Overall Study|Randomized but not treated|1
7812671|NCT00422461|27138858|P4|Overall Study|Participants no longer willing to participate in study|0
7812672|NCT00422461|27138859|P3|Overall Study|Participants no longer willing to participate in study|0
7812673|NCT00422461|27138860|P2|Overall Study|Participants no longer willing to participate in study|0
7812674|NCT00422461|27138861|P1|Overall Study|Participants no longer willing to participate in study|1
7812675|NCT00422461|27138858|P4|Overall Study|Other|2
7812676|NCT00422461|27138859|P3|Overall Study|Other|0
7812677|NCT00422461|27138860|P2|Overall Study|Other|0
7812678|NCT00422461|27138861|P1|Overall Study|Other|0
7812679|NCT00422461|27138858|P4|Overall Study|Adverse Event|1
7812680|NCT00422461|27138859|P3|Overall Study|Adverse Event|1
7812681|NCT00422461|27138860|P2|Overall Study|Adverse Event|2
7812682|NCT00422461|27138861|P1|Overall Study|Adverse Event|1
7812683|NCT00422422|27138916|P1|Overall Study|AE, non-serious non-fatal|5
7812684|NCT00422422|27138916|P1|Overall Study|SAE, non-fatal|1
7812685|NCT00422422|27138916|P1|Overall Study|Withdrawal by Subject|2
7812686|NCT00422422|27138916|P1|Overall Study|Protocol Violation|1
7812687|NCT00422422|27138916|P1|Overall Study|Lack of Efficacy|1
7812688|NCT00422383|27138933|P5|Overall Study|Withdrawal by Subject|1
7812689|NCT00422383|27138934|P4|Overall Study|Withdrawal by Subject|0
7812690|NCT00422383|27138935|P3|Overall Study|Withdrawal by Subject|0
7812691|NCT00422383|27138936|P2|Overall Study|Withdrawal by Subject|5
7812692|NCT00422383|27138937|P1|Overall Study|Withdrawal by Subject|5
7812693|NCT00422383|27138933|P5|Overall Study|Protocol Violation|0
7812694|NCT00422383|27138934|P4|Overall Study|Protocol Violation|0
7812695|NCT00422383|27138935|P3|Overall Study|Protocol Violation|1
7812696|NCT00422383|27138936|P2|Overall Study|Protocol Violation|1
7812697|NCT00422383|27138937|P1|Overall Study|Protocol Violation|1
7812698|NCT00422383|27138933|P5|Overall Study|Lost to Follow-up|1
7812699|NCT00422383|27138934|P4|Overall Study|Lost to Follow-up|0
7812700|NCT00422383|27138935|P3|Overall Study|Lost to Follow-up|0
7812701|NCT00422383|27138936|P2|Overall Study|Lost to Follow-up|1
7812702|NCT00422383|27138937|P1|Overall Study|Lost to Follow-up|0
7812703|NCT00422383|27138933|P5|Overall Study|Lack of Efficacy|1
7812704|NCT00422383|27138934|P4|Overall Study|Lack of Efficacy|1
7812705|NCT00422383|27138935|P3|Overall Study|Lack of Efficacy|2
7812706|NCT00422383|27138936|P2|Overall Study|Lack of Efficacy|4
7812707|NCT00422383|27138937|P1|Overall Study|Lack of Efficacy|4
7812708|NCT00422383|27138933|P5|Overall Study|Adverse Event|0
7812709|NCT00422383|27138934|P4|Overall Study|Adverse Event|1
7812710|NCT00422383|27138935|P3|Overall Study|Adverse Event|1
7812711|NCT00422383|27138936|P2|Overall Study|Adverse Event|3
7812712|NCT00422383|27138937|P1|Overall Study|Adverse Event|5
7812713|NCT00422292|27139080|P4|Overall Study|Withdrawal by Subject|13
7812714|NCT00422292|27139081|P3|Overall Study|Withdrawal by Subject|7
7812715|NCT00422292|27139082|P2|Overall Study|Withdrawal by Subject|25
7812716|NCT00422292|27139083|P1|Overall Study|Withdrawal by Subject|6
7812717|NCT00422292|27139080|P4|Overall Study|Lost to Follow-up|6
7812718|NCT00422292|27139081|P3|Overall Study|Lost to Follow-up|6
7812719|NCT00422292|27139082|P2|Overall Study|Lost to Follow-up|12
7812720|NCT00422292|27139083|P1|Overall Study|Lost to Follow-up|6
7812721|NCT00422292|27139080|P4|Overall Study|Protocol Violation|5
7812722|NCT00422292|27139081|P3|Overall Study|Protocol Violation|8
7812723|NCT00422292|27139082|P2|Overall Study|Protocol Violation|25
7812724|NCT00422292|27139083|P1|Overall Study|Protocol Violation|4
7812725|NCT00422292|27139080|P4|Overall Study|Adverse Event|0
7812726|NCT00422292|27139081|P3|Overall Study|Adverse Event|1
7812727|NCT00422292|27139082|P2|Overall Study|Adverse Event|0
7812728|NCT00422292|27139083|P1|Overall Study|Adverse Event|1
7812729|NCT00422292|27139080|P4|Overall Study|Serious adverse events|0
7812730|NCT00422292|27139081|P3|Overall Study|Serious adverse events|0
7812731|NCT00422292|27139082|P2|Overall Study|Serious adverse events|4
7812732|NCT00422292|27139083|P1|Overall Study|Serious adverse events|1
7812733|NCT00422227|27139122|P2|Overall Study|Withdrawal by Subject|4
7812734|NCT00422227|27139123|P1|Overall Study|Withdrawal by Subject|0
7812735|NCT00422227|27139122|P2|Overall Study|Lost to Follow-up|3
7812736|NCT00422227|27139123|P1|Overall Study|Lost to Follow-up|1
7812737|NCT00422227|27139122|P2|Overall Study|Adverse Event|8
7812738|NCT00422227|27139123|P1|Overall Study|Adverse Event|3
7812739|NCT00422162|27139154|P2|Overall Study|Didn't Receive Treatment|1
7812740|NCT00422162|27139155|P1|Overall Study|Didn't Receive Treatment|0
7812741|NCT00422162|27139154|P2|Overall Study|Other|1
7812742|NCT00422162|27139155|P1|Overall Study|Other|0
7812743|NCT00422162|27139154|P2|Overall Study|Non-Compliant with Protocol|1
7812744|NCT00422162|27139155|P1|Overall Study|Non-Compliant with Protocol|1
7812745|NCT00422162|27139154|P2|Overall Study|Lost to Follow-up|2
7812746|NCT00422162|27139155|P1|Overall Study|Lost to Follow-up|1
7812747|NCT00422162|27139154|P2|Overall Study|Withdrawal by Subject|6
7812748|NCT00422162|27139155|P1|Overall Study|Withdrawal by Subject|7
7812749|NCT00422162|27139154|P2|Overall Study|Lack of Efficacy|10
7812750|NCT00422162|27139155|P1|Overall Study|Lack of Efficacy|4
7812751|NCT00422162|27139154|P2|Overall Study|Adverse Event|9
7812752|NCT00422162|27139155|P1|Overall Study|Adverse Event|11
7812753|NCT00422097|27139215|P8|Dose Level 2|Still on treatment|0
7812754|NCT00422097|27139216|P7|Dose Level 2|Still on treatment|0
7812755|NCT00422097|27139217|P6|Dose Level 2|Still on treatment|0
7812756|NCT00422097|27139218|P5|Dose Level 2|Still on treatment|0
7812757|NCT00422097|27139219|P4|Dose Level 2|Still on treatment|0
7812758|NCT00422097|27139220|P3|Dose Level 2|Still on treatment|0
7812759|NCT00422097|27139221|P2|Dose Level 2|Still on treatment|1
7812760|NCT00422097|27139222|P1|Dose Level 2|Still on treatment|0
7812761|NCT00422084|27139283|P2|Overall Study|Not defined|1
7812762|NCT00422084|27139284|P1|Overall Study|Not defined|1
7812763|NCT00422084|27139283|P2|Overall Study|Re-location|1
7812764|NCT00422084|27139284|P1|Overall Study|Re-location|0
7812765|NCT00422084|27139283|P2|Overall Study|Non-compliance|0
7812766|NCT00422084|27139284|P1|Overall Study|Non-compliance|1
7812767|NCT00422084|27139283|P2|Overall Study|Withdrawn from study accidentally|0
7812768|NCT00422084|27139284|P1|Overall Study|Withdrawn from study accidentally|1
7812769|NCT00422084|27139283|P2|Overall Study|Cyesis|0
7812770|NCT00422084|27139284|P1|Overall Study|Cyesis|1
7812771|NCT00422084|27139283|P2|Overall Study|P. vivax infection|6
7812772|NCT00422084|27139284|P1|Overall Study|P. vivax infection|3
7812773|NCT00422084|27139283|P2|Overall Study|Lack of Efficacy|42
7812774|NCT00422084|27139284|P1|Overall Study|Lack of Efficacy|40
7812775|NCT00422084|27139283|P2|Overall Study|Protocol Violation|1
7812776|NCT00422084|27139284|P1|Overall Study|Protocol Violation|4
7812777|NCT00422084|27139283|P2|Overall Study|Lost to Follow-up|9
7812778|NCT00422084|27139284|P1|Overall Study|Lost to Follow-up|14
7812779|NCT00422084|27139283|P2|Overall Study|Withdrawal by Subject|9
7812780|NCT00422084|27139284|P1|Overall Study|Withdrawal by Subject|12
7812781|NCT00422084|27139283|P2|Overall Study|Adverse Event|7
7812782|NCT00422084|27139284|P1|Overall Study|Adverse Event|21
7812783|NCT00422058|27139310|P6|Open-Label Extension, Week 20-104|Other|18
7812784|NCT00422058|27139311|P5|Open-Label Extension, Week 20-104|Other|16
7812785|NCT00422058|27139312|P4|Open-Label Extension, Week 20-104|Other|13
7812786|NCT00422058|27139313|P3|Open-Label Extension, Week 20-104|Other|6
7812787|NCT00422058|27139314|P2|Open-Label Extension, Week 20-104|Other|14
7812788|NCT00422058|27139315|P1|Open-Label Extension, Week 20-104|Other|13
7812789|NCT00422058|27139310|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
7812790|NCT00422058|27139311|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
7812791|NCT00422058|27139312|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
7812792|NCT00422058|27139313|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
7812793|NCT00422058|27139314|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
7812794|NCT00422058|27139315|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
7812795|NCT00422058|27139310|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
7812796|NCT00422058|27139311|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
7812797|NCT00422058|27139312|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
7812798|NCT00422058|27139313|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
7812799|NCT00422058|27139314|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
7812800|NCT00422058|27139315|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
7812801|NCT00422058|27139310|P6|Open-Label Extension, Week 20-104|Adverse Event|0
7812802|NCT00422058|27139311|P5|Open-Label Extension, Week 20-104|Adverse Event|4
7812803|NCT00422058|27139312|P4|Open-Label Extension, Week 20-104|Adverse Event|4
7812804|NCT00422058|27139313|P3|Open-Label Extension, Week 20-104|Adverse Event|7
7812805|NCT00422058|27139314|P2|Open-Label Extension, Week 20-104|Adverse Event|4
7812806|NCT00422058|27139315|P1|Open-Label Extension, Week 20-104|Adverse Event|3
7812807|NCT00422058|27139310|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7812808|NCT00422058|27139311|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
7812809|NCT00422058|27139312|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
7812810|NCT00422058|27139313|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
7812811|NCT00422058|27139314|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
7812812|NCT00422058|27139315|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7812813|NCT00422058|27139310|P6|Double-Blind, Week 0-20|Other|10
7812814|NCT00422058|27139311|P5|Double-Blind, Week 0-20|Other|4
7812815|NCT00422058|27139312|P4|Double-Blind, Week 0-20|Other|8
7812816|NCT00422058|27139313|P3|Double-Blind, Week 0-20|Other|8
7812817|NCT00422058|27139314|P2|Double-Blind, Week 0-20|Other|3
7812818|NCT00422058|27139315|P1|Double-Blind, Week 0-20|Other|11
7812819|NCT00422058|27139310|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
7812820|NCT00422058|27139311|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
7812821|NCT00422058|27139312|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
7812822|NCT00422058|27139313|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
7812823|NCT00422058|27139314|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
7812824|NCT00422058|27139315|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
7812825|NCT00422058|27139310|P6|Double-Blind, Week 0-20|Protocol Violation|2
7812826|NCT00422058|27139311|P5|Double-Blind, Week 0-20|Protocol Violation|2
7812827|NCT00422058|27139312|P4|Double-Blind, Week 0-20|Protocol Violation|3
7812828|NCT00422058|27139313|P3|Double-Blind, Week 0-20|Protocol Violation|2
7812829|NCT00422058|27139314|P2|Double-Blind, Week 0-20|Protocol Violation|2
7812830|NCT00422058|27139315|P1|Double-Blind, Week 0-20|Protocol Violation|3
7812831|NCT00422058|27139310|P6|Double-Blind, Week 0-20|Adverse Event|3
7812832|NCT00422058|27139311|P5|Double-Blind, Week 0-20|Adverse Event|5
7812833|NCT00422058|27139312|P4|Double-Blind, Week 0-20|Adverse Event|9
7812834|NCT00422058|27139313|P3|Double-Blind, Week 0-20|Adverse Event|5
7812835|NCT00422058|27139314|P2|Double-Blind, Week 0-20|Adverse Event|4
7812836|NCT00422058|27139315|P1|Double-Blind, Week 0-20|Adverse Event|3
7812837|NCT00421993|27139456|P4|Overall Study|Subject transportation issues|1
7812838|NCT00421993|27139457|P3|Overall Study|Subject transportation issues|0
7812839|NCT00421993|27139458|P2|Overall Study|Subject transportation issues|0
7812840|NCT00421993|27139459|P1|Overall Study|Subject transportation issues|0
7812841|NCT00421993|27139456|P4|Overall Study|Pregnancy|2
7812842|NCT00421993|27139457|P3|Overall Study|Pregnancy|1
7812843|NCT00421993|27139458|P2|Overall Study|Pregnancy|1
7812844|NCT00421993|27139459|P1|Overall Study|Pregnancy|0
7812845|NCT00421993|27139456|P4|Overall Study|Lack of Efficacy|5
7812846|NCT00421993|27139457|P3|Overall Study|Lack of Efficacy|0
7812847|NCT00421993|27139458|P2|Overall Study|Lack of Efficacy|3
7812848|NCT00421993|27139459|P1|Overall Study|Lack of Efficacy|0
7812849|NCT00421993|27139456|P4|Overall Study|Protocol Violation|1
7812850|NCT00421993|27139457|P3|Overall Study|Protocol Violation|0
7812851|NCT00421993|27139458|P2|Overall Study|Protocol Violation|2
7812852|NCT00421993|27139459|P1|Overall Study|Protocol Violation|2
7812853|NCT00421993|27139456|P4|Overall Study|Adverse Event|4
7812854|NCT00421993|27139457|P3|Overall Study|Adverse Event|6
7812855|NCT00421993|27139458|P2|Overall Study|Adverse Event|1
7812856|NCT00421993|27139459|P1|Overall Study|Adverse Event|11
7812857|NCT00421993|27139456|P4|Overall Study|Lost to Follow-up|20
7812858|NCT00421993|27139457|P3|Overall Study|Lost to Follow-up|22
7812859|NCT00421993|27139458|P2|Overall Study|Lost to Follow-up|19
7812860|NCT00421993|27139459|P1|Overall Study|Lost to Follow-up|18
7812861|NCT00421993|27139456|P4|Overall Study|Withdrawal by Subject|24
7812862|NCT00421993|27139457|P3|Overall Study|Withdrawal by Subject|23
7812863|NCT00421993|27139458|P2|Overall Study|Withdrawal by Subject|23
7812864|NCT00421993|27139459|P1|Overall Study|Withdrawal by Subject|22
7812865|NCT00421928|27139496|P3|Overall Study|Death|0
7812866|NCT00421928|27139497|P2|Overall Study|Death|1
7812867|NCT00421928|27139498|P1|Overall Study|Death|0
7812868|NCT00421928|27139496|P3|Overall Study|All other|27
7812869|NCT00421928|27139497|P2|Overall Study|All other|21
7812870|NCT00421928|27139498|P1|Overall Study|All other|26
7812871|NCT00421928|27139496|P3|Overall Study|Study drug non-compliant|4
7812872|NCT00421928|27139497|P2|Overall Study|Study drug non-compliant|7
7812873|NCT00421928|27139498|P1|Overall Study|Study drug non-compliant|6
7812874|NCT00421928|27139496|P3|Overall Study|Lack of Efficacy|35
7812875|NCT00421928|27139497|P2|Overall Study|Lack of Efficacy|7
7812876|NCT00421928|27139498|P1|Overall Study|Lack of Efficacy|15
7812877|NCT00421928|27139496|P3|Overall Study|Withdrawal by Subject|43
7812878|NCT00421928|27139497|P2|Overall Study|Withdrawal by Subject|48
7812879|NCT00421928|27139498|P1|Overall Study|Withdrawal by Subject|50
7812880|NCT00421928|27139496|P3|Overall Study|Lost to Follow-up|3
7812881|NCT00421928|27139497|P2|Overall Study|Lost to Follow-up|0
7812882|NCT00421928|27139498|P1|Overall Study|Lost to Follow-up|5
7812883|NCT00421928|27139496|P3|Overall Study|Adverse Event|22
7812884|NCT00421928|27139497|P2|Overall Study|Adverse Event|140
7812885|NCT00421928|27139498|P1|Overall Study|Adverse Event|61
7812886|NCT00421889|27139533|P9|Overall Study|Lost to Follow-up|1
7812887|NCT00421889|27139534|P8|Overall Study|Lost to Follow-up|0
7812888|NCT00421889|27139535|P7|Overall Study|Lost to Follow-up|0
7812889|NCT00421889|27139536|P6|Overall Study|Lost to Follow-up|0
7812890|NCT00421889|27139537|P5|Overall Study|Lost to Follow-up|0
7812891|NCT00421889|27139538|P4|Overall Study|Lost to Follow-up|0
7812892|NCT00421889|27139539|P3|Overall Study|Lost to Follow-up|0
7812893|NCT00421889|27139540|P2|Overall Study|Lost to Follow-up|0
7812894|NCT00421889|27139541|P1|Overall Study|Lost to Follow-up|0
7812895|NCT00421889|27139533|P9|Overall Study|Patient/Investigator request|3
7812896|NCT00421889|27139534|P8|Overall Study|Patient/Investigator request|1
7812897|NCT00421889|27139535|P7|Overall Study|Patient/Investigator request|0
7812898|NCT00421889|27139536|P6|Overall Study|Patient/Investigator request|9
7812899|NCT00421889|27139537|P5|Overall Study|Patient/Investigator request|0
7812900|NCT00421889|27139538|P4|Overall Study|Patient/Investigator request|0
7812901|NCT00421889|27139539|P3|Overall Study|Patient/Investigator request|0
7812902|NCT00421889|27139540|P2|Overall Study|Patient/Investigator request|0
7812903|NCT00421889|27139541|P1|Overall Study|Patient/Investigator request|0
7812904|NCT00421889|27139533|P9|Overall Study|Progressive disease|5
7812905|NCT00421889|27139534|P8|Overall Study|Progressive disease|1
7812906|NCT00421889|27139535|P7|Overall Study|Progressive disease|3
7812907|NCT00421889|27139536|P6|Overall Study|Progressive disease|21
7812908|NCT00421889|27139537|P5|Overall Study|Progressive disease|2
7812909|NCT00421889|27139538|P4|Overall Study|Progressive disease|3
7812910|NCT00421889|27139539|P3|Overall Study|Progressive disease|2
7812911|NCT00421889|27139540|P2|Overall Study|Progressive disease|2
7812912|NCT00421889|27139541|P1|Overall Study|Progressive disease|3
7812913|NCT00421889|27139533|P9|Overall Study|Death|0
7812914|NCT00421889|27139534|P8|Overall Study|Death|0
7812915|NCT00421889|27139535|P7|Overall Study|Death|0
7812916|NCT00421889|27139536|P6|Overall Study|Death|1
7812917|NCT00421889|27139537|P5|Overall Study|Death|1
7812918|NCT00421889|27139538|P4|Overall Study|Death|0
7812919|NCT00421889|27139539|P3|Overall Study|Death|0
7812920|NCT00421889|27139540|P2|Overall Study|Death|0
7812921|NCT00421889|27139541|P1|Overall Study|Death|0
7812922|NCT00421889|27139533|P9|Overall Study|Withdrawal by Subject|0
7812923|NCT00421889|27139534|P8|Overall Study|Withdrawal by Subject|0
7812924|NCT00421889|27139535|P7|Overall Study|Withdrawal by Subject|0
7812925|NCT00421889|27139536|P6|Overall Study|Withdrawal by Subject|0
7812926|NCT00421889|27139537|P5|Overall Study|Withdrawal by Subject|2
7812927|NCT00421889|27139538|P4|Overall Study|Withdrawal by Subject|0
7812928|NCT00421889|27139539|P3|Overall Study|Withdrawal by Subject|0
7812929|NCT00421889|27139540|P2|Overall Study|Withdrawal by Subject|3
7812930|NCT00421889|27139541|P1|Overall Study|Withdrawal by Subject|1
7812931|NCT00421889|27139533|P9|Overall Study|Adverse Event|2
7812932|NCT00421889|27139534|P8|Overall Study|Adverse Event|0
7812933|NCT00421889|27139535|P7|Overall Study|Adverse Event|1
7812934|NCT00421889|27139536|P6|Overall Study|Adverse Event|4
7812935|NCT00421889|27139537|P5|Overall Study|Adverse Event|1
7812936|NCT00421889|27139538|P4|Overall Study|Adverse Event|1
7812937|NCT00421889|27139539|P3|Overall Study|Adverse Event|1
7812938|NCT00421889|27139540|P2|Overall Study|Adverse Event|0
7812939|NCT00421889|27139541|P1|Overall Study|Adverse Event|1
7812940|NCT00421733|27139586|P3|Overall Study|Protocol deviation|2
7812941|NCT00421733|27139587|P2|Overall Study|Protocol deviation|7
7812942|NCT00421733|27139588|P1|Overall Study|Protocol deviation|4
7812943|NCT00421733|27139586|P3|Overall Study|Sponsor request|3
7812944|NCT00421733|27139587|P2|Overall Study|Sponsor request|0
7812945|NCT00421733|27139588|P1|Overall Study|Sponsor request|1
7812946|NCT00421733|27139586|P3|Overall Study|Did not satisfy entry criteria|2
7812947|NCT00421733|27139587|P2|Overall Study|Did not satisfy entry criteria|3
7812948|NCT00421733|27139588|P1|Overall Study|Did not satisfy entry criteria|1
7812949|NCT00421733|27139586|P3|Overall Study|Administrative|0
7812950|NCT00421733|27139587|P2|Overall Study|Administrative|0
7812951|NCT00421733|27139588|P1|Overall Study|Administrative|2
7812952|NCT00421733|27139586|P3|Overall Study|Required dialysis|0
7812953|NCT00421733|27139587|P2|Overall Study|Required dialysis|0
7812954|NCT00421733|27139588|P1|Overall Study|Required dialysis|1
7812955|NCT00421733|27139586|P3|Overall Study|Death|0
7812956|NCT00421733|27139587|P2|Overall Study|Death|3
7812957|NCT00421733|27139588|P1|Overall Study|Death|0
7812958|NCT00421733|27139586|P3|Overall Study|Withdrawal by Subject|7
7812959|NCT00421733|27139587|P2|Overall Study|Withdrawal by Subject|2
7812960|NCT00421733|27139588|P1|Overall Study|Withdrawal by Subject|1
7812961|NCT00421733|27139586|P3|Overall Study|Lost to Follow-up|4
7812962|NCT00421733|27139587|P2|Overall Study|Lost to Follow-up|2
7812963|NCT00421733|27139588|P1|Overall Study|Lost to Follow-up|1
7812964|NCT00421733|27139586|P3|Overall Study|Adverse Event|2
7812965|NCT00421733|27139587|P2|Overall Study|Adverse Event|9
7812966|NCT00421733|27139588|P1|Overall Study|Adverse Event|4
7812967|NCT00421707|27139608|P2|Period 3:Treatment Period 2|Adverse Event|2
7812968|NCT00421707|27139609|P1|Period 3:Treatment Period 2|Adverse Event|0
7812969|NCT00421707|27139608|P2|Period 3:Treatment Period 2|Protocol Violation|0
7812970|NCT00421707|27139609|P1|Period 3:Treatment Period 2|Protocol Violation|1
7812971|NCT00421707|27139608|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
7812972|NCT00421707|27139609|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
7812973|NCT00421707|27139608|P2|Period 2: Washout|Other: Pregnancy|1
7812974|NCT00421707|27139609|P1|Period 2: Washout|Other: Pregnancy|0
7812975|NCT00421707|27139608|P2|Period 2: Washout|Lost to Follow-up|1
7812976|NCT00421707|27139609|P1|Period 2: Washout|Lost to Follow-up|0
7812977|NCT00421707|27139608|P2|Period 2: Washout|Withdrawal by Subject|1
7812978|NCT00421707|27139609|P1|Period 2: Washout|Withdrawal by Subject|0
7812979|NCT00421707|27139608|P2|Period 2: Washout|Adverse Event|1
7812980|NCT00421707|27139609|P1|Period 2: Washout|Adverse Event|1
7812981|NCT00421707|27139608|P2|Period 1: Treatment Period 1|Protocol Violation|0
7812982|NCT00421707|27139609|P1|Period 1: Treatment Period 1|Protocol Violation|1
7812983|NCT00421707|27139608|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
7812984|NCT00421707|27139609|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
7812985|NCT00421707|27139608|P2|Period 1: Treatment Period 1|Adverse Event|2
7812986|NCT00421707|27139609|P1|Period 1: Treatment Period 1|Adverse Event|7
7812987|NCT00421707|27139608|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
7812988|NCT00421707|27139609|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
7812989|NCT00421408|27139660|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
7812990|NCT00421408|27139661|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
7812991|NCT00421408|27139660|P2|Overall Study|Lost to Follow-up|20
7812992|NCT00421408|27139661|P1|Overall Study|Lost to Follow-up|30
7812993|NCT00421343|27139679|P1|Overall Study|Lost to Follow-up|3
7812994|NCT00421343|27139679|P1|Overall Study|Withdrawal by Subject|2
7812995|NCT00421343|27139679|P1|Overall Study|Death|1
7812996|NCT00421304|27139686|P3|Overall Study|Did not attend Day 360 visit|1
7812997|NCT00421304|27139687|P2|Overall Study|Did not attend Day 360 visit|0
7812998|NCT00421304|27139688|P1|Overall Study|Did not attend Day 360 visit|0
7812999|NCT00421304|27139686|P3|Overall Study|Mistakenly randomized, chose not to participate in study|0
7813000|NCT00421304|27139687|P2|Overall Study|Mistakenly randomized, chose not to participate in study|0
7813001|NCT00421304|27139688|P1|Overall Study|Mistakenly randomized, chose not to participate in study|1
7813002|NCT00421304|27139686|P3|Overall Study|Withdrawal by Subject|2
7813003|NCT00421304|27139687|P2|Overall Study|Withdrawal by Subject|2
7813004|NCT00421304|27139688|P1|Overall Study|Withdrawal by Subject|2
7813005|NCT00421304|27139686|P3|Overall Study|Lost to Follow-up|5
7813006|NCT00421304|27139687|P2|Overall Study|Lost to Follow-up|2
7813007|NCT00421304|27139688|P1|Overall Study|Lost to Follow-up|5
7813008|NCT00421174|27139790|P2|Overall Study|Ineligible due to infection|0
7813009|NCT00421174|27139791|P1|Overall Study|Ineligible due to infection|2
7813010|NCT00421174|27139790|P2|Overall Study|Withdrawal by Subject|1
7813011|NCT00421174|27139791|P1|Overall Study|Withdrawal by Subject|0
7813012|NCT00421148|27139839|P20|Overall Study|Protocol Violation|0
7813013|NCT00421148|27139840|P19|Overall Study|Protocol Violation|1
7813014|NCT00421148|27139841|P18|Overall Study|Protocol Violation|0
7813015|NCT00421148|27139842|P17|Overall Study|Protocol Violation|0
7813016|NCT00421148|27139843|P16|Overall Study|Protocol Violation|0
7813017|NCT00421148|27139844|P15|Overall Study|Protocol Violation|0
7813018|NCT00421148|27139845|P14|Overall Study|Protocol Violation|0
7813019|NCT00421148|27139846|P13|Overall Study|Protocol Violation|0
7813020|NCT00421148|27139847|P12|Overall Study|Protocol Violation|0
7813021|NCT00421148|27139848|P11|Overall Study|Protocol Violation|0
7813022|NCT00421148|27139849|P10|Overall Study|Protocol Violation|0
7813023|NCT00421148|27139850|P9|Overall Study|Protocol Violation|0
7813024|NCT00421148|27139851|P8|Overall Study|Protocol Violation|0
7813025|NCT00421148|27139852|P7|Overall Study|Protocol Violation|0
7813026|NCT00421148|27139853|P6|Overall Study|Protocol Violation|1
7813027|NCT00421148|27139854|P5|Overall Study|Protocol Violation|0
7813028|NCT00421148|27139855|P4|Overall Study|Protocol Violation|0
7813029|NCT00421148|27139856|P3|Overall Study|Protocol Violation|0
7813030|NCT00421148|27139857|P2|Overall Study|Protocol Violation|0
7813031|NCT00421148|27139858|P1|Overall Study|Protocol Violation|0
7813032|NCT00421148|27139839|P20|Overall Study|Withdrawal by Subject|0
7813033|NCT00421148|27139840|P19|Overall Study|Withdrawal by Subject|0
7813034|NCT00421148|27139841|P18|Overall Study|Withdrawal by Subject|1
7813035|NCT00421148|27139842|P17|Overall Study|Withdrawal by Subject|0
7813036|NCT00421148|27139843|P16|Overall Study|Withdrawal by Subject|0
7813037|NCT00421148|27139844|P15|Overall Study|Withdrawal by Subject|0
7813038|NCT00421148|27139845|P14|Overall Study|Withdrawal by Subject|0
7813039|NCT00421148|27139846|P13|Overall Study|Withdrawal by Subject|0
7813040|NCT00421148|27139847|P12|Overall Study|Withdrawal by Subject|0
7813041|NCT00421148|27139848|P11|Overall Study|Withdrawal by Subject|0
7813042|NCT00421148|27139849|P10|Overall Study|Withdrawal by Subject|0
7813043|NCT00421148|27139850|P9|Overall Study|Withdrawal by Subject|0
7813044|NCT00421148|27139851|P8|Overall Study|Withdrawal by Subject|0
7813045|NCT00421148|27139852|P7|Overall Study|Withdrawal by Subject|0
7813046|NCT00421148|27139853|P6|Overall Study|Withdrawal by Subject|0
7813047|NCT00421148|27139854|P5|Overall Study|Withdrawal by Subject|0
7813048|NCT00421148|27139855|P4|Overall Study|Withdrawal by Subject|0
7813049|NCT00421148|27139856|P3|Overall Study|Withdrawal by Subject|0
7813050|NCT00421148|27139857|P2|Overall Study|Withdrawal by Subject|0
7813051|NCT00421148|27139858|P1|Overall Study|Withdrawal by Subject|0
7813052|NCT00421148|27139839|P20|Overall Study|Lost to Follow-up|0
7813053|NCT00421148|27139840|P19|Overall Study|Lost to Follow-up|0
7813054|NCT00421148|27139841|P18|Overall Study|Lost to Follow-up|1
7813055|NCT00421148|27139842|P17|Overall Study|Lost to Follow-up|0
7813056|NCT00421148|27139843|P16|Overall Study|Lost to Follow-up|0
7813057|NCT00421148|27139844|P15|Overall Study|Lost to Follow-up|0
7813058|NCT00421148|27139845|P14|Overall Study|Lost to Follow-up|0
7813059|NCT00421148|27139846|P13|Overall Study|Lost to Follow-up|0
7813060|NCT00421148|27139847|P12|Overall Study|Lost to Follow-up|0
7813061|NCT00421148|27139848|P11|Overall Study|Lost to Follow-up|0
7813062|NCT00421148|27139849|P10|Overall Study|Lost to Follow-up|0
7813063|NCT00421148|27139850|P9|Overall Study|Lost to Follow-up|0
7813064|NCT00421148|27139851|P8|Overall Study|Lost to Follow-up|0
7813065|NCT00421148|27139852|P7|Overall Study|Lost to Follow-up|0
7813066|NCT00421148|27139853|P6|Overall Study|Lost to Follow-up|0
7813067|NCT00421148|27139854|P5|Overall Study|Lost to Follow-up|0
7813068|NCT00421148|27139855|P4|Overall Study|Lost to Follow-up|0
7813069|NCT00421148|27139856|P3|Overall Study|Lost to Follow-up|0
7813070|NCT00421148|27139857|P2|Overall Study|Lost to Follow-up|0
7813071|NCT00421148|27139858|P1|Overall Study|Lost to Follow-up|0
7813072|NCT00420927|27139957|P7|Period 2|Took prohibited medication|0
7813073|NCT00420927|27139958|P6|Period 2|Took prohibited medication|0
7813074|NCT00420927|27139959|P5|Period 2|Took prohibited medication|1
7813075|NCT00420927|27139960|P4|Period 2|Took prohibited medication|0
7813076|NCT00420927|27139961|P3|Period 2|Took prohibited medication|0
7813077|NCT00420927|27139962|P2|Period 2|Took prohibited medication|0
7813078|NCT00420927|27139963|P1|Period 2|Took prohibited medication|0
7813079|NCT00420927|27139957|P7|Period 2|Methotrexate intolerance|1
7813080|NCT00420927|27139958|P6|Period 2|Methotrexate intolerance|0
7813081|NCT00420927|27139959|P5|Period 2|Methotrexate intolerance|0
7813082|NCT00420927|27139960|P4|Period 2|Methotrexate intolerance|0
7813083|NCT00420927|27139961|P3|Period 2|Methotrexate intolerance|0
7813084|NCT00420927|27139962|P2|Period 2|Methotrexate intolerance|0
7813085|NCT00420927|27139963|P1|Period 2|Methotrexate intolerance|0
7813086|NCT00420927|27139957|P7|Period 2|Noncompliant with study drug|2
7813087|NCT00420927|27139958|P6|Period 2|Noncompliant with study drug|0
7813088|NCT00420927|27139959|P5|Period 2|Noncompliant with study drug|0
7813089|NCT00420927|27139960|P4|Period 2|Noncompliant with study drug|1
7813090|NCT00420927|27139961|P3|Period 2|Noncompliant with study drug|0
7813091|NCT00420927|27139962|P2|Period 2|Noncompliant with study drug|0
7813092|NCT00420927|27139963|P1|Period 2|Noncompliant with study drug|0
7813093|NCT00420927|27139957|P7|Period 2|Randomization error|0
7813094|NCT00420927|27139958|P6|Period 2|Randomization error|1
7813095|NCT00420927|27139959|P5|Period 2|Randomization error|1
7813096|NCT00420927|27139960|P4|Period 2|Randomization error|0
7813097|NCT00420927|27139961|P3|Period 2|Randomization error|0
7813098|NCT00420927|27139962|P2|Period 2|Randomization error|0
7813099|NCT00420927|27139963|P1|Period 2|Randomization error|0
7813100|NCT00420927|27139957|P7|Period 2|Sponsor decision|1
7813101|NCT00420927|27139958|P6|Period 2|Sponsor decision|0
7813102|NCT00420927|27139959|P5|Period 2|Sponsor decision|0
7813103|NCT00420927|27139960|P4|Period 2|Sponsor decision|0
7813104|NCT00420927|27139961|P3|Period 2|Sponsor decision|1
7813105|NCT00420927|27139962|P2|Period 2|Sponsor decision|0
7813106|NCT00420927|27139963|P1|Period 2|Sponsor decision|0
7813107|NCT00420927|27139957|P7|Period 2|Physician Decision|0
7813108|NCT00420927|27139958|P6|Period 2|Physician Decision|1
7813109|NCT00420927|27139959|P5|Period 2|Physician Decision|1
7813110|NCT00420927|27139960|P4|Period 2|Physician Decision|0
7813111|NCT00420927|27139961|P3|Period 2|Physician Decision|0
7813112|NCT00420927|27139962|P2|Period 2|Physician Decision|0
7813113|NCT00420927|27139963|P1|Period 2|Physician Decision|0
7813114|NCT00420927|27139957|P7|Period 2|Subject unable to find transportation|1
7813115|NCT00420927|27139958|P6|Period 2|Subject unable to find transportation|0
7813116|NCT00420927|27139959|P5|Period 2|Subject unable to find transportation|0
7813117|NCT00420927|27139960|P4|Period 2|Subject unable to find transportation|0
7813118|NCT00420927|27139961|P3|Period 2|Subject unable to find transportation|0
7813119|NCT00420927|27139962|P2|Period 2|Subject unable to find transportation|0
7813120|NCT00420927|27139963|P1|Period 2|Subject unable to find transportation|0
7813121|NCT00420927|27139957|P7|Period 2|Received wrong treatment/incorrect dose|1
7813122|NCT00420927|27139958|P6|Period 2|Received wrong treatment/incorrect dose|0
7813123|NCT00420927|27139959|P5|Period 2|Received wrong treatment/incorrect dose|0
7813124|NCT00420927|27139960|P4|Period 2|Received wrong treatment/incorrect dose|0
7813125|NCT00420927|27139961|P3|Period 2|Received wrong treatment/incorrect dose|0
7813126|NCT00420927|27139962|P2|Period 2|Received wrong treatment/incorrect dose|0
7813127|NCT00420927|27139963|P1|Period 2|Received wrong treatment/incorrect dose|0
7813128|NCT00420927|27139957|P7|Period 2|Lack of efficacy/Loss of efficacy|6
7813129|NCT00420927|27139958|P6|Period 2|Lack of efficacy/Loss of efficacy|2
7813130|NCT00420927|27139959|P5|Period 2|Lack of efficacy/Loss of efficacy|6
7813131|NCT00420927|27139960|P4|Period 2|Lack of efficacy/Loss of efficacy|1
7813132|NCT00420927|27139961|P3|Period 2|Lack of efficacy/Loss of efficacy|2
7813133|NCT00420927|27139962|P2|Period 2|Lack of efficacy/Loss of efficacy|0
7813134|NCT00420927|27139963|P1|Period 2|Lack of efficacy/Loss of efficacy|0
7813135|NCT00420927|27139957|P7|Period 2|Lost to Follow-up|9
7813136|NCT00420927|27139958|P6|Period 2|Lost to Follow-up|3
7813137|NCT00420927|27139959|P5|Period 2|Lost to Follow-up|6
7813138|NCT00420927|27139960|P4|Period 2|Lost to Follow-up|2
7813139|NCT00420927|27139961|P3|Period 2|Lost to Follow-up|2
7813140|NCT00420927|27139962|P2|Period 2|Lost to Follow-up|0
7813141|NCT00420927|27139963|P1|Period 2|Lost to Follow-up|0
7813142|NCT00420927|27139957|P7|Period 2|Withdrawal by Subject|12
7813143|NCT00420927|27139958|P6|Period 2|Withdrawal by Subject|2
7813144|NCT00420927|27139959|P5|Period 2|Withdrawal by Subject|11
7813145|NCT00420927|27139960|P4|Period 2|Withdrawal by Subject|3
7813146|NCT00420927|27139961|P3|Period 2|Withdrawal by Subject|1
7813147|NCT00420927|27139962|P2|Period 2|Withdrawal by Subject|0
7813148|NCT00420927|27139963|P1|Period 2|Withdrawal by Subject|0
7813149|NCT00420927|27139957|P7|Period 2|Adverse Event|20
7813150|NCT00420927|27139958|P6|Period 2|Adverse Event|6
7813151|NCT00420927|27139959|P5|Period 2|Adverse Event|17
7813152|NCT00420927|27139960|P4|Period 2|Adverse Event|3
7813153|NCT00420927|27139961|P3|Period 2|Adverse Event|7
7813154|NCT00420927|27139962|P2|Period 2|Adverse Event|0
7813155|NCT00420927|27139963|P1|Period 2|Adverse Event|0
7813156|NCT00420927|27139957|P7|Period 1|Took prohibited medication|0
7813157|NCT00420927|27139958|P6|Period 1|Took prohibited medication|0
7813158|NCT00420927|27139959|P5|Period 1|Took prohibited medication|0
7813159|NCT00420927|27139960|P4|Period 1|Took prohibited medication|0
7813160|NCT00420927|27139961|P3|Period 1|Took prohibited medication|0
7813161|NCT00420927|27139962|P2|Period 1|Took prohibited medication|3
7813162|NCT00420927|27139963|P1|Period 1|Took prohibited medication|1
7813163|NCT00420927|27139957|P7|Period 1|Failed to meet entry criteria|0
7813164|NCT00420927|27139958|P6|Period 1|Failed to meet entry criteria|0
7813165|NCT00420927|27139959|P5|Period 1|Failed to meet entry criteria|0
7813166|NCT00420927|27139960|P4|Period 1|Failed to meet entry criteria|0
7813167|NCT00420927|27139961|P3|Period 1|Failed to meet entry criteria|0
7813168|NCT00420927|27139962|P2|Period 1|Failed to meet entry criteria|7
7813169|NCT00420927|27139963|P1|Period 1|Failed to meet entry criteria|8
7813170|NCT00420927|27139957|P7|Period 1|Received wrong treatment/incorrect dose|0
7813171|NCT00420927|27139958|P6|Period 1|Received wrong treatment/incorrect dose|0
7813172|NCT00420927|27139959|P5|Period 1|Received wrong treatment/incorrect dose|0
7813173|NCT00420927|27139960|P4|Period 1|Received wrong treatment/incorrect dose|0
7813174|NCT00420927|27139961|P3|Period 1|Received wrong treatment/incorrect dose|0
7813175|NCT00420927|27139962|P2|Period 1|Received wrong treatment/incorrect dose|1
7813176|NCT00420927|27139963|P1|Period 1|Received wrong treatment/incorrect dose|0
7813177|NCT00420927|27139957|P7|Period 1|Subject received new diagnosis|0
7813178|NCT00420927|27139958|P6|Period 1|Subject received new diagnosis|0
7813179|NCT00420927|27139959|P5|Period 1|Subject received new diagnosis|0
7813180|NCT00420927|27139960|P4|Period 1|Subject received new diagnosis|0
7813181|NCT00420927|27139961|P3|Period 1|Subject received new diagnosis|0
7813182|NCT00420927|27139962|P2|Period 1|Subject received new diagnosis|2
7813183|NCT00420927|27139963|P1|Period 1|Subject received new diagnosis|0
7813184|NCT00420927|27139957|P7|Period 1|Study site closure|0
7813185|NCT00420927|27139958|P6|Period 1|Study site closure|0
7813186|NCT00420927|27139959|P5|Period 1|Study site closure|0
7813187|NCT00420927|27139960|P4|Period 1|Study site closure|0
7813188|NCT00420927|27139961|P3|Period 1|Study site closure|0
7813189|NCT00420927|27139962|P2|Period 1|Study site closure|1
7813190|NCT00420927|27139963|P1|Period 1|Study site closure|0
7813191|NCT00420927|27139957|P7|Period 1|Suspected tuberculosis/positive test|0
7813192|NCT00420927|27139958|P6|Period 1|Suspected tuberculosis/positive test|0
7813193|NCT00420927|27139959|P5|Period 1|Suspected tuberculosis/positive test|0
7813194|NCT00420927|27139960|P4|Period 1|Suspected tuberculosis/positive test|0
7813195|NCT00420927|27139961|P3|Period 1|Suspected tuberculosis/positive test|0
7813196|NCT00420927|27139962|P2|Period 1|Suspected tuberculosis/positive test|1
7813197|NCT00420927|27139963|P1|Period 1|Suspected tuberculosis/positive test|1
7813198|NCT00420927|27139957|P7|Period 1|Randomization error|0
7813199|NCT00420927|27139958|P6|Period 1|Randomization error|0
7813200|NCT00420927|27139959|P5|Period 1|Randomization error|0
7813201|NCT00420927|27139960|P4|Period 1|Randomization error|0
7813202|NCT00420927|27139961|P3|Period 1|Randomization error|0
7813203|NCT00420927|27139962|P2|Period 1|Randomization error|0
7813204|NCT00420927|27139963|P1|Period 1|Randomization error|1
7813205|NCT00420927|27139957|P7|Period 1|Noncompliant with study drug|0
7813206|NCT00420927|27139958|P6|Period 1|Noncompliant with study drug|0
7813207|NCT00420927|27139959|P5|Period 1|Noncompliant with study drug|0
7813208|NCT00420927|27139960|P4|Period 1|Noncompliant with study drug|0
7813209|NCT00420927|27139961|P3|Period 1|Noncompliant with study drug|0
7813210|NCT00420927|27139962|P2|Period 1|Noncompliant with study drug|1
7813211|NCT00420927|27139963|P1|Period 1|Noncompliant with study drug|1
7813212|NCT00420927|27139957|P7|Period 1|Subject moved/relocated|0
7813213|NCT00420927|27139958|P6|Period 1|Subject moved/relocated|0
7813214|NCT00420927|27139959|P5|Period 1|Subject moved/relocated|0
7813215|NCT00420927|27139960|P4|Period 1|Subject moved/relocated|0
7813216|NCT00420927|27139961|P3|Period 1|Subject moved/relocated|0
7813217|NCT00420927|27139962|P2|Period 1|Subject moved/relocated|2
7813218|NCT00420927|27139963|P1|Period 1|Subject moved/relocated|0
7813219|NCT00420927|27139957|P7|Period 1|Death|0
7813220|NCT00420927|27139958|P6|Period 1|Death|0
7813221|NCT00420927|27139959|P5|Period 1|Death|0
7813222|NCT00420927|27139960|P4|Period 1|Death|0
7813223|NCT00420927|27139961|P3|Period 1|Death|0
7813224|NCT00420927|27139962|P2|Period 1|Death|0
7813225|NCT00420927|27139963|P1|Period 1|Death|2
7813226|NCT00420927|27139957|P7|Period 1|Lack of efficacy/Loss of efficacy|0
7813227|NCT00420927|27139958|P6|Period 1|Lack of efficacy/Loss of efficacy|0
7813228|NCT00420927|27139959|P5|Period 1|Lack of efficacy/Loss of efficacy|0
7813229|NCT00420927|27139960|P4|Period 1|Lack of efficacy/Loss of efficacy|0
7813230|NCT00420927|27139961|P3|Period 1|Lack of efficacy/Loss of efficacy|0
7813231|NCT00420927|27139962|P2|Period 1|Lack of efficacy/Loss of efficacy|6
7813232|NCT00420927|27139963|P1|Period 1|Lack of efficacy/Loss of efficacy|1
7813233|NCT00420927|27139957|P7|Period 1|Lost to Follow-up|0
7813234|NCT00420927|27139958|P6|Period 1|Lost to Follow-up|0
7813235|NCT00420927|27139959|P5|Period 1|Lost to Follow-up|0
7813236|NCT00420927|27139960|P4|Period 1|Lost to Follow-up|0
7813237|NCT00420927|27139961|P3|Period 1|Lost to Follow-up|0
7813238|NCT00420927|27139962|P2|Period 1|Lost to Follow-up|6
7813239|NCT00420927|27139963|P1|Period 1|Lost to Follow-up|8
7813240|NCT00420927|27139957|P7|Period 1|Withdrawal by Subject|0
7813241|NCT00420927|27139958|P6|Period 1|Withdrawal by Subject|0
7813242|NCT00420927|27139959|P5|Period 1|Withdrawal by Subject|0
7813243|NCT00420927|27139960|P4|Period 1|Withdrawal by Subject|0
7813244|NCT00420927|27139961|P3|Period 1|Withdrawal by Subject|0
7813245|NCT00420927|27139962|P2|Period 1|Withdrawal by Subject|12
7813246|NCT00420927|27139963|P1|Period 1|Withdrawal by Subject|7
7813247|NCT00420927|27139957|P7|Period 1|Adverse Event|0
7813248|NCT00420927|27139958|P6|Period 1|Adverse Event|0
7813249|NCT00420927|27139959|P5|Period 1|Adverse Event|0
7813250|NCT00420927|27139960|P4|Period 1|Adverse Event|0
7813251|NCT00420927|27139961|P3|Period 1|Adverse Event|0
7813252|NCT00420927|27139962|P2|Period 1|Adverse Event|15
7813253|NCT00420927|27139963|P1|Period 1|Adverse Event|19
7813254|NCT00420849|27140067|P1|Overall Study|Lost to Follow-up|1
7813255|NCT00420849|27140067|P1|Overall Study|Protocol Violation|1
7813256|NCT00420849|27140067|P1|Overall Study|Transplant|8
7813257|NCT00420849|27140067|P1|Overall Study|Other|14
7813258|NCT00420849|27140067|P1|Overall Study|Death|18
7813259|NCT00420849|27140067|P1|Overall Study|Withdrawal by Subject|28
7813260|NCT00420849|27140067|P1|Overall Study|Adverse Event|107
7813261|NCT00420849|27140067|P1|Overall Study|Lack of Efficacy|154
7813262|NCT00420784|27140136|P4|Overall Study|Other|5
7813263|NCT00420784|27140137|P3|Overall Study|Other|0
7813264|NCT00420784|27140138|P2|Overall Study|Other|2
7813265|NCT00420784|27140139|P1|Overall Study|Other|1
7813266|NCT00420784|27140136|P4|Overall Study|Virologic Stopping Rule|67
7813267|NCT00420784|27140137|P3|Overall Study|Virologic Stopping Rule|41
7813268|NCT00420784|27140138|P2|Overall Study|Virologic Stopping Rule|26
7813269|NCT00420784|27140139|P1|Overall Study|Virologic Stopping Rule|17
7813270|NCT00420784|27140136|P4|Overall Study|Lost to Follow-up|1
7813271|NCT00420784|27140137|P3|Overall Study|Lost to Follow-up|2
7813272|NCT00420784|27140138|P2|Overall Study|Lost to Follow-up|0
7813273|NCT00420784|27140139|P1|Overall Study|Lost to Follow-up|0
7813274|NCT00420784|27140136|P4|Overall Study|Withdrawal by Subject|0
7813275|NCT00420784|27140137|P3|Overall Study|Withdrawal by Subject|0
7813276|NCT00420784|27140138|P2|Overall Study|Withdrawal by Subject|1
7813277|NCT00420784|27140139|P1|Overall Study|Withdrawal by Subject|0
7813278|NCT00420784|27140136|P4|Overall Study|Adverse Event|5
7813279|NCT00420784|27140137|P3|Overall Study|Adverse Event|10
7813280|NCT00420784|27140138|P2|Overall Study|Adverse Event|29
7813281|NCT00420784|27140139|P1|Overall Study|Adverse Event|11
7813282|NCT00420745|27140177|P2|Overall Study|Age limit exceeded for Dose 2|0
7813283|NCT00420745|27140178|P1|Overall Study|Age limit exceeded for Dose 2|1
7813284|NCT00420745|27140177|P2|Overall Study|Recurrent pneumonia & bronchitis|1
7813285|NCT00420745|27140178|P1|Overall Study|Recurrent pneumonia & bronchitis|0
7813286|NCT00420745|27140177|P2|Overall Study|Physician Decision|1
7813287|NCT00420745|27140178|P1|Overall Study|Physician Decision|1
7813288|NCT00420745|27140177|P2|Overall Study|Protocol Violation|0
7813289|NCT00420745|27140178|P1|Overall Study|Protocol Violation|1
7813290|NCT00420745|27140177|P2|Overall Study|Lost to Follow-up|2
7813291|NCT00420745|27140178|P1|Overall Study|Lost to Follow-up|10
7813292|NCT00420745|27140177|P2|Overall Study|Adverse Event|2
7813293|NCT00420745|27140178|P1|Overall Study|Adverse Event|2
7813294|NCT00420641|27140197|P3|Overall Study|Other|3
7813295|NCT00420641|27140198|P2|Overall Study|Other|4
7813296|NCT00420641|27140199|P1|Overall Study|Other|4
7813297|NCT00420641|27140197|P3|Overall Study|Non-compliance|4
7813298|NCT00420641|27140198|P2|Overall Study|Non-compliance|5
7813299|NCT00420641|27140199|P1|Overall Study|Non-compliance|7
7813300|NCT00420641|27140197|P3|Overall Study|Lack of Efficacy|4
7813301|NCT00420641|27140198|P2|Overall Study|Lack of Efficacy|5
7813302|NCT00420641|27140199|P1|Overall Study|Lack of Efficacy|6
7813303|NCT00420641|27140197|P3|Overall Study|Withdrawal by Subject|14
7813304|NCT00420641|27140198|P2|Overall Study|Withdrawal by Subject|21
7813305|NCT00420641|27140199|P1|Overall Study|Withdrawal by Subject|15
7813306|NCT00420641|27140197|P3|Overall Study|Protocol Violation|7
7813307|NCT00420641|27140198|P2|Overall Study|Protocol Violation|8
7813308|NCT00420641|27140199|P1|Overall Study|Protocol Violation|8
7813309|NCT00420641|27140197|P3|Overall Study|Lost to Follow-up|2
7813310|NCT00420641|27140198|P2|Overall Study|Lost to Follow-up|4
7813311|NCT00420641|27140199|P1|Overall Study|Lost to Follow-up|2
7813312|NCT00420641|27140197|P3|Overall Study|Adverse Event|10
7813313|NCT00420641|27140198|P2|Overall Study|Adverse Event|25
7813314|NCT00420641|27140199|P1|Overall Study|Adverse Event|3
7813315|NCT00420628|27140275|P2|Overall Study|Adverse Event|0
7813316|NCT00420628|27140276|P1|Overall Study|Adverse Event|1
7813317|NCT00420628|27140275|P2|Overall Study|Lost to Follow-up|2
7813318|NCT00420628|27140276|P1|Overall Study|Lost to Follow-up|3
7813319|NCT00420628|27140275|P2|Overall Study|Withdrawn by parent or gaurdian|2
7813320|NCT00420628|27140276|P1|Overall Study|Withdrawn by parent or gaurdian|5
7813321|NCT00420511|27140292|P2|Overall Study|Lost to Follow-up|0
7813322|NCT00420511|27140293|P1|Overall Study|Lost to Follow-up|1
7813323|NCT00420511|27140292|P2|Overall Study|Adverse Event|1
7813324|NCT00420511|27140293|P1|Overall Study|Adverse Event|1
7813325|NCT00420420|27140314|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
7813326|NCT00420420|27140315|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
7813327|NCT00420420|27140314|P2|Overall Study|Withdrawal by Subject|0
7813328|NCT00420420|27140315|P1|Overall Study|Withdrawal by Subject|1
7813329|NCT00420420|27140314|P2|Overall Study|Protocol Violation|1
7813330|NCT00420420|27140315|P1|Overall Study|Protocol Violation|1
7813331|NCT00420420|27140314|P2|Overall Study|Adverse Event|3
7813332|NCT00420420|27140315|P1|Overall Study|Adverse Event|5
7813333|NCT00420407|27140333|P2|Overall Study|Withdrawal by Subject|2
7813334|NCT00420407|27140334|P1|Overall Study|Withdrawal by Subject|0
7813335|NCT00420407|27140333|P2|Overall Study|subject identified as Jehovah's witness|0
7813336|NCT00420407|27140334|P1|Overall Study|subject identified as Jehovah's witness|1
7813337|NCT00420407|27140333|P2|Overall Study|subject identified as detainee|0
7813338|NCT00420407|27140334|P1|Overall Study|subject identified as detainee|1
7813339|NCT00420407|27140333|P2|Overall Study|Physician Decision|1
7813340|NCT00420407|27140334|P1|Overall Study|Physician Decision|2
7813341|NCT00420407|27140333|P2|Overall Study|Lost to Follow-up|3
7813342|NCT00420407|27140334|P1|Overall Study|Lost to Follow-up|0
7813343|NCT00420381|27140341|P1|Overall Study|Protocol Violation|1
7813344|NCT00420342|27140353|P3|Overall Study|Withdrawal by Subject|0
7813345|NCT00420342|27140354|P2|Overall Study|Withdrawal by Subject|2
7813346|NCT00420342|27140355|P1|Overall Study|Withdrawal by Subject|0
7813347|NCT00420342|27140353|P3|Overall Study|Lost to Follow-up|1
7813348|NCT00420342|27140354|P2|Overall Study|Lost to Follow-up|0
7813349|NCT00420342|27140355|P1|Overall Study|Lost to Follow-up|1
7813350|NCT00420316|27140398|P2|Overall Study|Lost to Follow-up|8
7813351|NCT00420316|27140399|P1|Overall Study|Lost to Follow-up|12
7813352|NCT00420316|27140398|P2|Overall Study|Withdrawal by Subject|1
7813353|NCT00420316|27140399|P1|Overall Study|Withdrawal by Subject|0
7813354|NCT00420303|27140423|P2|Overall Study|Physician Decision|1
7813355|NCT00420303|27140424|P1|Overall Study|Physician Decision|0
7813356|NCT00420303|27140423|P2|Overall Study|Lack of Efficacy|3
7813357|NCT00420303|27140424|P1|Overall Study|Lack of Efficacy|0
7813358|NCT00420303|27140423|P2|Overall Study|Serious Adverse Event|0
7813359|NCT00420303|27140424|P1|Overall Study|Serious Adverse Event|1
7813360|NCT00420290|27140436|P2|Overall Study|did not meet inclusion/exclusion|1
7813361|NCT00420290|27140437|P1|Overall Study|did not meet inclusion/exclusion|1
7813362|NCT00420290|27140436|P2|Overall Study|Withdrawal by Subject|2
7813363|NCT00420290|27140437|P1|Overall Study|Withdrawal by Subject|0
7813364|NCT00420290|27140436|P2|Overall Study|Adverse Event|1
7813365|NCT00420290|27140437|P1|Overall Study|Adverse Event|3
7813366|NCT00420238|27140453|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
7813367|NCT00420238|27140454|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
7813368|NCT00420238|27140453|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
7813369|NCT00420238|27140454|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
7813370|NCT00420238|27140453|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
7813371|NCT00420238|27140454|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
7813372|NCT00420238|27140453|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
7813373|NCT00420238|27140454|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
7813374|NCT00420238|27140453|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
7813375|NCT00420238|27140454|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
7813376|NCT00420238|27140453|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
7813377|NCT00420238|27140454|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
7813378|NCT00420212|27140593|P3|Overall Study|Other-Unspecified|18
7813379|NCT00420212|27140594|P2|Overall Study|Other-Unspecified|14
7813380|NCT00420212|27140595|P1|Overall Study|Other-Unspecified|21
7813381|NCT00420212|27140593|P3|Overall Study|Death|1
7813382|NCT00420212|27140594|P2|Overall Study|Death|0
7813383|NCT00420212|27140595|P1|Overall Study|Death|0
7813384|NCT00420212|27140593|P3|Overall Study|Protocol Violation|8
7813385|NCT00420212|27140594|P2|Overall Study|Protocol Violation|4
7813386|NCT00420212|27140595|P1|Overall Study|Protocol Violation|4
7813387|NCT00420212|27140593|P3|Overall Study|Physician Decision|3
7813388|NCT00420212|27140594|P2|Overall Study|Physician Decision|4
7813389|NCT00420212|27140595|P1|Overall Study|Physician Decision|4
7813390|NCT00420212|27140593|P3|Overall Study|Withdrawal by Subject|19
7813391|NCT00420212|27140594|P2|Overall Study|Withdrawal by Subject|22
7813392|NCT00420212|27140595|P1|Overall Study|Withdrawal by Subject|31
7813393|NCT00420212|27140593|P3|Overall Study|Lost to Follow-up|11
7813394|NCT00420212|27140594|P2|Overall Study|Lost to Follow-up|11
7813395|NCT00420212|27140595|P1|Overall Study|Lost to Follow-up|9
7813396|NCT00420212|27140593|P3|Overall Study|Adverse Event|36
7813397|NCT00420212|27140594|P2|Overall Study|Adverse Event|40
7813398|NCT00420212|27140595|P1|Overall Study|Adverse Event|22
7813399|NCT00420199|27140621|P2|Overall Study|Participant no longer met study criteria|0
7813400|NCT00420199|27140622|P1|Overall Study|Participant no longer met study criteria|1
7813401|NCT00420095|27140688|P2|Overall Study|Lost to Follow-up|0
7813402|NCT00420095|27140689|P1|Overall Study|Lost to Follow-up|1
7813403|NCT00420095|27140688|P2|Overall Study|Protocol Violation|1
7813404|NCT00420095|27140689|P1|Overall Study|Protocol Violation|1
7813405|NCT00420095|27140688|P2|Overall Study|Adverse Event|0
7813406|NCT00420095|27140689|P1|Overall Study|Adverse Event|1
7813407|NCT00420056|27140707|P1|Overall Study|Objective progression or relapse|17
7813408|NCT00420004|27140747|P3|Overall Study|Sponsor Decision|1
7813409|NCT00420004|27140748|P2|Overall Study|Sponsor Decision|3
7813410|NCT00420004|27140749|P1|Overall Study|Sponsor Decision|3
7813411|NCT00420004|27140747|P3|Overall Study|Withdrawal by Subject|14
7813412|NCT00420004|27140748|P2|Overall Study|Withdrawal by Subject|42
7813413|NCT00420004|27140749|P1|Overall Study|Withdrawal by Subject|67
7813414|NCT00420004|27140747|P3|Overall Study|Protocol Violation|3
7813415|NCT00420004|27140748|P2|Overall Study|Protocol Violation|4
7813416|NCT00420004|27140749|P1|Overall Study|Protocol Violation|5
7813417|NCT00420004|27140747|P3|Overall Study|Physician Decision|2
7813418|NCT00420004|27140748|P2|Overall Study|Physician Decision|4
7813419|NCT00420004|27140749|P1|Overall Study|Physician Decision|14
7813420|NCT00420004|27140747|P3|Overall Study|Entry Criteria Not Met|0
7813421|NCT00420004|27140748|P2|Overall Study|Entry Criteria Not Met|1
7813422|NCT00420004|27140749|P1|Overall Study|Entry Criteria Not Met|0
7813423|NCT00420004|27140747|P3|Overall Study|Lost to Follow-up|10
7813424|NCT00420004|27140748|P2|Overall Study|Lost to Follow-up|12
7813425|NCT00420004|27140749|P1|Overall Study|Lost to Follow-up|31
7813426|NCT00420004|27140747|P3|Overall Study|Lack of Efficacy|1
7813427|NCT00420004|27140748|P2|Overall Study|Lack of Efficacy|4
7813428|NCT00420004|27140749|P1|Overall Study|Lack of Efficacy|5
7813429|NCT00420004|27140747|P3|Overall Study|Adverse Event|1
7813430|NCT00420004|27140748|P2|Overall Study|Adverse Event|1
7813431|NCT00420004|27140749|P1|Overall Study|Adverse Event|4
7813432|NCT00419952|27140814|P2|Overall Study|Abnormal ECG|0
7813433|NCT00419952|27140815|P1|Overall Study|Abnormal ECG|1
7813434|NCT00419952|27140814|P2|Overall Study|Diary or medication non-compliance|4
7813435|NCT00419952|27140815|P1|Overall Study|Diary or medication non-compliance|2
7813436|NCT00419952|27140814|P2|Overall Study|Occurence of 2 or more exacerbations|0
7813437|NCT00419952|27140815|P1|Overall Study|Occurence of 2 or more exacerbations|2
7813438|NCT00419952|27140814|P2|Overall Study|Intake of prohibited medication|2
7813439|NCT00419952|27140815|P1|Overall Study|Intake of prohibited medication|2
7813440|NCT00419952|27140814|P2|Overall Study|Incorrectly enrolled|3
7813441|NCT00419952|27140815|P1|Overall Study|Incorrectly enrolled|10
7813442|NCT00419952|27140814|P2|Overall Study|Physician Decision|3
7813443|NCT00419952|27140815|P1|Overall Study|Physician Decision|1
7813444|NCT00419952|27140814|P2|Overall Study|Pregnancy|2
7813445|NCT00419952|27140815|P1|Overall Study|Pregnancy|4
7813446|NCT00419952|27140814|P2|Overall Study|Protocol Violation|24
7813447|NCT00419952|27140815|P1|Overall Study|Protocol Violation|32
7813448|NCT00419952|27140814|P2|Overall Study|Lost to Follow-up|34
7813449|NCT00419952|27140815|P1|Overall Study|Lost to Follow-up|43
7813450|NCT00419952|27140814|P2|Overall Study|Withdrawal by Subject|43
7813451|NCT00419952|27140815|P1|Overall Study|Withdrawal by Subject|44
7813452|NCT00419952|27140814|P2|Overall Study|Adverse Event|10
7813453|NCT00419952|27140815|P1|Overall Study|Adverse Event|8
7813454|NCT00419926|27140849|P2|Overall Study|Death|1
7813455|NCT00419926|27140850|P1|Overall Study|Death|2
7813456|NCT00419926|27140849|P2|Overall Study|Lost to Follow-up|2
7813457|NCT00419926|27140850|P1|Overall Study|Lost to Follow-up|1
7813458|NCT00419926|27140849|P2|Overall Study|Administrative Problem|4
7813459|NCT00419926|27140850|P1|Overall Study|Administrative Problem|4
7813460|NCT00419926|27140849|P2|Overall Study|Withdrawal by Subject|3
7813461|NCT00419926|27140850|P1|Overall Study|Withdrawal by Subject|7
7813462|NCT00419770|27140866|P2|Overall Study|Withdrawal by Subject|1
7813463|NCT00419770|27140867|P1|Overall Study|Withdrawal by Subject|5
7813464|NCT00419757|27140875|P2|Overall Study|Multiple reasons|1
7813465|NCT00419757|27140876|P1|Overall Study|Multiple reasons|3
7813466|NCT00419757|27140875|P2|Overall Study|Study specific discontinuation criteria|8
7813467|NCT00419757|27140876|P1|Overall Study|Study specific discontinuation criteria|4
7813468|NCT00419757|27140875|P2|Overall Study|Protocol Violation|3
7813469|NCT00419757|27140876|P1|Overall Study|Protocol Violation|2
7813470|NCT00419757|27140875|P2|Overall Study|Withdrawal by Subject|1
7813471|NCT00419757|27140876|P1|Overall Study|Withdrawal by Subject|7
7813472|NCT00419757|27140875|P2|Overall Study|Lost to Follow-up|4
7813473|NCT00419757|27140876|P1|Overall Study|Lost to Follow-up|1
7813474|NCT00419757|27140875|P2|Overall Study|Adverse Event|4
7813475|NCT00419757|27140876|P1|Overall Study|Adverse Event|1
7813476|NCT00419744|27140915|P3|Overall Study|Incorrect medication kit dispensed|1
7813477|NCT00419744|27140916|P2|Overall Study|Incorrect medication kit dispensed|0
7813478|NCT00419744|27140917|P1|Overall Study|Incorrect medication kit dispensed|0
7813479|NCT00419744|27140915|P3|Overall Study|Spirometry mouthpiece issues|2
7813480|NCT00419744|27140916|P2|Overall Study|Spirometry mouthpiece issues|1
7813481|NCT00419744|27140917|P1|Overall Study|Spirometry mouthpiece issues|0
7813482|NCT00419744|27140915|P3|Overall Study|Physician Decision|6
7813483|NCT00419744|27140916|P2|Overall Study|Physician Decision|5
7813484|NCT00419744|27140917|P1|Overall Study|Physician Decision|10
7813485|NCT00419744|27140915|P3|Overall Study|Moving out of state|1
7813486|NCT00419744|27140916|P2|Overall Study|Moving out of state|0
7813487|NCT00419744|27140917|P1|Overall Study|Moving out of state|2
7813488|NCT00419744|27140915|P3|Overall Study|Randomized in error|7
7813489|NCT00419744|27140916|P2|Overall Study|Randomized in error|6
7813490|NCT00419744|27140917|P1|Overall Study|Randomized in error|9
7813491|NCT00419744|27140915|P3|Overall Study|Protocol Violation|8
7813492|NCT00419744|27140916|P2|Overall Study|Protocol Violation|7
7813493|NCT00419744|27140917|P1|Overall Study|Protocol Violation|4
7813494|NCT00419744|27140915|P3|Overall Study|Lost to Follow-up|6
7813495|NCT00419744|27140916|P2|Overall Study|Lost to Follow-up|10
7813496|NCT00419744|27140917|P1|Overall Study|Lost to Follow-up|8
7813497|NCT00419744|27140915|P3|Overall Study|Withdrawal by Subject|52
7813498|NCT00419744|27140916|P2|Overall Study|Withdrawal by Subject|49
7813499|NCT00419744|27140917|P1|Overall Study|Withdrawal by Subject|45
7813500|NCT00419744|27140915|P3|Overall Study|Adverse Event|50
7813501|NCT00419744|27140916|P2|Overall Study|Adverse Event|40
7813502|NCT00419744|27140917|P1|Overall Study|Adverse Event|39
7813503|NCT00419562|27140960|P2|Overall Study|Participant Institutionalized|0
7813504|NCT00419562|27140961|P1|Overall Study|Participant Institutionalized|1
7813505|NCT00419562|27140960|P2|Overall Study|Withdrawal by Subject|18
7813506|NCT00419562|27140961|P1|Overall Study|Withdrawal by Subject|20
7813507|NCT00419562|27140960|P2|Overall Study|Lost to Follow-up|13
7813508|NCT00419562|27140961|P1|Overall Study|Lost to Follow-up|12
7813509|NCT00419393|27140984|P1|Overall Study|Other: Investigator decision|1
7813510|NCT00419393|27140984|P1|Overall Study|Other: Other health problems|1
7813511|NCT00419393|27140984|P1|Overall Study|Other: Site closure|1
7813512|NCT00419393|27140984|P1|Overall Study|Other: Subject had temporal lobectomy|1
7813513|NCT00419393|27140984|P1|Overall Study|Other: Sponsor request|3
7813514|NCT00419393|27140984|P1|Overall Study|Withdrawal by Subject|7
7813515|NCT00419393|27140984|P1|Overall Study|Protocol Violation|5
7813516|NCT00419393|27140984|P1|Overall Study|Adverse Event|5
7813517|NCT00419380|27140994|P2|Overall Study|Withdrawal by Subject|1
7813518|NCT00419380|27140995|P1|Overall Study|Withdrawal by Subject|0
7813519|NCT00419380|27140994|P2|Overall Study|Lost to Follow-up|1
7813520|NCT00419380|27140995|P1|Overall Study|Lost to Follow-up|0
7813521|NCT00419380|27140994|P2|Overall Study|Physician Decision|1
7813522|NCT00419380|27140995|P1|Overall Study|Physician Decision|0
7813523|NCT00419380|27140994|P2|Overall Study|Lack of Efficacy|7
7813524|NCT00419380|27140995|P1|Overall Study|Lack of Efficacy|1
7813525|NCT00419341|27141003|P1|Efficacy Period|Termination of study site|1
7813526|NCT00419341|27141003|P1|Efficacy Period|Non-compliance|1
7813527|NCT00419341|27141003|P1|Efficacy Period|Lost to Follow-up|1
7813528|NCT00419341|27141003|P1|Efficacy Period|Protocol Violation|1
7813529|NCT00419341|27141003|P1|Efficacy Period|Withdrawal by Subject|6
7813530|NCT00419341|27141003|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
7813531|NCT00419341|27141003|P1|Wash in/Wash Out Period|Adverse Event|2
7813532|NCT00419341|27141003|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
7813533|NCT00419263|27141038|P3|Overall Study|Withdrawal by Subject|1
7813534|NCT00419263|27141039|P2|Overall Study|Withdrawal by Subject|0
7813535|NCT00419263|27141040|P1|Overall Study|Withdrawal by Subject|0
7813536|NCT00419263|27141038|P3|Overall Study|Adverse Event|1
7813537|NCT00419263|27141039|P2|Overall Study|Adverse Event|0
7813538|NCT00419263|27141040|P1|Overall Study|Adverse Event|0
7813539|NCT00419263|27141038|P3|Overall Study|Randomized in Error, Not Treated|0
7813540|NCT00419263|27141039|P2|Overall Study|Randomized in Error, Not Treated|1
7813541|NCT00419263|27141040|P1|Overall Study|Randomized in Error, Not Treated|1
7813542|NCT00419263|27141038|P3|Overall Study|Lost to Follow-up|1
7813543|NCT00419263|27141039|P2|Overall Study|Lost to Follow-up|1
7813544|NCT00419263|27141040|P1|Overall Study|Lost to Follow-up|2
7813545|NCT00419159|27141069|P2|Overall Study|Disease progression|76
7813546|NCT00419159|27141070|P1|Overall Study|Disease progression|79
7813547|NCT00419159|27141069|P2|Overall Study|Death|2
7813548|NCT00419159|27141070|P1|Overall Study|Death|2
7813549|NCT00419159|27141069|P2|Overall Study|Lost to Follow-up|1
7813550|NCT00419159|27141070|P1|Overall Study|Lost to Follow-up|0
7813551|NCT00419159|27141069|P2|Overall Study|Withdrawal by Subject|3
7813552|NCT00419159|27141070|P1|Overall Study|Withdrawal by Subject|10
7813553|NCT00419159|27141069|P2|Overall Study|Protocol Violation|0
7813554|NCT00419159|27141070|P1|Overall Study|Protocol Violation|1
7813555|NCT00419159|27141069|P2|Overall Study|Subject's no longer requires study drug|1
7813556|NCT00419159|27141070|P1|Overall Study|Subject's no longer requires study drug|0
7813557|NCT00419159|27141069|P2|Overall Study|Abnormal laboratory value(s)|2
7813558|NCT00419159|27141070|P1|Overall Study|Abnormal laboratory value(s)|0
7813559|NCT00419159|27141069|P2|Overall Study|Adverse Event|15
7813560|NCT00419159|27141070|P1|Overall Study|Adverse Event|7
7813561|NCT00419120|27141100|P1|Long Term Follow up Period|study ongoing|10
7813562|NCT00419094|27141107|P2|Overall Study|Other: No contact for extended period|1
7813563|NCT00419094|27141108|P1|Overall Study|Other: No contact for extended period|0
7813564|NCT00419094|27141107|P2|Overall Study|Other: Patient non-compliant|1
7813565|NCT00419094|27141108|P1|Overall Study|Other: Patient non-compliant|0
7813566|NCT00419094|27141107|P2|Overall Study|Other: Error determining exit criteria|0
7813567|NCT00419094|27141108|P1|Overall Study|Other: Error determining exit criteria|1
7813568|NCT00419094|27141107|P2|Overall Study|Withdrawal of consent|5
7813569|NCT00419094|27141108|P1|Overall Study|Withdrawal of consent|1
7813570|NCT00419094|27141107|P2|Overall Study|Protocol Violation|14
7813571|NCT00419094|27141108|P1|Overall Study|Protocol Violation|1
7813572|NCT00419094|27141107|P2|Overall Study|Lost to Follow-up|2
7813573|NCT00419094|27141108|P1|Overall Study|Lost to Follow-up|0
7813574|NCT00419094|27141107|P2|Overall Study|Lack of Efficacy|0
7813575|NCT00419094|27141108|P1|Overall Study|Lack of Efficacy|1
7813576|NCT00419094|27141107|P2|Overall Study|Adverse Event|7
7813577|NCT00419094|27141108|P1|Overall Study|Adverse Event|3
7813578|NCT00419003|27141122|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
7813579|NCT00419003|27141123|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
7813580|NCT00419003|27141122|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
7813581|NCT00419003|27141123|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
7813582|NCT00418938|27141177|P2|Overall Study|Ineligibility Determined|0
7813583|NCT00418938|27141178|P1|Overall Study|Ineligibility Determined|1
7813584|NCT00418938|27141177|P2|Overall Study|On-going|1
7813585|NCT00418938|27141178|P1|Overall Study|On-going|1
7813586|NCT00418938|27141177|P2|Overall Study|Adverse Event|1
7813587|NCT00418938|27141178|P1|Overall Study|Adverse Event|1
7813588|NCT00418938|27141177|P2|Overall Study|Lost to Follow-up|3
7813589|NCT00418938|27141178|P1|Overall Study|Lost to Follow-up|1
7813590|NCT00418938|27141177|P2|Overall Study|Withdrawal by Subject|15
7813591|NCT00418938|27141178|P1|Overall Study|Withdrawal by Subject|16
7813592|NCT00418938|27141177|P2|Overall Study|Administrative decision|3
7813593|NCT00418938|27141178|P1|Overall Study|Administrative decision|3
7813594|NCT00418938|27141177|P2|Overall Study|Reimbursement|0
7813595|NCT00418938|27141178|P1|Overall Study|Reimbursement|1
7813596|NCT00418886|27141198|P2|Overall Study|randomised but no treatment received|1
7813597|NCT00418886|27141199|P1|Overall Study|randomised but no treatment received|0
7813598|NCT00418886|27141198|P2|Overall Study|withdrawn due to other reason|0
7813599|NCT00418886|27141199|P1|Overall Study|withdrawn due to other reason|1
7813600|NCT00418886|27141198|P2|Overall Study|Lost to Follow-up|6
7813601|NCT00418886|27141199|P1|Overall Study|Lost to Follow-up|4
7813602|NCT00418886|27141198|P2|Overall Study|Withdrawal by Subject|10
7813603|NCT00418886|27141199|P1|Overall Study|Withdrawal by Subject|9
7813604|NCT00418886|27141198|P2|Overall Study|Death|147
7813605|NCT00418886|27141199|P1|Overall Study|Death|122
7813606|NCT00418886|27141198|P2|Overall Study|discontinue treatment survival follow up|91
7813607|NCT00418886|27141199|P1|Overall Study|discontinue treatment survival follow up|90
7813608|NCT00418834|27141225|P2|Overall Study|Withdrawal by Subject|7
7813609|NCT00418834|27141226|P1|Overall Study|Withdrawal by Subject|3
7813610|NCT00418834|27141225|P2|Overall Study|Protocol Violation|3
7813611|NCT00418834|27141226|P1|Overall Study|Protocol Violation|4
7813612|NCT00418834|27141225|P2|Overall Study|Lost to Follow-up|1
7813613|NCT00418834|27141226|P1|Overall Study|Lost to Follow-up|0
7813614|NCT00418834|27141225|P2|Overall Study|Adverse Event|9
7813615|NCT00418834|27141226|P1|Overall Study|Adverse Event|16
7813616|NCT00418717|27141286|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
7813617|NCT00418717|27141286|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
7813618|NCT00418691|27141294|P3|Overall Study|Progressive Disease|1
7813619|NCT00418691|27141295|P2|Overall Study|Progressive Disease|0
7813620|NCT00418691|27141296|P1|Overall Study|Progressive Disease|1
7813621|NCT00418691|27141294|P3|Overall Study|Started new medication voiding entry|1
7813622|NCT00418691|27141295|P2|Overall Study|Started new medication voiding entry|0
7813623|NCT00418691|27141296|P1|Overall Study|Started new medication voiding entry|0
7813624|NCT00418691|27141294|P3|Overall Study|Lost to Follow-up|3
7813625|NCT00418691|27141295|P2|Overall Study|Lost to Follow-up|2
7813626|NCT00418691|27141296|P1|Overall Study|Lost to Follow-up|1
7813627|NCT00418665|27141307|P3|Treatment Extension|Death|1
7813628|NCT00418665|27141308|P2|Treatment Extension|Death|0
7813629|NCT00418665|27141309|P1|Treatment Extension|Death|0
7813630|NCT00418665|27141307|P3|Treatment Extension|Physician Decision|1
7813631|NCT00418665|27141308|P2|Treatment Extension|Physician Decision|2
7813632|NCT00418665|27141309|P1|Treatment Extension|Physician Decision|2
7813633|NCT00418665|27141307|P3|Treatment Extension|Requirement for alternative therapy|0
7813634|NCT00418665|27141308|P2|Treatment Extension|Requirement for alternative therapy|2
7813635|NCT00418665|27141309|P1|Treatment Extension|Requirement for alternative therapy|2
7813636|NCT00418665|27141307|P3|Treatment Extension|Withdrawal by Subject|0
7813637|NCT00418665|27141308|P2|Treatment Extension|Withdrawal by Subject|0
7813638|NCT00418665|27141309|P1|Treatment Extension|Withdrawal by Subject|1
7813639|NCT00418665|27141307|P3|Treatment Extension|Adverse Event|0
7813640|NCT00418665|27141308|P2|Treatment Extension|Adverse Event|0
7813641|NCT00418665|27141309|P1|Treatment Extension|Adverse Event|1
7813642|NCT00418665|27141307|P3|Treatment Period|Physician Decision|3
7813643|NCT00418665|27141308|P2|Treatment Period|Physician Decision|0
7813644|NCT00418665|27141309|P1|Treatment Period|Physician Decision|1
7813645|NCT00418665|27141307|P3|Treatment Period|Requirement for alternative therapy|0
7813646|NCT00418665|27141308|P2|Treatment Period|Requirement for alternative therapy|0
7813647|NCT00418665|27141309|P1|Treatment Period|Requirement for alternative therapy|1
7813648|NCT00418665|27141307|P3|Treatment Period|Withdrawal by Subject|1
7813649|NCT00418665|27141308|P2|Treatment Period|Withdrawal by Subject|3
7813650|NCT00418665|27141309|P1|Treatment Period|Withdrawal by Subject|0
7813651|NCT00418665|27141307|P3|Treatment Period|Adverse Event|0
7813652|NCT00418665|27141308|P2|Treatment Period|Adverse Event|2
7813653|NCT00418665|27141309|P1|Treatment Period|Adverse Event|2
7813654|NCT00418665|27141307|P3|Treatment Period|Ineligibility determined|0
7813655|NCT00418665|27141308|P2|Treatment Period|Ineligibility determined|1
7813656|NCT00418665|27141309|P1|Treatment Period|Ineligibility determined|1
7813657|NCT00418561|27141343|P3|Overall Study|Participant's (guardian's) decision|0
7813658|NCT00418561|27141344|P2|Overall Study|Participant's (guardian's) decision|1
7813659|NCT00418561|27141345|P1|Overall Study|Participant's (guardian's) decision|0
7813660|NCT00418522|27141415|P2|Overall Study|Randomized but did not receive treatment|4
7813661|NCT00418522|27141416|P1|Overall Study|Randomized but did not receive treatment|7
7813662|NCT00418522|27141415|P2|Overall Study|Other|23
7813663|NCT00418522|27141416|P1|Overall Study|Other|27
7813664|NCT00418522|27141415|P2|Overall Study|Withdrawal by Subject|7
7813665|NCT00418522|27141416|P1|Overall Study|Withdrawal by Subject|31
7813666|NCT00418522|27141415|P2|Overall Study|Lost to Follow-up|4
7813667|NCT00418522|27141416|P1|Overall Study|Lost to Follow-up|10
7813668|NCT00418522|27141415|P2|Overall Study|Lack of Efficacy|3
7813669|NCT00418522|27141416|P1|Overall Study|Lack of Efficacy|1
7813670|NCT00418522|27141415|P2|Overall Study|Adverse Event|1
7813671|NCT00418522|27141416|P1|Overall Study|Adverse Event|7
7813672|NCT00418379|27141480|P3|Year 5|Any other reason not above-mentioned|3
7813673|NCT00418379|27141481|P2|Year 5|Any other reason not above-mentioned|4
7813674|NCT00418379|27141482|P1|Year 5|Any other reason not above-mentioned|2
7813675|NCT00418379|27141480|P3|Year 5|Adverse Event|0
7813676|NCT00418379|27141481|P2|Year 5|Adverse Event|1
7813677|NCT00418379|27141482|P1|Year 5|Adverse Event|0
7813678|NCT00418379|27141480|P3|Year 4|Any other reason not above-mentioned|0
7813679|NCT00418379|27141481|P2|Year 4|Any other reason not above-mentioned|1
7813680|NCT00418379|27141482|P1|Year 4|Any other reason not above-mentioned|1
7813681|NCT00418379|27141480|P3|Year 4|Withdrawal by Subject|2
7813682|NCT00418379|27141481|P2|Year 4|Withdrawal by Subject|3
7813683|NCT00418379|27141482|P1|Year 4|Withdrawal by Subject|2
7813684|NCT00418379|27141480|P3|Year 4|Adverse Event|0
7813685|NCT00418379|27141481|P2|Year 4|Adverse Event|1
7813686|NCT00418379|27141482|P1|Year 4|Adverse Event|0
7813687|NCT00418379|27141480|P3|Year 3|Any other reason not above-mentioned|1
7813688|NCT00418379|27141481|P2|Year 3|Any other reason not above-mentioned|1
7813689|NCT00418379|27141482|P1|Year 3|Any other reason not above-mentioned|2
7813690|NCT00418379|27141480|P3|Year 3|Withdrawal by Subject|2
7813691|NCT00418379|27141481|P2|Year 3|Withdrawal by Subject|1
7813692|NCT00418379|27141482|P1|Year 3|Withdrawal by Subject|1
7813693|NCT00418379|27141480|P3|Year 2|Any other reason not above-mentioned|6
7813694|NCT00418379|27141481|P2|Year 2|Any other reason not above-mentioned|1
7813695|NCT00418379|27141482|P1|Year 2|Any other reason not above-mentioned|2
7813696|NCT00418379|27141480|P3|Year 2|Withdrawal by Subject|3
7813697|NCT00418379|27141481|P2|Year 2|Withdrawal by Subject|1
7813698|NCT00418379|27141482|P1|Year 2|Withdrawal by Subject|1
7813699|NCT00418379|27141480|P3|Year 2|Adverse Event|1
7813700|NCT00418379|27141481|P2|Year 2|Adverse Event|2
7813701|NCT00418379|27141482|P1|Year 2|Adverse Event|5
7813702|NCT00418379|27141480|P3|Year 1|Any other reason not above-mentioned|7
7813703|NCT00418379|27141481|P2|Year 1|Any other reason not above-mentioned|5
7813704|NCT00418379|27141482|P1|Year 1|Any other reason not above-mentioned|2
7813705|NCT00418379|27141480|P3|Year 1|Withdrawal by Subject|5
7813706|NCT00418379|27141481|P2|Year 1|Withdrawal by Subject|8
7813707|NCT00418379|27141482|P1|Year 1|Withdrawal by Subject|7
7813708|NCT00418379|27141480|P3|Year 1|Adverse Event|3
7813709|NCT00418379|27141481|P2|Year 1|Adverse Event|15
7813710|NCT00418379|27141482|P1|Year 1|Adverse Event|9
7813711|NCT00418314|27141492|P2|Overall Study|Withdrawal by Subject|2
7813712|NCT00418314|27141493|P1|Overall Study|Withdrawal by Subject|1
7813713|NCT00418184|27141528|P2|Double-blind Phase|Poor compliance|1
7813714|NCT00418184|27141529|P1|Double-blind Phase|Poor compliance|3
7813715|NCT00418184|27141528|P2|Double-blind Phase|Adverse Event|1
7813716|NCT00418184|27141529|P1|Double-blind Phase|Adverse Event|2
7813717|NCT00418184|27141528|P2|Double-blind Phase|Withdrawal by Subject|9
7813718|NCT00418184|27141529|P1|Double-blind Phase|Withdrawal by Subject|22
7813719|NCT00418145|27141537|P1|Overall Study|study terminated|6
7813720|NCT00417989|27141612|P2|Overall Study|Physician Decision|2
7813721|NCT00417989|27141613|P1|Overall Study|Physician Decision|5
7813722|NCT00417989|27141612|P2|Overall Study|Death|1
7813723|NCT00417989|27141613|P1|Overall Study|Death|0
7813724|NCT00417989|27141612|P2|Overall Study|Protocol Violation|0
7813725|NCT00417989|27141613|P1|Overall Study|Protocol Violation|1
7813726|NCT00417989|27141612|P2|Overall Study|Lost to Follow-up|6
7813727|NCT00417989|27141613|P1|Overall Study|Lost to Follow-up|1
7813728|NCT00417989|27141612|P2|Overall Study|Withdrawal by Subject|13
7813729|NCT00417989|27141613|P1|Overall Study|Withdrawal by Subject|13
7813730|NCT00417976|27141635|P1|Overall Study|Treatment -related toxicity|2
7813731|NCT00417976|27141635|P1|Overall Study|Non compliance unrelated to toxicity|1
7813732|NCT00417963|27141640|P1|Overall Study|Study device could not be deployed|3
7813733|NCT00417963|27141640|P1|Overall Study|Death|17
7813734|NCT00417963|27141640|P1|Overall Study|Withdrawal by Subject|18
7813735|NCT00417963|27141640|P1|Overall Study|Lost to Follow-up|3
7813736|NCT00417885|27141657|P1|Overall Study|Transferred to Another Sunitinib Study|2
7813737|NCT00417885|27141657|P1|Overall Study|Objective Progression or Relapse|3
7813738|NCT00417885|27141657|P1|Overall Study|Adverse Event|1
7813739|NCT00417612|27141683|P2|Overall Study|Lost to Follow-up|0
7813740|NCT00417612|27141684|P1|Overall Study|Lost to Follow-up|1
7813741|NCT00417612|27141683|P2|Overall Study|Protocol Violation|2
7813742|NCT00417612|27141684|P1|Overall Study|Protocol Violation|0
7813743|NCT00417612|27141683|P2|Overall Study|Adverse Event|0
7813744|NCT00417612|27141684|P1|Overall Study|Adverse Event|2
7813745|NCT00417612|27141683|P2|Overall Study|Errant diagnosis|1
7813746|NCT00417612|27141684|P1|Overall Study|Errant diagnosis|0
7813747|NCT00417482|27141710|P3|Phase B 2nd 16 Weeks|Death|0
7813748|NCT00417482|27141711|P2|Phase B 2nd 16 Weeks|Death|1
7813749|NCT00417482|27141712|P1|Phase B 2nd 16 Weeks|Death|1
7813750|NCT00417482|27141710|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
7813751|NCT00417482|27141711|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
7813752|NCT00417482|27141712|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
7813753|NCT00417482|27141710|P3|Phase B 2nd 16 Weeks|Adverse Event|1
7813754|NCT00417482|27141711|P2|Phase B 2nd 16 Weeks|Adverse Event|0
7813755|NCT00417482|27141712|P1|Phase B 2nd 16 Weeks|Adverse Event|0
7813756|NCT00417482|27141710|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
7813757|NCT00417482|27141711|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
7813758|NCT00417482|27141712|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
7813759|NCT00417482|27141710|P3|Phase B 1st 16 Weeks|Death|0
7813760|NCT00417482|27141711|P2|Phase B 1st 16 Weeks|Death|0
7813761|NCT00417482|27141712|P1|Phase B 1st 16 Weeks|Death|1
7813762|NCT00417482|27141710|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
7813763|NCT00417482|27141711|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
7813764|NCT00417482|27141712|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
7813765|NCT00417482|27141710|P3|Phase B 1st 16 Weeks|Adverse Event|1
7813766|NCT00417482|27141711|P2|Phase B 1st 16 Weeks|Adverse Event|0
7813767|NCT00417482|27141712|P1|Phase B 1st 16 Weeks|Adverse Event|2
7813768|NCT00417482|27141710|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
7813769|NCT00417482|27141711|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
7813770|NCT00417482|27141712|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
7813771|NCT00417248|27141751|P1|Overall Study|Lack of Efficacy|1
7813772|NCT00417248|27141751|P1|Overall Study|Death|1
7813773|NCT00417248|27141751|P1|Overall Study|Study Terminated|6
7813774|NCT00417170|27141758|P2|Overall Study|Lost to Follow-up|1
7813775|NCT00417170|27141759|P1|Overall Study|Lost to Follow-up|0
7813776|NCT00417170|27141758|P2|Overall Study|Withdrawal by Subject|1
7813777|NCT00417170|27141759|P1|Overall Study|Withdrawal by Subject|1
7813778|NCT00417170|27141758|P2|Overall Study|Adverse Event|1
7813779|NCT00417170|27141759|P1|Overall Study|Adverse Event|1
7813780|NCT00417079|27141775|P2|Overall Study|abnormal liver function tests|1
7813781|NCT00417079|27141776|P1|Overall Study|abnormal liver function tests|0
7813782|NCT00417079|27141775|P2|Overall Study|Patient unable to come to the clinic|1
7813783|NCT00417079|27141776|P1|Overall Study|Patient unable to come to the clinic|0
7813784|NCT00417079|27141775|P2|Overall Study|Withdrawal by subject's family|1
7813785|NCT00417079|27141776|P1|Overall Study|Withdrawal by subject's family|0
7813786|NCT00417079|27141775|P2|Overall Study|Screening error|1
7813787|NCT00417079|27141776|P1|Overall Study|Screening error|2
7813788|NCT00417079|27141775|P2|Overall Study|Clinical deterioration|0
7813789|NCT00417079|27141776|P1|Overall Study|Clinical deterioration|1
7813790|NCT00417079|27141775|P2|Overall Study|Non-confirmed Disease progression|1
7813791|NCT00417079|27141776|P1|Overall Study|Non-confirmed Disease progression|1
7813792|NCT00417079|27141775|P2|Overall Study|Investigator's decision|4
7813793|NCT00417079|27141776|P1|Overall Study|Investigator's decision|1
7813794|NCT00417079|27141775|P2|Overall Study|Screened failure|1
7813795|NCT00417079|27141776|P1|Overall Study|Screened failure|2
7813796|NCT00417079|27141775|P2|Overall Study|Not treated|7
7813797|NCT00417079|27141776|P1|Overall Study|Not treated|6
7813798|NCT00417079|27141775|P2|Overall Study|Withdrawal by Subject|8
7813799|NCT00417079|27141776|P1|Overall Study|Withdrawal by Subject|17
7813800|NCT00417079|27141775|P2|Overall Study|Lost to Follow-up|0
7813801|NCT00417079|27141776|P1|Overall Study|Lost to Follow-up|2
7813802|NCT00417079|27141775|P2|Overall Study|Non-compliance to protocol|1
7813803|NCT00417079|27141776|P1|Overall Study|Non-compliance to protocol|0
7813804|NCT00417079|27141775|P2|Overall Study|Adverse Event|67
7813805|NCT00417079|27141776|P1|Overall Study|Adverse Event|32
7813806|NCT00417079|27141775|P2|Overall Study|Disease progression|180
7813807|NCT00417079|27141776|P1|Overall Study|Disease progression|267
7813808|NCT00417027|27141799|P3|Overall Study|Protocol Violation|5
7813809|NCT00417027|27141800|P2|Overall Study|Protocol Violation|5
7813810|NCT00417027|27141801|P1|Overall Study|Protocol Violation|0
7813811|NCT00416949|27141827|P1|Overall Study|Patients refused to participate|5
7813812|NCT00416884|27141831|P1|Overall Study|Study terminated due to low accrual|1
7813813|NCT00416715|27141840|P1|Overall Study|Vitamin D levels not evaluable|8
7813814|NCT00416715|27141840|P1|Overall Study|Not evaluable for joint aches|7
7813815|NCT00416624|27141851|P4|Overall Study|Cancel|0
7813816|NCT00416624|27141852|P3|Overall Study|Cancel|0
7813817|NCT00416624|27141853|P2|Overall Study|Cancel|0
7813818|NCT00416624|27141854|P1|Overall Study|Cancel|1
7813819|NCT00416624|27141851|P4|Overall Study|Other|5
7813820|NCT00416624|27141852|P3|Overall Study|Other|5
7813821|NCT00416624|27141853|P2|Overall Study|Other|11
7813822|NCT00416624|27141854|P1|Overall Study|Other|8
7813823|NCT00416624|27141851|P4|Overall Study|Adverse Event|2
7813824|NCT00416624|27141852|P3|Overall Study|Adverse Event|2
7813825|NCT00416624|27141853|P2|Overall Study|Adverse Event|3
7813826|NCT00416624|27141854|P1|Overall Study|Adverse Event|8
7813827|NCT00416624|27141851|P4|Overall Study|Death|1
7813828|NCT00416624|27141852|P3|Overall Study|Death|7
7813829|NCT00416624|27141853|P2|Overall Study|Death|7
7813830|NCT00416624|27141854|P1|Overall Study|Death|4
7813831|NCT00416624|27141851|P4|Overall Study|Withdrawal by Subject|9
7813832|NCT00416624|27141852|P3|Overall Study|Withdrawal by Subject|4
7813833|NCT00416624|27141853|P2|Overall Study|Withdrawal by Subject|6
7813834|NCT00416624|27141854|P1|Overall Study|Withdrawal by Subject|1
7813835|NCT00416598|27141908|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
7813836|NCT00416598|27141908|P1|Decitabine Maintenance|Alternative treatment|2
7813837|NCT00416598|27141908|P1|Decitabine Maintenance|Progression/relapse|38
7813838|NCT00416598|27141908|P1|Decitabine Maintenance|Withdrawal by Subject|18
7813839|NCT00416598|27141908|P1|Decitabine Maintenance|Adverse Event|5
7813840|NCT00416598|27141908|P1|Induction & Intensification|Failed induction|87
7813841|NCT00416598|27141908|P1|Induction & Intensification|Relapse/progression|29
7813842|NCT00416598|27141908|P1|Induction & Intensification|Physician discretion/other medical issue|45
7813843|NCT00416598|27141908|P1|Induction & Intensification|Alternative Treatment|135
7813844|NCT00416598|27141908|P1|Induction & Intensification|Withdrawal by Subject|46
7813845|NCT00416598|27141908|P1|Induction & Intensification|Death|32
7813846|NCT00416598|27141908|P1|Induction & Intensification|Adverse Event|38
7813847|NCT00416520|27141934|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
7813848|NCT00416520|27141935|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
7813849|NCT00416520|27141936|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
7813850|NCT00416520|27141937|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
7813851|NCT00416520|27141934|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
7813852|NCT00416520|27141935|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7813853|NCT00416520|27141936|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7813854|NCT00416520|27141937|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7813855|NCT00416520|27141934|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
7813856|NCT00416520|27141935|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
7813857|NCT00416520|27141936|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
7813858|NCT00416520|27141937|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
7813859|NCT00416520|27141934|P4|Open-label Period|Other Reasons|0
7813860|NCT00416520|27141935|P3|Open-label Period|Other Reasons|0
7813861|NCT00416520|27141936|P2|Open-label Period|Other Reasons|12
7813862|NCT00416520|27141937|P1|Open-label Period|Other Reasons|3
7813863|NCT00416520|27141934|P4|Open-label Period|Withdrawal by Subject|0
7813864|NCT00416520|27141935|P3|Open-label Period|Withdrawal by Subject|0
7813865|NCT00416520|27141936|P2|Open-label Period|Withdrawal by Subject|5
7813866|NCT00416520|27141937|P1|Open-label Period|Withdrawal by Subject|16
7813867|NCT00416520|27141934|P4|Open-label Period|Protocol Violation|0
7813868|NCT00416520|27141935|P3|Open-label Period|Protocol Violation|0
7813869|NCT00416520|27141936|P2|Open-label Period|Protocol Violation|3
7813870|NCT00416520|27141937|P1|Open-label Period|Protocol Violation|3
7813871|NCT00416520|27141934|P4|Open-label Period|Lack of Efficacy|0
7813872|NCT00416520|27141935|P3|Open-label Period|Lack of Efficacy|0
7813873|NCT00416520|27141936|P2|Open-label Period|Lack of Efficacy|1
7813874|NCT00416520|27141937|P1|Open-label Period|Lack of Efficacy|8
7813875|NCT00416520|27141934|P4|Open-label Period|Death|0
7813876|NCT00416520|27141935|P3|Open-label Period|Death|0
7813877|NCT00416520|27141936|P2|Open-label Period|Death|1
7813878|NCT00416520|27141937|P1|Open-label Period|Death|2
7813879|NCT00416520|27141934|P4|Open-label Period|Adverse Event|0
7813880|NCT00416520|27141935|P3|Open-label Period|Adverse Event|0
7813881|NCT00416520|27141936|P2|Open-label Period|Adverse Event|10
7813882|NCT00416520|27141937|P1|Open-label Period|Adverse Event|28
7813883|NCT00416455|27141966|P2|Overall Study|Inadequate pathology|2
7813884|NCT00416455|27141967|P1|Overall Study|Inadequate pathology|11
7813885|NCT00416455|27141966|P2|Overall Study|PET / CT poor quality|1
7813886|NCT00416455|27141967|P1|Overall Study|PET / CT poor quality|2
7813887|NCT00416455|27141966|P2|Overall Study|PET / CT not done|5
7813888|NCT00416455|27141967|P1|Overall Study|PET / CT not done|3
7813889|NCT00416312|27142002|P1|Overall Study|tumors not visible on imaging|2
7813890|NCT00416195|27142008|P2|Overall Study|Other|1
7813891|NCT00416195|27142009|P1|Overall Study|Other|0
7813892|NCT00416195|27142008|P2|Overall Study|Protocol Violation|1
7813893|NCT00416195|27142009|P1|Overall Study|Protocol Violation|1
7813894|NCT00416195|27142008|P2|Overall Study|Adverse Event|2
7813895|NCT00416195|27142009|P1|Overall Study|Adverse Event|1
7813896|NCT00416078|27142034|P2|Overall Study|Lost to Follow-up|2
7813897|NCT00416078|27142035|P1|Overall Study|Lost to Follow-up|4
7813898|NCT00416078|27142034|P2|Overall Study|Physician Decision|0
7813899|NCT00416078|27142035|P1|Overall Study|Physician Decision|1
7813900|NCT00416078|27142034|P2|Overall Study|Withdrawal by Subject|2
7813901|NCT00416078|27142035|P1|Overall Study|Withdrawal by Subject|3
7813902|NCT00416078|27142034|P2|Overall Study|Death|4
7813903|NCT00416078|27142035|P1|Overall Study|Death|3
7813904|NCT00415909|27142051|P1|Overall Study|Death|1
7813905|NCT00415909|27142051|P1|Overall Study|Withdrawal by Subject|2
7813906|NCT00415636|27142085|P6|Overall Study|Disease progression|1
7813907|NCT00415636|27142086|P5|Overall Study|Disease progression|0
7813908|NCT00415636|27142087|P4|Overall Study|Disease progression|3
7813909|NCT00415636|27142088|P3|Overall Study|Disease progression|0
7813910|NCT00415636|27142089|P2|Overall Study|Disease progression|0
7813911|NCT00415636|27142090|P1|Overall Study|Disease progression|0
7813912|NCT00415636|27142085|P6|Overall Study|Withdrawal by Subject|0
7813913|NCT00415636|27142086|P5|Overall Study|Withdrawal by Subject|1
7813914|NCT00415636|27142087|P4|Overall Study|Withdrawal by Subject|0
7813915|NCT00415636|27142088|P3|Overall Study|Withdrawal by Subject|0
7813916|NCT00415636|27142089|P2|Overall Study|Withdrawal by Subject|0
7813917|NCT00415636|27142090|P1|Overall Study|Withdrawal by Subject|0
7813918|NCT00415636|27142085|P6|Overall Study|Adverse Event|0
7813919|NCT00415636|27142086|P5|Overall Study|Adverse Event|1
7813920|NCT00415636|27142087|P4|Overall Study|Adverse Event|1
7813921|NCT00415636|27142088|P3|Overall Study|Adverse Event|0
7813922|NCT00415636|27142089|P2|Overall Study|Adverse Event|0
7813923|NCT00415636|27142090|P1|Overall Study|Adverse Event|0
7813924|NCT00415636|27142085|P6|Overall Study|Symptomatic deterioration|1
7813925|NCT00415636|27142086|P5|Overall Study|Symptomatic deterioration|0
7813926|NCT00415636|27142087|P4|Overall Study|Symptomatic deterioration|2
7813927|NCT00415636|27142088|P3|Overall Study|Symptomatic deterioration|1
7813928|NCT00415636|27142089|P2|Overall Study|Symptomatic deterioration|0
7813929|NCT00415636|27142090|P1|Overall Study|Symptomatic deterioration|1
7813930|NCT00415623|27142124|P2|Overall Study|Withdrawal by Subject|1
7813931|NCT00415623|27142125|P1|Overall Study|Withdrawal by Subject|1
7813932|NCT00415623|27142124|P2|Overall Study|Death|0
7813933|NCT00415623|27142125|P1|Overall Study|Death|1
7813934|NCT00415623|27142124|P2|Overall Study|Adverse Event|4
7813935|NCT00415623|27142125|P1|Overall Study|Adverse Event|3
7813936|NCT00415610|27142152|P3|Overall Study|Death|5
7813937|NCT00415610|27142153|P2|Overall Study|Death|2
7813938|NCT00415610|27142154|P1|Overall Study|Death|3
7813939|NCT00415597|27142174|P1|Treatment|Multiple Reasons|1
7813940|NCT00415597|27142174|P1|Treatment|Sponsor Decision|1
7813941|NCT00415597|27142174|P1|Treatment|Administrative|3
7813942|NCT00415597|27142174|P1|Treatment|Drug Screen|2
7813943|NCT00415597|27142174|P1|Treatment|Lost to Follow-up|28
7813944|NCT00415597|27142174|P1|Treatment|Withdrawal by Subject|51
7813945|NCT00415597|27142174|P1|Treatment|Physician Decision|3
7813946|NCT00415597|27142174|P1|Treatment|Protocol Violation|67
7813947|NCT00415597|27142174|P1|Treatment|Lack of Efficacy|39
7813948|NCT00415597|27142174|P1|Treatment|Adverse Event|110
7813949|NCT00415597|27142174|P1|Enrollment|Protocol Violation|1
7813950|NCT00415597|27142174|P1|Enrollment|Withdrawal by Subject|1
7813951|NCT00415532|27142182|P2|Safety Follow Up Period|Requirement for alternative therapy|1
7813952|NCT00415532|27142183|P1|Safety Follow Up Period|Requirement for alternative therapy|0
7813953|NCT00415532|27142182|P2|Safety Follow Up Period|Noncompliance|0
7813954|NCT00415532|27142183|P1|Safety Follow Up Period|Noncompliance|1
7813955|NCT00415532|27142182|P2|Safety Follow Up Period|Ineligibility determined|1
7813956|NCT00415532|27142183|P1|Safety Follow Up Period|Ineligibility determined|1
7813957|NCT00415532|27142182|P2|Safety Follow Up Period|Other|4
7813958|NCT00415532|27142183|P1|Safety Follow Up Period|Other|1
7813959|NCT00415532|27142182|P2|Safety Follow Up Period|Withdrawal by Subject|3
7813960|NCT00415532|27142183|P1|Safety Follow Up Period|Withdrawal by Subject|2
7813961|NCT00415532|27142182|P2|Safety Follow Up Period|Death|0
7813962|NCT00415532|27142183|P1|Safety Follow Up Period|Death|3
7813963|NCT00415532|27142182|P2|Safety Follow Up Period|Adverse Event|3
7813964|NCT00415532|27142183|P1|Safety Follow Up Period|Adverse Event|1
7813965|NCT00415532|27142182|P2|Treatment Period|Requirement for alternative therapy|0
7813966|NCT00415532|27142183|P1|Treatment Period|Requirement for alternative therapy|1
7813967|NCT00415532|27142182|P2|Treatment Period|Noncompliance|1
7813968|NCT00415532|27142183|P1|Treatment Period|Noncompliance|1
7813969|NCT00415532|27142182|P2|Treatment Period|Ineligibility determined|1
7813970|NCT00415532|27142183|P1|Treatment Period|Ineligibility determined|1
7813971|NCT00415532|27142182|P2|Treatment Period|Other|2
7813972|NCT00415532|27142183|P1|Treatment Period|Other|2
7813973|NCT00415532|27142182|P2|Treatment Period|Withdrawal by Subject|6
7813974|NCT00415532|27142183|P1|Treatment Period|Withdrawal by Subject|6
7813975|NCT00415532|27142182|P2|Treatment Period|Protocol Violation|0
7813976|NCT00415532|27142183|P1|Treatment Period|Protocol Violation|1
7813977|NCT00415532|27142182|P2|Treatment Period|Lost to Follow-up|1
7813978|NCT00415532|27142183|P1|Treatment Period|Lost to Follow-up|1
7813979|NCT00415532|27142182|P2|Treatment Period|Death|1
7813980|NCT00415532|27142183|P1|Treatment Period|Death|2
7813981|NCT00415532|27142182|P2|Treatment Period|Adverse Event|3
7813982|NCT00415532|27142183|P1|Treatment Period|Adverse Event|2
7813983|NCT00415519|27142205|P2|Overall Study|Patient's convenience|0
7813984|NCT00415519|27142206|P1|Overall Study|Patient's convenience|1
7813985|NCT00415519|27142205|P2|Overall Study|Withdrawal by Subject|0
7813986|NCT00415519|27142206|P1|Overall Study|Withdrawal by Subject|2
7813987|NCT00415519|27142205|P2|Overall Study|Adverse Event|0
7813988|NCT00415519|27142206|P1|Overall Study|Adverse Event|1
7813989|NCT00415363|27142246|P2|Overall Study|Progressive disease|32
7813990|NCT00415363|27142247|P1|Overall Study|Progressive disease|26
7813991|NCT00415363|27142246|P2|Overall Study|Death|12
7813992|NCT00415363|27142247|P1|Overall Study|Death|16
7813993|NCT00415363|27142246|P2|Overall Study|Physician Decision|1
7813994|NCT00415363|27142247|P1|Overall Study|Physician Decision|3
7813995|NCT00415363|27142246|P2|Overall Study|Lost to Follow-up|1
7813996|NCT00415363|27142247|P1|Overall Study|Lost to Follow-up|2
7813997|NCT00415363|27142246|P2|Overall Study|Adverse Event|4
7813998|NCT00415363|27142247|P1|Overall Study|Adverse Event|4
7813999|NCT00415363|27142246|P2|Overall Study|Withdrawal by Subject|4
7814000|NCT00415363|27142247|P1|Overall Study|Withdrawal by Subject|4
7814001|NCT00415194|27142277|P2|Overall Study|Death Due to AE (Other Causes)|15
7814002|NCT00415194|27142278|P1|Overall Study|Death Due to AE (Other Causes)|27
7814003|NCT00415194|27142277|P2|Overall Study|Death Due to Procedural Related AE|1
7814004|NCT00415194|27142278|P1|Overall Study|Death Due to Procedural Related AE|0
7814005|NCT00415194|27142277|P2|Overall Study|Death Due to Study Drug Related AE|1
7814006|NCT00415194|27142278|P1|Overall Study|Death Due to Study Drug Related AE|11
7814007|NCT00415194|27142277|P2|Overall Study|Death Due to Study Disease|29
7814008|NCT00415194|27142278|P1|Overall Study|Death Due to Study Disease|26
7814009|NCT00415194|27142277|P2|Overall Study|Withdrawal by Subject|21
7814010|NCT00415194|27142278|P1|Overall Study|Withdrawal by Subject|28
7814011|NCT00415194|27142277|P2|Overall Study|Protocol Violation|2
7814012|NCT00415194|27142278|P1|Overall Study|Protocol Violation|4
7814013|NCT00415194|27142277|P2|Overall Study|Progressive Disease|217
7814014|NCT00415194|27142278|P1|Overall Study|Progressive Disease|180
7814015|NCT00415194|27142277|P2|Overall Study|Physician Decision|16
7814016|NCT00415194|27142278|P1|Overall Study|Physician Decision|10
7814017|NCT00415194|27142277|P2|Overall Study|Lost to Follow-up|0
7814018|NCT00415194|27142278|P1|Overall Study|Lost to Follow-up|1
7814019|NCT00415194|27142277|P2|Overall Study|Entry Criteria Not Met|8
7814020|NCT00415194|27142278|P1|Overall Study|Entry Criteria Not Met|4
7814021|NCT00415194|27142277|P2|Overall Study|Adverse Event|32
7814022|NCT00415194|27142278|P1|Overall Study|Adverse Event|37
7814023|NCT00415168|27142294|P1|Overall Study|Withdrawal by Subject|6
7814024|NCT00415168|27142294|P1|Overall Study|Sponsor Decision|4
7814025|NCT00415168|27142294|P1|Overall Study|Physician Decision|13
7814026|NCT00415168|27142294|P1|Overall Study|Lost to Follow-up|3
7814027|NCT00415168|27142294|P1|Overall Study|Death|26
7814028|NCT00415051|27142304|P1|Overall Study|Protocol Violation|1
7814029|NCT00414973|27142315|P4|Overall Study|Death|0
7814030|NCT00414973|27142316|P3|Overall Study|Death|1
7814031|NCT00414973|27142317|P2|Overall Study|Death|0
7814032|NCT00414973|27142318|P1|Overall Study|Death|0
7814033|NCT00414973|27142315|P4|Overall Study|Sponsor Decision|0
7814034|NCT00414973|27142316|P3|Overall Study|Sponsor Decision|0
7814035|NCT00414973|27142317|P2|Overall Study|Sponsor Decision|0
7814036|NCT00414973|27142318|P1|Overall Study|Sponsor Decision|1
7814037|NCT00414973|27142315|P4|Overall Study|Lost to Follow-up|0
7814038|NCT00414973|27142316|P3|Overall Study|Lost to Follow-up|0
7814039|NCT00414973|27142317|P2|Overall Study|Lost to Follow-up|2
7814040|NCT00414973|27142318|P1|Overall Study|Lost to Follow-up|0
7814041|NCT00414973|27142315|P4|Overall Study|Protocol Violation|0
7814042|NCT00414973|27142316|P3|Overall Study|Protocol Violation|0
7814043|NCT00414973|27142317|P2|Overall Study|Protocol Violation|4
7814044|NCT00414973|27142318|P1|Overall Study|Protocol Violation|3
7814045|NCT00414973|27142315|P4|Overall Study|Adverse Event|0
7814046|NCT00414973|27142316|P3|Overall Study|Adverse Event|1
7814047|NCT00414973|27142317|P2|Overall Study|Adverse Event|0
7814048|NCT00414973|27142318|P1|Overall Study|Adverse Event|10
7814049|NCT00414973|27142315|P4|Overall Study|Withdrawal by Subject|0
7814050|NCT00414973|27142316|P3|Overall Study|Withdrawal by Subject|1
7814051|NCT00414973|27142317|P2|Overall Study|Withdrawal by Subject|4
7814052|NCT00414973|27142318|P1|Overall Study|Withdrawal by Subject|14
7814053|NCT00414960|27142338|P2|Overall Study|Physician Decision|1
7814054|NCT00414960|27142339|P1|Overall Study|Physician Decision|0
7814055|NCT00414960|27142338|P2|Overall Study|Withdrawal by Subject|0
7814056|NCT00414960|27142339|P1|Overall Study|Withdrawal by Subject|3
7814057|NCT00414960|27142338|P2|Overall Study|Adverse Event|0
7814058|NCT00414960|27142339|P1|Overall Study|Adverse Event|4
7814059|NCT00414908|27142349|P2|Overall Study|Protocol Violation|1
7814060|NCT00414908|27142350|P1|Overall Study|Protocol Violation|1
7814061|NCT00414765|27142387|P2|Overall Study|Disease Progression|1
7814062|NCT00414765|27142388|P1|Overall Study|Disease Progression|0
7814063|NCT00414765|27142387|P2|Overall Study|Withdrawal by Subject|1
7814064|NCT00414765|27142388|P1|Overall Study|Withdrawal by Subject|1
7814065|NCT00414765|27142387|P2|Overall Study|Adverse Event|9
7814066|NCT00414765|27142388|P1|Overall Study|Adverse Event|5
7814067|NCT00414726|27142396|P2|Overall Study|Withdrawal by Subject|1
7814068|NCT00414726|27142397|P1|Overall Study|Withdrawal by Subject|0
7814069|NCT00414661|27142432|P4|Overall Study|Other|0
7814070|NCT00414661|27142433|P3|Overall Study|Other|0
7814071|NCT00414661|27142434|P2|Overall Study|Other|3
7814072|NCT00414661|27142435|P1|Overall Study|Other|6
7814073|NCT00414661|27142432|P4|Overall Study|Withdrawal by Subject|2
7814074|NCT00414661|27142433|P3|Overall Study|Withdrawal by Subject|2
7814075|NCT00414661|27142434|P2|Overall Study|Withdrawal by Subject|2
7814076|NCT00414661|27142435|P1|Overall Study|Withdrawal by Subject|5
7814077|NCT00414661|27142432|P4|Overall Study|Lost to Follow-up|1
7814078|NCT00414661|27142433|P3|Overall Study|Lost to Follow-up|0
7814079|NCT00414661|27142434|P2|Overall Study|Lost to Follow-up|4
7814080|NCT00414661|27142435|P1|Overall Study|Lost to Follow-up|1
7814081|NCT00414661|27142432|P4|Overall Study|Death|0
7814082|NCT00414661|27142433|P3|Overall Study|Death|0
7814083|NCT00414661|27142434|P2|Overall Study|Death|5
7814084|NCT00414661|27142435|P1|Overall Study|Death|2
7814085|NCT00414609|27142480|P3|Extension Study|Death|17
7814086|NCT00414609|27142481|P2|Extension Study|Death|0
7814087|NCT00414609|27142482|P1|Extension Study|Death|0
7814088|NCT00414609|27142480|P3|Extension Study|Administrative problems|1
7814089|NCT00414609|27142481|P2|Extension Study|Administrative problems|0
7814090|NCT00414609|27142482|P1|Extension Study|Administrative problems|0
7814091|NCT00414609|27142480|P3|Extension Study|Lost to Follow-up|10
7814092|NCT00414609|27142481|P2|Extension Study|Lost to Follow-up|0
7814093|NCT00414609|27142482|P1|Extension Study|Lost to Follow-up|0
7814094|NCT00414609|27142480|P3|Extension Study|Withdrawal by Subject|13
7814095|NCT00414609|27142481|P2|Extension Study|Withdrawal by Subject|0
7814096|NCT00414609|27142482|P1|Extension Study|Withdrawal by Subject|0
7814097|NCT00414609|27142480|P3|Extension Study|Unsatisfactory therapeutic effect|2
7814098|NCT00414609|27142481|P2|Extension Study|Unsatisfactory therapeutic effect|0
7814099|NCT00414609|27142482|P1|Extension Study|Unsatisfactory therapeutic effect|0
7814100|NCT00414609|27142480|P3|Extension Study|Adverse Event|14
7814101|NCT00414609|27142481|P2|Extension Study|Adverse Event|0
7814102|NCT00414609|27142482|P1|Extension Study|Adverse Event|0
7814103|NCT00414609|27142480|P3|Core Study|Death|0
7814104|NCT00414609|27142481|P2|Core Study|Death|14
7814105|NCT00414609|27142482|P1|Core Study|Death|7
7814106|NCT00414609|27142480|P3|Core Study|Administrative problems|0
7814107|NCT00414609|27142481|P2|Core Study|Administrative problems|2
7814108|NCT00414609|27142482|P1|Core Study|Administrative problems|0
7814109|NCT00414609|27142480|P3|Core Study|Lost to Follow-up|0
7814110|NCT00414609|27142481|P2|Core Study|Lost to Follow-up|4
7814111|NCT00414609|27142482|P1|Core Study|Lost to Follow-up|7
7814112|NCT00414609|27142480|P3|Core Study|Patient withdrew consent|0
7814113|NCT00414609|27142481|P2|Core Study|Patient withdrew consent|11
7814114|NCT00414609|27142482|P1|Core Study|Patient withdrew consent|10
7814115|NCT00414609|27142480|P3|Core Study|Protocol deviation|0
7814116|NCT00414609|27142481|P2|Core Study|Protocol deviation|1
7814117|NCT00414609|27142482|P1|Core Study|Protocol deviation|0
7814118|NCT00414609|27142480|P3|Core Study|Abnormal test procedure results|0
7814119|NCT00414609|27142481|P2|Core Study|Abnormal test procedure results|1
7814120|NCT00414609|27142482|P1|Core Study|Abnormal test procedure results|1
7814121|NCT00414609|27142480|P3|Core Study|Abnormal laboratory values|0
7814122|NCT00414609|27142481|P2|Core Study|Abnormal laboratory values|1
7814123|NCT00414609|27142482|P1|Core Study|Abnormal laboratory values|0
7814124|NCT00414609|27142480|P3|Core Study|Adverse Event|0
7814125|NCT00414609|27142481|P2|Core Study|Adverse Event|11
7814126|NCT00414609|27142482|P1|Core Study|Adverse Event|9
7814127|NCT00414596|27142505|P1|Overall Study|Protocol Violation|2
7814128|NCT00414544|27142514|P1|Overall Study|Lost to Follow-up|14
7814129|NCT00414466|27142537|P4|Overall Study|Withdrawn by Sponsor|0
7814130|NCT00414466|27142538|P3|Overall Study|Withdrawn by Sponsor|0
7814131|NCT00414466|27142539|P2|Overall Study|Withdrawn by Sponsor|0
7814132|NCT00414466|27142540|P1|Overall Study|Withdrawn by Sponsor|1
7814133|NCT00414466|27142537|P4|Overall Study|Lack of Efficacy|0
7814134|NCT00414466|27142538|P3|Overall Study|Lack of Efficacy|0
7814135|NCT00414466|27142539|P2|Overall Study|Lack of Efficacy|0
7814136|NCT00414466|27142540|P1|Overall Study|Lack of Efficacy|1
7814137|NCT00414466|27142537|P4|Overall Study|Adverse Event|1
7814138|NCT00414466|27142538|P3|Overall Study|Adverse Event|1
7814139|NCT00414466|27142539|P2|Overall Study|Adverse Event|0
7814140|NCT00414466|27142540|P1|Overall Study|Adverse Event|0
7814141|NCT00414453|27142558|P1|Overall Study|Abnormal lab work|16
7814142|NCT00414440|27142606|P2|Extension Period|Not included in follow up period|8
7814143|NCT00414440|27142607|P1|Extension Period|Not included in follow up period|18
7814144|NCT00414440|27142606|P2|Extension Period|Withdrawal by Subject|7
7814145|NCT00414440|27142607|P1|Extension Period|Withdrawal by Subject|9
7814146|NCT00414440|27142606|P2|Extension Period|Death|2
7814147|NCT00414440|27142607|P1|Extension Period|Death|1
7814148|NCT00414440|27142606|P2|Extension Period|Administrative|16
7814149|NCT00414440|27142607|P1|Extension Period|Administrative|16
7814150|NCT00414440|27142606|P2|Extension Period|Other|1
7814151|NCT00414440|27142607|P1|Extension Period|Other|1
7814152|NCT00414440|27142606|P2|Extension Period|Did not consent to continue follow up|54
7814153|NCT00414440|27142607|P1|Extension Period|Did not consent to continue follow up|61
7814154|NCT00414440|27142606|P2|Extension Period|Lost to Follow-up|52
7814155|NCT00414440|27142607|P1|Extension Period|Lost to Follow-up|44
7814156|NCT00414440|27142606|P2|Core Period|Withdrawal by Subject|32
7814157|NCT00414440|27142607|P1|Core Period|Withdrawal by Subject|70
7814158|NCT00414388|27142621|P1|Overall Study|Adverse Event|1
7814159|NCT00414310|27142629|P2|Overall Study|Not treated|0
7814160|NCT00414310|27142630|P1|Overall Study|Not treated|1
7814161|NCT00414076|27142674|P2|Overall Study|Adverse Event|0
7814162|NCT00414076|27142675|P1|Overall Study|Adverse Event|1
7814163|NCT00414076|27142674|P2|Overall Study|Withdrawal by Subject|3
7814164|NCT00414076|27142675|P1|Overall Study|Withdrawal by Subject|1
7814165|NCT00414076|27142674|P2|Overall Study|Progression|2
7814166|NCT00414076|27142675|P1|Overall Study|Progression|1
7814167|NCT00414050|27142685|P4|Overall Study|Subject Moved|1
7814168|NCT00414050|27142686|P3|Overall Study|Subject Moved|0
7814169|NCT00414050|27142687|P2|Overall Study|Subject Moved|0
7814170|NCT00414050|27142688|P1|Overall Study|Subject Moved|0
7814171|NCT00414050|27142685|P4|Overall Study|Subject discontinued for other reason|1
7814172|NCT00414050|27142686|P3|Overall Study|Subject discontinued for other reason|2
7814173|NCT00414050|27142687|P2|Overall Study|Subject discontinued for other reason|2
7814174|NCT00414050|27142688|P1|Overall Study|Subject discontinued for other reason|1
7814175|NCT00414050|27142685|P4|Overall Study|Withdrawal by Subject|4
7814176|NCT00414050|27142686|P3|Overall Study|Withdrawal by Subject|2
7814177|NCT00414050|27142687|P2|Overall Study|Withdrawal by Subject|3
7814178|NCT00414050|27142688|P1|Overall Study|Withdrawal by Subject|5
7814179|NCT00414050|27142685|P4|Overall Study|Lost to Follow-up|1
7814180|NCT00414050|27142686|P3|Overall Study|Lost to Follow-up|1
7814181|NCT00414050|27142687|P2|Overall Study|Lost to Follow-up|2
7814182|NCT00414050|27142688|P1|Overall Study|Lost to Follow-up|2
7814183|NCT00414050|27142685|P4|Overall Study|Adverse Event|1
7814184|NCT00414050|27142686|P3|Overall Study|Adverse Event|1
7814185|NCT00414050|27142687|P2|Overall Study|Adverse Event|1
7814186|NCT00414050|27142688|P1|Overall Study|Adverse Event|1
7814187|NCT00414011|27142702|P1|Overall Study|Withdrawal by Subject|2
7814188|NCT00414011|27142702|P1|Overall Study|Physician Decision|3
7814189|NCT00413972|27142711|P4|Overall Study|Other|1
7814190|NCT00413972|27142712|P3|Overall Study|Other|0
7814191|NCT00413972|27142713|P2|Overall Study|Other|0
7814192|NCT00413972|27142714|P1|Overall Study|Other|0
7814193|NCT00413972|27142711|P4|Overall Study|Protocol Violation|0
7814194|NCT00413972|27142712|P3|Overall Study|Protocol Violation|2
7814195|NCT00413972|27142713|P2|Overall Study|Protocol Violation|0
7814196|NCT00413972|27142714|P1|Overall Study|Protocol Violation|0
7814197|NCT00413972|27142711|P4|Overall Study|Withdrawal by Subject|2
7814198|NCT00413972|27142712|P3|Overall Study|Withdrawal by Subject|7
7814199|NCT00413972|27142713|P2|Overall Study|Withdrawal by Subject|5
7814200|NCT00413972|27142714|P1|Overall Study|Withdrawal by Subject|4
7814201|NCT00413972|27142711|P4|Overall Study|Lost to Follow-up|0
7814202|NCT00413972|27142712|P3|Overall Study|Lost to Follow-up|1
7814203|NCT00413972|27142713|P2|Overall Study|Lost to Follow-up|2
7814204|NCT00413972|27142714|P1|Overall Study|Lost to Follow-up|1
7814205|NCT00413972|27142711|P4|Overall Study|Adverse Event|0
7814206|NCT00413972|27142712|P3|Overall Study|Adverse Event|0
7814207|NCT00413972|27142713|P2|Overall Study|Adverse Event|1
7814208|NCT00413972|27142714|P1|Overall Study|Adverse Event|2
7814209|NCT00413959|27142724|P1|Overall Study|Pt had only one cycle.|1
7814210|NCT00413920|27142731|P2|Overall Study|Graft Loss|3
7814211|NCT00413920|27142732|P1|Overall Study|Graft Loss|5
7814212|NCT00413920|27142731|P2|Overall Study|Death|5
7814213|NCT00413920|27142732|P1|Overall Study|Death|3
7814214|NCT00413920|27142731|P2|Overall Study|Lack of Efficacy|9
7814215|NCT00413920|27142732|P1|Overall Study|Lack of Efficacy|11
7814216|NCT00413920|27142731|P2|Overall Study|Adverse Event|11
7814217|NCT00413920|27142732|P1|Overall Study|Adverse Event|9
7814218|NCT00413894|27142747|P1|Overall Study|Other|18
7814219|NCT00413894|27142747|P1|Overall Study|Protocol Violation|11
7814220|NCT00413894|27142747|P1|Overall Study|Adverse Event|28
7814221|NCT00413894|27142747|P1|Overall Study|Hb <10 grams/deciliter|12
7814222|NCT00413894|27142747|P1|Overall Study|Administrative Reasons|1
7814223|NCT00413894|27142747|P1|Overall Study|Withdrawal by Subject|10
7814224|NCT00413777|27142764|P2|Fixed-dose Period|Withdrew Consent|1
7814225|NCT00413777|27142765|P1|Fixed-dose Period|Withdrew Consent|0
7814226|NCT00413777|27142764|P2|Fixed-dose Period|Met Withdrawal Criteria|0
7814227|NCT00413777|27142765|P1|Fixed-dose Period|Met Withdrawal Criteria|1
7814228|NCT00413777|27142764|P2|Fixed-dose Period|Adverse Event|1
7814229|NCT00413777|27142765|P1|Fixed-dose Period|Adverse Event|2
7814230|NCT00413777|27142764|P2|Fixed-dose Period|Lost to Follow-up|1
7814231|NCT00413777|27142765|P1|Fixed-dose Period|Lost to Follow-up|1
7814232|NCT00413699|27142813|P3|Extension Period|Adverse Event|2
7814233|NCT00413699|27142814|P2|Extension Period|Adverse Event|0
7814234|NCT00413699|27142815|P1|Extension Period|Adverse Event|0
7814235|NCT00413699|27142813|P3|Extension Period|Protocol Violation|1
7814236|NCT00413699|27142814|P2|Extension Period|Protocol Violation|0
7814237|NCT00413699|27142815|P1|Extension Period|Protocol Violation|0
7814238|NCT00413699|27142813|P3|Extension Period|No Longer Willing to Participate|2
7814239|NCT00413699|27142814|P2|Extension Period|No Longer Willing to Participate|0
7814240|NCT00413699|27142815|P1|Extension Period|No Longer Willing to Participate|0
7814241|NCT00413699|27142813|P3|Initial Period|No longer willing to participate|0
7814242|NCT00413699|27142814|P2|Initial Period|No longer willing to participate|368
7814243|NCT00413699|27142815|P1|Initial Period|No longer willing to participate|116
7814244|NCT00413699|27142813|P3|Initial Period|Missing end of study page|0
7814245|NCT00413699|27142814|P2|Initial Period|Missing end of study page|4
7814246|NCT00413699|27142815|P1|Initial Period|Missing end of study page|0
7814247|NCT00413699|27142813|P3|Initial Period|Adverse event not related to study drug|0
7814248|NCT00413699|27142814|P2|Initial Period|Adverse event not related to study drug|248
7814249|NCT00413699|27142815|P1|Initial Period|Adverse event not related to study drug|113
7814250|NCT00413699|27142813|P3|Initial Period|Adverse event related to study drug|0
7814251|NCT00413699|27142814|P2|Initial Period|Adverse event related to study drug|527
7814252|NCT00413699|27142815|P1|Initial Period|Adverse event related to study drug|178
7814253|NCT00413699|27142813|P3|Initial Period|Other|0
7814254|NCT00413699|27142814|P2|Initial Period|Other|211
7814255|NCT00413699|27142815|P1|Initial Period|Other|67
7814256|NCT00413699|27142813|P3|Initial Period|Study terminated by Sponsor|0
7814257|NCT00413699|27142814|P2|Initial Period|Study terminated by Sponsor|1
7814258|NCT00413699|27142815|P1|Initial Period|Study terminated by Sponsor|0
7814259|NCT00413699|27142813|P3|Initial Period|Medication error without adverse event|0
7814260|NCT00413699|27142814|P2|Initial Period|Medication error without adverse event|1
7814261|NCT00413699|27142815|P1|Initial Period|Medication error without adverse event|0
7814262|NCT00413699|27142813|P3|Initial Period|Did not meet entrance criteria|0
7814263|NCT00413699|27142814|P2|Initial Period|Did not meet entrance criteria|2
7814264|NCT00413699|27142815|P1|Initial Period|Did not meet entrance criteria|2
7814265|NCT00413699|27142813|P3|Initial Period|Pregnancy|0
7814266|NCT00413699|27142814|P2|Initial Period|Pregnancy|8
7814267|NCT00413699|27142815|P1|Initial Period|Pregnancy|10
7814268|NCT00413699|27142813|P3|Initial Period|Protocol Violation|0
7814269|NCT00413699|27142814|P2|Initial Period|Protocol Violation|89
7814270|NCT00413699|27142815|P1|Initial Period|Protocol Violation|38
7814271|NCT00413699|27142813|P3|Initial Period|Lost to Follow-up|0
7814272|NCT00413699|27142814|P2|Initial Period|Lost to Follow-up|101
7814273|NCT00413699|27142815|P1|Initial Period|Lost to Follow-up|31
7814274|NCT00413699|27142813|P3|Initial Period|Lack of Efficacy|0
7814275|NCT00413699|27142814|P2|Initial Period|Lack of Efficacy|115
7814276|NCT00413699|27142815|P1|Initial Period|Lack of Efficacy|59
7814277|NCT00413699|27142813|P3|Initial Period|Death|0
7814278|NCT00413699|27142814|P2|Initial Period|Death|30
7814279|NCT00413699|27142815|P1|Initial Period|Death|25
7814280|NCT00413660|27142897|P11|Post Week 12|Other|0
7814281|NCT00413660|27142898|P10|Post Week 12|Other|0
7814282|NCT00413660|27142899|P9|Post Week 12|Other|0
7814283|NCT00413660|27142900|P8|Post Week 12|Other|0
7814284|NCT00413660|27142901|P7|Post Week 12|Other|1
7814285|NCT00413660|27142902|P6|Post Week 12|Other|1
7814286|NCT00413660|27142903|P5|Post Week 12|Other|1
7814287|NCT00413660|27142904|P4|Post Week 12|Other|0
7814288|NCT00413660|27142905|P3|Post Week 12|Other|3
7814289|NCT00413660|27142906|P2|Post Week 12|Other|2
7814290|NCT00413660|27142907|P1|Post Week 12|Other|1
7814291|NCT00413660|27142897|P11|Post Week 12|Withdrawal by Subject|1
7814292|NCT00413660|27142898|P10|Post Week 12|Withdrawal by Subject|0
7814293|NCT00413660|27142899|P9|Post Week 12|Withdrawal by Subject|0
7814294|NCT00413660|27142900|P8|Post Week 12|Withdrawal by Subject|0
7814295|NCT00413660|27142901|P7|Post Week 12|Withdrawal by Subject|0
7814296|NCT00413660|27142902|P6|Post Week 12|Withdrawal by Subject|0
7814297|NCT00413660|27142903|P5|Post Week 12|Withdrawal by Subject|1
7814298|NCT00413660|27142904|P4|Post Week 12|Withdrawal by Subject|0
7814299|NCT00413660|27142905|P3|Post Week 12|Withdrawal by Subject|1
7814300|NCT00413660|27142906|P2|Post Week 12|Withdrawal by Subject|1
7814301|NCT00413660|27142907|P1|Post Week 12|Withdrawal by Subject|0
7814302|NCT00413660|27142897|P11|Post Week 12|Lost to Follow-up|0
7814303|NCT00413660|27142898|P10|Post Week 12|Lost to Follow-up|0
7814304|NCT00413660|27142899|P9|Post Week 12|Lost to Follow-up|0
7814305|NCT00413660|27142900|P8|Post Week 12|Lost to Follow-up|0
7814306|NCT00413660|27142901|P7|Post Week 12|Lost to Follow-up|0
7814307|NCT00413660|27142902|P6|Post Week 12|Lost to Follow-up|0
7814308|NCT00413660|27142903|P5|Post Week 12|Lost to Follow-up|0
7814309|NCT00413660|27142904|P4|Post Week 12|Lost to Follow-up|0
7814310|NCT00413660|27142905|P3|Post Week 12|Lost to Follow-up|1
7814311|NCT00413660|27142906|P2|Post Week 12|Lost to Follow-up|1
7814312|NCT00413660|27142907|P1|Post Week 12|Lost to Follow-up|0
7814313|NCT00413660|27142897|P11|Post Week 12|Lack of Efficacy|0
7814314|NCT00413660|27142898|P10|Post Week 12|Lack of Efficacy|1
7814315|NCT00413660|27142899|P9|Post Week 12|Lack of Efficacy|0
7814316|NCT00413660|27142900|P8|Post Week 12|Lack of Efficacy|0
7814317|NCT00413660|27142901|P7|Post Week 12|Lack of Efficacy|0
7814318|NCT00413660|27142902|P6|Post Week 12|Lack of Efficacy|0
7814319|NCT00413660|27142903|P5|Post Week 12|Lack of Efficacy|0
7814320|NCT00413660|27142904|P4|Post Week 12|Lack of Efficacy|0
7814321|NCT00413660|27142905|P3|Post Week 12|Lack of Efficacy|1
7814322|NCT00413660|27142906|P2|Post Week 12|Lack of Efficacy|0
7814323|NCT00413660|27142907|P1|Post Week 12|Lack of Efficacy|0
7814324|NCT00413660|27142897|P11|Post Week 12|Adverse Event|0
7814325|NCT00413660|27142898|P10|Post Week 12|Adverse Event|0
7814326|NCT00413660|27142899|P9|Post Week 12|Adverse Event|0
7814327|NCT00413660|27142900|P8|Post Week 12|Adverse Event|0
7814328|NCT00413660|27142901|P7|Post Week 12|Adverse Event|2
7814329|NCT00413660|27142902|P6|Post Week 12|Adverse Event|2
7814330|NCT00413660|27142903|P5|Post Week 12|Adverse Event|4
7814331|NCT00413660|27142904|P4|Post Week 12|Adverse Event|1
7814332|NCT00413660|27142905|P3|Post Week 12|Adverse Event|2
7814333|NCT00413660|27142906|P2|Post Week 12|Adverse Event|0
7814334|NCT00413660|27142907|P1|Post Week 12|Adverse Event|2
7814335|NCT00413660|27142897|P11|Up To Week 12|Other|0
7814336|NCT00413660|27142898|P10|Up To Week 12|Other|0
7814337|NCT00413660|27142899|P9|Up To Week 12|Other|0
7814338|NCT00413660|27142900|P8|Up To Week 12|Other|0
7814339|NCT00413660|27142901|P7|Up To Week 12|Other|3
7814340|NCT00413660|27142902|P6|Up To Week 12|Other|4
7814341|NCT00413660|27142903|P5|Up To Week 12|Other|2
7814342|NCT00413660|27142904|P4|Up To Week 12|Other|1
7814343|NCT00413660|27142905|P3|Up To Week 12|Other|6
7814344|NCT00413660|27142906|P2|Up To Week 12|Other|1
7814345|NCT00413660|27142907|P1|Up To Week 12|Other|3
7814346|NCT00413660|27142897|P11|Up To Week 12|Randomized, Not Treated|0
7814347|NCT00413660|27142898|P10|Up To Week 12|Randomized, Not Treated|0
7814348|NCT00413660|27142899|P9|Up To Week 12|Randomized, Not Treated|0
7814349|NCT00413660|27142900|P8|Up To Week 12|Randomized, Not Treated|0
7814350|NCT00413660|27142901|P7|Up To Week 12|Randomized, Not Treated|0
7814351|NCT00413660|27142902|P6|Up To Week 12|Randomized, Not Treated|0
7814352|NCT00413660|27142903|P5|Up To Week 12|Randomized, Not Treated|0
7814353|NCT00413660|27142904|P4|Up To Week 12|Randomized, Not Treated|1
7814354|NCT00413660|27142905|P3|Up To Week 12|Randomized, Not Treated|0
7814355|NCT00413660|27142906|P2|Up To Week 12|Randomized, Not Treated|0
7814356|NCT00413660|27142907|P1|Up To Week 12|Randomized, Not Treated|1
7814357|NCT00413660|27142897|P11|Up To Week 12|Withdrawal by Subject|0
7814358|NCT00413660|27142898|P10|Up To Week 12|Withdrawal by Subject|0
7814359|NCT00413660|27142899|P9|Up To Week 12|Withdrawal by Subject|0
7814360|NCT00413660|27142900|P8|Up To Week 12|Withdrawal by Subject|0
7814361|NCT00413660|27142901|P7|Up To Week 12|Withdrawal by Subject|2
7814362|NCT00413660|27142902|P6|Up To Week 12|Withdrawal by Subject|2
7814363|NCT00413660|27142903|P5|Up To Week 12|Withdrawal by Subject|0
7814364|NCT00413660|27142904|P4|Up To Week 12|Withdrawal by Subject|2
7814365|NCT00413660|27142905|P3|Up To Week 12|Withdrawal by Subject|0
7814366|NCT00413660|27142906|P2|Up To Week 12|Withdrawal by Subject|2
7814367|NCT00413660|27142907|P1|Up To Week 12|Withdrawal by Subject|0
7814368|NCT00413660|27142897|P11|Up To Week 12|Lost to Follow-up|0
7814369|NCT00413660|27142898|P10|Up To Week 12|Lost to Follow-up|0
7814370|NCT00413660|27142899|P9|Up To Week 12|Lost to Follow-up|0
7814371|NCT00413660|27142900|P8|Up To Week 12|Lost to Follow-up|0
7814372|NCT00413660|27142901|P7|Up To Week 12|Lost to Follow-up|0
7814373|NCT00413660|27142902|P6|Up To Week 12|Lost to Follow-up|0
7814374|NCT00413660|27142903|P5|Up To Week 12|Lost to Follow-up|1
7814375|NCT00413660|27142904|P4|Up To Week 12|Lost to Follow-up|0
7814376|NCT00413660|27142905|P3|Up To Week 12|Lost to Follow-up|0
7814377|NCT00413660|27142906|P2|Up To Week 12|Lost to Follow-up|1
7814378|NCT00413660|27142907|P1|Up To Week 12|Lost to Follow-up|0
7814379|NCT00413660|27142897|P11|Up To Week 12|Lack of Efficacy|0
7814380|NCT00413660|27142898|P10|Up To Week 12|Lack of Efficacy|0
7814381|NCT00413660|27142899|P9|Up To Week 12|Lack of Efficacy|0
7814382|NCT00413660|27142900|P8|Up To Week 12|Lack of Efficacy|0
7814383|NCT00413660|27142901|P7|Up To Week 12|Lack of Efficacy|5
7814384|NCT00413660|27142902|P6|Up To Week 12|Lack of Efficacy|0
7814385|NCT00413660|27142903|P5|Up To Week 12|Lack of Efficacy|0
7814386|NCT00413660|27142904|P4|Up To Week 12|Lack of Efficacy|0
7814387|NCT00413660|27142905|P3|Up To Week 12|Lack of Efficacy|0
7814388|NCT00413660|27142906|P2|Up To Week 12|Lack of Efficacy|0
7814389|NCT00413660|27142907|P1|Up To Week 12|Lack of Efficacy|2
7814390|NCT00413660|27142897|P11|Up To Week 12|Adverse Event|0
7814391|NCT00413660|27142898|P10|Up To Week 12|Adverse Event|0
7814392|NCT00413660|27142899|P9|Up To Week 12|Adverse Event|0
7814393|NCT00413660|27142900|P8|Up To Week 12|Adverse Event|0
7814394|NCT00413660|27142901|P7|Up To Week 12|Adverse Event|1
7814395|NCT00413660|27142902|P6|Up To Week 12|Adverse Event|4
7814396|NCT00413660|27142903|P5|Up To Week 12|Adverse Event|6
7814397|NCT00413660|27142904|P4|Up To Week 12|Adverse Event|4
7814398|NCT00413660|27142905|P3|Up To Week 12|Adverse Event|1
7814399|NCT00413660|27142906|P2|Up To Week 12|Adverse Event|3
7814400|NCT00413660|27142907|P1|Up To Week 12|Adverse Event|1
7814401|NCT00413413|27143310|P3|Double-Blind|Lost to Follow-up|2
7814402|NCT00413413|27143311|P2|Double-Blind|Lost to Follow-up|4
7814403|NCT00413413|27143312|P1|Double-Blind|Lost to Follow-up|3
7814404|NCT00413413|27143310|P3|Double-Blind|Subject withdrew consent|9
7814405|NCT00413413|27143311|P2|Double-Blind|Subject withdrew consent|6
7814406|NCT00413413|27143312|P1|Double-Blind|Subject withdrew consent|4
7814407|NCT00413413|27143310|P3|Double-Blind|Protocol deviation|1
7814408|NCT00413413|27143311|P2|Double-Blind|Protocol deviation|2
7814409|NCT00413413|27143312|P1|Double-Blind|Protocol deviation|1
7814410|NCT00413413|27143310|P3|Double-Blind|Unsatisfactory therapeutic effect|1
7814411|NCT00413413|27143311|P2|Double-Blind|Unsatisfactory therapeutic effect|2
7814412|NCT00413413|27143312|P1|Double-Blind|Unsatisfactory therapeutic effect|1
7814413|NCT00413413|27143310|P3|Double-Blind|Adverse Event|5
7814414|NCT00413413|27143311|P2|Double-Blind|Adverse Event|0
7814415|NCT00413413|27143312|P1|Double-Blind|Adverse Event|6
7814416|NCT00413413|27143310|P3|Single-Blind|Lost to Follow-up|0
7814417|NCT00413413|27143311|P2|Single-Blind|Lost to Follow-up|8
7814418|NCT00413413|27143312|P1|Single-Blind|Lost to Follow-up|0
7814419|NCT00413413|27143310|P3|Single-Blind|Withdrawal by Subject|0
7814420|NCT00413413|27143311|P2|Single-Blind|Withdrawal by Subject|27
7814421|NCT00413413|27143312|P1|Single-Blind|Withdrawal by Subject|0
7814422|NCT00413413|27143310|P3|Single-Blind|Protocol Violation|0
7814423|NCT00413413|27143311|P2|Single-Blind|Protocol Violation|16
7814424|NCT00413413|27143312|P1|Single-Blind|Protocol Violation|0
7814425|NCT00413413|27143310|P3|Single-Blind|Subject no longer requires study drug|0
7814426|NCT00413413|27143311|P2|Single-Blind|Subject no longer requires study drug|151
7814427|NCT00413413|27143312|P1|Single-Blind|Subject no longer requires study drug|0
7814428|NCT00413413|27143310|P3|Single-Blind|Lack of Efficacy|0
7814429|NCT00413413|27143311|P2|Single-Blind|Lack of Efficacy|5
7814430|NCT00413413|27143312|P1|Single-Blind|Lack of Efficacy|0
7814431|NCT00413413|27143310|P3|Single-Blind|Adverse Event|0
7814432|NCT00413413|27143311|P2|Single-Blind|Adverse Event|9
7814433|NCT00413413|27143312|P1|Single-Blind|Adverse Event|0
7814434|NCT00413374|27143365|P2|Overall Study|Surgery|0
7814435|NCT00413374|27143366|P1|Overall Study|Surgery|1
7814436|NCT00413374|27143365|P2|Overall Study|Lost to Follow-up|0
7814437|NCT00413374|27143366|P1|Overall Study|Lost to Follow-up|1
7814438|NCT00413374|27143365|P2|Overall Study|Adverse Event|0
7814439|NCT00413374|27143366|P1|Overall Study|Adverse Event|1
7814440|NCT00413374|27143365|P2|Overall Study|Ineligible due to screening criteria.|0
7814441|NCT00413374|27143366|P1|Overall Study|Ineligible due to screening criteria.|3
7814442|NCT00413283|27143397|P4|Overall Study|Other|0
7814443|NCT00413283|27143398|P3|Overall Study|Other|1
7814444|NCT00413283|27143399|P2|Overall Study|Other|0
7814445|NCT00413283|27143400|P1|Overall Study|Other|0
7814446|NCT00413283|27143397|P4|Overall Study|Requirement for alternative therapy|0
7814447|NCT00413283|27143398|P3|Overall Study|Requirement for alternative therapy|0
7814448|NCT00413283|27143399|P2|Overall Study|Requirement for alternative therapy|2
7814449|NCT00413283|27143400|P1|Overall Study|Requirement for alternative therapy|0
7814450|NCT00413283|27143397|P4|Overall Study|Protocol deviation|0
7814451|NCT00413283|27143398|P3|Overall Study|Protocol deviation|0
7814452|NCT00413283|27143399|P2|Overall Study|Protocol deviation|1
7814453|NCT00413283|27143400|P1|Overall Study|Protocol deviation|0
7814454|NCT00413283|27143397|P4|Overall Study|Ineligibility determined|1
7814455|NCT00413283|27143398|P3|Overall Study|Ineligibility determined|0
7814456|NCT00413283|27143399|P2|Overall Study|Ineligibility determined|0
7814457|NCT00413283|27143400|P1|Overall Study|Ineligibility determined|0
7814458|NCT00413283|27143397|P4|Overall Study|Adverse Event|1
7814459|NCT00413283|27143398|P3|Overall Study|Adverse Event|0
7814460|NCT00413283|27143399|P2|Overall Study|Adverse Event|0
7814461|NCT00413283|27143400|P1|Overall Study|Adverse Event|0
7814462|NCT00413283|27143397|P4|Overall Study|Death|1
7814463|NCT00413283|27143398|P3|Overall Study|Death|1
7814464|NCT00413283|27143399|P2|Overall Study|Death|0
7814465|NCT00413283|27143400|P1|Overall Study|Death|0
7814466|NCT00413283|27143397|P4|Overall Study|Withdrawal by Subject|1
7814467|NCT00413283|27143398|P3|Overall Study|Withdrawal by Subject|0
7814468|NCT00413283|27143399|P2|Overall Study|Withdrawal by Subject|0
7814469|NCT00413283|27143400|P1|Overall Study|Withdrawal by Subject|1
7814470|NCT00413244|27143432|P2|Overall Study|Withdrawal by Subject|1
7814471|NCT00413244|27143433|P1|Overall Study|Withdrawal by Subject|10
7814472|NCT00413231|27143461|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
7814473|NCT00413231|27143461|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
7814474|NCT00413231|27143461|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
7814475|NCT00413231|27143461|P1|365-day to 60-month Post Treatment|Death|36
7814476|NCT00413231|27143461|P1|30-day to 365-day Post Treatment|Death|13
7814477|NCT00413231|27143461|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
7814478|NCT00413231|27143461|P1|0 to 30-day Post Treatment|Death|5
7814479|NCT00413218|27143493|P2|Overall Study|Withdrawal by Subject|1
7814480|NCT00413218|27143494|P1|Overall Study|Withdrawal by Subject|9
7814481|NCT00413218|27143493|P2|Overall Study|Missing|0
7814482|NCT00413218|27143494|P1|Overall Study|Missing|1
7814483|NCT00413218|27143493|P2|Overall Study|Admin|14
7814484|NCT00413218|27143494|P1|Overall Study|Admin|20
7814485|NCT00413218|27143493|P2|Overall Study|Lost to Follow-up|17
7814486|NCT00413218|27143494|P1|Overall Study|Lost to Follow-up|14
7814487|NCT00413218|27143493|P2|Overall Study|Death|56
7814488|NCT00413218|27143494|P1|Overall Study|Death|57
7814489|NCT00413218|27143493|P2|Overall Study|Randomized but didn't receive study drug|8
7814490|NCT00413218|27143494|P1|Overall Study|Randomized but didn't receive study drug|2
7814491|NCT00413192|27143520|P4|Overall Study|Not treated|1
7814492|NCT00413192|27143521|P3|Overall Study|Not treated|0
7814493|NCT00413192|27143522|P2|Overall Study|Not treated|0
7814494|NCT00413192|27143523|P1|Overall Study|Not treated|0
7814495|NCT00413192|27143520|P4|Overall Study|Other|2
7814496|NCT00413192|27143521|P3|Overall Study|Other|1
7814497|NCT00413192|27143522|P2|Overall Study|Other|1
7814498|NCT00413192|27143523|P1|Overall Study|Other|5
7814499|NCT00413192|27143520|P4|Overall Study|Intercurrent death|0
7814500|NCT00413192|27143521|P3|Overall Study|Intercurrent death|0
7814501|NCT00413192|27143522|P2|Overall Study|Intercurrent death|1
7814502|NCT00413192|27143523|P1|Overall Study|Intercurrent death|0
7814503|NCT00413192|27143520|P4|Overall Study|Intercurrent illness|1
7814504|NCT00413192|27143521|P3|Overall Study|Intercurrent illness|0
7814505|NCT00413192|27143522|P2|Overall Study|Intercurrent illness|0
7814506|NCT00413192|27143523|P1|Overall Study|Intercurrent illness|0
7814507|NCT00413192|27143520|P4|Overall Study|Withdrawal by Subject|1
7814508|NCT00413192|27143521|P3|Overall Study|Withdrawal by Subject|0
7814509|NCT00413192|27143522|P2|Overall Study|Withdrawal by Subject|5
7814510|NCT00413192|27143523|P1|Overall Study|Withdrawal by Subject|3
7814511|NCT00413192|27143520|P4|Overall Study|Toxicity|2
7814512|NCT00413192|27143521|P3|Overall Study|Toxicity|2
7814513|NCT00413192|27143522|P2|Overall Study|Toxicity|2
7814514|NCT00413192|27143523|P1|Overall Study|Toxicity|3
7814515|NCT00413192|27143520|P4|Overall Study|Disease progression|25
7814516|NCT00413192|27143521|P3|Overall Study|Disease progression|16
7814517|NCT00413192|27143522|P2|Overall Study|Disease progression|31
7814518|NCT00413192|27143523|P1|Overall Study|Disease progression|26
7814519|NCT00413153|27143576|P2|Overall Study|Adverse Event|0
7814520|NCT00413153|27143577|P1|Overall Study|Adverse Event|1
7814521|NCT00413153|27143576|P2|Overall Study|Withdrawal by Subject|1
7814522|NCT00413153|27143577|P1|Overall Study|Withdrawal by Subject|1
7814523|NCT00413062|27143601|P2|Overall Study|Other reason|34
7814524|NCT00413062|27143602|P1|Overall Study|Other reason|70
7814525|NCT00413062|27143601|P2|Overall Study|Lost to Follow-up|73
7814526|NCT00413062|27143602|P1|Overall Study|Lost to Follow-up|175
7814527|NCT00413062|27143601|P2|Overall Study|Pregnancy wish|6
7814528|NCT00413062|27143602|P1|Overall Study|Pregnancy wish|17
7814529|NCT00413062|27143601|P2|Overall Study|Pregnancy|5
7814530|NCT00413062|27143602|P1|Overall Study|Pregnancy|15
7814531|NCT00413062|27143601|P2|Overall Study|Withdrawal of informed consent|36
7814532|NCT00413062|27143602|P1|Overall Study|Withdrawal of informed consent|111
7814533|NCT00413062|27143601|P2|Overall Study|Pre-treatment (serious) adverse event|0
7814534|NCT00413062|27143602|P1|Overall Study|Pre-treatment (serious) adverse event|1
7814535|NCT00413062|27143601|P2|Overall Study|Adverse event/serious adverse event|56
7814536|NCT00413062|27143602|P1|Overall Study|Adverse event/serious adverse event|289
7814537|NCT00413049|27143628|P2|Overall Study|Lack of Efficacy|0
7814538|NCT00413049|27143629|P1|Overall Study|Lack of Efficacy|1
7814539|NCT00413049|27143628|P2|Overall Study|Abnormal laboratory value(s)|0
7814540|NCT00413049|27143629|P1|Overall Study|Abnormal laboratory value(s)|1
7814541|NCT00413049|27143628|P2|Overall Study|Subject no longer requires study drug|1
7814542|NCT00413049|27143629|P1|Overall Study|Subject no longer requires study drug|0
7814543|NCT00413049|27143628|P2|Overall Study|Protocol Violation|1
7814544|NCT00413049|27143629|P1|Overall Study|Protocol Violation|3
7814545|NCT00413049|27143628|P2|Overall Study|Lost to Follow-up|3
7814546|NCT00413049|27143629|P1|Overall Study|Lost to Follow-up|2
7814547|NCT00413049|27143628|P2|Overall Study|Withdrawal by Subject|5
7814548|NCT00413049|27143629|P1|Overall Study|Withdrawal by Subject|7
7814549|NCT00413049|27143628|P2|Overall Study|Adverse Event|8
7814550|NCT00413049|27143629|P1|Overall Study|Adverse Event|10
7814551|NCT00413036|27143645|P1|Overall Study|Missing|2
7814552|NCT00413036|27143645|P1|Overall Study|Other|26
7814553|NCT00413036|27143645|P1|Overall Study|Death|9
7814554|NCT00413036|27143645|P1|Overall Study|Withdrawal by Subject|7
7814555|NCT00413036|27143645|P1|Overall Study|Lack of Efficacy|129
7814556|NCT00413036|27143645|P1|Overall Study|Adverse Event|44
7814557|NCT00413010|27143655|P2|Overall Study|Due to termination of the study|52
7814558|NCT00413010|27143656|P1|Overall Study|Due to termination of the study|54
7814559|NCT00413010|27143655|P2|Overall Study|Withdrawal by Subject|2
7814560|NCT00413010|27143656|P1|Overall Study|Withdrawal by Subject|7
7814561|NCT00413010|27143655|P2|Overall Study|Lost to Follow-up|0
7814562|NCT00413010|27143656|P1|Overall Study|Lost to Follow-up|3
7814563|NCT00413010|27143655|P2|Overall Study|Lack of Efficacy|3
7814564|NCT00413010|27143656|P1|Overall Study|Lack of Efficacy|0
7814565|NCT00413010|27143655|P2|Overall Study|Laboratory abnormality|2
7814566|NCT00413010|27143656|P1|Overall Study|Laboratory abnormality|0
7814567|NCT00413010|27143655|P2|Overall Study|Adverse Event|4
7814568|NCT00413010|27143656|P1|Overall Study|Adverse Event|8
7814569|NCT00412984|27143678|P2|Overall Study|Not Reported|12
7814570|NCT00412984|27143679|P1|Overall Study|Not Reported|11
7814571|NCT00412984|27143678|P2|Overall Study|Other Reason|92
7814572|NCT00412984|27143679|P1|Overall Study|Other Reason|80
7814573|NCT00412984|27143678|P2|Overall Study|Physician Refused to Continue Treatment|89
7814574|NCT00412984|27143679|P1|Overall Study|Physician Refused to Continue Treatment|81
7814575|NCT00412984|27143678|P2|Overall Study|Administrative Reason by Sponsor|8
7814576|NCT00412984|27143679|P1|Overall Study|Administrative Reason by Sponsor|11
7814577|NCT00412984|27143678|P2|Overall Study|Subject No Longer Meets Study Criteria|100
7814578|NCT00412984|27143679|P1|Overall Study|Subject No Longer Meets Study Criteria|87
7814579|NCT00412984|27143678|P2|Overall Study|Pregnancy|0
7814580|NCT00412984|27143679|P1|Overall Study|Pregnancy|1
7814581|NCT00412984|27143678|P2|Overall Study|Poor/Noncompliance|77
7814582|NCT00412984|27143679|P1|Overall Study|Poor/Noncompliance|57
7814583|NCT00412984|27143678|P2|Overall Study|Lost to Follow-up|39
7814584|NCT00412984|27143679|P1|Overall Study|Lost to Follow-up|51
7814585|NCT00412984|27143678|P2|Overall Study|Withdrawal by Subject|989
7814586|NCT00412984|27143679|P1|Overall Study|Withdrawal by Subject|921
7814587|NCT00412984|27143678|P2|Overall Study|Adverse Event|738
7814588|NCT00412984|27143679|P1|Overall Study|Adverse Event|679
7814589|NCT00412984|27143678|P2|Overall Study|Death|349
7814590|NCT00412984|27143679|P1|Overall Study|Death|331
7814591|NCT00412971|27143723|P2|Overall Study|Protocol Violation|1
7814592|NCT00412971|27143724|P1|Overall Study|Protocol Violation|13
7814593|NCT00412971|27143723|P2|Overall Study|Lost to Follow-up|9
7814594|NCT00412971|27143724|P1|Overall Study|Lost to Follow-up|17
7814595|NCT00412958|27143737|P4|Overall Study|Transport issue|0
7814596|NCT00412958|27143738|P3|Overall Study|Transport issue|0
7814597|NCT00412958|27143739|P2|Overall Study|Transport issue|1
7814598|NCT00412958|27143740|P1|Overall Study|Transport issue|0
7814599|NCT00412958|27143737|P4|Overall Study|Death|0
7814600|NCT00412958|27143738|P3|Overall Study|Death|0
7814601|NCT00412958|27143739|P2|Overall Study|Death|1
7814602|NCT00412958|27143740|P1|Overall Study|Death|0
7814603|NCT00412958|27143737|P4|Overall Study|Lost to Follow-up|0
7814604|NCT00412958|27143738|P3|Overall Study|Lost to Follow-up|0
7814605|NCT00412958|27143739|P2|Overall Study|Lost to Follow-up|1
7814606|NCT00412958|27143740|P1|Overall Study|Lost to Follow-up|0
7814607|NCT00412958|27143737|P4|Overall Study|Adverse Event|0
7814608|NCT00412958|27143738|P3|Overall Study|Adverse Event|0
7814609|NCT00412958|27143739|P2|Overall Study|Adverse Event|1
7814610|NCT00412958|27143740|P1|Overall Study|Adverse Event|0
7814611|NCT00412958|27143737|P4|Overall Study|Withdrawal by Subject|1
7814612|NCT00412958|27143738|P3|Overall Study|Withdrawal by Subject|0
7814613|NCT00412958|27143739|P2|Overall Study|Withdrawal by Subject|0
7814614|NCT00412958|27143740|P1|Overall Study|Withdrawal by Subject|3
7814615|NCT00412932|27143750|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
7814616|NCT00412932|27143750|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
7814617|NCT00412932|27143750|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
7814618|NCT00412932|27143750|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
7814619|NCT00412932|27143750|P1|Olmesartan 40 mg|Withdrawal by Subject|1
7814620|NCT00412932|27143750|P1|Olmesartan 40 mg|Lack of Efficacy|3
7814621|NCT00412932|27143750|P1|Olmesartan 40 mg|Adverse Event|4
7814622|NCT00412932|27143750|P1|Olmesartan (Olm) 20 mg|Other|1
7814623|NCT00412932|27143750|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
7814624|NCT00412932|27143750|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
7814625|NCT00412932|27143750|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
7814626|NCT00412932|27143750|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
7814627|NCT00412893|27143761|P2|Overall Study|Randomized but Never Received Study Drug|6
7814628|NCT00412893|27143762|P1|Overall Study|Randomized but Never Received Study Drug|5
7814629|NCT00412893|27143761|P2|Overall Study|Administrative Reason|15
7814630|NCT00412893|27143762|P1|Overall Study|Administrative Reason|12
7814631|NCT00412893|27143761|P2|Overall Study|Did Not Cooperate|9
7814632|NCT00412893|27143762|P1|Overall Study|Did Not Cooperate|12
7814633|NCT00412893|27143761|P2|Overall Study|Other Protocol Violation|6
7814634|NCT00412893|27143762|P1|Overall Study|Other Protocol Violation|10
7814635|NCT00412893|27143761|P2|Overall Study|Violation of Selection at Entry|10
7814636|NCT00412893|27143762|P1|Overall Study|Violation of Selection at Entry|17
7814637|NCT00412893|27143761|P2|Overall Study|Lost to Follow-up|1
7814638|NCT00412893|27143762|P1|Overall Study|Lost to Follow-up|2
7814639|NCT00412893|27143761|P2|Overall Study|Insufficient Therapeutic Response|23
7814640|NCT00412893|27143762|P1|Overall Study|Insufficient Therapeutic Response|39
7814641|NCT00412893|27143761|P2|Overall Study|Death|21
7814642|NCT00412893|27143762|P1|Overall Study|Death|17
7814643|NCT00412893|27143761|P2|Overall Study|Adverse Event|53
7814644|NCT00412893|27143762|P1|Overall Study|Adverse Event|31
7814645|NCT00412854|27143800|P2|Overall Study|Withdrawn for other reasons|11
7814646|NCT00412854|27143801|P1|Overall Study|Withdrawn for other reasons|13
7814647|NCT00412854|27143800|P2|Overall Study|Withdrawn due to adverse events|5
7814648|NCT00412854|27143801|P1|Overall Study|Withdrawn due to adverse events|1
7814649|NCT00412750|27143845|P3|Overall Study|Lack of Efficacy|3
7814650|NCT00412750|27143846|P2|Overall Study|Lack of Efficacy|0
7814651|NCT00412750|27143847|P1|Overall Study|Lack of Efficacy|0
7814652|NCT00412750|27143845|P3|Overall Study|Withdrawal by Subject|2
7814653|NCT00412750|27143846|P2|Overall Study|Withdrawal by Subject|1
7814654|NCT00412750|27143847|P1|Overall Study|Withdrawal by Subject|0
7814655|NCT00412750|27143845|P3|Overall Study|Lost to Follow-up|1
7814656|NCT00412750|27143846|P2|Overall Study|Lost to Follow-up|0
7814657|NCT00412750|27143847|P1|Overall Study|Lost to Follow-up|1
7814658|NCT00412750|27143845|P3|Overall Study|Adverse Event|3
7814659|NCT00412750|27143846|P2|Overall Study|Adverse Event|3
7814660|NCT00412750|27143847|P1|Overall Study|Adverse Event|8
7814661|NCT00412750|27143845|P3|Overall Study|Administrative problems|14
7814662|NCT00412750|27143846|P2|Overall Study|Administrative problems|17
7814663|NCT00412750|27143847|P1|Overall Study|Administrative problems|21
7814664|NCT00412750|27143845|P3|Overall Study|Abnormal laboratory value(s)|0
7814665|NCT00412750|27143846|P2|Overall Study|Abnormal laboratory value(s)|0
7814666|NCT00412750|27143847|P1|Overall Study|Abnormal laboratory value(s)|1
7814667|NCT00412737|27143872|P2|Overall Study|Failure to Return|2
7814668|NCT00412737|27143873|P1|Overall Study|Failure to Return|6
7814669|NCT00412737|27143872|P2|Overall Study|Refused Treatment|2
7814670|NCT00412737|27143873|P1|Overall Study|Refused Treatment|6
7814671|NCT00412737|27143872|P2|Overall Study|Adverse Event|2
7814672|NCT00412737|27143873|P1|Overall Study|Adverse Event|3
7814673|NCT00412737|27143872|P2|Overall Study|Death|0
7814674|NCT00412737|27143873|P1|Overall Study|Death|1
7814675|NCT00412607|27143891|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
7814676|NCT00412607|27143891|P1|Overall Study|Death|61
7814677|NCT00412607|27143891|P1|Overall Study|Lost to Follow-up|19
7814678|NCT00412607|27143891|P1|Overall Study|Withdrawal by Subject|9
7814679|NCT00412542|27143904|P2|Overall Study|Not Eligible|1
7814680|NCT00412542|27143905|P1|Overall Study|Not Eligible|0
7814681|NCT00412542|27143904|P2|Overall Study|Withdrawal by Subject|2
7814682|NCT00412542|27143905|P1|Overall Study|Withdrawal by Subject|0
7814683|NCT00412373|27143990|P2|Overall Study|Other|2
7814684|NCT00412373|27143991|P1|Overall Study|Other|2
7814685|NCT00412373|27143990|P2|Overall Study|Withdrawal by Subject|27
7814686|NCT00412373|27143991|P1|Overall Study|Withdrawal by Subject|8
7814687|NCT00412373|27143990|P2|Overall Study|Lost to Follow-up|13
7814688|NCT00412373|27143991|P1|Overall Study|Lost to Follow-up|7
7814689|NCT00412373|27143990|P2|Overall Study|Lack of Efficacy|22
7814690|NCT00412373|27143991|P1|Overall Study|Lack of Efficacy|16
7814691|NCT00412373|27143990|P2|Overall Study|Adverse Event|13
7814692|NCT00412373|27143991|P1|Overall Study|Adverse Event|8
7814697|NCT00412217|27144064|P2|Overall Study|Other|1
7814698|NCT00412217|27144065|P1|Overall Study|Other|1
7814699|NCT00412217|27144064|P2|Overall Study|Study Terminated by Sponsor|33
7814700|NCT00412217|27144065|P1|Overall Study|Study Terminated by Sponsor|26
7814701|NCT00412217|27144064|P2|Overall Study|Lost to Follow-up|4
7814702|NCT00412217|27144065|P1|Overall Study|Lost to Follow-up|1
7814703|NCT00412217|27144064|P2|Overall Study|Withdrawal by Subject|0
7814704|NCT00412217|27144065|P1|Overall Study|Withdrawal by Subject|2
7814705|NCT00412217|27144064|P2|Overall Study|Investigator Decision|0
7814706|NCT00412217|27144065|P1|Overall Study|Investigator Decision|1
7814707|NCT00412217|27144064|P2|Overall Study|Disease Progression|3
7814708|NCT00412217|27144065|P1|Overall Study|Disease Progression|2
7814709|NCT00412217|27144064|P2|Overall Study|Death|4
7814710|NCT00412217|27144065|P1|Overall Study|Death|5
7814711|NCT00412217|27144064|P2|Overall Study|Insufficient Data Available|3
7814712|NCT00412217|27144065|P1|Overall Study|Insufficient Data Available|8
7814713|NCT00412113|27144079|P2|Overall Study|did not receive treatment|0
7814714|NCT00412113|27144080|P1|Overall Study|did not receive treatment|1
7814715|NCT00412113|27144079|P2|Overall Study|Adverse Event|15
7814716|NCT00412113|27144080|P1|Overall Study|Adverse Event|11
7814717|NCT00412061|27144164|P2|Open Label Phase|New Cancer Therapy|1
7814718|NCT00412061|27144165|P1|Open Label Phase|New Cancer Therapy|0
7814719|NCT00412061|27144164|P2|Open Label Phase|Lost to Follow-up|2
7814720|NCT00412061|27144165|P1|Open Label Phase|Lost to Follow-up|0
7814721|NCT00412061|27144164|P2|Open Label Phase|Death|7
7814722|NCT00412061|27144165|P1|Open Label Phase|Death|0
7814723|NCT00412061|27144164|P2|Open Label Phase|Administrative Problems|13
7814724|NCT00412061|27144165|P1|Open Label Phase|Administrative Problems|0
7814725|NCT00412061|27144164|P2|Open Label Phase|Withdrawal by Subject|15
7814726|NCT00412061|27144165|P1|Open Label Phase|Withdrawal by Subject|0
7814727|NCT00412061|27144164|P2|Open Label Phase|Adverse Event|46
7814728|NCT00412061|27144165|P1|Open Label Phase|Adverse Event|0
7814729|NCT00412061|27144164|P2|Open Label Phase|Disease Progression|86
7814730|NCT00412061|27144165|P1|Open Label Phase|Disease Progression|0
7814731|NCT00412061|27144164|P2|Double Blind Phase|Lost to Follow-up|1
7814732|NCT00412061|27144165|P1|Double Blind Phase|Lost to Follow-up|0
7814733|NCT00412061|27144164|P2|Double Blind Phase|New Cander Therapy|1
7814734|NCT00412061|27144165|P1|Double Blind Phase|New Cander Therapy|1
7814735|NCT00412061|27144164|P2|Double Blind Phase|Protocol Violation|4
7814736|NCT00412061|27144165|P1|Double Blind Phase|Protocol Violation|3
7814737|NCT00412061|27144164|P2|Double Blind Phase|Death|3
7814738|NCT00412061|27144165|P1|Double Blind Phase|Death|6
7814739|NCT00412061|27144164|P2|Double Blind Phase|Withdrawal by Subject|20
7814740|NCT00412061|27144165|P1|Double Blind Phase|Withdrawal by Subject|18
7814741|NCT00412061|27144164|P2|Double Blind Phase|Final Primary Analysis|14
7814742|NCT00412061|27144165|P1|Double Blind Phase|Final Primary Analysis|26
7814743|NCT00412061|27144164|P2|Double Blind Phase|Adverse Event|16
7814744|NCT00412061|27144165|P1|Double Blind Phase|Adverse Event|61
7814745|NCT00412061|27144164|P2|Double Blind Phase|Disease Progression|154
7814746|NCT00412061|27144165|P1|Double Blind Phase|Disease Progression|101
7814747|NCT00411788|27144183|P1|Overall Study|Adverse Event|1
7814748|NCT00411788|27144183|P1|Overall Study|Protocol Violation|1
7814749|NCT00411762|27144192|P1|Overall Study|Withdrawal by Subject|5
7814750|NCT00411671|27144223|P1|Overall Study|Lost to Follow-up|3
7814751|NCT00411671|27144223|P1|Overall Study|Death|2
7814752|NCT00411671|27144223|P1|Overall Study|Adverse Event|15
7814753|NCT00411645|27144231|P2|Overall Study|Lost to Follow-up|0
7814754|NCT00411645|27144232|P1|Overall Study|Lost to Follow-up|2
7814755|NCT00411645|27144231|P2|Overall Study|Investigator/Sponsor Decision|7
7814756|NCT00411645|27144232|P1|Overall Study|Investigator/Sponsor Decision|10
7814757|NCT00411645|27144231|P2|Overall Study|Death|135
7814758|NCT00411645|27144232|P1|Overall Study|Death|56
7814759|NCT00411645|27144231|P2|Overall Study|Consent Withdrawn|22
7814760|NCT00411645|27144232|P1|Overall Study|Consent Withdrawn|13
7814761|NCT00411632|27144256|P1|Overall Study|Death|1
7814762|NCT00411554|27144267|P2|Overall Study|Patient Moved|0
7814763|NCT00411554|27144268|P1|Overall Study|Patient Moved|1
7814764|NCT00411554|27144267|P2|Overall Study|Withdrawal by Subject|0
7814765|NCT00411554|27144268|P1|Overall Study|Withdrawal by Subject|3
7814766|NCT00411554|27144267|P2|Overall Study|Lack of Efficacy|5
7814767|NCT00411554|27144268|P1|Overall Study|Lack of Efficacy|2
7814768|NCT00411554|27144267|P2|Overall Study|Adverse Event|4
7814769|NCT00411554|27144268|P1|Overall Study|Adverse Event|2
7814770|NCT00411450|27144294|P1|Overall Study|Ongoing at time of data cut-off.|3
7814771|NCT00411216|27144337|P2|Overall Study|Ten participants were entered into the c|2
7814772|NCT00411216|27144338|P1|Overall Study|Ten participants were entered into the c|0
7814773|NCT00411151|27144344|P1|Overall Study|Trial prematurely closed|4
7814774|NCT00411151|27144344|P1|Overall Study|Protocol Violation|1
7814775|NCT00411151|27144344|P1|Overall Study|Lost to Follow-up|2
7814776|NCT00411151|27144344|P1|Overall Study|Withdrawal by Subject|2
7814777|NCT00411151|27144344|P1|Overall Study|Death|38
7814778|NCT00410813|27144388|P2|Overall Study|Death|2
7814779|NCT00410813|27144389|P1|Overall Study|Death|0
7814780|NCT00410813|27144388|P2|Overall Study|Ineligible|4
7814781|NCT00410813|27144389|P1|Overall Study|Ineligible|2
7814782|NCT00410813|27144388|P2|Overall Study|Not protocol specified|4
7814783|NCT00410813|27144389|P1|Overall Study|Not protocol specified|3
7814784|NCT00410813|27144388|P2|Overall Study|Progression|21
7814785|NCT00410813|27144389|P1|Overall Study|Progression|32
7814786|NCT00410813|27144388|P2|Overall Study|Adverse Event|11
7814787|NCT00410813|27144389|P1|Overall Study|Adverse Event|6
7814788|NCT00410761|27144426|P2|Overall Study|Never received randomised treatment|1
7814789|NCT00410761|27144427|P1|Overall Study|Never received randomised treatment|0
7814790|NCT00410761|27144426|P2|Overall Study|Other|9
7814791|NCT00410761|27144427|P1|Overall Study|Other|12
7814792|NCT00410761|27144426|P2|Overall Study|Withdrawal by Subject|4
7814793|NCT00410761|27144427|P1|Overall Study|Withdrawal by Subject|8
7814794|NCT00410761|27144426|P2|Overall Study|objective disease progression|55
7814795|NCT00410761|27144427|P1|Overall Study|objective disease progression|71
7814796|NCT00410761|27144426|P2|Overall Study|Adverse Event|3
7814797|NCT00410761|27144427|P1|Overall Study|Adverse Event|29
7814798|NCT00410605|27144447|P1|Overall Study|Transferred to another Institution|1
7814799|NCT00410605|27144447|P1|Overall Study|Stopped treatmen to collect stem cells|1
7814800|NCT00410605|27144447|P1|Overall Study|Started Non-Protocol Therapy|3
7814801|NCT00410605|27144447|P1|Overall Study|Withdrawal by Subject|5
7814802|NCT00410605|27144447|P1|Overall Study|Physician Decision|3
7814803|NCT00410605|27144447|P1|Overall Study|Adverse Event|12
7814804|NCT00410514|27144459|P3|Overall Study|Non-compliant with study procedures|2
7814805|NCT00410514|27144460|P2|Overall Study|Non-compliant with study procedures|0
7814806|NCT00410514|27144461|P1|Overall Study|Non-compliant with study procedures|0
7814807|NCT00410514|27144459|P3|Overall Study|Lost to Follow-up|2
7814808|NCT00410514|27144460|P2|Overall Study|Lost to Follow-up|0
7814809|NCT00410514|27144461|P1|Overall Study|Lost to Follow-up|0
7814810|NCT00410514|27144459|P3|Overall Study|Protocol Violation|1
7814811|NCT00410514|27144460|P2|Overall Study|Protocol Violation|1
7814812|NCT00410514|27144461|P1|Overall Study|Protocol Violation|0
7814813|NCT00410514|27144459|P3|Overall Study|Adverse Event|2
7814814|NCT00410514|27144460|P2|Overall Study|Adverse Event|2
7814815|NCT00410514|27144461|P1|Overall Study|Adverse Event|2
7814816|NCT00410410|27144544|P9|Open-Label Period (OL)|Other|7
7814817|NCT00410410|27144545|P8|Open-Label Period (OL)|Other|0
7814818|NCT00410410|27144546|P7|Open-Label Period (OL)|Other|0
7814819|NCT00410410|27144547|P6|Open-Label Period (OL)|Other|0
7814820|NCT00410410|27144548|P5|Open-Label Period (OL)|Other|0
7814821|NCT00410410|27144549|P4|Open-Label Period (OL)|Other|0
7814822|NCT00410410|27144550|P3|Open-Label Period (OL)|Other|0
7814823|NCT00410410|27144551|P2|Open-Label Period (OL)|Other|0
7814824|NCT00410410|27144552|P1|Open-Label Period (OL)|Other|0
7814825|NCT00410410|27144544|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
7814826|NCT00410410|27144545|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814827|NCT00410410|27144546|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814828|NCT00410410|27144547|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814829|NCT00410410|27144548|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814830|NCT00410410|27144549|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814831|NCT00410410|27144550|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814832|NCT00410410|27144551|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814833|NCT00410410|27144552|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7814834|NCT00410410|27144544|P9|Open-Label Period (OL)|Pregnancy|1
7814835|NCT00410410|27144545|P8|Open-Label Period (OL)|Pregnancy|0
7814836|NCT00410410|27144546|P7|Open-Label Period (OL)|Pregnancy|0
7814837|NCT00410410|27144547|P6|Open-Label Period (OL)|Pregnancy|0
7814838|NCT00410410|27144548|P5|Open-Label Period (OL)|Pregnancy|0
7814839|NCT00410410|27144549|P4|Open-Label Period (OL)|Pregnancy|0
7814840|NCT00410410|27144550|P3|Open-Label Period (OL)|Pregnancy|0
7814841|NCT00410410|27144551|P2|Open-Label Period (OL)|Pregnancy|0
7814842|NCT00410410|27144552|P1|Open-Label Period (OL)|Pregnancy|0
7814843|NCT00410410|27144544|P9|Open-Label Period (OL)|Withdrawal by Subject|20
7814844|NCT00410410|27144545|P8|Open-Label Period (OL)|Withdrawal by Subject|0
7814845|NCT00410410|27144546|P7|Open-Label Period (OL)|Withdrawal by Subject|0
7814846|NCT00410410|27144547|P6|Open-Label Period (OL)|Withdrawal by Subject|0
7814847|NCT00410410|27144548|P5|Open-Label Period (OL)|Withdrawal by Subject|0
7814848|NCT00410410|27144549|P4|Open-Label Period (OL)|Withdrawal by Subject|0
7814849|NCT00410410|27144550|P3|Open-Label Period (OL)|Withdrawal by Subject|0
7814850|NCT00410410|27144551|P2|Open-Label Period (OL)|Withdrawal by Subject|0
7814851|NCT00410410|27144552|P1|Open-Label Period (OL)|Withdrawal by Subject|0
7814852|NCT00410410|27144544|P9|Open-Label Period (OL)|Lost to Follow-up|4
7814853|NCT00410410|27144545|P8|Open-Label Period (OL)|Lost to Follow-up|0
7814854|NCT00410410|27144546|P7|Open-Label Period (OL)|Lost to Follow-up|0
7814855|NCT00410410|27144547|P6|Open-Label Period (OL)|Lost to Follow-up|0
7814856|NCT00410410|27144548|P5|Open-Label Period (OL)|Lost to Follow-up|0
7814857|NCT00410410|27144549|P4|Open-Label Period (OL)|Lost to Follow-up|0
7814858|NCT00410410|27144550|P3|Open-Label Period (OL)|Lost to Follow-up|0
7814859|NCT00410410|27144551|P2|Open-Label Period (OL)|Lost to Follow-up|0
7814860|NCT00410410|27144552|P1|Open-Label Period (OL)|Lost to Follow-up|0
7814861|NCT00410410|27144544|P9|Open-Label Period (OL)|Lack of Efficacy|161
7814862|NCT00410410|27144545|P8|Open-Label Period (OL)|Lack of Efficacy|0
7814863|NCT00410410|27144546|P7|Open-Label Period (OL)|Lack of Efficacy|0
7814864|NCT00410410|27144547|P6|Open-Label Period (OL)|Lack of Efficacy|0
7814865|NCT00410410|27144548|P5|Open-Label Period (OL)|Lack of Efficacy|0
7814866|NCT00410410|27144549|P4|Open-Label Period (OL)|Lack of Efficacy|0
7814867|NCT00410410|27144550|P3|Open-Label Period (OL)|Lack of Efficacy|0
7814868|NCT00410410|27144551|P2|Open-Label Period (OL)|Lack of Efficacy|0
7814869|NCT00410410|27144552|P1|Open-Label Period (OL)|Lack of Efficacy|0
7814870|NCT00410410|27144544|P9|Open-Label Period (OL)|Adverse Event|10
7814871|NCT00410410|27144545|P8|Open-Label Period (OL)|Adverse Event|0
7814872|NCT00410410|27144546|P7|Open-Label Period (OL)|Adverse Event|0
7814873|NCT00410410|27144547|P6|Open-Label Period (OL)|Adverse Event|0
7814874|NCT00410410|27144548|P5|Open-Label Period (OL)|Adverse Event|0
7814875|NCT00410410|27144549|P4|Open-Label Period (OL)|Adverse Event|0
7814876|NCT00410410|27144550|P3|Open-Label Period (OL)|Adverse Event|0
7814877|NCT00410410|27144551|P2|Open-Label Period (OL)|Adverse Event|0
7814878|NCT00410410|27144552|P1|Open-Label Period (OL)|Adverse Event|0
7814879|NCT00410410|27144544|P9|Open-Label Period (OL)|Death|1
7814880|NCT00410410|27144545|P8|Open-Label Period (OL)|Death|0
7814881|NCT00410410|27144546|P7|Open-Label Period (OL)|Death|0
7814882|NCT00410410|27144547|P6|Open-Label Period (OL)|Death|0
7814883|NCT00410410|27144548|P5|Open-Label Period (OL)|Death|0
7814884|NCT00410410|27144549|P4|Open-Label Period (OL)|Death|0
7814885|NCT00410410|27144550|P3|Open-Label Period (OL)|Death|0
7814886|NCT00410410|27144551|P2|Open-Label Period (OL)|Death|0
7814887|NCT00410410|27144552|P1|Open-Label Period (OL)|Death|0
7814888|NCT00410410|27144544|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814889|NCT00410410|27144545|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
7814890|NCT00410410|27144546|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
7814891|NCT00410410|27144547|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814892|NCT00410410|27144548|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814893|NCT00410410|27144549|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814894|NCT00410410|27144550|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814895|NCT00410410|27144551|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814896|NCT00410410|27144552|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7814897|NCT00410410|27144544|P9|Maintenance Period (MP)|Withdrawal by Subject|0
7814898|NCT00410410|27144545|P8|Maintenance Period (MP)|Withdrawal by Subject|1
7814899|NCT00410410|27144546|P7|Maintenance Period (MP)|Withdrawal by Subject|1
7814900|NCT00410410|27144547|P6|Maintenance Period (MP)|Withdrawal by Subject|0
7814901|NCT00410410|27144548|P5|Maintenance Period (MP)|Withdrawal by Subject|0
7814902|NCT00410410|27144549|P4|Maintenance Period (MP)|Withdrawal by Subject|0
7814903|NCT00410410|27144550|P3|Maintenance Period (MP)|Withdrawal by Subject|0
7814904|NCT00410410|27144551|P2|Maintenance Period (MP)|Withdrawal by Subject|0
7814905|NCT00410410|27144552|P1|Maintenance Period (MP)|Withdrawal by Subject|0
7814906|NCT00410410|27144544|P9|Maintenance Period (MP)|Lost to Follow-up|0
7814907|NCT00410410|27144545|P8|Maintenance Period (MP)|Lost to Follow-up|2
7814908|NCT00410410|27144546|P7|Maintenance Period (MP)|Lost to Follow-up|1
7814909|NCT00410410|27144547|P6|Maintenance Period (MP)|Lost to Follow-up|0
7814910|NCT00410410|27144548|P5|Maintenance Period (MP)|Lost to Follow-up|0
7814911|NCT00410410|27144549|P4|Maintenance Period (MP)|Lost to Follow-up|0
7814912|NCT00410410|27144550|P3|Maintenance Period (MP)|Lost to Follow-up|0
7814913|NCT00410410|27144551|P2|Maintenance Period (MP)|Lost to Follow-up|0
7814914|NCT00410410|27144552|P1|Maintenance Period (MP)|Lost to Follow-up|0
7814915|NCT00410410|27144544|P9|Maintenance Period (MP)|Lack of Efficacy|0
7814916|NCT00410410|27144545|P8|Maintenance Period (MP)|Lack of Efficacy|24
7814917|NCT00410410|27144546|P7|Maintenance Period (MP)|Lack of Efficacy|25
7814918|NCT00410410|27144547|P6|Maintenance Period (MP)|Lack of Efficacy|0
7814919|NCT00410410|27144548|P5|Maintenance Period (MP)|Lack of Efficacy|0
7814920|NCT00410410|27144549|P4|Maintenance Period (MP)|Lack of Efficacy|0
7814921|NCT00410410|27144550|P3|Maintenance Period (MP)|Lack of Efficacy|0
7814922|NCT00410410|27144551|P2|Maintenance Period (MP)|Lack of Efficacy|0
7814923|NCT00410410|27144552|P1|Maintenance Period (MP)|Lack of Efficacy|0
7814924|NCT00410410|27144544|P9|Maintenance Period (MP)|Adverse Event|0
7814925|NCT00410410|27144545|P8|Maintenance Period (MP)|Adverse Event|3
7814926|NCT00410410|27144546|P7|Maintenance Period (MP)|Adverse Event|1
7814927|NCT00410410|27144547|P6|Maintenance Period (MP)|Adverse Event|0
7814928|NCT00410410|27144548|P5|Maintenance Period (MP)|Adverse Event|0
7814929|NCT00410410|27144549|P4|Maintenance Period (MP)|Adverse Event|0
7814930|NCT00410410|27144550|P3|Maintenance Period (MP)|Adverse Event|0
7814931|NCT00410410|27144551|P2|Maintenance Period (MP)|Adverse Event|0
7814932|NCT00410410|27144552|P1|Maintenance Period (MP)|Adverse Event|0
7814933|NCT00410410|27144544|P9|Maintenance Period (MP)|Death|0
7814934|NCT00410410|27144545|P8|Maintenance Period (MP)|Death|0
7814935|NCT00410410|27144546|P7|Maintenance Period (MP)|Death|1
7814936|NCT00410410|27144547|P6|Maintenance Period (MP)|Death|0
7814937|NCT00410410|27144548|P5|Maintenance Period (MP)|Death|0
7814938|NCT00410410|27144549|P4|Maintenance Period (MP)|Death|0
7814939|NCT00410410|27144550|P3|Maintenance Period (MP)|Death|0
7814940|NCT00410410|27144551|P2|Maintenance Period (MP)|Death|0
7814941|NCT00410410|27144552|P1|Maintenance Period (MP)|Death|0
7814942|NCT00410410|27144544|P9|Induction Period (IP)|Other|0
7814943|NCT00410410|27144545|P8|Induction Period (IP)|Other|0
7814944|NCT00410410|27144546|P7|Induction Period (IP)|Other|0
7814945|NCT00410410|27144547|P6|Induction Period (IP)|Other|0
7814946|NCT00410410|27144548|P5|Induction Period (IP)|Other|0
7814947|NCT00410410|27144549|P4|Induction Period (IP)|Other|0
7814948|NCT00410410|27144550|P3|Induction Period (IP)|Other|1
7814949|NCT00410410|27144551|P2|Induction Period (IP)|Other|0
7814950|NCT00410410|27144552|P1|Induction Period (IP)|Other|0
7814951|NCT00410410|27144544|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
7814952|NCT00410410|27144545|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
7814953|NCT00410410|27144546|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
7814954|NCT00410410|27144547|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
7814955|NCT00410410|27144548|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
7814956|NCT00410410|27144549|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
7814957|NCT00410410|27144550|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
7814958|NCT00410410|27144551|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
7814959|NCT00410410|27144552|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
7814960|NCT00410410|27144544|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814961|NCT00410410|27144545|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814962|NCT00410410|27144546|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814963|NCT00410410|27144547|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814964|NCT00410410|27144548|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814965|NCT00410410|27144549|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814966|NCT00410410|27144550|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
7814967|NCT00410410|27144551|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814968|NCT00410410|27144552|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7814969|NCT00410410|27144544|P9|Induction Period (IP)|Withdrawal by Subject|0
7814970|NCT00410410|27144545|P8|Induction Period (IP)|Withdrawal by Subject|0
7814971|NCT00410410|27144546|P7|Induction Period (IP)|Withdrawal by Subject|0
7814972|NCT00410410|27144547|P6|Induction Period (IP)|Withdrawal by Subject|0
7814973|NCT00410410|27144548|P5|Induction Period (IP)|Withdrawal by Subject|2
7814974|NCT00410410|27144549|P4|Induction Period (IP)|Withdrawal by Subject|5
7814975|NCT00410410|27144550|P3|Induction Period (IP)|Withdrawal by Subject|3
7814976|NCT00410410|27144551|P2|Induction Period (IP)|Withdrawal by Subject|5
7814977|NCT00410410|27144552|P1|Induction Period (IP)|Withdrawal by Subject|3
7814978|NCT00410410|27144544|P9|Induction Period (IP)|Lost to Follow-up|0
7814979|NCT00410410|27144545|P8|Induction Period (IP)|Lost to Follow-up|0
7814980|NCT00410410|27144546|P7|Induction Period (IP)|Lost to Follow-up|0
7814981|NCT00410410|27144547|P6|Induction Period (IP)|Lost to Follow-up|1
7814982|NCT00410410|27144548|P5|Induction Period (IP)|Lost to Follow-up|0
7814983|NCT00410410|27144549|P4|Induction Period (IP)|Lost to Follow-up|3
7814984|NCT00410410|27144550|P3|Induction Period (IP)|Lost to Follow-up|2
7814985|NCT00410410|27144551|P2|Induction Period (IP)|Lost to Follow-up|2
7814986|NCT00410410|27144552|P1|Induction Period (IP)|Lost to Follow-up|2
7814987|NCT00410410|27144544|P9|Induction Period (IP)|Lack of Efficacy|0
7814988|NCT00410410|27144545|P8|Induction Period (IP)|Lack of Efficacy|0
7814989|NCT00410410|27144546|P7|Induction Period (IP)|Lack of Efficacy|0
7814990|NCT00410410|27144547|P6|Induction Period (IP)|Lack of Efficacy|7
7814991|NCT00410410|27144548|P5|Induction Period (IP)|Lack of Efficacy|7
7814992|NCT00410410|27144549|P4|Induction Period (IP)|Lack of Efficacy|8
7814993|NCT00410410|27144550|P3|Induction Period (IP)|Lack of Efficacy|8
7814994|NCT00410410|27144551|P2|Induction Period (IP)|Lack of Efficacy|24
7814995|NCT00410410|27144552|P1|Induction Period (IP)|Lack of Efficacy|26
7814996|NCT00410410|27144544|P9|Induction Period (IP)|Adverse Event|0
7814997|NCT00410410|27144545|P8|Induction Period (IP)|Adverse Event|0
7814998|NCT00410410|27144546|P7|Induction Period (IP)|Adverse Event|0
7814999|NCT00410410|27144547|P6|Induction Period (IP)|Adverse Event|0
7815000|NCT00410410|27144548|P5|Induction Period (IP)|Adverse Event|1
7815001|NCT00410410|27144549|P4|Induction Period (IP)|Adverse Event|4
7815002|NCT00410410|27144550|P3|Induction Period (IP)|Adverse Event|2
7815003|NCT00410410|27144551|P2|Induction Period (IP)|Adverse Event|4
7815004|NCT00410410|27144552|P1|Induction Period (IP)|Adverse Event|3
7815005|NCT00410410|27144544|P9|Induction Period (IP)|Death|0
7815006|NCT00410410|27144545|P8|Induction Period (IP)|Death|0
7815007|NCT00410410|27144546|P7|Induction Period (IP)|Death|0
7815008|NCT00410410|27144547|P6|Induction Period (IP)|Death|0
7815009|NCT00410410|27144548|P5|Induction Period (IP)|Death|0
7815010|NCT00410410|27144549|P4|Induction Period (IP)|Death|0
7815011|NCT00410410|27144550|P3|Induction Period (IP)|Death|0
7815012|NCT00410410|27144551|P2|Induction Period (IP)|Death|0
7815013|NCT00410410|27144552|P1|Induction Period (IP)|Death|1
7815014|NCT00410384|27144713|P3|Overall Study|Other|4
7815015|NCT00410384|27144714|P2|Overall Study|Other|8
7815016|NCT00410384|27144715|P1|Overall Study|Other|3
7815017|NCT00410384|27144713|P3|Overall Study|Physician Decision|4
7815018|NCT00410384|27144714|P2|Overall Study|Physician Decision|3
7815019|NCT00410384|27144715|P1|Overall Study|Physician Decision|3
7815020|NCT00410384|27144713|P3|Overall Study|Protocol Violation|6
7815021|NCT00410384|27144714|P2|Overall Study|Protocol Violation|6
7815022|NCT00410384|27144715|P1|Overall Study|Protocol Violation|6
7815023|NCT00410384|27144713|P3|Overall Study|Lost to Follow-up|6
7815024|NCT00410384|27144714|P2|Overall Study|Lost to Follow-up|6
7815025|NCT00410384|27144715|P1|Overall Study|Lost to Follow-up|4
7815026|NCT00410384|27144713|P3|Overall Study|Lack of Compliance|2
7815027|NCT00410384|27144714|P2|Overall Study|Lack of Compliance|2
7815028|NCT00410384|27144715|P1|Overall Study|Lack of Compliance|2
7815029|NCT00410384|27144713|P3|Overall Study|Lack of Efficacy|17
7815030|NCT00410384|27144714|P2|Overall Study|Lack of Efficacy|12
7815031|NCT00410384|27144715|P1|Overall Study|Lack of Efficacy|20
7815032|NCT00410384|27144713|P3|Overall Study|Adverse Event|23
7815033|NCT00410384|27144714|P2|Overall Study|Adverse Event|18
7815034|NCT00410384|27144715|P1|Overall Study|Adverse Event|23
7815035|NCT00410384|27144713|P3|Overall Study|Withdrawal by Subject|20
7815036|NCT00410384|27144714|P2|Overall Study|Withdrawal by Subject|17
7815037|NCT00410384|27144715|P1|Overall Study|Withdrawal by Subject|28
7815038|NCT00410202|27144788|P3|Off-treatment Follow up|Lost to Follow-up|0
7815039|NCT00410202|27144789|P2|Off-treatment Follow up|Lost to Follow-up|0
7815040|NCT00410202|27144790|P1|Off-treatment Follow up|Lost to Follow-up|1
7815041|NCT00410202|27144788|P3|Off-treatment Follow up|Follow up not required per protocol|1
7815042|NCT00410202|27144789|P2|Off-treatment Follow up|Follow up not required per protocol|0
7815043|NCT00410202|27144790|P1|Off-treatment Follow up|Follow up not required per protocol|3
7815044|NCT00410202|27144788|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
7815045|NCT00410202|27144789|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
7815046|NCT00410202|27144790|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
7815047|NCT00410202|27144788|P3|On-Treatment|Other Reason|1
7815048|NCT00410202|27144789|P2|On-Treatment|Other Reason|0
7815049|NCT00410202|27144790|P1|On-Treatment|Other Reason|0
7815050|NCT00410202|27144788|P3|On-Treatment|Withdrawal by Subject|1
7815051|NCT00410202|27144789|P2|On-Treatment|Withdrawal by Subject|1
7815052|NCT00410202|27144790|P1|On-Treatment|Withdrawal by Subject|2
7815053|NCT00410202|27144788|P3|On-Treatment|Lack of Efficacy|0
7815054|NCT00410202|27144789|P2|On-Treatment|Lack of Efficacy|4
7815055|NCT00410202|27144790|P1|On-Treatment|Lack of Efficacy|1
7815056|NCT00410202|27144788|P3|On-Treatment|Lost to Follow-up|1
7815057|NCT00410202|27144789|P2|On-Treatment|Lost to Follow-up|0
7815058|NCT00410202|27144790|P1|On-Treatment|Lost to Follow-up|1
7815059|NCT00410202|27144788|P3|On-Treatment|Death|0
7815060|NCT00410202|27144789|P2|On-Treatment|Death|0
7815061|NCT00410202|27144790|P1|On-Treatment|Death|1
7815062|NCT00410202|27144788|P3|On-Treatment|Adverse Event|2
7815063|NCT00410202|27144789|P2|On-Treatment|Adverse Event|3
7815064|NCT00410202|27144790|P1|On-Treatment|Adverse Event|1
7815065|NCT00410202|27144788|P3|On-Treatment|Continuing treatment|66
7815066|NCT00410202|27144789|P2|On-Treatment|Continuing treatment|71
7815067|NCT00410202|27144790|P1|On-Treatment|Continuing treatment|69
7815068|NCT00410163|27144877|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
7815069|NCT00410163|27144878|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
7815070|NCT00410163|27144877|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
7815071|NCT00410163|27144878|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
7815072|NCT00410163|27144877|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
7815073|NCT00410163|27144878|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
7815074|NCT00410163|27144877|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
7815075|NCT00410163|27144878|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
7815076|NCT00410163|27144877|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
7815077|NCT00410163|27144878|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
7815078|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
7815079|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
7815080|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
7815081|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
7815082|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
7815083|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
7815084|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
7815085|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
7815086|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
7815087|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
7815088|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
7815089|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
7815090|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
7815091|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
7815092|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Death|1
7815093|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Death|1
7815094|NCT00410163|27144877|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
7815095|NCT00410163|27144878|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
7815096|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
7815097|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
7815098|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
7815099|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
7815100|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
7815101|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
7815102|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Death|10
7815103|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Death|2
7815104|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
7815105|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
7815106|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
7815107|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
7815108|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
7815109|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
7815110|NCT00410124|27144931|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
7815111|NCT00410124|27144932|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
7815112|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
7815113|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
7815114|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Death|4
7815115|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Death|7
7815116|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
7815117|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
7815118|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
7815119|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
7815120|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
7815121|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
7815122|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
7815123|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
7815124|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
7815125|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
7815126|NCT00410124|27144931|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
7815127|NCT00410124|27144932|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
7815128|NCT00410072|27144963|P2|After Week 48 to Week 96|Withdrawal by Subject|1
7815129|NCT00410072|27144964|P1|After Week 48 to Week 96|Withdrawal by Subject|0
7815130|NCT00410072|27144963|P2|After Week 48 to Week 96|Pregnancy|2
7815131|NCT00410072|27144964|P1|After Week 48 to Week 96|Pregnancy|0
7815132|NCT00410072|27144963|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
7815133|NCT00410072|27144964|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
7815134|NCT00410072|27144963|P2|After Week 48 to Week 96|Other|0
7815135|NCT00410072|27144964|P1|After Week 48 to Week 96|Other|2
7815136|NCT00410072|27144963|P2|After Week 48 to Week 96|Lost to Follow-up|4
7815137|NCT00410072|27144964|P1|After Week 48 to Week 96|Lost to Follow-up|2
7815138|NCT00410072|27144963|P2|After Week 48 to Week 96|Lack of Efficacy|0
7815139|NCT00410072|27144964|P1|After Week 48 to Week 96|Lack of Efficacy|1
7815140|NCT00410072|27144963|P2|After Week 48 to Week 96|Death|1
7815141|NCT00410072|27144964|P1|After Week 48 to Week 96|Death|0
7815142|NCT00410072|27144963|P2|After Week 48 to Week 96|Adverse Event|2
7815143|NCT00410072|27144964|P1|After Week 48 to Week 96|Adverse Event|1
7815144|NCT00410072|27144963|P2|Day 1 to Week 48|Withdrawal by Subject|2
7815145|NCT00410072|27144964|P1|Day 1 to Week 48|Withdrawal by Subject|0
7815146|NCT00410072|27144963|P2|Day 1 to Week 48|Pregnancy|2
7815147|NCT00410072|27144964|P1|Day 1 to Week 48|Pregnancy|0
7815148|NCT00410072|27144963|P2|Day 1 to Week 48|poor compliance/noncompliance|3
7815149|NCT00410072|27144964|P1|Day 1 to Week 48|poor compliance/noncompliance|0
7815150|NCT00410072|27144963|P2|Day 1 to Week 48|Other|1
7815151|NCT00410072|27144964|P1|Day 1 to Week 48|Other|0
7815152|NCT00410072|27144963|P2|Day 1 to Week 48|Lost to Follow-up|2
7815153|NCT00410072|27144964|P1|Day 1 to Week 48|Lost to Follow-up|5
7815154|NCT00410072|27144963|P2|Day 1 to Week 48|Adverse Event|2
7815155|NCT00410072|27144964|P1|Day 1 to Week 48|Adverse Event|1
7815156|NCT00410046|27145004|P1|Overall Study|Lost to Follow-up|1
7815157|NCT00410046|27145004|P1|Overall Study|Withdrawal by Subject|1
7815158|NCT00410046|27145004|P1|Overall Study|Adverse Event|3
7815159|NCT00409838|27145035|P2|Long-term Extension Period|Pregnancy|0
7815160|NCT00409838|27145036|P1|Long-term Extension Period|Pregnancy|1
7815161|NCT00409838|27145035|P2|Long-term Extension Period|Poor compliance/noncompliance|0
7815162|NCT00409838|27145036|P1|Long-term Extension Period|Poor compliance/noncompliance|1
7815163|NCT00409838|27145035|P2|Long-term Extension Period|Withdrawal by Subject|0
7815164|NCT00409838|27145036|P1|Long-term Extension Period|Withdrawal by Subject|3
7815165|NCT00409838|27145035|P2|Long-term Extension Period|Lack of Efficacy|0
7815166|NCT00409838|27145036|P1|Long-term Extension Period|Lack of Efficacy|2
7815167|NCT00409838|27145035|P2|Long-term Extension Period|Death|0
7815168|NCT00409838|27145036|P1|Long-term Extension Period|Death|1
7815169|NCT00409838|27145035|P2|Long-term Extension Period|Adverse Event|0
7815170|NCT00409838|27145036|P1|Long-term Extension Period|Adverse Event|10
7815171|NCT00409838|27145035|P2|Short-term Period|Never Treated|0
7815172|NCT00409838|27145036|P1|Short-term Period|Never Treated|1
7815173|NCT00409838|27145035|P2|Short-term Period|Withdrawal by Subject|3
7815174|NCT00409838|27145036|P1|Short-term Period|Withdrawal by Subject|2
7815175|NCT00409838|27145035|P2|Short-term Period|Lost to Follow-up|1
7815176|NCT00409838|27145036|P1|Short-term Period|Lost to Follow-up|0
7815177|NCT00409838|27145035|P2|Short-term Period|Adverse Event|1
7815178|NCT00409838|27145036|P1|Short-term Period|Adverse Event|0
7815179|NCT00409786|27145101|P1|Overall Study|Withdrawal by Subject|3
7815180|NCT00409773|27145110|P5|Overall Study|Lack of Eligibility|1
7815181|NCT00409773|27145111|P4|Overall Study|Lack of Eligibility|0
7815182|NCT00409773|27145112|P3|Overall Study|Lack of Eligibility|0
7815183|NCT00409773|27145113|P2|Overall Study|Lack of Eligibility|0
7815184|NCT00409773|27145114|P1|Overall Study|Lack of Eligibility|0
7815185|NCT00409773|27145110|P5|Overall Study|Withdrawal by Subject|1
7815186|NCT00409773|27145111|P4|Overall Study|Withdrawal by Subject|2
7815187|NCT00409773|27145112|P3|Overall Study|Withdrawal by Subject|0
7815188|NCT00409773|27145113|P2|Overall Study|Withdrawal by Subject|0
7815189|NCT00409773|27145114|P1|Overall Study|Withdrawal by Subject|0
7815190|NCT00409773|27145110|P5|Overall Study|Protocol Violation|1
7815191|NCT00409773|27145111|P4|Overall Study|Protocol Violation|3
7815192|NCT00409773|27145112|P3|Overall Study|Protocol Violation|3
7815193|NCT00409773|27145113|P2|Overall Study|Protocol Violation|2
7815194|NCT00409773|27145114|P1|Overall Study|Protocol Violation|0
7815195|NCT00409773|27145110|P5|Overall Study|Physician Decision|0
7815196|NCT00409773|27145111|P4|Overall Study|Physician Decision|2
7815197|NCT00409773|27145112|P3|Overall Study|Physician Decision|0
7815198|NCT00409773|27145113|P2|Overall Study|Physician Decision|0
7815199|NCT00409773|27145114|P1|Overall Study|Physician Decision|0
7815200|NCT00409773|27145110|P5|Overall Study|Lost to Follow-up|1
7815201|NCT00409773|27145111|P4|Overall Study|Lost to Follow-up|3
7815202|NCT00409773|27145112|P3|Overall Study|Lost to Follow-up|2
7815203|NCT00409773|27145113|P2|Overall Study|Lost to Follow-up|1
7815204|NCT00409773|27145114|P1|Overall Study|Lost to Follow-up|6
7815205|NCT00409773|27145110|P5|Overall Study|Adverse Event|6
7815206|NCT00409773|27145111|P4|Overall Study|Adverse Event|2
7815207|NCT00409773|27145112|P3|Overall Study|Adverse Event|4
7815208|NCT00409773|27145113|P2|Overall Study|Adverse Event|4
7815209|NCT00409773|27145114|P1|Overall Study|Adverse Event|3
7815210|NCT00409747|27145196|P1|Overall Study|Withdrawal by Subject|1
7815211|NCT00409708|27145203|P2|Washout|Lost to Follow-up|3
7815212|NCT00409708|27145204|P1|Washout|Lost to Follow-up|1
7815213|NCT00409708|27145203|P2|Washout|Withdrawal by Subject|5
7815214|NCT00409708|27145204|P1|Washout|Withdrawal by Subject|11
7815215|NCT00409708|27145203|P2|Washout|Protocol Violation|1
7815216|NCT00409708|27145204|P1|Washout|Protocol Violation|0
7815217|NCT00409708|27145203|P2|Washout|Lack of Efficacy|1
7815218|NCT00409708|27145204|P1|Washout|Lack of Efficacy|9
7815219|NCT00409708|27145203|P2|Treatment|Administrative problems|0
7815220|NCT00409708|27145204|P1|Treatment|Administrative problems|5
7815221|NCT00409708|27145203|P2|Treatment|Lost to Follow-up|6
7815222|NCT00409708|27145204|P1|Treatment|Lost to Follow-up|0
7815223|NCT00409708|27145203|P2|Treatment|Withdrawal by Subject|8
7815224|NCT00409708|27145204|P1|Treatment|Withdrawal by Subject|3
7815225|NCT00409708|27145203|P2|Treatment|Protocol Violation|2
7815226|NCT00409708|27145204|P1|Treatment|Protocol Violation|6
7815227|NCT00409708|27145203|P2|Treatment|Lack of Efficacy|1
7815228|NCT00409708|27145204|P1|Treatment|Lack of Efficacy|0
7815229|NCT00409708|27145203|P2|Treatment|Abnormal test procedure result(s)|0
7815230|NCT00409708|27145204|P1|Treatment|Abnormal test procedure result(s)|1
7815231|NCT00409682|27145225|P3|EOW Double-blind Maintenance Period|Non-compliance|1
7815232|NCT00409682|27145226|P2|EOW Double-blind Maintenance Period|Non-compliance|0
7815233|NCT00409682|27145227|P1|EOW Double-blind Maintenance Period|Non-compliance|0
7815234|NCT00409682|27145225|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
7815235|NCT00409682|27145226|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
7815236|NCT00409682|27145227|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
7815237|NCT00409682|27145225|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
7815238|NCT00409682|27145226|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
7815239|NCT00409682|27145227|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
7815240|NCT00409682|27145225|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
7815241|NCT00409682|27145226|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
7815242|NCT00409682|27145227|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
7815243|NCT00409682|27145225|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
7815244|NCT00409682|27145226|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
7815245|NCT00409682|27145227|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
7815246|NCT00409682|27145225|P3|EOW Double-blind Maintenance Period|Adverse Event|12
7815247|NCT00409682|27145226|P2|EOW Double-blind Maintenance Period|Adverse Event|10
7815248|NCT00409682|27145227|P1|EOW Double-blind Maintenance Period|Adverse Event|0
7815249|NCT00409682|27145225|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
7815250|NCT00409682|27145226|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
7815338|NCT00408993|27145433|P1|Overall Study|Lack of Efficacy|1
7815251|NCT00409682|27145227|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
7815252|NCT00409682|27145225|P3|Open-label Induction Period|Protocol Violation|0
7815253|NCT00409682|27145226|P2|Open-label Induction Period|Protocol Violation|0
7815254|NCT00409682|27145227|P1|Open-label Induction Period|Protocol Violation|1
7815255|NCT00409682|27145225|P3|Open-label Induction Period|Lack of Efficacy|0
7815256|NCT00409682|27145226|P2|Open-label Induction Period|Lack of Efficacy|0
7815257|NCT00409682|27145227|P1|Open-label Induction Period|Lack of Efficacy|1
7815258|NCT00409682|27145225|P3|Open-label Induction Period|Adverse Event|0
7815259|NCT00409682|27145226|P2|Open-label Induction Period|Adverse Event|0
7815260|NCT00409682|27145227|P1|Open-label Induction Period|Adverse Event|1
7815261|NCT00409617|27145244|P1|Overall Study|Not described|14
7815262|NCT00409617|27145244|P1|Overall Study|Administrative reasons|1
7815263|NCT00409617|27145244|P1|Overall Study|Withdrawal by Subject|8
7815264|NCT00409617|27145244|P1|Overall Study|Protocol Violation|24
7815265|NCT00409617|27145244|P1|Overall Study|Lost to Follow-up|2
7815266|NCT00409617|27145244|P1|Overall Study|Lack of Efficacy|54
7815267|NCT00409617|27145244|P1|Overall Study|Adverse Event|57
7815268|NCT00409578|27145260|P4|Overall Study|Missing|1
7815269|NCT00409578|27145261|P3|Overall Study|Missing|0
7815270|NCT00409578|27145262|P2|Overall Study|Missing|1
7815271|NCT00409578|27145263|P1|Overall Study|Missing|0
7815272|NCT00409578|27145260|P4|Overall Study|Protocol Violation|1
7815273|NCT00409578|27145261|P3|Overall Study|Protocol Violation|3
7815274|NCT00409578|27145262|P2|Overall Study|Protocol Violation|2
7815275|NCT00409578|27145263|P1|Overall Study|Protocol Violation|3
7815276|NCT00409578|27145260|P4|Overall Study|Death|2
7815277|NCT00409578|27145261|P3|Overall Study|Death|4
7815278|NCT00409578|27145262|P2|Overall Study|Death|4
7815279|NCT00409578|27145263|P1|Overall Study|Death|2
7815280|NCT00409578|27145260|P4|Overall Study|Administrative problems|4
7815281|NCT00409578|27145261|P3|Overall Study|Administrative problems|2
7815282|NCT00409578|27145262|P2|Overall Study|Administrative problems|9
7815283|NCT00409578|27145263|P1|Overall Study|Administrative problems|8
7815284|NCT00409578|27145260|P4|Overall Study|Lost to Follow-up|2
7815285|NCT00409578|27145261|P3|Overall Study|Lost to Follow-up|2
7815286|NCT00409578|27145262|P2|Overall Study|Lost to Follow-up|0
7815287|NCT00409578|27145263|P1|Overall Study|Lost to Follow-up|2
7815288|NCT00409578|27145260|P4|Overall Study|Withdrawal by Subject|17
7815289|NCT00409578|27145261|P3|Overall Study|Withdrawal by Subject|16
7815290|NCT00409578|27145262|P2|Overall Study|Withdrawal by Subject|15
7815291|NCT00409578|27145263|P1|Overall Study|Withdrawal by Subject|8
7815292|NCT00409578|27145260|P4|Overall Study|Subject no longer requires study drug|1
7815293|NCT00409578|27145261|P3|Overall Study|Subject no longer requires study drug|0
7815294|NCT00409578|27145262|P2|Overall Study|Subject no longer requires study drug|0
7815295|NCT00409578|27145263|P1|Overall Study|Subject no longer requires study drug|0
7815296|NCT00409578|27145260|P4|Overall Study|Lack of Efficacy|2
7815297|NCT00409578|27145261|P3|Overall Study|Lack of Efficacy|0
7815298|NCT00409578|27145262|P2|Overall Study|Lack of Efficacy|0
7815299|NCT00409578|27145263|P1|Overall Study|Lack of Efficacy|0
7815300|NCT00409578|27145260|P4|Overall Study|Abnormal laboratory value(s)|4
7815301|NCT00409578|27145261|P3|Overall Study|Abnormal laboratory value(s)|2
7815302|NCT00409578|27145262|P2|Overall Study|Abnormal laboratory value(s)|2
7815303|NCT00409578|27145263|P1|Overall Study|Abnormal laboratory value(s)|2
7815304|NCT00409578|27145260|P4|Overall Study|Adverse Event|33
7815305|NCT00409578|27145261|P3|Overall Study|Adverse Event|25
7815306|NCT00409578|27145262|P2|Overall Study|Adverse Event|37
7815307|NCT00409578|27145263|P1|Overall Study|Adverse Event|27
7815308|NCT00409409|27145321|P2|Overall Study|Any other reason not above-mentioned|1
7815309|NCT00409409|27145322|P1|Overall Study|Any other reason not above-mentioned|0
7815310|NCT00409409|27145321|P2|Overall Study|Withdrawal by Subject|1
7815311|NCT00409409|27145322|P1|Overall Study|Withdrawal by Subject|1
7815312|NCT00409409|27145321|P2|Overall Study|Adverse Event|2
7815313|NCT00409409|27145322|P1|Overall Study|Adverse Event|7
7815314|NCT00409344|27145330|P2|Overall Study|no enrollment|0
7815315|NCT00409344|27145331|P1|Overall Study|no enrollment|0
7815316|NCT00409331|27145349|P1|Overall Study|Physician Decision|1
7815317|NCT00409188|27145371|P2|Overall Study|Ongoing at data cut-off|175
7815318|NCT00409188|27145372|P1|Overall Study|Ongoing at data cut-off|383
7815319|NCT00409175|27145388|P2|Overall Study|Liver transplantation|13
7815320|NCT00409175|27145389|P1|Overall Study|Liver transplantation|13
7815321|NCT00409175|27145388|P2|Overall Study|Negative genotype|1
7815322|NCT00409175|27145389|P1|Overall Study|Negative genotype|0
7815323|NCT00409175|27145388|P2|Overall Study|Withdrawal by Subject|2
7815324|NCT00409175|27145389|P1|Overall Study|Withdrawal by Subject|1
7815325|NCT00409175|27145388|P2|Overall Study|Adverse Event|3
7815326|NCT00409175|27145389|P1|Overall Study|Adverse Event|4
7815327|NCT00409006|27145415|P2|Overall Study|Physician Decision|2
7815328|NCT00409006|27145416|P1|Overall Study|Physician Decision|1
7815329|NCT00409006|27145415|P2|Overall Study|Withdrawal by Subject|2
7815330|NCT00409006|27145416|P1|Overall Study|Withdrawal by Subject|3
7815331|NCT00409006|27145415|P2|Overall Study|Lost to Follow-up|2
7815332|NCT00409006|27145416|P1|Overall Study|Lost to Follow-up|1
7815333|NCT00409006|27145415|P2|Overall Study|Death|6
7815334|NCT00409006|27145416|P1|Overall Study|Death|15
7815335|NCT00408993|27145432|P2|Overall Study|Withdrawal by Subject|3
7815336|NCT00408993|27145433|P1|Overall Study|Withdrawal by Subject|2
7815337|NCT00408993|27145432|P2|Overall Study|Lack of Efficacy|4
7815339|NCT00408993|27145432|P2|Overall Study|Protocol Violation|6
7815340|NCT00408993|27145433|P1|Overall Study|Protocol Violation|1
7815341|NCT00408993|27145432|P2|Overall Study|Adverse Event|4
7815342|NCT00408993|27145433|P1|Overall Study|Adverse Event|15
7815343|NCT00408928|27145465|P1|Overall Study|Infection indistinguishable from GVHD|1
7815344|NCT00408928|27145465|P1|Overall Study|Death|1
7815345|NCT00408928|27145465|P1|Overall Study|Withdrawal by Subject|1
7815346|NCT00408902|27145470|P1|Overall Study|Adverse Event|3
7815347|NCT00408902|27145470|P1|Overall Study|Lack of Efficacy|7
7815348|NCT00408876|27145480|P4|Overall Study|Physician Decision|0
7815349|NCT00408876|27145481|P3|Overall Study|Physician Decision|3
7815350|NCT00408876|27145482|P2|Overall Study|Physician Decision|0
7815351|NCT00408876|27145483|P1|Overall Study|Physician Decision|1
7815352|NCT00408876|27145480|P4|Overall Study|Protocol Violation|3
7815353|NCT00408876|27145481|P3|Overall Study|Protocol Violation|4
7815354|NCT00408876|27145482|P2|Overall Study|Protocol Violation|3
7815355|NCT00408876|27145483|P1|Overall Study|Protocol Violation|0
7815356|NCT00408876|27145480|P4|Overall Study|Lost to Follow-up|2
7815357|NCT00408876|27145481|P3|Overall Study|Lost to Follow-up|5
7815358|NCT00408876|27145482|P2|Overall Study|Lost to Follow-up|6
7815359|NCT00408876|27145483|P1|Overall Study|Lost to Follow-up|1
7815360|NCT00408876|27145480|P4|Overall Study|Lack of Efficacy|6
7815361|NCT00408876|27145481|P3|Overall Study|Lack of Efficacy|5
7815362|NCT00408876|27145482|P2|Overall Study|Lack of Efficacy|4
7815363|NCT00408876|27145483|P1|Overall Study|Lack of Efficacy|2
7815364|NCT00408876|27145480|P4|Overall Study|Withdrawal by Subject|14
7815365|NCT00408876|27145481|P3|Overall Study|Withdrawal by Subject|6
7815366|NCT00408876|27145482|P2|Overall Study|Withdrawal by Subject|6
7815367|NCT00408876|27145483|P1|Overall Study|Withdrawal by Subject|3
7815368|NCT00408876|27145480|P4|Overall Study|Adverse Event|10
7815369|NCT00408876|27145481|P3|Overall Study|Adverse Event|27
7815370|NCT00408876|27145482|P2|Overall Study|Adverse Event|17
7815371|NCT00408876|27145483|P1|Overall Study|Adverse Event|9
7815372|NCT00408694|27145733|P1|Overall Study|No protocol treatment|1
7815373|NCT00408694|27145733|P1|Overall Study|Ineligible|1
7815374|NCT00408681|27145745|P1|Overall Study|Adverse Event|7
7815375|NCT00408681|27145745|P1|Overall Study|Lack of Efficacy|2
7815376|NCT00408629|27145764|P2|Overall Study|Miscellaneous|15
7815377|NCT00408629|27145765|P1|Overall Study|Miscellaneous|11
7815378|NCT00408629|27145764|P2|Overall Study|Protocol Violation|5
7815379|NCT00408629|27145765|P1|Overall Study|Protocol Violation|1
7815380|NCT00408629|27145764|P2|Overall Study|Lack of Efficacy|73
7815381|NCT00408629|27145765|P1|Overall Study|Lack of Efficacy|63
7815382|NCT00408629|27145764|P2|Overall Study|Lost to Follow-up|1
7815383|NCT00408629|27145765|P1|Overall Study|Lost to Follow-up|1
7815384|NCT00408629|27145764|P2|Overall Study|Withdrawal by Subject|4
7815385|NCT00408629|27145765|P1|Overall Study|Withdrawal by Subject|8
7815386|NCT00408629|27145764|P2|Overall Study|Adverse Event|27
7815387|NCT00408629|27145765|P1|Overall Study|Adverse Event|13
7815388|NCT00408499|27145861|P5|Phase II- MTD Expansion|treatment delay|3
7815389|NCT00408499|27145862|P4|Phase II- MTD Expansion|treatment delay|0
7815390|NCT00408499|27145863|P3|Phase II- MTD Expansion|treatment delay|0
7815391|NCT00408499|27145864|P2|Phase II- MTD Expansion|treatment delay|0
7815392|NCT00408499|27145865|P1|Phase II- MTD Expansion|treatment delay|0
7815393|NCT00408499|27145861|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
7815394|NCT00408499|27145862|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
7815395|NCT00408499|27145863|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
7815396|NCT00408499|27145864|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
7815397|NCT00408499|27145865|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
7815398|NCT00408499|27145861|P5|Phase II- MTD Expansion|Physician Decision|1
7815399|NCT00408499|27145862|P4|Phase II- MTD Expansion|Physician Decision|0
7815400|NCT00408499|27145863|P3|Phase II- MTD Expansion|Physician Decision|0
7815401|NCT00408499|27145864|P2|Phase II- MTD Expansion|Physician Decision|0
7815402|NCT00408499|27145865|P1|Phase II- MTD Expansion|Physician Decision|0
7815403|NCT00408499|27145861|P5|Phase II- MTD Expansion|Death|2
7815404|NCT00408499|27145862|P4|Phase II- MTD Expansion|Death|0
7815405|NCT00408499|27145863|P3|Phase II- MTD Expansion|Death|0
7815406|NCT00408499|27145864|P2|Phase II- MTD Expansion|Death|0
7815407|NCT00408499|27145865|P1|Phase II- MTD Expansion|Death|0
7815408|NCT00408499|27145861|P5|Phase II- MTD Expansion|Adverse Event|9
7815409|NCT00408499|27145862|P4|Phase II- MTD Expansion|Adverse Event|0
7815410|NCT00408499|27145863|P3|Phase II- MTD Expansion|Adverse Event|0
7815411|NCT00408499|27145864|P2|Phase II- MTD Expansion|Adverse Event|0
7815412|NCT00408499|27145865|P1|Phase II- MTD Expansion|Adverse Event|0
7815413|NCT00408499|27145861|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
7815414|NCT00408499|27145862|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
7815415|NCT00408499|27145863|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
7815416|NCT00408499|27145864|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
7815417|NCT00408499|27145865|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
7815418|NCT00408499|27145861|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7815419|NCT00408499|27145862|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7815420|NCT00408499|27145863|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7815421|NCT00408499|27145864|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
7815422|NCT00408499|27145865|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
7815423|NCT00408499|27145861|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
7815424|NCT00408499|27145862|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
7815425|NCT00408499|27145863|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
7815426|NCT00408499|27145864|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
7815427|NCT00408499|27145865|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
7815428|NCT00408434|27145887|P7|Overall Study|Terminated by Investigator|0
7815429|NCT00408434|27145888|P6|Overall Study|Terminated by Investigator|1
7815430|NCT00408434|27145889|P5|Overall Study|Terminated by Investigator|1
7815431|NCT00408434|27145890|P4|Overall Study|Terminated by Investigator|0
7815432|NCT00408434|27145891|P3|Overall Study|Terminated by Investigator|0
7815433|NCT00408434|27145892|P2|Overall Study|Terminated by Investigator|0
7815434|NCT00408434|27145893|P1|Overall Study|Terminated by Investigator|0
7815435|NCT00408434|27145887|P7|Overall Study|Other|0
7815436|NCT00408434|27145888|P6|Overall Study|Other|1
7815437|NCT00408434|27145889|P5|Overall Study|Other|2
7815438|NCT00408434|27145890|P4|Overall Study|Other|0
7815439|NCT00408434|27145891|P3|Overall Study|Other|1
7815440|NCT00408434|27145892|P2|Overall Study|Other|0
7815441|NCT00408434|27145893|P1|Overall Study|Other|0
7815442|NCT00408434|27145887|P7|Overall Study|Progressive disease|4
7815443|NCT00408434|27145888|P6|Overall Study|Progressive disease|1
7815444|NCT00408434|27145889|P5|Overall Study|Progressive disease|3
7815445|NCT00408434|27145890|P4|Overall Study|Progressive disease|3
7815446|NCT00408434|27145891|P3|Overall Study|Progressive disease|4
7815447|NCT00408434|27145892|P2|Overall Study|Progressive disease|3
7815448|NCT00408434|27145893|P1|Overall Study|Progressive disease|6
7815449|NCT00408434|27145887|P7|Overall Study|Adverse Event|0
7815450|NCT00408434|27145888|P6|Overall Study|Adverse Event|0
7815451|NCT00408434|27145889|P5|Overall Study|Adverse Event|0
7815452|NCT00408434|27145890|P4|Overall Study|Adverse Event|0
7815453|NCT00408434|27145891|P3|Overall Study|Adverse Event|1
7815454|NCT00408434|27145892|P2|Overall Study|Adverse Event|0
7815455|NCT00408434|27145893|P1|Overall Study|Adverse Event|0
7815456|NCT00408421|27145940|P3|Treatment Re-Randomization|Withdrawal by Subject|0
7815457|NCT00408421|27145941|P2|Treatment Re-Randomization|Withdrawal by Subject|1
7815458|NCT00408421|27145942|P1|Treatment Re-Randomization|Withdrawal by Subject|2
7815459|NCT00408421|27145940|P3|Treatment Re-Randomization|Protocol Violation|0
7815460|NCT00408421|27145941|P2|Treatment Re-Randomization|Protocol Violation|1
7815461|NCT00408421|27145942|P1|Treatment Re-Randomization|Protocol Violation|1
7815462|NCT00408421|27145940|P3|Treatment Re-Randomization|Physician Decision|0
7815463|NCT00408421|27145941|P2|Treatment Re-Randomization|Physician Decision|3
7815464|NCT00408421|27145942|P1|Treatment Re-Randomization|Physician Decision|1
7815465|NCT00408421|27145940|P3|Treatment Re-Randomization|Lost to Follow-up|1
7815466|NCT00408421|27145941|P2|Treatment Re-Randomization|Lost to Follow-up|0
7815467|NCT00408421|27145942|P1|Treatment Re-Randomization|Lost to Follow-up|0
7815468|NCT00408421|27145940|P3|Treatment Re-Randomization|Lack of Efficacy|0
7815469|NCT00408421|27145941|P2|Treatment Re-Randomization|Lack of Efficacy|0
7815470|NCT00408421|27145942|P1|Treatment Re-Randomization|Lack of Efficacy|1
7815471|NCT00408421|27145940|P3|Treatment Re-Randomization|Adverse Event|4
7815472|NCT00408421|27145941|P2|Treatment Re-Randomization|Adverse Event|2
7815473|NCT00408421|27145942|P1|Treatment Re-Randomization|Adverse Event|2
7815474|NCT00408421|27145940|P3|Treatment Initial Randomization|Sponsor Decision|0
7815475|NCT00408421|27145941|P2|Treatment Initial Randomization|Sponsor Decision|0
7815476|NCT00408421|27145942|P1|Treatment Initial Randomization|Sponsor Decision|1
7815477|NCT00408421|27145940|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
7815478|NCT00408421|27145941|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
7815479|NCT00408421|27145942|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
7815480|NCT00408421|27145940|P3|Treatment Initial Randomization|Withdrawal by Subject|0
7815481|NCT00408421|27145941|P2|Treatment Initial Randomization|Withdrawal by Subject|7
7815482|NCT00408421|27145942|P1|Treatment Initial Randomization|Withdrawal by Subject|7
7815483|NCT00408421|27145940|P3|Treatment Initial Randomization|Protocol Violation|0
7815484|NCT00408421|27145941|P2|Treatment Initial Randomization|Protocol Violation|1
7815485|NCT00408421|27145942|P1|Treatment Initial Randomization|Protocol Violation|0
7815486|NCT00408421|27145940|P3|Treatment Initial Randomization|Physician Decision|0
7815487|NCT00408421|27145941|P2|Treatment Initial Randomization|Physician Decision|0
7815488|NCT00408421|27145942|P1|Treatment Initial Randomization|Physician Decision|1
7815489|NCT00408421|27145940|P3|Treatment Initial Randomization|Lost to Follow-up|0
7815490|NCT00408421|27145941|P2|Treatment Initial Randomization|Lost to Follow-up|3
7815491|NCT00408421|27145942|P1|Treatment Initial Randomization|Lost to Follow-up|0
7815492|NCT00408421|27145940|P3|Treatment Initial Randomization|Lack of Efficacy|0
7815493|NCT00408421|27145941|P2|Treatment Initial Randomization|Lack of Efficacy|2
7815494|NCT00408421|27145942|P1|Treatment Initial Randomization|Lack of Efficacy|2
7815495|NCT00408421|27145940|P3|Treatment Initial Randomization|Adverse Event|0
7815496|NCT00408421|27145941|P2|Treatment Initial Randomization|Adverse Event|9
7815497|NCT00408421|27145942|P1|Treatment Initial Randomization|Adverse Event|5
7815498|NCT00408408|27146022|P6|Overall Study|No follow up data|3
7815499|NCT00408408|27146023|P5|Overall Study|No follow up data|5
7815500|NCT00408408|27146024|P4|Overall Study|No follow up data|7
7815501|NCT00408408|27146025|P3|Overall Study|No follow up data|0
7815502|NCT00408408|27146026|P2|Overall Study|No follow up data|3
7815503|NCT00408408|27146027|P1|Overall Study|No follow up data|2
7815504|NCT00408317|27146089|P2|Second Intervention Period|Withdrawal of consent|1
7815505|NCT00408317|27146090|P1|Second Intervention Period|Withdrawal of consent|0
7815506|NCT00408317|27146089|P2|Second Intervention Period|Protocol Violation|1
7815507|NCT00408317|27146090|P1|Second Intervention Period|Protocol Violation|0
7815508|NCT00408317|27146089|P2|Second Intervention Period|Adverse Event|0
7815509|NCT00408317|27146090|P1|Second Intervention Period|Adverse Event|2
7815510|NCT00408317|27146089|P2|First Intervention Period|Adverse Event|1
7815511|NCT00408317|27146090|P1|First Intervention Period|Adverse Event|0
7815512|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
7815513|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
7815514|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
7815515|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
7815516|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
7815517|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
7815518|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
7815519|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
7815520|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7815521|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
7815522|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
7815523|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
7815524|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
7815525|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
7815526|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7815527|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7815528|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7815529|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7815530|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
7815531|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
7815532|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7815533|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7815534|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7815535|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7815536|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7815537|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7815538|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7815539|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7815540|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7815541|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7815542|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7815543|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7815544|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815545|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815546|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
7815547|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815548|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815549|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815550|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815551|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
7815552|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7815553|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7815554|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7815555|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
7815556|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7815557|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7815558|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7815559|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7815560|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7815561|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7815562|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7815563|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7815564|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7815565|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
7815566|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7815567|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7815568|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815569|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815570|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815571|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
7815572|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815573|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815574|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815575|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7815576|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
7815577|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
7815578|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
7815579|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
7815580|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
7815581|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
7815582|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7815583|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7815584|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7815585|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7815586|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
7815587|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7815588|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7815589|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7815590|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7815591|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7815592|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
7815593|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
7815594|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
7815595|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
7815596|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
7815597|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
7815598|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
7815599|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
7815600|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7815601|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7815602|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7815603|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
7815604|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7815605|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
7815606|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7815607|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7815608|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Death|1
7815609|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Death|3
7815610|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Death|5
7815611|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Death|5
7815612|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Death|0
7815613|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Death|3
7815614|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Death|0
7815615|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Death|0
7815616|NCT00408005|27146123|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
7815617|NCT00408005|27146124|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
7815618|NCT00408005|27146125|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
7815619|NCT00408005|27146126|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
7815620|NCT00408005|27146127|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
7815621|NCT00408005|27146128|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
7815622|NCT00408005|27146129|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
7815623|NCT00408005|27146130|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
7815624|NCT00408005|27146123|P8|Induction|Recurrent leukemia|0
7815625|NCT00408005|27146124|P7|Induction|Recurrent leukemia|0
7815626|NCT00408005|27146125|P6|Induction|Recurrent leukemia|0
7815627|NCT00408005|27146126|P5|Induction|Recurrent leukemia|0
7815628|NCT00408005|27146127|P4|Induction|Recurrent leukemia|0
7815629|NCT00408005|27146128|P3|Induction|Recurrent leukemia|0
7815630|NCT00408005|27146129|P2|Induction|Recurrent leukemia|0
7815631|NCT00408005|27146130|P1|Induction|Recurrent leukemia|1
7815632|NCT00408005|27146123|P8|Induction|Hematopoietic Stem Cell Transplantation|0
7815633|NCT00408005|27146124|P7|Induction|Hematopoietic Stem Cell Transplantation|0
7815634|NCT00408005|27146125|P6|Induction|Hematopoietic Stem Cell Transplantation|0
7815635|NCT00408005|27146126|P5|Induction|Hematopoietic Stem Cell Transplantation|0
7815636|NCT00408005|27146127|P4|Induction|Hematopoietic Stem Cell Transplantation|0
7815637|NCT00408005|27146128|P3|Induction|Hematopoietic Stem Cell Transplantation|0
7815638|NCT00408005|27146129|P2|Induction|Hematopoietic Stem Cell Transplantation|0
7815639|NCT00408005|27146130|P1|Induction|Hematopoietic Stem Cell Transplantation|1
7815640|NCT00408005|27146123|P8|Induction|Protocol Deviation|0
7815641|NCT00408005|27146124|P7|Induction|Protocol Deviation|0
7815642|NCT00408005|27146125|P6|Induction|Protocol Deviation|0
7815643|NCT00408005|27146126|P5|Induction|Protocol Deviation|0
7815644|NCT00408005|27146127|P4|Induction|Protocol Deviation|0
7815645|NCT00408005|27146128|P3|Induction|Protocol Deviation|0
7815646|NCT00408005|27146129|P2|Induction|Protocol Deviation|1
7815647|NCT00408005|27146130|P1|Induction|Protocol Deviation|3
7815648|NCT00408005|27146123|P8|Induction|Failed to Complete Randomization|0
7815649|NCT00408005|27146124|P7|Induction|Failed to Complete Randomization|0
7815650|NCT00408005|27146125|P6|Induction|Failed to Complete Randomization|0
7815651|NCT00408005|27146126|P5|Induction|Failed to Complete Randomization|0
7815652|NCT00408005|27146127|P4|Induction|Failed to Complete Randomization|0
7815653|NCT00408005|27146128|P3|Induction|Failed to Complete Randomization|0
7815654|NCT00408005|27146129|P2|Induction|Failed to Complete Randomization|2
7815655|NCT00408005|27146130|P1|Induction|Failed to Complete Randomization|3
7815656|NCT00408005|27146123|P8|Induction|Inevaluable|0
7815657|NCT00408005|27146124|P7|Induction|Inevaluable|0
7815658|NCT00408005|27146125|P6|Induction|Inevaluable|0
7815659|NCT00408005|27146126|P5|Induction|Inevaluable|0
7815660|NCT00408005|27146127|P4|Induction|Inevaluable|0
7815661|NCT00408005|27146128|P3|Induction|Inevaluable|0
7815662|NCT00408005|27146129|P2|Induction|Inevaluable|14
7815663|NCT00408005|27146130|P1|Induction|Inevaluable|18
7815664|NCT00408005|27146123|P8|Induction|Progressive Disease|0
7815665|NCT00408005|27146124|P7|Induction|Progressive Disease|0
7815666|NCT00408005|27146125|P6|Induction|Progressive Disease|0
7815667|NCT00408005|27146126|P5|Induction|Progressive Disease|0
7815668|NCT00408005|27146127|P4|Induction|Progressive Disease|0
7815669|NCT00408005|27146128|P3|Induction|Progressive Disease|0
7815670|NCT00408005|27146129|P2|Induction|Progressive Disease|1
7815671|NCT00408005|27146130|P1|Induction|Progressive Disease|0
7815672|NCT00408005|27146123|P8|Induction|Identified as Philadelphia Chr. Positive|0
7815673|NCT00408005|27146124|P7|Induction|Identified as Philadelphia Chr. Positive|0
7815674|NCT00408005|27146125|P6|Induction|Identified as Philadelphia Chr. Positive|0
7815675|NCT00408005|27146126|P5|Induction|Identified as Philadelphia Chr. Positive|0
7815676|NCT00408005|27146127|P4|Induction|Identified as Philadelphia Chr. Positive|0
7815677|NCT00408005|27146128|P3|Induction|Identified as Philadelphia Chr. Positive|0
7815678|NCT00408005|27146129|P2|Induction|Identified as Philadelphia Chr. Positive|0
7815679|NCT00408005|27146130|P1|Induction|Identified as Philadelphia Chr. Positive|6
7815680|NCT00408005|27146123|P8|Induction|Patient transferred Tx to Non-COG Site|0
7815681|NCT00408005|27146124|P7|Induction|Patient transferred Tx to Non-COG Site|0
7815682|NCT00408005|27146125|P6|Induction|Patient transferred Tx to Non-COG Site|0
7815683|NCT00408005|27146126|P5|Induction|Patient transferred Tx to Non-COG Site|0
7815684|NCT00408005|27146127|P4|Induction|Patient transferred Tx to Non-COG Site|0
7815685|NCT00408005|27146128|P3|Induction|Patient transferred Tx to Non-COG Site|0
7815686|NCT00408005|27146129|P2|Induction|Patient transferred Tx to Non-COG Site|2
7815687|NCT00408005|27146130|P1|Induction|Patient transferred Tx to Non-COG Site|3
7815688|NCT00408005|27146123|P8|Induction|Entered another COG therapeutic protocol|0
7815689|NCT00408005|27146124|P7|Induction|Entered another COG therapeutic protocol|0
7815690|NCT00408005|27146125|P6|Induction|Entered another COG therapeutic protocol|0
7815691|NCT00408005|27146126|P5|Induction|Entered another COG therapeutic protocol|0
7815692|NCT00408005|27146127|P4|Induction|Entered another COG therapeutic protocol|0
7815693|NCT00408005|27146128|P3|Induction|Entered another COG therapeutic protocol|0
7815694|NCT00408005|27146129|P2|Induction|Entered another COG therapeutic protocol|0
7815695|NCT00408005|27146130|P1|Induction|Entered another COG therapeutic protocol|4
7815696|NCT00408005|27146123|P8|Induction|Refusal of Further Protocol Therapy|0
7815697|NCT00408005|27146124|P7|Induction|Refusal of Further Protocol Therapy|0
7815698|NCT00408005|27146125|P6|Induction|Refusal of Further Protocol Therapy|0
7815699|NCT00408005|27146126|P5|Induction|Refusal of Further Protocol Therapy|0
7815700|NCT00408005|27146127|P4|Induction|Refusal of Further Protocol Therapy|0
7815701|NCT00408005|27146128|P3|Induction|Refusal of Further Protocol Therapy|0
7815702|NCT00408005|27146129|P2|Induction|Refusal of Further Protocol Therapy|44
7815703|NCT00408005|27146130|P1|Induction|Refusal of Further Protocol Therapy|225
7815704|NCT00408005|27146123|P8|Induction|Ineligible|0
7815705|NCT00408005|27146124|P7|Induction|Ineligible|0
7815706|NCT00408005|27146125|P6|Induction|Ineligible|0
7815707|NCT00408005|27146126|P5|Induction|Ineligible|0
7815708|NCT00408005|27146127|P4|Induction|Ineligible|0
7815709|NCT00408005|27146128|P3|Induction|Ineligible|0
7815710|NCT00408005|27146129|P2|Induction|Ineligible|14
7815711|NCT00408005|27146130|P1|Induction|Ineligible|33
7815712|NCT00408005|27146123|P8|Induction|Withdrawal by Subject|0
7815713|NCT00408005|27146124|P7|Induction|Withdrawal by Subject|0
7815714|NCT00408005|27146125|P6|Induction|Withdrawal by Subject|0
7815715|NCT00408005|27146126|P5|Induction|Withdrawal by Subject|0
7815716|NCT00408005|27146127|P4|Induction|Withdrawal by Subject|0
7815717|NCT00408005|27146128|P3|Induction|Withdrawal by Subject|0
7815718|NCT00408005|27146129|P2|Induction|Withdrawal by Subject|4
7815719|NCT00408005|27146130|P1|Induction|Withdrawal by Subject|2
7815720|NCT00408005|27146123|P8|Induction|Physician Decision|0
7815721|NCT00408005|27146124|P7|Induction|Physician Decision|0
7815722|NCT00408005|27146125|P6|Induction|Physician Decision|0
7815723|NCT00408005|27146126|P5|Induction|Physician Decision|0
7815724|NCT00408005|27146127|P4|Induction|Physician Decision|0
7815725|NCT00408005|27146128|P3|Induction|Physician Decision|0
7815726|NCT00408005|27146129|P2|Induction|Physician Decision|9
7815727|NCT00408005|27146130|P1|Induction|Physician Decision|83
7815728|NCT00408005|27146123|P8|Induction|Death|0
7815729|NCT00408005|27146124|P7|Induction|Death|0
7815730|NCT00408005|27146125|P6|Induction|Death|0
7815731|NCT00408005|27146126|P5|Induction|Death|0
7815732|NCT00408005|27146127|P4|Induction|Death|0
7815733|NCT00408005|27146128|P3|Induction|Death|0
7815734|NCT00408005|27146129|P2|Induction|Death|0
7815735|NCT00408005|27146130|P1|Induction|Death|6
7815736|NCT00408005|27146123|P8|Induction|Adverse Event|0
7815737|NCT00408005|27146124|P7|Induction|Adverse Event|0
7815738|NCT00408005|27146125|P6|Induction|Adverse Event|0
7815739|NCT00408005|27146126|P5|Induction|Adverse Event|0
7815740|NCT00408005|27146127|P4|Induction|Adverse Event|0
7815741|NCT00408005|27146128|P3|Induction|Adverse Event|0
7815742|NCT00408005|27146129|P2|Induction|Adverse Event|3
7815743|NCT00408005|27146130|P1|Induction|Adverse Event|19
7815744|NCT00407797|27146172|P1|Overall Study|Withdrawal by Subject|3
7815745|NCT00407797|27146172|P1|Overall Study|Other|7
7815746|NCT00407797|27146172|P1|Overall Study|Adverse Event|6
7815747|NCT00407797|27146172|P1|Overall Study|Lost to Follow-up|2
7815748|NCT00407758|27146187|P1|Overall Study|ineligible -improper prior treatment|1
7815749|NCT00407745|27146200|P2|Overall Study|Randomized, unknown if treated|1
7815750|NCT00407745|27146201|P1|Overall Study|Randomized, unknown if treated|0
7815751|NCT00407745|27146200|P2|Overall Study|Other|0
7815752|NCT00407745|27146201|P1|Overall Study|Other|2
7815753|NCT00407745|27146200|P2|Overall Study|Adverse Event|8
7815754|NCT00407745|27146201|P1|Overall Study|Adverse Event|8
7815755|NCT00407745|27146200|P2|Overall Study|Protocol Violation|3
7815756|NCT00407745|27146201|P1|Overall Study|Protocol Violation|5
7815757|NCT00407745|27146200|P2|Overall Study|Withdrawal by Subject|3
7815758|NCT00407745|27146201|P1|Overall Study|Withdrawal by Subject|3
7815759|NCT00407745|27146200|P2|Overall Study|Lack of Efficacy|2
7815760|NCT00407745|27146201|P1|Overall Study|Lack of Efficacy|1
7815761|NCT00407563|27146287|P1|Overall Study|Patient continues on treatment|1
7815762|NCT00407550|27146297|P2|Overall Study|Insurance or Other medical condition|1
7815763|NCT00407550|27146298|P1|Overall Study|Insurance or Other medical condition|2
7815764|NCT00407550|27146297|P2|Overall Study|Death|0
7815765|NCT00407550|27146298|P1|Overall Study|Death|1
7815766|NCT00407550|27146297|P2|Overall Study|Withdrawal by Subject|2
7815767|NCT00407550|27146298|P1|Overall Study|Withdrawal by Subject|0
7815768|NCT00407550|27146297|P2|Overall Study|Adverse Event|1
7815769|NCT00407550|27146298|P1|Overall Study|Adverse Event|0
7815770|NCT00407537|27146312|P2|Overall Study|Withdrawal by Subject|16
7815771|NCT00407537|27146313|P1|Overall Study|Withdrawal by Subject|34
7815772|NCT00407537|27146312|P2|Overall Study|Other|7
7815773|NCT00407537|27146313|P1|Overall Study|Other|6
7815774|NCT00407537|27146312|P2|Overall Study|Lost to Follow-up|19
7815775|NCT00407537|27146313|P1|Overall Study|Lost to Follow-up|12
7815776|NCT00407537|27146312|P2|Overall Study|Adverse Event|0
7815777|NCT00407537|27146313|P1|Overall Study|Adverse Event|36
7815778|NCT00407537|27146312|P2|Overall Study|Death|2
7815779|NCT00407537|27146313|P1|Overall Study|Death|5
7815780|NCT00407511|27146361|P1|Overall Study|Withdrawal by Subject|4
7815781|NCT00407511|27146361|P1|Overall Study|Other|5
7815782|NCT00407511|27146361|P1|Overall Study|Lost to Follow-up|4
7815783|NCT00407511|27146361|P1|Overall Study|Adverse Event|9
7815784|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Physician Decision|0
7815785|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Physician Decision|2
7815786|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Physician Decision|1
7815787|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Patient Decision|0
7815788|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Patient Decision|2
7815789|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Patient Decision|1
7815790|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
7815791|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7815792|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7815793|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
7815794|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
7815795|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
7815796|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Adverse Event|0
7815797|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Adverse Event|0
7815798|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Adverse Event|1
7815799|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
7815800|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
7815801|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
7815802|NCT00407030|27146422|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
7815803|NCT00407030|27146423|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
7815804|NCT00407030|27146424|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
7815805|NCT00407030|27146422|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
7815806|NCT00407030|27146423|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
7815807|NCT00407030|27146424|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
7815808|NCT00407030|27146422|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
7815809|NCT00407030|27146423|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
7815810|NCT00407030|27146424|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
7815811|NCT00407030|27146422|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7815812|NCT00407030|27146423|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7815813|NCT00407030|27146424|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7815814|NCT00407030|27146422|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7815815|NCT00407030|27146423|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7815816|NCT00407030|27146424|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7815817|NCT00407030|27146422|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
7815818|NCT00407030|27146423|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
7815819|NCT00407030|27146424|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
7815820|NCT00407030|27146422|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
7815821|NCT00407030|27146423|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
7815822|NCT00407030|27146424|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
7815823|NCT00406848|27146452|P2|Overall Study|Sponsor Decision|1
7815824|NCT00406848|27146453|P1|Overall Study|Sponsor Decision|1
7815825|NCT00406848|27146452|P2|Overall Study|Physician Decision|2
7815826|NCT00406848|27146453|P1|Overall Study|Physician Decision|2
7815827|NCT00406848|27146452|P2|Overall Study|Lost to Follow-up|2
7815828|NCT00406848|27146453|P1|Overall Study|Lost to Follow-up|6
7815829|NCT00406848|27146452|P2|Overall Study|Protocol Violation|6
7815830|NCT00406848|27146453|P1|Overall Study|Protocol Violation|10
7815831|NCT00406848|27146452|P2|Overall Study|Lack of Efficacy|14
7815832|NCT00406848|27146453|P1|Overall Study|Lack of Efficacy|9
7815833|NCT00406848|27146452|P2|Overall Study|Adverse Event|7
7815834|NCT00406848|27146453|P1|Overall Study|Adverse Event|38
7815835|NCT00406848|27146452|P2|Overall Study|Withdrawal by Subject|22
7815836|NCT00406848|27146453|P1|Overall Study|Withdrawal by Subject|27
7815837|NCT00406783|27146517|P2|Overall Study|Protocol Violation|4
7815838|NCT00406783|27146518|P1|Overall Study|Protocol Violation|4
7815839|NCT00406783|27146517|P2|Overall Study|Withdrawal by Subject|4
7815840|NCT00406783|27146518|P1|Overall Study|Withdrawal by Subject|1
7815841|NCT00406783|27146517|P2|Overall Study|Lost to Follow-up|0
7815842|NCT00406783|27146518|P1|Overall Study|Lost to Follow-up|3
7815843|NCT00406783|27146517|P2|Overall Study|Treatment Failure|3
7815844|NCT00406783|27146518|P1|Overall Study|Treatment Failure|2
7815845|NCT00406783|27146517|P2|Overall Study|Adverse Event|4
7815846|NCT00406783|27146518|P1|Overall Study|Adverse Event|4
7815847|NCT00406718|27146533|P3|Overall Study|Lost to Follow-up|4
7815848|NCT00406718|27146534|P2|Overall Study|Lost to Follow-up|5
7815849|NCT00406718|27146535|P1|Overall Study|Lost to Follow-up|2
7815850|NCT00406718|27146533|P3|Overall Study|Withdrawal by Subject|4
7815851|NCT00406718|27146534|P2|Overall Study|Withdrawal by Subject|9
7815852|NCT00406718|27146535|P1|Overall Study|Withdrawal by Subject|2
7815853|NCT00406692|27146549|P1|Overall Study|Lack of Efficacy|1
7815854|NCT00406692|27146549|P1|Overall Study|Adverse Event|1
7815855|NCT00406692|27146549|P1|Overall Study|Physician Decision|1
7815856|NCT00406692|27146549|P1|Overall Study|Withdrawal by Subject|4
7815857|NCT00406653|27146559|P7|Open-Label Period|Refused followup|1
7815858|NCT00406653|27146560|P6|Open-Label Period|Refused followup|0
7815859|NCT00406653|27146561|P5|Open-Label Period|Refused followup|0
7815860|NCT00406653|27146562|P4|Open-Label Period|Refused followup|0
7815861|NCT00406653|27146563|P3|Open-Label Period|Refused followup|0
7815862|NCT00406653|27146564|P2|Open-Label Period|Refused followup|0
7815863|NCT00406653|27146565|P1|Open-Label Period|Refused followup|0
7815864|NCT00406653|27146559|P7|Open-Label Period|Discontinued by Sponsor|1
7815865|NCT00406653|27146560|P6|Open-Label Period|Discontinued by Sponsor|0
7815866|NCT00406653|27146561|P5|Open-Label Period|Discontinued by Sponsor|0
7815867|NCT00406653|27146562|P4|Open-Label Period|Discontinued by Sponsor|0
7815868|NCT00406653|27146563|P3|Open-Label Period|Discontinued by Sponsor|0
7815869|NCT00406653|27146564|P2|Open-Label Period|Discontinued by Sponsor|0
7815870|NCT00406653|27146565|P1|Open-Label Period|Discontinued by Sponsor|0
7815871|NCT00406653|27146559|P7|Open-Label Period|Declined participation but followup done|8
7815872|NCT00406653|27146560|P6|Open-Label Period|Declined participation but followup done|0
7815873|NCT00406653|27146561|P5|Open-Label Period|Declined participation but followup done|0
7815874|NCT00406653|27146562|P4|Open-Label Period|Declined participation but followup done|0
7815875|NCT00406653|27146563|P3|Open-Label Period|Declined participation but followup done|0
7815876|NCT00406653|27146564|P2|Open-Label Period|Declined participation but followup done|0
7815877|NCT00406653|27146565|P1|Open-Label Period|Declined participation but followup done|0
7815878|NCT00406653|27146559|P7|Open-Label Period|Administrative Reason By Sponsor|115
7815879|NCT00406653|27146560|P6|Open-Label Period|Administrative Reason By Sponsor|0
7815880|NCT00406653|27146561|P5|Open-Label Period|Administrative Reason By Sponsor|0
7815881|NCT00406653|27146562|P4|Open-Label Period|Administrative Reason By Sponsor|0
7815882|NCT00406653|27146563|P3|Open-Label Period|Administrative Reason By Sponsor|0
7815883|NCT00406653|27146564|P2|Open-Label Period|Administrative Reason By Sponsor|0
7815884|NCT00406653|27146565|P1|Open-Label Period|Administrative Reason By Sponsor|0
7815885|NCT00406653|27146559|P7|Open-Label Period|Pregnancy|2
7815886|NCT00406653|27146560|P6|Open-Label Period|Pregnancy|0
7815887|NCT00406653|27146561|P5|Open-Label Period|Pregnancy|0
7815888|NCT00406653|27146562|P4|Open-Label Period|Pregnancy|0
7815889|NCT00406653|27146563|P3|Open-Label Period|Pregnancy|0
7815890|NCT00406653|27146564|P2|Open-Label Period|Pregnancy|0
7815891|NCT00406653|27146565|P1|Open-Label Period|Pregnancy|0
7815892|NCT00406653|27146559|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
7815893|NCT00406653|27146560|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
7815894|NCT00406653|27146561|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
7815895|NCT00406653|27146562|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
7815896|NCT00406653|27146563|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
7815897|NCT00406653|27146564|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
7815898|NCT00406653|27146565|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
7815899|NCT00406653|27146559|P7|Open-Label Period|Withdrawal of Consent|11
7815900|NCT00406653|27146560|P6|Open-Label Period|Withdrawal of Consent|0
7815901|NCT00406653|27146561|P5|Open-Label Period|Withdrawal of Consent|0
7815902|NCT00406653|27146562|P4|Open-Label Period|Withdrawal of Consent|0
7815903|NCT00406653|27146563|P3|Open-Label Period|Withdrawal of Consent|0
7815904|NCT00406653|27146564|P2|Open-Label Period|Withdrawal of Consent|0
7815905|NCT00406653|27146565|P1|Open-Label Period|Withdrawal of Consent|0
7815906|NCT00406653|27146559|P7|Open-Label Period|Lost to Follow-up|6
7815907|NCT00406653|27146560|P6|Open-Label Period|Lost to Follow-up|0
7815908|NCT00406653|27146561|P5|Open-Label Period|Lost to Follow-up|0
7815909|NCT00406653|27146562|P4|Open-Label Period|Lost to Follow-up|0
7815910|NCT00406653|27146563|P3|Open-Label Period|Lost to Follow-up|0
7815911|NCT00406653|27146564|P2|Open-Label Period|Lost to Follow-up|0
7815912|NCT00406653|27146565|P1|Open-Label Period|Lost to Follow-up|0
7815913|NCT00406653|27146559|P7|Open-Label Period|Lack of Efficacy|160
7815914|NCT00406653|27146560|P6|Open-Label Period|Lack of Efficacy|0
7815915|NCT00406653|27146561|P5|Open-Label Period|Lack of Efficacy|0
7815916|NCT00406653|27146562|P4|Open-Label Period|Lack of Efficacy|0
7815917|NCT00406653|27146563|P3|Open-Label Period|Lack of Efficacy|0
7815918|NCT00406653|27146564|P2|Open-Label Period|Lack of Efficacy|0
7815919|NCT00406653|27146565|P1|Open-Label Period|Lack of Efficacy|0
7815920|NCT00406653|27146559|P7|Open-Label Period|Adverse Event|18
7815921|NCT00406653|27146560|P6|Open-Label Period|Adverse Event|0
7815922|NCT00406653|27146561|P5|Open-Label Period|Adverse Event|0
7815923|NCT00406653|27146562|P4|Open-Label Period|Adverse Event|0
7815924|NCT00406653|27146563|P3|Open-Label Period|Adverse Event|0
7815925|NCT00406653|27146564|P2|Open-Label Period|Adverse Event|0
7815926|NCT00406653|27146565|P1|Open-Label Period|Adverse Event|0
7815927|NCT00406653|27146559|P7|Open-Label Period|Death|1
7815928|NCT00406653|27146560|P6|Open-Label Period|Death|0
7815929|NCT00406653|27146561|P5|Open-Label Period|Death|0
7815930|NCT00406653|27146562|P4|Open-Label Period|Death|0
7815931|NCT00406653|27146563|P3|Open-Label Period|Death|0
7815932|NCT00406653|27146564|P2|Open-Label Period|Death|0
7815933|NCT00406653|27146565|P1|Open-Label Period|Death|0
7815934|NCT00406653|27146559|P7|Maintenance Period|Error in disease score evaluation|0
7815935|NCT00406653|27146560|P6|Maintenance Period|Error in disease score evaluation|0
7815936|NCT00406653|27146561|P5|Maintenance Period|Error in disease score evaluation|1
7815937|NCT00406653|27146562|P4|Maintenance Period|Error in disease score evaluation|0
7815938|NCT00406653|27146563|P3|Maintenance Period|Error in disease score evaluation|0
7815939|NCT00406653|27146564|P2|Maintenance Period|Error in disease score evaluation|0
7815940|NCT00406653|27146565|P1|Maintenance Period|Error in disease score evaluation|0
7815941|NCT00406653|27146559|P7|Maintenance Period|Administrative Reason By Sponsor|0
7815942|NCT00406653|27146560|P6|Maintenance Period|Administrative Reason By Sponsor|7
7815943|NCT00406653|27146561|P5|Maintenance Period|Administrative Reason By Sponsor|4
7815944|NCT00406653|27146562|P4|Maintenance Period|Administrative Reason By Sponsor|0
7815945|NCT00406653|27146563|P3|Maintenance Period|Administrative Reason By Sponsor|0
7815946|NCT00406653|27146564|P2|Maintenance Period|Administrative Reason By Sponsor|0
7815947|NCT00406653|27146565|P1|Maintenance Period|Administrative Reason By Sponsor|0
7815948|NCT00406653|27146559|P7|Maintenance Period|Pregnancy|0
7815949|NCT00406653|27146560|P6|Maintenance Period|Pregnancy|1
7815950|NCT00406653|27146561|P5|Maintenance Period|Pregnancy|0
7815951|NCT00406653|27146562|P4|Maintenance Period|Pregnancy|0
7815952|NCT00406653|27146563|P3|Maintenance Period|Pregnancy|0
7815953|NCT00406653|27146564|P2|Maintenance Period|Pregnancy|0
7815954|NCT00406653|27146565|P1|Maintenance Period|Pregnancy|0
7815955|NCT00406653|27146559|P7|Maintenance Period|Withdrawal of Consent|0
7815956|NCT00406653|27146560|P6|Maintenance Period|Withdrawal of Consent|0
7815957|NCT00406653|27146561|P5|Maintenance Period|Withdrawal of Consent|2
7815958|NCT00406653|27146562|P4|Maintenance Period|Withdrawal of Consent|0
7815959|NCT00406653|27146563|P3|Maintenance Period|Withdrawal of Consent|0
7815960|NCT00406653|27146564|P2|Maintenance Period|Withdrawal of Consent|0
7815961|NCT00406653|27146565|P1|Maintenance Period|Withdrawal of Consent|0
7815962|NCT00406653|27146559|P7|Maintenance Period|Lost to Follow-up|0
7815963|NCT00406653|27146560|P6|Maintenance Period|Lost to Follow-up|1
7815964|NCT00406653|27146561|P5|Maintenance Period|Lost to Follow-up|2
7815965|NCT00406653|27146562|P4|Maintenance Period|Lost to Follow-up|0
7815966|NCT00406653|27146563|P3|Maintenance Period|Lost to Follow-up|0
7815967|NCT00406653|27146564|P2|Maintenance Period|Lost to Follow-up|0
7815968|NCT00406653|27146565|P1|Maintenance Period|Lost to Follow-up|0
7815969|NCT00406653|27146559|P7|Maintenance Period|Lack of Efficacy|0
7815970|NCT00406653|27146560|P6|Maintenance Period|Lack of Efficacy|26
7815971|NCT00406653|27146561|P5|Maintenance Period|Lack of Efficacy|20
7815972|NCT00406653|27146562|P4|Maintenance Period|Lack of Efficacy|0
7815973|NCT00406653|27146563|P3|Maintenance Period|Lack of Efficacy|0
7815974|NCT00406653|27146564|P2|Maintenance Period|Lack of Efficacy|0
7815975|NCT00406653|27146565|P1|Maintenance Period|Lack of Efficacy|0
7815976|NCT00406653|27146559|P7|Maintenance Period|Adverse Event|0
7815977|NCT00406653|27146560|P6|Maintenance Period|Adverse Event|1
7815978|NCT00406653|27146561|P5|Maintenance Period|Adverse Event|1
7815979|NCT00406653|27146562|P4|Maintenance Period|Adverse Event|0
7815980|NCT00406653|27146563|P3|Maintenance Period|Adverse Event|0
7815981|NCT00406653|27146564|P2|Maintenance Period|Adverse Event|0
7815982|NCT00406653|27146565|P1|Maintenance Period|Adverse Event|0
7815983|NCT00406653|27146559|P7|Induction Period|Patient relocated|0
7815984|NCT00406653|27146560|P6|Induction Period|Patient relocated|0
7815985|NCT00406653|27146561|P5|Induction Period|Patient relocated|0
7815986|NCT00406653|27146562|P4|Induction Period|Patient relocated|0
7815987|NCT00406653|27146563|P3|Induction Period|Patient relocated|1
7815988|NCT00406653|27146564|P2|Induction Period|Patient relocated|0
7815989|NCT00406653|27146565|P1|Induction Period|Patient relocated|0
7815990|NCT00406653|27146559|P7|Induction Period|Incarcerated|0
7815991|NCT00406653|27146560|P6|Induction Period|Incarcerated|0
7815992|NCT00406653|27146561|P5|Induction Period|Incarcerated|0
7815993|NCT00406653|27146562|P4|Induction Period|Incarcerated|0
7815994|NCT00406653|27146563|P3|Induction Period|Incarcerated|1
7815995|NCT00406653|27146564|P2|Induction Period|Incarcerated|0
7815996|NCT00406653|27146565|P1|Induction Period|Incarcerated|0
7815997|NCT00406653|27146559|P7|Induction Period|Given prohibited drug|0
7815998|NCT00406653|27146560|P6|Induction Period|Given prohibited drug|0
7815999|NCT00406653|27146561|P5|Induction Period|Given prohibited drug|0
7816000|NCT00406653|27146562|P4|Induction Period|Given prohibited drug|0
7816001|NCT00406653|27146563|P3|Induction Period|Given prohibited drug|2
7816002|NCT00406653|27146564|P2|Induction Period|Given prohibited drug|1
7816003|NCT00406653|27146565|P1|Induction Period|Given prohibited drug|0
7816004|NCT00406653|27146559|P7|Induction Period|Declined participation but followup done|0
7816005|NCT00406653|27146560|P6|Induction Period|Declined participation but followup done|0
7816006|NCT00406653|27146561|P5|Induction Period|Declined participation but followup done|0
7816007|NCT00406653|27146562|P4|Induction Period|Declined participation but followup done|1
7816008|NCT00406653|27146563|P3|Induction Period|Declined participation but followup done|1
7816009|NCT00406653|27146564|P2|Induction Period|Declined participation but followup done|2
7816010|NCT00406653|27146565|P1|Induction Period|Declined participation but followup done|0
7816011|NCT00406653|27146559|P7|Induction Period|Pregnancy|0
7816012|NCT00406653|27146560|P6|Induction Period|Pregnancy|0
7816013|NCT00406653|27146561|P5|Induction Period|Pregnancy|0
7816014|NCT00406653|27146562|P4|Induction Period|Pregnancy|0
7816015|NCT00406653|27146563|P3|Induction Period|Pregnancy|0
7816016|NCT00406653|27146564|P2|Induction Period|Pregnancy|0
7816017|NCT00406653|27146565|P1|Induction Period|Pregnancy|1
7816018|NCT00406653|27146559|P7|Induction Period|Subject No Longer Meets Study Criteria|0
7816019|NCT00406653|27146560|P6|Induction Period|Subject No Longer Meets Study Criteria|0
7816020|NCT00406653|27146561|P5|Induction Period|Subject No Longer Meets Study Criteria|0
7816021|NCT00406653|27146562|P4|Induction Period|Subject No Longer Meets Study Criteria|2
7816022|NCT00406653|27146563|P3|Induction Period|Subject No Longer Meets Study Criteria|0
7816023|NCT00406653|27146564|P2|Induction Period|Subject No Longer Meets Study Criteria|0
7816024|NCT00406653|27146565|P1|Induction Period|Subject No Longer Meets Study Criteria|0
7816025|NCT00406653|27146559|P7|Induction Period|Withdrawal of Consent|0
7816026|NCT00406653|27146560|P6|Induction Period|Withdrawal of Consent|0
7816027|NCT00406653|27146561|P5|Induction Period|Withdrawal of Consent|0
7816028|NCT00406653|27146562|P4|Induction Period|Withdrawal of Consent|2
7816029|NCT00406653|27146563|P3|Induction Period|Withdrawal of Consent|1
7816030|NCT00406653|27146564|P2|Induction Period|Withdrawal of Consent|5
7816031|NCT00406653|27146565|P1|Induction Period|Withdrawal of Consent|2
7816032|NCT00406653|27146559|P7|Induction Period|Lost to Follow-up|0
7816033|NCT00406653|27146560|P6|Induction Period|Lost to Follow-up|0
7816034|NCT00406653|27146561|P5|Induction Period|Lost to Follow-up|0
7816035|NCT00406653|27146562|P4|Induction Period|Lost to Follow-up|0
7816036|NCT00406653|27146563|P3|Induction Period|Lost to Follow-up|0
7816037|NCT00406653|27146564|P2|Induction Period|Lost to Follow-up|2
7816038|NCT00406653|27146565|P1|Induction Period|Lost to Follow-up|0
7816039|NCT00406653|27146559|P7|Induction Period|Lack of Efficacy|0
7816040|NCT00406653|27146560|P6|Induction Period|Lack of Efficacy|0
7816041|NCT00406653|27146561|P5|Induction Period|Lack of Efficacy|0
7816042|NCT00406653|27146562|P4|Induction Period|Lack of Efficacy|10
7816043|NCT00406653|27146563|P3|Induction Period|Lack of Efficacy|8
7816044|NCT00406653|27146564|P2|Induction Period|Lack of Efficacy|14
7816045|NCT00406653|27146565|P1|Induction Period|Lack of Efficacy|11
7816046|NCT00406653|27146559|P7|Induction Period|Adverse Event|0
7816047|NCT00406653|27146560|P6|Induction Period|Adverse Event|0
7816048|NCT00406653|27146561|P5|Induction Period|Adverse Event|0
7816049|NCT00406653|27146562|P4|Induction Period|Adverse Event|11
7816050|NCT00406653|27146563|P3|Induction Period|Adverse Event|4
7816051|NCT00406653|27146564|P2|Induction Period|Adverse Event|10
7816052|NCT00406653|27146565|P1|Induction Period|Adverse Event|1
7816053|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
7816054|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
7816055|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
7816056|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
7816057|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|non-compliance|2
7816058|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|non-compliance|3
7816059|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
7816060|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
7816061|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|Physician Decision|0
7816062|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|Physician Decision|1
7816063|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|Failed to Return|0
7816064|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|Failed to Return|1
7816065|NCT00406640|27146646|P2|OL Extension Phase for Non-Responders|Adverse Event|6
7816066|NCT00406640|27146647|P1|OL Extension Phase for Non-Responders|Adverse Event|6
7816067|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
7816068|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
7816069|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
7816070|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
7816071|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Protocol Violation|2
7816072|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Protocol Violation|2
7816073|NCT00406640|27146646|P2|DB Continuation Phase for Responders|non-compliance|5
7816074|NCT00406640|27146647|P1|DB Continuation Phase for Responders|non-compliance|7
7816075|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
7816076|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
7816077|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Physician Decision|3
7816078|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Physician Decision|2
7816079|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Failed to Return|2
7816080|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Failed to Return|0
7816081|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Death|0
7816082|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Death|1
7816083|NCT00406640|27146646|P2|DB Continuation Phase for Responders|Adverse Event|11
7816084|NCT00406640|27146647|P1|DB Continuation Phase for Responders|Adverse Event|11
7816085|NCT00406640|27146646|P2|Acute Phase|Lack of Efficacy|3
7816086|NCT00406640|27146647|P1|Acute Phase|Lack of Efficacy|3
7816087|NCT00406640|27146646|P2|Acute Phase|Withdrawal by Subject|9
7816088|NCT00406640|27146647|P1|Acute Phase|Withdrawal by Subject|11
7816089|NCT00406640|27146646|P2|Acute Phase|Protocol Violation|2
7816090|NCT00406640|27146647|P1|Acute Phase|Protocol Violation|3
7816091|NCT00406640|27146646|P2|Acute Phase|Protocol deviation|10
7816092|NCT00406640|27146647|P1|Acute Phase|Protocol deviation|4
7816093|NCT00406640|27146646|P2|Acute Phase|Lost to Follow-up|4
7816094|NCT00406640|27146647|P1|Acute Phase|Lost to Follow-up|7
7816095|NCT00406640|27146646|P2|Acute Phase|Physician Decision|1
7816096|NCT00406640|27146647|P1|Acute Phase|Physician Decision|0
7816097|NCT00406640|27146646|P2|Acute Phase|Failed to Return|1
7816098|NCT00406640|27146647|P1|Acute Phase|Failed to Return|5
7816099|NCT00406640|27146646|P2|Acute Phase|Adverse Event|13
7816100|NCT00406640|27146647|P1|Acute Phase|Adverse Event|18
7816101|NCT00406419|27146680|P3|Overall Study|Lost to Follow-up|5
7816102|NCT00406419|27146681|P2|Overall Study|Lost to Follow-up|10
7816103|NCT00406419|27146682|P1|Overall Study|Lost to Follow-up|11
7816104|NCT00406419|27146680|P3|Overall Study|Adverse Event|16
7816105|NCT00406419|27146681|P2|Overall Study|Adverse Event|12
7816106|NCT00406419|27146682|P1|Overall Study|Adverse Event|10
7816107|NCT00406419|27146680|P3|Overall Study|Non-Compliance with Study Drug|3
7816108|NCT00406419|27146681|P2|Overall Study|Non-Compliance with Study Drug|6
7816109|NCT00406419|27146682|P1|Overall Study|Non-Compliance with Study Drug|5
7816110|NCT00406419|27146680|P3|Overall Study|Lack of Efficacy|6
7816111|NCT00406419|27146681|P2|Overall Study|Lack of Efficacy|1
7816112|NCT00406419|27146682|P1|Overall Study|Lack of Efficacy|12
7816113|NCT00406419|27146680|P3|Overall Study|Withdrawal by Subject|26
7816114|NCT00406419|27146681|P2|Overall Study|Withdrawal by Subject|24
7816115|NCT00406419|27146682|P1|Overall Study|Withdrawal by Subject|17
7816116|NCT00406419|27146680|P3|Overall Study|Study Terminated by Sponsor|282
7816117|NCT00406419|27146681|P2|Overall Study|Study Terminated by Sponsor|288
7816118|NCT00406419|27146682|P1|Overall Study|Study Terminated by Sponsor|260
7816119|NCT00406419|27146680|P3|Overall Study|Protocol Violation|5
7816120|NCT00406419|27146681|P2|Overall Study|Protocol Violation|2
7816121|NCT00406419|27146682|P1|Overall Study|Protocol Violation|6
7816122|NCT00406419|27146680|P3|Overall Study|Death|4
7816123|NCT00406419|27146681|P2|Overall Study|Death|1
7816124|NCT00406419|27146682|P1|Overall Study|Death|3
7816125|NCT00406393|27146767|P2|Overall Study|Did not undergo transplantation|1
7816126|NCT00406393|27146768|P1|Overall Study|Did not undergo transplantation|2
7816127|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
7816128|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
7816129|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
7816130|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
7816131|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
7816132|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
7816133|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
7816134|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
7816135|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
7816136|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
7816137|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
7816138|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
7816139|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
7816140|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
7816141|NCT00406367|27146798|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
7816142|NCT00406367|27146799|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
7816143|NCT00406367|27146798|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
7816228|NCT00405756|27147157|P3|Follow-up|Death|24
7816144|NCT00406367|27146799|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
7816145|NCT00406367|27146798|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
7816146|NCT00406367|27146799|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
7816147|NCT00406367|27146798|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
7816148|NCT00406367|27146799|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
7816149|NCT00406367|27146798|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
7816150|NCT00406367|27146799|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
7816151|NCT00406354|27146814|P3|All Randomized and Treated Patients|Physician Decision|1
7816152|NCT00406354|27146815|P2|All Randomized and Treated Patients|Physician Decision|0
7816153|NCT00406354|27146816|P1|All Randomized and Treated Patients|Physician Decision|0
7816154|NCT00406354|27146814|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
7816155|NCT00406354|27146815|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
7816156|NCT00406354|27146816|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
7816157|NCT00406354|27146814|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
7816158|NCT00406354|27146815|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
7816159|NCT00406354|27146816|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
7816160|NCT00406354|27146814|P3|All Randomized and Treated Patients|Adverse Event|1
7816161|NCT00406354|27146815|P2|All Randomized and Treated Patients|Adverse Event|2
7816162|NCT00406354|27146816|P1|All Randomized and Treated Patients|Adverse Event|6
7816163|NCT00406354|27146814|P3|All Randomized and Treated Patients|Lack of Efficacy|17
7816164|NCT00406354|27146815|P2|All Randomized and Treated Patients|Lack of Efficacy|4
7816165|NCT00406354|27146816|P1|All Randomized and Treated Patients|Lack of Efficacy|7
7816166|NCT00406354|27146814|P3|All Randomized Patients|Protocol Violation|1
7816167|NCT00406354|27146815|P2|All Randomized Patients|Protocol Violation|0
7816168|NCT00406354|27146816|P1|All Randomized Patients|Protocol Violation|0
7816169|NCT00406315|27146887|P1|Overall Study|Withdrawal by Subject|30
7816170|NCT00406315|27146887|P1|Overall Study|Lost to Follow-up|21
7816171|NCT00406315|27146887|P1|Overall Study|Other|33
7816172|NCT00406315|27146887|P1|Overall Study|Lack of Efficacy|13
7816173|NCT00406315|27146887|P1|Overall Study|Laboratory Abnormality|4
7816174|NCT00406315|27146887|P1|Overall Study|Adverse Event|39
7816175|NCT00406315|27146887|P1|Overall Study|Death|1
7816176|NCT00406029|27146997|P5|Overall Study|Randomized in Error|1
7816177|NCT00406029|27146998|P4|Overall Study|Randomized in Error|3
7816178|NCT00406029|27146999|P3|Overall Study|Randomized in Error|2
7816179|NCT00406029|27147000|P2|Overall Study|Randomized in Error|0
7816180|NCT00406029|27147001|P1|Overall Study|Randomized in Error|0
7816181|NCT00406029|27146997|P5|Overall Study|Did Not Meet Eligibility Criteria|0
7816182|NCT00406029|27146998|P4|Overall Study|Did Not Meet Eligibility Criteria|0
7816183|NCT00406029|27146999|P3|Overall Study|Did Not Meet Eligibility Criteria|1
7816184|NCT00406029|27147000|P2|Overall Study|Did Not Meet Eligibility Criteria|0
7816185|NCT00406029|27147001|P1|Overall Study|Did Not Meet Eligibility Criteria|0
7816186|NCT00406029|27146997|P5|Overall Study|Protocol Violation|0
7816187|NCT00406029|27146998|P4|Overall Study|Protocol Violation|2
7816188|NCT00406029|27146999|P3|Overall Study|Protocol Violation|0
7816189|NCT00406029|27147000|P2|Overall Study|Protocol Violation|2
7816190|NCT00406029|27147001|P1|Overall Study|Protocol Violation|1
7816191|NCT00406029|27146997|P5|Overall Study|Withdrawal by Subject|0
7816192|NCT00406029|27146998|P4|Overall Study|Withdrawal by Subject|2
7816193|NCT00406029|27146999|P3|Overall Study|Withdrawal by Subject|2
7816194|NCT00406029|27147000|P2|Overall Study|Withdrawal by Subject|4
7816195|NCT00406029|27147001|P1|Overall Study|Withdrawal by Subject|3
7816196|NCT00406029|27146997|P5|Overall Study|Adverse Event|7
7816197|NCT00406029|27146998|P4|Overall Study|Adverse Event|10
7816198|NCT00406029|27146999|P3|Overall Study|Adverse Event|5
7816199|NCT00406029|27147000|P2|Overall Study|Adverse Event|2
7816200|NCT00406029|27147001|P1|Overall Study|Adverse Event|12
7816201|NCT00405964|27147105|P2|Overall Study|Protocol Violation|6
7816202|NCT00405964|27147106|P1|Overall Study|Protocol Violation|11
7816203|NCT00405964|27147105|P2|Overall Study|Withdrawal by Subject|23
7816204|NCT00405964|27147106|P1|Overall Study|Withdrawal by Subject|19
7816205|NCT00405964|27147105|P2|Overall Study|Lost to Follow-up|5
7816206|NCT00405964|27147106|P1|Overall Study|Lost to Follow-up|5
7816207|NCT00405964|27147105|P2|Overall Study|Adverse Event|16
7816208|NCT00405964|27147106|P1|Overall Study|Adverse Event|7
7816209|NCT00405964|27147105|P2|Overall Study|Treatment Failure|45
7816210|NCT00405964|27147106|P1|Overall Study|Treatment Failure|17
7816211|NCT00405912|27147128|P3|Overall Study|Lost to Follow-up|4
7816212|NCT00405912|27147129|P2|Overall Study|Lost to Follow-up|8
7816213|NCT00405912|27147130|P1|Overall Study|Lost to Follow-up|4
7816214|NCT00405912|27147128|P3|Overall Study|Withdrawal by Subject|12
7816215|NCT00405912|27147129|P2|Overall Study|Withdrawal by Subject|11
7816216|NCT00405912|27147130|P1|Overall Study|Withdrawal by Subject|12
7816217|NCT00405821|27147143|P2|Overall Study|initiated ART|8
7816218|NCT00405821|27147144|P1|Overall Study|initiated ART|9
7816219|NCT00405821|27147143|P2|Overall Study|Protocol Violation|0
7816220|NCT00405821|27147144|P1|Overall Study|Protocol Violation|1
7816221|NCT00405821|27147143|P2|Overall Study|Lost to Follow-up|7
7816222|NCT00405821|27147144|P1|Overall Study|Lost to Follow-up|7
7816223|NCT00405821|27147143|P2|Overall Study|Death|7
7816224|NCT00405821|27147144|P1|Overall Study|Death|5
7816225|NCT00405756|27147157|P3|Follow-up|Lost to Follow-up|4
7816226|NCT00405756|27147158|P2|Follow-up|Lost to Follow-up|8
7816227|NCT00405756|27147159|P1|Follow-up|Lost to Follow-up|2
7816229|NCT00405756|27147158|P2|Follow-up|Death|31
7816230|NCT00405756|27147159|P1|Follow-up|Death|21
7816231|NCT00405756|27147157|P3|Follow-up|Ongoing in Follow-up Period|60
7816232|NCT00405756|27147158|P2|Follow-up|Ongoing in Follow-up Period|51
7816233|NCT00405756|27147159|P1|Follow-up|Ongoing in Follow-up Period|52
7816234|NCT00405756|27147157|P3|Open-label Extension|Other|7
7816235|NCT00405756|27147158|P2|Open-label Extension|Other|1
7816236|NCT00405756|27147159|P1|Open-label Extension|Other|0
7816237|NCT00405756|27147157|P3|Open-label Extension|Death|4
7816238|NCT00405756|27147158|P2|Open-label Extension|Death|2
7816239|NCT00405756|27147159|P1|Open-label Extension|Death|1
7816240|NCT00405756|27147157|P3|Open-label Extension|Withdrawal by Subject|3
7816241|NCT00405756|27147158|P2|Open-label Extension|Withdrawal by Subject|3
7816242|NCT00405756|27147159|P1|Open-label Extension|Withdrawal by Subject|2
7816243|NCT00405756|27147157|P3|Open-label Extension|Disease Progression|26
7816244|NCT00405756|27147158|P2|Open-label Extension|Disease Progression|23
7816245|NCT00405756|27147159|P1|Open-label Extension|Disease Progression|8
7816246|NCT00405756|27147157|P3|Open-label Extension|Adverse Event|7
7816247|NCT00405756|27147158|P2|Open-label Extension|Adverse Event|3
7816248|NCT00405756|27147159|P1|Open-label Extension|Adverse Event|1
7816249|NCT00405756|27147157|P3|Open-label Extension|Ongoing in Open Label Period|25
7816250|NCT00405756|27147158|P2|Open-label Extension|Ongoing in Open Label Period|15
7816251|NCT00405756|27147159|P1|Open-label Extension|Ongoing in Open Label Period|7
7816252|NCT00405756|27147157|P3|Double-blind Treatment|Other|4
7816253|NCT00405756|27147158|P2|Double-blind Treatment|Other|4
7816254|NCT00405756|27147159|P1|Double-blind Treatment|Other|7
7816255|NCT00405756|27147157|P3|Double-blind Treatment|Protocol Violation|2
7816256|NCT00405756|27147158|P2|Double-blind Treatment|Protocol Violation|0
7816257|NCT00405756|27147159|P1|Double-blind Treatment|Protocol Violation|1
7816258|NCT00405756|27147157|P3|Double-blind Treatment|Death|4
7816259|NCT00405756|27147158|P2|Double-blind Treatment|Death|4
7816260|NCT00405756|27147159|P1|Double-blind Treatment|Death|4
7816261|NCT00405756|27147157|P3|Double-blind Treatment|Lost to Follow-up|0
7816262|NCT00405756|27147158|P2|Double-blind Treatment|Lost to Follow-up|0
7816263|NCT00405756|27147159|P1|Double-blind Treatment|Lost to Follow-up|1
7816264|NCT00405756|27147157|P3|Double-blind Treatment|Withdrawal by Subject|10
7816265|NCT00405756|27147158|P2|Double-blind Treatment|Withdrawal by Subject|9
7816266|NCT00405756|27147159|P1|Double-blind Treatment|Withdrawal by Subject|15
7816267|NCT00405756|27147157|P3|Double-blind Treatment|Lack of Efficacy|2
7816268|NCT00405756|27147158|P2|Double-blind Treatment|Lack of Efficacy|4
7816269|NCT00405756|27147159|P1|Double-blind Treatment|Lack of Efficacy|1
7816270|NCT00405756|27147157|P3|Double-blind Treatment|Disease Progression|102
7816271|NCT00405756|27147158|P2|Double-blind Treatment|Disease Progression|81
7816272|NCT00405756|27147159|P1|Double-blind Treatment|Disease Progression|47
7816273|NCT00405756|27147157|P3|Double-blind Treatment|Adverse Event|12
7816274|NCT00405756|27147158|P2|Double-blind Treatment|Adverse Event|27
7816275|NCT00405756|27147159|P1|Double-blind Treatment|Adverse Event|31
7816276|NCT00405756|27147157|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
7816277|NCT00405756|27147158|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
7816278|NCT00405756|27147159|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
7816279|NCT00405652|27147270|P1|Overall Study|Adverse Event|4
7816280|NCT00405639|27147277|P2|Overall Study|Seizure prior to receiving BNP|0
7816281|NCT00405639|27147278|P1|Overall Study|Seizure prior to receiving BNP|1
7816282|NCT00405639|27147277|P2|Overall Study|Adverse Event|0
7816283|NCT00405639|27147278|P1|Overall Study|Adverse Event|1
7816284|NCT00405639|27147277|P2|Overall Study|Withdrawal by Subject|0
7816285|NCT00405639|27147278|P1|Overall Study|Withdrawal by Subject|1
7816286|NCT00405587|27147294|P4|Overall Study|Participant not dosed|0
7816287|NCT00405587|27147295|P3|Overall Study|Participant not dosed|0
7816288|NCT00405587|27147296|P2|Overall Study|Participant not dosed|1
7816289|NCT00405587|27147297|P1|Overall Study|Participant not dosed|0
7816290|NCT00405587|27147294|P4|Overall Study|Withdrawal by Subject|2
7816291|NCT00405587|27147295|P3|Overall Study|Withdrawal by Subject|0
7816292|NCT00405587|27147296|P2|Overall Study|Withdrawal by Subject|0
7816293|NCT00405587|27147297|P1|Overall Study|Withdrawal by Subject|0
7816294|NCT00405587|27147294|P4|Overall Study|Radiation induced necrosis|0
7816295|NCT00405587|27147295|P3|Overall Study|Radiation induced necrosis|0
7816296|NCT00405587|27147296|P2|Overall Study|Radiation induced necrosis|1
7816297|NCT00405587|27147297|P1|Overall Study|Radiation induced necrosis|0
7816298|NCT00405587|27147294|P4|Overall Study|Lost to Follow-up|0
7816299|NCT00405587|27147295|P3|Overall Study|Lost to Follow-up|1
7816300|NCT00405587|27147296|P2|Overall Study|Lost to Follow-up|1
7816301|NCT00405587|27147297|P1|Overall Study|Lost to Follow-up|0
7816302|NCT00405587|27147294|P4|Overall Study|Adverse Event|0
7816303|NCT00405587|27147295|P3|Overall Study|Adverse Event|0
7816304|NCT00405587|27147296|P2|Overall Study|Adverse Event|0
7816305|NCT00405587|27147297|P1|Overall Study|Adverse Event|1
7816306|NCT00405587|27147294|P4|Overall Study|Physician Decision|0
7816307|NCT00405587|27147295|P3|Overall Study|Physician Decision|0
7816308|NCT00405587|27147296|P2|Overall Study|Physician Decision|2
7816309|NCT00405587|27147297|P1|Overall Study|Physician Decision|3
7816310|NCT00405587|27147294|P4|Overall Study|Disease Progression|17
7816311|NCT00405587|27147295|P3|Overall Study|Disease Progression|21
7816312|NCT00405587|27147296|P2|Overall Study|Disease Progression|23
7816313|NCT00405587|27147297|P1|Overall Study|Disease Progression|22
7816314|NCT00405587|27147294|P4|Overall Study|Death|1
7816315|NCT00405587|27147295|P3|Overall Study|Death|0
7816316|NCT00405587|27147296|P2|Overall Study|Death|0
7816317|NCT00405587|27147297|P1|Overall Study|Death|0
7816318|NCT00405548|27147415|P2|Overall Study|Withdrawal by Subject|0
7816319|NCT00405548|27147416|P1|Overall Study|Withdrawal by Subject|1
7816320|NCT00405548|27147415|P2|Overall Study|Venous access failed during study day|0
7816321|NCT00405548|27147416|P1|Overall Study|Venous access failed during study day|1
7816322|NCT00405548|27147415|P2|Overall Study|Unable to self-administer shots|0
7816323|NCT00405548|27147416|P1|Overall Study|Unable to self-administer shots|1
7816324|NCT00405548|27147415|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
7816325|NCT00405548|27147416|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
7816326|NCT00405548|27147415|P2|Overall Study|Cognitive Memory problems on study day|0
7816327|NCT00405548|27147416|P1|Overall Study|Cognitive Memory problems on study day|1
7816328|NCT00405392|27147460|P2|Overall Study|Other|5
7816329|NCT00405392|27147461|P1|Overall Study|Other|1
7816330|NCT00405392|27147460|P2|Overall Study|Non-compliance|1
7816331|NCT00405392|27147461|P1|Overall Study|Non-compliance|0
7816332|NCT00405392|27147460|P2|Overall Study|Data missing|0
7816333|NCT00405392|27147461|P1|Overall Study|Data missing|2
7816334|NCT00405392|27147460|P2|Overall Study|Lost to Follow-up|2
7816335|NCT00405392|27147461|P1|Overall Study|Lost to Follow-up|1
7816336|NCT00405392|27147460|P2|Overall Study|Withdrawal by Subject|3
7816337|NCT00405392|27147461|P1|Overall Study|Withdrawal by Subject|4
7816338|NCT00405392|27147460|P2|Overall Study|Did not meet Eligibility criteria|2
7816339|NCT00405392|27147461|P1|Overall Study|Did not meet Eligibility criteria|7
7816340|NCT00405392|27147460|P2|Overall Study|Adverse Event|14
7816341|NCT00405392|27147461|P1|Overall Study|Adverse Event|15
7816342|NCT00405275|27147508|P2|Overall Study|Unwilling to continue|9
7816343|NCT00405275|27147509|P1|Overall Study|Unwilling to continue|10
7816344|NCT00405275|27147508|P2|Overall Study|Withdrawal by Subject|9
7816345|NCT00405275|27147509|P1|Overall Study|Withdrawal by Subject|7
7816346|NCT00405275|27147508|P2|Overall Study|Lost to Follow-up|1
7816347|NCT00405275|27147509|P1|Overall Study|Lost to Follow-up|5
7816348|NCT00405275|27147508|P2|Overall Study|Death|0
7816349|NCT00405275|27147509|P1|Overall Study|Death|1
7816350|NCT00405067|27147518|P3|Overall Study|Lost to Follow-up|1
7816351|NCT00405067|27147519|P2|Overall Study|Lost to Follow-up|0
7816352|NCT00405067|27147520|P1|Overall Study|Lost to Follow-up|0
7816353|NCT00405067|27147518|P3|Overall Study|Adverse Event|4
7816354|NCT00405067|27147519|P2|Overall Study|Adverse Event|9
7816355|NCT00405067|27147520|P1|Overall Study|Adverse Event|4
7816356|NCT00404924|27147557|P2|Overall Study|Randomised but not received treatment|1
7816357|NCT00404924|27147558|P1|Overall Study|Randomised but not received treatment|1
7816358|NCT00404924|27147557|P2|Overall Study|Other|11
7816359|NCT00404924|27147558|P1|Overall Study|Other|25
7816360|NCT00404924|27147557|P2|Overall Study|Withdrawal by Subject|13
7816361|NCT00404924|27147558|P1|Overall Study|Withdrawal by Subject|26
7816362|NCT00404924|27147557|P2|Overall Study|Lost to Follow-up|1
7816363|NCT00404924|27147558|P1|Overall Study|Lost to Follow-up|1
7816364|NCT00404924|27147557|P2|Overall Study|Condition under investigation worsened|264
7816365|NCT00404924|27147558|P1|Overall Study|Condition under investigation worsened|475
7816366|NCT00404924|27147557|P2|Overall Study|Adverse Event|16
7816367|NCT00404924|27147558|P1|Overall Study|Adverse Event|75
7816368|NCT00404820|27147576|P2|Overall Study|Other|2
7816369|NCT00404820|27147577|P1|Overall Study|Other|0
7816370|NCT00404820|27147576|P2|Overall Study|Death|0
7816371|NCT00404820|27147577|P1|Overall Study|Death|1
7816372|NCT00404820|27147576|P2|Overall Study|Administrative problems|0
7816373|NCT00404820|27147577|P1|Overall Study|Administrative problems|2
7816374|NCT00404820|27147576|P2|Overall Study|Lost to Follow-up|3
7816375|NCT00404820|27147577|P1|Overall Study|Lost to Follow-up|7
7816376|NCT00404820|27147576|P2|Overall Study|Withdrawal by Subject|3
7816377|NCT00404820|27147577|P1|Overall Study|Withdrawal by Subject|5
7816378|NCT00404820|27147576|P2|Overall Study|Adverse Event|16
7816379|NCT00404820|27147577|P1|Overall Study|Adverse Event|4
7816380|NCT00404768|27147599|P4|Part C|Researcher suspended study medication|1
7816381|NCT00404768|27147600|P3|Part C|Researcher suspended study medication|0
7816382|NCT00404768|27147601|P2|Part C|Researcher suspended study medication|0
7816383|NCT00404768|27147602|P1|Part C|Researcher suspended study medication|0
7816384|NCT00404768|27147599|P4|Part C|Investigator discretion|1
7816385|NCT00404768|27147600|P3|Part C|Investigator discretion|0
7816386|NCT00404768|27147601|P2|Part C|Investigator discretion|0
7816387|NCT00404768|27147602|P1|Part C|Investigator discretion|0
7816388|NCT00404768|27147599|P4|Part C|Treatment failure|1
7816389|NCT00404768|27147600|P3|Part C|Treatment failure|0
7816390|NCT00404768|27147601|P2|Part C|Treatment failure|0
7816391|NCT00404768|27147602|P1|Part C|Treatment failure|0
7816392|NCT00404768|27147599|P4|Part C|Lack of Efficacy|2
7816393|NCT00404768|27147600|P3|Part C|Lack of Efficacy|0
7816394|NCT00404768|27147601|P2|Part C|Lack of Efficacy|0
7816395|NCT00404768|27147602|P1|Part C|Lack of Efficacy|0
7816396|NCT00404768|27147599|P4|Part C|Active labor|1
7816397|NCT00404768|27147600|P3|Part C|Active labor|0
7816398|NCT00404768|27147601|P2|Part C|Active labor|0
7816399|NCT00404768|27147602|P1|Part C|Active labor|0
7816400|NCT00404768|27147599|P4|Part C|Unsatisfactory uterine response to IP|1
7816401|NCT00404768|27147600|P3|Part C|Unsatisfactory uterine response to IP|0
7816402|NCT00404768|27147601|P2|Part C|Unsatisfactory uterine response to IP|0
7816403|NCT00404768|27147602|P1|Part C|Unsatisfactory uterine response to IP|0
7816404|NCT00404768|27147599|P4|Part C|Participant delivered baby|1
7816405|NCT00404768|27147600|P3|Part C|Participant delivered baby|0
7816406|NCT00404768|27147601|P2|Part C|Participant delivered baby|0
7816407|NCT00404768|27147602|P1|Part C|Participant delivered baby|0
7816408|NCT00404768|27147599|P4|Part C|Physician withdrew the study medication|0
7816409|NCT00404768|27147600|P3|Part C|Physician withdrew the study medication|1
7816410|NCT00404768|27147601|P2|Part C|Physician withdrew the study medication|0
7816411|NCT00404768|27147602|P1|Part C|Physician withdrew the study medication|0
7816412|NCT00404768|27147599|P4|Part C|Participant did not respond to therapy|1
7816413|NCT00404768|27147600|P3|Part C|Participant did not respond to therapy|1
7816414|NCT00404768|27147601|P2|Part C|Participant did not respond to therapy|0
7816415|NCT00404768|27147602|P1|Part C|Participant did not respond to therapy|0
7816416|NCT00404768|27147599|P4|Part C|Early withdrawal from study medication|0
7816417|NCT00404768|27147600|P3|Part C|Early withdrawal from study medication|1
7816418|NCT00404768|27147601|P2|Part C|Early withdrawal from study medication|0
7816419|NCT00404768|27147602|P1|Part C|Early withdrawal from study medication|0
7816420|NCT00404768|27147599|P4|Part C|Withdrawal by Subject|1
7816421|NCT00404768|27147600|P3|Part C|Withdrawal by Subject|2
7816422|NCT00404768|27147601|P2|Part C|Withdrawal by Subject|0
7816423|NCT00404768|27147602|P1|Part C|Withdrawal by Subject|0
7816424|NCT00404768|27147599|P4|Part C|Lost to Follow-up|1
7816425|NCT00404768|27147600|P3|Part C|Lost to Follow-up|3
7816426|NCT00404768|27147601|P2|Part C|Lost to Follow-up|0
7816427|NCT00404768|27147602|P1|Part C|Lost to Follow-up|0
7816428|NCT00404768|27147599|P4|Part C|Adverse Event|3
7816429|NCT00404768|27147600|P3|Part C|Adverse Event|0
7816430|NCT00404768|27147601|P2|Part C|Adverse Event|0
7816431|NCT00404768|27147602|P1|Part C|Adverse Event|0
7816432|NCT00404768|27147599|P4|Part A and B|Withdrawn as delivery imminemnt|0
7816433|NCT00404768|27147600|P3|Part A and B|Withdrawn as delivery imminemnt|0
7816434|NCT00404768|27147601|P2|Part A and B|Withdrawn as delivery imminemnt|1
7816435|NCT00404768|27147602|P1|Part A and B|Withdrawn as delivery imminemnt|0
7816436|NCT00404768|27147599|P4|Part A and B|Withdrawn due to labor progression|0
7816437|NCT00404768|27147600|P3|Part A and B|Withdrawn due to labor progression|0
7816438|NCT00404768|27147601|P2|Part A and B|Withdrawn due to labor progression|0
7816439|NCT00404768|27147602|P1|Part A and B|Withdrawn due to labor progression|1
7816440|NCT00404755|27147663|P1|Phase II (Escitalopram)|Lost to Follow-up|2
7816441|NCT00404755|27147663|P1|Phase I (Bupropion)|Other|1
7816442|NCT00404755|27147663|P1|Phase I (Bupropion)|Adverse Event|3
7816443|NCT00404651|27147678|P4|Overall Study|Withdrawal by Subject|6
7816444|NCT00404651|27147679|P3|Overall Study|Withdrawal by Subject|16
7816445|NCT00404651|27147680|P2|Overall Study|Withdrawal by Subject|12
7816446|NCT00404651|27147681|P1|Overall Study|Withdrawal by Subject|14
7816447|NCT00404651|27147678|P4|Overall Study|Lost to Follow-up|10
7816448|NCT00404651|27147679|P3|Overall Study|Lost to Follow-up|13
7816449|NCT00404651|27147680|P2|Overall Study|Lost to Follow-up|11
7816450|NCT00404651|27147681|P1|Overall Study|Lost to Follow-up|15
7816451|NCT00404651|27147678|P4|Overall Study|Protocol Violation|5
7816452|NCT00404651|27147679|P3|Overall Study|Protocol Violation|14
7816453|NCT00404651|27147680|P2|Overall Study|Protocol Violation|5
7816454|NCT00404651|27147681|P1|Overall Study|Protocol Violation|10
7816455|NCT00404651|27147678|P4|Overall Study|Serious Adverse Event|0
7816456|NCT00404651|27147679|P3|Overall Study|Serious Adverse Event|2
7816457|NCT00404651|27147680|P2|Overall Study|Serious Adverse Event|0
7816458|NCT00404651|27147681|P1|Overall Study|Serious Adverse Event|0
7816459|NCT00404547|27147709|P2|Overall Study|Reason not stated|6
7816460|NCT00404547|27147710|P1|Overall Study|Reason not stated|3
7816461|NCT00404547|27147709|P2|Overall Study|Other|0
7816462|NCT00404547|27147710|P1|Overall Study|Other|4
7816463|NCT00404547|27147709|P2|Overall Study|Lack of compliance|1
7816464|NCT00404547|27147710|P1|Overall Study|Lack of compliance|5
7816465|NCT00404547|27147709|P2|Overall Study|Lost to Follow-up|9
7816466|NCT00404547|27147710|P1|Overall Study|Lost to Follow-up|20
7816467|NCT00404547|27147709|P2|Overall Study|Protocol Violation|1
7816468|NCT00404547|27147710|P1|Overall Study|Protocol Violation|0
7816469|NCT00404547|27147709|P2|Overall Study|Withdrawal by Subject|2
7816470|NCT00404547|27147710|P1|Overall Study|Withdrawal by Subject|19
7816471|NCT00404547|27147709|P2|Overall Study|Adverse Event|6
7816472|NCT00404547|27147710|P1|Overall Study|Adverse Event|39
7816473|NCT00404495|27147720|P2|Overall Study|Withdrawal by Subject|0
7816474|NCT00404495|27147721|P1|Overall Study|Withdrawal by Subject|1
7816475|NCT00404495|27147720|P2|Overall Study|Other|0
7816476|NCT00404495|27147721|P1|Overall Study|Other|1
7816477|NCT00404495|27147720|P2|Overall Study|Lost to Follow-up|0
7816478|NCT00404495|27147721|P1|Overall Study|Lost to Follow-up|5
7816479|NCT00404495|27147720|P2|Overall Study|Death|11
7816480|NCT00404495|27147721|P1|Overall Study|Death|37
7816481|NCT00404352|27147740|P9|Open Label Extension (up to 36 Months)|Other|2
7816482|NCT00404352|27147741|P8|Open Label Extension (up to 36 Months)|Other|0
7816483|NCT00404352|27147742|P7|Open Label Extension (up to 36 Months)|Other|0
7816484|NCT00404352|27147743|P6|Open Label Extension (up to 36 Months)|Other|0
7816485|NCT00404352|27147744|P5|Open Label Extension (up to 36 Months)|Other|0
7816486|NCT00404352|27147745|P4|Open Label Extension (up to 36 Months)|Other|0
7816487|NCT00404352|27147746|P3|Open Label Extension (up to 36 Months)|Other|0
7816488|NCT00404352|27147747|P2|Open Label Extension (up to 36 Months)|Other|0
7816489|NCT00404352|27147748|P1|Open Label Extension (up to 36 Months)|Other|0
7816490|NCT00404352|27147740|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
7816491|NCT00404352|27147741|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
7816647|NCT00404248|27147787|P5|Overall Study|pts declining status|0
7816492|NCT00404352|27147742|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
7816493|NCT00404352|27147743|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
7816494|NCT00404352|27147744|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
7816495|NCT00404352|27147745|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
7816496|NCT00404352|27147746|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
7816497|NCT00404352|27147747|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
7816498|NCT00404352|27147748|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
7816499|NCT00404352|27147740|P9|Open Label (up to 24 Month)|Disease progression|0
7816500|NCT00404352|27147741|P8|Open Label (up to 24 Month)|Disease progression|0
7816501|NCT00404352|27147742|P7|Open Label (up to 24 Month)|Disease progression|0
7816502|NCT00404352|27147743|P6|Open Label (up to 24 Month)|Disease progression|0
7816503|NCT00404352|27147744|P5|Open Label (up to 24 Month)|Disease progression|0
7816504|NCT00404352|27147745|P4|Open Label (up to 24 Month)|Disease progression|1
7816505|NCT00404352|27147746|P3|Open Label (up to 24 Month)|Disease progression|0
7816506|NCT00404352|27147747|P2|Open Label (up to 24 Month)|Disease progression|0
7816507|NCT00404352|27147748|P1|Open Label (up to 24 Month)|Disease progression|0
7816508|NCT00404352|27147740|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816509|NCT00404352|27147741|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816510|NCT00404352|27147742|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816511|NCT00404352|27147743|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
7816512|NCT00404352|27147744|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816513|NCT00404352|27147745|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816514|NCT00404352|27147746|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816515|NCT00404352|27147747|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816516|NCT00404352|27147748|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
7816517|NCT00404352|27147740|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
7816518|NCT00404352|27147741|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
7816519|NCT00404352|27147742|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
7816520|NCT00404352|27147743|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
7816521|NCT00404352|27147744|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
7816522|NCT00404352|27147745|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
7816523|NCT00404352|27147746|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
7816524|NCT00404352|27147747|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
7816525|NCT00404352|27147748|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
7816526|NCT00404352|27147740|P9|Open Label (up to 24 Month)|Pregnancy|0
7816527|NCT00404352|27147741|P8|Open Label (up to 24 Month)|Pregnancy|0
7816528|NCT00404352|27147742|P7|Open Label (up to 24 Month)|Pregnancy|0
7816529|NCT00404352|27147743|P6|Open Label (up to 24 Month)|Pregnancy|1
7816530|NCT00404352|27147744|P5|Open Label (up to 24 Month)|Pregnancy|0
7816531|NCT00404352|27147745|P4|Open Label (up to 24 Month)|Pregnancy|0
7816532|NCT00404352|27147746|P3|Open Label (up to 24 Month)|Pregnancy|0
7816533|NCT00404352|27147747|P2|Open Label (up to 24 Month)|Pregnancy|0
7816534|NCT00404352|27147748|P1|Open Label (up to 24 Month)|Pregnancy|0
7816535|NCT00404352|27147740|P9|Open Label (up to 24 Month)|Adverse Event|0
7816536|NCT00404352|27147741|P8|Open Label (up to 24 Month)|Adverse Event|0
7816537|NCT00404352|27147742|P7|Open Label (up to 24 Month)|Adverse Event|0
7816538|NCT00404352|27147743|P6|Open Label (up to 24 Month)|Adverse Event|1
7816539|NCT00404352|27147744|P5|Open Label (up to 24 Month)|Adverse Event|1
7816540|NCT00404352|27147745|P4|Open Label (up to 24 Month)|Adverse Event|2
7816541|NCT00404352|27147746|P3|Open Label (up to 24 Month)|Adverse Event|0
7816542|NCT00404352|27147747|P2|Open Label (up to 24 Month)|Adverse Event|0
7816543|NCT00404352|27147748|P1|Open Label (up to 24 Month)|Adverse Event|0
7816544|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Other|0
7816545|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Other|0
7816546|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Other|0
7816547|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Other|0
7816548|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Other|0
7816549|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Other|0
7816550|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Other|0
7816551|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Other|1
7816552|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Other|0
7816553|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Physician Decision|0
7816554|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Physician Decision|0
7816555|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Physician Decision|0
7816556|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Physician Decision|0
7816557|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Physician Decision|0
7816558|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Physician Decision|0
7816559|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Physician Decision|1
7816560|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Physician Decision|0
7816561|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Physician Decision|0
7816562|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
7816563|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
7816564|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
7816565|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
7816566|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
7816567|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
7816568|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
7816569|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
7816570|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
7816571|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
7816572|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
7816573|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
7816574|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
7816575|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
7816576|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
7816577|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
7816578|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
7816579|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
7816580|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Poor compliance|0
7816581|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Poor compliance|0
7816582|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Poor compliance|0
7816583|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Poor compliance|0
7816584|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Poor compliance|0
7816585|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Poor compliance|0
7816586|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Poor compliance|0
7816587|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Poor compliance|0
7816588|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Poor compliance|1
7816589|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Disease progression|0
7816590|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Disease progression|0
7816591|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Disease progression|0
7816592|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Disease progression|0
7816593|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Disease progression|0
7816594|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Disease progression|0
7816595|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Disease progression|2
7816596|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Disease progression|0
7816597|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Disease progression|3
7816598|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7816599|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7816600|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7816601|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7816602|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7816603|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7816604|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
7816605|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
7816606|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
7816607|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
7816608|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
7816609|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
7816610|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
7816611|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
7816612|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
7816613|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
7816614|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
7816615|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
7816616|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Death|0
7816617|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Death|0
7816618|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Death|0
7816619|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Death|0
7816620|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Death|0
7816621|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Death|0
7816622|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Death|1
7816623|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Death|0
7816624|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Death|0
7816625|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Pregnancy|0
7816626|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Pregnancy|0
7816627|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Pregnancy|0
7816628|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Pregnancy|0
7816629|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Pregnancy|0
7816630|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Pregnancy|0
7816631|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Pregnancy|2
7816632|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Pregnancy|0
7816633|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Pregnancy|0
7816634|NCT00404352|27147740|P9|Double Blind (up to 24 Month)|Adverse Event|0
7816635|NCT00404352|27147741|P8|Double Blind (up to 24 Month)|Adverse Event|0
7816636|NCT00404352|27147742|P7|Double Blind (up to 24 Month)|Adverse Event|0
7816637|NCT00404352|27147743|P6|Double Blind (up to 24 Month)|Adverse Event|0
7816638|NCT00404352|27147744|P5|Double Blind (up to 24 Month)|Adverse Event|0
7816639|NCT00404352|27147745|P4|Double Blind (up to 24 Month)|Adverse Event|0
7816640|NCT00404352|27147746|P3|Double Blind (up to 24 Month)|Adverse Event|6
7816641|NCT00404352|27147747|P2|Double Blind (up to 24 Month)|Adverse Event|4
7816642|NCT00404352|27147748|P1|Double Blind (up to 24 Month)|Adverse Event|5
7816643|NCT00404248|27147783|P9|Overall Study|pts declining status|0
7816644|NCT00404248|27147784|P8|Overall Study|pts declining status|0
7816645|NCT00404248|27147785|P7|Overall Study|pts declining status|0
7816646|NCT00404248|27147786|P6|Overall Study|pts declining status|0
7816648|NCT00404248|27147788|P4|Overall Study|pts declining status|0
7816649|NCT00404248|27147789|P3|Overall Study|pts declining status|0
7816650|NCT00404248|27147790|P2|Overall Study|pts declining status|1
7816651|NCT00404248|27147791|P1|Overall Study|pts declining status|0
7816652|NCT00404235|27147824|P2|Overall Study|Withdrawal by Subject|2
7816653|NCT00404235|27147825|P1|Overall Study|Withdrawal by Subject|1
7816654|NCT00404092|27147843|P4|Overall Study|Adverse Event|0
7816655|NCT00404092|27147844|P3|Overall Study|Adverse Event|1
7816656|NCT00404092|27147845|P2|Overall Study|Adverse Event|0
7816657|NCT00404092|27147846|P1|Overall Study|Adverse Event|0
7816658|NCT00404092|27147843|P4|Overall Study|Death|0
7816659|NCT00404092|27147844|P3|Overall Study|Death|0
7816660|NCT00404092|27147845|P2|Overall Study|Death|0
7816661|NCT00404092|27147846|P1|Overall Study|Death|1
7816662|NCT00404079|27147862|P2|Overall Study|Lost to follow up, adverse event etc|20
7816663|NCT00404079|27147863|P1|Overall Study|Lost to follow up, adverse event etc|22
7816664|NCT00404066|27147869|P1|Overall Study|Withdrawal by Subject - Adverse event|2
7816665|NCT00404066|27147869|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
7816666|NCT00403845|27147874|P4|Treatment Period 3|Adverse Event|1
7816667|NCT00403845|27147875|P3|Treatment Period 3|Adverse Event|0
7816668|NCT00403845|27147876|P2|Treatment Period 3|Adverse Event|0
7816669|NCT00403845|27147877|P1|Treatment Period 3|Adverse Event|0
7816670|NCT00403845|27147874|P4|Treatment Period 3|Subject withdrew consent|1
7816671|NCT00403845|27147875|P3|Treatment Period 3|Subject withdrew consent|0
7816672|NCT00403845|27147876|P2|Treatment Period 3|Subject withdrew consent|0
7816673|NCT00403845|27147877|P1|Treatment Period 3|Subject withdrew consent|0
7816674|NCT00403845|27147874|P4|Treatment Period 2|Subject withdrew consent|0
7816675|NCT00403845|27147875|P3|Treatment Period 2|Subject withdrew consent|0
7816676|NCT00403845|27147876|P2|Treatment Period 2|Subject withdrew consent|0
7816677|NCT00403845|27147877|P1|Treatment Period 2|Subject withdrew consent|1
7816678|NCT00403845|27147874|P4|Treatment Period 1|Subject no longer needs study drug|1
7816679|NCT00403845|27147875|P3|Treatment Period 1|Subject no longer needs study drug|0
7816680|NCT00403845|27147876|P2|Treatment Period 1|Subject no longer needs study drug|0
7816681|NCT00403845|27147877|P1|Treatment Period 1|Subject no longer needs study drug|0
7816682|NCT00403845|27147874|P4|Treatment Period 1|Subject withdrew consent|0
7816683|NCT00403845|27147875|P3|Treatment Period 1|Subject withdrew consent|0
7816684|NCT00403845|27147876|P2|Treatment Period 1|Subject withdrew consent|0
7816685|NCT00403845|27147877|P1|Treatment Period 1|Subject withdrew consent|1
7816686|NCT00403767|27147901|P2|Overall Study|Missing/incomplete data|1
7816687|NCT00403767|27147902|P1|Overall Study|Missing/incomplete data|1
7816688|NCT00403767|27147901|P2|Overall Study|Study terminated by sponsor|69
7816689|NCT00403767|27147902|P1|Overall Study|Study terminated by sponsor|82
7816690|NCT00403767|27147901|P2|Overall Study|Clinical efficacy endpoint reached|332
7816691|NCT00403767|27147902|P1|Overall Study|Clinical efficacy endpoint reached|300
7816692|NCT00403767|27147901|P2|Overall Study|Protocol Violation|124
7816693|NCT00403767|27147902|P1|Overall Study|Protocol Violation|142
7816694|NCT00403767|27147901|P2|Overall Study|Lost to Follow-up|8
7816695|NCT00403767|27147902|P1|Overall Study|Lost to Follow-up|6
7816696|NCT00403767|27147901|P2|Overall Study|Investigator dec./not protocol-related|178
7816697|NCT00403767|27147902|P1|Overall Study|Investigator dec./not protocol-related|191
7816698|NCT00403767|27147901|P2|Overall Study|Consent withdrawn|673
7816699|NCT00403767|27147902|P1|Overall Study|Consent withdrawn|671
7816700|NCT00403767|27147901|P2|Overall Study|Non-compliant with study medication|164
7816701|NCT00403767|27147902|P1|Overall Study|Non-compliant with study medication|134
7816702|NCT00403767|27147901|P2|Overall Study|Adverse Event|919
7816703|NCT00403767|27147902|P1|Overall Study|Adverse Event|993
7816704|NCT00403754|27147926|P4|Core Treatment Period 2|Lack of Efficacy|0
7816705|NCT00403754|27147927|P3|Core Treatment Period 2|Lack of Efficacy|1
7816706|NCT00403754|27147928|P2|Core Treatment Period 2|Lack of Efficacy|0
7816707|NCT00403754|27147929|P1|Core Treatment Period 2|Lack of Efficacy|0
7816708|NCT00403754|27147926|P4|Core Treatment Period 1|Withdrawal by Subject|0
7816709|NCT00403754|27147927|P3|Core Treatment Period 1|Withdrawal by Subject|0
7816710|NCT00403754|27147928|P2|Core Treatment Period 1|Withdrawal by Subject|1
7816711|NCT00403754|27147929|P1|Core Treatment Period 1|Withdrawal by Subject|0
7816712|NCT00403585|27147956|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
7816713|NCT00403585|27147956|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
7816714|NCT00403585|27147956|P1|Initial Treatment Phase|Lost to Follow-up|2
7816715|NCT00403546|27147967|P3|Randomized Trial|Early Terminations|16
7816716|NCT00403546|27147968|P2|Randomized Trial|Early Terminations|17
7816717|NCT00403546|27147969|P1|Randomized Trial|Early Terminations|0
7816718|NCT00403546|27147967|P3|Screening Phase|Terminated Prior to Randomization|0
7816719|NCT00403546|27147968|P2|Screening Phase|Terminated Prior to Randomization|0
7816720|NCT00403546|27147969|P1|Screening Phase|Terminated Prior to Randomization|5
7816721|NCT00403546|27147967|P3|Screening Phase|Adverse Event|0
7816722|NCT00403546|27147968|P2|Screening Phase|Adverse Event|0
7816723|NCT00403546|27147969|P1|Screening Phase|Adverse Event|1
7816724|NCT00403546|27147967|P3|Screening Phase|Screening Failure|0
7816725|NCT00403546|27147968|P2|Screening Phase|Screening Failure|0
7816726|NCT00403546|27147969|P1|Screening Phase|Screening Failure|22
7816727|NCT00403546|27147967|P3|Signed Informed Consent/Open-Label|Adverse Event|0
7816728|NCT00403546|27147968|P2|Signed Informed Consent/Open-Label|Adverse Event|0
7816729|NCT00403546|27147969|P1|Signed Informed Consent/Open-Label|Adverse Event|5
7816813|NCT00403130|27148150|P1|2 Years From Start of Treatment|Not Eligible|3
7816730|NCT00403546|27147967|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
7816731|NCT00403546|27147968|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
7816732|NCT00403546|27147969|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
7816733|NCT00403546|27147967|P3|Signed Informed Consent/Open-Label|Early Termination|0
7816734|NCT00403546|27147968|P2|Signed Informed Consent/Open-Label|Early Termination|0
7816735|NCT00403546|27147969|P1|Signed Informed Consent/Open-Label|Early Termination|8
7816736|NCT00403546|27147967|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
7816737|NCT00403546|27147968|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
7816738|NCT00403546|27147969|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
7816739|NCT00403494|27148011|P2|Overall Study|Sponsor Request|0
7816740|NCT00403494|27148012|P1|Overall Study|Sponsor Request|1
7816741|NCT00403494|27148011|P2|Overall Study|Death|0
7816742|NCT00403494|27148012|P1|Overall Study|Death|1
7816743|NCT00403494|27148011|P2|Overall Study|Protocol noncompliance|1
7816744|NCT00403494|27148012|P1|Overall Study|Protocol noncompliance|0
7816745|NCT00403494|27148011|P2|Overall Study|Lost to Follow-up|2
7816746|NCT00403494|27148012|P1|Overall Study|Lost to Follow-up|0
7816747|NCT00403494|27148011|P2|Overall Study|Inappropriately enrolled|1
7816748|NCT00403494|27148012|P1|Overall Study|Inappropriately enrolled|0
7816749|NCT00403494|27148011|P2|Overall Study|Withdrew Consent|2
7816750|NCT00403494|27148012|P1|Overall Study|Withdrew Consent|3
7816751|NCT00403494|27148011|P2|Overall Study|Adverse Event|8
7816752|NCT00403494|27148012|P1|Overall Study|Adverse Event|10
7816753|NCT00403481|27148024|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
7816754|NCT00403481|27148024|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
7816755|NCT00403481|27148024|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
7816756|NCT00403481|27148024|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
7816757|NCT00403481|27148024|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
7816758|NCT00403481|27148024|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
7816759|NCT00403481|27148024|P1|Olm 40 mg|Other|1
7816760|NCT00403481|27148024|P1|Olm 40 mg|Withdrawal by Subject|1
7816761|NCT00403481|27148024|P1|Olm 40 mg|Protocol Violation|1
7816762|NCT00403481|27148024|P1|Olm 40 mg|Adverse Event|2
7816763|NCT00403481|27148024|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
7816764|NCT00403481|27148024|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
7816765|NCT00403481|27148024|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
7816766|NCT00403481|27148024|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
7816767|NCT00403455|27148039|P1|Overall Study|Withdrawal by Subject|1
7816768|NCT00403390|27148062|P2|Overall Study|non-compliant|0
7816769|NCT00403390|27148063|P1|Overall Study|non-compliant|1
7816770|NCT00403390|27148062|P2|Overall Study|samples lost|0
7816771|NCT00403390|27148063|P1|Overall Study|samples lost|1
7816772|NCT00403390|27148062|P2|Overall Study|Withdrawal by Subject|0
7816773|NCT00403390|27148063|P1|Overall Study|Withdrawal by Subject|1
7816774|NCT00403273|27148071|P2|Overall Study|pt. wanted to have a surgical procedure|1
7816775|NCT00403273|27148072|P1|Overall Study|pt. wanted to have a surgical procedure|0
7816776|NCT00403273|27148071|P2|Overall Study|Physician Decision|1
7816777|NCT00403273|27148072|P1|Overall Study|Physician Decision|0
7816778|NCT00403273|27148071|P2|Overall Study|Lost to Follow-up|2
7816779|NCT00403273|27148072|P1|Overall Study|Lost to Follow-up|3
7816780|NCT00403260|27148112|P2|Overall Study|Withdrawn from study accidentally|1
7816781|NCT00403260|27148113|P1|Overall Study|Withdrawn from study accidentally|0
7816782|NCT00403260|27148112|P2|Overall Study|Gametocyte re-appearance|1
7816783|NCT00403260|27148113|P1|Overall Study|Gametocyte re-appearance|1
7816784|NCT00403260|27148112|P2|Overall Study|P. ovale infection|0
7816785|NCT00403260|27148113|P1|Overall Study|P. ovale infection|1
7816786|NCT00403260|27148112|P2|Overall Study|P. vivax infection at screening|0
7816787|NCT00403260|27148113|P1|Overall Study|P. vivax infection at screening|1
7816788|NCT00403260|27148112|P2|Overall Study|Mixed infection with P. falciparum|0
7816789|NCT00403260|27148113|P1|Overall Study|Mixed infection with P. falciparum|1
7816790|NCT00403260|27148112|P2|Overall Study|Mixed infection with P. vivax|0
7816791|NCT00403260|27148113|P1|Overall Study|Mixed infection with P. vivax|2
7816792|NCT00403260|27148112|P2|Overall Study|P. vivax infection|4
7816793|NCT00403260|27148113|P1|Overall Study|P. vivax infection|26
7816794|NCT00403260|27148112|P2|Overall Study|Re-appearance of P. falciparum|25
7816795|NCT00403260|27148113|P1|Overall Study|Re-appearance of P. falciparum|34
7816796|NCT00403260|27148112|P2|Overall Study|Lost to Follow-up|25
7816797|NCT00403260|27148113|P1|Overall Study|Lost to Follow-up|49
7816798|NCT00403260|27148112|P2|Overall Study|Withdrawal by Subject|6
7816799|NCT00403260|27148113|P1|Overall Study|Withdrawal by Subject|5
7816800|NCT00403260|27148112|P2|Overall Study|Adverse Event|4
7816801|NCT00403260|27148113|P1|Overall Study|Adverse Event|5
7816802|NCT00403234|27148137|P4|Overall Study|Adverse Event|0
7816803|NCT00403234|27148138|P3|Overall Study|Adverse Event|1
7816804|NCT00403234|27148139|P2|Overall Study|Adverse Event|0
7816805|NCT00403234|27148140|P1|Overall Study|Adverse Event|1
7816806|NCT00403234|27148137|P4|Overall Study|Withdrawal by Subject|0
7816807|NCT00403234|27148138|P3|Overall Study|Withdrawal by Subject|0
7816808|NCT00403234|27148139|P2|Overall Study|Withdrawal by Subject|1
7816809|NCT00403234|27148140|P1|Overall Study|Withdrawal by Subject|0
7816810|NCT00403130|27148150|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
7816811|NCT00403130|27148150|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
7816812|NCT00403130|27148150|P1|2 Years From Start of Treatment|Lost to Follow up|1
7816814|NCT00402987|27148203|P4|Overall Study|Lack of Efficacy|0
7816815|NCT00402987|27148204|P3|Overall Study|Lack of Efficacy|1
7816816|NCT00402987|27148205|P2|Overall Study|Lack of Efficacy|0
7816817|NCT00402987|27148206|P1|Overall Study|Lack of Efficacy|0
7816818|NCT00402831|27148378|P2|Overall Study|Non-compliance with protocol|1
7816819|NCT00402831|27148379|P1|Overall Study|Non-compliance with protocol|0
7816820|NCT00402831|27148378|P2|Overall Study|Lost to Follow-up|2
7816821|NCT00402831|27148379|P1|Overall Study|Lost to Follow-up|1
7816822|NCT00402779|27148413|P2|Overall Study|Screen Failure|76
7816823|NCT00402779|27148414|P1|Overall Study|Screen Failure|77
7816824|NCT00402740|27148420|P1|Overall Study|Subject disposition unknown.|1
7816825|NCT00402740|27148420|P1|Overall Study|No stent. Completed FU at 30 days.|5
7816826|NCT00402740|27148420|P1|Overall Study|Lost to Follow-up|6
7816827|NCT00402740|27148420|P1|Overall Study|Death|50
7816828|NCT00402740|27148420|P1|Overall Study|Withdrawal by Subject|18
7816829|NCT00402727|27148432|P2|Overall Study|non-compliance|1
7816830|NCT00402727|27148433|P1|Overall Study|non-compliance|0
7816831|NCT00402727|27148432|P2|Overall Study|supply problems|1
7816832|NCT00402727|27148433|P1|Overall Study|supply problems|2
7816833|NCT00402727|27148432|P2|Overall Study|Withdrawal by Subject|7
7816834|NCT00402727|27148433|P1|Overall Study|Withdrawal by Subject|3
7816835|NCT00402727|27148432|P2|Overall Study|Protocol Violation|4
7816836|NCT00402727|27148433|P1|Overall Study|Protocol Violation|0
7816837|NCT00402727|27148432|P2|Overall Study|Physician Decision|1
7816838|NCT00402727|27148433|P1|Overall Study|Physician Decision|1
7816839|NCT00402727|27148432|P2|Overall Study|Lost to Follow-up|11
7816840|NCT00402727|27148433|P1|Overall Study|Lost to Follow-up|24
7816841|NCT00402727|27148432|P2|Overall Study|Lack of Efficacy|3
7816842|NCT00402727|27148433|P1|Overall Study|Lack of Efficacy|1
7816843|NCT00402727|27148432|P2|Overall Study|Death|0
7816844|NCT00402727|27148433|P1|Overall Study|Death|1
7816845|NCT00402727|27148432|P2|Overall Study|Adverse Event|6
7816846|NCT00402727|27148433|P1|Overall Study|Adverse Event|10
7816847|NCT00402688|27148475|P3|Overall Study|Patient Left Town and Forgot Medication|1
7816848|NCT00402688|27148476|P2|Overall Study|Patient Left Town and Forgot Medication|0
7816849|NCT00402688|27148477|P1|Overall Study|Patient Left Town and Forgot Medication|0
7816850|NCT00402688|27148475|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
7816851|NCT00402688|27148476|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
7816852|NCT00402688|27148477|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
7816853|NCT00402688|27148475|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
7816854|NCT00402688|27148476|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
7816855|NCT00402688|27148477|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
7816856|NCT00402688|27148475|P3|Overall Study|Lost to Follow-up|2
7816857|NCT00402688|27148476|P2|Overall Study|Lost to Follow-up|0
7816858|NCT00402688|27148477|P1|Overall Study|Lost to Follow-up|1
7816859|NCT00402688|27148475|P3|Overall Study|Protocol Violation|1
7816860|NCT00402688|27148476|P2|Overall Study|Protocol Violation|1
7816861|NCT00402688|27148477|P1|Overall Study|Protocol Violation|1
7816862|NCT00402688|27148475|P3|Overall Study|Lack of Efficacy|5
7816863|NCT00402688|27148476|P2|Overall Study|Lack of Efficacy|4
7816864|NCT00402688|27148477|P1|Overall Study|Lack of Efficacy|4
7816865|NCT00402688|27148475|P3|Overall Study|Physician Decision|1
7816866|NCT00402688|27148476|P2|Overall Study|Physician Decision|0
7816867|NCT00402688|27148477|P1|Overall Study|Physician Decision|0
7816868|NCT00402688|27148475|P3|Overall Study|Withdrawal by Subject|1
7816869|NCT00402688|27148476|P2|Overall Study|Withdrawal by Subject|1
7816870|NCT00402688|27148477|P1|Overall Study|Withdrawal by Subject|3
7816871|NCT00402688|27148475|P3|Overall Study|Adverse Event|3
7816872|NCT00402688|27148476|P2|Overall Study|Adverse Event|9
7816873|NCT00402688|27148477|P1|Overall Study|Adverse Event|12
7816874|NCT00402649|27148500|P1|Overall Study|Withdrawal by Subject|1
7816875|NCT00402649|27148500|P1|Overall Study|Lost to Follow-up|1
7816876|NCT00402597|27148515|P5|Overall Study|reason not specified|20
7816877|NCT00402597|27148516|P4|Overall Study|reason not specified|14
7816878|NCT00402597|27148517|P3|Overall Study|reason not specified|27
7816879|NCT00402597|27148518|P2|Overall Study|reason not specified|4
7816880|NCT00402597|27148519|P1|Overall Study|reason not specified|30
7816881|NCT00402597|27148515|P5|Overall Study|Withdrawal by Subject|24
7816882|NCT00402597|27148516|P4|Overall Study|Withdrawal by Subject|15
7816883|NCT00402597|27148517|P3|Overall Study|Withdrawal by Subject|65
7816884|NCT00402597|27148518|P2|Overall Study|Withdrawal by Subject|16
7816885|NCT00402597|27148519|P1|Overall Study|Withdrawal by Subject|57
7816886|NCT00402597|27148515|P5|Overall Study|Lost to Follow-up|3
7816887|NCT00402597|27148516|P4|Overall Study|Lost to Follow-up|2
7816888|NCT00402597|27148517|P3|Overall Study|Lost to Follow-up|8
7816889|NCT00402597|27148518|P2|Overall Study|Lost to Follow-up|1
7816890|NCT00402597|27148519|P1|Overall Study|Lost to Follow-up|8
7816891|NCT00402597|27148515|P5|Overall Study|Adverse Event|71
7816892|NCT00402597|27148516|P4|Overall Study|Adverse Event|39
7816893|NCT00402597|27148517|P3|Overall Study|Adverse Event|106
7816894|NCT00402597|27148518|P2|Overall Study|Adverse Event|18
7816895|NCT00402597|27148519|P1|Overall Study|Adverse Event|81
7816896|NCT00402597|27148515|P5|Overall Study|Death|6
7816897|NCT00402597|27148516|P4|Overall Study|Death|4
7816898|NCT00402597|27148517|P3|Overall Study|Death|6
7816899|NCT00402597|27148518|P2|Overall Study|Death|7
7816900|NCT00402597|27148519|P1|Overall Study|Death|15
7816901|NCT00402363|27148560|P4|Overall Study|"Captured as Other"|2
7816902|NCT00402363|27148561|P3|Overall Study|"Captured as Other"|2
7816903|NCT00402363|27148562|P2|Overall Study|"Captured as Other"|2
7816904|NCT00402363|27148563|P1|Overall Study|"Captured as Other"|6
7816905|NCT00402363|27148560|P4|Overall Study|Lost to Follow-up|2
7816906|NCT00402363|27148561|P3|Overall Study|Lost to Follow-up|0
7816907|NCT00402363|27148562|P2|Overall Study|Lost to Follow-up|4
7816908|NCT00402363|27148563|P1|Overall Study|Lost to Follow-up|5
7816909|NCT00402363|27148560|P4|Overall Study|Protocol Violation|3
7816910|NCT00402363|27148561|P3|Overall Study|Protocol Violation|0
7816911|NCT00402363|27148562|P2|Overall Study|Protocol Violation|5
7816912|NCT00402363|27148563|P1|Overall Study|Protocol Violation|3
7816913|NCT00402363|27148560|P4|Overall Study|Withdrew Consent|1
7816914|NCT00402363|27148561|P3|Overall Study|Withdrew Consent|2
7816915|NCT00402363|27148562|P2|Overall Study|Withdrew Consent|5
7816916|NCT00402363|27148563|P1|Overall Study|Withdrew Consent|10
7816917|NCT00402363|27148560|P4|Overall Study|Adverse Event|2
7816918|NCT00402363|27148561|P3|Overall Study|Adverse Event|2
7816919|NCT00402363|27148562|P2|Overall Study|Adverse Event|14
7816920|NCT00402363|27148563|P1|Overall Study|Adverse Event|9
7816921|NCT00402337|27148626|P5|Overall Study|Other Reason|0
7816922|NCT00402337|27148627|P4|Overall Study|Other Reason|0
7816923|NCT00402337|27148628|P3|Overall Study|Other Reason|0
7816924|NCT00402337|27148629|P2|Overall Study|Other Reason|1
7816925|NCT00402337|27148630|P1|Overall Study|Other Reason|0
7816926|NCT00402337|27148626|P5|Overall Study|Physician Decision|0
7816927|NCT00402337|27148627|P4|Overall Study|Physician Decision|1
7816928|NCT00402337|27148628|P3|Overall Study|Physician Decision|0
7816929|NCT00402337|27148629|P2|Overall Study|Physician Decision|0
7816930|NCT00402337|27148630|P1|Overall Study|Physician Decision|0
7816931|NCT00402337|27148626|P5|Overall Study|Lost to Follow-up|0
7816932|NCT00402337|27148627|P4|Overall Study|Lost to Follow-up|2
7816933|NCT00402337|27148628|P3|Overall Study|Lost to Follow-up|1
7816934|NCT00402337|27148629|P2|Overall Study|Lost to Follow-up|0
7816935|NCT00402337|27148630|P1|Overall Study|Lost to Follow-up|0
7816936|NCT00402337|27148626|P5|Overall Study|Withdrawal by Subject|4
7816937|NCT00402337|27148627|P4|Overall Study|Withdrawal by Subject|6
7816938|NCT00402337|27148628|P3|Overall Study|Withdrawal by Subject|1
7816939|NCT00402337|27148629|P2|Overall Study|Withdrawal by Subject|3
7816940|NCT00402337|27148630|P1|Overall Study|Withdrawal by Subject|5
7816941|NCT00402337|27148626|P5|Overall Study|Noncompliance|2
7816942|NCT00402337|27148627|P4|Overall Study|Noncompliance|0
7816943|NCT00402337|27148628|P3|Overall Study|Noncompliance|0
7816944|NCT00402337|27148629|P2|Overall Study|Noncompliance|0
7816945|NCT00402337|27148630|P1|Overall Study|Noncompliance|0
7816946|NCT00402337|27148626|P5|Overall Study|Adverse Event|2
7816947|NCT00402337|27148627|P4|Overall Study|Adverse Event|3
7816948|NCT00402337|27148628|P3|Overall Study|Adverse Event|2
7816949|NCT00402337|27148629|P2|Overall Study|Adverse Event|2
7816950|NCT00402337|27148630|P1|Overall Study|Adverse Event|0
7816951|NCT00402324|27148669|P2|Overall Study|Death|0
7816952|NCT00402324|27148670|P1|Overall Study|Death|1
7816953|NCT00402324|27148669|P2|Overall Study|Adverse Event|4
7816954|NCT00402324|27148670|P1|Overall Study|Adverse Event|6
7816955|NCT00402324|27148669|P2|Overall Study|Lack of Efficacy|4
7816956|NCT00402324|27148670|P1|Overall Study|Lack of Efficacy|1
7816957|NCT00402324|27148669|P2|Overall Study|Sponsor Decision|5
7816958|NCT00402324|27148670|P1|Overall Study|Sponsor Decision|4
7816959|NCT00402324|27148669|P2|Overall Study|Physician Decision|4
7816960|NCT00402324|27148670|P1|Overall Study|Physician Decision|2
7816961|NCT00402324|27148669|P2|Overall Study|Withdrawal by Subject|2
7816962|NCT00402324|27148670|P1|Overall Study|Withdrawal by Subject|5
7816963|NCT00402324|27148669|P2|Overall Study|Protocol Violation|7
7816964|NCT00402324|27148670|P1|Overall Study|Protocol Violation|8
7816965|NCT00402324|27148669|P2|Overall Study|Protocol Entry Criteria Not Met|4
7816966|NCT00402324|27148670|P1|Overall Study|Protocol Entry Criteria Not Met|5
7816967|NCT00402324|27148669|P2|Overall Study|Lost to Follow-up|11
7816968|NCT00402324|27148670|P1|Overall Study|Lost to Follow-up|11
7816969|NCT00402298|27148702|P2|Overall Study|Withdrawal by Subject|0
7816970|NCT00402298|27148703|P1|Overall Study|Withdrawal by Subject|1
7816971|NCT00402285|27148716|P3|Overall Study|insufficient RNA quality|2
7816972|NCT00402285|27148717|P2|Overall Study|insufficient RNA quality|6
7816973|NCT00402285|27148718|P1|Overall Study|insufficient RNA quality|7
7816974|NCT00402246|27148726|P2|Overall Study|Deterioriating Condition|2
7816975|NCT00402246|27148727|P1|Overall Study|Deterioriating Condition|3
7816976|NCT00402246|27148726|P2|Overall Study|Center Closure|3
7816977|NCT00402246|27148727|P1|Overall Study|Center Closure|5
7816978|NCT00402246|27148726|P2|Overall Study|Patient's device explanted|2
7816979|NCT00402246|27148727|P1|Overall Study|Patient's device explanted|6
7816980|NCT00402246|27148726|P2|Overall Study|Heart Transplant|1
7816981|NCT00402246|27148727|P1|Overall Study|Heart Transplant|0
7816982|NCT00402246|27148726|P2|Overall Study|Insurance Issues|1
7816983|NCT00402246|27148727|P1|Overall Study|Insurance Issues|2
7816984|NCT00402246|27148726|P2|Overall Study|Missed Final Visit|2
7816985|NCT00402246|27148727|P1|Overall Study|Missed Final Visit|1
7816986|NCT00402246|27148726|P2|Overall Study|Protocol Violation|24
7816987|NCT00402246|27148727|P1|Overall Study|Protocol Violation|25
7816988|NCT00402246|27148726|P2|Overall Study|Physician Decision|26
7816989|NCT00402246|27148727|P1|Overall Study|Physician Decision|24
7816990|NCT00402246|27148726|P2|Overall Study|Withdrawal by Subject|87
7816991|NCT00402246|27148727|P1|Overall Study|Withdrawal by Subject|72
7816992|NCT00402246|27148726|P2|Overall Study|Lost to Follow-up|28
7816993|NCT00402246|27148727|P1|Overall Study|Lost to Follow-up|20
7816994|NCT00402246|27148726|P2|Overall Study|Death|58
7816995|NCT00402246|27148727|P1|Overall Study|Death|62
7816996|NCT00402233|27148761|P4|Overall Study|Worsening of other pre-existing disease|0
7816997|NCT00402233|27148762|P3|Overall Study|Worsening of other pre-existing disease|0
7816998|NCT00402233|27148763|P2|Overall Study|Worsening of other pre-existing disease|1
7816999|NCT00402233|27148764|P1|Overall Study|Worsening of other pre-existing disease|0
7817000|NCT00402233|27148761|P4|Overall Study|Worsening of disease under study|0
7817001|NCT00402233|27148762|P3|Overall Study|Worsening of disease under study|0
7817002|NCT00402233|27148763|P2|Overall Study|Worsening of disease under study|0
7817003|NCT00402233|27148764|P1|Overall Study|Worsening of disease under study|2
7817004|NCT00402233|27148761|P4|Overall Study|Withdrawal by Subject|2
7817005|NCT00402233|27148762|P3|Overall Study|Withdrawal by Subject|2
7817006|NCT00402233|27148763|P2|Overall Study|Withdrawal by Subject|1
7817007|NCT00402233|27148764|P1|Overall Study|Withdrawal by Subject|2
7817008|NCT00402233|27148761|P4|Overall Study|Protocol Violation|0
7817009|NCT00402233|27148762|P3|Overall Study|Protocol Violation|0
7817010|NCT00402233|27148763|P2|Overall Study|Protocol Violation|1
7817011|NCT00402233|27148764|P1|Overall Study|Protocol Violation|0
7817012|NCT00402233|27148761|P4|Overall Study|Adverse Event|9
7817013|NCT00402233|27148762|P3|Overall Study|Adverse Event|9
7817014|NCT00402233|27148763|P2|Overall Study|Adverse Event|7
7817015|NCT00402233|27148764|P1|Overall Study|Adverse Event|1
7817016|NCT00402168|27148799|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
7817017|NCT00402168|27148800|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
7817018|NCT00402168|27148799|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
7817019|NCT00402168|27148800|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
7817020|NCT00402168|27148799|P2|Long Term (LT)|non-specified|2
7817021|NCT00402168|27148800|P1|Long Term (LT)|non-specified|1
7817022|NCT00402168|27148799|P2|Long Term (LT)|Lack of Efficacy|2
7817023|NCT00402168|27148800|P1|Long Term (LT)|Lack of Efficacy|0
7817024|NCT00402168|27148799|P2|Long Term (LT)|Death|0
7817025|NCT00402168|27148800|P1|Long Term (LT)|Death|4
7817026|NCT00402168|27148799|P2|Long Term (LT)|Lost to Follow-up|0
7817027|NCT00402168|27148800|P1|Long Term (LT)|Lost to Follow-up|1
7817028|NCT00402168|27148799|P2|Long Term (LT)|Pregnancy|1
7817029|NCT00402168|27148800|P1|Long Term (LT)|Pregnancy|0
7817030|NCT00402168|27148799|P2|Long Term (LT)|Withdrawal by Subject|7
7817031|NCT00402168|27148800|P1|Long Term (LT)|Withdrawal by Subject|4
7817032|NCT00402168|27148799|P2|Long Term (LT)|Adverse Event|5
7817033|NCT00402168|27148800|P1|Long Term (LT)|Adverse Event|1
7817034|NCT00402168|27148799|P2|Treatment (up to 12 Months)|non-specified|1
7817035|NCT00402168|27148800|P1|Treatment (up to 12 Months)|non-specified|0
7817036|NCT00402168|27148799|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
7817037|NCT00402168|27148800|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
7817038|NCT00402168|27148799|P2|Treatment (up to 12 Months)|Death|1
7817039|NCT00402168|27148800|P1|Treatment (up to 12 Months)|Death|0
7817040|NCT00402168|27148799|P2|Randomized|Withdrawal by Subject|1
7817041|NCT00402168|27148800|P1|Randomized|Withdrawal by Subject|0
7817042|NCT00402168|27148799|P2|Randomized|Lost to Follow-up|0
7817043|NCT00402168|27148800|P1|Randomized|Lost to Follow-up|1
7817044|NCT00402116|27148858|P3|Overall Study|Adverse Event|6
7817045|NCT00402116|27148859|P2|Overall Study|Adverse Event|1
7817046|NCT00402116|27148860|P1|Overall Study|Adverse Event|0
7817047|NCT00402116|27148858|P3|Overall Study|decline related hyponatremia/tumor|1
7817048|NCT00402116|27148859|P2|Overall Study|decline related hyponatremia/tumor|0
7817049|NCT00402116|27148860|P1|Overall Study|decline related hyponatremia/tumor|0
7817050|NCT00402116|27148858|P3|Overall Study|mistaken thrombocytopenia|1
7817051|NCT00402116|27148859|P2|Overall Study|mistaken thrombocytopenia|0
7817052|NCT00402116|27148860|P1|Overall Study|mistaken thrombocytopenia|0
7817053|NCT00402116|27148858|P3|Overall Study|Disease Progression|38
7817054|NCT00402116|27148859|P2|Overall Study|Disease Progression|4
7817055|NCT00402116|27148860|P1|Overall Study|Disease Progression|0
7817056|NCT00402116|27148858|P3|Overall Study|other complicating disease|2
7817057|NCT00402116|27148859|P2|Overall Study|other complicating disease|0
7817058|NCT00402116|27148860|P1|Overall Study|other complicating disease|0
7817059|NCT00402116|27148858|P3|Overall Study|Treatment completed per protocol|2
7817060|NCT00402116|27148859|P2|Overall Study|Treatment completed per protocol|1
7817061|NCT00402116|27148860|P1|Overall Study|Treatment completed per protocol|1
7817062|NCT00402116|27148858|P3|Overall Study|Withdrawal by Subject|5
7817063|NCT00402116|27148859|P2|Overall Study|Withdrawal by Subject|0
7817064|NCT00402116|27148860|P1|Overall Study|Withdrawal by Subject|1
7817065|NCT00402116|27148858|P3|Overall Study|Jaw infection after surgery-other|0
7817066|NCT00402116|27148859|P2|Overall Study|Jaw infection after surgery-other|0
7817067|NCT00402116|27148860|P1|Overall Study|Jaw infection after surgery-other|1
7817068|NCT00402103|27148890|P2|Overall Study|Administrative problems|0
7817069|NCT00402103|27148891|P1|Overall Study|Administrative problems|2
7817070|NCT00402103|27148890|P2|Overall Study|Lost to Follow-up|3
7817071|NCT00402103|27148891|P1|Overall Study|Lost to Follow-up|6
7817072|NCT00402103|27148890|P2|Overall Study|Patient withdrew consent|1
7817073|NCT00402103|27148891|P1|Overall Study|Patient withdrew consent|12
7817074|NCT00402103|27148890|P2|Overall Study|Protocol Deviation|0
7817075|NCT00402103|27148891|P1|Overall Study|Protocol Deviation|8
7817076|NCT00402103|27148890|P2|Overall Study|Condition no longer requires study drug|0
7817077|NCT00402103|27148891|P1|Overall Study|Condition no longer requires study drug|2
7817078|NCT00402103|27148890|P2|Overall Study|Unsatisfactory therapeutic effect|2
7817079|NCT00402103|27148891|P1|Overall Study|Unsatisfactory therapeutic effect|1
7817080|NCT00402103|27148890|P2|Overall Study|Adverse Event|7
7817081|NCT00402103|27148891|P1|Overall Study|Adverse Event|60
7817082|NCT00402051|27148907|P2|Overall Study|Lost to Follow-up|0
7817083|NCT00402051|27148908|P1|Overall Study|Lost to Follow-up|1
7817084|NCT00402051|27148907|P2|Overall Study|Death Due to Adverse Event|2
7817085|NCT00402051|27148908|P1|Overall Study|Death Due to Adverse Event|0
7817086|NCT00402051|27148907|P2|Overall Study|Death Due to Study Disease|1
7817087|NCT00402051|27148908|P1|Overall Study|Death Due to Study Disease|2
7817088|NCT00402051|27148907|P2|Overall Study|Death - Related to Study Drug|2
7817089|NCT00402051|27148908|P1|Overall Study|Death - Related to Study Drug|1
7817090|NCT00402051|27148907|P2|Overall Study|Withdrawal by Subject|3
7817091|NCT00402051|27148908|P1|Overall Study|Withdrawal by Subject|3
7817092|NCT00402051|27148907|P2|Overall Study|Physician Decision|3
7817093|NCT00402051|27148908|P1|Overall Study|Physician Decision|7
7817094|NCT00402051|27148907|P2|Overall Study|Adverse Event|4
7817095|NCT00402051|27148908|P1|Overall Study|Adverse Event|11
7817096|NCT00402051|27148907|P2|Overall Study|Progressive Disease|20
7817097|NCT00402051|27148908|P1|Overall Study|Progressive Disease|13
7817098|NCT00402025|27148925|P3|Overall Study|Participant Decision|1
7817099|NCT00402025|27148926|P2|Overall Study|Participant Decision|0
7817100|NCT00402025|27148927|P1|Overall Study|Participant Decision|0
7817101|NCT00402025|27148925|P3|Overall Study|Physician Decision|0
7817102|NCT00402025|27148926|P2|Overall Study|Physician Decision|1
7817103|NCT00402025|27148927|P1|Overall Study|Physician Decision|1
7817104|NCT00402025|27148925|P3|Overall Study|Disease Progression|2
7817105|NCT00402025|27148926|P2|Overall Study|Disease Progression|1
7817106|NCT00402025|27148927|P1|Overall Study|Disease Progression|1
7817107|NCT00402025|27148925|P3|Overall Study|Death|5
7817108|NCT00402025|27148926|P2|Overall Study|Death|1
7817109|NCT00402025|27148927|P1|Overall Study|Death|0
7817110|NCT00402025|27148925|P3|Overall Study|Adverse Event|2
7817111|NCT00402025|27148926|P2|Overall Study|Adverse Event|0
7817112|NCT00402025|27148927|P1|Overall Study|Adverse Event|0
7817113|NCT00401973|27148963|P3|Overall Study|Withdrawal by Subject|9
7817114|NCT00401973|27148964|P2|Overall Study|Withdrawal by Subject|12
7817115|NCT00401973|27148965|P1|Overall Study|Withdrawal by Subject|4
7817116|NCT00401973|27148963|P3|Overall Study|Sponsor Decision|0
7817117|NCT00401973|27148964|P2|Overall Study|Sponsor Decision|1
7817118|NCT00401973|27148965|P1|Overall Study|Sponsor Decision|0
7817119|NCT00401973|27148963|P3|Overall Study|Protocol Violation|3
7817120|NCT00401973|27148964|P2|Overall Study|Protocol Violation|2
7817121|NCT00401973|27148965|P1|Overall Study|Protocol Violation|1
7817122|NCT00401973|27148963|P3|Overall Study|Physician Decision|1
7817123|NCT00401973|27148964|P2|Overall Study|Physician Decision|0
7817124|NCT00401973|27148965|P1|Overall Study|Physician Decision|2
7817125|NCT00401973|27148963|P3|Overall Study|Lost to Follow-up|2
7817126|NCT00401973|27148964|P2|Overall Study|Lost to Follow-up|2
7817127|NCT00401973|27148965|P1|Overall Study|Lost to Follow-up|2
7817128|NCT00401973|27148963|P3|Overall Study|Lack of Efficacy|3
7817129|NCT00401973|27148964|P2|Overall Study|Lack of Efficacy|0
7817130|NCT00401973|27148965|P1|Overall Study|Lack of Efficacy|0
7817131|NCT00401973|27148963|P3|Overall Study|Clinical Relapse|1
7817132|NCT00401973|27148964|P2|Overall Study|Clinical Relapse|1
7817133|NCT00401973|27148965|P1|Overall Study|Clinical Relapse|0
7817134|NCT00401973|27148963|P3|Overall Study|Adverse Event|4
7817135|NCT00401973|27148964|P2|Overall Study|Adverse Event|8
7817136|NCT00401973|27148965|P1|Overall Study|Adverse Event|2
7817137|NCT00401960|27149004|P2|Overall Study|Death|0
7817138|NCT00401960|27149005|P1|Overall Study|Death|2
7817139|NCT00401960|27149004|P2|Overall Study|Lost to Follow-up|0
7817140|NCT00401960|27149005|P1|Overall Study|Lost to Follow-up|3
7817141|NCT00401843|27149035|P3|Overall Study|Received incorrect treatment|0
7817142|NCT00401843|27149036|P2|Overall Study|Received incorrect treatment|3
7817143|NCT00401843|27149037|P1|Overall Study|Received incorrect treatment|0
7817144|NCT00401843|27149035|P3|Overall Study|Randomized but not Treated|3
7817145|NCT00401843|27149036|P2|Overall Study|Randomized but not Treated|2
7817146|NCT00401843|27149037|P1|Overall Study|Randomized but not Treated|0
7817147|NCT00401843|27149035|P3|Overall Study|Withdrawal of consent to study agent|17
7817148|NCT00401843|27149036|P2|Overall Study|Withdrawal of consent to study agent|15
7817149|NCT00401843|27149037|P1|Overall Study|Withdrawal of consent to study agent|1
7817150|NCT00401843|27149035|P3|Overall Study|Withdrawal by Subject|5
7817151|NCT00401843|27149036|P2|Overall Study|Withdrawal by Subject|5
7817152|NCT00401843|27149037|P1|Overall Study|Withdrawal by Subject|1
7817153|NCT00401843|27149035|P3|Overall Study|Protocol Violation|1
7817154|NCT00401843|27149036|P2|Overall Study|Protocol Violation|0
7817155|NCT00401843|27149037|P1|Overall Study|Protocol Violation|0
7817156|NCT00401843|27149035|P3|Overall Study|Physician Decision|10
7817157|NCT00401843|27149036|P2|Overall Study|Physician Decision|16
7817158|NCT00401843|27149037|P1|Overall Study|Physician Decision|0
7817159|NCT00401843|27149035|P3|Overall Study|Other Unspecified|5
7817160|NCT00401843|27149036|P2|Overall Study|Other Unspecified|3
7817161|NCT00401843|27149037|P1|Overall Study|Other Unspecified|0
7817162|NCT00401843|27149035|P3|Overall Study|Lost to Follow-up|2
7817163|NCT00401843|27149036|P2|Overall Study|Lost to Follow-up|0
7817164|NCT00401843|27149037|P1|Overall Study|Lost to Follow-up|0
7817165|NCT00401843|27149035|P3|Overall Study|End of Study|2
7817166|NCT00401843|27149036|P2|Overall Study|End of Study|1
7817167|NCT00401843|27149037|P1|Overall Study|End of Study|1
7817168|NCT00401843|27149035|P3|Overall Study|Disease progression|49
7817169|NCT00401843|27149036|P2|Overall Study|Disease progression|60
7817170|NCT00401843|27149037|P1|Overall Study|Disease progression|10
7817171|NCT00401843|27149035|P3|Overall Study|Death|10
7817172|NCT00401843|27149036|P2|Overall Study|Death|8
7817173|NCT00401843|27149037|P1|Overall Study|Death|0
7817174|NCT00401843|27149035|P3|Overall Study|Adverse Event|27
7817175|NCT00401843|27149036|P2|Overall Study|Adverse Event|26
7817176|NCT00401843|27149037|P1|Overall Study|Adverse Event|7
7817177|NCT00401843|27149035|P3|Overall Study|Achieved Complete Response|11
7817178|NCT00401843|27149036|P2|Overall Study|Achieved Complete Response|5
7817179|NCT00401843|27149037|P1|Overall Study|Achieved Complete Response|1
7817180|NCT00401830|27149055|P2|Overall Study|Other: Personal / Family problems|0
7817181|NCT00401830|27149056|P1|Overall Study|Other: Personal / Family problems|1
7817182|NCT00401830|27149055|P2|Overall Study|Lost to Follow-up|3
7817183|NCT00401830|27149056|P1|Overall Study|Lost to Follow-up|1
7817184|NCT00401830|27149055|P2|Overall Study|Non-compliance with drug study|0
7817185|NCT00401830|27149056|P1|Overall Study|Non-compliance with drug study|1
7817186|NCT00401830|27149055|P2|Overall Study|Protocol Violation|3
7817187|NCT00401830|27149056|P1|Overall Study|Protocol Violation|3
7817188|NCT00401830|27149055|P2|Overall Study|Withdrawal by Subject|3
7817189|NCT00401830|27149056|P1|Overall Study|Withdrawal by Subject|4
7817190|NCT00401830|27149055|P2|Overall Study|Lack of Efficacy|5
7817191|NCT00401830|27149056|P1|Overall Study|Lack of Efficacy|11
7817192|NCT00401830|27149055|P2|Overall Study|Adverse Event|18
7817193|NCT00401830|27149056|P1|Overall Study|Adverse Event|10
7817194|NCT00401752|27149114|P2|Overall Study|Physician Decision|1
7817195|NCT00401752|27149115|P1|Overall Study|Physician Decision|1
7817196|NCT00401752|27149114|P2|Overall Study|Development of any exclusion criteria|2
7817197|NCT00401752|27149115|P1|Overall Study|Development of any exclusion criteria|4
7817198|NCT00401752|27149114|P2|Overall Study|Lost to Follow-up|4
7817199|NCT00401752|27149115|P1|Overall Study|Lost to Follow-up|1
7817200|NCT00401752|27149114|P2|Overall Study|Withdrawal by Subject|6
7817201|NCT00401752|27149115|P1|Overall Study|Withdrawal by Subject|2
7817202|NCT00401752|27149114|P2|Overall Study|Adverse Event|5
7817203|NCT00401752|27149115|P1|Overall Study|Adverse Event|2
7817204|NCT00401726|27149133|P2|Overall Study|Protocol Deviation|4
7817205|NCT00401726|27149134|P1|Overall Study|Protocol Deviation|9
7817206|NCT00401726|27149133|P2|Overall Study|Lack of Efficacy|6
7817207|NCT00401726|27149134|P1|Overall Study|Lack of Efficacy|4
7817208|NCT00401726|27149133|P2|Overall Study|Withdrawal by Subject|24
7817209|NCT00401726|27149134|P1|Overall Study|Withdrawal by Subject|18
7817210|NCT00401726|27149133|P2|Overall Study|Protocol Violation|3
7817211|NCT00401726|27149134|P1|Overall Study|Protocol Violation|6
7817212|NCT00401726|27149133|P2|Overall Study|Lost to Follow-up|20
7817213|NCT00401726|27149134|P1|Overall Study|Lost to Follow-up|23
7817214|NCT00401726|27149133|P2|Overall Study|Physician Decision|6
7817215|NCT00401726|27149134|P1|Overall Study|Physician Decision|3
7817216|NCT00401726|27149133|P2|Overall Study|Sponsor Request|1
7817217|NCT00401726|27149134|P1|Overall Study|Sponsor Request|0
7817218|NCT00401726|27149133|P2|Overall Study|Death|3
7817219|NCT00401726|27149134|P1|Overall Study|Death|0
7817220|NCT00401726|27149133|P2|Overall Study|Adverse Event|45
7817221|NCT00401726|27149134|P1|Overall Study|Adverse Event|34
7817222|NCT00401544|27149169|P4|Overall Study|Other|2
7817223|NCT00401544|27149170|P3|Overall Study|Other|2
7817224|NCT00401544|27149171|P2|Overall Study|Other|0
7817225|NCT00401544|27149172|P1|Overall Study|Other|0
7817226|NCT00401544|27149169|P4|Overall Study|Disease progression|0
7817227|NCT00401544|27149170|P3|Overall Study|Disease progression|0
7817228|NCT00401544|27149171|P2|Overall Study|Disease progression|1
7817229|NCT00401544|27149172|P1|Overall Study|Disease progression|0
7817230|NCT00401544|27149169|P4|Overall Study|Ineligibility determined|2
7817231|NCT00401544|27149170|P3|Overall Study|Ineligibility determined|0
7817232|NCT00401544|27149171|P2|Overall Study|Ineligibility determined|1
7817233|NCT00401544|27149172|P1|Overall Study|Ineligibility determined|0
7817234|NCT00401544|27149169|P4|Overall Study|Physician Decision|0
7817235|NCT00401544|27149170|P3|Overall Study|Physician Decision|0
7817236|NCT00401544|27149171|P2|Overall Study|Physician Decision|3
7817237|NCT00401544|27149172|P1|Overall Study|Physician Decision|1
7817238|NCT00401544|27149169|P4|Overall Study|Withdrawal by Subject|5
7817239|NCT00401544|27149170|P3|Overall Study|Withdrawal by Subject|6
7817240|NCT00401544|27149171|P2|Overall Study|Withdrawal by Subject|6
7817241|NCT00401544|27149172|P1|Overall Study|Withdrawal by Subject|7
7817242|NCT00401544|27149169|P4|Overall Study|Lost to Follow-up|1
7817243|NCT00401544|27149170|P3|Overall Study|Lost to Follow-up|1
7817244|NCT00401544|27149171|P2|Overall Study|Lost to Follow-up|0
7817245|NCT00401544|27149172|P1|Overall Study|Lost to Follow-up|2
7817246|NCT00401544|27149169|P4|Overall Study|Death|5
7817247|NCT00401544|27149170|P3|Overall Study|Death|2
7817248|NCT00401544|27149171|P2|Overall Study|Death|6
7817249|NCT00401544|27149172|P1|Overall Study|Death|3
7817250|NCT00401544|27149169|P4|Overall Study|Adverse Event|1
7817251|NCT00401544|27149170|P3|Overall Study|Adverse Event|1
7817252|NCT00401544|27149171|P2|Overall Study|Adverse Event|1
7817253|NCT00401544|27149172|P1|Overall Study|Adverse Event|5
7817254|NCT00401531|27149212|P2|Overall Study|Withdrawal by Subject|2
7817255|NCT00401531|27149213|P1|Overall Study|Withdrawal by Subject|3
7817256|NCT00401531|27149212|P2|Overall Study|Lost to Follow-up|1
7817257|NCT00401531|27149213|P1|Overall Study|Lost to Follow-up|1
7817258|NCT00401531|27149212|P2|Overall Study|Protocol Violation|7
7817259|NCT00401531|27149213|P1|Overall Study|Protocol Violation|3
7817260|NCT00401531|27149212|P2|Overall Study|Adverse Event|0
7817261|NCT00401531|27149213|P1|Overall Study|Adverse Event|2
7817262|NCT00401375|27149317|P3|Overall Study|Randomized but not treated|3
7817263|NCT00401375|27149318|P2|Overall Study|Randomized but not treated|3
7817264|NCT00401375|27149319|P1|Overall Study|Randomized but not treated|3
7817265|NCT00401375|27149317|P3|Overall Study|Other than specified|3
7817266|NCT00401375|27149318|P2|Overall Study|Other than specified|1
7817267|NCT00401375|27149319|P1|Overall Study|Other than specified|2
7817268|NCT00401375|27149317|P3|Overall Study|Lost to Follow-up|1
7817269|NCT00401375|27149318|P2|Overall Study|Lost to Follow-up|1
7817270|NCT00401375|27149319|P1|Overall Study|Lost to Follow-up|0
7817271|NCT00401375|27149317|P3|Overall Study|Withdrawal by Subject|7
7817272|NCT00401375|27149318|P2|Overall Study|Withdrawal by Subject|7
7817273|NCT00401375|27149319|P1|Overall Study|Withdrawal by Subject|9
7817274|NCT00401375|27149317|P3|Overall Study|Adverse Event|10
7817275|NCT00401375|27149318|P2|Overall Study|Adverse Event|11
7817276|NCT00401375|27149319|P1|Overall Study|Adverse Event|6
7817277|NCT00401375|27149317|P3|Overall Study|Protocol Violation|1
7817278|NCT00401375|27149318|P2|Overall Study|Protocol Violation|2
7817279|NCT00401375|27149319|P1|Overall Study|Protocol Violation|2
7817280|NCT00401258|27149336|P1|Overall Study|Adverse Event|7
7817281|NCT00401245|27149351|P8|Double Blind Tapering Phase|Lack of Efficacy|0
7817282|NCT00401245|27149352|P7|Double Blind Tapering Phase|Lack of Efficacy|0
7817283|NCT00401245|27149353|P6|Double Blind Tapering Phase|Lack of Efficacy|1
7817284|NCT00401245|27149354|P5|Double Blind Tapering Phase|Lack of Efficacy|0
7817285|NCT00401245|27149355|P4|Double Blind Tapering Phase|Lack of Efficacy|0
7817286|NCT00401245|27149356|P3|Double Blind Tapering Phase|Lack of Efficacy|0
7817287|NCT00401245|27149357|P2|Double Blind Tapering Phase|Lack of Efficacy|0
7817288|NCT00401245|27149358|P1|Double Blind Tapering Phase|Lack of Efficacy|0
7817289|NCT00401245|27149351|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
7817290|NCT00401245|27149352|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
7817291|NCT00401245|27149353|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
7817292|NCT00401245|27149354|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
7817293|NCT00401245|27149355|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
7817294|NCT00401245|27149356|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
7817295|NCT00401245|27149357|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
7817296|NCT00401245|27149358|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
7817297|NCT00401245|27149351|P8|Double Blind Tapering Phase|Other|2
7817298|NCT00401245|27149352|P7|Double Blind Tapering Phase|Other|2
7817299|NCT00401245|27149353|P6|Double Blind Tapering Phase|Other|0
7817300|NCT00401245|27149354|P5|Double Blind Tapering Phase|Other|1
7817301|NCT00401245|27149355|P4|Double Blind Tapering Phase|Other|0
7817302|NCT00401245|27149356|P3|Double Blind Tapering Phase|Other|0
7817303|NCT00401245|27149357|P2|Double Blind Tapering Phase|Other|0
7817304|NCT00401245|27149358|P1|Double Blind Tapering Phase|Other|0
7817305|NCT00401245|27149351|P8|Double Blind Tapering Phase|Investigator request|1
7817306|NCT00401245|27149352|P7|Double Blind Tapering Phase|Investigator request|0
7817307|NCT00401245|27149353|P6|Double Blind Tapering Phase|Investigator request|0
7817308|NCT00401245|27149354|P5|Double Blind Tapering Phase|Investigator request|0
7817309|NCT00401245|27149355|P4|Double Blind Tapering Phase|Investigator request|0
7817310|NCT00401245|27149356|P3|Double Blind Tapering Phase|Investigator request|0
7817311|NCT00401245|27149357|P2|Double Blind Tapering Phase|Investigator request|0
7817312|NCT00401245|27149358|P1|Double Blind Tapering Phase|Investigator request|0
7817313|NCT00401245|27149351|P8|Double Blind Tapering Phase|Adverse Event|4
7817314|NCT00401245|27149352|P7|Double Blind Tapering Phase|Adverse Event|2
7817315|NCT00401245|27149353|P6|Double Blind Tapering Phase|Adverse Event|1
7817316|NCT00401245|27149354|P5|Double Blind Tapering Phase|Adverse Event|1
7817317|NCT00401245|27149355|P4|Double Blind Tapering Phase|Adverse Event|0
7817318|NCT00401245|27149356|P3|Double Blind Tapering Phase|Adverse Event|0
7817319|NCT00401245|27149357|P2|Double Blind Tapering Phase|Adverse Event|0
7817320|NCT00401245|27149358|P1|Double Blind Tapering Phase|Adverse Event|0
7817321|NCT00401245|27149351|P8|Open Label Phase|Lack of Efficacy|0
7817322|NCT00401245|27149352|P7|Open Label Phase|Lack of Efficacy|0
7817323|NCT00401245|27149353|P6|Open Label Phase|Lack of Efficacy|0
7817324|NCT00401245|27149354|P5|Open Label Phase|Lack of Efficacy|0
7817325|NCT00401245|27149355|P4|Open Label Phase|Lack of Efficacy|0
7817326|NCT00401245|27149356|P3|Open Label Phase|Lack of Efficacy|3
7817327|NCT00401245|27149357|P2|Open Label Phase|Lack of Efficacy|2
7817328|NCT00401245|27149358|P1|Open Label Phase|Lack of Efficacy|4
7817329|NCT00401245|27149351|P8|Open Label Phase|Withdrawal by Subject|0
7817330|NCT00401245|27149352|P7|Open Label Phase|Withdrawal by Subject|0
7817331|NCT00401245|27149353|P6|Open Label Phase|Withdrawal by Subject|0
7817332|NCT00401245|27149354|P5|Open Label Phase|Withdrawal by Subject|0
7817333|NCT00401245|27149355|P4|Open Label Phase|Withdrawal by Subject|1
7817334|NCT00401245|27149356|P3|Open Label Phase|Withdrawal by Subject|2
7817335|NCT00401245|27149357|P2|Open Label Phase|Withdrawal by Subject|3
7817336|NCT00401245|27149358|P1|Open Label Phase|Withdrawal by Subject|3
7817337|NCT00401245|27149351|P8|Open Label Phase|Protocol Violation|0
7817338|NCT00401245|27149352|P7|Open Label Phase|Protocol Violation|0
7817339|NCT00401245|27149353|P6|Open Label Phase|Protocol Violation|0
7817340|NCT00401245|27149354|P5|Open Label Phase|Protocol Violation|0
7817341|NCT00401245|27149355|P4|Open Label Phase|Protocol Violation|1
7817342|NCT00401245|27149356|P3|Open Label Phase|Protocol Violation|0
7817343|NCT00401245|27149357|P2|Open Label Phase|Protocol Violation|1
7817344|NCT00401245|27149358|P1|Open Label Phase|Protocol Violation|0
7817345|NCT00401245|27149351|P8|Open Label Phase|Other|0
7817346|NCT00401245|27149352|P7|Open Label Phase|Other|0
7817347|NCT00401245|27149353|P6|Open Label Phase|Other|0
7817348|NCT00401245|27149354|P5|Open Label Phase|Other|0
7817349|NCT00401245|27149355|P4|Open Label Phase|Other|8
7817350|NCT00401245|27149356|P3|Open Label Phase|Other|7
7817351|NCT00401245|27149357|P2|Open Label Phase|Other|8
7817352|NCT00401245|27149358|P1|Open Label Phase|Other|4
7817353|NCT00401245|27149351|P8|Open Label Phase|Lost to Follow-up|0
7817354|NCT00401245|27149352|P7|Open Label Phase|Lost to Follow-up|0
7817355|NCT00401245|27149353|P6|Open Label Phase|Lost to Follow-up|0
7817356|NCT00401245|27149354|P5|Open Label Phase|Lost to Follow-up|0
7817357|NCT00401245|27149355|P4|Open Label Phase|Lost to Follow-up|4
7817358|NCT00401245|27149356|P3|Open Label Phase|Lost to Follow-up|5
7817359|NCT00401245|27149357|P2|Open Label Phase|Lost to Follow-up|7
7817360|NCT00401245|27149358|P1|Open Label Phase|Lost to Follow-up|5
7817361|NCT00401245|27149351|P8|Open Label Phase|Adverse Event|0
7817362|NCT00401245|27149352|P7|Open Label Phase|Adverse Event|0
7817363|NCT00401245|27149353|P6|Open Label Phase|Adverse Event|0
7817364|NCT00401245|27149354|P5|Open Label Phase|Adverse Event|0
7817365|NCT00401245|27149355|P4|Open Label Phase|Adverse Event|7
7817366|NCT00401245|27149356|P3|Open Label Phase|Adverse Event|6
7817367|NCT00401245|27149357|P2|Open Label Phase|Adverse Event|14
7817368|NCT00401245|27149358|P1|Open Label Phase|Adverse Event|5
7817369|NCT00401245|27149351|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
7817370|NCT00401245|27149352|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
7817371|NCT00401245|27149353|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
7817372|NCT00401245|27149354|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
7817373|NCT00401245|27149355|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
7817374|NCT00401245|27149356|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
7817375|NCT00401245|27149357|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
7817376|NCT00401245|27149358|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
7817377|NCT00401245|27149351|P8|Double Blind Titration Phase|Withdrawal by Subject|0
7817378|NCT00401245|27149352|P7|Double Blind Titration Phase|Withdrawal by Subject|0
7817379|NCT00401245|27149353|P6|Double Blind Titration Phase|Withdrawal by Subject|0
7817380|NCT00401245|27149354|P5|Double Blind Titration Phase|Withdrawal by Subject|0
7817381|NCT00401245|27149355|P4|Double Blind Titration Phase|Withdrawal by Subject|2
7817382|NCT00401245|27149356|P3|Double Blind Titration Phase|Withdrawal by Subject|0
7817383|NCT00401245|27149357|P2|Double Blind Titration Phase|Withdrawal by Subject|1
7817384|NCT00401245|27149358|P1|Double Blind Titration Phase|Withdrawal by Subject|1
7817385|NCT00401245|27149351|P8|Double Blind Titration Phase|Protocol Violation|0
7817386|NCT00401245|27149352|P7|Double Blind Titration Phase|Protocol Violation|0
7817387|NCT00401245|27149353|P6|Double Blind Titration Phase|Protocol Violation|0
7817388|NCT00401245|27149354|P5|Double Blind Titration Phase|Protocol Violation|0
7817389|NCT00401245|27149355|P4|Double Blind Titration Phase|Protocol Violation|1
7817390|NCT00401245|27149356|P3|Double Blind Titration Phase|Protocol Violation|0
7817391|NCT00401245|27149357|P2|Double Blind Titration Phase|Protocol Violation|0
7817392|NCT00401245|27149358|P1|Double Blind Titration Phase|Protocol Violation|0
7817393|NCT00401245|27149351|P8|Double Blind Titration Phase|Other|0
7817394|NCT00401245|27149352|P7|Double Blind Titration Phase|Other|0
7817395|NCT00401245|27149353|P6|Double Blind Titration Phase|Other|0
7817396|NCT00401245|27149354|P5|Double Blind Titration Phase|Other|0
7817397|NCT00401245|27149355|P4|Double Blind Titration Phase|Other|0
7817398|NCT00401245|27149356|P3|Double Blind Titration Phase|Other|1
7817399|NCT00401245|27149357|P2|Double Blind Titration Phase|Other|0
7817400|NCT00401245|27149358|P1|Double Blind Titration Phase|Other|0
7817401|NCT00401245|27149351|P8|Double Blind Titration Phase|Adverse Event|0
7817402|NCT00401245|27149352|P7|Double Blind Titration Phase|Adverse Event|0
7817403|NCT00401245|27149353|P6|Double Blind Titration Phase|Adverse Event|0
7817404|NCT00401245|27149354|P5|Double Blind Titration Phase|Adverse Event|0
7817405|NCT00401245|27149355|P4|Double Blind Titration Phase|Adverse Event|12
7817406|NCT00401245|27149356|P3|Double Blind Titration Phase|Adverse Event|5
7817407|NCT00401245|27149357|P2|Double Blind Titration Phase|Adverse Event|2
7817408|NCT00401245|27149358|P1|Double Blind Titration Phase|Adverse Event|3
7817409|NCT00401193|27149426|P3|Overall Study|Other Event|2
7817410|NCT00401193|27149427|P2|Overall Study|Other Event|2
7817411|NCT00401193|27149428|P1|Overall Study|Other Event|3
7817412|NCT00401193|27149426|P3|Overall Study|Withdrawal by Subject|1
7817413|NCT00401193|27149427|P2|Overall Study|Withdrawal by Subject|0
7817414|NCT00401193|27149428|P1|Overall Study|Withdrawal by Subject|2
7817415|NCT00401193|27149426|P3|Overall Study|Lost to Follow-up|1
7817416|NCT00401193|27149427|P2|Overall Study|Lost to Follow-up|5
7817417|NCT00401193|27149428|P1|Overall Study|Lost to Follow-up|6
7817418|NCT00401193|27149426|P3|Overall Study|Protocol Violation|1
7817419|NCT00401193|27149427|P2|Overall Study|Protocol Violation|1
7817420|NCT00401193|27149428|P1|Overall Study|Protocol Violation|3
7817421|NCT00401193|27149426|P3|Overall Study|Adverse Event|1
7817422|NCT00401193|27149427|P2|Overall Study|Adverse Event|3
7817423|NCT00401193|27149428|P1|Overall Study|Adverse Event|1
7817424|NCT00400985|27149446|P1|Overall Study|Lost to Follow-up|9
7817425|NCT00400985|27149446|P1|Overall Study|Death|30
7817426|NCT00400985|27149446|P1|Overall Study|system modification|8
7817427|NCT00400985|27149446|P1|Overall Study|Withdrawal by Subject|5
7817428|NCT00400946|27149455|P5|Overall Study|Other|1
7817429|NCT00400946|27149456|P4|Overall Study|Other|0
7817430|NCT00400946|27149457|P3|Overall Study|Other|0
7817431|NCT00400946|27149458|P2|Overall Study|Other|0
7817432|NCT00400946|27149459|P1|Overall Study|Other|0
7817433|NCT00400946|27149455|P5|Overall Study|Clinical|9
7817434|NCT00400946|27149456|P4|Overall Study|Clinical|2
7817435|NCT00400946|27149457|P3|Overall Study|Clinical|0
7817436|NCT00400946|27149458|P2|Overall Study|Clinical|2
7817437|NCT00400946|27149459|P1|Overall Study|Clinical|1
7817438|NCT00400946|27149455|P5|Overall Study|Withdrawal by Subject|8
7817439|NCT00400946|27149456|P4|Overall Study|Withdrawal by Subject|5
7817440|NCT00400946|27149457|P3|Overall Study|Withdrawal by Subject|1
7817441|NCT00400946|27149458|P2|Overall Study|Withdrawal by Subject|5
7817442|NCT00400946|27149459|P1|Overall Study|Withdrawal by Subject|2
7817443|NCT00400946|27149455|P5|Overall Study|Transplant in CR1|1
7817444|NCT00400946|27149456|P4|Overall Study|Transplant in CR1|10
7817445|NCT00400946|27149457|P3|Overall Study|Transplant in CR1|0
7817446|NCT00400946|27149458|P2|Overall Study|Transplant in CR1|0
7817447|NCT00400946|27149459|P1|Overall Study|Transplant in CR1|0
7817448|NCT00400946|27149455|P5|Overall Study|Relapse|5
7817449|NCT00400946|27149456|P4|Overall Study|Relapse|1
7817450|NCT00400946|27149457|P3|Overall Study|Relapse|1
7817451|NCT00400946|27149458|P2|Overall Study|Relapse|2
7817452|NCT00400946|27149459|P1|Overall Study|Relapse|9
7817453|NCT00400946|27149455|P5|Overall Study|Remission Death|1
7817454|NCT00400946|27149456|P4|Overall Study|Remission Death|0
7817455|NCT00400946|27149457|P3|Overall Study|Remission Death|0
7817456|NCT00400946|27149458|P2|Overall Study|Remission Death|1
7817457|NCT00400946|27149459|P1|Overall Study|Remission Death|1
7817458|NCT00400946|27149455|P5|Overall Study|Lost to Follow-up|1
7817459|NCT00400946|27149456|P4|Overall Study|Lost to Follow-up|0
7817460|NCT00400946|27149457|P3|Overall Study|Lost to Follow-up|0
7817461|NCT00400946|27149458|P2|Overall Study|Lost to Follow-up|1
7817462|NCT00400946|27149459|P1|Overall Study|Lost to Follow-up|1
7817463|NCT00400946|27149455|P5|Overall Study|Induction Death|3
7817464|NCT00400946|27149456|P4|Overall Study|Induction Death|13
7817465|NCT00400946|27149457|P3|Overall Study|Induction Death|0
7817466|NCT00400946|27149458|P2|Overall Study|Induction Death|0
7817467|NCT00400946|27149459|P1|Overall Study|Induction Death|0
7817468|NCT00400946|27149455|P5|Overall Study|Induction Failure|8
7817469|NCT00400946|27149456|P4|Overall Study|Induction Failure|11
7817470|NCT00400946|27149457|P3|Overall Study|Induction Failure|0
7817471|NCT00400946|27149458|P2|Overall Study|Induction Failure|0
7817472|NCT00400946|27149459|P1|Overall Study|Induction Failure|0
7817473|NCT00400946|27149455|P5|Overall Study|Ineligible|1
7817474|NCT00400946|27149456|P4|Overall Study|Ineligible|5
7817475|NCT00400946|27149457|P3|Overall Study|Ineligible|0
7817476|NCT00400946|27149458|P2|Overall Study|Ineligible|0
7817477|NCT00400946|27149459|P1|Overall Study|Ineligible|0
7817478|NCT00400764|27149518|P5|Phase II|Withdrawal by Subject|0
7817479|NCT00400764|27149519|P4|Phase II|Withdrawal by Subject|1
7817480|NCT00400764|27149520|P3|Phase II|Withdrawal by Subject|1
7817481|NCT00400764|27149521|P2|Phase II|Withdrawal by Subject|0
7817482|NCT00400764|27149522|P1|Phase II|Withdrawal by Subject|0
7817483|NCT00400764|27149518|P5|Phase II|Patient began new, non-protocol, therapy|0
7817484|NCT00400764|27149519|P4|Phase II|Patient began new, non-protocol, therapy|0
7817485|NCT00400764|27149520|P3|Phase II|Patient began new, non-protocol, therapy|1
7817486|NCT00400764|27149521|P2|Phase II|Patient began new, non-protocol, therapy|0
7817487|NCT00400764|27149522|P1|Phase II|Patient began new, non-protocol, therapy|0
7817488|NCT00400764|27149518|P5|Phase II|Sponsor's decision to terminate|11
7817489|NCT00400764|27149519|P4|Phase II|Sponsor's decision to terminate|22
7817490|NCT00400764|27149520|P3|Phase II|Sponsor's decision to terminate|18
7817491|NCT00400764|27149521|P2|Phase II|Sponsor's decision to terminate|0
7817492|NCT00400764|27149522|P1|Phase II|Sponsor's decision to terminate|0
7817493|NCT00400764|27149518|P5|Phase II|Physician Decision|0
7817494|NCT00400764|27149519|P4|Phase II|Physician Decision|1
7817495|NCT00400764|27149520|P3|Phase II|Physician Decision|1
7817496|NCT00400764|27149521|P2|Phase II|Physician Decision|0
7817497|NCT00400764|27149522|P1|Phase II|Physician Decision|0
7817498|NCT00400764|27149518|P5|Phase II|Lost to Follow-up|0
7817499|NCT00400764|27149519|P4|Phase II|Lost to Follow-up|0
7817500|NCT00400764|27149520|P3|Phase II|Lost to Follow-up|1
7817501|NCT00400764|27149521|P2|Phase II|Lost to Follow-up|0
7817502|NCT00400764|27149522|P1|Phase II|Lost to Follow-up|0
7817503|NCT00400764|27149518|P5|Phase II|Death|0
7817504|NCT00400764|27149519|P4|Phase II|Death|2
7817505|NCT00400764|27149520|P3|Phase II|Death|1
7817506|NCT00400764|27149521|P2|Phase II|Death|0
7817507|NCT00400764|27149522|P1|Phase II|Death|0
7817508|NCT00400764|27149518|P5|Phase Ib|Disease Progression|0
7817509|NCT00400764|27149519|P4|Phase Ib|Disease Progression|0
7817510|NCT00400764|27149520|P3|Phase Ib|Disease Progression|0
7817511|NCT00400764|27149521|P2|Phase Ib|Disease Progression|4
7817512|NCT00400764|27149522|P1|Phase Ib|Disease Progression|4
7817513|NCT00400764|27149518|P5|Phase Ib|Death|0
7817514|NCT00400764|27149519|P4|Phase Ib|Death|0
7817515|NCT00400764|27149520|P3|Phase Ib|Death|0
7817516|NCT00400764|27149521|P2|Phase Ib|Death|0
7817517|NCT00400764|27149522|P1|Phase Ib|Death|1
7817518|NCT00400764|27149518|P5|Phase Ib|Adverse Event|0
7817519|NCT00400764|27149519|P4|Phase Ib|Adverse Event|0
7817520|NCT00400764|27149520|P3|Phase Ib|Adverse Event|0
7817521|NCT00400764|27149521|P2|Phase Ib|Adverse Event|0
7817522|NCT00400764|27149522|P1|Phase Ib|Adverse Event|1
7817523|NCT00400712|27149575|P2|Overall Study|Physician Decision|4
7817524|NCT00400712|27149576|P1|Overall Study|Physician Decision|5
7817525|NCT00400712|27149575|P2|Overall Study|Withdrawal by Subject|12
7817526|NCT00400712|27149576|P1|Overall Study|Withdrawal by Subject|11
7817527|NCT00400712|27149575|P2|Overall Study|Death|0
7817528|NCT00400712|27149576|P1|Overall Study|Death|1
7817529|NCT00400569|27149611|P1|Overall Study|Death|1
7817530|NCT00400517|27149622|P1|Overall Study|Physician Decision|1
7817531|NCT00400517|27149622|P1|Overall Study|Withdrawal by Subject|1
7817532|NCT00400400|27149642|P2|Overall Study|Did not receive study drug|3
7817533|NCT00400400|27149643|P1|Overall Study|Did not receive study drug|1
7817534|NCT00400400|27149642|P2|Overall Study|Lost to Follow-up|1
7817535|NCT00400400|27149643|P1|Overall Study|Lost to Follow-up|0
7817536|NCT00400400|27149642|P2|Overall Study|Administrative Problem|0
7817537|NCT00400400|27149643|P1|Overall Study|Administrative Problem|1
7817538|NCT00400400|27149642|P2|Overall Study|Withdrawal by Subject|3
7817539|NCT00400400|27149643|P1|Overall Study|Withdrawal by Subject|1
7817540|NCT00400400|27149642|P2|Overall Study|Protocol Violation|0
7817541|NCT00400400|27149643|P1|Overall Study|Protocol Violation|2
7817542|NCT00400400|27149642|P2|Overall Study|Adverse Event|8
7817543|NCT00400400|27149643|P1|Overall Study|Adverse Event|9
7817544|NCT00400179|27149668|P2|Overall Study|Randomization error/patient ineligible|6
7817545|NCT00400179|27149669|P1|Overall Study|Randomization error/patient ineligible|1
7817546|NCT00400179|27149668|P2|Overall Study|Investigator judgment|1
7817547|NCT00400179|27149669|P1|Overall Study|Investigator judgment|0
7817548|NCT00400179|27149668|P2|Overall Study|Intercurrent illness|1
7817549|NCT00400179|27149669|P1|Overall Study|Intercurrent illness|0
7817550|NCT00400179|27149668|P2|Overall Study|Disease progression|1
7817551|NCT00400179|27149669|P1|Overall Study|Disease progression|1
7817552|NCT00400179|27149668|P2|Overall Study|Withdrew Consent|5
7817553|NCT00400179|27149669|P1|Overall Study|Withdrew Consent|1
7817554|NCT00400179|27149668|P2|Overall Study|Death|2
7817555|NCT00400179|27149669|P1|Overall Study|Death|1
7817556|NCT00400179|27149668|P2|Overall Study|Adverse Event|2
7817557|NCT00400179|27149669|P1|Overall Study|Adverse Event|2
7817558|NCT00400153|27149686|P3|Overall Study|Other reasons - not mentioned above|3
7817559|NCT00400153|27149687|P2|Overall Study|Other reasons - not mentioned above|5
7817560|NCT00400153|27149688|P1|Overall Study|Other reasons - not mentioned above|8
7817561|NCT00400153|27149686|P3|Overall Study|Withdrawal by Subject|10
7817562|NCT00400153|27149687|P2|Overall Study|Withdrawal by Subject|11
7817563|NCT00400153|27149688|P1|Overall Study|Withdrawal by Subject|12
7817564|NCT00400153|27149686|P3|Overall Study|Lost to Follow-up|4
7817565|NCT00400153|27149687|P2|Overall Study|Lost to Follow-up|1
7817566|NCT00400153|27149688|P1|Overall Study|Lost to Follow-up|2
7817567|NCT00400153|27149686|P3|Overall Study|Protocol Violation|9
7817568|NCT00400153|27149687|P2|Overall Study|Protocol Violation|4
7817569|NCT00400153|27149688|P1|Overall Study|Protocol Violation|7
7817570|NCT00400153|27149686|P3|Overall Study|AE due to other condition|15
7817571|NCT00400153|27149687|P2|Overall Study|AE due to other condition|14
7817572|NCT00400153|27149688|P1|Overall Study|AE due to other condition|3
7817573|NCT00400153|27149686|P3|Overall Study|AE due to other disease worsening|0
7817574|NCT00400153|27149687|P2|Overall Study|AE due to other disease worsening|1
7817575|NCT00400153|27149688|P1|Overall Study|AE due to other disease worsening|2
7817576|NCT00400153|27149686|P3|Overall Study|AE due to study disease worsening|20
7817577|NCT00400153|27149687|P2|Overall Study|AE due to study disease worsening|19
7817578|NCT00400153|27149688|P1|Overall Study|AE due to study disease worsening|14
7817579|NCT00399893|27149935|P2|Overall Study|Withdrawal by Subject|0
7817580|NCT00399893|27149936|P1|Overall Study|Withdrawal by Subject|1
7817581|NCT00399802|27149982|P2|Overall Study|Participant discontinued by mistake|1
7817582|NCT00399802|27149983|P1|Overall Study|Participant discontinued by mistake|0
7817583|NCT00399802|27149982|P2|Overall Study|Adverse Event|2
7817584|NCT00399802|27149983|P1|Overall Study|Adverse Event|0
7817585|NCT00399763|27149997|P2|Overall Study|Lost to Follow-up|3
7817586|NCT00399763|27149998|P1|Overall Study|Lost to Follow-up|2
7817587|NCT00399568|27150010|P2|Overall Study|Lost to Follow-up|2
7817588|NCT00399568|27150011|P1|Overall Study|Lost to Follow-up|2
7817589|NCT00399568|27150010|P2|Overall Study|Protocol non-compliance|2
7817590|NCT00399568|27150011|P1|Overall Study|Protocol non-compliance|2
7817591|NCT00399568|27150010|P2|Overall Study|Withdrawal by Subject|3
7817592|NCT00399568|27150011|P1|Overall Study|Withdrawal by Subject|7
7817593|NCT00399568|27150010|P2|Overall Study|Adverse Event|2
7817594|NCT00399568|27150011|P1|Overall Study|Adverse Event|1
7817595|NCT00399542|27150025|P2|Overall Study|Physician Decision|1
7817596|NCT00399542|27150026|P1|Overall Study|Physician Decision|0
7817597|NCT00399542|27150025|P2|Overall Study|Other|0
7817598|NCT00399542|27150026|P1|Overall Study|Other|1
7817599|NCT00399542|27150025|P2|Overall Study|Lost to Follow-up|6
7817600|NCT00399542|27150026|P1|Overall Study|Lost to Follow-up|6
7817601|NCT00399542|27150025|P2|Overall Study|Lack of Efficacy|8
7817602|NCT00399542|27150026|P1|Overall Study|Lack of Efficacy|18
7817603|NCT00399542|27150025|P2|Overall Study|Withdrawal by Subject|10
7817604|NCT00399542|27150026|P1|Overall Study|Withdrawal by Subject|28
7817605|NCT00399542|27150025|P2|Overall Study|Protocol Violation|3
7817606|NCT00399542|27150026|P1|Overall Study|Protocol Violation|13
7817607|NCT00399542|27150025|P2|Overall Study|Adverse Event|15
7817608|NCT00399542|27150026|P1|Overall Study|Adverse Event|18
7817609|NCT00399529|27150088|P1|Overall Study|Off Study Prior to Treatment|2
7817610|NCT00399516|27150094|P1|Overall Study|Lost to Follow-up|2
7817611|NCT00399490|27150098|P1|Overall Study|Other|25
7817612|NCT00399490|27150098|P1|Overall Study|Withdrawal by Subject|18
7817613|NCT00399490|27150098|P1|Overall Study|Lost to Follow-up|5
7817614|NCT00399490|27150098|P1|Overall Study|Lack of Efficacy|31
7817615|NCT00399490|27150098|P1|Overall Study|Adverse Event|19
7817616|NCT00399360|27150121|P4|Overall Study|Withdrawal by Subject|2
7817617|NCT00399360|27150122|P3|Overall Study|Withdrawal by Subject|0
7817618|NCT00399360|27150123|P2|Overall Study|Withdrawal by Subject|2
7817619|NCT00399360|27150124|P1|Overall Study|Withdrawal by Subject|0
7817620|NCT00399360|27150121|P4|Overall Study|Adverse Event|0
7817621|NCT00399360|27150122|P3|Overall Study|Adverse Event|1
7817622|NCT00399360|27150123|P2|Overall Study|Adverse Event|0
7817623|NCT00399360|27150124|P1|Overall Study|Adverse Event|0
7817624|NCT00399360|27150121|P4|Overall Study|Lost to Follow-up|4
7817625|NCT00399360|27150122|P3|Overall Study|Lost to Follow-up|2
7817626|NCT00399360|27150123|P2|Overall Study|Lost to Follow-up|1
7817627|NCT00399360|27150124|P1|Overall Study|Lost to Follow-up|2
7817628|NCT00399035|27150195|P3|Overall Study|Severe non-compliance with protocol|0
7817629|NCT00399035|27150196|P2|Overall Study|Severe non-compliance with protocol|1
7817630|NCT00399035|27150197|P1|Overall Study|Severe non-compliance with protocol|2
7817631|NCT00399035|27150195|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
7817632|NCT00399035|27150196|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
7817633|NCT00399035|27150197|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
7817634|NCT00399035|27150195|P3|Overall Study|Withdrawal by Subject|12
7817635|NCT00399035|27150196|P2|Overall Study|Withdrawal by Subject|15
7817636|NCT00399035|27150197|P1|Overall Study|Withdrawal by Subject|19
7817637|NCT00399035|27150195|P3|Overall Study|Lost to Follow-up|5
7817638|NCT00399035|27150196|P2|Overall Study|Lost to Follow-up|1
7817639|NCT00399035|27150197|P1|Overall Study|Lost to Follow-up|2
7817640|NCT00399035|27150195|P3|Overall Study|Death|234
7817641|NCT00399035|27150196|P2|Overall Study|Death|141
7817642|NCT00399035|27150197|P1|Overall Study|Death|289
7817643|NCT00398866|27150233|P3|Overall Study|Unable to complete requirements of study|1
7817644|NCT00398866|27150234|P2|Overall Study|Unable to complete requirements of study|1
7817645|NCT00398866|27150235|P1|Overall Study|Unable to complete requirements of study|1
7817646|NCT00398866|27150233|P3|Overall Study|Withdrawal by Subject|2
7817647|NCT00398866|27150234|P2|Overall Study|Withdrawal by Subject|1
7817648|NCT00398866|27150235|P1|Overall Study|Withdrawal by Subject|5
7817649|NCT00398866|27150233|P3|Overall Study|Lost to Follow-up|4
7817650|NCT00398866|27150234|P2|Overall Study|Lost to Follow-up|6
7817651|NCT00398866|27150235|P1|Overall Study|Lost to Follow-up|7
7817652|NCT00398866|27150233|P3|Overall Study|Lack of Efficacy|1
7817653|NCT00398866|27150234|P2|Overall Study|Lack of Efficacy|0
7817654|NCT00398866|27150235|P1|Overall Study|Lack of Efficacy|0
7817655|NCT00398866|27150233|P3|Overall Study|Adverse Event|0
7817656|NCT00398866|27150234|P2|Overall Study|Adverse Event|0
7817657|NCT00398866|27150235|P1|Overall Study|Adverse Event|1
7817658|NCT00398632|27150246|P1|Overall Study|Lack of Efficacy|1
7817659|NCT00398632|27150246|P1|Overall Study|Withdrawal by Subject|1
7817660|NCT00398567|27150254|P3|Overall Study|Protocol Violation|1
7817661|NCT00398567|27150255|P2|Overall Study|Protocol Violation|0
7817662|NCT00398567|27150256|P1|Overall Study|Protocol Violation|0
7817663|NCT00398567|27150254|P3|Overall Study|Adverse Event|2
7817664|NCT00398567|27150255|P2|Overall Study|Adverse Event|0
7817665|NCT00398567|27150256|P1|Overall Study|Adverse Event|0
7817666|NCT00398567|27150254|P3|Overall Study|Withdrawal by Subject|4
7817667|NCT00398567|27150255|P2|Overall Study|Withdrawal by Subject|0
7817668|NCT00398567|27150256|P1|Overall Study|Withdrawal by Subject|1
7817669|NCT00398567|27150254|P3|Overall Study|Disease Progression|27
7817670|NCT00398567|27150255|P2|Overall Study|Disease Progression|4
7817671|NCT00398567|27150256|P1|Overall Study|Disease Progression|3
7817672|NCT00398411|27150310|P2|Overall Study|Death|1
7817673|NCT00398411|27150311|P1|Overall Study|Death|0
7817674|NCT00398320|27150334|P1|Overall Study|Physician Decision|1
7817675|NCT00398320|27150334|P1|Overall Study|Adverse Event|4
7817676|NCT00398320|27150334|P1|Overall Study|Death|1
7817677|NCT00398216|27150347|P5|Overall Study|entrance criteria|2
7817678|NCT00398216|27150348|P4|Overall Study|entrance criteria|0
7817679|NCT00398216|27150349|P3|Overall Study|entrance criteria|0
7817680|NCT00398216|27150350|P2|Overall Study|entrance criteria|0
7817681|NCT00398216|27150351|P1|Overall Study|entrance criteria|0
7817682|NCT00398216|27150347|P5|Overall Study|administrative reasons|3
7817683|NCT00398216|27150348|P4|Overall Study|administrative reasons|3
7817684|NCT00398216|27150349|P3|Overall Study|administrative reasons|4
7817685|NCT00398216|27150350|P2|Overall Study|administrative reasons|4
7817686|NCT00398216|27150351|P1|Overall Study|administrative reasons|3
7817687|NCT00398216|27150347|P5|Overall Study|Withdrawal by Subject|2
7817688|NCT00398216|27150348|P4|Overall Study|Withdrawal by Subject|1
7817689|NCT00398216|27150349|P3|Overall Study|Withdrawal by Subject|3
7817690|NCT00398216|27150350|P2|Overall Study|Withdrawal by Subject|0
7817691|NCT00398216|27150351|P1|Overall Study|Withdrawal by Subject|1
7817692|NCT00398216|27150347|P5|Overall Study|Death|0
7817693|NCT00398216|27150348|P4|Overall Study|Death|0
7817694|NCT00398216|27150349|P3|Overall Study|Death|0
7817695|NCT00398216|27150350|P2|Overall Study|Death|3
7817696|NCT00398216|27150351|P1|Overall Study|Death|0
7817697|NCT00398216|27150347|P5|Overall Study|Lost to Follow-up|1
7817698|NCT00398216|27150348|P4|Overall Study|Lost to Follow-up|4
7817699|NCT00398216|27150349|P3|Overall Study|Lost to Follow-up|4
7817700|NCT00398216|27150350|P2|Overall Study|Lost to Follow-up|6
7817701|NCT00398216|27150351|P1|Overall Study|Lost to Follow-up|1
7817702|NCT00398216|27150347|P5|Overall Study|Protocol Violation|5
7817703|NCT00398216|27150348|P4|Overall Study|Protocol Violation|7
7817704|NCT00398216|27150349|P3|Overall Study|Protocol Violation|5
7817705|NCT00398216|27150350|P2|Overall Study|Protocol Violation|4
7817706|NCT00398216|27150351|P1|Overall Study|Protocol Violation|2
7817707|NCT00398216|27150347|P5|Overall Study|Adverse Event|2
7817708|NCT00398216|27150348|P4|Overall Study|Adverse Event|7
7817709|NCT00398216|27150349|P3|Overall Study|Adverse Event|5
7817710|NCT00398216|27150350|P2|Overall Study|Adverse Event|2
7817711|NCT00398216|27150351|P1|Overall Study|Adverse Event|4
7817712|NCT00398138|27150378|P1|Overall Study|Adverse Event|2
7817713|NCT00398112|27150383|P1|Overall Study|Death|1
7817714|NCT00398112|27150383|P1|Overall Study|Withdrawal by Subject|3
7817715|NCT00398112|27150383|P1|Overall Study|Alternative treatment|1
7817716|NCT00398112|27150383|P1|Overall Study|Disease progression|9
7817717|NCT00398112|27150383|P1|Overall Study|Adverse Event|4
7817718|NCT00398086|27150394|P3|Overall Study|Withdrawal by Subject|0
7817719|NCT00398086|27150395|P2|Overall Study|Withdrawal by Subject|7
7817720|NCT00398086|27150396|P1|Overall Study|Withdrawal by Subject|5
7817721|NCT00398086|27150394|P3|Overall Study|Physician Decision|0
7817722|NCT00398086|27150395|P2|Overall Study|Physician Decision|4
7817723|NCT00398086|27150396|P1|Overall Study|Physician Decision|1
7817724|NCT00398086|27150394|P3|Overall Study|Adverse Event|0
7817725|NCT00398086|27150395|P2|Overall Study|Adverse Event|4
7817726|NCT00398086|27150396|P1|Overall Study|Adverse Event|1
7817727|NCT00398086|27150394|P3|Overall Study|Unacceptable Toxicity|2
7817728|NCT00398086|27150395|P2|Overall Study|Unacceptable Toxicity|8
7817729|NCT00398086|27150396|P1|Overall Study|Unacceptable Toxicity|2
7817730|NCT00398073|27150430|P2|Overall Study|Withdrawal by Subject|0
7817731|NCT00398073|27150431|P1|Overall Study|Withdrawal by Subject|1
7817732|NCT00398047|27150441|P1|Overall Study|all patient progressed before completion|3
7817733|NCT00397982|27150451|P1|Overall Study|Unrelated health issues|1
7817734|NCT00397982|27150451|P1|Overall Study|noncompliance|1
7817735|NCT00397982|27150451|P1|Overall Study|Adverse Event|1
7817736|NCT00397982|27150451|P1|Overall Study|Withdrawal by Subject|1
7817737|NCT00397943|27150465|P5|Overall Study|Unspecified reasons|0
7817738|NCT00397943|27150466|P4|Overall Study|Unspecified reasons|0
7817739|NCT00397943|27150467|P3|Overall Study|Unspecified reasons|0
7817740|NCT00397943|27150468|P2|Overall Study|Unspecified reasons|9
7817741|NCT00397943|27150469|P1|Overall Study|Unspecified reasons|12
7817742|NCT00397930|27150625|P2|Overall Study|Missing data|4
7817743|NCT00397930|27150626|P1|Overall Study|Missing data|0
7817744|NCT00397930|27150625|P2|Overall Study|Withdrawal by Subject|8
7817745|NCT00397930|27150626|P1|Overall Study|Withdrawal by Subject|0
7817746|NCT00397930|27150625|P2|Overall Study|Did not want to be in control group|1
7817747|NCT00397930|27150626|P1|Overall Study|Did not want to be in control group|0
7817748|NCT00397930|27150625|P2|Overall Study|Started own yoga program|1
7817749|NCT00397930|27150626|P1|Overall Study|Started own yoga program|1
7817750|NCT00397930|27150625|P2|Overall Study|Too time-consuming|9
7817751|NCT00397930|27150626|P1|Overall Study|Too time-consuming|2
7817752|NCT00397930|27150625|P2|Overall Study|Noncompliant|2
7817753|NCT00397930|27150626|P1|Overall Study|Noncompliant|3
7817754|NCT00397930|27150625|P2|Overall Study|Unknown reasons|14
7817755|NCT00397930|27150626|P1|Overall Study|Unknown reasons|9
7817756|NCT00397930|27150625|P2|Overall Study|Other medical|4
7817757|NCT00397930|27150626|P1|Overall Study|Other medical|9
7817758|NCT00397930|27150625|P2|Overall Study|Personal reasons|8
7817759|NCT00397930|27150626|P1|Overall Study|Personal reasons|14
7817760|NCT00397891|27150641|P5|Overall Study|Withdrawal by Subject|1
7817761|NCT00397891|27150642|P4|Overall Study|Withdrawal by Subject|0
7817762|NCT00397891|27150643|P3|Overall Study|Withdrawal by Subject|0
7817763|NCT00397891|27150644|P2|Overall Study|Withdrawal by Subject|0
7817764|NCT00397891|27150645|P1|Overall Study|Withdrawal by Subject|1
7817765|NCT00397631|27150818|P2|Overall Study|protocol discontinuation criteria|4
7817766|NCT00397631|27150819|P1|Overall Study|protocol discontinuation criteria|1
7817767|NCT00397631|27150818|P2|Overall Study|Withdrawal by Subject|14
7817768|NCT00397631|27150819|P1|Overall Study|Withdrawal by Subject|7
7817769|NCT00397631|27150818|P2|Overall Study|Protocol Violation|1
7817770|NCT00397631|27150819|P1|Overall Study|Protocol Violation|0
7817771|NCT00397631|27150818|P2|Overall Study|Physician Decision|0
7817772|NCT00397631|27150819|P1|Overall Study|Physician Decision|2
7817773|NCT00397631|27150818|P2|Overall Study|Lost to Follow-up|9
7817774|NCT00397631|27150819|P1|Overall Study|Lost to Follow-up|8
7817775|NCT00397631|27150818|P2|Overall Study|Lack of Efficacy|10
7817776|NCT00397631|27150819|P1|Overall Study|Lack of Efficacy|7
7817777|NCT00397631|27150818|P2|Overall Study|Adverse Event|6
7817778|NCT00397631|27150819|P1|Overall Study|Adverse Event|5
7817779|NCT00397540|27150835|P2|Overall Study|short follow-up duration < 12 months|0
7817780|NCT00397540|27150836|P1|Overall Study|short follow-up duration < 12 months|1
7817781|NCT00397514|27150844|P1|Overall Study|poor echocardiographic windows|1
7817782|NCT00397514|27150844|P1|Overall Study|early extubation|2
7817783|NCT00397514|27150844|P1|Overall Study|Not able to capture & pace LV intraoper.|4
7817784|NCT00397514|27150844|P1|Overall Study|Pacing wire malfunction|1
7817785|NCT00397514|27150844|P1|Overall Study|Withdrawal by Subject|1
7817786|NCT00397488|27150854|P1|Overall Study|Death|1
7817787|NCT00397488|27150854|P1|Overall Study|Adverse Event|3
7817788|NCT00397488|27150854|P1|Overall Study|Withdrawal by Subject|3
7817789|NCT00397254|27150874|P2|Overall Study|Lost to Follow-up|2
7817790|NCT00397254|27150875|P1|Overall Study|Lost to Follow-up|2
7817791|NCT00397215|27150897|P4|Month 6 (Day 180)|Other|0
7817792|NCT00397215|27150898|P3|Month 6 (Day 180)|Other|3
7817793|NCT00397215|27150899|P2|Month 6 (Day 180)|Other|0
7817794|NCT00397215|27150900|P1|Month 6 (Day 180)|Other|2
7817795|NCT00397215|27150897|P4|Month 6 (Day 180)|Adverse Event|0
7817796|NCT00397215|27150898|P3|Month 6 (Day 180)|Adverse Event|2
7817797|NCT00397215|27150899|P2|Month 6 (Day 180)|Adverse Event|3
7817798|NCT00397215|27150900|P1|Month 6 (Day 180)|Adverse Event|0
7817799|NCT00397215|27150897|P4|Month 0 (Day 0)|Other|3
7817800|NCT00397215|27150898|P3|Month 0 (Day 0)|Other|3
7817801|NCT00397215|27150899|P2|Month 0 (Day 0)|Other|1
7817802|NCT00397215|27150900|P1|Month 0 (Day 0)|Other|4
7817803|NCT00397215|27150897|P4|Month 0 (Day 0)|Withdrawal by Subject|1
7817804|NCT00397215|27150898|P3|Month 0 (Day 0)|Withdrawal by Subject|3
7817805|NCT00397215|27150899|P2|Month 0 (Day 0)|Withdrawal by Subject|3
7817806|NCT00397215|27150900|P1|Month 0 (Day 0)|Withdrawal by Subject|3
7817807|NCT00397215|27150897|P4|Month 0 (Day 0)|Adverse Event|0
7817808|NCT00397215|27150898|P3|Month 0 (Day 0)|Adverse Event|0
7817809|NCT00397215|27150899|P2|Month 0 (Day 0)|Adverse Event|1
7817810|NCT00397215|27150900|P1|Month 0 (Day 0)|Adverse Event|0
7817811|NCT00397189|27151036|P2|3 Weeks Period|Other|2
7817812|NCT00397189|27151037|P1|3 Weeks Period|Other|0
7817813|NCT00397189|27151036|P2|3 Weeks Period|Protocol Violation|3
7817814|NCT00397189|27151037|P1|3 Weeks Period|Protocol Violation|0
7817815|NCT00397189|27151036|P2|3 Weeks Period|Physician Decision|2
7817816|NCT00397189|27151037|P1|3 Weeks Period|Physician Decision|0
7817817|NCT00397189|27151036|P2|3 Weeks Period|Withdrawal by Subject|9
7817818|NCT00397189|27151037|P1|3 Weeks Period|Withdrawal by Subject|13
7817819|NCT00397189|27151036|P2|3 Weeks Period|Adverse Event|2
7817820|NCT00397189|27151037|P1|3 Weeks Period|Adverse Event|3
7817821|NCT00397189|27151036|P2|3 Weeks Period|Lost to Follow-up|4
7817822|NCT00397189|27151037|P1|3 Weeks Period|Lost to Follow-up|5
7817823|NCT00397046|27151064|P4|Overall Study|Disease Progression|5
7817824|NCT00397046|27151065|P3|Overall Study|Disease Progression|10
7817825|NCT00397046|27151066|P2|Overall Study|Disease Progression|3
7817826|NCT00397046|27151067|P1|Overall Study|Disease Progression|3
7817827|NCT00397033|27151089|P3|Overall Study|Other|2
7817828|NCT00397033|27151090|P2|Overall Study|Other|5
7817829|NCT00397033|27151091|P1|Overall Study|Other|0
7817830|NCT00397033|27151089|P3|Overall Study|Withdrawal by Subject|5
7817831|NCT00397033|27151090|P2|Overall Study|Withdrawal by Subject|7
7817832|NCT00397033|27151091|P1|Overall Study|Withdrawal by Subject|12
7817833|NCT00397033|27151089|P3|Overall Study|Lost to Follow-up|3
7817834|NCT00397033|27151090|P2|Overall Study|Lost to Follow-up|3
7817835|NCT00397033|27151091|P1|Overall Study|Lost to Follow-up|3
7817836|NCT00397033|27151089|P3|Overall Study|Lack of Efficacy|9
7817837|NCT00397033|27151090|P2|Overall Study|Lack of Efficacy|12
7817838|NCT00397033|27151091|P1|Overall Study|Lack of Efficacy|22
7817839|NCT00397033|27151089|P3|Overall Study|Adverse Event|4
7817840|NCT00397033|27151090|P2|Overall Study|Adverse Event|10
7817841|NCT00397033|27151091|P1|Overall Study|Adverse Event|7
7817842|NCT00396877|27151182|P2|Overall Study|Parent(s)/guardian(s)'s request|7
7817843|NCT00396877|27151183|P1|Overall Study|Parent(s)/guardian(s)'s request|4
7817844|NCT00396877|27151182|P2|Overall Study|Lost to Follow-up|1
7817845|NCT00396877|27151183|P1|Overall Study|Lost to Follow-up|2
7817846|NCT00396812|27151193|P1|Overall Study|Physician Decision|1
7817847|NCT00396656|27151205|P2|Second Treatment Period|Adverse Event|1
7817848|NCT00396656|27151206|P1|Second Treatment Period|Adverse Event|0
7817849|NCT00396656|27151205|P2|First Treatment Period|Withdrawal by Subject|2
7817850|NCT00396656|27151206|P1|First Treatment Period|Withdrawal by Subject|0
7817851|NCT00396630|27151224|P2|Overall Study|Not vaccinated at Visit 3|3
7817852|NCT00396630|27151225|P1|Overall Study|Not vaccinated at Visit 3|3
7817853|NCT00396630|27151224|P2|Overall Study|Withdrawal by Subject|1
7817854|NCT00396630|27151225|P1|Overall Study|Withdrawal by Subject|1
7817855|NCT00396630|27151224|P2|Overall Study|Lost to Follow-up|1
7817856|NCT00396630|27151225|P1|Overall Study|Lost to Follow-up|1
7817857|NCT00396591|27151245|P1|Overall Study|Participant request|1
7817858|NCT00396591|27151245|P1|Overall Study|Adverse Event|2
7817859|NCT00396591|27151245|P1|Overall Study|Disease Progression|13
7817860|NCT00396565|27151258|P3|Overall Study|Lack of Efficacy|11
7817861|NCT00396565|27151259|P2|Overall Study|Lack of Efficacy|64
7817862|NCT00396565|27151260|P1|Overall Study|Lack of Efficacy|32
7817863|NCT00396565|27151258|P3|Overall Study|Withdrawal by Subject|1
7817864|NCT00396565|27151259|P2|Overall Study|Withdrawal by Subject|13
7817865|NCT00396565|27151260|P1|Overall Study|Withdrawal by Subject|8
7817866|NCT00396565|27151258|P3|Overall Study|Adverse Event|3
7817867|NCT00396565|27151259|P2|Overall Study|Adverse Event|13
7817868|NCT00396565|27151260|P1|Overall Study|Adverse Event|5
7817869|NCT00396565|27151258|P3|Overall Study|Physician Decision|2
7817870|NCT00396565|27151259|P2|Overall Study|Physician Decision|1
7817871|NCT00396565|27151260|P1|Overall Study|Physician Decision|3
7817872|NCT00396409|27151285|P2|Period 2 - 2008|Lost to Follow-up|1
7817873|NCT00396409|27151286|P1|Period 2 - 2008|Lost to Follow-up|3
7817874|NCT00396409|27151285|P2|Period 2 - 2008|Withdrawal by Subject|1
7817875|NCT00396409|27151286|P1|Period 2 - 2008|Withdrawal by Subject|3
7817876|NCT00396409|27151285|P2|Period 2 - 2008|Protocol Violation|0
7817877|NCT00396409|27151286|P1|Period 2 - 2008|Protocol Violation|1
7817878|NCT00396409|27151285|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
7817879|NCT00396409|27151286|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
7817880|NCT00396409|27151285|P2|Period 1 - 2007|Lost to Follow-up|3
7817881|NCT00396409|27151286|P1|Period 1 - 2007|Lost to Follow-up|2
7817882|NCT00396409|27151285|P2|Period 1 - 2007|Withdrawal by Subject|1
7817883|NCT00396409|27151286|P1|Period 1 - 2007|Withdrawal by Subject|1
7817884|NCT00396409|27151285|P2|Period 1 - 2007|Lack of Efficacy|1
7817885|NCT00396409|27151286|P1|Period 1 - 2007|Lack of Efficacy|0
7817886|NCT00396409|27151285|P2|Period 1 - 2007|Adverse Event|1
7817887|NCT00396409|27151286|P1|Period 1 - 2007|Adverse Event|0
7817888|NCT00396383|27151316|P1|Overall Study|Lost to Follow-up|1
7817889|NCT00396383|27151316|P1|Overall Study|Death|2
7817890|NCT00396331|27151329|P1|Overall Study|Death|16
7817891|NCT00396331|27151329|P1|Overall Study|Lost to Follow-up|3
7817892|NCT00396331|27151329|P1|Overall Study|Did not go on to transplant|5
7817893|NCT00396331|27151329|P1|Overall Study|Failed to mobilize - no transplant|8
7817894|NCT00396318|27151382|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
7817895|NCT00396279|27151402|P1|Overall Study|Physician Decision|1
7817896|NCT00396279|27151402|P1|Overall Study|Withdrawal by Subject|1
7817897|NCT00396279|27151402|P1|Overall Study|Disease progression|2
7817898|NCT00396279|27151402|P1|Overall Study|Ongoing in study|26
7817899|NCT00396253|27151435|P1|Overall Study|Change in eligibility status|1
7817900|NCT00396253|27151435|P1|Overall Study|Physician Decision|1
7817901|NCT00396253|27151435|P1|Overall Study|Death|3
7817902|NCT00396253|27151435|P1|Overall Study|Withdrawal by Subject|7
7817903|NCT00396253|27151435|P1|Overall Study|Protocol Violation|1
7817904|NCT00396162|27151466|P2|Overall Study|Withdrawal by Subject|3
7817905|NCT00396162|27151467|P1|Overall Study|Withdrawal by Subject|2
7817906|NCT00396136|27151479|P1|Overall Study|Study device explanted|8
7817907|NCT00396136|27151479|P1|Overall Study|Lost to Follow-up|15
7817908|NCT00396136|27151479|P1|Overall Study|Withdrawal by Subject|59
7817909|NCT00396136|27151479|P1|Overall Study|Death|43
7817910|NCT00396097|27151486|P2|Overall Study|Insufficient Clinical Response|4
7817911|NCT00396097|27151487|P1|Overall Study|Insufficient Clinical Response|1
7817912|NCT00396097|27151486|P2|Overall Study|Adverse Event|5
7817913|NCT00396097|27151487|P1|Overall Study|Adverse Event|1
7817914|NCT00396097|27151486|P2|Overall Study|Protocol Violation|6
7817915|NCT00396097|27151487|P1|Overall Study|Protocol Violation|0
7817916|NCT00396097|27151486|P2|Overall Study|Other|5
7817917|NCT00396097|27151487|P1|Overall Study|Other|3
7817918|NCT00396097|27151486|P2|Overall Study|Lost to Follow-up|9
7817919|NCT00396097|27151487|P1|Overall Study|Lost to Follow-up|4
7817920|NCT00396097|27151486|P2|Overall Study|Withdrawal by Subject|17
7817921|NCT00396097|27151487|P1|Overall Study|Withdrawal by Subject|17
7817922|NCT00396084|27151515|P6|Overall Study|Withdrawal by Subject|0
7817923|NCT00396084|27151516|P5|Overall Study|Withdrawal by Subject|0
7817924|NCT00396084|27151517|P4|Overall Study|Withdrawal by Subject|1
7817925|NCT00396084|27151518|P3|Overall Study|Withdrawal by Subject|0
7817926|NCT00396084|27151519|P2|Overall Study|Withdrawal by Subject|0
7817927|NCT00396084|27151520|P1|Overall Study|Withdrawal by Subject|0
7817928|NCT00396084|27151515|P6|Overall Study|Adverse Event|2
7817929|NCT00396084|27151516|P5|Overall Study|Adverse Event|1
7817930|NCT00396084|27151517|P4|Overall Study|Adverse Event|0
7817931|NCT00396084|27151518|P3|Overall Study|Adverse Event|0
7817932|NCT00396084|27151519|P2|Overall Study|Adverse Event|0
7817933|NCT00396084|27151520|P1|Overall Study|Adverse Event|0
7817934|NCT00395967|27151649|P1|Follow-up Period|Lost to Follow-up|1
7817935|NCT00395967|27151649|P1|Follow-up Period|Death|1
7817936|NCT00395967|27151649|P1|Treatment Period|Failed Mobilization|1
7817937|NCT00395863|27151689|P2|Overall Study|Patients did not complete both exams|3
7817938|NCT00395863|27151690|P1|Overall Study|Patients did not complete both exams|2
7817939|NCT00395850|27151725|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7817940|NCT00395850|27151726|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7817941|NCT00395850|27151727|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7817942|NCT00395850|27151728|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
7817943|NCT00395850|27151725|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7817944|NCT00395850|27151726|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7817945|NCT00395850|27151727|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7817946|NCT00395850|27151728|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
7817947|NCT00395850|27151725|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7817948|NCT00395850|27151726|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7817949|NCT00395850|27151727|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7817950|NCT00395850|27151728|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
7817951|NCT00395850|27151725|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
7817952|NCT00395850|27151726|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
7817953|NCT00395850|27151727|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
7817954|NCT00395850|27151728|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
7817955|NCT00395850|27151725|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7817956|NCT00395850|27151726|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7817957|NCT00395850|27151727|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7817958|NCT00395850|27151728|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
7817959|NCT00395850|27151725|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7817960|NCT00395850|27151726|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7817961|NCT00395850|27151727|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7817962|NCT00395850|27151728|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
7817963|NCT00395850|27151725|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7817964|NCT00395850|27151726|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7817965|NCT00395850|27151727|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7817966|NCT00395850|27151728|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
7817967|NCT00395746|27151745|P3|Overall Study|Unable to visit site on schedule|0
7817968|NCT00395746|27151746|P2|Overall Study|Unable to visit site on schedule|0
7817969|NCT00395746|27151747|P1|Overall Study|Unable to visit site on schedule|1
7817970|NCT00395746|27151745|P3|Overall Study|Difficultulty in use of device|1
7817971|NCT00395746|27151746|P2|Overall Study|Difficultulty in use of device|0
7817972|NCT00395746|27151747|P1|Overall Study|Difficultulty in use of device|0
7817973|NCT00395746|27151745|P3|Overall Study|Withdrawal of consent|1
7817974|NCT00395746|27151746|P2|Overall Study|Withdrawal of consent|0
7817975|NCT00395746|27151747|P1|Overall Study|Withdrawal of consent|0
7817976|NCT00395746|27151745|P3|Overall Study|Subject decision|1
7817977|NCT00395746|27151746|P2|Overall Study|Subject decision|0
7817978|NCT00395746|27151747|P1|Overall Study|Subject decision|0
7817979|NCT00395746|27151745|P3|Overall Study|Hypoglycaemia|0
7817980|NCT00395746|27151746|P2|Overall Study|Hypoglycaemia|1
7817981|NCT00395746|27151747|P1|Overall Study|Hypoglycaemia|2
7817982|NCT00395746|27151745|P3|Overall Study|Lack of Efficacy|17
7817983|NCT00395746|27151746|P2|Overall Study|Lack of Efficacy|0
7817984|NCT00395746|27151747|P1|Overall Study|Lack of Efficacy|2
7817985|NCT00395746|27151745|P3|Overall Study|Protocol Violation|0
7817986|NCT00395746|27151746|P2|Overall Study|Protocol Violation|1
7817987|NCT00395746|27151747|P1|Overall Study|Protocol Violation|0
7817988|NCT00395746|27151745|P3|Overall Study|Adverse Event|2
7817989|NCT00395746|27151746|P2|Overall Study|Adverse Event|2
7817990|NCT00395746|27151747|P1|Overall Study|Adverse Event|5
7817991|NCT00395733|27151793|P2|Period 2|Technical problems|0
7817992|NCT00395733|27151794|P1|Period 2|Technical problems|1
7817993|NCT00395733|27151793|P2|Period 2|Adverse Event|2
7817994|NCT00395733|27151794|P1|Period 2|Adverse Event|0
7817995|NCT00395733|27151793|P2|Period 2|Protocol Violation|1
7817996|NCT00395733|27151794|P1|Period 2|Protocol Violation|0
7817997|NCT00395733|27151793|P2|Period 2|Withdrawal by Subject|2
7817998|NCT00395733|27151794|P1|Period 2|Withdrawal by Subject|1
7817999|NCT00395694|27151818|P2|Continuation Phase|Withdrawal by Subject|2
7818000|NCT00395694|27151819|P1|Continuation Phase|Withdrawal by Subject|0
7818001|NCT00395694|27151818|P2|Continuation Phase|Poor Compliance|0
7818002|NCT00395694|27151819|P1|Continuation Phase|Poor Compliance|1
7818003|NCT00395694|27151818|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
7818004|NCT00395694|27151819|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
7818005|NCT00395694|27151818|P2|Continuation Phase|Lack of Efficacy|11
7818006|NCT00395694|27151819|P1|Continuation Phase|Lack of Efficacy|12
7818007|NCT00395694|27151818|P2|Continuation Phase|Adverse Event|0
7818008|NCT00395694|27151819|P1|Continuation Phase|Adverse Event|1
7818009|NCT00395694|27151818|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
7818010|NCT00395694|27151819|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
7818011|NCT00395642|27151850|P1|Overall Study|Withdrawal by Subject|1
7818012|NCT00395642|27151850|P1|Overall Study|Physician Decision|7
7818013|NCT00395642|27151850|P1|Overall Study|Lost to Follow-up|1
7818014|NCT00395642|27151850|P1|Overall Study|Death|4
7818015|NCT00395629|27151857|P3|Extension Study|Administrative problems|1
7818016|NCT00395629|27151858|P2|Extension Study|Administrative problems|0
7818017|NCT00395629|27151859|P1|Extension Study|Administrative problems|0
7818018|NCT00395629|27151857|P3|Extension Study|Adverse Event|2
7818019|NCT00395629|27151858|P2|Extension Study|Adverse Event|0
7818020|NCT00395629|27151859|P1|Extension Study|Adverse Event|0
7818021|NCT00395629|27151857|P3|Core Study|Lost to Follow-up|1
7818022|NCT00395629|27151858|P2|Core Study|Lost to Follow-up|0
7818023|NCT00395629|27151859|P1|Core Study|Lost to Follow-up|0
7818024|NCT00395629|27151857|P3|Core Study|Withdrawal by Subject|1
7818025|NCT00395629|27151858|P2|Core Study|Withdrawal by Subject|1
7818026|NCT00395629|27151859|P1|Core Study|Withdrawal by Subject|0
7818027|NCT00395629|27151857|P3|Core Study|Protocol Violation|0
7818028|NCT00395629|27151858|P2|Core Study|Protocol Violation|0
7818029|NCT00395629|27151859|P1|Core Study|Protocol Violation|1
7818030|NCT00395629|27151857|P3|Core Study|Abnormal laboratory value(s)|1
7818031|NCT00395629|27151858|P2|Core Study|Abnormal laboratory value(s)|0
7818032|NCT00395629|27151859|P1|Core Study|Abnormal laboratory value(s)|0
7818033|NCT00395629|27151857|P3|Core Study|Adverse Event|4
7818034|NCT00395629|27151858|P2|Core Study|Adverse Event|3
7818035|NCT00395629|27151859|P1|Core Study|Adverse Event|0
7818036|NCT00395538|27151876|P3|Overall Study|Participant elected to discontinue|1
7818037|NCT00395538|27151877|P2|Overall Study|Participant elected to discontinue|0
7818038|NCT00395538|27151878|P1|Overall Study|Participant elected to discontinue|0
7818039|NCT00395538|27151876|P3|Overall Study|Partial recovery of parathyroid function|1
7818040|NCT00395538|27151877|P2|Overall Study|Partial recovery of parathyroid function|0
7818041|NCT00395538|27151878|P1|Overall Study|Partial recovery of parathyroid function|0
7818042|NCT00395538|27151876|P3|Overall Study|Pregnancy|0
7818043|NCT00395538|27151877|P2|Overall Study|Pregnancy|0
7818044|NCT00395538|27151878|P1|Overall Study|Pregnancy|1
7818045|NCT00395538|27151876|P3|Overall Study|PTH resistance|1
7818046|NCT00395538|27151877|P2|Overall Study|PTH resistance|0
7818047|NCT00395538|27151878|P1|Overall Study|PTH resistance|0
7818048|NCT00395538|27151876|P3|Overall Study|Non-compliance with study protocol|0
7818049|NCT00395538|27151877|P2|Overall Study|Non-compliance with study protocol|1
7818050|NCT00395538|27151878|P1|Overall Study|Non-compliance with study protocol|0
7818051|NCT00395538|27151876|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
7818052|NCT00395538|27151877|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
7818053|NCT00395538|27151878|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
7818054|NCT00395538|27151876|P3|Overall Study|Adverse Event|2
7818055|NCT00395538|27151877|P2|Overall Study|Adverse Event|0
7818056|NCT00395538|27151878|P1|Overall Study|Adverse Event|1
7818057|NCT00395538|27151876|P3|Overall Study|Switch to Natpara|3
7818058|NCT00395538|27151877|P2|Overall Study|Switch to Natpara|0
7818059|NCT00395538|27151878|P1|Overall Study|Switch to Natpara|0
7818060|NCT00395538|27151876|P3|Overall Study|Failed screening|4
7818061|NCT00395538|27151877|P2|Overall Study|Failed screening|0
7818062|NCT00395538|27151878|P1|Overall Study|Failed screening|0
7818063|NCT00395538|27151876|P3|Overall Study|FDA partial hold on PTH|11
7818064|NCT00395538|27151877|P2|Overall Study|FDA partial hold on PTH|0
7818065|NCT00395538|27151878|P1|Overall Study|FDA partial hold on PTH|0
7818066|NCT00395538|27151876|P3|Overall Study|Did not re-consent to revised protocol|0
7818067|NCT00395538|27151877|P2|Overall Study|Did not re-consent to revised protocol|10
7818068|NCT00395538|27151878|P1|Overall Study|Did not re-consent to revised protocol|1
7818069|NCT00395512|27151951|P4|Overall Study|Hyperglycemic Rescue|6
7818070|NCT00395512|27151952|P3|Overall Study|Hyperglycemic Rescue|4
7818071|NCT00395512|27151953|P2|Overall Study|Hyperglycemic Rescue|10
7818072|NCT00395512|27151954|P1|Overall Study|Hyperglycemic Rescue|18
7818073|NCT00395512|27151951|P4|Overall Study|Other|0
7818074|NCT00395512|27151952|P3|Overall Study|Other|0
7818075|NCT00395512|27151953|P2|Overall Study|Other|1
7818076|NCT00395512|27151954|P1|Overall Study|Other|1
7818077|NCT00395512|27151951|P4|Overall Study|Physician Decision|2
7818078|NCT00395512|27151952|P3|Overall Study|Physician Decision|2
7818079|NCT00395512|27151953|P2|Overall Study|Physician Decision|4
7818080|NCT00395512|27151954|P1|Overall Study|Physician Decision|6
7818081|NCT00395512|27151951|P4|Overall Study|Withdrawal by Subject|12
7818082|NCT00395512|27151952|P3|Overall Study|Withdrawal by Subject|5
7818083|NCT00395512|27151953|P2|Overall Study|Withdrawal by Subject|5
7818084|NCT00395512|27151954|P1|Overall Study|Withdrawal by Subject|6
7818085|NCT00395512|27151951|P4|Overall Study|Lost to Follow-up|5
7818086|NCT00395512|27151952|P3|Overall Study|Lost to Follow-up|5
7818087|NCT00395512|27151953|P2|Overall Study|Lost to Follow-up|6
7818088|NCT00395512|27151954|P1|Overall Study|Lost to Follow-up|2
7818089|NCT00395512|27151951|P4|Overall Study|Protocol Violation|7
7818090|NCT00395512|27151952|P3|Overall Study|Protocol Violation|6
7818091|NCT00395512|27151953|P2|Overall Study|Protocol Violation|3
7818092|NCT00395512|27151954|P1|Overall Study|Protocol Violation|2
7818093|NCT00395512|27151951|P4|Overall Study|Adverse Event|6
7818094|NCT00395512|27151952|P3|Overall Study|Adverse Event|6
7818095|NCT00395512|27151953|P2|Overall Study|Adverse Event|8
7818096|NCT00395512|27151954|P1|Overall Study|Adverse Event|3
7818097|NCT00395486|27152126|P2|Overall Study|Lost to Follow-up|1
7818098|NCT00395486|27152127|P1|Overall Study|Lost to Follow-up|0
7818099|NCT00395486|27152126|P2|Overall Study|Withdrawal by Subject|2
7818100|NCT00395486|27152127|P1|Overall Study|Withdrawal by Subject|5
7818101|NCT00395486|27152126|P2|Overall Study|Adverse Event|2
7818102|NCT00395486|27152127|P1|Overall Study|Adverse Event|1
7818103|NCT00395460|27152157|P2|Overall Study|Withdrawal by Subject|0
7818104|NCT00395460|27152158|P1|Overall Study|Withdrawal by Subject|1
7818105|NCT00395447|27152182|P2|Overall Study|Withdrawl - Other (not subject)|17
7818106|NCT00395447|27152183|P1|Overall Study|Withdrawl - Other (not subject)|8
7818107|NCT00395447|27152182|P2|Overall Study|Withdrawal by Subject|19
7818108|NCT00395447|27152183|P1|Overall Study|Withdrawal by Subject|24
7818109|NCT00395447|27152182|P2|Overall Study|Lost to Follow-up|43
7818110|NCT00395447|27152183|P1|Overall Study|Lost to Follow-up|52
7818111|NCT00395447|27152182|P2|Overall Study|Death|32
7818112|NCT00395447|27152183|P1|Overall Study|Death|37
7818113|NCT00395343|27152191|P2|Overall Study|Other|2
7818114|NCT00395343|27152192|P1|Overall Study|Other|5
7818115|NCT00395343|27152191|P2|Overall Study|Withdrawal by Subject|12
7818116|NCT00395343|27152192|P1|Overall Study|Withdrawal by Subject|11
7818117|NCT00395343|27152191|P2|Overall Study|Protocol Violation|8
7818118|NCT00395343|27152192|P1|Overall Study|Protocol Violation|6
7818119|NCT00395343|27152191|P2|Overall Study|Physician Decision|4
7818120|NCT00395343|27152192|P1|Overall Study|Physician Decision|2
7818121|NCT00395343|27152191|P2|Overall Study|Lost to Follow-up|4
7818122|NCT00395343|27152192|P1|Overall Study|Lost to Follow-up|4
7818123|NCT00395343|27152191|P2|Overall Study|Lack of Efficacy|1
7818124|NCT00395343|27152192|P1|Overall Study|Lack of Efficacy|0
7818125|NCT00395343|27152191|P2|Overall Study|Adverse Event|5
7818126|NCT00395343|27152192|P1|Overall Study|Adverse Event|13
7818127|NCT00395304|27152210|P6|Treatment Period 3|Other|0
7818128|NCT00395304|27152211|P5|Treatment Period 3|Other|0
7818129|NCT00395304|27152212|P4|Treatment Period 3|Other|1
7818130|NCT00395304|27152213|P3|Treatment Period 3|Other|0
7818131|NCT00395304|27152214|P2|Treatment Period 3|Other|0
7818132|NCT00395304|27152215|P1|Treatment Period 3|Other|0
7818133|NCT00395304|27152210|P6|Treatment Period 3|Physician Decision|0
7818134|NCT00395304|27152211|P5|Treatment Period 3|Physician Decision|0
7818135|NCT00395304|27152212|P4|Treatment Period 3|Physician Decision|0
7818136|NCT00395304|27152213|P3|Treatment Period 3|Physician Decision|0
7818137|NCT00395304|27152214|P2|Treatment Period 3|Physician Decision|1
7818138|NCT00395304|27152215|P1|Treatment Period 3|Physician Decision|0
7818139|NCT00395304|27152210|P6|Treatment Period 3|Lost to Follow-up|0
7818140|NCT00395304|27152211|P5|Treatment Period 3|Lost to Follow-up|0
7818141|NCT00395304|27152212|P4|Treatment Period 3|Lost to Follow-up|0
7818142|NCT00395304|27152213|P3|Treatment Period 3|Lost to Follow-up|0
7818143|NCT00395304|27152214|P2|Treatment Period 3|Lost to Follow-up|1
7818144|NCT00395304|27152215|P1|Treatment Period 3|Lost to Follow-up|1
7818145|NCT00395304|27152210|P6|Treatment Period 3|Withdrawal by Subject|1
7818146|NCT00395304|27152211|P5|Treatment Period 3|Withdrawal by Subject|0
7818147|NCT00395304|27152212|P4|Treatment Period 3|Withdrawal by Subject|1
7818148|NCT00395304|27152213|P3|Treatment Period 3|Withdrawal by Subject|0
7818149|NCT00395304|27152214|P2|Treatment Period 3|Withdrawal by Subject|0
7818150|NCT00395304|27152215|P1|Treatment Period 3|Withdrawal by Subject|0
7818151|NCT00395304|27152210|P6|Treatment Period 2|Other|0
7818152|NCT00395304|27152211|P5|Treatment Period 2|Other|0
7818153|NCT00395304|27152212|P4|Treatment Period 2|Other|0
7818154|NCT00395304|27152213|P3|Treatment Period 2|Other|0
7818155|NCT00395304|27152214|P2|Treatment Period 2|Other|1
7818156|NCT00395304|27152215|P1|Treatment Period 2|Other|0
7818157|NCT00395304|27152210|P6|Treatment Period 2|Physician Decision|0
7818158|NCT00395304|27152211|P5|Treatment Period 2|Physician Decision|0
7818159|NCT00395304|27152212|P4|Treatment Period 2|Physician Decision|0
7818160|NCT00395304|27152213|P3|Treatment Period 2|Physician Decision|1
7818161|NCT00395304|27152214|P2|Treatment Period 2|Physician Decision|0
7818162|NCT00395304|27152215|P1|Treatment Period 2|Physician Decision|0
7818163|NCT00395304|27152210|P6|Treatment Period 2|Lost to Follow-up|0
7818164|NCT00395304|27152211|P5|Treatment Period 2|Lost to Follow-up|0
7818165|NCT00395304|27152212|P4|Treatment Period 2|Lost to Follow-up|0
7818166|NCT00395304|27152213|P3|Treatment Period 2|Lost to Follow-up|0
7818167|NCT00395304|27152214|P2|Treatment Period 2|Lost to Follow-up|3
7818168|NCT00395304|27152215|P1|Treatment Period 2|Lost to Follow-up|0
7818169|NCT00395304|27152210|P6|Treatment Period 2|Withdrawal by Subject|2
7818170|NCT00395304|27152211|P5|Treatment Period 2|Withdrawal by Subject|0
7818171|NCT00395304|27152212|P4|Treatment Period 2|Withdrawal by Subject|1
7818172|NCT00395304|27152213|P3|Treatment Period 2|Withdrawal by Subject|0
7818173|NCT00395304|27152214|P2|Treatment Period 2|Withdrawal by Subject|0
7818174|NCT00395304|27152215|P1|Treatment Period 2|Withdrawal by Subject|0
7818175|NCT00395304|27152210|P6|Treatment Period 1|Physician Decision|0
7818176|NCT00395304|27152211|P5|Treatment Period 1|Physician Decision|0
7818177|NCT00395304|27152212|P4|Treatment Period 1|Physician Decision|0
7818178|NCT00395304|27152213|P3|Treatment Period 1|Physician Decision|0
7818179|NCT00395304|27152214|P2|Treatment Period 1|Physician Decision|1
7818180|NCT00395304|27152215|P1|Treatment Period 1|Physician Decision|0
7818181|NCT00395304|27152210|P6|Treatment Period 1|Lost to Follow-up|1
7818182|NCT00395304|27152211|P5|Treatment Period 1|Lost to Follow-up|0
7818183|NCT00395304|27152212|P4|Treatment Period 1|Lost to Follow-up|1
7818184|NCT00395304|27152213|P3|Treatment Period 1|Lost to Follow-up|0
7818185|NCT00395304|27152214|P2|Treatment Period 1|Lost to Follow-up|0
7818186|NCT00395304|27152215|P1|Treatment Period 1|Lost to Follow-up|1
7818187|NCT00395304|27152210|P6|Treatment Period 1|Withdrawal by Subject|1
7818188|NCT00395304|27152211|P5|Treatment Period 1|Withdrawal by Subject|1
7818189|NCT00395304|27152212|P4|Treatment Period 1|Withdrawal by Subject|2
7818190|NCT00395304|27152213|P3|Treatment Period 1|Withdrawal by Subject|0
7818191|NCT00395304|27152214|P2|Treatment Period 1|Withdrawal by Subject|3
7818192|NCT00395304|27152215|P1|Treatment Period 1|Withdrawal by Subject|0
7818193|NCT00395226|27152291|P2|Overall Study|Lost to Follow-up|1
7818194|NCT00395226|27152292|P1|Overall Study|Lost to Follow-up|0
7818195|NCT00395226|27152291|P2|Overall Study|Withdrawal by Subject|1
7818196|NCT00395226|27152292|P1|Overall Study|Withdrawal by Subject|0
7818197|NCT00395226|27152291|P2|Overall Study|Adverse Event|3
7818198|NCT00395226|27152292|P1|Overall Study|Adverse Event|4
7818199|NCT00395083|27152339|P2|Overall Study|Developed another disease|3
7818200|NCT00395083|27152340|P1|Overall Study|Developed another disease|4
7818201|NCT00395083|27152339|P2|Overall Study|Withdrawal by Subject|5
7818202|NCT00395083|27152340|P1|Overall Study|Withdrawal by Subject|6
7818203|NCT00395018|27152406|P1|Off-Treatment Follow-up|Poor/non-compliance|1
7818204|NCT00395018|27152406|P1|Off-Treatment Follow-up|Lost to Follow-up|2
7818205|NCT00395018|27152406|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
7818206|NCT00395018|27152406|P1|On-Treatment|Subject no longer meets study criteria|2
7818207|NCT00395018|27152406|P1|On-Treatment|Poor/non-compliance|2
7818208|NCT00395018|27152406|P1|On-Treatment|Other Reason|2
7818209|NCT00395018|27152406|P1|On-Treatment|Death|4
7818210|NCT00394953|27152427|P2|Second Treatment Period|Not defined|8
7818211|NCT00394953|27152428|P1|Second Treatment Period|Not defined|3
7818212|NCT00394953|27152427|P2|Second Treatment Period|Renal transplant|6
7818213|NCT00394953|27152428|P1|Second Treatment Period|Renal transplant|4
7818214|NCT00394953|27152427|P2|Second Treatment Period|Lost to Follow-up|1
7818215|NCT00394953|27152428|P1|Second Treatment Period|Lost to Follow-up|0
7818216|NCT00394953|27152427|P2|Second Treatment Period|Withdrawal by Subject|3
7818217|NCT00394953|27152428|P1|Second Treatment Period|Withdrawal by Subject|3
7818218|NCT00394953|27152427|P2|Second Treatment Period|Lack of Efficacy|47
7818219|NCT00394953|27152428|P1|Second Treatment Period|Lack of Efficacy|9
7818220|NCT00394953|27152427|P2|Second Treatment Period|Death|4
7818221|NCT00394953|27152428|P1|Second Treatment Period|Death|8
7818222|NCT00394953|27152427|P2|Second Treatment Period|Adverse Event|5
7818223|NCT00394953|27152428|P1|Second Treatment Period|Adverse Event|2
7818224|NCT00394953|27152427|P2|First Treatment Period|Not defined|1
7818225|NCT00394953|27152428|P1|First Treatment Period|Not defined|4
7818226|NCT00394953|27152427|P2|First Treatment Period|Renal transplant|7
7818227|NCT00394953|27152428|P1|First Treatment Period|Renal transplant|11
7818228|NCT00394953|27152427|P2|First Treatment Period|Lost to Follow-up|1
7818229|NCT00394953|27152428|P1|First Treatment Period|Lost to Follow-up|0
7818230|NCT00394953|27152427|P2|First Treatment Period|Withdrawal by Subject|3
7818231|NCT00394953|27152428|P1|First Treatment Period|Withdrawal by Subject|6
7818232|NCT00394953|27152427|P2|First Treatment Period|Lack of Efficacy|1
7818233|NCT00394953|27152428|P1|First Treatment Period|Lack of Efficacy|1
7818234|NCT00394953|27152427|P2|First Treatment Period|Death|7
7818235|NCT00394953|27152428|P1|First Treatment Period|Death|6
7818236|NCT00394953|27152427|P2|First Treatment Period|Adverse Event|2
7818237|NCT00394953|27152428|P1|First Treatment Period|Adverse Event|1
7818238|NCT00394914|27152446|P3|Treatment Period|Did not meet protocol eligibility|1
7818239|NCT00394914|27152447|P2|Treatment Period|Did not meet protocol eligibility|1
7818240|NCT00394914|27152448|P1|Treatment Period|Did not meet protocol eligibility|0
7818241|NCT00394914|27152446|P3|Treatment Period|Noncompliance with protocol|2
7818242|NCT00394914|27152447|P2|Treatment Period|Noncompliance with protocol|3
7818243|NCT00394914|27152448|P1|Treatment Period|Noncompliance with protocol|0
7818244|NCT00394914|27152446|P3|Treatment Period|Withdrawal by Subject|2
7818245|NCT00394914|27152447|P2|Treatment Period|Withdrawal by Subject|2
7818246|NCT00394914|27152448|P1|Treatment Period|Withdrawal by Subject|0
7818247|NCT00394914|27152446|P3|Treatment Period|Lost to Follow-up|0
7818248|NCT00394914|27152447|P2|Treatment Period|Lost to Follow-up|1
7818249|NCT00394914|27152448|P1|Treatment Period|Lost to Follow-up|0
7818250|NCT00394914|27152446|P3|Treatment Period|Adverse Event|1
7818251|NCT00394914|27152447|P2|Treatment Period|Adverse Event|3
7818252|NCT00394914|27152448|P1|Treatment Period|Adverse Event|0
7818253|NCT00394901|27152476|P4|Double-blind Phase|Found not to meet entrance criteria|1
7818254|NCT00394901|27152477|P3|Double-blind Phase|Found not to meet entrance criteria|0
7818255|NCT00394901|27152478|P2|Double-blind Phase|Found not to meet entrance criteria|0
7818256|NCT00394901|27152479|P1|Double-blind Phase|Found not to meet entrance criteria|0
7818257|NCT00394901|27152476|P4|Double-blind Phase|Entry into another study was found|0
7818258|NCT00394901|27152477|P3|Double-blind Phase|Entry into another study was found|1
7818259|NCT00394901|27152478|P2|Double-blind Phase|Entry into another study was found|0
7818260|NCT00394901|27152479|P1|Double-blind Phase|Entry into another study was found|0
7818261|NCT00394901|27152476|P4|Double-blind Phase|Lack of Compliance|0
7818262|NCT00394901|27152477|P3|Double-blind Phase|Lack of Compliance|0
7818263|NCT00394901|27152478|P2|Double-blind Phase|Lack of Compliance|3
7818264|NCT00394901|27152479|P1|Double-blind Phase|Lack of Compliance|0
7818265|NCT00394901|27152476|P4|Double-blind Phase|Subject's Personal Reason|1
7818266|NCT00394901|27152477|P3|Double-blind Phase|Subject's Personal Reason|0
7818267|NCT00394901|27152478|P2|Double-blind Phase|Subject's Personal Reason|0
7818268|NCT00394901|27152479|P1|Double-blind Phase|Subject's Personal Reason|1
7818269|NCT00394901|27152476|P4|Double-blind Phase|Death|0
7818270|NCT00394901|27152477|P3|Double-blind Phase|Death|0
7818271|NCT00394901|27152478|P2|Double-blind Phase|Death|0
7818272|NCT00394901|27152479|P1|Double-blind Phase|Death|1
7818273|NCT00394901|27152476|P4|Double-blind Phase|Protocol Violation|1
7818274|NCT00394901|27152477|P3|Double-blind Phase|Protocol Violation|0
7818275|NCT00394901|27152478|P2|Double-blind Phase|Protocol Violation|0
7818276|NCT00394901|27152479|P1|Double-blind Phase|Protocol Violation|0
7818277|NCT00394901|27152476|P4|Double-blind Phase|Lost to Follow-up|1
7818278|NCT00394901|27152477|P3|Double-blind Phase|Lost to Follow-up|0
7818279|NCT00394901|27152478|P2|Double-blind Phase|Lost to Follow-up|0
7818280|NCT00394901|27152479|P1|Double-blind Phase|Lost to Follow-up|0
7818281|NCT00394901|27152476|P4|Double-blind Phase|Withdrawal by Subject|0
7818282|NCT00394901|27152477|P3|Double-blind Phase|Withdrawal by Subject|0
7818283|NCT00394901|27152478|P2|Double-blind Phase|Withdrawal by Subject|0
7818284|NCT00394901|27152479|P1|Double-blind Phase|Withdrawal by Subject|2
7818285|NCT00394901|27152476|P4|Double-blind Phase|Lack of Efficacy|3
7818286|NCT00394901|27152477|P3|Double-blind Phase|Lack of Efficacy|1
7818287|NCT00394901|27152478|P2|Double-blind Phase|Lack of Efficacy|4
7818288|NCT00394901|27152479|P1|Double-blind Phase|Lack of Efficacy|6
7818289|NCT00394901|27152476|P4|Double-blind Phase|Adverse Event|20
7818290|NCT00394901|27152477|P3|Double-blind Phase|Adverse Event|16
7818291|NCT00394901|27152478|P2|Double-blind Phase|Adverse Event|7
7818292|NCT00394901|27152479|P1|Double-blind Phase|Adverse Event|5
7818293|NCT00394901|27152476|P4|Baseline Phase|Protocol Violation|0
7818294|NCT00394901|27152477|P3|Baseline Phase|Protocol Violation|1
7818295|NCT00394901|27152478|P2|Baseline Phase|Protocol Violation|0
7818296|NCT00394901|27152479|P1|Baseline Phase|Protocol Violation|0
7818297|NCT00394836|27152722|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
7818298|NCT00394836|27152723|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
7818299|NCT00394836|27152722|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
7818300|NCT00394836|27152723|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
7818301|NCT00394836|27152722|P2|Extended Follow-up Phase (2-5 Years)|Death|1
7818302|NCT00394836|27152723|P1|Extended Follow-up Phase (2-5 Years)|Death|0
7818303|NCT00394836|27152722|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
7818304|NCT00394836|27152723|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
7818305|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Non compliance|1
7818306|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Non compliance|0
7818307|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
7818308|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
7818309|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Physician Decision|1
7818310|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Physician Decision|0
7818311|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
7818312|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
7818313|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Started alternative treatment|6
7818314|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Started alternative treatment|0
7818315|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
7818316|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
7818317|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Death|1
7818318|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Death|0
7818319|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Patient Refusal|2
7818320|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Patient Refusal|1
7818321|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Disease Progression|60
7818322|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Disease Progression|27
7818323|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Protocol Violation|2
7818324|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Protocol Violation|0
7818325|NCT00394836|27152722|P2|Teatment or Follow-up Phase|Adverse Event|2
7818326|NCT00394836|27152723|P1|Teatment or Follow-up Phase|Adverse Event|0
7818327|NCT00394771|27152769|P4|Overall Study|Other|0
7818328|NCT00394771|27152770|P3|Overall Study|Other|1
7818329|NCT00394771|27152771|P2|Overall Study|Other|3
7818330|NCT00394771|27152772|P1|Overall Study|Other|3
7818331|NCT00394771|27152769|P4|Overall Study|Lost to Follow-up|10
7818332|NCT00394771|27152770|P3|Overall Study|Lost to Follow-up|13
7818333|NCT00394771|27152771|P2|Overall Study|Lost to Follow-up|15
7818334|NCT00394771|27152772|P1|Overall Study|Lost to Follow-up|15
7818335|NCT00394771|27152769|P4|Overall Study|Participant pregnant|2
7818336|NCT00394771|27152770|P3|Overall Study|Participant pregnant|2
7818337|NCT00394771|27152771|P2|Overall Study|Participant pregnant|1
7818338|NCT00394771|27152772|P1|Overall Study|Participant pregnant|0
7818339|NCT00394771|27152769|P4|Overall Study|Adverse Event|8
7818340|NCT00394771|27152770|P3|Overall Study|Adverse Event|12
7818341|NCT00394771|27152771|P2|Overall Study|Adverse Event|5
7818342|NCT00394771|27152772|P1|Overall Study|Adverse Event|10
7818343|NCT00394771|27152769|P4|Overall Study|Withdrawal by Subject|12
7818344|NCT00394771|27152770|P3|Overall Study|Withdrawal by Subject|8
7818345|NCT00394771|27152771|P2|Overall Study|Withdrawal by Subject|6
7818346|NCT00394771|27152772|P1|Overall Study|Withdrawal by Subject|10
7818347|NCT00394771|27152769|P4|Overall Study|Protocol Violation|7
7818348|NCT00394771|27152770|P3|Overall Study|Protocol Violation|9
7818349|NCT00394771|27152771|P2|Overall Study|Protocol Violation|4
7818350|NCT00394771|27152772|P1|Overall Study|Protocol Violation|2
7818351|NCT00394771|27152769|P4|Overall Study|Did not meet protocol requirements|0
7818352|NCT00394771|27152770|P3|Overall Study|Did not meet protocol requirements|2
7818353|NCT00394771|27152771|P2|Overall Study|Did not meet protocol requirements|0
7818354|NCT00394771|27152772|P1|Overall Study|Did not meet protocol requirements|1
7818355|NCT00394706|27152842|P8|Overall Study|Lost to Follow-up|0
7818356|NCT00394706|27152843|P7|Overall Study|Lost to Follow-up|2
7818357|NCT00394706|27152844|P6|Overall Study|Lost to Follow-up|5
7818358|NCT00394706|27152845|P5|Overall Study|Lost to Follow-up|2
7818359|NCT00394706|27152846|P4|Overall Study|Lost to Follow-up|1
7818360|NCT00394706|27152847|P3|Overall Study|Lost to Follow-up|8
7818361|NCT00394706|27152848|P2|Overall Study|Lost to Follow-up|2
7818362|NCT00394706|27152849|P1|Overall Study|Lost to Follow-up|2
7818363|NCT00394706|27152842|P8|Overall Study|Withdrawal by Subject|0
7818364|NCT00394706|27152843|P7|Overall Study|Withdrawal by Subject|1
7818365|NCT00394706|27152844|P6|Overall Study|Withdrawal by Subject|2
7818366|NCT00394706|27152845|P5|Overall Study|Withdrawal by Subject|0
7818367|NCT00394706|27152846|P4|Overall Study|Withdrawal by Subject|0
7818368|NCT00394706|27152847|P3|Overall Study|Withdrawal by Subject|1
7818369|NCT00394706|27152848|P2|Overall Study|Withdrawal by Subject|0
7818370|NCT00394706|27152849|P1|Overall Study|Withdrawal by Subject|2
7818371|NCT00394654|27152881|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
7818372|NCT00394654|27152882|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
7818373|NCT00394654|27152881|P2|Overall Study|Lost to Follow-up|0
7818374|NCT00394654|27152882|P1|Overall Study|Lost to Follow-up|1
7818375|NCT00394589|27152947|P3|Overall Study|Protocol Violation|2
7818376|NCT00394589|27152948|P2|Overall Study|Protocol Violation|0
7818377|NCT00394589|27152949|P1|Overall Study|Protocol Violation|4
7818378|NCT00394589|27152947|P3|Overall Study|Lack of Efficacy|3
7818379|NCT00394589|27152948|P2|Overall Study|Lack of Efficacy|2
7818380|NCT00394589|27152949|P1|Overall Study|Lack of Efficacy|2
7818381|NCT00394589|27152947|P3|Overall Study|Adverse Event|2
7818382|NCT00394589|27152948|P2|Overall Study|Adverse Event|1
7818383|NCT00394589|27152949|P1|Overall Study|Adverse Event|2
7818384|NCT00394524|27152959|P2|Overall Study|Withdrawal by Subject|1
7818385|NCT00394524|27152960|P1|Overall Study|Withdrawal by Subject|0
7818386|NCT00394524|27152959|P2|Overall Study|Death|0
7818387|NCT00394524|27152960|P1|Overall Study|Death|1
7818388|NCT00394524|27152959|P2|Overall Study|Protocol Violation|3
7818389|NCT00394524|27152960|P1|Overall Study|Protocol Violation|2
7818390|NCT00394472|27152974|P2|Overall Study|Lost to Follow-up|1
7818391|NCT00394472|27152975|P1|Overall Study|Lost to Follow-up|0
7818392|NCT00394472|27152974|P2|Overall Study|Physician Decision|1
7818393|NCT00394472|27152975|P1|Overall Study|Physician Decision|0
7818394|NCT00394472|27152974|P2|Overall Study|Withdrawal by Subject|2
7818395|NCT00394472|27152975|P1|Overall Study|Withdrawal by Subject|0
7818396|NCT00394472|27152974|P2|Overall Study|Adverse Event|2
7818397|NCT00394472|27152975|P1|Overall Study|Adverse Event|4
7818398|NCT00394472|27152974|P2|Overall Study|incorrect enrolment|2
7818399|NCT00394472|27152975|P1|Overall Study|incorrect enrolment|4
7818400|NCT00394472|27152974|P2|Overall Study|Protocol Violation|3
7818401|NCT00394472|27152975|P1|Overall Study|Protocol Violation|1
7818402|NCT00394433|27152983|P1|Overall Study|Alternative Therapy|1
7818403|NCT00394433|27152983|P1|Overall Study|Adverse Event|2
7818404|NCT00394355|27152994|P4|Overall Study|Lack of Efficacy|3
7818405|NCT00394355|27152995|P3|Overall Study|Lack of Efficacy|2
7818406|NCT00394355|27152996|P2|Overall Study|Lack of Efficacy|0
7818407|NCT00394355|27152997|P1|Overall Study|Lack of Efficacy|0
7818408|NCT00394355|27152994|P4|Overall Study|Administrative|1
7818409|NCT00394355|27152995|P3|Overall Study|Administrative|1
7818410|NCT00394355|27152996|P2|Overall Study|Administrative|1
7818411|NCT00394355|27152997|P1|Overall Study|Administrative|0
7818412|NCT00394355|27152994|P4|Overall Study|Noncompliance with protocol|8
7818413|NCT00394355|27152995|P3|Overall Study|Noncompliance with protocol|10
7818414|NCT00394355|27152996|P2|Overall Study|Noncompliance with protocol|3
7818415|NCT00394355|27152997|P1|Overall Study|Noncompliance with protocol|4
7818416|NCT00394355|27152994|P4|Overall Study|Lost to Follow-up|3
7818417|NCT00394355|27152995|P3|Overall Study|Lost to Follow-up|4
7818418|NCT00394355|27152996|P2|Overall Study|Lost to Follow-up|5
7818419|NCT00394355|27152997|P1|Overall Study|Lost to Follow-up|7
7818420|NCT00394355|27152994|P4|Overall Study|Subject withdrawal - related to drug|0
7818421|NCT00394355|27152995|P3|Overall Study|Subject withdrawal - related to drug|0
7818422|NCT00394355|27152996|P2|Overall Study|Subject withdrawal - related to drug|0
7818423|NCT00394355|27152997|P1|Overall Study|Subject withdrawal - related to drug|1
7818424|NCT00394355|27152994|P4|Overall Study|Subject withdrawal - unrelated to drug|6
7818425|NCT00394355|27152995|P3|Overall Study|Subject withdrawal - unrelated to drug|10
7818426|NCT00394355|27152996|P2|Overall Study|Subject withdrawal - unrelated to drug|14
7818427|NCT00394355|27152997|P1|Overall Study|Subject withdrawal - unrelated to drug|12
7818428|NCT00394355|27152994|P4|Overall Study|Did not meet protocol eligibility|2
7818429|NCT00394355|27152995|P3|Overall Study|Did not meet protocol eligibility|4
7818430|NCT00394355|27152996|P2|Overall Study|Did not meet protocol eligibility|5
7818431|NCT00394355|27152997|P1|Overall Study|Did not meet protocol eligibility|1
7818432|NCT00394355|27152994|P4|Overall Study|Adverse Event|8
7818433|NCT00394355|27152995|P3|Overall Study|Adverse Event|7
7818434|NCT00394355|27152996|P2|Overall Study|Adverse Event|6
7818435|NCT00394355|27152997|P1|Overall Study|Adverse Event|10
7818436|NCT00394251|27153103|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
7818437|NCT00394251|27153104|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
7818438|NCT00394251|27153103|P2|Overall Study|Withdrawal by Subject|11
7818439|NCT00394251|27153104|P1|Overall Study|Withdrawal by Subject|7
7818440|NCT00394251|27153103|P2|Overall Study|Protocol Violation|1
7818441|NCT00394251|27153104|P1|Overall Study|Protocol Violation|0
7818442|NCT00394251|27153103|P2|Overall Study|Physician Decision|1
7818443|NCT00394251|27153104|P1|Overall Study|Physician Decision|1
7818444|NCT00394251|27153103|P2|Overall Study|Unacceptable Toxicity|18
7818445|NCT00394251|27153104|P1|Overall Study|Unacceptable Toxicity|20
7818446|NCT00394251|27153103|P2|Overall Study|Adverse Event|5
7818447|NCT00394251|27153104|P1|Overall Study|Adverse Event|7
7818448|NCT00394212|27153132|P2|Overall Study|Withdrawal by Subject|1
7818449|NCT00394212|27153133|P1|Overall Study|Withdrawal by Subject|4
7818450|NCT00394212|27153132|P2|Overall Study|Lost to Follow-up|0
7818451|NCT00394212|27153133|P1|Overall Study|Lost to Follow-up|3
7818452|NCT00394095|27153147|P2|Overall Study|Adverse Event|0
7818453|NCT00394095|27153148|P1|Overall Study|Adverse Event|1
7818454|NCT00394082|27153156|P1|Overall Study|Other|1
7818455|NCT00394082|27153156|P1|Overall Study|Withdrawal by Subject|2
7818456|NCT00394082|27153156|P1|Overall Study|Physician Decision|4
7818457|NCT00394082|27153156|P1|Overall Study|Adverse Event|4
7818458|NCT00394082|27153156|P1|Overall Study|Unacceptable toxicity|15
7818459|NCT00393939|27153178|P2|Overall Study|Other|45
7818460|NCT00393939|27153179|P1|Overall Study|Other|37
7818461|NCT00393939|27153178|P2|Overall Study|Withdrawal by Subject|7
7818462|NCT00393939|27153179|P1|Overall Study|Withdrawal by Subject|2
7818463|NCT00393939|27153178|P2|Overall Study|Objective progression or relapse|223
7818464|NCT00393939|27153179|P1|Overall Study|Objective progression or relapse|239
7818465|NCT00393939|27153178|P2|Overall Study|Sponsor|13
7818466|NCT00393939|27153179|P1|Overall Study|Sponsor|5
7818467|NCT00393939|27153178|P2|Overall Study|Death|4
7818468|NCT00393939|27153179|P1|Overall Study|Death|10
7818469|NCT00393939|27153178|P2|Overall Study|Lost to Follow-up|4
7818470|NCT00393939|27153179|P1|Overall Study|Lost to Follow-up|2
7818471|NCT00393939|27153178|P2|Overall Study|Protocol Violation|1
7818472|NCT00393939|27153179|P1|Overall Study|Protocol Violation|1
7818473|NCT00393913|27153197|P1|CPAP|TEchnical problem with CPAP|3
7818474|NCT00393913|27153197|P1|CPAP|Physician Decision|1
7818475|NCT00393913|27153197|P1|CPAP|Withdrawal by Subject|3
7818476|NCT00393913|27153197|P1|Initial Assessment|Withdrawal by Subject|16
7818477|NCT00393913|27153197|P1|Initial Assessment|diagnosed with other sleep disorder|21
7818478|NCT00393887|27153205|P2|Overall Study|Lost to Follow-up|9
7818479|NCT00393887|27153206|P1|Overall Study|Lost to Follow-up|11
7818480|NCT00393887|27153205|P2|Overall Study|Physician Decision|0
7818481|NCT00393887|27153206|P1|Overall Study|Physician Decision|5
7818482|NCT00393861|27153234|P1|Overall Study|Disease Progression|24
7818483|NCT00393861|27153234|P1|Overall Study|Adverse Event|2
7818484|NCT00393848|27153245|P4|Overall Study|Personal reasons|0
7818485|NCT00393848|27153246|P3|Overall Study|Personal reasons|2
7818486|NCT00393848|27153247|P2|Overall Study|Personal reasons|0
7818487|NCT00393848|27153248|P1|Overall Study|Personal reasons|0
7818488|NCT00393848|27153245|P4|Overall Study|Surgical schedule|1
7818489|NCT00393848|27153246|P3|Overall Study|Surgical schedule|0
7818490|NCT00393848|27153247|P2|Overall Study|Surgical schedule|0
7818491|NCT00393848|27153248|P1|Overall Study|Surgical schedule|0
7818492|NCT00393718|27153271|P2|Overall Study|Move|0
7818493|NCT00393718|27153272|P1|Overall Study|Move|1
7818494|NCT00393718|27153271|P2|Overall Study|Missed measurement|0
7818495|NCT00393718|27153272|P1|Overall Study|Missed measurement|1
7818496|NCT00393718|27153271|P2|Overall Study|Withdrawal of consent|1
7818497|NCT00393718|27153272|P1|Overall Study|Withdrawal of consent|2
7818498|NCT00393718|27153271|P2|Overall Study|Subject decision|0
7818499|NCT00393718|27153272|P1|Overall Study|Subject decision|5
7818500|NCT00393718|27153271|P2|Overall Study|Hypoglycaemia|2
7818501|NCT00393718|27153272|P1|Overall Study|Hypoglycaemia|3
7818502|NCT00393718|27153271|P2|Overall Study|Lack of Efficacy|9
7818503|NCT00393718|27153272|P1|Overall Study|Lack of Efficacy|10
7818504|NCT00393718|27153271|P2|Overall Study|Protocol Violation|2
7818505|NCT00393718|27153272|P1|Overall Study|Protocol Violation|1
7818506|NCT00393718|27153271|P2|Overall Study|Adverse Event|8
7818507|NCT00393718|27153272|P1|Overall Study|Adverse Event|20
7818508|NCT00393705|27153304|P2|Overall Study|Physician Decision|2
7818509|NCT00393705|27153305|P1|Overall Study|Physician Decision|2
7818510|NCT00393705|27153304|P2|Overall Study|Withdrawal by Subject|3
7818511|NCT00393705|27153305|P1|Overall Study|Withdrawal by Subject|5
7818512|NCT00393705|27153304|P2|Overall Study|Protocol Violation|3
7818513|NCT00393705|27153305|P1|Overall Study|Protocol Violation|4
7818514|NCT00393705|27153304|P2|Overall Study|Entry Criteria Not Met|10
7818515|NCT00393705|27153305|P1|Overall Study|Entry Criteria Not Met|10
7818516|NCT00393705|27153304|P2|Overall Study|Lost to Follow-up|2
7818517|NCT00393705|27153305|P1|Overall Study|Lost to Follow-up|2
7818518|NCT00393705|27153304|P2|Overall Study|Death|1
7818519|NCT00393705|27153305|P1|Overall Study|Death|0
7818520|NCT00393705|27153304|P2|Overall Study|Adverse Event|2
7818521|NCT00393705|27153305|P1|Overall Study|Adverse Event|0
7818522|NCT00393523|27153334|P5|Overall Study|Vaccine supply issue|0
7818523|NCT00393523|27153335|P4|Overall Study|Vaccine supply issue|0
7818524|NCT00393523|27153336|P3|Overall Study|Vaccine supply issue|1
7818525|NCT00393523|27153337|P2|Overall Study|Vaccine supply issue|0
7818526|NCT00393523|27153338|P1|Overall Study|Vaccine supply issue|0
7818527|NCT00393523|27153334|P5|Overall Study|Difficulties in specimen collection|0
7818528|NCT00393523|27153335|P4|Overall Study|Difficulties in specimen collection|0
7818529|NCT00393523|27153336|P3|Overall Study|Difficulties in specimen collection|1
7818530|NCT00393523|27153337|P2|Overall Study|Difficulties in specimen collection|0
7818531|NCT00393523|27153338|P1|Overall Study|Difficulties in specimen collection|0
7818532|NCT00393523|27153334|P5|Overall Study|Withdrawal by Subject|0
7818533|NCT00393523|27153335|P4|Overall Study|Withdrawal by Subject|3
7818534|NCT00393523|27153336|P3|Overall Study|Withdrawal by Subject|2
7818535|NCT00393523|27153337|P2|Overall Study|Withdrawal by Subject|7
7818536|NCT00393523|27153338|P1|Overall Study|Withdrawal by Subject|6
7818537|NCT00393523|27153334|P5|Overall Study|Protocol Violation|0
7818538|NCT00393523|27153335|P4|Overall Study|Protocol Violation|1
7818539|NCT00393523|27153336|P3|Overall Study|Protocol Violation|0
7818540|NCT00393523|27153337|P2|Overall Study|Protocol Violation|2
7818541|NCT00393523|27153338|P1|Overall Study|Protocol Violation|6
7818542|NCT00393523|27153334|P5|Overall Study|Lost to Follow-up|1
7818543|NCT00393523|27153335|P4|Overall Study|Lost to Follow-up|2
7818544|NCT00393523|27153336|P3|Overall Study|Lost to Follow-up|0
7818545|NCT00393523|27153337|P2|Overall Study|Lost to Follow-up|0
7818546|NCT00393523|27153338|P1|Overall Study|Lost to Follow-up|0
7818547|NCT00393510|27153355|P2|Overall Study|Physician Decision|9
7818548|NCT00393510|27153356|P1|Overall Study|Physician Decision|3
7818549|NCT00393484|27153368|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
7818550|NCT00393484|27153369|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
7818551|NCT00393484|27153368|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
7818552|NCT00393484|27153369|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
7818553|NCT00393484|27153368|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
7818554|NCT00393484|27153369|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
7818555|NCT00393484|27153368|P2|Open-label Period (Weeks 96 to 240)|Death|0
7818556|NCT00393484|27153369|P1|Open-label Period (Weeks 96 to 240)|Death|1
7818557|NCT00393484|27153368|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
7818558|NCT00393484|27153369|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
7818559|NCT00393484|27153368|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
7818560|NCT00393484|27153369|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
7818561|NCT00393484|27153368|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
7818562|NCT00393484|27153369|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
7818563|NCT00393484|27153368|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
7818564|NCT00393484|27153369|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
7818565|NCT00393484|27153368|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
7818566|NCT00393484|27153369|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
7818567|NCT00393484|27153368|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
7818568|NCT00393484|27153369|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
7818569|NCT00393458|27153405|P4|Overall Study|Subject no longer requires study drug|0
7818570|NCT00393458|27153406|P3|Overall Study|Subject no longer requires study drug|0
7818571|NCT00393458|27153407|P2|Overall Study|Subject no longer requires study drug|1
7818572|NCT00393458|27153408|P1|Overall Study|Subject no longer requires study drug|0
7818573|NCT00393458|27153405|P4|Overall Study|Abnormal test procedure result(s)|2
7818574|NCT00393458|27153406|P3|Overall Study|Abnormal test procedure result(s)|1
7818575|NCT00393458|27153407|P2|Overall Study|Abnormal test procedure result(s)|1
7818576|NCT00393458|27153408|P1|Overall Study|Abnormal test procedure result(s)|0
7818577|NCT00393458|27153405|P4|Overall Study|Death|5
7818578|NCT00393458|27153406|P3|Overall Study|Death|5
7818579|NCT00393458|27153407|P2|Overall Study|Death|1
7818580|NCT00393458|27153408|P1|Overall Study|Death|1
7818581|NCT00393458|27153405|P4|Overall Study|Abnormal laboratory value(s)|0
7818582|NCT00393458|27153406|P3|Overall Study|Abnormal laboratory value(s)|0
7818583|NCT00393458|27153407|P2|Overall Study|Abnormal laboratory value(s)|1
7818584|NCT00393458|27153408|P1|Overall Study|Abnormal laboratory value(s)|1
7818585|NCT00393458|27153405|P4|Overall Study|Lost to Follow-up|3
7818586|NCT00393458|27153406|P3|Overall Study|Lost to Follow-up|5
7818587|NCT00393458|27153407|P2|Overall Study|Lost to Follow-up|6
7818588|NCT00393458|27153408|P1|Overall Study|Lost to Follow-up|5
7818589|NCT00393458|27153405|P4|Overall Study|Administrative problems|2
7818590|NCT00393458|27153406|P3|Overall Study|Administrative problems|5
7818591|NCT00393458|27153407|P2|Overall Study|Administrative problems|8
7818592|NCT00393458|27153408|P1|Overall Study|Administrative problems|7
7818593|NCT00393458|27153405|P4|Overall Study|Protocol deviation|10
7818594|NCT00393458|27153406|P3|Overall Study|Protocol deviation|11
7818595|NCT00393458|27153407|P2|Overall Study|Protocol deviation|11
7818596|NCT00393458|27153408|P1|Overall Study|Protocol deviation|11
7818597|NCT00393458|27153405|P4|Overall Study|Unsatisfactory therapeutic effect|30
7818598|NCT00393458|27153406|P3|Overall Study|Unsatisfactory therapeutic effect|12
7818599|NCT00393458|27153407|P2|Overall Study|Unsatisfactory therapeutic effect|9
7818600|NCT00393458|27153408|P1|Overall Study|Unsatisfactory therapeutic effect|12
7818601|NCT00393458|27153405|P4|Overall Study|Subject withdrew consent|50
7818602|NCT00393458|27153406|P3|Overall Study|Subject withdrew consent|33
7818603|NCT00393458|27153407|P2|Overall Study|Subject withdrew consent|40
7818604|NCT00393458|27153408|P1|Overall Study|Subject withdrew consent|27
7818605|NCT00393458|27153405|P4|Overall Study|Adverse Event|35
7818606|NCT00393458|27153406|P3|Overall Study|Adverse Event|40
7818607|NCT00393458|27153407|P2|Overall Study|Adverse Event|24
7818608|NCT00393458|27153408|P1|Overall Study|Adverse Event|35
7818609|NCT00393367|27153435|P2|Overall Study|Withdrawal by Subject|2
7818610|NCT00393367|27153436|P1|Overall Study|Withdrawal by Subject|0
7818611|NCT00393367|27153435|P2|Overall Study|Protocol Violation|5
7818612|NCT00393367|27153436|P1|Overall Study|Protocol Violation|2
7818613|NCT00393094|27153464|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
7818614|NCT00393094|27153464|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
7818615|NCT00393042|27153475|P2|Second Intervetion|Protocol Violation|1
7818616|NCT00393042|27153476|P1|Second Intervetion|Protocol Violation|1
7818617|NCT00393042|27153475|P2|Second Intervetion|Lost to Follow-up|2
7818618|NCT00393042|27153476|P1|Second Intervetion|Lost to Follow-up|0
7818619|NCT00393042|27153475|P2|Second Intervetion|Lack of Efficacy|0
7818620|NCT00393042|27153476|P1|Second Intervetion|Lack of Efficacy|1
7818621|NCT00393042|27153475|P2|Second Intervetion|Withdrawal by Subject|2
7818622|NCT00393042|27153476|P1|Second Intervetion|Withdrawal by Subject|0
7818623|NCT00393042|27153475|P2|Second Intervetion|Adverse Event|3
7818624|NCT00393042|27153476|P1|Second Intervetion|Adverse Event|0
7818625|NCT00393042|27153475|P2|First Intervention|Adverse Event|1
7818626|NCT00393042|27153476|P1|First Intervention|Adverse Event|0
7818627|NCT00393042|27153475|P2|First Intervention|Protocol Violation|0
7818628|NCT00393042|27153476|P1|First Intervention|Protocol Violation|1
7818629|NCT00393042|27153475|P2|First Intervention|Lost to Follow-up|3
7818630|NCT00393042|27153476|P1|First Intervention|Lost to Follow-up|3
7818631|NCT00393042|27153475|P2|First Intervention|Withdrawal by Subject|2
7818632|NCT00393042|27153476|P1|First Intervention|Withdrawal by Subject|1
7818633|NCT00393029|27153548|P2|Overall Study|Not treated|1
7818634|NCT00393029|27153549|P1|Overall Study|Not treated|0
7818635|NCT00392990|27153560|P2|Follow up for 2 Years|Death|0
7818636|NCT00392990|27153561|P1|Follow up for 2 Years|Death|4
7818637|NCT00392990|27153560|P2|Treatment on Study|Adverse Event|1
7818638|NCT00392990|27153561|P1|Treatment on Study|Adverse Event|3
7818639|NCT00392925|27153585|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
7818640|NCT00392925|27153586|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
7818641|NCT00392925|27153587|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
7818642|NCT00392925|27153588|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
7818643|NCT00392925|27153585|P4|Randomization to Treatment Group Period|Protocol Violation|1
7818644|NCT00392925|27153586|P3|Randomization to Treatment Group Period|Protocol Violation|2
7818645|NCT00392925|27153587|P2|Randomization to Treatment Group Period|Protocol Violation|0
7818646|NCT00392925|27153588|P1|Randomization to Treatment Group Period|Protocol Violation|0
7818647|NCT00392925|27153585|P4|Randomization to Treatment Group Period|Adverse Event|5
7818648|NCT00392925|27153586|P3|Randomization to Treatment Group Period|Adverse Event|3
7818649|NCT00392925|27153587|P2|Randomization to Treatment Group Period|Adverse Event|3
7818650|NCT00392925|27153588|P1|Randomization to Treatment Group Period|Adverse Event|0
7818651|NCT00392925|27153585|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
7818652|NCT00392925|27153586|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
7818653|NCT00392925|27153587|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
7818654|NCT00392925|27153588|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
7818655|NCT00392925|27153585|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7818656|NCT00392925|27153586|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7818657|NCT00392925|27153587|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7818658|NCT00392925|27153588|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
7818659|NCT00392925|27153585|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7818660|NCT00392925|27153586|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7818661|NCT00392925|27153587|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7818662|NCT00392925|27153588|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
7818663|NCT00392925|27153585|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7818664|NCT00392925|27153586|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7818665|NCT00392925|27153587|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7818666|NCT00392925|27153588|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
7818667|NCT00392925|27153585|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7818668|NCT00392925|27153586|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7818669|NCT00392925|27153587|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7818670|NCT00392925|27153588|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
7818671|NCT00392925|27153585|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7818672|NCT00392925|27153586|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7818673|NCT00392925|27153587|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7818674|NCT00392925|27153588|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
7818675|NCT00392808|27153702|P4|Overall Study|Unable to withdraw blood|2
7818676|NCT00392808|27153703|P3|Overall Study|Unable to withdraw blood|1
7818677|NCT00392808|27153704|P2|Overall Study|Unable to withdraw blood|1
7818678|NCT00392808|27153705|P1|Overall Study|Unable to withdraw blood|3
7818679|NCT00392808|27153702|P4|Overall Study|Lost to Follow-up|2
7818680|NCT00392808|27153703|P3|Overall Study|Lost to Follow-up|1
7818681|NCT00392808|27153704|P2|Overall Study|Lost to Follow-up|2
7818682|NCT00392808|27153705|P1|Overall Study|Lost to Follow-up|3
7818683|NCT00392769|27153729|P1|Overall Study|Adverse Event|1
7818684|NCT00392769|27153729|P1|Overall Study|Clinical Deterioration|9
7818685|NCT00392665|27153781|P2|Overall Study|Lost to Follow-up|1
7818686|NCT00392665|27153782|P1|Overall Study|Lost to Follow-up|1
7818687|NCT00392665|27153781|P2|Overall Study|Death|14
7818688|NCT00392665|27153782|P1|Overall Study|Death|16
7818689|NCT00392379|27153808|P2|Overall Study|Adverse Event|1
7818690|NCT00392379|27153809|P1|Overall Study|Adverse Event|1
7818691|NCT00392379|27153808|P2|Overall Study|Lost to Follow-up|9
7818692|NCT00392379|27153809|P1|Overall Study|Lost to Follow-up|4
7818693|NCT00392379|27153808|P2|Overall Study|Withdrawal by Subject|28
7818694|NCT00392379|27153809|P1|Overall Study|Withdrawal by Subject|17
7818695|NCT00392327|27153827|P8|Overall Study|Ineligible|0
7818696|NCT00392327|27153828|P7|Overall Study|Ineligible|0
7818697|NCT00392327|27153829|P6|Overall Study|Ineligible|0
7818698|NCT00392327|27153830|P5|Overall Study|Ineligible|0
7818699|NCT00392327|27153831|P4|Overall Study|Ineligible|2
7818700|NCT00392327|27153832|P3|Overall Study|Ineligible|3
7818701|NCT00392327|27153833|P2|Overall Study|Ineligible|4
7818702|NCT00392327|27153834|P1|Overall Study|Ineligible|0
7818703|NCT00392327|27153827|P8|Overall Study|Withdrawal by Subject|5
7818704|NCT00392327|27153828|P7|Overall Study|Withdrawal by Subject|1
7818705|NCT00392327|27153829|P6|Overall Study|Withdrawal by Subject|1
7818706|NCT00392327|27153830|P5|Overall Study|Withdrawal by Subject|0
7818707|NCT00392327|27153831|P4|Overall Study|Withdrawal by Subject|6
7818708|NCT00392327|27153832|P3|Overall Study|Withdrawal by Subject|4
7818709|NCT00392327|27153833|P2|Overall Study|Withdrawal by Subject|2
7818710|NCT00392327|27153834|P1|Overall Study|Withdrawal by Subject|3
7818711|NCT00392327|27153827|P8|Overall Study|Protocol Violation|0
7818712|NCT00392327|27153828|P7|Overall Study|Protocol Violation|0
7818713|NCT00392327|27153829|P6|Overall Study|Protocol Violation|0
7818714|NCT00392327|27153830|P5|Overall Study|Protocol Violation|0
7818715|NCT00392327|27153831|P4|Overall Study|Protocol Violation|0
7818716|NCT00392327|27153832|P3|Overall Study|Protocol Violation|1
7818717|NCT00392327|27153833|P2|Overall Study|Protocol Violation|0
7818718|NCT00392327|27153834|P1|Overall Study|Protocol Violation|0
7818719|NCT00392327|27153827|P8|Overall Study|Physician Decision|3
7818720|NCT00392327|27153828|P7|Overall Study|Physician Decision|5
7818721|NCT00392327|27153829|P6|Overall Study|Physician Decision|1
7818722|NCT00392327|27153830|P5|Overall Study|Physician Decision|0
7818723|NCT00392327|27153831|P4|Overall Study|Physician Decision|2
7818724|NCT00392327|27153832|P3|Overall Study|Physician Decision|2
7818725|NCT00392327|27153833|P2|Overall Study|Physician Decision|5
7818726|NCT00392327|27153834|P1|Overall Study|Physician Decision|3
7818727|NCT00392327|27153827|P8|Overall Study|Lack of Efficacy|3
7818728|NCT00392327|27153828|P7|Overall Study|Lack of Efficacy|3
7818729|NCT00392327|27153829|P6|Overall Study|Lack of Efficacy|3
7818730|NCT00392327|27153830|P5|Overall Study|Lack of Efficacy|3
7818731|NCT00392327|27153831|P4|Overall Study|Lack of Efficacy|6
7818732|NCT00392327|27153832|P3|Overall Study|Lack of Efficacy|9
7818733|NCT00392327|27153833|P2|Overall Study|Lack of Efficacy|8
7818734|NCT00392327|27153834|P1|Overall Study|Lack of Efficacy|8
7818735|NCT00392327|27153827|P8|Overall Study|Death|0
7818736|NCT00392327|27153828|P7|Overall Study|Death|0
7818737|NCT00392327|27153829|P6|Overall Study|Death|0
7818738|NCT00392327|27153830|P5|Overall Study|Death|0
7818739|NCT00392327|27153831|P4|Overall Study|Death|0
7818740|NCT00392327|27153832|P3|Overall Study|Death|1
7818741|NCT00392327|27153833|P2|Overall Study|Death|0
7818742|NCT00392327|27153834|P1|Overall Study|Death|1
7818743|NCT00392288|27153903|P3|Overall Study|Other|1
7818744|NCT00392288|27153904|P2|Overall Study|Other|4
7818745|NCT00392288|27153905|P1|Overall Study|Other|3
7818746|NCT00392288|27153903|P3|Overall Study|Parent/legal guardian withdrawal|1
7818747|NCT00392288|27153904|P2|Overall Study|Parent/legal guardian withdrawal|2
7818748|NCT00392288|27153905|P1|Overall Study|Parent/legal guardian withdrawal|1
7818749|NCT00392288|27153903|P3|Overall Study|Withdrawal by Subject|2
7818750|NCT00392288|27153904|P2|Overall Study|Withdrawal by Subject|0
7818751|NCT00392288|27153905|P1|Overall Study|Withdrawal by Subject|1
7818752|NCT00392288|27153903|P3|Overall Study|Lost to Follow-up|1
7818753|NCT00392288|27153904|P2|Overall Study|Lost to Follow-up|1
7818754|NCT00392288|27153905|P1|Overall Study|Lost to Follow-up|1
7818755|NCT00392288|27153903|P3|Overall Study|Protocol Violation|1
7818756|NCT00392288|27153904|P2|Overall Study|Protocol Violation|3
7818757|NCT00392288|27153905|P1|Overall Study|Protocol Violation|1
7818758|NCT00392288|27153903|P3|Overall Study|Lack of Efficacy|3
7818759|NCT00392288|27153904|P2|Overall Study|Lack of Efficacy|5
7818760|NCT00392288|27153905|P1|Overall Study|Lack of Efficacy|8
7818761|NCT00392288|27153903|P3|Overall Study|Adverse Event|8
7818762|NCT00392288|27153904|P2|Overall Study|Adverse Event|7
7818763|NCT00392288|27153905|P1|Overall Study|Adverse Event|17
7818764|NCT00392223|27153930|P2|Overall Study|Withdrawal by Subject|2
7818765|NCT00392223|27153931|P1|Overall Study|Withdrawal by Subject|3
7818766|NCT00392223|27153930|P2|Overall Study|Protocol Violation|3
7818767|NCT00392223|27153931|P1|Overall Study|Protocol Violation|0
7818768|NCT00392223|27153930|P2|Overall Study|Lost to Follow-up|4
7818769|NCT00392223|27153931|P1|Overall Study|Lost to Follow-up|1
7818770|NCT00392223|27153930|P2|Overall Study|Adverse Event|4
7818771|NCT00392223|27153931|P1|Overall Study|Adverse Event|5
7818772|NCT00392210|27153949|P2|First Voiding Trial|Physician Decision|2
7818773|NCT00392210|27153950|P1|First Voiding Trial|Physician Decision|2
7818774|NCT00392197|27153958|P2|Overall Study|Withdrawal by Subject|6
7818775|NCT00392197|27153959|P1|Overall Study|Withdrawal by Subject|4
7818776|NCT00392197|27153958|P2|Overall Study|Protocol Violation|5
7818777|NCT00392197|27153959|P1|Overall Study|Protocol Violation|7
7818778|NCT00392197|27153958|P2|Overall Study|Physician Decision|2
7818779|NCT00392197|27153959|P1|Overall Study|Physician Decision|3
7818780|NCT00392197|27153958|P2|Overall Study|Lost to Follow-up|1
7818781|NCT00392197|27153959|P1|Overall Study|Lost to Follow-up|0
7818782|NCT00392197|27153958|P2|Overall Study|Lack of Efficacy|4
7818783|NCT00392197|27153959|P1|Overall Study|Lack of Efficacy|3
7818784|NCT00392197|27153958|P2|Overall Study|Adverse Event|12
7818785|NCT00392197|27153959|P1|Overall Study|Adverse Event|4
7818786|NCT00392171|27153967|P1|Overall Study|Disease progression|101
7818787|NCT00392171|27153967|P1|Overall Study|Did not meet inclusion criteria|4
7818788|NCT00392015|27154017|P6|Overall Study|Previous trial recipient|0
7818789|NCT00392015|27154018|P5|Overall Study|Previous trial recipient|1
7818790|NCT00392015|27154019|P4|Overall Study|Previous trial recipient|0
7818791|NCT00392015|27154020|P3|Overall Study|Previous trial recipient|0
7818792|NCT00392015|27154021|P2|Overall Study|Previous trial recipient|0
7818793|NCT00392015|27154022|P1|Overall Study|Previous trial recipient|0
7818794|NCT00392015|27154017|P6|Overall Study|Adverse Event|0
7818795|NCT00392015|27154018|P5|Overall Study|Adverse Event|1
7818796|NCT00392015|27154019|P4|Overall Study|Adverse Event|0
7818797|NCT00392015|27154020|P3|Overall Study|Adverse Event|0
7818798|NCT00392015|27154021|P2|Overall Study|Adverse Event|0
7818799|NCT00392015|27154022|P1|Overall Study|Adverse Event|0
7818800|NCT00392015|27154017|P6|Overall Study|Withdrawal by Subject|0
7818801|NCT00392015|27154018|P5|Overall Study|Withdrawal by Subject|0
7818802|NCT00392015|27154019|P4|Overall Study|Withdrawal by Subject|0
7818803|NCT00392015|27154020|P3|Overall Study|Withdrawal by Subject|2
7818804|NCT00392015|27154021|P2|Overall Study|Withdrawal by Subject|0
7818805|NCT00392015|27154022|P1|Overall Study|Withdrawal by Subject|0
7818806|NCT00392015|27154017|P6|Overall Study|Lost to Follow-up|0
7818807|NCT00392015|27154018|P5|Overall Study|Lost to Follow-up|1
7818808|NCT00392015|27154019|P4|Overall Study|Lost to Follow-up|1
7818809|NCT00392015|27154020|P3|Overall Study|Lost to Follow-up|2
7818810|NCT00392015|27154021|P2|Overall Study|Lost to Follow-up|0
7818811|NCT00392015|27154022|P1|Overall Study|Lost to Follow-up|2
7818812|NCT00391976|27154055|P3|Overall Study|Positive P. aeruginosa antibody test|31
7818813|NCT00391976|27154056|P2|Overall Study|Positive P. aeruginosa antibody test|0
7818814|NCT00391976|27154057|P1|Overall Study|Positive P. aeruginosa antibody test|0
7818815|NCT00391976|27154055|P3|Overall Study|Unable to classify|1
7818816|NCT00391976|27154056|P2|Overall Study|Unable to classify|0
7818817|NCT00391976|27154057|P1|Overall Study|Unable to classify|0
7818818|NCT00391976|27154055|P3|Overall Study|Recurrence/no eradication of infection|0
7818819|NCT00391976|27154056|P2|Overall Study|Recurrence/no eradication of infection|19
7818820|NCT00391976|27154057|P1|Overall Study|Recurrence/no eradication of infection|21
7818821|NCT00391976|27154055|P3|Overall Study|Protocol deviation/violation|1
7818822|NCT00391976|27154056|P2|Overall Study|Protocol deviation/violation|2
7818823|NCT00391976|27154057|P1|Overall Study|Protocol deviation/violation|4
7818824|NCT00391976|27154055|P3|Overall Study|Inappropriate enrollment|0
7818825|NCT00391976|27154056|P2|Overall Study|Inappropriate enrollment|1
7818826|NCT00391976|27154057|P1|Overall Study|Inappropriate enrollment|1
7818827|NCT00391976|27154055|P3|Overall Study|Lost to Follow-up|0
7818828|NCT00391976|27154056|P2|Overall Study|Lost to Follow-up|2
7818829|NCT00391976|27154057|P1|Overall Study|Lost to Follow-up|1
7818830|NCT00391976|27154055|P3|Overall Study|Withdrawal of consent|1
7818831|NCT00391976|27154056|P2|Overall Study|Withdrawal of consent|1
7818832|NCT00391976|27154057|P1|Overall Study|Withdrawal of consent|0
7818833|NCT00391976|27154055|P3|Overall Study|Adverse Event|1
7818834|NCT00391976|27154056|P2|Overall Study|Adverse Event|0
7818835|NCT00391976|27154057|P1|Overall Study|Adverse Event|0
7818836|NCT00391898|27154081|P2|Overall Study|Other|10
7818837|NCT00391898|27154082|P1|Overall Study|Other|8
7818838|NCT00391898|27154081|P2|Overall Study|Adverse Event|0
7818839|NCT00391898|27154082|P1|Overall Study|Adverse Event|3
7818840|NCT00391872|27154102|P2|Overall Study|Lost to Follow-up|0
7818841|NCT00391872|27154103|P1|Overall Study|Lost to Follow-up|2
7818842|NCT00391872|27154102|P2|Overall Study|Reason unknown|4
7818843|NCT00391872|27154103|P1|Overall Study|Reason unknown|2
7818844|NCT00391872|27154102|P2|Overall Study|Withdrawal by Subject|249
7818845|NCT00391872|27154103|P1|Overall Study|Withdrawal by Subject|296
7818846|NCT00391872|27154102|P2|Overall Study|Protocol Violation|2
7818847|NCT00391872|27154103|P1|Overall Study|Protocol Violation|7
7818848|NCT00391846|27154141|P2|Overall Study|Developed study specific DC criteria|1
7818849|NCT00391846|27154142|P1|Overall Study|Developed study specific DC criteria|0
7818850|NCT00391846|27154141|P2|Overall Study|Withdrawal by Subject|3
7818851|NCT00391846|27154142|P1|Overall Study|Withdrawal by Subject|2
7818852|NCT00391846|27154141|P2|Overall Study|Did not meet the required elig. crit|2
7818853|NCT00391846|27154142|P1|Overall Study|Did not meet the required elig. crit|2
7818854|NCT00391846|27154141|P2|Overall Study|Adverse Event|1
7818855|NCT00391846|27154142|P1|Overall Study|Adverse Event|4
7818856|NCT00391807|27154162|P1|Overall Study|Various|96
7818857|NCT00391807|27154162|P1|Overall Study|Protocol Violation|20
7818858|NCT00391807|27154162|P1|Overall Study|Withdrawal by Subject|147
7818859|NCT00391807|27154162|P1|Overall Study|Lost to Follow-up|227
7818860|NCT00391807|27154162|P1|Overall Study|Pregnancy|25
7818861|NCT00391807|27154162|P1|Overall Study|Adverse Event|177
7818862|NCT00391807|27154162|P1|Overall Study|Did not receive study medication|23
7818863|NCT00391768|27154189|P7|Overall Study|Lost to Follow-up|3
7818864|NCT00391768|27154190|P6|Overall Study|Lost to Follow-up|2
7818865|NCT00391768|27154191|P5|Overall Study|Lost to Follow-up|2
7818866|NCT00391768|27154192|P4|Overall Study|Lost to Follow-up|1
7818867|NCT00391768|27154193|P3|Overall Study|Lost to Follow-up|0
7818868|NCT00391768|27154194|P2|Overall Study|Lost to Follow-up|0
7818869|NCT00391768|27154195|P1|Overall Study|Lost to Follow-up|0
7818870|NCT00391768|27154189|P7|Overall Study|Withdrawal by Subject|1
7818871|NCT00391768|27154190|P6|Overall Study|Withdrawal by Subject|1
7818872|NCT00391768|27154191|P5|Overall Study|Withdrawal by Subject|0
7818873|NCT00391768|27154192|P4|Overall Study|Withdrawal by Subject|0
7818874|NCT00391768|27154193|P3|Overall Study|Withdrawal by Subject|1
7818875|NCT00391768|27154194|P2|Overall Study|Withdrawal by Subject|0
7818876|NCT00391768|27154195|P1|Overall Study|Withdrawal by Subject|0
7818877|NCT00391625|27154282|P1|Month 50|Physician Decision|1
7818878|NCT00391625|27154282|P1|Month 14|Withdrawal by Subject|1
7818879|NCT00391586|27154335|P1|Overall Study|Death|4
7818880|NCT00391586|27154335|P1|Overall Study|Physician Decision|2
7818881|NCT00391586|27154335|P1|Overall Study|Adverse Event|5
7818882|NCT00391586|27154335|P1|Overall Study|Progressive disease|13
7818883|NCT00391430|27154371|P3|Overall Study|Withdrawal by Subject|12
7818884|NCT00391430|27154372|P2|Overall Study|Withdrawal by Subject|0
7818885|NCT00391430|27154373|P1|Overall Study|Withdrawal by Subject|3
7818886|NCT00391391|27154448|P4|Overall Study|Withdrawal by Subject|7
7818887|NCT00391391|27154449|P3|Overall Study|Withdrawal by Subject|10
7818888|NCT00391391|27154450|P2|Overall Study|Withdrawal by Subject|4
7818889|NCT00391391|27154451|P1|Overall Study|Withdrawal by Subject|6
7818890|NCT00391391|27154448|P4|Overall Study|Protocol Violation|7
7818891|NCT00391391|27154449|P3|Overall Study|Protocol Violation|6
7818892|NCT00391391|27154450|P2|Overall Study|Protocol Violation|3
7818893|NCT00391391|27154451|P1|Overall Study|Protocol Violation|2
7818894|NCT00391391|27154448|P4|Overall Study|Lost to Follow-up|4
7818895|NCT00391391|27154449|P3|Overall Study|Lost to Follow-up|7
7818896|NCT00391391|27154450|P2|Overall Study|Lost to Follow-up|3
7818897|NCT00391391|27154451|P1|Overall Study|Lost to Follow-up|1
7818898|NCT00391391|27154448|P4|Overall Study|Adverse Event|1
7818899|NCT00391391|27154449|P3|Overall Study|Adverse Event|0
7818900|NCT00391391|27154450|P2|Overall Study|Adverse Event|0
7818901|NCT00391391|27154451|P1|Overall Study|Adverse Event|0
7818902|NCT00391274|27154496|P2|Overall Study|Death Not Study Related|1
7818903|NCT00391274|27154497|P1|Overall Study|Death Not Study Related|0
7818904|NCT00391274|27154496|P2|Overall Study|Death Due to Indeterminate Cause|0
7818905|NCT00391274|27154497|P1|Overall Study|Death Due to Indeterminate Cause|1
7818906|NCT00391274|27154496|P2|Overall Study|Death Due to Adverse Event|3
7818907|NCT00391274|27154497|P1|Overall Study|Death Due to Adverse Event|1
7818908|NCT00391274|27154496|P2|Overall Study|Withdrawal by Subject|3
7818909|NCT00391274|27154497|P1|Overall Study|Withdrawal by Subject|0
7818910|NCT00391274|27154496|P2|Overall Study|Physician Decision|2
7818911|NCT00391274|27154497|P1|Overall Study|Physician Decision|4
7818912|NCT00391274|27154496|P2|Overall Study|Lost to Follow-up|3
7818913|NCT00391274|27154497|P1|Overall Study|Lost to Follow-up|0
7818914|NCT00391274|27154496|P2|Overall Study|Death Due to Study Disease|45
7818915|NCT00391274|27154497|P1|Overall Study|Death Due to Study Disease|55
7818916|NCT00391222|27154516|P4|Period III (Double-Blind Treatment)|Other|0
7818917|NCT00391222|27154517|P3|Period III (Double-Blind Treatment)|Other|6
7818918|NCT00391222|27154518|P2|Period III (Double-Blind Treatment)|Other|1
7818919|NCT00391222|27154519|P1|Period III (Double-Blind Treatment)|Other|6
7818920|NCT00391222|27154516|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
7818921|NCT00391222|27154517|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
7818922|NCT00391222|27154518|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
7818923|NCT00391222|27154519|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
7818924|NCT00391222|27154516|P4|Period III (Double-Blind Treatment)|Pregnancy|0
7818925|NCT00391222|27154517|P3|Period III (Double-Blind Treatment)|Pregnancy|0
7818926|NCT00391222|27154518|P2|Period III (Double-Blind Treatment)|Pregnancy|2
7818927|NCT00391222|27154519|P1|Period III (Double-Blind Treatment)|Pregnancy|0
7818928|NCT00391222|27154516|P4|Period III (Double-Blind Treatment)|Adverse Event|0
7818929|NCT00391222|27154517|P3|Period III (Double-Blind Treatment)|Adverse Event|4
7818930|NCT00391222|27154518|P2|Period III (Double-Blind Treatment)|Adverse Event|2
7818931|NCT00391222|27154519|P1|Period III (Double-Blind Treatment)|Adverse Event|5
7818932|NCT00391222|27154516|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
7818933|NCT00391222|27154517|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
7818934|NCT00391222|27154518|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
7818935|NCT00391222|27154519|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
7818936|NCT00391222|27154516|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
7818937|NCT00391222|27154517|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
7818938|NCT00391222|27154518|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
7818939|NCT00391222|27154519|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
7818940|NCT00391222|27154516|P4|Period II (Open-label Risperidone LAI)|Other|24
7818941|NCT00391222|27154517|P3|Period II (Open-label Risperidone LAI)|Other|0
7818942|NCT00391222|27154518|P2|Period II (Open-label Risperidone LAI)|Other|0
7818943|NCT00391222|27154519|P1|Period II (Open-label Risperidone LAI)|Other|0
7818944|NCT00391222|27154516|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
7818945|NCT00391222|27154517|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
7818946|NCT00391222|27154518|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
7818947|NCT00391222|27154519|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
7818948|NCT00391222|27154516|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
7818949|NCT00391222|27154517|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
7818950|NCT00391222|27154518|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
7818951|NCT00391222|27154519|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
7818952|NCT00391222|27154516|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
7818953|NCT00391222|27154517|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7818954|NCT00391222|27154518|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7818955|NCT00391222|27154519|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7818956|NCT00391222|27154516|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
7818957|NCT00391222|27154517|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7818958|NCT00391222|27154518|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7818959|NCT00391222|27154519|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7818960|NCT00391118|27154546|P3|Overall Study|Protocol Violation|0
7818961|NCT00391118|27154547|P2|Overall Study|Protocol Violation|0
7818962|NCT00391118|27154548|P1|Overall Study|Protocol Violation|1
7818963|NCT00391118|27154546|P3|Overall Study|Sponsor Decision|3
7818964|NCT00391118|27154547|P2|Overall Study|Sponsor Decision|1
7818965|NCT00391118|27154548|P1|Overall Study|Sponsor Decision|0
7818966|NCT00391118|27154546|P3|Overall Study|Progressive Disease|43
7818967|NCT00391118|27154547|P2|Overall Study|Progressive Disease|26
7818968|NCT00391118|27154548|P1|Overall Study|Progressive Disease|7
7818969|NCT00391118|27154546|P3|Overall Study|Protocol Entry Criteria Not Met|1
7818970|NCT00391118|27154547|P2|Overall Study|Protocol Entry Criteria Not Met|3
7818971|NCT00391118|27154548|P1|Overall Study|Protocol Entry Criteria Not Met|0
7818972|NCT00391118|27154546|P3|Overall Study|Physician Decision|0
7818973|NCT00391118|27154547|P2|Overall Study|Physician Decision|3
7818974|NCT00391118|27154548|P1|Overall Study|Physician Decision|0
7818975|NCT00391118|27154546|P3|Overall Study|Death|0
7818976|NCT00391118|27154547|P2|Overall Study|Death|1
7818977|NCT00391118|27154548|P1|Overall Study|Death|0
7818978|NCT00391118|27154546|P3|Overall Study|Withdrawal by Subject|1
7818979|NCT00391118|27154547|P2|Overall Study|Withdrawal by Subject|9
7818980|NCT00391118|27154548|P1|Overall Study|Withdrawal by Subject|0
7818981|NCT00391118|27154546|P3|Overall Study|Lost to Follow-up|3
7818982|NCT00391118|27154547|P2|Overall Study|Lost to Follow-up|2
7818983|NCT00391118|27154548|P1|Overall Study|Lost to Follow-up|0
7818984|NCT00391118|27154546|P3|Overall Study|Adverse Event|7
7818985|NCT00391118|27154547|P2|Overall Study|Adverse Event|10
7818986|NCT00391118|27154548|P1|Overall Study|Adverse Event|3
7818987|NCT00391092|27154574|P2|Overall Study|Alive in follow-up|84
7818988|NCT00391092|27154575|P1|Overall Study|Alive in follow-up|88
7818989|NCT00391092|27154574|P2|Overall Study|Alive on treatment|33
7818990|NCT00391092|27154575|P1|Overall Study|Alive on treatment|29
7818991|NCT00391092|27154574|P2|Overall Study|Lost to Follow-up|18
7818992|NCT00391092|27154575|P1|Overall Study|Lost to Follow-up|13
7818993|NCT00391092|27154574|P2|Overall Study|Death|81
7818994|NCT00391092|27154575|P1|Overall Study|Death|78
7818995|NCT00391053|27154618|P4|Overall Study|Withdrawal by Subject|1
7818996|NCT00391053|27154619|P3|Overall Study|Withdrawal by Subject|1
7818997|NCT00391053|27154620|P2|Overall Study|Withdrawal by Subject|1
7818998|NCT00391053|27154621|P1|Overall Study|Withdrawal by Subject|5
7818999|NCT00391053|27154618|P4|Overall Study|Lost to Follow-up|5
7819000|NCT00391053|27154619|P3|Overall Study|Lost to Follow-up|0
7819001|NCT00391053|27154620|P2|Overall Study|Lost to Follow-up|0
7819002|NCT00391053|27154621|P1|Overall Study|Lost to Follow-up|1
7819003|NCT00391053|27154618|P4|Overall Study|Protocol Violation|0
7819004|NCT00391053|27154619|P3|Overall Study|Protocol Violation|0
7819005|NCT00391053|27154620|P2|Overall Study|Protocol Violation|0
7819006|NCT00391053|27154621|P1|Overall Study|Protocol Violation|2
7819007|NCT00391053|27154618|P4|Overall Study|Serious Adverse Events|4
7819008|NCT00391053|27154619|P3|Overall Study|Serious Adverse Events|1
7819009|NCT00391053|27154620|P2|Overall Study|Serious Adverse Events|0
7819010|NCT00391053|27154621|P1|Overall Study|Serious Adverse Events|1
7819011|NCT00391027|27154645|P2|Overall Study|Other|3
7819012|NCT00391027|27154646|P1|Overall Study|Other|4
7819013|NCT00391027|27154645|P2|Overall Study|Withdrawal by Subject|1
7819014|NCT00391027|27154646|P1|Overall Study|Withdrawal by Subject|10
7819015|NCT00391027|27154645|P2|Overall Study|Lack of Efficacy|0
7819016|NCT00391027|27154646|P1|Overall Study|Lack of Efficacy|3
7819017|NCT00391027|27154645|P2|Overall Study|Adverse Event|8
7819018|NCT00391027|27154646|P1|Overall Study|Adverse Event|8
7819019|NCT00390910|27154696|P3|Overall Study|Migrated/moved from study area|3
7819020|NCT00390910|27154697|P2|Overall Study|Migrated/moved from study area|0
7819021|NCT00390910|27154698|P1|Overall Study|Migrated/moved from study area|0
7819022|NCT00390910|27154696|P3|Overall Study|Withdrawal by Subject|2
7819023|NCT00390910|27154697|P2|Overall Study|Withdrawal by Subject|3
7819024|NCT00390910|27154698|P1|Overall Study|Withdrawal by Subject|1
7819025|NCT00390910|27154696|P3|Overall Study|Lost to Follow-up|5
7819026|NCT00390910|27154697|P2|Overall Study|Lost to Follow-up|1
7819027|NCT00390910|27154698|P1|Overall Study|Lost to Follow-up|0
7819028|NCT00390910|27154696|P3|Overall Study|Adverse Event|0
7819029|NCT00390910|27154697|P2|Overall Study|Adverse Event|0
7819030|NCT00390910|27154698|P1|Overall Study|Adverse Event|1
7819031|NCT00390884|27154786|P2|Overall Study|Withdrawal by Subject|2
7819032|NCT00390884|27154787|P1|Overall Study|Withdrawal by Subject|2
7819033|NCT00390858|27154799|P2|Overall Study|Withdrawal by Subject|4
7819034|NCT00390858|27154800|P1|Overall Study|Withdrawal by Subject|3
7819035|NCT00390858|27154799|P2|Overall Study|Lack of Efficacy|1
7819036|NCT00390858|27154800|P1|Overall Study|Lack of Efficacy|0
7819037|NCT00390858|27154799|P2|Overall Study|Adverse Event|2
7819038|NCT00390858|27154800|P1|Overall Study|Adverse Event|6
7819039|NCT00390806|27154814|P2|Overall Study|Ongoing|2
7819040|NCT00390806|27154815|P1|Overall Study|Ongoing|4
7819041|NCT00390806|27154814|P2|Overall Study|Physician Decision|1
7819042|NCT00390806|27154815|P1|Overall Study|Physician Decision|0
7819043|NCT00390806|27154814|P2|Overall Study|Death|0
7819044|NCT00390806|27154815|P1|Overall Study|Death|1
7819045|NCT00390806|27154814|P2|Overall Study|Investigator Decision|6
7819046|NCT00390806|27154815|P1|Overall Study|Investigator Decision|4
7819047|NCT00390806|27154814|P2|Overall Study|Withdrawal by Subject|15
7819048|NCT00390806|27154815|P1|Overall Study|Withdrawal by Subject|12
7819049|NCT00390806|27154814|P2|Overall Study|Protocol Violation|2
7819050|NCT00390806|27154815|P1|Overall Study|Protocol Violation|2
7819051|NCT00390806|27154814|P2|Overall Study|Lost to Follow-up|6
7819052|NCT00390806|27154815|P1|Overall Study|Lost to Follow-up|7
7819053|NCT00390780|27154883|P2|Overall Study|SAE, death|1
7819054|NCT00390780|27154884|P1|Overall Study|SAE, death|0
7819055|NCT00390780|27154883|P2|Overall Study|Investigator decision, SAE, other reason|1
7819056|NCT00390780|27154884|P1|Overall Study|Investigator decision, SAE, other reason|0
7819057|NCT00390780|27154883|P2|Overall Study|Lost to follow up and other reasons|1
7819058|NCT00390780|27154884|P1|Overall Study|Lost to follow up and other reasons|0
7819059|NCT00390780|27154883|P2|Overall Study|Inclusion criteria not satisfied|2
7819060|NCT00390780|27154884|P1|Overall Study|Inclusion criteria not satisfied|0
7819061|NCT00390780|27154883|P2|Overall Study|Withdrawal by Subject|2
7819062|NCT00390780|27154884|P1|Overall Study|Withdrawal by Subject|1
7819063|NCT00390780|27154883|P2|Overall Study|Death|3
7819064|NCT00390780|27154884|P1|Overall Study|Death|1
7819065|NCT00390780|27154883|P2|Overall Study|Adverse Event|3
7819066|NCT00390780|27154884|P1|Overall Study|Adverse Event|2
7819067|NCT00390780|27154883|P2|Overall Study|Lost to Follow-up|6
7819068|NCT00390780|27154884|P1|Overall Study|Lost to Follow-up|3
7819069|NCT00390780|27154883|P2|Overall Study|Protocol Violation|4
7819070|NCT00390780|27154884|P1|Overall Study|Protocol Violation|6
7819071|NCT00390780|27154883|P2|Overall Study|Not completed|4
7819072|NCT00390780|27154884|P1|Overall Study|Not completed|10
7819073|NCT00390689|27154917|P3|Overall Study|Investigator's judgement|0
7819074|NCT00390689|27154918|P2|Overall Study|Investigator's judgement|0
7819075|NCT00390689|27154919|P1|Overall Study|Investigator's judgement|2
7819076|NCT00390689|27154917|P3|Overall Study|Protocol Violation|0
7819077|NCT00390689|27154918|P2|Overall Study|Protocol Violation|0
7819078|NCT00390689|27154919|P1|Overall Study|Protocol Violation|1
7819079|NCT00390689|27154917|P3|Overall Study|Lack of Efficacy|1
7819080|NCT00390689|27154918|P2|Overall Study|Lack of Efficacy|0
7819081|NCT00390689|27154919|P1|Overall Study|Lack of Efficacy|0
7819082|NCT00390689|27154917|P3|Overall Study|Adverse Event|2
7819083|NCT00390689|27154918|P2|Overall Study|Adverse Event|5
7819084|NCT00390689|27154919|P1|Overall Study|Adverse Event|2
7819085|NCT00390572|27154994|P2|Overall Study|health condition|1
7819086|NCT00390572|27154995|P1|Overall Study|health condition|0
7819087|NCT00390572|27154994|P2|Overall Study|Lost to Follow-up|4
7819088|NCT00390572|27154995|P1|Overall Study|Lost to Follow-up|8
7819089|NCT00390546|27155021|P2|Overall Study|Physician Decision|5
7819090|NCT00390546|27155022|P1|Overall Study|Physician Decision|5
7819091|NCT00390546|27155021|P2|Overall Study|Renal impairment|0
7819092|NCT00390546|27155022|P1|Overall Study|Renal impairment|1
7819093|NCT00390468|27155032|P1|Overall Study|Lack of Efficacy|1
7819094|NCT00390468|27155032|P1|Overall Study|Protocol Violation|2
7819095|NCT00390455|27155038|P2|Overall Study|Other Medical Reasons|11
7819096|NCT00390455|27155039|P1|Overall Study|Other Medical Reasons|7
7819097|NCT00390455|27155038|P2|Overall Study|Alternate Treatment|1
7819098|NCT00390455|27155039|P1|Overall Study|Alternate Treatment|0
7819099|NCT00390455|27155038|P2|Overall Study|Withdrawal by Subject|8
7819100|NCT00390455|27155039|P1|Overall Study|Withdrawal by Subject|8
7819101|NCT00390455|27155038|P2|Overall Study|Adverse Event|3
7819102|NCT00390455|27155039|P1|Overall Study|Adverse Event|17
7819103|NCT00390416|27155084|P1|Overall Study|Not treated|3
7819104|NCT00390416|27155084|P1|Overall Study|Withdrawal by Subject|1
7819105|NCT00390299|27155122|P5|Overall Study|Cancellation|0
7819106|NCT00390299|27155123|P4|Overall Study|Cancellation|0
7819107|NCT00390299|27155124|P3|Overall Study|Cancellation|0
7819108|NCT00390299|27155125|P2|Overall Study|Cancellation|0
7819109|NCT00390299|27155126|P1|Overall Study|Cancellation|1
7819110|NCT00390221|27155157|P3|Overall Study|Other|2
7819111|NCT00390221|27155158|P2|Overall Study|Other|4
7819112|NCT00390221|27155159|P1|Overall Study|Other|3
7819113|NCT00390221|27155157|P3|Overall Study|Subject Non-compliance|2
7819114|NCT00390221|27155158|P2|Overall Study|Subject Non-compliance|0
7819115|NCT00390221|27155159|P1|Overall Study|Subject Non-compliance|1
7819116|NCT00390221|27155157|P3|Overall Study|Withdrawal by Subject|7
7819117|NCT00390221|27155158|P2|Overall Study|Withdrawal by Subject|9
7819118|NCT00390221|27155159|P1|Overall Study|Withdrawal by Subject|13
7819119|NCT00390221|27155157|P3|Overall Study|Investigator Decision|1
7819120|NCT00390221|27155158|P2|Overall Study|Investigator Decision|0
7819121|NCT00390221|27155159|P1|Overall Study|Investigator Decision|0
7819122|NCT00390221|27155157|P3|Overall Study|Adverse Event|3
7819123|NCT00390221|27155158|P2|Overall Study|Adverse Event|4
7819124|NCT00390221|27155159|P1|Overall Study|Adverse Event|1
7819125|NCT00390221|27155157|P3|Overall Study|Lost to Follow-up|0
7819126|NCT00390221|27155158|P2|Overall Study|Lost to Follow-up|3
7819127|NCT00390221|27155159|P1|Overall Study|Lost to Follow-up|0
7819128|NCT00390013|27155189|P4|Phase 2 First Treatment|Withdrawal by Subject|0
7819129|NCT00390013|27155190|P3|Phase 2 First Treatment|Withdrawal by Subject|0
7819130|NCT00390013|27155191|P2|Phase 2 First Treatment|Withdrawal by Subject|1
7819131|NCT00390013|27155192|P1|Phase 2 First Treatment|Withdrawal by Subject|0
7819132|NCT00390013|27155189|P4|Phase 2 First Treatment|tired|0
7819133|NCT00390013|27155190|P3|Phase 2 First Treatment|tired|0
7819134|NCT00390013|27155191|P2|Phase 2 First Treatment|tired|0
7819135|NCT00390013|27155192|P1|Phase 2 First Treatment|tired|1
7819136|NCT00390013|27155189|P4|Phase 1|tired|1
7819137|NCT00390013|27155190|P3|Phase 1|tired|0
7819138|NCT00390013|27155191|P2|Phase 1|tired|0
7819139|NCT00390013|27155192|P1|Phase 1|tired|0
7819140|NCT00389831|27155217|P2|Overall Study|Lost to Follow-up|1
7819141|NCT00389831|27155218|P1|Overall Study|Lost to Follow-up|0
7819142|NCT00389831|27155217|P2|Overall Study|Other reasons|2
7819143|NCT00389831|27155218|P1|Overall Study|Other reasons|0
7819144|NCT00389831|27155217|P2|Overall Study|Did not receive treatment.|2
7819145|NCT00389831|27155218|P1|Overall Study|Did not receive treatment.|0
7819146|NCT00389831|27155217|P2|Overall Study|Lack of Efficacy|2
7819147|NCT00389831|27155218|P1|Overall Study|Lack of Efficacy|0
7819148|NCT00389597|27155281|P4|Overall Study|Lost to Follow-up|6
7819149|NCT00389597|27155282|P3|Overall Study|Lost to Follow-up|4
7819150|NCT00389597|27155283|P2|Overall Study|Lost to Follow-up|6
7819151|NCT00389597|27155284|P1|Overall Study|Lost to Follow-up|8
7819152|NCT00389519|27155309|P4|Treated|Reason not specified|2
7819153|NCT00389519|27155310|P3|Treated|Reason not specified|0
7819154|NCT00389519|27155311|P2|Treated|Reason not specified|1
7819155|NCT00389519|27155312|P1|Treated|Reason not specified|1
7819156|NCT00389519|27155309|P4|Treated|Adverse Event|2
7819157|NCT00389519|27155310|P3|Treated|Adverse Event|0
7819158|NCT00389519|27155311|P2|Treated|Adverse Event|0
7819159|NCT00389519|27155312|P1|Treated|Adverse Event|1
7819160|NCT00389519|27155309|P4|Randomized|Did not receive study drug|0
7819161|NCT00389519|27155310|P3|Randomized|Did not receive study drug|0
7819162|NCT00389519|27155311|P2|Randomized|Did not receive study drug|0
7819163|NCT00389519|27155312|P1|Randomized|Did not receive study drug|2
7819164|NCT00389519|27155309|P4|Placebo Run-In|Reason not specified|0
7819165|NCT00389519|27155310|P3|Placebo Run-In|Reason not specified|0
7819166|NCT00389519|27155311|P2|Placebo Run-In|Reason not specified|0
7819167|NCT00389519|27155312|P1|Placebo Run-In|Reason not specified|40
7819168|NCT00389519|27155309|P4|Placebo Run-In|Withdrawal by Subject|0
7819169|NCT00389519|27155310|P3|Placebo Run-In|Withdrawal by Subject|0
7819170|NCT00389519|27155311|P2|Placebo Run-In|Withdrawal by Subject|0
7819171|NCT00389519|27155312|P1|Placebo Run-In|Withdrawal by Subject|19
7819172|NCT00389519|27155309|P4|Placebo Run-In|Did not meet blood pressure criteria|0
7819173|NCT00389519|27155310|P3|Placebo Run-In|Did not meet blood pressure criteria|0
7819174|NCT00389519|27155311|P2|Placebo Run-In|Did not meet blood pressure criteria|0
7819175|NCT00389519|27155312|P1|Placebo Run-In|Did not meet blood pressure criteria|119
7819176|NCT00389441|27155389|P1|Overall Study|Clinical progression|1
7819177|NCT00389441|27155389|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
7819178|NCT00389441|27155389|P1|Overall Study|Objective progression or relapse|26
7819179|NCT00389441|27155389|P1|Overall Study|Global deterioration of health status|4
7819180|NCT00389441|27155389|P1|Overall Study|Protocol Violation|1
7819181|NCT00389441|27155389|P1|Overall Study|Physician Decision|1
7819182|NCT00389441|27155389|P1|Overall Study|Withdrawal by Subject|4
7819183|NCT00389441|27155389|P1|Overall Study|Lost to Follow-up|2
7819184|NCT00389441|27155389|P1|Overall Study|Death|4
7819185|NCT00389441|27155389|P1|Overall Study|Adverse Event|7
7819186|NCT00389324|27155398|P1|Subcutaneous Phase|Lost to Follow-up|1
7819187|NCT00389324|27155398|P1|Subcutaneous Phase|Withdrawal by Subject|2
7819188|NCT00389324|27155398|P1|Subcutaneous Phase|Non-compliance with study medication|2
7819189|NCT00389324|27155398|P1|Subcutaneous Phase|Adverse Event|2
7819190|NCT00389324|27155398|P1|Run-In Phase|Withdrawal by Subject|1
7819191|NCT00389324|27155398|P1|Run-In Phase|Lost to Follow-up|1
7819192|NCT00389324|27155398|P1|Run-In Phase|Adverse Event|1
7819193|NCT00389207|27155408|P3|Overall Study|Other|9
7819194|NCT00389207|27155409|P2|Overall Study|Other|23
7819195|NCT00389207|27155410|P1|Overall Study|Other|17
7819196|NCT00389207|27155408|P3|Overall Study|Withdrawal by Subject|11
7819197|NCT00389207|27155409|P2|Overall Study|Withdrawal by Subject|7
7819198|NCT00389207|27155410|P1|Overall Study|Withdrawal by Subject|5
7819199|NCT00389207|27155408|P3|Overall Study|Lost to Follow-up|7
7819200|NCT00389207|27155409|P2|Overall Study|Lost to Follow-up|9
7819201|NCT00389207|27155410|P1|Overall Study|Lost to Follow-up|12
7819202|NCT00389207|27155408|P3|Overall Study|Protocol Violation|4
7819203|NCT00389207|27155409|P2|Overall Study|Protocol Violation|1
7819204|NCT00389207|27155410|P1|Overall Study|Protocol Violation|3
7819205|NCT00389207|27155408|P3|Overall Study|Adverse Event|10
7819206|NCT00389207|27155409|P2|Overall Study|Adverse Event|32
7819207|NCT00389207|27155410|P1|Overall Study|Adverse Event|26
7819208|NCT00389064|27155533|P2|Overall Study|Multiple Reasons|11
7819209|NCT00389064|27155534|P1|Overall Study|Multiple Reasons|9
7819210|NCT00389064|27155533|P2|Overall Study|Protocol Violation|0
7819211|NCT00389064|27155534|P1|Overall Study|Protocol Violation|2
7819212|NCT00389064|27155533|P2|Overall Study|Lost to Follow-up|2
7819213|NCT00389064|27155534|P1|Overall Study|Lost to Follow-up|1
7819214|NCT00389064|27155533|P2|Overall Study|Physician Decision|2
7819215|NCT00389064|27155534|P1|Overall Study|Physician Decision|2
7819216|NCT00389064|27155533|P2|Overall Study|Withdrawal by Subject|27
7819217|NCT00389064|27155534|P1|Overall Study|Withdrawal by Subject|17
7819218|NCT00389064|27155533|P2|Overall Study|Lack of Efficacy|14
7819219|NCT00389064|27155534|P1|Overall Study|Lack of Efficacy|3
7819220|NCT00389064|27155533|P2|Overall Study|Adverse Event|3
7819221|NCT00389064|27155534|P1|Overall Study|Adverse Event|11
7819222|NCT00388973|27155562|P2|Overall Study|Did not complete 2-week follow-up visit|17
7819223|NCT00388973|27155563|P1|Overall Study|Did not complete 2-week follow-up visit|17
7819224|NCT00388973|27155562|P2|Overall Study|Left region|1
7819225|NCT00388973|27155563|P1|Overall Study|Left region|0
7819226|NCT00388973|27155562|P2|Overall Study|Did not complete 61 days of treatment|4
7819227|NCT00388973|27155563|P1|Overall Study|Did not complete 61 days of treatment|5
7819228|NCT00388973|27155562|P2|Overall Study|Study specific Discontinuation Criteria|1
7819229|NCT00388973|27155563|P1|Overall Study|Study specific Discontinuation Criteria|0
7819230|NCT00388973|27155562|P2|Overall Study|Withdrawal by Subject|17
7819231|NCT00388973|27155563|P1|Overall Study|Withdrawal by Subject|14
7819232|NCT00388973|27155562|P2|Overall Study|Protocol Violation|0
7819233|NCT00388973|27155563|P1|Overall Study|Protocol Violation|3
7819234|NCT00388973|27155562|P2|Overall Study|Lack of Efficacy|12
7819235|NCT00388973|27155563|P1|Overall Study|Lack of Efficacy|1
7819236|NCT00388973|27155562|P2|Overall Study|Adverse Event|6
7819237|NCT00388973|27155563|P1|Overall Study|Adverse Event|16
7819238|NCT00388947|27155583|P1|Overall Study|Protocol Violation|47
7819239|NCT00388726|27155599|P2|Overall Study|Death|2
7819240|NCT00388726|27155600|P1|Overall Study|Death|3
7819241|NCT00388726|27155599|P2|Overall Study|Physician Decision|13
7819242|NCT00388726|27155600|P1|Overall Study|Physician Decision|18
7819243|NCT00388726|27155599|P2|Overall Study|Administrative|9
7819244|NCT00388726|27155600|P1|Overall Study|Administrative|6
7819245|NCT00388726|27155599|P2|Overall Study|Withdrawal by Subject|7
7819246|NCT00388726|27155600|P1|Overall Study|Withdrawal by Subject|10
7819247|NCT00388726|27155599|P2|Overall Study|Clinical Progression|36
7819248|NCT00388726|27155600|P1|Overall Study|Clinical Progression|61
7819249|NCT00388726|27155599|P2|Overall Study|Progressive Disease|153
7819250|NCT00388726|27155600|P1|Overall Study|Progressive Disease|336
7819251|NCT00388726|27155599|P2|Overall Study|Adverse Event|24
7819252|NCT00388726|27155600|P1|Overall Study|Adverse Event|50
7819253|NCT00388674|27155616|P2|End of Study|Not Reported|1
7819254|NCT00388674|27155617|P1|End of Study|Not Reported|0
7819255|NCT00388674|27155616|P2|End of Study|No Off-Treatment Status Data|30
7819256|NCT00388674|27155617|P1|End of Study|No Off-Treatment Status Data|22
7819257|NCT00388674|27155616|P2|End of Study|Participant Withdrew Consent|673
7819258|NCT00388674|27155617|P1|End of Study|Participant Withdrew Consent|437
7819259|NCT00388674|27155616|P2|End of Study|Not Defined|214
7819260|NCT00388674|27155617|P1|End of Study|Not Defined|135
7819261|NCT00388674|27155616|P2|End of Study|Non-Study Related Comorbidities|4
7819262|NCT00388674|27155617|P1|End of Study|Non-Study Related Comorbidities|3
7819263|NCT00388674|27155616|P2|End of Study|Malignancy (Non-HCC)|1
7819264|NCT00388674|27155617|P1|End of Study|Malignancy (Non-HCC)|1
7819265|NCT00388674|27155616|P2|End of Study|Lost to Follow-up|715
7819266|NCT00388674|27155617|P1|End of Study|Lost to Follow-up|587
7819267|NCT00388674|27155616|P2|End of Study|HCC|7
7819268|NCT00388674|27155617|P1|End of Study|HCC|8
7819269|NCT00388674|27155616|P2|End of Study|HBV Disease Progression (Non-HCC)|9
7819270|NCT00388674|27155617|P1|End of Study|HBV Disease Progression (Non-HCC)|3
7819271|NCT00388674|27155616|P2|End of Study|Death|262
7819272|NCT00388674|27155617|P1|End of Study|Death|239
7819273|NCT00388674|27155616|P2|End of Study|Administrative Reason By Sponsor|253
7819274|NCT00388674|27155617|P1|End of Study|Administrative Reason By Sponsor|299
7819275|NCT00388674|27155616|P2|Initial Treatment|Not Reported|12
7819276|NCT00388674|27155617|P1|Initial Treatment|Not Reported|10
7819277|NCT00388674|27155616|P2|Initial Treatment|No Off-Treatment Status Data|13
7819278|NCT00388674|27155617|P1|Initial Treatment|No Off-Treatment Status Data|11
7819279|NCT00388674|27155616|P2|Initial Treatment|Participant Request|673
7819280|NCT00388674|27155617|P1|Initial Treatment|Participant Request|501
7819281|NCT00388674|27155616|P2|Initial Treatment|Study Drug Toxicity|92
7819282|NCT00388674|27155617|P1|Initial Treatment|Study Drug Toxicity|5
7819283|NCT00388674|27155616|P2|Initial Treatment|Pregnancy|16
7819284|NCT00388674|27155617|P1|Initial Treatment|Pregnancy|26
7819285|NCT00388674|27155616|P2|Initial Treatment|Partial or inadequate Treatment|472
7819286|NCT00388674|27155617|P1|Initial Treatment|Partial or inadequate Treatment|112
7819287|NCT00388674|27155616|P2|Initial Treatment|Not Defined|172
7819288|NCT00388674|27155617|P1|Initial Treatment|Not Defined|125
7819289|NCT00388674|27155616|P2|Initial Treatment|Non-Study related Comorbidities|4
7819290|NCT00388674|27155617|P1|Initial Treatment|Non-Study related Comorbidities|3
7819291|NCT00388674|27155616|P2|Initial Treatment|Never Treated with Study Medication|7
7819292|NCT00388674|27155617|P1|Initial Treatment|Never Treated with Study Medication|1
7819293|NCT00388674|27155616|P2|Initial Treatment|Malignancy (Non-HCC)|3
7819294|NCT00388674|27155617|P1|Initial Treatment|Malignancy (Non-HCC)|7
7819295|NCT00388674|27155616|P2|Initial Treatment|Lost to Follow-up|624
7819296|NCT00388674|27155617|P1|Initial Treatment|Lost to Follow-up|526
7819297|NCT00388674|27155616|P2|Initial Treatment|HCC|20
7819298|NCT00388674|27155617|P1|Initial Treatment|HCC|12
7819299|NCT00388674|27155616|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
7819300|NCT00388674|27155617|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
7819301|NCT00388674|27155616|P2|Initial Treatment|Death|216
7819302|NCT00388674|27155617|P1|Initial Treatment|Death|215
7819303|NCT00388674|27155616|P2|Initial Treatment|Adverse Event|87
7819304|NCT00388674|27155617|P1|Initial Treatment|Adverse Event|22
7819305|NCT00388674|27155616|P2|Initial Treatment|Administrative Reason by Sponsor|158
7819306|NCT00388674|27155617|P1|Initial Treatment|Administrative Reason by Sponsor|241
7819307|NCT00388583|27155635|P2|Overall Study|Did not receive vaccine|1
7819308|NCT00388583|27155636|P1|Overall Study|Did not receive vaccine|0
7819309|NCT00388583|27155635|P2|Overall Study|Serious Adverse Event|0
7819310|NCT00388583|27155636|P1|Overall Study|Serious Adverse Event|2
7819311|NCT00388583|27155635|P2|Overall Study|Withdrawal by Subject|3
7819312|NCT00388583|27155636|P1|Overall Study|Withdrawal by Subject|3
7819313|NCT00388583|27155635|P2|Overall Study|Protocol Violation|0
7819314|NCT00388583|27155636|P1|Overall Study|Protocol Violation|1
7819315|NCT00388505|27155650|P2|Overall Study|Unable to classify|3
7819316|NCT00388505|27155651|P1|Overall Study|Unable to classify|4
7819317|NCT00388505|27155650|P2|Overall Study|Protocol Violation|5
7819318|NCT00388505|27155651|P1|Overall Study|Protocol Violation|6
7819319|NCT00388505|27155650|P2|Overall Study|Administrative Reason|0
7819320|NCT00388505|27155651|P1|Overall Study|Administrative Reason|1
7819321|NCT00388505|27155650|P2|Overall Study|Inappropriate Enrollment|1
7819322|NCT00388505|27155651|P1|Overall Study|Inappropriate Enrollment|0
7819323|NCT00388505|27155650|P2|Overall Study|Lost to Follow-up|3
7819324|NCT00388505|27155651|P1|Overall Study|Lost to Follow-up|5
7819325|NCT00388505|27155650|P2|Overall Study|Withdrawal by Subject|9
7819326|NCT00388505|27155651|P1|Overall Study|Withdrawal by Subject|24
7819327|NCT00388505|27155650|P2|Overall Study|Adverse Event or Death|17
7819328|NCT00388505|27155651|P1|Overall Study|Adverse Event or Death|43
7819329|NCT00388362|27155706|P1|Remained on Study Median of 514 Days|Death|2
7819330|NCT00388362|27155706|P1|Enrolled|Withdrawal by Subject|1
7819331|NCT00388362|27155706|P1|Enrolled|Loss insurance|1
7819332|NCT00388362|27155706|P1|Enrolled|Death|1
7819333|NCT00388362|27155706|P1|Enrolled|Adverse Event|9
7819334|NCT00388362|27155706|P1|Enrolled|Ineligible|1
7819335|NCT00388349|27155711|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
7819336|NCT00388349|27155712|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
7819337|NCT00388297|27155725|P4|Overall Study|Lost to Follow-up|8
7819338|NCT00388297|27155726|P3|Overall Study|Lost to Follow-up|11
7819339|NCT00388297|27155727|P2|Overall Study|Lost to Follow-up|12
7819340|NCT00388297|27155728|P1|Overall Study|Lost to Follow-up|16
7819341|NCT00388154|27155838|P1|Overall Study|Withdrawal by Subject|1
7819342|NCT00388037|27155843|P1|Overall Study|Protocol Violation|1
7819343|NCT00387894|27155851|P1|Overall Study|Withdrawal by Subject|1
7819344|NCT00387881|27155858|P2|Overall Study|Not otherwise specified|7
7819345|NCT00387881|27155859|P1|Overall Study|Not otherwise specified|11
7819346|NCT00387881|27155858|P2|Overall Study|No opportunity to treat headache|34
7819347|NCT00387881|27155859|P1|Overall Study|No opportunity to treat headache|32
7819348|NCT00387881|27155858|P2|Overall Study|Not eligible|7
7819349|NCT00387881|27155859|P1|Overall Study|Not eligible|6
7819350|NCT00387881|27155858|P2|Overall Study|Sponsor terminated Study|1
7819351|NCT00387881|27155859|P1|Overall Study|Sponsor terminated Study|0
7819352|NCT00387881|27155858|P2|Overall Study|Withdrawal by Subject|18
7819353|NCT00387881|27155859|P1|Overall Study|Withdrawal by Subject|15
7819354|NCT00387881|27155858|P2|Overall Study|Protocol Violation|12
7819355|NCT00387881|27155859|P1|Overall Study|Protocol Violation|2
7819356|NCT00387881|27155858|P2|Overall Study|Lost to Follow-up|23
7819357|NCT00387881|27155859|P1|Overall Study|Lost to Follow-up|23
7819358|NCT00387790|27155892|P1|Overall Study|Ineligible for study|2
7819359|NCT00387790|27155892|P1|Overall Study|Withdrawal by Subject|3
7819360|NCT00387790|27155892|P1|Overall Study|Physician Decision|2
7819361|NCT00387790|27155892|P1|Overall Study|Lack of Efficacy|2
7819362|NCT00387790|27155892|P1|Overall Study|Adverse Event|5
7819363|NCT00387764|27155898|P1|Overall Study|Death|7
7819364|NCT00387764|27155898|P1|Overall Study|Other|2
7819365|NCT00387764|27155898|P1|Overall Study|Physician Decision|1
7819366|NCT00387764|27155898|P1|Overall Study|Sponsor Terminated Study|1
7819367|NCT00387764|27155898|P1|Overall Study|Withdrawal by Subject|8
7819368|NCT00387764|27155898|P1|Overall Study|Adverse Event|12
7819369|NCT00387725|27155926|P4|Overall Study|Parent/legal guardian request|1
7819370|NCT00387725|27155927|P3|Overall Study|Parent/legal guardian request|1
7819371|NCT00387725|27155928|P2|Overall Study|Parent/legal guardian request|0
7819372|NCT00387725|27155929|P1|Overall Study|Parent/legal guardian request|0
7819373|NCT00387725|27155926|P4|Overall Study|Withdrawal by Subject|0
7819374|NCT00387725|27155927|P3|Overall Study|Withdrawal by Subject|1
7819375|NCT00387725|27155928|P2|Overall Study|Withdrawal by Subject|0
7819376|NCT00387725|27155929|P1|Overall Study|Withdrawal by Subject|1
7819377|NCT00387725|27155926|P4|Overall Study|Protocol Violation|0
7819378|NCT00387725|27155927|P3|Overall Study|Protocol Violation|0
7819379|NCT00387725|27155928|P2|Overall Study|Protocol Violation|1
7819380|NCT00387725|27155929|P1|Overall Study|Protocol Violation|0
7819381|NCT00387725|27155926|P4|Overall Study|Adverse Event|1
7819382|NCT00387725|27155927|P3|Overall Study|Adverse Event|0
7819383|NCT00387725|27155928|P2|Overall Study|Adverse Event|0
7819384|NCT00387725|27155929|P1|Overall Study|Adverse Event|0
7819385|NCT00387712|27155949|P2|Overall Study|Withdrawal by Subject|12
7819386|NCT00387712|27155950|P1|Overall Study|Withdrawal by Subject|6
7819387|NCT00387712|27155949|P2|Overall Study|Lost to Follow-up|20
7819388|NCT00387712|27155950|P1|Overall Study|Lost to Follow-up|17
7819389|NCT00387712|27155949|P2|Overall Study|Physician Decision|4
7819390|NCT00387712|27155950|P1|Overall Study|Physician Decision|6
7819391|NCT00387647|27155981|P1|Overall Study|Death|18
7819392|NCT00387465|27156024|P3|Overall Study|Withdrawal by Subject|0
7819393|NCT00387465|27156025|P2|Overall Study|Withdrawal by Subject|1
7819394|NCT00387465|27156026|P1|Overall Study|Withdrawal by Subject|0
7819395|NCT00387426|27156043|P1|Overall Study|Disease Progression|3
7819396|NCT00387426|27156043|P1|Overall Study|Toxicities|4
7819397|NCT00387426|27156043|P1|Overall Study|Lack of Response|7
7819398|NCT00387348|27156050|P3|Overall Study|Adverse Event|1
7819399|NCT00387348|27156051|P2|Overall Study|Adverse Event|0
7819400|NCT00387348|27156052|P1|Overall Study|Adverse Event|1
7819401|NCT00387348|27156050|P3|Overall Study|Withdrawal by Subject|2
7819402|NCT00387348|27156051|P2|Overall Study|Withdrawal by Subject|2
7819403|NCT00387348|27156052|P1|Overall Study|Withdrawal by Subject|0
7819404|NCT00387348|27156050|P3|Overall Study|Physician Decision|1
7819405|NCT00387348|27156051|P2|Overall Study|Physician Decision|0
7819406|NCT00387348|27156052|P1|Overall Study|Physician Decision|1
7819407|NCT00387348|27156050|P3|Overall Study|Death|0
7819408|NCT00387348|27156051|P2|Overall Study|Death|1
7819409|NCT00387348|27156052|P1|Overall Study|Death|1
7819410|NCT00387153|27156085|P1|Overall Study|Lack of Response|4
7819411|NCT00387153|27156085|P1|Overall Study|Disease Progression|3
7819412|NCT00387153|27156085|P1|Overall Study|Adverse Event|1
7819413|NCT00387127|27156091|P2|Overall Study|Sponsor Unblinded|0
7819414|NCT00387127|27156092|P1|Overall Study|Sponsor Unblinded|1
7819415|NCT00387127|27156091|P2|Overall Study|Serious Adverse Event|1
7819416|NCT00387127|27156092|P1|Overall Study|Serious Adverse Event|1
7819417|NCT00387127|27156091|P2|Overall Study|Required by Protocol Amendment #4|10
7819418|NCT00387127|27156092|P1|Overall Study|Required by Protocol Amendment #4|12
7819419|NCT00387127|27156091|P2|Overall Study|Withdrawal by Subject|2
7819420|NCT00387127|27156092|P1|Overall Study|Withdrawal by Subject|3
7819421|NCT00387127|27156091|P2|Overall Study|Physician Decision|1
7819422|NCT00387127|27156092|P1|Overall Study|Physician Decision|0
7819423|NCT00387127|27156091|P2|Overall Study|Death|16
7819424|NCT00387127|27156092|P1|Overall Study|Death|16
7819425|NCT00387127|27156091|P2|Overall Study|Lost to Follow-up|4
7819426|NCT00387127|27156092|P1|Overall Study|Lost to Follow-up|0
7819427|NCT00387088|27156134|P2|Overall Study|Other|52
7819428|NCT00387088|27156135|P1|Overall Study|Other|58
7819429|NCT00387088|27156134|P2|Overall Study|Lost to Follow-up|28
7819430|NCT00387088|27156135|P1|Overall Study|Lost to Follow-up|22
7819431|NCT00387088|27156134|P2|Overall Study|Lack of Efficacy|67
7819432|NCT00387088|27156135|P1|Overall Study|Lack of Efficacy|28
7819433|NCT00387088|27156134|P2|Overall Study|Withdrawal by Subject|35
7819434|NCT00387088|27156135|P1|Overall Study|Withdrawal by Subject|20
7819435|NCT00387088|27156134|P2|Overall Study|Protocol Violation|35
7819436|NCT00387088|27156135|P1|Overall Study|Protocol Violation|47
7819437|NCT00387088|27156134|P2|Overall Study|Adverse Event|156
7819438|NCT00387088|27156135|P1|Overall Study|Adverse Event|143
7819439|NCT00387010|27156192|P1|Treatment Period|Participant reported study drug stolen|1
7819440|NCT00387010|27156192|P1|Treatment Period|Noncompliance with study procedures|3
7819441|NCT00387010|27156192|P1|Treatment Period|Noncompliance with study medication|2
7819442|NCT00387010|27156192|P1|Treatment Period|Withdrawal by Subject|1
7819443|NCT00387010|27156192|P1|Treatment Period|Adverse Event|4
7819444|NCT00387010|27156192|P1|Dose Titration Period|Noncompliance with study procedures|7
7819445|NCT00387010|27156192|P1|Dose Titration Period|Noncompliance with study medication|8
7819446|NCT00387010|27156192|P1|Dose Titration Period|Lost to Follow-up|2
7819447|NCT00387010|27156192|P1|Dose Titration Period|Protocol Violation|1
7819448|NCT00387010|27156192|P1|Dose Titration Period|Withdrawal by Subject|3
7819449|NCT00387010|27156192|P1|Dose Titration Period|Lack of Efficacy|5
7819450|NCT00387010|27156192|P1|Dose Titration Period|Adverse Event|12
7819451|NCT00386776|27156219|P1|Overall Study|Withdrawal by Subject|8
7819452|NCT00386607|27156233|P2|Extension|Unsatisfactory therapeutic effect|1
7819453|NCT00386607|27156234|P1|Extension|Unsatisfactory therapeutic effect|0
7819454|NCT00386607|27156233|P2|Extension|Patient withdrew consent|5
7819455|NCT00386607|27156234|P1|Extension|Patient withdrew consent|0
7819456|NCT00386607|27156233|P2|Extension|Lost to Follow-up|3
7819457|NCT00386607|27156234|P1|Extension|Lost to Follow-up|0
7819458|NCT00386607|27156233|P2|Extension|Administrative problems|1
7819459|NCT00386607|27156234|P1|Extension|Administrative problems|0
7819460|NCT00386607|27156233|P2|Extension|Abnormal laboratory value(s)|1
7819461|NCT00386607|27156234|P1|Extension|Abnormal laboratory value(s)|0
7819462|NCT00386607|27156233|P2|Extension|Adverse Event|6
7819463|NCT00386607|27156234|P1|Extension|Adverse Event|0
7819464|NCT00386607|27156233|P2|Core|Protocol Deviation|0
7819465|NCT00386607|27156234|P1|Core|Protocol Deviation|6
7819466|NCT00386607|27156233|P2|Core|Administrative problems|0
7819467|NCT00386607|27156234|P1|Core|Administrative problems|1
7819468|NCT00386607|27156233|P2|Core|Lost to Follow-up|0
7819469|NCT00386607|27156234|P1|Core|Lost to Follow-up|23
7819470|NCT00386607|27156233|P2|Core|Patient withdrew consent|0
7819471|NCT00386607|27156234|P1|Core|Patient withdrew consent|15
7819472|NCT00386607|27156233|P2|Core|Condition no longer requires study drug|0
7819473|NCT00386607|27156234|P1|Core|Condition no longer requires study drug|4
7819474|NCT00386607|27156233|P2|Core|Unsatisfactory therapeutic effect|0
7819475|NCT00386607|27156234|P1|Core|Unsatisfactory therapeutic effect|23
7819476|NCT00386607|27156233|P2|Core|Abnormal laboratory value(s)|0
7819477|NCT00386607|27156234|P1|Core|Abnormal laboratory value(s)|3
7819478|NCT00386607|27156233|P2|Core|Adverse Event|0
7819479|NCT00386607|27156234|P1|Core|Adverse Event|40
7819480|NCT00386425|27156262|P3|Overall Study|Withdrawal by Subject|0
7819481|NCT00386425|27156263|P2|Overall Study|Withdrawal by Subject|1
7819482|NCT00386425|27156264|P1|Overall Study|Withdrawal by Subject|0
7819483|NCT00386425|27156262|P3|Overall Study|Physician Decision|0
7819484|NCT00386425|27156263|P2|Overall Study|Physician Decision|0
7819485|NCT00386425|27156264|P1|Overall Study|Physician Decision|3
7819486|NCT00386360|27156290|P2|Overall Study|Did not take any study medication|2
7819487|NCT00386360|27156291|P1|Overall Study|Did not take any study medication|0
7819488|NCT00386360|27156290|P2|Overall Study|Withdrawal by Subject|6
7819489|NCT00386360|27156291|P1|Overall Study|Withdrawal by Subject|3
7819490|NCT00386360|27156290|P2|Overall Study|Protocol Violation|3
7819491|NCT00386360|27156291|P1|Overall Study|Protocol Violation|0
7819492|NCT00386360|27156290|P2|Overall Study|Lost to Follow-up|2
7819493|NCT00386360|27156291|P1|Overall Study|Lost to Follow-up|0
7819494|NCT00386360|27156290|P2|Overall Study|Physician Decision|2
7819495|NCT00386360|27156291|P1|Overall Study|Physician Decision|2
7819496|NCT00386360|27156290|P2|Overall Study|Adverse Event|2
7819497|NCT00386360|27156291|P1|Overall Study|Adverse Event|4
7819498|NCT00386334|27156325|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
7819499|NCT00386334|27156326|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
7819500|NCT00386334|27156325|P2|Double Blind Period|Other|3
7819501|NCT00386334|27156326|P1|Double Blind Period|Other|3
7819502|NCT00386334|27156325|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
7819503|NCT00386334|27156326|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
7819504|NCT00386334|27156325|P2|Double Blind Period|Lack of Efficacy|11
7819505|NCT00386334|27156326|P1|Double Blind Period|Lack of Efficacy|20
7819506|NCT00386334|27156325|P2|Double Blind Period|Withdrawal by Subject|13
7819507|NCT00386334|27156326|P1|Double Blind Period|Withdrawal by Subject|9
7819508|NCT00386334|27156325|P2|Double Blind Period|Protocol Violation|1
7819509|NCT00386334|27156326|P1|Double Blind Period|Protocol Violation|1
7819510|NCT00386334|27156325|P2|Double Blind Period|Adverse Event|14
7819511|NCT00386334|27156326|P1|Double Blind Period|Adverse Event|9
7819512|NCT00386308|27156470|P2|Overall Study|Other Event|1
7819513|NCT00386308|27156471|P1|Overall Study|Other Event|8
7819514|NCT00386308|27156470|P2|Overall Study|Withdrawal by Subject|2
7819515|NCT00386308|27156471|P1|Overall Study|Withdrawal by Subject|6
7819516|NCT00386308|27156470|P2|Overall Study|Lost to Follow-up|6
7819517|NCT00386308|27156471|P1|Overall Study|Lost to Follow-up|10
7819518|NCT00386308|27156470|P2|Overall Study|Lack of Efficacy|2
7819519|NCT00386308|27156471|P1|Overall Study|Lack of Efficacy|0
7819520|NCT00386308|27156470|P2|Overall Study|Protocol Violation|5
7819521|NCT00386308|27156471|P1|Overall Study|Protocol Violation|2
7819522|NCT00386308|27156470|P2|Overall Study|Adverse Event|3
7819523|NCT00386308|27156471|P1|Overall Study|Adverse Event|3
7819524|NCT00386152|27156528|P3|Overall Study|Withdrawal by Subject|10
7819525|NCT00386152|27156529|P2|Overall Study|Withdrawal by Subject|6
7819526|NCT00386152|27156530|P1|Overall Study|Withdrawal by Subject|3
7819527|NCT00386152|27156528|P3|Overall Study|Protocol Violation|2
7819528|NCT00386152|27156529|P2|Overall Study|Protocol Violation|5
7819529|NCT00386152|27156530|P1|Overall Study|Protocol Violation|3
7819530|NCT00386152|27156528|P3|Overall Study|Completed chemotherapy|1
7819531|NCT00386152|27156529|P2|Overall Study|Completed chemotherapy|5
7819532|NCT00386152|27156530|P1|Overall Study|Completed chemotherapy|4
7819533|NCT00386152|27156528|P3|Overall Study|Lost to Follow-up|0
7819534|NCT00386152|27156529|P2|Overall Study|Lost to Follow-up|0
7819535|NCT00386152|27156530|P1|Overall Study|Lost to Follow-up|1
7819536|NCT00386152|27156528|P3|Overall Study|Physician Decision|4
7819537|NCT00386152|27156529|P2|Overall Study|Physician Decision|10
7819538|NCT00386152|27156530|P1|Overall Study|Physician Decision|13
7819539|NCT00386152|27156528|P3|Overall Study|Disease progression|5
7819540|NCT00386152|27156529|P2|Overall Study|Disease progression|4
7819541|NCT00386152|27156530|P1|Overall Study|Disease progression|7
7819542|NCT00386152|27156528|P3|Overall Study|Death|1
7819543|NCT00386152|27156529|P2|Overall Study|Death|0
7819544|NCT00386152|27156530|P1|Overall Study|Death|3
7819545|NCT00386152|27156528|P3|Overall Study|Chang from original chemo stratification|6
7819546|NCT00386152|27156529|P2|Overall Study|Chang from original chemo stratification|5
7819547|NCT00386152|27156530|P1|Overall Study|Chang from original chemo stratification|4
7819548|NCT00386152|27156528|P3|Overall Study|Adverse Event|4
7819549|NCT00386152|27156529|P2|Overall Study|Adverse Event|5
7819550|NCT00386152|27156530|P1|Overall Study|Adverse Event|6
7819551|NCT00386100|27156549|P2|Overall Study|Participant randomized in error|0
7819552|NCT00386100|27156550|P1|Overall Study|Participant randomized in error|1
7819553|NCT00386100|27156549|P2|Overall Study|Hb1Ac >8%|1
7819554|NCT00386100|27156550|P1|Overall Study|Hb1Ac >8%|0
7819555|NCT00386100|27156549|P2|Overall Study|Out of country for 5 months|0
7819556|NCT00386100|27156550|P1|Overall Study|Out of country for 5 months|1
7819557|NCT00386100|27156549|P2|Overall Study|Positive pregnancy test|3
7819558|NCT00386100|27156550|P1|Overall Study|Positive pregnancy test|1
7819559|NCT00386100|27156549|P2|Overall Study|Osteoporosis|1
7819560|NCT00386100|27156550|P1|Overall Study|Osteoporosis|0
7819561|NCT00386100|27156549|P2|Overall Study|7.6% bone loss|0
7819562|NCT00386100|27156550|P1|Overall Study|7.6% bone loss|1
7819563|NCT00386100|27156549|P2|Overall Study|DBP 93 mmHg at randomization|0
7819564|NCT00386100|27156550|P1|Overall Study|DBP 93 mmHg at randomization|1
7819565|NCT00386100|27156549|P2|Overall Study|Bone loss by DXA bone scan|0
7819566|NCT00386100|27156550|P1|Overall Study|Bone loss by DXA bone scan|1
7819567|NCT00386100|27156549|P2|Overall Study|Bad metabolic control & patient security|0
7819568|NCT00386100|27156550|P1|Overall Study|Bad metabolic control & patient security|1
7819569|NCT00386100|27156549|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
7819570|NCT00386100|27156550|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
7819571|NCT00386100|27156549|P2|Overall Study|Participant's PCP wanted to stop drug|0
7819572|NCT00386100|27156550|P1|Overall Study|Participant's PCP wanted to stop drug|1
7819573|NCT00386100|27156549|P2|Overall Study|Didn't meet entry criteria|1
7819574|NCT00386100|27156550|P1|Overall Study|Didn't meet entry criteria|1
7819575|NCT00386100|27156549|P2|Overall Study|Excessive bone loss vs. baseline value|1
7819576|NCT00386100|27156550|P1|Overall Study|Excessive bone loss vs. baseline value|0
7819577|NCT00386100|27156549|P2|Overall Study|Participant moving out of state|0
7819578|NCT00386100|27156550|P1|Overall Study|Participant moving out of state|2
7819579|NCT00386100|27156549|P2|Overall Study|Participant's concern due to CPK levels|0
7819580|NCT00386100|27156550|P1|Overall Study|Participant's concern due to CPK levels|1
7819581|NCT00386100|27156549|P2|Overall Study|Laboratory findings|0
7819582|NCT00386100|27156550|P1|Overall Study|Laboratory findings|1
7819583|NCT00386100|27156549|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
7819584|NCT00386100|27156550|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
7819585|NCT00386100|27156549|P2|Overall Study|Consecutive elevated Hba1C|0
7819586|NCT00386100|27156550|P1|Overall Study|Consecutive elevated Hba1C|1
7819587|NCT00386100|27156549|P2|Overall Study|BMD <2.5|0
7819588|NCT00386100|27156550|P1|Overall Study|BMD <2.5|1
7819589|NCT00386100|27156549|P2|Overall Study|Bone mass density (BMD) loss >6%|4
7819590|NCT00386100|27156550|P1|Overall Study|Bone mass density (BMD) loss >6%|4
7819591|NCT00386100|27156549|P2|Overall Study|Withdrawal by Subject|31
7819592|NCT00386100|27156550|P1|Overall Study|Withdrawal by Subject|32
7819593|NCT00386100|27156549|P2|Overall Study|Protocol Violation|3
7819594|NCT00386100|27156550|P1|Overall Study|Protocol Violation|5
7819595|NCT00386100|27156549|P2|Overall Study|Non-compliance|19
7819596|NCT00386100|27156550|P1|Overall Study|Non-compliance|18
7819597|NCT00386100|27156549|P2|Overall Study|Lost to Follow-up|29
7819598|NCT00386100|27156550|P1|Overall Study|Lost to Follow-up|29
7819599|NCT00386100|27156549|P2|Overall Study|Insufficient therapeutic effect|6
7819600|NCT00386100|27156550|P1|Overall Study|Insufficient therapeutic effect|30
7819601|NCT00386100|27156549|P2|Overall Study|Death|1
7819602|NCT00386100|27156550|P1|Overall Study|Death|0
7819603|NCT00386100|27156549|P2|Overall Study|Adverse Event|25
7819604|NCT00386100|27156550|P1|Overall Study|Adverse Event|15
7819605|NCT00386100|27156549|P2|Overall Study|Did not receive study medication|4
7819606|NCT00386100|27156550|P1|Overall Study|Did not receive study medication|6
7819607|NCT00386022|27156614|P2|Plus Estrogen|Adverse Event|1
7819608|NCT00386022|27156615|P1|Plus Estrogen|Adverse Event|0
7819609|NCT00386022|27156614|P2|Plus Estrogen|Lost to Follow-up|0
7819610|NCT00386022|27156615|P1|Plus Estrogen|Lost to Follow-up|2
7819611|NCT00386009|27156625|P2|Overall Study|Withdrawal by Subject|4
7819612|NCT00386009|27156626|P1|Overall Study|Withdrawal by Subject|5
7819613|NCT00386009|27156625|P2|Overall Study|Sponsor Decision|1
7819614|NCT00386009|27156626|P1|Overall Study|Sponsor Decision|1
7819615|NCT00386009|27156625|P2|Overall Study|Protocol Violation|0
7819616|NCT00386009|27156626|P1|Overall Study|Protocol Violation|1
7819617|NCT00386009|27156625|P2|Overall Study|Lost to Follow-up|1
7819618|NCT00386009|27156626|P1|Overall Study|Lost to Follow-up|1
7819619|NCT00386009|27156625|P2|Overall Study|Entry Criteria Not Met|2
7819620|NCT00386009|27156626|P1|Overall Study|Entry Criteria Not Met|0
7819621|NCT00386009|27156625|P2|Overall Study|Death|0
7819622|NCT00386009|27156626|P1|Overall Study|Death|1
7819623|NCT00386009|27156625|P2|Overall Study|Adverse Event|2
7819624|NCT00386009|27156626|P1|Overall Study|Adverse Event|0
7819625|NCT00385944|27156673|P3|2nd Maintenance Dose Period|Invalid PD Data|0
7819626|NCT00385944|27156674|P2|2nd Maintenance Dose Period|Invalid PD Data|3
7819627|NCT00385944|27156675|P1|2nd Maintenance Dose Period|Invalid PD Data|2
7819628|NCT00385944|27156673|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
7819629|NCT00385944|27156674|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
7819630|NCT00385944|27156675|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
7819631|NCT00385944|27156673|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
7819632|NCT00385944|27156674|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
7819633|NCT00385944|27156675|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
7819634|NCT00385944|27156673|P3|1st Maintenance Dose Period|Physician Decision|0
7819635|NCT00385944|27156674|P2|1st Maintenance Dose Period|Physician Decision|0
7819636|NCT00385944|27156675|P1|1st Maintenance Dose Period|Physician Decision|1
7819637|NCT00385918|27156718|P3|Intervention Phase After Randomization|Lost to Follow-up|0
7819638|NCT00385918|27156719|P2|Intervention Phase After Randomization|Lost to Follow-up|0
7819639|NCT00385918|27156720|P1|Intervention Phase After Randomization|Lost to Follow-up|1
7819640|NCT00385918|27156718|P3|Intervention Phase After Randomization|Physician Decision|0
7819641|NCT00385918|27156719|P2|Intervention Phase After Randomization|Physician Decision|0
7819642|NCT00385918|27156720|P1|Intervention Phase After Randomization|Physician Decision|1
7819643|NCT00385918|27156718|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
7819644|NCT00385918|27156719|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
7819645|NCT00385918|27156720|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
7819646|NCT00385918|27156718|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
7819647|NCT00385918|27156719|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
7819648|NCT00385918|27156720|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
7819649|NCT00385918|27156718|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
7819650|NCT00385918|27156719|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
7819651|NCT00385918|27156720|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
7819652|NCT00385918|27156718|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
7819653|NCT00385918|27156719|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
7819654|NCT00385918|27156720|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
7819655|NCT00385840|27156744|P2|Overall Study|Lost to Follow-up|13
7819656|NCT00385840|27156745|P1|Overall Study|Lost to Follow-up|3
7819657|NCT00385840|27156744|P2|Overall Study|Adverse Event|1
7819658|NCT00385840|27156745|P1|Overall Study|Adverse Event|1
7819659|NCT00385827|27156768|P3|Part 2|Other|21
7819660|NCT00385827|27156769|P2|Part 2|Other|11
7819661|NCT00385827|27156770|P1|Part 2|Other|0
7819662|NCT00385827|27156768|P3|Part 2|Randomized but not treated|2
7819663|NCT00385827|27156769|P2|Part 2|Randomized but not treated|2
7819664|NCT00385827|27156770|P1|Part 2|Randomized but not treated|0
7819665|NCT00385827|27156768|P3|Part 2|Lack of Efficacy|13
7819666|NCT00385827|27156769|P2|Part 2|Lack of Efficacy|14
7819667|NCT00385827|27156770|P1|Part 2|Lack of Efficacy|0
7819668|NCT00385827|27156768|P3|Part 2|Death|2
7819669|NCT00385827|27156769|P2|Part 2|Death|0
7819670|NCT00385827|27156770|P1|Part 2|Death|0
7819671|NCT00385827|27156768|P3|Part 2|Adverse Event|10
7819672|NCT00385827|27156769|P2|Part 2|Adverse Event|6
7819673|NCT00385827|27156770|P1|Part 2|Adverse Event|0
7819674|NCT00385827|27156768|P3|Part 1|Other|0
7819675|NCT00385827|27156769|P2|Part 1|Other|0
7819676|NCT00385827|27156770|P1|Part 1|Other|1
7819677|NCT00385827|27156768|P3|Part 1|Lack of Efficacy|0
7819678|NCT00385827|27156769|P2|Part 1|Lack of Efficacy|0
7819679|NCT00385827|27156770|P1|Part 1|Lack of Efficacy|5
7819680|NCT00385827|27156768|P3|Part 1|Death|0
7819681|NCT00385827|27156769|P2|Part 1|Death|0
7819682|NCT00385827|27156770|P1|Part 1|Death|2
7819683|NCT00385827|27156768|P3|Part 1|Adverse Event|0
7819684|NCT00385827|27156769|P2|Part 1|Adverse Event|0
7819685|NCT00385827|27156770|P1|Part 1|Adverse Event|1
7819686|NCT00385762|27156814|P1|Overall Study|Lost to Follow-up|1
7819687|NCT00385762|27156814|P1|Overall Study|Adverse Event|1
7819688|NCT00385736|27156824|P3|Safety Analysis Set|Other|4
7819689|NCT00385736|27156825|P2|Safety Analysis Set|Other|4
7819690|NCT00385736|27156826|P1|Safety Analysis Set|Other|1
7819691|NCT00385736|27156824|P3|Safety Analysis Set|Protocol Violation|6
7819692|NCT00385736|27156825|P2|Safety Analysis Set|Protocol Violation|1
7819693|NCT00385736|27156826|P1|Safety Analysis Set|Protocol Violation|2
7819694|NCT00385736|27156824|P3|Safety Analysis Set|Lack of Efficacy|31
7819695|NCT00385736|27156825|P2|Safety Analysis Set|Lack of Efficacy|16
7819696|NCT00385736|27156826|P1|Safety Analysis Set|Lack of Efficacy|38
7819697|NCT00385736|27156824|P3|Safety Analysis Set|Lost to Follow-up|2
7819698|NCT00385736|27156825|P2|Safety Analysis Set|Lost to Follow-up|2
7819699|NCT00385736|27156826|P1|Safety Analysis Set|Lost to Follow-up|0
7819700|NCT00385736|27156824|P3|Safety Analysis Set|Withdrawal by Subject|14
7819701|NCT00385736|27156825|P2|Safety Analysis Set|Withdrawal by Subject|6
7819702|NCT00385736|27156826|P1|Safety Analysis Set|Withdrawal by Subject|6
7819703|NCT00385736|27156824|P3|Safety Analysis Set|Adverse Event|23
7819704|NCT00385736|27156825|P2|Safety Analysis Set|Adverse Event|15
7819705|NCT00385736|27156826|P1|Safety Analysis Set|Adverse Event|23
7819706|NCT00385736|27156824|P3|Efficacy Analysis Set - Maintenance|Other|4
7819707|NCT00385736|27156825|P2|Efficacy Analysis Set - Maintenance|Other|4
7819708|NCT00385736|27156826|P1|Efficacy Analysis Set - Maintenance|Other|0
7819709|NCT00385736|27156824|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
7819710|NCT00385736|27156825|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
7819711|NCT00385736|27156826|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
7819712|NCT00385736|27156824|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
7819713|NCT00385736|27156825|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
7819714|NCT00385736|27156826|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
7819715|NCT00385736|27156824|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
7819716|NCT00385736|27156825|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
7819717|NCT00385736|27156826|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
7819718|NCT00385736|27156824|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
7819719|NCT00385736|27156825|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
7819720|NCT00385736|27156826|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
7819721|NCT00385736|27156824|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
7819722|NCT00385736|27156825|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
7819723|NCT00385736|27156826|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
7819724|NCT00385736|27156824|P3|Efficacy Analysis Set - Induction|Other|1
7819725|NCT00385736|27156825|P2|Efficacy Analysis Set - Induction|Other|0
7819726|NCT00385736|27156826|P1|Efficacy Analysis Set - Induction|Other|0
7819727|NCT00385736|27156824|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
7819728|NCT00385736|27156825|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
7819729|NCT00385736|27156826|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
7819730|NCT00385736|27156824|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
7819731|NCT00385736|27156825|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
7819732|NCT00385736|27156826|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
7819733|NCT00385736|27156824|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
7819734|NCT00385736|27156825|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
7819735|NCT00385736|27156826|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
7819736|NCT00385736|27156824|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
7819737|NCT00385736|27156825|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
7819738|NCT00385736|27156826|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
7819739|NCT00385736|27156824|P3|Efficacy Analysis Set - Induction|Adverse Event|4
7819740|NCT00385736|27156825|P2|Efficacy Analysis Set - Induction|Adverse Event|6
7819741|NCT00385736|27156826|P1|Efficacy Analysis Set - Induction|Adverse Event|5
7819742|NCT00385723|27156871|P3|Overall Study|Withdrawal by Subject|2
7819743|NCT00385723|27156872|P2|Overall Study|Withdrawal by Subject|0
7819744|NCT00385723|27156873|P1|Overall Study|Withdrawal by Subject|1
7819745|NCT00385723|27156871|P3|Overall Study|Lost to Follow-up|0
7819746|NCT00385723|27156872|P2|Overall Study|Lost to Follow-up|1
7819747|NCT00385723|27156873|P1|Overall Study|Lost to Follow-up|1
7819748|NCT00385684|27156887|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
7819749|NCT00385684|27156888|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
7819750|NCT00385684|27156887|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
7819751|NCT00385684|27156888|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
7819752|NCT00385684|27156887|P2|FIRST INTERVENTION OF PHASE A|Death|0
7819753|NCT00385684|27156888|P1|FIRST INTERVENTION OF PHASE A|Death|1
7819754|NCT00385671|27156897|P3|Overall Study|Withdrawal by Subject|4
7819755|NCT00385671|27156898|P2|Overall Study|Withdrawal by Subject|4
7819756|NCT00385671|27156899|P1|Overall Study|Withdrawal by Subject|4
7819757|NCT00385671|27156897|P3|Overall Study|Sponsor Decision|1
7819758|NCT00385671|27156898|P2|Overall Study|Sponsor Decision|2
7819759|NCT00385671|27156899|P1|Overall Study|Sponsor Decision|2
7819760|NCT00385671|27156897|P3|Overall Study|Protocol Violation|1
7819761|NCT00385671|27156898|P2|Overall Study|Protocol Violation|2
7819762|NCT00385671|27156899|P1|Overall Study|Protocol Violation|5
7819763|NCT00385671|27156897|P3|Overall Study|Physician Decision|2
7819764|NCT00385671|27156898|P2|Overall Study|Physician Decision|1
7819765|NCT00385671|27156899|P1|Overall Study|Physician Decision|2
7819766|NCT00385671|27156897|P3|Overall Study|Lost to Follow-up|5
7819767|NCT00385671|27156898|P2|Overall Study|Lost to Follow-up|6
7819768|NCT00385671|27156899|P1|Overall Study|Lost to Follow-up|6
7819769|NCT00385671|27156897|P3|Overall Study|Lack of Efficacy|5
7819770|NCT00385671|27156898|P2|Overall Study|Lack of Efficacy|9
7819771|NCT00385671|27156899|P1|Overall Study|Lack of Efficacy|5
7819772|NCT00385671|27156897|P3|Overall Study|Adverse Event|18
7819773|NCT00385671|27156898|P2|Overall Study|Adverse Event|27
7819774|NCT00385671|27156899|P1|Overall Study|Adverse Event|14
7819775|NCT00385593|27157055|P2|Overall Study|Incorrect randomization|1
7819776|NCT00385593|27157056|P1|Overall Study|Incorrect randomization|0
7819777|NCT00385593|27157055|P2|Overall Study|Incorrect inclusion|0
7819778|NCT00385593|27157056|P1|Overall Study|Incorrect inclusion|2
7819779|NCT00385593|27157055|P2|Overall Study|Several reasons|15
7819780|NCT00385593|27157056|P1|Overall Study|Several reasons|17
7819781|NCT00385593|27157055|P2|Overall Study|Protocol Violation|4
7819782|NCT00385593|27157056|P1|Overall Study|Protocol Violation|7
7819783|NCT00385593|27157055|P2|Overall Study|Lost to Follow-up|8
7819784|NCT00385593|27157056|P1|Overall Study|Lost to Follow-up|12
7819785|NCT00385593|27157055|P2|Overall Study|Withdrawal by Subject|7
7819786|NCT00385593|27157056|P1|Overall Study|Withdrawal by Subject|17
7819787|NCT00385593|27157055|P2|Overall Study|Adverse Event|2
7819788|NCT00385593|27157056|P1|Overall Study|Adverse Event|3
7819789|NCT00385541|27157166|P2|Overall Study|severe pain, clinician requested unblind|1
7819790|NCT00385541|27157167|P1|Overall Study|severe pain, clinician requested unblind|0
7819791|NCT00385255|27157201|P2|Overall Study|Lost to Follow-up|58
7819792|NCT00385255|27157202|P1|Overall Study|Lost to Follow-up|20
7819793|NCT00385255|27157201|P2|Overall Study|Migrated/moved from study area|1
7819794|NCT00385255|27157202|P1|Overall Study|Migrated/moved from study area|0
7819795|NCT00385255|27157201|P2|Overall Study|Withdrawal by Subject|8
7819796|NCT00385255|27157202|P1|Overall Study|Withdrawal by Subject|0
7819797|NCT00385255|27157201|P2|Overall Study|Protocol Violation|4
7819798|NCT00385255|27157202|P1|Overall Study|Protocol Violation|0
7819799|NCT00385255|27157201|P2|Overall Study|Serious Adverse Event|2
7819800|NCT00385255|27157202|P1|Overall Study|Serious Adverse Event|1
7819801|NCT00385203|27157281|P2|Overall Study|Incorrect enrollment|0
7819802|NCT00385203|27157282|P1|Overall Study|Incorrect enrollment|2
7819803|NCT00385203|27157281|P2|Overall Study|Condition under investigation worsened|3
7819804|NCT00385203|27157282|P1|Overall Study|Condition under investigation worsened|18
7819805|NCT00385203|27157281|P2|Overall Study|Death|0
7819806|NCT00385203|27157282|P1|Overall Study|Death|1
7819807|NCT00385203|27157281|P2|Overall Study|Adverse Event|4
7819808|NCT00385203|27157282|P1|Overall Study|Adverse Event|5
7819809|NCT00384956|27157370|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
7819810|NCT00384930|27157387|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
7819811|NCT00384930|27157388|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
7819812|NCT00384930|27157389|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
7819813|NCT00384930|27157390|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
7819814|NCT00384930|27157391|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
7819815|NCT00384930|27157387|P5|Overall Study|Withdrawal by Subject|16
7819816|NCT00384930|27157388|P4|Overall Study|Withdrawal by Subject|6
7819817|NCT00384930|27157389|P3|Overall Study|Withdrawal by Subject|7
7819818|NCT00384930|27157390|P2|Overall Study|Withdrawal by Subject|7
7819819|NCT00384930|27157391|P1|Overall Study|Withdrawal by Subject|9
7819820|NCT00384930|27157387|P5|Overall Study|Sponsor Decision|0
7819821|NCT00384930|27157388|P4|Overall Study|Sponsor Decision|5
7819822|NCT00384930|27157389|P3|Overall Study|Sponsor Decision|0
7819823|NCT00384930|27157390|P2|Overall Study|Sponsor Decision|4
7819824|NCT00384930|27157391|P1|Overall Study|Sponsor Decision|3
7819825|NCT00384930|27157387|P5|Overall Study|Protocol Violation|4
7819826|NCT00384930|27157388|P4|Overall Study|Protocol Violation|6
7819827|NCT00384930|27157389|P3|Overall Study|Protocol Violation|1
7819828|NCT00384930|27157390|P2|Overall Study|Protocol Violation|0
7819829|NCT00384930|27157391|P1|Overall Study|Protocol Violation|1
7819830|NCT00384930|27157387|P5|Overall Study|Physician Decision|1
7819831|NCT00384930|27157388|P4|Overall Study|Physician Decision|0
7819832|NCT00384930|27157389|P3|Overall Study|Physician Decision|1
7819833|NCT00384930|27157390|P2|Overall Study|Physician Decision|1
7819834|NCT00384930|27157391|P1|Overall Study|Physician Decision|0
7819835|NCT00384930|27157387|P5|Overall Study|Lost to Follow-up|6
7819836|NCT00384930|27157388|P4|Overall Study|Lost to Follow-up|4
7819837|NCT00384930|27157389|P3|Overall Study|Lost to Follow-up|0
7819838|NCT00384930|27157390|P2|Overall Study|Lost to Follow-up|3
7819839|NCT00384930|27157391|P1|Overall Study|Lost to Follow-up|5
7819840|NCT00384930|27157387|P5|Overall Study|Lack of Efficacy|2
7819841|NCT00384930|27157388|P4|Overall Study|Lack of Efficacy|1
7819842|NCT00384930|27157389|P3|Overall Study|Lack of Efficacy|2
7819843|NCT00384930|27157390|P2|Overall Study|Lack of Efficacy|1
7819844|NCT00384930|27157391|P1|Overall Study|Lack of Efficacy|1
7819845|NCT00384930|27157387|P5|Overall Study|Entry Criteria Not Met|4
7819846|NCT00384930|27157388|P4|Overall Study|Entry Criteria Not Met|8
7819847|NCT00384930|27157389|P3|Overall Study|Entry Criteria Not Met|7
7819848|NCT00384930|27157390|P2|Overall Study|Entry Criteria Not Met|6
7819849|NCT00384930|27157391|P1|Overall Study|Entry Criteria Not Met|2
7819850|NCT00384930|27157387|P5|Overall Study|Adverse Event|14
7819851|NCT00384930|27157388|P4|Overall Study|Adverse Event|11
7819852|NCT00384930|27157389|P3|Overall Study|Adverse Event|12
7819853|NCT00384930|27157390|P2|Overall Study|Adverse Event|4
7819854|NCT00384930|27157391|P1|Overall Study|Adverse Event|5
7819855|NCT00384839|27157470|P1|Overall Study|Ineligible|2
7819856|NCT00384839|27157470|P1|Overall Study|Patient Request|1
7819857|NCT00384839|27157470|P1|Overall Study|Investigator Request|1
7819858|NCT00384839|27157470|P1|Overall Study|Adverse Event|4
7819859|NCT00384397|27157603|P3|Overall Study|Withdrawal by Subject|15
7819860|NCT00384397|27157604|P2|Overall Study|Withdrawal by Subject|17
7819861|NCT00384397|27157605|P1|Overall Study|Withdrawal by Subject|14
7819862|NCT00384397|27157603|P3|Overall Study|Lost to Follow-up|3
7819863|NCT00384397|27157604|P2|Overall Study|Lost to Follow-up|13
7819864|NCT00384397|27157605|P1|Overall Study|Lost to Follow-up|11
7819865|NCT00384397|27157603|P3|Overall Study|Protocol Violation|13
7819866|NCT00384397|27157604|P2|Overall Study|Protocol Violation|15
7819867|NCT00384397|27157605|P1|Overall Study|Protocol Violation|7
7819868|NCT00384397|27157603|P3|Overall Study|Adverse Event|2
7819869|NCT00384397|27157604|P2|Overall Study|Adverse Event|1
7819870|NCT00384397|27157605|P1|Overall Study|Adverse Event|0
7819871|NCT00384332|27157624|P2|Overall Study|Lost to Follow-up|0
7819872|NCT00384332|27157625|P1|Overall Study|Lost to Follow-up|4
7819873|NCT00384293|27157635|P3|Post-randomization Period|Patient Randomized in Error|1
7819874|NCT00384293|27157636|P2|Post-randomization Period|Patient Randomized in Error|0
7819875|NCT00384293|27157637|P1|Post-randomization Period|Patient Randomized in Error|0
7819876|NCT00384293|27157635|P3|Post-randomization Period|Trial Termination|204
7819877|NCT00384293|27157636|P2|Post-randomization Period|Trial Termination|180
7819878|NCT00384293|27157637|P1|Post-randomization Period|Trial Termination|0
7819879|NCT00384293|27157635|P3|Post-randomization Period|Withdrawal by Subject|6
7819880|NCT00384293|27157636|P2|Post-randomization Period|Withdrawal by Subject|8
7819881|NCT00384293|27157637|P1|Post-randomization Period|Withdrawal by Subject|0
7819882|NCT00384293|27157635|P3|Post-randomization Period|Protocol Violation|0
7819883|NCT00384293|27157636|P2|Post-randomization Period|Protocol Violation|1
7819884|NCT00384293|27157637|P1|Post-randomization Period|Protocol Violation|0
7819885|NCT00384293|27157635|P3|Post-randomization Period|Lost to Follow-up|1
7819886|NCT00384293|27157636|P2|Post-randomization Period|Lost to Follow-up|2
7819887|NCT00384293|27157637|P1|Post-randomization Period|Lost to Follow-up|0
7819888|NCT00384293|27157635|P3|Post-randomization Period|Adverse Event|7
7819889|NCT00384293|27157636|P2|Post-randomization Period|Adverse Event|23
7819890|NCT00384293|27157637|P1|Post-randomization Period|Adverse Event|0
7819891|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
7819892|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
7819893|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
7819894|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7819895|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7819896|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
7819897|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
7819898|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
7819899|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
7819900|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
7819901|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
7819902|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
7819903|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
7819904|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
7819905|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
7819906|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
7819907|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
7819908|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
7819909|NCT00384293|27157635|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
7819910|NCT00384293|27157636|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
7819911|NCT00384293|27157637|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
7819912|NCT00384189|27157661|P4|Overall Study|Reason Not Specified|40
7819913|NCT00384189|27157662|P3|Overall Study|Reason Not Specified|58
7819914|NCT00384189|27157663|P2|Overall Study|Reason Not Specified|57
7819915|NCT00384189|27157664|P1|Overall Study|Reason Not Specified|50
7819916|NCT00384176|27157725|P3|Overall Study|Liver metastases, colon resec. planned|0
7819917|NCT00384176|27157726|P2|Overall Study|Liver metastases, colon resec. planned|0
7819918|NCT00384176|27157727|P1|Overall Study|Liver metastases, colon resec. planned|1
7819919|NCT00384176|27157725|P3|Overall Study|Physician Decision|0
7819920|NCT00384176|27157726|P2|Overall Study|Physician Decision|2
7819921|NCT00384176|27157727|P1|Overall Study|Physician Decision|0
7819922|NCT00384176|27157725|P3|Overall Study|Did not receive study treatment|1
7819923|NCT00384176|27157726|P2|Overall Study|Did not receive study treatment|1
7819924|NCT00384176|27157727|P1|Overall Study|Did not receive study treatment|0
7819925|NCT00384176|27157725|P3|Overall Study|Toxicity of treatment|0
7819926|NCT00384176|27157726|P2|Overall Study|Toxicity of treatment|0
7819927|NCT00384176|27157727|P1|Overall Study|Toxicity of treatment|1
7819928|NCT00384176|27157725|P3|Overall Study|Longer QTC as Visit 1|0
7819929|NCT00384176|27157726|P2|Overall Study|Longer QTC as Visit 1|0
7819930|NCT00384176|27157727|P1|Overall Study|Longer QTC as Visit 1|1
7819931|NCT00384176|27157725|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
7819932|NCT00384176|27157726|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
7819933|NCT00384176|27157727|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
7819934|NCT00384176|27157725|P3|Overall Study|Lost to Follow-up|4
7819935|NCT00384176|27157726|P2|Overall Study|Lost to Follow-up|18
7819936|NCT00384176|27157727|P1|Overall Study|Lost to Follow-up|16
7819937|NCT00384176|27157725|P3|Overall Study|Withdrawal by Subject|22
7819938|NCT00384176|27157726|P2|Overall Study|Withdrawal by Subject|48
7819939|NCT00384176|27157727|P1|Overall Study|Withdrawal by Subject|52
7819940|NCT00384176|27157725|P3|Overall Study|Death|105
7819941|NCT00384176|27157726|P2|Overall Study|Death|247
7819942|NCT00384176|27157727|P1|Overall Study|Death|239
7819943|NCT00384085|27157753|P3|Overall Study|Patient required surgery|0
7819944|NCT00384085|27157754|P2|Overall Study|Patient required surgery|1
7819945|NCT00384085|27157755|P1|Overall Study|Patient required surgery|0
7819946|NCT00384085|27157753|P3|Overall Study|Patient moved|1
7819947|NCT00384085|27157754|P2|Overall Study|Patient moved|0
7819948|NCT00384085|27157755|P1|Overall Study|Patient moved|1
7819949|NCT00384085|27157753|P3|Overall Study|Sponsor decision|1
7819950|NCT00384085|27157754|P2|Overall Study|Sponsor decision|2
7819951|NCT00384085|27157755|P1|Overall Study|Sponsor decision|1
7819952|NCT00384085|27157753|P3|Overall Study|Loss of site personnel|1
7819953|NCT00384085|27157754|P2|Overall Study|Loss of site personnel|0
7819954|NCT00384085|27157755|P1|Overall Study|Loss of site personnel|1
7819955|NCT00384085|27157753|P3|Overall Study|Physician Decision|0
7819956|NCT00384085|27157754|P2|Overall Study|Physician Decision|0
7819957|NCT00384085|27157755|P1|Overall Study|Physician Decision|1
7819958|NCT00384085|27157753|P3|Overall Study|Patient non-compliant|5
7819959|NCT00384085|27157754|P2|Overall Study|Patient non-compliant|4
7819960|NCT00384085|27157755|P1|Overall Study|Patient non-compliant|4
7819961|NCT00384085|27157753|P3|Overall Study|Withdrawal by Subject|29
7819962|NCT00384085|27157754|P2|Overall Study|Withdrawal by Subject|19
7819963|NCT00384085|27157755|P1|Overall Study|Withdrawal by Subject|14
7819964|NCT00384085|27157753|P3|Overall Study|Progressive Disease|0
7819965|NCT00384085|27157754|P2|Overall Study|Progressive Disease|1
7819966|NCT00384085|27157755|P1|Overall Study|Progressive Disease|0
7819967|NCT00384085|27157753|P3|Overall Study|Lost to Follow-up|10
7819968|NCT00384085|27157754|P2|Overall Study|Lost to Follow-up|9
7819969|NCT00384085|27157755|P1|Overall Study|Lost to Follow-up|9
7819970|NCT00384085|27157753|P3|Overall Study|Protocol Violation|2
7819971|NCT00384085|27157754|P2|Overall Study|Protocol Violation|2
7819972|NCT00384085|27157755|P1|Overall Study|Protocol Violation|2
7819973|NCT00384085|27157753|P3|Overall Study|No longer Requires Study Treatment|1
7819974|NCT00384085|27157754|P2|Overall Study|No longer Requires Study Treatment|0
7819975|NCT00384085|27157755|P1|Overall Study|No longer Requires Study Treatment|1
7819976|NCT00384085|27157753|P3|Overall Study|Lack of Efficacy|2
7819977|NCT00384085|27157754|P2|Overall Study|Lack of Efficacy|3
7819978|NCT00384085|27157755|P1|Overall Study|Lack of Efficacy|0
7819979|NCT00384085|27157753|P3|Overall Study|Adverse Event|4
7819980|NCT00384085|27157754|P2|Overall Study|Adverse Event|5
7819981|NCT00384085|27157755|P1|Overall Study|Adverse Event|5
7819982|NCT00384059|27157781|P2|Toddler Dose|Failed to return|1
7819983|NCT00384059|27157782|P1|Toddler Dose|Failed to return|0
7819984|NCT00384059|27157781|P2|Toddler Dose|Lost to Follow-up|1
7819985|NCT00384059|27157782|P1|Toddler Dose|Lost to Follow-up|1
7819986|NCT00384059|27157781|P2|After Infant Series|Lost to Follow-up|1
7819987|NCT00384059|27157782|P1|After Infant Series|Lost to Follow-up|0
7819988|NCT00384059|27157781|P2|After Infant Series|Physician Decision|1
7819989|NCT00384059|27157782|P1|After Infant Series|Physician Decision|0
7819990|NCT00384059|27157781|P2|After Infant Series|Adverse Event|1
7819991|NCT00384059|27157782|P1|After Infant Series|Adverse Event|0
7819992|NCT00384059|27157781|P2|After Infant Series|Failed to Return|2
7819993|NCT00384059|27157782|P1|After Infant Series|Failed to Return|0
7819994|NCT00384059|27157781|P2|After Infant Series|Withdrawal by Subject|2
7819995|NCT00384059|27157782|P1|After Infant Series|Withdrawal by Subject|2
7819996|NCT00384059|27157781|P2|After Infant Series|Protocol Violation|3
7819997|NCT00384059|27157782|P1|After Infant Series|Protocol Violation|2
7819998|NCT00384059|27157781|P2|Infant Series|Lost to Follow-up|1
7819999|NCT00384059|27157782|P1|Infant Series|Lost to Follow-up|0
7820000|NCT00384059|27157781|P2|Infant Series|Protocol Violation|2
7820001|NCT00384059|27157782|P1|Infant Series|Protocol Violation|1
7820002|NCT00384059|27157781|P2|Infant Series|Adverse Event|2
7820003|NCT00384059|27157782|P1|Infant Series|Adverse Event|1
7820004|NCT00384059|27157781|P2|Infant Series|Withdrawal by Subject|2
7820005|NCT00384059|27157782|P1|Infant Series|Withdrawal by Subject|2
7820006|NCT00384059|27157781|P2|Infant Series|Not consented|6
7820007|NCT00384059|27157782|P1|Infant Series|Not consented|2
7820008|NCT00384033|27157832|P4|Overall Study|Randomized but not treated|2
7820009|NCT00384033|27157833|P3|Overall Study|Randomized but not treated|10
7820010|NCT00384033|27157834|P2|Overall Study|Randomized but not treated|7
7820011|NCT00384033|27157835|P1|Overall Study|Randomized but not treated|3
7820012|NCT00384033|27157832|P4|Overall Study|Lack of Efficacy|1
7820013|NCT00384033|27157833|P3|Overall Study|Lack of Efficacy|3
7820014|NCT00384033|27157834|P2|Overall Study|Lack of Efficacy|3
7820015|NCT00384033|27157835|P1|Overall Study|Lack of Efficacy|7
7820016|NCT00384033|27157832|P4|Overall Study|Withdrawal by Subject|2
7820017|NCT00384033|27157833|P3|Overall Study|Withdrawal by Subject|5
7820018|NCT00384033|27157834|P2|Overall Study|Withdrawal by Subject|2
7820019|NCT00384033|27157835|P1|Overall Study|Withdrawal by Subject|6
7820020|NCT00384033|27157832|P4|Overall Study|Protocol Violation|6
7820021|NCT00384033|27157833|P3|Overall Study|Protocol Violation|5
7820022|NCT00384033|27157834|P2|Overall Study|Protocol Violation|0
7820023|NCT00384033|27157835|P1|Overall Study|Protocol Violation|5
7820024|NCT00384033|27157832|P4|Overall Study|Other|0
7820025|NCT00384033|27157833|P3|Overall Study|Other|0
7820026|NCT00384033|27157834|P2|Overall Study|Other|0
7820027|NCT00384033|27157835|P1|Overall Study|Other|2
7820028|NCT00384033|27157832|P4|Overall Study|Lost to Follow-up|7
7820029|NCT00384033|27157833|P3|Overall Study|Lost to Follow-up|7
7820030|NCT00384033|27157834|P2|Overall Study|Lost to Follow-up|12
7820031|NCT00384033|27157835|P1|Overall Study|Lost to Follow-up|6
7820032|NCT00384033|27157832|P4|Overall Study|Physician Decision|0
7820033|NCT00384033|27157833|P3|Overall Study|Physician Decision|0
7820034|NCT00384033|27157834|P2|Overall Study|Physician Decision|0
7820035|NCT00384033|27157835|P1|Overall Study|Physician Decision|1
7820036|NCT00384033|27157832|P4|Overall Study|Failed to return|2
7820037|NCT00384033|27157833|P3|Overall Study|Failed to return|2
7820038|NCT00384033|27157834|P2|Overall Study|Failed to return|3
7820039|NCT00384033|27157835|P1|Overall Study|Failed to return|1
7820040|NCT00384033|27157832|P4|Overall Study|Adverse Event|20
7820041|NCT00384033|27157833|P3|Overall Study|Adverse Event|11
7820042|NCT00384033|27157834|P2|Overall Study|Adverse Event|8
7820043|NCT00384033|27157835|P1|Overall Study|Adverse Event|10
7820044|NCT00383786|27157888|P2|Overall Study|Physician Decision|1
7820045|NCT00383786|27157889|P1|Overall Study|Physician Decision|0
7820046|NCT00383786|27157888|P2|Overall Study|Withdrawal by Subject|5
7820047|NCT00383786|27157889|P1|Overall Study|Withdrawal by Subject|2
7820048|NCT00383786|27157888|P2|Overall Study|Protocol Violation|6
7820049|NCT00383786|27157889|P1|Overall Study|Protocol Violation|2
7820050|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Administrative|0
7820051|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Administrative|1
7820052|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Administrative|3
7820053|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Administrative|2
7820054|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Administrative|1
7820055|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7820056|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7820057|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7820058|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7820059|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7820060|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
7820061|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
7820062|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7820063|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7820064|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
7820065|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
7820066|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
7820067|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
7820068|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
7820069|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
7820070|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
7820071|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
7820072|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7820073|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
7820074|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7820075|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
7820076|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
7820077|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
7820078|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
7820079|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
7820080|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
7820081|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
7820082|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
7820083|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
7820084|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
7820085|NCT00383721|27157939|P5|26-Week Treatment Safety Extension|Adverse Event|0
7820086|NCT00383721|27157940|P4|26-Week Treatment Safety Extension|Adverse Event|1
7820087|NCT00383721|27157941|P3|26-Week Treatment Safety Extension|Adverse Event|10
7820088|NCT00383721|27157942|P2|26-Week Treatment Safety Extension|Adverse Event|7
7820089|NCT00383721|27157943|P1|26-Week Treatment Safety Extension|Adverse Event|6
7820090|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Ongoing|0
7820091|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Ongoing|0
7820092|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Ongoing|0
7820093|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Ongoing|0
7820094|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Ongoing|1
7820095|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Administrative|3
7820096|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Administrative|3
7820097|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Administrative|3
7820098|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Administrative|3
7820099|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Administrative|1
7820100|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
7820101|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
7820102|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
7820103|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
7820104|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
7820105|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
7820106|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
7820107|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
7820108|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7820109|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
7820110|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
7820111|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
7820112|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
7820113|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7820114|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
7820115|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
7820116|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
7820117|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
7820118|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
7820119|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
7820120|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
7820121|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
7820122|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7820123|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
7820124|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
7820125|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
7820126|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
7820127|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7820128|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7820129|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
7820130|NCT00383721|27157939|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
7820131|NCT00383721|27157940|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
7820132|NCT00383721|27157941|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
7820133|NCT00383721|27157942|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
7820134|NCT00383721|27157943|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
7820135|NCT00383708|27157980|P1|Co-administration Period|Adverse Event|5
7820136|NCT00383708|27157980|P1|Run-in Period|Claustrophobia|1
7820137|NCT00383708|27157980|P1|Run-in Period|Adverse Event|2
7820138|NCT00383708|27157980|P1|Run-in Period|Protocol Violation|4
7820139|NCT00383708|27157980|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
7820140|NCT00383708|27157980|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
7820141|NCT00383552|27158055|P4|Overall Study|Administrative|1
7820142|NCT00383552|27158056|P3|Overall Study|Administrative|1
7820143|NCT00383552|27158057|P2|Overall Study|Administrative|0
7820144|NCT00383552|27158058|P1|Overall Study|Administrative|1
7820145|NCT00383552|27158055|P4|Overall Study|Did not meet protocol eligibility|3
7820146|NCT00383552|27158056|P3|Overall Study|Did not meet protocol eligibility|2
7820147|NCT00383552|27158057|P2|Overall Study|Did not meet protocol eligibility|6
7820148|NCT00383552|27158058|P1|Overall Study|Did not meet protocol eligibility|8
7820149|NCT00383552|27158055|P4|Overall Study|Noncompliance with the protocol|10
7820150|NCT00383552|27158056|P3|Overall Study|Noncompliance with the protocol|8
7820151|NCT00383552|27158057|P2|Overall Study|Noncompliance with the protocol|6
7820152|NCT00383552|27158058|P1|Overall Study|Noncompliance with the protocol|11
7820153|NCT00383552|27158055|P4|Overall Study|Did not wish to continue (related)|3
7820154|NCT00383552|27158056|P3|Overall Study|Did not wish to continue (related)|2
7820155|NCT00383552|27158057|P2|Overall Study|Did not wish to continue (related)|0
7820156|NCT00383552|27158058|P1|Overall Study|Did not wish to continue (related)|1
7820157|NCT00383552|27158055|P4|Overall Study|Did not wish to continue (unrelated)|6
7820158|NCT00383552|27158056|P3|Overall Study|Did not wish to continue (unrelated)|5
7820159|NCT00383552|27158057|P2|Overall Study|Did not wish to continue (unrelated)|9
7820160|NCT00383552|27158058|P1|Overall Study|Did not wish to continue (unrelated)|4
7820161|NCT00383552|27158055|P4|Overall Study|Lost to Follow-up|1
7820162|NCT00383552|27158056|P3|Overall Study|Lost to Follow-up|5
7820163|NCT00383552|27158057|P2|Overall Study|Lost to Follow-up|1
7820164|NCT00383552|27158058|P1|Overall Study|Lost to Follow-up|0
7820165|NCT00383552|27158055|P4|Overall Study|Lack of Efficacy|42
7820166|NCT00383552|27158056|P3|Overall Study|Lack of Efficacy|29
7820167|NCT00383552|27158057|P2|Overall Study|Lack of Efficacy|13
7820168|NCT00383552|27158058|P1|Overall Study|Lack of Efficacy|4
7820169|NCT00383552|27158055|P4|Overall Study|Adverse Event|6
7820170|NCT00383552|27158056|P3|Overall Study|Adverse Event|9
7820171|NCT00383552|27158057|P2|Overall Study|Adverse Event|6
7820172|NCT00383552|27158058|P1|Overall Study|Adverse Event|7
7820173|NCT00383500|27158100|P3|Overall Study|Lost to Follow-up|2
7820174|NCT00383500|27158101|P2|Overall Study|Lost to Follow-up|0
7820175|NCT00383500|27158102|P1|Overall Study|Lost to Follow-up|0
7820176|NCT00383500|27158100|P3|Overall Study|Withdrawal by Subject|0
7820177|NCT00383500|27158101|P2|Overall Study|Withdrawal by Subject|3
7820178|NCT00383500|27158102|P1|Overall Study|Withdrawal by Subject|8
7820179|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Administrative|0
7820180|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Administrative|1
7820181|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Administrative|0
7820182|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Administrative|1
7820183|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Administrative|1
7820184|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7820185|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7820186|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7820187|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7820188|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7820189|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
7820190|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7820191|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7820192|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7820193|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
7820194|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
7820195|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
7820196|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
7820197|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
7820198|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
7820199|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
7820200|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7820201|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7820202|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7820203|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7820204|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
7820205|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
7820206|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
7820207|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
7820208|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
7820209|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
7820210|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
7820211|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
7820212|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
7820213|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
7820214|NCT00383435|27158126|P5|26-Week Treatment Safety Extension|Adverse Event|1
7820215|NCT00383435|27158127|P4|26-Week Treatment Safety Extension|Adverse Event|5
7820216|NCT00383435|27158128|P3|26-Week Treatment Safety Extension|Adverse Event|5
7820217|NCT00383435|27158129|P2|26-Week Treatment Safety Extension|Adverse Event|2
7820218|NCT00383435|27158130|P1|26-Week Treatment Safety Extension|Adverse Event|4
7820219|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Administrative|1
7820220|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Administrative|1
7820221|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Administrative|1
7820222|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Administrative|3
7820223|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Administrative|5
7820224|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
7820225|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
7820226|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
7820304|NCT00383240|27158232|P4|Overall Study|Adverse Event|7
7820227|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
7820228|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
7820229|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
7820230|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7820231|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
7820232|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7820233|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
7820234|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
7820235|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7820236|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
7820237|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7820238|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
7820239|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
7820240|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
7820241|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
7820242|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
7820243|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
7820244|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7820245|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7820246|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
7820247|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
7820248|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
7820249|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
7820250|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
7820251|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7820252|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
7820253|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7820254|NCT00383435|27158126|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
7820255|NCT00383435|27158127|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
7820256|NCT00383435|27158128|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
7820257|NCT00383435|27158129|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
7820258|NCT00383435|27158130|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
7820259|NCT00383331|27158169|P2|Overall Study|Protocol Violation|1
7820260|NCT00383331|27158170|P1|Overall Study|Protocol Violation|0
7820261|NCT00383292|27158189|P3|Overall Study|Other|0
7820262|NCT00383292|27158190|P2|Overall Study|Other|0
7820263|NCT00383292|27158191|P1|Overall Study|Other|1
7820264|NCT00383292|27158189|P3|Overall Study|Withdrawal by Subject|2
7820265|NCT00383292|27158190|P2|Overall Study|Withdrawal by Subject|2
7820266|NCT00383292|27158191|P1|Overall Study|Withdrawal by Subject|3
7820267|NCT00383292|27158189|P3|Overall Study|Physician Decision|1
7820268|NCT00383292|27158190|P2|Overall Study|Physician Decision|0
7820269|NCT00383292|27158191|P1|Overall Study|Physician Decision|4
7820270|NCT00383292|27158189|P3|Overall Study|Death|3
7820271|NCT00383292|27158190|P2|Overall Study|Death|3
7820272|NCT00383292|27158191|P1|Overall Study|Death|3
7820273|NCT00383292|27158189|P3|Overall Study|Adverse Event|2
7820274|NCT00383292|27158190|P2|Overall Study|Adverse Event|1
7820275|NCT00383292|27158191|P1|Overall Study|Adverse Event|4
7820276|NCT00383240|27158232|P4|Overall Study|Administrative|0
7820277|NCT00383240|27158233|P3|Overall Study|Administrative|0
7820278|NCT00383240|27158234|P2|Overall Study|Administrative|1
7820279|NCT00383240|27158235|P1|Overall Study|Administrative|1
7820280|NCT00383240|27158232|P4|Overall Study|Did not meet protocol eligibility|3
7820281|NCT00383240|27158233|P3|Overall Study|Did not meet protocol eligibility|9
7820282|NCT00383240|27158234|P2|Overall Study|Did not meet protocol eligibility|4
7820283|NCT00383240|27158235|P1|Overall Study|Did not meet protocol eligibility|9
7820284|NCT00383240|27158232|P4|Overall Study|Protocol Violation|6
7820285|NCT00383240|27158233|P3|Overall Study|Protocol Violation|9
7820286|NCT00383240|27158234|P2|Overall Study|Protocol Violation|5
7820287|NCT00383240|27158235|P1|Overall Study|Protocol Violation|4
7820288|NCT00383240|27158232|P4|Overall Study|Withdrawal by subjects, reasons related|5
7820289|NCT00383240|27158233|P3|Overall Study|Withdrawal by subjects, reasons related|3
7820290|NCT00383240|27158234|P2|Overall Study|Withdrawal by subjects, reasons related|1
7820291|NCT00383240|27158235|P1|Overall Study|Withdrawal by subjects, reasons related|0
7820292|NCT00383240|27158232|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
7820293|NCT00383240|27158233|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
7820294|NCT00383240|27158234|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
7820295|NCT00383240|27158235|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
7820296|NCT00383240|27158232|P4|Overall Study|Lost to Follow-up|2
7820297|NCT00383240|27158233|P3|Overall Study|Lost to Follow-up|0
7820298|NCT00383240|27158234|P2|Overall Study|Lost to Follow-up|0
7820299|NCT00383240|27158235|P1|Overall Study|Lost to Follow-up|3
7820300|NCT00383240|27158232|P4|Overall Study|Treatment Failure|46
7820301|NCT00383240|27158233|P3|Overall Study|Treatment Failure|47
7820302|NCT00383240|27158234|P2|Overall Study|Treatment Failure|13
7820303|NCT00383240|27158235|P1|Overall Study|Treatment Failure|8
7820305|NCT00383240|27158233|P3|Overall Study|Adverse Event|9
7820306|NCT00383240|27158234|P2|Overall Study|Adverse Event|6
7820307|NCT00383240|27158235|P1|Overall Study|Adverse Event|4
7820308|NCT00383188|27158271|P5|Overall Study|Lost to Follow-up|1
7820309|NCT00383188|27158272|P4|Overall Study|Lost to Follow-up|0
7820310|NCT00383188|27158273|P3|Overall Study|Lost to Follow-up|0
7820311|NCT00383188|27158274|P2|Overall Study|Lost to Follow-up|0
7820312|NCT00383188|27158275|P1|Overall Study|Lost to Follow-up|0
7820313|NCT00383188|27158271|P5|Overall Study|No longer willing to participate|2
7820314|NCT00383188|27158272|P4|Overall Study|No longer willing to participate|0
7820315|NCT00383188|27158273|P3|Overall Study|No longer willing to participate|1
7820316|NCT00383188|27158274|P2|Overall Study|No longer willing to participate|0
7820317|NCT00383188|27158275|P1|Overall Study|No longer willing to participate|1
7820318|NCT00383188|27158271|P5|Overall Study|Other|6
7820319|NCT00383188|27158272|P4|Overall Study|Other|2
7820320|NCT00383188|27158273|P3|Overall Study|Other|0
7820321|NCT00383188|27158274|P2|Overall Study|Other|1
7820322|NCT00383188|27158275|P1|Overall Study|Other|3
7820323|NCT00383188|27158271|P5|Overall Study|Lack of Efficacy|6
7820324|NCT00383188|27158272|P4|Overall Study|Lack of Efficacy|2
7820325|NCT00383188|27158273|P3|Overall Study|Lack of Efficacy|3
7820326|NCT00383188|27158274|P2|Overall Study|Lack of Efficacy|3
7820327|NCT00383188|27158275|P1|Overall Study|Lack of Efficacy|9
7820328|NCT00383188|27158271|P5|Overall Study|Adverse Event|8
7820329|NCT00383188|27158272|P4|Overall Study|Adverse Event|8
7820330|NCT00383188|27158273|P3|Overall Study|Adverse Event|9
7820331|NCT00383188|27158274|P2|Overall Study|Adverse Event|7
7820332|NCT00383188|27158275|P1|Overall Study|Adverse Event|4
7820333|NCT00383162|27158396|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
7820334|NCT00383162|27158397|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
7820335|NCT00383162|27158396|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
7820336|NCT00383162|27158397|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
7820337|NCT00383162|27158396|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
7820338|NCT00383162|27158397|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
7820339|NCT00383162|27158396|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
7820340|NCT00383162|27158397|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
7820341|NCT00383162|27158396|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
7820342|NCT00383162|27158397|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
7820343|NCT00383162|27158396|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
7820344|NCT00383162|27158397|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
7820345|NCT00383162|27158396|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
7820346|NCT00383162|27158397|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
7820347|NCT00383162|27158396|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
7820348|NCT00383162|27158397|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
7820349|NCT00383162|27158396|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
7820350|NCT00383162|27158397|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
7820351|NCT00383149|27158439|P1|Overall Study|Participant Withdrew Consent|1
7820352|NCT00383149|27158439|P1|Overall Study|Request to Discontinue Treatment|4
7820353|NCT00383149|27158439|P1|Overall Study|Study Drug Toxicity|4
7820354|NCT00383149|27158439|P1|Overall Study|Other|1
7820355|NCT00383149|27158439|P1|Overall Study|Lost to Follow-up|1
7820356|NCT00383149|27158439|P1|Overall Study|Disease Progression|38
7820357|NCT00383149|27158439|P1|Overall Study|Death|2
7820358|NCT00383149|27158439|P1|Overall Study|Adverse Event not Related to Study Drug|3
7820359|NCT00383123|27158458|P2|Overall Study|Other reason|6
7820360|NCT00383123|27158459|P1|Overall Study|Other reason|10
7820361|NCT00383123|27158458|P2|Overall Study|Withdrawal by Subject|18
7820362|NCT00383123|27158459|P1|Overall Study|Withdrawal by Subject|27
7820363|NCT00383123|27158458|P2|Overall Study|Protocol Violation|1
7820364|NCT00383123|27158459|P1|Overall Study|Protocol Violation|5
7820365|NCT00383123|27158458|P2|Overall Study|Lost to Follow-up|61
7820366|NCT00383123|27158459|P1|Overall Study|Lost to Follow-up|68
7820367|NCT00383123|27158458|P2|Overall Study|Adverse Event|0
7820368|NCT00383123|27158459|P1|Overall Study|Adverse Event|1
7820369|NCT00383084|27158500|P2|Overall Study|Withdrawal by Subject|10
7820370|NCT00383084|27158501|P1|Overall Study|Withdrawal by Subject|12
7820371|NCT00383019|27158532|P2|Overall Study|Withdrawal by Subject|1
7820372|NCT00383019|27158533|P1|Overall Study|Withdrawal by Subject|0
7820373|NCT00383019|27158532|P2|Overall Study|Adverse Event|1
7820374|NCT00383019|27158533|P1|Overall Study|Adverse Event|5
7820375|NCT00382993|27158555|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
7820376|NCT00382993|27158556|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
7820377|NCT00382993|27158555|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
7820378|NCT00382993|27158556|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
7820379|NCT00382993|27158555|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
7820380|NCT00382993|27158556|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
7820381|NCT00382993|27158555|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
7820382|NCT00382993|27158556|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
7820383|NCT00382993|27158555|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
7820384|NCT00382993|27158556|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
7820385|NCT00382993|27158555|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
7820386|NCT00382993|27158556|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
7820387|NCT00382993|27158555|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
7820388|NCT00382993|27158556|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
7820389|NCT00382993|27158555|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
7820390|NCT00382993|27158556|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
7820391|NCT00382993|27158555|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
7820392|NCT00382993|27158556|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
7820393|NCT00382993|27158555|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
7820394|NCT00382993|27158556|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
7820395|NCT00382967|27158600|P2|Overall Study|Protocol Violation|1
7820396|NCT00382967|27158601|P1|Overall Study|Protocol Violation|1
7820397|NCT00382863|27158626|P2|Overall Study|Withdrawal by Subject|25
7820398|NCT00382863|27158627|P1|Overall Study|Withdrawal by Subject|5
7820399|NCT00382863|27158626|P2|Overall Study|Lost to Follow-up|2
7820400|NCT00382863|27158627|P1|Overall Study|Lost to Follow-up|1
7820401|NCT00382863|27158626|P2|Overall Study|Death|9
7820402|NCT00382863|27158627|P1|Overall Study|Death|9
7820403|NCT00382733|27158711|P5|Overall Study|Withdrawal by Subject|0
7820404|NCT00382733|27158712|P4|Overall Study|Withdrawal by Subject|0
7820405|NCT00382733|27158713|P3|Overall Study|Withdrawal by Subject|0
7820406|NCT00382733|27158714|P2|Overall Study|Withdrawal by Subject|1
7820407|NCT00382733|27158715|P1|Overall Study|Withdrawal by Subject|0
7820408|NCT00382720|27158736|P3|Overall Study|Discontinued at end of study|2
7820409|NCT00382720|27158737|P2|Overall Study|Discontinued at end of study|1
7820410|NCT00382720|27158738|P1|Overall Study|Discontinued at end of study|0
7820411|NCT00382720|27158736|P3|Overall Study|Investigator/Clinical decision|6
7820412|NCT00382720|27158737|P2|Overall Study|Investigator/Clinical decision|6
7820413|NCT00382720|27158738|P1|Overall Study|Investigator/Clinical decision|5
7820414|NCT00382720|27158736|P3|Overall Study|Good prognosis|0
7820415|NCT00382720|27158737|P2|Overall Study|Good prognosis|1
7820416|NCT00382720|27158738|P1|Overall Study|Good prognosis|0
7820417|NCT00382720|27158736|P3|Overall Study|Clinically progressive disease|0
7820418|NCT00382720|27158737|P2|Overall Study|Clinically progressive disease|1
7820419|NCT00382720|27158738|P1|Overall Study|Clinically progressive disease|0
7820420|NCT00382720|27158736|P3|Overall Study|Patient did not receive study medication|4
7820421|NCT00382720|27158737|P2|Overall Study|Patient did not receive study medication|1
7820422|NCT00382720|27158738|P1|Overall Study|Patient did not receive study medication|1
7820423|NCT00382720|27158736|P3|Overall Study|Surgery|4
7820424|NCT00382720|27158737|P2|Overall Study|Surgery|1
7820425|NCT00382720|27158738|P1|Overall Study|Surgery|1
7820426|NCT00382720|27158736|P3|Overall Study|Withdrawal by Subject|12
7820427|NCT00382720|27158737|P2|Overall Study|Withdrawal by Subject|20
7820428|NCT00382720|27158738|P1|Overall Study|Withdrawal by Subject|11
7820429|NCT00382720|27158736|P3|Overall Study|Withdrew consent|2
7820430|NCT00382720|27158737|P2|Overall Study|Withdrew consent|1
7820431|NCT00382720|27158738|P1|Overall Study|Withdrew consent|1
7820432|NCT00382720|27158736|P3|Overall Study|Progressive disease|38
7820433|NCT00382720|27158737|P2|Overall Study|Progressive disease|28
7820434|NCT00382720|27158738|P1|Overall Study|Progressive disease|37
7820435|NCT00382720|27158736|P3|Overall Study|Death|2
7820436|NCT00382720|27158737|P2|Overall Study|Death|1
7820437|NCT00382720|27158738|P1|Overall Study|Death|0
7820438|NCT00382720|27158736|P3|Overall Study|Protocol Violation|1
7820439|NCT00382720|27158737|P2|Overall Study|Protocol Violation|5
7820440|NCT00382720|27158738|P1|Overall Study|Protocol Violation|2
7820441|NCT00382720|27158736|P3|Overall Study|Adverse Event|15
7820442|NCT00382720|27158737|P2|Overall Study|Adverse Event|23
7820443|NCT00382720|27158738|P1|Overall Study|Adverse Event|21
7820444|NCT00382408|27158763|P2|Overall Study|Other|35
7820445|NCT00382408|27158764|P1|Overall Study|Other|100
7820446|NCT00382408|27158763|P2|Overall Study|Lost to Follow-up|8
7820447|NCT00382408|27158764|P1|Overall Study|Lost to Follow-up|19
7820448|NCT00382408|27158763|P2|Overall Study|Pregnancy|0
7820449|NCT00382408|27158764|P1|Overall Study|Pregnancy|2
7820450|NCT00382408|27158763|P2|Overall Study|Withdrawal by Subject|6
7820451|NCT00382408|27158764|P1|Overall Study|Withdrawal by Subject|17
7820452|NCT00382408|27158763|P2|Overall Study|Physician Decision|0
7820453|NCT00382408|27158764|P1|Overall Study|Physician Decision|1
7820454|NCT00382408|27158763|P2|Overall Study|Protocol Violation|2
7820455|NCT00382408|27158764|P1|Overall Study|Protocol Violation|2
7820456|NCT00382408|27158763|P2|Overall Study|Did not meet protocol requirement|3
7820457|NCT00382408|27158764|P1|Overall Study|Did not meet protocol requirement|3
7820458|NCT00382291|27158791|P3|Overall Study|Lack of Efficacy|1
7820459|NCT00382291|27158792|P2|Overall Study|Lack of Efficacy|0
7820460|NCT00382291|27158793|P1|Overall Study|Lack of Efficacy|0
7820461|NCT00382291|27158791|P3|Overall Study|Physician Decision|0
7820462|NCT00382291|27158792|P2|Overall Study|Physician Decision|1
7820463|NCT00382291|27158793|P1|Overall Study|Physician Decision|0
7820464|NCT00382291|27158791|P3|Overall Study|Withdrawal by Subject|0
7820465|NCT00382291|27158792|P2|Overall Study|Withdrawal by Subject|2
7820466|NCT00382291|27158793|P1|Overall Study|Withdrawal by Subject|0
7820467|NCT00382291|27158791|P3|Overall Study|Temporary study suspension|5
7820468|NCT00382291|27158792|P2|Overall Study|Temporary study suspension|2
7820469|NCT00382291|27158793|P1|Overall Study|Temporary study suspension|2
7820470|NCT00382291|27158791|P3|Overall Study|Protocol Violation|0
7820471|NCT00382291|27158792|P2|Overall Study|Protocol Violation|0
7820472|NCT00382291|27158793|P1|Overall Study|Protocol Violation|1
7820473|NCT00382291|27158791|P3|Overall Study|Adverse Event|2
7820474|NCT00382291|27158792|P2|Overall Study|Adverse Event|2
7820475|NCT00382291|27158793|P1|Overall Study|Adverse Event|1
7820476|NCT00382174|27158825|P3|Overall Study|Wounds merged|2
7820477|NCT00382174|27158826|P2|Overall Study|Wounds merged|2
7820478|NCT00382174|27158827|P1|Overall Study|Wounds merged|0
7820479|NCT00382174|27158825|P3|Overall Study|Failed to meet criteria|1
7820480|NCT00382174|27158826|P2|Overall Study|Failed to meet criteria|1
7820481|NCT00382174|27158827|P1|Overall Study|Failed to meet criteria|0
7820482|NCT00382174|27158825|P3|Overall Study|Physician Decision|2
7820483|NCT00382174|27158826|P2|Overall Study|Physician Decision|2
7820484|NCT00382174|27158827|P1|Overall Study|Physician Decision|0
7820485|NCT00382174|27158825|P3|Overall Study|Non compliance|1
7820486|NCT00382174|27158826|P2|Overall Study|Non compliance|0
7820487|NCT00382174|27158827|P1|Overall Study|Non compliance|1
7820488|NCT00382174|27158825|P3|Overall Study|Withdrawal by Subject|5
7820489|NCT00382174|27158826|P2|Overall Study|Withdrawal by Subject|4
7820490|NCT00382174|27158827|P1|Overall Study|Withdrawal by Subject|1
7820491|NCT00382174|27158825|P3|Overall Study|Adverse Event|5
7820492|NCT00382174|27158826|P2|Overall Study|Adverse Event|4
7820493|NCT00382174|27158827|P1|Overall Study|Adverse Event|1
7820494|NCT00382174|27158825|P3|Overall Study|Lost to Follow-up|5
7820495|NCT00382174|27158826|P2|Overall Study|Lost to Follow-up|4
7820496|NCT00382174|27158827|P1|Overall Study|Lost to Follow-up|1
7820497|NCT00382109|27158855|P2|Overall Study|consent withdrawal|1
7820498|NCT00382109|27158856|P1|Overall Study|consent withdrawal|0
7820499|NCT00382109|27158855|P2|Overall Study|Other|2
7820500|NCT00382109|27158856|P1|Overall Study|Other|0
7820501|NCT00382109|27158855|P2|Overall Study|ineligible|0
7820502|NCT00382109|27158856|P1|Overall Study|ineligible|2
7820503|NCT00382109|27158855|P2|Overall Study|Withdrawal by Subject|0
7820504|NCT00382109|27158856|P1|Overall Study|Withdrawal by Subject|1
7820505|NCT00382109|27158855|P2|Overall Study|Physician Decision|1
7820506|NCT00382109|27158856|P1|Overall Study|Physician Decision|6
7820507|NCT00382109|27158855|P2|Overall Study|Adverse Event|0
7820508|NCT00382109|27158856|P1|Overall Study|Adverse Event|3
7820509|NCT00382070|27158878|P2|Overall Study|No clinical assessment|11
7820510|NCT00382070|27158879|P1|Overall Study|No clinical assessment|9
7820511|NCT00382070|27158878|P2|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
7820512|NCT00382070|27158879|P1|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
7820513|NCT00382070|27158878|P2|Overall Study|No follow up data mapped to Other|19
7820514|NCT00382070|27158879|P1|Overall Study|No follow up data mapped to Other|17
7820515|NCT00382018|27158914|P4|Overall Study|Other, not protocol specified|1
7820516|NCT00382018|27158915|P3|Overall Study|Other, not protocol specified|3
7820517|NCT00382018|27158916|P2|Overall Study|Other, not protocol specified|16
7820518|NCT00382018|27158917|P1|Overall Study|Other, not protocol specified|0
7820519|NCT00382018|27158914|P4|Overall Study|Withdrawal by Subject|4
7820520|NCT00382018|27158915|P3|Overall Study|Withdrawal by Subject|3
7820521|NCT00382018|27158916|P2|Overall Study|Withdrawal by Subject|4
7820522|NCT00382018|27158917|P1|Overall Study|Withdrawal by Subject|0
7820523|NCT00382018|27158914|P4|Overall Study|Death|11
7820524|NCT00382018|27158915|P3|Overall Study|Death|7
7820525|NCT00382018|27158916|P2|Overall Study|Death|9
7820526|NCT00382018|27158917|P1|Overall Study|Death|0
7820527|NCT00382018|27158914|P4|Overall Study|Progression|43
7820528|NCT00382018|27158915|P3|Overall Study|Progression|51
7820529|NCT00382018|27158916|P2|Overall Study|Progression|136
7820530|NCT00382018|27158917|P1|Overall Study|Progression|0
7820531|NCT00381940|27158940|P1|Overall Study|Ineligible|1
7820532|NCT00381940|27158940|P1|Overall Study|Protocol Violation|1
7820533|NCT00381940|27158940|P1|Overall Study|Lack of Efficacy|3
7820534|NCT00381888|27158949|P1|Overall Study|Adverse Event|1
7820535|NCT00381888|27158949|P1|Overall Study|Surgery was cancelled|2
7820536|NCT00381888|27158949|P1|Overall Study|Had laparoscopic surgery|2
7820537|NCT00381888|27158949|P1|Overall Study|Protocol Violation|9
7820538|NCT00381888|27158949|P1|Overall Study|Physician Decision|1
7820539|NCT00381888|27158949|P1|Overall Study|Withdrawal by Subject|1
7820540|NCT00381888|27158949|P1|Overall Study|Death|1
7820541|NCT00381849|27158960|P2|Wash Out|Withdrawal by Subject|1
7820542|NCT00381849|27158961|P1|Wash Out|Withdrawal by Subject|0
7820543|NCT00381797|27158988|P5|Overall Study|Ineligible|0
7820544|NCT00381797|27158989|P4|Overall Study|Ineligible|1
7820545|NCT00381797|27158990|P3|Overall Study|Ineligible|0
7820546|NCT00381797|27158991|P2|Overall Study|Ineligible|0
7820547|NCT00381797|27158992|P1|Overall Study|Ineligible|0
7820548|NCT00381797|27158988|P5|Overall Study|Withdrawal by Subject|2
7820549|NCT00381797|27158989|P4|Overall Study|Withdrawal by Subject|0
7820550|NCT00381797|27158990|P3|Overall Study|Withdrawal by Subject|0
7820551|NCT00381797|27158991|P2|Overall Study|Withdrawal by Subject|1
7820552|NCT00381797|27158992|P1|Overall Study|Withdrawal by Subject|1
7820553|NCT00381706|27159067|P3|Overall Study|Never treated|1
7820554|NCT00381706|27159068|P2|Overall Study|Never treated|2
7820555|NCT00381706|27159069|P1|Overall Study|Never treated|7
7820556|NCT00381693|27159092|P1|Overall Study|Progression|2
7820557|NCT00381693|27159092|P1|Overall Study|Patient Choice|1
7820558|NCT00381693|27159092|P1|Overall Study|Adverse Event|4
7820559|NCT00381693|27159092|P1|Overall Study|Death|1
7820560|NCT00381680|27159101|P2|Overall Study|Ineligible|1
7820561|NCT00381680|27159102|P1|Overall Study|Ineligible|3
7820562|NCT00381680|27159101|P2|Overall Study|Other not otherwise specified|2
7820563|NCT00381680|27159102|P1|Overall Study|Other not otherwise specified|7
7820564|NCT00381680|27159101|P2|Overall Study|Progression|1
7820565|NCT00381680|27159102|P1|Overall Study|Progression|1
7820566|NCT00381680|27159101|P2|Overall Study|Induction Failure|1
7820567|NCT00381680|27159102|P1|Overall Study|Induction Failure|4
7820568|NCT00381680|27159101|P2|Overall Study|Relapse|9
7820569|NCT00381680|27159102|P1|Overall Study|Relapse|18
7820570|NCT00381680|27159101|P2|Overall Study|Stem Cell Transplant|10
7820571|NCT00381680|27159102|P1|Overall Study|Stem Cell Transplant|26
7820572|NCT00381680|27159101|P2|Overall Study|Delay initiation|0
7820573|NCT00381680|27159102|P1|Overall Study|Delay initiation|1
7820574|NCT00381680|27159101|P2|Overall Study|Secondary Malignancy|0
7820575|NCT00381680|27159102|P1|Overall Study|Secondary Malignancy|3
7820576|NCT00381680|27159101|P2|Overall Study|Alternative Therapy|5
7820577|NCT00381680|27159102|P1|Overall Study|Alternative Therapy|11
7820578|NCT00381680|27159101|P2|Overall Study|Entry onto another COG Trial|2
7820579|NCT00381680|27159102|P1|Overall Study|Entry onto another COG Trial|1
7820580|NCT00381680|27159101|P2|Overall Study|Withdrawal by Subject|1
7820581|NCT00381680|27159102|P1|Overall Study|Withdrawal by Subject|3
7820582|NCT00381680|27159101|P2|Overall Study|Physician Decision|6
7820583|NCT00381680|27159102|P1|Overall Study|Physician Decision|25
7820584|NCT00381680|27159101|P2|Overall Study|Lost to Follow-up|2
7820585|NCT00381680|27159102|P1|Overall Study|Lost to Follow-up|3
7820586|NCT00381680|27159101|P2|Overall Study|Death|7
7820587|NCT00381680|27159102|P1|Overall Study|Death|10
7820588|NCT00381680|27159101|P2|Overall Study|Adverse Event|3
7820589|NCT00381680|27159102|P1|Overall Study|Adverse Event|9
7820592|NCT00381615|27159153|P4|Overall Study|Protocol Violation|0
7820593|NCT00381615|27159154|P3|Overall Study|Protocol Violation|1
7820594|NCT00381615|27159155|P2|Overall Study|Protocol Violation|0
7820595|NCT00381615|27159156|P1|Overall Study|Protocol Violation|0
7820596|NCT00381615|27159153|P4|Overall Study|Lost to Follow-up|1
7820597|NCT00381615|27159154|P3|Overall Study|Lost to Follow-up|0
7820598|NCT00381615|27159155|P2|Overall Study|Lost to Follow-up|2
7820599|NCT00381615|27159156|P1|Overall Study|Lost to Follow-up|3
7820600|NCT00381615|27159153|P4|Overall Study|Withdrawal by Subject|1
7820601|NCT00381615|27159154|P3|Overall Study|Withdrawal by Subject|0
7820602|NCT00381615|27159155|P2|Overall Study|Withdrawal by Subject|3
7820603|NCT00381615|27159156|P1|Overall Study|Withdrawal by Subject|1
7820604|NCT00381563|27159208|P2|Overall Study|Protocol Violation|1
7820605|NCT00381563|27159209|P1|Overall Study|Protocol Violation|0
7820606|NCT00381563|27159208|P2|Overall Study|Lost to Follow-up|0
7820607|NCT00381563|27159209|P1|Overall Study|Lost to Follow-up|2
7820608|NCT00381563|27159208|P2|Overall Study|Withdrawal by Subject|5
7820609|NCT00381563|27159209|P1|Overall Study|Withdrawal by Subject|5
7820610|NCT00381485|27159224|P4|Double-Blind Treatment Period|Administrative|1
7820611|NCT00381485|27159225|P3|Double-Blind Treatment Period|Administrative|0
7820612|NCT00381485|27159226|P2|Double-Blind Treatment Period|Administrative|1
7820613|NCT00381485|27159227|P1|Double-Blind Treatment Period|Administrative|0
7820614|NCT00381485|27159224|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
7820615|NCT00381485|27159225|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7820616|NCT00381485|27159226|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7820617|NCT00381485|27159227|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7820618|NCT00381485|27159224|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
7820619|NCT00381485|27159225|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
7820620|NCT00381485|27159226|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
7820621|NCT00381485|27159227|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
7820622|NCT00381485|27159224|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
7820623|NCT00381485|27159225|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
7820624|NCT00381485|27159226|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
7820625|NCT00381485|27159227|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
7820626|NCT00381485|27159224|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
7820627|NCT00381485|27159225|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
7820628|NCT00381485|27159226|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
7820629|NCT00381485|27159227|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
7820630|NCT00381485|27159224|P4|Double-Blind Treatment Period|Lost to Follow-up|1
7820631|NCT00381485|27159225|P3|Double-Blind Treatment Period|Lost to Follow-up|1
7820632|NCT00381485|27159226|P2|Double-Blind Treatment Period|Lost to Follow-up|0
7820633|NCT00381485|27159227|P1|Double-Blind Treatment Period|Lost to Follow-up|0
7820634|NCT00381485|27159224|P4|Double-Blind Treatment Period|Lack of Efficacy|13
7820635|NCT00381485|27159225|P3|Double-Blind Treatment Period|Lack of Efficacy|11
7820636|NCT00381485|27159226|P2|Double-Blind Treatment Period|Lack of Efficacy|8
7820637|NCT00381485|27159227|P1|Double-Blind Treatment Period|Lack of Efficacy|0
7820638|NCT00381485|27159224|P4|Double-Blind Treatment Period|Adverse Event|5
7820639|NCT00381485|27159225|P3|Double-Blind Treatment Period|Adverse Event|2
7820640|NCT00381485|27159226|P2|Double-Blind Treatment Period|Adverse Event|2
7820641|NCT00381485|27159227|P1|Double-Blind Treatment Period|Adverse Event|0
7820642|NCT00381485|27159224|P4|Open-Label Run-In Period|Treatment failure|0
7820643|NCT00381485|27159225|P3|Open-Label Run-In Period|Treatment failure|0
7820644|NCT00381485|27159226|P2|Open-Label Run-In Period|Treatment failure|0
7820645|NCT00381485|27159227|P1|Open-Label Run-In Period|Treatment failure|1
7820646|NCT00381485|27159224|P4|Open-Label Run-In Period|Lost to Follow-up|0
7820647|NCT00381485|27159225|P3|Open-Label Run-In Period|Lost to Follow-up|0
7820648|NCT00381485|27159226|P2|Open-Label Run-In Period|Lost to Follow-up|0
7820649|NCT00381485|27159227|P1|Open-Label Run-In Period|Lost to Follow-up|3
7820650|NCT00381485|27159224|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7820651|NCT00381485|27159225|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7820652|NCT00381485|27159226|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7820653|NCT00381485|27159227|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
7820654|NCT00381485|27159224|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7820655|NCT00381485|27159225|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7820656|NCT00381485|27159226|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7820657|NCT00381485|27159227|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
7820658|NCT00381485|27159224|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
7820659|NCT00381485|27159225|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
7820660|NCT00381485|27159226|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
7820661|NCT00381485|27159227|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
7820662|NCT00381485|27159224|P4|Open-Label Run-In Period|Adverse Event|0
7820663|NCT00381485|27159225|P3|Open-Label Run-In Period|Adverse Event|0
7820664|NCT00381485|27159226|P2|Open-Label Run-In Period|Adverse Event|0
7820665|NCT00381485|27159227|P1|Open-Label Run-In Period|Adverse Event|9
7820666|NCT00381381|27159245|P1|Overall Study|Withdrawal by Subject|9
7820667|NCT00381381|27159245|P1|Overall Study|Lost to Follow-up|52
7820668|NCT00381381|27159245|P1|Overall Study|Adverse Event|3
7820669|NCT00381303|27159254|P2|Overall Study|Subject primary physician's decision|0
7820670|NCT00381303|27159255|P1|Overall Study|Subject primary physician's decision|1
7820671|NCT00381303|27159254|P2|Overall Study|Subject did not continue visits|0
7820672|NCT00381303|27159255|P1|Overall Study|Subject did not continue visits|1
7820673|NCT00381303|27159254|P2|Overall Study|Subject was too busy for appointments|0
7820674|NCT00381303|27159255|P1|Overall Study|Subject was too busy for appointments|1
7820675|NCT00381303|27159254|P2|Overall Study|No virologic response by week 12|0
7820676|NCT00381303|27159255|P1|Overall Study|No virologic response by week 12|1
7820677|NCT00381303|27159254|P2|Overall Study|Subject taking too many different meds|0
7820678|NCT00381303|27159255|P1|Overall Study|Subject taking too many different meds|1
7820679|NCT00381303|27159254|P2|Overall Study|Subject moved out of state|0
7820680|NCT00381303|27159255|P1|Overall Study|Subject moved out of state|2
7820681|NCT00381303|27159254|P2|Overall Study|Physician's decision to close the site|1
7820682|NCT00381303|27159255|P1|Overall Study|Physician's decision to close the site|3
7820683|NCT00381303|27159254|P2|Overall Study|Physician Decision|0
7820684|NCT00381303|27159255|P1|Overall Study|Physician Decision|1
7820685|NCT00381303|27159254|P2|Overall Study|Pregnancy|0
7820686|NCT00381303|27159255|P1|Overall Study|Pregnancy|2
7820687|NCT00381303|27159254|P2|Overall Study|Ineligible to continue the trial|1
7820688|NCT00381303|27159255|P1|Overall Study|Ineligible to continue the trial|2
7820689|NCT00381303|27159254|P2|Overall Study|Virologic failure|4
7820690|NCT00381303|27159255|P1|Overall Study|Virologic failure|6
7820691|NCT00381303|27159254|P2|Overall Study|Withdrawal by Subject|6
7820692|NCT00381303|27159255|P1|Overall Study|Withdrawal by Subject|13
7820693|NCT00381303|27159254|P2|Overall Study|Non-Adherence|6
7820694|NCT00381303|27159255|P1|Overall Study|Non-Adherence|13
7820695|NCT00381303|27159254|P2|Overall Study|AE/HIV-related event|6
7820696|NCT00381303|27159255|P1|Overall Study|AE/HIV-related event|22
7820697|NCT00381303|27159254|P2|Overall Study|Lost to Follow-up|9
7820698|NCT00381303|27159255|P1|Overall Study|Lost to Follow-up|25
7820699|NCT00381238|27159315|P1|Overall Study|Disease progression|1
7820700|NCT00381238|27159315|P1|Overall Study|Withdrew by physician|1
7820701|NCT00381238|27159315|P1|Overall Study|Lack of Efficacy|2
7820702|NCT00381238|27159315|P1|Overall Study|Withdrawal by Subject|4
7820703|NCT00381238|27159315|P1|Overall Study|Protocol Violation|1
7820704|NCT00381238|27159315|P1|Overall Study|Adverse Event|3
7820705|NCT00381095|27159331|P2|Overall Study|Adverse Event|7
7820706|NCT00381095|27159332|P1|Overall Study|Adverse Event|2
7820707|NCT00381095|27159331|P2|Overall Study|Withdrawal by Subject|3
7820708|NCT00381095|27159332|P1|Overall Study|Withdrawal by Subject|3
7820709|NCT00381095|27159331|P2|Overall Study|Protocol Violation|1
7820710|NCT00381095|27159332|P1|Overall Study|Protocol Violation|1
7820711|NCT00381095|27159331|P2|Overall Study|Other|2
7820712|NCT00381095|27159332|P1|Overall Study|Other|2
7820713|NCT00381095|27159331|P2|Overall Study|Lack of Efficacy|4
7820714|NCT00381095|27159332|P1|Overall Study|Lack of Efficacy|2
7820715|NCT00381095|27159331|P2|Overall Study|Death|4
7820716|NCT00381095|27159332|P1|Overall Study|Death|3
7820717|NCT00381043|27159364|P2|Overall Study|incarcerated|0
7820718|NCT00381043|27159365|P1|Overall Study|incarcerated|1
7820719|NCT00381043|27159364|P2|Overall Study|wanted more care|1
7820720|NCT00381043|27159365|P1|Overall Study|wanted more care|0
7820721|NCT00381043|27159364|P2|Overall Study|Withdrawal by Subject|1
7820722|NCT00381043|27159365|P1|Overall Study|Withdrawal by Subject|3
7820723|NCT00381043|27159364|P2|Overall Study|Lost to Follow-up|6
7820724|NCT00381043|27159365|P1|Overall Study|Lost to Follow-up|8
7820725|NCT00380978|27159391|P2|Overall Study|Parous patient|0
7820726|NCT00380978|27159392|P1|Overall Study|Parous patient|1
7820727|NCT00380978|27159391|P2|Overall Study|Allocation prior to analgesia request|2
7820728|NCT00380978|27159392|P1|Overall Study|Allocation prior to analgesia request|1
7820729|NCT00380978|27159391|P2|Overall Study|Wrong study envelope|2
7820730|NCT00380978|27159392|P1|Overall Study|Wrong study envelope|0
7820731|NCT00380978|27159391|P2|Overall Study|Refused allocated intervention|6
7820732|NCT00380978|27159392|P1|Overall Study|Refused allocated intervention|0
7820733|NCT00380874|27159414|P2|Overall Study|Not related to study drug|2
7820734|NCT00380874|27159415|P1|Overall Study|Not related to study drug|3
7820735|NCT00380874|27159414|P2|Overall Study|Withdrawal by Subject|1
7820736|NCT00380874|27159415|P1|Overall Study|Withdrawal by Subject|2
7820737|NCT00380874|27159414|P2|Overall Study|Death|0
7820738|NCT00380874|27159415|P1|Overall Study|Death|1
7820739|NCT00380874|27159414|P2|Overall Study|Adverse Event|7
7820740|NCT00380874|27159415|P1|Overall Study|Adverse Event|7
7820741|NCT00380744|27159447|P7|Overall Study|Withdrawal by Subject|0
7820742|NCT00380744|27159448|P6|Overall Study|Withdrawal by Subject|0
7820743|NCT00380744|27159449|P5|Overall Study|Withdrawal by Subject|0
7820744|NCT00380744|27159450|P4|Overall Study|Withdrawal by Subject|0
7820745|NCT00380744|27159451|P3|Overall Study|Withdrawal by Subject|0
7820746|NCT00380744|27159452|P2|Overall Study|Withdrawal by Subject|0
7820747|NCT00380744|27159453|P1|Overall Study|Withdrawal by Subject|1
7820748|NCT00380744|27159447|P7|Overall Study|Death|1
7820749|NCT00380744|27159448|P6|Overall Study|Death|0
7820750|NCT00380744|27159449|P5|Overall Study|Death|0
7820751|NCT00380744|27159450|P4|Overall Study|Death|0
7820752|NCT00380744|27159451|P3|Overall Study|Death|0
7820753|NCT00380744|27159452|P2|Overall Study|Death|0
7820754|NCT00380744|27159453|P1|Overall Study|Death|0
7820755|NCT00380718|27159503|P1|Overall Study|Death after 30-day post-therapy followup|17
7820756|NCT00380718|27159503|P1|Overall Study|Adverse Event|1
7820757|NCT00380692|27159515|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
7820758|NCT00380692|27159516|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
7820759|NCT00380692|27159515|P2|Study Period III - Open Label|Lack of Efficacy|4
7820760|NCT00380692|27159516|P1|Study Period III - Open Label|Lack of Efficacy|0
7820761|NCT00380692|27159515|P2|Study Period III - Open Label|Physician Decision|3
7820762|NCT00380692|27159516|P1|Study Period III - Open Label|Physician Decision|0
7820763|NCT00380692|27159515|P2|Study Period III - Open Label|Withdrawal by Subject|1
7820764|NCT00380692|27159516|P1|Study Period III - Open Label|Withdrawal by Subject|0
7820765|NCT00380692|27159515|P2|Study Period III - Open Label|Protocol Violation|0
7820766|NCT00380692|27159516|P1|Study Period III - Open Label|Protocol Violation|0
7820767|NCT00380692|27159515|P2|Study Period III - Open Label|Adverse Event|3
7820768|NCT00380692|27159516|P1|Study Period III - Open Label|Adverse Event|5
7820769|NCT00380692|27159515|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
7820770|NCT00380692|27159516|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
7820771|NCT00380692|27159515|P2|Study Period II - Double Blind|Lack of Efficacy|0
7820772|NCT00380692|27159516|P1|Study Period II - Double Blind|Lack of Efficacy|1
7820773|NCT00380692|27159515|P2|Study Period II - Double Blind|Physician Decision|1
7820774|NCT00380692|27159516|P1|Study Period II - Double Blind|Physician Decision|0
7820775|NCT00380692|27159515|P2|Study Period II - Double Blind|Withdrawal by Subject|0
7820776|NCT00380692|27159516|P1|Study Period II - Double Blind|Withdrawal by Subject|0
7820777|NCT00380692|27159515|P2|Study Period II - Double Blind|Protocol Violation|2
7820778|NCT00380692|27159516|P1|Study Period II - Double Blind|Protocol Violation|2
7820779|NCT00380692|27159515|P2|Study Period II - Double Blind|Adverse Event|0
7820780|NCT00380692|27159516|P1|Study Period II - Double Blind|Adverse Event|1
7820781|NCT00380588|27159564|P2|Overall Study|Physician Decision|0
7820782|NCT00380588|27159565|P1|Overall Study|Physician Decision|2
7820783|NCT00380588|27159564|P2|Overall Study|Withdrawal by Subject|3
7820784|NCT00380588|27159565|P1|Overall Study|Withdrawal by Subject|1
7820785|NCT00380588|27159564|P2|Overall Study|Adverse Event|3
7820786|NCT00380588|27159565|P1|Overall Study|Adverse Event|7
7820787|NCT00380588|27159564|P2|Overall Study|Next Cycle Not Started|0
7820788|NCT00380588|27159565|P1|Overall Study|Next Cycle Not Started|4
7820789|NCT00380588|27159564|P2|Overall Study|Unequivocal Disease Progression|34
7820790|NCT00380588|27159565|P1|Overall Study|Unequivocal Disease Progression|25
7820791|NCT00380393|27159579|P2|Month 14|Others|6
7820792|NCT00380393|27159580|P1|Month 14|Others|6
7820793|NCT00380393|27159579|P2|Month 14|Protocol Violation|0
7820794|NCT00380393|27159580|P1|Month 14|Protocol Violation|2
7820795|NCT00380393|27159579|P2|Month 14|Migrated/moved from study area|42
7820796|NCT00380393|27159580|P1|Month 14|Migrated/moved from study area|39
7820797|NCT00380393|27159579|P2|Month 14|Lost to Follow-up|1
7820798|NCT00380393|27159580|P1|Month 14|Lost to Follow-up|0
7820799|NCT00380393|27159579|P2|Month 14|Death|0
7820800|NCT00380393|27159580|P1|Month 14|Death|1
7820801|NCT00380393|27159579|P2|Month 14|Withdrawal by Subject|7
7820802|NCT00380393|27159580|P1|Month 14|Withdrawal by Subject|9
7820803|NCT00380393|27159579|P2|Month 8 (Cross-sectional Visit)|Others|4
7820804|NCT00380393|27159580|P1|Month 8 (Cross-sectional Visit)|Others|5
7820805|NCT00380393|27159579|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
7820806|NCT00380393|27159580|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
7820807|NCT00380393|27159579|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
7820808|NCT00380393|27159580|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
7820809|NCT00380393|27159579|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
7820810|NCT00380393|27159580|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
7820811|NCT00380393|27159579|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
7820812|NCT00380393|27159580|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
7820813|NCT00380367|27159628|P1|Overall Study|Withdrawal by Subject|1
7820814|NCT00380367|27159628|P1|Overall Study|Lost to Follow-up|1
7820815|NCT00380250|27159635|P2|Overall Study|Physician Decision|0
7820816|NCT00380250|27159636|P1|Overall Study|Physician Decision|1
7820817|NCT00380250|27159635|P2|Overall Study|Lost to Follow-up|5
7820818|NCT00380250|27159636|P1|Overall Study|Lost to Follow-up|14
7820819|NCT00380250|27159635|P2|Overall Study|Protocol Violation|5
7820820|NCT00380250|27159636|P1|Overall Study|Protocol Violation|15
7820821|NCT00380250|27159635|P2|Overall Study|Lack of Efficacy|8
7820822|NCT00380250|27159636|P1|Overall Study|Lack of Efficacy|10
7820823|NCT00380250|27159635|P2|Overall Study|Adverse Event|9
7820824|NCT00380250|27159636|P1|Overall Study|Adverse Event|20
7820825|NCT00380250|27159635|P2|Overall Study|Withdrawal by Subject|28
7820826|NCT00380250|27159636|P1|Overall Study|Withdrawal by Subject|39
7820827|NCT00380081|27159704|P6|Overall Study|Family Emergency|1
7820828|NCT00380081|27159705|P5|Overall Study|Family Emergency|0
7820829|NCT00380081|27159706|P4|Overall Study|Family Emergency|0
7820830|NCT00380081|27159707|P3|Overall Study|Family Emergency|0
7820831|NCT00380081|27159708|P2|Overall Study|Family Emergency|0
7820832|NCT00380081|27159709|P1|Overall Study|Family Emergency|0
7820833|NCT00380081|27159704|P6|Overall Study|Withdrawal by Subject|0
7820834|NCT00380081|27159705|P5|Overall Study|Withdrawal by Subject|1
7820835|NCT00380081|27159706|P4|Overall Study|Withdrawal by Subject|0
7820836|NCT00380081|27159707|P3|Overall Study|Withdrawal by Subject|0
7820837|NCT00380081|27159708|P2|Overall Study|Withdrawal by Subject|0
7820838|NCT00380081|27159709|P1|Overall Study|Withdrawal by Subject|0
7820839|NCT00380068|27159759|P1|Overall Study|Lack of Efficacy|5
7820840|NCT00380068|27159759|P1|Overall Study|Partipant moved away|1
7820841|NCT00380068|27159759|P1|Overall Study|Physician Decision|2
7820842|NCT00380068|27159759|P1|Overall Study|Lung transplant|3
7820843|NCT00380068|27159759|P1|Overall Study|Addition of other PAH therapeutic agent|1
7820844|NCT00380068|27159759|P1|Overall Study|Lost to Follow-up|1
7820845|NCT00380068|27159759|P1|Overall Study|Not compliant|6
7820846|NCT00380068|27159759|P1|Overall Study|Withdrawal by Subject|10
7820847|NCT00380068|27159759|P1|Overall Study|Adverse Event|40
7820848|NCT00379912|27159791|P2|Overall Study|Lack of Efficacy|0
7820849|NCT00379912|27159792|P1|Overall Study|Lack of Efficacy|1
7820850|NCT00379899|27159814|P2|Overall Study|Other|1
7820851|NCT00379899|27159815|P1|Overall Study|Other|3
7820852|NCT00379899|27159814|P2|Overall Study|Other protocol-specified criteria|4
7820853|NCT00379899|27159815|P1|Overall Study|Other protocol-specified criteria|3
7820854|NCT00379899|27159814|P2|Overall Study|Coronary artery bypass graft|1
7820855|NCT00379899|27159815|P1|Overall Study|Coronary artery bypass graft|1
7820856|NCT00379899|27159814|P2|Overall Study|Renal transplantation|4
7820857|NCT00379899|27159815|P1|Overall Study|Renal transplantation|5
7820858|NCT00379899|27159814|P2|Overall Study|Parathyroidectomy|2
7820859|NCT00379899|27159815|P1|Overall Study|Parathyroidectomy|0
7820860|NCT00379899|27159814|P2|Overall Study|Noncompliance|1
7820861|NCT00379899|27159815|P1|Overall Study|Noncompliance|1
7820862|NCT00379899|27159814|P2|Overall Study|Ineligibility determined|1
7820863|NCT00379899|27159815|P1|Overall Study|Ineligibility determined|0
7820864|NCT00379899|27159814|P2|Overall Study|Withdrawal by Subject|5
7820865|NCT00379899|27159815|P1|Overall Study|Withdrawal by Subject|5
7820866|NCT00379899|27159814|P2|Overall Study|Physician Decision|4
7820867|NCT00379899|27159815|P1|Overall Study|Physician Decision|3
7820868|NCT00379899|27159814|P2|Overall Study|Lost to Follow-up|4
7820869|NCT00379899|27159815|P1|Overall Study|Lost to Follow-up|2
7820870|NCT00379899|27159814|P2|Overall Study|Death|10
7820871|NCT00379899|27159815|P1|Overall Study|Death|10
7820872|NCT00379899|27159814|P2|Overall Study|Adverse Event|3
7820873|NCT00379899|27159815|P1|Overall Study|Adverse Event|7
7820874|NCT00379834|27159843|P1|Overall Study|Time constraints|2
7820875|NCT00379808|27159995|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
7820876|NCT00379808|27159996|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
7820877|NCT00379795|27160017|P5|Overall Study|Sponsor's decision|10
7820878|NCT00379795|27160018|P4|Overall Study|Sponsor's decision|47
7820879|NCT00379795|27160019|P3|Overall Study|Sponsor's decision|54
7820880|NCT00379795|27160020|P2|Overall Study|Sponsor's decision|17
7820881|NCT00379795|27160021|P1|Overall Study|Sponsor's decision|257
7820882|NCT00379795|27160017|P5|Overall Study|Subjects condition mandated intervention|7
7820883|NCT00379795|27160018|P4|Overall Study|Subjects condition mandated intervention|5
7820884|NCT00379795|27160019|P3|Overall Study|Subjects condition mandated intervention|7
7820885|NCT00379795|27160020|P2|Overall Study|Subjects condition mandated intervention|9
7820886|NCT00379795|27160021|P1|Overall Study|Subjects condition mandated intervention|34
7820887|NCT00379795|27160017|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
7820888|NCT00379795|27160018|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
7820889|NCT00379795|27160019|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
7820890|NCT00379795|27160020|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
7820891|NCT00379795|27160021|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
7820892|NCT00379795|27160017|P5|Overall Study|Subject non-compliance|1
7820893|NCT00379795|27160018|P4|Overall Study|Subject non-compliance|0
7820894|NCT00379795|27160019|P3|Overall Study|Subject non-compliance|0
7820895|NCT00379795|27160020|P2|Overall Study|Subject non-compliance|2
7820896|NCT00379795|27160021|P1|Overall Study|Subject non-compliance|7
7820897|NCT00379795|27160017|P5|Overall Study|Withdrawal by Subject|14
7820898|NCT00379795|27160018|P4|Overall Study|Withdrawal by Subject|7
7820899|NCT00379795|27160019|P3|Overall Study|Withdrawal by Subject|19
7820900|NCT00379795|27160020|P2|Overall Study|Withdrawal by Subject|11
7820901|NCT00379795|27160021|P1|Overall Study|Withdrawal by Subject|94
7820902|NCT00379795|27160017|P5|Overall Study|Physician Decision|2
7820903|NCT00379795|27160018|P4|Overall Study|Physician Decision|2
7820904|NCT00379795|27160019|P3|Overall Study|Physician Decision|2
7820905|NCT00379795|27160020|P2|Overall Study|Physician Decision|0
7820906|NCT00379795|27160021|P1|Overall Study|Physician Decision|25
7820907|NCT00379795|27160017|P5|Overall Study|Lost to Follow-up|4
7820908|NCT00379795|27160018|P4|Overall Study|Lost to Follow-up|1
7820909|NCT00379795|27160019|P3|Overall Study|Lost to Follow-up|2
7820910|NCT00379795|27160020|P2|Overall Study|Lost to Follow-up|1
7820911|NCT00379795|27160021|P1|Overall Study|Lost to Follow-up|8
7820912|NCT00379795|27160017|P5|Overall Study|Adverse Event|4
7820913|NCT00379795|27160018|P4|Overall Study|Adverse Event|1
7820914|NCT00379795|27160019|P3|Overall Study|Adverse Event|3
7820915|NCT00379795|27160020|P2|Overall Study|Adverse Event|3
7820916|NCT00379795|27160021|P1|Overall Study|Adverse Event|17
7820917|NCT00379795|27160017|P5|Overall Study|Death|7
7820918|NCT00379795|27160018|P4|Overall Study|Death|4
7820919|NCT00379795|27160019|P3|Overall Study|Death|6
7820920|NCT00379795|27160020|P2|Overall Study|Death|8
7820921|NCT00379795|27160021|P1|Overall Study|Death|31
7820922|NCT00379769|27160051|P6|Observational Follow-up|Unknown; Reason Not Provided|1
7820923|NCT00379769|27160052|P5|Observational Follow-up|Unknown; Reason Not Provided|1
7820924|NCT00379769|27160053|P4|Observational Follow-up|Unknown; Reason Not Provided|0
7820925|NCT00379769|27160054|P3|Observational Follow-up|Unknown; Reason Not Provided|0
7820926|NCT00379769|27160055|P2|Observational Follow-up|Unknown; Reason Not Provided|0
7820927|NCT00379769|27160056|P1|Observational Follow-up|Unknown; Reason Not Provided|0
7820928|NCT00379769|27160051|P6|Observational Follow-up|Participant Moved|1
7820929|NCT00379769|27160052|P5|Observational Follow-up|Participant Moved|0
7820930|NCT00379769|27160053|P4|Observational Follow-up|Participant Moved|0
7820931|NCT00379769|27160054|P3|Observational Follow-up|Participant Moved|0
7820932|NCT00379769|27160055|P2|Observational Follow-up|Participant Moved|0
7820933|NCT00379769|27160056|P1|Observational Follow-up|Participant Moved|0
7820934|NCT00379769|27160051|P6|Observational Follow-up|Site Closed Early|7
7820935|NCT00379769|27160052|P5|Observational Follow-up|Site Closed Early|6
7820936|NCT00379769|27160053|P4|Observational Follow-up|Site Closed Early|0
7820937|NCT00379769|27160054|P3|Observational Follow-up|Site Closed Early|0
7820938|NCT00379769|27160055|P2|Observational Follow-up|Site Closed Early|0
7820939|NCT00379769|27160056|P1|Observational Follow-up|Site Closed Early|0
7820940|NCT00379769|27160051|P6|Observational Follow-up|Physician Decision|8
7820941|NCT00379769|27160052|P5|Observational Follow-up|Physician Decision|8
7820942|NCT00379769|27160053|P4|Observational Follow-up|Physician Decision|0
7820943|NCT00379769|27160054|P3|Observational Follow-up|Physician Decision|0
7820944|NCT00379769|27160055|P2|Observational Follow-up|Physician Decision|0
7820945|NCT00379769|27160056|P1|Observational Follow-up|Physician Decision|0
7820946|NCT00379769|27160051|P6|Observational Follow-up|Entered into Another Clinical Trial|22
7820947|NCT00379769|27160052|P5|Observational Follow-up|Entered into Another Clinical Trial|18
7820948|NCT00379769|27160053|P4|Observational Follow-up|Entered into Another Clinical Trial|0
7820949|NCT00379769|27160054|P3|Observational Follow-up|Entered into Another Clinical Trial|0
7820950|NCT00379769|27160055|P2|Observational Follow-up|Entered into Another Clinical Trial|0
7820951|NCT00379769|27160056|P1|Observational Follow-up|Entered into Another Clinical Trial|0
7820952|NCT00379769|27160051|P6|Observational Follow-up|Withdrawal by Subject|12
7820953|NCT00379769|27160052|P5|Observational Follow-up|Withdrawal by Subject|12
7820954|NCT00379769|27160053|P4|Observational Follow-up|Withdrawal by Subject|0
7820955|NCT00379769|27160054|P3|Observational Follow-up|Withdrawal by Subject|0
7820956|NCT00379769|27160055|P2|Observational Follow-up|Withdrawal by Subject|0
7820957|NCT00379769|27160056|P1|Observational Follow-up|Withdrawal by Subject|0
7820958|NCT00379769|27160051|P6|Observational Follow-up|Lost to Follow-up|27
7820959|NCT00379769|27160052|P5|Observational Follow-up|Lost to Follow-up|25
7820960|NCT00379769|27160053|P4|Observational Follow-up|Lost to Follow-up|0
7820961|NCT00379769|27160054|P3|Observational Follow-up|Lost to Follow-up|0
7820962|NCT00379769|27160055|P2|Observational Follow-up|Lost to Follow-up|0
7820963|NCT00379769|27160056|P1|Observational Follow-up|Lost to Follow-up|0
7820964|NCT00379769|27160051|P6|Observational Follow-up|Adverse Event|0
7820965|NCT00379769|27160052|P5|Observational Follow-up|Adverse Event|1
7820966|NCT00379769|27160053|P4|Observational Follow-up|Adverse Event|0
7820967|NCT00379769|27160054|P3|Observational Follow-up|Adverse Event|0
7820968|NCT00379769|27160055|P2|Observational Follow-up|Adverse Event|0
7820969|NCT00379769|27160056|P1|Observational Follow-up|Adverse Event|0
7820970|NCT00379769|27160051|P6|Observational Follow-up|Death|70
7820971|NCT00379769|27160052|P5|Observational Follow-up|Death|78
7820972|NCT00379769|27160053|P4|Observational Follow-up|Death|0
7820973|NCT00379769|27160054|P3|Observational Follow-up|Death|0
7820974|NCT00379769|27160055|P2|Observational Follow-up|Death|0
7820975|NCT00379769|27160056|P1|Observational Follow-up|Death|0
7820976|NCT00379769|27160051|P6|Main Study|Reason unspecified|0
7820977|NCT00379769|27160052|P5|Main Study|Reason unspecified|0
7820978|NCT00379769|27160053|P4|Main Study|Reason unspecified|0
7820979|NCT00379769|27160054|P3|Main Study|Reason unspecified|1
7820980|NCT00379769|27160055|P2|Main Study|Reason unspecified|0
7820981|NCT00379769|27160056|P1|Main Study|Reason unspecified|0
7820982|NCT00379769|27160051|P6|Main Study|Investigator refused to log temperature|0
7820983|NCT00379769|27160052|P5|Main Study|Investigator refused to log temperature|0
7820984|NCT00379769|27160053|P4|Main Study|Investigator refused to log temperature|0
7820985|NCT00379769|27160054|P3|Main Study|Investigator refused to log temperature|1
7820986|NCT00379769|27160055|P2|Main Study|Investigator refused to log temperature|0
7820987|NCT00379769|27160056|P1|Main Study|Investigator refused to log temperature|0
7820988|NCT00379769|27160051|P6|Main Study|Risk of heart failure|0
7820989|NCT00379769|27160052|P5|Main Study|Risk of heart failure|0
7820990|NCT00379769|27160053|P4|Main Study|Risk of heart failure|0
7820991|NCT00379769|27160054|P3|Main Study|Risk of heart failure|0
7820992|NCT00379769|27160055|P2|Main Study|Risk of heart failure|1
7820993|NCT00379769|27160056|P1|Main Study|Risk of heart failure|0
7820994|NCT00379769|27160051|P6|Main Study|Personal reasons|0
7820995|NCT00379769|27160052|P5|Main Study|Personal reasons|0
7820996|NCT00379769|27160053|P4|Main Study|Personal reasons|0
7820997|NCT00379769|27160054|P3|Main Study|Personal reasons|0
7820998|NCT00379769|27160055|P2|Main Study|Personal reasons|0
7820999|NCT00379769|27160056|P1|Main Study|Personal reasons|1
7821000|NCT00379769|27160051|P6|Main Study|Participant completed study at visit 27|0
7821001|NCT00379769|27160052|P5|Main Study|Participant completed study at visit 27|0
7821002|NCT00379769|27160053|P4|Main Study|Participant completed study at visit 27|0
7821003|NCT00379769|27160054|P3|Main Study|Participant completed study at visit 27|0
7821004|NCT00379769|27160055|P2|Main Study|Participant completed study at visit 27|0
7821005|NCT00379769|27160056|P1|Main Study|Participant completed study at visit 27|1
7821006|NCT00379769|27160051|P6|Main Study|Physician Decision|0
7821007|NCT00379769|27160052|P5|Main Study|Physician Decision|0
7821008|NCT00379769|27160053|P4|Main Study|Physician Decision|1
7821009|NCT00379769|27160054|P3|Main Study|Physician Decision|1
7821010|NCT00379769|27160055|P2|Main Study|Physician Decision|2
7821011|NCT00379769|27160056|P1|Main Study|Physician Decision|2
7821012|NCT00379769|27160051|P6|Main Study|Participant did not take study drug|0
7821013|NCT00379769|27160052|P5|Main Study|Participant did not take study drug|0
7821014|NCT00379769|27160053|P4|Main Study|Participant did not take study drug|0
7821015|NCT00379769|27160054|P3|Main Study|Participant did not take study drug|1
7821016|NCT00379769|27160055|P2|Main Study|Participant did not take study drug|0
7821017|NCT00379769|27160056|P1|Main Study|Participant did not take study drug|0
7821018|NCT00379769|27160051|P6|Main Study|Entry criteria violation|0
7821019|NCT00379769|27160052|P5|Main Study|Entry criteria violation|0
7821020|NCT00379769|27160053|P4|Main Study|Entry criteria violation|1
7821021|NCT00379769|27160054|P3|Main Study|Entry criteria violation|1
7821022|NCT00379769|27160055|P2|Main Study|Entry criteria violation|0
7821023|NCT00379769|27160056|P1|Main Study|Entry criteria violation|0
7821024|NCT00379769|27160051|P6|Main Study|Site closed|0
7821025|NCT00379769|27160052|P5|Main Study|Site closed|0
7821026|NCT00379769|27160053|P4|Main Study|Site closed|8
7821027|NCT00379769|27160054|P3|Main Study|Site closed|4
7821028|NCT00379769|27160055|P2|Main Study|Site closed|4
7821029|NCT00379769|27160056|P1|Main Study|Site closed|4
7821030|NCT00379769|27160051|P6|Main Study|Prohibited glucose lowering medication|0
7821031|NCT00379769|27160052|P5|Main Study|Prohibited glucose lowering medication|0
7821032|NCT00379769|27160053|P4|Main Study|Prohibited glucose lowering medication|1
7821033|NCT00379769|27160054|P3|Main Study|Prohibited glucose lowering medication|0
7821034|NCT00379769|27160055|P2|Main Study|Prohibited glucose lowering medication|3
7821035|NCT00379769|27160056|P1|Main Study|Prohibited glucose lowering medication|0
7821036|NCT00379769|27160051|P6|Main Study|Poor compliance|0
7821037|NCT00379769|27160052|P5|Main Study|Poor compliance|0
7821038|NCT00379769|27160053|P4|Main Study|Poor compliance|1
7821039|NCT00379769|27160054|P3|Main Study|Poor compliance|2
7821040|NCT00379769|27160055|P2|Main Study|Poor compliance|2
7821041|NCT00379769|27160056|P1|Main Study|Poor compliance|3
7821042|NCT00379769|27160051|P6|Main Study|Participant moved|0
7821043|NCT00379769|27160052|P5|Main Study|Participant moved|0
7821044|NCT00379769|27160053|P4|Main Study|Participant moved|3
7821045|NCT00379769|27160054|P3|Main Study|Participant moved|3
7821046|NCT00379769|27160055|P2|Main Study|Participant moved|2
7821047|NCT00379769|27160056|P1|Main Study|Participant moved|3
7821048|NCT00379769|27160051|P6|Main Study|Moved to survival status follow-up only|0
7821049|NCT00379769|27160052|P5|Main Study|Moved to survival status follow-up only|0
7821050|NCT00379769|27160053|P4|Main Study|Moved to survival status follow-up only|36
7821051|NCT00379769|27160054|P3|Main Study|Moved to survival status follow-up only|32
7821052|NCT00379769|27160055|P2|Main Study|Moved to survival status follow-up only|25
7821053|NCT00379769|27160056|P1|Main Study|Moved to survival status follow-up only|27
7821054|NCT00379769|27160051|P6|Main Study|Withdrawal by Subject|0
7821055|NCT00379769|27160052|P5|Main Study|Withdrawal by Subject|0
7821056|NCT00379769|27160053|P4|Main Study|Withdrawal by Subject|70
7821057|NCT00379769|27160054|P3|Main Study|Withdrawal by Subject|72
7821058|NCT00379769|27160055|P2|Main Study|Withdrawal by Subject|56
7821059|NCT00379769|27160056|P1|Main Study|Withdrawal by Subject|46
7821060|NCT00379769|27160051|P6|Main Study|Lost to Follow-up|0
7821061|NCT00379769|27160052|P5|Main Study|Lost to Follow-up|0
7821062|NCT00379769|27160053|P4|Main Study|Lost to Follow-up|26
7821063|NCT00379769|27160054|P3|Main Study|Lost to Follow-up|25
7821064|NCT00379769|27160055|P2|Main Study|Lost to Follow-up|29
7821065|NCT00379769|27160056|P1|Main Study|Lost to Follow-up|29
7821066|NCT00379769|27160051|P6|Main Study|Adverse Event|0
7821067|NCT00379769|27160052|P5|Main Study|Adverse Event|0
7821068|NCT00379769|27160053|P4|Main Study|Adverse Event|11
7821069|NCT00379769|27160054|P3|Main Study|Adverse Event|10
7821070|NCT00379769|27160055|P2|Main Study|Adverse Event|8
7821071|NCT00379769|27160056|P1|Main Study|Adverse Event|5
7821072|NCT00379769|27160051|P6|Main Study|Death|0
7821073|NCT00379769|27160052|P5|Main Study|Death|0
7821074|NCT00379769|27160053|P4|Main Study|Death|72
7821075|NCT00379769|27160054|P3|Main Study|Death|54
7821076|NCT00379769|27160055|P2|Main Study|Death|67
7821077|NCT00379769|27160056|P1|Main Study|Death|57
7821078|NCT00379639|27160215|P5|Overall Study|Other|0
7821079|NCT00379639|27160216|P4|Overall Study|Other|0
7821080|NCT00379639|27160217|P3|Overall Study|Other|3
7821081|NCT00379639|27160218|P2|Overall Study|Other|0
7821082|NCT00379639|27160219|P1|Overall Study|Other|0
7821083|NCT00379639|27160215|P5|Overall Study|Lost to Follow-up|0
7821084|NCT00379639|27160216|P4|Overall Study|Lost to Follow-up|1
7821085|NCT00379639|27160217|P3|Overall Study|Lost to Follow-up|0
7821086|NCT00379639|27160218|P2|Overall Study|Lost to Follow-up|0
7821087|NCT00379639|27160219|P1|Overall Study|Lost to Follow-up|0
7821088|NCT00379639|27160215|P5|Overall Study|Adverse Event|1
7821089|NCT00379639|27160216|P4|Overall Study|Adverse Event|0
7821090|NCT00379639|27160217|P3|Overall Study|Adverse Event|1
7821091|NCT00379639|27160218|P2|Overall Study|Adverse Event|0
7821092|NCT00379639|27160219|P1|Overall Study|Adverse Event|0
7821093|NCT00379639|27160215|P5|Overall Study|Symptomatic Deterioration|1
7821094|NCT00379639|27160216|P4|Overall Study|Symptomatic Deterioration|0
7821095|NCT00379639|27160217|P3|Overall Study|Symptomatic Deterioration|1
7821096|NCT00379639|27160218|P2|Overall Study|Symptomatic Deterioration|0
7821097|NCT00379639|27160219|P1|Overall Study|Symptomatic Deterioration|0
7821098|NCT00379639|27160215|P5|Overall Study|Physician Decision|0
7821099|NCT00379639|27160216|P4|Overall Study|Physician Decision|1
7821100|NCT00379639|27160217|P3|Overall Study|Physician Decision|1
7821101|NCT00379639|27160218|P2|Overall Study|Physician Decision|2
7821102|NCT00379639|27160219|P1|Overall Study|Physician Decision|0
7821103|NCT00379639|27160215|P5|Overall Study|Disease Progression|4
7821104|NCT00379639|27160216|P4|Overall Study|Disease Progression|4
7821105|NCT00379639|27160217|P3|Overall Study|Disease Progression|3
7821106|NCT00379639|27160218|P2|Overall Study|Disease Progression|3
7821107|NCT00379639|27160219|P1|Overall Study|Disease Progression|3
7821108|NCT00379587|27160241|P1|Overall Study|Lost to Follow-up|2
7821109|NCT00379353|27160255|P2|Overall Study|Conflicting drug treatment|1
7821110|NCT00379353|27160256|P1|Overall Study|Conflicting drug treatment|0
7821111|NCT00379353|27160255|P2|Overall Study|Non-compliance|0
7821112|NCT00379353|27160256|P1|Overall Study|Non-compliance|1
7821113|NCT00379353|27160255|P2|Overall Study|Cardiac Tamponade|0
7821114|NCT00379353|27160256|P1|Overall Study|Cardiac Tamponade|1
7821115|NCT00379353|27160255|P2|Overall Study|Death|0
7821116|NCT00379353|27160256|P1|Overall Study|Death|1
7821117|NCT00379353|27160255|P2|Overall Study|Withdrawal by Subject|2
7821118|NCT00379353|27160256|P1|Overall Study|Withdrawal by Subject|5
7821119|NCT00379353|27160255|P2|Overall Study|Hospitalization|3
7821120|NCT00379353|27160256|P1|Overall Study|Hospitalization|3
7821121|NCT00379340|27160291|P5|Overall Study|Delayed nephrectomy and anaplasia|1
7821122|NCT00379340|27160292|P4|Overall Study|Delayed nephrectomy and anaplasia|1
7821123|NCT00379340|27160293|P3|Overall Study|Delayed nephrectomy and anaplasia|0
7821124|NCT00379340|27160294|P2|Overall Study|Delayed nephrectomy and anaplasia|0
7821125|NCT00379340|27160295|P1|Overall Study|Delayed nephrectomy and anaplasia|0
7821126|NCT00379340|27160291|P5|Overall Study|On more than 1 tumor therapeutic study|0
7821127|NCT00379340|27160292|P4|Overall Study|On more than 1 tumor therapeutic study|2
7821128|NCT00379340|27160293|P3|Overall Study|On more than 1 tumor therapeutic study|0
7821129|NCT00379340|27160294|P2|Overall Study|On more than 1 tumor therapeutic study|0
7821130|NCT00379340|27160295|P1|Overall Study|On more than 1 tumor therapeutic study|0
7821131|NCT00379340|27160291|P5|Overall Study|Refusal of further protocol therapy|7
7821132|NCT00379340|27160292|P4|Overall Study|Refusal of further protocol therapy|1
7821133|NCT00379340|27160293|P3|Overall Study|Refusal of further protocol therapy|1
7821134|NCT00379340|27160294|P2|Overall Study|Refusal of further protocol therapy|0
7821135|NCT00379340|27160295|P1|Overall Study|Refusal of further protocol therapy|1
7821136|NCT00379340|27160291|P5|Overall Study|Withdrawal by Subject|0
7821137|NCT00379340|27160292|P4|Overall Study|Withdrawal by Subject|1
7821138|NCT00379340|27160293|P3|Overall Study|Withdrawal by Subject|0
7821139|NCT00379340|27160294|P2|Overall Study|Withdrawal by Subject|0
7821140|NCT00379340|27160295|P1|Overall Study|Withdrawal by Subject|0
7821141|NCT00379340|27160291|P5|Overall Study|Physician Decision|3
7821142|NCT00379340|27160292|P4|Overall Study|Physician Decision|2
7821143|NCT00379340|27160293|P3|Overall Study|Physician Decision|1
7821144|NCT00379340|27160294|P2|Overall Study|Physician Decision|2
7821145|NCT00379340|27160295|P1|Overall Study|Physician Decision|6
7821146|NCT00379340|27160291|P5|Overall Study|Lack of Efficacy|3
7821147|NCT00379340|27160292|P4|Overall Study|Lack of Efficacy|4
7821148|NCT00379340|27160293|P3|Overall Study|Lack of Efficacy|0
7821149|NCT00379340|27160294|P2|Overall Study|Lack of Efficacy|1
7821150|NCT00379340|27160295|P1|Overall Study|Lack of Efficacy|6
7821151|NCT00379340|27160291|P5|Overall Study|Death|0
7821152|NCT00379340|27160292|P4|Overall Study|Death|2
7821153|NCT00379340|27160293|P3|Overall Study|Death|0
7821154|NCT00379340|27160294|P2|Overall Study|Death|0
7821155|NCT00379340|27160295|P1|Overall Study|Death|0
7821156|NCT00379288|27160312|P4|Overall Study|Administrative|1
7821157|NCT00379288|27160313|P3|Overall Study|Administrative|0
7821158|NCT00379288|27160314|P2|Overall Study|Administrative|2
7821159|NCT00379288|27160315|P1|Overall Study|Administrative|2
7821160|NCT00379288|27160312|P4|Overall Study|Did not meet protocol eligibility|2
7821161|NCT00379288|27160313|P3|Overall Study|Did not meet protocol eligibility|0
7821162|NCT00379288|27160314|P2|Overall Study|Did not meet protocol eligibility|1
7821163|NCT00379288|27160315|P1|Overall Study|Did not meet protocol eligibility|0
7821164|NCT00379288|27160312|P4|Overall Study|Noncompliance with protocol|1
7821165|NCT00379288|27160313|P3|Overall Study|Noncompliance with protocol|2
7821166|NCT00379288|27160314|P2|Overall Study|Noncompliance with protocol|6
7821167|NCT00379288|27160315|P1|Overall Study|Noncompliance with protocol|8
7821168|NCT00379288|27160312|P4|Overall Study|Subject withdrew-related to study drug|1
7821169|NCT00379288|27160313|P3|Overall Study|Subject withdrew-related to study drug|0
7821170|NCT00379288|27160314|P2|Overall Study|Subject withdrew-related to study drug|0
7821171|NCT00379288|27160315|P1|Overall Study|Subject withdrew-related to study drug|1
7821172|NCT00379288|27160312|P4|Overall Study|Subject withdrew-unrelated to study drug|2
7821173|NCT00379288|27160313|P3|Overall Study|Subject withdrew-unrelated to study drug|4
7821174|NCT00379288|27160314|P2|Overall Study|Subject withdrew-unrelated to study drug|3
7821175|NCT00379288|27160315|P1|Overall Study|Subject withdrew-unrelated to study drug|0
7821176|NCT00379288|27160312|P4|Overall Study|Lost to Follow-up|0
7821177|NCT00379288|27160313|P3|Overall Study|Lost to Follow-up|2
7821178|NCT00379288|27160314|P2|Overall Study|Lost to Follow-up|3
7821179|NCT00379288|27160315|P1|Overall Study|Lost to Follow-up|3
7821180|NCT00379288|27160312|P4|Overall Study|Treatment Failure|1
7821181|NCT00379288|27160313|P3|Overall Study|Treatment Failure|0
7821182|NCT00379288|27160314|P2|Overall Study|Treatment Failure|1
7821183|NCT00379288|27160315|P1|Overall Study|Treatment Failure|0
7821184|NCT00379288|27160312|P4|Overall Study|Adverse Event|0
7821185|NCT00379288|27160313|P3|Overall Study|Adverse Event|2
7821186|NCT00379288|27160314|P2|Overall Study|Adverse Event|6
7821187|NCT00379288|27160315|P1|Overall Study|Adverse Event|5
7821188|NCT00379236|27160327|P3|Open-label Extension|Other|7
7821189|NCT00379236|27160328|P2|Open-label Extension|Other|0
7821190|NCT00379236|27160329|P1|Open-label Extension|Other|0
7821191|NCT00379236|27160327|P3|Open-label Extension|Use of exclusionary medication|3
7821192|NCT00379236|27160328|P2|Open-label Extension|Use of exclusionary medication|0
7821193|NCT00379236|27160329|P1|Open-label Extension|Use of exclusionary medication|0
7821194|NCT00379236|27160327|P3|Open-label Extension|Lost to Follow-up|12
7821195|NCT00379236|27160328|P2|Open-label Extension|Lost to Follow-up|0
7821196|NCT00379236|27160329|P1|Open-label Extension|Lost to Follow-up|0
7821197|NCT00379236|27160327|P3|Open-label Extension|Withdrawal by Subject|13
7821198|NCT00379236|27160328|P2|Open-label Extension|Withdrawal by Subject|0
7821199|NCT00379236|27160329|P1|Open-label Extension|Withdrawal by Subject|0
7821200|NCT00379236|27160327|P3|Open-label Extension|Protocol Violation|7
7821201|NCT00379236|27160328|P2|Open-label Extension|Protocol Violation|0
7821202|NCT00379236|27160329|P1|Open-label Extension|Protocol Violation|0
7821203|NCT00379236|27160327|P3|Open-label Extension|Adverse Event|13
7821204|NCT00379236|27160328|P2|Open-label Extension|Adverse Event|0
7821205|NCT00379236|27160329|P1|Open-label Extension|Adverse Event|0
7821206|NCT00379236|27160327|P3|Double-blind|Data could not be retrieved|0
7821207|NCT00379236|27160328|P2|Double-blind|Data could not be retrieved|2
7821208|NCT00379236|27160329|P1|Double-blind|Data could not be retrieved|2
7821209|NCT00379236|27160327|P3|Double-blind|Other|0
7821210|NCT00379236|27160328|P2|Double-blind|Other|7
7821211|NCT00379236|27160329|P1|Double-blind|Other|3
7821212|NCT00379236|27160327|P3|Double-blind|Use of exclusionary medication|0
7821213|NCT00379236|27160328|P2|Double-blind|Use of exclusionary medication|2
7821214|NCT00379236|27160329|P1|Double-blind|Use of exclusionary medication|1
7821215|NCT00379236|27160327|P3|Double-blind|Lost to Follow-up|0
7821216|NCT00379236|27160328|P2|Double-blind|Lost to Follow-up|3
7821217|NCT00379236|27160329|P1|Double-blind|Lost to Follow-up|4
7821218|NCT00379236|27160327|P3|Double-blind|Withdrawal by Subject|0
7821219|NCT00379236|27160328|P2|Double-blind|Withdrawal by Subject|13
7821220|NCT00379236|27160329|P1|Double-blind|Withdrawal by Subject|12
7821221|NCT00379236|27160327|P3|Double-blind|Protocol Violation|0
7821222|NCT00379236|27160328|P2|Double-blind|Protocol Violation|3
7821223|NCT00379236|27160329|P1|Double-blind|Protocol Violation|3
7821224|NCT00379236|27160327|P3|Double-blind|Adverse Event|0
7821225|NCT00379236|27160328|P2|Double-blind|Adverse Event|6
7821226|NCT00379236|27160329|P1|Double-blind|Adverse Event|11
7821227|NCT00379210|27160374|P2|Overall Study|Withdrawal by Subject|7
7821228|NCT00379210|27160375|P1|Overall Study|Withdrawal by Subject|10
7821229|NCT00379080|27160398|P3|Overall Study|Withdrawal by Subject|0
7821230|NCT00379080|27160399|P2|Overall Study|Withdrawal by Subject|4
7821231|NCT00379080|27160400|P1|Overall Study|Withdrawal by Subject|0
7821232|NCT00378898|27160445|P2|Overall Study|Protocol Violation|1
7821233|NCT00378898|27160446|P1|Overall Study|Protocol Violation|1
7821234|NCT00378898|27160445|P2|Overall Study|Withdrawal by Subject|5
7821235|NCT00378898|27160446|P1|Overall Study|Withdrawal by Subject|10
7821236|NCT00378703|27160458|P4|Overall Study|Other|3
7821237|NCT00378703|27160459|P3|Overall Study|Other|2
7821238|NCT00378703|27160460|P2|Overall Study|Other|1
7821239|NCT00378703|27160461|P1|Overall Study|Other|1
7821240|NCT00378703|27160458|P4|Overall Study|Never started treatment|0
7821241|NCT00378703|27160459|P3|Overall Study|Never started treatment|0
7821242|NCT00378703|27160460|P2|Overall Study|Never started treatment|4
7821243|NCT00378703|27160461|P1|Overall Study|Never started treatment|1
7821244|NCT00378703|27160458|P4|Overall Study|Ineligible|7
7821245|NCT00378703|27160459|P3|Overall Study|Ineligible|7
7821246|NCT00378703|27160460|P2|Overall Study|Ineligible|7
7821247|NCT00378703|27160461|P1|Overall Study|Ineligible|4
7821248|NCT00378703|27160458|P4|Overall Study|Relocation|0
7821249|NCT00378703|27160459|P3|Overall Study|Relocation|1
7821250|NCT00378703|27160460|P2|Overall Study|Relocation|0
7821251|NCT00378703|27160461|P1|Overall Study|Relocation|0
7821252|NCT00378703|27160458|P4|Overall Study|Adverse events and progressive disease|1
7821253|NCT00378703|27160459|P3|Overall Study|Adverse events and progressive disease|0
7821254|NCT00378703|27160460|P2|Overall Study|Adverse events and progressive disease|0
7821255|NCT00378703|27160461|P1|Overall Study|Adverse events and progressive disease|0
7821256|NCT00378703|27160458|P4|Overall Study|Joint decision of physician and patient|0
7821257|NCT00378703|27160459|P3|Overall Study|Joint decision of physician and patient|0
7821258|NCT00378703|27160460|P2|Overall Study|Joint decision of physician and patient|0
7821259|NCT00378703|27160461|P1|Overall Study|Joint decision of physician and patient|1
7821260|NCT00378703|27160458|P4|Overall Study|Surgery|1
7821261|NCT00378703|27160459|P3|Overall Study|Surgery|0
7821262|NCT00378703|27160460|P2|Overall Study|Surgery|0
7821263|NCT00378703|27160461|P1|Overall Study|Surgery|1
7821264|NCT00378703|27160458|P4|Overall Study|Symptomatic deterioration|2
7821265|NCT00378703|27160459|P3|Overall Study|Symptomatic deterioration|0
7821266|NCT00378703|27160460|P2|Overall Study|Symptomatic deterioration|1
7821267|NCT00378703|27160461|P1|Overall Study|Symptomatic deterioration|0
7821268|NCT00378703|27160458|P4|Overall Study|Other complicated disease|0
7821269|NCT00378703|27160459|P3|Overall Study|Other complicated disease|2
7821270|NCT00378703|27160460|P2|Overall Study|Other complicated disease|2
7821271|NCT00378703|27160461|P1|Overall Study|Other complicated disease|0
7821272|NCT00378703|27160458|P4|Overall Study|Alternative therapy|0
7821273|NCT00378703|27160459|P3|Overall Study|Alternative therapy|0
7821274|NCT00378703|27160460|P2|Overall Study|Alternative therapy|2
7821275|NCT00378703|27160461|P1|Overall Study|Alternative therapy|4
7821276|NCT00378703|27160458|P4|Overall Study|Physician Decision|0
7821277|NCT00378703|27160459|P3|Overall Study|Physician Decision|1
7821278|NCT00378703|27160460|P2|Overall Study|Physician Decision|4
7821279|NCT00378703|27160461|P1|Overall Study|Physician Decision|1
7821280|NCT00378703|27160458|P4|Overall Study|Withdrawal by Subject|7
7821281|NCT00378703|27160459|P3|Overall Study|Withdrawal by Subject|5
7821282|NCT00378703|27160460|P2|Overall Study|Withdrawal by Subject|8
7821283|NCT00378703|27160461|P1|Overall Study|Withdrawal by Subject|4
7821284|NCT00378703|27160458|P4|Overall Study|Death|3
7821285|NCT00378703|27160459|P3|Overall Study|Death|4
7821286|NCT00378703|27160460|P2|Overall Study|Death|2
7821287|NCT00378703|27160461|P1|Overall Study|Death|2
7821288|NCT00378703|27160458|P4|Overall Study|Adverse Event|18
7821289|NCT00378703|27160459|P3|Overall Study|Adverse Event|20
7821290|NCT00378703|27160460|P2|Overall Study|Adverse Event|17
7821291|NCT00378703|27160461|P1|Overall Study|Adverse Event|11
7821292|NCT00378703|27160458|P4|Overall Study|Disease progression|49
7821293|NCT00378703|27160459|P3|Overall Study|Disease progression|48
7821294|NCT00378703|27160460|P2|Overall Study|Disease progression|43
7821295|NCT00378703|27160461|P1|Overall Study|Disease progression|59
7821296|NCT00378599|27160483|P1|Overall Study|Withdrawal by Subject|5
7821297|NCT00378599|27160483|P1|Overall Study|Treatment failure|7
7821298|NCT00378599|27160483|P1|Overall Study|Protocol Violation|2
7821299|NCT00378599|27160483|P1|Overall Study|Adverse Event|38
7821300|NCT00378573|27160487|P1|Follow-up|Withdrawal by Subject|1
7821301|NCT00378573|27160487|P1|Follow-up|Lost to Follow-up|1
7821302|NCT00378573|27160487|P1|Follow-up|Death|12
7821303|NCT00378573|27160487|P1|Treatment Period|Sponsor decision to close study|1
7821304|NCT00378573|27160487|P1|Treatment Period|Disease Progression|4
7821305|NCT00378573|27160487|P1|Treatment Period|Withdrawal by Subject|2
7821306|NCT00378573|27160487|P1|Treatment Period|Physician Decision|1
7821307|NCT00378573|27160487|P1|Treatment Period|Adverse Event|9
7821308|NCT00378560|27160495|P2|Overall Study|Laboratory test values abnormal|0
7821309|NCT00378560|27160496|P1|Overall Study|Laboratory test values abnormal|1
7821310|NCT00378560|27160495|P2|Overall Study|Pregnancy|5
7821311|NCT00378560|27160496|P1|Overall Study|Pregnancy|7
7821312|NCT00378560|27160495|P2|Overall Study|Moved|3
7821313|NCT00378560|27160496|P1|Overall Study|Moved|4
7821314|NCT00378560|27160495|P2|Overall Study|Withdrawal by Subject|21
7821315|NCT00378560|27160496|P1|Overall Study|Withdrawal by Subject|17
7821316|NCT00378560|27160495|P2|Overall Study|Protocol Violation|0
7821317|NCT00378560|27160496|P1|Overall Study|Protocol Violation|2
7821318|NCT00378560|27160495|P2|Overall Study|Lost to Follow-up|29
7821319|NCT00378560|27160496|P1|Overall Study|Lost to Follow-up|24
7821320|NCT00378560|27160495|P2|Overall Study|Adverse Event|0
7821321|NCT00378560|27160496|P1|Overall Study|Adverse Event|1
7821322|NCT00378534|27160512|P2|Overall Study|Participants did not receive transplant|0
7821323|NCT00378534|27160513|P1|Overall Study|Participants did not receive transplant|3
7821324|NCT00378508|27160524|P2|Overall Study|Lost to Follow-up|0
7821325|NCT00378508|27160525|P1|Overall Study|Lost to Follow-up|1
7821326|NCT00378508|27160524|P2|Overall Study|Withdrawal by Subject|3
7821327|NCT00378508|27160525|P1|Overall Study|Withdrawal by Subject|1
7821328|NCT00378482|27160541|P1|Overall Study|Adverse Event|9
7821329|NCT00378482|27160541|P1|Overall Study|Withdrawal by Subject|4
7821330|NCT00378482|27160541|P1|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
7821331|NCT00378482|27160541|P1|Overall Study|Lack of Efficacy|8
7821332|NCT00378482|27160541|P1|Overall Study|Lost to Follow-up|1
7821333|NCT00378378|27160553|P3|Overall Study|Non-compliance with protocol|1
7821334|NCT00378378|27160554|P2|Overall Study|Non-compliance with protocol|0
7821335|NCT00378378|27160555|P1|Overall Study|Non-compliance with protocol|0
7821336|NCT00378378|27160553|P3|Overall Study|Treatment Failure|1
7821337|NCT00378378|27160554|P2|Overall Study|Treatment Failure|0
7821338|NCT00378378|27160555|P1|Overall Study|Treatment Failure|0
7821339|NCT00378378|27160553|P3|Overall Study|Withdrawal by Subject|0
7821340|NCT00378378|27160554|P2|Overall Study|Withdrawal by Subject|1
7821341|NCT00378378|27160555|P1|Overall Study|Withdrawal by Subject|0
7821342|NCT00378209|27160601|P1|Overall Study|Treatment delay|1
7821343|NCT00378209|27160601|P1|Overall Study|Death|1
7821344|NCT00378209|27160601|P1|Overall Study|Physician Decision|3
7821345|NCT00378209|27160601|P1|Overall Study|Initiation of non-protocol therapy|3
7821346|NCT00378209|27160601|P1|Overall Study|Adverse Event|3
7821347|NCT00378209|27160601|P1|Overall Study|Progressive disease|11
7821348|NCT00378105|27160611|P2|Overall Study|necessity to increase lenalidomide dose|1
7821349|NCT00378105|27160612|P1|Overall Study|necessity to increase lenalidomide dose|0
7821350|NCT00378105|27160611|P2|Overall Study|Going non-protocol therapy|1
7821351|NCT00378105|27160612|P1|Overall Study|Going non-protocol therapy|0
7821352|NCT00378105|27160611|P2|Overall Study|Physician Decision|2
7821353|NCT00378105|27160612|P1|Overall Study|Physician Decision|0
7821354|NCT00378105|27160611|P2|Overall Study|remain on study|11
7821355|NCT00378105|27160612|P1|Overall Study|remain on study|3
7821356|NCT00378105|27160611|P2|Overall Study|Progressive disease|3
7821357|NCT00378105|27160612|P1|Overall Study|Progressive disease|3
7821358|NCT00378105|27160611|P2|Overall Study|Going to transplant|8
7821359|NCT00378105|27160612|P1|Overall Study|Going to transplant|7
7821360|NCT00378105|27160611|P2|Overall Study|Death|0
7821361|NCT00378105|27160612|P1|Overall Study|Death|1
7821362|NCT00378105|27160611|P2|Overall Study|Withdrawal by Subject|3
7821363|NCT00378105|27160612|P1|Overall Study|Withdrawal by Subject|3
7821364|NCT00378105|27160611|P2|Overall Study|Adverse Event|1
7821365|NCT00378105|27160612|P1|Overall Study|Adverse Event|3
7821366|NCT00378079|27160624|P3|Overall Study|Lost to Follow-up|0
7821367|NCT00378079|27160625|P2|Overall Study|Lost to Follow-up|1
7821368|NCT00378079|27160626|P1|Overall Study|Lost to Follow-up|6
7821369|NCT00378014|27160648|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
7821370|NCT00378014|27160649|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
7821371|NCT00378014|27160648|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
7821372|NCT00378014|27160649|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
7821373|NCT00378014|27160648|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
7821374|NCT00378014|27160649|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
7821375|NCT00378014|27160648|P2|Extension (Month 12 to Month 59)|Administrative problems|0
7821376|NCT00378014|27160649|P1|Extension (Month 12 to Month 59)|Administrative problems|1
7821377|NCT00378014|27160648|P2|Extension (Month 12 to Month 59)|Death|2
7821378|NCT00378014|27160649|P1|Extension (Month 12 to Month 59)|Death|1
7821379|NCT00378014|27160648|P2|Extension (Month 12 to Month 59)|Adverse Event|7
7821380|NCT00378014|27160649|P1|Extension (Month 12 to Month 59)|Adverse Event|8
7821381|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
7821382|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
7821383|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Protocol deviation|1
7821384|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Protocol deviation|0
7821385|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
7821386|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
7821387|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
7821388|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
7821389|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Administrative Problems|2
7821390|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Administrative Problems|2
7821391|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Death|3
7821392|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Death|5
7821393|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Graft loss|2
7821394|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Graft loss|1
7821395|NCT00378014|27160648|P2|Core (Randomization to Month 11)|Adverse Event|0
7821396|NCT00378014|27160649|P1|Core (Randomization to Month 11)|Adverse Event|1
7821397|NCT00377962|27160675|P2|Extension Study: 12-24 Months|Unspecified reason|3
7821398|NCT00377962|27160676|P1|Extension Study: 12-24 Months|Unspecified reason|0
7821399|NCT00377962|27160675|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
7821400|NCT00377962|27160676|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
7821401|NCT00377962|27160675|P2|Extension Study: 12-24 Months|Adverse Event|0
7821402|NCT00377962|27160676|P1|Extension Study: 12-24 Months|Adverse Event|8
7821403|NCT00377962|27160675|P2|Extension Study: 12-24 Months|Death|1
7821404|NCT00377962|27160676|P1|Extension Study: 12-24 Months|Death|1
7821405|NCT00377962|27160675|P2|Core Study: 0-12 Months|Unspecified reasons|4
7821406|NCT00377962|27160676|P1|Core Study: 0-12 Months|Unspecified reasons|1
7821407|NCT00377962|27160675|P2|Core Study: 0-12 Months|Administrative Reason|1
7821408|NCT00377962|27160676|P1|Core Study: 0-12 Months|Administrative Reason|1
7821409|NCT00377962|27160675|P2|Core Study: 0-12 Months|Withdrew Consent|2
7821410|NCT00377962|27160676|P1|Core Study: 0-12 Months|Withdrew Consent|5
7821411|NCT00377962|27160675|P2|Core Study: 0-12 Months|Death|0
7821412|NCT00377962|27160676|P1|Core Study: 0-12 Months|Death|3
7821413|NCT00377962|27160675|P2|Core Study: 0-12 Months|Adverse Event|2
7821414|NCT00377962|27160676|P1|Core Study: 0-12 Months|Adverse Event|18
7821415|NCT00377858|27160712|P2|Overall Study|Death|3
7821416|NCT00377858|27160713|P1|Overall Study|Death|0
7821417|NCT00377858|27160712|P2|Overall Study|Sponsor Decision|2
7821418|NCT00377858|27160713|P1|Overall Study|Sponsor Decision|1
7821419|NCT00377858|27160712|P2|Overall Study|Entry Criteria Not Met|0
7821420|NCT00377858|27160713|P1|Overall Study|Entry Criteria Not Met|2
7821421|NCT00377858|27160712|P2|Overall Study|Adverse Event|1
7821422|NCT00377858|27160713|P1|Overall Study|Adverse Event|2
7821423|NCT00377858|27160712|P2|Overall Study|Protocol Violation|4
7821424|NCT00377858|27160713|P1|Overall Study|Protocol Violation|3
7821425|NCT00377858|27160712|P2|Overall Study|Physician Decision|5
7821426|NCT00377858|27160713|P1|Overall Study|Physician Decision|5
7821427|NCT00377858|27160712|P2|Overall Study|Lost to Follow-up|1
7821428|NCT00377858|27160713|P1|Overall Study|Lost to Follow-up|6
7821429|NCT00377858|27160712|P2|Overall Study|Withdrawal by Subject|11
7821430|NCT00377858|27160713|P1|Overall Study|Withdrawal by Subject|12
7821431|NCT00377819|27160766|P2|Overall Study|Protocol Violation|1
7821432|NCT00377819|27160767|P1|Overall Study|Protocol Violation|1
7821433|NCT00377819|27160766|P2|Overall Study|Lost to Follow-up|1
7821434|NCT00377819|27160767|P1|Overall Study|Lost to Follow-up|0
7821435|NCT00377819|27160766|P2|Overall Study|Death|1
7821436|NCT00377819|27160767|P1|Overall Study|Death|0
7821437|NCT00377819|27160766|P2|Overall Study|Withdrawal by Subject|4
7821438|NCT00377819|27160767|P1|Overall Study|Withdrawal by Subject|10
7821439|NCT00377819|27160766|P2|Overall Study|Adverse Event|3
7821440|NCT00377819|27160767|P1|Overall Study|Adverse Event|2
7821441|NCT00377676|27160796|P2|Overall Study|Other|58
7821442|NCT00377676|27160797|P1|Overall Study|Other|118
7821443|NCT00377676|27160796|P2|Overall Study|Lost to Follow-up|56
7821444|NCT00377676|27160797|P1|Overall Study|Lost to Follow-up|120
7821445|NCT00377676|27160796|P2|Overall Study|Withdrawal by Subject|72
7821446|NCT00377676|27160797|P1|Overall Study|Withdrawal by Subject|187
7821447|NCT00377676|27160796|P2|Overall Study|Death|2
7821448|NCT00377676|27160797|P1|Overall Study|Death|5
7821449|NCT00377676|27160796|P2|Overall Study|Protocol Violation|27
7821450|NCT00377676|27160797|P1|Overall Study|Protocol Violation|33
7821451|NCT00377676|27160796|P2|Overall Study|Adverse Event|107
7821452|NCT00377676|27160797|P1|Overall Study|Adverse Event|498
7821453|NCT00377637|27160813|P4|Maintenance Phase|Death|1
7821454|NCT00377637|27160814|P3|Maintenance Phase|Death|0
7821455|NCT00377637|27160815|P2|Maintenance Phase|Death|0
7821456|NCT00377637|27160816|P1|Maintenance Phase|Death|0
7821457|NCT00377637|27160813|P4|Maintenance Phase|Study medication stopped > 14 days|1
7821458|NCT00377637|27160814|P3|Maintenance Phase|Study medication stopped > 14 days|0
7821459|NCT00377637|27160815|P2|Maintenance Phase|Study medication stopped > 14 days|0
7821460|NCT00377637|27160816|P1|Maintenance Phase|Study medication stopped > 14 days|0
7821461|NCT00377637|27160813|P4|Maintenance Phase|Non-compliance|1
7821462|NCT00377637|27160814|P3|Maintenance Phase|Non-compliance|1
7821463|NCT00377637|27160815|P2|Maintenance Phase|Non-compliance|0
7821464|NCT00377637|27160816|P1|Maintenance Phase|Non-compliance|0
7821465|NCT00377637|27160813|P4|Maintenance Phase|Sponsor decision|3
7821466|NCT00377637|27160814|P3|Maintenance Phase|Sponsor decision|2
7821467|NCT00377637|27160815|P2|Maintenance Phase|Sponsor decision|0
7821468|NCT00377637|27160816|P1|Maintenance Phase|Sponsor decision|0
7821469|NCT00377637|27160813|P4|Maintenance Phase|Withdrawal by Subject|3
7821470|NCT00377637|27160814|P3|Maintenance Phase|Withdrawal by Subject|3
7821471|NCT00377637|27160815|P2|Maintenance Phase|Withdrawal by Subject|0
7821472|NCT00377637|27160816|P1|Maintenance Phase|Withdrawal by Subject|0
7821473|NCT00377637|27160813|P4|Maintenance Phase|Lost to Follow-up|1
7821474|NCT00377637|27160814|P3|Maintenance Phase|Lost to Follow-up|3
7821475|NCT00377637|27160815|P2|Maintenance Phase|Lost to Follow-up|0
7821476|NCT00377637|27160816|P1|Maintenance Phase|Lost to Follow-up|0
7821477|NCT00377637|27160813|P4|Maintenance Phase|Physician Decision|4
7821478|NCT00377637|27160814|P3|Maintenance Phase|Physician Decision|5
7821479|NCT00377637|27160815|P2|Maintenance Phase|Physician Decision|0
7821480|NCT00377637|27160816|P1|Maintenance Phase|Physician Decision|0
7821481|NCT00377637|27160813|P4|Maintenance Phase|Adverse Event|43
7821482|NCT00377637|27160814|P3|Maintenance Phase|Adverse Event|29
7821483|NCT00377637|27160815|P2|Maintenance Phase|Adverse Event|0
7821484|NCT00377637|27160816|P1|Maintenance Phase|Adverse Event|0
7821485|NCT00377637|27160813|P4|Induction Phase|Reason for withdrawal is not noted|0
7821486|NCT00377637|27160814|P3|Induction Phase|Reason for withdrawal is not noted|0
7821487|NCT00377637|27160815|P2|Induction Phase|Reason for withdrawal is not noted|0
7821488|NCT00377637|27160816|P1|Induction Phase|Reason for withdrawal is not noted|2
7821489|NCT00377637|27160813|P4|Induction Phase|Non-Compliance|0
7821490|NCT00377637|27160814|P3|Induction Phase|Non-Compliance|0
7821491|NCT00377637|27160815|P2|Induction Phase|Non-Compliance|0
7821492|NCT00377637|27160816|P1|Induction Phase|Non-Compliance|1
7821493|NCT00377637|27160813|P4|Induction Phase|Sponsor decision|0
7821494|NCT00377637|27160814|P3|Induction Phase|Sponsor decision|0
7821495|NCT00377637|27160815|P2|Induction Phase|Sponsor decision|2
7821496|NCT00377637|27160816|P1|Induction Phase|Sponsor decision|1
7821497|NCT00377637|27160813|P4|Induction Phase|Physician Decision|0
7821498|NCT00377637|27160814|P3|Induction Phase|Physician Decision|0
7821499|NCT00377637|27160815|P2|Induction Phase|Physician Decision|1
7821500|NCT00377637|27160816|P1|Induction Phase|Physician Decision|3
7821501|NCT00377637|27160813|P4|Induction Phase|Withdrawal by Subject|0
7821502|NCT00377637|27160814|P3|Induction Phase|Withdrawal by Subject|0
7821503|NCT00377637|27160815|P2|Induction Phase|Withdrawal by Subject|6
7821504|NCT00377637|27160816|P1|Induction Phase|Withdrawal by Subject|5
7821505|NCT00377637|27160813|P4|Induction Phase|Death|0
7821506|NCT00377637|27160814|P3|Induction Phase|Death|0
7821507|NCT00377637|27160815|P2|Induction Phase|Death|3
7821508|NCT00377637|27160816|P1|Induction Phase|Death|1
7821509|NCT00377637|27160813|P4|Induction Phase|Lost to Follow-up|0
7821510|NCT00377637|27160814|P3|Induction Phase|Lost to Follow-up|0
7821511|NCT00377637|27160815|P2|Induction Phase|Lost to Follow-up|1
7821512|NCT00377637|27160816|P1|Induction Phase|Lost to Follow-up|2
7821513|NCT00377637|27160813|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7821514|NCT00377637|27160814|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7821515|NCT00377637|27160815|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
7821516|NCT00377637|27160816|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7821517|NCT00377637|27160813|P4|Induction Phase|Deterioration/serum creatinine|0
7821518|NCT00377637|27160814|P3|Induction Phase|Deterioration/serum creatinine|0
7821519|NCT00377637|27160815|P2|Induction Phase|Deterioration/serum creatinine|0
7821520|NCT00377637|27160816|P1|Induction Phase|Deterioration/serum creatinine|2
7821521|NCT00377637|27160813|P4|Induction Phase|Adverse Event|0
7821522|NCT00377637|27160814|P3|Induction Phase|Adverse Event|0
7821523|NCT00377637|27160815|P2|Induction Phase|Adverse Event|21
7821524|NCT00377637|27160816|P1|Induction Phase|Adverse Event|12
7821525|NCT00377611|27160852|P2|Overall Study|Other|3
7821526|NCT00377611|27160853|P1|Overall Study|Other|0
7821527|NCT00377611|27160852|P2|Overall Study|Lost to Follow-up|16
7821528|NCT00377611|27160853|P1|Overall Study|Lost to Follow-up|18
7821529|NCT00377611|27160852|P2|Overall Study|Withdrawal by Subject|5
7821530|NCT00377611|27160853|P1|Overall Study|Withdrawal by Subject|0
7821531|NCT00377611|27160852|P2|Overall Study|Protocol Violation|0
7821532|NCT00377611|27160853|P1|Overall Study|Protocol Violation|2
7821533|NCT00377611|27160852|P2|Overall Study|Adverse Event|9
7821534|NCT00377611|27160853|P1|Overall Study|Adverse Event|2
7821535|NCT00377520|27160955|P1|Overall Study|Ineligible (Prior radiation)|1
7821536|NCT00377455|27160960|P1|Overall Study|Withdrawal by Subject|1
7821537|NCT00377429|27160968|P1|Overall Study|Patient non-compliance|1
7821538|NCT00377429|27160968|P1|Overall Study|Physician Decision|1
7821539|NCT00377429|27160968|P1|Overall Study|Adverse Event|8
7821540|NCT00377429|27160968|P1|Overall Study|Withdrawal by Subject|5
7821541|NCT00377403|27160979|P2|Overall Study|Unable to contact for telephone intervie|7
7821542|NCT00377403|27160980|P1|Overall Study|Unable to contact for telephone intervie|4
7821543|NCT00377364|27160988|P2|Overall Study|Withdrawal by Subject|0
7821544|NCT00377364|27160989|P1|Overall Study|Withdrawal by Subject|1
7821545|NCT00377364|27160988|P2|Overall Study|Lost to Follow-up|0
7821546|NCT00377364|27160989|P1|Overall Study|Lost to Follow-up|1
7821547|NCT00377312|27161015|P2|Overall Study|Adverse Event|1
7821548|NCT00377312|27161016|P1|Overall Study|Adverse Event|1
7821549|NCT00377299|27161048|P2|Overall Study|Withdrawal by Subject|4
7821550|NCT00377299|27161049|P1|Overall Study|Withdrawal by Subject|5
7821551|NCT00377299|27161048|P2|Overall Study|Adverse Event|1
7821552|NCT00377299|27161049|P1|Overall Study|Adverse Event|0
7821553|NCT00377299|27161048|P2|Overall Study|Lost to Follow-up|19
7821554|NCT00377299|27161049|P1|Overall Study|Lost to Follow-up|14
7821555|NCT00377260|27161065|P2|Overall Study|Withdrawal by Subject|4
7821556|NCT00377260|27161066|P1|Overall Study|Withdrawal by Subject|2
7821557|NCT00377260|27161065|P2|Overall Study|Lost to Follow-up|1
7821558|NCT00377260|27161066|P1|Overall Study|Lost to Follow-up|0
7821559|NCT00377234|27161120|P2|Overall Study|Not assigned|2
7821560|NCT00377234|27161121|P1|Overall Study|Not assigned|3
7821561|NCT00377234|27161120|P2|Overall Study|Administrative|1
7821562|NCT00377234|27161121|P1|Overall Study|Administrative|2
7821563|NCT00377234|27161120|P2|Overall Study|Lost to Follow-up|2
7821564|NCT00377234|27161121|P1|Overall Study|Lost to Follow-up|4
7821565|NCT00377234|27161120|P2|Overall Study|Withdrawal by Subject|9
7821566|NCT00377234|27161121|P1|Overall Study|Withdrawal by Subject|11
7821567|NCT00377234|27161120|P2|Overall Study|Adverse Event|17
7821568|NCT00377234|27161121|P1|Overall Study|Adverse Event|14
7821569|NCT00377156|27161139|P2|Overall Study|Other|2
7821570|NCT00377156|27161140|P1|Overall Study|Other|5
7821571|NCT00377156|27161139|P2|Overall Study|Disability or language problem|1
7821572|NCT00377156|27161140|P1|Overall Study|Disability or language problem|0
7821573|NCT00377156|27161139|P2|Overall Study|Ineligible|1
7821574|NCT00377156|27161140|P1|Overall Study|Ineligible|0
7821575|NCT00377156|27161139|P2|Overall Study|Refused testing|1
7821576|NCT00377156|27161140|P1|Overall Study|Refused testing|0
7821577|NCT00377156|27161139|P2|Overall Study|Cancellation|0
7821578|NCT00377156|27161140|P1|Overall Study|Cancellation|1
7821579|NCT00377156|27161139|P2|Overall Study|Had follow-up <90 d|6
7821580|NCT00377156|27161140|P1|Overall Study|Had follow-up <90 d|3
7821581|NCT00377156|27161139|P2|Overall Study|Withdrawal by Subject|24
7821582|NCT00377156|27161140|P1|Overall Study|Withdrawal by Subject|16
7821583|NCT00377156|27161139|P2|Overall Study|Death|19
7821584|NCT00377156|27161140|P1|Overall Study|Death|23
7821585|NCT00376961|27161154|P2|Maintenance|Ineligible|3
7821586|NCT00376961|27161155|P1|Maintenance|Ineligible|0
7821587|NCT00376961|27161154|P2|Maintenance|Progression/relapse|18
7821588|NCT00376961|27161155|P1|Maintenance|Progression/relapse|0
7821589|NCT00376961|27161154|P2|Maintenance|Refusal Unrelated to Adverse Event|1
7821590|NCT00376961|27161155|P1|Maintenance|Refusal Unrelated to Adverse Event|0
7821591|NCT00376961|27161154|P2|Maintenance|Adverse Event|1
7821592|NCT00376961|27161155|P1|Maintenance|Adverse Event|0
7821593|NCT00376961|27161154|P2|Initial Registration|Ineligible|0
7821594|NCT00376961|27161155|P1|Initial Registration|Ineligible|3
7821595|NCT00376961|27161154|P2|Initial Registration|Progression/relapse|0
7821596|NCT00376961|27161155|P1|Initial Registration|Progression/relapse|1
7821597|NCT00376961|27161154|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
7821598|NCT00376961|27161155|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
7821599|NCT00376961|27161154|P2|Initial Registration|Adverse Event|0
7821600|NCT00376961|27161155|P1|Initial Registration|Adverse Event|1
7821601|NCT00376688|27161227|P1|Overall Study|Death|1
7821602|NCT00376688|27161227|P1|Overall Study|Adverse Event|3
7821603|NCT00376675|27161233|P2|Overall Study|Other Reason|7
7821604|NCT00376675|27161234|P1|Overall Study|Other Reason|1
7821605|NCT00376675|27161233|P2|Overall Study|Adverse Event|5
7821606|NCT00376675|27161234|P1|Overall Study|Adverse Event|10
7821607|NCT00376675|27161233|P2|Overall Study|Withdrawal by Subject|2
7821608|NCT00376675|27161234|P1|Overall Study|Withdrawal by Subject|9
7821609|NCT00376532|27161283|P2|Overall Study|Lack sufficient blood sample|6
7821610|NCT00376532|27161284|P1|Overall Study|Lack sufficient blood sample|6
7821611|NCT00376506|27161294|P2|Overall Study|Death|2
7821612|NCT00376506|27161295|P1|Overall Study|Death|0
7821613|NCT00376259|27161326|P2|Overall Study|Patient request|0
7821614|NCT00376259|27161327|P1|Overall Study|Patient request|1
7821615|NCT00376259|27161326|P2|Overall Study|Sponsor request - study termination|21
7821616|NCT00376259|27161327|P1|Overall Study|Sponsor request - study termination|21
7821617|NCT00376246|27161339|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
7821618|NCT00376246|27161340|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
7821619|NCT00376246|27161339|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
7821620|NCT00376246|27161340|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
7821621|NCT00376246|27161339|P2|First Intervention (2 Weeks)|Adverse Event|0
7821622|NCT00376246|27161340|P1|First Intervention (2 Weeks)|Adverse Event|2
7821623|NCT00376220|27161350|P2|Overall Study|Withdrawal by Subject|2
7821624|NCT00376220|27161351|P1|Overall Study|Withdrawal by Subject|3
7821625|NCT00376220|27161350|P2|Overall Study|Lost to Follow-up|10
7821626|NCT00376220|27161351|P1|Overall Study|Lost to Follow-up|7
7821627|NCT00376168|27161359|P2|Overall Study|Pregnancy|0
7821628|NCT00376168|27161360|P1|Overall Study|Pregnancy|1
7821629|NCT00376168|27161359|P2|Overall Study|Adverse Event|1
7821630|NCT00376168|27161360|P1|Overall Study|Adverse Event|1
7821631|NCT00375934|27161401|P2|Overall Study|Physician Decision|1
7821632|NCT00375934|27161402|P1|Overall Study|Physician Decision|0
7821633|NCT00375934|27161401|P2|Overall Study|Lack of Efficacy|2
7821634|NCT00375934|27161402|P1|Overall Study|Lack of Efficacy|0
7821635|NCT00375934|27161401|P2|Overall Study|Withdrawal by Subject|2
7821636|NCT00375934|27161402|P1|Overall Study|Withdrawal by Subject|2
7821637|NCT00375934|27161401|P2|Overall Study|Adverse Event|1
7821638|NCT00375934|27161402|P1|Overall Study|Adverse Event|1
7821639|NCT00375752|27161460|P2|Overall Study|Administrative Problems|1
7821640|NCT00375752|27161461|P1|Overall Study|Administrative Problems|0
7821641|NCT00375752|27161460|P2|Overall Study|Protocol Violation|2
7821642|NCT00375752|27161461|P1|Overall Study|Protocol Violation|0
7821643|NCT00375752|27161460|P2|Overall Study|Abnormal Laboratory Value(s)|1
7821644|NCT00375752|27161461|P1|Overall Study|Abnormal Laboratory Value(s)|1
7821645|NCT00375752|27161460|P2|Overall Study|Withdrawal by Subject|1
7821646|NCT00375752|27161461|P1|Overall Study|Withdrawal by Subject|6
7821647|NCT00375752|27161460|P2|Overall Study|Adverse Event|6
7821648|NCT00375752|27161461|P1|Overall Study|Adverse Event|1
7821649|NCT00375752|27161460|P2|Overall Study|Lack of Efficacy|4
7821650|NCT00375752|27161461|P1|Overall Study|Lack of Efficacy|4
7821651|NCT00375674|27161492|P2|Overall Study|Enrolled but not treated|2
7821652|NCT00375674|27161493|P1|Overall Study|Enrolled but not treated|3
7821653|NCT00375674|27161492|P2|Overall Study|Lost to Follow-up|15
7821654|NCT00375674|27161493|P1|Overall Study|Lost to Follow-up|17
7821655|NCT00375674|27161492|P2|Overall Study|Participants refused further follow-up|30
7821656|NCT00375674|27161493|P1|Overall Study|Participants refused further follow-up|31
7821657|NCT00375674|27161492|P2|Overall Study|Death|76
7821658|NCT00375674|27161493|P1|Overall Study|Death|67
7821659|NCT00375674|27161492|P2|Overall Study|Other|18
7821660|NCT00375674|27161493|P1|Overall Study|Other|26
7821661|NCT00375609|27161522|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
7821662|NCT00375609|27161523|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
7821663|NCT00375609|27161524|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
7821664|NCT00375609|27161522|P3|Overall Study|Withdrawal by Subject|0
7821665|NCT00375609|27161523|P2|Overall Study|Withdrawal by Subject|4
7821666|NCT00375609|27161524|P1|Overall Study|Withdrawal by Subject|1
7821667|NCT00375609|27161522|P3|Overall Study|Physician Decision|1
7821668|NCT00375609|27161523|P2|Overall Study|Physician Decision|0
7821669|NCT00375609|27161524|P1|Overall Study|Physician Decision|0
7821670|NCT00375609|27161522|P3|Overall Study|Lost to Follow-up|0
7821671|NCT00375609|27161523|P2|Overall Study|Lost to Follow-up|0
7821672|NCT00375609|27161524|P1|Overall Study|Lost to Follow-up|1
7821673|NCT00375609|27161522|P3|Overall Study|Adverse Event|0
7821674|NCT00375609|27161523|P2|Overall Study|Adverse Event|3
7821675|NCT00375609|27161524|P1|Overall Study|Adverse Event|0
7821676|NCT00375609|27161522|P3|Overall Study|Did not receive treatment|0
7821677|NCT00375609|27161523|P2|Overall Study|Did not receive treatment|0
7821678|NCT00375609|27161524|P1|Overall Study|Did not receive treatment|1
7821679|NCT00375518|27161540|P2|Overall Study|Death|1
7821680|NCT00375518|27161541|P1|Overall Study|Death|0
7821681|NCT00375518|27161540|P2|Overall Study|Patient Not Treated|6
7821682|NCT00375518|27161541|P1|Overall Study|Patient Not Treated|6
7821683|NCT00375518|27161540|P2|Overall Study|Withdrawal by Subject|10
7821684|NCT00375518|27161541|P1|Overall Study|Withdrawal by Subject|2
7821685|NCT00375505|27161549|P2|Overall Study|Adverse Event|2
7821686|NCT00375505|27161550|P1|Overall Study|Adverse Event|1
7821687|NCT00375492|27161594|P2|Overall Study|Withdrawal by Subject|6
7821688|NCT00375492|27161595|P1|Overall Study|Withdrawal by Subject|6
7821689|NCT00375492|27161594|P2|Overall Study|Sponsor Decision|1
7821690|NCT00375492|27161595|P1|Overall Study|Sponsor Decision|0
7821691|NCT00375492|27161594|P2|Overall Study|Protocol Violation|3
7821692|NCT00375492|27161595|P1|Overall Study|Protocol Violation|6
7821693|NCT00375492|27161594|P2|Overall Study|Physician Decision|4
7821694|NCT00375492|27161595|P1|Overall Study|Physician Decision|0
7821695|NCT00375492|27161594|P2|Overall Study|Lost to Follow-up|5
7821696|NCT00375492|27161595|P1|Overall Study|Lost to Follow-up|10
7821697|NCT00375492|27161594|P2|Overall Study|Loss of Glucose Control|1
7821698|NCT00375492|27161595|P1|Overall Study|Loss of Glucose Control|0
7821699|NCT00375492|27161594|P2|Overall Study|Entry Criteria Not Met|1
7821700|NCT00375492|27161595|P1|Overall Study|Entry Criteria Not Met|0
7821701|NCT00375492|27161594|P2|Overall Study|Adverse Event|5
7821702|NCT00375492|27161595|P1|Overall Study|Adverse Event|4
7821703|NCT00375427|27161625|P2|Overall Study|Death|10
7821704|NCT00375427|27161626|P1|Overall Study|Death|11
7821705|NCT00375427|27161625|P2|Overall Study|Administrative reasons|1
7821706|NCT00375427|27161626|P1|Overall Study|Administrative reasons|0
7821707|NCT00375427|27161625|P2|Overall Study|Lost to Follow-up|1
7821708|NCT00375427|27161626|P1|Overall Study|Lost to Follow-up|1
7821709|NCT00375427|27161625|P2|Overall Study|Withdrawal by Subject|13
7821710|NCT00375427|27161626|P1|Overall Study|Withdrawal by Subject|9
7821711|NCT00375427|27161625|P2|Overall Study|Protocol Violation|8
7821712|NCT00375427|27161626|P1|Overall Study|Protocol Violation|10
7821713|NCT00375427|27161625|P2|Overall Study|Patient no longer requires study drug|7
7821714|NCT00375427|27161626|P1|Overall Study|Patient no longer requires study drug|3
7821715|NCT00375427|27161625|P2|Overall Study|Unsatisfactory therapeutic effect|4
7821716|NCT00375427|27161626|P1|Overall Study|Unsatisfactory therapeutic effect|4
7821717|NCT00375427|27161625|P2|Overall Study|Abnormal laboratory value(s)|2
7821718|NCT00375427|27161626|P1|Overall Study|Abnormal laboratory value(s)|1
7821719|NCT00375427|27161625|P2|Overall Study|Abnormal test procedure result(s)|1
7821720|NCT00375427|27161626|P1|Overall Study|Abnormal test procedure result(s)|0
7821721|NCT00375427|27161625|P2|Overall Study|Adverse Event|27
7821722|NCT00375427|27161626|P1|Overall Study|Adverse Event|21
7821723|NCT00375219|27161651|P3|Overall Study|Withdrawal by Subject|0
7821724|NCT00375219|27161652|P2|Overall Study|Withdrawal by Subject|0
7821725|NCT00375219|27161653|P1|Overall Study|Withdrawal by Subject|1
7821726|NCT00375219|27161651|P3|Overall Study|Cord blood transplantation|0
7821727|NCT00375219|27161652|P2|Overall Study|Cord blood transplantation|0
7821728|NCT00375219|27161653|P1|Overall Study|Cord blood transplantation|1
7821729|NCT00375219|27161651|P3|Overall Study|Allograft|0
7821730|NCT00375219|27161652|P2|Overall Study|Allograft|0
7821731|NCT00375219|27161653|P1|Overall Study|Allograft|2
7821732|NCT00375219|27161651|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
7821733|NCT00375219|27161652|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
7821734|NCT00375219|27161653|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
7821735|NCT00375219|27161651|P3|Overall Study|Hematologic resistance|0
7821736|NCT00375219|27161652|P2|Overall Study|Hematologic resistance|0
7821737|NCT00375219|27161653|P1|Overall Study|Hematologic resistance|1
7821738|NCT00375219|27161651|P3|Overall Study|Death|7
7821739|NCT00375219|27161652|P2|Overall Study|Death|3
7821740|NCT00375219|27161653|P1|Overall Study|Death|4
7821741|NCT00375219|27161651|P3|Overall Study|Disease progression|12
7821742|NCT00375219|27161652|P2|Overall Study|Disease progression|9
7821743|NCT00375219|27161653|P1|Overall Study|Disease progression|18
7821744|NCT00375219|27161651|P3|Overall Study|Lost to Follow-up|0
7821745|NCT00375219|27161652|P2|Overall Study|Lost to Follow-up|1
7821746|NCT00375219|27161653|P1|Overall Study|Lost to Follow-up|1
7821747|NCT00375219|27161651|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
7821748|NCT00375219|27161652|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
7821749|NCT00375219|27161653|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
7821750|NCT00375219|27161651|P3|Overall Study|Protocol Violation|1
7821751|NCT00375219|27161652|P2|Overall Study|Protocol Violation|0
7821752|NCT00375219|27161653|P1|Overall Study|Protocol Violation|1
7821753|NCT00375219|27161651|P3|Overall Study|Adverse Event|1
7821754|NCT00375219|27161652|P2|Overall Study|Adverse Event|2
7821755|NCT00375219|27161653|P1|Overall Study|Adverse Event|8
7821756|NCT00375219|27161651|P3|Overall Study|Failure to achieve a response|0
7821757|NCT00375219|27161652|P2|Overall Study|Failure to achieve a response|2
7821758|NCT00375219|27161653|P1|Overall Study|Failure to achieve a response|16
7821759|NCT00374907|27161736|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
7821760|NCT00374907|27161737|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
7821761|NCT00374907|27161736|P2|116-Week Short-term + Long-term Period|Adverse Event|2
7821762|NCT00374907|27161737|P1|116-Week Short-term + Long-term Period|Adverse Event|0
7821763|NCT00374907|27161736|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
7821764|NCT00374907|27161737|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
7821765|NCT00374907|27161736|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
7821766|NCT00374907|27161737|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
7821767|NCT00374907|27161736|P2|12-Week Short-term Period|Subject Withdrew Consent|1
7821768|NCT00374907|27161737|P1|12-Week Short-term Period|Subject Withdrew Consent|3
7821769|NCT00374868|27161749|P1|Overall Study|Other - Not Specified|1
7821770|NCT00374868|27161749|P1|Overall Study|Death|2
7821771|NCT00374868|27161749|P1|Overall Study|Lost to Follow-up|1
7821772|NCT00374868|27161749|P1|Overall Study|Physician Decision|13
7821773|NCT00374868|27161749|P1|Overall Study|Progressive Disease|7
7821774|NCT00374868|27161749|P1|Overall Study|Adverse Event|12
7821775|NCT00374556|27161813|P2|Overall Study|Removed at baseline due to medical cond|1
7821776|NCT00374556|27161814|P1|Overall Study|Removed at baseline due to medical cond|0
7821777|NCT00374556|27161813|P2|Overall Study|Lost to Follow-up|0
7821778|NCT00374556|27161814|P1|Overall Study|Lost to Follow-up|1
7821779|NCT00374452|27161875|P2|Overall Study|Withdrawal by Subject|2
7821780|NCT00374452|27161876|P1|Overall Study|Withdrawal by Subject|0
7821781|NCT00374452|27161875|P2|Overall Study|Left clinic after intervention started|1
7821782|NCT00374452|27161876|P1|Overall Study|Left clinic after intervention started|1
7821783|NCT00374452|27161875|P2|Overall Study|Change in job role before intervention|1
7821784|NCT00374452|27161876|P1|Overall Study|Change in job role before intervention|0
7821785|NCT00374452|27161875|P2|Overall Study|Left clinic before intervention started|1
7821786|NCT00374452|27161876|P1|Overall Study|Left clinic before intervention started|4
7821787|NCT00374322|27161889|P2|Overall Study|Did Not Receive Study Medication|6
7821788|NCT00374322|27161890|P1|Overall Study|Did Not Receive Study Medication|8
7821789|NCT00374322|27161889|P2|Overall Study|Withdrew Consent During Follow-up|5
7821790|NCT00374322|27161890|P1|Overall Study|Withdrew Consent During Follow-up|0
7821791|NCT00374322|27161889|P2|Overall Study|Noncompliance with Study Requirements|1
7821792|NCT00374322|27161890|P1|Overall Study|Noncompliance with Study Requirements|0
7821793|NCT00374322|27161889|P2|Overall Study|Started Another Chemotherapy Regimen|1
7821794|NCT00374322|27161890|P1|Overall Study|Started Another Chemotherapy Regimen|0
7821795|NCT00374322|27161889|P2|Overall Study|Participant Changed Physician|0
7821796|NCT00374322|27161890|P1|Overall Study|Participant Changed Physician|1
7821797|NCT00374322|27161889|P2|Overall Study|Site Closed|2
7821798|NCT00374322|27161890|P1|Overall Study|Site Closed|2
7821799|NCT00374322|27161889|P2|Overall Study|Severe Toxicity|0
7821800|NCT00374322|27161890|P1|Overall Study|Severe Toxicity|1
7821801|NCT00374322|27161889|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
7821802|NCT00374322|27161890|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
7821803|NCT00374322|27161889|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
7821804|NCT00374322|27161890|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
7821805|NCT00374322|27161889|P2|Overall Study|Sponsor Decision|3
7821806|NCT00374322|27161890|P1|Overall Study|Sponsor Decision|2
7821807|NCT00374322|27161889|P2|Overall Study|Par. Consented to Survival FU Only|1
7821808|NCT00374322|27161890|P1|Overall Study|Par. Consented to Survival FU Only|3
7821809|NCT00374322|27161889|P2|Overall Study|Physician Decision|32
7821810|NCT00374322|27161890|P1|Overall Study|Physician Decision|36
7821811|NCT00374322|27161889|P2|Overall Study|Sponsor Terminated Study|990
7821812|NCT00374322|27161890|P1|Overall Study|Sponsor Terminated Study|866
7821813|NCT00374322|27161889|P2|Overall Study|Withdrawal by Subject|167
7821814|NCT00374322|27161890|P1|Overall Study|Withdrawal by Subject|235
7821815|NCT00374322|27161889|P2|Overall Study|Protocol Violation|3
7821816|NCT00374322|27161890|P1|Overall Study|Protocol Violation|8
7821817|NCT00374322|27161889|P2|Overall Study|Lost to Follow-up|90
7821818|NCT00374322|27161890|P1|Overall Study|Lost to Follow-up|92
7821819|NCT00374140|27161981|P1|Overall Study|Protocol Violation|1
7821820|NCT00374140|27161981|P1|Overall Study|Lost to Follow-up|1
7821821|NCT00374127|27161988|P1|Overall Study|Pregnancy|1
7821822|NCT00374127|27161988|P1|Overall Study|Protocol Violation|5
7821823|NCT00374127|27161988|P1|Overall Study|Blood could not be drawn.|2
7821824|NCT00374127|27161988|P1|Overall Study|Did not inhale during smoking procedure.|3
7821825|NCT00373958|27162037|P2|Toddler Dose|Withdrawn after infant series|25
7821826|NCT00373958|27162038|P1|Toddler Dose|Withdrawn after infant series|22
7821827|NCT00373958|27162037|P2|Toddler Dose|Protocol Violation|1
7821828|NCT00373958|27162038|P1|Toddler Dose|Protocol Violation|0
7821829|NCT00373958|27162037|P2|Toddler Dose|Failed to return|2
7821830|NCT00373958|27162038|P1|Toddler Dose|Failed to return|1
7821831|NCT00373958|27162037|P2|Toddler Dose|Withdrawal by Subject|2
7821832|NCT00373958|27162038|P1|Toddler Dose|Withdrawal by Subject|2
7821833|NCT00373958|27162037|P2|Toddler Dose|Lost to Follow-up|8
7821834|NCT00373958|27162038|P1|Toddler Dose|Lost to Follow-up|5
7821835|NCT00373958|27162037|P2|Infant Series|Physician Decision|1
7821836|NCT00373958|27162038|P1|Infant Series|Physician Decision|1
7821837|NCT00373958|27162037|P2|Infant Series|Adverse Event|1
7821838|NCT00373958|27162038|P1|Infant Series|Adverse Event|3
7821839|NCT00373958|27162037|P2|Infant Series|Consent was not received|0
7821840|NCT00373958|27162038|P1|Infant Series|Consent was not received|1
7821841|NCT00373958|27162037|P2|Infant Series|Child relocated|0
7821842|NCT00373958|27162038|P1|Infant Series|Child relocated|1
7821843|NCT00373958|27162037|P2|Infant Series|Lost Kaiser coverage|0
7821844|NCT00373958|27162038|P1|Infant Series|Lost Kaiser coverage|4
7821845|NCT00373958|27162037|P2|Infant Series|Protocol Violation|7
7821846|NCT00373958|27162038|P1|Infant Series|Protocol Violation|3
7821847|NCT00373958|27162037|P2|Infant Series|Lost to Follow-up|5
7821848|NCT00373958|27162038|P1|Infant Series|Lost to Follow-up|6
7821849|NCT00373958|27162037|P2|Infant Series|Failed to return|13
7821850|NCT00373958|27162038|P1|Infant Series|Failed to return|8
7821851|NCT00373958|27162037|P2|Infant Series|Withdrawal by Subject|15
7821852|NCT00373958|27162038|P1|Infant Series|Withdrawal by Subject|13
7821853|NCT00373880|27162086|P1|Overall Study|Protocol Violation|14
7821854|NCT00373880|27162086|P1|Overall Study|Arrested|1
7821855|NCT00373880|27162086|P1|Overall Study|Physician Decision|3
7821856|NCT00373685|27162131|P2|Overall Study|Randomized, not treated|77
7821857|NCT00373685|27162132|P1|Overall Study|Randomized, not treated|51
7821858|NCT00373685|27162131|P2|Overall Study|Final Status Unknown|4
7821859|NCT00373685|27162132|P1|Overall Study|Final Status Unknown|12
7821860|NCT00373685|27162131|P2|Overall Study|Protocol Violation|182
7821861|NCT00373685|27162132|P1|Overall Study|Protocol Violation|191
7821862|NCT00373685|27162131|P2|Overall Study|Other|146
7821863|NCT00373685|27162132|P1|Overall Study|Other|149
7821864|NCT00373685|27162131|P2|Overall Study|No longer willing to participate|352
7821865|NCT00373685|27162132|P1|Overall Study|No longer willing to participate|337
7821866|NCT00373685|27162131|P2|Overall Study|Lost to follow up|103
7821867|NCT00373685|27162132|P1|Overall Study|Lost to follow up|83
7821868|NCT00373685|27162131|P2|Overall Study|Did not meet entrance criteria|184
7821869|NCT00373685|27162132|P1|Overall Study|Did not meet entrance criteria|167
7821870|NCT00373685|27162131|P2|Overall Study|Insufficient clinical response|119
7821871|NCT00373685|27162132|P1|Overall Study|Insufficient clinical response|169
7821872|NCT00373685|27162131|P2|Overall Study|Adverse Event|253
7821873|NCT00373685|27162132|P1|Overall Study|Adverse Event|278
7821874|NCT00373685|27162131|P2|Overall Study|Death|1
7821875|NCT00373685|27162132|P1|Overall Study|Death|2
7821876|NCT00373529|27162166|P1|Overall Study|Consent violation|1
7821877|NCT00373529|27162166|P1|Overall Study|Failed independent confirmation of AML|3
7821878|NCT00373529|27162166|P1|Overall Study|Other|8
7821879|NCT00373529|27162166|P1|Overall Study|Need for treatment prohibited by study|1
7821880|NCT00373529|27162166|P1|Overall Study|Death|16
7821881|NCT00373529|27162166|P1|Overall Study|Disease recurrence|10
7821882|NCT00373529|27162166|P1|Overall Study|Treatment failure|36
7821883|NCT00373529|27162166|P1|Overall Study|Adverse Event|7
7821884|NCT00373529|27162166|P1|Overall Study|Withdrawal by Subject|7
7821885|NCT00373529|27162166|P1|Overall Study|Physician Decision|19
7821886|NCT00373490|27162178|P2|Overall Study|Withdrawal by Subject|1
7821887|NCT00373490|27162179|P1|Overall Study|Withdrawal by Subject|0
7821888|NCT00373490|27162178|P2|Overall Study|Lack of Efficacy|4
7821889|NCT00373490|27162179|P1|Overall Study|Lack of Efficacy|9
7821890|NCT00373490|27162178|P2|Overall Study|Adverse Event|1
7821891|NCT00373490|27162179|P1|Overall Study|Adverse Event|0
7821892|NCT00373425|27162202|P5|Overall Study|Death|0
7821893|NCT00373425|27162203|P4|Overall Study|Death|1
7821894|NCT00373425|27162204|P3|Overall Study|Death|3
7821895|NCT00373425|27162205|P2|Overall Study|Death|0
7821896|NCT00373425|27162206|P1|Overall Study|Death|7
7821897|NCT00373425|27162202|P5|Overall Study|Medical/ethical/noncompliance reason|5
7821898|NCT00373425|27162203|P4|Overall Study|Medical/ethical/noncompliance reason|2
7821899|NCT00373425|27162204|P3|Overall Study|Medical/ethical/noncompliance reason|10
7821900|NCT00373425|27162205|P2|Overall Study|Medical/ethical/noncompliance reason|9
7821901|NCT00373425|27162206|P1|Overall Study|Medical/ethical/noncompliance reason|21
7821902|NCT00373425|27162202|P5|Overall Study|Patient request|7
7821903|NCT00373425|27162203|P4|Overall Study|Patient request|6
7821904|NCT00373425|27162204|P3|Overall Study|Patient request|43
7821905|NCT00373425|27162205|P2|Overall Study|Patient request|18
7821906|NCT00373425|27162206|P1|Overall Study|Patient request|35
7821907|NCT00373425|27162202|P5|Overall Study|Adverse Event|34
7821908|NCT00373425|27162203|P4|Overall Study|Adverse Event|0
7821909|NCT00373425|27162204|P3|Overall Study|Adverse Event|59
7821910|NCT00373425|27162205|P2|Overall Study|Adverse Event|22
7821911|NCT00373425|27162206|P1|Overall Study|Adverse Event|191
7821912|NCT00373425|27162202|P5|Overall Study|Relapse of NSCLC|26
7821913|NCT00373425|27162203|P4|Overall Study|Relapse of NSCLC|2
7821914|NCT00373425|27162204|P3|Overall Study|Relapse of NSCLC|19
7821915|NCT00373425|27162205|P2|Overall Study|Relapse of NSCLC|104
7821916|NCT00373425|27162206|P1|Overall Study|Relapse of NSCLC|116
7821917|NCT00373295|27162301|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
7821918|NCT00373295|27162302|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
7821919|NCT00373295|27162303|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
7821920|NCT00373295|27162304|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
7821921|NCT00373295|27162305|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
7821922|NCT00373295|27162306|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
7821923|NCT00373256|27162327|P2|Overall Study|Study Terminated by Sponsor|13
7821924|NCT00373256|27162328|P1|Overall Study|Study Terminated by Sponsor|41
7821925|NCT00373256|27162327|P2|Overall Study|Protocol Violation|2
7821926|NCT00373256|27162328|P1|Overall Study|Protocol Violation|0
7821927|NCT00373256|27162327|P2|Overall Study|Other|107
7821928|NCT00373256|27162328|P1|Overall Study|Other|73
7821929|NCT00373256|27162327|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
7821930|NCT00373256|27162328|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
7821931|NCT00373256|27162327|P2|Overall Study|Objective Progression or Relapse|104
7821932|NCT00373256|27162328|P1|Overall Study|Objective Progression or Relapse|111
7821933|NCT00373256|27162327|P2|Overall Study|Death|8
7821934|NCT00373256|27162328|P1|Overall Study|Death|9
7821935|NCT00373256|27162327|P2|Overall Study|Lost to Follow-up|1
7821936|NCT00373256|27162328|P1|Overall Study|Lost to Follow-up|2
7821937|NCT00373256|27162327|P2|Overall Study|Adverse Event (AE)|5
7821938|NCT00373256|27162328|P1|Overall Study|Adverse Event (AE)|1
7821939|NCT00373113|27162354|P2|Overall Study|Withdrawal by Subject|15
7821940|NCT00373113|27162355|P1|Overall Study|Withdrawal by Subject|10
7821941|NCT00373113|27162354|P2|Overall Study|Protocol Violation|1
7821942|NCT00373113|27162355|P1|Overall Study|Protocol Violation|5
7821943|NCT00373113|27162354|P2|Overall Study|Other|17
7821944|NCT00373113|27162355|P1|Overall Study|Other|14
7821945|NCT00373113|27162354|P2|Overall Study|Objective progression or relapse|169
7821946|NCT00373113|27162355|P1|Overall Study|Objective progression or relapse|150
7821947|NCT00373113|27162354|P2|Overall Study|Lost to Follow-up|3
7821948|NCT00373113|27162355|P1|Overall Study|Lost to Follow-up|1
7821949|NCT00373113|27162354|P2|Overall Study|Global deterioration of health status|7
7821950|NCT00373113|27162355|P1|Overall Study|Global deterioration of health status|10
7821951|NCT00373113|27162354|P2|Overall Study|Study terminated by sponsor|1
7821952|NCT00373113|27162355|P1|Overall Study|Study terminated by sponsor|9
7821953|NCT00373113|27162354|P2|Overall Study|Adverse Event|24
7821954|NCT00373113|27162355|P1|Overall Study|Adverse Event|38
7821955|NCT00373113|27162354|P2|Overall Study|Death|7
7821956|NCT00373113|27162355|P1|Overall Study|Death|1
7821957|NCT00372996|27162377|P4|Overall Study|Other|7
7821958|NCT00372996|27162378|P3|Overall Study|Other|7
7821959|NCT00372996|27162379|P2|Overall Study|Other|2
7821960|NCT00372996|27162380|P1|Overall Study|Other|10
7821961|NCT00372996|27162377|P4|Overall Study|Study Terminated by Sponsor|0
7821962|NCT00372996|27162378|P3|Overall Study|Study Terminated by Sponsor|4
7821963|NCT00372996|27162379|P2|Overall Study|Study Terminated by Sponsor|0
7821964|NCT00372996|27162380|P1|Overall Study|Study Terminated by Sponsor|4
7821965|NCT00372996|27162377|P4|Overall Study|Withdrawal by Subject|5
7821966|NCT00372996|27162378|P3|Overall Study|Withdrawal by Subject|9
7821967|NCT00372996|27162379|P2|Overall Study|Withdrawal by Subject|6
7821968|NCT00372996|27162380|P1|Overall Study|Withdrawal by Subject|12
7821969|NCT00372996|27162377|P4|Overall Study|Lost to Follow-up|1
7821970|NCT00372996|27162378|P3|Overall Study|Lost to Follow-up|0
7821971|NCT00372996|27162379|P2|Overall Study|Lost to Follow-up|2
7821972|NCT00372996|27162380|P1|Overall Study|Lost to Follow-up|0
7821973|NCT00372996|27162377|P4|Overall Study|Death|7
7821974|NCT00372996|27162378|P3|Overall Study|Death|8
7821975|NCT00372996|27162379|P2|Overall Study|Death|4
7821976|NCT00372996|27162380|P1|Overall Study|Death|11
7821977|NCT00372905|27162465|P4|Follow up Until Relapse or Progression|Other|0
7821978|NCT00372905|27162466|P3|Follow up Until Relapse or Progression|Other|0
7821979|NCT00372905|27162467|P2|Follow up Until Relapse or Progression|Other|1
7821980|NCT00372905|27162468|P1|Follow up Until Relapse or Progression|Other|0
7821981|NCT00372905|27162465|P4|Follow up Until Relapse or Progression|Study closed|3
7821982|NCT00372905|27162466|P3|Follow up Until Relapse or Progression|Study closed|0
7821983|NCT00372905|27162467|P2|Follow up Until Relapse or Progression|Study closed|0
7821984|NCT00372905|27162468|P1|Follow up Until Relapse or Progression|Study closed|0
7821985|NCT00372905|27162465|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
7821986|NCT00372905|27162466|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7821987|NCT00372905|27162467|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7821988|NCT00372905|27162468|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7821989|NCT00372905|27162465|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7821990|NCT00372905|27162466|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
7821991|NCT00372905|27162467|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7821992|NCT00372905|27162468|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7821993|NCT00372905|27162465|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7821994|NCT00372905|27162466|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
7821995|NCT00372905|27162467|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7821996|NCT00372905|27162468|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7821997|NCT00372905|27162465|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7821998|NCT00372905|27162466|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7821999|NCT00372905|27162467|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7822000|NCT00372905|27162468|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
7822001|NCT00372775|27162480|P1|Overall Study|Not Treated|2
7822002|NCT00372775|27162480|P1|Overall Study|Other|1
7822003|NCT00372775|27162480|P1|Overall Study|Withdrawal by Subject|1
7822004|NCT00372775|27162480|P1|Overall Study|Global deterioration of health status|6
7822005|NCT00372775|27162480|P1|Overall Study|Objective progression or relapse|30
7822006|NCT00372775|27162480|P1|Overall Study|Death|15
7822007|NCT00372775|27162480|P1|Overall Study|Adverse Event|8
7822008|NCT00372697|27162502|P2|Overall Study|Protocol Violation|1
7822009|NCT00372697|27162503|P1|Overall Study|Protocol Violation|1
7822010|NCT00372619|27162528|P7|Overall Study|Inevaluable|0
7822011|NCT00372619|27162529|P6|Overall Study|Inevaluable|1
7822012|NCT00372619|27162530|P5|Overall Study|Inevaluable|0
7822013|NCT00372619|27162531|P4|Overall Study|Inevaluable|0
7822014|NCT00372619|27162532|P3|Overall Study|Inevaluable|0
7822015|NCT00372619|27162533|P2|Overall Study|Inevaluable|0
7822016|NCT00372619|27162534|P1|Overall Study|Inevaluable|0
7822017|NCT00372619|27162528|P7|Overall Study|Ineligible|0
7822018|NCT00372619|27162529|P6|Overall Study|Ineligible|2
7822019|NCT00372619|27162530|P5|Overall Study|Ineligible|0
7822020|NCT00372619|27162531|P4|Overall Study|Ineligible|0
7822021|NCT00372619|27162532|P3|Overall Study|Ineligible|0
7822022|NCT00372619|27162533|P2|Overall Study|Ineligible|0
7822023|NCT00372619|27162534|P1|Overall Study|Ineligible|0
7822024|NCT00372593|27162567|P3|Overall Study|Ineligible|1
7822025|NCT00372593|27162568|P2|Overall Study|Ineligible|21
7822026|NCT00372593|27162569|P1|Overall Study|Ineligible|20
7822027|NCT00372593|27162567|P3|Overall Study|Physician Decision|0
7822028|NCT00372593|27162568|P2|Overall Study|Physician Decision|41
7822029|NCT00372593|27162569|P1|Overall Study|Physician Decision|42
7822030|NCT00372593|27162567|P3|Overall Study|Lost to Follow-up|0
7822031|NCT00372593|27162568|P2|Overall Study|Lost to Follow-up|0
7822032|NCT00372593|27162569|P1|Overall Study|Lost to Follow-up|1
7822033|NCT00372593|27162567|P3|Overall Study|Lack of Efficacy|2
7822034|NCT00372593|27162568|P2|Overall Study|Lack of Efficacy|71
7822035|NCT00372593|27162569|P1|Overall Study|Lack of Efficacy|82
7822036|NCT00372593|27162567|P3|Overall Study|Death|1
7822037|NCT00372593|27162568|P2|Overall Study|Death|20
7822038|NCT00372593|27162569|P1|Overall Study|Death|16
7822039|NCT00372593|27162567|P3|Overall Study|Adverse Event|0
7822040|NCT00372593|27162568|P2|Overall Study|Adverse Event|45
7822041|NCT00372593|27162569|P1|Overall Study|Adverse Event|43
7822042|NCT00372567|27162598|P3|Phase 3 Study|study terminated by sponsor|5
7822043|NCT00372567|27162599|P2|Phase 3 Study|study terminated by sponsor|8
7822044|NCT00372567|27162600|P1|Phase 3 Study|study terminated by sponsor|13
7822045|NCT00372567|27162598|P3|Phase 3 Study|Other|1
7822046|NCT00372567|27162599|P2|Phase 3 Study|Other|2
7822047|NCT00372567|27162600|P1|Phase 3 Study|Other|2
7822048|NCT00372567|27162598|P3|Phase 3 Study|Global deterioration of health status|0
7822049|NCT00372567|27162599|P2|Phase 3 Study|Global deterioration of health status|1
7822050|NCT00372567|27162600|P1|Phase 3 Study|Global deterioration of health status|0
7822051|NCT00372567|27162598|P3|Phase 3 Study|Objective progression or relapse|4
7822052|NCT00372567|27162599|P2|Phase 3 Study|Objective progression or relapse|13
7822053|NCT00372567|27162600|P1|Phase 3 Study|Objective progression or relapse|10
7822054|NCT00372567|27162598|P3|Phase 3 Study|Protocol Violation|1
7822055|NCT00372567|27162599|P2|Phase 3 Study|Protocol Violation|0
7822056|NCT00372567|27162600|P1|Phase 3 Study|Protocol Violation|0
7822057|NCT00372567|27162598|P3|Phase 3 Study|Death|0
7822058|NCT00372567|27162599|P2|Phase 3 Study|Death|1
7822059|NCT00372567|27162600|P1|Phase 3 Study|Death|1
7822060|NCT00372567|27162598|P3|Phase 3 Study|Adverse Event|1
7822061|NCT00372567|27162599|P2|Phase 3 Study|Adverse Event|1
7822062|NCT00372567|27162600|P1|Phase 3 Study|Adverse Event|5
7822063|NCT00372528|27162628|P1|Overall Study|Other|1
7822064|NCT00372528|27162628|P1|Overall Study|Study Terminated by Sponsor|18
7822065|NCT00372528|27162628|P1|Overall Study|Adverse Event|1
7822066|NCT00372528|27162628|P1|Overall Study|Lack of Efficacy|1
7822067|NCT00372489|27162633|P1|Overall Study|Sponsor Decision to Terminate Study|41
7822068|NCT00372489|27162633|P1|Overall Study|Renal transplant|6
7822069|NCT00372489|27162633|P1|Overall Study|Patient Relocation|2
7822070|NCT00372489|27162633|P1|Overall Study|Withdrawal by Subject|5
7822071|NCT00372489|27162633|P1|Overall Study|Physician Decision|3
7822072|NCT00372489|27162633|P1|Overall Study|Lost to Follow-up|3
7822073|NCT00372489|27162633|P1|Overall Study|Lack of Efficacy|1
7822074|NCT00372489|27162633|P1|Overall Study|Adverse Event|18
7822075|NCT00372424|27162637|P1|Overall Study|Enrolled, Not Treated|1
7822076|NCT00372424|27162637|P1|Overall Study|Other|7
7822077|NCT00372424|27162637|P1|Overall Study|Objective Progression or Relapse|14
7822078|NCT00372424|27162637|P1|Overall Study|Death|1
7822079|NCT00372424|27162637|P1|Overall Study|Withdrawal by Subject|1
7822080|NCT00372424|27162637|P1|Overall Study|Adverse Event|2
7822081|NCT00372411|27162651|P3|Overall Study|Adverse Event|0
7822082|NCT00372411|27162652|P2|Overall Study|Adverse Event|1
7822083|NCT00372411|27162653|P1|Overall Study|Adverse Event|1
7822084|NCT00372411|27162651|P3|Overall Study|Lost to Follow-up|1
7822085|NCT00372411|27162652|P2|Overall Study|Lost to Follow-up|1
7822086|NCT00372411|27162653|P1|Overall Study|Lost to Follow-up|1
7822087|NCT00372411|27162651|P3|Overall Study|Death|1
7822088|NCT00372411|27162652|P2|Overall Study|Death|2
7822089|NCT00372411|27162653|P1|Overall Study|Death|0
7822090|NCT00372411|27162651|P3|Overall Study|Withdrawal by Subject|1
7822091|NCT00372411|27162652|P2|Overall Study|Withdrawal by Subject|4
7822092|NCT00372411|27162653|P1|Overall Study|Withdrawal by Subject|3
7822093|NCT00372385|27162677|P4|Overall Study|Virologic Stopping Rule|0
7822094|NCT00372385|27162678|P3|Overall Study|Virologic Stopping Rule|0
7822095|NCT00372385|27162679|P2|Overall Study|Virologic Stopping Rule|0
7822096|NCT00372385|27162680|P1|Overall Study|Virologic Stopping Rule|17
7822097|NCT00372385|27162677|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
7822098|NCT00372385|27162678|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
7822099|NCT00372385|27162679|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
7822100|NCT00372385|27162680|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
7822101|NCT00372385|27162677|P4|Overall Study|No Response|0
7822102|NCT00372385|27162678|P3|Overall Study|No Response|0
7822103|NCT00372385|27162679|P2|Overall Study|No Response|1
7822104|NCT00372385|27162680|P1|Overall Study|No Response|1
7822105|NCT00372385|27162677|P4|Overall Study|Refusal of Treatment|0
7822106|NCT00372385|27162678|P3|Overall Study|Refusal of Treatment|0
7822107|NCT00372385|27162679|P2|Overall Study|Refusal of Treatment|6
7822108|NCT00372385|27162680|P1|Overall Study|Refusal of Treatment|3
7822109|NCT00372385|27162677|P4|Overall Study|Withdrawal by Subject|0
7822110|NCT00372385|27162678|P3|Overall Study|Withdrawal by Subject|0
7822111|NCT00372385|27162679|P2|Overall Study|Withdrawal by Subject|1
7822112|NCT00372385|27162680|P1|Overall Study|Withdrawal by Subject|2
7822113|NCT00372385|27162677|P4|Overall Study|Lost to Follow-up|0
7822114|NCT00372385|27162678|P3|Overall Study|Lost to Follow-up|0
7822115|NCT00372385|27162679|P2|Overall Study|Lost to Follow-up|0
7822116|NCT00372385|27162680|P1|Overall Study|Lost to Follow-up|2
7822117|NCT00372385|27162677|P4|Overall Study|Physician Decision|0
7822118|NCT00372385|27162678|P3|Overall Study|Physician Decision|0
7822119|NCT00372385|27162679|P2|Overall Study|Physician Decision|0
7822120|NCT00372385|27162680|P1|Overall Study|Physician Decision|1
7822121|NCT00372385|27162677|P4|Overall Study|Noncompliance|1
7822122|NCT00372385|27162678|P3|Overall Study|Noncompliance|1
7822123|NCT00372385|27162679|P2|Overall Study|Noncompliance|1
7822124|NCT00372385|27162680|P1|Overall Study|Noncompliance|0
7822125|NCT00372385|27162677|P4|Overall Study|Adverse Event|7
7822126|NCT00372385|27162678|P3|Overall Study|Adverse Event|9
7822127|NCT00372385|27162679|P2|Overall Study|Adverse Event|11
7822128|NCT00372385|27162680|P1|Overall Study|Adverse Event|6
7822129|NCT00372255|27162709|P2|Overall Study|Withdrawn for other reasons|1
7822130|NCT00372255|27162710|P1|Overall Study|Withdrawn for other reasons|2
7822131|NCT00372229|27162732|P2|Follow-Up Phase|Lost to Follow-up|10
7822132|NCT00372229|27162733|P1|Follow-Up Phase|Lost to Follow-up|12
7822133|NCT00372229|27162732|P2|Follow-Up Phase|Reason not specified|3
7822134|NCT00372229|27162733|P1|Follow-Up Phase|Reason not specified|2
7822135|NCT00372229|27162732|P2|Follow-Up Phase|Administrative|0
7822136|NCT00372229|27162733|P1|Follow-Up Phase|Administrative|1
7822137|NCT00372229|27162732|P2|Follow-Up Phase|Death|12
7822138|NCT00372229|27162733|P1|Follow-Up Phase|Death|9
7822139|NCT00372229|27162732|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
7822140|NCT00372229|27162733|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
7822141|NCT00372229|27162732|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
7822142|NCT00372229|27162733|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
7822143|NCT00372229|27162732|P2|Follow-Up Phase|Consent withdrawn|19
7822144|NCT00372229|27162733|P1|Follow-Up Phase|Consent withdrawn|13
7822145|NCT00372229|27162732|P2|Follow-Up Phase|Graft loss|7
7822146|NCT00372229|27162733|P1|Follow-Up Phase|Graft loss|8
7822147|NCT00372229|27162732|P2|Study Phase|Lost to Follow-up|3
7822148|NCT00372229|27162733|P1|Study Phase|Lost to Follow-up|3
7822149|NCT00372229|27162732|P2|Study Phase|Reason not specified|2
7822150|NCT00372229|27162733|P1|Study Phase|Reason not specified|3
7822151|NCT00372229|27162732|P2|Study Phase|Death|2
7822152|NCT00372229|27162733|P1|Study Phase|Death|3
7822153|NCT00372229|27162732|P2|Study Phase|Refused treatment/did not cooperate|1
7822154|NCT00372229|27162733|P1|Study Phase|Refused treatment/did not cooperate|3
7822155|NCT00372229|27162732|P2|Study Phase|Consent withdrawn|14
7822156|NCT00372229|27162733|P1|Study Phase|Consent withdrawn|16
7822157|NCT00372229|27162732|P2|Study Phase|Protocol Violation|4
7822158|NCT00372229|27162733|P1|Study Phase|Protocol Violation|3
7822159|NCT00372229|27162732|P2|Study Phase|Graft loss|3
7822160|NCT00372229|27162733|P1|Study Phase|Graft loss|0
7822161|NCT00372190|27162823|P2|Overall Study|Lost to Follow-up|1
7822162|NCT00372190|27162824|P1|Overall Study|Lost to Follow-up|3
7822163|NCT00372112|27162840|P4|Overall Study|Other-protocol violation|0
7822164|NCT00372112|27162841|P3|Overall Study|Other-protocol violation|1
7822165|NCT00372112|27162842|P2|Overall Study|Other-protocol violation|0
7822166|NCT00372112|27162843|P1|Overall Study|Other-protocol violation|0
7822167|NCT00372112|27162840|P4|Overall Study|Hepatitis B|0
7822168|NCT00372112|27162841|P3|Overall Study|Hepatitis B|0
7822169|NCT00372112|27162842|P2|Overall Study|Hepatitis B|0
7822170|NCT00372112|27162843|P1|Overall Study|Hepatitis B|1
7822171|NCT00372112|27162840|P4|Overall Study|PR >240 at Visit 3|1
7822172|NCT00372112|27162841|P3|Overall Study|PR >240 at Visit 3|0
7822173|NCT00372112|27162842|P2|Overall Study|PR >240 at Visit 3|0
7822174|NCT00372112|27162843|P1|Overall Study|PR >240 at Visit 3|0
7822175|NCT00372112|27162840|P4|Overall Study|Exacerbation|1
7822176|NCT00372112|27162841|P3|Overall Study|Exacerbation|0
7822177|NCT00372112|27162842|P2|Overall Study|Exacerbation|0
7822178|NCT00372112|27162843|P1|Overall Study|Exacerbation|0
7822179|NCT00372112|27162840|P4|Overall Study|Withdrawal by Subject|1
7822180|NCT00372112|27162841|P3|Overall Study|Withdrawal by Subject|2
7822181|NCT00372112|27162842|P2|Overall Study|Withdrawal by Subject|0
7822182|NCT00372112|27162843|P1|Overall Study|Withdrawal by Subject|0
7822183|NCT00372112|27162840|P4|Overall Study|Adverse Event|1
7822184|NCT00372112|27162841|P3|Overall Study|Adverse Event|1
7822185|NCT00372112|27162842|P2|Overall Study|Adverse Event|1
7822186|NCT00372112|27162843|P1|Overall Study|Adverse Event|0
7822187|NCT00372060|27162974|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
7822188|NCT00372060|27162975|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
7822189|NCT00372060|27162974|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
7822190|NCT00372060|27162975|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
7822191|NCT00372060|27162974|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
7822192|NCT00372060|27162975|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
7822193|NCT00372060|27162974|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
7822194|NCT00372060|27162975|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
7822195|NCT00372060|27162974|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
7822196|NCT00372060|27162975|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
7822197|NCT00372060|27162974|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
7822198|NCT00372060|27162975|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
7822199|NCT00371865|27162990|P2|Overall Study|Withdrawal by Subject|10
7822200|NCT00371865|27162991|P1|Overall Study|Withdrawal by Subject|12
7822201|NCT00371865|27162990|P2|Overall Study|Protocol Violation|2
7822202|NCT00371865|27162991|P1|Overall Study|Protocol Violation|3
7822203|NCT00371865|27162990|P2|Overall Study|Lack of Efficacy|2
7822204|NCT00371865|27162991|P1|Overall Study|Lack of Efficacy|0
7822205|NCT00371839|27163008|P3|Overall Study|Lost to Follow-up|2
7822206|NCT00371839|27163009|P2|Overall Study|Lost to Follow-up|3
7822207|NCT00371839|27163010|P1|Overall Study|Lost to Follow-up|6
7822208|NCT00371839|27163008|P3|Overall Study|Withdrawal by Subject|0
7822209|NCT00371839|27163009|P2|Overall Study|Withdrawal by Subject|4
7822210|NCT00371839|27163010|P1|Overall Study|Withdrawal by Subject|7
7822211|NCT00371839|27163008|P3|Overall Study|Death|0
7822212|NCT00371839|27163009|P2|Overall Study|Death|0
7822213|NCT00371839|27163010|P1|Overall Study|Death|4
7822214|NCT00371826|27163019|P3|Extension Phase (24 Months)|Administrative problems|2
7822215|NCT00371826|27163020|P2|Extension Phase (24 Months)|Administrative problems|0
7822216|NCT00371826|27163021|P1|Extension Phase (24 Months)|Administrative problems|0
7822217|NCT00371826|27163019|P3|Extension Phase (24 Months)|Subject withdrew consent|0
7822218|NCT00371826|27163020|P2|Extension Phase (24 Months)|Subject withdrew consent|2
7822219|NCT00371826|27163021|P1|Extension Phase (24 Months)|Subject withdrew consent|1
7822220|NCT00371826|27163019|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
7822221|NCT00371826|27163020|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
7822222|NCT00371826|27163021|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
7822223|NCT00371826|27163019|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
7822224|NCT00371826|27163020|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
7822225|NCT00371826|27163021|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
7822226|NCT00371826|27163019|P3|Extension Phase (24 Months)|Adverse Event|0
7822227|NCT00371826|27163020|P2|Extension Phase (24 Months)|Adverse Event|5
7822228|NCT00371826|27163021|P1|Extension Phase (24 Months)|Adverse Event|4
7822229|NCT00371826|27163019|P3|Core Phase (12 Months)|Graft Loss|0
7822230|NCT00371826|27163020|P2|Core Phase (12 Months)|Graft Loss|1
7822231|NCT00371826|27163021|P1|Core Phase (12 Months)|Graft Loss|0
7822232|NCT00371826|27163019|P3|Core Phase (12 Months)|Administrative problems|8
7822233|NCT00371826|27163020|P2|Core Phase (12 Months)|Administrative problems|0
7822234|NCT00371826|27163021|P1|Core Phase (12 Months)|Administrative problems|1
7822235|NCT00371826|27163019|P3|Core Phase (12 Months)|Subject withdrew consent|3
7822236|NCT00371826|27163020|P2|Core Phase (12 Months)|Subject withdrew consent|0
7822237|NCT00371826|27163021|P1|Core Phase (12 Months)|Subject withdrew consent|0
7822238|NCT00371826|27163019|P3|Core Phase (12 Months)|Protocol Violation|1
7822239|NCT00371826|27163020|P2|Core Phase (12 Months)|Protocol Violation|0
7822240|NCT00371826|27163021|P1|Core Phase (12 Months)|Protocol Violation|1
7822241|NCT00371826|27163019|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
7822242|NCT00371826|27163020|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
7822243|NCT00371826|27163021|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
7822244|NCT00371826|27163019|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
7822245|NCT00371826|27163020|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
7822246|NCT00371826|27163021|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
7822247|NCT00371826|27163019|P3|Core Phase (12 Months)|Adverse Event|9
7822248|NCT00371826|27163020|P2|Core Phase (12 Months)|Adverse Event|4
7822249|NCT00371826|27163021|P1|Core Phase (12 Months)|Adverse Event|15
7822250|NCT00371787|27163145|P2|Overall Study|Withdrawal by Subject|1
7822251|NCT00371787|27163146|P1|Overall Study|Withdrawal by Subject|3
7822252|NCT00371761|27163160|P2|Overall Study|Study termination|3
7822253|NCT00371761|27163161|P1|Overall Study|Study termination|4
7822254|NCT00371761|27163160|P2|Overall Study|Investigator Judgment|3
7822255|NCT00371761|27163161|P1|Overall Study|Investigator Judgment|2
7822256|NCT00371761|27163160|P2|Overall Study|Withdrawal by Subject|3
7822257|NCT00371761|27163161|P1|Overall Study|Withdrawal by Subject|1
7822258|NCT00371761|27163160|P2|Overall Study|Adverse Event|1
7822259|NCT00371761|27163161|P1|Overall Study|Adverse Event|1
7822260|NCT00371683|27163169|P2|Follow-Up Period - Randomized Patients|non-specified|12
7822261|NCT00371683|27163170|P1|Follow-Up Period - Randomized Patients|non-specified|6
7822262|NCT00371683|27163169|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
7822263|NCT00371683|27163170|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
7822264|NCT00371683|27163169|P2|Follow-Up Period - Randomized Patients|Death|2
7822265|NCT00371683|27163170|P1|Follow-Up Period - Randomized Patients|Death|0
7822266|NCT00371683|27163169|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
7822267|NCT00371683|27163170|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
7822268|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|non-specified|8
7822269|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|non-specified|9
7822270|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
7822271|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
7822272|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
7822273|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
7822274|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
7822275|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
7822276|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
7822277|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
7822278|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
7822279|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
7822280|NCT00371683|27163169|P2|DB Treatment Period-Randomized Patients|Death|1
7822281|NCT00371683|27163170|P1|DB Treatment Period-Randomized Patients|Death|1
7822282|NCT00371566|27163238|P2|Follow Up Phase|Lost to Follow-up|0
7822283|NCT00371566|27163239|P1|Follow Up Phase|Lost to Follow-up|1
7822284|NCT00371566|27163238|P2|Follow Up Phase|Physician Decision|1
7822285|NCT00371566|27163239|P1|Follow Up Phase|Physician Decision|1
7822286|NCT00371566|27163238|P2|Follow Up Phase|Withdrawal by Subject|1
7822287|NCT00371566|27163239|P1|Follow Up Phase|Withdrawal by Subject|0
7822288|NCT00371566|27163238|P2|Follow Up Phase|Disease progression|0
7822289|NCT00371566|27163239|P1|Follow Up Phase|Disease progression|1
7822290|NCT00371566|27163238|P2|Follow Up Phase|Death|5
7822291|NCT00371566|27163239|P1|Follow Up Phase|Death|0
7822292|NCT00371566|27163238|P2|Chemoradiation Phase|Death|0
7822293|NCT00371566|27163239|P1|Chemoradiation Phase|Death|2
7822294|NCT00371566|27163238|P2|Chemoradiation Phase|Progressive Disease|1
7822295|NCT00371566|27163239|P1|Chemoradiation Phase|Progressive Disease|1
7822296|NCT00371566|27163238|P2|Chemoradiation Phase|Non compliant|1
7822297|NCT00371566|27163239|P1|Chemoradiation Phase|Non compliant|0
7822298|NCT00371566|27163238|P2|Chemoradiation Phase|Withdrawal by Subject|1
7822299|NCT00371566|27163239|P1|Chemoradiation Phase|Withdrawal by Subject|0
7822300|NCT00371566|27163238|P2|Chemoradiation Phase|Physician Decision|0
7822301|NCT00371566|27163239|P1|Chemoradiation Phase|Physician Decision|2
7822302|NCT00371566|27163238|P2|Treatment Phase|Protocol Violation|1
7822303|NCT00371566|27163239|P1|Treatment Phase|Protocol Violation|0
7822304|NCT00371566|27163238|P2|Treatment Phase|Adverse Event|1
7822305|NCT00371566|27163239|P1|Treatment Phase|Adverse Event|0
7822306|NCT00371566|27163238|P2|Treatment Phase|Withdrawal by Subject|1
7822307|NCT00371566|27163239|P1|Treatment Phase|Withdrawal by Subject|0
7822308|NCT00371462|27163324|P2|Overall Study|Other|8
7822309|NCT00371462|27163325|P1|Overall Study|Other|7
7822310|NCT00371462|27163324|P2|Overall Study|Withdrawal by Subject|0
7822311|NCT00371462|27163325|P1|Overall Study|Withdrawal by Subject|1
7822312|NCT00371397|27163349|P12|Session 1|Withdrawal by Subject|0
7822313|NCT00371397|27163350|P11|Session 1|Withdrawal by Subject|0
7822314|NCT00371397|27163351|P10|Session 1|Withdrawal by Subject|0
7822315|NCT00371397|27163352|P9|Session 1|Withdrawal by Subject|0
7822316|NCT00371397|27163353|P8|Session 1|Withdrawal by Subject|1
7822317|NCT00371397|27163354|P7|Session 1|Withdrawal by Subject|0
7822318|NCT00371397|27163355|P6|Session 1|Withdrawal by Subject|0
7822319|NCT00371397|27163356|P5|Session 1|Withdrawal by Subject|0
7822320|NCT00371397|27163357|P4|Session 1|Withdrawal by Subject|0
7822321|NCT00371397|27163358|P3|Session 1|Withdrawal by Subject|0
7822322|NCT00371397|27163359|P2|Session 1|Withdrawal by Subject|0
7822323|NCT00371397|27163360|P1|Session 1|Withdrawal by Subject|1
7822324|NCT00371345|27163368|P2|Overall Study|Participant Withdrew Consent|1
7822325|NCT00371345|27163369|P1|Overall Study|Participant Withdrew Consent|0
7822326|NCT00371345|27163368|P2|Overall Study|Participant Request|1
7822327|NCT00371345|27163369|P1|Overall Study|Participant Request|1
7822328|NCT00371345|27163368|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
7822329|NCT00371345|27163369|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
7822330|NCT00371345|27163368|P2|Overall Study|Study Drug Toxicity|7
7822331|NCT00371345|27163369|P1|Overall Study|Study Drug Toxicity|1
7822332|NCT00371345|27163368|P2|Overall Study|Disease Progression|35
7822333|NCT00371345|27163369|P1|Overall Study|Disease Progression|21
7822334|NCT00371254|27163470|P2|Overall Study|Withdrawal by Subject|1
7822335|NCT00371254|27163471|P1|Overall Study|Withdrawal by Subject|0
7822336|NCT00371254|27163470|P2|Overall Study|Lost to Follow-up|1
7822337|NCT00371254|27163471|P1|Overall Study|Lost to Follow-up|0
7822338|NCT00371254|27163470|P2|Overall Study|Adverse event unrelated to study drug|1
7822339|NCT00371254|27163471|P1|Overall Study|Adverse event unrelated to study drug|0
7822340|NCT00371254|27163470|P2|Overall Study|Investigator Decision|0
7822341|NCT00371254|27163471|P1|Overall Study|Investigator Decision|2
7822342|NCT00371254|27163470|P2|Overall Study|Subject request|0
7822343|NCT00371254|27163471|P1|Overall Study|Subject request|5
7822344|NCT00371254|27163470|P2|Overall Study|Study drug toxicity|5
7822345|NCT00371254|27163471|P1|Overall Study|Study drug toxicity|3
7822346|NCT00371254|27163470|P2|Overall Study|Disease progression|13
7822347|NCT00371254|27163471|P1|Overall Study|Disease progression|13
7822348|NCT00371150|27163554|P2|Overall Study|Lost to Follow-up|2
7822349|NCT00371150|27163555|P1|Overall Study|Lost to Follow-up|3
7822350|NCT00371137|27163590|P3|Overall Study|Protocol Violation|1
7822351|NCT00371137|27163591|P2|Overall Study|Protocol Violation|1
7822352|NCT00371137|27163592|P1|Overall Study|Protocol Violation|2
7822353|NCT00371137|27163590|P3|Overall Study|Physician Decision|1
7822354|NCT00371137|27163591|P2|Overall Study|Physician Decision|1
7822355|NCT00371137|27163592|P1|Overall Study|Physician Decision|1
7822356|NCT00371137|27163590|P3|Overall Study|Sponsor Decision|2
7822357|NCT00371137|27163591|P2|Overall Study|Sponsor Decision|1
7822358|NCT00371137|27163592|P1|Overall Study|Sponsor Decision|2
7822359|NCT00371137|27163590|P3|Overall Study|Lack of Efficacy|13
7822360|NCT00371137|27163591|P2|Overall Study|Lack of Efficacy|12
7822361|NCT00371137|27163592|P1|Overall Study|Lack of Efficacy|30
7822362|NCT00371137|27163590|P3|Overall Study|Lost to Follow-up|5
7822363|NCT00371137|27163591|P2|Overall Study|Lost to Follow-up|3
7822364|NCT00371137|27163592|P1|Overall Study|Lost to Follow-up|6
7822365|NCT00371137|27163590|P3|Overall Study|Withdrawal by Subject|15
7822366|NCT00371137|27163591|P2|Overall Study|Withdrawal by Subject|10
7822367|NCT00371137|27163592|P1|Overall Study|Withdrawal by Subject|11
7822368|NCT00371137|27163590|P3|Overall Study|Adverse Event|42
7822369|NCT00371137|27163591|P2|Overall Study|Adverse Event|35
7822370|NCT00371137|27163592|P1|Overall Study|Adverse Event|20
7822371|NCT00370682|27163639|P3|Overall Study|Lost to Follow-up|1
7822372|NCT00370682|27163640|P2|Overall Study|Lost to Follow-up|1
7822373|NCT00370682|27163641|P1|Overall Study|Lost to Follow-up|0
7822374|NCT00370682|27163639|P3|Overall Study|Moved from area|0
7822375|NCT00370682|27163640|P2|Overall Study|Moved from area|2
7822376|NCT00370682|27163641|P1|Overall Study|Moved from area|0
7822377|NCT00370552|27163683|P3|Overall Study|Planned radiation for palliation|0
7822378|NCT00370552|27163684|P2|Overall Study|Planned radiation for palliation|1
7822379|NCT00370552|27163685|P1|Overall Study|Planned radiation for palliation|0
7822380|NCT00370552|27163683|P3|Overall Study|High risk of allergic reaction|0
7822381|NCT00370552|27163684|P2|Overall Study|High risk of allergic reaction|1
7822382|NCT00370552|27163685|P1|Overall Study|High risk of allergic reaction|0
7822383|NCT00370552|27163683|P3|Overall Study|Investigator decision|0
7822384|NCT00370552|27163684|P2|Overall Study|Investigator decision|1
7822385|NCT00370552|27163685|P1|Overall Study|Investigator decision|2
7822386|NCT00370552|27163683|P3|Overall Study|Physician Decision|0
7822387|NCT00370552|27163684|P2|Overall Study|Physician Decision|1
7822388|NCT00370552|27163685|P1|Overall Study|Physician Decision|1
7822389|NCT00370552|27163683|P3|Overall Study|Never treated|0
7822390|NCT00370552|27163684|P2|Overall Study|Never treated|0
7822391|NCT00370552|27163685|P1|Overall Study|Never treated|1
7822392|NCT00370552|27163683|P3|Overall Study|Still on treatment|2
7822393|NCT00370552|27163684|P2|Overall Study|Still on treatment|3
7822394|NCT00370552|27163685|P1|Overall Study|Still on treatment|1
7822395|NCT00370552|27163683|P3|Overall Study|Withdrawal by Subject|1
7822396|NCT00370552|27163684|P2|Overall Study|Withdrawal by Subject|0
7822397|NCT00370552|27163685|P1|Overall Study|Withdrawal by Subject|2
7822398|NCT00370552|27163683|P3|Overall Study|Study drug toxicity|6
7822399|NCT00370552|27163684|P2|Overall Study|Study drug toxicity|8
7822400|NCT00370552|27163685|P1|Overall Study|Study drug toxicity|11
7822401|NCT00370552|27163683|P3|Overall Study|Poor or noncompliance|1
7822402|NCT00370552|27163684|P2|Overall Study|Poor or noncompliance|0
7822403|NCT00370552|27163685|P1|Overall Study|Poor or noncompliance|0
7822404|NCT00370552|27163683|P3|Overall Study|Maximum clinical benefit|5
7822405|NCT00370552|27163684|P2|Overall Study|Maximum clinical benefit|5
7822406|NCT00370552|27163685|P1|Overall Study|Maximum clinical benefit|3
7822407|NCT00370552|27163683|P3|Overall Study|Disease progression|15
7822408|NCT00370552|27163684|P2|Overall Study|Disease progression|23
7822409|NCT00370552|27163685|P1|Overall Study|Disease progression|23
7822410|NCT00370552|27163683|P3|Overall Study|Adverse Event|2
7822411|NCT00370552|27163684|P2|Overall Study|Adverse Event|2
7822412|NCT00370552|27163685|P1|Overall Study|Adverse Event|2
7822413|NCT00370396|27163726|P3|Overall Study|Lost to Follow-up|0
7822414|NCT00370396|27163727|P2|Overall Study|Lost to Follow-up|1
7822415|NCT00370396|27163728|P1|Overall Study|Lost to Follow-up|11
7822416|NCT00370396|27163726|P3|Overall Study|Withdrawal by Subject|1
7822417|NCT00370396|27163727|P2|Overall Study|Withdrawal by Subject|0
7822418|NCT00370396|27163728|P1|Overall Study|Withdrawal by Subject|0
7822419|NCT00370331|27163782|P2|Overall Study|Protocol Violation|1
7822420|NCT00370331|27163783|P1|Overall Study|Protocol Violation|1
7822421|NCT00370331|27163782|P2|Overall Study|Non-compliance|1
7822422|NCT00370331|27163783|P1|Overall Study|Non-compliance|0
7822423|NCT00370331|27163782|P2|Overall Study|Lack of Efficacy|1
7822424|NCT00370331|27163783|P1|Overall Study|Lack of Efficacy|0
7822425|NCT00370331|27163782|P2|Overall Study|Lost to Follow-up|3
7822426|NCT00370331|27163783|P1|Overall Study|Lost to Follow-up|0
7822427|NCT00370331|27163782|P2|Overall Study|Withdrawal by Subject|4
7822428|NCT00370331|27163783|P1|Overall Study|Withdrawal by Subject|2
7822429|NCT00370331|27163782|P2|Overall Study|Adverse Event|13
7822430|NCT00370331|27163783|P1|Overall Study|Adverse Event|4
7822431|NCT00370292|27163809|P1|Overall Study|Physician Decision|2
7822432|NCT00370292|27163809|P1|Overall Study|Adverse Event|7
7822433|NCT00370292|27163809|P1|Overall Study|Disease Progression|4
7822434|NCT00370149|27163822|P2|Overall Study|Antibiotic coated dressing placed|1
7822435|NCT00370149|27163823|P1|Overall Study|Antibiotic coated dressing placed|0
7822436|NCT00370149|27163822|P2|Overall Study|Pre-existing infection|1
7822437|NCT00370149|27163823|P1|Overall Study|Pre-existing infection|0
7822438|NCT00370149|27163822|P2|Overall Study|Catheter inserted in wrong vessel-|1
7822439|NCT00370149|27163823|P1|Overall Study|Catheter inserted in wrong vessel-|2
7822440|NCT00370149|27163822|P2|Overall Study|Protocol Violation|0
7822441|NCT00370149|27163823|P1|Overall Study|Protocol Violation|1
7822442|NCT00370149|27163822|P2|Overall Study|Physician Decision|16
7822443|NCT00370149|27163823|P1|Overall Study|Physician Decision|16
7822444|NCT00370071|27163833|P1|Overall Study|Withdrawal by Subject|2
7822445|NCT00370032|27163850|P2|Follow-up Period|Withdrawal by Subject|0
7822446|NCT00370032|27163851|P1|Follow-up Period|Withdrawal by Subject|1
7822447|NCT00370032|27163850|P2|Washout Period|Adverse Event|0
7822448|NCT00370032|27163851|P1|Washout Period|Adverse Event|1
7822449|NCT00370032|27163850|P2|Washout Period|Lost to Follow-up|1
7822450|NCT00370032|27163851|P1|Washout Period|Lost to Follow-up|0
7822451|NCT00370032|27163850|P2|Washout Period|Withdrawal by Subject|1
7822452|NCT00370032|27163851|P1|Washout Period|Withdrawal by Subject|0
7822453|NCT00370032|27163850|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
7822454|NCT00370032|27163851|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
7822455|NCT00369967|27163871|P2|Overall Study|Lost to Follow-up|12
7822456|NCT00369967|27163872|P1|Overall Study|Lost to Follow-up|23
7822457|NCT00369941|27163890|P2|Overall Study|Miscellaneous|3
7822458|NCT00369941|27163891|P1|Overall Study|Miscellaneous|3
7822459|NCT00369941|27163890|P2|Overall Study|Study Site Terminated|0
7822460|NCT00369941|27163891|P1|Overall Study|Study Site Terminated|2
7822461|NCT00369941|27163890|P2|Overall Study|Employment Interfered with Study Visits|0
7822462|NCT00369941|27163891|P1|Overall Study|Employment Interfered with Study Visits|1
7822463|NCT00369941|27163890|P2|Overall Study|Treatment with Prohibited Medication|1
7822464|NCT00369941|27163891|P1|Overall Study|Treatment with Prohibited Medication|3
7822465|NCT00369941|27163890|P2|Overall Study|Moved|5
7822466|NCT00369941|27163891|P1|Overall Study|Moved|11
7822467|NCT00369941|27163890|P2|Overall Study|Completed, Did Not Enter Extension|6
7822468|NCT00369941|27163891|P1|Overall Study|Completed, Did Not Enter Extension|5
7822469|NCT00369941|27163890|P2|Overall Study|Pregnancy|2
7822470|NCT00369941|27163891|P1|Overall Study|Pregnancy|4
7822471|NCT00369941|27163890|P2|Overall Study|Withdrawal by Subject|18
7822472|NCT00369941|27163891|P1|Overall Study|Withdrawal by Subject|5
7822473|NCT00369941|27163890|P2|Overall Study|Protocol Violation|3
7822474|NCT00369941|27163891|P1|Overall Study|Protocol Violation|5
7822475|NCT00369941|27163890|P2|Overall Study|Lost to Follow-up|22
7822476|NCT00369941|27163891|P1|Overall Study|Lost to Follow-up|12
7822477|NCT00369941|27163890|P2|Overall Study|Lack of Efficacy|10
7822478|NCT00369941|27163891|P1|Overall Study|Lack of Efficacy|6
7822479|NCT00369941|27163890|P2|Overall Study|Adverse Event|28
7822480|NCT00369941|27163891|P1|Overall Study|Adverse Event|14
7822481|NCT00369941|27163890|P2|Overall Study|Never Treated|2
7822482|NCT00369941|27163891|P1|Overall Study|Never Treated|1
7822483|NCT00369915|27164056|P2|Overall Study|W/drawl by investigators|1
7822484|NCT00369915|27164057|P1|Overall Study|W/drawl by investigators|0
7822485|NCT00369915|27164056|P2|Overall Study|Withdrawal by Subject|1
7822486|NCT00369915|27164057|P1|Overall Study|Withdrawal by Subject|4
7822487|NCT00369915|27164056|P2|Overall Study|expected side effects|1
7822488|NCT00369915|27164057|P1|Overall Study|expected side effects|2
7822489|NCT00369824|27164071|P6|Overall Study|Other|3
7822490|NCT00369824|27164072|P5|Overall Study|Other|1
7822491|NCT00369824|27164073|P4|Overall Study|Other|2
7822492|NCT00369824|27164074|P3|Overall Study|Other|0
7822493|NCT00369824|27164075|P2|Overall Study|Other|0
7822494|NCT00369824|27164076|P1|Overall Study|Other|0
7822495|NCT00369824|27164071|P6|Overall Study|Lost to Follow-up|6
7822496|NCT00369824|27164072|P5|Overall Study|Lost to Follow-up|9
7822497|NCT00369824|27164073|P4|Overall Study|Lost to Follow-up|8
7822498|NCT00369824|27164074|P3|Overall Study|Lost to Follow-up|7
7822499|NCT00369824|27164075|P2|Overall Study|Lost to Follow-up|11
7822500|NCT00369824|27164076|P1|Overall Study|Lost to Follow-up|6
7822501|NCT00369824|27164071|P6|Overall Study|Withdrawal by Subject|2
7822502|NCT00369824|27164072|P5|Overall Study|Withdrawal by Subject|6
7822503|NCT00369824|27164073|P4|Overall Study|Withdrawal by Subject|4
7822504|NCT00369824|27164074|P3|Overall Study|Withdrawal by Subject|5
7822505|NCT00369824|27164075|P2|Overall Study|Withdrawal by Subject|5
7822506|NCT00369824|27164076|P1|Overall Study|Withdrawal by Subject|9
7822507|NCT00369824|27164071|P6|Overall Study|Protocol Violation|0
7822508|NCT00369824|27164072|P5|Overall Study|Protocol Violation|1
7822509|NCT00369824|27164073|P4|Overall Study|Protocol Violation|1
7822510|NCT00369824|27164074|P3|Overall Study|Protocol Violation|0
7822511|NCT00369824|27164075|P2|Overall Study|Protocol Violation|1
7822512|NCT00369824|27164076|P1|Overall Study|Protocol Violation|0
7822513|NCT00369824|27164071|P6|Overall Study|Adverse Event|0
7822514|NCT00369824|27164072|P5|Overall Study|Adverse Event|1
7822515|NCT00369824|27164073|P4|Overall Study|Adverse Event|0
7822516|NCT00369824|27164074|P3|Overall Study|Adverse Event|0
7822517|NCT00369824|27164075|P2|Overall Study|Adverse Event|2
7822518|NCT00369824|27164076|P1|Overall Study|Adverse Event|0
7822533|NCT00369707|27164198|P1|Follow up for 2 Years After Treatment|Other|2
7822534|NCT00369707|27164198|P1|Follow up for 2 Years After Treatment|Death|1
7822535|NCT00369707|27164198|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
7822536|NCT00369707|27164198|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
7822537|NCT00369707|27164198|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
7822538|NCT00369707|27164198|P1|Induction Part B (2 Cycles)|Progressive disease|1
7822539|NCT00369707|27164198|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
7822540|NCT00369707|27164198|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
7822541|NCT00369707|27164198|P1|Induction Part B (2 Cycles)|Adverse Event|3
7822542|NCT00369681|27164211|P1|Overall Study|Death|1
7822543|NCT00369668|27164221|P3|Overall Study|Lack of Efficacy|7
7822544|NCT00369668|27164222|P2|Overall Study|Lack of Efficacy|5
7822545|NCT00369668|27164223|P1|Overall Study|Lack of Efficacy|4
7822546|NCT00369655|27164237|P1|Overall Study|Refusal of further treatment|2
7822547|NCT00369629|27164246|P4|Follow up for 1 Year|stopped being followed as study closed|0
7822548|NCT00369629|27164247|P3|Follow up for 1 Year|stopped being followed as study closed|2
7822549|NCT00369629|27164248|P2|Follow up for 1 Year|stopped being followed as study closed|0
7822550|NCT00369629|27164249|P1|Follow up for 1 Year|stopped being followed as study closed|0
7822551|NCT00369629|27164246|P4|Follow up for 1 Year|Lost to Follow-up|0
7822552|NCT00369629|27164247|P3|Follow up for 1 Year|Lost to Follow-up|0
7822553|NCT00369629|27164248|P2|Follow up for 1 Year|Lost to Follow-up|1
7822554|NCT00369629|27164249|P1|Follow up for 1 Year|Lost to Follow-up|0
7822555|NCT00369629|27164246|P4|Follow up for 1 Year|Death|0
7822556|NCT00369629|27164247|P3|Follow up for 1 Year|Death|1
7822557|NCT00369629|27164248|P2|Follow up for 1 Year|Death|1
7822558|NCT00369629|27164249|P1|Follow up for 1 Year|Death|2
7822559|NCT00369629|27164246|P4|Completed 4 More Cycles|Progressive disease|0
7822560|NCT00369629|27164247|P3|Completed 4 More Cycles|Progressive disease|2
7822561|NCT00369629|27164248|P2|Completed 4 More Cycles|Progressive disease|1
7822562|NCT00369629|27164249|P1|Completed 4 More Cycles|Progressive disease|2
7822563|NCT00369629|27164246|P4|Completed 4 More Cycles|Withdrawal by Subject|0
7822564|NCT00369629|27164247|P3|Completed 4 More Cycles|Withdrawal by Subject|0
7822565|NCT00369629|27164248|P2|Completed 4 More Cycles|Withdrawal by Subject|1
7822566|NCT00369629|27164249|P1|Completed 4 More Cycles|Withdrawal by Subject|2
7822567|NCT00369629|27164246|P4|Moved on to 4 More Cycles|Progressive Disease|0
7822568|NCT00369629|27164247|P3|Moved on to 4 More Cycles|Progressive Disease|1
7822569|NCT00369629|27164248|P2|Moved on to 4 More Cycles|Progressive Disease|0
7822570|NCT00369629|27164249|P1|Moved on to 4 More Cycles|Progressive Disease|0
7822571|NCT00369629|27164246|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
7822572|NCT00369629|27164247|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
7822573|NCT00369629|27164248|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
7822574|NCT00369629|27164249|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
7822575|NCT00369629|27164246|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
7822576|NCT00369629|27164247|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
7822577|NCT00369629|27164248|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
7822578|NCT00369629|27164249|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
7822579|NCT00369629|27164246|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
7822580|NCT00369629|27164247|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
7822581|NCT00369629|27164248|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
7822582|NCT00369629|27164249|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
7822583|NCT00369577|27164280|P3|Overall Study|Withdrawal by Subject|1
7822584|NCT00369577|27164281|P2|Overall Study|Withdrawal by Subject|0
7822585|NCT00369577|27164282|P1|Overall Study|Withdrawal by Subject|0
7822586|NCT00369486|27164325|P5|34-Week Visit|Dropped|3
7822587|NCT00369486|27164326|P4|34-Week Visit|Dropped|3
7822588|NCT00369486|27164327|P3|34-Week Visit|Dropped|1
7822589|NCT00369486|27164328|P2|34-Week Visit|Dropped|1
7822590|NCT00369486|27164329|P1|34-Week Visit|Dropped|0
7822591|NCT00369486|27164325|P5|17-Week Visit|Missed visit|1
7822592|NCT00369486|27164326|P4|17-Week Visit|Missed visit|1
7822593|NCT00369486|27164327|P3|17-Week Visit|Missed visit|1
7822594|NCT00369486|27164328|P2|17-Week Visit|Missed visit|0
7822595|NCT00369486|27164329|P1|17-Week Visit|Missed visit|0
7822596|NCT00369486|27164325|P5|8-Week Visit|Dropped|0
7822597|NCT00369486|27164326|P4|8-Week Visit|Dropped|1
7822598|NCT00369486|27164327|P3|8-Week Visit|Dropped|0
7822599|NCT00369486|27164328|P2|8-Week Visit|Dropped|0
7822600|NCT00369486|27164329|P1|8-Week Visit|Dropped|0
7822601|NCT00369486|27164325|P5|8-Week Visit|Missed visit|1
7822602|NCT00369486|27164326|P4|8-Week Visit|Missed visit|0
7822603|NCT00369486|27164327|P3|8-Week Visit|Missed visit|0
7822604|NCT00369486|27164328|P2|8-Week Visit|Missed visit|1
7822605|NCT00369486|27164329|P1|8-Week Visit|Missed visit|0
7822606|NCT00369486|27164325|P5|4-Week Visit|Dropped|0
7822607|NCT00369486|27164326|P4|4-Week Visit|Dropped|0
7822608|NCT00369486|27164327|P3|4-Week Visit|Dropped|1
7822609|NCT00369486|27164328|P2|4-Week Visit|Dropped|0
7822610|NCT00369486|27164329|P1|4-Week Visit|Dropped|0
7822611|NCT00369486|27164325|P5|4-Week Visit|Missed visit|1
7822612|NCT00369486|27164326|P4|4-Week Visit|Missed visit|2
7822613|NCT00369486|27164327|P3|4-Week Visit|Missed visit|0
7822614|NCT00369486|27164328|P2|4-Week Visit|Missed visit|2
7822615|NCT00369486|27164329|P1|4-Week Visit|Missed visit|2
7822616|NCT00369382|27164368|P2|Overall Study|Other|0
7822617|NCT00369382|27164369|P1|Overall Study|Other|1
7822618|NCT00369382|27164368|P2|Overall Study|Randomized, not treated|0
7822619|NCT00369382|27164369|P1|Overall Study|Randomized, not treated|2
7822620|NCT00369382|27164368|P2|Overall Study|Withdrawal by Subject|0
7822621|NCT00369382|27164369|P1|Overall Study|Withdrawal by Subject|5
7822622|NCT00369382|27164368|P2|Overall Study|Physician Decision|1
7822623|NCT00369382|27164369|P1|Overall Study|Physician Decision|2
7822624|NCT00369382|27164368|P2|Overall Study|Death|2
7822625|NCT00369382|27164369|P1|Overall Study|Death|0
7822626|NCT00369343|27164402|P2|Open-label Phase|did not take study drug|2
7822627|NCT00369343|27164403|P1|Open-label Phase|did not take study drug|1
7822628|NCT00369343|27164402|P2|Open-label Phase|Lack of continuance tolerability|4
7822629|NCT00369343|27164403|P1|Open-label Phase|Lack of continuance tolerability|3
7822630|NCT00369343|27164402|P2|Open-label Phase|Lack of Efficacy|3
7822631|NCT00369343|27164403|P1|Open-label Phase|Lack of Efficacy|4
7822632|NCT00369343|27164402|P2|Open-label Phase|Withdrawal by Subject|6
7822633|NCT00369343|27164403|P1|Open-label Phase|Withdrawal by Subject|15
7822634|NCT00369343|27164402|P2|Open-label Phase|Protocol Violation|3
7822635|NCT00369343|27164403|P1|Open-label Phase|Protocol Violation|1
7822636|NCT00369343|27164402|P2|Open-label Phase|inadvertently reported study completers|2
7822637|NCT00369343|27164403|P1|Open-label Phase|inadvertently reported study completers|3
7822638|NCT00369343|27164402|P2|Open-label Phase|Lost to Follow-up|3
7822639|NCT00369343|27164403|P1|Open-label Phase|Lost to Follow-up|5
7822640|NCT00369343|27164402|P2|Open-label Phase|Physician Decision|0
7822641|NCT00369343|27164403|P1|Open-label Phase|Physician Decision|2
7822642|NCT00369343|27164402|P2|Open-label Phase|Failed to return|0
7822643|NCT00369343|27164403|P1|Open-label Phase|Failed to return|4
7822644|NCT00369343|27164402|P2|Open-label Phase|Adverse Event|7
7822645|NCT00369343|27164403|P1|Open-label Phase|Adverse Event|19
7822646|NCT00369343|27164402|P2|Double-blind Phase|Protocol deviation|0
7822647|NCT00369343|27164403|P1|Double-blind Phase|Protocol deviation|4
7822648|NCT00369343|27164402|P2|Double-blind Phase|Lack of Efficacy|4
7822649|NCT00369343|27164403|P1|Double-blind Phase|Lack of Efficacy|0
7822650|NCT00369343|27164402|P2|Double-blind Phase|Withdrawal by Subject|6
7822651|NCT00369343|27164403|P1|Double-blind Phase|Withdrawal by Subject|8
7822652|NCT00369343|27164402|P2|Double-blind Phase|Protocol Violation|0
7822653|NCT00369343|27164403|P1|Double-blind Phase|Protocol Violation|2
7822654|NCT00369343|27164402|P2|Double-blind Phase|Lost to Follow-up|2
7822655|NCT00369343|27164403|P1|Double-blind Phase|Lost to Follow-up|9
7822656|NCT00369343|27164402|P2|Double-blind Phase|Failed to return|0
7822657|NCT00369343|27164403|P1|Double-blind Phase|Failed to return|2
7822658|NCT00369343|27164402|P2|Double-blind Phase|Adverse Event|4
7822659|NCT00369343|27164403|P1|Double-blind Phase|Adverse Event|19
7822660|NCT00369317|27164436|P1|Overall Study|Ineligible|1
7822661|NCT00369317|27164436|P1|Overall Study|Withdrawal by Subject|8
7822662|NCT00369317|27164436|P1|Overall Study|Physician Decision|2
7822663|NCT00369317|27164436|P1|Overall Study|Lack of Efficacy|5
7822664|NCT00369317|27164436|P1|Overall Study|Death|1
7822665|NCT00369317|27164436|P1|Overall Study|Adverse Event|3
7822666|NCT00369278|27164452|P2|Overall Study|Graft loss|2
7822667|NCT00369278|27164453|P1|Overall Study|Graft loss|1
7822668|NCT00369278|27164452|P2|Overall Study|Lost to Follow-up|0
7822669|NCT00369278|27164453|P1|Overall Study|Lost to Follow-up|1
7822670|NCT00369278|27164452|P2|Overall Study|Withdrawal by Subject|2
7822671|NCT00369278|27164453|P1|Overall Study|Withdrawal by Subject|2
7822672|NCT00369278|27164452|P2|Overall Study|Protocol Violation|1
7822673|NCT00369278|27164453|P1|Overall Study|Protocol Violation|2
7822674|NCT00369278|27164452|P2|Overall Study|Unsatisfactory therapeutic effect|5
7822675|NCT00369278|27164453|P1|Overall Study|Unsatisfactory therapeutic effect|4
7822676|NCT00369278|27164452|P2|Overall Study|Adverse Event|11
7822677|NCT00369278|27164453|P1|Overall Study|Adverse Event|14
7822678|NCT00369265|27164469|P2|Overall Study|Study terminated|7
7822679|NCT00369265|27164470|P1|Overall Study|Study terminated|4
7822680|NCT00369161|27164491|P2|Overall Study|Administrative Problem|2
7822681|NCT00369161|27164492|P1|Overall Study|Administrative Problem|2
7822682|NCT00369161|27164491|P2|Overall Study|Graft loss|0
7822683|NCT00369161|27164492|P1|Overall Study|Graft loss|4
7822684|NCT00369161|27164491|P2|Overall Study|Death|2
7822685|NCT00369161|27164492|P1|Overall Study|Death|1
7822686|NCT00369161|27164491|P2|Overall Study|Withdrawal by Subject|3
7822687|NCT00369161|27164492|P1|Overall Study|Withdrawal by Subject|2
7822688|NCT00369161|27164491|P2|Overall Study|Protocol Violation|2
7822689|NCT00369161|27164492|P1|Overall Study|Protocol Violation|0
7822690|NCT00369161|27164491|P2|Overall Study|Lack of Efficacy|1
7822691|NCT00369161|27164492|P1|Overall Study|Lack of Efficacy|3
7822692|NCT00369161|27164491|P2|Overall Study|Abnormal laboratory value|1
7822693|NCT00369161|27164492|P1|Overall Study|Abnormal laboratory value|0
7822694|NCT00369161|27164491|P2|Overall Study|Adverse Event|13
7822695|NCT00369161|27164492|P1|Overall Study|Adverse Event|15
7822696|NCT00369122|27164502|P1|Overall Study|No protocol treatment|1
7822697|NCT00369122|27164502|P1|Overall Study|Ineligible|10
7822698|NCT00368992|27164509|P1|Overall Study|Other|9
7822699|NCT00368992|27164509|P1|Overall Study|Death|4
7822700|NCT00368992|27164509|P1|Overall Study|Adverse Event|26
7822701|NCT00368992|27164509|P1|Overall Study|Lack of Efficacy|63
7822702|NCT00368992|27164509|P1|Overall Study|Refused treatment|3
7822703|NCT00368992|27164509|P1|Overall Study|Ineligible|5
7822704|NCT00368979|27164518|P2|Overall Study|Withdrawal by Subject|9
7822705|NCT00368979|27164519|P1|Overall Study|Withdrawal by Subject|5
7822706|NCT00368979|27164518|P2|Overall Study|Protocol Violation|1
7822707|NCT00368979|27164519|P1|Overall Study|Protocol Violation|2
7822708|NCT00368979|27164518|P2|Overall Study|Lost to Follow-up|0
7822709|NCT00368979|27164519|P1|Overall Study|Lost to Follow-up|1
7822710|NCT00368979|27164518|P2|Overall Study|Other|1
7822711|NCT00368979|27164519|P1|Overall Study|Other|3
7822712|NCT00368979|27164518|P2|Overall Study|Lack of Efficacy|3
7822713|NCT00368979|27164519|P1|Overall Study|Lack of Efficacy|5
7822714|NCT00368979|27164518|P2|Overall Study|Adverse Event|16
7822715|NCT00368979|27164519|P1|Overall Study|Adverse Event|9
7822716|NCT00368966|27164535|P2|Toddler Dose|Lost to Follow-up|2
7822717|NCT00368966|27164536|P1|Toddler Dose|Lost to Follow-up|0
7822718|NCT00368966|27164535|P2|Toddler Dose|Withdrawal by Subject|1
7822719|NCT00368966|27164536|P1|Toddler Dose|Withdrawal by Subject|1
7822720|NCT00368966|27164535|P2|After Infant|Lost to Follow-up|1
7822721|NCT00368966|27164536|P1|After Infant|Lost to Follow-up|0
7822722|NCT00368966|27164535|P2|After Infant|Death|0
7822723|NCT00368966|27164536|P1|After Infant|Death|1
7822724|NCT00368966|27164535|P2|After Infant|Withdrawal by Subject|1
7822725|NCT00368966|27164536|P1|After Infant|Withdrawal by Subject|1
7822726|NCT00368966|27164535|P2|After Infant|Adverse Event|2
7822727|NCT00368966|27164536|P1|After Infant|Adverse Event|1
7822728|NCT00368966|27164535|P2|After Infant|Failed to return|1
7822729|NCT00368966|27164536|P1|After Infant|Failed to return|3
7822730|NCT00368966|27164535|P2|Infant Series|Failed to return|0
7822731|NCT00368966|27164536|P1|Infant Series|Failed to return|1
7822732|NCT00368966|27164535|P2|Infant Series|Adverse Event|1
7822733|NCT00368966|27164536|P1|Infant Series|Adverse Event|0
7822734|NCT00368966|27164535|P2|Infant Series|Failed to meet eligibility criteria|1
7822735|NCT00368966|27164536|P1|Infant Series|Failed to meet eligibility criteria|0
7822736|NCT00368966|27164535|P2|Infant Series|Randomization error|1
7822737|NCT00368966|27164536|P1|Infant Series|Randomization error|0
7822738|NCT00368966|27164535|P2|Infant Series|Lost to Follow-up|0
7822739|NCT00368966|27164536|P1|Infant Series|Lost to Follow-up|2
7822740|NCT00368966|27164535|P2|Infant Series|Protocol Violation|1
7822741|NCT00368966|27164536|P1|Infant Series|Protocol Violation|2
7822742|NCT00368966|27164535|P2|Infant Series|Withdrawal by Subject|6
7822743|NCT00368966|27164536|P1|Infant Series|Withdrawal by Subject|11
7822744|NCT00368927|27164607|P2|Overall Study|Physician Decision|0
7822745|NCT00368927|27164608|P1|Overall Study|Physician Decision|1
7822746|NCT00368927|27164607|P2|Overall Study|Withdrawal by Subject|2
7822747|NCT00368927|27164608|P1|Overall Study|Withdrawal by Subject|1
7822748|NCT00368927|27164607|P2|Overall Study|Adverse Event|1
7822749|NCT00368927|27164608|P1|Overall Study|Adverse Event|1
7822750|NCT00368927|27164607|P2|Overall Study|Lost to Follow-up|0
7822751|NCT00368927|27164608|P1|Overall Study|Lost to Follow-up|2
7822752|NCT00368875|27164616|P2|Overall Study|Alternative Therapy|1
7822753|NCT00368875|27164617|P1|Overall Study|Alternative Therapy|1
7822754|NCT00368875|27164616|P2|Overall Study|Other Reason|2
7822755|NCT00368875|27164617|P1|Overall Study|Other Reason|0
7822756|NCT00368875|27164616|P2|Overall Study|Withdrawal by Subject|6
7822757|NCT00368875|27164617|P1|Overall Study|Withdrawal by Subject|2
7822758|NCT00368875|27164616|P2|Overall Study|Progressive disease|27
7822759|NCT00368875|27164617|P1|Overall Study|Progressive disease|3
7822760|NCT00368875|27164616|P2|Overall Study|Adverse Event|12
7822761|NCT00368875|27164617|P1|Overall Study|Adverse Event|0
7822762|NCT00368849|27164625|P2|Overall Study|Physician Decision|1
7822763|NCT00368849|27164626|P1|Overall Study|Physician Decision|0
7822764|NCT00368849|27164625|P2|Overall Study|Withdrawal by Subject|1
7822765|NCT00368849|27164626|P1|Overall Study|Withdrawal by Subject|0
7822766|NCT00368836|27164642|P1|Phase II|Protocol Violation|2
7822767|NCT00368836|27164642|P1|Phase II|unable to collect blood and/or breath|17
7822768|NCT00368836|27164642|P1|Phase II|Withdrawal by Subject|1
7822769|NCT00368836|27164642|P1|Phase II|Screen Failure|1
7822770|NCT00368745|27164651|P2|Double-blind Treatment Period|Other|6
7822771|NCT00368745|27164652|P1|Double-blind Treatment Period|Other|7
7822772|NCT00368745|27164651|P2|Double-blind Treatment Period|Withdrawal by Subject|3
7822773|NCT00368745|27164652|P1|Double-blind Treatment Period|Withdrawal by Subject|5
7822774|NCT00368745|27164651|P2|Double-blind Treatment Period|Lost to Follow-up|0
7822775|NCT00368745|27164652|P1|Double-blind Treatment Period|Lost to Follow-up|1
7822776|NCT00368745|27164651|P2|Double-blind Treatment Period|Lack of Efficacy|16
7822777|NCT00368745|27164652|P1|Double-blind Treatment Period|Lack of Efficacy|7
7822778|NCT00368745|27164651|P2|Double-blind Treatment Period|Adverse Event|6
7822779|NCT00368745|27164652|P1|Double-blind Treatment Period|Adverse Event|6
7822780|NCT00368641|27164705|P2|Overall Study|Sponsor decision to terminate study|5
7822781|NCT00368641|27164706|P1|Overall Study|Sponsor decision to terminate study|2
7822782|NCT00368641|27164705|P2|Overall Study|Withdrawal by Subject|0
7822783|NCT00368641|27164706|P1|Overall Study|Withdrawal by Subject|1
7822784|NCT00368641|27164705|P2|Overall Study|Death|0
7822785|NCT00368641|27164706|P1|Overall Study|Death|1
7822786|NCT00368641|27164705|P2|Overall Study|Adverse Event|1
7822787|NCT00368641|27164706|P1|Overall Study|Adverse Event|2
7822788|NCT00368550|27164714|P2|Overall Study|Withdrawal by Subject|10
7822789|NCT00368550|27164715|P1|Overall Study|Withdrawal by Subject|17
7822790|NCT00368550|27164714|P2|Overall Study|Lack of Efficacy|9
7822791|NCT00368550|27164715|P1|Overall Study|Lack of Efficacy|4
7822792|NCT00368550|27164714|P2|Overall Study|Adverse Event|4
7822793|NCT00368550|27164715|P1|Overall Study|Adverse Event|7
7822794|NCT00368537|27164727|P2|Baseline Participants|Patient uncompliant|1
7822795|NCT00368537|27164728|P1|Baseline Participants|Patient uncompliant|0
7822796|NCT00368537|27164727|P2|Baseline Participants|No susceptibility|0
7822797|NCT00368537|27164728|P1|Baseline Participants|No susceptibility|1
7822798|NCT00368537|27164727|P2|Baseline Participants|Death|2
7822799|NCT00368537|27164728|P1|Baseline Participants|Death|1
7822800|NCT00368537|27164727|P2|Baseline Participants|Withdrawal by Subject|4
7822801|NCT00368537|27164728|P1|Baseline Participants|Withdrawal by Subject|6
7822802|NCT00368537|27164727|P2|Baseline Participants|Lost to Follow-up|17
7822803|NCT00368537|27164728|P1|Baseline Participants|Lost to Follow-up|16
7822804|NCT00368537|27164727|P2|Randomization|No study drug dosed|6
7822805|NCT00368537|27164728|P1|Randomization|No study drug dosed|13
7822806|NCT00368472|27164742|P1|Overall Study|Missing Final Disposition Date|1
7822807|NCT00368472|27164742|P1|Overall Study|Other|32
7822808|NCT00368472|27164742|P1|Overall Study|Diary non-compliance|1
7822809|NCT00368472|27164742|P1|Overall Study|Withdrawal by Subject|40
7822810|NCT00368472|27164742|P1|Overall Study|Request of Investigator or Sponsor|3
7822811|NCT00368472|27164742|P1|Overall Study|Protocol Violation|2
7822812|NCT00368472|27164742|P1|Overall Study|Medication non-compliance|4
7822813|NCT00368472|27164742|P1|Overall Study|Adverse Event|22
7822814|NCT00368355|27164777|P2|Overall Study|Treatment - hematopoietic cell product|0
7822815|NCT00368355|27164778|P1|Overall Study|Treatment - hematopoietic cell product|2
7822816|NCT00368355|27164777|P2|Overall Study|Subsequent transplant|3
7822817|NCT00368355|27164778|P1|Overall Study|Subsequent transplant|0
7822818|NCT00368355|27164777|P2|Overall Study|Relapse|10
7822819|NCT00368355|27164778|P1|Overall Study|Relapse|6
7822820|NCT00368355|27164777|P2|Overall Study|Death|4
7822821|NCT00368355|27164778|P1|Overall Study|Death|2
7822822|NCT00368355|27164777|P2|Overall Study|Adverse Event|0
7822823|NCT00368355|27164778|P1|Overall Study|Adverse Event|1
7822824|NCT00368277|27164818|P2|Overall Study|Lost to Follow-up|6
7822825|NCT00368277|27164819|P1|Overall Study|Lost to Follow-up|8
7822826|NCT00368277|27164818|P2|Overall Study|Patient withdrew consent|28
7822827|NCT00368277|27164819|P1|Overall Study|Patient withdrew consent|32
7822828|NCT00368277|27164818|P2|Overall Study|Protocol deviation|0
7822829|NCT00368277|27164819|P1|Overall Study|Protocol deviation|7
7822830|NCT00368277|27164818|P2|Overall Study|Unsatisfactory therapeutic effect|24
7822831|NCT00368277|27164819|P1|Overall Study|Unsatisfactory therapeutic effect|31
7822832|NCT00368277|27164818|P2|Overall Study|Death|1
7822833|NCT00368277|27164819|P1|Overall Study|Death|2
7822834|NCT00368277|27164818|P2|Overall Study|Adverse Event|49
7822835|NCT00368277|27164819|P1|Overall Study|Adverse Event|33
7822836|NCT00368251|27164834|P3|Overall Study|AE, non-serious non-fatal|1
7822837|NCT00368251|27164835|P2|Overall Study|AE, non-serious non-fatal|0
7822838|NCT00368251|27164836|P1|Overall Study|AE, non-serious non-fatal|0
7822839|NCT00368251|27164834|P3|Overall Study|SAE, non-fatal|0
7822840|NCT00368251|27164835|P2|Overall Study|SAE, non-fatal|0
7822841|NCT00368251|27164836|P1|Overall Study|SAE, non-fatal|1
7822842|NCT00368108|27164859|P3|Overall Study|Other|1
7822843|NCT00368108|27164860|P2|Overall Study|Other|7
7822844|NCT00368108|27164861|P1|Overall Study|Other|3
7822845|NCT00368108|27164859|P3|Overall Study|Physician Decision|1
7822846|NCT00368108|27164860|P2|Overall Study|Physician Decision|0
7822847|NCT00368108|27164861|P1|Overall Study|Physician Decision|2
7822848|NCT00368108|27164859|P3|Overall Study|Lack of Efficacy|5
7822849|NCT00368108|27164860|P2|Overall Study|Lack of Efficacy|8
7822850|NCT00368108|27164861|P1|Overall Study|Lack of Efficacy|7
7822851|NCT00368108|27164859|P3|Overall Study|Withdrawal by Subject|5
7822852|NCT00368108|27164860|P2|Overall Study|Withdrawal by Subject|3
7822853|NCT00368108|27164861|P1|Overall Study|Withdrawal by Subject|9
7822854|NCT00368108|27164859|P3|Overall Study|Protocol Violation|9
7822855|NCT00368108|27164860|P2|Overall Study|Protocol Violation|9
7822856|NCT00368108|27164861|P1|Overall Study|Protocol Violation|5
7822857|NCT00368108|27164859|P3|Overall Study|Abnormal Laboratory Value|3
7822858|NCT00368108|27164860|P2|Overall Study|Abnormal Laboratory Value|0
7822859|NCT00368108|27164861|P1|Overall Study|Abnormal Laboratory Value|0
7822860|NCT00368108|27164859|P3|Overall Study|Adverse Event|44
7822861|NCT00368108|27164860|P2|Overall Study|Adverse Event|26
7822862|NCT00368108|27164861|P1|Overall Study|Adverse Event|38
7822863|NCT00368069|27164880|P2|Overall Study|no blood sampling possible|1
7822864|NCT00368069|27164881|P1|Overall Study|no blood sampling possible|0
7822865|NCT00368069|27164880|P2|Overall Study|Withdrawal of Consent|1
7822866|NCT00368069|27164881|P1|Overall Study|Withdrawal of Consent|2
7822867|NCT00368069|27164880|P2|Overall Study|Protocol Violation|2
7822868|NCT00368069|27164881|P1|Overall Study|Protocol Violation|0
7822869|NCT00368069|27164880|P2|Overall Study|Lost to Follow-up|0
7822870|NCT00368069|27164881|P1|Overall Study|Lost to Follow-up|1
7822871|NCT00368069|27164880|P2|Overall Study|Lack of Efficacy|1
7822872|NCT00368069|27164881|P1|Overall Study|Lack of Efficacy|0
7822873|NCT00368069|27164880|P2|Overall Study|Adverse Event|2
7822874|NCT00368069|27164881|P1|Overall Study|Adverse Event|5
7822875|NCT00367991|27164899|P2|Overall Study|Adverse Event|1
7822876|NCT00367991|27164900|P1|Overall Study|Adverse Event|1
7822877|NCT00367991|27164899|P2|Overall Study|Withdrawal by Subject|1
7822878|NCT00367991|27164900|P1|Overall Study|Withdrawal by Subject|1
7822879|NCT00367835|27164918|P2|Overall Study|History of lead poisoning|1
7822880|NCT00367835|27164919|P1|Overall Study|History of lead poisoning|0
7822881|NCT00367835|27164918|P2|Overall Study|Did not respond to calls|0
7822882|NCT00367835|27164919|P1|Overall Study|Did not respond to calls|1
7822883|NCT00367835|27164918|P2|Overall Study|refused blood collection|0
7822884|NCT00367835|27164919|P1|Overall Study|refused blood collection|1
7822885|NCT00367835|27164918|P2|Overall Study|Subject in juvenile detention center|0
7822886|NCT00367835|27164919|P1|Overall Study|Subject in juvenile detention center|1
7822887|NCT00367835|27164918|P2|Overall Study|Lack of Efficacy|12
7822888|NCT00367835|27164919|P1|Overall Study|Lack of Efficacy|3
7822889|NCT00367835|27164918|P2|Overall Study|Lost to Follow-up|4
7822890|NCT00367835|27164919|P1|Overall Study|Lost to Follow-up|1
7822891|NCT00367835|27164918|P2|Overall Study|Withdrawal by Subject|6
7822892|NCT00367835|27164919|P1|Overall Study|Withdrawal by Subject|7
7822893|NCT00367835|27164918|P2|Overall Study|Protocol Violation|7
7822894|NCT00367835|27164919|P1|Overall Study|Protocol Violation|1
7822895|NCT00367835|27164918|P2|Overall Study|Adverse Event|1
7822896|NCT00367835|27164919|P1|Overall Study|Adverse Event|14
7822897|NCT00367770|27164945|P1|Overall Study|Withdrawal by Subject|1
7822898|NCT00367770|27164945|P1|Overall Study|Adverse Event|1
7822899|NCT00367744|27164953|P2|Overall Study|Lost to Follow-up|5
7822900|NCT00367744|27164954|P1|Overall Study|Lost to Follow-up|4
7822901|NCT00367640|27164983|P4|Overall Study|Any other reason not above-mentioned|4
7822902|NCT00367640|27164984|P3|Overall Study|Any other reason not above-mentioned|3
7822903|NCT00367640|27164985|P2|Overall Study|Any other reason not above-mentioned|5
7822904|NCT00367640|27164986|P1|Overall Study|Any other reason not above-mentioned|7
7822905|NCT00367640|27164983|P4|Overall Study|Withdrawal by Subject|6
7822906|NCT00367640|27164984|P3|Overall Study|Withdrawal by Subject|8
7822907|NCT00367640|27164985|P2|Overall Study|Withdrawal by Subject|11
7822908|NCT00367640|27164986|P1|Overall Study|Withdrawal by Subject|8
7822909|NCT00367640|27164983|P4|Overall Study|Adverse Event|0
7822910|NCT00367640|27164984|P3|Overall Study|Adverse Event|8
7822911|NCT00367640|27164985|P2|Overall Study|Adverse Event|6
7822912|NCT00367640|27164986|P1|Overall Study|Adverse Event|3
7822913|NCT00367484|27165002|P1|Overall Study|Lack of Efficacy|1
7822914|NCT00367484|27165002|P1|Overall Study|The choice of the patient|1
7822915|NCT00367484|27165002|P1|Overall Study|Protocol Violation|1
7822916|NCT00367484|27165002|P1|Overall Study|Lost to Follow-up|1
7822917|NCT00367484|27165002|P1|Overall Study|Travel to USA|1
7822918|NCT00367484|27165002|P1|Overall Study|Withdrew informed consent|5
7822919|NCT00367484|27165002|P1|Overall Study|Adverse Event|7
7822920|NCT00367458|27165008|P2|First Intervention - 8 Weeks|Adverse Event|0
7822921|NCT00367458|27165009|P1|First Intervention - 8 Weeks|Adverse Event|2
7822922|NCT00367432|27165023|P2|Second Period (up to 54 Months)|Other Reason|2
7822923|NCT00367432|27165024|P1|Second Period (up to 54 Months)|Other Reason|6
7822924|NCT00367432|27165023|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
7822925|NCT00367432|27165024|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
7822926|NCT00367432|27165023|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
7822927|NCT00367432|27165024|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
7822928|NCT00367432|27165023|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
7822929|NCT00367432|27165024|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
7822930|NCT00367432|27165023|P2|Second Period (up to 54 Months)|Adverse Event|3
7822931|NCT00367432|27165024|P1|Second Period (up to 54 Months)|Adverse Event|14
7822932|NCT00367432|27165023|P2|First Period (16 Weeks)|Other Reason|0
7822933|NCT00367432|27165024|P1|First Period (16 Weeks)|Other Reason|2
7822934|NCT00367432|27165023|P2|First Period (16 Weeks)|Withdrawal by Subject|0
7822935|NCT00367432|27165024|P1|First Period (16 Weeks)|Withdrawal by Subject|6
7822936|NCT00367432|27165023|P2|First Period (16 Weeks)|Lack of Efficacy|0
7822937|NCT00367432|27165024|P1|First Period (16 Weeks)|Lack of Efficacy|24
7822938|NCT00367432|27165023|P2|First Period (16 Weeks)|Adverse Event|0
7822939|NCT00367432|27165024|P1|First Period (16 Weeks)|Adverse Event|6
7822940|NCT00367341|27165051|P2|Overall Study|Protocol Violation|0
7822941|NCT00367341|27165052|P1|Overall Study|Protocol Violation|1
7822942|NCT00367341|27165051|P2|Overall Study|Physician Decision|0
7822943|NCT00367341|27165052|P1|Overall Study|Physician Decision|1
7822944|NCT00367237|27165062|P2|Overall Study|Protocol Violation|5
7822945|NCT00367237|27165063|P1|Overall Study|Protocol Violation|2
7822946|NCT00367237|27165062|P2|Overall Study|Withdrawal by Subject|4
7822947|NCT00367237|27165063|P1|Overall Study|Withdrawal by Subject|0
7822948|NCT00367237|27165062|P2|Overall Study|Lost to Follow-up|0
7822949|NCT00367237|27165063|P1|Overall Study|Lost to Follow-up|1
7822950|NCT00367237|27165062|P2|Overall Study|Adverse Event|2
7822951|NCT00367237|27165063|P1|Overall Study|Adverse Event|7
7822952|NCT00367133|27165072|P3|2 Years|Missed visit|4
7822953|NCT00367133|27165073|P2|2 Years|Missed visit|5
7822954|NCT00367133|27165074|P1|2 Years|Missed visit|4
7822955|NCT00367133|27165072|P3|2 Years|Dropped|33
7822956|NCT00367133|27165073|P2|2 Years|Dropped|19
7822957|NCT00367133|27165074|P1|2 Years|Dropped|34
7822958|NCT00367133|27165072|P3|2 Years|Death|12
7822959|NCT00367133|27165073|P2|2 Years|Death|12
7822960|NCT00367133|27165074|P1|2 Years|Death|20
7822961|NCT00367055|27165126|P2|Overall Study|Participant Living too Far from Hospital|1
7822962|NCT00367055|27165127|P1|Overall Study|Participant Living too Far from Hospital|0
7822963|NCT00367055|27165126|P2|Overall Study|Stopping Criterion Met|1
7822964|NCT00367055|27165127|P1|Overall Study|Stopping Criterion Met|0
7822965|NCT00367055|27165126|P2|Overall Study|Protocol Violation|1
7822966|NCT00367055|27165127|P1|Overall Study|Protocol Violation|0
7822967|NCT00367055|27165126|P2|Overall Study|Lost to Follow-up|1
7822968|NCT00367055|27165127|P1|Overall Study|Lost to Follow-up|1
7822969|NCT00367055|27165126|P2|Overall Study|Lack of Efficacy|2
7822970|NCT00367055|27165127|P1|Overall Study|Lack of Efficacy|1
7822971|NCT00367055|27165126|P2|Overall Study|Patient's Willing|2
7822972|NCT00367055|27165127|P1|Overall Study|Patient's Willing|3
7822973|NCT00367055|27165126|P2|Overall Study|Adverse Event|3
7822974|NCT00367055|27165127|P1|Overall Study|Adverse Event|6
7822975|NCT00366899|27165160|P2|Toddler Dose|Protocol Violation|0
7822976|NCT00366899|27165161|P1|Toddler Dose|Protocol Violation|1
7822977|NCT00366899|27165160|P2|Toddler Dose|Withdrawal by Subject|1
7822978|NCT00366899|27165161|P1|Toddler Dose|Withdrawal by Subject|1
7822979|NCT00366899|27165160|P2|After Infant Series|Protocol Violation|0
7822980|NCT00366899|27165161|P1|After Infant Series|Protocol Violation|1
7822981|NCT00366899|27165160|P2|After Infant Series|Adverse Event|2
7822982|NCT00366899|27165161|P1|After Infant Series|Adverse Event|1
7822983|NCT00366899|27165160|P2|After Infant Series|Withdrawal by Subject|4
7822984|NCT00366899|27165161|P1|After Infant Series|Withdrawal by Subject|1
7822985|NCT00366899|27165160|P2|After Infant Series|Lost to Follow-up|3
7822986|NCT00366899|27165161|P1|After Infant Series|Lost to Follow-up|4
7822987|NCT00366899|27165160|P2|Infant Series|Randomized but not consented|0
7822988|NCT00366899|27165161|P1|Infant Series|Randomized but not consented|1
7822989|NCT00366899|27165160|P2|Infant Series|Physician Decision|0
7822990|NCT00366899|27165161|P1|Infant Series|Physician Decision|1
7822991|NCT00366899|27165160|P2|Infant Series|Adverse Event|1
7822992|NCT00366899|27165161|P1|Infant Series|Adverse Event|0
7822993|NCT00366899|27165160|P2|Infant Series|Lost to Follow-up|2
7822994|NCT00366899|27165161|P1|Infant Series|Lost to Follow-up|0
7822995|NCT00366899|27165160|P2|Infant Series|Failed to return|1
7822996|NCT00366899|27165161|P1|Infant Series|Failed to return|1
7822997|NCT00366899|27165160|P2|Infant Series|Protocol Violation|1
7822998|NCT00366899|27165161|P1|Infant Series|Protocol Violation|2
7822999|NCT00366899|27165160|P2|Infant Series|Withdrawal by Subject|7
7823000|NCT00366899|27165161|P1|Infant Series|Withdrawal by Subject|4
7823001|NCT00366678|27165221|P3|Toddler Dose|protocol deviation|0
7823002|NCT00366678|27165222|P2|Toddler Dose|protocol deviation|0
7823003|NCT00366678|27165223|P1|Toddler Dose|protocol deviation|1
7823004|NCT00366678|27165221|P3|Toddler Dose|Withdrawal by Subject|0
7823005|NCT00366678|27165222|P2|Toddler Dose|Withdrawal by Subject|0
7823006|NCT00366678|27165223|P1|Toddler Dose|Withdrawal by Subject|1
7823007|NCT00366678|27165221|P3|Toddler Dose|Failed to return|0
7823008|NCT00366678|27165222|P2|Toddler Dose|Failed to return|0
7823009|NCT00366678|27165223|P1|Toddler Dose|Failed to return|1
7823010|NCT00366678|27165221|P3|Toddler Dose|Protocol Violation|0
7823011|NCT00366678|27165222|P2|Toddler Dose|Protocol Violation|1
7823012|NCT00366678|27165223|P1|Toddler Dose|Protocol Violation|2
7823013|NCT00366678|27165221|P3|After Infant|Protocol Violation|0
7823014|NCT00366678|27165222|P2|After Infant|Protocol Violation|0
7823015|NCT00366678|27165223|P1|After Infant|Protocol Violation|1
7823016|NCT00366678|27165221|P3|After Infant|Adverse Event|0
7823017|NCT00366678|27165222|P2|After Infant|Adverse Event|0
7823018|NCT00366678|27165223|P1|After Infant|Adverse Event|1
7823019|NCT00366678|27165221|P3|After Infant|Failed to return|0
7823020|NCT00366678|27165222|P2|After Infant|Failed to return|5
7823021|NCT00366678|27165223|P1|After Infant|Failed to return|5
7823022|NCT00366678|27165221|P3|After Infant|Lost to Follow-up|0
7823023|NCT00366678|27165222|P2|After Infant|Lost to Follow-up|1
7823024|NCT00366678|27165223|P1|After Infant|Lost to Follow-up|2
7823025|NCT00366678|27165221|P3|After Infant|Withdrawal by Subject|0
7823026|NCT00366678|27165222|P2|After Infant|Withdrawal by Subject|4
7823027|NCT00366678|27165223|P1|After Infant|Withdrawal by Subject|8
7823028|NCT00366678|27165221|P3|Infant Series|Adverse Event|0
7823029|NCT00366678|27165222|P2|Infant Series|Adverse Event|0
7823030|NCT00366678|27165223|P1|Infant Series|Adverse Event|1
7823031|NCT00366678|27165221|P3|Infant Series|Failed to return|0
7823032|NCT00366678|27165222|P2|Infant Series|Failed to return|1
7823033|NCT00366678|27165223|P1|Infant Series|Failed to return|1
7823034|NCT00366678|27165221|P3|Infant Series|Protocol Violation|0
7823035|NCT00366678|27165222|P2|Infant Series|Protocol Violation|3
7823036|NCT00366678|27165223|P1|Infant Series|Protocol Violation|4
7823037|NCT00366678|27165221|P3|Infant Series|Withdrawal by Subject|0
7823038|NCT00366678|27165222|P2|Infant Series|Withdrawal by Subject|6
7823039|NCT00366678|27165223|P1|Infant Series|Withdrawal by Subject|8
7823040|NCT00366548|27165305|P2|After Infant Series|Lost to Follow-up|0
7823041|NCT00366548|27165306|P1|After Infant Series|Lost to Follow-up|1
7823042|NCT00366548|27165305|P2|After Infant Series|Adverse Event|0
7823043|NCT00366548|27165306|P1|After Infant Series|Adverse Event|2
7823044|NCT00366548|27165305|P2|After Infant Series|Withdrawal by Subject|1
7823045|NCT00366548|27165306|P1|After Infant Series|Withdrawal by Subject|3
7823046|NCT00366548|27165305|P2|Infant Series|Withdrawal by Subject|1
7823047|NCT00366548|27165306|P1|Infant Series|Withdrawal by Subject|3
7823048|NCT00366548|27165305|P2|Infant Series|Protocol Violation|1
7823049|NCT00366548|27165306|P1|Infant Series|Protocol Violation|0
7823050|NCT00366548|27165305|P2|Infant Series|Adverse Event|3
7823051|NCT00366548|27165306|P1|Infant Series|Adverse Event|1
7823052|NCT00366535|27165342|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
7823053|NCT00366535|27165343|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
7823054|NCT00366535|27165342|P2|Second Phase: 12 Weeks|Adverse Event|1
7823055|NCT00366535|27165343|P1|Second Phase: 12 Weeks|Adverse Event|1
7823056|NCT00366535|27165342|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
7823057|NCT00366535|27165343|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
7823058|NCT00366535|27165342|P2|First Phase: 12 Weeks|Adverse Event|3
7823059|NCT00366535|27165343|P1|First Phase: 12 Weeks|Adverse Event|1
7823060|NCT00366457|27165357|P1|Overall Study|never began study therapy|2
7823061|NCT00366444|27165366|P2|Overall Study|Lack of Efficacy|1
7823062|NCT00366444|27165367|P1|Overall Study|Lack of Efficacy|0
7823063|NCT00366444|27165366|P2|Overall Study|Withdrawal by Subject|1
7823064|NCT00366444|27165367|P1|Overall Study|Withdrawal by Subject|1
7823065|NCT00366340|27165395|P2|Toddler Dose|Parent/legal guardian request|1
7823066|NCT00366340|27165396|P1|Toddler Dose|Parent/legal guardian request|0
7823067|NCT00366340|27165395|P2|Toddler Dose|Failed to return|0
7823068|NCT00366340|27165396|P1|Toddler Dose|Failed to return|1
7823069|NCT00366340|27165395|P2|After the Infant Series|Lost to Follow-up|1
7823070|NCT00366340|27165396|P1|After the Infant Series|Lost to Follow-up|0
7823071|NCT00366340|27165395|P2|After the Infant Series|Adverse Event|1
7823072|NCT00366340|27165396|P1|After the Infant Series|Adverse Event|0
7823073|NCT00366340|27165395|P2|After the Infant Series|Protocol Violation|2
7823074|NCT00366340|27165396|P1|After the Infant Series|Protocol Violation|2
7823075|NCT00366340|27165395|P2|After the Infant Series|Failed to return|1
7823076|NCT00366340|27165396|P1|After the Infant Series|Failed to return|0
7823077|NCT00366340|27165395|P2|After the Infant Series|Parent/legal guardian request|1
7823078|NCT00366340|27165396|P1|After the Infant Series|Parent/legal guardian request|1
7823079|NCT00366340|27165395|P2|Infant Series|Failure to return|0
7823080|NCT00366340|27165396|P1|Infant Series|Failure to return|1
7823081|NCT00366340|27165395|P2|Infant Series|Lost to Follow-up|1
7823082|NCT00366340|27165396|P1|Infant Series|Lost to Follow-up|1
7823083|NCT00366340|27165395|P2|Infant Series|Adverse Event|2
7823084|NCT00366340|27165396|P1|Infant Series|Adverse Event|0
7823085|NCT00366340|27165395|P2|Infant Series|Withdrawal by Subject|3
7823086|NCT00366340|27165396|P1|Infant Series|Withdrawal by Subject|3
7823087|NCT00366340|27165395|P2|Infant Series|Protocol Violation|4
7823088|NCT00366340|27165396|P1|Infant Series|Protocol Violation|3
7823089|NCT00366301|27165454|P4|Overall Study|Withdrawal by Subject|1
7823090|NCT00366301|27165455|P3|Overall Study|Withdrawal by Subject|1
7823091|NCT00366301|27165456|P2|Overall Study|Withdrawal by Subject|2
7823092|NCT00366301|27165457|P1|Overall Study|Withdrawal by Subject|4
7823093|NCT00366301|27165454|P4|Overall Study|Lost to Follow-up|7
7823094|NCT00366301|27165455|P3|Overall Study|Lost to Follow-up|3
7823095|NCT00366301|27165456|P2|Overall Study|Lost to Follow-up|4
7823096|NCT00366301|27165457|P1|Overall Study|Lost to Follow-up|4
7823097|NCT00366249|27165473|P2|Overall Study|Most due to osteomylitis status|20
7823098|NCT00366249|27165474|P1|Overall Study|Most due to osteomylitis status|31
7823099|NCT00366249|27165473|P2|Overall Study|Lack of Efficacy|21
7823100|NCT00366249|27165474|P1|Overall Study|Lack of Efficacy|21
7823101|NCT00366249|27165473|P2|Overall Study|Withdrawal by Subject|4
7823102|NCT00366249|27165474|P1|Overall Study|Withdrawal by Subject|18
7823103|NCT00366249|27165473|P2|Overall Study|Protocol Violation|2
7823104|NCT00366249|27165474|P1|Overall Study|Protocol Violation|1
7823105|NCT00366249|27165473|P2|Overall Study|Lost to Follow-up|0
7823106|NCT00366249|27165474|P1|Overall Study|Lost to Follow-up|2
7823107|NCT00366249|27165473|P2|Overall Study|Physician Decision|2
7823108|NCT00366249|27165474|P1|Overall Study|Physician Decision|5
7823109|NCT00366249|27165473|P2|Overall Study|Death|1
7823110|NCT00366249|27165474|P1|Overall Study|Death|0
7823111|NCT00366249|27165473|P2|Overall Study|Adverse Event|28
7823112|NCT00366249|27165474|P1|Overall Study|Adverse Event|53
7823113|NCT00365989|27165506|P1|Overall Study|Non-compliance|1
7823114|NCT00365989|27165506|P1|Overall Study|Withdrawal by Subject|1
7823115|NCT00365976|27165514|P2|Overall Study|Withdrawal by Subject|5
7823116|NCT00365976|27165515|P1|Overall Study|Withdrawal by Subject|1
7823117|NCT00365846|27165653|P1|Overall Study|Lost to Follow-up|1
7823118|NCT00365794|27165662|P1|Overall Study|Withdrawal by Subject|2
7823119|NCT00365716|27165691|P7|Extension 2|Withdrawal by Subject|5
7823120|NCT00365716|27165692|P6|Extension 2|Withdrawal by Subject|0
7823121|NCT00365716|27165693|P5|Extension 2|Withdrawal by Subject|0
7823122|NCT00365716|27165694|P4|Extension 2|Withdrawal by Subject|0
7823123|NCT00365716|27165695|P3|Extension 2|Withdrawal by Subject|0
7823124|NCT00365716|27165696|P2|Extension 2|Withdrawal by Subject|0
7823125|NCT00365716|27165697|P1|Extension 2|Withdrawal by Subject|0
7823126|NCT00365716|27165691|P7|Extension 2|Other|3
7823127|NCT00365716|27165692|P6|Extension 2|Other|0
7823128|NCT00365716|27165693|P5|Extension 2|Other|0
7823129|NCT00365716|27165694|P4|Extension 2|Other|0
7823130|NCT00365716|27165695|P3|Extension 2|Other|0
7823131|NCT00365716|27165696|P2|Extension 2|Other|0
7823132|NCT00365716|27165697|P1|Extension 2|Other|0
7823133|NCT00365716|27165691|P7|Extension 2|Lost to Follow-up|2
7823134|NCT00365716|27165692|P6|Extension 2|Lost to Follow-up|0
7823135|NCT00365716|27165693|P5|Extension 2|Lost to Follow-up|0
7823136|NCT00365716|27165694|P4|Extension 2|Lost to Follow-up|0
7823137|NCT00365716|27165695|P3|Extension 2|Lost to Follow-up|0
7823138|NCT00365716|27165696|P2|Extension 2|Lost to Follow-up|0
7823139|NCT00365716|27165697|P1|Extension 2|Lost to Follow-up|0
7823140|NCT00365716|27165691|P7|Extension 1|Protocol Violation|0
7823141|NCT00365716|27165692|P6|Extension 1|Protocol Violation|1
7823142|NCT00365716|27165693|P5|Extension 1|Protocol Violation|0
7823143|NCT00365716|27165694|P4|Extension 1|Protocol Violation|0
7823144|NCT00365716|27165695|P3|Extension 1|Protocol Violation|0
7823145|NCT00365716|27165696|P2|Extension 1|Protocol Violation|0
7823146|NCT00365716|27165697|P1|Extension 1|Protocol Violation|0
7823147|NCT00365716|27165691|P7|Extension 1|Pregnancy|0
7823148|NCT00365716|27165692|P6|Extension 1|Pregnancy|4
7823149|NCT00365716|27165693|P5|Extension 1|Pregnancy|0
7823150|NCT00365716|27165694|P4|Extension 1|Pregnancy|0
7823151|NCT00365716|27165695|P3|Extension 1|Pregnancy|0
7823152|NCT00365716|27165696|P2|Extension 1|Pregnancy|0
7823153|NCT00365716|27165697|P1|Extension 1|Pregnancy|0
7823154|NCT00365716|27165691|P7|Extension 1|Withdrawal by Subject|0
7823155|NCT00365716|27165692|P6|Extension 1|Withdrawal by Subject|3
7823156|NCT00365716|27165693|P5|Extension 1|Withdrawal by Subject|0
7823157|NCT00365716|27165694|P4|Extension 1|Withdrawal by Subject|0
7823158|NCT00365716|27165695|P3|Extension 1|Withdrawal by Subject|0
7823159|NCT00365716|27165696|P2|Extension 1|Withdrawal by Subject|0
7823160|NCT00365716|27165697|P1|Extension 1|Withdrawal by Subject|0
7823161|NCT00365716|27165691|P7|Extension 1|Moved|0
7823162|NCT00365716|27165692|P6|Extension 1|Moved|4
7823163|NCT00365716|27165693|P5|Extension 1|Moved|0
7823164|NCT00365716|27165694|P4|Extension 1|Moved|0
7823165|NCT00365716|27165695|P3|Extension 1|Moved|0
7823166|NCT00365716|27165696|P2|Extension 1|Moved|0
7823167|NCT00365716|27165697|P1|Extension 1|Moved|0
7823168|NCT00365716|27165691|P7|Extension 1|Other|0
7823169|NCT00365716|27165692|P6|Extension 1|Other|9
7823170|NCT00365716|27165693|P5|Extension 1|Other|0
7823171|NCT00365716|27165694|P4|Extension 1|Other|0
7823172|NCT00365716|27165695|P3|Extension 1|Other|0
7823173|NCT00365716|27165696|P2|Extension 1|Other|0
7823174|NCT00365716|27165697|P1|Extension 1|Other|0
7823175|NCT00365716|27165691|P7|Extension 1|Lost to Follow-up|0
7823176|NCT00365716|27165692|P6|Extension 1|Lost to Follow-up|1
7823177|NCT00365716|27165693|P5|Extension 1|Lost to Follow-up|0
7823178|NCT00365716|27165694|P4|Extension 1|Lost to Follow-up|0
7823179|NCT00365716|27165695|P3|Extension 1|Lost to Follow-up|0
7823180|NCT00365716|27165696|P2|Extension 1|Lost to Follow-up|0
7823181|NCT00365716|27165697|P1|Extension 1|Lost to Follow-up|0
7823182|NCT00365716|27165691|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
7823183|NCT00365716|27165692|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
7823184|NCT00365716|27165693|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
7823185|NCT00365716|27165694|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
7823186|NCT00365716|27165695|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
7823187|NCT00365716|27165696|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
7823188|NCT00365716|27165697|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
7823189|NCT00365716|27165691|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7823190|NCT00365716|27165692|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7823191|NCT00365716|27165693|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7823192|NCT00365716|27165694|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7823193|NCT00365716|27165695|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
7823194|NCT00365716|27165696|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
7823195|NCT00365716|27165697|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7823196|NCT00365716|27165691|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7823197|NCT00365716|27165692|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7823198|NCT00365716|27165693|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
7823199|NCT00365716|27165694|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7823200|NCT00365716|27165695|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7823201|NCT00365716|27165696|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7823202|NCT00365716|27165697|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
7823203|NCT00365716|27165691|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7823204|NCT00365716|27165692|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7823205|NCT00365716|27165693|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7823206|NCT00365716|27165694|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
7823207|NCT00365716|27165695|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
7823208|NCT00365716|27165696|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
7823209|NCT00365716|27165697|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
7823210|NCT00365716|27165691|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
7823211|NCT00365716|27165692|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
7823212|NCT00365716|27165693|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
7823213|NCT00365716|27165694|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
7823214|NCT00365716|27165695|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
7823215|NCT00365716|27165696|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
7823216|NCT00365716|27165697|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
7823217|NCT00365716|27165691|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7823218|NCT00365716|27165692|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7823219|NCT00365716|27165693|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
7823220|NCT00365716|27165694|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
7823221|NCT00365716|27165695|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7823222|NCT00365716|27165696|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7823223|NCT00365716|27165697|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
7823224|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
7823225|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
7823226|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
7823227|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
7823228|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
7823229|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
7823230|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
7823231|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
7823232|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
7823233|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
7823234|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
7823235|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
7823236|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
7823237|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
7823238|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
7823239|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
7823240|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
7823241|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
7823242|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
7823243|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
7823244|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
7823245|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Other|0
7823246|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Other|0
7823247|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Other|0
7823248|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Other|0
7823249|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Other|0
7823250|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Other|1
7823251|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Other|0
7823252|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7823253|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7823254|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7823255|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
7823256|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
7823257|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
7823258|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
7823259|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
7823260|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
7823261|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
7823262|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
7823263|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
7823264|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
7823265|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
7823266|NCT00365716|27165691|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7823267|NCT00365716|27165692|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7823268|NCT00365716|27165693|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7823269|NCT00365716|27165694|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7823270|NCT00365716|27165695|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7823271|NCT00365716|27165696|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
7823272|NCT00365716|27165697|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
7823273|NCT00365547|27165718|P1|Overall Study|Withdrawal by Subject|1
7823274|NCT00365547|27165718|P1|Overall Study|Screen failure|1
7823275|NCT00365547|27165718|P1|Overall Study|Insurance did not cover Avastin|1
7823276|NCT00365508|27165728|P2|Overall Study|Lost to Follow-up|154
7823277|NCT00365508|27165729|P1|Overall Study|Lost to Follow-up|139
7823278|NCT00365456|27165737|P2|Trial Period III (12 Months)|Other|1
7823279|NCT00365456|27165738|P1|Trial Period III (12 Months)|Other|1
7823280|NCT00365456|27165737|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
7823281|NCT00365456|27165738|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
7823282|NCT00365456|27165737|P2|Trial Period III (12 Months)|Adverse Event|3
7823283|NCT00365456|27165738|P1|Trial Period III (12 Months)|Adverse Event|13
7823284|NCT00365456|27165737|P2|Trial Period II (12 Months)|Other|1
7823285|NCT00365456|27165738|P1|Trial Period II (12 Months)|Other|0
7823286|NCT00365456|27165737|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
7823287|NCT00365456|27165738|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
7823288|NCT00365456|27165737|P2|Trial Period II (12 Months)|Non-compliance|2
7823289|NCT00365456|27165738|P1|Trial Period II (12 Months)|Non-compliance|0
7823290|NCT00365456|27165737|P2|Trial Period II (12 Months)|Adverse Event|6
7823291|NCT00365456|27165738|P1|Trial Period II (12 Months)|Adverse Event|0
7823292|NCT00365456|27165737|P2|Trial Period I (12 Months)|Other|0
7823293|NCT00365456|27165738|P1|Trial Period I (12 Months)|Other|11
7823294|NCT00365456|27165737|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
7823295|NCT00365456|27165738|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
7823296|NCT00365456|27165737|P2|Trial Period I (12 Months)|Non-compliance|0
7823297|NCT00365456|27165738|P1|Trial Period I (12 Months)|Non-compliance|3
7823298|NCT00365456|27165737|P2|Trial Period I (12 Months)|Adverse Event|0
7823299|NCT00365456|27165738|P1|Trial Period I (12 Months)|Adverse Event|84
7823300|NCT00365378|27165765|P3|Extension|Other|31
7823301|NCT00365378|27165766|P2|Extension|Other|0
7823302|NCT00365378|27165767|P1|Extension|Other|0
7823303|NCT00365378|27165765|P3|Extension|Withdrawal by Subject|98
7823304|NCT00365378|27165766|P2|Extension|Withdrawal by Subject|0
7823305|NCT00365378|27165767|P1|Extension|Withdrawal by Subject|0
7823306|NCT00365378|27165765|P3|Extension|Protocol Violation|2
7823307|NCT00365378|27165766|P2|Extension|Protocol Violation|0
7823308|NCT00365378|27165767|P1|Extension|Protocol Violation|0
7823309|NCT00365378|27165765|P3|Extension|Lost to Follow-up|57
7823310|NCT00365378|27165766|P2|Extension|Lost to Follow-up|0
7823311|NCT00365378|27165767|P1|Extension|Lost to Follow-up|0
7823312|NCT00365378|27165765|P3|Extension|Moved|8
7823313|NCT00365378|27165766|P2|Extension|Moved|0
7823314|NCT00365378|27165767|P1|Extension|Moved|0
7823315|NCT00365378|27165765|P3|Extension|Adverse Event|1
7823316|NCT00365378|27165766|P2|Extension|Adverse Event|0
7823317|NCT00365378|27165767|P1|Extension|Adverse Event|0
7823318|NCT00365378|27165765|P3|Follow-up (Month 7 Though Month 48)|Other|0
7823319|NCT00365378|27165766|P2|Follow-up (Month 7 Though Month 48)|Other|21
7823320|NCT00365378|27165767|P1|Follow-up (Month 7 Though Month 48)|Other|11
7823321|NCT00365378|27165765|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
7823322|NCT00365378|27165766|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
7823323|NCT00365378|27165767|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
7823324|NCT00365378|27165765|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
7823325|NCT00365378|27165766|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
7823326|NCT00365378|27165767|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
7823327|NCT00365378|27165765|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
7823328|NCT00365378|27165766|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
7823329|NCT00365378|27165767|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
7823330|NCT00365378|27165765|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
7823331|NCT00365378|27165766|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
7823332|NCT00365378|27165767|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
7823333|NCT00365378|27165765|P3|Follow-up (Month 7 Though Month 48)|Moved|0
7823334|NCT00365378|27165766|P2|Follow-up (Month 7 Though Month 48)|Moved|5
7823335|NCT00365378|27165767|P1|Follow-up (Month 7 Though Month 48)|Moved|6
7823336|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Other|0
7823337|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Other|9
7823338|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Other|17
7823339|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
7823340|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
7823341|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
7823342|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
7823343|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
7823344|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
7823345|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
7823346|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
7823347|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
7823348|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
7823349|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
7823350|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
7823351|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
7823352|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
7823353|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
7823354|NCT00365378|27165765|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
7823355|NCT00365378|27165766|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
7823356|NCT00365378|27165767|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
7823357|NCT00365365|27165781|P3|Overall Study|Patient/physician decision|1
7823358|NCT00365365|27165782|P2|Overall Study|Patient/physician decision|0
7823359|NCT00365365|27165783|P1|Overall Study|Patient/physician decision|0
7823360|NCT00365365|27165781|P3|Overall Study|Second malignancy|0
7823361|NCT00365365|27165782|P2|Overall Study|Second malignancy|1
7823362|NCT00365365|27165783|P1|Overall Study|Second malignancy|0
7823363|NCT00365365|27165781|P3|Overall Study|Withdrew consent|0
7823364|NCT00365365|27165782|P2|Overall Study|Withdrew consent|1
7823365|NCT00365365|27165783|P1|Overall Study|Withdrew consent|1
7823366|NCT00365365|27165781|P3|Overall Study|New cancer|0
7823367|NCT00365365|27165782|P2|Overall Study|New cancer|0
7823368|NCT00365365|27165783|P1|Overall Study|New cancer|1
7823369|NCT00365365|27165781|P3|Overall Study|Moved|0
7823370|NCT00365365|27165782|P2|Overall Study|Moved|0
7823371|NCT00365365|27165783|P1|Overall Study|Moved|2
7823372|NCT00365365|27165781|P3|Overall Study|Adverse Event|3
7823373|NCT00365365|27165782|P2|Overall Study|Adverse Event|6
7823374|NCT00365365|27165783|P1|Overall Study|Adverse Event|6
7823375|NCT00365365|27165781|P3|Overall Study|Disease progression/relapse|7
7823376|NCT00365365|27165782|P2|Overall Study|Disease progression/relapse|6
7823377|NCT00365365|27165783|P1|Overall Study|Disease progression/relapse|9
7823378|NCT00365365|27165781|P3|Overall Study|Subject's request|1
7823379|NCT00365365|27165782|P2|Overall Study|Subject's request|13
7823380|NCT00365365|27165783|P1|Overall Study|Subject's request|11
7823381|NCT00365365|27165781|P3|Overall Study|Death|0
7823382|NCT00365365|27165782|P2|Overall Study|Death|3
7823383|NCT00365365|27165783|P1|Overall Study|Death|1
7823384|NCT00365365|27165781|P3|Overall Study|Lost to Follow-up|3
7823385|NCT00365365|27165782|P2|Overall Study|Lost to Follow-up|3
7823386|NCT00365365|27165783|P1|Overall Study|Lost to Follow-up|3
7823387|NCT00365365|27165781|P3|Overall Study|Poor compliance to protocol|0
7823388|NCT00365365|27165782|P2|Overall Study|Poor compliance to protocol|1
7823389|NCT00365365|27165783|P1|Overall Study|Poor compliance to protocol|0
7823390|NCT00365365|27165781|P3|Overall Study|Randomized but not treated|0
7823391|NCT00365365|27165782|P2|Overall Study|Randomized but not treated|2
7823392|NCT00365365|27165783|P1|Overall Study|Randomized but not treated|0
7823393|NCT00365352|27165800|P3|Overall Study|Withdrawal of Participant by Sponsor|0
7823394|NCT00365352|27165801|P2|Overall Study|Withdrawal of Participant by Sponsor|0
7823395|NCT00365352|27165802|P1|Overall Study|Withdrawal of Participant by Sponsor|1
7823396|NCT00365352|27165800|P3|Overall Study|Lost to Follow-up|0
7823397|NCT00365352|27165801|P2|Overall Study|Lost to Follow-up|1
7823398|NCT00365352|27165802|P1|Overall Study|Lost to Follow-up|1
7823399|NCT00365352|27165800|P3|Overall Study|Non-Compliance (after Randomization)|1
7823400|NCT00365352|27165801|P2|Overall Study|Non-Compliance (after Randomization)|0
7823401|NCT00365352|27165802|P1|Overall Study|Non-Compliance (after Randomization)|1
7823402|NCT00365352|27165800|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
7823403|NCT00365352|27165801|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
7823404|NCT00365352|27165802|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
7823405|NCT00365352|27165800|P3|Overall Study|Lack of Efficacy|0
7823406|NCT00365352|27165801|P2|Overall Study|Lack of Efficacy|0
7823407|NCT00365352|27165802|P1|Overall Study|Lack of Efficacy|3
7823408|NCT00365352|27165800|P3|Overall Study|Participant Withdrew Consent|4
7823409|NCT00365352|27165801|P2|Overall Study|Participant Withdrew Consent|3
7823410|NCT00365352|27165802|P1|Overall Study|Participant Withdrew Consent|8
7823411|NCT00365352|27165800|P3|Overall Study|Adverse Event|8
7823412|NCT00365352|27165801|P2|Overall Study|Adverse Event|7
7823413|NCT00365352|27165802|P1|Overall Study|Adverse Event|6
7823414|NCT00365300|27165886|P2|Double-blind Phase|Lack of Efficacy|6
7823415|NCT00365300|27165887|P1|Double-blind Phase|Lack of Efficacy|6
7823416|NCT00365300|27165886|P2|Double-blind Phase|Protocol Violation|1
7823417|NCT00365300|27165887|P1|Double-blind Phase|Protocol Violation|3
7823418|NCT00365300|27165886|P2|Double-blind Phase|Withdrawal by Subject|1
7823419|NCT00365300|27165887|P1|Double-blind Phase|Withdrawal by Subject|0
7823420|NCT00365300|27165886|P2|Double-blind Phase|Noncompliance|1
7823421|NCT00365300|27165887|P1|Double-blind Phase|Noncompliance|1
7823422|NCT00365300|27165886|P2|Double-blind Phase|Failed to return|0
7823423|NCT00365300|27165887|P1|Double-blind Phase|Failed to return|1
7823424|NCT00365300|27165886|P2|Open-label Phase|Patient skipped open label phase|0
7823425|NCT00365300|27165887|P1|Open-label Phase|Patient skipped open label phase|1
7823426|NCT00365300|27165886|P2|Open-label Phase|Lack of Efficacy|0
7823427|NCT00365300|27165887|P1|Open-label Phase|Lack of Efficacy|1
7823428|NCT00365300|27165886|P2|Open-label Phase|Protocol Violation|0
7823429|NCT00365300|27165887|P1|Open-label Phase|Protocol Violation|1
7823430|NCT00365300|27165886|P2|Open-label Phase|Parent/Legal Guardian Request|0
7823431|NCT00365300|27165887|P1|Open-label Phase|Parent/Legal Guardian Request|4
7823432|NCT00365300|27165886|P2|Open-label Phase|Noncompliance|0
7823433|NCT00365300|27165887|P1|Open-label Phase|Noncompliance|9
7823434|NCT00365300|27165886|P2|Open-label Phase|Physician Decision|0
7823435|NCT00365300|27165887|P1|Open-label Phase|Physician Decision|1
7823436|NCT00365300|27165886|P2|Open-label Phase|Failed to Return|0
7823437|NCT00365300|27165887|P1|Open-label Phase|Failed to Return|1
7823438|NCT00365300|27165886|P2|Open-label Phase|Adverse Event|0
7823439|NCT00365300|27165887|P1|Open-label Phase|Adverse Event|4
7823440|NCT00365105|27165952|P2|Overall Study|Protocol Violation|8
7823441|NCT00365105|27165953|P1|Overall Study|Protocol Violation|5
7823442|NCT00364923|27165999|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
7823443|NCT00364923|27165999|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
7823444|NCT00364858|27166008|P2|Overall Study|Clinical baseline issue|1
7823445|NCT00364858|27166009|P1|Overall Study|Clinical baseline issue|0
7823446|NCT00364858|27166008|P2|Overall Study|Return to Q2 regimen|1
7823447|NCT00364858|27166009|P1|Overall Study|Return to Q2 regimen|0
7823448|NCT00364858|27166008|P2|Overall Study|Non-compliant|0
7823449|NCT00364858|27166009|P1|Overall Study|Non-compliant|1
7823450|NCT00364858|27166008|P2|Overall Study|Discontinuation at baseline|0
7823451|NCT00364858|27166009|P1|Overall Study|Discontinuation at baseline|1
7823452|NCT00364858|27166008|P2|Overall Study|Clinical failure|13
7823453|NCT00364858|27166009|P1|Overall Study|Clinical failure|2
7823454|NCT00364858|27166008|P2|Overall Study|Pregnancy|1
7823455|NCT00364858|27166009|P1|Overall Study|Pregnancy|1
7823456|NCT00364858|27166008|P2|Overall Study|Withdrawal by Subject|1
7823457|NCT00364858|27166009|P1|Overall Study|Withdrawal by Subject|1
7823458|NCT00364858|27166008|P2|Overall Study|Adverse Event|5
7823459|NCT00364858|27166009|P1|Overall Study|Adverse Event|1
7823460|NCT00364845|27166024|P2|Overall Study|Death|1
7823461|NCT00364845|27166025|P1|Overall Study|Death|0
7823462|NCT00364845|27166024|P2|Overall Study|Lost to Follow-up|1
7823463|NCT00364845|27166025|P1|Overall Study|Lost to Follow-up|0
7823464|NCT00364845|27166024|P2|Overall Study|Physician Decision|8
7823465|NCT00364845|27166025|P1|Overall Study|Physician Decision|8
7823466|NCT00364845|27166024|P2|Overall Study|Withdrawal by Subject|1
7823467|NCT00364845|27166025|P1|Overall Study|Withdrawal by Subject|2
7823468|NCT00364845|27166024|P2|Overall Study|Adverse Event|0
7823469|NCT00364845|27166025|P1|Overall Study|Adverse Event|1
7823470|NCT00364832|27166046|P12|Extension Year 2|Early Withdrawals|3
7823471|NCT00364832|27166047|P11|Extension Year 2|Early Withdrawals|5
7823472|NCT00364832|27166048|P10|Extension Year 2|Early Withdrawals|5
7823473|NCT00364832|27166049|P9|Extension Year 2|Early Withdrawals|0
7823474|NCT00364832|27166050|P8|Extension Year 2|Early Withdrawals|0
7823475|NCT00364832|27166051|P7|Extension Year 2|Early Withdrawals|0
7823476|NCT00364832|27166052|P6|Extension Year 2|Early Withdrawals|0
7823477|NCT00364832|27166053|P5|Extension Year 2|Early Withdrawals|0
7823478|NCT00364832|27166054|P4|Extension Year 2|Early Withdrawals|0
7823479|NCT00364832|27166055|P3|Extension Year 2|Early Withdrawals|0
7823480|NCT00364832|27166056|P2|Extension Year 2|Early Withdrawals|0
7823481|NCT00364832|27166057|P1|Extension Year 2|Early Withdrawals|0
7823482|NCT00364832|27166046|P12|Extension Year 1|Early Withdrawals|10
7823483|NCT00364832|27166047|P11|Extension Year 1|Early Withdrawals|2
7823484|NCT00364832|27166048|P10|Extension Year 1|Early Withdrawals|4
7823485|NCT00364832|27166049|P9|Extension Year 1|Early Withdrawals|0
7823486|NCT00364832|27166050|P8|Extension Year 1|Early Withdrawals|0
7823487|NCT00364832|27166051|P7|Extension Year 1|Early Withdrawals|0
7823488|NCT00364832|27166052|P6|Extension Year 1|Early Withdrawals|0
7823489|NCT00364832|27166053|P5|Extension Year 1|Early Withdrawals|0
7823490|NCT00364832|27166054|P4|Extension Year 1|Early Withdrawals|0
7823491|NCT00364832|27166055|P3|Extension Year 1|Early Withdrawals|0
7823492|NCT00364832|27166056|P2|Extension Year 1|Early Withdrawals|0
7823493|NCT00364832|27166057|P1|Extension Year 1|Early Withdrawals|0
7823494|NCT00364832|27166046|P12|Core Period|Early Withdrawals|0
7823495|NCT00364832|27166047|P11|Core Period|Early Withdrawals|0
7823496|NCT00364832|27166048|P10|Core Period|Early Withdrawals|0
7823497|NCT00364832|27166049|P9|Core Period|Early Withdrawals|0
7823498|NCT00364832|27166050|P8|Core Period|Early Withdrawals|1
7823499|NCT00364832|27166051|P7|Core Period|Early Withdrawals|4
7823500|NCT00364832|27166052|P6|Core Period|Early Withdrawals|0
7823501|NCT00364832|27166053|P5|Core Period|Early Withdrawals|0
7823502|NCT00364832|27166054|P4|Core Period|Early Withdrawals|1
7823503|NCT00364832|27166055|P3|Core Period|Early Withdrawals|1
7823504|NCT00364832|27166056|P2|Core Period|Early Withdrawals|2
7823505|NCT00364832|27166057|P1|Core Period|Early Withdrawals|2
7823506|NCT00364793|27166122|P4|Overall Study|Withdrawal by Subject|0
7823507|NCT00364793|27166123|P3|Overall Study|Withdrawal by Subject|0
7823508|NCT00364793|27166124|P2|Overall Study|Withdrawal by Subject|1
7823509|NCT00364793|27166125|P1|Overall Study|Withdrawal by Subject|0
7823510|NCT00364793|27166122|P4|Overall Study|No longer meets criteria|1
7823511|NCT00364793|27166123|P3|Overall Study|No longer meets criteria|0
7823512|NCT00364793|27166124|P2|Overall Study|No longer meets criteria|0
7823513|NCT00364793|27166125|P1|Overall Study|No longer meets criteria|0
7823514|NCT00364793|27166122|P4|Overall Study|Poor or non-compliance|1
7823515|NCT00364793|27166123|P3|Overall Study|Poor or non-compliance|0
7823516|NCT00364793|27166124|P2|Overall Study|Poor or non-compliance|1
7823517|NCT00364793|27166125|P1|Overall Study|Poor or non-compliance|1
7823518|NCT00364793|27166122|P4|Overall Study|Lost to Follow-up|0
7823519|NCT00364793|27166123|P3|Overall Study|Lost to Follow-up|2
7823520|NCT00364793|27166124|P2|Overall Study|Lost to Follow-up|0
7823521|NCT00364793|27166125|P1|Overall Study|Lost to Follow-up|1
7823522|NCT00364793|27166122|P4|Overall Study|Lack of Efficacy|1
7823523|NCT00364793|27166123|P3|Overall Study|Lack of Efficacy|1
7823524|NCT00364793|27166124|P2|Overall Study|Lack of Efficacy|3
7823525|NCT00364793|27166125|P1|Overall Study|Lack of Efficacy|3
7823526|NCT00364793|27166122|P4|Overall Study|Death|0
7823527|NCT00364793|27166123|P3|Overall Study|Death|1
7823528|NCT00364793|27166124|P2|Overall Study|Death|0
7823529|NCT00364793|27166125|P1|Overall Study|Death|1
7823530|NCT00364793|27166122|P4|Overall Study|Adverse Event|0
7823531|NCT00364793|27166123|P3|Overall Study|Adverse Event|0
7823532|NCT00364793|27166124|P2|Overall Study|Adverse Event|0
7823533|NCT00364793|27166125|P1|Overall Study|Adverse Event|2
7823534|NCT00364689|27166262|P1|Overall Study|Lost to Follow-up|1
7823535|NCT00364611|27166282|P2|Overall Study|Receiving Liver Ablation|1
7823536|NCT00364611|27166283|P1|Overall Study|Receiving Liver Ablation|0
7823537|NCT00364611|27166282|P2|Overall Study|Presumed CR on Study|1
7823538|NCT00364611|27166283|P1|Overall Study|Presumed CR on Study|0
7823539|NCT00364611|27166282|P2|Overall Study|Found Ineligible|0
7823540|NCT00364611|27166283|P1|Overall Study|Found Ineligible|1
7823541|NCT00364611|27166282|P2|Overall Study|Investigator decision|2
7823542|NCT00364611|27166283|P1|Overall Study|Investigator decision|2
7823543|NCT00364611|27166282|P2|Overall Study|Disease Progression|8
7823544|NCT00364611|27166283|P1|Overall Study|Disease Progression|38
7823545|NCT00364611|27166282|P2|Overall Study|Participant's Request|4
7823546|NCT00364611|27166283|P1|Overall Study|Participant's Request|3
7823547|NCT00364611|27166282|P2|Overall Study|Adverse Event|4
7823548|NCT00364611|27166283|P1|Overall Study|Adverse Event|7
7823549|NCT00364611|27166282|P2|Overall Study|Did not receive study medication|1
7823550|NCT00364611|27166283|P1|Overall Study|Did not receive study medication|0
7823551|NCT00364533|27166306|P5|Overall Study|Protocol Violation|0
7823552|NCT00364533|27166307|P4|Overall Study|Protocol Violation|0
7823553|NCT00364533|27166308|P3|Overall Study|Protocol Violation|0
7823554|NCT00364533|27166309|P2|Overall Study|Protocol Violation|1
7823555|NCT00364533|27166310|P1|Overall Study|Protocol Violation|1
7823556|NCT00364533|27166306|P5|Overall Study|Non-compliance|0
7823557|NCT00364533|27166307|P4|Overall Study|Non-compliance|0
7823558|NCT00364533|27166308|P3|Overall Study|Non-compliance|0
7823559|NCT00364533|27166309|P2|Overall Study|Non-compliance|0
7823560|NCT00364533|27166310|P1|Overall Study|Non-compliance|1
7823561|NCT00364533|27166306|P5|Overall Study|Variations in drug compliance|0
7823562|NCT00364533|27166307|P4|Overall Study|Variations in drug compliance|0
7823563|NCT00364533|27166308|P3|Overall Study|Variations in drug compliance|1
7823564|NCT00364533|27166309|P2|Overall Study|Variations in drug compliance|1
7823565|NCT00364533|27166310|P1|Overall Study|Variations in drug compliance|2
7823651|NCT00364013|27166437|P2|Overall Study|Physician Decision|3
7823566|NCT00364533|27166306|P5|Overall Study|Subject discharged from hospital|1
7823567|NCT00364533|27166307|P4|Overall Study|Subject discharged from hospital|3
7823568|NCT00364533|27166308|P3|Overall Study|Subject discharged from hospital|2
7823569|NCT00364533|27166309|P2|Overall Study|Subject discharged from hospital|1
7823570|NCT00364533|27166310|P1|Overall Study|Subject discharged from hospital|4
7823571|NCT00364533|27166306|P5|Overall Study|Lack of Efficacy|42
7823572|NCT00364533|27166307|P4|Overall Study|Lack of Efficacy|17
7823573|NCT00364533|27166308|P3|Overall Study|Lack of Efficacy|21
7823574|NCT00364533|27166309|P2|Overall Study|Lack of Efficacy|22
7823575|NCT00364533|27166310|P1|Overall Study|Lack of Efficacy|22
7823576|NCT00364533|27166306|P5|Overall Study|Withdrawal by Subject|6
7823577|NCT00364533|27166307|P4|Overall Study|Withdrawal by Subject|6
7823578|NCT00364533|27166308|P3|Overall Study|Withdrawal by Subject|6
7823579|NCT00364533|27166309|P2|Overall Study|Withdrawal by Subject|8
7823580|NCT00364533|27166310|P1|Overall Study|Withdrawal by Subject|4
7823581|NCT00364533|27166306|P5|Overall Study|Adverse Event|2
7823582|NCT00364533|27166307|P4|Overall Study|Adverse Event|5
7823583|NCT00364533|27166308|P3|Overall Study|Adverse Event|15
7823584|NCT00364533|27166309|P2|Overall Study|Adverse Event|7
7823585|NCT00364533|27166310|P1|Overall Study|Adverse Event|8
7823586|NCT00364351|27166343|P2|Overall Study|Randomised treatment not started|3
7823587|NCT00364351|27166344|P1|Overall Study|Randomised treatment not started|0
7823588|NCT00364351|27166343|P2|Overall Study|Patient could not travel to site|1
7823589|NCT00364351|27166344|P1|Overall Study|Patient could not travel to site|0
7823590|NCT00364351|27166343|P2|Overall Study|Investigator error|2
7823591|NCT00364351|27166344|P1|Overall Study|Investigator error|0
7823592|NCT00364351|27166343|P2|Overall Study|Poor treatment compliance|3
7823593|NCT00364351|27166344|P1|Overall Study|Poor treatment compliance|0
7823594|NCT00364351|27166343|P2|Overall Study|Sponsor decision|0
7823595|NCT00364351|27166344|P1|Overall Study|Sponsor decision|1
7823596|NCT00364351|27166343|P2|Overall Study|Incorrect enrollment|1
7823597|NCT00364351|27166344|P1|Overall Study|Incorrect enrollment|1
7823598|NCT00364351|27166343|P2|Overall Study|Withdrawal by Subject|29
7823599|NCT00364351|27166344|P1|Overall Study|Withdrawal by Subject|30
7823600|NCT00364351|27166343|P2|Overall Study|Lost to Follow-up|1
7823601|NCT00364351|27166344|P1|Overall Study|Lost to Follow-up|1
7823602|NCT00364351|27166343|P2|Overall Study|Prohibited concomitant medication|2
7823603|NCT00364351|27166344|P1|Overall Study|Prohibited concomitant medication|0
7823604|NCT00364351|27166343|P2|Overall Study|Condition under investigation worsened|497
7823605|NCT00364351|27166344|P1|Overall Study|Condition under investigation worsened|469
7823606|NCT00364351|27166343|P2|Overall Study|Adverse Event|44
7823607|NCT00364351|27166344|P1|Overall Study|Adverse Event|90
7823608|NCT00364286|27166362|P1|Overall Study|Adverse Event|2
7823609|NCT00364286|27166362|P1|Overall Study|Withdrawal by Subject|1
7823610|NCT00364182|27166369|P3|Third Intervention|Lost to Follow-up|1
7823611|NCT00364182|27166370|P2|Third Intervention|Lost to Follow-up|0
7823612|NCT00364182|27166371|P1|Third Intervention|Lost to Follow-up|0
7823613|NCT00364182|27166369|P3|Third Intervention|non-compliance|0
7823614|NCT00364182|27166370|P2|Third Intervention|non-compliance|1
7823615|NCT00364182|27166371|P1|Third Intervention|non-compliance|0
7823616|NCT00364182|27166369|P3|Second Intervention|Adverse Event|1
7823617|NCT00364182|27166370|P2|Second Intervention|Adverse Event|0
7823618|NCT00364182|27166371|P1|Second Intervention|Adverse Event|0
7823619|NCT00364182|27166369|P3|Second Intervention|Protocol Violation|0
7823620|NCT00364182|27166370|P2|Second Intervention|Protocol Violation|1
7823621|NCT00364182|27166371|P1|Second Intervention|Protocol Violation|0
7823622|NCT00364182|27166369|P3|Second Intervention|non-compliance|1
7823623|NCT00364182|27166370|P2|Second Intervention|non-compliance|1
7823624|NCT00364182|27166371|P1|Second Intervention|non-compliance|0
7823625|NCT00364182|27166369|P3|First Intervention|Withdrawal by Subject|0
7823626|NCT00364182|27166370|P2|First Intervention|Withdrawal by Subject|0
7823627|NCT00364182|27166371|P1|First Intervention|Withdrawal by Subject|2
7823628|NCT00364182|27166369|P3|First Intervention|Secondary prophylaxis|0
7823629|NCT00364182|27166370|P2|First Intervention|Secondary prophylaxis|0
7823630|NCT00364182|27166371|P1|First Intervention|Secondary prophylaxis|1
7823631|NCT00364156|27166405|P2|Overall Study|Protocol Violation|1
7823632|NCT00364156|27166406|P1|Overall Study|Protocol Violation|6
7823633|NCT00364156|27166405|P2|Overall Study|Withdrawal by Subject|80
7823634|NCT00364156|27166406|P1|Overall Study|Withdrawal by Subject|73
7823635|NCT00364130|27166414|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
7823636|NCT00364130|27166415|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
7823637|NCT00364130|27166414|P2|Intervention Period|Withdrawal by Subject|5
7823638|NCT00364130|27166415|P1|Intervention Period|Withdrawal by Subject|4
7823639|NCT00364130|27166414|P2|Intervention Period|Pregnancy|0
7823640|NCT00364130|27166415|P1|Intervention Period|Pregnancy|1
7823641|NCT00364130|27166414|P2|Intervention Period|Lost to Follow-up|3
7823642|NCT00364130|27166415|P1|Intervention Period|Lost to Follow-up|4
7823643|NCT00364013|27166437|P2|Overall Study|Ongoing|13
7823644|NCT00364013|27166438|P1|Overall Study|Ongoing|20
7823645|NCT00364013|27166437|P2|Overall Study|Other|47
7823646|NCT00364013|27166438|P1|Overall Study|Other|41
7823647|NCT00364013|27166437|P2|Overall Study|Protocol-specified criteria|6
7823648|NCT00364013|27166438|P1|Overall Study|Protocol-specified criteria|6
7823649|NCT00364013|27166437|P2|Overall Study|Lost to Follow-up|3
7823650|NCT00364013|27166438|P1|Overall Study|Lost to Follow-up|10
7823652|NCT00364013|27166438|P1|Overall Study|Physician Decision|3
7823653|NCT00364013|27166437|P2|Overall Study|Withdrawal by Subject|18
7823654|NCT00364013|27166438|P1|Overall Study|Withdrawal by Subject|13
7823655|NCT00364013|27166437|P2|Overall Study|Adverse Event|3
7823656|NCT00364013|27166438|P1|Overall Study|Adverse Event|4
7823657|NCT00364013|27166437|P2|Overall Study|Ineligibility determined|2
7823658|NCT00364013|27166438|P1|Overall Study|Ineligibility determined|4
7823659|NCT00363896|27166466|P2|Overall Study|Other|2
7823660|NCT00363896|27166467|P1|Overall Study|Other|1
7823661|NCT00363896|27166466|P2|Overall Study|Non-fulfilment of entry criteria|0
7823662|NCT00363896|27166467|P1|Overall Study|Non-fulfilment of entry criteria|1
7823663|NCT00363896|27166466|P2|Overall Study|Lost to Follow-up|0
7823664|NCT00363896|27166467|P1|Overall Study|Lost to Follow-up|3
7823665|NCT00363896|27166466|P2|Overall Study|Protocol Violation|1
7823666|NCT00363896|27166467|P1|Overall Study|Protocol Violation|6
7823667|NCT00363896|27166466|P2|Overall Study|Lack of Efficacy|8
7823668|NCT00363896|27166467|P1|Overall Study|Lack of Efficacy|12
7823669|NCT00363896|27166466|P2|Overall Study|COPD exacerbation|7
7823670|NCT00363896|27166467|P1|Overall Study|COPD exacerbation|13
7823671|NCT00363896|27166466|P2|Overall Study|Adverse Event|13
7823672|NCT00363896|27166467|P1|Overall Study|Adverse Event|24
7823673|NCT00363896|27166466|P2|Overall Study|Withdrawal by Subject|16
7823674|NCT00363896|27166467|P1|Overall Study|Withdrawal by Subject|29
7823675|NCT00363766|27166508|P2|Overall Study|Physician Decision|2
7823676|NCT00363766|27166509|P1|Overall Study|Physician Decision|1
7823677|NCT00363766|27166508|P2|Overall Study|Withdrawal by Subject|0
7823678|NCT00363766|27166509|P1|Overall Study|Withdrawal by Subject|2
7823679|NCT00363766|27166508|P2|Overall Study|Not Disease Related Death|4
7823680|NCT00363766|27166509|P1|Overall Study|Not Disease Related Death|3
7823681|NCT00363766|27166508|P2|Overall Study|Disease Related Death|3
7823682|NCT00363766|27166509|P1|Overall Study|Disease Related Death|1
7823683|NCT00363766|27166508|P2|Overall Study|Adverse Event|2
7823684|NCT00363766|27166509|P1|Overall Study|Adverse Event|10
7823685|NCT00363766|27166508|P2|Overall Study|Progressive Disease|9
7823686|NCT00363766|27166509|P1|Overall Study|Progressive Disease|15
7823687|NCT00363649|27166538|P2|Overall Study|Adverse Event|0
7823688|NCT00363649|27166539|P1|Overall Study|Adverse Event|6
7823689|NCT00363649|27166538|P2|Overall Study|Withdrawal by Subject|1
7823690|NCT00363649|27166539|P1|Overall Study|Withdrawal by Subject|1
7823691|NCT00363545|27166555|P2|Overall Study|Others|0
7823692|NCT00363545|27166556|P1|Overall Study|Others|1
7823693|NCT00363545|27166555|P2|Overall Study|Lost to follow-up (complete vaccination)|17
7823694|NCT00363545|27166556|P1|Overall Study|Lost to follow-up (complete vaccination)|14
7823695|NCT00363545|27166555|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
7823696|NCT00363545|27166556|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
7823697|NCT00363545|27166555|P2|Overall Study|Migrated/moved from study area|6
7823698|NCT00363545|27166556|P1|Overall Study|Migrated/moved from study area|3
7823699|NCT00363545|27166555|P2|Overall Study|Withdrawal by Subject|15
7823700|NCT00363545|27166556|P1|Overall Study|Withdrawal by Subject|12
7823701|NCT00363545|27166555|P2|Overall Study|Serious Adverse Event|1
7823702|NCT00363545|27166556|P1|Overall Study|Serious Adverse Event|0
7823703|NCT00363480|27166574|P1|Overall Study|Participant discontinued on its own|1
7823704|NCT00363480|27166574|P1|Overall Study|Non-compliance of subject|1
7823705|NCT00363480|27166574|P1|Overall Study|Withdrawal by Subject|5
7823706|NCT00363480|27166574|P1|Overall Study|Lost to Follow-up|5
7823707|NCT00363480|27166574|P1|Overall Study|Adverse Event|4
7823708|NCT00363480|27166574|P1|Overall Study|Criteria for treatment period not fulfil|1
7823709|NCT00363467|27166594|P1|Overall Study|Physician Decision|1
7823710|NCT00363415|27166604|P2|Overall Study|Protocol Violation|4
7823711|NCT00363415|27166605|P1|Overall Study|Protocol Violation|1
7823712|NCT00363415|27166604|P2|Overall Study|Lost to Follow-up|3
7823713|NCT00363415|27166605|P1|Overall Study|Lost to Follow-up|3
7823714|NCT00363415|27166604|P2|Overall Study|Withdrawal by Subject|15
7823715|NCT00363415|27166605|P1|Overall Study|Withdrawal by Subject|9
7823716|NCT00363415|27166604|P2|Overall Study|Entry Criteria Not Met|10
7823717|NCT00363415|27166605|P1|Overall Study|Entry Criteria Not Met|11
7823718|NCT00363415|27166604|P2|Overall Study|Physician Decision|35
7823719|NCT00363415|27166605|P1|Overall Study|Physician Decision|18
7823720|NCT00363415|27166604|P2|Overall Study|Adverse Event|15
7823721|NCT00363415|27166605|P1|Overall Study|Adverse Event|24
7823722|NCT00363415|27166604|P2|Overall Study|Death|29
7823723|NCT00363415|27166605|P1|Overall Study|Death|32
7823724|NCT00363415|27166604|P2|Overall Study|Sponsor Decision|31
7823725|NCT00363415|27166605|P1|Overall Study|Sponsor Decision|67
7823726|NCT00363415|27166604|P2|Overall Study|Progressive Disease|107
7823727|NCT00363415|27166605|P1|Overall Study|Progressive Disease|196
7823728|NCT00363311|27166623|P2|Overall Study|Participant Moved to Louisiana|1
7823729|NCT00363311|27166624|P1|Overall Study|Participant Moved to Louisiana|0
7823730|NCT00363311|27166623|P2|Overall Study|Withdrawn per Instructions of Monitor|1
7823731|NCT00363311|27166624|P1|Overall Study|Withdrawn per Instructions of Monitor|0
7823732|NCT00363311|27166623|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
7823733|NCT00363311|27166624|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
7823734|NCT00363311|27166623|P2|Overall Study|Participant Moved to Another Country|0
7823735|NCT00363311|27166624|P1|Overall Study|Participant Moved to Another Country|1
7823736|NCT00363311|27166623|P2|Overall Study|Participant Opted for Treatment|0
7823737|NCT00363311|27166624|P1|Overall Study|Participant Opted for Treatment|1
7823738|NCT00363311|27166623|P2|Overall Study|Prostate Volume/PSA Doubled|0
7823739|NCT00363311|27166624|P1|Overall Study|Prostate Volume/PSA Doubled|1
7823740|NCT00363311|27166623|P2|Overall Study|Participant Refused Biopsy|0
7823741|NCT00363311|27166624|P1|Overall Study|Participant Refused Biopsy|1
7823742|NCT00363311|27166623|P2|Overall Study|Non-Compliance|1
7823743|NCT00363311|27166624|P1|Overall Study|Non-Compliance|1
7823744|NCT00363311|27166623|P2|Overall Study|Disease Progression|26
7823745|NCT00363311|27166624|P1|Overall Study|Disease Progression|46
7823746|NCT00363311|27166623|P2|Overall Study|Sponsor Terminated Study|2
7823747|NCT00363311|27166624|P1|Overall Study|Sponsor Terminated Study|2
7823748|NCT00363311|27166623|P2|Overall Study|Physician Decision|1
7823749|NCT00363311|27166624|P1|Overall Study|Physician Decision|1
7823750|NCT00363311|27166623|P2|Overall Study|Withdrawal by Subject|6
7823751|NCT00363311|27166624|P1|Overall Study|Withdrawal by Subject|12
7823752|NCT00363311|27166623|P2|Overall Study|Protocol Violation|2
7823753|NCT00363311|27166624|P1|Overall Study|Protocol Violation|1
7823754|NCT00363311|27166623|P2|Overall Study|Lost to Follow-up|0
7823755|NCT00363311|27166624|P1|Overall Study|Lost to Follow-up|3
7823756|NCT00363311|27166623|P2|Overall Study|Adverse Event|4
7823757|NCT00363311|27166624|P1|Overall Study|Adverse Event|6
7823758|NCT00363298|27166690|P2|4-week Study Continuation Phase|Lack of Efficacy|0
7823759|NCT00363298|27166691|P1|4-week Study Continuation Phase|Lack of Efficacy|1
7823760|NCT00363298|27166690|P2|First Study Week|Lack of Efficacy|5
7823761|NCT00363298|27166691|P1|First Study Week|Lack of Efficacy|6
7823762|NCT00363246|27166699|P1|Overall Study|Eligibility changed due to Hospice move|5
7823763|NCT00363246|27166699|P1|Overall Study|Subject expressed security concerns|2
7823764|NCT00363246|27166699|P1|Overall Study|Stopped using wheelchair|11
7823765|NCT00363246|27166699|P1|Overall Study|Bad health|6
7823766|NCT00363246|27166699|P1|Overall Study|Lost to Follow-up|14
7823767|NCT00363246|27166699|P1|Overall Study|Withdrawal by Subject|19
7823768|NCT00363246|27166699|P1|Overall Study|Death|40
7823769|NCT00363142|27166717|P2|Overall Study|Withdrawal by Subject|1
7823770|NCT00363142|27166718|P1|Overall Study|Withdrawal by Subject|3
7823771|NCT00363142|27166717|P2|Overall Study|Non-compliance|1
7823772|NCT00363142|27166718|P1|Overall Study|Non-compliance|1
7823773|NCT00363142|27166717|P2|Overall Study|Lost to Follow-up|0
7823774|NCT00363142|27166718|P1|Overall Study|Lost to Follow-up|1
7823775|NCT00363142|27166717|P2|Overall Study|Lack of Efficacy|1
7823776|NCT00363142|27166718|P1|Overall Study|Lack of Efficacy|0
7823777|NCT00363142|27166717|P2|Overall Study|Adverse Event|0
7823778|NCT00363142|27166718|P1|Overall Study|Adverse Event|2
7823779|NCT00363129|27166747|P2|Overall Study|Other Reasons|3
7823780|NCT00363129|27166748|P1|Overall Study|Other Reasons|6
7823781|NCT00363129|27166747|P2|Overall Study|Death|1
7823782|NCT00363129|27166748|P1|Overall Study|Death|0
7823783|NCT00363129|27166747|P2|Overall Study|Other Medical Problems|4
7823784|NCT00363129|27166748|P1|Overall Study|Other Medical Problems|2
7823785|NCT00363129|27166747|P2|Overall Study|Alternate Treatment|4
7823786|NCT00363129|27166748|P1|Overall Study|Alternate Treatment|2
7823787|NCT00363129|27166747|P2|Overall Study|Adverse Event|3
7823788|NCT00363129|27166748|P1|Overall Study|Adverse Event|8
7823789|NCT00363129|27166747|P2|Overall Study|Withdrawal by Subject|18
7823790|NCT00363129|27166748|P1|Overall Study|Withdrawal by Subject|11
7823791|NCT00363051|27166791|P2|Overall Study|Death|2
7823792|NCT00363051|27166792|P1|Overall Study|Death|3
7823793|NCT00363051|27166791|P2|Overall Study|Protocol Violation|2
7823794|NCT00363051|27166792|P1|Overall Study|Protocol Violation|0
7823795|NCT00363051|27166791|P2|Overall Study|Lost to Follow-up|1
7823796|NCT00363051|27166792|P1|Overall Study|Lost to Follow-up|0
7823797|NCT00363051|27166791|P2|Overall Study|Withdrawal by Subject|3
7823798|NCT00363051|27166792|P1|Overall Study|Withdrawal by Subject|11
7823799|NCT00363051|27166791|P2|Overall Study|New Cancer Therapy|1
7823800|NCT00363051|27166792|P1|Overall Study|New Cancer Therapy|2
7823801|NCT00363051|27166791|P2|Overall Study|Adverse Event|12
7823802|NCT00363051|27166792|P1|Overall Study|Adverse Event|21
7823803|NCT00363051|27166791|P2|Overall Study|Adminstrative problems|1
7823804|NCT00363051|27166792|P1|Overall Study|Adminstrative problems|1
7823805|NCT00362648|27166841|P4|Overall Study|Withdrawal by Subject|6
7823806|NCT00362648|27166842|P3|Overall Study|Withdrawal by Subject|2
7823807|NCT00362648|27166843|P2|Overall Study|Withdrawal by Subject|42
7823808|NCT00362648|27166844|P1|Overall Study|Withdrawal by Subject|48
7823809|NCT00362648|27166841|P4|Overall Study|Protocol Violation|2
7823810|NCT00362648|27166842|P3|Overall Study|Protocol Violation|2
7823811|NCT00362648|27166843|P2|Overall Study|Protocol Violation|2
7823812|NCT00362648|27166844|P1|Overall Study|Protocol Violation|4
7823813|NCT00362648|27166841|P4|Overall Study|Lost to Follow-up|3
7823814|NCT00362648|27166842|P3|Overall Study|Lost to Follow-up|4
7823815|NCT00362648|27166843|P2|Overall Study|Lost to Follow-up|69
7823816|NCT00362648|27166844|P1|Overall Study|Lost to Follow-up|62
7823817|NCT00362648|27166841|P4|Overall Study|Adverse Event|0
7823818|NCT00362648|27166842|P3|Overall Study|Adverse Event|1
7823819|NCT00362648|27166843|P2|Overall Study|Adverse Event|21
7823820|NCT00362648|27166844|P1|Overall Study|Adverse Event|12
7823821|NCT00362609|27166862|P2|Overall Study|Protocol Violation|1
7823822|NCT00362609|27166863|P1|Overall Study|Protocol Violation|0
7823823|NCT00362609|27166862|P2|Overall Study|Withdrawal by Subject|1
7823824|NCT00362609|27166863|P1|Overall Study|Withdrawal by Subject|0
7823825|NCT00362414|27166944|P1|Overall Study|Adverse Event|1
7823826|NCT00362414|27166944|P1|Overall Study|Death|2
7823827|NCT00362375|27166973|P2|Overall Study|Lost to Follow-up|35
7823828|NCT00362375|27166974|P1|Overall Study|Lost to Follow-up|40
7823829|NCT00362336|27166991|P3|Overall Study|Withdrawal by Subject|1
7823830|NCT00362336|27166992|P2|Overall Study|Withdrawal by Subject|3
7823831|NCT00362336|27166993|P1|Overall Study|Withdrawal by Subject|3
7823832|NCT00362336|27166991|P3|Overall Study|Lost to Follow-up|0
7823833|NCT00362336|27166992|P2|Overall Study|Lost to Follow-up|4
7823834|NCT00362336|27166993|P1|Overall Study|Lost to Follow-up|6
7823835|NCT00362336|27166991|P3|Overall Study|Protocol Violation|1
7823836|NCT00362336|27166992|P2|Overall Study|Protocol Violation|0
7823837|NCT00362336|27166993|P1|Overall Study|Protocol Violation|0
7823838|NCT00362336|27166991|P3|Overall Study|Serious Adverse Event|1
7823839|NCT00362336|27166992|P2|Overall Study|Serious Adverse Event|0
7823840|NCT00362336|27166993|P1|Overall Study|Serious Adverse Event|1
7823841|NCT00362297|27167021|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
7823842|NCT00362297|27167022|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
7823843|NCT00362232|27167030|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
7823844|NCT00362232|27167031|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
7823845|NCT00362232|27167030|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
7823846|NCT00362232|27167031|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
7823847|NCT00362232|27167030|P2|Follow-up (30 (+ 5) Days)|Death|1
7823848|NCT00362232|27167031|P1|Follow-up (30 (+ 5) Days)|Death|1
7823849|NCT00362232|27167030|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
7823850|NCT00362232|27167031|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
7823851|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
7823852|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
7823853|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
7823854|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
7823855|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
7823856|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
7823857|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
7823858|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
7823859|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
7823860|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
7823861|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
7823862|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
7823863|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
7823864|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
7823865|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Death|3
7823866|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Death|1
7823867|NCT00362232|27167030|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
7823868|NCT00362232|27167031|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
7823869|NCT00362180|27167076|P9|Treated Period|Adverse Event|0
7823870|NCT00362180|27167077|P8|Treated Period|Adverse Event|1
7823871|NCT00362180|27167078|P7|Treated Period|Adverse Event|0
7823872|NCT00362180|27167079|P6|Treated Period|Adverse Event|1
7823873|NCT00362180|27167080|P5|Treated Period|Adverse Event|0
7823874|NCT00362180|27167081|P4|Treated Period|Adverse Event|0
7823875|NCT00362180|27167082|P3|Treated Period|Adverse Event|0
7823876|NCT00362180|27167083|P2|Treated Period|Adverse Event|0
7823877|NCT00362180|27167084|P1|Treated Period|Adverse Event|0
7823878|NCT00362180|27167076|P9|Treated Period|Withdrawal by Subject|0
7823879|NCT00362180|27167077|P8|Treated Period|Withdrawal by Subject|0
7823880|NCT00362180|27167078|P7|Treated Period|Withdrawal by Subject|0
7823881|NCT00362180|27167079|P6|Treated Period|Withdrawal by Subject|0
7823882|NCT00362180|27167080|P5|Treated Period|Withdrawal by Subject|0
7823883|NCT00362180|27167081|P4|Treated Period|Withdrawal by Subject|0
7823884|NCT00362180|27167082|P3|Treated Period|Withdrawal by Subject|0
7823885|NCT00362180|27167083|P2|Treated Period|Withdrawal by Subject|0
7823886|NCT00362180|27167084|P1|Treated Period|Withdrawal by Subject|1
7823887|NCT00362115|27167156|P7|Overall Study|Other|0
7823888|NCT00362115|27167157|P6|Overall Study|Other|1
7823889|NCT00362115|27167158|P5|Overall Study|Other|0
7823890|NCT00362115|27167159|P4|Overall Study|Other|1
7823891|NCT00362115|27167160|P3|Overall Study|Other|0
7823892|NCT00362115|27167161|P2|Overall Study|Other|1
7823893|NCT00362115|27167162|P1|Overall Study|Other|0
7823894|NCT00362115|27167156|P7|Overall Study|Physician Decision|3
7823895|NCT00362115|27167157|P6|Overall Study|Physician Decision|0
7823896|NCT00362115|27167158|P5|Overall Study|Physician Decision|0
7823897|NCT00362115|27167159|P4|Overall Study|Physician Decision|0
7823898|NCT00362115|27167160|P3|Overall Study|Physician Decision|0
7823899|NCT00362115|27167161|P2|Overall Study|Physician Decision|0
7823900|NCT00362115|27167162|P1|Overall Study|Physician Decision|0
7823901|NCT00362115|27167156|P7|Overall Study|Lack of Efficacy|3
7823902|NCT00362115|27167157|P6|Overall Study|Lack of Efficacy|0
7823903|NCT00362115|27167158|P5|Overall Study|Lack of Efficacy|2
7823904|NCT00362115|27167159|P4|Overall Study|Lack of Efficacy|2
7823905|NCT00362115|27167160|P3|Overall Study|Lack of Efficacy|5
7823906|NCT00362115|27167161|P2|Overall Study|Lack of Efficacy|0
7823907|NCT00362115|27167162|P1|Overall Study|Lack of Efficacy|1
7823908|NCT00362115|27167156|P7|Overall Study|Withdrawal by Subject|4
7823909|NCT00362115|27167157|P6|Overall Study|Withdrawal by Subject|3
7823910|NCT00362115|27167158|P5|Overall Study|Withdrawal by Subject|1
7823911|NCT00362115|27167159|P4|Overall Study|Withdrawal by Subject|0
7823912|NCT00362115|27167160|P3|Overall Study|Withdrawal by Subject|1
7823913|NCT00362115|27167161|P2|Overall Study|Withdrawal by Subject|3
7823914|NCT00362115|27167162|P1|Overall Study|Withdrawal by Subject|1
7823915|NCT00362115|27167156|P7|Overall Study|Lost to Follow-up|1
7823916|NCT00362115|27167157|P6|Overall Study|Lost to Follow-up|0
7823917|NCT00362115|27167158|P5|Overall Study|Lost to Follow-up|2
7823918|NCT00362115|27167159|P4|Overall Study|Lost to Follow-up|0
7823919|NCT00362115|27167160|P3|Overall Study|Lost to Follow-up|0
7823920|NCT00362115|27167161|P2|Overall Study|Lost to Follow-up|1
7823921|NCT00362115|27167162|P1|Overall Study|Lost to Follow-up|0
7823922|NCT00362115|27167156|P7|Overall Study|Protocol Violation|0
7823923|NCT00362115|27167157|P6|Overall Study|Protocol Violation|1
7823924|NCT00362115|27167158|P5|Overall Study|Protocol Violation|0
7823925|NCT00362115|27167159|P4|Overall Study|Protocol Violation|0
7823926|NCT00362115|27167160|P3|Overall Study|Protocol Violation|0
7823927|NCT00362115|27167161|P2|Overall Study|Protocol Violation|0
7823928|NCT00362115|27167162|P1|Overall Study|Protocol Violation|0
7823929|NCT00362115|27167156|P7|Overall Study|Adverse Event|1
7823930|NCT00362115|27167157|P6|Overall Study|Adverse Event|2
7823931|NCT00362115|27167158|P5|Overall Study|Adverse Event|2
7823932|NCT00362115|27167159|P4|Overall Study|Adverse Event|1
7823933|NCT00362115|27167160|P3|Overall Study|Adverse Event|1
7823934|NCT00362115|27167161|P2|Overall Study|Adverse Event|1
7823935|NCT00362115|27167162|P1|Overall Study|Adverse Event|0
7823936|NCT00361842|27167324|P2|Overall Study|Other|2
7823937|NCT00361842|27167325|P1|Overall Study|Other|0
7823938|NCT00361842|27167324|P2|Overall Study|Other|0
7823939|NCT00361842|27167325|P1|Overall Study|Other|1
7823940|NCT00361842|27167324|P2|Overall Study|Occurrence of unacceptable toxicity|5
7823941|NCT00361842|27167325|P1|Overall Study|Occurrence of unacceptable toxicity|1
7823942|NCT00361842|27167324|P2|Overall Study|Adverse Event|3
7823943|NCT00361842|27167325|P1|Overall Study|Adverse Event|2
7823944|NCT00361842|27167324|P2|Overall Study|Disease progression|20
7823945|NCT00361842|27167325|P1|Overall Study|Disease progression|19
7823946|NCT00361842|27167324|P2|Overall Study|Death|1
7823947|NCT00361842|27167325|P1|Overall Study|Death|2
7823948|NCT00361842|27167324|P2|Overall Study|Withdrawal by Subject|3
7823949|NCT00361842|27167325|P1|Overall Study|Withdrawal by Subject|2
7823950|NCT00361634|27167348|P1|Overall Study|Withdrawal by Subject|1
7823951|NCT00361634|27167348|P1|Overall Study|Lost to Follow-up|1
7823952|NCT00361569|27167377|P4|Overall Study|Not specified by investigator|1
7823953|NCT00361569|27167378|P3|Overall Study|Not specified by investigator|0
7823954|NCT00361569|27167379|P2|Overall Study|Not specified by investigator|0
7823955|NCT00361569|27167380|P1|Overall Study|Not specified by investigator|2
7823956|NCT00361569|27167377|P4|Overall Study|Lost to Follow-up|2
7823957|NCT00361569|27167378|P3|Overall Study|Lost to Follow-up|3
7823958|NCT00361569|27167379|P2|Overall Study|Lost to Follow-up|3
7823959|NCT00361569|27167380|P1|Overall Study|Lost to Follow-up|2
7823960|NCT00361569|27167377|P4|Overall Study|Adverse Event|2
7823961|NCT00361569|27167378|P3|Overall Study|Adverse Event|2
7823962|NCT00361569|27167379|P2|Overall Study|Adverse Event|5
7823963|NCT00361569|27167380|P1|Overall Study|Adverse Event|3
7823964|NCT00361569|27167377|P4|Overall Study|Withdrawal by Subject|14
7823965|NCT00361569|27167378|P3|Overall Study|Withdrawal by Subject|9
7823966|NCT00361569|27167379|P2|Overall Study|Withdrawal by Subject|1
7823967|NCT00361569|27167380|P1|Overall Study|Withdrawal by Subject|2
7823968|NCT00361569|27167377|P4|Overall Study|Protocol Violation|2
7823969|NCT00361569|27167378|P3|Overall Study|Protocol Violation|4
7823970|NCT00361569|27167379|P2|Overall Study|Protocol Violation|2
7823971|NCT00361569|27167380|P1|Overall Study|Protocol Violation|3
7823972|NCT00361504|27167404|P2|Overall Study|All other|3
7823973|NCT00361504|27167405|P1|Overall Study|All other|28
7823974|NCT00361504|27167404|P2|Overall Study|Study medication non compliant|15
7823975|NCT00361504|27167405|P1|Overall Study|Study medication non compliant|42
7823976|NCT00361504|27167404|P2|Overall Study|Resolution of Pain|0
7823977|NCT00361504|27167405|P1|Overall Study|Resolution of Pain|2
7823978|NCT00361504|27167404|P2|Overall Study|Lack of Efficacy|7
7823979|NCT00361504|27167405|P1|Overall Study|Lack of Efficacy|72
7823980|NCT00361504|27167404|P2|Overall Study|Adverse Event|82
7823981|NCT00361504|27167405|P1|Overall Study|Adverse Event|203
7823982|NCT00361504|27167404|P2|Overall Study|Lost to Follow-up|7
7823983|NCT00361504|27167405|P1|Overall Study|Lost to Follow-up|40
7823984|NCT00361504|27167404|P2|Overall Study|Withdrawal by Subject|31
7823985|NCT00361504|27167405|P1|Overall Study|Withdrawal by Subject|94
7823986|NCT00361335|27167446|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
7823987|NCT00361335|27167447|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7823988|NCT00361335|27167448|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7823989|NCT00361335|27167449|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7823990|NCT00361335|27167450|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
7823991|NCT00361335|27167451|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7823992|NCT00361335|27167452|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7823993|NCT00361335|27167446|P7|SC Period: Week E0 to Week E24|Other|2
7823994|NCT00361335|27167447|P6|SC Period: Week E0 to Week E24|Other|1
7823995|NCT00361335|27167448|P5|SC Period: Week E0 to Week E24|Other|0
7823996|NCT00361335|27167449|P4|SC Period: Week E0 to Week E24|Other|1
7823997|NCT00361335|27167450|P3|SC Period: Week E0 to Week E24|Other|0
7823998|NCT00361335|27167451|P2|SC Period: Week E0 to Week E24|Other|0
7823999|NCT00361335|27167452|P1|SC Period: Week E0 to Week E24|Other|1
7824000|NCT00361335|27167446|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
7824001|NCT00361335|27167447|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
7824002|NCT00361335|27167448|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
7824003|NCT00361335|27167449|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
7824004|NCT00361335|27167450|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
7824005|NCT00361335|27167451|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
7824006|NCT00361335|27167452|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
7824007|NCT00361335|27167446|P7|SC Period: Week E0 to Week E24|Death|1
7824008|NCT00361335|27167447|P6|SC Period: Week E0 to Week E24|Death|0
7824009|NCT00361335|27167448|P5|SC Period: Week E0 to Week E24|Death|0
7824010|NCT00361335|27167449|P4|SC Period: Week E0 to Week E24|Death|0
7824011|NCT00361335|27167450|P3|SC Period: Week E0 to Week E24|Death|0
7824012|NCT00361335|27167451|P2|SC Period: Week E0 to Week E24|Death|0
7824013|NCT00361335|27167452|P1|SC Period: Week E0 to Week E24|Death|0
7824014|NCT00361335|27167446|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7824015|NCT00361335|27167447|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7824016|NCT00361335|27167448|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7824017|NCT00361335|27167449|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7824018|NCT00361335|27167450|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7824019|NCT00361335|27167451|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7824020|NCT00361335|27167452|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7824021|NCT00361335|27167446|P7|SC Period: Week E0 to Week E24|Adverse Event|2
7824022|NCT00361335|27167447|P6|SC Period: Week E0 to Week E24|Adverse Event|0
7824023|NCT00361335|27167448|P5|SC Period: Week E0 to Week E24|Adverse Event|0
7824024|NCT00361335|27167449|P4|SC Period: Week E0 to Week E24|Adverse Event|2
7824025|NCT00361335|27167450|P3|SC Period: Week E0 to Week E24|Adverse Event|1
7824026|NCT00361335|27167451|P2|SC Period: Week E0 to Week E24|Adverse Event|2
7824027|NCT00361335|27167452|P1|SC Period: Week E0 to Week E24|Adverse Event|0
7824028|NCT00361335|27167446|P7|IV Period: Baseline to E0|Lack of Efficacy|0
7824029|NCT00361335|27167447|P6|IV Period: Baseline to E0|Lack of Efficacy|0
7824030|NCT00361335|27167448|P5|IV Period: Baseline to E0|Lack of Efficacy|8
7824031|NCT00361335|27167449|P4|IV Period: Baseline to E0|Lack of Efficacy|7
7824032|NCT00361335|27167450|P3|IV Period: Baseline to E0|Lack of Efficacy|3
7824033|NCT00361335|27167451|P2|IV Period: Baseline to E0|Lack of Efficacy|9
7824034|NCT00361335|27167452|P1|IV Period: Baseline to E0|Lack of Efficacy|5
7824035|NCT00361335|27167446|P7|IV Period: Baseline to E0|Other|0
7824036|NCT00361335|27167447|P6|IV Period: Baseline to E0|Other|0
7824037|NCT00361335|27167448|P5|IV Period: Baseline to E0|Other|2
7824038|NCT00361335|27167449|P4|IV Period: Baseline to E0|Other|3
7824039|NCT00361335|27167450|P3|IV Period: Baseline to E0|Other|9
7824040|NCT00361335|27167451|P2|IV Period: Baseline to E0|Other|9
7824041|NCT00361335|27167452|P1|IV Period: Baseline to E0|Other|2
7824042|NCT00361335|27167446|P7|IV Period: Baseline to E0|Worsening of RA|0
7824043|NCT00361335|27167447|P6|IV Period: Baseline to E0|Worsening of RA|0
7824044|NCT00361335|27167448|P5|IV Period: Baseline to E0|Worsening of RA|2
7824045|NCT00361335|27167449|P4|IV Period: Baseline to E0|Worsening of RA|4
7824046|NCT00361335|27167450|P3|IV Period: Baseline to E0|Worsening of RA|1
7824047|NCT00361335|27167451|P2|IV Period: Baseline to E0|Worsening of RA|5
7824048|NCT00361335|27167452|P1|IV Period: Baseline to E0|Worsening of RA|0
7824049|NCT00361335|27167446|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
7824050|NCT00361335|27167447|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
7824051|NCT00361335|27167448|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
7824052|NCT00361335|27167449|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
7824053|NCT00361335|27167450|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
7824054|NCT00361335|27167451|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
7824055|NCT00361335|27167452|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
7824056|NCT00361335|27167446|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
7824057|NCT00361335|27167447|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
7824058|NCT00361335|27167448|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
7824059|NCT00361335|27167449|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
7824060|NCT00361335|27167450|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
7824061|NCT00361335|27167451|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
7824062|NCT00361335|27167452|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
7824063|NCT00361335|27167446|P7|IV Period: Baseline to E0|Death|0
7824064|NCT00361335|27167447|P6|IV Period: Baseline to E0|Death|0
7824065|NCT00361335|27167448|P5|IV Period: Baseline to E0|Death|0
7824066|NCT00361335|27167449|P4|IV Period: Baseline to E0|Death|1
7824067|NCT00361335|27167450|P3|IV Period: Baseline to E0|Death|1
7824068|NCT00361335|27167451|P2|IV Period: Baseline to E0|Death|1
7824069|NCT00361335|27167452|P1|IV Period: Baseline to E0|Death|1
7824070|NCT00361335|27167446|P7|IV Period: Baseline to E0|Lost to Follow-up|0
7824071|NCT00361335|27167447|P6|IV Period: Baseline to E0|Lost to Follow-up|0
7824072|NCT00361335|27167448|P5|IV Period: Baseline to E0|Lost to Follow-up|2
7824073|NCT00361335|27167449|P4|IV Period: Baseline to E0|Lost to Follow-up|2
7824074|NCT00361335|27167450|P3|IV Period: Baseline to E0|Lost to Follow-up|0
7824075|NCT00361335|27167451|P2|IV Period: Baseline to E0|Lost to Follow-up|0
7824076|NCT00361335|27167452|P1|IV Period: Baseline to E0|Lost to Follow-up|1
7824077|NCT00361335|27167446|P7|IV Period: Baseline to E0|Adverse Event|0
7824078|NCT00361335|27167447|P6|IV Period: Baseline to E0|Adverse Event|0
7824079|NCT00361335|27167448|P5|IV Period: Baseline to E0|Adverse Event|8
7824080|NCT00361335|27167449|P4|IV Period: Baseline to E0|Adverse Event|9
7824081|NCT00361335|27167450|P3|IV Period: Baseline to E0|Adverse Event|5
7824082|NCT00361335|27167451|P2|IV Period: Baseline to E0|Adverse Event|4
7824083|NCT00361335|27167452|P1|IV Period: Baseline to E0|Adverse Event|9
7824084|NCT00361296|27167496|P1|Overall Study|Lack of Efficacy|2
7824085|NCT00361296|27167496|P1|Overall Study|Physician Decision|1
7824086|NCT00361283|27167503|P1|Overall Study|Lost to Follow-up|27
7824087|NCT00361270|27167511|P4|Overall Study|Adverse Event|0
7824088|NCT00361270|27167512|P3|Overall Study|Adverse Event|1
7824089|NCT00361270|27167513|P2|Overall Study|Adverse Event|1
7824090|NCT00361270|27167514|P1|Overall Study|Adverse Event|0
7824091|NCT00361270|27167511|P4|Overall Study|Problems with Transportation|0
7824092|NCT00361270|27167512|P3|Overall Study|Problems with Transportation|0
7824093|NCT00361270|27167513|P2|Overall Study|Problems with Transportation|0
7824094|NCT00361270|27167514|P1|Overall Study|Problems with Transportation|4
7824095|NCT00361270|27167511|P4|Overall Study|Afraid of Hypnosis|0
7824096|NCT00361270|27167512|P3|Overall Study|Afraid of Hypnosis|0
7824097|NCT00361270|27167513|P2|Overall Study|Afraid of Hypnosis|2
7824098|NCT00361270|27167514|P1|Overall Study|Afraid of Hypnosis|1
7824099|NCT00361270|27167511|P4|Overall Study|Withdrawal by Subject|7
7824100|NCT00361270|27167512|P3|Overall Study|Withdrawal by Subject|3
7824101|NCT00361270|27167513|P2|Overall Study|Withdrawal by Subject|6
7824102|NCT00361270|27167514|P1|Overall Study|Withdrawal by Subject|6
7824103|NCT00361270|27167511|P4|Overall Study|Protocol Violation|4
7824104|NCT00361270|27167512|P3|Overall Study|Protocol Violation|5
7824105|NCT00361270|27167513|P2|Overall Study|Protocol Violation|4
7824106|NCT00361270|27167514|P1|Overall Study|Protocol Violation|9
7824107|NCT00361270|27167511|P4|Overall Study|Physician Decision|0
7824108|NCT00361270|27167512|P3|Overall Study|Physician Decision|1
7824109|NCT00361270|27167513|P2|Overall Study|Physician Decision|0
7824110|NCT00361270|27167514|P1|Overall Study|Physician Decision|0
7824111|NCT00361270|27167511|P4|Overall Study|Lost to Follow-up|0
7824112|NCT00361270|27167512|P3|Overall Study|Lost to Follow-up|0
7824113|NCT00361270|27167513|P2|Overall Study|Lost to Follow-up|1
7824114|NCT00361270|27167514|P1|Overall Study|Lost to Follow-up|4
7824115|NCT00361270|27167511|P4|Overall Study|Death|2
7824116|NCT00361270|27167512|P3|Overall Study|Death|0
7824117|NCT00361270|27167513|P2|Overall Study|Death|0
7824118|NCT00361270|27167514|P1|Overall Study|Death|0
7824119|NCT00361231|27167587|P1|Overall Study|Adverse Event|6
7824120|NCT00361231|27167587|P1|Overall Study|Withdrawal by Subject|4
7824121|NCT00361231|27167587|P1|Overall Study|Radiographic disease progression|16
7824122|NCT00361231|27167587|P1|Overall Study|Symptomatic deterioration|5
7824123|NCT00361231|27167587|P1|Overall Study|Physician Decision|3
7824124|NCT00361218|27167592|P1|Overall Study|terminated / withdrawn due to toxicity /|5
7824125|NCT00361218|27167592|P1|Overall Study|Personal Reasons|7
7824126|NCT00361218|27167592|P1|Overall Study|Lost to Follow-up|11
7824127|NCT00360698|27167671|P2|Treatment Period|Early termination by error|1
7824128|NCT00360698|27167672|P1|Treatment Period|Early termination by error|0
7824129|NCT00360698|27167671|P2|Treatment Period|Non compliance with treatment procedure|0
7824130|NCT00360698|27167672|P1|Treatment Period|Non compliance with treatment procedure|1
7824131|NCT00360698|27167671|P2|Run-In|Need of insulin with meals|1
7824132|NCT00360698|27167672|P1|Run-In|Need of insulin with meals|0
7824133|NCT00360698|27167671|P2|Run-In|Patient personal reasons|2
7824134|NCT00360698|27167672|P1|Run-In|Patient personal reasons|0
7824135|NCT00360698|27167671|P2|Run-In|Patient did not meet inclusion criteria|1
7824136|NCT00360698|27167672|P1|Run-In|Patient did not meet inclusion criteria|0
7824137|NCT00360698|27167671|P2|Run-In|Sponsor request|2
7824138|NCT00360698|27167672|P1|Run-In|Sponsor request|0
7824139|NCT00360698|27167671|P2|Run-In|Non compliance with treatment procedure|1
7824140|NCT00360698|27167672|P1|Run-In|Non compliance with treatment procedure|0
7824141|NCT00360698|27167671|P2|Run-In|Withdrawal by Subject|2
7824142|NCT00360698|27167672|P1|Run-In|Withdrawal by Subject|0
7824143|NCT00360698|27167671|P2|Run-In|Physician Decision|1
7824144|NCT00360698|27167672|P1|Run-In|Physician Decision|0
7824145|NCT00360568|27167717|P2|Overall Study|Withdrawal by Subject|3
7824146|NCT00360568|27167718|P1|Overall Study|Withdrawal by Subject|0
7824147|NCT00360568|27167717|P2|Overall Study|Lack of Efficacy|0
7824148|NCT00360568|27167718|P1|Overall Study|Lack of Efficacy|1
7824149|NCT00360568|27167717|P2|Overall Study|Adverse Event|2
7824150|NCT00360568|27167718|P1|Overall Study|Adverse Event|1
7824151|NCT00360529|27167849|P3|Overall Study|Reason discontinued not explained above|11
7824152|NCT00360529|27167850|P2|Overall Study|Reason discontinued not explained above|9
7824153|NCT00360529|27167851|P1|Overall Study|Reason discontinued not explained above|4
7824154|NCT00360529|27167849|P3|Overall Study|Lack of Efficacy|5
7824155|NCT00360529|27167850|P2|Overall Study|Lack of Efficacy|6
7824156|NCT00360529|27167851|P1|Overall Study|Lack of Efficacy|8
7824157|NCT00360529|27167849|P3|Overall Study|Withdrawal by Subject|18
7824158|NCT00360529|27167850|P2|Overall Study|Withdrawal by Subject|14
7824159|NCT00360529|27167851|P1|Overall Study|Withdrawal by Subject|22
7824160|NCT00360529|27167849|P3|Overall Study|Lost to Follow-up|13
7824161|NCT00360529|27167850|P2|Overall Study|Lost to Follow-up|10
7824162|NCT00360529|27167851|P1|Overall Study|Lost to Follow-up|14
7824163|NCT00360529|27167849|P3|Overall Study|Protocol Violation|11
7824164|NCT00360529|27167850|P2|Overall Study|Protocol Violation|3
7824165|NCT00360529|27167851|P1|Overall Study|Protocol Violation|3
7824166|NCT00360529|27167849|P3|Overall Study|Adverse Event|33
7824167|NCT00360529|27167850|P2|Overall Study|Adverse Event|23
7824168|NCT00360529|27167851|P1|Overall Study|Adverse Event|10
7824169|NCT00360490|27167879|P2|Overall Study|Withdrawal by Subject|3
7824170|NCT00360490|27167880|P1|Overall Study|Withdrawal by Subject|1
7824171|NCT00360490|27167879|P2|Overall Study|Protocol Violation|4
7824172|NCT00360490|27167880|P1|Overall Study|Protocol Violation|0
7824173|NCT00360490|27167879|P2|Overall Study|Physician Decision|1
7824174|NCT00360490|27167880|P1|Overall Study|Physician Decision|2
7824175|NCT00360490|27167879|P2|Overall Study|Lost to Follow-up|1
7824176|NCT00360490|27167880|P1|Overall Study|Lost to Follow-up|2
7824177|NCT00360490|27167879|P2|Overall Study|Adverse Event|2
7824178|NCT00360490|27167880|P1|Overall Study|Adverse Event|4
7824179|NCT00360412|27167915|P2|Overall Study|Study termination by Sponsor|469
7824180|NCT00360412|27167916|P1|Overall Study|Study termination by Sponsor|214
7824181|NCT00360412|27167915|P2|Overall Study|Other|6
7824182|NCT00360412|27167916|P1|Overall Study|Other|5
7824183|NCT00360412|27167915|P2|Overall Study|Physician Decision|4
7824184|NCT00360412|27167916|P1|Overall Study|Physician Decision|2
7824185|NCT00360412|27167915|P2|Overall Study|Lack of therapeutic efficacy|61
7824186|NCT00360412|27167916|P1|Overall Study|Lack of therapeutic efficacy|46
7824187|NCT00360412|27167915|P2|Overall Study|Patient withdrew consent|52
7824188|NCT00360412|27167916|P1|Overall Study|Patient withdrew consent|27
7824189|NCT00360412|27167915|P2|Overall Study|Protocol Violation|5
7824190|NCT00360412|27167916|P1|Overall Study|Protocol Violation|2
7824191|NCT00360412|27167915|P2|Overall Study|Adverse Event|65
7824192|NCT00360412|27167916|P1|Overall Study|Adverse Event|37
7824193|NCT00360334|27167963|P2|Overall Study|Subject decision|2
7824194|NCT00360334|27167964|P1|Overall Study|Subject decision|8
7824195|NCT00360334|27167963|P2|Overall Study|Entry criterion not met|2
7824196|NCT00360334|27167964|P1|Overall Study|Entry criterion not met|1
7824197|NCT00360334|27167963|P2|Overall Study|Lack of Efficacy|1
7824198|NCT00360334|27167964|P1|Overall Study|Lack of Efficacy|0
7824199|NCT00360334|27167963|P2|Overall Study|Physician Decision|3
7824200|NCT00360334|27167964|P1|Overall Study|Physician Decision|2
7824201|NCT00360334|27167963|P2|Overall Study|Protocol Violation|1
7824202|NCT00360334|27167964|P1|Overall Study|Protocol Violation|1
7824203|NCT00360334|27167963|P2|Overall Study|Adverse Event|4
7824204|NCT00360334|27167964|P1|Overall Study|Adverse Event|7
7824205|NCT00360308|27168027|P3|Overall Study|Study termination by sponsor|44
7824206|NCT00360308|27168028|P2|Overall Study|Study termination by sponsor|55
7824207|NCT00360308|27168029|P1|Overall Study|Study termination by sponsor|43
7824208|NCT00360308|27168027|P3|Overall Study|Other|1
7824209|NCT00360308|27168028|P2|Overall Study|Other|1
7824210|NCT00360308|27168029|P1|Overall Study|Other|2
7824211|NCT00360308|27168027|P3|Overall Study|Lack of Efficacy|2
7824212|NCT00360308|27168028|P2|Overall Study|Lack of Efficacy|0
7824213|NCT00360308|27168029|P1|Overall Study|Lack of Efficacy|3
7824214|NCT00360308|27168027|P3|Overall Study|Withdrawal by Subject|14
7824215|NCT00360308|27168028|P2|Overall Study|Withdrawal by Subject|7
7824216|NCT00360308|27168029|P1|Overall Study|Withdrawal by Subject|11
7824217|NCT00360308|27168027|P3|Overall Study|Protocol Violation|2
7824218|NCT00360308|27168028|P2|Overall Study|Protocol Violation|1
7824219|NCT00360308|27168029|P1|Overall Study|Protocol Violation|2
7824220|NCT00360308|27168027|P3|Overall Study|Abnormal Laboratory Value(s)|0
7824221|NCT00360308|27168028|P2|Overall Study|Abnormal Laboratory Value(s)|1
7824222|NCT00360308|27168029|P1|Overall Study|Abnormal Laboratory Value(s)|0
7824223|NCT00360308|27168027|P3|Overall Study|Adverse Event|25
7824224|NCT00360308|27168028|P2|Overall Study|Adverse Event|14
7824225|NCT00360308|27168029|P1|Overall Study|Adverse Event|15
7824226|NCT00360282|27168046|P4|Second Intervention|Adverse Event|0
7824227|NCT00360282|27168047|P3|Second Intervention|Adverse Event|0
7824228|NCT00360282|27168048|P2|Second Intervention|Adverse Event|1
7824229|NCT00360282|27168049|P1|Second Intervention|Adverse Event|0
7824230|NCT00360282|27168046|P4|Washout 1-3 Weeks|Lost to Follow-up|0
7824231|NCT00360282|27168047|P3|Washout 1-3 Weeks|Lost to Follow-up|1
7824232|NCT00360282|27168048|P2|Washout 1-3 Weeks|Lost to Follow-up|0
7824233|NCT00360282|27168049|P1|Washout 1-3 Weeks|Lost to Follow-up|0
7824234|NCT00360269|27168061|P2|Overall Study|Withdrawal by Subject|1
7824235|NCT00360269|27168062|P1|Overall Study|Withdrawal by Subject|1
7824236|NCT00360269|27168061|P2|Overall Study|Adverse Event|0
7824237|NCT00360269|27168062|P1|Overall Study|Adverse Event|1
7824238|NCT00360269|27168061|P2|Overall Study|Physician Decision|2
7824239|NCT00360269|27168062|P1|Overall Study|Physician Decision|1
7824240|NCT00360269|27168061|P2|Overall Study|Lost to Follow-up|9
7824241|NCT00360269|27168062|P1|Overall Study|Lost to Follow-up|7
7824242|NCT00360230|27168104|P7|Overall Study|Death|1
7824243|NCT00360230|27168105|P6|Overall Study|Death|1
7824244|NCT00360230|27168106|P5|Overall Study|Death|0
7824245|NCT00360230|27168107|P4|Overall Study|Death|0
7824246|NCT00360230|27168108|P3|Overall Study|Death|0
7824247|NCT00360230|27168109|P2|Overall Study|Death|1
7824248|NCT00360230|27168110|P1|Overall Study|Death|0
7824249|NCT00360230|27168104|P7|Overall Study|Protocol Violation|0
7824250|NCT00360230|27168105|P6|Overall Study|Protocol Violation|1
7824251|NCT00360230|27168106|P5|Overall Study|Protocol Violation|0
7824252|NCT00360230|27168107|P4|Overall Study|Protocol Violation|0
7824253|NCT00360230|27168108|P3|Overall Study|Protocol Violation|0
7824254|NCT00360230|27168109|P2|Overall Study|Protocol Violation|0
7824255|NCT00360230|27168110|P1|Overall Study|Protocol Violation|0
7824256|NCT00360230|27168104|P7|Overall Study|Other|0
7824257|NCT00360230|27168105|P6|Overall Study|Other|0
7824258|NCT00360230|27168106|P5|Overall Study|Other|0
7824259|NCT00360230|27168107|P4|Overall Study|Other|0
7824260|NCT00360230|27168108|P3|Overall Study|Other|0
7824261|NCT00360230|27168109|P2|Overall Study|Other|0
7824262|NCT00360230|27168110|P1|Overall Study|Other|1
7824263|NCT00360230|27168104|P7|Overall Study|Migrated|1
7824264|NCT00360230|27168105|P6|Overall Study|Migrated|1
7824265|NCT00360230|27168106|P5|Overall Study|Migrated|4
7824266|NCT00360230|27168107|P4|Overall Study|Migrated|1
7824267|NCT00360230|27168108|P3|Overall Study|Migrated|3
7824268|NCT00360230|27168109|P2|Overall Study|Migrated|1
7824269|NCT00360230|27168110|P1|Overall Study|Migrated|4
7824270|NCT00360230|27168104|P7|Overall Study|Withdrawal by Subject|0
7824271|NCT00360230|27168105|P6|Overall Study|Withdrawal by Subject|1
7824272|NCT00360230|27168106|P5|Overall Study|Withdrawal by Subject|1
7824273|NCT00360230|27168107|P4|Overall Study|Withdrawal by Subject|1
7824274|NCT00360230|27168108|P3|Overall Study|Withdrawal by Subject|0
7824275|NCT00360230|27168109|P2|Overall Study|Withdrawal by Subject|1
7824276|NCT00360230|27168110|P1|Overall Study|Withdrawal by Subject|1
7824277|NCT00359801|27168266|P2|Overall Study|Sponsor Decision|16
7824278|NCT00359801|27168267|P1|Overall Study|Sponsor Decision|17
7824279|NCT00359801|27168266|P2|Overall Study|Final Status Unknown: missing data|4
7824280|NCT00359801|27168267|P1|Overall Study|Final Status Unknown: missing data|7
7824281|NCT00359801|27168266|P2|Overall Study|Other|46
7824282|NCT00359801|27168267|P1|Overall Study|Other|66
7824283|NCT00359801|27168266|P2|Overall Study|Withdrawal by Subject|96
7824284|NCT00359801|27168267|P1|Overall Study|Withdrawal by Subject|143
7824285|NCT00359801|27168266|P2|Overall Study|Lost to Follow-up|58
7824286|NCT00359801|27168267|P1|Overall Study|Lost to Follow-up|72
7824287|NCT00359788|27168301|P2|Overall Study|Protocol Violation|2
7824288|NCT00359788|27168302|P1|Overall Study|Protocol Violation|4
7824289|NCT00359788|27168301|P2|Overall Study|Withdrawal by Subject|1
7824290|NCT00359788|27168302|P1|Overall Study|Withdrawal by Subject|4
7824291|NCT00359788|27168301|P2|Overall Study|Lost to Follow-up|2
7824292|NCT00359788|27168302|P1|Overall Study|Lost to Follow-up|3
7824293|NCT00359788|27168301|P2|Overall Study|Lack of Efficacy|2
7824294|NCT00359788|27168302|P1|Overall Study|Lack of Efficacy|1
7824295|NCT00359788|27168301|P2|Overall Study|Adverse Event|10
7824296|NCT00359788|27168302|P1|Overall Study|Adverse Event|11
7824297|NCT00359762|27168536|P5|Period III|Subject Decision|0
7824298|NCT00359762|27168537|P4|Period III|Subject Decision|20
7824299|NCT00359762|27168538|P3|Period III|Subject Decision|8
7824300|NCT00359762|27168539|P2|Period III|Subject Decision|7
7824301|NCT00359762|27168540|P1|Period III|Subject Decision|0
7824302|NCT00359762|27168536|P5|Period III|Entry Criteria Not Met|0
7824303|NCT00359762|27168537|P4|Period III|Entry Criteria Not Met|1
7824304|NCT00359762|27168538|P3|Period III|Entry Criteria Not Met|0
7824305|NCT00359762|27168539|P2|Period III|Entry Criteria Not Met|1
7824306|NCT00359762|27168540|P1|Period III|Entry Criteria Not Met|0
7824307|NCT00359762|27168536|P5|Period III|Lost to follow up|0
7824308|NCT00359762|27168537|P4|Period III|Lost to follow up|2
7824309|NCT00359762|27168538|P3|Period III|Lost to follow up|1
7824310|NCT00359762|27168539|P2|Period III|Lost to follow up|1
7824311|NCT00359762|27168540|P1|Period III|Lost to follow up|0
7824312|NCT00359762|27168536|P5|Period III|Lack of Efficacy|0
7824313|NCT00359762|27168537|P4|Period III|Lack of Efficacy|9
7824314|NCT00359762|27168538|P3|Period III|Lack of Efficacy|5
7824315|NCT00359762|27168539|P2|Period III|Lack of Efficacy|7
7824316|NCT00359762|27168540|P1|Period III|Lack of Efficacy|0
7824317|NCT00359762|27168536|P5|Period III|Physician Decision|0
7824318|NCT00359762|27168537|P4|Period III|Physician Decision|15
7824319|NCT00359762|27168538|P3|Period III|Physician Decision|9
7824320|NCT00359762|27168539|P2|Period III|Physician Decision|5
7824321|NCT00359762|27168540|P1|Period III|Physician Decision|0
7824322|NCT00359762|27168536|P5|Period III|Adverse Event|0
7824323|NCT00359762|27168537|P4|Period III|Adverse Event|10
7824324|NCT00359762|27168538|P3|Period III|Adverse Event|4
7824325|NCT00359762|27168539|P2|Period III|Adverse Event|3
7824326|NCT00359762|27168540|P1|Period III|Adverse Event|0
7824327|NCT00359762|27168536|P5|Period III|Protocol Violation|0
7824328|NCT00359762|27168537|P4|Period III|Protocol Violation|8
7824329|NCT00359762|27168538|P3|Period III|Protocol Violation|3
7824330|NCT00359762|27168539|P2|Period III|Protocol Violation|5
7824331|NCT00359762|27168540|P1|Period III|Protocol Violation|0
7824332|NCT00359762|27168536|P5|Period II|Subject Decision|70
7824333|NCT00359762|27168537|P4|Period II|Subject Decision|0
7824334|NCT00359762|27168538|P3|Period II|Subject Decision|0
7824335|NCT00359762|27168539|P2|Period II|Subject Decision|0
7824336|NCT00359762|27168540|P1|Period II|Subject Decision|50
7824337|NCT00359762|27168536|P5|Period II|Entry Criteria Not Met|4
7824338|NCT00359762|27168537|P4|Period II|Entry Criteria Not Met|0
7824339|NCT00359762|27168538|P3|Period II|Entry Criteria Not Met|0
7824340|NCT00359762|27168539|P2|Period II|Entry Criteria Not Met|0
7824341|NCT00359762|27168540|P1|Period II|Entry Criteria Not Met|8
7824342|NCT00359762|27168536|P5|Period II|Lost to follow up|5
7824343|NCT00359762|27168537|P4|Period II|Lost to follow up|0
7824344|NCT00359762|27168538|P3|Period II|Lost to follow up|0
7824345|NCT00359762|27168539|P2|Period II|Lost to follow up|0
7824346|NCT00359762|27168540|P1|Period II|Lost to follow up|5
7824347|NCT00359762|27168536|P5|Period II|Lack of Efficacy|8
7824348|NCT00359762|27168537|P4|Period II|Lack of Efficacy|0
7824349|NCT00359762|27168538|P3|Period II|Lack of Efficacy|0
7824350|NCT00359762|27168539|P2|Period II|Lack of Efficacy|0
7824351|NCT00359762|27168540|P1|Period II|Lack of Efficacy|11
7824352|NCT00359762|27168536|P5|Period II|Death|4
7824353|NCT00359762|27168537|P4|Period II|Death|0
7824354|NCT00359762|27168538|P3|Period II|Death|0
7824355|NCT00359762|27168539|P2|Period II|Death|0
7824356|NCT00359762|27168540|P1|Period II|Death|2
7824357|NCT00359762|27168536|P5|Period II|Physician Decision|23
7824358|NCT00359762|27168537|P4|Period II|Physician Decision|0
7824359|NCT00359762|27168538|P3|Period II|Physician Decision|0
7824360|NCT00359762|27168539|P2|Period II|Physician Decision|0
7824361|NCT00359762|27168540|P1|Period II|Physician Decision|17
7824362|NCT00359762|27168536|P5|Period II|Protocol Violation|11
7824363|NCT00359762|27168537|P4|Period II|Protocol Violation|0
7824364|NCT00359762|27168538|P3|Period II|Protocol Violation|0
7824365|NCT00359762|27168539|P2|Period II|Protocol Violation|0
7824366|NCT00359762|27168540|P1|Period II|Protocol Violation|18
7824367|NCT00359762|27168536|P5|Period II|Adverse Event|49
7824368|NCT00359762|27168537|P4|Period II|Adverse Event|0
7824369|NCT00359762|27168538|P3|Period II|Adverse Event|0
7824370|NCT00359762|27168539|P2|Period II|Adverse Event|0
7824371|NCT00359762|27168540|P1|Period II|Adverse Event|17
7824372|NCT00359632|27168614|P2|Overall Study|Non-compliance with visit schedule|0
7824373|NCT00359632|27168615|P1|Overall Study|Non-compliance with visit schedule|1
7824374|NCT00359632|27168614|P2|Overall Study|Adverse Event|0
7824375|NCT00359632|27168615|P1|Overall Study|Adverse Event|1
7824376|NCT00359632|27168614|P2|Overall Study|Death|0
7824377|NCT00359632|27168615|P1|Overall Study|Death|2
7824378|NCT00359619|27168629|P7|Overall Study|Lost to Follow-up|0
7824379|NCT00359619|27168630|P6|Overall Study|Lost to Follow-up|5
7824380|NCT00359619|27168631|P5|Overall Study|Lost to Follow-up|1
7824381|NCT00359619|27168632|P4|Overall Study|Lost to Follow-up|1
7824382|NCT00359619|27168633|P3|Overall Study|Lost to Follow-up|2
7824383|NCT00359619|27168634|P2|Overall Study|Lost to Follow-up|4
7824384|NCT00359619|27168635|P1|Overall Study|Lost to Follow-up|4
7824385|NCT00359619|27168629|P7|Overall Study|Other|0
7824386|NCT00359619|27168630|P6|Overall Study|Other|0
7824387|NCT00359619|27168631|P5|Overall Study|Other|0
7824388|NCT00359619|27168632|P4|Overall Study|Other|0
7824389|NCT00359619|27168633|P3|Overall Study|Other|0
7824390|NCT00359619|27168634|P2|Overall Study|Other|0
7824391|NCT00359619|27168635|P1|Overall Study|Other|1
7824392|NCT00359619|27168629|P7|Overall Study|Withdrawal by Subject|3
7824393|NCT00359619|27168630|P6|Overall Study|Withdrawal by Subject|0
7824394|NCT00359619|27168631|P5|Overall Study|Withdrawal by Subject|2
7824395|NCT00359619|27168632|P4|Overall Study|Withdrawal by Subject|2
7824396|NCT00359619|27168633|P3|Overall Study|Withdrawal by Subject|4
7824397|NCT00359619|27168634|P2|Overall Study|Withdrawal by Subject|1
7824398|NCT00359619|27168635|P1|Overall Study|Withdrawal by Subject|3
7824399|NCT00359619|27168629|P7|Overall Study|Adverse Event|1
7824400|NCT00359619|27168630|P6|Overall Study|Adverse Event|0
7824401|NCT00359619|27168631|P5|Overall Study|Adverse Event|0
7824402|NCT00359619|27168632|P4|Overall Study|Adverse Event|0
7824403|NCT00359619|27168633|P3|Overall Study|Adverse Event|1
7824404|NCT00359619|27168634|P2|Overall Study|Adverse Event|0
7824405|NCT00359619|27168635|P1|Overall Study|Adverse Event|0
7824406|NCT00359424|27168765|P2|Overall Study|follow up not conducted|0
7824407|NCT00359424|27168766|P1|Overall Study|follow up not conducted|2
7824408|NCT00359424|27168765|P2|Overall Study|Withdrawal by Subject|2
7824409|NCT00359424|27168766|P1|Overall Study|Withdrawal by Subject|10
7824410|NCT00359424|27168765|P2|Overall Study|Lost to Follow-up|7
7824411|NCT00359424|27168766|P1|Overall Study|Lost to Follow-up|19
7824412|NCT00359424|27168765|P2|Overall Study|Death|58
7824413|NCT00359424|27168766|P1|Overall Study|Death|99
7824414|NCT00359294|27168801|P5|Overall Study|Physician Decision|0
7824415|NCT00359294|27168802|P4|Overall Study|Physician Decision|0
7824416|NCT00359294|27168803|P3|Overall Study|Physician Decision|1
7824417|NCT00359294|27168804|P2|Overall Study|Physician Decision|0
7824418|NCT00359294|27168805|P1|Overall Study|Physician Decision|0
7824419|NCT00359294|27168801|P5|Overall Study|Not treated|0
7824420|NCT00359294|27168802|P4|Overall Study|Not treated|1
7824421|NCT00359294|27168803|P3|Overall Study|Not treated|0
7824422|NCT00359294|27168804|P2|Overall Study|Not treated|0
7824423|NCT00359294|27168805|P1|Overall Study|Not treated|0
7824424|NCT00359294|27168801|P5|Overall Study|Withdrawal by Subject|1
7824425|NCT00359294|27168802|P4|Overall Study|Withdrawal by Subject|0
7824426|NCT00359294|27168803|P3|Overall Study|Withdrawal by Subject|0
7824427|NCT00359294|27168804|P2|Overall Study|Withdrawal by Subject|0
7824428|NCT00359294|27168805|P1|Overall Study|Withdrawal by Subject|0
7824429|NCT00359294|27168801|P5|Overall Study|Progressive disease|2
7824430|NCT00359294|27168802|P4|Overall Study|Progressive disease|3
7824431|NCT00359294|27168803|P3|Overall Study|Progressive disease|2
7824432|NCT00359294|27168804|P2|Overall Study|Progressive disease|1
7824433|NCT00359294|27168805|P1|Overall Study|Progressive disease|1
7824434|NCT00359281|27168827|P9|Overall Study|Withdrawal by Subject|0
7824435|NCT00359281|27168828|P8|Overall Study|Withdrawal by Subject|0
7824436|NCT00359281|27168829|P7|Overall Study|Withdrawal by Subject|1
7824437|NCT00359281|27168830|P6|Overall Study|Withdrawal by Subject|0
7824438|NCT00359281|27168831|P5|Overall Study|Withdrawal by Subject|0
7824439|NCT00359281|27168832|P4|Overall Study|Withdrawal by Subject|0
7824440|NCT00359281|27168833|P3|Overall Study|Withdrawal by Subject|0
7824441|NCT00359281|27168834|P2|Overall Study|Withdrawal by Subject|0
7824442|NCT00359281|27168835|P1|Overall Study|Withdrawal by Subject|0
7824443|NCT00359281|27168827|P9|Overall Study|Adverse Event|0
7824444|NCT00359281|27168828|P8|Overall Study|Adverse Event|0
7824445|NCT00359281|27168829|P7|Overall Study|Adverse Event|1
7824446|NCT00359281|27168830|P6|Overall Study|Adverse Event|0
7824447|NCT00359281|27168831|P5|Overall Study|Adverse Event|0
7824448|NCT00359281|27168832|P4|Overall Study|Adverse Event|0
7824449|NCT00359281|27168833|P3|Overall Study|Adverse Event|0
7824450|NCT00359281|27168834|P2|Overall Study|Adverse Event|0
7824451|NCT00359281|27168835|P1|Overall Study|Adverse Event|1
7824452|NCT00359073|27168898|P2|Overall Study|developed RV16 antibody|1
7824453|NCT00359073|27168899|P1|Overall Study|developed RV16 antibody|0
7824454|NCT00359073|27168898|P2|Overall Study|Eligibility criteria no longer met|0
7824455|NCT00359073|27168899|P1|Overall Study|Eligibility criteria no longer met|3
7824456|NCT00359073|27168898|P2|Overall Study|Withdrawal by Subject|1
7824457|NCT00359073|27168899|P1|Overall Study|Withdrawal by Subject|1
7824458|NCT00359021|27168911|P2|Overall Study|Pregnancy|0
7824459|NCT00359021|27168912|P1|Overall Study|Pregnancy|1
7824460|NCT00359021|27168911|P2|Overall Study|Other|1
7824461|NCT00359021|27168912|P1|Overall Study|Other|4
7824462|NCT00359021|27168911|P2|Overall Study|Lost to Follow-up|0
7824463|NCT00359021|27168912|P1|Overall Study|Lost to Follow-up|1
7824464|NCT00359021|27168911|P2|Overall Study|Withdrawal by Subject|9
7824465|NCT00359021|27168912|P1|Overall Study|Withdrawal by Subject|2
7824466|NCT00359021|27168911|P2|Overall Study|Subject Reached A Virologic Endpoint|32
7824467|NCT00359021|27168912|P1|Overall Study|Subject Reached A Virologic Endpoint|45
7824468|NCT00359021|27168911|P2|Overall Study|Subject Ineligible To Continue The Trial|0
7824469|NCT00359021|27168912|P1|Overall Study|Subject Ineligible To Continue The Trial|1
7824470|NCT00359021|27168911|P2|Overall Study|Subject Non-Compliant|2
7824471|NCT00359021|27168912|P1|Overall Study|Subject Non-Compliant|1
7824472|NCT00359021|27168911|P2|Overall Study|Adverse Event|8
7824473|NCT00359021|27168912|P1|Overall Study|Adverse Event|26
7824474|NCT00358956|27168924|P1|Overall Study|Withdrawal by Subject|1
7824475|NCT00358956|27168924|P1|Overall Study|condition under investigation worsened|4
7824476|NCT00358956|27168924|P1|Overall Study|Adverse Event|3
7824477|NCT00358917|27168936|P2|Overall Study|Unable to Continue Participation|2
7824478|NCT00358917|27168937|P1|Overall Study|Unable to Continue Participation|2
7824479|NCT00358917|27168936|P2|Overall Study|Virologic failure|8
7824480|NCT00358917|27168937|P1|Overall Study|Virologic failure|11
7824481|NCT00358917|27168936|P2|Overall Study|Death|3
7824482|NCT00358917|27168937|P1|Overall Study|Death|2
7824483|NCT00358917|27168936|P2|Overall Study|Noncompliance|11
7824484|NCT00358917|27168937|P1|Overall Study|Noncompliance|12
7824485|NCT00358917|27168936|P2|Overall Study|Lost to Follow-up|17
7824486|NCT00358917|27168937|P1|Overall Study|Lost to Follow-up|20
7824487|NCT00358917|27168936|P2|Overall Study|Withdrawal by Subject|7
7824488|NCT00358917|27168937|P1|Overall Study|Withdrawal by Subject|5
7824489|NCT00358917|27168936|P2|Overall Study|Adverse Event|21
7824490|NCT00358917|27168937|P1|Overall Study|Adverse Event|14
7824491|NCT00358826|27168955|P8|MDCT Substudy|Withdrawal by Subject|0
7824492|NCT00358826|27168956|P7|MDCT Substudy|Withdrawal by Subject|0
7824493|NCT00358826|27168957|P6|MDCT Substudy|Withdrawal by Subject|1
7824494|NCT00358826|27168958|P5|MDCT Substudy|Withdrawal by Subject|0
7824495|NCT00358826|27168959|P4|MDCT Substudy|Withdrawal by Subject|0
7824496|NCT00358826|27168960|P3|MDCT Substudy|Withdrawal by Subject|0
7824497|NCT00358826|27168961|P2|MDCT Substudy|Withdrawal by Subject|0
7824498|NCT00358826|27168962|P1|MDCT Substudy|Withdrawal by Subject|0
7824499|NCT00358826|27168955|P8|MDCT Substudy|Lost to Follow-up|0
7824500|NCT00358826|27168956|P7|MDCT Substudy|Lost to Follow-up|0
7824501|NCT00358826|27168957|P6|MDCT Substudy|Lost to Follow-up|1
7824502|NCT00358826|27168958|P5|MDCT Substudy|Lost to Follow-up|0
7824503|NCT00358826|27168959|P4|MDCT Substudy|Lost to Follow-up|0
7824504|NCT00358826|27168960|P3|MDCT Substudy|Lost to Follow-up|0
7824505|NCT00358826|27168961|P2|MDCT Substudy|Lost to Follow-up|0
7824506|NCT00358826|27168962|P1|MDCT Substudy|Lost to Follow-up|0
7824507|NCT00358826|27168955|P8|MDCT Substudy|Adverse Event|0
7824508|NCT00358826|27168956|P7|MDCT Substudy|Adverse Event|0
7824509|NCT00358826|27168957|P6|MDCT Substudy|Adverse Event|0
7824510|NCT00358826|27168958|P5|MDCT Substudy|Adverse Event|1
7824511|NCT00358826|27168959|P4|MDCT Substudy|Adverse Event|0
7824512|NCT00358826|27168960|P3|MDCT Substudy|Adverse Event|0
7824513|NCT00358826|27168961|P2|MDCT Substudy|Adverse Event|0
7824514|NCT00358826|27168962|P1|MDCT Substudy|Adverse Event|0
7824515|NCT00358826|27168955|P8|Core Study|Physician Decision|0
7824516|NCT00358826|27168956|P7|Core Study|Physician Decision|0
7824517|NCT00358826|27168957|P6|Core Study|Physician Decision|0
7824518|NCT00358826|27168958|P5|Core Study|Physician Decision|0
7824519|NCT00358826|27168959|P4|Core Study|Physician Decision|0
7824520|NCT00358826|27168960|P3|Core Study|Physician Decision|1
7824521|NCT00358826|27168961|P2|Core Study|Physician Decision|0
7824522|NCT00358826|27168962|P1|Core Study|Physician Decision|0
7824523|NCT00358826|27168955|P8|Core Study|Lost to Follow-up|0
7824524|NCT00358826|27168956|P7|Core Study|Lost to Follow-up|0
7824525|NCT00358826|27168957|P6|Core Study|Lost to Follow-up|0
7824526|NCT00358826|27168958|P5|Core Study|Lost to Follow-up|0
7824527|NCT00358826|27168959|P4|Core Study|Lost to Follow-up|1
7824528|NCT00358826|27168960|P3|Core Study|Lost to Follow-up|0
7824529|NCT00358826|27168961|P2|Core Study|Lost to Follow-up|0
7824530|NCT00358826|27168962|P1|Core Study|Lost to Follow-up|0
7824531|NCT00358826|27168955|P8|Core Study|Withdrawal by Subject|0
7824532|NCT00358826|27168956|P7|Core Study|Withdrawal by Subject|0
7824533|NCT00358826|27168957|P6|Core Study|Withdrawal by Subject|0
7824534|NCT00358826|27168958|P5|Core Study|Withdrawal by Subject|0
7824535|NCT00358826|27168959|P4|Core Study|Withdrawal by Subject|0
7824536|NCT00358826|27168960|P3|Core Study|Withdrawal by Subject|0
7824537|NCT00358826|27168961|P2|Core Study|Withdrawal by Subject|2
7824538|NCT00358826|27168962|P1|Core Study|Withdrawal by Subject|2
7824539|NCT00358826|27168955|P8|Core Study|Adverse Event|0
7824540|NCT00358826|27168956|P7|Core Study|Adverse Event|0
7824541|NCT00358826|27168957|P6|Core Study|Adverse Event|0
7824542|NCT00358826|27168958|P5|Core Study|Adverse Event|0
7824543|NCT00358826|27168959|P4|Core Study|Adverse Event|1
7824544|NCT00358826|27168960|P3|Core Study|Adverse Event|1
7824545|NCT00358826|27168961|P2|Core Study|Adverse Event|3
7824546|NCT00358826|27168962|P1|Core Study|Adverse Event|1
7824547|NCT00358670|27169029|P2|Overall Study|Administrative|125
7824548|NCT00358670|27169030|P1|Overall Study|Administrative|153
7824549|NCT00358670|27169029|P2|Overall Study|Did Not Meet Protocol Eligibility|3
7824550|NCT00358670|27169030|P1|Overall Study|Did Not Meet Protocol Eligibility|0
7824551|NCT00358670|27169029|P2|Overall Study|Protocol Defined Clinical Event|1
7824552|NCT00358670|27169030|P1|Overall Study|Protocol Defined Clinical Event|0
7824553|NCT00358670|27169029|P2|Overall Study|Withdrawal by Subject|24
7824554|NCT00358670|27169030|P1|Overall Study|Withdrawal by Subject|13
7824555|NCT00358670|27169029|P2|Overall Study|Lost to Follow-up|5
7824556|NCT00358670|27169030|P1|Overall Study|Lost to Follow-up|4
7824557|NCT00358670|27169029|P2|Overall Study|Protocol Violation|9
7824558|NCT00358670|27169030|P1|Overall Study|Protocol Violation|6
7824559|NCT00358670|27169029|P2|Overall Study|Lack of Efficacy|23
7824560|NCT00358670|27169030|P1|Overall Study|Lack of Efficacy|20
7824561|NCT00358670|27169029|P2|Overall Study|Adverse Event|29
7824562|NCT00358670|27169030|P1|Overall Study|Adverse Event|26
7824563|NCT00358644|27169056|P1|Overall Study|Patient not eligible for study|1
7824564|NCT00358644|27169056|P1|Overall Study|Physician Decision|6
7824565|NCT00358644|27169056|P1|Overall Study|Withdrawal by Subject|4
7824566|NCT00358644|27169056|P1|Overall Study|Death|11
7824567|NCT00358644|27169056|P1|Overall Study|Adverse Event|7
7824568|NCT00358644|27169056|P1|Overall Study|Progressive Disease|21
7824569|NCT00358527|27169079|P2|Overall Study|Administrative|1
7824570|NCT00358527|27169080|P1|Overall Study|Administrative|2
7824571|NCT00358527|27169079|P2|Overall Study|Non-compliance with protocol|1
7824572|NCT00358527|27169080|P1|Overall Study|Non-compliance with protocol|6
7824573|NCT00358527|27169079|P2|Overall Study|Withdrawal by Subject|1
7824574|NCT00358527|27169080|P1|Overall Study|Withdrawal by Subject|1
7824575|NCT00358527|27169079|P2|Overall Study|Adverse Event|0
7824576|NCT00358527|27169080|P1|Overall Study|Adverse Event|4
7824577|NCT00358449|27169130|P3|Overall Study|Steriod Inhaler was Increased|1
7824578|NCT00358449|27169131|P2|Overall Study|Steriod Inhaler was Increased|0
7824579|NCT00358449|27169132|P1|Overall Study|Steriod Inhaler was Increased|0
7824580|NCT00358449|27169130|P3|Overall Study|Lack of Efficacy|0
7824581|NCT00358449|27169131|P2|Overall Study|Lack of Efficacy|1
7824582|NCT00358449|27169132|P1|Overall Study|Lack of Efficacy|0
7824583|NCT00358449|27169130|P3|Overall Study|Withdrawal by Subject|0
7824584|NCT00358449|27169131|P2|Overall Study|Withdrawal by Subject|0
7824585|NCT00358449|27169132|P1|Overall Study|Withdrawal by Subject|2
7824586|NCT00358449|27169130|P3|Overall Study|Lost to Follow-up|0
7824587|NCT00358449|27169131|P2|Overall Study|Lost to Follow-up|0
7824588|NCT00358449|27169132|P1|Overall Study|Lost to Follow-up|1
7824589|NCT00358449|27169130|P3|Overall Study|Adverse Event|1
7824590|NCT00358449|27169131|P2|Overall Study|Adverse Event|0
7824591|NCT00358449|27169132|P1|Overall Study|Adverse Event|1
7824592|NCT00358436|27169235|P2|Overall Study|Other|1
7824593|NCT00358436|27169236|P1|Overall Study|Other|6
7824594|NCT00358436|27169235|P2|Overall Study|COPD exacerbation|10
7824595|NCT00358436|27169236|P1|Overall Study|COPD exacerbation|22
7824596|NCT00358436|27169235|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
7824597|NCT00358436|27169236|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
7824598|NCT00358436|27169235|P2|Overall Study|Withdrawal by Subject|17
7824599|NCT00358436|27169236|P1|Overall Study|Withdrawal by Subject|40
7824600|NCT00358436|27169235|P2|Overall Study|Protocol Violation|3
7824601|NCT00358436|27169236|P1|Overall Study|Protocol Violation|8
7824602|NCT00358436|27169235|P2|Overall Study|Lost to Follow-up|6
7824603|NCT00358436|27169236|P1|Overall Study|Lost to Follow-up|11
7824604|NCT00358436|27169235|P2|Overall Study|Lack of Efficacy|36
7824605|NCT00358436|27169236|P1|Overall Study|Lack of Efficacy|34
7824606|NCT00358436|27169235|P2|Overall Study|Adverse Event|13
7824607|NCT00358436|27169236|P1|Overall Study|Adverse Event|29
7824608|NCT00358215|27169307|P2|Overall Study|Did not receive investigational product|3
7824609|NCT00358215|27169308|P1|Overall Study|Did not receive investigational product|2
7824610|NCT00358215|27169307|P2|Overall Study|Other|14
7824611|NCT00358215|27169308|P1|Overall Study|Other|21
7824612|NCT00358215|27169307|P2|Overall Study|Pregnancy|0
7824613|NCT00358215|27169308|P1|Overall Study|Pregnancy|1
7824614|NCT00358215|27169307|P2|Overall Study|Protocol Violation|59
7824615|NCT00358215|27169308|P1|Overall Study|Protocol Violation|64
7824616|NCT00358215|27169307|P2|Overall Study|Death|281
7824617|NCT00358215|27169308|P1|Overall Study|Death|265
7824618|NCT00358215|27169307|P2|Overall Study|Lost to Follow-up|22
7824619|NCT00358215|27169308|P1|Overall Study|Lost to Follow-up|16
7824620|NCT00358215|27169307|P2|Overall Study|Physician Decision|39
7824621|NCT00358215|27169308|P1|Overall Study|Physician Decision|47
7824622|NCT00358215|27169307|P2|Overall Study|Participant request|64
7824623|NCT00358215|27169308|P1|Overall Study|Participant request|65
7824624|NCT00358215|27169307|P2|Overall Study|Withdrawal by Subject|102
7824625|NCT00358215|27169308|P1|Overall Study|Withdrawal by Subject|111
7824626|NCT00358215|27169307|P2|Overall Study|Adverse Event|65
7824627|NCT00358215|27169308|P1|Overall Study|Adverse Event|83
7824628|NCT00358215|27169307|P2|Overall Study|Ineligibility determined|3
7824629|NCT00358215|27169308|P1|Overall Study|Ineligibility determined|4
7824630|NCT00358150|27169322|P1|Overall Study|Undefined|3
7824631|NCT00358150|27169322|P1|Overall Study|Withdrawal by Subject|1
7824632|NCT00358150|27169322|P1|Overall Study|Adverse Event|3
7824633|NCT00357994|27169351|P2|Overall Study|Protocol Violation|0
7824634|NCT00357994|27169352|P1|Overall Study|Protocol Violation|1
7824635|NCT00357994|27169351|P2|Overall Study|Lack of Efficacy|1
7824636|NCT00357994|27169352|P1|Overall Study|Lack of Efficacy|0
7824637|NCT00357994|27169351|P2|Overall Study|Adverse Event|2
7824638|NCT00357994|27169352|P1|Overall Study|Adverse Event|1
7824639|NCT00357968|27169406|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
7824640|NCT00357968|27169407|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
7824641|NCT00357968|27169406|P2|First Maintenance Dose Phase|Not a PCI patient|42
7824642|NCT00357968|27169407|P1|First Maintenance Dose Phase|Not a PCI patient|47
7824643|NCT00357903|27169460|P2|Overall Study|Other|10
7824644|NCT00357903|27169461|P1|Overall Study|Other|49
7824645|NCT00357903|27169460|P2|Overall Study|Response status|9
7824646|NCT00357903|27169461|P1|Overall Study|Response status|61
7824647|NCT00357903|27169460|P2|Overall Study|Protocol issues|3
7824648|NCT00357903|27169461|P1|Overall Study|Protocol issues|14
7824649|NCT00357903|27169460|P2|Overall Study|Completed month 12 only|1
7824650|NCT00357903|27169461|P1|Overall Study|Completed month 12 only|0
7824651|NCT00357903|27169460|P2|Overall Study|Withdrawal by Subject|7
7824652|NCT00357903|27169461|P1|Overall Study|Withdrawal by Subject|57
7824653|NCT00357903|27169460|P2|Overall Study|Physician Decision|5
7824654|NCT00357903|27169461|P1|Overall Study|Physician Decision|39
7824655|NCT00357903|27169460|P2|Overall Study|Lost to Follow-up|4
7824656|NCT00357903|27169461|P1|Overall Study|Lost to Follow-up|23
7824657|NCT00357903|27169460|P2|Overall Study|Death|0
7824658|NCT00357903|27169461|P1|Overall Study|Death|33
7824659|NCT00357903|27169460|P2|Overall Study|Adverse Event|4
7824660|NCT00357903|27169461|P1|Overall Study|Adverse Event|87
7824661|NCT00357877|27169501|P2|Overall Study|Other|2
7824662|NCT00357877|27169502|P1|Overall Study|Other|0
7824663|NCT00357877|27169501|P2|Overall Study|Administrative withdrawal|1
7824664|NCT00357877|27169502|P1|Overall Study|Administrative withdrawal|1
7824665|NCT00357877|27169501|P2|Overall Study|Withdrawal by Subject|3
7824666|NCT00357877|27169502|P1|Overall Study|Withdrawal by Subject|3
7824667|NCT00357877|27169501|P2|Overall Study|Lost to Follow-up|23
7824668|NCT00357877|27169502|P1|Overall Study|Lost to Follow-up|20
7824669|NCT00357877|27169501|P2|Overall Study|Death|1
7824670|NCT00357877|27169502|P1|Overall Study|Death|2
7824671|NCT00357760|27169516|P2|Overall Study|To receive hospice care|1
7824672|NCT00357760|27169517|P1|Overall Study|To receive hospice care|0
7824673|NCT00357760|27169516|P2|Overall Study|Protocol Violation|1
7824674|NCT00357760|27169517|P1|Overall Study|Protocol Violation|0
7824675|NCT00357760|27169516|P2|Overall Study|Physician Decision|1
7824676|NCT00357760|27169517|P1|Overall Study|Physician Decision|2
7824677|NCT00357760|27169516|P2|Overall Study|Ineligible|2
7824678|NCT00357760|27169517|P1|Overall Study|Ineligible|0
7824679|NCT00357760|27169516|P2|Overall Study|Never started treatment|1
7824680|NCT00357760|27169517|P1|Overall Study|Never started treatment|2
7824681|NCT00357760|27169516|P2|Overall Study|Withdrawal by Subject|2
7824682|NCT00357760|27169517|P1|Overall Study|Withdrawal by Subject|0
7824683|NCT00357760|27169516|P2|Overall Study|Alternative therapy|0
7824684|NCT00357760|27169517|P1|Overall Study|Alternative therapy|1
7824685|NCT00357760|27169516|P2|Overall Study|Death|3
7824686|NCT00357760|27169517|P1|Overall Study|Death|0
7824687|NCT00357760|27169516|P2|Overall Study|Adverse Event|7
7824688|NCT00357760|27169517|P1|Overall Study|Adverse Event|10
7824689|NCT00357760|27169516|P2|Overall Study|Disease progression|17
7824690|NCT00357760|27169517|P1|Overall Study|Disease progression|44
7824691|NCT00357656|27169538|P2|Overall Study|Other, No surgery performed|3
7824692|NCT00357656|27169539|P1|Overall Study|Other, No surgery performed|0
7824693|NCT00357552|27169590|P1|Weeks 24 to 104|Not able to get to clinic|2
7824694|NCT00357552|27169590|P1|Weeks 24 to 104|Death|3
7824695|NCT00357552|27169590|P1|Weeks 0 to 24|Death|1
7824696|NCT00357552|27169590|P1|Screening|Did not meet eligibility criteria|84
7824697|NCT00357500|27169605|P1|Overall Study|Not Started Protocol Therapy|4
7824698|NCT00357500|27169605|P1|Overall Study|Progressive Disease|65
7824699|NCT00357500|27169605|P1|Overall Study|Withdrawal by Subject|5
7824700|NCT00357500|27169605|P1|Overall Study|Adverse Event|3
7824701|NCT00357396|27169614|P2|Overall Study|Adverse Event|0
7824702|NCT00357396|27169615|P1|Overall Study|Adverse Event|1
7824703|NCT00357370|27169623|P3|Cohort 2|Withdrawal by Subject|0
7824704|NCT00357370|27169624|P2|Cohort 2|Withdrawal by Subject|2
7824705|NCT00357370|27169625|P1|Cohort 2|Withdrawal by Subject|0
7824706|NCT00357370|27169623|P3|Cohort 2|non-compliance, not met criteria, etc|0
7824707|NCT00357370|27169624|P2|Cohort 2|non-compliance, not met criteria, etc|1
7824708|NCT00357370|27169625|P1|Cohort 2|non-compliance, not met criteria, etc|1
7824709|NCT00357370|27169623|P3|Cohort 2|Lost to Follow-up|0
7824710|NCT00357370|27169624|P2|Cohort 2|Lost to Follow-up|1
7824711|NCT00357370|27169625|P1|Cohort 2|Lost to Follow-up|0
7824712|NCT00357370|27169623|P3|Cohort 2|Adverse Event|1
7824713|NCT00357370|27169624|P2|Cohort 2|Adverse Event|1
7824714|NCT00357370|27169625|P1|Cohort 2|Adverse Event|1
7824715|NCT00357370|27169623|P3|Cohort 2|Lack of Efficacy|1
7824716|NCT00357370|27169624|P2|Cohort 2|Lack of Efficacy|2
7824717|NCT00357370|27169625|P1|Cohort 2|Lack of Efficacy|0
7824718|NCT00357110|27169688|P2|Overall Study|Early study termination|5
7824719|NCT00357110|27169689|P1|Overall Study|Early study termination|5
7824720|NCT00357097|27169697|P2|Overall Study|Increase of RLS Symptoms|1
7824721|NCT00357097|27169698|P1|Overall Study|Increase of RLS Symptoms|0
7824722|NCT00357097|27169697|P2|Overall Study|Other|1
7824723|NCT00357097|27169698|P1|Overall Study|Other|1
7824724|NCT00357097|27169697|P2|Overall Study|Met Exclusion Criteria|1
7824725|NCT00357097|27169698|P1|Overall Study|Met Exclusion Criteria|3
7824726|NCT00357097|27169697|P2|Overall Study|Lack of Efficacy|8
7824727|NCT00357097|27169698|P1|Overall Study|Lack of Efficacy|2
7824728|NCT00357097|27169697|P2|Overall Study|Non-compliance|2
7824729|NCT00357097|27169698|P1|Overall Study|Non-compliance|1
7824730|NCT00357097|27169697|P2|Overall Study|Withdrawal by Subject|7
7824731|NCT00357097|27169698|P1|Overall Study|Withdrawal by Subject|8
7824732|NCT00357097|27169697|P2|Overall Study|Adverse Event|6
7824733|NCT00357097|27169698|P1|Overall Study|Adverse Event|34
7824734|NCT00357097|27169697|P2|Overall Study|Did not meet inclusion criteria|3
7824735|NCT00357097|27169698|P1|Overall Study|Did not meet inclusion criteria|5
7824736|NCT00357006|27169752|P3|Overall Study|Withdrawal by Subject|2
7824737|NCT00357006|27169753|P2|Overall Study|Withdrawal by Subject|3
7824738|NCT00357006|27169754|P1|Overall Study|Withdrawal by Subject|1
7824739|NCT00357006|27169752|P3|Overall Study|Lost to Follow-up|1
7824740|NCT00357006|27169753|P2|Overall Study|Lost to Follow-up|2
7824741|NCT00357006|27169754|P1|Overall Study|Lost to Follow-up|1
7824742|NCT00356915|27169769|P3|Overall Study|Miscellaneous reasons|3
7824743|NCT00356915|27169770|P2|Overall Study|Miscellaneous reasons|8
7824744|NCT00356915|27169771|P1|Overall Study|Miscellaneous reasons|11
7824745|NCT00356915|27169769|P3|Overall Study|Adverse Event|8
7824746|NCT00356915|27169770|P2|Overall Study|Adverse Event|31
7824747|NCT00356915|27169771|P1|Overall Study|Adverse Event|21
7824748|NCT00356915|27169769|P3|Overall Study|Physician Decision|0
7824749|NCT00356915|27169770|P2|Overall Study|Physician Decision|2
7824750|NCT00356915|27169771|P1|Overall Study|Physician Decision|0
7824751|NCT00356915|27169769|P3|Overall Study|Administrative Decision|1
7824752|NCT00356915|27169770|P2|Overall Study|Administrative Decision|0
7824753|NCT00356915|27169771|P1|Overall Study|Administrative Decision|0
7824754|NCT00356915|27169769|P3|Overall Study|Lost to Follow-up|14
7824755|NCT00356915|27169770|P2|Overall Study|Lost to Follow-up|34
7824756|NCT00356915|27169771|P1|Overall Study|Lost to Follow-up|27
7824757|NCT00356915|27169769|P3|Overall Study|Lack of Efficacy|3
7824758|NCT00356915|27169770|P2|Overall Study|Lack of Efficacy|0
7824759|NCT00356915|27169771|P1|Overall Study|Lack of Efficacy|0
7824760|NCT00356915|27169769|P3|Overall Study|Withdrawal by Subject|10
7824761|NCT00356915|27169770|P2|Overall Study|Withdrawal by Subject|14
7824762|NCT00356915|27169771|P1|Overall Study|Withdrawal by Subject|14
7824763|NCT00356915|27169769|P3|Overall Study|Protocol Violation|2
7824764|NCT00356915|27169770|P2|Overall Study|Protocol Violation|3
7824765|NCT00356915|27169771|P1|Overall Study|Protocol Violation|2
7824766|NCT00356915|27169769|P3|Overall Study|Non compliance|1
7824767|NCT00356915|27169770|P2|Overall Study|Non compliance|2
7824768|NCT00356915|27169771|P1|Overall Study|Non compliance|1
7824769|NCT00356889|27169788|P1|Overall Study|Adverse Event|1
7824770|NCT00356889|27169788|P1|Overall Study|Protocol Violation|2
7824771|NCT00356863|27169797|P2|Overall Study|Lost to Follow-up|43
7824772|NCT00356863|27169798|P1|Overall Study|Lost to Follow-up|76
7824773|NCT00356863|27169797|P2|Overall Study|Death|32
7824774|NCT00356863|27169798|P1|Overall Study|Death|16
7824775|NCT00356811|27169824|P1|Overall Study|Site Closed during Follow-up|2
7824776|NCT00356811|27169824|P1|Overall Study|Study Is Terminating|3
7824777|NCT00356811|27169824|P1|Overall Study|Participant Could Not Make a Checkup|1
7824778|NCT00356811|27169824|P1|Overall Study|Withdrawal by Subject|6
7824779|NCT00356811|27169824|P1|Overall Study|Lost to Follow-up|2
7824780|NCT00356811|27169824|P1|Overall Study|Death|35
7824781|NCT00356759|27169839|P2|Overall Study|Intercurrent disease or persistent extre|2
7824782|NCT00356759|27169840|P1|Overall Study|Intercurrent disease or persistent extre|5
7824783|NCT00356759|27169839|P2|Overall Study|Lost to Follow-up|1
7824784|NCT00356759|27169840|P1|Overall Study|Lost to Follow-up|1
7824785|NCT00356759|27169839|P2|Overall Study|Adverse Event|3
7824786|NCT00356759|27169840|P1|Overall Study|Adverse Event|1
7824787|NCT00356759|27169839|P2|Overall Study|Withdrawal by Subject|2
7824788|NCT00356759|27169840|P1|Overall Study|Withdrawal by Subject|2
7824789|NCT00356759|27169839|P2|Overall Study|Death|2
7824790|NCT00356759|27169840|P1|Overall Study|Death|5
7824791|NCT00356603|27169858|P2|Overall Study|Other|3
7824792|NCT00356603|27169859|P1|Overall Study|Other|6
7824793|NCT00356590|27169873|P1|Overall Study|Other|52
7824794|NCT00356590|27169873|P1|Overall Study|Response status|28
7824795|NCT00356590|27169873|P1|Overall Study|Protocol issues|6
7824796|NCT00356590|27169873|P1|Overall Study|Completed month 12 only|2
7824797|NCT00356590|27169873|P1|Overall Study|Withdrawal by Subject|41
7824798|NCT00356590|27169873|P1|Overall Study|Physician Decision|46
7824799|NCT00356590|27169873|P1|Overall Study|Lost to Follow-up|35
7824800|NCT00356590|27169873|P1|Overall Study|Death|10
7824801|NCT00356590|27169873|P1|Overall Study|Adverse Event|54
7824802|NCT00356525|27169909|P4|Overall Study|Sponsor Decision|1
7824803|NCT00356525|27169910|P3|Overall Study|Sponsor Decision|0
7824804|NCT00356525|27169911|P2|Overall Study|Sponsor Decision|0
7824805|NCT00356525|27169912|P1|Overall Study|Sponsor Decision|0
7824806|NCT00356525|27169909|P4|Overall Study|Death|1
7824807|NCT00356525|27169910|P3|Overall Study|Death|0
7824808|NCT00356525|27169911|P2|Overall Study|Death|0
7824809|NCT00356525|27169912|P1|Overall Study|Death|0
7824810|NCT00356525|27169909|P4|Overall Study|Withdrawal by Subject|3
7824811|NCT00356525|27169910|P3|Overall Study|Withdrawal by Subject|0
7824812|NCT00356525|27169911|P2|Overall Study|Withdrawal by Subject|1
7824813|NCT00356525|27169912|P1|Overall Study|Withdrawal by Subject|1
7824814|NCT00356525|27169909|P4|Overall Study|Protocol Entry Criteria Not Met|0
7824815|NCT00356525|27169910|P3|Overall Study|Protocol Entry Criteria Not Met|0
7824816|NCT00356525|27169911|P2|Overall Study|Protocol Entry Criteria Not Met|0
7824817|NCT00356525|27169912|P1|Overall Study|Protocol Entry Criteria Not Met|1
7824818|NCT00356525|27169909|P4|Overall Study|Physician Decision|1
7824819|NCT00356525|27169910|P3|Overall Study|Physician Decision|2
7824820|NCT00356525|27169911|P2|Overall Study|Physician Decision|2
7824821|NCT00356525|27169912|P1|Overall Study|Physician Decision|2
7824822|NCT00356525|27169909|P4|Overall Study|Lost to Follow-up|0
7824823|NCT00356525|27169910|P3|Overall Study|Lost to Follow-up|0
7824824|NCT00356525|27169911|P2|Overall Study|Lost to Follow-up|0
7824825|NCT00356525|27169912|P1|Overall Study|Lost to Follow-up|1
7824826|NCT00356525|27169909|P4|Overall Study|Adverse Event|1
7824827|NCT00356525|27169910|P3|Overall Study|Adverse Event|1
7824828|NCT00356525|27169911|P2|Overall Study|Adverse Event|3
7824829|NCT00356525|27169912|P1|Overall Study|Adverse Event|1
7824830|NCT00356525|27169909|P4|Overall Study|Progressive Disease|2
7824831|NCT00356525|27169910|P3|Overall Study|Progressive Disease|4
7824832|NCT00356525|27169911|P2|Overall Study|Progressive Disease|5
7824833|NCT00356525|27169912|P1|Overall Study|Progressive Disease|8
7824834|NCT00356421|27169953|P2|Overall Study|Not related to study drug|3
7824835|NCT00356421|27169954|P1|Overall Study|Not related to study drug|5
7824836|NCT00356421|27169953|P2|Overall Study|Related to study drug|12
7824837|NCT00356421|27169954|P1|Overall Study|Related to study drug|15
7824838|NCT00356421|27169953|P2|Overall Study|Withdrawal by Subject|2
7824839|NCT00356421|27169954|P1|Overall Study|Withdrawal by Subject|9
7824840|NCT00356421|27169953|P2|Overall Study|Lack of Efficacy|0
7824841|NCT00356421|27169954|P1|Overall Study|Lack of Efficacy|3
7824842|NCT00356408|27169994|P1|Overall Study|Other: Subject chose commerical dosing|1
7824843|NCT00356408|27169994|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
7824844|NCT00356408|27169994|P1|Overall Study|Other: Azathioprine stopped|1
7824845|NCT00356408|27169994|P1|Overall Study|Other: Sponsor request|1
7824846|NCT00356408|27169994|P1|Overall Study|Other: Principal investigator discretion|3
7824847|NCT00356408|27169994|P1|Overall Study|Withdrawal by Subject|6
7824848|NCT00356408|27169994|P1|Overall Study|Lost to Follow-up|2
7824849|NCT00356408|27169994|P1|Overall Study|Lack of Efficacy|36
7824850|NCT00356408|27169994|P1|Overall Study|Adverse Event|9
7824851|NCT00356369|27170011|P2|Active Phase|Withdrawal by Subject|1
7824852|NCT00356369|27170012|P1|Active Phase|Withdrawal by Subject|2
7824853|NCT00356278|27170094|P3|Overall Study|Withdrawal by Subject|19
7824854|NCT00356278|27170095|P2|Overall Study|Withdrawal by Subject|15
7824855|NCT00356278|27170096|P1|Overall Study|Withdrawal by Subject|25
7824856|NCT00356265|27170134|P3|Overall Study|Withdrawal by Subject|1
7824857|NCT00356265|27170135|P2|Overall Study|Withdrawal by Subject|0
7824858|NCT00356265|27170136|P1|Overall Study|Withdrawal by Subject|0
7824859|NCT00356200|27170148|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
7824860|NCT00356200|27170149|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
7824861|NCT00356200|27170148|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
7824862|NCT00356200|27170149|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
7824863|NCT00356148|27170178|P2|Overall Study|Reoperation within 30 days|1
7824864|NCT00356148|27170179|P1|Overall Study|Reoperation within 30 days|2
7824865|NCT00356135|27170190|P3|Overall Study|Subject non-compliance|3
7824866|NCT00356135|27170191|P2|Overall Study|Subject non-compliance|1
7824867|NCT00356135|27170192|P1|Overall Study|Subject non-compliance|1
7824868|NCT00356135|27170190|P3|Overall Study|Physician Decision|1
7824869|NCT00356135|27170191|P2|Overall Study|Physician Decision|1
7824870|NCT00356135|27170192|P1|Overall Study|Physician Decision|1
7824871|NCT00356135|27170190|P3|Overall Study|Lost to Follow-up|1
7824872|NCT00356135|27170191|P2|Overall Study|Lost to Follow-up|0
7824873|NCT00356135|27170192|P1|Overall Study|Lost to Follow-up|0
7824874|NCT00356135|27170190|P3|Overall Study|Adverse Event|0
7824875|NCT00356135|27170191|P2|Overall Study|Adverse Event|0
7824876|NCT00356135|27170192|P1|Overall Study|Adverse Event|1
7824877|NCT00356135|27170190|P3|Overall Study|Protocol Violation|0
7824878|NCT00356135|27170191|P2|Overall Study|Protocol Violation|0
7824879|NCT00356135|27170192|P1|Overall Study|Protocol Violation|1
7824880|NCT00356122|27170214|P1|FOLLOW-UP|Other|2
7824881|NCT00356122|27170214|P1|FOLLOW-UP|Lost to Follow-up|2
7824882|NCT00356122|27170214|P1|FOLLOW-UP|Death|37
7824883|NCT00356122|27170214|P1|TREATMENT|Did not receive study medication|1
7824884|NCT00356122|27170214|P1|TREATMENT|Other|4
7824885|NCT00356122|27170214|P1|TREATMENT|Subject's request|4
7824886|NCT00356122|27170214|P1|TREATMENT|Adverse Event|10
7824887|NCT00356122|27170214|P1|TREATMENT|Lack of Efficacy|26
7824888|NCT00355784|27170322|P3|Overall Study|Withdrawal by Subject|2
7824889|NCT00355784|27170323|P2|Overall Study|Withdrawal by Subject|0
7824890|NCT00355784|27170324|P1|Overall Study|Withdrawal by Subject|0
7824891|NCT00355615|27170373|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
7824892|NCT00355615|27170374|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
7824893|NCT00355615|27170375|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
7824894|NCT00355615|27170376|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
7824895|NCT00355615|27170377|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
7824896|NCT00355615|27170373|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
7824897|NCT00355615|27170374|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7824898|NCT00355615|27170375|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7824899|NCT00355615|27170376|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7824900|NCT00355615|27170377|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7824901|NCT00355615|27170373|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
7824902|NCT00355615|27170374|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7824903|NCT00355615|27170375|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7824904|NCT00355615|27170376|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7824905|NCT00355615|27170377|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7824906|NCT00355615|27170373|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
7824907|NCT00355615|27170374|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
7824908|NCT00355615|27170375|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
7824909|NCT00355615|27170376|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
7824910|NCT00355615|27170377|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
7824911|NCT00355615|27170373|P5|Randomized Double Blind Period|Protocol Violation|0
7824912|NCT00355615|27170374|P4|Randomized Double Blind Period|Protocol Violation|1
7824913|NCT00355615|27170375|P3|Randomized Double Blind Period|Protocol Violation|1
7824914|NCT00355615|27170376|P2|Randomized Double Blind Period|Protocol Violation|0
7824915|NCT00355615|27170377|P1|Randomized Double Blind Period|Protocol Violation|0
7824916|NCT00355615|27170373|P5|Randomized Double Blind Period|Adverse Event|0
7824917|NCT00355615|27170374|P4|Randomized Double Blind Period|Adverse Event|0
7824918|NCT00355615|27170375|P3|Randomized Double Blind Period|Adverse Event|0
7824919|NCT00355615|27170376|P2|Randomized Double Blind Period|Adverse Event|0
7824920|NCT00355615|27170377|P1|Randomized Double Blind Period|Adverse Event|1
7824921|NCT00355472|27170436|P1|Overall Study|Physician Decision|1
7824922|NCT00355368|27170482|P2|Overall Study|cardiac arrest prior to intubation|2
7824923|NCT00355368|27170483|P1|Overall Study|cardiac arrest prior to intubation|2
7824924|NCT00355368|27170482|P2|Overall Study|Protocol Violation|7
7824925|NCT00355368|27170483|P1|Overall Study|Protocol Violation|8
7824926|NCT00355342|27170497|P2|Overall Study|Use of protocol excluded medication|1
7824927|NCT00355342|27170498|P1|Overall Study|Use of protocol excluded medication|0
7824928|NCT00355342|27170497|P2|Overall Study|Protocol Violation|1
7824929|NCT00355342|27170498|P1|Overall Study|Protocol Violation|0
7824930|NCT00355342|27170497|P2|Overall Study|Study management|1
7824931|NCT00355342|27170498|P1|Overall Study|Study management|0
7824932|NCT00355342|27170497|P2|Overall Study|Participant discontinued study drug|1
7824933|NCT00355342|27170498|P1|Overall Study|Participant discontinued study drug|0
7824934|NCT00355342|27170497|P2|Overall Study|Participant relocated|1
7824935|NCT00355342|27170498|P1|Overall Study|Participant relocated|0
7824936|NCT00355342|27170497|P2|Overall Study|Withdrawal by participant and physician|0
7824937|NCT00355342|27170498|P1|Overall Study|Withdrawal by participant and physician|1
7824938|NCT00355342|27170497|P2|Overall Study|Non-compliance with Dexa scans|0
7824939|NCT00355342|27170498|P1|Overall Study|Non-compliance with Dexa scans|1
7824940|NCT00355342|27170497|P2|Overall Study|Dispensed wrong study drug kit|0
7824941|NCT00355342|27170498|P1|Overall Study|Dispensed wrong study drug kit|1
7824942|NCT00355342|27170497|P2|Overall Study|COPD exacerbation|1
7824943|NCT00355342|27170498|P1|Overall Study|COPD exacerbation|1
7824944|NCT00355342|27170497|P2|Overall Study|Use of prohibited medication|0
7824945|NCT00355342|27170498|P1|Overall Study|Use of prohibited medication|1
7824946|NCT00355342|27170497|P2|Overall Study|Overcompliant-PI discretion|0
7824947|NCT00355342|27170498|P1|Overall Study|Overcompliant-PI discretion|1
7824948|NCT00355342|27170497|P2|Overall Study|Sponsor terminated study|2
7824949|NCT00355342|27170498|P1|Overall Study|Sponsor terminated study|2
7824950|NCT00355342|27170497|P2|Overall Study|Withdrawal by Subject|11
7824951|NCT00355342|27170498|P1|Overall Study|Withdrawal by Subject|14
7824952|NCT00355342|27170497|P2|Overall Study|Lost to Follow-up|2
7824953|NCT00355342|27170498|P1|Overall Study|Lost to Follow-up|4
7824954|NCT00355342|27170497|P2|Overall Study|Adverse Event|15
7824955|NCT00355342|27170498|P1|Overall Study|Adverse Event|13
7824956|NCT00355264|27170506|P1|Extension (Variable Duration)|Withdrew Consent|1
7824957|NCT00355264|27170506|P1|Extension (Variable Duration)|Adverse Event|1
7824958|NCT00355147|27170534|P2|Overall Study|Withdrawal by Subject|12
7824959|NCT00355147|27170535|P1|Overall Study|Withdrawal by Subject|8
7824960|NCT00355147|27170534|P2|Overall Study|Lost to Follow-up|8
7824961|NCT00355147|27170535|P1|Overall Study|Lost to Follow-up|10
7824962|NCT00355134|27170554|P5|Extension Phase|Protocol Violation|0
7824963|NCT00355134|27170555|P4|Extension Phase|Protocol Violation|1
7824964|NCT00355134|27170556|P3|Extension Phase|Protocol Violation|0
7824965|NCT00355134|27170557|P2|Extension Phase|Protocol Violation|0
7824966|NCT00355134|27170558|P1|Extension Phase|Protocol Violation|0
7824967|NCT00355134|27170554|P5|Extension Phase|Abnormal test procedure result(s)|1
7824968|NCT00355134|27170555|P4|Extension Phase|Abnormal test procedure result(s)|0
7824969|NCT00355134|27170556|P3|Extension Phase|Abnormal test procedure result(s)|0
7824970|NCT00355134|27170557|P2|Extension Phase|Abnormal test procedure result(s)|1
7824971|NCT00355134|27170558|P1|Extension Phase|Abnormal test procedure result(s)|0
7824972|NCT00355134|27170554|P5|Extension Phase|Unsatisfactory therapeutic effect|1
7824973|NCT00355134|27170555|P4|Extension Phase|Unsatisfactory therapeutic effect|0
7824974|NCT00355134|27170556|P3|Extension Phase|Unsatisfactory therapeutic effect|0
7824975|NCT00355134|27170557|P2|Extension Phase|Unsatisfactory therapeutic effect|4
7824976|NCT00355134|27170558|P1|Extension Phase|Unsatisfactory therapeutic effect|3
7824977|NCT00355134|27170554|P5|Extension Phase|Administrative problems|1
7824978|NCT00355134|27170555|P4|Extension Phase|Administrative problems|1
7824979|NCT00355134|27170556|P3|Extension Phase|Administrative problems|0
7824980|NCT00355134|27170557|P2|Extension Phase|Administrative problems|4
7824981|NCT00355134|27170558|P1|Extension Phase|Administrative problems|2
7824982|NCT00355134|27170554|P5|Extension Phase|Abnormal laboratory value(s)|2
7824983|NCT00355134|27170555|P4|Extension Phase|Abnormal laboratory value(s)|2
7824984|NCT00355134|27170556|P3|Extension Phase|Abnormal laboratory value(s)|0
7824985|NCT00355134|27170557|P2|Extension Phase|Abnormal laboratory value(s)|2
7824986|NCT00355134|27170558|P1|Extension Phase|Abnormal laboratory value(s)|4
7824987|NCT00355134|27170554|P5|Extension Phase|Lost to Follow-up|4
7824988|NCT00355134|27170555|P4|Extension Phase|Lost to Follow-up|2
7824989|NCT00355134|27170556|P3|Extension Phase|Lost to Follow-up|0
7824990|NCT00355134|27170557|P2|Extension Phase|Lost to Follow-up|6
7824991|NCT00355134|27170558|P1|Extension Phase|Lost to Follow-up|2
7824992|NCT00355134|27170554|P5|Extension Phase|Adverse Event|5
7824993|NCT00355134|27170555|P4|Extension Phase|Adverse Event|3
7824994|NCT00355134|27170556|P3|Extension Phase|Adverse Event|0
7824995|NCT00355134|27170557|P2|Extension Phase|Adverse Event|9
7824996|NCT00355134|27170558|P1|Extension Phase|Adverse Event|13
7824997|NCT00355134|27170554|P5|Extension Phase|Withdrawal by Subject|5
7824998|NCT00355134|27170555|P4|Extension Phase|Withdrawal by Subject|7
7824999|NCT00355134|27170556|P3|Extension Phase|Withdrawal by Subject|0
7825000|NCT00355134|27170557|P2|Extension Phase|Withdrawal by Subject|11
7825001|NCT00355134|27170558|P1|Extension Phase|Withdrawal by Subject|7
7825002|NCT00355134|27170554|P5|Core Phase|Condition no longer requires study drug|0
7825003|NCT00355134|27170555|P4|Core Phase|Condition no longer requires study drug|0
7825004|NCT00355134|27170556|P3|Core Phase|Condition no longer requires study drug|1
7825005|NCT00355134|27170557|P2|Core Phase|Condition no longer requires study drug|0
7825006|NCT00355134|27170558|P1|Core Phase|Condition no longer requires study drug|1
7825007|NCT00355134|27170554|P5|Core Phase|Abnormal test procedure result(s)|0
7825008|NCT00355134|27170555|P4|Core Phase|Abnormal test procedure result(s)|0
7825009|NCT00355134|27170556|P3|Core Phase|Abnormal test procedure result(s)|1
7825010|NCT00355134|27170557|P2|Core Phase|Abnormal test procedure result(s)|2
7825011|NCT00355134|27170558|P1|Core Phase|Abnormal test procedure result(s)|1
7825012|NCT00355134|27170554|P5|Core Phase|Protocol Violation|0
7825013|NCT00355134|27170555|P4|Core Phase|Protocol Violation|0
7825014|NCT00355134|27170556|P3|Core Phase|Protocol Violation|2
7825015|NCT00355134|27170557|P2|Core Phase|Protocol Violation|2
7825016|NCT00355134|27170558|P1|Core Phase|Protocol Violation|3
7825017|NCT00355134|27170554|P5|Core Phase|Administrative problems|0
7825018|NCT00355134|27170555|P4|Core Phase|Administrative problems|0
7825019|NCT00355134|27170556|P3|Core Phase|Administrative problems|5
7825020|NCT00355134|27170557|P2|Core Phase|Administrative problems|3
7825021|NCT00355134|27170558|P1|Core Phase|Administrative problems|5
7825022|NCT00355134|27170554|P5|Core Phase|Unsatisfactory therapeutic effect|0
7825023|NCT00355134|27170555|P4|Core Phase|Unsatisfactory therapeutic effect|0
7825024|NCT00355134|27170556|P3|Core Phase|Unsatisfactory therapeutic effect|17
7825025|NCT00355134|27170557|P2|Core Phase|Unsatisfactory therapeutic effect|6
7825026|NCT00355134|27170558|P1|Core Phase|Unsatisfactory therapeutic effect|10
7825027|NCT00355134|27170554|P5|Core Phase|Abnormal laboratory value(s)|0
7825028|NCT00355134|27170555|P4|Core Phase|Abnormal laboratory value(s)|0
7825029|NCT00355134|27170556|P3|Core Phase|Abnormal laboratory value(s)|2
7825030|NCT00355134|27170557|P2|Core Phase|Abnormal laboratory value(s)|14
7825031|NCT00355134|27170558|P1|Core Phase|Abnormal laboratory value(s)|19
7825032|NCT00355134|27170554|P5|Core Phase|Lost to Follow-up|0
7825033|NCT00355134|27170555|P4|Core Phase|Lost to Follow-up|0
7825034|NCT00355134|27170556|P3|Core Phase|Lost to Follow-up|21
7825035|NCT00355134|27170557|P2|Core Phase|Lost to Follow-up|13
7825036|NCT00355134|27170558|P1|Core Phase|Lost to Follow-up|17
7825037|NCT00355134|27170554|P5|Core Phase|Adverse Event|0
7825038|NCT00355134|27170555|P4|Core Phase|Adverse Event|0
7825039|NCT00355134|27170556|P3|Core Phase|Adverse Event|16
7825040|NCT00355134|27170557|P2|Core Phase|Adverse Event|22
7825041|NCT00355134|27170558|P1|Core Phase|Adverse Event|28
7825042|NCT00355134|27170554|P5|Core Phase|Withdrawal by Subject|0
7825043|NCT00355134|27170555|P4|Core Phase|Withdrawal by Subject|0
7825044|NCT00355134|27170556|P3|Core Phase|Withdrawal by Subject|35
7825045|NCT00355134|27170557|P2|Core Phase|Withdrawal by Subject|24
7825046|NCT00355134|27170558|P1|Core Phase|Withdrawal by Subject|35
7825047|NCT00355121|27170601|P3|Overall Study|Serious adverse events|0
7825048|NCT00355121|27170602|P2|Overall Study|Serious adverse events|2
7825049|NCT00355121|27170603|P1|Overall Study|Serious adverse events|0
7825050|NCT00355121|27170601|P3|Overall Study|Withdrawal by Subject|2
7825051|NCT00355121|27170602|P2|Overall Study|Withdrawal by Subject|10
7825052|NCT00355121|27170603|P1|Overall Study|Withdrawal by Subject|9
7825053|NCT00355121|27170601|P3|Overall Study|Lost to Follow-up|1
7825054|NCT00355121|27170602|P2|Overall Study|Lost to Follow-up|7
7825055|NCT00355121|27170603|P1|Overall Study|Lost to Follow-up|4
7825056|NCT00355121|27170601|P3|Overall Study|Protocol Violation|1
7825057|NCT00355121|27170602|P2|Overall Study|Protocol Violation|9
7825058|NCT00355121|27170603|P1|Overall Study|Protocol Violation|7
7825059|NCT00355121|27170601|P3|Overall Study|Adverse Event|0
7825060|NCT00355121|27170602|P2|Overall Study|Adverse Event|1
7825061|NCT00355121|27170603|P1|Overall Study|Adverse Event|0
7825062|NCT00355121|27170601|P3|Overall Study|Did not receive study vaccine|1
7825063|NCT00355121|27170602|P2|Overall Study|Did not receive study vaccine|0
7825064|NCT00355121|27170603|P1|Overall Study|Did not receive study vaccine|1
7825065|NCT00355082|27170634|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
7825066|NCT00355082|27170635|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
7825067|NCT00355082|27170636|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
7825068|NCT00355082|27170634|P3|Continuation Phase|Scheduling Error|0
7825069|NCT00355082|27170635|P2|Continuation Phase|Scheduling Error|0
7825070|NCT00355082|27170636|P1|Continuation Phase|Scheduling Error|1
7825071|NCT00355082|27170634|P3|Continuation Phase|Site Closed by Sponsor|0
7825072|NCT00355082|27170635|P2|Continuation Phase|Site Closed by Sponsor|0
7825073|NCT00355082|27170636|P1|Continuation Phase|Site Closed by Sponsor|8
7825074|NCT00355082|27170634|P3|Continuation Phase|Lack of Efficacy|0
7825075|NCT00355082|27170635|P2|Continuation Phase|Lack of Efficacy|0
7825076|NCT00355082|27170636|P1|Continuation Phase|Lack of Efficacy|5
7825077|NCT00355082|27170634|P3|Continuation Phase|Withdrawal by Subject|0
7825078|NCT00355082|27170635|P2|Continuation Phase|Withdrawal by Subject|0
7825079|NCT00355082|27170636|P1|Continuation Phase|Withdrawal by Subject|4
7825080|NCT00355082|27170634|P3|Continuation Phase|Protocol Violation|1
7825081|NCT00355082|27170635|P2|Continuation Phase|Protocol Violation|0
7825082|NCT00355082|27170636|P1|Continuation Phase|Protocol Violation|1
7825083|NCT00355082|27170634|P3|Continuation Phase|Lost to Follow-up|1
7825084|NCT00355082|27170635|P2|Continuation Phase|Lost to Follow-up|0
7825085|NCT00355082|27170636|P1|Continuation Phase|Lost to Follow-up|2
7825086|NCT00355082|27170634|P3|Continuation Phase|Adverse Event|1
7825087|NCT00355082|27170635|P2|Continuation Phase|Adverse Event|0
7825088|NCT00355082|27170636|P1|Continuation Phase|Adverse Event|2
7825089|NCT00355082|27170634|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
7825090|NCT00355082|27170635|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
7825091|NCT00355082|27170636|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
7825092|NCT00355082|27170634|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
7825093|NCT00355082|27170635|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
7825094|NCT00355082|27170636|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
7825095|NCT00355082|27170634|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
7825096|NCT00355082|27170635|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
7825097|NCT00355082|27170636|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
7825098|NCT00355082|27170634|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
7825099|NCT00355082|27170635|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
7825100|NCT00355082|27170636|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
7825101|NCT00355082|27170634|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
7825102|NCT00355082|27170635|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
7825103|NCT00355082|27170636|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
7825104|NCT00355082|27170634|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
7825105|NCT00355082|27170635|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
7825106|NCT00355082|27170636|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
7825107|NCT00355056|27170658|P2|Randomization Period|Early Termination|6
7825108|NCT00355056|27170659|P1|Randomization Period|Early Termination|4
7825109|NCT00355030|27170689|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
7825110|NCT00355030|27170690|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
7825111|NCT00355030|27170689|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
7825112|NCT00355030|27170690|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
7825113|NCT00355030|27170689|P2|Study Period 1 Treatment|Other|6
7825114|NCT00355030|27170690|P1|Study Period 1 Treatment|Other|2
7825115|NCT00355030|27170689|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
7825116|NCT00355030|27170690|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
7825117|NCT00355030|27170689|P2|Study Period 1 Treatment|Sponsor Decision|32
7825118|NCT00355030|27170690|P1|Study Period 1 Treatment|Sponsor Decision|34
7825119|NCT00355030|27170689|P2|Study Period 1 Treatment|Physician Decision|1
7825120|NCT00355030|27170690|P1|Study Period 1 Treatment|Physician Decision|0
7825121|NCT00355030|27170689|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
7825122|NCT00355030|27170690|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
7825123|NCT00355030|27170689|P2|Study Period 1 Treatment|Withdrawal by Subject|1
7825124|NCT00355030|27170690|P1|Study Period 1 Treatment|Withdrawal by Subject|4
7825125|NCT00355030|27170689|P2|Study Period 1 Treatment|Lost to Follow-up|0
7825126|NCT00355030|27170690|P1|Study Period 1 Treatment|Lost to Follow-up|3
7825127|NCT00355030|27170689|P2|Study Period 1 Treatment|Adverse Event|1
7825128|NCT00355030|27170690|P1|Study Period 1 Treatment|Adverse Event|1
7825129|NCT00354835|27170729|P2|Overall Study|Refusal of further therapy|8
7825130|NCT00354835|27170730|P1|Overall Study|Refusal of further therapy|3
7825131|NCT00354835|27170729|P2|Overall Study|Adverse Event|0
7825132|NCT00354835|27170730|P1|Overall Study|Adverse Event|6
7825133|NCT00354835|27170729|P2|Overall Study|Disease progression or relapse|22
7825134|NCT00354835|27170730|P1|Overall Study|Disease progression or relapse|15
7825135|NCT00354835|27170729|P2|Overall Study|Ineligible|16
7825136|NCT00354835|27170730|P1|Overall Study|Ineligible|17
7825137|NCT00354835|27170729|P2|Overall Study|Withdrawal by Subject|1
7825138|NCT00354835|27170730|P1|Overall Study|Withdrawal by Subject|2
7825139|NCT00354835|27170729|P2|Overall Study|Physician Decision|13
7825140|NCT00354835|27170730|P1|Overall Study|Physician Decision|8
7825141|NCT00354835|27170729|P2|Overall Study|Death|1
7825142|NCT00354835|27170730|P1|Overall Study|Death|1
7825143|NCT00354744|27170769|P1|Overall Study|Withdrawal by Subject|14
7825144|NCT00354744|27170769|P1|Overall Study|Physician Decision|11
7825145|NCT00354744|27170769|P1|Overall Study|Lost to Follow-up|2
7825146|NCT00354744|27170769|P1|Overall Study|Lack of Efficacy|11
7825147|NCT00354744|27170769|P1|Overall Study|Death|2
7825148|NCT00354744|27170769|P1|Overall Study|Adverse Event|2
7825149|NCT00354679|27170775|P1|Overall Study|Patient Not Treated|1
7825150|NCT00354614|27170784|P1|Overall Study|Lack of Efficacy|28
7825151|NCT00354601|27170788|P1|Overall Study|progression|1
7825152|NCT00354601|27170788|P1|Overall Study|Protocol Violation|1
7825153|NCT00354432|27170808|P4|Overall Study|Off/Toxicity|5
7825154|NCT00354432|27170809|P3|Overall Study|Off/Toxicity|5
7825155|NCT00354432|27170810|P2|Overall Study|Off/Toxicity|7
7825156|NCT00354432|27170811|P1|Overall Study|Off/Toxicity|3
7825157|NCT00354432|27170808|P4|Overall Study|Adverse Event|5
7825158|NCT00354432|27170809|P3|Overall Study|Adverse Event|5
7825159|NCT00354432|27170810|P2|Overall Study|Adverse Event|1
7825160|NCT00354432|27170811|P1|Overall Study|Adverse Event|3
7825161|NCT00354341|27170827|P2|Overall Study|Other|2
7825162|NCT00354341|27170828|P1|Overall Study|Other|1
7825163|NCT00354341|27170827|P2|Overall Study|Failure to return|1
7825164|NCT00354341|27170828|P1|Overall Study|Failure to return|0
7825165|NCT00354341|27170827|P2|Overall Study|Refused treatment|2
7825166|NCT00354341|27170828|P1|Overall Study|Refused treatment|1
7825167|NCT00354341|27170827|P2|Overall Study|Death|2
7825168|NCT00354341|27170828|P1|Overall Study|Death|0
7825169|NCT00354341|27170827|P2|Overall Study|Adverse Event|0
7825170|NCT00354341|27170828|P1|Overall Study|Adverse Event|1
7825171|NCT00354172|27170850|P1|Overall Study|Did not receive transplant|1
7825172|NCT00354159|27170870|P2|Long-term Follow-up|Study Closed|34
7825173|NCT00354159|27170871|P1|Long-term Follow-up|Study Closed|29
7825174|NCT00354159|27170870|P2|Long-term Follow-up|Death|11
7825175|NCT00354159|27170871|P1|Long-term Follow-up|Death|14
7825176|NCT00354159|27170870|P2|Long-term Follow-up|Lost to Follow-up|0
7825177|NCT00354159|27170871|P1|Long-term Follow-up|Lost to Follow-up|1
7825178|NCT00354159|27170870|P2|Long-term Follow-up|Physician Decision|122
7825179|NCT00354159|27170871|P1|Long-term Follow-up|Physician Decision|127
7825180|NCT00354159|27170870|P2|Long-term Follow-up|Withdrawal by Subject|9
7825181|NCT00354159|27170871|P1|Long-term Follow-up|Withdrawal by Subject|9
7825182|NCT00354159|27170870|P2|Randomized Study Period|Death|9
7825183|NCT00354159|27170871|P1|Randomized Study Period|Death|7
7825184|NCT00354159|27170870|P2|Randomized Study Period|Lost to Follow-up|0
7825185|NCT00354159|27170871|P1|Randomized Study Period|Lost to Follow-up|4
7825186|NCT00354159|27170870|P2|Randomized Study Period|Physician Decision|10
7825187|NCT00354159|27170871|P1|Randomized Study Period|Physician Decision|6
7825188|NCT00354159|27170870|P2|Randomized Study Period|Withdrawal by Subject|3
7825189|NCT00354159|27170871|P1|Randomized Study Period|Withdrawal by Subject|5
7825190|NCT00354107|27170914|P1|Overall Study|Withdrawal by Subject|1
7825191|NCT00354107|27170914|P1|Overall Study|Physician Decision|2
7825192|NCT00354107|27170914|P1|Overall Study|Adverse Event|2
7825193|NCT00354029|27170924|P2|Overall Study|Protocol Violation|2
7825194|NCT00354029|27170925|P1|Overall Study|Protocol Violation|4
7825195|NCT00353873|27170948|P2|Overall Study|Withdrawal by Subject|1
7825196|NCT00353873|27170949|P1|Overall Study|Withdrawal by Subject|1
7825197|NCT00353873|27170948|P2|Overall Study|Physician Decision|0
7825198|NCT00353873|27170949|P1|Overall Study|Physician Decision|2
7825199|NCT00353873|27170948|P2|Overall Study|Adverse Event|0
7825200|NCT00353873|27170949|P1|Overall Study|Adverse Event|1
7825201|NCT00353873|27170948|P2|Overall Study|Exacerbation|0
7825202|NCT00353873|27170949|P1|Overall Study|Exacerbation|1
7825203|NCT00353873|27170948|P2|Overall Study|Protocol Violation|2
7825204|NCT00353873|27170949|P1|Overall Study|Protocol Violation|1
7825205|NCT00353704|27170978|P2|Overall Study|Protocol Violation|1
7825206|NCT00353704|27170979|P1|Overall Study|Protocol Violation|3
7825207|NCT00353496|27171049|P2|Overall Study|Not otherwise specified|2
7825208|NCT00353496|27171050|P1|Overall Study|Not otherwise specified|4
7825209|NCT00353496|27171049|P2|Overall Study|Physician Decision|9
7825210|NCT00353496|27171050|P1|Overall Study|Physician Decision|6
7825211|NCT00353496|27171049|P2|Overall Study|Withdrawal by Subject|4
7825212|NCT00353496|27171050|P1|Overall Study|Withdrawal by Subject|3
7825213|NCT00353496|27171049|P2|Overall Study|Protocol Violation|2
7825214|NCT00353496|27171050|P1|Overall Study|Protocol Violation|2
7825215|NCT00353496|27171049|P2|Overall Study|Adverse Event|0
7825216|NCT00353496|27171050|P1|Overall Study|Adverse Event|1
7825217|NCT00353366|27171103|P1|Overall Study|Other|19
7825218|NCT00353366|27171103|P1|Overall Study|Lost to Follow-up|92
7825219|NCT00353366|27171103|P1|Overall Study|Withdrawal by Subject|12
7825220|NCT00353366|27171103|P1|Overall Study|Protocol Violation|12
7825221|NCT00353366|27171103|P1|Overall Study|Adverse Event|8
7825222|NCT00353262|27171130|P1|Overall Study|Break from Chemotherapy|1
7825223|NCT00353262|27171130|P1|Overall Study|Surgery|4
7825224|NCT00353262|27171130|P1|Overall Study|Progression|1
7825225|NCT00353262|27171130|P1|Overall Study|Insufficient Therapeutic Response|13
7825226|NCT00353262|27171130|P1|Overall Study|Withdrawal by Subject|2
7825227|NCT00353262|27171130|P1|Overall Study|Adverse Event|8
7825228|NCT00352885|27171171|P2|Overall Study|Side effects of IL-2 administration|0
7825229|NCT00352885|27171172|P1|Overall Study|Side effects of IL-2 administration|1
7825230|NCT00352885|27171171|P2|Overall Study|Progression of metastatic melanoma|3
7825231|NCT00352885|27171172|P1|Overall Study|Progression of metastatic melanoma|5
7825232|NCT00352885|27171171|P2|Overall Study|Development of major depression|1
7825233|NCT00352885|27171172|P1|Overall Study|Development of major depression|0
7825234|NCT00352885|27171171|P2|Overall Study|Withdrawal by Subject|3
7825235|NCT00352885|27171172|P1|Overall Study|Withdrawal by Subject|0
7825236|NCT00352846|27171190|P2|Overall Study|Death|1
7825237|NCT00352846|27171191|P1|Overall Study|Death|0
7825238|NCT00352846|27171190|P2|Overall Study|Non-compliance|0
7825239|NCT00352846|27171191|P1|Overall Study|Non-compliance|2
7825240|NCT00352846|27171190|P2|Overall Study|Ineligible|2
7825241|NCT00352846|27171191|P1|Overall Study|Ineligible|3
7825242|NCT00352846|27171190|P2|Overall Study|Withdrawal by Subject|8
7825243|NCT00352846|27171191|P1|Overall Study|Withdrawal by Subject|3
7825244|NCT00352846|27171190|P2|Overall Study|Disease progression|2
7825245|NCT00352846|27171191|P1|Overall Study|Disease progression|0
7825246|NCT00352755|27171206|P1|Overall Study|Adverse Event|1
7825247|NCT00352755|27171206|P1|Overall Study|Physician Decision|1
7825248|NCT00352690|27171216|P2|Overall Study|Determined to be ineligible|0
7825249|NCT00352690|27171217|P1|Overall Study|Determined to be ineligible|2
7825250|NCT00352664|27171237|P2|Overall Study|Withdrawal by Subject|0
7825251|NCT00352664|27171238|P1|Overall Study|Withdrawal by Subject|7
7825252|NCT00352534|27171255|P7|Final Risk Group Assignment|Death|0
7825253|NCT00352534|27171256|P6|Final Risk Group Assignment|Death|2
7825254|NCT00352534|27171257|P5|Final Risk Group Assignment|Death|0
7825255|NCT00352534|27171258|P4|Final Risk Group Assignment|Death|0
7825256|NCT00352534|27171259|P3|Final Risk Group Assignment|Death|0
7825257|NCT00352534|27171260|P2|Final Risk Group Assignment|Death|0
7825258|NCT00352534|27171261|P1|Final Risk Group Assignment|Death|0
7825259|NCT00352534|27171255|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
7825260|NCT00352534|27171256|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7825261|NCT00352534|27171257|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7825262|NCT00352534|27171258|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7825263|NCT00352534|27171259|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7825264|NCT00352534|27171260|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7825265|NCT00352534|27171261|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7825266|NCT00352534|27171255|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
7825267|NCT00352534|27171256|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
7825268|NCT00352534|27171257|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
7825269|NCT00352534|27171258|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
7825270|NCT00352534|27171259|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
7825271|NCT00352534|27171260|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
7825272|NCT00352534|27171261|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
7825273|NCT00352534|27171255|P7|Final Risk Group Assignment|Ineligible|0
7825274|NCT00352534|27171256|P6|Final Risk Group Assignment|Ineligible|13
7825275|NCT00352534|27171257|P5|Final Risk Group Assignment|Ineligible|0
7825276|NCT00352534|27171258|P4|Final Risk Group Assignment|Ineligible|1
7825277|NCT00352534|27171259|P3|Final Risk Group Assignment|Ineligible|3
7825278|NCT00352534|27171260|P2|Final Risk Group Assignment|Ineligible|0
7825279|NCT00352534|27171261|P1|Final Risk Group Assignment|Ineligible|0
7825280|NCT00352534|27171255|P7|Final Risk Group Assignment|Withdrawal by Subject|0
7825281|NCT00352534|27171256|P6|Final Risk Group Assignment|Withdrawal by Subject|3
7825282|NCT00352534|27171257|P5|Final Risk Group Assignment|Withdrawal by Subject|0
7825283|NCT00352534|27171258|P4|Final Risk Group Assignment|Withdrawal by Subject|0
7825284|NCT00352534|27171259|P3|Final Risk Group Assignment|Withdrawal by Subject|0
7825285|NCT00352534|27171260|P2|Final Risk Group Assignment|Withdrawal by Subject|0
7825286|NCT00352534|27171261|P1|Final Risk Group Assignment|Withdrawal by Subject|0
7825287|NCT00352534|27171255|P7|Final Risk Group Assignment|Physician Decision|0
7825288|NCT00352534|27171256|P6|Final Risk Group Assignment|Physician Decision|8
7825289|NCT00352534|27171257|P5|Final Risk Group Assignment|Physician Decision|0
7825290|NCT00352534|27171258|P4|Final Risk Group Assignment|Physician Decision|0
7825291|NCT00352534|27171259|P3|Final Risk Group Assignment|Physician Decision|0
7825292|NCT00352534|27171260|P2|Final Risk Group Assignment|Physician Decision|0
7825293|NCT00352534|27171261|P1|Final Risk Group Assignment|Physician Decision|0
7825294|NCT00352534|27171255|P7|Final Risk Group Assignment|Lack of Efficacy|0
7825295|NCT00352534|27171256|P6|Final Risk Group Assignment|Lack of Efficacy|19
7825296|NCT00352534|27171257|P5|Final Risk Group Assignment|Lack of Efficacy|1
7825297|NCT00352534|27171258|P4|Final Risk Group Assignment|Lack of Efficacy|2
7825298|NCT00352534|27171259|P3|Final Risk Group Assignment|Lack of Efficacy|0
7825299|NCT00352534|27171260|P2|Final Risk Group Assignment|Lack of Efficacy|0
7825300|NCT00352534|27171261|P1|Final Risk Group Assignment|Lack of Efficacy|0
7825301|NCT00352534|27171255|P7|Initial Staging|Ineligible|0
7825302|NCT00352534|27171256|P6|Initial Staging|Ineligible|0
7825303|NCT00352534|27171257|P5|Initial Staging|Ineligible|0
7825304|NCT00352534|27171258|P4|Initial Staging|Ineligible|0
7825305|NCT00352534|27171259|P3|Initial Staging|Ineligible|0
7825306|NCT00352534|27171260|P2|Initial Staging|Ineligible|9
7825307|NCT00352534|27171261|P1|Initial Staging|Ineligible|8
7825308|NCT00352417|27171278|P2|Overall Study|Schedule Change|1
7825309|NCT00352417|27171279|P1|Overall Study|Schedule Change|2
7825310|NCT00352417|27171278|P2|Overall Study|Lost to Follow-up|0
7825311|NCT00352417|27171279|P1|Overall Study|Lost to Follow-up|1
7825312|NCT00352417|27171278|P2|Overall Study|Withdrawal by Subject|2
7825313|NCT00352417|27171279|P1|Overall Study|Withdrawal by Subject|1
7825314|NCT00352417|27171278|P2|Overall Study|Protocol Violation|2
7825315|NCT00352417|27171279|P1|Overall Study|Protocol Violation|0
7825316|NCT00352417|27171278|P2|Overall Study|Adverse Event|0
7825317|NCT00352417|27171279|P1|Overall Study|Adverse Event|1
7825318|NCT00352365|27171293|P1|Maintenance Therapy|Not eligible|4
7825319|NCT00352365|27171293|P1|Maintenance Therapy|Not protocol specified|3
7825320|NCT00352365|27171293|P1|Maintenance Therapy|Death|2
7825321|NCT00352365|27171293|P1|Maintenance Therapy|Progression/Relapse|3
7825322|NCT00352365|27171293|P1|Induction Therapy|Death before starting protocol therapy|1
7825323|NCT00352365|27171293|P1|Induction Therapy|Not eligible|3
7825324|NCT00352365|27171293|P1|Induction Therapy|Not protocol specified|1
7825325|NCT00352365|27171293|P1|Induction Therapy|Death|7
7825326|NCT00352365|27171293|P1|Induction Therapy|Progression/Relapse|8
7825327|NCT00352365|27171293|P1|Induction Therapy|Adverse Event|7
7825328|NCT00352118|27171303|P1|Overall Study|Physician Decision|4
7825329|NCT00352105|27171313|P1|Overall Study|Protocol Violation|2
7825330|NCT00352105|27171313|P1|Overall Study|Adverse Event|19
7825331|NCT00352105|27171313|P1|Overall Study|Lack of Efficacy|9
7825332|NCT00352105|27171313|P1|Overall Study|Withdrawal by Subject|5
7825333|NCT00352105|27171313|P1|Overall Study|Death|5
7825334|NCT00352053|27171324|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
7825335|NCT00352053|27171325|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
7825336|NCT00352053|27171324|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
7825337|NCT00352053|27171325|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
7825338|NCT00352053|27171324|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
7825339|NCT00352053|27171325|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
7825340|NCT00352053|27171324|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
7825341|NCT00352053|27171325|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
7825342|NCT00352053|27171324|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
7825343|NCT00352053|27171325|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
7825344|NCT00352053|27171324|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
7825345|NCT00352053|27171325|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
7825346|NCT00352053|27171324|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
7825347|NCT00352053|27171325|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
7825348|NCT00352053|27171324|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
7825349|NCT00352053|27171325|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
7825350|NCT00352053|27171324|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
7825351|NCT00352053|27171325|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
7825352|NCT00352053|27171324|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
7825353|NCT00352053|27171325|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
7825354|NCT00352053|27171324|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
7825355|NCT00352053|27171325|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
7825356|NCT00352053|27171324|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
7825357|NCT00352053|27171325|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
7825358|NCT00352053|27171324|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
7825359|NCT00352053|27171325|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
7825360|NCT00352027|27171492|P1|Overall Study|Progressive disease|3
7825361|NCT00351819|27171791|P2|Overall Study|Enrolled in another trial|1
7825362|NCT00351819|27171792|P1|Overall Study|Enrolled in another trial|0
7825363|NCT00351819|27171791|P2|Overall Study|Incarcerated|1
7825364|NCT00351819|27171792|P1|Overall Study|Incarcerated|0
7825365|NCT00351819|27171791|P2|Overall Study|Non-compliance|1
7825366|NCT00351819|27171792|P1|Overall Study|Non-compliance|0
7825367|NCT00351819|27171791|P2|Overall Study|Unprofessional behavior|0
7825368|NCT00351819|27171792|P1|Overall Study|Unprofessional behavior|1
7825369|NCT00351819|27171791|P2|Overall Study|Traumatic ankle fracture|0
7825370|NCT00351819|27171792|P1|Overall Study|Traumatic ankle fracture|1
7825371|NCT00351819|27171791|P2|Overall Study|Elevated PSA|1
7825372|NCT00351819|27171792|P1|Overall Study|Elevated PSA|1
7825373|NCT00351819|27171791|P2|Overall Study|Withdrawal by Subject|4
7825374|NCT00351819|27171792|P1|Overall Study|Withdrawal by Subject|0
7825375|NCT00351819|27171791|P2|Overall Study|Lost to Follow-up|4
7825376|NCT00351819|27171792|P1|Overall Study|Lost to Follow-up|4
7825377|NCT00351611|27171863|P2|Overall Study|Protocol Violation|2
7825378|NCT00351611|27171864|P1|Overall Study|Protocol Violation|0
7825379|NCT00351611|27171863|P2|Overall Study|Other|0
7825380|NCT00351611|27171864|P1|Overall Study|Other|1
7825381|NCT00351611|27171863|P2|Overall Study|No Longer Willing to Participate in Study|5
7825382|NCT00351611|27171864|P1|Overall Study|No Longer Willing to Participate in Study|0
7825383|NCT00351611|27171863|P2|Overall Study|Lost to Follow-up|0
7825384|NCT00351611|27171864|P1|Overall Study|Lost to Follow-up|1
7825385|NCT00351611|27171863|P2|Overall Study|Death|0
7825386|NCT00351611|27171864|P1|Overall Study|Death|1
7825387|NCT00351611|27171863|P2|Overall Study|Adverse Event|3
7825388|NCT00351611|27171864|P1|Overall Study|Adverse Event|11
7825389|NCT00351533|27171876|P2|Overall Study|Withdrawal by Subject|1
7825390|NCT00351533|27171877|P1|Overall Study|Withdrawal by Subject|0
7825391|NCT00351533|27171876|P2|Overall Study|Physician Decision|1
7825392|NCT00351533|27171877|P1|Overall Study|Physician Decision|0
7825393|NCT00351533|27171876|P2|Overall Study|Lost to Follow-up|3
7825394|NCT00351533|27171877|P1|Overall Study|Lost to Follow-up|1
7825395|NCT00351533|27171876|P2|Overall Study|Extubated before first BAL|0
7825396|NCT00351533|27171877|P1|Overall Study|Extubated before first BAL|1
7825397|NCT00351468|27171937|P1|Overall Study|Protocol Violation|3
7825398|NCT00351468|27171937|P1|Overall Study|Lost to Follow-up|4
7825399|NCT00351468|27171937|P1|Overall Study|Non-compliance|8
7825400|NCT00351468|27171937|P1|Overall Study|Lack of Efficacy|32
7825401|NCT00351468|27171937|P1|Overall Study|Various -follow up w clinical team|39
7825402|NCT00351468|27171937|P1|Overall Study|Withdrawal by Subject|39
7825403|NCT00351468|27171937|P1|Overall Study|Adverse Event|42
7825404|NCT00351377|27171961|P1|Overall Study|Unsatisfactory therapeutic effect|1
7825405|NCT00351377|27171961|P1|Overall Study|Death|1
7825406|NCT00351377|27171961|P1|Overall Study|Adverse Event|5
7825407|NCT00351351|27171975|P2|Overall Study|surgical access pbs; device issues|4
7825408|NCT00351351|27171976|P1|Overall Study|surgical access pbs; device issues|9
7825409|NCT00351273|27172002|P3|Overall Study|Lost to Follow-up|5
7825410|NCT00351273|27172003|P2|Overall Study|Lost to Follow-up|2
7825411|NCT00351273|27172004|P1|Overall Study|Lost to Follow-up|1
7825412|NCT00350870|27172047|P4|Overall Study|Physician Decision|1
7825413|NCT00350870|27172048|P3|Overall Study|Physician Decision|1
7825414|NCT00350870|27172049|P2|Overall Study|Physician Decision|0
7825415|NCT00350870|27172050|P1|Overall Study|Physician Decision|1
7825416|NCT00350870|27172047|P4|Overall Study|Withdrawal by Subject|14
7825417|NCT00350870|27172048|P3|Overall Study|Withdrawal by Subject|15
7825418|NCT00350870|27172049|P2|Overall Study|Withdrawal by Subject|17
7825419|NCT00350870|27172050|P1|Overall Study|Withdrawal by Subject|21
7825420|NCT00350844|27172064|P1|Overall Study|Lost to Follow-up|1
7825421|NCT00350792|27172068|P1|Overall Study|Lack of Efficacy|11
7825422|NCT00350792|27172068|P1|Overall Study|Physician Decision|2
7825423|NCT00350792|27172068|P1|Overall Study|Withdrawal by Subject|4
7825424|NCT00350792|27172068|P1|Overall Study|Protocol Violation|1
7825425|NCT00350792|27172068|P1|Overall Study|Death Not Study Drug Related|2
7825426|NCT00350792|27172068|P1|Overall Study|Death from Study Drug Toxicity|1
7825427|NCT00350792|27172068|P1|Overall Study|Death from Study Disease|1
7825428|NCT00350792|27172068|P1|Overall Study|Adverse Event|11
7825429|NCT00350779|27172078|P2|Overall Study|Non-compliance with study procedures|1
7825430|NCT00350779|27172079|P1|Overall Study|Non-compliance with study procedures|0
7825431|NCT00350779|27172078|P2|Overall Study|Patient Moved|1
7825432|NCT00350779|27172079|P1|Overall Study|Patient Moved|2
7825433|NCT00350779|27172078|P2|Overall Study|Withdrawal by Subject|8
7825434|NCT00350779|27172079|P1|Overall Study|Withdrawal by Subject|9
7825435|NCT00350779|27172078|P2|Overall Study|Protocol Violation|1
7825436|NCT00350779|27172079|P1|Overall Study|Protocol Violation|3
7825437|NCT00350779|27172078|P2|Overall Study|Physician Decision|4
7825438|NCT00350779|27172079|P1|Overall Study|Physician Decision|2
7825439|NCT00350779|27172078|P2|Overall Study|Lost to Follow-up|0
7825440|NCT00350779|27172079|P1|Overall Study|Lost to Follow-up|2
7825441|NCT00350779|27172078|P2|Overall Study|Lack of Efficacy|4
7825442|NCT00350779|27172079|P1|Overall Study|Lack of Efficacy|0
7825443|NCT00350779|27172078|P2|Overall Study|Adverse Event|2
7825444|NCT00350779|27172079|P1|Overall Study|Adverse Event|4
7825445|NCT00350727|27172100|P3|Phase II|Enrolled in Rollover Study|1
7825446|NCT00350727|27172101|P2|Phase II|Enrolled in Rollover Study|0
7825447|NCT00350727|27172102|P1|Phase II|Enrolled in Rollover Study|0
7825448|NCT00350727|27172100|P3|Phase II|Sponsor Terminated Study|1
7825449|NCT00350727|27172101|P2|Phase II|Sponsor Terminated Study|0
7825450|NCT00350727|27172102|P1|Phase II|Sponsor Terminated Study|0
7825451|NCT00350727|27172100|P3|Phase II|Death|2
7825452|NCT00350727|27172101|P2|Phase II|Death|0
7825453|NCT00350727|27172102|P1|Phase II|Death|0
7825454|NCT00350727|27172100|P3|Phase II|Adverse Event|1
7825455|NCT00350727|27172101|P2|Phase II|Adverse Event|1
7825456|NCT00350727|27172102|P1|Phase II|Adverse Event|0
7825457|NCT00350727|27172100|P3|Phase II|Withdrawal by Subject|1
7825458|NCT00350727|27172101|P2|Phase II|Withdrawal by Subject|2
7825459|NCT00350727|27172102|P1|Phase II|Withdrawal by Subject|0
7825460|NCT00350727|27172100|P3|Phase II|Clinical Deterioration|0
7825461|NCT00350727|27172101|P2|Phase II|Clinical Deterioration|1
7825462|NCT00350727|27172102|P1|Phase II|Clinical Deterioration|0
7825463|NCT00350727|27172100|P3|Phase II|Disease Progression|16
7825464|NCT00350727|27172101|P2|Phase II|Disease Progression|15
7825465|NCT00350727|27172102|P1|Phase II|Disease Progression|0
7825466|NCT00350727|27172100|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
7825467|NCT00350727|27172101|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
7825468|NCT00350727|27172102|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
7825469|NCT00350727|27172100|P3|Phase I: Dose Escalation|Physician Decision|0
7825470|NCT00350727|27172101|P2|Phase I: Dose Escalation|Physician Decision|0
7825471|NCT00350727|27172102|P1|Phase I: Dose Escalation|Physician Decision|1
7825472|NCT00350727|27172100|P3|Phase I: Dose Escalation|Death|0
7825473|NCT00350727|27172101|P2|Phase I: Dose Escalation|Death|0
7825474|NCT00350727|27172102|P1|Phase I: Dose Escalation|Death|1
7825475|NCT00350727|27172100|P3|Phase I: Dose Escalation|Lack of Efficacy|0
7825476|NCT00350727|27172101|P2|Phase I: Dose Escalation|Lack of Efficacy|0
7825477|NCT00350727|27172102|P1|Phase I: Dose Escalation|Lack of Efficacy|25
7825478|NCT00350727|27172100|P3|Phase I: Dose Escalation|Adverse Event|0
7825479|NCT00350727|27172101|P2|Phase I: Dose Escalation|Adverse Event|0
7825480|NCT00350727|27172102|P1|Phase I: Dose Escalation|Adverse Event|4
7825481|NCT00350636|27172246|P2|Overall Study|Other|2
7825482|NCT00350636|27172247|P1|Overall Study|Other|1
7825483|NCT00350636|27172246|P2|Overall Study|Physician Decision|2
7825484|NCT00350636|27172247|P1|Overall Study|Physician Decision|0
7825485|NCT00350636|27172246|P2|Overall Study|Lost to Follow-up|8
7825486|NCT00350636|27172247|P1|Overall Study|Lost to Follow-up|9
7825487|NCT00350636|27172246|P2|Overall Study|Withdrawal by Subject|17
7825488|NCT00350636|27172247|P1|Overall Study|Withdrawal by Subject|13
7825489|NCT00350636|27172246|P2|Overall Study|Protocol Violation|3
7825490|NCT00350636|27172247|P1|Overall Study|Protocol Violation|1
7825491|NCT00350636|27172246|P2|Overall Study|Adverse Event|13
7825492|NCT00350636|27172247|P1|Overall Study|Adverse Event|19
7825493|NCT00350623|27172266|P3|Overall Study|patient traveling outside the country|1
7825494|NCT00350623|27172267|P2|Overall Study|patient traveling outside the country|0
7825495|NCT00350623|27172268|P1|Overall Study|patient traveling outside the country|0
7825496|NCT00350623|27172266|P3|Overall Study|Withdrawal by Subject|1
7825497|NCT00350623|27172267|P2|Overall Study|Withdrawal by Subject|1
7825498|NCT00350623|27172268|P1|Overall Study|Withdrawal by Subject|0
7825499|NCT00350623|27172266|P3|Overall Study|Lost to Follow-up|4
7825500|NCT00350623|27172267|P2|Overall Study|Lost to Follow-up|3
7825501|NCT00350623|27172268|P1|Overall Study|Lost to Follow-up|8
7825502|NCT00350545|27172276|P1|Overall Study|Withdrawal by Subject|2
7825503|NCT00350519|27172295|P2|Overall Study|Withdrawal by Subject|2
7825504|NCT00350519|27172296|P1|Overall Study|Withdrawal by Subject|3
7825505|NCT00350519|27172295|P2|Overall Study|Protocol Violation|2
7825506|NCT00350519|27172296|P1|Overall Study|Protocol Violation|1
7825507|NCT00350519|27172295|P2|Overall Study|Physician Decision|1
7825508|NCT00350519|27172296|P1|Overall Study|Physician Decision|0
7825509|NCT00350519|27172295|P2|Overall Study|Death|1
7825510|NCT00350519|27172296|P1|Overall Study|Death|0
7825511|NCT00350402|27172310|P2|Overall Study|Lost to Follow-up|1
7825512|NCT00350402|27172311|P1|Overall Study|Lost to Follow-up|1
7825513|NCT00350298|27172384|P2|Overall Study|Withdrawal by Subject|3
7825514|NCT00350298|27172385|P1|Overall Study|Withdrawal by Subject|1
7825515|NCT00350298|27172384|P2|Overall Study|Lost to Follow-up|2
7825516|NCT00350298|27172385|P1|Overall Study|Lost to Follow-up|1
7825517|NCT00350298|27172384|P2|Overall Study|Death|8
7825518|NCT00350298|27172385|P1|Overall Study|Death|7
7825519|NCT00350272|27172403|P2|Open-Label 84 Week Treatment|Sponsor decision|1
7825520|NCT00350272|27172404|P1|Open-Label 84 Week Treatment|Sponsor decision|2
7825521|NCT00350272|27172403|P2|Open-Label 84 Week Treatment|Physician Decision|2
7825522|NCT00350272|27172404|P1|Open-Label 84 Week Treatment|Physician Decision|1
7825523|NCT00350272|27172403|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
7825524|NCT00350272|27172404|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
7825525|NCT00350272|27172403|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
7825526|NCT00350272|27172404|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
7825527|NCT00350272|27172403|P2|Open-Label 84 Week Treatment|Adverse Event|1
7825528|NCT00350272|27172404|P1|Open-Label 84 Week Treatment|Adverse Event|2
7825529|NCT00350272|27172403|P2|Blinded 12 Week Treatment|Sponsor decision|1
7825530|NCT00350272|27172404|P1|Blinded 12 Week Treatment|Sponsor decision|0
7825531|NCT00350272|27172403|P2|Blinded 12 Week Treatment|Physician Decision|1
7825532|NCT00350272|27172404|P1|Blinded 12 Week Treatment|Physician Decision|2
7825533|NCT00350272|27172403|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
7825534|NCT00350272|27172404|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
7825535|NCT00350272|27172403|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
7825536|NCT00350272|27172404|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
7825537|NCT00350272|27172403|P2|Blinded 12 Week Treatment|Death|0
7825538|NCT00350272|27172404|P1|Blinded 12 Week Treatment|Death|1
7825539|NCT00350272|27172403|P2|Blinded 12 Week Treatment|Adverse Event|0
7825540|NCT00350272|27172404|P1|Blinded 12 Week Treatment|Adverse Event|1
7825541|NCT00350207|27172426|P3|Overall Study|Other|1
7825542|NCT00350207|27172427|P2|Overall Study|Other|3
7825543|NCT00350207|27172428|P1|Overall Study|Other|1
7825544|NCT00350207|27172426|P3|Overall Study|Withdrawal by Subject|1
7825545|NCT00350207|27172427|P2|Overall Study|Withdrawal by Subject|1
7825546|NCT00350207|27172428|P1|Overall Study|Withdrawal by Subject|0
7825547|NCT00350207|27172426|P3|Overall Study|Lost to Follow-up|1
7825548|NCT00350207|27172427|P2|Overall Study|Lost to Follow-up|0
7825549|NCT00350207|27172428|P1|Overall Study|Lost to Follow-up|1
7825550|NCT00350207|27172426|P3|Overall Study|Lack of Efficacy|2
7825551|NCT00350207|27172427|P2|Overall Study|Lack of Efficacy|0
7825552|NCT00350207|27172428|P1|Overall Study|Lack of Efficacy|1
7825553|NCT00350207|27172426|P3|Overall Study|Adverse Event|2
7825554|NCT00350207|27172427|P2|Overall Study|Adverse Event|2
7825555|NCT00350207|27172428|P1|Overall Study|Adverse Event|5
7825556|NCT00349973|27172640|P2|Overall Study|Withdrawal by Subject|0
7825557|NCT00349973|27172641|P1|Overall Study|Withdrawal by Subject|1
7825558|NCT00349973|27172640|P2|Overall Study|Adverse Event|3
7825559|NCT00349973|27172641|P1|Overall Study|Adverse Event|3
7825560|NCT00349921|27172655|P4|First Spinal Injection|Adverse Event|0
7825561|NCT00349921|27172656|P3|First Spinal Injection|Adverse Event|1
7825562|NCT00349921|27172657|P2|First Spinal Injection|Adverse Event|0
7825563|NCT00349921|27172658|P1|First Spinal Injection|Adverse Event|0
7825564|NCT00349921|27172655|P4|First Spinal Injection|Physician Decision|0
7825565|NCT00349921|27172656|P3|First Spinal Injection|Physician Decision|0
7825566|NCT00349921|27172657|P2|First Spinal Injection|Physician Decision|0
7825567|NCT00349921|27172658|P1|First Spinal Injection|Physician Decision|1
7825568|NCT00349908|27172669|P2|Overall Study|Withdrawal by Subject|4
7825569|NCT00349908|27172670|P1|Overall Study|Withdrawal by Subject|0
7825570|NCT00349752|27172696|P2|Overall Study|Other:History of squamous cell carcinoma|0
7825571|NCT00349752|27172697|P1|Overall Study|Other:History of squamous cell carcinoma|1
7825572|NCT00349752|27172696|P2|Overall Study|Other: Inadvertently unblinded|0
7825573|NCT00349752|27172697|P1|Overall Study|Other: Inadvertently unblinded|1
7825574|NCT00349752|27172696|P2|Overall Study|Other: Ineligible|0
7825575|NCT00349752|27172697|P1|Overall Study|Other: Ineligible|1
7825576|NCT00349752|27172696|P2|Overall Study|Other: Patient's steroid use|0
7825577|NCT00349752|27172697|P1|Overall Study|Other: Patient's steroid use|1
7825578|NCT00349752|27172696|P2|Overall Study|Other: Patient stopped steroids|1
7825579|NCT00349752|27172697|P1|Overall Study|Other: Patient stopped steroids|0
7825580|NCT00349752|27172696|P2|Overall Study|Other: Non compliance|1
7825581|NCT00349752|27172697|P1|Overall Study|Other: Non compliance|0
7825582|NCT00349752|27172696|P2|Overall Study|Other: Required exclusionary medication|1
7825583|NCT00349752|27172697|P1|Overall Study|Other: Required exclusionary medication|0
7825584|NCT00349752|27172696|P2|Overall Study|Personal reasons|5
7825585|NCT00349752|27172697|P1|Overall Study|Personal reasons|6
7825586|NCT00349752|27172696|P2|Overall Study|Lost to Follow-up|2
7825587|NCT00349752|27172697|P1|Overall Study|Lost to Follow-up|4
7825588|NCT00349752|27172696|P2|Overall Study|Lack of Efficacy|42
7825589|NCT00349752|27172697|P1|Overall Study|Lack of Efficacy|37
7825590|NCT00349752|27172696|P2|Overall Study|Adverse Event|12
7825591|NCT00349752|27172697|P1|Overall Study|Adverse Event|8
7825592|NCT00349622|27172750|P2|Overall Study|Withdrawal by Subject|9
7825593|NCT00349622|27172751|P1|Overall Study|Withdrawal by Subject|5
7825594|NCT00349622|27172750|P2|Overall Study|Lost to Follow-up|1
7825595|NCT00349622|27172751|P1|Overall Study|Lost to Follow-up|5
7825596|NCT00349622|27172750|P2|Overall Study|Death|86
7825597|NCT00349622|27172751|P1|Overall Study|Death|168
7825598|NCT00349349|27172790|P3|Overall Study|New Malignancy (Bladder Cancer)|0
7825599|NCT00349349|27172791|P2|Overall Study|New Malignancy (Bladder Cancer)|1
7825600|NCT00349349|27172792|P1|Overall Study|New Malignancy (Bladder Cancer)|0
7825601|NCT00349349|27172790|P3|Overall Study|No Response|0
7825602|NCT00349349|27172791|P2|Overall Study|No Response|3
7825603|NCT00349349|27172792|P1|Overall Study|No Response|0
7825604|NCT00349349|27172790|P3|Overall Study|Physician Decision|1
7825605|NCT00349349|27172791|P2|Overall Study|Physician Decision|2
7825606|NCT00349349|27172792|P1|Overall Study|Physician Decision|1
7825607|NCT00349349|27172790|P3|Overall Study|Participant Reduced General Condition|0
7825608|NCT00349349|27172791|P2|Overall Study|Participant Reduced General Condition|1
7825609|NCT00349349|27172792|P1|Overall Study|Participant Reduced General Condition|0
7825610|NCT00349349|27172790|P3|Overall Study|Other Treatment Selected|0
7825611|NCT00349349|27172791|P2|Overall Study|Other Treatment Selected|0
7825612|NCT00349349|27172792|P1|Overall Study|Other Treatment Selected|2
7825613|NCT00349349|27172790|P3|Overall Study|Death|1
7825614|NCT00349349|27172791|P2|Overall Study|Death|10
7825615|NCT00349349|27172792|P1|Overall Study|Death|13
7825616|NCT00349349|27172790|P3|Overall Study|Withdrawn due to Disease Progression|1
7825617|NCT00349349|27172791|P2|Overall Study|Withdrawn due to Disease Progression|37
7825618|NCT00349349|27172792|P1|Overall Study|Withdrawn due to Disease Progression|27
7825619|NCT00349349|27172790|P3|Overall Study|Withdrawal by Subject|1
7825620|NCT00349349|27172791|P2|Overall Study|Withdrawal by Subject|2
7825621|NCT00349349|27172792|P1|Overall Study|Withdrawal by Subject|5
7825622|NCT00349349|27172790|P3|Overall Study|Adverse Event|2
7825623|NCT00349349|27172791|P2|Overall Study|Adverse Event|6
7825624|NCT00349349|27172792|P1|Overall Study|Adverse Event|5
7825625|NCT00348933|27172898|P1|Overall Study|Adverse Event|7
7825626|NCT00348933|27172898|P1|Overall Study|Protocol Violation|2
7825627|NCT00348933|27172898|P1|Overall Study|Lost to Follow-up|6
7825628|NCT00348933|27172898|P1|Overall Study|Withdrawal by Subject|10
7825629|NCT00348881|27172906|P2|Overall Study|Serious Adverse Event|2
7825630|NCT00348881|27172907|P1|Overall Study|Serious Adverse Event|0
7825631|NCT00348881|27172906|P2|Overall Study|Adverse Event|0
7825632|NCT00348881|27172907|P1|Overall Study|Adverse Event|2
7825633|NCT00348881|27172906|P2|Overall Study|Withdrawal by Subject|4
7825634|NCT00348881|27172907|P1|Overall Study|Withdrawal by Subject|3
7825635|NCT00348881|27172906|P2|Overall Study|Lost to Follow-up|6
7825636|NCT00348881|27172907|P1|Overall Study|Lost to Follow-up|12
7825637|NCT00348816|27172919|P1|Overall Study|Noncompliance with radiation treatment|1
7825638|NCT00348790|27172926|P1|Completed Treatment|Unable to travel to study site|1
7825639|NCT00348790|27172926|P1|Completed Treatment|Required surgery|2
7825640|NCT00348790|27172926|P1|Completed Treatment|Adverse Event|4
7825641|NCT00348790|27172926|P1|Completed Treatment|Disease progression|14
7825642|NCT00348790|27172926|P1|Completed Treatment|Withdrawal by Subject|4
7825643|NCT00348686|27172938|P1|Overall Study|Multiple Reasons|8
7825644|NCT00348686|27172938|P1|Overall Study|Lost to Follow-up|2
7825645|NCT00348686|27172938|P1|Overall Study|Protocol Violation|6
7825646|NCT00348686|27172938|P1|Overall Study|Adverse Event|5
7825647|NCT00348686|27172938|P1|Overall Study|Withdrawal by Subject|45
7825648|NCT00348673|27172955|P9|Stage 1|Randomized but not Treated|0
7825649|NCT00348673|27172956|P8|Stage 1|Randomized but not Treated|0
7825650|NCT00348673|27172957|P7|Stage 1|Randomized but not Treated|0
7825651|NCT00348673|27172958|P6|Stage 1|Randomized but not Treated|0
7825652|NCT00348673|27172959|P5|Stage 1|Randomized but not Treated|0
7825653|NCT00348673|27172960|P4|Stage 1|Randomized but not Treated|0
7825654|NCT00348673|27172961|P3|Stage 1|Randomized but not Treated|1
7825655|NCT00348673|27172962|P2|Stage 1|Randomized but not Treated|0
7825656|NCT00348673|27172963|P1|Stage 1|Randomized but not Treated|0
7825657|NCT00348595|27173012|P2|Overall Study|Adverse Event|8
7825658|NCT00348595|27173013|P1|Overall Study|Adverse Event|5
7825659|NCT00348556|27173025|P1|Overall Study|Adverse Event|1
7825660|NCT00348374|27173032|P2|Overall Study|randomized but did not receive treatment|7
7825661|NCT00348374|27173033|P1|Overall Study|randomized but did not receive treatment|0
7825662|NCT00348374|27173032|P2|Overall Study|ongoing at date of cutoff|1
7825663|NCT00348374|27173033|P1|Overall Study|ongoing at date of cutoff|1
7825664|NCT00348374|27173032|P2|Overall Study|Other|12
7825665|NCT00348374|27173033|P1|Overall Study|Other|11
7825666|NCT00348374|27173032|P2|Overall Study|Withdrawal by Subject|5
7825667|NCT00348374|27173033|P1|Overall Study|Withdrawal by Subject|5
7825668|NCT00348374|27173032|P2|Overall Study|Lost to Follow-up|3
7825669|NCT00348374|27173033|P1|Overall Study|Lost to Follow-up|1
7825670|NCT00348374|27173032|P2|Overall Study|Adverse Event|4
7825671|NCT00348374|27173033|P1|Overall Study|Adverse Event|1
7825672|NCT00348348|27173080|P2|Overall Study|Adverse event probably related to study|0
7825673|NCT00348348|27173081|P1|Overall Study|Adverse event probably related to study|1
7825674|NCT00348348|27173080|P2|Overall Study|Worsening of BC - Unlikely related|2
7825675|NCT00348348|27173081|P1|Overall Study|Worsening of BC - Unlikely related|1
7825676|NCT00348348|27173080|P2|Overall Study|Worsening of BC - Unrelated to study|3
7825677|NCT00348348|27173081|P1|Overall Study|Worsening of BC - Unrelated to study|0
7825678|NCT00348348|27173080|P2|Overall Study|Dissallowed Meds - possibly releated|1
7825679|NCT00348348|27173081|P1|Overall Study|Dissallowed Meds - possibly releated|1
7825680|NCT00348348|27173080|P2|Overall Study|Dissallowed Meds - unlikley related|1
7825681|NCT00348348|27173081|P1|Overall Study|Dissallowed Meds - unlikley related|1
7825682|NCT00348348|27173080|P2|Overall Study|Dissallowed Meds - unrelated to study|3
7825683|NCT00348348|27173081|P1|Overall Study|Dissallowed Meds - unrelated to study|1
7825684|NCT00348348|27173080|P2|Overall Study|Other|4
7825685|NCT00348348|27173081|P1|Overall Study|Other|7
7825686|NCT00348348|27173080|P2|Overall Study|Withdrawal by Subject|1
7825687|NCT00348348|27173081|P1|Overall Study|Withdrawal by Subject|4
7825688|NCT00348348|27173080|P2|Overall Study|Lost to Follow-up|10
7825689|NCT00348348|27173081|P1|Overall Study|Lost to Follow-up|8
7825690|NCT00348348|27173080|P2|Overall Study|Lack of Efficacy|1
7825691|NCT00348348|27173081|P1|Overall Study|Lack of Efficacy|1
7825692|NCT00348348|27173080|P2|Overall Study|Adverse event - unrelated to study drug|1
7825693|NCT00348348|27173081|P1|Overall Study|Adverse event - unrelated to study drug|0
7825694|NCT00348309|27173096|P3|Overall Study|HCV career|1
7825695|NCT00348309|27173097|P2|Overall Study|HCV career|0
7825696|NCT00348309|27173098|P1|Overall Study|HCV career|0
7825697|NCT00348309|27173096|P3|Overall Study|Cardiologist recommendations|1
7825698|NCT00348309|27173097|P2|Overall Study|Cardiologist recommendations|0
7825699|NCT00348309|27173098|P1|Overall Study|Cardiologist recommendations|0
7825700|NCT00348309|27173096|P3|Overall Study|ECG abnormal|2
7825701|NCT00348309|27173097|P2|Overall Study|ECG abnormal|0
7825702|NCT00348309|27173098|P1|Overall Study|ECG abnormal|0
7825703|NCT00348309|27173096|P3|Overall Study|Adverse event not attended|1
7825704|NCT00348309|27173097|P2|Overall Study|Adverse event not attended|0
7825705|NCT00348309|27173098|P1|Overall Study|Adverse event not attended|0
7825706|NCT00348309|27173096|P3|Overall Study|Site closure|1
7825707|NCT00348309|27173097|P2|Overall Study|Site closure|0
7825708|NCT00348309|27173098|P1|Overall Study|Site closure|0
7825709|NCT00348309|27173096|P3|Overall Study|Increased dose of Aricept|1
7825710|NCT00348309|27173097|P2|Overall Study|Increased dose of Aricept|0
7825711|NCT00348309|27173098|P1|Overall Study|Increased dose of Aricept|0
7825712|NCT00348309|27173096|P3|Overall Study|Medical Monitor decision|1
7825713|NCT00348309|27173097|P2|Overall Study|Medical Monitor decision|0
7825714|NCT00348309|27173098|P1|Overall Study|Medical Monitor decision|0
7825715|NCT00348309|27173096|P3|Overall Study|Forgot often medication|0
7825716|NCT00348309|27173097|P2|Overall Study|Forgot often medication|1
7825717|NCT00348309|27173098|P1|Overall Study|Forgot often medication|0
7825718|NCT00348309|27173096|P3|Overall Study|Sponsor refuseal|1
7825719|NCT00348309|27173097|P2|Overall Study|Sponsor refuseal|1
7825720|NCT00348309|27173098|P1|Overall Study|Sponsor refuseal|0
7825721|NCT00348309|27173096|P3|Overall Study|Participant was hospitalized|0
7825722|NCT00348309|27173097|P2|Overall Study|Participant was hospitalized|1
7825723|NCT00348309|27173098|P1|Overall Study|Participant was hospitalized|0
7825724|NCT00348309|27173096|P3|Overall Study|A foul of exclusion criteria|0
7825725|NCT00348309|27173097|P2|Overall Study|A foul of exclusion criteria|1
7825726|NCT00348309|27173098|P1|Overall Study|A foul of exclusion criteria|0
7825727|NCT00348309|27173096|P3|Overall Study|Ineffectiveness of treatment|0
7825728|NCT00348309|27173097|P2|Overall Study|Ineffectiveness of treatment|1
7825729|NCT00348309|27173098|P1|Overall Study|Ineffectiveness of treatment|0
7825730|NCT00348309|27173096|P3|Overall Study|Decision of sponsor|0
7825731|NCT00348309|27173097|P2|Overall Study|Decision of sponsor|0
7825732|NCT00348309|27173098|P1|Overall Study|Decision of sponsor|1
7825733|NCT00348309|27173096|P3|Overall Study|Participant died|1
7825734|NCT00348309|27173097|P2|Overall Study|Participant died|1
7825735|NCT00348309|27173098|P1|Overall Study|Participant died|2
7825823|NCT00348140|27173201|P3|Overall Study|Memory declined|1
7825736|NCT00348309|27173096|P3|Overall Study|Did not appear in time for Visit 3|0
7825737|NCT00348309|27173097|P2|Overall Study|Did not appear in time for Visit 3|0
7825738|NCT00348309|27173098|P1|Overall Study|Did not appear in time for Visit 3|1
7825739|NCT00348309|27173096|P3|Overall Study|Worsening of alzheimer|1
7825740|NCT00348309|27173097|P2|Overall Study|Worsening of alzheimer|0
7825741|NCT00348309|27173098|P1|Overall Study|Worsening of alzheimer|1
7825742|NCT00348309|27173096|P3|Overall Study|Cognitive and behaviour worsening|0
7825743|NCT00348309|27173097|P2|Overall Study|Cognitive and behaviour worsening|0
7825744|NCT00348309|27173098|P1|Overall Study|Cognitive and behaviour worsening|2
7825745|NCT00348309|27173096|P3|Overall Study|Worsened neurodegenerative disease|0
7825746|NCT00348309|27173097|P2|Overall Study|Worsened neurodegenerative disease|0
7825747|NCT00348309|27173098|P1|Overall Study|Worsened neurodegenerative disease|1
7825748|NCT00348309|27173096|P3|Overall Study|No disponibility of medication|0
7825749|NCT00348309|27173097|P2|Overall Study|No disponibility of medication|0
7825750|NCT00348309|27173098|P1|Overall Study|No disponibility of medication|1
7825751|NCT00348309|27173096|P3|Overall Study|Principal investigator's decision|0
7825752|NCT00348309|27173097|P2|Overall Study|Principal investigator's decision|0
7825753|NCT00348309|27173098|P1|Overall Study|Principal investigator's decision|1
7825754|NCT00348309|27173096|P3|Overall Study|PI closing medical practice|0
7825755|NCT00348309|27173097|P2|Overall Study|PI closing medical practice|0
7825756|NCT00348309|27173098|P1|Overall Study|PI closing medical practice|1
7825757|NCT00348309|27173096|P3|Overall Study|Unable to complete ET visit|0
7825758|NCT00348309|27173097|P2|Overall Study|Unable to complete ET visit|0
7825759|NCT00348309|27173098|P1|Overall Study|Unable to complete ET visit|1
7825760|NCT00348309|27173096|P3|Overall Study|Caregiver withdrawal|7
7825761|NCT00348309|27173097|P2|Overall Study|Caregiver withdrawal|0
7825762|NCT00348309|27173098|P1|Overall Study|Caregiver withdrawal|3
7825763|NCT00348309|27173096|P3|Overall Study|Use of prohibited medication|2
7825764|NCT00348309|27173097|P2|Overall Study|Use of prohibited medication|2
7825765|NCT00348309|27173098|P1|Overall Study|Use of prohibited medication|5
7825766|NCT00348309|27173096|P3|Overall Study|Caregiver sick|0
7825767|NCT00348309|27173097|P2|Overall Study|Caregiver sick|0
7825768|NCT00348309|27173098|P1|Overall Study|Caregiver sick|1
7825769|NCT00348309|27173096|P3|Overall Study|Wrong bottle allocated|0
7825770|NCT00348309|27173097|P2|Overall Study|Wrong bottle allocated|0
7825771|NCT00348309|27173098|P1|Overall Study|Wrong bottle allocated|1
7825772|NCT00348309|27173096|P3|Overall Study|Lack of insight, dementia|0
7825773|NCT00348309|27173097|P2|Overall Study|Lack of insight, dementia|0
7825774|NCT00348309|27173098|P1|Overall Study|Lack of insight, dementia|1
7825775|NCT00348309|27173096|P3|Overall Study|Death of caregiver|1
7825776|NCT00348309|27173097|P2|Overall Study|Death of caregiver|0
7825777|NCT00348309|27173098|P1|Overall Study|Death of caregiver|1
7825778|NCT00348309|27173096|P3|Overall Study|Non-compliance|8
7825779|NCT00348309|27173097|P2|Overall Study|Non-compliance|6
7825780|NCT00348309|27173098|P1|Overall Study|Non-compliance|8
7825781|NCT00348309|27173096|P3|Overall Study|Withdrawal by Subject|40
7825782|NCT00348309|27173097|P2|Overall Study|Withdrawal by Subject|37
7825783|NCT00348309|27173098|P1|Overall Study|Withdrawal by Subject|33
7825784|NCT00348309|27173096|P3|Overall Study|Protocol Violation|7
7825785|NCT00348309|27173097|P2|Overall Study|Protocol Violation|12
7825786|NCT00348309|27173098|P1|Overall Study|Protocol Violation|7
7825787|NCT00348309|27173096|P3|Overall Study|Lost to Follow-up|4
7825788|NCT00348309|27173097|P2|Overall Study|Lost to Follow-up|7
7825789|NCT00348309|27173098|P1|Overall Study|Lost to Follow-up|6
7825790|NCT00348309|27173096|P3|Overall Study|Adverse Event|63
7825791|NCT00348309|27173097|P2|Overall Study|Adverse Event|28
7825792|NCT00348309|27173098|P1|Overall Study|Adverse Event|56
7825793|NCT00348283|27173171|P2|Open Label|Sponsor decision|1
7825794|NCT00348283|27173172|P1|Open Label|Sponsor decision|0
7825795|NCT00348283|27173171|P2|Open Label|Pregnancy|1
7825796|NCT00348283|27173172|P1|Open Label|Pregnancy|0
7825797|NCT00348283|27173171|P2|Open Label|Subject moved to the United States|1
7825798|NCT00348283|27173172|P1|Open Label|Subject moved to the United States|0
7825799|NCT00348283|27173171|P2|Open Label|Administrative reasons|5
7825800|NCT00348283|27173172|P1|Open Label|Administrative reasons|0
7825801|NCT00348283|27173171|P2|Open Label|Lack of Efficacy|13
7825802|NCT00348283|27173172|P1|Open Label|Lack of Efficacy|0
7825803|NCT00348283|27173171|P2|Open Label|Lost to Follow-up|1
7825804|NCT00348283|27173172|P1|Open Label|Lost to Follow-up|0
7825805|NCT00348283|27173171|P2|Open Label|Withdrawal by Subject|4
7825806|NCT00348283|27173172|P1|Open Label|Withdrawal by Subject|0
7825807|NCT00348283|27173171|P2|Open Label|Adverse Event|8
7825808|NCT00348283|27173172|P1|Open Label|Adverse Event|0
7825809|NCT00348283|27173171|P2|Double Blind|Pregnancy|1
7825810|NCT00348283|27173172|P1|Double Blind|Pregnancy|0
7825811|NCT00348283|27173171|P2|Double Blind|Lack of Efficacy|2
7825812|NCT00348283|27173172|P1|Double Blind|Lack of Efficacy|2
7825813|NCT00348283|27173171|P2|Double Blind|Protocol Violation|1
7825814|NCT00348283|27173172|P1|Double Blind|Protocol Violation|0
7825815|NCT00348283|27173171|P2|Double Blind|Withdrawal by Subject|1
7825816|NCT00348283|27173172|P1|Double Blind|Withdrawal by Subject|1
7825817|NCT00348283|27173171|P2|Double Blind|Adverse Event|5
7825818|NCT00348283|27173172|P1|Double Blind|Adverse Event|2
7825819|NCT00348283|27173171|P2|Induction|Protocol Violation|4
7825820|NCT00348283|27173172|P1|Induction|Protocol Violation|0
7825821|NCT00348283|27173171|P2|Induction|Adverse Event|2
7825822|NCT00348283|27173172|P1|Induction|Adverse Event|0
7825824|NCT00348140|27173202|P2|Overall Study|Memory declined|0
7825825|NCT00348140|27173203|P1|Overall Study|Memory declined|0
7825826|NCT00348140|27173201|P3|Overall Study|Exclusion criteria met|1
7825827|NCT00348140|27173202|P2|Overall Study|Exclusion criteria met|0
7825828|NCT00348140|27173203|P1|Overall Study|Exclusion criteria met|0
7825829|NCT00348140|27173201|P3|Overall Study|Participant died|0
7825830|NCT00348140|27173202|P2|Overall Study|Participant died|1
7825831|NCT00348140|27173203|P1|Overall Study|Participant died|0
7825832|NCT00348140|27173201|P3|Overall Study|Abnormal ECG|3
7825833|NCT00348140|27173202|P2|Overall Study|Abnormal ECG|1
7825834|NCT00348140|27173203|P1|Overall Study|Abnormal ECG|0
7825835|NCT00348140|27173201|P3|Overall Study|Serious adverse event|0
7825836|NCT00348140|27173202|P2|Overall Study|Serious adverse event|1
7825837|NCT00348140|27173203|P1|Overall Study|Serious adverse event|0
7825838|NCT00348140|27173201|P3|Overall Study|Increased risk of cardiac infarction|0
7825839|NCT00348140|27173202|P2|Overall Study|Increased risk of cardiac infarction|1
7825840|NCT00348140|27173203|P1|Overall Study|Increased risk of cardiac infarction|0
7825841|NCT00348140|27173201|P3|Overall Study|Disease progression|5
7825842|NCT00348140|27173202|P2|Overall Study|Disease progression|2
7825843|NCT00348140|27173203|P1|Overall Study|Disease progression|1
7825844|NCT00348140|27173201|P3|Overall Study|Use of prohibited drug|2
7825845|NCT00348140|27173202|P2|Overall Study|Use of prohibited drug|0
7825846|NCT00348140|27173203|P1|Overall Study|Use of prohibited drug|1
7825847|NCT00348140|27173201|P3|Overall Study|Decided to discontinue on their own|1
7825848|NCT00348140|27173202|P2|Overall Study|Decided to discontinue on their own|4
7825849|NCT00348140|27173203|P1|Overall Study|Decided to discontinue on their own|1
7825850|NCT00348140|27173201|P3|Overall Study|Investigator decided to discontinue|4
7825851|NCT00348140|27173202|P2|Overall Study|Investigator decided to discontinue|1
7825852|NCT00348140|27173203|P1|Overall Study|Investigator decided to discontinue|4
7825853|NCT00348140|27173201|P3|Overall Study|Screen failure|0
7825854|NCT00348140|27173202|P2|Overall Study|Screen failure|0
7825855|NCT00348140|27173203|P1|Overall Study|Screen failure|1
7825856|NCT00348140|27173201|P3|Overall Study|Participant unwell|0
7825857|NCT00348140|27173202|P2|Overall Study|Participant unwell|0
7825858|NCT00348140|27173203|P1|Overall Study|Participant unwell|1
7825859|NCT00348140|27173201|P3|Overall Study|Unmet inclusion-exclusion criteria|1
7825860|NCT00348140|27173202|P2|Overall Study|Unmet inclusion-exclusion criteria|0
7825861|NCT00348140|27173203|P1|Overall Study|Unmet inclusion-exclusion criteria|1
7825862|NCT00348140|27173201|P3|Overall Study|Administration related|1
7825863|NCT00348140|27173202|P2|Overall Study|Administration related|1
7825864|NCT00348140|27173203|P1|Overall Study|Administration related|3
7825865|NCT00348140|27173201|P3|Overall Study|Efficacy related|0
7825866|NCT00348140|27173202|P2|Overall Study|Efficacy related|1
7825867|NCT00348140|27173203|P1|Overall Study|Efficacy related|1
7825868|NCT00348140|27173201|P3|Overall Study|Participant hospitalised|0
7825869|NCT00348140|27173202|P2|Overall Study|Participant hospitalised|0
7825870|NCT00348140|27173203|P1|Overall Study|Participant hospitalised|3
7825871|NCT00348140|27173201|P3|Overall Study|Caregiver related|3
7825872|NCT00348140|27173202|P2|Overall Study|Caregiver related|7
7825873|NCT00348140|27173203|P1|Overall Study|Caregiver related|4
7825874|NCT00348140|27173201|P3|Overall Study|Conditional medication increased dose|0
7825875|NCT00348140|27173202|P2|Overall Study|Conditional medication increased dose|0
7825876|NCT00348140|27173203|P1|Overall Study|Conditional medication increased dose|1
7825877|NCT00348140|27173201|P3|Overall Study|Participant at risk due to study drug|0
7825878|NCT00348140|27173202|P2|Overall Study|Participant at risk due to study drug|0
7825879|NCT00348140|27173203|P1|Overall Study|Participant at risk due to study drug|2
7825880|NCT00348140|27173201|P3|Overall Study|Non-compliance|5
7825881|NCT00348140|27173202|P2|Overall Study|Non-compliance|13
7825882|NCT00348140|27173203|P1|Overall Study|Non-compliance|8
7825883|NCT00348140|27173201|P3|Overall Study|Withdrawal by Subject|40
7825884|NCT00348140|27173202|P2|Overall Study|Withdrawal by Subject|40
7825885|NCT00348140|27173203|P1|Overall Study|Withdrawal by Subject|32
7825886|NCT00348140|27173201|P3|Overall Study|Protocol Violation|14
7825887|NCT00348140|27173202|P2|Overall Study|Protocol Violation|13
7825888|NCT00348140|27173203|P1|Overall Study|Protocol Violation|12
7825889|NCT00348140|27173201|P3|Overall Study|Lost to Follow-up|4
7825890|NCT00348140|27173202|P2|Overall Study|Lost to Follow-up|4
7825891|NCT00348140|27173203|P1|Overall Study|Lost to Follow-up|4
7825892|NCT00348140|27173201|P3|Overall Study|Adverse Event|78
7825893|NCT00348140|27173202|P2|Overall Study|Adverse Event|49
7825894|NCT00348140|27173203|P1|Overall Study|Adverse Event|46
7825895|NCT00347958|27173301|P1|Overall Study|Withdrawal by Subject|1
7825896|NCT00347958|27173301|P1|Overall Study|Protocol Violation|2
7825897|NCT00347958|27173301|P1|Overall Study|Adverse Event|1
7825898|NCT00347932|27173310|P2|Overall Study|Did not meet inclusion criteria|8
7825899|NCT00347932|27173311|P1|Overall Study|Did not meet inclusion criteria|4
7825900|NCT00347932|27173310|P2|Overall Study|Withdrawal by Subject|16
7825901|NCT00347932|27173311|P1|Overall Study|Withdrawal by Subject|10
7825902|NCT00347932|27173310|P2|Overall Study|Lost to Follow-up|9
7825903|NCT00347932|27173311|P1|Overall Study|Lost to Follow-up|10
7825904|NCT00347932|27173310|P2|Overall Study|Lack of Efficacy|14
7825905|NCT00347932|27173311|P1|Overall Study|Lack of Efficacy|3
7825906|NCT00347932|27173310|P2|Overall Study|Adverse Event|5
7825907|NCT00347932|27173311|P1|Overall Study|Adverse Event|4
7825908|NCT00347919|27173326|P3|Overall Study|Missing|2
7825909|NCT00347919|27173327|P2|Overall Study|Missing|1
7825910|NCT00347919|27173328|P1|Overall Study|Missing|2
7825911|NCT00347919|27173326|P3|Overall Study|Par. Started Other Treatment|1
7825912|NCT00347919|27173327|P2|Overall Study|Par. Started Other Treatment|1
7825913|NCT00347919|27173328|P1|Overall Study|Par. Started Other Treatment|1
7825914|NCT00347919|27173326|P3|Overall Study|Death|19
7825915|NCT00347919|27173327|P2|Overall Study|Death|42
7825916|NCT00347919|27173328|P1|Overall Study|Death|35
7825917|NCT00347919|27173326|P3|Overall Study|Sponsor terminated study|16
7825918|NCT00347919|27173327|P2|Overall Study|Sponsor terminated study|10
7825919|NCT00347919|27173328|P1|Overall Study|Sponsor terminated study|15
7825920|NCT00347919|27173326|P3|Overall Study|Physician Decision|0
7825921|NCT00347919|27173327|P2|Overall Study|Physician Decision|1
7825922|NCT00347919|27173328|P1|Overall Study|Physician Decision|1
7825923|NCT00347919|27173326|P3|Overall Study|Withdrawal by Subject|0
7825924|NCT00347919|27173327|P2|Overall Study|Withdrawal by Subject|8
7825925|NCT00347919|27173328|P1|Overall Study|Withdrawal by Subject|6
7825926|NCT00347919|27173326|P3|Overall Study|Lost to Follow-up|0
7825927|NCT00347919|27173327|P2|Overall Study|Lost to Follow-up|13
7825928|NCT00347919|27173328|P1|Overall Study|Lost to Follow-up|11
7825929|NCT00347776|27173351|P3|12 Month Follow-up|Reached endpoint|9
7825930|NCT00347776|27173352|P2|12 Month Follow-up|Reached endpoint|6
7825931|NCT00347776|27173353|P1|12 Month Follow-up|Reached endpoint|13
7825932|NCT00347776|27173351|P3|12 Month Follow-up|Death|4
7825933|NCT00347776|27173352|P2|12 Month Follow-up|Death|4
7825934|NCT00347776|27173353|P1|12 Month Follow-up|Death|3
7825935|NCT00347776|27173351|P3|12 Month Follow-up|Lost to Follow-up|6
7825936|NCT00347776|27173352|P2|12 Month Follow-up|Lost to Follow-up|6
7825937|NCT00347776|27173353|P1|12 Month Follow-up|Lost to Follow-up|7
7825938|NCT00347776|27173351|P3|6 Month Follow-up|reached endpont|15
7825939|NCT00347776|27173352|P2|6 Month Follow-up|reached endpont|12
7825940|NCT00347776|27173353|P1|6 Month Follow-up|reached endpont|20
7825941|NCT00347776|27173351|P3|6 Month Follow-up|Death|3
7825942|NCT00347776|27173352|P2|6 Month Follow-up|Death|1
7825943|NCT00347776|27173353|P1|6 Month Follow-up|Death|2
7825944|NCT00347776|27173351|P3|1.5 Month Follow-up|reached the endpoint|12
7825945|NCT00347776|27173352|P2|1.5 Month Follow-up|reached the endpoint|8
7825946|NCT00347776|27173353|P1|1.5 Month Follow-up|reached the endpoint|12
7825947|NCT00347776|27173351|P3|1.5 Month Follow-up|Death|0
7825948|NCT00347776|27173352|P2|1.5 Month Follow-up|Death|0
7825949|NCT00347776|27173353|P1|1.5 Month Follow-up|Death|2
7825950|NCT00347438|27173365|P1|Overall Study|Physician Decision|1
7825951|NCT00347438|27173365|P1|Overall Study|Withdrawal by Subject|1
7825952|NCT00347360|27173387|P15|Overall Study|Visits conflicted with new job|0
7825953|NCT00347360|27173388|P14|Overall Study|Visits conflicted with new job|0
7825954|NCT00347360|27173389|P13|Overall Study|Visits conflicted with new job|0
7825955|NCT00347360|27173390|P12|Overall Study|Visits conflicted with new job|0
7825956|NCT00347360|27173391|P11|Overall Study|Visits conflicted with new job|0
7825957|NCT00347360|27173392|P10|Overall Study|Visits conflicted with new job|0
7825958|NCT00347360|27173393|P9|Overall Study|Visits conflicted with new job|0
7825959|NCT00347360|27173394|P8|Overall Study|Visits conflicted with new job|0
7825960|NCT00347360|27173395|P7|Overall Study|Visits conflicted with new job|1
7825961|NCT00347360|27173396|P6|Overall Study|Visits conflicted with new job|0
7825962|NCT00347360|27173397|P5|Overall Study|Visits conflicted with new job|0
7825963|NCT00347360|27173398|P4|Overall Study|Visits conflicted with new job|0
7825964|NCT00347360|27173399|P3|Overall Study|Visits conflicted with new job|0
7825965|NCT00347360|27173400|P2|Overall Study|Visits conflicted with new job|0
7825966|NCT00347360|27173401|P1|Overall Study|Visits conflicted with new job|0
7825967|NCT00347360|27173387|P15|Overall Study|Subject refuse to sign updated consent|1
7825968|NCT00347360|27173388|P14|Overall Study|Subject refuse to sign updated consent|0
7825969|NCT00347360|27173389|P13|Overall Study|Subject refuse to sign updated consent|0
7825970|NCT00347360|27173390|P12|Overall Study|Subject refuse to sign updated consent|0
7825971|NCT00347360|27173391|P11|Overall Study|Subject refuse to sign updated consent|0
7825972|NCT00347360|27173392|P10|Overall Study|Subject refuse to sign updated consent|0
7825973|NCT00347360|27173393|P9|Overall Study|Subject refuse to sign updated consent|0
7825974|NCT00347360|27173394|P8|Overall Study|Subject refuse to sign updated consent|0
7825975|NCT00347360|27173395|P7|Overall Study|Subject refuse to sign updated consent|0
7825976|NCT00347360|27173396|P6|Overall Study|Subject refuse to sign updated consent|0
7825977|NCT00347360|27173397|P5|Overall Study|Subject refuse to sign updated consent|0
7825978|NCT00347360|27173398|P4|Overall Study|Subject refuse to sign updated consent|0
7825979|NCT00347360|27173399|P3|Overall Study|Subject refuse to sign updated consent|0
7825980|NCT00347360|27173400|P2|Overall Study|Subject refuse to sign updated consent|0
7825981|NCT00347360|27173401|P1|Overall Study|Subject refuse to sign updated consent|0
7825982|NCT00347360|27173387|P15|Overall Study|Subject left town, ran out of study drug|0
7825983|NCT00347360|27173388|P14|Overall Study|Subject left town, ran out of study drug|1
7825984|NCT00347360|27173389|P13|Overall Study|Subject left town, ran out of study drug|0
7825985|NCT00347360|27173390|P12|Overall Study|Subject left town, ran out of study drug|0
7825986|NCT00347360|27173391|P11|Overall Study|Subject left town, ran out of study drug|0
7825987|NCT00347360|27173392|P10|Overall Study|Subject left town, ran out of study drug|0
7825988|NCT00347360|27173393|P9|Overall Study|Subject left town, ran out of study drug|0
7825989|NCT00347360|27173394|P8|Overall Study|Subject left town, ran out of study drug|0
7825990|NCT00347360|27173395|P7|Overall Study|Subject left town, ran out of study drug|0
7826148|NCT00347360|27173388|P14|Overall Study|Lack of Efficacy|0
7825991|NCT00347360|27173396|P6|Overall Study|Subject left town, ran out of study drug|0
7825992|NCT00347360|27173397|P5|Overall Study|Subject left town, ran out of study drug|0
7825993|NCT00347360|27173398|P4|Overall Study|Subject left town, ran out of study drug|0
7825994|NCT00347360|27173399|P3|Overall Study|Subject left town, ran out of study drug|0
7825995|NCT00347360|27173400|P2|Overall Study|Subject left town, ran out of study drug|0
7825996|NCT00347360|27173401|P1|Overall Study|Subject left town, ran out of study drug|0
7825997|NCT00347360|27173387|P15|Overall Study|Prolonged duration between visits|0
7825998|NCT00347360|27173388|P14|Overall Study|Prolonged duration between visits|0
7825999|NCT00347360|27173389|P13|Overall Study|Prolonged duration between visits|1
7826000|NCT00347360|27173390|P12|Overall Study|Prolonged duration between visits|0
7826001|NCT00347360|27173391|P11|Overall Study|Prolonged duration between visits|0
7826002|NCT00347360|27173392|P10|Overall Study|Prolonged duration between visits|0
7826003|NCT00347360|27173393|P9|Overall Study|Prolonged duration between visits|0
7826004|NCT00347360|27173394|P8|Overall Study|Prolonged duration between visits|0
7826005|NCT00347360|27173395|P7|Overall Study|Prolonged duration between visits|0
7826006|NCT00347360|27173396|P6|Overall Study|Prolonged duration between visits|0
7826007|NCT00347360|27173397|P5|Overall Study|Prolonged duration between visits|0
7826008|NCT00347360|27173398|P4|Overall Study|Prolonged duration between visits|0
7826009|NCT00347360|27173399|P3|Overall Study|Prolonged duration between visits|0
7826010|NCT00347360|27173400|P2|Overall Study|Prolonged duration between visits|0
7826011|NCT00347360|27173401|P1|Overall Study|Prolonged duration between visits|0
7826012|NCT00347360|27173387|P15|Overall Study|Failed inclusion criteria #4|0
7826013|NCT00347360|27173388|P14|Overall Study|Failed inclusion criteria #4|0
7826014|NCT00347360|27173389|P13|Overall Study|Failed inclusion criteria #4|0
7826015|NCT00347360|27173390|P12|Overall Study|Failed inclusion criteria #4|1
7826016|NCT00347360|27173391|P11|Overall Study|Failed inclusion criteria #4|0
7826017|NCT00347360|27173392|P10|Overall Study|Failed inclusion criteria #4|0
7826018|NCT00347360|27173393|P9|Overall Study|Failed inclusion criteria #4|0
7826019|NCT00347360|27173394|P8|Overall Study|Failed inclusion criteria #4|0
7826020|NCT00347360|27173395|P7|Overall Study|Failed inclusion criteria #4|0
7826021|NCT00347360|27173396|P6|Overall Study|Failed inclusion criteria #4|0
7826022|NCT00347360|27173397|P5|Overall Study|Failed inclusion criteria #4|0
7826023|NCT00347360|27173398|P4|Overall Study|Failed inclusion criteria #4|0
7826024|NCT00347360|27173399|P3|Overall Study|Failed inclusion criteria #4|0
7826025|NCT00347360|27173400|P2|Overall Study|Failed inclusion criteria #4|0
7826026|NCT00347360|27173401|P1|Overall Study|Failed inclusion criteria #4|0
7826027|NCT00347360|27173387|P15|Overall Study|Randomized in error|0
7826028|NCT00347360|27173388|P14|Overall Study|Randomized in error|0
7826029|NCT00347360|27173389|P13|Overall Study|Randomized in error|0
7826030|NCT00347360|27173390|P12|Overall Study|Randomized in error|1
7826031|NCT00347360|27173391|P11|Overall Study|Randomized in error|0
7826032|NCT00347360|27173392|P10|Overall Study|Randomized in error|0
7826033|NCT00347360|27173393|P9|Overall Study|Randomized in error|0
7826034|NCT00347360|27173394|P8|Overall Study|Randomized in error|0
7826035|NCT00347360|27173395|P7|Overall Study|Randomized in error|0
7826036|NCT00347360|27173396|P6|Overall Study|Randomized in error|0
7826037|NCT00347360|27173397|P5|Overall Study|Randomized in error|0
7826038|NCT00347360|27173398|P4|Overall Study|Randomized in error|0
7826039|NCT00347360|27173399|P3|Overall Study|Randomized in error|0
7826040|NCT00347360|27173400|P2|Overall Study|Randomized in error|0
7826041|NCT00347360|27173401|P1|Overall Study|Randomized in error|0
7826042|NCT00347360|27173387|P15|Overall Study|Did not meet criteria before ABPM|0
7826043|NCT00347360|27173388|P14|Overall Study|Did not meet criteria before ABPM|0
7826044|NCT00347360|27173389|P13|Overall Study|Did not meet criteria before ABPM|0
7826045|NCT00347360|27173390|P12|Overall Study|Did not meet criteria before ABPM|0
7826046|NCT00347360|27173391|P11|Overall Study|Did not meet criteria before ABPM|1
7826047|NCT00347360|27173392|P10|Overall Study|Did not meet criteria before ABPM|0
7826048|NCT00347360|27173393|P9|Overall Study|Did not meet criteria before ABPM|0
7826049|NCT00347360|27173394|P8|Overall Study|Did not meet criteria before ABPM|0
7826050|NCT00347360|27173395|P7|Overall Study|Did not meet criteria before ABPM|0
7826051|NCT00347360|27173396|P6|Overall Study|Did not meet criteria before ABPM|0
7826052|NCT00347360|27173397|P5|Overall Study|Did not meet criteria before ABPM|0
7826053|NCT00347360|27173398|P4|Overall Study|Did not meet criteria before ABPM|0
7826054|NCT00347360|27173399|P3|Overall Study|Did not meet criteria before ABPM|0
7826055|NCT00347360|27173400|P2|Overall Study|Did not meet criteria before ABPM|0
7826056|NCT00347360|27173401|P1|Overall Study|Did not meet criteria before ABPM|0
7826057|NCT00347360|27173387|P15|Overall Study|PI recommended early withdrawal|0
7826058|NCT00347360|27173388|P14|Overall Study|PI recommended early withdrawal|0
7826059|NCT00347360|27173389|P13|Overall Study|PI recommended early withdrawal|0
7826060|NCT00347360|27173390|P12|Overall Study|PI recommended early withdrawal|0
7826061|NCT00347360|27173391|P11|Overall Study|PI recommended early withdrawal|0
7826062|NCT00347360|27173392|P10|Overall Study|PI recommended early withdrawal|1
7826063|NCT00347360|27173393|P9|Overall Study|PI recommended early withdrawal|0
7826064|NCT00347360|27173394|P8|Overall Study|PI recommended early withdrawal|0
7826065|NCT00347360|27173395|P7|Overall Study|PI recommended early withdrawal|0
7826066|NCT00347360|27173396|P6|Overall Study|PI recommended early withdrawal|0
7826067|NCT00347360|27173397|P5|Overall Study|PI recommended early withdrawal|0
7826068|NCT00347360|27173398|P4|Overall Study|PI recommended early withdrawal|0
7826069|NCT00347360|27173399|P3|Overall Study|PI recommended early withdrawal|0
7826070|NCT00347360|27173400|P2|Overall Study|PI recommended early withdrawal|0
7826071|NCT00347360|27173401|P1|Overall Study|PI recommended early withdrawal|0
7826072|NCT00347360|27173387|P15|Overall Study|Abnormal lab values|0
7826073|NCT00347360|27173388|P14|Overall Study|Abnormal lab values|0
7826074|NCT00347360|27173389|P13|Overall Study|Abnormal lab values|0
7826075|NCT00347360|27173390|P12|Overall Study|Abnormal lab values|0
7826076|NCT00347360|27173391|P11|Overall Study|Abnormal lab values|0
7826077|NCT00347360|27173392|P10|Overall Study|Abnormal lab values|0
7826078|NCT00347360|27173393|P9|Overall Study|Abnormal lab values|0
7826079|NCT00347360|27173394|P8|Overall Study|Abnormal lab values|0
7826080|NCT00347360|27173395|P7|Overall Study|Abnormal lab values|1
7826081|NCT00347360|27173396|P6|Overall Study|Abnormal lab values|0
7826082|NCT00347360|27173397|P5|Overall Study|Abnormal lab values|0
7826083|NCT00347360|27173398|P4|Overall Study|Abnormal lab values|0
7826084|NCT00347360|27173399|P3|Overall Study|Abnormal lab values|0
7826085|NCT00347360|27173400|P2|Overall Study|Abnormal lab values|0
7826086|NCT00347360|27173401|P1|Overall Study|Abnormal lab values|0
7826087|NCT00347360|27173387|P15|Overall Study|Subject did not meet end of study ABPM|0
7826088|NCT00347360|27173388|P14|Overall Study|Subject did not meet end of study ABPM|1
7826089|NCT00347360|27173389|P13|Overall Study|Subject did not meet end of study ABPM|1
7826090|NCT00347360|27173390|P12|Overall Study|Subject did not meet end of study ABPM|0
7826091|NCT00347360|27173391|P11|Overall Study|Subject did not meet end of study ABPM|1
7826092|NCT00347360|27173392|P10|Overall Study|Subject did not meet end of study ABPM|0
7826093|NCT00347360|27173393|P9|Overall Study|Subject did not meet end of study ABPM|0
7826094|NCT00347360|27173394|P8|Overall Study|Subject did not meet end of study ABPM|0
7826095|NCT00347360|27173395|P7|Overall Study|Subject did not meet end of study ABPM|1
7826096|NCT00347360|27173396|P6|Overall Study|Subject did not meet end of study ABPM|0
7826097|NCT00347360|27173397|P5|Overall Study|Subject did not meet end of study ABPM|0
7826098|NCT00347360|27173398|P4|Overall Study|Subject did not meet end of study ABPM|0
7826099|NCT00347360|27173399|P3|Overall Study|Subject did not meet end of study ABPM|0
7826100|NCT00347360|27173400|P2|Overall Study|Subject did not meet end of study ABPM|0
7826101|NCT00347360|27173401|P1|Overall Study|Subject did not meet end of study ABPM|0
7826102|NCT00347360|27173387|P15|Overall Study|P.I. recommended due to blood pressure|0
7826103|NCT00347360|27173388|P14|Overall Study|P.I. recommended due to blood pressure|0
7826104|NCT00347360|27173389|P13|Overall Study|P.I. recommended due to blood pressure|0
7826105|NCT00347360|27173390|P12|Overall Study|P.I. recommended due to blood pressure|0
7826106|NCT00347360|27173391|P11|Overall Study|P.I. recommended due to blood pressure|0
7826107|NCT00347360|27173392|P10|Overall Study|P.I. recommended due to blood pressure|0
7826108|NCT00347360|27173393|P9|Overall Study|P.I. recommended due to blood pressure|0
7826109|NCT00347360|27173394|P8|Overall Study|P.I. recommended due to blood pressure|0
7826110|NCT00347360|27173395|P7|Overall Study|P.I. recommended due to blood pressure|0
7826111|NCT00347360|27173396|P6|Overall Study|P.I. recommended due to blood pressure|0
7826112|NCT00347360|27173397|P5|Overall Study|P.I. recommended due to blood pressure|1
7826113|NCT00347360|27173398|P4|Overall Study|P.I. recommended due to blood pressure|0
7826114|NCT00347360|27173399|P3|Overall Study|P.I. recommended due to blood pressure|0
7826115|NCT00347360|27173400|P2|Overall Study|P.I. recommended due to blood pressure|0
7826116|NCT00347360|27173401|P1|Overall Study|P.I. recommended due to blood pressure|0
7826117|NCT00347360|27173387|P15|Overall Study|Per sponsors instruction|0
7826118|NCT00347360|27173388|P14|Overall Study|Per sponsors instruction|0
7826119|NCT00347360|27173389|P13|Overall Study|Per sponsors instruction|0
7826120|NCT00347360|27173390|P12|Overall Study|Per sponsors instruction|0
7826121|NCT00347360|27173391|P11|Overall Study|Per sponsors instruction|0
7826122|NCT00347360|27173392|P10|Overall Study|Per sponsors instruction|0
7826123|NCT00347360|27173393|P9|Overall Study|Per sponsors instruction|0
7826124|NCT00347360|27173394|P8|Overall Study|Per sponsors instruction|0
7826125|NCT00347360|27173395|P7|Overall Study|Per sponsors instruction|0
7826126|NCT00347360|27173396|P6|Overall Study|Per sponsors instruction|0
7826127|NCT00347360|27173397|P5|Overall Study|Per sponsors instruction|0
7826128|NCT00347360|27173398|P4|Overall Study|Per sponsors instruction|0
7826129|NCT00347360|27173399|P3|Overall Study|Per sponsors instruction|0
7826130|NCT00347360|27173400|P2|Overall Study|Per sponsors instruction|1
7826131|NCT00347360|27173401|P1|Overall Study|Per sponsors instruction|0
7826132|NCT00347360|27173387|P15|Overall Study|Reason not listed/blank|0
7826133|NCT00347360|27173388|P14|Overall Study|Reason not listed/blank|1
7826134|NCT00347360|27173389|P13|Overall Study|Reason not listed/blank|0
7826135|NCT00347360|27173390|P12|Overall Study|Reason not listed/blank|0
7826136|NCT00347360|27173391|P11|Overall Study|Reason not listed/blank|0
7826137|NCT00347360|27173392|P10|Overall Study|Reason not listed/blank|0
7826138|NCT00347360|27173393|P9|Overall Study|Reason not listed/blank|0
7826139|NCT00347360|27173394|P8|Overall Study|Reason not listed/blank|0
7826140|NCT00347360|27173395|P7|Overall Study|Reason not listed/blank|1
7826141|NCT00347360|27173396|P6|Overall Study|Reason not listed/blank|0
7826142|NCT00347360|27173397|P5|Overall Study|Reason not listed/blank|0
7826143|NCT00347360|27173398|P4|Overall Study|Reason not listed/blank|0
7826144|NCT00347360|27173399|P3|Overall Study|Reason not listed/blank|0
7826145|NCT00347360|27173400|P2|Overall Study|Reason not listed/blank|0
7826146|NCT00347360|27173401|P1|Overall Study|Reason not listed/blank|1
7826147|NCT00347360|27173387|P15|Overall Study|Lack of Efficacy|0
7826149|NCT00347360|27173389|P13|Overall Study|Lack of Efficacy|0
7826150|NCT00347360|27173390|P12|Overall Study|Lack of Efficacy|0
7826151|NCT00347360|27173391|P11|Overall Study|Lack of Efficacy|0
7826152|NCT00347360|27173392|P10|Overall Study|Lack of Efficacy|0
7826153|NCT00347360|27173393|P9|Overall Study|Lack of Efficacy|1
7826154|NCT00347360|27173394|P8|Overall Study|Lack of Efficacy|1
7826155|NCT00347360|27173395|P7|Overall Study|Lack of Efficacy|0
7826156|NCT00347360|27173396|P6|Overall Study|Lack of Efficacy|1
7826157|NCT00347360|27173397|P5|Overall Study|Lack of Efficacy|0
7826158|NCT00347360|27173398|P4|Overall Study|Lack of Efficacy|1
7826159|NCT00347360|27173399|P3|Overall Study|Lack of Efficacy|3
7826160|NCT00347360|27173400|P2|Overall Study|Lack of Efficacy|1
7826161|NCT00347360|27173401|P1|Overall Study|Lack of Efficacy|1
7826162|NCT00347360|27173387|P15|Overall Study|Withdrawal by Subject|1
7826163|NCT00347360|27173388|P14|Overall Study|Withdrawal by Subject|2
7826164|NCT00347360|27173389|P13|Overall Study|Withdrawal by Subject|4
7826165|NCT00347360|27173390|P12|Overall Study|Withdrawal by Subject|3
7826166|NCT00347360|27173391|P11|Overall Study|Withdrawal by Subject|0
7826167|NCT00347360|27173392|P10|Overall Study|Withdrawal by Subject|1
7826168|NCT00347360|27173393|P9|Overall Study|Withdrawal by Subject|1
7826169|NCT00347360|27173394|P8|Overall Study|Withdrawal by Subject|1
7826170|NCT00347360|27173395|P7|Overall Study|Withdrawal by Subject|1
7826171|NCT00347360|27173396|P6|Overall Study|Withdrawal by Subject|2
7826172|NCT00347360|27173397|P5|Overall Study|Withdrawal by Subject|1
7826173|NCT00347360|27173398|P4|Overall Study|Withdrawal by Subject|4
7826174|NCT00347360|27173399|P3|Overall Study|Withdrawal by Subject|2
7826175|NCT00347360|27173400|P2|Overall Study|Withdrawal by Subject|1
7826176|NCT00347360|27173401|P1|Overall Study|Withdrawal by Subject|0
7826177|NCT00347360|27173387|P15|Overall Study|Protocol Violation|0
7826178|NCT00347360|27173388|P14|Overall Study|Protocol Violation|1
7826179|NCT00347360|27173389|P13|Overall Study|Protocol Violation|0
7826180|NCT00347360|27173390|P12|Overall Study|Protocol Violation|0
7826181|NCT00347360|27173391|P11|Overall Study|Protocol Violation|0
7826182|NCT00347360|27173392|P10|Overall Study|Protocol Violation|2
7826183|NCT00347360|27173393|P9|Overall Study|Protocol Violation|1
7826184|NCT00347360|27173394|P8|Overall Study|Protocol Violation|0
7826185|NCT00347360|27173395|P7|Overall Study|Protocol Violation|0
7826186|NCT00347360|27173396|P6|Overall Study|Protocol Violation|2
7826187|NCT00347360|27173397|P5|Overall Study|Protocol Violation|1
7826188|NCT00347360|27173398|P4|Overall Study|Protocol Violation|2
7826189|NCT00347360|27173399|P3|Overall Study|Protocol Violation|1
7826190|NCT00347360|27173400|P2|Overall Study|Protocol Violation|3
7826191|NCT00347360|27173401|P1|Overall Study|Protocol Violation|2
7826192|NCT00347360|27173387|P15|Overall Study|Lost to Follow-up|0
7826193|NCT00347360|27173388|P14|Overall Study|Lost to Follow-up|0
7826194|NCT00347360|27173389|P13|Overall Study|Lost to Follow-up|1
7826195|NCT00347360|27173390|P12|Overall Study|Lost to Follow-up|0
7826196|NCT00347360|27173391|P11|Overall Study|Lost to Follow-up|0
7826197|NCT00347360|27173392|P10|Overall Study|Lost to Follow-up|2
7826198|NCT00347360|27173393|P9|Overall Study|Lost to Follow-up|1
7826199|NCT00347360|27173394|P8|Overall Study|Lost to Follow-up|1
7826200|NCT00347360|27173395|P7|Overall Study|Lost to Follow-up|0
7826201|NCT00347360|27173396|P6|Overall Study|Lost to Follow-up|1
7826202|NCT00347360|27173397|P5|Overall Study|Lost to Follow-up|1
7826203|NCT00347360|27173398|P4|Overall Study|Lost to Follow-up|2
7826204|NCT00347360|27173399|P3|Overall Study|Lost to Follow-up|0
7826205|NCT00347360|27173400|P2|Overall Study|Lost to Follow-up|0
7826206|NCT00347360|27173401|P1|Overall Study|Lost to Follow-up|0
7826207|NCT00347360|27173387|P15|Overall Study|Adverse Event|2
7826208|NCT00347360|27173388|P14|Overall Study|Adverse Event|2
7826209|NCT00347360|27173389|P13|Overall Study|Adverse Event|3
7826210|NCT00347360|27173390|P12|Overall Study|Adverse Event|1
7826211|NCT00347360|27173391|P11|Overall Study|Adverse Event|3
7826212|NCT00347360|27173392|P10|Overall Study|Adverse Event|3
7826213|NCT00347360|27173393|P9|Overall Study|Adverse Event|2
7826214|NCT00347360|27173394|P8|Overall Study|Adverse Event|0
7826215|NCT00347360|27173395|P7|Overall Study|Adverse Event|2
7826216|NCT00347360|27173396|P6|Overall Study|Adverse Event|2
7826217|NCT00347360|27173397|P5|Overall Study|Adverse Event|1
7826218|NCT00347360|27173398|P4|Overall Study|Adverse Event|4
7826219|NCT00347360|27173399|P3|Overall Study|Adverse Event|0
7826220|NCT00347360|27173400|P2|Overall Study|Adverse Event|2
7826221|NCT00347360|27173401|P1|Overall Study|Adverse Event|1
7826222|NCT00347269|27173589|P2|Overall Study|Death|3
7826223|NCT00347269|27173590|P1|Overall Study|Death|2
7826224|NCT00347269|27173589|P2|Overall Study|Withdrawal by Subject|38
7826225|NCT00347269|27173590|P1|Overall Study|Withdrawal by Subject|18
7826226|NCT00347269|27173589|P2|Overall Study|Lost to Follow-up|65
7826227|NCT00347269|27173590|P1|Overall Study|Lost to Follow-up|74
7826228|NCT00347009|27173605|P1|Overall Study|Serious Adverse Event|1
7826229|NCT00347009|27173605|P1|Overall Study|Increased ALT/HBV DNA|1
7826230|NCT00347009|27173605|P1|Overall Study|Insufficient Viral Suppression|3
7826231|NCT00347009|27173605|P1|Overall Study|Adverse Laboratory Experience|1
7826232|NCT00347009|27173605|P1|Overall Study|Protocol Violation|2
7826233|NCT00347009|27173605|P1|Overall Study|Lost to Follow-up|4
7826234|NCT00347009|27173605|P1|Overall Study|Physician Decision|5
7826235|NCT00347009|27173605|P1|Overall Study|Withdrawal by Subject|3
7826236|NCT00347009|27173605|P1|Overall Study|Adverse Event|6
7826237|NCT00347009|27173605|P1|Overall Study|Death|1
7826238|NCT00346775|27173626|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
7826239|NCT00346775|27173627|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
7826240|NCT00346775|27173626|P2|Period 1: Intervention Period 1|Protocol Violation|2
7826241|NCT00346775|27173627|P1|Period 1: Intervention Period 1|Protocol Violation|3
7826242|NCT00346775|27173626|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
7826243|NCT00346775|27173627|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
7826244|NCT00346697|27173639|P2|Overall Study|Lost to Follow-up|1
7826245|NCT00346697|27173640|P1|Overall Study|Lost to Follow-up|0
7826246|NCT00346632|27173676|P10|Overall Study|Not Stated|1
7826247|NCT00346632|27173677|P9|Overall Study|Not Stated|2
7826248|NCT00346632|27173678|P8|Overall Study|Not Stated|2
7826249|NCT00346632|27173679|P7|Overall Study|Not Stated|0
7826250|NCT00346632|27173680|P6|Overall Study|Not Stated|0
7826251|NCT00346632|27173681|P5|Overall Study|Not Stated|0
7826252|NCT00346632|27173682|P4|Overall Study|Not Stated|0
7826253|NCT00346632|27173683|P3|Overall Study|Not Stated|0
7826254|NCT00346632|27173684|P2|Overall Study|Not Stated|1
7826255|NCT00346632|27173685|P1|Overall Study|Not Stated|1
7826256|NCT00346632|27173676|P10|Overall Study|Switched to alternative treatment|0
7826257|NCT00346632|27173677|P9|Overall Study|Switched to alternative treatment|0
7826258|NCT00346632|27173678|P8|Overall Study|Switched to alternative treatment|0
7826259|NCT00346632|27173679|P7|Overall Study|Switched to alternative treatment|0
7826260|NCT00346632|27173680|P6|Overall Study|Switched to alternative treatment|0
7826261|NCT00346632|27173681|P5|Overall Study|Switched to alternative treatment|0
7826262|NCT00346632|27173682|P4|Overall Study|Switched to alternative treatment|0
7826263|NCT00346632|27173683|P3|Overall Study|Switched to alternative treatment|1
7826264|NCT00346632|27173684|P2|Overall Study|Switched to alternative treatment|0
7826265|NCT00346632|27173685|P1|Overall Study|Switched to alternative treatment|0
7826266|NCT00346632|27173676|P10|Overall Study|Withdrawal by Subject|0
7826267|NCT00346632|27173677|P9|Overall Study|Withdrawal by Subject|0
7826268|NCT00346632|27173678|P8|Overall Study|Withdrawal by Subject|0
7826269|NCT00346632|27173679|P7|Overall Study|Withdrawal by Subject|1
7826270|NCT00346632|27173680|P6|Overall Study|Withdrawal by Subject|0
7826271|NCT00346632|27173681|P5|Overall Study|Withdrawal by Subject|0
7826272|NCT00346632|27173682|P4|Overall Study|Withdrawal by Subject|0
7826273|NCT00346632|27173683|P3|Overall Study|Withdrawal by Subject|0
7826274|NCT00346632|27173684|P2|Overall Study|Withdrawal by Subject|0
7826275|NCT00346632|27173685|P1|Overall Study|Withdrawal by Subject|0
7826276|NCT00346632|27173676|P10|Overall Study|Protocol Violation|0
7826277|NCT00346632|27173677|P9|Overall Study|Protocol Violation|0
7826278|NCT00346632|27173678|P8|Overall Study|Protocol Violation|0
7826279|NCT00346632|27173679|P7|Overall Study|Protocol Violation|1
7826280|NCT00346632|27173680|P6|Overall Study|Protocol Violation|0
7826281|NCT00346632|27173681|P5|Overall Study|Protocol Violation|0
7826282|NCT00346632|27173682|P4|Overall Study|Protocol Violation|0
7826283|NCT00346632|27173683|P3|Overall Study|Protocol Violation|0
7826284|NCT00346632|27173684|P2|Overall Study|Protocol Violation|0
7826285|NCT00346632|27173685|P1|Overall Study|Protocol Violation|0
7826286|NCT00346632|27173676|P10|Overall Study|Death|0
7826287|NCT00346632|27173677|P9|Overall Study|Death|0
7826288|NCT00346632|27173678|P8|Overall Study|Death|0
7826289|NCT00346632|27173679|P7|Overall Study|Death|0
7826290|NCT00346632|27173680|P6|Overall Study|Death|0
7826291|NCT00346632|27173681|P5|Overall Study|Death|0
7826292|NCT00346632|27173682|P4|Overall Study|Death|0
7826293|NCT00346632|27173683|P3|Overall Study|Death|1
7826294|NCT00346632|27173684|P2|Overall Study|Death|0
7826295|NCT00346632|27173685|P1|Overall Study|Death|0
7826296|NCT00346632|27173676|P10|Overall Study|Adverse Event|0
7826297|NCT00346632|27173677|P9|Overall Study|Adverse Event|0
7826298|NCT00346632|27173678|P8|Overall Study|Adverse Event|0
7826299|NCT00346632|27173679|P7|Overall Study|Adverse Event|1
7826300|NCT00346632|27173680|P6|Overall Study|Adverse Event|1
7826301|NCT00346632|27173681|P5|Overall Study|Adverse Event|1
7826302|NCT00346632|27173682|P4|Overall Study|Adverse Event|0
7826303|NCT00346632|27173683|P3|Overall Study|Adverse Event|0
7826304|NCT00346632|27173684|P2|Overall Study|Adverse Event|0
7826305|NCT00346632|27173685|P1|Overall Study|Adverse Event|0
7826306|NCT00346632|27173676|P10|Overall Study|Progressive Disease|2
7826307|NCT00346632|27173677|P9|Overall Study|Progressive Disease|2
7826308|NCT00346632|27173678|P8|Overall Study|Progressive Disease|2
7826309|NCT00346632|27173679|P7|Overall Study|Progressive Disease|2
7826310|NCT00346632|27173680|P6|Overall Study|Progressive Disease|1
7826311|NCT00346632|27173681|P5|Overall Study|Progressive Disease|3
7826312|NCT00346632|27173682|P4|Overall Study|Progressive Disease|3
7826313|NCT00346632|27173683|P3|Overall Study|Progressive Disease|4
7826314|NCT00346632|27173684|P2|Overall Study|Progressive Disease|2
7826315|NCT00346632|27173685|P1|Overall Study|Progressive Disease|2
7826316|NCT00346398|27173835|P2|Overall Study|Withdrawal by Subject|2
7826317|NCT00346398|27173836|P1|Overall Study|Withdrawal by Subject|0
7826318|NCT00346398|27173835|P2|Overall Study|Lost to Follow-up|0
7826319|NCT00346398|27173836|P1|Overall Study|Lost to Follow-up|3
7826320|NCT00346333|27173848|P2|Overall Study|unwilling or unable to continue|8
7826321|NCT00346333|27173849|P1|Overall Study|unwilling or unable to continue|4
7826322|NCT00346333|27173848|P2|Overall Study|Death|0
7826323|NCT00346333|27173849|P1|Overall Study|Death|1
7826324|NCT00346268|27173865|P2|Overall Study|Participant refused|3
7826325|NCT00346268|27173866|P1|Overall Study|Participant refused|0
7826326|NCT00346268|27173865|P2|Overall Study|Protocol Violation|0
7826327|NCT00346268|27173866|P1|Overall Study|Protocol Violation|1
7826328|NCT00346268|27173865|P2|Overall Study|Adverse Event|0
7826329|NCT00346268|27173866|P1|Overall Study|Adverse Event|1
7826330|NCT00346216|27173901|P3|Overall Study|Missing Subject Summary Status|62
7826331|NCT00346216|27173902|P2|Overall Study|Missing Subject Summary Status|61
7826332|NCT00346216|27173903|P1|Overall Study|Missing Subject Summary Status|62
7826333|NCT00346216|27173901|P3|Overall Study|Study terminated by sponsor|8
7826334|NCT00346216|27173902|P2|Overall Study|Study terminated by sponsor|4
7826335|NCT00346216|27173903|P1|Overall Study|Study terminated by sponsor|11
7826336|NCT00346216|27173901|P3|Overall Study|Death|228
7826337|NCT00346216|27173902|P2|Overall Study|Death|192
7826338|NCT00346216|27173903|P1|Overall Study|Death|189
7826339|NCT00346216|27173901|P3|Overall Study|Does not meet entrance criteria|8
7826340|NCT00346216|27173902|P2|Overall Study|Does not meet entrance criteria|10
7826341|NCT00346216|27173903|P1|Overall Study|Does not meet entrance criteria|13
7826342|NCT00346216|27173901|P3|Overall Study|Physician Decision|59
7826343|NCT00346216|27173902|P2|Overall Study|Physician Decision|76
7826344|NCT00346216|27173903|P1|Overall Study|Physician Decision|80
7826345|NCT00346216|27173901|P3|Overall Study|Lost to Follow-up|542
7826346|NCT00346216|27173902|P2|Overall Study|Lost to Follow-up|588
7826347|NCT00346216|27173903|P1|Overall Study|Lost to Follow-up|611
7826348|NCT00346216|27173901|P3|Overall Study|Withdrawal by Subject|651
7826349|NCT00346216|27173902|P2|Overall Study|Withdrawal by Subject|692
7826350|NCT00346216|27173903|P1|Overall Study|Withdrawal by Subject|661
7826351|NCT00346216|27173901|P3|Overall Study|No longer willing to participate|585
7826352|NCT00346216|27173902|P2|Overall Study|No longer willing to participate|606
7826353|NCT00346216|27173903|P1|Overall Study|No longer willing to participate|600
7826354|NCT00346216|27173901|P3|Overall Study|Other|205
7826355|NCT00346216|27173902|P2|Overall Study|Other|231
7826356|NCT00346216|27173903|P1|Overall Study|Other|181
7826357|NCT00346164|27173924|P4|Overall Study|Inability to start week 16 tx on time|11
7826358|NCT00346164|27173925|P3|Overall Study|Inability to start week 16 tx on time|0
7826359|NCT00346164|27173926|P2|Overall Study|Inability to start week 16 tx on time|0
7826360|NCT00346164|27173927|P1|Overall Study|Inability to start week 16 tx on time|0
7826361|NCT00346164|27173924|P4|Overall Study|Refusal of further protocol therapy|15
7826362|NCT00346164|27173925|P3|Overall Study|Refusal of further protocol therapy|3
7826363|NCT00346164|27173926|P2|Overall Study|Refusal of further protocol therapy|1
7826364|NCT00346164|27173927|P1|Overall Study|Refusal of further protocol therapy|0
7826365|NCT00346164|27173924|P4|Overall Study|Ineligible|23
7826366|NCT00346164|27173925|P3|Overall Study|Ineligible|2
7826367|NCT00346164|27173926|P2|Overall Study|Ineligible|2
7826368|NCT00346164|27173927|P1|Overall Study|Ineligible|11
7826369|NCT00346164|27173924|P4|Overall Study|Withdrawal by Subject|0
7826370|NCT00346164|27173925|P3|Overall Study|Withdrawal by Subject|2
7826371|NCT00346164|27173926|P2|Overall Study|Withdrawal by Subject|0
7826372|NCT00346164|27173927|P1|Overall Study|Withdrawal by Subject|0
7826373|NCT00346164|27173924|P4|Overall Study|Protocol Violation|4
7826374|NCT00346164|27173925|P3|Overall Study|Protocol Violation|10
7826375|NCT00346164|27173926|P2|Overall Study|Protocol Violation|2
7826376|NCT00346164|27173927|P1|Overall Study|Protocol Violation|6
7826377|NCT00346164|27173924|P4|Overall Study|Physician Decision|27
7826378|NCT00346164|27173925|P3|Overall Study|Physician Decision|2
7826379|NCT00346164|27173926|P2|Overall Study|Physician Decision|1
7826380|NCT00346164|27173927|P1|Overall Study|Physician Decision|0
7826381|NCT00346164|27173924|P4|Overall Study|Lack of Efficacy|25
7826382|NCT00346164|27173925|P3|Overall Study|Lack of Efficacy|7
7826383|NCT00346164|27173926|P2|Overall Study|Lack of Efficacy|1
7826384|NCT00346164|27173927|P1|Overall Study|Lack of Efficacy|0
7826385|NCT00346164|27173924|P4|Overall Study|Adverse Event|1
7826386|NCT00346164|27173925|P3|Overall Study|Adverse Event|0
7826387|NCT00346164|27173926|P2|Overall Study|Adverse Event|0
7826388|NCT00346164|27173927|P1|Overall Study|Adverse Event|0
7826389|NCT00346151|27173962|P1|Overall Study|Withdrawal by Subject|3
7826390|NCT00346073|27173982|P2|Overall Study|Lost to Follow-up|24
7826391|NCT00346073|27173983|P1|Overall Study|Lost to Follow-up|39
7826392|NCT00346073|27173982|P2|Overall Study|Serious Adverse Event|0
7826393|NCT00346073|27173983|P1|Overall Study|Serious Adverse Event|2
7826394|NCT00346034|27174017|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
7826395|NCT00346034|27174017|P1|Overall Study|Patient Stopped Taking Study Drug|1
7826396|NCT00346034|27174017|P1|Overall Study|Withdrawal by Subject|13
7826397|NCT00346034|27174017|P1|Overall Study|Lack of Efficacy|8
7826398|NCT00346034|27174017|P1|Overall Study|Adverse Event|34
7826399|NCT00345878|27174057|P2|Overall Study|Other|0
7826400|NCT00345878|27174058|P1|Overall Study|Other|1
7826401|NCT00345878|27174057|P2|Overall Study|Lost to Follow-up|1
7826402|NCT00345878|27174058|P1|Overall Study|Lost to Follow-up|2
7826403|NCT00345878|27174057|P2|Overall Study|Adverse Event|0
7826404|NCT00345878|27174058|P1|Overall Study|Adverse Event|1
7826405|NCT00345839|27174117|P2|Overall Study|Lost to Follow-up|61
7826406|NCT00345839|27174118|P1|Overall Study|Lost to Follow-up|58
7826407|NCT00345839|27174117|P2|Overall Study|Withdrawal by Subject|98
7826408|NCT00345839|27174118|P1|Overall Study|Withdrawal by Subject|91
7826409|NCT00345683|27174144|P2|Overall Study|Other|2
7826410|NCT00345683|27174145|P1|Overall Study|Other|6
7826411|NCT00345683|27174144|P2|Overall Study|Lost to Follow-up|7
7826412|NCT00345683|27174145|P1|Overall Study|Lost to Follow-up|19
7826413|NCT00345631|27174168|P3|Overall Study|Other reasons|1
7826414|NCT00345631|27174169|P2|Overall Study|Other reasons|0
7826415|NCT00345631|27174170|P1|Overall Study|Other reasons|0
7826416|NCT00345631|27174168|P3|Overall Study|Lost to Follow-up|4
7826417|NCT00345631|27174169|P2|Overall Study|Lost to Follow-up|7
7826418|NCT00345631|27174170|P1|Overall Study|Lost to Follow-up|3
7826419|NCT00345631|27174168|P3|Overall Study|Adverse Event|0
7826420|NCT00345631|27174169|P2|Overall Study|Adverse Event|1
7826421|NCT00345631|27174170|P1|Overall Study|Adverse Event|0
7826422|NCT00345631|27174168|P3|Overall Study|Withdrawal by Subject|1
7826423|NCT00345631|27174169|P2|Overall Study|Withdrawal by Subject|0
7826424|NCT00345631|27174170|P1|Overall Study|Withdrawal by Subject|1
7826425|NCT00345605|27174202|P2|Arm 2, Opposite Treatment|Adverse Event|0
7826426|NCT00345605|27174203|P1|Arm 2, Opposite Treatment|Adverse Event|1
7826427|NCT00345605|27174202|P2|Arm 1|Adverse Event|1
7826428|NCT00345605|27174203|P1|Arm 1|Adverse Event|0
7826429|NCT00345592|27174223|P2|Overall Study|Withdrawal by Subject|8
7826430|NCT00345592|27174224|P1|Overall Study|Withdrawal by Subject|11
7826431|NCT00345592|27174223|P2|Overall Study|Death|16
7826432|NCT00345592|27174224|P1|Overall Study|Death|14
7826433|NCT00345579|27174232|P2|Overall Study|Other|1
7826434|NCT00345579|27174233|P1|Overall Study|Other|9
7826435|NCT00345579|27174232|P2|Overall Study|Lost to Follow-up|36
7826436|NCT00345579|27174233|P1|Overall Study|Lost to Follow-up|82
7826437|NCT00345579|27174232|P2|Overall Study|Withdrawal by Subject|17
7826438|NCT00345579|27174233|P1|Overall Study|Withdrawal by Subject|50
7826439|NCT00345579|27174232|P2|Overall Study|Protocol Violation|5
7826440|NCT00345579|27174233|P1|Overall Study|Protocol Violation|14
7826441|NCT00345579|27174232|P2|Overall Study|Adverse Event|6
7826442|NCT00345579|27174233|P1|Overall Study|Adverse Event|9
7826443|NCT00345540|27174253|P1|Overall Study|Withdrawal by Subject|1
7826444|NCT00345397|27174259|P1|Overall Study|Death|1
7826445|NCT00345358|27174290|P4|Booster Vaccination Phase|Lost to Follow-up|0
7826446|NCT00345358|27174291|P3|Booster Vaccination Phase|Lost to Follow-up|0
7826447|NCT00345358|27174292|P2|Booster Vaccination Phase|Lost to Follow-up|0
7826448|NCT00345358|27174293|P1|Booster Vaccination Phase|Lost to Follow-up|3
7826449|NCT00345358|27174290|P4|Booster Vaccination Phase|Withdrawal by Subject|0
7826450|NCT00345358|27174291|P3|Booster Vaccination Phase|Withdrawal by Subject|0
7826451|NCT00345358|27174292|P2|Booster Vaccination Phase|Withdrawal by Subject|0
7826452|NCT00345358|27174293|P1|Booster Vaccination Phase|Withdrawal by Subject|1
7826453|NCT00345358|27174290|P4|Primary Vaccination Phase|Lost to Follow-up|2
7826454|NCT00345358|27174291|P3|Primary Vaccination Phase|Lost to Follow-up|2
7826455|NCT00345358|27174292|P2|Primary Vaccination Phase|Lost to Follow-up|0
7826456|NCT00345358|27174293|P1|Primary Vaccination Phase|Lost to Follow-up|1
7826457|NCT00345358|27174290|P4|Primary Vaccination Phase|Withdrawal by Subject|0
7826458|NCT00345358|27174291|P3|Primary Vaccination Phase|Withdrawal by Subject|4
7826459|NCT00345358|27174292|P2|Primary Vaccination Phase|Withdrawal by Subject|2
7826460|NCT00345358|27174293|P1|Primary Vaccination Phase|Withdrawal by Subject|1
7826461|NCT00345358|27174290|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
7826462|NCT00345358|27174291|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
7826463|NCT00345358|27174292|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
7826464|NCT00345358|27174293|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
7826465|NCT00345358|27174290|P4|Primary Vaccination Phase|Other|0
7826466|NCT00345358|27174291|P3|Primary Vaccination Phase|Other|1
7826467|NCT00345358|27174292|P2|Primary Vaccination Phase|Other|1
7826468|NCT00345358|27174293|P1|Primary Vaccination Phase|Other|0
7826469|NCT00345293|27174383|P2|Overall Study|Withdrawal by Subject|0
7826470|NCT00345293|27174384|P1|Overall Study|Withdrawal by Subject|1
7826471|NCT00345293|27174383|P2|Overall Study|Unable to access line for sample|0
7826472|NCT00345293|27174384|P1|Overall Study|Unable to access line for sample|1
7826473|NCT00345046|27174430|P3|Overall Study|Protocol Violation|2
7826474|NCT00345046|27174431|P2|Overall Study|Protocol Violation|1
7826475|NCT00345046|27174432|P1|Overall Study|Protocol Violation|1
7826476|NCT00344968|27174462|P3|Overall Study|Other|0
7826477|NCT00344968|27174463|P2|Overall Study|Other|1
7826478|NCT00344968|27174464|P1|Overall Study|Other|0
7826479|NCT00344968|27174462|P3|Overall Study|Death|31
7826480|NCT00344968|27174463|P2|Overall Study|Death|27
7826481|NCT00344968|27174464|P1|Overall Study|Death|11
7826482|NCT00344968|27174462|P3|Overall Study|Lost to Follow-up|37
7826483|NCT00344968|27174463|P2|Overall Study|Lost to Follow-up|37
7826484|NCT00344968|27174464|P1|Overall Study|Lost to Follow-up|24
7826485|NCT00344968|27174462|P3|Overall Study|Withdrawal by Subject|27
7826486|NCT00344968|27174463|P2|Overall Study|Withdrawal by Subject|31
7826487|NCT00344968|27174464|P1|Overall Study|Withdrawal by Subject|14
7826488|NCT00344968|27174462|P3|Overall Study|Protocol Violation|5
7826489|NCT00344968|27174463|P2|Overall Study|Protocol Violation|2
7826490|NCT00344968|27174464|P1|Overall Study|Protocol Violation|2
7826491|NCT00344968|27174462|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
7826492|NCT00344968|27174463|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
7826493|NCT00344968|27174464|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
7826494|NCT00344968|27174462|P3|Overall Study|Adverse Event|15
7826495|NCT00344968|27174463|P2|Overall Study|Adverse Event|4
7826496|NCT00344968|27174464|P1|Overall Study|Adverse Event|5
7826497|NCT00344773|27174475|P1|Overall Study|Not Eligible for the study|2
7826498|NCT00344773|27174475|P1|Overall Study|Withdrawal by Subject|1
7826499|NCT00344773|27174475|P1|Overall Study|Objective Disease Progression|16
7826500|NCT00344773|27174475|P1|Overall Study|Adverse Event|2
7826501|NCT00344500|27174498|P3|Overall Study|Not Noted|0
7826502|NCT00344500|27174499|P2|Overall Study|Not Noted|3
7826503|NCT00344500|27174500|P1|Overall Study|Not Noted|1
7826504|NCT00344500|27174498|P3|Overall Study|Protocol Violation|1
7826505|NCT00344500|27174499|P2|Overall Study|Protocol Violation|7
7826506|NCT00344500|27174500|P1|Overall Study|Protocol Violation|4
7826507|NCT00344500|27174498|P3|Overall Study|Withdrawal by Subject|0
7826508|NCT00344500|27174499|P2|Overall Study|Withdrawal by Subject|10
7826509|NCT00344500|27174500|P1|Overall Study|Withdrawal by Subject|7
7826510|NCT00344500|27174498|P3|Overall Study|Lost to Follow-up|1
7826511|NCT00344500|27174499|P2|Overall Study|Lost to Follow-up|13
7826512|NCT00344500|27174500|P1|Overall Study|Lost to Follow-up|5
7826513|NCT00344500|27174498|P3|Overall Study|Adverse Event|0
7826514|NCT00344500|27174499|P2|Overall Study|Adverse Event|2
7826515|NCT00344500|27174500|P1|Overall Study|Adverse Event|6
7826517|NCT00344461|27174515|P1|Overall Study|Withdrawal by Subject|2
7826518|NCT00344461|27174515|P1|Overall Study|Protocol Violation|6
7826519|NCT00344461|27174515|P1|Overall Study|Physician Decision|2
7826520|NCT00344461|27174515|P1|Overall Study|Lost to Follow-up|2
7826521|NCT00344461|27174515|P1|Overall Study|Lack of Efficacy|2
7826522|NCT00344461|27174515|P1|Overall Study|Death|1
7826523|NCT00344461|27174515|P1|Overall Study|Adverse Event|6
7826524|NCT00344448|27174526|P2|Open Label|Study terminated|0
7826525|NCT00344448|27174527|P1|Open Label|Study terminated|1
7826526|NCT00344448|27174526|P2|Open Label|Withdrawal by Subject|1
7826527|NCT00344448|27174527|P1|Open Label|Withdrawal by Subject|1
7826528|NCT00344448|27174526|P2|Double Blind, Placebo Controlled|Study terminated|0
7826529|NCT00344448|27174527|P1|Double Blind, Placebo Controlled|Study terminated|1
7826530|NCT00344448|27174526|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
7826531|NCT00344448|27174527|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
7826532|NCT00344448|27174526|P2|Screening|Withdrawal by Subject|1
7826533|NCT00344448|27174527|P1|Screening|Withdrawal by Subject|0
7826534|NCT00344318|27174548|P4|Overall Study|Lost to Follow-up|0
7826535|NCT00344318|27174549|P3|Overall Study|Lost to Follow-up|1
7826536|NCT00344318|27174550|P2|Overall Study|Lost to Follow-up|0
7826537|NCT00344318|27174551|P1|Overall Study|Lost to Follow-up|2
7826538|NCT00344318|27174548|P4|Overall Study|Withdrawal by Subject|2
7826539|NCT00344318|27174549|P3|Overall Study|Withdrawal by Subject|0
7826540|NCT00344318|27174550|P2|Overall Study|Withdrawal by Subject|2
7826541|NCT00344318|27174551|P1|Overall Study|Withdrawal by Subject|2
7826542|NCT00344318|27174548|P4|Overall Study|Adverse Event|1
7826543|NCT00344318|27174549|P3|Overall Study|Adverse Event|0
7826544|NCT00344318|27174550|P2|Overall Study|Adverse Event|3
7826545|NCT00344318|27174551|P1|Overall Study|Adverse Event|0
7826546|NCT00344305|27174673|P2|Overall Study|Participant was not contacted in window|1
7826547|NCT00344305|27174674|P1|Overall Study|Participant was not contacted in window|0
7826548|NCT00344305|27174673|P2|Overall Study|Lost to Follow-up|0
7826549|NCT00344305|27174674|P1|Overall Study|Lost to Follow-up|2
7826550|NCT00344032|27174724|P2|Overall Study|Physician Decision|1
7826551|NCT00344032|27174725|P1|Overall Study|Physician Decision|4
7826552|NCT00344032|27174724|P2|Overall Study|Lost to Follow-up|6
7826553|NCT00344032|27174725|P1|Overall Study|Lost to Follow-up|4
7826554|NCT00344032|27174724|P2|Overall Study|Withdrawal by Subject|2
7826555|NCT00344032|27174725|P1|Overall Study|Withdrawal by Subject|6
7826556|NCT00344032|27174724|P2|Overall Study|Adverse Event|1
7826557|NCT00344032|27174725|P1|Overall Study|Adverse Event|0
7826558|NCT00344019|27174744|P3|Overall Study|did not meet final inclusion criteria|74
7826559|NCT00344019|27174745|P2|Overall Study|did not meet final inclusion criteria|0
7826560|NCT00344019|27174746|P1|Overall Study|did not meet final inclusion criteria|0
7826561|NCT00343915|27174764|P2|Primary Study|Other|0
7826562|NCT00343915|27174765|P1|Primary Study|Other|1
7826563|NCT00343915|27174764|P2|Primary Study|Lost to Follow-up|3
7826564|NCT00343915|27174765|P1|Primary Study|Lost to Follow-up|2
7826565|NCT00343915|27174764|P2|Primary Study|Withdrawal by Subject|0
7826566|NCT00343915|27174765|P1|Primary Study|Withdrawal by Subject|1
7826567|NCT00343889|27174791|P2|Overall Study|Protocol Violation|0
7826568|NCT00343889|27174792|P1|Overall Study|Protocol Violation|1
7826569|NCT00343889|27174791|P2|Overall Study|Withdrawal by Subject|1
7826570|NCT00343889|27174792|P1|Overall Study|Withdrawal by Subject|0
7826571|NCT00343889|27174791|P2|Overall Study|Lost to Follow-up|0
7826572|NCT00343889|27174792|P1|Overall Study|Lost to Follow-up|2
7826573|NCT00343642|27174842|P3|Overall Study|Flare up|0
7826574|NCT00343642|27174843|P2|Overall Study|Flare up|4
7826575|NCT00343642|27174844|P1|Overall Study|Flare up|6
7826576|NCT00343642|27174842|P3|Overall Study|Adverse Event|1
7826577|NCT00343642|27174843|P2|Overall Study|Adverse Event|0
7826578|NCT00343642|27174844|P1|Overall Study|Adverse Event|0
7826579|NCT00343642|27174842|P3|Overall Study|Withdrawal by Subject|4
7826580|NCT00343642|27174843|P2|Overall Study|Withdrawal by Subject|3
7826581|NCT00343642|27174844|P1|Overall Study|Withdrawal by Subject|2
7826582|NCT00343642|27174842|P3|Overall Study|Pregnancy|2
7826583|NCT00343642|27174843|P2|Overall Study|Pregnancy|0
7826584|NCT00343642|27174844|P1|Overall Study|Pregnancy|1
7826585|NCT00343642|27174842|P3|Overall Study|Lost to Follow-up|0
7826586|NCT00343642|27174843|P2|Overall Study|Lost to Follow-up|1
7826587|NCT00343642|27174844|P1|Overall Study|Lost to Follow-up|0
7826588|NCT00343512|27174978|P1|Overall Study|Withdrawal by Subject|2
7826589|NCT00343382|27175066|P3|Overall Study|Other Reason Not Specified|4
7826590|NCT00343382|27175067|P2|Overall Study|Other Reason Not Specified|2
7826591|NCT00343382|27175068|P1|Overall Study|Other Reason Not Specified|1
7826592|NCT00343382|27175066|P3|Overall Study|Withdrawal by Subject|6
7826593|NCT00343382|27175067|P2|Overall Study|Withdrawal by Subject|2
7826594|NCT00343382|27175068|P1|Overall Study|Withdrawal by Subject|1
7826595|NCT00343382|27175066|P3|Overall Study|Adverse Event|7
7826596|NCT00343382|27175067|P2|Overall Study|Adverse Event|10
7826597|NCT00343382|27175068|P1|Overall Study|Adverse Event|2
7826598|NCT00343291|27175087|P2|Overall Study|Other|5
7826599|NCT00343291|27175088|P1|Overall Study|Other|8
7826600|NCT00343291|27175087|P2|Overall Study|Withdrawal by Subject|2
7826601|NCT00343291|27175088|P1|Overall Study|Withdrawal by Subject|0
7826602|NCT00343291|27175087|P2|Overall Study|Progressive disease|34
7826603|NCT00343291|27175088|P1|Overall Study|Progressive disease|33
7826604|NCT00343291|27175087|P2|Overall Study|Death|2
7826605|NCT00343291|27175088|P1|Overall Study|Death|3
7826606|NCT00343291|27175087|P2|Overall Study|Adverse Event|13
7826607|NCT00343291|27175088|P1|Overall Study|Adverse Event|13
7826608|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
7826609|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
7826610|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Sponsor Decision|5
7826611|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Sponsor Decision|8
7826612|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Protocol Violation|3
7826613|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Protocol Violation|3
7826614|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Physician Decision|7
7826615|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Physician Decision|4
7826616|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
7826617|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
7826618|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
7826619|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
7826620|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
7826621|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
7826622|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Death|5
7826623|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Death|4
7826624|NCT00343252|27175104|P2|18 Months (All Treated Participants)|Adverse Event|23
7826625|NCT00343252|27175105|P1|18 Months (All Treated Participants)|Adverse Event|31
7826626|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
7826627|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
7826628|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Sponsor Decision|6
7826629|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Sponsor Decision|9
7826630|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Protocol Violation|2
7826631|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Protocol Violation|3
7826632|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Physician Decision|5
7826633|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Physician Decision|4
7826634|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
7826635|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
7826636|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
7826637|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
7826638|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
7826639|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
7826640|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Death|3
7826641|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Death|3
7826642|NCT00343252|27175104|P2|12 Months (All Treated Participants)|Adverse Event|20
7826643|NCT00343252|27175105|P1|12 Months (All Treated Participants)|Adverse Event|22
7826644|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
7826645|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
7826646|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Sponsor Decision|4
7826647|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Sponsor Decision|7
7826648|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Protocol Violation|2
7826649|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Protocol Violation|2
7826650|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Physician Decision|3
7826651|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Physician Decision|1
7826652|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
7826653|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
7826654|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
7826655|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
7826656|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
7826657|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
7826658|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Death|2
7826659|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Death|0
7826660|NCT00343252|27175104|P2|6 Months (All Treated Participants)|Adverse Event|11
7826661|NCT00343252|27175105|P1|6 Months (All Treated Participants)|Adverse Event|17
7826662|NCT00342628|27175170|P3|Overall Study|moved residence|1
7826663|NCT00342628|27175171|P2|Overall Study|moved residence|1
7826664|NCT00342628|27175172|P1|Overall Study|moved residence|0
7826665|NCT00342628|27175170|P3|Overall Study|Death|0
7826666|NCT00342628|27175171|P2|Overall Study|Death|1
7826667|NCT00342628|27175172|P1|Overall Study|Death|1
7826668|NCT00342628|27175170|P3|Overall Study|Withdrawal by Subject|18
7826669|NCT00342628|27175171|P2|Overall Study|Withdrawal by Subject|19
7826670|NCT00342628|27175172|P1|Overall Study|Withdrawal by Subject|19
7826671|NCT00340834|27175238|P5|Extension Phase of Study|Death|1
7826672|NCT00340834|27175239|P4|Extension Phase of Study|Death|0
7826673|NCT00340834|27175240|P3|Extension Phase of Study|Death|0
7826674|NCT00340834|27175241|P2|Extension Phase of Study|Death|0
7826675|NCT00340834|27175242|P1|Extension Phase of Study|Death|0
7826676|NCT00340834|27175238|P5|Extension Phase of Study|Protocol Violation|0
7826677|NCT00340834|27175239|P4|Extension Phase of Study|Protocol Violation|0
7826678|NCT00340834|27175240|P3|Extension Phase of Study|Protocol Violation|0
7826679|NCT00340834|27175241|P2|Extension Phase of Study|Protocol Violation|0
7826680|NCT00340834|27175242|P1|Extension Phase of Study|Protocol Violation|3
7826681|NCT00340834|27175238|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
7826682|NCT00340834|27175239|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
7826683|NCT00340834|27175240|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
7826684|NCT00340834|27175241|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
7826685|NCT00340834|27175242|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
7826686|NCT00340834|27175238|P5|Extension Phase of Study|Administrative problems|1
7826687|NCT00340834|27175239|P4|Extension Phase of Study|Administrative problems|1
7826688|NCT00340834|27175240|P3|Extension Phase of Study|Administrative problems|0
7826689|NCT00340834|27175241|P2|Extension Phase of Study|Administrative problems|0
7826690|NCT00340834|27175242|P1|Extension Phase of Study|Administrative problems|3
7826691|NCT00340834|27175238|P5|Extension Phase of Study|Subject no longer requires study drug|2
7826692|NCT00340834|27175239|P4|Extension Phase of Study|Subject no longer requires study drug|0
7826693|NCT00340834|27175240|P3|Extension Phase of Study|Subject no longer requires study drug|0
7826694|NCT00340834|27175241|P2|Extension Phase of Study|Subject no longer requires study drug|0
7826695|NCT00340834|27175242|P1|Extension Phase of Study|Subject no longer requires study drug|4
7826696|NCT00340834|27175238|P5|Extension Phase of Study|Lost to Follow-up|3
7826697|NCT00340834|27175239|P4|Extension Phase of Study|Lost to Follow-up|2
7826698|NCT00340834|27175240|P3|Extension Phase of Study|Lost to Follow-up|0
7826699|NCT00340834|27175241|P2|Extension Phase of Study|Lost to Follow-up|1
7826700|NCT00340834|27175242|P1|Extension Phase of Study|Lost to Follow-up|1
7826701|NCT00340834|27175238|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
7826702|NCT00340834|27175239|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
7826703|NCT00340834|27175240|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
7826704|NCT00340834|27175241|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
7826705|NCT00340834|27175242|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
7826706|NCT00340834|27175238|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
7826707|NCT00340834|27175239|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
7826708|NCT00340834|27175240|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
7826709|NCT00340834|27175241|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
7826710|NCT00340834|27175242|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
7826711|NCT00340834|27175238|P5|Extension Phase of Study|Adverse Event|7
7826712|NCT00340834|27175239|P4|Extension Phase of Study|Adverse Event|19
7826713|NCT00340834|27175240|P3|Extension Phase of Study|Adverse Event|0
7826714|NCT00340834|27175241|P2|Extension Phase of Study|Adverse Event|22
7826715|NCT00340834|27175242|P1|Extension Phase of Study|Adverse Event|21
7826716|NCT00340834|27175238|P5|Extension Phase of Study|Subject withdrew consent|15
7826717|NCT00340834|27175239|P4|Extension Phase of Study|Subject withdrew consent|12
7826718|NCT00340834|27175240|P3|Extension Phase of Study|Subject withdrew consent|0
7826719|NCT00340834|27175241|P2|Extension Phase of Study|Subject withdrew consent|31
7826720|NCT00340834|27175242|P1|Extension Phase of Study|Subject withdrew consent|26
7826721|NCT00340834|27175238|P5|Extension Phase of Study|Subject did not receive study drug|0
7826722|NCT00340834|27175239|P4|Extension Phase of Study|Subject did not receive study drug|2
7826723|NCT00340834|27175240|P3|Extension Phase of Study|Subject did not receive study drug|0
7826724|NCT00340834|27175241|P2|Extension Phase of Study|Subject did not receive study drug|1
7826725|NCT00340834|27175242|P1|Extension Phase of Study|Subject did not receive study drug|0
7826726|NCT00340834|27175238|P5|Core Phase of Study|Protocol Violation|0
7826727|NCT00340834|27175239|P4|Core Phase of Study|Protocol Violation|0
7826728|NCT00340834|27175240|P3|Core Phase of Study|Protocol Violation|2
7826729|NCT00340834|27175241|P2|Core Phase of Study|Protocol Violation|0
7826730|NCT00340834|27175242|P1|Core Phase of Study|Protocol Violation|0
7826731|NCT00340834|27175238|P5|Core Phase of Study|Death|0
7826732|NCT00340834|27175239|P4|Core Phase of Study|Death|0
7826733|NCT00340834|27175240|P3|Core Phase of Study|Death|0
7826734|NCT00340834|27175241|P2|Core Phase of Study|Death|0
7826735|NCT00340834|27175242|P1|Core Phase of Study|Death|2
7826736|NCT00340834|27175238|P5|Core Phase of Study|Lost to Follow-up|0
7826737|NCT00340834|27175239|P4|Core Phase of Study|Lost to Follow-up|0
7826738|NCT00340834|27175240|P3|Core Phase of Study|Lost to Follow-up|4
7826739|NCT00340834|27175241|P2|Core Phase of Study|Lost to Follow-up|1
7826740|NCT00340834|27175242|P1|Core Phase of Study|Lost to Follow-up|1
7826741|NCT00340834|27175238|P5|Core Phase of Study|Abnormal test procedure result(s)|0
7826742|NCT00340834|27175239|P4|Core Phase of Study|Abnormal test procedure result(s)|0
7826743|NCT00340834|27175240|P3|Core Phase of Study|Abnormal test procedure result(s)|3
7826744|NCT00340834|27175241|P2|Core Phase of Study|Abnormal test procedure result(s)|3
7826745|NCT00340834|27175242|P1|Core Phase of Study|Abnormal test procedure result(s)|4
7826746|NCT00340834|27175238|P5|Core Phase of Study|Abnormal laboratory value(s)|0
7826747|NCT00340834|27175239|P4|Core Phase of Study|Abnormal laboratory value(s)|0
7826748|NCT00340834|27175240|P3|Core Phase of Study|Abnormal laboratory value(s)|1
7826749|NCT00340834|27175241|P2|Core Phase of Study|Abnormal laboratory value(s)|6
7826750|NCT00340834|27175242|P1|Core Phase of Study|Abnormal laboratory value(s)|4
7826751|NCT00340834|27175238|P5|Core Phase of Study|Lack of Efficacy|0
7826752|NCT00340834|27175239|P4|Core Phase of Study|Lack of Efficacy|0
7826753|NCT00340834|27175240|P3|Core Phase of Study|Lack of Efficacy|7
7826754|NCT00340834|27175241|P2|Core Phase of Study|Lack of Efficacy|3
7826755|NCT00340834|27175242|P1|Core Phase of Study|Lack of Efficacy|3
7826756|NCT00340834|27175238|P5|Core Phase of Study|Administrative Problems|0
7826757|NCT00340834|27175239|P4|Core Phase of Study|Administrative Problems|0
7826758|NCT00340834|27175240|P3|Core Phase of Study|Administrative Problems|7
7826759|NCT00340834|27175241|P2|Core Phase of Study|Administrative Problems|2
7826760|NCT00340834|27175242|P1|Core Phase of Study|Administrative Problems|6
7826761|NCT00340834|27175238|P5|Core Phase of Study|Withdrawal by Subject|0
7826762|NCT00340834|27175239|P4|Core Phase of Study|Withdrawal by Subject|0
7826763|NCT00340834|27175240|P3|Core Phase of Study|Withdrawal by Subject|16
7826764|NCT00340834|27175241|P2|Core Phase of Study|Withdrawal by Subject|9
7826765|NCT00340834|27175242|P1|Core Phase of Study|Withdrawal by Subject|11
7826766|NCT00340834|27175238|P5|Core Phase of Study|Adverse Event|0
7826767|NCT00340834|27175239|P4|Core Phase of Study|Adverse Event|0
7826768|NCT00340834|27175240|P3|Core Phase of Study|Adverse Event|9
7826769|NCT00340834|27175241|P2|Core Phase of Study|Adverse Event|9
7826770|NCT00340834|27175242|P1|Core Phase of Study|Adverse Event|26
7826771|NCT00340704|27175276|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
7826772|NCT00340704|27175277|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
7826773|NCT00340704|27175278|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
7826774|NCT00340704|27175279|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
7826775|NCT00340704|27175280|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7826776|NCT00340704|27175281|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7826777|NCT00340704|27175282|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7826778|NCT00340704|27175283|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7826779|NCT00340704|27175284|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7826780|NCT00340704|27175276|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826781|NCT00340704|27175277|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826782|NCT00340704|27175278|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826783|NCT00340704|27175279|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
7826784|NCT00340704|27175280|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
7826785|NCT00340704|27175281|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826786|NCT00340704|27175282|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826787|NCT00340704|27175283|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826788|NCT00340704|27175284|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7826789|NCT00340704|27175276|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826790|NCT00340704|27175277|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826791|NCT00340704|27175278|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826792|NCT00340704|27175279|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
7826793|NCT00340704|27175280|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826794|NCT00340704|27175281|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826795|NCT00340704|27175282|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826796|NCT00340704|27175283|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826797|NCT00340704|27175284|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7826798|NCT00340704|27175276|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
7826799|NCT00340704|27175277|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
7826800|NCT00340704|27175278|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7826801|NCT00340704|27175279|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7826802|NCT00340704|27175280|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
7826803|NCT00340704|27175281|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
7826804|NCT00340704|27175282|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7826805|NCT00340704|27175283|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7826806|NCT00340704|27175284|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7826807|NCT00340704|27175276|P9|PK Study|Not treated|0
7826808|NCT00340704|27175277|P8|PK Study|Not treated|0
7826809|NCT00340704|27175278|P7|PK Study|Not treated|0
7826810|NCT00340704|27175279|P6|PK Study|Not treated|0
7826811|NCT00340704|27175280|P5|PK Study|Not treated|0
7826812|NCT00340704|27175281|P4|PK Study|Not treated|0
7826813|NCT00340704|27175282|P3|PK Study|Not treated|1
7826814|NCT00340704|27175283|P2|PK Study|Not treated|0
7826815|NCT00340704|27175284|P1|PK Study|Not treated|0
7826816|NCT00340704|27175276|P9|PK Study|Adverse Event|0
7826817|NCT00340704|27175277|P8|PK Study|Adverse Event|0
7826818|NCT00340704|27175278|P7|PK Study|Adverse Event|0
7826819|NCT00340704|27175279|P6|PK Study|Adverse Event|0
7826820|NCT00340704|27175280|P5|PK Study|Adverse Event|0
7826821|NCT00340704|27175281|P4|PK Study|Adverse Event|0
7826822|NCT00340704|27175282|P3|PK Study|Adverse Event|0
7826823|NCT00340704|27175283|P2|PK Study|Adverse Event|1
7826824|NCT00340704|27175284|P1|PK Study|Adverse Event|0
7826825|NCT00340678|27175390|P4|Overall Study|Lost to Follow-up|0
7826826|NCT00340678|27175391|P3|Overall Study|Lost to Follow-up|0
7826827|NCT00340678|27175392|P2|Overall Study|Lost to Follow-up|0
7826828|NCT00340678|27175393|P1|Overall Study|Lost to Follow-up|1
7826829|NCT00339833|27175420|P2|Overall Study|Error in data records|0
7826830|NCT00339833|27175421|P1|Overall Study|Error in data records|1
7826831|NCT00339833|27175420|P2|Overall Study|anaemia or excess drop in glycaemia|0
7826832|NCT00339833|27175421|P1|Overall Study|anaemia or excess drop in glycaemia|2
7826833|NCT00339833|27175420|P2|Overall Study|Poor venous access|2
7826834|NCT00339833|27175421|P1|Overall Study|Poor venous access|2
7826835|NCT00339833|27175420|P2|Overall Study|minor infection|1
7826836|NCT00339833|27175421|P1|Overall Study|minor infection|0
7826837|NCT00339833|27175420|P2|Overall Study|Chest pain|1
7826838|NCT00339833|27175421|P1|Overall Study|Chest pain|0
7826839|NCT00339833|27175420|P2|Overall Study|indigestion|1
7826840|NCT00339833|27175421|P1|Overall Study|indigestion|0
7826841|NCT00339833|27175420|P2|Overall Study|toothache|1
7826842|NCT00339833|27175421|P1|Overall Study|toothache|0
7826843|NCT00339833|27175420|P2|Overall Study|Withdrawal by Subject|2
7826844|NCT00339833|27175421|P1|Overall Study|Withdrawal by Subject|1
7826845|NCT00339183|27175431|P2|Overall Study|Ongoing|13
7826846|NCT00339183|27175432|P1|Overall Study|Ongoing|20
7826847|NCT00339183|27175431|P2|Overall Study|Other|40
7826848|NCT00339183|27175432|P1|Overall Study|Other|46
7826849|NCT00339183|27175431|P2|Overall Study|Missing reason|1
7826850|NCT00339183|27175432|P1|Overall Study|Missing reason|3
7826851|NCT00339183|27175431|P2|Overall Study|Protocol-specified criteria|8
7826852|NCT00339183|27175432|P1|Overall Study|Protocol-specified criteria|12
7826853|NCT00339183|27175431|P2|Overall Study|Lost to Follow-up|17
7826854|NCT00339183|27175432|P1|Overall Study|Lost to Follow-up|17
7826855|NCT00339183|27175431|P2|Overall Study|Physician Decision|4
7826856|NCT00339183|27175432|P1|Overall Study|Physician Decision|2
7826857|NCT00339183|27175431|P2|Overall Study|Withdrawal by Subject|19
7826858|NCT00339183|27175432|P1|Overall Study|Withdrawal by Subject|16
7826859|NCT00339183|27175431|P2|Overall Study|Adverse Event|3
7826860|NCT00339183|27175432|P1|Overall Study|Adverse Event|5
7826861|NCT00339144|27175461|P3|Overall Study|Participant's request to discontinuation|1
7826862|NCT00339144|27175462|P2|Overall Study|Participant's request to discontinuation|0
7826863|NCT00339144|27175463|P1|Overall Study|Participant's request to discontinuation|1
7826864|NCT00339144|27175461|P3|Overall Study|Study drug toxicity|1
7826865|NCT00339144|27175462|P2|Overall Study|Study drug toxicity|1
7826866|NCT00339144|27175463|P1|Overall Study|Study drug toxicity|3
7826867|NCT00339144|27175461|P3|Overall Study|Disease progression|2
7826868|NCT00339144|27175462|P2|Overall Study|Disease progression|2
7826869|NCT00339144|27175463|P1|Overall Study|Disease progression|5
7826870|NCT00339040|27175568|P2|Stage II|Site closing|0
7826871|NCT00339040|27175569|P1|Stage II|Site closing|2
7826872|NCT00339040|27175568|P2|Stage II|Not able to attend clinic|0
7826873|NCT00339040|27175569|P1|Stage II|Not able to attend clinic|1
7826874|NCT00339040|27175568|P2|Stage II|Protocol Violation|0
7826875|NCT00339040|27175569|P1|Stage II|Protocol Violation|3
7826876|NCT00339040|27175568|P2|Stage II|Withdrawal by Subject|2
7826877|NCT00339040|27175569|P1|Stage II|Withdrawal by Subject|1
7826878|NCT00339040|27175568|P2|Stage II|Lost to Follow-up|0
7826879|NCT00339040|27175569|P1|Stage II|Lost to Follow-up|3
7826880|NCT00339040|27175568|P2|Stage I|Protocol Violation|1
7826881|NCT00339040|27175569|P1|Stage I|Protocol Violation|1
7826882|NCT00339040|27175568|P2|Stage I|Not able to attend clinic|0
7826883|NCT00339040|27175569|P1|Stage I|Not able to attend clinic|1
7826884|NCT00338962|27175596|P4|Overall Study|Poor Compliance|0
7826885|NCT00338962|27175597|P3|Overall Study|Poor Compliance|2
7826886|NCT00338962|27175598|P2|Overall Study|Poor Compliance|0
7826887|NCT00338962|27175599|P1|Overall Study|Poor Compliance|0
7826888|NCT00338962|27175596|P4|Overall Study|Adverse Event|0
7826889|NCT00338962|27175597|P3|Overall Study|Adverse Event|2
7826890|NCT00338962|27175598|P2|Overall Study|Adverse Event|0
7826891|NCT00338962|27175599|P1|Overall Study|Adverse Event|0
7826892|NCT00338962|27175596|P4|Overall Study|Moved|0
7826893|NCT00338962|27175597|P3|Overall Study|Moved|0
7826894|NCT00338962|27175598|P2|Overall Study|Moved|1
7826895|NCT00338962|27175599|P1|Overall Study|Moved|0
7826896|NCT00338962|27175596|P4|Overall Study|Time Constraint|0
7826897|NCT00338962|27175597|P3|Overall Study|Time Constraint|0
7826898|NCT00338962|27175598|P2|Overall Study|Time Constraint|0
7826899|NCT00338962|27175599|P1|Overall Study|Time Constraint|2
7826900|NCT00338962|27175596|P4|Overall Study|No Transportation|0
7826901|NCT00338962|27175597|P3|Overall Study|No Transportation|0
7826902|NCT00338962|27175598|P2|Overall Study|No Transportation|0
7826903|NCT00338962|27175599|P1|Overall Study|No Transportation|2
7826904|NCT00338962|27175596|P4|Overall Study|Withdrawal by Subject|0
7826905|NCT00338962|27175597|P3|Overall Study|Withdrawal by Subject|0
7826906|NCT00338962|27175598|P2|Overall Study|Withdrawal by Subject|0
7826907|NCT00338962|27175599|P1|Overall Study|Withdrawal by Subject|1
7826908|NCT00338962|27175596|P4|Overall Study|Lost to Follow-up|3
7826909|NCT00338962|27175597|P3|Overall Study|Lost to Follow-up|2
7826910|NCT00338962|27175598|P2|Overall Study|Lost to Follow-up|3
7826911|NCT00338962|27175599|P1|Overall Study|Lost to Follow-up|3
7826912|NCT00338949|27175623|P2|Randomization|Adverse Event|5
7826913|NCT00338949|27175624|P1|Randomization|Adverse Event|0
7826914|NCT00338949|27175623|P2|Randomization|Withdrawal by Subject|0
7826915|NCT00338949|27175624|P1|Randomization|Withdrawal by Subject|1
7826916|NCT00338949|27175623|P2|Subject Screening|Screen failures|11
7826917|NCT00338949|27175624|P1|Subject Screening|Screen failures|11
7826918|NCT00338884|27175632|P1|Overall Study|Randomized But Did Not Receive Treatment|1
7826919|NCT00338884|27175632|P1|Overall Study|Lost to Follow-up|1
7826920|NCT00338884|27175632|P1|Overall Study|Withdrawal by Subject|3
7826921|NCT00338884|27175632|P1|Overall Study|Global Deterioration of Health Status|3
7826922|NCT00338884|27175632|P1|Overall Study|Other|4
7826923|NCT00338884|27175632|P1|Overall Study|Death|8
7826924|NCT00338884|27175632|P1|Overall Study|Adverse Event|14
7826925|NCT00338884|27175632|P1|Overall Study|Objective Disease Progression or Relapse|44
7826926|NCT00338806|27175666|P2|Follow-up|Lost to Follow-up|3
7826927|NCT00338806|27175667|P1|Follow-up|Lost to Follow-up|1
7826928|NCT00338806|27175666|P2|Acute Phase|Withdrawal by Subject|1
7826929|NCT00338806|27175667|P1|Acute Phase|Withdrawal by Subject|0
7826930|NCT00338741|27175729|P2|Overall Study|Lost to Follow-up|0
7826931|NCT00338741|27175730|P1|Overall Study|Lost to Follow-up|2
7826932|NCT00338728|27175738|P1|Overall Study|Screen Failure|14
7826933|NCT00338455|27175766|P2|Overall Study|Physician Decision|0
7826934|NCT00338455|27175767|P1|Overall Study|Physician Decision|1
7826935|NCT00338455|27175766|P2|Overall Study|Death|1
7826936|NCT00338455|27175767|P1|Overall Study|Death|2
7826937|NCT00338286|27175781|P2|Overall Study|Other|93
7826938|NCT00338286|27175782|P1|Overall Study|Other|103
7826939|NCT00338286|27175781|P2|Overall Study|Lost to Follow-up|66
7826940|NCT00338286|27175782|P1|Overall Study|Lost to Follow-up|80
7826941|NCT00338286|27175781|P2|Overall Study|Withdrawal by Subject|54
7826942|NCT00338286|27175782|P1|Overall Study|Withdrawal by Subject|50
7826943|NCT00338104|27175799|P3|Overall Study|Protocol Violation|3
7826944|NCT00338104|27175800|P2|Overall Study|Protocol Violation|1
7826945|NCT00338104|27175801|P1|Overall Study|Protocol Violation|2
7826946|NCT00337935|27175824|P2|Overall Study|Lack of Efficacy|1
7826947|NCT00337935|27175825|P1|Overall Study|Lack of Efficacy|0
7826948|NCT00337935|27175824|P2|Overall Study|Other|1
7826949|NCT00337935|27175825|P1|Overall Study|Other|0
7826950|NCT00337935|27175824|P2|Overall Study|Withdrawal by Subject|7
7826951|NCT00337935|27175825|P1|Overall Study|Withdrawal by Subject|1
7826952|NCT00337935|27175824|P2|Overall Study|Protocol Violation|3
7826953|NCT00337935|27175825|P1|Overall Study|Protocol Violation|4
7826954|NCT00337935|27175824|P2|Overall Study|Lost to Follow-up|1
7826955|NCT00337935|27175825|P1|Overall Study|Lost to Follow-up|0
7826956|NCT00337935|27175824|P2|Overall Study|Physician Decision|1
7826957|NCT00337935|27175825|P1|Overall Study|Physician Decision|1
7826958|NCT00337935|27175824|P2|Overall Study|Death|8
7826959|NCT00337935|27175825|P1|Overall Study|Death|2
7826960|NCT00337935|27175824|P2|Overall Study|Adverse Event|5
7826961|NCT00337935|27175825|P1|Overall Study|Adverse Event|2
7826962|NCT00337818|27175838|P3|Overall Study|Lost to Follow-up|107
7826963|NCT00337818|27175839|P2|Overall Study|Lost to Follow-up|91
7826964|NCT00337818|27175840|P1|Overall Study|Lost to Follow-up|289
7826965|NCT00337779|27175862|P2|Overall Study|Death|1
7826966|NCT00337779|27175863|P1|Overall Study|Death|0
7826967|NCT00337779|27175862|P2|Overall Study|Pregnancy|2
7826968|NCT00337779|27175863|P1|Overall Study|Pregnancy|3
7826969|NCT00337779|27175862|P2|Overall Study|Adverse Event|51
7826970|NCT00337779|27175863|P1|Overall Study|Adverse Event|28
7826971|NCT00337779|27175862|P2|Overall Study|Lost to Follow-up|5
7826972|NCT00337779|27175863|P1|Overall Study|Lost to Follow-up|6
7826973|NCT00337779|27175862|P2|Overall Study|Protocol Violation|1
7826974|NCT00337779|27175863|P1|Overall Study|Protocol Violation|1
7826975|NCT00337779|27175862|P2|Overall Study|Physician Decision|6
7826976|NCT00337779|27175863|P1|Overall Study|Physician Decision|3
7826977|NCT00337779|27175862|P2|Overall Study|Sponsor decision|1
7826978|NCT00337779|27175863|P1|Overall Study|Sponsor decision|1
7826979|NCT00337779|27175862|P2|Overall Study|Withdrawal by Subject|12
7826980|NCT00337779|27175863|P1|Overall Study|Withdrawal by Subject|10
7826981|NCT00337727|27175875|P2|Overall Study|Withdrawal by Subject|5
7826982|NCT00337727|27175876|P1|Overall Study|Withdrawal by Subject|3
7826983|NCT00337727|27175875|P2|Overall Study|Protocol Violation|0
7826984|NCT00337727|27175876|P1|Overall Study|Protocol Violation|4
7826985|NCT00337727|27175875|P2|Overall Study|Physician Decision|0
7826986|NCT00337727|27175876|P1|Overall Study|Physician Decision|1
7826987|NCT00337727|27175875|P2|Overall Study|Lost to Follow-up|4
7826988|NCT00337727|27175876|P1|Overall Study|Lost to Follow-up|5
7826989|NCT00337727|27175875|P2|Overall Study|Adverse Event|3
7826990|NCT00337727|27175876|P1|Overall Study|Adverse Event|5
7826991|NCT00337675|27175887|P3|Overall Study|Trial Terminated|2
7826992|NCT00337675|27175888|P2|Overall Study|Trial Terminated|0
7826993|NCT00337675|27175889|P1|Overall Study|Trial Terminated|0
7826994|NCT00337675|27175887|P3|Overall Study|Progressive Disease|0
7826995|NCT00337675|27175888|P2|Overall Study|Progressive Disease|2
7826996|NCT00337675|27175889|P1|Overall Study|Progressive Disease|0
7826997|NCT00337675|27175887|P3|Overall Study|Withdrawal by Subject|19
7826998|NCT00337675|27175888|P2|Overall Study|Withdrawal by Subject|25
7826999|NCT00337675|27175889|P1|Overall Study|Withdrawal by Subject|25
7827000|NCT00337675|27175887|P3|Overall Study|Protocol Violation|19
7827001|NCT00337675|27175888|P2|Overall Study|Protocol Violation|24
7827002|NCT00337675|27175889|P1|Overall Study|Protocol Violation|21
7827003|NCT00337675|27175887|P3|Overall Study|Physician Decision|14
7827004|NCT00337675|27175888|P2|Overall Study|Physician Decision|17
7827005|NCT00337675|27175889|P1|Overall Study|Physician Decision|9
7827006|NCT00337675|27175887|P3|Overall Study|Lost to Follow-up|17
7827007|NCT00337675|27175888|P2|Overall Study|Lost to Follow-up|19
7827008|NCT00337675|27175889|P1|Overall Study|Lost to Follow-up|22
7827009|NCT00337675|27175887|P3|Overall Study|Lack of Efficacy|9
7827010|NCT00337675|27175888|P2|Overall Study|Lack of Efficacy|7
7827011|NCT00337675|27175889|P1|Overall Study|Lack of Efficacy|10
7827012|NCT00337675|27175887|P3|Overall Study|Adverse Event|19
7827013|NCT00337675|27175888|P2|Overall Study|Adverse Event|9
7827014|NCT00337675|27175889|P1|Overall Study|Adverse Event|10
7827015|NCT00337662|27175906|P4|Study Period III|Clinical Relapse|0
7827016|NCT00337662|27175907|P3|Study Period III|Clinical Relapse|0
7827017|NCT00337662|27175908|P2|Study Period III|Clinical Relapse|0
7827018|NCT00337662|27175909|P1|Study Period III|Clinical Relapse|1
7827019|NCT00337662|27175906|P4|Study Period III|Sponsor Decision|0
7827020|NCT00337662|27175907|P3|Study Period III|Sponsor Decision|1
7827021|NCT00337662|27175908|P2|Study Period III|Sponsor Decision|0
7827022|NCT00337662|27175909|P1|Study Period III|Sponsor Decision|1
7827023|NCT00337662|27175906|P4|Study Period III|Parent/Caregiver Decision|0
7827024|NCT00337662|27175907|P3|Study Period III|Parent/Caregiver Decision|2
7827025|NCT00337662|27175908|P2|Study Period III|Parent/Caregiver Decision|0
7827026|NCT00337662|27175909|P1|Study Period III|Parent/Caregiver Decision|0
7827027|NCT00337662|27175906|P4|Study Period III|Lack of Efficacy|0
7827028|NCT00337662|27175907|P3|Study Period III|Lack of Efficacy|2
7827029|NCT00337662|27175908|P2|Study Period III|Lack of Efficacy|4
7827030|NCT00337662|27175909|P1|Study Period III|Lack of Efficacy|4
7827031|NCT00337662|27175906|P4|Study Period III|Entry Criteria Not Met|0
7827032|NCT00337662|27175907|P3|Study Period III|Entry Criteria Not Met|3
7827033|NCT00337662|27175908|P2|Study Period III|Entry Criteria Not Met|1
7827034|NCT00337662|27175909|P1|Study Period III|Entry Criteria Not Met|4
7827035|NCT00337662|27175906|P4|Study Period III|Physician Decision|0
7827036|NCT00337662|27175907|P3|Study Period III|Physician Decision|0
7827037|NCT00337662|27175908|P2|Study Period III|Physician Decision|5
7827038|NCT00337662|27175909|P1|Study Period III|Physician Decision|6
7827039|NCT00337662|27175906|P4|Study Period III|Protocol Violation|0
7827040|NCT00337662|27175907|P3|Study Period III|Protocol Violation|2
7827041|NCT00337662|27175908|P2|Study Period III|Protocol Violation|8
7827042|NCT00337662|27175909|P1|Study Period III|Protocol Violation|3
7827043|NCT00337662|27175906|P4|Study Period III|Adverse Event|0
7827044|NCT00337662|27175907|P3|Study Period III|Adverse Event|8
7827045|NCT00337662|27175908|P2|Study Period III|Adverse Event|10
7827046|NCT00337662|27175909|P1|Study Period III|Adverse Event|9
7827047|NCT00337662|27175906|P4|Study Period III|Withdrawal by Subject|0
7827048|NCT00337662|27175907|P3|Study Period III|Withdrawal by Subject|12
7827049|NCT00337662|27175908|P2|Study Period III|Withdrawal by Subject|14
7827050|NCT00337662|27175909|P1|Study Period III|Withdrawal by Subject|18
7827051|NCT00337662|27175906|P4|Study Period III|Lost to Follow-up|0
7827052|NCT00337662|27175907|P3|Study Period III|Lost to Follow-up|14
7827053|NCT00337662|27175908|P2|Study Period III|Lost to Follow-up|16
7827054|NCT00337662|27175909|P1|Study Period III|Lost to Follow-up|14
7827055|NCT00337662|27175906|P4|Study Period II|Parent/Caregiver Decision|1
7827056|NCT00337662|27175907|P3|Study Period II|Parent/Caregiver Decision|0
7827057|NCT00337662|27175908|P2|Study Period II|Parent/Caregiver Decision|0
7827058|NCT00337662|27175909|P1|Study Period II|Parent/Caregiver Decision|0
7827059|NCT00337662|27175906|P4|Study Period II|Sponsor Decision|2
7827060|NCT00337662|27175907|P3|Study Period II|Sponsor Decision|0
7827061|NCT00337662|27175908|P2|Study Period II|Sponsor Decision|0
7827062|NCT00337662|27175909|P1|Study Period II|Sponsor Decision|0
7827063|NCT00337662|27175906|P4|Study Period II|Lack of Efficacy|7
7827064|NCT00337662|27175907|P3|Study Period II|Lack of Efficacy|0
7827065|NCT00337662|27175908|P2|Study Period II|Lack of Efficacy|0
7827066|NCT00337662|27175909|P1|Study Period II|Lack of Efficacy|0
7827067|NCT00337662|27175906|P4|Study Period II|Protocol Violation|6
7827068|NCT00337662|27175907|P3|Study Period II|Protocol Violation|0
7827069|NCT00337662|27175908|P2|Study Period II|Protocol Violation|0
7827070|NCT00337662|27175909|P1|Study Period II|Protocol Violation|0
7827071|NCT00337662|27175906|P4|Study Period II|Entry Criteria Not Met|6
7827072|NCT00337662|27175907|P3|Study Period II|Entry Criteria Not Met|0
7827073|NCT00337662|27175908|P2|Study Period II|Entry Criteria Not Met|0
7827074|NCT00337662|27175909|P1|Study Period II|Entry Criteria Not Met|0
7827075|NCT00337662|27175906|P4|Study Period II|Physician Decision|13
7827076|NCT00337662|27175907|P3|Study Period II|Physician Decision|0
7827077|NCT00337662|27175908|P2|Study Period II|Physician Decision|0
7827078|NCT00337662|27175909|P1|Study Period II|Physician Decision|0
7827079|NCT00337662|27175906|P4|Study Period II|Adverse Event|16
7827080|NCT00337662|27175907|P3|Study Period II|Adverse Event|0
7827081|NCT00337662|27175908|P2|Study Period II|Adverse Event|0
7827082|NCT00337662|27175909|P1|Study Period II|Adverse Event|0
7827083|NCT00337662|27175906|P4|Study Period II|Withdrawal by Subject|20
7827084|NCT00337662|27175907|P3|Study Period II|Withdrawal by Subject|0
7827085|NCT00337662|27175908|P2|Study Period II|Withdrawal by Subject|0
7827086|NCT00337662|27175909|P1|Study Period II|Withdrawal by Subject|0
7827087|NCT00337662|27175906|P4|Study Period II|Lost to Follow-up|35
7827088|NCT00337662|27175907|P3|Study Period II|Lost to Follow-up|0
7827089|NCT00337662|27175908|P2|Study Period II|Lost to Follow-up|0
7827090|NCT00337662|27175909|P1|Study Period II|Lost to Follow-up|0
7827091|NCT00337610|27175963|P2|Overall Study|Withdrawal by Subject|5
7827092|NCT00337610|27175964|P1|Overall Study|Withdrawal by Subject|6
7827093|NCT00337610|27175963|P2|Overall Study|Lost to Follow-up|3
7827094|NCT00337610|27175964|P1|Overall Study|Lost to Follow-up|3
7827095|NCT00337610|27175963|P2|Overall Study|Lack of Efficacy|3
7827096|NCT00337610|27175964|P1|Overall Study|Lack of Efficacy|6
7827097|NCT00337610|27175963|P2|Overall Study|Death|1
7827098|NCT00337610|27175964|P1|Overall Study|Death|0
7827099|NCT00337610|27175963|P2|Overall Study|Adverse Event|2
7827100|NCT00337610|27175964|P1|Overall Study|Adverse Event|2
7827101|NCT00337571|27175980|P4|Overall Study|High Potassium level|1
7827102|NCT00337571|27175981|P3|Overall Study|High Potassium level|0
7827103|NCT00337571|27175982|P2|Overall Study|High Potassium level|0
7827104|NCT00337571|27175983|P1|Overall Study|High Potassium level|0
7827105|NCT00337571|27175980|P4|Overall Study|No longer met study criteria|0
7827106|NCT00337571|27175981|P3|Overall Study|No longer met study criteria|0
7827107|NCT00337571|27175982|P2|Overall Study|No longer met study criteria|0
7827108|NCT00337571|27175983|P1|Overall Study|No longer met study criteria|1
7827109|NCT00337571|27175980|P4|Overall Study|Poor/noncompliance|1
7827110|NCT00337571|27175981|P3|Overall Study|Poor/noncompliance|1
7827111|NCT00337571|27175982|P2|Overall Study|Poor/noncompliance|1
7827112|NCT00337571|27175983|P1|Overall Study|Poor/noncompliance|1
7827113|NCT00337571|27175980|P4|Overall Study|Lost to Follow-up|1
7827114|NCT00337571|27175981|P3|Overall Study|Lost to Follow-up|0
7827115|NCT00337571|27175982|P2|Overall Study|Lost to Follow-up|1
7827116|NCT00337571|27175983|P1|Overall Study|Lost to Follow-up|3
7827117|NCT00337571|27175980|P4|Overall Study|Withdrawal by Subject|0
7827118|NCT00337571|27175981|P3|Overall Study|Withdrawal by Subject|1
7827119|NCT00337571|27175982|P2|Overall Study|Withdrawal by Subject|2
7827120|NCT00337571|27175983|P1|Overall Study|Withdrawal by Subject|2
7827121|NCT00337571|27175980|P4|Overall Study|Adverse Event|4
7827122|NCT00337571|27175981|P3|Overall Study|Adverse Event|8
7827123|NCT00337571|27175982|P2|Overall Study|Adverse Event|5
7827124|NCT00337571|27175983|P1|Overall Study|Adverse Event|4
7827125|NCT00337571|27175980|P4|Overall Study|Lack of Efficacy|0
7827126|NCT00337571|27175981|P3|Overall Study|Lack of Efficacy|0
7827127|NCT00337571|27175982|P2|Overall Study|Lack of Efficacy|0
7827128|NCT00337571|27175983|P1|Overall Study|Lack of Efficacy|3
7827129|NCT00337467|27176021|P1|Overall Study|Subject No Longer Met Study Criteria|2
7827130|NCT00337467|27176021|P1|Overall Study|Lost to Follow-up|2
7827131|NCT00337467|27176021|P1|Overall Study|Pregnancy|1
7827132|NCT00337467|27176021|P1|Overall Study|Subject Withdrew Consent|2
7827133|NCT00337467|27176021|P1|Overall Study|Adverse Event|3
7827134|NCT00337428|27176040|P2|Overall Study|Anorexia|0
7827135|NCT00337428|27176041|P1|Overall Study|Anorexia|1
7827136|NCT00337428|27176040|P2|Overall Study|Unwilling to Continue|0
7827137|NCT00337428|27176041|P1|Overall Study|Unwilling to Continue|1
7827138|NCT00337428|27176040|P2|Overall Study|Lack of Time|1
7827139|NCT00337428|27176041|P1|Overall Study|Lack of Time|1
7827140|NCT00337428|27176040|P2|Overall Study|Withdrawal by Subject|2
7827141|NCT00337428|27176041|P1|Overall Study|Withdrawal by Subject|1
7827142|NCT00337285|27176092|P1|Overall Study|Lack of protocol compliance|7
7827143|NCT00337285|27176092|P1|Overall Study|Physician Decision|1
7827144|NCT00337285|27176092|P1|Overall Study|Death|1
7827145|NCT00337285|27176092|P1|Overall Study|Lack of Efficacy|11
7827146|NCT00337285|27176092|P1|Overall Study|Protocol Violation|27
7827147|NCT00337285|27176092|P1|Overall Study|Adverse Event|28
7827148|NCT00337285|27176092|P1|Overall Study|Lost to Follow-up|41
7827149|NCT00337285|27176092|P1|Overall Study|Withdrawal by Subject|42
7827150|NCT00337272|27176100|P2|Withdrawal Period|Non-compliance|1
7827151|NCT00337272|27176101|P1|Withdrawal Period|Non-compliance|0
7827152|NCT00337272|27176100|P2|Treatment Period|Withdrawal by Subject|1
7827153|NCT00337272|27176101|P1|Treatment Period|Withdrawal by Subject|0
7827154|NCT00337272|27176100|P2|Treatment Period|Non-compliance|1
7827155|NCT00337272|27176101|P1|Treatment Period|Non-compliance|1
7827156|NCT00337272|27176100|P2|Screening Period (Pre-randomization)|Screen failure|0
7827157|NCT00337272|27176101|P1|Screening Period (Pre-randomization)|Screen failure|3
7827158|NCT00337272|27176100|P2|Screening Period (Pre-randomization)|Non-compliance|0
7827159|NCT00337272|27176101|P1|Screening Period (Pre-randomization)|Non-compliance|1
7827160|NCT00337272|27176100|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
7827161|NCT00337272|27176101|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
7827162|NCT00337207|27176121|P1|Overall Study|Withdrawal by Subject|3
7827163|NCT00337194|27176129|P2|Overall Study|Subsequent non-protocol therapy|1
7827164|NCT00337194|27176130|P1|Overall Study|Subsequent non-protocol therapy|3
7827165|NCT00337194|27176129|P2|Overall Study|Disease progression|2
7827166|NCT00337194|27176130|P1|Overall Study|Disease progression|1
7827167|NCT00337194|27176129|P2|Overall Study|Withdrawal by Subject|0
7827168|NCT00337194|27176130|P1|Overall Study|Withdrawal by Subject|1
7827169|NCT00337194|27176129|P2|Overall Study|Death|0
7827170|NCT00337194|27176130|P1|Overall Study|Death|2
7827171|NCT00337194|27176129|P2|Overall Study|Adverse Event|1
7827172|NCT00337194|27176130|P1|Overall Study|Adverse Event|5
7827173|NCT00337168|27176154|P1|Overall Study|Did not start therapy|1
7827174|NCT00337168|27176154|P1|Overall Study|Not protocol specified|2
7827175|NCT00337168|27176154|P1|Overall Study|Death|5
7827176|NCT00337129|27176161|P1|Overall Study|not protocol specified|1
7827177|NCT00337129|27176161|P1|Overall Study|Death|2
7827178|NCT00337129|27176161|P1|Overall Study|Lack of Efficacy|32
7827179|NCT00337129|27176161|P1|Overall Study|Withdrawal by Subject|1
7827180|NCT00337129|27176161|P1|Overall Study|Adverse Event|4
7827181|NCT00337103|27176170|P2|Overall Study|Death|0
7827182|NCT00337103|27176171|P1|Overall Study|Death|1
7827183|NCT00337103|27176170|P2|Overall Study|Lost to Follow-up|2
7827184|NCT00337103|27176171|P1|Overall Study|Lost to Follow-up|1
7827185|NCT00337103|27176170|P2|Overall Study|Entry Criteria Not Met|1
7827186|NCT00337103|27176171|P1|Overall Study|Entry Criteria Not Met|4
7827187|NCT00337103|27176170|P2|Overall Study|Other|6
7827188|NCT00337103|27176171|P1|Overall Study|Other|5
7827189|NCT00337103|27176170|P2|Overall Study|Withdrawal by Subject|5
7827190|NCT00337103|27176171|P1|Overall Study|Withdrawal by Subject|8
7827191|NCT00337103|27176170|P2|Overall Study|Physician Decision|14
7827192|NCT00337103|27176171|P1|Overall Study|Physician Decision|15
7827193|NCT00337103|27176170|P2|Overall Study|Clinical Progression|24
7827194|NCT00337103|27176171|P1|Overall Study|Clinical Progression|27
7827195|NCT00337103|27176170|P2|Overall Study|Subject Choice|27
7827196|NCT00337103|27176171|P1|Overall Study|Subject Choice|34
7827197|NCT00337103|27176170|P2|Overall Study|Adverse Event|59
7827198|NCT00337103|27176171|P1|Overall Study|Adverse Event|45
7827199|NCT00337103|27176170|P2|Overall Study|Progressive Disease|410
7827200|NCT00337103|27176171|P1|Overall Study|Progressive Disease|414
7827201|NCT00337077|27176205|P3|Overall Study|Ineligible|1
7827202|NCT00337077|27176206|P2|Overall Study|Ineligible|1
7827203|NCT00337077|27176207|P1|Overall Study|Ineligible|1
7827204|NCT00337077|27176205|P3|Overall Study|Never started treatment|0
7827205|NCT00337077|27176206|P2|Overall Study|Never started treatment|1
7827206|NCT00337077|27176207|P1|Overall Study|Never started treatment|1
7827207|NCT00337077|27176205|P3|Overall Study|Physician Decision|2
7827208|NCT00337077|27176206|P2|Overall Study|Physician Decision|4
7827209|NCT00337077|27176207|P1|Overall Study|Physician Decision|1
7827210|NCT00337077|27176205|P3|Overall Study|Alternative therapy|0
7827211|NCT00337077|27176206|P2|Overall Study|Alternative therapy|0
7827212|NCT00337077|27176207|P1|Overall Study|Alternative therapy|1
7827213|NCT00337077|27176205|P3|Overall Study|Withdrawal by Subject|2
7827214|NCT00337077|27176206|P2|Overall Study|Withdrawal by Subject|2
7827215|NCT00337077|27176207|P1|Overall Study|Withdrawal by Subject|7
7827216|NCT00337077|27176205|P3|Overall Study|Death|0
7827217|NCT00337077|27176206|P2|Overall Study|Death|1
7827218|NCT00337077|27176207|P1|Overall Study|Death|0
7827219|NCT00337077|27176205|P3|Overall Study|Adverse Event|1
7827220|NCT00337077|27176206|P2|Overall Study|Adverse Event|7
7827221|NCT00337077|27176207|P1|Overall Study|Adverse Event|7
7827222|NCT00337077|27176205|P3|Overall Study|Progressive disease|19
7827223|NCT00337077|27176206|P2|Overall Study|Progressive disease|37
7827224|NCT00337077|27176207|P1|Overall Study|Progressive disease|25
7827225|NCT00336895|27176222|P1|Overall Study|screen failed|1
7827226|NCT00336895|27176222|P1|Overall Study|Physician Decision|1
7827227|NCT00336895|27176222|P1|Overall Study|nausea and upset stomach|1
7827228|NCT00336895|27176222|P1|Overall Study|diarrhea|1
7827229|NCT00336856|27176228|P1|Overall Study|Found ineligible at time of analysis|1
7827230|NCT00336856|27176228|P1|Overall Study|Withdrawal by Subject|3
7827231|NCT00336583|27176276|P1|Overall Study|Death|1
7827232|NCT00336583|27176276|P1|Overall Study|Lost to Follow-up|1
7827233|NCT00336544|27176283|P2|Overall Study|Other|5
7827234|NCT00336544|27176284|P1|Overall Study|Other|3
7827235|NCT00336544|27176283|P2|Overall Study|Withdrawal by Subject|3
7827236|NCT00336544|27176284|P1|Overall Study|Withdrawal by Subject|4
7827237|NCT00336544|27176283|P2|Overall Study|Adverse Event|9
7827238|NCT00336544|27176284|P1|Overall Study|Adverse Event|4
7827239|NCT00336544|27176283|P2|Overall Study|Lack of Efficacy|5
7827240|NCT00336544|27176284|P1|Overall Study|Lack of Efficacy|8
7827241|NCT00336505|27176298|P2|Overall Study|Other|7
7827242|NCT00336505|27176299|P1|Overall Study|Other|7
7827243|NCT00336505|27176298|P2|Overall Study|Withdrawal by Subject|3
7827244|NCT00336505|27176299|P1|Overall Study|Withdrawal by Subject|5
7827245|NCT00336505|27176298|P2|Overall Study|Lost to Follow-up|4
7827246|NCT00336505|27176299|P1|Overall Study|Lost to Follow-up|7
7827247|NCT00336505|27176298|P2|Overall Study|Lack of Efficacy|4
7827248|NCT00336505|27176299|P1|Overall Study|Lack of Efficacy|8
7827249|NCT00336505|27176298|P2|Overall Study|Adverse Event|9
7827250|NCT00336505|27176299|P1|Overall Study|Adverse Event|10
7827251|NCT00336492|27176314|P3|Overall Study|Other|1
7827252|NCT00336492|27176315|P2|Overall Study|Other|0
7827253|NCT00336492|27176316|P1|Overall Study|Other|5
7827254|NCT00336492|27176314|P3|Overall Study|Lack of Efficacy|4
7827255|NCT00336492|27176315|P2|Overall Study|Lack of Efficacy|1
7827256|NCT00336492|27176316|P1|Overall Study|Lack of Efficacy|6
7827257|NCT00336492|27176314|P3|Overall Study|Adverse Event|6
7827258|NCT00336492|27176315|P2|Overall Study|Adverse Event|3
7827259|NCT00336492|27176316|P1|Overall Study|Adverse Event|4
7827260|NCT00336479|27176328|P4|Overall Study|Virologic Stopping Rule|0
7827261|NCT00336479|27176329|P3|Overall Study|Virologic Stopping Rule|0
7827262|NCT00336479|27176330|P2|Overall Study|Virologic Stopping Rule|0
7827263|NCT00336479|27176331|P1|Overall Study|Virologic Stopping Rule|20
7827264|NCT00336479|27176328|P4|Overall Study|Other|0
7827265|NCT00336479|27176329|P3|Overall Study|Other|1
7827266|NCT00336479|27176330|P2|Overall Study|Other|0
7827267|NCT00336479|27176331|P1|Overall Study|Other|0
7827268|NCT00336479|27176328|P4|Overall Study|Withdrawal by Subject|0
7827269|NCT00336479|27176329|P3|Overall Study|Withdrawal by Subject|3
7827270|NCT00336479|27176330|P2|Overall Study|Withdrawal by Subject|2
7827271|NCT00336479|27176331|P1|Overall Study|Withdrawal by Subject|3
7827272|NCT00336479|27176328|P4|Overall Study|Lost to Follow-up|0
7827273|NCT00336479|27176329|P3|Overall Study|Lost to Follow-up|0
7827274|NCT00336479|27176330|P2|Overall Study|Lost to Follow-up|2
7827275|NCT00336479|27176331|P1|Overall Study|Lost to Follow-up|3
7827276|NCT00336479|27176328|P4|Overall Study|Physician Decision|0
7827277|NCT00336479|27176329|P3|Overall Study|Physician Decision|1
7827278|NCT00336479|27176330|P2|Overall Study|Physician Decision|3
7827279|NCT00336479|27176331|P1|Overall Study|Physician Decision|2
7827280|NCT00336479|27176328|P4|Overall Study|Noncompliant|0
7827281|NCT00336479|27176329|P3|Overall Study|Noncompliant|3
7827282|NCT00336479|27176330|P2|Overall Study|Noncompliant|7
7827283|NCT00336479|27176331|P1|Overall Study|Noncompliant|1
7827284|NCT00336479|27176328|P4|Overall Study|Adverse Event|4
7827285|NCT00336479|27176329|P3|Overall Study|Adverse Event|18
7827286|NCT00336479|27176330|P2|Overall Study|Adverse Event|11
7827287|NCT00336479|27176331|P1|Overall Study|Adverse Event|8
7827288|NCT00336284|27176420|P2|Overall Study|Withdrawal by Physician or Subject|64
7827289|NCT00336284|27176421|P1|Overall Study|Withdrawal by Physician or Subject|102
7827290|NCT00336284|27176420|P2|Overall Study|Lost to Follow-up|61
7827291|NCT00336284|27176421|P1|Overall Study|Lost to Follow-up|82
7827292|NCT00336284|27176420|P2|Overall Study|Death|26
7827293|NCT00336284|27176421|P1|Overall Study|Death|52
7827294|NCT00336024|27176439|P2|Overall Study|Ineligible|7
7827295|NCT00336024|27176440|P1|Overall Study|Ineligible|7
7827296|NCT00336024|27176439|P2|Overall Study|Progressive Disease|7
7827297|NCT00336024|27176440|P1|Overall Study|Progressive Disease|4
7827298|NCT00336024|27176439|P2|Overall Study|Failure to fulfill consolidation|1
7827299|NCT00336024|27176440|P1|Overall Study|Failure to fulfill consolidation|1
7827300|NCT00336024|27176439|P2|Overall Study|Withdrawal by Subject|2
7827301|NCT00336024|27176440|P1|Overall Study|Withdrawal by Subject|1
7827302|NCT00336024|27176439|P2|Overall Study|Protocol Violation|0
7827303|NCT00336024|27176440|P1|Overall Study|Protocol Violation|1
7827304|NCT00336024|27176439|P2|Overall Study|Physician Decision|1
7827305|NCT00336024|27176440|P1|Overall Study|Physician Decision|4
7827306|NCT00336024|27176439|P2|Overall Study|Death|1
7827307|NCT00336024|27176440|P1|Overall Study|Death|2
7827308|NCT00335972|27176476|P2|Overall Study|not given treatments|3
7827309|NCT00335972|27176477|P1|Overall Study|not given treatments|0
7827310|NCT00335959|27176487|P1|Overall Study|Ineligible|1
7827311|NCT00335959|27176487|P1|Overall Study|Adverse Event|2
7827312|NCT00335829|27176492|P1|Overall Study|Adverse Event|1
7827313|NCT00335829|27176492|P1|Overall Study|Lost to Follow-up|1
7827314|NCT00335829|27176492|P1|Overall Study|Withdrawal by Subject|1
7827315|NCT00335777|27176506|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
7827316|NCT00335777|27176506|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
7827317|NCT00335777|27176506|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
7827318|NCT00335777|27176506|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
7827319|NCT00335777|27176506|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
7827320|NCT00335764|27176516|P5|Overall Study|wrong histology|1
7827321|NCT00335764|27176517|P4|Overall Study|wrong histology|0
7827322|NCT00335764|27176518|P3|Overall Study|wrong histology|0
7827323|NCT00335764|27176519|P2|Overall Study|wrong histology|0
7827324|NCT00335764|27176520|P1|Overall Study|wrong histology|1
7827325|NCT00335738|27176569|P2|Overall Study|Ineligible|4
7827326|NCT00335738|27176570|P1|Overall Study|Ineligible|3
7827327|NCT00335738|27176569|P2|Overall Study|Withdrawal by Subject|0
7827328|NCT00335738|27176570|P1|Overall Study|Withdrawal by Subject|2
7827329|NCT00335738|27176569|P2|Overall Study|Physician Decision|0
7827330|NCT00335738|27176570|P1|Overall Study|Physician Decision|6
7827331|NCT00335556|27176602|P6|Overall Study|Refusal of further protocol therapy|0
7827332|NCT00335556|27176603|P5|Overall Study|Refusal of further protocol therapy|0
7827333|NCT00335556|27176604|P4|Overall Study|Refusal of further protocol therapy|1
7827334|NCT00335556|27176605|P3|Overall Study|Refusal of further protocol therapy|0
7827335|NCT00335556|27176606|P2|Overall Study|Refusal of further protocol therapy|4
7827336|NCT00335556|27176607|P1|Overall Study|Refusal of further protocol therapy|0
7827337|NCT00335556|27176602|P6|Overall Study|Ineligible|0
7827338|NCT00335556|27176603|P5|Overall Study|Ineligible|0
7827339|NCT00335556|27176604|P4|Overall Study|Ineligible|0
7827340|NCT00335556|27176605|P3|Overall Study|Ineligible|0
7827341|NCT00335556|27176606|P2|Overall Study|Ineligible|0
7827342|NCT00335556|27176607|P1|Overall Study|Ineligible|2
7827343|NCT00335556|27176602|P6|Overall Study|Physician Decision|0
7827344|NCT00335556|27176603|P5|Overall Study|Physician Decision|0
7827345|NCT00335556|27176604|P4|Overall Study|Physician Decision|1
7827346|NCT00335556|27176605|P3|Overall Study|Physician Decision|2
7827347|NCT00335556|27176606|P2|Overall Study|Physician Decision|6
7827348|NCT00335556|27176607|P1|Overall Study|Physician Decision|0
7827349|NCT00335556|27176602|P6|Overall Study|Lack of Efficacy|1
7827350|NCT00335556|27176603|P5|Overall Study|Lack of Efficacy|0
7827351|NCT00335556|27176604|P4|Overall Study|Lack of Efficacy|3
7827352|NCT00335556|27176605|P3|Overall Study|Lack of Efficacy|3
7827353|NCT00335556|27176606|P2|Overall Study|Lack of Efficacy|19
7827354|NCT00335556|27176607|P1|Overall Study|Lack of Efficacy|0
7827355|NCT00335556|27176602|P6|Overall Study|Death|0
7827356|NCT00335556|27176603|P5|Overall Study|Death|1
7827357|NCT00335556|27176604|P4|Overall Study|Death|0
7827358|NCT00335556|27176605|P3|Overall Study|Death|0
7827359|NCT00335556|27176606|P2|Overall Study|Death|5
7827360|NCT00335556|27176607|P1|Overall Study|Death|0
7827361|NCT00335452|27176669|P4|Overall Study|Lost to Follow-up|2
7827362|NCT00335452|27176670|P3|Overall Study|Lost to Follow-up|1
7827363|NCT00335452|27176671|P2|Overall Study|Lost to Follow-up|3
7827364|NCT00335452|27176672|P1|Overall Study|Lost to Follow-up|2
7827365|NCT00335452|27176669|P4|Overall Study|Death|129
7827366|NCT00335452|27176670|P3|Overall Study|Death|158
7827367|NCT00335452|27176671|P2|Overall Study|Death|144
7827368|NCT00335452|27176672|P1|Overall Study|Death|156
7827369|NCT00335322|27176697|P3|Overall Study|Randomised but withdrew prior to ART sta|2
7827370|NCT00335322|27176698|P2|Overall Study|Randomised but withdrew prior to ART sta|2
7827371|NCT00335322|27176699|P1|Overall Study|Randomised but withdrew prior to ART sta|1
7827372|NCT00335153|27176747|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
7827373|NCT00335153|27176747|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
7827374|NCT00335153|27176747|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
7827375|NCT00335153|27176747|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
7827376|NCT00335153|27176747|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
7827377|NCT00335153|27176747|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
7827378|NCT00335153|27176747|P1|Nasojejunal (NJ) Test Period|Administrative|1
7827379|NCT00335153|27176747|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
7827380|NCT00335153|27176747|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
7827381|NCT00335153|27176747|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
7827382|NCT00335140|27176784|P1|Overall Study|Ineligible|1
7827383|NCT00334958|27176790|P2|Overall Study|Other|2
7827384|NCT00334958|27176791|P1|Overall Study|Other|1
7827385|NCT00334958|27176790|P2|Overall Study|Adverse Event|12
7827386|NCT00334958|27176791|P1|Overall Study|Adverse Event|27
7827387|NCT00334958|27176790|P2|Overall Study|Withdrawal by Subject|4
7827388|NCT00334958|27176791|P1|Overall Study|Withdrawal by Subject|7
7827389|NCT00334958|27176790|P2|Overall Study|Request of the investigator or sponsor|1
7827390|NCT00334958|27176791|P1|Overall Study|Request of the investigator or sponsor|0
7827391|NCT00334958|27176790|P2|Overall Study|Protocol Violation|2
7827392|NCT00334958|27176791|P1|Overall Study|Protocol Violation|2
7827393|NCT00334958|27176790|P2|Overall Study|Medication Noncompliance|3
7827394|NCT00334958|27176791|P1|Overall Study|Medication Noncompliance|0
7827395|NCT00334893|27176805|P2|Overall Study|Not Treated|0
7827396|NCT00334893|27176806|P1|Overall Study|Not Treated|1
7827409|NCT00334802|27176831|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
7827410|NCT00334802|27176832|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
7827411|NCT00334802|27176831|P2|Overall Study|Adverse Event|3
7827412|NCT00334802|27176832|P1|Overall Study|Adverse Event|0
7827413|NCT00334802|27176831|P2|Overall Study|Withdrawal by Subject|4
7827414|NCT00334802|27176832|P1|Overall Study|Withdrawal by Subject|0
7827415|NCT00334802|27176831|P2|Overall Study|Physician Decision|0
7827416|NCT00334802|27176832|P1|Overall Study|Physician Decision|1
7827417|NCT00334802|27176831|P2|Overall Study|Patient Condition Aggrevated|0
7827418|NCT00334802|27176832|P1|Overall Study|Patient Condition Aggrevated|1
7827419|NCT00334802|27176831|P2|Overall Study|Lack of Efficacy|3
7827420|NCT00334802|27176832|P1|Overall Study|Lack of Efficacy|1
7827421|NCT00334802|27176831|P2|Overall Study|Toxicity|5
7827422|NCT00334802|27176832|P1|Overall Study|Toxicity|1
7827423|NCT00334802|27176831|P2|Overall Study|Progressive Disease|24
7827424|NCT00334802|27176832|P1|Overall Study|Progressive Disease|2
7827425|NCT00334737|27176852|P3|Follow up Phase|Lost to Follow-up|6
7827426|NCT00334737|27176853|P2|Follow up Phase|Lost to Follow-up|3
7827427|NCT00334737|27176854|P1|Follow up Phase|Lost to Follow-up|5
7827428|NCT00334737|27176852|P3|Hospital Phase|Did not receive study drug|0
7827429|NCT00334737|27176853|P2|Hospital Phase|Did not receive study drug|0
7827430|NCT00334737|27176854|P1|Hospital Phase|Did not receive study drug|1
7827431|NCT00334737|27176852|P3|Hospital Phase|Withdrawal by Subject|1
7827432|NCT00334737|27176853|P2|Hospital Phase|Withdrawal by Subject|0
7827433|NCT00334737|27176854|P1|Hospital Phase|Withdrawal by Subject|0
7827434|NCT00334737|27176852|P3|Hospital Phase|Death|3
7827435|NCT00334737|27176853|P2|Hospital Phase|Death|2
7827436|NCT00334737|27176854|P1|Hospital Phase|Death|1
7827437|NCT00334542|27176902|P1|Overall Study|New cancer diagnosis|1
7827438|NCT00334542|27176902|P1|Overall Study|Withdrawal by Subject|1
7827439|NCT00334542|27176902|P1|Overall Study|Adverse Event|3
7827440|NCT00334295|27176909|P1|Overall Study|Patients received fewer than 3 injection|5
7827441|NCT00334282|27176919|P2|Overall Study|Death|100
7827442|NCT00334282|27176920|P1|Overall Study|Death|194
7827443|NCT00334282|27176919|P2|Overall Study|Withdrawal by Subject|3
7827444|NCT00334282|27176920|P1|Overall Study|Withdrawal by Subject|17
7827445|NCT00334282|27176919|P2|Overall Study|Lost to Follow-up|5
7827446|NCT00334282|27176920|P1|Overall Study|Lost to Follow-up|11
7827447|NCT00334113|27176951|P2|Overall Study|Withdrawal by Subject|1
7827448|NCT00334113|27176952|P1|Overall Study|Withdrawal by Subject|0
7827449|NCT00334113|27176951|P2|Overall Study|Lost to Follow-up|2
7827450|NCT00334113|27176952|P1|Overall Study|Lost to Follow-up|2
7827451|NCT00333983|27176975|P3|Overall Study|Withdrawal by Subject|1
7827452|NCT00333983|27176976|P2|Overall Study|Withdrawal by Subject|3
7827453|NCT00333983|27176977|P1|Overall Study|Withdrawal by Subject|0
7827454|NCT00333983|27176975|P3|Overall Study|Adverse Event|1
7827455|NCT00333983|27176976|P2|Overall Study|Adverse Event|1
7827456|NCT00333983|27176977|P1|Overall Study|Adverse Event|1
7827457|NCT00333983|27176975|P3|Overall Study|Lost to Follow-up|0
7827458|NCT00333983|27176976|P2|Overall Study|Lost to Follow-up|1
7827459|NCT00333983|27176977|P1|Overall Study|Lost to Follow-up|2
7827460|NCT00333970|27176987|P2|Overall Study|Withdrawal by Subject|7
7827461|NCT00333970|27176988|P1|Overall Study|Withdrawal by Subject|13
7827462|NCT00333866|27177003|P4|Overall Study|Randomized but not Treated|1
7827463|NCT00333866|27177004|P3|Overall Study|Randomized but not Treated|2
7827464|NCT00333866|27177005|P2|Overall Study|Randomized but not Treated|3
7827465|NCT00333866|27177006|P1|Overall Study|Randomized but not Treated|5
7827466|NCT00333866|27177003|P4|Overall Study|Withdrawal by Subject|9
7827467|NCT00333866|27177004|P3|Overall Study|Withdrawal by Subject|4
7827468|NCT00333866|27177005|P2|Overall Study|Withdrawal by Subject|14
7827469|NCT00333866|27177006|P1|Overall Study|Withdrawal by Subject|8
7827470|NCT00333866|27177003|P4|Overall Study|Lost to Follow-up|2
7827471|NCT00333866|27177004|P3|Overall Study|Lost to Follow-up|2
7827472|NCT00333866|27177005|P2|Overall Study|Lost to Follow-up|2
7827473|NCT00333866|27177006|P1|Overall Study|Lost to Follow-up|1
7827474|NCT00333866|27177003|P4|Overall Study|Lack of Efficacy|5
7827475|NCT00333866|27177004|P3|Overall Study|Lack of Efficacy|3
7827476|NCT00333866|27177005|P2|Overall Study|Lack of Efficacy|6
7827477|NCT00333866|27177006|P1|Overall Study|Lack of Efficacy|8
7827478|NCT00333866|27177003|P4|Overall Study|Other|2
7827479|NCT00333866|27177004|P3|Overall Study|Other|2
7827480|NCT00333866|27177005|P2|Overall Study|Other|2
7827481|NCT00333866|27177006|P1|Overall Study|Other|3
7827482|NCT00333866|27177003|P4|Overall Study|Adverse Event|47
7827483|NCT00333866|27177004|P3|Overall Study|Adverse Event|38
7827484|NCT00333866|27177005|P2|Overall Study|Adverse Event|37
7827485|NCT00333866|27177006|P1|Overall Study|Adverse Event|23
7827486|NCT00333840|27177066|P4|Second-line Treatment Period|Death|9
7827487|NCT00333840|27177067|P3|Second-line Treatment Period|Death|0
7827488|NCT00333840|27177068|P2|Second-line Treatment Period|Death|0
7827489|NCT00333840|27177069|P1|Second-line Treatment Period|Death|0
7827490|NCT00333840|27177066|P4|Second-line Treatment Period|Administrative problems|7
7827491|NCT00333840|27177067|P3|Second-line Treatment Period|Administrative problems|0
7827492|NCT00333840|27177068|P2|Second-line Treatment Period|Administrative problems|0
7827493|NCT00333840|27177069|P1|Second-line Treatment Period|Administrative problems|0
7827494|NCT00333840|27177066|P4|Second-line Treatment Period|Lost to Follow-up|6
7827495|NCT00333840|27177067|P3|Second-line Treatment Period|Lost to Follow-up|0
7827496|NCT00333840|27177068|P2|Second-line Treatment Period|Lost to Follow-up|0
7827497|NCT00333840|27177069|P1|Second-line Treatment Period|Lost to Follow-up|0
7827498|NCT00333840|27177066|P4|Second-line Treatment Period|Subject withdrew consent|34
7827499|NCT00333840|27177067|P3|Second-line Treatment Period|Subject withdrew consent|0
7827500|NCT00333840|27177068|P2|Second-line Treatment Period|Subject withdrew consent|0
7827501|NCT00333840|27177069|P1|Second-line Treatment Period|Subject withdrew consent|0
7827502|NCT00333840|27177066|P4|Second-line Treatment Period|Protocol Violation|10
7827503|NCT00333840|27177067|P3|Second-line Treatment Period|Protocol Violation|1
7827504|NCT00333840|27177068|P2|Second-line Treatment Period|Protocol Violation|0
7827505|NCT00333840|27177069|P1|Second-line Treatment Period|Protocol Violation|0
7827506|NCT00333840|27177066|P4|Second-line Treatment Period|No longer required study drug|14
7827507|NCT00333840|27177067|P3|Second-line Treatment Period|No longer required study drug|1
7827508|NCT00333840|27177068|P2|Second-line Treatment Period|No longer required study drug|0
7827509|NCT00333840|27177069|P1|Second-line Treatment Period|No longer required study drug|0
7827510|NCT00333840|27177066|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
7827511|NCT00333840|27177067|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
7827512|NCT00333840|27177068|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
7827513|NCT00333840|27177069|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
7827514|NCT00333840|27177066|P4|Second-line Treatment Period|Abnormal procedure|1
7827515|NCT00333840|27177067|P3|Second-line Treatment Period|Abnormal procedure|0
7827516|NCT00333840|27177068|P2|Second-line Treatment Period|Abnormal procedure|0
7827517|NCT00333840|27177069|P1|Second-line Treatment Period|Abnormal procedure|0
7827518|NCT00333840|27177066|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
7827519|NCT00333840|27177067|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
7827520|NCT00333840|27177068|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
7827521|NCT00333840|27177069|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
7827522|NCT00333840|27177066|P4|Second-line Treatment Period|Adverse Event|34
7827523|NCT00333840|27177067|P3|Second-line Treatment Period|Adverse Event|3
7827524|NCT00333840|27177068|P2|Second-line Treatment Period|Adverse Event|0
7827525|NCT00333840|27177069|P1|Second-line Treatment Period|Adverse Event|0
7827526|NCT00333840|27177066|P4|First-line Treatment Period|Crossed over to other treatment arm|0
7827527|NCT00333840|27177067|P3|First-line Treatment Period|Crossed over to other treatment arm|0
7827528|NCT00333840|27177068|P2|First-line Treatment Period|Crossed over to other treatment arm|363
7827529|NCT00333840|27177069|P1|First-line Treatment Period|Crossed over to other treatment arm|14
7827530|NCT00333840|27177066|P4|First-line Treatment Period|Death|0
7827531|NCT00333840|27177067|P3|First-line Treatment Period|Death|0
7827532|NCT00333840|27177068|P2|First-line Treatment Period|Death|2
7827533|NCT00333840|27177069|P1|First-line Treatment Period|Death|19
7827534|NCT00333840|27177066|P4|First-line Treatment Period|Administrative problems|0
7827535|NCT00333840|27177067|P3|First-line Treatment Period|Administrative problems|0
7827536|NCT00333840|27177068|P2|First-line Treatment Period|Administrative problems|6
7827537|NCT00333840|27177069|P1|First-line Treatment Period|Administrative problems|12
7827538|NCT00333840|27177066|P4|First-line Treatment Period|Lost to Follow-up|0
7827539|NCT00333840|27177067|P3|First-line Treatment Period|Lost to Follow-up|0
7827540|NCT00333840|27177068|P2|First-line Treatment Period|Lost to Follow-up|6
7827541|NCT00333840|27177069|P1|First-line Treatment Period|Lost to Follow-up|15
7827542|NCT00333840|27177066|P4|First-line Treatment Period|Subject withdrew consent|0
7827543|NCT00333840|27177067|P3|First-line Treatment Period|Subject withdrew consent|0
7827544|NCT00333840|27177068|P2|First-line Treatment Period|Subject withdrew consent|77
7827545|NCT00333840|27177069|P1|First-line Treatment Period|Subject withdrew consent|57
7827546|NCT00333840|27177066|P4|First-line Treatment Period|Protocol Violation|0
7827547|NCT00333840|27177067|P3|First-line Treatment Period|Protocol Violation|0
7827548|NCT00333840|27177068|P2|First-line Treatment Period|Protocol Violation|17
7827549|NCT00333840|27177069|P1|First-line Treatment Period|Protocol Violation|17
7827550|NCT00333840|27177066|P4|First-line Treatment Period|No longer required study drug|0
7827551|NCT00333840|27177067|P3|First-line Treatment Period|No longer required study drug|0
7827552|NCT00333840|27177068|P2|First-line Treatment Period|No longer required study drug|8
7827553|NCT00333840|27177069|P1|First-line Treatment Period|No longer required study drug|21
7827554|NCT00333840|27177066|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
7827555|NCT00333840|27177067|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
7827556|NCT00333840|27177068|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
7827557|NCT00333840|27177069|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
7827558|NCT00333840|27177066|P4|First-line Treatment Period|Abnormal procedure|0
7827559|NCT00333840|27177067|P3|First-line Treatment Period|Abnormal procedure|0
7827560|NCT00333840|27177068|P2|First-line Treatment Period|Abnormal procedure|0
7827561|NCT00333840|27177069|P1|First-line Treatment Period|Abnormal procedure|2
7827562|NCT00333840|27177066|P4|First-line Treatment Period|Abnormal laboratory values|0
7827563|NCT00333840|27177067|P3|First-line Treatment Period|Abnormal laboratory values|0
7827564|NCT00333840|27177068|P2|First-line Treatment Period|Abnormal laboratory values|1
7827565|NCT00333840|27177069|P1|First-line Treatment Period|Abnormal laboratory values|3
7827566|NCT00333840|27177066|P4|First-line Treatment Period|Adverse Event|0
7827567|NCT00333840|27177067|P3|First-line Treatment Period|Adverse Event|0
7827568|NCT00333840|27177068|P2|First-line Treatment Period|Adverse Event|37
7827569|NCT00333840|27177069|P1|First-line Treatment Period|Adverse Event|38
7827570|NCT00333801|27177115|P2|Overall Study|Withdrawal by Subject|1
7827571|NCT00333801|27177116|P1|Overall Study|Withdrawal by Subject|0
7827572|NCT00333801|27177115|P2|Overall Study|Incarcerated|2
7827573|NCT00333801|27177116|P1|Overall Study|Incarcerated|1
7827574|NCT00333801|27177115|P2|Overall Study|Lost to Follow-up|0
7827575|NCT00333801|27177116|P1|Overall Study|Lost to Follow-up|2
7827576|NCT00333801|27177115|P2|Overall Study|Moved to another state|3
7827577|NCT00333801|27177116|P1|Overall Study|Moved to another state|5
7827578|NCT00333788|27177134|P1|Overall Study|Other: Signed consent for another study|1
7827579|NCT00333788|27177134|P1|Overall Study|Other: Physician decision|1
7827580|NCT00333788|27177134|P1|Overall Study|Other: Medical monitor decision|1
7827581|NCT00333788|27177134|P1|Overall Study|Other: Subject in need of an Entocort|1
7827582|NCT00333788|27177134|P1|Overall Study|Other: Sponsor decision|1
7827583|NCT00333788|27177134|P1|Overall Study|Other: Quality of life concern|1
7827584|NCT00333788|27177134|P1|Overall Study|Other: Investigator decision|1
7827585|NCT00333788|27177134|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
7827586|NCT00333788|27177134|P1|Overall Study|Other: Moved|2
7827587|NCT00333788|27177134|P1|Overall Study|Other: Non-compliance|2
7827588|NCT00333788|27177134|P1|Overall Study|Withdrawal by Subject|24
7827589|NCT00333788|27177134|P1|Overall Study|Lost to Follow-up|2
7827590|NCT00333788|27177134|P1|Overall Study|Lack of Efficacy|80
7827591|NCT00333788|27177134|P1|Overall Study|Adverse Event|44
7827592|NCT00333775|27177164|P3|Overall Study|Lost to Follow-up|8
7827593|NCT00333775|27177165|P2|Overall Study|Lost to Follow-up|7
7827594|NCT00333775|27177166|P1|Overall Study|Lost to Follow-up|10
7827595|NCT00333775|27177164|P3|Overall Study|In Follow-up When Study Stopped|96
7827596|NCT00333775|27177165|P2|Overall Study|In Follow-up When Study Stopped|92
7827597|NCT00333775|27177166|P1|Overall Study|In Follow-up When Study Stopped|87
7827598|NCT00333775|27177164|P3|Overall Study|Death|143
7827599|NCT00333775|27177165|P2|Overall Study|Death|149
7827600|NCT00333775|27177166|P1|Overall Study|Death|144
7827601|NCT00333619|27177205|P2|Overall Study|Lost to Follow-up|3
7827602|NCT00333619|27177206|P1|Overall Study|Lost to Follow-up|3
7827603|NCT00333619|27177205|P2|Overall Study|Withdrawal by Subject|1
7827604|NCT00333619|27177206|P1|Overall Study|Withdrawal by Subject|6
7827605|NCT00333619|27177205|P2|Overall Study|Death|6
7827606|NCT00333619|27177206|P1|Overall Study|Death|12
7827607|NCT00333359|27177235|P2|Overall Study|Withdrew before Receiving One Dose|6
7827608|NCT00333359|27177236|P1|Overall Study|Withdrew before Receiving One Dose|2
7827609|NCT00333359|27177235|P2|Overall Study|Treatment Failure|8
7827610|NCT00333359|27177236|P1|Overall Study|Treatment Failure|3
7827611|NCT00333359|27177235|P2|Overall Study|Termination or Withdrawal by Sponsor|1
7827612|NCT00333359|27177236|P1|Overall Study|Termination or Withdrawal by Sponsor|1
7827613|NCT00333359|27177235|P2|Overall Study|Lost to Follow-up|25
7827614|NCT00333359|27177236|P1|Overall Study|Lost to Follow-up|15
7827615|NCT00333359|27177235|P2|Overall Study|Protocol Non-compliance|8
7827616|NCT00333359|27177236|P1|Overall Study|Protocol Non-compliance|2
7827617|NCT00333359|27177235|P2|Overall Study|Physician Decision|2
7827618|NCT00333359|27177236|P1|Overall Study|Physician Decision|2
7827619|NCT00333359|27177235|P2|Overall Study|Withdrawal by Subject|37
7827620|NCT00333359|27177236|P1|Overall Study|Withdrawal by Subject|19
7827621|NCT00333359|27177235|P2|Overall Study|Adverse Event|35
7827622|NCT00333359|27177236|P1|Overall Study|Adverse Event|29
7827623|NCT00333229|27177279|P2|Overall Study|Lack of Efficacy|1
7827624|NCT00333229|27177280|P1|Overall Study|Lack of Efficacy|0
7827625|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Death|0
7827626|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Death|1
7827627|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Death|0
7827628|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
7827629|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
7827630|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
7827631|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
7827632|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
7827633|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
7827634|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
7827635|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
7827636|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
7827637|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
7827638|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
7827639|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
7827640|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
7827641|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
7827642|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
7827643|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
7827644|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
7827645|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
7827646|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
7827647|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
7827648|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
7827649|NCT00333138|27177350|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
7827650|NCT00333138|27177351|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
7827651|NCT00333138|27177352|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
7827652|NCT00333138|27177350|P3|Core Study (6 Months)|Laboratory abnormality|1
7827653|NCT00333138|27177351|P2|Core Study (6 Months)|Laboratory abnormality|0
7827654|NCT00333138|27177352|P1|Core Study (6 Months)|Laboratory abnormality|0
7827655|NCT00333138|27177350|P3|Core Study (6 Months)|Protocol Violation|1
7827656|NCT00333138|27177351|P2|Core Study (6 Months)|Protocol Violation|0
7827657|NCT00333138|27177352|P1|Core Study (6 Months)|Protocol Violation|1
7827658|NCT00333138|27177350|P3|Core Study (6 Months)|Lack of Efficacy|0
7827659|NCT00333138|27177351|P2|Core Study (6 Months)|Lack of Efficacy|0
7827660|NCT00333138|27177352|P1|Core Study (6 Months)|Lack of Efficacy|1
7827661|NCT00333138|27177350|P3|Core Study (6 Months)|Withdrawal by Subject|2
7827662|NCT00333138|27177351|P2|Core Study (6 Months)|Withdrawal by Subject|1
7827663|NCT00333138|27177352|P1|Core Study (6 Months)|Withdrawal by Subject|1
7827664|NCT00333138|27177350|P3|Core Study (6 Months)|Adverse Event|8
7827665|NCT00333138|27177351|P2|Core Study (6 Months)|Adverse Event|5
7827666|NCT00333138|27177352|P1|Core Study (6 Months)|Adverse Event|4
7827667|NCT00332839|27177391|P2|Follow-up (Months 12 - 60)|Death|1
7827668|NCT00332839|27177392|P1|Follow-up (Months 12 - 60)|Death|1
7827669|NCT00332839|27177391|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
7827670|NCT00332839|27177392|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
7827671|NCT00332839|27177391|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
7827672|NCT00332839|27177392|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
7827673|NCT00332839|27177391|P2|Core (Months 0 - 12)|Adverse Event|15
7827674|NCT00332839|27177392|P1|Core (Months 0 - 12)|Adverse Event|5
7827675|NCT00332839|27177391|P2|Core (Months 0 - 12)|Protocol deviation|1
7827676|NCT00332839|27177392|P1|Core (Months 0 - 12)|Protocol deviation|1
7827677|NCT00332839|27177391|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
7827678|NCT00332839|27177392|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
7827679|NCT00332839|27177391|P2|Core (Months 0 - 12)|Administrative problems|1
7827680|NCT00332839|27177392|P1|Core (Months 0 - 12)|Administrative problems|1
7827681|NCT00332709|27177423|P2|Overall Study|Abnormal test procedure result|0
7827682|NCT00332709|27177424|P1|Overall Study|Abnormal test procedure result|1
7827683|NCT00332709|27177423|P2|Overall Study|Administrative Problems|3
7827684|NCT00332709|27177424|P1|Overall Study|Administrative Problems|0
7827685|NCT00332709|27177423|P2|Overall Study|Lost to Follow-up|0
7827686|NCT00332709|27177424|P1|Overall Study|Lost to Follow-up|2
7827687|NCT00332709|27177423|P2|Overall Study|Withdrawal by Subject|3
7827688|NCT00332709|27177424|P1|Overall Study|Withdrawal by Subject|2
7827689|NCT00332709|27177423|P2|Overall Study|Adverse Event|14
7827690|NCT00332709|27177424|P1|Overall Study|Adverse Event|11
7827691|NCT00332696|27177448|P2|Overall Study|Withdrawal by Subject|0
7827692|NCT00332696|27177449|P1|Overall Study|Withdrawal by Subject|1
7827693|NCT00332696|27177448|P2|Overall Study|Lost to Follow-up|1
7827694|NCT00332696|27177449|P1|Overall Study|Lost to Follow-up|0
7827695|NCT00332696|27177448|P2|Overall Study|Condition does not justify treatment|2
7827696|NCT00332696|27177449|P1|Overall Study|Condition does not justify treatment|0
7827697|NCT00332696|27177448|P2|Overall Study|Adverse Event|2
7827698|NCT00332696|27177449|P1|Overall Study|Adverse Event|1
7827699|NCT00332696|27177448|P2|Overall Study|Insufficient therapeutic effect|11
7827700|NCT00332696|27177449|P1|Overall Study|Insufficient therapeutic effect|4
7827701|NCT00332696|27177448|P2|Overall Study|Death|14
7827702|NCT00332696|27177449|P1|Overall Study|Death|24
7827703|NCT00332488|27177525|P3|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
7827704|NCT00332488|27177526|P2|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
7827705|NCT00332488|27177527|P1|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
7827706|NCT00332488|27177525|P3|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
7827707|NCT00332488|27177526|P2|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
7827708|NCT00332488|27177527|P1|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
7827709|NCT00332488|27177525|P3|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
7827710|NCT00332488|27177526|P2|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
7827711|NCT00332488|27177527|P1|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
7827712|NCT00332488|27177525|P3|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
7827713|NCT00332488|27177526|P2|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
7827714|NCT00332488|27177527|P1|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
7827715|NCT00332488|27177525|P3|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
7827716|NCT00332488|27177526|P2|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
7827717|NCT00332488|27177527|P1|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
7827718|NCT00332488|27177525|P3|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
7827719|NCT00332488|27177526|P2|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
7827720|NCT00332488|27177527|P1|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
7827721|NCT00332488|27177525|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
7827722|NCT00332488|27177526|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
7827723|NCT00332488|27177527|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
7827724|NCT00332488|27177525|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
7827725|NCT00332488|27177526|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
7827726|NCT00332488|27177527|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
7827727|NCT00332488|27177525|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
7827728|NCT00332488|27177526|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
7827729|NCT00332488|27177527|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
7827730|NCT00332488|27177525|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
7827731|NCT00332488|27177526|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
7827732|NCT00332488|27177527|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
7827733|NCT00332488|27177525|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
7827734|NCT00332488|27177526|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
7827735|NCT00332488|27177527|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
7827736|NCT00332488|27177525|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
7827737|NCT00332488|27177526|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
7827738|NCT00332488|27177527|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
7827739|NCT00332462|27177539|P1|Overall Study|Graft Loss|2
7827740|NCT00332462|27177539|P1|Overall Study|Death|3
7827741|NCT00332462|27177539|P1|Overall Study|no longer requires study drug|1
7827742|NCT00332462|27177539|P1|Overall Study|Unsatisfactory therapeutic effect|4
7827743|NCT00332462|27177539|P1|Overall Study|Abnormal Lab Value|1
7827744|NCT00332462|27177539|P1|Overall Study|Adverse Event|5
7827745|NCT00332332|27177546|P1|Overall Study|Did not receive study treatment|16
7827746|NCT00332332|27177546|P1|Overall Study|Other|18
7827747|NCT00332332|27177546|P1|Overall Study|Disease progression|2
7827748|NCT00332332|27177546|P1|Overall Study|Noncompliance|2
7827749|NCT00332332|27177546|P1|Overall Study|Protocol deviation|4
7827750|NCT00332332|27177546|P1|Overall Study|Lost to Follow-up|3
7827751|NCT00332332|27177546|P1|Overall Study|Physician Decision|1
7827752|NCT00332332|27177546|P1|Overall Study|Withdrawal by Subject|8
7827753|NCT00332332|27177546|P1|Overall Study|Death|1
7827754|NCT00332332|27177546|P1|Overall Study|Adverse Event|13
7827755|NCT00332241|27177555|P2|Overall Study|Lost to Follow-up|1
7827756|NCT00332241|27177556|P1|Overall Study|Lost to Follow-up|4
7827757|NCT00332241|27177555|P2|Overall Study|Withdrawal by Subject|1
7827758|NCT00332241|27177556|P1|Overall Study|Withdrawal by Subject|2
7827759|NCT00332241|27177555|P2|Overall Study|Adverse Event|5
7827760|NCT00332241|27177556|P1|Overall Study|Adverse Event|3
7827761|NCT00332241|27177555|P2|Overall Study|Lack of Efficacy|1
7827762|NCT00332241|27177556|P1|Overall Study|Lack of Efficacy|6
7827763|NCT00332202|27177578|P2|Overall Study|Death|2
7827764|NCT00332202|27177579|P1|Overall Study|Death|5
7827765|NCT00332202|27177578|P2|Overall Study|Progressive Disease|60
7827766|NCT00332202|27177579|P1|Overall Study|Progressive Disease|106
7827767|NCT00332202|27177578|P2|Overall Study|Withdrawal by Subject|17
7827768|NCT00332202|27177579|P1|Overall Study|Withdrawal by Subject|36
7827769|NCT00332202|27177578|P2|Overall Study|Sponsor Decision|2
7827770|NCT00332202|27177579|P1|Overall Study|Sponsor Decision|1
7827771|NCT00332202|27177578|P2|Overall Study|Protocol Violation|2
7827772|NCT00332202|27177579|P1|Overall Study|Protocol Violation|7
7827773|NCT00332202|27177578|P2|Overall Study|Protocol Entry Criteria Not Met|5
7827774|NCT00332202|27177579|P1|Overall Study|Protocol Entry Criteria Not Met|6
7827775|NCT00332202|27177578|P2|Overall Study|Physician Decision|8
7827776|NCT00332202|27177579|P1|Overall Study|Physician Decision|6
7827777|NCT00332202|27177578|P2|Overall Study|Lost to Follow-up|1
7827778|NCT00332202|27177579|P1|Overall Study|Lost to Follow-up|2
7827779|NCT00332202|27177578|P2|Overall Study|Adverse Event|28
7827780|NCT00332202|27177579|P1|Overall Study|Adverse Event|72
7827781|NCT00332189|27177608|P1|Overall Study|Moved out of country|2
7827782|NCT00332189|27177608|P1|Overall Study|Lack of Efficacy|4
7827783|NCT00332189|27177608|P1|Overall Study|Withdrawal by Subject|9
7827784|NCT00332189|27177608|P1|Overall Study|Uncooperative/Noncompliant|3
7827785|NCT00332189|27177608|P1|Overall Study|Adverse Event|3
7827786|NCT00331864|27177650|P2|Overall Study|Death|0
7827787|NCT00331864|27177651|P1|Overall Study|Death|6
7827788|NCT00331864|27177650|P2|Overall Study|Administrative Problems|0
7827789|NCT00331864|27177651|P1|Overall Study|Administrative Problems|1
7827790|NCT00331864|27177650|P2|Overall Study|Lost to Follow-up|3
7827791|NCT00331864|27177651|P1|Overall Study|Lost to Follow-up|4
7827792|NCT00331864|27177650|P2|Overall Study|Withdrawal by Subject|0
7827793|NCT00331864|27177651|P1|Overall Study|Withdrawal by Subject|10
7827794|NCT00331864|27177650|P2|Overall Study|Protocol Violation|0
7827795|NCT00331864|27177651|P1|Overall Study|Protocol Violation|3
7827796|NCT00331864|27177650|P2|Overall Study|Lack of Efficacy|0
7827797|NCT00331864|27177651|P1|Overall Study|Lack of Efficacy|4
7827798|NCT00331864|27177650|P2|Overall Study|Adverse Event|1
7827799|NCT00331864|27177651|P1|Overall Study|Adverse Event|30
7827800|NCT00331799|27177670|P1|Overall Study|Sedation|1
7827801|NCT00331799|27177670|P1|Overall Study|Withdrawal by Subject|2
7827802|NCT00331773|27177676|P2|Overall Study|Protocol Violation|3
7827803|NCT00331773|27177677|P1|Overall Study|Protocol Violation|10
7827804|NCT00331773|27177676|P2|Overall Study|Withdrawal by Subject|4
7827805|NCT00331773|27177677|P1|Overall Study|Withdrawal by Subject|6
7827806|NCT00331760|27177707|P2|Overall Study|Ineligible / no protocol treatment|8
7827807|NCT00331760|27177708|P1|Overall Study|Ineligible / no protocol treatment|15
7827808|NCT00331682|27177729|P1|Overall Study|Adverse Event|1
7827809|NCT00331630|27177735|P1|Follow up for 5 Years|Data collection was stopped|24
7827810|NCT00331630|27177735|P1|Follow up for 5 Years|Death|5
7827811|NCT00331630|27177735|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
7827812|NCT00331630|27177735|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
7827813|NCT00331552|27177747|P2|Period 3: Phase II|Severe Nausea|0
7827814|NCT00331552|27177748|P1|Period 3: Phase II|Severe Nausea|1
7827815|NCT00331552|27177747|P2|Period 3: Phase II|Neurological Symptoms|0
7827816|NCT00331552|27177748|P1|Period 3: Phase II|Neurological Symptoms|1
7827817|NCT00331422|27177762|P1|Overall Study|Did not receive entire study regimen|5
7827818|NCT00331409|27177771|P1|Overall Study|Lack of Efficacy|4
7827819|NCT00331344|27177779|P9|Phase II|Death|4
7827820|NCT00331344|27177780|P8|Phase II|Death|0
7827821|NCT00331344|27177781|P7|Phase II|Death|0
7827822|NCT00331344|27177782|P6|Phase II|Death|0
7827823|NCT00331344|27177783|P5|Phase II|Death|0
7827824|NCT00331344|27177784|P4|Phase II|Death|0
7827825|NCT00331344|27177785|P3|Phase II|Death|0
7827826|NCT00331344|27177786|P2|Phase II|Death|0
7827827|NCT00331344|27177787|P1|Phase II|Death|0
7827828|NCT00331344|27177779|P9|Phase I|Adverse Event|0
7827829|NCT00331344|27177780|P8|Phase I|Adverse Event|1
7827830|NCT00331344|27177781|P7|Phase I|Adverse Event|0
7827831|NCT00331344|27177782|P6|Phase I|Adverse Event|2
7827832|NCT00331344|27177783|P5|Phase I|Adverse Event|2
7827833|NCT00331344|27177784|P4|Phase I|Adverse Event|1
7827834|NCT00331344|27177785|P3|Phase I|Adverse Event|0
7827835|NCT00331344|27177786|P2|Phase I|Adverse Event|0
7827836|NCT00331344|27177787|P1|Phase I|Adverse Event|0
7827837|NCT00331006|27177824|P1|Follow-Up Phase II|Lost to Follow-up|3
7827838|NCT00331006|27177824|P1|Follow-Up Phase I|Lost to Follow-up|1
7827839|NCT00331006|27177824|P1|Treatment Phase|Withdrawal by Subject|1
7827840|NCT00331006|27177824|P1|Screening Phase|Ineligible for treatment phase|4
7827841|NCT00331006|27177824|P1|Screening Phase|Lost to Follow-up|1
7827842|NCT00331006|27177824|P1|Screening Phase|enrollment halted|1
7827843|NCT00331006|27177824|P1|Screening Phase|Withdrawal by Subject|1
7827844|NCT00330967|27177837|P2|Overall Study|Physician Decision|9
7827845|NCT00330967|27177838|P1|Overall Study|Physician Decision|0
7827846|NCT00330967|27177837|P2|Overall Study|Withdrawal by Subject|5
7827847|NCT00330967|27177838|P1|Overall Study|Withdrawal by Subject|0
7827848|NCT00330928|27177849|P1|Overall Study|IVUS could not be performed.|1
7827849|NCT00330928|27177849|P1|Overall Study|Death|1
7827850|NCT00330928|27177849|P1|Overall Study|Physician Decision|9
7827851|NCT00330928|27177849|P1|Overall Study|Lost to Follow-up|6
7827852|NCT00330759|27177891|P2|Overall Study|Other|44
7827853|NCT00330759|27177892|P1|Overall Study|Other|36
7827854|NCT00330759|27177891|P2|Overall Study|Ineligibility determined|1
7827855|NCT00330759|27177892|P1|Overall Study|Ineligibility determined|2
7827856|NCT00330759|27177891|P2|Overall Study|Protocol deviation|2
7827857|NCT00330759|27177892|P1|Overall Study|Protocol deviation|0
7827858|NCT00330759|27177891|P2|Overall Study|Physician Decision|2
7827859|NCT00330759|27177892|P1|Overall Study|Physician Decision|1
7827860|NCT00330759|27177891|P2|Overall Study|Noncompliance|17
7827861|NCT00330759|27177892|P1|Overall Study|Noncompliance|15
7827862|NCT00330759|27177891|P2|Overall Study|Lost to Follow-up|22
7827863|NCT00330759|27177892|P1|Overall Study|Lost to Follow-up|16
7827864|NCT00330759|27177891|P2|Overall Study|Participant request|22
7827865|NCT00330759|27177892|P1|Overall Study|Participant request|31
7827866|NCT00330759|27177891|P2|Overall Study|Adverse Event|36
7827867|NCT00330759|27177892|P1|Overall Study|Adverse Event|48
7827868|NCT00330759|27177891|P2|Overall Study|Withdrawal by Subject|124
7827869|NCT00330759|27177892|P1|Overall Study|Withdrawal by Subject|143
7827870|NCT00330759|27177891|P2|Overall Study|Disease progression|126
7827871|NCT00330759|27177892|P1|Overall Study|Disease progression|104
7827872|NCT00330759|27177891|P2|Overall Study|Death|310
7827873|NCT00330759|27177892|P1|Overall Study|Death|316
7827874|NCT00330681|27177925|P2|Overall Study|Tracheotomy due to worsening of ALS|2
7827875|NCT00330681|27177926|P1|Overall Study|Tracheotomy due to worsening of ALS|1
7827876|NCT00330681|27177925|P2|Overall Study|Withdrawal by Subject|5
7827877|NCT00330681|27177926|P1|Overall Study|Withdrawal by Subject|5
7827878|NCT00330681|27177925|P2|Overall Study|Protocol Violation|1
7827879|NCT00330681|27177926|P1|Overall Study|Protocol Violation|0
7827880|NCT00330681|27177925|P2|Overall Study|Adverse Event|6
7827881|NCT00330681|27177926|P1|Overall Study|Adverse Event|3
7827882|NCT00330668|27177948|P1|QD Dosing Period|Lost to Follow-up|2
7827883|NCT00330668|27177948|P1|QD Dosing Period|Withdrawal by Subject|1
7827884|NCT00330668|27177948|P1|QD Dosing Period|Other|1
7827885|NCT00330668|27177948|P1|QD Dosing Period|Sponsor decision to terminate study|74
7827886|NCT00330668|27177948|P1|BID Dosing Period|Other|3
7827887|NCT00330668|27177948|P1|BID Dosing Period|Sponsor's decision|1
7827888|NCT00330668|27177948|P1|BID Dosing Period|Withdrawal by Subject|19
7827889|NCT00330668|27177948|P1|BID Dosing Period|Non-Compliance|5
7827890|NCT00330668|27177948|P1|BID Dosing Period|Lost to Follow-up|7
7827891|NCT00330668|27177948|P1|BID Dosing Period|Adverse Event|1
7827892|NCT00330616|27177956|P1|Overall Study|Other|1
7827893|NCT00330616|27177956|P1|Overall Study|Withdrawal by Subject|4
7827894|NCT00330616|27177956|P1|Overall Study|Lost to Follow-up|2
7827895|NCT00330616|27177956|P1|Overall Study|Lack of Efficacy|1
7827896|NCT00330616|27177956|P1|Overall Study|Adverse Event|13
7827897|NCT00330460|27178007|P2|Overall Study|Other|0
7827898|NCT00330460|27178008|P1|Overall Study|Other|1
7827899|NCT00330460|27178007|P2|Overall Study|Noncompliance|1
7827900|NCT00330460|27178008|P1|Overall Study|Noncompliance|2
7827901|NCT00330460|27178007|P2|Overall Study|Lost to Follow-up|3
7827902|NCT00330460|27178008|P1|Overall Study|Lost to Follow-up|8
7827903|NCT00330460|27178007|P2|Overall Study|Ineligibility determined|3
7827904|NCT00330460|27178008|P1|Overall Study|Ineligibility determined|1
7827905|NCT00330460|27178007|P2|Overall Study|Death|1
7827906|NCT00330460|27178008|P1|Overall Study|Death|1
7827907|NCT00330460|27178007|P2|Overall Study|Withdrawal by Subject|17
7827908|NCT00330460|27178008|P1|Overall Study|Withdrawal by Subject|18
7827909|NCT00330460|27178007|P2|Overall Study|Adverse Event|8
7827910|NCT00330460|27178008|P1|Overall Study|Adverse Event|10
7827911|NCT00330460|27178007|P2|Overall Study|Physician Decision|0
7827912|NCT00330460|27178008|P1|Overall Study|Physician Decision|1
7827913|NCT00330343|27178051|P1|Overall Study|Lost to Follow-up|5
7827914|NCT00330187|27178059|P4|Overall Study|Withdrawal by Subject|4
7827915|NCT00330187|27178060|P3|Overall Study|Withdrawal by Subject|4
7827916|NCT00330187|27178061|P2|Overall Study|Withdrawal by Subject|5
7827917|NCT00330187|27178062|P1|Overall Study|Withdrawal by Subject|8
7827918|NCT00330187|27178059|P4|Overall Study|Lost to Follow-up|10
7827919|NCT00330187|27178060|P3|Overall Study|Lost to Follow-up|14
7827920|NCT00330187|27178061|P2|Overall Study|Lost to Follow-up|13
7827921|NCT00330187|27178062|P1|Overall Study|Lost to Follow-up|12
7827922|NCT00330174|27178074|P2|Overall Study|Miscellaneous reasons|1
7827923|NCT00330174|27178075|P1|Overall Study|Miscellaneous reasons|7
7827924|NCT00330174|27178074|P2|Overall Study|Excessive missed visits|8
7827925|NCT00330174|27178075|P1|Overall Study|Excessive missed visits|3
7827926|NCT00330174|27178074|P2|Overall Study|Clinical deterioration|2
7827927|NCT00330174|27178075|P1|Overall Study|Clinical deterioration|1
7827928|NCT00330174|27178074|P2|Overall Study|Lost to Follow-up|1
7827929|NCT00330174|27178075|P1|Overall Study|Lost to Follow-up|4
7827930|NCT00330174|27178074|P2|Overall Study|Withdrawal by Subject|7
7827931|NCT00330174|27178075|P1|Overall Study|Withdrawal by Subject|7
7827932|NCT00329901|27178099|P3|Overall Study|Unable to classify|0
7827933|NCT00329901|27178100|P2|Overall Study|Unable to classify|2
7827934|NCT00329901|27178101|P1|Overall Study|Unable to classify|2
7827935|NCT00329901|27178099|P3|Overall Study|Protocol Violation|1
7827936|NCT00329901|27178100|P2|Overall Study|Protocol Violation|0
7827937|NCT00329901|27178101|P1|Overall Study|Protocol Violation|1
7827938|NCT00329901|27178099|P3|Overall Study|Lost to Follow-up|1
7827939|NCT00329901|27178100|P2|Overall Study|Lost to Follow-up|0
7827940|NCT00329901|27178101|P1|Overall Study|Lost to Follow-up|2
7827941|NCT00329901|27178099|P3|Overall Study|Withdrawal by Subject|2
7827942|NCT00329901|27178100|P2|Overall Study|Withdrawal by Subject|3
7827943|NCT00329901|27178101|P1|Overall Study|Withdrawal by Subject|4
7827944|NCT00329849|27178131|P2|Overall Study|Withdrawal by Subject|4
7827945|NCT00329849|27178132|P1|Overall Study|Withdrawal by Subject|6
7827946|NCT00329797|27178158|P2|Overall Study|Withdrawal by Subject|6
7827947|NCT00329797|27178159|P1|Overall Study|Withdrawal by Subject|6
7827948|NCT00329797|27178158|P2|Overall Study|Protocol Violation|0
7827949|NCT00329797|27178159|P1|Overall Study|Protocol Violation|1
7827950|NCT00329784|27178175|P4|Overall Study|Other|0
7827951|NCT00329784|27178176|P3|Overall Study|Other|0
7827952|NCT00329784|27178177|P2|Overall Study|Other|2
7827953|NCT00329784|27178178|P1|Overall Study|Other|1
7827954|NCT00329784|27178175|P4|Overall Study|Withdrawal by Subject|0
7827955|NCT00329784|27178176|P3|Overall Study|Withdrawal by Subject|0
7827956|NCT00329784|27178177|P2|Overall Study|Withdrawal by Subject|2
7827957|NCT00329784|27178178|P1|Overall Study|Withdrawal by Subject|4
7827958|NCT00329784|27178175|P4|Overall Study|Lost to Follow-up|0
7827959|NCT00329784|27178176|P3|Overall Study|Lost to Follow-up|0
7827960|NCT00329784|27178177|P2|Overall Study|Lost to Follow-up|1
7827961|NCT00329784|27178178|P1|Overall Study|Lost to Follow-up|0
7827962|NCT00329745|27178206|P2|Overall Study|Lost to Follow-up|101
7827963|NCT00329745|27178207|P1|Overall Study|Lost to Follow-up|86
7827964|NCT00329745|27178206|P2|Overall Study|Withdrawal by Subject|1
7827965|NCT00329745|27178207|P1|Overall Study|Withdrawal by Subject|0
7827966|NCT00329745|27178206|P2|Overall Study|Protocol Violation|0
7827967|NCT00329745|27178207|P1|Overall Study|Protocol Violation|1
7827968|NCT00329719|27178227|P4|Overall Study|Lost to Follow-up|1
7827969|NCT00329719|27178228|P3|Overall Study|Lost to Follow-up|0
7827970|NCT00329719|27178229|P2|Overall Study|Lost to Follow-up|0
7827971|NCT00329719|27178230|P1|Overall Study|Lost to Follow-up|0
7827972|NCT00329641|27178252|P1|Overall Study|Other reason, not protocol specified|1
7827973|NCT00329641|27178252|P1|Overall Study|Adverse Event|3
7827974|NCT00329641|27178252|P1|Overall Study|Not eligible|1
7827975|NCT00329641|27178252|P1|Overall Study|Did not start treatment|1
7827976|NCT00329602|27178261|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
7827977|NCT00329602|27178262|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
7827978|NCT00329602|27178263|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
7827979|NCT00329602|27178261|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
7827980|NCT00329602|27178262|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7827981|NCT00329602|27178263|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7827982|NCT00329602|27178261|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
7827983|NCT00329602|27178262|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
7827984|NCT00329602|27178263|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
7827985|NCT00329602|27178261|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
7827986|NCT00329602|27178262|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
7827987|NCT00329602|27178263|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
7827988|NCT00329602|27178261|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
7827989|NCT00329602|27178262|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
7827990|NCT00329602|27178263|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
7827991|NCT00329602|27178261|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
7827992|NCT00329602|27178262|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
7827993|NCT00329602|27178263|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
7827994|NCT00329550|27178301|P3|Overall Study|Due to Relocation|1
7827995|NCT00329550|27178302|P2|Overall Study|Due to Relocation|0
7827996|NCT00329550|27178303|P1|Overall Study|Due to Relocation|0
7827997|NCT00329550|27178301|P3|Overall Study|Withdrawal of Consent|1
7827998|NCT00329550|27178302|P2|Overall Study|Withdrawal of Consent|0
7827999|NCT00329550|27178303|P1|Overall Study|Withdrawal of Consent|1
7828000|NCT00329550|27178301|P3|Overall Study|Adverse Event|2
7828001|NCT00329550|27178302|P2|Overall Study|Adverse Event|4
7828002|NCT00329550|27178303|P1|Overall Study|Adverse Event|3
7828003|NCT00329420|27178572|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
7828004|NCT00329420|27178573|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
7828005|NCT00329420|27178574|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
7828006|NCT00329420|27178572|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
7828007|NCT00329420|27178573|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
7828008|NCT00329420|27178574|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
7828009|NCT00329420|27178572|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
7828010|NCT00329420|27178573|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
7828011|NCT00329420|27178574|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
7828012|NCT00329420|27178572|P3|Re-induction Phase|Did not respond to re-induction|7
7828013|NCT00329420|27178573|P2|Re-induction Phase|Did not respond to re-induction|5
7828014|NCT00329420|27178574|P1|Re-induction Phase|Did not respond to re-induction|6
7828015|NCT00329420|27178572|P3|Re-induction Phase|Withdrawal of Consent|1
7828016|NCT00329420|27178573|P2|Re-induction Phase|Withdrawal of Consent|0
7828017|NCT00329420|27178574|P1|Re-induction Phase|Withdrawal of Consent|0
7828018|NCT00329420|27178572|P3|Re-induction Phase|Lack of Efficacy|0
7828019|NCT00329420|27178573|P2|Re-induction Phase|Lack of Efficacy|1
7828020|NCT00329420|27178574|P1|Re-induction Phase|Lack of Efficacy|0
7828021|NCT00329407|27178953|P1|Overall Study|Withdrawal by Subject|1
7828022|NCT00329303|27178960|P2|Overall Study|Patient relocated|1
7828023|NCT00329303|27178961|P1|Overall Study|Patient relocated|0
7828024|NCT00329303|27178960|P2|Overall Study|Patient no longer available|0
7828025|NCT00329303|27178961|P1|Overall Study|Patient no longer available|1
7828026|NCT00329303|27178960|P2|Overall Study|Decision of the sponsor|1
7828027|NCT00329303|27178961|P1|Overall Study|Decision of the sponsor|0
7828028|NCT00329303|27178960|P2|Overall Study|Lack of Efficacy|0
7828029|NCT00329303|27178961|P1|Overall Study|Lack of Efficacy|1
7828030|NCT00329238|27179123|P2|Overall Study|Other reason (not specified)|54
7828031|NCT00329238|27179124|P1|Overall Study|Other reason (not specified)|40
7828032|NCT00329238|27179123|P2|Overall Study|Withdrawal by Subject|58
7828033|NCT00329238|27179124|P1|Overall Study|Withdrawal by Subject|64
7828034|NCT00329238|27179123|P2|Overall Study|Lost to Follow-up|6
7828035|NCT00329238|27179124|P1|Overall Study|Lost to Follow-up|2
7828036|NCT00329238|27179123|P2|Overall Study|Protocol Violation|34
7828037|NCT00329238|27179124|P1|Overall Study|Protocol Violation|23
7828038|NCT00329238|27179123|P2|Overall Study|Adverse Event|129
7828039|NCT00329238|27179124|P1|Overall Study|Adverse Event|147
7828040|NCT00329160|27179160|P1|Overall Study|Incomplete IVUS|45
7828041|NCT00329160|27179160|P1|Overall Study|Did not Receive Study Drug|1
7828042|NCT00329160|27179160|P1|Overall Study|Protocol Violation|2
7828043|NCT00329160|27179160|P1|Overall Study|Withdrawal by Subject|13
7828044|NCT00329160|27179160|P1|Overall Study|Adverse Event|27
7828045|NCT00329108|27179169|P2|Overall Study|Protocol Violation|2
7828046|NCT00329108|27179170|P1|Overall Study|Protocol Violation|0
7828047|NCT00329108|27179169|P2|Overall Study|withdrew patient after SAE resolved|0
7828048|NCT00329108|27179170|P1|Overall Study|withdrew patient after SAE resolved|1
7828049|NCT00329108|27179169|P2|Overall Study|study terminated by sponsor|0
7828050|NCT00329108|27179170|P1|Overall Study|study terminated by sponsor|1
7828051|NCT00329108|27179169|P2|Overall Study|Subject no longer willing to participate|2
7828052|NCT00329108|27179170|P1|Overall Study|Subject no longer willing to participate|2
7828053|NCT00329108|27179169|P2|Overall Study|symptomatic deterioration|1
7828054|NCT00329108|27179170|P1|Overall Study|symptomatic deterioration|1
7828055|NCT00329108|27179169|P2|Overall Study|Withdrawal by Subject|2
7828056|NCT00329108|27179170|P1|Overall Study|Withdrawal by Subject|0
7828057|NCT00329108|27179169|P2|Overall Study|Lack of Efficacy|3
7828058|NCT00329108|27179170|P1|Overall Study|Lack of Efficacy|3
7828059|NCT00329108|27179169|P2|Overall Study|Adverse Event|2
7828060|NCT00329108|27179170|P1|Overall Study|Adverse Event|2
7828061|NCT00329030|27179178|P2|Overall Study|Ineligible Pathology|1
7828062|NCT00329030|27179179|P1|Overall Study|Ineligible Pathology|1
7828063|NCT00329030|27179178|P2|Overall Study|Progressive Disease|2
7828064|NCT00329030|27179179|P1|Overall Study|Progressive Disease|6
7828065|NCT00329030|27179178|P2|Overall Study|Withdrawal by Subject|3
7828066|NCT00329030|27179179|P1|Overall Study|Withdrawal by Subject|1
7828067|NCT00328926|27179210|P3|Overall Study|Lack of ovarian response|0
7828068|NCT00328926|27179211|P2|Overall Study|Lack of ovarian response|1
7828069|NCT00328926|27179212|P1|Overall Study|Lack of ovarian response|0
7828070|NCT00328926|27179210|P3|Overall Study|In vitro fertilization treatment|1
7828071|NCT00328926|27179211|P2|Overall Study|In vitro fertilization treatment|0
7828072|NCT00328926|27179212|P1|Overall Study|In vitro fertilization treatment|0
7828073|NCT00328926|27179210|P3|Overall Study|Death|1
7828074|NCT00328926|27179211|P2|Overall Study|Death|0
7828075|NCT00328926|27179212|P1|Overall Study|Death|0
7828076|NCT00328926|27179210|P3|Overall Study|Lost to Follow-up|0
7828077|NCT00328926|27179211|P2|Overall Study|Lost to Follow-up|1
7828078|NCT00328926|27179212|P1|Overall Study|Lost to Follow-up|0
7828079|NCT00328926|27179210|P3|Overall Study|Pregnancy|0
7828080|NCT00328926|27179211|P2|Overall Study|Pregnancy|1
7828081|NCT00328926|27179212|P1|Overall Study|Pregnancy|2
7828082|NCT00328783|27179237|P1|Overall Study|Withdrawal by Subject|1
7828083|NCT00328783|27179237|P1|Overall Study|No heart in RT field|4
7828084|NCT00328783|27179237|P1|Overall Study|Could not tolerate ABC|21
7828085|NCT00328627|27179263|P12|Overall Study|Other|0
7828086|NCT00328627|27179264|P11|Overall Study|Other|1
7828087|NCT00328627|27179265|P10|Overall Study|Other|1
7828088|NCT00328627|27179266|P9|Overall Study|Other|0
7828089|NCT00328627|27179267|P8|Overall Study|Other|0
7828090|NCT00328627|27179268|P7|Overall Study|Other|1
7828091|NCT00328627|27179269|P6|Overall Study|Other|0
7828092|NCT00328627|27179270|P5|Overall Study|Other|0
7828093|NCT00328627|27179271|P4|Overall Study|Other|1
7828094|NCT00328627|27179272|P3|Overall Study|Other|0
7828095|NCT00328627|27179273|P2|Overall Study|Other|0
7828096|NCT00328627|27179274|P1|Overall Study|Other|0
7828097|NCT00328627|27179263|P12|Overall Study|Physician Decision|0
7828098|NCT00328627|27179264|P11|Overall Study|Physician Decision|1
7828099|NCT00328627|27179265|P10|Overall Study|Physician Decision|2
7828100|NCT00328627|27179266|P9|Overall Study|Physician Decision|3
7828101|NCT00328627|27179267|P8|Overall Study|Physician Decision|0
7828102|NCT00328627|27179268|P7|Overall Study|Physician Decision|1
7828103|NCT00328627|27179269|P6|Overall Study|Physician Decision|1
7828104|NCT00328627|27179270|P5|Overall Study|Physician Decision|1
7828105|NCT00328627|27179271|P4|Overall Study|Physician Decision|2
7828106|NCT00328627|27179272|P3|Overall Study|Physician Decision|1
7828107|NCT00328627|27179273|P2|Overall Study|Physician Decision|3
7828108|NCT00328627|27179274|P1|Overall Study|Physician Decision|4
7828109|NCT00328627|27179263|P12|Overall Study|Pregnancy|0
7828110|NCT00328627|27179264|P11|Overall Study|Pregnancy|0
7828111|NCT00328627|27179265|P10|Overall Study|Pregnancy|0
7828112|NCT00328627|27179266|P9|Overall Study|Pregnancy|0
7828113|NCT00328627|27179267|P8|Overall Study|Pregnancy|0
7828114|NCT00328627|27179268|P7|Overall Study|Pregnancy|0
7828115|NCT00328627|27179269|P6|Overall Study|Pregnancy|0
7828116|NCT00328627|27179270|P5|Overall Study|Pregnancy|0
7828117|NCT00328627|27179271|P4|Overall Study|Pregnancy|0
7828118|NCT00328627|27179272|P3|Overall Study|Pregnancy|0
7828119|NCT00328627|27179273|P2|Overall Study|Pregnancy|1
7828120|NCT00328627|27179274|P1|Overall Study|Pregnancy|0
7828121|NCT00328627|27179263|P12|Overall Study|Withdrawal by Subject|7
7828122|NCT00328627|27179264|P11|Overall Study|Withdrawal by Subject|2
7828123|NCT00328627|27179265|P10|Overall Study|Withdrawal by Subject|5
7828124|NCT00328627|27179266|P9|Overall Study|Withdrawal by Subject|4
7828125|NCT00328627|27179267|P8|Overall Study|Withdrawal by Subject|4
7828126|NCT00328627|27179268|P7|Overall Study|Withdrawal by Subject|4
7828127|NCT00328627|27179269|P6|Overall Study|Withdrawal by Subject|5
7828128|NCT00328627|27179270|P5|Overall Study|Withdrawal by Subject|2
7828129|NCT00328627|27179271|P4|Overall Study|Withdrawal by Subject|6
7828130|NCT00328627|27179272|P3|Overall Study|Withdrawal by Subject|5
7828131|NCT00328627|27179273|P2|Overall Study|Withdrawal by Subject|4
7828132|NCT00328627|27179274|P1|Overall Study|Withdrawal by Subject|5
7828133|NCT00328627|27179263|P12|Overall Study|Lost to Follow-up|1
7828134|NCT00328627|27179264|P11|Overall Study|Lost to Follow-up|0
7828135|NCT00328627|27179265|P10|Overall Study|Lost to Follow-up|2
7828136|NCT00328627|27179266|P9|Overall Study|Lost to Follow-up|3
7828137|NCT00328627|27179267|P8|Overall Study|Lost to Follow-up|0
7828138|NCT00328627|27179268|P7|Overall Study|Lost to Follow-up|3
7828139|NCT00328627|27179269|P6|Overall Study|Lost to Follow-up|2
7828140|NCT00328627|27179270|P5|Overall Study|Lost to Follow-up|0
7828141|NCT00328627|27179271|P4|Overall Study|Lost to Follow-up|4
7828142|NCT00328627|27179272|P3|Overall Study|Lost to Follow-up|2
7828143|NCT00328627|27179273|P2|Overall Study|Lost to Follow-up|2
7828144|NCT00328627|27179274|P1|Overall Study|Lost to Follow-up|4
7828145|NCT00328627|27179263|P12|Overall Study|Protocol Violation|2
7828146|NCT00328627|27179264|P11|Overall Study|Protocol Violation|6
7828147|NCT00328627|27179265|P10|Overall Study|Protocol Violation|4
7828148|NCT00328627|27179266|P9|Overall Study|Protocol Violation|1
7828149|NCT00328627|27179267|P8|Overall Study|Protocol Violation|2
7828150|NCT00328627|27179268|P7|Overall Study|Protocol Violation|6
7828151|NCT00328627|27179269|P6|Overall Study|Protocol Violation|5
7828152|NCT00328627|27179270|P5|Overall Study|Protocol Violation|5
7828153|NCT00328627|27179271|P4|Overall Study|Protocol Violation|8
7828154|NCT00328627|27179272|P3|Overall Study|Protocol Violation|2
7828155|NCT00328627|27179273|P2|Overall Study|Protocol Violation|2
7828156|NCT00328627|27179274|P1|Overall Study|Protocol Violation|2
7828157|NCT00328627|27179263|P12|Overall Study|Adverse Event|4
7828158|NCT00328627|27179264|P11|Overall Study|Adverse Event|5
7828159|NCT00328627|27179265|P10|Overall Study|Adverse Event|7
7828160|NCT00328627|27179266|P9|Overall Study|Adverse Event|0
7828161|NCT00328627|27179267|P8|Overall Study|Adverse Event|2
7828162|NCT00328627|27179268|P7|Overall Study|Adverse Event|1
7828163|NCT00328627|27179269|P6|Overall Study|Adverse Event|2
7828164|NCT00328627|27179270|P5|Overall Study|Adverse Event|1
7828165|NCT00328627|27179271|P4|Overall Study|Adverse Event|3
7828166|NCT00328627|27179272|P3|Overall Study|Adverse Event|2
7828167|NCT00328627|27179273|P2|Overall Study|Adverse Event|1
7828168|NCT00328627|27179274|P1|Overall Study|Adverse Event|3
7828169|NCT00328627|27179263|P12|Overall Study|Hyperglycemic Rescue|2
7828170|NCT00328627|27179264|P11|Overall Study|Hyperglycemic Rescue|3
7828171|NCT00328627|27179265|P10|Overall Study|Hyperglycemic Rescue|11
7828172|NCT00328627|27179266|P9|Overall Study|Hyperglycemic Rescue|6
7828173|NCT00328627|27179267|P8|Overall Study|Hyperglycemic Rescue|6
7828174|NCT00328627|27179268|P7|Overall Study|Hyperglycemic Rescue|19
7828175|NCT00328627|27179269|P6|Overall Study|Hyperglycemic Rescue|5
7828176|NCT00328627|27179270|P5|Overall Study|Hyperglycemic Rescue|6
7828177|NCT00328627|27179271|P4|Overall Study|Hyperglycemic Rescue|13
7828178|NCT00328627|27179272|P3|Overall Study|Hyperglycemic Rescue|16
7828179|NCT00328627|27179273|P2|Overall Study|Hyperglycemic Rescue|18
7828180|NCT00328627|27179274|P1|Overall Study|Hyperglycemic Rescue|41
7828181|NCT00328562|27180811|P1|Overall Study|Disease progression|1
7828182|NCT00328510|27180820|P2|Overall Study|Treatment changed to a single fraction|1
7828183|NCT00328510|27180821|P1|Overall Study|Treatment changed to a single fraction|1
7828184|NCT00328510|27180820|P2|Overall Study|Severe kyphosis, could not use mask|1
7828185|NCT00328510|27180821|P1|Overall Study|Severe kyphosis, could not use mask|0
7828186|NCT00328510|27180820|P2|Overall Study|Withdrawal by Subject|2
7828187|NCT00328510|27180821|P1|Overall Study|Withdrawal by Subject|4
7828188|NCT00328510|27180820|P2|Overall Study|Dentition problems, could not use frame|0
7828189|NCT00328510|27180821|P1|Overall Study|Dentition problems, could not use frame|1
7828190|NCT00328510|27180820|P2|Overall Study|Gag disorder, could not use frame|0
7828191|NCT00328510|27180821|P1|Overall Study|Gag disorder, could not use frame|4
7828192|NCT00328198|27180836|P1|Follow-up|Death|31
7828193|NCT00328198|27180836|P1|Follow-up|Lost to Follow-up|4
7828194|NCT00328198|27180836|P1|Treatment|Confirmed complete response, MRD -|3
7828195|NCT00328198|27180836|P1|Treatment|Non-compliance|1
7828196|NCT00328198|27180836|P1|Treatment|Evidence of disease progression|2
7828197|NCT00328198|27180836|P1|Treatment|Withdrawal by Subject|5
7828198|NCT00328198|27180836|P1|Treatment|Physician Decision|5
7828199|NCT00328198|27180836|P1|Treatment|Death|1
7828200|NCT00328198|27180836|P1|Treatment|Adverse Event|21
7828201|NCT00328172|27180851|P5|Overall Study|Other reason (not specified)|0
7828202|NCT00328172|27180852|P4|Overall Study|Other reason (not specified)|0
7828203|NCT00328172|27180853|P3|Overall Study|Other reason (not specified)|1
7828204|NCT00328172|27180854|P2|Overall Study|Other reason (not specified)|0
7828205|NCT00328172|27180855|P1|Overall Study|Other reason (not specified)|3
7828206|NCT00328172|27180851|P5|Overall Study|Lack of Efficacy|3
7828207|NCT00328172|27180852|P4|Overall Study|Lack of Efficacy|4
7828208|NCT00328172|27180853|P3|Overall Study|Lack of Efficacy|4
7828209|NCT00328172|27180854|P2|Overall Study|Lack of Efficacy|9
7828210|NCT00328172|27180855|P1|Overall Study|Lack of Efficacy|14
7828211|NCT00328172|27180851|P5|Overall Study|Withdrawal by Subject|0
7828212|NCT00328172|27180852|P4|Overall Study|Withdrawal by Subject|6
7828213|NCT00328172|27180853|P3|Overall Study|Withdrawal by Subject|1
7828214|NCT00328172|27180854|P2|Overall Study|Withdrawal by Subject|1
7828215|NCT00328172|27180855|P1|Overall Study|Withdrawal by Subject|1
7828216|NCT00328172|27180851|P5|Overall Study|Lost to Follow-up|1
7828217|NCT00328172|27180852|P4|Overall Study|Lost to Follow-up|1
7828218|NCT00328172|27180853|P3|Overall Study|Lost to Follow-up|2
7828219|NCT00328172|27180854|P2|Overall Study|Lost to Follow-up|1
7828220|NCT00328172|27180855|P1|Overall Study|Lost to Follow-up|1
7828221|NCT00328172|27180851|P5|Overall Study|Protocol Violation|0
7828222|NCT00328172|27180852|P4|Overall Study|Protocol Violation|0
7828223|NCT00328172|27180853|P3|Overall Study|Protocol Violation|1
7828224|NCT00328172|27180854|P2|Overall Study|Protocol Violation|1
7828225|NCT00328172|27180855|P1|Overall Study|Protocol Violation|0
7828226|NCT00328172|27180851|P5|Overall Study|Adverse Event|1
7828227|NCT00328172|27180852|P4|Overall Study|Adverse Event|2
7828228|NCT00328172|27180853|P3|Overall Study|Adverse Event|1
7828229|NCT00328172|27180854|P2|Overall Study|Adverse Event|2
7828230|NCT00328172|27180855|P1|Overall Study|Adverse Event|3
7828231|NCT00328094|27180879|P2|Overall Study|Physician Decision|3
7828232|NCT00328094|27180880|P1|Overall Study|Physician Decision|3
7828233|NCT00327717|27180914|P2|Overall Study|Withdrawal by Subject|7
7828234|NCT00327717|27180915|P1|Overall Study|Withdrawal by Subject|3
7828235|NCT00327717|27180914|P2|Overall Study|Lack of Efficacy|1
7828236|NCT00327717|27180915|P1|Overall Study|Lack of Efficacy|0
7828237|NCT00327717|27180914|P2|Overall Study|Adverse Event|6
7828238|NCT00327717|27180915|P1|Overall Study|Adverse Event|6
7828239|NCT00327470|27180941|P2|Overall Study|Death|4
7828240|NCT00327470|27180942|P1|Overall Study|Death|1
7828241|NCT00327470|27180941|P2|Overall Study|Withdrawal by Subject|12
7828242|NCT00327470|27180942|P1|Overall Study|Withdrawal by Subject|6
7828243|NCT00327470|27180941|P2|Overall Study|Lost to Follow-up|3
7828244|NCT00327470|27180942|P1|Overall Study|Lost to Follow-up|1
7828245|NCT00327470|27180941|P2|Overall Study|Other|9
7828246|NCT00327470|27180942|P1|Overall Study|Other|5
7828247|NCT00327470|27180941|P2|Overall Study|Lack of Efficacy|19
7828248|NCT00327470|27180942|P1|Overall Study|Lack of Efficacy|7
7828249|NCT00327470|27180941|P2|Overall Study|Adverse Event|14
7828250|NCT00327470|27180942|P1|Overall Study|Adverse Event|9
7828251|NCT00327470|27180941|P2|Overall Study|Randomized, but not treated|2
7828252|NCT00327470|27180942|P1|Overall Study|Randomized, but not treated|0
7828253|NCT00327444|27180962|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
7828254|NCT00327444|27180963|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
7828255|NCT00327444|27180962|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
7828256|NCT00327444|27180963|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
7828257|NCT00327444|27180962|P2|Open Label Treatment (OL) Period|Adverse Event|2
7828258|NCT00327444|27180963|P1|Open Label Treatment (OL) Period|Adverse Event|2
7828259|NCT00327444|27180962|P2|Open Label Treatment (OL) Period|Disease progression|7
7828260|NCT00327444|27180963|P1|Open Label Treatment (OL) Period|Disease progression|8
7828261|NCT00327444|27180962|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
7828262|NCT00327444|27180963|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
7828263|NCT00327444|27180962|P2|Double Blind Treatment (DB) Period|Subject request|1
7828264|NCT00327444|27180963|P1|Double Blind Treatment (DB) Period|Subject request|0
7828265|NCT00327444|27180962|P2|Double Blind Treatment (DB) Period|Adverse Event|5
7828266|NCT00327444|27180963|P1|Double Blind Treatment (DB) Period|Adverse Event|5
7828267|NCT00327444|27180962|P2|Double Blind Treatment (DB) Period|Disease progression|13
7828268|NCT00327444|27180963|P1|Double Blind Treatment (DB) Period|Disease progression|10
7828269|NCT00327340|27180981|P2|Overall Study|Adverse Event|3
7828270|NCT00327340|27180982|P1|Overall Study|Adverse Event|3
7828271|NCT00327340|27180981|P2|Overall Study|Symptomatic Disease|2
7828272|NCT00327340|27180982|P1|Overall Study|Symptomatic Disease|0
7828273|NCT00327340|27180981|P2|Overall Study|Disease Progression|19
7828274|NCT00327340|27180982|P1|Overall Study|Disease Progression|10
7828275|NCT00327340|27180981|P2|Overall Study|Physician Decision|1
7828276|NCT00327340|27180982|P1|Overall Study|Physician Decision|1
7828277|NCT00327340|27180981|P2|Overall Study|Withdrawal by Subject|5
7828278|NCT00327340|27180982|P1|Overall Study|Withdrawal by Subject|1
7828279|NCT00327171|27180996|P2|Overall Study|Other|0
7828280|NCT00327171|27180997|P1|Overall Study|Other|1
7828281|NCT00327171|27180996|P2|Overall Study|Undisclosed history of ischemia|1
7828282|NCT00327171|27180997|P1|Overall Study|Undisclosed history of ischemia|0
7828283|NCT00327171|27180996|P2|Overall Study|Clinical progression|8
7828284|NCT00327171|27180997|P1|Overall Study|Clinical progression|12
7828285|NCT00327171|27180996|P2|Overall Study|Investigator/participant request|8
7828286|NCT00327171|27180997|P1|Overall Study|Investigator/participant request|1
7828287|NCT00327171|27180996|P2|Overall Study|Disease progression/lack of efficacy|69
7828288|NCT00327171|27180997|P1|Overall Study|Disease progression/lack of efficacy|68
7828289|NCT00327171|27180996|P2|Overall Study|Adverse Event|23
7828290|NCT00327171|27180997|P1|Overall Study|Adverse Event|23
7828291|NCT00327171|27180996|P2|Overall Study|Did not receive study medication|0
7828292|NCT00327171|27180997|P1|Overall Study|Did not receive study medication|3
7828293|NCT00327015|27181029|P4|Overall Study|Administrative Reason by Sponsor|1
7828294|NCT00327015|27181030|P3|Overall Study|Administrative Reason by Sponsor|2
7828295|NCT00327015|27181031|P2|Overall Study|Administrative Reason by Sponsor|2
7828296|NCT00327015|27181032|P1|Overall Study|Administrative Reason by Sponsor|1
7828297|NCT00327015|27181029|P4|Overall Study|Pregnancy|1
7828298|NCT00327015|27181030|P3|Overall Study|Pregnancy|1
7828299|NCT00327015|27181031|P2|Overall Study|Pregnancy|2
7828300|NCT00327015|27181032|P1|Overall Study|Pregnancy|0
7828301|NCT00327015|27181029|P4|Overall Study|Death|3
7828302|NCT00327015|27181030|P3|Overall Study|Death|2
7828303|NCT00327015|27181031|P2|Overall Study|Death|2
7828304|NCT00327015|27181032|P1|Overall Study|Death|1
7828305|NCT00327015|27181029|P4|Overall Study|Physician Decision|2
7828306|NCT00327015|27181030|P3|Overall Study|Physician Decision|3
7828307|NCT00327015|27181031|P2|Overall Study|Physician Decision|1
7828308|NCT00327015|27181032|P1|Overall Study|Physician Decision|0
7828309|NCT00327015|27181029|P4|Overall Study|Poor/Noncompliance|5
7828310|NCT00327015|27181030|P3|Overall Study|Poor/Noncompliance|4
7828311|NCT00327015|27181031|P2|Overall Study|Poor/Noncompliance|8
7828312|NCT00327015|27181032|P1|Overall Study|Poor/Noncompliance|11
7828313|NCT00327015|27181029|P4|Overall Study|Subject no longer meets study criteria|7
7828314|NCT00327015|27181030|P3|Overall Study|Subject no longer meets study criteria|8
7828315|NCT00327015|27181031|P2|Overall Study|Subject no longer meets study criteria|2
7828316|NCT00327015|27181032|P1|Overall Study|Subject no longer meets study criteria|4
7828317|NCT00327015|27181029|P4|Overall Study|Adverse Event|14
7828318|NCT00327015|27181030|P3|Overall Study|Adverse Event|14
7828319|NCT00327015|27181031|P2|Overall Study|Adverse Event|10
7828320|NCT00327015|27181032|P1|Overall Study|Adverse Event|14
7828321|NCT00327015|27181029|P4|Overall Study|Lost to Follow-up|22
7828322|NCT00327015|27181030|P3|Overall Study|Lost to Follow-up|29
7828323|NCT00327015|27181031|P2|Overall Study|Lost to Follow-up|23
7828324|NCT00327015|27181032|P1|Overall Study|Lost to Follow-up|22
7828325|NCT00327015|27181029|P4|Overall Study|Withdrawal of Consent by Subject|25
7828326|NCT00327015|27181030|P3|Overall Study|Withdrawal of Consent by Subject|28
7828327|NCT00327015|27181031|P2|Overall Study|Withdrawal of Consent by Subject|24
7828328|NCT00327015|27181032|P1|Overall Study|Withdrawal of Consent by Subject|20
7828329|NCT00327015|27181029|P4|Overall Study|Lack of Efficacy|29
7828330|NCT00327015|27181030|P3|Overall Study|Lack of Efficacy|35
7828331|NCT00327015|27181031|P2|Overall Study|Lack of Efficacy|18
7828332|NCT00327015|27181032|P1|Overall Study|Lack of Efficacy|18
7828333|NCT00326963|27181074|P1|Overall Study|Administrative / other|1
7828334|NCT00326963|27181074|P1|Overall Study|Other protocol violation|1
7828335|NCT00326963|27181074|P1|Overall Study|Violation of selection criteria at entry|2
7828336|NCT00326963|27181074|P1|Overall Study|Refused treatment / did not cooperate|5
7828337|NCT00326963|27181074|P1|Overall Study|Withdrawal by Subject|10
7828338|NCT00326963|27181074|P1|Overall Study|Failure to return|10
7828339|NCT00326963|27181074|P1|Overall Study|Death|1
7828340|NCT00326963|27181074|P1|Overall Study|Injection site reaction|1
7828341|NCT00326963|27181074|P1|Overall Study|Adverse Event|2
7828342|NCT00326950|27181094|P1|Overall Study|Progressive Disease|1
7828343|NCT00326911|27181116|P2|Overall Study|Withdrawal by subject prior to treatment|1
7828344|NCT00326911|27181117|P1|Overall Study|Withdrawal by subject prior to treatment|0
7828345|NCT00326911|27181116|P2|Overall Study|Physician decision prior to treatment|0
7828346|NCT00326911|27181117|P1|Overall Study|Physician decision prior to treatment|1
7828347|NCT00326911|27181116|P2|Overall Study|Hospitalization prior to treatment|1
7828348|NCT00326911|27181117|P1|Overall Study|Hospitalization prior to treatment|0
7828349|NCT00326898|27181170|P3|Overall Study|Other/Missing/Unknown|32
7828350|NCT00326898|27181171|P2|Overall Study|Other/Missing/Unknown|28
7828351|NCT00326898|27181172|P1|Overall Study|Other/Missing/Unknown|33
7828352|NCT00326898|27181170|P3|Overall Study|Other complicating disease|4
7828353|NCT00326898|27181171|P2|Overall Study|Other complicating disease|5
7828354|NCT00326898|27181172|P1|Overall Study|Other complicating disease|5
7828355|NCT00326898|27181170|P3|Overall Study|Alternative therapy|0
7828356|NCT00326898|27181171|P2|Overall Study|Alternative therapy|0
7828357|NCT00326898|27181172|P1|Overall Study|Alternative therapy|1
7828358|NCT00326898|27181170|P3|Overall Study|Withdrawal by Subject|32
7828359|NCT00326898|27181171|P2|Overall Study|Withdrawal by Subject|128
7828360|NCT00326898|27181172|P1|Overall Study|Withdrawal by Subject|134
7828361|NCT00326898|27181170|P3|Overall Study|Death|0
7828362|NCT00326898|27181171|P2|Overall Study|Death|0
7828363|NCT00326898|27181172|P1|Overall Study|Death|2
7828364|NCT00326898|27181170|P3|Overall Study|Adverse Event|33
7828365|NCT00326898|27181171|P2|Overall Study|Adverse Event|128
7828366|NCT00326898|27181172|P1|Overall Study|Adverse Event|124
7828367|NCT00326898|27181170|P3|Overall Study|Disease progression|102
7828368|NCT00326898|27181171|P2|Overall Study|Disease progression|54
7828369|NCT00326898|27181172|P1|Overall Study|Disease progression|52
7828370|NCT00326885|27181189|P1|Overall Study|Hospice withdrew consent|2
7828371|NCT00326885|27181189|P1|Overall Study|Physician Decision|1
7828372|NCT00326885|27181189|P1|Overall Study|Withdrawal by Subject|3
7828373|NCT00326885|27181189|P1|Overall Study|Adverse Event|1
7828374|NCT00326716|27181220|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
7828375|NCT00326716|27181221|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
7828376|NCT00326716|27181222|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
7828377|NCT00326716|27181223|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
7828378|NCT00326612|27181295|P2|Overall Study|They did not have a seizure requiring tx|137
7828379|NCT00326612|27181296|P1|Overall Study|They did not have a seizure requiring tx|129
7828380|NCT00326599|27181318|P4|Overall Study|Other Unspecified Reason|1
7828381|NCT00326599|27181319|P3|Overall Study|Other Unspecified Reason|2
7828382|NCT00326599|27181320|P2|Overall Study|Other Unspecified Reason|0
7828383|NCT00326599|27181321|P1|Overall Study|Other Unspecified Reason|0
7828384|NCT00326599|27181318|P4|Overall Study|Death|2
7828385|NCT00326599|27181319|P3|Overall Study|Death|1
7828386|NCT00326599|27181320|P2|Overall Study|Death|0
7828387|NCT00326599|27181321|P1|Overall Study|Death|0
7828388|NCT00326599|27181318|P4|Overall Study|Alternate Treatment|0
7828389|NCT00326599|27181319|P3|Overall Study|Alternate Treatment|0
7828390|NCT00326599|27181320|P2|Overall Study|Alternate Treatment|0
7828391|NCT00326599|27181321|P1|Overall Study|Alternate Treatment|1
7828392|NCT00326599|27181318|P4|Overall Study|Disease Progression|11
7828393|NCT00326599|27181319|P3|Overall Study|Disease Progression|13
7828394|NCT00326599|27181320|P2|Overall Study|Disease Progression|1
7828395|NCT00326599|27181321|P1|Overall Study|Disease Progression|3
7828396|NCT00326599|27181318|P4|Overall Study|Adverse Event|3
7828397|NCT00326599|27181319|P3|Overall Study|Adverse Event|32
7828398|NCT00326599|27181320|P2|Overall Study|Adverse Event|0
7828399|NCT00326599|27181321|P1|Overall Study|Adverse Event|1
7828400|NCT00326599|27181318|P4|Overall Study|Withdrawal by Subject|2
7828401|NCT00326599|27181319|P3|Overall Study|Withdrawal by Subject|5
7828402|NCT00326599|27181320|P2|Overall Study|Withdrawal by Subject|0
7828403|NCT00326599|27181321|P1|Overall Study|Withdrawal by Subject|1
7828404|NCT00326495|27181340|P1|Overall Study|Subject off study before assessment|1
7828405|NCT00326495|27181340|P1|Overall Study|Refused further treatment|2
7828406|NCT00326495|27181340|P1|Overall Study|Disease progression before treatment|1
7828407|NCT00326495|27181340|P1|Overall Study|Switched to alternative treatment|1
7828420|NCT00326209|27181366|P1|Overall Study|Pregnancy|1
7828421|NCT00326209|27181366|P1|Overall Study|Withdrawn in error|1
7828422|NCT00326209|27181366|P1|Overall Study|Violation of entry criteria|1
7828423|NCT00326209|27181366|P1|Overall Study|Prohibited medication use|1
7828424|NCT00326209|27181366|P1|Overall Study|Sponsor closed study|173
7828425|NCT00326209|27181366|P1|Overall Study|Participant non-compliant|6
7828426|NCT00326209|27181366|P1|Overall Study|Lost to Follow-up|18
7828427|NCT00326209|27181366|P1|Overall Study|Lack of Efficacy|31
7828428|NCT00326209|27181366|P1|Overall Study|Withdrawal by Subject|22
7828429|NCT00326209|27181366|P1|Overall Study|Adverse Event|28
7828430|NCT00326183|27181384|P2|Overall Study|Adverse Event|0
7828431|NCT00326183|27181385|P1|Overall Study|Adverse Event|1
7828432|NCT00326183|27181384|P2|Overall Study|Other|13
7828433|NCT00326183|27181385|P1|Overall Study|Other|47
7828434|NCT00326183|27181384|P2|Overall Study|Subject Moved|4
7828435|NCT00326183|27181385|P1|Overall Study|Subject Moved|7
7828436|NCT00326183|27181384|P2|Overall Study|Withdrawal by Subject|7
7828437|NCT00326183|27181385|P1|Overall Study|Withdrawal by Subject|35
7828438|NCT00326183|27181384|P2|Overall Study|Protocol Violation|3
7828439|NCT00326183|27181385|P1|Overall Study|Protocol Violation|6
7828440|NCT00326183|27181384|P2|Overall Study|Lost to Follow-up|56
7828441|NCT00326183|27181385|P1|Overall Study|Lost to Follow-up|104
7828442|NCT00326118|27181417|P2|Active Phase|Withdrawal by Subject|1
7828443|NCT00326118|27181418|P1|Active Phase|Withdrawal by Subject|4
7828444|NCT00326001|27181454|P2|Overall Study|Physician Decision|3
7828445|NCT00326001|27181455|P1|Overall Study|Physician Decision|3
7828446|NCT00326001|27181454|P2|Overall Study|Adverse Event|5
7828447|NCT00326001|27181455|P1|Overall Study|Adverse Event|4
7828448|NCT00325897|27181469|P2|Overall Study|Lost to Follow-up|13
7828449|NCT00325897|27181470|P1|Overall Study|Lost to Follow-up|12
7828450|NCT00325819|27181490|P2|Overall Study|Lost to Follow-up|3
7828451|NCT00325819|27181491|P1|Overall Study|Lost to Follow-up|3
7828452|NCT00325819|27181490|P2|Overall Study|Did not take a dose of study product|9
7828453|NCT00325819|27181491|P1|Overall Study|Did not take a dose of study product|4
7828454|NCT00325819|27181490|P2|Overall Study|Study product lost in mail|1
7828455|NCT00325819|27181491|P1|Overall Study|Study product lost in mail|2
7828456|NCT00325754|27181518|P2|Overall Study|Adverse Event|1
7828457|NCT00325754|27181519|P1|Overall Study|Adverse Event|4
7828458|NCT00325468|27181574|P5|Overall Study|site closure etc|1
7828459|NCT00325468|27181575|P4|Overall Study|site closure etc|8
7828460|NCT00325468|27181576|P3|Overall Study|site closure etc|1
7828461|NCT00325468|27181577|P2|Overall Study|site closure etc|2
7828462|NCT00325468|27181578|P1|Overall Study|site closure etc|4
7828463|NCT00325468|27181574|P5|Overall Study|Withdrawal by Subject|4
7828464|NCT00325468|27181575|P4|Overall Study|Withdrawal by Subject|14
7828465|NCT00325468|27181576|P3|Overall Study|Withdrawal by Subject|0
7828466|NCT00325468|27181577|P2|Overall Study|Withdrawal by Subject|1
7828467|NCT00325468|27181578|P1|Overall Study|Withdrawal by Subject|3
7828468|NCT00325468|27181574|P5|Overall Study|Physician Decision|0
7828469|NCT00325468|27181575|P4|Overall Study|Physician Decision|1
7828470|NCT00325468|27181576|P3|Overall Study|Physician Decision|0
7828471|NCT00325468|27181577|P2|Overall Study|Physician Decision|1
7828472|NCT00325468|27181578|P1|Overall Study|Physician Decision|1
7828473|NCT00325468|27181574|P5|Overall Study|Lost to Follow-up|2
7828474|NCT00325468|27181575|P4|Overall Study|Lost to Follow-up|2
7828475|NCT00325468|27181576|P3|Overall Study|Lost to Follow-up|1
7828476|NCT00325468|27181577|P2|Overall Study|Lost to Follow-up|0
7828477|NCT00325468|27181578|P1|Overall Study|Lost to Follow-up|0
7828478|NCT00325468|27181574|P5|Overall Study|Death|0
7828479|NCT00325468|27181575|P4|Overall Study|Death|4
7828480|NCT00325468|27181576|P3|Overall Study|Death|2
7828481|NCT00325468|27181577|P2|Overall Study|Death|0
7828482|NCT00325468|27181578|P1|Overall Study|Death|2
7828483|NCT00325468|27181574|P5|Overall Study|Adverse Event|1
7828484|NCT00325468|27181575|P4|Overall Study|Adverse Event|5
7828485|NCT00325468|27181576|P3|Overall Study|Adverse Event|0
7828486|NCT00325468|27181577|P2|Overall Study|Adverse Event|1
7828487|NCT00325468|27181578|P1|Overall Study|Adverse Event|1
7828488|NCT00325416|27181661|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
7828489|NCT00325416|27181662|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
7828490|NCT00325416|27181661|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
7828491|NCT00325416|27181662|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
7828492|NCT00325416|27181661|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
7828493|NCT00325416|27181662|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
7828494|NCT00325416|27181661|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
7828495|NCT00325416|27181662|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
7828496|NCT00325416|27181661|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
7828497|NCT00325416|27181662|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
7828498|NCT00325416|27181661|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
7828499|NCT00325416|27181662|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
7828500|NCT00325234|27181715|P2|Overall Study|Progressive Disease|37
7828501|NCT00325234|27181716|P1|Overall Study|Progressive Disease|34
7828502|NCT00325234|27181715|P2|Overall Study|Physician Decision|12
7828503|NCT00325234|27181716|P1|Overall Study|Physician Decision|17
7828504|NCT00325234|27181715|P2|Overall Study|Subject Decision|8
7828505|NCT00325234|27181716|P1|Overall Study|Subject Decision|6
7828506|NCT00325234|27181715|P2|Overall Study|Entry Criteria Not Met|2
7828507|NCT00325234|27181716|P1|Overall Study|Entry Criteria Not Met|1
7828508|NCT00325234|27181715|P2|Overall Study|Death due to Study Disease|0
7828509|NCT00325234|27181716|P1|Overall Study|Death due to Study Disease|1
7828510|NCT00325234|27181715|P2|Overall Study|Adverse Event|7
7828511|NCT00325234|27181716|P1|Overall Study|Adverse Event|10
7828512|NCT00325195|27181735|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
7828513|NCT00325195|27181736|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
7828514|NCT00325195|27181737|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
7828515|NCT00325195|27181735|P3|Received Intervention: ITT Population|Lost to Follow-up|2
7828516|NCT00325195|27181736|P2|Received Intervention: ITT Population|Lost to Follow-up|0
7828517|NCT00325195|27181737|P1|Received Intervention: ITT Population|Lost to Follow-up|0
7828518|NCT00325195|27181735|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
7828519|NCT00325195|27181736|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
7828520|NCT00325195|27181737|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
7828521|NCT00325195|27181735|P3|Received Intervention: ITT Population|Death|0
7828522|NCT00325195|27181736|P2|Received Intervention: ITT Population|Death|1
7828523|NCT00325195|27181737|P1|Received Intervention: ITT Population|Death|3
7828524|NCT00325195|27181735|P3|Received Intervention: ITT Population|Adverse Event|1
7828525|NCT00325195|27181736|P2|Received Intervention: ITT Population|Adverse Event|17
7828526|NCT00325195|27181737|P1|Received Intervention: ITT Population|Adverse Event|15
7828527|NCT00325195|27181735|P3|Randomized|Not dosed|3
7828528|NCT00325195|27181736|P2|Randomized|Not dosed|5
7828529|NCT00325195|27181737|P1|Randomized|Not dosed|5
7828530|NCT00325156|27181760|P1|Overall Study|Withdrawal by Subject|31
7828531|NCT00325156|27181760|P1|Overall Study|Other|1
7828532|NCT00325156|27181760|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
7828533|NCT00325156|27181760|P1|Overall Study|Adverse event, non-fatal|3
7828534|NCT00325156|27181760|P1|Overall Study|Migrated/moved from study area|12
7828535|NCT00325156|27181760|P1|Overall Study|Lost to follow-up (complete vaccination)|41
7828536|NCT00325156|27181760|P1|Overall Study|Protocol Violation|8
7828537|NCT00325143|27181767|P1|Overall Study|Withdrawal by Subject|8
7828538|NCT00325143|27181767|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
7828539|NCT00325143|27181767|P1|Overall Study|Migrated/moved from study area|1
7828540|NCT00325143|27181767|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
7828541|NCT00325130|27181777|P2|Overall Study|Patient Discontinued for Other|0
7828542|NCT00325130|27181778|P1|Overall Study|Patient Discontinued for Other|1
7828543|NCT00325130|27181777|P2|Overall Study|Moved|1
7828544|NCT00325130|27181778|P1|Overall Study|Moved|0
7828545|NCT00325130|27181777|P2|Overall Study|Protocol Deviation|1
7828546|NCT00325130|27181778|P1|Overall Study|Protocol Deviation|0
7828547|NCT00325130|27181777|P2|Overall Study|Withdrawal by Subject|14
7828548|NCT00325130|27181778|P1|Overall Study|Withdrawal by Subject|12
7828549|NCT00325130|27181777|P2|Overall Study|Lost to Follow-up|14
7828550|NCT00325130|27181778|P1|Overall Study|Lost to Follow-up|6
7828551|NCT00325039|27181835|P2|Overall Study|Lost to Follow-up|14
7828552|NCT00325039|27181836|P1|Overall Study|Lost to Follow-up|18
7828553|NCT00324987|27181852|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
7828554|NCT00324987|27181853|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
7828555|NCT00324987|27181852|P2|Overall Study|Progression|1
7828556|NCT00324987|27181853|P1|Overall Study|Progression|1
7828557|NCT00324987|27181852|P2|Overall Study|Withdrawal by Subject|1
7828558|NCT00324987|27181853|P1|Overall Study|Withdrawal by Subject|1
7828559|NCT00324987|27181852|P2|Overall Study|Adverse Event|1
7828560|NCT00324987|27181853|P1|Overall Study|Adverse Event|2
7828561|NCT00324961|27181867|P1|Overall Study|Other|2
7828562|NCT00324961|27181867|P1|Overall Study|Protocol Violation|3
7828563|NCT00324961|27181867|P1|Overall Study|Lost to Follow-up|22
7828564|NCT00324961|27181867|P1|Overall Study|Consent Withdrawn|11
7828565|NCT00324961|27181867|P1|Overall Study|Adverse Event|5
7828584|NCT00324740|27181944|P3|Overall Study|Withdrawal by Subject|1
7828585|NCT00324740|27181945|P2|Overall Study|Withdrawal by Subject|0
7828586|NCT00324740|27181946|P1|Overall Study|Withdrawal by Subject|1
7828587|NCT00324675|27181969|P2|Overall Study|Adverse Event|0
7828588|NCT00324675|27181970|P1|Overall Study|Adverse Event|1
7828589|NCT00324649|27181978|P2|Overall Study|Noncompliance|0
7828590|NCT00324649|27181979|P1|Overall Study|Noncompliance|1
7828591|NCT00324649|27181978|P2|Overall Study|Withdrawal by Subject|1
7828592|NCT00324649|27181979|P1|Overall Study|Withdrawal by Subject|0
7828593|NCT00324649|27181978|P2|Overall Study|Adverse Event|4
7828594|NCT00324649|27181979|P1|Overall Study|Adverse Event|1
7828595|NCT00324233|27182110|P2|Second Period|Protocol Violation|6
7828596|NCT00324233|27182111|P1|Second Period|Protocol Violation|4
7828597|NCT00324233|27182110|P2|Second Period|unable to insert catheter|1
7828598|NCT00324233|27182111|P1|Second Period|unable to insert catheter|1
7828599|NCT00324233|27182110|P2|First Period|unable to insert catheter|0
7828600|NCT00324233|27182111|P1|First Period|unable to insert catheter|1
7828601|NCT00324168|27182119|P2|Overall Study|Patient did not visit in f/u window|9
7828602|NCT00324168|27182120|P1|Overall Study|Patient did not visit in f/u window|6
7828603|NCT00324168|27182119|P2|Overall Study|Death|3
7828604|NCT00324168|27182120|P1|Overall Study|Death|3
7828605|NCT00324168|27182119|P2|Overall Study|Lost to Follow-up|18
7828606|NCT00324168|27182120|P1|Overall Study|Lost to Follow-up|19
7828607|NCT00324155|27182148|P2|Follow-up Phase|On-going participants still on drug|6
7828608|NCT00324155|27182149|P1|Follow-up Phase|On-going participants still on drug|11
7828609|NCT00324155|27182148|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
7828610|NCT00324155|27182149|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
7828611|NCT00324155|27182148|P2|Received Treatment in Maintenance Phase|Adverse Event|3
7828612|NCT00324155|27182149|P1|Received Treatment in Maintenance Phase|Adverse Event|0
7828613|NCT00324155|27182148|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
7828614|NCT00324155|27182149|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
7828615|NCT00324155|27182148|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
7828616|NCT00324155|27182149|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
7828617|NCT00324155|27182148|P2|Received Treatment in Maintenance Phase|Disease Progression|41
7828618|NCT00324155|27182149|P1|Received Treatment in Maintenance Phase|Disease Progression|26
7828619|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Physician Decision|0
7828620|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Physician Decision|2
7828621|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
7828622|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
7828623|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Adverse Event|7
7828624|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Adverse Event|6
7828625|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
7828626|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
7828627|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Death|15
7828628|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Death|8
7828629|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
7828630|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
7828631|NCT00324155|27182148|P2|Received Treatment in Induction Phase|Disease Progression|152
7828632|NCT00324155|27182149|P1|Received Treatment in Induction Phase|Disease Progression|88
7828633|NCT00324155|27182148|P2|Enrolled and Randomized|Lost to Follow-up|1
7828634|NCT00324155|27182149|P1|Enrolled and Randomized|Lost to Follow-up|0
7828635|NCT00324155|27182148|P2|Enrolled and Randomized|No longer met study criteria|0
7828636|NCT00324155|27182149|P1|Enrolled and Randomized|No longer met study criteria|3
7828637|NCT00324116|27182179|P1|Overall Study|Other|5
7828638|NCT00324116|27182179|P1|Overall Study|Withdrawal by Subject|5
7828639|NCT00324116|27182179|P1|Overall Study|Lack of Efficacy|17
7828640|NCT00324116|27182179|P1|Overall Study|Adverse Event|5
7828641|NCT00324038|27182191|P2|Overall Study|Other|13
7828642|NCT00324038|27182192|P1|Overall Study|Other|6
7828643|NCT00324038|27182191|P2|Overall Study|Lost to Follow-up|2
7828644|NCT00324038|27182192|P1|Overall Study|Lost to Follow-up|0
7828645|NCT00324038|27182191|P2|Overall Study|Lack of Efficacy|13
7828646|NCT00324038|27182192|P1|Overall Study|Lack of Efficacy|5
7828647|NCT00324038|27182191|P2|Overall Study|Adverse Event|23
7828648|NCT00324038|27182192|P1|Overall Study|Adverse Event|38
7828649|NCT00323882|27182225|P5|Overall Study|Other|1
7828650|NCT00323882|27182226|P4|Overall Study|Other|1
7828651|NCT00323882|27182227|P3|Overall Study|Other|0
7828652|NCT00323882|27182228|P2|Overall Study|Other|0
7828653|NCT00323882|27182229|P1|Overall Study|Other|0
7828654|NCT00323882|27182225|P5|Overall Study|Lost to Follow-up|1
7828655|NCT00323882|27182226|P4|Overall Study|Lost to Follow-up|0
7828656|NCT00323882|27182227|P3|Overall Study|Lost to Follow-up|1
7828657|NCT00323882|27182228|P2|Overall Study|Lost to Follow-up|0
7828658|NCT00323882|27182229|P1|Overall Study|Lost to Follow-up|0
7828659|NCT00323882|27182225|P5|Overall Study|Death|5
7828660|NCT00323882|27182226|P4|Overall Study|Death|0
7828661|NCT00323882|27182227|P3|Overall Study|Death|1
7828662|NCT00323882|27182228|P2|Overall Study|Death|1
7828663|NCT00323882|27182229|P1|Overall Study|Death|0
7828664|NCT00323882|27182225|P5|Overall Study|Disease Progression|22
7828665|NCT00323882|27182226|P4|Overall Study|Disease Progression|5
7828666|NCT00323882|27182227|P3|Overall Study|Disease Progression|10
7828667|NCT00323882|27182228|P2|Overall Study|Disease Progression|4
7828668|NCT00323882|27182229|P1|Overall Study|Disease Progression|6
7828669|NCT00323882|27182225|P5|Overall Study|Adverse Event|3
7828670|NCT00323882|27182226|P4|Overall Study|Adverse Event|1
7828671|NCT00323882|27182227|P3|Overall Study|Adverse Event|1
7828672|NCT00323882|27182228|P2|Overall Study|Adverse Event|1
7828673|NCT00323882|27182229|P1|Overall Study|Adverse Event|2
7828674|NCT00323869|27182300|P1|Overall Study|Death|1
7828675|NCT00323622|27182356|P8|Overall Study|Death|2
7828676|NCT00323622|27182357|P7|Overall Study|Death|0
7828677|NCT00323622|27182358|P6|Overall Study|Death|0
7828678|NCT00323622|27182359|P5|Overall Study|Death|7
7828679|NCT00323622|27182360|P4|Overall Study|Death|0
7828680|NCT00323622|27182361|P3|Overall Study|Death|0
7828681|NCT00323622|27182362|P2|Overall Study|Death|1
7828682|NCT00323622|27182363|P1|Overall Study|Death|1
7828683|NCT00323622|27182356|P8|Overall Study|Other|13
7828684|NCT00323622|27182357|P7|Overall Study|Other|5
7828685|NCT00323622|27182358|P6|Overall Study|Other|74
7828686|NCT00323622|27182359|P5|Overall Study|Other|32
7828687|NCT00323622|27182360|P4|Overall Study|Other|12
7828688|NCT00323622|27182361|P3|Overall Study|Other|4
7828689|NCT00323622|27182362|P2|Overall Study|Other|91
7828690|NCT00323622|27182363|P1|Overall Study|Other|30
7828691|NCT00323609|27182405|P4|Overall Study|Other reason|9
7828692|NCT00323609|27182406|P3|Overall Study|Other reason|4
7828693|NCT00323609|27182407|P2|Overall Study|Other reason|8
7828694|NCT00323609|27182408|P1|Overall Study|Other reason|11
7828695|NCT00323609|27182405|P4|Overall Study|Logistical withdrawal|1
7828696|NCT00323609|27182406|P3|Overall Study|Logistical withdrawal|0
7828697|NCT00323609|27182407|P2|Overall Study|Logistical withdrawal|5
7828698|NCT00323609|27182408|P1|Overall Study|Logistical withdrawal|9
7828699|NCT00323609|27182405|P4|Overall Study|Unrelenting or severe back pain|0
7828700|NCT00323609|27182406|P3|Overall Study|Unrelenting or severe back pain|0
7828701|NCT00323609|27182407|P2|Overall Study|Unrelenting or severe back pain|1
7828702|NCT00323609|27182408|P1|Overall Study|Unrelenting or severe back pain|1
7828703|NCT00323609|27182405|P4|Overall Study|Sponsor discontinued trial|0
7828704|NCT00323609|27182406|P3|Overall Study|Sponsor discontinued trial|0
7828705|NCT00323609|27182407|P2|Overall Study|Sponsor discontinued trial|29
7828706|NCT00323609|27182408|P1|Overall Study|Sponsor discontinued trial|29
7828707|NCT00323609|27182405|P4|Overall Study|Other non-VCF-related medical condition|0
7828708|NCT00323609|27182406|P3|Overall Study|Other non-VCF-related medical condition|0
7828709|NCT00323609|27182407|P2|Overall Study|Other non-VCF-related medical condition|2
7828710|NCT00323609|27182408|P1|Overall Study|Other non-VCF-related medical condition|3
7828711|NCT00323609|27182405|P4|Overall Study|Withdrawal by Subject|4
7828712|NCT00323609|27182406|P3|Overall Study|Withdrawal by Subject|4
7828713|NCT00323609|27182407|P2|Overall Study|Withdrawal by Subject|23
7828714|NCT00323609|27182408|P1|Overall Study|Withdrawal by Subject|11
7828715|NCT00323609|27182405|P4|Overall Study|Physician Decision|1
7828716|NCT00323609|27182406|P3|Overall Study|Physician Decision|0
7828717|NCT00323609|27182407|P2|Overall Study|Physician Decision|0
7828718|NCT00323609|27182408|P1|Overall Study|Physician Decision|2
7828719|NCT00323609|27182405|P4|Overall Study|Lost to Follow-up|0
7828720|NCT00323609|27182406|P3|Overall Study|Lost to Follow-up|0
7828721|NCT00323609|27182407|P2|Overall Study|Lost to Follow-up|10
7828722|NCT00323609|27182408|P1|Overall Study|Lost to Follow-up|9
7828723|NCT00323609|27182405|P4|Overall Study|Death|0
7828724|NCT00323609|27182406|P3|Overall Study|Death|0
7828725|NCT00323609|27182407|P2|Overall Study|Death|21
7828726|NCT00323609|27182408|P1|Overall Study|Death|16
7828727|NCT00323557|27182444|P2|Overall Study|Physician Decision|0
7828728|NCT00323557|27182445|P1|Overall Study|Physician Decision|1
7828729|NCT00323492|27182454|P3|Study Phase 2|Protocol Violation|0
7828730|NCT00323492|27182455|P2|Study Phase 2|Protocol Violation|0
7828731|NCT00323492|27182456|P1|Study Phase 2|Protocol Violation|1
7828732|NCT00323492|27182454|P3|Study Phase 2|Noncompliance with study schedule|1
7828733|NCT00323492|27182455|P2|Study Phase 2|Noncompliance with study schedule|0
7828734|NCT00323492|27182456|P1|Study Phase 2|Noncompliance with study schedule|0
7828735|NCT00323492|27182454|P3|Study Phase 2|Withdrawal by Subject|0
7828736|NCT00323492|27182455|P2|Study Phase 2|Withdrawal by Subject|1
7828737|NCT00323492|27182456|P1|Study Phase 2|Withdrawal by Subject|0
7828738|NCT00323492|27182454|P3|Study Phase 2|Lost to Follow-up|0
7828739|NCT00323492|27182455|P2|Study Phase 2|Lost to Follow-up|0
7828740|NCT00323492|27182456|P1|Study Phase 2|Lost to Follow-up|1
7828741|NCT00323492|27182454|P3|Study Phase 2|Physician Decision|0
7828742|NCT00323492|27182455|P2|Study Phase 2|Physician Decision|0
7828743|NCT00323492|27182456|P1|Study Phase 2|Physician Decision|1
7828744|NCT00323492|27182454|P3|Study Phase 2|Adverse Event|0
7828745|NCT00323492|27182455|P2|Study Phase 2|Adverse Event|0
7828746|NCT00323492|27182456|P1|Study Phase 2|Adverse Event|1
7828747|NCT00323492|27182454|P3|Study Phase 1|Adverse Event|0
7828748|NCT00323492|27182455|P2|Study Phase 1|Adverse Event|0
7828749|NCT00323492|27182456|P1|Study Phase 1|Adverse Event|2
7828750|NCT00323479|27182487|P1|Overall Study|house moving|1
7828751|NCT00323479|27182487|P1|Overall Study|Protocol Violation|3
7828752|NCT00323479|27182487|P1|Overall Study|Withdrawal by Subject|2
7828753|NCT00323479|27182487|P1|Overall Study|Adverse Event|2
7828754|NCT00323414|27182520|P2|Overall Study|Withdrawal by Subject|1
7828755|NCT00323414|27182521|P1|Overall Study|Withdrawal by Subject|0
7828756|NCT00323310|27182543|P1|Overall Study|did not complete the 24-hr f-up visit|1
7828757|NCT00323310|27182543|P1|Overall Study|a parent refused blood draw|1
7828758|NCT00323310|27182543|P1|Overall Study|Withdrawal by Subject|1
7828759|NCT00323297|27182558|P2|Part B (Open-label)|Protocol Violation|1
7828760|NCT00323297|27182559|P1|Part B (Open-label)|Protocol Violation|0
7828761|NCT00323297|27182558|P2|Part B (Open-label)|Adverse Event|5
7828762|NCT00323297|27182559|P1|Part B (Open-label)|Adverse Event|5
7828763|NCT00323297|27182558|P2|Part B (Open-label)|Lack of Efficacy|1
7828764|NCT00323297|27182559|P1|Part B (Open-label)|Lack of Efficacy|3
7828765|NCT00323297|27182558|P2|Part B (Open-label)|Withdrawal by Subject|3
7828766|NCT00323297|27182559|P1|Part B (Open-label)|Withdrawal by Subject|1
7828767|NCT00323297|27182558|P2|Part B (Open-label)|Reason unspecified|1
7828768|NCT00323297|27182559|P1|Part B (Open-label)|Reason unspecified|0
7828769|NCT00323297|27182558|P2|Part B (Open-label)|Death|1
7828770|NCT00323297|27182559|P1|Part B (Open-label)|Death|0
7828771|NCT00323297|27182558|P2|Part A (Double Blind Randomized)|Related adverse event|2
7828772|NCT00323297|27182559|P1|Part A (Double Blind Randomized)|Related adverse event|2
7828773|NCT00323297|27182558|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
7828774|NCT00323297|27182559|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
7828775|NCT00323297|27182558|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
7828776|NCT00323297|27182559|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
7828777|NCT00323297|27182558|P2|Part A (Double Blind Randomized)|Protocol Violation|3
7828778|NCT00323297|27182559|P1|Part A (Double Blind Randomized)|Protocol Violation|1
7828779|NCT00323297|27182558|P2|Part A (Double Blind Randomized)|Death|1
7828780|NCT00323297|27182559|P1|Part A (Double Blind Randomized)|Death|0
7828781|NCT00323297|27182558|P2|Part A (Double Blind Randomized)|Reason unspecified|1
7828782|NCT00323297|27182559|P1|Part A (Double Blind Randomized)|Reason unspecified|0
7828783|NCT00323258|27182599|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
7828784|NCT00323258|27182600|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
7828785|NCT00323258|27182599|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
7828786|NCT00323258|27182600|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
7828787|NCT00323258|27182599|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
7828788|NCT00323258|27182600|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
7828789|NCT00323258|27182599|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
7828790|NCT00323258|27182600|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
7828791|NCT00323258|27182599|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
7828792|NCT00323258|27182600|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
7828793|NCT00323258|27182599|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
7828794|NCT00323258|27182600|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
7828795|NCT00323258|27182599|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
7828796|NCT00323258|27182600|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
7828797|NCT00323115|27182625|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
7828798|NCT00323115|27182625|P1|Vaccine Administration|Adverse Event|1
7828799|NCT00323063|27182652|P2|Overall Study|brain mets discovered prior to treatment|0
7828800|NCT00323063|27182653|P1|Overall Study|brain mets discovered prior to treatment|1
7828801|NCT00323063|27182652|P2|Overall Study|Adverse Event|0
7828802|NCT00323063|27182653|P1|Overall Study|Adverse Event|1
7828803|NCT00322881|27182670|P1|Overall Study|Disease Progression|2
7828804|NCT00322881|27182670|P1|Overall Study|Adverse Event|1
7828805|NCT00322881|27182670|P1|Overall Study|Death|2
7828806|NCT00322868|27182674|P1|Overall Study|disease progression|1
7828807|NCT00322842|27182699|P2|Overall Study|Death|0
7828808|NCT00322842|27182700|P1|Overall Study|Death|1
7828809|NCT00322842|27182699|P2|Overall Study|Refused transplant|0
7828810|NCT00322842|27182700|P1|Overall Study|Refused transplant|1
7828811|NCT00322842|27182699|P2|Overall Study|Lost to Follow-up|1
7828812|NCT00322842|27182700|P1|Overall Study|Lost to Follow-up|0
7828813|NCT00322842|27182699|P2|Overall Study|Withdrawal by Subject|1
7828814|NCT00322842|27182700|P1|Overall Study|Withdrawal by Subject|0
7828815|NCT00322712|27182738|P1|Overall Study|treated with bevacizumab not cetuximab|1
7828816|NCT00322621|27182742|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
7828817|NCT00322621|27182743|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
7828818|NCT00322621|27182744|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
7828819|NCT00322621|27182742|P3|Period III - Maintenance / Rescue Phase|Death|0
7828820|NCT00322621|27182743|P2|Period III - Maintenance / Rescue Phase|Death|1
7828821|NCT00322621|27182744|P1|Period III - Maintenance / Rescue Phase|Death|0
7828822|NCT00322621|27182742|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
7828823|NCT00322621|27182743|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
7828824|NCT00322621|27182744|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
7828825|NCT00322621|27182742|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
7828826|NCT00322621|27182743|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
7828827|NCT00322621|27182744|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
7828828|NCT00322621|27182742|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
7828829|NCT00322621|27182743|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
7828830|NCT00322621|27182744|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
7828831|NCT00322621|27182742|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
7828832|NCT00322621|27182743|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
7828833|NCT00322621|27182744|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
7828834|NCT00322621|27182742|P3|Period II - Acute Therapy Phase|Physician Decision|0
7828835|NCT00322621|27182743|P2|Period II - Acute Therapy Phase|Physician Decision|0
7828836|NCT00322621|27182744|P1|Period II - Acute Therapy Phase|Physician Decision|1
7828837|NCT00322621|27182742|P3|Period II - Acute Therapy Phase|Protocol Violation|0
7828838|NCT00322621|27182743|P2|Period II - Acute Therapy Phase|Protocol Violation|0
7828839|NCT00322621|27182744|P1|Period II - Acute Therapy Phase|Protocol Violation|2
7828840|NCT00322621|27182742|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
7828841|NCT00322621|27182743|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
7828842|NCT00322621|27182744|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
7828843|NCT00322621|27182742|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
7828844|NCT00322621|27182743|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
7828845|NCT00322621|27182744|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
7828846|NCT00322621|27182742|P3|Period II - Acute Therapy Phase|Adverse Event|0
7828847|NCT00322621|27182743|P2|Period II - Acute Therapy Phase|Adverse Event|0
7828848|NCT00322621|27182744|P1|Period II - Acute Therapy Phase|Adverse Event|20
7828849|NCT00322556|27182796|P1|Overall Study|Other Reason|7
7828850|NCT00322556|27182796|P1|Overall Study|Lost to Follow-up|3
7828851|NCT00322556|27182796|P1|Overall Study|Withdrawal by Subject|1
7828852|NCT00322556|27182796|P1|Overall Study|Adverse Event|1
7828853|NCT00322491|27182812|P2|Overall Study|Death|2
7828854|NCT00322491|27182813|P1|Overall Study|Death|1
7828855|NCT00322491|27182812|P2|Overall Study|Adverse Event|0
7828856|NCT00322491|27182813|P1|Overall Study|Adverse Event|1
7828857|NCT00322452|27182903|P2|Overall Study|Death|227
7828858|NCT00322452|27182904|P1|Overall Study|Death|223
7828859|NCT00322452|27182903|P2|Overall Study|Withdrawal by Subject|46
7828860|NCT00322452|27182904|P1|Overall Study|Withdrawal by Subject|19
7828861|NCT00322452|27182903|P2|Overall Study|Lost to Follow-up|2
7828862|NCT00322452|27182904|P1|Overall Study|Lost to Follow-up|5
7828863|NCT00322452|27182903|P2|Overall Study|Eligibility criteria not fulfilled|1
7828864|NCT00322452|27182904|P1|Overall Study|Eligibility criteria not fulfilled|0
7828865|NCT00322387|27182955|P2|Follow-up Period|Death|0
7828866|NCT00322387|27182956|P1|Follow-up Period|Death|1
7828867|NCT00322387|27182955|P2|Follow-up Period|Final assessment not done|3
7828868|NCT00322387|27182956|P1|Follow-up Period|Final assessment not done|1
7828869|NCT00322387|27182955|P2|Treatment Period|Adverse Event|1
7828870|NCT00322387|27182956|P1|Treatment Period|Adverse Event|0
7828871|NCT00322374|27182990|P4|Second Escalation|Study Drug Toxicity|0
7828872|NCT00322374|27182991|P3|Second Escalation|Study Drug Toxicity|1
7828873|NCT00322374|27182992|P2|Second Escalation|Study Drug Toxicity|0
7828874|NCT00322374|27182993|P1|Second Escalation|Study Drug Toxicity|0
7828875|NCT00322374|27182990|P4|Second Escalation|Physician Decision|0
7828876|NCT00322374|27182991|P3|Second Escalation|Physician Decision|5
7828877|NCT00322374|27182992|P2|Second Escalation|Physician Decision|0
7828878|NCT00322374|27182993|P1|Second Escalation|Physician Decision|0
7828879|NCT00322374|27182990|P4|First Escalation|Participant Request|0
7828880|NCT00322374|27182991|P3|First Escalation|Participant Request|0
7828881|NCT00322374|27182992|P2|First Escalation|Participant Request|1
7828882|NCT00322374|27182993|P1|First Escalation|Participant Request|0
7828883|NCT00322374|27182990|P4|First Escalation|Study Drug Toxicity|0
7828884|NCT00322374|27182991|P3|First Escalation|Study Drug Toxicity|0
7828885|NCT00322374|27182992|P2|First Escalation|Study Drug Toxicity|11
7828886|NCT00322374|27182993|P1|First Escalation|Study Drug Toxicity|0
7828887|NCT00322374|27182990|P4|First Escalation|Physician Decision|0
7828888|NCT00322374|27182991|P3|First Escalation|Physician Decision|0
7828889|NCT00322374|27182992|P2|First Escalation|Physician Decision|12
7828890|NCT00322374|27182993|P1|First Escalation|Physician Decision|0
7828891|NCT00322374|27182990|P4|First Escalation|Documented Disease Progression|0
7828892|NCT00322374|27182991|P3|First Escalation|Documented Disease Progression|0
7828893|NCT00322374|27182992|P2|First Escalation|Documented Disease Progression|6
7828894|NCT00322374|27182993|P1|First Escalation|Documented Disease Progression|0
7828895|NCT00322374|27182990|P4|Starting Dose|Study Drug Toxicity|0
7828896|NCT00322374|27182991|P3|Starting Dose|Study Drug Toxicity|0
7828897|NCT00322374|27182992|P2|Starting Dose|Study Drug Toxicity|0
7828898|NCT00322374|27182993|P1|Starting Dose|Study Drug Toxicity|4
7828899|NCT00322374|27182990|P4|Starting Dose|Physician Decision|0
7828900|NCT00322374|27182991|P3|Starting Dose|Physician Decision|0
7828901|NCT00322374|27182992|P2|Starting Dose|Physician Decision|0
7828902|NCT00322374|27182993|P1|Starting Dose|Physician Decision|2
7828903|NCT00322348|27183043|P2|Overall Study|Reasons not specified|1
7828904|NCT00322348|27183044|P1|Overall Study|Reasons not specified|5
7828905|NCT00322348|27183043|P2|Overall Study|Disease Progression|25
7828906|NCT00322348|27183044|P1|Overall Study|Disease Progression|30
7828907|NCT00322348|27183043|P2|Overall Study|Death|2
7828908|NCT00322348|27183044|P1|Overall Study|Death|0
7828909|NCT00322348|27183043|P2|Overall Study|Lost to Follow-up|0
7828910|NCT00322348|27183044|P1|Overall Study|Lost to Follow-up|1
7828911|NCT00322348|27183043|P2|Overall Study|Withdrawal by Subject|4
7828912|NCT00322348|27183044|P1|Overall Study|Withdrawal by Subject|1
7828913|NCT00322348|27183043|P2|Overall Study|Adverse Event|1
7828914|NCT00322348|27183044|P1|Overall Study|Adverse Event|0
7828915|NCT00322153|27183135|P2|Overall Study|Withdrawn for other reasons|4
7828916|NCT00322153|27183136|P1|Overall Study|Withdrawn for other reasons|5
7828917|NCT00322153|27183135|P2|Overall Study|Lost to Follow-up|4
7828918|NCT00322153|27183136|P1|Overall Study|Lost to Follow-up|5
7828919|NCT00322153|27183135|P2|Overall Study|Lack of Efficacy|3
7828920|NCT00322153|27183136|P1|Overall Study|Lack of Efficacy|8
7828921|NCT00322153|27183135|P2|Overall Study|Withdrawal by Subject|10
7828922|NCT00322153|27183136|P1|Overall Study|Withdrawal by Subject|18
7828923|NCT00322153|27183135|P2|Overall Study|Protocol Violation|14
7828924|NCT00322153|27183136|P1|Overall Study|Protocol Violation|6
7828925|NCT00322153|27183135|P2|Overall Study|Adverse Event|34
7828926|NCT00322153|27183136|P1|Overall Study|Adverse Event|21
7828927|NCT00322049|27183169|P4|Overall Study|Infected with Dengue during study|0
7828928|NCT00322049|27183170|P3|Overall Study|Infected with Dengue during study|0
7828929|NCT00322049|27183171|P2|Overall Study|Infected with Dengue during study|1
7828930|NCT00322049|27183172|P1|Overall Study|Infected with Dengue during study|0
7828931|NCT00322049|27183169|P4|Overall Study|Moved out of area|1
7828932|NCT00322049|27183170|P3|Overall Study|Moved out of area|0
7828933|NCT00322049|27183171|P2|Overall Study|Moved out of area|0
7828934|NCT00322049|27183172|P1|Overall Study|Moved out of area|0
7828935|NCT00322023|27183205|P3|Overall Study|various|6
7828936|NCT00322023|27183206|P2|Overall Study|various|2
7828937|NCT00322023|27183207|P1|Overall Study|various|0
7828938|NCT00321984|27183224|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
7828939|NCT00321984|27183225|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
7828940|NCT00321984|27183226|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
7828941|NCT00321984|27183224|P3|Overall Study|Per Investigator Request|0
7828942|NCT00321984|27183225|P2|Overall Study|Per Investigator Request|0
7828943|NCT00321984|27183226|P1|Overall Study|Per Investigator Request|1
7828944|NCT00321984|27183224|P3|Overall Study|Per Subject Request|0
7828945|NCT00321984|27183225|P2|Overall Study|Per Subject Request|0
7828946|NCT00321984|27183226|P1|Overall Study|Per Subject Request|1
7828947|NCT00321984|27183224|P3|Overall Study|Pregnancy|0
7828948|NCT00321984|27183225|P2|Overall Study|Pregnancy|1
7828949|NCT00321984|27183226|P1|Overall Study|Pregnancy|0
7828950|NCT00321984|27183224|P3|Overall Study|Noncompliant|2
7828951|NCT00321984|27183225|P2|Overall Study|Noncompliant|0
7828952|NCT00321984|27183226|P1|Overall Study|Noncompliant|0
7828953|NCT00321984|27183224|P3|Overall Study|Lack of Efficacy|3
7828954|NCT00321984|27183225|P2|Overall Study|Lack of Efficacy|1
7828955|NCT00321984|27183226|P1|Overall Study|Lack of Efficacy|3
7828956|NCT00321984|27183224|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7828957|NCT00321984|27183225|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
7828958|NCT00321984|27183226|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
7828959|NCT00321984|27183224|P3|Overall Study|Withdrawal by Subject|5
7828960|NCT00321984|27183225|P2|Overall Study|Withdrawal by Subject|6
7828961|NCT00321984|27183226|P1|Overall Study|Withdrawal by Subject|8
7828962|NCT00321984|27183224|P3|Overall Study|Lost to Follow-up|2
7828963|NCT00321984|27183225|P2|Overall Study|Lost to Follow-up|4
7828964|NCT00321984|27183226|P1|Overall Study|Lost to Follow-up|2
7828965|NCT00321984|27183224|P3|Overall Study|Protocol Violation|1
7828966|NCT00321984|27183225|P2|Overall Study|Protocol Violation|1
7828967|NCT00321984|27183226|P1|Overall Study|Protocol Violation|0
7828968|NCT00321984|27183224|P3|Overall Study|Adverse Event|8
7828969|NCT00321984|27183225|P2|Overall Study|Adverse Event|6
7828970|NCT00321984|27183226|P1|Overall Study|Adverse Event|9
7828971|NCT00321932|27183254|P2|Overall Study|Missing data|1
7828972|NCT00321932|27183255|P1|Overall Study|Missing data|2
7828973|NCT00321932|27183254|P2|Overall Study|Early relapse|8
7828974|NCT00321932|27183255|P1|Overall Study|Early relapse|2
7828975|NCT00321932|27183254|P2|Overall Study|Withdrawal by Subject|6
7828976|NCT00321932|27183255|P1|Overall Study|Withdrawal by Subject|3
7828977|NCT00321932|27183254|P2|Overall Study|Death|6
7828978|NCT00321932|27183255|P1|Overall Study|Death|3
7828979|NCT00321919|27183279|P2|Overall Study|Other withdrawal reason|6
7828980|NCT00321919|27183280|P1|Overall Study|Other withdrawal reason|7
7828981|NCT00321919|27183279|P2|Overall Study|Failure to Return|1
7828982|NCT00321919|27183280|P1|Overall Study|Failure to Return|3
7828983|NCT00321919|27183279|P2|Overall Study|Other Protocol Violation|3
7828984|NCT00321919|27183280|P1|Overall Study|Other Protocol Violation|2
7828985|NCT00321919|27183279|P2|Overall Study|Refused Treatment|14
7828986|NCT00321919|27183280|P1|Overall Study|Refused Treatment|23
7828987|NCT00321919|27183279|P2|Overall Study|Violation of Selection Criteria at Entry|1
7828988|NCT00321919|27183280|P1|Overall Study|Violation of Selection Criteria at Entry|1
7828989|NCT00321919|27183279|P2|Overall Study|Insufficient Therapeutic Response|0
7828990|NCT00321919|27183280|P1|Overall Study|Insufficient Therapeutic Response|1
7828991|NCT00321919|27183279|P2|Overall Study|Death|17
7828992|NCT00321919|27183280|P1|Overall Study|Death|21
7828993|NCT00321919|27183279|P2|Overall Study|Adverse Event|10
7828994|NCT00321919|27183280|P1|Overall Study|Adverse Event|17
7828995|NCT00321906|27183322|P2|Overall Study|Withdrawal by Subject|4
7828996|NCT00321906|27183323|P1|Overall Study|Withdrawal by Subject|0
7828997|NCT00321906|27183322|P2|Overall Study|Lost to Follow-up|2
7828998|NCT00321906|27183323|P1|Overall Study|Lost to Follow-up|1
7828999|NCT00321906|27183322|P2|Overall Study|Death|6
7829000|NCT00321906|27183323|P1|Overall Study|Death|9
7829001|NCT00321906|27183322|P2|Overall Study|Adverse Event|44
7829002|NCT00321906|27183323|P1|Overall Study|Adverse Event|36
7829003|NCT00321893|27183345|P2|Overall Study|Adverse Event|3
7829004|NCT00321893|27183346|P1|Overall Study|Adverse Event|6
7829005|NCT00321893|27183345|P2|Overall Study|Lost to Follow-up|1
7829006|NCT00321893|27183346|P1|Overall Study|Lost to Follow-up|2
7829007|NCT00321893|27183345|P2|Overall Study|Non-Compliance/Refusal|10
7829008|NCT00321893|27183346|P1|Overall Study|Non-Compliance/Refusal|16
7829009|NCT00321854|27183360|P2|Overall Study|Other|1
7829010|NCT00321854|27183361|P1|Overall Study|Other|1
7829011|NCT00321854|27183360|P2|Overall Study|Withdrawal by Subject|17
7829012|NCT00321854|27183361|P1|Overall Study|Withdrawal by Subject|6
7829013|NCT00321854|27183360|P2|Overall Study|Lost to Follow-up|2
7829014|NCT00321854|27183361|P1|Overall Study|Lost to Follow-up|0
7829015|NCT00321854|27183360|P2|Overall Study|Protocol Violation|5
7829016|NCT00321854|27183361|P1|Overall Study|Protocol Violation|6
7829017|NCT00321854|27183360|P2|Overall Study|Lack of Efficacy|14
7829018|NCT00321854|27183361|P1|Overall Study|Lack of Efficacy|9
7829019|NCT00321854|27183360|P2|Overall Study|Adverse Event|43
7829020|NCT00321854|27183361|P1|Overall Study|Adverse Event|41
7829021|NCT00321828|27183479|P1|Overall Study|No follow up data|1
7829022|NCT00321828|27183479|P1|Overall Study|Ineligible|3
7829023|NCT00321789|27183485|P2|Overall Study|Protocol Violation|3
7829024|NCT00321789|27183486|P1|Overall Study|Protocol Violation|5
7829025|NCT00321789|27183485|P2|Overall Study|Withdrawal by Subject|6
7829026|NCT00321789|27183486|P1|Overall Study|Withdrawal by Subject|6
7829027|NCT00321789|27183485|P2|Overall Study|Lost to Follow-up|7
7829028|NCT00321789|27183486|P1|Overall Study|Lost to Follow-up|4
7829029|NCT00321763|27183518|P4|Overall Study|Lost to Follow-up|4
7829030|NCT00321763|27183519|P3|Overall Study|Lost to Follow-up|5
7829031|NCT00321763|27183520|P2|Overall Study|Lost to Follow-up|1
7829032|NCT00321763|27183521|P1|Overall Study|Lost to Follow-up|3
7829033|NCT00321763|27183518|P4|Overall Study|Withdrawal by Subject|0
7829034|NCT00321763|27183519|P3|Overall Study|Withdrawal by Subject|1
7829035|NCT00321763|27183520|P2|Overall Study|Withdrawal by Subject|0
7829036|NCT00321763|27183521|P1|Overall Study|Withdrawal by Subject|2
7829037|NCT00321763|27183518|P4|Overall Study|Adverse Event|1
7829038|NCT00321763|27183519|P3|Overall Study|Adverse Event|0
7829039|NCT00321763|27183520|P2|Overall Study|Adverse Event|1
7829040|NCT00321763|27183521|P1|Overall Study|Adverse Event|1
7829041|NCT00321737|27183581|P3|Overall Study|Subject Request/ Subject Unavailable|2
7829042|NCT00321737|27183582|P2|Overall Study|Subject Request/ Subject Unavailable|0
7829043|NCT00321737|27183583|P1|Overall Study|Subject Request/ Subject Unavailable|0
7829044|NCT00321737|27183581|P3|Overall Study|Noncompliance|0
7829045|NCT00321737|27183582|P2|Overall Study|Noncompliance|0
7829046|NCT00321737|27183583|P1|Overall Study|Noncompliance|2
7829047|NCT00321737|27183581|P3|Overall Study|Pregnancy|0
7829048|NCT00321737|27183582|P2|Overall Study|Pregnancy|2
7829049|NCT00321737|27183583|P1|Overall Study|Pregnancy|0
7829050|NCT00321737|27183581|P3|Overall Study|Therapeutic Failure|2
7829051|NCT00321737|27183582|P2|Overall Study|Therapeutic Failure|0
7829052|NCT00321737|27183583|P1|Overall Study|Therapeutic Failure|6
7829053|NCT00321737|27183581|P3|Overall Study|Possible Barrett's Esophagus|1
7829054|NCT00321737|27183582|P2|Overall Study|Possible Barrett's Esophagus|1
7829055|NCT00321737|27183583|P1|Overall Study|Possible Barrett's Esophagus|2
7829056|NCT00321737|27183581|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7829057|NCT00321737|27183582|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7829058|NCT00321737|27183583|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
7829059|NCT00321737|27183581|P3|Overall Study|Protocol Violation|1
7829060|NCT00321737|27183582|P2|Overall Study|Protocol Violation|0
7829061|NCT00321737|27183583|P1|Overall Study|Protocol Violation|0
7829062|NCT00321737|27183581|P3|Overall Study|Withdrawal by Subject|17
7829063|NCT00321737|27183582|P2|Overall Study|Withdrawal by Subject|12
7829064|NCT00321737|27183583|P1|Overall Study|Withdrawal by Subject|19
7829065|NCT00321737|27183581|P3|Overall Study|Lost to Follow-up|6
7829066|NCT00321737|27183582|P2|Overall Study|Lost to Follow-up|5
7829067|NCT00321737|27183583|P1|Overall Study|Lost to Follow-up|5
7829068|NCT00321737|27183581|P3|Overall Study|Adverse Event|6
7829069|NCT00321737|27183582|P2|Overall Study|Adverse Event|3
7829070|NCT00321737|27183583|P1|Overall Study|Adverse Event|11
7829071|NCT00321737|27183581|P3|Overall Study|Relapse of Erosive Esophagitis|19
7829072|NCT00321737|27183582|P2|Overall Study|Relapse of Erosive Esophagitis|25
7829073|NCT00321737|27183583|P1|Overall Study|Relapse of Erosive Esophagitis|76
7829074|NCT00321711|27183611|P5|Part B|Death|1
7829075|NCT00321711|27183612|P4|Part B|Death|2
7829076|NCT00321711|27183613|P3|Part B|Death|0
7829077|NCT00321711|27183614|P2|Part B|Death|0
7829078|NCT00321711|27183615|P1|Part B|Death|0
7829079|NCT00321711|27183611|P5|Part B|Physician Decision|2
7829080|NCT00321711|27183612|P4|Part B|Physician Decision|1
7829081|NCT00321711|27183613|P3|Part B|Physician Decision|0
7829082|NCT00321711|27183614|P2|Part B|Physician Decision|0
7829083|NCT00321711|27183615|P1|Part B|Physician Decision|0
7829084|NCT00321711|27183611|P5|Part B|Disease progression|0
7829085|NCT00321711|27183612|P4|Part B|Disease progression|1
7829086|NCT00321711|27183613|P3|Part B|Disease progression|0
7829087|NCT00321711|27183614|P2|Part B|Disease progression|0
7829088|NCT00321711|27183615|P1|Part B|Disease progression|0
7829089|NCT00321711|27183611|P5|Part B|Adverse Event|1
7829090|NCT00321711|27183612|P4|Part B|Adverse Event|2
7829091|NCT00321711|27183613|P3|Part B|Adverse Event|0
7829092|NCT00321711|27183614|P2|Part B|Adverse Event|0
7829093|NCT00321711|27183615|P1|Part B|Adverse Event|0
7829094|NCT00321711|27183611|P5|Part B|Noncompliance|1
7829095|NCT00321711|27183612|P4|Part B|Noncompliance|0
7829096|NCT00321711|27183613|P3|Part B|Noncompliance|0
7829097|NCT00321711|27183614|P2|Part B|Noncompliance|0
7829098|NCT00321711|27183615|P1|Part B|Noncompliance|0
7829099|NCT00321711|27183611|P5|Part A|Protocol deviation|0
7829100|NCT00321711|27183612|P4|Part A|Protocol deviation|0
7829101|NCT00321711|27183613|P3|Part A|Protocol deviation|1
7829102|NCT00321711|27183614|P2|Part A|Protocol deviation|0
7829103|NCT00321711|27183615|P1|Part A|Protocol deviation|0
7829104|NCT00321711|27183611|P5|Part A|Other|0
7829105|NCT00321711|27183612|P4|Part A|Other|0
7829106|NCT00321711|27183613|P3|Part A|Other|3
7829107|NCT00321711|27183614|P2|Part A|Other|2
7829108|NCT00321711|27183615|P1|Part A|Other|1
7829109|NCT00321711|27183611|P5|Part A|Physician Decision|0
7829110|NCT00321711|27183612|P4|Part A|Physician Decision|0
7829111|NCT00321711|27183613|P3|Part A|Physician Decision|3
7829112|NCT00321711|27183614|P2|Part A|Physician Decision|1
7829113|NCT00321711|27183615|P1|Part A|Physician Decision|0
7829114|NCT00321711|27183611|P5|Part A|Requirement for alternative therapy|0
7829115|NCT00321711|27183612|P4|Part A|Requirement for alternative therapy|0
7829116|NCT00321711|27183613|P3|Part A|Requirement for alternative therapy|1
7829117|NCT00321711|27183614|P2|Part A|Requirement for alternative therapy|2
7829118|NCT00321711|27183615|P1|Part A|Requirement for alternative therapy|0
7829119|NCT00321711|27183611|P5|Part A|Disease progression|0
7829120|NCT00321711|27183612|P4|Part A|Disease progression|0
7829121|NCT00321711|27183613|P3|Part A|Disease progression|0
7829122|NCT00321711|27183614|P2|Part A|Disease progression|1
7829123|NCT00321711|27183615|P1|Part A|Disease progression|0
7829124|NCT00321711|27183611|P5|Part A|Withdrawal by Subject|0
7829125|NCT00321711|27183612|P4|Part A|Withdrawal by Subject|0
7829126|NCT00321711|27183613|P3|Part A|Withdrawal by Subject|1
7829127|NCT00321711|27183614|P2|Part A|Withdrawal by Subject|1
7829128|NCT00321711|27183615|P1|Part A|Withdrawal by Subject|1
7829129|NCT00321711|27183611|P5|Part A|Adverse Event|0
7829130|NCT00321711|27183612|P4|Part A|Adverse Event|0
7829131|NCT00321711|27183613|P3|Part A|Adverse Event|2
7829132|NCT00321711|27183614|P2|Part A|Adverse Event|3
7829133|NCT00321711|27183615|P1|Part A|Adverse Event|3
7829134|NCT00321685|27183665|P1|Overall Study|Ineligible|2
7829135|NCT00321685|27183665|P1|Overall Study|Not start protocol therapy|2
7829136|NCT00321685|27183665|P1|Overall Study|Other|5
7829137|NCT00321685|27183665|P1|Overall Study|Complicating disese|1
7829138|NCT00321685|27183665|P1|Overall Study|Alternative therapy|1
7829139|NCT00321685|27183665|P1|Overall Study|Withdrawal by Subject|8
7829140|NCT00321685|27183665|P1|Overall Study|Death|2
7829141|NCT00321685|27183665|P1|Overall Study|Adverse Event|18
7829142|NCT00321672|27183677|P4|Overall Study|Extensive travel required for new job|0
7829143|NCT00321672|27183678|P3|Overall Study|Extensive travel required for new job|0
7829144|NCT00321672|27183679|P2|Overall Study|Extensive travel required for new job|1
7829145|NCT00321672|27183680|P1|Overall Study|Extensive travel required for new job|0
7829146|NCT00321672|27183677|P4|Overall Study|Diagnosis of testicular cancer|0
7829147|NCT00321672|27183678|P3|Overall Study|Diagnosis of testicular cancer|0
7829148|NCT00321672|27183679|P2|Overall Study|Diagnosis of testicular cancer|1
7829149|NCT00321672|27183680|P1|Overall Study|Diagnosis of testicular cancer|0
7829150|NCT00321672|27183677|P4|Overall Study|Protocol Violation|0
7829151|NCT00321672|27183678|P3|Overall Study|Protocol Violation|1
7829152|NCT00321672|27183679|P2|Overall Study|Protocol Violation|0
7829153|NCT00321672|27183680|P1|Overall Study|Protocol Violation|0
7829154|NCT00321672|27183677|P4|Overall Study|Moved out of state|0
7829155|NCT00321672|27183678|P3|Overall Study|Moved out of state|1
7829156|NCT00321672|27183679|P2|Overall Study|Moved out of state|1
7829157|NCT00321672|27183680|P1|Overall Study|Moved out of state|0
7829158|NCT00321672|27183677|P4|Overall Study|Incarcerated|0
7829159|NCT00321672|27183678|P3|Overall Study|Incarcerated|2
7829160|NCT00321672|27183679|P2|Overall Study|Incarcerated|0
7829161|NCT00321672|27183680|P1|Overall Study|Incarcerated|0
7829162|NCT00321672|27183677|P4|Overall Study|Too far to travel for visits|0
7829163|NCT00321672|27183678|P3|Overall Study|Too far to travel for visits|0
7829164|NCT00321672|27183679|P2|Overall Study|Too far to travel for visits|0
7829165|NCT00321672|27183680|P1|Overall Study|Too far to travel for visits|1
7829166|NCT00321672|27183677|P4|Overall Study|Death|0
7829167|NCT00321672|27183678|P3|Overall Study|Death|0
7829168|NCT00321672|27183679|P2|Overall Study|Death|0
7829169|NCT00321672|27183680|P1|Overall Study|Death|1
7829170|NCT00321672|27183677|P4|Overall Study|Lost to Follow-up|2
7829171|NCT00321672|27183678|P3|Overall Study|Lost to Follow-up|4
7829172|NCT00321672|27183679|P2|Overall Study|Lost to Follow-up|0
7829173|NCT00321672|27183680|P1|Overall Study|Lost to Follow-up|2
7829174|NCT00321672|27183677|P4|Overall Study|Lack of Efficacy|0
7829175|NCT00321672|27183678|P3|Overall Study|Lack of Efficacy|0
7829176|NCT00321672|27183679|P2|Overall Study|Lack of Efficacy|1
7829177|NCT00321672|27183680|P1|Overall Study|Lack of Efficacy|1
7829178|NCT00321672|27183677|P4|Overall Study|Adverse Event|0
7829179|NCT00321672|27183678|P3|Overall Study|Adverse Event|0
7829180|NCT00321672|27183679|P2|Overall Study|Adverse Event|1
7829181|NCT00321672|27183680|P1|Overall Study|Adverse Event|1
7829182|NCT00321672|27183677|P4|Overall Study|Noncompliance|0
7829183|NCT00321672|27183678|P3|Overall Study|Noncompliance|1
7829184|NCT00321672|27183679|P2|Overall Study|Noncompliance|2
7829185|NCT00321672|27183680|P1|Overall Study|Noncompliance|1
7829186|NCT00321672|27183677|P4|Overall Study|Withdrawal by Subject|0
7829187|NCT00321672|27183678|P3|Overall Study|Withdrawal by Subject|2
7829188|NCT00321672|27183679|P2|Overall Study|Withdrawal by Subject|1
7829189|NCT00321672|27183680|P1|Overall Study|Withdrawal by Subject|5
7829190|NCT00321646|27183706|P1|Neoadjuvant Chemotherapy|Disease progression|1
7829191|NCT00321646|27183706|P1|Neoadjuvant Chemotherapy|Adverse Event|2
7829192|NCT00321646|27183706|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7829193|NCT00321620|27183713|P2|Overall Study|Other|33
7829194|NCT00321620|27183714|P1|Overall Study|Other|42
7829195|NCT00321620|27183713|P2|Overall Study|Participant request|52
7829196|NCT00321620|27183714|P1|Overall Study|Participant request|75
7829197|NCT00321620|27183713|P2|Overall Study|Ineligibility determined|3
7829198|NCT00321620|27183714|P1|Overall Study|Ineligibility determined|2
7829199|NCT00321620|27183713|P2|Overall Study|Protocol deviation|3
7829200|NCT00321620|27183714|P1|Overall Study|Protocol deviation|4
7829201|NCT00321620|27183713|P2|Overall Study|Noncompliance|7
7829202|NCT00321620|27183714|P1|Overall Study|Noncompliance|14
7829203|NCT00321620|27183713|P2|Overall Study|Physician Decision|1
7829204|NCT00321620|27183714|P1|Overall Study|Physician Decision|4
7829205|NCT00321620|27183713|P2|Overall Study|Lost to Follow-up|9
7829206|NCT00321620|27183714|P1|Overall Study|Lost to Follow-up|13
7829207|NCT00321620|27183713|P2|Overall Study|Adverse Event|56
7829208|NCT00321620|27183714|P1|Overall Study|Adverse Event|43
7829209|NCT00321620|27183713|P2|Overall Study|Disease progression|117
7829210|NCT00321620|27183714|P1|Overall Study|Disease progression|113
7829211|NCT00321620|27183713|P2|Overall Study|Withdrawal by Subject|147
7829212|NCT00321620|27183714|P1|Overall Study|Withdrawal by Subject|164
7829213|NCT00321620|27183713|P2|Overall Study|Death|294
7829214|NCT00321620|27183714|P1|Overall Study|Death|269
7829215|NCT00321555|27183742|P1|Overall Study|Disease progression on study|1
7829216|NCT00321555|27183742|P1|Overall Study|Physician Decision|1
7829217|NCT00321555|27183742|P1|Overall Study|Switched to alternative treatment|3
7829218|NCT00321555|27183742|P1|Overall Study|Developed antibodies|1
7829219|NCT00321464|27183750|P2|Overall Study|Other|18
7829220|NCT00321464|27183751|P1|Overall Study|Other|21
7829221|NCT00321464|27183750|P2|Overall Study|Ineligibility determined|1
7829222|NCT00321464|27183751|P1|Overall Study|Ineligibility determined|2
7829223|NCT00321464|27183750|P2|Overall Study|Protocol deviation|2
7829224|NCT00321464|27183751|P1|Overall Study|Protocol deviation|0
7829225|NCT00321464|27183750|P2|Overall Study|Lost to Follow-up|8
7829226|NCT00321464|27183751|P1|Overall Study|Lost to Follow-up|7
7829227|NCT00321464|27183750|P2|Overall Study|Noncompliance|10
7829228|NCT00321464|27183751|P1|Overall Study|Noncompliance|4
7829229|NCT00321464|27183750|P2|Overall Study|Physician Decision|14
7829230|NCT00321464|27183751|P1|Overall Study|Physician Decision|15
7829231|NCT00321464|27183750|P2|Overall Study|Adverse Event|28
7829232|NCT00321464|27183751|P1|Overall Study|Adverse Event|43
7829233|NCT00321464|27183750|P2|Overall Study|Participant request|61
7829234|NCT00321464|27183751|P1|Overall Study|Participant request|57
7829235|NCT00321464|27183750|P2|Overall Study|Withdrawal by Subject|118
7829236|NCT00321464|27183751|P1|Overall Study|Withdrawal by Subject|117
7829237|NCT00321464|27183750|P2|Overall Study|Disease progression|124
7829238|NCT00321464|27183751|P1|Overall Study|Disease progression|124
7829239|NCT00321464|27183750|P2|Overall Study|Death|174
7829240|NCT00321464|27183751|P1|Overall Study|Death|169
7829241|NCT00321373|27183764|P3|Overall Study|Other|1
7829242|NCT00321373|27183765|P2|Overall Study|Other|0
7829243|NCT00321373|27183766|P1|Overall Study|Other|0
7829244|NCT00321373|27183764|P3|Overall Study|Withdrawal by Subject|0
7829245|NCT00321373|27183765|P2|Overall Study|Withdrawal by Subject|0
7829246|NCT00321373|27183766|P1|Overall Study|Withdrawal by Subject|1
7829247|NCT00321373|27183764|P3|Overall Study|Lost to Follow-up|1
7829248|NCT00321373|27183765|P2|Overall Study|Lost to Follow-up|0
7829249|NCT00321373|27183766|P1|Overall Study|Lost to Follow-up|1
7829250|NCT00321373|27183764|P3|Overall Study|Adverse Event|1
7829251|NCT00321373|27183765|P2|Overall Study|Adverse Event|0
7829252|NCT00321373|27183766|P1|Overall Study|Adverse Event|0
7829253|NCT00321048|27183806|P2|Overall Study|Withdrawal by Subject|8
7829254|NCT00321048|27183807|P1|Overall Study|Withdrawal by Subject|6
7829255|NCT00320801|27183819|P4|Extension Phase|Lost to Follow-up|3
7829256|NCT00320801|27183820|P3|Extension Phase|Lost to Follow-up|0
7829257|NCT00320801|27183821|P2|Extension Phase|Lost to Follow-up|0
7829258|NCT00320801|27183822|P1|Extension Phase|Lost to Follow-up|0
7829259|NCT00320801|27183819|P4|Extension Phase|Lack of Efficacy|2
7829260|NCT00320801|27183820|P3|Extension Phase|Lack of Efficacy|0
7829261|NCT00320801|27183821|P2|Extension Phase|Lack of Efficacy|0
7829262|NCT00320801|27183822|P1|Extension Phase|Lack of Efficacy|0
7829263|NCT00320801|27183819|P4|Extension Phase|Administrative|29
7829264|NCT00320801|27183820|P3|Extension Phase|Administrative|0
7829265|NCT00320801|27183821|P2|Extension Phase|Administrative|0
7829266|NCT00320801|27183822|P1|Extension Phase|Administrative|0
7829267|NCT00320801|27183819|P4|Extension Phase|Adverse Event|8
7829268|NCT00320801|27183820|P3|Extension Phase|Adverse Event|0
7829269|NCT00320801|27183821|P2|Extension Phase|Adverse Event|0
7829270|NCT00320801|27183822|P1|Extension Phase|Adverse Event|0
7829271|NCT00320801|27183819|P4|Extension Phase|Withdrawal by Subject|6
7829272|NCT00320801|27183820|P3|Extension Phase|Withdrawal by Subject|0
7829273|NCT00320801|27183821|P2|Extension Phase|Withdrawal by Subject|0
7829274|NCT00320801|27183822|P1|Extension Phase|Withdrawal by Subject|0
7829275|NCT00320801|27183819|P4|Double-blind Phase|Lack of Efficacy|0
7829276|NCT00320801|27183820|P3|Double-blind Phase|Lack of Efficacy|1
7829277|NCT00320801|27183821|P2|Double-blind Phase|Lack of Efficacy|9
7829278|NCT00320801|27183822|P1|Double-blind Phase|Lack of Efficacy|0
7829279|NCT00320801|27183819|P4|Double-blind Phase|Administrative|0
7829280|NCT00320801|27183820|P3|Double-blind Phase|Administrative|4
7829281|NCT00320801|27183821|P2|Double-blind Phase|Administrative|0
7829282|NCT00320801|27183822|P1|Double-blind Phase|Administrative|0
7829283|NCT00320801|27183819|P4|Double-blind Phase|Adverse Event|0
7829284|NCT00320801|27183820|P3|Double-blind Phase|Adverse Event|8
7829285|NCT00320801|27183821|P2|Double-blind Phase|Adverse Event|2
7829286|NCT00320801|27183822|P1|Double-blind Phase|Adverse Event|0
7829287|NCT00320801|27183819|P4|Double-blind Phase|Withdrawal by Subject|0
7829288|NCT00320801|27183820|P3|Double-blind Phase|Withdrawal by Subject|1
7829289|NCT00320801|27183821|P2|Double-blind Phase|Withdrawal by Subject|0
7829290|NCT00320801|27183822|P1|Double-blind Phase|Withdrawal by Subject|0
7829291|NCT00320801|27183819|P4|Open-label Run-in Period|Did not qualify|0
7829292|NCT00320801|27183820|P3|Open-label Run-in Period|Did not qualify|0
7829293|NCT00320801|27183821|P2|Open-label Run-in Period|Did not qualify|0
7829294|NCT00320801|27183822|P1|Open-label Run-in Period|Did not qualify|1
7829295|NCT00320801|27183819|P4|Open-label Run-in Period|Lost to Follow-up|0
7829296|NCT00320801|27183820|P3|Open-label Run-in Period|Lost to Follow-up|0
7829297|NCT00320801|27183821|P2|Open-label Run-in Period|Lost to Follow-up|0
7829298|NCT00320801|27183822|P1|Open-label Run-in Period|Lost to Follow-up|2
7829299|NCT00320801|27183819|P4|Open-label Run-in Period|Lack of Efficacy|0
7829300|NCT00320801|27183820|P3|Open-label Run-in Period|Lack of Efficacy|0
7829301|NCT00320801|27183821|P2|Open-label Run-in Period|Lack of Efficacy|0
7829302|NCT00320801|27183822|P1|Open-label Run-in Period|Lack of Efficacy|44
7829303|NCT00320801|27183819|P4|Open-label Run-in Period|Administrative|0
7829304|NCT00320801|27183820|P3|Open-label Run-in Period|Administrative|0
7829305|NCT00320801|27183821|P2|Open-label Run-in Period|Administrative|0
7829306|NCT00320801|27183822|P1|Open-label Run-in Period|Administrative|10
7829307|NCT00320801|27183819|P4|Open-label Run-in Period|Adverse Event|0
7829308|NCT00320801|27183820|P3|Open-label Run-in Period|Adverse Event|0
7829309|NCT00320801|27183821|P2|Open-label Run-in Period|Adverse Event|0
7829310|NCT00320801|27183822|P1|Open-label Run-in Period|Adverse Event|33
7829311|NCT00320801|27183819|P4|Open-label Run-in Period|Withdrawal by Subject|0
7829312|NCT00320801|27183820|P3|Open-label Run-in Period|Withdrawal by Subject|0
7829313|NCT00320801|27183821|P2|Open-label Run-in Period|Withdrawal by Subject|0
7829314|NCT00320801|27183822|P1|Open-label Run-in Period|Withdrawal by Subject|2
7829315|NCT00320788|27183837|P5|Overall Study|Withdrawal by Subject|1
7829316|NCT00320788|27183838|P4|Overall Study|Withdrawal by Subject|3
7829317|NCT00320788|27183839|P3|Overall Study|Withdrawal by Subject|0
7829318|NCT00320788|27183840|P2|Overall Study|Withdrawal by Subject|0
7829319|NCT00320788|27183841|P1|Overall Study|Withdrawal by Subject|3
7829320|NCT00320788|27183837|P5|Overall Study|Protocol Violation|1
7829321|NCT00320788|27183838|P4|Overall Study|Protocol Violation|0
7829322|NCT00320788|27183839|P3|Overall Study|Protocol Violation|0
7829323|NCT00320788|27183840|P2|Overall Study|Protocol Violation|0
7829324|NCT00320788|27183841|P1|Overall Study|Protocol Violation|0
7829325|NCT00320788|27183837|P5|Overall Study|Physician Decision|0
7829326|NCT00320788|27183838|P4|Overall Study|Physician Decision|0
7829327|NCT00320788|27183839|P3|Overall Study|Physician Decision|0
7829328|NCT00320788|27183840|P2|Overall Study|Physician Decision|1
7829329|NCT00320788|27183841|P1|Overall Study|Physician Decision|1
7829330|NCT00320788|27183837|P5|Overall Study|Other|1
7829331|NCT00320788|27183838|P4|Overall Study|Other|1
7829332|NCT00320788|27183839|P3|Overall Study|Other|1
7829333|NCT00320788|27183840|P2|Overall Study|Other|2
7829334|NCT00320788|27183841|P1|Overall Study|Other|1
7829335|NCT00320788|27183837|P5|Overall Study|Decision by the Sponsor|1
7829336|NCT00320788|27183838|P4|Overall Study|Decision by the Sponsor|0
7829337|NCT00320788|27183839|P3|Overall Study|Decision by the Sponsor|0
7829338|NCT00320788|27183840|P2|Overall Study|Decision by the Sponsor|1
7829339|NCT00320788|27183841|P1|Overall Study|Decision by the Sponsor|1
7829340|NCT00320788|27183837|P5|Overall Study|Lost to Follow-up|0
7829341|NCT00320788|27183838|P4|Overall Study|Lost to Follow-up|0
7829342|NCT00320788|27183839|P3|Overall Study|Lost to Follow-up|1
7829343|NCT00320788|27183840|P2|Overall Study|Lost to Follow-up|2
7829344|NCT00320788|27183841|P1|Overall Study|Lost to Follow-up|0
7829345|NCT00320788|27183837|P5|Overall Study|Death|1
7829346|NCT00320788|27183838|P4|Overall Study|Death|0
7829347|NCT00320788|27183839|P3|Overall Study|Death|1
7829348|NCT00320788|27183840|P2|Overall Study|Death|0
7829349|NCT00320788|27183841|P1|Overall Study|Death|0
7829350|NCT00320788|27183837|P5|Overall Study|Adverse Event|0
7829351|NCT00320788|27183838|P4|Overall Study|Adverse Event|1
7829352|NCT00320788|27183839|P3|Overall Study|Adverse Event|0
7829353|NCT00320788|27183840|P2|Overall Study|Adverse Event|0
7829354|NCT00320788|27183841|P1|Overall Study|Adverse Event|0
7829355|NCT00320710|27183895|P3|Overall Study|Lost to Follow-up|0
7829356|NCT00320710|27183896|P2|Overall Study|Lost to Follow-up|0
7829357|NCT00320710|27183897|P1|Overall Study|Lost to Follow-up|1
7829358|NCT00320710|27183895|P3|Overall Study|Adverse Event|1
7829359|NCT00320710|27183896|P2|Overall Study|Adverse Event|14
7829360|NCT00320710|27183897|P1|Overall Study|Adverse Event|18
7829361|NCT00320710|27183895|P3|Overall Study|Abnormal laboratory value(s)|0
7829362|NCT00320710|27183896|P2|Overall Study|Abnormal laboratory value(s)|3
7829363|NCT00320710|27183897|P1|Overall Study|Abnormal laboratory value(s)|12
7829364|NCT00320710|27183895|P3|Overall Study|Abnormal test procedure result(s)|0
7829365|NCT00320710|27183896|P2|Overall Study|Abnormal test procedure result(s)|0
7829366|NCT00320710|27183897|P1|Overall Study|Abnormal test procedure result(s)|2
7829367|NCT00320710|27183895|P3|Overall Study|Protocol Violation|0
7829368|NCT00320710|27183896|P2|Overall Study|Protocol Violation|5
7829369|NCT00320710|27183897|P1|Overall Study|Protocol Violation|6
7829370|NCT00320710|27183895|P3|Overall Study|Withdrawal by Subject|1
7829371|NCT00320710|27183896|P2|Overall Study|Withdrawal by Subject|26
7829372|NCT00320710|27183897|P1|Overall Study|Withdrawal by Subject|20
7829373|NCT00320710|27183895|P3|Overall Study|Administrative problems|0
7829374|NCT00320710|27183896|P2|Overall Study|Administrative problems|2
7829375|NCT00320710|27183897|P1|Overall Study|Administrative problems|1
7829376|NCT00320710|27183895|P3|Overall Study|Death|1
7829377|NCT00320710|27183896|P2|Overall Study|Death|7
7829378|NCT00320710|27183897|P1|Overall Study|Death|10
7829379|NCT00320710|27183895|P3|Overall Study|Disease progression|2
7829380|NCT00320710|27183896|P2|Overall Study|Disease progression|19
7829381|NCT00320710|27183897|P1|Overall Study|Disease progression|24
7829382|NCT00320606|27183927|P1|Overall Study|Withdrawal by Subject|1
7829383|NCT00320606|27183927|P1|Overall Study|Protocol Violation|1
7829384|NCT00320606|27183927|P1|Overall Study|Adverse Event|1
7829385|NCT00320593|27183943|P2|Overall Study|Withdrawal by clinical center|0
7829386|NCT00320593|27183944|P1|Overall Study|Withdrawal by clinical center|1
7829387|NCT00320593|27183943|P2|Overall Study|Withdrawal by Subject|1
7829388|NCT00320593|27183944|P1|Overall Study|Withdrawal by Subject|2
7829389|NCT00320593|27183943|P2|Overall Study|Moved to another state|0
7829390|NCT00320593|27183944|P1|Overall Study|Moved to another state|1
7829391|NCT00320593|27183943|P2|Overall Study|Lost to Follow-up|0
7829392|NCT00320593|27183944|P1|Overall Study|Lost to Follow-up|3
7829393|NCT00320541|27183968|P2|Overall Study|Protocol Entry Criterion Not Met|0
7829394|NCT00320541|27183969|P1|Overall Study|Protocol Entry Criterion Not Met|1
7829395|NCT00320541|27183968|P2|Overall Study|Death due to Adverse Event(s)|0
7829396|NCT00320541|27183969|P1|Overall Study|Death due to Adverse Event(s)|1
7829397|NCT00320541|27183968|P2|Overall Study|Death due to Study Disease|3
7829398|NCT00320541|27183969|P1|Overall Study|Death due to Study Disease|1
7829399|NCT00320541|27183968|P2|Overall Study|Sponsor Decision|1
7829400|NCT00320541|27183969|P1|Overall Study|Sponsor Decision|2
7829401|NCT00320541|27183968|P2|Overall Study|Other|4
7829402|NCT00320541|27183969|P1|Overall Study|Other|3
7829403|NCT00320541|27183968|P2|Overall Study|Physician Decision|13
7829404|NCT00320541|27183969|P1|Overall Study|Physician Decision|9
7829405|NCT00320541|27183968|P2|Overall Study|Withdrawal by Subject|16
7829406|NCT00320541|27183969|P1|Overall Study|Withdrawal by Subject|12
7829407|NCT00320541|27183968|P2|Overall Study|Protocol Violation|1
7829408|NCT00320541|27183969|P1|Overall Study|Protocol Violation|0
7829409|NCT00320541|27183968|P2|Overall Study|Adverse Event|19
7829410|NCT00320541|27183969|P1|Overall Study|Adverse Event|21
7829411|NCT00320528|27183996|P3|Study Period III|Atomoxetine Commercially Available|90
7829412|NCT00320528|27183997|P2|Study Period III|Atomoxetine Commercially Available|25
7829413|NCT00320528|27183998|P1|Study Period III|Atomoxetine Commercially Available|68
7829414|NCT00320528|27183996|P3|Study Period III|Sponsor Decision|1
7829415|NCT00320528|27183997|P2|Study Period III|Sponsor Decision|0
7829416|NCT00320528|27183998|P1|Study Period III|Sponsor Decision|0
7829417|NCT00320528|27183996|P3|Study Period III|Physician Decision|2
7829418|NCT00320528|27183997|P2|Study Period III|Physician Decision|1
7829419|NCT00320528|27183998|P1|Study Period III|Physician Decision|0
7829420|NCT00320528|27183996|P3|Study Period III|Protocol Violation|0
7829421|NCT00320528|27183997|P2|Study Period III|Protocol Violation|1
7829422|NCT00320528|27183998|P1|Study Period III|Protocol Violation|0
7829423|NCT00320528|27183996|P3|Study Period III|Parent/Caregiver Decision|11
7829424|NCT00320528|27183997|P2|Study Period III|Parent/Caregiver Decision|3
7829425|NCT00320528|27183998|P1|Study Period III|Parent/Caregiver Decision|14
7829426|NCT00320528|27183996|P3|Study Period III|Lack of Efficacy|0
7829427|NCT00320528|27183997|P2|Study Period III|Lack of Efficacy|0
7829428|NCT00320528|27183998|P1|Study Period III|Lack of Efficacy|2
7829429|NCT00320528|27183996|P3|Study Period III|Withdrawal by Subject|2
7829430|NCT00320528|27183997|P2|Study Period III|Withdrawal by Subject|1
7829431|NCT00320528|27183998|P1|Study Period III|Withdrawal by Subject|1
7829432|NCT00320528|27183996|P3|Study Period III|Lost to Follow-up|0
7829433|NCT00320528|27183997|P2|Study Period III|Lost to Follow-up|0
7829434|NCT00320528|27183998|P1|Study Period III|Lost to Follow-up|1
7829435|NCT00320528|27183996|P3|Study Period III|Adverse Event|0
7829436|NCT00320528|27183997|P2|Study Period III|Adverse Event|0
7829437|NCT00320528|27183998|P1|Study Period III|Adverse Event|1
7829438|NCT00320528|27183996|P3|Study Period II|Entry Criteria Exclusion|2
7829439|NCT00320528|27183997|P2|Study Period II|Entry Criteria Exclusion|2
7829440|NCT00320528|27183998|P1|Study Period II|Entry Criteria Exclusion|0
7829441|NCT00320528|27183996|P3|Study Period II|Withdrawal by Subject|1
7829442|NCT00320528|27183997|P2|Study Period II|Withdrawal by Subject|1
7829443|NCT00320528|27183998|P1|Study Period II|Withdrawal by Subject|0
7829444|NCT00320528|27183996|P3|Study Period II|Parent/Caregiver Decision|11
7829445|NCT00320528|27183997|P2|Study Period II|Parent/Caregiver Decision|3
7829446|NCT00320528|27183998|P1|Study Period II|Parent/Caregiver Decision|8
7829447|NCT00320528|27183996|P3|Study Period II|Adverse Event|8
7829448|NCT00320528|27183997|P2|Study Period II|Adverse Event|4
7829449|NCT00320528|27183998|P1|Study Period II|Adverse Event|3
7829450|NCT00320515|27184033|P1|Overall Study|Withdrawal by Subject|8
7829451|NCT00320515|27184033|P1|Overall Study|Physician Decision|2
7829452|NCT00320515|27184033|P1|Overall Study|Lost to Follow-up|6
7829453|NCT00320515|27184033|P1|Overall Study|Death|33
7829454|NCT00320489|27184042|P2|Overall Study|Withdrawal by Subject|41
7829455|NCT00320489|27184043|P1|Overall Study|Withdrawal by Subject|39
7829456|NCT00320489|27184042|P2|Overall Study|Sponsor Decision|3
7829457|NCT00320489|27184043|P1|Overall Study|Sponsor Decision|3
7829458|NCT00320489|27184042|P2|Overall Study|Protocol Violation|4
7829459|NCT00320489|27184043|P1|Overall Study|Protocol Violation|4
7829460|NCT00320489|27184042|P2|Overall Study|Physician Decision|8
7829461|NCT00320489|27184043|P1|Overall Study|Physician Decision|8
7829462|NCT00320489|27184042|P2|Overall Study|Lost to Follow-up|22
7829463|NCT00320489|27184043|P1|Overall Study|Lost to Follow-up|21
7829464|NCT00320489|27184042|P2|Overall Study|Lack of Efficacy|7
7829465|NCT00320489|27184043|P1|Overall Study|Lack of Efficacy|16
7829466|NCT00320489|27184042|P2|Overall Study|Entry Criteria Exclusion|4
7829467|NCT00320489|27184043|P1|Overall Study|Entry Criteria Exclusion|2
7829468|NCT00320489|27184042|P2|Overall Study|Death|2
7829469|NCT00320489|27184043|P1|Overall Study|Death|0
7829470|NCT00320489|27184042|P2|Overall Study|Clinical Relapse|20
7829471|NCT00320489|27184043|P1|Overall Study|Clinical Relapse|26
7829472|NCT00320489|27184042|P2|Overall Study|Adverse Event|25
7829473|NCT00320489|27184043|P1|Overall Study|Adverse Event|26
7829474|NCT00320424|27184099|P1|Overall Study|Other|3
7829475|NCT00320424|27184099|P1|Overall Study|Adverse Event|3
7829476|NCT00320411|27184113|P1|Overall Study|No investigational product admin.|4
7829477|NCT00320398|27184136|P2|Overall Study|Other|0
7829478|NCT00320398|27184137|P1|Overall Study|Other|1
7829479|NCT00320398|27184136|P2|Overall Study|Adverse Event|4
7829480|NCT00320398|27184137|P1|Overall Study|Adverse Event|1
7829481|NCT00320385|27184165|P2|Overall Study|Adverse Event|1
7829482|NCT00320385|27184166|P1|Overall Study|Adverse Event|0
7829483|NCT00320385|27184165|P2|Overall Study|Withdrew Consent|0
7829484|NCT00320385|27184166|P1|Overall Study|Withdrew Consent|1
7829485|NCT00320385|27184165|P2|Overall Study|Serious Adverse Event|0
7829486|NCT00320385|27184166|P1|Overall Study|Serious Adverse Event|1
7829487|NCT00320385|27184165|P2|Overall Study|Death|2
7829488|NCT00320385|27184166|P1|Overall Study|Death|1
7829489|NCT00320385|27184165|P2|Overall Study|Investigator Decision|1
7829490|NCT00320385|27184166|P1|Overall Study|Investigator Decision|0
7829491|NCT00320385|27184165|P2|Overall Study|Sponsor Terminated Study|1
7829492|NCT00320385|27184166|P1|Overall Study|Sponsor Terminated Study|2
7829493|NCT00320385|27184165|P2|Overall Study|Withdrawal by Subject|7
7829494|NCT00320385|27184166|P1|Overall Study|Withdrawal by Subject|6
7829495|NCT00320385|27184165|P2|Overall Study|Lost to Follow-up|10
7829496|NCT00320385|27184166|P1|Overall Study|Lost to Follow-up|7
7829497|NCT00320372|27184189|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
7829498|NCT00320372|27184190|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
7829499|NCT00320372|27184189|P2|Overall Study|Did not Meet (I/E)|1
7829500|NCT00320372|27184190|P1|Overall Study|Did not Meet (I/E)|3
7829501|NCT00320372|27184189|P2|Overall Study|Non-Compliance|39
7829502|NCT00320372|27184190|P1|Overall Study|Non-Compliance|40
7829503|NCT00320372|27184189|P2|Overall Study|Withdrawal by Subject|37
7829504|NCT00320372|27184190|P1|Overall Study|Withdrawal by Subject|55
7829505|NCT00320372|27184189|P2|Overall Study|Death|8
7829506|NCT00320372|27184190|P1|Overall Study|Death|7
7829507|NCT00320372|27184189|P2|Overall Study|Physician Decision|7
7829508|NCT00320372|27184190|P1|Overall Study|Physician Decision|4
7829509|NCT00320255|27184232|P6|Overall Study|Other|0
7829510|NCT00320255|27184233|P5|Overall Study|Other|0
7829511|NCT00320255|27184234|P4|Overall Study|Other|0
7829512|NCT00320255|27184235|P3|Overall Study|Other|1
7829513|NCT00320255|27184236|P2|Overall Study|Other|2
7829514|NCT00320255|27184237|P1|Overall Study|Other|3
7829515|NCT00320255|27184232|P6|Overall Study|No longer meets study criteria|0
7829516|NCT00320255|27184233|P5|Overall Study|No longer meets study criteria|0
7829517|NCT00320255|27184234|P4|Overall Study|No longer meets study criteria|1
7829518|NCT00320255|27184235|P3|Overall Study|No longer meets study criteria|0
7829519|NCT00320255|27184236|P2|Overall Study|No longer meets study criteria|0
7829520|NCT00320255|27184237|P1|Overall Study|No longer meets study criteria|0
7829521|NCT00320255|27184232|P6|Overall Study|Poor compliance/noncompliance|0
7829522|NCT00320255|27184233|P5|Overall Study|Poor compliance/noncompliance|0
7829523|NCT00320255|27184234|P4|Overall Study|Poor compliance/noncompliance|1
7829524|NCT00320255|27184235|P3|Overall Study|Poor compliance/noncompliance|0
7829525|NCT00320255|27184236|P2|Overall Study|Poor compliance/noncompliance|1
7829526|NCT00320255|27184237|P1|Overall Study|Poor compliance/noncompliance|1
7829527|NCT00320255|27184232|P6|Overall Study|Withdrawal by Subject|0
7829528|NCT00320255|27184233|P5|Overall Study|Withdrawal by Subject|0
7829529|NCT00320255|27184234|P4|Overall Study|Withdrawal by Subject|4
7829530|NCT00320255|27184235|P3|Overall Study|Withdrawal by Subject|2
7829531|NCT00320255|27184236|P2|Overall Study|Withdrawal by Subject|2
7829532|NCT00320255|27184237|P1|Overall Study|Withdrawal by Subject|1
7829533|NCT00320255|27184232|P6|Overall Study|Adverse Event|0
7829534|NCT00320255|27184233|P5|Overall Study|Adverse Event|0
7829535|NCT00320255|27184234|P4|Overall Study|Adverse Event|2
7829536|NCT00320255|27184235|P3|Overall Study|Adverse Event|3
7829537|NCT00320255|27184236|P2|Overall Study|Adverse Event|2
7829538|NCT00320255|27184237|P1|Overall Study|Adverse Event|5
7829539|NCT00320255|27184232|P6|Overall Study|Lack of Efficacy|0
7829540|NCT00320255|27184233|P5|Overall Study|Lack of Efficacy|0
7829541|NCT00320255|27184234|P4|Overall Study|Lack of Efficacy|0
7829542|NCT00320255|27184235|P3|Overall Study|Lack of Efficacy|0
7829543|NCT00320255|27184236|P2|Overall Study|Lack of Efficacy|0
7829544|NCT00320255|27184237|P1|Overall Study|Lack of Efficacy|1
7829545|NCT00320216|27184330|P5|Overall Study|Other|3
7829546|NCT00320216|27184331|P4|Overall Study|Other|1
7829547|NCT00320216|27184332|P3|Overall Study|Other|5
7829548|NCT00320216|27184333|P2|Overall Study|Other|2
7829549|NCT00320216|27184334|P1|Overall Study|Other|7
7829550|NCT00320216|27184330|P5|Overall Study|Lost to Follow-up|0
7829551|NCT00320216|27184331|P4|Overall Study|Lost to Follow-up|0
7829552|NCT00320216|27184332|P3|Overall Study|Lost to Follow-up|0
7829553|NCT00320216|27184333|P2|Overall Study|Lost to Follow-up|0
7829554|NCT00320216|27184334|P1|Overall Study|Lost to Follow-up|3
7829555|NCT00320216|27184330|P5|Overall Study|Lack of Efficacy|1
7829556|NCT00320216|27184331|P4|Overall Study|Lack of Efficacy|0
7829557|NCT00320216|27184332|P3|Overall Study|Lack of Efficacy|1
7829558|NCT00320216|27184333|P2|Overall Study|Lack of Efficacy|2
7829559|NCT00320216|27184334|P1|Overall Study|Lack of Efficacy|6
7829560|NCT00320216|27184330|P5|Overall Study|Adverse Event|2
7829561|NCT00320216|27184331|P4|Overall Study|Adverse Event|2
7829562|NCT00320216|27184332|P3|Overall Study|Adverse Event|0
7829563|NCT00320216|27184333|P2|Overall Study|Adverse Event|6
7829564|NCT00320216|27184334|P1|Overall Study|Adverse Event|0
7829565|NCT00320190|27184368|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
7829566|NCT00320190|27184369|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
7829567|NCT00320190|27184368|P2|Long-term (12-month) Extension|Lack of major molecular response|2
7829568|NCT00320190|27184369|P1|Long-term (12-month) Extension|Lack of major molecular response|1
7829569|NCT00320190|27184368|P2|Long-term (12-month) Extension|Sponsor terminated study|0
7829570|NCT00320190|27184369|P1|Long-term (12-month) Extension|Sponsor terminated study|7
7829571|NCT00320190|27184368|P2|First 12 Months|Withdrawal by Subject|1
7829572|NCT00320190|27184369|P1|First 12 Months|Withdrawal by Subject|0
7829573|NCT00320190|27184368|P2|First 12 Months|Study drug toxicity|1
7829574|NCT00320190|27184369|P1|First 12 Months|Study drug toxicity|0
7829575|NCT00320190|27184368|P2|First 12 Months|Investigator request|1
7829576|NCT00320190|27184369|P1|First 12 Months|Investigator request|0
7829577|NCT00320190|27184368|P2|First 12 Months|Adverse event unrelated to study drug|0
7829578|NCT00320190|27184369|P1|First 12 Months|Adverse event unrelated to study drug|1
7829579|NCT00320190|27184368|P2|First 12 Months|Enrollment failure|1
7829580|NCT00320190|27184369|P1|First 12 Months|Enrollment failure|0
7829581|NCT00320190|27184368|P2|First 12 Months|Lost to Follow-up|1
7829582|NCT00320190|27184369|P1|First 12 Months|Lost to Follow-up|0
7829583|NCT00320190|27184368|P2|First 12 Months|Sponsor terminated study|2
7829584|NCT00320190|27184369|P1|First 12 Months|Sponsor terminated study|2
7829585|NCT00320190|27184368|P2|First 12 Months|Completed but did not enter extension|3
7829586|NCT00320190|27184369|P1|First 12 Months|Completed but did not enter extension|5
7829587|NCT00320112|27184389|P2|Overall Study|Death|1
7829588|NCT00320112|27184390|P1|Overall Study|Death|2
7829589|NCT00320112|27184389|P2|Overall Study|Withdrawal by Subject|0
7829590|NCT00320112|27184390|P1|Overall Study|Withdrawal by Subject|3
7829591|NCT00320112|27184389|P2|Overall Study|Lost to Follow-up|4
7829592|NCT00320112|27184390|P1|Overall Study|Lost to Follow-up|3
7829593|NCT00319982|27184404|P2|Overall Study|Withdrawal by Subject|0
7829594|NCT00319982|27184405|P1|Overall Study|Withdrawal by Subject|1
7829595|NCT00319956|27184425|P2|Overall Study|Death|24
7829596|NCT00319956|27184426|P1|Overall Study|Death|20
7829597|NCT00319839|27184438|P1|Overall Study|Withdrawal by Subject|1
7829598|NCT00319839|27184438|P1|Overall Study|Adverse Event|5
7829599|NCT00319735|27184454|P1|Overall Study|Death|2
7829600|NCT00319696|27184467|P1|Overall Study|Lost to Follow-up|3
7829601|NCT00319696|27184467|P1|Overall Study|administrative|7
7829602|NCT00319696|27184467|P1|Overall Study|withdrawal of consent|14
7829603|NCT00319696|27184467|P1|Overall Study|Adverse Event|36
7829604|NCT00319592|27184504|P2|Overall Study|Physician Decision|1
7829605|NCT00319592|27184505|P1|Overall Study|Physician Decision|0
7829606|NCT00319592|27184504|P2|Overall Study|Protocol Violation|0
7829607|NCT00319592|27184505|P1|Overall Study|Protocol Violation|1
7829608|NCT00319553|27184521|P2|Overall Study|Withdrawal by Subject|1
7829609|NCT00319553|27184522|P1|Overall Study|Withdrawal by Subject|1
7829610|NCT00319553|27184521|P2|Overall Study|Lost to Follow-up|1
7829611|NCT00319553|27184522|P1|Overall Study|Lost to Follow-up|2
7829612|NCT00319553|27184521|P2|Overall Study|Protocol Violation|2
7829613|NCT00319553|27184522|P1|Overall Study|Protocol Violation|1
7829614|NCT00319501|27184536|P2|Open-label Extension Period|Withdrawal by Subject|0
7829615|NCT00319501|27184537|P1|Open-label Extension Period|Withdrawal by Subject|2
7829616|NCT00319501|27184536|P2|Open-label Extension Period|Sponsor request|0
7829617|NCT00319501|27184537|P1|Open-label Extension Period|Sponsor request|26
7829618|NCT00319501|27184536|P2|Open-label Extension Period|Principal investigator decision|0
7829619|NCT00319501|27184537|P1|Open-label Extension Period|Principal investigator decision|2
7829620|NCT00319501|27184536|P2|Open-label Extension Period|Other|0
7829621|NCT00319501|27184537|P1|Open-label Extension Period|Other|1
7829622|NCT00319501|27184536|P2|Open-label Extension Period|Did not receive treatment|0
7829623|NCT00319501|27184537|P1|Open-label Extension Period|Did not receive treatment|18
7829624|NCT00319501|27184536|P2|Open-label Extension Period|Adverse Event|0
7829625|NCT00319501|27184537|P1|Open-label Extension Period|Adverse Event|2
7829626|NCT00319501|27184536|P2|Open-label Period|Other|0
7829627|NCT00319501|27184537|P1|Open-label Period|Other|11
7829628|NCT00319501|27184536|P2|Open-label Period|Did not receive treatment|0
7829629|NCT00319501|27184537|P1|Open-label Period|Did not receive treatment|33
7829630|NCT00319501|27184536|P2|Open-label Period|Lost to Follow-up|0
7829631|NCT00319501|27184537|P1|Open-label Period|Lost to Follow-up|5
7829632|NCT00319501|27184536|P2|Open-label Period|Sponsor request|0
7829633|NCT00319501|27184537|P1|Open-label Period|Sponsor request|12
7829634|NCT00319501|27184536|P2|Open-label Period|Principal Investigator decision|0
7829635|NCT00319501|27184537|P1|Open-label Period|Principal Investigator decision|6
7829636|NCT00319501|27184536|P2|Open-label Period|Withdrawal by Subject|0
7829637|NCT00319501|27184537|P1|Open-label Period|Withdrawal by Subject|38
7829638|NCT00319501|27184536|P2|Open-label Period|Protocol Violation|0
7829639|NCT00319501|27184537|P1|Open-label Period|Protocol Violation|6
7829640|NCT00319501|27184536|P2|Open-label Period|Adverse Event|0
7829641|NCT00319501|27184537|P1|Open-label Period|Adverse Event|5
7829642|NCT00319501|27184536|P2|Double-blind Period|Did not receive treatment|29
7829643|NCT00319501|27184537|P1|Double-blind Period|Did not receive treatment|42
7829644|NCT00319501|27184536|P2|Double-blind Period|Sponsor Request|0
7829645|NCT00319501|27184537|P1|Double-blind Period|Sponsor Request|1
7829646|NCT00319501|27184536|P2|Double-blind Period|Withdrawal by Subject|3
7829647|NCT00319501|27184537|P1|Double-blind Period|Withdrawal by Subject|0
7829648|NCT00319449|27184563|P2|Overall Study|Noncompliance with the protocol|0
7829649|NCT00319449|27184564|P1|Overall Study|Noncompliance with the protocol|1
7829650|NCT00319449|27184563|P2|Overall Study|Subject did not wish to continue|0
7829651|NCT00319449|27184564|P1|Overall Study|Subject did not wish to continue|1
7829652|NCT00319436|27184576|P2|Overall Study|Withdrawal by Subject|7
7829653|NCT00319436|27184577|P1|Overall Study|Withdrawal by Subject|6
7829654|NCT00319254|27184595|P1|Overall Study|Enrolled, Not Treated|2
7829655|NCT00319254|27184595|P1|Overall Study|Lost to Follow-up|2
7829656|NCT00319254|27184595|P1|Overall Study|Death|46
7829657|NCT00319254|27184595|P1|Overall Study|Withdrawal by Subject|4
7829658|NCT00319111|27184608|P1|Overall Study|Treatment failure|1
7829659|NCT00319111|27184608|P1|Overall Study|Administrative|2
7829660|NCT00319111|27184608|P1|Overall Study|Lack of clinical improvement|4
7829661|NCT00319111|27184608|P1|Overall Study|Death|9
7829662|NCT00319111|27184608|P1|Overall Study|Withdrawal of consent|11
7829663|NCT00319111|27184608|P1|Overall Study|Adverse Event|20
7829664|NCT00319098|27184622|P2|Overall Study|Protocol Violation|1
7829665|NCT00319098|27184623|P1|Overall Study|Protocol Violation|3
7829666|NCT00319098|27184622|P2|Overall Study|Others|8
7829667|NCT00319098|27184623|P1|Overall Study|Others|33
7829668|NCT00319098|27184622|P2|Overall Study|Lost to Follow-up|13
7829669|NCT00319098|27184623|P1|Overall Study|Lost to Follow-up|37
7829670|NCT00319098|27184622|P2|Overall Study|Migrated/moved from study area|1
7829671|NCT00319098|27184623|P1|Overall Study|Migrated/moved from study area|2
7829672|NCT00319098|27184622|P2|Overall Study|Withdrawal by Subject|8
7829673|NCT00319098|27184623|P1|Overall Study|Withdrawal by Subject|37
7829674|NCT00319098|27184622|P2|Overall Study|Adverse Event|1
7829675|NCT00319098|27184623|P1|Overall Study|Adverse Event|20
7829676|NCT00319098|27184622|P2|Overall Study|Serious adverse event|0
7829677|NCT00319098|27184623|P1|Overall Study|Serious adverse event|3
7829678|NCT00319046|27184681|P1|Overall Study|administrative reason|1
7829679|NCT00319046|27184681|P1|Overall Study|withdrawal of subject's consent|7
7829680|NCT00319020|27184690|P2|Overall Study|Adverse Event|1
7829681|NCT00319020|27184691|P1|Overall Study|Adverse Event|0
7829682|NCT00319020|27184690|P2|Overall Study|Treatment failure|1
7829683|NCT00319020|27184691|P1|Overall Study|Treatment failure|0
7829684|NCT00319020|27184690|P2|Overall Study|Transplant|1
7829685|NCT00319020|27184691|P1|Overall Study|Transplant|0
7829686|NCT00319020|27184690|P2|Overall Study|Disease progression|2
7829687|NCT00319020|27184691|P1|Overall Study|Disease progression|0
7829688|NCT00319020|27184690|P2|Overall Study|Administrative reason|5
7829689|NCT00319020|27184691|P1|Overall Study|Administrative reason|0
7829690|NCT00319020|27184690|P2|Overall Study|F-1 completed but not enrolled in F-2|0
7829691|NCT00319020|27184691|P1|Overall Study|F-1 completed but not enrolled in F-2|1
7829692|NCT00319020|27184690|P2|Overall Study|Withdrawal by Subject|1
7829693|NCT00319020|27184691|P1|Overall Study|Withdrawal by Subject|4
7829694|NCT00319020|27184690|P2|Overall Study|Death|2
7829695|NCT00319020|27184691|P1|Overall Study|Death|2
7829696|NCT00318656|27184763|P2|Overall Study|Did not receive any treatment|1
7829697|NCT00318656|27184764|P1|Overall Study|Did not receive any treatment|0
7829698|NCT00318656|27184763|P2|Overall Study|Took Avandamet instead of Glim/Met|1
7829699|NCT00318656|27184764|P1|Overall Study|Took Avandamet instead of Glim/Met|0
7829700|NCT00318565|27184821|P1|Overall Study|Excluded per protocol|24
7829701|NCT00318474|27184828|P2|Overall Study|Trial terminated|7
7829702|NCT00318474|27184829|P1|Overall Study|Trial terminated|10
7829703|NCT00318474|27184828|P2|Overall Study|Post-therapy hyperflycemia|1
7829704|NCT00318474|27184829|P1|Overall Study|Post-therapy hyperflycemia|0
7829705|NCT00318474|27184828|P2|Overall Study|Fall in GFR|3
7829706|NCT00318474|27184829|P1|Overall Study|Fall in GFR|3
7829707|NCT00318474|27184828|P2|Overall Study|Withdrawal by Subject|2
7829708|NCT00318474|27184829|P1|Overall Study|Withdrawal by Subject|3
7829709|NCT00318474|27184828|P2|Overall Study|Protocol Violation|0
7829710|NCT00318474|27184829|P1|Overall Study|Protocol Violation|1
7829711|NCT00318474|27184828|P2|Overall Study|Pregnancy|2
7829712|NCT00318474|27184829|P1|Overall Study|Pregnancy|0
7829713|NCT00318474|27184828|P2|Overall Study|Lost to Follow-up|1
7829714|NCT00318474|27184829|P1|Overall Study|Lost to Follow-up|0
7829715|NCT00318474|27184828|P2|Overall Study|Adverse Event|1
7829716|NCT00318474|27184829|P1|Overall Study|Adverse Event|1
7829717|NCT00318461|27184840|P5|Open-Label Extension, 18 Months|Protocol Violation|6
7829718|NCT00318461|27184841|P4|Open-Label Extension, 18 Months|Protocol Violation|4
7829719|NCT00318461|27184842|P3|Open-Label Extension, 18 Months|Protocol Violation|3
7829720|NCT00318461|27184843|P2|Open-Label Extension, 18 Months|Protocol Violation|5
7829721|NCT00318461|27184844|P1|Open-Label Extension, 18 Months|Protocol Violation|7
7829722|NCT00318461|27184840|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
7829723|NCT00318461|27184841|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
7829724|NCT00318461|27184842|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
7829725|NCT00318461|27184843|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
7829726|NCT00318461|27184844|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
7829727|NCT00318461|27184840|P5|Open-Label Extension, 18 Months|Adverse Event|6
7829728|NCT00318461|27184841|P4|Open-Label Extension, 18 Months|Adverse Event|1
7829729|NCT00318461|27184842|P3|Open-Label Extension, 18 Months|Adverse Event|6
7829730|NCT00318461|27184843|P2|Open-Label Extension, 18 Months|Adverse Event|8
7829731|NCT00318461|27184844|P1|Open-Label Extension, 18 Months|Adverse Event|11
7829732|NCT00318461|27184840|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
7829733|NCT00318461|27184841|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
7829734|NCT00318461|27184842|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
7829735|NCT00318461|27184843|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
7829736|NCT00318461|27184844|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
7829737|NCT00318461|27184840|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
7829738|NCT00318461|27184841|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
7829739|NCT00318461|27184842|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
7829740|NCT00318461|27184843|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
7829741|NCT00318461|27184844|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
7829742|NCT00318461|27184840|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
7829743|NCT00318461|27184841|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7829744|NCT00318461|27184842|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7829745|NCT00318461|27184843|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7829746|NCT00318461|27184844|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7829747|NCT00318461|27184840|P5|Double-Blind, 6 Months|Hyperglicaemia|0
7829748|NCT00318461|27184841|P4|Double-Blind, 6 Months|Hyperglicaemia|1
7829749|NCT00318461|27184842|P3|Double-Blind, 6 Months|Hyperglicaemia|0
7829750|NCT00318461|27184843|P2|Double-Blind, 6 Months|Hyperglicaemia|0
7829751|NCT00318461|27184844|P1|Double-Blind, 6 Months|Hyperglicaemia|0
7829752|NCT00318461|27184840|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
7829753|NCT00318461|27184841|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7829754|NCT00318461|27184842|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7829755|NCT00318461|27184843|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7829756|NCT00318461|27184844|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7829757|NCT00318461|27184840|P5|Double-Blind, 6 Months|Lack of time|0
7829758|NCT00318461|27184841|P4|Double-Blind, 6 Months|Lack of time|0
7829759|NCT00318461|27184842|P3|Double-Blind, 6 Months|Lack of time|0
7829760|NCT00318461|27184843|P2|Double-Blind, 6 Months|Lack of time|0
7829761|NCT00318461|27184844|P1|Double-Blind, 6 Months|Lack of time|1
7829762|NCT00318461|27184840|P5|Double-Blind, 6 Months|Investigator decision|1
7829763|NCT00318461|27184841|P4|Double-Blind, 6 Months|Investigator decision|0
7829764|NCT00318461|27184842|P3|Double-Blind, 6 Months|Investigator decision|0
7829765|NCT00318461|27184843|P2|Double-Blind, 6 Months|Investigator decision|0
7829766|NCT00318461|27184844|P1|Double-Blind, 6 Months|Investigator decision|0
7829767|NCT00318461|27184840|P5|Double-Blind, 6 Months|Work commitment|1
7829768|NCT00318461|27184841|P4|Double-Blind, 6 Months|Work commitment|0
7829769|NCT00318461|27184842|P3|Double-Blind, 6 Months|Work commitment|0
7829770|NCT00318461|27184843|P2|Double-Blind, 6 Months|Work commitment|0
7829771|NCT00318461|27184844|P1|Double-Blind, 6 Months|Work commitment|0
7829772|NCT00318461|27184840|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7829773|NCT00318461|27184841|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
7829774|NCT00318461|27184842|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7829775|NCT00318461|27184843|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7829776|NCT00318461|27184844|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
7829777|NCT00318461|27184840|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
7829778|NCT00318461|27184841|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7829779|NCT00318461|27184842|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7829780|NCT00318461|27184843|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7829781|NCT00318461|27184844|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7829782|NCT00318461|27184840|P5|Double-Blind, 6 Months|Move|0
7829783|NCT00318461|27184841|P4|Double-Blind, 6 Months|Move|0
7829784|NCT00318461|27184842|P3|Double-Blind, 6 Months|Move|0
7829785|NCT00318461|27184843|P2|Double-Blind, 6 Months|Move|1
7829786|NCT00318461|27184844|P1|Double-Blind, 6 Months|Move|0
7829787|NCT00318461|27184840|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
7829788|NCT00318461|27184841|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
7829789|NCT00318461|27184842|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
7829790|NCT00318461|27184843|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
7829791|NCT00318461|27184844|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
7829792|NCT00318461|27184840|P5|Double-Blind, 6 Months|Consent withdrawn|4
7829793|NCT00318461|27184841|P4|Double-Blind, 6 Months|Consent withdrawn|10
7829794|NCT00318461|27184842|P3|Double-Blind, 6 Months|Consent withdrawn|4
7829795|NCT00318461|27184843|P2|Double-Blind, 6 Months|Consent withdrawn|3
7829796|NCT00318461|27184844|P1|Double-Blind, 6 Months|Consent withdrawn|0
7829797|NCT00318461|27184840|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7829798|NCT00318461|27184841|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7829799|NCT00318461|27184842|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7829800|NCT00318461|27184843|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
7829801|NCT00318461|27184844|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7829802|NCT00318461|27184840|P5|Double-Blind, 6 Months|Lost to follow up|0
7829803|NCT00318461|27184841|P4|Double-Blind, 6 Months|Lost to follow up|0
7829804|NCT00318461|27184842|P3|Double-Blind, 6 Months|Lost to follow up|0
7829805|NCT00318461|27184843|P2|Double-Blind, 6 Months|Lost to follow up|1
7829806|NCT00318461|27184844|P1|Double-Blind, 6 Months|Lost to follow up|0
7829807|NCT00318461|27184840|P5|Double-Blind, 6 Months|Protocol Violation|5
7829808|NCT00318461|27184841|P4|Double-Blind, 6 Months|Protocol Violation|4
7829809|NCT00318461|27184842|P3|Double-Blind, 6 Months|Protocol Violation|4
7829810|NCT00318461|27184843|P2|Double-Blind, 6 Months|Protocol Violation|4
7829811|NCT00318461|27184844|P1|Double-Blind, 6 Months|Protocol Violation|2
7829812|NCT00318461|27184840|P5|Double-Blind, 6 Months|Lack of Efficacy|9
7829813|NCT00318461|27184841|P4|Double-Blind, 6 Months|Lack of Efficacy|29
7829814|NCT00318461|27184842|P3|Double-Blind, 6 Months|Lack of Efficacy|13
7829815|NCT00318461|27184843|P2|Double-Blind, 6 Months|Lack of Efficacy|8
7829816|NCT00318461|27184844|P1|Double-Blind, 6 Months|Lack of Efficacy|19
7829817|NCT00318461|27184840|P5|Double-Blind, 6 Months|Adverse Event|8
7829818|NCT00318461|27184841|P4|Double-Blind, 6 Months|Adverse Event|2
7829819|NCT00318461|27184842|P3|Double-Blind, 6 Months|Adverse Event|29
7829820|NCT00318461|27184843|P2|Double-Blind, 6 Months|Adverse Event|23
7829821|NCT00318461|27184844|P1|Double-Blind, 6 Months|Adverse Event|11
7829822|NCT00318370|27184943|P3|Period 3|Other|3
7829823|NCT00318370|27184944|P2|Period 3|Other|0
7829824|NCT00318370|27184945|P1|Period 3|Other|0
7829825|NCT00318370|27184943|P3|Period 3|Withdrawal by Subject|3
7829826|NCT00318370|27184944|P2|Period 3|Withdrawal by Subject|0
7829827|NCT00318370|27184945|P1|Period 3|Withdrawal by Subject|0
7829828|NCT00318370|27184943|P3|Period 3|Physician Decision|1
7829829|NCT00318370|27184944|P2|Period 3|Physician Decision|0
7829830|NCT00318370|27184945|P1|Period 3|Physician Decision|0
7829831|NCT00318370|27184943|P3|Period 3|Death|1
7829832|NCT00318370|27184944|P2|Period 3|Death|0
7829833|NCT00318370|27184945|P1|Period 3|Death|0
7829834|NCT00318370|27184943|P3|Period 3|Lack of Efficacy|24
7829835|NCT00318370|27184944|P2|Period 3|Lack of Efficacy|0
7829836|NCT00318370|27184945|P1|Period 3|Lack of Efficacy|0
7829837|NCT00318370|27184943|P3|Period 3|Adverse Event|1
7829838|NCT00318370|27184944|P2|Period 3|Adverse Event|0
7829839|NCT00318370|27184945|P1|Period 3|Adverse Event|0
7829840|NCT00318370|27184943|P3|Period 2|Other|0
7829841|NCT00318370|27184944|P2|Period 2|Other|1
7829842|NCT00318370|27184945|P1|Period 2|Other|0
7829843|NCT00318370|27184943|P3|Period 2|Withdrawal by Subject|0
7829844|NCT00318370|27184944|P2|Period 2|Withdrawal by Subject|1
7829845|NCT00318370|27184945|P1|Period 2|Withdrawal by Subject|0
7829846|NCT00318370|27184943|P3|Period 2|Physician Decision|0
7829847|NCT00318370|27184944|P2|Period 2|Physician Decision|1
7829848|NCT00318370|27184945|P1|Period 2|Physician Decision|0
7829849|NCT00318370|27184943|P3|Period 2|Lack of Efficacy|0
7829850|NCT00318370|27184944|P2|Period 2|Lack of Efficacy|5
7829851|NCT00318370|27184945|P1|Period 2|Lack of Efficacy|0
7829852|NCT00318370|27184943|P3|Period 2|Adverse Event|0
7829853|NCT00318370|27184944|P2|Period 2|Adverse Event|3
7829854|NCT00318370|27184945|P1|Period 2|Adverse Event|0
7829855|NCT00318370|27184943|P3|Period 1|Withdrawal by Subject|0
7829856|NCT00318370|27184944|P2|Period 1|Withdrawal by Subject|0
7829857|NCT00318370|27184945|P1|Period 1|Withdrawal by Subject|1
7829858|NCT00318370|27184943|P3|Period 1|Physician Decision|0
7829859|NCT00318370|27184944|P2|Period 1|Physician Decision|0
7829860|NCT00318370|27184945|P1|Period 1|Physician Decision|1
7829861|NCT00318370|27184943|P3|Period 1|Lack of Efficacy|0
7829862|NCT00318370|27184944|P2|Period 1|Lack of Efficacy|0
7829863|NCT00318370|27184945|P1|Period 1|Lack of Efficacy|5
7829864|NCT00318149|27184979|P6|Overall Study|Adverse Event|2
7829865|NCT00318149|27184980|P5|Overall Study|Adverse Event|0
7829866|NCT00318149|27184981|P4|Overall Study|Adverse Event|0
7829867|NCT00318149|27184982|P3|Overall Study|Adverse Event|0
7829868|NCT00318149|27184983|P2|Overall Study|Adverse Event|0
7829869|NCT00318149|27184984|P1|Overall Study|Adverse Event|0
7829870|NCT00317642|27185130|P2|Overall Study|AML Not Centrally Confirmed|5
7829871|NCT00317642|27185131|P1|Overall Study|AML Not Centrally Confirmed|1
7829872|NCT00317642|27185130|P2|Overall Study|Referred For Transplantation|0
7829873|NCT00317642|27185131|P1|Overall Study|Referred For Transplantation|1
7829874|NCT00317642|27185130|P2|Overall Study|Withdrawal by Subject|1
7829875|NCT00317642|27185131|P1|Overall Study|Withdrawal by Subject|0
7829876|NCT00317642|27185130|P2|Overall Study|Not Continue to Consolidation|0
7829877|NCT00317642|27185131|P1|Overall Study|Not Continue to Consolidation|2
7829878|NCT00317642|27185130|P2|Overall Study|Death|7
7829879|NCT00317642|27185131|P1|Overall Study|Death|14
7829880|NCT00317642|27185130|P2|Overall Study|Disease Recurrence|2
7829881|NCT00317642|27185131|P1|Overall Study|Disease Recurrence|1
7829882|NCT00317642|27185130|P2|Overall Study|Treatment Failure|102
7829883|NCT00317642|27185131|P1|Overall Study|Treatment Failure|56
7829884|NCT00317642|27185130|P2|Overall Study|Adverse Event|5
7829885|NCT00317642|27185131|P1|Overall Study|Adverse Event|17
7829886|NCT00317642|27185130|P2|Overall Study|Participant declined treatment|3
7829887|NCT00317642|27185131|P1|Overall Study|Participant declined treatment|14
7829888|NCT00317642|27185130|P2|Overall Study|Physician Decision|7
7829889|NCT00317642|27185131|P1|Overall Study|Physician Decision|15
7829890|NCT00317642|27185130|P2|Overall Study|Not Received Either Study Drug|3
7829891|NCT00317642|27185131|P1|Overall Study|Not Received Either Study Drug|1
7829892|NCT00317603|27185204|P1|Overall Study|Progressive Disease|3
7829893|NCT00317473|27185216|P6|Overall Study|Other|0
7829894|NCT00317473|27185217|P5|Overall Study|Other|0
7829895|NCT00317473|27185218|P4|Overall Study|Other|0
7829896|NCT00317473|27185219|P3|Overall Study|Other|0
7829897|NCT00317473|27185220|P2|Overall Study|Other|2
7829898|NCT00317473|27185221|P1|Overall Study|Other|0
7829899|NCT00317473|27185216|P6|Overall Study|Death|0
7829900|NCT00317473|27185217|P5|Overall Study|Death|0
7829901|NCT00317473|27185218|P4|Overall Study|Death|0
7829902|NCT00317473|27185219|P3|Overall Study|Death|0
7829903|NCT00317473|27185220|P2|Overall Study|Death|0
7829904|NCT00317473|27185221|P1|Overall Study|Death|1
7829905|NCT00317473|27185216|P6|Overall Study|Relocation|2
7829906|NCT00317473|27185217|P5|Overall Study|Relocation|5
7829907|NCT00317473|27185218|P4|Overall Study|Relocation|1
7829908|NCT00317473|27185219|P3|Overall Study|Relocation|1
7829909|NCT00317473|27185220|P2|Overall Study|Relocation|0
7829910|NCT00317473|27185221|P1|Overall Study|Relocation|1
7829911|NCT00317473|27185216|P6|Overall Study|Withdrawal by Subject|1
7829912|NCT00317473|27185217|P5|Overall Study|Withdrawal by Subject|3
7829913|NCT00317473|27185218|P4|Overall Study|Withdrawal by Subject|1
7829914|NCT00317473|27185219|P3|Overall Study|Withdrawal by Subject|2
7829915|NCT00317473|27185220|P2|Overall Study|Withdrawal by Subject|1
7829916|NCT00317473|27185221|P1|Overall Study|Withdrawal by Subject|2
7829917|NCT00317369|27185248|P3|Overall Study|Withdrawal by Subject|1
7829918|NCT00317369|27185249|P2|Overall Study|Withdrawal by Subject|0
7829919|NCT00317369|27185250|P1|Overall Study|Withdrawal by Subject|0
7829920|NCT00317369|27185248|P3|Overall Study|Lack of Efficacy|1
7829921|NCT00317369|27185249|P2|Overall Study|Lack of Efficacy|1
7829922|NCT00317369|27185250|P1|Overall Study|Lack of Efficacy|0
7829923|NCT00317369|27185248|P3|Overall Study|Adverse Event|0
7829924|NCT00317369|27185249|P2|Overall Study|Adverse Event|1
7829925|NCT00317369|27185250|P1|Overall Study|Adverse Event|2
7829926|NCT00317356|27185283|P4|Overall Study|Physician Decision|0
7829927|NCT00317356|27185284|P3|Overall Study|Physician Decision|0
7829928|NCT00317356|27185285|P2|Overall Study|Physician Decision|1
7829929|NCT00317356|27185286|P1|Overall Study|Physician Decision|0
7829930|NCT00317356|27185283|P4|Overall Study|Lack of Efficacy|3
7829931|NCT00317356|27185284|P3|Overall Study|Lack of Efficacy|0
7829932|NCT00317356|27185285|P2|Overall Study|Lack of Efficacy|1
7829933|NCT00317356|27185286|P1|Overall Study|Lack of Efficacy|1
7829934|NCT00317356|27185283|P4|Overall Study|Adverse Event|0
7829935|NCT00317356|27185284|P3|Overall Study|Adverse Event|1
7829936|NCT00317356|27185285|P2|Overall Study|Adverse Event|0
7829937|NCT00317356|27185286|P1|Overall Study|Adverse Event|0
7829938|NCT00317109|27185339|P2|Overall Study|Migated/moved from study area|0
7829939|NCT00317109|27185340|P1|Overall Study|Migated/moved from study area|1
7829940|NCT00317109|27185339|P2|Overall Study|Withdrawal by Subject|0
7829941|NCT00317109|27185340|P1|Overall Study|Withdrawal by Subject|2
7829942|NCT00317044|27185377|P3|Overall Study|Multiple Reasons|6
7829943|NCT00317044|27185378|P2|Overall Study|Multiple Reasons|2
7829944|NCT00317044|27185379|P1|Overall Study|Multiple Reasons|6
7829945|NCT00317044|27185377|P3|Overall Study|Lost to Follow-up|3
7829946|NCT00317044|27185378|P2|Overall Study|Lost to Follow-up|2
7829947|NCT00317044|27185379|P1|Overall Study|Lost to Follow-up|0
7829948|NCT00317044|27185377|P3|Overall Study|Withdrawal by Subject|12
7829949|NCT00317044|27185378|P2|Overall Study|Withdrawal by Subject|7
7829950|NCT00317044|27185379|P1|Overall Study|Withdrawal by Subject|10
7829951|NCT00317044|27185377|P3|Overall Study|Adverse Event|4
7829952|NCT00317044|27185378|P2|Overall Study|Adverse Event|7
7829953|NCT00317044|27185379|P1|Overall Study|Adverse Event|4
7829954|NCT00317044|27185377|P3|Overall Study|Protocol Violation|20
7829955|NCT00317044|27185378|P2|Overall Study|Protocol Violation|22
7829956|NCT00317044|27185379|P1|Overall Study|Protocol Violation|28
7829957|NCT00316914|27185425|P2|Overall Study|Missing end of treatment documentation|15
7829958|NCT00316914|27185426|P1|Overall Study|Missing end of treatment documentation|14
7829959|NCT00316914|27185425|P2|Overall Study|Other Problems|11
7829960|NCT00316914|27185426|P1|Overall Study|Other Problems|6
7829961|NCT00316914|27185425|P2|Overall Study|Adverse Event|7
7829962|NCT00316914|27185426|P1|Overall Study|Adverse Event|8
7829963|NCT00316914|27185425|P2|Overall Study|Withdrawal by Subject|3
7829964|NCT00316914|27185426|P1|Overall Study|Withdrawal by Subject|5
7829965|NCT00316888|27185456|P2|Overall Study|Not start protocol therapy|1
7829966|NCT00316888|27185457|P1|Overall Study|Not start protocol therapy|0
7829967|NCT00316888|27185456|P2|Overall Study|Withdrawal by Subject|2
7829968|NCT00316888|27185457|P1|Overall Study|Withdrawal by Subject|2
7829969|NCT00316888|27185456|P2|Overall Study|Adverse Event|5
7829970|NCT00316888|27185457|P1|Overall Study|Adverse Event|4
7829971|NCT00316719|27185479|P2|Overall Study|Consent withdrawn|0
7829972|NCT00316719|27185480|P1|Overall Study|Consent withdrawn|2
7829973|NCT00316719|27185479|P2|Overall Study|Adverse Event|6
7829974|NCT00316719|27185480|P1|Overall Study|Adverse Event|0
7829975|NCT00316706|27185506|P2|Overall Study|Lost to Follow-up|48
7829976|NCT00316706|27185507|P1|Overall Study|Lost to Follow-up|38
7829977|NCT00316693|27185523|P2|Overall Study|Other|44
7829978|NCT00316693|27185524|P1|Overall Study|Other|38
7829979|NCT00316693|27185523|P2|Overall Study|Lost to Follow-up|34
7829980|NCT00316693|27185524|P1|Overall Study|Lost to Follow-up|26
7829981|NCT00316693|27185523|P2|Overall Study|Withdrawal by Subject|6
7829982|NCT00316693|27185524|P1|Overall Study|Withdrawal by Subject|6
7829983|NCT00316693|27185523|P2|Overall Study|Protocol Violation|0
7829984|NCT00316693|27185524|P1|Overall Study|Protocol Violation|1
7829985|NCT00316693|27185523|P2|Overall Study|Adverse Event|1
7829986|NCT00316693|27185524|P1|Overall Study|Adverse Event|6
7829987|NCT00316602|27185566|P2|Overall Study|Other|6
7829988|NCT00316602|27185567|P1|Overall Study|Other|3
7829989|NCT00316602|27185566|P2|Overall Study|Adverse Event|0
7829990|NCT00316602|27185567|P1|Overall Study|Adverse Event|1
7829991|NCT00316602|27185566|P2|Overall Study|Subject unwilling/unable to comply with|17
7829992|NCT00316602|27185567|P1|Overall Study|Subject unwilling/unable to comply with|3
7829993|NCT00316602|27185566|P2|Overall Study|Withdrawal by Subject|2
7829994|NCT00316602|27185567|P1|Overall Study|Withdrawal by Subject|3
7829995|NCT00316589|27185599|P4|Overall Study|Other reason|1
7829996|NCT00316589|27185600|P3|Overall Study|Other reason|1
7829997|NCT00316589|27185601|P2|Overall Study|Other reason|12
7829998|NCT00316589|27185602|P1|Overall Study|Other reason|0
7829999|NCT00316589|27185599|P4|Overall Study|Physician Decision|0
7830000|NCT00316589|27185600|P3|Overall Study|Physician Decision|0
7830001|NCT00316589|27185601|P2|Overall Study|Physician Decision|1
7830002|NCT00316589|27185602|P1|Overall Study|Physician Decision|0
7830003|NCT00316589|27185599|P4|Overall Study|Adverse Event|1
7830004|NCT00316589|27185600|P3|Overall Study|Adverse Event|0
7830005|NCT00316589|27185601|P2|Overall Study|Adverse Event|0
7830006|NCT00316589|27185602|P1|Overall Study|Adverse Event|1
7830007|NCT00316589|27185599|P4|Overall Study|Subject unwilling/unable to comply|2
7830008|NCT00316589|27185600|P3|Overall Study|Subject unwilling/unable to comply|0
7830009|NCT00316589|27185601|P2|Overall Study|Subject unwilling/unable to comply|6
7830010|NCT00316589|27185602|P1|Overall Study|Subject unwilling/unable to comply|0
7830011|NCT00316589|27185599|P4|Overall Study|Withdrawal by Subject|1
7830012|NCT00316589|27185600|P3|Overall Study|Withdrawal by Subject|0
7830013|NCT00316589|27185601|P2|Overall Study|Withdrawal by Subject|5
7830014|NCT00316589|27185602|P1|Overall Study|Withdrawal by Subject|0
7830015|NCT00316303|27185736|P2|Overall Study|Lost to Follow-up|16
7830016|NCT00316303|27185737|P1|Overall Study|Lost to Follow-up|11
7830017|NCT00316277|27185753|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
7830018|NCT00316277|27185754|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
7830019|NCT00316277|27185753|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
7830020|NCT00316277|27185754|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
7830021|NCT00316277|27185753|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
7830022|NCT00316277|27185754|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
7830023|NCT00316277|27185753|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
7830024|NCT00316277|27185754|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
7830025|NCT00316277|27185753|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
7830026|NCT00316277|27185754|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
7830027|NCT00316264|27185775|P3|Overall Study|Other|0
7830028|NCT00316264|27185776|P2|Overall Study|Other|1
7830029|NCT00316264|27185777|P1|Overall Study|Other|1
7830030|NCT00316264|27185775|P3|Overall Study|Death|0
7830031|NCT00316264|27185776|P2|Overall Study|Death|0
7830032|NCT00316264|27185777|P1|Overall Study|Death|2
7830033|NCT00316264|27185775|P3|Overall Study|Withdrawal of Consent|6
7830034|NCT00316264|27185776|P2|Overall Study|Withdrawal of Consent|5
7830035|NCT00316264|27185777|P1|Overall Study|Withdrawal of Consent|3
7830036|NCT00316264|27185775|P3|Overall Study|Lost to Follow-up|0
7830037|NCT00316264|27185776|P2|Overall Study|Lost to Follow-up|1
7830038|NCT00316264|27185777|P1|Overall Study|Lost to Follow-up|0
7830039|NCT00316225|27185845|P1|Overall Study|Death|2
7830040|NCT00316225|27185845|P1|Overall Study|Withdrawal by Subject|3
7830041|NCT00316225|27185845|P1|Overall Study|Progressive Disease|15
7830042|NCT00316225|27185845|P1|Overall Study|Physician Decision|3
7830043|NCT00316225|27185845|P1|Overall Study|Adverse Event|2
7830044|NCT00316199|27185854|P1|Overall Study|Lost to Follow-up|2
7830045|NCT00316199|27185854|P1|Overall Study|Death|8
7830046|NCT00316199|27185854|P1|Overall Study|Adverse Event|2
7830047|NCT00316186|27185862|P1|Overall Study|Other|1
7830048|NCT00316186|27185862|P1|Overall Study|Lost to Follow-up|1
7830049|NCT00316186|27185862|P1|Overall Study|Disease Progression|4
7830050|NCT00316186|27185862|P1|Overall Study|Adverse Event|6
7830051|NCT00316173|27185876|P2|Treatment Phase|Study Follow-up Stopped|34
7830052|NCT00316173|27185877|P1|Treatment Phase|Study Follow-up Stopped|0
7830053|NCT00316173|27185876|P2|Treatment Phase|Withdrawal by Subject|1
7830054|NCT00316173|27185877|P1|Treatment Phase|Withdrawal by Subject|0
7830055|NCT00316173|27185876|P2|Treatment Phase|Lost to Follow-up|3
7830056|NCT00316173|27185877|P1|Treatment Phase|Lost to Follow-up|0
7830057|NCT00316173|27185876|P2|Treatment Phase|Lack of Efficacy|3
7830058|NCT00316173|27185877|P1|Treatment Phase|Lack of Efficacy|0
7830059|NCT00316173|27185876|P2|Treatment Phase|Adverse Event|1
7830060|NCT00316173|27185877|P1|Treatment Phase|Adverse Event|0
7830061|NCT00316173|27185876|P2|Run-in Phase|Study Follow-up Stopped|0
7830062|NCT00316173|27185877|P1|Run-in Phase|Study Follow-up Stopped|5
7830063|NCT00316173|27185876|P2|Run-in Phase|Protocol Violation|0
7830064|NCT00316173|27185877|P1|Run-in Phase|Protocol Violation|1
7830065|NCT00316173|27185876|P2|Run-in Phase|Adverse Event|0
7830066|NCT00316173|27185877|P1|Run-in Phase|Adverse Event|1
7830067|NCT00316121|27185890|P2|Overall Study|Subject did not have 24 month visit|0
7830068|NCT00316121|27185891|P1|Overall Study|Subject did not have 24 month visit|1
7830069|NCT00316121|27185890|P2|Overall Study|Subject no show for visit x 3|0
7830070|NCT00316121|27185891|P1|Overall Study|Subject no show for visit x 3|1
7830071|NCT00316121|27185890|P2|Overall Study|Subject refused to return|0
7830072|NCT00316121|27185891|P1|Overall Study|Subject refused to return|1
7830073|NCT00316121|27185890|P2|Overall Study|Subject relocated|1
7830074|NCT00316121|27185891|P1|Overall Study|Subject relocated|1
7830075|NCT00316121|27185890|P2|Overall Study|Reason is missing|0
7830076|NCT00316121|27185891|P1|Overall Study|Reason is missing|1
7830077|NCT00316121|27185890|P2|Overall Study|Withdrawal by Subject|0
7830078|NCT00316121|27185891|P1|Overall Study|Withdrawal by Subject|2
7830079|NCT00316121|27185890|P2|Overall Study|Lost to Follow-up|8
7830080|NCT00316121|27185891|P1|Overall Study|Lost to Follow-up|14
7830081|NCT00316121|27185890|P2|Overall Study|Death|0
7830082|NCT00316121|27185891|P1|Overall Study|Death|1
7830083|NCT00316082|27185902|P5|Overall Study|Administrative reason by sponsor|0
7830084|NCT00316082|27185903|P4|Overall Study|Administrative reason by sponsor|0
7830085|NCT00316082|27185904|P3|Overall Study|Administrative reason by sponsor|1
7830086|NCT00316082|27185905|P2|Overall Study|Administrative reason by sponsor|0
7830087|NCT00316082|27185906|P1|Overall Study|Administrative reason by sponsor|0
7830088|NCT00316082|27185902|P5|Overall Study|Death|0
7830089|NCT00316082|27185903|P4|Overall Study|Death|0
7830090|NCT00316082|27185904|P3|Overall Study|Death|1
7830091|NCT00316082|27185905|P2|Overall Study|Death|0
7830092|NCT00316082|27185906|P1|Overall Study|Death|0
7830093|NCT00316082|27185902|P5|Overall Study|Physician Decision|1
7830094|NCT00316082|27185903|P4|Overall Study|Physician Decision|1
7830095|NCT00316082|27185904|P3|Overall Study|Physician Decision|2
7830096|NCT00316082|27185905|P2|Overall Study|Physician Decision|1
7830097|NCT00316082|27185906|P1|Overall Study|Physician Decision|1
7830098|NCT00316082|27185902|P5|Overall Study|Subject no longer meets study criteria|1
7830099|NCT00316082|27185903|P4|Overall Study|Subject no longer meets study criteria|2
7830100|NCT00316082|27185904|P3|Overall Study|Subject no longer meets study criteria|2
7830101|NCT00316082|27185905|P2|Overall Study|Subject no longer meets study criteria|1
7830102|NCT00316082|27185906|P1|Overall Study|Subject no longer meets study criteria|3
7830103|NCT00316082|27185902|P5|Overall Study|Adverse Event|3
7830104|NCT00316082|27185903|P4|Overall Study|Adverse Event|1
7830105|NCT00316082|27185904|P3|Overall Study|Adverse Event|5
7830106|NCT00316082|27185905|P2|Overall Study|Adverse Event|2
7830107|NCT00316082|27185906|P1|Overall Study|Adverse Event|4
7830108|NCT00316082|27185902|P5|Overall Study|Poor/noncompliance|4
7830109|NCT00316082|27185903|P4|Overall Study|Poor/noncompliance|1
7830110|NCT00316082|27185904|P3|Overall Study|Poor/noncompliance|4
7830111|NCT00316082|27185905|P2|Overall Study|Poor/noncompliance|1
7830112|NCT00316082|27185906|P1|Overall Study|Poor/noncompliance|6
7830113|NCT00316082|27185902|P5|Overall Study|Lost to Follow-up|6
7830114|NCT00316082|27185903|P4|Overall Study|Lost to Follow-up|8
7830115|NCT00316082|27185904|P3|Overall Study|Lost to Follow-up|7
7830116|NCT00316082|27185905|P2|Overall Study|Lost to Follow-up|6
7830117|NCT00316082|27185906|P1|Overall Study|Lost to Follow-up|7
7830118|NCT00316082|27185902|P5|Overall Study|Withdrawal of Consent by Subject|5
7830119|NCT00316082|27185903|P4|Overall Study|Withdrawal of Consent by Subject|9
7830120|NCT00316082|27185904|P3|Overall Study|Withdrawal of Consent by Subject|2
7830121|NCT00316082|27185905|P2|Overall Study|Withdrawal of Consent by Subject|8
7830122|NCT00316082|27185906|P1|Overall Study|Withdrawal of Consent by Subject|10
7830123|NCT00316082|27185902|P5|Overall Study|Lack of Efficacy|6
7830124|NCT00316082|27185903|P4|Overall Study|Lack of Efficacy|4
7830125|NCT00316082|27185904|P3|Overall Study|Lack of Efficacy|3
7830126|NCT00316082|27185905|P2|Overall Study|Lack of Efficacy|3
7830127|NCT00316082|27185906|P1|Overall Study|Lack of Efficacy|2
7830128|NCT00316017|27185937|P3|Overall Study|Protocol Violation|19
7830129|NCT00316017|27185938|P2|Overall Study|Protocol Violation|13
7830130|NCT00316017|27185939|P1|Overall Study|Protocol Violation|11
7830131|NCT00316004|27186013|P3|Overall Study|Subject was not given study fluid.|21
7830132|NCT00316004|27186014|P2|Overall Study|Subject was not given study fluid.|14
7830133|NCT00316004|27186015|P1|Overall Study|Subject was not given study fluid.|14
7830134|NCT00315731|27186086|P1|Overall Study|Death|5
7830135|NCT00315731|27186086|P1|Overall Study|Lost to Follow-up|1
7830136|NCT00315705|27186114|P1|Phase 2|Death|7
7830137|NCT00315705|27186114|P1|Phase 2|Other|1
7830138|NCT00315705|27186114|P1|Phase 2|Scheduled for transplant|8
7830139|NCT00315705|27186114|P1|Phase 2|Disease relapse|1
7830140|NCT00315705|27186114|P1|Phase 2|Failure to achieve response|3
7830141|NCT00315705|27186114|P1|Phase 2|Adverse Event|1
7830142|NCT00315705|27186114|P1|Phase 2|Physician Decision|4
7830143|NCT00315705|27186114|P1|Phase 1|Death|3
7830144|NCT00315705|27186114|P1|Phase 1|Scheduled for transplant|9
7830145|NCT00315705|27186114|P1|Phase 1|Disease relapse|4
7830146|NCT00315705|27186114|P1|Phase 1|Failure to achieve response|8
7830147|NCT00315705|27186114|P1|Phase 1|Refused further treatment|1
7830148|NCT00315458|27186175|P4|Overall Study|Did not qualify|0
7830149|NCT00315458|27186176|P3|Overall Study|Did not qualify|1
7830150|NCT00315458|27186177|P2|Overall Study|Did not qualify|0
7830151|NCT00315458|27186178|P1|Overall Study|Did not qualify|0
7830152|NCT00315458|27186175|P4|Overall Study|Lack of Efficacy|1
7830153|NCT00315458|27186176|P3|Overall Study|Lack of Efficacy|20
7830154|NCT00315458|27186177|P2|Overall Study|Lack of Efficacy|0
7830155|NCT00315458|27186178|P1|Overall Study|Lack of Efficacy|0
7830156|NCT00315458|27186175|P4|Overall Study|Withdrawal by Subject|2
7830157|NCT00315458|27186176|P3|Overall Study|Withdrawal by Subject|0
7830158|NCT00315458|27186177|P2|Overall Study|Withdrawal by Subject|3
7830159|NCT00315458|27186178|P1|Overall Study|Withdrawal by Subject|0
7830160|NCT00315458|27186175|P4|Overall Study|Lost to Follow-up|2
7830161|NCT00315458|27186176|P3|Overall Study|Lost to Follow-up|0
7830162|NCT00315458|27186177|P2|Overall Study|Lost to Follow-up|2
7830163|NCT00315458|27186178|P1|Overall Study|Lost to Follow-up|1
7830164|NCT00315458|27186175|P4|Overall Study|Adverse Event|3
7830165|NCT00315458|27186176|P3|Overall Study|Adverse Event|23
7830166|NCT00315458|27186177|P2|Overall Study|Adverse Event|4
7830167|NCT00315458|27186178|P1|Overall Study|Adverse Event|2
7830168|NCT00315458|27186175|P4|Overall Study|Administrative|21
7830169|NCT00315458|27186176|P3|Overall Study|Administrative|8
7830170|NCT00315458|27186177|P2|Overall Study|Administrative|3
7830171|NCT00315458|27186178|P1|Overall Study|Administrative|0
7830172|NCT00315445|27186191|P3|Overall Study|Other|0
7830173|NCT00315445|27186192|P2|Overall Study|Other|3
7830174|NCT00315445|27186193|P1|Overall Study|Other|1
7830175|NCT00315445|27186191|P3|Overall Study|Protocol Violation|1
7830176|NCT00315445|27186192|P2|Overall Study|Protocol Violation|0
7830177|NCT00315445|27186193|P1|Overall Study|Protocol Violation|2
7830178|NCT00315445|27186191|P3|Overall Study|Lost to Follow-up|1
7830179|NCT00315445|27186192|P2|Overall Study|Lost to Follow-up|0
7830180|NCT00315445|27186193|P1|Overall Study|Lost to Follow-up|1
7830181|NCT00315445|27186191|P3|Overall Study|Lack of Efficacy|7
7830182|NCT00315445|27186192|P2|Overall Study|Lack of Efficacy|1
7830183|NCT00315445|27186193|P1|Overall Study|Lack of Efficacy|16
7830184|NCT00315445|27186191|P3|Overall Study|Adverse Event|15
7830185|NCT00315445|27186192|P2|Overall Study|Adverse Event|12
7830186|NCT00315445|27186193|P1|Overall Study|Adverse Event|7
7830187|NCT00315055|27186483|P2|Overall Study|Lost to Follow-up|1
7830188|NCT00315055|27186484|P1|Overall Study|Lost to Follow-up|1
7830189|NCT00315055|27186483|P2|Overall Study|Protocol Violation|4
7830190|NCT00315055|27186484|P1|Overall Study|Protocol Violation|2
7830191|NCT00314951|27186502|P2|Follow-up|mITT failure|34
7830192|NCT00314951|27186503|P1|Follow-up|mITT failure|44
7830193|NCT00314951|27186502|P2|Treatment|Didn't meet criteria for mITT population|11
7830194|NCT00314951|27186503|P1|Treatment|Didn't meet criteria for mITT population|16
7830195|NCT00314808|27186513|P1|Overall Study|Withdrawal by Subject/PI without AE|4
7830196|NCT00314808|27186513|P1|Overall Study|Disease Progression without AE|4
7830197|NCT00314795|27186521|P1|Overall Study|Participants Withdrew Consent|2
7830198|NCT00314795|27186521|P1|Overall Study|Renal Transplant|3
7830199|NCT00314795|27186521|P1|Overall Study|Reason not Specified|3
7830200|NCT00314795|27186521|P1|Overall Study|Death|4
7830201|NCT00314795|27186521|P1|Overall Study|Adverse Event|8
7830202|NCT00314574|27186531|P2|Overall Study|Data unknown at database lock|1
7830203|NCT00314574|27186532|P1|Overall Study|Data unknown at database lock|0
7830204|NCT00314574|27186531|P2|Overall Study|Pregnancy|4
7830205|NCT00314574|27186532|P1|Overall Study|Pregnancy|6
7830206|NCT00314574|27186531|P2|Overall Study|Physician Decision|15
7830207|NCT00314574|27186532|P1|Overall Study|Physician Decision|22
7830208|NCT00314574|27186531|P2|Overall Study|Withdrawal by Subject|22
7830209|NCT00314574|27186532|P1|Overall Study|Withdrawal by Subject|33
7830210|NCT00314574|27186531|P2|Overall Study|Lost to Follow-up|25
7830211|NCT00314574|27186532|P1|Overall Study|Lost to Follow-up|19
7830212|NCT00314574|27186531|P2|Overall Study|Adverse Event|16
7830213|NCT00314574|27186532|P1|Overall Study|Adverse Event|11
7830214|NCT00314574|27186531|P2|Overall Study|Death|0
7830215|NCT00314574|27186532|P1|Overall Study|Death|3
7830216|NCT00314366|27186548|P2|Overall Study|not treated due to patient medical condi|0
7830217|NCT00314366|27186549|P1|Overall Study|not treated due to patient medical condi|1
7830218|NCT00314340|27186594|P1|Overall Study|lost interest|1
7830219|NCT00314327|27186600|P1|Overall Study|Withdrawal by Subject|1
7830220|NCT00314262|27186605|P1|Overall Study|Physician Decision|1
7830221|NCT00314262|27186605|P1|Overall Study|Withdrawal by Subject|2
7830222|NCT00314262|27186605|P1|Overall Study|Adverse Event|2
7830223|NCT00314249|27186613|P2|Overall Study|Non-Compliant|6
7830224|NCT00314249|27186614|P1|Overall Study|Non-Compliant|5
7830225|NCT00314249|27186613|P2|Overall Study|Withdrawn for other reasons|1
7830226|NCT00314249|27186614|P1|Overall Study|Withdrawn for other reasons|4
7830227|NCT00314249|27186613|P2|Overall Study|Physician Decision|1
7830228|NCT00314249|27186614|P1|Overall Study|Physician Decision|1
7830229|NCT00314249|27186613|P2|Overall Study|Lost to Follow-up|9
7830230|NCT00314249|27186614|P1|Overall Study|Lost to Follow-up|15
7830231|NCT00314249|27186613|P2|Overall Study|Withdrawal by Subject|28
7830232|NCT00314249|27186614|P1|Overall Study|Withdrawal by Subject|21
7830233|NCT00314249|27186613|P2|Overall Study|Lack of Efficacy|24
7830234|NCT00314249|27186614|P1|Overall Study|Lack of Efficacy|33
7830235|NCT00314249|27186613|P2|Overall Study|Adverse Event|94
7830236|NCT00314249|27186614|P1|Overall Study|Adverse Event|73
7830237|NCT00314145|27186647|P2|Overall Study|Sponsor Decision|0
7830238|NCT00314145|27186648|P1|Overall Study|Sponsor Decision|2
7830239|NCT00314145|27186647|P2|Overall Study|Protocol Violation|0
7830240|NCT00314145|27186648|P1|Overall Study|Protocol Violation|3
7830241|NCT00314145|27186647|P2|Overall Study|Adverse Event|3
7830242|NCT00314145|27186648|P1|Overall Study|Adverse Event|0
7830243|NCT00314145|27186647|P2|Overall Study|Physician Decision|4
7830244|NCT00314145|27186648|P1|Overall Study|Physician Decision|3
7830245|NCT00314145|27186647|P2|Overall Study|Lost to Follow-up|12
7830246|NCT00314145|27186648|P1|Overall Study|Lost to Follow-up|5
7830247|NCT00314145|27186647|P2|Overall Study|Withdrawal by Subject|10
7830248|NCT00314145|27186648|P1|Overall Study|Withdrawal by Subject|8
7830249|NCT00314132|27186662|P2|Overall Study|Physician Decision|0
7830250|NCT00314132|27186663|P1|Overall Study|Physician Decision|1
7830251|NCT00314132|27186662|P2|Overall Study|Adverse Event|0
7830252|NCT00314132|27186663|P1|Overall Study|Adverse Event|1
7830253|NCT00314132|27186662|P2|Overall Study|Withdrawal by Subject|5
7830254|NCT00314132|27186663|P1|Overall Study|Withdrawal by Subject|3
7830255|NCT00314132|27186662|P2|Overall Study|Lost to Follow-up|13
7830256|NCT00314132|27186663|P1|Overall Study|Lost to Follow-up|3
7830257|NCT00313911|27186690|P2|Overall Study|Did not meet age criteria|1
7830258|NCT00313911|27186691|P1|Overall Study|Did not meet age criteria|1
7830259|NCT00313911|27186690|P2|Overall Study|Withdrawal by Subject|12
7830260|NCT00313911|27186691|P1|Overall Study|Withdrawal by Subject|39
7830261|NCT00313911|27186690|P2|Overall Study|Lost to Follow-up|14
7830262|NCT00313911|27186691|P1|Overall Study|Lost to Follow-up|27
7830263|NCT00313911|27186690|P2|Overall Study|Protocol Violation|10
7830264|NCT00313911|27186691|P1|Overall Study|Protocol Violation|19
7830265|NCT00313911|27186690|P2|Overall Study|Adverse Event|3
7830266|NCT00313911|27186691|P1|Overall Study|Adverse Event|2
7830267|NCT00313911|27186690|P2|Overall Study|Serious adverse event|1
7830268|NCT00313911|27186691|P1|Overall Study|Serious adverse event|6
7830269|NCT00313846|27186705|P2|Overall Study|Administrative|3
7830270|NCT00313846|27186706|P1|Overall Study|Administrative|2
7830271|NCT00313846|27186705|P2|Overall Study|Adverse Event|8
7830272|NCT00313846|27186706|P1|Overall Study|Adverse Event|1
7830273|NCT00313846|27186705|P2|Overall Study|Withdrawal by Subject|0
7830274|NCT00313846|27186706|P1|Overall Study|Withdrawal by Subject|2
7830275|NCT00313820|27186717|P2|Pregabalin or Placebo Treatment Period|Other|3
7830276|NCT00313820|27186718|P1|Pregabalin or Placebo Treatment Period|Other|2
7830277|NCT00313820|27186717|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
7830278|NCT00313820|27186718|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
7830279|NCT00313820|27186717|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
7830280|NCT00313820|27186718|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
7830281|NCT00313820|27186717|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
7830282|NCT00313820|27186718|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
7830283|NCT00313820|27186717|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
7830284|NCT00313820|27186718|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
7830285|NCT00313820|27186717|P2|Assigned to Treatment|Other|0
7830286|NCT00313820|27186718|P1|Assigned to Treatment|Other|1
7830287|NCT00313781|27186756|P3|After Crossover|Other|18
7830288|NCT00313781|27186757|P2|After Crossover|Other|0
7830289|NCT00313781|27186758|P1|After Crossover|Other|0
7830290|NCT00313781|27186756|P3|After Crossover|Withdrawal by Subject|3
7830291|NCT00313781|27186757|P2|After Crossover|Withdrawal by Subject|0
7830292|NCT00313781|27186758|P1|After Crossover|Withdrawal by Subject|0
7830293|NCT00313781|27186756|P3|After Crossover|Death|6
7830294|NCT00313781|27186757|P2|After Crossover|Death|0
7830295|NCT00313781|27186758|P1|After Crossover|Death|0
7830296|NCT00313781|27186756|P3|Before Crossover|Randomized, not treated|0
7830297|NCT00313781|27186757|P2|Before Crossover|Randomized, not treated|0
7830298|NCT00313781|27186758|P1|Before Crossover|Randomized, not treated|5
7830299|NCT00313781|27186756|P3|Before Crossover|Crossover|0
7830300|NCT00313781|27186757|P2|Before Crossover|Crossover|37
7830301|NCT00313781|27186758|P1|Before Crossover|Crossover|0
7830302|NCT00313781|27186756|P3|Before Crossover|Other|0
7830303|NCT00313781|27186757|P2|Before Crossover|Other|30
7830304|NCT00313781|27186758|P1|Before Crossover|Other|45
7830305|NCT00313781|27186756|P3|Before Crossover|Withdrawal by Subject|0
7830306|NCT00313781|27186757|P2|Before Crossover|Withdrawal by Subject|1
7830307|NCT00313781|27186758|P1|Before Crossover|Withdrawal by Subject|3
7830308|NCT00313781|27186756|P3|Before Crossover|Lost to Follow-up|0
7830309|NCT00313781|27186757|P2|Before Crossover|Lost to Follow-up|3
7830310|NCT00313781|27186758|P1|Before Crossover|Lost to Follow-up|0
7830311|NCT00313781|27186756|P3|Before Crossover|Death|0
7830312|NCT00313781|27186757|P2|Before Crossover|Death|8
7830313|NCT00313781|27186758|P1|Before Crossover|Death|22
7830314|NCT00313716|27186804|P6|Overall Study|Withdrawal by Subject|0
7830315|NCT00313716|27186805|P5|Overall Study|Withdrawal by Subject|1
7830316|NCT00313716|27186806|P4|Overall Study|Withdrawal by Subject|0
7830317|NCT00313716|27186807|P3|Overall Study|Withdrawal by Subject|1
7830318|NCT00313716|27186808|P2|Overall Study|Withdrawal by Subject|1
7830319|NCT00313716|27186809|P1|Overall Study|Withdrawal by Subject|0
7830320|NCT00313716|27186804|P6|Overall Study|Lost to Follow-up|4
7830321|NCT00313716|27186805|P5|Overall Study|Lost to Follow-up|0
7830322|NCT00313716|27186806|P4|Overall Study|Lost to Follow-up|1
7830323|NCT00313716|27186807|P3|Overall Study|Lost to Follow-up|2
7830324|NCT00313716|27186808|P2|Overall Study|Lost to Follow-up|5
7830325|NCT00313716|27186809|P1|Overall Study|Lost to Follow-up|2
7830326|NCT00313716|27186804|P6|Overall Study|Death|9
7830327|NCT00313716|27186805|P5|Overall Study|Death|5
7830328|NCT00313716|27186806|P4|Overall Study|Death|3
7830329|NCT00313716|27186807|P3|Overall Study|Death|9
7830330|NCT00313716|27186808|P2|Overall Study|Death|2
7830331|NCT00313716|27186809|P1|Overall Study|Death|3
7830332|NCT00313703|27186836|P4|Overall Study|Lost to Follow-up|12
7830333|NCT00313703|27186837|P3|Overall Study|Lost to Follow-up|5
7830334|NCT00313703|27186838|P2|Overall Study|Lost to Follow-up|2
7830335|NCT00313703|27186839|P1|Overall Study|Lost to Follow-up|11
7830336|NCT00313612|27186855|P2|Overall Study|Patient never received treatment|1
7830337|NCT00313612|27186856|P1|Overall Study|Patient never received treatment|0
7830338|NCT00313586|27186868|P4|Overall Study|Death before starting treatment|0
7830339|NCT00313586|27186869|P3|Overall Study|Death before starting treatment|0
7830340|NCT00313586|27186870|P2|Overall Study|Death before starting treatment|0
7830341|NCT00313586|27186871|P1|Overall Study|Death before starting treatment|1
7830342|NCT00313586|27186868|P4|Overall Study|Moved|0
7830343|NCT00313586|27186869|P3|Overall Study|Moved|0
7830344|NCT00313586|27186870|P2|Overall Study|Moved|1
7830345|NCT00313586|27186871|P1|Overall Study|Moved|0
7830346|NCT00313586|27186868|P4|Overall Study|Lost insurance|0
7830347|NCT00313586|27186869|P3|Overall Study|Lost insurance|0
7830348|NCT00313586|27186870|P2|Overall Study|Lost insurance|1
7830349|NCT00313586|27186871|P1|Overall Study|Lost insurance|0
7830350|NCT00313586|27186868|P4|Overall Study|Absolute neutrophil count not recovered|0
7830351|NCT00313586|27186869|P3|Overall Study|Absolute neutrophil count not recovered|0
7830352|NCT00313586|27186870|P2|Overall Study|Absolute neutrophil count not recovered|1
7830353|NCT00313586|27186871|P1|Overall Study|Absolute neutrophil count not recovered|2
7830354|NCT00313586|27186868|P4|Overall Study|Physician Decision|0
7830355|NCT00313586|27186869|P3|Overall Study|Physician Decision|0
7830356|NCT00313586|27186870|P2|Overall Study|Physician Decision|1
7830357|NCT00313586|27186871|P1|Overall Study|Physician Decision|2
7830358|NCT00313586|27186868|P4|Overall Study|Did not achieve HI-major/better response|1
7830359|NCT00313586|27186869|P3|Overall Study|Did not achieve HI-major/better response|2
7830360|NCT00313586|27186870|P2|Overall Study|Did not achieve HI-major/better response|7
7830361|NCT00313586|27186871|P1|Overall Study|Did not achieve HI-major/better response|10
7830362|NCT00313586|27186868|P4|Overall Study|Other complicating disease|0
7830363|NCT00313586|27186869|P3|Overall Study|Other complicating disease|0
7830364|NCT00313586|27186870|P2|Overall Study|Other complicating disease|2
7830365|NCT00313586|27186871|P1|Overall Study|Other complicating disease|2
7830366|NCT00313586|27186868|P4|Overall Study|Alternative therapy|0
7830367|NCT00313586|27186869|P3|Overall Study|Alternative therapy|2
7830368|NCT00313586|27186870|P2|Overall Study|Alternative therapy|6
7830369|NCT00313586|27186871|P1|Overall Study|Alternative therapy|3
7830370|NCT00313586|27186868|P4|Overall Study|Withdrawal by Subject|2
7830371|NCT00313586|27186869|P3|Overall Study|Withdrawal by Subject|6
7830372|NCT00313586|27186870|P2|Overall Study|Withdrawal by Subject|6
7830373|NCT00313586|27186871|P1|Overall Study|Withdrawal by Subject|13
7830374|NCT00313586|27186868|P4|Overall Study|Death|7
7830375|NCT00313586|27186869|P3|Overall Study|Death|1
7830376|NCT00313586|27186870|P2|Overall Study|Death|8
7830377|NCT00313586|27186871|P1|Overall Study|Death|11
7830378|NCT00313586|27186868|P4|Overall Study|Adverse Event|10
7830379|NCT00313586|27186869|P3|Overall Study|Adverse Event|3
7830380|NCT00313586|27186870|P2|Overall Study|Adverse Event|18
7830381|NCT00313586|27186871|P1|Overall Study|Adverse Event|12
7830382|NCT00313586|27186868|P4|Overall Study|Disease progression|3
7830383|NCT00313586|27186869|P3|Overall Study|Disease progression|10
7830384|NCT00313586|27186870|P2|Overall Study|Disease progression|19
7830385|NCT00313586|27186871|P1|Overall Study|Disease progression|14
7830386|NCT00313313|27186899|P3|Overall Study|Subject No Longer Meets Study Criteria|2
7830387|NCT00313313|27186900|P2|Overall Study|Subject No Longer Meets Study Criteria|3
7830388|NCT00313313|27186901|P1|Overall Study|Subject No Longer Meets Study Criteria|0
7830389|NCT00313313|27186899|P3|Overall Study|Death|2
7830390|NCT00313313|27186900|P2|Overall Study|Death|0
7830391|NCT00313313|27186901|P1|Overall Study|Death|0
7830392|NCT00313313|27186899|P3|Overall Study|Pregnancy|0
7830393|NCT00313313|27186900|P2|Overall Study|Pregnancy|2
7830394|NCT00313313|27186901|P1|Overall Study|Pregnancy|1
7830395|NCT00313313|27186899|P3|Overall Study|Poor/Noncompliance|2
7830396|NCT00313313|27186900|P2|Overall Study|Poor/Noncompliance|6
7830397|NCT00313313|27186901|P1|Overall Study|Poor/Noncompliance|3
7830398|NCT00313313|27186899|P3|Overall Study|Physician Decision|4
7830399|NCT00313313|27186900|P2|Overall Study|Physician Decision|6
7830400|NCT00313313|27186901|P1|Overall Study|Physician Decision|2
7830401|NCT00313313|27186899|P3|Overall Study|Adverse Event|12
7830402|NCT00313313|27186900|P2|Overall Study|Adverse Event|16
7830403|NCT00313313|27186901|P1|Overall Study|Adverse Event|15
7830404|NCT00313313|27186899|P3|Overall Study|Lost to Follow-up|9
7830405|NCT00313313|27186900|P2|Overall Study|Lost to Follow-up|7
7830406|NCT00313313|27186901|P1|Overall Study|Lost to Follow-up|10
7830407|NCT00313313|27186899|P3|Overall Study|Withdrawal of consent by subject|31
7830408|NCT00313313|27186900|P2|Overall Study|Withdrawal of consent by subject|17
7830409|NCT00313313|27186901|P1|Overall Study|Withdrawal of consent by subject|18
7830410|NCT00313313|27186899|P3|Overall Study|Lack of Efficacy|20
7830411|NCT00313313|27186900|P2|Overall Study|Lack of Efficacy|9
7830412|NCT00313313|27186901|P1|Overall Study|Lack of Efficacy|14
7830413|NCT00313300|27186923|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7830414|NCT00313300|27186924|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
7830415|NCT00313300|27186925|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7830416|NCT00313300|27186926|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7830417|NCT00313300|27186927|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
7830418|NCT00313300|27186923|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
7830419|NCT00313300|27186924|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
7830420|NCT00313300|27186925|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7830421|NCT00313300|27186926|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7830422|NCT00313300|27186927|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7830423|NCT00313300|27186923|P5|Follow-Up(30days)-Randomized Phase B|Death|0
7830424|NCT00313300|27186924|P4|Follow-Up(30days)-Randomized Phase B|Death|0
7830425|NCT00313300|27186925|P3|Follow-Up(30days)-Randomized Phase B|Death|0
7830426|NCT00313300|27186926|P2|Follow-Up(30days)-Randomized Phase B|Death|0
7830427|NCT00313300|27186927|P1|Follow-Up(30days)-Randomized Phase B|Death|1
7830428|NCT00313300|27186923|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7830429|NCT00313300|27186924|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7830430|NCT00313300|27186925|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
7830431|NCT00313300|27186926|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
7830432|NCT00313300|27186927|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7830433|NCT00313300|27186923|P5|Follow-Up(30days)-Randomized Phase A|Death|0
7830434|NCT00313300|27186924|P4|Follow-Up(30days)-Randomized Phase A|Death|0
7830435|NCT00313300|27186925|P3|Follow-Up(30days)-Randomized Phase A|Death|0
7830436|NCT00313300|27186926|P2|Follow-Up(30days)-Randomized Phase A|Death|1
7830437|NCT00313300|27186927|P1|Follow-Up(30days)-Randomized Phase A|Death|0
7830438|NCT00313300|27186923|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
7830439|NCT00313300|27186924|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
7830440|NCT00313300|27186925|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
7830441|NCT00313300|27186926|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
7830442|NCT00313300|27186927|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
7830443|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|non-specified|0
7830444|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|non-specified|0
7830445|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|non-specified|0
7830446|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|non-specified|0
7830447|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|non-specified|1
7830448|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
7830449|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
7830450|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
7830451|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
7830452|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
7830453|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
7830454|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
7830455|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
7830456|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
7830457|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
7830458|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
7830459|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
7831553|NCT00306891|27189878|P3|Part B|Death|1
7830460|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
7830461|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
7830462|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
7830463|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
7830464|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
7830465|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
7830466|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
7830467|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
7830468|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|Death|1
7830469|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|Death|0
7830470|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|Death|1
7830471|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|Death|3
7830472|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|Death|5
7830473|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
7830474|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
7830475|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
7830476|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
7830477|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
7830478|NCT00313300|27186923|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
7830479|NCT00313300|27186924|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
7830480|NCT00313300|27186925|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
7830481|NCT00313300|27186926|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
7830482|NCT00313300|27186927|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
7830483|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7830484|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7830485|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7830486|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7830487|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
7830488|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
7830489|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
7830490|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
7830491|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
7830492|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
7830493|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
7830494|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
7830495|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
7830496|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
7830497|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
7830498|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
7830499|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
7830500|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
7830501|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
7830502|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
7830503|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|Death|0
7830504|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|Death|0
7830505|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|Death|0
7830506|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|Death|4
7830507|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|Death|3
7830508|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
7830509|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
7830510|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
7830511|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
7830512|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
7830513|NCT00313300|27186923|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
7830514|NCT00313300|27186924|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
7830515|NCT00313300|27186925|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
7830516|NCT00313300|27186926|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
7830517|NCT00313300|27186927|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
7830518|NCT00313170|27186997|P3|Overall Study|Progression (investigators opinion)|0
7830519|NCT00313170|27186998|P2|Overall Study|Progression (investigators opinion)|0
7830520|NCT00313170|27186999|P1|Overall Study|Progression (investigators opinion)|1
7830521|NCT00313170|27186997|P3|Overall Study|Lost to Follow-up|1
7830522|NCT00313170|27186998|P2|Overall Study|Lost to Follow-up|0
7830523|NCT00313170|27186999|P1|Overall Study|Lost to Follow-up|0
7830524|NCT00313170|27186997|P3|Overall Study|Incorrect enrollment|1
7830525|NCT00313170|27186998|P2|Overall Study|Incorrect enrollment|2
7830526|NCT00313170|27186999|P1|Overall Study|Incorrect enrollment|0
7830527|NCT00313170|27186997|P3|Overall Study|Withdrawal by Subject|1
7830528|NCT00313170|27186998|P2|Overall Study|Withdrawal by Subject|0
7830529|NCT00313170|27186999|P1|Overall Study|Withdrawal by Subject|1
7830530|NCT00313170|27186997|P3|Overall Study|Disease progression|27
7830531|NCT00313170|27186998|P2|Overall Study|Disease progression|26
7830532|NCT00313170|27186999|P1|Overall Study|Disease progression|31
7830533|NCT00313170|27186997|P3|Overall Study|Adverse Event|0
7830534|NCT00313170|27186998|P2|Overall Study|Adverse Event|2
7830535|NCT00313170|27186999|P1|Overall Study|Adverse Event|1
7830536|NCT00313170|27186997|P3|Overall Study|Death|2
7830537|NCT00313170|27186998|P2|Overall Study|Death|4
7830538|NCT00313170|27186999|P1|Overall Study|Death|2
7830539|NCT00313144|27187018|P1|Overall Study|Due to termination of the study|66
7830540|NCT00313144|27187018|P1|Overall Study|Change to different product|1
7830541|NCT00313144|27187018|P1|Overall Study|Insurance (homecare provider) change|1
7830542|NCT00313144|27187018|P1|Overall Study|Liver transplant|1
7830543|NCT00313144|27187018|P1|Overall Study|Adverse event - transient|5
7830544|NCT00313144|27187018|P1|Overall Study|Physician Decision|4
7830545|NCT00313144|27187018|P1|Overall Study|Terminated by sponsor/ homecare provider|4
7830546|NCT00313144|27187018|P1|Overall Study|Withdrawal by Subject|4
7830547|NCT00313144|27187018|P1|Overall Study|Lost to Follow-up|5
7830548|NCT00313144|27187018|P1|Overall Study|Death|7
7830549|NCT00313144|27187018|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
7830550|NCT00313014|27187105|P3|Overall Study|Lack of Efficacy|16
7830551|NCT00313014|27187106|P2|Overall Study|Lack of Efficacy|25
7830552|NCT00313014|27187107|P1|Overall Study|Lack of Efficacy|52
7830553|NCT00313014|27187105|P3|Overall Study|Administrative|14
7830554|NCT00313014|27187106|P2|Overall Study|Administrative|6
7830555|NCT00313014|27187107|P1|Overall Study|Administrative|9
7830556|NCT00313014|27187105|P3|Overall Study|Lost to Follow-up|10
7830557|NCT00313014|27187106|P2|Overall Study|Lost to Follow-up|6
7830558|NCT00313014|27187107|P1|Overall Study|Lost to Follow-up|7
7830559|NCT00313014|27187105|P3|Overall Study|Adverse Event|16
7830560|NCT00313014|27187106|P2|Overall Study|Adverse Event|29
7830561|NCT00313014|27187107|P1|Overall Study|Adverse Event|14
7830562|NCT00313014|27187105|P3|Overall Study|Withdrawal by Subject|5
7830563|NCT00313014|27187106|P2|Overall Study|Withdrawal by Subject|7
7830564|NCT00313014|27187107|P1|Overall Study|Withdrawal by Subject|11
7830565|NCT00312897|27187138|P2|Overall Study|discontinued prior to getting treatment|3
7830566|NCT00312897|27187139|P1|Overall Study|discontinued prior to getting treatment|0
7830567|NCT00312897|27187138|P2|Overall Study|Pregnancy|0
7830568|NCT00312897|27187139|P1|Overall Study|Pregnancy|1
7830569|NCT00312897|27187138|P2|Overall Study|Withdrawal by Subject|3
7830570|NCT00312897|27187139|P1|Overall Study|Withdrawal by Subject|1
7830571|NCT00312897|27187138|P2|Overall Study|Physician Decision|0
7830572|NCT00312897|27187139|P1|Overall Study|Physician Decision|1
7830573|NCT00312897|27187138|P2|Overall Study|Lost to Follow-up|0
7830574|NCT00312897|27187139|P1|Overall Study|Lost to Follow-up|2
7830575|NCT00312897|27187138|P2|Overall Study|Adverse Event|0
7830576|NCT00312897|27187139|P1|Overall Study|Adverse Event|1
7830577|NCT00312858|27187164|P2|Overall Study|Other|12
7830578|NCT00312858|27187165|P1|Overall Study|Other|9
7830579|NCT00312858|27187164|P2|Overall Study|Participant Moved|10
7830580|NCT00312858|27187165|P1|Overall Study|Participant Moved|11
7830581|NCT00312858|27187164|P2|Overall Study|Withdraw by Participant|20
7830582|NCT00312858|27187165|P1|Overall Study|Withdraw by Participant|20
7830583|NCT00312858|27187164|P2|Overall Study|Protocol Violation|8
7830584|NCT00312858|27187165|P1|Overall Study|Protocol Violation|3
7830585|NCT00312858|27187164|P2|Overall Study|Lost to Follow-up|42
7830586|NCT00312858|27187165|P1|Overall Study|Lost to Follow-up|25
7830587|NCT00312858|27187164|P2|Overall Study|Adverse Event|1
7830588|NCT00312858|27187165|P1|Overall Study|Adverse Event|0
7830589|NCT00312845|27187219|P2|Overall Study|Other|5
7830590|NCT00312845|27187220|P1|Overall Study|Other|6
7830591|NCT00312845|27187219|P2|Overall Study|Lost to Follow-up|0
7830592|NCT00312845|27187220|P1|Overall Study|Lost to Follow-up|2
7830593|NCT00312845|27187219|P2|Overall Study|Disease Progression|77
7830594|NCT00312845|27187220|P1|Overall Study|Disease Progression|56
7830595|NCT00312845|27187219|P2|Overall Study|Withdrawal by Subject|6
7830596|NCT00312845|27187220|P1|Overall Study|Withdrawal by Subject|14
7830597|NCT00312845|27187219|P2|Overall Study|Death|2
7830598|NCT00312845|27187220|P1|Overall Study|Death|2
7830599|NCT00312845|27187219|P2|Overall Study|Adverse Event|5
7830600|NCT00312845|27187220|P1|Overall Study|Adverse Event|19
7830601|NCT00312728|27187228|P1|Overall Study|Other|1
7830602|NCT00312728|27187228|P1|Overall Study|Other|10
7830603|NCT00312728|27187228|P1|Overall Study|Protocol Violation|2
7830604|NCT00312728|27187228|P1|Overall Study|Required non-protocol cancer treatment|2
7830605|NCT00312728|27187228|P1|Overall Study|Withdrawal by Subject|10
7830606|NCT00312728|27187228|P1|Overall Study|Adverse Event|32
7830607|NCT00312728|27187228|P1|Overall Study|Progressive disease|53
7830608|NCT00312702|27187240|P3|Immunization Phase|Lost to Follow-up|0
7830609|NCT00312702|27187241|P2|Immunization Phase|Lost to Follow-up|1
7830610|NCT00312702|27187242|P1|Immunization Phase|Lost to Follow-up|0
7830611|NCT00312663|27187255|P3|Immunization Phase|Adverse Event|0
7830612|NCT00312663|27187256|P2|Immunization Phase|Adverse Event|1
7830613|NCT00312663|27187257|P1|Immunization Phase|Adverse Event|0
7830614|NCT00312572|27187270|P2|Overall Study|Lack of Efficacy|2
7830615|NCT00312572|27187271|P1|Overall Study|Lack of Efficacy|1
7830616|NCT00312572|27187270|P2|Overall Study|Administrative|2
7830617|NCT00312572|27187271|P1|Overall Study|Administrative|4
7830618|NCT00312572|27187270|P2|Overall Study|Lost to Follow-up|1
7830619|NCT00312572|27187271|P1|Overall Study|Lost to Follow-up|1
7830620|NCT00312572|27187270|P2|Overall Study|Adverse Event|16
7830621|NCT00312572|27187271|P1|Overall Study|Adverse Event|10
7830622|NCT00312494|27187282|P3|Overall Study|Other|1
7830623|NCT00312494|27187283|P2|Overall Study|Other|10
7830624|NCT00312494|27187284|P1|Overall Study|Other|10
7830625|NCT00312494|27187282|P3|Overall Study|Withdrawal by Subject|10
7830626|NCT00312494|27187283|P2|Overall Study|Withdrawal by Subject|9
7830627|NCT00312494|27187284|P1|Overall Study|Withdrawal by Subject|6
7830628|NCT00312494|27187282|P3|Overall Study|Lost to Follow-up|8
7830629|NCT00312494|27187283|P2|Overall Study|Lost to Follow-up|8
7830630|NCT00312494|27187284|P1|Overall Study|Lost to Follow-up|8
7830631|NCT00312494|27187282|P3|Overall Study|Laboratory abnormality|0
7830632|NCT00312494|27187283|P2|Overall Study|Laboratory abnormality|0
7830633|NCT00312494|27187284|P1|Overall Study|Laboratory abnormality|1
7830634|NCT00312494|27187282|P3|Overall Study|Lack of Efficacy|8
7830635|NCT00312494|27187283|P2|Overall Study|Lack of Efficacy|6
7830636|NCT00312494|27187284|P1|Overall Study|Lack of Efficacy|4
7830637|NCT00312494|27187282|P3|Overall Study|Adverse Event|11
7830638|NCT00312494|27187283|P2|Overall Study|Adverse Event|15
7830639|NCT00312494|27187284|P1|Overall Study|Adverse Event|33
7830640|NCT00312494|27187282|P3|Overall Study|Randomized; not treated with study drug|5
7830641|NCT00312494|27187283|P2|Overall Study|Randomized; not treated with study drug|10
7830642|NCT00312494|27187284|P1|Overall Study|Randomized; not treated with study drug|9
7830643|NCT00312377|27187318|P2|Overall Study|Site ended participation in study|0
7830644|NCT00312377|27187319|P1|Overall Study|Site ended participation in study|1
7830645|NCT00312377|27187318|P2|Overall Study|Discontinue treatment survival follow up|200
7830646|NCT00312377|27187319|P1|Overall Study|Discontinue treatment survival follow up|202
7830647|NCT00312377|27187318|P2|Overall Study|Randomised but never received treatment|6
7830648|NCT00312377|27187319|P1|Overall Study|Randomised but never received treatment|6
7830649|NCT00312377|27187318|P2|Overall Study|Non-compliance|2
7830650|NCT00312377|27187319|P1|Overall Study|Non-compliance|0
7830651|NCT00312377|27187318|P2|Overall Study|Lost to Follow-up|12
7830652|NCT00312377|27187319|P1|Overall Study|Lost to Follow-up|9
7830653|NCT00312377|27187318|P2|Overall Study|Withdrawal by Subject|30
7830654|NCT00312377|27187319|P1|Overall Study|Withdrawal by Subject|23
7830655|NCT00312377|27187318|P2|Overall Study|Death|418
7830656|NCT00312377|27187319|P1|Overall Study|Death|403
7830657|NCT00312338|27187343|P2|Overall Study|Subsequent infection|0
7830658|NCT00312338|27187344|P1|Overall Study|Subsequent infection|2
7830659|NCT00312338|27187343|P2|Overall Study|Withdrawal by Subject|0
7830660|NCT00312338|27187344|P1|Overall Study|Withdrawal by Subject|4
7830661|NCT00312338|27187343|P2|Overall Study|Lost to Follow-up|1
7830662|NCT00312338|27187344|P1|Overall Study|Lost to Follow-up|9
7830663|NCT00312338|27187343|P2|Overall Study|Adverse Event|2
7830664|NCT00312338|27187344|P1|Overall Study|Adverse Event|7
7830665|NCT00312221|27187357|P4|Double-blind Phase|Lack of Efficacy|10
7830666|NCT00312221|27187358|P3|Double-blind Phase|Lack of Efficacy|6
7830667|NCT00312221|27187359|P2|Double-blind Phase|Lack of Efficacy|17
7830668|NCT00312221|27187360|P1|Double-blind Phase|Lack of Efficacy|0
7830669|NCT00312221|27187357|P4|Double-blind Phase|Administrative|33
7830670|NCT00312221|27187358|P3|Double-blind Phase|Administrative|37
7830671|NCT00312221|27187359|P2|Double-blind Phase|Administrative|26
7830672|NCT00312221|27187360|P1|Double-blind Phase|Administrative|0
7830673|NCT00312221|27187357|P4|Double-blind Phase|Lost to Follow-up|2
7830674|NCT00312221|27187358|P3|Double-blind Phase|Lost to Follow-up|2
7830675|NCT00312221|27187359|P2|Double-blind Phase|Lost to Follow-up|0
7830676|NCT00312221|27187360|P1|Double-blind Phase|Lost to Follow-up|0
7830677|NCT00312221|27187357|P4|Double-blind Phase|Adverse Event|18
7830678|NCT00312221|27187358|P3|Double-blind Phase|Adverse Event|19
7830679|NCT00312221|27187359|P2|Double-blind Phase|Adverse Event|10
7830680|NCT00312221|27187360|P1|Double-blind Phase|Adverse Event|0
7830681|NCT00312221|27187357|P4|Double-blind Phase|Withdrawal by Subject|7
7830682|NCT00312221|27187358|P3|Double-blind Phase|Withdrawal by Subject|8
7830683|NCT00312221|27187359|P2|Double-blind Phase|Withdrawal by Subject|6
7830684|NCT00312221|27187360|P1|Double-blind Phase|Withdrawal by Subject|0
7830685|NCT00312221|27187357|P4|Open-label Run-in Period|Did not qualify|0
7830686|NCT00312221|27187358|P3|Open-label Run-in Period|Did not qualify|0
7830687|NCT00312221|27187359|P2|Open-label Run-in Period|Did not qualify|0
7830688|NCT00312221|27187360|P1|Open-label Run-in Period|Did not qualify|5
7830689|NCT00312221|27187357|P4|Open-label Run-in Period|Lack of Efficacy|0
7830690|NCT00312221|27187358|P3|Open-label Run-in Period|Lack of Efficacy|0
7830691|NCT00312221|27187359|P2|Open-label Run-in Period|Lack of Efficacy|0
7830692|NCT00312221|27187360|P1|Open-label Run-in Period|Lack of Efficacy|102
7830693|NCT00312221|27187357|P4|Open-label Run-in Period|Administrative|0
7830694|NCT00312221|27187358|P3|Open-label Run-in Period|Administrative|0
7830695|NCT00312221|27187359|P2|Open-label Run-in Period|Administrative|0
7830696|NCT00312221|27187360|P1|Open-label Run-in Period|Administrative|42
7830697|NCT00312221|27187357|P4|Open-label Run-in Period|Lost to Follow-up|0
7830698|NCT00312221|27187358|P3|Open-label Run-in Period|Lost to Follow-up|0
7830699|NCT00312221|27187359|P2|Open-label Run-in Period|Lost to Follow-up|0
7830700|NCT00312221|27187360|P1|Open-label Run-in Period|Lost to Follow-up|5
7830701|NCT00312221|27187357|P4|Open-label Run-in Period|Adverse Event|0
7830702|NCT00312221|27187358|P3|Open-label Run-in Period|Adverse Event|0
7830703|NCT00312221|27187359|P2|Open-label Run-in Period|Adverse Event|0
7830704|NCT00312221|27187360|P1|Open-label Run-in Period|Adverse Event|74
7830705|NCT00312221|27187357|P4|Open-label Run-in Period|Withdrawal by Subject|0
7830706|NCT00312221|27187358|P3|Open-label Run-in Period|Withdrawal by Subject|0
7830707|NCT00312221|27187359|P2|Open-label Run-in Period|Withdrawal by Subject|0
7830708|NCT00312221|27187360|P1|Open-label Run-in Period|Withdrawal by Subject|6
7830709|NCT00312208|27187380|P2|Overall Study|Other|7
7830710|NCT00312208|27187381|P1|Overall Study|Other|5
7830711|NCT00312208|27187380|P2|Overall Study|Withdrawal by Subject|42
7830712|NCT00312208|27187381|P1|Overall Study|Withdrawal by Subject|53
7830713|NCT00312208|27187380|P2|Overall Study|Lost to Follow-up|5
7830714|NCT00312208|27187381|P1|Overall Study|Lost to Follow-up|3
7830715|NCT00312208|27187380|P2|Overall Study|Lack of Efficacy|4
7830716|NCT00312208|27187381|P1|Overall Study|Lack of Efficacy|7
7830717|NCT00312208|27187380|P2|Overall Study|Death|1
7830718|NCT00312208|27187381|P1|Overall Study|Death|2
7830719|NCT00312208|27187380|P2|Overall Study|Protocol Violation|3
7830720|NCT00312208|27187381|P1|Overall Study|Protocol Violation|5
7830721|NCT00312208|27187380|P2|Overall Study|Adverse Event|61
7830722|NCT00312208|27187381|P1|Overall Study|Adverse Event|97
7830723|NCT00312195|27187391|P2|Overall Study|Protocol Violation|0
7830724|NCT00312195|27187392|P1|Overall Study|Protocol Violation|1
7830725|NCT00312195|27187391|P2|Overall Study|Lost to Follow-up|0
7830726|NCT00312195|27187392|P1|Overall Study|Lost to Follow-up|1
7830727|NCT00312195|27187391|P2|Overall Study|Adverse Event|6
7830728|NCT00312195|27187392|P1|Overall Study|Adverse Event|4
7830729|NCT00311623|27187420|P3|Overall Study|Physician Decision|2
7830730|NCT00311623|27187421|P2|Overall Study|Physician Decision|0
7830731|NCT00311623|27187422|P1|Overall Study|Physician Decision|0
7830732|NCT00311584|27187464|P2|Overall Study|ineligible|2
7830733|NCT00311584|27187465|P1|Overall Study|ineligible|2
7830734|NCT00311584|27187464|P2|Overall Study|Withdrawal by Subject|1
7830735|NCT00311584|27187465|P1|Overall Study|Withdrawal by Subject|1
7830736|NCT00311584|27187464|P2|Overall Study|Physician Decision|5
7830737|NCT00311584|27187465|P1|Overall Study|Physician Decision|4
7830738|NCT00311584|27187464|P2|Overall Study|Lack of Efficacy|15
7830739|NCT00311584|27187465|P1|Overall Study|Lack of Efficacy|12
7830740|NCT00311584|27187464|P2|Overall Study|Death|0
7830741|NCT00311584|27187465|P1|Overall Study|Death|1
7830742|NCT00311402|27187473|P2|Overall Study|IRB's rejection etc.|3
7830743|NCT00311402|27187474|P1|Overall Study|IRB's rejection etc.|10
7830744|NCT00311402|27187473|P2|Overall Study|Protocol Violation|6
7830745|NCT00311402|27187474|P1|Overall Study|Protocol Violation|7
7830746|NCT00311402|27187473|P2|Overall Study|Lack of Efficacy|42
7830747|NCT00311402|27187474|P1|Overall Study|Lack of Efficacy|58
7830748|NCT00311402|27187473|P2|Overall Study|Withdrawal by Subject|18
7830749|NCT00311402|27187474|P1|Overall Study|Withdrawal by Subject|17
7830750|NCT00311402|27187473|P2|Overall Study|Lost to Follow-up|3
7830751|NCT00311402|27187474|P1|Overall Study|Lost to Follow-up|0
7830752|NCT00311402|27187473|P2|Overall Study|Adverse Event|105
7830753|NCT00311402|27187474|P1|Overall Study|Adverse Event|118
7830754|NCT00311363|27187523|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
7830755|NCT00311363|27187524|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
7830756|NCT00311363|27187525|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
7830757|NCT00311363|27187523|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
7830758|NCT00311363|27187524|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
7830759|NCT00311363|27187525|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
7830760|NCT00311363|27187523|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
7830761|NCT00311363|27187524|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
7830762|NCT00311363|27187525|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
7830763|NCT00311363|27187523|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
7830764|NCT00311363|27187524|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
7830765|NCT00311363|27187525|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
7830766|NCT00311363|27187523|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
7830767|NCT00311363|27187524|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
7830768|NCT00311363|27187525|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
7830769|NCT00311363|27187523|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
7830770|NCT00311363|27187524|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
7830771|NCT00311363|27187525|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
7830772|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Death|0
7830773|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Death|0
7830774|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Death|1
7830775|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
7830776|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
7830777|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
7830778|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
7830779|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
7830780|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
7830781|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
7830782|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
7830783|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
7830784|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
7830785|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
7830786|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
7830787|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
7830788|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
7830789|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
7830790|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
7830791|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
7831554|NCT00306891|27189879|P2|Part B|Death|0
7830792|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
7830793|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
7830794|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
7830795|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
7830796|NCT00311363|27187523|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
7830797|NCT00311363|27187524|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
7830798|NCT00311363|27187525|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
7830799|NCT00311311|27187585|P2|Overall Study|Lack of ancillary assistance|1
7830800|NCT00311311|27187586|P1|Overall Study|Lack of ancillary assistance|0
7830801|NCT00311311|27187585|P2|Overall Study|Death|0
7830802|NCT00311311|27187586|P1|Overall Study|Death|1
7830803|NCT00311311|27187585|P2|Overall Study|Study Termination by Sponsor|4
7830804|NCT00311311|27187586|P1|Overall Study|Study Termination by Sponsor|3
7830805|NCT00311311|27187585|P2|Overall Study|Noncompliance|1
7830806|NCT00311311|27187586|P1|Overall Study|Noncompliance|0
7830807|NCT00311311|27187585|P2|Overall Study|Withdrawal by Subject|1
7830808|NCT00311311|27187586|P1|Overall Study|Withdrawal by Subject|1
7830809|NCT00311311|27187585|P2|Overall Study|Adverse Event|2
7830810|NCT00311311|27187586|P1|Overall Study|Adverse Event|3
7830811|NCT00311181|27187644|P1|Overall Study|Final DFTs were not obtained|96
7830812|NCT00311168|27187652|P2|Second Intervention|Other|1
7830813|NCT00311168|27187653|P1|Second Intervention|Other|1
7830814|NCT00311168|27187652|P2|Second Intervention|Withdrawal by Subject|1
7830815|NCT00311168|27187653|P1|Second Intervention|Withdrawal by Subject|0
7830816|NCT00311168|27187652|P2|Second Intervention|Lost to Follow-up|2
7830817|NCT00311168|27187653|P1|Second Intervention|Lost to Follow-up|9
7830818|NCT00311168|27187652|P2|First Intervention|Other|2
7830819|NCT00311168|27187653|P1|First Intervention|Other|2
7830820|NCT00311168|27187652|P2|First Intervention|Adverse Event|0
7830821|NCT00311168|27187653|P1|First Intervention|Adverse Event|1
7830822|NCT00311168|27187652|P2|First Intervention|Protocol Violation|1
7830823|NCT00311168|27187653|P1|First Intervention|Protocol Violation|1
7830824|NCT00311168|27187652|P2|First Intervention|Lost to Follow-up|1
7830825|NCT00311168|27187653|P1|First Intervention|Lost to Follow-up|1
7830826|NCT00311168|27187652|P2|First Intervention|Withdrawal by Subject|2
7830827|NCT00311168|27187653|P1|First Intervention|Withdrawal by Subject|2
7830828|NCT00311155|27187673|P1|Overall Study|Did not meet entry criteria|55
7830829|NCT00311155|27187673|P1|Overall Study|Withdrawal by Subject|17
7830830|NCT00311155|27187673|P1|Overall Study|Adverse Event|21
7830831|NCT00310856|27187685|P3|Overall Study|Unable to classify|0
7830832|NCT00310856|27187686|P2|Overall Study|Unable to classify|0
7830833|NCT00310856|27187687|P1|Overall Study|Unable to classify|1
7830834|NCT00310856|27187685|P3|Overall Study|Inappropriate enrollment|0
7830835|NCT00310856|27187686|P2|Overall Study|Inappropriate enrollment|1
7830836|NCT00310856|27187687|P1|Overall Study|Inappropriate enrollment|1
7830837|NCT00310856|27187685|P3|Overall Study|Lost to Follow-up|6
7830838|NCT00310856|27187686|P2|Overall Study|Lost to Follow-up|2
7830839|NCT00310856|27187687|P1|Overall Study|Lost to Follow-up|1
7830840|NCT00310856|27187685|P3|Overall Study|Withdrawal by Subject|2
7830841|NCT00310856|27187686|P2|Overall Study|Withdrawal by Subject|2
7830842|NCT00310856|27187687|P1|Overall Study|Withdrawal by Subject|2
7830843|NCT00310817|27187711|P4|Overall Study|Unable to classify|0
7830844|NCT00310817|27187712|P3|Overall Study|Unable to classify|0
7830845|NCT00310817|27187713|P2|Overall Study|Unable to classify|1
7830846|NCT00310817|27187714|P1|Overall Study|Unable to classify|3
7830847|NCT00310817|27187711|P4|Overall Study|Protocol Violation|1
7830848|NCT00310817|27187712|P3|Overall Study|Protocol Violation|1
7830849|NCT00310817|27187713|P2|Overall Study|Protocol Violation|1
7830850|NCT00310817|27187714|P1|Overall Study|Protocol Violation|1
7830851|NCT00310817|27187711|P4|Overall Study|Inappropriate Enrollment|0
7830852|NCT00310817|27187712|P3|Overall Study|Inappropriate Enrollment|1
7830853|NCT00310817|27187713|P2|Overall Study|Inappropriate Enrollment|0
7830854|NCT00310817|27187714|P1|Overall Study|Inappropriate Enrollment|1
7830855|NCT00310817|27187711|P4|Overall Study|Lost to Follow-up|0
7830856|NCT00310817|27187712|P3|Overall Study|Lost to Follow-up|0
7830857|NCT00310817|27187713|P2|Overall Study|Lost to Follow-up|1
7830858|NCT00310817|27187714|P1|Overall Study|Lost to Follow-up|2
7830859|NCT00310817|27187711|P4|Overall Study|Withdrawal by Subject|7
7830860|NCT00310817|27187712|P3|Overall Study|Withdrawal by Subject|6
7830861|NCT00310817|27187713|P2|Overall Study|Withdrawal by Subject|4
7830862|NCT00310817|27187714|P1|Overall Study|Withdrawal by Subject|1
7830863|NCT00310817|27187711|P4|Overall Study|AE or Death|0
7830864|NCT00310817|27187712|P3|Overall Study|AE or Death|0
7830865|NCT00310817|27187713|P2|Overall Study|AE or Death|1
7830866|NCT00310817|27187714|P1|Overall Study|AE or Death|3
7830867|NCT00310804|27187802|P2|Overall Study|Withdrawal by Subject|0
7830868|NCT00310804|27187803|P1|Overall Study|Withdrawal by Subject|3
7830869|NCT00310804|27187802|P2|Overall Study|Lost to Follow-up|0
7830870|NCT00310804|27187803|P1|Overall Study|Lost to Follow-up|2
7830871|NCT00310440|27187862|P2|Overall Study|Missed 12 Month Visit|4
7830872|NCT00310440|27187863|P1|Overall Study|Missed 12 Month Visit|7
7830873|NCT00310440|27187862|P2|Overall Study|Withdrawal by Subject|1
7830874|NCT00310440|27187863|P1|Overall Study|Withdrawal by Subject|2
7830875|NCT00310440|27187862|P2|Overall Study|Lost to Follow-up|8
7830876|NCT00310440|27187863|P1|Overall Study|Lost to Follow-up|17
7830877|NCT00310388|27187927|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
7830878|NCT00310388|27187928|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
7830879|NCT00310388|27187927|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
7830880|NCT00310388|27187928|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
7830881|NCT00310388|27187927|P2|Safety Follow-up Continuation Phase|Adverse Event|1
7830882|NCT00310388|27187928|P1|Safety Follow-up Continuation Phase|Adverse Event|0
7830883|NCT00310388|27187927|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
7830884|NCT00310388|27187928|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
7830885|NCT00310388|27187927|P2|Primary Reporting Phase|Other|0
7830886|NCT00310388|27187928|P1|Primary Reporting Phase|Other|1
7830887|NCT00310388|27187927|P2|Primary Reporting Phase|Missing|0
7830888|NCT00310388|27187928|P1|Primary Reporting Phase|Missing|1
7830889|NCT00310388|27187927|P2|Primary Reporting Phase|Participant retired the informed consent|0
7830890|NCT00310388|27187928|P1|Primary Reporting Phase|Participant retired the informed consent|1
7830891|NCT00310388|27187927|P2|Primary Reporting Phase|Participant passed away|0
7830892|NCT00310388|27187928|P1|Primary Reporting Phase|Participant passed away|1
7830893|NCT00310388|27187927|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
7830894|NCT00310388|27187928|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
7830895|NCT00310388|27187927|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
7830896|NCT00310388|27187928|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
7830897|NCT00310388|27187927|P2|Primary Reporting Phase|Termination of study at sponsor request|0
7830898|NCT00310388|27187928|P1|Primary Reporting Phase|Termination of study at sponsor request|3
7830899|NCT00310388|27187927|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
7830900|NCT00310388|27187928|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
7830901|NCT00310388|27187927|P2|Primary Reporting Phase|Discontinuation of study|0
7830902|NCT00310388|27187928|P1|Primary Reporting Phase|Discontinuation of study|1
7830903|NCT00310388|27187927|P2|Primary Reporting Phase|Ministry of Health decision|0
7830904|NCT00310388|27187928|P1|Primary Reporting Phase|Ministry of Health decision|25
7830905|NCT00310388|27187927|P2|Primary Reporting Phase|Participant request|0
7830906|NCT00310388|27187928|P1|Primary Reporting Phase|Participant request|2
7830907|NCT00310388|27187927|P2|Primary Reporting Phase|Participant request unrelated to study|0
7830908|NCT00310388|27187928|P1|Primary Reporting Phase|Participant request unrelated to study|2
7830909|NCT00310388|27187927|P2|Primary Reporting Phase|Failed to return|0
7830910|NCT00310388|27187928|P1|Primary Reporting Phase|Failed to return|8
7830911|NCT00310388|27187927|P2|Primary Reporting Phase|Request of the sponsor|0
7830912|NCT00310388|27187928|P1|Primary Reporting Phase|Request of the sponsor|19
7830913|NCT00310388|27187927|P2|Primary Reporting Phase|Physician Decision|0
7830914|NCT00310388|27187928|P1|Primary Reporting Phase|Physician Decision|2
7830915|NCT00310388|27187927|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
7830916|NCT00310388|27187928|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
7830917|NCT00310388|27187927|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
7830918|NCT00310388|27187928|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
7830919|NCT00310388|27187927|P2|Primary Reporting Phase|Change in participant medical condition|0
7830920|NCT00310388|27187928|P1|Primary Reporting Phase|Change in participant medical condition|3
7830921|NCT00310388|27187927|P2|Primary Reporting Phase|Pregnancy|0
7830922|NCT00310388|27187928|P1|Primary Reporting Phase|Pregnancy|3
7830923|NCT00310388|27187927|P2|Primary Reporting Phase|Protocol Violation|0
7830924|NCT00310388|27187928|P1|Primary Reporting Phase|Protocol Violation|10
7830925|NCT00310388|27187927|P2|Primary Reporting Phase|Withdrawal by Subject|0
7830926|NCT00310388|27187928|P1|Primary Reporting Phase|Withdrawal by Subject|97
7830927|NCT00310388|27187927|P2|Primary Reporting Phase|Lack of Efficacy|0
7830928|NCT00310388|27187928|P1|Primary Reporting Phase|Lack of Efficacy|56
7830929|NCT00310388|27187927|P2|Primary Reporting Phase|Adverse Event|0
7830930|NCT00310388|27187928|P1|Primary Reporting Phase|Adverse Event|101
7830931|NCT00310375|27187970|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
7830932|NCT00310375|27187971|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
7830933|NCT00310375|27187972|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
7830934|NCT00310375|27187970|P3|Primary Reporting Phase|Request of Ethics Committee|0
7830935|NCT00310375|27187971|P2|Primary Reporting Phase|Request of Ethics Committee|1
7830936|NCT00310375|27187972|P1|Primary Reporting Phase|Request of Ethics Committee|0
7830937|NCT00310375|27187970|P3|Primary Reporting Phase|Par. switched to commercial product|0
7830938|NCT00310375|27187971|P2|Primary Reporting Phase|Par. switched to commercial product|1
7830939|NCT00310375|27187972|P1|Primary Reporting Phase|Par. switched to commercial product|0
7830940|NCT00310375|27187970|P3|Primary Reporting Phase|Missed study drug for 2 months|0
7830941|NCT00310375|27187971|P2|Primary Reporting Phase|Missed study drug for 2 months|0
7830942|NCT00310375|27187972|P1|Primary Reporting Phase|Missed study drug for 2 months|1
7830943|NCT00310375|27187970|P3|Primary Reporting Phase|Site closure|0
7830944|NCT00310375|27187971|P2|Primary Reporting Phase|Site closure|0
7830945|NCT00310375|27187972|P1|Primary Reporting Phase|Site closure|3
7830946|NCT00310375|27187970|P3|Primary Reporting Phase|Missed study drug >5 days|0
7830947|NCT00310375|27187971|P2|Primary Reporting Phase|Missed study drug >5 days|0
7830948|NCT00310375|27187972|P1|Primary Reporting Phase|Missed study drug >5 days|1
7830949|NCT00310375|27187970|P3|Primary Reporting Phase|Going for temporal lobectomy|0
7830950|NCT00310375|27187971|P2|Primary Reporting Phase|Going for temporal lobectomy|0
7830951|NCT00310375|27187972|P1|Primary Reporting Phase|Going for temporal lobectomy|1
7830952|NCT00310375|27187970|P3|Primary Reporting Phase|Participant request unrelated to study|0
7830953|NCT00310375|27187971|P2|Primary Reporting Phase|Participant request unrelated to study|2
7830954|NCT00310375|27187972|P1|Primary Reporting Phase|Participant request unrelated to study|1
7830955|NCT00310375|27187970|P3|Primary Reporting Phase|Failed to return|0
7830956|NCT00310375|27187971|P2|Primary Reporting Phase|Failed to return|3
7830957|NCT00310375|27187972|P1|Primary Reporting Phase|Failed to return|1
7830958|NCT00310375|27187970|P3|Primary Reporting Phase|Request of the sponsor|0
7830959|NCT00310375|27187971|P2|Primary Reporting Phase|Request of the sponsor|2
7830960|NCT00310375|27187972|P1|Primary Reporting Phase|Request of the sponsor|2
7830961|NCT00310375|27187970|P3|Primary Reporting Phase|Physician Decision|0
7830962|NCT00310375|27187971|P2|Primary Reporting Phase|Physician Decision|3
7830963|NCT00310375|27187972|P1|Primary Reporting Phase|Physician Decision|5
7830964|NCT00310375|27187970|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
7830965|NCT00310375|27187971|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
7830966|NCT00310375|27187972|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
7830967|NCT00310375|27187970|P3|Primary Reporting Phase|Change in Par medical condition|0
7830968|NCT00310375|27187971|P2|Primary Reporting Phase|Change in Par medical condition|0
7830969|NCT00310375|27187972|P1|Primary Reporting Phase|Change in Par medical condition|2
7830970|NCT00310375|27187970|P3|Primary Reporting Phase|Protocol Violation|0
7830971|NCT00310375|27187971|P2|Primary Reporting Phase|Protocol Violation|5
7830972|NCT00310375|27187972|P1|Primary Reporting Phase|Protocol Violation|8
7830973|NCT00310375|27187970|P3|Primary Reporting Phase|Withdrawal by Subject|0
7830974|NCT00310375|27187971|P2|Primary Reporting Phase|Withdrawal by Subject|7
7830975|NCT00310375|27187972|P1|Primary Reporting Phase|Withdrawal by Subject|10
7830976|NCT00310375|27187970|P3|Primary Reporting Phase|Pregnancy|0
7830977|NCT00310375|27187971|P2|Primary Reporting Phase|Pregnancy|2
7830978|NCT00310375|27187972|P1|Primary Reporting Phase|Pregnancy|2
7830979|NCT00310375|27187970|P3|Primary Reporting Phase|Lack of Efficacy|0
7830980|NCT00310375|27187971|P2|Primary Reporting Phase|Lack of Efficacy|19
7830981|NCT00310375|27187972|P1|Primary Reporting Phase|Lack of Efficacy|24
7830982|NCT00310375|27187970|P3|Primary Reporting Phase|Adverse Event|0
7830983|NCT00310375|27187971|P2|Primary Reporting Phase|Adverse Event|22
7830984|NCT00310375|27187972|P1|Primary Reporting Phase|Adverse Event|28
7830985|NCT00310037|27188117|P2|Overall Study|Non-protocol treatment|0
7830986|NCT00310037|27188118|P1|Overall Study|Non-protocol treatment|1
7830987|NCT00310037|27188117|P2|Overall Study|Progression|0
7830988|NCT00310037|27188118|P1|Overall Study|Progression|6
7830989|NCT00310037|27188117|P2|Overall Study|Withdrawal by Subject|3
7830990|NCT00310037|27188118|P1|Overall Study|Withdrawal by Subject|4
7830991|NCT00310037|27188117|P2|Overall Study|Adverse Event|14
7830992|NCT00310037|27188118|P1|Overall Study|Adverse Event|7
7830993|NCT00309985|27188132|P2|Overall Study|Chemotherapy discontinued only|0
7830994|NCT00309985|27188133|P1|Overall Study|Chemotherapy discontinued only|1
7830995|NCT00309985|27188132|P2|Overall Study|Non-compliance|0
7830996|NCT00309985|27188133|P1|Overall Study|Non-compliance|1
7830997|NCT00309985|27188132|P2|Overall Study|Complicating disease|0
7830998|NCT00309985|27188133|P1|Overall Study|Complicating disease|1
7830999|NCT00309985|27188132|P2|Overall Study|Never started treatment|0
7831000|NCT00309985|27188133|P1|Overall Study|Never started treatment|7
7831001|NCT00309985|27188132|P2|Overall Study|Physician Decision|0
7831002|NCT00309985|27188133|P1|Overall Study|Physician Decision|3
7831003|NCT00309985|27188132|P2|Overall Study|Withdrawal by Subject|1
7831004|NCT00309985|27188133|P1|Overall Study|Withdrawal by Subject|5
7831005|NCT00309985|27188132|P2|Overall Study|Death|0
7831006|NCT00309985|27188133|P1|Overall Study|Death|2
7831007|NCT00309985|27188132|P2|Overall Study|Adverse Event|0
7831008|NCT00309985|27188133|P1|Overall Study|Adverse Event|30
7831009|NCT00309985|27188132|P2|Overall Study|Disease progression|0
7831010|NCT00309985|27188133|P1|Overall Study|Disease progression|12
7831011|NCT00309959|27188149|P1|Overall Study|Ineligible - no prior chemotherapy|2
7831012|NCT00309946|27188158|P1|Overall Study|Withdrawal by Subject|1
7831013|NCT00309907|27188164|P1|Overall Study|Major infectious event|4
7831014|NCT00309907|27188164|P1|Overall Study|Ineligible|11
7831015|NCT00309907|27188164|P1|Overall Study|Physician Decision|1
7831016|NCT00309907|27188164|P1|Overall Study|Death|4
7831017|NCT00309842|27188173|P1|Overall Study|Lost to Follow-up|1
7831018|NCT00309777|27188191|P4|Overall Study|Death|0
7831019|NCT00309777|27188192|P3|Overall Study|Death|0
7831020|NCT00309777|27188193|P2|Overall Study|Death|1
7831021|NCT00309777|27188194|P1|Overall Study|Death|0
7831022|NCT00309777|27188191|P4|Overall Study|Lost to Follow-up|0
7831023|NCT00309777|27188192|P3|Overall Study|Lost to Follow-up|1
7831024|NCT00309777|27188193|P2|Overall Study|Lost to Follow-up|0
7831025|NCT00309777|27188194|P1|Overall Study|Lost to Follow-up|0
7831026|NCT00309777|27188191|P4|Overall Study|Withdrawal by Subject|2
7831027|NCT00309777|27188192|P3|Overall Study|Withdrawal by Subject|7
7831028|NCT00309777|27188193|P2|Overall Study|Withdrawal by Subject|5
7831029|NCT00309777|27188194|P1|Overall Study|Withdrawal by Subject|6
7831030|NCT00309777|27188191|P4|Overall Study|Protocol Violation|1
7831031|NCT00309777|27188192|P3|Overall Study|Protocol Violation|3
7831032|NCT00309777|27188193|P2|Overall Study|Protocol Violation|1
7831033|NCT00309777|27188194|P1|Overall Study|Protocol Violation|4
7831034|NCT00309777|27188191|P4|Overall Study|Adverse Event|1
7831035|NCT00309777|27188192|P3|Overall Study|Adverse Event|8
7831036|NCT00309777|27188193|P2|Overall Study|Adverse Event|2
7831037|NCT00309777|27188194|P1|Overall Study|Adverse Event|13
7831038|NCT00309608|27188235|P5|Overall Study|Other incl. Lack of efficacy|0
7831039|NCT00309608|27188236|P4|Overall Study|Other incl. Lack of efficacy|4
7831040|NCT00309608|27188237|P3|Overall Study|Other incl. Lack of efficacy|3
7831041|NCT00309608|27188238|P2|Overall Study|Other incl. Lack of efficacy|4
7831042|NCT00309608|27188239|P1|Overall Study|Other incl. Lack of efficacy|10
7831043|NCT00309608|27188235|P5|Overall Study|Withdrawal by Subject|0
7831044|NCT00309608|27188236|P4|Overall Study|Withdrawal by Subject|0
7831045|NCT00309608|27188237|P3|Overall Study|Withdrawal by Subject|2
7831046|NCT00309608|27188238|P2|Overall Study|Withdrawal by Subject|4
7831047|NCT00309608|27188239|P1|Overall Study|Withdrawal by Subject|1
7831048|NCT00309608|27188235|P5|Overall Study|Lost to Follow-up|1
7831049|NCT00309608|27188236|P4|Overall Study|Lost to Follow-up|0
7831050|NCT00309608|27188237|P3|Overall Study|Lost to Follow-up|2
7831051|NCT00309608|27188238|P2|Overall Study|Lost to Follow-up|0
7831052|NCT00309608|27188239|P1|Overall Study|Lost to Follow-up|0
7831053|NCT00309608|27188235|P5|Overall Study|Protocol Violation|0
7831054|NCT00309608|27188236|P4|Overall Study|Protocol Violation|0
7831055|NCT00309608|27188237|P3|Overall Study|Protocol Violation|0
7831056|NCT00309608|27188238|P2|Overall Study|Protocol Violation|0
7831057|NCT00309608|27188239|P1|Overall Study|Protocol Violation|2
7831058|NCT00309608|27188235|P5|Overall Study|Adverse Event|3
7831059|NCT00309608|27188236|P4|Overall Study|Adverse Event|2
7831060|NCT00309608|27188237|P3|Overall Study|Adverse Event|3
7831061|NCT00309608|27188238|P2|Overall Study|Adverse Event|5
7831062|NCT00309608|27188239|P1|Overall Study|Adverse Event|1
7831063|NCT00309452|27188287|P2|Overall Study|Withdrawal by Subject|0
7831064|NCT00309452|27188288|P1|Overall Study|Withdrawal by Subject|3
7831065|NCT00309387|27188316|P2|Overall Study|Lost to Follow-up|86
7831066|NCT00309387|27188317|P1|Overall Study|Lost to Follow-up|70
7831067|NCT00309387|27188316|P2|Overall Study|Death|73
7831068|NCT00309387|27188317|P1|Overall Study|Death|72
7831069|NCT00309244|27188335|P2|Overall Study|Death|1
7831070|NCT00309244|27188336|P1|Overall Study|Death|4
7831071|NCT00309244|27188335|P2|Overall Study|Randomized but not dosed|12
7831072|NCT00309244|27188336|P1|Overall Study|Randomized but not dosed|11
7831073|NCT00309244|27188335|P2|Overall Study|Various|7
7831074|NCT00309244|27188336|P1|Overall Study|Various|7
7831075|NCT00309244|27188335|P2|Overall Study|Withdrawal by Subject|32
7831076|NCT00309244|27188336|P1|Overall Study|Withdrawal by Subject|50
7831077|NCT00309244|27188335|P2|Overall Study|Protocol Violation|3
7831078|NCT00309244|27188336|P1|Overall Study|Protocol Violation|6
7831079|NCT00309244|27188335|P2|Overall Study|Physician Decision|8
7831080|NCT00309244|27188336|P1|Overall Study|Physician Decision|5
7831081|NCT00309244|27188335|P2|Overall Study|Lost to Follow-up|22
7831082|NCT00309244|27188336|P1|Overall Study|Lost to Follow-up|6
7831083|NCT00309244|27188335|P2|Overall Study|Adverse Event|12
7831084|NCT00309244|27188336|P1|Overall Study|Adverse Event|29
7831085|NCT00309166|27188358|P2|Overall Study|Withdrawal by Subject|3
7831086|NCT00309166|27188359|P1|Overall Study|Withdrawal by Subject|4
7831087|NCT00309166|27188358|P2|Overall Study|Adverse event, non-fatal|0
7831088|NCT00309166|27188359|P1|Overall Study|Adverse event, non-fatal|1
7831089|NCT00308997|27188393|P2|Overall Study|Unable to tolerate intervention|0
7831090|NCT00308997|27188394|P1|Overall Study|Unable to tolerate intervention|1
7831091|NCT00308997|27188393|P2|Overall Study|Subject feigned clinical data|1
7831092|NCT00308997|27188394|P1|Overall Study|Subject feigned clinical data|0
7831093|NCT00308750|27188413|P3|Overall Study|New Primary Disease Identified|0
7831094|NCT00308750|27188414|P2|Overall Study|New Primary Disease Identified|1
7831095|NCT00308750|27188415|P1|Overall Study|New Primary Disease Identified|1
7831096|NCT00308750|27188413|P3|Overall Study|Protocol Violation|0
7831097|NCT00308750|27188414|P2|Overall Study|Protocol Violation|0
7831098|NCT00308750|27188415|P1|Overall Study|Protocol Violation|1
7831099|NCT00308750|27188413|P3|Overall Study|Death|1
7831100|NCT00308750|27188414|P2|Overall Study|Death|0
7831101|NCT00308750|27188415|P1|Overall Study|Death|1
7831102|NCT00308750|27188413|P3|Overall Study|Unrelated Complication|1
7831103|NCT00308750|27188414|P2|Overall Study|Unrelated Complication|0
7831104|NCT00308750|27188415|P1|Overall Study|Unrelated Complication|3
7831105|NCT00308750|27188413|P3|Overall Study|Disease Progression|28
7831106|NCT00308750|27188414|P2|Overall Study|Disease Progression|24
7831107|NCT00308750|27188415|P1|Overall Study|Disease Progression|47
7831108|NCT00308750|27188413|P3|Overall Study|Sponsor Decision|0
7831109|NCT00308750|27188414|P2|Overall Study|Sponsor Decision|0
7831110|NCT00308750|27188415|P1|Overall Study|Sponsor Decision|1
7831111|NCT00308750|27188413|P3|Overall Study|Physician Decision|3
7831112|NCT00308750|27188414|P2|Overall Study|Physician Decision|4
7831113|NCT00308750|27188415|P1|Overall Study|Physician Decision|3
7831114|NCT00308750|27188413|P3|Overall Study|Withdrawal by Subject|3
7831115|NCT00308750|27188414|P2|Overall Study|Withdrawal by Subject|2
7831116|NCT00308750|27188415|P1|Overall Study|Withdrawal by Subject|6
7831117|NCT00308750|27188413|P3|Overall Study|Adverse Event|13
7831118|NCT00308750|27188414|P2|Overall Study|Adverse Event|9
7831119|NCT00308750|27188415|P1|Overall Study|Adverse Event|9
7831120|NCT00308737|27188453|P3|Overall Study|Various|8
7831121|NCT00308737|27188454|P2|Overall Study|Various|20
7831122|NCT00308737|27188455|P1|Overall Study|Various|32
7831123|NCT00308737|27188453|P3|Overall Study|Withdrawal by Subject|18
7831124|NCT00308737|27188454|P2|Overall Study|Withdrawal by Subject|166
7831125|NCT00308737|27188455|P1|Overall Study|Withdrawal by Subject|218
7831555|NCT00306891|27189880|P1|Part B|Death|0
7831126|NCT00308737|27188453|P3|Overall Study|Protocol Violation|5
7831127|NCT00308737|27188454|P2|Overall Study|Protocol Violation|9
7831128|NCT00308737|27188455|P1|Overall Study|Protocol Violation|34
7831129|NCT00308737|27188453|P3|Overall Study|Physician Decision|1
7831130|NCT00308737|27188454|P2|Overall Study|Physician Decision|2
7831131|NCT00308737|27188455|P1|Overall Study|Physician Decision|15
7831132|NCT00308737|27188453|P3|Overall Study|Lost to Follow-up|5
7831133|NCT00308737|27188454|P2|Overall Study|Lost to Follow-up|80
7831134|NCT00308737|27188455|P1|Overall Study|Lost to Follow-up|56
7831135|NCT00308737|27188453|P3|Overall Study|Death|0
7831136|NCT00308737|27188454|P2|Overall Study|Death|3
7831137|NCT00308737|27188455|P1|Overall Study|Death|4
7831138|NCT00308737|27188453|P3|Overall Study|Adverse Event|0
7831139|NCT00308737|27188454|P2|Overall Study|Adverse Event|9
7831140|NCT00308737|27188455|P1|Overall Study|Adverse Event|104
7831141|NCT00308711|27188495|P3|Overall Study|Subject incarcerated, data not allowed|1
7831142|NCT00308711|27188496|P2|Overall Study|Subject incarcerated, data not allowed|0
7831143|NCT00308711|27188497|P1|Overall Study|Subject incarcerated, data not allowed|0
7831144|NCT00308711|27188495|P3|Overall Study|Baby not born within 7 days of treatment|2
7831145|NCT00308711|27188496|P2|Overall Study|Baby not born within 7 days of treatment|2
7831146|NCT00308711|27188497|P1|Overall Study|Baby not born within 7 days of treatment|1
7831147|NCT00308711|27188495|P3|Overall Study|Lost to Follow-up|0
7831148|NCT00308711|27188496|P2|Overall Study|Lost to Follow-up|1
7831149|NCT00308711|27188497|P1|Overall Study|Lost to Follow-up|0
7831150|NCT00308711|27188495|P3|Overall Study|Protocol Violation|1
7831151|NCT00308711|27188496|P2|Overall Study|Protocol Violation|1
7831152|NCT00308711|27188497|P1|Overall Study|Protocol Violation|0
7831153|NCT00308711|27188495|P3|Overall Study|Withdrawal by Subject|1
7831154|NCT00308711|27188496|P2|Overall Study|Withdrawal by Subject|0
7831155|NCT00308711|27188497|P1|Overall Study|Withdrawal by Subject|1
7831156|NCT00308620|27188532|P3|Overall Study|Lost to Follow-up|1
7831157|NCT00308620|27188533|P2|Overall Study|Lost to Follow-up|0
7831158|NCT00308620|27188534|P1|Overall Study|Lost to Follow-up|0
7831159|NCT00308620|27188532|P3|Overall Study|Death|0
7831160|NCT00308620|27188533|P2|Overall Study|Death|1
7831161|NCT00308620|27188534|P1|Overall Study|Death|1
7831162|NCT00308581|27188543|P3|Randomized Maintenance Phase|Unknown reason|0
7831163|NCT00308581|27188544|P2|Randomized Maintenance Phase|Unknown reason|0
7831164|NCT00308581|27188545|P1|Randomized Maintenance Phase|Unknown reason|3
7831165|NCT00308581|27188543|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
7831166|NCT00308581|27188544|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
7831167|NCT00308581|27188545|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
7831168|NCT00308581|27188543|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
7831169|NCT00308581|27188544|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
7831170|NCT00308581|27188545|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
7831171|NCT00308581|27188543|P3|Randomized Maintenance Phase|Lost to Follow-up|0
7831172|NCT00308581|27188544|P2|Randomized Maintenance Phase|Lost to Follow-up|2
7831173|NCT00308581|27188545|P1|Randomized Maintenance Phase|Lost to Follow-up|0
7831174|NCT00308581|27188543|P3|Randomized Maintenance Phase|Lack of Efficacy|0
7831175|NCT00308581|27188544|P2|Randomized Maintenance Phase|Lack of Efficacy|21
7831176|NCT00308581|27188545|P1|Randomized Maintenance Phase|Lack of Efficacy|9
7831177|NCT00308581|27188543|P3|Randomized Maintenance Phase|Adverse Event|0
7831178|NCT00308581|27188544|P2|Randomized Maintenance Phase|Adverse Event|17
7831179|NCT00308581|27188545|P1|Randomized Maintenance Phase|Adverse Event|10
7831180|NCT00308581|27188543|P3|Induction Phase|Unknown reason|3
7831181|NCT00308581|27188544|P2|Induction Phase|Unknown reason|0
7831182|NCT00308581|27188545|P1|Induction Phase|Unknown reason|0
7831183|NCT00308581|27188543|P3|Induction Phase|Withdrawal by Subject|5
7831184|NCT00308581|27188544|P2|Induction Phase|Withdrawal by Subject|0
7831185|NCT00308581|27188545|P1|Induction Phase|Withdrawal by Subject|0
7831186|NCT00308581|27188543|P3|Induction Phase|Lack of Efficacy|121
7831187|NCT00308581|27188544|P2|Induction Phase|Lack of Efficacy|0
7831188|NCT00308581|27188545|P1|Induction Phase|Lack of Efficacy|0
7831189|NCT00308581|27188543|P3|Induction Phase|Adverse Event|37
7831190|NCT00308581|27188544|P2|Induction Phase|Adverse Event|0
7831191|NCT00308581|27188545|P1|Induction Phase|Adverse Event|0
7831192|NCT00308555|27188671|P2|Overall Study|Physician Decision|0
7831193|NCT00308555|27188672|P1|Overall Study|Physician Decision|2
7831194|NCT00308555|27188671|P2|Overall Study|Withdrawal by Subject|0
7831195|NCT00308555|27188672|P1|Overall Study|Withdrawal by Subject|1
7831196|NCT00308308|27188689|P2|Overall Study|Other|0
7831197|NCT00308308|27188690|P1|Overall Study|Other|1
7831198|NCT00308308|27188689|P2|Overall Study|Randomized but not dosed|16
7831199|NCT00308308|27188690|P1|Overall Study|Randomized but not dosed|8
7831200|NCT00308308|27188689|P2|Overall Study|Various|5
7831201|NCT00308308|27188690|P1|Overall Study|Various|7
7831202|NCT00308308|27188689|P2|Overall Study|Withdrawal by Subject|19
7831203|NCT00308308|27188690|P1|Overall Study|Withdrawal by Subject|47
7831204|NCT00308308|27188689|P2|Overall Study|Protocol Violation|14
7831205|NCT00308308|27188690|P1|Overall Study|Protocol Violation|3
7831206|NCT00308308|27188689|P2|Overall Study|Physician Decision|7
7831207|NCT00308308|27188690|P1|Overall Study|Physician Decision|15
7831208|NCT00308308|27188689|P2|Overall Study|Lost to Follow-up|5
7831209|NCT00308308|27188690|P1|Overall Study|Lost to Follow-up|5
7831210|NCT00308308|27188689|P2|Overall Study|Adverse Event|2
7831211|NCT00308308|27188690|P1|Overall Study|Adverse Event|17
7831212|NCT00308139|27188769|P2|Overall Study|Other|0
7831213|NCT00308139|27188770|P1|Overall Study|Other|1
7831214|NCT00308139|27188769|P2|Overall Study|Administrative|4
7831215|NCT00308139|27188770|P1|Overall Study|Administrative|1
7831216|NCT00308139|27188769|P2|Overall Study|Loss of Glucose Control|7
7831217|NCT00308139|27188770|P1|Overall Study|Loss of Glucose Control|5
7831218|NCT00308139|27188769|P2|Overall Study|Investigator Decision|10
7831219|NCT00308139|27188770|P1|Overall Study|Investigator Decision|11
7831220|NCT00308139|27188769|P2|Overall Study|Withdrawal of Consent|42
7831221|NCT00308139|27188770|P1|Overall Study|Withdrawal of Consent|40
7831222|NCT00308139|27188769|P2|Overall Study|Protocol Violation|2
7831223|NCT00308139|27188770|P1|Overall Study|Protocol Violation|3
7831224|NCT00308139|27188769|P2|Overall Study|Lost to Follow-up|8
7831225|NCT00308139|27188770|P1|Overall Study|Lost to Follow-up|13
7831226|NCT00308139|27188769|P2|Overall Study|Adverse Event|14
7831227|NCT00308139|27188770|P1|Overall Study|Adverse Event|20
7831228|NCT00308113|27188844|P4|Overall Study|Protocol closure|1
7831229|NCT00308113|27188845|P3|Overall Study|Protocol closure|0
7831230|NCT00308113|27188846|P2|Overall Study|Protocol closure|0
7831231|NCT00308113|27188847|P1|Overall Study|Protocol closure|0
7831232|NCT00308087|27188867|P2|Overall Study|Other|3
7831233|NCT00308087|27188868|P1|Overall Study|Other|4
7831234|NCT00308087|27188867|P2|Overall Study|Withdrawal by Subject|1
7831235|NCT00308087|27188868|P1|Overall Study|Withdrawal by Subject|2
7831236|NCT00308087|27188867|P2|Overall Study|Study Closure|12
7831237|NCT00308087|27188868|P1|Overall Study|Study Closure|11
7831238|NCT00308087|27188867|P2|Overall Study|Progressive Disease|21
7831239|NCT00308087|27188868|P1|Overall Study|Progressive Disease|19
7831240|NCT00308074|27188884|P1|Overall Study|Withdrawal by Subject|1
7831241|NCT00307931|27188901|P1|Overall Study|Adverse Event|1
7831242|NCT00307801|27188918|P2|Overall Study|Pregnancy|1
7831243|NCT00307801|27188919|P1|Overall Study|Pregnancy|0
7831244|NCT00307801|27188918|P2|Overall Study|No reason specified|0
7831245|NCT00307801|27188919|P1|Overall Study|No reason specified|2
7831246|NCT00307801|27188918|P2|Overall Study|Protocol Violation|2
7831247|NCT00307801|27188919|P1|Overall Study|Protocol Violation|3
7831248|NCT00307801|27188918|P2|Overall Study|Frustration with e-diary|0
7831249|NCT00307801|27188919|P1|Overall Study|Frustration with e-diary|1
7831250|NCT00307801|27188918|P2|Overall Study|Lost to Follow-up, moved abroad|1
7831251|NCT00307801|27188919|P1|Overall Study|Lost to Follow-up, moved abroad|1
7831252|NCT00307801|27188918|P2|Overall Study|Lack of Efficacy|2
7831253|NCT00307801|27188919|P1|Overall Study|Lack of Efficacy|0
7831254|NCT00307801|27188918|P2|Overall Study|Wrong Randomization|0
7831255|NCT00307801|27188919|P1|Overall Study|Wrong Randomization|1
7831256|NCT00307801|27188918|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
7831257|NCT00307801|27188919|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
7831258|NCT00307801|27188918|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
7831259|NCT00307801|27188919|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
7831260|NCT00307801|27188918|P2|Overall Study|Non-compliance, not taken all tablets|2
7831261|NCT00307801|27188919|P1|Overall Study|Non-compliance, not taken all tablets|1
7831262|NCT00307801|27188918|P2|Overall Study|Withdrawal by Subject|4
7831263|NCT00307801|27188919|P1|Overall Study|Withdrawal by Subject|9
7831264|NCT00307801|27188918|P2|Overall Study|Adverse Event|4
7831265|NCT00307801|27188919|P1|Overall Study|Adverse Event|12
7831266|NCT00307736|27189031|P4|Overall Study|Withdrawal by Subject|0
7831267|NCT00307736|27189032|P3|Overall Study|Withdrawal by Subject|2
7831268|NCT00307736|27189033|P2|Overall Study|Withdrawal by Subject|0
7831269|NCT00307736|27189034|P1|Overall Study|Withdrawal by Subject|0
7831270|NCT00307736|27189031|P4|Overall Study|Adverse Event|3
7831271|NCT00307736|27189032|P3|Overall Study|Adverse Event|1
7831272|NCT00307736|27189033|P2|Overall Study|Adverse Event|0
7831273|NCT00307736|27189034|P1|Overall Study|Adverse Event|0
7831274|NCT00307684|27189045|P3|Double Blind Phase|Lack of Efficacy|0
7831275|NCT00307684|27189046|P2|Double Blind Phase|Lack of Efficacy|5
7831276|NCT00307684|27189047|P1|Double Blind Phase|Lack of Efficacy|2
7831277|NCT00307684|27189045|P3|Open Label Phase|other|6
7831278|NCT00307684|27189046|P2|Open Label Phase|other|0
7831279|NCT00307684|27189047|P1|Open Label Phase|other|0
7831280|NCT00307684|27189045|P3|Open Label Phase|non compliance|5
7831281|NCT00307684|27189046|P2|Open Label Phase|non compliance|0
7831282|NCT00307684|27189047|P1|Open Label Phase|non compliance|0
7831283|NCT00307684|27189045|P3|Open Label Phase|Lost to Follow-up|11
7831284|NCT00307684|27189046|P2|Open Label Phase|Lost to Follow-up|0
7831285|NCT00307684|27189047|P1|Open Label Phase|Lost to Follow-up|0
7831286|NCT00307684|27189045|P3|Open Label Phase|Withdrawal by Subject|15
7831287|NCT00307684|27189046|P2|Open Label Phase|Withdrawal by Subject|0
7831288|NCT00307684|27189047|P1|Open Label Phase|Withdrawal by Subject|0
7831289|NCT00307684|27189045|P3|Open Label Phase|Adverse Event|16
7831290|NCT00307684|27189046|P2|Open Label Phase|Adverse Event|0
7831291|NCT00307684|27189047|P1|Open Label Phase|Adverse Event|0
7831292|NCT00307684|27189045|P3|Open Label Phase|Lack of Efficacy|3
7831293|NCT00307684|27189046|P2|Open Label Phase|Lack of Efficacy|0
7831294|NCT00307684|27189047|P1|Open Label Phase|Lack of Efficacy|0
7831295|NCT00307489|27189075|P2|Week 48 Through Week 168|Seroconversion|0
7831296|NCT00307489|27189076|P1|Week 48 Through Week 168|Seroconversion|1
7831297|NCT00307489|27189075|P2|Week 48 Through Week 168|Lost to Follow-up|1
7831298|NCT00307489|27189076|P1|Week 48 Through Week 168|Lost to Follow-up|0
7831299|NCT00307489|27189075|P2|Week 48 Through Week 168|Death|1
7831300|NCT00307489|27189076|P1|Week 48 Through Week 168|Death|0
7831301|NCT00307489|27189075|P2|Week 48 Through Week 168|Lack of Efficacy|2
7831302|NCT00307489|27189076|P1|Week 48 Through Week 168|Lack of Efficacy|2
7831303|NCT00307489|27189075|P2|Week 48 Through Week 168|Withdrawal by Subject|2
7831304|NCT00307489|27189076|P1|Week 48 Through Week 168|Withdrawal by Subject|1
7831305|NCT00307489|27189075|P2|Week 48 Through Week 168|Physician Decision|0
7831306|NCT00307489|27189076|P1|Week 48 Through Week 168|Physician Decision|1
7831307|NCT00307489|27189075|P2|Week 48 Through Week 168|Adverse Event|0
7831308|NCT00307489|27189076|P1|Week 48 Through Week 168|Adverse Event|1
7831309|NCT00307489|27189075|P2|Baseline Through Week 48|Withdrawal by Subject|1
7831310|NCT00307489|27189076|P1|Baseline Through Week 48|Withdrawal by Subject|0
7831311|NCT00307489|27189075|P2|Baseline Through Week 48|Physician Decision|0
7831312|NCT00307489|27189076|P1|Baseline Through Week 48|Physician Decision|1
7831313|NCT00307489|27189075|P2|Baseline Through Week 48|Lost to Follow-up|1
7831314|NCT00307489|27189076|P1|Baseline Through Week 48|Lost to Follow-up|0
7831315|NCT00307437|27189121|P7|After Controlled Period|Other|28
7831316|NCT00307437|27189122|P6|After Controlled Period|Other|40
7831317|NCT00307437|27189123|P5|After Controlled Period|Other|9
7831318|NCT00307437|27189124|P4|After Controlled Period|Other|15
7831319|NCT00307437|27189125|P3|After Controlled Period|Other|0
7831320|NCT00307437|27189126|P2|After Controlled Period|Other|0
7831321|NCT00307437|27189127|P1|After Controlled Period|Other|0
7831322|NCT00307437|27189121|P7|After Controlled Period|Lost to Follow-up|18
7831323|NCT00307437|27189122|P6|After Controlled Period|Lost to Follow-up|13
7831324|NCT00307437|27189123|P5|After Controlled Period|Lost to Follow-up|12
7831325|NCT00307437|27189124|P4|After Controlled Period|Lost to Follow-up|7
7831326|NCT00307437|27189125|P3|After Controlled Period|Lost to Follow-up|0
7831327|NCT00307437|27189126|P2|After Controlled Period|Lost to Follow-up|0
7831328|NCT00307437|27189127|P1|After Controlled Period|Lost to Follow-up|0
7831329|NCT00307437|27189121|P7|After Controlled Period|Lack of Efficacy|24
7831330|NCT00307437|27189122|P6|After Controlled Period|Lack of Efficacy|37
7831331|NCT00307437|27189123|P5|After Controlled Period|Lack of Efficacy|17
7831332|NCT00307437|27189124|P4|After Controlled Period|Lack of Efficacy|15
7831333|NCT00307437|27189125|P3|After Controlled Period|Lack of Efficacy|0
7831334|NCT00307437|27189126|P2|After Controlled Period|Lack of Efficacy|0
7831335|NCT00307437|27189127|P1|After Controlled Period|Lack of Efficacy|0
7831336|NCT00307437|27189121|P7|After Controlled Period|Death|3
7831337|NCT00307437|27189122|P6|After Controlled Period|Death|1
7831338|NCT00307437|27189123|P5|After Controlled Period|Death|1
7831339|NCT00307437|27189124|P4|After Controlled Period|Death|3
7831340|NCT00307437|27189125|P3|After Controlled Period|Death|0
7831341|NCT00307437|27189126|P2|After Controlled Period|Death|0
7831342|NCT00307437|27189127|P1|After Controlled Period|Death|0
7831343|NCT00307437|27189121|P7|After Controlled Period|Adverse Event|40
7831344|NCT00307437|27189122|P6|After Controlled Period|Adverse Event|31
7831345|NCT00307437|27189123|P5|After Controlled Period|Adverse Event|16
7831346|NCT00307437|27189124|P4|After Controlled Period|Adverse Event|18
7831347|NCT00307437|27189125|P3|After Controlled Period|Adverse Event|0
7831348|NCT00307437|27189126|P2|After Controlled Period|Adverse Event|0
7831349|NCT00307437|27189127|P1|After Controlled Period|Adverse Event|0
7831350|NCT00307437|27189121|P7|Controlled Period|Other|0
7831351|NCT00307437|27189122|P6|Controlled Period|Other|0
7831352|NCT00307437|27189123|P5|Controlled Period|Other|0
7831353|NCT00307437|27189124|P4|Controlled Period|Other|0
7831354|NCT00307437|27189125|P3|Controlled Period|Other|3
7831355|NCT00307437|27189126|P2|Controlled Period|Other|1
7831356|NCT00307437|27189127|P1|Controlled Period|Other|5
7831357|NCT00307437|27189121|P7|Controlled Period|Lost to Follow-up|0
7831358|NCT00307437|27189122|P6|Controlled Period|Lost to Follow-up|0
7831359|NCT00307437|27189123|P5|Controlled Period|Lost to Follow-up|0
7831360|NCT00307437|27189124|P4|Controlled Period|Lost to Follow-up|0
7831361|NCT00307437|27189125|P3|Controlled Period|Lost to Follow-up|0
7831362|NCT00307437|27189126|P2|Controlled Period|Lost to Follow-up|3
7831363|NCT00307437|27189127|P1|Controlled Period|Lost to Follow-up|2
7831364|NCT00307437|27189121|P7|Controlled Period|Lack of Efficacy|0
7831365|NCT00307437|27189122|P6|Controlled Period|Lack of Efficacy|0
7831366|NCT00307437|27189123|P5|Controlled Period|Lack of Efficacy|0
7831367|NCT00307437|27189124|P4|Controlled Period|Lack of Efficacy|0
7831368|NCT00307437|27189125|P3|Controlled Period|Lack of Efficacy|0
7831369|NCT00307437|27189126|P2|Controlled Period|Lack of Efficacy|0
7831370|NCT00307437|27189127|P1|Controlled Period|Lack of Efficacy|2
7831371|NCT00307437|27189121|P7|Controlled Period|Death|0
7831372|NCT00307437|27189122|P6|Controlled Period|Death|0
7831373|NCT00307437|27189123|P5|Controlled Period|Death|0
7831374|NCT00307437|27189124|P4|Controlled Period|Death|0
7831375|NCT00307437|27189125|P3|Controlled Period|Death|1
7831376|NCT00307437|27189126|P2|Controlled Period|Death|0
7831377|NCT00307437|27189127|P1|Controlled Period|Death|0
7831378|NCT00307437|27189121|P7|Controlled Period|Adverse Event|0
7831379|NCT00307437|27189122|P6|Controlled Period|Adverse Event|0
7831380|NCT00307437|27189123|P5|Controlled Period|Adverse Event|0
7831381|NCT00307437|27189124|P4|Controlled Period|Adverse Event|0
7831382|NCT00307437|27189125|P3|Controlled Period|Adverse Event|5
7831383|NCT00307437|27189126|P2|Controlled Period|Adverse Event|2
7831384|NCT00307437|27189127|P1|Controlled Period|Adverse Event|7
7831385|NCT00307333|27189153|P2|Overall Study|Lost to Follow-up|3
7831386|NCT00307333|27189154|P1|Overall Study|Lost to Follow-up|11
7831387|NCT00307294|27189166|P1|Overall Study|Withdrawal by Subject|1
7831388|NCT00307164|27189175|P2|Overall Study|Lost to Follow-up|1
7831389|NCT00307164|27189176|P1|Overall Study|Lost to Follow-up|6
7831390|NCT00307164|27189175|P2|Overall Study|Not compliant with requirements|4
7831391|NCT00307164|27189176|P1|Overall Study|Not compliant with requirements|4
7831392|NCT00307164|27189175|P2|Overall Study|Withdrawal by Subject|8
7831393|NCT00307164|27189176|P1|Overall Study|Withdrawal by Subject|1
7831394|NCT00307164|27189175|P2|Overall Study|Subject/parent not able to get to clinic|1
7831395|NCT00307164|27189176|P1|Overall Study|Subject/parent not able to get to clinic|2
7831396|NCT00307164|27189175|P2|Overall Study|Severe debilitation, unable to continue|0
7831397|NCT00307164|27189176|P1|Overall Study|Severe debilitation, unable to continue|1
7831398|NCT00307164|27189175|P2|Overall Study|Death|0
7831399|NCT00307164|27189176|P1|Overall Study|Death|1
7831400|NCT00307151|27189216|P4|Overall Study|Clinic unable to contact subject|1
7831401|NCT00307151|27189217|P3|Overall Study|Clinic unable to contact subject|1
7831402|NCT00307151|27189218|P2|Overall Study|Clinic unable to contact subject|3
7831403|NCT00307151|27189219|P1|Overall Study|Clinic unable to contact subject|3
7831404|NCT00307151|27189216|P4|Overall Study|Not willing to adhere to study reqs|2
7831405|NCT00307151|27189217|P3|Overall Study|Not willing to adhere to study reqs|2
7831406|NCT00307151|27189218|P2|Overall Study|Not willing to adhere to study reqs|0
7831407|NCT00307151|27189219|P1|Overall Study|Not willing to adhere to study reqs|2
7831408|NCT00307151|27189216|P4|Overall Study|Withdrew consent|3
7831409|NCT00307151|27189217|P3|Overall Study|Withdrew consent|1
7831410|NCT00307151|27189218|P2|Overall Study|Withdrew consent|1
7831411|NCT00307151|27189219|P1|Overall Study|Withdrew consent|0
7831412|NCT00307151|27189216|P4|Overall Study|Subject unable to get to clinic|2
7831413|NCT00307151|27189217|P3|Overall Study|Subject unable to get to clinic|6
7831414|NCT00307151|27189218|P2|Overall Study|Subject unable to get to clinic|0
7831415|NCT00307151|27189219|P1|Overall Study|Subject unable to get to clinic|1
7831416|NCT00307151|27189216|P4|Overall Study|Severe debilitation, unable to continue|0
7831417|NCT00307151|27189217|P3|Overall Study|Severe debilitation, unable to continue|0
7831418|NCT00307151|27189218|P2|Overall Study|Severe debilitation, unable to continue|0
7831419|NCT00307151|27189219|P1|Overall Study|Severe debilitation, unable to continue|1
7831420|NCT00307151|27189216|P4|Overall Study|Death|3
7831421|NCT00307151|27189217|P3|Overall Study|Death|10
7831422|NCT00307151|27189218|P2|Overall Study|Death|3
7831423|NCT00307151|27189219|P1|Overall Study|Death|4
7831424|NCT00307125|27189263|P3|Pilot Phase|Withdrawal by Subject|1
7831425|NCT00307125|27189264|P2|Pilot Phase|Withdrawal by Subject|1
7831426|NCT00307125|27189265|P1|Pilot Phase|Withdrawal by Subject|0
7831427|NCT00307125|27189263|P3|Pilot Phase|Lost to Follow-up|0
7831428|NCT00307125|27189264|P2|Pilot Phase|Lost to Follow-up|1
7831429|NCT00307125|27189265|P1|Pilot Phase|Lost to Follow-up|0
7831430|NCT00307125|27189263|P3|Screening Phase|Coronary artery bypass|0
7831431|NCT00307125|27189264|P2|Screening Phase|Coronary artery bypass|0
7831432|NCT00307125|27189265|P1|Screening Phase|Coronary artery bypass|1
7831433|NCT00307125|27189263|P3|Screening Phase|AMR and treated with rituximab|0
7831434|NCT00307125|27189264|P2|Screening Phase|AMR and treated with rituximab|0
7831435|NCT00307125|27189265|P1|Screening Phase|AMR and treated with rituximab|1
7831436|NCT00307125|27189263|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
7831437|NCT00307125|27189264|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
7831438|NCT00307125|27189265|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
7831439|NCT00307125|27189263|P3|Screening Phase|Screen Error|0
7831440|NCT00307125|27189264|P2|Screening Phase|Screen Error|0
7831441|NCT00307125|27189265|P1|Screening Phase|Screen Error|1
7831442|NCT00307125|27189263|P3|Screening Phase|Ineligible|0
7831443|NCT00307125|27189264|P2|Screening Phase|Ineligible|0
7831444|NCT00307125|27189265|P1|Screening Phase|Ineligible|1
7831445|NCT00307125|27189263|P3|Screening Phase|PAK|0
7831446|NCT00307125|27189264|P2|Screening Phase|PAK|0
7831447|NCT00307125|27189265|P1|Screening Phase|PAK|1
7831448|NCT00307125|27189263|P3|Screening Phase|Malignancy|0
7831449|NCT00307125|27189264|P2|Screening Phase|Malignancy|0
7831450|NCT00307125|27189265|P1|Screening Phase|Malignancy|1
7831451|NCT00307125|27189263|P3|Screening Phase|Metastatic colon cancer|0
7831452|NCT00307125|27189264|P2|Screening Phase|Metastatic colon cancer|0
7831453|NCT00307125|27189265|P1|Screening Phase|Metastatic colon cancer|1
7831454|NCT00307125|27189263|P3|Screening Phase|Developed acute leukemia|0
7831455|NCT00307125|27189264|P2|Screening Phase|Developed acute leukemia|0
7831456|NCT00307125|27189265|P1|Screening Phase|Developed acute leukemia|1
7831457|NCT00307125|27189263|P3|Screening Phase|Try to get pregnant|0
7831458|NCT00307125|27189264|P2|Screening Phase|Try to get pregnant|0
7831459|NCT00307125|27189265|P1|Screening Phase|Try to get pregnant|1
7831460|NCT00307125|27189263|P3|Screening Phase|Ineligible for pilot|0
7831461|NCT00307125|27189264|P2|Screening Phase|Ineligible for pilot|0
7831462|NCT00307125|27189265|P1|Screening Phase|Ineligible for pilot|4
7831463|NCT00307125|27189263|P3|Screening Phase|Received Pancreas Transplant|0
7831464|NCT00307125|27189264|P2|Screening Phase|Received Pancreas Transplant|0
7831465|NCT00307125|27189265|P1|Screening Phase|Received Pancreas Transplant|8
7831466|NCT00307125|27189263|P3|Screening Phase|Moved or transferred facilities|0
7831467|NCT00307125|27189264|P2|Screening Phase|Moved or transferred facilities|0
7831468|NCT00307125|27189265|P1|Screening Phase|Moved or transferred facilities|34
7831469|NCT00307125|27189263|P3|Screening Phase|Scheduling issues/Non-compliance|0
7831470|NCT00307125|27189264|P2|Screening Phase|Scheduling issues/Non-compliance|0
7831471|NCT00307125|27189265|P1|Screening Phase|Scheduling issues/Non-compliance|55
7831472|NCT00307125|27189263|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
7831473|NCT00307125|27189264|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
7831474|NCT00307125|27189265|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
7831475|NCT00307125|27189263|P3|Screening Phase|Graft Failure|0
7831476|NCT00307125|27189264|P2|Screening Phase|Graft Failure|0
7831477|NCT00307125|27189265|P1|Screening Phase|Graft Failure|8
7831478|NCT00307125|27189263|P3|Screening Phase|Graft Loss|0
7831479|NCT00307125|27189264|P2|Screening Phase|Graft Loss|0
7831480|NCT00307125|27189265|P1|Screening Phase|Graft Loss|3
7831481|NCT00307125|27189263|P3|Screening Phase|Study Terminated|0
7831482|NCT00307125|27189264|P2|Screening Phase|Study Terminated|0
7831483|NCT00307125|27189265|P1|Screening Phase|Study Terminated|17
7831484|NCT00307125|27189263|P3|Screening Phase|Sponsor Decision|0
7831485|NCT00307125|27189264|P2|Screening Phase|Sponsor Decision|0
7831486|NCT00307125|27189265|P1|Screening Phase|Sponsor Decision|4
7831487|NCT00307125|27189263|P3|Screening Phase|Physician Decision|0
7831488|NCT00307125|27189264|P2|Screening Phase|Physician Decision|0
7831489|NCT00307125|27189265|P1|Screening Phase|Physician Decision|26
7831490|NCT00307125|27189263|P3|Screening Phase|Withdrawal by Subject|0
7831491|NCT00307125|27189264|P2|Screening Phase|Withdrawal by Subject|0
7831492|NCT00307125|27189265|P1|Screening Phase|Withdrawal by Subject|77
7831493|NCT00307125|27189263|P3|Screening Phase|Death|0
7831494|NCT00307125|27189264|P2|Screening Phase|Death|0
7831495|NCT00307125|27189265|P1|Screening Phase|Death|10
7831496|NCT00307125|27189263|P3|Screening Phase|Lost to Follow-up|0
7831497|NCT00307125|27189264|P2|Screening Phase|Lost to Follow-up|0
7831498|NCT00307125|27189265|P1|Screening Phase|Lost to Follow-up|87
7831499|NCT00307125|27189263|P3|Screening Phase|Protocol Violation|0
7831500|NCT00307125|27189264|P2|Screening Phase|Protocol Violation|0
7831501|NCT00307125|27189265|P1|Screening Phase|Protocol Violation|27
7831502|NCT00307125|27189263|P3|Screening Phase|Adverse Event|0
7831503|NCT00307125|27189264|P2|Screening Phase|Adverse Event|0
7831504|NCT00307125|27189265|P1|Screening Phase|Adverse Event|1
7831505|NCT00307086|27189287|P1|Overall Study|ineligible|5
7831506|NCT00307047|27189293|P2|Overall Study|All death, all MI, all Revascularization|16
7831507|NCT00307047|27189294|P1|Overall Study|All death, all MI, all Revascularization|27
7831508|NCT00307047|27189293|P2|Overall Study|Lost to follow-up for other reasons|1
7831509|NCT00307047|27189294|P1|Overall Study|Lost to follow-up for other reasons|0
7831510|NCT00307047|27189293|P2|Overall Study|Physician Decision|2
7831511|NCT00307047|27189294|P1|Overall Study|Physician Decision|1
7831512|NCT00307047|27189293|P2|Overall Study|Withdrawal by Subject|6
7831513|NCT00307047|27189294|P1|Overall Study|Withdrawal by Subject|6
7831514|NCT00307047|27189293|P2|Overall Study|Lost to Follow-up|24
7831515|NCT00307047|27189294|P1|Overall Study|Lost to Follow-up|35
7831516|NCT00307034|27189432|P2|Overall Study|Lost to Follow-up|3
7831517|NCT00307034|27189433|P1|Overall Study|Lost to Follow-up|0
7831518|NCT00307034|27189432|P2|Overall Study|Withdrawal by Subject|2
7831519|NCT00307034|27189433|P1|Overall Study|Withdrawal by Subject|1
7831520|NCT00307034|27189432|P2|Overall Study|Adverse Event|2
7831521|NCT00307034|27189433|P1|Overall Study|Adverse Event|1
7831522|NCT00306995|27189478|P7|Study Part II for Subset 2|Serious Adverse Event|0
7831523|NCT00306995|27189479|P6|Study Part II for Subset 2|Serious Adverse Event|0
7831524|NCT00306995|27189480|P5|Study Part II for Subset 2|Serious Adverse Event|0
7831525|NCT00306995|27189481|P4|Study Part II for Subset 2|Serious Adverse Event|0
7831526|NCT00306995|27189482|P3|Study Part II for Subset 2|Serious Adverse Event|0
7831527|NCT00306995|27189483|P2|Study Part II for Subset 2|Serious Adverse Event|1
7831528|NCT00306995|27189484|P1|Study Part II for Subset 2|Serious Adverse Event|0
7831529|NCT00306995|27189478|P7|Study Part I|Withdrawal by Subject|1
7831530|NCT00306995|27189479|P6|Study Part I|Withdrawal by Subject|0
7831531|NCT00306995|27189480|P5|Study Part I|Withdrawal by Subject|0
7831532|NCT00306995|27189481|P4|Study Part I|Withdrawal by Subject|0
7831533|NCT00306995|27189482|P3|Study Part I|Withdrawal by Subject|0
7831534|NCT00306995|27189483|P2|Study Part I|Withdrawal by Subject|0
7831535|NCT00306995|27189484|P1|Study Part I|Withdrawal by Subject|0
7831536|NCT00306891|27189877|P4|Part B|Development of study specific disc crit.|1
7831537|NCT00306891|27189878|P3|Part B|Development of study specific disc crit.|0
7831538|NCT00306891|27189879|P2|Part B|Development of study specific disc crit.|0
7831539|NCT00306891|27189880|P1|Part B|Development of study specific disc crit.|0
7831540|NCT00306891|27189877|P4|Part B|Condition under investigation worsened|8
7831541|NCT00306891|27189878|P3|Part B|Condition under investigation worsened|2
7831542|NCT00306891|27189879|P2|Part B|Condition under investigation worsened|0
7831543|NCT00306891|27189880|P1|Part B|Condition under investigation worsened|0
7831544|NCT00306891|27189877|P4|Part B|Withdrawal by Subject|1
7831545|NCT00306891|27189878|P3|Part B|Withdrawal by Subject|3
7831546|NCT00306891|27189879|P2|Part B|Withdrawal by Subject|0
7831547|NCT00306891|27189880|P1|Part B|Withdrawal by Subject|0
7831548|NCT00306891|27189877|P4|Part B|Adverse Event|5
7831549|NCT00306891|27189878|P3|Part B|Adverse Event|5
7831550|NCT00306891|27189879|P2|Part B|Adverse Event|0
7831551|NCT00306891|27189880|P1|Part B|Adverse Event|0
7831552|NCT00306891|27189877|P4|Part B|Death|2
7831556|NCT00306891|27189877|P4|Part A|QTC interval outwith elig. criteria|0
7831557|NCT00306891|27189878|P3|Part A|QTC interval outwith elig. criteria|0
7831558|NCT00306891|27189879|P2|Part A|QTC interval outwith elig. criteria|0
7831559|NCT00306891|27189880|P1|Part A|QTC interval outwith elig. criteria|1
7831560|NCT00306891|27189877|P4|Part A|Suspicion of second malignancy|0
7831561|NCT00306891|27189878|P3|Part A|Suspicion of second malignancy|0
7831562|NCT00306891|27189879|P2|Part A|Suspicion of second malignancy|1
7831563|NCT00306891|27189880|P1|Part A|Suspicion of second malignancy|0
7831564|NCT00306891|27189877|P4|Part A|Reaccumul. of ascites following drainage|0
7831565|NCT00306891|27189878|P3|Part A|Reaccumul. of ascites following drainage|0
7831566|NCT00306891|27189879|P2|Part A|Reaccumul. of ascites following drainage|1
7831567|NCT00306891|27189880|P1|Part A|Reaccumul. of ascites following drainage|0
7831568|NCT00306891|27189877|P4|Part A|Partial bowel obstruction|0
7831569|NCT00306891|27189878|P3|Part A|Partial bowel obstruction|0
7831570|NCT00306891|27189879|P2|Part A|Partial bowel obstruction|0
7831571|NCT00306891|27189880|P1|Part A|Partial bowel obstruction|1
7831572|NCT00306891|27189877|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
7831573|NCT00306891|27189878|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
7831574|NCT00306891|27189879|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
7831575|NCT00306891|27189880|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
7831576|NCT00306891|27189877|P4|Part A|Condition under investigation worsened|0
7831577|NCT00306891|27189878|P3|Part A|Condition under investigation worsened|0
7831578|NCT00306891|27189879|P2|Part A|Condition under investigation worsened|2
7831579|NCT00306891|27189880|P1|Part A|Condition under investigation worsened|2
7831580|NCT00306891|27189877|P4|Part A|Withdrawal by Subject|0
7831581|NCT00306891|27189878|P3|Part A|Withdrawal by Subject|0
7831582|NCT00306891|27189879|P2|Part A|Withdrawal by Subject|1
7831583|NCT00306891|27189880|P1|Part A|Withdrawal by Subject|1
7831584|NCT00306852|27189903|P2|Overall Study|Lost to Follow-up|24
7831585|NCT00306852|27189904|P1|Overall Study|Lost to Follow-up|15
7831586|NCT00306852|27189903|P2|Overall Study|Death|14
7831587|NCT00306852|27189904|P1|Overall Study|Death|14
7831588|NCT00306787|27189922|P2|Overall Study|Abnormal laboratory value(s)|0
7831589|NCT00306787|27189923|P1|Overall Study|Abnormal laboratory value(s)|1
7831590|NCT00306787|27189922|P2|Overall Study|Administrative problems|0
7831591|NCT00306787|27189923|P1|Overall Study|Administrative problems|4
7831592|NCT00306787|27189922|P2|Overall Study|Lost to Follow-up|6
7831593|NCT00306787|27189923|P1|Overall Study|Lost to Follow-up|9
7831594|NCT00306787|27189922|P2|Overall Study|Withdrawal by Subject|9
7831595|NCT00306787|27189923|P1|Overall Study|Withdrawal by Subject|2
7831596|NCT00306787|27189922|P2|Overall Study|Protocol Violation|10
7831597|NCT00306787|27189923|P1|Overall Study|Protocol Violation|8
7831598|NCT00306787|27189922|P2|Overall Study|Lack of Efficacy|0
7831599|NCT00306787|27189923|P1|Overall Study|Lack of Efficacy|1
7831600|NCT00306787|27189922|P2|Overall Study|Adverse Event|1
7831601|NCT00306787|27189923|P1|Overall Study|Adverse Event|1
7831602|NCT00306787|27189922|P2|Overall Study|Discontinued without taking study drug|215
7831603|NCT00306787|27189923|P1|Overall Study|Discontinued without taking study drug|208
7831604|NCT00306670|27189941|P2|Overall Study|patients recruited; Genentech, the st|2
7831605|NCT00306670|27189942|P1|Overall Study|patients recruited; Genentech, the st|0
7831606|NCT00306592|27189948|P2|Overall Study|48-week Treatment Period Ongoing|20
7831607|NCT00306592|27189949|P1|Overall Study|48-week Treatment Period Ongoing|0
7831608|NCT00306592|27189948|P2|Overall Study|Other|2
7831609|NCT00306592|27189949|P1|Overall Study|Other|1
7831610|NCT00306592|27189948|P2|Overall Study|Other|10
7831611|NCT00306592|27189949|P1|Overall Study|Other|5
7831612|NCT00306592|27189948|P2|Overall Study|Voluntary|6
7831613|NCT00306592|27189949|P1|Overall Study|Voluntary|10
7831614|NCT00306592|27189948|P2|Overall Study|Persistent Antibodies|3
7831615|NCT00306592|27189949|P1|Overall Study|Persistent Antibodies|6
7831616|NCT00306592|27189948|P2|Overall Study|Noncompliance|2
7831617|NCT00306592|27189949|P1|Overall Study|Noncompliance|0
7831618|NCT00306592|27189948|P2|Overall Study|Lost to Follow-up|0
7831619|NCT00306592|27189949|P1|Overall Study|Lost to Follow-up|1
7831620|NCT00306592|27189948|P2|Overall Study|Adverse Event|15
7831621|NCT00306592|27189949|P1|Overall Study|Adverse Event|8
7831622|NCT00306527|27189959|P4|Overall Study|Death|2
7831623|NCT00306527|27189960|P3|Overall Study|Death|1
7831624|NCT00306527|27189961|P2|Overall Study|Death|0
7831625|NCT00306527|27189962|P1|Overall Study|Death|1
7831626|NCT00306527|27189959|P4|Overall Study|Adverse Event|1
7831627|NCT00306527|27189960|P3|Overall Study|Adverse Event|1
7831628|NCT00306527|27189961|P2|Overall Study|Adverse Event|0
7831629|NCT00306527|27189962|P1|Overall Study|Adverse Event|0
7831630|NCT00306527|27189959|P4|Overall Study|Withdrawal by Subject|3
7831631|NCT00306527|27189960|P3|Overall Study|Withdrawal by Subject|0
7831632|NCT00306527|27189961|P2|Overall Study|Withdrawal by Subject|3
7831633|NCT00306527|27189962|P1|Overall Study|Withdrawal by Subject|2
7831634|NCT00306527|27189959|P4|Overall Study|Lost to Follow-up|0
7831635|NCT00306527|27189960|P3|Overall Study|Lost to Follow-up|3
7831636|NCT00306527|27189961|P2|Overall Study|Lost to Follow-up|4
7831637|NCT00306527|27189962|P1|Overall Study|Lost to Follow-up|3
7831638|NCT00306384|27190034|P3|Overall Study|Site closure|0
7831639|NCT00306384|27190035|P2|Overall Study|Site closure|0
7831640|NCT00306384|27190036|P1|Overall Study|Site closure|2
7831641|NCT00306384|27190034|P3|Overall Study|Other|32
7831642|NCT00306384|27190035|P2|Overall Study|Other|70
7831643|NCT00306384|27190036|P1|Overall Study|Other|80
7831644|NCT00306384|27190034|P3|Overall Study|Investigator discretion|21
7831645|NCT00306384|27190035|P2|Overall Study|Investigator discretion|31
7831646|NCT00306384|27190036|P1|Overall Study|Investigator discretion|28
7831647|NCT00306384|27190034|P3|Overall Study|Lack of Efficacy|38
7831648|NCT00306384|27190035|P2|Overall Study|Lack of Efficacy|40
7831649|NCT00306384|27190036|P1|Overall Study|Lack of Efficacy|26
7831650|NCT00306384|27190034|P3|Overall Study|Pregnancy|1
7831651|NCT00306384|27190035|P2|Overall Study|Pregnancy|1
7831652|NCT00306384|27190036|P1|Overall Study|Pregnancy|3
7831653|NCT00306384|27190034|P3|Overall Study|Study termination|1
7831654|NCT00306384|27190035|P2|Overall Study|Study termination|0
7831655|NCT00306384|27190036|P1|Overall Study|Study termination|1
7831656|NCT00306384|27190034|P3|Overall Study|Voluntary withdrawal|91
7831657|NCT00306384|27190035|P2|Overall Study|Voluntary withdrawal|187
7831658|NCT00306384|27190036|P1|Overall Study|Voluntary withdrawal|199
7831659|NCT00306384|27190034|P3|Overall Study|Lost to Follow-up|35
7831660|NCT00306384|27190035|P2|Overall Study|Lost to Follow-up|41
7831661|NCT00306384|27190036|P1|Overall Study|Lost to Follow-up|57
7831662|NCT00306384|27190034|P3|Overall Study|Major protocol deviation|18
7831663|NCT00306384|27190035|P2|Overall Study|Major protocol deviation|51
7831664|NCT00306384|27190036|P1|Overall Study|Major protocol deviation|43
7831665|NCT00306384|27190034|P3|Overall Study|Adverse Event|40
7831666|NCT00306384|27190035|P2|Overall Study|Adverse Event|87
7831667|NCT00306384|27190036|P1|Overall Study|Adverse Event|103
7831668|NCT00306293|27190068|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
7831669|NCT00306293|27190069|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
7831670|NCT00306293|27190068|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
7831671|NCT00306293|27190069|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
7831672|NCT00306293|27190068|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
7831673|NCT00306293|27190069|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
7831674|NCT00306293|27190068|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
7831675|NCT00306293|27190069|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
7831676|NCT00306293|27190068|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
7831677|NCT00306293|27190069|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
7831678|NCT00306293|27190068|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
7831679|NCT00306293|27190069|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
7831680|NCT00306293|27190068|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
7831681|NCT00306293|27190069|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
7831682|NCT00306293|27190068|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
7831683|NCT00306293|27190069|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
7831684|NCT00306189|27190252|P4|Overall Study|Other|0
7831685|NCT00306189|27190253|P3|Overall Study|Other|0
7831686|NCT00306189|27190254|P2|Overall Study|Other|0
7831687|NCT00306189|27190255|P1|Overall Study|Other|1
7831688|NCT00306189|27190252|P4|Overall Study|Ineligibility determined|1
7831689|NCT00306189|27190253|P3|Overall Study|Ineligibility determined|1
7831690|NCT00306189|27190254|P2|Overall Study|Ineligibility determined|1
7831691|NCT00306189|27190255|P1|Overall Study|Ineligibility determined|1
7831692|NCT00306189|27190252|P4|Overall Study|Withdrawal by Subject|1
7831693|NCT00306189|27190253|P3|Overall Study|Withdrawal by Subject|8
7831694|NCT00306189|27190254|P2|Overall Study|Withdrawal by Subject|2
7831695|NCT00306189|27190255|P1|Overall Study|Withdrawal by Subject|4
7831696|NCT00306189|27190252|P4|Overall Study|Adverse Event|2
7831697|NCT00306189|27190253|P3|Overall Study|Adverse Event|2
7831698|NCT00306189|27190254|P2|Overall Study|Adverse Event|3
7831699|NCT00306189|27190255|P1|Overall Study|Adverse Event|3
7831700|NCT00306189|27190252|P4|Overall Study|Physician Decision|1
7831701|NCT00306189|27190253|P3|Overall Study|Physician Decision|0
7831702|NCT00306189|27190254|P2|Overall Study|Physician Decision|0
7831703|NCT00306189|27190255|P1|Overall Study|Physician Decision|0
7831704|NCT00305877|27190282|P2|Overall Study|Transportation issue with daily RT|1
7831705|NCT00305877|27190283|P1|Overall Study|Transportation issue with daily RT|0
7831706|NCT00305877|27190282|P2|Overall Study|Ineligible|1
7831707|NCT00305877|27190283|P1|Overall Study|Ineligible|2
7831708|NCT00305877|27190282|P2|Overall Study|Never start treatment|5
7831709|NCT00305877|27190283|P1|Overall Study|Never start treatment|2
7831710|NCT00305877|27190282|P2|Overall Study|Physician Decision|1
7831711|NCT00305877|27190283|P1|Overall Study|Physician Decision|1
7831712|NCT00305877|27190282|P2|Overall Study|Withdrawal by Subject|2
7831713|NCT00305877|27190283|P1|Overall Study|Withdrawal by Subject|4
7831714|NCT00305877|27190282|P2|Overall Study|Death|1
7831715|NCT00305877|27190283|P1|Overall Study|Death|0
7831716|NCT00305877|27190282|P2|Overall Study|Adverse Event|14
7831717|NCT00305877|27190283|P1|Overall Study|Adverse Event|9
7831718|NCT00305877|27190282|P2|Overall Study|Lack of Efficacy|9
7831719|NCT00305877|27190283|P1|Overall Study|Lack of Efficacy|6
7831720|NCT00305864|27190297|P4|Overall Study|Ineligible / No protocol treatment|13
7831721|NCT00305864|27190298|P3|Overall Study|Ineligible / No protocol treatment|1
7831722|NCT00305864|27190299|P2|Overall Study|Ineligible / No protocol treatment|1
7831723|NCT00305864|27190300|P1|Overall Study|Ineligible / No protocol treatment|0
7831724|NCT00305773|27190313|P2|Overall Study|All other reasons|2
7831725|NCT00305773|27190314|P1|Overall Study|All other reasons|3
7831726|NCT00305773|27190313|P2|Overall Study|Disease Progression|3
7831727|NCT00305773|27190314|P1|Overall Study|Disease Progression|1
7831728|NCT00305773|27190313|P2|Overall Study|Withdrawal by Subject|4
7831729|NCT00305773|27190314|P1|Overall Study|Withdrawal by Subject|1
7831730|NCT00305773|27190313|P2|Overall Study|Physician Decision|1
7831731|NCT00305773|27190314|P1|Overall Study|Physician Decision|1
7831732|NCT00305773|27190313|P2|Overall Study|Alternative Treatment|4
7831733|NCT00305773|27190314|P1|Overall Study|Alternative Treatment|4
7831734|NCT00305773|27190313|P2|Overall Study|Adverse Event|2
7831735|NCT00305773|27190314|P1|Overall Study|Adverse Event|1
7831736|NCT00305773|27190313|P2|Overall Study|Death|2
7831737|NCT00305773|27190314|P1|Overall Study|Death|3
7831738|NCT00305695|27190334|P2|Overall Study|Did not have baseline scan|1
7831739|NCT00305695|27190335|P1|Overall Study|Did not have baseline scan|1
7831740|NCT00305695|27190334|P2|Overall Study|Withdrawal by subject prior to 18 month|26
7831741|NCT00305695|27190335|P1|Overall Study|Withdrawal by subject prior to 18 month|40
7831742|NCT00305604|27190469|P2|Overall Study|Patient moved|0
7831743|NCT00305604|27190470|P1|Overall Study|Patient moved|1
7831744|NCT00305604|27190469|P2|Overall Study|Withdrawal by Subject|21
7831745|NCT00305604|27190470|P1|Overall Study|Withdrawal by Subject|12
7831746|NCT00305604|27190469|P2|Overall Study|Protocol Violation|1
7831747|NCT00305604|27190470|P1|Overall Study|Protocol Violation|2
7831748|NCT00305604|27190469|P2|Overall Study|Lost to Follow-up|4
7831749|NCT00305604|27190470|P1|Overall Study|Lost to Follow-up|0
7831750|NCT00305604|27190469|P2|Overall Study|Lack of Efficacy|18
7831751|NCT00305604|27190470|P1|Overall Study|Lack of Efficacy|11
7831752|NCT00305604|27190469|P2|Overall Study|Adverse Event|3
7831753|NCT00305604|27190470|P1|Overall Study|Adverse Event|6
7831754|NCT00305448|27190614|P3|Overall Study|Tumor Marker Elevation|1
7831755|NCT00305448|27190615|P2|Overall Study|Tumor Marker Elevation|0
7831756|NCT00305448|27190616|P1|Overall Study|Tumor Marker Elevation|0
7831757|NCT00305448|27190614|P3|Overall Study|Subjective Disease Progression|2
7831758|NCT00305448|27190615|P2|Overall Study|Subjective Disease Progression|2
7831759|NCT00305448|27190616|P1|Overall Study|Subjective Disease Progression|1
7831760|NCT00305448|27190614|P3|Overall Study|Disease Progression|28
7831761|NCT00305448|27190615|P2|Overall Study|Disease Progression|31
7831762|NCT00305448|27190616|P1|Overall Study|Disease Progression|27
7831763|NCT00305448|27190614|P3|Overall Study|Adverse Event|1
7831764|NCT00305448|27190615|P2|Overall Study|Adverse Event|0
7831765|NCT00305448|27190616|P1|Overall Study|Adverse Event|1
7831766|NCT00305448|27190614|P3|Overall Study|Withdrawal by Subject|1
7831767|NCT00305448|27190615|P2|Overall Study|Withdrawal by Subject|0
7831768|NCT00305448|27190616|P1|Overall Study|Withdrawal by Subject|2
7831769|NCT00305448|27190614|P3|Overall Study|Protocol Violation|0
7831770|NCT00305448|27190615|P2|Overall Study|Protocol Violation|1
7831771|NCT00305448|27190616|P1|Overall Study|Protocol Violation|0
7831772|NCT00305253|27190638|P2|Overall Study|Withdrawal by Subject|1
7831773|NCT00305253|27190639|P1|Overall Study|Withdrawal by Subject|0
7831774|NCT00305227|27190651|P2|Overall Study|Lost to Follow-up|6
7831775|NCT00305227|27190652|P1|Overall Study|Lost to Follow-up|7
7831776|NCT00305110|27190699|P1|Overall Study|Missing data|29
7831777|NCT00305058|27190772|P2|Overall Study|Missing outcome data|2
7831778|NCT00305058|27190773|P1|Overall Study|Missing outcome data|3
7831779|NCT00305058|27190772|P2|Overall Study|Missing data collection instrument|2
7831780|NCT00305058|27190773|P1|Overall Study|Missing data collection instrument|3
7831781|NCT00305058|27190772|P2|Overall Study|Participant too young|0
7831782|NCT00305058|27190773|P1|Overall Study|Participant too young|1
7831783|NCT00305006|27190787|P2|Overall Study|Failure to complete pretest|1
7831784|NCT00305006|27190788|P1|Overall Study|Failure to complete pretest|0
7831785|NCT00305006|27190787|P2|Overall Study|Withdrawal by Subject|0
7831786|NCT00305006|27190788|P1|Overall Study|Withdrawal by Subject|1
7831787|NCT00304954|27190800|P4|Overall Study|Adverse Event|0
7831788|NCT00304954|27190801|P3|Overall Study|Adverse Event|0
7831789|NCT00304954|27190802|P2|Overall Study|Adverse Event|0
7831790|NCT00304954|27190803|P1|Overall Study|Adverse Event|1
7831791|NCT00304954|27190800|P4|Overall Study|Withdrawal by Subject|0
7831792|NCT00304954|27190801|P3|Overall Study|Withdrawal by Subject|1
7831793|NCT00304954|27190802|P2|Overall Study|Withdrawal by Subject|0
7831794|NCT00304954|27190803|P1|Overall Study|Withdrawal by Subject|0
7831795|NCT00304915|27190823|P2|Overall Study|Withdrawal by Subject|0
7831796|NCT00304915|27190824|P1|Overall Study|Withdrawal by Subject|3
7831797|NCT00304915|27190823|P2|Overall Study|Death|5
7831798|NCT00304915|27190824|P1|Overall Study|Death|4
7831799|NCT00304915|27190823|P2|Overall Study|Lost to Follow-up|11
7831800|NCT00304915|27190824|P1|Overall Study|Lost to Follow-up|11
7831801|NCT00304356|27190869|P1|Nitazoxanide|Physician Decision|1
7831802|NCT00304356|27190869|P1|Nitazoxanide|Physician Decision|1
7831803|NCT00304356|27190869|P1|Nitazoxanide|Physician Decision|1
7831804|NCT00304356|27190869|P1|Nitazoxanide|number is 0|1
7831805|NCT00304356|27190869|P1|Nitazoxanide|Physician Decision|1
7831806|NCT00304356|27190869|P1|Nitazoxanide|Physician Decision|5
7831807|NCT00304278|27190873|P1|Overall Study|PT had medical condition preventing TX|1
7831808|NCT00304278|27190873|P1|Overall Study|lack of insurance coverage for chemoRT|1
7831809|NCT00304083|27190922|P2|Overall Study|Other|2
7831810|NCT00304083|27190923|P1|Overall Study|Other|5
7831811|NCT00304083|27190922|P2|Overall Study|Disease Progression|1
7831812|NCT00304083|27190923|P1|Overall Study|Disease Progression|5
7831813|NCT00304083|27190922|P2|Overall Study|Physician Decision|3
7831814|NCT00304083|27190923|P1|Overall Study|Physician Decision|8
7831815|NCT00304083|27190922|P2|Overall Study|Withdrawal by Subject|2
7831816|NCT00304083|27190923|P1|Overall Study|Withdrawal by Subject|4
7831817|NCT00304070|27190942|P3|Overall Study|Progressive Disease|4
7831818|NCT00304070|27190943|P2|Overall Study|Progressive Disease|7
7831819|NCT00304070|27190944|P1|Overall Study|Progressive Disease|3
7831820|NCT00304070|27190942|P3|Overall Study|Withdrawal by Subject|1
7831821|NCT00304070|27190943|P2|Overall Study|Withdrawal by Subject|0
7831822|NCT00304070|27190944|P1|Overall Study|Withdrawal by Subject|0
7831823|NCT00304070|27190942|P3|Overall Study|Physician Decision|3
7831824|NCT00304070|27190943|P2|Overall Study|Physician Decision|0
7831825|NCT00304070|27190944|P1|Overall Study|Physician Decision|0
7831826|NCT00304070|27190942|P3|Overall Study|Lost to Follow-up|1
7831827|NCT00304070|27190943|P2|Overall Study|Lost to Follow-up|0
7831828|NCT00304070|27190944|P1|Overall Study|Lost to Follow-up|0
7831829|NCT00304070|27190942|P3|Overall Study|Death|3
7831830|NCT00304070|27190943|P2|Overall Study|Death|0
7831831|NCT00304070|27190944|P1|Overall Study|Death|0
7831832|NCT00304031|27190959|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
7831833|NCT00304031|27190960|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
7831834|NCT00304031|27190961|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
7831835|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
7831836|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
7831837|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
7831838|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
7831839|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
7831840|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
7831841|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
7831842|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
7831843|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
7831844|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
7831845|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
7831846|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
7831847|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Death|0
7831848|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Death|0
7831849|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Death|18
7831850|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
7831851|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
7831852|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
7831853|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
7831854|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
7831855|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
7831856|NCT00304031|27190959|P3|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
7831857|NCT00304031|27190960|P2|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
7831858|NCT00304031|27190961|P1|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
7831859|NCT00303953|27191043|P1|Overall Study|Physician Decision|1
7831860|NCT00303953|27191043|P1|Overall Study|Lack of Efficacy|12
7831861|NCT00303953|27191043|P1|Overall Study|Adverse Event|4
7831862|NCT00303953|27191043|P1|Overall Study|Death|1
7831863|NCT00303953|27191043|P1|Overall Study|Ineligible|1
7831864|NCT00303719|27191079|P2|Overall Study|Lost to Follow-up|7
7831865|NCT00303719|27191080|P1|Overall Study|Lost to Follow-up|0
7831866|NCT00303719|27191079|P2|Overall Study|Not evaluable, prior therapies|30
7831867|NCT00303719|27191080|P1|Overall Study|Not evaluable, prior therapies|0
7831868|NCT00303667|27191096|P2|Overall Study|Death|4
7831869|NCT00303667|27191097|P1|Overall Study|Death|0
7831870|NCT00303628|27191121|P2|Overall Study|Other|9
7831871|NCT00303628|27191122|P1|Overall Study|Other|8
7831872|NCT00303628|27191121|P2|Overall Study|Not start protocol therapy|5
7831873|NCT00303628|27191122|P1|Overall Study|Not start protocol therapy|3
7831874|NCT00303628|27191121|P2|Overall Study|Other complicating disease|1
7831875|NCT00303628|27191122|P1|Overall Study|Other complicating disease|0
7831876|NCT00303628|27191121|P2|Overall Study|Alternative therapy|0
7831877|NCT00303628|27191122|P1|Overall Study|Alternative therapy|2
7831878|NCT00303628|27191121|P2|Overall Study|Withdrawal by Subject|20
7831879|NCT00303628|27191122|P1|Overall Study|Withdrawal by Subject|11
7831880|NCT00303628|27191121|P2|Overall Study|Death|1
7831881|NCT00303628|27191122|P1|Overall Study|Death|0
7831882|NCT00303628|27191121|P2|Overall Study|Adverse Event|36
7831883|NCT00303628|27191122|P1|Overall Study|Adverse Event|26
7831884|NCT00303628|27191121|P2|Overall Study|Disease progression|1
7831885|NCT00303628|27191122|P1|Overall Study|Disease progression|0
7831886|NCT00303602|27191140|P2|Overall Study|Protocol Violation|0
7831887|NCT00303602|27191141|P1|Overall Study|Protocol Violation|1
7831888|NCT00303602|27191140|P2|Overall Study|Noncompliance|2
7831889|NCT00303602|27191141|P1|Overall Study|Noncompliance|2
7831890|NCT00303602|27191140|P2|Overall Study|Physician Decision|1
7831891|NCT00303602|27191141|P1|Overall Study|Physician Decision|2
7831892|NCT00303602|27191140|P2|Overall Study|Protocol entry criteria not met|2
7831893|NCT00303602|27191141|P1|Overall Study|Protocol entry criteria not met|2
7831894|NCT00303602|27191140|P2|Overall Study|Lost to Follow-up|2
7831895|NCT00303602|27191141|P1|Overall Study|Lost to Follow-up|5
7831896|NCT00303602|27191140|P2|Overall Study|Withdrawal by Subject|6
7831897|NCT00303602|27191141|P1|Overall Study|Withdrawal by Subject|5
7831898|NCT00303602|27191140|P2|Overall Study|Adverse Event|2
7831899|NCT00303602|27191141|P1|Overall Study|Adverse Event|2
7831900|NCT00303485|27191187|P2|Overall Study|Withdrawal by Subject|0
7831901|NCT00303485|27191188|P1|Overall Study|Withdrawal by Subject|1
7831902|NCT00303485|27191187|P2|Overall Study|Failure to return|1
7831903|NCT00303485|27191188|P1|Overall Study|Failure to return|0
7831904|NCT00303485|27191187|P2|Overall Study|Adverse Event/Intercurrent Illness|1
7831905|NCT00303485|27191188|P1|Overall Study|Adverse Event/Intercurrent Illness|0
7831906|NCT00303472|27191219|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
7831907|NCT00303472|27191220|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
7831908|NCT00303472|27191221|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
7831909|NCT00303472|27191222|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
7831910|NCT00303472|27191223|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
7831911|NCT00303472|27191224|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
7831912|NCT00303472|27191225|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
7831913|NCT00303472|27191219|P7|Treatment Extension (Optional)|Other|0
7831914|NCT00303472|27191220|P6|Treatment Extension (Optional)|Other|0
7831915|NCT00303472|27191221|P5|Treatment Extension (Optional)|Other|1
7831916|NCT00303472|27191222|P4|Treatment Extension (Optional)|Other|2
7831917|NCT00303472|27191223|P3|Treatment Extension (Optional)|Other|4
7831918|NCT00303472|27191224|P2|Treatment Extension (Optional)|Other|2
7831919|NCT00303472|27191225|P1|Treatment Extension (Optional)|Other|0
7831920|NCT00303472|27191219|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
7831921|NCT00303472|27191220|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
7831922|NCT00303472|27191221|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
7831923|NCT00303472|27191222|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
7831924|NCT00303472|27191223|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
7831925|NCT00303472|27191224|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
7831926|NCT00303472|27191225|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
7831927|NCT00303472|27191219|P7|Treatment Extension (Optional)|Physician Decision|0
7831928|NCT00303472|27191220|P6|Treatment Extension (Optional)|Physician Decision|0
7831929|NCT00303472|27191221|P5|Treatment Extension (Optional)|Physician Decision|2
7831930|NCT00303472|27191222|P4|Treatment Extension (Optional)|Physician Decision|3
7831931|NCT00303472|27191223|P3|Treatment Extension (Optional)|Physician Decision|2
7831932|NCT00303472|27191224|P2|Treatment Extension (Optional)|Physician Decision|4
7831933|NCT00303472|27191225|P1|Treatment Extension (Optional)|Physician Decision|0
7831934|NCT00303472|27191219|P7|Treatment Extension (Optional)|Lost to Follow-up|0
7831935|NCT00303472|27191220|P6|Treatment Extension (Optional)|Lost to Follow-up|0
7831936|NCT00303472|27191221|P5|Treatment Extension (Optional)|Lost to Follow-up|0
7831937|NCT00303472|27191222|P4|Treatment Extension (Optional)|Lost to Follow-up|1
7831938|NCT00303472|27191223|P3|Treatment Extension (Optional)|Lost to Follow-up|0
7831939|NCT00303472|27191224|P2|Treatment Extension (Optional)|Lost to Follow-up|0
7831940|NCT00303472|27191225|P1|Treatment Extension (Optional)|Lost to Follow-up|0
7831941|NCT00303472|27191219|P7|Treatment Extension (Optional)|Death|0
7831942|NCT00303472|27191220|P6|Treatment Extension (Optional)|Death|0
7831943|NCT00303472|27191221|P5|Treatment Extension (Optional)|Death|0
7831944|NCT00303472|27191222|P4|Treatment Extension (Optional)|Death|0
7831945|NCT00303472|27191223|P3|Treatment Extension (Optional)|Death|1
7831946|NCT00303472|27191224|P2|Treatment Extension (Optional)|Death|0
7831947|NCT00303472|27191225|P1|Treatment Extension (Optional)|Death|2
7831948|NCT00303472|27191219|P7|Treatment Extension (Optional)|Adverse Event|0
7831949|NCT00303472|27191220|P6|Treatment Extension (Optional)|Adverse Event|0
7831950|NCT00303472|27191221|P5|Treatment Extension (Optional)|Adverse Event|0
7831951|NCT00303472|27191222|P4|Treatment Extension (Optional)|Adverse Event|0
7831952|NCT00303472|27191223|P3|Treatment Extension (Optional)|Adverse Event|1
7831953|NCT00303472|27191224|P2|Treatment Extension (Optional)|Adverse Event|0
7831954|NCT00303472|27191225|P1|Treatment Extension (Optional)|Adverse Event|1
7831955|NCT00303472|27191219|P7|Treatment Period|Disease Progression (to AML)|0
7831956|NCT00303472|27191220|P6|Treatment Period|Disease Progression (to AML)|0
7831957|NCT00303472|27191221|P5|Treatment Period|Disease Progression (to AML)|1
7831958|NCT00303472|27191222|P4|Treatment Period|Disease Progression (to AML)|0
7831959|NCT00303472|27191223|P3|Treatment Period|Disease Progression (to AML)|0
7831960|NCT00303472|27191224|P2|Treatment Period|Disease Progression (to AML)|0
7831961|NCT00303472|27191225|P1|Treatment Period|Disease Progression (to AML)|0
7831962|NCT00303472|27191219|P7|Treatment Period|Other|1
7831963|NCT00303472|27191220|P6|Treatment Period|Other|0
7831964|NCT00303472|27191221|P5|Treatment Period|Other|1
7831965|NCT00303472|27191222|P4|Treatment Period|Other|0
7831966|NCT00303472|27191223|P3|Treatment Period|Other|0
7831967|NCT00303472|27191224|P2|Treatment Period|Other|0
7831968|NCT00303472|27191225|P1|Treatment Period|Other|0
7831969|NCT00303472|27191219|P7|Treatment Period|Withdrawal by Subject|0
7831970|NCT00303472|27191220|P6|Treatment Period|Withdrawal by Subject|1
7831971|NCT00303472|27191221|P5|Treatment Period|Withdrawal by Subject|0
7831972|NCT00303472|27191222|P4|Treatment Period|Withdrawal by Subject|1
7831973|NCT00303472|27191223|P3|Treatment Period|Withdrawal by Subject|0
7831974|NCT00303472|27191224|P2|Treatment Period|Withdrawal by Subject|0
7831975|NCT00303472|27191225|P1|Treatment Period|Withdrawal by Subject|0
7831976|NCT00303472|27191219|P7|Treatment Period|Death|1
7831977|NCT00303472|27191220|P6|Treatment Period|Death|0
7831978|NCT00303472|27191221|P5|Treatment Period|Death|0
7831979|NCT00303472|27191222|P4|Treatment Period|Death|1
7831980|NCT00303472|27191223|P3|Treatment Period|Death|0
7831981|NCT00303472|27191224|P2|Treatment Period|Death|0
7831982|NCT00303472|27191225|P1|Treatment Period|Death|0
7831983|NCT00303472|27191219|P7|Treatment Period|Adverse Event|0
7831984|NCT00303472|27191220|P6|Treatment Period|Adverse Event|0
7831985|NCT00303472|27191221|P5|Treatment Period|Adverse Event|1
7831986|NCT00303472|27191222|P4|Treatment Period|Adverse Event|0
7831987|NCT00303472|27191223|P3|Treatment Period|Adverse Event|0
7831988|NCT00303472|27191224|P2|Treatment Period|Adverse Event|0
7831989|NCT00303472|27191225|P1|Treatment Period|Adverse Event|0
7831990|NCT00303459|27191285|P2|Overall Study|Lung transplantation|1
7831991|NCT00303459|27191286|P1|Overall Study|Lung transplantation|1
7831992|NCT00303459|27191285|P2|Overall Study|Decision by the investigator|7
7831993|NCT00303459|27191286|P1|Overall Study|Decision by the investigator|5
7831994|NCT00303459|27191285|P2|Overall Study|Administrative reason|7
7831995|NCT00303459|27191286|P1|Overall Study|Administrative reason|7
7831996|NCT00303459|27191285|P2|Overall Study|Lost to Follow-up|4
7831997|NCT00303459|27191286|P1|Overall Study|Lost to Follow-up|5
7831998|NCT00303459|27191285|P2|Overall Study|Withdrawal of consent|26
7831999|NCT00303459|27191286|P1|Overall Study|Withdrawal of consent|32
7832000|NCT00303459|27191285|P2|Overall Study|Death|44
7832001|NCT00303459|27191286|P1|Overall Study|Death|33
7832002|NCT00303446|27191312|P2|Overall Study|Physician Decision|1
7832003|NCT00303446|27191313|P1|Overall Study|Physician Decision|0
7832004|NCT00303446|27191312|P2|Overall Study|Death|1
7832005|NCT00303446|27191313|P1|Overall Study|Death|0
7832006|NCT00303446|27191312|P2|Overall Study|Withdrawal by Subject|2
7832007|NCT00303446|27191313|P1|Overall Study|Withdrawal by Subject|2
7832008|NCT00303329|27191349|P2|Overall Study|Stopped at end of extension 1|0
7832009|NCT00303329|27191350|P1|Overall Study|Stopped at end of extension 1|1
7832010|NCT00303329|27191349|P2|Overall Study|Stopped at end of core|9
7832011|NCT00303329|27191350|P1|Overall Study|Stopped at end of core|3
7832012|NCT00303329|27191349|P2|Overall Study|Death|12
7832013|NCT00303329|27191350|P1|Overall Study|Death|2
7832014|NCT00303329|27191349|P2|Overall Study|Administrative problems|0
7832015|NCT00303329|27191350|P1|Overall Study|Administrative problems|1
7832016|NCT00303329|27191349|P2|Overall Study|Lost to Follow-up|1
7832017|NCT00303329|27191350|P1|Overall Study|Lost to Follow-up|0
7832018|NCT00303329|27191349|P2|Overall Study|Withdrawal by Subject|15
7832019|NCT00303329|27191350|P1|Overall Study|Withdrawal by Subject|9
7832020|NCT00303329|27191349|P2|Overall Study|Protocol Violation|0
7832021|NCT00303329|27191350|P1|Overall Study|Protocol Violation|3
7832022|NCT00303329|27191349|P2|Overall Study|Condition no longer requires study drug|8
7832023|NCT00303329|27191350|P1|Overall Study|Condition no longer requires study drug|0
7832024|NCT00303329|27191349|P2|Overall Study|Unsatisfactory therapeutic effect|2
7832025|NCT00303329|27191350|P1|Overall Study|Unsatisfactory therapeutic effect|9
7832026|NCT00303329|27191349|P2|Overall Study|Abnormal Laboratory Values|1
7832027|NCT00303329|27191350|P1|Overall Study|Abnormal Laboratory Values|0
7832028|NCT00303329|27191349|P2|Overall Study|Adverse Event|14
7832029|NCT00303329|27191350|P1|Overall Study|Adverse Event|7
7832030|NCT00303316|27191364|P2|Overall Study|Withdrawal by Subject|2
7832031|NCT00303316|27191365|P1|Overall Study|Withdrawal by Subject|1
7832032|NCT00303316|27191364|P2|Overall Study|Lost to Follow-up|1
7832033|NCT00303316|27191365|P1|Overall Study|Lost to Follow-up|0
7832034|NCT00303316|27191364|P2|Overall Study|Protocol Violation|0
7832035|NCT00303316|27191365|P1|Overall Study|Protocol Violation|1
7832036|NCT00303186|27191377|P1|Overall Study|Other|52
7832037|NCT00303108|27191411|P3|Overall Study|ineligible|0
7832038|NCT00303108|27191412|P2|Overall Study|ineligible|1
7832039|NCT00303108|27191413|P1|Overall Study|ineligible|2
7832040|NCT00303108|27191411|P3|Overall Study|Failed Entry|1
7832041|NCT00303108|27191412|P2|Overall Study|Failed Entry|0
7832042|NCT00303108|27191413|P1|Overall Study|Failed Entry|1
7832043|NCT00303108|27191411|P3|Overall Study|Patient Request|8
7832044|NCT00303108|27191412|P2|Overall Study|Patient Request|2
7832045|NCT00303108|27191413|P1|Overall Study|Patient Request|4
7832046|NCT00303108|27191411|P3|Overall Study|Adverse Event|7
7832047|NCT00303108|27191412|P2|Overall Study|Adverse Event|6
7832048|NCT00303108|27191413|P1|Overall Study|Adverse Event|5
7832049|NCT00303069|27191433|P4|Overall Study|Recruitment into Army Reserves|0
7832050|NCT00303069|27191434|P3|Overall Study|Recruitment into Army Reserves|1
7832051|NCT00303069|27191435|P2|Overall Study|Recruitment into Army Reserves|0
7832052|NCT00303069|27191436|P1|Overall Study|Recruitment into Army Reserves|0
7832053|NCT00303069|27191433|P4|Overall Study|subject moved|0
7832054|NCT00303069|27191434|P3|Overall Study|subject moved|0
7832055|NCT00303069|27191435|P2|Overall Study|subject moved|0
7832056|NCT00303069|27191436|P1|Overall Study|subject moved|1
7832057|NCT00303069|27191433|P4|Overall Study|Lost to Follow-up|2
7832058|NCT00303069|27191434|P3|Overall Study|Lost to Follow-up|0
7832059|NCT00303069|27191435|P2|Overall Study|Lost to Follow-up|0
7832060|NCT00303069|27191436|P1|Overall Study|Lost to Follow-up|1
7832061|NCT00302952|27191456|P2|Overall Study|Elevated SGOT (AST) lab value|1
7832062|NCT00302952|27191457|P1|Overall Study|Elevated SGOT (AST) lab value|0
7832063|NCT00302952|27191456|P2|Overall Study|Withdrawal by Subject|3
7832064|NCT00302952|27191457|P1|Overall Study|Withdrawal by Subject|2
7832065|NCT00302952|27191456|P2|Overall Study|Physician Decision|1
7832066|NCT00302952|27191457|P1|Overall Study|Physician Decision|1
7832067|NCT00302731|27191507|P4|Overall Study|cancer unrelated to study discovered|0
7832068|NCT00302731|27191508|P3|Overall Study|cancer unrelated to study discovered|1
7832069|NCT00302731|27191509|P2|Overall Study|cancer unrelated to study discovered|0
7832070|NCT00302731|27191510|P1|Overall Study|cancer unrelated to study discovered|1
7832071|NCT00302731|27191507|P4|Overall Study|Protocol Violation|0
7832072|NCT00302731|27191508|P3|Overall Study|Protocol Violation|0
7832073|NCT00302731|27191509|P2|Overall Study|Protocol Violation|0
7832074|NCT00302731|27191510|P1|Overall Study|Protocol Violation|1
7832075|NCT00302731|27191507|P4|Overall Study|Withdrawal by Subject|0
7832076|NCT00302731|27191508|P3|Overall Study|Withdrawal by Subject|0
7832077|NCT00302731|27191509|P2|Overall Study|Withdrawal by Subject|1
7832078|NCT00302731|27191510|P1|Overall Study|Withdrawal by Subject|1
7832079|NCT00302731|27191507|P4|Overall Study|Adverse Event|0
7832080|NCT00302731|27191508|P3|Overall Study|Adverse Event|2
7832081|NCT00302731|27191509|P2|Overall Study|Adverse Event|2
7832082|NCT00302731|27191510|P1|Overall Study|Adverse Event|0
7832083|NCT00302731|27191507|P4|Overall Study|Lost to Follow-up|0
7832084|NCT00302731|27191508|P3|Overall Study|Lost to Follow-up|0
7832085|NCT00302731|27191509|P2|Overall Study|Lost to Follow-up|2
7832086|NCT00302731|27191510|P1|Overall Study|Lost to Follow-up|1
7832087|NCT00302718|27191536|P4|Overall Study|Participant left primary care setting|1
7832088|NCT00302718|27191537|P3|Overall Study|Participant left primary care setting|2
7832089|NCT00302718|27191538|P2|Overall Study|Participant left primary care setting|0
7832090|NCT00302718|27191539|P1|Overall Study|Participant left primary care setting|0
7832091|NCT00302718|27191536|P4|Overall Study|Withdrawal by Subject|0
7832092|NCT00302718|27191537|P3|Overall Study|Withdrawal by Subject|0
7832093|NCT00302718|27191538|P2|Overall Study|Withdrawal by Subject|1
7832094|NCT00302718|27191539|P1|Overall Study|Withdrawal by Subject|0
7832095|NCT00302718|27191536|P4|Overall Study|Participant left the hospital|1
7832096|NCT00302718|27191537|P3|Overall Study|Participant left the hospital|0
7832097|NCT00302718|27191538|P2|Overall Study|Participant left the hospital|0
7832098|NCT00302718|27191539|P1|Overall Study|Participant left the hospital|1
7832099|NCT00302458|27191605|P1|Overall Study|Withdrawal by Subject|1
7832100|NCT00302458|27191605|P1|Overall Study|Ineligible after screening|1
7832101|NCT00302458|27191605|P1|Overall Study|Lost to Follow-up|1
7832102|NCT00302328|27191616|P3|Overall Study|Physician Decision|0
7832103|NCT00302328|27191617|P2|Overall Study|Physician Decision|1
7832104|NCT00302328|27191618|P1|Overall Study|Physician Decision|0
7832105|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7832106|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
7832107|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7832108|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7832109|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7832110|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
7832111|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7832112|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7832113|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7832114|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7832115|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
7832116|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7832117|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7832118|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7832119|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7832120|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Death|1
7832121|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Death|1
7832122|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Death|0
7832123|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Death|0
7832124|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Death|0
7832125|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Disease progression|2
7832126|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Disease progression|1
7832127|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Disease progression|0
7832128|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Disease progression|0
7832129|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Disease progression|0
7832130|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
7832131|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
7832132|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
7832133|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
7832134|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
7832135|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Adverse Event|0
7832136|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Adverse Event|1
7832137|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Adverse Event|0
7832138|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Adverse Event|0
7832139|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Adverse Event|0
7832140|NCT00302211|27191635|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
7832141|NCT00302211|27191636|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
7832142|NCT00302211|27191637|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7832143|NCT00302211|27191638|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7832144|NCT00302211|27191639|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7832145|NCT00302211|27191635|P5|Double Blind Period (New Patients)|Disease progression|0
7832146|NCT00302211|27191636|P4|Double Blind Period (New Patients)|Disease progression|0
7832147|NCT00302211|27191637|P3|Double Blind Period (New Patients)|Disease progression|1
7832148|NCT00302211|27191638|P2|Double Blind Period (New Patients)|Disease progression|1
7832149|NCT00302211|27191639|P1|Double Blind Period (New Patients)|Disease progression|0
7832150|NCT00302211|27191635|P5|Double Blind Period (New Patients)|Investigator's judgement|0
7832151|NCT00302211|27191636|P4|Double Blind Period (New Patients)|Investigator's judgement|0
7832152|NCT00302211|27191637|P3|Double Blind Period (New Patients)|Investigator's judgement|0
7832153|NCT00302211|27191638|P2|Double Blind Period (New Patients)|Investigator's judgement|0
7832154|NCT00302211|27191639|P1|Double Blind Period (New Patients)|Investigator's judgement|1
7832155|NCT00302211|27191635|P5|Double Blind Period (New Patients)|Adverse Event|0
7832156|NCT00302211|27191636|P4|Double Blind Period (New Patients)|Adverse Event|0
7832157|NCT00302211|27191637|P3|Double Blind Period (New Patients)|Adverse Event|3
7832158|NCT00302211|27191638|P2|Double Blind Period (New Patients)|Adverse Event|0
7832159|NCT00302211|27191639|P1|Double Blind Period (New Patients)|Adverse Event|0
7832160|NCT00302211|27191635|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
7832161|NCT00302211|27191636|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
7832162|NCT00302211|27191637|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
7832163|NCT00302211|27191638|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
7832164|NCT00302211|27191639|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
7832165|NCT00302159|27191665|P1|Overall Study|pt started Avastin|1
7832166|NCT00302159|27191665|P1|Overall Study|pt declined before treatment started|1
7832167|NCT00302107|27191687|P2|Overall Study|Adverse Event|0
7832168|NCT00302107|27191688|P1|Overall Study|Adverse Event|1
7832169|NCT00302107|27191687|P2|Overall Study|Withdrawal by Subject|3
7832170|NCT00302107|27191688|P1|Overall Study|Withdrawal by Subject|0
7832171|NCT00302107|27191687|P2|Overall Study|Relocation|1
7832172|NCT00302107|27191688|P1|Overall Study|Relocation|0
7832173|NCT00302107|27191687|P2|Overall Study|Protocol Violation|0
7832174|NCT00302107|27191688|P1|Overall Study|Protocol Violation|1
7832175|NCT00302107|27191687|P2|Overall Study|Lost to Follow-up|5
7832176|NCT00302107|27191688|P1|Overall Study|Lost to Follow-up|6
7832177|NCT00302081|27191697|P3|Overall Study|Other|5
7832178|NCT00302081|27191698|P2|Overall Study|Other|6
7832179|NCT00302081|27191699|P1|Overall Study|Other|13
7832180|NCT00302081|27191697|P3|Overall Study|Death|0
7832181|NCT00302081|27191698|P2|Overall Study|Death|1
7832182|NCT00302081|27191699|P1|Overall Study|Death|2
7832183|NCT00302081|27191697|P3|Overall Study|Lack of Efficacy|5
7832184|NCT00302081|27191698|P2|Overall Study|Lack of Efficacy|0
7832185|NCT00302081|27191699|P1|Overall Study|Lack of Efficacy|1
7832186|NCT00302081|27191697|P3|Overall Study|Protocol Violation|2
7832187|NCT00302081|27191698|P2|Overall Study|Protocol Violation|1
7832188|NCT00302081|27191699|P1|Overall Study|Protocol Violation|5
7832189|NCT00302081|27191697|P3|Overall Study|Withdrawal by Subject|8
7832190|NCT00302081|27191698|P2|Overall Study|Withdrawal by Subject|12
7832191|NCT00302081|27191699|P1|Overall Study|Withdrawal by Subject|8
7832192|NCT00302081|27191697|P3|Overall Study|Lost to Follow-up|28
7832193|NCT00302081|27191698|P2|Overall Study|Lost to Follow-up|18
7832194|NCT00302081|27191699|P1|Overall Study|Lost to Follow-up|21
7832195|NCT00302081|27191697|P3|Overall Study|Adverse Event|4
7832196|NCT00302081|27191698|P2|Overall Study|Adverse Event|5
7832197|NCT00302081|27191699|P1|Overall Study|Adverse Event|6
7832198|NCT00302003|27191756|P1|Overall Study|Protocol Violation|1
7832199|NCT00302003|27191756|P1|Overall Study|Ineligible|9
7832200|NCT00302003|27191756|P1|Overall Study|Withdrawal by Subject|5
7832201|NCT00302003|27191756|P1|Overall Study|Physician Decision|2
7832202|NCT00302003|27191756|P1|Overall Study|Lost to Follow-up|1
7832203|NCT00302003|27191756|P1|Overall Study|Lack of Efficacy|62
7832204|NCT00301964|27191763|P1|Overall Study|Inadequate pathology|1
7832205|NCT00301964|27191763|P1|Overall Study|Wrong primary|1
7832206|NCT00301964|27191763|P1|Overall Study|Second primary|2
7832207|NCT00301834|27191784|P1|Overall Study|Death|1
7832208|NCT00301821|27191793|P1|Overall Study|Cancel|1
7832209|NCT00301821|27191793|P1|Overall Study|Ineligible|25
7832210|NCT00301808|27191800|P1|Overall Study|Lack of Efficacy|4
7832211|NCT00301808|27191800|P1|Overall Study|Death|3
7832212|NCT00301808|27191800|P1|Overall Study|Adverse Event|5
7832213|NCT00301366|27191825|P1|Overall Study|Adverse Event|1
7832214|NCT00301262|27191831|P2|Open Label Phase (OL)|Other|0
7832215|NCT00301262|27191832|P1|Open Label Phase (OL)|Other|2
7832216|NCT00301262|27191831|P2|Open Label Phase (OL)|Lost to Follow-up|2
7832217|NCT00301262|27191832|P1|Open Label Phase (OL)|Lost to Follow-up|1
7832218|NCT00301262|27191831|P2|Open Label Phase (OL)|Adverse Event|0
7832219|NCT00301262|27191832|P1|Open Label Phase (OL)|Adverse Event|1
7832220|NCT00301262|27191831|P2|Double Blind Phase (DB)|Other|4
7832221|NCT00301262|27191832|P1|Double Blind Phase (DB)|Other|1
7832222|NCT00301262|27191831|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
7832223|NCT00301262|27191832|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
7832224|NCT00301262|27191831|P2|Double Blind Phase (DB)|Lost to Follow-up|3
7832225|NCT00301262|27191832|P1|Double Blind Phase (DB)|Lost to Follow-up|3
7832226|NCT00301262|27191831|P2|Double Blind Phase (DB)|Lack of Efficacy|1
7832227|NCT00301262|27191832|P1|Double Blind Phase (DB)|Lack of Efficacy|0
7832228|NCT00301262|27191831|P2|Double Blind Phase (DB)|Adverse Event|0
7832229|NCT00301262|27191832|P1|Double Blind Phase (DB)|Adverse Event|1
7832230|NCT00301080|27191990|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7832231|NCT00301080|27191991|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7832232|NCT00301080|27191992|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7832233|NCT00301080|27191993|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7832234|NCT00301080|27191994|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
7832235|NCT00301067|27192023|P4|Follow up Until Death|Alive at last data cut point|1
7832236|NCT00301067|27192024|P3|Follow up Until Death|Alive at last data cut point|0
7832237|NCT00301067|27192025|P2|Follow up Until Death|Alive at last data cut point|0
7832238|NCT00301067|27192026|P1|Follow up Until Death|Alive at last data cut point|1
7832239|NCT00301067|27192023|P4|Completed 12 Cycles of Treatment|Adverse Event|1
7832240|NCT00301067|27192024|P3|Completed 12 Cycles of Treatment|Adverse Event|0
7832241|NCT00301067|27192025|P2|Completed 12 Cycles of Treatment|Adverse Event|0
7832242|NCT00301067|27192026|P1|Completed 12 Cycles of Treatment|Adverse Event|0
7832243|NCT00301067|27192023|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
7832244|NCT00301067|27192024|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
7832245|NCT00301067|27192025|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
7832246|NCT00301067|27192026|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
7832247|NCT00301067|27192023|P4|Completed 4 Cycles of Treatment|Progressive disease|5
7832248|NCT00301067|27192024|P3|Completed 4 Cycles of Treatment|Progressive disease|2
7832249|NCT00301067|27192025|P2|Completed 4 Cycles of Treatment|Progressive disease|1
7832250|NCT00301067|27192026|P1|Completed 4 Cycles of Treatment|Progressive disease|1
7832251|NCT00301067|27192023|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
7832252|NCT00301067|27192024|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
7832253|NCT00301067|27192025|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
7832254|NCT00301067|27192026|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
7832255|NCT00301067|27192023|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
7832256|NCT00301067|27192024|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
7832257|NCT00301067|27192025|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
7832258|NCT00301067|27192026|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
7832259|NCT00300885|27192051|P2|Follow-up|Withdrawal by Subject|25
7832260|NCT00300885|27192052|P1|Follow-up|Withdrawal by Subject|26
7832261|NCT00300885|27192051|P2|Follow-up|Lost to Follow-up|7
7832262|NCT00300885|27192052|P1|Follow-up|Lost to Follow-up|11
7832263|NCT00300885|27192051|P2|Follow-up|Death|163
7832264|NCT00300885|27192052|P1|Follow-up|Death|141
7832265|NCT00300885|27192051|P2|Treatment|Non-compliant with study medication|4
7832266|NCT00300885|27192052|P1|Treatment|Non-compliant with study medication|3
7832267|NCT00300885|27192051|P2|Treatment|Random code broken (subject died)|1
7832268|NCT00300885|27192052|P1|Treatment|Random code broken (subject died)|0
7832269|NCT00300885|27192051|P2|Treatment|Disease progression|238
7832270|NCT00300885|27192052|P1|Treatment|Disease progression|171
7832271|NCT00300885|27192051|P2|Treatment|Withdrawal by Subject|23
7832272|NCT00300885|27192052|P1|Treatment|Withdrawal by Subject|26
7832273|NCT00300885|27192051|P2|Treatment|Protocol Violation|11
7832274|NCT00300885|27192052|P1|Treatment|Protocol Violation|11
7832275|NCT00300885|27192051|P2|Treatment|Physician Decision|5
7832276|NCT00300885|27192052|P1|Treatment|Physician Decision|4
7832277|NCT00300885|27192051|P2|Treatment|Lost to Follow-up|2
7832278|NCT00300885|27192052|P1|Treatment|Lost to Follow-up|3
7832279|NCT00300885|27192051|P2|Treatment|Lack of Efficacy|1
7832280|NCT00300885|27192052|P1|Treatment|Lack of Efficacy|1
7832281|NCT00300885|27192051|P2|Treatment|Death|7
7832282|NCT00300885|27192052|P1|Treatment|Death|20
7832283|NCT00300885|27192051|P2|Treatment|Adverse Event|82
7832284|NCT00300885|27192052|P1|Treatment|Adverse Event|134
7832285|NCT00300781|27192070|P2|Overall Study|Lost to Follow-up|1
7832286|NCT00300781|27192071|P1|Overall Study|Lost to Follow-up|0
7832287|NCT00300781|27192070|P2|Overall Study|Symptomatic Deterioration|0
7832288|NCT00300781|27192071|P1|Overall Study|Symptomatic Deterioration|1
7832289|NCT00300781|27192070|P2|Overall Study|Not Recorded|1
7832290|NCT00300781|27192071|P1|Overall Study|Not Recorded|0
7832291|NCT00300781|27192070|P2|Overall Study|Physician Decision|0
7832292|NCT00300781|27192071|P1|Overall Study|Physician Decision|1
7832293|NCT00300781|27192070|P2|Overall Study|Withdrawal by Subject|2
7832294|NCT00300781|27192071|P1|Overall Study|Withdrawal by Subject|1
7832295|NCT00300781|27192070|P2|Overall Study|Adverse Event|6
7832296|NCT00300781|27192071|P1|Overall Study|Adverse Event|5
7832297|NCT00300781|27192070|P2|Overall Study|Disease Progression|52
7832298|NCT00300781|27192071|P1|Overall Study|Disease Progression|55
7832299|NCT00300755|27192086|P3|Overall Study|Protocol Violation|1
7832300|NCT00300755|27192087|P2|Overall Study|Protocol Violation|0
7832301|NCT00300755|27192088|P1|Overall Study|Protocol Violation|0
7832302|NCT00300755|27192086|P3|Overall Study|Withdrawal by Subject|0
7832303|NCT00300755|27192087|P2|Overall Study|Withdrawal by Subject|2
7832304|NCT00300755|27192088|P1|Overall Study|Withdrawal by Subject|0
7832305|NCT00300755|27192086|P3|Overall Study|Adverse Event|1
7832306|NCT00300755|27192087|P2|Overall Study|Adverse Event|2
7832307|NCT00300755|27192088|P1|Overall Study|Adverse Event|1
7832308|NCT00300495|27192122|P2|Overall Study|Protocol Violation|1
7832309|NCT00300495|27192123|P1|Overall Study|Protocol Violation|4
7832310|NCT00300365|27192390|P2|Overall Study|Adverse Event|2
7832311|NCT00300365|27192391|P1|Overall Study|Adverse Event|0
7832312|NCT00300365|27192390|P2|Overall Study|Withdrawal by Subject|0
7832313|NCT00300365|27192391|P1|Overall Study|Withdrawal by Subject|1
7832314|NCT00300365|27192390|P2|Overall Study|Physician Decision|0
7832315|NCT00300365|27192391|P1|Overall Study|Physician Decision|2
7832316|NCT00300365|27192390|P2|Overall Study|Lost to Follow-up|0
7832317|NCT00300365|27192391|P1|Overall Study|Lost to Follow-up|1
7832318|NCT00300274|27192400|P3|Overall Study|Re-transplant|1
7832319|NCT00300274|27192401|P2|Overall Study|Re-transplant|0
7832320|NCT00300274|27192402|P1|Overall Study|Re-transplant|0
7832321|NCT00300274|27192400|P3|Overall Study|Death|25
7832322|NCT00300274|27192401|P2|Overall Study|Death|20
7832323|NCT00300274|27192402|P1|Overall Study|Death|31
7832324|NCT00300274|27192400|P3|Overall Study|Lost to Follow-up|5
7832325|NCT00300274|27192401|P2|Overall Study|Lost to Follow-up|4
7832326|NCT00300274|27192402|P1|Overall Study|Lost to Follow-up|3
7832327|NCT00300274|27192400|P3|Overall Study|Withdrawal by Subject|14
7832328|NCT00300274|27192401|P2|Overall Study|Withdrawal by Subject|3
7832329|NCT00300274|27192402|P1|Overall Study|Withdrawal by Subject|12
7832330|NCT00300053|27192461|P3|Overall Study|Lost to Follow-up|0
7832331|NCT00300053|27192462|P2|Overall Study|Lost to Follow-up|1
7832332|NCT00300053|27192463|P1|Overall Study|Lost to Follow-up|0
7832333|NCT00300053|27192461|P3|Overall Study|Death|3
7832334|NCT00300053|27192462|P2|Overall Study|Death|0
7832335|NCT00300053|27192463|P1|Overall Study|Death|0
7832336|NCT00300053|27192461|P3|Overall Study|Patient/Caregiver Preference|3
7832337|NCT00300053|27192462|P2|Overall Study|Patient/Caregiver Preference|2
7832338|NCT00300053|27192463|P1|Overall Study|Patient/Caregiver Preference|2
7832339|NCT00299975|27192501|P3|Overall Study|Physician Decision|1
7832340|NCT00299975|27192502|P2|Overall Study|Physician Decision|0
7832341|NCT00299975|27192503|P1|Overall Study|Physician Decision|0
7832342|NCT00299975|27192501|P3|Overall Study|Withdrawal by Subject|3
7832343|NCT00299975|27192502|P2|Overall Study|Withdrawal by Subject|1
7832344|NCT00299975|27192503|P1|Overall Study|Withdrawal by Subject|0
7832345|NCT00299975|27192501|P3|Overall Study|Lost to Follow-up|0
7832346|NCT00299975|27192502|P2|Overall Study|Lost to Follow-up|0
7832347|NCT00299975|27192503|P1|Overall Study|Lost to Follow-up|1
7832348|NCT00299975|27192501|P3|Overall Study|Lack of Efficacy|1
7832349|NCT00299975|27192502|P2|Overall Study|Lack of Efficacy|0
7832350|NCT00299975|27192503|P1|Overall Study|Lack of Efficacy|1
7832351|NCT00299975|27192501|P3|Overall Study|Pregnancy|1
7832352|NCT00299975|27192502|P2|Overall Study|Pregnancy|0
7832353|NCT00299975|27192503|P1|Overall Study|Pregnancy|0
7832354|NCT00299975|27192501|P3|Overall Study|Adverse Event|2
7832355|NCT00299975|27192502|P2|Overall Study|Adverse Event|0
7832356|NCT00299975|27192503|P1|Overall Study|Adverse Event|1
7832357|NCT00299702|27192560|P2|Overall Study|Admin issues, sponsor decision, etc.|9
7832358|NCT00299702|27192561|P1|Overall Study|Admin issues, sponsor decision, etc.|5
7832359|NCT00299702|27192560|P2|Overall Study|Insufficient Response|3
7832360|NCT00299702|27192561|P1|Overall Study|Insufficient Response|4
7832361|NCT00299702|27192560|P2|Overall Study|Pregnancy|1
7832362|NCT00299702|27192561|P1|Overall Study|Pregnancy|0
7832363|NCT00299702|27192560|P2|Overall Study|Withdrawal by Subject|23
7832364|NCT00299702|27192561|P1|Overall Study|Withdrawal by Subject|25
7832365|NCT00299702|27192560|P2|Overall Study|Lost to Follow-up|10
7832366|NCT00299702|27192561|P1|Overall Study|Lost to Follow-up|18
7832367|NCT00299702|27192560|P2|Overall Study|Adverse Event|4
7832368|NCT00299702|27192561|P1|Overall Study|Adverse Event|0
7832369|NCT00299702|27192560|P2|Overall Study|Death|0
7832370|NCT00299702|27192561|P1|Overall Study|Death|1
7832371|NCT00299546|27192576|P3|Overall Study|Not treated|1
7832372|NCT00299546|27192577|P2|Overall Study|Not treated|1
7832373|NCT00299546|27192578|P1|Overall Study|Not treated|0
7832374|NCT00299546|27192576|P3|Overall Study|Other|19
7832375|NCT00299546|27192577|P2|Overall Study|Other|26
7832376|NCT00299546|27192578|P1|Overall Study|Other|24
7832377|NCT00299546|27192576|P3|Overall Study|Unsatisfactory therapeutic effect|34
7832378|NCT00299546|27192577|P2|Overall Study|Unsatisfactory therapeutic effect|39
7832379|NCT00299546|27192578|P1|Overall Study|Unsatisfactory therapeutic effect|34
7832380|NCT00299546|27192576|P3|Overall Study|Adverse Event|27
7832381|NCT00299546|27192577|P2|Overall Study|Adverse Event|22
7832382|NCT00299546|27192578|P1|Overall Study|Adverse Event|37
7832383|NCT00299546|27192576|P3|Overall Study|Lost to Follow-up|5
7832384|NCT00299546|27192577|P2|Overall Study|Lost to Follow-up|2
7832385|NCT00299546|27192578|P1|Overall Study|Lost to Follow-up|2
7832386|NCT00299546|27192576|P3|Overall Study|Death|0
7832387|NCT00299546|27192577|P2|Overall Study|Death|2
7832388|NCT00299546|27192578|P1|Overall Study|Death|3
7832389|NCT00299494|27192609|P6|Overall Study|Other - site closure|1
7832390|NCT00299494|27192610|P5|Overall Study|Other - site closure|1
7832391|NCT00299494|27192611|P4|Overall Study|Other - site closure|1
7832392|NCT00299494|27192612|P3|Overall Study|Other - site closure|0
7832393|NCT00299494|27192613|P2|Overall Study|Other - site closure|0
7832394|NCT00299494|27192614|P1|Overall Study|Other - site closure|0
7832395|NCT00299494|27192609|P6|Overall Study|Other - Unspecified|1
7832396|NCT00299494|27192610|P5|Overall Study|Other - Unspecified|3
7832397|NCT00299494|27192611|P4|Overall Study|Other - Unspecified|0
7832398|NCT00299494|27192612|P3|Overall Study|Other - Unspecified|0
7832399|NCT00299494|27192613|P2|Overall Study|Other - Unspecified|0
7832400|NCT00299494|27192614|P1|Overall Study|Other - Unspecified|0
7832401|NCT00299494|27192609|P6|Overall Study|Lost to Follow-up|1
7832402|NCT00299494|27192610|P5|Overall Study|Lost to Follow-up|3
7832403|NCT00299494|27192611|P4|Overall Study|Lost to Follow-up|0
7832404|NCT00299494|27192612|P3|Overall Study|Lost to Follow-up|0
7832405|NCT00299494|27192613|P2|Overall Study|Lost to Follow-up|0
7832406|NCT00299494|27192614|P1|Overall Study|Lost to Follow-up|0
7832407|NCT00299494|27192609|P6|Overall Study|Death|19
7832408|NCT00299494|27192610|P5|Overall Study|Death|18
7832409|NCT00299494|27192611|P4|Overall Study|Death|6
7832410|NCT00299494|27192612|P3|Overall Study|Death|4
7832411|NCT00299494|27192613|P2|Overall Study|Death|1
7832412|NCT00299494|27192614|P1|Overall Study|Death|3
7832413|NCT00299494|27192609|P6|Overall Study|Physician Decision|0
7832414|NCT00299494|27192610|P5|Overall Study|Physician Decision|1
7832415|NCT00299494|27192611|P4|Overall Study|Physician Decision|0
7832416|NCT00299494|27192612|P3|Overall Study|Physician Decision|0
7832417|NCT00299494|27192613|P2|Overall Study|Physician Decision|0
7832418|NCT00299494|27192614|P1|Overall Study|Physician Decision|0
7832419|NCT00299494|27192609|P6|Overall Study|Withdrawal by Subject|4
7832420|NCT00299494|27192610|P5|Overall Study|Withdrawal by Subject|1
7832421|NCT00299494|27192611|P4|Overall Study|Withdrawal by Subject|3
7832422|NCT00299494|27192612|P3|Overall Study|Withdrawal by Subject|0
7832423|NCT00299494|27192613|P2|Overall Study|Withdrawal by Subject|0
7832424|NCT00299494|27192614|P1|Overall Study|Withdrawal by Subject|0
7832425|NCT00299182|27192764|P7|Overall Study|Not Eligible|0
7832426|NCT00299182|27192765|P6|Overall Study|Not Eligible|0
7832427|NCT00299182|27192766|P5|Overall Study|Not Eligible|1
7832428|NCT00299182|27192767|P4|Overall Study|Not Eligible|0
7832429|NCT00299182|27192768|P3|Overall Study|Not Eligible|0
7832430|NCT00299182|27192769|P2|Overall Study|Not Eligible|0
7832431|NCT00299182|27192770|P1|Overall Study|Not Eligible|0
7832432|NCT00299182|27192764|P7|Overall Study|Adverse Event|0
7832433|NCT00299182|27192765|P6|Overall Study|Adverse Event|1
7832434|NCT00299182|27192766|P5|Overall Study|Adverse Event|0
7832435|NCT00299182|27192767|P4|Overall Study|Adverse Event|0
7832436|NCT00299182|27192768|P3|Overall Study|Adverse Event|0
7832437|NCT00299182|27192769|P2|Overall Study|Adverse Event|0
7832438|NCT00299182|27192770|P1|Overall Study|Adverse Event|0
7832439|NCT00299182|27192764|P7|Overall Study|Chemotherapy Changed|1
7832440|NCT00299182|27192765|P6|Overall Study|Chemotherapy Changed|0
7832441|NCT00299182|27192766|P5|Overall Study|Chemotherapy Changed|1
7832442|NCT00299182|27192767|P4|Overall Study|Chemotherapy Changed|0
7832443|NCT00299182|27192768|P3|Overall Study|Chemotherapy Changed|1
7832444|NCT00299182|27192769|P2|Overall Study|Chemotherapy Changed|0
7832445|NCT00299182|27192770|P1|Overall Study|Chemotherapy Changed|0
7832446|NCT00299182|27192764|P7|Overall Study|Withdrawal by Subject|0
7832447|NCT00299182|27192765|P6|Overall Study|Withdrawal by Subject|2
7832448|NCT00299182|27192766|P5|Overall Study|Withdrawal by Subject|1
7832449|NCT00299182|27192767|P4|Overall Study|Withdrawal by Subject|0
7832450|NCT00299182|27192768|P3|Overall Study|Withdrawal by Subject|1
7832451|NCT00299182|27192769|P2|Overall Study|Withdrawal by Subject|0
7832452|NCT00299182|27192770|P1|Overall Study|Withdrawal by Subject|0
7832453|NCT00299156|27192796|P3|Period 2 (Randomized)|Screen Failure|0
7832454|NCT00299156|27192797|P2|Period 2 (Randomized)|Screen Failure|1
7832455|NCT00299156|27192798|P1|Period 2 (Randomized)|Screen Failure|0
7832456|NCT00299130|27192809|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
7832457|NCT00299130|27192810|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
7832458|NCT00299130|27192811|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
7832459|NCT00299130|27192809|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
7832460|NCT00299130|27192810|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
7832461|NCT00299130|27192811|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
7832462|NCT00299130|27192809|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
7832463|NCT00299130|27192810|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
7832464|NCT00299130|27192811|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
7832465|NCT00299130|27192809|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
7832466|NCT00299130|27192810|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
7832467|NCT00299130|27192811|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
7832468|NCT00299130|27192809|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
7832469|NCT00299130|27192810|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
7832470|NCT00299130|27192811|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
7832471|NCT00299130|27192809|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
7832472|NCT00299130|27192810|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
7832473|NCT00299130|27192811|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
7832474|NCT00299130|27192809|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
7832475|NCT00299130|27192810|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
7832476|NCT00299130|27192811|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
7832477|NCT00299130|27192809|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
7832478|NCT00299130|27192810|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
7832479|NCT00299130|27192811|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
7832480|NCT00299130|27192809|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
7832481|NCT00299130|27192810|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
7832482|NCT00299130|27192811|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
7832483|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
7832484|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
7832485|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
7832486|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
7832487|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
7832488|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
7832489|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Failure to Return|6
7832490|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Failure to Return|6
7832491|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Failure to Return|4
7832492|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
7832493|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
7832494|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
7832495|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
7832496|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
7832497|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
7832498|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
7832499|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
7832500|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
7832501|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Death|1
7832502|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Death|3
7832503|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Death|1
7832504|NCT00299130|27192809|P3|Treatment Period (up to 5 Years)|Adverse Event|13
7832505|NCT00299130|27192810|P2|Treatment Period (up to 5 Years)|Adverse Event|8
7832506|NCT00299130|27192811|P1|Treatment Period (up to 5 Years)|Adverse Event|13
7832507|NCT00299104|27192916|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
7832508|NCT00299104|27192917|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
7832509|NCT00299104|27192918|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
7832510|NCT00299104|27192916|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
7832511|NCT00299104|27192917|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
7832512|NCT00299104|27192918|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
7832513|NCT00299104|27192916|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7832514|NCT00299104|27192917|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7832515|NCT00299104|27192918|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7832516|NCT00299104|27192916|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
7832517|NCT00299104|27192917|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
7832518|NCT00299104|27192918|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
7832519|NCT00299104|27192916|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
7832520|NCT00299104|27192917|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
7832521|NCT00299104|27192918|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
7832522|NCT00299104|27192916|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
7832523|NCT00299104|27192917|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
7832524|NCT00299104|27192918|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
7832525|NCT00299104|27192916|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
7832526|NCT00299104|27192917|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
7832527|NCT00299104|27192918|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
7832528|NCT00299104|27192916|P3|Safety Follow-Up (SFU) Period|Death|1
7832529|NCT00299104|27192917|P2|Safety Follow-Up (SFU) Period|Death|2
7832530|NCT00299104|27192918|P1|Safety Follow-Up (SFU) Period|Death|3
7832531|NCT00299104|27192916|P3|Treatment Period|Administrative reasons|137
7832532|NCT00299104|27192917|P2|Treatment Period|Administrative reasons|120
7832533|NCT00299104|27192918|P1|Treatment Period|Administrative reasons|106
7832534|NCT00299104|27192916|P3|Treatment Period|Withdrew consent|9
7832535|NCT00299104|27192917|P2|Treatment Period|Withdrew consent|19
7832536|NCT00299104|27192918|P1|Treatment Period|Withdrew consent|14
7832537|NCT00299104|27192916|P3|Treatment Period|Refused treatment|2
7832538|NCT00299104|27192917|P2|Treatment Period|Refused treatment|2
7832539|NCT00299104|27192918|P1|Treatment Period|Refused treatment|9
7832540|NCT00299104|27192916|P3|Treatment Period|Protocol Violation|0
7832541|NCT00299104|27192917|P2|Treatment Period|Protocol Violation|1
7832542|NCT00299104|27192918|P1|Treatment Period|Protocol Violation|1
7832543|NCT00299104|27192916|P3|Treatment Period|Violation of selection criteria|0
7832544|NCT00299104|27192917|P2|Treatment Period|Violation of selection criteria|2
7832545|NCT00299104|27192918|P1|Treatment Period|Violation of selection criteria|1
7832546|NCT00299104|27192916|P3|Treatment Period|Failure to return|8
7832547|NCT00299104|27192917|P2|Treatment Period|Failure to return|8
7832548|NCT00299104|27192918|P1|Treatment Period|Failure to return|9
7832549|NCT00299104|27192916|P3|Treatment Period|Insufficient therapeutic response|8
7832550|NCT00299104|27192917|P2|Treatment Period|Insufficient therapeutic response|13
7832551|NCT00299104|27192918|P1|Treatment Period|Insufficient therapeutic response|34
7832552|NCT00299104|27192916|P3|Treatment Period|Death|1
7832553|NCT00299104|27192917|P2|Treatment Period|Death|1
7832554|NCT00299104|27192918|P1|Treatment Period|Death|1
7832555|NCT00299104|27192916|P3|Treatment Period|Adverse Event|7
7832556|NCT00299104|27192917|P2|Treatment Period|Adverse Event|9
7832557|NCT00299104|27192918|P1|Treatment Period|Adverse Event|14
7832558|NCT00298896|27193028|P1|Overall Study|Assigned to treatment in error|1
7832559|NCT00298896|27193028|P1|Overall Study|Withdrawal by Subject|2
7832560|NCT00298896|27193028|P1|Overall Study|Disease Progression|41
7832561|NCT00298896|27193028|P1|Overall Study|Intercurrent Illness|1
7832562|NCT00298896|27193028|P1|Overall Study|Physician Decision|2
7832563|NCT00298896|27193028|P1|Overall Study|Death|3
7832564|NCT00298831|27193033|P1|Overall Study|Participants did not receive treatment|27
7832565|NCT00298831|27193033|P1|Overall Study|Withdrawal by Subject|1
7832566|NCT00298831|27193033|P1|Overall Study|Lost to Follow-up|3
7832567|NCT00298831|27193033|P1|Overall Study|Adverse Event|1
7832568|NCT00298766|27193042|P1|Overall Study|Other|4
7832569|NCT00298766|27193042|P1|Overall Study|Subjects overall condition deterioration|4
7832570|NCT00298766|27193042|P1|Overall Study|Deterioration in KPS and organ function|1
7832571|NCT00298766|27193042|P1|Overall Study|Progression of amyloid markers|4
7832572|NCT00298766|27193042|P1|Overall Study|Treatment ongoing|4
7832573|NCT00298766|27193042|P1|Overall Study|Withdrawal by Subject|9
7832574|NCT00298766|27193042|P1|Overall Study|Death|2
7832575|NCT00298766|27193042|P1|Overall Study|Adverse Event|18
7832576|NCT00298740|27193051|P1|Overall Study|Withdrawal by Subject|3
7832577|NCT00298740|27193051|P1|Overall Study|Lack of Efficacy|6
7832578|NCT00298363|27193121|P3|Overall Study|Lack of Efficacy|0
7832579|NCT00298363|27193122|P2|Overall Study|Lack of Efficacy|3
7832580|NCT00298363|27193123|P1|Overall Study|Lack of Efficacy|2
7832581|NCT00298363|27193121|P3|Overall Study|Adverse Event|2
7832582|NCT00298363|27193122|P2|Overall Study|Adverse Event|2
7832583|NCT00298363|27193123|P1|Overall Study|Adverse Event|5
7832584|NCT00298363|27193121|P3|Overall Study|Withdrawal by Subject|3
7832585|NCT00298363|27193122|P2|Overall Study|Withdrawal by Subject|1
7832586|NCT00298363|27193123|P1|Overall Study|Withdrawal by Subject|5
7832587|NCT00298363|27193121|P3|Overall Study|Protocol Violation|0
7832588|NCT00298363|27193122|P2|Overall Study|Protocol Violation|1
7832589|NCT00298363|27193123|P1|Overall Study|Protocol Violation|1
7832590|NCT00298363|27193121|P3|Overall Study|Physician Decision|0
7832591|NCT00298363|27193122|P2|Overall Study|Physician Decision|1
7832592|NCT00298363|27193123|P1|Overall Study|Physician Decision|4
7832593|NCT00298363|27193121|P3|Overall Study|Lost to Follow-up|1
7832594|NCT00298363|27193122|P2|Overall Study|Lost to Follow-up|0
7832595|NCT00298363|27193123|P1|Overall Study|Lost to Follow-up|0
7832596|NCT00298272|27193281|P2|Safety Follow-up Phase|Administrative/Other Reason|1
7832597|NCT00298272|27193282|P1|Safety Follow-up Phase|Administrative/Other Reason|1
7832598|NCT00298272|27193281|P2|Safety Follow-up Phase|Withdrawal by Subject|2
7832599|NCT00298272|27193282|P1|Safety Follow-up Phase|Withdrawal by Subject|2
7832600|NCT00298272|27193281|P2|Safety Follow-up Phase|Failure to Return|1
7832601|NCT00298272|27193282|P1|Safety Follow-up Phase|Failure to Return|1
7832602|NCT00298272|27193281|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
7832603|NCT00298272|27193282|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
7832604|NCT00298272|27193281|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
7832605|NCT00298272|27193282|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
7832606|NCT00298272|27193281|P2|Open Label Retreatment Phase|Protocol Violation|1
7832607|NCT00298272|27193282|P1|Open Label Retreatment Phase|Protocol Violation|2
7832608|NCT00298272|27193281|P2|Open Label Retreatment Phase|Failure to Return|0
7832609|NCT00298272|27193282|P1|Open Label Retreatment Phase|Failure to Return|1
7832610|NCT00298272|27193281|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
7832611|NCT00298272|27193282|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
7832612|NCT00298272|27193281|P2|Open Label Retreatment Phase|Adverse Event|2
7832613|NCT00298272|27193282|P1|Open Label Retreatment Phase|Adverse Event|1
7832614|NCT00298272|27193281|P2|Double-blind Phase|Withdrawal by Subject|0
7832615|NCT00298272|27193282|P1|Double-blind Phase|Withdrawal by Subject|2
7832616|NCT00298272|27193281|P2|Double-blind Phase|Protocol Violation|0
7832617|NCT00298272|27193282|P1|Double-blind Phase|Protocol Violation|2
7832618|NCT00298272|27193281|P2|Double-blind Phase|Failure to Return|0
7832619|NCT00298272|27193282|P1|Double-blind Phase|Failure to Return|2
7832620|NCT00298272|27193281|P2|Double-blind Phase|Adverse Event|0
7832621|NCT00298272|27193282|P1|Double-blind Phase|Adverse Event|2
7832622|NCT00298038|27193346|P2|Overall Study|Severe Gastrointestinal Bleed|0
7832623|NCT00298038|27193347|P1|Overall Study|Severe Gastrointestinal Bleed|1
7832624|NCT00298038|27193346|P2|Overall Study|Cocaine Abuse|0
7832625|NCT00298038|27193347|P1|Overall Study|Cocaine Abuse|1
7832626|NCT00298038|27193346|P2|Overall Study|Noncompliance|0
7832627|NCT00298038|27193347|P1|Overall Study|Noncompliance|1
7832628|NCT00298038|27193346|P2|Overall Study|Breakthrough overt HE episode|69
7832629|NCT00298038|27193347|P1|Overall Study|Breakthrough overt HE episode|28
7832630|NCT00298038|27193346|P2|Overall Study|Adverse Event|7
7832631|NCT00298038|27193347|P1|Overall Study|Adverse Event|8
7832632|NCT00298038|27193346|P2|Overall Study|Withdrawal by Subject|9
7832633|NCT00298038|27193347|P1|Overall Study|Withdrawal by Subject|6
7832634|NCT00298038|27193346|P2|Overall Study|Death|3
7832635|NCT00298038|27193347|P1|Overall Study|Death|6
7832636|NCT00298038|27193346|P2|Overall Study|Protocol Violation|3
7832637|NCT00298038|27193347|P1|Overall Study|Protocol Violation|1
7832638|NCT00298038|27193346|P2|Overall Study|Liver Transplant|1
7832639|NCT00298038|27193347|P1|Overall Study|Liver Transplant|0
7832640|NCT00298038|27193346|P2|Overall Study|Lost to Follow-up|1
7832641|NCT00298038|27193347|P1|Overall Study|Lost to Follow-up|0
7832642|NCT00297882|27193365|P2|Day 28|Lack of Efficacy|0
7832643|NCT00297882|27193366|P1|Day 28|Lack of Efficacy|3
7832644|NCT00297882|27193365|P2|Day 28|Lost to Follow-up|23
7832645|NCT00297882|27193366|P1|Day 28|Lost to Follow-up|13
7832646|NCT00297882|27193365|P2|Day 14|Lack of Efficacy|49
7832647|NCT00297882|27193366|P1|Day 14|Lack of Efficacy|12
7832648|NCT00297830|27193377|P3|12 Month Visit|Withdrawal by Subject|0
7832649|NCT00297830|27193378|P2|12 Month Visit|Withdrawal by Subject|3
7832650|NCT00297830|27193379|P1|12 Month Visit|Withdrawal by Subject|0
7832651|NCT00297830|27193377|P3|12 Month Visit|Adverse Event|0
7832652|NCT00297830|27193378|P2|12 Month Visit|Adverse Event|3
7832653|NCT00297830|27193379|P1|12 Month Visit|Adverse Event|0
7832654|NCT00297830|27193377|P3|12 Month Visit|Lost to Follow-up|0
7832655|NCT00297830|27193378|P2|12 Month Visit|Lost to Follow-up|0
7832656|NCT00297830|27193379|P1|12 Month Visit|Lost to Follow-up|1
7832657|NCT00297830|27193377|P3|6 Month Visit|Adverse Event|0
7832658|NCT00297830|27193378|P2|6 Month Visit|Adverse Event|1
7832659|NCT00297830|27193379|P1|6 Month Visit|Adverse Event|0
7832660|NCT00297830|27193377|P3|6 Month Visit|Withdrawal by Subject|1
7832661|NCT00297830|27193378|P2|6 Month Visit|Withdrawal by Subject|1
7832662|NCT00297830|27193379|P1|6 Month Visit|Withdrawal by Subject|2
7832663|NCT00297830|27193377|P3|6 Month Visit|Death|2
7832664|NCT00297830|27193378|P2|6 Month Visit|Death|0
7832665|NCT00297830|27193379|P1|6 Month Visit|Death|1
7832666|NCT00297778|27193398|P2|Overall Study|Other|1
7832667|NCT00297778|27193399|P1|Overall Study|Other|0
7832668|NCT00297778|27193398|P2|Overall Study|Non-compliant with trial protocol|3
7832669|NCT00297778|27193399|P1|Overall Study|Non-compliant with trial protocol|0
7832670|NCT00297778|27193398|P2|Overall Study|Lack of Efficacy|1
7832671|NCT00297778|27193399|P1|Overall Study|Lack of Efficacy|2
7832672|NCT00297778|27193398|P2|Overall Study|Withdrawal by Subject|5
7832673|NCT00297778|27193399|P1|Overall Study|Withdrawal by Subject|1
7832674|NCT00297778|27193398|P2|Overall Study|Adverse Event|10
7832675|NCT00297778|27193399|P1|Overall Study|Adverse Event|16
7832676|NCT00297648|27193433|P1|Overall Study|Other: Incompliance|1
7832677|NCT00297648|27193433|P1|Overall Study|Withdrawal by Subject|3
7832678|NCT00297648|27193433|P1|Overall Study|Lost to Follow-up|1
7832679|NCT00297648|27193433|P1|Overall Study|Lack of Efficacy|18
7832680|NCT00297648|27193433|P1|Overall Study|Adverse Event|13
7832681|NCT00297492|27193479|P3|6 Month Follow-up|Lost to Follow-up|27
7832682|NCT00297492|27193480|P2|6 Month Follow-up|Lost to Follow-up|49
7832683|NCT00297492|27193481|P1|6 Month Follow-up|Lost to Follow-up|63
7832684|NCT00297492|27193479|P3|Set Quit Date|Lost to Follow-up|5
7832685|NCT00297492|27193480|P2|Set Quit Date|Lost to Follow-up|13
7832686|NCT00297492|27193481|P1|Set Quit Date|Lost to Follow-up|7
7832687|NCT00297479|27193492|P3|Overall Study|Lost to Follow-up|51
7832688|NCT00297479|27193493|P2|Overall Study|Lost to Follow-up|54
7832689|NCT00297479|27193494|P1|Overall Study|Lost to Follow-up|37
7832690|NCT00297427|27193513|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
7832691|NCT00297427|27193514|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
7832692|NCT00297427|27193513|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
7832693|NCT00297427|27193514|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
7832694|NCT00297427|27193513|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
7832695|NCT00297427|27193514|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
7832696|NCT00297427|27193513|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
7832697|NCT00297427|27193514|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
7832698|NCT00297427|27193513|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
7832699|NCT00297427|27193514|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
7832700|NCT00297427|27193513|P2|Phase 1: Initial Intervention|Death|1
7832701|NCT00297427|27193514|P1|Phase 1: Initial Intervention|Death|0
7832702|NCT00297427|27193513|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
7832703|NCT00297427|27193514|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
7832704|NCT00297427|27193513|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
7832705|NCT00297427|27193514|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
7832706|NCT00297258|27193555|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
7832707|NCT00297258|27193555|P1|Overall Study|Switch to Commercial Treatment|1
7832708|NCT00297258|27193555|P1|Overall Study|Surgery Performed on Target Lesion|1
7832709|NCT00297258|27193555|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
7832710|NCT00297258|27193555|P1|Overall Study|Deteriorization of General Condition|1
7832711|NCT00297258|27193555|P1|Overall Study|Intercurrent Death|2
7832712|NCT00297258|27193555|P1|Overall Study|Intercurrent Illness|3
7832713|NCT00297258|27193555|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
7832714|NCT00297258|27193555|P1|Overall Study|Toxicity (or Toxic Death)|10
7832715|NCT00297258|27193555|P1|Overall Study|Disease Progression, Relapse, Death|120
7832716|NCT00297232|27193574|P1|Overall Study|Other|1
7832717|NCT00297232|27193574|P1|Overall Study|No data available after Week 264|161
7832718|NCT00297232|27193574|P1|Overall Study|Did Not Enroll to Week 480|17
7832719|NCT00297232|27193574|P1|Overall Study|Did Not Enroll to Week 264|34
7832720|NCT00297232|27193574|P1|Overall Study|Investigator Withdrew From Program|19
7832721|NCT00297232|27193574|P1|Overall Study|Persistently Positive Antibodies|11
7832722|NCT00297232|27193574|P1|Overall Study|Subject Withdrew Consent|37
7832723|NCT00297232|27193574|P1|Overall Study|Subject Relocated|7
7832724|NCT00297232|27193574|P1|Overall Study|Sponsor Decision|34
7832725|NCT00297232|27193574|P1|Overall Study|Miscellaneous|5
7832726|NCT00297232|27193574|P1|Overall Study|Anti-JCV Antibody Positive|13
7832727|NCT00297232|27193574|P1|Overall Study|Fear of PML|10
7832728|NCT00297232|27193574|P1|Overall Study|Disease Progression|8
7832729|NCT00297232|27193574|P1|Overall Study|Switched to Commercial Tysabri|22
7832730|NCT00297232|27193574|P1|Overall Study|Anti-natalizumab Positive|8
7832731|NCT00297232|27193574|P1|Overall Study|Death|9
7832732|NCT00297232|27193574|P1|Overall Study|Subject was Noncompliant|9
7832733|NCT00297232|27193574|P1|Overall Study|Voluntary Withdrawal|120
7832734|NCT00297232|27193574|P1|Overall Study|Adverse Event|63
7832735|NCT00297232|27193574|P1|Overall Study|Lost to Follow-up|10
7832736|NCT00297232|27193574|P1|Overall Study|Lack of Efficacy|7
7832737|NCT00297167|27193580|P3|Second Double-blind Intervention Period|Protocol Violation|0
7832738|NCT00297167|27193581|P2|Second Double-blind Intervention Period|Protocol Violation|0
7832739|NCT00297167|27193582|P1|Second Double-blind Intervention Period|Protocol Violation|1
7832740|NCT00297167|27193580|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
7832741|NCT00297167|27193581|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
7832742|NCT00297167|27193582|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
7832743|NCT00297037|27193646|P2|Overall Study|Withdrawal by Subject|0
7832744|NCT00297037|27193647|P1|Overall Study|Withdrawal by Subject|2
7832745|NCT00296816|27193659|P1|Overall Study|ineligibility due to radiation treatment|1
7832746|NCT00296816|27193659|P1|Overall Study|Proteinuria|1
7832747|NCT00296816|27193659|P1|Overall Study|Neuropathy/patient preference|1
7832748|NCT00296816|27193659|P1|Overall Study|Urine protein/creatinine ratio delay|1
7832749|NCT00296816|27193659|P1|Overall Study|Noncompliance/decision to discontinue|1
7832750|NCT00296816|27193659|P1|Overall Study|Relocation to Florida|1
7832751|NCT00296816|27193659|P1|Overall Study|Poor performance status|1
7832752|NCT00296816|27193659|P1|Overall Study|Progression based on CA-125 (biomarker)|2
7832753|NCT00296816|27193659|P1|Overall Study|Missing for end of treatment|4
7832754|NCT00296816|27193659|P1|Overall Study|Non-compliance|1
7832755|NCT00296816|27193659|P1|Overall Study|Investigator/Participant request|5
7832756|NCT00296816|27193659|P1|Overall Study|Adverse Event|18
7832757|NCT00296816|27193659|P1|Overall Study|Disease Progression|37
7832758|NCT00296725|27193671|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
7832759|NCT00296725|27193671|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
7832760|NCT00296725|27193671|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
7832761|NCT00296647|27193684|P5|Overall Study|Withdrawal by Subject|19
7832762|NCT00296647|27193685|P4|Overall Study|Withdrawal by Subject|16
7832763|NCT00296647|27193686|P3|Overall Study|Withdrawal by Subject|32
7832764|NCT00296647|27193687|P2|Overall Study|Withdrawal by Subject|27
7832765|NCT00296647|27193688|P1|Overall Study|Withdrawal by Subject|28
7832766|NCT00296647|27193684|P5|Overall Study|Death|1
7832767|NCT00296647|27193685|P4|Overall Study|Death|1
7832768|NCT00296647|27193686|P3|Overall Study|Death|2
7832769|NCT00296647|27193687|P2|Overall Study|Death|1
7832770|NCT00296647|27193688|P1|Overall Study|Death|4
7832771|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Other|2
7832772|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Other|0
7832773|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
7832774|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
7832775|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
7832776|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
7832777|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
7832778|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
7832779|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
7832780|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
7832781|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
7832782|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
7832783|NCT00296517|27193702|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
7832784|NCT00296517|27193703|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
7832785|NCT00296517|27193702|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
7832786|NCT00296517|27193703|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
7832787|NCT00296517|27193702|P2|Dose Level 2 - Week 2|Adverse Event|5
7832788|NCT00296517|27193703|P1|Dose Level 2 - Week 2|Adverse Event|1
7832789|NCT00296504|27193739|P9|Final Analysis|Poor Adherence|1
7832790|NCT00296504|27193740|P8|Final Analysis|Poor Adherence|0
7832791|NCT00296504|27193741|P7|Final Analysis|Poor Adherence|0
7832792|NCT00296504|27193742|P6|Final Analysis|Poor Adherence|0
7832793|NCT00296504|27193743|P5|Final Analysis|Poor Adherence|0
7832794|NCT00296504|27193744|P4|Final Analysis|Poor Adherence|0
7832795|NCT00296504|27193745|P3|Final Analysis|Poor Adherence|0
7832796|NCT00296504|27193746|P2|Final Analysis|Poor Adherence|0
7832797|NCT00296504|27193747|P1|Final Analysis|Poor Adherence|0
7832798|NCT00296504|27193739|P9|Final Analysis|Participant Moved to Another Country|1
7832799|NCT00296504|27193740|P8|Final Analysis|Participant Moved to Another Country|0
7832800|NCT00296504|27193741|P7|Final Analysis|Participant Moved to Another Country|0
7832801|NCT00296504|27193742|P6|Final Analysis|Participant Moved to Another Country|0
7832802|NCT00296504|27193743|P5|Final Analysis|Participant Moved to Another Country|0
7832803|NCT00296504|27193744|P4|Final Analysis|Participant Moved to Another Country|0
7832804|NCT00296504|27193745|P3|Final Analysis|Participant Moved to Another Country|0
7832805|NCT00296504|27193746|P2|Final Analysis|Participant Moved to Another Country|0
7832806|NCT00296504|27193747|P1|Final Analysis|Participant Moved to Another Country|0
7832807|NCT00296504|27193739|P9|Final Analysis|Tuberculosis|1
7832808|NCT00296504|27193740|P8|Final Analysis|Tuberculosis|0
7832809|NCT00296504|27193741|P7|Final Analysis|Tuberculosis|0
7832810|NCT00296504|27193742|P6|Final Analysis|Tuberculosis|0
7832811|NCT00296504|27193743|P5|Final Analysis|Tuberculosis|0
7832812|NCT00296504|27193744|P4|Final Analysis|Tuberculosis|0
7832813|NCT00296504|27193745|P3|Final Analysis|Tuberculosis|0
7832814|NCT00296504|27193746|P2|Final Analysis|Tuberculosis|0
7832815|NCT00296504|27193747|P1|Final Analysis|Tuberculosis|0
7832816|NCT00296504|27193739|P9|Final Analysis|Pregnancy|4
7832817|NCT00296504|27193740|P8|Final Analysis|Pregnancy|0
7832818|NCT00296504|27193741|P7|Final Analysis|Pregnancy|0
7832819|NCT00296504|27193742|P6|Final Analysis|Pregnancy|0
7832820|NCT00296504|27193743|P5|Final Analysis|Pregnancy|0
7832821|NCT00296504|27193744|P4|Final Analysis|Pregnancy|0
7832822|NCT00296504|27193745|P3|Final Analysis|Pregnancy|0
7832823|NCT00296504|27193746|P2|Final Analysis|Pregnancy|0
7832824|NCT00296504|27193747|P1|Final Analysis|Pregnancy|0
7832825|NCT00296504|27193739|P9|Final Analysis|Adverse Event|2
7832826|NCT00296504|27193740|P8|Final Analysis|Adverse Event|0
7832827|NCT00296504|27193741|P7|Final Analysis|Adverse Event|0
7832828|NCT00296504|27193742|P6|Final Analysis|Adverse Event|0
7832829|NCT00296504|27193743|P5|Final Analysis|Adverse Event|0
7832830|NCT00296504|27193744|P4|Final Analysis|Adverse Event|0
7832831|NCT00296504|27193745|P3|Final Analysis|Adverse Event|0
7832832|NCT00296504|27193746|P2|Final Analysis|Adverse Event|0
7832833|NCT00296504|27193747|P1|Final Analysis|Adverse Event|0
7832834|NCT00296504|27193739|P9|Final Analysis|Insufficient Viral Load Response|6
7832835|NCT00296504|27193740|P8|Final Analysis|Insufficient Viral Load Response|0
7832836|NCT00296504|27193741|P7|Final Analysis|Insufficient Viral Load Response|0
7832837|NCT00296504|27193742|P6|Final Analysis|Insufficient Viral Load Response|0
7832838|NCT00296504|27193743|P5|Final Analysis|Insufficient Viral Load Response|0
7832839|NCT00296504|27193744|P4|Final Analysis|Insufficient Viral Load Response|0
7832840|NCT00296504|27193745|P3|Final Analysis|Insufficient Viral Load Response|0
7832841|NCT00296504|27193746|P2|Final Analysis|Insufficient Viral Load Response|0
7832842|NCT00296504|27193747|P1|Final Analysis|Insufficient Viral Load Response|0
7832843|NCT00296504|27193739|P9|Final Analysis|Lost to Follow-up|5
7832844|NCT00296504|27193740|P8|Final Analysis|Lost to Follow-up|0
7832845|NCT00296504|27193741|P7|Final Analysis|Lost to Follow-up|0
7832846|NCT00296504|27193742|P6|Final Analysis|Lost to Follow-up|0
7832847|NCT00296504|27193743|P5|Final Analysis|Lost to Follow-up|0
7832848|NCT00296504|27193744|P4|Final Analysis|Lost to Follow-up|0
7832849|NCT00296504|27193745|P3|Final Analysis|Lost to Follow-up|0
7832850|NCT00296504|27193746|P2|Final Analysis|Lost to Follow-up|0
7832851|NCT00296504|27193747|P1|Final Analysis|Lost to Follow-up|0
7832852|NCT00296504|27193739|P9|Final Analysis|Withdrawal by Subject|1
7832853|NCT00296504|27193740|P8|Final Analysis|Withdrawal by Subject|0
7832854|NCT00296504|27193741|P7|Final Analysis|Withdrawal by Subject|0
7832855|NCT00296504|27193742|P6|Final Analysis|Withdrawal by Subject|0
7832856|NCT00296504|27193743|P5|Final Analysis|Withdrawal by Subject|0
7832857|NCT00296504|27193744|P4|Final Analysis|Withdrawal by Subject|0
7832858|NCT00296504|27193745|P3|Final Analysis|Withdrawal by Subject|0
7832859|NCT00296504|27193746|P2|Final Analysis|Withdrawal by Subject|0
7832860|NCT00296504|27193747|P1|Final Analysis|Withdrawal by Subject|0
7832861|NCT00296504|27193739|P9|Interim Analysis|Ongoing|0
7832862|NCT00296504|27193740|P8|Interim Analysis|Ongoing|1
7832863|NCT00296504|27193741|P7|Interim Analysis|Ongoing|30
7832864|NCT00296504|27193742|P6|Interim Analysis|Ongoing|0
7832865|NCT00296504|27193743|P5|Interim Analysis|Ongoing|0
7832866|NCT00296504|27193744|P4|Interim Analysis|Ongoing|22
7832867|NCT00296504|27193745|P3|Interim Analysis|Ongoing|16
7832868|NCT00296504|27193746|P2|Interim Analysis|Ongoing|12
7832869|NCT00296504|27193747|P1|Interim Analysis|Ongoing|32
7832870|NCT00296504|27193739|P9|Interim Analysis|Participant Needed Interferon|0
7832871|NCT00296504|27193740|P8|Interim Analysis|Participant Needed Interferon|1
7832872|NCT00296504|27193741|P7|Interim Analysis|Participant Needed Interferon|0
7832873|NCT00296504|27193742|P6|Interim Analysis|Participant Needed Interferon|0
7832874|NCT00296504|27193743|P5|Interim Analysis|Participant Needed Interferon|0
7832875|NCT00296504|27193744|P4|Interim Analysis|Participant Needed Interferon|0
7832876|NCT00296504|27193745|P3|Interim Analysis|Participant Needed Interferon|0
7832877|NCT00296504|27193746|P2|Interim Analysis|Participant Needed Interferon|0
7832878|NCT00296504|27193747|P1|Interim Analysis|Participant Needed Interferon|0
7832879|NCT00296504|27193739|P9|Interim Analysis|Study Ended|0
7832880|NCT00296504|27193740|P8|Interim Analysis|Study Ended|0
7832881|NCT00296504|27193741|P7|Interim Analysis|Study Ended|1
7832882|NCT00296504|27193742|P6|Interim Analysis|Study Ended|0
7832883|NCT00296504|27193743|P5|Interim Analysis|Study Ended|0
7832884|NCT00296504|27193744|P4|Interim Analysis|Study Ended|0
7832885|NCT00296504|27193745|P3|Interim Analysis|Study Ended|0
7832886|NCT00296504|27193746|P2|Interim Analysis|Study Ended|0
7832887|NCT00296504|27193747|P1|Interim Analysis|Study Ended|0
7832888|NCT00296504|27193739|P9|Interim Analysis|Participant Stopped HIV Medications|0
7832889|NCT00296504|27193740|P8|Interim Analysis|Participant Stopped HIV Medications|0
7832890|NCT00296504|27193741|P7|Interim Analysis|Participant Stopped HIV Medications|1
7832891|NCT00296504|27193742|P6|Interim Analysis|Participant Stopped HIV Medications|0
7832892|NCT00296504|27193743|P5|Interim Analysis|Participant Stopped HIV Medications|0
7832893|NCT00296504|27193744|P4|Interim Analysis|Participant Stopped HIV Medications|0
7832894|NCT00296504|27193745|P3|Interim Analysis|Participant Stopped HIV Medications|0
7832895|NCT00296504|27193746|P2|Interim Analysis|Participant Stopped HIV Medications|0
7832896|NCT00296504|27193747|P1|Interim Analysis|Participant Stopped HIV Medications|0
7832897|NCT00296504|27193739|P9|Interim Analysis|Physician and Participant Decision|0
7832898|NCT00296504|27193740|P8|Interim Analysis|Physician and Participant Decision|0
7832899|NCT00296504|27193741|P7|Interim Analysis|Physician and Participant Decision|0
7832900|NCT00296504|27193742|P6|Interim Analysis|Physician and Participant Decision|1
7832901|NCT00296504|27193743|P5|Interim Analysis|Physician and Participant Decision|0
7832902|NCT00296504|27193744|P4|Interim Analysis|Physician and Participant Decision|0
7832903|NCT00296504|27193745|P3|Interim Analysis|Physician and Participant Decision|0
7832904|NCT00296504|27193746|P2|Interim Analysis|Physician and Participant Decision|0
7832905|NCT00296504|27193747|P1|Interim Analysis|Physician and Participant Decision|0
7832906|NCT00296504|27193739|P9|Interim Analysis|Participant Stopped|0
7832907|NCT00296504|27193740|P8|Interim Analysis|Participant Stopped|0
7832908|NCT00296504|27193741|P7|Interim Analysis|Participant Stopped|0
7832909|NCT00296504|27193742|P6|Interim Analysis|Participant Stopped|0
7832910|NCT00296504|27193743|P5|Interim Analysis|Participant Stopped|1
7832911|NCT00296504|27193744|P4|Interim Analysis|Participant Stopped|0
7832912|NCT00296504|27193745|P3|Interim Analysis|Participant Stopped|0
7832913|NCT00296504|27193746|P2|Interim Analysis|Participant Stopped|0
7832914|NCT00296504|27193747|P1|Interim Analysis|Participant Stopped|0
7832915|NCT00296504|27193739|P9|Interim Analysis|Inclusion in Other Protocol|0
7832916|NCT00296504|27193740|P8|Interim Analysis|Inclusion in Other Protocol|0
7832917|NCT00296504|27193741|P7|Interim Analysis|Inclusion in Other Protocol|0
7832918|NCT00296504|27193742|P6|Interim Analysis|Inclusion in Other Protocol|0
7832919|NCT00296504|27193743|P5|Interim Analysis|Inclusion in Other Protocol|0
7832920|NCT00296504|27193744|P4|Interim Analysis|Inclusion in Other Protocol|1
7832921|NCT00296504|27193745|P3|Interim Analysis|Inclusion in Other Protocol|0
7832922|NCT00296504|27193746|P2|Interim Analysis|Inclusion in Other Protocol|0
7832923|NCT00296504|27193747|P1|Interim Analysis|Inclusion in Other Protocol|0
7832924|NCT00296504|27193739|P9|Interim Analysis|Missed Schedule Date|0
7832925|NCT00296504|27193740|P8|Interim Analysis|Missed Schedule Date|0
7832926|NCT00296504|27193741|P7|Interim Analysis|Missed Schedule Date|0
7832927|NCT00296504|27193742|P6|Interim Analysis|Missed Schedule Date|0
7832928|NCT00296504|27193743|P5|Interim Analysis|Missed Schedule Date|0
7832929|NCT00296504|27193744|P4|Interim Analysis|Missed Schedule Date|0
7832930|NCT00296504|27193745|P3|Interim Analysis|Missed Schedule Date|0
7832931|NCT00296504|27193746|P2|Interim Analysis|Missed Schedule Date|0
7832932|NCT00296504|27193747|P1|Interim Analysis|Missed Schedule Date|1
7832933|NCT00296504|27193739|P9|Interim Analysis|Lack of Personnel at Site|0
7832934|NCT00296504|27193740|P8|Interim Analysis|Lack of Personnel at Site|0
7832935|NCT00296504|27193741|P7|Interim Analysis|Lack of Personnel at Site|0
7832936|NCT00296504|27193742|P6|Interim Analysis|Lack of Personnel at Site|0
7832937|NCT00296504|27193743|P5|Interim Analysis|Lack of Personnel at Site|0
7832938|NCT00296504|27193744|P4|Interim Analysis|Lack of Personnel at Site|0
7832939|NCT00296504|27193745|P3|Interim Analysis|Lack of Personnel at Site|0
7832940|NCT00296504|27193746|P2|Interim Analysis|Lack of Personnel at Site|0
7832941|NCT00296504|27193747|P1|Interim Analysis|Lack of Personnel at Site|1
7832942|NCT00296504|27193739|P9|Interim Analysis|Site Closing|0
7832943|NCT00296504|27193740|P8|Interim Analysis|Site Closing|0
7832944|NCT00296504|27193741|P7|Interim Analysis|Site Closing|2
7832945|NCT00296504|27193742|P6|Interim Analysis|Site Closing|1
7832946|NCT00296504|27193743|P5|Interim Analysis|Site Closing|0
7832947|NCT00296504|27193744|P4|Interim Analysis|Site Closing|0
7832948|NCT00296504|27193745|P3|Interim Analysis|Site Closing|0
7832949|NCT00296504|27193746|P2|Interim Analysis|Site Closing|0
7832950|NCT00296504|27193747|P1|Interim Analysis|Site Closing|1
7832951|NCT00296504|27193739|P9|Interim Analysis|Non-adherence|0
7832952|NCT00296504|27193740|P8|Interim Analysis|Non-adherence|1
7832953|NCT00296504|27193741|P7|Interim Analysis|Non-adherence|0
7832954|NCT00296504|27193742|P6|Interim Analysis|Non-adherence|0
7832955|NCT00296504|27193743|P5|Interim Analysis|Non-adherence|1
7832956|NCT00296504|27193744|P4|Interim Analysis|Non-adherence|0
7832957|NCT00296504|27193745|P3|Interim Analysis|Non-adherence|0
7832958|NCT00296504|27193746|P2|Interim Analysis|Non-adherence|0
7832959|NCT00296504|27193747|P1|Interim Analysis|Non-adherence|2
7832960|NCT00296504|27193739|P9|Interim Analysis|Principle Investigator Terminated Study|0
7832961|NCT00296504|27193740|P8|Interim Analysis|Principle Investigator Terminated Study|0
7832962|NCT00296504|27193741|P7|Interim Analysis|Principle Investigator Terminated Study|0
7832963|NCT00296504|27193742|P6|Interim Analysis|Principle Investigator Terminated Study|0
7832964|NCT00296504|27193743|P5|Interim Analysis|Principle Investigator Terminated Study|0
7832965|NCT00296504|27193744|P4|Interim Analysis|Principle Investigator Terminated Study|0
7832966|NCT00296504|27193745|P3|Interim Analysis|Principle Investigator Terminated Study|1
7832967|NCT00296504|27193746|P2|Interim Analysis|Principle Investigator Terminated Study|0
7832968|NCT00296504|27193747|P1|Interim Analysis|Principle Investigator Terminated Study|0
7832969|NCT00296504|27193739|P9|Interim Analysis|Principle Investigator Discretion|0
7832970|NCT00296504|27193740|P8|Interim Analysis|Principle Investigator Discretion|0
7832971|NCT00296504|27193741|P7|Interim Analysis|Principle Investigator Discretion|0
7832972|NCT00296504|27193742|P6|Interim Analysis|Principle Investigator Discretion|0
7832973|NCT00296504|27193743|P5|Interim Analysis|Principle Investigator Discretion|0
7832974|NCT00296504|27193744|P4|Interim Analysis|Principle Investigator Discretion|1
7832975|NCT00296504|27193745|P3|Interim Analysis|Principle Investigator Discretion|1
7832976|NCT00296504|27193746|P2|Interim Analysis|Principle Investigator Discretion|0
7832977|NCT00296504|27193747|P1|Interim Analysis|Principle Investigator Discretion|2
7832978|NCT00296504|27193739|P9|Interim Analysis|Physician Decision|0
7832979|NCT00296504|27193740|P8|Interim Analysis|Physician Decision|0
7832980|NCT00296504|27193741|P7|Interim Analysis|Physician Decision|0
7832981|NCT00296504|27193742|P6|Interim Analysis|Physician Decision|0
7832982|NCT00296504|27193743|P5|Interim Analysis|Physician Decision|0
7832983|NCT00296504|27193744|P4|Interim Analysis|Physician Decision|0
7832984|NCT00296504|27193745|P3|Interim Analysis|Physician Decision|1
7832985|NCT00296504|27193746|P2|Interim Analysis|Physician Decision|0
7832986|NCT00296504|27193747|P1|Interim Analysis|Physician Decision|0
7832987|NCT00296504|27193739|P9|Interim Analysis|Resistance to FPV|0
7832988|NCT00296504|27193740|P8|Interim Analysis|Resistance to FPV|0
7832989|NCT00296504|27193741|P7|Interim Analysis|Resistance to FPV|0
7832990|NCT00296504|27193742|P6|Interim Analysis|Resistance to FPV|0
7832991|NCT00296504|27193743|P5|Interim Analysis|Resistance to FPV|0
7832992|NCT00296504|27193744|P4|Interim Analysis|Resistance to FPV|0
7832993|NCT00296504|27193745|P3|Interim Analysis|Resistance to FPV|1
7832994|NCT00296504|27193746|P2|Interim Analysis|Resistance to FPV|0
7832995|NCT00296504|27193747|P1|Interim Analysis|Resistance to FPV|0
7832996|NCT00296504|27193739|P9|Interim Analysis|Participant Was Incarcerated|0
7832997|NCT00296504|27193740|P8|Interim Analysis|Participant Was Incarcerated|0
7832998|NCT00296504|27193741|P7|Interim Analysis|Participant Was Incarcerated|0
7832999|NCT00296504|27193742|P6|Interim Analysis|Participant Was Incarcerated|0
7833000|NCT00296504|27193743|P5|Interim Analysis|Participant Was Incarcerated|0
7833001|NCT00296504|27193744|P4|Interim Analysis|Participant Was Incarcerated|0
7833002|NCT00296504|27193745|P3|Interim Analysis|Participant Was Incarcerated|1
7833003|NCT00296504|27193746|P2|Interim Analysis|Participant Was Incarcerated|0
7833004|NCT00296504|27193747|P1|Interim Analysis|Participant Was Incarcerated|2
7833005|NCT00296504|27193739|P9|Interim Analysis|Participant Moved|0
7833006|NCT00296504|27193740|P8|Interim Analysis|Participant Moved|0
7833007|NCT00296504|27193741|P7|Interim Analysis|Participant Moved|1
7833008|NCT00296504|27193742|P6|Interim Analysis|Participant Moved|1
7833009|NCT00296504|27193743|P5|Interim Analysis|Participant Moved|0
7833010|NCT00296504|27193744|P4|Interim Analysis|Participant Moved|0
7833011|NCT00296504|27193745|P3|Interim Analysis|Participant Moved|1
7833012|NCT00296504|27193746|P2|Interim Analysis|Participant Moved|0
7833013|NCT00296504|27193747|P1|Interim Analysis|Participant Moved|1
7833014|NCT00296504|27193739|P9|Interim Analysis|Participant Had Problems with Alcohol|0
7833015|NCT00296504|27193740|P8|Interim Analysis|Participant Had Problems with Alcohol|0
7833016|NCT00296504|27193741|P7|Interim Analysis|Participant Had Problems with Alcohol|0
7833017|NCT00296504|27193742|P6|Interim Analysis|Participant Had Problems with Alcohol|0
7833018|NCT00296504|27193743|P5|Interim Analysis|Participant Had Problems with Alcohol|0
7833019|NCT00296504|27193744|P4|Interim Analysis|Participant Had Problems with Alcohol|0
7833020|NCT00296504|27193745|P3|Interim Analysis|Participant Had Problems with Alcohol|1
7833021|NCT00296504|27193746|P2|Interim Analysis|Participant Had Problems with Alcohol|0
7833022|NCT00296504|27193747|P1|Interim Analysis|Participant Had Problems with Alcohol|0
7833023|NCT00296504|27193739|P9|Interim Analysis|To Simplify Treatment|0
7833024|NCT00296504|27193740|P8|Interim Analysis|To Simplify Treatment|0
7833025|NCT00296504|27193741|P7|Interim Analysis|To Simplify Treatment|2
7833026|NCT00296504|27193742|P6|Interim Analysis|To Simplify Treatment|0
7833027|NCT00296504|27193743|P5|Interim Analysis|To Simplify Treatment|0
7833028|NCT00296504|27193744|P4|Interim Analysis|To Simplify Treatment|0
7833029|NCT00296504|27193745|P3|Interim Analysis|To Simplify Treatment|1
7833030|NCT00296504|27193746|P2|Interim Analysis|To Simplify Treatment|0
7833031|NCT00296504|27193747|P1|Interim Analysis|To Simplify Treatment|0
7833032|NCT00296504|27193739|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
7833033|NCT00296504|27193740|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
7833034|NCT00296504|27193741|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
7833035|NCT00296504|27193742|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
7833036|NCT00296504|27193743|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
7833037|NCT00296504|27193744|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
7833038|NCT00296504|27193745|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
7833039|NCT00296504|27193746|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
7833040|NCT00296504|27193747|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
7833041|NCT00296504|27193739|P9|Interim Analysis|Participant Non-compliant|0
7833042|NCT00296504|27193740|P8|Interim Analysis|Participant Non-compliant|2
7833043|NCT00296504|27193741|P7|Interim Analysis|Participant Non-compliant|6
7833044|NCT00296504|27193742|P6|Interim Analysis|Participant Non-compliant|3
7833045|NCT00296504|27193743|P5|Interim Analysis|Participant Non-compliant|1
7833046|NCT00296504|27193744|P4|Interim Analysis|Participant Non-compliant|1
7833047|NCT00296504|27193745|P3|Interim Analysis|Participant Non-compliant|2
7833048|NCT00296504|27193746|P2|Interim Analysis|Participant Non-compliant|1
7833049|NCT00296504|27193747|P1|Interim Analysis|Participant Non-compliant|0
7833050|NCT00296504|27193739|P9|Interim Analysis|Death|0
7833051|NCT00296504|27193740|P8|Interim Analysis|Death|0
7833052|NCT00296504|27193741|P7|Interim Analysis|Death|0
7833053|NCT00296504|27193742|P6|Interim Analysis|Death|0
7833054|NCT00296504|27193743|P5|Interim Analysis|Death|0
7833055|NCT00296504|27193744|P4|Interim Analysis|Death|0
7833056|NCT00296504|27193745|P3|Interim Analysis|Death|3
7833057|NCT00296504|27193746|P2|Interim Analysis|Death|0
7833058|NCT00296504|27193747|P1|Interim Analysis|Death|1
7833059|NCT00296504|27193739|P9|Interim Analysis|Pregnancy|0
7833060|NCT00296504|27193740|P8|Interim Analysis|Pregnancy|1
7833061|NCT00296504|27193741|P7|Interim Analysis|Pregnancy|1
7833062|NCT00296504|27193742|P6|Interim Analysis|Pregnancy|1
7833063|NCT00296504|27193743|P5|Interim Analysis|Pregnancy|0
7833064|NCT00296504|27193744|P4|Interim Analysis|Pregnancy|2
7833065|NCT00296504|27193745|P3|Interim Analysis|Pregnancy|4
7833066|NCT00296504|27193746|P2|Interim Analysis|Pregnancy|1
7833067|NCT00296504|27193747|P1|Interim Analysis|Pregnancy|4
7833068|NCT00296504|27193739|P9|Interim Analysis|Switched to Commercially Available Drug|0
7833069|NCT00296504|27193740|P8|Interim Analysis|Switched to Commercially Available Drug|4
7833070|NCT00296504|27193741|P7|Interim Analysis|Switched to Commercially Available Drug|3
7833071|NCT00296504|27193742|P6|Interim Analysis|Switched to Commercially Available Drug|5
7833072|NCT00296504|27193743|P5|Interim Analysis|Switched to Commercially Available Drug|0
7833073|NCT00296504|27193744|P4|Interim Analysis|Switched to Commercially Available Drug|1
7833074|NCT00296504|27193745|P3|Interim Analysis|Switched to Commercially Available Drug|4
7833075|NCT00296504|27193746|P2|Interim Analysis|Switched to Commercially Available Drug|0
7833076|NCT00296504|27193747|P1|Interim Analysis|Switched to Commercially Available Drug|2
7833077|NCT00296504|27193739|P9|Interim Analysis|Insufficient CD4 Response|0
7833078|NCT00296504|27193740|P8|Interim Analysis|Insufficient CD4 Response|0
7833079|NCT00296504|27193741|P7|Interim Analysis|Insufficient CD4 Response|0
7833080|NCT00296504|27193742|P6|Interim Analysis|Insufficient CD4 Response|1
7833081|NCT00296504|27193743|P5|Interim Analysis|Insufficient CD4 Response|1
7833082|NCT00296504|27193744|P4|Interim Analysis|Insufficient CD4 Response|0
7833083|NCT00296504|27193745|P3|Interim Analysis|Insufficient CD4 Response|0
7833084|NCT00296504|27193746|P2|Interim Analysis|Insufficient CD4 Response|0
7833085|NCT00296504|27193747|P1|Interim Analysis|Insufficient CD4 Response|0
7833086|NCT00296504|27193739|P9|Interim Analysis|Protocol Violation|0
7833087|NCT00296504|27193740|P8|Interim Analysis|Protocol Violation|1
7833088|NCT00296504|27193741|P7|Interim Analysis|Protocol Violation|0
7833089|NCT00296504|27193742|P6|Interim Analysis|Protocol Violation|0
7833090|NCT00296504|27193743|P5|Interim Analysis|Protocol Violation|1
7833091|NCT00296504|27193744|P4|Interim Analysis|Protocol Violation|0
7833092|NCT00296504|27193745|P3|Interim Analysis|Protocol Violation|2
7833093|NCT00296504|27193746|P2|Interim Analysis|Protocol Violation|0
7833094|NCT00296504|27193747|P1|Interim Analysis|Protocol Violation|0
7833095|NCT00296504|27193739|P9|Interim Analysis|Adverse Event|0
7833096|NCT00296504|27193740|P8|Interim Analysis|Adverse Event|5
7833097|NCT00296504|27193741|P7|Interim Analysis|Adverse Event|4
7833098|NCT00296504|27193742|P6|Interim Analysis|Adverse Event|3
7833099|NCT00296504|27193743|P5|Interim Analysis|Adverse Event|6
7833100|NCT00296504|27193744|P4|Interim Analysis|Adverse Event|4
7833101|NCT00296504|27193745|P3|Interim Analysis|Adverse Event|13
7833102|NCT00296504|27193746|P2|Interim Analysis|Adverse Event|0
7833103|NCT00296504|27193747|P1|Interim Analysis|Adverse Event|0
7833104|NCT00296504|27193739|P9|Interim Analysis|Insufficient Viral Load Response|0
7833105|NCT00296504|27193740|P8|Interim Analysis|Insufficient Viral Load Response|24
7833106|NCT00296504|27193741|P7|Interim Analysis|Insufficient Viral Load Response|2
7833107|NCT00296504|27193742|P6|Interim Analysis|Insufficient Viral Load Response|9
7833108|NCT00296504|27193743|P5|Interim Analysis|Insufficient Viral Load Response|7
7833109|NCT00296504|27193744|P4|Interim Analysis|Insufficient Viral Load Response|2
7833110|NCT00296504|27193745|P3|Interim Analysis|Insufficient Viral Load Response|12
7833111|NCT00296504|27193746|P2|Interim Analysis|Insufficient Viral Load Response|1
7833112|NCT00296504|27193747|P1|Interim Analysis|Insufficient Viral Load Response|5
7833113|NCT00296504|27193739|P9|Interim Analysis|Clinical Progression|0
7833114|NCT00296504|27193740|P8|Interim Analysis|Clinical Progression|2
7833115|NCT00296504|27193741|P7|Interim Analysis|Clinical Progression|1
7833116|NCT00296504|27193742|P6|Interim Analysis|Clinical Progression|2
7833117|NCT00296504|27193743|P5|Interim Analysis|Clinical Progression|0
7833118|NCT00296504|27193744|P4|Interim Analysis|Clinical Progression|1
7833119|NCT00296504|27193745|P3|Interim Analysis|Clinical Progression|1
7833120|NCT00296504|27193746|P2|Interim Analysis|Clinical Progression|0
7833121|NCT00296504|27193747|P1|Interim Analysis|Clinical Progression|1
7833122|NCT00296504|27193739|P9|Interim Analysis|Lost to Follow-up|0
7833123|NCT00296504|27193740|P8|Interim Analysis|Lost to Follow-up|4
7833124|NCT00296504|27193741|P7|Interim Analysis|Lost to Follow-up|11
7833125|NCT00296504|27193742|P6|Interim Analysis|Lost to Follow-up|4
7833126|NCT00296504|27193743|P5|Interim Analysis|Lost to Follow-up|14
7833127|NCT00296504|27193744|P4|Interim Analysis|Lost to Follow-up|8
7833128|NCT00296504|27193745|P3|Interim Analysis|Lost to Follow-up|26
7833129|NCT00296504|27193746|P2|Interim Analysis|Lost to Follow-up|3
7833130|NCT00296504|27193747|P1|Interim Analysis|Lost to Follow-up|13
7833131|NCT00296504|27193739|P9|Interim Analysis|Withdrawal by Subject|0
7833132|NCT00296504|27193740|P8|Interim Analysis|Withdrawal by Subject|3
7833133|NCT00296504|27193741|P7|Interim Analysis|Withdrawal by Subject|9
7833134|NCT00296504|27193742|P6|Interim Analysis|Withdrawal by Subject|5
7833135|NCT00296504|27193743|P5|Interim Analysis|Withdrawal by Subject|5
7833136|NCT00296504|27193744|P4|Interim Analysis|Withdrawal by Subject|0
7833137|NCT00296504|27193745|P3|Interim Analysis|Withdrawal by Subject|12
7833138|NCT00296504|27193746|P2|Interim Analysis|Withdrawal by Subject|0
7833139|NCT00296504|27193747|P1|Interim Analysis|Withdrawal by Subject|8
7833140|NCT00296491|27193840|P4|Overall Study|Lost to Follow-up|0
7833141|NCT00296491|27193841|P3|Overall Study|Lost to Follow-up|2
7833142|NCT00296491|27193842|P2|Overall Study|Lost to Follow-up|2
7833143|NCT00296491|27193843|P1|Overall Study|Lost to Follow-up|0
7833144|NCT00296491|27193840|P4|Overall Study|Non-Compliance|14
7833145|NCT00296491|27193841|P3|Overall Study|Non-Compliance|10
7833146|NCT00296491|27193842|P2|Overall Study|Non-Compliance|13
7833147|NCT00296491|27193843|P1|Overall Study|Non-Compliance|12
7833148|NCT00296491|27193840|P4|Overall Study|Withdrawal by Subject|2
7833149|NCT00296491|27193841|P3|Overall Study|Withdrawal by Subject|3
7833150|NCT00296491|27193842|P2|Overall Study|Withdrawal by Subject|3
7833151|NCT00296491|27193843|P1|Overall Study|Withdrawal by Subject|7
7833152|NCT00296491|27193840|P4|Overall Study|Withdrawn due to Asthma|4
7833153|NCT00296491|27193841|P3|Overall Study|Withdrawn due to Asthma|0
7833154|NCT00296491|27193842|P2|Overall Study|Withdrawn due to Asthma|0
7833155|NCT00296491|27193843|P1|Overall Study|Withdrawn due to Asthma|0
7833156|NCT00296491|27193840|P4|Overall Study|Adverse Event|4
7833157|NCT00296491|27193841|P3|Overall Study|Adverse Event|1
7833158|NCT00296491|27193842|P2|Overall Study|Adverse Event|3
7833159|NCT00296491|27193843|P1|Overall Study|Adverse Event|1
7833160|NCT00296491|27193840|P4|Overall Study|Protocol Violation|3
7833161|NCT00296491|27193841|P3|Overall Study|Protocol Violation|2
7833162|NCT00296491|27193842|P2|Overall Study|Protocol Violation|6
7833163|NCT00296491|27193843|P1|Overall Study|Protocol Violation|4
7833164|NCT00296491|27193840|P4|Overall Study|Low Pollen Counts|16
7833165|NCT00296491|27193841|P3|Overall Study|Low Pollen Counts|25
7833166|NCT00296491|27193842|P2|Overall Study|Low Pollen Counts|26
7833167|NCT00296491|27193843|P1|Overall Study|Low Pollen Counts|18
7833168|NCT00296400|27193872|P3|Overall Study|Pregnancy|0
7833169|NCT00296400|27193873|P2|Overall Study|Pregnancy|2
7833170|NCT00296400|27193874|P1|Overall Study|Pregnancy|1
7833171|NCT00296400|27193872|P3|Overall Study|Visit 10 was performed earlier|0
7833172|NCT00296400|27193873|P2|Overall Study|Visit 10 was performed earlier|1
7833173|NCT00296400|27193874|P1|Overall Study|Visit 10 was performed earlier|0
7833174|NCT00296400|27193872|P3|Overall Study|Study specific discontinuation criteria|1
7833175|NCT00296400|27193873|P2|Overall Study|Study specific discontinuation criteria|0
7833176|NCT00296400|27193874|P1|Overall Study|Study specific discontinuation criteria|0
7833177|NCT00296400|27193872|P3|Overall Study|Lost to Follow-up|2
7833178|NCT00296400|27193873|P2|Overall Study|Lost to Follow-up|1
7833179|NCT00296400|27193874|P1|Overall Study|Lost to Follow-up|1
7833180|NCT00296400|27193872|P3|Overall Study|Protocol Violation|1
7833181|NCT00296400|27193873|P2|Overall Study|Protocol Violation|1
7833182|NCT00296400|27193874|P1|Overall Study|Protocol Violation|1
7833183|NCT00296400|27193872|P3|Overall Study|Incorrect enrollment|0
7833184|NCT00296400|27193873|P2|Overall Study|Incorrect enrollment|0
7833185|NCT00296400|27193874|P1|Overall Study|Incorrect enrollment|2
7833186|NCT00296400|27193872|P3|Overall Study|Withdrawal by Subject|2
7833187|NCT00296400|27193873|P2|Overall Study|Withdrawal by Subject|6
7833188|NCT00296400|27193874|P1|Overall Study|Withdrawal by Subject|5
7833189|NCT00296400|27193872|P3|Overall Study|Adverse Event|7
7833190|NCT00296400|27193873|P2|Overall Study|Adverse Event|7
7833191|NCT00296400|27193874|P1|Overall Study|Adverse Event|7
7833192|NCT00296374|27194098|P3|Overall Study|Other|1
7833193|NCT00296374|27194099|P2|Overall Study|Other|0
7833194|NCT00296374|27194100|P1|Overall Study|Other|0
7833195|NCT00296374|27194098|P3|Overall Study|Pregnancy|2
7833196|NCT00296374|27194099|P2|Overall Study|Pregnancy|0
7833197|NCT00296374|27194100|P1|Overall Study|Pregnancy|0
7833198|NCT00296374|27194098|P3|Overall Study|Nephrologist introduced ACE|0
7833199|NCT00296374|27194099|P2|Overall Study|Nephrologist introduced ACE|1
7833200|NCT00296374|27194100|P1|Overall Study|Nephrologist introduced ACE|0
7833201|NCT00296374|27194098|P3|Overall Study|Stopped drug before end of study visit|0
7833202|NCT00296374|27194099|P2|Overall Study|Stopped drug before end of study visit|1
7833203|NCT00296374|27194100|P1|Overall Study|Stopped drug before end of study visit|0
7833204|NCT00296374|27194098|P3|Overall Study|Relocated to another state|0
7833205|NCT00296374|27194099|P2|Overall Study|Relocated to another state|0
7833206|NCT00296374|27194100|P1|Overall Study|Relocated to another state|1
7833207|NCT00296374|27194098|P3|Overall Study|Lost to Follow-up|1
7833208|NCT00296374|27194099|P2|Overall Study|Lost to Follow-up|1
7833209|NCT00296374|27194100|P1|Overall Study|Lost to Follow-up|3
7833210|NCT00296374|27194098|P3|Overall Study|Protocol Violation|3
7833211|NCT00296374|27194099|P2|Overall Study|Protocol Violation|2
7833212|NCT00296374|27194100|P1|Overall Study|Protocol Violation|1
7833213|NCT00296374|27194098|P3|Overall Study|Incorrect enrollment|4
7833214|NCT00296374|27194099|P2|Overall Study|Incorrect enrollment|3
7833215|NCT00296374|27194100|P1|Overall Study|Incorrect enrollment|3
7833216|NCT00296374|27194098|P3|Overall Study|Withdrawal by Subject|11
7833217|NCT00296374|27194099|P2|Overall Study|Withdrawal by Subject|5
7833218|NCT00296374|27194100|P1|Overall Study|Withdrawal by Subject|3
7833219|NCT00296374|27194098|P3|Overall Study|Adverse Event|7
7833220|NCT00296374|27194099|P2|Overall Study|Adverse Event|10
7833221|NCT00296374|27194100|P1|Overall Study|Adverse Event|14
7833222|NCT00296335|27194323|P2|Overall Study|Physician Decision|11
7833223|NCT00296335|27194324|P1|Overall Study|Physician Decision|3
7833224|NCT00296335|27194323|P2|Overall Study|Lost to Follow-up|33
7833225|NCT00296335|27194324|P1|Overall Study|Lost to Follow-up|7
7833226|NCT00296335|27194323|P2|Overall Study|Adverse Event|27
7833227|NCT00296335|27194324|P1|Overall Study|Adverse Event|17
7833228|NCT00296335|27194323|P2|Overall Study|Recurrence|51
7833229|NCT00296335|27194324|P1|Overall Study|Recurrence|3
7833230|NCT00296244|27194364|P2|Overall Study|Underwent retransplant|1
7833231|NCT00296244|27194365|P1|Overall Study|Underwent retransplant|0
7833232|NCT00296140|27194429|P2|Overall Study|Discharge to Nursing Home|0
7833233|NCT00296140|27194430|P1|Overall Study|Discharge to Nursing Home|1
7833234|NCT00296140|27194429|P2|Overall Study|Withdrawal by Subject|0
7833235|NCT00296140|27194430|P1|Overall Study|Withdrawal by Subject|1
7833236|NCT00296140|27194429|P2|Overall Study|Lost to Follow-up|0
7833237|NCT00296140|27194430|P1|Overall Study|Lost to Follow-up|1
7833238|NCT00296036|27194442|P6|Overall Study|Protocol Violation|3
7833239|NCT00296036|27194443|P5|Overall Study|Protocol Violation|0
7833240|NCT00296036|27194444|P4|Overall Study|Protocol Violation|0
7833241|NCT00296036|27194445|P3|Overall Study|Protocol Violation|0
7833242|NCT00296036|27194446|P2|Overall Study|Protocol Violation|0
7833243|NCT00296036|27194447|P1|Overall Study|Protocol Violation|0
7833244|NCT00296036|27194442|P6|Overall Study|Withdrawal by Subject|1
7833245|NCT00296036|27194443|P5|Overall Study|Withdrawal by Subject|2
7833246|NCT00296036|27194444|P4|Overall Study|Withdrawal by Subject|1
7833247|NCT00296036|27194445|P3|Overall Study|Withdrawal by Subject|2
7833248|NCT00296036|27194446|P2|Overall Study|Withdrawal by Subject|0
7833249|NCT00296036|27194447|P1|Overall Study|Withdrawal by Subject|1
7833250|NCT00295932|27194484|P11|Overall Study|Not Treated|1
7833251|NCT00295932|27194485|P10|Overall Study|Not Treated|0
7833252|NCT00295932|27194486|P9|Overall Study|Not Treated|0
7833253|NCT00295932|27194487|P8|Overall Study|Not Treated|0
7833254|NCT00295932|27194488|P7|Overall Study|Not Treated|0
7833255|NCT00295932|27194489|P6|Overall Study|Not Treated|0
7833256|NCT00295932|27194490|P5|Overall Study|Not Treated|0
7833257|NCT00295932|27194491|P4|Overall Study|Not Treated|0
7833258|NCT00295932|27194492|P3|Overall Study|Not Treated|0
7833259|NCT00295932|27194493|P2|Overall Study|Not Treated|0
7833260|NCT00295932|27194494|P1|Overall Study|Not Treated|0
7833261|NCT00295880|27194528|P1|Overall Study|Unit randomization did not occur|1
7833262|NCT00295880|27194528|P1|Overall Study|IBMI unit could not be volume reduced|1
7833263|NCT00295854|27194548|P3|Overall Study|Other|1
7833264|NCT00295854|27194549|P2|Overall Study|Other|5
7833265|NCT00295854|27194550|P1|Overall Study|Other|3
7833266|NCT00295854|27194548|P3|Overall Study|required a prohibited medication|0
7833267|NCT00295854|27194549|P2|Overall Study|required a prohibited medication|0
7833268|NCT00295854|27194550|P1|Overall Study|required a prohibited medication|1
7833269|NCT00295854|27194548|P3|Overall Study|did not continue to meet criteria|2
7833270|NCT00295854|27194549|P2|Overall Study|did not continue to meet criteria|1
7833271|NCT00295854|27194550|P1|Overall Study|did not continue to meet criteria|1
7833272|NCT00295854|27194548|P3|Overall Study|Withdrawal by Subject|4
7833273|NCT00295854|27194549|P2|Overall Study|Withdrawal by Subject|7
7833274|NCT00295854|27194550|P1|Overall Study|Withdrawal by Subject|3
7833275|NCT00295854|27194548|P3|Overall Study|Lost to Follow-up|1
7833276|NCT00295854|27194549|P2|Overall Study|Lost to Follow-up|0
7833277|NCT00295854|27194550|P1|Overall Study|Lost to Follow-up|2
7833278|NCT00295854|27194548|P3|Overall Study|Protocol Violation|1
7833279|NCT00295854|27194549|P2|Overall Study|Protocol Violation|1
7833280|NCT00295854|27194550|P1|Overall Study|Protocol Violation|1
7833281|NCT00295854|27194548|P3|Overall Study|Adverse Event|6
7833282|NCT00295854|27194549|P2|Overall Study|Adverse Event|7
7833283|NCT00295854|27194550|P1|Overall Study|Adverse Event|7
7833284|NCT00295750|27194564|P3|Overall Study|Protocol Violation|2
7833285|NCT00295750|27194565|P2|Overall Study|Protocol Violation|4
7833286|NCT00295750|27194566|P1|Overall Study|Protocol Violation|2
7833287|NCT00295750|27194564|P3|Overall Study|Withdrawal by Subject|7
7833288|NCT00295750|27194565|P2|Overall Study|Withdrawal by Subject|4
7833289|NCT00295750|27194566|P1|Overall Study|Withdrawal by Subject|9
7833290|NCT00295750|27194564|P3|Overall Study|Randomized but never received trial drug|3
7833291|NCT00295750|27194565|P2|Overall Study|Randomized but never received trial drug|3
7833292|NCT00295750|27194566|P1|Overall Study|Randomized but never received trial drug|4
7833293|NCT00295750|27194564|P3|Overall Study|Personal reasons|0
7833294|NCT00295750|27194565|P2|Overall Study|Personal reasons|1
7833295|NCT00295750|27194566|P1|Overall Study|Personal reasons|0
7833296|NCT00295750|27194564|P3|Overall Study|Disease progression|0
7833297|NCT00295750|27194565|P2|Overall Study|Disease progression|1
7833298|NCT00295750|27194566|P1|Overall Study|Disease progression|2
7833299|NCT00295750|27194564|P3|Overall Study|Trial drug errors|0
7833300|NCT00295750|27194565|P2|Overall Study|Trial drug errors|1
7833301|NCT00295750|27194566|P1|Overall Study|Trial drug errors|1
7833302|NCT00295750|27194564|P3|Overall Study|Administrative errors|5
7833303|NCT00295750|27194565|P2|Overall Study|Administrative errors|4
7833304|NCT00295750|27194566|P1|Overall Study|Administrative errors|2
7833305|NCT00295750|27194564|P3|Overall Study|Taking prohibited therapy|2
7833306|NCT00295750|27194565|P2|Overall Study|Taking prohibited therapy|3
7833307|NCT00295750|27194566|P1|Overall Study|Taking prohibited therapy|2
7833308|NCT00295750|27194564|P3|Overall Study|Lost to Follow-up|1
7833309|NCT00295750|27194565|P2|Overall Study|Lost to Follow-up|4
7833310|NCT00295750|27194566|P1|Overall Study|Lost to Follow-up|1
7833311|NCT00295750|27194564|P3|Overall Study|Lack of Efficacy|0
7833312|NCT00295750|27194565|P2|Overall Study|Lack of Efficacy|1
7833313|NCT00295750|27194566|P1|Overall Study|Lack of Efficacy|1
7833314|NCT00295750|27194564|P3|Overall Study|Adverse Event|12
7833315|NCT00295750|27194565|P2|Overall Study|Adverse Event|15
7833316|NCT00295750|27194566|P1|Overall Study|Adverse Event|19
7833317|NCT00295633|27194601|P3|Overall Study|Administrative reason by sponsor|1
7833318|NCT00295633|27194602|P2|Overall Study|Administrative reason by sponsor|0
7833319|NCT00295633|27194603|P1|Overall Study|Administrative reason by sponsor|0
7833320|NCT00295633|27194601|P3|Overall Study|Death|0
7833321|NCT00295633|27194602|P2|Overall Study|Death|1
7833322|NCT00295633|27194603|P1|Overall Study|Death|1
7833323|NCT00295633|27194601|P3|Overall Study|Subject No Longer Meets Study Criteria|3
7833324|NCT00295633|27194602|P2|Overall Study|Subject No Longer Meets Study Criteria|3
7833325|NCT00295633|27194603|P1|Overall Study|Subject No Longer Meets Study Criteria|0
7833326|NCT00295633|27194601|P3|Overall Study|Poor/Noncompliance|6
7833327|NCT00295633|27194602|P2|Overall Study|Poor/Noncompliance|2
7833328|NCT00295633|27194603|P1|Overall Study|Poor/Noncompliance|2
7833329|NCT00295633|27194601|P3|Overall Study|Physician Decision|8
7833330|NCT00295633|27194602|P2|Overall Study|Physician Decision|10
7833331|NCT00295633|27194603|P1|Overall Study|Physician Decision|9
7833332|NCT00295633|27194601|P3|Overall Study|Lost to Follow-up|7
7833333|NCT00295633|27194602|P2|Overall Study|Lost to Follow-up|11
7833334|NCT00295633|27194603|P1|Overall Study|Lost to Follow-up|6
7833335|NCT00295633|27194601|P3|Overall Study|Adverse Event|9
7833336|NCT00295633|27194602|P2|Overall Study|Adverse Event|17
7833337|NCT00295633|27194603|P1|Overall Study|Adverse Event|9
7833338|NCT00295633|27194601|P3|Overall Study|Withdrawal of consent by subject|26
7833339|NCT00295633|27194602|P2|Overall Study|Withdrawal of consent by subject|16
7833340|NCT00295633|27194603|P1|Overall Study|Withdrawal of consent by subject|16
7833341|NCT00295633|27194601|P3|Overall Study|Lack of Efficacy|16
7833342|NCT00295633|27194602|P2|Overall Study|Lack of Efficacy|7
7833343|NCT00295633|27194603|P1|Overall Study|Lack of Efficacy|19
7833344|NCT00295620|27194622|P2|Overall Study|Protocol Violation|32
7833345|NCT00295620|27194623|P1|Overall Study|Protocol Violation|30
7833346|NCT00295620|27194622|P2|Overall Study|Discontinuation by sponsor|593
7833347|NCT00295620|27194623|P1|Overall Study|Discontinuation by sponsor|580
7833348|NCT00295620|27194622|P2|Overall Study|Other reasons|9
7833349|NCT00295620|27194623|P1|Overall Study|Other reasons|10
7833350|NCT00295620|27194622|P2|Overall Study|Death|207
7833351|NCT00295620|27194623|P1|Overall Study|Death|206
7833352|NCT00295620|27194622|P2|Overall Study|Withdrawal by Subject|50
7833353|NCT00295620|27194623|P1|Overall Study|Withdrawal by Subject|37
7833354|NCT00295620|27194622|P2|Overall Study|Lost to Follow-up|5
7833355|NCT00295620|27194623|P1|Overall Study|Lost to Follow-up|9
7833356|NCT00295490|27194647|P4|Overall Study|Other|1
7833357|NCT00295490|27194648|P3|Overall Study|Other|0
7833358|NCT00295490|27194649|P2|Overall Study|Other|2
7833359|NCT00295490|27194650|P1|Overall Study|Other|0
7833360|NCT00295490|27194647|P4|Overall Study|Adverse Event|0
7833361|NCT00295490|27194648|P3|Overall Study|Adverse Event|0
7833362|NCT00295490|27194649|P2|Overall Study|Adverse Event|0
7833363|NCT00295490|27194650|P1|Overall Study|Adverse Event|1
7833364|NCT00295490|27194647|P4|Overall Study|Lost to Follow-up|0
7833365|NCT00295490|27194648|P3|Overall Study|Lost to Follow-up|1
7833366|NCT00295490|27194649|P2|Overall Study|Lost to Follow-up|0
7833367|NCT00295490|27194650|P1|Overall Study|Lost to Follow-up|0
7833368|NCT00295490|27194647|P4|Overall Study|Withdrawal by Subject|1
7833369|NCT00295490|27194648|P3|Overall Study|Withdrawal by Subject|0
7833370|NCT00295490|27194649|P2|Overall Study|Withdrawal by Subject|2
7833371|NCT00295490|27194650|P1|Overall Study|Withdrawal by Subject|0
7833372|NCT00295490|27194647|P4|Overall Study|Protocol Violation|3
7833373|NCT00295490|27194648|P3|Overall Study|Protocol Violation|3
7833374|NCT00295490|27194649|P2|Overall Study|Protocol Violation|0
7833375|NCT00295490|27194650|P1|Overall Study|Protocol Violation|0
7833376|NCT00295022|27194700|P3|Overall Study|Withdrawal by Subject|2
7833377|NCT00295022|27194701|P2|Overall Study|Withdrawal by Subject|0
7833378|NCT00295022|27194702|P1|Overall Study|Withdrawal by Subject|0
7833379|NCT00295022|27194700|P3|Overall Study|Lost to Follow-up|1
7833380|NCT00295022|27194701|P2|Overall Study|Lost to Follow-up|0
7833381|NCT00295022|27194702|P1|Overall Study|Lost to Follow-up|0
7833382|NCT00295022|27194700|P3|Overall Study|Adverse Event|2
7833383|NCT00295022|27194701|P2|Overall Study|Adverse Event|1
7833384|NCT00295022|27194702|P1|Overall Study|Adverse Event|1
7833385|NCT00294762|27194818|P2|Overall Study|Did not receive study treatment|3
7833386|NCT00294762|27194819|P1|Overall Study|Did not receive study treatment|3
7833387|NCT00294723|27194838|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
7833388|NCT00294723|27194839|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
7833389|NCT00294723|27194840|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
7833390|NCT00294723|27194838|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7833391|NCT00294723|27194839|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7833392|NCT00294723|27194840|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7833393|NCT00294723|27194838|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
7833394|NCT00294723|27194839|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
7833395|NCT00294723|27194840|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
7833396|NCT00294723|27194838|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
7833397|NCT00294723|27194839|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
7833398|NCT00294723|27194840|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
7833399|NCT00294723|27194838|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
7833400|NCT00294723|27194839|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
7833401|NCT00294723|27194840|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
7833402|NCT00294723|27194838|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
7833403|NCT00294723|27194839|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
7833404|NCT00294723|27194840|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
7833405|NCT00294723|27194838|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
7833406|NCT00294723|27194839|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
7833407|NCT00294723|27194840|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
7833408|NCT00294723|27194838|P3|Open-Label Extension 52 Weeks|Adverse Event|2
7833409|NCT00294723|27194839|P2|Open-Label Extension 52 Weeks|Adverse Event|5
7833410|NCT00294723|27194840|P1|Open-Label Extension 52 Weeks|Adverse Event|5
7833411|NCT00294723|27194838|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
7833412|NCT00294723|27194839|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
7833413|NCT00294723|27194840|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
7833414|NCT00294723|27194838|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
7833415|NCT00294723|27194839|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
7833416|NCT00294723|27194840|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
7833417|NCT00294723|27194838|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
7833418|NCT00294723|27194839|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
7833419|NCT00294723|27194840|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
7833420|NCT00294723|27194838|P3|Double-Blind Period 52 Weeks|Adverse Event|15
7833421|NCT00294723|27194839|P2|Double-Blind Period 52 Weeks|Adverse Event|25
7833422|NCT00294723|27194840|P1|Double-Blind Period 52 Weeks|Adverse Event|18
7833423|NCT00294684|27194901|P2|Overall Study|Lost to Follow-up|8
7833424|NCT00294684|27194902|P1|Overall Study|Lost to Follow-up|5
7833425|NCT00294671|27194942|P2|Overall Study|Death|1
7833426|NCT00294671|27194943|P1|Overall Study|Death|0
7833427|NCT00294671|27194942|P2|Overall Study|Non-compliance|0
7833428|NCT00294671|27194943|P1|Overall Study|Non-compliance|1
7833429|NCT00294671|27194942|P2|Overall Study|Lost to Follow-up|3
7833430|NCT00294671|27194943|P1|Overall Study|Lost to Follow-up|1
7833431|NCT00294671|27194942|P2|Overall Study|Non-drug related AE|2
7833432|NCT00294671|27194943|P1|Overall Study|Non-drug related AE|3
7833433|NCT00294671|27194942|P2|Overall Study|Drug related adverse event (AE)|2
7833434|NCT00294671|27194943|P1|Overall Study|Drug related adverse event (AE)|4
7833435|NCT00294671|27194942|P2|Overall Study|Liver transplant|9
7833436|NCT00294671|27194943|P1|Overall Study|Liver transplant|7
7833437|NCT00294671|27194942|P2|Overall Study|Lack of Efficacy|23
7833438|NCT00294671|27194943|P1|Overall Study|Lack of Efficacy|11
7833439|NCT00294658|27194959|P2|Overall Study|Patient and family were not satisfied|1
7833440|NCT00294658|27194960|P1|Overall Study|Patient and family were not satisfied|0
7833441|NCT00294658|27194959|P2|Overall Study|Found to have invasive thymoma|0
7833442|NCT00294658|27194960|P1|Overall Study|Found to have invasive thymoma|1
7833443|NCT00294658|27194959|P2|Overall Study|Withdrawal by Subject|4
7833444|NCT00294658|27194960|P1|Overall Study|Withdrawal by Subject|0
7833445|NCT00294658|27194959|P2|Overall Study|Pregnancy|1
7833446|NCT00294658|27194960|P1|Overall Study|Pregnancy|0
7833447|NCT00294658|27194959|P2|Overall Study|Physician Decision|2
7833448|NCT00294658|27194960|P1|Overall Study|Physician Decision|1
7833449|NCT00294658|27194959|P2|Overall Study|Lost to Follow-up|0
7833450|NCT00294658|27194960|P1|Overall Study|Lost to Follow-up|4
7833451|NCT00294658|27194959|P2|Overall Study|Death|1
7833452|NCT00294658|27194960|P1|Overall Study|Death|0
7833453|NCT00294645|27195024|P2|Overall Study|Other|10
7833454|NCT00294645|27195025|P1|Overall Study|Other|4
7833455|NCT00294645|27195024|P2|Overall Study|Physician Decision|20
7833456|NCT00294645|27195025|P1|Overall Study|Physician Decision|15
7833457|NCT00294645|27195024|P2|Overall Study|Withdrawal by Subject|34
7833458|NCT00294645|27195025|P1|Overall Study|Withdrawal by Subject|18
7833459|NCT00294645|27195024|P2|Overall Study|Lost to Follow-up|10
7833460|NCT00294645|27195025|P1|Overall Study|Lost to Follow-up|1
7833461|NCT00294645|27195024|P2|Overall Study|Death|18
7833462|NCT00294645|27195025|P1|Overall Study|Death|10
7833463|NCT00294554|27195069|P2|Overall Study|Physician Decision|1
7833464|NCT00294554|27195070|P1|Overall Study|Physician Decision|0
7833465|NCT00294554|27195069|P2|Overall Study|Lack of Efficacy|1
7833466|NCT00294554|27195070|P1|Overall Study|Lack of Efficacy|0
7833467|NCT00294398|27195097|P2|Overall Study|Lost to Follow-up|26
7833468|NCT00294398|27195098|P1|Overall Study|Lost to Follow-up|21
7833469|NCT00294060|27195106|P1|Overall Study|Device explanted/not replaced|23
7833470|NCT00294060|27195106|P1|Overall Study|Medical condition|3
7833471|NCT00294060|27195106|P1|Overall Study|Physician Decision|797
7833472|NCT00294060|27195106|P1|Overall Study|Withdrawal by Subject|11
7833473|NCT00294060|27195106|P1|Overall Study|Lost to Follow-up|55
7833474|NCT00294060|27195106|P1|Overall Study|Other|59
7833475|NCT00294060|27195106|P1|Overall Study|Death|225
7833476|NCT00294047|27195114|P2|Month 84|No consent for Month 84 Follow-up|754
7833477|NCT00294047|27195115|P1|Month 84|No consent for Month 84 Follow-up|731
7833478|NCT00294047|27195114|P2|Month 84|Visit missed|1
7833479|NCT00294047|27195115|P1|Month 84|Visit missed|0
7833480|NCT00294047|27195114|P2|Month 84|Under investigation locally|0
7833481|NCT00294047|27195115|P1|Month 84|Under investigation locally|1
7833482|NCT00294047|27195114|P2|Month 84|Unable to reach study site|0
7833483|NCT00294047|27195115|P1|Month 84|Unable to reach study site|1
7833484|NCT00294047|27195114|P2|Month 84|Transport reimbursement delayed|1
7833485|NCT00294047|27195115|P1|Month 84|Transport reimbursement delayed|0
7833486|NCT00294047|27195114|P2|Month 84|Subject does not want male physician|0
7833487|NCT00294047|27195115|P1|Month 84|Subject does not want male physician|1
7833488|NCT00294047|27195114|P2|Month 84|Personal reason|4
7833489|NCT00294047|27195115|P1|Month 84|Personal reason|2
7833490|NCT00294047|27195114|P2|Month 84|Lack of time|1
7833491|NCT00294047|27195115|P1|Month 84|Lack of time|3
7833492|NCT00294047|27195114|P2|Month 84|Family problems|2
7833493|NCT00294047|27195115|P1|Month 84|Family problems|2
7833494|NCT00294047|27195114|P2|Month 84|Center closed, subject did not transfer|0
7833495|NCT00294047|27195115|P1|Month 84|Center closed, subject did not transfer|1
7833496|NCT00294047|27195114|P2|Month 84|Work related reasons|2
7833497|NCT00294047|27195115|P1|Month 84|Work related reasons|4
7833498|NCT00294047|27195114|P2|Month 84|Absent Cervix|0
7833499|NCT00294047|27195115|P1|Month 84|Absent Cervix|2
7833500|NCT00294047|27195114|P2|Month 84|Lost to Follow-up|190
7833501|NCT00294047|27195115|P1|Month 84|Lost to Follow-up|187
7833502|NCT00294047|27195114|P2|Month 84|Withdrawal by Subject|31
7833503|NCT00294047|27195115|P1|Month 84|Withdrawal by Subject|33
7833504|NCT00294047|27195114|P2|Month 84|Protocol Violation|1
7833505|NCT00294047|27195115|P1|Month 84|Protocol Violation|1
7833506|NCT00294047|27195114|P2|Month 84|Adverse Event|2
7833507|NCT00294047|27195115|P1|Month 84|Adverse Event|4
7833508|NCT00294047|27195114|P2|Month 48|Other|14
7833509|NCT00294047|27195115|P1|Month 48|Other|10
7833510|NCT00294047|27195114|P2|Month 48|Lost to Follow-up|287
7833511|NCT00294047|27195115|P1|Month 48|Lost to Follow-up|272
7833512|NCT00294047|27195114|P2|Month 48|Withdrawal by Subject|115
7833513|NCT00294047|27195115|P1|Month 48|Withdrawal by Subject|111
7833514|NCT00294047|27195114|P2|Month 48|Protocol Violation|4
7833515|NCT00294047|27195115|P1|Month 48|Protocol Violation|4
7833516|NCT00294047|27195114|P2|Month 48|Adverse Event|13
7833517|NCT00294047|27195115|P1|Month 48|Adverse Event|28
7833518|NCT00293813|27195220|P3|Overall Study|Noncompliance|0
7833519|NCT00293813|27195221|P2|Overall Study|Noncompliance|1
7833520|NCT00293813|27195222|P1|Overall Study|Noncompliance|0
7833521|NCT00293813|27195220|P3|Overall Study|Lost to Follow-up|3
7833522|NCT00293813|27195221|P2|Overall Study|Lost to Follow-up|2
7833523|NCT00293813|27195222|P1|Overall Study|Lost to Follow-up|3
7833524|NCT00293813|27195220|P3|Overall Study|Withdrawal by Subject|4
7833525|NCT00293813|27195221|P2|Overall Study|Withdrawal by Subject|4
7833526|NCT00293813|27195222|P1|Overall Study|Withdrawal by Subject|7
7833527|NCT00293813|27195220|P3|Overall Study|Adverse Event|1
7833528|NCT00293813|27195221|P2|Overall Study|Adverse Event|1
7833529|NCT00293813|27195222|P1|Overall Study|Adverse Event|3
7833530|NCT00293813|27195220|P3|Overall Study|Physician Decision|0
7833531|NCT00293813|27195221|P2|Overall Study|Physician Decision|1
7833532|NCT00293813|27195222|P1|Overall Study|Physician Decision|0
7833533|NCT00293722|27195233|P1|Overall Study|Other|427
7833534|NCT00293709|27195247|P1|Overall Study|Other|47
7833535|NCT00293579|27195261|P1|Overall Study|Withdrawal by Subject|1
7833536|NCT00293462|27195280|P3|Overall Study|Physician Decision|0
7833537|NCT00293462|27195281|P2|Overall Study|Physician Decision|1
7833538|NCT00293462|27195282|P1|Overall Study|Physician Decision|0
7833539|NCT00293462|27195280|P3|Overall Study|Low radiation dose in oral cavity|0
7833540|NCT00293462|27195281|P2|Overall Study|Low radiation dose in oral cavity|1
7833541|NCT00293462|27195282|P1|Overall Study|Low radiation dose in oral cavity|0
7833542|NCT00293462|27195280|P3|Overall Study|Possible Tracheostomy leakage|0
7833543|NCT00293462|27195281|P2|Overall Study|Possible Tracheostomy leakage|1
7833544|NCT00293462|27195282|P1|Overall Study|Possible Tracheostomy leakage|0
7833545|NCT00293462|27195280|P3|Overall Study|Ischemic stroke after chemotherapy|1
7833546|NCT00293462|27195281|P2|Overall Study|Ischemic stroke after chemotherapy|0
7833547|NCT00293462|27195282|P1|Overall Study|Ischemic stroke after chemotherapy|0
7833548|NCT00293462|27195280|P3|Overall Study|Blood clot after chemotherapy|1
7833549|NCT00293462|27195281|P2|Overall Study|Blood clot after chemotherapy|0
7833550|NCT00293462|27195282|P1|Overall Study|Blood clot after chemotherapy|0
7833551|NCT00293462|27195280|P3|Overall Study|Went back to his home country|1
7833552|NCT00293462|27195281|P2|Overall Study|Went back to his home country|0
7833553|NCT00293462|27195282|P1|Overall Study|Went back to his home country|0
7833554|NCT00293462|27195280|P3|Overall Study|No Show|1
7833555|NCT00293462|27195281|P2|Overall Study|No Show|0
7833556|NCT00293462|27195282|P1|Overall Study|No Show|0
7833557|NCT00293462|27195280|P3|Overall Study|Refuse Radiation Treatment|0
7833558|NCT00293462|27195281|P2|Overall Study|Refuse Radiation Treatment|0
7833559|NCT00293462|27195282|P1|Overall Study|Refuse Radiation Treatment|1
7833560|NCT00293462|27195280|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
7833561|NCT00293462|27195281|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
7833562|NCT00293462|27195282|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
7833563|NCT00293462|27195280|P3|Overall Study|Change Treatment Regimen (ineligible)|0
7833564|NCT00293462|27195281|P2|Overall Study|Change Treatment Regimen (ineligible)|0
7833565|NCT00293462|27195282|P1|Overall Study|Change Treatment Regimen (ineligible)|1
7833566|NCT00293462|27195280|P3|Overall Study|Lost to Follow-up|0
7833567|NCT00293462|27195281|P2|Overall Study|Lost to Follow-up|1
7833568|NCT00293462|27195282|P1|Overall Study|Lost to Follow-up|0
7833569|NCT00293462|27195280|P3|Overall Study|Death|0
7833570|NCT00293462|27195281|P2|Overall Study|Death|0
7833571|NCT00293462|27195282|P1|Overall Study|Death|1
7833572|NCT00293462|27195280|P3|Overall Study|Withdrawal by Subject|8
7833573|NCT00293462|27195281|P2|Overall Study|Withdrawal by Subject|3
7833574|NCT00293462|27195282|P1|Overall Study|Withdrawal by Subject|4
7833575|NCT00293423|27195303|P2|Vaccination Treatment Period|Received < 4 required vaccinations|3
7833576|NCT00293423|27195304|P1|Vaccination Treatment Period|Received < 4 required vaccinations|0
7833577|NCT00293423|27195303|P2|Surgical Resection|Withdrawal by Subject|0
7833578|NCT00293423|27195304|P1|Surgical Resection|Withdrawal by Subject|4
7833579|NCT00293423|27195303|P2|Surgical Resection|processing error during surgical resection|0
7833580|NCT00293423|27195304|P1|Surgical Resection|processing error during surgical resection|1
7833581|NCT00293423|27195303|P2|Surgical Resection|disease progression prior to initial vaccination|9
7833582|NCT00293423|27195304|P1|Surgical Resection|disease progression prior to initial vaccination|2
7833583|NCT00293423|27195303|P2|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
7833584|NCT00293423|27195304|P1|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
7833585|NCT00293423|27195303|P2|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
7833586|NCT00293423|27195304|P1|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
7833587|NCT00293423|27195303|P2|Surgical Resection|Less than a 90% extent of resection|1
7833588|NCT00293423|27195304|P1|Surgical Resection|Less than a 90% extent of resection|0
7833589|NCT00293397|27195319|P1|Overall Study|Death|2
7833590|NCT00293384|27195329|P1|Overall Study|Ineligible|2
7833591|NCT00293384|27195329|P1|Overall Study|Missed dosage/study drug|1
7833592|NCT00293384|27195329|P1|Overall Study|Non-compliance|2
7833593|NCT00293293|27195338|P2|Overall Study|Patient discontinued chemotherapy|1
7833594|NCT00293293|27195339|P1|Overall Study|Patient discontinued chemotherapy|0
7833595|NCT00293293|27195338|P2|Overall Study|"Patient too anxious to complete trial"|0
7833596|NCT00293293|27195339|P1|Overall Study|"Patient too anxious to complete trial"|1
7833597|NCT00293293|27195338|P2|Overall Study|Withdrawal by Subject|1
7833598|NCT00293293|27195339|P1|Overall Study|Withdrawal by Subject|1
7833599|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
7833600|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
7833601|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
7833602|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
7833603|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
7833604|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
7833605|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
7833606|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
7833607|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
7833608|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
7833609|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
7833610|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
7833611|NCT00293267|27195367|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
7833612|NCT00293267|27195368|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
7833613|NCT00293267|27195367|P2|Extension - Open-Label Week 157-240|Other Reason|1
7833614|NCT00293267|27195368|P1|Extension - Open-Label Week 157-240|Other Reason|3
7833615|NCT00293267|27195367|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
7833616|NCT00293267|27195368|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
7833617|NCT00293267|27195367|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
7833618|NCT00293267|27195368|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
7833619|NCT00293267|27195367|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
7833620|NCT00293267|27195368|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
7833621|NCT00293267|27195367|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
7833622|NCT00293267|27195368|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
7833623|NCT00293267|27195367|P2|Extension - Open-Label Week 157-240|Adverse Event|0
7833624|NCT00293267|27195368|P1|Extension - Open-Label Week 157-240|Adverse Event|5
7833625|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
7833626|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
7833627|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Other Reason|0
7833628|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Other Reason|7
7833629|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
7833630|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
7833631|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Death|0
7833632|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Death|3
7833633|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
7833634|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
7833635|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
7833636|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
7833637|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
7833638|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
7833639|NCT00293267|27195367|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
7833640|NCT00293267|27195368|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
7833641|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
7833642|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
7833643|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7833644|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7833645|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7833646|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7833647|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7833648|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
7833649|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Death|3
7833650|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Death|3
7833651|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7833652|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7833653|NCT00293267|27195367|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
7833654|NCT00293267|27195368|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
7833655|NCT00293254|27195408|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
7833656|NCT00293254|27195409|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
7833657|NCT00293254|27195408|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
7833658|NCT00293254|27195409|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
7833659|NCT00293254|27195408|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
7833660|NCT00293254|27195409|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
7833661|NCT00293254|27195408|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
7833662|NCT00293254|27195409|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
7833663|NCT00293254|27195408|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
7833664|NCT00293254|27195409|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
7833665|NCT00293254|27195408|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
7833666|NCT00293254|27195409|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
7833667|NCT00293254|27195408|P2|Extension - Open-Label Week 157-240|Other Reason|0
7833668|NCT00293254|27195409|P1|Extension - Open-Label Week 157-240|Other Reason|4
7833669|NCT00293254|27195408|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
7833670|NCT00293254|27195409|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
7833671|NCT00293254|27195408|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
7833672|NCT00293254|27195409|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
7833673|NCT00293254|27195408|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
7833674|NCT00293254|27195409|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
7833675|NCT00293254|27195408|P2|Extension - Open-Label Week 157-240|Adverse Event|1
7833676|NCT00293254|27195409|P1|Extension - Open-Label Week 157-240|Adverse Event|2
7833677|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
7833678|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
7833679|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Other Reason|2
7833680|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Other Reason|10
7833681|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
7833682|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
7833683|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
7833684|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
7833685|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
7833686|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
7833687|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
7833688|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
7833689|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Death|1
7833690|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Death|4
7833691|NCT00293254|27195408|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
7833692|NCT00293254|27195409|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
7833693|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
7833694|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
7833695|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
7833696|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
7833697|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7833698|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
7833699|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7833700|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
7833701|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7833702|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7833703|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Death|2
7833704|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Death|5
7833705|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7833706|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
7833707|NCT00293254|27195408|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
7833708|NCT00293254|27195409|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
7833709|NCT00293241|27195449|P2|Overall Study|Withdrawal by Subject|8
7833710|NCT00293241|27195450|P1|Overall Study|Withdrawal by Subject|4
7833711|NCT00293241|27195449|P2|Overall Study|Physician Decision|17
7833712|NCT00293241|27195450|P1|Overall Study|Physician Decision|23
7833713|NCT00293241|27195449|P2|Overall Study|Lost to Follow-up|16
7833714|NCT00293241|27195450|P1|Overall Study|Lost to Follow-up|9
7833715|NCT00293215|27195494|P2|Overall Study|Adverse Event|2
7833716|NCT00293215|27195495|P1|Overall Study|Adverse Event|2
7833717|NCT00293215|27195494|P2|Overall Study|Progressive disease|1
7833718|NCT00293215|27195495|P1|Overall Study|Progressive disease|3
7833719|NCT00293202|27195517|P2|Overall Study|on-hold due to fistula maturation time|0
7833720|NCT00293202|27195518|P1|Overall Study|on-hold due to fistula maturation time|1
7833721|NCT00293202|27195517|P2|Overall Study|positive ANA (antinuclear antibody)|0
7833722|NCT00293202|27195518|P1|Overall Study|positive ANA (antinuclear antibody)|1
7833723|NCT00293202|27195517|P2|Overall Study|Withdrawal by Subject|2
7833724|NCT00293202|27195518|P1|Overall Study|Withdrawal by Subject|1
7833725|NCT00293059|27195530|P2|Overall Study|missing|5
7833726|NCT00293059|27195531|P1|Overall Study|missing|3
7833727|NCT00293059|27195530|P2|Overall Study|Noncompliant - sanitary pads collection|1
7833728|NCT00293059|27195531|P1|Overall Study|Noncompliant - sanitary pads collection|0
7833729|NCT00293059|27195530|P2|Overall Study|Participant stopped study drug|0
7833730|NCT00293059|27195531|P1|Overall Study|Participant stopped study drug|1
7833731|NCT00293059|27195530|P2|Overall Study|Participant moved out of state|0
7833732|NCT00293059|27195531|P1|Overall Study|Participant moved out of state|1
7833733|NCT00293059|27195530|P2|Overall Study|Withdrawal by Subject|5
7833734|NCT00293059|27195531|P1|Overall Study|Withdrawal by Subject|11
7833735|NCT00293059|27195530|P2|Overall Study|Protocol Violation|0
7833736|NCT00293059|27195531|P1|Overall Study|Protocol Violation|2
7833737|NCT00293059|27195530|P2|Overall Study|Pregnancy|1
7833738|NCT00293059|27195531|P1|Overall Study|Pregnancy|1
7833739|NCT00293059|27195530|P2|Overall Study|Lost to Follow-up|3
7833740|NCT00293059|27195531|P1|Overall Study|Lost to Follow-up|2
7833741|NCT00293059|27195530|P2|Overall Study|Lack of Efficacy|0
7833742|NCT00293059|27195531|P1|Overall Study|Lack of Efficacy|2
7833743|NCT00293059|27195530|P2|Overall Study|Adverse Event|4
7833744|NCT00293059|27195531|P1|Overall Study|Adverse Event|12
7833745|NCT00293033|27195643|P1|Double-blind Treatment Period|Noncompliance|4
7833746|NCT00293033|27195643|P1|Double-blind Treatment Period|Withdrawal by Subject|4
7833747|NCT00293033|27195643|P1|Double-blind Treatment Period|Lack of Efficacy|1
7833748|NCT00293033|27195643|P1|Double-blind Treatment Period|Adverse Event|3
7833749|NCT00293033|27195643|P1|Open-label Titration Period|Noncompliance and other|27
7833750|NCT00293033|27195643|P1|Open-label Titration Period|Withdrawal by Subject|22
7833751|NCT00293033|27195643|P1|Open-label Titration Period|Protocol Violation|2
7833752|NCT00293033|27195643|P1|Open-label Titration Period|Lack of Efficacy|5
7833753|NCT00293033|27195643|P1|Open-label Titration Period|Death|3
7833754|NCT00293033|27195643|P1|Open-label Titration Period|Adverse Event|10
7833755|NCT00293020|27195746|P1|Overall Study|No dose taken|1
7833756|NCT00293020|27195746|P1|Overall Study|Other Reason|22
7833757|NCT00293020|27195746|P1|Overall Study|Physician Decision|21
7833758|NCT00293020|27195746|P1|Overall Study|Protocol Violation|6
7833759|NCT00293020|27195746|P1|Overall Study|Lost to Follow-up|4
7833760|NCT00293020|27195746|P1|Overall Study|Lack of Efficacy|12
7833761|NCT00293020|27195746|P1|Overall Study|Death|32
7833762|NCT00293020|27195746|P1|Overall Study|Adverse Event|30
7833763|NCT00293020|27195746|P1|Overall Study|Withdrawal by Subject|34
7833764|NCT00292981|27195750|P1|Overall Study|Other|3
7833765|NCT00292981|27195750|P1|Overall Study|Withdrawal by Subject|22
7833766|NCT00292981|27195750|P1|Overall Study|Lost to Follow-up|13
7833767|NCT00292981|27195750|P1|Overall Study|Adverse Event|1
7833768|NCT00292942|27195761|P4|Overall Study|Adverse Event|1
7833769|NCT00292942|27195762|P3|Overall Study|Adverse Event|0
7833770|NCT00292942|27195763|P2|Overall Study|Adverse Event|0
7833771|NCT00292942|27195764|P1|Overall Study|Adverse Event|0
7833772|NCT00292942|27195761|P4|Overall Study|Withdrawal by Subject|0
7833773|NCT00292942|27195762|P3|Overall Study|Withdrawal by Subject|1
7833774|NCT00292942|27195763|P2|Overall Study|Withdrawal by Subject|0
7833775|NCT00292942|27195764|P1|Overall Study|Withdrawal by Subject|0
7833776|NCT00292461|27195810|P2|Overall Study|Lost to Follow-up|0
7833777|NCT00292461|27195811|P1|Overall Study|Lost to Follow-up|1
7833778|NCT00292461|27195810|P2|Overall Study|Protocol Violation|3
7833779|NCT00292461|27195811|P1|Overall Study|Protocol Violation|4
7833780|NCT00292461|27195810|P2|Overall Study|Withdrawal by Subject|1
7833781|NCT00292461|27195811|P1|Overall Study|Withdrawal by Subject|0
7833782|NCT00292461|27195810|P2|Overall Study|Lack of Efficacy|0
7833783|NCT00292461|27195811|P1|Overall Study|Lack of Efficacy|1
7833784|NCT00292461|27195810|P2|Overall Study|Adverse Event|2
7833785|NCT00292461|27195811|P1|Overall Study|Adverse Event|4
7833786|NCT00292370|27195826|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
7833787|NCT00292370|27195827|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
7833788|NCT00292370|27195828|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
7833789|NCT00292370|27195826|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
7833790|NCT00292370|27195827|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
7833791|NCT00292370|27195828|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
7833792|NCT00292370|27195826|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
7833793|NCT00292370|27195827|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
7833794|NCT00292370|27195828|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
7833795|NCT00292370|27195826|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
7833796|NCT00292370|27195827|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
7833797|NCT00292370|27195828|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
7833798|NCT00292370|27195826|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
7833799|NCT00292370|27195827|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
7833800|NCT00292370|27195828|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
7833801|NCT00292370|27195826|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
7833802|NCT00292370|27195827|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
7833803|NCT00292370|27195828|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
7833804|NCT00292318|27195853|P2|Overall Study|Study terminated by officials|1
7833805|NCT00292318|27195854|P1|Overall Study|Study terminated by officials|2
7833806|NCT00292227|27195864|P3|Patch Period|Withdrawal by Subject|1
7833807|NCT00292227|27195865|P2|Patch Period|Withdrawal by Subject|0
7833808|NCT00292227|27195866|P1|Patch Period|Withdrawal by Subject|0
7833809|NCT00292227|27195864|P3|Patch Period|Adverse Event|2
7833810|NCT00292227|27195865|P2|Patch Period|Adverse Event|0
7833811|NCT00292227|27195866|P1|Patch Period|Adverse Event|1
7833812|NCT00292188|27195948|P3|Double-Blind|Laboratory Abnormality|1
7833813|NCT00292188|27195949|P2|Double-Blind|Laboratory Abnormality|0
7833814|NCT00292188|27195950|P1|Double-Blind|Laboratory Abnormality|0
7833815|NCT00292188|27195948|P3|Double-Blind|Withdrawal by Subject|3
7833816|NCT00292188|27195949|P2|Double-Blind|Withdrawal by Subject|0
7833817|NCT00292188|27195950|P1|Double-Blind|Withdrawal by Subject|0
7833818|NCT00292188|27195948|P3|Double-Blind|Other|4
7833819|NCT00292188|27195949|P2|Double-Blind|Other|3
7833820|NCT00292188|27195950|P1|Double-Blind|Other|0
7833821|NCT00292188|27195948|P3|Double-Blind|Lost to Follow-up|0
7833822|NCT00292188|27195949|P2|Double-Blind|Lost to Follow-up|1
7833823|NCT00292188|27195950|P1|Double-Blind|Lost to Follow-up|0
7833824|NCT00292188|27195948|P3|Double-Blind|Lack of Efficacy|12
7833825|NCT00292188|27195949|P2|Double-Blind|Lack of Efficacy|2
7833826|NCT00292188|27195950|P1|Double-Blind|Lack of Efficacy|0
7833827|NCT00292188|27195948|P3|Double-Blind|Adverse Event|9
7833828|NCT00292188|27195949|P2|Double-Blind|Adverse Event|25
7833829|NCT00292188|27195950|P1|Double-Blind|Adverse Event|0
7833830|NCT00292188|27195948|P3|Single-Blind|Did not receive treatment|0
7833831|NCT00292188|27195949|P2|Single-Blind|Did not receive treatment|0
7833832|NCT00292188|27195950|P1|Single-Blind|Did not receive treatment|1
7833833|NCT00292188|27195948|P3|Single-Blind|Withdrawal by Subject|0
7833834|NCT00292188|27195949|P2|Single-Blind|Withdrawal by Subject|0
7833835|NCT00292188|27195950|P1|Single-Blind|Withdrawal by Subject|12
7833836|NCT00292188|27195948|P3|Single-Blind|Other|0
7833837|NCT00292188|27195949|P2|Single-Blind|Other|0
7833838|NCT00292188|27195950|P1|Single-Blind|Other|77
7833839|NCT00292188|27195948|P3|Single-Blind|Lost to Follow-up|0
7833840|NCT00292188|27195949|P2|Single-Blind|Lost to Follow-up|0
7833841|NCT00292188|27195950|P1|Single-Blind|Lost to Follow-up|3
7833842|NCT00292188|27195948|P3|Single-Blind|Laboratory Abnormality|0
7833843|NCT00292188|27195949|P2|Single-Blind|Laboratory Abnormality|0
7833844|NCT00292188|27195950|P1|Single-Blind|Laboratory Abnormality|5
7833845|NCT00292188|27195948|P3|Single-Blind|Lack of Efficacy|0
7833846|NCT00292188|27195949|P2|Single-Blind|Lack of Efficacy|0
7833847|NCT00292188|27195950|P1|Single-Blind|Lack of Efficacy|2
7833848|NCT00292188|27195948|P3|Single-Blind|Adverse Event|0
7833849|NCT00292188|27195949|P2|Single-Blind|Adverse Event|0
7833850|NCT00292188|27195950|P1|Single-Blind|Adverse Event|14
7833851|NCT00292045|27196028|P1|Core Study (Through Week 13)|Withdrawal by Subject|1
7833852|NCT00292045|27196028|P1|Core Study (Through Week 13)|Adverse Event|1
7833853|NCT00291668|27196067|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7833854|NCT00291668|27196068|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7833855|NCT00291668|27196069|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7833856|NCT00291668|27196067|P3|Overall Study|AE, non-serious non-fatal|0
7833857|NCT00291668|27196068|P2|Overall Study|AE, non-serious non-fatal|0
7833858|NCT00291668|27196069|P1|Overall Study|AE, non-serious non-fatal|1
7833859|NCT00291668|27196067|P3|Overall Study|SAE, non-fatal|1
7833860|NCT00291668|27196068|P2|Overall Study|SAE, non-fatal|1
7833861|NCT00291668|27196069|P1|Overall Study|SAE, non-fatal|1
7833862|NCT00291668|27196067|P3|Overall Study|Lack of Efficacy|0
7833863|NCT00291668|27196068|P2|Overall Study|Lack of Efficacy|0
7833864|NCT00291668|27196069|P1|Overall Study|Lack of Efficacy|1
7833865|NCT00291642|27196165|P5|Overall Study|Intake of prohibited medication|0
7833866|NCT00291642|27196166|P4|Overall Study|Intake of prohibited medication|0
7833867|NCT00291642|27196167|P3|Overall Study|Intake of prohibited medication|0
7833868|NCT00291642|27196168|P2|Overall Study|Intake of prohibited medication|0
7833869|NCT00291642|27196169|P1|Overall Study|Intake of prohibited medication|1
7833870|NCT00291642|27196165|P5|Overall Study|Patient missed visit|0
7833871|NCT00291642|27196166|P4|Overall Study|Patient missed visit|0
7833872|NCT00291642|27196167|P3|Overall Study|Patient missed visit|1
7833873|NCT00291642|27196168|P2|Overall Study|Patient missed visit|0
7833874|NCT00291642|27196169|P1|Overall Study|Patient missed visit|0
7833875|NCT00291642|27196165|P5|Overall Study|Adverse Event|1
7833876|NCT00291642|27196166|P4|Overall Study|Adverse Event|0
7833877|NCT00291642|27196167|P3|Overall Study|Adverse Event|1
7833878|NCT00291642|27196168|P2|Overall Study|Adverse Event|0
7833879|NCT00291642|27196169|P1|Overall Study|Adverse Event|1
7833880|NCT00291577|27196221|P1|Overall Study|Lack of Efficacy|14
7833881|NCT00291577|27196221|P1|Overall Study|Withdrawal by Subject|2
7833882|NCT00291577|27196221|P1|Overall Study|Other|4
7833883|NCT00291577|27196221|P1|Overall Study|Adverse Event|1
7833884|NCT00291551|27196240|P1|Overall Study|Withdrawal by Subject|6
7833885|NCT00291551|27196240|P1|Overall Study|Death|7
7833886|NCT00291499|27196257|P2|Overall Study|Other reasons|4
7833887|NCT00291499|27196258|P1|Overall Study|Other reasons|1
7833888|NCT00291499|27196257|P2|Overall Study|Protocol Violation|2
7833889|NCT00291499|27196258|P1|Overall Study|Protocol Violation|2
7833890|NCT00291499|27196257|P2|Overall Study|Intercurrent illness|0
7833891|NCT00291499|27196258|P1|Overall Study|Intercurrent illness|1
7833892|NCT00291499|27196257|P2|Overall Study|Change to other therapy|1
7833893|NCT00291499|27196258|P1|Overall Study|Change to other therapy|2
7833894|NCT00291499|27196257|P2|Overall Study|Adverse Event|8
7833895|NCT00291499|27196258|P1|Overall Study|Adverse Event|3
7833896|NCT00291330|27196360|P2|Overall Study|Other|1
7833897|NCT00291330|27196361|P1|Overall Study|Other|3
7833898|NCT00291330|27196360|P2|Overall Study|Withdrawal by Subject|25
7833899|NCT00291330|27196361|P1|Overall Study|Withdrawal by Subject|22
7833900|NCT00291330|27196360|P2|Overall Study|Lost to Follow-up|11
7833901|NCT00291330|27196361|P1|Overall Study|Lost to Follow-up|16
7833902|NCT00291330|27196360|P2|Overall Study|Protocol Violation|20
7833903|NCT00291330|27196361|P1|Overall Study|Protocol Violation|13
7833904|NCT00291330|27196360|P2|Overall Study|Adverse Event|40
7833905|NCT00291330|27196361|P1|Overall Study|Adverse Event|47
7833906|NCT00291187|27196403|P4|Overall Study|Protocol Violation- No Drug Administered|0
7833907|NCT00291187|27196404|P3|Overall Study|Protocol Violation- No Drug Administered|1
7833908|NCT00291187|27196405|P2|Overall Study|Protocol Violation- No Drug Administered|0
7833909|NCT00291187|27196406|P1|Overall Study|Protocol Violation- No Drug Administered|0
7833910|NCT00291018|27196450|P3|Overall Study|Lost to Follow-up|18
7833911|NCT00291018|27196451|P2|Overall Study|Lost to Follow-up|4
7833912|NCT00291018|27196452|P1|Overall Study|Lost to Follow-up|3
7833913|NCT00291018|27196450|P3|Overall Study|Failures|5
7833914|NCT00291018|27196451|P2|Overall Study|Failures|12
7833915|NCT00291018|27196452|P1|Overall Study|Failures|5
7833916|NCT00291018|27196450|P3|Overall Study|Withdrawal by Subject|1
7833917|NCT00291018|27196451|P2|Overall Study|Withdrawal by Subject|8
7833918|NCT00291018|27196452|P1|Overall Study|Withdrawal by Subject|2
7833919|NCT00291018|27196450|P3|Overall Study|Death|4
7833920|NCT00291018|27196451|P2|Overall Study|Death|3
7833921|NCT00291018|27196452|P1|Overall Study|Death|3
7833922|NCT00291018|27196450|P3|Overall Study|Not Consented or Declined PAS|15
7833923|NCT00291018|27196451|P2|Overall Study|Not Consented or Declined PAS|15
7833924|NCT00291018|27196452|P1|Overall Study|Not Consented or Declined PAS|12
7833925|NCT00290888|27196492|P2|Overall Study|Physician Decision|1
7833926|NCT00290888|27196493|P1|Overall Study|Physician Decision|3
7833927|NCT00290771|27196510|P2|Overall Study|Lost to Follow-up|1
7833928|NCT00290771|27196511|P1|Overall Study|Lost to Follow-up|0
7833929|NCT00290771|27196510|P2|Overall Study|Protocol Violation|0
7833930|NCT00290771|27196511|P1|Overall Study|Protocol Violation|2
7833931|NCT00290771|27196510|P2|Overall Study|Administrative problems|1
7833932|NCT00290771|27196511|P1|Overall Study|Administrative problems|2
7833933|NCT00290771|27196510|P2|Overall Study|Withdrawal by Subject|6
7833934|NCT00290771|27196511|P1|Overall Study|Withdrawal by Subject|5
7833935|NCT00290771|27196510|P2|Overall Study|Adverse Event|6
7833936|NCT00290771|27196511|P1|Overall Study|Adverse Event|12
7833937|NCT00290771|27196510|P2|Overall Study|Death|10
7833938|NCT00290771|27196511|P1|Overall Study|Death|11
7833939|NCT00290771|27196510|P2|Overall Study|Disease progression|73
7833940|NCT00290771|27196511|P1|Overall Study|Disease progression|95
7833941|NCT00290758|27196535|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
7833942|NCT00290758|27196536|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
7833943|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
7833944|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
7833945|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
7833946|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
7833947|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
7833948|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
7833949|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7833950|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7833951|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
7833952|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
7833953|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
7833954|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
7833955|NCT00290758|27196535|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
7833956|NCT00290758|27196536|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
7833957|NCT00290745|27196556|P1|Overall Study|Baseline MRI not available|3
7833958|NCT00290745|27196556|P1|Overall Study|Surgery after 3 months for progression|3
7833959|NCT00290745|27196556|P1|Overall Study|Physician Decision|2
7833960|NCT00290745|27196556|P1|Overall Study|Withdrawal by Subject|4
7833961|NCT00290732|27196570|P5|Overall Study|Inability to instill drug intraductally.|0
7833962|NCT00290732|27196571|P4|Overall Study|Inability to instill drug intraductally.|0
7833963|NCT00290732|27196572|P3|Overall Study|Inability to instill drug intraductally.|1
7833964|NCT00290732|27196573|P2|Overall Study|Inability to instill drug intraductally.|1
7833965|NCT00290732|27196574|P1|Overall Study|Inability to instill drug intraductally.|0
7833966|NCT00290706|27196596|P4|Overall Study|Physician Decision|1
7833967|NCT00290706|27196597|P3|Overall Study|Physician Decision|0
7833968|NCT00290706|27196598|P2|Overall Study|Physician Decision|0
7833969|NCT00290706|27196599|P1|Overall Study|Physician Decision|0
7833970|NCT00290706|27196596|P4|Overall Study|Receive auto transplant or radiation|1
7833971|NCT00290706|27196597|P3|Overall Study|Receive auto transplant or radiation|0
7833972|NCT00290706|27196598|P2|Overall Study|Receive auto transplant or radiation|0
7833973|NCT00290706|27196599|P1|Overall Study|Receive auto transplant or radiation|0
7833974|NCT00290706|27196596|P4|Overall Study|Adverse Event|0
7833975|NCT00290706|27196597|P3|Overall Study|Adverse Event|2
7833976|NCT00290706|27196598|P2|Overall Study|Adverse Event|1
7833977|NCT00290706|27196599|P1|Overall Study|Adverse Event|0
7833978|NCT00290706|27196596|P4|Overall Study|Progressive Disease|10
7833979|NCT00290706|27196597|P3|Overall Study|Progressive Disease|4
7833980|NCT00290706|27196598|P2|Overall Study|Progressive Disease|5
7833981|NCT00290706|27196599|P1|Overall Study|Progressive Disease|3
7833982|NCT00290706|27196596|P4|Overall Study|Withdrawal by Subject|0
7833983|NCT00290706|27196597|P3|Overall Study|Withdrawal by Subject|0
7833984|NCT00290706|27196598|P2|Overall Study|Withdrawal by Subject|0
7833985|NCT00290706|27196599|P1|Overall Study|Withdrawal by Subject|2
7833986|NCT00290693|27196618|P1|Overall Study|Withdrawal by Subject|2
7833987|NCT00290589|27196646|P2|Overall Study|Lost to Follow-up|2
7833988|NCT00290589|27196647|P1|Overall Study|Lost to Follow-up|2
7833989|NCT00290498|27196665|P2|Overall Study|Non-Compliance|0
7833990|NCT00290498|27196666|P1|Overall Study|Non-Compliance|1
7833991|NCT00290498|27196665|P2|Overall Study|Ineligible|0
7833992|NCT00290498|27196666|P1|Overall Study|Ineligible|3
7833993|NCT00290498|27196665|P2|Overall Study|Withdrawal by Subject|0
7833994|NCT00290498|27196666|P1|Overall Study|Withdrawal by Subject|1
7833995|NCT00290498|27196665|P2|Overall Study|Physician Decision|0
7833996|NCT00290498|27196666|P1|Overall Study|Physician Decision|1
7833997|NCT00290498|27196665|P2|Overall Study|Death|0
7833998|NCT00290498|27196666|P1|Overall Study|Death|2
7833999|NCT00290433|27196691|P1|Overall Study|Unrelated Infection/Death|1
7834000|NCT00290433|27196691|P1|Overall Study|Transplant in CR|5
7834001|NCT00290433|27196691|P1|Overall Study|Congestive Heart Failure|1
7834002|NCT00290433|27196691|P1|Overall Study|Non-Compliance|1
7834003|NCT00290433|27196691|P1|Overall Study|Withdrawal by Subject|1
7834004|NCT00290433|27196691|P1|Overall Study|Adverse Event|14
7834005|NCT00290433|27196691|P1|Overall Study|Disease Progression|13
7834006|NCT00290407|27196695|P1|Overall Study|Physician Decision|2
7834007|NCT00290355|27196702|P2|Overall Study|Other|0
7834008|NCT00290355|27196703|P1|Overall Study|Other|2
7834009|NCT00290355|27196702|P2|Overall Study|Lost to Follow-up|1
7834010|NCT00290355|27196703|P1|Overall Study|Lost to Follow-up|3
7834011|NCT00290355|27196702|P2|Overall Study|Migrated / moved from the study area|0
7834012|NCT00290355|27196703|P1|Overall Study|Migrated / moved from the study area|1
7834013|NCT00290355|27196702|P2|Overall Study|Withdrawal by Subject|0
7834014|NCT00290355|27196703|P1|Overall Study|Withdrawal by Subject|2
7834015|NCT00290355|27196702|P2|Overall Study|Protocol Violation|0
7834016|NCT00290355|27196703|P1|Overall Study|Protocol Violation|1
7834017|NCT00290355|27196702|P2|Overall Study|Study product reactogenicity|0
7834018|NCT00290355|27196703|P1|Overall Study|Study product reactogenicity|1
7834019|NCT00290355|27196702|P2|Overall Study|Serious adverse event|4
7834020|NCT00290355|27196703|P1|Overall Study|Serious adverse event|7
7834021|NCT00290342|27196747|P2|Overall Study|Lost to Follow-up|0
7834022|NCT00290342|27196748|P1|Overall Study|Lost to Follow-up|1
7834023|NCT00290342|27196747|P2|Overall Study|Withdrawal by Subject|4
7834024|NCT00290342|27196748|P1|Overall Study|Withdrawal by Subject|6
7834025|NCT00290342|27196747|P2|Overall Study|Other|1
7834026|NCT00290342|27196748|P1|Overall Study|Other|0
7834027|NCT00290290|27196803|P2|Overall Study|Underwent clean surgical procedure|12
7834028|NCT00290290|27196804|P1|Overall Study|Underwent clean surgical procedure|13
7834029|NCT00290290|27196803|P2|Overall Study|Withdrawal by Subject|2
7834030|NCT00290290|27196804|P1|Overall Study|Withdrawal by Subject|2
7834031|NCT00290290|27196803|P2|Overall Study|Death|4
7834032|NCT00290290|27196804|P1|Overall Study|Death|3
7834033|NCT00290251|27196810|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
7834034|NCT00290251|27196811|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
7834035|NCT00290251|27196812|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
7834036|NCT00290251|27196810|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
7834037|NCT00290251|27196811|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
7834038|NCT00290251|27196812|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
7834039|NCT00290251|27196810|P3|Treatment 1 (Months 1 - 3)|headache|0
7834040|NCT00290251|27196811|P2|Treatment 1 (Months 1 - 3)|headache|1
7834041|NCT00290251|27196812|P1|Treatment 1 (Months 1 - 3)|headache|0
7834042|NCT00290251|27196810|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
7834043|NCT00290251|27196811|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
7834044|NCT00290251|27196812|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
7834045|NCT00290238|27196824|P2|Overall Study|Withdrawal by Subject|13
7834046|NCT00290238|27196825|P1|Overall Study|Withdrawal by Subject|15
7834047|NCT00290238|27196824|P2|Overall Study|Lost to Follow-up|1
7834048|NCT00290238|27196825|P1|Overall Study|Lost to Follow-up|0
7834049|NCT00290238|27196824|P2|Overall Study|Study terminated|27
7834050|NCT00290238|27196825|P1|Overall Study|Study terminated|27
7834051|NCT00290186|27196850|P2|Overall Study|Withdrawal by Subject|1
7834052|NCT00290186|27196851|P1|Overall Study|Withdrawal by Subject|0
7834053|NCT00290186|27196850|P2|Overall Study|Study was terminated prior to 3-month te|1
7834054|NCT00290186|27196851|P1|Overall Study|Study was terminated prior to 3-month te|1
7834055|NCT00290186|27196850|P2|Overall Study|Lost to Follow-up|2
7834056|NCT00290186|27196851|P1|Overall Study|Lost to Follow-up|3
7834057|NCT00290186|27196850|P2|Overall Study|Adverse Event|1
7834058|NCT00290186|27196851|P1|Overall Study|Adverse Event|1
7834059|NCT00289991|27196902|P2|Overall Study|Other|14
7834060|NCT00289991|27196903|P1|Overall Study|Other|5
7834061|NCT00289991|27196902|P2|Overall Study|Withdrawal by Subject|12
7834062|NCT00289991|27196903|P1|Overall Study|Withdrawal by Subject|2
7834063|NCT00289991|27196902|P2|Overall Study|Lost to Follow-up|1
7834064|NCT00289991|27196903|P1|Overall Study|Lost to Follow-up|0
7834065|NCT00289991|27196902|P2|Overall Study|Fungal breakthrough infection|1
7834066|NCT00289991|27196903|P1|Overall Study|Fungal breakthrough infection|0
7834067|NCT00289991|27196902|P2|Overall Study|Failure of prophylaxis|1
7834068|NCT00289991|27196903|P1|Overall Study|Failure of prophylaxis|1
7834069|NCT00289991|27196902|P2|Overall Study|Adverse Event|13
7834070|NCT00289991|27196903|P1|Overall Study|Adverse Event|15
7834071|NCT00289991|27196902|P2|Overall Study|Death|38
7834072|NCT00289991|27196903|P1|Overall Study|Death|35
7834073|NCT00289978|27196928|P3|Overall Study|Death|2
7834074|NCT00289978|27196929|P2|Overall Study|Death|0
7834075|NCT00289978|27196930|P1|Overall Study|Death|1
7834076|NCT00289978|27196928|P3|Overall Study|Abnormal test procedure result(s)|1
7834077|NCT00289978|27196929|P2|Overall Study|Abnormal test procedure result(s)|1
7834078|NCT00289978|27196930|P1|Overall Study|Abnormal test procedure result(s)|2
7834079|NCT00289978|27196928|P3|Overall Study|Protocol Violation|4
7834080|NCT00289978|27196929|P2|Overall Study|Protocol Violation|5
7834081|NCT00289978|27196930|P1|Overall Study|Protocol Violation|5
7834082|NCT00289978|27196928|P3|Overall Study|Lost to Follow-up|7
7834083|NCT00289978|27196929|P2|Overall Study|Lost to Follow-up|5
7834084|NCT00289978|27196930|P1|Overall Study|Lost to Follow-up|3
7834085|NCT00289978|27196928|P3|Overall Study|Abnormal laboratory value(s)|1
7834086|NCT00289978|27196929|P2|Overall Study|Abnormal laboratory value(s)|9
7834087|NCT00289978|27196930|P1|Overall Study|Abnormal laboratory value(s)|20
7834088|NCT00289978|27196928|P3|Overall Study|Lack of Efficacy|25
7834089|NCT00289978|27196929|P2|Overall Study|Lack of Efficacy|6
7834090|NCT00289978|27196930|P1|Overall Study|Lack of Efficacy|13
7834091|NCT00289978|27196928|P3|Overall Study|Adverse Event|18
7834092|NCT00289978|27196929|P2|Overall Study|Adverse Event|13
7834093|NCT00289978|27196930|P1|Overall Study|Adverse Event|22
7834094|NCT00289978|27196928|P3|Overall Study|Withdrawal by Subject|28
7834095|NCT00289978|27196929|P2|Overall Study|Withdrawal by Subject|17
7834096|NCT00289978|27196930|P1|Overall Study|Withdrawal by Subject|31
7834097|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7834098|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7834099|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7834100|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
7834101|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7834102|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
7834103|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7834104|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7834105|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7834106|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7834107|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7834108|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7834109|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
7834110|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
7834111|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7834112|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
7834113|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
7834114|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
7834115|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
7834116|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
7834117|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
7834118|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7834119|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7834120|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7834121|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7834122|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834123|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
7834124|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834125|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834126|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834127|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
7834128|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
7834129|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
7834130|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
7834131|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
7834132|NCT00289913|27196949|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834133|NCT00289913|27196950|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834134|NCT00289913|27196951|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834135|NCT00289913|27196952|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7834136|NCT00289913|27196953|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834137|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
7834138|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7834139|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7834140|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7834141|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7834142|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
7834143|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7834144|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7834145|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7834146|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7834147|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
7834148|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7834149|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7834150|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7834151|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7834152|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
7834153|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7834154|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7834155|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7834156|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7834157|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
7834158|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7834159|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7834160|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7834161|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7834162|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7834163|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7834164|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7834165|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7834166|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
7834167|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7834168|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7834169|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
7834170|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
7834171|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7834172|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
7834173|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
7834174|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
7834175|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
7834176|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
7834177|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7834178|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7834179|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
7834180|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7834181|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7834182|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7834183|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7834184|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
7834185|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7834186|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
7834187|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834188|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834189|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
7834190|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7834191|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
7834192|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7834193|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7834194|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7834195|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
7834196|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7834197|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
7834198|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
7834199|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
7834200|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
7834201|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
7834202|NCT00289913|27196949|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834203|NCT00289913|27196950|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834204|NCT00289913|27196951|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7834205|NCT00289913|27196952|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834206|NCT00289913|27196953|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834207|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7834208|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7834209|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
7834210|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7834211|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
7834212|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7834213|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
7834214|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
7834215|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
7834216|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7834217|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
7834218|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
7834219|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
7834220|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
7834221|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
7834222|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7834223|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7834224|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7834225|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
7834226|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7834227|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7834228|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
7834229|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7834230|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7834231|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7834232|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
7834233|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7834234|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7834235|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7834236|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7834237|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7834238|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7834239|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7834240|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7834241|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7834242|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
7834243|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7834244|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7834245|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7834246|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
7834247|NCT00289913|27196949|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834248|NCT00289913|27196950|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834249|NCT00289913|27196951|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834250|NCT00289913|27196952|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7834251|NCT00289913|27196953|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7834252|NCT00289900|27196984|P6|Overall Study|Not treated|0
7834253|NCT00289900|27196985|P5|Overall Study|Not treated|0
7834254|NCT00289900|27196986|P4|Overall Study|Not treated|0
7834255|NCT00289900|27196987|P3|Overall Study|Not treated|0
7834256|NCT00289900|27196988|P2|Overall Study|Not treated|1
7834257|NCT00289900|27196989|P1|Overall Study|Not treated|0
7834258|NCT00289900|27196984|P6|Overall Study|site terminated|0
7834259|NCT00289900|27196985|P5|Overall Study|site terminated|0
7834260|NCT00289900|27196986|P4|Overall Study|site terminated|0
7834261|NCT00289900|27196987|P3|Overall Study|site terminated|1
7834262|NCT00289900|27196988|P2|Overall Study|site terminated|0
7834263|NCT00289900|27196989|P1|Overall Study|site terminated|1
7834264|NCT00289900|27196984|P6|Overall Study|Protocol Violation|4
7834265|NCT00289900|27196985|P5|Overall Study|Protocol Violation|7
7834266|NCT00289900|27196986|P4|Overall Study|Protocol Violation|6
7834267|NCT00289900|27196987|P3|Overall Study|Protocol Violation|2
7834268|NCT00289900|27196988|P2|Overall Study|Protocol Violation|9
7834269|NCT00289900|27196989|P1|Overall Study|Protocol Violation|3
7834270|NCT00289900|27196984|P6|Overall Study|Withdrawal by Subject|11
7834271|NCT00289900|27196985|P5|Overall Study|Withdrawal by Subject|12
7834272|NCT00289900|27196986|P4|Overall Study|Withdrawal by Subject|18
7834273|NCT00289900|27196987|P3|Overall Study|Withdrawal by Subject|8
7834274|NCT00289900|27196988|P2|Overall Study|Withdrawal by Subject|21
7834275|NCT00289900|27196989|P1|Overall Study|Withdrawal by Subject|10
7834276|NCT00289900|27196984|P6|Overall Study|Participant moved|1
7834277|NCT00289900|27196985|P5|Overall Study|Participant moved|1
7834278|NCT00289900|27196986|P4|Overall Study|Participant moved|1
7834279|NCT00289900|27196987|P3|Overall Study|Participant moved|0
7834280|NCT00289900|27196988|P2|Overall Study|Participant moved|0
7834281|NCT00289900|27196989|P1|Overall Study|Participant moved|1
7834282|NCT00289900|27196984|P6|Overall Study|Other|0
7834283|NCT00289900|27196985|P5|Overall Study|Other|1
7834284|NCT00289900|27196986|P4|Overall Study|Other|5
7834285|NCT00289900|27196987|P3|Overall Study|Other|0
7834286|NCT00289900|27196988|P2|Overall Study|Other|0
7834287|NCT00289900|27196989|P1|Overall Study|Other|0
7834288|NCT00289900|27196984|P6|Overall Study|Participant had flushing|4
7834289|NCT00289900|27196985|P5|Overall Study|Participant had flushing|0
7834290|NCT00289900|27196986|P4|Overall Study|Participant had flushing|2
7834291|NCT00289900|27196987|P3|Overall Study|Participant had flushing|1
7834292|NCT00289900|27196988|P2|Overall Study|Participant had flushing|42
7834293|NCT00289900|27196989|P1|Overall Study|Participant had flushing|18
7834294|NCT00289900|27196984|P6|Overall Study|Lost to Follow-up|8
7834295|NCT00289900|27196985|P5|Overall Study|Lost to Follow-up|4
7834296|NCT00289900|27196986|P4|Overall Study|Lost to Follow-up|8
7834297|NCT00289900|27196987|P3|Overall Study|Lost to Follow-up|8
7834298|NCT00289900|27196988|P2|Overall Study|Lost to Follow-up|7
7834299|NCT00289900|27196989|P1|Overall Study|Lost to Follow-up|7
7834300|NCT00289900|27196984|P6|Overall Study|Adverse Event|33
7834301|NCT00289900|27196985|P5|Overall Study|Adverse Event|20
7834302|NCT00289900|27196986|P4|Overall Study|Adverse Event|19
7834303|NCT00289900|27196987|P3|Overall Study|Adverse Event|13
7834304|NCT00289900|27196988|P2|Overall Study|Adverse Event|40
7834305|NCT00289900|27196989|P1|Overall Study|Adverse Event|28
7834306|NCT00289887|27197093|P2|Overall Study|Other|3
7834307|NCT00289887|27197094|P1|Overall Study|Other|7
7834308|NCT00289887|27197093|P2|Overall Study|Withdrawal by Subject|8
7834309|NCT00289887|27197094|P1|Overall Study|Withdrawal by Subject|3
7834310|NCT00289887|27197093|P2|Overall Study|Protocol Violation|1
7834311|NCT00289887|27197094|P1|Overall Study|Protocol Violation|3
7834312|NCT00289887|27197093|P2|Overall Study|Lost to Follow-up|3
7834313|NCT00289887|27197094|P1|Overall Study|Lost to Follow-up|3
7834314|NCT00289887|27197093|P2|Overall Study|Lack of Efficacy|11
7834315|NCT00289887|27197094|P1|Overall Study|Lack of Efficacy|3
7834316|NCT00289887|27197093|P2|Overall Study|Adverse Event|3
7834317|NCT00289887|27197094|P1|Overall Study|Adverse Event|3
7834318|NCT00289874|27197112|P2|Overall Study|Did not meet eligibility|0
7834319|NCT00289874|27197113|P1|Overall Study|Did not meet eligibility|1
7834320|NCT00289874|27197112|P2|Overall Study|Protocol Violation|2
7834321|NCT00289874|27197113|P1|Overall Study|Protocol Violation|3
7834322|NCT00289874|27197112|P2|Overall Study|Lost to Follow-up|1
7834323|NCT00289874|27197113|P1|Overall Study|Lost to Follow-up|1
7834324|NCT00289874|27197112|P2|Overall Study|Adverse Event|5
7834325|NCT00289874|27197113|P1|Overall Study|Adverse Event|1
7834326|NCT00289848|27197123|P2|Overall Study|Open-Label AHA Treatment Requested|1
7834327|NCT00289848|27197124|P1|Overall Study|Open-Label AHA Treatment Requested|0
7834328|NCT00289848|27197123|P2|Overall Study|Patient Moved|2
7834329|NCT00289848|27197124|P1|Overall Study|Patient Moved|6
7834330|NCT00289848|27197123|P2|Overall Study|Withdrawal by Subject|11
7834331|NCT00289848|27197124|P1|Overall Study|Withdrawal by Subject|5
7834332|NCT00289848|27197123|P2|Overall Study|Protocol Violation|2
7834333|NCT00289848|27197124|P1|Overall Study|Protocol Violation|5
7834334|NCT00289848|27197123|P2|Overall Study|Lost to Follow-up|1
7834335|NCT00289848|27197124|P1|Overall Study|Lost to Follow-up|3
7834336|NCT00289848|27197123|P2|Overall Study|Lack of Efficacy|24
7834337|NCT00289848|27197124|P1|Overall Study|Lack of Efficacy|20
7834338|NCT00289848|27197123|P2|Overall Study|Death|0
7834339|NCT00289848|27197124|P1|Overall Study|Death|1
7834340|NCT00289848|27197123|P2|Overall Study|Adverse Event|4
7834341|NCT00289848|27197124|P1|Overall Study|Adverse Event|6
7834342|NCT00289783|27197136|P2|Fourth Dose Phase|Other|10
7834343|NCT00289783|27197137|P1|Fourth Dose Phase|Other|22
7834344|NCT00289783|27197136|P2|Fourth Dose Phase|Migration from the study area|1
7834345|NCT00289783|27197137|P1|Fourth Dose Phase|Migration from the study area|1
7834346|NCT00289783|27197136|P2|Fourth Dose Phase|Lost to Follow-up|12
7834347|NCT00289783|27197137|P1|Fourth Dose Phase|Lost to Follow-up|53
7834348|NCT00289783|27197136|P2|Fourth Dose Phase|Withdrawal by Subject|1
7834349|NCT00289783|27197137|P1|Fourth Dose Phase|Withdrawal by Subject|10
7834350|NCT00289783|27197136|P2|Fourth Dose Phase|Adverse Event|0
7834351|NCT00289783|27197137|P1|Fourth Dose Phase|Adverse Event|1
7834352|NCT00289783|27197136|P2|Primary Phase|Other|12
7834353|NCT00289783|27197137|P1|Primary Phase|Other|32
7834354|NCT00289783|27197136|P2|Primary Phase|Migration from the study area|10
7834355|NCT00289783|27197137|P1|Primary Phase|Migration from the study area|26
7834356|NCT00289783|27197136|P2|Primary Phase|Lost to Follow-up|14
7834357|NCT00289783|27197137|P1|Primary Phase|Lost to Follow-up|60
7834358|NCT00289783|27197136|P2|Primary Phase|Withdrawal by Subject|40
7834359|NCT00289783|27197137|P1|Primary Phase|Withdrawal by Subject|93
7834360|NCT00289783|27197136|P2|Primary Phase|Protocol Violation|6
7834361|NCT00289783|27197137|P1|Primary Phase|Protocol Violation|27
7834362|NCT00289783|27197136|P2|Primary Phase|Adverse Event|1
7834363|NCT00289783|27197137|P1|Primary Phase|Adverse Event|10
7834364|NCT00289770|27197315|P1|Year 15|Withdrawal by Subject|1
7834365|NCT00289731|27197361|P3|Overall Study|Other|0
7834366|NCT00289731|27197362|P2|Overall Study|Other|0
7834367|NCT00289731|27197363|P1|Overall Study|Other|1
7834368|NCT00289731|27197361|P3|Overall Study|Adverse Event|2
7834369|NCT00289731|27197362|P2|Overall Study|Adverse Event|2
7834370|NCT00289731|27197363|P1|Overall Study|Adverse Event|1
7834371|NCT00289536|27197475|P3|Period 3|Lost to Follow-up|1
7834372|NCT00289536|27197476|P2|Period 3|Lost to Follow-up|0
7834373|NCT00289536|27197477|P1|Period 3|Lost to Follow-up|0
7834374|NCT00289458|27197523|P3|Overall Study|Withdrawal by Subject|4
7834375|NCT00289458|27197524|P2|Overall Study|Withdrawal by Subject|2
7834376|NCT00289458|27197525|P1|Overall Study|Withdrawal by Subject|2
7834377|NCT00289458|27197523|P3|Overall Study|Physician Decision|2
7834378|NCT00289458|27197524|P2|Overall Study|Physician Decision|4
7834379|NCT00289458|27197525|P1|Overall Study|Physician Decision|3
7834380|NCT00289458|27197523|P3|Overall Study|Death|0
7834381|NCT00289458|27197524|P2|Overall Study|Death|0
7834382|NCT00289458|27197525|P1|Overall Study|Death|1
7834383|NCT00289289|27197586|P3|Overall Study|Other Exit Reason|12
7834384|NCT00289289|27197587|P2|Overall Study|Other Exit Reason|4
7834385|NCT00289289|27197588|P1|Overall Study|Other Exit Reason|6
7834386|NCT00289289|27197586|P3|Overall Study|Did not meet inclusion/exclusion|6
7834387|NCT00289289|27197587|P2|Overall Study|Did not meet inclusion/exclusion|0
7834388|NCT00289289|27197588|P1|Overall Study|Did not meet inclusion/exclusion|0
7834389|NCT00289289|27197586|P3|Overall Study|Non-study device implanted|3
7834390|NCT00289289|27197587|P2|Overall Study|Non-study device implanted|1
7834391|NCT00289289|27197588|P1|Overall Study|Non-study device implanted|2
7834392|NCT00289289|27197586|P3|Overall Study|Physician Decision|6
7834393|NCT00289289|27197587|P2|Overall Study|Physician Decision|0
7834394|NCT00289289|27197588|P1|Overall Study|Physician Decision|1
7834395|NCT00289289|27197586|P3|Overall Study|No implant attempted|1
7834396|NCT00289289|27197587|P2|Overall Study|No implant attempted|0
7834397|NCT00289289|27197588|P1|Overall Study|No implant attempted|0
7834398|NCT00289289|27197586|P3|Overall Study|Death|5
7834399|NCT00289289|27197587|P2|Overall Study|Death|2
7834400|NCT00289289|27197588|P1|Overall Study|Death|4
7834401|NCT00289289|27197586|P3|Overall Study|Lost to Follow-up|1
7834402|NCT00289289|27197587|P2|Overall Study|Lost to Follow-up|0
7834403|NCT00289289|27197588|P1|Overall Study|Lost to Follow-up|1
7834404|NCT00289289|27197586|P3|Overall Study|Withdrawal by Subject|15
7834405|NCT00289289|27197587|P2|Overall Study|Withdrawal by Subject|3
7834406|NCT00289289|27197588|P1|Overall Study|Withdrawal by Subject|5
7834407|NCT00289276|27197603|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
7834408|NCT00289276|27197604|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
7834409|NCT00289276|27197603|P2|Second Part of FAST Study (Expansion)|Death|2
7834410|NCT00289276|27197604|P1|Second Part of FAST Study (Expansion)|Death|0
7834411|NCT00289198|27197639|P2|Overall Study|Other: Impossible to come on visit|1
7834412|NCT00289198|27197640|P1|Overall Study|Other: Impossible to come on visit|0
7834413|NCT00289198|27197639|P2|Overall Study|Other: Miscalculation of the visit date|22
7834414|NCT00289198|27197640|P1|Overall Study|Other: Miscalculation of the visit date|21
7834415|NCT00289198|27197639|P2|Overall Study|Other: Unable to attend on schedule|1
7834416|NCT00289198|27197640|P1|Overall Study|Other: Unable to attend on schedule|2
7834417|NCT00289198|27197639|P2|Overall Study|Other: Physician's decision|1
7834418|NCT00289198|27197640|P1|Overall Study|Other: Physician's decision|0
7834419|NCT00289198|27197639|P2|Overall Study|Other: Low compliance|1
7834420|NCT00289198|27197640|P1|Overall Study|Other: Low compliance|0
7834421|NCT00289198|27197639|P2|Overall Study|Lack of Efficacy|0
7834422|NCT00289198|27197640|P1|Overall Study|Lack of Efficacy|2
7834423|NCT00289198|27197639|P2|Overall Study|Withdrawal by Subject|1
7834424|NCT00289198|27197640|P1|Overall Study|Withdrawal by Subject|4
7834425|NCT00289198|27197639|P2|Overall Study|Protocol Violation|1
7834426|NCT00289198|27197640|P1|Overall Study|Protocol Violation|2
7834427|NCT00289198|27197639|P2|Overall Study|Adverse Event|2
7834428|NCT00289198|27197640|P1|Overall Study|Adverse Event|0
7834429|NCT00289185|27197690|P2|Overall Study|Death|1
7834430|NCT00289185|27197691|P1|Overall Study|Death|1
7834431|NCT00289185|27197690|P2|Overall Study|Lost to Follow-up|17
7834432|NCT00289185|27197691|P1|Overall Study|Lost to Follow-up|23
7834433|NCT00289185|27197690|P2|Overall Study|Withdrawal by Subject|8
7834434|NCT00289185|27197691|P1|Overall Study|Withdrawal by Subject|4
7834435|NCT00289133|27197738|P2|Overall Study|Lost to Follow-up|115
7834436|NCT00289133|27197739|P1|Overall Study|Lost to Follow-up|92
7834437|NCT00289133|27197738|P2|Overall Study|Revision|6
7834438|NCT00289133|27197739|P1|Overall Study|Revision|8
7834439|NCT00289133|27197738|P2|Overall Study|Physician Decision|45
7834440|NCT00289133|27197739|P1|Overall Study|Physician Decision|41
7834441|NCT00289133|27197738|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
7834442|NCT00289133|27197739|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
7834443|NCT00289133|27197738|P2|Overall Study|Death|10
7834444|NCT00289133|27197739|P1|Overall Study|Death|5
7834445|NCT00289133|27197738|P2|Overall Study|Withdrawal by Subject|10
7834446|NCT00289133|27197739|P1|Overall Study|Withdrawal by Subject|9
7834447|NCT00289133|27197738|P2|Overall Study|Protocol Violation|38
7834448|NCT00289133|27197739|P1|Overall Study|Protocol Violation|32
7834449|NCT00289133|27197738|P2|Overall Study|Non-study device implanted|0
7834450|NCT00289133|27197739|P1|Overall Study|Non-study device implanted|12
7834451|NCT00289016|27197795|P1|Overall Study|Other|1
7834452|NCT00289016|27197795|P1|Overall Study|Adverse Event|1
7834453|NCT00289016|27197795|P1|Overall Study|Withdrawal by Subject|2
7834454|NCT00289016|27197795|P1|Overall Study|Unrelated Medical Condition or Accident|2
7834455|NCT00289016|27197795|P1|Overall Study|Death|2
7834456|NCT00289016|27197795|P1|Overall Study|Disease Progression|29
7834457|NCT00288912|27197807|P3|Overall Study|Withdrawal by Subject|12
7834458|NCT00288912|27197808|P2|Overall Study|Withdrawal by Subject|5
7834459|NCT00288912|27197809|P1|Overall Study|Withdrawal by Subject|4
7834460|NCT00288912|27197807|P3|Overall Study|Lost to Follow-up|9
7834461|NCT00288912|27197808|P2|Overall Study|Lost to Follow-up|6
7834462|NCT00288912|27197809|P1|Overall Study|Lost to Follow-up|9
7834463|NCT00288912|27197807|P3|Overall Study|Developed exclusion criterion|7
7834464|NCT00288912|27197808|P2|Overall Study|Developed exclusion criterion|6
7834465|NCT00288912|27197809|P1|Overall Study|Developed exclusion criterion|4
7834466|NCT00288860|27197849|P2|Overall Study|Lost to Follow-up|71
7834467|NCT00288860|27197850|P1|Overall Study|Lost to Follow-up|74
7834468|NCT00288860|27197849|P2|Overall Study|Withdrawal by Subject|15
7834469|NCT00288860|27197850|P1|Overall Study|Withdrawal by Subject|20
7834470|NCT00288860|27197849|P2|Overall Study|Death|3
7834471|NCT00288860|27197850|P1|Overall Study|Death|4
7834472|NCT00288860|27197849|P2|Overall Study|Did not complete intake|8
7834473|NCT00288860|27197850|P1|Overall Study|Did not complete intake|4
7834474|NCT00288704|27197863|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
7834475|NCT00288704|27197864|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
7834476|NCT00288704|27197865|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
7834477|NCT00288704|27197863|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
7834478|NCT00288704|27197864|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
7834479|NCT00288704|27197865|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
7834480|NCT00288704|27197863|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
7834481|NCT00288704|27197864|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
7834482|NCT00288704|27197865|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
7834483|NCT00288704|27197863|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
7834484|NCT00288704|27197864|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
7834485|NCT00288704|27197865|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
7834486|NCT00288704|27197863|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
7834487|NCT00288704|27197864|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
7834488|NCT00288704|27197865|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
7834489|NCT00288704|27197863|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
7834490|NCT00288704|27197864|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
7834491|NCT00288704|27197865|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
7834492|NCT00288704|27197863|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
7834493|NCT00288704|27197864|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
7834494|NCT00288704|27197865|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
7834495|NCT00288639|27197892|P1|Overall Study|Other|1
7834496|NCT00288639|27197892|P1|Overall Study|Withdrawal by Subject|2
7834497|NCT00288639|27197892|P1|Overall Study|Lack of Efficacy|4
7834498|NCT00288639|27197892|P1|Overall Study|Adverse Event|5
7834499|NCT00288626|27197909|P1|Overall Study|Withdrawal by Subject|4
7834500|NCT00288626|27197909|P1|Overall Study|Death|3
7834501|NCT00288587|27197943|P2|Overall Study|Severe Aortic Stenosis|0
7834502|NCT00288587|27197944|P1|Overall Study|Severe Aortic Stenosis|1
7834503|NCT00288587|27197943|P2|Overall Study|Physician Decision|2
7834504|NCT00288587|27197944|P1|Overall Study|Physician Decision|0
7834505|NCT00288587|27197943|P2|Overall Study|Adverse Event|1
7834506|NCT00288587|27197944|P1|Overall Study|Adverse Event|0
7834507|NCT00288587|27197943|P2|Overall Study|Transplant|3
7834508|NCT00288587|27197944|P1|Overall Study|Transplant|0
7834509|NCT00288587|27197943|P2|Overall Study|Death|4
7834510|NCT00288587|27197944|P1|Overall Study|Death|4
7834511|NCT00288509|27197987|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
7834512|NCT00288509|27197987|P1|Treatment Cycle 4|Physician Decision|4
7834513|NCT00288509|27197987|P1|Treatment Cycle 4|Withdrawal by Subject|3
7834514|NCT00288509|27197987|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
7834515|NCT00288509|27197987|P1|Treatment Cycle 3|Lost to Follow-up|2
7834516|NCT00288509|27197987|P1|Treatment Cycle 3|Withdrawal by Subject|1
7834517|NCT00288509|27197987|P1|Treatment Cycle 3|Lack of Efficacy|1
7834518|NCT00288509|27197987|P1|Treatment Cycle 2|Withdrawal by Subject|2
7834519|NCT00288509|27197987|P1|Treatment Cycle 2|Lack of Efficacy|1
7834520|NCT00288509|27197987|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
7834521|NCT00288509|27197987|P1|Treatment Cycle 1|Lost to Follow-up|2
7834522|NCT00288509|27197987|P1|Treatment Cycle 1|Withdrawal by Subject|1
7834523|NCT00288509|27197987|P1|Treatment Cycle 1|Lack of Efficacy|1
7834524|NCT00288509|27197987|P1|Treatment Cycle 1|Adverse Event|1
7834525|NCT00288080|27198005|P2|Overall Study|Protocol Violation|20
7834526|NCT00288080|27198006|P1|Overall Study|Protocol Violation|25
7834527|NCT00288080|27198005|P2|Overall Study|Withdrawal by Subject|3
7834528|NCT00288080|27198006|P1|Overall Study|Withdrawal by Subject|1
7834529|NCT00288054|27198032|P1|Overall Study|Not protocol specified|2
7834530|NCT00288054|27198032|P1|Overall Study|Withdrawal by Subject|1
7834531|NCT00288054|27198032|P1|Overall Study|Adverse Event|3
7834532|NCT00288054|27198032|P1|Overall Study|Lack of Efficacy|16
7834533|NCT00288054|27198032|P1|Overall Study|Protocol Violation|2
7834534|NCT00288015|27198040|P1|Follow up for Survival x 2 Years|Other|9
7834535|NCT00288015|27198040|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
7834536|NCT00288015|27198040|P1|Follow up for Survival x 2 Years|Death|13
7834537|NCT00288015|27198040|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
7834538|NCT00288015|27198040|P1|First Response Assessment|Physician Decision|2
7834539|NCT00288015|27198040|P1|First Response Assessment|Death|1
7834540|NCT00288015|27198040|P1|First Response Assessment|Withdrawal by Subject|1
7834541|NCT00288015|27198040|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
7834542|NCT00288015|27198040|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
7834543|NCT00287690|27198132|P2|Overall Study|Protocol Violation|26
7834544|NCT00287690|27198133|P1|Overall Study|Protocol Violation|20
7834545|NCT00287586|27198145|P2|Overall Study|Recurrent Melanoma|1
7834546|NCT00287586|27198146|P1|Overall Study|Recurrent Melanoma|0
7834547|NCT00287586|27198145|P2|Overall Study|Itchy Swollen Eyes|1
7834548|NCT00287586|27198146|P1|Overall Study|Itchy Swollen Eyes|0
7834549|NCT00287586|27198145|P2|Overall Study|Bradycardia|1
7834550|NCT00287586|27198146|P1|Overall Study|Bradycardia|0
7834551|NCT00287586|27198145|P2|Overall Study|Mood Swings and Irritability|1
7834552|NCT00287586|27198146|P1|Overall Study|Mood Swings and Irritability|0
7834553|NCT00287586|27198145|P2|Overall Study|Mastodynia and Gynecomastia|1
7834554|NCT00287586|27198146|P1|Overall Study|Mastodynia and Gynecomastia|0
7834555|NCT00287586|27198145|P2|Overall Study|Retroperitoneal Cancer|1
7834556|NCT00287586|27198146|P1|Overall Study|Retroperitoneal Cancer|0
7834557|NCT00287586|27198145|P2|Overall Study|Elevated IPSS Score|1
7834558|NCT00287586|27198146|P1|Overall Study|Elevated IPSS Score|0
7834559|NCT00287586|27198145|P2|Overall Study|Lung Cancer|2
7834560|NCT00287586|27198146|P1|Overall Study|Lung Cancer|0
7834561|NCT00287586|27198145|P2|Overall Study|Major Depression|2
7834562|NCT00287586|27198146|P1|Overall Study|Major Depression|0
7834563|NCT00287586|27198145|P2|Overall Study|Enrolled in Another Study|0
7834564|NCT00287586|27198146|P1|Overall Study|Enrolled in Another Study|1
7834565|NCT00287586|27198145|P2|Overall Study|Nonadherence|1
7834566|NCT00287586|27198146|P1|Overall Study|Nonadherence|1
7834567|NCT00287586|27198145|P2|Overall Study|Inappropriate Behaviour with Staff|0
7834568|NCT00287586|27198146|P1|Overall Study|Inappropriate Behaviour with Staff|1
7834569|NCT00287586|27198145|P2|Overall Study|Shoulder Pain|0
7834570|NCT00287586|27198146|P1|Overall Study|Shoulder Pain|1
7834571|NCT00287586|27198145|P2|Overall Study|Sleep Apnea|0
7834572|NCT00287586|27198146|P1|Overall Study|Sleep Apnea|1
7834573|NCT00287586|27198145|P2|Overall Study|Pancreatic Cancer|3
7834574|NCT00287586|27198146|P1|Overall Study|Pancreatic Cancer|1
7834575|NCT00287586|27198145|P2|Overall Study|Cognitive Impairment|0
7834576|NCT00287586|27198146|P1|Overall Study|Cognitive Impairment|1
7834577|NCT00287586|27198145|P2|Overall Study|Lower Urinary Tract Symptoms|0
7834578|NCT00287586|27198146|P1|Overall Study|Lower Urinary Tract Symptoms|1
7834579|NCT00287586|27198145|P2|Overall Study|Myocardial Infarction|0
7834580|NCT00287586|27198146|P1|Overall Study|Myocardial Infarction|1
7834581|NCT00287586|27198145|P2|Overall Study|Stroke|0
7834582|NCT00287586|27198146|P1|Overall Study|Stroke|2
7834583|NCT00287586|27198145|P2|Overall Study|Elevated Prostate Specific Antigen|0
7834584|NCT00287586|27198146|P1|Overall Study|Elevated Prostate Specific Antigen|2
7834585|NCT00287586|27198145|P2|Overall Study|Rash|0
7834586|NCT00287586|27198146|P1|Overall Study|Rash|3
7834587|NCT00287586|27198145|P2|Overall Study|Elevated Hematocrit|0
7834588|NCT00287586|27198146|P1|Overall Study|Elevated Hematocrit|3
7834589|NCT00287586|27198145|P2|Overall Study|Death|3
7834590|NCT00287586|27198146|P1|Overall Study|Death|2
7834591|NCT00287586|27198145|P2|Overall Study|Lost to Follow-up|4
7834592|NCT00287586|27198146|P1|Overall Study|Lost to Follow-up|5
7834593|NCT00287586|27198145|P2|Overall Study|Withdrew Consent|30
7834594|NCT00287586|27198146|P1|Overall Study|Withdrew Consent|19
7834595|NCT00287469|27198184|P2|Overall Study|Lost to Follow-up|69
7834596|NCT00287469|27198185|P1|Overall Study|Lost to Follow-up|74
7834597|NCT00287469|27198184|P2|Overall Study|moved from area|138
7834598|NCT00287469|27198185|P1|Overall Study|moved from area|144
7834599|NCT00287469|27198184|P2|Overall Study|Adverse Event|1
7834600|NCT00287469|27198185|P1|Overall Study|Adverse Event|1
7834601|NCT00287469|27198184|P2|Overall Study|serious adverse event|6
7834602|NCT00287469|27198185|P1|Overall Study|serious adverse event|1
7834603|NCT00287365|27198195|P1|Overall Study|sample not acquired|13
7834604|NCT00287118|27198221|P1|Overall Study|Other|7
7834605|NCT00287118|27198221|P1|Overall Study|Protocol Violation|2
7834606|NCT00287118|27198221|P1|Overall Study|Lost to Follow-up|1
7834607|NCT00287118|27198221|P1|Overall Study|Lack of Efficacy|11
7834608|NCT00287118|27198221|P1|Overall Study|Death|1
7834609|NCT00287118|27198221|P1|Overall Study|Adverse Event|30
7834610|NCT00287079|27198227|P2|Overall Study|Other|0
7834611|NCT00287079|27198228|P1|Overall Study|Other|3
7834612|NCT00287079|27198227|P2|Overall Study|Protocol Violation|0
7834613|NCT00287079|27198228|P1|Overall Study|Protocol Violation|1
7834614|NCT00287079|27198227|P2|Overall Study|Adverse Event|0
7834615|NCT00287079|27198228|P1|Overall Study|Adverse Event|5
7834616|NCT00287079|27198227|P2|Overall Study|Non-qualifying relapse|0
7834617|NCT00287079|27198228|P1|Overall Study|Non-qualifying relapse|1
7834618|NCT00287079|27198227|P2|Overall Study|Qualifying relapse|1
7834619|NCT00287079|27198228|P1|Overall Study|Qualifying relapse|12
7834620|NCT00286754|27198256|P3|Overall Study|Moved out of state|1
7834621|NCT00286754|27198257|P2|Overall Study|Moved out of state|0
7834622|NCT00286754|27198258|P1|Overall Study|Moved out of state|0
7834623|NCT00286754|27198256|P3|Overall Study|Lost to Follow-up|6
7834624|NCT00286754|27198257|P2|Overall Study|Lost to Follow-up|14
7834625|NCT00286754|27198258|P1|Overall Study|Lost to Follow-up|12
7834626|NCT00286754|27198256|P3|Overall Study|Withdrawal by Subject|0
7834627|NCT00286754|27198257|P2|Overall Study|Withdrawal by Subject|2
7834628|NCT00286754|27198258|P1|Overall Study|Withdrawal by Subject|6
7834629|NCT00286754|27198256|P3|Overall Study|Adverse Event|3
7834630|NCT00286754|27198257|P2|Overall Study|Adverse Event|2
7834631|NCT00286754|27198258|P1|Overall Study|Adverse Event|2
7834632|NCT00286494|27198317|P3|Overall Study|Protocol Violation|2
7834633|NCT00286494|27198318|P2|Overall Study|Protocol Violation|1
7834634|NCT00286494|27198319|P1|Overall Study|Protocol Violation|1
7834635|NCT00286494|27198317|P3|Overall Study|Lost to Follow-up|3
7834636|NCT00286494|27198318|P2|Overall Study|Lost to Follow-up|1
7834637|NCT00286494|27198319|P1|Overall Study|Lost to Follow-up|3
7834638|NCT00286494|27198317|P3|Overall Study|Physician Decision|1
7834639|NCT00286494|27198318|P2|Overall Study|Physician Decision|5
7834640|NCT00286494|27198319|P1|Overall Study|Physician Decision|5
7834641|NCT00286494|27198317|P3|Overall Study|Adverse Event|6
7834642|NCT00286494|27198318|P2|Overall Study|Adverse Event|8
7834643|NCT00286494|27198319|P1|Overall Study|Adverse Event|3
7834644|NCT00286494|27198317|P3|Overall Study|Withdrawal by Subject|9
7834645|NCT00286494|27198318|P2|Overall Study|Withdrawal by Subject|10
7834646|NCT00286494|27198319|P1|Overall Study|Withdrawal by Subject|2
7834647|NCT00286494|27198317|P3|Overall Study|Hyperglycemic rescue|18
7834648|NCT00286494|27198318|P2|Overall Study|Hyperglycemic rescue|19
7834649|NCT00286494|27198319|P1|Overall Study|Hyperglycemic rescue|12
7834650|NCT00286468|27198480|P3|Overall Study|Physician Decision|1
7834651|NCT00286468|27198481|P2|Overall Study|Physician Decision|2
7834652|NCT00286468|27198482|P1|Overall Study|Physician Decision|3
7834653|NCT00286468|27198480|P3|Overall Study|Withdrawal by Subject|11
7834654|NCT00286468|27198481|P2|Overall Study|Withdrawal by Subject|8
7834655|NCT00286468|27198482|P1|Overall Study|Withdrawal by Subject|3
7834656|NCT00286468|27198480|P3|Overall Study|Lost to Follow-up|2
7834657|NCT00286468|27198481|P2|Overall Study|Lost to Follow-up|1
7834658|NCT00286468|27198482|P1|Overall Study|Lost to Follow-up|1
7834659|NCT00286468|27198480|P3|Overall Study|Protocol Violation|1
7834660|NCT00286468|27198481|P2|Overall Study|Protocol Violation|3
7834661|NCT00286468|27198482|P1|Overall Study|Protocol Violation|0
7834662|NCT00286468|27198480|P3|Overall Study|Adverse Event|4
7834663|NCT00286468|27198481|P2|Overall Study|Adverse Event|6
7834664|NCT00286468|27198482|P1|Overall Study|Adverse Event|2
7834665|NCT00286468|27198480|P3|Overall Study|Hyperglycemic Rescue|31
7834666|NCT00286468|27198481|P2|Overall Study|Hyperglycemic Rescue|30
7834667|NCT00286468|27198482|P1|Overall Study|Hyperglycemic Rescue|28
7834668|NCT00286455|27198643|P3|Overall Study|Withdrawal by Subject|7
7834669|NCT00286455|27198644|P2|Overall Study|Withdrawal by Subject|8
7834670|NCT00286455|27198645|P1|Overall Study|Withdrawal by Subject|0
7834671|NCT00286455|27198643|P3|Overall Study|Participant Non-compliance|0
7834672|NCT00286455|27198644|P2|Overall Study|Participant Non-compliance|0
7834673|NCT00286455|27198645|P1|Overall Study|Participant Non-compliance|1
7834674|NCT00286455|27198643|P3|Overall Study|Protocol Violation|0
7834675|NCT00286455|27198644|P2|Overall Study|Protocol Violation|1
7834676|NCT00286455|27198645|P1|Overall Study|Protocol Violation|1
7834677|NCT00286455|27198643|P3|Overall Study|Physician Decision|2
7834678|NCT00286455|27198644|P2|Overall Study|Physician Decision|0
7834679|NCT00286455|27198645|P1|Overall Study|Physician Decision|3
7834680|NCT00286455|27198643|P3|Overall Study|Lost to Follow-up|3
7834681|NCT00286455|27198644|P2|Overall Study|Lost to Follow-up|3
7834682|NCT00286455|27198645|P1|Overall Study|Lost to Follow-up|0
7834683|NCT00286455|27198643|P3|Overall Study|Adverse Event|2
7834684|NCT00286455|27198644|P2|Overall Study|Adverse Event|3
7834685|NCT00286455|27198645|P1|Overall Study|Adverse Event|1
7834686|NCT00286455|27198643|P3|Overall Study|Hyperglycemia rescue|10
7834687|NCT00286455|27198644|P2|Overall Study|Hyperglycemia rescue|13
7834688|NCT00286455|27198645|P1|Overall Study|Hyperglycemia rescue|19
7834689|NCT00286442|27198824|P3|Overall Study|Withdrawal by Subject|2
7834690|NCT00286442|27198825|P2|Overall Study|Withdrawal by Subject|14
7834691|NCT00286442|27198826|P1|Overall Study|Withdrawal by Subject|2
7834692|NCT00286442|27198824|P3|Overall Study|Administrative Error|0
7834693|NCT00286442|27198825|P2|Overall Study|Administrative Error|1
7834694|NCT00286442|27198826|P1|Overall Study|Administrative Error|1
7834695|NCT00286442|27198824|P3|Overall Study|Physician Decision|1
7834696|NCT00286442|27198825|P2|Overall Study|Physician Decision|1
7834697|NCT00286442|27198826|P1|Overall Study|Physician Decision|1
7834698|NCT00286442|27198824|P3|Overall Study|Lost to Follow-up|1
7834699|NCT00286442|27198825|P2|Overall Study|Lost to Follow-up|2
7834700|NCT00286442|27198826|P1|Overall Study|Lost to Follow-up|5
7834701|NCT00286442|27198824|P3|Overall Study|Protocol Violation|2
7834702|NCT00286442|27198825|P2|Overall Study|Protocol Violation|4
7834703|NCT00286442|27198826|P1|Overall Study|Protocol Violation|2
7834704|NCT00286442|27198824|P3|Overall Study|Adverse Event|1
7834705|NCT00286442|27198825|P2|Overall Study|Adverse Event|6
7834706|NCT00286442|27198826|P1|Overall Study|Adverse Event|7
7834707|NCT00286442|27198824|P3|Overall Study|Hyperglycemic Rescue|25
7834708|NCT00286442|27198825|P2|Overall Study|Hyperglycemic Rescue|17
7834709|NCT00286442|27198826|P1|Overall Study|Hyperglycemic Rescue|19
7834710|NCT00286429|27198987|P3|Overall Study|Administrative Decision|0
7834711|NCT00286429|27198988|P2|Overall Study|Administrative Decision|1
7834712|NCT00286429|27198989|P1|Overall Study|Administrative Decision|0
7834713|NCT00286429|27198987|P3|Overall Study|Administrative Error|1
7834714|NCT00286429|27198988|P2|Overall Study|Administrative Error|1
7834715|NCT00286429|27198989|P1|Overall Study|Administrative Error|1
7834716|NCT00286429|27198987|P3|Overall Study|Withdrawal by Subject|6
7834717|NCT00286429|27198988|P2|Overall Study|Withdrawal by Subject|2
7834718|NCT00286429|27198989|P1|Overall Study|Withdrawal by Subject|3
7834719|NCT00286429|27198987|P3|Overall Study|Protocol Violation|4
7834720|NCT00286429|27198988|P2|Overall Study|Protocol Violation|5
7834721|NCT00286429|27198989|P1|Overall Study|Protocol Violation|3
7834722|NCT00286429|27198987|P3|Overall Study|Physician Decision|7
7834723|NCT00286429|27198988|P2|Overall Study|Physician Decision|7
7834724|NCT00286429|27198989|P1|Overall Study|Physician Decision|10
7834725|NCT00286429|27198987|P3|Overall Study|Lost to Follow-up|3
7834726|NCT00286429|27198988|P2|Overall Study|Lost to Follow-up|4
7834727|NCT00286429|27198989|P1|Overall Study|Lost to Follow-up|2
7834728|NCT00286429|27198987|P3|Overall Study|Lack of Efficacy|25
7834729|NCT00286429|27198988|P2|Overall Study|Lack of Efficacy|27
7834730|NCT00286429|27198989|P1|Overall Study|Lack of Efficacy|52
7834731|NCT00286429|27198987|P3|Overall Study|Adverse Event|6
7834732|NCT00286429|27198988|P2|Overall Study|Adverse Event|1
7834733|NCT00286429|27198989|P1|Overall Study|Adverse Event|4
7834734|NCT00286221|27199105|P4|Overall Study|Unrecognized exclusion criteria met|0
7834735|NCT00286221|27199106|P3|Overall Study|Unrecognized exclusion criteria met|0
7834736|NCT00286221|27199107|P2|Overall Study|Unrecognized exclusion criteria met|1
7834737|NCT00286221|27199108|P1|Overall Study|Unrecognized exclusion criteria met|0
7834738|NCT00286221|27199105|P4|Overall Study|Inability to trigger PCA|0
7834739|NCT00286221|27199106|P3|Overall Study|Inability to trigger PCA|0
7834740|NCT00286221|27199107|P2|Overall Study|Inability to trigger PCA|0
7834741|NCT00286221|27199108|P1|Overall Study|Inability to trigger PCA|2
7834742|NCT00286221|27199105|P4|Overall Study|Unanticipated Neurosurgical Complication|2
7834743|NCT00286221|27199106|P3|Overall Study|Unanticipated Neurosurgical Complication|3
7834744|NCT00286221|27199107|P2|Overall Study|Unanticipated Neurosurgical Complication|3
7834745|NCT00286221|27199108|P1|Overall Study|Unanticipated Neurosurgical Complication|6
7834746|NCT00286221|27199105|P4|Overall Study|Protocol Violation|4
7834747|NCT00286221|27199106|P3|Overall Study|Protocol Violation|6
7834748|NCT00286221|27199107|P2|Overall Study|Protocol Violation|1
7834749|NCT00286221|27199108|P1|Overall Study|Protocol Violation|2
7834750|NCT00286156|27199134|P3|Overall Study|AE: pneumonia|0
7834751|NCT00286156|27199135|P2|Overall Study|AE: pneumonia|0
7834752|NCT00286156|27199136|P1|Overall Study|AE: pneumonia|1
7834753|NCT00286156|27199134|P3|Overall Study|AE: nephrotic-range proteinuruia|0
7834754|NCT00286156|27199135|P2|Overall Study|AE: nephrotic-range proteinuruia|0
7834755|NCT00286156|27199136|P1|Overall Study|AE: nephrotic-range proteinuruia|1
7834756|NCT00286156|27199134|P3|Overall Study|AE: pulmonary embolus|0
7834757|NCT00286156|27199135|P2|Overall Study|AE: pulmonary embolus|1
7834758|NCT00286156|27199136|P1|Overall Study|AE: pulmonary embolus|0
7834759|NCT00286156|27199134|P3|Overall Study|Missed 12 month visit|1
7834760|NCT00286156|27199135|P2|Overall Study|Missed 12 month visit|0
7834761|NCT00286156|27199136|P1|Overall Study|Missed 12 month visit|0
7834762|NCT00286091|27199149|P2|Open-label Treatment Phase|Missing End of Study Information|1
7834763|NCT00286091|27199150|P1|Open-label Treatment Phase|Missing End of Study Information|0
7834764|NCT00286091|27199149|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
7834765|NCT00286091|27199150|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
7834766|NCT00286091|27199149|P2|Open-label Treatment Phase|Lost to Follow-up|1
7834767|NCT00286091|27199150|P1|Open-label Treatment Phase|Lost to Follow-up|0
7834768|NCT00286091|27199149|P2|Open-label Treatment Phase|Noncompliance|1
7834769|NCT00286091|27199150|P1|Open-label Treatment Phase|Noncompliance|3
7834770|NCT00286091|27199149|P2|Open-label Treatment Phase|Disease Progression|3
7834771|NCT00286091|27199150|P1|Open-label Treatment Phase|Disease Progression|9
7834772|NCT00286091|27199149|P2|Open-label Treatment Phase|Death|7
7834773|NCT00286091|27199150|P1|Open-label Treatment Phase|Death|10
7834774|NCT00286091|27199149|P2|Open-label Treatment Phase|Withdrawal by Subject|10
7834775|NCT00286091|27199150|P1|Open-label Treatment Phase|Withdrawal by Subject|14
7834776|NCT00286091|27199149|P2|Open-label Treatment Phase|Other|11
7834777|NCT00286091|27199150|P1|Open-label Treatment Phase|Other|11
7834778|NCT00286091|27199149|P2|Open-label Treatment Phase|Adverse Event|16
7834779|NCT00286091|27199150|P1|Open-label Treatment Phase|Adverse Event|5
7834780|NCT00286091|27199149|P2|Open-label Treatment Phase|Physician Decision|21
7834781|NCT00286091|27199150|P1|Open-label Treatment Phase|Physician Decision|24
7834782|NCT00286091|27199149|P2|Double-blind Treatment Phase|Ineligibility Determined|2
7834783|NCT00286091|27199150|P1|Double-blind Treatment Phase|Ineligibility Determined|1
7834784|NCT00286091|27199149|P2|Double-blind Treatment Phase|Protocol Deviation|3
7834785|NCT00286091|27199150|P1|Double-blind Treatment Phase|Protocol Deviation|1
7834786|NCT00286091|27199149|P2|Double-blind Treatment Phase|Lost to Follow-up|4
7834787|NCT00286091|27199150|P1|Double-blind Treatment Phase|Lost to Follow-up|11
7834788|NCT00286091|27199149|P2|Double-blind Treatment Phase|Noncompliance|8
7834789|NCT00286091|27199150|P1|Double-blind Treatment Phase|Noncompliance|8
7834790|NCT00286091|27199149|P2|Double-blind Treatment Phase|Administrative Decision|21
7834791|NCT00286091|27199150|P1|Double-blind Treatment Phase|Administrative Decision|20
7834792|NCT00286091|27199149|P2|Double-blind Treatment Phase|Other|33
7834793|NCT00286091|27199150|P1|Double-blind Treatment Phase|Other|25
7834794|NCT00286091|27199149|P2|Double-blind Treatment Phase|Disease Progression|35
7834795|NCT00286091|27199150|P1|Double-blind Treatment Phase|Disease Progression|22
7834796|NCT00286091|27199149|P2|Double-blind Treatment Phase|Adverse Event|40
7834797|NCT00286091|27199150|P1|Double-blind Treatment Phase|Adverse Event|28
7834798|NCT00286091|27199149|P2|Double-blind Treatment Phase|Death|65
7834799|NCT00286091|27199150|P1|Double-blind Treatment Phase|Death|58
7834800|NCT00286091|27199149|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
7834801|NCT00286091|27199150|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
7834802|NCT00286091|27199149|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
7834803|NCT00286091|27199150|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
7834804|NCT00285857|27199173|P1|Overall Study|Adverse Event|1
7834805|NCT00285857|27199173|P1|Overall Study|Inadequate initial breast cytology|1
7834806|NCT00285857|27199173|P1|Overall Study|Withdrawal by Subject|2
7834807|NCT00285818|27199186|P2|Overall Study|Lost to Follow-up|0
7834808|NCT00285818|27199187|P1|Overall Study|Lost to Follow-up|1
7834809|NCT00285818|27199186|P2|Overall Study|Withdrawal by Subject|2
7834810|NCT00285818|27199187|P1|Overall Study|Withdrawal by Subject|3
7834811|NCT00285649|27199232|P3|Overall Study|Withdrawal by Subject|2
7834812|NCT00285649|27199233|P2|Overall Study|Withdrawal by Subject|2
7834813|NCT00285649|27199234|P1|Overall Study|Withdrawal by Subject|3
7834814|NCT00285649|27199232|P3|Overall Study|Lost to Follow-up|4
7834815|NCT00285649|27199233|P2|Overall Study|Lost to Follow-up|4
7834816|NCT00285649|27199234|P1|Overall Study|Lost to Follow-up|6
7834817|NCT00285584|27199244|P2|Month 6|Lost to Follow-up|1
7834818|NCT00285584|27199245|P1|Month 6|Lost to Follow-up|0
7834819|NCT00285584|27199244|P2|Month 3|Withdrawal by Subject|0
7834820|NCT00285584|27199245|P1|Month 3|Withdrawal by Subject|1
7834821|NCT00285584|27199244|P2|Month 3|Lost to Follow-up|3
7834822|NCT00285584|27199245|P1|Month 3|Lost to Follow-up|3
7834823|NCT00285207|27199277|P2|Overall Study|non-compliance|1
7834824|NCT00285207|27199278|P1|Overall Study|non-compliance|0
7834825|NCT00285207|27199277|P2|Overall Study|Pregnancy|1
7834826|NCT00285207|27199278|P1|Overall Study|Pregnancy|1
7834827|NCT00285207|27199277|P2|Overall Study|Withdrawal by Subject|2
7834828|NCT00285207|27199278|P1|Overall Study|Withdrawal by Subject|5
7834829|NCT00285207|27199277|P2|Overall Study|Lost to Follow-up|2
7834830|NCT00285207|27199278|P1|Overall Study|Lost to Follow-up|3
7834831|NCT00285012|27199286|P2|Received Study Tx|Other|5
7834832|NCT00285012|27199287|P1|Received Study Tx|Other|5
7834833|NCT00285012|27199286|P2|Received Study Tx|Withdrawal by Subject|43
7834834|NCT00285012|27199287|P1|Received Study Tx|Withdrawal by Subject|31
7834835|NCT00285012|27199286|P2|Received Study Tx|Lost to Follow-up|31
7834836|NCT00285012|27199287|P1|Received Study Tx|Lost to Follow-up|29
7834837|NCT00285012|27199286|P2|Received Study Tx|Lack of Efficacy|3
7834838|NCT00285012|27199287|P1|Received Study Tx|Lack of Efficacy|0
7834839|NCT00285012|27199286|P2|Received Study Tx|Adverse Event|11
7834840|NCT00285012|27199287|P1|Received Study Tx|Adverse Event|5
7834841|NCT00285012|27199286|P2|Received Study Tx|Death|1
7834842|NCT00285012|27199287|P1|Received Study Tx|Death|2
7834843|NCT00285012|27199286|P2|Assigned to Study Treatment (Tx)|Other|3
7834844|NCT00285012|27199287|P1|Assigned to Study Treatment (Tx)|Other|2
7834845|NCT00284934|27199313|P2|Overall Study|Other reasons|1
7834846|NCT00284934|27199314|P1|Overall Study|Other reasons|3
7834847|NCT00284934|27199313|P2|Overall Study|Adverse Event|2
7834848|NCT00284934|27199314|P1|Overall Study|Adverse Event|1
7834849|NCT00284856|27199329|P3|Overall Study|Other|4
7834850|NCT00284856|27199330|P2|Overall Study|Other|5
7834851|NCT00284856|27199331|P1|Overall Study|Other|4
7834852|NCT00284856|27199329|P3|Overall Study|Withdrawal by Subject|18
7834853|NCT00284856|27199330|P2|Overall Study|Withdrawal by Subject|16
7834854|NCT00284856|27199331|P1|Overall Study|Withdrawal by Subject|12
7834855|NCT00284856|27199329|P3|Overall Study|Protocol Violation|5
7834856|NCT00284856|27199330|P2|Overall Study|Protocol Violation|4
7834857|NCT00284856|27199331|P1|Overall Study|Protocol Violation|5
7834858|NCT00284856|27199329|P3|Overall Study|Lost to Follow-up|22
7834859|NCT00284856|27199330|P2|Overall Study|Lost to Follow-up|21
7834860|NCT00284856|27199331|P1|Overall Study|Lost to Follow-up|25
7834861|NCT00284856|27199329|P3|Overall Study|Lack of Efficacy|8
7834862|NCT00284856|27199330|P2|Overall Study|Lack of Efficacy|1
7834863|NCT00284856|27199331|P1|Overall Study|Lack of Efficacy|2
7834864|NCT00284856|27199329|P3|Overall Study|Adverse Event|3
7834865|NCT00284856|27199330|P2|Overall Study|Adverse Event|3
7834866|NCT00284856|27199331|P1|Overall Study|Adverse Event|3
7834867|NCT00284141|27199430|P1|Overall Study|Ongoing treatment|2
7834868|NCT00284141|27199430|P1|Overall Study|Did not take study medication|2
7834869|NCT00284141|27199430|P1|Overall Study|Pneumonia|1
7834870|NCT00284141|27199430|P1|Overall Study|General decline|1
7834871|NCT00284141|27199430|P1|Overall Study|Clinical deterioration / death|2
7834872|NCT00284141|27199430|P1|Overall Study|Symptomatic / Clinical Progression|11
7834873|NCT00284141|27199430|P1|Overall Study|Participant's request|9
7834874|NCT00284141|27199430|P1|Overall Study|Adverse Event|19
7834875|NCT00284141|27199430|P1|Overall Study|Disease Progression / Lack of efficacy|51
7834876|NCT00284089|27199453|P4|Extension Phase|Withdrawal by Subject|3
7834877|NCT00284089|27199454|P3|Extension Phase|Withdrawal by Subject|1
7834878|NCT00284089|27199455|P2|Extension Phase|Withdrawal by Subject|0
7834879|NCT00284089|27199456|P1|Extension Phase|Withdrawal by Subject|0
7834880|NCT00284089|27199453|P4|Extension Phase|Protocol Violation|0
7834881|NCT00284089|27199454|P3|Extension Phase|Protocol Violation|1
7834882|NCT00284089|27199455|P2|Extension Phase|Protocol Violation|0
7834883|NCT00284089|27199456|P1|Extension Phase|Protocol Violation|0
7834884|NCT00284089|27199453|P4|Extension Phase|condition no longer requires study drug|7
7834885|NCT00284089|27199454|P3|Extension Phase|condition no longer requires study drug|2
7834886|NCT00284089|27199455|P2|Extension Phase|condition no longer requires study drug|0
7834887|NCT00284089|27199456|P1|Extension Phase|condition no longer requires study drug|2
7834888|NCT00284089|27199453|P4|Extension Phase|Adverse Event|2
7834889|NCT00284089|27199454|P3|Extension Phase|Adverse Event|2
7834890|NCT00284089|27199455|P2|Extension Phase|Adverse Event|0
7834891|NCT00284089|27199456|P1|Extension Phase|Adverse Event|0
7834892|NCT00284089|27199453|P4|Multiple Dose Phase|Death|1
7834893|NCT00284089|27199454|P3|Multiple Dose Phase|Death|1
7834894|NCT00284089|27199455|P2|Multiple Dose Phase|Death|0
7834895|NCT00284089|27199456|P1|Multiple Dose Phase|Death|0
7834896|NCT00284089|27199453|P4|Multiple Dose Phase|Withdrawal by Subject|2
7834897|NCT00284089|27199454|P3|Multiple Dose Phase|Withdrawal by Subject|1
7834898|NCT00284089|27199455|P2|Multiple Dose Phase|Withdrawal by Subject|0
7834899|NCT00284089|27199456|P1|Multiple Dose Phase|Withdrawal by Subject|0
7834900|NCT00284089|27199453|P4|Multiple Dose Phase|Protocol Violation|0
7834901|NCT00284089|27199454|P3|Multiple Dose Phase|Protocol Violation|1
7834902|NCT00284089|27199455|P2|Multiple Dose Phase|Protocol Violation|0
7834903|NCT00284089|27199456|P1|Multiple Dose Phase|Protocol Violation|0
7834904|NCT00284089|27199453|P4|Multiple Dose Phase|Adverse Event|1
7834905|NCT00284089|27199454|P3|Multiple Dose Phase|Adverse Event|1
7834906|NCT00284089|27199455|P2|Multiple Dose Phase|Adverse Event|0
7834907|NCT00284089|27199456|P1|Multiple Dose Phase|Adverse Event|1
7834908|NCT00284050|27199485|P3|Overall Study|Death|0
7834909|NCT00284050|27199486|P2|Overall Study|Death|0
7834910|NCT00284050|27199487|P1|Overall Study|Death|1
7834911|NCT00284050|27199485|P3|Overall Study|Lost to Follow-up|1
7834912|NCT00284050|27199486|P2|Overall Study|Lost to Follow-up|0
7834913|NCT00284050|27199487|P1|Overall Study|Lost to Follow-up|1
7834914|NCT00284050|27199485|P3|Overall Study|Withdrawal by Subject|2
7834915|NCT00284050|27199486|P2|Overall Study|Withdrawal by Subject|2
7834916|NCT00284050|27199487|P1|Overall Study|Withdrawal by Subject|2
7834917|NCT00284050|27199485|P3|Overall Study|Protocol Violation|2
7834918|NCT00284050|27199486|P2|Overall Study|Protocol Violation|1
7834919|NCT00284050|27199487|P1|Overall Study|Protocol Violation|0
7834920|NCT00284050|27199485|P3|Overall Study|Lack of Efficacy|3
7834921|NCT00284050|27199486|P2|Overall Study|Lack of Efficacy|1
7834922|NCT00284050|27199487|P1|Overall Study|Lack of Efficacy|0
7834923|NCT00284050|27199485|P3|Overall Study|Adverse Event|1
7834924|NCT00284050|27199486|P2|Overall Study|Adverse Event|1
7834925|NCT00284050|27199487|P1|Overall Study|Adverse Event|1
7834926|NCT00283959|27199501|P1|Extension Period|Low Compliance|1
7834927|NCT00283868|27199513|P2|Overall Study|Lost to Follow-up|8
7834928|NCT00283868|27199514|P1|Overall Study|Lost to Follow-up|7
7834929|NCT00283842|27199531|P5|Overall Study|Lost to Follow-up|1
7834930|NCT00283842|27199532|P4|Overall Study|Lost to Follow-up|1
7834931|NCT00283842|27199533|P3|Overall Study|Lost to Follow-up|4
7834932|NCT00283842|27199534|P2|Overall Study|Lost to Follow-up|2
7834933|NCT00283842|27199535|P1|Overall Study|Lost to Follow-up|0
7834934|NCT00283842|27199531|P5|Overall Study|Lack of Efficacy|3
7834935|NCT00283842|27199532|P4|Overall Study|Lack of Efficacy|0
7834936|NCT00283842|27199533|P3|Overall Study|Lack of Efficacy|1
7834937|NCT00283842|27199534|P2|Overall Study|Lack of Efficacy|3
7834938|NCT00283842|27199535|P1|Overall Study|Lack of Efficacy|1
7834939|NCT00283842|27199531|P5|Overall Study|Withdrawal by Subject|4
7834940|NCT00283842|27199532|P4|Overall Study|Withdrawal by Subject|5
7834941|NCT00283842|27199533|P3|Overall Study|Withdrawal by Subject|1
7834942|NCT00283842|27199534|P2|Overall Study|Withdrawal by Subject|1
7834943|NCT00283842|27199535|P1|Overall Study|Withdrawal by Subject|2
7834944|NCT00283842|27199531|P5|Overall Study|Protocol deviation|2
7834945|NCT00283842|27199532|P4|Overall Study|Protocol deviation|0
7834946|NCT00283842|27199533|P3|Overall Study|Protocol deviation|0
7834947|NCT00283842|27199534|P2|Overall Study|Protocol deviation|0
7834948|NCT00283842|27199535|P1|Overall Study|Protocol deviation|0
7834949|NCT00283842|27199531|P5|Overall Study|Protocol Violation|0
7834950|NCT00283842|27199532|P4|Overall Study|Protocol Violation|0
7834951|NCT00283842|27199533|P3|Overall Study|Protocol Violation|4
7834952|NCT00283842|27199534|P2|Overall Study|Protocol Violation|5
7834953|NCT00283842|27199535|P1|Overall Study|Protocol Violation|1
7834954|NCT00283842|27199531|P5|Overall Study|Adverse Event|5
7834955|NCT00283842|27199532|P4|Overall Study|Adverse Event|21
7834956|NCT00283842|27199533|P3|Overall Study|Adverse Event|21
7834957|NCT00283842|27199534|P2|Overall Study|Adverse Event|7
7834958|NCT00283842|27199535|P1|Overall Study|Adverse Event|8
7834959|NCT00283803|27199567|P1|Overall Study|Withdrawal by Subject|4
7834960|NCT00283803|27199567|P1|Overall Study|Physician Decision|9
7834961|NCT00283712|27199575|P2|Overall Study|Death|1
7834962|NCT00283712|27199576|P1|Overall Study|Death|0
7834963|NCT00283686|27199614|P4|Overall Study|Less than full participation|12
7834964|NCT00283686|27199615|P3|Overall Study|Less than full participation|6
7834965|NCT00283686|27199616|P2|Overall Study|Less than full participation|9
7834966|NCT00283686|27199617|P1|Overall Study|Less than full participation|7
7834967|NCT00283686|27199614|P4|Overall Study|Lost to Follow-up|20
7834968|NCT00283686|27199615|P3|Overall Study|Lost to Follow-up|26
7834969|NCT00283686|27199616|P2|Overall Study|Lost to Follow-up|31
7834970|NCT00283686|27199617|P1|Overall Study|Lost to Follow-up|21
7834971|NCT00283686|27199614|P4|Overall Study|Death|0
7834972|NCT00283686|27199615|P3|Overall Study|Death|1
7834973|NCT00283686|27199616|P2|Overall Study|Death|1
7834974|NCT00283686|27199617|P1|Overall Study|Death|1
7834975|NCT00283595|27199661|P2|Overall Study|Withdrawal by Subject|2
7834976|NCT00283595|27199662|P1|Overall Study|Withdrawal by Subject|1
7834977|NCT00283439|27199687|P4|Overall Study|Other|0
7834978|NCT00283439|27199688|P3|Overall Study|Other|0
7834979|NCT00283439|27199689|P2|Overall Study|Other|0
7834980|NCT00283439|27199690|P1|Overall Study|Other|1
7834981|NCT00283439|27199687|P4|Overall Study|Treatment discontinued|3
7834982|NCT00283439|27199688|P3|Overall Study|Treatment discontinued|1
7834983|NCT00283439|27199689|P2|Overall Study|Treatment discontinued|2
7834984|NCT00283439|27199690|P1|Overall Study|Treatment discontinued|0
7834985|NCT00283439|27199687|P4|Overall Study|Stem cell transplant|3
7834986|NCT00283439|27199688|P3|Overall Study|Stem cell transplant|4
7834987|NCT00283439|27199689|P2|Overall Study|Stem cell transplant|6
7834988|NCT00283439|27199690|P1|Overall Study|Stem cell transplant|6
7834989|NCT00283439|27199687|P4|Overall Study|Requirement for alternative therapy|2
7834990|NCT00283439|27199688|P3|Overall Study|Requirement for alternative therapy|5
7834991|NCT00283439|27199689|P2|Overall Study|Requirement for alternative therapy|2
7834992|NCT00283439|27199690|P1|Overall Study|Requirement for alternative therapy|1
7834993|NCT00283439|27199687|P4|Overall Study|Disease progression|0
7834994|NCT00283439|27199688|P3|Overall Study|Disease progression|0
7834995|NCT00283439|27199689|P2|Overall Study|Disease progression|1
7834996|NCT00283439|27199690|P1|Overall Study|Disease progression|0
7834997|NCT00283439|27199687|P4|Overall Study|Death|0
7834998|NCT00283439|27199688|P3|Overall Study|Death|1
7834999|NCT00283439|27199689|P2|Overall Study|Death|0
7835000|NCT00283439|27199690|P1|Overall Study|Death|0
7835001|NCT00283439|27199687|P4|Overall Study|Adverse Event|1
7835002|NCT00283439|27199688|P3|Overall Study|Adverse Event|0
7835003|NCT00283439|27199689|P2|Overall Study|Adverse Event|0
7835004|NCT00283439|27199690|P1|Overall Study|Adverse Event|0
7835005|NCT00283400|27199716|P4|Overall Study|Death|0
7835006|NCT00283400|27199717|P3|Overall Study|Death|1
7835007|NCT00283400|27199718|P2|Overall Study|Death|0
7835008|NCT00283400|27199719|P1|Overall Study|Death|1
7835009|NCT00283400|27199716|P4|Overall Study|Withdrawal by Subject|0
7835010|NCT00283400|27199717|P3|Overall Study|Withdrawal by Subject|0
7835011|NCT00283400|27199718|P2|Overall Study|Withdrawal by Subject|1
7835012|NCT00283400|27199719|P1|Overall Study|Withdrawal by Subject|1
7835013|NCT00283387|27199737|P2|First Intervention|Withdrawal by Subject|1
7835014|NCT00283387|27199738|P1|First Intervention|Withdrawal by Subject|0
7835015|NCT00283387|27199737|P2|First Intervention|Subject non-compliant|1
7835016|NCT00283387|27199738|P1|First Intervention|Subject non-compliant|1
7835017|NCT00283296|27199744|P1|Overall Study|in-home trial not completed|5
7835018|NCT00283244|27199775|P3|Overall Study|Clinical deterioration|3
7835019|NCT00283244|27199776|P2|Overall Study|Clinical deterioration|3
7835020|NCT00283244|27199777|P1|Overall Study|Clinical deterioration|1
7835021|NCT00283244|27199775|P3|Overall Study|Medical illness (other complicating dz)|6
7835022|NCT00283244|27199776|P2|Overall Study|Medical illness (other complicating dz)|3
7835023|NCT00283244|27199777|P1|Overall Study|Medical illness (other complicating dz)|4
7835024|NCT00283244|27199775|P3|Overall Study|Physician Decision|1
7835025|NCT00283244|27199776|P2|Overall Study|Physician Decision|0
7835026|NCT00283244|27199777|P1|Overall Study|Physician Decision|0
7835027|NCT00283244|27199775|P3|Overall Study|Withdrawal by Subject|2
7835028|NCT00283244|27199776|P2|Overall Study|Withdrawal by Subject|2
7835029|NCT00283244|27199777|P1|Overall Study|Withdrawal by Subject|1
7835030|NCT00283244|27199775|P3|Overall Study|Lack of Efficacy|26
7835031|NCT00283244|27199776|P2|Overall Study|Lack of Efficacy|32
7835032|NCT00283244|27199777|P1|Overall Study|Lack of Efficacy|8
7835033|NCT00283244|27199775|P3|Overall Study|Death|2
7835034|NCT00283244|27199776|P2|Overall Study|Death|3
7835035|NCT00283244|27199777|P1|Overall Study|Death|4
7835036|NCT00283244|27199775|P3|Overall Study|Adverse Event|11
7835037|NCT00283244|27199776|P2|Overall Study|Adverse Event|8
7835038|NCT00283244|27199777|P1|Overall Study|Adverse Event|0
7835039|NCT00283062|27199813|P4|Overall Study|chemotherapy not completed (cycle 6)|0
7835040|NCT00283062|27199814|P3|Overall Study|chemotherapy not completed (cycle 6)|0
7835041|NCT00283062|27199815|P2|Overall Study|chemotherapy not completed (cycle 6)|0
7835042|NCT00283062|27199816|P1|Overall Study|chemotherapy not completed (cycle 6)|1
7835043|NCT00283062|27199813|P4|Overall Study|Undefined|4
7835044|NCT00283062|27199814|P3|Overall Study|Undefined|1
7835045|NCT00283062|27199815|P2|Overall Study|Undefined|1
7835046|NCT00283062|27199816|P1|Overall Study|Undefined|0
7835047|NCT00283062|27199813|P4|Overall Study|Participant did not wish to continue|0
7835048|NCT00283062|27199814|P3|Overall Study|Participant did not wish to continue|1
7835049|NCT00283062|27199815|P2|Overall Study|Participant did not wish to continue|2
7835050|NCT00283062|27199816|P1|Overall Study|Participant did not wish to continue|3
7835051|NCT00283062|27199813|P4|Overall Study|Progressive disease|0
7835052|NCT00283062|27199814|P3|Overall Study|Progressive disease|1
7835053|NCT00283062|27199815|P2|Overall Study|Progressive disease|0
7835054|NCT00283062|27199816|P1|Overall Study|Progressive disease|0
7835055|NCT00283062|27199813|P4|Overall Study|Lost to Follow-up|0
7835056|NCT00283062|27199814|P3|Overall Study|Lost to Follow-up|1
7835057|NCT00283062|27199815|P2|Overall Study|Lost to Follow-up|0
7835058|NCT00283062|27199816|P1|Overall Study|Lost to Follow-up|1
7835059|NCT00283062|27199813|P4|Overall Study|Adverse Event|0
7835060|NCT00283062|27199814|P3|Overall Study|Adverse Event|1
7835061|NCT00283062|27199815|P2|Overall Study|Adverse Event|0
7835062|NCT00283062|27199816|P1|Overall Study|Adverse Event|2
7835063|NCT00283062|27199813|P4|Overall Study|Did not receive any study medication|45
7835064|NCT00283062|27199814|P3|Overall Study|Did not receive any study medication|36
7835065|NCT00283062|27199815|P2|Overall Study|Did not receive any study medication|4
7835066|NCT00283062|27199816|P1|Overall Study|Did not receive any study medication|5
7835067|NCT00283049|27199849|P3|Overall Study|No longer requires study treatment|1
7835068|NCT00283049|27199850|P2|Overall Study|No longer requires study treatment|0
7835069|NCT00283049|27199851|P1|Overall Study|No longer requires study treatment|0
7835070|NCT00283049|27199849|P3|Overall Study|Discontinuation of Study|20
7835071|NCT00283049|27199850|P2|Overall Study|Discontinuation of Study|16
7835072|NCT00283049|27199851|P1|Overall Study|Discontinuation of Study|18
7835073|NCT00283049|27199849|P3|Overall Study|Withdrawal by Subject|19
7835074|NCT00283049|27199850|P2|Overall Study|Withdrawal by Subject|24
7835075|NCT00283049|27199851|P1|Overall Study|Withdrawal by Subject|26
7835076|NCT00283049|27199849|P3|Overall Study|Lost to Follow-up|5
7835077|NCT00283049|27199850|P2|Overall Study|Lost to Follow-up|2
7835078|NCT00283049|27199851|P1|Overall Study|Lost to Follow-up|4
7835079|NCT00283049|27199849|P3|Overall Study|Lack of Efficacy|1
7835080|NCT00283049|27199850|P2|Overall Study|Lack of Efficacy|1
7835081|NCT00283049|27199851|P1|Overall Study|Lack of Efficacy|0
7835082|NCT00283049|27199849|P3|Overall Study|Death|1
7835083|NCT00283049|27199850|P2|Overall Study|Death|1
7835084|NCT00283049|27199851|P1|Overall Study|Death|1
7835085|NCT00283049|27199849|P3|Overall Study|Protocol Violation|3
7835086|NCT00283049|27199850|P2|Overall Study|Protocol Violation|0
7835087|NCT00283049|27199851|P1|Overall Study|Protocol Violation|3
7835088|NCT00283049|27199849|P3|Overall Study|Adverse Event|4
7835089|NCT00283049|27199850|P2|Overall Study|Adverse Event|1
7835090|NCT00283049|27199851|P1|Overall Study|Adverse Event|6
7835091|NCT00282984|27199879|P2|Overall Study|Protocol Violation|0
7835092|NCT00282984|27199880|P1|Overall Study|Protocol Violation|2
7835093|NCT00282984|27199879|P2|Overall Study|in prison|1
7835094|NCT00282984|27199880|P1|Overall Study|in prison|0
7835095|NCT00282984|27199879|P2|Overall Study|lack of motivation|0
7835096|NCT00282984|27199880|P1|Overall Study|lack of motivation|1
7835097|NCT00282984|27199879|P2|Overall Study|Participant used antipsychosis meds|1
7835098|NCT00282984|27199880|P1|Overall Study|Participant used antipsychosis meds|0
7835099|NCT00282984|27199879|P2|Overall Study|Participant only allowed phone follow-up|1
7835100|NCT00282984|27199880|P1|Overall Study|Participant only allowed phone follow-up|0
7835101|NCT00282984|27199879|P2|Overall Study|Participant stopped study medication|2
7835102|NCT00282984|27199880|P1|Overall Study|Participant stopped study medication|2
7835103|NCT00282984|27199879|P2|Overall Study|Withdrawal by Participant|34
7835104|NCT00282984|27199880|P1|Overall Study|Withdrawal by Participant|22
7835105|NCT00282984|27199879|P2|Overall Study|Lost to Follow-up|10
7835106|NCT00282984|27199880|P1|Overall Study|Lost to Follow-up|14
7835107|NCT00282984|27199879|P2|Overall Study|Lack of Efficacy|2
7835108|NCT00282984|27199880|P1|Overall Study|Lack of Efficacy|0
7835109|NCT00282984|27199879|P2|Overall Study|Adverse Event|5
7835110|NCT00282984|27199880|P1|Overall Study|Adverse Event|8
7835111|NCT00282984|27199879|P2|Overall Study|Death|5
7835112|NCT00282984|27199880|P1|Overall Study|Death|2
7835113|NCT00282919|27199917|P1|Overall Study|Asymptomatic Parasitemia|2
7835114|NCT00282919|27199917|P1|Overall Study|Withdrawal by Subject|1
7835115|NCT00282919|27199917|P1|Overall Study|Lack of Efficacy|4
7835116|NCT00282867|27199932|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
7835117|NCT00282867|27199933|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
7835118|NCT00282867|27199934|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
7835119|NCT00282568|27200036|P1|Extended Treatment Period|Lost to Follow-up|2
7835120|NCT00282568|27200036|P1|Extended Treatment Period|Physician Decision|1
7835121|NCT00282568|27200036|P1|Extended Treatment Period|Non-compliance|4
7835122|NCT00282568|27200036|P1|Extended Treatment Period|Adverse Event|17
7835123|NCT00282568|27200036|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
7835124|NCT00282568|27200036|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
7835125|NCT00282464|27200062|P2|Overall Study|dropped due to missed visits|1
7835126|NCT00282464|27200063|P1|Overall Study|dropped due to missed visits|0
7835127|NCT00282464|27200062|P2|Overall Study|dispensed wrong kit|1
7835128|NCT00282464|27200063|P1|Overall Study|dispensed wrong kit|0
7835129|NCT00282464|27200062|P2|Overall Study|family crisis|1
7835130|NCT00282464|27200063|P1|Overall Study|family crisis|0
7835131|NCT00282464|27200062|P2|Overall Study|patient incarcerated|1
7835132|NCT00282464|27200063|P1|Overall Study|patient incarcerated|0
7835133|NCT00282464|27200062|P2|Overall Study|patient no show|1
7835134|NCT00282464|27200063|P1|Overall Study|patient no show|0
7835135|NCT00282464|27200062|P2|Overall Study|patient non-compliant|0
7835136|NCT00282464|27200063|P1|Overall Study|patient non-compliant|3
7835137|NCT00282464|27200062|P2|Overall Study|Patient moved|0
7835138|NCT00282464|27200063|P1|Overall Study|Patient moved|1
7835139|NCT00282464|27200062|P2|Overall Study|Protocol Violation|7
7835140|NCT00282464|27200063|P1|Overall Study|Protocol Violation|0
7835141|NCT00282464|27200062|P2|Overall Study|laboratory abnormality|2
7835142|NCT00282464|27200063|P1|Overall Study|laboratory abnormality|1
7835143|NCT00282464|27200062|P2|Overall Study|Withdrawal by Subject|10
7835144|NCT00282464|27200063|P1|Overall Study|Withdrawal by Subject|24
7835145|NCT00282464|27200062|P2|Overall Study|Lost to Follow-up|10
7835146|NCT00282464|27200063|P1|Overall Study|Lost to Follow-up|10
7835147|NCT00282464|27200062|P2|Overall Study|Lack of Efficacy|8
7835148|NCT00282464|27200063|P1|Overall Study|Lack of Efficacy|8
7835149|NCT00282464|27200062|P2|Overall Study|Adverse Event|20
7835150|NCT00282464|27200063|P1|Overall Study|Adverse Event|26
7835151|NCT00282438|27200113|P2|Overall Study|Death|1
7835152|NCT00282438|27200114|P1|Overall Study|Death|0
7835153|NCT00282438|27200113|P2|Overall Study|Lack of Efficacy|0
7835154|NCT00282438|27200114|P1|Overall Study|Lack of Efficacy|1
7835155|NCT00282412|27200124|P1|Overall Study|Death|2
7835156|NCT00282347|27200130|P2|B Cell Follow-up Period|Reason Not Specified|0
7835157|NCT00282347|27200131|P1|B Cell Follow-up Period|Reason Not Specified|2
7835158|NCT00282347|27200130|P2|B Cell Follow-up Period|Physician Decision|0
7835159|NCT00282347|27200131|P1|B Cell Follow-up Period|Physician Decision|1
7835160|NCT00282347|27200130|P2|B Cell Follow-up Period|Withdrawal by Subject|0
7835161|NCT00282347|27200131|P1|B Cell Follow-up Period|Withdrawal by Subject|2
7835162|NCT00282347|27200130|P2|Safety Follow-up Period|Protocol Deviation|2
7835163|NCT00282347|27200131|P1|Safety Follow-up Period|Protocol Deviation|0
7835164|NCT00282347|27200130|P2|Safety Follow-up Period|Physician Decision|1
7835165|NCT00282347|27200131|P1|Safety Follow-up Period|Physician Decision|1
7835166|NCT00282347|27200130|P2|Safety Follow-up Period|Withdrawal by Subject|1
7835167|NCT00282347|27200131|P1|Safety Follow-up Period|Withdrawal by Subject|2
7835168|NCT00282347|27200130|P2|Safety Follow-up Period|Lost to Follow-up|2
7835169|NCT00282347|27200131|P1|Safety Follow-up Period|Lost to Follow-up|0
7835170|NCT00282347|27200130|P2|Treatment Period|Physician Decision|1
7835171|NCT00282347|27200131|P1|Treatment Period|Physician Decision|0
7835172|NCT00282347|27200130|P2|Treatment Period|Withdrawal by Subject|3
7835173|NCT00282347|27200131|P1|Treatment Period|Withdrawal by Subject|1
7835174|NCT00282347|27200130|P2|Treatment Period|Lost to Follow-up|5
7835175|NCT00282347|27200131|P1|Treatment Period|Lost to Follow-up|2
7835176|NCT00282347|27200130|P2|Treatment Period|Death|0
7835177|NCT00282347|27200131|P1|Treatment Period|Death|2
7835178|NCT00282334|27200157|P2|Overall Study|Withdrawal by Subject|5
7835179|NCT00282334|27200158|P1|Overall Study|Withdrawal by Subject|8
7835180|NCT00282308|27200166|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
7835181|NCT00282308|27200167|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
7835182|NCT00282308|27200168|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
7835183|NCT00282308|27200166|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
7835184|NCT00282308|27200167|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
7835185|NCT00282308|27200168|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
7835186|NCT00282308|27200166|P3|Safety Follow-up Period|Lost to Follow-up|5
7835187|NCT00282308|27200167|P2|Safety Follow-up Period|Lost to Follow-up|0
7835188|NCT00282308|27200168|P1|Safety Follow-up Period|Lost to Follow-up|0
7835189|NCT00282308|27200166|P3|Safety Follow-up Period|Adverse Event|1
7835190|NCT00282308|27200167|P2|Safety Follow-up Period|Adverse Event|0
7835191|NCT00282308|27200168|P1|Safety Follow-up Period|Adverse Event|0
7835192|NCT00282308|27200166|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
7835193|NCT00282308|27200167|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7835194|NCT00282308|27200168|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7835195|NCT00282308|27200166|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
7835196|NCT00282308|27200167|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
7835197|NCT00282308|27200168|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
7835198|NCT00282308|27200166|P3|Optional Extension Re-treatment Period|Adverse Event|4
7835199|NCT00282308|27200167|P2|Optional Extension Re-treatment Period|Adverse Event|0
7835200|NCT00282308|27200168|P1|Optional Extension Re-treatment Period|Adverse Event|0
7835201|NCT00282308|27200166|P3|Treatment Period|Not Treated with Study Drug|0
7835202|NCT00282308|27200167|P2|Treatment Period|Not Treated with Study Drug|0
7835203|NCT00282308|27200168|P1|Treatment Period|Not Treated with Study Drug|1
7835204|NCT00282308|27200166|P3|Treatment Period|Adverse Event|0
7835205|NCT00282308|27200167|P2|Treatment Period|Adverse Event|2
7835206|NCT00282308|27200168|P1|Treatment Period|Adverse Event|0
7835207|NCT00282308|27200166|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
7835208|NCT00282308|27200167|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
7835209|NCT00282308|27200168|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
7835210|NCT00282308|27200166|P3|Treatment Period|Lost to Follow-up|0
7835211|NCT00282308|27200167|P2|Treatment Period|Lost to Follow-up|0
7835212|NCT00282308|27200168|P1|Treatment Period|Lost to Follow-up|1
7835213|NCT00282295|27200198|P3|Overall Study|Other|0
7835214|NCT00282295|27200199|P2|Overall Study|Other|1
7835215|NCT00282295|27200200|P1|Overall Study|Other|0
7835216|NCT00282295|27200198|P3|Overall Study|Lost to Follow-up|2
7835217|NCT00282295|27200199|P2|Overall Study|Lost to Follow-up|7
7835218|NCT00282295|27200200|P1|Overall Study|Lost to Follow-up|1
7835219|NCT00282295|27200198|P3|Overall Study|Withdrawal by Subject|4
7835220|NCT00282295|27200199|P2|Overall Study|Withdrawal by Subject|6
7835221|NCT00282295|27200200|P1|Overall Study|Withdrawal by Subject|2
7835222|NCT00282295|27200198|P3|Overall Study|Protocol Violation|1
7835223|NCT00282295|27200199|P2|Overall Study|Protocol Violation|2
7835224|NCT00282295|27200200|P1|Overall Study|Protocol Violation|0
7835225|NCT00282295|27200198|P3|Overall Study|Serious Adverse Events|1
7835226|NCT00282295|27200199|P2|Overall Study|Serious Adverse Events|0
7835227|NCT00282295|27200200|P1|Overall Study|Serious Adverse Events|0
7835228|NCT00282295|27200198|P3|Overall Study|Adverse Event|0
7835229|NCT00282295|27200199|P2|Overall Study|Adverse Event|1
7835230|NCT00282295|27200200|P1|Overall Study|Adverse Event|0
7835231|NCT00282256|27200255|P1|Extension Treatment Period|Adverse Event|2
7835232|NCT00282256|27200255|P1|Pharmacokinetic Treatment Period|Poor venous access|1
7835233|NCT00282243|27200276|P1|Extension Treatment Period|Physician Decision|1
7835234|NCT00282243|27200276|P1|Extension Treatment Period|Non-compliance|2
7835235|NCT00282243|27200276|P1|Extension Treatment Period|Withdrawal by Subject|4
7835236|NCT00282243|27200276|P1|Extension Treatment Period|Adverse Event|15
7835237|NCT00282243|27200276|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
7835238|NCT00282243|27200276|P1|Pharmacokinetic Treatment Period|Adverse Event|3
7835239|NCT00282152|27200302|P2|Overall Study|Withdrawal by Subject|0
7835240|NCT00282152|27200303|P1|Overall Study|Withdrawal by Subject|1
7835241|NCT00282113|27200324|P3|Overall Study|Removed at parents request|0
7835242|NCT00282113|27200325|P2|Overall Study|Removed at parents request|0
7835243|NCT00282113|27200326|P1|Overall Study|Removed at parents request|1
7835244|NCT00282087|27200340|P1|Overall Study|Death|1
7835245|NCT00282048|27200353|P1|Overall Study|Ongoing|1
7835246|NCT00282048|27200353|P1|Overall Study|Other|8
7835247|NCT00282048|27200353|P1|Overall Study|Withdrawal by Subject|1
7835248|NCT00282048|27200353|P1|Overall Study|Adverse Event|22
7835249|NCT00282048|27200353|P1|Overall Study|Lack of Efficacy|30
7835250|NCT00281957|27200367|P2|Overall Study|Refusal unrelated to adverse events|1
7835251|NCT00281957|27200368|P1|Overall Study|Refusal unrelated to adverse events|0
7835252|NCT00281957|27200367|P2|Overall Study|Did not start treatment|1
7835253|NCT00281957|27200368|P1|Overall Study|Did not start treatment|3
7835254|NCT00281957|27200367|P2|Overall Study|Not eligible|2
7835255|NCT00281957|27200368|P1|Overall Study|Not eligible|1
7835256|NCT00281957|27200367|P2|Overall Study|Not protocol specified|1
7835257|NCT00281957|27200368|P1|Overall Study|Not protocol specified|8
7835258|NCT00281957|27200367|P2|Overall Study|Progression/relapse|35
7835259|NCT00281957|27200368|P1|Overall Study|Progression/relapse|47
7835260|NCT00281957|27200367|P2|Overall Study|Death|0
7835261|NCT00281957|27200368|P1|Overall Study|Death|1
7835262|NCT00281957|27200367|P2|Overall Study|Adverse Event|2
7835263|NCT00281957|27200368|P1|Overall Study|Adverse Event|7
7835264|NCT00281840|27200442|P1|Overall Study|Complicating Disease|1
7835265|NCT00281840|27200442|P1|Overall Study|exceed maximum delay in treatment|1
7835266|NCT00281840|27200442|P1|Overall Study|Disease Progression|2
7835267|NCT00281840|27200442|P1|Overall Study|Withdrawal by Subject|3
7835268|NCT00281840|27200442|P1|Overall Study|Physician Decision|6
7835269|NCT00281840|27200442|P1|Overall Study|Adverse Event|12
7835270|NCT00281697|27200458|P2|Overall Study|Did not receive study drug|2
7835271|NCT00281697|27200459|P1|Overall Study|Did not receive study drug|3
7835272|NCT00281697|27200458|P2|Overall Study|Subject/guardian's decision to withdraw|6
7835273|NCT00281697|27200459|P1|Overall Study|Subject/guardian's decision to withdraw|33
7835274|NCT00281697|27200458|P2|Overall Study|Physician's decision to withdraw|12
7835275|NCT00281697|27200459|P1|Overall Study|Physician's decision to withdraw|15
7835276|NCT00281697|27200458|P2|Overall Study|Other|6
7835277|NCT00281697|27200459|P1|Overall Study|Other|5
7835278|NCT00281697|27200458|P2|Overall Study|Disease progression|149
7835279|NCT00281697|27200459|P1|Overall Study|Disease progression|279
7835280|NCT00281697|27200458|P2|Overall Study|Death|3
7835281|NCT00281697|27200459|P1|Overall Study|Death|8
7835282|NCT00281697|27200458|P2|Overall Study|Adverse Event|15
7835283|NCT00281697|27200459|P1|Overall Study|Adverse Event|54
7835284|NCT00281697|27200458|P2|Overall Study|> 60 days since last dose of study drug|4
7835285|NCT00281697|27200459|P1|Overall Study|> 60 days since last dose of study drug|4
7835286|NCT00281684|27200479|P4|Overall Study|Withdrawal by Subject|0
7835287|NCT00281684|27200480|P3|Overall Study|Withdrawal by Subject|0
7835288|NCT00281684|27200481|P2|Overall Study|Withdrawal by Subject|0
7835289|NCT00281684|27200482|P1|Overall Study|Withdrawal by Subject|1
7835290|NCT00281684|27200479|P4|Overall Study|Lost to Follow-up|0
7835291|NCT00281684|27200480|P3|Overall Study|Lost to Follow-up|1
7835292|NCT00281684|27200481|P2|Overall Study|Lost to Follow-up|0
7835293|NCT00281684|27200482|P1|Overall Study|Lost to Follow-up|0
7835294|NCT00281658|27200569|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
7835295|NCT00281658|27200570|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
7835296|NCT00281658|27200571|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
7835297|NCT00281658|27200569|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
7835298|NCT00281658|27200570|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
7835299|NCT00281658|27200571|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
7835300|NCT00281658|27200569|P3|Open-label Monotherapy Extension Phase|Death|97
7835301|NCT00281658|27200570|P2|Open-label Monotherapy Extension Phase|Death|0
7835302|NCT00281658|27200571|P1|Open-label Monotherapy Extension Phase|Death|0
7835303|NCT00281658|27200569|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
7835304|NCT00281658|27200570|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
7835305|NCT00281658|27200571|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
7835306|NCT00281658|27200569|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
7835307|NCT00281658|27200570|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
7835308|NCT00281658|27200571|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
7835309|NCT00281658|27200569|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
7835310|NCT00281658|27200570|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
7835311|NCT00281658|27200571|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
7835312|NCT00281658|27200569|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
7835313|NCT00281658|27200570|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
7835314|NCT00281658|27200571|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
7835315|NCT00281658|27200569|P3|Double-blind, Randomized Phase|Death|0
7835316|NCT00281658|27200570|P2|Double-blind, Randomized Phase|Death|46
7835317|NCT00281658|27200571|P1|Double-blind, Randomized Phase|Death|120
7835318|NCT00281632|27200588|P1|Overall Study|Ongoing|3
7835319|NCT00281632|27200588|P1|Overall Study|Physician Decision|1
7835320|NCT00281632|27200588|P1|Overall Study|Death|1
7835321|NCT00281632|27200588|P1|Overall Study|Disease Progression|22
7835322|NCT00281632|27200588|P1|Overall Study|Withdrawal by Subject|2
7835323|NCT00281632|27200588|P1|Overall Study|Adverse Event|7
7835324|NCT00281580|27200630|P16|Overall Study|Randomised in error; pregnancy; moving|2
7835325|NCT00281580|27200631|P15|Overall Study|Randomised in error; pregnancy; moving|1
7835326|NCT00281580|27200632|P14|Overall Study|Randomised in error; pregnancy; moving|0
7835414|NCT00281580|27200640|P6|Overall Study|Adverse Event|0
7835327|NCT00281580|27200633|P13|Overall Study|Randomised in error; pregnancy; moving|2
7835328|NCT00281580|27200634|P12|Overall Study|Randomised in error; pregnancy; moving|1
7835329|NCT00281580|27200635|P11|Overall Study|Randomised in error; pregnancy; moving|1
7835330|NCT00281580|27200636|P10|Overall Study|Randomised in error; pregnancy; moving|1
7835331|NCT00281580|27200637|P9|Overall Study|Randomised in error; pregnancy; moving|2
7835332|NCT00281580|27200638|P8|Overall Study|Randomised in error; pregnancy; moving|0
7835333|NCT00281580|27200639|P7|Overall Study|Randomised in error; pregnancy; moving|1
7835334|NCT00281580|27200640|P6|Overall Study|Randomised in error; pregnancy; moving|0
7835335|NCT00281580|27200641|P5|Overall Study|Randomised in error; pregnancy; moving|0
7835336|NCT00281580|27200642|P4|Overall Study|Randomised in error; pregnancy; moving|2
7835337|NCT00281580|27200643|P3|Overall Study|Randomised in error; pregnancy; moving|0
7835338|NCT00281580|27200644|P2|Overall Study|Randomised in error; pregnancy; moving|0
7835339|NCT00281580|27200645|P1|Overall Study|Randomised in error; pregnancy; moving|0
7835340|NCT00281580|27200630|P16|Overall Study|Lost to Follow-up|0
7835341|NCT00281580|27200631|P15|Overall Study|Lost to Follow-up|0
7835342|NCT00281580|27200632|P14|Overall Study|Lost to Follow-up|0
7835343|NCT00281580|27200633|P13|Overall Study|Lost to Follow-up|1
7835344|NCT00281580|27200634|P12|Overall Study|Lost to Follow-up|0
7835345|NCT00281580|27200635|P11|Overall Study|Lost to Follow-up|1
7835346|NCT00281580|27200636|P10|Overall Study|Lost to Follow-up|1
7835347|NCT00281580|27200637|P9|Overall Study|Lost to Follow-up|2
7835348|NCT00281580|27200638|P8|Overall Study|Lost to Follow-up|1
7835349|NCT00281580|27200639|P7|Overall Study|Lost to Follow-up|0
7835350|NCT00281580|27200640|P6|Overall Study|Lost to Follow-up|1
7835351|NCT00281580|27200641|P5|Overall Study|Lost to Follow-up|0
7835352|NCT00281580|27200642|P4|Overall Study|Lost to Follow-up|3
7835353|NCT00281580|27200643|P3|Overall Study|Lost to Follow-up|0
7835354|NCT00281580|27200644|P2|Overall Study|Lost to Follow-up|0
7835355|NCT00281580|27200645|P1|Overall Study|Lost to Follow-up|0
7835356|NCT00281580|27200630|P16|Overall Study|Lack of Efficacy|0
7835357|NCT00281580|27200631|P15|Overall Study|Lack of Efficacy|1
7835358|NCT00281580|27200632|P14|Overall Study|Lack of Efficacy|2
7835359|NCT00281580|27200633|P13|Overall Study|Lack of Efficacy|0
7835360|NCT00281580|27200634|P12|Overall Study|Lack of Efficacy|1
7835361|NCT00281580|27200635|P11|Overall Study|Lack of Efficacy|0
7835362|NCT00281580|27200636|P10|Overall Study|Lack of Efficacy|0
7835363|NCT00281580|27200637|P9|Overall Study|Lack of Efficacy|0
7835364|NCT00281580|27200638|P8|Overall Study|Lack of Efficacy|0
7835365|NCT00281580|27200639|P7|Overall Study|Lack of Efficacy|0
7835366|NCT00281580|27200640|P6|Overall Study|Lack of Efficacy|0
7835367|NCT00281580|27200641|P5|Overall Study|Lack of Efficacy|2
7835368|NCT00281580|27200642|P4|Overall Study|Lack of Efficacy|6
7835369|NCT00281580|27200643|P3|Overall Study|Lack of Efficacy|1
7835370|NCT00281580|27200644|P2|Overall Study|Lack of Efficacy|1
7835371|NCT00281580|27200645|P1|Overall Study|Lack of Efficacy|2
7835372|NCT00281580|27200630|P16|Overall Study|Withdrawal by Subject|5
7835373|NCT00281580|27200631|P15|Overall Study|Withdrawal by Subject|1
7835374|NCT00281580|27200632|P14|Overall Study|Withdrawal by Subject|2
7835375|NCT00281580|27200633|P13|Overall Study|Withdrawal by Subject|2
7835376|NCT00281580|27200634|P12|Overall Study|Withdrawal by Subject|1
7835377|NCT00281580|27200635|P11|Overall Study|Withdrawal by Subject|1
7835378|NCT00281580|27200636|P10|Overall Study|Withdrawal by Subject|4
7835379|NCT00281580|27200637|P9|Overall Study|Withdrawal by Subject|1
7835380|NCT00281580|27200638|P8|Overall Study|Withdrawal by Subject|0
7835381|NCT00281580|27200639|P7|Overall Study|Withdrawal by Subject|2
7835382|NCT00281580|27200640|P6|Overall Study|Withdrawal by Subject|2
7835383|NCT00281580|27200641|P5|Overall Study|Withdrawal by Subject|1
7835384|NCT00281580|27200642|P4|Overall Study|Withdrawal by Subject|1
7835385|NCT00281580|27200643|P3|Overall Study|Withdrawal by Subject|1
7835386|NCT00281580|27200644|P2|Overall Study|Withdrawal by Subject|0
7835387|NCT00281580|27200645|P1|Overall Study|Withdrawal by Subject|3
7835388|NCT00281580|27200630|P16|Overall Study|Protocol Violation|3
7835389|NCT00281580|27200631|P15|Overall Study|Protocol Violation|1
7835390|NCT00281580|27200632|P14|Overall Study|Protocol Violation|1
7835391|NCT00281580|27200633|P13|Overall Study|Protocol Violation|0
7835392|NCT00281580|27200634|P12|Overall Study|Protocol Violation|2
7835393|NCT00281580|27200635|P11|Overall Study|Protocol Violation|1
7835394|NCT00281580|27200636|P10|Overall Study|Protocol Violation|0
7835395|NCT00281580|27200637|P9|Overall Study|Protocol Violation|2
7835396|NCT00281580|27200638|P8|Overall Study|Protocol Violation|0
7835397|NCT00281580|27200639|P7|Overall Study|Protocol Violation|1
7835398|NCT00281580|27200640|P6|Overall Study|Protocol Violation|0
7835399|NCT00281580|27200641|P5|Overall Study|Protocol Violation|0
7835400|NCT00281580|27200642|P4|Overall Study|Protocol Violation|1
7835401|NCT00281580|27200643|P3|Overall Study|Protocol Violation|1
7835402|NCT00281580|27200644|P2|Overall Study|Protocol Violation|0
7835403|NCT00281580|27200645|P1|Overall Study|Protocol Violation|0
7835404|NCT00281580|27200630|P16|Overall Study|Adverse Event|3
7835405|NCT00281580|27200631|P15|Overall Study|Adverse Event|3
7835406|NCT00281580|27200632|P14|Overall Study|Adverse Event|2
7835407|NCT00281580|27200633|P13|Overall Study|Adverse Event|8
7835408|NCT00281580|27200634|P12|Overall Study|Adverse Event|5
7835409|NCT00281580|27200635|P11|Overall Study|Adverse Event|0
7835410|NCT00281580|27200636|P10|Overall Study|Adverse Event|6
7835411|NCT00281580|27200637|P9|Overall Study|Adverse Event|1
7835412|NCT00281580|27200638|P8|Overall Study|Adverse Event|0
7835413|NCT00281580|27200639|P7|Overall Study|Adverse Event|1
7835415|NCT00281580|27200641|P5|Overall Study|Adverse Event|1
7835416|NCT00281580|27200642|P4|Overall Study|Adverse Event|4
7835417|NCT00281580|27200643|P3|Overall Study|Adverse Event|2
7835418|NCT00281580|27200644|P2|Overall Study|Adverse Event|0
7835419|NCT00281580|27200645|P1|Overall Study|Adverse Event|2
7835420|NCT00281528|27200992|P3|Overall Study|Other|5
7835421|NCT00281528|27200993|P2|Overall Study|Other|3
7835422|NCT00281528|27200994|P1|Overall Study|Other|6
7835423|NCT00281528|27200992|P3|Overall Study|Withdrawal by Subject|7
7835424|NCT00281528|27200993|P2|Overall Study|Withdrawal by Subject|5
7835425|NCT00281528|27200994|P1|Overall Study|Withdrawal by Subject|5
7835426|NCT00281528|27200992|P3|Overall Study|Protocol Violation|1
7835427|NCT00281528|27200993|P2|Overall Study|Protocol Violation|0
7835428|NCT00281528|27200994|P1|Overall Study|Protocol Violation|1
7835429|NCT00281528|27200992|P3|Overall Study|Physician Decision|5
7835430|NCT00281528|27200993|P2|Overall Study|Physician Decision|4
7835431|NCT00281528|27200994|P1|Overall Study|Physician Decision|11
7835432|NCT00281528|27200992|P3|Overall Study|Adverse Event-unrelated to treatment|2
7835433|NCT00281528|27200993|P2|Overall Study|Adverse Event-unrelated to treatment|0
7835434|NCT00281528|27200994|P1|Overall Study|Adverse Event-unrelated to treatment|3
7835435|NCT00281528|27200992|P3|Overall Study|Unacceptable Toxicity-related to trt|32
7835436|NCT00281528|27200993|P2|Overall Study|Unacceptable Toxicity-related to trt|24
7835437|NCT00281528|27200994|P1|Overall Study|Unacceptable Toxicity-related to trt|21
7835438|NCT00281528|27200992|P3|Overall Study|Progressive Disease|27
7835439|NCT00281528|27200993|P2|Overall Study|Progressive Disease|18
7835440|NCT00281528|27200994|P1|Overall Study|Progressive Disease|28
7835441|NCT00281320|27201045|P2|Overall Study|Other|1
7835442|NCT00281320|27201046|P1|Overall Study|Other|3
7835443|NCT00281320|27201045|P2|Overall Study|Lost to Follow-up|2
7835444|NCT00281320|27201046|P1|Overall Study|Lost to Follow-up|1
7835445|NCT00281320|27201045|P2|Overall Study|Withdrawal by Subject|6
7835446|NCT00281320|27201046|P1|Overall Study|Withdrawal by Subject|5
7835447|NCT00281320|27201045|P2|Overall Study|Lack of Efficacy|3
7835448|NCT00281320|27201046|P1|Overall Study|Lack of Efficacy|4
7835449|NCT00281320|27201045|P2|Overall Study|Adverse Event|9
7835450|NCT00281320|27201046|P1|Overall Study|Adverse Event|12
7835451|NCT00281099|27201068|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
7835452|NCT00281099|27201069|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
7835453|NCT00281099|27201068|P2|Overall Study|Physician Decision|72
7835454|NCT00281099|27201069|P1|Overall Study|Physician Decision|79
7835455|NCT00281099|27201068|P2|Overall Study|Withdrawal by Subject|70
7835456|NCT00281099|27201069|P1|Overall Study|Withdrawal by Subject|65
7835457|NCT00281099|27201068|P2|Overall Study|Lost to Follow-up|19
7835458|NCT00281099|27201069|P1|Overall Study|Lost to Follow-up|10
7835459|NCT00281099|27201068|P2|Overall Study|Death|57
7835460|NCT00281099|27201069|P1|Overall Study|Death|46
7835461|NCT00280917|27201118|P4|Overall Study|Noncompliance|0
7835462|NCT00280917|27201119|P3|Overall Study|Noncompliance|2
7835463|NCT00280917|27201120|P2|Overall Study|Noncompliance|1
7835464|NCT00280917|27201121|P1|Overall Study|Noncompliance|0
7835465|NCT00280917|27201118|P4|Overall Study|Withdrawal by Subject|1
7835466|NCT00280917|27201119|P3|Overall Study|Withdrawal by Subject|0
7835467|NCT00280917|27201120|P2|Overall Study|Withdrawal by Subject|2
7835468|NCT00280917|27201121|P1|Overall Study|Withdrawal by Subject|0
7835469|NCT00280917|27201118|P4|Overall Study|Change Therapy|0
7835470|NCT00280917|27201119|P3|Overall Study|Change Therapy|0
7835471|NCT00280917|27201120|P2|Overall Study|Change Therapy|2
7835472|NCT00280917|27201121|P1|Overall Study|Change Therapy|1
7835473|NCT00280917|27201118|P4|Overall Study|Adverse Event|1
7835474|NCT00280917|27201119|P3|Overall Study|Adverse Event|4
7835475|NCT00280917|27201120|P2|Overall Study|Adverse Event|1
7835476|NCT00280917|27201121|P1|Overall Study|Adverse Event|1
7835477|NCT00280748|27201144|P1|Overall Study|Extra-cranial disease progression|1
7835478|NCT00280748|27201144|P1|Overall Study|Decline in performance|3
7835479|NCT00280735|27201154|P1|Overall Study|Intercurrent Illness|2
7835480|NCT00280735|27201154|P1|Overall Study|Withdrawal by Subject|8
7835481|NCT00280735|27201154|P1|Overall Study|Lack of Efficacy|3
7835482|NCT00280735|27201154|P1|Overall Study|Adverse Event|5
7835483|NCT00280683|27201166|P2|Overall Study|Adverse Event|1
7835484|NCT00280683|27201167|P1|Overall Study|Adverse Event|1
7835485|NCT00280683|27201166|P2|Overall Study|Withdrawal by Subject|2
7835486|NCT00280683|27201167|P1|Overall Study|Withdrawal by Subject|1
7835487|NCT00280566|27201177|P3|Period 2 Double Blind|miscellaneous|5
7835488|NCT00280566|27201178|P2|Period 2 Double Blind|miscellaneous|10
7835489|NCT00280566|27201179|P1|Period 2 Double Blind|miscellaneous|0
7835490|NCT00280566|27201177|P3|Period 2 Double Blind|Withdrawal by Subject|9
7835491|NCT00280566|27201178|P2|Period 2 Double Blind|Withdrawal by Subject|9
7835492|NCT00280566|27201179|P1|Period 2 Double Blind|Withdrawal by Subject|0
7835493|NCT00280566|27201177|P3|Period 2 Double Blind|Lost to Follow-up|6
7835494|NCT00280566|27201178|P2|Period 2 Double Blind|Lost to Follow-up|3
7835495|NCT00280566|27201179|P1|Period 2 Double Blind|Lost to Follow-up|0
7835496|NCT00280566|27201177|P3|Period 2 Double Blind|Adverse Event|15
7835497|NCT00280566|27201178|P2|Period 2 Double Blind|Adverse Event|11
7835498|NCT00280566|27201179|P1|Period 2 Double Blind|Adverse Event|0
7835499|NCT00280566|27201177|P3|Period 2 Double Blind|Laboratory Abnormality|0
7835500|NCT00280566|27201178|P2|Period 2 Double Blind|Laboratory Abnormality|1
7835501|NCT00280566|27201179|P1|Period 2 Double Blind|Laboratory Abnormality|0
7835502|NCT00280566|27201177|P3|Period 2 Double Blind|Lack of Efficacy|22
7835503|NCT00280566|27201178|P2|Period 2 Double Blind|Lack of Efficacy|9
7835504|NCT00280566|27201179|P1|Period 2 Double Blind|Lack of Efficacy|0
7835505|NCT00280566|27201177|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
7835506|NCT00280566|27201178|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
7835507|NCT00280566|27201179|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
7835508|NCT00280566|27201177|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
7835509|NCT00280566|27201178|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
7835510|NCT00280566|27201179|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
7835511|NCT00280566|27201177|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
7835512|NCT00280566|27201178|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
7835513|NCT00280566|27201179|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
7835514|NCT00280566|27201177|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
7835515|NCT00280566|27201178|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
7835516|NCT00280566|27201179|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
7835517|NCT00280566|27201177|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
7835518|NCT00280566|27201178|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
7835519|NCT00280566|27201179|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
7835520|NCT00280566|27201177|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
7835521|NCT00280566|27201178|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
7835522|NCT00280566|27201179|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
7835523|NCT00280397|27201204|P1|Overall Study|Adverse Event|1
7835524|NCT00280293|27201270|P2|Overall Study|Adverse Event|1
7835525|NCT00280293|27201271|P1|Overall Study|Adverse Event|0
7835526|NCT00280293|27201270|P2|Overall Study|Incarceration/Legal Reasons|1
7835527|NCT00280293|27201271|P1|Overall Study|Incarceration/Legal Reasons|1
7835528|NCT00280293|27201270|P2|Overall Study|Withdrawal by Subject|5
7835529|NCT00280293|27201271|P1|Overall Study|Withdrawal by Subject|3
7835530|NCT00280293|27201270|P2|Overall Study|Lost to Follow-up|12
7835531|NCT00280293|27201271|P1|Overall Study|Lost to Follow-up|14
7835532|NCT00280293|27201270|P2|Overall Study|Physician Decision|4
7835533|NCT00280293|27201271|P1|Overall Study|Physician Decision|5
7835534|NCT00280293|27201270|P2|Overall Study|Protocol Violation|0
7835535|NCT00280293|27201271|P1|Overall Study|Protocol Violation|3
7835536|NCT00280150|27201294|P4|Overall Study|Declining Performance Status|1
7835537|NCT00280150|27201295|P3|Overall Study|Declining Performance Status|0
7835538|NCT00280150|27201296|P2|Overall Study|Declining Performance Status|0
7835539|NCT00280150|27201297|P1|Overall Study|Declining Performance Status|0
7835540|NCT00280150|27201294|P4|Overall Study|Did not get consolidation therapy|0
7835541|NCT00280150|27201295|P3|Overall Study|Did not get consolidation therapy|3
7835542|NCT00280150|27201296|P2|Overall Study|Did not get consolidation therapy|0
7835543|NCT00280150|27201297|P1|Overall Study|Did not get consolidation therapy|3
7835544|NCT00280150|27201294|P4|Overall Study|Withdrawal by Subject|1
7835545|NCT00280150|27201295|P3|Overall Study|Withdrawal by Subject|0
7835546|NCT00280150|27201296|P2|Overall Study|Withdrawal by Subject|0
7835547|NCT00280150|27201297|P1|Overall Study|Withdrawal by Subject|0
7835548|NCT00280150|27201294|P4|Overall Study|Protocol Violation|1
7835549|NCT00280150|27201295|P3|Overall Study|Protocol Violation|0
7835550|NCT00280150|27201296|P2|Overall Study|Protocol Violation|0
7835551|NCT00280150|27201297|P1|Overall Study|Protocol Violation|0
7835552|NCT00280150|27201294|P4|Overall Study|Physician Decision|1
7835553|NCT00280150|27201295|P3|Overall Study|Physician Decision|0
7835554|NCT00280150|27201296|P2|Overall Study|Physician Decision|0
7835555|NCT00280150|27201297|P1|Overall Study|Physician Decision|0
7835556|NCT00280150|27201294|P4|Overall Study|Lack of Efficacy|3
7835557|NCT00280150|27201295|P3|Overall Study|Lack of Efficacy|0
7835558|NCT00280150|27201296|P2|Overall Study|Lack of Efficacy|0
7835559|NCT00280150|27201297|P1|Overall Study|Lack of Efficacy|0
7835560|NCT00280150|27201294|P4|Overall Study|Adverse Event|3
7835561|NCT00280150|27201295|P3|Overall Study|Adverse Event|2
7835562|NCT00280150|27201296|P2|Overall Study|Adverse Event|1
7835563|NCT00280150|27201297|P1|Overall Study|Adverse Event|0
7835564|NCT00280059|27201312|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
7835565|NCT00280059|27201313|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
7835566|NCT00280059|27201312|P2|Efficacy Assessment Phase|Other|8
7835567|NCT00280059|27201313|P1|Efficacy Assessment Phase|Other|7
7835568|NCT00280059|27201312|P2|Efficacy Assessment Phase|Lost to Follow-up|13
7835569|NCT00280059|27201313|P1|Efficacy Assessment Phase|Lost to Follow-up|6
7835570|NCT00280059|27201312|P2|Efficacy Assessment Phase|Lack of Efficacy|3
7835571|NCT00280059|27201313|P1|Efficacy Assessment Phase|Lack of Efficacy|19
7835572|NCT00280059|27201312|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
7835573|NCT00280059|27201313|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
7835574|NCT00280059|27201312|P2|Efficacy Assessment Phase|Adverse Event|31
7835575|NCT00280059|27201313|P1|Efficacy Assessment Phase|Adverse Event|33
7835576|NCT00280059|27201312|P2|Efficacy Assessment Phase|Death|0
7835577|NCT00280059|27201313|P1|Efficacy Assessment Phase|Death|2
7835578|NCT00279916|27201377|P2|Overall Study|Lost to Follow-up|2
7835579|NCT00279916|27201378|P1|Overall Study|Lost to Follow-up|3
7835580|NCT00279916|27201377|P2|Overall Study|Withdrawal by Subject|3
7835581|NCT00279916|27201378|P1|Overall Study|Withdrawal by Subject|4
7835582|NCT00279812|27201404|P6|Overall Study|Adverse Event|1
7835583|NCT00279812|27201405|P5|Overall Study|Adverse Event|2
7835584|NCT00279812|27201406|P4|Overall Study|Adverse Event|0
7835585|NCT00279812|27201407|P3|Overall Study|Adverse Event|1
7835586|NCT00279812|27201408|P2|Overall Study|Adverse Event|1
7835587|NCT00279812|27201409|P1|Overall Study|Adverse Event|0
7835588|NCT00279812|27201404|P6|Overall Study|Withdrawal by Subject|0
7835589|NCT00279812|27201405|P5|Overall Study|Withdrawal by Subject|0
7835590|NCT00279812|27201406|P4|Overall Study|Withdrawal by Subject|0
7835591|NCT00279812|27201407|P3|Overall Study|Withdrawal by Subject|2
7835592|NCT00279812|27201408|P2|Overall Study|Withdrawal by Subject|4
7835593|NCT00279812|27201409|P1|Overall Study|Withdrawal by Subject|0
7835594|NCT00279812|27201404|P6|Overall Study|Protocol Violation|0
7835595|NCT00279812|27201405|P5|Overall Study|Protocol Violation|1
7835596|NCT00279812|27201406|P4|Overall Study|Protocol Violation|0
7835597|NCT00279812|27201407|P3|Overall Study|Protocol Violation|0
7835598|NCT00279812|27201408|P2|Overall Study|Protocol Violation|1
7835599|NCT00279812|27201409|P1|Overall Study|Protocol Violation|1
7835600|NCT00279708|27201437|P2|Overall Study|Adverse Event|1
7835601|NCT00279708|27201438|P1|Overall Study|Adverse Event|1
7835602|NCT00279708|27201437|P2|Overall Study|Withdrawal by Subject|3
7835603|NCT00279708|27201438|P1|Overall Study|Withdrawal by Subject|2
7835604|NCT00279305|27201476|P2|Overall Study|FDA Safety Alert|1
7835605|NCT00279305|27201477|P1|Overall Study|FDA Safety Alert|4
7835606|NCT00279305|27201476|P2|Overall Study|Dificulting establishing IV|0
7835607|NCT00279305|27201477|P1|Overall Study|Dificulting establishing IV|1
7835608|NCT00279305|27201476|P2|Overall Study|Withdrawal by Subject|0
7835609|NCT00279305|27201477|P1|Overall Study|Withdrawal by Subject|2
7835610|NCT00279305|27201476|P2|Overall Study|Pregnancy|0
7835611|NCT00279305|27201477|P1|Overall Study|Pregnancy|1
7835612|NCT00279214|27201485|P2|Overall Study|Physician Decision|2
7835613|NCT00279214|27201486|P1|Overall Study|Physician Decision|3
7835614|NCT00279201|27201516|P6|Intensification Addendum|Death|0
7835615|NCT00279201|27201517|P5|Intensification Addendum|Death|1
7835616|NCT00279201|27201518|P4|Intensification Addendum|Death|0
7835617|NCT00279201|27201519|P3|Intensification Addendum|Death|0
7835618|NCT00279201|27201520|P2|Intensification Addendum|Death|0
7835619|NCT00279201|27201521|P1|Intensification Addendum|Death|0
7835620|NCT00279201|27201516|P6|Intensification Addendum|Lack of Efficacy|0
7835621|NCT00279201|27201517|P5|Intensification Addendum|Lack of Efficacy|1
7835622|NCT00279201|27201518|P4|Intensification Addendum|Lack of Efficacy|1
7835623|NCT00279201|27201519|P3|Intensification Addendum|Lack of Efficacy|0
7835624|NCT00279201|27201520|P2|Intensification Addendum|Lack of Efficacy|0
7835625|NCT00279201|27201521|P1|Intensification Addendum|Lack of Efficacy|0
7835626|NCT00279201|27201516|P6|Intensification Addendum|Entry Criteria Exclusion|0
7835627|NCT00279201|27201517|P5|Intensification Addendum|Entry Criteria Exclusion|0
7835628|NCT00279201|27201518|P4|Intensification Addendum|Entry Criteria Exclusion|0
7835629|NCT00279201|27201519|P3|Intensification Addendum|Entry Criteria Exclusion|1
7835630|NCT00279201|27201520|P2|Intensification Addendum|Entry Criteria Exclusion|0
7835631|NCT00279201|27201521|P1|Intensification Addendum|Entry Criteria Exclusion|0
7835632|NCT00279201|27201516|P6|Intensification Addendum|Sponsor Decision|1
7835633|NCT00279201|27201517|P5|Intensification Addendum|Sponsor Decision|1
7835634|NCT00279201|27201518|P4|Intensification Addendum|Sponsor Decision|0
7835635|NCT00279201|27201519|P3|Intensification Addendum|Sponsor Decision|0
7835636|NCT00279201|27201520|P2|Intensification Addendum|Sponsor Decision|0
7835637|NCT00279201|27201521|P1|Intensification Addendum|Sponsor Decision|0
7835638|NCT00279201|27201516|P6|Intensification Addendum|Physician Decision|2
7835639|NCT00279201|27201517|P5|Intensification Addendum|Physician Decision|3
7835640|NCT00279201|27201518|P4|Intensification Addendum|Physician Decision|1
7835641|NCT00279201|27201519|P3|Intensification Addendum|Physician Decision|4
7835642|NCT00279201|27201520|P2|Intensification Addendum|Physician Decision|0
7835643|NCT00279201|27201521|P1|Intensification Addendum|Physician Decision|0
7835644|NCT00279201|27201516|P6|Intensification Addendum|Adverse Event|3
7835645|NCT00279201|27201517|P5|Intensification Addendum|Adverse Event|1
7835646|NCT00279201|27201518|P4|Intensification Addendum|Adverse Event|4
7835647|NCT00279201|27201519|P3|Intensification Addendum|Adverse Event|0
7835648|NCT00279201|27201520|P2|Intensification Addendum|Adverse Event|0
7835649|NCT00279201|27201521|P1|Intensification Addendum|Adverse Event|0
7835650|NCT00279201|27201516|P6|Intensification Addendum|Protocol Violation|6
7835651|NCT00279201|27201517|P5|Intensification Addendum|Protocol Violation|6
7835652|NCT00279201|27201518|P4|Intensification Addendum|Protocol Violation|2
7835653|NCT00279201|27201519|P3|Intensification Addendum|Protocol Violation|2
7835654|NCT00279201|27201520|P2|Intensification Addendum|Protocol Violation|0
7835655|NCT00279201|27201521|P1|Intensification Addendum|Protocol Violation|0
7835656|NCT00279201|27201516|P6|Intensification Addendum|Lost to Follow-up|7
7835657|NCT00279201|27201517|P5|Intensification Addendum|Lost to Follow-up|7
7835658|NCT00279201|27201518|P4|Intensification Addendum|Lost to Follow-up|6
7835659|NCT00279201|27201519|P3|Intensification Addendum|Lost to Follow-up|4
7835660|NCT00279201|27201520|P2|Intensification Addendum|Lost to Follow-up|0
7835661|NCT00279201|27201521|P1|Intensification Addendum|Lost to Follow-up|0
7835662|NCT00279201|27201516|P6|Intensification Addendum|Withdrawal by Subject|18
7835663|NCT00279201|27201517|P5|Intensification Addendum|Withdrawal by Subject|9
7835664|NCT00279201|27201518|P4|Intensification Addendum|Withdrawal by Subject|14
7835665|NCT00279201|27201519|P3|Intensification Addendum|Withdrawal by Subject|12
7835666|NCT00279201|27201520|P2|Intensification Addendum|Withdrawal by Subject|0
7835667|NCT00279201|27201521|P1|Intensification Addendum|Withdrawal by Subject|0
7835668|NCT00279201|27201516|P6|Maintenance|HbA1c>7.5%|0
7835669|NCT00279201|27201517|P5|Maintenance|HbA1c>7.5%|0
7835670|NCT00279201|27201518|P4|Maintenance|HbA1c>7.5%|0
7835671|NCT00279201|27201519|P3|Maintenance|HbA1c>7.5%|0
7835672|NCT00279201|27201520|P2|Maintenance|HbA1c>7.5%|126
7835673|NCT00279201|27201521|P1|Maintenance|HbA1c>7.5%|123
7835674|NCT00279201|27201516|P6|Maintenance|Sponsor Decision|0
7835675|NCT00279201|27201517|P5|Maintenance|Sponsor Decision|0
7835676|NCT00279201|27201518|P4|Maintenance|Sponsor Decision|0
7835677|NCT00279201|27201519|P3|Maintenance|Sponsor Decision|0
7835678|NCT00279201|27201520|P2|Maintenance|Sponsor Decision|0
7835679|NCT00279201|27201521|P1|Maintenance|Sponsor Decision|4
7835680|NCT00279201|27201516|P6|Maintenance|Physician Decision|0
7835681|NCT00279201|27201517|P5|Maintenance|Physician Decision|0
7835682|NCT00279201|27201518|P4|Maintenance|Physician Decision|0
7835683|NCT00279201|27201519|P3|Maintenance|Physician Decision|0
7835684|NCT00279201|27201520|P2|Maintenance|Physician Decision|9
7835685|NCT00279201|27201521|P1|Maintenance|Physician Decision|9
7835686|NCT00279201|27201516|P6|Maintenance|Withdrawal by Subject|0
7835687|NCT00279201|27201517|P5|Maintenance|Withdrawal by Subject|0
7835688|NCT00279201|27201518|P4|Maintenance|Withdrawal by Subject|0
7835689|NCT00279201|27201519|P3|Maintenance|Withdrawal by Subject|0
7835690|NCT00279201|27201520|P2|Maintenance|Withdrawal by Subject|18
7835691|NCT00279201|27201521|P1|Maintenance|Withdrawal by Subject|18
7835692|NCT00279201|27201516|P6|Maintenance|Protocol Violation|0
7835693|NCT00279201|27201517|P5|Maintenance|Protocol Violation|0
7835694|NCT00279201|27201518|P4|Maintenance|Protocol Violation|0
7835695|NCT00279201|27201519|P3|Maintenance|Protocol Violation|0
7835696|NCT00279201|27201520|P2|Maintenance|Protocol Violation|24
7835697|NCT00279201|27201521|P1|Maintenance|Protocol Violation|16
7835698|NCT00279201|27201516|P6|Maintenance|Entry Criteria Exclusion|0
7835699|NCT00279201|27201517|P5|Maintenance|Entry Criteria Exclusion|0
7835700|NCT00279201|27201518|P4|Maintenance|Entry Criteria Exclusion|0
7835701|NCT00279201|27201519|P3|Maintenance|Entry Criteria Exclusion|0
7835702|NCT00279201|27201520|P2|Maintenance|Entry Criteria Exclusion|4
7835703|NCT00279201|27201521|P1|Maintenance|Entry Criteria Exclusion|1
7835704|NCT00279201|27201516|P6|Maintenance|Lost to Follow-up|0
7835705|NCT00279201|27201517|P5|Maintenance|Lost to Follow-up|0
7835706|NCT00279201|27201518|P4|Maintenance|Lost to Follow-up|0
7835707|NCT00279201|27201519|P3|Maintenance|Lost to Follow-up|0
7835708|NCT00279201|27201520|P2|Maintenance|Lost to Follow-up|13
7835709|NCT00279201|27201521|P1|Maintenance|Lost to Follow-up|17
7835710|NCT00279201|27201516|P6|Maintenance|Death|0
7835711|NCT00279201|27201517|P5|Maintenance|Death|0
7835712|NCT00279201|27201518|P4|Maintenance|Death|0
7835713|NCT00279201|27201519|P3|Maintenance|Death|0
7835714|NCT00279201|27201520|P2|Maintenance|Death|4
7835715|NCT00279201|27201521|P1|Maintenance|Death|4
7835716|NCT00279201|27201516|P6|Maintenance|Adverse Event|0
7835717|NCT00279201|27201517|P5|Maintenance|Adverse Event|0
7835718|NCT00279201|27201518|P4|Maintenance|Adverse Event|0
7835719|NCT00279201|27201519|P3|Maintenance|Adverse Event|0
7835720|NCT00279201|27201520|P2|Maintenance|Adverse Event|4
7835721|NCT00279201|27201521|P1|Maintenance|Adverse Event|4
7835722|NCT00279201|27201516|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7835723|NCT00279201|27201517|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7835724|NCT00279201|27201518|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7835725|NCT00279201|27201519|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7835726|NCT00279201|27201520|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
7835727|NCT00279201|27201521|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
7835728|NCT00279201|27201516|P6|Maintenance|Lack of Efficacy|0
7835729|NCT00279201|27201517|P5|Maintenance|Lack of Efficacy|0
7835730|NCT00279201|27201518|P4|Maintenance|Lack of Efficacy|0
7835731|NCT00279201|27201519|P3|Maintenance|Lack of Efficacy|0
7835732|NCT00279201|27201520|P2|Maintenance|Lack of Efficacy|30
7835733|NCT00279201|27201521|P1|Maintenance|Lack of Efficacy|32
7835734|NCT00279201|27201516|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
7835735|NCT00279201|27201517|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
7835736|NCT00279201|27201518|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
7835737|NCT00279201|27201519|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
7835738|NCT00279201|27201520|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
7835739|NCT00279201|27201521|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
7835740|NCT00279201|27201516|P6|Initiation|Sponsor Decision|0
7835741|NCT00279201|27201517|P5|Initiation|Sponsor Decision|0
7835742|NCT00279201|27201518|P4|Initiation|Sponsor Decision|0
7835743|NCT00279201|27201519|P3|Initiation|Sponsor Decision|0
7835744|NCT00279201|27201520|P2|Initiation|Sponsor Decision|5
7835745|NCT00279201|27201521|P1|Initiation|Sponsor Decision|13
7835746|NCT00279201|27201516|P6|Initiation|Physician Decision|0
7835747|NCT00279201|27201517|P5|Initiation|Physician Decision|0
7835748|NCT00279201|27201518|P4|Initiation|Physician Decision|0
7835749|NCT00279201|27201519|P3|Initiation|Physician Decision|0
7835750|NCT00279201|27201520|P2|Initiation|Physician Decision|18
7835751|NCT00279201|27201521|P1|Initiation|Physician Decision|15
7835752|NCT00279201|27201516|P6|Initiation|Withdrawal by Subject|0
7835753|NCT00279201|27201517|P5|Initiation|Withdrawal by Subject|0
7835754|NCT00279201|27201518|P4|Initiation|Withdrawal by Subject|0
7835755|NCT00279201|27201519|P3|Initiation|Withdrawal by Subject|0
7835756|NCT00279201|27201520|P2|Initiation|Withdrawal by Subject|41
7835757|NCT00279201|27201521|P1|Initiation|Withdrawal by Subject|35
7835758|NCT00279201|27201516|P6|Initiation|Protocol Violation|0
7835759|NCT00279201|27201517|P5|Initiation|Protocol Violation|0
7835760|NCT00279201|27201518|P4|Initiation|Protocol Violation|0
7835761|NCT00279201|27201519|P3|Initiation|Protocol Violation|0
7835762|NCT00279201|27201520|P2|Initiation|Protocol Violation|10
7835763|NCT00279201|27201521|P1|Initiation|Protocol Violation|9
7835764|NCT00279201|27201516|P6|Initiation|Entry Criteria Exclusion|0
7835765|NCT00279201|27201517|P5|Initiation|Entry Criteria Exclusion|0
7835766|NCT00279201|27201518|P4|Initiation|Entry Criteria Exclusion|0
7835767|NCT00279201|27201519|P3|Initiation|Entry Criteria Exclusion|0
7835768|NCT00279201|27201520|P2|Initiation|Entry Criteria Exclusion|9
7835769|NCT00279201|27201521|P1|Initiation|Entry Criteria Exclusion|7
7835770|NCT00279201|27201516|P6|Initiation|Lost to Follow-up|0
7835771|NCT00279201|27201517|P5|Initiation|Lost to Follow-up|0
7835772|NCT00279201|27201518|P4|Initiation|Lost to Follow-up|0
7835773|NCT00279201|27201519|P3|Initiation|Lost to Follow-up|0
7835774|NCT00279201|27201520|P2|Initiation|Lost to Follow-up|41
7835775|NCT00279201|27201521|P1|Initiation|Lost to Follow-up|42
7835776|NCT00279201|27201516|P6|Initiation|Adverse Event|0
7835777|NCT00279201|27201517|P5|Initiation|Adverse Event|0
7835778|NCT00279201|27201518|P4|Initiation|Adverse Event|0
7835779|NCT00279201|27201519|P3|Initiation|Adverse Event|0
7835780|NCT00279201|27201520|P2|Initiation|Adverse Event|15
7835781|NCT00279201|27201521|P1|Initiation|Adverse Event|6
7835782|NCT00279201|27201516|P6|Initiation|Death|0
7835783|NCT00279201|27201517|P5|Initiation|Death|0
7835784|NCT00279201|27201518|P4|Initiation|Death|0
7835785|NCT00279201|27201519|P3|Initiation|Death|0
7835786|NCT00279201|27201520|P2|Initiation|Death|5
7835787|NCT00279201|27201521|P1|Initiation|Death|1
7835788|NCT00278993|27201665|P1|Overall Study|Not Otherwise Specified|4
7835789|NCT00278993|27201665|P1|Overall Study|Physician Decision|9
7835790|NCT00278993|27201665|P1|Overall Study|Progressive Disease|65
7835791|NCT00278993|27201665|P1|Overall Study|Withdrawal by Subject|5
7835792|NCT00278993|27201665|P1|Overall Study|Adverse Event|24
7835793|NCT00278954|27201673|P1|Overall Study|Withdrawal by Subject|1
7835794|NCT00278954|27201673|P1|Overall Study|Lost to Follow-up|1
7835795|NCT00278954|27201673|P1|Overall Study|Adverse Event|3
7835797|NCT00278889|27201717|P3|Overall Study|Death|17
7835798|NCT00278889|27201718|P2|Overall Study|Death|21
7835799|NCT00278889|27201719|P1|Overall Study|Death|24
7835800|NCT00278889|27201717|P3|Overall Study|Lost to Follow-up|0
7835801|NCT00278889|27201718|P2|Overall Study|Lost to Follow-up|1
7835802|NCT00278889|27201719|P1|Overall Study|Lost to Follow-up|1
7835803|NCT00278889|27201717|P3|Overall Study|Withdrawal by Subject|3
7835804|NCT00278889|27201718|P2|Overall Study|Withdrawal by Subject|5
7835805|NCT00278889|27201719|P1|Overall Study|Withdrawal by Subject|0
7835806|NCT00278629|27201767|P1|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
7835807|NCT00278564|27201774|P1|Overall Study|Lack of Efficacy|4
7835808|NCT00278512|27201795|P2|Overall Study|Death|0
7835809|NCT00278512|27201796|P1|Overall Study|Death|1
7835810|NCT00278473|27201804|P2|Overall Study|drop out|3
7835811|NCT00278473|27201805|P1|Overall Study|drop out|4
7835812|NCT00278395|27201821|P1|Overall Study|Nonevaluable|1
7835813|NCT00278395|27201821|P1|Overall Study|Adverse Event|2
7835814|NCT00278200|27201839|P2|Overall Study|Physician Decision|1
7835815|NCT00278200|27201840|P1|Overall Study|Physician Decision|0
7835816|NCT00278200|27201839|P2|Overall Study|Death|3
7835817|NCT00278200|27201840|P1|Overall Study|Death|1
7835818|NCT00278161|27201849|P1|Overall Study|Death|11
7835819|NCT00278148|27201855|P3|Phase II - Expansion Phase|Adverse Event|2
7835820|NCT00278148|27201856|P2|Phase II - Expansion Phase|Adverse Event|0
7835821|NCT00278148|27201857|P1|Phase II - Expansion Phase|Adverse Event|0
7835822|NCT00278148|27201855|P3|Phase II - Expansion Phase|Disease progression|4
7835823|NCT00278148|27201856|P2|Phase II - Expansion Phase|Disease progression|0
7835824|NCT00278148|27201857|P1|Phase II - Expansion Phase|Disease progression|0
7835825|NCT00278109|27201869|P1|Overall Study|social circumstances|1
7835826|NCT00278109|27201869|P1|Overall Study|Adverse Event|3
7835827|NCT00277355|27201915|P2|Overall Study|Physician Decision|0
7835828|NCT00277355|27201916|P1|Overall Study|Physician Decision|1
7835829|NCT00277355|27201915|P2|Overall Study|Death|0
7835830|NCT00277355|27201916|P1|Overall Study|Death|3
7835831|NCT00277355|27201915|P2|Overall Study|Adverse Event|0
7835832|NCT00277355|27201916|P1|Overall Study|Adverse Event|5
7835833|NCT00277355|27201915|P2|Overall Study|Lost to Follow-up|2
7835834|NCT00277355|27201916|P1|Overall Study|Lost to Follow-up|2
7835835|NCT00277355|27201915|P2|Overall Study|Withdrawal by Subject|3
7835836|NCT00277355|27201916|P1|Overall Study|Withdrawal by Subject|3
7835837|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
7835838|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
7835839|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
7835840|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
7835841|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
7835842|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
7835843|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
7835844|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
7835845|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
7835846|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
7835847|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
7835848|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
7835929|NCT00276094|27202166|P3|Overall Study|Other-Study medication lost|1
7835849|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
7835850|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
7835851|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
7835852|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7835853|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7835854|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
7835855|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
7835856|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
7835857|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
7835858|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
7835859|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
7835860|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
7835861|NCT00277212|27201924|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
7835862|NCT00277212|27201925|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
7835863|NCT00277212|27201926|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
7835864|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
7835865|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
7835866|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
7835867|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
7835868|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
7835869|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
7835870|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
7835871|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
7835872|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
7835873|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
7835874|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
7835875|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
7835876|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
7835877|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
7835878|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
7835879|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
7835880|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
7835881|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
7835882|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
7835883|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
7835884|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
7835885|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
7835886|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
7835887|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
7835888|NCT00277212|27201924|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
7835889|NCT00277212|27201925|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
7835890|NCT00277212|27201926|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
7835891|NCT00277095|27201964|P1|Overall Study|Physician Decision|1
7835892|NCT00277095|27201964|P1|Overall Study|Missed Follow-up|9
7835893|NCT00277095|27201964|P1|Overall Study|Lost to Follow-up|2
7835894|NCT00277095|27201964|P1|Overall Study|Explanted|7
7835895|NCT00277095|27201964|P1|Overall Study|Death|2
7835896|NCT00276744|27201973|P1|PART A|Reason unknown|98
7835897|NCT00276614|27201977|P1|Overall Study|Progression of disease under study|3
7835898|NCT00276484|27201988|P2|Overall Study|Could not take time off work|1
7835899|NCT00276484|27201989|P1|Overall Study|Could not take time off work|0
7835900|NCT00276484|27201988|P2|Overall Study|Withdrawal by Subject|3
7835901|NCT00276484|27201989|P1|Overall Study|Withdrawal by Subject|4
7835902|NCT00276484|27201988|P2|Overall Study|Protocol Violation|1
7835903|NCT00276484|27201989|P1|Overall Study|Protocol Violation|0
7835904|NCT00276484|27201988|P2|Overall Study|Lost to Follow-up|1
7835905|NCT00276484|27201989|P1|Overall Study|Lost to Follow-up|1
7835906|NCT00276484|27201988|P2|Overall Study|Adverse Event|7
7835907|NCT00276484|27201989|P1|Overall Study|Adverse Event|4
7835908|NCT00276458|27202021|P2|Overall Study|Protocol Violation|3
7835909|NCT00276458|27202022|P1|Overall Study|Protocol Violation|4
7835910|NCT00276458|27202021|P2|Overall Study|Lost to Follow-up|2
7835911|NCT00276458|27202022|P1|Overall Study|Lost to Follow-up|2
7835912|NCT00276458|27202021|P2|Overall Study|Adverse Event|2
7835913|NCT00276458|27202022|P1|Overall Study|Adverse Event|0
7835914|NCT00276419|27202056|P2|First Intervention|Withdrawal by Subject|2
7835915|NCT00276419|27202057|P1|First Intervention|Withdrawal by Subject|0
7835916|NCT00276419|27202056|P2|First Intervention|Adverse Event|0
7835917|NCT00276419|27202057|P1|First Intervention|Adverse Event|1
7835918|NCT00276380|27202100|P2|Overall Study|Abnormal aPPT Levels|1
7835919|NCT00276380|27202101|P1|Overall Study|Abnormal aPPT Levels|0
7835920|NCT00276380|27202100|P2|Overall Study|Death|3
7835921|NCT00276380|27202101|P1|Overall Study|Death|5
7835922|NCT00276380|27202100|P2|Overall Study|Withdrawal by Subject|6
7835923|NCT00276380|27202101|P1|Overall Study|Withdrawal by Subject|3
7835924|NCT00276380|27202100|P2|Overall Study|Lost to Follow-up|1
7835925|NCT00276380|27202101|P1|Overall Study|Lost to Follow-up|1
7835926|NCT00276380|27202100|P2|Overall Study|Adverse Event|3
7835927|NCT00276380|27202101|P1|Overall Study|Adverse Event|5
7835928|NCT00276159|27202156|P1|Overall Study|Did not receive all 24 doses of 852A|6
7835930|NCT00276094|27202167|P2|Overall Study|Other-Study medication lost|0
7835931|NCT00276094|27202168|P1|Overall Study|Other-Study medication lost|0
7835932|NCT00276094|27202166|P3|Overall Study|Other-Relocation|0
7835933|NCT00276094|27202167|P2|Overall Study|Other-Relocation|1
7835934|NCT00276094|27202168|P1|Overall Study|Other-Relocation|0
7835935|NCT00276094|27202166|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
7835936|NCT00276094|27202167|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
7835937|NCT00276094|27202168|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
7835938|NCT00276094|27202166|P3|Overall Study|Other-Refused follow-up visit|0
7835939|NCT00276094|27202167|P2|Overall Study|Other-Refused follow-up visit|0
7835940|NCT00276094|27202168|P1|Overall Study|Other-Refused follow-up visit|1
7835941|NCT00276094|27202166|P3|Overall Study|Other-Lack of efficacy|0
7835942|NCT00276094|27202167|P2|Overall Study|Other-Lack of efficacy|0
7835943|NCT00276094|27202168|P1|Overall Study|Other-Lack of efficacy|1
7835944|NCT00276094|27202166|P3|Overall Study|Other-Scheduled gastroplasty|0
7835945|NCT00276094|27202167|P2|Overall Study|Other-Scheduled gastroplasty|0
7835946|NCT00276094|27202168|P1|Overall Study|Other-Scheduled gastroplasty|1
7835947|NCT00276094|27202166|P3|Overall Study|Other-Subject moved out of country|0
7835948|NCT00276094|27202167|P2|Overall Study|Other-Subject moved out of country|0
7835949|NCT00276094|27202168|P1|Overall Study|Other-Subject moved out of country|1
7835950|NCT00276094|27202166|P3|Overall Study|Lost to Follow-up|4
7835951|NCT00276094|27202167|P2|Overall Study|Lost to Follow-up|6
7835952|NCT00276094|27202168|P1|Overall Study|Lost to Follow-up|8
7835953|NCT00276094|27202166|P3|Overall Study|Protocol Violation|10
7835954|NCT00276094|27202167|P2|Overall Study|Protocol Violation|7
7835955|NCT00276094|27202168|P1|Overall Study|Protocol Violation|16
7835956|NCT00276094|27202166|P3|Overall Study|Withdrawal by Subject|12
7835957|NCT00276094|27202167|P2|Overall Study|Withdrawal by Subject|14
7835958|NCT00276094|27202168|P1|Overall Study|Withdrawal by Subject|14
7835959|NCT00276094|27202166|P3|Overall Study|Adverse Event|11
7835960|NCT00276094|27202167|P2|Overall Study|Adverse Event|13
7835961|NCT00276094|27202168|P1|Overall Study|Adverse Event|15
7835962|NCT00276016|27202221|P6|Intervention 1|Withdrawal by Subject|0
7835963|NCT00276016|27202222|P5|Intervention 1|Withdrawal by Subject|0
7835964|NCT00276016|27202223|P4|Intervention 1|Withdrawal by Subject|0
7835965|NCT00276016|27202224|P3|Intervention 1|Withdrawal by Subject|0
7835966|NCT00276016|27202225|P2|Intervention 1|Withdrawal by Subject|1
7835967|NCT00276016|27202226|P1|Intervention 1|Withdrawal by Subject|0
7835968|NCT00275821|27202272|P3|Overall Study|Protocol Violation|0
7835969|NCT00275821|27202273|P2|Overall Study|Protocol Violation|1
7835970|NCT00275821|27202274|P1|Overall Study|Protocol Violation|5
7835971|NCT00275821|27202272|P3|Overall Study|Lack of Efficacy|0
7835972|NCT00275821|27202273|P2|Overall Study|Lack of Efficacy|1
7835973|NCT00275821|27202274|P1|Overall Study|Lack of Efficacy|2
7835974|NCT00275821|27202272|P3|Overall Study|Death|1
7835975|NCT00275821|27202273|P2|Overall Study|Death|2
7835976|NCT00275821|27202274|P1|Overall Study|Death|0
7835977|NCT00275821|27202272|P3|Overall Study|Lost to Follow-up|1
7835978|NCT00275821|27202273|P2|Overall Study|Lost to Follow-up|1
7835979|NCT00275821|27202274|P1|Overall Study|Lost to Follow-up|0
7835980|NCT00275821|27202272|P3|Overall Study|Withdrawal by Subject|1
7835981|NCT00275821|27202273|P2|Overall Study|Withdrawal by Subject|2
7835982|NCT00275821|27202274|P1|Overall Study|Withdrawal by Subject|0
7835983|NCT00275821|27202272|P3|Overall Study|Administrative problems|4
7835984|NCT00275821|27202273|P2|Overall Study|Administrative problems|4
7835985|NCT00275821|27202274|P1|Overall Study|Administrative problems|3
7835986|NCT00275821|27202272|P3|Overall Study|Adverse Event|5
7835987|NCT00275821|27202273|P2|Overall Study|Adverse Event|12
7835988|NCT00275821|27202274|P1|Overall Study|Adverse Event|4
7835989|NCT00275561|27202293|P2|Overall Study|Family Issues|2
7835990|NCT00275561|27202294|P1|Overall Study|Family Issues|0
7835991|NCT00275561|27202293|P2|Overall Study|Scheduling|2
7835992|NCT00275561|27202294|P1|Overall Study|Scheduling|1
7835993|NCT00275561|27202293|P2|Overall Study|Travel|1
7835994|NCT00275561|27202294|P1|Overall Study|Travel|1
7835995|NCT00275561|27202293|P2|Overall Study|Withdrawal by Subject|1
7835996|NCT00275561|27202294|P1|Overall Study|Withdrawal by Subject|0
7835997|NCT00275509|27202306|P2|Overall Study|graft thrombosis, post-operative day #8|1
7835998|NCT00275509|27202307|P1|Overall Study|graft thrombosis, post-operative day #8|0
7835999|NCT00275340|27202330|P2|Overall Study|Lost to Follow-up|4
7836000|NCT00275340|27202331|P1|Overall Study|Lost to Follow-up|2
7836001|NCT00275301|27202335|P1|Overall Study|Adverse Event|5
7836002|NCT00275262|27202354|P2|Overall Study|Started Chemotherapy|0
7836003|NCT00275262|27202355|P1|Overall Study|Started Chemotherapy|1
7836004|NCT00275262|27202354|P2|Overall Study|Death|0
7836005|NCT00275262|27202355|P1|Overall Study|Death|1
7836006|NCT00275262|27202354|P2|Overall Study|Protocol Violation|2
7836007|NCT00275262|27202355|P1|Overall Study|Protocol Violation|0
7836008|NCT00275262|27202354|P2|Overall Study|Lost to Follow-up|2
7836009|NCT00275262|27202355|P1|Overall Study|Lost to Follow-up|0
7836010|NCT00275262|27202354|P2|Overall Study|Disease progression|5
7836011|NCT00275262|27202355|P1|Overall Study|Disease progression|2
7836012|NCT00275262|27202354|P2|Overall Study|Adverse Event|0
7836013|NCT00275262|27202355|P1|Overall Study|Adverse Event|2
7836014|NCT00275028|27202369|P1|Overall Study|Physician Decision|2
7836015|NCT00275028|27202369|P1|Overall Study|Progressive Disease|30
7836016|NCT00275028|27202369|P1|Overall Study|Adverse Event|9
7836017|NCT00275028|27202369|P1|Overall Study|Withdrawal by Subject|5
7836018|NCT00275028|27202369|P1|Overall Study|Withdrew consent before treatment began|1
7836019|NCT00275002|27202376|P2|Overall Study|Adverse Event|1
7836020|NCT00275002|27202377|P1|Overall Study|Adverse Event|0
7836021|NCT00275002|27202376|P2|Overall Study|Disease progression|15
7836022|NCT00275002|27202377|P1|Overall Study|Disease progression|21
7836023|NCT00275002|27202376|P2|Overall Study|Death|0
7836024|NCT00275002|27202377|P1|Overall Study|Death|1
7836025|NCT00274937|27202385|P1|Overall Study|Progressive Disease|4
7836026|NCT00274937|27202385|P1|Overall Study|Withdrawal by Subject|6
7836027|NCT00274937|27202385|P1|Overall Study|Physician Decision|10
7836028|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
7836029|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
7836030|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
7836031|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
7836032|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
7836033|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
7836034|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
7836035|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
7836036|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
7836037|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
7836038|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
7836039|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
7836040|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
7836041|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
7836042|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
7836043|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
7836044|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
7836045|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
7836046|NCT00274924|27202397|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
7836047|NCT00274924|27202398|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
7836048|NCT00274924|27202399|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
7836049|NCT00274924|27202397|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
7836050|NCT00274924|27202398|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
7836051|NCT00274924|27202399|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
7836052|NCT00274924|27202397|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
7836053|NCT00274924|27202398|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
7836054|NCT00274924|27202399|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
7836055|NCT00274924|27202397|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
7836056|NCT00274924|27202398|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
7836057|NCT00274924|27202399|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
7836058|NCT00274924|27202397|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
7836059|NCT00274924|27202398|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
7836060|NCT00274924|27202399|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
7836061|NCT00274924|27202397|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
7836062|NCT00274924|27202398|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
7836063|NCT00274924|27202399|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
7836064|NCT00274924|27202397|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
7836065|NCT00274924|27202398|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
7836066|NCT00274924|27202399|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
7836067|NCT00274846|27202408|P1|Overall Study|Did not receive adequate NK cells|1
7836068|NCT00274742|27202437|P6|Overall Study|Other|0
7836069|NCT00274742|27202438|P5|Overall Study|Other|2
7836070|NCT00274742|27202439|P4|Overall Study|Other|0
7836071|NCT00274742|27202440|P3|Overall Study|Other|0
7836072|NCT00274742|27202441|P2|Overall Study|Other|3
7836073|NCT00274742|27202442|P1|Overall Study|Other|0
7836074|NCT00274742|27202437|P6|Overall Study|Disease Progression|0
7836075|NCT00274742|27202438|P5|Overall Study|Disease Progression|1
7836076|NCT00274742|27202439|P4|Overall Study|Disease Progression|0
7836077|NCT00274742|27202440|P3|Overall Study|Disease Progression|1
7836078|NCT00274742|27202441|P2|Overall Study|Disease Progression|1
7836079|NCT00274742|27202442|P1|Overall Study|Disease Progression|0
7836080|NCT00274742|27202437|P6|Overall Study|End of Study|0
7836081|NCT00274742|27202438|P5|Overall Study|End of Study|0
7836082|NCT00274742|27202439|P4|Overall Study|End of Study|1
7836083|NCT00274742|27202440|P3|Overall Study|End of Study|0
7836084|NCT00274742|27202441|P2|Overall Study|End of Study|0
7836085|NCT00274742|27202442|P1|Overall Study|End of Study|0
7836086|NCT00274742|27202437|P6|Overall Study|Lost to Follow-up|0
7836087|NCT00274742|27202438|P5|Overall Study|Lost to Follow-up|1
7836088|NCT00274742|27202439|P4|Overall Study|Lost to Follow-up|0
7836089|NCT00274742|27202440|P3|Overall Study|Lost to Follow-up|0
7836090|NCT00274742|27202441|P2|Overall Study|Lost to Follow-up|0
7836091|NCT00274742|27202442|P1|Overall Study|Lost to Follow-up|0
7836092|NCT00274742|27202437|P6|Overall Study|Adverse Event|3
7836093|NCT00274742|27202438|P5|Overall Study|Adverse Event|12
7836094|NCT00274742|27202439|P4|Overall Study|Adverse Event|4
7836095|NCT00274742|27202440|P3|Overall Study|Adverse Event|1
7836096|NCT00274742|27202441|P2|Overall Study|Adverse Event|4
7836097|NCT00274742|27202442|P1|Overall Study|Adverse Event|0
7836098|NCT00274716|27202480|P6|Phase B|Lost to Follow-up|0
7836099|NCT00274716|27202481|P5|Phase B|Lost to Follow-up|0
7836100|NCT00274716|27202482|P4|Phase B|Lost to Follow-up|0
7836101|NCT00274716|27202483|P3|Phase B|Lost to Follow-up|0
7836102|NCT00274716|27202484|P2|Phase B|Lost to Follow-up|1
7836103|NCT00274716|27202485|P1|Phase B|Lost to Follow-up|0
7836104|NCT00274716|27202480|P6|Phase B|Other non-reported reason|0
7836105|NCT00274716|27202481|P5|Phase B|Other non-reported reason|0
7836106|NCT00274716|27202482|P4|Phase B|Other non-reported reason|1
7836107|NCT00274716|27202483|P3|Phase B|Other non-reported reason|1
7836108|NCT00274716|27202484|P2|Phase B|Other non-reported reason|0
7836109|NCT00274716|27202485|P1|Phase B|Other non-reported reason|0
7836110|NCT00274716|27202480|P6|Phase B|Participant moved|0
7836111|NCT00274716|27202481|P5|Phase B|Participant moved|0
7836112|NCT00274716|27202482|P4|Phase B|Participant moved|0
7836113|NCT00274716|27202483|P3|Phase B|Participant moved|0
7836114|NCT00274716|27202484|P2|Phase B|Participant moved|0
7836115|NCT00274716|27202485|P1|Phase B|Participant moved|1
7836116|NCT00274716|27202480|P6|Phase B|Withdrawal by Subject|0
7836117|NCT00274716|27202481|P5|Phase B|Withdrawal by Subject|0
7836118|NCT00274716|27202482|P4|Phase B|Withdrawal by Subject|0
7836119|NCT00274716|27202483|P3|Phase B|Withdrawal by Subject|0
7836120|NCT00274716|27202484|P2|Phase B|Withdrawal by Subject|1
7836121|NCT00274716|27202485|P1|Phase B|Withdrawal by Subject|0
7836122|NCT00274716|27202480|P6|Phase B|Protocol Violation|0
7836123|NCT00274716|27202481|P5|Phase B|Protocol Violation|0
7836124|NCT00274716|27202482|P4|Phase B|Protocol Violation|0
7836125|NCT00274716|27202483|P3|Phase B|Protocol Violation|0
7836126|NCT00274716|27202484|P2|Phase B|Protocol Violation|2
7836127|NCT00274716|27202485|P1|Phase B|Protocol Violation|0
7836128|NCT00274716|27202480|P6|Phase B|Adverse Event|1
7836129|NCT00274716|27202481|P5|Phase B|Adverse Event|0
7836130|NCT00274716|27202482|P4|Phase B|Adverse Event|0
7836131|NCT00274716|27202483|P3|Phase B|Adverse Event|2
7836132|NCT00274716|27202484|P2|Phase B|Adverse Event|0
7836133|NCT00274716|27202485|P1|Phase B|Adverse Event|0
7836134|NCT00274716|27202480|P6|Phase A|Completed but did not enter Phase B|1
7836135|NCT00274716|27202481|P5|Phase A|Completed but did not enter Phase B|1
7836136|NCT00274716|27202482|P4|Phase A|Completed but did not enter Phase B|2
7836137|NCT00274716|27202483|P3|Phase A|Completed but did not enter Phase B|2
7836138|NCT00274716|27202484|P2|Phase A|Completed but did not enter Phase B|2
7836139|NCT00274716|27202485|P1|Phase A|Completed but did not enter Phase B|1
7836140|NCT00274716|27202480|P6|Phase A|Adverse Event|0
7836141|NCT00274716|27202481|P5|Phase A|Adverse Event|2
7836142|NCT00274716|27202482|P4|Phase A|Adverse Event|0
7836143|NCT00274716|27202483|P3|Phase A|Adverse Event|3
7836144|NCT00274716|27202484|P2|Phase A|Adverse Event|3
7836145|NCT00274716|27202485|P1|Phase A|Adverse Event|2
7836146|NCT00274716|27202480|P6|Phase A|Withdrawal by Subject|1
7836147|NCT00274716|27202481|P5|Phase A|Withdrawal by Subject|0
7836148|NCT00274716|27202482|P4|Phase A|Withdrawal by Subject|3
7836149|NCT00274716|27202483|P3|Phase A|Withdrawal by Subject|1
7836150|NCT00274716|27202484|P2|Phase A|Withdrawal by Subject|2
7836151|NCT00274716|27202485|P1|Phase A|Withdrawal by Subject|2
7836152|NCT00274716|27202480|P6|Phase A|Met criteria for discontinuation|0
7836153|NCT00274716|27202481|P5|Phase A|Met criteria for discontinuation|0
7836154|NCT00274716|27202482|P4|Phase A|Met criteria for discontinuation|0
7836155|NCT00274716|27202483|P3|Phase A|Met criteria for discontinuation|0
7836156|NCT00274716|27202484|P2|Phase A|Met criteria for discontinuation|1
7836157|NCT00274716|27202485|P1|Phase A|Met criteria for discontinuation|1
7836158|NCT00274716|27202480|P6|Phase A|Protocol Violation|0
7836159|NCT00274716|27202481|P5|Phase A|Protocol Violation|0
7836160|NCT00274716|27202482|P4|Phase A|Protocol Violation|1
7836161|NCT00274716|27202483|P3|Phase A|Protocol Violation|0
7836162|NCT00274716|27202484|P2|Phase A|Protocol Violation|0
7836163|NCT00274716|27202485|P1|Phase A|Protocol Violation|1
7836164|NCT00274716|27202480|P6|Phase A|Site Terminated|0
7836165|NCT00274716|27202481|P5|Phase A|Site Terminated|0
7836166|NCT00274716|27202482|P4|Phase A|Site Terminated|1
7836167|NCT00274716|27202483|P3|Phase A|Site Terminated|0
7836168|NCT00274716|27202484|P2|Phase A|Site Terminated|0
7836169|NCT00274716|27202485|P1|Phase A|Site Terminated|0
7836170|NCT00274716|27202480|P6|Phase A|Participant moved|1
7836171|NCT00274716|27202481|P5|Phase A|Participant moved|0
7836172|NCT00274716|27202482|P4|Phase A|Participant moved|0
7836173|NCT00274716|27202483|P3|Phase A|Participant moved|1
7836174|NCT00274716|27202484|P2|Phase A|Participant moved|0
7836175|NCT00274716|27202485|P1|Phase A|Participant moved|0
7836176|NCT00274716|27202480|P6|Phase A|Other non-reported reason|1
7836177|NCT00274716|27202481|P5|Phase A|Other non-reported reason|0
7836178|NCT00274716|27202482|P4|Phase A|Other non-reported reason|2
7836179|NCT00274716|27202483|P3|Phase A|Other non-reported reason|1
7836180|NCT00274716|27202484|P2|Phase A|Other non-reported reason|2
7836181|NCT00274716|27202485|P1|Phase A|Other non-reported reason|4
7836182|NCT00274651|27202547|P2|Overall Study|Physician Decision|7
7836183|NCT00274651|27202548|P1|Overall Study|Physician Decision|8
7836184|NCT00274651|27202547|P2|Overall Study|Withdrawal by Subject|1
7836185|NCT00274651|27202548|P1|Overall Study|Withdrawal by Subject|0
7836186|NCT00274651|27202547|P2|Overall Study|Death|3
7836187|NCT00274651|27202548|P1|Overall Study|Death|1
7836188|NCT00274651|27202547|P2|Overall Study|Lack of Efficacy|6
7836189|NCT00274651|27202548|P1|Overall Study|Lack of Efficacy|13
7836190|NCT00274651|27202547|P2|Overall Study|Adverse Event|3
7836191|NCT00274651|27202548|P1|Overall Study|Adverse Event|6
7836192|NCT00274625|27202563|P2|Overall Study|Excluded from analysis|8
7836193|NCT00274625|27202564|P1|Overall Study|Excluded from analysis|14
7836194|NCT00274625|27202563|P2|Overall Study|Lost to Follow-up|54
7836195|NCT00274625|27202564|P1|Overall Study|Lost to Follow-up|46
7836196|NCT00274469|27202572|P2|Overall Study|Did not consent to OS follow-up|19
7836197|NCT00274469|27202573|P1|Overall Study|Did not consent to OS follow-up|16
7836198|NCT00274469|27202572|P2|Overall Study|Death|74
7836199|NCT00274469|27202573|P1|Overall Study|Death|63
7836200|NCT00274456|27202593|P4|Overall Study|Withdrawal by Subject|13
7836201|NCT00274456|27202594|P3|Overall Study|Withdrawal by Subject|9
7836202|NCT00274456|27202595|P2|Overall Study|Withdrawal by Subject|13
7836203|NCT00274456|27202596|P1|Overall Study|Withdrawal by Subject|18
7836204|NCT00274456|27202593|P4|Overall Study|Lost to Follow-up|0
7836205|NCT00274456|27202594|P3|Overall Study|Lost to Follow-up|1
7836206|NCT00274456|27202595|P2|Overall Study|Lost to Follow-up|0
7836207|NCT00274456|27202596|P1|Overall Study|Lost to Follow-up|0
7836208|NCT00274456|27202593|P4|Overall Study|Physician Decision|13
7836209|NCT00274456|27202594|P3|Overall Study|Physician Decision|6
7836210|NCT00274456|27202595|P2|Overall Study|Physician Decision|5
7836211|NCT00274456|27202596|P1|Overall Study|Physician Decision|7
7836212|NCT00274456|27202593|P4|Overall Study|Adverse Event|2
7836213|NCT00274456|27202594|P3|Overall Study|Adverse Event|2
7836214|NCT00274456|27202595|P2|Overall Study|Adverse Event|1
7836215|NCT00274456|27202596|P1|Overall Study|Adverse Event|0
7836216|NCT00274456|27202593|P4|Overall Study|Unacceptable toxicity|16
7836217|NCT00274456|27202594|P3|Overall Study|Unacceptable toxicity|12
7836218|NCT00274456|27202595|P2|Overall Study|Unacceptable toxicity|5
7836219|NCT00274456|27202596|P1|Overall Study|Unacceptable toxicity|10
7836220|NCT00274456|27202593|P4|Overall Study|Still on treatment|1
7836221|NCT00274456|27202594|P3|Overall Study|Still on treatment|5
7836222|NCT00274456|27202595|P2|Overall Study|Still on treatment|3
7836223|NCT00274456|27202596|P1|Overall Study|Still on treatment|2
7836224|NCT00274287|27202638|P1|Overall Study|subject non-compliance|1
7836225|NCT00274287|27202638|P1|Overall Study|Withdrawal by Subject|1
7836226|NCT00274261|27202648|P2|Overall Study|Lost to Follow-up|75
7836227|NCT00274261|27202649|P1|Overall Study|Lost to Follow-up|106
7836228|NCT00274261|27202648|P2|Overall Study|Protocol Violation|42
7836229|NCT00274261|27202649|P1|Overall Study|Protocol Violation|71
7836230|NCT00274261|27202648|P2|Overall Study|Withdrawal by Subject|126
7836231|NCT00274261|27202649|P1|Overall Study|Withdrawal by Subject|179
7836232|NCT00274261|27202648|P2|Overall Study|Pregnancy|83
7836233|NCT00274261|27202649|P1|Overall Study|Pregnancy|114
7836234|NCT00274261|27202648|P2|Overall Study|Adverse Event|11
7836235|NCT00274261|27202649|P1|Overall Study|Adverse Event|19
7836236|NCT00273858|27202688|P1|Overall Study|Adverse Event|81
7836237|NCT00273858|27202688|P1|Overall Study|Withdrawal by Subject|21
7836238|NCT00273858|27202688|P1|Overall Study|Lost to Follow-up|101
7836239|NCT00273858|27202688|P1|Overall Study|Not completed 24 month observation time|334
7836240|NCT00273182|27202756|P1|Overall Study|Site exit, system change, 36 m FU missed|36
7836241|NCT00273182|27202756|P1|Overall Study|Device/System Explant|154
7836242|NCT00273182|27202756|P1|Overall Study|Withdrawal by Subject|257
7836243|NCT00273182|27202756|P1|Overall Study|Lost to Follow-up|88
7836244|NCT00273182|27202756|P1|Overall Study|Death|450
7836245|NCT00273052|27202766|P2|Overall Study|Worsening serum lipid levels|2
7836246|NCT00273052|27202767|P1|Overall Study|Worsening serum lipid levels|0
7836247|NCT00273052|27202766|P2|Overall Study|Other|0
7836248|NCT00273052|27202767|P1|Overall Study|Other|2
7836249|NCT00273052|27202766|P2|Overall Study|Non-Compliance|1
7836250|NCT00273052|27202767|P1|Overall Study|Non-Compliance|3
7836251|NCT00273052|27202766|P2|Overall Study|Lack of Efficacy|4
7836252|NCT00273052|27202767|P1|Overall Study|Lack of Efficacy|6
7836253|NCT00273052|27202766|P2|Overall Study|Lost to Follow-up|25
7836254|NCT00273052|27202767|P1|Overall Study|Lost to Follow-up|7
7836255|NCT00273052|27202766|P2|Overall Study|Protocol Violation|18
7836256|NCT00273052|27202767|P1|Overall Study|Protocol Violation|14
7836257|NCT00273052|27202766|P2|Overall Study|Adverse Event|19
7836258|NCT00273052|27202767|P1|Overall Study|Adverse Event|21
7836259|NCT00273052|27202766|P2|Overall Study|Withdrawal by Subject|19
7836260|NCT00273052|27202767|P1|Overall Study|Withdrawal by Subject|16
7836261|NCT00272987|27202802|P3|Overall Study|Death|0
7836262|NCT00272987|27202803|P2|Overall Study|Death|0
7836263|NCT00272987|27202804|P1|Overall Study|Death|1
7836264|NCT00272987|27202802|P3|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
7836265|NCT00272987|27202803|P2|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
7836266|NCT00272987|27202804|P1|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
7836267|NCT00272987|27202802|P3|Overall Study|Disease progression|2
7836268|NCT00272987|27202803|P2|Overall Study|Disease progression|1
7836269|NCT00272987|27202804|P1|Overall Study|Disease progression|1
7836270|NCT00272987|27202802|P3|Overall Study|Sponsor Terminated study|1
7836271|NCT00272987|27202803|P2|Overall Study|Sponsor Terminated study|1
7836272|NCT00272987|27202804|P1|Overall Study|Sponsor Terminated study|0
7836273|NCT00272987|27202802|P3|Overall Study|Withdrawal by Subject|3
7836274|NCT00272987|27202803|P2|Overall Study|Withdrawal by Subject|0
7836275|NCT00272987|27202804|P1|Overall Study|Withdrawal by Subject|1
7836276|NCT00272987|27202802|P3|Overall Study|Lost to Follow-up|1
7836277|NCT00272987|27202803|P2|Overall Study|Lost to Follow-up|1
7836278|NCT00272987|27202804|P1|Overall Study|Lost to Follow-up|3
7836279|NCT00272987|27202802|P3|Overall Study|Adverse Event|0
7836280|NCT00272987|27202803|P2|Overall Study|Adverse Event|0
7836281|NCT00272987|27202804|P1|Overall Study|Adverse Event|1
7836282|NCT00272961|27202874|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
7836283|NCT00272961|27202875|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
7836284|NCT00272961|27202876|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
7836285|NCT00272961|27202877|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
7836286|NCT00272961|27202878|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
7836287|NCT00272961|27202874|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7836288|NCT00272961|27202875|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7836289|NCT00272961|27202876|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
7836290|NCT00272961|27202877|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7836291|NCT00272961|27202878|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
7836292|NCT00272961|27202874|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
7836293|NCT00272961|27202875|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7836294|NCT00272961|27202876|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
7836295|NCT00272961|27202877|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7836296|NCT00272961|27202878|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
7836297|NCT00272961|27202874|P5|Placebo Run-in Phase: Up to Week 2|Other|0
7836298|NCT00272961|27202875|P4|Placebo Run-in Phase: Up to Week 2|Other|0
7836299|NCT00272961|27202876|P3|Placebo Run-in Phase: Up to Week 2|Other|0
7836300|NCT00272961|27202877|P2|Placebo Run-in Phase: Up to Week 2|Other|0
7836301|NCT00272961|27202878|P1|Placebo Run-in Phase: Up to Week 2|Other|2
7836302|NCT00272961|27202874|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7836303|NCT00272961|27202875|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7836304|NCT00272961|27202876|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7836305|NCT00272961|27202877|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7836306|NCT00272961|27202878|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
7836307|NCT00272961|27202874|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7836308|NCT00272961|27202875|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7836309|NCT00272961|27202876|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7836310|NCT00272961|27202877|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7836311|NCT00272961|27202878|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
7836312|NCT00272961|27202874|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7836313|NCT00272961|27202875|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7836314|NCT00272961|27202876|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7836315|NCT00272961|27202877|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7836316|NCT00272961|27202878|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
7836317|NCT00272961|27202874|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7836318|NCT00272961|27202875|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7836319|NCT00272961|27202876|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7836320|NCT00272961|27202877|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7836321|NCT00272961|27202878|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
7836322|NCT00272844|27202935|P1|Overall Study|Withdrawal by Subject|5
7836323|NCT00272792|27202943|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
7836324|NCT00272792|27202944|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
7836325|NCT00272792|27202943|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
7836326|NCT00272792|27202944|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
7836327|NCT00272792|27202943|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
7836328|NCT00272792|27202944|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
7836329|NCT00272792|27202943|P2|Part 1: Responsiveness|Lost to Follow-up|0
7836330|NCT00272792|27202944|P1|Part 1: Responsiveness|Lost to Follow-up|1
7836331|NCT00272779|27202954|P2|Baseline Through Week 96|Continuing on treatment|38
7836332|NCT00272779|27202955|P1|Baseline Through Week 96|Continuing on treatment|61
7836333|NCT00272779|27202954|P2|Baseline Through Week 96|Never treated|3
7836334|NCT00272779|27202955|P1|Baseline Through Week 96|Never treated|2
7836335|NCT00272779|27202954|P2|Baseline Through Week 96|Pregnancy at Week 96|0
7836336|NCT00272779|27202955|P1|Baseline Through Week 96|Pregnancy at Week 96|1
7836337|NCT00272779|27202954|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
7836338|NCT00272779|27202955|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
7836339|NCT00272779|27202954|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
7836340|NCT00272779|27202955|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
7836341|NCT00272779|27202954|P2|Baseline Through Week 96|Changed address before Week 96|1
7836342|NCT00272779|27202955|P1|Baseline Through Week 96|Changed address before Week 96|0
7836343|NCT00272779|27202954|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
7836344|NCT00272779|27202955|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
7836345|NCT00272779|27202954|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
7836346|NCT00272779|27202955|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
7836347|NCT00272779|27202954|P2|Baseline Through Week 96|Pregnancy before Week 96|7
7836348|NCT00272779|27202955|P1|Baseline Through Week 96|Pregnancy before Week 96|5
7836349|NCT00272779|27202954|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
7836350|NCT00272779|27202955|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
7836351|NCT00272779|27202954|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
7836352|NCT00272779|27202955|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
7836353|NCT00272779|27202954|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
7836354|NCT00272779|27202955|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
7836355|NCT00272779|27202954|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
7836356|NCT00272779|27202955|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
7836357|NCT00272779|27202954|P2|Baseline Through Week 96|Death before Week 96|5
7836358|NCT00272779|27202955|P1|Baseline Through Week 96|Death before Week 96|6
7836359|NCT00272779|27202954|P2|Baseline Through Week 96|Adverse event before Week 96|22
7836360|NCT00272779|27202955|P1|Baseline Through Week 96|Adverse event before Week 96|13
7836361|NCT00272779|27202954|P2|Baseline Through Week 48|Never treated|3
7836362|NCT00272779|27202955|P1|Baseline Through Week 48|Never treated|2
7836363|NCT00272779|27202954|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
7836364|NCT00272779|27202955|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
7836365|NCT00272779|27202954|P2|Baseline Through Week 48|Continuing treatment|368
7836366|NCT00272779|27202955|P1|Baseline Through Week 48|Continuing treatment|385
7836367|NCT00272779|27202954|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
7836368|NCT00272779|27202955|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
7836369|NCT00272779|27202954|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
7836370|NCT00272779|27202955|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
7836371|NCT00272779|27202954|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7836372|NCT00272779|27202955|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7836373|NCT00272779|27202954|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
7836374|NCT00272779|27202955|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
7836375|NCT00272779|27202954|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
7836376|NCT00272779|27202955|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
7836377|NCT00272779|27202954|P2|Baseline Through Week 48|Death on/after Week 48|1
7836378|NCT00272779|27202955|P1|Baseline Through Week 48|Death on/after Week 48|1
7836379|NCT00272779|27202954|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
7836380|NCT00272779|27202955|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
7836381|NCT00272779|27202954|P2|Baseline Through Week 48|Chose different site before wk 48|1
7836382|NCT00272779|27202955|P1|Baseline Through Week 48|Chose different site before wk 48|0
7836383|NCT00272779|27202954|P2|Baseline Through Week 48|Participant's decision before wk 48|1
7836384|NCT00272779|27202955|P1|Baseline Through Week 48|Participant's decision before wk 48|0
7836385|NCT00272779|27202954|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
7836386|NCT00272779|27202955|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
7836387|NCT00272779|27202954|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
7836388|NCT00272779|27202955|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
7836389|NCT00272779|27202954|P2|Baseline Through Week 48|Pregnancy before Week 48|2
7836390|NCT00272779|27202955|P1|Baseline Through Week 48|Pregnancy before Week 48|2
7836391|NCT00272779|27202954|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
7836392|NCT00272779|27202955|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
7836393|NCT00272779|27202954|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
7836394|NCT00272779|27202955|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
7836395|NCT00272779|27202954|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
7836396|NCT00272779|27202955|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
7836397|NCT00272779|27202954|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
7836398|NCT00272779|27202955|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
7836399|NCT00272779|27202954|P2|Baseline Through Week 48|Death before Week 48|4
7836400|NCT00272779|27202955|P1|Baseline Through Week 48|Death before Week 48|4
7836401|NCT00272779|27202954|P2|Baseline Through Week 48|Adverse event before Week 48|14
7836402|NCT00272779|27202955|P1|Baseline Through Week 48|Adverse event before Week 48|10
7836403|NCT00272038|27203215|P1|Overall Study|withdrew before they received 2 cycles|7
7836404|NCT00271947|27203221|P1|Overall Study|Lost to Follow-up|1
7836405|NCT00271856|27203227|P2|Overall Study|Lost to Follow-up|11
7836406|NCT00271856|27203228|P1|Overall Study|Lost to Follow-up|10
7836407|NCT00271856|27203227|P2|Overall Study|Withdrawal by Subject|7
7836408|NCT00271856|27203228|P1|Overall Study|Withdrawal by Subject|1
7836409|NCT00271817|27203247|P3|Part 2|LDL < 50 mg/dL|4
7836410|NCT00271817|27203248|P2|Part 2|LDL < 50 mg/dL|3
7836411|NCT00271817|27203249|P1|Part 2|LDL < 50 mg/dL|0
7836412|NCT00271817|27203247|P3|Part 2|Withdrawal by Subject|13
7836413|NCT00271817|27203248|P2|Part 2|Withdrawal by Subject|2
7836414|NCT00271817|27203249|P1|Part 2|Withdrawal by Subject|0
7836415|NCT00271817|27203247|P3|Part 2|Patient Moved|5
7836416|NCT00271817|27203248|P2|Part 2|Patient Moved|0
7836417|NCT00271817|27203249|P1|Part 2|Patient Moved|0
7836418|NCT00271817|27203247|P3|Part 2|Protocol Violation|5
7836419|NCT00271817|27203248|P2|Part 2|Protocol Violation|3
7836420|NCT00271817|27203249|P1|Part 2|Protocol Violation|0
7836421|NCT00271817|27203247|P3|Part 2|Lost to Follow-up|18
7836422|NCT00271817|27203248|P2|Part 2|Lost to Follow-up|6
7836423|NCT00271817|27203249|P1|Part 2|Lost to Follow-up|0
7836424|NCT00271817|27203247|P3|Part 2|Lack of Efficacy|6
7836425|NCT00271817|27203248|P2|Part 2|Lack of Efficacy|1
7836426|NCT00271817|27203249|P1|Part 2|Lack of Efficacy|0
7836427|NCT00271817|27203247|P3|Part 2|Adverse Event|33
7836428|NCT00271817|27203248|P2|Part 2|Adverse Event|17
7836429|NCT00271817|27203249|P1|Part 2|Adverse Event|0
7836430|NCT00271817|27203247|P3|Part 1|LDL < 50 mg/dL|48
7836431|NCT00271817|27203248|P2|Part 1|LDL < 50 mg/dL|4
7836432|NCT00271817|27203249|P1|Part 1|LDL < 50 mg/dL|1
7836433|NCT00271817|27203247|P3|Part 1|Withdrawal by Subject|45
7836434|NCT00271817|27203248|P2|Part 1|Withdrawal by Subject|17
7836435|NCT00271817|27203249|P1|Part 1|Withdrawal by Subject|23
7836436|NCT00271817|27203247|P3|Part 1|Patient Moved|5
7836437|NCT00271817|27203248|P2|Part 1|Patient Moved|1
7836438|NCT00271817|27203249|P1|Part 1|Patient Moved|3
7836439|NCT00271817|27203247|P3|Part 1|Protocol Violation|7
7836440|NCT00271817|27203248|P2|Part 1|Protocol Violation|4
7836441|NCT00271817|27203249|P1|Part 1|Protocol Violation|5
7836442|NCT00271817|27203247|P3|Part 1|Lost to Follow-up|24
7836443|NCT00271817|27203248|P2|Part 1|Lost to Follow-up|8
7836444|NCT00271817|27203249|P1|Part 1|Lost to Follow-up|6
7836445|NCT00271817|27203247|P3|Part 1|Adverse Event|156
7836446|NCT00271817|27203248|P2|Part 1|Adverse Event|25
7836447|NCT00271817|27203249|P1|Part 1|Adverse Event|68
7836448|NCT00271609|27203291|P2|Overall Study|Withdrawal by Subject|0
7836449|NCT00271609|27203292|P1|Overall Study|Withdrawal by Subject|2
7836450|NCT00271609|27203291|P2|Overall Study|Adverse Event|3
7836451|NCT00271609|27203292|P1|Overall Study|Adverse Event|11
7836452|NCT00271596|27203302|P2|Overall Study|Withdrawal by Subject|1
7836453|NCT00271596|27203303|P1|Overall Study|Withdrawal by Subject|0
7836454|NCT00271596|27203302|P2|Overall Study|Protocol Violation|0
7836455|NCT00271596|27203303|P1|Overall Study|Protocol Violation|1
7836456|NCT00271544|27203338|P1|Overall Study|Implant not attempted|4
7836457|NCT00271544|27203338|P1|Overall Study|Model 4196 lead not attempted|9
7836458|NCT00271544|27203338|P1|Overall Study|Subjects did not receive a 4196 lead|7
7836459|NCT00271505|27203359|P1|Overall Study|Death|1
7836460|NCT00271505|27203359|P1|Overall Study|Adverse Event|1
7836461|NCT00271505|27203359|P1|Overall Study|Screen Failure|3
7836462|NCT00271024|27203458|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
7836463|NCT00271024|27203459|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
7836464|NCT00271024|27203460|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
7836465|NCT00271024|27203461|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
7836466|NCT00271024|27203458|P4|Overall Study|Unpleasant Reaction To Tablet|2
7836467|NCT00271024|27203459|P3|Overall Study|Unpleasant Reaction To Tablet|4
7836468|NCT00271024|27203460|P2|Overall Study|Unpleasant Reaction To Tablet|3
7836469|NCT00271024|27203461|P1|Overall Study|Unpleasant Reaction To Tablet|1
7836470|NCT00271024|27203458|P4|Overall Study|Protocol Violation|11
7836471|NCT00271024|27203459|P3|Overall Study|Protocol Violation|5
7836472|NCT00271024|27203460|P2|Overall Study|Protocol Violation|6
7836473|NCT00271024|27203461|P1|Overall Study|Protocol Violation|1
7836474|NCT00271024|27203458|P4|Overall Study|Unknown/Unspecified|4
7836475|NCT00271024|27203459|P3|Overall Study|Unknown/Unspecified|8
7836476|NCT00271024|27203460|P2|Overall Study|Unknown/Unspecified|11
7836477|NCT00271024|27203461|P1|Overall Study|Unknown/Unspecified|11
7836478|NCT00271024|27203458|P4|Overall Study|Lost Interest|3
7836479|NCT00271024|27203459|P3|Overall Study|Lost Interest|2
7836480|NCT00271024|27203460|P2|Overall Study|Lost Interest|4
7836481|NCT00271024|27203461|P1|Overall Study|Lost Interest|3
7836482|NCT00270998|27203511|P3|12 Month Follow-up|Received/desired alternate treatment|1
7836483|NCT00270998|27203512|P2|12 Month Follow-up|Received/desired alternate treatment|4
7836484|NCT00270998|27203513|P1|12 Month Follow-up|Received/desired alternate treatment|1
7836485|NCT00270998|27203511|P3|12 Month Follow-up|Personal/family health|1
7836486|NCT00270998|27203512|P2|12 Month Follow-up|Personal/family health|5
7836487|NCT00270998|27203513|P1|12 Month Follow-up|Personal/family health|0
7836488|NCT00270998|27203511|P3|12 Month Follow-up|Pessary did not fit|0
7836489|NCT00270998|27203512|P2|12 Month Follow-up|Pessary did not fit|0
7836490|NCT00270998|27203513|P1|12 Month Follow-up|Pessary did not fit|1
7836491|NCT00270998|27203511|P3|12 Month Follow-up|Withdrawal by Subject|16
7836492|NCT00270998|27203512|P2|12 Month Follow-up|Withdrawal by Subject|12
7836493|NCT00270998|27203513|P1|12 Month Follow-up|Withdrawal by Subject|7
7836494|NCT00270998|27203511|P3|12 Month Follow-up|Lack of Efficacy|3
7836495|NCT00270998|27203512|P2|12 Month Follow-up|Lack of Efficacy|4
7836496|NCT00270998|27203513|P1|12 Month Follow-up|Lack of Efficacy|5
7836497|NCT00270998|27203511|P3|3 Month Follow-up|Received/desired alternate treatment|2
7836498|NCT00270998|27203512|P2|3 Month Follow-up|Received/desired alternate treatment|5
7836499|NCT00270998|27203513|P1|3 Month Follow-up|Received/desired alternate treatment|13
7836500|NCT00270998|27203511|P3|3 Month Follow-up|Personal/family health|0
7836501|NCT00270998|27203512|P2|3 Month Follow-up|Personal/family health|1
7836502|NCT00270998|27203513|P1|3 Month Follow-up|Personal/family health|1
7836503|NCT00270998|27203511|P3|3 Month Follow-up|Pessary did not fit|0
7836504|NCT00270998|27203512|P2|3 Month Follow-up|Pessary did not fit|0
7836505|NCT00270998|27203513|P1|3 Month Follow-up|Pessary did not fit|12
7836506|NCT00270998|27203511|P3|3 Month Follow-up|Withdrawal by Subject|15
7836507|NCT00270998|27203512|P2|3 Month Follow-up|Withdrawal by Subject|14
7836508|NCT00270998|27203513|P1|3 Month Follow-up|Withdrawal by Subject|11
7836509|NCT00270998|27203511|P3|3 Month Follow-up|Lack of Efficacy|1
7836510|NCT00270998|27203512|P2|3 Month Follow-up|Lack of Efficacy|2
7836511|NCT00270998|27203513|P1|3 Month Follow-up|Lack of Efficacy|1
7836512|NCT00270998|27203511|P3|3 Month Follow-up|Adverse Event|0
7836513|NCT00270998|27203512|P2|3 Month Follow-up|Adverse Event|0
7836514|NCT00270998|27203513|P1|3 Month Follow-up|Adverse Event|1
7836515|NCT00270894|27203542|P1|Overall Study|Withdrawal by Subject|1
7836516|NCT00270894|27203542|P1|Overall Study|Adverse Event|1
7836517|NCT00270855|27203554|P2|Overall Study|Withdrawal by Subject|8
7836518|NCT00270855|27203555|P1|Overall Study|Withdrawal by Subject|8
7836608|NCT00268905|27204059|P1|Overall Study|Lost to Follow-up|0
7836519|NCT00270257|27203691|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
7836520|NCT00270257|27203692|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
7836521|NCT00270231|27203710|P2|Second Intervention|Lost to Follow-up|1
7836522|NCT00270231|27203711|P1|Second Intervention|Lost to Follow-up|0
7836523|NCT00270231|27203710|P2|Washout Period|Lost to Follow-up|0
7836524|NCT00270231|27203711|P1|Washout Period|Lost to Follow-up|1
7836525|NCT00270231|27203710|P2|First Intervention|Lost to Follow-up|1
7836526|NCT00270231|27203711|P1|First Intervention|Lost to Follow-up|1
7836527|NCT00270205|27203721|P4|Overall Study|Lost to Follow-up|1
7836528|NCT00270205|27203722|P3|Overall Study|Lost to Follow-up|0
7836529|NCT00270205|27203723|P2|Overall Study|Lost to Follow-up|0
7836530|NCT00270205|27203724|P1|Overall Study|Lost to Follow-up|1
7836531|NCT00269919|27203842|P1|Overall Study|Started but not treated|1
7836532|NCT00269919|27203842|P1|Overall Study|Other|26
7836533|NCT00269633|27203861|P2|Overall Study|Withdrawal by Subject|0
7836534|NCT00269633|27203862|P1|Overall Study|Withdrawal by Subject|1
7836535|NCT00269477|27203872|P4|Overall Study|Missed post-vaccination blood draw|0
7836536|NCT00269477|27203873|P3|Overall Study|Missed post-vaccination blood draw|0
7836537|NCT00269477|27203874|P2|Overall Study|Missed post-vaccination blood draw|1
7836538|NCT00269477|27203875|P1|Overall Study|Missed post-vaccination blood draw|0
7836539|NCT00269477|27203872|P4|Overall Study|Protocol Violation|0
7836540|NCT00269477|27203873|P3|Overall Study|Protocol Violation|1
7836541|NCT00269477|27203874|P2|Overall Study|Protocol Violation|5
7836542|NCT00269477|27203875|P1|Overall Study|Protocol Violation|5
7836543|NCT00269399|27203891|P2|Overall Study|Development of exclusion criteria|1
7836544|NCT00269399|27203892|P1|Overall Study|Development of exclusion criteria|0
7836545|NCT00269399|27203891|P2|Overall Study|Other|4
7836546|NCT00269399|27203892|P1|Overall Study|Other|0
7836547|NCT00269399|27203891|P2|Overall Study|Negative Lab Result for C. difficile|3
7836548|NCT00269399|27203892|P1|Overall Study|Negative Lab Result for C. difficile|2
7836549|NCT00269399|27203891|P2|Overall Study|Withdrawal by Subject|5
7836550|NCT00269399|27203892|P1|Overall Study|Withdrawal by Subject|2
7836551|NCT00269399|27203891|P2|Overall Study|Adverse Event|4
7836552|NCT00269399|27203892|P1|Overall Study|Adverse Event|10
7836553|NCT00269399|27203891|P2|Overall Study|Lack of Efficacy|10
7836554|NCT00269399|27203892|P1|Overall Study|Lack of Efficacy|27
7836555|NCT00269152|27203902|P2|Overall Study|Protocol Violation|1
7836556|NCT00269152|27203903|P1|Overall Study|Protocol Violation|0
7836557|NCT00269152|27203902|P2|Overall Study|Physician Decision|3
7836558|NCT00269152|27203903|P1|Overall Study|Physician Decision|2
7836559|NCT00269152|27203902|P2|Overall Study|Withdrawal by Subject|3
7836560|NCT00269152|27203903|P1|Overall Study|Withdrawal by Subject|7
7836561|NCT00269152|27203902|P2|Overall Study|Adverse Event|3
7836562|NCT00269152|27203903|P1|Overall Study|Adverse Event|9
7836563|NCT00269113|27203919|P2|Overall Study|Other|2
7836564|NCT00269113|27203920|P1|Overall Study|Other|0
7836565|NCT00269113|27203919|P2|Overall Study|Protocol Violation|5
7836566|NCT00269113|27203920|P1|Overall Study|Protocol Violation|15
7836567|NCT00269113|27203919|P2|Overall Study|Lost to Follow-up|1
7836568|NCT00269113|27203920|P1|Overall Study|Lost to Follow-up|2
7836569|NCT00269113|27203919|P2|Overall Study|Death|2
7836570|NCT00269113|27203920|P1|Overall Study|Death|6
7836571|NCT00269113|27203919|P2|Overall Study|Withdrawal by Subject|2
7836572|NCT00269113|27203920|P1|Overall Study|Withdrawal by Subject|0
7836573|NCT00269113|27203919|P2|Overall Study|Early Improvement|0
7836574|NCT00269113|27203920|P1|Overall Study|Early Improvement|2
7836575|NCT00269113|27203919|P2|Overall Study|Lack of Efficacy|18
7836576|NCT00269113|27203920|P1|Overall Study|Lack of Efficacy|35
7836577|NCT00269113|27203919|P2|Overall Study|Adverse Event|7
7836578|NCT00269113|27203920|P1|Overall Study|Adverse Event|14
7836579|NCT00269087|27203938|P1|Overall Study|Exacerbation of COPD|13
7836580|NCT00269087|27203938|P1|Overall Study|Withdrawal by Subject|1
7836581|NCT00269087|27203938|P1|Overall Study|Adverse Event|20
7836582|NCT00268996|27203968|P2|Overall Study|Other|1
7836583|NCT00268996|27203969|P1|Overall Study|Other|1
7836584|NCT00268996|27203968|P2|Overall Study|Non-compliance|0
7836585|NCT00268996|27203969|P1|Overall Study|Non-compliance|1
7836586|NCT00268996|27203968|P2|Overall Study|Withdrawal by Subject|11
7836587|NCT00268996|27203969|P1|Overall Study|Withdrawal by Subject|5
7836588|NCT00268996|27203968|P2|Overall Study|Lost to Follow-up|1
7836589|NCT00268996|27203969|P1|Overall Study|Lost to Follow-up|3
7836590|NCT00268996|27203968|P2|Overall Study|Adverse Event|7
7836591|NCT00268996|27203969|P1|Overall Study|Adverse Event|11
7836592|NCT00268983|27204013|P2|Overall Study|Death|0
7836593|NCT00268983|27204014|P1|Overall Study|Death|3
7836594|NCT00268905|27204057|P3|Overall Study|Clinical Progression|1
7836595|NCT00268905|27204058|P2|Overall Study|Clinical Progression|4
7836596|NCT00268905|27204059|P1|Overall Study|Clinical Progression|9
7836597|NCT00268905|27204057|P3|Overall Study|Physician Decision|1
7836598|NCT00268905|27204058|P2|Overall Study|Physician Decision|0
7836599|NCT00268905|27204059|P1|Overall Study|Physician Decision|3
7836600|NCT00268905|27204057|P3|Overall Study|Progressive Disease|3
7836601|NCT00268905|27204058|P2|Overall Study|Progressive Disease|4
7836602|NCT00268905|27204059|P1|Overall Study|Progressive Disease|28
7836603|NCT00268905|27204057|P3|Overall Study|Withdrawal by Subject|3
7836604|NCT00268905|27204058|P2|Overall Study|Withdrawal by Subject|0
7836605|NCT00268905|27204059|P1|Overall Study|Withdrawal by Subject|0
7836606|NCT00268905|27204057|P3|Overall Study|Lost to Follow-up|0
7836607|NCT00268905|27204058|P2|Overall Study|Lost to Follow-up|1
7836609|NCT00268905|27204057|P3|Overall Study|Adverse Event|4
7836610|NCT00268905|27204058|P2|Overall Study|Adverse Event|0
7836611|NCT00268905|27204059|P1|Overall Study|Adverse Event|3
7836612|NCT00268892|27204076|P3|Overall Study|Trial Site Closed|2
7836613|NCT00268892|27204077|P2|Overall Study|Trial Site Closed|2
7836614|NCT00268892|27204078|P1|Overall Study|Trial Site Closed|4
7836615|NCT00268892|27204076|P3|Overall Study|Disease Progression|0
7836616|NCT00268892|27204077|P2|Overall Study|Disease Progression|1
7836617|NCT00268892|27204078|P1|Overall Study|Disease Progression|1
7836618|NCT00268892|27204076|P3|Overall Study|Protocol Violation|0
7836619|NCT00268892|27204077|P2|Overall Study|Protocol Violation|1
7836620|NCT00268892|27204078|P1|Overall Study|Protocol Violation|0
7836621|NCT00268892|27204076|P3|Overall Study|Lost to Follow-up|4
7836622|NCT00268892|27204077|P2|Overall Study|Lost to Follow-up|2
7836623|NCT00268892|27204078|P1|Overall Study|Lost to Follow-up|5
7836624|NCT00268892|27204076|P3|Overall Study|Physician Decision|0
7836625|NCT00268892|27204077|P2|Overall Study|Physician Decision|1
7836626|NCT00268892|27204078|P1|Overall Study|Physician Decision|0
7836627|NCT00268892|27204076|P3|Overall Study|Withdrawal by Subject|13
7836628|NCT00268892|27204077|P2|Overall Study|Withdrawal by Subject|15
7836629|NCT00268892|27204078|P1|Overall Study|Withdrawal by Subject|14
7836630|NCT00268892|27204076|P3|Overall Study|Lack of Efficacy|0
7836631|NCT00268892|27204077|P2|Overall Study|Lack of Efficacy|3
7836632|NCT00268892|27204078|P1|Overall Study|Lack of Efficacy|1
7836633|NCT00268892|27204076|P3|Overall Study|Adverse Event|20
7836634|NCT00268892|27204077|P2|Overall Study|Adverse Event|17
7836635|NCT00268892|27204078|P1|Overall Study|Adverse Event|14
7836636|NCT00268463|27204097|P2|Overall Study|study terminated due to low accrual|12
7836637|NCT00268463|27204098|P1|Overall Study|study terminated due to low accrual|10
7836638|NCT00268437|27204114|P1|Overall Study|Ineligible|1
7836639|NCT00268346|27204121|P2|Overall Study|Withdrawal by Subject|1
7836640|NCT00268346|27204122|P1|Overall Study|Withdrawal by Subject|0
7836641|NCT00268346|27204121|P2|Overall Study|Death|1
7836642|NCT00268346|27204122|P1|Overall Study|Death|0
7836643|NCT00268346|27204121|P2|Overall Study|Adverse Event|1
7836644|NCT00268346|27204122|P1|Overall Study|Adverse Event|0
7836645|NCT00268242|27204128|P1|Overall Study|Death|1
7836646|NCT00268203|27204137|P1|Overall Study|Completed 2 Years of Follow-up|62
7836647|NCT00268203|27204137|P1|Overall Study|Reason Not Specified|34
7836648|NCT00268203|27204137|P1|Overall Study|Death|84
7836649|NCT00268203|27204137|P1|Overall Study|Progressive Disease|359
7836650|NCT00268203|27204137|P1|Overall Study|Received Other NHL Therapy|7
7836651|NCT00268203|27204137|P1|Overall Study|Withdrawal by Subject|9
7836652|NCT00268203|27204137|P1|Overall Study|Lost to Follow-up|92
7836653|NCT00267969|27204151|P7|After Controlled Period|Other|25
7836654|NCT00267969|27204152|P6|After Controlled Period|Other|22
7836655|NCT00267969|27204153|P5|After Controlled Period|Other|11
7836656|NCT00267969|27204154|P4|After Controlled Period|Other|13
7836657|NCT00267969|27204155|P3|After Controlled Period|Other|0
7836658|NCT00267969|27204156|P2|After Controlled Period|Other|0
7836659|NCT00267969|27204157|P1|After Controlled Period|Other|0
7836660|NCT00267969|27204151|P7|After Controlled Period|Lost to Follow-up|10
7836661|NCT00267969|27204152|P6|After Controlled Period|Lost to Follow-up|9
7836662|NCT00267969|27204153|P5|After Controlled Period|Lost to Follow-up|8
7836663|NCT00267969|27204154|P4|After Controlled Period|Lost to Follow-up|5
7836664|NCT00267969|27204155|P3|After Controlled Period|Lost to Follow-up|0
7836665|NCT00267969|27204156|P2|After Controlled Period|Lost to Follow-up|0
7836666|NCT00267969|27204157|P1|After Controlled Period|Lost to Follow-up|0
7836667|NCT00267969|27204151|P7|After Controlled Period|Lack of Efficacy|15
7836668|NCT00267969|27204152|P6|After Controlled Period|Lack of Efficacy|28
7836669|NCT00267969|27204153|P5|After Controlled Period|Lack of Efficacy|6
7836670|NCT00267969|27204154|P4|After Controlled Period|Lack of Efficacy|10
7836671|NCT00267969|27204155|P3|After Controlled Period|Lack of Efficacy|0
7836672|NCT00267969|27204156|P2|After Controlled Period|Lack of Efficacy|0
7836673|NCT00267969|27204157|P1|After Controlled Period|Lack of Efficacy|0
7836674|NCT00267969|27204151|P7|After Controlled Period|Death|1
7836675|NCT00267969|27204152|P6|After Controlled Period|Death|0
7836676|NCT00267969|27204153|P5|After Controlled Period|Death|2
7836677|NCT00267969|27204154|P4|After Controlled Period|Death|1
7836678|NCT00267969|27204155|P3|After Controlled Period|Death|0
7836679|NCT00267969|27204156|P2|After Controlled Period|Death|0
7836680|NCT00267969|27204157|P1|After Controlled Period|Death|0
7836681|NCT00267969|27204151|P7|After Controlled Period|Adverse Event|21
7836682|NCT00267969|27204152|P6|After Controlled Period|Adverse Event|23
7836683|NCT00267969|27204153|P5|After Controlled Period|Adverse Event|8
7836684|NCT00267969|27204154|P4|After Controlled Period|Adverse Event|7
7836685|NCT00267969|27204155|P3|After Controlled Period|Adverse Event|0
7836686|NCT00267969|27204156|P2|After Controlled Period|Adverse Event|0
7836687|NCT00267969|27204157|P1|After Controlled Period|Adverse Event|0
7836688|NCT00267969|27204151|P7|Controlled Period|Other|0
7836689|NCT00267969|27204152|P6|Controlled Period|Other|0
7836690|NCT00267969|27204153|P5|Controlled Period|Other|0
7836691|NCT00267969|27204154|P4|Controlled Period|Other|0
7836692|NCT00267969|27204155|P3|Controlled Period|Other|6
7836693|NCT00267969|27204156|P2|Controlled Period|Other|1
7836694|NCT00267969|27204157|P1|Controlled Period|Other|2
7836695|NCT00267969|27204151|P7|Controlled Period|Randomized but not treated|0
7836696|NCT00267969|27204152|P6|Controlled Period|Randomized but not treated|0
7836697|NCT00267969|27204153|P5|Controlled Period|Randomized but not treated|0
7836698|NCT00267969|27204154|P4|Controlled Period|Randomized but not treated|0
7836699|NCT00267969|27204155|P3|Controlled Period|Randomized but not treated|1
7836700|NCT00267969|27204156|P2|Controlled Period|Randomized but not treated|0
7836701|NCT00267969|27204157|P1|Controlled Period|Randomized but not treated|0
7836702|NCT00267969|27204151|P7|Controlled Period|Lost to Follow-up|0
7836703|NCT00267969|27204152|P6|Controlled Period|Lost to Follow-up|0
7836704|NCT00267969|27204153|P5|Controlled Period|Lost to Follow-up|0
7836705|NCT00267969|27204154|P4|Controlled Period|Lost to Follow-up|0
7836706|NCT00267969|27204155|P3|Controlled Period|Lost to Follow-up|1
7836707|NCT00267969|27204156|P2|Controlled Period|Lost to Follow-up|0
7836708|NCT00267969|27204157|P1|Controlled Period|Lost to Follow-up|1
7836709|NCT00267969|27204151|P7|Controlled Period|Lack of Efficacy|0
7836710|NCT00267969|27204152|P6|Controlled Period|Lack of Efficacy|0
7836711|NCT00267969|27204153|P5|Controlled Period|Lack of Efficacy|0
7836712|NCT00267969|27204154|P4|Controlled Period|Lack of Efficacy|0
7836713|NCT00267969|27204155|P3|Controlled Period|Lack of Efficacy|1
7836714|NCT00267969|27204156|P2|Controlled Period|Lack of Efficacy|0
7836715|NCT00267969|27204157|P1|Controlled Period|Lack of Efficacy|3
7836716|NCT00267969|27204151|P7|Controlled Period|Adverse Event|0
7836717|NCT00267969|27204152|P6|Controlled Period|Adverse Event|0
7836718|NCT00267969|27204153|P5|Controlled Period|Adverse Event|0
7836719|NCT00267969|27204154|P4|Controlled Period|Adverse Event|0
7836720|NCT00267969|27204155|P3|Controlled Period|Adverse Event|2
7836721|NCT00267969|27204156|P2|Controlled Period|Adverse Event|0
7836722|NCT00267969|27204157|P1|Controlled Period|Adverse Event|6
7836723|NCT00267956|27204183|P4|After Controlled Period|Withdrew consent|0
7836724|NCT00267956|27204184|P3|After Controlled Period|Withdrew consent|1
7836725|NCT00267956|27204185|P2|After Controlled Period|Withdrew consent|0
7836726|NCT00267956|27204186|P1|After Controlled Period|Withdrew consent|0
7836727|NCT00267956|27204183|P4|After Controlled Period|Lost to Follow-up|0
7836728|NCT00267956|27204184|P3|After Controlled Period|Lost to Follow-up|1
7836729|NCT00267956|27204185|P2|After Controlled Period|Lost to Follow-up|0
7836730|NCT00267956|27204186|P1|After Controlled Period|Lost to Follow-up|0
7836731|NCT00267956|27204183|P4|After Controlled Period|Lack of Efficacy|1
7836732|NCT00267956|27204184|P3|After Controlled Period|Lack of Efficacy|1
7836733|NCT00267956|27204185|P2|After Controlled Period|Lack of Efficacy|0
7836734|NCT00267956|27204186|P1|After Controlled Period|Lack of Efficacy|0
7836735|NCT00267956|27204183|P4|After Controlled Period|Adverse Event|1
7836736|NCT00267956|27204184|P3|After Controlled Period|Adverse Event|2
7836737|NCT00267956|27204185|P2|After Controlled Period|Adverse Event|0
7836738|NCT00267956|27204186|P1|After Controlled Period|Adverse Event|0
7836739|NCT00267956|27204183|P4|Controlled Period|Withdrew consent|0
7836740|NCT00267956|27204184|P3|Controlled Period|Withdrew consent|0
7836741|NCT00267956|27204185|P2|Controlled Period|Withdrew consent|1
7836742|NCT00267956|27204186|P1|Controlled Period|Withdrew consent|3
7836743|NCT00267956|27204183|P4|Controlled Period|Lost to Follow-up|0
7836744|NCT00267956|27204184|P3|Controlled Period|Lost to Follow-up|0
7836745|NCT00267956|27204185|P2|Controlled Period|Lost to Follow-up|0
7836746|NCT00267956|27204186|P1|Controlled Period|Lost to Follow-up|2
7836747|NCT00267956|27204183|P4|Controlled Period|Lack of Efficacy|0
7836748|NCT00267956|27204184|P3|Controlled Period|Lack of Efficacy|0
7836749|NCT00267956|27204185|P2|Controlled Period|Lack of Efficacy|2
7836750|NCT00267956|27204186|P1|Controlled Period|Lack of Efficacy|4
7836751|NCT00267956|27204183|P4|Controlled Period|Adverse Event|0
7836752|NCT00267956|27204184|P3|Controlled Period|Adverse Event|0
7836753|NCT00267956|27204185|P2|Controlled Period|Adverse Event|1
7836754|NCT00267956|27204186|P1|Controlled Period|Adverse Event|4
7836755|NCT00267865|27204204|P1|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
7836756|NCT00267865|27204204|P1|Induction Treatment|Died before completing.|2
7836757|NCT00267748|27204227|P3|Randomized Period|randomized but not treated|3
7836758|NCT00267748|27204228|P2|Randomized Period|randomized but not treated|0
7836759|NCT00267748|27204229|P1|Randomized Period|randomized but not treated|0
7836760|NCT00267748|27204227|P3|Randomized Period|Other|6
7836761|NCT00267748|27204228|P2|Randomized Period|Other|9
7836762|NCT00267748|27204229|P1|Randomized Period|Other|0
7836763|NCT00267748|27204227|P3|Randomized Period|Withdrawal by Subject|2
7836764|NCT00267748|27204228|P2|Randomized Period|Withdrawal by Subject|9
7836765|NCT00267748|27204229|P1|Randomized Period|Withdrawal by Subject|0
7836766|NCT00267748|27204227|P3|Randomized Period|Objective progression or relapse|86
7836767|NCT00267748|27204228|P2|Randomized Period|Objective progression or relapse|77
7836768|NCT00267748|27204229|P1|Randomized Period|Objective progression or relapse|0
7836769|NCT00267748|27204227|P3|Randomized Period|Lost to Follow-up|0
7836770|NCT00267748|27204228|P2|Randomized Period|Lost to Follow-up|1
7836771|NCT00267748|27204229|P1|Randomized Period|Lost to Follow-up|0
7836772|NCT00267748|27204227|P3|Randomized Period|Global deterioration of health status|7
7836773|NCT00267748|27204228|P2|Randomized Period|Global deterioration of health status|6
7836774|NCT00267748|27204229|P1|Randomized Period|Global deterioration of health status|0
7836775|NCT00267748|27204227|P3|Randomized Period|Adverse Event|25
7836776|NCT00267748|27204228|P2|Randomized Period|Adverse Event|23
7836777|NCT00267748|27204229|P1|Randomized Period|Adverse Event|0
7836778|NCT00267748|27204227|P3|Randomized Period|Death|3
7836779|NCT00267748|27204228|P2|Randomized Period|Death|2
7836780|NCT00267748|27204229|P1|Randomized Period|Death|0
7836781|NCT00267748|27204227|P3|Non-randomized Period|Other|0
7836782|NCT00267748|27204228|P2|Non-randomized Period|Other|0
7836783|NCT00267748|27204229|P1|Non-randomized Period|Other|3
7836784|NCT00267748|27204227|P3|Non-randomized Period|Participant not willing to participate|0
7836785|NCT00267748|27204228|P2|Non-randomized Period|Participant not willing to participate|0
7836786|NCT00267748|27204229|P1|Non-randomized Period|Participant not willing to participate|1
7836787|NCT00267748|27204227|P3|Non-randomized Period|Death|0
7836788|NCT00267748|27204228|P2|Non-randomized Period|Death|0
7836789|NCT00267748|27204229|P1|Non-randomized Period|Death|1
7836790|NCT00267748|27204227|P3|Non-randomized Period|Adverse Event|0
7836791|NCT00267748|27204228|P2|Non-randomized Period|Adverse Event|0
7836792|NCT00267748|27204229|P1|Non-randomized Period|Adverse Event|8
7836793|NCT00267748|27204227|P3|Non-randomized Period|Progressive disease|0
7836794|NCT00267748|27204228|P2|Non-randomized Period|Progressive disease|0
7836795|NCT00267748|27204229|P1|Non-randomized Period|Progressive disease|10
7836796|NCT00267488|27204286|P1|Overall Study|Other (Disease Progression)|1
7836797|NCT00267488|27204286|P1|Overall Study|Protocol Violation|1
7836798|NCT00267488|27204286|P1|Overall Study|Sponsor Terminated Study|9
7836799|NCT00267202|27204310|P2|Overall Study|Lost to Follow-up|0
7836800|NCT00267202|27204311|P1|Overall Study|Lost to Follow-up|3
7836801|NCT00267202|27204310|P2|Overall Study|Administrative problems|1
7836802|NCT00267202|27204311|P1|Overall Study|Administrative problems|2
7836803|NCT00267202|27204310|P2|Overall Study|Protocol Violation|3
7836804|NCT00267202|27204311|P1|Overall Study|Protocol Violation|2
7836805|NCT00267202|27204310|P2|Overall Study|Adverse Event|7
7836806|NCT00267202|27204311|P1|Overall Study|Adverse Event|13
7836807|NCT00267202|27204310|P2|Overall Study|Withdrawal by Subject|15
7836808|NCT00267202|27204311|P1|Overall Study|Withdrawal by Subject|12
7836809|NCT00267202|27204310|P2|Overall Study|Unsatisfactory therapeutic effect|8
7836810|NCT00267202|27204311|P1|Overall Study|Unsatisfactory therapeutic effect|21
7836811|NCT00267189|27204332|P2|Overall Study|Missing|0
7836812|NCT00267189|27204333|P1|Overall Study|Missing|3
7836813|NCT00267189|27204332|P2|Overall Study|Death|0
7836814|NCT00267189|27204333|P1|Overall Study|Death|1
7836815|NCT00267189|27204332|P2|Overall Study|Patient withdrew consent|1
7836816|NCT00267189|27204333|P1|Overall Study|Patient withdrew consent|1
7836817|NCT00267150|27204343|P1|Overall Study|Adverse Event|1
7836818|NCT00267098|27204367|P8|Overall Study|Sponsor withdrew subject|0
7836819|NCT00267098|27204368|P7|Overall Study|Sponsor withdrew subject|0
7836820|NCT00267098|27204369|P6|Overall Study|Sponsor withdrew subject|0
7836821|NCT00267098|27204370|P5|Overall Study|Sponsor withdrew subject|0
7836822|NCT00267098|27204371|P4|Overall Study|Sponsor withdrew subject|1
7836823|NCT00267098|27204372|P3|Overall Study|Sponsor withdrew subject|0
7836824|NCT00267098|27204373|P2|Overall Study|Sponsor withdrew subject|0
7836825|NCT00267098|27204374|P1|Overall Study|Sponsor withdrew subject|0
7836826|NCT00267098|27204367|P8|Overall Study|Subject listed for heart transplant|0
7836827|NCT00267098|27204368|P7|Overall Study|Subject listed for heart transplant|1
7836828|NCT00267098|27204369|P6|Overall Study|Subject listed for heart transplant|0
7836829|NCT00267098|27204370|P5|Overall Study|Subject listed for heart transplant|0
7836830|NCT00267098|27204371|P4|Overall Study|Subject listed for heart transplant|0
7836831|NCT00267098|27204372|P3|Overall Study|Subject listed for heart transplant|0
7836832|NCT00267098|27204373|P2|Overall Study|Subject listed for heart transplant|0
7836833|NCT00267098|27204374|P1|Overall Study|Subject listed for heart transplant|0
7836834|NCT00267098|27204367|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
7836835|NCT00267098|27204368|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
7836836|NCT00267098|27204369|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
7836837|NCT00267098|27204370|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
7836838|NCT00267098|27204371|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
7836839|NCT00267098|27204372|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
7836840|NCT00267098|27204373|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
7836841|NCT00267098|27204374|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
7836842|NCT00267098|27204367|P8|Overall Study|Explanted Medtronic device|0
7836843|NCT00267098|27204368|P7|Overall Study|Explanted Medtronic device|0
7836844|NCT00267098|27204369|P6|Overall Study|Explanted Medtronic device|0
7836845|NCT00267098|27204370|P5|Overall Study|Explanted Medtronic device|0
7836846|NCT00267098|27204371|P4|Overall Study|Explanted Medtronic device|1
7836847|NCT00267098|27204372|P3|Overall Study|Explanted Medtronic device|0
7836848|NCT00267098|27204373|P2|Overall Study|Explanted Medtronic device|0
7836849|NCT00267098|27204374|P1|Overall Study|Explanted Medtronic device|0
7836850|NCT00267098|27204367|P8|Overall Study|Site closure|0
7836851|NCT00267098|27204368|P7|Overall Study|Site closure|1
7836852|NCT00267098|27204369|P6|Overall Study|Site closure|1
7836853|NCT00267098|27204370|P5|Overall Study|Site closure|0
7836854|NCT00267098|27204371|P4|Overall Study|Site closure|1
7836855|NCT00267098|27204372|P3|Overall Study|Site closure|0
7836856|NCT00267098|27204373|P2|Overall Study|Site closure|0
7836857|NCT00267098|27204374|P1|Overall Study|Site closure|0
7836858|NCT00267098|27204367|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836859|NCT00267098|27204368|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836860|NCT00267098|27204369|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836861|NCT00267098|27204370|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836862|NCT00267098|27204371|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836863|NCT00267098|27204372|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836864|NCT00267098|27204373|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
7836865|NCT00267098|27204374|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7836866|NCT00267098|27204367|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7836867|NCT00267098|27204368|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7836868|NCT00267098|27204369|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7836869|NCT00267098|27204370|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7836870|NCT00267098|27204371|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7836871|NCT00267098|27204372|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7836872|NCT00267098|27204373|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7836873|NCT00267098|27204374|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
7836874|NCT00267098|27204367|P8|Overall Study|Physician Decision|0
7836875|NCT00267098|27204368|P7|Overall Study|Physician Decision|3
7836876|NCT00267098|27204369|P6|Overall Study|Physician Decision|4
7836877|NCT00267098|27204370|P5|Overall Study|Physician Decision|5
7836878|NCT00267098|27204371|P4|Overall Study|Physician Decision|11
7836879|NCT00267098|27204372|P3|Overall Study|Physician Decision|7
7836880|NCT00267098|27204373|P2|Overall Study|Physician Decision|0
7836881|NCT00267098|27204374|P1|Overall Study|Physician Decision|5
7836882|NCT00267098|27204367|P8|Overall Study|Withdrawal by Subject|5
7836883|NCT00267098|27204368|P7|Overall Study|Withdrawal by Subject|12
7836884|NCT00267098|27204369|P6|Overall Study|Withdrawal by Subject|9
7836885|NCT00267098|27204370|P5|Overall Study|Withdrawal by Subject|12
7836886|NCT00267098|27204371|P4|Overall Study|Withdrawal by Subject|21
7836887|NCT00267098|27204372|P3|Overall Study|Withdrawal by Subject|24
7836888|NCT00267098|27204373|P2|Overall Study|Withdrawal by Subject|0
7836889|NCT00267098|27204374|P1|Overall Study|Withdrawal by Subject|8
7836890|NCT00267098|27204367|P8|Overall Study|Lost to Follow-up|1
7836891|NCT00267098|27204368|P7|Overall Study|Lost to Follow-up|1
7836892|NCT00267098|27204369|P6|Overall Study|Lost to Follow-up|3
7836893|NCT00267098|27204370|P5|Overall Study|Lost to Follow-up|2
7836894|NCT00267098|27204371|P4|Overall Study|Lost to Follow-up|5
7836895|NCT00267098|27204372|P3|Overall Study|Lost to Follow-up|6
7836896|NCT00267098|27204373|P2|Overall Study|Lost to Follow-up|0
7836897|NCT00267098|27204374|P1|Overall Study|Lost to Follow-up|0
7836898|NCT00267098|27204367|P8|Overall Study|Death|9
7836899|NCT00267098|27204368|P7|Overall Study|Death|28
7836900|NCT00267098|27204369|P6|Overall Study|Death|23
7836901|NCT00267098|27204370|P5|Overall Study|Death|14
7836902|NCT00267098|27204371|P4|Overall Study|Death|66
7836903|NCT00267098|27204372|P3|Overall Study|Death|57
7836904|NCT00267098|27204373|P2|Overall Study|Death|0
7836905|NCT00267098|27204374|P1|Overall Study|Death|0
7836906|NCT00267046|27204517|P2|Overall Study|Radiation|1
7836907|NCT00267046|27204518|P1|Overall Study|Radiation|0
7836908|NCT00267046|27204517|P2|Overall Study|Withdrawal by Subject|0
7836909|NCT00267046|27204518|P1|Overall Study|Withdrawal by Subject|1
7836910|NCT00267046|27204517|P2|Overall Study|Surgery|1
7836911|NCT00267046|27204518|P1|Overall Study|Surgery|3
7836912|NCT00267046|27204517|P2|Overall Study|Open-label palifermin|7
7836913|NCT00267046|27204518|P1|Overall Study|Open-label palifermin|2
7836914|NCT00267046|27204517|P2|Overall Study|Chemotoxicity|0
7836915|NCT00267046|27204518|P1|Overall Study|Chemotoxicity|2
7836916|NCT00267046|27204517|P2|Overall Study|Disease progression|2
7836917|NCT00267046|27204518|P1|Overall Study|Disease progression|4
7836918|NCT00267020|27204528|P2|Overall Study|Other|2
7836919|NCT00267020|27204529|P1|Overall Study|Other|1
7836920|NCT00267020|27204528|P2|Overall Study|Sponsor Request|0
7836921|NCT00267020|27204529|P1|Overall Study|Sponsor Request|1
7836922|NCT00267020|27204528|P2|Overall Study|Unrelated Complication|1
7836923|NCT00267020|27204529|P1|Overall Study|Unrelated Complication|1
7836924|NCT00267020|27204528|P2|Overall Study|Disease Progression|25
7836925|NCT00267020|27204529|P1|Overall Study|Disease Progression|39
7836926|NCT00267020|27204528|P2|Overall Study|Physician Decision|2
7836927|NCT00267020|27204529|P1|Overall Study|Physician Decision|3
7836928|NCT00267020|27204528|P2|Overall Study|Withdrawal by Subject|7
7836929|NCT00267020|27204529|P1|Overall Study|Withdrawal by Subject|17
7836930|NCT00267020|27204528|P2|Overall Study|Death|1
7836931|NCT00267020|27204529|P1|Overall Study|Death|2
7836932|NCT00267020|27204528|P2|Overall Study|Adverse Event|5
7836933|NCT00267020|27204529|P1|Overall Study|Adverse Event|22
7836934|NCT00267007|27204551|P2|Overall Study|Adverse Event|0
7836935|NCT00267007|27204552|P1|Overall Study|Adverse Event|1
7836936|NCT00267007|27204551|P2|Overall Study|Non-compliance|1
7836937|NCT00267007|27204552|P1|Overall Study|Non-compliance|0
7836938|NCT00267007|27204551|P2|Overall Study|Lost to Follow-up|0
7836939|NCT00267007|27204552|P1|Overall Study|Lost to Follow-up|1
7836940|NCT00267007|27204551|P2|Overall Study|Withdrawal by Subject|0
7836941|NCT00267007|27204552|P1|Overall Study|Withdrawal by Subject|6
7836942|NCT00266877|27204563|P3|Overall Study|Concomitant Radiotherapy|0
7836943|NCT00266877|27204564|P2|Overall Study|Concomitant Radiotherapy|1
7836944|NCT00266877|27204565|P1|Overall Study|Concomitant Radiotherapy|0
7836945|NCT00266877|27204563|P3|Overall Study|Hospitalization|0
7836946|NCT00266877|27204564|P2|Overall Study|Hospitalization|0
7836947|NCT00266877|27204565|P1|Overall Study|Hospitalization|1
7836948|NCT00266877|27204563|P3|Overall Study|Symptomatic Deterioration|1
7836949|NCT00266877|27204564|P2|Overall Study|Symptomatic Deterioration|3
7836950|NCT00266877|27204565|P1|Overall Study|Symptomatic Deterioration|6
7836951|NCT00266877|27204563|P3|Overall Study|Disease Progression|23
7836952|NCT00266877|27204564|P2|Overall Study|Disease Progression|37
7836953|NCT00266877|27204565|P1|Overall Study|Disease Progression|72
7836954|NCT00266877|27204563|P3|Overall Study|Withdrawal by Subject|1
7836955|NCT00266877|27204564|P2|Overall Study|Withdrawal by Subject|1
7836956|NCT00266877|27204565|P1|Overall Study|Withdrawal by Subject|3
7836957|NCT00266877|27204563|P3|Overall Study|Physician Decision|1
7836958|NCT00266877|27204564|P2|Overall Study|Physician Decision|1
7836959|NCT00266877|27204565|P1|Overall Study|Physician Decision|2
7836960|NCT00266877|27204563|P3|Overall Study|Adverse Event|1
7836961|NCT00266877|27204564|P2|Overall Study|Adverse Event|4
7836962|NCT00266877|27204565|P1|Overall Study|Adverse Event|6
7836963|NCT00266877|27204563|P3|Overall Study|Death|1
7836964|NCT00266877|27204564|P2|Overall Study|Death|1
7836965|NCT00266877|27204565|P1|Overall Study|Death|1
7836966|NCT00266864|27204584|P2|Overall Study|Withdrawal by Subject|1
7836967|NCT00266864|27204585|P1|Overall Study|Withdrawal by Subject|1
7836968|NCT00266864|27204584|P2|Overall Study|Lost to Follow-up|1
7836969|NCT00266864|27204585|P1|Overall Study|Lost to Follow-up|4
7836970|NCT00266825|27204616|P2|Completed Follow-Up|Withdrawal by Subject|5
7836971|NCT00266825|27204617|P1|Completed Follow-Up|Withdrawal by Subject|11
7836972|NCT00266825|27204616|P2|Completed Follow-Up|Lost to Follow-up|19
7836973|NCT00266825|27204617|P1|Completed Follow-Up|Lost to Follow-up|14
7836974|NCT00266812|27204643|P2|Overall Study|Discontinued before starting study drug|0
7836975|NCT00266812|27204644|P1|Overall Study|Discontinued before starting study drug|4
7836976|NCT00266812|27204643|P2|Overall Study|Withdrawal by Subject|2
7836977|NCT00266812|27204644|P1|Overall Study|Withdrawal by Subject|0
7836978|NCT00266812|27204643|P2|Overall Study|Protocol Violation|1
7836979|NCT00266812|27204644|P1|Overall Study|Protocol Violation|0
7836980|NCT00266812|27204643|P2|Overall Study|Adverse Event|1
7836981|NCT00266812|27204644|P1|Overall Study|Adverse Event|3
7836982|NCT00266812|27204643|P2|Overall Study|Death|4
7836983|NCT00266812|27204644|P1|Overall Study|Death|5
7836984|NCT00266812|27204643|P2|Overall Study|Disease Progression|3
7836985|NCT00266812|27204644|P1|Overall Study|Disease Progression|9
7836986|NCT00266708|27204669|P2|Overall Study|Asthma|2
7836987|NCT00266708|27204670|P1|Overall Study|Asthma|0
7836988|NCT00266708|27204669|P2|Overall Study|Refused biopsy|6
7836989|NCT00266708|27204670|P1|Overall Study|Refused biopsy|3
7836990|NCT00266708|27204669|P2|Overall Study|No renal function|1
7836991|NCT00266708|27204670|P1|Overall Study|No renal function|1
7836992|NCT00266695|27204710|P1|Overall Study|Withdrawal by Subject|15
7836993|NCT00266695|27204710|P1|Overall Study|Lost to Follow-up|3
7836994|NCT00266695|27204710|P1|Overall Study|Physician Decision|1
7836995|NCT00266695|27204710|P1|Overall Study|Death|9
7836996|NCT00266695|27204710|P1|Overall Study|Adverse Event|1
7836997|NCT00266656|27204722|P2|Overall Study|Parent/Caregiver Decision|2
7836998|NCT00266656|27204723|P1|Overall Study|Parent/Caregiver Decision|1
7836999|NCT00266656|27204722|P2|Overall Study|Did Not Reach Final Height|8
7837000|NCT00266656|27204723|P1|Overall Study|Did Not Reach Final Height|4
7837001|NCT00266656|27204722|P2|Overall Study|Withdrawal by Subject|2
7837002|NCT00266656|27204723|P1|Overall Study|Withdrawal by Subject|4
7837003|NCT00266656|27204722|P2|Overall Study|Lost to Follow-up|1
7837004|NCT00266656|27204723|P1|Overall Study|Lost to Follow-up|4
7837005|NCT00266656|27204722|P2|Overall Study|Death|0
7837006|NCT00266656|27204723|P1|Overall Study|Death|1
7837007|NCT00266630|27204747|P2|Overall Study|Other|11
7837008|NCT00266630|27204748|P1|Overall Study|Other|19
7837009|NCT00266630|27204747|P2|Overall Study|Lost to Follow-up|0
7837010|NCT00266630|27204748|P1|Overall Study|Lost to Follow-up|1
7837011|NCT00266630|27204747|P2|Overall Study|Withdrawal by Subject|2
7837012|NCT00266630|27204748|P1|Overall Study|Withdrawal by Subject|10
7837013|NCT00266630|27204747|P2|Overall Study|Physician Decision|2
7837014|NCT00266630|27204748|P1|Overall Study|Physician Decision|1
7837015|NCT00266630|27204747|P2|Overall Study|Protocol Violation|3
7837016|NCT00266630|27204748|P1|Overall Study|Protocol Violation|1
7837017|NCT00266630|27204747|P2|Overall Study|Entry Criteria not met|0
7837018|NCT00266630|27204748|P1|Overall Study|Entry Criteria not met|1
7837019|NCT00266630|27204747|P2|Overall Study|Lack of Efficacy|4
7837020|NCT00266630|27204748|P1|Overall Study|Lack of Efficacy|1
7837021|NCT00266630|27204747|P2|Overall Study|Adverse Event|6
7837022|NCT00266630|27204748|P1|Overall Study|Adverse Event|8
7837023|NCT00266409|27204790|P4|Overall Study|Other|0
7837024|NCT00266409|27204791|P3|Overall Study|Other|2
7837025|NCT00266409|27204792|P2|Overall Study|Other|4
7837026|NCT00266409|27204793|P1|Overall Study|Other|7
7837027|NCT00266409|27204790|P4|Overall Study|Protocol Violation|2
7837028|NCT00266409|27204791|P3|Overall Study|Protocol Violation|4
7837029|NCT00266409|27204792|P2|Overall Study|Protocol Violation|3
7837030|NCT00266409|27204793|P1|Overall Study|Protocol Violation|5
7837031|NCT00266409|27204790|P4|Overall Study|Withdrawal by Subject|9
7837032|NCT00266409|27204791|P3|Overall Study|Withdrawal by Subject|3
7837033|NCT00266409|27204792|P2|Overall Study|Withdrawal by Subject|10
7837034|NCT00266409|27204793|P1|Overall Study|Withdrawal by Subject|6
7837035|NCT00266409|27204790|P4|Overall Study|Lost to Follow-up|8
7837036|NCT00266409|27204791|P3|Overall Study|Lost to Follow-up|6
7837037|NCT00266409|27204792|P2|Overall Study|Lost to Follow-up|21
7837038|NCT00266409|27204793|P1|Overall Study|Lost to Follow-up|18
7837039|NCT00266409|27204790|P4|Overall Study|Adverse Event|1
7837040|NCT00266409|27204791|P3|Overall Study|Adverse Event|1
7837041|NCT00266409|27204792|P2|Overall Study|Adverse Event|2
7837042|NCT00266409|27204793|P1|Overall Study|Adverse Event|7
7837043|NCT00266409|27204790|P4|Overall Study|Lack of Efficacy|2
7837044|NCT00266409|27204791|P3|Overall Study|Lack of Efficacy|1
7837045|NCT00266409|27204792|P2|Overall Study|Lack of Efficacy|6
7837046|NCT00266409|27204793|P1|Overall Study|Lack of Efficacy|2
7837047|NCT00266227|27205082|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
7837048|NCT00266227|27205083|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
7837049|NCT00266227|27205084|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
7837050|NCT00266227|27205082|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
7837051|NCT00266227|27205083|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
7837052|NCT00266227|27205084|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
7837053|NCT00266227|27205082|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
7837054|NCT00266227|27205083|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
7837055|NCT00266227|27205084|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
7837056|NCT00266227|27205082|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
7837057|NCT00266227|27205083|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
7837058|NCT00266227|27205084|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
7837059|NCT00266227|27205082|P3|Retreatment: Week 48 to Week 72|Death|0
7837060|NCT00266227|27205083|P2|Retreatment: Week 48 to Week 72|Death|1
7837061|NCT00266227|27205084|P1|Retreatment: Week 48 to Week 72|Death|1
7837062|NCT00266227|27205082|P3|Retreatment: Up to Week 48|Pregnancy|0
7837063|NCT00266227|27205083|P2|Retreatment: Up to Week 48|Pregnancy|0
7837064|NCT00266227|27205084|P1|Retreatment: Up to Week 48|Pregnancy|1
7837065|NCT00266227|27205082|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
7837066|NCT00266227|27205083|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
7837067|NCT00266227|27205084|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
7837068|NCT00266227|27205082|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
7837069|NCT00266227|27205083|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
7837070|NCT00266227|27205084|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
7837071|NCT00266227|27205082|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
7837072|NCT00266227|27205083|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
7837073|NCT00266227|27205084|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
7837074|NCT00266227|27205082|P3|Retreatment: Up to Week 48|Adverse Event|0
7837075|NCT00266227|27205083|P2|Retreatment: Up to Week 48|Adverse Event|7
7837076|NCT00266227|27205084|P1|Retreatment: Up to Week 48|Adverse Event|7
7837077|NCT00266227|27205082|P3|Retreatment: Up to Week 48|Death|0
7837078|NCT00266227|27205083|P2|Retreatment: Up to Week 48|Death|0
7837079|NCT00266227|27205084|P1|Retreatment: Up to Week 48|Death|1
7837080|NCT00266227|27205082|P3|Initial Treatment|Pregnancy|1
7837081|NCT00266227|27205083|P2|Initial Treatment|Pregnancy|0
7837082|NCT00266227|27205084|P1|Initial Treatment|Pregnancy|0
7837083|NCT00266227|27205082|P3|Initial Treatment|Physician decision to withdraw|12
7837084|NCT00266227|27205083|P2|Initial Treatment|Physician decision to withdraw|0
7837085|NCT00266227|27205084|P1|Initial Treatment|Physician decision to withdraw|0
7837086|NCT00266227|27205082|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
7837087|NCT00266227|27205083|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
7837088|NCT00266227|27205084|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
7837089|NCT00266227|27205082|P3|Initial Treatment|Lost to Follow-up|6
7837090|NCT00266227|27205083|P2|Initial Treatment|Lost to Follow-up|0
7837091|NCT00266227|27205084|P1|Initial Treatment|Lost to Follow-up|0
7837092|NCT00266227|27205082|P3|Initial Treatment|Adverse Event|13
7837093|NCT00266227|27205083|P2|Initial Treatment|Adverse Event|0
7837094|NCT00266227|27205084|P1|Initial Treatment|Adverse Event|0
7837095|NCT00266032|27205138|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
7837096|NCT00266032|27205139|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
7837097|NCT00266032|27205140|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
7837098|NCT00266032|27205138|P3|Open-label Safety Extension|Withdrawal by Subject|12
7837099|NCT00266032|27205139|P2|Open-label Safety Extension|Withdrawal by Subject|3
7837100|NCT00266032|27205140|P1|Open-label Safety Extension|Withdrawal by Subject|19
7837101|NCT00266032|27205138|P3|Open-label Safety Extension|Protocol Violation|2
7837102|NCT00266032|27205139|P2|Open-label Safety Extension|Protocol Violation|3
7837103|NCT00266032|27205140|P1|Open-label Safety Extension|Protocol Violation|1
7837104|NCT00266032|27205138|P3|Open-label Safety Extension|Pregnancy|2
7837105|NCT00266032|27205139|P2|Open-label Safety Extension|Pregnancy|1
7837106|NCT00266032|27205140|P1|Open-label Safety Extension|Pregnancy|4
7837107|NCT00266032|27205138|P3|Open-label Safety Extension|Lost to Follow-up|4
7837108|NCT00266032|27205139|P2|Open-label Safety Extension|Lost to Follow-up|5
7837109|NCT00266032|27205140|P1|Open-label Safety Extension|Lost to Follow-up|2
7837110|NCT00266032|27205138|P3|Open-label Safety Extension|Adverse Event|4
7837111|NCT00266032|27205139|P2|Open-label Safety Extension|Adverse Event|0
7837112|NCT00266032|27205140|P1|Open-label Safety Extension|Adverse Event|5
7837113|NCT00266032|27205138|P3|Treatment|patient moved/wish for pregnancy/no need|8
7837114|NCT00266032|27205139|P2|Treatment|patient moved/wish for pregnancy/no need|5
7837115|NCT00266032|27205140|P1|Treatment|patient moved/wish for pregnancy/no need|13
7837116|NCT00266032|27205138|P3|Treatment|Withdrawal by Subject|12
7837117|NCT00266032|27205139|P2|Treatment|Withdrawal by Subject|13
7837118|NCT00266032|27205140|P1|Treatment|Withdrawal by Subject|28
7837119|NCT00266032|27205138|P3|Treatment|Protocol Violation|13
7837120|NCT00266032|27205139|P2|Treatment|Protocol Violation|14
7837121|NCT00266032|27205140|P1|Treatment|Protocol Violation|6
7837122|NCT00266032|27205138|P3|Treatment|Pregnancy|2
7837123|NCT00266032|27205139|P2|Treatment|Pregnancy|2
7837124|NCT00266032|27205140|P1|Treatment|Pregnancy|3
7837125|NCT00266032|27205138|P3|Treatment|Lost to Follow-up|2
7837126|NCT00266032|27205139|P2|Treatment|Lost to Follow-up|4
7837127|NCT00266032|27205140|P1|Treatment|Lost to Follow-up|19
7837128|NCT00266032|27205138|P3|Treatment|Adverse Event|10
7837129|NCT00266032|27205139|P2|Treatment|Adverse Event|26
7837130|NCT00266032|27205140|P1|Treatment|Adverse Event|42
7837131|NCT00265941|27205175|P2|Overall Study|Lost to Follow-up|1
7837132|NCT00265941|27205176|P1|Overall Study|Lost to Follow-up|1
7837133|NCT00265941|27205175|P2|Overall Study|Protocol Violation|25
7837134|NCT00265941|27205176|P1|Overall Study|Protocol Violation|22
7837135|NCT00265889|27205208|P1|Overall Study|Insurance denied the request|3
7837136|NCT00265889|27205208|P1|Overall Study|Protocol Violation|1
7837137|NCT00265889|27205208|P1|Overall Study|Physician Decision|1
7837138|NCT00265785|27205235|P1|Overall Study|Did not receive protocol treatment|2
7837139|NCT00265785|27205235|P1|Overall Study|Ineligible|1
7837140|NCT00265785|27205235|P1|Overall Study|Not protocol specified|2
7837141|NCT00265785|27205235|P1|Overall Study|Progression/Relapse|15
7837142|NCT00265785|27205235|P1|Overall Study|Withdrawal by Subject|3
7837143|NCT00265785|27205235|P1|Overall Study|Adverse Event|4
7837144|NCT00265759|27205248|P4|Overall Study|Discontinued due to intolerability|1
7837145|NCT00265759|27205249|P3|Overall Study|Discontinued due to intolerability|0
7837146|NCT00265759|27205250|P2|Overall Study|Discontinued due to intolerability|0
7837147|NCT00265759|27205251|P1|Overall Study|Discontinued due to intolerability|0
7837148|NCT00265759|27205248|P4|Overall Study|Bilateral disease|2
7837149|NCT00265759|27205249|P3|Overall Study|Bilateral disease|0
7837150|NCT00265759|27205250|P2|Overall Study|Bilateral disease|0
7837151|NCT00265759|27205251|P1|Overall Study|Bilateral disease|0
7837152|NCT00265759|27205248|P4|Overall Study|Ineligible|1
7837153|NCT00265759|27205249|P3|Overall Study|Ineligible|0
7837154|NCT00265759|27205250|P2|Overall Study|Ineligible|0
7837155|NCT00265759|27205251|P1|Overall Study|Ineligible|0
7837156|NCT00265759|27205248|P4|Overall Study|Cancel|3
7837157|NCT00265759|27205249|P3|Overall Study|Cancel|0
7837158|NCT00265759|27205250|P2|Overall Study|Cancel|0
7837159|NCT00265759|27205251|P1|Overall Study|Cancel|0
7837160|NCT00265759|27205248|P4|Overall Study|Withdrawal by Subject|2
7837161|NCT00265759|27205249|P3|Overall Study|Withdrawal by Subject|2
7837162|NCT00265759|27205250|P2|Overall Study|Withdrawal by Subject|1
7837163|NCT00265759|27205251|P1|Overall Study|Withdrawal by Subject|0
7837164|NCT00265564|27205301|P2|Overall Study|met exclusion criteria|2
7837165|NCT00265564|27205302|P1|Overall Study|met exclusion criteria|5
7837166|NCT00265564|27205301|P2|Overall Study|Lost to Follow-up|7
7837167|NCT00265564|27205302|P1|Overall Study|Lost to Follow-up|5
7837168|NCT00265395|27205352|P2|Overall Study|Administrative|1
7837169|NCT00265395|27205353|P1|Overall Study|Administrative|0
7837170|NCT00265395|27205352|P2|Overall Study|Lack of Efficacy|1
7837171|NCT00265395|27205353|P1|Overall Study|Lack of Efficacy|0
7837172|NCT00265395|27205352|P2|Overall Study|Protocol Violation|2
7837173|NCT00265395|27205353|P1|Overall Study|Protocol Violation|2
7837174|NCT00265395|27205352|P2|Overall Study|Withdrawal by Subject|6
7837175|NCT00265395|27205353|P1|Overall Study|Withdrawal by Subject|1
7837176|NCT00265395|27205352|P2|Overall Study|Lost to Follow-up|1
7837177|NCT00265395|27205353|P1|Overall Study|Lost to Follow-up|2
7837178|NCT00265395|27205352|P2|Overall Study|Adverse Event|6
7837179|NCT00265395|27205353|P1|Overall Study|Adverse Event|3
7837180|NCT00265382|27205358|P1|Overall Study|Death|1
7837181|NCT00265382|27205358|P1|Overall Study|Study terminated by sponsor|94
7837182|NCT00265382|27205358|P1|Overall Study|Withdrawal by Subject|13
7837183|NCT00265382|27205358|P1|Overall Study|Miscellaneous|6
7837184|NCT00265382|27205358|P1|Overall Study|Lack of Efficacy|6
7837185|NCT00265382|27205358|P1|Overall Study|Lost to Follow-up|3
7837186|NCT00265382|27205358|P1|Overall Study|Laboratory Abnormality|1
7837187|NCT00265382|27205358|P1|Overall Study|Adverse Event|21
7837188|NCT00265343|27205378|P2|Overall Study|Other|3
7837189|NCT00265343|27205379|P1|Overall Study|Other|8
7837190|NCT00265343|27205378|P2|Overall Study|Withdrawal by Subject|9
7837191|NCT00265343|27205379|P1|Overall Study|Withdrawal by Subject|3
7837192|NCT00265343|27205378|P2|Overall Study|Adverse Event|7
7837193|NCT00265343|27205379|P1|Overall Study|Adverse Event|10
7837194|NCT00265330|27205387|P1|Overall Study|Protocol Violation|1
7837195|NCT00265330|27205387|P1|Overall Study|Withdrew Consent|1
7837196|NCT00265330|27205387|P1|Overall Study|Principal Investigators Request|1
7837197|NCT00265330|27205387|P1|Overall Study|Site Closed by Sponsor|1
7837198|NCT00265330|27205387|P1|Overall Study|Discharged from Unit for Long Term Care|1
7837199|NCT00265330|27205387|P1|Overall Study|Began Taking Formulary Geodon|1
7837200|NCT00265330|27205387|P1|Overall Study|Family Scheduling Conflicts|1
7837201|NCT00265330|27205387|P1|Overall Study|Lack of Efficacy|4
7837202|NCT00265330|27205387|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
7837203|NCT00265330|27205387|P1|Overall Study|Withdrawal by Subject|34
7837204|NCT00265330|27205387|P1|Overall Study|Lost to Follow-up|8
7837205|NCT00265330|27205387|P1|Overall Study|Adverse Event|41
7837206|NCT00265317|27205413|P4|Phase 2|Other|1
7837207|NCT00265317|27205414|P3|Phase 2|Other|1
7837208|NCT00265317|27205415|P2|Phase 2|Other|0
7837209|NCT00265317|27205416|P1|Phase 2|Other|0
7837210|NCT00265317|27205413|P4|Phase 2|Study terminated by sponsor|0
7837211|NCT00265317|27205414|P3|Phase 2|Study terminated by sponsor|1
7837212|NCT00265317|27205415|P2|Phase 2|Study terminated by sponsor|0
7837213|NCT00265317|27205416|P1|Phase 2|Study terminated by sponsor|0
7837214|NCT00265317|27205413|P4|Phase 2|Withdrawal/other than adverse event|1
7837215|NCT00265317|27205414|P3|Phase 2|Withdrawal/other than adverse event|2
7837216|NCT00265317|27205415|P2|Phase 2|Withdrawal/other than adverse event|0
7837217|NCT00265317|27205416|P1|Phase 2|Withdrawal/other than adverse event|0
7837218|NCT00265317|27205413|P4|Phase 2|Lost to Follow-up|1
7837219|NCT00265317|27205414|P3|Phase 2|Lost to Follow-up|0
7837220|NCT00265317|27205415|P2|Phase 2|Lost to Follow-up|0
7837221|NCT00265317|27205416|P1|Phase 2|Lost to Follow-up|0
7837222|NCT00265317|27205413|P4|Phase 2|Protocol Violation|4
7837223|NCT00265317|27205414|P3|Phase 2|Protocol Violation|1
7837224|NCT00265317|27205415|P2|Phase 2|Protocol Violation|0
7837225|NCT00265317|27205416|P1|Phase 2|Protocol Violation|0
7837226|NCT00265317|27205413|P4|Phase 2|Death|15
7837227|NCT00265317|27205414|P3|Phase 2|Death|12
7837228|NCT00265317|27205415|P2|Phase 2|Death|0
7837229|NCT00265317|27205416|P1|Phase 2|Death|0
7837230|NCT00265317|27205413|P4|Phase 2|Adverse Event|5
7837231|NCT00265317|27205414|P3|Phase 2|Adverse Event|7
7837232|NCT00265317|27205415|P2|Phase 2|Adverse Event|0
7837233|NCT00265317|27205416|P1|Phase 2|Adverse Event|0
7837234|NCT00265317|27205413|P4|Phase 2|Global deterioration of health status|0
7837235|NCT00265317|27205414|P3|Phase 2|Global deterioration of health status|3
7837236|NCT00265317|27205415|P2|Phase 2|Global deterioration of health status|0
7837237|NCT00265317|27205416|P1|Phase 2|Global deterioration of health status|0
7837238|NCT00265317|27205413|P4|Phase 2|Objective progression or relapse|38
7837239|NCT00265317|27205414|P3|Phase 2|Objective progression or relapse|37
7837240|NCT00265317|27205415|P2|Phase 2|Objective progression or relapse|0
7837241|NCT00265317|27205416|P1|Phase 2|Objective progression or relapse|0
7837242|NCT00265317|27205413|P4|Lead-In|Withdrawal/other than adverse event|0
7837243|NCT00265317|27205414|P3|Lead-In|Withdrawal/other than adverse event|0
7837244|NCT00265317|27205415|P2|Lead-In|Withdrawal/other than adverse event|0
7837245|NCT00265317|27205416|P1|Lead-In|Withdrawal/other than adverse event|1
7837246|NCT00265317|27205413|P4|Lead-In|Death|0
7837247|NCT00265317|27205414|P3|Lead-In|Death|0
7837248|NCT00265317|27205415|P2|Lead-In|Death|5
7837249|NCT00265317|27205416|P1|Lead-In|Death|3
7837250|NCT00265317|27205413|P4|Lead-In|Adverse Event|0
7837251|NCT00265317|27205414|P3|Lead-In|Adverse Event|0
7837252|NCT00265317|27205415|P2|Lead-In|Adverse Event|1
7837253|NCT00265317|27205416|P1|Lead-In|Adverse Event|2
7837254|NCT00265317|27205413|P4|Lead-In|Objective progression or relapse|0
7837255|NCT00265317|27205414|P3|Lead-In|Objective progression or relapse|0
7837256|NCT00265317|27205415|P2|Lead-In|Objective progression or relapse|11
7837257|NCT00265317|27205416|P1|Lead-In|Objective progression or relapse|6
7837258|NCT00265239|27205531|P2|Overall Study|Adverse Event|1
7837259|NCT00265239|27205532|P1|Overall Study|Adverse Event|2
7837260|NCT00265148|27205550|P2|Overall Study|Subject chose to change of the dose|0
7837261|NCT00265148|27205551|P1|Overall Study|Subject chose to change of the dose|1
7837262|NCT00265148|27205550|P2|Overall Study|Increasing frailty|1
7837263|NCT00265148|27205551|P1|Overall Study|Increasing frailty|0
7837264|NCT00265148|27205550|P2|Overall Study|Physician Decision|0
7837265|NCT00265148|27205551|P1|Overall Study|Physician Decision|1
7837266|NCT00265148|27205550|P2|Overall Study|Withdrawal by Subject|1
7837267|NCT00265148|27205551|P1|Overall Study|Withdrawal by Subject|2
7837268|NCT00265148|27205550|P2|Overall Study|Lost to Follow-up|1
7837269|NCT00265148|27205551|P1|Overall Study|Lost to Follow-up|0
7837270|NCT00265148|27205550|P2|Overall Study|Protocol Violation|2
7837271|NCT00265148|27205551|P1|Overall Study|Protocol Violation|3
7837272|NCT00265148|27205550|P2|Overall Study|Lack of Efficacy|2
7837273|NCT00265148|27205551|P1|Overall Study|Lack of Efficacy|0
7837274|NCT00265148|27205550|P2|Overall Study|Adverse Event|2
7837275|NCT00265148|27205551|P1|Overall Study|Adverse Event|2
7837276|NCT00265122|27205615|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
7837277|NCT00265122|27205616|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
7837278|NCT00265122|27205617|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
7837279|NCT00265122|27205618|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
7837280|NCT00265122|27205619|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
7837281|NCT00265122|27205620|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
7837282|NCT00265122|27205615|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
7837283|NCT00265122|27205616|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
7837284|NCT00265122|27205617|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
7837285|NCT00265122|27205618|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7837286|NCT00265122|27205619|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7837287|NCT00265122|27205620|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
7837288|NCT00265122|27205615|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
7837289|NCT00265122|27205616|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
7837290|NCT00265122|27205617|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
7837291|NCT00265122|27205618|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
7837292|NCT00265122|27205619|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
7837293|NCT00265122|27205620|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
7837294|NCT00265122|27205615|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
7837295|NCT00265122|27205616|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
7837296|NCT00265122|27205617|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
7837297|NCT00265122|27205618|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
7837298|NCT00265122|27205619|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
7837299|NCT00265122|27205620|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
7837300|NCT00265122|27205615|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7837301|NCT00265122|27205616|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7837302|NCT00265122|27205617|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
7837303|NCT00265122|27205618|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7837304|NCT00265122|27205619|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7837305|NCT00265122|27205620|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
7837306|NCT00265122|27205615|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
7837307|NCT00265122|27205616|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7837308|NCT00265122|27205617|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
7837309|NCT00265122|27205618|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
7837310|NCT00265122|27205619|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7837311|NCT00265122|27205620|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7837312|NCT00265109|27205642|P1|Overall Study|Adverse Event|1
7837313|NCT00265109|27205642|P1|Overall Study|Withdrawal by Subject|5
7837314|NCT00265096|27205661|P3|Overall Study|Other|10
7837315|NCT00265096|27205662|P2|Overall Study|Other|19
7837316|NCT00265096|27205663|P1|Overall Study|Other|11
7837317|NCT00265096|27205661|P3|Overall Study|Unsatisfactory therapeutic effect|6
7837318|NCT00265096|27205662|P2|Overall Study|Unsatisfactory therapeutic effect|8
7837319|NCT00265096|27205663|P1|Overall Study|Unsatisfactory therapeutic effect|9
7837320|NCT00265096|27205661|P3|Overall Study|Death|2
7837321|NCT00265096|27205662|P2|Overall Study|Death|1
7837322|NCT00265096|27205663|P1|Overall Study|Death|0
7837323|NCT00265096|27205661|P3|Overall Study|Lost to Follow-up|3
7837324|NCT00265096|27205662|P2|Overall Study|Lost to Follow-up|5
7837325|NCT00265096|27205663|P1|Overall Study|Lost to Follow-up|2
7837326|NCT00265096|27205661|P3|Overall Study|Adverse Event|18
7837327|NCT00265096|27205662|P2|Overall Study|Adverse Event|18
7837328|NCT00265096|27205663|P1|Overall Study|Adverse Event|14
7837329|NCT00265083|27205695|P3|Overall Study|Other|9
7837330|NCT00265083|27205696|P2|Overall Study|Other|12
7837331|NCT00265083|27205697|P1|Overall Study|Other|1
7837332|NCT00265083|27205695|P3|Overall Study|Unsatisfactory therapeutic effect|14
7837333|NCT00265083|27205696|P2|Overall Study|Unsatisfactory therapeutic effect|13
7837334|NCT00265083|27205697|P1|Overall Study|Unsatisfactory therapeutic effect|8
7837335|NCT00265083|27205695|P3|Overall Study|Lost to Follow-up|4
7837336|NCT00265083|27205696|P2|Overall Study|Lost to Follow-up|4
7837337|NCT00265083|27205697|P1|Overall Study|Lost to Follow-up|3
7837338|NCT00265083|27205695|P3|Overall Study|Adverse Event|15
7837339|NCT00265083|27205696|P2|Overall Study|Adverse Event|13
7837340|NCT00265083|27205697|P1|Overall Study|Adverse Event|5
7837341|NCT00264875|27205718|P1|Overall Study|Withdrawal by Subject|7
7837342|NCT00264875|27205718|P1|Overall Study|Protocol Violation|11
7837343|NCT00264875|27205718|P1|Overall Study|Lost to Follow-up|6
7837344|NCT00264875|27205718|P1|Overall Study|Adverse Event|6
7837345|NCT00264849|27205724|P2|Overall Study|Administrative Problems|0
7837346|NCT00264849|27205725|P1|Overall Study|Administrative Problems|2
7837347|NCT00264849|27205724|P2|Overall Study|Death|1
7837348|NCT00264849|27205725|P1|Overall Study|Death|0
7837349|NCT00264849|27205724|P2|Overall Study|Lost to Follow-up|2
7837350|NCT00264849|27205725|P1|Overall Study|Lost to Follow-up|0
7837351|NCT00264849|27205724|P2|Overall Study|Lack of Efficacy|6
7837352|NCT00264849|27205725|P1|Overall Study|Lack of Efficacy|1
7837353|NCT00264849|27205724|P2|Overall Study|Protocol Violation|3
7837354|NCT00264849|27205725|P1|Overall Study|Protocol Violation|5
7837355|NCT00264849|27205724|P2|Overall Study|Withdrawal by Subject|11
7837356|NCT00264849|27205725|P1|Overall Study|Withdrawal by Subject|7
7837357|NCT00264849|27205724|P2|Overall Study|Adverse Event|2
7837358|NCT00264849|27205725|P1|Overall Study|Adverse Event|7
7837359|NCT00264810|27205759|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
7837360|NCT00264810|27205760|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
7837361|NCT00264810|27205759|P2|Open Label Evaluation Period|Death|2
7837362|NCT00264810|27205760|P1|Open Label Evaluation Period|Death|3
7837363|NCT00264810|27205759|P2|Open Label Evaluation Period|Explant due to infection|1
7837364|NCT00264810|27205760|P1|Open Label Evaluation Period|Explant due to infection|1
7837365|NCT00264810|27205759|P2|Blinded Evaluation Period|Explant due to infection|1
7837366|NCT00264810|27205760|P1|Blinded Evaluation Period|Explant due to infection|1
7837367|NCT00264810|27205759|P2|Stimulation Optimization Period|Death|1
7837368|NCT00264810|27205760|P1|Stimulation Optimization Period|Death|0
7837369|NCT00264810|27205759|P2|Stimulation Optimization Period|Withdrawal by Subject|0
7837370|NCT00264810|27205760|P1|Stimulation Optimization Period|Withdrawal by Subject|1
7837371|NCT00264810|27205759|P2|Baseline|Other|1
7837372|NCT00264810|27205760|P1|Baseline|Other|0
7837373|NCT00264810|27205759|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
7837374|NCT00264810|27205760|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
7837375|NCT00264810|27205759|P2|Baseline|Insufficient Seizure Frequency|2
7837376|NCT00264810|27205760|P1|Baseline|Insufficient Seizure Frequency|2
7837377|NCT00264810|27205759|P2|Baseline|Subject Compliance Failure|3
7837378|NCT00264810|27205760|P1|Baseline|Subject Compliance Failure|3
7837379|NCT00264810|27205759|P2|Baseline|Physician Decision|8
7837380|NCT00264810|27205760|P1|Baseline|Physician Decision|7
7837381|NCT00264810|27205759|P2|Baseline|Withdrawal by Subject|10
7837382|NCT00264810|27205760|P1|Baseline|Withdrawal by Subject|10
7837383|NCT00264797|27205770|P2|Overall Study|Other|4
7837384|NCT00264797|27205771|P1|Overall Study|Other|3
7837385|NCT00264797|27205770|P2|Overall Study|Feels treatment not necessary, not worki|1
7837386|NCT00264797|27205771|P1|Overall Study|Feels treatment not necessary, not worki|0
7837387|NCT00264797|27205770|P2|Overall Study|Pressure/advice from Outsiders|1
7837388|NCT00264797|27205771|P1|Overall Study|Pressure/advice from Outsiders|1
7837389|NCT00264797|27205770|P2|Overall Study|Incarceration|5
7837390|NCT00264797|27205771|P1|Overall Study|Incarceration|4
7837391|NCT00264797|27205770|P2|Overall Study|Practical Problems|3
7837392|NCT00264797|27205771|P1|Overall Study|Practical Problems|2
7837393|NCT00264797|27205770|P2|Overall Study|Moved from area|1
7837394|NCT00264797|27205771|P1|Overall Study|Moved from area|3
7837395|NCT00264797|27205770|P2|Overall Study|Lost to Follow-up|17
7837396|NCT00264797|27205771|P1|Overall Study|Lost to Follow-up|9
7837397|NCT00264797|27205770|P2|Overall Study|Withdrawal by Subject|11
7837398|NCT00264797|27205771|P1|Overall Study|Withdrawal by Subject|11
7837399|NCT00264576|27205793|P2|Overall Study|Lost to Follow-up|1
7837400|NCT00264576|27205794|P1|Overall Study|Lost to Follow-up|1
7837401|NCT00264550|27205818|P4|Overall Study|Other|9
7837402|NCT00264550|27205819|P3|Overall Study|Other|3
7837403|NCT00264550|27205820|P2|Overall Study|Other|7
7837404|NCT00264550|27205821|P1|Overall Study|Other|13
7837405|NCT00264550|27205818|P4|Overall Study|Discontinued oral study agent|0
7837406|NCT00264550|27205819|P3|Overall Study|Discontinued oral study agent|0
7837407|NCT00264550|27205820|P2|Overall Study|Discontinued oral study agent|1
7837408|NCT00264550|27205821|P1|Overall Study|Discontinued oral study agent|0
7837409|NCT00264550|27205818|P4|Overall Study|Unsatisfactory therapeutic effect|6
7837410|NCT00264550|27205819|P3|Overall Study|Unsatisfactory therapeutic effect|4
7837411|NCT00264550|27205820|P2|Overall Study|Unsatisfactory therapeutic effect|11
7837412|NCT00264550|27205821|P1|Overall Study|Unsatisfactory therapeutic effect|4
7837413|NCT00264550|27205818|P4|Overall Study|Adverse Event|14
7837414|NCT00264550|27205819|P3|Overall Study|Adverse Event|9
7837415|NCT00264550|27205820|P2|Overall Study|Adverse Event|18
7837416|NCT00264550|27205821|P1|Overall Study|Adverse Event|23
7837417|NCT00264550|27205818|P4|Overall Study|Lost to Follow-up|1
7837418|NCT00264550|27205819|P3|Overall Study|Lost to Follow-up|1
7837419|NCT00264550|27205820|P2|Overall Study|Lost to Follow-up|1
7837420|NCT00264550|27205821|P1|Overall Study|Lost to Follow-up|3
7837421|NCT00264550|27205818|P4|Overall Study|Death|0
7837422|NCT00264550|27205819|P3|Overall Study|Death|0
7837423|NCT00264550|27205820|P2|Overall Study|Death|3
7837424|NCT00264550|27205821|P1|Overall Study|Death|0
7837425|NCT00264537|27205860|P4|Overall Study|Not treated|0
7837426|NCT00264537|27205861|P3|Overall Study|Not treated|1
7837427|NCT00264537|27205862|P2|Overall Study|Not treated|2
7837428|NCT00264537|27205863|P1|Overall Study|Not treated|0
7837429|NCT00264537|27205860|P4|Overall Study|Other|11
7837430|NCT00264537|27205861|P3|Overall Study|Other|10
7837431|NCT00264537|27205862|P2|Overall Study|Other|11
7837432|NCT00264537|27205863|P1|Overall Study|Other|21
7837433|NCT00264537|27205860|P4|Overall Study|Unsatisfactory therapeutic effect|7
7837434|NCT00264537|27205861|P3|Overall Study|Unsatisfactory therapeutic effect|5
7837435|NCT00264537|27205862|P2|Overall Study|Unsatisfactory therapeutic effect|6
7837436|NCT00264537|27205863|P1|Overall Study|Unsatisfactory therapeutic effect|5
7837437|NCT00264537|27205860|P4|Overall Study|Adverse Event|34
7837438|NCT00264537|27205861|P3|Overall Study|Adverse Event|24
7837439|NCT00264537|27205862|P2|Overall Study|Adverse Event|32
7837440|NCT00264537|27205863|P1|Overall Study|Adverse Event|21
7837441|NCT00264537|27205860|P4|Overall Study|Lost to Follow-up|6
7837442|NCT00264537|27205861|P3|Overall Study|Lost to Follow-up|7
7837443|NCT00264537|27205862|P2|Overall Study|Lost to Follow-up|4
7837444|NCT00264537|27205863|P1|Overall Study|Lost to Follow-up|3
7837445|NCT00264537|27205860|P4|Overall Study|Death|2
7837446|NCT00264537|27205861|P3|Overall Study|Death|3
7837447|NCT00264537|27205862|P2|Overall Study|Death|3
7837448|NCT00264537|27205863|P1|Overall Study|Death|0
7837449|NCT00264498|27205895|P2|Crossover Treatment|Withdrawal by Subject|0
7837450|NCT00264498|27205896|P1|Crossover Treatment|Withdrawal by Subject|1
7837451|NCT00264498|27205895|P2|Crossover Treatment|Study closure|1
7837452|NCT00264498|27205896|P1|Crossover Treatment|Study closure|0
7837453|NCT00264498|27205895|P2|Crossover Treatment|Objective disease progression|5
7837454|NCT00264498|27205896|P1|Crossover Treatment|Objective disease progression|4
7837455|NCT00264498|27205895|P2|Crossover Treatment|Death|3
7837456|NCT00264498|27205896|P1|Crossover Treatment|Death|1
7837457|NCT00264498|27205895|P2|Randomized Treatment|Protocol Violation|0
7837458|NCT00264498|27205896|P1|Randomized Treatment|Protocol Violation|1
7837459|NCT00264498|27205895|P2|Randomized Treatment|Study Closure|0
7837460|NCT00264498|27205896|P1|Randomized Treatment|Study Closure|1
7837461|NCT00264498|27205895|P2|Randomized Treatment|Incorrectly randomized|0
7837462|NCT00264498|27205896|P1|Randomized Treatment|Incorrectly randomized|1
7837463|NCT00264498|27205895|P2|Randomized Treatment|Physician Decision|0
7837464|NCT00264498|27205896|P1|Randomized Treatment|Physician Decision|1
7837465|NCT00264498|27205895|P2|Randomized Treatment|Objective disease Progression|14
7837466|NCT00264498|27205896|P1|Randomized Treatment|Objective disease Progression|13
7837467|NCT00264498|27205895|P2|Randomized Treatment|Withdrawal by Subject|1
7837468|NCT00264498|27205896|P1|Randomized Treatment|Withdrawal by Subject|0
7837469|NCT00264498|27205895|P2|Randomized Treatment|Death|3
7837470|NCT00264498|27205896|P1|Randomized Treatment|Death|0
7837471|NCT00264303|27205919|P2|Overall Study|Various reasons listed in study report|7
7837552|NCT00264147|27205969|P4|Treatment I Period|Lost to Follow-up|1
7837472|NCT00264303|27205920|P1|Overall Study|Various reasons listed in study report|6
7837473|NCT00264303|27205919|P2|Overall Study|Withdrawal by Subject|3
7837474|NCT00264303|27205920|P1|Overall Study|Withdrawal by Subject|2
7837475|NCT00264303|27205919|P2|Overall Study|Lost to Follow-up|3
7837476|NCT00264303|27205920|P1|Overall Study|Lost to Follow-up|3
7837477|NCT00264303|27205919|P2|Overall Study|Lack of Efficacy|13
7837478|NCT00264303|27205920|P1|Overall Study|Lack of Efficacy|10
7837479|NCT00264303|27205919|P2|Overall Study|Adverse Event|3
7837480|NCT00264303|27205920|P1|Overall Study|Adverse Event|4
7837481|NCT00264290|27205938|P2|Intervention (8 Weeks)|Adverse Event|0
7837482|NCT00264290|27205939|P1|Intervention (8 Weeks)|Adverse Event|1
7837483|NCT00264238|27205955|P1|Overall Study|Protocol Violation|1
7837484|NCT00264147|27205967|P6|Treatment II Period|Pre-scheduled total hip replacement|1
7837485|NCT00264147|27205968|P5|Treatment II Period|Pre-scheduled total hip replacement|0
7837486|NCT00264147|27205969|P4|Treatment II Period|Pre-scheduled total hip replacement|0
7837487|NCT00264147|27205970|P3|Treatment II Period|Pre-scheduled total hip replacement|0
7837488|NCT00264147|27205971|P2|Treatment II Period|Pre-scheduled total hip replacement|0
7837489|NCT00264147|27205972|P1|Treatment II Period|Pre-scheduled total hip replacement|0
7837490|NCT00264147|27205967|P6|Treatment II Period|Withdrawal by Subject|2
7837491|NCT00264147|27205968|P5|Treatment II Period|Withdrawal by Subject|3
7837492|NCT00264147|27205969|P4|Treatment II Period|Withdrawal by Subject|0
7837493|NCT00264147|27205970|P3|Treatment II Period|Withdrawal by Subject|0
7837494|NCT00264147|27205971|P2|Treatment II Period|Withdrawal by Subject|0
7837495|NCT00264147|27205972|P1|Treatment II Period|Withdrawal by Subject|0
7837496|NCT00264147|27205967|P6|Treatment II Period|Lost to Follow-up|1
7837497|NCT00264147|27205968|P5|Treatment II Period|Lost to Follow-up|1
7837498|NCT00264147|27205969|P4|Treatment II Period|Lost to Follow-up|0
7837499|NCT00264147|27205970|P3|Treatment II Period|Lost to Follow-up|0
7837500|NCT00264147|27205971|P2|Treatment II Period|Lost to Follow-up|0
7837501|NCT00264147|27205972|P1|Treatment II Period|Lost to Follow-up|0
7837502|NCT00264147|27205967|P6|Treatment II Period|Lack of Efficacy|19
7837503|NCT00264147|27205968|P5|Treatment II Period|Lack of Efficacy|20
7837504|NCT00264147|27205969|P4|Treatment II Period|Lack of Efficacy|0
7837505|NCT00264147|27205970|P3|Treatment II Period|Lack of Efficacy|0
7837506|NCT00264147|27205971|P2|Treatment II Period|Lack of Efficacy|0
7837507|NCT00264147|27205972|P1|Treatment II Period|Lack of Efficacy|0
7837508|NCT00264147|27205967|P6|Treatment II Period|Laboratory Adverse Event|1
7837509|NCT00264147|27205968|P5|Treatment II Period|Laboratory Adverse Event|0
7837510|NCT00264147|27205969|P4|Treatment II Period|Laboratory Adverse Event|0
7837511|NCT00264147|27205970|P3|Treatment II Period|Laboratory Adverse Event|0
7837512|NCT00264147|27205971|P2|Treatment II Period|Laboratory Adverse Event|0
7837513|NCT00264147|27205972|P1|Treatment II Period|Laboratory Adverse Event|0
7837514|NCT00264147|27205967|P6|Treatment II Period|Adverse Event|9
7837515|NCT00264147|27205968|P5|Treatment II Period|Adverse Event|9
7837516|NCT00264147|27205969|P4|Treatment II Period|Adverse Event|0
7837517|NCT00264147|27205970|P3|Treatment II Period|Adverse Event|0
7837518|NCT00264147|27205971|P2|Treatment II Period|Adverse Event|0
7837519|NCT00264147|27205972|P1|Treatment II Period|Adverse Event|0
7837520|NCT00264147|27205967|P6|Treatment I Period|Reassigned to Treatment II Period|0
7837521|NCT00264147|27205968|P5|Treatment I Period|Reassigned to Treatment II Period|45
7837522|NCT00264147|27205969|P4|Treatment I Period|Reassigned to Treatment II Period|63
7837523|NCT00264147|27205970|P3|Treatment I Period|Reassigned to Treatment II Period|65
7837524|NCT00264147|27205971|P2|Treatment I Period|Reassigned to Treatment II Period|72
7837525|NCT00264147|27205972|P1|Treatment I Period|Reassigned to Treatment II Period|84
7837526|NCT00264147|27205967|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
7837527|NCT00264147|27205968|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
7837528|NCT00264147|27205969|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
7837529|NCT00264147|27205970|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
7837530|NCT00264147|27205971|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
7837531|NCT00264147|27205972|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
7837532|NCT00264147|27205967|P6|Treatment I Period|Patient out of town for an extended time|0
7837533|NCT00264147|27205968|P5|Treatment I Period|Patient out of town for an extended time|0
7837534|NCT00264147|27205969|P4|Treatment I Period|Patient out of town for an extended time|0
7837535|NCT00264147|27205970|P3|Treatment I Period|Patient out of town for an extended time|0
7837536|NCT00264147|27205971|P2|Treatment I Period|Patient out of town for an extended time|1
7837537|NCT00264147|27205972|P1|Treatment I Period|Patient out of town for an extended time|0
7837538|NCT00264147|27205967|P6|Treatment I Period|Withdrawal by Subject|0
7837539|NCT00264147|27205968|P5|Treatment I Period|Withdrawal by Subject|2
7837540|NCT00264147|27205969|P4|Treatment I Period|Withdrawal by Subject|2
7837541|NCT00264147|27205970|P3|Treatment I Period|Withdrawal by Subject|0
7837542|NCT00264147|27205971|P2|Treatment I Period|Withdrawal by Subject|0
7837543|NCT00264147|27205972|P1|Treatment I Period|Withdrawal by Subject|2
7837544|NCT00264147|27205967|P6|Treatment I Period|Protocol Violation|0
7837545|NCT00264147|27205968|P5|Treatment I Period|Protocol Violation|0
7837546|NCT00264147|27205969|P4|Treatment I Period|Protocol Violation|0
7837547|NCT00264147|27205970|P3|Treatment I Period|Protocol Violation|0
7837548|NCT00264147|27205971|P2|Treatment I Period|Protocol Violation|2
7837549|NCT00264147|27205972|P1|Treatment I Period|Protocol Violation|2
7837550|NCT00264147|27205967|P6|Treatment I Period|Lost to Follow-up|0
7837551|NCT00264147|27205968|P5|Treatment I Period|Lost to Follow-up|1
7837553|NCT00264147|27205970|P3|Treatment I Period|Lost to Follow-up|0
7837554|NCT00264147|27205971|P2|Treatment I Period|Lost to Follow-up|0
7837555|NCT00264147|27205972|P1|Treatment I Period|Lost to Follow-up|1
7837556|NCT00264147|27205967|P6|Treatment I Period|Lack of Efficacy|0
7837557|NCT00264147|27205968|P5|Treatment I Period|Lack of Efficacy|1
7837558|NCT00264147|27205969|P4|Treatment I Period|Lack of Efficacy|0
7837559|NCT00264147|27205970|P3|Treatment I Period|Lack of Efficacy|8
7837560|NCT00264147|27205971|P2|Treatment I Period|Lack of Efficacy|2
7837561|NCT00264147|27205972|P1|Treatment I Period|Lack of Efficacy|6
7837562|NCT00264147|27205967|P6|Treatment I Period|Laboratory Adverse Event|0
7837563|NCT00264147|27205968|P5|Treatment I Period|Laboratory Adverse Event|0
7837564|NCT00264147|27205969|P4|Treatment I Period|Laboratory Adverse Event|1
7837565|NCT00264147|27205970|P3|Treatment I Period|Laboratory Adverse Event|0
7837566|NCT00264147|27205971|P2|Treatment I Period|Laboratory Adverse Event|0
7837567|NCT00264147|27205972|P1|Treatment I Period|Laboratory Adverse Event|0
7837568|NCT00264147|27205967|P6|Treatment I Period|Adverse Event|0
7837569|NCT00264147|27205968|P5|Treatment I Period|Adverse Event|7
7837570|NCT00264147|27205969|P4|Treatment I Period|Adverse Event|5
7837571|NCT00264147|27205970|P3|Treatment I Period|Adverse Event|3
7837572|NCT00264147|27205971|P2|Treatment I Period|Adverse Event|6
7837573|NCT00264147|27205972|P1|Treatment I Period|Adverse Event|3
7837574|NCT00264004|27206015|P4|Overall Study|Not treated|2
7837575|NCT00264004|27206016|P3|Overall Study|Not treated|2
7837576|NCT00264004|27206017|P2|Overall Study|Not treated|0
7837577|NCT00264004|27206018|P1|Overall Study|Not treated|3
7837578|NCT00264004|27206015|P4|Overall Study|Cond. under inv. worsened|4
7837579|NCT00264004|27206016|P3|Overall Study|Cond. under inv. worsened|3
7837580|NCT00264004|27206017|P2|Overall Study|Cond. under inv. worsened|5
7837581|NCT00264004|27206018|P1|Overall Study|Cond. under inv. worsened|9
7837582|NCT00264004|27206015|P4|Overall Study|Development study specific disc. crit.|0
7837583|NCT00264004|27206016|P3|Overall Study|Development study specific disc. crit.|1
7837584|NCT00264004|27206017|P2|Overall Study|Development study specific disc. crit.|0
7837585|NCT00264004|27206018|P1|Overall Study|Development study specific disc. crit.|1
7837586|NCT00264004|27206015|P4|Overall Study|Other|3
7837587|NCT00264004|27206016|P3|Overall Study|Other|0
7837588|NCT00264004|27206017|P2|Overall Study|Other|2
7837589|NCT00264004|27206018|P1|Overall Study|Other|2
7837590|NCT00264004|27206015|P4|Overall Study|Withdrawal by Subject|2
7837591|NCT00264004|27206016|P3|Overall Study|Withdrawal by Subject|2
7837592|NCT00264004|27206017|P2|Overall Study|Withdrawal by Subject|1
7837593|NCT00264004|27206018|P1|Overall Study|Withdrawal by Subject|0
7837594|NCT00264004|27206015|P4|Overall Study|Adverse Event|4
7837595|NCT00264004|27206016|P3|Overall Study|Adverse Event|6
7837596|NCT00264004|27206017|P2|Overall Study|Adverse Event|3
7837597|NCT00264004|27206018|P1|Overall Study|Adverse Event|2
7837598|NCT00263887|27206046|P2|Overall Study|Lack of Efficacy|1
7837599|NCT00263887|27206047|P1|Overall Study|Lack of Efficacy|0
7837600|NCT00263887|27206046|P2|Overall Study|Disease progression|1
7837601|NCT00263887|27206047|P1|Overall Study|Disease progression|0
7837602|NCT00263887|27206046|P2|Overall Study|Adverse Event|2
7837603|NCT00263887|27206047|P1|Overall Study|Adverse Event|0
7837604|NCT00263887|27206046|P2|Overall Study|Too ill to attend visit|0
7837605|NCT00263887|27206047|P1|Overall Study|Too ill to attend visit|1
7837606|NCT00263887|27206046|P2|Overall Study|Lung transplantation|2
7837607|NCT00263887|27206047|P1|Overall Study|Lung transplantation|1
7837608|NCT00263887|27206046|P2|Overall Study|Withdrawal by Subject|1
7837609|NCT00263887|27206047|P1|Overall Study|Withdrawal by Subject|1
7837610|NCT00263757|27206055|P2|Overall Study|Adverse Event|3
7837611|NCT00263757|27206056|P1|Overall Study|Adverse Event|3
7837612|NCT00263757|27206055|P2|Overall Study|Screen failure|1
7837613|NCT00263757|27206056|P1|Overall Study|Screen failure|0
7837614|NCT00263757|27206055|P2|Overall Study|Withdrawal by Subject|4
7837615|NCT00263757|27206056|P1|Overall Study|Withdrawal by Subject|5
7837616|NCT00263666|27206068|P2|Overall Study|Withdrawal by Subject|1
7837617|NCT00263666|27206069|P1|Overall Study|Withdrawal by Subject|0
7837618|NCT00263666|27206068|P2|Overall Study|Lost to Follow-up|2
7837619|NCT00263666|27206069|P1|Overall Study|Lost to Follow-up|1
7837620|NCT00263666|27206068|P2|Overall Study|Adverse Event|8
7837621|NCT00263666|27206069|P1|Overall Study|Adverse Event|6
7837622|NCT00263588|27206122|P2|Overall Study|Sponsor terminated study|1
7837623|NCT00263588|27206123|P1|Overall Study|Sponsor terminated study|0
7837624|NCT00263588|27206122|P2|Overall Study|Investigator decision|15
7837625|NCT00263588|27206123|P1|Overall Study|Investigator decision|7
7837626|NCT00263588|27206122|P2|Overall Study|Protocol Violation|1
7837627|NCT00263588|27206123|P1|Overall Study|Protocol Violation|0
7837628|NCT00263588|27206122|P2|Overall Study|Withdrawal by Subject|4
7837629|NCT00263588|27206123|P1|Overall Study|Withdrawal by Subject|3
7837630|NCT00263588|27206122|P2|Overall Study|Lost to Follow-up|10
7837631|NCT00263588|27206123|P1|Overall Study|Lost to Follow-up|7
7837632|NCT00263588|27206122|P2|Overall Study|disease progression, coma, 1 unknown|11
7837633|NCT00263588|27206123|P1|Overall Study|disease progression, coma, 1 unknown|10
7837634|NCT00263588|27206122|P2|Overall Study|Death|90
7837635|NCT00263588|27206123|P1|Overall Study|Death|54
7837636|NCT00263575|27206146|P1|Maintence Period|Other|7
7837637|NCT00263575|27206146|P1|Maintence Period|Sponsor Decision|24
7837638|NCT00263575|27206146|P1|Maintence Period|Lost to Follow-up|1
7837639|NCT00263575|27206146|P1|Maintence Period|Physician Decision|6
7837640|NCT00263575|27206146|P1|Maintence Period|Lack of Efficacy|4
7837641|NCT00263575|27206146|P1|Maintence Period|Protocol Violation|4
7837642|NCT00263575|27206146|P1|Maintence Period|Withdrawal by Subject|8
7837643|NCT00263575|27206146|P1|Maintence Period|Adverse Event|23
7837644|NCT00263575|27206146|P1|Titration Period|Lack of Efficacy|6
7837645|NCT00263575|27206146|P1|Titration Period|Other|2
7837646|NCT00263575|27206146|P1|Titration Period|Sponsor Decision|2
7837647|NCT00263575|27206146|P1|Titration Period|Protocol Violation|9
7837648|NCT00263575|27206146|P1|Titration Period|Withdrawal by Subject|10
7837649|NCT00263575|27206146|P1|Titration Period|Adverse Event|14
7837650|NCT00263562|27206154|P2|Overall Study|Protocol Violation|0
7837651|NCT00263562|27206155|P1|Overall Study|Protocol Violation|3
7837652|NCT00263328|27206172|P3|Overall Study|Adverse Event|4
7837653|NCT00263328|27206173|P2|Overall Study|Adverse Event|1
7837654|NCT00263328|27206174|P1|Overall Study|Adverse Event|1
7837655|NCT00263328|27206172|P3|Overall Study|Other|1
7837656|NCT00263328|27206173|P2|Overall Study|Other|0
7837657|NCT00263328|27206174|P1|Overall Study|Other|3
7837658|NCT00263328|27206172|P3|Overall Study|Withdrawal by Subject|1
7837659|NCT00263328|27206173|P2|Overall Study|Withdrawal by Subject|0
7837660|NCT00263328|27206174|P1|Overall Study|Withdrawal by Subject|3
7837661|NCT00263328|27206172|P3|Overall Study|Lost to Follow-up|0
7837662|NCT00263328|27206173|P2|Overall Study|Lost to Follow-up|1
7837663|NCT00263328|27206174|P1|Overall Study|Lost to Follow-up|1
7837664|NCT00263328|27206172|P3|Overall Study|Death|1
7837665|NCT00263328|27206173|P2|Overall Study|Death|0
7837666|NCT00263328|27206174|P1|Overall Study|Death|0
7837667|NCT00263211|27206332|P2|Overall Study|Disease Progression|1
7837668|NCT00263211|27206333|P1|Overall Study|Disease Progression|0
7837669|NCT00263211|27206332|P2|Overall Study|Protocol Violation|0
7837670|NCT00263211|27206333|P1|Overall Study|Protocol Violation|1
7837671|NCT00263211|27206332|P2|Overall Study|Withdrawal by Subject|0
7837672|NCT00263211|27206333|P1|Overall Study|Withdrawal by Subject|3
7837673|NCT00263211|27206332|P2|Overall Study|Death|0
7837674|NCT00263211|27206333|P1|Overall Study|Death|1
7837675|NCT00262951|27206384|P1|Overall Study|Off treatment for other disease|1
7837676|NCT00262951|27206384|P1|Overall Study|Alternative treatment|3
7837677|NCT00262951|27206384|P1|Overall Study|Withdrawal by Subject|1
7837678|NCT00262951|27206384|P1|Overall Study|Death|1
7837679|NCT00262951|27206384|P1|Overall Study|Adverse Event|7
7837680|NCT00262951|27206384|P1|Overall Study|Progressive disease/relapse|3
7837681|NCT00262925|27206389|P1|Overall Study|Other|1
7837682|NCT00262925|27206389|P1|Overall Study|alternative therapy|1
7837683|NCT00262925|27206389|P1|Overall Study|Death|2
7837684|NCT00262925|27206389|P1|Overall Study|Adverse Event|4
7837685|NCT00262925|27206389|P1|Overall Study|Lack of Efficacy|3
7837686|NCT00262873|27206395|P1|Overall Study|Withdrawal by Subject|5
7837687|NCT00262873|27206395|P1|Overall Study|Adverse Event|3
7837688|NCT00262860|27206406|P1|Overall Study|Adverse Event|2
7837689|NCT00262847|27206415|P3|Overall Study|Did not receive study treatment|4
7837690|NCT00262847|27206416|P2|Overall Study|Did not receive study treatment|1
7837691|NCT00262847|27206417|P1|Overall Study|Did not receive study treatment|4
7837692|NCT00262847|27206415|P3|Overall Study|Other Reasons|27
7837693|NCT00262847|27206416|P2|Overall Study|Other Reasons|88
7837694|NCT00262847|27206417|P1|Overall Study|Other Reasons|79
7837695|NCT00262847|27206415|P3|Overall Study|Concomitant disease|4
7837696|NCT00262847|27206416|P2|Overall Study|Concomitant disease|2
7837697|NCT00262847|27206417|P1|Overall Study|Concomitant disease|3
7837698|NCT00262847|27206415|P3|Overall Study|Death|11
7837699|NCT00262847|27206416|P2|Overall Study|Death|8
7837700|NCT00262847|27206417|P1|Overall Study|Death|8
7837701|NCT00262847|27206415|P3|Overall Study|Adverse Event|108
7837702|NCT00262847|27206416|P2|Overall Study|Adverse Event|88
7837703|NCT00262847|27206417|P1|Overall Study|Adverse Event|74
7837704|NCT00262847|27206415|P3|Overall Study|Patient Refusal|47
7837705|NCT00262847|27206416|P2|Overall Study|Patient Refusal|52
7837706|NCT00262847|27206417|P1|Overall Study|Patient Refusal|41
7837707|NCT00262847|27206415|P3|Overall Study|Disease Progression|195
7837708|NCT00262847|27206416|P2|Overall Study|Disease Progression|274
7837709|NCT00262847|27206417|P1|Overall Study|Disease Progression|309
7837710|NCT00262834|27206436|P2|Overall Study|Surgery delayed/tissue not collected|4
7837711|NCT00262834|27206437|P1|Overall Study|Surgery delayed/tissue not collected|1
7837712|NCT00262821|27206450|P2|Overall Study|Inevaluable - inadequate data|4
7837713|NCT00262821|27206451|P1|Overall Study|Inevaluable - inadequate data|0
7837714|NCT00262821|27206450|P2|Overall Study|Ineligible - required test not done|4
7837715|NCT00262821|27206451|P1|Overall Study|Ineligible - required test not done|1
7837716|NCT00262821|27206450|P2|Overall Study|Ineligible - elevated creatinine|2
7837717|NCT00262821|27206451|P1|Overall Study|Ineligible - elevated creatinine|0
7837718|NCT00262821|27206450|P2|Overall Study|Ineligible - inadequate pathology|3
7837719|NCT00262821|27206451|P1|Overall Study|Ineligible - inadequate pathology|1
7837720|NCT00262821|27206450|P2|Overall Study|Ineligible - wrong primary|1
7837721|NCT00262821|27206451|P1|Overall Study|Ineligible - wrong primary|0
7837722|NCT00262821|27206450|P2|Overall Study|Ineligible - wrong cell type|2
7837723|NCT00262821|27206451|P1|Overall Study|Ineligible - wrong cell type|2
7837724|NCT00262821|27206450|P2|Overall Study|Ineligible - wrong stage|3
7837725|NCT00262821|27206451|P1|Overall Study|Ineligible - wrong stage|0
7837726|NCT00262743|27206463|P2|Overall Study|Disease progression|3
7837727|NCT00262743|27206464|P1|Overall Study|Disease progression|0
7837728|NCT00262743|27206463|P2|Overall Study|Adverse Event|9
7837729|NCT00262743|27206464|P1|Overall Study|Adverse Event|0
7837730|NCT00262600|27206499|P3|Overall Study|Other|62
7837731|NCT00262600|27206500|P2|Overall Study|Other|59
7837732|NCT00262600|27206501|P1|Overall Study|Other|58
7837733|NCT00262600|27206499|P3|Overall Study|Not Treated|24
7837734|NCT00262600|27206500|P2|Overall Study|Not Treated|17
7837735|NCT00262600|27206501|P1|Overall Study|Not Treated|32
7837736|NCT00262600|27206499|P3|Overall Study|Withdrawal by Subject|139
7837737|NCT00262600|27206500|P2|Overall Study|Withdrawal by Subject|145
7837738|NCT00262600|27206501|P1|Overall Study|Withdrawal by Subject|128
7837739|NCT00262600|27206499|P3|Overall Study|Lost to Follow-up|41
7837740|NCT00262600|27206500|P2|Overall Study|Lost to Follow-up|31
7837741|NCT00262600|27206501|P1|Overall Study|Lost to Follow-up|17
7837742|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
7837743|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
7837744|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
7837745|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
7837746|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Virologic failure|0
7837747|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Virologic failure|8
7837748|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Virologic failure|0
7837749|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Virologic failure|5
7837750|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Death|0
7837751|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Death|2
7837752|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Death|0
7837753|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Death|2
7837754|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Noncompliance|0
7837755|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Noncompliance|11
7837756|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Noncompliance|0
7837757|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Noncompliance|6
7837758|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
7837759|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
7837760|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
7837761|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
7837762|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
7837763|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
7837764|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
7837765|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
7837766|NCT00262522|27206528|P4|Study Start Through 96 Weeks|Adverse Event|0
7837767|NCT00262522|27206529|P3|Study Start Through 96 Weeks|Adverse Event|16
7837768|NCT00262522|27206530|P2|Study Start Through 96 Weeks|Adverse Event|0
7837769|NCT00262522|27206531|P1|Study Start Through 96 Weeks|Adverse Event|20
7837770|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
7837771|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
7837772|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
7837773|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
7837774|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Virologic failure|0
7837775|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Virologic failure|4
7837776|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Virologic failure|0
7837777|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Virologic failure|2
7837778|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Death|0
7837779|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Death|1
7837780|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Death|0
7837781|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Death|2
7837782|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Noncompliance|0
7837783|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Noncompliance|8
7837784|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Noncompliance|0
7837785|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Noncompliance|3
7837786|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
7837787|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
7837788|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
7837789|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
7837790|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
7837791|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
7837792|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
7837793|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
7837794|NCT00262522|27206528|P4|Study Start Through 48 Weeks|Adverse Event|0
7837795|NCT00262522|27206529|P3|Study Start Through 48 Weeks|Adverse Event|10
7837796|NCT00262522|27206530|P2|Study Start Through 48 Weeks|Adverse Event|0
7837797|NCT00262522|27206531|P1|Study Start Through 48 Weeks|Adverse Event|16
7837798|NCT00262522|27206528|P4|Study Start Through 8 Weeks|Death|0
7837799|NCT00262522|27206529|P3|Study Start Through 8 Weeks|Death|0
7837800|NCT00262522|27206530|P2|Study Start Through 8 Weeks|Death|0
7837801|NCT00262522|27206531|P1|Study Start Through 8 Weeks|Death|1
7837802|NCT00262522|27206528|P4|Study Start Through 8 Weeks|Noncompliance|2
7837803|NCT00262522|27206529|P3|Study Start Through 8 Weeks|Noncompliance|2
7837804|NCT00262522|27206530|P2|Study Start Through 8 Weeks|Noncompliance|0
7837805|NCT00262522|27206531|P1|Study Start Through 8 Weeks|Noncompliance|0
7837806|NCT00262522|27206528|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
7837807|NCT00262522|27206529|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
7837808|NCT00262522|27206530|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
7837809|NCT00262522|27206531|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
7837810|NCT00262522|27206528|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
7837811|NCT00262522|27206529|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
7837812|NCT00262522|27206530|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
7837813|NCT00262522|27206531|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
7837814|NCT00262522|27206528|P4|Study Start Through 8 Weeks|Adverse Event|1
7837815|NCT00262522|27206529|P3|Study Start Through 8 Weeks|Adverse Event|3
7837816|NCT00262522|27206530|P2|Study Start Through 8 Weeks|Adverse Event|2
7837817|NCT00262522|27206531|P1|Study Start Through 8 Weeks|Adverse Event|1
7837818|NCT00262314|27206560|P1|Overall Study|Administrative withdrawal|30
7837819|NCT00262314|27206560|P1|Overall Study|Lost to Follow-up|70
7837820|NCT00262314|27206560|P1|Overall Study|Other|95
7837821|NCT00262314|27206560|P1|Overall Study|Patient's decision|92
7837822|NCT00262314|27206560|P1|Overall Study|Death|12
7837823|NCT00262314|27206560|P1|Overall Study|Changing physicians|38
7837824|NCT00262301|27206578|P3|Double-blind Phase|"worsening of HAE symptoms"|0
7837825|NCT00262301|27206579|P2|Double-blind Phase|"worsening of HAE symptoms"|1
7837826|NCT00262301|27206580|P1|Double-blind Phase|"worsening of HAE symptoms"|0
7837827|NCT00262301|27206578|P3|Double-blind Phase|Lost to Follow-up|0
7837828|NCT00262301|27206579|P2|Double-blind Phase|Lost to Follow-up|0
7837829|NCT00262301|27206580|P1|Double-blind Phase|Lost to Follow-up|1
7837830|NCT00262223|27206593|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
7837831|NCT00262223|27206594|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
7837832|NCT00262223|27206593|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
7837833|NCT00262223|27206594|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
7837834|NCT00262223|27206593|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
7837835|NCT00262223|27206594|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
7837836|NCT00262223|27206593|P2|Treatment Phase|Adverse Event|2
7837837|NCT00262223|27206594|P1|Treatment Phase|Adverse Event|1
7837838|NCT00262223|27206593|P2|Treatment Phase|Withdrawal by Subject|6
7837839|NCT00262223|27206594|P1|Treatment Phase|Withdrawal by Subject|3
7837840|NCT00262119|27206605|P3|Overall Study|Death|16
7837841|NCT00262119|27206606|P2|Overall Study|Death|19
7837842|NCT00262119|27206607|P1|Overall Study|Death|20
7837843|NCT00262119|27206605|P3|Overall Study|Lost to Follow-up|42
7837844|NCT00262119|27206606|P2|Overall Study|Lost to Follow-up|51
7837845|NCT00262119|27206607|P1|Overall Study|Lost to Follow-up|38
7837846|NCT00262080|27206627|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
7837847|NCT00262080|27206628|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
7837848|NCT00262080|27206629|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
7837849|NCT00262080|27206627|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
7837850|NCT00262080|27206628|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
7837851|NCT00262080|27206629|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
7837852|NCT00262080|27206627|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
7837853|NCT00262080|27206628|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
7837854|NCT00262080|27206629|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
7837855|NCT00262080|27206627|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
7837856|NCT00262080|27206628|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
7837857|NCT00262080|27206629|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
7837858|NCT00262080|27206627|P3|Repeat Dose Treatment Period|Adverse Event|0
7837859|NCT00262080|27206628|P2|Repeat Dose Treatment Period|Adverse Event|0
7837860|NCT00262080|27206629|P1|Repeat Dose Treatment Period|Adverse Event|1
7837861|NCT00262080|27206627|P3|Double Blind Treatment Period|Lost to Follow-up|0
7837862|NCT00262080|27206628|P2|Double Blind Treatment Period|Lost to Follow-up|0
7837863|NCT00262080|27206629|P1|Double Blind Treatment Period|Lost to Follow-up|1
7837864|NCT00262067|27206649|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
7837865|NCT00262067|27206650|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
7837866|NCT00262067|27206651|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
7837867|NCT00262067|27206652|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
7837868|NCT00262067|27206649|P4|Overall Study|Sponsor's Decision to Terminate Study|0
7837869|NCT00262067|27206650|P3|Overall Study|Sponsor's Decision to Terminate Study|0
7837870|NCT00262067|27206651|P2|Overall Study|Sponsor's Decision to Terminate Study|0
7837871|NCT00262067|27206652|P1|Overall Study|Sponsor's Decision to Terminate Study|1
7837872|NCT00262067|27206649|P4|Overall Study|Lost to Follow-up|5
7837873|NCT00262067|27206650|P3|Overall Study|Lost to Follow-up|7
7837874|NCT00262067|27206651|P2|Overall Study|Lost to Follow-up|4
7837875|NCT00262067|27206652|P1|Overall Study|Lost to Follow-up|5
7837876|NCT00262067|27206649|P4|Overall Study|Death|99
7837877|NCT00262067|27206650|P3|Overall Study|Death|186
7837878|NCT00262067|27206651|P2|Overall Study|Death|89
7837879|NCT00262067|27206652|P1|Overall Study|Death|190
7837880|NCT00262041|27206686|P3|Overall Study|Unable to classify|0
7837881|NCT00262041|27206687|P2|Overall Study|Unable to classify|0
7837882|NCT00262041|27206688|P1|Overall Study|Unable to classify|1
7837883|NCT00262041|27206686|P3|Overall Study|Lost to Follow-up|5
7837884|NCT00262041|27206687|P2|Overall Study|Lost to Follow-up|1
7837885|NCT00262041|27206688|P1|Overall Study|Lost to Follow-up|1
7837886|NCT00262041|27206686|P3|Overall Study|Withdrawal by Subject|1
7837887|NCT00262041|27206687|P2|Overall Study|Withdrawal by Subject|3
7837888|NCT00262041|27206688|P1|Overall Study|Withdrawal by Subject|0
7837889|NCT00262028|27206717|P9|Overall Study|Unable to classify|1
7837890|NCT00262028|27206718|P8|Overall Study|Unable to classify|0
7837891|NCT00262028|27206719|P7|Overall Study|Unable to classify|0
7837892|NCT00262028|27206720|P6|Overall Study|Unable to classify|0
7837893|NCT00262028|27206721|P5|Overall Study|Unable to classify|0
7837894|NCT00262028|27206722|P4|Overall Study|Unable to classify|0
7837895|NCT00262028|27206723|P3|Overall Study|Unable to classify|0
7837896|NCT00262028|27206724|P2|Overall Study|Unable to classify|3
7837897|NCT00262028|27206725|P1|Overall Study|Unable to classify|0
7837898|NCT00262028|27206717|P9|Overall Study|Protocol Violation|0
7837899|NCT00262028|27206718|P8|Overall Study|Protocol Violation|0
7837900|NCT00262028|27206719|P7|Overall Study|Protocol Violation|0
7837901|NCT00262028|27206720|P6|Overall Study|Protocol Violation|0
7837902|NCT00262028|27206721|P5|Overall Study|Protocol Violation|0
7837903|NCT00262028|27206722|P4|Overall Study|Protocol Violation|1
7837904|NCT00262028|27206723|P3|Overall Study|Protocol Violation|0
7837905|NCT00262028|27206724|P2|Overall Study|Protocol Violation|0
7837906|NCT00262028|27206725|P1|Overall Study|Protocol Violation|0
7837907|NCT00262028|27206717|P9|Overall Study|Administrative Reason|10
7837908|NCT00262028|27206718|P8|Overall Study|Administrative Reason|6
7837909|NCT00262028|27206719|P7|Overall Study|Administrative Reason|4
7837910|NCT00262028|27206720|P6|Overall Study|Administrative Reason|7
7837911|NCT00262028|27206721|P5|Overall Study|Administrative Reason|6
7837912|NCT00262028|27206722|P4|Overall Study|Administrative Reason|12
7837913|NCT00262028|27206723|P3|Overall Study|Administrative Reason|9
7837914|NCT00262028|27206724|P2|Overall Study|Administrative Reason|14
7837915|NCT00262028|27206725|P1|Overall Study|Administrative Reason|11
7837916|NCT00262028|27206717|P9|Overall Study|Lost to Follow-up|6
7837917|NCT00262028|27206718|P8|Overall Study|Lost to Follow-up|5
7837918|NCT00262028|27206719|P7|Overall Study|Lost to Follow-up|3
7837919|NCT00262028|27206720|P6|Overall Study|Lost to Follow-up|3
7837920|NCT00262028|27206721|P5|Overall Study|Lost to Follow-up|4
7837921|NCT00262028|27206722|P4|Overall Study|Lost to Follow-up|5
7837922|NCT00262028|27206723|P3|Overall Study|Lost to Follow-up|5
7837923|NCT00262028|27206724|P2|Overall Study|Lost to Follow-up|7
7837924|NCT00262028|27206725|P1|Overall Study|Lost to Follow-up|7
7837925|NCT00262028|27206717|P9|Overall Study|Withdrawal by Subject|2
7837926|NCT00262028|27206718|P8|Overall Study|Withdrawal by Subject|7
7837927|NCT00262028|27206719|P7|Overall Study|Withdrawal by Subject|5
7837928|NCT00262028|27206720|P6|Overall Study|Withdrawal by Subject|3
7837929|NCT00262028|27206721|P5|Overall Study|Withdrawal by Subject|2
7837930|NCT00262028|27206722|P4|Overall Study|Withdrawal by Subject|5
7837931|NCT00262028|27206723|P3|Overall Study|Withdrawal by Subject|6
7837932|NCT00262028|27206724|P2|Overall Study|Withdrawal by Subject|3
7837933|NCT00262028|27206725|P1|Overall Study|Withdrawal by Subject|6
7837934|NCT00262002|27206787|P7|Overall Study|Unable to classify|2
7837935|NCT00262002|27206788|P6|Overall Study|Unable to classify|0
7837936|NCT00262002|27206789|P5|Overall Study|Unable to classify|0
7837937|NCT00262002|27206790|P4|Overall Study|Unable to classify|0
7837938|NCT00262002|27206791|P3|Overall Study|Unable to classify|0
7837939|NCT00262002|27206792|P2|Overall Study|Unable to classify|0
7837940|NCT00262002|27206793|P1|Overall Study|Unable to classify|0
7837941|NCT00262002|27206787|P7|Overall Study|Protocol Violation|2
7837942|NCT00262002|27206788|P6|Overall Study|Protocol Violation|3
7837943|NCT00262002|27206789|P5|Overall Study|Protocol Violation|5
7837944|NCT00262002|27206790|P4|Overall Study|Protocol Violation|2
7837945|NCT00262002|27206791|P3|Overall Study|Protocol Violation|0
7837946|NCT00262002|27206792|P2|Overall Study|Protocol Violation|2
7837947|NCT00262002|27206793|P1|Overall Study|Protocol Violation|3
7837948|NCT00262002|27206787|P7|Overall Study|Inapropriate enrollment|0
7837949|NCT00262002|27206788|P6|Overall Study|Inapropriate enrollment|0
7837950|NCT00262002|27206789|P5|Overall Study|Inapropriate enrollment|0
7837951|NCT00262002|27206790|P4|Overall Study|Inapropriate enrollment|0
7837952|NCT00262002|27206791|P3|Overall Study|Inapropriate enrollment|0
7837953|NCT00262002|27206792|P2|Overall Study|Inapropriate enrollment|1
7837954|NCT00262002|27206793|P1|Overall Study|Inapropriate enrollment|0
7837955|NCT00262002|27206787|P7|Overall Study|Lost to Follow-up|0
7837956|NCT00262002|27206788|P6|Overall Study|Lost to Follow-up|1
7837957|NCT00262002|27206789|P5|Overall Study|Lost to Follow-up|0
7837958|NCT00262002|27206790|P4|Overall Study|Lost to Follow-up|2
7837959|NCT00262002|27206791|P3|Overall Study|Lost to Follow-up|0
7837960|NCT00262002|27206792|P2|Overall Study|Lost to Follow-up|0
7837961|NCT00262002|27206793|P1|Overall Study|Lost to Follow-up|2
7837962|NCT00262002|27206787|P7|Overall Study|Withdrawal by Subject|2
7837963|NCT00262002|27206788|P6|Overall Study|Withdrawal by Subject|2
7837964|NCT00262002|27206789|P5|Overall Study|Withdrawal by Subject|2
7837965|NCT00262002|27206790|P4|Overall Study|Withdrawal by Subject|1
7837966|NCT00262002|27206791|P3|Overall Study|Withdrawal by Subject|0
7837967|NCT00262002|27206792|P2|Overall Study|Withdrawal by Subject|2
7837968|NCT00262002|27206793|P1|Overall Study|Withdrawal by Subject|4
7837969|NCT00262002|27206787|P7|Overall Study|Adverse Event|0
7837970|NCT00262002|27206788|P6|Overall Study|Adverse Event|1
7837971|NCT00262002|27206789|P5|Overall Study|Adverse Event|0
7837972|NCT00262002|27206790|P4|Overall Study|Adverse Event|0
7837973|NCT00262002|27206791|P3|Overall Study|Adverse Event|0
7837974|NCT00262002|27206792|P2|Overall Study|Adverse Event|1
7837975|NCT00262002|27206793|P1|Overall Study|Adverse Event|2
7837976|NCT00261950|27206886|P1|Overall Study|Protocol specified Criteria|11
7837977|NCT00261950|27206886|P1|Overall Study|Physician Decision|1
7837978|NCT00261950|27206886|P1|Overall Study|Other|1
7837979|NCT00261950|27206886|P1|Overall Study|Withdrawal by Subject|5
7837980|NCT00261950|27206886|P1|Overall Study|Death|6
7837981|NCT00261950|27206886|P1|Overall Study|Lost to Follow-up|2
7837982|NCT00261846|27206911|P12|Period 2: Part 2 (Efficacy)|Extension study|1
7837983|NCT00261846|27206912|P11|Period 2: Part 2 (Efficacy)|Extension study|1
7837984|NCT00261846|27206913|P10|Period 2: Part 2 (Efficacy)|Extension study|9
7837985|NCT00261846|27206914|P9|Period 2: Part 2 (Efficacy)|Extension study|5
7837986|NCT00261846|27206915|P8|Period 2: Part 2 (Efficacy)|Extension study|9
7837987|NCT00261846|27206916|P7|Period 2: Part 2 (Efficacy)|Extension study|4
7837988|NCT00261846|27206917|P6|Period 2: Part 2 (Efficacy)|Extension study|0
7837989|NCT00261846|27206918|P5|Period 2: Part 2 (Efficacy)|Extension study|27
7837990|NCT00261846|27206919|P4|Period 2: Part 2 (Efficacy)|Extension study|61
7837991|NCT00261846|27206920|P3|Period 2: Part 2 (Efficacy)|Extension study|0
7837992|NCT00261846|27206921|P2|Period 2: Part 2 (Efficacy)|Extension study|0
7837993|NCT00261846|27206922|P1|Period 2: Part 2 (Efficacy)|Extension study|0
7837994|NCT00261846|27206911|P12|Period 2: Part 2 (Efficacy)|Death|22
7837995|NCT00261846|27206912|P11|Period 2: Part 2 (Efficacy)|Death|44
7837996|NCT00261846|27206913|P10|Period 2: Part 2 (Efficacy)|Death|30
7837997|NCT00261846|27206914|P9|Period 2: Part 2 (Efficacy)|Death|3
7837998|NCT00261846|27206915|P8|Period 2: Part 2 (Efficacy)|Death|12
7837999|NCT00261846|27206916|P7|Period 2: Part 2 (Efficacy)|Death|10
7838000|NCT00261846|27206917|P6|Period 2: Part 2 (Efficacy)|Death|1
7838001|NCT00261846|27206918|P5|Period 2: Part 2 (Efficacy)|Death|7
7838002|NCT00261846|27206919|P4|Period 2: Part 2 (Efficacy)|Death|37
7838003|NCT00261846|27206920|P3|Period 2: Part 2 (Efficacy)|Death|0
7838004|NCT00261846|27206921|P2|Period 2: Part 2 (Efficacy)|Death|0
7838005|NCT00261846|27206922|P1|Period 2: Part 2 (Efficacy)|Death|0
7838006|NCT00261846|27206911|P12|Period 2: Part 2 (Efficacy)|Other|0
7838007|NCT00261846|27206912|P11|Period 2: Part 2 (Efficacy)|Other|0
7838008|NCT00261846|27206913|P10|Period 2: Part 2 (Efficacy)|Other|4
7838009|NCT00261846|27206914|P9|Period 2: Part 2 (Efficacy)|Other|4
7838010|NCT00261846|27206915|P8|Period 2: Part 2 (Efficacy)|Other|5
7838011|NCT00261846|27206916|P7|Period 2: Part 2 (Efficacy)|Other|1
7838012|NCT00261846|27206917|P6|Period 2: Part 2 (Efficacy)|Other|0
7838013|NCT00261846|27206918|P5|Period 2: Part 2 (Efficacy)|Other|4
7838014|NCT00261846|27206919|P4|Period 2: Part 2 (Efficacy)|Other|15
7838015|NCT00261846|27206920|P3|Period 2: Part 2 (Efficacy)|Other|0
7838016|NCT00261846|27206921|P2|Period 2: Part 2 (Efficacy)|Other|0
7838017|NCT00261846|27206922|P1|Period 2: Part 2 (Efficacy)|Other|0
7838018|NCT00261846|27206911|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7838019|NCT00261846|27206912|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7838020|NCT00261846|27206913|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7838021|NCT00261846|27206914|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
7838022|NCT00261846|27206915|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7838023|NCT00261846|27206916|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7838024|NCT00261846|27206917|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7838025|NCT00261846|27206918|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7838026|NCT00261846|27206919|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
7838027|NCT00261846|27206920|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7838028|NCT00261846|27206921|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7838029|NCT00261846|27206922|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7838030|NCT00261846|27206911|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7838031|NCT00261846|27206912|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7838032|NCT00261846|27206913|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
7838033|NCT00261846|27206914|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7838034|NCT00261846|27206915|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
7838035|NCT00261846|27206916|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
7838036|NCT00261846|27206917|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
7838037|NCT00261846|27206918|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
7838038|NCT00261846|27206919|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
7838039|NCT00261846|27206920|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7838040|NCT00261846|27206921|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7838041|NCT00261846|27206922|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7838042|NCT00261846|27206911|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838043|NCT00261846|27206912|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838044|NCT00261846|27206913|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838045|NCT00261846|27206914|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
7838046|NCT00261846|27206915|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838047|NCT00261846|27206916|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838048|NCT00261846|27206917|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838049|NCT00261846|27206918|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838050|NCT00261846|27206919|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
7838051|NCT00261846|27206920|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838052|NCT00261846|27206921|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838053|NCT00261846|27206922|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7838054|NCT00261846|27206911|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838055|NCT00261846|27206912|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838056|NCT00261846|27206913|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838057|NCT00261846|27206914|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838058|NCT00261846|27206915|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838059|NCT00261846|27206916|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838060|NCT00261846|27206917|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838061|NCT00261846|27206918|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838062|NCT00261846|27206919|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7838063|NCT00261846|27206920|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
7838064|NCT00261846|27206921|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
7838065|NCT00261846|27206922|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
7838066|NCT00261833|27207181|P2|Overall Study|Not interested in being participant|1
7838067|NCT00261833|27207182|P1|Overall Study|Not interested in being participant|0
7838068|NCT00261833|27207181|P2|Overall Study|Missing reason|0
7838069|NCT00261833|27207182|P1|Overall Study|Missing reason|1
7838070|NCT00261833|27207181|P2|Overall Study|Lung transplantation|1
7838071|NCT00261833|27207182|P1|Overall Study|Lung transplantation|1
7838072|NCT00261833|27207181|P2|Overall Study|Suspicion of pulmonary cancer|1
7838073|NCT00261833|27207182|P1|Overall Study|Suspicion of pulmonary cancer|0
7838074|NCT00261833|27207181|P2|Overall Study|Protocol Violation|1
7838075|NCT00261833|27207182|P1|Overall Study|Protocol Violation|0
7838076|NCT00261833|27207181|P2|Overall Study|Withdrawal by Subject|7
7838077|NCT00261833|27207182|P1|Overall Study|Withdrawal by Subject|5
7838078|NCT00261833|27207181|P2|Overall Study|Adverse Event|4
7838079|NCT00261833|27207182|P1|Overall Study|Adverse Event|1
7838080|NCT00261833|27207181|P2|Overall Study|Death|3
7838081|NCT00261833|27207182|P1|Overall Study|Death|1
7838082|NCT00261807|27207214|P1|Overall Study|Protocol Violation|2
7838083|NCT00261807|27207214|P1|Overall Study|Death|1
7838084|NCT00261807|27207214|P1|Overall Study|Adverse Event|2
7838085|NCT00261807|27207214|P1|Overall Study|Lost to Follow-up|2
7838086|NCT00261716|27207222|P2|Overall Study|Lost to Follow-up|2
7838087|NCT00261716|27207223|P1|Overall Study|Lost to Follow-up|0
7838088|NCT00261716|27207222|P2|Overall Study|Withdrawal by Subject|8
7838089|NCT00261716|27207223|P1|Overall Study|Withdrawal by Subject|6
7838090|NCT00261495|27207243|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7838091|NCT00261495|27207244|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7838092|NCT00261495|27207243|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
7838093|NCT00261495|27207244|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
7838094|NCT00261495|27207243|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7838095|NCT00261495|27207244|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7838096|NCT00261495|27207243|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7838097|NCT00261495|27207244|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7838098|NCT00261495|27207243|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7838099|NCT00261495|27207244|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
7838100|NCT00261495|27207243|P2|Extension Phase (Weeks 24 to 52)|Other|2
7838101|NCT00261495|27207244|P1|Extension Phase (Weeks 24 to 52)|Other|4
7838102|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
7838103|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
7838104|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
7838105|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
7838106|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
7838107|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
7838108|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
7838109|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
7838110|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
7838111|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
7838112|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
7838113|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
7838114|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
7838115|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
7838116|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
7838117|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
7838118|NCT00261495|27207243|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
7838119|NCT00261495|27207244|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
7838120|NCT00261495|27207243|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
7838121|NCT00261495|27207244|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
7838122|NCT00261495|27207243|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
7838123|NCT00261495|27207244|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
7838124|NCT00261495|27207243|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
7838125|NCT00261495|27207244|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
7838126|NCT00261495|27207243|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
7838127|NCT00261495|27207244|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
7838128|NCT00261495|27207243|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
7838129|NCT00261495|27207244|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
7838130|NCT00261495|27207243|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
7838131|NCT00261495|27207244|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
7838132|NCT00261443|27207408|P3|4: Extension Phase|Lost to Follow-up|0
7838133|NCT00261443|27207409|P2|4: Extension Phase|Lost to Follow-up|1
7838134|NCT00261443|27207410|P1|4: Extension Phase|Lost to Follow-up|0
7838135|NCT00261443|27207408|P3|4: Extension Phase|Withdrawal by Subject|2
7838136|NCT00261443|27207409|P2|4: Extension Phase|Withdrawal by Subject|1
7838137|NCT00261443|27207410|P1|4: Extension Phase|Withdrawal by Subject|0
7838138|NCT00261443|27207408|P3|4: Extension Phase|Adverse Event|0
7838139|NCT00261443|27207409|P2|4: Extension Phase|Adverse Event|1
7838140|NCT00261443|27207410|P1|4: Extension Phase|Adverse Event|0
7838141|NCT00261443|27207408|P3|3: Assessment of Relapse|Other Reasons|3
7838142|NCT00261443|27207409|P2|3: Assessment of Relapse|Other Reasons|4
7838143|NCT00261443|27207410|P1|3: Assessment of Relapse|Other Reasons|0
7838144|NCT00261443|27207408|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
7838145|NCT00261443|27207409|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7838146|NCT00261443|27207410|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7838147|NCT00261443|27207408|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
7838148|NCT00261443|27207409|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
7838149|NCT00261443|27207410|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
7838150|NCT00261443|27207408|P3|3: Assessment of Relapse|Pregnancy|1
7838151|NCT00261443|27207409|P2|3: Assessment of Relapse|Pregnancy|2
7838152|NCT00261443|27207410|P1|3: Assessment of Relapse|Pregnancy|0
7838153|NCT00261443|27207408|P3|3: Assessment of Relapse|Poor/Noncompliance|3
7838154|NCT00261443|27207409|P2|3: Assessment of Relapse|Poor/Noncompliance|5
7838155|NCT00261443|27207410|P1|3: Assessment of Relapse|Poor/Noncompliance|0
7838156|NCT00261443|27207408|P3|3: Assessment of Relapse|Lost to Follow-up|6
7838157|NCT00261443|27207409|P2|3: Assessment of Relapse|Lost to Follow-up|7
7838158|NCT00261443|27207410|P1|3: Assessment of Relapse|Lost to Follow-up|0
7838159|NCT00261443|27207408|P3|3: Assessment of Relapse|Death|1
7838160|NCT00261443|27207409|P2|3: Assessment of Relapse|Death|0
7838161|NCT00261443|27207410|P1|3: Assessment of Relapse|Death|0
7838162|NCT00261443|27207408|P3|3: Assessment of Relapse|Withdrawal by Subject|15
7838163|NCT00261443|27207409|P2|3: Assessment of Relapse|Withdrawal by Subject|14
7838164|NCT00261443|27207410|P1|3: Assessment of Relapse|Withdrawal by Subject|0
7838165|NCT00261443|27207408|P3|3: Assessment of Relapse|Adverse Event|19
7838166|NCT00261443|27207409|P2|3: Assessment of Relapse|Adverse Event|15
7838167|NCT00261443|27207410|P1|3: Assessment of Relapse|Adverse Event|0
7838168|NCT00261443|27207408|P3|3: Assessment of Relapse|Lack of Efficacy|14
7838169|NCT00261443|27207409|P2|3: Assessment of Relapse|Lack of Efficacy|31
7838170|NCT00261443|27207410|P1|3: Assessment of Relapse|Lack of Efficacy|0
7838171|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Other Reasons|0
7838172|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Other Reasons|0
7838173|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Other Reasons|13
7838174|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
7838175|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
7838176|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
7838177|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
7838178|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
7838179|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
7838180|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Pregnancy|0
7838181|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Pregnancy|0
7838182|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Pregnancy|1
7838183|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
7838184|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
7838185|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
7838186|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
7838187|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
7838188|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
7838189|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
7838190|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
7838191|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
7838192|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Adverse Event|0
7838193|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Adverse Event|0
7838194|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Adverse Event|93
7838195|NCT00261443|27207408|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
7838196|NCT00261443|27207409|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
7838197|NCT00261443|27207410|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
7838198|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
7838199|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
7838200|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
7838201|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
7838202|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
7838203|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
7838204|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
7838205|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
7838206|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
7838207|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
7838208|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
7838209|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
7838210|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
7838211|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
7838212|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
7838213|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
7838214|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
7838215|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
7838216|NCT00261443|27207408|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
7838217|NCT00261443|27207409|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
7838218|NCT00261443|27207410|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
7838219|NCT00260832|27207695|P2|Overall Study|Protocol Violation|1
7838220|NCT00260832|27207696|P1|Overall Study|Protocol Violation|3
7838221|NCT00260832|27207695|P2|Overall Study|Other|7
7838222|NCT00260832|27207696|P1|Overall Study|Other|10
7838223|NCT00260832|27207695|P2|Overall Study|Death|62
7838224|NCT00260832|27207696|P1|Overall Study|Death|43
7838225|NCT00260832|27207695|P2|Overall Study|Physician Decision|9
7838226|NCT00260832|27207696|P1|Overall Study|Physician Decision|15
7838227|NCT00260832|27207695|P2|Overall Study|Withdrawal by Subject|17
7838228|NCT00260832|27207696|P1|Overall Study|Withdrawal by Subject|15
7838229|NCT00260832|27207695|P2|Overall Study|Progression|96
7838230|NCT00260832|27207696|P1|Overall Study|Progression|116
7838231|NCT00260832|27207695|P2|Overall Study|Adverse Event|19
7838232|NCT00260832|27207696|P1|Overall Study|Adverse Event|26
7838233|NCT00260533|27207725|P2|Overall Study|Other|3
7838234|NCT00260533|27207726|P1|Overall Study|Other|3
7838235|NCT00260429|27207734|P2|Overall Study|scheduled hand surgery|0
7838236|NCT00260429|27207735|P1|Overall Study|scheduled hand surgery|1
7838237|NCT00260429|27207734|P2|Overall Study|failure to follow appointments|0
7838238|NCT00260429|27207735|P1|Overall Study|failure to follow appointments|1
7838239|NCT00260208|27207743|P2|Overall Study|Missing|16
7838240|NCT00260208|27207744|P1|Overall Study|Missing|18
7838241|NCT00260208|27207743|P2|Overall Study|Death|10
7838242|NCT00260208|27207744|P1|Overall Study|Death|12
7838243|NCT00260208|27207743|P2|Overall Study|Lost to Follow-up|1
7838244|NCT00260208|27207744|P1|Overall Study|Lost to Follow-up|6
7838245|NCT00260208|27207743|P2|Overall Study|Subject withdrew consent|7
7838246|NCT00260208|27207744|P1|Overall Study|Subject withdrew consent|11
7838247|NCT00260065|27207787|P1|Overall Study|Medication Noncompliance|1
7838248|NCT00260065|27207787|P1|Overall Study|Not otherwise specified|8
7838249|NCT00260065|27207787|P1|Overall Study|Physician Decision|19
7838250|NCT00260065|27207787|P1|Overall Study|Withdrawal by Subject|13
7838251|NCT00260065|27207787|P1|Overall Study|Death|13
7838252|NCT00260065|27207787|P1|Overall Study|Adverse Event|17
7838253|NCT00260065|27207787|P1|Overall Study|Progressive Disease|22
7838254|NCT00259857|27207794|P2|24 Months Treatment|Lost to Follow-up|3
7838255|NCT00259857|27207795|P1|24 Months Treatment|Lost to Follow-up|0
7838256|NCT00259857|27207794|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
7838257|NCT00259857|27207795|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
7838258|NCT00259740|27207813|P2|Overall Study|Requirement for alternative therapy|4
7838259|NCT00259740|27207814|P1|Overall Study|Requirement for alternative therapy|0
7838260|NCT00259740|27207813|P2|Overall Study|Other|0
7838261|NCT00259740|27207814|P1|Overall Study|Other|3
7838262|NCT00259740|27207813|P2|Overall Study|Ongoing|3
7838263|NCT00259740|27207814|P1|Overall Study|Ongoing|17
7838264|NCT00259740|27207813|P2|Overall Study|Disease progression|36
7838265|NCT00259740|27207814|P1|Overall Study|Disease progression|19
7838266|NCT00259740|27207813|P2|Overall Study|Death|1
7838267|NCT00259740|27207814|P1|Overall Study|Death|1
7838268|NCT00259740|27207813|P2|Overall Study|Withdrawal by Subject|6
7838269|NCT00259740|27207814|P1|Overall Study|Withdrawal by Subject|2
7838270|NCT00259740|27207813|P2|Overall Study|Adverse Event|2
7838271|NCT00259740|27207814|P1|Overall Study|Adverse Event|0
7838272|NCT00259740|27207813|P2|Overall Study|Physician Decision|1
7838273|NCT00259740|27207814|P1|Overall Study|Physician Decision|1
7838274|NCT00259649|27207824|P1|Overall Study|irregular menses|3
7838275|NCT00259649|27207824|P1|Overall Study|Lost to Follow-up|7
7838276|NCT00259610|27207832|P4|Overall Study|Serious Adverse Event|2
7838277|NCT00259610|27207833|P3|Overall Study|Serious Adverse Event|2
7838278|NCT00259610|27207834|P2|Overall Study|Serious Adverse Event|2
7838279|NCT00259610|27207835|P1|Overall Study|Serious Adverse Event|8
7838280|NCT00259610|27207832|P4|Overall Study|Adverse Event|2
7838281|NCT00259610|27207833|P3|Overall Study|Adverse Event|5
7838282|NCT00259610|27207834|P2|Overall Study|Adverse Event|4
7838283|NCT00259610|27207835|P1|Overall Study|Adverse Event|3
7838284|NCT00259610|27207832|P4|Overall Study|non medical reason|3
7838285|NCT00259610|27207833|P3|Overall Study|non medical reason|10
7838286|NCT00259610|27207834|P2|Overall Study|non medical reason|2
7838287|NCT00259610|27207835|P1|Overall Study|non medical reason|6
7838288|NCT00259610|27207832|P4|Overall Study|Death|0
7838289|NCT00259610|27207833|P3|Overall Study|Death|2
7838290|NCT00259610|27207834|P2|Overall Study|Death|1
7838291|NCT00259610|27207835|P1|Overall Study|Death|1
7838292|NCT00259610|27207832|P4|Overall Study|Physician Decision|2
7838293|NCT00259610|27207833|P3|Overall Study|Physician Decision|7
7838294|NCT00259610|27207834|P2|Overall Study|Physician Decision|4
7838295|NCT00259610|27207835|P1|Overall Study|Physician Decision|6
7838296|NCT00259610|27207832|P4|Overall Study|Lost to Follow-up|15
7838297|NCT00259610|27207833|P3|Overall Study|Lost to Follow-up|18
7838298|NCT00259610|27207834|P2|Overall Study|Lost to Follow-up|8
7838299|NCT00259610|27207835|P1|Overall Study|Lost to Follow-up|19
7838300|NCT00259610|27207832|P4|Overall Study|Withdrawal by Subject|19
7838301|NCT00259610|27207833|P3|Overall Study|Withdrawal by Subject|29
7838302|NCT00259610|27207834|P2|Overall Study|Withdrawal by Subject|25
7838303|NCT00259610|27207835|P1|Overall Study|Withdrawal by Subject|33
7838304|NCT00259298|27207849|P1|Overall Study|Physician Decision|2
7838305|NCT00259298|27207849|P1|Overall Study|Withdrawal by Subject|1
7838306|NCT00259272|27207867|P4|Overall Study|Lost to Follow-up|1
7838307|NCT00259272|27207868|P3|Overall Study|Lost to Follow-up|0
7838308|NCT00259272|27207869|P2|Overall Study|Lost to Follow-up|0
7838309|NCT00259272|27207870|P1|Overall Study|Lost to Follow-up|1
7838310|NCT00259272|27207867|P4|Overall Study|Withdrawal by Subject|7
7838311|NCT00259272|27207868|P3|Overall Study|Withdrawal by Subject|2
7838312|NCT00259272|27207869|P2|Overall Study|Withdrawal by Subject|2
7838313|NCT00259272|27207870|P1|Overall Study|Withdrawal by Subject|4
7838314|NCT00259272|27207867|P4|Overall Study|Sponsor Decision|0
7838315|NCT00259272|27207868|P3|Overall Study|Sponsor Decision|0
7838316|NCT00259272|27207869|P2|Overall Study|Sponsor Decision|1
7838317|NCT00259272|27207870|P1|Overall Study|Sponsor Decision|0
7838318|NCT00259272|27207867|P4|Overall Study|Protocol Violation|1
7838319|NCT00259272|27207868|P3|Overall Study|Protocol Violation|0
7838320|NCT00259272|27207869|P2|Overall Study|Protocol Violation|0
7838321|NCT00259272|27207870|P1|Overall Study|Protocol Violation|2
7838322|NCT00259272|27207867|P4|Overall Study|Physician Decision|3
7838323|NCT00259272|27207868|P3|Overall Study|Physician Decision|1
7838324|NCT00259272|27207869|P2|Overall Study|Physician Decision|2
7838325|NCT00259272|27207870|P1|Overall Study|Physician Decision|1
7838326|NCT00259272|27207867|P4|Overall Study|Lack of Efficacy|6
7838327|NCT00259272|27207868|P3|Overall Study|Lack of Efficacy|2
7838328|NCT00259272|27207869|P2|Overall Study|Lack of Efficacy|1
7838329|NCT00259272|27207870|P1|Overall Study|Lack of Efficacy|5
7838330|NCT00259272|27207867|P4|Overall Study|Adverse Event|3
7838331|NCT00259272|27207868|P3|Overall Study|Adverse Event|0
7838332|NCT00259272|27207869|P2|Overall Study|Adverse Event|1
7838333|NCT00259272|27207870|P1|Overall Study|Adverse Event|2
7838334|NCT00259012|27207966|P2|Overall Study|Protocol Violation|1
7838335|NCT00259012|27207967|P1|Overall Study|Protocol Violation|1
7838336|NCT00259012|27207966|P2|Overall Study|Lost to Follow-up|1
7838337|NCT00259012|27207967|P1|Overall Study|Lost to Follow-up|0
7838338|NCT00259012|27207966|P2|Overall Study|Physician Decision|1
7838339|NCT00259012|27207967|P1|Overall Study|Physician Decision|0
7838340|NCT00259012|27207966|P2|Overall Study|Withdrawal by Subject|0
7838341|NCT00259012|27207967|P1|Overall Study|Withdrawal by Subject|1
7838342|NCT00259012|27207966|P2|Overall Study|Adverse Event|1
7838343|NCT00259012|27207967|P1|Overall Study|Adverse Event|0
7838344|NCT00258960|27207999|P1|Overall Study|Mistake|2
7838345|NCT00258960|27207999|P1|Overall Study|Withdrawal by Subject|1
7838346|NCT00258960|27207999|P1|Overall Study|Physician Decision|1
7838347|NCT00258960|27207999|P1|Overall Study|Adverse Event|4
7838348|NCT00258960|27207999|P1|Overall Study|Disease Progression|7
7838349|NCT00258960|27207999|P1|Overall Study|Death|2
7838350|NCT00258895|27208015|P2|Overall Study|Withdrawal by Subject|0
7838351|NCT00258895|27208016|P1|Overall Study|Withdrawal by Subject|1
7838352|NCT00258895|27208015|P2|Overall Study|Protocol Violation|2
7838353|NCT00258895|27208016|P1|Overall Study|Protocol Violation|6
7838354|NCT00258895|27208015|P2|Overall Study|Lost to Follow-up|1
7838355|NCT00258895|27208016|P1|Overall Study|Lost to Follow-up|3
7838356|NCT00258856|27208052|P4|Overall Study|Non-compliance|1
7838357|NCT00258856|27208053|P3|Overall Study|Non-compliance|0
7838358|NCT00258856|27208054|P2|Overall Study|Non-compliance|0
7838359|NCT00258856|27208055|P1|Overall Study|Non-compliance|2
7838360|NCT00258856|27208052|P4|Overall Study|Lost to Follow-up|0
7838361|NCT00258856|27208053|P3|Overall Study|Lost to Follow-up|2
7838362|NCT00258856|27208054|P2|Overall Study|Lost to Follow-up|0
7838363|NCT00258856|27208055|P1|Overall Study|Lost to Follow-up|1
7838364|NCT00258674|27208096|P3|Overall Study|Death|34
7838365|NCT00258674|27208097|P2|Overall Study|Death|53
7838366|NCT00258674|27208098|P1|Overall Study|Death|32
7838367|NCT00258440|27208157|P3|Overall Study|Withdrawal by Subject|1
7838368|NCT00258440|27208158|P2|Overall Study|Withdrawal by Subject|0
7838369|NCT00258440|27208159|P1|Overall Study|Withdrawal by Subject|0
7838370|NCT00258154|27208197|P2|Overall Study|Patient Moved|1
7838371|NCT00258154|27208198|P1|Overall Study|Patient Moved|3
7838372|NCT00258154|27208197|P2|Overall Study|Withdrawal by Subject|4
7838373|NCT00258154|27208198|P1|Overall Study|Withdrawal by Subject|3
7838374|NCT00258154|27208197|P2|Overall Study|Protocol Violation|1
7838375|NCT00258154|27208198|P1|Overall Study|Protocol Violation|2
7838376|NCT00258154|27208197|P2|Overall Study|Lost to Follow-up|1
7838377|NCT00258154|27208198|P1|Overall Study|Lost to Follow-up|0
7838378|NCT00258154|27208197|P2|Overall Study|Adverse Event|0
7838379|NCT00258154|27208198|P1|Overall Study|Adverse Event|1
7838380|NCT00257920|27208293|P2|Period: Second Intervention|Other|1
7838381|NCT00257920|27208294|P1|Period: Second Intervention|Other|2
7838382|NCT00257920|27208293|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
7838383|NCT00257920|27208294|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
7838384|NCT00257725|27208317|P1|Overall Study|Adverse Event|3
7838385|NCT00257660|27208356|P2|Overall Study|No longer wanted to do blood draws|0
7838386|NCT00257660|27208357|P1|Overall Study|No longer wanted to do blood draws|1
7838387|NCT00257660|27208356|P2|Overall Study|PI & Subject Schedule Conflicts|0
7838388|NCT00257660|27208357|P1|Overall Study|PI & Subject Schedule Conflicts|1
7838389|NCT00257660|27208356|P2|Overall Study|Lost to Follow-up|0
7838390|NCT00257660|27208357|P1|Overall Study|Lost to Follow-up|1
7838391|NCT00257660|27208356|P2|Overall Study|Withdrawal by Subject|0
7838392|NCT00257660|27208357|P1|Overall Study|Withdrawal by Subject|2
7838393|NCT00257660|27208356|P2|Overall Study|Lack of Efficacy|23
7838394|NCT00257660|27208357|P1|Overall Study|Lack of Efficacy|5
7838395|NCT00257608|27208387|P3|Post Chemotherapy Phase|Not treated|7
7838396|NCT00257608|27208388|P2|Post Chemotherapy Phase|Not treated|4
7838397|NCT00257608|27208389|P1|Post Chemotherapy Phase|Not treated|0
7838398|NCT00257608|27208387|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
7838399|NCT00257608|27208388|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
7838400|NCT00257608|27208389|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
7838401|NCT00257608|27208387|P3|Post Chemotherapy Phase|Physician Decision|11
7838402|NCT00257608|27208388|P2|Post Chemotherapy Phase|Physician Decision|8
7838403|NCT00257608|27208389|P1|Post Chemotherapy Phase|Physician Decision|0
7838404|NCT00257608|27208387|P3|Post Chemotherapy Phase|Lost to Follow-up|1
7838405|NCT00257608|27208388|P2|Post Chemotherapy Phase|Lost to Follow-up|0
7838406|NCT00257608|27208389|P1|Post Chemotherapy Phase|Lost to Follow-up|0
7838407|NCT00257608|27208387|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
7838408|NCT00257608|27208388|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
7838409|NCT00257608|27208389|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
7838410|NCT00257608|27208387|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
7838411|NCT00257608|27208388|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
7838412|NCT00257608|27208389|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
7838413|NCT00257608|27208387|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
7838414|NCT00257608|27208388|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
7838415|NCT00257608|27208389|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7838416|NCT00257608|27208387|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
7838417|NCT00257608|27208388|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
7838418|NCT00257608|27208389|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
7838419|NCT00257608|27208387|P3|Post Chemotherapy Phase|Disease progression|168
7838420|NCT00257608|27208388|P2|Post Chemotherapy Phase|Disease progression|204
7838421|NCT00257608|27208389|P1|Post Chemotherapy Phase|Disease progression|0
7838422|NCT00257608|27208387|P3|Post Chemotherapy Phase|Adverse Event|38
7838423|NCT00257608|27208388|P2|Post Chemotherapy Phase|Adverse Event|34
7838424|NCT00257608|27208389|P1|Post Chemotherapy Phase|Adverse Event|0
7838425|NCT00257608|27208387|P3|Chemotherapy Phase|Physician Decision|0
7838426|NCT00257608|27208388|P2|Chemotherapy Phase|Physician Decision|0
7838427|NCT00257608|27208389|P1|Chemotherapy Phase|Physician Decision|28
7838428|NCT00257608|27208387|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
7838429|NCT00257608|27208388|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
7838430|NCT00257608|27208389|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
7838431|NCT00257608|27208387|P3|Chemotherapy Phase|Patient's decision to discontinue|0
7838432|NCT00257608|27208388|P2|Chemotherapy Phase|Patient's decision to discontinue|0
7838433|NCT00257608|27208389|P1|Chemotherapy Phase|Patient's decision to discontinue|35
7838434|NCT00257608|27208387|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7838435|NCT00257608|27208388|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7838436|NCT00257608|27208389|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
7838437|NCT00257608|27208387|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
7838438|NCT00257608|27208388|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
7838439|NCT00257608|27208389|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
7838440|NCT00257608|27208387|P3|Chemotherapy Phase|Disease progression|0
7838441|NCT00257608|27208388|P2|Chemotherapy Phase|Disease progression|0
7838442|NCT00257608|27208389|P1|Chemotherapy Phase|Disease progression|139
7838443|NCT00257608|27208387|P3|Chemotherapy Phase|Adverse Event|0
7838444|NCT00257608|27208388|P2|Chemotherapy Phase|Adverse Event|0
7838445|NCT00257608|27208389|P1|Chemotherapy Phase|Adverse Event|138
7838446|NCT00257556|27208415|P2|Overall Study|other reason|6
7838447|NCT00257556|27208416|P1|Overall Study|other reason|4
7838448|NCT00257556|27208415|P2|Overall Study|Did not meet hCG criterion|0
7838449|NCT00257556|27208416|P1|Overall Study|Did not meet hCG criterion|3
7838450|NCT00257556|27208415|P2|Overall Study|Physician Decision|0
7838451|NCT00257556|27208416|P1|Overall Study|Physician Decision|6
7838452|NCT00257556|27208415|P2|Overall Study|Adverse Event|4
7838453|NCT00257556|27208416|P1|Overall Study|Adverse Event|1
7838454|NCT00257192|27208460|P2|Overall Study|Miscellaneous|4
7838455|NCT00257192|27208461|P1|Overall Study|Miscellaneous|0
7838456|NCT00257192|27208460|P2|Overall Study|Study terminated by sponsor|0
7838457|NCT00257192|27208461|P1|Overall Study|Study terminated by sponsor|1
7838458|NCT00257192|27208460|P2|Overall Study|Randomized but not treated|1
7838459|NCT00257192|27208461|P1|Overall Study|Randomized but not treated|0
7838460|NCT00257192|27208460|P2|Overall Study|Withdrawal by Subject|2
7838461|NCT00257192|27208461|P1|Overall Study|Withdrawal by Subject|14
7838462|NCT00257192|27208460|P2|Overall Study|Insufficient clinical response|18
7838463|NCT00257192|27208461|P1|Overall Study|Insufficient clinical response|18
7838464|NCT00257192|27208460|P2|Overall Study|Lost to Follow-up|3
7838465|NCT00257192|27208461|P1|Overall Study|Lost to Follow-up|3
7838466|NCT00257192|27208460|P2|Overall Study|Laboratory abnormality|1
7838467|NCT00257192|27208461|P1|Overall Study|Laboratory abnormality|1
7838468|NCT00257192|27208460|P2|Overall Study|Adverse Event|10
7838469|NCT00257192|27208461|P1|Overall Study|Adverse Event|21
7838470|NCT00257166|27208505|P2|Overall Study|Randomized, but not treated|0
7838471|NCT00257166|27208506|P1|Overall Study|Randomized, but not treated|1
7838472|NCT00257166|27208505|P2|Overall Study|Other|21
7838473|NCT00257166|27208506|P1|Overall Study|Other|16
7838474|NCT00257166|27208505|P2|Overall Study|Withdrawal by Subject|2
7838475|NCT00257166|27208506|P1|Overall Study|Withdrawal by Subject|9
7838476|NCT00257166|27208505|P2|Overall Study|Lost to Follow-up|1
7838477|NCT00257166|27208506|P1|Overall Study|Lost to Follow-up|8
7838478|NCT00257166|27208505|P2|Overall Study|Laboratory abnormality|0
7838479|NCT00257166|27208506|P1|Overall Study|Laboratory abnormality|1
7838480|NCT00257166|27208505|P2|Overall Study|Adverse Event|13
7838481|NCT00257166|27208506|P1|Overall Study|Adverse Event|18
7838482|NCT00257010|27208518|P1|Overall Study|no headache reported|9
7838483|NCT00257010|27208518|P1|Overall Study|various|11
7838484|NCT00257010|27208518|P1|Overall Study|Adverse Event|10
7838485|NCT00257010|27208518|P1|Overall Study|Withdrawal by Subject|34
7838486|NCT00257010|27208518|P1|Overall Study|Lost to Follow-up|53
7838487|NCT00257010|27208518|P1|Overall Study|Lack of Efficacy|11
7838488|NCT00256997|27208529|P2|Overall Study|Investigator Withdrew Participant|1
7838489|NCT00256997|27208530|P1|Overall Study|Investigator Withdrew Participant|2
7838490|NCT00256997|27208529|P2|Overall Study|Participant Non-compliant|6
7838491|NCT00256997|27208530|P1|Overall Study|Participant Non-compliant|3
7838492|NCT00256997|27208529|P2|Overall Study|End of Study (As Per Sponsor)|24
7838493|NCT00256997|27208530|P1|Overall Study|End of Study (As Per Sponsor)|12
7838494|NCT00256997|27208529|P2|Overall Study|Other|8
7838495|NCT00256997|27208530|P1|Overall Study|Other|5
7838496|NCT00256997|27208529|P2|Overall Study|Started but not treated|0
7838497|NCT00256997|27208530|P1|Overall Study|Started but not treated|2
7838498|NCT00256997|27208529|P2|Overall Study|Withdrawal by Subject|3
7838499|NCT00256997|27208530|P1|Overall Study|Withdrawal by Subject|13
7838500|NCT00256997|27208529|P2|Overall Study|Lost to Follow-up|5
7838501|NCT00256997|27208530|P1|Overall Study|Lost to Follow-up|3
7838502|NCT00256997|27208529|P2|Overall Study|Adverse Event|0
7838503|NCT00256997|27208530|P1|Overall Study|Adverse Event|4
7838504|NCT00256997|27208529|P2|Overall Study|Death|0
7838505|NCT00256997|27208530|P1|Overall Study|Death|2
7838506|NCT00256997|27208529|P2|Overall Study|Lack of Efficacy|4
7838507|NCT00256997|27208530|P1|Overall Study|Lack of Efficacy|1
7838508|NCT00256997|27208529|P2|Overall Study|Protocol Violation|4
7838509|NCT00256997|27208530|P1|Overall Study|Protocol Violation|1
7838510|NCT00256867|27208572|P8|Overall Study|Withdrawal by participant|0
7838511|NCT00256867|27208573|P7|Overall Study|Withdrawal by participant|0
7838512|NCT00256867|27208574|P6|Overall Study|Withdrawal by participant|1
7838513|NCT00256867|27208575|P5|Overall Study|Withdrawal by participant|0
7838514|NCT00256867|27208576|P4|Overall Study|Withdrawal by participant|0
7838515|NCT00256867|27208577|P3|Overall Study|Withdrawal by participant|0
7838516|NCT00256867|27208578|P2|Overall Study|Withdrawal by participant|0
7838517|NCT00256867|27208579|P1|Overall Study|Withdrawal by participant|0
7838518|NCT00256867|27208572|P8|Overall Study|Participant out of assessment window|0
7838519|NCT00256867|27208573|P7|Overall Study|Participant out of assessment window|0
7838520|NCT00256867|27208574|P6|Overall Study|Participant out of assessment window|0
7838521|NCT00256867|27208575|P5|Overall Study|Participant out of assessment window|0
7838522|NCT00256867|27208576|P4|Overall Study|Participant out of assessment window|0
7838523|NCT00256867|27208577|P3|Overall Study|Participant out of assessment window|1
7838524|NCT00256867|27208578|P2|Overall Study|Participant out of assessment window|0
7838525|NCT00256867|27208579|P1|Overall Study|Participant out of assessment window|0
7838526|NCT00256867|27208572|P8|Overall Study|Participant travelled Overseas|0
7838527|NCT00256867|27208573|P7|Overall Study|Participant travelled Overseas|0
7838528|NCT00256867|27208574|P6|Overall Study|Participant travelled Overseas|0
7838529|NCT00256867|27208575|P5|Overall Study|Participant travelled Overseas|0
7838530|NCT00256867|27208576|P4|Overall Study|Participant travelled Overseas|0
7838531|NCT00256867|27208577|P3|Overall Study|Participant travelled Overseas|0
7838532|NCT00256867|27208578|P2|Overall Study|Participant travelled Overseas|1
7838533|NCT00256867|27208579|P1|Overall Study|Participant travelled Overseas|0
7838534|NCT00256867|27208572|P8|Overall Study|Non-compliance with study medication|1
7838535|NCT00256867|27208573|P7|Overall Study|Non-compliance with study medication|0
7838536|NCT00256867|27208574|P6|Overall Study|Non-compliance with study medication|0
7838537|NCT00256867|27208575|P5|Overall Study|Non-compliance with study medication|0
7838538|NCT00256867|27208576|P4|Overall Study|Non-compliance with study medication|0
7838539|NCT00256867|27208577|P3|Overall Study|Non-compliance with study medication|0
7838540|NCT00256867|27208578|P2|Overall Study|Non-compliance with study medication|0
7838541|NCT00256867|27208579|P1|Overall Study|Non-compliance with study medication|0
7838542|NCT00256867|27208572|P8|Overall Study|Investigator's Decision|0
7838543|NCT00256867|27208573|P7|Overall Study|Investigator's Decision|0
7838544|NCT00256867|27208574|P6|Overall Study|Investigator's Decision|0
7838545|NCT00256867|27208575|P5|Overall Study|Investigator's Decision|1
7838546|NCT00256867|27208576|P4|Overall Study|Investigator's Decision|0
7838547|NCT00256867|27208577|P3|Overall Study|Investigator's Decision|0
7838548|NCT00256867|27208578|P2|Overall Study|Investigator's Decision|0
7838549|NCT00256867|27208579|P1|Overall Study|Investigator's Decision|0
7838550|NCT00256867|27208572|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
7838551|NCT00256867|27208573|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
7838552|NCT00256867|27208574|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
7838553|NCT00256867|27208575|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
7838554|NCT00256867|27208576|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
7838555|NCT00256867|27208577|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
7838556|NCT00256867|27208578|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
7838557|NCT00256867|27208579|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
7838558|NCT00256867|27208572|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838559|NCT00256867|27208573|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838560|NCT00256867|27208574|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838561|NCT00256867|27208575|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838562|NCT00256867|27208576|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838563|NCT00256867|27208577|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838564|NCT00256867|27208578|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
7838565|NCT00256867|27208579|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
7838566|NCT00256867|27208572|P8|Overall Study|Withdrawal by Subject|2
7838567|NCT00256867|27208573|P7|Overall Study|Withdrawal by Subject|3
7838568|NCT00256867|27208574|P6|Overall Study|Withdrawal by Subject|2
7838569|NCT00256867|27208575|P5|Overall Study|Withdrawal by Subject|2
7838570|NCT00256867|27208576|P4|Overall Study|Withdrawal by Subject|1
7838571|NCT00256867|27208577|P3|Overall Study|Withdrawal by Subject|1
7838572|NCT00256867|27208578|P2|Overall Study|Withdrawal by Subject|0
7838573|NCT00256867|27208579|P1|Overall Study|Withdrawal by Subject|0
7838574|NCT00256867|27208572|P8|Overall Study|Protocol Violation|1
7838575|NCT00256867|27208573|P7|Overall Study|Protocol Violation|0
7838576|NCT00256867|27208574|P6|Overall Study|Protocol Violation|1
7838577|NCT00256867|27208575|P5|Overall Study|Protocol Violation|0
7838578|NCT00256867|27208576|P4|Overall Study|Protocol Violation|1
7838579|NCT00256867|27208577|P3|Overall Study|Protocol Violation|0
7838580|NCT00256867|27208578|P2|Overall Study|Protocol Violation|0
7838581|NCT00256867|27208579|P1|Overall Study|Protocol Violation|0
7838582|NCT00256867|27208572|P8|Overall Study|Lost to Follow-up|2
7838583|NCT00256867|27208573|P7|Overall Study|Lost to Follow-up|1
7838584|NCT00256867|27208574|P6|Overall Study|Lost to Follow-up|0
7838585|NCT00256867|27208575|P5|Overall Study|Lost to Follow-up|2
7838586|NCT00256867|27208576|P4|Overall Study|Lost to Follow-up|3
7838587|NCT00256867|27208577|P3|Overall Study|Lost to Follow-up|2
7838588|NCT00256867|27208578|P2|Overall Study|Lost to Follow-up|2
7838589|NCT00256867|27208579|P1|Overall Study|Lost to Follow-up|2
7838590|NCT00256867|27208572|P8|Overall Study|Adverse Event|4
7838591|NCT00256867|27208573|P7|Overall Study|Adverse Event|1
7838592|NCT00256867|27208574|P6|Overall Study|Adverse Event|2
7838593|NCT00256867|27208575|P5|Overall Study|Adverse Event|2
7838594|NCT00256867|27208576|P4|Overall Study|Adverse Event|1
7838595|NCT00256867|27208577|P3|Overall Study|Adverse Event|1
7838596|NCT00256867|27208578|P2|Overall Study|Adverse Event|1
7838597|NCT00256867|27208579|P1|Overall Study|Adverse Event|0
7838598|NCT00256854|27208669|P6|Overall Study|Not compliant with the study drug|0
7838599|NCT00256854|27208670|P5|Overall Study|Not compliant with the study drug|1
7838600|NCT00256854|27208671|P4|Overall Study|Not compliant with the study drug|0
7838601|NCT00256854|27208672|P3|Overall Study|Not compliant with the study drug|0
7838602|NCT00256854|27208673|P2|Overall Study|Not compliant with the study drug|0
7838603|NCT00256854|27208674|P1|Overall Study|Not compliant with the study drug|0
7838604|NCT00256854|27208669|P6|Overall Study|Adverse Event|1
7838605|NCT00256854|27208670|P5|Overall Study|Adverse Event|0
7838606|NCT00256854|27208671|P4|Overall Study|Adverse Event|2
7838607|NCT00256854|27208672|P3|Overall Study|Adverse Event|2
7838608|NCT00256854|27208673|P2|Overall Study|Adverse Event|0
7838609|NCT00256854|27208674|P1|Overall Study|Adverse Event|0
7838610|NCT00256854|27208669|P6|Overall Study|Protocol Violation|0
7838611|NCT00256854|27208670|P5|Overall Study|Protocol Violation|0
7838612|NCT00256854|27208671|P4|Overall Study|Protocol Violation|1
7838613|NCT00256854|27208672|P3|Overall Study|Protocol Violation|1
7838614|NCT00256854|27208673|P2|Overall Study|Protocol Violation|1
7838615|NCT00256854|27208674|P1|Overall Study|Protocol Violation|0
7838616|NCT00256854|27208669|P6|Overall Study|Lack of Efficacy|0
7838617|NCT00256854|27208670|P5|Overall Study|Lack of Efficacy|0
7838618|NCT00256854|27208671|P4|Overall Study|Lack of Efficacy|0
7838619|NCT00256854|27208672|P3|Overall Study|Lack of Efficacy|0
7838620|NCT00256854|27208673|P2|Overall Study|Lack of Efficacy|0
7838621|NCT00256854|27208674|P1|Overall Study|Lack of Efficacy|1
7838622|NCT00256854|27208669|P6|Overall Study|Withdrawal by Subject|0
7838623|NCT00256854|27208670|P5|Overall Study|Withdrawal by Subject|0
7838624|NCT00256854|27208671|P4|Overall Study|Withdrawal by Subject|0
7838625|NCT00256854|27208672|P3|Overall Study|Withdrawal by Subject|0
7838626|NCT00256854|27208673|P2|Overall Study|Withdrawal by Subject|3
7838627|NCT00256854|27208674|P1|Overall Study|Withdrawal by Subject|2
7838628|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Other|5
7838629|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Other|4
7838630|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Other|5
7838631|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
7838632|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
7838633|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
7838634|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
7838635|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
7838636|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
7838637|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
7838638|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
7838639|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
7838640|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
7838641|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
7838642|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
7838643|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Death|4
7838644|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Death|4
7838645|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Death|9
7838646|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
7838647|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
7838648|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
7838649|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
7838650|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
7838651|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
7838652|NCT00256750|27208733|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
7838653|NCT00256750|27208734|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
7838654|NCT00256750|27208735|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
7838655|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Other|1
7838656|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Other|1
7838657|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Other|0
7838658|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
7838659|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
7838660|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
7838661|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
7838662|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
7838663|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
7838664|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
7838665|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
7838666|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
7838667|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Death|1
7838668|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Death|2
7838669|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Death|0
7838670|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
7838671|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
7838672|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
7838673|NCT00256750|27208733|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
7838674|NCT00256750|27208734|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
7838675|NCT00256750|27208735|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
7838676|NCT00256750|27208733|P3|Post-Transplant Treated (24 Months)|Other|1
7838677|NCT00256750|27208734|P2|Post-Transplant Treated (24 Months)|Other|0
7838678|NCT00256750|27208735|P1|Post-Transplant Treated (24 Months)|Other|2
7838679|NCT00256750|27208733|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
7838680|NCT00256750|27208734|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
7838681|NCT00256750|27208735|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
7838682|NCT00256750|27208733|P3|Post-Transplant Treated (24 Months)|Death|0
7838683|NCT00256750|27208734|P2|Post-Transplant Treated (24 Months)|Death|0
7838684|NCT00256750|27208735|P1|Post-Transplant Treated (24 Months)|Death|3
7838685|NCT00256750|27208733|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
7838686|NCT00256750|27208734|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
7838687|NCT00256750|27208735|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
7838688|NCT00256750|27208733|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
7838689|NCT00256750|27208734|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
7838690|NCT00256750|27208735|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
7838691|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
7838692|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
7838693|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
7838694|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
7838695|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
7838696|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
7838697|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Other|2
7838698|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Other|4
7838699|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Other|5
7838700|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
7838701|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
7838702|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
7838703|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
7838704|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
7838705|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
7838706|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Death|4
7838707|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Death|2
7838708|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Death|3
7838709|NCT00256750|27208733|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
7838710|NCT00256750|27208734|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
7838711|NCT00256750|27208735|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
7838712|NCT00256750|27208733|P3|Transplanted Pre-Treatment|Death|0
7838713|NCT00256750|27208734|P2|Transplanted Pre-Treatment|Death|0
7838714|NCT00256750|27208735|P1|Transplanted Pre-Treatment|Death|1
7838715|NCT00256750|27208733|P3|Transplanted Pre-Treatment|Other|0
7838716|NCT00256750|27208734|P2|Transplanted Pre-Treatment|Other|0
7838717|NCT00256750|27208735|P1|Transplanted Pre-Treatment|Other|2
7838718|NCT00256750|27208733|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
7838719|NCT00256750|27208734|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
7838720|NCT00256750|27208735|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
7838721|NCT00256724|27208871|P2|Overall Study|Protocol Violation|3
7838722|NCT00256724|27208872|P1|Overall Study|Protocol Violation|3
7838723|NCT00256724|27208871|P2|Overall Study|Physician Decision|5
7838724|NCT00256724|27208872|P1|Overall Study|Physician Decision|2
7838725|NCT00256698|27208882|P2|Overall Study|Prematurely Discontinued|0
7838726|NCT00256698|27208883|P1|Overall Study|Prematurely Discontinued|1
7838727|NCT00256698|27208882|P2|Overall Study|withdrawn due to osteoporosis|0
7838728|NCT00256698|27208883|P1|Overall Study|withdrawn due to osteoporosis|1
7838729|NCT00256698|27208882|P2|Overall Study|still ongoing at data cut-off|46
7838730|NCT00256698|27208883|P1|Overall Study|still ongoing at data cut-off|41
7838731|NCT00256698|27208882|P2|Overall Study|disease progression|105
7838732|NCT00256698|27208883|P1|Overall Study|disease progression|97
7838733|NCT00256698|27208882|P2|Overall Study|Lost to Follow-up|3
7838734|NCT00256698|27208883|P1|Overall Study|Lost to Follow-up|1
7838735|NCT00256698|27208882|P2|Overall Study|Protocol Violation|5
7838736|NCT00256698|27208883|P1|Overall Study|Protocol Violation|6
7838737|NCT00256698|27208882|P2|Overall Study|Adverse Event|6
7838738|NCT00256698|27208883|P1|Overall Study|Adverse Event|13
7838739|NCT00256698|27208882|P2|Overall Study|Withdrawal by Subject|7
7838740|NCT00256698|27208883|P1|Overall Study|Withdrawal by Subject|7
7838741|NCT00256308|27208930|P1|Overall Study|Death|2
7838742|NCT00256295|27208938|P1|Overall Study|Death|1
7838743|NCT00256295|27208938|P1|Overall Study|Withdrawal by Subject|3
7838744|NCT00256282|27208944|P1|Overall Study|Physician Decision|1
7838745|NCT00256282|27208944|P1|Overall Study|Adverse Event|3
7838746|NCT00256282|27208944|P1|Overall Study|Disease progression, relapse during acti|12
7838747|NCT00256243|27208949|P1|Overall Study|Not treated|1
7838748|NCT00256243|27208949|P1|Overall Study|Death|7
7838749|NCT00256243|27208949|P1|Overall Study|Lost to Follow-up|2
7838750|NCT00256204|27208965|P4|Overall Study|Need for additional prohibited treatment|25
7838751|NCT00256204|27208966|P3|Overall Study|Need for additional prohibited treatment|27
7838752|NCT00256204|27208967|P2|Overall Study|Need for additional prohibited treatment|28
7838753|NCT00256204|27208968|P1|Overall Study|Need for additional prohibited treatment|38
7838754|NCT00256204|27208965|P4|Overall Study|Withdrawal by Subject|5
7838755|NCT00256204|27208966|P3|Overall Study|Withdrawal by Subject|7
7838756|NCT00256204|27208967|P2|Overall Study|Withdrawal by Subject|6
7838757|NCT00256204|27208968|P1|Overall Study|Withdrawal by Subject|17
7838758|NCT00256204|27208965|P4|Overall Study|Physician Decision|2
7838759|NCT00256204|27208966|P3|Overall Study|Physician Decision|1
7838760|NCT00256204|27208967|P2|Overall Study|Physician Decision|0
7838761|NCT00256204|27208968|P1|Overall Study|Physician Decision|0
7838762|NCT00256204|27208965|P4|Overall Study|Protocol Violation|1
7838763|NCT00256204|27208966|P3|Overall Study|Protocol Violation|2
7838764|NCT00256204|27208967|P2|Overall Study|Protocol Violation|0
7838765|NCT00256204|27208968|P1|Overall Study|Protocol Violation|1
7838766|NCT00256204|27208965|P4|Overall Study|Lost to Follow-up|2
7838767|NCT00256204|27208966|P3|Overall Study|Lost to Follow-up|1
7838768|NCT00256204|27208967|P2|Overall Study|Lost to Follow-up|1
7838769|NCT00256204|27208968|P1|Overall Study|Lost to Follow-up|1
7838770|NCT00256204|27208965|P4|Overall Study|Death|0
7838771|NCT00256204|27208966|P3|Overall Study|Death|0
7838772|NCT00256204|27208967|P2|Overall Study|Death|1
7838773|NCT00256204|27208968|P1|Overall Study|Death|0
7838774|NCT00256204|27208965|P4|Overall Study|Adverse Event|14
7838775|NCT00256204|27208966|P3|Overall Study|Adverse Event|16
7838776|NCT00256204|27208967|P2|Overall Study|Adverse Event|14
7838777|NCT00256204|27208968|P1|Overall Study|Adverse Event|10
7838778|NCT00256126|27208983|P2|Overall Study|Other|2
7838779|NCT00256126|27208984|P1|Overall Study|Other|1
7838780|NCT00256126|27208983|P2|Overall Study|Adverse Event|0
7838781|NCT00256126|27208984|P1|Overall Study|Adverse Event|1
7838782|NCT00255944|27209023|P2|Overall Study|Lost to Follow-up|834
7838783|NCT00255944|27209024|P1|Overall Study|Lost to Follow-up|797
7838784|NCT00255840|27209032|P2|Overall Study|Discontinued intervention|56
7838785|NCT00255840|27209033|P1|Overall Study|Discontinued intervention|53
7838786|NCT00255840|27209032|P2|Overall Study|Lost to Follow-up|14
7838787|NCT00255840|27209033|P1|Overall Study|Lost to Follow-up|10
7838788|NCT00255723|27209046|P2|Overall Study|Response Data Not Available|0
7838789|NCT00255723|27209047|P1|Overall Study|Response Data Not Available|1
7838790|NCT00255723|27209046|P2|Overall Study|Death|1
7838791|NCT00255723|27209047|P1|Overall Study|Death|0
7838792|NCT00255723|27209046|P2|Overall Study|Adverse Event|1
7838793|NCT00255723|27209047|P1|Overall Study|Adverse Event|1
7838794|NCT00255346|27209063|P5|Overall Study|Adverse Event|0
7838795|NCT00255346|27209064|P4|Overall Study|Adverse Event|0
7838796|NCT00255346|27209065|P3|Overall Study|Adverse Event|0
7838797|NCT00255346|27209066|P2|Overall Study|Adverse Event|0
7838798|NCT00255346|27209067|P1|Overall Study|Adverse Event|1
7838799|NCT00255190|27209082|P2|Overall Study|Various|23
7838800|NCT00255190|27209083|P1|Overall Study|Various|4
7838801|NCT00255190|27209082|P2|Overall Study|Erosive esophagitis not healed|20
7838802|NCT00255190|27209083|P1|Overall Study|Erosive esophagitis not healed|0
7838803|NCT00255190|27209082|P2|Overall Study|Inclusion/Exclusion criteria not met|1
7838804|NCT00255190|27209083|P1|Overall Study|Inclusion/Exclusion criteria not met|0
7838805|NCT00255190|27209082|P2|Overall Study|Withdrew Consent|48
7838806|NCT00255190|27209083|P1|Overall Study|Withdrew Consent|17
7838807|NCT00255190|27209082|P2|Overall Study|Lost to Follow-up|27
7838808|NCT00255190|27209083|P1|Overall Study|Lost to Follow-up|10
7838809|NCT00255190|27209082|P2|Overall Study|Protocol Violation|2
7838810|NCT00255190|27209083|P1|Overall Study|Protocol Violation|2
7838811|NCT00255190|27209082|P2|Overall Study|Adverse Event|36
7838812|NCT00255190|27209083|P1|Overall Study|Adverse Event|17
7838813|NCT00255164|27209167|P3|Overall Study|Therapeutic Failure|3
7838814|NCT00255164|27209168|P2|Overall Study|Therapeutic Failure|2
7838815|NCT00255164|27209169|P1|Overall Study|Therapeutic Failure|11
7838816|NCT00255164|27209167|P3|Overall Study|Esophageal Stricture|1
7838817|NCT00255164|27209168|P2|Overall Study|Esophageal Stricture|0
7838818|NCT00255164|27209169|P1|Overall Study|Esophageal Stricture|0
7838819|NCT00255164|27209167|P3|Overall Study|Possible Barrett's Esophagus|8
7838820|NCT00255164|27209168|P2|Overall Study|Possible Barrett's Esophagus|3
7838821|NCT00255164|27209169|P1|Overall Study|Possible Barrett's Esophagus|1
7838822|NCT00255164|27209167|P3|Overall Study|Relapse of Erosive Esophagitis|12
7838823|NCT00255164|27209168|P2|Overall Study|Relapse of Erosive Esophagitis|16
7838824|NCT00255164|27209169|P1|Overall Study|Relapse of Erosive Esophagitis|78
7838825|NCT00255164|27209167|P3|Overall Study|Subject Request/Subject Unavailable|2
7838826|NCT00255164|27209168|P2|Overall Study|Subject Request/Subject Unavailable|1
7838827|NCT00255164|27209169|P1|Overall Study|Subject Request/Subject Unavailable|1
7838828|NCT00255164|27209167|P3|Overall Study|Noncompliance|2
7838829|NCT00255164|27209168|P2|Overall Study|Noncompliance|1
7838830|NCT00255164|27209169|P1|Overall Study|Noncompliance|0
7838831|NCT00255164|27209167|P3|Overall Study|Withdrawal by Subject|8
7838832|NCT00255164|27209168|P2|Overall Study|Withdrawal by Subject|17
7838833|NCT00255164|27209169|P1|Overall Study|Withdrawal by Subject|18
7838834|NCT00255164|27209167|P3|Overall Study|Lost to Follow-up|4
7838835|NCT00255164|27209168|P2|Overall Study|Lost to Follow-up|3
7838836|NCT00255164|27209169|P1|Overall Study|Lost to Follow-up|4
7838837|NCT00255164|27209167|P3|Overall Study|Adverse Event|9
7838838|NCT00255164|27209168|P2|Overall Study|Adverse Event|6
7838839|NCT00255164|27209169|P1|Overall Study|Adverse Event|10
7838840|NCT00255151|27209195|P3|Overall Study|Therapeutic Failure|3
7838841|NCT00255151|27209196|P2|Overall Study|Therapeutic Failure|2
7838842|NCT00255151|27209197|P1|Overall Study|Therapeutic Failure|11
7838843|NCT00255151|27209195|P3|Overall Study|Esophageal Stricture|1
7838844|NCT00255151|27209196|P2|Overall Study|Esophageal Stricture|0
7838845|NCT00255151|27209197|P1|Overall Study|Esophageal Stricture|0
7838846|NCT00255151|27209195|P3|Overall Study|Possible Barrett's Esophagus|8
7838847|NCT00255151|27209196|P2|Overall Study|Possible Barrett's Esophagus|3
7838848|NCT00255151|27209197|P1|Overall Study|Possible Barrett's Esophagus|1
7838849|NCT00255151|27209195|P3|Overall Study|Relapse of Erosive Esophagitis|12
7838850|NCT00255151|27209196|P2|Overall Study|Relapse of Erosive Esophagitis|16
7838851|NCT00255151|27209197|P1|Overall Study|Relapse of Erosive Esophagitis|78
7838852|NCT00255151|27209195|P3|Overall Study|Subject Request/Subject Unavailable|2
7838853|NCT00255151|27209196|P2|Overall Study|Subject Request/Subject Unavailable|1
7838854|NCT00255151|27209197|P1|Overall Study|Subject Request/Subject Unavailable|1
7838855|NCT00255151|27209195|P3|Overall Study|Noncompliance|2
7838856|NCT00255151|27209196|P2|Overall Study|Noncompliance|1
7838857|NCT00255151|27209197|P1|Overall Study|Noncompliance|0
7838858|NCT00255151|27209195|P3|Overall Study|Withdrawal by Subject|8
7838859|NCT00255151|27209196|P2|Overall Study|Withdrawal by Subject|17
7838860|NCT00255151|27209197|P1|Overall Study|Withdrawal by Subject|18
7838861|NCT00255151|27209195|P3|Overall Study|Lost to Follow-up|4
7838862|NCT00255151|27209196|P2|Overall Study|Lost to Follow-up|3
7838863|NCT00255151|27209197|P1|Overall Study|Lost to Follow-up|4
7838864|NCT00255151|27209195|P3|Overall Study|Adverse Event|9
7838865|NCT00255151|27209196|P2|Overall Study|Adverse Event|6
7838866|NCT00255151|27209197|P1|Overall Study|Adverse Event|10
7838867|NCT00255086|27209235|P2|Overall Study|Protocol Violation|1
7838868|NCT00255086|27209236|P1|Overall Study|Protocol Violation|1
7838869|NCT00255086|27209235|P2|Overall Study|Adverse Event|1
7838870|NCT00255086|27209236|P1|Overall Study|Adverse Event|1
7838871|NCT00255047|27209248|P4|Overall Study|Withdrawal by Subject|18
7838872|NCT00255047|27209249|P3|Overall Study|Withdrawal by Subject|25
7838873|NCT00255047|27209250|P2|Overall Study|Withdrawal by Subject|23
7838874|NCT00255047|27209251|P1|Overall Study|Withdrawal by Subject|24
7838875|NCT00255047|27209248|P4|Overall Study|Lost to Follow-up|6
7838876|NCT00255047|27209249|P3|Overall Study|Lost to Follow-up|5
7838877|NCT00255047|27209250|P2|Overall Study|Lost to Follow-up|8
7838878|NCT00255047|27209251|P1|Overall Study|Lost to Follow-up|9
7838879|NCT00255047|27209248|P4|Overall Study|Protocol Violation|20
7838880|NCT00255047|27209249|P3|Overall Study|Protocol Violation|16
7838881|NCT00255047|27209250|P2|Overall Study|Protocol Violation|13
7838882|NCT00255047|27209251|P1|Overall Study|Protocol Violation|13
7838883|NCT00255047|27209248|P4|Overall Study|Adverse Event|1
7838884|NCT00255047|27209249|P3|Overall Study|Adverse Event|2
7838885|NCT00255047|27209250|P2|Overall Study|Adverse Event|3
7838886|NCT00255047|27209251|P1|Overall Study|Adverse Event|0
7838887|NCT00255047|27209248|P4|Overall Study|Serious Adverse Events|1
7838888|NCT00255047|27209249|P3|Overall Study|Serious Adverse Events|2
7838889|NCT00255047|27209250|P2|Overall Study|Serious Adverse Events|1
7838890|NCT00255047|27209251|P1|Overall Study|Serious Adverse Events|2
7838891|NCT00255034|27209275|P2|Overall Study|Withdrawal by Subject|38
7838892|NCT00255034|27209276|P1|Overall Study|Withdrawal by Subject|15
7838893|NCT00255008|27209286|P4|Overall Study|Other|2
7838894|NCT00255008|27209287|P3|Overall Study|Other|3
7838895|NCT00255008|27209288|P2|Overall Study|Other|0
7838896|NCT00255008|27209289|P1|Overall Study|Other|7
7838897|NCT00255008|27209286|P4|Overall Study|Adverse lab experience|0
7838898|NCT00255008|27209287|P3|Overall Study|Adverse lab experience|0
7838899|NCT00255008|27209288|P2|Overall Study|Adverse lab experience|0
7838900|NCT00255008|27209289|P1|Overall Study|Adverse lab experience|1
7838901|NCT00255008|27209286|P4|Overall Study|Sponsor request|17
7838902|NCT00255008|27209287|P3|Overall Study|Sponsor request|8
7838903|NCT00255008|27209288|P2|Overall Study|Sponsor request|3
7838904|NCT00255008|27209289|P1|Overall Study|Sponsor request|18
7838905|NCT00255008|27209286|P4|Overall Study|Withdrew consent|0
7838906|NCT00255008|27209287|P3|Overall Study|Withdrew consent|2
7838907|NCT00255008|27209288|P2|Overall Study|Withdrew consent|0
7838908|NCT00255008|27209289|P1|Overall Study|Withdrew consent|0
7838909|NCT00255008|27209286|P4|Overall Study|Did not meet viral reduction criteria|1
7838910|NCT00255008|27209287|P3|Overall Study|Did not meet viral reduction criteria|0
7838911|NCT00255008|27209288|P2|Overall Study|Did not meet viral reduction criteria|5
7838912|NCT00255008|27209289|P1|Overall Study|Did not meet viral reduction criteria|4
7838913|NCT00255008|27209286|P4|Overall Study|Lost to Follow-up|2
7838914|NCT00255008|27209287|P3|Overall Study|Lost to Follow-up|1
7838915|NCT00255008|27209288|P2|Overall Study|Lost to Follow-up|0
7838916|NCT00255008|27209289|P1|Overall Study|Lost to Follow-up|1
7838917|NCT00255008|27209286|P4|Overall Study|Adverse Event|0
7838918|NCT00255008|27209287|P3|Overall Study|Adverse Event|2
7838919|NCT00255008|27209288|P2|Overall Study|Adverse Event|1
7838920|NCT00255008|27209289|P1|Overall Study|Adverse Event|1
7838921|NCT00254982|27209325|P2|Overall Study|Abnormal liver function tests|1
7838922|NCT00254982|27209326|P1|Overall Study|Abnormal liver function tests|2
7838923|NCT00254982|27209325|P2|Overall Study|Opportunistic infection|0
7838924|NCT00254982|27209326|P1|Overall Study|Opportunistic infection|1
7838925|NCT00254982|27209325|P2|Overall Study|Malignancy|2
7838926|NCT00254982|27209326|P1|Overall Study|Malignancy|0
7838927|NCT00254982|27209325|P2|Overall Study|Diagnosis of Tuberculosis|1
7838928|NCT00254982|27209326|P1|Overall Study|Diagnosis of Tuberculosis|1
7838929|NCT00254982|27209325|P2|Overall Study|Protocol deviation|1
7838930|NCT00254982|27209326|P1|Overall Study|Protocol deviation|1
7838931|NCT00254982|27209325|P2|Overall Study|Inclusion/exclusion criteria violation|2
7838932|NCT00254982|27209326|P1|Overall Study|Inclusion/exclusion criteria violation|0
7838933|NCT00254982|27209325|P2|Overall Study|Withdrawal by Subject|1
7838934|NCT00254982|27209326|P1|Overall Study|Withdrawal by Subject|1
7838935|NCT00254982|27209325|P2|Overall Study|Adverse Event|16
7838936|NCT00254982|27209326|P1|Overall Study|Adverse Event|18
7838937|NCT00254982|27209325|P2|Overall Study|Lost to Follow-up|3
7838938|NCT00254982|27209326|P1|Overall Study|Lost to Follow-up|5
7838939|NCT00254982|27209325|P2|Overall Study|Lack of Efficacy|3
7838940|NCT00254982|27209326|P1|Overall Study|Lack of Efficacy|5
7838941|NCT00254982|27209325|P2|Overall Study|Other|1
7838942|NCT00254982|27209326|P1|Overall Study|Other|2
7838943|NCT00254566|27209338|P2|Overall Study|Lost to Follow-up|2
7838944|NCT00254566|27209339|P1|Overall Study|Lost to Follow-up|7
7838945|NCT00254566|27209338|P2|Overall Study|Withdrawal by Subject|6
7838946|NCT00254566|27209339|P1|Overall Study|Withdrawal by Subject|5
7838947|NCT00254566|27209338|P2|Overall Study|Other|5
7838948|NCT00254566|27209339|P1|Overall Study|Other|1
7838949|NCT00254566|27209338|P2|Overall Study|Lack of Efficacy|9
7838950|NCT00254566|27209339|P1|Overall Study|Lack of Efficacy|12
7838951|NCT00254566|27209338|P2|Overall Study|Adverse Event|4
7838952|NCT00254566|27209339|P1|Overall Study|Adverse Event|5
7838953|NCT00254566|27209338|P2|Overall Study|Death|0
7838954|NCT00254566|27209339|P1|Overall Study|Death|1
7838955|NCT00254540|27209363|P2|Overall Study|Laboratory Test Abnormality|1
7838956|NCT00254540|27209364|P1|Overall Study|Laboratory Test Abnormality|0
7838957|NCT00254540|27209363|P2|Overall Study|Death|1
7838958|NCT00254540|27209364|P1|Overall Study|Death|0
7838959|NCT00254540|27209363|P2|Overall Study|Lack of Efficacy|13
7838960|NCT00254540|27209364|P1|Overall Study|Lack of Efficacy|13
7838961|NCT00254540|27209363|P2|Overall Study|Adverse Event|7
7838962|NCT00254540|27209364|P1|Overall Study|Adverse Event|6
7838963|NCT00254501|27209393|P2|Overall Study|Lost to Follow-up|1
7838964|NCT00254501|27209394|P1|Overall Study|Lost to Follow-up|1
7838965|NCT00254397|27209439|P4|Overall Study|Adverse Event|1
7838966|NCT00254397|27209440|P3|Overall Study|Adverse Event|3
7838967|NCT00254397|27209441|P2|Overall Study|Adverse Event|0
7838968|NCT00254397|27209442|P1|Overall Study|Adverse Event|2
7838969|NCT00254397|27209439|P4|Overall Study|Non-Compliant|1
7838970|NCT00254397|27209440|P3|Overall Study|Non-Compliant|0
7838971|NCT00254397|27209441|P2|Overall Study|Non-Compliant|0
7838972|NCT00254397|27209442|P1|Overall Study|Non-Compliant|0
7838973|NCT00254397|27209439|P4|Overall Study|Disease Progression|23
7838974|NCT00254397|27209440|P3|Overall Study|Disease Progression|16
7838975|NCT00254397|27209441|P2|Overall Study|Disease Progression|1
7838976|NCT00254397|27209442|P1|Overall Study|Disease Progression|4
7838977|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Other|1
7838978|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Other|0
7838979|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Other|0
7838980|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Other|0
7838981|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Other|0
7838982|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Other|0
7838983|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Other|0
7838984|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
7838985|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7838986|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7838987|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7838988|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7838989|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7838990|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7838991|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
7838992|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7838993|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7838994|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7838995|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7838996|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7838997|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7838998|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
7838999|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7839000|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7839001|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7839002|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7839003|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7839004|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7839005|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
7839006|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7839007|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7839008|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7839009|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7839010|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7839011|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7839012|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Adverse Event|1
7839013|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Adverse Event|0
7839014|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Adverse Event|0
7839015|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Adverse Event|0
7839016|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Adverse Event|0
7839017|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Adverse Event|0
7839018|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Adverse Event|0
7839019|NCT00254293|27209466|P7|LTE Open Label Fixed Dosing|Death|3
7839020|NCT00254293|27209467|P6|LTE Open Label Fixed Dosing|Death|0
7839021|NCT00254293|27209468|P5|LTE Open Label Fixed Dosing|Death|0
7839022|NCT00254293|27209469|P4|LTE Open Label Fixed Dosing|Death|0
7839023|NCT00254293|27209470|P3|LTE Open Label Fixed Dosing|Death|0
7839024|NCT00254293|27209471|P2|LTE Open Label Fixed Dosing|Death|0
7839025|NCT00254293|27209472|P1|LTE Open Label Fixed Dosing|Death|0
7839026|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Other|0
7839027|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Other|0
7839028|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Other|0
7839029|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Other|0
7839030|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Other|2
7839031|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Other|0
7839032|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Other|0
7839033|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7839034|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7839035|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7839036|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7839037|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
7839038|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7839039|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7839040|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7839041|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7839042|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7839043|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7839044|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
7839045|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7839046|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7839047|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7839048|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7839049|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7839050|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7839051|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
7839052|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7839053|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7839054|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7839055|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7839056|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
7839057|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7839058|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
7839059|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7839060|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
7839061|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
7839062|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
7839063|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
7839064|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
7839065|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
7839066|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
7839067|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
7839068|NCT00254293|27209466|P7|LTE Open Label Variable SC Dosing|Death|0
7839069|NCT00254293|27209467|P6|LTE Open Label Variable SC Dosing|Death|0
7839070|NCT00254293|27209468|P5|LTE Open Label Variable SC Dosing|Death|0
7839071|NCT00254293|27209469|P4|LTE Open Label Variable SC Dosing|Death|0
7839072|NCT00254293|27209470|P3|LTE Open Label Variable SC Dosing|Death|1
7839073|NCT00254293|27209471|P2|LTE Open Label Variable SC Dosing|Death|0
7839074|NCT00254293|27209472|P1|LTE Open Label Variable SC Dosing|Death|0
7839075|NCT00254293|27209466|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7839076|NCT00254293|27209467|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7839077|NCT00254293|27209468|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7839078|NCT00254293|27209469|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7839079|NCT00254293|27209470|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
7839080|NCT00254293|27209471|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7839081|NCT00254293|27209472|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7839082|NCT00254293|27209466|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7839083|NCT00254293|27209467|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7839084|NCT00254293|27209468|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7839085|NCT00254293|27209469|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7839086|NCT00254293|27209470|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
7839087|NCT00254293|27209471|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7839088|NCT00254293|27209472|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7839089|NCT00254293|27209466|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7839090|NCT00254293|27209467|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7839091|NCT00254293|27209468|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7839092|NCT00254293|27209469|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
7839093|NCT00254293|27209470|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7839094|NCT00254293|27209471|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
7839095|NCT00254293|27209472|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7839096|NCT00254163|27209555|P2|Overall Study|Other|8
7839097|NCT00254163|27209556|P1|Overall Study|Other|8
7839098|NCT00254163|27209555|P2|Overall Study|Death|1
7839099|NCT00254163|27209556|P1|Overall Study|Death|0
7839100|NCT00254163|27209555|P2|Overall Study|Progressive disease|1
7839101|NCT00254163|27209556|P1|Overall Study|Progressive disease|0
7839102|NCT00254163|27209555|P2|Overall Study|Failed entry|3
7839103|NCT00254163|27209556|P1|Overall Study|Failed entry|1
7839104|NCT00254163|27209555|P2|Overall Study|Investigator request|3
7839105|NCT00254163|27209556|P1|Overall Study|Investigator request|1
7839106|NCT00254163|27209555|P2|Overall Study|Patient request/withdrew consent|4
7839107|NCT00254163|27209556|P1|Overall Study|Patient request/withdrew consent|6
7839108|NCT00254163|27209555|P2|Overall Study|Adverse Event|26
7839109|NCT00254163|27209556|P1|Overall Study|Adverse Event|29
7839110|NCT00253747|27209607|P2|Overall Study|Administrative Discharge (1), Other (2)|2
7839111|NCT00253747|27209608|P1|Overall Study|Administrative Discharge (1), Other (2)|1
7839112|NCT00253747|27209607|P2|Overall Study|Withdrawal by Subject|11
7839113|NCT00253747|27209608|P1|Overall Study|Withdrawal by Subject|10
7839114|NCT00253747|27209607|P2|Overall Study|Lost to Follow-up|14
7839115|NCT00253747|27209608|P1|Overall Study|Lost to Follow-up|13
7839116|NCT00253643|27209661|P4|Overall Study|Non-Compliance|2
7839117|NCT00253643|27209662|P3|Overall Study|Non-Compliance|0
7839118|NCT00253643|27209663|P2|Overall Study|Non-Compliance|0
7839119|NCT00253643|27209664|P1|Overall Study|Non-Compliance|0
7839120|NCT00253643|27209661|P4|Overall Study|Withdrawal by Subject|1
7839121|NCT00253643|27209662|P3|Overall Study|Withdrawal by Subject|1
7839122|NCT00253643|27209663|P2|Overall Study|Withdrawal by Subject|0
7839123|NCT00253643|27209664|P1|Overall Study|Withdrawal by Subject|0
7839124|NCT00253630|27209678|P1|Overall Study|ineligible|2
7839125|NCT00253448|27209694|P1|Overall Study|Withdrawal by Subject|1
7839126|NCT00253370|27209713|P1|Overall Study|Abdominal pain due to disease|1
7839127|NCT00253370|27209713|P1|Overall Study|Protocol Violation|1
7839128|NCT00253370|27209713|P1|Overall Study|Physician Decision|1
7839129|NCT00253370|27209713|P1|Overall Study|Non-protocol therapy|1
7839130|NCT00253370|27209713|P1|Overall Study|Withdrawal by Subject|6
7839131|NCT00253370|27209713|P1|Overall Study|Death|2
7839132|NCT00253370|27209713|P1|Overall Study|Disease progression|13
7839133|NCT00253370|27209713|P1|Overall Study|Adverse Event|18
7839134|NCT00252733|27209759|P2|Overall Study|Multiple Reasons|14
7839135|NCT00252733|27209760|P1|Overall Study|Multiple Reasons|14
7839136|NCT00252733|27209759|P2|Overall Study|Lost to Follow-up|6
7839137|NCT00252733|27209760|P1|Overall Study|Lost to Follow-up|12
7839138|NCT00252733|27209759|P2|Overall Study|Death|5
7839139|NCT00252733|27209760|P1|Overall Study|Death|7
7839140|NCT00252733|27209759|P2|Overall Study|Withdrawal by Subject|67
7839141|NCT00252733|27209760|P1|Overall Study|Withdrawal by Subject|73
7839142|NCT00252720|27209770|P2|Overall Study|Mainly patients lost to follow-up|18
7839143|NCT00252720|27209771|P1|Overall Study|Mainly patients lost to follow-up|7
7839144|NCT00252720|27209770|P2|Overall Study|Moving|42
7839145|NCT00252720|27209771|P1|Overall Study|Moving|23
7839146|NCT00252720|27209770|P2|Overall Study|Death|8
7839147|NCT00252720|27209771|P1|Overall Study|Death|7
7839148|NCT00252720|27209770|P2|Overall Study|Withdrawal by Subject|97
7839149|NCT00252720|27209771|P1|Overall Study|Withdrawal by Subject|95
7839150|NCT00252694|27209785|P2|Overall Study|Patient Moving|16
7839151|NCT00252694|27209786|P1|Overall Study|Patient Moving|17
7839152|NCT00252694|27209785|P2|Overall Study|Mostly Lost to Follow Up|13
7839153|NCT00252694|27209786|P1|Overall Study|Mostly Lost to Follow Up|8
7839154|NCT00252694|27209785|P2|Overall Study|Death|34
7839155|NCT00252694|27209786|P1|Overall Study|Death|36
7839156|NCT00252694|27209785|P2|Overall Study|Withdrawal by Subject|91
7839157|NCT00252694|27209786|P1|Overall Study|Withdrawal by Subject|83
7839158|NCT00252577|27209832|P1|Overall Study|Lost to Follow-up|20
7839159|NCT00252564|27209838|P2|Overall Study|Withdrawal by Subject|2
7839160|NCT00252564|27209839|P1|Overall Study|Withdrawal by Subject|0
7839161|NCT00252564|27209838|P2|Overall Study|Patient Request|5
7839162|NCT00252564|27209839|P1|Overall Study|Patient Request|4
7839163|NCT00252564|27209838|P2|Overall Study|Lost to Follow-up|0
7839164|NCT00252564|27209839|P1|Overall Study|Lost to Follow-up|1
7839165|NCT00252564|27209838|P2|Overall Study|Physician Decision|0
7839166|NCT00252564|27209839|P1|Overall Study|Physician Decision|1
7839167|NCT00252564|27209838|P2|Overall Study|Death|3
7839168|NCT00252564|27209839|P1|Overall Study|Death|0
7839169|NCT00252564|27209838|P2|Overall Study|Disease Progression|20
7839170|NCT00252564|27209839|P1|Overall Study|Disease Progression|14
7839171|NCT00252564|27209838|P2|Overall Study|Unrelated Complication|1
7839172|NCT00252564|27209839|P1|Overall Study|Unrelated Complication|2
7839173|NCT00252564|27209838|P2|Overall Study|Adverse Event|13
7839174|NCT00252564|27209839|P1|Overall Study|Adverse Event|17
7839175|NCT00252499|27209879|P3|Overall Study|Lost to Follow-up|0
7839176|NCT00252499|27209880|P2|Overall Study|Lost to Follow-up|0
7839177|NCT00252499|27209881|P1|Overall Study|Lost to Follow-up|1
7839178|NCT00252239|27209913|P4|Overall Study|Lost to Follow-up|0
7839179|NCT00252239|27209914|P3|Overall Study|Lost to Follow-up|2
7839180|NCT00252239|27209915|P2|Overall Study|Lost to Follow-up|0
7839181|NCT00252239|27209916|P1|Overall Study|Lost to Follow-up|0
7839182|NCT00252239|27209913|P4|Overall Study|Withdrawal by Subject|1
7839183|NCT00252239|27209914|P3|Overall Study|Withdrawal by Subject|0
7839184|NCT00252239|27209915|P2|Overall Study|Withdrawal by Subject|0
7839185|NCT00252239|27209916|P1|Overall Study|Withdrawal by Subject|1
7839186|NCT00252187|27209928|P2|Overall Study|Withdrawal by Subject|0
7839187|NCT00252187|27209929|P1|Overall Study|Withdrawal by Subject|1
7839188|NCT00252187|27209928|P2|Overall Study|Adverse Event|1
7839189|NCT00252187|27209929|P1|Overall Study|Adverse Event|3
7839190|NCT00252174|27209952|P3|Overall Study|Withdrawal by Subject|0
7839191|NCT00252174|27209953|P2|Overall Study|Withdrawal by Subject|1
7839192|NCT00252174|27209954|P1|Overall Study|Withdrawal by Subject|0
7839193|NCT00252057|27209994|P2|Overall Study|Participant previously enrolled|1
7839194|NCT00252057|27209995|P1|Overall Study|Participant previously enrolled|0
7839195|NCT00252057|27209994|P2|Overall Study|Death|2
7839196|NCT00252057|27209995|P1|Overall Study|Death|1
7839197|NCT00252057|27209994|P2|Overall Study|Withdrawal by Subject|5
7839198|NCT00252057|27209995|P1|Overall Study|Withdrawal by Subject|2
7839199|NCT00251979|27210003|P2|Overall Study|Death|5
7839200|NCT00251979|27210004|P1|Overall Study|Death|3
7839201|NCT00251979|27210003|P2|Overall Study|Lost to Follow-up|6
7839202|NCT00251979|27210004|P1|Overall Study|Lost to Follow-up|8
7839203|NCT00251979|27210003|P2|Overall Study|Withdrawal by Subject|7
7839204|NCT00251979|27210004|P1|Overall Study|Withdrawal by Subject|13
7839205|NCT00251979|27210003|P2|Overall Study|Adverse Event|17
7839206|NCT00251979|27210004|P1|Overall Study|Adverse Event|11
7839207|NCT00251979|27210003|P2|Overall Study|Protocol Violation|5
7839208|NCT00251979|27210004|P1|Overall Study|Protocol Violation|3
7839209|NCT00251927|27210036|P2|Overall Study|Study procedure non-compliance|6
7839210|NCT00251927|27210037|P1|Overall Study|Study procedure non-compliance|5
7839211|NCT00251927|27210036|P2|Overall Study|Study-specific discont. achieved|2
7839212|NCT00251927|27210037|P1|Overall Study|Study-specific discont. achieved|13
7839213|NCT00251927|27210036|P2|Overall Study|Withdrawal by Subject|25
7839214|NCT00251927|27210037|P1|Overall Study|Withdrawal by Subject|40
7839215|NCT00251927|27210036|P2|Overall Study|Pregnancy|0
7839216|NCT00251927|27210037|P1|Overall Study|Pregnancy|2
7839217|NCT00251927|27210036|P2|Overall Study|Protocol Violation|2
7839218|NCT00251927|27210037|P1|Overall Study|Protocol Violation|1
7839219|NCT00251927|27210036|P2|Overall Study|Lost to Follow-up|8
7839220|NCT00251927|27210037|P1|Overall Study|Lost to Follow-up|22
7839221|NCT00251927|27210036|P2|Overall Study|Lack of Efficacy|16
7839222|NCT00251927|27210037|P1|Overall Study|Lack of Efficacy|22
7839223|NCT00251927|27210036|P2|Overall Study|Adverse Event|15
7839224|NCT00251927|27210037|P1|Overall Study|Adverse Event|3
7839225|NCT00251758|27210089|P3|Overall Study|Per Investigator Request|0
7839226|NCT00251758|27210090|P2|Overall Study|Per Investigator Request|0
7839227|NCT00251758|27210091|P1|Overall Study|Per Investigator Request|1
7839228|NCT00251758|27210089|P3|Overall Study|Per Subject Request|1
7839229|NCT00251758|27210090|P2|Overall Study|Per Subject Request|0
7839230|NCT00251758|27210091|P1|Overall Study|Per Subject Request|0
7839231|NCT00251758|27210089|P3|Overall Study|Pregnancy|0
7839232|NCT00251758|27210090|P2|Overall Study|Pregnancy|1
7839233|NCT00251758|27210091|P1|Overall Study|Pregnancy|0
7839234|NCT00251758|27210089|P3|Overall Study|Noncompliant|2
7839235|NCT00251758|27210090|P2|Overall Study|Noncompliant|2
7839236|NCT00251758|27210091|P1|Overall Study|Noncompliant|0
7839237|NCT00251758|27210089|P3|Overall Study|Lack of Efficacy|0
7839238|NCT00251758|27210090|P2|Overall Study|Lack of Efficacy|0
7839239|NCT00251758|27210091|P1|Overall Study|Lack of Efficacy|3
7839240|NCT00251758|27210089|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7839241|NCT00251758|27210090|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
7839242|NCT00251758|27210091|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7839243|NCT00251758|27210089|P3|Overall Study|Withdrawal by Subject|3
7839244|NCT00251758|27210090|P2|Overall Study|Withdrawal by Subject|7
7839245|NCT00251758|27210091|P1|Overall Study|Withdrawal by Subject|13
7839246|NCT00251758|27210089|P3|Overall Study|Lost to Follow-up|5
7839247|NCT00251758|27210090|P2|Overall Study|Lost to Follow-up|2
7839248|NCT00251758|27210091|P1|Overall Study|Lost to Follow-up|4
7839249|NCT00251758|27210089|P3|Overall Study|Adverse Event|11
7839250|NCT00251758|27210090|P2|Overall Study|Adverse Event|9
7839251|NCT00251758|27210091|P1|Overall Study|Adverse Event|7
7839252|NCT00251745|27210111|P3|Overall Study|Per Investigator Request|0
7839253|NCT00251745|27210112|P2|Overall Study|Per Investigator Request|0
7839254|NCT00251745|27210113|P1|Overall Study|Per Investigator Request|1
7839255|NCT00251745|27210111|P3|Overall Study|Per Subject Request|1
7839256|NCT00251745|27210112|P2|Overall Study|Per Subject Request|0
7839257|NCT00251745|27210113|P1|Overall Study|Per Subject Request|0
7839258|NCT00251745|27210111|P3|Overall Study|Pregnancy|0
7839259|NCT00251745|27210112|P2|Overall Study|Pregnancy|1
7839260|NCT00251745|27210113|P1|Overall Study|Pregnancy|0
7839261|NCT00251745|27210111|P3|Overall Study|Noncompliant|2
7839262|NCT00251745|27210112|P2|Overall Study|Noncompliant|2
7839263|NCT00251745|27210113|P1|Overall Study|Noncompliant|0
7839264|NCT00251745|27210111|P3|Overall Study|Lack of Efficacy|0
7839265|NCT00251745|27210112|P2|Overall Study|Lack of Efficacy|0
7839266|NCT00251745|27210113|P1|Overall Study|Lack of Efficacy|3
7839267|NCT00251745|27210111|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7839268|NCT00251745|27210112|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
7839269|NCT00251745|27210113|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7839270|NCT00251745|27210111|P3|Overall Study|Withdrawal by Subject|3
7839271|NCT00251745|27210112|P2|Overall Study|Withdrawal by Subject|7
7839272|NCT00251745|27210113|P1|Overall Study|Withdrawal by Subject|13
7839273|NCT00251745|27210111|P3|Overall Study|Lost to Follow-up|5
7839274|NCT00251745|27210112|P2|Overall Study|Lost to Follow-up|2
7839275|NCT00251745|27210113|P1|Overall Study|Lost to Follow-up|4
7839276|NCT00251745|27210111|P3|Overall Study|Adverse Event|11
7839277|NCT00251745|27210112|P2|Overall Study|Adverse Event|9
7839278|NCT00251745|27210113|P1|Overall Study|Adverse Event|7
7839279|NCT00251719|27210133|P3|Overall Study|Barrett's esophagus|0
7839280|NCT00251719|27210134|P2|Overall Study|Barrett's esophagus|2
7839281|NCT00251719|27210135|P1|Overall Study|Barrett's esophagus|2
7839282|NCT00251719|27210133|P3|Overall Study|Noncompliance|1
7839283|NCT00251719|27210134|P2|Overall Study|Noncompliance|3
7839284|NCT00251719|27210135|P1|Overall Study|Noncompliance|2
7839285|NCT00251719|27210133|P3|Overall Study|Investigator decision|0
7839286|NCT00251719|27210134|P2|Overall Study|Investigator decision|1
7839287|NCT00251719|27210135|P1|Overall Study|Investigator decision|1
7839288|NCT00251719|27210133|P3|Overall Study|Inclusion/exclusion criteria not met|2
7839289|NCT00251719|27210134|P2|Overall Study|Inclusion/exclusion criteria not met|6
7839290|NCT00251719|27210135|P1|Overall Study|Inclusion/exclusion criteria not met|12
7839291|NCT00251719|27210133|P3|Overall Study|Lack of Efficacy|0
7839292|NCT00251719|27210134|P2|Overall Study|Lack of Efficacy|1
7839293|NCT00251719|27210135|P1|Overall Study|Lack of Efficacy|2
7839294|NCT00251719|27210133|P3|Overall Study|Withdrawal by Subject|11
7839295|NCT00251719|27210134|P2|Overall Study|Withdrawal by Subject|12
7839296|NCT00251719|27210135|P1|Overall Study|Withdrawal by Subject|14
7839297|NCT00251719|27210133|P3|Overall Study|Lost to Follow-up|8
7839298|NCT00251719|27210134|P2|Overall Study|Lost to Follow-up|11
7839299|NCT00251719|27210135|P1|Overall Study|Lost to Follow-up|5
7839300|NCT00251719|27210133|P3|Overall Study|Protocol Violation|1
7839301|NCT00251719|27210134|P2|Overall Study|Protocol Violation|1
7839302|NCT00251719|27210135|P1|Overall Study|Protocol Violation|1
7839303|NCT00251719|27210133|P3|Overall Study|Adverse Event|7
7839304|NCT00251719|27210134|P2|Overall Study|Adverse Event|8
7839305|NCT00251719|27210135|P1|Overall Study|Adverse Event|14
7839306|NCT00251693|27210161|P3|Overall Study|Abnormal laboratory findings|1
7839307|NCT00251693|27210162|P2|Overall Study|Abnormal laboratory findings|0
7839308|NCT00251693|27210163|P1|Overall Study|Abnormal laboratory findings|0
7839309|NCT00251693|27210161|P3|Overall Study|Subject request/subject unavailable|0
7839310|NCT00251693|27210162|P2|Overall Study|Subject request/subject unavailable|2
7839311|NCT00251693|27210163|P1|Overall Study|Subject request/subject unavailable|1
7839312|NCT00251693|27210161|P3|Overall Study|Possible Barrett's esophagus|2
7839313|NCT00251693|27210162|P2|Overall Study|Possible Barrett's esophagus|5
7839314|NCT00251693|27210163|P1|Overall Study|Possible Barrett's esophagus|3
7839315|NCT00251693|27210161|P3|Overall Study|Noncompliant|2
7839316|NCT00251693|27210162|P2|Overall Study|Noncompliant|0
7839317|NCT00251693|27210163|P1|Overall Study|Noncompliant|0
7839318|NCT00251693|27210161|P3|Overall Study|Inclusion/exclusion criteria not met|8
7839319|NCT00251693|27210162|P2|Overall Study|Inclusion/exclusion criteria not met|3
7839320|NCT00251693|27210163|P1|Overall Study|Inclusion/exclusion criteria not met|5
7839321|NCT00251693|27210161|P3|Overall Study|Lack of Efficacy|0
7839322|NCT00251693|27210162|P2|Overall Study|Lack of Efficacy|1
7839323|NCT00251693|27210163|P1|Overall Study|Lack of Efficacy|0
7839324|NCT00251693|27210161|P3|Overall Study|Withdrawal by Subject|14
7839325|NCT00251693|27210162|P2|Overall Study|Withdrawal by Subject|17
7839326|NCT00251693|27210163|P1|Overall Study|Withdrawal by Subject|11
7839327|NCT00251693|27210161|P3|Overall Study|Lost to Follow-up|8
7839328|NCT00251693|27210162|P2|Overall Study|Lost to Follow-up|7
7839329|NCT00251693|27210163|P1|Overall Study|Lost to Follow-up|12
7839330|NCT00251693|27210161|P3|Overall Study|Protocol Violation|2
7839331|NCT00251693|27210162|P2|Overall Study|Protocol Violation|0
7839332|NCT00251693|27210163|P1|Overall Study|Protocol Violation|2
7839333|NCT00251693|27210161|P3|Overall Study|Adverse Event|9
7839334|NCT00251693|27210162|P2|Overall Study|Adverse Event|9
7839335|NCT00251693|27210163|P1|Overall Study|Adverse Event|17
7839336|NCT00251641|27210188|P2|Overall Study|Switched Treatment|63
7839337|NCT00251641|27210189|P1|Overall Study|Switched Treatment|9
7839338|NCT00251641|27210188|P2|Overall Study|Did not Meet protocol Eligibility|1
7839339|NCT00251641|27210189|P1|Overall Study|Did not Meet protocol Eligibility|2
7839340|NCT00251641|27210188|P2|Overall Study|Protocol Violation|2
7839341|NCT00251641|27210189|P1|Overall Study|Protocol Violation|10
7839342|NCT00251641|27210188|P2|Overall Study|Withdrawal by Subject|8
7839343|NCT00251641|27210189|P1|Overall Study|Withdrawal by Subject|6
7839344|NCT00251641|27210188|P2|Overall Study|Lost to Follow-up|3
7839345|NCT00251641|27210189|P1|Overall Study|Lost to Follow-up|3
7839346|NCT00251641|27210188|P2|Overall Study|Progression of Disease|2
7839347|NCT00251641|27210189|P1|Overall Study|Progression of Disease|0
7839348|NCT00251641|27210188|P2|Overall Study|Lack of Efficacy|1
7839349|NCT00251641|27210189|P1|Overall Study|Lack of Efficacy|2
7839350|NCT00251641|27210188|P2|Overall Study|Adverse Event|8
7839351|NCT00251641|27210189|P1|Overall Study|Adverse Event|80
7839352|NCT00251589|27210207|P4|Overall Study|Discontinued due to progressive disease|1
7839353|NCT00251589|27210208|P3|Overall Study|Discontinued due to progressive disease|0
7839354|NCT00251589|27210209|P2|Overall Study|Discontinued due to progressive disease|1
7839355|NCT00251589|27210210|P1|Overall Study|Discontinued due to progressive disease|9
7839356|NCT00251589|27210207|P4|Overall Study|Withdrawal by Subject|0
7839357|NCT00251589|27210208|P3|Overall Study|Withdrawal by Subject|0
7839358|NCT00251589|27210209|P2|Overall Study|Withdrawal by Subject|1
7839359|NCT00251589|27210210|P1|Overall Study|Withdrawal by Subject|1
7839360|NCT00251589|27210207|P4|Overall Study|Adverse Event|1
7839361|NCT00251589|27210208|P3|Overall Study|Adverse Event|2
7839362|NCT00251589|27210209|P2|Overall Study|Adverse Event|1
7839363|NCT00251589|27210210|P1|Overall Study|Adverse Event|5
7839364|NCT00251316|27210247|P2|Overall Study|Physician Decision|3
7839365|NCT00251316|27210248|P1|Overall Study|Physician Decision|2
7839366|NCT00251004|27210287|P3|Overall Study|Graft Loss|8
7839367|NCT00251004|27210288|P2|Overall Study|Graft Loss|13
7839368|NCT00251004|27210289|P1|Overall Study|Graft Loss|12
7839369|NCT00251004|27210287|P3|Overall Study|Lost to Follow-up|1
7839370|NCT00251004|27210288|P2|Overall Study|Lost to Follow-up|2
7839371|NCT00251004|27210289|P1|Overall Study|Lost to Follow-up|1
7839372|NCT00251004|27210287|P3|Overall Study|Death|8
7839373|NCT00251004|27210288|P2|Overall Study|Death|10
7839374|NCT00251004|27210289|P1|Overall Study|Death|9
7839375|NCT00251004|27210287|P3|Overall Study|Withdrawal by Subject|14
7839376|NCT00251004|27210288|P2|Overall Study|Withdrawal by Subject|16
7839377|NCT00251004|27210289|P1|Overall Study|Withdrawal by Subject|23
7839378|NCT00250835|27210313|P1|Overall Study|Withdrawal by Subject|1
7839379|NCT00250718|27210322|P1|Overall Study|Withdrawal by Subject|1
7839380|NCT00250718|27210322|P1|Overall Study|Adverse Event|1
7839381|NCT00250718|27210322|P1|Overall Study|Death|1
7839382|NCT00250705|27210327|P1|Overall Study|Lack of Efficacy|2
7839383|NCT00250679|27210338|P3|Overall Study|various single events: hip surgery,diary|1
7839384|NCT00250679|27210339|P2|Overall Study|various single events: hip surgery,diary|1
7839385|NCT00250679|27210340|P1|Overall Study|various single events: hip surgery,diary|3
7839386|NCT00250679|27210338|P3|Overall Study|Non-compliance|0
7839387|NCT00250679|27210339|P2|Overall Study|Non-compliance|1
7839388|NCT00250679|27210340|P1|Overall Study|Non-compliance|1
7839389|NCT00250679|27210338|P3|Overall Study|Moved|0
7839390|NCT00250679|27210339|P2|Overall Study|Moved|1
7839391|NCT00250679|27210340|P1|Overall Study|Moved|1
7839392|NCT00250679|27210338|P3|Overall Study|Technical Holter issues|2
7839393|NCT00250679|27210339|P2|Overall Study|Technical Holter issues|0
7839394|NCT00250679|27210340|P1|Overall Study|Technical Holter issues|1
7839395|NCT00250679|27210338|P3|Overall Study|Lack of Efficacy|3
7839396|NCT00250679|27210339|P2|Overall Study|Lack of Efficacy|1
7839397|NCT00250679|27210340|P1|Overall Study|Lack of Efficacy|0
7839398|NCT00250679|27210338|P3|Overall Study|Does Not Meet Entry Criteria|2
7839399|NCT00250679|27210339|P2|Overall Study|Does Not Meet Entry Criteria|4
7839400|NCT00250679|27210340|P1|Overall Study|Does Not Meet Entry Criteria|1
7839401|NCT00250679|27210338|P3|Overall Study|Lost to Follow-up|2
7839402|NCT00250679|27210339|P2|Overall Study|Lost to Follow-up|4
7839403|NCT00250679|27210340|P1|Overall Study|Lost to Follow-up|3
7839404|NCT00250679|27210338|P3|Overall Study|Withdrawal by Subject|15
7839405|NCT00250679|27210339|P2|Overall Study|Withdrawal by Subject|18
7839406|NCT00250679|27210340|P1|Overall Study|Withdrawal by Subject|15
7839407|NCT00250679|27210338|P3|Overall Study|Protocol Violation|3
7839408|NCT00250679|27210339|P2|Overall Study|Protocol Violation|4
7839409|NCT00250679|27210340|P1|Overall Study|Protocol Violation|2
7839410|NCT00250679|27210338|P3|Overall Study|Adverse Event|16
7839411|NCT00250679|27210339|P2|Overall Study|Adverse Event|15
7839412|NCT00250679|27210340|P1|Overall Study|Adverse Event|12
7839413|NCT00250588|27210441|P3|Overall Study|Lost to Follow-up|13
7839414|NCT00250588|27210442|P2|Overall Study|Lost to Follow-up|13
7839415|NCT00250588|27210443|P1|Overall Study|Lost to Follow-up|6
7839416|NCT00250588|27210441|P3|Overall Study|Withdrawal by Subject|0
7839417|NCT00250588|27210442|P2|Overall Study|Withdrawal by Subject|6
7839418|NCT00250588|27210443|P1|Overall Study|Withdrawal by Subject|3
7839419|NCT00250458|27210491|P2|Overall Study|Other|0
7839420|NCT00250458|27210492|P1|Overall Study|Other|1
7839421|NCT00250458|27210491|P2|Overall Study|Qualifying migraine but did not treat|3
7839422|NCT00250458|27210492|P1|Overall Study|Qualifying migraine but did not treat|3
7839423|NCT00250458|27210491|P2|Overall Study|Lack of Migraine Attack|9
7839424|NCT00250458|27210492|P1|Overall Study|Lack of Migraine Attack|20
7839425|NCT00250458|27210491|P2|Overall Study|Withdrawal by Subject|2
7839426|NCT00250458|27210492|P1|Overall Study|Withdrawal by Subject|4
7839427|NCT00250458|27210491|P2|Overall Study|Protocol Violation|1
7839428|NCT00250458|27210492|P1|Overall Study|Protocol Violation|0
7839429|NCT00250458|27210491|P2|Overall Study|Lost to Follow-up|2
7839430|NCT00250458|27210492|P1|Overall Study|Lost to Follow-up|4
7839431|NCT00250432|27210502|P2|Overall Study|Pt was considered untreatable|1
7839432|NCT00250432|27210503|P1|Overall Study|Pt was considered untreatable|0
7839433|NCT00250432|27210502|P2|Overall Study|Pt died out of posttherapy report period|5
7839434|NCT00250432|27210503|P1|Overall Study|Pt died out of posttherapy report period|6
7839435|NCT00250432|27210502|P2|Overall Study|Withdrawal by Subject|2
7839436|NCT00250432|27210503|P1|Overall Study|Withdrawal by Subject|6
7839437|NCT00250432|27210502|P2|Overall Study|Protocol Violation|3
7839438|NCT00250432|27210503|P1|Overall Study|Protocol Violation|0
7839439|NCT00250432|27210502|P2|Overall Study|Patient Moved|1
7839440|NCT00250432|27210503|P1|Overall Study|Patient Moved|0
7839441|NCT00250432|27210502|P2|Overall Study|Lost to Follow-up|5
7839442|NCT00250432|27210503|P1|Overall Study|Lost to Follow-up|6
7839443|NCT00250432|27210502|P2|Overall Study|Lack of Efficacy|1
7839444|NCT00250432|27210503|P1|Overall Study|Lack of Efficacy|2
7839445|NCT00250432|27210502|P2|Overall Study|Adverse Event|29
7839446|NCT00250432|27210503|P1|Overall Study|Adverse Event|25
7839447|NCT00250276|27210515|P4|Overall Study|Lost to Follow-up|8
7839448|NCT00250276|27210516|P3|Overall Study|Lost to Follow-up|13
7839449|NCT00250276|27210517|P2|Overall Study|Lost to Follow-up|18
7839450|NCT00250276|27210518|P1|Overall Study|Lost to Follow-up|11
7839451|NCT00250276|27210515|P4|Overall Study|Migrated/moved from study area|7
7839452|NCT00250276|27210516|P3|Overall Study|Migrated/moved from study area|2
7839453|NCT00250276|27210517|P2|Overall Study|Migrated/moved from study area|0
7839454|NCT00250276|27210518|P1|Overall Study|Migrated/moved from study area|3
7839455|NCT00250276|27210515|P4|Overall Study|Withdrawal by Subject|2
7839456|NCT00250276|27210516|P3|Overall Study|Withdrawal by Subject|3
7839457|NCT00250276|27210517|P2|Overall Study|Withdrawal by Subject|2
7839458|NCT00250276|27210518|P1|Overall Study|Withdrawal by Subject|1
7839459|NCT00250276|27210515|P4|Overall Study|Protocol Violation|0
7839460|NCT00250276|27210516|P3|Overall Study|Protocol Violation|0
7839461|NCT00250276|27210517|P2|Overall Study|Protocol Violation|1
7839462|NCT00250276|27210518|P1|Overall Study|Protocol Violation|0
7839463|NCT00250276|27210515|P4|Overall Study|Non-serious Adverse Event|2
7839464|NCT00250276|27210516|P3|Overall Study|Non-serious Adverse Event|0
7839465|NCT00250276|27210517|P2|Overall Study|Non-serious Adverse Event|0
7839466|NCT00250276|27210518|P1|Overall Study|Non-serious Adverse Event|2
7839467|NCT00250276|27210515|P4|Overall Study|Serious Adverse Event|0
7839468|NCT00250276|27210516|P3|Overall Study|Serious Adverse Event|1
7839469|NCT00250276|27210517|P2|Overall Study|Serious Adverse Event|0
7839470|NCT00250276|27210518|P1|Overall Study|Serious Adverse Event|0
7839471|NCT00249873|27210598|P2|Overall Study|Thromboembolic/outcome event|122
7839472|NCT00249873|27210599|P1|Overall Study|Thromboembolic/outcome event|82
7839473|NCT00249873|27210598|P2|Overall Study|Event related to cardiac condition|21
7839474|NCT00249873|27210599|P1|Overall Study|Event related to cardiac condition|12
7839475|NCT00249873|27210598|P2|Overall Study|Surgery/ procedure|9
7839476|NCT00249873|27210599|P1|Overall Study|Surgery/ procedure|9
7839477|NCT00249873|27210598|P2|Overall Study|Study drug intolerance|0
7839478|NCT00249873|27210599|P1|Overall Study|Study drug intolerance|5
7839479|NCT00249873|27210598|P2|Overall Study|Oral anticoagulant required|157
7839480|NCT00249873|27210599|P1|Overall Study|Oral anticoagulant required|159
7839481|NCT00249873|27210598|P2|Overall Study|Angiotensin II receptor blocker required|0
7839482|NCT00249873|27210599|P1|Overall Study|Angiotensin II receptor blocker required|1
7839483|NCT00249873|27210598|P2|Overall Study|Open label clopidogrel required|42
7839484|NCT00249873|27210599|P1|Overall Study|Open label clopidogrel required|31
7839485|NCT00249873|27210598|P2|Overall Study|Physician withdrew consent|60
7839486|NCT00249873|27210599|P1|Overall Study|Physician withdrew consent|59
7839487|NCT00249873|27210598|P2|Overall Study|Patient not wish to continue after May08|4
7839488|NCT00249873|27210599|P1|Overall Study|Patient not wish to continue after May08|3
7839489|NCT00249873|27210598|P2|Overall Study|Other contraindicated medication|0
7839490|NCT00249873|27210599|P1|Overall Study|Other contraindicated medication|1
7839491|NCT00249873|27210598|P2|Overall Study|Other non serious Adverse Event|108
7839492|NCT00249873|27210599|P1|Overall Study|Other non serious Adverse Event|112
7839493|NCT00249873|27210598|P2|Overall Study|Non-compliance|46
7839494|NCT00249873|27210599|P1|Overall Study|Non-compliance|41
7839495|NCT00249873|27210598|P2|Overall Study|Minor bleeding|37
7839496|NCT00249873|27210599|P1|Overall Study|Minor bleeding|99
7839497|NCT00249873|27210598|P2|Overall Study|Lost to Follow-up|7
7839498|NCT00249873|27210599|P1|Overall Study|Lost to Follow-up|4
7839499|NCT00249873|27210598|P2|Overall Study|Withdrawal by Subject|466
7839500|NCT00249873|27210599|P1|Overall Study|Withdrawal by Subject|504
7839501|NCT00249873|27210598|P2|Overall Study|Contraindication to oral anticoagulant|8
7839502|NCT00249873|27210599|P1|Overall Study|Contraindication to oral anticoagulant|4
7839503|NCT00249873|27210598|P2|Overall Study|Qualifying condition not present|23
7839504|NCT00249873|27210599|P1|Overall Study|Qualifying condition not present|20
7839505|NCT00249873|27210598|P2|Overall Study|Other Serious Adverse Event|97
7839506|NCT00249873|27210599|P1|Overall Study|Other Serious Adverse Event|86
7839507|NCT00249873|27210598|P2|Overall Study|Serious haemorrhagic Adverse Event|30
7839508|NCT00249873|27210599|P1|Overall Study|Serious haemorrhagic Adverse Event|74
7839509|NCT00249873|27210598|P2|Overall Study|Severe allergic reaction|1
7839510|NCT00249873|27210599|P1|Overall Study|Severe allergic reaction|8
7839511|NCT00249873|27210598|P2|Overall Study|Significant thrombocytopenia|8
7839512|NCT00249873|27210599|P1|Overall Study|Significant thrombocytopenia|9
7839513|NCT00249873|27210598|P2|Overall Study|Not treated|8
7839514|NCT00249873|27210599|P1|Overall Study|Not treated|7
7839515|NCT00249834|27210619|P8|Overall Study|Protocol Violation|0
7839516|NCT00249834|27210620|P7|Overall Study|Protocol Violation|0
7839517|NCT00249834|27210621|P6|Overall Study|Protocol Violation|2
7839518|NCT00249834|27210622|P5|Overall Study|Protocol Violation|5
7839519|NCT00249834|27210623|P4|Overall Study|Protocol Violation|8
7839520|NCT00249834|27210624|P3|Overall Study|Protocol Violation|14
7839521|NCT00249834|27210625|P2|Overall Study|Protocol Violation|19
7839522|NCT00249834|27210626|P1|Overall Study|Protocol Violation|0
7839523|NCT00249834|27210619|P8|Overall Study|Failure of down-regulation|0
7839524|NCT00249834|27210620|P7|Overall Study|Failure of down-regulation|1
7839525|NCT00249834|27210621|P6|Overall Study|Failure of down-regulation|0
7839526|NCT00249834|27210622|P5|Overall Study|Failure of down-regulation|0
7839527|NCT00249834|27210623|P4|Overall Study|Failure of down-regulation|0
7839528|NCT00249834|27210624|P3|Overall Study|Failure of down-regulation|0
7839529|NCT00249834|27210625|P2|Overall Study|Failure of down-regulation|0
7839530|NCT00249834|27210626|P1|Overall Study|Failure of down-regulation|0
7839531|NCT00249834|27210619|P8|Overall Study|Ovarian stimulation failed|0
7839532|NCT00249834|27210620|P7|Overall Study|Ovarian stimulation failed|0
7839533|NCT00249834|27210621|P6|Overall Study|Ovarian stimulation failed|0
7839534|NCT00249834|27210622|P5|Overall Study|Ovarian stimulation failed|0
7839535|NCT00249834|27210623|P4|Overall Study|Ovarian stimulation failed|0
7839536|NCT00249834|27210624|P3|Overall Study|Ovarian stimulation failed|0
7839537|NCT00249834|27210625|P2|Overall Study|Ovarian stimulation failed|0
7839538|NCT00249834|27210626|P1|Overall Study|Ovarian stimulation failed|1
7839539|NCT00249821|27210675|P2|Overall Study|Technical problem|1
7839540|NCT00249821|27210676|P1|Overall Study|Technical problem|0
7839541|NCT00249808|27210696|P1|Overall Study|Did Not Provide Post-Baseline Data|11
7839542|NCT00249808|27210696|P1|Overall Study|Lack of Efficacy|52
7839543|NCT00249808|27210696|P1|Overall Study|Adverse Event|81
7839544|NCT00249808|27210696|P1|Overall Study|Lost to Follow-up|8
7839545|NCT00249808|27210696|P1|Overall Study|Protocol Violation|3
7839546|NCT00249808|27210696|P1|Overall Study|Other|27
7839547|NCT00249795|27210704|P2|Overall Study|Missing|1
7839548|NCT00249795|27210705|P1|Overall Study|Missing|0
7839549|NCT00249795|27210704|P2|Overall Study|Lost to Follow-up|2
7839550|NCT00249795|27210705|P1|Overall Study|Lost to Follow-up|0
7839551|NCT00249795|27210704|P2|Overall Study|Site not agree to continue after May08|1
7839552|NCT00249795|27210705|P1|Overall Study|Site not agree to continue after May08|1
7839553|NCT00249795|27210704|P2|Overall Study|Patient not wish to continue after May08|6
7839554|NCT00249795|27210705|P1|Overall Study|Patient not wish to continue after May08|4
7839555|NCT00249795|27210704|P2|Overall Study|Event related to cardiac condition|16
7839556|NCT00249795|27210705|P1|Overall Study|Event related to cardiac condition|17
7839557|NCT00249795|27210704|P2|Overall Study|Other contraindicated medication|1
7839558|NCT00249795|27210705|P1|Overall Study|Other contraindicated medication|1
7839559|NCT00249795|27210704|P2|Overall Study|Hypotension (non-symptomatic)|5
7839560|NCT00249795|27210705|P1|Overall Study|Hypotension (non-symptomatic)|5
7839561|NCT00249795|27210704|P2|Overall Study|Lightheadedness / dizziness|11
7839562|NCT00249795|27210705|P1|Overall Study|Lightheadedness / dizziness|15
7839563|NCT00249795|27210704|P2|Overall Study|Angiotensin II receptor blocker required|58
7839564|NCT00249795|27210705|P1|Overall Study|Angiotensin II receptor blocker required|35
7839565|NCT00249795|27210704|P2|Overall Study|Surgery / procedure|5
7839566|NCT00249795|27210705|P1|Overall Study|Surgery / procedure|4
7839567|NCT00249795|27210704|P2|Overall Study|Physician withdrew consent|63
7839568|NCT00249795|27210705|P1|Overall Study|Physician withdrew consent|71
7839569|NCT00249795|27210704|P2|Overall Study|Other adverse events (non-serious)|159
7839570|NCT00249795|27210705|P1|Overall Study|Other adverse events (non-serious)|188
7839571|NCT00249795|27210704|P2|Overall Study|Study drug intolerance|3
7839572|NCT00249795|27210705|P1|Overall Study|Study drug intolerance|3
7839573|NCT00249795|27210704|P2|Overall Study|Non-compliance|69
7839574|NCT00249795|27210705|P1|Overall Study|Non-compliance|71
7839575|NCT00249795|27210704|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
7839576|NCT00249795|27210705|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
7839577|NCT00249795|27210704|P2|Overall Study|Oral anticoagulant required|0
7839578|NCT00249795|27210705|P1|Overall Study|Oral anticoagulant required|2
7839579|NCT00249795|27210704|P2|Overall Study|Thromboembolic / outcome event|45
7839580|NCT00249795|27210705|P1|Overall Study|Thromboembolic / outcome event|39
7839581|NCT00249795|27210704|P2|Overall Study|Withdrawal by Subject|742
7839582|NCT00249795|27210705|P1|Overall Study|Withdrawal by Subject|678
7839583|NCT00249795|27210704|P2|Overall Study|Qualifying condition not present|29
7839584|NCT00249795|27210705|P1|Overall Study|Qualifying condition not present|26
7839585|NCT00249795|27210704|P2|Overall Study|Other Serious Adverse Event|93
7839586|NCT00249795|27210705|P1|Overall Study|Other Serious Adverse Event|84
7839587|NCT00249795|27210704|P2|Overall Study|Symptomatic hypotension|64
7839588|NCT00249795|27210705|P1|Overall Study|Symptomatic hypotension|127
7839589|NCT00249795|27210704|P2|Overall Study|Not treated|14
7839590|NCT00249795|27210705|P1|Overall Study|Not treated|16
7839591|NCT00249769|27210726|P3|Overall Study|Lost to Follow-up|3
7839592|NCT00249769|27210727|P2|Overall Study|Lost to Follow-up|0
7839593|NCT00249769|27210728|P1|Overall Study|Lost to Follow-up|0
7839594|NCT00249769|27210726|P3|Overall Study|Physician Decision|2
7839595|NCT00249769|27210727|P2|Overall Study|Physician Decision|0
7839596|NCT00249769|27210728|P1|Overall Study|Physician Decision|0
7839597|NCT00249769|27210726|P3|Overall Study|Adverse Event|1
7839598|NCT00249769|27210727|P2|Overall Study|Adverse Event|0
7839599|NCT00249769|27210728|P1|Overall Study|Adverse Event|0
7839600|NCT00249769|27210726|P3|Overall Study|Miscellaneous|2
7839601|NCT00249769|27210727|P2|Overall Study|Miscellaneous|2
7839602|NCT00249769|27210728|P1|Overall Study|Miscellaneous|0
7839603|NCT00249769|27210726|P3|Overall Study|Migration from Study Area|14
7839604|NCT00249769|27210727|P2|Overall Study|Migration from Study Area|3
7839605|NCT00249769|27210728|P1|Overall Study|Migration from Study Area|1
7839606|NCT00249769|27210726|P3|Overall Study|Withdrawal by Subject|6
7839607|NCT00249769|27210727|P2|Overall Study|Withdrawal by Subject|10
7839608|NCT00249769|27210728|P1|Overall Study|Withdrawal by Subject|1
7839609|NCT00249613|27210756|P2|12 Month Follow-up|Lost to Follow-up|8
7839610|NCT00249613|27210757|P1|12 Month Follow-up|Lost to Follow-up|10
7839611|NCT00249613|27210756|P2|12 Month Follow-up|Withdrawal by Subject|6
7839612|NCT00249613|27210757|P1|12 Month Follow-up|Withdrawal by Subject|6
7839613|NCT00249613|27210756|P2|12 Month Follow-up|Death|1
7839614|NCT00249613|27210757|P1|12 Month Follow-up|Death|1
7839615|NCT00249444|27210798|P2|Overall Study|life event|1
7839616|NCT00249444|27210799|P1|Overall Study|life event|0
7839617|NCT00249444|27210798|P2|Overall Study|Adverse Event|1
7839618|NCT00249444|27210799|P1|Overall Study|Adverse Event|1
7839619|NCT00249444|27210798|P2|Overall Study|non-compliant|11
7839620|NCT00249444|27210799|P1|Overall Study|non-compliant|9
7839621|NCT00249444|27210798|P2|Overall Study|Lost to Follow-up|2
7839622|NCT00249444|27210799|P1|Overall Study|Lost to Follow-up|2
7839623|NCT00249288|27210824|P2|Overall Study|Withdrawal by Subject|2
7839624|NCT00249288|27210825|P1|Overall Study|Withdrawal by Subject|2
7839625|NCT00249288|27210824|P2|Overall Study|Lost to Follow-up|3
7839626|NCT00249288|27210825|P1|Overall Study|Lost to Follow-up|3
7839627|NCT00249002|27210917|P1|Overall Study|Other|2
7839628|NCT00249002|27210917|P1|Overall Study|Study cancellation|3
7839629|NCT00249002|27210917|P1|Overall Study|Adverse Event|2
7839630|NCT00248833|27210936|P3|Overall Study|Other|0
7839631|NCT00248833|27210937|P2|Overall Study|Other|1
7839632|NCT00248833|27210938|P1|Overall Study|Other|0
7839633|NCT00248833|27210936|P3|Overall Study|Lost to Follow-up|1
7839634|NCT00248833|27210937|P2|Overall Study|Lost to Follow-up|1
7839635|NCT00248833|27210938|P1|Overall Study|Lost to Follow-up|1
7839636|NCT00248833|27210936|P3|Overall Study|Withdrawal by Subject|1
7839637|NCT00248833|27210937|P2|Overall Study|Withdrawal by Subject|1
7839638|NCT00248833|27210938|P1|Overall Study|Withdrawal by Subject|0
7839639|NCT00248833|27210936|P3|Overall Study|Adverse Event|0
7839640|NCT00248833|27210937|P2|Overall Study|Adverse Event|0
7839641|NCT00248833|27210938|P1|Overall Study|Adverse Event|2
7839642|NCT00248794|27210974|P3|Overall Study|Lost to Follow-up|3
7839643|NCT00248794|27210975|P2|Overall Study|Lost to Follow-up|8
7839644|NCT00248794|27210976|P1|Overall Study|Lost to Follow-up|6
7839645|NCT00248651|27211026|P3|Overall Study|Withdrawal by Subject|32
7839646|NCT00248651|27211027|P2|Overall Study|Withdrawal by Subject|40
7839647|NCT00248651|27211028|P1|Overall Study|Withdrawal by Subject|28
7839648|NCT00248625|27211064|P2|Overall Study|Withdrawal by Subject|2
7839649|NCT00248625|27211065|P1|Overall Study|Withdrawal by Subject|0
7839650|NCT00248495|27211157|P1|Overall Study|Withdrawal by Subject|1
7839651|NCT00248287|27211168|P2|Overall Study|Other|2
7839652|NCT00248287|27211169|P1|Overall Study|Other|3
7839653|NCT00248287|27211168|P2|Overall Study|Patient Request|3
7839654|NCT00248287|27211169|P1|Overall Study|Patient Request|5
7839655|NCT00248287|27211168|P2|Overall Study|Investigator Request|3
7839656|NCT00248287|27211169|P1|Overall Study|Investigator Request|4
7839657|NCT00248287|27211168|P2|Overall Study|Lost to Follow-up|1
7839658|NCT00248287|27211169|P1|Overall Study|Lost to Follow-up|0
7839659|NCT00248287|27211168|P2|Overall Study|Death|0
7839660|NCT00248287|27211169|P1|Overall Study|Death|1
7839661|NCT00248287|27211168|P2|Overall Study|Adverse Event|10
7839662|NCT00248287|27211169|P1|Overall Study|Adverse Event|11
7839663|NCT00248170|27211183|P2|Overall Study|Protocol deviation|19
7839664|NCT00248170|27211184|P1|Overall Study|Protocol deviation|17
7839665|NCT00248170|27211183|P2|Overall Study|Abnormal laboratory values|0
7839666|NCT00248170|27211184|P1|Overall Study|Abnormal laboratory values|4
7839667|NCT00248170|27211183|P2|Overall Study|Abnormal test procedure(s) result|61
7839668|NCT00248170|27211184|P1|Overall Study|Abnormal test procedure(s) result|49
7839669|NCT00248170|27211183|P2|Overall Study|Administrative problems|25
7839670|NCT00248170|27211184|P1|Overall Study|Administrative problems|22
7839671|NCT00248170|27211183|P2|Overall Study|Adverse Event|296
7839672|NCT00248170|27211184|P1|Overall Study|Adverse Event|311
7839673|NCT00248170|27211183|P2|Overall Study|Death|47
7839674|NCT00248170|27211184|P1|Overall Study|Death|28
7839675|NCT00248170|27211183|P2|Overall Study|Disease progression|216
7839676|NCT00248170|27211184|P1|Overall Study|Disease progression|196
7839677|NCT00248170|27211183|P2|Overall Study|Lost to Follow-up|35
7839678|NCT00248170|27211184|P1|Overall Study|Lost to Follow-up|28
7839679|NCT00248170|27211183|P2|Overall Study|Protocol Violation|30
7839680|NCT00248170|27211184|P1|Overall Study|Protocol Violation|35
7839681|NCT00248170|27211183|P2|Overall Study|Withdrawal by Subject|79
7839682|NCT00248170|27211184|P1|Overall Study|Withdrawal by Subject|71
7839683|NCT00248040|27211207|P3|Overall Study|Death|1
7839684|NCT00248040|27211208|P2|Overall Study|Death|0
7839685|NCT00248040|27211209|P1|Overall Study|Death|0
7839686|NCT00248040|27211207|P3|Overall Study|transplant cancelled post treat start|0
7839687|NCT00248040|27211208|P2|Overall Study|transplant cancelled post treat start|0
7839688|NCT00248040|27211209|P1|Overall Study|transplant cancelled post treat start|1
7839689|NCT00248040|27211207|P3|Overall Study|transplantectomy|3
7839690|NCT00248040|27211208|P2|Overall Study|transplantectomy|1
7839691|NCT00248040|27211209|P1|Overall Study|transplantectomy|2
7839692|NCT00247962|27211258|P2|Overall Study|Lack of Efficacy|2
7839693|NCT00247962|27211259|P1|Overall Study|Lack of Efficacy|4
7839694|NCT00247962|27211258|P2|Overall Study|Withdrawal by Subject|2
7839695|NCT00247962|27211259|P1|Overall Study|Withdrawal by Subject|3
7839696|NCT00247962|27211258|P2|Overall Study|Protocol Violation|1
7839697|NCT00247962|27211259|P1|Overall Study|Protocol Violation|1
7839698|NCT00247962|27211258|P2|Overall Study|Physician Decision|1
7839699|NCT00247962|27211259|P1|Overall Study|Physician Decision|0
7839700|NCT00247962|27211258|P2|Overall Study|Lost to Follow-up|1
7839701|NCT00247962|27211259|P1|Overall Study|Lost to Follow-up|3
7839702|NCT00247962|27211258|P2|Overall Study|Adverse Event|12
7839703|NCT00247962|27211259|P1|Overall Study|Adverse Event|15
7839704|NCT00247676|27211286|P1|Overall Study|Withdrawal by Subject|2
7839705|NCT00247676|27211286|P1|Overall Study|Other|3
7839706|NCT00247676|27211286|P1|Overall Study|Lack of Efficacy|15
7839707|NCT00247676|27211286|P1|Overall Study|Adverse Event|11
7839708|NCT00247676|27211286|P1|Overall Study|Death|5
7839709|NCT00247611|27211331|P2|Baselined|Completed baseline only|8
7839710|NCT00247611|27211332|P1|Baselined|Completed baseline only|9
7839711|NCT00247611|27211331|P2|Baselined|Completed baseline, never placed on ARVs|5
7839712|NCT00247611|27211332|P1|Baselined|Completed baseline, never placed on ARVs|8
7839713|NCT00247416|27211350|P2|Overall Study|3 patients were found to be ineligible|2
7839714|NCT00247416|27211351|P1|Overall Study|3 patients were found to be ineligible|1
7839715|NCT00247273|27211392|P2|Overall Study|Did not take any study drug|0
7839716|NCT00247273|27211393|P1|Overall Study|Did not take any study drug|2
7839717|NCT00247273|27211392|P2|Overall Study|Withdrawal by Subject|47
7839718|NCT00247273|27211393|P1|Overall Study|Withdrawal by Subject|46
7839719|NCT00247273|27211392|P2|Overall Study|Lost to Follow-up|7
7839720|NCT00247273|27211393|P1|Overall Study|Lost to Follow-up|7
7839721|NCT00247273|27211392|P2|Overall Study|Physician Decision|3
7839722|NCT00247273|27211393|P1|Overall Study|Physician Decision|6
7839723|NCT00247273|27211392|P2|Overall Study|Adverse Event|80
7839724|NCT00247273|27211393|P1|Overall Study|Adverse Event|85
7839725|NCT00246805|27211439|P2|Phase 1|Lost to Follow-up|0
7839726|NCT00246805|27211440|P1|Phase 1|Lost to Follow-up|1
7839727|NCT00246753|27211446|P1|Overall Study|Unacceptable toxicity|2
7839728|NCT00246753|27211446|P1|Overall Study|Adverse Event|2
7839729|NCT00246753|27211446|P1|Overall Study|Physician Decision|2
7839730|NCT00246753|27211446|P1|Overall Study|Withdrawal by Subject|2
7839731|NCT00246740|27211454|P2|Initial Enrollment|Other|2
7839732|NCT00246740|27211455|P1|Initial Enrollment|Other|1
7839733|NCT00246740|27211454|P2|Initial Enrollment|Surgery schedule change|4
7839734|NCT00246740|27211455|P1|Initial Enrollment|Surgery schedule change|4
7839735|NCT00246740|27211454|P2|Initial Enrollment|Additional surgery scheduled|2
7839736|NCT00246740|27211455|P1|Initial Enrollment|Additional surgery scheduled|0
7839737|NCT00246740|27211454|P2|Initial Enrollment|Death|0
7839738|NCT00246740|27211455|P1|Initial Enrollment|Death|1
7839739|NCT00246571|27211479|P2|Overall Study|Crossover participants|74
7839740|NCT00246571|27211480|P1|Overall Study|Crossover participants|0
7839741|NCT00246571|27211479|P2|Overall Study|Laboratory abnormalities|0
7839742|NCT00246571|27211480|P1|Overall Study|Laboratory abnormalities|1
7839743|NCT00246571|27211479|P2|Overall Study|Did not meet entrance criteria|1
7839744|NCT00246571|27211480|P1|Overall Study|Did not meet entrance criteria|2
7839745|NCT00246571|27211479|P2|Overall Study|Sponsor|1
7839746|NCT00246571|27211480|P1|Overall Study|Sponsor|0
7839747|NCT00246571|27211479|P2|Overall Study|Death|3
7839748|NCT00246571|27211480|P1|Overall Study|Death|17
7839749|NCT00246571|27211479|P2|Overall Study|Lack of Efficacy|21
7839750|NCT00246571|27211480|P1|Overall Study|Lack of Efficacy|84
7839751|NCT00246571|27211479|P2|Overall Study|Withdrawal by Subject|3
7839752|NCT00246571|27211480|P1|Overall Study|Withdrawal by Subject|2
7839753|NCT00246571|27211479|P2|Overall Study|Protocol Violation|1
7839754|NCT00246571|27211480|P1|Overall Study|Protocol Violation|0
7839755|NCT00246571|27211479|P2|Overall Study|Adverse Event|0
7839756|NCT00246571|27211480|P1|Overall Study|Adverse Event|7
7839757|NCT00246376|27211545|P5|Overall Study|Lost to Follow-up|13
7839758|NCT00246376|27211546|P4|Overall Study|Lost to Follow-up|16
7839759|NCT00246376|27211547|P3|Overall Study|Lost to Follow-up|11
7839760|NCT00246376|27211548|P2|Overall Study|Lost to Follow-up|11
7839761|NCT00246376|27211549|P1|Overall Study|Lost to Follow-up|2
7839762|NCT00246376|27211545|P5|Overall Study|Adverse Event|1
7839763|NCT00246376|27211546|P4|Overall Study|Adverse Event|3
7839764|NCT00246376|27211547|P3|Overall Study|Adverse Event|1
7839765|NCT00246376|27211548|P2|Overall Study|Adverse Event|3
7839766|NCT00246376|27211549|P1|Overall Study|Adverse Event|2
7839767|NCT00246376|27211545|P5|Overall Study|Dropped/withdrew during dietary run-in|3
7839768|NCT00246376|27211546|P4|Overall Study|Dropped/withdrew during dietary run-in|7
7839769|NCT00246376|27211547|P3|Overall Study|Dropped/withdrew during dietary run-in|4
7839770|NCT00246376|27211548|P2|Overall Study|Dropped/withdrew during dietary run-in|5
7839771|NCT00246376|27211549|P1|Overall Study|Dropped/withdrew during dietary run-in|11
7839772|NCT00246337|27211600|P9|Overall Study|Reported as completing trial in error|0
7839773|NCT00246337|27211601|P8|Overall Study|Reported as completing trial in error|1
7839774|NCT00246337|27211602|P7|Overall Study|Reported as completing trial in error|0
7839775|NCT00246337|27211603|P6|Overall Study|Reported as completing trial in error|0
7839776|NCT00246337|27211604|P5|Overall Study|Reported as completing trial in error|0
7839777|NCT00246337|27211605|P4|Overall Study|Reported as completing trial in error|0
7839778|NCT00246337|27211606|P3|Overall Study|Reported as completing trial in error|0
7839779|NCT00246337|27211607|P2|Overall Study|Reported as completing trial in error|0
7839780|NCT00246337|27211608|P1|Overall Study|Reported as completing trial in error|0
7839781|NCT00246337|27211600|P9|Overall Study|Protocol Violator|0
7839782|NCT00246337|27211601|P8|Overall Study|Protocol Violator|0
7839783|NCT00246337|27211602|P7|Overall Study|Protocol Violator|0
7839784|NCT00246337|27211603|P6|Overall Study|Protocol Violator|0
7839785|NCT00246337|27211604|P5|Overall Study|Protocol Violator|0
7839786|NCT00246337|27211605|P4|Overall Study|Protocol Violator|0
7839787|NCT00246337|27211606|P3|Overall Study|Protocol Violator|0
7839788|NCT00246337|27211607|P2|Overall Study|Protocol Violator|0
7839789|NCT00246337|27211608|P1|Overall Study|Protocol Violator|1
7839790|NCT00246337|27211600|P9|Overall Study|Overwhelmed|0
7839791|NCT00246337|27211601|P8|Overall Study|Overwhelmed|0
7839792|NCT00246337|27211602|P7|Overall Study|Overwhelmed|0
7839793|NCT00246337|27211603|P6|Overall Study|Overwhelmed|1
7839794|NCT00246337|27211604|P5|Overall Study|Overwhelmed|0
7839795|NCT00246337|27211605|P4|Overall Study|Overwhelmed|0
7839796|NCT00246337|27211606|P3|Overall Study|Overwhelmed|0
7839797|NCT00246337|27211607|P2|Overall Study|Overwhelmed|0
7839798|NCT00246337|27211608|P1|Overall Study|Overwhelmed|0
7839799|NCT00246337|27211600|P9|Overall Study|Abnormal baseline lab values|4
7839800|NCT00246337|27211601|P8|Overall Study|Abnormal baseline lab values|0
7839801|NCT00246337|27211602|P7|Overall Study|Abnormal baseline lab values|2
7839802|NCT00246337|27211603|P6|Overall Study|Abnormal baseline lab values|2
7839803|NCT00246337|27211604|P5|Overall Study|Abnormal baseline lab values|0
7839804|NCT00246337|27211605|P4|Overall Study|Abnormal baseline lab values|0
7839805|NCT00246337|27211606|P3|Overall Study|Abnormal baseline lab values|2
7839806|NCT00246337|27211607|P2|Overall Study|Abnormal baseline lab values|0
7839807|NCT00246337|27211608|P1|Overall Study|Abnormal baseline lab values|7
7839808|NCT00246337|27211600|P9|Overall Study|Site Terminated|2
7839809|NCT00246337|27211601|P8|Overall Study|Site Terminated|6
7839810|NCT00246337|27211602|P7|Overall Study|Site Terminated|1
7839811|NCT00246337|27211603|P6|Overall Study|Site Terminated|7
7839812|NCT00246337|27211604|P5|Overall Study|Site Terminated|0
7839813|NCT00246337|27211605|P4|Overall Study|Site Terminated|0
7839814|NCT00246337|27211606|P3|Overall Study|Site Terminated|0
7839815|NCT00246337|27211607|P2|Overall Study|Site Terminated|0
7839816|NCT00246337|27211608|P1|Overall Study|Site Terminated|10
7839817|NCT00246337|27211600|P9|Overall Study|Lack of Qualifying Event|5
7839818|NCT00246337|27211601|P8|Overall Study|Lack of Qualifying Event|2
7839819|NCT00246337|27211602|P7|Overall Study|Lack of Qualifying Event|3
7839820|NCT00246337|27211603|P6|Overall Study|Lack of Qualifying Event|3
7839821|NCT00246337|27211604|P5|Overall Study|Lack of Qualifying Event|1
7839822|NCT00246337|27211605|P4|Overall Study|Lack of Qualifying Event|1
7839823|NCT00246337|27211606|P3|Overall Study|Lack of Qualifying Event|1
7839824|NCT00246337|27211607|P2|Overall Study|Lack of Qualifying Event|2
7839825|NCT00246337|27211608|P1|Overall Study|Lack of Qualifying Event|8
7839826|NCT00246337|27211600|P9|Overall Study|Withdrawal by Subject|0
7839827|NCT00246337|27211601|P8|Overall Study|Withdrawal by Subject|1
7839828|NCT00246337|27211602|P7|Overall Study|Withdrawal by Subject|1
7839829|NCT00246337|27211603|P6|Overall Study|Withdrawal by Subject|0
7839830|NCT00246337|27211604|P5|Overall Study|Withdrawal by Subject|0
7839831|NCT00246337|27211605|P4|Overall Study|Withdrawal by Subject|0
7839832|NCT00246337|27211606|P3|Overall Study|Withdrawal by Subject|0
7839833|NCT00246337|27211607|P2|Overall Study|Withdrawal by Subject|0
7839834|NCT00246337|27211608|P1|Overall Study|Withdrawal by Subject|2
7839835|NCT00246337|27211600|P9|Overall Study|Protocol Violation|0
7839836|NCT00246337|27211601|P8|Overall Study|Protocol Violation|1
7839837|NCT00246337|27211602|P7|Overall Study|Protocol Violation|1
7839838|NCT00246337|27211603|P6|Overall Study|Protocol Violation|0
7839839|NCT00246337|27211604|P5|Overall Study|Protocol Violation|1
7839840|NCT00246337|27211605|P4|Overall Study|Protocol Violation|0
7839841|NCT00246337|27211606|P3|Overall Study|Protocol Violation|0
7839842|NCT00246337|27211607|P2|Overall Study|Protocol Violation|0
7839843|NCT00246337|27211608|P1|Overall Study|Protocol Violation|1
7839844|NCT00246337|27211600|P9|Overall Study|Lost to Follow-up|0
7839845|NCT00246337|27211601|P8|Overall Study|Lost to Follow-up|2
7839846|NCT00246337|27211602|P7|Overall Study|Lost to Follow-up|1
7839847|NCT00246337|27211603|P6|Overall Study|Lost to Follow-up|2
7839848|NCT00246337|27211604|P5|Overall Study|Lost to Follow-up|2
7839849|NCT00246337|27211605|P4|Overall Study|Lost to Follow-up|0
7839850|NCT00246337|27211606|P3|Overall Study|Lost to Follow-up|0
7839851|NCT00246337|27211607|P2|Overall Study|Lost to Follow-up|0
7839852|NCT00246337|27211608|P1|Overall Study|Lost to Follow-up|3
7839853|NCT00246324|27211655|P1|Overall Study|Withdrawal by Subject|1
7839854|NCT00246259|27211662|P2|Overall Study|randomly assigned, not eligible for ITT|6
7839855|NCT00246259|27211663|P1|Overall Study|randomly assigned, not eligible for ITT|2
7839856|NCT00246259|27211662|P2|Overall Study|Withdrawal by Subject|1
7839857|NCT00246259|27211663|P1|Overall Study|Withdrawal by Subject|5
7839858|NCT00246259|27211662|P2|Overall Study|Lost to Follow-up|4
7839859|NCT00246259|27211663|P1|Overall Study|Lost to Follow-up|3
7839860|NCT00246259|27211662|P2|Overall Study|Adverse Event|0
7839861|NCT00246259|27211663|P1|Overall Study|Adverse Event|5
7839862|NCT00246259|27211662|P2|Overall Study|Investigator withdrew participant|0
7839863|NCT00246259|27211663|P1|Overall Study|Investigator withdrew participant|2
7839864|NCT00246259|27211662|P2|Overall Study|Lack of Efficacy|2
7839865|NCT00246259|27211663|P1|Overall Study|Lack of Efficacy|2
7839866|NCT00246259|27211662|P2|Overall Study|Participant non-compliant|9
7839867|NCT00246259|27211663|P1|Overall Study|Participant non-compliant|4
7839868|NCT00246259|27211662|P2|Overall Study|Not stable by Week 18|1
7839869|NCT00246259|27211663|P1|Overall Study|Not stable by Week 18|2
7839870|NCT00246259|27211662|P2|Overall Study|Other|3
7839871|NCT00246259|27211663|P1|Overall Study|Other|3
7839872|NCT00246129|27211699|P2|Overall Study|grafts failed|1
7839873|NCT00246129|27211700|P1|Overall Study|grafts failed|3
7839874|NCT00246129|27211699|P2|Overall Study|suffered primary non-function|0
7839875|NCT00246129|27211700|P1|Overall Study|suffered primary non-function|1
7839876|NCT00246129|27211699|P2|Overall Study|Death|1
7839877|NCT00246129|27211700|P1|Overall Study|Death|2
7839878|NCT00246129|27211699|P2|Overall Study|Lost to Follow-up|0
7839879|NCT00246129|27211700|P1|Overall Study|Lost to Follow-up|1
7839880|NCT00246090|27211722|P1|Overall Study|Not Otherwise Specified|10
7839881|NCT00246090|27211722|P1|Overall Study|Physician Decision|11
7839882|NCT00246090|27211722|P1|Overall Study|Clinical Progression|30
7839883|NCT00246090|27211722|P1|Overall Study|Progressive Disease|212
7839884|NCT00246090|27211722|P1|Overall Study|Withdrawal by Subject|7
7839885|NCT00246090|27211722|P1|Overall Study|Adverse Event|25
7839886|NCT00246025|27211731|P4|Overall Study|unsuitable medical history was found|1
7839887|NCT00246025|27211732|P3|Overall Study|unsuitable medical history was found|0
7839888|NCT00246025|27211733|P2|Overall Study|unsuitable medical history was found|0
7839889|NCT00246025|27211734|P1|Overall Study|unsuitable medical history was found|0
7839890|NCT00246025|27211731|P4|Overall Study|Withdrawal by Subject|2
7839891|NCT00246025|27211732|P3|Overall Study|Withdrawal by Subject|1
7839892|NCT00246025|27211733|P2|Overall Study|Withdrawal by Subject|0
7839893|NCT00246025|27211734|P1|Overall Study|Withdrawal by Subject|3
7839894|NCT00246025|27211731|P4|Overall Study|Adverse Event|10
7839895|NCT00246025|27211732|P3|Overall Study|Adverse Event|9
7839896|NCT00246025|27211733|P2|Overall Study|Adverse Event|9
7839897|NCT00246025|27211734|P1|Overall Study|Adverse Event|7
7839898|NCT00246012|27211793|P9|Overall Study|Randomly assigned but not treated|0
7839899|NCT00246012|27211794|P8|Overall Study|Randomly assigned but not treated|0
7839900|NCT00246012|27211795|P7|Overall Study|Randomly assigned but not treated|1
7839901|NCT00246012|27211796|P6|Overall Study|Randomly assigned but not treated|1
7839902|NCT00246012|27211797|P5|Overall Study|Randomly assigned but not treated|0
7839903|NCT00246012|27211798|P4|Overall Study|Randomly assigned but not treated|0
7839904|NCT00246012|27211799|P3|Overall Study|Randomly assigned but not treated|0
7839905|NCT00246012|27211800|P2|Overall Study|Randomly assigned but not treated|0
7839906|NCT00246012|27211801|P1|Overall Study|Randomly assigned but not treated|0
7839907|NCT00246012|27211793|P9|Overall Study|Other|0
7839908|NCT00246012|27211794|P8|Overall Study|Other|1
7839909|NCT00246012|27211795|P7|Overall Study|Other|0
7839910|NCT00246012|27211796|P6|Overall Study|Other|0
7839911|NCT00246012|27211797|P5|Overall Study|Other|0
7839912|NCT00246012|27211798|P4|Overall Study|Other|0
7839913|NCT00246012|27211799|P3|Overall Study|Other|0
7839914|NCT00246012|27211800|P2|Overall Study|Other|0
7839915|NCT00246012|27211801|P1|Overall Study|Other|0
7839916|NCT00246012|27211793|P9|Overall Study|Disease progression|26
7839917|NCT00246012|27211794|P8|Overall Study|Disease progression|27
7839918|NCT00246012|27211795|P7|Overall Study|Disease progression|30
7839919|NCT00246012|27211796|P6|Overall Study|Disease progression|25
7839920|NCT00246012|27211797|P5|Overall Study|Disease progression|3
7839921|NCT00246012|27211798|P4|Overall Study|Disease progression|3
7839922|NCT00246012|27211799|P3|Overall Study|Disease progression|2
7839923|NCT00246012|27211800|P2|Overall Study|Disease progression|1
7839924|NCT00246012|27211801|P1|Overall Study|Disease progression|3
7839925|NCT00246012|27211793|P9|Overall Study|Withdrawal by Subject|0
7839926|NCT00246012|27211794|P8|Overall Study|Withdrawal by Subject|0
7839927|NCT00246012|27211795|P7|Overall Study|Withdrawal by Subject|0
7839928|NCT00246012|27211796|P6|Overall Study|Withdrawal by Subject|1
7839929|NCT00246012|27211797|P5|Overall Study|Withdrawal by Subject|0
7839930|NCT00246012|27211798|P4|Overall Study|Withdrawal by Subject|0
7839931|NCT00246012|27211799|P3|Overall Study|Withdrawal by Subject|0
7839932|NCT00246012|27211800|P2|Overall Study|Withdrawal by Subject|0
7839933|NCT00246012|27211801|P1|Overall Study|Withdrawal by Subject|0
7839934|NCT00246012|27211793|P9|Overall Study|Adverse Event|2
7839935|NCT00246012|27211794|P8|Overall Study|Adverse Event|0
7839936|NCT00246012|27211795|P7|Overall Study|Adverse Event|0
7839937|NCT00246012|27211796|P6|Overall Study|Adverse Event|1
7839938|NCT00246012|27211797|P5|Overall Study|Adverse Event|0
7839939|NCT00246012|27211798|P4|Overall Study|Adverse Event|0
7839940|NCT00246012|27211799|P3|Overall Study|Adverse Event|0
7839941|NCT00246012|27211800|P2|Overall Study|Adverse Event|0
7839942|NCT00246012|27211801|P1|Overall Study|Adverse Event|0
7839943|NCT00245960|27211896|P2|Overall Study|Lack of Efficacy|6
7839944|NCT00245960|27211897|P1|Overall Study|Lack of Efficacy|4
7839945|NCT00245960|27211896|P2|Overall Study|Withdrawal by Subject|7
7839946|NCT00245960|27211897|P1|Overall Study|Withdrawal by Subject|5
7839947|NCT00245960|27211896|P2|Overall Study|Protocol Violation|3
7839948|NCT00245960|27211897|P1|Overall Study|Protocol Violation|4
7839949|NCT00245960|27211896|P2|Overall Study|Lost to Follow-up|2
7839950|NCT00245960|27211897|P1|Overall Study|Lost to Follow-up|2
7839951|NCT00245960|27211896|P2|Overall Study|Adverse Event|10
7839952|NCT00245960|27211897|P1|Overall Study|Adverse Event|14
7839953|NCT00245856|27211905|P2|Period Two|Withdrawal by Subject|1
7839954|NCT00245856|27211906|P1|Period Two|Withdrawal by Subject|0
7839955|NCT00245765|27211916|P3|Overall Study|Other|4
7839956|NCT00245765|27211917|P2|Overall Study|Other|4
7839957|NCT00245765|27211918|P1|Overall Study|Other|13
7839958|NCT00245765|27211916|P3|Overall Study|Other reason|1
7839959|NCT00245765|27211917|P2|Overall Study|Other reason|0
7839960|NCT00245765|27211918|P1|Overall Study|Other reason|2
7839961|NCT00245765|27211916|P3|Overall Study|Withdrawal by Subject|3
7839962|NCT00245765|27211917|P2|Overall Study|Withdrawal by Subject|0
7839963|NCT00245765|27211918|P1|Overall Study|Withdrawal by Subject|1
7839964|NCT00245765|27211916|P3|Overall Study|Lost to Follow-up|0
7839965|NCT00245765|27211917|P2|Overall Study|Lost to Follow-up|2
7839966|NCT00245765|27211918|P1|Overall Study|Lost to Follow-up|1
7839967|NCT00245765|27211916|P3|Overall Study|Lack of Efficacy|0
7839968|NCT00245765|27211917|P2|Overall Study|Lack of Efficacy|7
7839969|NCT00245765|27211918|P1|Overall Study|Lack of Efficacy|14
7839970|NCT00245765|27211916|P3|Overall Study|Adverse Event|0
7839971|NCT00245765|27211917|P2|Overall Study|Adverse Event|1
7839972|NCT00245765|27211918|P1|Overall Study|Adverse Event|1
7839973|NCT00245583|27211967|P2|Overall Study|Withdrawal by Subject|3
7839974|NCT00245583|27211968|P1|Overall Study|Withdrawal by Subject|2
7839975|NCT00245583|27211967|P2|Overall Study|Lack of Efficacy|0
7839976|NCT00245583|27211968|P1|Overall Study|Lack of Efficacy|1
7839977|NCT00245583|27211967|P2|Overall Study|Adverse Event|1
7839978|NCT00245583|27211968|P1|Overall Study|Adverse Event|2
7839979|NCT00245583|27211967|P2|Overall Study|Lost to Follow-up|5
7839980|NCT00245583|27211968|P1|Overall Study|Lost to Follow-up|1
7839981|NCT00245570|27211988|P6|Washout Between Periods III and IV|Adverse Event|0
7839982|NCT00245570|27211989|P5|Washout Between Periods III and IV|Adverse Event|0
7839983|NCT00245570|27211990|P4|Washout Between Periods III and IV|Adverse Event|0
7839984|NCT00245570|27211991|P3|Washout Between Periods III and IV|Adverse Event|0
7839985|NCT00245570|27211992|P2|Washout Between Periods III and IV|Adverse Event|1
7839986|NCT00245570|27211993|P1|Washout Between Periods III and IV|Adverse Event|0
7839987|NCT00245466|27212127|P3|Overall Study|Administrative reasons|0
7839988|NCT00245466|27212128|P2|Overall Study|Administrative reasons|1
7839989|NCT00245466|27212129|P1|Overall Study|Administrative reasons|0
7839990|NCT00245466|27212127|P3|Overall Study|Death|0
7839991|NCT00245466|27212128|P2|Overall Study|Death|2
7839992|NCT00245466|27212129|P1|Overall Study|Death|0
7839993|NCT00245466|27212127|P3|Overall Study|Protocol Violation|2
7839994|NCT00245466|27212128|P2|Overall Study|Protocol Violation|2
7839995|NCT00245466|27212129|P1|Overall Study|Protocol Violation|1
7839996|NCT00245466|27212127|P3|Overall Study|Disease progression|1
7839997|NCT00245466|27212128|P2|Overall Study|Disease progression|3
7839998|NCT00245466|27212129|P1|Overall Study|Disease progression|0
7839999|NCT00245466|27212127|P3|Overall Study|Lost to Follow-up|0
7840000|NCT00245466|27212128|P2|Overall Study|Lost to Follow-up|0
7840001|NCT00245466|27212129|P1|Overall Study|Lost to Follow-up|3
7840002|NCT00245466|27212127|P3|Overall Study|Withdrawal by Subject|1
7840003|NCT00245466|27212128|P2|Overall Study|Withdrawal by Subject|2
7840004|NCT00245466|27212129|P1|Overall Study|Withdrawal by Subject|2
7840005|NCT00245466|27212127|P3|Overall Study|Insufficient PSA and testosterone suppr|3
7840006|NCT00245466|27212128|P2|Overall Study|Insufficient PSA and testosterone suppr|0
7840007|NCT00245466|27212129|P1|Overall Study|Insufficient PSA and testosterone suppr|0
7840008|NCT00245466|27212127|P3|Overall Study|Insufficient testosterone suppr|21
7840009|NCT00245466|27212128|P2|Overall Study|Insufficient testosterone suppr|12
7840010|NCT00245466|27212129|P1|Overall Study|Insufficient testosterone suppr|12
7840011|NCT00245466|27212127|P3|Overall Study|Low prostate specific antigen suppr|5
7840012|NCT00245466|27212128|P2|Overall Study|Low prostate specific antigen suppr|14
7840013|NCT00245466|27212129|P1|Overall Study|Low prostate specific antigen suppr|16
7840014|NCT00245466|27212127|P3|Overall Study|Adverse Event|4
7840015|NCT00245466|27212128|P2|Overall Study|Adverse Event|8
7840016|NCT00245466|27212129|P1|Overall Study|Adverse Event|2
7840017|NCT00245102|27212172|P6|Overall Study|Clinical progression|0
7840018|NCT00245102|27212173|P5|Overall Study|Clinical progression|0
7840019|NCT00245102|27212174|P4|Overall Study|Clinical progression|0
7840020|NCT00245102|27212175|P3|Overall Study|Clinical progression|0
7840021|NCT00245102|27212176|P2|Overall Study|Clinical progression|0
7840022|NCT00245102|27212177|P1|Overall Study|Clinical progression|1
7840023|NCT00245102|27212172|P6|Overall Study|Participant needed surgery|0
7840024|NCT00245102|27212173|P5|Overall Study|Participant needed surgery|0
7840025|NCT00245102|27212174|P4|Overall Study|Participant needed surgery|0
7840026|NCT00245102|27212175|P3|Overall Study|Participant needed surgery|1
7840027|NCT00245102|27212176|P2|Overall Study|Participant needed surgery|0
7840028|NCT00245102|27212177|P1|Overall Study|Participant needed surgery|0
7840029|NCT00245102|27212172|P6|Overall Study|Decline in performance|2
7840030|NCT00245102|27212173|P5|Overall Study|Decline in performance|0
7840031|NCT00245102|27212174|P4|Overall Study|Decline in performance|1
7840032|NCT00245102|27212175|P3|Overall Study|Decline in performance|0
7840033|NCT00245102|27212176|P2|Overall Study|Decline in performance|2
7840034|NCT00245102|27212177|P1|Overall Study|Decline in performance|0
7840035|NCT00245102|27212172|P6|Overall Study|Adverse Event|2
7840036|NCT00245102|27212173|P5|Overall Study|Adverse Event|0
7840037|NCT00245102|27212174|P4|Overall Study|Adverse Event|1
7840038|NCT00245102|27212175|P3|Overall Study|Adverse Event|5
7840039|NCT00245102|27212176|P2|Overall Study|Adverse Event|2
7840040|NCT00245102|27212177|P1|Overall Study|Adverse Event|4
7840041|NCT00245102|27212172|P6|Overall Study|Death|0
7840042|NCT00245102|27212173|P5|Overall Study|Death|0
7840043|NCT00245102|27212174|P4|Overall Study|Death|1
7840044|NCT00245102|27212175|P3|Overall Study|Death|0
7840045|NCT00245102|27212176|P2|Overall Study|Death|0
7840046|NCT00245102|27212177|P1|Overall Study|Death|0
7840047|NCT00245102|27212172|P6|Overall Study|Protocol Violation|0
7840048|NCT00245102|27212173|P5|Overall Study|Protocol Violation|0
7840049|NCT00245102|27212174|P4|Overall Study|Protocol Violation|0
7840050|NCT00245102|27212175|P3|Overall Study|Protocol Violation|0
7840051|NCT00245102|27212176|P2|Overall Study|Protocol Violation|0
7840052|NCT00245102|27212177|P1|Overall Study|Protocol Violation|1
7840053|NCT00245102|27212172|P6|Overall Study|Not Treated|0
7840054|NCT00245102|27212173|P5|Overall Study|Not Treated|0
7840055|NCT00245102|27212174|P4|Overall Study|Not Treated|0
7840056|NCT00245102|27212175|P3|Overall Study|Not Treated|1
7840057|NCT00245102|27212176|P2|Overall Study|Not Treated|0
7840058|NCT00245102|27212177|P1|Overall Study|Not Treated|1
7840059|NCT00245063|27212193|P2|Overall Study|Death|0
7840060|NCT00245063|27212194|P1|Overall Study|Death|1
7840061|NCT00245063|27212193|P2|Overall Study|Adverse Event|5
7840062|NCT00245063|27212194|P1|Overall Study|Adverse Event|6
7840063|NCT00245050|27212202|P2|Overall Study|Adverse Event|2
7840064|NCT00245050|27212203|P1|Overall Study|Adverse Event|3
7840065|NCT00245037|27212211|P1|Overall Study|Death|17
7840066|NCT00245011|27212221|P1|Overall Study|Lack of Efficacy|1
7840067|NCT00244933|27212238|P1|Overall Study|Not response evaluable|2
7840068|NCT00244881|27212242|P1|Overall Study|Withdrawal by Subject|3
7840069|NCT00244855|27212250|P2|Overall Study|Withdrawal by Subject|1
7840070|NCT00244855|27212251|P1|Overall Study|Withdrawal by Subject|0
7840071|NCT00244764|27212259|P1|Overall Study|Developed Secondary Malignancy|1
7840072|NCT00244764|27212259|P1|Overall Study|Sponsor Terminated Study|2
7840073|NCT00244764|27212259|P1|Overall Study|Primary Investigator Discretion|2
7840074|NCT00244764|27212259|P1|Overall Study|Participant was Hospitalized until Death|1
7840075|NCT00244764|27212259|P1|Overall Study|Declining Performance Status|1
7840076|NCT00244764|27212259|P1|Overall Study|Off Study Medication for >21 Days|1
7840077|NCT00244764|27212259|P1|Overall Study|Death|1
7840078|NCT00244764|27212259|P1|Overall Study|Protocol Violation|2
7840079|NCT00244764|27212259|P1|Overall Study|Disease Progression|13
7840080|NCT00244764|27212259|P1|Overall Study|Withdrawal by Subject|12
7840081|NCT00244764|27212259|P1|Overall Study|Lost to Follow-up|23
7840082|NCT00244764|27212259|P1|Overall Study|Adverse Event|37
7840083|NCT00244751|27212269|P3|Overall Study|Participant randomized by mistake|1
7840084|NCT00244751|27212270|P2|Overall Study|Participant randomized by mistake|0
7840085|NCT00244751|27212271|P1|Overall Study|Participant randomized by mistake|0
7840086|NCT00244751|27212269|P3|Overall Study|Safety reasons|0
7840087|NCT00244751|27212270|P2|Overall Study|Safety reasons|1
7840088|NCT00244751|27212271|P1|Overall Study|Safety reasons|0
7840089|NCT00244751|27212269|P3|Overall Study|Lack of compliance with protocol|0
7840090|NCT00244751|27212270|P2|Overall Study|Lack of compliance with protocol|1
7840091|NCT00244751|27212271|P1|Overall Study|Lack of compliance with protocol|0
7840092|NCT00244751|27212269|P3|Overall Study|Elevated liver enzymes|0
7840093|NCT00244751|27212270|P2|Overall Study|Elevated liver enzymes|0
7840094|NCT00244751|27212271|P1|Overall Study|Elevated liver enzymes|1
7840095|NCT00244751|27212269|P3|Overall Study|Withdrawal by Subject|3
7840096|NCT00244751|27212270|P2|Overall Study|Withdrawal by Subject|5
7840097|NCT00244751|27212271|P1|Overall Study|Withdrawal by Subject|7
7840098|NCT00244751|27212269|P3|Overall Study|Protocol Violation|1
7840099|NCT00244751|27212270|P2|Overall Study|Protocol Violation|0
7840100|NCT00244751|27212271|P1|Overall Study|Protocol Violation|1
7840101|NCT00244751|27212269|P3|Overall Study|Lost to Follow-up|0
7840102|NCT00244751|27212270|P2|Overall Study|Lost to Follow-up|1
7840103|NCT00244751|27212271|P1|Overall Study|Lost to Follow-up|0
7840104|NCT00244751|27212269|P3|Overall Study|Adverse Event|5
7840105|NCT00244751|27212270|P2|Overall Study|Adverse Event|7
7840106|NCT00244751|27212271|P1|Overall Study|Adverse Event|7
7840107|NCT00244725|27212372|P4|Overall Study|Failed to follow-up|1
7840108|NCT00244725|27212373|P3|Overall Study|Failed to follow-up|1
7840109|NCT00244725|27212374|P2|Overall Study|Failed to follow-up|0
7840110|NCT00244725|27212375|P1|Overall Study|Failed to follow-up|0
7840111|NCT00244725|27212372|P4|Overall Study|Vomit|0
7840112|NCT00244725|27212373|P3|Overall Study|Vomit|1
7840113|NCT00244725|27212374|P2|Overall Study|Vomit|0
7840114|NCT00244725|27212375|P1|Overall Study|Vomit|0
7840115|NCT00244725|27212372|P4|Overall Study|Administrative reason|0
7840116|NCT00244725|27212373|P3|Overall Study|Administrative reason|1
7840117|NCT00244725|27212374|P2|Overall Study|Administrative reason|0
7840118|NCT00244725|27212375|P1|Overall Study|Administrative reason|0
7840119|NCT00244725|27212372|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
7840120|NCT00244725|27212373|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
7840121|NCT00244725|27212374|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
7840122|NCT00244725|27212375|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
7840123|NCT00244725|27212372|P4|Overall Study|Received prohibited medication|1
7840124|NCT00244725|27212373|P3|Overall Study|Received prohibited medication|0
7840125|NCT00244725|27212374|P2|Overall Study|Received prohibited medication|1
7840126|NCT00244725|27212375|P1|Overall Study|Received prohibited medication|0
7840127|NCT00244725|27212372|P4|Overall Study|Headache|0
7840128|NCT00244725|27212373|P3|Overall Study|Headache|0
7840129|NCT00244725|27212374|P2|Overall Study|Headache|1
7840130|NCT00244725|27212375|P1|Overall Study|Headache|0
7840131|NCT00244725|27212372|P4|Overall Study|Rehab Refused to allow participantion|0
7840132|NCT00244725|27212373|P3|Overall Study|Rehab Refused to allow participantion|0
7840133|NCT00244725|27212374|P2|Overall Study|Rehab Refused to allow participantion|1
7840134|NCT00244725|27212375|P1|Overall Study|Rehab Refused to allow participantion|0
7840135|NCT00244725|27212372|P4|Overall Study|Mediciation Error|0
7840136|NCT00244725|27212373|P3|Overall Study|Mediciation Error|0
7840137|NCT00244725|27212374|P2|Overall Study|Mediciation Error|1
7840138|NCT00244725|27212375|P1|Overall Study|Mediciation Error|0
7840139|NCT00244725|27212372|P4|Overall Study|Sponsor withdrew the participant|1
7840140|NCT00244725|27212373|P3|Overall Study|Sponsor withdrew the participant|0
7840141|NCT00244725|27212374|P2|Overall Study|Sponsor withdrew the participant|0
7840142|NCT00244725|27212375|P1|Overall Study|Sponsor withdrew the participant|1
7840143|NCT00244725|27212372|P4|Overall Study|Liver function test abnormality|1
7840144|NCT00244725|27212373|P3|Overall Study|Liver function test abnormality|0
7840145|NCT00244725|27212374|P2|Overall Study|Liver function test abnormality|0
7840146|NCT00244725|27212375|P1|Overall Study|Liver function test abnormality|2
7840147|NCT00244725|27212372|P4|Overall Study|Withdrwal by participant|1
7840148|NCT00244725|27212373|P3|Overall Study|Withdrwal by participant|0
7840149|NCT00244725|27212374|P2|Overall Study|Withdrwal by participant|0
7840150|NCT00244725|27212375|P1|Overall Study|Withdrwal by participant|1
7840151|NCT00244725|27212372|P4|Overall Study|Adverse Events|4
7840152|NCT00244725|27212373|P3|Overall Study|Adverse Events|4
7840153|NCT00244725|27212374|P2|Overall Study|Adverse Events|1
7840154|NCT00244725|27212375|P1|Overall Study|Adverse Events|3
7840155|NCT00244725|27212372|P4|Overall Study|Physician Decision|2
7840156|NCT00244725|27212373|P3|Overall Study|Physician Decision|1
7840157|NCT00244725|27212374|P2|Overall Study|Physician Decision|0
7840158|NCT00244725|27212375|P1|Overall Study|Physician Decision|3
7840159|NCT00244725|27212372|P4|Overall Study|Not meet treatment eligibility criteria|0
7840160|NCT00244725|27212373|P3|Overall Study|Not meet treatment eligibility criteria|0
7840161|NCT00244725|27212374|P2|Overall Study|Not meet treatment eligibility criteria|2
7840162|NCT00244725|27212375|P1|Overall Study|Not meet treatment eligibility criteria|1
7840163|NCT00244725|27212372|P4|Overall Study|Withdrawal by Subject|8
7840164|NCT00244725|27212373|P3|Overall Study|Withdrawal by Subject|7
7840165|NCT00244725|27212374|P2|Overall Study|Withdrawal by Subject|7
7840166|NCT00244725|27212375|P1|Overall Study|Withdrawal by Subject|9
7840167|NCT00244725|27212372|P4|Overall Study|Lost to Follow-up|2
7840168|NCT00244725|27212373|P3|Overall Study|Lost to Follow-up|9
7840169|NCT00244725|27212374|P2|Overall Study|Lost to Follow-up|4
7840170|NCT00244725|27212375|P1|Overall Study|Lost to Follow-up|3
7840171|NCT00244712|27212431|P2|Overall Study|Protocol Violation, disease progression|11
7840172|NCT00244712|27212432|P1|Overall Study|Protocol Violation, disease progression|13
7840173|NCT00244712|27212431|P2|Overall Study|Withdrawal by Subject|23
7840174|NCT00244712|27212432|P1|Overall Study|Withdrawal by Subject|13
7840175|NCT00244712|27212431|P2|Overall Study|Lost to Follow-up|52
7840176|NCT00244712|27212432|P1|Overall Study|Lost to Follow-up|45
7840177|NCT00244712|27212431|P2|Overall Study|Lack of Compliance|11
7840178|NCT00244712|27212432|P1|Overall Study|Lack of Compliance|10
7840179|NCT00244712|27212431|P2|Overall Study|Protocol-Defined Virologic Failure|6
7840180|NCT00244712|27212432|P1|Overall Study|Protocol-Defined Virologic Failure|8
7840181|NCT00244712|27212431|P2|Overall Study|Adverse Event|21
7840182|NCT00244712|27212432|P1|Overall Study|Adverse Event|20
7840183|NCT00244621|27212467|P3|Open-label Treatment Period|Moved abroad|1
7840184|NCT00244621|27212468|P2|Open-label Treatment Period|Moved abroad|0
7840185|NCT00244621|27212469|P1|Open-label Treatment Period|Moved abroad|0
7840186|NCT00244621|27212467|P3|Open-label Treatment Period|Adverse Event|1
7840187|NCT00244621|27212468|P2|Open-label Treatment Period|Adverse Event|0
7840188|NCT00244621|27212469|P1|Open-label Treatment Period|Adverse Event|0
7840189|NCT00244621|27212467|P3|Open-label Treatment Period|Withdrawal by Subject|0
7840190|NCT00244621|27212468|P2|Open-label Treatment Period|Withdrawal by Subject|0
7840191|NCT00244621|27212469|P1|Open-label Treatment Period|Withdrawal by Subject|1
7840192|NCT00244621|27212467|P3|Open-label Treatment Period|Lost to Follow-up|0
7840193|NCT00244621|27212468|P2|Open-label Treatment Period|Lost to Follow-up|1
7840194|NCT00244621|27212469|P1|Open-label Treatment Period|Lost to Follow-up|0
7840195|NCT00244621|27212467|P3|Double-blind Treatment Period|Multiple Reasons|1
7840196|NCT00244621|27212468|P2|Double-blind Treatment Period|Multiple Reasons|1
7840197|NCT00244621|27212469|P1|Double-blind Treatment Period|Multiple Reasons|2
7840198|NCT00244621|27212467|P3|Double-blind Treatment Period|Lack of Efficacy|0
7840199|NCT00244621|27212468|P2|Double-blind Treatment Period|Lack of Efficacy|1
7840200|NCT00244621|27212469|P1|Double-blind Treatment Period|Lack of Efficacy|0
7840201|NCT00244621|27212467|P3|Double-blind Treatment Period|Withdrawal by Subject|0
7840202|NCT00244621|27212468|P2|Double-blind Treatment Period|Withdrawal by Subject|1
7840203|NCT00244621|27212469|P1|Double-blind Treatment Period|Withdrawal by Subject|0
7840204|NCT00244621|27212467|P3|Double-blind Treatment Period|Lost to Follow-up|1
7840205|NCT00244621|27212468|P2|Double-blind Treatment Period|Lost to Follow-up|0
7840206|NCT00244621|27212469|P1|Double-blind Treatment Period|Lost to Follow-up|0
7840207|NCT00244374|27212486|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7840208|NCT00244374|27212487|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7840209|NCT00244374|27212488|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7840210|NCT00244374|27212489|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7840211|NCT00244374|27212490|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
7840212|NCT00244374|27212486|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7840213|NCT00244374|27212487|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7840214|NCT00244374|27212488|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7840215|NCT00244374|27212489|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7840216|NCT00244374|27212490|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
7840217|NCT00244374|27212486|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7840218|NCT00244374|27212487|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7840219|NCT00244374|27212488|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7840220|NCT00244374|27212489|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7840221|NCT00244374|27212490|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
7840222|NCT00244374|27212486|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7840223|NCT00244374|27212487|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7840224|NCT00244374|27212488|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7840225|NCT00244374|27212489|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7840226|NCT00244374|27212490|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
7840227|NCT00244374|27212486|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7840228|NCT00244374|27212487|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7840229|NCT00244374|27212488|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7840230|NCT00244374|27212489|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7840231|NCT00244374|27212490|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
7840232|NCT00244374|27212486|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7840233|NCT00244374|27212487|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7840234|NCT00244374|27212488|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7840235|NCT00244374|27212489|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7840236|NCT00244374|27212490|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
7840237|NCT00244374|27212486|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7840238|NCT00244374|27212487|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7840239|NCT00244374|27212488|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7840240|NCT00244374|27212489|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7840241|NCT00244374|27212490|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
7840242|NCT00244374|27212486|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7840243|NCT00244374|27212487|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7840244|NCT00244374|27212488|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7840245|NCT00244374|27212489|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7840246|NCT00244374|27212490|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
7840247|NCT00244374|27212486|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7840248|NCT00244374|27212487|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7840249|NCT00244374|27212488|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7840250|NCT00244374|27212489|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7840251|NCT00244374|27212490|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
7840252|NCT00243932|27212546|P3|Stage 1: Dose Selection|Lost to Follow-up|0
7840253|NCT00243932|27212547|P2|Stage 1: Dose Selection|Lost to Follow-up|0
7840254|NCT00243932|27212548|P1|Stage 1: Dose Selection|Lost to Follow-up|2
7840255|NCT00243919|27212559|P3|Overall Study|Physician Decision|0
7840256|NCT00243919|27212560|P2|Overall Study|Physician Decision|1
7840257|NCT00243919|27212561|P1|Overall Study|Physician Decision|1
7840258|NCT00243919|27212559|P3|Overall Study|Administrative Error|0
7840259|NCT00243919|27212560|P2|Overall Study|Administrative Error|0
7840260|NCT00243919|27212561|P1|Overall Study|Administrative Error|1
7840261|NCT00243919|27212559|P3|Overall Study|Lost to Follow-up|3
7840262|NCT00243919|27212560|P2|Overall Study|Lost to Follow-up|7
7840263|NCT00243919|27212561|P1|Overall Study|Lost to Follow-up|6
7840264|NCT00243919|27212559|P3|Overall Study|Withdrawal by Subject|2
7840265|NCT00243919|27212560|P2|Overall Study|Withdrawal by Subject|6
7840266|NCT00243919|27212561|P1|Overall Study|Withdrawal by Subject|6
7840267|NCT00243919|27212559|P3|Overall Study|Death|6
7840268|NCT00243919|27212560|P2|Overall Study|Death|4
7840269|NCT00243919|27212561|P1|Overall Study|Death|3
7840270|NCT00243841|27212605|P6|Overall Study|Physician Decision|2
7840271|NCT00243841|27212606|P5|Overall Study|Physician Decision|0
7840272|NCT00243841|27212607|P4|Overall Study|Physician Decision|0
7840273|NCT00243841|27212608|P3|Overall Study|Physician Decision|1
7840274|NCT00243841|27212609|P2|Overall Study|Physician Decision|0
7840275|NCT00243841|27212610|P1|Overall Study|Physician Decision|0
7840276|NCT00243659|27212632|P2|Overall Study|Protocol Violation|2
7840277|NCT00243659|27212633|P1|Overall Study|Protocol Violation|1
7840278|NCT00243659|27212632|P2|Overall Study|Withdrawal by Subject|1
7840279|NCT00243659|27212633|P1|Overall Study|Withdrawal by Subject|1
7840280|NCT00243503|27212641|P1|Overall Study|Other|1
7840281|NCT00243503|27212641|P1|Overall Study|Death|1
7840282|NCT00243503|27212641|P1|Overall Study|Lack of Efficacy|44
7840283|NCT00243503|27212641|P1|Overall Study|Withdrawal by Subject|1
7840284|NCT00243503|27212641|P1|Overall Study|Adverse Event|11
7840285|NCT00243412|27212658|P2|Overall Study|Other|1
7840286|NCT00243412|27212659|P1|Overall Study|Other|1
7840287|NCT00243412|27212658|P2|Overall Study|Withdrawal by Subject|5
7840288|NCT00243412|27212659|P1|Overall Study|Withdrawal by Subject|4
7840289|NCT00243412|27212658|P2|Overall Study|Physician Decision|1
7840290|NCT00243412|27212659|P1|Overall Study|Physician Decision|1
7840291|NCT00243412|27212658|P2|Overall Study|Lost to Follow-up|1
7840292|NCT00243412|27212659|P1|Overall Study|Lost to Follow-up|0
7840293|NCT00243412|27212658|P2|Overall Study|Adverse Event|2
7840294|NCT00243412|27212659|P1|Overall Study|Adverse Event|4
7840295|NCT00243412|27212658|P2|Overall Study|Death|1
7840296|NCT00243412|27212659|P1|Overall Study|Death|0
7840297|NCT00243386|27212685|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
7840298|NCT00243386|27212686|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
7840299|NCT00243386|27212687|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
7840300|NCT00243386|27212685|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
7840301|NCT00243386|27212686|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
7840302|NCT00243386|27212687|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
7840303|NCT00243386|27212685|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
7840304|NCT00243386|27212686|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
7840305|NCT00243386|27212687|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
7840306|NCT00243386|27212685|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
7840307|NCT00243386|27212686|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
7840308|NCT00243386|27212687|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
7840309|NCT00243386|27212685|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
7840310|NCT00243386|27212686|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
7840311|NCT00243386|27212687|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
7840312|NCT00243386|27212685|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
7840313|NCT00243386|27212686|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
7840314|NCT00243386|27212687|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
7840315|NCT00243386|27212685|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
7840316|NCT00243386|27212686|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
7840317|NCT00243386|27212687|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
7840318|NCT00243386|27212685|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
7840319|NCT00243386|27212686|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
7840320|NCT00243386|27212687|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
7840321|NCT00243347|27212752|P1|Overall Study|Condition worsened|7
7840322|NCT00243347|27212752|P1|Overall Study|Withdrawal by Subject|5
7840323|NCT00243347|27212752|P1|Overall Study|Death|1
7840324|NCT00243347|27212752|P1|Overall Study|Adverse Event|2
7840325|NCT00243347|27212752|P1|Overall Study|Lack of Efficacy|4
7840326|NCT00243269|27212761|P4|Overall Study|Lost to Follow-up|3
7840327|NCT00243269|27212762|P3|Overall Study|Lost to Follow-up|1
7840328|NCT00243269|27212763|P2|Overall Study|Lost to Follow-up|0
7840329|NCT00243269|27212764|P1|Overall Study|Lost to Follow-up|1
7840330|NCT00243269|27212761|P4|Overall Study|Protocol Violation|1
7840331|NCT00243269|27212762|P3|Overall Study|Protocol Violation|0
7840332|NCT00243269|27212763|P2|Overall Study|Protocol Violation|1
7840333|NCT00243269|27212764|P1|Overall Study|Protocol Violation|2
7840334|NCT00243230|27212790|P4|Open Label Period|Administrative Reason|63
7840335|NCT00243230|27212791|P3|Open Label Period|Administrative Reason|0
7840336|NCT00243230|27212792|P2|Open Label Period|Administrative Reason|0
7840337|NCT00243230|27212793|P1|Open Label Period|Administrative Reason|0
7840338|NCT00243230|27212790|P4|Open Label Period|Protocol Violation|2
7840339|NCT00243230|27212791|P3|Open Label Period|Protocol Violation|0
7840340|NCT00243230|27212792|P2|Open Label Period|Protocol Violation|0
7840341|NCT00243230|27212793|P1|Open Label Period|Protocol Violation|0
7840342|NCT00243230|27212790|P4|Open Label Period|Withdrawal by Subject|2
7840343|NCT00243230|27212791|P3|Open Label Period|Withdrawal by Subject|0
7840344|NCT00243230|27212792|P2|Open Label Period|Withdrawal by Subject|0
7840345|NCT00243230|27212793|P1|Open Label Period|Withdrawal by Subject|0
7840346|NCT00243230|27212790|P4|Open Label Period|Lost to Follow-up|2
7840347|NCT00243230|27212791|P3|Open Label Period|Lost to Follow-up|0
7840348|NCT00243230|27212792|P2|Open Label Period|Lost to Follow-up|0
7840349|NCT00243230|27212793|P1|Open Label Period|Lost to Follow-up|0
7840350|NCT00243230|27212790|P4|Open Label Period|Progressive Disease (AIDS-Event)|1
7840351|NCT00243230|27212791|P3|Open Label Period|Progressive Disease (AIDS-Event)|0
7840352|NCT00243230|27212792|P2|Open Label Period|Progressive Disease (AIDS-Event)|0
7840353|NCT00243230|27212793|P1|Open Label Period|Progressive Disease (AIDS-Event)|0
7840354|NCT00243230|27212790|P4|Open Label Period|Treatment Failure - Virologic Failure|13
7840355|NCT00243230|27212791|P3|Open Label Period|Treatment Failure - Virologic Failure|0
7840356|NCT00243230|27212792|P2|Open Label Period|Treatment Failure - Virologic Failure|0
7840357|NCT00243230|27212793|P1|Open Label Period|Treatment Failure - Virologic Failure|0
7840358|NCT00243230|27212790|P4|Open Label Period|Adverse Event|2
7840359|NCT00243230|27212791|P3|Open Label Period|Adverse Event|0
7840360|NCT00243230|27212792|P2|Open Label Period|Adverse Event|0
7840361|NCT00243230|27212793|P1|Open Label Period|Adverse Event|0
7840362|NCT00243230|27212790|P4|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
7840363|NCT00243230|27212791|P3|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
7840364|NCT00243230|27212792|P2|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
7840365|NCT00243230|27212793|P1|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
7840366|NCT00243230|27212790|P4|Double-Blind Period|Randomized but Not Treated|0
7840367|NCT00243230|27212791|P3|Double-Blind Period|Randomized but Not Treated|2
7840368|NCT00243230|27212792|P2|Double-Blind Period|Randomized but Not Treated|0
7840369|NCT00243230|27212793|P1|Double-Blind Period|Randomized but Not Treated|0
7840370|NCT00243230|27212790|P4|Double-Blind Period|Protocol Violation|0
7840371|NCT00243230|27212791|P3|Double-Blind Period|Protocol Violation|1
7840372|NCT00243230|27212792|P2|Double-Blind Period|Protocol Violation|0
7840373|NCT00243230|27212793|P1|Double-Blind Period|Protocol Violation|0
7840374|NCT00243230|27212790|P4|Double-Blind Period|Withdrawal by Subject|0
7840375|NCT00243230|27212791|P3|Double-Blind Period|Withdrawal by Subject|0
7840376|NCT00243230|27212792|P2|Double-Blind Period|Withdrawal by Subject|0
7840377|NCT00243230|27212793|P1|Double-Blind Period|Withdrawal by Subject|1
7840378|NCT00243230|27212790|P4|Double-Blind Period|Adverse Event|0
7840379|NCT00243230|27212791|P3|Double-Blind Period|Adverse Event|2
7840380|NCT00243230|27212792|P2|Double-Blind Period|Adverse Event|2
7840381|NCT00243230|27212793|P1|Double-Blind Period|Adverse Event|0
7840382|NCT00243074|27212880|P1|Overall Study|Did not receive any treatment|1
7840383|NCT00243074|27212880|P1|Overall Study|not protocol specified|1
7840384|NCT00243074|27212880|P1|Overall Study|Death|2
7840385|NCT00243074|27212880|P1|Overall Study|Lack of Efficacy|36
7840386|NCT00243074|27212880|P1|Overall Study|Withdrawal by Subject|2
7840387|NCT00243074|27212880|P1|Overall Study|Adverse Event|6
7840388|NCT00243074|27212880|P1|Overall Study|Ineligible|6
7840389|NCT00243022|27212906|P2|Overall Study|Difficult Travel Distance|1
7840390|NCT00243022|27212907|P1|Overall Study|Difficult Travel Distance|0
7840391|NCT00243022|27212906|P2|Overall Study|Death|0
7840392|NCT00243022|27212907|P1|Overall Study|Death|1
7840393|NCT00243022|27212906|P2|Overall Study|Withdrawal by Subject|0
7840394|NCT00243022|27212907|P1|Overall Study|Withdrawal by Subject|1
7840395|NCT00242710|27212931|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
7840396|NCT00242710|27212932|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
7840397|NCT00242710|27212933|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
7840398|NCT00242710|27212934|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
7840399|NCT00242710|27212931|P4|Study Extension (up to Year 2)|Protocol Violation|1
7840400|NCT00242710|27212932|P3|Study Extension (up to Year 2)|Protocol Violation|0
7840401|NCT00242710|27212933|P2|Study Extension (up to Year 2)|Protocol Violation|2
7840402|NCT00242710|27212934|P1|Study Extension (up to Year 2)|Protocol Violation|0
7840403|NCT00242710|27212931|P4|Study Extension (up to Year 2)|Other|3
7840404|NCT00242710|27212932|P3|Study Extension (up to Year 2)|Other|4
7840405|NCT00242710|27212933|P2|Study Extension (up to Year 2)|Other|5
7840406|NCT00242710|27212934|P1|Study Extension (up to Year 2)|Other|3
7840407|NCT00242710|27212931|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
7840408|NCT00242710|27212932|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
7840409|NCT00242710|27212933|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
7840410|NCT00242710|27212934|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
7840411|NCT00242710|27212931|P4|Study Extension (up to Year 2)|Death|1
7840412|NCT00242710|27212932|P3|Study Extension (up to Year 2)|Death|0
7840413|NCT00242710|27212933|P2|Study Extension (up to Year 2)|Death|0
7840414|NCT00242710|27212934|P1|Study Extension (up to Year 2)|Death|0
7840415|NCT00242710|27212931|P4|Study Extension (up to Year 2)|Adverse Event|4
7840416|NCT00242710|27212932|P3|Study Extension (up to Year 2)|Adverse Event|2
7840417|NCT00242710|27212933|P2|Study Extension (up to Year 2)|Adverse Event|9
7840418|NCT00242710|27212934|P1|Study Extension (up to Year 2)|Adverse Event|7
7840419|NCT00242710|27212931|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
7840420|NCT00242710|27212932|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
7840421|NCT00242710|27212933|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
7840422|NCT00242710|27212934|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
7840423|NCT00242710|27212931|P4|Period Between Core Study and Extension|Protocol Violation|1
7840424|NCT00242710|27212932|P3|Period Between Core Study and Extension|Protocol Violation|2
7840425|NCT00242710|27212933|P2|Period Between Core Study and Extension|Protocol Violation|0
7840426|NCT00242710|27212934|P1|Period Between Core Study and Extension|Protocol Violation|0
7840427|NCT00242710|27212931|P4|Period Between Core Study and Extension|Extension not Available|7
7840428|NCT00242710|27212932|P3|Period Between Core Study and Extension|Extension not Available|8
7840429|NCT00242710|27212933|P2|Period Between Core Study and Extension|Extension not Available|21
7840430|NCT00242710|27212934|P1|Period Between Core Study and Extension|Extension not Available|17
7840431|NCT00242710|27212931|P4|Period Between Core Study and Extension|Other|11
7840432|NCT00242710|27212932|P3|Period Between Core Study and Extension|Other|9
7840433|NCT00242710|27212933|P2|Period Between Core Study and Extension|Other|24
7840434|NCT00242710|27212934|P1|Period Between Core Study and Extension|Other|24
7840435|NCT00242710|27212931|P4|Period Between Core Study and Extension|Physician Decision|0
7840436|NCT00242710|27212932|P3|Period Between Core Study and Extension|Physician Decision|0
7840437|NCT00242710|27212933|P2|Period Between Core Study and Extension|Physician Decision|1
7840438|NCT00242710|27212934|P1|Period Between Core Study and Extension|Physician Decision|1
7840439|NCT00242710|27212931|P4|Period Between Core Study and Extension|Adverse Event|2
7840440|NCT00242710|27212932|P3|Period Between Core Study and Extension|Adverse Event|5
7840441|NCT00242710|27212933|P2|Period Between Core Study and Extension|Adverse Event|3
7840442|NCT00242710|27212934|P1|Period Between Core Study and Extension|Adverse Event|2
7840443|NCT00242710|27212931|P4|Core Study (up to Year 1)|Randomized but not Treated|2
7840444|NCT00242710|27212932|P3|Core Study (up to Year 1)|Randomized but not Treated|4
7840445|NCT00242710|27212933|P2|Core Study (up to Year 1)|Randomized but not Treated|4
7840446|NCT00242710|27212934|P1|Core Study (up to Year 1)|Randomized but not Treated|12
7840447|NCT00242710|27212931|P4|Core Study (up to Year 1)|Lack of Efficacy|0
7840448|NCT00242710|27212932|P3|Core Study (up to Year 1)|Lack of Efficacy|0
7840449|NCT00242710|27212933|P2|Core Study (up to Year 1)|Lack of Efficacy|0
7840450|NCT00242710|27212934|P1|Core Study (up to Year 1)|Lack of Efficacy|1
7840451|NCT00242710|27212931|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
7840452|NCT00242710|27212932|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
7840453|NCT00242710|27212933|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
7840454|NCT00242710|27212934|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
7840455|NCT00242710|27212931|P4|Core Study (up to Year 1)|Protocol Violation|3
7840456|NCT00242710|27212932|P3|Core Study (up to Year 1)|Protocol Violation|1
7840457|NCT00242710|27212933|P2|Core Study (up to Year 1)|Protocol Violation|9
7840458|NCT00242710|27212934|P1|Core Study (up to Year 1)|Protocol Violation|2
7840459|NCT00242710|27212931|P4|Core Study (up to Year 1)|Other|2
7840460|NCT00242710|27212932|P3|Core Study (up to Year 1)|Other|0
7840461|NCT00242710|27212933|P2|Core Study (up to Year 1)|Other|1
7840462|NCT00242710|27212934|P1|Core Study (up to Year 1)|Other|6
7840463|NCT00242710|27212931|P4|Core Study (up to Year 1)|Lost to Follow-up|3
7840464|NCT00242710|27212932|P3|Core Study (up to Year 1)|Lost to Follow-up|7
7840465|NCT00242710|27212933|P2|Core Study (up to Year 1)|Lost to Follow-up|8
7840466|NCT00242710|27212934|P1|Core Study (up to Year 1)|Lost to Follow-up|8
7840467|NCT00242710|27212931|P4|Core Study (up to Year 1)|Physician Decision|1
7840468|NCT00242710|27212932|P3|Core Study (up to Year 1)|Physician Decision|0
7840469|NCT00242710|27212933|P2|Core Study (up to Year 1)|Physician Decision|1
7840470|NCT00242710|27212934|P1|Core Study (up to Year 1)|Physician Decision|0
7840471|NCT00242710|27212931|P4|Core Study (up to Year 1)|Death|0
7840472|NCT00242710|27212932|P3|Core Study (up to Year 1)|Death|1
7840473|NCT00242710|27212933|P2|Core Study (up to Year 1)|Death|0
7840474|NCT00242710|27212934|P1|Core Study (up to Year 1)|Death|0
7840475|NCT00242710|27212931|P4|Core Study (up to Year 1)|Adverse Event|14
7840476|NCT00242710|27212932|P3|Core Study (up to Year 1)|Adverse Event|23
7840477|NCT00242710|27212933|P2|Core Study (up to Year 1)|Adverse Event|25
7840478|NCT00242710|27212934|P1|Core Study (up to Year 1)|Adverse Event|30
7840479|NCT00242658|27212991|P2|Overall Study|Lost to Follow-up|19
7840480|NCT00242658|27212992|P1|Overall Study|Lost to Follow-up|22
7840481|NCT00242580|27213023|P3|Overall Study|Death|1
7840482|NCT00242580|27213024|P2|Overall Study|Death|2
7840483|NCT00242580|27213025|P1|Overall Study|Death|1
7840484|NCT00242580|27213023|P3|Overall Study|Lost to Follow-up|0
7840485|NCT00242580|27213024|P2|Overall Study|Lost to Follow-up|3
7840486|NCT00242580|27213025|P1|Overall Study|Lost to Follow-up|0
7840487|NCT00242580|27213023|P3|Overall Study|Subject withdrew consent|5
7840488|NCT00242580|27213024|P2|Overall Study|Subject withdrew consent|2
7840489|NCT00242580|27213025|P1|Overall Study|Subject withdrew consent|2
7840490|NCT00242580|27213023|P3|Overall Study|Protocol Violation|1
7840491|NCT00242580|27213024|P2|Overall Study|Protocol Violation|0
7840492|NCT00242580|27213025|P1|Overall Study|Protocol Violation|0
7840493|NCT00242580|27213023|P3|Overall Study|Unsatisfactory therapeutic effect|5
7840494|NCT00242580|27213024|P2|Overall Study|Unsatisfactory therapeutic effect|5
7840495|NCT00242580|27213025|P1|Overall Study|Unsatisfactory therapeutic effect|4
7840496|NCT00242580|27213023|P3|Overall Study|Adverse Event|2
7840497|NCT00242580|27213024|P2|Overall Study|Adverse Event|0
7840498|NCT00242580|27213025|P1|Overall Study|Adverse Event|3
7840499|NCT00242567|27213050|P2|Overall Study|Other|9
7840500|NCT00242567|27213051|P1|Overall Study|Other|14
7840501|NCT00242567|27213050|P2|Overall Study|Use of an inhibitor of bone resorption|2
7840502|NCT00242567|27213051|P1|Overall Study|Use of an inhibitor of bone resorption|0
7840503|NCT00242567|27213050|P2|Overall Study|Protocol Violation|12
7840504|NCT00242567|27213051|P1|Overall Study|Protocol Violation|12
7840505|NCT00242567|27213050|P2|Overall Study|Withdrawal by Subject|28
7840506|NCT00242567|27213051|P1|Overall Study|Withdrawal by Subject|33
7840507|NCT00242567|27213050|P2|Overall Study|Lost to Follow-up|19
7840508|NCT00242567|27213051|P1|Overall Study|Lost to Follow-up|9
7840509|NCT00242567|27213050|P2|Overall Study|Lack of Efficacy|2
7840510|NCT00242567|27213051|P1|Overall Study|Lack of Efficacy|2
7840511|NCT00242567|27213050|P2|Overall Study|Symptomatic deterioration|3
7840512|NCT00242567|27213051|P1|Overall Study|Symptomatic deterioration|9
7840513|NCT00242567|27213050|P2|Overall Study|Disease Progression|22
7840514|NCT00242567|27213051|P1|Overall Study|Disease Progression|17
7840515|NCT00242567|27213050|P2|Overall Study|Adverse Event|43
7840516|NCT00242567|27213051|P1|Overall Study|Adverse Event|70
7840517|NCT00242216|27213098|P2|Overall Study|no medicaiton dispensed|1
7840518|NCT00242216|27213099|P1|Overall Study|no medicaiton dispensed|1
7840519|NCT00242216|27213098|P2|Overall Study|Lack of Efficacy|2
7840520|NCT00242216|27213099|P1|Overall Study|Lack of Efficacy|1
7840521|NCT00242216|27213098|P2|Overall Study|Death|2
7840522|NCT00242216|27213099|P1|Overall Study|Death|4
7840523|NCT00242216|27213098|P2|Overall Study|Lost to Follow-up|17
7840524|NCT00242216|27213099|P1|Overall Study|Lost to Follow-up|12
7840525|NCT00241839|27213137|P2|Overall Study|Adverse Event|1
7840526|NCT00241839|27213138|P1|Overall Study|Adverse Event|1
7840527|NCT00241839|27213137|P2|Overall Study|Withdrawal by Subject|17
7840528|NCT00241839|27213138|P1|Overall Study|Withdrawal by Subject|18
7840529|NCT00241644|27213154|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
7840530|NCT00241644|27213155|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
7840531|NCT00241644|27213156|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
7840532|NCT00241644|27213157|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
7840533|NCT00241644|27213154|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
7840534|NCT00241644|27213155|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
7840535|NCT00241644|27213156|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
7840536|NCT00241644|27213157|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
7840537|NCT00241644|27213154|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
7840538|NCT00241644|27213155|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
7840539|NCT00241644|27213156|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
7840540|NCT00241644|27213157|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
7840541|NCT00241644|27213154|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
7840542|NCT00241644|27213155|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
7840543|NCT00241644|27213156|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
7840544|NCT00241644|27213157|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
7840545|NCT00241644|27213154|P4|Second Efficacy Period (Year 2)|Adverse Event|20
7840546|NCT00241644|27213155|P3|Second Efficacy Period (Year 2)|Adverse Event|12
7840547|NCT00241644|27213156|P2|Second Efficacy Period (Year 2)|Adverse Event|9
7840548|NCT00241644|27213157|P1|Second Efficacy Period (Year 2)|Adverse Event|11
7840549|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
7840550|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
7840551|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
7840552|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
7840553|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7840554|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
7840555|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7840556|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7840557|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
7840558|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
7840559|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
7840560|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
7840561|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Non-compliance|3
7840562|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Non-compliance|2
7840563|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Non-compliance|1
7840564|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Non-compliance|2
7840565|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
7840566|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
7840567|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
7840568|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
7840569|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
7840570|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
7840571|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
7840572|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
7840573|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Protocol Violation|8
7840574|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Protocol Violation|4
7840575|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Protocol Violation|5
7840576|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Protocol Violation|3
7840577|NCT00241644|27213154|P4|First Efficacy Period (Year 1)|Adverse Event|91
7840578|NCT00241644|27213155|P3|First Efficacy Period (Year 1)|Adverse Event|45
7840579|NCT00241644|27213156|P2|First Efficacy Period (Year 1)|Adverse Event|45
7840580|NCT00241644|27213157|P1|First Efficacy Period (Year 1)|Adverse Event|46
7840581|NCT00241631|27213241|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
7840582|NCT00241631|27213242|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
7840583|NCT00241631|27213241|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
7840584|NCT00241631|27213242|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
7840585|NCT00241631|27213241|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
7840586|NCT00241631|27213242|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
7840587|NCT00241631|27213241|P2|Phase 1 (4 Weeks)|sore throat|0
7840588|NCT00241631|27213242|P1|Phase 1 (4 Weeks)|sore throat|1
7840589|NCT00241631|27213241|P2|Run in (2 Weeks)|Physician Decision|3
7840590|NCT00241631|27213242|P1|Run in (2 Weeks)|Physician Decision|3
7840591|NCT00241358|27213255|P3|Overall Study|Determined to be not ineligible|1
7840592|NCT00241358|27213256|P2|Overall Study|Determined to be not ineligible|1
7840593|NCT00241358|27213257|P1|Overall Study|Determined to be not ineligible|0
7840594|NCT00241280|27213290|P2|Overall Study|Excessive Dryness|1
7840595|NCT00241280|27213291|P1|Overall Study|Excessive Dryness|0
7840596|NCT00241280|27213290|P2|Overall Study|Coating on Lens|0
7840597|NCT00241280|27213291|P1|Overall Study|Coating on Lens|1
7840598|NCT00241280|27213290|P2|Overall Study|History of Ocular Surgery|1
7840599|NCT00241280|27213291|P1|Overall Study|History of Ocular Surgery|0
7840600|NCT00241280|27213290|P2|Overall Study|Scheduling Conflict|2
7840601|NCT00241280|27213291|P1|Overall Study|Scheduling Conflict|0
7840602|NCT00241280|27213290|P2|Overall Study|Unacceptable Fit|1
7840603|NCT00241280|27213291|P1|Overall Study|Unacceptable Fit|0
7840604|NCT00241280|27213290|P2|Overall Study|Dispensed incorrect test article|2
7840605|NCT00241280|27213291|P1|Overall Study|Dispensed incorrect test article|1
7840606|NCT00241280|27213290|P2|Overall Study|Subject Ineligible/Dispensed|6
7840607|NCT00241280|27213291|P1|Overall Study|Subject Ineligible/Dispensed|9
7840608|NCT00241280|27213290|P2|Overall Study|Diabetic|0
7840609|NCT00241280|27213291|P1|Overall Study|Diabetic|1
7840610|NCT00241280|27213290|P2|Overall Study|Unsatisfactory Visual Response|1
7840611|NCT00241280|27213291|P1|Overall Study|Unsatisfactory Visual Response|1
7840612|NCT00241280|27213290|P2|Overall Study|Unsatisfactory Physiological Response|1
7840613|NCT00241280|27213291|P1|Overall Study|Unsatisfactory Physiological Response|1
7840614|NCT00241280|27213290|P2|Overall Study|Relocation|4
7840615|NCT00241280|27213291|P1|Overall Study|Relocation|4
7840616|NCT00241280|27213290|P2|Overall Study|Protocol Violation|10
7840617|NCT00241280|27213291|P1|Overall Study|Protocol Violation|4
7840618|NCT00241280|27213290|P2|Overall Study|Withdrawal by Subject|4
7840619|NCT00241280|27213291|P1|Overall Study|Withdrawal by Subject|7
7840620|NCT00241280|27213290|P2|Overall Study|Lost to Follow-up|8
7840621|NCT00241280|27213291|P1|Overall Study|Lost to Follow-up|5
7840622|NCT00241280|27213290|P2|Overall Study|Pregnancy|5
7840623|NCT00241280|27213291|P1|Overall Study|Pregnancy|1
7840624|NCT00241280|27213290|P2|Overall Study|Discomfort|16
7840625|NCT00241280|27213291|P1|Overall Study|Discomfort|11
7840626|NCT00241280|27213290|P2|Overall Study|Adverse Event|6
7840627|NCT00241280|27213291|P1|Overall Study|Adverse Event|2
7840628|NCT00240994|27213306|P1|Overall Study|Graft failure|1
7840629|NCT00240994|27213306|P1|Overall Study|Protocol Violation|1
7840630|NCT00240994|27213306|P1|Overall Study|Lost to Follow-up|1
7840631|NCT00240331|27213441|P2|Overall Study|Option selected by investigator|2
7840632|NCT00240331|27213442|P1|Overall Study|Option selected by investigator|1
7840633|NCT00240331|27213441|P2|Overall Study|Withdrawal by Subject|132
7840634|NCT00240331|27213442|P1|Overall Study|Withdrawal by Subject|125
7840635|NCT00240110|27213485|P2|Overall Study|Lost to Follow-up|7
7840636|NCT00240110|27213486|P1|Overall Study|Lost to Follow-up|6
7840637|NCT00240097|27213494|P1|Part II|did not continue from Part I|23
7840638|NCT00240097|27213494|P1|Part I|unevaluable|1
7840639|NCT00240097|27213494|P1|Part I|histology|1
7840640|NCT00240097|27213494|P1|Part I|Death|1
7840641|NCT00240097|27213494|P1|Part I|Adverse Event|1
7840642|NCT00240071|27213504|P1|Overall Study|Withdrawal by Subject|3
7840643|NCT00239928|27213509|P1|Overall Study|Withdrawal by Subject|2
7840644|NCT00239928|27213509|P1|Overall Study|Not need to continue study|3
7840645|NCT00239928|27213509|P1|Overall Study|Adverse Event|4
7840646|NCT00239928|27213509|P1|Overall Study|Lack of Efficacy|1
7840647|NCT00239837|27213521|P2|Overall Study|Lost to Follow-up|7
7840648|NCT00239837|27213522|P1|Overall Study|Lost to Follow-up|3
7840649|NCT00239720|27213549|P2|Overall Study|Lost to Follow-up|1
7840650|NCT00239720|27213550|P1|Overall Study|Lost to Follow-up|0
7840651|NCT00239720|27213549|P2|Overall Study|Adverse Event|0
7840652|NCT00239720|27213550|P1|Overall Study|Adverse Event|1
7840653|NCT00239681|27213558|P2|Overall Study|No information chacked on CaseReportForm|84
7840654|NCT00239681|27213559|P1|Overall Study|No information chacked on CaseReportForm|90
7840655|NCT00239681|27213558|P2|Overall Study|Physician Decision|17
7840656|NCT00239681|27213559|P1|Overall Study|Physician Decision|13
7840657|NCT00239681|27213558|P2|Overall Study|Protocol Violation|4
7840658|NCT00239681|27213559|P1|Overall Study|Protocol Violation|4
7840659|NCT00239681|27213558|P2|Overall Study|Lost to Follow-up|22
7840660|NCT00239681|27213559|P1|Overall Study|Lost to Follow-up|28
7840661|NCT00239681|27213558|P2|Overall Study|Withdrawal by Subject|489
7840662|NCT00239681|27213559|P1|Overall Study|Withdrawal by Subject|458
7840663|NCT00239681|27213558|P2|Overall Study|Adverse Event|99
7840664|NCT00239681|27213559|P1|Overall Study|Adverse Event|100
7840665|NCT00239590|27213612|P2|Completed Study Protocol|Withdrawal by Subject|1
7840666|NCT00239590|27213613|P1|Completed Study Protocol|Withdrawal by Subject|0
7840667|NCT00239590|27213612|P2|Completed Study Protocol|Adverse Event|1
7840668|NCT00239590|27213613|P1|Completed Study Protocol|Adverse Event|1
7840669|NCT00239590|27213612|P2|Randomized|Withdrawal by Subject|1
7840670|NCT00239590|27213613|P1|Randomized|Withdrawal by Subject|0
7840671|NCT00239590|27213612|P2|Randomized|Lost to Follow-up|1
7840672|NCT00239590|27213613|P1|Randomized|Lost to Follow-up|0
7840673|NCT00239577|27213625|P4|Primary Phase|Other|0
7840674|NCT00239577|27213626|P3|Primary Phase|Other|2
7840675|NCT00239577|27213627|P2|Primary Phase|Other|3
7840676|NCT00239577|27213628|P1|Primary Phase|Other|5
7840677|NCT00239577|27213625|P4|Primary Phase|Adverse Event|0
7840678|NCT00239577|27213626|P3|Primary Phase|Adverse Event|1
7840679|NCT00239577|27213627|P2|Primary Phase|Adverse Event|0
7840680|NCT00239577|27213628|P1|Primary Phase|Adverse Event|0
7840681|NCT00239356|27213732|P2|Overall Study|Drug available on market|2
7840682|NCT00239356|27213733|P1|Overall Study|Drug available on market|11
7840683|NCT00239356|27213732|P2|Overall Study|Administrative reason|1
7840684|NCT00239356|27213733|P1|Overall Study|Administrative reason|0
7840685|NCT00239356|27213732|P2|Overall Study|Pregnancy|0
7840686|NCT00239356|27213733|P1|Overall Study|Pregnancy|1
7840687|NCT00239356|27213732|P2|Overall Study|poor/non-compliance|0
7840688|NCT00239356|27213733|P1|Overall Study|poor/non-compliance|2
7840689|NCT00239356|27213732|P2|Overall Study|Lost to Follow-up|0
7840690|NCT00239356|27213733|P1|Overall Study|Lost to Follow-up|3
7840691|NCT00239356|27213732|P2|Overall Study|Withdrawal by Subject|6
7840692|NCT00239356|27213733|P1|Overall Study|Withdrawal by Subject|15
7840693|NCT00239356|27213732|P2|Overall Study|Adverse Event|0
7840694|NCT00239356|27213733|P1|Overall Study|Adverse Event|6
7840695|NCT00239356|27213732|P2|Overall Study|Lack of Efficacy|0
7840696|NCT00239356|27213733|P1|Overall Study|Lack of Efficacy|1
7840697|NCT00239226|27213755|P4|Overall Study|Lost to Follow-up|0
7840698|NCT00239226|27213756|P3|Overall Study|Lost to Follow-up|1
7840699|NCT00239226|27213757|P2|Overall Study|Lost to Follow-up|0
7840700|NCT00239226|27213758|P1|Overall Study|Lost to Follow-up|1
7840701|NCT00239226|27213755|P4|Overall Study|permAF during stabilization period|3
7840702|NCT00239226|27213756|P3|Overall Study|permAF during stabilization period|0
7840703|NCT00239226|27213757|P2|Overall Study|permAF during stabilization period|0
7840704|NCT00239226|27213758|P1|Overall Study|permAF during stabilization period|0
7840705|NCT00239005|27213770|P2|Overall Study|Lost to Follow-up|1
7840706|NCT00239005|27213771|P1|Overall Study|Lost to Follow-up|0
7840707|NCT00239005|27213770|P2|Overall Study|Subj. cond. no longer needs study drug|1
7840708|NCT00239005|27213771|P1|Overall Study|Subj. cond. no longer needs study drug|0
7840709|NCT00239005|27213770|P2|Overall Study|Protocol Violation|0
7840710|NCT00239005|27213771|P1|Overall Study|Protocol Violation|1
7840711|NCT00239005|27213770|P2|Overall Study|Unsatisfactory Therapeutic effect|0
7840712|NCT00239005|27213771|P1|Overall Study|Unsatisfactory Therapeutic effect|2
7840713|NCT00239005|27213770|P2|Overall Study|Withdrawal by Subject|4
7840714|NCT00239005|27213771|P1|Overall Study|Withdrawal by Subject|3
7840715|NCT00239005|27213770|P2|Overall Study|Adverse Event|6
7840716|NCT00239005|27213771|P1|Overall Study|Adverse Event|6
7840717|NCT00238433|27213787|P1|Overall Study|Death|1
7840718|NCT00238433|27213787|P1|Overall Study|Lost to Follow-up|1
7840719|NCT00238433|27213787|P1|Overall Study|Screen failure|1
7840720|NCT00238420|27213794|P2|Overall Study|Protocol Violation|1
7840721|NCT00238420|27213795|P1|Overall Study|Protocol Violation|1
7840722|NCT00238303|27213816|P3|Overall Study|Adverse Event|3
7840723|NCT00238303|27213817|P2|Overall Study|Adverse Event|1
7840724|NCT00238303|27213818|P1|Overall Study|Adverse Event|0
7840725|NCT00238303|27213816|P3|Overall Study|Poor tolerance of study treatment|1
7840726|NCT00238303|27213817|P2|Overall Study|Poor tolerance of study treatment|0
7840727|NCT00238303|27213818|P1|Overall Study|Poor tolerance of study treatment|1
7840728|NCT00238303|27213816|P3|Overall Study|Other Medical Problems|2
7840729|NCT00238303|27213817|P2|Overall Study|Other Medical Problems|0
7840730|NCT00238303|27213818|P1|Overall Study|Other Medical Problems|2
7840731|NCT00238303|27213816|P3|Overall Study|Death|1
7840732|NCT00238303|27213817|P2|Overall Study|Death|0
7840733|NCT00238303|27213818|P1|Overall Study|Death|1
7840734|NCT00238303|27213816|P3|Overall Study|Withdrawal by Subject|2
7840735|NCT00238303|27213817|P2|Overall Study|Withdrawal by Subject|1
7840736|NCT00238303|27213818|P1|Overall Study|Withdrawal by Subject|11
7840737|NCT00238264|27213835|P1|Overall Study|Ineligible|7
7840738|NCT00238264|27213835|P1|Overall Study|Withdrawal by Subject|4
7840739|NCT00238264|27213835|P1|Overall Study|Lost to Follow-up|18
7840740|NCT00238264|27213835|P1|Overall Study|Death|7
7840741|NCT00238238|27213848|P3|Overall Study|Withdrawal by Subject|0
7840742|NCT00238238|27213849|P2|Overall Study|Withdrawal by Subject|3
7840743|NCT00238238|27213850|P1|Overall Study|Withdrawal by Subject|0
7840744|NCT00238121|27213863|P2|Overall Study|Adverse Event|1
7840745|NCT00238121|27213864|P1|Overall Study|Adverse Event|2
7840746|NCT00238121|27213863|P2|Overall Study|Withdrawal by Subject|1
7840747|NCT00238121|27213864|P1|Overall Study|Withdrawal by Subject|1
7840748|NCT00237809|27213890|P4|Overall Study|Lost to Follow-up|9
7840749|NCT00237809|27213891|P3|Overall Study|Lost to Follow-up|9
7840750|NCT00237809|27213892|P2|Overall Study|Lost to Follow-up|10
7840751|NCT00237809|27213893|P1|Overall Study|Lost to Follow-up|11
7840752|NCT00237796|27213929|P2|Overall Study|Baseline and one other ILSS required|5
7840753|NCT00237796|27213930|P1|Overall Study|Baseline and one other ILSS required|10
7840754|NCT00237744|27213964|P3|Overall Study|Withdrawal by Subject|0
7840755|NCT00237744|27213965|P2|Overall Study|Withdrawal by Subject|1
7840756|NCT00237744|27213966|P1|Overall Study|Withdrawal by Subject|3
7840757|NCT00237692|27213992|P4|Overall Study|Withdrawal by Subject|4
7840758|NCT00237692|27213993|P3|Overall Study|Withdrawal by Subject|10
7840759|NCT00237692|27213994|P2|Overall Study|Withdrawal by Subject|6
7840760|NCT00237692|27213995|P1|Overall Study|Withdrawal by Subject|4
7840761|NCT00237692|27213992|P4|Overall Study|Excluded - did not meet criteria|9
7840762|NCT00237692|27213993|P3|Overall Study|Excluded - did not meet criteria|5
7840763|NCT00237692|27213994|P2|Overall Study|Excluded - did not meet criteria|3
7840764|NCT00237692|27213995|P1|Overall Study|Excluded - did not meet criteria|4
7840765|NCT00237692|27213992|P4|Overall Study|Death|3
7840766|NCT00237692|27213993|P3|Overall Study|Death|2
7840767|NCT00237692|27213994|P2|Overall Study|Death|2
7840768|NCT00237692|27213995|P1|Overall Study|Death|1
7840769|NCT00237692|27213992|P4|Overall Study|Lost to Follow-up|3
7840770|NCT00237692|27213993|P3|Overall Study|Lost to Follow-up|5
7840771|NCT00237692|27213994|P2|Overall Study|Lost to Follow-up|3
7840772|NCT00237692|27213995|P1|Overall Study|Lost to Follow-up|9
7840773|NCT00237458|27214035|P1|Overall Study|Withdrawal by Subject|1
7840774|NCT00237458|27214035|P1|Overall Study|Adverse Event|1
7840775|NCT00237458|27214035|P1|Overall Study|Lack of Efficacy|1
7840776|NCT00237185|27214053|P2|Extension|Death|1
7840777|NCT00237185|27214054|P1|Extension|Death|1
7840778|NCT00237185|27214053|P2|Extension|Administrative problems|0
7840779|NCT00237185|27214054|P1|Extension|Administrative problems|1
7840780|NCT00237185|27214053|P2|Extension|Lost to Follow-up|0
7840781|NCT00237185|27214054|P1|Extension|Lost to Follow-up|1
7840782|NCT00237185|27214053|P2|Extension|Withdrawal by Subject|2
7840783|NCT00237185|27214054|P1|Extension|Withdrawal by Subject|3
7840784|NCT00237185|27214053|P2|Extension|Condition no longer required study drug|1
7840785|NCT00237185|27214054|P1|Extension|Condition no longer required study drug|0
7840786|NCT00237185|27214053|P2|Extension|Lack of Efficacy|14
7840787|NCT00237185|27214054|P1|Extension|Lack of Efficacy|9
7840788|NCT00237185|27214053|P2|Extension|Abnormal laboratory value|1
7840789|NCT00237185|27214054|P1|Extension|Abnormal laboratory value|0
7840790|NCT00237185|27214053|P2|Extension|Adverse Event|0
7840791|NCT00237185|27214054|P1|Extension|Adverse Event|1
7840792|NCT00237185|27214053|P2|Core|Determined ineligible post randomization|0
7840793|NCT00237185|27214054|P1|Core|Determined ineligible post randomization|1
7840794|NCT00237185|27214053|P2|Core|Death|0
7840795|NCT00237185|27214054|P1|Core|Death|4
7840796|NCT00237185|27214053|P2|Core|Administrative problems|1
7840797|NCT00237185|27214054|P1|Core|Administrative problems|0
7840798|NCT00237185|27214053|P2|Core|Withdrawal by Subject|4
7840799|NCT00237185|27214054|P1|Core|Withdrawal by Subject|4
7840800|NCT00237185|27214053|P2|Core|Protocol Violation|1
7840801|NCT00237185|27214054|P1|Core|Protocol Violation|1
7840802|NCT00237185|27214053|P2|Core|Lack of Efficacy|23
7840803|NCT00237185|27214054|P1|Core|Lack of Efficacy|30
7840804|NCT00237185|27214053|P2|Core|Abnormal test procedure results|0
7840805|NCT00237185|27214054|P1|Core|Abnormal test procedure results|1
7840806|NCT00237185|27214053|P2|Core|Abnormal laboratory value|4
7840807|NCT00237185|27214054|P1|Core|Abnormal laboratory value|0
7840808|NCT00237185|27214053|P2|Core|Adverse Event|4
7840809|NCT00237185|27214054|P1|Core|Adverse Event|3
7840810|NCT00237042|27214085|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
7840811|NCT00237042|27214086|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
7840812|NCT00237042|27214087|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
7840813|NCT00237042|27214085|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
7840814|NCT00237042|27214086|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
7840815|NCT00237042|27214087|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
7840816|NCT00237042|27214085|P3|Treatment|Completed no treatment|21
7840817|NCT00237042|27214086|P2|Treatment|Completed no treatment|5
7840818|NCT00237042|27214087|P1|Treatment|Completed no treatment|5
7840819|NCT00237042|27214085|P3|Treatment|Moved out of state|1
7840820|NCT00237042|27214086|P2|Treatment|Moved out of state|1
7840821|NCT00237042|27214087|P1|Treatment|Moved out of state|1
7840822|NCT00237042|27214085|P3|Treatment|Became ineligible post-randomization|16
7840823|NCT00237042|27214086|P2|Treatment|Became ineligible post-randomization|1
7840824|NCT00237042|27214087|P1|Treatment|Became ineligible post-randomization|0
7840825|NCT00236899|27214161|P4|Overall Study|Lack of Efficacy|23
7840826|NCT00236899|27214162|P3|Overall Study|Lack of Efficacy|25
7840827|NCT00236899|27214163|P2|Overall Study|Lack of Efficacy|18
7840828|NCT00236899|27214164|P1|Overall Study|Lack of Efficacy|18
7840829|NCT00236899|27214161|P4|Overall Study|Satisfactory Response|1
7840830|NCT00236899|27214162|P3|Overall Study|Satisfactory Response|0
7840831|NCT00236899|27214163|P2|Overall Study|Satisfactory Response|0
7840832|NCT00236899|27214164|P1|Overall Study|Satisfactory Response|2
7840833|NCT00236899|27214161|P4|Overall Study|Physician Decision|6
7840834|NCT00236899|27214162|P3|Overall Study|Physician Decision|7
7840835|NCT00236899|27214163|P2|Overall Study|Physician Decision|8
7840836|NCT00236899|27214164|P1|Overall Study|Physician Decision|7
7840837|NCT00236899|27214161|P4|Overall Study|Withdrawal by Subject|2
7840838|NCT00236899|27214162|P3|Overall Study|Withdrawal by Subject|5
7840839|NCT00236899|27214163|P2|Overall Study|Withdrawal by Subject|4
7840840|NCT00236899|27214164|P1|Overall Study|Withdrawal by Subject|6
7840841|NCT00236899|27214161|P4|Overall Study|Protocol Violation|0
7840842|NCT00236899|27214162|P3|Overall Study|Protocol Violation|0
7840843|NCT00236899|27214163|P2|Overall Study|Protocol Violation|0
7840844|NCT00236899|27214164|P1|Overall Study|Protocol Violation|1
7840845|NCT00236899|27214161|P4|Overall Study|Entry Criteria Exclusion|0
7840846|NCT00236899|27214162|P3|Overall Study|Entry Criteria Exclusion|1
7840847|NCT00236899|27214163|P2|Overall Study|Entry Criteria Exclusion|1
7840848|NCT00236899|27214164|P1|Overall Study|Entry Criteria Exclusion|0
7840849|NCT00236899|27214161|P4|Overall Study|Lost to Follow-up|0
7840850|NCT00236899|27214162|P3|Overall Study|Lost to Follow-up|0
7840851|NCT00236899|27214163|P2|Overall Study|Lost to Follow-up|1
7840852|NCT00236899|27214164|P1|Overall Study|Lost to Follow-up|0
7840853|NCT00236899|27214161|P4|Overall Study|Death (Study Drug Toxicity)|0
7840854|NCT00236899|27214162|P3|Overall Study|Death (Study Drug Toxicity)|0
7840855|NCT00236899|27214163|P2|Overall Study|Death (Study Drug Toxicity)|0
7840856|NCT00236899|27214164|P1|Overall Study|Death (Study Drug Toxicity)|1
7840857|NCT00236899|27214161|P4|Overall Study|Death (Not Study Related)|0
7840858|NCT00236899|27214162|P3|Overall Study|Death (Not Study Related)|0
7840859|NCT00236899|27214163|P2|Overall Study|Death (Not Study Related)|0
7840860|NCT00236899|27214164|P1|Overall Study|Death (Not Study Related)|2
7840861|NCT00236899|27214161|P4|Overall Study|Death (Study Disease)|0
7840862|NCT00236899|27214162|P3|Overall Study|Death (Study Disease)|0
7840863|NCT00236899|27214163|P2|Overall Study|Death (Study Disease)|4
7840864|NCT00236899|27214164|P1|Overall Study|Death (Study Disease)|1
7840865|NCT00236899|27214161|P4|Overall Study|Adverse Event (Not Study Related)|7
7840866|NCT00236899|27214162|P3|Overall Study|Adverse Event (Not Study Related)|4
7840867|NCT00236899|27214163|P2|Overall Study|Adverse Event (Not Study Related)|3
7840868|NCT00236899|27214164|P1|Overall Study|Adverse Event (Not Study Related)|3
7840869|NCT00236899|27214161|P4|Overall Study|Adverse Event (Study Related)|1
7840870|NCT00236899|27214162|P3|Overall Study|Adverse Event (Study Related)|2
7840871|NCT00236899|27214163|P2|Overall Study|Adverse Event (Study Related)|1
7840872|NCT00236899|27214164|P1|Overall Study|Adverse Event (Study Related)|1
7840873|NCT00236197|27214196|P2|Overall Study|Other|2
7840874|NCT00236197|27214197|P1|Overall Study|Other|0
7840875|NCT00236197|27214196|P2|Overall Study|Medication non-compliance|2
7840876|NCT00236197|27214197|P1|Overall Study|Medication non-compliance|1
7840877|NCT00236197|27214196|P2|Overall Study|Protocol Violation|3
7840878|NCT00236197|27214197|P1|Overall Study|Protocol Violation|0
7840879|NCT00236197|27214196|P2|Overall Study|Lost to Follow-up|5
7840880|NCT00236197|27214197|P1|Overall Study|Lost to Follow-up|1
7840881|NCT00236197|27214196|P2|Overall Study|Withdrawal by Subject|2
7840882|NCT00236197|27214197|P1|Overall Study|Withdrawal by Subject|3
7840883|NCT00236184|27214205|P2|Overall Study|other|2
7840884|NCT00236184|27214206|P1|Overall Study|other|1
7840885|NCT00236184|27214205|P2|Overall Study|non-compliance with study drug|1
7840886|NCT00236184|27214206|P1|Overall Study|non-compliance with study drug|2
7840887|NCT00236184|27214205|P2|Overall Study|Protocol Violation|0
7840888|NCT00236184|27214206|P1|Overall Study|Protocol Violation|3
7840889|NCT00236184|27214205|P2|Overall Study|Withdrawal by Subject|0
7840890|NCT00236184|27214206|P1|Overall Study|Withdrawal by Subject|3
7840891|NCT00236184|27214205|P2|Overall Study|Physician Decision|1
7840892|NCT00236184|27214206|P1|Overall Study|Physician Decision|1
7840893|NCT00236184|27214205|P2|Overall Study|Lost to Follow-up|4
7840894|NCT00236184|27214206|P1|Overall Study|Lost to Follow-up|3
7840895|NCT00236184|27214205|P2|Overall Study|Lack of Efficacy|1
7840896|NCT00236184|27214206|P1|Overall Study|Lack of Efficacy|0
7840897|NCT00236184|27214205|P2|Overall Study|Adverse Event|2
7840898|NCT00236184|27214206|P1|Overall Study|Adverse Event|5
7840899|NCT00236080|27214217|P5|Overall Study|Miscellaneous|0
7840900|NCT00236080|27214218|P4|Overall Study|Miscellaneous|0
7840901|NCT00236080|27214219|P3|Overall Study|Miscellaneous|1
7840902|NCT00236080|27214220|P2|Overall Study|Miscellaneous|0
7840903|NCT00236080|27214221|P1|Overall Study|Miscellaneous|0
7840904|NCT00236080|27214217|P5|Overall Study|Withdrawal by Subject|0
7840905|NCT00236080|27214218|P4|Overall Study|Withdrawal by Subject|0
7840906|NCT00236080|27214219|P3|Overall Study|Withdrawal by Subject|0
7840907|NCT00236080|27214220|P2|Overall Study|Withdrawal by Subject|0
7840908|NCT00236080|27214221|P1|Overall Study|Withdrawal by Subject|1
7840909|NCT00236080|27214217|P5|Overall Study|Physician Decision|1
7840910|NCT00236080|27214218|P4|Overall Study|Physician Decision|1
7840911|NCT00236080|27214219|P3|Overall Study|Physician Decision|1
7840912|NCT00236080|27214220|P2|Overall Study|Physician Decision|0
7840913|NCT00236080|27214221|P1|Overall Study|Physician Decision|1
7840914|NCT00236080|27214217|P5|Overall Study|Lost to Follow-up|0
7840915|NCT00236080|27214218|P4|Overall Study|Lost to Follow-up|0
7840916|NCT00236080|27214219|P3|Overall Study|Lost to Follow-up|0
7840917|NCT00236080|27214220|P2|Overall Study|Lost to Follow-up|1
7840918|NCT00236080|27214221|P1|Overall Study|Lost to Follow-up|0
7840919|NCT00236080|27214217|P5|Overall Study|Adverse Event|0
7840920|NCT00236080|27214218|P4|Overall Study|Adverse Event|1
7840921|NCT00236080|27214219|P3|Overall Study|Adverse Event|3
7840922|NCT00236080|27214220|P2|Overall Study|Adverse Event|0
7840923|NCT00236080|27214221|P1|Overall Study|Adverse Event|0
7840924|NCT00235989|27214242|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
7840925|NCT00235989|27214243|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
7840926|NCT00235989|27214244|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
7840927|NCT00235989|27214245|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
7840928|NCT00235989|27214246|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
7840929|NCT00235989|27214247|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
7840930|NCT00235989|27214242|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
7840931|NCT00235989|27214243|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
7840932|NCT00235989|27214244|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
7840933|NCT00235989|27214245|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
7840934|NCT00235989|27214246|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
7840935|NCT00235989|27214247|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
7840936|NCT00235989|27214242|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
7840937|NCT00235989|27214243|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
7840938|NCT00235989|27214244|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
7840939|NCT00235989|27214245|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
7840940|NCT00235989|27214246|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
7840941|NCT00235989|27214247|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
7840942|NCT00235989|27214242|P6|Extension Treatment Period (ET)|Adverse Event|0
7840943|NCT00235989|27214243|P5|Extension Treatment Period (ET)|Adverse Event|0
7840944|NCT00235989|27214244|P4|Extension Treatment Period (ET)|Adverse Event|0
7840945|NCT00235989|27214245|P3|Extension Treatment Period (ET)|Adverse Event|2
7840946|NCT00235989|27214246|P2|Extension Treatment Period (ET)|Adverse Event|0
7840947|NCT00235989|27214247|P1|Extension Treatment Period (ET)|Adverse Event|3
7840948|NCT00235989|27214242|P6|Core Treatment Period (CT)|Lost to Follow-up|2
7840949|NCT00235989|27214243|P5|Core Treatment Period (CT)|Lost to Follow-up|0
7840950|NCT00235989|27214244|P4|Core Treatment Period (CT)|Lost to Follow-up|0
7840951|NCT00235989|27214245|P3|Core Treatment Period (CT)|Lost to Follow-up|0
7840952|NCT00235989|27214246|P2|Core Treatment Period (CT)|Lost to Follow-up|0
7840953|NCT00235989|27214247|P1|Core Treatment Period (CT)|Lost to Follow-up|0
7840954|NCT00235872|27214261|P1|Overall Study|Administrative reason|61
7840955|NCT00235872|27214261|P1|Overall Study|Withdrawal by Subject|50
7840956|NCT00235872|27214261|P1|Overall Study|Lost to Follow-up|1
7840957|NCT00235872|27214261|P1|Overall Study|Death|1
7840958|NCT00235872|27214261|P1|Overall Study|Adverse Event|34
7840959|NCT00235755|27214292|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
7840960|NCT00235755|27214293|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
7840961|NCT00235755|27214294|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
7840962|NCT00235755|27214292|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
7840963|NCT00235755|27214293|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
7840964|NCT00235755|27214294|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
7840965|NCT00235755|27214292|P3|12-Week Maintenance Phase|Protocol Violation|2
7840966|NCT00235755|27214293|P2|12-Week Maintenance Phase|Protocol Violation|4
7840967|NCT00235755|27214294|P1|12-Week Maintenance Phase|Protocol Violation|0
7840968|NCT00235755|27214292|P3|12-Week Maintenance Phase|Lack of Efficacy|0
7840969|NCT00235755|27214293|P2|12-Week Maintenance Phase|Lack of Efficacy|0
7840970|NCT00235755|27214294|P1|12-Week Maintenance Phase|Lack of Efficacy|5
7840971|NCT00235755|27214292|P3|12-Week Maintenance Phase|Lost to Follow-up|0
7840972|NCT00235755|27214293|P2|12-Week Maintenance Phase|Lost to Follow-up|3
7840973|NCT00235755|27214294|P1|12-Week Maintenance Phase|Lost to Follow-up|2
7840974|NCT00235755|27214292|P3|12-Week Maintenance Phase|Adverse Event|26
7840975|NCT00235755|27214293|P2|12-Week Maintenance Phase|Adverse Event|12
7840976|NCT00235755|27214294|P1|12-Week Maintenance Phase|Adverse Event|8
7840977|NCT00235755|27214292|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
7840978|NCT00235755|27214293|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
7840979|NCT00235755|27214294|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
7840980|NCT00235755|27214292|P3|4-Week Titration Phase|Randomization Occurred in Error|0
7840981|NCT00235755|27214293|P2|4-Week Titration Phase|Randomization Occurred in Error|0
7840982|NCT00235755|27214294|P1|4-Week Titration Phase|Randomization Occurred in Error|1
7840983|NCT00235755|27214292|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
7840984|NCT00235755|27214293|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
7840985|NCT00235755|27214294|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
7840986|NCT00235755|27214292|P3|4-Week Titration Phase|Withdrawal by Subject|3
7840987|NCT00235755|27214293|P2|4-Week Titration Phase|Withdrawal by Subject|2
7840988|NCT00235755|27214294|P1|4-Week Titration Phase|Withdrawal by Subject|1
7840989|NCT00235755|27214292|P3|4-Week Titration Phase|Protocol Violation|1
7840990|NCT00235755|27214293|P2|4-Week Titration Phase|Protocol Violation|2
7840991|NCT00235755|27214294|P1|4-Week Titration Phase|Protocol Violation|2
7840992|NCT00235755|27214292|P3|4-Week Titration Phase|Lost to Follow-up|1
7840993|NCT00235755|27214293|P2|4-Week Titration Phase|Lost to Follow-up|1
7840994|NCT00235755|27214294|P1|4-Week Titration Phase|Lost to Follow-up|0
7840995|NCT00235755|27214292|P3|4-Week Titration Phase|Adverse Event|20
7840996|NCT00235755|27214293|P2|4-Week Titration Phase|Adverse Event|14
7840997|NCT00235755|27214294|P1|4-Week Titration Phase|Adverse Event|6
7840998|NCT00235716|27214372|P4|Overall Study|Physician Decision|3
7840999|NCT00235716|27214373|P3|Overall Study|Physician Decision|1
7841000|NCT00235716|27214374|P2|Overall Study|Physician Decision|1
7841001|NCT00235716|27214375|P1|Overall Study|Physician Decision|0
7841002|NCT00235716|27214372|P4|Overall Study|Adverse Event|0
7841003|NCT00235716|27214373|P3|Overall Study|Adverse Event|1
7841004|NCT00235716|27214374|P2|Overall Study|Adverse Event|1
7841005|NCT00235716|27214375|P1|Overall Study|Adverse Event|1
7841006|NCT00235716|27214372|P4|Overall Study|Lost to Follow-up|10
7841007|NCT00235716|27214373|P3|Overall Study|Lost to Follow-up|14
7841008|NCT00235716|27214374|P2|Overall Study|Lost to Follow-up|7
7841009|NCT00235716|27214375|P1|Overall Study|Lost to Follow-up|12
7841010|NCT00235716|27214372|P4|Overall Study|Withdrawal by Subject|18
7841011|NCT00235716|27214373|P3|Overall Study|Withdrawal by Subject|17
7841012|NCT00235716|27214374|P2|Overall Study|Withdrawal by Subject|19
7841013|NCT00235716|27214375|P1|Overall Study|Withdrawal by Subject|23
7841014|NCT00235716|27214372|P4|Overall Study|Death|31
7841015|NCT00235716|27214373|P3|Overall Study|Death|32
7841016|NCT00235716|27214374|P2|Overall Study|Death|39
7841017|NCT00235716|27214375|P1|Overall Study|Death|26
7841018|NCT00235495|27214426|P2|Overall Study|Visit/assessmen outside window/missing|10
7841019|NCT00235495|27214427|P1|Overall Study|Visit/assessmen outside window/missing|0
7841020|NCT00235495|27214426|P2|Overall Study|Lost to Follow-up|13
7841021|NCT00235495|27214427|P1|Overall Study|Lost to Follow-up|11
7841022|NCT00235495|27214426|P2|Overall Study|Withdrawal by Subject|3
7841023|NCT00235495|27214427|P1|Overall Study|Withdrawal by Subject|5
7841024|NCT00235495|27214426|P2|Overall Study|Death|42
7841025|NCT00235495|27214427|P1|Overall Study|Death|52
7841026|NCT00235443|27214500|P6|Overall Study|Other reasons for premature termination|6
7841027|NCT00235443|27214501|P5|Overall Study|Other reasons for premature termination|3
7841028|NCT00235443|27214502|P4|Overall Study|Other reasons for premature termination|7
7841029|NCT00235443|27214503|P3|Overall Study|Other reasons for premature termination|6
7841030|NCT00235443|27214504|P2|Overall Study|Other reasons for premature termination|6
7841031|NCT00235443|27214505|P1|Overall Study|Other reasons for premature termination|1
7841032|NCT00235443|27214500|P6|Overall Study|Unsatisfactory compliance|0
7841033|NCT00235443|27214501|P5|Overall Study|Unsatisfactory compliance|1
7841034|NCT00235443|27214502|P4|Overall Study|Unsatisfactory compliance|4
7841035|NCT00235443|27214503|P3|Overall Study|Unsatisfactory compliance|3
7841036|NCT00235443|27214504|P2|Overall Study|Unsatisfactory compliance|2
7841037|NCT00235443|27214505|P1|Overall Study|Unsatisfactory compliance|0
7841038|NCT00235443|27214500|P6|Overall Study|Lost to Follow-up|3
7841039|NCT00235443|27214501|P5|Overall Study|Lost to Follow-up|4
7841040|NCT00235443|27214502|P4|Overall Study|Lost to Follow-up|6
7841041|NCT00235443|27214503|P3|Overall Study|Lost to Follow-up|6
7841042|NCT00235443|27214504|P2|Overall Study|Lost to Follow-up|8
7841043|NCT00235443|27214505|P1|Overall Study|Lost to Follow-up|0
7841044|NCT00235443|27214500|P6|Overall Study|Withdrawal by Subject|12
7841045|NCT00235443|27214501|P5|Overall Study|Withdrawal by Subject|10
7841046|NCT00235443|27214502|P4|Overall Study|Withdrawal by Subject|24
7841047|NCT00235443|27214503|P3|Overall Study|Withdrawal by Subject|25
7841048|NCT00235443|27214504|P2|Overall Study|Withdrawal by Subject|9
7841049|NCT00235443|27214505|P1|Overall Study|Withdrawal by Subject|3
7841050|NCT00235443|27214500|P6|Overall Study|Lack of Efficacy|9
7841051|NCT00235443|27214501|P5|Overall Study|Lack of Efficacy|2
7841052|NCT00235443|27214502|P4|Overall Study|Lack of Efficacy|12
7841053|NCT00235443|27214503|P3|Overall Study|Lack of Efficacy|5
7841054|NCT00235443|27214504|P2|Overall Study|Lack of Efficacy|1
7841055|NCT00235443|27214505|P1|Overall Study|Lack of Efficacy|0
7841056|NCT00235443|27214500|P6|Overall Study|Adverse Event|15
7841057|NCT00235443|27214501|P5|Overall Study|Adverse Event|10
7841058|NCT00235443|27214502|P4|Overall Study|Adverse Event|44
7841059|NCT00235443|27214503|P3|Overall Study|Adverse Event|17
7841060|NCT00235443|27214504|P2|Overall Study|Adverse Event|12
7841061|NCT00235443|27214505|P1|Overall Study|Adverse Event|4
7841062|NCT00235391|27214646|P6|Overall Study|Death|0
7841063|NCT00235391|27214647|P5|Overall Study|Death|0
7841064|NCT00235391|27214648|P4|Overall Study|Death|4
7841065|NCT00235391|27214649|P3|Overall Study|Death|1
7841066|NCT00235391|27214650|P2|Overall Study|Death|0
7841067|NCT00235391|27214651|P1|Overall Study|Death|0
7841068|NCT00235391|27214646|P6|Overall Study|Administrative problems|0
7841069|NCT00235391|27214647|P5|Overall Study|Administrative problems|0
7841070|NCT00235391|27214648|P4|Overall Study|Administrative problems|1
7841071|NCT00235391|27214649|P3|Overall Study|Administrative problems|0
7841072|NCT00235391|27214650|P2|Overall Study|Administrative problems|0
7841073|NCT00235391|27214651|P1|Overall Study|Administrative problems|0
7841074|NCT00235391|27214646|P6|Overall Study|Lost to Follow-up|0
7841075|NCT00235391|27214647|P5|Overall Study|Lost to Follow-up|0
7841076|NCT00235391|27214648|P4|Overall Study|Lost to Follow-up|16
7841077|NCT00235391|27214649|P3|Overall Study|Lost to Follow-up|3
7841078|NCT00235391|27214650|P2|Overall Study|Lost to Follow-up|3
7841079|NCT00235391|27214651|P1|Overall Study|Lost to Follow-up|0
7841080|NCT00235391|27214646|P6|Overall Study|Withdrawal by Subject|0
7841081|NCT00235391|27214647|P5|Overall Study|Withdrawal by Subject|5
7841082|NCT00235391|27214648|P4|Overall Study|Withdrawal by Subject|61
7841083|NCT00235391|27214649|P3|Overall Study|Withdrawal by Subject|3
7841084|NCT00235391|27214650|P2|Overall Study|Withdrawal by Subject|3
7841085|NCT00235391|27214651|P1|Overall Study|Withdrawal by Subject|2
7841086|NCT00235391|27214646|P6|Overall Study|Protocol deviation|0
7841087|NCT00235391|27214647|P5|Overall Study|Protocol deviation|0
7841088|NCT00235391|27214648|P4|Overall Study|Protocol deviation|11
7841089|NCT00235391|27214649|P3|Overall Study|Protocol deviation|1
7841090|NCT00235391|27214650|P2|Overall Study|Protocol deviation|0
7841091|NCT00235391|27214651|P1|Overall Study|Protocol deviation|0
7841092|NCT00235391|27214646|P6|Overall Study|Condition no longer requires treatment|0
7841093|NCT00235391|27214647|P5|Overall Study|Condition no longer requires treatment|1
7841094|NCT00235391|27214648|P4|Overall Study|Condition no longer requires treatment|11
7841095|NCT00235391|27214649|P3|Overall Study|Condition no longer requires treatment|0
7841096|NCT00235391|27214650|P2|Overall Study|Condition no longer requires treatment|0
7841097|NCT00235391|27214651|P1|Overall Study|Condition no longer requires treatment|3
7841098|NCT00235391|27214646|P6|Overall Study|Unsatisfactory therapeutic effect|0
7841099|NCT00235391|27214647|P5|Overall Study|Unsatisfactory therapeutic effect|0
7841100|NCT00235391|27214648|P4|Overall Study|Unsatisfactory therapeutic effect|17
7841101|NCT00235391|27214649|P3|Overall Study|Unsatisfactory therapeutic effect|2
7841102|NCT00235391|27214650|P2|Overall Study|Unsatisfactory therapeutic effect|2
7841103|NCT00235391|27214651|P1|Overall Study|Unsatisfactory therapeutic effect|0
7841104|NCT00235391|27214646|P6|Overall Study|Abnormal laboratory value(s)|2
7841105|NCT00235391|27214647|P5|Overall Study|Abnormal laboratory value(s)|1
7841106|NCT00235391|27214648|P4|Overall Study|Abnormal laboratory value(s)|27
7841107|NCT00235391|27214649|P3|Overall Study|Abnormal laboratory value(s)|4
7841108|NCT00235391|27214650|P2|Overall Study|Abnormal laboratory value(s)|5
7841109|NCT00235391|27214651|P1|Overall Study|Abnormal laboratory value(s)|3
7841110|NCT00235391|27214646|P6|Overall Study|Adverse Event|2
7841111|NCT00235391|27214647|P5|Overall Study|Adverse Event|5
7841112|NCT00235391|27214648|P4|Overall Study|Adverse Event|72
7841113|NCT00235391|27214649|P3|Overall Study|Adverse Event|10
7841114|NCT00235391|27214650|P2|Overall Study|Adverse Event|5
7841115|NCT00235391|27214651|P1|Overall Study|Adverse Event|4
7841116|NCT00235326|27214668|P2|Overall Study|Lost to Follow-up|1400
7841117|NCT00235326|27214669|P1|Overall Study|Lost to Follow-up|746
7841118|NCT00234533|27214709|P1|Overall Study|Enrolled but not treated|3
7841119|NCT00234533|27214709|P1|Overall Study|Adverse Event|2
7841120|NCT00234533|27214709|P1|Overall Study|Withdrawal by Subject|6
7841121|NCT00234494|27214728|P1|Overall Study|Protocol Violation|2
7841122|NCT00234104|27214774|P4|Overall Study|Physician Decision|2
7841123|NCT00234104|27214775|P3|Overall Study|Physician Decision|2
7841124|NCT00234104|27214776|P2|Overall Study|Physician Decision|1
7841125|NCT00234104|27214777|P1|Overall Study|Physician Decision|0
7841126|NCT00234104|27214774|P4|Overall Study|Protocol Violation|1
7841127|NCT00234104|27214775|P3|Overall Study|Protocol Violation|0
7841128|NCT00234104|27214776|P2|Overall Study|Protocol Violation|0
7841129|NCT00234104|27214777|P1|Overall Study|Protocol Violation|0
7841130|NCT00234104|27214774|P4|Overall Study|Adverse Event|5
7841131|NCT00234104|27214775|P3|Overall Study|Adverse Event|3
7841132|NCT00234104|27214776|P2|Overall Study|Adverse Event|0
7841133|NCT00234104|27214777|P1|Overall Study|Adverse Event|4
7841134|NCT00234065|27214818|P2|Overall Study|Not Classified|112
7841135|NCT00234065|27214819|P1|Overall Study|Not Classified|111
7841136|NCT00234065|27214818|P2|Overall Study|Physician Decision|22
7841137|NCT00234065|27214819|P1|Overall Study|Physician Decision|23
7841138|NCT00234065|27214818|P2|Overall Study|Withdrawal by Subject|56
7841139|NCT00234065|27214819|P1|Overall Study|Withdrawal by Subject|73
7841140|NCT00234065|27214818|P2|Overall Study|Adverse Event|166
7841141|NCT00234065|27214819|P1|Overall Study|Adverse Event|268
7841142|NCT00234052|27214835|P1|Follow-up for 5 Years|Other|7
7841143|NCT00234052|27214835|P1|Follow-up for 5 Years|Lost to Follow-up|1
7841144|NCT00234052|27214835|P1|Follow-up for 5 Years|Death|41
7841145|NCT00234052|27214835|P1|Treatment|Progressive Disease|11
7841146|NCT00234052|27214835|P1|Treatment|Death|2
7841147|NCT00234052|27214835|P1|Treatment|Adverse Event|5
7841148|NCT00234052|27214835|P1|Treatment|Withdrawal by Subject|3
7841149|NCT00234039|27214845|P1|Overall Study|No Protocol Treatment Received|2
7841150|NCT00234039|27214845|P1|Overall Study|Ineligible|9
7841151|NCT00234039|27214845|P1|Overall Study|Other - Not Protocol Specified|3
7841152|NCT00234039|27214845|P1|Overall Study|Progression/relapse|34
7841153|NCT00234039|27214845|P1|Overall Study|Adverse Event|2
7841154|NCT00233987|27214852|P1|Overall Study|Ineligible|4
7841155|NCT00233987|27214852|P1|Overall Study|Eligible but No Treatment Received|2
7841156|NCT00233987|27214852|P1|Overall Study|Other - Not Protocol Specified|5
7841157|NCT00233987|27214852|P1|Overall Study|Reason Under Review|1
7841158|NCT00233987|27214852|P1|Overall Study|Lack of Efficacy|2
7841159|NCT00233987|27214852|P1|Overall Study|Withdrawal by Subject|1
7841160|NCT00233948|27214861|P6|Overall Study|Adverse Event|0
7841161|NCT00233948|27214862|P5|Overall Study|Adverse Event|0
7841162|NCT00233948|27214863|P4|Overall Study|Adverse Event|0
7841163|NCT00233948|27214864|P3|Overall Study|Adverse Event|0
7841164|NCT00233948|27214865|P2|Overall Study|Adverse Event|0
7841165|NCT00233948|27214866|P1|Overall Study|Adverse Event|1
7841166|NCT00233480|27214892|P2|Overall Study|Underwent status II heart transplant|1
7841167|NCT00233480|27214893|P1|Overall Study|Underwent status II heart transplant|0
7841168|NCT00233454|27214909|P1|Overall Study|Death|6
7841169|NCT00233402|27214917|P2|Overall Study|Lost to follow up etc|21
7841170|NCT00233402|27214918|P1|Overall Study|Lost to follow up etc|3
7841171|NCT00233402|27214917|P2|Overall Study|No Ta/T1|94
7841172|NCT00233402|27214918|P1|Overall Study|No Ta/T1|89
7841173|NCT00233402|27214917|P2|Overall Study|No pathology data|9
7841174|NCT00233402|27214918|P1|Overall Study|No pathology data|12
7841175|NCT00233389|27214931|P2|Overall Study|Withdrawal by Subject|1
7841176|NCT00233389|27214932|P1|Overall Study|Withdrawal by Subject|0
7841177|NCT00233389|27214931|P2|Overall Study|Protocol Violation|1
7841178|NCT00233389|27214932|P1|Overall Study|Protocol Violation|0
7841179|NCT00233389|27214931|P2|Overall Study|Physician Decision|0
7841180|NCT00233389|27214932|P1|Overall Study|Physician Decision|1
7841181|NCT00233389|27214931|P2|Overall Study|Lost to Follow-up|1
7841182|NCT00233389|27214932|P1|Overall Study|Lost to Follow-up|1
7841183|NCT00233389|27214931|P2|Overall Study|Lack of Efficacy|8
7841184|NCT00233389|27214932|P1|Overall Study|Lack of Efficacy|11
7841185|NCT00233389|27214931|P2|Overall Study|Adverse Event|5
7841186|NCT00233389|27214932|P1|Overall Study|Adverse Event|5
7841187|NCT00233363|27214940|P2|Overall Study|Aggravation of complication|0
7841188|NCT00233363|27214941|P1|Overall Study|Aggravation of complication|1
7841189|NCT00233363|27214940|P2|Overall Study|Withdrawal by Subject|1
7841190|NCT00233363|27214941|P1|Overall Study|Withdrawal by Subject|1
7841191|NCT00233363|27214940|P2|Overall Study|Lack of Efficacy|2
7841192|NCT00233363|27214941|P1|Overall Study|Lack of Efficacy|0
7841193|NCT00233363|27214940|P2|Overall Study|Adverse Event|2
7841194|NCT00233363|27214941|P1|Overall Study|Adverse Event|1
7841195|NCT00233324|27214951|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
7841196|NCT00233324|27214952|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
7841197|NCT00233324|27214953|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
7841198|NCT00233324|27214954|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
7841199|NCT00233324|27214951|P4|Follow up at 18-22 Months Corrected Age|Death|4
7841200|NCT00233324|27214952|P3|Follow up at 18-22 Months Corrected Age|Death|5
7841201|NCT00233324|27214953|P2|Follow up at 18-22 Months Corrected Age|Death|7
7841202|NCT00233324|27214954|P1|Follow up at 18-22 Months Corrected Age|Death|5
7841203|NCT00233324|27214951|P4|Main Study|Death|47
7841204|NCT00233324|27214952|P3|Main Study|Death|62
7841205|NCT00233324|27214953|P2|Main Study|Death|60
7841206|NCT00233324|27214954|P1|Main Study|Death|68
7841207|NCT00233064|27215076|P2|Overall Study|Moved to Dom. Republic|0
7841208|NCT00233064|27215077|P1|Overall Study|Moved to Dom. Republic|1
7841209|NCT00233064|27215076|P2|Overall Study|Protocol Violation|0
7841210|NCT00233064|27215077|P1|Overall Study|Protocol Violation|1
7841211|NCT00233064|27215076|P2|Overall Study|Relocation|1
7841212|NCT00233064|27215077|P1|Overall Study|Relocation|0
7841213|NCT00233064|27215076|P2|Overall Study|Death|1
7841214|NCT00233064|27215077|P1|Overall Study|Death|0
7841215|NCT00233064|27215076|P2|Overall Study|Withdrawal by Subject|3
7841216|NCT00233064|27215077|P1|Overall Study|Withdrawal by Subject|5
7841217|NCT00233064|27215076|P2|Overall Study|Lost to Follow-up|7
7841218|NCT00233064|27215077|P1|Overall Study|Lost to Follow-up|7
7841219|NCT00232596|27215103|P2|12-Week Maintenance Phase|Other|3
7841220|NCT00232596|27215104|P1|12-Week Maintenance Phase|Other|1
7841221|NCT00232596|27215103|P2|12-Week Maintenance Phase|Protocol Violation|1
7841222|NCT00232596|27215104|P1|12-Week Maintenance Phase|Protocol Violation|3
7841223|NCT00232596|27215103|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
7841224|NCT00232596|27215104|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
7841225|NCT00232596|27215103|P2|12-Week Maintenance Phase|Adverse Event|22
7841226|NCT00232596|27215104|P1|12-Week Maintenance Phase|Adverse Event|7
7841227|NCT00232596|27215103|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
7841228|NCT00232596|27215104|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
7841229|NCT00232596|27215103|P2|6-Week Titration Phase|Other|3
7841230|NCT00232596|27215104|P1|6-Week Titration Phase|Other|3
7841231|NCT00232596|27215103|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
7841232|NCT00232596|27215104|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
7841233|NCT00232596|27215103|P2|6-Week Titration Phase|Protocol Violation|3
7841234|NCT00232596|27215104|P1|6-Week Titration Phase|Protocol Violation|1
7841235|NCT00232596|27215103|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
7841236|NCT00232596|27215104|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
7841237|NCT00232596|27215103|P2|6-Week Titration Phase|Failed to Return|1
7841238|NCT00232596|27215104|P1|6-Week Titration Phase|Failed to Return|2
7841239|NCT00232596|27215103|P2|6-Week Titration Phase|Adverse Event|19
7841240|NCT00232596|27215104|P1|6-Week Titration Phase|Adverse Event|6
7841241|NCT00232557|27215195|P2|Overall Study|Lost to Follow-up|5
7841242|NCT00232557|27215196|P1|Overall Study|Lost to Follow-up|3
7841243|NCT00232544|27215206|P2|Overall Study|Lost to Follow-up|15
7841244|NCT00232544|27215207|P1|Overall Study|Lost to Follow-up|20
7841245|NCT00232180|27215238|P3|Open Label Phase|Randomized but not treated|1
7841246|NCT00232180|27215239|P2|Open Label Phase|Randomized but not treated|0
7841247|NCT00232180|27215240|P1|Open Label Phase|Randomized but not treated|0
7841248|NCT00232180|27215238|P3|Open Label Phase|Laboratory abnormality|10
7841249|NCT00232180|27215239|P2|Open Label Phase|Laboratory abnormality|0
7841250|NCT00232180|27215240|P1|Open Label Phase|Laboratory abnormality|0
7841251|NCT00232180|27215238|P3|Open Label Phase|Adverse Event|25
7841252|NCT00232180|27215239|P2|Open Label Phase|Adverse Event|0
7841253|NCT00232180|27215240|P1|Open Label Phase|Adverse Event|0
7841254|NCT00232180|27215238|P3|Open Label Phase|Other|16
7841255|NCT00232180|27215239|P2|Open Label Phase|Other|0
7841256|NCT00232180|27215240|P1|Open Label Phase|Other|0
7841257|NCT00232180|27215238|P3|Open Label Phase|Withdrawal by Subject|37
7841258|NCT00232180|27215239|P2|Open Label Phase|Withdrawal by Subject|0
7841259|NCT00232180|27215240|P1|Open Label Phase|Withdrawal by Subject|0
7841260|NCT00232180|27215238|P3|Open Label Phase|Study terminated by sponsor|3
7841261|NCT00232180|27215239|P2|Open Label Phase|Study terminated by sponsor|0
7841262|NCT00232180|27215240|P1|Open Label Phase|Study terminated by sponsor|0
7841263|NCT00232180|27215238|P3|Open Label Phase|Protocol Violation|3
7841264|NCT00232180|27215239|P2|Open Label Phase|Protocol Violation|0
7841265|NCT00232180|27215240|P1|Open Label Phase|Protocol Violation|0
7841266|NCT00232180|27215238|P3|Open Label Phase|Lost to Follow-up|5
7841267|NCT00232180|27215239|P2|Open Label Phase|Lost to Follow-up|0
7841268|NCT00232180|27215240|P1|Open Label Phase|Lost to Follow-up|0
7841269|NCT00232180|27215238|P3|Open Label Phase|Death|48
7841270|NCT00232180|27215239|P2|Open Label Phase|Death|0
7841271|NCT00232180|27215240|P1|Open Label Phase|Death|0
7841272|NCT00232180|27215238|P3|Double-blind (DB) Phase|Laboratory abnormality|0
7841273|NCT00232180|27215239|P2|Double-blind (DB) Phase|Laboratory abnormality|7
7841274|NCT00232180|27215240|P1|Double-blind (DB) Phase|Laboratory abnormality|6
7841275|NCT00232180|27215238|P3|Double-blind (DB) Phase|Randomized but not treated|0
7841276|NCT00232180|27215239|P2|Double-blind (DB) Phase|Randomized but not treated|4
7841277|NCT00232180|27215240|P1|Double-blind (DB) Phase|Randomized but not treated|3
7841278|NCT00232180|27215238|P3|Double-blind (DB) Phase|Other|0
7841279|NCT00232180|27215239|P2|Double-blind (DB) Phase|Other|75
7841280|NCT00232180|27215240|P1|Double-blind (DB) Phase|Other|70
7841281|NCT00232180|27215238|P3|Double-blind (DB) Phase|Adverse Event|0
7841282|NCT00232180|27215239|P2|Double-blind (DB) Phase|Adverse Event|100
7841283|NCT00232180|27215240|P1|Double-blind (DB) Phase|Adverse Event|83
7841284|NCT00232180|27215238|P3|Double-blind (DB) Phase|Protocol Violation|0
7841285|NCT00232180|27215239|P2|Double-blind (DB) Phase|Protocol Violation|21
7841286|NCT00232180|27215240|P1|Double-blind (DB) Phase|Protocol Violation|28
7841287|NCT00232180|27215238|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
7841288|NCT00232180|27215239|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
7841289|NCT00232180|27215240|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
7841290|NCT00232180|27215238|P3|Double-blind (DB) Phase|Lost to Follow-up|0
7841291|NCT00232180|27215239|P2|Double-blind (DB) Phase|Lost to Follow-up|28
7841292|NCT00232180|27215240|P1|Double-blind (DB) Phase|Lost to Follow-up|34
7841293|NCT00232180|27215238|P3|Double-blind (DB) Phase|Death|0
7841294|NCT00232180|27215239|P2|Double-blind (DB) Phase|Death|222
7841295|NCT00232180|27215240|P1|Double-blind (DB) Phase|Death|186
7841296|NCT00232141|27215285|P2|Overall Study|Withdrawal by Subject|3
7841297|NCT00232141|27215286|P1|Overall Study|Withdrawal by Subject|5
7841298|NCT00232141|27215285|P2|Overall Study|Other|10
7841299|NCT00232141|27215286|P1|Overall Study|Other|8
7841300|NCT00232141|27215285|P2|Overall Study|Lost to Follow-up|6
7841301|NCT00232141|27215286|P1|Overall Study|Lost to Follow-up|9
7841302|NCT00232141|27215285|P2|Overall Study|Lack of Efficacy|3
7841303|NCT00232141|27215286|P1|Overall Study|Lack of Efficacy|0
7841304|NCT00232141|27215285|P2|Overall Study|Adverse Event|4
7841305|NCT00232141|27215286|P1|Overall Study|Adverse Event|9
7841306|NCT00231894|27215356|P2|Overall Study|Withdrawal by Subject|1
7841307|NCT00231894|27215357|P1|Overall Study|Withdrawal by Subject|1
7841308|NCT00231842|27215383|P1|Overall Study|Did not complete the last 3 cycle|8
7841309|NCT00231842|27215383|P1|Overall Study|Withdrawal by Subject|3
7841310|NCT00231816|27215390|P2|Overall Study|Other|1
7841311|NCT00231816|27215391|P1|Overall Study|Other|2
7841312|NCT00231816|27215390|P2|Overall Study|Withdrawal by Subject|3
7841313|NCT00231816|27215391|P1|Overall Study|Withdrawal by Subject|3
7841314|NCT00231816|27215390|P2|Overall Study|Protocol Violation|3
7841315|NCT00231816|27215391|P1|Overall Study|Protocol Violation|2
7841316|NCT00231816|27215390|P2|Overall Study|Lost to Follow-up|5
7841317|NCT00231816|27215391|P1|Overall Study|Lost to Follow-up|8
7841318|NCT00231816|27215390|P2|Overall Study|Adverse Event|0
7841319|NCT00231816|27215391|P1|Overall Study|Adverse Event|1
7841320|NCT00231777|27215406|P2|Overall Study|Other|2
7841321|NCT00231777|27215407|P1|Overall Study|Other|3
7841322|NCT00231777|27215406|P2|Overall Study|Lost to Follow-up|0
7841323|NCT00231777|27215407|P1|Overall Study|Lost to Follow-up|3
7841324|NCT00231478|27215421|P2|Overall Study|Administrative|2
7841325|NCT00231478|27215422|P1|Overall Study|Administrative|3
7841326|NCT00231478|27215421|P2|Overall Study|Adverse Event|1
7841327|NCT00231478|27215422|P1|Overall Study|Adverse Event|0
7841328|NCT00231478|27215421|P2|Overall Study|Withdrawal by Subject|0
7841329|NCT00231478|27215422|P1|Overall Study|Withdrawal by Subject|1
7841330|NCT00231478|27215421|P2|Overall Study|Refused Treatment|1
7841331|NCT00231478|27215422|P1|Overall Study|Refused Treatment|1
7841332|NCT00231478|27215421|P2|Overall Study|Protocol Violation|2
7841333|NCT00231478|27215422|P1|Overall Study|Protocol Violation|3
7841334|NCT00231465|27215434|P1|Overall Study|Did not have follow up CT scans|1
7841335|NCT00231465|27215434|P1|Overall Study|Completed only one cycle|1
7841336|NCT00231413|27215447|P7|Overall Study|Pregnancy|0
7841337|NCT00231413|27215448|P6|Overall Study|Pregnancy|0
7841338|NCT00231413|27215449|P5|Overall Study|Pregnancy|0
7841339|NCT00231413|27215450|P4|Overall Study|Pregnancy|0
7841340|NCT00231413|27215451|P3|Overall Study|Pregnancy|0
7841341|NCT00231413|27215452|P2|Overall Study|Pregnancy|0
7841342|NCT00231413|27215453|P1|Overall Study|Pregnancy|1
7841343|NCT00231413|27215447|P7|Overall Study|Lost to Follow-up|0
7841344|NCT00231413|27215448|P6|Overall Study|Lost to Follow-up|4
7841345|NCT00231413|27215449|P5|Overall Study|Lost to Follow-up|1
7841346|NCT00231413|27215450|P4|Overall Study|Lost to Follow-up|1
7841347|NCT00231413|27215451|P3|Overall Study|Lost to Follow-up|1
7841348|NCT00231413|27215452|P2|Overall Study|Lost to Follow-up|4
7841349|NCT00231413|27215453|P1|Overall Study|Lost to Follow-up|4
7841350|NCT00231413|27215447|P7|Overall Study|Migrated/moved from study area|0
7841351|NCT00231413|27215448|P6|Overall Study|Migrated/moved from study area|1
7841352|NCT00231413|27215449|P5|Overall Study|Migrated/moved from study area|0
7841353|NCT00231413|27215450|P4|Overall Study|Migrated/moved from study area|0
7841354|NCT00231413|27215451|P3|Overall Study|Migrated/moved from study area|1
7841355|NCT00231413|27215452|P2|Overall Study|Migrated/moved from study area|0
7841356|NCT00231413|27215453|P1|Overall Study|Migrated/moved from study area|0
7841357|NCT00231413|27215447|P7|Overall Study|Withdrawal by Subject|3
7841358|NCT00231413|27215448|P6|Overall Study|Withdrawal by Subject|0
7841359|NCT00231413|27215449|P5|Overall Study|Withdrawal by Subject|2
7841360|NCT00231413|27215450|P4|Overall Study|Withdrawal by Subject|2
7841361|NCT00231413|27215451|P3|Overall Study|Withdrawal by Subject|4
7841362|NCT00231413|27215452|P2|Overall Study|Withdrawal by Subject|1
7841363|NCT00231413|27215453|P1|Overall Study|Withdrawal by Subject|3
7841364|NCT00231413|27215447|P7|Overall Study|Non-serious AE|1
7841365|NCT00231413|27215448|P6|Overall Study|Non-serious AE|0
7841366|NCT00231413|27215449|P5|Overall Study|Non-serious AE|0
7841367|NCT00231413|27215450|P4|Overall Study|Non-serious AE|0
7841368|NCT00231413|27215451|P3|Overall Study|Non-serious AE|1
7841369|NCT00231413|27215452|P2|Overall Study|Non-serious AE|0
7841370|NCT00231413|27215453|P1|Overall Study|Non-serious AE|0
7841371|NCT00231179|27215623|P2|Overall Study|Withdrawal by Subject|3
7841372|NCT00231179|27215624|P1|Overall Study|Withdrawal by Subject|3
7841373|NCT00231179|27215623|P2|Overall Study|Lost to Follow-up|21
7841374|NCT00231179|27215624|P1|Overall Study|Lost to Follow-up|21
7841375|NCT00231114|27215651|P2|Post-Treatment Period|Withdrawal by Subject|0
7841376|NCT00231114|27215652|P1|Post-Treatment Period|Withdrawal by Subject|1
7841377|NCT00231114|27215651|P2|Post-Treatment Period|Physician Decision|0
7841378|NCT00231114|27215652|P1|Post-Treatment Period|Physician Decision|1
7841379|NCT00231114|27215651|P2|Post-Treatment Period|Lost to Follow-up|1
7841380|NCT00231114|27215652|P1|Post-Treatment Period|Lost to Follow-up|6
7841381|NCT00231114|27215651|P2|Treatment Period|Death: Motor Vehicle Accident|0
7841382|NCT00231114|27215652|P1|Treatment Period|Death: Motor Vehicle Accident|1
7841383|NCT00231114|27215651|P2|Randomized|Withdrawal by Subject|3
7841384|NCT00231114|27215652|P1|Randomized|Withdrawal by Subject|6
7841385|NCT00231062|27215688|P1|Overall Study|Physician Decision|6
7841386|NCT00230971|27215696|P2|Baseline Participants|Reintervention|0
7841387|NCT00230971|27215697|P1|Baseline Participants|Reintervention|1
7841388|NCT00230971|27215696|P2|Baseline Participants|Failure to return|1
7841389|NCT00230971|27215697|P1|Baseline Participants|Failure to return|1
7841390|NCT00230971|27215696|P2|Baseline Participants|No bacteria observed|0
7841391|NCT00230971|27215697|P1|Baseline Participants|No bacteria observed|1
7841392|NCT00230971|27215696|P2|Baseline Participants|Adverse Event|0
7841393|NCT00230971|27215697|P1|Baseline Participants|Adverse Event|1
7841394|NCT00230971|27215696|P2|Baseline Participants|Withdrawal by Subject|1
7841395|NCT00230971|27215697|P1|Baseline Participants|Withdrawal by Subject|7
7841396|NCT00230971|27215696|P2|Baseline Participants|Death|5
7841397|NCT00230971|27215697|P1|Baseline Participants|Death|6
7841398|NCT00230971|27215696|P2|Baseline Participants|Lost to Follow-up|12
7841399|NCT00230971|27215697|P1|Baseline Participants|Lost to Follow-up|5
7841400|NCT00230971|27215696|P2|Randomization|No study drug administered|3
7841401|NCT00230971|27215697|P1|Randomization|No study drug administered|3
7841402|NCT00230282|27215735|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
7841403|NCT00230282|27215735|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
7841404|NCT00230282|27215735|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
7841405|NCT00230282|27215735|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
7841406|NCT00230178|27215743|P3|Overall Study|Various other reasons|4
7841407|NCT00230178|27215744|P2|Overall Study|Various other reasons|2
7841408|NCT00230178|27215745|P1|Overall Study|Various other reasons|3
7841409|NCT00230178|27215743|P3|Overall Study|Withdrawal by Subject|1
7841410|NCT00230178|27215744|P2|Overall Study|Withdrawal by Subject|0
7841411|NCT00230178|27215745|P1|Overall Study|Withdrawal by Subject|0
7841412|NCT00230178|27215743|P3|Overall Study|Adverse Event|2
7841413|NCT00230178|27215744|P2|Overall Study|Adverse Event|5
7841414|NCT00230178|27215745|P1|Overall Study|Adverse Event|1
7841415|NCT00230048|27215797|P2|Overall Study|Lost to Follow-up|18
7841416|NCT00230048|27215798|P1|Overall Study|Lost to Follow-up|13
7841417|NCT00229931|27215856|P2|Overall Study|Lost to Follow-up|2
7841418|NCT00229931|27215857|P1|Overall Study|Lost to Follow-up|3
7841419|NCT00229931|27215856|P2|Overall Study|Death|0
7841420|NCT00229931|27215857|P1|Overall Study|Death|1
7841421|NCT00229723|27215872|P7|Maintenance Phase|Other|1
7841422|NCT00229723|27215873|P6|Maintenance Phase|Other|3
7841423|NCT00229723|27215874|P5|Maintenance Phase|Other|3
7841424|NCT00229723|27215875|P4|Maintenance Phase|Other|2
7841425|NCT00229723|27215876|P3|Maintenance Phase|Other|1
7841426|NCT00229723|27215877|P2|Maintenance Phase|Other|4
7841427|NCT00229723|27215878|P1|Maintenance Phase|Other|5
7841428|NCT00229723|27215872|P7|Maintenance Phase|Severe non-compliance|0
7841429|NCT00229723|27215873|P6|Maintenance Phase|Severe non-compliance|0
7841430|NCT00229723|27215874|P5|Maintenance Phase|Severe non-compliance|1
7841431|NCT00229723|27215875|P4|Maintenance Phase|Severe non-compliance|0
7841432|NCT00229723|27215876|P3|Maintenance Phase|Severe non-compliance|0
7841433|NCT00229723|27215877|P2|Maintenance Phase|Severe non-compliance|1
7841434|NCT00229723|27215878|P1|Maintenance Phase|Severe non-compliance|3
7841435|NCT00229723|27215872|P7|Maintenance Phase|Informed consent withdrawn|0
7841436|NCT00229723|27215873|P6|Maintenance Phase|Informed consent withdrawn|1
7841437|NCT00229723|27215874|P5|Maintenance Phase|Informed consent withdrawn|1
7841438|NCT00229723|27215875|P4|Maintenance Phase|Informed consent withdrawn|1
7841439|NCT00229723|27215876|P3|Maintenance Phase|Informed consent withdrawn|0
7841440|NCT00229723|27215877|P2|Maintenance Phase|Informed consent withdrawn|0
7841441|NCT00229723|27215878|P1|Maintenance Phase|Informed consent withdrawn|1
7841442|NCT00229723|27215872|P7|Maintenance Phase|Lost to Follow-up|1
7841443|NCT00229723|27215873|P6|Maintenance Phase|Lost to Follow-up|0
7841444|NCT00229723|27215874|P5|Maintenance Phase|Lost to Follow-up|0
7841445|NCT00229723|27215875|P4|Maintenance Phase|Lost to Follow-up|2
7841446|NCT00229723|27215876|P3|Maintenance Phase|Lost to Follow-up|2
7841447|NCT00229723|27215877|P2|Maintenance Phase|Lost to Follow-up|1
7841448|NCT00229723|27215878|P1|Maintenance Phase|Lost to Follow-up|0
7841449|NCT00229723|27215872|P7|Maintenance Phase|Clinical progression|1
7841450|NCT00229723|27215873|P6|Maintenance Phase|Clinical progression|1
7841451|NCT00229723|27215874|P5|Maintenance Phase|Clinical progression|1
7841452|NCT00229723|27215875|P4|Maintenance Phase|Clinical progression|2
7841453|NCT00229723|27215876|P3|Maintenance Phase|Clinical progression|2
7841454|NCT00229723|27215877|P2|Maintenance Phase|Clinical progression|1
7841455|NCT00229723|27215878|P1|Maintenance Phase|Clinical progression|4
7841456|NCT00229723|27215872|P7|Maintenance Phase|Objective disease progression|5
7841457|NCT00229723|27215873|P6|Maintenance Phase|Objective disease progression|9
7841458|NCT00229723|27215874|P5|Maintenance Phase|Objective disease progression|2
7841459|NCT00229723|27215875|P4|Maintenance Phase|Objective disease progression|6
7841460|NCT00229723|27215876|P3|Maintenance Phase|Objective disease progression|3
7841461|NCT00229723|27215877|P2|Maintenance Phase|Objective disease progression|5
7841462|NCT00229723|27215878|P1|Maintenance Phase|Objective disease progression|5
7841463|NCT00229723|27215872|P7|Maintenance Phase|Adverse Event|2
7841464|NCT00229723|27215873|P6|Maintenance Phase|Adverse Event|5
7841465|NCT00229723|27215874|P5|Maintenance Phase|Adverse Event|7
7841466|NCT00229723|27215875|P4|Maintenance Phase|Adverse Event|4
7841467|NCT00229723|27215876|P3|Maintenance Phase|Adverse Event|1
7841468|NCT00229723|27215877|P2|Maintenance Phase|Adverse Event|2
7841469|NCT00229723|27215878|P1|Maintenance Phase|Adverse Event|7
7841470|NCT00229723|27215872|P7|Concomitant Phase|Other|0
7841471|NCT00229723|27215873|P6|Concomitant Phase|Other|2
7841472|NCT00229723|27215874|P5|Concomitant Phase|Other|0
7841473|NCT00229723|27215875|P4|Concomitant Phase|Other|1
7841474|NCT00229723|27215876|P3|Concomitant Phase|Other|1
7841475|NCT00229723|27215877|P2|Concomitant Phase|Other|0
7841476|NCT00229723|27215878|P1|Concomitant Phase|Other|3
7841477|NCT00229723|27215872|P7|Concomitant Phase|Severe non-compliance|0
7841478|NCT00229723|27215873|P6|Concomitant Phase|Severe non-compliance|0
7841479|NCT00229723|27215874|P5|Concomitant Phase|Severe non-compliance|1
7841480|NCT00229723|27215875|P4|Concomitant Phase|Severe non-compliance|0
7841481|NCT00229723|27215876|P3|Concomitant Phase|Severe non-compliance|0
7841482|NCT00229723|27215877|P2|Concomitant Phase|Severe non-compliance|1
7841483|NCT00229723|27215878|P1|Concomitant Phase|Severe non-compliance|0
7841484|NCT00229723|27215872|P7|Concomitant Phase|Informed consent withdrawn|0
7841485|NCT00229723|27215873|P6|Concomitant Phase|Informed consent withdrawn|0
7841486|NCT00229723|27215874|P5|Concomitant Phase|Informed consent withdrawn|0
7841487|NCT00229723|27215875|P4|Concomitant Phase|Informed consent withdrawn|2
7841488|NCT00229723|27215876|P3|Concomitant Phase|Informed consent withdrawn|0
7841489|NCT00229723|27215877|P2|Concomitant Phase|Informed consent withdrawn|2
7841490|NCT00229723|27215878|P1|Concomitant Phase|Informed consent withdrawn|3
7841491|NCT00229723|27215872|P7|Concomitant Phase|Lost to Follow-up|0
7841492|NCT00229723|27215873|P6|Concomitant Phase|Lost to Follow-up|0
7841493|NCT00229723|27215874|P5|Concomitant Phase|Lost to Follow-up|1
7841494|NCT00229723|27215875|P4|Concomitant Phase|Lost to Follow-up|0
7841495|NCT00229723|27215876|P3|Concomitant Phase|Lost to Follow-up|0
7841496|NCT00229723|27215877|P2|Concomitant Phase|Lost to Follow-up|0
7841497|NCT00229723|27215878|P1|Concomitant Phase|Lost to Follow-up|0
7841498|NCT00229723|27215872|P7|Concomitant Phase|Clinical progression|1
7841499|NCT00229723|27215873|P6|Concomitant Phase|Clinical progression|0
7841500|NCT00229723|27215874|P5|Concomitant Phase|Clinical progression|0
7841501|NCT00229723|27215875|P4|Concomitant Phase|Clinical progression|0
7841502|NCT00229723|27215876|P3|Concomitant Phase|Clinical progression|0
7841503|NCT00229723|27215877|P2|Concomitant Phase|Clinical progression|0
7841504|NCT00229723|27215878|P1|Concomitant Phase|Clinical progression|0
7841505|NCT00229723|27215872|P7|Concomitant Phase|Objective disease progression|0
7841506|NCT00229723|27215873|P6|Concomitant Phase|Objective disease progression|0
7841507|NCT00229723|27215874|P5|Concomitant Phase|Objective disease progression|0
7841508|NCT00229723|27215875|P4|Concomitant Phase|Objective disease progression|0
7841509|NCT00229723|27215876|P3|Concomitant Phase|Objective disease progression|0
7841510|NCT00229723|27215877|P2|Concomitant Phase|Objective disease progression|0
7841511|NCT00229723|27215878|P1|Concomitant Phase|Objective disease progression|0
7841512|NCT00229723|27215872|P7|Concomitant Phase|Adverse Event|2
7841513|NCT00229723|27215873|P6|Concomitant Phase|Adverse Event|1
7841514|NCT00229723|27215874|P5|Concomitant Phase|Adverse Event|0
7841515|NCT00229723|27215875|P4|Concomitant Phase|Adverse Event|2
7841516|NCT00229723|27215876|P3|Concomitant Phase|Adverse Event|5
7841517|NCT00229723|27215877|P2|Concomitant Phase|Adverse Event|2
7841518|NCT00229723|27215878|P1|Concomitant Phase|Adverse Event|4
7841519|NCT00229658|27215931|P2|Overall Study|Withdrawal of consent|39
7841520|NCT00229658|27215932|P1|Overall Study|Withdrawal of consent|46
7841521|NCT00229658|27215931|P2|Overall Study|Serious Adverse Event|2
7841522|NCT00229658|27215932|P1|Overall Study|Serious Adverse Event|2
7841523|NCT00229658|27215931|P2|Overall Study|Lost to Follow-up|55
7841524|NCT00229658|27215932|P1|Overall Study|Lost to Follow-up|82
7841525|NCT00229658|27215931|P2|Overall Study|Other|60
7841526|NCT00229658|27215932|P1|Overall Study|Other|80
7841527|NCT00229658|27215931|P2|Overall Study|Investigator decision|10
7841528|NCT00229658|27215932|P1|Overall Study|Investigator decision|13
7841529|NCT00229658|27215931|P2|Overall Study|Administrative|1
7841530|NCT00229658|27215932|P1|Overall Study|Administrative|2
7841531|NCT00229203|27215968|P2|Overall Study|Withdrawal by Subject|4
7841532|NCT00229203|27215969|P1|Overall Study|Withdrawal by Subject|1
7841533|NCT00229203|27215968|P2|Overall Study|Other|3
7841534|NCT00229203|27215969|P1|Overall Study|Other|3
7841535|NCT00229203|27215968|P2|Overall Study|Death|2
7841536|NCT00229203|27215969|P1|Overall Study|Death|4
7841537|NCT00229203|27215968|P2|Overall Study|Toxicity|1
7841538|NCT00229203|27215969|P1|Overall Study|Toxicity|6
7841539|NCT00229203|27215968|P2|Overall Study|Progressive disease|9
7841540|NCT00229203|27215969|P1|Overall Study|Progressive disease|18
7841541|NCT00228917|27215997|P8|Overall Study|Migrated/moved from study area|0
7841542|NCT00228917|27215998|P7|Overall Study|Migrated/moved from study area|0
7841543|NCT00228917|27215999|P6|Overall Study|Migrated/moved from study area|2
7841544|NCT00228917|27216000|P5|Overall Study|Migrated/moved from study area|0
7841545|NCT00228917|27216001|P4|Overall Study|Migrated/moved from study area|0
7841546|NCT00228917|27216002|P3|Overall Study|Migrated/moved from study area|0
7841547|NCT00228917|27216003|P2|Overall Study|Migrated/moved from study area|0
7841548|NCT00228917|27216004|P1|Overall Study|Migrated/moved from study area|0
7841549|NCT00228813|27216050|P1|Overall Study|Death|4
7841550|NCT00228566|27216056|P1|Overall Study|Miscellaneous|1
7841551|NCT00228566|27216056|P1|Overall Study|Withdrawal by Subject|4
7841552|NCT00228566|27216056|P1|Overall Study|Physician Decision|5
7841553|NCT00228566|27216056|P1|Overall Study|Lost to Follow-up|16
7841554|NCT00228566|27216056|P1|Overall Study|Lack of Efficacy|14
7841555|NCT00228566|27216056|P1|Overall Study|Adverse Event|31
7841556|NCT00228553|27216060|P1|Overall Study|Miscellaneous|46
7841557|NCT00228553|27216060|P1|Overall Study|Pregnancy|2
7841558|NCT00228553|27216060|P1|Overall Study|Withdrawal by Subject|115
7841559|NCT00228553|27216060|P1|Overall Study|Protocol Violation|6
7841560|NCT00228553|27216060|P1|Overall Study|Physician Decision|48
7841561|NCT00228553|27216060|P1|Overall Study|Lost to Follow-up|67
7841562|NCT00228553|27216060|P1|Overall Study|Lack of Efficacy|34
7841563|NCT00228553|27216060|P1|Overall Study|Adverse Event|112
7841564|NCT00228423|27216066|P2|Overall Study|Physician Decision|1
7841565|NCT00228423|27216067|P1|Overall Study|Physician Decision|0
7841566|NCT00228423|27216066|P2|Overall Study|Protocol Violation|3
7841567|NCT00228423|27216067|P1|Overall Study|Protocol Violation|1
7841568|NCT00228423|27216066|P2|Overall Study|Withdrawal by Subject|3
7841569|NCT00228423|27216067|P1|Overall Study|Withdrawal by Subject|7
7841570|NCT00228423|27216066|P2|Overall Study|Adverse Event|5
7841571|NCT00228423|27216067|P1|Overall Study|Adverse Event|2
7841572|NCT00228384|27216081|P2|Overall Study|Physician Decision|1
7841573|NCT00228384|27216082|P1|Overall Study|Physician Decision|0
7841574|NCT00228384|27216081|P2|Overall Study|Withdrawal by Subject|10
7841575|NCT00228384|27216082|P1|Overall Study|Withdrawal by Subject|9
7841576|NCT00228384|27216081|P2|Overall Study|Surgical Intervention (bypass)|5
7841577|NCT00228384|27216082|P1|Overall Study|Surgical Intervention (bypass)|5
7841578|NCT00228384|27216081|P2|Overall Study|Lost to Follow-up|10
7841579|NCT00228384|27216082|P1|Overall Study|Lost to Follow-up|6
7841580|NCT00228384|27216081|P2|Overall Study|Death|3
7841581|NCT00228384|27216082|P1|Overall Study|Death|9
7841582|NCT00227903|27216133|P2|Overall Study|Miscarriage|0
7841583|NCT00227903|27216134|P1|Overall Study|Miscarriage|1
7841584|NCT00227903|27216133|P2|Overall Study|Lost to Follow-up|3
7841585|NCT00227903|27216134|P1|Overall Study|Lost to Follow-up|1
7841586|NCT00227903|27216133|P2|Overall Study|Subject moved out of area|2
7841587|NCT00227903|27216134|P1|Overall Study|Subject moved out of area|1
7841588|NCT00227903|27216133|P2|Overall Study|Withdrawal by Subject|5
7841589|NCT00227903|27216134|P1|Overall Study|Withdrawal by Subject|2
7841590|NCT00227877|27216198|P4|12-months Follow-up|Lost to Follow-up|26
7841591|NCT00227877|27216199|P3|12-months Follow-up|Lost to Follow-up|30
7841592|NCT00227877|27216200|P2|12-months Follow-up|Lost to Follow-up|189
7841593|NCT00227877|27216201|P1|12-months Follow-up|Lost to Follow-up|232
7841594|NCT00227877|27216198|P4|12-months Follow-up|Completed late|0
7841595|NCT00227877|27216199|P3|12-months Follow-up|Completed late|1
7841596|NCT00227877|27216200|P2|12-months Follow-up|Completed late|74
7841597|NCT00227877|27216201|P1|12-months Follow-up|Completed late|78
7841598|NCT00227877|27216198|P4|3-months Follow-up|Lost to Follow-up|13
7841599|NCT00227877|27216199|P3|3-months Follow-up|Lost to Follow-up|18
7841600|NCT00227877|27216200|P2|3-months Follow-up|Lost to Follow-up|139
7841601|NCT00227877|27216201|P1|3-months Follow-up|Lost to Follow-up|178
7841602|NCT00227877|27216198|P4|3-months Follow-up|Completed late|8
7841603|NCT00227877|27216199|P3|3-months Follow-up|Completed late|34
7841604|NCT00227877|27216200|P2|3-months Follow-up|Completed late|128
7841605|NCT00227877|27216201|P1|3-months Follow-up|Completed late|135
7841606|NCT00227877|27216198|P4|Post-visit Checklist|Lost to Follow-up|0
7841607|NCT00227877|27216199|P3|Post-visit Checklist|Lost to Follow-up|1
7841608|NCT00227877|27216200|P2|Post-visit Checklist|Lost to Follow-up|13
7841609|NCT00227877|27216201|P1|Post-visit Checklist|Lost to Follow-up|24
7841610|NCT00227877|27216198|P4|Pre-visit Assessment|Technical difficulties|0
7841611|NCT00227877|27216199|P3|Pre-visit Assessment|Technical difficulties|0
7841612|NCT00227877|27216200|P2|Pre-visit Assessment|Technical difficulties|3
7841613|NCT00227877|27216201|P1|Pre-visit Assessment|Technical difficulties|7
7841614|NCT00227721|27216237|P1|Overall Study|On study, but never treated.|1
7841615|NCT00227591|27216260|P1|Overall Study|Withdrawal by Subject|1
7841616|NCT00227539|27216264|P1|Overall Study|Protocol Violation|1
7841617|NCT00227370|27216272|P2|Overall Study|Other reasons|1
7841618|NCT00227370|27216273|P1|Overall Study|Other reasons|2
7841619|NCT00227370|27216272|P2|Overall Study|Physician Decision|6
7841620|NCT00227370|27216273|P1|Overall Study|Physician Decision|9
7841621|NCT00227370|27216272|P2|Overall Study|Adverse Event|11
7841622|NCT00227370|27216273|P1|Overall Study|Adverse Event|6
7841623|NCT00227370|27216272|P2|Overall Study|Death|4
7841624|NCT00227370|27216273|P1|Overall Study|Death|3
7841625|NCT00227370|27216272|P2|Overall Study|Withdrawal by Subject|2
7841626|NCT00227370|27216273|P1|Overall Study|Withdrawal by Subject|1
7841627|NCT00227344|27216293|P2|Overall Study|study terminated early|5
7841628|NCT00227344|27216294|P1|Overall Study|study terminated early|12
7841629|NCT00227305|27216314|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
7841630|NCT00227305|27216314|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
7841631|NCT00227305|27216314|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
7841632|NCT00227305|27216314|P1|Overall Study|Physician Decision|3
7841633|NCT00227305|27216314|P1|Overall Study|Lack of Efficacy|7
7841634|NCT00227305|27216314|P1|Overall Study|MOVED OUT OF AREA|3
7841635|NCT00227305|27216314|P1|Overall Study|Study specific discontinuation|13
7841636|NCT00227305|27216314|P1|Overall Study|Lost to Follow-up|33
7841637|NCT00227305|27216314|P1|Overall Study|Withdrawal by Subject|42
7841638|NCT00227305|27216314|P1|Overall Study|Adverse Event|40
7841639|NCT00227266|27216331|P3|Overall Study|Excessive weight gain|2
7841640|NCT00227266|27216332|P2|Overall Study|Excessive weight gain|0
7841641|NCT00227266|27216333|P1|Overall Study|Excessive weight gain|0
7841642|NCT00227266|27216331|P3|Overall Study|Protocol Violation|1
7841643|NCT00227266|27216332|P2|Overall Study|Protocol Violation|0
7841644|NCT00227266|27216333|P1|Overall Study|Protocol Violation|1
7841645|NCT00227266|27216331|P3|Overall Study|Withdrawal by Subject|1
7841646|NCT00227266|27216332|P2|Overall Study|Withdrawal by Subject|0
7841647|NCT00227266|27216333|P1|Overall Study|Withdrawal by Subject|0
7841648|NCT00226941|27216363|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
7841649|NCT00226941|27216364|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
7841650|NCT00226941|27216365|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
7841651|NCT00226941|27216366|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
7841652|NCT00226941|27216363|P4|Overall Study|Withdrawal by subject - toxicity|1
7841653|NCT00226941|27216364|P3|Overall Study|Withdrawal by subject - toxicity|0
7841654|NCT00226941|27216365|P2|Overall Study|Withdrawal by subject - toxicity|0
7841655|NCT00226941|27216366|P1|Overall Study|Withdrawal by subject - toxicity|0
7841656|NCT00226811|27216400|P1|Overall Study|Withdrawal by Subject|2
7841657|NCT00226811|27216400|P1|Overall Study|Lack of Efficacy|55
7841658|NCT00226811|27216400|P1|Overall Study|Adverse Event|11
7841659|NCT00226811|27216400|P1|Overall Study|Death|8
7841660|NCT00226655|27216410|P1|Overall Study|Clinical deterioration|10
7841661|NCT00226655|27216410|P1|Overall Study|Physician Decision|6
7841662|NCT00226655|27216410|P1|Overall Study|Adverse Event|35
7841663|NCT00226655|27216410|P1|Overall Study|Withdrawal by Subject|15
7841664|NCT00226655|27216410|P1|Overall Study|Death|13
7841665|NCT00226499|27216432|P3|Overall Study|Others|356
7841666|NCT00226499|27216433|P2|Overall Study|Others|1066
7841667|NCT00226499|27216434|P1|Overall Study|Others|1064
7841668|NCT00226499|27216432|P3|Overall Study|Adverse Event|3
7841669|NCT00226499|27216433|P2|Overall Study|Adverse Event|6
7841670|NCT00226499|27216434|P1|Overall Study|Adverse Event|10
7841671|NCT00225758|27216569|P1|Overall Study|Adverse Event|4
7841672|NCT00225277|27216601|P2|Overall Study|Other|9
7841673|NCT00225277|27216602|P1|Overall Study|Other|7
7841674|NCT00225277|27216601|P2|Overall Study|Withdrawal by Subject|34
7841675|NCT00225277|27216602|P1|Overall Study|Withdrawal by Subject|40
7841676|NCT00225277|27216601|P2|Overall Study|Protocol Violation|3
7841677|NCT00225277|27216602|P1|Overall Study|Protocol Violation|6
7841678|NCT00225277|27216601|P2|Overall Study|Physician Decision|8
7841679|NCT00225277|27216602|P1|Overall Study|Physician Decision|6
7841680|NCT00225277|27216601|P2|Overall Study|Lost to Follow-up|6
7841681|NCT00225277|27216602|P1|Overall Study|Lost to Follow-up|4
7841682|NCT00225277|27216601|P2|Overall Study|Lack of Efficacy|1
7841683|NCT00225277|27216602|P1|Overall Study|Lack of Efficacy|4
7841684|NCT00225277|27216601|P2|Overall Study|Adverse Event|34
7841685|NCT00225277|27216602|P1|Overall Study|Adverse Event|30
7841686|NCT00225251|27216620|P2|Overall Study|Withdrawal by Subject|1
7841687|NCT00225251|27216621|P1|Overall Study|Withdrawal by Subject|1
7841688|NCT00225212|27216635|P1|Overall Study|Intercurrent illness|1
7841689|NCT00225212|27216635|P1|Overall Study|Adverse Event|2
7841690|NCT00225212|27216635|P1|Overall Study|Death|1
7841691|NCT00225212|27216635|P1|Overall Study|Disease progression|2
7841692|NCT00225147|27216644|P4|Open-label Phase|Withdrawal by Subject|6
7841693|NCT00225147|27216645|P3|Open-label Phase|Withdrawal by Subject|0
7841694|NCT00225147|27216646|P2|Open-label Phase|Withdrawal by Subject|0
7841695|NCT00225147|27216647|P1|Open-label Phase|Withdrawal by Subject|0
7841696|NCT00225147|27216644|P4|Open-label Phase|Lost to Follow-up|4
7841697|NCT00225147|27216645|P3|Open-label Phase|Lost to Follow-up|0
7841698|NCT00225147|27216646|P2|Open-label Phase|Lost to Follow-up|0
7841699|NCT00225147|27216647|P1|Open-label Phase|Lost to Follow-up|0
7841700|NCT00224887|27216692|P2|Overall Study|Pregnancy|6
7841701|NCT00224887|27216693|P1|Overall Study|Pregnancy|6
7841702|NCT00224874|27216703|P4|Overall Study|Withdrawal by Subject|0
7841703|NCT00224874|27216704|P3|Overall Study|Withdrawal by Subject|1
7841704|NCT00224874|27216705|P2|Overall Study|Withdrawal by Subject|0
7841705|NCT00224874|27216706|P1|Overall Study|Withdrawal by Subject|0
7841706|NCT00224770|27216751|P3|Overall Study|Lost to Follow-up|0
7841707|NCT00224770|27216752|P2|Overall Study|Lost to Follow-up|2
7841708|NCT00224770|27216753|P1|Overall Study|Lost to Follow-up|4
7841709|NCT00224484|27216788|P3|Overall Study|Reason not specified|2
7841710|NCT00224484|27216789|P2|Overall Study|Reason not specified|4
7841711|NCT00224484|27216790|P1|Overall Study|Reason not specified|5
7841712|NCT00224484|27216788|P3|Overall Study|Lost to Follow-up|36
7841713|NCT00224484|27216789|P2|Overall Study|Lost to Follow-up|28
7841714|NCT00224484|27216790|P1|Overall Study|Lost to Follow-up|66
7841715|NCT00224484|27216788|P3|Overall Study|Migrated/moved from study area|5
7841716|NCT00224484|27216789|P2|Overall Study|Migrated/moved from study area|5
7841717|NCT00224484|27216790|P1|Overall Study|Migrated/moved from study area|18
7841718|NCT00224484|27216788|P3|Overall Study|Withdrawal by Subject|16
7841719|NCT00224484|27216789|P2|Overall Study|Withdrawal by Subject|18
7841720|NCT00224484|27216790|P1|Overall Study|Withdrawal by Subject|49
7841721|NCT00224484|27216788|P3|Overall Study|Protocol Violation|0
7841722|NCT00224484|27216789|P2|Overall Study|Protocol Violation|2
7841723|NCT00224484|27216790|P1|Overall Study|Protocol Violation|2
7841724|NCT00224484|27216788|P3|Overall Study|Non-Serious Adverse Event|3
7841725|NCT00224484|27216789|P2|Overall Study|Non-Serious Adverse Event|7
7841726|NCT00224484|27216790|P1|Overall Study|Non-Serious Adverse Event|5
7841727|NCT00224484|27216788|P3|Overall Study|Serious Adverse Event|0
7841728|NCT00224484|27216789|P2|Overall Study|Serious Adverse Event|1
7841729|NCT00224484|27216790|P1|Overall Study|Serious Adverse Event|1
7841730|NCT00224133|27216854|P1|Overall Study|Other|14
7841731|NCT00224133|27216854|P1|Overall Study|Physician Decision|1
7841732|NCT00224133|27216854|P1|Overall Study|Lost to Follow-up|21
7841733|NCT00224133|27216854|P1|Overall Study|Lack of Efficacy|58
7841734|NCT00224133|27216854|P1|Overall Study|Withdrawal by Subject|33
7841735|NCT00224133|27216854|P1|Overall Study|Protocol Violation|6
7841736|NCT00224133|27216854|P1|Overall Study|Adverse Event|93
7841737|NCT00224120|27216860|P2|Overall Study|Other|5
7841738|NCT00224120|27216861|P1|Overall Study|Other|4
7841739|NCT00224120|27216860|P2|Overall Study|Lost to Follow-up|3
7841740|NCT00224120|27216861|P1|Overall Study|Lost to Follow-up|2
7841741|NCT00224120|27216860|P2|Overall Study|Lack of Efficacy|2
7841742|NCT00224120|27216861|P1|Overall Study|Lack of Efficacy|0
7841743|NCT00224120|27216860|P2|Overall Study|Withdrawal by Subject|10
7841744|NCT00224120|27216861|P1|Overall Study|Withdrawal by Subject|5
7841745|NCT00224120|27216860|P2|Overall Study|Protocol Violation|0
7841746|NCT00224120|27216861|P1|Overall Study|Protocol Violation|1
7841747|NCT00224120|27216860|P2|Overall Study|Adverse Event|4
7841748|NCT00224120|27216861|P1|Overall Study|Adverse Event|10
7841749|NCT00224107|27216871|P2|Overall Study|Other|1
7841750|NCT00224107|27216872|P1|Overall Study|Other|1
7841751|NCT00224107|27216871|P2|Overall Study|Physician Decision|0
7841752|NCT00224107|27216872|P1|Overall Study|Physician Decision|1
7841753|NCT00224107|27216871|P2|Overall Study|Lost to Follow-up|0
7841754|NCT00224107|27216872|P1|Overall Study|Lost to Follow-up|4
7841755|NCT00224107|27216871|P2|Overall Study|Lack of Efficacy|0
7841756|NCT00224107|27216872|P1|Overall Study|Lack of Efficacy|2
7841757|NCT00224107|27216871|P2|Overall Study|Withdrawal by Subject|4
7841758|NCT00224107|27216872|P1|Overall Study|Withdrawal by Subject|1
7841759|NCT00224107|27216871|P2|Overall Study|Protocol Violation|3
7841760|NCT00224107|27216872|P1|Overall Study|Protocol Violation|2
7841761|NCT00224107|27216871|P2|Overall Study|Adverse Event|6
7841762|NCT00224107|27216872|P1|Overall Study|Adverse Event|20
7841763|NCT00224055|27216882|P2|Overall Study|Other|0
7841764|NCT00224055|27216883|P1|Overall Study|Other|1
7841765|NCT00224055|27216882|P2|Overall Study|Withdrawal by Subject|2
7841766|NCT00224055|27216883|P1|Overall Study|Withdrawal by Subject|0
7841767|NCT00224055|27216882|P2|Overall Study|Inclusion Violation|6
7841768|NCT00224055|27216883|P1|Overall Study|Inclusion Violation|3
7841769|NCT00224055|27216882|P2|Overall Study|Protocol Violation|1
7841770|NCT00224055|27216883|P1|Overall Study|Protocol Violation|1
7841771|NCT00224055|27216882|P2|Overall Study|Lost to Follow-up|2
7841772|NCT00224055|27216883|P1|Overall Study|Lost to Follow-up|1
7841773|NCT00224055|27216882|P2|Overall Study|Adverse Event|3
7841774|NCT00224055|27216883|P1|Overall Study|Adverse Event|9
7841775|NCT00224042|27216893|P2|Overall Study|Other|0
7841776|NCT00224042|27216894|P1|Overall Study|Other|2
7841777|NCT00224042|27216893|P2|Overall Study|Did not meet lab incusion criteria|3
7841778|NCT00224042|27216894|P1|Overall Study|Did not meet lab incusion criteria|2
7841779|NCT00224042|27216893|P2|Overall Study|Physician Decision|1
7841780|NCT00224042|27216894|P1|Overall Study|Physician Decision|0
7841781|NCT00224042|27216893|P2|Overall Study|Protocol Violation|1
7841782|NCT00224042|27216894|P1|Overall Study|Protocol Violation|0
7841783|NCT00224042|27216893|P2|Overall Study|Adverse Event|1
7841784|NCT00224042|27216894|P1|Overall Study|Adverse Event|2
7841785|NCT00224029|27216906|P1|Overall Study|Other|1
7841786|NCT00224029|27216906|P1|Overall Study|Withdrawal by Subject|4
7841787|NCT00224029|27216906|P1|Overall Study|Lost to Follow-up|1
7841788|NCT00224016|27216912|P2|Maintenance Period|Lost to Follow-up|1
7841789|NCT00224016|27216913|P1|Maintenance Period|Lost to Follow-up|0
7841790|NCT00224016|27216912|P2|Maintenance Period|Withdrawal by Subject|0
7841791|NCT00224016|27216913|P1|Maintenance Period|Withdrawal by Subject|2
7841792|NCT00224016|27216912|P2|Titration Period|Lost to Follow-up|0
7841793|NCT00224016|27216913|P1|Titration Period|Lost to Follow-up|1
7841794|NCT00224016|27216912|P2|Titration Period|Withdrawal by Subject|1
7841795|NCT00224016|27216913|P1|Titration Period|Withdrawal by Subject|0
7841796|NCT00224003|27216921|P1|Overall Study|unk|3
7841797|NCT00224003|27216921|P1|Overall Study|Withdrawal by Subject|1
7841798|NCT00224003|27216921|P1|Overall Study|Protocol Violation|2
7841799|NCT00224003|27216921|P1|Overall Study|Adverse Event|1
7841800|NCT00223990|27216927|P2|Overall Study|Lost to Follow-up|0
7841801|NCT00223990|27216928|P1|Overall Study|Lost to Follow-up|1
7841802|NCT00223990|27216927|P2|Overall Study|Withdrawal by Subject|8
7841803|NCT00223990|27216928|P1|Overall Study|Withdrawal by Subject|4
7841804|NCT00223990|27216927|P2|Overall Study|Moved from area|1
7841805|NCT00223990|27216928|P1|Overall Study|Moved from area|2
7841806|NCT00223977|27216953|P3|Overall Study|Other|0
7841807|NCT00223977|27216954|P2|Overall Study|Other|0
7841808|NCT00223977|27216955|P1|Overall Study|Other|1
7841809|NCT00223977|27216953|P3|Overall Study|Withdrawal by Subject|2
7841810|NCT00223977|27216954|P2|Overall Study|Withdrawal by Subject|1
7841811|NCT00223977|27216955|P1|Overall Study|Withdrawal by Subject|1
7841812|NCT00223977|27216953|P3|Overall Study|Protocol Violation|1
7841813|NCT00223977|27216954|P2|Overall Study|Protocol Violation|0
7841814|NCT00223977|27216955|P1|Overall Study|Protocol Violation|0
7841815|NCT00223977|27216953|P3|Overall Study|Adverse Event|0
7841816|NCT00223977|27216954|P2|Overall Study|Adverse Event|10
7841817|NCT00223977|27216955|P1|Overall Study|Adverse Event|7
7841818|NCT00223808|27216989|P3|Overall Study|<5 hrs therapy before discharge|5
7841819|NCT00223808|27216990|P2|Overall Study|<5 hrs therapy before discharge|5
7841820|NCT00223808|27216991|P1|Overall Study|<5 hrs therapy before discharge|3
7841821|NCT00223795|27217008|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
7841822|NCT00223795|27217009|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
7841823|NCT00223795|27217008|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
7841824|NCT00223795|27217009|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
7841825|NCT00223496|27217087|P1|Overall Study|Physician Decision|2
7841826|NCT00223496|27217087|P1|Overall Study|Withdrawal by Subject|1
7841827|NCT00223496|27217087|P1|Overall Study|Lack of Efficacy|6
7841828|NCT00223496|27217087|P1|Overall Study|Lost to Follow-up|4
7841829|NCT00223496|27217087|P1|Overall Study|screen failure|9
7841830|NCT00223080|27217117|P2|Overall Study|Adverse Event|1
7841831|NCT00223080|27217118|P1|Overall Study|Adverse Event|0
7841832|NCT00223080|27217117|P2|Overall Study|Reason not provided|140
7841833|NCT00223080|27217118|P1|Overall Study|Reason not provided|141
7841834|NCT00223080|27217117|P2|Overall Study|Other|11
7841835|NCT00223080|27217118|P1|Overall Study|Other|14
7841836|NCT00223080|27217117|P2|Overall Study|Death|74
7841837|NCT00223080|27217118|P1|Overall Study|Death|85
7841838|NCT00223080|27217117|P2|Overall Study|Lost to Follow-up|284
7841839|NCT00223080|27217118|P1|Overall Study|Lost to Follow-up|259
7841840|NCT00223080|27217117|P2|Overall Study|Moved from study area|47
7841841|NCT00223080|27217118|P1|Overall Study|Moved from study area|37
7841842|NCT00223080|27217117|P2|Overall Study|Non-compliant|7
7841843|NCT00223080|27217118|P1|Overall Study|Non-compliant|7
7841844|NCT00223080|27217117|P2|Overall Study|Required contraindicated med|1
7841845|NCT00223080|27217118|P1|Overall Study|Required contraindicated med|0
7841846|NCT00223080|27217117|P2|Overall Study|Withdrawal by Subject|232
7841847|NCT00223080|27217118|P1|Overall Study|Withdrawal by Subject|253
7841848|NCT00222729|27217136|P1|Overall Study|Adverse Event|3
7841849|NCT00222105|27217154|P1|Overall Study|Death|2
7841850|NCT00222105|27217154|P1|Overall Study|Treatment delays|2
7841851|NCT00222105|27217154|P1|Overall Study|Adverse Event|8
7841852|NCT00222105|27217154|P1|Overall Study|Withdrawal by Subject|1
7841853|NCT00222105|27217154|P1|Overall Study|Removed due to wrong diagnosis|1
7841854|NCT00221403|27217162|P3|Overall Study|Adverse Event|0
7841855|NCT00221403|27217163|P2|Overall Study|Adverse Event|1
7841856|NCT00221403|27217164|P1|Overall Study|Adverse Event|0
7841857|NCT00221403|27217162|P3|Overall Study|Lack of Efficacy|0
7841858|NCT00221403|27217163|P2|Overall Study|Lack of Efficacy|1
7841859|NCT00221403|27217164|P1|Overall Study|Lack of Efficacy|0
7841860|NCT00221403|27217162|P3|Overall Study|Withdrawal by Subject|0
7841861|NCT00221403|27217163|P2|Overall Study|Withdrawal by Subject|3
7841862|NCT00221403|27217164|P1|Overall Study|Withdrawal by Subject|0
7841863|NCT00221403|27217162|P3|Overall Study|Physician Decision|0
7841864|NCT00221403|27217163|P2|Overall Study|Physician Decision|0
7841865|NCT00221403|27217164|P1|Overall Study|Physician Decision|1
7841866|NCT00221403|27217162|P3|Overall Study|Protocol Violation|0
7841867|NCT00221403|27217163|P2|Overall Study|Protocol Violation|0
7841868|NCT00221403|27217164|P1|Overall Study|Protocol Violation|1
7841869|NCT00221195|27217207|P2|Therapy 2 (Months 10-15)|Adverse Event|0
7841870|NCT00221195|27217208|P1|Therapy 2 (Months 10-15)|Adverse Event|1
7841871|NCT00221195|27217207|P2|Therapy 2 (Months 10-15)|Death|0
7841872|NCT00221195|27217208|P1|Therapy 2 (Months 10-15)|Death|1
7841873|NCT00221195|27217207|P2|Washout Period (Months 7-9)|Death|1
7841874|NCT00221195|27217208|P1|Washout Period (Months 7-9)|Death|0
7841875|NCT00221195|27217207|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
7841876|NCT00221195|27217208|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
7841877|NCT00221195|27217207|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
7841878|NCT00221195|27217208|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
7841879|NCT00221104|27217230|P2|Overall Study|Others|47
7841880|NCT00221104|27217231|P1|Overall Study|Others|37
7841881|NCT00221104|27217230|P2|Overall Study|Withdrawal by Subject|29
7841882|NCT00221104|27217231|P1|Overall Study|Withdrawal by Subject|42
7841883|NCT00221104|27217230|P2|Overall Study|Protocol Violation|0
7841884|NCT00221104|27217231|P1|Overall Study|Protocol Violation|2
7841885|NCT00221104|27217230|P2|Overall Study|Physician Decision|0
7841886|NCT00221104|27217231|P1|Overall Study|Physician Decision|1
7841887|NCT00221104|27217230|P2|Overall Study|Adverse Event|0
7841888|NCT00221104|27217231|P1|Overall Study|Adverse Event|1
7841889|NCT00220805|27217264|P2|Overall Study|Develop. of choroidal neovascularization|8
7841890|NCT00220805|27217265|P1|Overall Study|Develop. of choroidal neovascularization|3
7841891|NCT00220805|27217264|P2|Overall Study|Lack of Efficacy|0
7841892|NCT00220805|27217265|P1|Overall Study|Lack of Efficacy|1
7841893|NCT00220805|27217264|P2|Overall Study|Withdrawal by Subject|0
7841894|NCT00220805|27217265|P1|Overall Study|Withdrawal by Subject|3
7841895|NCT00220805|27217264|P2|Overall Study|Adverse Event|3
7841896|NCT00220805|27217265|P1|Overall Study|Adverse Event|1
7841897|NCT00220779|27217286|P3|Overall Study|Lack of Efficacy|1
7841898|NCT00220779|27217287|P2|Overall Study|Lack of Efficacy|0
7841899|NCT00220779|27217288|P1|Overall Study|Lack of Efficacy|3
7841900|NCT00220779|27217286|P3|Overall Study|Pregnancy|2
7841901|NCT00220779|27217287|P2|Overall Study|Pregnancy|0
7841902|NCT00220779|27217288|P1|Overall Study|Pregnancy|0
7841903|NCT00220779|27217286|P3|Overall Study|Too time consuming|0
7841904|NCT00220779|27217287|P2|Overall Study|Too time consuming|0
7841905|NCT00220779|27217288|P1|Overall Study|Too time consuming|1
7841906|NCT00220779|27217286|P3|Overall Study|Non-compliance|0
7841907|NCT00220779|27217287|P2|Overall Study|Non-compliance|0
7841908|NCT00220779|27217288|P1|Overall Study|Non-compliance|1
7841909|NCT00220779|27217286|P3|Overall Study|Withdrawal by Subject|1
7841910|NCT00220779|27217287|P2|Overall Study|Withdrawal by Subject|4
7841911|NCT00220779|27217288|P1|Overall Study|Withdrawal by Subject|1
7841912|NCT00220779|27217286|P3|Overall Study|Adverse Event|0
7841913|NCT00220779|27217287|P2|Overall Study|Adverse Event|0
7841914|NCT00220779|27217288|P1|Overall Study|Adverse Event|1
7841915|NCT00220740|27217298|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
7841916|NCT00220740|27217299|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
7841917|NCT00220740|27217298|P2|Efficacy Period|Protocol Violation|0
7841918|NCT00220740|27217299|P1|Efficacy Period|Protocol Violation|1
7841919|NCT00220740|27217298|P2|Efficacy Period|Withdrawal by Subject|0
7841920|NCT00220740|27217299|P1|Efficacy Period|Withdrawal by Subject|1
7841921|NCT00220740|27217298|P2|Efficacy Period|Adverse Event|1
7841922|NCT00220740|27217299|P1|Efficacy Period|Adverse Event|1
7841923|NCT00220740|27217298|P2|Efficacy Period|Entered rescue treatment with placebo|0
7841924|NCT00220740|27217299|P1|Efficacy Period|Entered rescue treatment with placebo|23
7841925|NCT00220727|27217313|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
7841926|NCT00220727|27217314|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
7841927|NCT00220701|27217330|P2|Overall Study|Lost to Follow-up|4
7841928|NCT00220701|27217331|P1|Overall Study|Lost to Follow-up|5
7841929|NCT00220636|27217347|P1|Overall Study|Withdrawal by Subject|4
7841930|NCT00219557|27217357|P3|Phase 2|Treatment not received|3
7841931|NCT00219557|27217358|P2|Phase 2|Treatment not received|1
7841932|NCT00219557|27217359|P1|Phase 2|Treatment not received|0
7841933|NCT00219557|27217357|P3|Phase 2|Withdrawal by Subject|5
7841934|NCT00219557|27217358|P2|Phase 2|Withdrawal by Subject|9
7841935|NCT00219557|27217359|P1|Phase 2|Withdrawal by Subject|0
7841936|NCT00219557|27217357|P3|Phase 2|Other|6
7841937|NCT00219557|27217358|P2|Phase 2|Other|8
7841938|NCT00219557|27217359|P1|Phase 2|Other|0
7841939|NCT00219557|27217357|P3|Phase 2|Death|2
7841940|NCT00219557|27217358|P2|Phase 2|Death|8
7841941|NCT00219557|27217359|P1|Phase 2|Death|0
7841942|NCT00219557|27217357|P3|Phase 2|Adverse Event|2
7841943|NCT00219557|27217358|P2|Phase 2|Adverse Event|22
7841944|NCT00219557|27217359|P1|Phase 2|Adverse Event|0
7841945|NCT00219557|27217357|P3|Phase 2|Lack of Efficacy|15
7841946|NCT00219557|27217358|P2|Phase 2|Lack of Efficacy|21
7841947|NCT00219557|27217359|P1|Phase 2|Lack of Efficacy|0
7841948|NCT00219557|27217357|P3|Phase 1|Started chemotherapy at other institute|0
7841949|NCT00219557|27217358|P2|Phase 1|Started chemotherapy at other institute|0
7841950|NCT00219557|27217359|P1|Phase 1|Started chemotherapy at other institute|1
7841951|NCT00219557|27217357|P3|Phase 1|Withdrawal by Subject|0
7841952|NCT00219557|27217358|P2|Phase 1|Withdrawal by Subject|0
7841953|NCT00219557|27217359|P1|Phase 1|Withdrawal by Subject|1
7841954|NCT00219557|27217357|P3|Phase 1|Adverse Event|0
7841955|NCT00219557|27217358|P2|Phase 1|Adverse Event|0
7841956|NCT00219557|27217359|P1|Phase 1|Adverse Event|2
7841957|NCT00219557|27217357|P3|Phase 1|Lack of Efficacy|0
7841958|NCT00219557|27217358|P2|Phase 1|Lack of Efficacy|0
7841959|NCT00219557|27217359|P1|Phase 1|Lack of Efficacy|3
7841960|NCT00219544|27217387|P2|Single Blind Treatment Period|Withdrawal by Subject|0
7841961|NCT00219544|27217388|P1|Single Blind Treatment Period|Withdrawal by Subject|1
7841962|NCT00219544|27217387|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
7841963|NCT00219544|27217388|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
7841964|NCT00219544|27217387|P2|Single Blind Treatment Period|Lost to Follow-up|0
7841965|NCT00219544|27217388|P1|Single Blind Treatment Period|Lost to Follow-up|2
7841966|NCT00219544|27217387|P2|Single Blind Treatment Period|Protocol Violation|0
7841967|NCT00219544|27217388|P1|Single Blind Treatment Period|Protocol Violation|4
7841968|NCT00219544|27217387|P2|Single Blind Treatment Period|Adverse Event|0
7841969|NCT00219544|27217388|P1|Single Blind Treatment Period|Adverse Event|9
7841970|NCT00219544|27217387|P2|Single Blind Treatment Period|Lack of Efficacy|0
7841971|NCT00219544|27217388|P1|Single Blind Treatment Period|Lack of Efficacy|5
7841972|NCT00219349|27217426|P1|Escitalopram Phase|Withdrawal by Subject|3
7841973|NCT00219349|27217426|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
7841974|NCT00219349|27217426|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
7841975|NCT00219349|27217426|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
7841976|NCT00219284|27217439|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
7841977|NCT00219284|27217440|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
7841978|NCT00219284|27217439|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
7841979|NCT00219284|27217440|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
7841980|NCT00219284|27217439|P2|Extension Phase - 8 Weeks|Adverse Event|3
7841981|NCT00219284|27217440|P1|Extension Phase - 8 Weeks|Adverse Event|2
7841982|NCT00219284|27217439|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
7841983|NCT00219284|27217440|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
7841984|NCT00219284|27217439|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
7841985|NCT00219284|27217440|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
7841986|NCT00219284|27217439|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
7841987|NCT00219284|27217440|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
7841988|NCT00219284|27217439|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
7841989|NCT00219284|27217440|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
7841990|NCT00219284|27217439|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
7841991|NCT00219284|27217440|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
7841992|NCT00219284|27217439|P2|Treatment Phase - 16 Weeks|Adverse Event|24
7841993|NCT00219284|27217440|P1|Treatment Phase - 16 Weeks|Adverse Event|26
7841994|NCT00219141|27217465|P3|Overall Study|Condition no longer requires study drug|0
7841995|NCT00219141|27217466|P2|Overall Study|Condition no longer requires study drug|0
7841996|NCT00219141|27217467|P1|Overall Study|Condition no longer requires study drug|1
7841997|NCT00219141|27217465|P3|Overall Study|Withdrawal by Subject|5
7841998|NCT00219141|27217466|P2|Overall Study|Withdrawal by Subject|3
7841999|NCT00219141|27217467|P1|Overall Study|Withdrawal by Subject|1
7842000|NCT00219141|27217465|P3|Overall Study|Protocol Violation|1
7842001|NCT00219141|27217466|P2|Overall Study|Protocol Violation|1
7842002|NCT00219141|27217467|P1|Overall Study|Protocol Violation|3
7842003|NCT00219141|27217465|P3|Overall Study|Lost to Follow-up|1
7842004|NCT00219141|27217466|P2|Overall Study|Lost to Follow-up|4
7842005|NCT00219141|27217467|P1|Overall Study|Lost to Follow-up|2
7842006|NCT00219141|27217465|P3|Overall Study|Administrative problems|0
7842007|NCT00219141|27217466|P2|Overall Study|Administrative problems|1
7842008|NCT00219141|27217467|P1|Overall Study|Administrative problems|0
7842009|NCT00219141|27217465|P3|Overall Study|Lack of Efficacy|0
7842010|NCT00219141|27217466|P2|Overall Study|Lack of Efficacy|2
7842011|NCT00219141|27217467|P1|Overall Study|Lack of Efficacy|3
7842012|NCT00219141|27217465|P3|Overall Study|Adverse Event|5
7842013|NCT00219141|27217466|P2|Overall Study|Adverse Event|10
7842014|NCT00219141|27217467|P1|Overall Study|Adverse Event|4
7842015|NCT00218634|27217513|P2|Overall Study|Lost to Follow-up|15
7842016|NCT00218634|27217514|P1|Overall Study|Lost to Follow-up|8
7842017|NCT00218543|27217534|P1|Overall Study|Adverse Event|2
7842018|NCT00218543|27217534|P1|Overall Study|Physician Decision|3
7842019|NCT00218543|27217534|P1|Overall Study|Withdrawal by Subject|1
7842020|NCT00218543|27217534|P1|Overall Study|relocated|1
7842021|NCT00218543|27217534|P1|Overall Study|Lost to Follow-up|8
7842022|NCT00218296|27217712|P2|Overall Study|Randomized but did not enter treatment|67
7842023|NCT00218296|27217713|P1|Overall Study|Randomized but did not enter treatment|66
7842024|NCT00218296|27217712|P2|Overall Study|Withdrawal by Subject|47
7842025|NCT00218296|27217713|P1|Overall Study|Withdrawal by Subject|36
7842026|NCT00218296|27217712|P2|Overall Study|Lost to Follow-up|7
7842027|NCT00218296|27217713|P1|Overall Study|Lost to Follow-up|9
7842028|NCT00218257|27217729|P2|Period Between Visit 1 and 2|Lost to Follow-up|3
7842029|NCT00218257|27217730|P1|Period Between Visit 1 and 2|Lost to Follow-up|4
7842030|NCT00217971|27217831|P2|Overall Study|non compliant|0
7842031|NCT00217971|27217832|P1|Overall Study|non compliant|1
7842032|NCT00217971|27217831|P2|Overall Study|Withdrawal by Subject|12
7842033|NCT00217971|27217832|P1|Overall Study|Withdrawal by Subject|7
7842034|NCT00217971|27217831|P2|Overall Study|Physician Decision|1
7842035|NCT00217971|27217832|P1|Overall Study|Physician Decision|0
7842036|NCT00217971|27217831|P2|Overall Study|Lost to Follow-up|19
7842037|NCT00217971|27217832|P1|Overall Study|Lost to Follow-up|15
7842038|NCT00217971|27217831|P2|Overall Study|Adverse Event|1
7842039|NCT00217971|27217832|P1|Overall Study|Adverse Event|1
7842040|NCT00217672|27217847|P2|Follow-up|Lost to Follow-up|0
7842041|NCT00217672|27217848|P1|Follow-up|Lost to Follow-up|1
7842042|NCT00217672|27217847|P2|Follow-up|Withdrawal by Subject|0
7842043|NCT00217672|27217848|P1|Follow-up|Withdrawal by Subject|4
7842044|NCT00217672|27217847|P2|Treatment|secondary malignancy|0
7842045|NCT00217672|27217848|P1|Treatment|secondary malignancy|1
7842046|NCT00217672|27217847|P2|Treatment|Death|0
7842047|NCT00217672|27217848|P1|Treatment|Death|2
7842048|NCT00217672|27217847|P2|Treatment|insurance issues|1
7842049|NCT00217672|27217848|P1|Treatment|insurance issues|1
7842050|NCT00217672|27217847|P2|Treatment|Physician Decision|0
7842051|NCT00217672|27217848|P1|Treatment|Physician Decision|6
7842052|NCT00217672|27217847|P2|Treatment|reqd treatment not permitted by protocol|0
7842053|NCT00217672|27217848|P1|Treatment|reqd treatment not permitted by protocol|6
7842054|NCT00217672|27217847|P2|Treatment|Adverse Event|2
7842055|NCT00217672|27217848|P1|Treatment|Adverse Event|18
7842056|NCT00217672|27217847|P2|Treatment|disease progression|4
7842057|NCT00217672|27217848|P1|Treatment|disease progression|33
7842058|NCT00217672|27217847|P2|Allocation|Ineligible|0
7842059|NCT00217672|27217848|P1|Allocation|Ineligible|2
7842060|NCT00217620|27217854|P1|Overall Study|Never received treatment|1
7842061|NCT00217620|27217854|P1|Overall Study|Ineligible|13
7842062|NCT00217620|27217854|P1|Overall Study|Not Protocol Specified|4
7842063|NCT00217620|27217854|P1|Overall Study|Progression|31
7842064|NCT00217620|27217854|P1|Overall Study|Adverse Event|2
7842065|NCT00217581|27217869|P1|Overall Study|Withdrawal by Subject|1
7842066|NCT00217464|27217898|P1|Overall Study|Other|2
7842067|NCT00217464|27217898|P1|Overall Study|Progression|15
7842068|NCT00217425|27217914|P1|Overall Study|Other|4
7842069|NCT00217425|27217914|P1|Overall Study|Other complicating disease|1
7842070|NCT00217425|27217914|P1|Overall Study|Withdrawal by Subject|4
7842071|NCT00217425|27217914|P1|Overall Study|Adverse Event|8
7842072|NCT00217425|27217914|P1|Overall Study|Lack of Efficacy|13
7842073|NCT00217425|27217914|P1|Overall Study|Patient ineligible|5
7842074|NCT00217425|27217914|P1|Overall Study|Never started treatment|2
7842075|NCT00217087|27217928|P2|Overall Study|completed less than 12 months return|18
7842076|NCT00217087|27217929|P1|Overall Study|completed less than 12 months return|10
7842077|NCT00217087|27217928|P2|Overall Study|decided to have esophagectomy|2
7842078|NCT00217087|27217929|P1|Overall Study|decided to have esophagectomy|1
7842079|NCT00217022|27217943|P2|Overall Study|Withdrawal by Subject|1
7842080|NCT00217022|27217944|P1|Overall Study|Withdrawal by Subject|1
7842081|NCT00216736|27217954|P2|Overall Study|Lost to Follow-up|1
7842082|NCT00216736|27217955|P1|Overall Study|Lost to Follow-up|1
7842083|NCT00216671|27217969|P2|Overall Study|Insufficient Response Adverse Event|1
7842084|NCT00216671|27217970|P1|Overall Study|Insufficient Response Adverse Event|2
7842085|NCT00216671|27217969|P2|Overall Study|Ineligible, no efficacy data|2
7842086|NCT00216671|27217970|P1|Overall Study|Ineligible, no efficacy data|2
7842087|NCT00216671|27217969|P2|Overall Study|Patient Moved|1
7842088|NCT00216671|27217970|P1|Overall Study|Patient Moved|0
7842089|NCT00216671|27217969|P2|Overall Study|Investigator Illness|1
7842090|NCT00216671|27217970|P1|Overall Study|Investigator Illness|0
7842091|NCT00216671|27217969|P2|Overall Study|Relapse|0
7842092|NCT00216671|27217970|P1|Overall Study|Relapse|1
7842093|NCT00216671|27217969|P2|Overall Study|Protocol Violation|5
7842094|NCT00216671|27217970|P1|Overall Study|Protocol Violation|3
7842095|NCT00216671|27217969|P2|Overall Study|Physician Decision|1
7842096|NCT00216671|27217970|P1|Overall Study|Physician Decision|1
7842097|NCT00216671|27217969|P2|Overall Study|Ineligible|2
7842098|NCT00216671|27217970|P1|Overall Study|Ineligible|0
7842099|NCT00216671|27217969|P2|Overall Study|Non compliant|2
7842100|NCT00216671|27217970|P1|Overall Study|Non compliant|2
7842101|NCT00216671|27217969|P2|Overall Study|Lost to Follow-up|5
7842102|NCT00216671|27217970|P1|Overall Study|Lost to Follow-up|3
7842103|NCT00216671|27217969|P2|Overall Study|Insufficient Response|4
7842104|NCT00216671|27217970|P1|Overall Study|Insufficient Response|9
7842105|NCT00216671|27217969|P2|Overall Study|No Need to Continue Medication|1
7842106|NCT00216671|27217970|P1|Overall Study|No Need to Continue Medication|1
7842107|NCT00216671|27217969|P2|Overall Study|Refused Injections|13
7842108|NCT00216671|27217970|P1|Overall Study|Refused Injections|3
7842109|NCT00216671|27217969|P2|Overall Study|Withdrawal by Subject|2
7842110|NCT00216671|27217970|P1|Overall Study|Withdrawal by Subject|4
7842111|NCT00216671|27217969|P2|Overall Study|Pregnancy|1
7842112|NCT00216671|27217970|P1|Overall Study|Pregnancy|0
7842113|NCT00216671|27217969|P2|Overall Study|Adverse Event|9
7842114|NCT00216671|27217970|P1|Overall Study|Adverse Event|4
7842115|NCT00216476|27217988|P3|Overall Study|Patient Moved|0
7842116|NCT00216476|27217989|P2|Overall Study|Patient Moved|2
7842117|NCT00216476|27217990|P1|Overall Study|Patient Moved|2
7842118|NCT00216476|27217988|P3|Overall Study|Protocol Deviation|0
7842119|NCT00216476|27217989|P2|Overall Study|Protocol Deviation|1
7842120|NCT00216476|27217990|P1|Overall Study|Protocol Deviation|5
7842121|NCT00216476|27217988|P3|Overall Study|Administrative Reasons|0
7842122|NCT00216476|27217989|P2|Overall Study|Administrative Reasons|1
7842123|NCT00216476|27217990|P1|Overall Study|Administrative Reasons|1
7842124|NCT00216476|27217988|P3|Overall Study|Higher dose/Extra Medication Required|2
7842125|NCT00216476|27217989|P2|Overall Study|Higher dose/Extra Medication Required|0
7842126|NCT00216476|27217990|P1|Overall Study|Higher dose/Extra Medication Required|2
7842127|NCT00216476|27217988|P3|Overall Study|Non-compliance|1
7842128|NCT00216476|27217989|P2|Overall Study|Non-compliance|4
7842129|NCT00216476|27217990|P1|Overall Study|Non-compliance|0
7842130|NCT00216476|27217988|P3|Overall Study|No Further Need for Treatment|1
7842131|NCT00216476|27217989|P2|Overall Study|No Further Need for Treatment|4
7842132|NCT00216476|27217990|P1|Overall Study|No Further Need for Treatment|3
7842133|NCT00216476|27217988|P3|Overall Study|Refuses Injection|0
7842134|NCT00216476|27217989|P2|Overall Study|Refuses Injection|0
7842135|NCT00216476|27217990|P1|Overall Study|Refuses Injection|11
7842136|NCT00216476|27217988|P3|Overall Study|Other|1
7842137|NCT00216476|27217989|P2|Overall Study|Other|0
7842138|NCT00216476|27217990|P1|Overall Study|Other|0
7842139|NCT00216476|27217988|P3|Overall Study|Pregnancy|1
7842140|NCT00216476|27217989|P2|Overall Study|Pregnancy|1
7842141|NCT00216476|27217990|P1|Overall Study|Pregnancy|0
7842142|NCT00216476|27217988|P3|Overall Study|Death|0
7842143|NCT00216476|27217989|P2|Overall Study|Death|0
7842144|NCT00216476|27217990|P1|Overall Study|Death|2
7842145|NCT00216476|27217988|P3|Overall Study|Lack of Efficacy|0
7842146|NCT00216476|27217989|P2|Overall Study|Lack of Efficacy|3
7842147|NCT00216476|27217990|P1|Overall Study|Lack of Efficacy|4
7842148|NCT00216476|27217988|P3|Overall Study|Adverse Event|1
7842149|NCT00216476|27217989|P2|Overall Study|Adverse Event|10
7842150|NCT00216476|27217990|P1|Overall Study|Adverse Event|6
7842151|NCT00216476|27217988|P3|Overall Study|Lost to Follow-up|1
7842152|NCT00216476|27217989|P2|Overall Study|Lost to Follow-up|9
7842153|NCT00216476|27217990|P1|Overall Study|Lost to Follow-up|10
7842154|NCT00216476|27217988|P3|Overall Study|Withdrawal by Subject|9
7842155|NCT00216476|27217989|P2|Overall Study|Withdrawal by Subject|72
7842156|NCT00216476|27217990|P1|Overall Study|Withdrawal by Subject|59
7842157|NCT00216203|27218027|P1|Overall Study|Withdrawal by Subject|2
7842158|NCT00216086|27218057|P1|Overall Study|Social Reasons|2
7842159|NCT00216086|27218057|P1|Overall Study|Diagnosis of Metastatic Disease|1
7842160|NCT00216086|27218057|P1|Overall Study|Protocol Violation|1
7842161|NCT00215943|27218089|P2|Overall Study|Other complications|1
7842162|NCT00215943|27218090|P1|Overall Study|Other complications|3
7842163|NCT00215943|27218089|P2|Overall Study|Other disease|1
7842164|NCT00215943|27218090|P1|Overall Study|Other disease|0
7842165|NCT00215943|27218089|P2|Overall Study|Adverse Event|6
7842166|NCT00215943|27218090|P1|Overall Study|Adverse Event|3
7842167|NCT00215943|27218089|P2|Overall Study|Alternate therapy|1
7842168|NCT00215943|27218090|P1|Overall Study|Alternate therapy|0
7842169|NCT00215943|27218089|P2|Overall Study|Disease Progression|5
7842170|NCT00215943|27218090|P1|Overall Study|Disease Progression|3
7842171|NCT00215683|27218115|P3|Overall Study|Intermittent therapy required|0
7842172|NCT00215683|27218116|P2|Overall Study|Intermittent therapy required|1
7842173|NCT00215683|27218117|P1|Overall Study|Intermittent therapy required|0
7842174|NCT00215683|27218115|P3|Overall Study|No study drug available|0
7842175|NCT00215683|27218116|P2|Overall Study|No study drug available|1
7842176|NCT00215683|27218117|P1|Overall Study|No study drug available|0
7842177|NCT00215683|27218115|P3|Overall Study|Difficult to attend visits|0
7842178|NCT00215683|27218116|P2|Overall Study|Difficult to attend visits|1
7842179|NCT00215683|27218117|P1|Overall Study|Difficult to attend visits|0
7842180|NCT00215683|27218115|P3|Overall Study|Physician Decision|1
7842181|NCT00215683|27218116|P2|Overall Study|Physician Decision|0
7842182|NCT00215683|27218117|P1|Overall Study|Physician Decision|0
7842183|NCT00215683|27218115|P3|Overall Study|Withdrawal by Subject|13
7842184|NCT00215683|27218116|P2|Overall Study|Withdrawal by Subject|4
7842185|NCT00215683|27218117|P1|Overall Study|Withdrawal by Subject|9
7842186|NCT00215683|27218115|P3|Overall Study|Lost to Follow-up|1
7842187|NCT00215683|27218116|P2|Overall Study|Lost to Follow-up|2
7842188|NCT00215683|27218117|P1|Overall Study|Lost to Follow-up|0
7842189|NCT00215683|27218115|P3|Overall Study|Lack of Efficacy|2
7842190|NCT00215683|27218116|P2|Overall Study|Lack of Efficacy|1
7842191|NCT00215683|27218117|P1|Overall Study|Lack of Efficacy|5
7842192|NCT00215683|27218115|P3|Overall Study|Adverse Event|15
7842193|NCT00215683|27218116|P2|Overall Study|Adverse Event|16
7842194|NCT00215683|27218117|P1|Overall Study|Adverse Event|15
7842195|NCT00215657|27218136|P8|Overall Study|Other|1
7842196|NCT00215657|27218137|P7|Overall Study|Other|6
7842197|NCT00215657|27218138|P6|Overall Study|Other|4
7842198|NCT00215657|27218139|P5|Overall Study|Other|5
7842199|NCT00215657|27218140|P4|Overall Study|Other|3
7842200|NCT00215657|27218141|P3|Overall Study|Other|2
7842201|NCT00215657|27218142|P2|Overall Study|Other|1
7842202|NCT00215657|27218143|P1|Overall Study|Other|3
7842203|NCT00215657|27218136|P8|Overall Study|Insufficient testosterone response|7
7842204|NCT00215657|27218137|P7|Overall Study|Insufficient testosterone response|4
7842205|NCT00215657|27218138|P6|Overall Study|Insufficient testosterone response|12
7842206|NCT00215657|27218139|P5|Overall Study|Insufficient testosterone response|8
7842207|NCT00215657|27218140|P4|Overall Study|Insufficient testosterone response|12
7842208|NCT00215657|27218141|P3|Overall Study|Insufficient testosterone response|1
7842209|NCT00215657|27218142|P2|Overall Study|Insufficient testosterone response|4
7842210|NCT00215657|27218143|P1|Overall Study|Insufficient testosterone response|5
7842211|NCT00215657|27218136|P8|Overall Study|Insuff prostate specific antigen resp|2
7842212|NCT00215657|27218137|P7|Overall Study|Insuff prostate specific antigen resp|3
7842213|NCT00215657|27218138|P6|Overall Study|Insuff prostate specific antigen resp|2
7842214|NCT00215657|27218139|P5|Overall Study|Insuff prostate specific antigen resp|1
7842215|NCT00215657|27218140|P4|Overall Study|Insuff prostate specific antigen resp|2
7842216|NCT00215657|27218141|P3|Overall Study|Insuff prostate specific antigen resp|2
7842217|NCT00215657|27218142|P2|Overall Study|Insuff prostate specific antigen resp|2
7842218|NCT00215657|27218143|P1|Overall Study|Insuff prostate specific antigen resp|3
7842219|NCT00215657|27218136|P8|Overall Study|Withdrawal by Subject|3
7842220|NCT00215657|27218137|P7|Overall Study|Withdrawal by Subject|10
7842221|NCT00215657|27218138|P6|Overall Study|Withdrawal by Subject|1
7842222|NCT00215657|27218139|P5|Overall Study|Withdrawal by Subject|6
7842223|NCT00215657|27218140|P4|Overall Study|Withdrawal by Subject|1
7842224|NCT00215657|27218141|P3|Overall Study|Withdrawal by Subject|3
7842225|NCT00215657|27218142|P2|Overall Study|Withdrawal by Subject|3
7842226|NCT00215657|27218143|P1|Overall Study|Withdrawal by Subject|6
7842227|NCT00215657|27218136|P8|Overall Study|Adverse Event|3
7842228|NCT00215657|27218137|P7|Overall Study|Adverse Event|0
7842229|NCT00215657|27218138|P6|Overall Study|Adverse Event|1
7842230|NCT00215657|27218139|P5|Overall Study|Adverse Event|3
7842231|NCT00215657|27218140|P4|Overall Study|Adverse Event|0
7842232|NCT00215657|27218141|P3|Overall Study|Adverse Event|3
7842233|NCT00215657|27218142|P2|Overall Study|Adverse Event|1
7842234|NCT00215657|27218143|P1|Overall Study|Adverse Event|5
7842235|NCT00215644|27218171|P2|Overall Study|Randomized but Not Treated|0
7842236|NCT00215644|27218172|P1|Overall Study|Randomized but Not Treated|1
7842237|NCT00215644|27218171|P2|Overall Study|Other|15
7842238|NCT00215644|27218172|P1|Overall Study|Other|3
7842239|NCT00215644|27218171|P2|Overall Study|Withdrawal by Subject|0
7842240|NCT00215644|27218172|P1|Overall Study|Withdrawal by Subject|1
7842241|NCT00215644|27218171|P2|Overall Study|Death|2
7842242|NCT00215644|27218172|P1|Overall Study|Death|1
7842243|NCT00215644|27218171|P2|Overall Study|Adverse Event|9
7842244|NCT00215644|27218172|P1|Overall Study|Adverse Event|2
7842245|NCT00215644|27218171|P2|Overall Study|Disease Progression|10
7842246|NCT00215644|27218172|P1|Overall Study|Disease Progression|28
7842247|NCT00215553|27218199|P7|Overall Study|Adverse Event|0
7842248|NCT00215553|27218200|P6|Overall Study|Adverse Event|6
7842249|NCT00215553|27218201|P5|Overall Study|Adverse Event|2
7842250|NCT00215553|27218202|P4|Overall Study|Adverse Event|1
7842251|NCT00215553|27218203|P3|Overall Study|Adverse Event|2
7842252|NCT00215553|27218204|P2|Overall Study|Adverse Event|1
7842253|NCT00215553|27218205|P1|Overall Study|Adverse Event|0
7842254|NCT00215540|27218238|P3|Overall Study|Withdrew from study medication|0
7842255|NCT00215540|27218239|P2|Overall Study|Withdrew from study medication|0
7842256|NCT00215540|27218240|P1|Overall Study|Withdrew from study medication|1
7842257|NCT00215150|27218275|P1|Randomization Phase Placebo|Withdrawal by Subject|1
7842258|NCT00215150|27218275|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
7842259|NCT00215150|27218275|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
7842260|NCT00215150|27218275|P1|Open Label Phase|Did not meet randomization criteria|9
7842261|NCT00215150|27218275|P1|Open Label Phase|Did not complete a post base visit|13
7842262|NCT00215150|27218275|P1|Open Label Phase|Withdrawal by Subject|1
7842263|NCT00215150|27218275|P1|Open Label Phase|Lost to Follow-up|7
7842264|NCT00215137|27218283|P3|Randomization Period|Withdrawal by Subject|0
7842265|NCT00215137|27218284|P2|Randomization Period|Withdrawal by Subject|1
7842266|NCT00215137|27218285|P1|Randomization Period|Withdrawal by Subject|0
7842267|NCT00215137|27218283|P3|Randomization Period|Lost to Follow-up|0
7842268|NCT00215137|27218284|P2|Randomization Period|Lost to Follow-up|1
7842269|NCT00215137|27218285|P1|Randomization Period|Lost to Follow-up|0
7842270|NCT00215137|27218283|P3|Open Label Escitalopram|Lack of Efficacy|0
7842271|NCT00215137|27218284|P2|Open Label Escitalopram|Lack of Efficacy|0
7842272|NCT00215137|27218285|P1|Open Label Escitalopram|Lack of Efficacy|1
7842273|NCT00214500|27218402|P1|Extension Period|Withdrawal by Subject|2
7842274|NCT00214500|27218402|P1|Treatment Period|Adverse Event|1
7842275|NCT00214461|27218423|P4|Overall Study|Withdrawal by Subject|0
7842276|NCT00214461|27218424|P3|Overall Study|Withdrawal by Subject|1
7842277|NCT00214461|27218425|P2|Overall Study|Withdrawal by Subject|0
7842278|NCT00214461|27218426|P1|Overall Study|Withdrawal by Subject|0
7842279|NCT00214461|27218423|P4|Overall Study|Adverse Event|1
7842280|NCT00214461|27218424|P3|Overall Study|Adverse Event|1
7842281|NCT00214461|27218425|P2|Overall Study|Adverse Event|0
7842282|NCT00214461|27218426|P1|Overall Study|Adverse Event|0
7842283|NCT00214422|27218443|P3|Overall Study|Unable to make a radiation treatment|1
7842284|NCT00214422|27218444|P2|Overall Study|Unable to make a radiation treatment|0
7842285|NCT00214422|27218445|P1|Overall Study|Unable to make a radiation treatment|0
7842286|NCT00214422|27218443|P3|Overall Study|Disease progression on study|0
7842287|NCT00214422|27218444|P2|Overall Study|Disease progression on study|0
7842288|NCT00214422|27218445|P1|Overall Study|Disease progression on study|1
7842289|NCT00214422|27218443|P3|Overall Study|Pt taken off study|0
7842290|NCT00214422|27218444|P2|Overall Study|Pt taken off study|1
7842291|NCT00214422|27218445|P1|Overall Study|Pt taken off study|1
7842292|NCT00214422|27218443|P3|Overall Study|Developed esophageal ca|0
7842293|NCT00214422|27218444|P2|Overall Study|Developed esophageal ca|0
7842294|NCT00214422|27218445|P1|Overall Study|Developed esophageal ca|1
7842295|NCT00214422|27218443|P3|Overall Study|Physician Decision|0
7842296|NCT00214422|27218444|P2|Overall Study|Physician Decision|0
7842297|NCT00214422|27218445|P1|Overall Study|Physician Decision|2
7842298|NCT00214383|27218468|P2|Overall Study|Lost to Follow-up|26
7842299|NCT00214383|27218469|P1|Overall Study|Lost to Follow-up|16
7842300|NCT00214201|27218481|P2|Overall Study|Death|2
7842301|NCT00214201|27218482|P1|Overall Study|Death|0
7842302|NCT00214201|27218481|P2|Overall Study|Withdrawal by Subject|0
7842303|NCT00214201|27218482|P1|Overall Study|Withdrawal by Subject|2
7842304|NCT00214136|27218497|P1|Overall Study|Death|5
7842305|NCT00214019|27218542|P1|Overall Study|Screen Failed prior to randomization|17
7842306|NCT00214019|27218542|P1|Overall Study|Withdrawal by Subject|2
7842307|NCT00214019|27218542|P1|Overall Study|Lost to Follow-up|11
7842308|NCT00213980|27218551|P2|Overall Study|Failed to obtain all 3 DXAs|3
7842309|NCT00213980|27218552|P1|Overall Study|Failed to obtain all 3 DXAs|1
7842310|NCT00213980|27218551|P2|Overall Study|Developed ovarian cancer|0
7842311|NCT00213980|27218552|P1|Overall Study|Developed ovarian cancer|1
7842312|NCT00213980|27218551|P2|Overall Study|Disease progression|2
7842313|NCT00213980|27218552|P1|Overall Study|Disease progression|0
7842314|NCT00213980|27218551|P2|Overall Study|Adverse Event|1
7842315|NCT00213980|27218552|P1|Overall Study|Adverse Event|1
7842316|NCT00213980|27218551|P2|Overall Study|Withdrawal by Subject|1
7842317|NCT00213980|27218552|P1|Overall Study|Withdrawal by Subject|3
7842318|NCT00213148|27218579|P5|Cycle 3 (1 Month)|Other|0
7842319|NCT00213148|27218580|P4|Cycle 3 (1 Month)|Other|1
7842320|NCT00213148|27218581|P3|Cycle 3 (1 Month)|Other|1
7842321|NCT00213148|27218582|P2|Cycle 3 (1 Month)|Other|0
7842322|NCT00213148|27218583|P1|Cycle 3 (1 Month)|Other|0
7842323|NCT00213148|27218579|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
7842324|NCT00213148|27218580|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
7842325|NCT00213148|27218581|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
7842326|NCT00213148|27218582|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
7842327|NCT00213148|27218583|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
7842328|NCT00213148|27218579|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
7842329|NCT00213148|27218580|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
7842330|NCT00213148|27218581|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
7842331|NCT00213148|27218582|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
7842332|NCT00213148|27218583|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
7842333|NCT00213148|27218579|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7842334|NCT00213148|27218580|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7842335|NCT00213148|27218581|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7842336|NCT00213148|27218582|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7842337|NCT00213148|27218583|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
7842338|NCT00213148|27218579|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7842339|NCT00213148|27218580|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7842340|NCT00213148|27218581|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7842341|NCT00213148|27218582|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
7842342|NCT00213148|27218583|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7842343|NCT00213148|27218579|P5|Cycle 2 (1 Month)|Other|7
7842344|NCT00213148|27218580|P4|Cycle 2 (1 Month)|Other|8
7842345|NCT00213148|27218581|P3|Cycle 2 (1 Month)|Other|2
7842346|NCT00213148|27218582|P2|Cycle 2 (1 Month)|Other|1
7842347|NCT00213148|27218583|P1|Cycle 2 (1 Month)|Other|2
7842348|NCT00213148|27218579|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
7842349|NCT00213148|27218580|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
7842350|NCT00213148|27218581|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
7842351|NCT00213148|27218582|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
7842352|NCT00213148|27218583|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
7842353|NCT00213148|27218579|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
7842354|NCT00213148|27218580|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
7842355|NCT00213148|27218581|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
7842356|NCT00213148|27218582|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
7842357|NCT00213148|27218583|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
7842358|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
7842359|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
7842360|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
7842361|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
7842362|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
7842363|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
7842364|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7842365|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7842366|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7842367|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7842368|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7842369|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
7842370|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7842371|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7842372|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7842373|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Other|7
7842374|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Other|2
7842375|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Other|2
7842376|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Other|0
7842377|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Other|3
7842378|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Protocol Violation|0
7842379|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Protocol Violation|0
7842380|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Protocol Violation|1
7842381|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Protocol Violation|0
7842382|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Protocol Violation|1
7842383|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
7842384|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
7842385|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
7842386|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
7842387|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
7842388|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Adverse Event|0
7842389|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Adverse Event|0
7842390|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Adverse Event|1
7842391|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Adverse Event|0
7842392|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Adverse Event|0
7842393|NCT00213148|27218579|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
7842394|NCT00213148|27218580|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
7842395|NCT00213148|27218581|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
7842396|NCT00213148|27218582|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
7842397|NCT00213148|27218583|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
7842398|NCT00213135|27218610|P3|Overall Study|Other|15
7842399|NCT00213135|27218611|P2|Overall Study|Other|12
7842400|NCT00213135|27218612|P1|Overall Study|Other|21
7842401|NCT00213135|27218610|P3|Overall Study|Disease progression|21
7842402|NCT00213135|27218611|P2|Overall Study|Disease progression|5
7842403|NCT00213135|27218612|P1|Overall Study|Disease progression|4
7842404|NCT00213135|27218610|P3|Overall Study|Death|2
7842405|NCT00213135|27218611|P2|Overall Study|Death|1
7842406|NCT00213135|27218612|P1|Overall Study|Death|1
7842407|NCT00213135|27218610|P3|Overall Study|Protocol Violation|10
7842408|NCT00213135|27218611|P2|Overall Study|Protocol Violation|4
7842409|NCT00213135|27218612|P1|Overall Study|Protocol Violation|4
7842410|NCT00213135|27218610|P3|Overall Study|Lost to Follow-up|4
7842411|NCT00213135|27218611|P2|Overall Study|Lost to Follow-up|8
7842412|NCT00213135|27218612|P1|Overall Study|Lost to Follow-up|11
7842413|NCT00213135|27218610|P3|Overall Study|Adverse Event|5
7842414|NCT00213135|27218611|P2|Overall Study|Adverse Event|5
7842415|NCT00213135|27218612|P1|Overall Study|Adverse Event|9
7842416|NCT00212758|27218655|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
7842417|NCT00212758|27218656|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
7842418|NCT00212758|27218655|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
7842419|NCT00212758|27218656|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
7842420|NCT00212355|27218672|P1|Overall Study|A change of address|1
7842421|NCT00212355|27218672|P1|Overall Study|Withdrawal by Subject|1
7842422|NCT00212355|27218672|P1|Overall Study|Adverse Event|1
7842425|NCT00211887|27218715|P3|Overall Study|Side effects|5
7842426|NCT00211887|27218716|P2|Overall Study|Side effects|13
7842427|NCT00211887|27218717|P1|Overall Study|Side effects|19
7842428|NCT00211887|27218715|P3|Overall Study|Other medical reason|7
7842429|NCT00211887|27218716|P2|Overall Study|Other medical reason|11
7842430|NCT00211887|27218717|P1|Overall Study|Other medical reason|15
7842431|NCT00211887|27218715|P3|Overall Study|Non-medical reason|8
7842432|NCT00211887|27218716|P2|Overall Study|Non-medical reason|14
7842433|NCT00211887|27218717|P1|Overall Study|Non-medical reason|31
7842434|NCT00211887|27218715|P3|Overall Study|Lost to Follow-up|9
7842435|NCT00211887|27218716|P2|Overall Study|Lost to Follow-up|13
7842436|NCT00211887|27218717|P1|Overall Study|Lost to Follow-up|28
7842437|NCT00211887|27218715|P3|Overall Study|Death|1
7842438|NCT00211887|27218716|P2|Overall Study|Death|1
7842439|NCT00211887|27218717|P1|Overall Study|Death|1
7842440|NCT00211887|27218715|P3|Overall Study|Adverse Event|6
7842441|NCT00211887|27218716|P2|Overall Study|Adverse Event|4
7842442|NCT00211887|27218717|P1|Overall Study|Adverse Event|8
7842443|NCT00211809|27218734|P1|Overall Study|side effects|2
7842444|NCT00211809|27218734|P1|Overall Study|Pregnancy|1
7842445|NCT00211809|27218734|P1|Overall Study|Lost to Follow-up|2
7842446|NCT00211809|27218734|P1|Overall Study|Lack of Efficacy|1
7842447|NCT00211757|27218750|P2|Overall Study|Lack of Efficacy|1
7842448|NCT00211757|27218751|P1|Overall Study|Lack of Efficacy|0
7842449|NCT00211757|27218750|P2|Overall Study|Withdrawal by Subject|1
7842450|NCT00211757|27218751|P1|Overall Study|Withdrawal by Subject|1
7842451|NCT00211536|27218772|P2|Overall Study|Adverse Event|0
7842452|NCT00211536|27218773|P1|Overall Study|Adverse Event|2
7842453|NCT00211536|27218772|P2|Overall Study|Physician Decision|5
7842454|NCT00211536|27218773|P1|Overall Study|Physician Decision|0
7842455|NCT00211536|27218772|P2|Overall Study|Withdrawal by Subject|2
7842456|NCT00211536|27218773|P1|Overall Study|Withdrawal by Subject|2
7842457|NCT00211510|27218789|P2|Overall Study|Withdrawal by Subject|1
7842458|NCT00211510|27218790|P1|Overall Study|Withdrawal by Subject|3
7842459|NCT00211510|27218789|P2|Overall Study|Physician Decision|1
7842460|NCT00211510|27218790|P1|Overall Study|Physician Decision|3
7842461|NCT00211237|27218808|P3|12 Months|unrelated medical problem|1
7842462|NCT00211237|27218809|P2|12 Months|unrelated medical problem|0
7842463|NCT00211237|27218810|P1|12 Months|unrelated medical problem|0
7842464|NCT00211237|27218808|P3|12 Months|Withdrew|1
7842465|NCT00211237|27218809|P2|12 Months|Withdrew|0
7842466|NCT00211237|27218810|P1|12 Months|Withdrew|0
7842467|NCT00211237|27218808|P3|12 Months|Lost to Follow-up|1
7842468|NCT00211237|27218809|P2|12 Months|Lost to Follow-up|0
7842469|NCT00211237|27218810|P1|12 Months|Lost to Follow-up|1
7842470|NCT00211237|27218808|P3|12 Months|Death|3
7842471|NCT00211237|27218809|P2|12 Months|Death|2
7842472|NCT00211237|27218810|P1|12 Months|Death|8
7842473|NCT00211237|27218808|P3|6 Months|Could not comply with protocol|0
7842474|NCT00211237|27218809|P2|6 Months|Could not comply with protocol|2
7842475|NCT00211237|27218810|P1|6 Months|Could not comply with protocol|0
7842476|NCT00211237|27218808|P3|6 Months|Lost to Follow-up|0
7842477|NCT00211237|27218809|P2|6 Months|Lost to Follow-up|0
7842478|NCT00211237|27218810|P1|6 Months|Lost to Follow-up|2
7842479|NCT00211237|27218808|P3|6 Months|Death|3
7842480|NCT00211237|27218809|P2|6 Months|Death|0
7842481|NCT00211237|27218810|P1|6 Months|Death|6
7842482|NCT00211237|27218808|P3|3 Months|Non-medical problem|1
7842483|NCT00211237|27218809|P2|3 Months|Non-medical problem|0
7842484|NCT00211237|27218810|P1|3 Months|Non-medical problem|0
7842485|NCT00211237|27218808|P3|3 Months|Withdrew|0
7842486|NCT00211237|27218809|P2|3 Months|Withdrew|1
7842487|NCT00211237|27218810|P1|3 Months|Withdrew|0
7842488|NCT00211237|27218808|P3|3 Months|Could not comply with protocol|0
7842489|NCT00211237|27218809|P2|3 Months|Could not comply with protocol|0
7842490|NCT00211237|27218810|P1|3 Months|Could not comply with protocol|1
7842491|NCT00211237|27218808|P3|3 Months|Death|0
7842492|NCT00211237|27218809|P2|3 Months|Death|3
7842493|NCT00211237|27218810|P1|3 Months|Death|7
7842494|NCT00211237|27218808|P3|1 Month|Non-medical problem|0
7842495|NCT00211237|27218809|P2|1 Month|Non-medical problem|2
7842496|NCT00211237|27218810|P1|1 Month|Non-medical problem|0
7842497|NCT00211237|27218808|P3|1 Month|Additional surgery needed|0
7842498|NCT00211237|27218809|P2|1 Month|Additional surgery needed|0
7842499|NCT00211237|27218810|P1|1 Month|Additional surgery needed|1
7842500|NCT00211237|27218808|P3|1 Month|Withdrew|0
7842501|NCT00211237|27218809|P2|1 Month|Withdrew|4
7842502|NCT00211237|27218810|P1|1 Month|Withdrew|0
7842503|NCT00211237|27218808|P3|1 Month|Lost to Follow-up|0
7842504|NCT00211237|27218809|P2|1 Month|Lost to Follow-up|2
7842505|NCT00211237|27218810|P1|1 Month|Lost to Follow-up|0
7842506|NCT00211237|27218808|P3|1 Month|Death|0
7842507|NCT00211237|27218809|P2|1 Month|Death|1
7842508|NCT00211237|27218810|P1|1 Month|Death|2
7842509|NCT00211237|27218808|P3|Baseline|Refused random assignment|0
7842510|NCT00211237|27218809|P2|Baseline|Refused random assignment|0
7842511|NCT00211237|27218810|P1|Baseline|Refused random assignment|1
7842512|NCT00211237|27218808|P3|Baseline|Withdrew|0
7842513|NCT00211237|27218809|P2|Baseline|Withdrew|3
7842514|NCT00211237|27218810|P1|Baseline|Withdrew|1
7842515|NCT00211185|27218900|P1|Overall Study|Physician Decision|5
7842516|NCT00211185|27218900|P1|Overall Study|Withdrawal by Subject|6
7842517|NCT00211185|27218900|P1|Overall Study|Disease progression|7
7842518|NCT00211185|27218900|P1|Overall Study|Death|2
7842519|NCT00211172|27218914|P2|Overall Study|Died or lost health plan eligibility|32
7842520|NCT00211172|27218915|P1|Overall Study|Died or lost health plan eligibility|39
7842521|NCT00211081|27218921|P1|Overall Study|Withdrawal by Subject|2
7842522|NCT00210639|27218933|P2|Overall Study|Other|12
7842523|NCT00210639|27218934|P1|Overall Study|Other|18
7842524|NCT00210639|27218933|P2|Overall Study|Withdrawal by Subject|1
7842525|NCT00210639|27218934|P1|Overall Study|Withdrawal by Subject|8
7842526|NCT00210639|27218933|P2|Overall Study|Lost to Follow-up|29
7842527|NCT00210639|27218934|P1|Overall Study|Lost to Follow-up|37
7842528|NCT00210626|27218942|P2|Overall Study|Other|5
7842529|NCT00210626|27218943|P1|Overall Study|Other|4
7842530|NCT00210626|27218942|P2|Overall Study|Sponser Request|0
7842531|NCT00210626|27218943|P1|Overall Study|Sponser Request|1
7842532|NCT00210626|27218942|P2|Overall Study|Physician Decision|2
7842533|NCT00210626|27218943|P1|Overall Study|Physician Decision|0
7842534|NCT00210626|27218942|P2|Overall Study|Withdrawal by Subject|20
7842535|NCT00210626|27218943|P1|Overall Study|Withdrawal by Subject|29
7842536|NCT00210626|27218942|P2|Overall Study|Death|0
7842537|NCT00210626|27218943|P1|Overall Study|Death|1
7842538|NCT00210626|27218942|P2|Overall Study|Lost to Follow-up|11
7842539|NCT00210626|27218943|P1|Overall Study|Lost to Follow-up|11
7842540|NCT00210626|27218942|P2|Overall Study|Protocol Violation|5
7842541|NCT00210626|27218943|P1|Overall Study|Protocol Violation|1
7842542|NCT00210626|27218942|P2|Overall Study|Adverse Event|2
7842543|NCT00210626|27218943|P1|Overall Study|Adverse Event|1
7842544|NCT00210184|27218988|P1|Overall Study|The medical record was lost for these patients: no clinical data is available|2
7842545|NCT00210106|27218994|P1|Overall Study|Protocol Violation|13
7842546|NCT00210106|27218994|P1|Overall Study|Death|1
7842547|NCT00209560|27219002|P2|Overall Study|Lack of Efficacy|0
7842548|NCT00209560|27219003|P1|Overall Study|Lack of Efficacy|1
7842549|NCT00209339|27219022|P1|At 5 Years Follow-up|Death|1
7842550|NCT00209339|27219022|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
7842551|NCT00209339|27219022|P1|At 5 Years Follow-up|Withdrawal by Subject|2
7842552|NCT00209339|27219022|P1|At 4 Years Follow-up|Death|1
7842553|NCT00209339|27219022|P1|At 4 Years Follow-up|Withdrawal by Subject|4
7842554|NCT00209339|27219022|P1|At 3 Years Follow-up|Withdrawal by Subject|1
7842555|NCT00209339|27219022|P1|At 24 Months Follow-up|Death|1
7842556|NCT00209339|27219022|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
7842557|NCT00209339|27219022|P1|At 24 Months Follow-up|Withdrawal by Subject|4
7842558|NCT00209339|27219022|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
7842559|NCT00209339|27219022|P1|At 12 Months Follow-up|Death|1
7842560|NCT00209339|27219022|P1|At 12 Months Follow-up|Withdrawal by Subject|8
7842561|NCT00209274|27219106|P2|Overall Study|Randomized not treated (RNT)|15
7842562|NCT00209274|27219107|P1|Overall Study|Randomized not treated (RNT)|6
7842563|NCT00209274|27219106|P2|Overall Study|Withdrawal by Subject|15
7842564|NCT00209274|27219107|P1|Overall Study|Withdrawal by Subject|30
7842565|NCT00209274|27219106|P2|Overall Study|Death|15
7842566|NCT00209274|27219107|P1|Overall Study|Death|32
7842567|NCT00209274|27219106|P2|Overall Study|Missed visit|2
7842568|NCT00209274|27219107|P1|Overall Study|Missed visit|3
7842569|NCT00209170|27219427|P2|Overall Study|Lack of Efficacy|1
7842570|NCT00209170|27219428|P1|Overall Study|Lack of Efficacy|0
7842571|NCT00209170|27219427|P2|Overall Study|Withdrawal by Subject|1
7842572|NCT00209170|27219428|P1|Overall Study|Withdrawal by Subject|2
7842573|NCT00209170|27219427|P2|Overall Study|Adverse Event|1
7842574|NCT00209170|27219428|P1|Overall Study|Adverse Event|0
7842575|NCT00209131|27219436|P2|Overall Study|Lack of personnel due to turnovers.|11
7842576|NCT00209131|27219437|P1|Overall Study|Lack of personnel due to turnovers.|15
7842577|NCT00209092|27219447|P2|Overall Study|Withdrawal by Subject|0
7842578|NCT00209092|27219448|P1|Overall Study|Withdrawal by Subject|1
7842579|NCT00209092|27219447|P2|Overall Study|Adverse Event|1
7842580|NCT00209092|27219448|P1|Overall Study|Adverse Event|0
7842581|NCT00209092|27219447|P2|Overall Study|Progression of disease|1
7842582|NCT00209092|27219448|P1|Overall Study|Progression of disease|7
7842583|NCT00209027|27219458|P2|Overall Study|study terminated|0
7842584|NCT00209027|27219459|P1|Overall Study|study terminated|10
7842585|NCT00208767|27219483|P2|Overall Study|Lost to Follow-up|3
7842586|NCT00208767|27219484|P1|Overall Study|Lost to Follow-up|3
7842587|NCT00208767|27219483|P2|Overall Study|Death|0
7842588|NCT00208767|27219484|P1|Overall Study|Death|1
7842589|NCT00208767|27219483|P2|Overall Study|Withdrawal by Subject|3
7842590|NCT00208767|27219484|P1|Overall Study|Withdrawal by Subject|14
7842591|NCT00208767|27219483|P2|Overall Study|Adverse Event|1
7842592|NCT00208767|27219484|P1|Overall Study|Adverse Event|9
7842593|NCT00208325|27219512|P4|Overall Study|Mis-Randomized|0
7842594|NCT00208325|27219513|P3|Overall Study|Mis-Randomized|0
7842595|NCT00208325|27219514|P2|Overall Study|Mis-Randomized|20
7842596|NCT00208325|27219515|P1|Overall Study|Mis-Randomized|17
7842597|NCT00208325|27219512|P4|Overall Study|Other|0
7842598|NCT00208325|27219513|P3|Overall Study|Other|1
7842599|NCT00208325|27219514|P2|Overall Study|Other|1
7842600|NCT00208325|27219515|P1|Overall Study|Other|2
7842601|NCT00208325|27219512|P4|Overall Study|Does not wish to Continue in Study|2
7842602|NCT00208325|27219513|P3|Overall Study|Does not wish to Continue in Study|3
7842603|NCT00208325|27219514|P2|Overall Study|Does not wish to Continue in Study|8
7842604|NCT00208325|27219515|P1|Overall Study|Does not wish to Continue in Study|5
7842605|NCT00208325|27219512|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
7842606|NCT00208325|27219513|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
7842607|NCT00208325|27219514|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
7842608|NCT00208325|27219515|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
7842609|NCT00208325|27219512|P4|Overall Study|Lost to Follow-up|0
7842610|NCT00208325|27219513|P3|Overall Study|Lost to Follow-up|2
7842611|NCT00208325|27219514|P2|Overall Study|Lost to Follow-up|0
7842612|NCT00208325|27219515|P1|Overall Study|Lost to Follow-up|1
7842613|NCT00208325|27219512|P4|Overall Study|Revision|4
7842614|NCT00208325|27219513|P3|Overall Study|Revision|0
7842615|NCT00208325|27219514|P2|Overall Study|Revision|1
7842616|NCT00208325|27219515|P1|Overall Study|Revision|4
7842617|NCT00208325|27219512|P4|Overall Study|Withdrawal by Subject|0
7842618|NCT00208325|27219513|P3|Overall Study|Withdrawal by Subject|0
7842619|NCT00208325|27219514|P2|Overall Study|Withdrawal by Subject|1
7842620|NCT00208325|27219515|P1|Overall Study|Withdrawal by Subject|0
7842621|NCT00208325|27219512|P4|Overall Study|Death|5
7842622|NCT00208325|27219513|P3|Overall Study|Death|7
7842623|NCT00208325|27219514|P2|Overall Study|Death|19
7842624|NCT00208325|27219515|P1|Overall Study|Death|18
7842625|NCT00207740|27219652|P4|Overall Study|Other|5
7842626|NCT00207740|27219653|P3|Overall Study|Other|7
7842627|NCT00207740|27219654|P2|Overall Study|Other|10
7842628|NCT00207740|27219655|P1|Overall Study|Other|2
7842629|NCT00207740|27219652|P4|Overall Study|Sponsor Directive|21
7842630|NCT00207740|27219653|P3|Overall Study|Sponsor Directive|16
7842631|NCT00207740|27219654|P2|Overall Study|Sponsor Directive|15
7842632|NCT00207740|27219655|P1|Overall Study|Sponsor Directive|22
7842633|NCT00207740|27219652|P4|Overall Study|Death|1
7842634|NCT00207740|27219653|P3|Overall Study|Death|0
7842635|NCT00207740|27219654|P2|Overall Study|Death|0
7842636|NCT00207740|27219655|P1|Overall Study|Death|0
7842637|NCT00207740|27219652|P4|Overall Study|Lost to Follow-up|1
7842638|NCT00207740|27219653|P3|Overall Study|Lost to Follow-up|1
7842639|NCT00207740|27219654|P2|Overall Study|Lost to Follow-up|2
7842640|NCT00207740|27219655|P1|Overall Study|Lost to Follow-up|0
7842641|NCT00207740|27219652|P4|Overall Study|Unsatisfactory therapeutic effect|4
7842642|NCT00207740|27219653|P3|Overall Study|Unsatisfactory therapeutic effect|2
7842643|NCT00207740|27219654|P2|Overall Study|Unsatisfactory therapeutic effect|0
7842644|NCT00207740|27219655|P1|Overall Study|Unsatisfactory therapeutic effect|1
7842645|NCT00207740|27219652|P4|Overall Study|Adverse Event|11
7842646|NCT00207740|27219653|P3|Overall Study|Adverse Event|14
7842647|NCT00207740|27219654|P2|Overall Study|Adverse Event|14
7842648|NCT00207740|27219655|P1|Overall Study|Adverse Event|4
7842649|NCT00207727|27219701|P5|Overall Study|Other|33
7842650|NCT00207727|27219702|P4|Overall Study|Other|37
7842651|NCT00207727|27219703|P3|Overall Study|Other|41
7842652|NCT00207727|27219704|P2|Overall Study|Other|41
7842653|NCT00207727|27219705|P1|Overall Study|Other|38
7842654|NCT00207727|27219701|P5|Overall Study|Lost to Follow-up|0
7842655|NCT00207727|27219702|P4|Overall Study|Lost to Follow-up|0
7842656|NCT00207727|27219703|P3|Overall Study|Lost to Follow-up|0
7842657|NCT00207727|27219704|P2|Overall Study|Lost to Follow-up|1
7842658|NCT00207727|27219705|P1|Overall Study|Lost to Follow-up|0
7842659|NCT00207727|27219701|P5|Overall Study|Withdrawal by Subject|1
7842660|NCT00207727|27219702|P4|Overall Study|Withdrawal by Subject|0
7842661|NCT00207727|27219703|P3|Overall Study|Withdrawal by Subject|0
7842662|NCT00207727|27219704|P2|Overall Study|Withdrawal by Subject|0
7842663|NCT00207727|27219705|P1|Overall Study|Withdrawal by Subject|0
7842664|NCT00207714|27219732|P5|Overall Study|Other|0
7842665|NCT00207714|27219733|P4|Overall Study|Other|1
7842666|NCT00207714|27219734|P3|Overall Study|Other|5
7842667|NCT00207714|27219735|P2|Overall Study|Other|2
7842668|NCT00207714|27219736|P1|Overall Study|Other|3
7842669|NCT00207714|27219732|P5|Overall Study|Unsatisfactory therapeutic effect|4
7842670|NCT00207714|27219733|P4|Overall Study|Unsatisfactory therapeutic effect|4
7842671|NCT00207714|27219734|P3|Overall Study|Unsatisfactory therapeutic effect|1
7842672|NCT00207714|27219735|P2|Overall Study|Unsatisfactory therapeutic effect|3
7842673|NCT00207714|27219736|P1|Overall Study|Unsatisfactory therapeutic effect|5
7842674|NCT00207714|27219732|P5|Overall Study|Adverse Event|1
7842675|NCT00207714|27219733|P4|Overall Study|Adverse Event|3
7842676|NCT00207714|27219734|P3|Overall Study|Adverse Event|4
7842677|NCT00207714|27219735|P2|Overall Study|Adverse Event|2
7842678|NCT00207714|27219736|P1|Overall Study|Adverse Event|6
7842679|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
7842680|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7842681|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7842682|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7842683|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Death|1
7842684|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Death|0
7842685|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Death|0
7842686|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Death|0
7842687|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
7842688|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
7842689|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
7842690|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
7842691|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7842692|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
7842693|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7842694|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7842695|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
7842696|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
7842697|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
7842698|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
7842699|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
7842700|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
7842701|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
7842702|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
7842703|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7842704|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
7842705|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7842706|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7842707|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
7842708|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
7842709|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
7842710|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
7842711|NCT00207142|27219758|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
7842712|NCT00207142|27219759|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
7842713|NCT00207142|27219760|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
7842714|NCT00207142|27219761|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
7842715|NCT00207142|27219758|P4|Induction Phase|Missing lab data|0
7842716|NCT00207142|27219759|P3|Induction Phase|Missing lab data|0
7842717|NCT00207142|27219760|P2|Induction Phase|Missing lab data|0
7842718|NCT00207142|27219761|P1|Induction Phase|Missing lab data|1
7842719|NCT00207142|27219758|P4|Induction Phase|Incarceration|0
7842720|NCT00207142|27219759|P3|Induction Phase|Incarceration|0
7842721|NCT00207142|27219760|P2|Induction Phase|Incarceration|0
7842722|NCT00207142|27219761|P1|Induction Phase|Incarceration|1
7842723|NCT00207142|27219758|P4|Induction Phase|Withdrawal by Subject|0
7842724|NCT00207142|27219759|P3|Induction Phase|Withdrawal by Subject|0
7842725|NCT00207142|27219760|P2|Induction Phase|Withdrawal by Subject|0
7842726|NCT00207142|27219761|P1|Induction Phase|Withdrawal by Subject|4
7842727|NCT00207142|27219758|P4|Induction Phase|Subject no longer meets study criteria|0
7842728|NCT00207142|27219759|P3|Induction Phase|Subject no longer meets study criteria|0
7842729|NCT00207142|27219760|P2|Induction Phase|Subject no longer meets study criteria|0
7842730|NCT00207142|27219761|P1|Induction Phase|Subject no longer meets study criteria|3
7842731|NCT00207142|27219758|P4|Induction Phase|Pregnancy|0
7842732|NCT00207142|27219759|P3|Induction Phase|Pregnancy|0
7842733|NCT00207142|27219760|P2|Induction Phase|Pregnancy|0
7842734|NCT00207142|27219761|P1|Induction Phase|Pregnancy|1
7842735|NCT00207142|27219758|P4|Induction Phase|Poor/noncompliance|0
7842736|NCT00207142|27219759|P3|Induction Phase|Poor/noncompliance|0
7842737|NCT00207142|27219760|P2|Induction Phase|Poor/noncompliance|0
7842738|NCT00207142|27219761|P1|Induction Phase|Poor/noncompliance|2
7842739|NCT00207142|27219758|P4|Induction Phase|Physician Decision|0
7842740|NCT00207142|27219759|P3|Induction Phase|Physician Decision|0
7842741|NCT00207142|27219760|P2|Induction Phase|Physician Decision|0
7842742|NCT00207142|27219761|P1|Induction Phase|Physician Decision|2
7842743|NCT00207142|27219758|P4|Induction Phase|Lost to Follow-up|0
7842744|NCT00207142|27219759|P3|Induction Phase|Lost to Follow-up|0
7842745|NCT00207142|27219760|P2|Induction Phase|Lost to Follow-up|0
7842746|NCT00207142|27219761|P1|Induction Phase|Lost to Follow-up|5
7842747|NCT00207142|27219758|P4|Induction Phase|Lack of Efficacy|0
7842748|NCT00207142|27219759|P3|Induction Phase|Lack of Efficacy|0
7842749|NCT00207142|27219760|P2|Induction Phase|Lack of Efficacy|0
7842750|NCT00207142|27219761|P1|Induction Phase|Lack of Efficacy|1
7842751|NCT00207142|27219758|P4|Induction Phase|Death|0
7842752|NCT00207142|27219759|P3|Induction Phase|Death|0
7842753|NCT00207142|27219760|P2|Induction Phase|Death|0
7842754|NCT00207142|27219761|P1|Induction Phase|Death|1
7842755|NCT00207142|27219758|P4|Induction Phase|Adverse Event|0
7842756|NCT00207142|27219759|P3|Induction Phase|Adverse Event|0
7842757|NCT00207142|27219760|P2|Induction Phase|Adverse Event|0
7842758|NCT00207142|27219761|P1|Induction Phase|Adverse Event|9
7842759|NCT00207090|27219798|P1|Overall Study|Physician Decision|1
7842760|NCT00207090|27219798|P1|Overall Study|Disease progression/relapse|2
7842761|NCT00207090|27219798|P1|Overall Study|Chest wall mass larger|1
7842762|NCT00207090|27219798|P1|Overall Study|Study drug toxicity|3
7842763|NCT00206726|27219827|P1|Overall Study|Withdrawal by Subject|8
7842764|NCT00206726|27219827|P1|Overall Study|Protocol Violation|1
7842765|NCT00206726|27219827|P1|Overall Study|Death|4
7842766|NCT00206726|27219827|P1|Overall Study|Adverse Event|17
7842767|NCT00206726|27219827|P1|Overall Study|Bone marrow transplant|1
7842768|NCT00206726|27219827|P1|Overall Study|Placed on new protocol|1
7842769|NCT00206726|27219827|P1|Overall Study|Progressive disease or relapsed disease|18
7842770|NCT00206726|27219827|P1|Overall Study|Delayed recovery of blood counts|1
7842771|NCT00206518|27219838|P2|Overall Study|Protocol Violation|1
7842772|NCT00206518|27219839|P1|Overall Study|Protocol Violation|1
7842773|NCT00206518|27219838|P2|Overall Study|Physician Decision|0
7842774|NCT00206518|27219839|P1|Overall Study|Physician Decision|1
7842775|NCT00206518|27219838|P2|Overall Study|Adverse Event|1
7842776|NCT00206518|27219839|P1|Overall Study|Adverse Event|2
7842777|NCT00206518|27219838|P2|Overall Study|Lack of Efficacy|4
7842778|NCT00206518|27219839|P1|Overall Study|Lack of Efficacy|6
7842779|NCT00206440|27219851|P2|Overall Study|Adverse Event|2
7842780|NCT00206440|27219852|P1|Overall Study|Adverse Event|4
7842781|NCT00206440|27219851|P2|Overall Study|Protocol Violation|2
7842782|NCT00206440|27219852|P1|Overall Study|Protocol Violation|1
7842783|NCT00206427|27219858|P1|Overall Study|Adverse Event|2
7842784|NCT00206375|27219867|P3|Overall Study|Study terminated due to lack of funds|1
7842785|NCT00206375|27219868|P2|Overall Study|Study terminated due to lack of funds|1
7842786|NCT00206375|27219869|P1|Overall Study|Study terminated due to lack of funds|0
7842787|NCT00206375|27219867|P3|Overall Study|Withdrawal by Subject|3
7842788|NCT00206375|27219868|P2|Overall Study|Withdrawal by Subject|1
7842789|NCT00206375|27219869|P1|Overall Study|Withdrawal by Subject|2
7842790|NCT00206375|27219867|P3|Overall Study|Lost to Follow-up|0
7842791|NCT00206375|27219868|P2|Overall Study|Lost to Follow-up|0
7842792|NCT00206375|27219869|P1|Overall Study|Lost to Follow-up|1
7842793|NCT00206323|27219889|P2|Overall Study|Lost to Follow-up|1
7842794|NCT00206323|27219890|P1|Overall Study|Lost to Follow-up|1
7842795|NCT00206323|27219889|P2|Overall Study|Adverse Event|1
7842796|NCT00206323|27219890|P1|Overall Study|Adverse Event|1
7842797|NCT00206323|27219889|P2|Overall Study|Lack of Efficacy|1
7842798|NCT00206323|27219890|P1|Overall Study|Lack of Efficacy|4
7842799|NCT00206102|27219898|P2|Overall Study|None of those categories|36
7842800|NCT00206102|27219899|P1|Overall Study|None of those categories|42
7842801|NCT00206102|27219898|P2|Overall Study|Study-specific discontinuation criteria|17
7842802|NCT00206102|27219899|P1|Overall Study|Study-specific discontinuation criteria|18
7842803|NCT00206102|27219898|P2|Overall Study|Withdrawal by Subject|101
7842804|NCT00206102|27219899|P1|Overall Study|Withdrawal by Subject|118
7842805|NCT00206102|27219898|P2|Overall Study|Lost to Follow-up|66
7842806|NCT00206102|27219899|P1|Overall Study|Lost to Follow-up|95
7842807|NCT00206102|27219898|P2|Overall Study|Lack of therapeutic response|11
7842808|NCT00206102|27219899|P1|Overall Study|Lack of therapeutic response|16
7842809|NCT00206102|27219898|P2|Overall Study|Protocol Violation|2
7842810|NCT00206102|27219899|P1|Overall Study|Protocol Violation|0
7842811|NCT00206102|27219898|P2|Overall Study|Adverse Event|82
7842812|NCT00206102|27219899|P1|Overall Study|Adverse Event|119
7842813|NCT00206076|27219935|P2|Overall Study|Withdrawal by Subject|1
7842814|NCT00206076|27219936|P1|Overall Study|Withdrawal by Subject|1
7842815|NCT00206076|27219935|P2|Overall Study|Physician Decision|0
7842816|NCT00206076|27219936|P1|Overall Study|Physician Decision|2
7842817|NCT00205881|27219946|P1|Overall Study|Withdrawal by Subject|16
7842818|NCT00205855|27219957|P1|Overall Study|Withdrawal by Subject|5
7842819|NCT00205855|27219957|P1|Overall Study|Only received temporary implants|16
7842820|NCT00205803|27219963|P2|Toddler Dose|Lost to Follow-up|3
7842821|NCT00205803|27219964|P1|Toddler Dose|Lost to Follow-up|2
7842822|NCT00205803|27219963|P2|After Infant Series|Other|4
7842823|NCT00205803|27219964|P1|After Infant Series|Other|10
7842824|NCT00205803|27219963|P2|After Infant Series|Withdrawal by Subject|4
7842825|NCT00205803|27219964|P1|After Infant Series|Withdrawal by Subject|1
7842826|NCT00205803|27219963|P2|After Infant Series|Physician Decision|2
7842827|NCT00205803|27219964|P1|After Infant Series|Physician Decision|3
7842828|NCT00205803|27219963|P2|After Infant Series|Lost to Follow-up|1
7842829|NCT00205803|27219964|P1|After Infant Series|Lost to Follow-up|2
7842830|NCT00205803|27219963|P2|After Infant Series|Protocol Violation|1
7842831|NCT00205803|27219964|P1|After Infant Series|Protocol Violation|1
7842832|NCT00205803|27219963|P2|After Infant Series|Adverse Event|1
7842833|NCT00205803|27219964|P1|After Infant Series|Adverse Event|1
7842834|NCT00205803|27219963|P2|Infant Series|Sponsor request|0
7842835|NCT00205803|27219964|P1|Infant Series|Sponsor request|1
7842836|NCT00205803|27219963|P2|Infant Series|Non-compliant|0
7842837|NCT00205803|27219964|P1|Infant Series|Non-compliant|1
7842838|NCT00205803|27219963|P2|Infant Series|Lost Kaiser coverage|1
7842839|NCT00205803|27219964|P1|Infant Series|Lost Kaiser coverage|0
7842840|NCT00205803|27219963|P2|Infant Series|Protocol Violation|0
7842841|NCT00205803|27219964|P1|Infant Series|Protocol Violation|1
7842842|NCT00205803|27219963|P2|Infant Series|Physician Decision|1
7842843|NCT00205803|27219964|P1|Infant Series|Physician Decision|3
7842844|NCT00205803|27219963|P2|Infant Series|Withdrawal by Subject|5
7842845|NCT00205803|27219964|P1|Infant Series|Withdrawal by Subject|2
7842846|NCT00205803|27219963|P2|Infant Series|Lost to Follow-up|4
7842847|NCT00205803|27219964|P1|Infant Series|Lost to Follow-up|10
7842848|NCT00205777|27220020|P6|Study Extension II|Enrolled but not treated|131
7842849|NCT00205777|27220021|P5|Study Extension II|Enrolled but not treated|0
7842850|NCT00205777|27220022|P4|Study Extension II|Enrolled but not treated|71
7842851|NCT00205777|27220023|P3|Study Extension II|Enrolled but not treated|0
7842852|NCT00205777|27220024|P2|Study Extension II|Enrolled but not treated|0
7842853|NCT00205777|27220025|P1|Study Extension II|Enrolled but not treated|0
7842854|NCT00205777|27220020|P6|Study Extension II|Other Event|20
7842855|NCT00205777|27220021|P5|Study Extension II|Other Event|0
7842856|NCT00205777|27220022|P4|Study Extension II|Other Event|12
7842857|NCT00205777|27220023|P3|Study Extension II|Other Event|0
7842858|NCT00205777|27220024|P2|Study Extension II|Other Event|0
7842859|NCT00205777|27220025|P1|Study Extension II|Other Event|0
7842860|NCT00205777|27220020|P6|Study Extension II|Failed to return|26
7842861|NCT00205777|27220021|P5|Study Extension II|Failed to return|0
7842862|NCT00205777|27220022|P4|Study Extension II|Failed to return|14
7842863|NCT00205777|27220023|P3|Study Extension II|Failed to return|0
7842864|NCT00205777|27220024|P2|Study Extension II|Failed to return|0
7842865|NCT00205777|27220025|P1|Study Extension II|Failed to return|0
7842866|NCT00205777|27220020|P6|Study Extension II|Lack of Efficacy|1
7842867|NCT00205777|27220021|P5|Study Extension II|Lack of Efficacy|0
7842868|NCT00205777|27220022|P4|Study Extension II|Lack of Efficacy|0
7842869|NCT00205777|27220023|P3|Study Extension II|Lack of Efficacy|0
7842870|NCT00205777|27220024|P2|Study Extension II|Lack of Efficacy|0
7842871|NCT00205777|27220025|P1|Study Extension II|Lack of Efficacy|0
7842872|NCT00205777|27220020|P6|Study Extension II|Protocol Violation|10
7842873|NCT00205777|27220021|P5|Study Extension II|Protocol Violation|0
7842874|NCT00205777|27220022|P4|Study Extension II|Protocol Violation|1
7842875|NCT00205777|27220023|P3|Study Extension II|Protocol Violation|0
7842876|NCT00205777|27220024|P2|Study Extension II|Protocol Violation|0
7842877|NCT00205777|27220025|P1|Study Extension II|Protocol Violation|0
7842878|NCT00205777|27220020|P6|Study Extension II|Withdrawal by Subject|59
7842879|NCT00205777|27220021|P5|Study Extension II|Withdrawal by Subject|0
7842880|NCT00205777|27220022|P4|Study Extension II|Withdrawal by Subject|35
7842881|NCT00205777|27220023|P3|Study Extension II|Withdrawal by Subject|0
7842882|NCT00205777|27220024|P2|Study Extension II|Withdrawal by Subject|0
7842883|NCT00205777|27220025|P1|Study Extension II|Withdrawal by Subject|0
7842884|NCT00205777|27220020|P6|Study Extension II|Death|5
7842885|NCT00205777|27220021|P5|Study Extension II|Death|0
7842886|NCT00205777|27220022|P4|Study Extension II|Death|2
7842887|NCT00205777|27220023|P3|Study Extension II|Death|0
7842888|NCT00205777|27220024|P2|Study Extension II|Death|0
7842889|NCT00205777|27220025|P1|Study Extension II|Death|0
7842890|NCT00205777|27220020|P6|Study Extension II|Adverse Event|30
7842891|NCT00205777|27220021|P5|Study Extension II|Adverse Event|0
7842892|NCT00205777|27220022|P4|Study Extension II|Adverse Event|14
7842893|NCT00205777|27220023|P3|Study Extension II|Adverse Event|0
7842894|NCT00205777|27220024|P2|Study Extension II|Adverse Event|0
7842895|NCT00205777|27220025|P1|Study Extension II|Adverse Event|0
7842896|NCT00205777|27220020|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7842897|NCT00205777|27220021|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
7842898|NCT00205777|27220022|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
7842899|NCT00205777|27220023|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7842900|NCT00205777|27220024|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7842901|NCT00205777|27220025|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
7842902|NCT00205777|27220020|P6|Study Extension I|Withdrawn as per protocol|0
7842903|NCT00205777|27220021|P5|Study Extension I|Withdrawn as per protocol|0
7842904|NCT00205777|27220022|P4|Study Extension I|Withdrawn as per protocol|0
7842905|NCT00205777|27220023|P3|Study Extension I|Withdrawn as per protocol|1070
7842906|NCT00205777|27220024|P2|Study Extension I|Withdrawn as per protocol|0
7842907|NCT00205777|27220025|P1|Study Extension I|Withdrawn as per protocol|0
7842908|NCT00205777|27220020|P6|Study Extension I|Other Event|0
7842909|NCT00205777|27220021|P5|Study Extension I|Other Event|29
7842910|NCT00205777|27220022|P4|Study Extension I|Other Event|34
7842911|NCT00205777|27220023|P3|Study Extension I|Other Event|0
7842912|NCT00205777|27220024|P2|Study Extension I|Other Event|0
7842913|NCT00205777|27220025|P1|Study Extension I|Other Event|34
7842914|NCT00205777|27220020|P6|Study Extension I|Failed to return|0
7842915|NCT00205777|27220021|P5|Study Extension I|Failed to return|13
7842916|NCT00205777|27220022|P4|Study Extension I|Failed to return|17
7842917|NCT00205777|27220023|P3|Study Extension I|Failed to return|0
7842918|NCT00205777|27220024|P2|Study Extension I|Failed to return|0
7842919|NCT00205777|27220025|P1|Study Extension I|Failed to return|15
7842920|NCT00205777|27220020|P6|Study Extension I|Lack of Efficacy|0
7842921|NCT00205777|27220021|P5|Study Extension I|Lack of Efficacy|2
7842922|NCT00205777|27220022|P4|Study Extension I|Lack of Efficacy|1
7842923|NCT00205777|27220023|P3|Study Extension I|Lack of Efficacy|0
7842924|NCT00205777|27220024|P2|Study Extension I|Lack of Efficacy|0
7842925|NCT00205777|27220025|P1|Study Extension I|Lack of Efficacy|0
7842926|NCT00205777|27220020|P6|Study Extension I|Protocol Violation|0
7842927|NCT00205777|27220021|P5|Study Extension I|Protocol Violation|8
7842928|NCT00205777|27220022|P4|Study Extension I|Protocol Violation|8
7842929|NCT00205777|27220023|P3|Study Extension I|Protocol Violation|0
7842930|NCT00205777|27220024|P2|Study Extension I|Protocol Violation|0
7842931|NCT00205777|27220025|P1|Study Extension I|Protocol Violation|4
7842932|NCT00205777|27220020|P6|Study Extension I|Withdrawal by Subject|0
7842933|NCT00205777|27220021|P5|Study Extension I|Withdrawal by Subject|89
7842934|NCT00205777|27220022|P4|Study Extension I|Withdrawal by Subject|106
7842935|NCT00205777|27220023|P3|Study Extension I|Withdrawal by Subject|0
7842936|NCT00205777|27220024|P2|Study Extension I|Withdrawal by Subject|0
7842937|NCT00205777|27220025|P1|Study Extension I|Withdrawal by Subject|99
7842938|NCT00205777|27220020|P6|Study Extension I|Death|0
7842939|NCT00205777|27220021|P5|Study Extension I|Death|2
7842940|NCT00205777|27220022|P4|Study Extension I|Death|1
7842941|NCT00205777|27220023|P3|Study Extension I|Death|0
7842942|NCT00205777|27220024|P2|Study Extension I|Death|0
7842943|NCT00205777|27220025|P1|Study Extension I|Death|5
7842944|NCT00205777|27220020|P6|Study Extension I|Adverse Event|0
7842945|NCT00205777|27220021|P5|Study Extension I|Adverse Event|58
7842946|NCT00205777|27220022|P4|Study Extension I|Adverse Event|61
7842947|NCT00205777|27220023|P3|Study Extension I|Adverse Event|0
7842948|NCT00205777|27220024|P2|Study Extension I|Adverse Event|0
7842949|NCT00205777|27220025|P1|Study Extension I|Adverse Event|57
7842950|NCT00205777|27220020|P6|Completed Core Study, Entered SE I|Other Event|0
7842951|NCT00205777|27220021|P5|Completed Core Study, Entered SE I|Other Event|0
7842952|NCT00205777|27220022|P4|Completed Core Study, Entered SE I|Other Event|50
7842953|NCT00205777|27220023|P3|Completed Core Study, Entered SE I|Other Event|47
7842954|NCT00205777|27220024|P2|Completed Core Study, Entered SE I|Other Event|46
7842955|NCT00205777|27220025|P1|Completed Core Study, Entered SE I|Other Event|52
7842956|NCT00205777|27220020|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
7842957|NCT00205777|27220021|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
7842958|NCT00205777|27220022|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
7842959|NCT00205777|27220023|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
7842960|NCT00205777|27220024|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
7842961|NCT00205777|27220025|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
7842962|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
7842963|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
7842964|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
7842965|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
7842966|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
7842967|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
7842968|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
7842969|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
7842970|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
7842971|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
7842972|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
7842973|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
7842974|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Protocol Violation|0
7842975|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Protocol Violation|0
7842976|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Protocol Violation|42
7842977|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Protocol Violation|50
7842978|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Protocol Violation|55
7842979|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Protocol Violation|53
7842980|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
7842981|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
7842982|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
7842983|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
7842984|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
7842985|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
7842986|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Other Event|0
7842987|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Other Event|0
7842988|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Other Event|58
7842989|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Other Event|41
7842990|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Other Event|52
7842991|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Other Event|49
7842992|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Failed to return|0
7842993|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Failed to return|0
7842994|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Failed to return|27
7842995|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Failed to return|27
7842996|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Failed to return|25
7842997|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Failed to return|40
7842998|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Death|0
7842999|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Death|0
7843000|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Death|7
7843001|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Death|14
7843002|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Death|7
7843003|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Death|9
7843004|NCT00205777|27220020|P6|Core Study (Up to 3 Years)|Adverse Event|0
7843005|NCT00205777|27220021|P5|Core Study (Up to 3 Years)|Adverse Event|0
7843006|NCT00205777|27220022|P4|Core Study (Up to 3 Years)|Adverse Event|232
7843007|NCT00205777|27220023|P3|Core Study (Up to 3 Years)|Adverse Event|252
7843008|NCT00205777|27220024|P2|Core Study (Up to 3 Years)|Adverse Event|267
7843009|NCT00205777|27220025|P1|Core Study (Up to 3 Years)|Adverse Event|260
7843010|NCT00205712|27220234|P2|Overall Study|Lost to Follow-up|1
7843011|NCT00205712|27220235|P1|Overall Study|Lost to Follow-up|0
7843012|NCT00205699|27220248|P3|Overall Study|Lack of Efficacy|0
7843013|NCT00205699|27220249|P2|Overall Study|Lack of Efficacy|1
7843014|NCT00205699|27220250|P1|Overall Study|Lack of Efficacy|0
7843015|NCT00205699|27220248|P3|Overall Study|Withdrawal by Subject|1
7843016|NCT00205699|27220249|P2|Overall Study|Withdrawal by Subject|2
7843017|NCT00205699|27220250|P1|Overall Study|Withdrawal by Subject|1
7843018|NCT00205699|27220248|P3|Overall Study|Adverse Event|0
7843019|NCT00205699|27220249|P2|Overall Study|Adverse Event|0
7843020|NCT00205699|27220250|P1|Overall Study|Adverse Event|1
7843021|NCT00205699|27220248|P3|Overall Study|Lost to Follow-up|5
7843022|NCT00205699|27220249|P2|Overall Study|Lost to Follow-up|3
7843023|NCT00205699|27220250|P1|Overall Study|Lost to Follow-up|1
7843024|NCT00205179|27220330|P2|Overall Study|Adverse Event|1
7843025|NCT00205179|27220331|P1|Overall Study|Adverse Event|1
7843026|NCT00205179|27220330|P2|Overall Study|Physician Decision|1
7843027|NCT00205179|27220331|P1|Overall Study|Physician Decision|1
7843028|NCT00205179|27220330|P2|Overall Study|Death|2
7843029|NCT00205179|27220331|P1|Overall Study|Death|0
7843030|NCT00203996|27220449|P10|Overall Study|Scheduling issue|0
7843031|NCT00203996|27220450|P9|Overall Study|Scheduling issue|0
7843032|NCT00203996|27220451|P8|Overall Study|Scheduling issue|2
7843033|NCT00203996|27220452|P7|Overall Study|Scheduling issue|0
7843034|NCT00203996|27220453|P6|Overall Study|Scheduling issue|0
7843035|NCT00203996|27220454|P5|Overall Study|Scheduling issue|0
7843036|NCT00203996|27220455|P4|Overall Study|Scheduling issue|0
7843037|NCT00203996|27220456|P3|Overall Study|Scheduling issue|0
7843038|NCT00203996|27220457|P2|Overall Study|Scheduling issue|0
7843039|NCT00203996|27220458|P1|Overall Study|Scheduling issue|0
7843040|NCT00203996|27220449|P10|Overall Study|CPAP machine malfunction|0
7843041|NCT00203996|27220450|P9|Overall Study|CPAP machine malfunction|0
7843042|NCT00203996|27220451|P8|Overall Study|CPAP machine malfunction|0
7843043|NCT00203996|27220452|P7|Overall Study|CPAP machine malfunction|0
7843044|NCT00203996|27220453|P6|Overall Study|CPAP machine malfunction|0
7843045|NCT00203996|27220454|P5|Overall Study|CPAP machine malfunction|0
7843046|NCT00203996|27220455|P4|Overall Study|CPAP machine malfunction|1
7843047|NCT00203996|27220456|P3|Overall Study|CPAP machine malfunction|0
7843048|NCT00203996|27220457|P2|Overall Study|CPAP machine malfunction|0
7843049|NCT00203996|27220458|P1|Overall Study|CPAP machine malfunction|0
7843050|NCT00203996|27220449|P10|Overall Study|Physician Decision|1
7843051|NCT00203996|27220450|P9|Overall Study|Physician Decision|0
7843052|NCT00203996|27220451|P8|Overall Study|Physician Decision|0
7843053|NCT00203996|27220452|P7|Overall Study|Physician Decision|0
7843054|NCT00203996|27220453|P6|Overall Study|Physician Decision|0
7843055|NCT00203996|27220454|P5|Overall Study|Physician Decision|0
7843056|NCT00203996|27220455|P4|Overall Study|Physician Decision|2
7843057|NCT00203996|27220456|P3|Overall Study|Physician Decision|0
7843058|NCT00203996|27220457|P2|Overall Study|Physician Decision|0
7843059|NCT00203996|27220458|P1|Overall Study|Physician Decision|0
7843060|NCT00203996|27220449|P10|Overall Study|Protocol Violation|0
7843061|NCT00203996|27220450|P9|Overall Study|Protocol Violation|0
7843062|NCT00203996|27220451|P8|Overall Study|Protocol Violation|0
7843063|NCT00203996|27220452|P7|Overall Study|Protocol Violation|0
7843064|NCT00203996|27220453|P6|Overall Study|Protocol Violation|0
7843065|NCT00203996|27220454|P5|Overall Study|Protocol Violation|1
7843066|NCT00203996|27220455|P4|Overall Study|Protocol Violation|6
7843067|NCT00203996|27220456|P3|Overall Study|Protocol Violation|0
7843068|NCT00203996|27220457|P2|Overall Study|Protocol Violation|0
7843069|NCT00203996|27220458|P1|Overall Study|Protocol Violation|0
7843070|NCT00203996|27220449|P10|Overall Study|Lost to Follow-up|0
7843071|NCT00203996|27220450|P9|Overall Study|Lost to Follow-up|0
7843072|NCT00203996|27220451|P8|Overall Study|Lost to Follow-up|0
7843073|NCT00203996|27220452|P7|Overall Study|Lost to Follow-up|0
7843074|NCT00203996|27220453|P6|Overall Study|Lost to Follow-up|0
7843075|NCT00203996|27220454|P5|Overall Study|Lost to Follow-up|0
7843076|NCT00203996|27220455|P4|Overall Study|Lost to Follow-up|1
7843077|NCT00203996|27220456|P3|Overall Study|Lost to Follow-up|0
7843078|NCT00203996|27220457|P2|Overall Study|Lost to Follow-up|0
7843079|NCT00203996|27220458|P1|Overall Study|Lost to Follow-up|0
7843080|NCT00203892|27220525|P3|Overall Study|Death|0
7843081|NCT00203892|27220526|P2|Overall Study|Death|0
7843082|NCT00203892|27220527|P1|Overall Study|Death|1
7843083|NCT00203892|27220525|P3|Overall Study|Physician Decision|0
7843084|NCT00203892|27220526|P2|Overall Study|Physician Decision|2
7843085|NCT00203892|27220527|P1|Overall Study|Physician Decision|1
7843086|NCT00203502|27220538|P1|Overall Study|Death|1
7843087|NCT00203476|27220549|P3|Overall Study|Withdrawal by Subject|0
7843088|NCT00203476|27220550|P2|Overall Study|Withdrawal by Subject|1
7843089|NCT00203476|27220551|P1|Overall Study|Withdrawal by Subject|0
7843090|NCT00203476|27220549|P3|Overall Study|Lost to Follow-up|0
7843091|NCT00203476|27220550|P2|Overall Study|Lost to Follow-up|0
7843092|NCT00203476|27220551|P1|Overall Study|Lost to Follow-up|1
7843093|NCT00203424|27220568|P1|Follow-up Period|Lost to Follow-up|1
7843094|NCT00203424|27220568|P1|Follow-up Period|progressive disease|4
7843095|NCT00203424|27220568|P1|Follow-up Period|Withdrawal by Subject|1
7843096|NCT00203424|27220568|P1|Treatment Period|progressive disease|2
7843097|NCT00203424|27220568|P1|Treatment Period|Adverse Event|5
7843098|NCT00203424|27220568|P1|Treatment Period|Withdrawal by Subject|4
7843099|NCT00203411|27220575|P1|Follow-up|Progressive Disease|4
7843100|NCT00203307|27220584|P2|First Intervention|Adverse Event|0
7843101|NCT00203307|27220585|P1|First Intervention|Adverse Event|2
7843102|NCT00203294|27220593|P2|Overall Study|Withdrawal by Subject|13
7843103|NCT00203294|27220594|P1|Overall Study|Withdrawal by Subject|8
7843104|NCT00203268|27220600|P1|Early Treatment|Withdrawal by Subject|1
7843105|NCT00203268|27220600|P1|Early Treatment|Lost to Follow-up|1
7843106|NCT00203268|27220600|P1|Early Treatment|only treated one headache|2
7843107|NCT00203242|27220606|P1|Overall Study|Lost to Follow-up|1
7843108|NCT00203047|27220658|P2|Overall Study|Other|5
7843109|NCT00203047|27220659|P1|Overall Study|Other|5
7843110|NCT00203047|27220658|P2|Overall Study|Pregnancy|0
7843111|NCT00203047|27220659|P1|Overall Study|Pregnancy|3
7843112|NCT00203047|27220658|P2|Overall Study|Death|2
7843113|NCT00203047|27220659|P1|Overall Study|Death|1
7843114|NCT00203047|27220658|P2|Overall Study|Adverse Event|18
7843115|NCT00203047|27220659|P1|Overall Study|Adverse Event|8
7843116|NCT00203047|27220658|P2|Overall Study|Lost to Follow-up|5
7843117|NCT00203047|27220659|P1|Overall Study|Lost to Follow-up|11
7843118|NCT00203047|27220658|P2|Overall Study|Protocol Violation|0
7843119|NCT00203047|27220659|P1|Overall Study|Protocol Violation|1
7843120|NCT00203047|27220658|P2|Overall Study|Non-compliance|8
7843121|NCT00203047|27220659|P1|Overall Study|Non-compliance|4
7843122|NCT00203047|27220658|P2|Overall Study|Physician Decision|7
7843123|NCT00203047|27220659|P1|Overall Study|Physician Decision|8
7843124|NCT00203047|27220658|P2|Overall Study|Teva requested participant withdrawal|1
7843125|NCT00203047|27220659|P1|Overall Study|Teva requested participant withdrawal|1
7843126|NCT00203047|27220658|P2|Overall Study|Withdrawal by Subject|47
7843127|NCT00203047|27220659|P1|Overall Study|Withdrawal by Subject|13
7843128|NCT00203047|27220658|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
7843129|NCT00203047|27220659|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
7843130|NCT00203047|27220658|P2|Overall Study|Ongoing: in database - January 29, 2009|109
7843131|NCT00203047|27220659|P1|Overall Study|Ongoing: in database - January 29, 2009|131
7843132|NCT00203021|27220673|P2|Overall Study|Other than specified|16
7843133|NCT00203021|27220674|P1|Overall Study|Other than specified|11
7843134|NCT00203021|27220673|P2|Overall Study|Lost to Follow-up|7
7843135|NCT00203021|27220674|P1|Overall Study|Lost to Follow-up|9
7843136|NCT00203021|27220673|P2|Overall Study|Withdrawal by Subject|48
7843137|NCT00203021|27220674|P1|Overall Study|Withdrawal by Subject|45
7843138|NCT00203021|27220673|P2|Overall Study|Adverse Event|5
7843139|NCT00203021|27220674|P1|Overall Study|Adverse Event|10
7843140|NCT00203021|27220673|P2|Overall Study|Death|1
7843141|NCT00203021|27220674|P1|Overall Study|Death|4
7843142|NCT00202878|27220692|P2|Overall Study|Withdrawal by Subject|808
7843143|NCT00202878|27220693|P1|Overall Study|Withdrawal by Subject|795
7843144|NCT00202878|27220692|P2|Overall Study|Site Closure|36
7843145|NCT00202878|27220693|P1|Overall Study|Site Closure|39
7843146|NCT00202878|27220692|P2|Overall Study|Lost to Follow-up|49
7843147|NCT00202878|27220693|P1|Overall Study|Lost to Follow-up|44
7843148|NCT00202878|27220692|P2|Overall Study|Only Vital Status Known|356
7843149|NCT00202878|27220693|P1|Overall Study|Only Vital Status Known|357
7843150|NCT00202878|27220692|P2|Overall Study|Death|968
7843151|NCT00202878|27220693|P1|Overall Study|Death|964
7843152|NCT00202839|27220707|P2|Overall Study|Lost to Follow-up|2
7843153|NCT00202839|27220708|P1|Overall Study|Lost to Follow-up|3
7843154|NCT00202839|27220707|P2|Overall Study|Protocol Violation|1
7843155|NCT00202839|27220708|P1|Overall Study|Protocol Violation|2
7843156|NCT00202839|27220707|P2|Overall Study|Withdrawal by Subject|2
7843157|NCT00202839|27220708|P1|Overall Study|Withdrawal by Subject|6
7843158|NCT00202839|27220707|P2|Overall Study|Physician Decision|0
7843159|NCT00202839|27220708|P1|Overall Study|Physician Decision|12
7843160|NCT00202839|27220707|P2|Overall Study|Adverse Event|5
7843161|NCT00202839|27220708|P1|Overall Study|Adverse Event|1
7843162|NCT00202644|27220723|P2|Overall Study|Other|1
7843163|NCT00202644|27220724|P1|Overall Study|Other|9
7843164|NCT00202644|27220723|P2|Overall Study|Lost to Follow-up|1
7843165|NCT00202644|27220724|P1|Overall Study|Lost to Follow-up|0
7843166|NCT00202644|27220723|P2|Overall Study|Lack of Efficacy|6
7843167|NCT00202644|27220724|P1|Overall Study|Lack of Efficacy|6
7843168|NCT00202644|27220723|P2|Overall Study|Withdrawal by Subject|6
7843169|NCT00202644|27220724|P1|Overall Study|Withdrawal by Subject|8
7843170|NCT00202644|27220723|P2|Overall Study|Adverse Event|13
7843171|NCT00202644|27220724|P1|Overall Study|Adverse Event|12
7843172|NCT00201851|27220785|P3|Overall Study|Ineligible post enrollment|1
7843173|NCT00201851|27220786|P2|Overall Study|Ineligible post enrollment|1
7843174|NCT00201851|27220787|P1|Overall Study|Ineligible post enrollment|6
7843175|NCT00201851|27220785|P3|Overall Study|Lost to Follow-up|0
7843176|NCT00201851|27220786|P2|Overall Study|Lost to Follow-up|1
7843177|NCT00201851|27220787|P1|Overall Study|Lost to Follow-up|2
7843178|NCT00201643|27220859|P2|Overall Study|Withdrawal by Subject|4
7843179|NCT00201643|27220860|P1|Overall Study|Withdrawal by Subject|5
7843180|NCT00201201|27220924|P2|Overall Study|Withdrawal by Subject|5
7843181|NCT00201201|27220925|P1|Overall Study|Withdrawal by Subject|5
7843182|NCT00201201|27220924|P2|Overall Study|Death|2
7843183|NCT00201201|27220925|P1|Overall Study|Death|0
7843184|NCT00201006|27220963|P3|Overall Study|Adverse Event|1
7843185|NCT00201006|27220964|P2|Overall Study|Adverse Event|0
7843186|NCT00201006|27220965|P1|Overall Study|Adverse Event|1
7843187|NCT00201006|27220963|P3|Overall Study|Withdrawal by Subject|3
7843188|NCT00201006|27220964|P2|Overall Study|Withdrawal by Subject|2
7843189|NCT00201006|27220965|P1|Overall Study|Withdrawal by Subject|7
7843190|NCT00200967|27220975|P2|Run-out Period|Lost to Follow-up|0
7843191|NCT00200967|27220976|P1|Run-out Period|Lost to Follow-up|1
7843192|NCT00200967|27220975|P2|Second Treatment Period|Withdrawal by Subject|2
7843193|NCT00200967|27220976|P1|Second Treatment Period|Withdrawal by Subject|1
7843194|NCT00200967|27220975|P2|Wash-out Period|Lost to Follow-up|1
7843195|NCT00200967|27220976|P1|Wash-out Period|Lost to Follow-up|0
7843196|NCT00200967|27220975|P2|First Treatment Period|Pregnancy|0
7843197|NCT00200967|27220976|P1|First Treatment Period|Pregnancy|1
7843198|NCT00200967|27220975|P2|First Treatment Period|Withdrawal by Subject|1
7843199|NCT00200967|27220976|P1|First Treatment Period|Withdrawal by Subject|5
7843200|NCT00200850|27221026|P3|Overall Study|Adverse Event|2
7843201|NCT00200850|27221027|P2|Overall Study|Adverse Event|1
7843202|NCT00200850|27221028|P1|Overall Study|Adverse Event|1
7843203|NCT00200850|27221026|P3|Overall Study|optic neuritis|1
7843204|NCT00200850|27221027|P2|Overall Study|optic neuritis|0
7843205|NCT00200850|27221028|P1|Overall Study|optic neuritis|0
7843206|NCT00200850|27221026|P3|Overall Study|Poor adherence|1
7843207|NCT00200850|27221027|P2|Overall Study|Poor adherence|0
7843208|NCT00200850|27221028|P1|Overall Study|Poor adherence|0
7843209|NCT00200850|27221026|P3|Overall Study|Pregnancy|1
7843210|NCT00200850|27221027|P2|Overall Study|Pregnancy|0
7843211|NCT00200850|27221028|P1|Overall Study|Pregnancy|0
7843212|NCT00200850|27221026|P3|Overall Study|too busy|0
7843213|NCT00200850|27221027|P2|Overall Study|too busy|0
7843214|NCT00200850|27221028|P1|Overall Study|too busy|1
7843215|NCT00200850|27221026|P3|Overall Study|relocation|1
7843216|NCT00200850|27221027|P2|Overall Study|relocation|0
7843217|NCT00200850|27221028|P1|Overall Study|relocation|1
7843218|NCT00200356|27221049|P2|Overall Study|Nontreatment|0
7843219|NCT00200356|27221050|P1|Overall Study|Nontreatment|1
7843220|NCT00200356|27221049|P2|Overall Study|Protocol Violation|4
7843221|NCT00200356|27221050|P1|Overall Study|Protocol Violation|4
7843222|NCT00200356|27221049|P2|Overall Study|Lack of Efficacy|3
7843223|NCT00200356|27221050|P1|Overall Study|Lack of Efficacy|3
7843224|NCT00200057|27221117|P1|Overall Study|Death|1
7843225|NCT00200057|27221117|P1|Overall Study|Infection|1
7843226|NCT00200057|27221117|P1|Overall Study|Change in medical condition|1
7843227|NCT00200057|27221117|P1|Overall Study|Withdrawal by Subject|1
7843228|NCT00200057|27221117|P1|Overall Study|Exited due to terminal illness of PI|2
7843229|NCT00200057|27221117|P1|Overall Study|Lack of Efficacy|3
7843230|NCT00199901|27221138|P2|Overall Study|Progressive Disease|24
7843231|NCT00199901|27221139|P1|Overall Study|Progressive Disease|24
7843232|NCT00199901|27221138|P2|Overall Study|Withdrawal by Subject|0
7843233|NCT00199901|27221139|P1|Overall Study|Withdrawal by Subject|1
7843234|NCT00199901|27221138|P2|Overall Study|Protocol Violation|0
7843235|NCT00199901|27221139|P1|Overall Study|Protocol Violation|2
7843236|NCT00199888|27221161|P1|Overall Study|Lost to Follow-up|1
7843237|NCT00199875|27221173|P5|Overall Study|Withdrawal by Subject|1
7843238|NCT00199875|27221174|P4|Overall Study|Withdrawal by Subject|0
7843239|NCT00199875|27221175|P3|Overall Study|Withdrawal by Subject|0
7843240|NCT00199875|27221176|P2|Overall Study|Withdrawal by Subject|0
7843241|NCT00199875|27221177|P1|Overall Study|Withdrawal by Subject|0
7843242|NCT00199849|27221202|P3|Overall Study|Did not meet eligibility criteria - not dosed|1
7843243|NCT00199849|27221203|P2|Overall Study|Did not meet eligibility criteria - not dosed|0
7843244|NCT00199849|27221204|P1|Overall Study|Did not meet eligibility criteria - not dosed|0
7843245|NCT00199849|27221202|P3|Overall Study|Progressive disease requiring intervention|1
7843246|NCT00199849|27221203|P2|Overall Study|Progressive disease requiring intervention|0
7843247|NCT00199849|27221204|P1|Overall Study|Progressive disease requiring intervention|0
7843248|NCT00199849|27221202|P3|Overall Study|Unrelated illness or complication|0
7843249|NCT00199849|27221203|P2|Overall Study|Unrelated illness or complication|1
7843250|NCT00199849|27221204|P1|Overall Study|Unrelated illness or complication|0
7843251|NCT00199836|27221224|P1|Overall Study|Death|1
7843252|NCT00199836|27221224|P1|Overall Study|Progressive Disease|5
7843253|NCT00199797|27221232|P1|Overall Study|Physician Decision|1
7843254|NCT00199797|27221232|P1|Overall Study|Adverse Event|1
7843255|NCT00199797|27221232|P1|Overall Study|Progressive Disease|1
7843256|NCT00199381|27221238|P1|Overall Study|Study termination by Sponsor|323
7843257|NCT00199381|27221238|P1|Overall Study|Not including due to early termination|37
7843258|NCT00199381|27221238|P1|Overall Study|Lack of Efficacy|27
7843259|NCT00199381|27221238|P1|Overall Study|Protocol Violation|6
7843260|NCT00199381|27221238|P1|Overall Study|Adverse Event|73
7843261|NCT00199381|27221238|P1|Overall Study|Withdrawal by Subject|38
7843262|NCT00198822|27221245|P3|Overall Study|Lost to Follow-up|21
7843263|NCT00198822|27221246|P2|Overall Study|Lost to Follow-up|20
7843264|NCT00198822|27221247|P1|Overall Study|Lost to Follow-up|14
7843265|NCT00198133|27221266|P2|Overall Study|Physician Decision|0
7843266|NCT00198133|27221267|P1|Overall Study|Physician Decision|1
7843267|NCT00198133|27221266|P2|Overall Study|Withdrawal by Subject|0
7843268|NCT00198133|27221267|P1|Overall Study|Withdrawal by Subject|1
7843269|NCT00198133|27221266|P2|Overall Study|Adverse Event|3
7843270|NCT00198133|27221267|P1|Overall Study|Adverse Event|1
7843271|NCT00198133|27221266|P2|Overall Study|Disease progression|5
7843272|NCT00198133|27221267|P1|Overall Study|Disease progression|2
7843273|NCT00198107|27221279|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
7843274|NCT00198107|27221280|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
7843275|NCT00198107|27221281|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
7843276|NCT00198107|27221279|P3|Double-Blind Period|Withdrawal by Subject|0
7843277|NCT00198107|27221280|P2|Double-Blind Period|Withdrawal by Subject|1
7843278|NCT00198107|27221281|P1|Double-Blind Period|Withdrawal by Subject|0
7843279|NCT00198107|27221279|P3|Double-Blind Period|Physician Decision|0
7843280|NCT00198107|27221280|P2|Double-Blind Period|Physician Decision|0
7843281|NCT00198107|27221281|P1|Double-Blind Period|Physician Decision|1
7843282|NCT00198107|27221279|P3|Double-Blind Period|Lost to Follow-up|0
7843283|NCT00198107|27221280|P2|Double-Blind Period|Lost to Follow-up|1
7843284|NCT00198107|27221281|P1|Double-Blind Period|Lost to Follow-up|2
7843285|NCT00198107|27221279|P3|Double-Blind Period|Lack of Efficacy|0
7843286|NCT00198107|27221280|P2|Double-Blind Period|Lack of Efficacy|0
7843287|NCT00198107|27221281|P1|Double-Blind Period|Lack of Efficacy|2
7843288|NCT00198107|27221279|P3|Double-Blind Period|Adverse Event|0
7843289|NCT00198107|27221280|P2|Double-Blind Period|Adverse Event|1
7843290|NCT00198107|27221281|P1|Double-Blind Period|Adverse Event|1
7843291|NCT00198029|27221349|P1|Overall Study|Withdrawal by Subject|4
7843292|NCT00197496|27221356|P2|Follow-up|Lost to Follow-up|1
7843293|NCT00197496|27221357|P1|Follow-up|Lost to Follow-up|2
7843294|NCT00197496|27221356|P2|Baseline to Discharge|Protocol Violation|1
7843295|NCT00197496|27221357|P1|Baseline to Discharge|Protocol Violation|0
7843296|NCT00197496|27221356|P2|Baseline to Discharge|Physician Decision|1
7843297|NCT00197496|27221357|P1|Baseline to Discharge|Physician Decision|0
7843298|NCT00197496|27221356|P2|Baseline to Discharge|MRSA|0
7843299|NCT00197496|27221357|P1|Baseline to Discharge|MRSA|1
7843300|NCT00197496|27221356|P2|Baseline to Discharge|not interested|0
7843301|NCT00197496|27221357|P1|Baseline to Discharge|not interested|1
7843302|NCT00197236|27221405|P3|Overall Study|Returned out of specified time window|1
7843303|NCT00197236|27221406|P2|Overall Study|Returned out of specified time window|0
7843304|NCT00197236|27221407|P1|Overall Study|Returned out of specified time window|0
7843305|NCT00197236|27221405|P3|Overall Study|Study drug/medication expiration|3
7843306|NCT00197236|27221406|P2|Overall Study|Study drug/medication expiration|0
7843307|NCT00197236|27221407|P1|Overall Study|Study drug/medication expiration|1
7843308|NCT00197236|27221405|P3|Overall Study|Withdrawal by Subject|11
7843309|NCT00197236|27221406|P2|Overall Study|Withdrawal by Subject|3
7843310|NCT00197236|27221407|P1|Overall Study|Withdrawal by Subject|7
7843311|NCT00197236|27221405|P3|Overall Study|Protocol Violation|1
7843312|NCT00197236|27221406|P2|Overall Study|Protocol Violation|0
7843313|NCT00197236|27221407|P1|Overall Study|Protocol Violation|0
7843314|NCT00197236|27221405|P3|Overall Study|Lost to Follow-up|6
7843315|NCT00197236|27221406|P2|Overall Study|Lost to Follow-up|14
7843316|NCT00197236|27221407|P1|Overall Study|Lost to Follow-up|5
7843317|NCT00197236|27221405|P3|Overall Study|Adverse Event|1
7843318|NCT00197236|27221406|P2|Overall Study|Adverse Event|0
7843319|NCT00197236|27221407|P1|Overall Study|Adverse Event|1
7843320|NCT00197145|27221481|P2|Period 2 : Open Label Phase|Other|0
7843321|NCT00197145|27221482|P1|Period 2 : Open Label Phase|Other|1
7843322|NCT00197145|27221481|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
7843323|NCT00197145|27221482|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
7843324|NCT00197145|27221481|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
7843325|NCT00197145|27221482|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
7843326|NCT00197145|27221481|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
7843327|NCT00197145|27221482|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
7843328|NCT00197145|27221481|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
7843329|NCT00197145|27221482|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
7843330|NCT00197145|27221481|P2|Period 1: Randomized Treatment Phase|Other|2
7843331|NCT00197145|27221482|P1|Period 1: Randomized Treatment Phase|Other|2
7843332|NCT00197145|27221481|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
7843333|NCT00197145|27221482|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
7843334|NCT00197145|27221481|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
7843335|NCT00197145|27221482|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
7843336|NCT00197106|27221553|P3|Overall Treatment Period|Withdrawal by Subject|2
7843337|NCT00197106|27221554|P2|Overall Treatment Period|Withdrawal by Subject|0
7843338|NCT00197106|27221555|P1|Overall Treatment Period|Withdrawal by Subject|0
7843339|NCT00197106|27221553|P3|Overall Treatment Period|Protocol Violation|2
7843340|NCT00197106|27221554|P2|Overall Treatment Period|Protocol Violation|0
7843341|NCT00197106|27221555|P1|Overall Treatment Period|Protocol Violation|0
7843342|NCT00197106|27221553|P3|Overall Treatment Period|Lost to Follow-up|2
7843343|NCT00197106|27221554|P2|Overall Treatment Period|Lost to Follow-up|0
7843344|NCT00197106|27221555|P1|Overall Treatment Period|Lost to Follow-up|0
7843345|NCT00197106|27221553|P3|Overall Treatment Period|Lack of Efficacy|0
7843346|NCT00197106|27221554|P2|Overall Treatment Period|Lack of Efficacy|1
7843347|NCT00197106|27221555|P1|Overall Treatment Period|Lack of Efficacy|0
7843348|NCT00197106|27221553|P3|4-Week Run-In Period|Did not meet entry criteria|0
7843349|NCT00197106|27221554|P2|4-Week Run-In Period|Did not meet entry criteria|0
7843350|NCT00197106|27221555|P1|4-Week Run-In Period|Did not meet entry criteria|99
7843351|NCT00197054|27221592|P3|Overall Study|Lost to Follow-up|0
7843352|NCT00197054|27221593|P2|Overall Study|Lost to Follow-up|4
7843353|NCT00197054|27221594|P1|Overall Study|Lost to Follow-up|1
7843354|NCT00197054|27221592|P3|Overall Study|Moved from area|9
7843355|NCT00197054|27221593|P2|Overall Study|Moved from area|14
7843356|NCT00197054|27221594|P1|Overall Study|Moved from area|7
7843357|NCT00197054|27221592|P3|Overall Study|Withdrawal by Subject|3
7843358|NCT00197054|27221593|P2|Overall Study|Withdrawal by Subject|3
7843359|NCT00197054|27221594|P1|Overall Study|Withdrawal by Subject|9
7843360|NCT00197028|27221704|P2|Overall Study|Other|6
7843361|NCT00197028|27221705|P1|Overall Study|Other|3
7843362|NCT00197028|27221704|P2|Overall Study|Lost to Follow-up|0
7843363|NCT00197028|27221705|P1|Overall Study|Lost to Follow-up|1
7843364|NCT00197028|27221704|P2|Overall Study|Withdrawal by Subject|12
7843365|NCT00197028|27221705|P1|Overall Study|Withdrawal by Subject|8
7843366|NCT00197028|27221704|P2|Overall Study|Protocol Violation|1
7843367|NCT00197028|27221705|P1|Overall Study|Protocol Violation|2
7843368|NCT00197028|27221704|P2|Overall Study|Adverse Event|2
7843369|NCT00197028|27221705|P1|Overall Study|Adverse Event|2
7843370|NCT00197015|27221748|P3|Overall Study|Other|2
7843371|NCT00197015|27221749|P2|Overall Study|Other|3
7843372|NCT00197015|27221750|P1|Overall Study|Other|2
7843373|NCT00197015|27221748|P3|Overall Study|Lost to Follow-up|37
7843374|NCT00197015|27221749|P2|Overall Study|Lost to Follow-up|46
7843375|NCT00197015|27221750|P1|Overall Study|Lost to Follow-up|28
7843376|NCT00197015|27221748|P3|Overall Study|Withdrawal by Subject|34
7843377|NCT00197015|27221749|P2|Overall Study|Withdrawal by Subject|37
7843378|NCT00197015|27221750|P1|Overall Study|Withdrawal by Subject|17
7843379|NCT00197015|27221748|P3|Overall Study|Protocol Violation|3
7843380|NCT00197015|27221749|P2|Overall Study|Protocol Violation|3
7843381|NCT00197015|27221750|P1|Overall Study|Protocol Violation|0
7843382|NCT00197015|27221748|P3|Overall Study|Adverse Event|1
7843383|NCT00197015|27221749|P2|Overall Study|Adverse Event|0
7843384|NCT00197015|27221750|P1|Overall Study|Adverse Event|3
7843385|NCT00197002|27221809|P3|Overall Study|Others|1
7843386|NCT00197002|27221810|P2|Overall Study|Others|1
7843387|NCT00197002|27221811|P1|Overall Study|Others|3
7843388|NCT00197002|27221809|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
7843389|NCT00197002|27221810|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
7843390|NCT00197002|27221811|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
7843391|NCT00197002|27221809|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
7843392|NCT00197002|27221810|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
7843393|NCT00197002|27221811|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
7843394|NCT00197002|27221809|P3|Overall Study|Migrated/moved from study area|1
7843395|NCT00197002|27221810|P2|Overall Study|Migrated/moved from study area|5
7843396|NCT00197002|27221811|P1|Overall Study|Migrated/moved from study area|3
7843397|NCT00197002|27221809|P3|Overall Study|Withdrawal by Subject|7
7843398|NCT00197002|27221810|P2|Overall Study|Withdrawal by Subject|5
7843399|NCT00197002|27221811|P1|Overall Study|Withdrawal by Subject|9
7843400|NCT00197002|27221809|P3|Overall Study|Protocol Violation|2
7843401|NCT00197002|27221810|P2|Overall Study|Protocol Violation|0
7843402|NCT00197002|27221811|P1|Overall Study|Protocol Violation|1
7843403|NCT00197002|27221809|P3|Overall Study|Adverse Event|0
7843404|NCT00197002|27221810|P2|Overall Study|Adverse Event|1
7843405|NCT00197002|27221811|P1|Overall Study|Adverse Event|0
7843406|NCT00196976|27221862|P14|Booster Study|Lost to Follow-up|0
7843407|NCT00196976|27221863|P13|Booster Study|Lost to Follow-up|0
7843408|NCT00196976|27221864|P12|Booster Study|Lost to Follow-up|2
7843409|NCT00196976|27221865|P11|Booster Study|Lost to Follow-up|1
7843410|NCT00196976|27221866|P10|Booster Study|Lost to Follow-up|0
7843411|NCT00196976|27221867|P9|Booster Study|Lost to Follow-up|0
7843412|NCT00196976|27221868|P8|Booster Study|Lost to Follow-up|0
7843413|NCT00196976|27221869|P7|Booster Study|Lost to Follow-up|0
7843414|NCT00196976|27221870|P6|Booster Study|Lost to Follow-up|0
7843415|NCT00196976|27221871|P5|Booster Study|Lost to Follow-up|0
7843416|NCT00196976|27221872|P4|Booster Study|Lost to Follow-up|0
7843417|NCT00196976|27221873|P3|Booster Study|Lost to Follow-up|0
7843418|NCT00196976|27221874|P2|Booster Study|Lost to Follow-up|0
7843419|NCT00196976|27221875|P1|Booster Study|Lost to Follow-up|0
7843420|NCT00196976|27221862|P14|Booster Study|Withdrawal by Subject|0
7843421|NCT00196976|27221863|P13|Booster Study|Withdrawal by Subject|0
7843422|NCT00196976|27221864|P12|Booster Study|Withdrawal by Subject|0
7843423|NCT00196976|27221865|P11|Booster Study|Withdrawal by Subject|1
7843424|NCT00196976|27221866|P10|Booster Study|Withdrawal by Subject|0
7843425|NCT00196976|27221867|P9|Booster Study|Withdrawal by Subject|0
7843426|NCT00196976|27221868|P8|Booster Study|Withdrawal by Subject|0
7843427|NCT00196976|27221869|P7|Booster Study|Withdrawal by Subject|0
7843428|NCT00196976|27221870|P6|Booster Study|Withdrawal by Subject|0
7843429|NCT00196976|27221871|P5|Booster Study|Withdrawal by Subject|0
7843430|NCT00196976|27221872|P4|Booster Study|Withdrawal by Subject|0
7843431|NCT00196976|27221873|P3|Booster Study|Withdrawal by Subject|0
7843432|NCT00196976|27221874|P2|Booster Study|Withdrawal by Subject|0
7843433|NCT00196976|27221875|P1|Booster Study|Withdrawal by Subject|0
7843434|NCT00196976|27221862|P14|Primary Study|Other|0
7843435|NCT00196976|27221863|P13|Primary Study|Other|0
7843436|NCT00196976|27221864|P12|Primary Study|Other|0
7843437|NCT00196976|27221865|P11|Primary Study|Other|0
7843438|NCT00196976|27221866|P10|Primary Study|Other|0
7843439|NCT00196976|27221867|P9|Primary Study|Other|0
7843440|NCT00196976|27221868|P8|Primary Study|Other|0
7843441|NCT00196976|27221869|P7|Primary Study|Other|0
7843442|NCT00196976|27221870|P6|Primary Study|Other|0
7843443|NCT00196976|27221871|P5|Primary Study|Other|0
7843444|NCT00196976|27221872|P4|Primary Study|Other|0
7843445|NCT00196976|27221873|P3|Primary Study|Other|2
7843446|NCT00196976|27221874|P2|Primary Study|Other|0
7843447|NCT00196976|27221875|P1|Primary Study|Other|0
7843448|NCT00196976|27221862|P14|Primary Study|Lost to Follow-up|0
7843449|NCT00196976|27221863|P13|Primary Study|Lost to Follow-up|0
7843450|NCT00196976|27221864|P12|Primary Study|Lost to Follow-up|0
7843451|NCT00196976|27221865|P11|Primary Study|Lost to Follow-up|0
7843452|NCT00196976|27221866|P10|Primary Study|Lost to Follow-up|0
7843453|NCT00196976|27221867|P9|Primary Study|Lost to Follow-up|0
7843454|NCT00196976|27221868|P8|Primary Study|Lost to Follow-up|2
7843455|NCT00196976|27221869|P7|Primary Study|Lost to Follow-up|0
7843456|NCT00196976|27221870|P6|Primary Study|Lost to Follow-up|1
7843457|NCT00196976|27221871|P5|Primary Study|Lost to Follow-up|1
7843458|NCT00196976|27221872|P4|Primary Study|Lost to Follow-up|0
7843459|NCT00196976|27221873|P3|Primary Study|Lost to Follow-up|0
7843460|NCT00196976|27221874|P2|Primary Study|Lost to Follow-up|0
7843461|NCT00196976|27221875|P1|Primary Study|Lost to Follow-up|0
7843462|NCT00196976|27221862|P14|Primary Study|Withdrawal by Subject|0
7843463|NCT00196976|27221863|P13|Primary Study|Withdrawal by Subject|0
7843464|NCT00196976|27221864|P12|Primary Study|Withdrawal by Subject|0
7843465|NCT00196976|27221865|P11|Primary Study|Withdrawal by Subject|0
7843466|NCT00196976|27221866|P10|Primary Study|Withdrawal by Subject|1
7843467|NCT00196976|27221867|P9|Primary Study|Withdrawal by Subject|0
7843468|NCT00196976|27221868|P8|Primary Study|Withdrawal by Subject|0
7843469|NCT00196976|27221869|P7|Primary Study|Withdrawal by Subject|0
7843470|NCT00196976|27221870|P6|Primary Study|Withdrawal by Subject|1
7843471|NCT00196976|27221871|P5|Primary Study|Withdrawal by Subject|2
7843472|NCT00196976|27221872|P4|Primary Study|Withdrawal by Subject|1
7843473|NCT00196976|27221873|P3|Primary Study|Withdrawal by Subject|1
7843474|NCT00196976|27221874|P2|Primary Study|Withdrawal by Subject|0
7843475|NCT00196976|27221875|P1|Primary Study|Withdrawal by Subject|1
7843476|NCT00196976|27221862|P14|Primary Study|Protocol Violation|0
7843477|NCT00196976|27221863|P13|Primary Study|Protocol Violation|0
7843478|NCT00196976|27221864|P12|Primary Study|Protocol Violation|0
7843479|NCT00196976|27221865|P11|Primary Study|Protocol Violation|0
7843480|NCT00196976|27221866|P10|Primary Study|Protocol Violation|0
7843481|NCT00196976|27221867|P9|Primary Study|Protocol Violation|0
7843482|NCT00196976|27221868|P8|Primary Study|Protocol Violation|0
7843483|NCT00196976|27221869|P7|Primary Study|Protocol Violation|0
7843484|NCT00196976|27221870|P6|Primary Study|Protocol Violation|0
7843485|NCT00196976|27221871|P5|Primary Study|Protocol Violation|0
7843486|NCT00196976|27221872|P4|Primary Study|Protocol Violation|0
7843487|NCT00196976|27221873|P3|Primary Study|Protocol Violation|1
7843488|NCT00196976|27221874|P2|Primary Study|Protocol Violation|1
7843489|NCT00196976|27221875|P1|Primary Study|Protocol Violation|0
7843490|NCT00196976|27221862|P14|Primary Study|Migrated from study area|0
7843491|NCT00196976|27221863|P13|Primary Study|Migrated from study area|0
7843492|NCT00196976|27221864|P12|Primary Study|Migrated from study area|0
7843493|NCT00196976|27221865|P11|Primary Study|Migrated from study area|0
7843494|NCT00196976|27221866|P10|Primary Study|Migrated from study area|0
7843495|NCT00196976|27221867|P9|Primary Study|Migrated from study area|0
7843496|NCT00196976|27221868|P8|Primary Study|Migrated from study area|1
7843497|NCT00196976|27221869|P7|Primary Study|Migrated from study area|0
7843498|NCT00196976|27221870|P6|Primary Study|Migrated from study area|0
7843499|NCT00196976|27221871|P5|Primary Study|Migrated from study area|0
7843500|NCT00196976|27221872|P4|Primary Study|Migrated from study area|0
7843501|NCT00196976|27221873|P3|Primary Study|Migrated from study area|0
7843502|NCT00196976|27221874|P2|Primary Study|Migrated from study area|0
7843503|NCT00196976|27221875|P1|Primary Study|Migrated from study area|0
7843504|NCT00196937|27222071|P3|Overall Study|Other|1
7843505|NCT00196937|27222072|P2|Overall Study|Other|1
7843506|NCT00196937|27222073|P1|Overall Study|Other|3
7843507|NCT00196937|27222071|P3|Overall Study|Lost to Follow-up|3
7843508|NCT00196937|27222072|P2|Overall Study|Lost to Follow-up|3
7843509|NCT00196937|27222073|P1|Overall Study|Lost to Follow-up|4
7843510|NCT00196937|27222071|P3|Overall Study|Withdrawal by Subject|2
7843511|NCT00196937|27222072|P2|Overall Study|Withdrawal by Subject|0
7843512|NCT00196937|27222073|P1|Overall Study|Withdrawal by Subject|0
7843513|NCT00196937|27222071|P3|Overall Study|Non-serious adverse event|1
7843514|NCT00196937|27222072|P2|Overall Study|Non-serious adverse event|1
7843515|NCT00196937|27222073|P1|Overall Study|Non-serious adverse event|1
7843516|NCT00196937|27222071|P3|Overall Study|Serious Adverse Event|0
7843517|NCT00196937|27222072|P2|Overall Study|Serious Adverse Event|0
7843518|NCT00196937|27222073|P1|Overall Study|Serious Adverse Event|1
7843519|NCT00196326|27222127|P1|Overall Study|Other|22
7843520|NCT00196326|27222127|P1|Overall Study|Lost to Follow-up|304
7843521|NCT00196326|27222127|P1|Overall Study|Pregnancy|34
7843522|NCT00196326|27222127|P1|Overall Study|Adverse Event|253
7843523|NCT00196326|27222127|P1|Overall Study|Withdrawal by Subject|225
7843524|NCT00196326|27222127|P1|Overall Study|Physician Decision|3
7843525|NCT00196326|27222127|P1|Overall Study|Non-compliance with the protocol|81
7843526|NCT00196326|27222127|P1|Overall Study|Did not meet protocol requirements|64
7843527|NCT00196313|27222135|P2|Overall Study|Lost to Follow-up|2
7843528|NCT00196313|27222136|P1|Overall Study|Lost to Follow-up|2
7843529|NCT00196313|27222135|P2|Overall Study|Subject Pregnant|1
7843530|NCT00196313|27222136|P1|Overall Study|Subject Pregnant|1
7843531|NCT00196313|27222135|P2|Overall Study|Adverse Event|1
7843532|NCT00196313|27222136|P1|Overall Study|Adverse Event|3
7843533|NCT00196313|27222135|P2|Overall Study|Withdrawal by Subject|1
7843534|NCT00196313|27222136|P1|Overall Study|Withdrawal by Subject|3
7843535|NCT00196313|27222135|P2|Overall Study|Protocol Violation|3
7843536|NCT00196313|27222136|P1|Overall Study|Protocol Violation|2
7843537|NCT00196196|27222150|P1|Overall Study|Did not have required condition (hydroce|5
7843538|NCT00196196|27222150|P1|Overall Study|Withdrawal by Subject|2
7843539|NCT00196105|27222158|P3|Overall Study|Lost to Follow-up|7
7843540|NCT00196105|27222159|P2|Overall Study|Lost to Follow-up|5
7843541|NCT00196105|27222160|P1|Overall Study|Lost to Follow-up|4
7843542|NCT00195819|27222180|P2|Open-label|Withdrawal by Subject|5
7843543|NCT00195819|27222181|P1|Open-label|Withdrawal by Subject|0
7843544|NCT00195819|27222180|P2|Open-label|Moved|1
7843545|NCT00195819|27222181|P1|Open-label|Moved|0
7843546|NCT00195819|27222180|P2|Open-label|Protocol Violation|2
7843547|NCT00195819|27222181|P1|Open-label|Protocol Violation|0
7843548|NCT00195819|27222180|P2|Open-label|Pregnancy|1
7843549|NCT00195819|27222181|P1|Open-label|Pregnancy|0
7843550|NCT00195819|27222180|P2|Open-label|Lack of Efficacy|2
7843551|NCT00195819|27222181|P1|Open-label|Lack of Efficacy|0
7843552|NCT00195819|27222180|P2|Open-label|Adverse Event|9
7843553|NCT00195819|27222181|P1|Open-label|Adverse Event|0
7843554|NCT00195819|27222180|P2|Double-Blind|Moved|0
7843555|NCT00195819|27222181|P1|Double-Blind|Moved|1
7843556|NCT00195819|27222180|P2|Double-Blind|Withdrawal by Subject|0
7843557|NCT00195819|27222181|P1|Double-Blind|Withdrawal by Subject|1
7843558|NCT00195715|27222231|P1|Overall Study|Sponsor discretion - trial ended early|1
7843559|NCT00195715|27222231|P1|Overall Study|Sponsor discontinued trial|1
7843560|NCT00195715|27222231|P1|Overall Study|Colonic stricture|1
7843561|NCT00195715|27222231|P1|Overall Study|Ineligible|1
7843562|NCT00195715|27222231|P1|Overall Study|Increased infection rate|1
7843563|NCT00195715|27222231|P1|Overall Study|Planned surgery|2
7843564|NCT00195715|27222231|P1|Overall Study|Use of prohibited medication|2
7843565|NCT00195715|27222231|P1|Overall Study|Subject wants to get pregnant|4
7843566|NCT00195715|27222231|P1|Overall Study|Investigator's decision|2
7843567|NCT00195715|27222231|P1|Overall Study|Administrative reasons|2
7843568|NCT00195715|27222231|P1|Overall Study|Sponsor stopped study|1
7843569|NCT00195715|27222231|P1|Overall Study|Loss of response/no improvement|3
7843570|NCT00195715|27222231|P1|Overall Study|Subject choice|3
7843571|NCT00195715|27222231|P1|Overall Study|Subject started commercial Humira|5
7843572|NCT00195715|27222231|P1|Overall Study|Subject non-compliance|6
7843573|NCT00195715|27222231|P1|Overall Study|Subject moved/relocated|7
7843574|NCT00195715|27222231|P1|Overall Study|Investigative site closure|8
7843575|NCT00195715|27222231|P1|Overall Study|Pregnancy|14
7843576|NCT00195715|27222231|P1|Overall Study|Lack of Efficacy|93
7843577|NCT00195715|27222231|P1|Overall Study|Protocol Violation|13
7843578|NCT00195715|27222231|P1|Overall Study|Lost to Follow-up|27
7843579|NCT00195715|27222231|P1|Overall Study|Withdrawal by Subject|58
7843580|NCT00195715|27222231|P1|Overall Study|Adverse Event|122
7843581|NCT00195676|27222331|P1|Period R - Retreatment 16 Weeks|Other reasons|6
7843582|NCT00195676|27222331|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
7843583|NCT00195676|27222331|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
7843584|NCT00195676|27222331|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
7843585|NCT00195676|27222331|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
7843586|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
7843587|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
7843588|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
7843589|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
7843590|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
7843591|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
7843592|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Death|2
7843593|NCT00195676|27222331|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
7843594|NCT00195676|27222331|P1|Period O - Open-label Treatment|Other reasons|68
7843595|NCT00195676|27222331|P1|Period O - Open-label Treatment|Administrative reasons|2
7843596|NCT00195676|27222331|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
7843597|NCT00195676|27222331|P1|Period O - Open-label Treatment|Protocol Violation|12
7843598|NCT00195676|27222331|P1|Period O - Open-label Treatment|Lost to Follow-up|91
7843599|NCT00195676|27222331|P1|Period O - Open-label Treatment|Lack of Efficacy|198
7843600|NCT00195676|27222331|P1|Period O - Open-label Treatment|Death|6
7843601|NCT00195676|27222331|P1|Period O - Open-label Treatment|Adverse Event|82
7843602|NCT00195663|27222345|P3|Open-Label Extension Period|Administrative reasons|13
7843603|NCT00195663|27222346|P2|Open-Label Extension Period|Administrative reasons|11
7843604|NCT00195663|27222347|P1|Open-Label Extension Period|Administrative reasons|11
7843605|NCT00195663|27222345|P3|Open-Label Extension Period|Lack of Efficacy|12
7843606|NCT00195663|27222346|P2|Open-Label Extension Period|Lack of Efficacy|6
7843607|NCT00195663|27222347|P1|Open-Label Extension Period|Lack of Efficacy|14
7843608|NCT00195663|27222345|P3|Open-Label Extension Period|Withdrawal by Subject|22
7843609|NCT00195663|27222346|P2|Open-Label Extension Period|Withdrawal by Subject|15
7843610|NCT00195663|27222347|P1|Open-Label Extension Period|Withdrawal by Subject|16
7843611|NCT00195663|27222345|P3|Open-Label Extension Period|Death|2
7843612|NCT00195663|27222346|P2|Open-Label Extension Period|Death|2
7843613|NCT00195663|27222347|P1|Open-Label Extension Period|Death|2
7843614|NCT00195663|27222345|P3|Open-Label Extension Period|Protocol Violation|4
7843615|NCT00195663|27222346|P2|Open-Label Extension Period|Protocol Violation|4
7843616|NCT00195663|27222347|P1|Open-Label Extension Period|Protocol Violation|3
7843617|NCT00195663|27222345|P3|Open-Label Extension Period|Recovery|2
7843618|NCT00195663|27222346|P2|Open-Label Extension Period|Recovery|2
7843619|NCT00195663|27222347|P1|Open-Label Extension Period|Recovery|0
7843620|NCT00195663|27222345|P3|Open-Label Extension Period|Lost to Follow-up|6
7843621|NCT00195663|27222346|P2|Open-Label Extension Period|Lost to Follow-up|2
7843622|NCT00195663|27222347|P1|Open-Label Extension Period|Lost to Follow-up|9
7843623|NCT00195663|27222345|P3|Open-Label Extension Period|Adverse Event|36
7843624|NCT00195663|27222346|P2|Open-Label Extension Period|Adverse Event|32
7843625|NCT00195663|27222347|P1|Open-Label Extension Period|Adverse Event|21
7843626|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Administrative reasons|9
7843627|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Administrative reasons|2
7843628|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Administrative reasons|3
7843629|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Recovery|1
7843630|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Recovery|0
7843631|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Recovery|1
7843632|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
7843633|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
7843634|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
7843635|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Protocol Violation|4
7843636|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Protocol Violation|6
7843637|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Protocol Violation|6
7843638|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
7843639|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
7843640|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
7843641|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
7843642|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
7843643|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
7843644|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
7843645|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
7843646|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
7843647|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Death|0
7843648|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Death|2
7843649|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Death|0
7843650|NCT00195663|27222345|P3|2-year Double-blind Treatment Period|Adverse Event|32
7843651|NCT00195663|27222346|P2|2-year Double-blind Treatment Period|Adverse Event|27
7843652|NCT00195663|27222347|P1|2-year Double-blind Treatment Period|Adverse Event|21
7843653|NCT00195650|27222441|P1|Overall Study|Administrative reasons|83
7843654|NCT00195650|27222441|P1|Overall Study|Protocol Violation|15
7843655|NCT00195650|27222441|P1|Overall Study|Death|23
7843656|NCT00195650|27222441|P1|Overall Study|Lost to Follow-up|44
7843657|NCT00195650|27222441|P1|Overall Study|Withdrawal by Subject|67
7843658|NCT00195650|27222441|P1|Overall Study|Lack of Efficacy|99
7843659|NCT00195650|27222441|P1|Overall Study|Adverse Event|194
7843660|NCT00195507|27222466|P2|Overall Study|Protocol Deviation|3
7843661|NCT00195507|27222467|P1|Overall Study|Protocol Deviation|6
7843662|NCT00195507|27222466|P2|Overall Study|Withdrawal by Subject|23
7843663|NCT00195507|27222467|P1|Overall Study|Withdrawal by Subject|16
7843664|NCT00195507|27222466|P2|Overall Study|Lack of Efficacy|67
7843665|NCT00195507|27222467|P1|Overall Study|Lack of Efficacy|40
7843666|NCT00195507|27222466|P2|Overall Study|Protocol Violation|4
7843667|NCT00195507|27222467|P1|Overall Study|Protocol Violation|5
7843668|NCT00195507|27222466|P2|Overall Study|Lost to Follow-up|2
7843669|NCT00195507|27222467|P1|Overall Study|Lost to Follow-up|3
7843670|NCT00195507|27222466|P2|Overall Study|Physician Decision|2
7843671|NCT00195507|27222467|P1|Overall Study|Physician Decision|1
7843672|NCT00195507|27222466|P2|Overall Study|Failed to Return|3
7843673|NCT00195507|27222467|P1|Overall Study|Failed to Return|4
7843674|NCT00195507|27222466|P2|Overall Study|Death|1
7843675|NCT00195507|27222467|P1|Overall Study|Death|0
7843676|NCT00195507|27222466|P2|Overall Study|Adverse Event|13
7843677|NCT00195507|27222467|P1|Overall Study|Adverse Event|24
7843678|NCT00195494|27222481|P6|Year 2|System toxicity|0
7843679|NCT00195494|27222482|P5|Year 2|System toxicity|0
7843680|NCT00195494|27222483|P4|Year 2|System toxicity|1
7843681|NCT00195494|27222484|P3|Year 2|System toxicity|0
7843682|NCT00195494|27222485|P2|Year 2|System toxicity|0
7843683|NCT00195494|27222486|P1|Year 2|System toxicity|0
7843684|NCT00195494|27222481|P6|Year 2|Withdrawal by Subject|0
7843685|NCT00195494|27222482|P5|Year 2|Withdrawal by Subject|0
7843686|NCT00195494|27222483|P4|Year 2|Withdrawal by Subject|3
7843687|NCT00195494|27222484|P3|Year 2|Withdrawal by Subject|4
7843688|NCT00195494|27222485|P2|Year 2|Withdrawal by Subject|5
7843689|NCT00195494|27222486|P1|Year 2|Withdrawal by Subject|1
7843690|NCT00195494|27222481|P6|Year 2|Physician Decision|0
7843691|NCT00195494|27222482|P5|Year 2|Physician Decision|0
7843692|NCT00195494|27222483|P4|Year 2|Physician Decision|0
7843693|NCT00195494|27222484|P3|Year 2|Physician Decision|0
7843694|NCT00195494|27222485|P2|Year 2|Physician Decision|1
7843695|NCT00195494|27222486|P1|Year 2|Physician Decision|1
7843696|NCT00195494|27222481|P6|Year 2|Protocol deviation|0
7843697|NCT00195494|27222482|P5|Year 2|Protocol deviation|0
7843698|NCT00195494|27222483|P4|Year 2|Protocol deviation|0
7843699|NCT00195494|27222484|P3|Year 2|Protocol deviation|0
7843700|NCT00195494|27222485|P2|Year 2|Protocol deviation|1
7843701|NCT00195494|27222486|P1|Year 2|Protocol deviation|0
7843702|NCT00195494|27222481|P6|Year 2|Missed >4 consecutive doses|0
7843703|NCT00195494|27222482|P5|Year 2|Missed >4 consecutive doses|0
7843704|NCT00195494|27222483|P4|Year 2|Missed >4 consecutive doses|0
7843705|NCT00195494|27222484|P3|Year 2|Missed >4 consecutive doses|1
7843706|NCT00195494|27222485|P2|Year 2|Missed >4 consecutive doses|1
7843707|NCT00195494|27222486|P1|Year 2|Missed >4 consecutive doses|1
7843708|NCT00195494|27222481|P6|Year 2|Lost to Follow-up|0
7843709|NCT00195494|27222482|P5|Year 2|Lost to Follow-up|0
7843710|NCT00195494|27222483|P4|Year 2|Lost to Follow-up|1
7843711|NCT00195494|27222484|P3|Year 2|Lost to Follow-up|1
7843712|NCT00195494|27222485|P2|Year 2|Lost to Follow-up|0
7843713|NCT00195494|27222486|P1|Year 2|Lost to Follow-up|0
7843714|NCT00195494|27222481|P6|Year 2|Compliance|0
7843715|NCT00195494|27222482|P5|Year 2|Compliance|0
7843716|NCT00195494|27222483|P4|Year 2|Compliance|2
7843717|NCT00195494|27222484|P3|Year 2|Compliance|0
7843718|NCT00195494|27222485|P2|Year 2|Compliance|0
7843719|NCT00195494|27222486|P1|Year 2|Compliance|1
7843720|NCT00195494|27222481|P6|Year 2|Lack of Efficacy|0
7843721|NCT00195494|27222482|P5|Year 2|Lack of Efficacy|0
7843722|NCT00195494|27222483|P4|Year 2|Lack of Efficacy|7
7843723|NCT00195494|27222484|P3|Year 2|Lack of Efficacy|7
7843724|NCT00195494|27222485|P2|Year 2|Lack of Efficacy|1
7843725|NCT00195494|27222486|P1|Year 2|Lack of Efficacy|0
7843726|NCT00195494|27222481|P6|Year 2|Adverse Event|0
7843727|NCT00195494|27222482|P5|Year 2|Adverse Event|0
7843728|NCT00195494|27222483|P4|Year 2|Adverse Event|9
7843729|NCT00195494|27222484|P3|Year 2|Adverse Event|5
7843730|NCT00195494|27222485|P2|Year 2|Adverse Event|7
7843731|NCT00195494|27222486|P1|Year 2|Adverse Event|3
7843732|NCT00195494|27222481|P6|Year 1|Protocol Violation|1
7843733|NCT00195494|27222482|P5|Year 1|Protocol Violation|1
7843734|NCT00195494|27222483|P4|Year 1|Protocol Violation|0
7843735|NCT00195494|27222484|P3|Year 1|Protocol Violation|0
7843736|NCT00195494|27222485|P2|Year 1|Protocol Violation|0
7843737|NCT00195494|27222486|P1|Year 1|Protocol Violation|0
7843738|NCT00195494|27222481|P6|Year 1|Withdrawal by Subject|9
7843739|NCT00195494|27222482|P5|Year 1|Withdrawal by Subject|8
7843740|NCT00195494|27222483|P4|Year 1|Withdrawal by Subject|0
7843741|NCT00195494|27222484|P3|Year 1|Withdrawal by Subject|0
7843742|NCT00195494|27222485|P2|Year 1|Withdrawal by Subject|0
7843743|NCT00195494|27222486|P1|Year 1|Withdrawal by Subject|0
7843744|NCT00195494|27222481|P6|Year 1|Physician Decision|0
7843745|NCT00195494|27222482|P5|Year 1|Physician Decision|1
7843746|NCT00195494|27222483|P4|Year 1|Physician Decision|0
7843747|NCT00195494|27222484|P3|Year 1|Physician Decision|0
7843748|NCT00195494|27222485|P2|Year 1|Physician Decision|0
7843749|NCT00195494|27222486|P1|Year 1|Physician Decision|0
7843750|NCT00195494|27222481|P6|Year 1|Protocol deviation|3
7843751|NCT00195494|27222482|P5|Year 1|Protocol deviation|2
7843752|NCT00195494|27222483|P4|Year 1|Protocol deviation|0
7843753|NCT00195494|27222484|P3|Year 1|Protocol deviation|0
7843754|NCT00195494|27222485|P2|Year 1|Protocol deviation|0
7843755|NCT00195494|27222486|P1|Year 1|Protocol deviation|0
7843756|NCT00195494|27222481|P6|Year 1|Missed >4 consecutive doses|2
7843757|NCT00195494|27222482|P5|Year 1|Missed >4 consecutive doses|3
7843758|NCT00195494|27222483|P4|Year 1|Missed >4 consecutive doses|0
7843759|NCT00195494|27222484|P3|Year 1|Missed >4 consecutive doses|0
7843760|NCT00195494|27222485|P2|Year 1|Missed >4 consecutive doses|0
7843761|NCT00195494|27222486|P1|Year 1|Missed >4 consecutive doses|0
7843762|NCT00195494|27222481|P6|Year 1|Lost to Follow-up|0
7843763|NCT00195494|27222482|P5|Year 1|Lost to Follow-up|1
7843764|NCT00195494|27222483|P4|Year 1|Lost to Follow-up|0
7843765|NCT00195494|27222484|P3|Year 1|Lost to Follow-up|0
7843766|NCT00195494|27222485|P2|Year 1|Lost to Follow-up|0
7843767|NCT00195494|27222486|P1|Year 1|Lost to Follow-up|0
7843768|NCT00195494|27222481|P6|Year 1|Compliance|1
7843769|NCT00195494|27222482|P5|Year 1|Compliance|5
7843770|NCT00195494|27222483|P4|Year 1|Compliance|0
7843771|NCT00195494|27222484|P3|Year 1|Compliance|0
7843772|NCT00195494|27222485|P2|Year 1|Compliance|0
7843773|NCT00195494|27222486|P1|Year 1|Compliance|0
7843774|NCT00195494|27222481|P6|Year 1|Lack of Efficacy|9
7843775|NCT00195494|27222482|P5|Year 1|Lack of Efficacy|24
7843776|NCT00195494|27222483|P4|Year 1|Lack of Efficacy|0
7843777|NCT00195494|27222484|P3|Year 1|Lack of Efficacy|0
7843778|NCT00195494|27222485|P2|Year 1|Lack of Efficacy|0
7843779|NCT00195494|27222486|P1|Year 1|Lack of Efficacy|0
7843780|NCT00195494|27222481|P6|Year 1|System Toxicity|1
7843781|NCT00195494|27222482|P5|Year 1|System Toxicity|0
7843782|NCT00195494|27222483|P4|Year 1|System Toxicity|0
7843783|NCT00195494|27222484|P3|Year 1|System Toxicity|0
7843784|NCT00195494|27222485|P2|Year 1|System Toxicity|0
7843785|NCT00195494|27222486|P1|Year 1|System Toxicity|0
7843786|NCT00195494|27222481|P6|Year 1|Adverse Event|27
7843787|NCT00195494|27222482|P5|Year 1|Adverse Event|34
7843788|NCT00195494|27222483|P4|Year 1|Adverse Event|0
7843789|NCT00195494|27222484|P3|Year 1|Adverse Event|0
7843790|NCT00195494|27222485|P2|Year 1|Adverse Event|0
7843791|NCT00195494|27222486|P1|Year 1|Adverse Event|0
7843792|NCT00195442|27222504|P1|Overall Study|Other|14
7843793|NCT00195442|27222504|P1|Overall Study|Poor cooperation|2
7843794|NCT00195442|27222504|P1|Overall Study|No reason specified|4
7843795|NCT00195442|27222504|P1|Overall Study|Death|7
7843796|NCT00195442|27222504|P1|Overall Study|Intermittent product shortage|21
7843797|NCT00195442|27222504|P1|Overall Study|Switch to other Factor VIII preparation|23
7843798|NCT00195442|27222504|P1|Overall Study|Lost to Follow-up|27
7843799|NCT00195442|27222504|P1|Overall Study|Less than expected therapeutic effect|38
7843800|NCT00195429|27222523|P2|Overall Study|Lost to Follow-up|0
7843801|NCT00195429|27222524|P1|Overall Study|Lost to Follow-up|1
7843802|NCT00195429|27222523|P2|Overall Study|Lack of Efficacy|1
7843803|NCT00195429|27222524|P1|Overall Study|Lack of Efficacy|2
7843804|NCT00195429|27222523|P2|Overall Study|Adverse Event|4
7843805|NCT00195429|27222524|P1|Overall Study|Adverse Event|2
7843806|NCT00195351|27222540|P2|Overall Study|Lack of Efficacy|1
7843807|NCT00195351|27222541|P1|Overall Study|Lack of Efficacy|0
7843808|NCT00195351|27222540|P2|Overall Study|Death|1
7843809|NCT00195351|27222541|P1|Overall Study|Death|3
7843810|NCT00195351|27222540|P2|Overall Study|Protocol Deviation|2
7843811|NCT00195351|27222541|P1|Overall Study|Protocol Deviation|3
7843812|NCT00195351|27222540|P2|Overall Study|Withdrawal by Subject|3
7843813|NCT00195351|27222541|P1|Overall Study|Withdrawal by Subject|6
7843814|NCT00195351|27222540|P2|Overall Study|Lost to Follow-up|9
7843815|NCT00195351|27222541|P1|Overall Study|Lost to Follow-up|9
7843816|NCT00195338|27222551|P1|Overall Study|Early closure of the site|4
7843817|NCT00195338|27222551|P1|Overall Study|Lack of Efficacy|1
7843818|NCT00195338|27222551|P1|Overall Study|Adverse Event|5
7843819|NCT00195338|27222551|P1|Overall Study|Lost to Follow-up|2
7843820|NCT00195273|27222561|P2|Overall Study|Procedural complications|3
7843821|NCT00195273|27222562|P1|Overall Study|Procedural complications|9
7843822|NCT00195273|27222561|P2|Overall Study|Lack of Efficacy|1
7843823|NCT00195273|27222562|P1|Overall Study|Lack of Efficacy|3
7843824|NCT00195273|27222561|P2|Overall Study|Protocol deviation|1
7843825|NCT00195273|27222562|P1|Overall Study|Protocol deviation|0
7843826|NCT00195273|27222561|P2|Overall Study|Adverse Event|9
7843827|NCT00195273|27222562|P1|Overall Study|Adverse Event|9
7843828|NCT00195260|27222576|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
7843829|NCT00195260|27222577|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
7843830|NCT00195260|27222578|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
7843831|NCT00195260|27222579|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843832|NCT00195260|27222580|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843833|NCT00195260|27222581|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843834|NCT00195260|27222582|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843835|NCT00195260|27222583|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843836|NCT00195260|27222584|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843837|NCT00195260|27222585|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843838|NCT00195260|27222586|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7843839|NCT00195260|27222576|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
7843840|NCT00195260|27222577|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
7843841|NCT00195260|27222578|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
7843842|NCT00195260|27222579|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843843|NCT00195260|27222580|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843844|NCT00195260|27222581|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843845|NCT00195260|27222582|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843846|NCT00195260|27222583|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843847|NCT00195260|27222584|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843848|NCT00195260|27222585|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843849|NCT00195260|27222586|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7843850|NCT00195260|27222576|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
7843851|NCT00195260|27222577|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
7843852|NCT00195260|27222578|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
7843853|NCT00195260|27222579|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843854|NCT00195260|27222580|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843855|NCT00195260|27222581|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843856|NCT00195260|27222582|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843857|NCT00195260|27222583|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843858|NCT00195260|27222584|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843859|NCT00195260|27222585|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843860|NCT00195260|27222586|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7843861|NCT00195260|27222576|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
7843862|NCT00195260|27222577|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
7843863|NCT00195260|27222578|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
7843864|NCT00195260|27222579|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843865|NCT00195260|27222580|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843866|NCT00195260|27222581|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843867|NCT00195260|27222582|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843868|NCT00195260|27222583|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843869|NCT00195260|27222584|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843870|NCT00195260|27222585|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843871|NCT00195260|27222586|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7843872|NCT00195260|27222576|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843873|NCT00195260|27222577|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843874|NCT00195260|27222578|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843875|NCT00195260|27222579|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843876|NCT00195260|27222580|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843877|NCT00195260|27222581|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
7843878|NCT00195260|27222582|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843879|NCT00195260|27222583|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
7843880|NCT00195260|27222584|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
7843881|NCT00195260|27222585|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
7843882|NCT00195260|27222586|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
7843883|NCT00195260|27222576|P11|Part 1: Dose Escalation|Disease Progression|0
7843884|NCT00195260|27222577|P10|Part 1: Dose Escalation|Disease Progression|0
7843885|NCT00195260|27222578|P9|Part 1: Dose Escalation|Disease Progression|0
7843886|NCT00195260|27222579|P8|Part 1: Dose Escalation|Disease Progression|4
7843887|NCT00195260|27222580|P7|Part 1: Dose Escalation|Disease Progression|7
7843888|NCT00195260|27222581|P6|Part 1: Dose Escalation|Disease Progression|6
7843889|NCT00195260|27222582|P5|Part 1: Dose Escalation|Disease Progression|4
7843890|NCT00195260|27222583|P4|Part 1: Dose Escalation|Disease Progression|6
7843891|NCT00195260|27222584|P3|Part 1: Dose Escalation|Disease Progression|5
7843892|NCT00195260|27222585|P2|Part 1: Dose Escalation|Disease Progression|2
7843893|NCT00195260|27222586|P1|Part 1: Dose Escalation|Disease Progression|3
7843894|NCT00195260|27222576|P11|Part 1: Dose Escalation|Death|0
7843895|NCT00195260|27222577|P10|Part 1: Dose Escalation|Death|0
7843896|NCT00195260|27222578|P9|Part 1: Dose Escalation|Death|0
7843897|NCT00195260|27222579|P8|Part 1: Dose Escalation|Death|1
7843898|NCT00195260|27222580|P7|Part 1: Dose Escalation|Death|0
7843899|NCT00195260|27222581|P6|Part 1: Dose Escalation|Death|0
7843900|NCT00195260|27222582|P5|Part 1: Dose Escalation|Death|0
7843901|NCT00195260|27222583|P4|Part 1: Dose Escalation|Death|0
7843902|NCT00195260|27222584|P3|Part 1: Dose Escalation|Death|0
7843903|NCT00195260|27222585|P2|Part 1: Dose Escalation|Death|0
7843904|NCT00195260|27222586|P1|Part 1: Dose Escalation|Death|0
7843905|NCT00195260|27222576|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
7843906|NCT00195260|27222577|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
7843907|NCT00195260|27222578|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
7843908|NCT00195260|27222579|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
7843909|NCT00195260|27222580|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
7843910|NCT00195260|27222581|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
7843911|NCT00195260|27222582|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
7843912|NCT00195260|27222583|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
7843913|NCT00195260|27222584|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
7843914|NCT00195260|27222585|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
7843915|NCT00195260|27222586|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
7843916|NCT00195260|27222576|P11|Part 1: Dose Escalation|Adverse Event|0
7843917|NCT00195260|27222577|P10|Part 1: Dose Escalation|Adverse Event|0
7843918|NCT00195260|27222578|P9|Part 1: Dose Escalation|Adverse Event|0
7843919|NCT00195260|27222579|P8|Part 1: Dose Escalation|Adverse Event|0
7843920|NCT00195260|27222580|P7|Part 1: Dose Escalation|Adverse Event|3
7843921|NCT00195260|27222581|P6|Part 1: Dose Escalation|Adverse Event|0
7843922|NCT00195260|27222582|P5|Part 1: Dose Escalation|Adverse Event|1
7843923|NCT00195260|27222583|P4|Part 1: Dose Escalation|Adverse Event|1
7843924|NCT00195260|27222584|P3|Part 1: Dose Escalation|Adverse Event|0
7843925|NCT00195260|27222585|P2|Part 1: Dose Escalation|Adverse Event|1
7843926|NCT00195260|27222586|P1|Part 1: Dose Escalation|Adverse Event|0
7843927|NCT00194987|27222754|P2|Overall Study|Withdrawal by Subject|3
7843928|NCT00194987|27222755|P1|Overall Study|Withdrawal by Subject|0
7843929|NCT00194792|27222788|P1|Overall Study|Withdrawal by Subject|1
7843930|NCT00194675|27222812|P2|Overall Study|Death|0
7843931|NCT00194675|27222813|P1|Overall Study|Death|1
7843932|NCT00194675|27222812|P2|Overall Study|Protocol Violation|0
7843933|NCT00194675|27222813|P1|Overall Study|Protocol Violation|1
7843934|NCT00194675|27222812|P2|Overall Study|"withdrew due to edgy feeling"|0
7843935|NCT00194675|27222813|P1|Overall Study|"withdrew due to edgy feeling"|1
7843936|NCT00194675|27222812|P2|Overall Study|lack of interest|1
7843937|NCT00194675|27222813|P1|Overall Study|lack of interest|1
7843938|NCT00194675|27222812|P2|Overall Study|Lost to Follow-up|1
7843939|NCT00194675|27222813|P1|Overall Study|Lost to Follow-up|1
7843940|NCT00194077|27222888|P2|Overall Study|Withdrawal by Subject|1
7843941|NCT00194077|27222889|P1|Overall Study|Withdrawal by Subject|1
7843942|NCT00194077|27222888|P2|Overall Study|Study nonadherence|0
7843943|NCT00194077|27222889|P1|Overall Study|Study nonadherence|1
7843944|NCT00194077|27222888|P2|Overall Study|Lack of Efficacy|29
7843945|NCT00194077|27222889|P1|Overall Study|Lack of Efficacy|22
7843946|NCT00194025|27222895|P1|Overall Study|non-adherence with study medication|4
7843947|NCT00194025|27222895|P1|Overall Study|Adverse Event|1
7843948|NCT00194012|27222910|P2|Open Label Extension (OLE)|Lack of Efficacy|0
7843949|NCT00194012|27222911|P1|Open Label Extension (OLE)|Lack of Efficacy|1
7843950|NCT00194012|27222910|P2|Open Label Extension (OLE)|Lost to Follow-up|5
7843951|NCT00194012|27222911|P1|Open Label Extension (OLE)|Lost to Follow-up|3
7843952|NCT00194012|27222910|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
7843953|NCT00194012|27222911|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
7843954|NCT00194012|27222910|P2|Open Label Extension (OLE)|Weight Gain|0
7843955|NCT00194012|27222911|P1|Open Label Extension (OLE)|Weight Gain|1
7843956|NCT00194012|27222910|P2|Randomized Phase|Oral/nasal twitching|1
7843957|NCT00194012|27222911|P1|Randomized Phase|Oral/nasal twitching|0
7843958|NCT00194012|27222910|P2|Randomized Phase|Emesis and enuresis|1
7843959|NCT00194012|27222911|P1|Randomized Phase|Emesis and enuresis|0
7843960|NCT00194012|27222910|P2|Randomized Phase|Participant reported having a rash|0
7843961|NCT00194012|27222911|P1|Randomized Phase|Participant reported having a rash|1
7843962|NCT00194012|27222910|P2|Randomized Phase|Adverse Event|1
7843963|NCT00194012|27222911|P1|Randomized Phase|Adverse Event|2
7843964|NCT00194012|27222910|P2|Randomized Phase|Withdrawal by Subject|3
7843965|NCT00194012|27222911|P1|Randomized Phase|Withdrawal by Subject|3
7843966|NCT00194012|27222910|P2|Randomized Phase|Study nonadherence|1
7843967|NCT00194012|27222911|P1|Randomized Phase|Study nonadherence|2
7843968|NCT00194012|27222910|P2|Randomized Phase|Lack of Efficacy|18
7843969|NCT00194012|27222911|P1|Randomized Phase|Lack of Efficacy|8
7843970|NCT00193609|27222947|P1|Overall Study|Adverse Event|2
7843971|NCT00193609|27222947|P1|Overall Study|Lack of Efficacy|2
7843972|NCT00193479|27222974|P1|Induction Chemotherapy|Disease Progression|1
7843973|NCT00193479|27222974|P1|Induction Chemotherapy|Adverse Event|2
7843974|NCT00193206|27223015|P1|Postoperative Therapy|Protocol Violation|1
7843975|NCT00193206|27223015|P1|Postoperative Therapy|Lack of Efficacy|1
7843976|NCT00193206|27223015|P1|Postoperative Therapy|Intercurrent Illness|2
7843977|NCT00193206|27223015|P1|Postoperative Therapy|Physician Decision|3
7843978|NCT00193206|27223015|P1|Postoperative Therapy|Withdrawal by Subject|7
7843979|NCT00193206|27223015|P1|Preoperative Therapy|False Positive Pregnancy Test|1
7843980|NCT00193206|27223015|P1|Preoperative Therapy|Withdrawal by Subject|2
7843981|NCT00193206|27223015|P1|Preoperative Therapy|Adverse Event|2
7843982|NCT00193206|27223015|P1|Preoperative Therapy|Lack of Efficacy|2
7843983|NCT00193180|27223019|P1|Overall Study|Protocol Violation|1
7843984|NCT00193180|27223019|P1|Overall Study|Adverse Event|8
7843985|NCT00193180|27223019|P1|Overall Study|Lack of Efficacy|1
7843986|NCT00193063|27223034|P1|Overall Study|Adverse Event|1
7843987|NCT00193063|27223034|P1|Overall Study|Lack of Efficacy|3
7843995|NCT00192647|27223057|P2|Overall Study|Other/Administrative|3
7843996|NCT00192647|27223058|P1|Overall Study|Other/Administrative|5
7843997|NCT00192647|27223057|P2|Overall Study|Failure to Return|13
7843998|NCT00192647|27223058|P1|Overall Study|Failure to Return|11
7843999|NCT00192647|27223057|P2|Overall Study|Refused Treatment/Did not Cooperate|8
7844000|NCT00192647|27223058|P1|Overall Study|Refused Treatment/Did not Cooperate|10
7844001|NCT00192647|27223057|P2|Overall Study|Protocol Violation|1
7844002|NCT00192647|27223058|P1|Overall Study|Protocol Violation|3
7844003|NCT00192647|27223057|P2|Overall Study|Entry Criteria Violation|6
7844004|NCT00192647|27223058|P1|Overall Study|Entry Criteria Violation|6
7844005|NCT00192647|27223057|P2|Overall Study|Insufficient Therapeutic Response|83
7844006|NCT00192647|27223058|P1|Overall Study|Insufficient Therapeutic Response|53
7844007|NCT00192647|27223057|P2|Overall Study|Laboratory Test Abnormality|2
7844008|NCT00192647|27223058|P1|Overall Study|Laboratory Test Abnormality|4
7844009|NCT00192647|27223057|P2|Overall Study|Adverse Event|29
7844010|NCT00192647|27223058|P1|Overall Study|Adverse Event|35
7844011|NCT00192647|27223057|P2|Overall Study|Death|1
7844012|NCT00192647|27223058|P1|Overall Study|Death|1
7844013|NCT00192504|27223078|P4|Overall Study|Dosing window missed|0
7844014|NCT00192504|27223079|P3|Overall Study|Dosing window missed|1
7844015|NCT00192504|27223080|P2|Overall Study|Dosing window missed|0
7844016|NCT00192504|27223081|P1|Overall Study|Dosing window missed|0
7844017|NCT00192504|27223078|P4|Overall Study|Lost to Follow-up|0
7844018|NCT00192504|27223079|P3|Overall Study|Lost to Follow-up|0
7844019|NCT00192504|27223080|P2|Overall Study|Lost to Follow-up|0
7844020|NCT00192504|27223081|P1|Overall Study|Lost to Follow-up|1
7844021|NCT00192296|27223115|P4|Overall Study|Withdrawal by Subject|0
7844022|NCT00192296|27223116|P3|Overall Study|Withdrawal by Subject|0
7844023|NCT00192296|27223117|P2|Overall Study|Withdrawal by Subject|1
7844024|NCT00192296|27223118|P1|Overall Study|Withdrawal by Subject|0
7844025|NCT00192114|27223172|P1|Overall Study|Death|1
7844026|NCT00192114|27223172|P1|Overall Study|Clinical Progression|2
7844027|NCT00192114|27223172|P1|Overall Study|Adverse Event|2
7844028|NCT00192114|27223172|P1|Overall Study|Objective Tumor Progression|19
7844029|NCT00192075|27223189|P2|Overall Study|Other|2
7844030|NCT00192075|27223190|P1|Overall Study|Other|5
7844031|NCT00192075|27223189|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
7844032|NCT00192075|27223190|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
7844033|NCT00192075|27223189|P2|Overall Study|Patient Non-Compliance|1
7844034|NCT00192075|27223190|P1|Overall Study|Patient Non-Compliance|0
7844035|NCT00192075|27223189|P2|Overall Study|Withdrawal by Subject|5
7844036|NCT00192075|27223190|P1|Overall Study|Withdrawal by Subject|5
7844037|NCT00192075|27223189|P2|Overall Study|Physician Decision|0
7844038|NCT00192075|27223190|P1|Overall Study|Physician Decision|3
7844039|NCT00192075|27223189|P2|Overall Study|Lack of Efficacy|0
7844040|NCT00192075|27223190|P1|Overall Study|Lack of Efficacy|0
7844041|NCT00192075|27223189|P2|Overall Study|Death|1
7844042|NCT00192075|27223190|P1|Overall Study|Death|0
7844043|NCT00192075|27223189|P2|Overall Study|Adverse Event|3
7844044|NCT00192075|27223190|P1|Overall Study|Adverse Event|1
7844045|NCT00192075|27223189|P2|Overall Study|Disease Progression|6
7844046|NCT00192075|27223190|P1|Overall Study|Disease Progression|23
7844047|NCT00192036|27223215|P1|Overall Study|Unknown or Not Specified|5
7844048|NCT00192036|27223215|P1|Overall Study|Death|1
7844049|NCT00192036|27223215|P1|Overall Study|Clinical Disease Progression|1
7844050|NCT00192036|27223215|P1|Overall Study|Objective Tumor Progression|4
7844051|NCT00192036|27223215|P1|Overall Study|Patient/Physician Perception|1
7844052|NCT00192036|27223215|P1|Overall Study|Adverse Event|6
7844053|NCT00192036|27223215|P1|Overall Study|Protocol Violation|3
7844054|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Physician Decision|0
7844055|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Physician Decision|9
7844056|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
7844057|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
7844058|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Protocol Violation|0
7844059|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Protocol Violation|1
7844060|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
7844061|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
7844062|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
7844063|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
7844064|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
7844065|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
7844066|NCT00192023|27223225|P2|Period IV - Optional Open-Label|Adverse Event|0
7844067|NCT00192023|27223226|P1|Period IV - Optional Open-Label|Adverse Event|6
7844068|NCT00192023|27223225|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
7844069|NCT00192023|27223226|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
7844070|NCT00192023|27223225|P2|Period III - Double-Blind|Physician Decision|0
7844071|NCT00192023|27223226|P1|Period III - Double-Blind|Physician Decision|2
7844072|NCT00192023|27223225|P2|Period III - Double-Blind|Adverse Event|0
7844073|NCT00192023|27223226|P1|Period III - Double-Blind|Adverse Event|3
7844074|NCT00191984|27223248|P1|Overall Study|Physician Decision|4
7844075|NCT00191984|27223248|P1|Overall Study|Withdrawal by Subject|7
7844076|NCT00191984|27223248|P1|Overall Study|Entry Criteria Exclusion|1
7844077|NCT00191984|27223248|P1|Overall Study|Death|2
7844078|NCT00191984|27223248|P1|Overall Study|Adverse Event|4
7844079|NCT00191984|27223248|P1|Overall Study|Disease Progression|21
7844080|NCT00191945|27223258|P2|Double-Blind Acute Treatment|Physician Decision|2
7844081|NCT00191945|27223259|P1|Double-Blind Acute Treatment|Physician Decision|0
7844082|NCT00191945|27223258|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
7844083|NCT00191945|27223259|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
7844084|NCT00191945|27223258|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
7844085|NCT00191945|27223259|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
7844086|NCT00191945|27223258|P2|Double-Blind Acute Treatment|Parent's Decision|0
7844087|NCT00191945|27223259|P1|Double-Blind Acute Treatment|Parent's Decision|3
7844088|NCT00191906|27223295|P4|Study Period III|Lack of Efficacy|0
7844089|NCT00191906|27223296|P3|Study Period III|Lack of Efficacy|0
7844090|NCT00191906|27223297|P2|Study Period III|Lack of Efficacy|3
7844091|NCT00191906|27223298|P1|Study Period III|Lack of Efficacy|3
7844092|NCT00191906|27223295|P4|Study Period III|Parent/Caregiver Decision|0
7844093|NCT00191906|27223296|P3|Study Period III|Parent/Caregiver Decision|0
7844094|NCT00191906|27223297|P2|Study Period III|Parent/Caregiver Decision|0
7844095|NCT00191906|27223298|P1|Study Period III|Parent/Caregiver Decision|1
7844096|NCT00191906|27223295|P4|Study Period III|Lost to Follow-up|0
7844097|NCT00191906|27223296|P3|Study Period III|Lost to Follow-up|0
7844098|NCT00191906|27223297|P2|Study Period III|Lost to Follow-up|1
7844099|NCT00191906|27223298|P1|Study Period III|Lost to Follow-up|0
7844100|NCT00191906|27223295|P4|Study Period III|Adverse Event|0
7844101|NCT00191906|27223296|P3|Study Period III|Adverse Event|0
7844102|NCT00191906|27223297|P2|Study Period III|Adverse Event|0
7844103|NCT00191906|27223298|P1|Study Period III|Adverse Event|1
7844104|NCT00191906|27223295|P4|Study Period II|Entry Criteria Exclusion|0
7844105|NCT00191906|27223296|P3|Study Period II|Entry Criteria Exclusion|1
7844106|NCT00191906|27223297|P2|Study Period II|Entry Criteria Exclusion|0
7844107|NCT00191906|27223298|P1|Study Period II|Entry Criteria Exclusion|0
7844108|NCT00191906|27223295|P4|Study Period II|Parent/Caregiver Decision|0
7844109|NCT00191906|27223296|P3|Study Period II|Parent/Caregiver Decision|0
7844110|NCT00191906|27223297|P2|Study Period II|Parent/Caregiver Decision|1
7844111|NCT00191906|27223298|P1|Study Period II|Parent/Caregiver Decision|0
7844112|NCT00191906|27223295|P4|Study Period II|Withdrawal by Subject|0
7844113|NCT00191906|27223296|P3|Study Period II|Withdrawal by Subject|0
7844114|NCT00191906|27223297|P2|Study Period II|Withdrawal by Subject|3
7844115|NCT00191906|27223298|P1|Study Period II|Withdrawal by Subject|0
7844116|NCT00191906|27223295|P4|Study Period II|Adverse Event|0
7844117|NCT00191906|27223296|P3|Study Period II|Adverse Event|0
7844118|NCT00191906|27223297|P2|Study Period II|Adverse Event|1
7844119|NCT00191906|27223298|P1|Study Period II|Adverse Event|0
7844120|NCT00191854|27223341|P3|Overall Study|Screen Failure|1
7844121|NCT00191854|27223342|P2|Overall Study|Screen Failure|0
7844122|NCT00191854|27223343|P1|Overall Study|Screen Failure|0
7844123|NCT00191854|27223341|P3|Overall Study|Sponsor Decision|1
7844124|NCT00191854|27223342|P2|Overall Study|Sponsor Decision|0
7844125|NCT00191854|27223343|P1|Overall Study|Sponsor Decision|0
7844126|NCT00191854|27223341|P3|Overall Study|Withdrawal by Subject|3
7844127|NCT00191854|27223342|P2|Overall Study|Withdrawal by Subject|2
7844128|NCT00191854|27223343|P1|Overall Study|Withdrawal by Subject|4
7844129|NCT00191854|27223341|P3|Overall Study|Lost to Follow-up|5
7844130|NCT00191854|27223342|P2|Overall Study|Lost to Follow-up|5
7844131|NCT00191854|27223343|P1|Overall Study|Lost to Follow-up|7
7844132|NCT00191854|27223341|P3|Overall Study|Death|29
7844133|NCT00191854|27223342|P2|Overall Study|Death|23
7844134|NCT00191854|27223343|P1|Overall Study|Death|26
7844135|NCT00191815|27223363|P1|Overall Study|Withdrawal by Subject|7
7844136|NCT00191815|27223363|P1|Overall Study|Physician Decision|2
7844137|NCT00191815|27223363|P1|Overall Study|Protocol Violation|3
7844138|NCT00191815|27223363|P1|Overall Study|Death|2
7844139|NCT00191815|27223363|P1|Overall Study|Disease progression or relapse|24
7844140|NCT00191815|27223363|P1|Overall Study|Adverse Event|2
7844141|NCT00191789|27223375|P1|Overall Study|Death - Not Study-Drug Related|1
7844142|NCT00191789|27223375|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
7844143|NCT00191789|27223375|P1|Overall Study|Death - Possibly Study Drug Related|4
7844144|NCT00191789|27223375|P1|Overall Study|Withdrawal by Subject|4
7844145|NCT00191789|27223375|P1|Overall Study|Patient/Physician: Satisfactory Response|4
7844146|NCT00191789|27223375|P1|Overall Study|Patient: Satisfactory Response|5
7844147|NCT00191789|27223375|P1|Overall Study|Adverse Event|5
7844148|NCT00191724|27223392|P5|Overall Study|Withdrawal by Subject|0
7844149|NCT00191724|27223393|P4|Overall Study|Withdrawal by Subject|1
7844150|NCT00191724|27223394|P3|Overall Study|Withdrawal by Subject|0
7844151|NCT00191724|27223395|P2|Overall Study|Withdrawal by Subject|0
7844152|NCT00191724|27223396|P1|Overall Study|Withdrawal by Subject|0
7844153|NCT00191724|27223392|P5|Overall Study|Lost to Follow-up|3
7844154|NCT00191724|27223393|P4|Overall Study|Lost to Follow-up|2
7844155|NCT00191724|27223394|P3|Overall Study|Lost to Follow-up|0
7844156|NCT00191724|27223395|P2|Overall Study|Lost to Follow-up|1
7844157|NCT00191724|27223396|P1|Overall Study|Lost to Follow-up|1
7844158|NCT00191724|27223392|P5|Overall Study|Adverse Event|0
7844159|NCT00191724|27223393|P4|Overall Study|Adverse Event|0
7844160|NCT00191724|27223394|P3|Overall Study|Adverse Event|1
7844161|NCT00191724|27223395|P2|Overall Study|Adverse Event|0
7844162|NCT00191724|27223396|P1|Overall Study|Adverse Event|0
7844163|NCT00191646|27223425|P2|Overall Study|Missing Data|11
7844164|NCT00191646|27223426|P1|Overall Study|Missing Data|18
7844165|NCT00191646|27223425|P2|Overall Study|Other|34
7844166|NCT00191646|27223426|P1|Overall Study|Other|33
7844167|NCT00191646|27223425|P2|Overall Study|Death|8
7844168|NCT00191646|27223426|P1|Overall Study|Death|6
7844169|NCT00191646|27223425|P2|Overall Study|Protocol Violation|7
7844170|NCT00191646|27223426|P1|Overall Study|Protocol Violation|5
7844171|NCT00191646|27223425|P2|Overall Study|Withdrawal by Subject|39
7844172|NCT00191646|27223426|P1|Overall Study|Withdrawal by Subject|58
7844173|NCT00191646|27223425|P2|Overall Study|Physician Decision|11
7844174|NCT00191646|27223426|P1|Overall Study|Physician Decision|20
7844175|NCT00191646|27223425|P2|Overall Study|Disease Progression|6
7844176|NCT00191646|27223426|P1|Overall Study|Disease Progression|5
7844177|NCT00191646|27223425|P2|Overall Study|Toxicity|37
7844178|NCT00191646|27223426|P1|Overall Study|Toxicity|26
7844179|NCT00191477|27223446|P2|Overall Study|Discontinued Prior to Instillation|14
7844180|NCT00191477|27223447|P1|Overall Study|Discontinued Prior to Instillation|13
7844181|NCT00191477|27223446|P2|Overall Study|Pathological Specimen Lost|0
7844182|NCT00191477|27223447|P1|Overall Study|Pathological Specimen Lost|1
7844183|NCT00191477|27223446|P2|Overall Study|Not Eligible|38
7844184|NCT00191477|27223447|P1|Overall Study|Not Eligible|41
7844185|NCT00191477|27223446|P2|Overall Study|Other|0
7844186|NCT00191477|27223447|P1|Overall Study|Other|2
7844187|NCT00191477|27223446|P2|Overall Study|Withdrawal by Subject|0
7844188|NCT00191477|27223447|P1|Overall Study|Withdrawal by Subject|2
7844189|NCT00191477|27223446|P2|Overall Study|Treatment Change|0
7844190|NCT00191477|27223447|P1|Overall Study|Treatment Change|2
7844191|NCT00191477|27223446|P2|Overall Study|Protocol Violation|1
7844192|NCT00191477|27223447|P1|Overall Study|Protocol Violation|1
7844193|NCT00191477|27223446|P2|Overall Study|Lost to Follow-up|21
7844194|NCT00191477|27223447|P1|Overall Study|Lost to Follow-up|23
7844195|NCT00191477|27223446|P2|Overall Study|Death, Other Cause|6
7844196|NCT00191477|27223447|P1|Overall Study|Death, Other Cause|3
7844197|NCT00191477|27223446|P2|Overall Study|Death, Study Disease|1
7844198|NCT00191477|27223447|P1|Overall Study|Death, Study Disease|1
7844199|NCT00191477|27223446|P2|Overall Study|Tumor Recurrence|48
7844200|NCT00191477|27223447|P1|Overall Study|Tumor Recurrence|49
7844201|NCT00191451|27223466|P3|Overall Study|Reason Not Specified|3
7844202|NCT00191451|27223467|P2|Overall Study|Reason Not Specified|1
7844203|NCT00191451|27223468|P1|Overall Study|Reason Not Specified|2
7844204|NCT00191451|27223466|P3|Overall Study|Ineligible|0
7844205|NCT00191451|27223467|P2|Overall Study|Ineligible|1
7844206|NCT00191451|27223468|P1|Overall Study|Ineligible|0
7844207|NCT00191451|27223466|P3|Overall Study|Sponsor Decision|0
7844208|NCT00191451|27223467|P2|Overall Study|Sponsor Decision|0
7844209|NCT00191451|27223468|P1|Overall Study|Sponsor Decision|1
7844210|NCT00191451|27223466|P3|Overall Study|Physician Decision|6
7844211|NCT00191451|27223467|P2|Overall Study|Physician Decision|9
7844212|NCT00191451|27223468|P1|Overall Study|Physician Decision|2
7844213|NCT00191451|27223466|P3|Overall Study|Withdrawal by Subject|5
7844214|NCT00191451|27223467|P2|Overall Study|Withdrawal by Subject|3
7844215|NCT00191451|27223468|P1|Overall Study|Withdrawal by Subject|2
7844216|NCT00191386|27223488|P1|Overall Study|Lack of Efficacy|15
7844217|NCT00191386|27223488|P1|Overall Study|Physician Decision|11
7844218|NCT00191386|27223488|P1|Overall Study|Withdrawal by Subject|96
7844219|NCT00191386|27223488|P1|Overall Study|Protocol Violation|18
7844220|NCT00191386|27223488|P1|Overall Study|Entry Criteria Exclusion|3
7844221|NCT00191386|27223488|P1|Overall Study|Lost to Follow-up|1
7844222|NCT00191386|27223488|P1|Overall Study|Adverse Event|16
7844223|NCT00191334|27223495|P1|Overall Study|Withdrawal by Subject|4
7844224|NCT00191334|27223495|P1|Overall Study|Physician Decision|1
7844225|NCT00191334|27223495|P1|Overall Study|Disease Progression or Relapse|8
7844226|NCT00191334|27223495|P1|Overall Study|Adverse Event|4
7844227|NCT00191308|27223503|P1|Overall Study|Adverse Event|1
7844228|NCT00191282|27223513|P2|Overall Study|Lost to Follow-up|31
7844229|NCT00191282|27223514|P1|Overall Study|Lost to Follow-up|24
7844230|NCT00191282|27223513|P2|Overall Study|Sponsor's decision|2
7844231|NCT00191282|27223514|P1|Overall Study|Sponsor's decision|2
7844232|NCT00191282|27223513|P2|Overall Study|Severity of outcome|5
7844233|NCT00191282|27223514|P1|Overall Study|Severity of outcome|2
7844234|NCT00191282|27223513|P2|Overall Study|Protocol Violation|12
7844235|NCT00191282|27223514|P1|Overall Study|Protocol Violation|9
7844236|NCT00191282|27223513|P2|Overall Study|Protocol entry criteria not met|9
7844237|NCT00191282|27223514|P1|Overall Study|Protocol entry criteria not met|14
7844238|NCT00191282|27223513|P2|Overall Study|Physician Decision|15
7844239|NCT00191282|27223514|P1|Overall Study|Physician Decision|18
7844240|NCT00191282|27223513|P2|Overall Study|Withdrawal by Subject|44
7844241|NCT00191282|27223514|P1|Overall Study|Withdrawal by Subject|59
7844242|NCT00191282|27223513|P2|Overall Study|Patient moved|14
7844243|NCT00191282|27223514|P1|Overall Study|Patient moved|11
7844244|NCT00191282|27223513|P2|Overall Study|Noncompliance|17
7844245|NCT00191282|27223514|P1|Overall Study|Noncompliance|14
7844246|NCT00191282|27223513|P2|Overall Study|Lack of Efficacy|6
7844247|NCT00191282|27223514|P1|Overall Study|Lack of Efficacy|11
7844248|NCT00191282|27223513|P2|Overall Study|Death|51
7844249|NCT00191282|27223514|P1|Overall Study|Death|51
7844250|NCT00191282|27223513|P2|Overall Study|Adverse Event|6
7844251|NCT00191282|27223514|P1|Overall Study|Adverse Event|5
7844252|NCT00191269|27223574|P2|Overall Study|Physician Decision|3
7844253|NCT00191269|27223575|P1|Overall Study|Physician Decision|0
7844254|NCT00191269|27223574|P2|Overall Study|Pathologic Aggrevation|1
7844255|NCT00191269|27223575|P1|Overall Study|Pathologic Aggrevation|0
7844256|NCT00191269|27223574|P2|Overall Study|Withdrawal by Subject|1
7844257|NCT00191269|27223575|P1|Overall Study|Withdrawal by Subject|0
7844258|NCT00191269|27223574|P2|Overall Study|Lack of Efficacy|5
7844259|NCT00191269|27223575|P1|Overall Study|Lack of Efficacy|1
7844260|NCT00191269|27223574|P2|Overall Study|Progression of Disease|42
7844261|NCT00191269|27223575|P1|Overall Study|Progression of Disease|4
7844262|NCT00191269|27223574|P2|Overall Study|Adverse Event|4
7844263|NCT00191269|27223575|P1|Overall Study|Adverse Event|1
7844264|NCT00191269|27223574|P2|Overall Study|Protocol Violation|2
7844265|NCT00191269|27223575|P1|Overall Study|Protocol Violation|0
7844266|NCT00191191|27223591|P2|Overall Study|Good Clinical Practice Violation|1
7844267|NCT00191191|27223592|P1|Overall Study|Good Clinical Practice Violation|0
7844268|NCT00191191|27223591|P2|Overall Study|Physician Decision|2
7844269|NCT00191191|27223592|P1|Overall Study|Physician Decision|3
7844270|NCT00191191|27223591|P2|Overall Study|Lost to Follow-up|0
7844271|NCT00191191|27223592|P1|Overall Study|Lost to Follow-up|1
7844272|NCT00191191|27223591|P2|Overall Study|Family/Caregiver Decision|7
7844273|NCT00191191|27223592|P1|Overall Study|Family/Caregiver Decision|5
7844274|NCT00191191|27223591|P2|Overall Study|Toxicity After Dose Reduction|8
7844275|NCT00191191|27223592|P1|Overall Study|Toxicity After Dose Reduction|7
7844276|NCT00191191|27223591|P2|Overall Study|Progressive Disease|72
7844277|NCT00191191|27223592|P1|Overall Study|Progressive Disease|84
7844278|NCT00191191|27223591|P2|Overall Study|Adverse Event|21
7844279|NCT00191191|27223592|P1|Overall Study|Adverse Event|11
7844280|NCT00191191|27223591|P2|Overall Study|Treated with Another Systemic Agent|1
7844281|NCT00191191|27223592|P1|Overall Study|Treated with Another Systemic Agent|1
7844282|NCT00191191|27223591|P2|Overall Study|Entry Criteria Exclusion|0
7844283|NCT00191191|27223592|P1|Overall Study|Entry Criteria Exclusion|2
7844284|NCT00191165|27223608|P2|Overall Study|Participant Moved Away|1
7844285|NCT00191165|27223609|P1|Overall Study|Participant Moved Away|0
7844286|NCT00191165|27223608|P2|Overall Study|Protocol Violation|1
7844287|NCT00191165|27223609|P1|Overall Study|Protocol Violation|0
7844288|NCT00191165|27223608|P2|Overall Study|Adverse Event|0
7844289|NCT00191165|27223609|P1|Overall Study|Adverse Event|2
7844290|NCT00191152|27223621|P2|Crossover Treatment|Other|3
7844291|NCT00191152|27223622|P1|Crossover Treatment|Other|4
7844292|NCT00191152|27223621|P2|Crossover Treatment|Lost to Follow-up|1
7844293|NCT00191152|27223622|P1|Crossover Treatment|Lost to Follow-up|2
7844294|NCT00191152|27223621|P2|Crossover Treatment|Withdrawal by Subject|9
7844295|NCT00191152|27223622|P1|Crossover Treatment|Withdrawal by Subject|6
7844296|NCT00191152|27223621|P2|Crossover Treatment|Physician Decision|7
7844297|NCT00191152|27223622|P1|Crossover Treatment|Physician Decision|7
7844298|NCT00191152|27223621|P2|Crossover Treatment|Adverse Event|8
7844299|NCT00191152|27223622|P1|Crossover Treatment|Adverse Event|8
7844300|NCT00191152|27223621|P2|Initial Treatment|Other|21
7844301|NCT00191152|27223622|P1|Initial Treatment|Other|18
7844302|NCT00191152|27223621|P2|Initial Treatment|Lost to Follow-up|6
7844303|NCT00191152|27223622|P1|Initial Treatment|Lost to Follow-up|0
7844304|NCT00191152|27223621|P2|Initial Treatment|Withdrawal by Subject|28
7844305|NCT00191152|27223622|P1|Initial Treatment|Withdrawal by Subject|40
7844306|NCT00191152|27223621|P2|Initial Treatment|Physician Decision|31
7844307|NCT00191152|27223622|P1|Initial Treatment|Physician Decision|40
7844308|NCT00191152|27223621|P2|Initial Treatment|Adverse Event|67
7844309|NCT00191152|27223622|P1|Initial Treatment|Adverse Event|43
7844310|NCT00191139|27223654|P2|Overall Study|Other|2
7844311|NCT00191139|27223655|P1|Overall Study|Other|1
7844312|NCT00191139|27223654|P2|Overall Study|Disease Progression|1
7844313|NCT00191139|27223655|P1|Overall Study|Disease Progression|0
7844314|NCT00191139|27223654|P2|Overall Study|Withdrawal by Subject|3
7844315|NCT00191139|27223655|P1|Overall Study|Withdrawal by Subject|0
7844316|NCT00191139|27223654|P2|Overall Study|Death|0
7844317|NCT00191139|27223655|P1|Overall Study|Death|2
7844318|NCT00191139|27223654|P2|Overall Study|Adverse Event|6
7844319|NCT00191139|27223655|P1|Overall Study|Adverse Event|2
7844320|NCT00191113|27223671|P2|Core Study|Death|0
7844321|NCT00191113|27223672|P1|Core Study|Death|1
7844322|NCT00191113|27223671|P2|Core Study|Lack of Efficacy|2
7844323|NCT00191113|27223672|P1|Core Study|Lack of Efficacy|0
7844324|NCT00191113|27223671|P2|Core Study|Adverse Event|2
7844325|NCT00191113|27223672|P1|Core Study|Adverse Event|0
7844326|NCT00191113|27223671|P2|Core Study|Lost to Follow-up|0
7844327|NCT00191113|27223672|P1|Core Study|Lost to Follow-up|3
7844328|NCT00191113|27223671|P2|Core Study|Protocol Violation|2
7844329|NCT00191113|27223672|P1|Core Study|Protocol Violation|6
7844330|NCT00191113|27223671|P2|Core Study|Withdrawal by Subject|9
7844331|NCT00191113|27223672|P1|Core Study|Withdrawal by Subject|25
7844332|NCT00191100|27223714|P2|Overall Study|Reason Not Specified|1
7844333|NCT00191100|27223715|P1|Overall Study|Reason Not Specified|0
7844334|NCT00191100|27223714|P2|Overall Study|Death from Other Cause|0
7844335|NCT00191100|27223715|P1|Overall Study|Death from Other Cause|1
7844336|NCT00191100|27223714|P2|Overall Study|Protocol Violation|1
7844337|NCT00191100|27223715|P1|Overall Study|Protocol Violation|1
7844338|NCT00191100|27223714|P2|Overall Study|Death from Study Drug Toxicity|0
7844339|NCT00191100|27223715|P1|Overall Study|Death from Study Drug Toxicity|2
7844340|NCT00191100|27223714|P2|Overall Study|Physician Decision|1
7844341|NCT00191100|27223715|P1|Overall Study|Physician Decision|3
7844342|NCT00191100|27223714|P2|Overall Study|Lack of Efficacy, Stable Disease|0
7844343|NCT00191100|27223715|P1|Overall Study|Lack of Efficacy, Stable Disease|1
7844344|NCT00191100|27223714|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
7844345|NCT00191100|27223715|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
7844346|NCT00191100|27223714|P2|Overall Study|Clinical Relapse|1
7844347|NCT00191100|27223715|P1|Overall Study|Clinical Relapse|2
7844348|NCT00191100|27223714|P2|Overall Study|Protocol Entry Criteria Not Met|1
7844349|NCT00191100|27223715|P1|Overall Study|Protocol Entry Criteria Not Met|2
7844350|NCT00191100|27223714|P2|Overall Study|Withdrawal by Subject|3
7844351|NCT00191100|27223715|P1|Overall Study|Withdrawal by Subject|9
7844352|NCT00191100|27223714|P2|Overall Study|Patient Moved|1
7844353|NCT00191100|27223715|P1|Overall Study|Patient Moved|0
7844354|NCT00191100|27223714|P2|Overall Study|Lost to Follow-up|0
7844355|NCT00191100|27223715|P1|Overall Study|Lost to Follow-up|2
7844356|NCT00191100|27223714|P2|Overall Study|Adverse Event|1
7844357|NCT00191100|27223715|P1|Overall Study|Adverse Event|18
7844358|NCT00190983|27223731|P1|Overall Study|Inevaluable (never treated)|2
7844359|NCT00190775|27223740|P2|Overall Study|Exclusion Criteria Met|3
7844360|NCT00190775|27223741|P1|Overall Study|Exclusion Criteria Met|1
7844361|NCT00190775|27223740|P2|Overall Study|Protocol Violation|1
7844362|NCT00190775|27223741|P1|Overall Study|Protocol Violation|0
7844363|NCT00190775|27223740|P2|Overall Study|Noncompliance|5
7844364|NCT00190775|27223741|P1|Overall Study|Noncompliance|3
7844365|NCT00190775|27223740|P2|Overall Study|Physician Decision|0
7844366|NCT00190775|27223741|P1|Overall Study|Physician Decision|3
7844367|NCT00190775|27223740|P2|Overall Study|Sponsor Decision|0
7844368|NCT00190775|27223741|P1|Overall Study|Sponsor Decision|1
7844369|NCT00190775|27223740|P2|Overall Study|Withdrawal by Subject|13
7844370|NCT00190775|27223741|P1|Overall Study|Withdrawal by Subject|24
7844371|NCT00190775|27223740|P2|Overall Study|Participant Moved|1
7844372|NCT00190775|27223741|P1|Overall Study|Participant Moved|0
7844373|NCT00190775|27223740|P2|Overall Study|Lost to Follow-up|23
7844374|NCT00190775|27223741|P1|Overall Study|Lost to Follow-up|31
7844375|NCT00190775|27223740|P2|Overall Study|Lack of Efficacy|32
7844376|NCT00190775|27223741|P1|Overall Study|Lack of Efficacy|28
7844377|NCT00190775|27223740|P2|Overall Study|Satisfactory Response|0
7844378|NCT00190775|27223741|P1|Overall Study|Satisfactory Response|1
7844379|NCT00190775|27223740|P2|Overall Study|Adverse Event|22
7844380|NCT00190775|27223741|P1|Overall Study|Adverse Event|57
7844381|NCT00190749|27223812|P2|Overall Study|Sponsor Decision|0
7844382|NCT00190749|27223813|P1|Overall Study|Sponsor Decision|1
7844383|NCT00190749|27223812|P2|Overall Study|Reason Not Specified|2
7844384|NCT00190749|27223813|P1|Overall Study|Reason Not Specified|0
7844385|NCT00190749|27223812|P2|Overall Study|Lack of Efficacy|3
7844386|NCT00190749|27223813|P1|Overall Study|Lack of Efficacy|2
7844387|NCT00190749|27223812|P2|Overall Study|Adverse Event|5
7844388|NCT00190749|27223813|P1|Overall Study|Adverse Event|0
7844389|NCT00190749|27223812|P2|Overall Study|Protocol Violation|4
7844390|NCT00190749|27223813|P1|Overall Study|Protocol Violation|5
7844391|NCT00190749|27223812|P2|Overall Study|Withdrawal by Subject|6
7844392|NCT00190749|27223813|P1|Overall Study|Withdrawal by Subject|10
7844393|NCT00190749|27223812|P2|Overall Study|Lost to Follow-up|11
7844394|NCT00190749|27223813|P1|Overall Study|Lost to Follow-up|8
7844395|NCT00190684|27223877|P1|Overall Study|Study Period V Completed|1
7844396|NCT00190684|27223877|P1|Overall Study|Study Period III Completed|103
7844397|NCT00190684|27223877|P1|Overall Study|Protocol Violation|123
7844398|NCT00190684|27223877|P1|Overall Study|Physician Decision|84
7844399|NCT00190684|27223877|P1|Overall Study|Sponsor's decision|17
7844400|NCT00190684|27223877|P1|Overall Study|Clinical relapse|67
7844401|NCT00190684|27223877|P1|Overall Study|Patient Decision|432
7844402|NCT00190684|27223877|P1|Overall Study|Patient moved|60
7844403|NCT00190684|27223877|P1|Overall Study|Lost to Follow-up|232
7844404|NCT00190684|27223877|P1|Overall Study|Lack of efficacy|204
7844405|NCT00190684|27223877|P1|Overall Study|Satisfactory response|80
7844406|NCT00190684|27223877|P1|Overall Study|Adverse Event|86
7844407|NCT00190671|27223898|P2|Overall Study|Withdrawal by Subject|2
7844408|NCT00190671|27223899|P1|Overall Study|Withdrawal by Subject|0
7844409|NCT00190671|27223898|P2|Overall Study|Protocol Violation|1
7844410|NCT00190671|27223899|P1|Overall Study|Protocol Violation|0
7844411|NCT00190671|27223898|P2|Overall Study|Death from Other Causes|2
7844412|NCT00190671|27223899|P1|Overall Study|Death from Other Causes|0
7844413|NCT00190671|27223898|P2|Overall Study|Death from Study-Drug Toxicity|2
7844414|NCT00190671|27223899|P1|Overall Study|Death from Study-Drug Toxicity|0
7844415|NCT00190671|27223898|P2|Overall Study|Clinical Relapse|1
7844416|NCT00190671|27223899|P1|Overall Study|Clinical Relapse|0
7844417|NCT00190671|27223898|P2|Overall Study|Adverse Event|2
7844418|NCT00190671|27223899|P1|Overall Study|Adverse Event|3
7844419|NCT00190671|27223898|P2|Overall Study|Death from Study Disease|1
7844420|NCT00190671|27223899|P1|Overall Study|Death from Study Disease|1
7844421|NCT00190671|27223898|P2|Overall Study|Lack of Efficacy|24
7844422|NCT00190671|27223899|P1|Overall Study|Lack of Efficacy|19
7844423|NCT00190671|27223898|P2|Overall Study|Satisfactory Response|7
7844424|NCT00190671|27223899|P1|Overall Study|Satisfactory Response|4
7844429|NCT00189488|27223938|P2|Overall Study|Other|0
7844430|NCT00189488|27223939|P1|Overall Study|Other|1
7844431|NCT00189488|27223938|P2|Overall Study|Death|8
7844432|NCT00189488|27223939|P1|Overall Study|Death|5
7844433|NCT00189488|27223938|P2|Overall Study|Administrative Decision|2
7844434|NCT00189488|27223939|P1|Overall Study|Administrative Decision|0
7844435|NCT00189488|27223938|P2|Overall Study|Disease progression|4
7844436|NCT00189488|27223939|P1|Overall Study|Disease progression|2
7844437|NCT00189488|27223938|P2|Overall Study|Withdrawal by Subject|6
7844438|NCT00189488|27223939|P1|Overall Study|Withdrawal by Subject|2
7844439|NCT00189488|27223938|P2|Overall Study|Adverse Event|1
7844440|NCT00189488|27223939|P1|Overall Study|Adverse Event|2
7844441|NCT00189488|27223938|P2|Overall Study|Protocol deviation|1
7844442|NCT00189488|27223939|P1|Overall Study|Protocol deviation|2
7844443|NCT00189488|27223938|P2|Overall Study|Ineligibility determined|0
7844444|NCT00189488|27223939|P1|Overall Study|Ineligibility determined|1
7844445|NCT00189462|27223970|P2|Overall Study|Lost to Follow-up|20
7844446|NCT00189462|27223971|P1|Overall Study|Lost to Follow-up|18
7844447|NCT00189462|27223970|P2|Overall Study|Lack of Efficacy|1
7844448|NCT00189462|27223971|P1|Overall Study|Lack of Efficacy|5
7844449|NCT00189423|27223992|P2|Overall Study|Lost to Follow-up|10
7844450|NCT00189423|27223993|P1|Overall Study|Lost to Follow-up|10
7844451|NCT00189423|27223992|P2|Overall Study|Withdrawal by Subject|9
7844452|NCT00189423|27223993|P1|Overall Study|Withdrawal by Subject|9
7844453|NCT00189423|27223992|P2|Overall Study|Death|747
7844454|NCT00189423|27223993|P1|Overall Study|Death|746
7844455|NCT00189306|27224015|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
7844456|NCT00189306|27224015|P1|Long-Term Follow-up|Lost to Follow-up|9
7844457|NCT00189306|27224015|P1|Long-Term Follow-up|Intercurrent disease|2
7844458|NCT00189306|27224015|P1|Long-Term Follow-up|Withdrawal by Subject|1
7844459|NCT00189306|27224015|P1|Long-Term Follow-up|Death|4
7844460|NCT00189306|27224015|P1|Long-Term Follow-up|Adverse Event|2
7844461|NCT00189306|27224015|P1|Posttreatment Period|Local skin reaction/sign|1
7844462|NCT00189306|27224015|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
7844463|NCT00189306|27224015|P1|Posttreatment Period|Protocol Violation|1
7844464|NCT00189306|27224015|P1|Posttreatment Period|Target lesion excised|1
7844465|NCT00189306|27224015|P1|Posttreatment Period|Noncompliance|1
7844466|NCT00189306|27224015|P1|Posttreatment Period|Withdrawal by Subject|2
7844467|NCT00189306|27224015|P1|Posttreatment Period|Death|1
7844468|NCT00189306|27224015|P1|Treatment Period|Protocol Violation|1
7844469|NCT00189306|27224015|P1|Treatment Period|Adverse Event|2
7844470|NCT00189306|27224015|P1|Treatment Period|Withdrawal by Subject|2
7844471|NCT00189202|27224024|P1|Overall Study|Physician Decision|5
7844472|NCT00187889|27224065|P2|Overall Study|Withdrawal by Subject|4
7844473|NCT00187889|27224066|P1|Overall Study|Withdrawal by Subject|6
7844474|NCT00187486|27224108|P1|Overall Study|Protocol Violation|1
7844475|NCT00187278|27224144|P2|Overall Study|Protocol Violation|13
7844476|NCT00187278|27224145|P1|Overall Study|Protocol Violation|10
7844477|NCT00187135|27224229|P6|Visit Three|Study Discontinued|6
7844478|NCT00187135|27224230|P5|Visit Three|Study Discontinued|7
7844479|NCT00187135|27224231|P4|Visit Three|Study Discontinued|7
7844480|NCT00187135|27224232|P3|Visit Three|Study Discontinued|7
7844481|NCT00187135|27224233|P2|Visit Three|Study Discontinued|6
7844482|NCT00187135|27224234|P1|Visit Three|Study Discontinued|7
7844483|NCT00187135|27224229|P6|Visit Three|Withdrawal by Subject|0
7844484|NCT00187135|27224230|P5|Visit Three|Withdrawal by Subject|0
7844485|NCT00187135|27224231|P4|Visit Three|Withdrawal by Subject|2
7844486|NCT00187135|27224232|P3|Visit Three|Withdrawal by Subject|1
7844487|NCT00187135|27224233|P2|Visit Three|Withdrawal by Subject|1
7844488|NCT00187135|27224234|P1|Visit Three|Withdrawal by Subject|0
7844489|NCT00187135|27224229|P6|Visit Three|Death|0
7844490|NCT00187135|27224230|P5|Visit Three|Death|1
7844491|NCT00187135|27224231|P4|Visit Three|Death|0
7844492|NCT00187135|27224232|P3|Visit Three|Death|1
7844493|NCT00187135|27224233|P2|Visit Three|Death|0
7844494|NCT00187135|27224234|P1|Visit Three|Death|0
7844495|NCT00187135|27224229|P6|Visit Two|Study Discontinued|6
7844496|NCT00187135|27224230|P5|Visit Two|Study Discontinued|5
7844497|NCT00187135|27224231|P4|Visit Two|Study Discontinued|7
7844498|NCT00187135|27224232|P3|Visit Two|Study Discontinued|1
7844499|NCT00187135|27224233|P2|Visit Two|Study Discontinued|2
7844500|NCT00187135|27224234|P1|Visit Two|Study Discontinued|3
7844501|NCT00187135|27224229|P6|Visit Two|Withdrawal by Subject|1
7844502|NCT00187135|27224230|P5|Visit Two|Withdrawal by Subject|1
7844503|NCT00187135|27224231|P4|Visit Two|Withdrawal by Subject|0
7844504|NCT00187135|27224232|P3|Visit Two|Withdrawal by Subject|1
7844505|NCT00187135|27224233|P2|Visit Two|Withdrawal by Subject|1
7844506|NCT00187135|27224234|P1|Visit Two|Withdrawal by Subject|1
7844507|NCT00187135|27224229|P6|Visit Two|Physician Decision|0
7844508|NCT00187135|27224230|P5|Visit Two|Physician Decision|0
7844509|NCT00187135|27224231|P4|Visit Two|Physician Decision|0
7844510|NCT00187135|27224232|P3|Visit Two|Physician Decision|0
7844511|NCT00187135|27224233|P2|Visit Two|Physician Decision|0
7844512|NCT00187135|27224234|P1|Visit Two|Physician Decision|1
7844513|NCT00187135|27224229|P6|Visit Two|Death|1
7844514|NCT00187135|27224230|P5|Visit Two|Death|0
7844515|NCT00187135|27224231|P4|Visit Two|Death|1
7844516|NCT00187135|27224232|P3|Visit Two|Death|0
7844517|NCT00187135|27224233|P2|Visit Two|Death|0
7844518|NCT00187135|27224234|P1|Visit Two|Death|0
7844519|NCT00187135|27224229|P6|Visit One|Physician Decision|1
7844520|NCT00187135|27224230|P5|Visit One|Physician Decision|0
7844521|NCT00187135|27224231|P4|Visit One|Physician Decision|0
7844522|NCT00187135|27224232|P3|Visit One|Physician Decision|0
7844523|NCT00187135|27224233|P2|Visit One|Physician Decision|1
7844524|NCT00187135|27224234|P1|Visit One|Physician Decision|3
7844525|NCT00187135|27224229|P6|Visit One|Withdrawal by Subject|1
7844526|NCT00187135|27224230|P5|Visit One|Withdrawal by Subject|0
7844527|NCT00187135|27224231|P4|Visit One|Withdrawal by Subject|0
7844528|NCT00187135|27224232|P3|Visit One|Withdrawal by Subject|0
7844529|NCT00187135|27224233|P2|Visit One|Withdrawal by Subject|0
7844530|NCT00187135|27224234|P1|Visit One|Withdrawal by Subject|1
7844531|NCT00187096|27224257|P3|Overall Study|unacceptable toxicity|1
7844532|NCT00187096|27224258|P2|Overall Study|unacceptable toxicity|0
7844533|NCT00187096|27224259|P1|Overall Study|unacceptable toxicity|0
7844534|NCT00186901|27224297|P3|Overall Study|Bone Mineral Density > 0|149
7844535|NCT00186901|27224298|P2|Overall Study|Bone Mineral Density > 0|0
7844536|NCT00186901|27224299|P1|Overall Study|Bone Mineral Density > 0|0
7844537|NCT00186901|27224297|P3|Overall Study|Limited adherence to study requirements|0
7844538|NCT00186901|27224298|P2|Overall Study|Limited adherence to study requirements|23
7844539|NCT00186901|27224299|P1|Overall Study|Limited adherence to study requirements|20
7844540|NCT00186901|27224297|P3|Overall Study|Open label|0
7844541|NCT00186901|27224298|P2|Overall Study|Open label|2
7844542|NCT00186901|27224299|P1|Overall Study|Open label|3
7844543|NCT00186901|27224297|P3|Overall Study|Withdrawal by Subject|0
7844544|NCT00186901|27224298|P2|Overall Study|Withdrawal by Subject|5
7844545|NCT00186901|27224299|P1|Overall Study|Withdrawal by Subject|4
7844546|NCT00186901|27224297|P3|Overall Study|ALL relapse or second malignancy|0
7844547|NCT00186901|27224298|P2|Overall Study|ALL relapse or second malignancy|2
7844548|NCT00186901|27224299|P1|Overall Study|ALL relapse or second malignancy|1
7844549|NCT00186901|27224297|P3|Overall Study|Bone Mineral Density dropped > 5%|0
7844550|NCT00186901|27224298|P2|Overall Study|Bone Mineral Density dropped > 5%|7
7844551|NCT00186901|27224299|P1|Overall Study|Bone Mineral Density dropped > 5%|9
7844552|NCT00186901|27224297|P3|Overall Study|Lost to Follow-up|0
7844553|NCT00186901|27224298|P2|Overall Study|Lost to Follow-up|3
7844554|NCT00186901|27224299|P1|Overall Study|Lost to Follow-up|6
7844555|NCT00186901|27224297|P3|Overall Study|Pregnancy|0
7844556|NCT00186901|27224298|P2|Overall Study|Pregnancy|3
7844557|NCT00186901|27224299|P1|Overall Study|Pregnancy|6
7844558|NCT00186888|27224339|P3|Overall Study|Relapse or progression of disease|0
7844559|NCT00186888|27224340|P2|Overall Study|Relapse or progression of disease|2
7844560|NCT00186888|27224341|P1|Overall Study|Relapse or progression of disease|4
7844561|NCT00186888|27224339|P3|Overall Study|Toxicity|0
7844562|NCT00186888|27224340|P2|Overall Study|Toxicity|1
7844563|NCT00186888|27224341|P1|Overall Study|Toxicity|0
7844564|NCT00186628|27224433|P1|Overall Study|Withdrawal by subject (before treatment)|1
7844565|NCT00186628|27224433|P1|Overall Study|Death|2
7844566|NCT00186537|27224444|P3|Overall Study|ALT > 1.5 x ULN|0
7844567|NCT00186537|27224445|P2|Overall Study|ALT > 1.5 x ULN|0
7844568|NCT00186537|27224446|P1|Overall Study|ALT > 1.5 x ULN|3
7844569|NCT00186537|27224444|P3|Overall Study|Withdrawal by Subject|3
7844570|NCT00186537|27224445|P2|Overall Study|Withdrawal by Subject|0
7844571|NCT00186537|27224446|P1|Overall Study|Withdrawal by Subject|4
7844572|NCT00186485|27224469|P1|Overall Study|Lost to Follow-up|3
7844573|NCT00186186|27224481|P1|Overall Study|Not reported as to reason|2
7844574|NCT00186186|27224481|P1|Overall Study|Withdrawal by Subject|3
7844575|NCT00186186|27224481|P1|Overall Study|Lack of Efficacy|3
7844576|NCT00186121|27224486|P1|Overall Study|Not eligible (no treatment)|1
7844577|NCT00186121|27224486|P1|Overall Study|Underwent oophorectomy (no treatment)|1
7844578|NCT00186121|27224486|P1|Overall Study|Subject withdrawal (no treatment)|1
7844579|NCT00186043|27224520|P2|Overall Study|Protocol Violation|1
7844580|NCT00186043|27224521|P1|Overall Study|Protocol Violation|2
7844581|NCT00186043|27224520|P2|Overall Study|Adverse Event|3
7844582|NCT00186043|27224521|P1|Overall Study|Adverse Event|7
7844583|NCT00186043|27224520|P2|Overall Study|Withdrawal by Subject|0
7844584|NCT00186043|27224521|P1|Overall Study|Withdrawal by Subject|1
7844585|NCT00186043|27224520|P2|Overall Study|Lost to Follow-up|6
7844586|NCT00186043|27224521|P1|Overall Study|Lost to Follow-up|4
7844587|NCT00186043|27224520|P2|Overall Study|Lack of Efficacy|3
7844588|NCT00186043|27224521|P1|Overall Study|Lack of Efficacy|1
7844589|NCT00185965|27224548|P2|Overall Study|Adverse Event|1
7844590|NCT00185965|27224549|P1|Overall Study|Adverse Event|0
7844591|NCT00185731|27224574|P1|Overall Study|Not Eligible|1
7844592|NCT00185731|27224574|P1|Overall Study|Withdrawal by Subject|1
7844593|NCT00185640|27224591|P1|Overall Study|Death|138
7844594|NCT00185640|27224591|P1|Overall Study|Withdrawal by Subject|3
7844595|NCT00185640|27224591|P1|Overall Study|Not Eligible|4
7844596|NCT00185614|27224600|P1|Inter-treatment Period|Lack of allogenic donor|1
7844597|NCT00185614|27224600|P1|Inter-treatment Period|Relapse|2
7844598|NCT00185614|27224600|P1|Inter-treatment Period|Physician Decision|1
7844599|NCT00185588|27224612|P4|Overall Study|Physician Decision|0
7844600|NCT00185588|27224613|P3|Overall Study|Physician Decision|1
7844601|NCT00185588|27224614|P2|Overall Study|Physician Decision|0
7844602|NCT00185588|27224615|P1|Overall Study|Physician Decision|0
7844603|NCT00185588|27224612|P4|Overall Study|Withdrawal by Subject|0
7844604|NCT00185588|27224613|P3|Overall Study|Withdrawal by Subject|0
7844605|NCT00185588|27224614|P2|Overall Study|Withdrawal by Subject|1
7844606|NCT00185588|27224615|P1|Overall Study|Withdrawal by Subject|0
7844607|NCT00185588|27224612|P4|Overall Study|Lost to Follow-up|2
7844608|NCT00185588|27224613|P3|Overall Study|Lost to Follow-up|1
7844609|NCT00185588|27224614|P2|Overall Study|Lost to Follow-up|0
7844610|NCT00185588|27224615|P1|Overall Study|Lost to Follow-up|0
7844611|NCT00185588|27224612|P4|Overall Study|Adverse Event|2
7844612|NCT00185588|27224613|P3|Overall Study|Adverse Event|4
7844613|NCT00185588|27224614|P2|Overall Study|Adverse Event|1
7844614|NCT00185588|27224615|P1|Overall Study|Adverse Event|3
7844615|NCT00185458|27224629|P1|HRT Phase|Withdrawal by Subject|3
7844616|NCT00185458|27224629|P1|HRT Phase|Protocol Violation|2
7844617|NCT00185458|27224629|P1|HRT Phase|Lost to Follow-up|4
7844618|NCT00185458|27224629|P1|HRT Phase|Adverse Event|18
7844619|NCT00185458|27224629|P1|Contraception Phase|Withdrawal by Subject|7
7844620|NCT00185458|27224629|P1|Contraception Phase|Physician Decision|2
7844621|NCT00185458|27224629|P1|Contraception Phase|Protocol Violation|2
7844622|NCT00185458|27224629|P1|Contraception Phase|Lost to Follow-up|10
7844623|NCT00185458|27224629|P1|Contraception Phase|Adverse Event|37
7844624|NCT00185380|27224692|P3|Overall Study|personal reason|1
7844625|NCT00185380|27224693|P2|Overall Study|personal reason|1
7844626|NCT00185380|27224694|P1|Overall Study|personal reason|6
7844627|NCT00185380|27224692|P3|Overall Study|Could not attend visits|4
7844628|NCT00185380|27224693|P2|Overall Study|Could not attend visits|0
7844629|NCT00185380|27224694|P1|Overall Study|Could not attend visits|2
7844630|NCT00185380|27224692|P3|Overall Study|No need for contraception|3
7844631|NCT00185380|27224693|P2|Overall Study|No need for contraception|3
7844632|NCT00185380|27224694|P1|Overall Study|No need for contraception|3
7844633|NCT00185380|27224692|P3|Overall Study|Planned pregnancy|12
7844634|NCT00185380|27224693|P2|Overall Study|Planned pregnancy|12
7844635|NCT00185380|27224694|P1|Overall Study|Planned pregnancy|9
7844636|NCT00185380|27224692|P3|Overall Study|Failed insertion|2
7844637|NCT00185380|27224693|P2|Overall Study|Failed insertion|1
7844638|NCT00185380|27224694|P1|Overall Study|Failed insertion|1
7844639|NCT00185380|27224692|P3|Overall Study|Withdrawal by Subject|0
7844640|NCT00185380|27224693|P2|Overall Study|Withdrawal by Subject|2
7844641|NCT00185380|27224694|P1|Overall Study|Withdrawal by Subject|1
7844642|NCT00185380|27224692|P3|Overall Study|Protocol Violation|1
7844643|NCT00185380|27224693|P2|Overall Study|Protocol Violation|2
7844644|NCT00185380|27224694|P1|Overall Study|Protocol Violation|2
7844645|NCT00185380|27224692|P3|Overall Study|Pregnancy|0
7844646|NCT00185380|27224693|P2|Overall Study|Pregnancy|4
7844647|NCT00185380|27224694|P1|Overall Study|Pregnancy|1
7844648|NCT00185380|27224692|P3|Overall Study|Lost to Follow-up|3
7844649|NCT00185380|27224693|P2|Overall Study|Lost to Follow-up|4
7844650|NCT00185380|27224694|P1|Overall Study|Lost to Follow-up|0
7844651|NCT00185380|27224692|P3|Overall Study|Adverse Event|48
7844652|NCT00185380|27224693|P2|Overall Study|Adverse Event|43
7844653|NCT00185380|27224694|P1|Overall Study|Adverse Event|41
7844654|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
7844655|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
7844656|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
7844657|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
7844658|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
7844659|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
7844660|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
7844661|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
7844662|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
7844663|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
7844664|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
7844665|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
7844666|NCT00185211|27224722|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
7844667|NCT00185211|27224723|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
7844668|NCT00185211|27224722|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
7844669|NCT00185211|27224723|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
7844670|NCT00185211|27224722|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
7844671|NCT00185211|27224723|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
7844672|NCT00185211|27224722|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
7844673|NCT00185211|27224723|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
7844674|NCT00185211|27224722|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
7844675|NCT00185211|27224723|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
7844676|NCT00185211|27224722|P2|Placebo-controlled Study (92012)|Adverse Event|0
7844677|NCT00185211|27224723|P1|Placebo-controlled Study (92012)|Adverse Event|8
7844678|NCT00184600|27224796|P3|Overall Study|Unclassified|3
7844679|NCT00184600|27224797|P2|Overall Study|Unclassified|5
7844680|NCT00184600|27224798|P1|Overall Study|Unclassified|4
7844681|NCT00184600|27224796|P3|Overall Study|Withdrawal by Subject|12
7844682|NCT00184600|27224797|P2|Overall Study|Withdrawal by Subject|28
7844683|NCT00184600|27224798|P1|Overall Study|Withdrawal by Subject|20
7844684|NCT00184600|27224796|P3|Overall Study|Protocol Violation|3
7844685|NCT00184600|27224797|P2|Overall Study|Protocol Violation|2
7844686|NCT00184600|27224798|P1|Overall Study|Protocol Violation|2
7844687|NCT00184600|27224796|P3|Overall Study|Lost to Follow-up|1
7844688|NCT00184600|27224797|P2|Overall Study|Lost to Follow-up|6
7844689|NCT00184600|27224798|P1|Overall Study|Lost to Follow-up|4
7844690|NCT00184600|27224796|P3|Overall Study|Lack of Efficacy|3
7844691|NCT00184600|27224797|P2|Overall Study|Lack of Efficacy|1
7844692|NCT00184600|27224798|P1|Overall Study|Lack of Efficacy|3
7844693|NCT00184600|27224796|P3|Overall Study|Death|7
7844694|NCT00184600|27224797|P2|Overall Study|Death|9
7844695|NCT00184600|27224798|P1|Overall Study|Death|3
7844696|NCT00184600|27224796|P3|Overall Study|Adverse Event|5
7844697|NCT00184600|27224797|P2|Overall Study|Adverse Event|0
7844698|NCT00184600|27224798|P1|Overall Study|Adverse Event|9
7844699|NCT00184093|27224889|P1|Overall Study|Withdrawal by Subject|2
7844700|NCT00184093|27224889|P1|Overall Study|Physician Decision|1
7844701|NCT00184093|27224889|P1|Overall Study|Lost to Follow-up|3
7844702|NCT00184093|27224889|P1|Overall Study|Adverse Event|3
7844703|NCT00184054|27224894|P1|Overall Study|Adverse Event|1
7844704|NCT00184028|27224899|P1|Overall Study|Non-compliance|2
7844705|NCT00184028|27224899|P1|Overall Study|Withdrawal by Subject|1
7844706|NCT00184028|27224899|P1|Overall Study|Adverse Event|2
7844707|NCT00184028|27224899|P1|Overall Study|Lack of Efficacy|4
7844708|NCT00184028|27224899|P1|Overall Study|Death|1
7844709|NCT00184002|27224904|P1|Overall Study|Withdrawal by Subject|4
7844710|NCT00184002|27224904|P1|Overall Study|Physician Decision|1
7844711|NCT00184002|27224904|P1|Overall Study|Death|3
7844712|NCT00184002|27224904|P1|Overall Study|Adverse Event|9
7844713|NCT00183872|27224930|P1|Overall Study|Drug delayed more than 28 days|2
7844714|NCT00183872|27224930|P1|Overall Study|Withdrawal by Subject|2
7844715|NCT00183872|27224930|P1|Overall Study|Adverse Event|9
7844716|NCT00183872|27224930|P1|Overall Study|Death|3
7844717|NCT00183625|27224959|P4|Overall Study|Withdrawal by Subject|14
7844718|NCT00183625|27224960|P3|Overall Study|Withdrawal by Subject|19
7844719|NCT00183625|27224961|P2|Overall Study|Withdrawal by Subject|18
7844720|NCT00183625|27224962|P1|Overall Study|Withdrawal by Subject|18
7844721|NCT00183430|27225059|P2|Overall Study|Withdrawal by Subject|0
7844722|NCT00183430|27225060|P1|Overall Study|Withdrawal by Subject|1
7844723|NCT00183430|27225059|P2|Overall Study|did not meet inclusion criteria|0
7844724|NCT00183430|27225060|P1|Overall Study|did not meet inclusion criteria|1
7844725|NCT00183430|27225059|P2|Overall Study|Lost to Follow-up|0
7844726|NCT00183430|27225060|P1|Overall Study|Lost to Follow-up|3
7844727|NCT00183430|27225059|P2|Overall Study|Adverse Event|0
7844728|NCT00183430|27225060|P1|Overall Study|Adverse Event|1
7844729|NCT00183391|27225072|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
7844730|NCT00183391|27225073|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
7844731|NCT00183391|27225072|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
7844732|NCT00183391|27225073|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
7844733|NCT00183274|27225146|P6|Phase 3: Double-Blind|Relapsed|2
7844734|NCT00183274|27225147|P5|Phase 3: Double-Blind|Relapsed|11
7844735|NCT00183274|27225148|P4|Phase 3: Double-Blind|Relapsed|1
7844736|NCT00183274|27225149|P3|Phase 3: Double-Blind|Relapsed|0
7844737|NCT00183274|27225150|P2|Phase 3: Double-Blind|Relapsed|0
7844738|NCT00183274|27225151|P1|Phase 3: Double-Blind|Relapsed|0
7844739|NCT00183274|27225146|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
7844740|NCT00183274|27225147|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
7844741|NCT00183274|27225148|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
7844742|NCT00183274|27225149|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
7844743|NCT00183274|27225150|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
7844744|NCT00183274|27225151|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
7844745|NCT00183274|27225146|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
7844746|NCT00183274|27225147|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
7844747|NCT00183274|27225148|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
7844748|NCT00183274|27225149|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
7844749|NCT00183274|27225150|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
7844750|NCT00183274|27225151|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
7844751|NCT00183274|27225146|P6|Phase 2: Double-Blind|Relapsed|0
7844752|NCT00183274|27225147|P5|Phase 2: Double-Blind|Relapsed|0
7844753|NCT00183274|27225148|P4|Phase 2: Double-Blind|Relapsed|0
7844754|NCT00183274|27225149|P3|Phase 2: Double-Blind|Relapsed|29
7844755|NCT00183274|27225150|P2|Phase 2: Double-Blind|Relapsed|8
7844756|NCT00183274|27225151|P1|Phase 2: Double-Blind|Relapsed|0
7844757|NCT00183274|27225146|P6|Phase 1: Open-Label|Other|0
7844758|NCT00183274|27225147|P5|Phase 1: Open-Label|Other|0
7844759|NCT00183274|27225148|P4|Phase 1: Open-Label|Other|0
7844760|NCT00183274|27225149|P3|Phase 1: Open-Label|Other|0
7844761|NCT00183274|27225150|P2|Phase 1: Open-Label|Other|0
7844762|NCT00183274|27225151|P1|Phase 1: Open-Label|Other|9
7844763|NCT00183274|27225146|P6|Phase 1: Open-Label|Lost to Follow-up|0
7844764|NCT00183274|27225147|P5|Phase 1: Open-Label|Lost to Follow-up|0
7844765|NCT00183274|27225148|P4|Phase 1: Open-Label|Lost to Follow-up|0
7844766|NCT00183274|27225149|P3|Phase 1: Open-Label|Lost to Follow-up|0
7844767|NCT00183274|27225150|P2|Phase 1: Open-Label|Lost to Follow-up|0
7844768|NCT00183274|27225151|P1|Phase 1: Open-Label|Lost to Follow-up|33
7844769|NCT00183274|27225146|P6|Phase 1: Open-Label|Withdrawal by Subject|0
7844770|NCT00183274|27225147|P5|Phase 1: Open-Label|Withdrawal by Subject|0
7844771|NCT00183274|27225148|P4|Phase 1: Open-Label|Withdrawal by Subject|0
7844772|NCT00183274|27225149|P3|Phase 1: Open-Label|Withdrawal by Subject|0
7844773|NCT00183274|27225150|P2|Phase 1: Open-Label|Withdrawal by Subject|0
7844774|NCT00183274|27225151|P1|Phase 1: Open-Label|Withdrawal by Subject|13
7844775|NCT00183274|27225146|P6|Phase 1: Open-Label|Protocol Violation|0
7844776|NCT00183274|27225147|P5|Phase 1: Open-Label|Protocol Violation|0
7844777|NCT00183274|27225148|P4|Phase 1: Open-Label|Protocol Violation|0
7844778|NCT00183274|27225149|P3|Phase 1: Open-Label|Protocol Violation|0
7844779|NCT00183274|27225150|P2|Phase 1: Open-Label|Protocol Violation|0
7844780|NCT00183274|27225151|P1|Phase 1: Open-Label|Protocol Violation|11
7844781|NCT00183274|27225146|P6|Phase 1: Open-Label|Lack of Efficacy|0
7844782|NCT00183274|27225147|P5|Phase 1: Open-Label|Lack of Efficacy|0
7844783|NCT00183274|27225148|P4|Phase 1: Open-Label|Lack of Efficacy|0
7844784|NCT00183274|27225149|P3|Phase 1: Open-Label|Lack of Efficacy|0
7844785|NCT00183274|27225150|P2|Phase 1: Open-Label|Lack of Efficacy|0
7844786|NCT00183274|27225151|P1|Phase 1: Open-Label|Lack of Efficacy|13
7844787|NCT00183274|27225146|P6|Phase 1: Open-Label|Adverse Event|0
7844788|NCT00183274|27225147|P5|Phase 1: Open-Label|Adverse Event|0
7844789|NCT00183274|27225148|P4|Phase 1: Open-Label|Adverse Event|0
7844790|NCT00183274|27225149|P3|Phase 1: Open-Label|Adverse Event|0
7844791|NCT00183274|27225150|P2|Phase 1: Open-Label|Adverse Event|0
7844792|NCT00183274|27225151|P1|Phase 1: Open-Label|Adverse Event|31
7844793|NCT00183248|27225168|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
7844794|NCT00183248|27225169|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
7844795|NCT00183248|27225168|P2|Overall Study|Lost to Follow-up|1
7844796|NCT00183248|27225169|P1|Overall Study|Lost to Follow-up|0
7844797|NCT00183196|27225190|P3|Overall Study|Required more intensive care|2
7844798|NCT00183196|27225191|P2|Overall Study|Required more intensive care|1
7844799|NCT00183196|27225192|P1|Overall Study|Required more intensive care|0
7844800|NCT00183196|27225190|P3|Overall Study|Legal event|1
7844801|NCT00183196|27225191|P2|Overall Study|Legal event|1
7844802|NCT00183196|27225192|P1|Overall Study|Legal event|1
7844803|NCT00183196|27225190|P3|Overall Study|Adverse Event|2
7844804|NCT00183196|27225191|P2|Overall Study|Adverse Event|2
7844805|NCT00183196|27225192|P1|Overall Study|Adverse Event|1
7844806|NCT00183196|27225190|P3|Overall Study|Withdrawal by Subject|13
7844807|NCT00183196|27225191|P2|Overall Study|Withdrawal by Subject|11
7844808|NCT00183196|27225192|P1|Overall Study|Withdrawal by Subject|18
7844809|NCT00183170|27225202|P2|Second Intervention|Did not meet targeted BrAC|2
7844810|NCT00183170|27225203|P1|Second Intervention|Did not meet targeted BrAC|0
7844811|NCT00183170|27225202|P2|Second Intervention|Did not complete study|0
7844812|NCT00183170|27225203|P1|Second Intervention|Did not complete study|1
7844813|NCT00183170|27225202|P2|Washout 1 Week|Did not complete study|8
7844814|NCT00183170|27225203|P1|Washout 1 Week|Did not complete study|6
7844815|NCT00183170|27225202|P2|First Intervention|Did not meet targeted BrAC|0
7844816|NCT00183170|27225203|P1|First Intervention|Did not meet targeted BrAC|1
7844817|NCT00183170|27225202|P2|First Intervention|Did not complete study|0
7844818|NCT00183170|27225203|P1|First Intervention|Did not complete study|1
7844819|NCT00182689|27225292|P2|Overall Study|Never received treatment|0
7844820|NCT00182689|27225293|P1|Overall Study|Never received treatment|1
7844821|NCT00182689|27225292|P2|Overall Study|Ineligible|4
7844822|NCT00182689|27225293|P1|Overall Study|Ineligible|1
7844823|NCT00182689|27225292|P2|Overall Study|not protocol specified|3
7844824|NCT00182689|27225293|P1|Overall Study|not protocol specified|0
7844825|NCT00182689|27225292|P2|Overall Study|Death|0
7844826|NCT00182689|27225293|P1|Overall Study|Death|1
7844827|NCT00182689|27225292|P2|Overall Study|Progression|29
7844828|NCT00182689|27225293|P1|Overall Study|Progression|27
7844829|NCT00182689|27225292|P2|Overall Study|Withdrawal by Subject|2
7844830|NCT00182689|27225293|P1|Overall Study|Withdrawal by Subject|2
7844831|NCT00182689|27225292|P2|Overall Study|Adverse Event|11
7844832|NCT00182689|27225293|P1|Overall Study|Adverse Event|8
7844833|NCT00182637|27225303|P1|Overall Study|Disease Progression|1
7844834|NCT00182637|27225303|P1|Overall Study|Adverse Event|2
7844835|NCT00182325|27225311|P2|Overall Study|Did not complete survey|43
7844836|NCT00182325|27225312|P1|Overall Study|Did not complete survey|22
7844837|NCT00182325|27225311|P2|Overall Study|Miscarriage|3
7844838|NCT00182325|27225312|P1|Overall Study|Miscarriage|5
7844839|NCT00182325|27225311|P2|Overall Study|Lost to Follow-up|7
7844840|NCT00182325|27225312|P1|Overall Study|Lost to Follow-up|7
7844841|NCT00182091|27225340|P4|Overall Study|Withdrawal by Subject|0
7844842|NCT00182091|27225341|P3|Overall Study|Withdrawal by Subject|0
7844843|NCT00182091|27225342|P2|Overall Study|Withdrawal by Subject|0
7844844|NCT00182091|27225343|P1|Overall Study|Withdrawal by Subject|1
7844845|NCT00182078|27225359|P2|Overall Study|Withdrawal by Subject|0
7844846|NCT00182078|27225360|P1|Overall Study|Withdrawal by Subject|1
7844847|NCT00181883|27225388|P1|Overall Study|Lost to Follow-up|1
7844848|NCT00181883|27225388|P1|Overall Study|Withdrawal by Subject|4
7844849|NCT00181883|27225388|P1|Overall Study|Treatment Limiting AEs|3
7844850|NCT00181883|27225388|P1|Overall Study|Lack of Efficacy|2
7844851|NCT00181844|27225392|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
7844852|NCT00181844|27225392|P1|Exposed to Study Medication|Withdrawal by Subject|1
7844853|NCT00181844|27225392|P1|Exposed to Study Medication|Non-compliance|2
7844854|NCT00181844|27225392|P1|Exposed to Study Medication|Lack of Efficacy|2
7844855|NCT00181844|27225392|P1|Exposed to Study Medication|Adverse Event|10
7844856|NCT00181844|27225392|P1|Signed Consent|Did not meet entrance criteria|7
7844857|NCT00181844|27225392|P1|Signed Consent|Withdrawal by Subject|5
7844858|NCT00181766|27225396|P1|Overall Study|non-compliance|2
7844859|NCT00181766|27225396|P1|Overall Study|Adverse Event|4
7844860|NCT00181766|27225396|P1|Overall Study|Lost to Follow-up|6
7844861|NCT00181155|27225470|P2|Overall Study|Withdrawal by Subject|0
7844862|NCT00181155|27225471|P1|Overall Study|Withdrawal by Subject|1
7844863|NCT00181155|27225470|P2|Overall Study|Physician Decision|0
7844864|NCT00181155|27225471|P1|Overall Study|Physician Decision|1
7844865|NCT00180713|27225481|P2|Overall Study|Adverse Event|3
7844866|NCT00180713|27225482|P1|Overall Study|Adverse Event|3
7844867|NCT00180713|27225481|P2|Overall Study|Withdrawal by Subject|0
7844868|NCT00180713|27225482|P1|Overall Study|Withdrawal by Subject|2
7844869|NCT00180674|27225525|P1|Phase 2, Warfarin Treatment Period|Adverse Event|1
7844870|NCT00180674|27225525|P1|Phase 1, Observation Period|Withdrawal by Subject|4
7844871|NCT00180479|27225554|P2|Overall Study|Informed consent not signed|1
7844872|NCT00180479|27225555|P1|Overall Study|Informed consent not signed|0
7844873|NCT00180479|27225554|P2|Overall Study|Withdrawal by Subject|3
7844874|NCT00180479|27225555|P1|Overall Study|Withdrawal by Subject|3
7844875|NCT00180479|27225554|P2|Overall Study|Lost to Follow-up|7
7844876|NCT00180479|27225555|P1|Overall Study|Lost to Follow-up|9
7844877|NCT00180479|27225554|P2|Overall Study|Death|2
7844878|NCT00180479|27225555|P1|Overall Study|Death|4
7844879|NCT00179959|27225699|P2|Overall Study|Withdrawal by Subject|2
7844880|NCT00179959|27225700|P1|Overall Study|Withdrawal by Subject|3
7844881|NCT00179959|27225699|P2|Overall Study|Lost to Follow-up|1
7844882|NCT00179959|27225700|P1|Overall Study|Lost to Follow-up|3
7844883|NCT00179673|27225717|P1|Overall Study|Other Observations and options|14
7844884|NCT00179673|27225717|P1|Overall Study|Death|4
7844885|NCT00179673|27225717|P1|Overall Study|Withdrawal by Subject|3
7844886|NCT00179673|27225717|P1|Overall Study|Lack of Efficacy|15
7844887|NCT00179673|27225717|P1|Overall Study|Adverse Event|7
7844888|NCT00179660|27225725|P1|Overall Study|Other - Unspecified|9
7844889|NCT00179660|27225725|P1|Overall Study|Death|3
7844890|NCT00179660|27225725|P1|Overall Study|Lost to Follow-up|1
7844891|NCT00179660|27225725|P1|Overall Study|Withdrawal by Subject|2
7844892|NCT00179660|27225725|P1|Overall Study|Lack of therapeutic effect|28
7844893|NCT00179660|27225725|P1|Overall Study|Adverse Event|7
7844894|NCT00179647|27225734|P1|Overall Study|Other|960
7844895|NCT00179647|27225734|P1|Overall Study|Death|94
7844896|NCT00179647|27225734|P1|Overall Study|Lost to Follow-up|4
7844897|NCT00179647|27225734|P1|Overall Study|Withdrawal by Subject|83
7844898|NCT00179647|27225734|P1|Overall Study|Lack of Efficacy|478
7844899|NCT00179647|27225734|P1|Overall Study|Adverse Event|294
7844900|NCT00179621|27225741|P4|Open-Label Period|Other|2
7844901|NCT00179621|27225742|P3|Open-Label Period|Other|1
7844902|NCT00179621|27225743|P2|Open-Label Period|Other|1
7844903|NCT00179621|27225744|P1|Open-Label Period|Other|0
7844904|NCT00179621|27225741|P4|Open-Label Period|Death|2
7844905|NCT00179621|27225742|P3|Open-Label Period|Death|1
7844906|NCT00179621|27225743|P2|Open-Label Period|Death|0
7844907|NCT00179621|27225744|P1|Open-Label Period|Death|0
7844908|NCT00179621|27225741|P4|Open-Label Period|Withdrawal by Subject|2
7844909|NCT00179621|27225742|P3|Open-Label Period|Withdrawal by Subject|2
7844910|NCT00179621|27225743|P2|Open-Label Period|Withdrawal by Subject|2
7844911|NCT00179621|27225744|P1|Open-Label Period|Withdrawal by Subject|0
7844912|NCT00179621|27225741|P4|Open-Label Period|Adverse Event|6
7844913|NCT00179621|27225742|P3|Open-Label Period|Adverse Event|5
7844914|NCT00179621|27225743|P2|Open-Label Period|Adverse Event|6
7844915|NCT00179621|27225744|P1|Open-Label Period|Adverse Event|0
7844916|NCT00179621|27225741|P4|Open-Label Period|Lack of Therapeutic Effect|31
7844917|NCT00179621|27225742|P3|Open-Label Period|Lack of Therapeutic Effect|19
7844918|NCT00179621|27225743|P2|Open-Label Period|Lack of Therapeutic Effect|19
7844919|NCT00179621|27225744|P1|Open-Label Period|Lack of Therapeutic Effect|0
7844920|NCT00179621|27225741|P4|Double-Blind Period|Other|0
7844921|NCT00179621|27225742|P3|Double-Blind Period|Other|2
7844922|NCT00179621|27225743|P2|Double-Blind Period|Other|2
7844923|NCT00179621|27225744|P1|Double-Blind Period|Other|0
7844924|NCT00179621|27225741|P4|Double-Blind Period|Protocol Violation|0
7844925|NCT00179621|27225742|P3|Double-Blind Period|Protocol Violation|0
7844926|NCT00179621|27225743|P2|Double-Blind Period|Protocol Violation|0
7844927|NCT00179621|27225744|P1|Double-Blind Period|Protocol Violation|1
7844928|NCT00179621|27225741|P4|Double-Blind Period|Death|0
7844929|NCT00179621|27225742|P3|Double-Blind Period|Death|2
7844930|NCT00179621|27225743|P2|Double-Blind Period|Death|1
7844931|NCT00179621|27225744|P1|Double-Blind Period|Death|0
7844932|NCT00179621|27225741|P4|Double-Blind Period|Withdrawal by Subject|0
7844933|NCT00179621|27225742|P3|Double-Blind Period|Withdrawal by Subject|3
7844934|NCT00179621|27225743|P2|Double-Blind Period|Withdrawal by Subject|1
7844935|NCT00179621|27225744|P1|Double-Blind Period|Withdrawal by Subject|2
7844936|NCT00179621|27225741|P4|Double-Blind Period|Adverse Event|0
7844937|NCT00179621|27225742|P3|Double-Blind Period|Adverse Event|4
7844938|NCT00179621|27225743|P2|Double-Blind Period|Adverse Event|7
7844939|NCT00179621|27225744|P1|Double-Blind Period|Adverse Event|2
7844940|NCT00179621|27225741|P4|Double-Blind Period|Lack of Therapeutic Effect|0
7844941|NCT00179621|27225742|P3|Double-Blind Period|Lack of Therapeutic Effect|19
7844942|NCT00179621|27225743|P2|Double-Blind Period|Lack of Therapeutic Effect|35
7844943|NCT00179621|27225744|P1|Double-Blind Period|Lack of Therapeutic Effect|59
7844944|NCT00179517|27225797|P2|Overall Study|Withdrawal by Subject|1
7844945|NCT00179517|27225798|P1|Overall Study|Withdrawal by Subject|2
7844946|NCT00179413|27225836|P2|Overall Study|Withdrawal by Subject|95
7844947|NCT00179413|27225837|P1|Overall Study|Withdrawal by Subject|87
7844948|NCT00179413|27225836|P2|Overall Study|Adverse Event|20
7844949|NCT00179413|27225837|P1|Overall Study|Adverse Event|38
7844950|NCT00179309|27225849|P2|Treatment|Allergy|0
7844951|NCT00179309|27225850|P1|Treatment|Allergy|1
7844952|NCT00179309|27225849|P2|Treatment|Withdrawal by Subject|2
7844953|NCT00179309|27225850|P1|Treatment|Withdrawal by Subject|1
7844954|NCT00179309|27225849|P2|Treatment|Toxicity|3
7844955|NCT00179309|27225850|P1|Treatment|Toxicity|2
7844956|NCT00179010|27225873|P2|Overall Study|Failure to place arterial line|1
7844957|NCT00179010|27225874|P1|Overall Study|Failure to place arterial line|0
7844958|NCT00179010|27225873|P2|Overall Study|Muscle probe defective|1
7844959|NCT00179010|27225874|P1|Overall Study|Muscle probe defective|1
7844960|NCT00178685|27225913|P3|Overall Study|Withdrawal by Subject|7
7844961|NCT00178685|27225914|P2|Overall Study|Withdrawal by Subject|14
7844962|NCT00178685|27225915|P1|Overall Study|Withdrawal by Subject|8
7844963|NCT00178685|27225913|P3|Overall Study|Lost to Follow-up|183
7844964|NCT00178685|27225914|P2|Overall Study|Lost to Follow-up|187
7844965|NCT00178685|27225915|P1|Overall Study|Lost to Follow-up|100
7844966|NCT00178685|27225913|P3|Overall Study|Death|6
7844967|NCT00178685|27225914|P2|Overall Study|Death|3
7844968|NCT00178685|27225915|P1|Overall Study|Death|3
7844969|NCT00178633|27225957|P1|Overall Study|Lost to Follow-up|6
7844970|NCT00178464|27225987|P1|Overall Study|Physician Decision|1
7844971|NCT00178464|27225987|P1|Overall Study|Withdrawal by Subject|1
7844972|NCT00178399|27225992|P1|Overall Study|Lost to Follow-up|1
7844973|NCT00178399|27225992|P1|Overall Study|Withdrawal by Subject|8
7844974|NCT00178399|27225992|P1|Overall Study|Physician Decision|4
7844975|NCT00178256|27225999|P4|Overall Study|Cancer progression|1
7844976|NCT00178256|27226000|P3|Overall Study|Cancer progression|0
7844977|NCT00178256|27226001|P2|Overall Study|Cancer progression|0
7844978|NCT00178256|27226002|P1|Overall Study|Cancer progression|2
7844979|NCT00178256|27225999|P4|Overall Study|Death|1
7844980|NCT00178256|27226000|P3|Overall Study|Death|0
7844981|NCT00178256|27226001|P2|Overall Study|Death|1
7844982|NCT00178256|27226002|P1|Overall Study|Death|0
7844983|NCT00178256|27225999|P4|Overall Study|Adverse Event|0
7844984|NCT00178256|27226000|P3|Overall Study|Adverse Event|0
7844985|NCT00178256|27226001|P2|Overall Study|Adverse Event|0
7844986|NCT00178256|27226002|P1|Overall Study|Adverse Event|2
7844987|NCT00178126|27226041|P2|Overall Study|did not receive intervention|6
7844988|NCT00178126|27226042|P1|Overall Study|did not receive intervention|4
7844989|NCT00178126|27226041|P2|Overall Study|Lost to Follow-up|21
7844990|NCT00178126|27226042|P1|Overall Study|Lost to Follow-up|21
7844991|NCT00177671|27226084|P2|Overall Study|Physician Decision|8
7844992|NCT00177671|27226085|P1|Overall Study|Physician Decision|12
7844993|NCT00177671|27226084|P2|Overall Study|Adverse Event|0
7844994|NCT00177671|27226085|P1|Overall Study|Adverse Event|6
7844995|NCT00177671|27226084|P2|Overall Study|medical complications|0
7844996|NCT00177671|27226085|P1|Overall Study|medical complications|2
7844997|NCT00177671|27226084|P2|Overall Study|Withdrawal by Subject|6
7844998|NCT00177671|27226085|P1|Overall Study|Withdrawal by Subject|5
7844999|NCT00177307|27226097|P1|Overall Study|Withdrawal by Subject|1
7845000|NCT00177294|27226106|P2|Overall Study|Withdrawal by Subject|5
7845001|NCT00177294|27226107|P1|Overall Study|Withdrawal by Subject|7
7845002|NCT00177216|27226121|P3|Overall Study|Withdrawal by Subject|1
7845003|NCT00177216|27226122|P2|Overall Study|Withdrawal by Subject|3
7845004|NCT00177216|27226123|P1|Overall Study|Withdrawal by Subject|6
7845005|NCT00177164|27226139|P2|Overall Study|Pregnancy|1
7845006|NCT00177164|27226140|P1|Overall Study|Pregnancy|0
7845007|NCT00177164|27226139|P2|Overall Study|Lack of Efficacy|1
7845008|NCT00177164|27226140|P1|Overall Study|Lack of Efficacy|2
7845009|NCT00177164|27226139|P2|Overall Study|discharge from hospital|0
7845010|NCT00177164|27226140|P1|Overall Study|discharge from hospital|1
7845011|NCT00177164|27226139|P2|Overall Study|Adverse Event|0
7845012|NCT00177164|27226140|P1|Overall Study|Adverse Event|1
7845013|NCT00177164|27226139|P2|Overall Study|increase in alcohol and drug use|2
7845014|NCT00177164|27226140|P1|Overall Study|increase in alcohol and drug use|1
7845015|NCT00177164|27226139|P2|Overall Study|Lost to Follow-up|5
7845016|NCT00177164|27226140|P1|Overall Study|Lost to Follow-up|4
7845017|NCT00177164|27226139|P2|Overall Study|Protocol Violation|7
7845018|NCT00177164|27226140|P1|Overall Study|Protocol Violation|0
7845019|NCT00176644|27226418|P1|Overall Study|Withdrawal by Subject|1
7845020|NCT00176605|27226431|P1|Overall Study|Withdrawal by Subject|2
7845021|NCT00176488|27226442|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
7845022|NCT00176462|27226450|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
7845023|NCT00176462|27226451|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
7845024|NCT00176462|27226450|P2|Intensive Continuation (8X8-week Cycles)|Death|0
7845025|NCT00176462|27226451|P1|Intensive Continuation (8X8-week Cycles)|Death|1
7845026|NCT00176462|27226450|P2|Consolidation (12 Weeks)|Not documented|1
7845027|NCT00176462|27226451|P1|Consolidation (12 Weeks)|Not documented|0
7845028|NCT00176462|27226450|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
7845029|NCT00176462|27226451|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
7845030|NCT00176462|27226450|P2|Consolidation (12 Weeks)|Adverse Event|1
7845031|NCT00176462|27226451|P1|Consolidation (12 Weeks)|Adverse Event|0
7845032|NCT00176462|27226450|P2|Consolidation (12 Weeks)|Patient moved to another state|1
7845033|NCT00176462|27226451|P1|Consolidation (12 Weeks)|Patient moved to another state|0
7845034|NCT00176462|27226450|P2|Induction (4 Weeks)|Lack of Efficacy|1
7845035|NCT00176462|27226451|P1|Induction (4 Weeks)|Lack of Efficacy|0
7845036|NCT00176462|27226450|P2|Induction (4 Weeks)|Death|2
7845037|NCT00176462|27226451|P1|Induction (4 Weeks)|Death|1
7845038|NCT00176462|27226450|P2|Induction (4 Weeks)|Withdrawal by Subject|2
7845039|NCT00176462|27226451|P1|Induction (4 Weeks)|Withdrawal by Subject|0
7845040|NCT00176254|27226486|P1|Overall Study|Lost to Follow-up|1
7845041|NCT00175916|27226514|P1|Overall Study|Patient went to prison|1
7845042|NCT00175916|27226514|P1|Overall Study|Site was closed|9
7845043|NCT00175916|27226514|P1|Overall Study|Loss of job and economic burden|1
7845044|NCT00175916|27226514|P1|Overall Study|Moved overseas|1
7845045|NCT00175916|27226514|P1|Overall Study|Treating physiciant's choice|1
7845046|NCT00175916|27226514|P1|Overall Study|Patient's request|2
7845047|NCT00175916|27226514|P1|Overall Study|Pregnancy|1
7845048|NCT00175916|27226514|P1|Overall Study|Administrative reason|1
7845049|NCT00175916|27226514|P1|Overall Study|Seizure - free|4
7845050|NCT00175916|27226514|P1|Overall Study|Withdrawal by Subject|1
7845051|NCT00175916|27226514|P1|Overall Study|Suicidal behaviour|1
7845052|NCT00175916|27226514|P1|Overall Study|Vigabatrin intake|1
7845053|NCT00175916|27226514|P1|Overall Study|Sponsor decision|17
7845054|NCT00175916|27226514|P1|Overall Study|Patient cannot record seizures|1
7845055|NCT00175916|27226514|P1|Overall Study|Lack of compliance|8
7845056|NCT00175916|27226514|P1|Overall Study|Subject Choice|98
7845057|NCT00175916|27226514|P1|Overall Study|Lost to Follow-up|17
7845058|NCT00175916|27226514|P1|Overall Study|Lack of Efficacy|354
7845059|NCT00175916|27226514|P1|Overall Study|Adverse Event|81
7845060|NCT00175916|27226514|P1|Overall Study|Death|19
7845061|NCT00175877|27226523|P1|Overall Study|Withdrawal by subject & Other|1
7845062|NCT00175877|27226523|P1|Overall Study|AE & Other|1
7845063|NCT00175877|27226523|P1|Overall Study|Other Reason|20
7845064|NCT00175877|27226523|P1|Overall Study|Protocol Violation|15
7845065|NCT00175877|27226523|P1|Overall Study|Lack of Efficacy|26
7845066|NCT00175877|27226523|P1|Overall Study|Lost to Follow-up|9
7845067|NCT00175877|27226523|P1|Overall Study|Withdrawal by Subject|141
7845068|NCT00175877|27226523|P1|Overall Study|Adverse Event|136
7845069|NCT00175825|27226558|P4|Overall Study|Withdrawal by Subject|0
7845070|NCT00175825|27226559|P3|Overall Study|Withdrawal by Subject|0
7845071|NCT00175825|27226560|P2|Overall Study|Withdrawal by Subject|0
7845072|NCT00175825|27226561|P1|Overall Study|Withdrawal by Subject|1
7845073|NCT00175825|27226558|P4|Overall Study|Lost to Follow-up|0
7845074|NCT00175825|27226559|P3|Overall Study|Lost to Follow-up|0
7845075|NCT00175825|27226560|P2|Overall Study|Lost to Follow-up|2
7845076|NCT00175825|27226561|P1|Overall Study|Lost to Follow-up|1
7845077|NCT00175825|27226558|P4|Overall Study|Adverse Event|1
7845078|NCT00175825|27226559|P3|Overall Study|Adverse Event|1
7845079|NCT00175825|27226560|P2|Overall Study|Adverse Event|2
7845080|NCT00175825|27226561|P1|Overall Study|Adverse Event|3
7845081|NCT00175019|27226614|P3|Overall Study|Reason Not Specified|11
7845082|NCT00175019|27226615|P2|Overall Study|Reason Not Specified|34
7845083|NCT00175019|27226616|P1|Overall Study|Reason Not Specified|40
7845084|NCT00175019|27226614|P3|Overall Study|Gout Flare|0
7845085|NCT00175019|27226615|P2|Overall Study|Gout Flare|3
7845086|NCT00175019|27226616|P1|Overall Study|Gout Flare|2
7845087|NCT00175019|27226614|P3|Overall Study|Therapeutic Failure|22
7845088|NCT00175019|27226615|P2|Overall Study|Therapeutic Failure|38
7845089|NCT00175019|27226616|P1|Overall Study|Therapeutic Failure|10
7845090|NCT00175019|27226614|P3|Overall Study|Personal Reason(s)|8
7845091|NCT00175019|27226615|P2|Overall Study|Personal Reason(s)|31
7845092|NCT00175019|27226616|P1|Overall Study|Personal Reason(s)|39
7845093|NCT00175019|27226614|P3|Overall Study|Did not continue under Amendment 4|2
7845094|NCT00175019|27226615|P2|Overall Study|Did not continue under Amendment 4|1
7845095|NCT00175019|27226616|P1|Overall Study|Did not continue under Amendment 4|1
7845096|NCT00175019|27226614|P3|Overall Study|Lost to Follow-up|9
7845097|NCT00175019|27226615|P2|Overall Study|Lost to Follow-up|39
7845098|NCT00175019|27226616|P1|Overall Study|Lost to Follow-up|42
7845099|NCT00175019|27226614|P3|Overall Study|Protocol Violation|3
7845100|NCT00175019|27226615|P2|Overall Study|Protocol Violation|3
7845101|NCT00175019|27226616|P1|Overall Study|Protocol Violation|6
7845102|NCT00175019|27226614|P3|Overall Study|Adverse Event|2
7845103|NCT00175019|27226615|P2|Overall Study|Adverse Event|22
7845104|NCT00175019|27226616|P1|Overall Study|Adverse Event|54
7845105|NCT00174967|27226669|P4|Overall Study|Other|0
7845106|NCT00174967|27226670|P3|Overall Study|Other|0
7845107|NCT00174967|27226671|P2|Overall Study|Other|1
7845108|NCT00174967|27226672|P1|Overall Study|Other|0
7845109|NCT00174967|27226669|P4|Overall Study|Gout Flare|1
7845110|NCT00174967|27226670|P3|Overall Study|Gout Flare|0
7845111|NCT00174967|27226671|P2|Overall Study|Gout Flare|0
7845112|NCT00174967|27226672|P1|Overall Study|Gout Flare|0
7845113|NCT00174967|27226669|P4|Overall Study|Adverse Event|1
7845114|NCT00174967|27226670|P3|Overall Study|Adverse Event|2
7845115|NCT00174967|27226671|P2|Overall Study|Adverse Event|2
7845116|NCT00174967|27226672|P1|Overall Study|Adverse Event|1
7845117|NCT00174954|27226718|P1|Overall Study|Physician Decision|1
7845118|NCT00174954|27226718|P1|Overall Study|No tophi found in MRI|1
7845119|NCT00174954|27226718|P1|Overall Study|Adverse Event|2
7845120|NCT00174941|27226726|P4|Overall Study|Reason Not Specified|9
7845121|NCT00174941|27226727|P3|Overall Study|Reason Not Specified|2
7845122|NCT00174941|27226728|P2|Overall Study|Reason Not Specified|6
7845123|NCT00174941|27226729|P1|Overall Study|Reason Not Specified|1
7845124|NCT00174941|27226726|P4|Overall Study|Gout Flare|8
7845125|NCT00174941|27226727|P3|Overall Study|Gout Flare|4
7845126|NCT00174941|27226728|P2|Overall Study|Gout Flare|4
7845127|NCT00174941|27226729|P1|Overall Study|Gout Flare|0
7845128|NCT00174941|27226726|P4|Overall Study|Personal Reason(s)|22
7845129|NCT00174941|27226727|P3|Overall Study|Personal Reason(s)|8
7845130|NCT00174941|27226728|P2|Overall Study|Personal Reason(s)|14
7845131|NCT00174941|27226729|P1|Overall Study|Personal Reason(s)|0
7845132|NCT00174941|27226726|P4|Overall Study|Lost to Follow-up|5
7845133|NCT00174941|27226727|P3|Overall Study|Lost to Follow-up|2
7845134|NCT00174941|27226728|P2|Overall Study|Lost to Follow-up|3
7845135|NCT00174941|27226729|P1|Overall Study|Lost to Follow-up|0
7845136|NCT00174941|27226726|P4|Overall Study|Protocol Violation|1
7845137|NCT00174941|27226727|P3|Overall Study|Protocol Violation|0
7845138|NCT00174941|27226728|P2|Overall Study|Protocol Violation|1
7845139|NCT00174941|27226729|P1|Overall Study|Protocol Violation|0
7845140|NCT00174941|27226726|P4|Overall Study|Adverse Event|13
7845141|NCT00174941|27226727|P3|Overall Study|Adverse Event|2
7845142|NCT00174941|27226728|P2|Overall Study|Adverse Event|10
7845143|NCT00174941|27226729|P1|Overall Study|Adverse Event|1
7845144|NCT00174915|27226804|P5|Overall Study|Therapeutic Failure|3
7845145|NCT00174915|27226805|P4|Overall Study|Therapeutic Failure|1
7845146|NCT00174915|27226806|P3|Overall Study|Therapeutic Failure|2
7845147|NCT00174915|27226807|P2|Overall Study|Therapeutic Failure|3
7845148|NCT00174915|27226808|P1|Overall Study|Therapeutic Failure|6
7845149|NCT00174915|27226804|P5|Overall Study|Protocol Violation|3
7845150|NCT00174915|27226805|P4|Overall Study|Protocol Violation|6
7845151|NCT00174915|27226806|P3|Overall Study|Protocol Violation|3
7845152|NCT00174915|27226807|P2|Overall Study|Protocol Violation|3
7845153|NCT00174915|27226808|P1|Overall Study|Protocol Violation|6
7845154|NCT00174915|27226804|P5|Overall Study|Gout Flare|0
7845155|NCT00174915|27226805|P4|Overall Study|Gout Flare|1
7845156|NCT00174915|27226806|P3|Overall Study|Gout Flare|8
7845157|NCT00174915|27226807|P2|Overall Study|Gout Flare|6
7845158|NCT00174915|27226808|P1|Overall Study|Gout Flare|13
7845159|NCT00174915|27226804|P5|Overall Study|Other|3
7845160|NCT00174915|27226805|P4|Overall Study|Other|5
7845161|NCT00174915|27226806|P3|Overall Study|Other|6
7845162|NCT00174915|27226807|P2|Overall Study|Other|8
7845163|NCT00174915|27226808|P1|Overall Study|Other|15
7845164|NCT00174915|27226804|P5|Overall Study|Personal Reason(s)|9
7845165|NCT00174915|27226805|P4|Overall Study|Personal Reason(s)|9
7845166|NCT00174915|27226806|P3|Overall Study|Personal Reason(s)|9
7845167|NCT00174915|27226807|P2|Overall Study|Personal Reason(s)|16
7845168|NCT00174915|27226808|P1|Overall Study|Personal Reason(s)|16
7845169|NCT00174915|27226804|P5|Overall Study|Adverse Event|5
7845170|NCT00174915|27226805|P4|Overall Study|Adverse Event|18
7845171|NCT00174915|27226806|P3|Overall Study|Adverse Event|11
7845172|NCT00174915|27226807|P2|Overall Study|Adverse Event|16
7845173|NCT00174915|27226808|P1|Overall Study|Adverse Event|18
7845174|NCT00174915|27226804|P5|Overall Study|Lost to Follow-up|10
7845175|NCT00174915|27226805|P4|Overall Study|Lost to Follow-up|17
7845176|NCT00174915|27226806|P3|Overall Study|Lost to Follow-up|9
7845177|NCT00174915|27226807|P2|Overall Study|Lost to Follow-up|17
7845178|NCT00174915|27226808|P1|Overall Study|Lost to Follow-up|19
7845179|NCT00174785|27226867|P2|Overall Study|Not pre-specified/Not coded|70
7845180|NCT00174785|27226868|P1|Overall Study|Not pre-specified/Not coded|56
7845181|NCT00174785|27226867|P2|Overall Study|Family request|8
7845182|NCT00174785|27226868|P1|Overall Study|Family request|6
7845183|NCT00174785|27226867|P2|Overall Study|Other prohibited medication|3
7845184|NCT00174785|27226868|P1|Overall Study|Other prohibited medication|5
7845185|NCT00174785|27226867|P2|Overall Study|Prohibited antiarrhythmic medication|88
7845186|NCT00174785|27226868|P1|Overall Study|Prohibited antiarrhythmic medication|39
7845187|NCT00174785|27226867|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
7845188|NCT00174785|27226868|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
7845189|NCT00174785|27226867|P2|Overall Study|Withdrawal by Subject|175
7845190|NCT00174785|27226868|P1|Overall Study|Withdrawal by Subject|173
7845191|NCT00174785|27226867|P2|Overall Study|Protocol Violation|14
7845192|NCT00174785|27226868|P1|Overall Study|Protocol Violation|14
7845193|NCT00174785|27226867|P2|Overall Study|Adverse Event|191
7845194|NCT00174785|27226868|P1|Overall Study|Adverse Event|293
7845195|NCT00174460|27226884|P2|Overall Study|Withdrawal by Subject|1
7845196|NCT00174460|27226885|P1|Overall Study|Withdrawal by Subject|0
7845197|NCT00174447|27226931|P1|Overall Study|Administrative reason/Other|2
7845198|NCT00174447|27226931|P1|Overall Study|Lack of Efficacy|1
7845199|NCT00174447|27226931|P1|Overall Study|Protocol Violation|1
7845200|NCT00174447|27226931|P1|Overall Study|Withdrawal by Subject|15
7845201|NCT00174447|27226931|P1|Overall Study|Adverse Event|19
7845202|NCT00174382|27226940|P1|Overall Study|Lost to Follow-up|1
7845203|NCT00174382|27226940|P1|Overall Study|Subject felt pill not effective enough|1
7845204|NCT00174382|27226940|P1|Overall Study|Arrived early for last visit in error|1
7845205|NCT00174382|27226940|P1|Overall Study|Protocol Violation|3
7845206|NCT00174382|27226940|P1|Overall Study|Withdrawal by Subject|6
7845207|NCT00174382|27226940|P1|Overall Study|Adverse Event|19
7845208|NCT00174382|27226940|P1|Overall Study|Death|2
7845209|NCT00174291|27226959|P2|Overall Study|Withdrawal by Subject|3
7845210|NCT00174291|27226960|P1|Overall Study|Withdrawal by Subject|3
7845211|NCT00174291|27226959|P2|Overall Study|Study terminated by sponsor|0
7845212|NCT00174291|27226960|P1|Overall Study|Study terminated by sponsor|1
7845213|NCT00174291|27226959|P2|Overall Study|Protocol Violation|2
7845214|NCT00174291|27226960|P1|Overall Study|Protocol Violation|0
7845215|NCT00174291|27226959|P2|Overall Study|Lost to Follow-up|1
7845216|NCT00174291|27226960|P1|Overall Study|Lost to Follow-up|1
7845217|NCT00174265|27226990|P2|Overall Study|Other (Not specified)|10
7845218|NCT00174265|27226991|P1|Overall Study|Other (Not specified)|16
7845219|NCT00174265|27226990|P2|Overall Study|Lost to Follow-up|0
7845220|NCT00174265|27226991|P1|Overall Study|Lost to Follow-up|1
7845221|NCT00174265|27226990|P2|Overall Study|Withdrawal by Subject|5
7845222|NCT00174265|27226991|P1|Overall Study|Withdrawal by Subject|3
7845223|NCT00174265|27226990|P2|Overall Study|Lack of Efficacy|2
7845224|NCT00174265|27226991|P1|Overall Study|Lack of Efficacy|2
7845225|NCT00174265|27226990|P2|Overall Study|Adverse Event|4
7845226|NCT00174265|27226991|P1|Overall Study|Adverse Event|7
7845227|NCT00174252|27226999|P1|Overall Study|Protocol Violation|2
7845228|NCT00174187|27227034|P3|Period 2 (After 3 Years)|Other|5
7845229|NCT00174187|27227035|P2|Period 2 (After 3 Years)|Other|0
7845230|NCT00174187|27227036|P1|Period 2 (After 3 Years)|Other|0
7845231|NCT00174187|27227034|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
7845232|NCT00174187|27227035|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
7845233|NCT00174187|27227036|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
7845234|NCT00174187|27227034|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
7845235|NCT00174187|27227035|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
7845236|NCT00174187|27227036|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
7845237|NCT00174187|27227034|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
7845238|NCT00174187|27227035|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
7845239|NCT00174187|27227036|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
7845240|NCT00174187|27227034|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
7845241|NCT00174187|27227035|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
7845242|NCT00174187|27227036|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
7845243|NCT00174187|27227034|P3|Period 1 (up to 3 Years)|Other|0
7845244|NCT00174187|27227035|P2|Period 1 (up to 3 Years)|Other|1
7845245|NCT00174187|27227036|P1|Period 1 (up to 3 Years)|Other|0
7845246|NCT00174187|27227034|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
7845247|NCT00174187|27227035|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
7845248|NCT00174187|27227036|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
7845249|NCT00174187|27227034|P3|Period 1 (up to 3 Years)|Non compliance|0
7845250|NCT00174187|27227035|P2|Period 1 (up to 3 Years)|Non compliance|1
7845251|NCT00174187|27227036|P1|Period 1 (up to 3 Years)|Non compliance|0
7845252|NCT00174187|27227034|P3|Period 1 (up to 3 Years)|Serious adverse event|0
7845253|NCT00174187|27227035|P2|Period 1 (up to 3 Years)|Serious adverse event|1
7845254|NCT00174187|27227036|P1|Period 1 (up to 3 Years)|Serious adverse event|0
7845255|NCT00172185|27227101|P4|Overall Study|Withdrawal by Subject|0
7845256|NCT00172185|27227102|P3|Overall Study|Withdrawal by Subject|1
7845257|NCT00172185|27227103|P2|Overall Study|Withdrawal by Subject|0
7845258|NCT00172185|27227104|P1|Overall Study|Withdrawal by Subject|0
7845259|NCT00172185|27227101|P4|Overall Study|SPONSOR Decision|0
7845260|NCT00172185|27227102|P3|Overall Study|SPONSOR Decision|0
7845261|NCT00172185|27227103|P2|Overall Study|SPONSOR Decision|1
7845262|NCT00172185|27227104|P1|Overall Study|SPONSOR Decision|0
7845263|NCT00172185|27227101|P4|Overall Study|Physician Decision|0
7845264|NCT00172185|27227102|P3|Overall Study|Physician Decision|1
7845265|NCT00172185|27227103|P2|Overall Study|Physician Decision|0
7845266|NCT00172185|27227104|P1|Overall Study|Physician Decision|0
7845267|NCT00172185|27227101|P4|Overall Study|Adverse Event|4
7845268|NCT00172185|27227102|P3|Overall Study|Adverse Event|3
7845269|NCT00172185|27227103|P2|Overall Study|Adverse Event|1
7845270|NCT00172185|27227104|P1|Overall Study|Adverse Event|0
7845271|NCT00172042|27227120|P2|Overall Study|Death|42
7845272|NCT00172042|27227121|P1|Overall Study|Death|42
7845273|NCT00172042|27227120|P2|Overall Study|Administrative problems|10
7845274|NCT00172042|27227121|P1|Overall Study|Administrative problems|13
7845275|NCT00172042|27227120|P2|Overall Study|Lost to Follow-up|5
7845276|NCT00172042|27227121|P1|Overall Study|Lost to Follow-up|3
7845277|NCT00172042|27227120|P2|Overall Study|Withdrawal by Subject|25
7845278|NCT00172042|27227121|P1|Overall Study|Withdrawal by Subject|37
7845279|NCT00172042|27227120|P2|Overall Study|Protocol Violation|7
7845280|NCT00172042|27227121|P1|Overall Study|Protocol Violation|8
7845281|NCT00172042|27227120|P2|Overall Study|Patient no longer requires study drug|8
7845282|NCT00172042|27227121|P1|Overall Study|Patient no longer requires study drug|10
7845283|NCT00172042|27227120|P2|Overall Study|Unsatisfactory therapeutic effect|11
7845284|NCT00172042|27227121|P1|Overall Study|Unsatisfactory therapeutic effect|13
7845285|NCT00172042|27227120|P2|Overall Study|Abnormal test procedure(s)|3
7845286|NCT00172042|27227121|P1|Overall Study|Abnormal test procedure(s)|0
7845287|NCT00172042|27227120|P2|Overall Study|Abnormal laboratory value(s)|1
7845288|NCT00172042|27227121|P1|Overall Study|Abnormal laboratory value(s)|5
7845289|NCT00172042|27227120|P2|Overall Study|Adverse Event|13
7845290|NCT00172042|27227121|P1|Overall Study|Adverse Event|27
7845291|NCT00171951|27227141|P1|Overall Study|Reason not Specified|2
7845292|NCT00171951|27227141|P1|Overall Study|New Cancer Therapy|5
7845293|NCT00171951|27227141|P1|Overall Study|Participants Withdrew Consent|3
7845294|NCT00171951|27227141|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
7845295|NCT00171951|27227141|P1|Overall Study|Abnormal Laboratory Values|2
7845296|NCT00171951|27227141|P1|Overall Study|Adverse Event|1
7845297|NCT00171925|27227155|P2|Overall Study|Death|2
7845298|NCT00171925|27227156|P1|Overall Study|Death|1
7845299|NCT00171925|27227155|P2|Overall Study|Administrative problems|11
7845300|NCT00171925|27227156|P1|Overall Study|Administrative problems|10
7845301|NCT00171925|27227155|P2|Overall Study|Lost to Follow-up|2
7845302|NCT00171925|27227156|P1|Overall Study|Lost to Follow-up|2
7845303|NCT00171925|27227155|P2|Overall Study|Withdrawal by Subject|9
7845304|NCT00171925|27227156|P1|Overall Study|Withdrawal by Subject|6
7845305|NCT00171925|27227155|P2|Overall Study|Protocol Violation|1
7845306|NCT00171925|27227156|P1|Overall Study|Protocol Violation|1
7845307|NCT00171925|27227155|P2|Overall Study|Adverse Event|6
7845308|NCT00171925|27227156|P1|Overall Study|Adverse Event|10
7845309|NCT00171873|27227168|P2|Overall Study|Switched to Octreotide|1
7845310|NCT00171873|27227169|P1|Overall Study|Switched to Octreotide|0
7845311|NCT00171873|27227168|P2|Overall Study|Adverse Event|0
7845312|NCT00171873|27227169|P1|Overall Study|Adverse Event|5
7845313|NCT00171873|27227168|P2|Overall Study|Withdrawal by Subject|2
7845314|NCT00171873|27227169|P1|Overall Study|Withdrawal by Subject|4
7845315|NCT00171834|27227182|P7|Overall Study|Treatment Duration Completed|0
7845316|NCT00171834|27227183|P6|Overall Study|Treatment Duration Completed|1
7845317|NCT00171834|27227184|P5|Overall Study|Treatment Duration Completed|2
7845318|NCT00171834|27227185|P4|Overall Study|Treatment Duration Completed|0
7845319|NCT00171834|27227186|P3|Overall Study|Treatment Duration Completed|1
7845320|NCT00171834|27227187|P2|Overall Study|Treatment Duration Completed|0
7845321|NCT00171834|27227188|P1|Overall Study|Treatment Duration Completed|0
7845322|NCT00171834|27227182|P7|Overall Study|Disease Progression|3
7845323|NCT00171834|27227183|P6|Overall Study|Disease Progression|18
7845324|NCT00171834|27227184|P5|Overall Study|Disease Progression|2
7845325|NCT00171834|27227185|P4|Overall Study|Disease Progression|9
7845326|NCT00171834|27227186|P3|Overall Study|Disease Progression|8
7845327|NCT00171834|27227187|P2|Overall Study|Disease Progression|8
7845328|NCT00171834|27227188|P1|Overall Study|Disease Progression|4
7845329|NCT00171834|27227182|P7|Overall Study|Death from study indication|0
7845330|NCT00171834|27227183|P6|Overall Study|Death from study indication|0
7845331|NCT00171834|27227184|P5|Overall Study|Death from study indication|1
7845332|NCT00171834|27227185|P4|Overall Study|Death from study indication|0
7845333|NCT00171834|27227186|P3|Overall Study|Death from study indication|0
7845334|NCT00171834|27227187|P2|Overall Study|Death from study indication|1
7845335|NCT00171834|27227188|P1|Overall Study|Death from study indication|0
7845336|NCT00171834|27227182|P7|Overall Study|Withdrawal by Subject|0
7845337|NCT00171834|27227183|P6|Overall Study|Withdrawal by Subject|1
7845338|NCT00171834|27227184|P5|Overall Study|Withdrawal by Subject|1
7845339|NCT00171834|27227185|P4|Overall Study|Withdrawal by Subject|1
7845340|NCT00171834|27227186|P3|Overall Study|Withdrawal by Subject|0
7845341|NCT00171834|27227187|P2|Overall Study|Withdrawal by Subject|2
7845342|NCT00171834|27227188|P1|Overall Study|Withdrawal by Subject|0
7845343|NCT00171834|27227182|P7|Overall Study|Adverse Event|1
7845344|NCT00171834|27227183|P6|Overall Study|Adverse Event|15
7845345|NCT00171834|27227184|P5|Overall Study|Adverse Event|2
7845346|NCT00171834|27227185|P4|Overall Study|Adverse Event|2
7845347|NCT00171834|27227186|P3|Overall Study|Adverse Event|3
7845348|NCT00171834|27227187|P2|Overall Study|Adverse Event|1
7845349|NCT00171834|27227188|P1|Overall Study|Adverse Event|2
7845350|NCT00171730|27227226|P1|Overall Study|Withdrawal by Subject|3
7845351|NCT00171730|27227226|P1|Overall Study|Unsatisfactory Therapeutic Effect|8
7845352|NCT00171730|27227226|P1|Overall Study|Abnormal Laboratory Value(s)|1
7845353|NCT00171730|27227226|P1|Overall Study|Adverse Event|3
7845354|NCT00171704|27227244|P2|Overall Study|Protocol Violation|1
7845355|NCT00171704|27227245|P1|Overall Study|Protocol Violation|0
7845356|NCT00171704|27227244|P2|Overall Study|Withdrawal by Subject|3
7845357|NCT00171704|27227245|P1|Overall Study|Withdrawal by Subject|1
7845358|NCT00171704|27227244|P2|Overall Study|Death|2
7845359|NCT00171704|27227245|P1|Overall Study|Death|2
7845360|NCT00171704|27227244|P2|Overall Study|Administrative Problems|1
7845361|NCT00171704|27227245|P1|Overall Study|Administrative Problems|2
7845362|NCT00171704|27227244|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
7845363|NCT00171704|27227245|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
7845364|NCT00171704|27227244|P2|Overall Study|Disease Progression|9
7845365|NCT00171704|27227245|P1|Overall Study|Disease Progression|14
7845366|NCT00171704|27227244|P2|Overall Study|Adverse Event|33
7845367|NCT00171704|27227245|P1|Overall Study|Adverse Event|24
7845368|NCT00171340|27227267|P2|Overall Study|Death|6
7845369|NCT00171340|27227268|P1|Overall Study|Death|6
7845370|NCT00171340|27227267|P2|Overall Study|Administrative Problems|2
7845371|NCT00171340|27227268|P1|Overall Study|Administrative Problems|5
7845372|NCT00171340|27227267|P2|Overall Study|No Longer Required Study Drug|1
7845373|NCT00171340|27227268|P1|Overall Study|No Longer Required Study Drug|1
7845374|NCT00171340|27227267|P2|Overall Study|Abnormal Test Procedure Results|11
7845375|NCT00171340|27227268|P1|Overall Study|Abnormal Test Procedure Results|6
7845376|NCT00171340|27227267|P2|Overall Study|Abnormal Laboratory Results|0
7845377|NCT00171340|27227268|P1|Overall Study|Abnormal Laboratory Results|2
7845378|NCT00171340|27227267|P2|Overall Study|Lost to Follow-up|5
7845379|NCT00171340|27227268|P1|Overall Study|Lost to Follow-up|0
7845380|NCT00171340|27227267|P2|Overall Study|Withdrawal by Subject|19
7845381|NCT00171340|27227268|P1|Overall Study|Withdrawal by Subject|22
7845382|NCT00171340|27227267|P2|Overall Study|Protocol Violation|8
7845383|NCT00171340|27227268|P1|Overall Study|Protocol Violation|7
7845384|NCT00171340|27227267|P2|Overall Study|Lack of Efficacy|41
7845385|NCT00171340|27227268|P1|Overall Study|Lack of Efficacy|29
7845386|NCT00171340|27227267|P2|Overall Study|Adverse Event|42
7845387|NCT00171340|27227268|P1|Overall Study|Adverse Event|46
7845388|NCT00171314|27227284|P2|Overall Study|Death|1
7845389|NCT00171314|27227285|P1|Overall Study|Death|2
7845390|NCT00171314|27227284|P2|Overall Study|Lost to Follow-up|3
7845391|NCT00171314|27227285|P1|Overall Study|Lost to Follow-up|1
7845392|NCT00171314|27227284|P2|Overall Study|Administrative Problems|3
7845393|NCT00171314|27227285|P1|Overall Study|Administrative Problems|4
7845394|NCT00171314|27227284|P2|Overall Study|Protocol Violation|7
7845395|NCT00171314|27227285|P1|Overall Study|Protocol Violation|3
7845396|NCT00171314|27227284|P2|Overall Study|Abnormal Test Procedure Results|3
7845397|NCT00171314|27227285|P1|Overall Study|Abnormal Test Procedure Results|9
7845398|NCT00171314|27227284|P2|Overall Study|Withdrawal by Subject|6
7845399|NCT00171314|27227285|P1|Overall Study|Withdrawal by Subject|9
7845400|NCT00171314|27227284|P2|Overall Study|Lack of Efficacy|14
7845401|NCT00171314|27227285|P1|Overall Study|Lack of Efficacy|19
7845402|NCT00171314|27227284|P2|Overall Study|Adverse Event|41
7845403|NCT00171314|27227285|P1|Overall Study|Adverse Event|44
7845404|NCT00171301|27227301|P2|Overall Study|Withdrawal by Subject|1
7845405|NCT00171301|27227302|P1|Overall Study|Withdrawal by Subject|0
7845406|NCT00171301|27227301|P2|Overall Study|Protocol Violation|2
7845407|NCT00171301|27227302|P1|Overall Study|Protocol Violation|0
7845408|NCT00171301|27227301|P2|Overall Study|Lost to Follow-up|2
7845409|NCT00171301|27227302|P1|Overall Study|Lost to Follow-up|6
7845410|NCT00171301|27227301|P2|Overall Study|Adverse Event|2
7845411|NCT00171301|27227302|P1|Overall Study|Adverse Event|1
7845412|NCT00171301|27227301|P2|Overall Study|Death|2
7845413|NCT00171301|27227302|P1|Overall Study|Death|1
7845414|NCT00171249|27227313|P7|Overall Study|Lost to Follow-up|0
7845415|NCT00171249|27227314|P6|Overall Study|Lost to Follow-up|0
7845416|NCT00171249|27227315|P5|Overall Study|Lost to Follow-up|0
7845417|NCT00171249|27227316|P4|Overall Study|Lost to Follow-up|9
7845418|NCT00171249|27227317|P3|Overall Study|Lost to Follow-up|0
7845419|NCT00171249|27227318|P2|Overall Study|Lost to Follow-up|0
7845420|NCT00171249|27227319|P1|Overall Study|Lost to Follow-up|5
7845421|NCT00171249|27227313|P7|Overall Study|Adverse Event|0
7845422|NCT00171249|27227314|P6|Overall Study|Adverse Event|2
7845423|NCT00171249|27227315|P5|Overall Study|Adverse Event|0
7845424|NCT00171249|27227316|P4|Overall Study|Adverse Event|15
7845425|NCT00171249|27227317|P3|Overall Study|Adverse Event|0
7845426|NCT00171249|27227318|P2|Overall Study|Adverse Event|1
7845427|NCT00171249|27227319|P1|Overall Study|Adverse Event|3
7845428|NCT00171249|27227313|P7|Overall Study|Administrative Problems|0
7845429|NCT00171249|27227314|P6|Overall Study|Administrative Problems|0
7845430|NCT00171249|27227315|P5|Overall Study|Administrative Problems|0
7845431|NCT00171249|27227316|P4|Overall Study|Administrative Problems|2
7845432|NCT00171249|27227317|P3|Overall Study|Administrative Problems|0
7845433|NCT00171249|27227318|P2|Overall Study|Administrative Problems|0
7845434|NCT00171249|27227319|P1|Overall Study|Administrative Problems|1
7845435|NCT00171249|27227313|P7|Overall Study|No Longer Requires Study Drug|0
7845436|NCT00171249|27227314|P6|Overall Study|No Longer Requires Study Drug|5
7845437|NCT00171249|27227315|P5|Overall Study|No Longer Requires Study Drug|0
7845438|NCT00171249|27227316|P4|Overall Study|No Longer Requires Study Drug|3
7845439|NCT00171249|27227317|P3|Overall Study|No Longer Requires Study Drug|0
7845440|NCT00171249|27227318|P2|Overall Study|No Longer Requires Study Drug|0
7845441|NCT00171249|27227319|P1|Overall Study|No Longer Requires Study Drug|4
7845442|NCT00171249|27227313|P7|Overall Study|Other|0
7845443|NCT00171249|27227314|P6|Overall Study|Other|2
7845444|NCT00171249|27227315|P5|Overall Study|Other|0
7845445|NCT00171249|27227316|P4|Overall Study|Other|43
7845446|NCT00171249|27227317|P3|Overall Study|Other|0
7845447|NCT00171249|27227318|P2|Overall Study|Other|0
7845448|NCT00171249|27227319|P1|Overall Study|Other|10
7845449|NCT00171249|27227313|P7|Overall Study|Death|1
7845450|NCT00171249|27227314|P6|Overall Study|Death|3
7845451|NCT00171249|27227315|P5|Overall Study|Death|0
7845452|NCT00171249|27227316|P4|Overall Study|Death|4
7845453|NCT00171249|27227317|P3|Overall Study|Death|0
7845454|NCT00171249|27227318|P2|Overall Study|Death|1
7845455|NCT00171249|27227319|P1|Overall Study|Death|7
7845456|NCT00171249|27227313|P7|Overall Study|Unsatisfactory Therapeutic Effect|1
7845457|NCT00171249|27227314|P6|Overall Study|Unsatisfactory Therapeutic Effect|31
7845458|NCT00171249|27227315|P5|Overall Study|Unsatisfactory Therapeutic Effect|3
7845459|NCT00171249|27227316|P4|Overall Study|Unsatisfactory Therapeutic Effect|70
7845460|NCT00171249|27227317|P3|Overall Study|Unsatisfactory Therapeutic Effect|5
7845461|NCT00171249|27227318|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
7845462|NCT00171249|27227319|P1|Overall Study|Unsatisfactory Therapeutic Effect|44
7845463|NCT00171249|27227313|P7|Overall Study|Withdrawal by Subject|0
7845464|NCT00171249|27227314|P6|Overall Study|Withdrawal by Subject|0
7845465|NCT00171249|27227315|P5|Overall Study|Withdrawal by Subject|0
7845466|NCT00171249|27227316|P4|Overall Study|Withdrawal by Subject|6
7845467|NCT00171249|27227317|P3|Overall Study|Withdrawal by Subject|0
7845468|NCT00171249|27227318|P2|Overall Study|Withdrawal by Subject|0
7845469|NCT00171249|27227319|P1|Overall Study|Withdrawal by Subject|2
7845470|NCT00171223|27227341|P3|Overall Study|Not Specified (No Data Collected After Cut-off)|58
7845471|NCT00171223|27227342|P2|Overall Study|Not Specified (No Data Collected After Cut-off)|47
7845472|NCT00171223|27227343|P1|Overall Study|Not Specified (No Data Collected After Cut-off)|41
7845473|NCT00171223|27227341|P3|Overall Study|Adverse Event (Serious Fatal)|9
7845474|NCT00171223|27227342|P2|Overall Study|Adverse Event (Serious Fatal)|8
7845475|NCT00171223|27227343|P1|Overall Study|Adverse Event (Serious Fatal)|6
7845476|NCT00171223|27227341|P3|Overall Study|Administrative Problems|6
7845477|NCT00171223|27227342|P2|Overall Study|Administrative Problems|7
7845478|NCT00171223|27227343|P1|Overall Study|Administrative Problems|4
7845479|NCT00171223|27227341|P3|Overall Study|Lost to Follow-up|3
7845480|NCT00171223|27227342|P2|Overall Study|Lost to Follow-up|2
7845481|NCT00171223|27227343|P1|Overall Study|Lost to Follow-up|5
7845482|NCT00171223|27227341|P3|Overall Study|Participant Withdrew Consent|15
7845483|NCT00171223|27227342|P2|Overall Study|Participant Withdrew Consent|21
7845484|NCT00171223|27227343|P1|Overall Study|Participant Withdrew Consent|12
7845485|NCT00171223|27227341|P3|Overall Study|Protocol Violation|3
7845486|NCT00171223|27227342|P2|Overall Study|Protocol Violation|2
7845487|NCT00171223|27227343|P1|Overall Study|Protocol Violation|2
7845488|NCT00171223|27227341|P3|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
7845489|NCT00171223|27227342|P2|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
7845490|NCT00171223|27227343|P1|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
7845491|NCT00171223|27227341|P3|Overall Study|Unsatisfactory Therapeutic Effect|52
7845492|NCT00171223|27227342|P2|Overall Study|Unsatisfactory Therapeutic Effect|43
7845493|NCT00171223|27227343|P1|Overall Study|Unsatisfactory Therapeutic Effect|57
7845494|NCT00171223|27227341|P3|Overall Study|Abnormal Procedure|0
7845495|NCT00171223|27227342|P2|Overall Study|Abnormal Procedure|0
7845496|NCT00171223|27227343|P1|Overall Study|Abnormal Procedure|1
7845497|NCT00171223|27227341|P3|Overall Study|Abnormal Laboratory Value (s)|3
7845498|NCT00171223|27227342|P2|Overall Study|Abnormal Laboratory Value (s)|2
7845499|NCT00171223|27227343|P1|Overall Study|Abnormal Laboratory Value (s)|4
7845500|NCT00171223|27227341|P3|Overall Study|Adverse Event (Non-fatal)|19
7845501|NCT00171223|27227342|P2|Overall Study|Adverse Event (Non-fatal)|5
7845502|NCT00171223|27227343|P1|Overall Study|Adverse Event (Non-fatal)|6
7845503|NCT00171210|27227369|P2|Overall Study|Stopped at end of extension 1|1
7845504|NCT00171210|27227370|P1|Overall Study|Stopped at end of extension 1|0
7845505|NCT00171210|27227369|P2|Overall Study|Stopped at end of core|32
7845506|NCT00171210|27227370|P1|Overall Study|Stopped at end of core|0
7845507|NCT00171210|27227369|P2|Overall Study|Death|3
7845508|NCT00171210|27227370|P1|Overall Study|Death|2
7845509|NCT00171210|27227369|P2|Overall Study|Administrative problems|1
7845510|NCT00171210|27227370|P1|Overall Study|Administrative problems|1
7845511|NCT00171210|27227369|P2|Overall Study|Lost to Follow-up|0
7845512|NCT00171210|27227370|P1|Overall Study|Lost to Follow-up|1
7845513|NCT00171210|27227369|P2|Overall Study|Withdrawal by Subject|30
7845514|NCT00171210|27227370|P1|Overall Study|Withdrawal by Subject|32
7845515|NCT00171210|27227369|P2|Overall Study|Protocol Violation|2
7845516|NCT00171210|27227370|P1|Overall Study|Protocol Violation|0
7845517|NCT00171210|27227369|P2|Overall Study|Unsatisfactory therapeutic effect|15
7845518|NCT00171210|27227370|P1|Overall Study|Unsatisfactory therapeutic effect|11
7845519|NCT00171210|27227369|P2|Overall Study|Abnormal test procedure result(s)|1
7845520|NCT00171210|27227370|P1|Overall Study|Abnormal test procedure result(s)|0
7845521|NCT00171210|27227369|P2|Overall Study|Abnormal laboratory value(s)|3
7845522|NCT00171210|27227370|P1|Overall Study|Abnormal laboratory value(s)|6
7845523|NCT00171210|27227369|P2|Overall Study|Adverse Event|27
7845524|NCT00171210|27227370|P1|Overall Study|Adverse Event|16
7845525|NCT00171158|27227398|P1|E2 Extension|Other|7
7845526|NCT00171158|27227398|P1|Core Study|Lost to Follow-up|1
7845527|NCT00171158|27227398|P1|Core Study|Abnormal Laboratory Values|2
7845528|NCT00171158|27227398|P1|Core Study|No longer required drug (BMT)|14
7845529|NCT00171158|27227398|P1|Core Study|Consent withdrawn by subject|6
7845530|NCT00171158|27227398|P1|Core Study|Adverse event, non-fatal|21
7845531|NCT00171158|27227398|P1|Core Study|Administrative problems|1
7845532|NCT00171158|27227398|P1|Core Study|Protocol Violation|4
7845533|NCT00171158|27227398|P1|Core Study|Unsatisfactory therapeutic effect|163
7845534|NCT00171158|27227398|P1|Core Study|Death|27
7845535|NCT00171054|27227405|P2|Overall Study|Condition no longer required study drug|1
7845536|NCT00171054|27227406|P1|Overall Study|Condition no longer required study drug|0
7845537|NCT00171054|27227405|P2|Overall Study|Adverse Event|8
7845538|NCT00171054|27227406|P1|Overall Study|Adverse Event|8
7845539|NCT00171054|27227405|P2|Overall Study|Lost to Follow-up|1
7845540|NCT00171054|27227406|P1|Overall Study|Lost to Follow-up|0
7845541|NCT00171054|27227405|P2|Overall Study|Patient withdrew consent|0
7845542|NCT00171054|27227406|P1|Overall Study|Patient withdrew consent|1
7845543|NCT00171054|27227405|P2|Overall Study|Protocol Violation|2
7845544|NCT00171054|27227406|P1|Overall Study|Protocol Violation|1
7845545|NCT00170950|27227438|P2|Overall Study|Termination Data Not Recorded|22
7845546|NCT00170950|27227439|P1|Overall Study|Termination Data Not Recorded|17
7845547|NCT00170950|27227438|P2|Overall Study|Missing|1
7845548|NCT00170950|27227439|P1|Overall Study|Missing|2
7845549|NCT00170950|27227438|P2|Overall Study|Lost to Follow-up|115
7845550|NCT00170950|27227439|P1|Overall Study|Lost to Follow-up|134
7845551|NCT00170950|27227438|P2|Overall Study|Withdrawal by Subject|498
7845552|NCT00170950|27227439|P1|Overall Study|Withdrawal by Subject|496
7845553|NCT00170950|27227438|P2|Overall Study|Death|274
7845554|NCT00170950|27227439|P1|Overall Study|Death|236
7845555|NCT00170846|27227452|P3|Overall Study|Reason Missing|0
7845556|NCT00170846|27227453|P2|Overall Study|Reason Missing|1
7845557|NCT00170846|27227454|P1|Overall Study|Reason Missing|0
7845558|NCT00170846|27227452|P3|Overall Study|Death|3
7845559|NCT00170846|27227453|P2|Overall Study|Death|3
7845560|NCT00170846|27227454|P1|Overall Study|Death|0
7845561|NCT00170846|27227452|P3|Overall Study|Lost to Follow-up|2
7845562|NCT00170846|27227453|P2|Overall Study|Lost to Follow-up|3
7845563|NCT00170846|27227454|P1|Overall Study|Lost to Follow-up|6
7845564|NCT00170846|27227452|P3|Overall Study|Subject withdrew Informed Consent|8
7845565|NCT00170846|27227453|P2|Overall Study|Subject withdrew Informed Consent|12
7845566|NCT00170846|27227454|P1|Overall Study|Subject withdrew Informed Consent|5
7845567|NCT00169442|27227486|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
7845568|NCT00169442|27227487|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
7845569|NCT00169442|27227488|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
7845570|NCT00169442|27227489|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
7845571|NCT00169442|27227490|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
7845572|NCT00169442|27227491|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
7845573|NCT00169442|27227486|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
7845574|NCT00169442|27227487|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
7845575|NCT00169442|27227488|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
7845576|NCT00169442|27227489|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
7845577|NCT00169442|27227490|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
7845578|NCT00169442|27227491|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
7845579|NCT00169442|27227486|P6|Overall Study|Migrated/moved from study area|2
7845580|NCT00169442|27227487|P5|Overall Study|Migrated/moved from study area|0
7845581|NCT00169442|27227488|P4|Overall Study|Migrated/moved from study area|0
7845582|NCT00169442|27227489|P3|Overall Study|Migrated/moved from study area|0
7845583|NCT00169442|27227490|P2|Overall Study|Migrated/moved from study area|0
7845584|NCT00169442|27227491|P1|Overall Study|Migrated/moved from study area|0
7845585|NCT00169442|27227486|P6|Overall Study|Withdrawal by Subject|0
7845586|NCT00169442|27227487|P5|Overall Study|Withdrawal by Subject|0
7845587|NCT00169442|27227488|P4|Overall Study|Withdrawal by Subject|0
7845588|NCT00169442|27227489|P3|Overall Study|Withdrawal by Subject|1
7845589|NCT00169442|27227490|P2|Overall Study|Withdrawal by Subject|0
7845590|NCT00169442|27227491|P1|Overall Study|Withdrawal by Subject|0
7845591|NCT00169104|27227600|P2|Overall Study|Physician Decision|1
7845592|NCT00169104|27227601|P1|Overall Study|Physician Decision|0
7845593|NCT00169104|27227600|P2|Overall Study|Protocol Violation|1
7845594|NCT00169104|27227601|P1|Overall Study|Protocol Violation|0
7845595|NCT00169104|27227600|P2|Overall Study|Withdrawal by Subject|0
7845596|NCT00169104|27227601|P1|Overall Study|Withdrawal by Subject|2
7845597|NCT00168844|27227615|P3|Overall Study|Other|9
7845598|NCT00168844|27227616|P2|Overall Study|Other|7
7845599|NCT00168844|27227617|P1|Overall Study|Other|6
7845600|NCT00168844|27227615|P3|Overall Study|Protocol Violation|4
7845601|NCT00168844|27227616|P2|Overall Study|Protocol Violation|2
7845602|NCT00168844|27227617|P1|Overall Study|Protocol Violation|2
7845603|NCT00168844|27227615|P3|Overall Study|Withdrawal by Subject|19
7845604|NCT00168844|27227616|P2|Overall Study|Withdrawal by Subject|9
7845605|NCT00168844|27227617|P1|Overall Study|Withdrawal by Subject|12
7845606|NCT00168844|27227615|P3|Overall Study|Lost to Follow-up|11
7845607|NCT00168844|27227616|P2|Overall Study|Lost to Follow-up|5
7845608|NCT00168844|27227617|P1|Overall Study|Lost to Follow-up|4
7845609|NCT00168844|27227615|P3|Overall Study|Adverse Event|48
7845610|NCT00168844|27227616|P2|Overall Study|Adverse Event|32
7845611|NCT00168844|27227617|P1|Overall Study|Adverse Event|31
7845612|NCT00168831|27227799|P3|Overall Study|Other|6
7845613|NCT00168831|27227800|P2|Overall Study|Other|3
7845614|NCT00168831|27227801|P1|Overall Study|Other|6
7845615|NCT00168831|27227799|P3|Overall Study|Protocol Violation|11
7845616|NCT00168831|27227800|P2|Overall Study|Protocol Violation|11
7845617|NCT00168831|27227801|P1|Overall Study|Protocol Violation|6
7845618|NCT00168831|27227799|P3|Overall Study|Withdrawal by Subject|19
7845619|NCT00168831|27227800|P2|Overall Study|Withdrawal by Subject|14
7845620|NCT00168831|27227801|P1|Overall Study|Withdrawal by Subject|7
7845621|NCT00168831|27227799|P3|Overall Study|Lost to Follow-up|4
7845622|NCT00168831|27227800|P2|Overall Study|Lost to Follow-up|6
7845623|NCT00168831|27227801|P1|Overall Study|Lost to Follow-up|5
7845624|NCT00168831|27227799|P3|Overall Study|Adverse Event|74
7845625|NCT00168831|27227800|P2|Overall Study|Adverse Event|47
7845626|NCT00168831|27227801|P1|Overall Study|Adverse Event|36
7845627|NCT00168818|27227983|P3|Treatment|Other|31
7845628|NCT00168818|27227984|P2|Treatment|Other|29
7845629|NCT00168818|27227985|P1|Treatment|Other|23
7845630|NCT00168818|27227983|P3|Treatment|Withdrawal by Subject|22
7845631|NCT00168818|27227984|P2|Treatment|Withdrawal by Subject|20
7845632|NCT00168818|27227985|P1|Treatment|Withdrawal by Subject|25
7845633|NCT00168818|27227983|P3|Treatment|Lost to Follow-up|1
7845634|NCT00168818|27227984|P2|Treatment|Lost to Follow-up|2
7845635|NCT00168818|27227985|P1|Treatment|Lost to Follow-up|0
7845636|NCT00168818|27227983|P3|Treatment|Protocol Violation|11
7845637|NCT00168818|27227984|P2|Treatment|Protocol Violation|11
7845638|NCT00168818|27227985|P1|Treatment|Protocol Violation|8
7845639|NCT00168818|27227983|P3|Treatment|Adverse Event|68
7845640|NCT00168818|27227984|P2|Treatment|Adverse Event|89
7845641|NCT00168818|27227985|P1|Treatment|Adverse Event|77
7845642|NCT00168818|27227983|P3|Overall Study|Other|30
7845643|NCT00168818|27227984|P2|Overall Study|Other|24
7845644|NCT00168818|27227985|P1|Overall Study|Other|22
7845645|NCT00168818|27227983|P3|Overall Study|Withdrawal by Subject|37
7845646|NCT00168818|27227984|P2|Overall Study|Withdrawal by Subject|41
7845647|NCT00168818|27227985|P1|Overall Study|Withdrawal by Subject|43
7845648|NCT00168818|27227983|P3|Overall Study|Lost to Follow-up|15
7845649|NCT00168818|27227984|P2|Overall Study|Lost to Follow-up|4
7845650|NCT00168818|27227985|P1|Overall Study|Lost to Follow-up|13
7845651|NCT00168818|27227983|P3|Overall Study|Protocol Violation|11
7845652|NCT00168818|27227984|P2|Overall Study|Protocol Violation|11
7845653|NCT00168818|27227985|P1|Overall Study|Protocol Violation|16
7845654|NCT00168818|27227983|P3|Overall Study|Adverse Event|31
7845655|NCT00168818|27227984|P2|Overall Study|Adverse Event|29
7845656|NCT00168818|27227985|P1|Overall Study|Adverse Event|23
7845657|NCT00168805|27228029|P3|Treatment|Other|17
7845658|NCT00168805|27228030|P2|Treatment|Other|18
7845659|NCT00168805|27228031|P1|Treatment|Other|18
7845660|NCT00168805|27228029|P3|Treatment|Withdrawal by Subject|8
7845661|NCT00168805|27228030|P2|Treatment|Withdrawal by Subject|7
7845662|NCT00168805|27228031|P1|Treatment|Withdrawal by Subject|3
7845663|NCT00168805|27228029|P3|Treatment|Protocol Violation|5
7845664|NCT00168805|27228030|P2|Treatment|Protocol Violation|5
7845665|NCT00168805|27228031|P1|Treatment|Protocol Violation|3
7845666|NCT00168805|27228029|P3|Treatment|Adverse Event|32
7845667|NCT00168805|27228030|P2|Treatment|Adverse Event|26
7845668|NCT00168805|27228031|P1|Treatment|Adverse Event|25
7845669|NCT00168805|27228029|P3|Overall Study|Other|22
7845670|NCT00168805|27228030|P2|Overall Study|Other|21
7845671|NCT00168805|27228031|P1|Overall Study|Other|24
7845672|NCT00168805|27228029|P3|Overall Study|Withdrawal by Subject|21
7845673|NCT00168805|27228030|P2|Overall Study|Withdrawal by Subject|18
7845674|NCT00168805|27228031|P1|Overall Study|Withdrawal by Subject|16
7845675|NCT00168805|27228029|P3|Overall Study|Lost to Follow-up|11
7845676|NCT00168805|27228030|P2|Overall Study|Lost to Follow-up|17
7845677|NCT00168805|27228031|P1|Overall Study|Lost to Follow-up|12
7845678|NCT00168805|27228029|P3|Overall Study|Protocol Violation|8
7845679|NCT00168805|27228030|P2|Overall Study|Protocol Violation|11
7845680|NCT00168805|27228031|P1|Overall Study|Protocol Violation|12
7845681|NCT00168805|27228029|P3|Overall Study|Adverse Event|16
7845682|NCT00168805|27228030|P2|Overall Study|Adverse Event|11
7845683|NCT00168805|27228031|P1|Overall Study|Adverse Event|7
7845684|NCT00168103|27228267|P4|Overall Study|Lost to Follow-up|0
7845685|NCT00168103|27228268|P3|Overall Study|Lost to Follow-up|0
7845686|NCT00168103|27228269|P2|Overall Study|Lost to Follow-up|3
7845687|NCT00168103|27228270|P1|Overall Study|Lost to Follow-up|1
7845688|NCT00168103|27228267|P4|Overall Study|Withdrawal by Subject|0
7845689|NCT00168103|27228268|P3|Overall Study|Withdrawal by Subject|1
7845690|NCT00168103|27228269|P2|Overall Study|Withdrawal by Subject|2
7845691|NCT00168103|27228270|P1|Overall Study|Withdrawal by Subject|1
7845692|NCT00168064|27228292|P2|Overall Study|Various|3
7845693|NCT00168064|27228293|P1|Overall Study|Various|4
7845694|NCT00168064|27228292|P2|Overall Study|Subject's Best interest|2
7845695|NCT00168064|27228293|P1|Overall Study|Subject's Best interest|2
7845696|NCT00168064|27228292|P2|Overall Study|Concurrent Illness|3
7845697|NCT00168064|27228293|P1|Overall Study|Concurrent Illness|4
7845698|NCT00168064|27228292|P2|Overall Study|Non-compliance|3
7845699|NCT00168064|27228293|P1|Overall Study|Non-compliance|2
7845700|NCT00168064|27228292|P2|Overall Study|Lost to Follow-up|3
7845701|NCT00168064|27228293|P1|Overall Study|Lost to Follow-up|4
7845702|NCT00168064|27228292|P2|Overall Study|Lack of Efficacy|4
7845703|NCT00168064|27228293|P1|Overall Study|Lack of Efficacy|4
7845704|NCT00168064|27228292|P2|Overall Study|Withdrawal by Subject|4
7845705|NCT00168064|27228293|P1|Overall Study|Withdrawal by Subject|3
7845706|NCT00168064|27228292|P2|Overall Study|Adverse Event|22
7845707|NCT00168064|27228293|P1|Overall Study|Adverse Event|26
7845708|NCT00168038|27228301|P1|Overall Study|Therapy failure|1
7845709|NCT00168038|27228301|P1|Overall Study|Adverse Event|1
7845710|NCT00167778|27228324|P1|Overall Study|Withdrawal by Subject|1
7845711|NCT00167414|27228403|P1|Overall Study|Death|10
7845712|NCT00167310|27228428|P2|Overall Study|Withdrawal by Subject|7
7845713|NCT00167310|27228429|P1|Overall Study|Withdrawal by Subject|3
7845714|NCT00167310|27228428|P2|Overall Study|Protocol Violation|3
7845715|NCT00167310|27228429|P1|Overall Study|Protocol Violation|5
7845716|NCT00167245|27228439|P2|Overall Study|Drowsy|0
7845717|NCT00167245|27228440|P1|Overall Study|Drowsy|1
7845718|NCT00167245|27228439|P2|Overall Study|Incarcerated|2
7845719|NCT00167245|27228440|P1|Overall Study|Incarcerated|3
7845720|NCT00167245|27228439|P2|Overall Study|Withdrawal by Subject|8
7845721|NCT00167245|27228440|P1|Overall Study|Withdrawal by Subject|5
7845722|NCT00167245|27228439|P2|Overall Study|Lost to Follow-up|31
7845723|NCT00167245|27228440|P1|Overall Study|Lost to Follow-up|20
7845724|NCT00166712|27228494|P2|Overall Study|Physician Decision|2
7845725|NCT00166712|27228495|P1|Overall Study|Physician Decision|0
7845726|NCT00166712|27228494|P2|Overall Study|Withdrawal by Subject|2
7845727|NCT00166712|27228495|P1|Overall Study|Withdrawal by Subject|1
7845728|NCT00166712|27228494|P2|Overall Study|Adverse Event|0
7845729|NCT00166712|27228495|P1|Overall Study|Adverse Event|1
7845730|NCT00166712|27228494|P2|Overall Study|Death|1
7845731|NCT00166712|27228495|P1|Overall Study|Death|0
7845732|NCT00166517|27228512|P2|Overall Study|Withdrawal by Subject|1
7845733|NCT00166517|27228513|P1|Overall Study|Withdrawal by Subject|0
7845734|NCT00166517|27228512|P2|Overall Study|Protocol Violation|1
7845735|NCT00166517|27228513|P1|Overall Study|Protocol Violation|4
7845736|NCT00166517|27228512|P2|Overall Study|Lost to Follow-up|0
7845737|NCT00166517|27228513|P1|Overall Study|Lost to Follow-up|1
7845738|NCT00166504|27228523|P2|Overall Study|Withdrawal by Subject|0
7845739|NCT00166504|27228524|P1|Overall Study|Withdrawal by Subject|1
7845740|NCT00166504|27228523|P2|Overall Study|Lost to Follow-up|1
7845741|NCT00166504|27228524|P1|Overall Study|Lost to Follow-up|1
7845742|NCT00166504|27228523|P2|Overall Study|Adverse Event|3
7845743|NCT00166504|27228524|P1|Overall Study|Adverse Event|3
7845744|NCT00166439|27228530|P1|Overall Study|Ineligible|5
7845745|NCT00166296|27228547|P2|Overall Study|Lost to Follow-up|2
7845746|NCT00166296|27228548|P1|Overall Study|Lost to Follow-up|4
7845747|NCT00166296|27228547|P2|Overall Study|Adverse Event|4
7845748|NCT00166296|27228548|P1|Overall Study|Adverse Event|2
7845749|NCT00166296|27228547|P2|Overall Study|Withdrawal by Subject|3
7845750|NCT00166296|27228548|P1|Overall Study|Withdrawal by Subject|1
7845751|NCT00166114|27228600|P2|Overall Study|Adverse Event|1
7845752|NCT00166114|27228601|P1|Overall Study|Adverse Event|2
7845753|NCT00166114|27228600|P2|Overall Study|Withdrawal by Subject|4
7845754|NCT00166114|27228601|P1|Overall Study|Withdrawal by Subject|10
7845755|NCT00166114|27228600|P2|Overall Study|Protocol Violation|1
7845756|NCT00166114|27228601|P1|Overall Study|Protocol Violation|2
7845757|NCT00165984|27228618|P1|Overall Study|Death|15
7845758|NCT00165841|27228636|P2|Overall Study|Medication Noncompliance|1
7845759|NCT00165841|27228637|P1|Overall Study|Medication Noncompliance|1
7845760|NCT00165841|27228636|P2|Overall Study|Other|5
7845761|NCT00165841|27228637|P1|Overall Study|Other|3
7845762|NCT00165841|27228636|P2|Overall Study|Protocol Violation|8
7845763|NCT00165841|27228637|P1|Overall Study|Protocol Violation|6
7845764|NCT00165841|27228636|P2|Overall Study|Physician Decision|0
7845765|NCT00165841|27228637|P1|Overall Study|Physician Decision|1
7845766|NCT00165841|27228636|P2|Overall Study|Withdrawal by Subject|8
7845767|NCT00165841|27228637|P1|Overall Study|Withdrawal by Subject|7
7845768|NCT00165841|27228636|P2|Overall Study|Lost to Follow-up|4
7845769|NCT00165841|27228637|P1|Overall Study|Lost to Follow-up|4
7845770|NCT00165841|27228636|P2|Overall Study|Lack of Efficacy|33
7845771|NCT00165841|27228637|P1|Overall Study|Lack of Efficacy|6
7845772|NCT00165841|27228636|P2|Overall Study|Adverse Event|3
7845773|NCT00165841|27228637|P1|Overall Study|Adverse Event|2
7845774|NCT00165789|27228647|P4|Overall Study|Withdrawal by Subject|2
7845775|NCT00165789|27228648|P3|Overall Study|Withdrawal by Subject|1
7845776|NCT00165789|27228649|P2|Overall Study|Withdrawal by Subject|1
7845777|NCT00165789|27228650|P1|Overall Study|Withdrawal by Subject|0
7845778|NCT00165789|27228647|P4|Overall Study|Adverse Event|12
7845779|NCT00165789|27228648|P3|Overall Study|Adverse Event|0
7845780|NCT00165789|27228649|P2|Overall Study|Adverse Event|3
7845781|NCT00165789|27228650|P1|Overall Study|Adverse Event|0
7845782|NCT00165776|27228704|P4|Overall Study|Worsening of Cervical Dystonia|1
7845783|NCT00165776|27228705|P3|Overall Study|Worsening of Cervical Dystonia|0
7845784|NCT00165776|27228706|P2|Overall Study|Worsening of Cervical Dystonia|0
7845785|NCT00165776|27228707|P1|Overall Study|Worsening of Cervical Dystonia|0
7845786|NCT00165776|27228704|P4|Overall Study|Withdrawal by Subject|0
7845787|NCT00165776|27228705|P3|Overall Study|Withdrawal by Subject|2
7845788|NCT00165776|27228706|P2|Overall Study|Withdrawal by Subject|1
7845789|NCT00165776|27228707|P1|Overall Study|Withdrawal by Subject|4
7845790|NCT00165776|27228704|P4|Overall Study|Lack of Efficacy|1
7845791|NCT00165776|27228705|P3|Overall Study|Lack of Efficacy|0
7845792|NCT00165776|27228706|P2|Overall Study|Lack of Efficacy|0
7845793|NCT00165776|27228707|P1|Overall Study|Lack of Efficacy|0
7845794|NCT00165698|27228743|P2|Overall Study|Not Taken/Lost the medicine|2
7845795|NCT00165698|27228744|P1|Overall Study|Not Taken/Lost the medicine|1
7845796|NCT00165698|27228743|P2|Overall Study|Protocol Violation|0
7845797|NCT00165698|27228744|P1|Overall Study|Protocol Violation|1
7845798|NCT00165698|27228743|P2|Overall Study|Withdrawal by Subject|1
7845799|NCT00165698|27228744|P1|Overall Study|Withdrawal by Subject|2
7845800|NCT00165698|27228743|P2|Overall Study|Lost to Follow-up|2
7845801|NCT00165698|27228744|P1|Overall Study|Lost to Follow-up|2
7845802|NCT00165698|27228743|P2|Overall Study|Adverse Event|10
7845803|NCT00165698|27228744|P1|Overall Study|Adverse Event|2
7845804|NCT00165672|27228770|P2|Overall Study|Adverse Event|1
7845805|NCT00165672|27228771|P1|Overall Study|Adverse Event|0
7845806|NCT00165646|27228780|P3|Overall Study|Protocol Violation|0
7845807|NCT00165646|27228781|P2|Overall Study|Protocol Violation|0
7845808|NCT00165646|27228782|P1|Overall Study|Protocol Violation|1
7845809|NCT00165646|27228780|P3|Overall Study|Physician Decision|2
7845810|NCT00165646|27228781|P2|Overall Study|Physician Decision|0
7845811|NCT00165646|27228782|P1|Overall Study|Physician Decision|2
7845812|NCT00165646|27228780|P3|Overall Study|Withdrawal by Subject|1
7845813|NCT00165646|27228781|P2|Overall Study|Withdrawal by Subject|2
7845814|NCT00165646|27228782|P1|Overall Study|Withdrawal by Subject|0
7845815|NCT00165646|27228780|P3|Overall Study|Lack of Efficacy|0
7845816|NCT00165646|27228781|P2|Overall Study|Lack of Efficacy|2
7845817|NCT00165646|27228782|P1|Overall Study|Lack of Efficacy|1
7845818|NCT00165646|27228780|P3|Overall Study|Adverse Event|1
7845819|NCT00165646|27228781|P2|Overall Study|Adverse Event|1
7845820|NCT00165646|27228782|P1|Overall Study|Adverse Event|1
7845821|NCT00165503|27228790|P1|Overall Study|Unresectable|3
7845822|NCT00165503|27228790|P1|Overall Study|Lost to Follow-up|12
7845823|NCT00165503|27228790|P1|Overall Study|Death|1
7845824|NCT00163657|27228797|P3|Overall Study|Other reason|3
7845825|NCT00163657|27228798|P2|Overall Study|Other reason|1
7845826|NCT00163657|27228799|P1|Overall Study|Other reason|0
7845827|NCT00163657|27228797|P3|Overall Study|Lost to Follow-up|10
7845828|NCT00163657|27228798|P2|Overall Study|Lost to Follow-up|3
7845829|NCT00163657|27228799|P1|Overall Study|Lost to Follow-up|1
7845830|NCT00163657|27228797|P3|Overall Study|Non Compliance|0
7845831|NCT00163657|27228798|P2|Overall Study|Non Compliance|0
7845832|NCT00163657|27228799|P1|Overall Study|Non Compliance|1
7845833|NCT00163657|27228797|P3|Overall Study|Physician Decision|1
7845834|NCT00163657|27228798|P2|Overall Study|Physician Decision|1
7845835|NCT00163657|27228799|P1|Overall Study|Physician Decision|0
7845836|NCT00163657|27228797|P3|Overall Study|Withdrawal by Subject|2
7845837|NCT00163657|27228798|P2|Overall Study|Withdrawal by Subject|3
7845838|NCT00163657|27228799|P1|Overall Study|Withdrawal by Subject|2
7845839|NCT00163657|27228797|P3|Overall Study|graft loss|2
7845840|NCT00163657|27228798|P2|Overall Study|graft loss|1
7845841|NCT00163657|27228799|P1|Overall Study|graft loss|4
7845842|NCT00163657|27228797|P3|Overall Study|Death|19
7845843|NCT00163657|27228798|P2|Overall Study|Death|14
7845844|NCT00163657|27228799|P1|Overall Study|Death|12
7845845|NCT00163215|27228889|P1|Overall Study|Other|7
7845846|NCT00163215|27228889|P1|Overall Study|Withdrawal by Subject|5
7845847|NCT00163215|27228889|P1|Overall Study|Lack of Efficacy|3
7845848|NCT00163189|27228909|P1|Overall Study|Did not meet continuation criterion|16
7845849|NCT00163189|27228909|P1|Overall Study|Withdrawal by Subject|11
7845850|NCT00163189|27228909|P1|Overall Study|Study terminated by sponsor|11
7845851|NCT00163189|27228909|P1|Overall Study|Lack of Efficacy|7
7845852|NCT00163189|27228909|P1|Overall Study|Adverse Event|6
7845853|NCT00163189|27228909|P1|Overall Study|Death|3
7845854|NCT00163189|27228909|P1|Overall Study|Protocol Violation|2
7845855|NCT00163189|27228909|P1|Overall Study|Lost to Follow-up|1
7845856|NCT00163189|27228909|P1|Overall Study|Other|6
7845857|NCT00163020|27228933|P2|Overall Study|Lost to Follow-up|2
7845858|NCT00163020|27228934|P1|Overall Study|Lost to Follow-up|0
7845859|NCT00162981|27228974|P2|Overall Study|Physician Decision|0
7845860|NCT00162981|27228975|P1|Overall Study|Physician Decision|1
7845861|NCT00162981|27228974|P2|Overall Study|Withdrawal by Subject|1
7845862|NCT00162981|27228975|P1|Overall Study|Withdrawal by Subject|1
7845863|NCT00162981|27228974|P2|Overall Study|Adverse Event|5
7845864|NCT00162981|27228975|P1|Overall Study|Adverse Event|2
7845865|NCT00162942|27228991|P2|Overall Study|2 or more consecutive treatments missed|0
7845866|NCT00162942|27228992|P1|Overall Study|2 or more consecutive treatments missed|1
7845867|NCT00162942|27228991|P2|Overall Study|Flare During Active Treatment|3
7845868|NCT00162942|27228992|P1|Overall Study|Flare During Active Treatment|7
7845869|NCT00162942|27228991|P2|Overall Study|Lack of Efficacy|0
7845870|NCT00162942|27228992|P1|Overall Study|Lack of Efficacy|1
7845871|NCT00162942|27228991|P2|Overall Study|Alternate Therapy|2
7845872|NCT00162942|27228992|P1|Overall Study|Alternate Therapy|6
7845873|NCT00162942|27228991|P2|Overall Study|Enter Open-Label Study|35
7845874|NCT00162942|27228992|P1|Overall Study|Enter Open-Label Study|76
7845875|NCT00162942|27228991|P2|Overall Study|Physician Decision|0
7845876|NCT00162942|27228992|P1|Overall Study|Physician Decision|1
7845877|NCT00162942|27228991|P2|Overall Study|Withdrawal by Subject|6
7845878|NCT00162942|27228992|P1|Overall Study|Withdrawal by Subject|3
7845879|NCT00162942|27228991|P2|Overall Study|Death|0
7845880|NCT00162942|27228992|P1|Overall Study|Death|1
7845881|NCT00162942|27228991|P2|Overall Study|Adverse Event|6
7845882|NCT00162942|27228992|P1|Overall Study|Adverse Event|10
7845883|NCT00162773|27229040|P1|Overall Study|P.I, Left institution. Study terminated|22
7845884|NCT00162370|27229044|P1|Efficacy Population|Lost to Follow-up|51
7845885|NCT00162266|27229062|P4|Open-Label Period|Other Reasons|15
7845886|NCT00162266|27229063|P3|Open-Label Period|Other Reasons|0
7845887|NCT00162266|27229064|P2|Open-Label Period|Other Reasons|0
7845888|NCT00162266|27229065|P1|Open-Label Period|Other Reasons|0
7845889|NCT00162266|27229062|P4|Open-Label Period|Administrative Reason By Sponsor|9
7845890|NCT00162266|27229063|P3|Open-Label Period|Administrative Reason By Sponsor|0
7845891|NCT00162266|27229064|P2|Open-Label Period|Administrative Reason By Sponsor|0
7845892|NCT00162266|27229065|P1|Open-Label Period|Administrative Reason By Sponsor|0
7845893|NCT00162266|27229062|P4|Open-Label Period|Withdrawal by Subject|31
7845894|NCT00162266|27229063|P3|Open-Label Period|Withdrawal by Subject|0
7845895|NCT00162266|27229064|P2|Open-Label Period|Withdrawal by Subject|0
7845896|NCT00162266|27229065|P1|Open-Label Period|Withdrawal by Subject|0
7845897|NCT00162266|27229062|P4|Open-Label Period|Lost to Follow-up|3
7845898|NCT00162266|27229063|P3|Open-Label Period|Lost to Follow-up|0
7845899|NCT00162266|27229064|P2|Open-Label Period|Lost to Follow-up|0
7845900|NCT00162266|27229065|P1|Open-Label Period|Lost to Follow-up|0
7845901|NCT00162266|27229062|P4|Open-Label Period|Lack of Efficacy|26
7845902|NCT00162266|27229063|P3|Open-Label Period|Lack of Efficacy|0
7845903|NCT00162266|27229064|P2|Open-Label Period|Lack of Efficacy|0
7845904|NCT00162266|27229065|P1|Open-Label Period|Lack of Efficacy|0
7845905|NCT00162266|27229062|P4|Open-Label Period|Adverse Event|46
7845906|NCT00162266|27229063|P3|Open-Label Period|Adverse Event|0
7845907|NCT00162266|27229064|P2|Open-Label Period|Adverse Event|0
7845908|NCT00162266|27229065|P1|Open-Label Period|Adverse Event|0
7845909|NCT00162266|27229062|P4|Open-Label Period|Death|7
7845910|NCT00162266|27229063|P3|Open-Label Period|Death|0
7845911|NCT00162266|27229064|P2|Open-Label Period|Death|0
7845912|NCT00162266|27229065|P1|Open-Label Period|Death|0
7845913|NCT00162266|27229062|P4|Double-Blind Period|Withdrawal by Subject|0
7845914|NCT00162266|27229063|P3|Double-Blind Period|Withdrawal by Subject|6
7845915|NCT00162266|27229064|P2|Double-Blind Period|Withdrawal by Subject|2
7845916|NCT00162266|27229065|P1|Double-Blind Period|Withdrawal by Subject|5
7845917|NCT00162266|27229062|P4|Double-Blind Period|Lack of Efficacy|0
7845918|NCT00162266|27229063|P3|Double-Blind Period|Lack of Efficacy|30
7845919|NCT00162266|27229064|P2|Double-Blind Period|Lack of Efficacy|17
7845920|NCT00162266|27229065|P1|Double-Blind Period|Lack of Efficacy|13
7845921|NCT00162266|27229062|P4|Double-Blind Period|Other Reason|0
7845922|NCT00162266|27229063|P3|Double-Blind Period|Other Reason|1
7845923|NCT00162266|27229064|P2|Double-Blind Period|Other Reason|0
7845924|NCT00162266|27229065|P1|Double-Blind Period|Other Reason|1
7845925|NCT00162266|27229062|P4|Double-Blind Period|Lost to Follow-up|0
7845926|NCT00162266|27229063|P3|Double-Blind Period|Lost to Follow-up|0
7845927|NCT00162266|27229064|P2|Double-Blind Period|Lost to Follow-up|2
7845928|NCT00162266|27229065|P1|Double-Blind Period|Lost to Follow-up|1
7845929|NCT00162266|27229062|P4|Double-Blind Period|Death|0
7845930|NCT00162266|27229063|P3|Double-Blind Period|Death|0
7845931|NCT00162266|27229064|P2|Double-Blind Period|Death|1
7845932|NCT00162266|27229065|P1|Double-Blind Period|Death|0
7845933|NCT00162266|27229062|P4|Double-Blind Period|Adverse Event|0
7845934|NCT00162266|27229063|P3|Double-Blind Period|Adverse Event|11
7845935|NCT00162266|27229064|P2|Double-Blind Period|Adverse Event|9
7845936|NCT00162266|27229065|P1|Double-Blind Period|Adverse Event|5
7845937|NCT00162136|27229266|P1|Overall Study|Withdrawal by Subject|1
7845938|NCT00162136|27229266|P1|Overall Study|Study Drug Toxicity|4
7845939|NCT00162136|27229266|P1|Overall Study|Investigator Request|5
7845940|NCT00162136|27229266|P1|Overall Study|Disease Progression/Relapse|23
7845941|NCT00162136|27229266|P1|Overall Study|Death|1
7845942|NCT00162136|27229266|P1|Overall Study|Adverse Event|1
7845943|NCT00162123|27229298|P8|Overall Study|Follow-up only (not treated or assessed)|57
7845944|NCT00162123|27229299|P7|Overall Study|Follow-up only (not treated or assessed)|0
7845945|NCT00162123|27229300|P6|Overall Study|Follow-up only (not treated or assessed)|0
7845946|NCT00162123|27229301|P5|Overall Study|Follow-up only (not treated or assessed)|0
7845947|NCT00162123|27229302|P4|Overall Study|Follow-up only (not treated or assessed)|0
7845948|NCT00162123|27229303|P3|Overall Study|Follow-up only (not treated or assessed)|0
7845949|NCT00162123|27229304|P2|Overall Study|Follow-up only (not treated or assessed)|0
7845950|NCT00162123|27229305|P1|Overall Study|Follow-up only (not treated or assessed)|0
7845951|NCT00162123|27229298|P8|Overall Study|Tumor assessment only (not treated)|1
7845952|NCT00162123|27229299|P7|Overall Study|Tumor assessment only (not treated)|0
7845953|NCT00162123|27229300|P6|Overall Study|Tumor assessment only (not treated)|0
7845954|NCT00162123|27229301|P5|Overall Study|Tumor assessment only (not treated)|0
7845955|NCT00162123|27229302|P4|Overall Study|Tumor assessment only (not treated)|0
7845956|NCT00162123|27229303|P3|Overall Study|Tumor assessment only (not treated)|0
7845957|NCT00162123|27229304|P2|Overall Study|Tumor assessment only (not treated)|0
7845958|NCT00162123|27229305|P1|Overall Study|Tumor assessment only (not treated)|0
7845959|NCT00162123|27229298|P8|Overall Study|Physician Decision|0
7845960|NCT00162123|27229299|P7|Overall Study|Physician Decision|1
7845961|NCT00162123|27229300|P6|Overall Study|Physician Decision|1
7845962|NCT00162123|27229301|P5|Overall Study|Physician Decision|0
7845963|NCT00162123|27229302|P4|Overall Study|Physician Decision|0
7845964|NCT00162123|27229303|P3|Overall Study|Physician Decision|0
7845965|NCT00162123|27229304|P2|Overall Study|Physician Decision|2
7845966|NCT00162123|27229305|P1|Overall Study|Physician Decision|1
7845967|NCT00162123|27229298|P8|Overall Study|Not specified (after start of treatment)|0
7845968|NCT00162123|27229299|P7|Overall Study|Not specified (after start of treatment)|0
7845969|NCT00162123|27229300|P6|Overall Study|Not specified (after start of treatment)|0
7845970|NCT00162123|27229301|P5|Overall Study|Not specified (after start of treatment)|3
7845971|NCT00162123|27229302|P4|Overall Study|Not specified (after start of treatment)|0
7845972|NCT00162123|27229303|P3|Overall Study|Not specified (after start of treatment)|0
7845973|NCT00162123|27229304|P2|Overall Study|Not specified (after start of treatment)|0
7845974|NCT00162123|27229305|P1|Overall Study|Not specified (after start of treatment)|0
7845975|NCT00162123|27229298|P8|Overall Study|Not specified (before treatment)|0
7845976|NCT00162123|27229299|P7|Overall Study|Not specified (before treatment)|0
7845977|NCT00162123|27229300|P6|Overall Study|Not specified (before treatment)|1
7845978|NCT00162123|27229301|P5|Overall Study|Not specified (before treatment)|12
7845979|NCT00162123|27229302|P4|Overall Study|Not specified (before treatment)|0
7845980|NCT00162123|27229303|P3|Overall Study|Not specified (before treatment)|0
7845981|NCT00162123|27229304|P2|Overall Study|Not specified (before treatment)|0
7845982|NCT00162123|27229305|P1|Overall Study|Not specified (before treatment)|2
7845983|NCT00162123|27229298|P8|Overall Study|Adverse Event|0
7845984|NCT00162123|27229299|P7|Overall Study|Adverse Event|0
7845985|NCT00162123|27229300|P6|Overall Study|Adverse Event|0
7845986|NCT00162123|27229301|P5|Overall Study|Adverse Event|1
7845987|NCT00162123|27229302|P4|Overall Study|Adverse Event|2
7845988|NCT00162123|27229303|P3|Overall Study|Adverse Event|0
7845989|NCT00162123|27229304|P2|Overall Study|Adverse Event|2
7845990|NCT00162123|27229305|P1|Overall Study|Adverse Event|1
7845991|NCT00162123|27229298|P8|Overall Study|Deterioration without progression|0
7845992|NCT00162123|27229299|P7|Overall Study|Deterioration without progression|0
7845993|NCT00162123|27229300|P6|Overall Study|Deterioration without progression|0
7845994|NCT00162123|27229301|P5|Overall Study|Deterioration without progression|1
7845995|NCT00162123|27229302|P4|Overall Study|Deterioration without progression|0
7845996|NCT00162123|27229303|P3|Overall Study|Deterioration without progression|3
7845997|NCT00162123|27229304|P2|Overall Study|Deterioration without progression|2
7845998|NCT00162123|27229305|P1|Overall Study|Deterioration without progression|2
7845999|NCT00162123|27229298|P8|Overall Study|Withdrawal by Subject|0
7846000|NCT00162123|27229299|P7|Overall Study|Withdrawal by Subject|1
7846001|NCT00162123|27229300|P6|Overall Study|Withdrawal by Subject|2
7846002|NCT00162123|27229301|P5|Overall Study|Withdrawal by Subject|1
7846003|NCT00162123|27229302|P4|Overall Study|Withdrawal by Subject|1
7846004|NCT00162123|27229303|P3|Overall Study|Withdrawal by Subject|2
7846005|NCT00162123|27229304|P2|Overall Study|Withdrawal by Subject|0
7846006|NCT00162123|27229305|P1|Overall Study|Withdrawal by Subject|2
7846007|NCT00162123|27229298|P8|Overall Study|Death|0
7846008|NCT00162123|27229299|P7|Overall Study|Death|0
7846009|NCT00162123|27229300|P6|Overall Study|Death|1
7846010|NCT00162123|27229301|P5|Overall Study|Death|1
7846011|NCT00162123|27229302|P4|Overall Study|Death|1
7846012|NCT00162123|27229303|P3|Overall Study|Death|1
7846013|NCT00162123|27229304|P2|Overall Study|Death|3
7846014|NCT00162123|27229305|P1|Overall Study|Death|3
7846015|NCT00162123|27229298|P8|Overall Study|Study drug toxicity|0
7846016|NCT00162123|27229299|P7|Overall Study|Study drug toxicity|1
7846017|NCT00162123|27229300|P6|Overall Study|Study drug toxicity|1
7846018|NCT00162123|27229301|P5|Overall Study|Study drug toxicity|4
7846019|NCT00162123|27229302|P4|Overall Study|Study drug toxicity|0
7846020|NCT00162123|27229303|P3|Overall Study|Study drug toxicity|5
7846021|NCT00162123|27229304|P2|Overall Study|Study drug toxicity|1
7846022|NCT00162123|27229305|P1|Overall Study|Study drug toxicity|6
7846023|NCT00162123|27229298|P8|Overall Study|Disease progression|0
7846024|NCT00162123|27229299|P7|Overall Study|Disease progression|1
7846025|NCT00162123|27229300|P6|Overall Study|Disease progression|3
7846026|NCT00162123|27229301|P5|Overall Study|Disease progression|8
7846027|NCT00162123|27229302|P4|Overall Study|Disease progression|4
7846028|NCT00162123|27229303|P3|Overall Study|Disease progression|10
7846029|NCT00162123|27229304|P2|Overall Study|Disease progression|19
7846030|NCT00162123|27229305|P1|Overall Study|Disease progression|27
7846031|NCT00162097|27229338|P4|Overall Study|Participant no longer met study criteria|1
7846032|NCT00162097|27229339|P3|Overall Study|Participant no longer met study criteria|0
7846033|NCT00162097|27229340|P2|Overall Study|Participant no longer met study criteria|0
7846034|NCT00162097|27229341|P1|Overall Study|Participant no longer met study criteria|0
7846035|NCT00162032|27229403|P2|Overall Study|Reason not specified|0
7846036|NCT00162032|27229404|P1|Overall Study|Reason not specified|1
7846037|NCT00162032|27229403|P2|Overall Study|Lost to Follow-up|2
7846038|NCT00162032|27229404|P1|Overall Study|Lost to Follow-up|4
7846039|NCT00161616|27229425|P2|Overall Study|Protocol deviation|0
7846040|NCT00161616|27229426|P1|Overall Study|Protocol deviation|1
7846041|NCT00161616|27229425|P2|Overall Study|Lost to Follow-up|13
7846042|NCT00161616|27229426|P1|Overall Study|Lost to Follow-up|17
7846043|NCT00161616|27229425|P2|Overall Study|Death|1
7846044|NCT00161616|27229426|P1|Overall Study|Death|1
7846045|NCT00161616|27229425|P2|Overall Study|Physician Decision|0
7846046|NCT00161616|27229426|P1|Overall Study|Physician Decision|1
7846047|NCT00161616|27229425|P2|Overall Study|Withdrawal by Subject|5
7846048|NCT00161616|27229426|P1|Overall Study|Withdrawal by Subject|6
7846049|NCT00161213|27229458|P1|Overall Study|Evaluable for toxicity but not response|1
7846050|NCT00161213|27229458|P1|Overall Study|Withdrawal by Subject|1
7846051|NCT00160706|27229465|P1|Overall Study|Other Reason|11
7846052|NCT00160706|27229465|P1|Overall Study|Lack of Efficacy and Other|1
7846053|NCT00160706|27229465|P1|Overall Study|Lack of Efficacy|42
7846054|NCT00160706|27229465|P1|Overall Study|Lost to Follow-up and Other|1
7846055|NCT00160706|27229465|P1|Overall Study|Lost to Follow-up|4
7846056|NCT00160706|27229465|P1|Overall Study|Physician Decision and Other|3
7846057|NCT00160706|27229465|P1|Overall Study|Physician Decision|10
7846058|NCT00160706|27229465|P1|Overall Study|Withdrawal by Subject and Other|12
7846059|NCT00160706|27229465|P1|Overall Study|Withdrawal by Subject|41
7846060|NCT00160706|27229465|P1|Overall Study|Protocol Violation|3
7846061|NCT00160706|27229465|P1|Overall Study|Adverse Event and Other Reason|105
7846062|NCT00160706|27229465|P1|Overall Study|Adverse Event|53
7846063|NCT00160693|27229477|P1|Overall Study|Study terminated by sponsor|15
7846064|NCT00160693|27229477|P1|Overall Study|Withdrawal by Subject|54
7846065|NCT00160693|27229477|P1|Overall Study|Lost to Follow-up|15
7846066|NCT00160693|27229477|P1|Overall Study|Protocol Violation|24
7846067|NCT00160693|27229477|P1|Overall Study|Lack of Efficacy|30
7846068|NCT00160693|27229477|P1|Overall Study|Adverse Event|97
7846069|NCT00160680|27229496|P2|Overall Study|Withdrawal by Subject|9
7846070|NCT00160680|27229497|P1|Overall Study|Withdrawal by Subject|4
7846071|NCT00160680|27229496|P2|Overall Study|Lost to Follow-up|2
7846072|NCT00160680|27229497|P1|Overall Study|Lost to Follow-up|3
7846073|NCT00160680|27229496|P2|Overall Study|Lack of Efficacy|1
7846074|NCT00160680|27229497|P1|Overall Study|Lack of Efficacy|2
7846075|NCT00160680|27229496|P2|Overall Study|Adverse Event|1
7846076|NCT00160680|27229497|P1|Overall Study|Adverse Event|0
7846077|NCT00160667|27229532|P3|Overall Study|Patient decision|1
7846078|NCT00160667|27229533|P2|Overall Study|Patient decision|0
7846079|NCT00160667|27229534|P1|Overall Study|Patient decision|0
7846080|NCT00160667|27229532|P3|Overall Study|Protocol Violation|0
7846081|NCT00160667|27229533|P2|Overall Study|Protocol Violation|1
7846082|NCT00160667|27229534|P1|Overall Study|Protocol Violation|0
7846083|NCT00160667|27229532|P3|Overall Study|Lack of Efficacy|0
7846084|NCT00160667|27229533|P2|Overall Study|Lack of Efficacy|1
7846085|NCT00160667|27229534|P1|Overall Study|Lack of Efficacy|0
7846086|NCT00160667|27229532|P3|Overall Study|Withdrawal by Subject|1
7846087|NCT00160667|27229533|P2|Overall Study|Withdrawal by Subject|0
7846088|NCT00160667|27229534|P1|Overall Study|Withdrawal by Subject|2
7846089|NCT00160667|27229532|P3|Overall Study|Adverse Event|4
7846090|NCT00160667|27229533|P2|Overall Study|Adverse Event|1
7846091|NCT00160667|27229534|P1|Overall Study|Adverse Event|3
7846092|NCT00160654|27229581|P1|Overall Study|Met exclusion criteria|1
7846093|NCT00160654|27229581|P1|Overall Study|Poor compliance, dilantin toxicity|1
7846094|NCT00160654|27229581|P1|Overall Study|Patient decision|1
7846095|NCT00160654|27229581|P1|Overall Study|Patient met exclusion criteria|1
7846096|NCT00160654|27229581|P1|Overall Study|Sponsor decision|1
7846097|NCT00160654|27229581|P1|Overall Study|Psychological trauma|1
7846098|NCT00160654|27229581|P1|Overall Study|Intake of expired drug|7
7846099|NCT00160654|27229581|P1|Overall Study|Lost to Follow-up|2
7846100|NCT00160654|27229581|P1|Overall Study|Lack of Efficacy|4
7846101|NCT00160654|27229581|P1|Overall Study|Adverse Event|14
7846102|NCT00160641|27229591|P1|Overall Study|Other|9
7846103|NCT00160641|27229591|P1|Overall Study|Protocol Violation|3
7846104|NCT00160641|27229591|P1|Overall Study|Lack of Efficacy|12
7846105|NCT00160641|27229591|P1|Overall Study|Lost to Follow-up|8
7846106|NCT00160641|27229591|P1|Overall Study|Withdrawal by Subject|87
7846107|NCT00160641|27229591|P1|Overall Study|Adverse Event|102
7846108|NCT00160615|27229624|P2|Overall Study|Poor compliance|1
7846109|NCT00160615|27229625|P1|Overall Study|Poor compliance|0
7846110|NCT00160615|27229624|P2|Overall Study|Non-compliance was suspected|1
7846111|NCT00160615|27229625|P1|Overall Study|Non-compliance was suspected|0
7846112|NCT00160615|27229624|P2|Overall Study|Switch to surgical treatment|2
7846113|NCT00160615|27229625|P1|Overall Study|Switch to surgical treatment|0
7846114|NCT00160615|27229624|P2|Overall Study|AE agents had to be discontinued (exam.)|1
7846115|NCT00160615|27229625|P1|Overall Study|AE agents had to be discontinued (exam.)|0
7846116|NCT00160615|27229624|P2|Overall Study|Investigator decision|1
7846117|NCT00160615|27229625|P1|Overall Study|Investigator decision|1
7846118|NCT00160615|27229624|P2|Overall Study|Patient decision|2
7846119|NCT00160615|27229625|P1|Overall Study|Patient decision|1
7846120|NCT00160615|27229624|P2|Overall Study|Lack of Efficacy|23
7846121|NCT00160615|27229625|P1|Overall Study|Lack of Efficacy|11
7846122|NCT00160615|27229624|P2|Overall Study|Withdrawal by Subject|2
7846123|NCT00160615|27229625|P1|Overall Study|Withdrawal by Subject|0
7846124|NCT00160615|27229624|P2|Overall Study|Adverse Event|12
7846125|NCT00160615|27229625|P1|Overall Study|Adverse Event|5
7846126|NCT00160563|27229648|P3|Overall Study|Missing reason|0
7846127|NCT00160563|27229649|P2|Overall Study|Missing reason|1
7846128|NCT00160563|27229650|P1|Overall Study|Missing reason|0
7846129|NCT00160563|27229648|P3|Overall Study|Other (listed in the study report)|81
7846130|NCT00160563|27229649|P2|Overall Study|Other (listed in the study report)|40
7846131|NCT00160563|27229650|P1|Overall Study|Other (listed in the study report)|48
7846132|NCT00160563|27229648|P3|Overall Study|Withdrawal by Subject|3
7846133|NCT00160563|27229649|P2|Overall Study|Withdrawal by Subject|2
7846134|NCT00160563|27229650|P1|Overall Study|Withdrawal by Subject|1
7846135|NCT00160563|27229648|P3|Overall Study|Protocol Violation|3
7846136|NCT00160563|27229649|P2|Overall Study|Protocol Violation|0
7846137|NCT00160563|27229650|P1|Overall Study|Protocol Violation|0
7846138|NCT00160563|27229648|P3|Overall Study|Lost to Follow-up|2
7846139|NCT00160563|27229649|P2|Overall Study|Lost to Follow-up|1
7846140|NCT00160563|27229650|P1|Overall Study|Lost to Follow-up|1
7846141|NCT00160563|27229648|P3|Overall Study|Adverse Event|1
7846142|NCT00160563|27229649|P2|Overall Study|Adverse Event|1
7846143|NCT00160563|27229650|P1|Overall Study|Adverse Event|1
7846144|NCT00160524|27229662|P1|Overall Study|Other|20
7846145|NCT00160524|27229662|P1|Overall Study|Lack of Efficacy and Other|1
7846146|NCT00160524|27229662|P1|Overall Study|Lack of Efficacy|21
7846147|NCT00160524|27229662|P1|Overall Study|Lost to Follow-up and Other|1
7846148|NCT00160524|27229662|P1|Overall Study|Lost to Follow-up|13
7846149|NCT00160524|27229662|P1|Overall Study|Physician Decision and Other|6
7846150|NCT00160524|27229662|P1|Overall Study|Physician Decision|27
7846151|NCT00160524|27229662|P1|Overall Study|Withdrawal by Subject and Other|17
7846152|NCT00160524|27229662|P1|Overall Study|Withdrawal by Subject|141
7846153|NCT00160524|27229662|P1|Overall Study|Protocol Violation and Other|2
7846154|NCT00160524|27229662|P1|Overall Study|Protocol Violation|16
7846155|NCT00160524|27229662|P1|Overall Study|Adverse Event and Other|94
7846156|NCT00160524|27229662|P1|Overall Study|Adverse Event|119
7846157|NCT00160251|27229679|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
7846158|NCT00160251|27229680|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846159|NCT00160251|27229681|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846160|NCT00160251|27229682|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846161|NCT00160251|27229683|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846162|NCT00160251|27229684|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846163|NCT00160251|27229685|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846164|NCT00160251|27229686|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7846165|NCT00160251|27229679|P8|Post-amendment 2|Lack of Efficacy|24
7846166|NCT00160251|27229680|P7|Post-amendment 2|Lack of Efficacy|0
7846167|NCT00160251|27229681|P6|Post-amendment 2|Lack of Efficacy|0
7846168|NCT00160251|27229682|P5|Post-amendment 2|Lack of Efficacy|0
7846169|NCT00160251|27229683|P4|Post-amendment 2|Lack of Efficacy|0
7846170|NCT00160251|27229684|P3|Post-amendment 2|Lack of Efficacy|0
7846171|NCT00160251|27229685|P2|Post-amendment 2|Lack of Efficacy|0
7846172|NCT00160251|27229686|P1|Post-amendment 2|Lack of Efficacy|0
7846173|NCT00160251|27229679|P8|Post-amendment 2|Adverse Event|20
7846174|NCT00160251|27229680|P7|Post-amendment 2|Adverse Event|0
7846175|NCT00160251|27229681|P6|Post-amendment 2|Adverse Event|0
7846176|NCT00160251|27229682|P5|Post-amendment 2|Adverse Event|0
7846177|NCT00160251|27229683|P4|Post-amendment 2|Adverse Event|0
7846178|NCT00160251|27229684|P3|Post-amendment 2|Adverse Event|0
7846179|NCT00160251|27229685|P2|Post-amendment 2|Adverse Event|0
7846180|NCT00160251|27229686|P1|Post-amendment 2|Adverse Event|0
7846181|NCT00160251|27229679|P8|Prior to Amendment 2|Completed Treatment Phase|0
7846182|NCT00160251|27229680|P7|Prior to Amendment 2|Completed Treatment Phase|0
7846183|NCT00160251|27229681|P6|Prior to Amendment 2|Completed Treatment Phase|23
7846184|NCT00160251|27229682|P5|Prior to Amendment 2|Completed Treatment Phase|0
7846185|NCT00160251|27229683|P4|Prior to Amendment 2|Completed Treatment Phase|0
7846186|NCT00160251|27229684|P3|Prior to Amendment 2|Completed Treatment Phase|0
7846187|NCT00160251|27229685|P2|Prior to Amendment 2|Completed Treatment Phase|0
7846188|NCT00160251|27229686|P1|Prior to Amendment 2|Completed Treatment Phase|3
7846189|NCT00160251|27229679|P8|Prior to Amendment 2|Noncompliance with protocol|0
7846190|NCT00160251|27229680|P7|Prior to Amendment 2|Noncompliance with protocol|0
7846191|NCT00160251|27229681|P6|Prior to Amendment 2|Noncompliance with protocol|0
7846192|NCT00160251|27229682|P5|Prior to Amendment 2|Noncompliance with protocol|0
7846193|NCT00160251|27229683|P4|Prior to Amendment 2|Noncompliance with protocol|0
7846194|NCT00160251|27229684|P3|Prior to Amendment 2|Noncompliance with protocol|0
7846195|NCT00160251|27229685|P2|Prior to Amendment 2|Noncompliance with protocol|0
7846196|NCT00160251|27229686|P1|Prior to Amendment 2|Noncompliance with protocol|1
7846197|NCT00160251|27229679|P8|Prior to Amendment 2|Withdrawal by Subject|0
7846198|NCT00160251|27229680|P7|Prior to Amendment 2|Withdrawal by Subject|3
7846199|NCT00160251|27229681|P6|Prior to Amendment 2|Withdrawal by Subject|3
7846200|NCT00160251|27229682|P5|Prior to Amendment 2|Withdrawal by Subject|2
7846201|NCT00160251|27229683|P4|Prior to Amendment 2|Withdrawal by Subject|4
7846202|NCT00160251|27229684|P3|Prior to Amendment 2|Withdrawal by Subject|3
7846203|NCT00160251|27229685|P2|Prior to Amendment 2|Withdrawal by Subject|1
7846204|NCT00160251|27229686|P1|Prior to Amendment 2|Withdrawal by Subject|3
7846205|NCT00160251|27229679|P8|Prior to Amendment 2|Lost to Follow-up|0
7846206|NCT00160251|27229680|P7|Prior to Amendment 2|Lost to Follow-up|0
7846207|NCT00160251|27229681|P6|Prior to Amendment 2|Lost to Follow-up|1
7846208|NCT00160251|27229682|P5|Prior to Amendment 2|Lost to Follow-up|1
7846209|NCT00160251|27229683|P4|Prior to Amendment 2|Lost to Follow-up|0
7846210|NCT00160251|27229684|P3|Prior to Amendment 2|Lost to Follow-up|1
7846211|NCT00160251|27229685|P2|Prior to Amendment 2|Lost to Follow-up|0
7846212|NCT00160251|27229686|P1|Prior to Amendment 2|Lost to Follow-up|0
7846213|NCT00160251|27229679|P8|Prior to Amendment 2|Lack of Efficacy|0
7846214|NCT00160251|27229680|P7|Prior to Amendment 2|Lack of Efficacy|0
7846215|NCT00160251|27229681|P6|Prior to Amendment 2|Lack of Efficacy|55
7846216|NCT00160251|27229682|P5|Prior to Amendment 2|Lack of Efficacy|24
7846217|NCT00160251|27229683|P4|Prior to Amendment 2|Lack of Efficacy|35
7846218|NCT00160251|27229684|P3|Prior to Amendment 2|Lack of Efficacy|37
7846219|NCT00160251|27229685|P2|Prior to Amendment 2|Lack of Efficacy|4
7846220|NCT00160251|27229686|P1|Prior to Amendment 2|Lack of Efficacy|0
7846221|NCT00160251|27229679|P8|Prior to Amendment 2|Adverse Event|0
7846222|NCT00160251|27229680|P7|Prior to Amendment 2|Adverse Event|1
7846223|NCT00160251|27229681|P6|Prior to Amendment 2|Adverse Event|1
7846224|NCT00160251|27229682|P5|Prior to Amendment 2|Adverse Event|1
7846225|NCT00160251|27229683|P4|Prior to Amendment 2|Adverse Event|1
7846226|NCT00160251|27229684|P3|Prior to Amendment 2|Adverse Event|3
7846227|NCT00160251|27229685|P2|Prior to Amendment 2|Adverse Event|1
7846228|NCT00160251|27229686|P1|Prior to Amendment 2|Adverse Event|2
7846229|NCT00160199|27229762|P2|Overall Study|Protocol Violation|8
7846230|NCT00160199|27229763|P1|Overall Study|Protocol Violation|8
7846231|NCT00160199|27229762|P2|Overall Study|Administrative|1
7846232|NCT00160199|27229763|P1|Overall Study|Administrative|0
7846233|NCT00160199|27229762|P2|Overall Study|Withdrawal by Subject|6
7846234|NCT00160199|27229763|P1|Overall Study|Withdrawal by Subject|4
7846235|NCT00160199|27229762|P2|Overall Study|Lost to Follow-up|7
7846236|NCT00160199|27229763|P1|Overall Study|Lost to Follow-up|7
7846237|NCT00160199|27229762|P2|Overall Study|Lack of Efficacy|1
7846238|NCT00160199|27229763|P1|Overall Study|Lack of Efficacy|0
7846239|NCT00160199|27229762|P2|Overall Study|Adverse Event|14
7846240|NCT00160199|27229763|P1|Overall Study|Adverse Event|5
7846241|NCT00159913|27229820|P4|Overall Study|Protocol Violation|0
7846242|NCT00159913|27229821|P3|Overall Study|Protocol Violation|1
7846243|NCT00159913|27229822|P2|Overall Study|Protocol Violation|0
7846244|NCT00159913|27229823|P1|Overall Study|Protocol Violation|1
7846245|NCT00159913|27229820|P4|Overall Study|Lost to Follow-up|1
7846246|NCT00159913|27229821|P3|Overall Study|Lost to Follow-up|0
7846247|NCT00159913|27229822|P2|Overall Study|Lost to Follow-up|0
7846248|NCT00159913|27229823|P1|Overall Study|Lost to Follow-up|0
7846249|NCT00159913|27229820|P4|Overall Study|Withdrawal by Subject|1
7846250|NCT00159913|27229821|P3|Overall Study|Withdrawal by Subject|0
7846251|NCT00159913|27229822|P2|Overall Study|Withdrawal by Subject|0
7846252|NCT00159913|27229823|P1|Overall Study|Withdrawal by Subject|0
7846253|NCT00159913|27229820|P4|Overall Study|Adverse Event|0
7846254|NCT00159913|27229821|P3|Overall Study|Adverse Event|1
7846255|NCT00159913|27229822|P2|Overall Study|Adverse Event|0
7846256|NCT00159913|27229823|P1|Overall Study|Adverse Event|1
7846257|NCT00159874|27229897|P7|Overall Study|Pregnancy|0
7846258|NCT00159874|27229898|P6|Overall Study|Pregnancy|0
7846259|NCT00159874|27229899|P5|Overall Study|Pregnancy|0
7846260|NCT00159874|27229900|P4|Overall Study|Pregnancy|0
7846261|NCT00159874|27229901|P3|Overall Study|Pregnancy|0
7846262|NCT00159874|27229902|P2|Overall Study|Pregnancy|1
7846263|NCT00159874|27229903|P1|Overall Study|Pregnancy|1
7846264|NCT00159874|27229897|P7|Overall Study|Withdrawal by Subject|1
7846265|NCT00159874|27229898|P6|Overall Study|Withdrawal by Subject|2
7846266|NCT00159874|27229899|P5|Overall Study|Withdrawal by Subject|3
7846267|NCT00159874|27229900|P4|Overall Study|Withdrawal by Subject|4
7846268|NCT00159874|27229901|P3|Overall Study|Withdrawal by Subject|8
7846269|NCT00159874|27229902|P2|Overall Study|Withdrawal by Subject|6
7846270|NCT00159874|27229903|P1|Overall Study|Withdrawal by Subject|2
7846271|NCT00159874|27229897|P7|Overall Study|Death|0
7846272|NCT00159874|27229898|P6|Overall Study|Death|2
7846273|NCT00159874|27229899|P5|Overall Study|Death|1
7846274|NCT00159874|27229900|P4|Overall Study|Death|0
7846275|NCT00159874|27229901|P3|Overall Study|Death|15
7846276|NCT00159874|27229902|P2|Overall Study|Death|8
7846277|NCT00159874|27229903|P1|Overall Study|Death|3
7846278|NCT00159874|27229897|P7|Overall Study|Protocol Violation|0
7846279|NCT00159874|27229898|P6|Overall Study|Protocol Violation|0
7846280|NCT00159874|27229899|P5|Overall Study|Protocol Violation|0
7846281|NCT00159874|27229900|P4|Overall Study|Protocol Violation|0
7846282|NCT00159874|27229901|P3|Overall Study|Protocol Violation|2
7846283|NCT00159874|27229902|P2|Overall Study|Protocol Violation|5
7846284|NCT00159874|27229903|P1|Overall Study|Protocol Violation|0
7846285|NCT00159874|27229897|P7|Overall Study|Other|3
7846286|NCT00159874|27229898|P6|Overall Study|Other|1
7846287|NCT00159874|27229899|P5|Overall Study|Other|2
7846288|NCT00159874|27229900|P4|Overall Study|Other|0
7846289|NCT00159874|27229901|P3|Overall Study|Other|8
7846290|NCT00159874|27229902|P2|Overall Study|Other|8
7846291|NCT00159874|27229903|P1|Overall Study|Other|8
7846292|NCT00159874|27229897|P7|Overall Study|Lost to Follow-up|1
7846293|NCT00159874|27229898|P6|Overall Study|Lost to Follow-up|2
7846294|NCT00159874|27229899|P5|Overall Study|Lost to Follow-up|1
7846295|NCT00159874|27229900|P4|Overall Study|Lost to Follow-up|0
7846296|NCT00159874|27229901|P3|Overall Study|Lost to Follow-up|3
7846297|NCT00159874|27229902|P2|Overall Study|Lost to Follow-up|0
7846298|NCT00159874|27229903|P1|Overall Study|Lost to Follow-up|1
7846299|NCT00159874|27229897|P7|Overall Study|Lack of Efficacy|0
7846300|NCT00159874|27229898|P6|Overall Study|Lack of Efficacy|3
7846301|NCT00159874|27229899|P5|Overall Study|Lack of Efficacy|0
7846302|NCT00159874|27229900|P4|Overall Study|Lack of Efficacy|1
7846303|NCT00159874|27229901|P3|Overall Study|Lack of Efficacy|1
7846304|NCT00159874|27229902|P2|Overall Study|Lack of Efficacy|0
7846305|NCT00159874|27229903|P1|Overall Study|Lack of Efficacy|2
7846306|NCT00159874|27229897|P7|Overall Study|Does Not Meet Entrance Criteria|0
7846307|NCT00159874|27229898|P6|Overall Study|Does Not Meet Entrance Criteria|0
7846308|NCT00159874|27229899|P5|Overall Study|Does Not Meet Entrance Criteria|0
7846309|NCT00159874|27229900|P4|Overall Study|Does Not Meet Entrance Criteria|0
7846310|NCT00159874|27229901|P3|Overall Study|Does Not Meet Entrance Criteria|1
7846311|NCT00159874|27229902|P2|Overall Study|Does Not Meet Entrance Criteria|0
7846312|NCT00159874|27229903|P1|Overall Study|Does Not Meet Entrance Criteria|1
7846313|NCT00159874|27229897|P7|Overall Study|Adverse Event|0
7846314|NCT00159874|27229898|P6|Overall Study|Adverse Event|2
7846315|NCT00159874|27229899|P5|Overall Study|Adverse Event|1
7846316|NCT00159874|27229900|P4|Overall Study|Adverse Event|1
7846317|NCT00159874|27229901|P3|Overall Study|Adverse Event|5
7846318|NCT00159874|27229902|P2|Overall Study|Adverse Event|2
7846319|NCT00159874|27229903|P1|Overall Study|Adverse Event|2
7846320|NCT00159861|27230073|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
7846321|NCT00159861|27230074|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
7846322|NCT00159861|27230073|P2|Extension Study - up to 3 Years|Reason Unspecified|19
7846323|NCT00159861|27230074|P1|Extension Study - up to 3 Years|Reason Unspecified|12
7846324|NCT00159861|27230073|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
7846325|NCT00159861|27230074|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
7846326|NCT00159861|27230073|P2|Extension Study - up to 3 Years|Adverse Event|14
7846327|NCT00159861|27230074|P1|Extension Study - up to 3 Years|Adverse Event|14
7846328|NCT00159861|27230073|P2|Extension Study - up to 3 Years|Death|28
7846329|NCT00159861|27230074|P1|Extension Study - up to 3 Years|Death|24
7846330|NCT00159861|27230073|P2|Core Study - 16 Weeks|Randomized but not Treated|0
7846331|NCT00159861|27230074|P1|Core Study - 16 Weeks|Randomized but not Treated|2
7846332|NCT00159861|27230073|P2|Core Study - 16 Weeks|Subject Defaulted|0
7846333|NCT00159861|27230074|P1|Core Study - 16 Weeks|Subject Defaulted|1
7846334|NCT00159861|27230073|P2|Core Study - 16 Weeks|Reason Unspecified|3
7846335|NCT00159861|27230074|P1|Core Study - 16 Weeks|Reason Unspecified|5
7846336|NCT00159861|27230073|P2|Core Study - 16 Weeks|Lack of Efficacy|3
7846337|NCT00159861|27230074|P1|Core Study - 16 Weeks|Lack of Efficacy|2
7846338|NCT00159861|27230073|P2|Core Study - 16 Weeks|Adverse Event|6
7846339|NCT00159861|27230074|P1|Core Study - 16 Weeks|Adverse Event|12
7846340|NCT00159861|27230073|P2|Core Study - 16 Weeks|Death|0
7846341|NCT00159861|27230074|P1|Core Study - 16 Weeks|Death|3
7846342|NCT00159822|27230095|P1|Post-treatment Follow-up Period|Reason unspecified|1
7846343|NCT00159822|27230095|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
7846344|NCT00159822|27230095|P1|Post-treatment Follow-up Period|Death|1
7846345|NCT00159822|27230095|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
7846346|NCT00159822|27230095|P1|Voriconazole Treatment Period|Lost to Follow-up|2
7846347|NCT00159822|27230095|P1|Voriconazole Treatment Period|Protocol Violation|2
7846348|NCT00159822|27230095|P1|Voriconazole Treatment Period|Death|4
7846349|NCT00159822|27230095|P1|Voriconazole Treatment Period|Adverse Event|9
7846350|NCT00159822|27230095|P1|Voriconazole Treatment Period|Lack of Efficacy|3
7846351|NCT00159783|27230113|P3|Overall Study|Other|4
7846352|NCT00159783|27230114|P2|Overall Study|Other|2
7846353|NCT00159783|27230115|P1|Overall Study|Other|0
7846354|NCT00159783|27230113|P3|Overall Study|Lost to Follow-up|11
7846355|NCT00159783|27230114|P2|Overall Study|Lost to Follow-up|5
7846356|NCT00159783|27230115|P1|Overall Study|Lost to Follow-up|6
7846357|NCT00159783|27230113|P3|Overall Study|Withdrawal by Subject|12
7846358|NCT00159783|27230114|P2|Overall Study|Withdrawal by Subject|11
7846359|NCT00159783|27230115|P1|Overall Study|Withdrawal by Subject|7
7846360|NCT00159783|27230113|P3|Overall Study|Lack of Efficacy|3
7846361|NCT00159783|27230114|P2|Overall Study|Lack of Efficacy|2
7846362|NCT00159783|27230115|P1|Overall Study|Lack of Efficacy|1
7846363|NCT00159783|27230113|P3|Overall Study|Adverse Event|9
7846364|NCT00159783|27230114|P2|Overall Study|Adverse Event|7
7846365|NCT00159783|27230115|P1|Overall Study|Adverse Event|5
7846366|NCT00159432|27230145|P1|Overall Study|Lack of Efficacy|8
7846367|NCT00159432|27230145|P1|Overall Study|Death|1
7846368|NCT00159432|27230145|P1|Overall Study|Adverse Event|1
7846369|NCT00158860|27230219|P2|Overall Study|Closed per sponsor|1
7846370|NCT00158860|27230220|P1|Overall Study|Closed per sponsor|0
7846371|NCT00158860|27230219|P2|Overall Study|Lost to Follow up but returned per GSK|1
7846372|NCT00158860|27230220|P1|Overall Study|Lost to Follow up but returned per GSK|0
7846373|NCT00158860|27230219|P2|Overall Study|SPONSOR REQUEST|1
7846374|NCT00158860|27230220|P1|Overall Study|SPONSOR REQUEST|0
7846375|NCT00158860|27230219|P2|Overall Study|SPONSOR STOPPED STUDY|2
7846376|NCT00158860|27230220|P1|Overall Study|SPONSOR STOPPED STUDY|2
7846377|NCT00158860|27230219|P2|Overall Study|Pregnancy|3
7846378|NCT00158860|27230220|P1|Overall Study|Pregnancy|3
7846379|NCT00158860|27230219|P2|Overall Study|MOVING OUT OF STATE|0
7846380|NCT00158860|27230220|P1|Overall Study|MOVING OUT OF STATE|1
7846381|NCT00158860|27230219|P2|Overall Study|Withdrawal by Subject|17
7846382|NCT00158860|27230220|P1|Overall Study|Withdrawal by Subject|7
7846383|NCT00158860|27230219|P2|Overall Study|Protocol Violation|23
7846384|NCT00158860|27230220|P1|Overall Study|Protocol Violation|8
7846385|NCT00158860|27230219|P2|Overall Study|Lost to Follow-up|17
7846386|NCT00158860|27230220|P1|Overall Study|Lost to Follow-up|11
7846387|NCT00158860|27230219|P2|Overall Study|Adverse Event|6
7846388|NCT00158860|27230220|P1|Overall Study|Adverse Event|3
7846389|NCT00158756|27230239|P5|Overall Study|Serious adverse event|0
7846390|NCT00158756|27230240|P4|Overall Study|Serious adverse event|0
7846391|NCT00158756|27230241|P3|Overall Study|Serious adverse event|1
7846392|NCT00158756|27230242|P2|Overall Study|Serious adverse event|0
7846393|NCT00158756|27230243|P1|Overall Study|Serious adverse event|0
7846394|NCT00158756|27230239|P5|Overall Study|Adverse Event|0
7846395|NCT00158756|27230240|P4|Overall Study|Adverse Event|0
7846396|NCT00158756|27230241|P3|Overall Study|Adverse Event|1
7846397|NCT00158756|27230242|P2|Overall Study|Adverse Event|0
7846398|NCT00158756|27230243|P1|Overall Study|Adverse Event|0
7846399|NCT00158756|27230239|P5|Overall Study|Withdrawal by Subject|3
7846400|NCT00158756|27230240|P4|Overall Study|Withdrawal by Subject|1
7846401|NCT00158756|27230241|P3|Overall Study|Withdrawal by Subject|6
7846402|NCT00158756|27230242|P2|Overall Study|Withdrawal by Subject|0
7846403|NCT00158756|27230243|P1|Overall Study|Withdrawal by Subject|5
7846404|NCT00158600|27230349|P2|Overall Study|Withdrawal by Subject|2
7846405|NCT00158600|27230350|P1|Overall Study|Withdrawal by Subject|2
7846406|NCT00158600|27230349|P2|Overall Study|Death|0
7846407|NCT00158600|27230350|P1|Overall Study|Death|1
7846408|NCT00158600|27230349|P2|Overall Study|Adverse Event|1
7846409|NCT00158600|27230350|P1|Overall Study|Adverse Event|2
7846410|NCT00158600|27230349|P2|Overall Study|unable to commit time to study|1
7846411|NCT00158600|27230350|P1|Overall Study|unable to commit time to study|0
7846412|NCT00158262|27230375|P2|Overall Study|Lost to Follow-up|1
7846413|NCT00158262|27230376|P1|Overall Study|Lost to Follow-up|1
7846414|NCT00158184|27230437|P2|Overall Study|Adverse Event|1
7846415|NCT00158184|27230438|P1|Overall Study|Adverse Event|1
7846416|NCT00158184|27230437|P2|Overall Study|failed for follow unit/study rules|0
7846417|NCT00158184|27230438|P1|Overall Study|failed for follow unit/study rules|2
7846418|NCT00158184|27230437|P2|Overall Study|personal issues|1
7846419|NCT00158184|27230438|P1|Overall Study|personal issues|3
7846420|NCT00158054|27230448|P2|Overall Study|Unavailable for follow up|3
7846421|NCT00158054|27230449|P1|Overall Study|Unavailable for follow up|7
7846422|NCT00158054|27230448|P2|Overall Study|Refused to continue|0
7846423|NCT00158054|27230449|P1|Overall Study|Refused to continue|3
7846424|NCT00157950|27230463|P2|Overall Study|Death|0
7846425|NCT00157950|27230464|P1|Overall Study|Death|1
7846426|NCT00157820|27230481|P3|2nd 8 Months|Premature cross-over|9
7846427|NCT00157820|27230482|P2|2nd 8 Months|Premature cross-over|7
7846428|NCT00157820|27230483|P1|2nd 8 Months|Premature cross-over|1
7846429|NCT00157820|27230481|P3|2nd 8 Months|Lost to Follow-up|2
7846430|NCT00157820|27230482|P2|2nd 8 Months|Lost to Follow-up|5
7846431|NCT00157820|27230483|P1|2nd 8 Months|Lost to Follow-up|1
7846432|NCT00157820|27230481|P3|2nd 8 Months|Death|3
7846433|NCT00157820|27230482|P2|2nd 8 Months|Death|1
7846434|NCT00157820|27230483|P1|2nd 8 Months|Death|3
7846435|NCT00157820|27230481|P3|1st 8 Month|Premature cross-over|2
7846436|NCT00157820|27230482|P2|1st 8 Month|Premature cross-over|2
7846437|NCT00157820|27230483|P1|1st 8 Month|Premature cross-over|0
7846438|NCT00157820|27230481|P3|1st 8 Month|Lost to Follow-up|1
7846439|NCT00157820|27230482|P2|1st 8 Month|Lost to Follow-up|2
7846440|NCT00157820|27230483|P1|1st 8 Month|Lost to Follow-up|1
7846441|NCT00157820|27230481|P3|1st 8 Month|Death|3
7846442|NCT00157820|27230482|P2|1st 8 Month|Death|8
7846443|NCT00157820|27230483|P1|1st 8 Month|Death|7
7846444|NCT00157820|27230481|P3|Randomized|Protocol Violation|2
7846445|NCT00157820|27230482|P2|Randomized|Protocol Violation|1
7846446|NCT00157820|27230483|P1|Randomized|Protocol Violation|2
7846447|NCT00157820|27230481|P3|Randomized|Withdrawal by Subject|3
7846448|NCT00157820|27230482|P2|Randomized|Withdrawal by Subject|2
7846449|NCT00157820|27230483|P1|Randomized|Withdrawal by Subject|1
7846450|NCT00157820|27230481|P3|Randomized|Physician Decision|3
7846451|NCT00157820|27230482|P2|Randomized|Physician Decision|2
7846452|NCT00157820|27230483|P1|Randomized|Physician Decision|4
7846453|NCT00157755|27230496|P6|Overall Study|Study completion|2
7846454|NCT00157755|27230497|P5|Overall Study|Study completion|1
7846455|NCT00157755|27230498|P4|Overall Study|Study completion|0
7846456|NCT00157755|27230499|P3|Overall Study|Study completion|0
7846457|NCT00157755|27230500|P2|Overall Study|Study completion|0
7846458|NCT00157755|27230501|P1|Overall Study|Study completion|0
7846459|NCT00157755|27230496|P6|Overall Study|Subject non-compliance|1
7846460|NCT00157755|27230497|P5|Overall Study|Subject non-compliance|0
7846461|NCT00157755|27230498|P4|Overall Study|Subject non-compliance|0
7846462|NCT00157755|27230499|P3|Overall Study|Subject non-compliance|0
7846463|NCT00157755|27230500|P2|Overall Study|Subject non-compliance|0
7846464|NCT00157755|27230501|P1|Overall Study|Subject non-compliance|0
7846465|NCT00157755|27230496|P6|Overall Study|Study site closure|0
7846466|NCT00157755|27230497|P5|Overall Study|Study site closure|0
7846467|NCT00157755|27230498|P4|Overall Study|Study site closure|0
7846468|NCT00157755|27230499|P3|Overall Study|Study site closure|0
7846469|NCT00157755|27230500|P2|Overall Study|Study site closure|1
7846470|NCT00157755|27230501|P1|Overall Study|Study site closure|0
7846471|NCT00157755|27230496|P6|Overall Study|Medical reason|0
7846472|NCT00157755|27230497|P5|Overall Study|Medical reason|0
7846473|NCT00157755|27230498|P4|Overall Study|Medical reason|1
7846474|NCT00157755|27230499|P3|Overall Study|Medical reason|1
7846475|NCT00157755|27230500|P2|Overall Study|Medical reason|0
7846476|NCT00157755|27230501|P1|Overall Study|Medical reason|0
7846477|NCT00157755|27230496|P6|Overall Study|Explant due to infection|0
7846478|NCT00157755|27230497|P5|Overall Study|Explant due to infection|0
7846479|NCT00157755|27230498|P4|Overall Study|Explant due to infection|0
7846480|NCT00157755|27230499|P3|Overall Study|Explant due to infection|1
7846481|NCT00157755|27230500|P2|Overall Study|Explant due to infection|0
7846482|NCT00157755|27230501|P1|Overall Study|Explant due to infection|0
7846483|NCT00157755|27230496|P6|Overall Study|Withdrawal by Subject|2
7846484|NCT00157755|27230497|P5|Overall Study|Withdrawal by Subject|1
7846485|NCT00157755|27230498|P4|Overall Study|Withdrawal by Subject|1
7846486|NCT00157755|27230499|P3|Overall Study|Withdrawal by Subject|1
7846487|NCT00157755|27230500|P2|Overall Study|Withdrawal by Subject|0
7846488|NCT00157755|27230501|P1|Overall Study|Withdrawal by Subject|0
7846489|NCT00157755|27230496|P6|Overall Study|Lost to Follow-up|0
7846490|NCT00157755|27230497|P5|Overall Study|Lost to Follow-up|0
7846491|NCT00157755|27230498|P4|Overall Study|Lost to Follow-up|0
7846492|NCT00157755|27230499|P3|Overall Study|Lost to Follow-up|1
7846493|NCT00157755|27230500|P2|Overall Study|Lost to Follow-up|0
7846494|NCT00157755|27230501|P1|Overall Study|Lost to Follow-up|0
7846495|NCT00157755|27230496|P6|Overall Study|Death|0
7846496|NCT00157755|27230497|P5|Overall Study|Death|0
7846497|NCT00157755|27230498|P4|Overall Study|Death|2
7846498|NCT00157755|27230499|P3|Overall Study|Death|3
7846499|NCT00157755|27230500|P2|Overall Study|Death|3
7846500|NCT00157755|27230501|P1|Overall Study|Death|2
7846501|NCT00157248|27230537|P4|Overall Study|site closures, subject moving|9
7846502|NCT00157248|27230538|P3|Overall Study|site closures, subject moving|3
7846503|NCT00157248|27230539|P2|Overall Study|site closures, subject moving|7
7846504|NCT00157248|27230540|P1|Overall Study|site closures, subject moving|7
7846505|NCT00157248|27230537|P4|Overall Study|Withdrawal by Subject|3
7846506|NCT00157248|27230538|P3|Overall Study|Withdrawal by Subject|3
7846507|NCT00157248|27230539|P2|Overall Study|Withdrawal by Subject|4
7846508|NCT00157248|27230540|P1|Overall Study|Withdrawal by Subject|1
7846509|NCT00157248|27230537|P4|Overall Study|Lost to Follow-up|0
7846510|NCT00157248|27230538|P3|Overall Study|Lost to Follow-up|0
7846511|NCT00157248|27230539|P2|Overall Study|Lost to Follow-up|1
7846512|NCT00157248|27230540|P1|Overall Study|Lost to Follow-up|0
7846513|NCT00157248|27230537|P4|Overall Study|Protocol Violation|2
7846514|NCT00157248|27230538|P3|Overall Study|Protocol Violation|2
7846515|NCT00157248|27230539|P2|Overall Study|Protocol Violation|0
7846516|NCT00157248|27230540|P1|Overall Study|Protocol Violation|4
7846517|NCT00157248|27230537|P4|Overall Study|Adverse Event|33
7846518|NCT00157248|27230538|P3|Overall Study|Adverse Event|13
7846519|NCT00157248|27230539|P2|Overall Study|Adverse Event|25
7846520|NCT00157248|27230540|P1|Overall Study|Adverse Event|36
7846521|NCT00157209|27230646|P2|Overall Study|Ongoing at data cut-off|0
7846522|NCT00157209|27230647|P1|Overall Study|Ongoing at data cut-off|10
7846523|NCT00157196|27230661|P1|Overall Study|Ongoing at data cut-off|9
7846524|NCT00157157|27230667|P1|Overall Study|Inclusion not met- baseline FVIII value|1
7846525|NCT00157157|27230667|P1|Overall Study|Met exclusion criteria|1
7846526|NCT00157157|27230667|P1|Overall Study|Enrolled in another study|1
7846527|NCT00157157|27230667|P1|Overall Study|Lost to Follow-up|1
7846528|NCT00157157|27230667|P1|Overall Study|Physician Decision|1
7846529|NCT00157157|27230667|P1|Overall Study|Withdrawal by Subject|6
7846530|NCT00157014|27230694|P4|Overall Study|Withdrawal by Subject|0
7846531|NCT00157014|27230695|P3|Overall Study|Withdrawal by Subject|0
7846532|NCT00157014|27230696|P2|Overall Study|Withdrawal by Subject|0
7846533|NCT00157014|27230697|P1|Overall Study|Withdrawal by Subject|1
7846534|NCT00157014|27230694|P4|Overall Study|Patient would not receive transplant|0
7846535|NCT00157014|27230695|P3|Overall Study|Patient would not receive transplant|0
7846536|NCT00157014|27230696|P2|Overall Study|Patient would not receive transplant|1
7846537|NCT00157014|27230697|P1|Overall Study|Patient would not receive transplant|0
7846538|NCT00157014|27230694|P4|Overall Study|Patient unable to return in nursing home|0
7846539|NCT00157014|27230695|P3|Overall Study|Patient unable to return in nursing home|0
7846540|NCT00157014|27230696|P2|Overall Study|Patient unable to return in nursing home|0
7846541|NCT00157014|27230697|P1|Overall Study|Patient unable to return in nursing home|1
7846542|NCT00157014|27230694|P4|Overall Study|Patient withdrawn by investigator|0
7846543|NCT00157014|27230695|P3|Overall Study|Patient withdrawn by investigator|0
7846544|NCT00157014|27230696|P2|Overall Study|Patient withdrawn by investigator|0
7846545|NCT00157014|27230697|P1|Overall Study|Patient withdrawn by investigator|1
7846546|NCT00157014|27230694|P4|Overall Study|Medications withdrawn on family request|0
7846547|NCT00157014|27230695|P3|Overall Study|Medications withdrawn on family request|0
7846548|NCT00157014|27230696|P2|Overall Study|Medications withdrawn on family request|1
7846549|NCT00157014|27230697|P1|Overall Study|Medications withdrawn on family request|0
7846550|NCT00157014|27230694|P4|Overall Study|Physician Decision|0
7846551|NCT00157014|27230695|P3|Overall Study|Physician Decision|0
7846552|NCT00157014|27230696|P2|Overall Study|Physician Decision|1
7846553|NCT00157014|27230697|P1|Overall Study|Physician Decision|0
7846554|NCT00157014|27230694|P4|Overall Study|Death|1
7846555|NCT00157014|27230695|P3|Overall Study|Death|1
7846556|NCT00157014|27230696|P2|Overall Study|Death|2
7846557|NCT00157014|27230697|P1|Overall Study|Death|4
7846558|NCT00156819|27230813|P3|Overall Study|Lost to Follow-up|3
7846559|NCT00156819|27230814|P2|Overall Study|Lost to Follow-up|1
7846560|NCT00156819|27230815|P1|Overall Study|Lost to Follow-up|1
7846561|NCT00156533|27230832|P4|Overall Study|Failed Screening|1
7846562|NCT00156533|27230833|P3|Overall Study|Failed Screening|1
7846563|NCT00156533|27230834|P2|Overall Study|Failed Screening|0
7846564|NCT00156533|27230835|P1|Overall Study|Failed Screening|1
7846565|NCT00156533|27230832|P4|Overall Study|Withdrawal by Subject|1
7846566|NCT00156533|27230833|P3|Overall Study|Withdrawal by Subject|0
7846567|NCT00156533|27230834|P2|Overall Study|Withdrawal by Subject|0
7846568|NCT00156533|27230835|P1|Overall Study|Withdrawal by Subject|1
7846569|NCT00156533|27230832|P4|Overall Study|Withdrawn - Medication Expiration|0
7846570|NCT00156533|27230833|P3|Overall Study|Withdrawn - Medication Expiration|1
7846571|NCT00156533|27230834|P2|Overall Study|Withdrawn - Medication Expiration|2
7846572|NCT00156533|27230835|P1|Overall Study|Withdrawn - Medication Expiration|0
7846573|NCT00156065|27230869|P3|Overall Study|Other|3
7846574|NCT00156065|27230870|P2|Overall Study|Other|9
7846575|NCT00156065|27230871|P1|Overall Study|Other|2
7846576|NCT00156065|27230869|P3|Overall Study|Lost to Follow-up|1
7846577|NCT00156065|27230870|P2|Overall Study|Lost to Follow-up|7
7846578|NCT00156065|27230871|P1|Overall Study|Lost to Follow-up|5
7846579|NCT00156065|27230869|P3|Overall Study|Withdrawal by Subject|16
7846580|NCT00156065|27230870|P2|Overall Study|Withdrawal by Subject|26
7846581|NCT00156065|27230871|P1|Overall Study|Withdrawal by Subject|13
7846582|NCT00156065|27230869|P3|Overall Study|Lack of Efficacy|3
7846583|NCT00156065|27230870|P2|Overall Study|Lack of Efficacy|9
7846584|NCT00156065|27230871|P1|Overall Study|Lack of Efficacy|2
7846585|NCT00156065|27230869|P3|Overall Study|Adverse Event|4
7846586|NCT00156065|27230870|P2|Overall Study|Adverse Event|11
7846587|NCT00156065|27230871|P1|Overall Study|Adverse Event|8
7846588|NCT00156065|27230869|P3|Overall Study|Enrolled But Never Received Treatment|0
7846589|NCT00156065|27230870|P2|Overall Study|Enrolled But Never Received Treatment|1
7846590|NCT00156065|27230871|P1|Overall Study|Enrolled But Never Received Treatment|1
7846591|NCT00154375|27230905|P2|Overall Study|Suspected progression of disease|30
7846592|NCT00154375|27230906|P1|Overall Study|Suspected progression of disease|44
7846593|NCT00154375|27230905|P2|Overall Study|Protocol Violation|1
7846594|NCT00154375|27230906|P1|Overall Study|Protocol Violation|0
7846595|NCT00154375|27230905|P2|Overall Study|Abnormal laboratory value(s)|2
7846596|NCT00154375|27230906|P1|Overall Study|Abnormal laboratory value(s)|0
7846597|NCT00154375|27230905|P2|Overall Study|Lost to Follow-up|1
7846598|NCT00154375|27230906|P1|Overall Study|Lost to Follow-up|2
7846599|NCT00154375|27230905|P2|Overall Study|Study drug no longer required|3
7846600|NCT00154375|27230906|P1|Overall Study|Study drug no longer required|5
7846601|NCT00154375|27230905|P2|Overall Study|Death|13
7846602|NCT00154375|27230906|P1|Overall Study|Death|5
7846603|NCT00154375|27230905|P2|Overall Study|Withdrawal by Subject|10
7846604|NCT00154375|27230906|P1|Overall Study|Withdrawal by Subject|14
7846605|NCT00154375|27230905|P2|Overall Study|Adverse Event|20
7846606|NCT00154375|27230906|P1|Overall Study|Adverse Event|18
7846607|NCT00154375|27230905|P2|Overall Study|Unsatisfactory therapeutic effect|26
7846608|NCT00154375|27230906|P1|Overall Study|Unsatisfactory therapeutic effect|25
7846609|NCT00154310|27230917|P2|Overall Study|Death|1
7846610|NCT00154310|27230918|P1|Overall Study|Death|0
7846611|NCT00154310|27230917|P2|Overall Study|Administrative problems|1
7846612|NCT00154310|27230918|P1|Overall Study|Administrative problems|0
7846613|NCT00154310|27230917|P2|Overall Study|Lost to Follow-up|8
7846614|NCT00154310|27230918|P1|Overall Study|Lost to Follow-up|0
7846615|NCT00154310|27230917|P2|Overall Study|Withdrawal by Subject|3
7846616|NCT00154310|27230918|P1|Overall Study|Withdrawal by Subject|9
7846617|NCT00154310|27230917|P2|Overall Study|Protocol Violation|2
7846618|NCT00154310|27230918|P1|Overall Study|Protocol Violation|4
7846619|NCT00154310|27230917|P2|Overall Study|Lack of Efficacy|4
7846620|NCT00154310|27230918|P1|Overall Study|Lack of Efficacy|5
7846621|NCT00154310|27230917|P2|Overall Study|Adverse Event|9
7846622|NCT00154310|27230918|P1|Overall Study|Adverse Event|19
7846623|NCT00154297|27230934|P2|Overall Study|Lost to Follow-up|0
7846624|NCT00154297|27230935|P1|Overall Study|Lost to Follow-up|3
7846625|NCT00154297|27230934|P2|Overall Study|Withdrawal by Subject|5
7846626|NCT00154297|27230935|P1|Overall Study|Withdrawal by Subject|0
7846627|NCT00154297|27230934|P2|Overall Study|Death|2
7846628|NCT00154297|27230935|P1|Overall Study|Death|5
7846629|NCT00154284|27230953|P2|Overall Study|Protocol Violation|1
7846630|NCT00154284|27230954|P1|Overall Study|Protocol Violation|0
7846631|NCT00154284|27230953|P2|Overall Study|Lack of Efficacy|2
7846632|NCT00154284|27230954|P1|Overall Study|Lack of Efficacy|1
7846633|NCT00154284|27230953|P2|Overall Study|Abnormal laboratory value(s)|1
7846634|NCT00154284|27230954|P1|Overall Study|Abnormal laboratory value(s)|0
7846635|NCT00154284|27230953|P2|Overall Study|Adverse Event|9
7846636|NCT00154284|27230954|P1|Overall Study|Adverse Event|6
7846637|NCT00154102|27230968|P2|Overall Study|investigational study phase ongoing|2
7846638|NCT00154102|27230969|P1|Overall Study|investigational study phase ongoing|7
7846639|NCT00154063|27231005|P2|Overall Study|Other|3
7846640|NCT00154063|27231006|P1|Overall Study|Other|3
7846641|NCT00154063|27231005|P2|Overall Study|Withdrawal by Subject|9
7846642|NCT00154063|27231006|P1|Overall Study|Withdrawal by Subject|4
7846643|NCT00154063|27231005|P2|Overall Study|Investigator or Sponsor Request|1
7846644|NCT00154063|27231006|P1|Overall Study|Investigator or Sponsor Request|0
7846645|NCT00154063|27231005|P2|Overall Study|Protocol Violation|1
7846646|NCT00154063|27231006|P1|Overall Study|Protocol Violation|1
7846647|NCT00154063|27231005|P2|Overall Study|Adverse Event|8
7846648|NCT00154063|27231006|P1|Overall Study|Adverse Event|4
7846649|NCT00153920|27231068|P1|Overall Study|Progressive Disease before Trt|1
7846650|NCT00153920|27231068|P1|Overall Study|Withdrawal of Consent before Trt|1
7846651|NCT00153920|27231068|P1|Overall Study|Non-Protocol Therapy|1
7846652|NCT00153920|27231068|P1|Overall Study|Withdrawal by Subject|1
7846653|NCT00153920|27231068|P1|Overall Study|Death|2
7846654|NCT00153920|27231068|P1|Overall Study|Lack of Response|3
7846655|NCT00153920|27231068|P1|Overall Study|Physician Decision|3
7846656|NCT00153920|27231068|P1|Overall Study|Progressive Disease|9
7846657|NCT00153920|27231068|P1|Overall Study|Adverse Event|9
7846658|NCT00153816|27231094|P6|Overall Study|Follow-up exam done, histology missing|2
7846659|NCT00153816|27231095|P5|Overall Study|Follow-up exam done, histology missing|1
7846660|NCT00153816|27231096|P4|Overall Study|Follow-up exam done, histology missing|3
7846661|NCT00153816|27231097|P3|Overall Study|Follow-up exam done, histology missing|3
7846662|NCT00153816|27231098|P2|Overall Study|Follow-up exam done, histology missing|3
7846663|NCT00153816|27231099|P1|Overall Study|Follow-up exam done, histology missing|2
7846664|NCT00153816|27231094|P6|Overall Study|Follow-up exam not done|9
7846665|NCT00153816|27231095|P5|Overall Study|Follow-up exam not done|8
7846666|NCT00153816|27231096|P4|Overall Study|Follow-up exam not done|10
7846667|NCT00153816|27231097|P3|Overall Study|Follow-up exam not done|11
7846668|NCT00153816|27231098|P2|Overall Study|Follow-up exam not done|7
7846669|NCT00153816|27231099|P1|Overall Study|Follow-up exam not done|8
7846670|NCT00153816|27231094|P6|Overall Study|Withdrawal by Subject|5
7846671|NCT00153816|27231095|P5|Overall Study|Withdrawal by Subject|1
7846672|NCT00153816|27231096|P4|Overall Study|Withdrawal by Subject|4
7846673|NCT00153816|27231097|P3|Overall Study|Withdrawal by Subject|9
7846674|NCT00153816|27231098|P2|Overall Study|Withdrawal by Subject|9
7846675|NCT00153816|27231099|P1|Overall Study|Withdrawal by Subject|9
7846676|NCT00153816|27231094|P6|Overall Study|Lost to Follow-up|9
7846677|NCT00153816|27231095|P5|Overall Study|Lost to Follow-up|7
7846678|NCT00153816|27231096|P4|Overall Study|Lost to Follow-up|8
7846679|NCT00153816|27231097|P3|Overall Study|Lost to Follow-up|5
7846680|NCT00153816|27231098|P2|Overall Study|Lost to Follow-up|8
7846681|NCT00153816|27231099|P1|Overall Study|Lost to Follow-up|7
7846682|NCT00153816|27231094|P6|Overall Study|Death|2
7846683|NCT00153816|27231095|P5|Overall Study|Death|0
7846684|NCT00153816|27231096|P4|Overall Study|Death|6
7846685|NCT00153816|27231097|P3|Overall Study|Death|4
7846686|NCT00153816|27231098|P2|Overall Study|Death|5
7846687|NCT00153816|27231099|P1|Overall Study|Death|6
7846688|NCT00153179|27231140|P4|Study Visit Day 2|Withdrawal by Subject|2
7846689|NCT00153179|27231141|P3|Study Visit Day 2|Withdrawal by Subject|2
7846690|NCT00153179|27231142|P2|Study Visit Day 2|Withdrawal by Subject|0
7846691|NCT00153179|27231143|P1|Study Visit Day 2|Withdrawal by Subject|1
7846692|NCT00153101|27231175|P5|Overall Study|Withdrawal by Subject|5
7846693|NCT00153101|27231176|P4|Overall Study|Withdrawal by Subject|3
7846694|NCT00153101|27231177|P3|Overall Study|Withdrawal by Subject|3
7846695|NCT00153101|27231178|P2|Overall Study|Withdrawal by Subject|4
7846696|NCT00153101|27231179|P1|Overall Study|Withdrawal by Subject|3
7846697|NCT00153101|27231175|P5|Overall Study|Lost to Follow-up|5
7846698|NCT00153101|27231176|P4|Overall Study|Lost to Follow-up|5
7846699|NCT00153101|27231177|P3|Overall Study|Lost to Follow-up|12
7846700|NCT00153101|27231178|P2|Overall Study|Lost to Follow-up|14
7846701|NCT00153101|27231179|P1|Overall Study|Lost to Follow-up|14
7846702|NCT00153062|27231287|P4|Overall Study|Other|0
7846703|NCT00153062|27231288|P3|Overall Study|Other|1
7846704|NCT00153062|27231289|P2|Overall Study|Other|0
7846705|NCT00153062|27231290|P1|Overall Study|Other|0
7846706|NCT00153062|27231287|P4|Overall Study|No disposition data available|1
7846707|NCT00153062|27231288|P3|Overall Study|No disposition data available|1
7846708|NCT00153062|27231289|P2|Overall Study|No disposition data available|1
7846709|NCT00153062|27231290|P1|Overall Study|No disposition data available|1
7846710|NCT00153062|27231287|P4|Overall Study|Protocol Violation|1
7846711|NCT00153062|27231288|P3|Overall Study|Protocol Violation|1
7846712|NCT00153062|27231289|P2|Overall Study|Protocol Violation|2
7846713|NCT00153062|27231290|P1|Overall Study|Protocol Violation|0
7846714|NCT00153062|27231287|P4|Overall Study|Adverse Event|0
7846715|NCT00153062|27231288|P3|Overall Study|Adverse Event|1
7846716|NCT00153062|27231289|P2|Overall Study|Adverse Event|1
7846717|NCT00153062|27231290|P1|Overall Study|Adverse Event|0
7846718|NCT00153062|27231287|P4|Overall Study|Lost to Follow-up|16
7846719|NCT00153062|27231288|P3|Overall Study|Lost to Follow-up|15
7846720|NCT00153062|27231289|P2|Overall Study|Lost to Follow-up|20
7846721|NCT00153062|27231290|P1|Overall Study|Lost to Follow-up|12
7846722|NCT00153062|27231287|P4|Overall Study|Withdrawal by Subject|28
7846723|NCT00153062|27231288|P3|Overall Study|Withdrawal by Subject|27
7846724|NCT00153062|27231289|P2|Overall Study|Withdrawal by Subject|30
7846725|NCT00153062|27231290|P1|Overall Study|Withdrawal by Subject|14
7846726|NCT00153062|27231287|P4|Overall Study|Death|365
7846727|NCT00153062|27231288|P3|Overall Study|Death|369
7846728|NCT00153062|27231289|P2|Overall Study|Death|352
7846729|NCT00153062|27231290|P1|Overall Study|Death|360
7846730|NCT00152971|27231309|P3|Treatment|Other|10
7846731|NCT00152971|27231310|P2|Treatment|Other|11
7846732|NCT00152971|27231311|P1|Treatment|Other|9
7846733|NCT00152971|27231309|P3|Treatment|Withdrawal by Subject|5
7846734|NCT00152971|27231310|P2|Treatment|Withdrawal by Subject|4
7846735|NCT00152971|27231311|P1|Treatment|Withdrawal by Subject|4
7846736|NCT00152971|27231309|P3|Treatment|Lost to Follow-up|1
7846737|NCT00152971|27231310|P2|Treatment|Lost to Follow-up|2
7846738|NCT00152971|27231311|P1|Treatment|Lost to Follow-up|1
7846739|NCT00152971|27231309|P3|Treatment|Protocol Violation|10
7846740|NCT00152971|27231310|P2|Treatment|Protocol Violation|6
7846741|NCT00152971|27231311|P1|Treatment|Protocol Violation|8
7846742|NCT00152971|27231309|P3|Treatment|Adverse Event|54
7846743|NCT00152971|27231310|P2|Treatment|Adverse Event|40
7846744|NCT00152971|27231311|P1|Treatment|Adverse Event|49
7846745|NCT00152971|27231309|P3|Overall Study|Other|5
7846746|NCT00152971|27231310|P2|Overall Study|Other|5
7846747|NCT00152971|27231311|P1|Overall Study|Other|3
7846748|NCT00152971|27231309|P3|Overall Study|Withdrawal by Subject|14
7846749|NCT00152971|27231310|P2|Overall Study|Withdrawal by Subject|8
7846750|NCT00152971|27231311|P1|Overall Study|Withdrawal by Subject|9
7846751|NCT00152971|27231309|P3|Overall Study|Lost to Follow-up|13
7846752|NCT00152971|27231310|P2|Overall Study|Lost to Follow-up|14
7846753|NCT00152971|27231311|P1|Overall Study|Lost to Follow-up|17
7846754|NCT00152971|27231309|P3|Overall Study|Protocol Violation|8
7846755|NCT00152971|27231310|P2|Overall Study|Protocol Violation|11
7846756|NCT00152971|27231311|P1|Overall Study|Protocol Violation|10
7846757|NCT00152971|27231309|P3|Overall Study|Adverse Event|9
7846758|NCT00152971|27231310|P2|Overall Study|Adverse Event|10
7846759|NCT00152971|27231311|P1|Overall Study|Adverse Event|12
7846760|NCT00152763|27231347|P4|Overall Study|Lost to Follow-up|13
7846761|NCT00152763|27231348|P3|Overall Study|Lost to Follow-up|2
7846762|NCT00152763|27231349|P2|Overall Study|Lost to Follow-up|4
7846763|NCT00152763|27231350|P1|Overall Study|Lost to Follow-up|6
7846764|NCT00152763|27231347|P4|Overall Study|Death|1
7846765|NCT00152763|27231348|P3|Overall Study|Death|2
7846766|NCT00152763|27231349|P2|Overall Study|Death|1
7846767|NCT00152763|27231350|P1|Overall Study|Death|4
7846768|NCT00152516|27231466|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
7846769|NCT00152516|27231466|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
7846770|NCT00152516|27231466|P1|Overall Study|Other: Moved Out Of State|1
7846771|NCT00152516|27231466|P1|Overall Study|Other: Primary Care Physician's Decision|1
7846772|NCT00152516|27231466|P1|Overall Study|Other: Non-Compliance|2
7846773|NCT00152516|27231466|P1|Overall Study|Other: Parents Withdrew Consent|2
7846774|NCT00152516|27231466|P1|Overall Study|Other: Given Commercial Drug in Error|2
7846775|NCT00152516|27231466|P1|Overall Study|Other: Mother Refused To Cooperate|1
7846776|NCT00152516|27231466|P1|Overall Study|Protocol Violation|3
7846777|NCT00152516|27231466|P1|Overall Study|Withdrawal by Subject|8
7846778|NCT00152516|27231466|P1|Overall Study|Lost to Follow-up|5
7846779|NCT00152516|27231466|P1|Overall Study|Lack and Loss of Efficacy|30
7846780|NCT00152516|27231466|P1|Overall Study|Adverse Event|18
7846781|NCT00152464|27231492|P2|Overall Study|Patient relocated|0
7846782|NCT00152464|27231493|P1|Overall Study|Patient relocated|1
7846783|NCT00152464|27231492|P2|Overall Study|Eczema poorly controlled|0
7846784|NCT00152464|27231493|P1|Overall Study|Eczema poorly controlled|1
7846785|NCT00152464|27231492|P2|Overall Study|Lack of Efficacy|0
7846786|NCT00152464|27231493|P1|Overall Study|Lack of Efficacy|1
7846787|NCT00152464|27231492|P2|Overall Study|Investigator decision|0
7846788|NCT00152464|27231493|P1|Overall Study|Investigator decision|1
7846789|NCT00152464|27231492|P2|Overall Study|Parent decision|1
7846790|NCT00152464|27231493|P1|Overall Study|Parent decision|1
7846791|NCT00152464|27231492|P2|Overall Study|Eczema deterioration|1
7846792|NCT00152464|27231493|P1|Overall Study|Eczema deterioration|0
7846793|NCT00152464|27231492|P2|Overall Study|Atopic dermatitis poorly controlled|1
7846794|NCT00152464|27231493|P1|Overall Study|Atopic dermatitis poorly controlled|0
7846795|NCT00152464|27231492|P2|Overall Study|Withdrawal by Subject|22
7846796|NCT00152464|27231493|P1|Overall Study|Withdrawal by Subject|21
7846797|NCT00152464|27231492|P2|Overall Study|Protocol Violation|1
7846798|NCT00152464|27231493|P1|Overall Study|Protocol Violation|3
7846799|NCT00152464|27231492|P2|Overall Study|Lost to Follow-up|4
7846800|NCT00152464|27231493|P1|Overall Study|Lost to Follow-up|8
7846801|NCT00152464|27231492|P2|Overall Study|Adverse Event|6
7846802|NCT00152464|27231493|P1|Overall Study|Adverse Event|3
7846803|NCT00152009|27231521|P4|Overall Study|Sponsor's decision|3
7846804|NCT00152009|27231522|P3|Overall Study|Sponsor's decision|1
7846805|NCT00152009|27231523|P2|Overall Study|Sponsor's decision|3
7846806|NCT00152009|27231524|P1|Overall Study|Sponsor's decision|3
7846807|NCT00152009|27231521|P4|Overall Study|ECG abnormalities|1
7846808|NCT00152009|27231522|P3|Overall Study|ECG abnormalities|2
7846809|NCT00152009|27231523|P2|Overall Study|ECG abnormalities|2
7846810|NCT00152009|27231524|P1|Overall Study|ECG abnormalities|2
7846811|NCT00152009|27231521|P4|Overall Study|Lack of Efficacy|15
7846812|NCT00152009|27231522|P3|Overall Study|Lack of Efficacy|7
7846813|NCT00152009|27231523|P2|Overall Study|Lack of Efficacy|6
7846814|NCT00152009|27231524|P1|Overall Study|Lack of Efficacy|8
7846815|NCT00152009|27231521|P4|Overall Study|Lost to Follow-up|3
7846816|NCT00152009|27231522|P3|Overall Study|Lost to Follow-up|3
7846817|NCT00152009|27231523|P2|Overall Study|Lost to Follow-up|4
7846818|NCT00152009|27231524|P1|Overall Study|Lost to Follow-up|2
7846819|NCT00152009|27231521|P4|Overall Study|Withdrawal by Subject|9
7846820|NCT00152009|27231522|P3|Overall Study|Withdrawal by Subject|4
7846821|NCT00152009|27231523|P2|Overall Study|Withdrawal by Subject|3
7846822|NCT00152009|27231524|P1|Overall Study|Withdrawal by Subject|2
7846823|NCT00152009|27231521|P4|Overall Study|Protocol Violation|1
7846824|NCT00152009|27231522|P3|Overall Study|Protocol Violation|0
7846825|NCT00152009|27231523|P2|Overall Study|Protocol Violation|0
7846826|NCT00152009|27231524|P1|Overall Study|Protocol Violation|3
7846827|NCT00152009|27231521|P4|Overall Study|Adverse Event|1
7846828|NCT00152009|27231522|P3|Overall Study|Adverse Event|20
7846829|NCT00152009|27231523|P2|Overall Study|Adverse Event|13
7846830|NCT00152009|27231524|P1|Overall Study|Adverse Event|9
7846831|NCT00151996|27231556|P2|Overall Study|Sponsor's decision|2
7846832|NCT00151996|27231557|P1|Overall Study|Sponsor's decision|0
7846833|NCT00151996|27231556|P2|Overall Study|Protocol Violation|2
7846834|NCT00151996|27231557|P1|Overall Study|Protocol Violation|1
7846835|NCT00151996|27231556|P2|Overall Study|Withdrawal by Subject|1
7846836|NCT00151996|27231557|P1|Overall Study|Withdrawal by Subject|1
7846837|NCT00151996|27231556|P2|Overall Study|Adverse Event|2
7846838|NCT00151996|27231557|P1|Overall Study|Adverse Event|3
7846839|NCT00151892|27231573|P2|Overall Study|Lack of study medication at center|1
7846840|NCT00151892|27231574|P1|Overall Study|Lack of study medication at center|0
7846841|NCT00151892|27231573|P2|Overall Study|Used prohibited corticosteroids|0
7846842|NCT00151892|27231574|P1|Overall Study|Used prohibited corticosteroids|1
7846843|NCT00151892|27231573|P2|Overall Study|Did not return for a visit|0
7846844|NCT00151892|27231574|P1|Overall Study|Did not return for a visit|1
7846845|NCT00151892|27231573|P2|Overall Study|Pregnancy|1
7846846|NCT00151892|27231574|P1|Overall Study|Pregnancy|0
7846847|NCT00151892|27231573|P2|Overall Study|Non-compliance|1
7846848|NCT00151892|27231574|P1|Overall Study|Non-compliance|0
7846849|NCT00151892|27231573|P2|Overall Study|Protocol Violation|3
7846850|NCT00151892|27231574|P1|Overall Study|Protocol Violation|3
7846851|NCT00151892|27231573|P2|Overall Study|Adverse Event|3
7846852|NCT00151892|27231574|P1|Overall Study|Adverse Event|6
7846853|NCT00151892|27231573|P2|Overall Study|Lost to Follow-up|10
7846854|NCT00151892|27231574|P1|Overall Study|Lost to Follow-up|5
7846855|NCT00151892|27231573|P2|Overall Study|Patient request|7
7846856|NCT00151892|27231574|P1|Overall Study|Patient request|10
7846857|NCT00151892|27231573|P2|Overall Study|Lack of Efficacy|57
7846858|NCT00151892|27231574|P1|Overall Study|Lack of Efficacy|50
7846859|NCT00151775|27231619|P12|Period 4: Open Label|Protocol Violation|0
7846860|NCT00151775|27231620|P11|Period 4: Open Label|Protocol Violation|0
7846861|NCT00151775|27231621|P10|Period 4: Open Label|Protocol Violation|0
7846862|NCT00151775|27231622|P9|Period 4: Open Label|Protocol Violation|0
7846863|NCT00151775|27231623|P8|Period 4: Open Label|Protocol Violation|0
7846864|NCT00151775|27231624|P7|Period 4: Open Label|Protocol Violation|0
7846865|NCT00151775|27231625|P6|Period 4: Open Label|Protocol Violation|0
7846866|NCT00151775|27231626|P5|Period 4: Open Label|Protocol Violation|1
7846867|NCT00151775|27231627|P4|Period 4: Open Label|Protocol Violation|0
7846868|NCT00151775|27231628|P3|Period 4: Open Label|Protocol Violation|0
7846869|NCT00151775|27231629|P2|Period 4: Open Label|Protocol Violation|0
7846870|NCT00151775|27231630|P1|Period 4: Open Label|Protocol Violation|0
7846871|NCT00151775|27231619|P12|Period 4: Open Label|Physician Decision|0
7846872|NCT00151775|27231620|P11|Period 4: Open Label|Physician Decision|0
7846873|NCT00151775|27231621|P10|Period 4: Open Label|Physician Decision|2
7846874|NCT00151775|27231622|P9|Period 4: Open Label|Physician Decision|0
7846875|NCT00151775|27231623|P8|Period 4: Open Label|Physician Decision|0
7846876|NCT00151775|27231624|P7|Period 4: Open Label|Physician Decision|0
7846877|NCT00151775|27231625|P6|Period 4: Open Label|Physician Decision|0
7846878|NCT00151775|27231626|P5|Period 4: Open Label|Physician Decision|0
7846879|NCT00151775|27231627|P4|Period 4: Open Label|Physician Decision|0
7846880|NCT00151775|27231628|P3|Period 4: Open Label|Physician Decision|0
7846881|NCT00151775|27231629|P2|Period 4: Open Label|Physician Decision|0
7846882|NCT00151775|27231630|P1|Period 4: Open Label|Physician Decision|0
7846883|NCT00151775|27231619|P12|Period 4: Open Label|Other|0
7846884|NCT00151775|27231620|P11|Period 4: Open Label|Other|0
7846885|NCT00151775|27231621|P10|Period 4: Open Label|Other|3
7846886|NCT00151775|27231622|P9|Period 4: Open Label|Other|0
7846887|NCT00151775|27231623|P8|Period 4: Open Label|Other|0
7846888|NCT00151775|27231624|P7|Period 4: Open Label|Other|0
7846889|NCT00151775|27231625|P6|Period 4: Open Label|Other|0
7846890|NCT00151775|27231626|P5|Period 4: Open Label|Other|1
7846891|NCT00151775|27231627|P4|Period 4: Open Label|Other|0
7846892|NCT00151775|27231628|P3|Period 4: Open Label|Other|0
7846893|NCT00151775|27231629|P2|Period 4: Open Label|Other|0
7846894|NCT00151775|27231630|P1|Period 4: Open Label|Other|0
7846895|NCT00151775|27231619|P12|Period 4: Open Label|Non-compliance with protocol|0
7846896|NCT00151775|27231620|P11|Period 4: Open Label|Non-compliance with protocol|0
7846897|NCT00151775|27231621|P10|Period 4: Open Label|Non-compliance with protocol|4
7846898|NCT00151775|27231622|P9|Period 4: Open Label|Non-compliance with protocol|0
7846899|NCT00151775|27231623|P8|Period 4: Open Label|Non-compliance with protocol|0
7846900|NCT00151775|27231624|P7|Period 4: Open Label|Non-compliance with protocol|0
7846901|NCT00151775|27231625|P6|Period 4: Open Label|Non-compliance with protocol|0
7846902|NCT00151775|27231626|P5|Period 4: Open Label|Non-compliance with protocol|4
7846903|NCT00151775|27231627|P4|Period 4: Open Label|Non-compliance with protocol|0
7846904|NCT00151775|27231628|P3|Period 4: Open Label|Non-compliance with protocol|0
7846905|NCT00151775|27231629|P2|Period 4: Open Label|Non-compliance with protocol|0
7846906|NCT00151775|27231630|P1|Period 4: Open Label|Non-compliance with protocol|0
7846907|NCT00151775|27231619|P12|Period 4: Open Label|Lost to Follow-up|0
7846908|NCT00151775|27231620|P11|Period 4: Open Label|Lost to Follow-up|0
7846909|NCT00151775|27231621|P10|Period 4: Open Label|Lost to Follow-up|7
7846910|NCT00151775|27231622|P9|Period 4: Open Label|Lost to Follow-up|0
7846911|NCT00151775|27231623|P8|Period 4: Open Label|Lost to Follow-up|0
7846912|NCT00151775|27231624|P7|Period 4: Open Label|Lost to Follow-up|0
7846913|NCT00151775|27231625|P6|Period 4: Open Label|Lost to Follow-up|0
7846914|NCT00151775|27231626|P5|Period 4: Open Label|Lost to Follow-up|17
7846915|NCT00151775|27231627|P4|Period 4: Open Label|Lost to Follow-up|0
7846916|NCT00151775|27231628|P3|Period 4: Open Label|Lost to Follow-up|0
7846917|NCT00151775|27231629|P2|Period 4: Open Label|Lost to Follow-up|0
7846918|NCT00151775|27231630|P1|Period 4: Open Label|Lost to Follow-up|0
7846919|NCT00151775|27231619|P12|Period 4: Open Label|Adverse Event|0
7846920|NCT00151775|27231620|P11|Period 4: Open Label|Adverse Event|0
7846921|NCT00151775|27231621|P10|Period 4: Open Label|Adverse Event|2
7846922|NCT00151775|27231622|P9|Period 4: Open Label|Adverse Event|0
7846923|NCT00151775|27231623|P8|Period 4: Open Label|Adverse Event|0
7846924|NCT00151775|27231624|P7|Period 4: Open Label|Adverse Event|0
7846925|NCT00151775|27231625|P6|Period 4: Open Label|Adverse Event|0
7846926|NCT00151775|27231626|P5|Period 4: Open Label|Adverse Event|1
7846927|NCT00151775|27231627|P4|Period 4: Open Label|Adverse Event|0
7846928|NCT00151775|27231628|P3|Period 4: Open Label|Adverse Event|0
7846929|NCT00151775|27231629|P2|Period 4: Open Label|Adverse Event|0
7846930|NCT00151775|27231630|P1|Period 4: Open Label|Adverse Event|0
7846931|NCT00151775|27231619|P12|Period 4: Open Label|Withdrawal by Subject|0
7846932|NCT00151775|27231620|P11|Period 4: Open Label|Withdrawal by Subject|0
7846933|NCT00151775|27231621|P10|Period 4: Open Label|Withdrawal by Subject|2
7846934|NCT00151775|27231622|P9|Period 4: Open Label|Withdrawal by Subject|0
7846935|NCT00151775|27231623|P8|Period 4: Open Label|Withdrawal by Subject|0
7846936|NCT00151775|27231624|P7|Period 4: Open Label|Withdrawal by Subject|0
7846937|NCT00151775|27231625|P6|Period 4: Open Label|Withdrawal by Subject|0
7846938|NCT00151775|27231626|P5|Period 4: Open Label|Withdrawal by Subject|5
7846939|NCT00151775|27231627|P4|Period 4: Open Label|Withdrawal by Subject|0
7846940|NCT00151775|27231628|P3|Period 4: Open Label|Withdrawal by Subject|0
7846941|NCT00151775|27231629|P2|Period 4: Open Label|Withdrawal by Subject|0
7846942|NCT00151775|27231630|P1|Period 4: Open Label|Withdrawal by Subject|0
7846943|NCT00151775|27231619|P12|Period 4: Open Label|Increased blood pressure|0
7846944|NCT00151775|27231620|P11|Period 4: Open Label|Increased blood pressure|0
7846945|NCT00151775|27231621|P10|Period 4: Open Label|Increased blood pressure|1
7846946|NCT00151775|27231622|P9|Period 4: Open Label|Increased blood pressure|0
7846947|NCT00151775|27231623|P8|Period 4: Open Label|Increased blood pressure|0
7846948|NCT00151775|27231624|P7|Period 4: Open Label|Increased blood pressure|0
7846949|NCT00151775|27231625|P6|Period 4: Open Label|Increased blood pressure|0
7846950|NCT00151775|27231626|P5|Period 4: Open Label|Increased blood pressure|1
7846951|NCT00151775|27231627|P4|Period 4: Open Label|Increased blood pressure|0
7846952|NCT00151775|27231628|P3|Period 4: Open Label|Increased blood pressure|0
7846953|NCT00151775|27231629|P2|Period 4: Open Label|Increased blood pressure|0
7846954|NCT00151775|27231630|P1|Period 4: Open Label|Increased blood pressure|0
7846955|NCT00151775|27231619|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
7846956|NCT00151775|27231620|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846957|NCT00151775|27231621|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846958|NCT00151775|27231622|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846959|NCT00151775|27231623|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846960|NCT00151775|27231624|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846961|NCT00151775|27231625|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846962|NCT00151775|27231626|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846963|NCT00151775|27231627|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846964|NCT00151775|27231628|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846965|NCT00151775|27231629|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846966|NCT00151775|27231630|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7846967|NCT00151775|27231619|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846968|NCT00151775|27231620|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846969|NCT00151775|27231621|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846970|NCT00151775|27231622|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846971|NCT00151775|27231623|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846972|NCT00151775|27231624|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846973|NCT00151775|27231625|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846974|NCT00151775|27231626|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846975|NCT00151775|27231627|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846976|NCT00151775|27231628|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
7846977|NCT00151775|27231629|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846978|NCT00151775|27231630|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7846979|NCT00151775|27231619|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846980|NCT00151775|27231620|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846981|NCT00151775|27231621|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846982|NCT00151775|27231622|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846983|NCT00151775|27231623|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846984|NCT00151775|27231624|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846985|NCT00151775|27231625|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846986|NCT00151775|27231626|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846987|NCT00151775|27231627|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846988|NCT00151775|27231628|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
7846989|NCT00151775|27231629|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846990|NCT00151775|27231630|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
7846991|NCT00151775|27231619|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846992|NCT00151775|27231620|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846993|NCT00151775|27231621|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846994|NCT00151775|27231622|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846995|NCT00151775|27231623|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846996|NCT00151775|27231624|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
7846997|NCT00151775|27231625|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846998|NCT00151775|27231626|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7846999|NCT00151775|27231627|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7847000|NCT00151775|27231628|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7847001|NCT00151775|27231629|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7847002|NCT00151775|27231630|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7847003|NCT00151775|27231619|P12|Period 3: Double-blind, Withdrawal|Other|0
7847004|NCT00151775|27231620|P11|Period 3: Double-blind, Withdrawal|Other|0
7847005|NCT00151775|27231621|P10|Period 3: Double-blind, Withdrawal|Other|0
7847006|NCT00151775|27231622|P9|Period 3: Double-blind, Withdrawal|Other|0
7847007|NCT00151775|27231623|P8|Period 3: Double-blind, Withdrawal|Other|1
7847008|NCT00151775|27231624|P7|Period 3: Double-blind, Withdrawal|Other|0
7847009|NCT00151775|27231625|P6|Period 3: Double-blind, Withdrawal|Other|0
7847010|NCT00151775|27231626|P5|Period 3: Double-blind, Withdrawal|Other|0
7847011|NCT00151775|27231627|P4|Period 3: Double-blind, Withdrawal|Other|0
7847012|NCT00151775|27231628|P3|Period 3: Double-blind, Withdrawal|Other|1
7847013|NCT00151775|27231629|P2|Period 3: Double-blind, Withdrawal|Other|0
7847014|NCT00151775|27231630|P1|Period 3: Double-blind, Withdrawal|Other|0
7847015|NCT00151775|27231619|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847016|NCT00151775|27231620|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847017|NCT00151775|27231621|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847018|NCT00151775|27231622|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847019|NCT00151775|27231623|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847020|NCT00151775|27231624|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847021|NCT00151775|27231625|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
7847022|NCT00151775|27231626|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847023|NCT00151775|27231627|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847024|NCT00151775|27231628|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847025|NCT00151775|27231629|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847026|NCT00151775|27231630|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7847027|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847028|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847029|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847030|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847031|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847032|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
7847033|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847034|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847035|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847036|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847037|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847038|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7847039|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847040|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847041|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847042|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847043|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847044|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847045|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
7847046|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847047|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847048|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847049|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847050|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
7847051|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
7847052|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
7847053|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
7847054|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
7847055|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
7847056|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
7847057|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
7847058|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
7847059|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
7847060|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
7847061|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
7847062|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
7847063|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|Other|0
7847064|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|Other|0
7847065|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|Other|0
7847066|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|Other|0
7847067|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|Other|0
7847068|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|Other|1
7847069|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|Other|0
7847070|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|Other|0
7847071|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|Other|0
7847072|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|Other|0
7847073|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|Other|0
7847074|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|Other|0
7847075|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847076|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847077|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847078|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847079|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847080|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847081|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847082|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847083|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847084|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847085|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
7847086|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7847087|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847088|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7847089|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847090|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847091|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847092|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7847093|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847094|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847095|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847096|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847097|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7847098|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7847099|NCT00151775|27231619|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847100|NCT00151775|27231620|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847101|NCT00151775|27231621|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847102|NCT00151775|27231622|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847103|NCT00151775|27231623|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847104|NCT00151775|27231624|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847105|NCT00151775|27231625|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847106|NCT00151775|27231626|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847107|NCT00151775|27231627|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847108|NCT00151775|27231628|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
7847109|NCT00151775|27231629|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
7847110|NCT00151775|27231630|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
7847111|NCT00151476|27231674|P2|FAP Analyzed Subjects|Other study participation|1
7847112|NCT00151476|27231675|P1|FAP Analyzed Subjects|Other study participation|0
7847113|NCT00151476|27231674|P2|FAP Analyzed Subjects|Lost to Follow-up|2
7847114|NCT00151476|27231675|P1|FAP Analyzed Subjects|Lost to Follow-up|0
7847115|NCT00151476|27231674|P2|FAP Identified Subjects|Protocol Violation|1
7847116|NCT00151476|27231675|P1|FAP Identified Subjects|Protocol Violation|0
7847117|NCT00151411|27231732|P2|Overall Study|Pregnancy|4
7847118|NCT00151411|27231733|P1|Overall Study|Pregnancy|0
7847119|NCT00151411|27231732|P2|Overall Study|Adverse Event|0
7847120|NCT00151411|27231733|P1|Overall Study|Adverse Event|6
7847121|NCT00151411|27231732|P2|Overall Study|Withdrawal by Subject|20
7847122|NCT00151411|27231733|P1|Overall Study|Withdrawal by Subject|12
7847123|NCT00151411|27231732|P2|Overall Study|Lost to Follow-up|19
7847124|NCT00151411|27231733|P1|Overall Study|Lost to Follow-up|15
7847125|NCT00151372|27231745|P2|Overall Study|Withdrawal by Subject|7
7847126|NCT00151372|27231746|P1|Overall Study|Withdrawal by Subject|7
7847127|NCT00151372|27231745|P2|Overall Study|Too sick medically to continue|6
7847128|NCT00151372|27231746|P1|Overall Study|Too sick medically to continue|5
7847129|NCT00151372|27231745|P2|Overall Study|Lost to Follow-up|5
7847130|NCT00151372|27231746|P1|Overall Study|Lost to Follow-up|5
7847131|NCT00151372|27231745|P2|Overall Study|Death|11
7847132|NCT00151372|27231746|P1|Overall Study|Death|12
7847133|NCT00151281|27231761|P1|Overall Study|Not evaluable|3
7847134|NCT00150969|27231770|P2|24-48 Month Extension|Other Reason|91
7847135|NCT00150969|27231771|P1|24-48 Month Extension|Other Reason|81
7847136|NCT00150969|27231770|P2|24-48 Month Extension|Adverse Event|3
7847137|NCT00150969|27231771|P1|24-48 Month Extension|Adverse Event|1
7847138|NCT00150969|27231770|P2|24-48 Month Extension|Lack of Efficacy|1
7847139|NCT00150969|27231771|P1|24-48 Month Extension|Lack of Efficacy|0
7847140|NCT00150969|27231770|P2|24-48 Month Extension|Withdrawal by Subject|5
7847141|NCT00150969|27231771|P1|24-48 Month Extension|Withdrawal by Subject|6
7847142|NCT00150969|27231770|P2|24 Month Main Study|Withdrawal by Subject|4
7847143|NCT00150969|27231771|P1|24 Month Main Study|Withdrawal by Subject|7
7847144|NCT00150969|27231770|P2|24 Month Main Study|Protocol Violation|2
7847145|NCT00150969|27231771|P1|24 Month Main Study|Protocol Violation|4
7847146|NCT00150969|27231770|P2|24 Month Main Study|Lost to Follow-up|2
7847147|NCT00150969|27231771|P1|24 Month Main Study|Lost to Follow-up|3
7847148|NCT00150969|27231770|P2|24 Month Main Study|Lack of Efficacy|8
7847149|NCT00150969|27231771|P1|24 Month Main Study|Lack of Efficacy|1
7847150|NCT00150969|27231770|P2|24 Month Main Study|Death|1
7847151|NCT00150969|27231771|P1|24 Month Main Study|Death|1
7847152|NCT00150969|27231770|P2|24 Month Main Study|Adverse Event|4
7847153|NCT00150969|27231771|P1|24 Month Main Study|Adverse Event|3
7847154|NCT00150813|27231803|P1|Overall Study|Switch to commercially available LEV|2
7847155|NCT00150813|27231803|P1|Overall Study|Planned pregancy|1
7847156|NCT00150813|27231803|P1|Overall Study|Remission|3
7847157|NCT00150813|27231803|P1|Overall Study|Withdrawal by Subject|5
7847158|NCT00150813|27231803|P1|Overall Study|Lost to Follow-up|5
7847159|NCT00150813|27231803|P1|Overall Study|Lack of Efficacy|1
7847160|NCT00150813|27231803|P1|Overall Study|Adverse Event|1
7847161|NCT00150800|27231807|P1|Overall Study|PI discontinuation request|1
7847162|NCT00150800|27231807|P1|Overall Study|Pregnancy planned|1
7847163|NCT00150800|27231807|P1|Overall Study|Surgical intervention|4
7847164|NCT00150800|27231807|P1|Overall Study|Patient insurance|1
7847165|NCT00150800|27231807|P1|Overall Study|PI leaving site|2
7847166|NCT00150800|27231807|P1|Overall Study|PI retiring|2
7847167|NCT00150800|27231807|P1|Overall Study|Moved from area/country|8
7847168|NCT00150800|27231807|P1|Overall Study|Generalized Epilepsy|1
7847169|NCT00150800|27231807|P1|Overall Study|Sponsor's request|2
7847170|NCT00150800|27231807|P1|Overall Study|Visit refusal|3
7847171|NCT00150800|27231807|P1|Overall Study|BRV monotherapy|1
7847172|NCT00150800|27231807|P1|Overall Study|Neurosurgery|2
7847173|NCT00150800|27231807|P1|Overall Study|Distance too long for patient|1
7847174|NCT00150800|27231807|P1|Overall Study|Nobody to accompany patient|1
7847175|NCT00150800|27231807|P1|Overall Study|Protocol non-adherence|2
7847176|NCT00150800|27231807|P1|Overall Study|Site closure|24
7847177|NCT00150800|27231807|P1|Overall Study|IP misshandling|1
7847178|NCT00150800|27231807|P1|Overall Study|No compliance|18
7847179|NCT00150800|27231807|P1|Overall Study|Subject's choice|90
7847180|NCT00150800|27231807|P1|Overall Study|Lost to Follow-up|58
7847181|NCT00150800|27231807|P1|Overall Study|Lack of Efficacy|166
7847182|NCT00150800|27231807|P1|Overall Study|Death|18
7847183|NCT00150800|27231807|P1|Overall Study|Adverse Event|89
7847184|NCT00150618|27231821|P5|Overall Study|Sponsor's decision|0
7847185|NCT00150618|27231822|P4|Overall Study|Sponsor's decision|1
7847186|NCT00150618|27231823|P3|Overall Study|Sponsor's decision|0
7847187|NCT00150618|27231824|P2|Overall Study|Sponsor's decision|0
7847188|NCT00150618|27231825|P1|Overall Study|Sponsor's decision|0
7847189|NCT00150618|27231821|P5|Overall Study|Abnormal ECG|0
7847190|NCT00150618|27231822|P4|Overall Study|Abnormal ECG|0
7847191|NCT00150618|27231823|P3|Overall Study|Abnormal ECG|0
7847192|NCT00150618|27231824|P2|Overall Study|Abnormal ECG|0
7847193|NCT00150618|27231825|P1|Overall Study|Abnormal ECG|1
7847194|NCT00150618|27231821|P5|Overall Study|Lack of compliance|1
7847195|NCT00150618|27231822|P4|Overall Study|Lack of compliance|0
7847196|NCT00150618|27231823|P3|Overall Study|Lack of compliance|1
7847197|NCT00150618|27231824|P2|Overall Study|Lack of compliance|1
7847198|NCT00150618|27231825|P1|Overall Study|Lack of compliance|2
7847199|NCT00150618|27231821|P5|Overall Study|Physician Decision|1
7847200|NCT00150618|27231822|P4|Overall Study|Physician Decision|0
7847201|NCT00150618|27231823|P3|Overall Study|Physician Decision|0
7847202|NCT00150618|27231824|P2|Overall Study|Physician Decision|2
7847203|NCT00150618|27231825|P1|Overall Study|Physician Decision|0
7847204|NCT00150618|27231821|P5|Overall Study|No study meds|2
7847205|NCT00150618|27231822|P4|Overall Study|No study meds|0
7847206|NCT00150618|27231823|P3|Overall Study|No study meds|0
7847207|NCT00150618|27231824|P2|Overall Study|No study meds|0
7847208|NCT00150618|27231825|P1|Overall Study|No study meds|0
7847209|NCT00150618|27231821|P5|Overall Study|Lack of Efficacy|6
7847210|NCT00150618|27231822|P4|Overall Study|Lack of Efficacy|4
7847211|NCT00150618|27231823|P3|Overall Study|Lack of Efficacy|7
7847212|NCT00150618|27231824|P2|Overall Study|Lack of Efficacy|4
7847213|NCT00150618|27231825|P1|Overall Study|Lack of Efficacy|1
7847214|NCT00150618|27231821|P5|Overall Study|Protocol Violation|1
7847215|NCT00150618|27231822|P4|Overall Study|Protocol Violation|0
7847216|NCT00150618|27231823|P3|Overall Study|Protocol Violation|0
7847217|NCT00150618|27231824|P2|Overall Study|Protocol Violation|0
7847218|NCT00150618|27231825|P1|Overall Study|Protocol Violation|1
7847219|NCT00150618|27231821|P5|Overall Study|Lost to Follow-up|4
7847220|NCT00150618|27231822|P4|Overall Study|Lost to Follow-up|8
7847221|NCT00150618|27231823|P3|Overall Study|Lost to Follow-up|5
7847222|NCT00150618|27231824|P2|Overall Study|Lost to Follow-up|1
7847223|NCT00150618|27231825|P1|Overall Study|Lost to Follow-up|4
7847224|NCT00150618|27231821|P5|Overall Study|Withdrawal by Subject|5
7847225|NCT00150618|27231822|P4|Overall Study|Withdrawal by Subject|4
7847226|NCT00150618|27231823|P3|Overall Study|Withdrawal by Subject|8
7847227|NCT00150618|27231824|P2|Overall Study|Withdrawal by Subject|8
7847228|NCT00150618|27231825|P1|Overall Study|Withdrawal by Subject|6
7847229|NCT00150618|27231821|P5|Overall Study|Adverse Event|5
7847230|NCT00150618|27231822|P4|Overall Study|Adverse Event|9
7847231|NCT00150618|27231823|P3|Overall Study|Adverse Event|6
7847232|NCT00150618|27231824|P2|Overall Study|Adverse Event|2
7847233|NCT00150618|27231825|P1|Overall Study|Adverse Event|2
7847234|NCT00150592|27231859|P2|Overall Study|Non-compliance|0
7847235|NCT00150592|27231860|P1|Overall Study|Non-compliance|1
7847236|NCT00150592|27231859|P2|Overall Study|Withdrawal by Subject|2
7847237|NCT00150592|27231860|P1|Overall Study|Withdrawal by Subject|1
7847238|NCT00150592|27231859|P2|Overall Study|Protocol Violation|0
7847239|NCT00150592|27231860|P1|Overall Study|Protocol Violation|1
7847240|NCT00150592|27231859|P2|Overall Study|Adverse Event|1
7847241|NCT00150592|27231860|P1|Overall Study|Adverse Event|4
7847242|NCT00150462|27231891|P11|Overall Study|Other|1
7847243|NCT00150462|27231892|P10|Overall Study|Other|1
7847244|NCT00150462|27231893|P9|Overall Study|Other|0
7847245|NCT00150462|27231894|P8|Overall Study|Other|0
7847246|NCT00150462|27231895|P7|Overall Study|Other|0
7847247|NCT00150462|27231896|P6|Overall Study|Other|0
7847248|NCT00150462|27231897|P5|Overall Study|Other|0
7847249|NCT00150462|27231898|P4|Overall Study|Other|0
7847250|NCT00150462|27231899|P3|Overall Study|Other|0
7847251|NCT00150462|27231900|P2|Overall Study|Other|0
7847252|NCT00150462|27231901|P1|Overall Study|Other|0
7847253|NCT00150462|27231891|P11|Overall Study|Physician Decision|0
7847254|NCT00150462|27231892|P10|Overall Study|Physician Decision|0
7847255|NCT00150462|27231893|P9|Overall Study|Physician Decision|0
7847256|NCT00150462|27231894|P8|Overall Study|Physician Decision|0
7847257|NCT00150462|27231895|P7|Overall Study|Physician Decision|0
7847258|NCT00150462|27231896|P6|Overall Study|Physician Decision|0
7847259|NCT00150462|27231897|P5|Overall Study|Physician Decision|0
7847260|NCT00150462|27231898|P4|Overall Study|Physician Decision|1
7847261|NCT00150462|27231899|P3|Overall Study|Physician Decision|1
7847262|NCT00150462|27231900|P2|Overall Study|Physician Decision|0
7847263|NCT00150462|27231901|P1|Overall Study|Physician Decision|0
7847264|NCT00150462|27231891|P11|Overall Study|Adverse Event|0
7847265|NCT00150462|27231892|P10|Overall Study|Adverse Event|1
7847266|NCT00150462|27231893|P9|Overall Study|Adverse Event|0
7847267|NCT00150462|27231894|P8|Overall Study|Adverse Event|2
7847268|NCT00150462|27231895|P7|Overall Study|Adverse Event|0
7847269|NCT00150462|27231896|P6|Overall Study|Adverse Event|0
7847270|NCT00150462|27231897|P5|Overall Study|Adverse Event|0
7847271|NCT00150462|27231898|P4|Overall Study|Adverse Event|1
7847272|NCT00150462|27231899|P3|Overall Study|Adverse Event|0
7847273|NCT00150462|27231900|P2|Overall Study|Adverse Event|0
7847274|NCT00150462|27231901|P1|Overall Study|Adverse Event|0
7847275|NCT00150462|27231891|P11|Overall Study|Death|0
7847276|NCT00150462|27231892|P10|Overall Study|Death|0
7847277|NCT00150462|27231893|P9|Overall Study|Death|1
7847278|NCT00150462|27231894|P8|Overall Study|Death|0
7847279|NCT00150462|27231895|P7|Overall Study|Death|0
7847280|NCT00150462|27231896|P6|Overall Study|Death|0
7847281|NCT00150462|27231897|P5|Overall Study|Death|0
7847282|NCT00150462|27231898|P4|Overall Study|Death|0
7847283|NCT00150462|27231899|P3|Overall Study|Death|0
7847284|NCT00150462|27231900|P2|Overall Study|Death|1
7847285|NCT00150462|27231901|P1|Overall Study|Death|0
7847286|NCT00150462|27231891|P11|Overall Study|Withdrawal by Subject|0
7847287|NCT00150462|27231892|P10|Overall Study|Withdrawal by Subject|1
7847288|NCT00150462|27231893|P9|Overall Study|Withdrawal by Subject|0
7847289|NCT00150462|27231894|P8|Overall Study|Withdrawal by Subject|1
7847290|NCT00150462|27231895|P7|Overall Study|Withdrawal by Subject|0
7847291|NCT00150462|27231896|P6|Overall Study|Withdrawal by Subject|2
7847292|NCT00150462|27231897|P5|Overall Study|Withdrawal by Subject|1
7847293|NCT00150462|27231898|P4|Overall Study|Withdrawal by Subject|0
7847294|NCT00150462|27231899|P3|Overall Study|Withdrawal by Subject|1
7847295|NCT00150462|27231900|P2|Overall Study|Withdrawal by Subject|1
7847296|NCT00150462|27231901|P1|Overall Study|Withdrawal by Subject|0
7847297|NCT00150462|27231891|P11|Overall Study|Disease Progression or Relapse|2
7847298|NCT00150462|27231892|P10|Overall Study|Disease Progression or Relapse|3
7847299|NCT00150462|27231893|P9|Overall Study|Disease Progression or Relapse|5
7847300|NCT00150462|27231894|P8|Overall Study|Disease Progression or Relapse|5
7847301|NCT00150462|27231895|P7|Overall Study|Disease Progression or Relapse|3
7847302|NCT00150462|27231896|P6|Overall Study|Disease Progression or Relapse|2
7847303|NCT00150462|27231897|P5|Overall Study|Disease Progression or Relapse|2
7847304|NCT00150462|27231898|P4|Overall Study|Disease Progression or Relapse|1
7847305|NCT00150462|27231899|P3|Overall Study|Disease Progression or Relapse|2
7847306|NCT00150462|27231900|P2|Overall Study|Disease Progression or Relapse|1
7847307|NCT00150462|27231901|P1|Overall Study|Disease Progression or Relapse|3
7847308|NCT00150345|27232011|P2|Overall Study|Other|14
7847309|NCT00150345|27232012|P1|Overall Study|Other|12
7847310|NCT00150345|27232011|P2|Overall Study|Laboratory abnormality|2
7847311|NCT00150345|27232012|P1|Overall Study|Laboratory abnormality|1
7847312|NCT00150345|27232011|P2|Overall Study|Withdrawal by Subject|4
7847313|NCT00150345|27232012|P1|Overall Study|Withdrawal by Subject|3
7847314|NCT00150345|27232011|P2|Overall Study|Lack of Efficacy|4
7847315|NCT00150345|27232012|P1|Overall Study|Lack of Efficacy|5
7847316|NCT00150345|27232011|P2|Overall Study|Adverse Event|6
7847317|NCT00150345|27232012|P1|Overall Study|Adverse Event|8
7847318|NCT00150345|27232011|P2|Overall Study|Death|2
7847319|NCT00150345|27232012|P1|Overall Study|Death|5
7847320|NCT00150176|27232076|P2|Overall Study|OTHER|13
7847321|NCT00150176|27232077|P1|Overall Study|OTHER|11
7847322|NCT00150176|27232076|P2|Overall Study|Lost to Follow-up|3
7847323|NCT00150176|27232077|P1|Overall Study|Lost to Follow-up|3
7847324|NCT00150176|27232076|P2|Overall Study|Withdrawal by Subject|12
7847325|NCT00150176|27232077|P1|Overall Study|Withdrawal by Subject|19
7847326|NCT00150176|27232076|P2|Overall Study|Relapse/Impending relapse, non-AE|39
7847327|NCT00150176|27232077|P1|Overall Study|Relapse/Impending relapse, non-AE|10
7847328|NCT00150176|27232076|P2|Overall Study|Adverse Event|53
7847329|NCT00150176|27232077|P1|Overall Study|Adverse Event|16
7847330|NCT00149994|27232088|P2|Overall Study|Protocol Violation|1
7847331|NCT00149994|27232089|P1|Overall Study|Protocol Violation|0
7847332|NCT00149994|27232088|P2|Overall Study|Administrative problems:|0
7847333|NCT00149994|27232089|P1|Overall Study|Administrative problems:|1
7847334|NCT00149890|27232097|P2|Overall Study|Graft Loss|1
7847335|NCT00149890|27232098|P1|Overall Study|Graft Loss|2
7847336|NCT00149890|27232097|P2|Overall Study|Lost to Follow-up|0
7847337|NCT00149890|27232098|P1|Overall Study|Lost to Follow-up|1
7847338|NCT00149890|27232097|P2|Overall Study|Protocol Violation|0
7847339|NCT00149890|27232098|P1|Overall Study|Protocol Violation|1
7847340|NCT00149890|27232097|P2|Overall Study|Lack of Efficacy|9
7847341|NCT00149890|27232098|P1|Overall Study|Lack of Efficacy|8
7847342|NCT00149890|27232097|P2|Overall Study|Adverse Event|8
7847343|NCT00149890|27232098|P1|Overall Study|Adverse Event|1
7847344|NCT00149825|27232133|P2|Overall Study|Other|0
7847345|NCT00149825|27232134|P1|Overall Study|Other|1
7847346|NCT00149825|27232133|P2|Overall Study|Not liking insomnia therapy|0
7847347|NCT00149825|27232134|P1|Overall Study|Not liking insomnia therapy|1
7847348|NCT00149825|27232133|P2|Overall Study|Time commitments|1
7847349|NCT00149825|27232134|P1|Overall Study|Time commitments|2
7847350|NCT00149825|27232133|P2|Overall Study|Intolerance to medication side effects|2
7847351|NCT00149825|27232134|P1|Overall Study|Intolerance to medication side effects|1
7847352|NCT00149747|27232162|P2|Overall Study|Withdrawal by Subject|3
7847353|NCT00149747|27232163|P1|Overall Study|Withdrawal by Subject|3
7847354|NCT00149747|27232162|P2|Overall Study|Death|0
7847355|NCT00149747|27232163|P1|Overall Study|Death|1
7847356|NCT00149630|27232218|P2|Overall Study|Adverse Event|0
7847357|NCT00149630|27232219|P1|Overall Study|Adverse Event|2
7847358|NCT00149630|27232218|P2|Overall Study|Treatment Programs|5
7847359|NCT00149630|27232219|P1|Overall Study|Treatment Programs|4
7847360|NCT00149630|27232218|P2|Overall Study|Incarceration|0
7847361|NCT00149630|27232219|P1|Overall Study|Incarceration|2
7847362|NCT00149396|27232229|P1|Overall Study|other treatment|5
7847363|NCT00149396|27232229|P1|Overall Study|Subject noncompliance|2
7847364|NCT00149396|27232229|P1|Overall Study|Withdrawal by Subject|1
7847365|NCT00149396|27232229|P1|Overall Study|Death|15
7847366|NCT00149214|27232299|P2|Overall Study|Progressive Disease|3
7847367|NCT00149214|27232300|P1|Overall Study|Progressive Disease|7
7847368|NCT00149214|27232299|P2|Overall Study|Sponsor Decision|1
7847369|NCT00149214|27232300|P1|Overall Study|Sponsor Decision|0
7847370|NCT00149214|27232299|P2|Overall Study|Physician Decision|3
7847371|NCT00149214|27232300|P1|Overall Study|Physician Decision|3
7847372|NCT00149214|27232299|P2|Overall Study|Withdrawal by Subject|1
7847373|NCT00149214|27232300|P1|Overall Study|Withdrawal by Subject|4
7847374|NCT00149214|27232299|P2|Overall Study|Adverse Event|9
7847375|NCT00149214|27232300|P1|Overall Study|Adverse Event|12
7847376|NCT00148941|27232327|P4|Overall Study|Other|2
7847377|NCT00148941|27232328|P3|Overall Study|Other|1
7847378|NCT00148941|27232329|P2|Overall Study|Other|0
7847379|NCT00148941|27232330|P1|Overall Study|Other|0
7847380|NCT00148941|27232327|P4|Overall Study|Withdrawal by Subject|0
7847381|NCT00148941|27232328|P3|Overall Study|Withdrawal by Subject|1
7847382|NCT00148941|27232329|P2|Overall Study|Withdrawal by Subject|0
7847383|NCT00148941|27232330|P1|Overall Study|Withdrawal by Subject|1
7847384|NCT00148941|27232327|P4|Overall Study|Lost to Follow-up|22
7847385|NCT00148941|27232328|P3|Overall Study|Lost to Follow-up|18
7847386|NCT00148941|27232329|P2|Overall Study|Lost to Follow-up|24
7847387|NCT00148941|27232330|P1|Overall Study|Lost to Follow-up|17
7847388|NCT00148759|27232445|P2|Overall Study|Lost to Follow-up|0
7847389|NCT00148759|27232446|P1|Overall Study|Lost to Follow-up|1
7847390|NCT00148759|27232445|P2|Overall Study|Withdrawal by Subject|1
7847391|NCT00148759|27232446|P1|Overall Study|Withdrawal by Subject|1
7847392|NCT00148343|27232474|P2|Overall Study|Physician Decision|4
7847393|NCT00148343|27232475|P1|Overall Study|Physician Decision|3
7847394|NCT00148343|27232474|P2|Overall Study|Withdrawal by Subject|7
7847395|NCT00148343|27232475|P1|Overall Study|Withdrawal by Subject|12
7847396|NCT00148317|27232489|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
7847397|NCT00148317|27232489|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
7847398|NCT00148317|27232489|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
7847399|NCT00148122|27232496|P1|Overall Study|Withdrawal by Subject|2
7847400|NCT00148109|27232504|P2|Overall Study|Withdrawal by Subject|0
7847401|NCT00148109|27232505|P1|Overall Study|Withdrawal by Subject|2
7847402|NCT00148109|27232504|P2|Overall Study|Adverse Event|2
7847403|NCT00148109|27232505|P1|Overall Study|Adverse Event|0
7847404|NCT00148109|27232504|P2|Overall Study|Lack of Efficacy|18
7847405|NCT00148109|27232505|P1|Overall Study|Lack of Efficacy|10
7847406|NCT00147823|27232521|P2|Overall Study|Did not receive vitoss due to infection|2
7847407|NCT00147823|27232522|P1|Overall Study|Did not receive vitoss due to infection|6
7847408|NCT00147823|27232521|P2|Overall Study|Withdrawal by Subject|1
7847409|NCT00147823|27232522|P1|Overall Study|Withdrawal by Subject|0
7847410|NCT00147823|27232521|P2|Overall Study|Physician Decision|0
7847411|NCT00147823|27232522|P1|Overall Study|Physician Decision|1
7847412|NCT00147823|27232521|P2|Overall Study|Lost to Follow-up|12
7847413|NCT00147823|27232522|P1|Overall Study|Lost to Follow-up|6
7847414|NCT00147745|27232553|P3|Overall Study|Withdrawal by Subject|0
7847415|NCT00147745|27232554|P2|Overall Study|Withdrawal by Subject|0
7847416|NCT00147745|27232555|P1|Overall Study|Withdrawal by Subject|1
7847417|NCT00147537|27232577|P11|Phase 2|Randomized but not treated|1
7847418|NCT00147537|27232578|P10|Phase 2|Randomized but not treated|1
7847419|NCT00147537|27232579|P9|Phase 2|Randomized but not treated|0
7847420|NCT00147537|27232580|P8|Phase 2|Randomized but not treated|0
7847421|NCT00147537|27232581|P7|Phase 2|Randomized but not treated|0
7847422|NCT00147537|27232582|P6|Phase 2|Randomized but not treated|0
7847423|NCT00147537|27232583|P5|Phase 2|Randomized but not treated|0
7847424|NCT00147537|27232584|P4|Phase 2|Randomized but not treated|0
7847425|NCT00147537|27232585|P3|Phase 2|Randomized but not treated|0
7847426|NCT00147537|27232586|P2|Phase 2|Randomized but not treated|0
7847427|NCT00147537|27232587|P1|Phase 2|Randomized but not treated|0
7847428|NCT00147537|27232577|P11|Phase 2|Withdrawal by Subject|4
7847429|NCT00147537|27232578|P10|Phase 2|Withdrawal by Subject|16
7847430|NCT00147537|27232579|P9|Phase 2|Withdrawal by Subject|0
7847431|NCT00147537|27232580|P8|Phase 2|Withdrawal by Subject|0
7847432|NCT00147537|27232581|P7|Phase 2|Withdrawal by Subject|0
7847433|NCT00147537|27232582|P6|Phase 2|Withdrawal by Subject|0
7847434|NCT00147537|27232583|P5|Phase 2|Withdrawal by Subject|0
7847435|NCT00147537|27232584|P4|Phase 2|Withdrawal by Subject|0
7847436|NCT00147537|27232585|P3|Phase 2|Withdrawal by Subject|0
7847437|NCT00147537|27232586|P2|Phase 2|Withdrawal by Subject|0
7847438|NCT00147537|27232587|P1|Phase 2|Withdrawal by Subject|0
7847439|NCT00147537|27232577|P11|Phase 2|Other|12
7847440|NCT00147537|27232578|P10|Phase 2|Other|47
7847441|NCT00147537|27232579|P9|Phase 2|Other|0
7847442|NCT00147537|27232580|P8|Phase 2|Other|0
7847443|NCT00147537|27232581|P7|Phase 2|Other|0
7847444|NCT00147537|27232582|P6|Phase 2|Other|0
7847445|NCT00147537|27232583|P5|Phase 2|Other|0
7847446|NCT00147537|27232584|P4|Phase 2|Other|0
7847447|NCT00147537|27232585|P3|Phase 2|Other|0
7847448|NCT00147537|27232586|P2|Phase 2|Other|0
7847449|NCT00147537|27232587|P1|Phase 2|Other|0
7847450|NCT00147537|27232577|P11|Phase 2|Lost to Follow-up|4
7847451|NCT00147537|27232578|P10|Phase 2|Lost to Follow-up|12
7847452|NCT00147537|27232579|P9|Phase 2|Lost to Follow-up|0
7847453|NCT00147537|27232580|P8|Phase 2|Lost to Follow-up|0
7847454|NCT00147537|27232581|P7|Phase 2|Lost to Follow-up|0
7847455|NCT00147537|27232582|P6|Phase 2|Lost to Follow-up|0
7847456|NCT00147537|27232583|P5|Phase 2|Lost to Follow-up|0
7847457|NCT00147537|27232584|P4|Phase 2|Lost to Follow-up|0
7847458|NCT00147537|27232585|P3|Phase 2|Lost to Follow-up|0
7847459|NCT00147537|27232586|P2|Phase 2|Lost to Follow-up|0
7847460|NCT00147537|27232587|P1|Phase 2|Lost to Follow-up|0
7847461|NCT00147537|27232577|P11|Phase 2|Death|31
7847462|NCT00147537|27232578|P10|Phase 2|Death|85
7847463|NCT00147537|27232579|P9|Phase 2|Death|0
7847464|NCT00147537|27232580|P8|Phase 2|Death|0
7847465|NCT00147537|27232581|P7|Phase 2|Death|0
7847466|NCT00147537|27232582|P6|Phase 2|Death|0
7847467|NCT00147537|27232583|P5|Phase 2|Death|0
7847468|NCT00147537|27232584|P4|Phase 2|Death|0
7847469|NCT00147537|27232585|P3|Phase 2|Death|0
7847470|NCT00147537|27232586|P2|Phase 2|Death|0
7847471|NCT00147537|27232587|P1|Phase 2|Death|0
7847472|NCT00147537|27232577|P11|Phase 1b|Randomized but not treated|0
7847473|NCT00147537|27232578|P10|Phase 1b|Randomized but not treated|0
7847474|NCT00147537|27232579|P9|Phase 1b|Randomized but not treated|1
7847475|NCT00147537|27232580|P8|Phase 1b|Randomized but not treated|0
7847476|NCT00147537|27232581|P7|Phase 1b|Randomized but not treated|1
7847477|NCT00147537|27232582|P6|Phase 1b|Randomized but not treated|0
7847478|NCT00147537|27232583|P5|Phase 1b|Randomized but not treated|0
7847479|NCT00147537|27232584|P4|Phase 1b|Randomized but not treated|0
7847480|NCT00147537|27232585|P3|Phase 1b|Randomized but not treated|0
7847481|NCT00147537|27232586|P2|Phase 1b|Randomized but not treated|0
7847482|NCT00147537|27232587|P1|Phase 1b|Randomized but not treated|0
7847483|NCT00147537|27232577|P11|Phase 1b|Withdrawal by Subject|0
7847484|NCT00147537|27232578|P10|Phase 1b|Withdrawal by Subject|0
7847485|NCT00147537|27232579|P9|Phase 1b|Withdrawal by Subject|2
7847486|NCT00147537|27232580|P8|Phase 1b|Withdrawal by Subject|0
7847487|NCT00147537|27232581|P7|Phase 1b|Withdrawal by Subject|0
7847488|NCT00147537|27232582|P6|Phase 1b|Withdrawal by Subject|0
7847489|NCT00147537|27232583|P5|Phase 1b|Withdrawal by Subject|0
7847490|NCT00147537|27232584|P4|Phase 1b|Withdrawal by Subject|0
7847491|NCT00147537|27232585|P3|Phase 1b|Withdrawal by Subject|0
7847492|NCT00147537|27232586|P2|Phase 1b|Withdrawal by Subject|0
7847493|NCT00147537|27232587|P1|Phase 1b|Withdrawal by Subject|0
7847494|NCT00147537|27232577|P11|Phase 1b|Other|0
7847495|NCT00147537|27232578|P10|Phase 1b|Other|0
7847496|NCT00147537|27232579|P9|Phase 1b|Other|4
7847497|NCT00147537|27232580|P8|Phase 1b|Other|4
7847498|NCT00147537|27232581|P7|Phase 1b|Other|14
7847499|NCT00147537|27232582|P6|Phase 1b|Other|1
7847500|NCT00147537|27232583|P5|Phase 1b|Other|1
7847501|NCT00147537|27232584|P4|Phase 1b|Other|1
7847502|NCT00147537|27232585|P3|Phase 1b|Other|2
7847503|NCT00147537|27232586|P2|Phase 1b|Other|0
7847504|NCT00147537|27232587|P1|Phase 1b|Other|0
7847505|NCT00147537|27232577|P11|Phase 1b|Lost to Follow-up|0
7847506|NCT00147537|27232578|P10|Phase 1b|Lost to Follow-up|0
7847507|NCT00147537|27232579|P9|Phase 1b|Lost to Follow-up|1
7847508|NCT00147537|27232580|P8|Phase 1b|Lost to Follow-up|0
7847509|NCT00147537|27232581|P7|Phase 1b|Lost to Follow-up|2
7847510|NCT00147537|27232582|P6|Phase 1b|Lost to Follow-up|0
7847511|NCT00147537|27232583|P5|Phase 1b|Lost to Follow-up|0
7847512|NCT00147537|27232584|P4|Phase 1b|Lost to Follow-up|0
7847513|NCT00147537|27232585|P3|Phase 1b|Lost to Follow-up|0
7847514|NCT00147537|27232586|P2|Phase 1b|Lost to Follow-up|1
7847515|NCT00147537|27232587|P1|Phase 1b|Lost to Follow-up|2
7847516|NCT00147537|27232577|P11|Phase 1b|Death|0
7847517|NCT00147537|27232578|P10|Phase 1b|Death|0
7847518|NCT00147537|27232579|P9|Phase 1b|Death|9
7847519|NCT00147537|27232580|P8|Phase 1b|Death|3
7847520|NCT00147537|27232581|P7|Phase 1b|Death|1
7847521|NCT00147537|27232582|P6|Phase 1b|Death|2
7847522|NCT00147537|27232583|P5|Phase 1b|Death|2
7847523|NCT00147537|27232584|P4|Phase 1b|Death|1
7847524|NCT00147537|27232585|P3|Phase 1b|Death|2
7847525|NCT00147537|27232586|P2|Phase 1b|Death|1
7847526|NCT00147537|27232587|P1|Phase 1b|Death|0
7847527|NCT00147498|27232770|P4|Overall Study|Other|3
7847528|NCT00147498|27232771|P3|Overall Study|Other|3
7847529|NCT00147498|27232772|P2|Overall Study|Other|1
7847530|NCT00147498|27232773|P1|Overall Study|Other|1
7847531|NCT00147498|27232770|P4|Overall Study|Participant defaulted|3
7847532|NCT00147498|27232771|P3|Overall Study|Participant defaulted|4
7847533|NCT00147498|27232772|P2|Overall Study|Participant defaulted|1
7847534|NCT00147498|27232773|P1|Overall Study|Participant defaulted|0
7847535|NCT00147498|27232770|P4|Overall Study|Laboratory abnormality|0
7847536|NCT00147498|27232771|P3|Overall Study|Laboratory abnormality|2
7847537|NCT00147498|27232772|P2|Overall Study|Laboratory abnormality|0
7847538|NCT00147498|27232773|P1|Overall Study|Laboratory abnormality|0
7847539|NCT00147498|27232770|P4|Overall Study|Lack of Efficacy|8
7847540|NCT00147498|27232771|P3|Overall Study|Lack of Efficacy|1
7847541|NCT00147498|27232772|P2|Overall Study|Lack of Efficacy|1
7847542|NCT00147498|27232773|P1|Overall Study|Lack of Efficacy|1
7847543|NCT00147498|27232770|P4|Overall Study|Adverse Event|3
7847544|NCT00147498|27232771|P3|Overall Study|Adverse Event|7
7847545|NCT00147498|27232772|P2|Overall Study|Adverse Event|6
7847546|NCT00147498|27232773|P1|Overall Study|Adverse Event|1
7847547|NCT00147251|27232899|P2|Recruitment and Enrollment|change in treatment guidelines|25
7847548|NCT00147251|27232900|P1|Recruitment and Enrollment|change in treatment guidelines|24
7847549|NCT00147238|27232908|P1|Overall Study|Inevaluable|8
7847550|NCT00147225|27232918|P6|Overall Study|Chemotherapy Changed|1
7847551|NCT00147225|27232919|P5|Overall Study|Chemotherapy Changed|0
7847552|NCT00147225|27232920|P4|Overall Study|Chemotherapy Changed|0
7847553|NCT00147225|27232921|P3|Overall Study|Chemotherapy Changed|0
7847554|NCT00147225|27232922|P2|Overall Study|Chemotherapy Changed|0
7847555|NCT00147225|27232923|P1|Overall Study|Chemotherapy Changed|0
7847556|NCT00147225|27232918|P6|Overall Study|Screen Failure|0
7847557|NCT00147225|27232919|P5|Overall Study|Screen Failure|1
7847558|NCT00147225|27232920|P4|Overall Study|Screen Failure|0
7847559|NCT00147225|27232921|P3|Overall Study|Screen Failure|0
7847560|NCT00147225|27232922|P2|Overall Study|Screen Failure|0
7847561|NCT00147225|27232923|P1|Overall Study|Screen Failure|0
7847562|NCT00147225|27232918|P6|Overall Study|Adverse Event|0
7847563|NCT00147225|27232919|P5|Overall Study|Adverse Event|0
7847564|NCT00147225|27232920|P4|Overall Study|Adverse Event|1
7847565|NCT00147225|27232921|P3|Overall Study|Adverse Event|1
7847566|NCT00147225|27232922|P2|Overall Study|Adverse Event|0
7847567|NCT00147225|27232923|P1|Overall Study|Adverse Event|0
7847568|NCT00147225|27232918|P6|Overall Study|Withdrawal by Subject|1
7847569|NCT00147225|27232919|P5|Overall Study|Withdrawal by Subject|0
7847570|NCT00147225|27232920|P4|Overall Study|Withdrawal by Subject|0
7847571|NCT00147225|27232921|P3|Overall Study|Withdrawal by Subject|1
7847572|NCT00147225|27232922|P2|Overall Study|Withdrawal by Subject|0
7847573|NCT00147225|27232923|P1|Overall Study|Withdrawal by Subject|1
7847574|NCT00146848|27233098|P3|Post-randomization|Withdrawn|27
7847575|NCT00146848|27233099|P2|Post-randomization|Withdrawn|32
7847576|NCT00146848|27233100|P1|Post-randomization|Withdrawn|26
7847577|NCT00146848|27233098|P3|Post-randomization|Lost to Follow-up|12
7847578|NCT00146848|27233099|P2|Post-randomization|Lost to Follow-up|15
7847579|NCT00146848|27233100|P1|Post-randomization|Lost to Follow-up|12
7847580|NCT00146848|27233098|P3|Pre-randomization|Withdrawal by Subject|0
7847581|NCT00146848|27233099|P2|Pre-randomization|Withdrawal by Subject|0
7847582|NCT00146848|27233100|P1|Pre-randomization|Withdrawal by Subject|40
7847583|NCT00146848|27233098|P3|Pre-randomization|Protocol Violation|0
7847584|NCT00146848|27233099|P2|Pre-randomization|Protocol Violation|0
7847585|NCT00146848|27233100|P1|Pre-randomization|Protocol Violation|172
7847586|NCT00146848|27233098|P3|Pre-randomization|Physician Decision|0
7847587|NCT00146848|27233099|P2|Pre-randomization|Physician Decision|0
7847588|NCT00146848|27233100|P1|Pre-randomization|Physician Decision|8
7847589|NCT00146848|27233098|P3|Pre-randomization|Lost to Follow-up|0
7847590|NCT00146848|27233099|P2|Pre-randomization|Lost to Follow-up|0
7847591|NCT00146848|27233100|P1|Pre-randomization|Lost to Follow-up|70
7847592|NCT00146848|27233098|P3|Pre-randomization|Death|0
7847593|NCT00146848|27233099|P2|Pre-randomization|Death|0
7847594|NCT00146848|27233100|P1|Pre-randomization|Death|19
7847595|NCT00146770|27233116|P2|Overall Study|Withdrawal by Subject|0
7847596|NCT00146770|27233117|P1|Overall Study|Withdrawal by Subject|2
7847597|NCT00146770|27233116|P2|Overall Study|Pregnancy|0
7847598|NCT00146770|27233117|P1|Overall Study|Pregnancy|1
7847599|NCT00146770|27233116|P2|Overall Study|Adverse Event|0
7847600|NCT00146770|27233117|P1|Overall Study|Adverse Event|2
7847601|NCT00146757|27233135|P2|Overall Study|Adverse Event|0
7847602|NCT00146757|27233136|P1|Overall Study|Adverse Event|1
7847603|NCT00146757|27233135|P2|Overall Study|Death|0
7847604|NCT00146757|27233136|P1|Overall Study|Death|1
7847605|NCT00146640|27233155|P2|Overall Study|Non-Medical Reasons|4
7847606|NCT00146640|27233156|P1|Overall Study|Non-Medical Reasons|8
7847607|NCT00146640|27233155|P2|Overall Study|Medical Reasons|0
7847608|NCT00146640|27233156|P1|Overall Study|Medical Reasons|3
7847609|NCT00146640|27233155|P2|Overall Study|Adverse Event|10
7847610|NCT00146640|27233156|P1|Overall Study|Adverse Event|12
7847611|NCT00146328|27233179|P3|Overall Study|Interaction with other medication|1
7847612|NCT00146328|27233180|P2|Overall Study|Interaction with other medication|0
7847613|NCT00146328|27233181|P1|Overall Study|Interaction with other medication|2
7847614|NCT00146328|27233179|P3|Overall Study|Moved|0
7847615|NCT00146328|27233180|P2|Overall Study|Moved|0
7847616|NCT00146328|27233181|P1|Overall Study|Moved|2
7847617|NCT00146328|27233179|P3|Overall Study|Death|1
7847618|NCT00146328|27233180|P2|Overall Study|Death|1
7847619|NCT00146328|27233181|P1|Overall Study|Death|0
7847620|NCT00146328|27233179|P3|Overall Study|Enroll into other trial|2
7847621|NCT00146328|27233180|P2|Overall Study|Enroll into other trial|4
7847622|NCT00146328|27233181|P1|Overall Study|Enroll into other trial|2
7847623|NCT00146328|27233179|P3|Overall Study|Patient decision to end|6
7847624|NCT00146328|27233180|P2|Overall Study|Patient decision to end|1
7847625|NCT00146328|27233181|P1|Overall Study|Patient decision to end|0
7847626|NCT00146328|27233179|P3|Overall Study|Trial ended/site closed|19
7847627|NCT00146328|27233180|P2|Overall Study|Trial ended/site closed|2
7847628|NCT00146328|27233181|P1|Overall Study|Trial ended/site closed|8
7847629|NCT00146328|27233179|P3|Overall Study|Virologic Failure/lack of efficacy|142
7847630|NCT00146328|27233180|P2|Overall Study|Virologic Failure/lack of efficacy|72
7847631|NCT00146328|27233181|P1|Overall Study|Virologic Failure/lack of efficacy|54
7847632|NCT00146328|27233179|P3|Overall Study|Withdrawal by Subject|22
7847633|NCT00146328|27233180|P2|Overall Study|Withdrawal by Subject|16
7847634|NCT00146328|27233181|P1|Overall Study|Withdrawal by Subject|16
7847635|NCT00146328|27233179|P3|Overall Study|Lost to Follow-up|7
7847636|NCT00146328|27233180|P2|Overall Study|Lost to Follow-up|4
7847637|NCT00146328|27233181|P1|Overall Study|Lost to Follow-up|7
7847638|NCT00146328|27233179|P3|Overall Study|Protocol Violation|12
7847639|NCT00146328|27233180|P2|Overall Study|Protocol Violation|6
7847640|NCT00146328|27233181|P1|Overall Study|Protocol Violation|11
7847641|NCT00146328|27233179|P3|Overall Study|Adverse Event|79
7847642|NCT00146328|27233180|P2|Overall Study|Adverse Event|48
7847643|NCT00146328|27233181|P1|Overall Study|Adverse Event|39
7847644|NCT00146172|27233272|P8|Overall Study|Symptomatic Deterioration|2
7847645|NCT00146172|27233273|P7|Overall Study|Symptomatic Deterioration|0
7847646|NCT00146172|27233274|P6|Overall Study|Symptomatic Deterioration|2
7847647|NCT00146172|27233275|P5|Overall Study|Symptomatic Deterioration|1
7847648|NCT00146172|27233276|P4|Overall Study|Symptomatic Deterioration|0
7847649|NCT00146172|27233277|P3|Overall Study|Symptomatic Deterioration|1
7847650|NCT00146172|27233278|P2|Overall Study|Symptomatic Deterioration|0
7847651|NCT00146172|27233279|P1|Overall Study|Symptomatic Deterioration|1
7847652|NCT00146172|27233272|P8|Overall Study|Withdrawal by Subject|4
7847653|NCT00146172|27233273|P7|Overall Study|Withdrawal by Subject|1
7847654|NCT00146172|27233274|P6|Overall Study|Withdrawal by Subject|1
7847655|NCT00146172|27233275|P5|Overall Study|Withdrawal by Subject|0
7847656|NCT00146172|27233276|P4|Overall Study|Withdrawal by Subject|0
7847657|NCT00146172|27233277|P3|Overall Study|Withdrawal by Subject|0
7847658|NCT00146172|27233278|P2|Overall Study|Withdrawal by Subject|0
7847659|NCT00146172|27233279|P1|Overall Study|Withdrawal by Subject|0
7847660|NCT00146172|27233272|P8|Overall Study|Physician Decision|1
7847661|NCT00146172|27233273|P7|Overall Study|Physician Decision|0
7847662|NCT00146172|27233274|P6|Overall Study|Physician Decision|0
7847663|NCT00146172|27233275|P5|Overall Study|Physician Decision|0
7847664|NCT00146172|27233276|P4|Overall Study|Physician Decision|0
7847665|NCT00146172|27233277|P3|Overall Study|Physician Decision|0
7847666|NCT00146172|27233278|P2|Overall Study|Physician Decision|0
7847667|NCT00146172|27233279|P1|Overall Study|Physician Decision|0
7847668|NCT00146172|27233272|P8|Overall Study|Death|0
7847669|NCT00146172|27233273|P7|Overall Study|Death|1
7847670|NCT00146172|27233274|P6|Overall Study|Death|0
7847671|NCT00146172|27233275|P5|Overall Study|Death|0
7847672|NCT00146172|27233276|P4|Overall Study|Death|0
7847673|NCT00146172|27233277|P3|Overall Study|Death|0
7847674|NCT00146172|27233278|P2|Overall Study|Death|0
7847675|NCT00146172|27233279|P1|Overall Study|Death|0
7847676|NCT00146172|27233272|P8|Overall Study|Disease Progression|22
7847677|NCT00146172|27233273|P7|Overall Study|Disease Progression|1
7847678|NCT00146172|27233274|P6|Overall Study|Disease Progression|2
7847679|NCT00146172|27233275|P5|Overall Study|Disease Progression|2
7847680|NCT00146172|27233276|P4|Overall Study|Disease Progression|5
7847681|NCT00146172|27233277|P3|Overall Study|Disease Progression|2
7847682|NCT00146172|27233278|P2|Overall Study|Disease Progression|4
7847683|NCT00146172|27233279|P1|Overall Study|Disease Progression|2
7847684|NCT00146172|27233272|P8|Overall Study|Lost to Follow-up|1
7847685|NCT00146172|27233273|P7|Overall Study|Lost to Follow-up|0
7847686|NCT00146172|27233274|P6|Overall Study|Lost to Follow-up|0
7847687|NCT00146172|27233275|P5|Overall Study|Lost to Follow-up|0
7847688|NCT00146172|27233276|P4|Overall Study|Lost to Follow-up|0
7847689|NCT00146172|27233277|P3|Overall Study|Lost to Follow-up|0
7847690|NCT00146172|27233278|P2|Overall Study|Lost to Follow-up|0
7847691|NCT00146172|27233279|P1|Overall Study|Lost to Follow-up|0
7847692|NCT00146172|27233272|P8|Overall Study|Adverse Event|10
7847693|NCT00146172|27233273|P7|Overall Study|Adverse Event|3
7847694|NCT00146172|27233274|P6|Overall Study|Adverse Event|2
7847695|NCT00146172|27233275|P5|Overall Study|Adverse Event|0
7847696|NCT00146172|27233276|P4|Overall Study|Adverse Event|1
7847697|NCT00146172|27233277|P3|Overall Study|Adverse Event|1
7847698|NCT00146172|27233278|P2|Overall Study|Adverse Event|0
7847699|NCT00146172|27233279|P1|Overall Study|Adverse Event|0
7847700|NCT00145977|27233314|P2|Overall Study|Withdrawal by Subject|0
7847701|NCT00145977|27233315|P1|Overall Study|Withdrawal by Subject|1
7847702|NCT00145977|27233314|P2|Overall Study|Lost to Follow-up|0
7847703|NCT00145977|27233315|P1|Overall Study|Lost to Follow-up|1
7847704|NCT00145977|27233314|P2|Overall Study|Lack of Efficacy|4
7847705|NCT00145977|27233315|P1|Overall Study|Lack of Efficacy|0
7847706|NCT00145795|27233341|P2|Overall Study|Adverse Event|0
7847707|NCT00145795|27233342|P1|Overall Study|Adverse Event|1
7847708|NCT00145626|27233377|P1|Overall Study|Withdrawal by Subject|1
7847709|NCT00145626|27233377|P1|Overall Study|Death|1
7847710|NCT00145626|27233377|P1|Overall Study|Turned 2 years old before treatment|1
7847711|NCT00145626|27233377|P1|Overall Study|Did not have NK infusions|2
7847712|NCT00145600|27233423|P4|Overall Study|Withdrawal by Subject|1
7847713|NCT00145600|27233424|P3|Overall Study|Withdrawal by Subject|0
7847714|NCT00145600|27233425|P2|Overall Study|Withdrawal by Subject|2
7847715|NCT00145600|27233426|P1|Overall Study|Withdrawal by Subject|1
7847716|NCT00145600|27233423|P4|Overall Study|Noncompliance|0
7847717|NCT00145600|27233424|P3|Overall Study|Noncompliance|0
7847718|NCT00145600|27233425|P2|Overall Study|Noncompliance|0
7847719|NCT00145600|27233426|P1|Overall Study|Noncompliance|1
7847720|NCT00145600|27233423|P4|Overall Study|Lost to Follow-up|4
7847721|NCT00145600|27233424|P3|Overall Study|Lost to Follow-up|2
7847722|NCT00145600|27233425|P2|Overall Study|Lost to Follow-up|6
7847723|NCT00145600|27233426|P1|Overall Study|Lost to Follow-up|2
7847724|NCT00145600|27233423|P4|Overall Study|Ineligible|5
7847725|NCT00145600|27233424|P3|Overall Study|Ineligible|1
7847726|NCT00145600|27233425|P2|Overall Study|Ineligible|0
7847727|NCT00145600|27233426|P1|Overall Study|Ineligible|3
7847728|NCT00145600|27233423|P4|Overall Study|Death|6
7847729|NCT00145600|27233424|P3|Overall Study|Death|2
7847730|NCT00145600|27233425|P2|Overall Study|Death|2
7847731|NCT00145600|27233426|P1|Overall Study|Death|1
7847732|NCT00145574|27233550|P3|Open Label Long-term Extension|required restricted medicine|1
7847733|NCT00145574|27233551|P2|Open Label Long-term Extension|required restricted medicine|0
7847734|NCT00145574|27233552|P1|Open Label Long-term Extension|required restricted medicine|0
7847735|NCT00145574|27233550|P3|Open Label Long-term Extension|Withdrawal by Subject|4
7847736|NCT00145574|27233551|P2|Open Label Long-term Extension|Withdrawal by Subject|0
7847737|NCT00145574|27233552|P1|Open Label Long-term Extension|Withdrawal by Subject|0
7847738|NCT00145574|27233550|P3|Open Label Long-term Extension|Lost to Follow-up|1
7847739|NCT00145574|27233551|P2|Open Label Long-term Extension|Lost to Follow-up|0
7847740|NCT00145574|27233552|P1|Open Label Long-term Extension|Lost to Follow-up|0
7847741|NCT00145574|27233550|P3|Open Label Long-term Extension|Adverse Event|5
7847742|NCT00145574|27233551|P2|Open Label Long-term Extension|Adverse Event|0
7847743|NCT00145574|27233552|P1|Open Label Long-term Extension|Adverse Event|0
7847744|NCT00145574|27233550|P3|Double Blind|required restricted medicine|0
7847745|NCT00145574|27233551|P2|Double Blind|required restricted medicine|1
7847746|NCT00145574|27233552|P1|Double Blind|required restricted medicine|0
7847747|NCT00145574|27233550|P3|Double Blind|Withdrawal by Subject|1
7847748|NCT00145574|27233551|P2|Double Blind|Withdrawal by Subject|1
7847749|NCT00145574|27233552|P1|Double Blind|Withdrawal by Subject|1
7847750|NCT00145574|27233550|P3|Double Blind|Adverse Event|1
7847751|NCT00145574|27233551|P2|Double Blind|Adverse Event|3
7847752|NCT00145574|27233552|P1|Double Blind|Adverse Event|0
7847753|NCT00145509|27233609|P2|Overall Study|Reason not provided|1
7847754|NCT00145509|27233610|P1|Overall Study|Reason not provided|2
7847755|NCT00145509|27233609|P2|Overall Study|Withdrew Consent|7
7847756|NCT00145509|27233610|P1|Overall Study|Withdrew Consent|2
7847757|NCT00145509|27233609|P2|Overall Study|Lost to Follow-up|9
7847758|NCT00145509|27233610|P1|Overall Study|Lost to Follow-up|5
7847759|NCT00145509|27233609|P2|Overall Study|Lack of Efficacy|1
7847760|NCT00145509|27233610|P1|Overall Study|Lack of Efficacy|3
7847761|NCT00145509|27233609|P2|Overall Study|Adverse Event|3
7847762|NCT00145509|27233610|P1|Overall Study|Adverse Event|10
7847763|NCT00145496|27233624|P2|Overall Study|Other|13
7847764|NCT00145496|27233625|P1|Overall Study|Other|25
7847765|NCT00145496|27233624|P2|Overall Study|Lost to Follow-up|5
7847766|NCT00145496|27233625|P1|Overall Study|Lost to Follow-up|12
7847767|NCT00145496|27233624|P2|Overall Study|Withdrawal by Subject|26
7847768|NCT00145496|27233625|P1|Overall Study|Withdrawal by Subject|32
7847769|NCT00145496|27233624|P2|Overall Study|Lack of Efficacy|7
7847770|NCT00145496|27233625|P1|Overall Study|Lack of Efficacy|12
7847771|NCT00145496|27233624|P2|Overall Study|Adverse Event|30
7847772|NCT00145496|27233625|P1|Overall Study|Adverse Event|42
7847773|NCT00145470|27233637|P2|Overall Study|Reason Not Reported|9
7847774|NCT00145470|27233638|P1|Overall Study|Reason Not Reported|9
7847775|NCT00145470|27233637|P2|Overall Study|Lost to Follow-up|17
7847776|NCT00145470|27233638|P1|Overall Study|Lost to Follow-up|21
7847777|NCT00145470|27233637|P2|Overall Study|Withdrawal by Subject|34
7847778|NCT00145470|27233638|P1|Overall Study|Withdrawal by Subject|36
7847779|NCT00145470|27233637|P2|Overall Study|Lack of Efficacy|13
7847780|NCT00145470|27233638|P1|Overall Study|Lack of Efficacy|27
7847781|NCT00145470|27233637|P2|Overall Study|Adverse Event|25
7847782|NCT00145470|27233638|P1|Overall Study|Adverse Event|19
7847783|NCT00145327|27233708|P3|Overall Study|Missing - not stated|1
7847784|NCT00145327|27233709|P2|Overall Study|Missing - not stated|0
7847785|NCT00145327|27233710|P1|Overall Study|Missing - not stated|1
7847786|NCT00145327|27233708|P3|Overall Study|Abnormal laboratory value(s)|2
7847787|NCT00145327|27233709|P2|Overall Study|Abnormal laboratory value(s)|0
7847788|NCT00145327|27233710|P1|Overall Study|Abnormal laboratory value(s)|1
7847789|NCT00145327|27233708|P3|Overall Study|Protocol Violation|2
7847790|NCT00145327|27233709|P2|Overall Study|Protocol Violation|0
7847791|NCT00145327|27233710|P1|Overall Study|Protocol Violation|2
7847792|NCT00145327|27233708|P3|Overall Study|Administrative problems|13
7847793|NCT00145327|27233709|P2|Overall Study|Administrative problems|9
7847794|NCT00145327|27233710|P1|Overall Study|Administrative problems|12
7847795|NCT00145327|27233708|P3|Overall Study|Lost to Follow-up|14
7847796|NCT00145327|27233709|P2|Overall Study|Lost to Follow-up|14
7847797|NCT00145327|27233710|P1|Overall Study|Lost to Follow-up|9
7847798|NCT00145327|27233708|P3|Overall Study|Adverse Event|22
7847799|NCT00145327|27233709|P2|Overall Study|Adverse Event|11
7847800|NCT00145327|27233710|P1|Overall Study|Adverse Event|14
7847801|NCT00145327|27233708|P3|Overall Study|Death|30
7847802|NCT00145327|27233709|P2|Overall Study|Death|18
7847803|NCT00145327|27233710|P1|Overall Study|Death|26
7847804|NCT00145327|27233708|P3|Overall Study|Withdrawal by Subject|164
7847805|NCT00145327|27233709|P2|Overall Study|Withdrawal by Subject|72
7847806|NCT00145327|27233710|P1|Overall Study|Withdrawal by Subject|77
7847807|NCT00145119|27233815|P1|Overall Study|Death|45
7847808|NCT00144781|27233833|P4|Overall Study|Non-compliant|0
7847809|NCT00144781|27233834|P3|Overall Study|Non-compliant|0
7847810|NCT00144781|27233835|P2|Overall Study|Non-compliant|1
7847811|NCT00144781|27233836|P1|Overall Study|Non-compliant|0
7847812|NCT00144781|27233833|P4|Overall Study|Adverse Event|0
7847813|NCT00144781|27233834|P3|Overall Study|Adverse Event|0
7847814|NCT00144781|27233835|P2|Overall Study|Adverse Event|1
7847815|NCT00144781|27233836|P1|Overall Study|Adverse Event|0
7847816|NCT00144339|27233865|P2|Overall Study|Other|60
7847817|NCT00144339|27233866|P1|Overall Study|Other|58
7847818|NCT00144339|27233865|P2|Overall Study|Lost to Follow-up|64
7847819|NCT00144339|27233866|P1|Overall Study|Lost to Follow-up|76
7847820|NCT00144339|27233865|P2|Overall Study|Withdrawal by Subject|300
7847821|NCT00144339|27233866|P1|Overall Study|Withdrawal by Subject|403
7847822|NCT00144339|27233865|P2|Overall Study|Protocol Violation|48
7847823|NCT00144339|27233866|P1|Overall Study|Protocol Violation|75
7847824|NCT00144339|27233865|P2|Overall Study|Adverse Event|627
7847825|NCT00144339|27233866|P1|Overall Study|Adverse Event|746
7847826|NCT00144300|27234074|P2|Overall Study|Other reason (not specified)|3
7847827|NCT00144300|27234075|P1|Overall Study|Other reason (not specified)|1
7847828|NCT00144300|27234074|P2|Overall Study|Withdrawal by Subject|6
7847829|NCT00144300|27234075|P1|Overall Study|Withdrawal by Subject|6
7847830|NCT00144300|27234074|P2|Overall Study|Lost to Follow-up|0
7847831|NCT00144300|27234075|P1|Overall Study|Lost to Follow-up|3
7847832|NCT00144300|27234074|P2|Overall Study|Protocol Violation|3
7847833|NCT00144300|27234075|P1|Overall Study|Protocol Violation|1
7847834|NCT00144300|27234074|P2|Overall Study|Adverse Event|16
7847835|NCT00144300|27234075|P1|Overall Study|Adverse Event|18
7847836|NCT00144170|27234123|P2|Overall Study|Other reason not defined above|316
7847837|NCT00144170|27234124|P1|Overall Study|Other reason not defined above|211
7847838|NCT00144170|27234123|P2|Overall Study|Withdrawal by Subject|13
7847839|NCT00144170|27234124|P1|Overall Study|Withdrawal by Subject|29
7847840|NCT00144170|27234123|P2|Overall Study|Lost to Follow-up|10
7847841|NCT00144170|27234124|P1|Overall Study|Lost to Follow-up|5
7847842|NCT00144170|27234123|P2|Overall Study|Protocol Violation|16
7847843|NCT00144170|27234124|P1|Overall Study|Protocol Violation|23
7847844|NCT00144170|27234123|P2|Overall Study|Adverse Event|41
7847845|NCT00144170|27234124|P1|Overall Study|Adverse Event|84
7847846|NCT00144027|27234314|P2|Overall Study|did not complete baseline assessment|6
7847847|NCT00144027|27234315|P1|Overall Study|did not complete baseline assessment|0
7847848|NCT00144027|27234314|P2|Overall Study|Withdrawal by Subject|2
7847849|NCT00144027|27234315|P1|Overall Study|Withdrawal by Subject|2
7847850|NCT00144027|27234314|P2|Overall Study|Lost to Follow-up|3
7847851|NCT00144027|27234315|P1|Overall Study|Lost to Follow-up|1
7847852|NCT00143598|27234345|P2|Overall Study|Death|36
7847853|NCT00143598|27234346|P1|Overall Study|Death|36
7847854|NCT00143598|27234345|P2|Overall Study|Withdrawal by Subject|37
7847855|NCT00143598|27234346|P1|Overall Study|Withdrawal by Subject|33
7847856|NCT00143598|27234345|P2|Overall Study|Lost to Follow-up|21
7847857|NCT00143598|27234346|P1|Overall Study|Lost to Follow-up|23
7847858|NCT00143507|27234360|P2|Overall Study|Withdrawn by sponsor's decision|3
7847859|NCT00143507|27234361|P1|Overall Study|Withdrawn by sponsor's decision|0
7847860|NCT00143507|27234360|P2|Overall Study|Lost to Follow-up|0
7847861|NCT00143507|27234361|P1|Overall Study|Lost to Follow-up|1
7847862|NCT00143507|27234360|P2|Overall Study|Withdrawal by Subject|102
7847863|NCT00143507|27234361|P1|Overall Study|Withdrawal by Subject|114
7847864|NCT00143507|27234360|P2|Overall Study|Death|547
7847865|NCT00143507|27234361|P1|Overall Study|Death|572
7847866|NCT00143455|27234395|P4|Cohort 2|Randomized But Not Treated|1
7847867|NCT00143455|27234396|P3|Cohort 2|Randomized But Not Treated|1
7847868|NCT00143455|27234397|P2|Cohort 2|Randomized But Not Treated|0
7847869|NCT00143455|27234398|P1|Cohort 2|Randomized But Not Treated|0
7847870|NCT00143455|27234395|P4|Cohort 2|Other|6
7847871|NCT00143455|27234396|P3|Cohort 2|Other|7
7847872|NCT00143455|27234397|P2|Cohort 2|Other|0
7847873|NCT00143455|27234398|P1|Cohort 2|Other|0
7847874|NCT00143455|27234395|P4|Cohort 2|Withdrawal by Subject|12
7847875|NCT00143455|27234396|P3|Cohort 2|Withdrawal by Subject|13
7847876|NCT00143455|27234397|P2|Cohort 2|Withdrawal by Subject|0
7847877|NCT00143455|27234398|P1|Cohort 2|Withdrawal by Subject|0
7847878|NCT00143455|27234395|P4|Cohort 2|Progressive Disease|27
7847879|NCT00143455|27234396|P3|Cohort 2|Progressive Disease|20
7847880|NCT00143455|27234397|P2|Cohort 2|Progressive Disease|0
7847881|NCT00143455|27234398|P1|Cohort 2|Progressive Disease|0
7847882|NCT00143455|27234395|P4|Cohort 2|Death|12
7847883|NCT00143455|27234396|P3|Cohort 2|Death|20
7847884|NCT00143455|27234397|P2|Cohort 2|Death|0
7847885|NCT00143455|27234398|P1|Cohort 2|Death|0
7847886|NCT00143455|27234395|P4|Cohort 2|Lost to Follow-up|4
7847887|NCT00143455|27234396|P3|Cohort 2|Lost to Follow-up|1
7847888|NCT00143455|27234397|P2|Cohort 2|Lost to Follow-up|0
7847889|NCT00143455|27234398|P1|Cohort 2|Lost to Follow-up|0
7847890|NCT00143455|27234395|P4|Cohort 2|Protocol Violation|1
7847891|NCT00143455|27234396|P3|Cohort 2|Protocol Violation|1
7847892|NCT00143455|27234397|P2|Cohort 2|Protocol Violation|0
7847893|NCT00143455|27234398|P1|Cohort 2|Protocol Violation|0
7847894|NCT00143455|27234395|P4|Cohort 2|No Longer Required Study Treatment|0
7847895|NCT00143455|27234396|P3|Cohort 2|No Longer Required Study Treatment|1
7847896|NCT00143455|27234397|P2|Cohort 2|No Longer Required Study Treatment|0
7847897|NCT00143455|27234398|P1|Cohort 2|No Longer Required Study Treatment|0
7847898|NCT00143455|27234395|P4|Cohort 2|Adverse Event|30
7847899|NCT00143455|27234396|P3|Cohort 2|Adverse Event|42
7847900|NCT00143455|27234397|P2|Cohort 2|Adverse Event|0
7847901|NCT00143455|27234398|P1|Cohort 2|Adverse Event|0
7847902|NCT00143455|27234395|P4|Cohort 1|Randomized But Not Treated|0
7847903|NCT00143455|27234396|P3|Cohort 1|Randomized But Not Treated|0
7847904|NCT00143455|27234397|P2|Cohort 1|Randomized But Not Treated|1
7847905|NCT00143455|27234398|P1|Cohort 1|Randomized But Not Treated|0
7847906|NCT00143455|27234395|P4|Cohort 1|Withdrawal by Subject|0
7847907|NCT00143455|27234396|P3|Cohort 1|Withdrawal by Subject|0
7847908|NCT00143455|27234397|P2|Cohort 1|Withdrawal by Subject|4
7847909|NCT00143455|27234398|P1|Cohort 1|Withdrawal by Subject|1
7847910|NCT00143455|27234395|P4|Cohort 1|Progressive Disease|0
7847911|NCT00143455|27234396|P3|Cohort 1|Progressive Disease|0
7847912|NCT00143455|27234397|P2|Cohort 1|Progressive Disease|6
7847913|NCT00143455|27234398|P1|Cohort 1|Progressive Disease|0
7847914|NCT00143455|27234395|P4|Cohort 1|Death|0
7847915|NCT00143455|27234396|P3|Cohort 1|Death|0
7847916|NCT00143455|27234397|P2|Cohort 1|Death|2
7847917|NCT00143455|27234398|P1|Cohort 1|Death|5
7847918|NCT00143455|27234395|P4|Cohort 1|Adverse Event|0
7847919|NCT00143455|27234396|P3|Cohort 1|Adverse Event|0
7847920|NCT00143455|27234397|P2|Cohort 1|Adverse Event|4
7847921|NCT00143455|27234398|P1|Cohort 1|Adverse Event|8
7847922|NCT00143403|27234432|P2|Overall Study|Randomized Not Treated|8
7847923|NCT00143403|27234433|P1|Overall Study|Randomized Not Treated|7
7847924|NCT00143403|27234432|P2|Overall Study|specified by site|9
7847925|NCT00143403|27234433|P1|Overall Study|specified by site|4
7847926|NCT00143403|27234432|P2|Overall Study|Protocol Violation|2
7847927|NCT00143403|27234433|P1|Overall Study|Protocol Violation|2
7847928|NCT00143403|27234432|P2|Overall Study|Relapse|7
7847929|NCT00143403|27234433|P1|Overall Study|Relapse|15
7847930|NCT00143403|27234432|P2|Overall Study|Withdrawal by Subject|12
7847931|NCT00143403|27234433|P1|Overall Study|Withdrawal by Subject|3
7847932|NCT00143403|27234432|P2|Overall Study|Death|0
7847933|NCT00143403|27234433|P1|Overall Study|Death|1
7847934|NCT00143403|27234432|P2|Overall Study|Adverse Event|8
7847935|NCT00143403|27234433|P1|Overall Study|Adverse Event|3
7847936|NCT00143390|27234443|P2|Overall Study|Other|2
7847937|NCT00143390|27234444|P1|Overall Study|Other|1
7847938|NCT00143390|27234443|P2|Overall Study|Adverse Event|8
7847939|NCT00143390|27234444|P1|Overall Study|Adverse Event|9
7847940|NCT00143390|27234443|P2|Overall Study|Study termination|15
7847941|NCT00143390|27234444|P1|Overall Study|Study termination|10
7847942|NCT00143390|27234443|P2|Overall Study|Protocol Violation|0
7847943|NCT00143390|27234444|P1|Overall Study|Protocol Violation|2
7847944|NCT00143390|27234443|P2|Overall Study|Progressive disease|115
7847945|NCT00143390|27234444|P1|Overall Study|Progressive disease|119
7847946|NCT00143390|27234443|P2|Overall Study|Withdrawal by Subject|4
7847947|NCT00143390|27234444|P1|Overall Study|Withdrawal by Subject|4
7847948|NCT00143390|27234443|P2|Overall Study|Not meeting entry criteria|5
7847949|NCT00143390|27234444|P1|Overall Study|Not meeting entry criteria|2
7847950|NCT00143390|27234443|P2|Overall Study|Death|0
7847951|NCT00143390|27234444|P1|Overall Study|Death|2
7847952|NCT00143312|27234460|P1|Overall Study|Withdrawal by Subject|1
7847953|NCT00143312|27234460|P1|Overall Study|Other|1
7847954|NCT00143312|27234460|P1|Overall Study|Lost to Follow-up|1
7847955|NCT00143312|27234460|P1|Overall Study|Adverse Event|2
7847956|NCT00143312|27234460|P1|Overall Study|Death|11
7847957|NCT00143247|27234470|P1|Overall Study|Other|12
7847958|NCT00143247|27234470|P1|Overall Study|following inaccurate lab adverse event|1
7847959|NCT00143247|27234470|P1|Overall Study|Lost to Follow-up|12
7847960|NCT00143247|27234470|P1|Overall Study|Protocol Violation|15
7847961|NCT00143247|27234470|P1|Overall Study|Study terminated by sponsor|31
7847962|NCT00143247|27234470|P1|Overall Study|Withdrawal by Subject|55
7847963|NCT00143247|27234470|P1|Overall Study|Lack of Efficacy|3
7847964|NCT00143247|27234470|P1|Overall Study|Adverse Event|19
7847965|NCT00143247|27234470|P1|Overall Study|Death|8
7847966|NCT00142935|27234487|P3|Overall Study|Death|1
7847967|NCT00142935|27234488|P2|Overall Study|Death|2
7847968|NCT00142935|27234489|P1|Overall Study|Death|0
7847969|NCT00142935|27234487|P3|Overall Study|Lost to Follow-up|5
7847970|NCT00142935|27234488|P2|Overall Study|Lost to Follow-up|5
7847971|NCT00142935|27234489|P1|Overall Study|Lost to Follow-up|2
7847972|NCT00142935|27234487|P3|Overall Study|Other reason|1
7847973|NCT00142935|27234488|P2|Overall Study|Other reason|1
7847974|NCT00142935|27234489|P1|Overall Study|Other reason|1
7847975|NCT00142909|27234514|P2|Medications Begin|Withdrawal by Subject|0
7847976|NCT00142909|27234515|P1|Medications Begin|Withdrawal by Subject|2
7847977|NCT00142909|27234514|P2|Medications Begin|Withdrawal by Subject|3
7847978|NCT00142909|27234515|P1|Medications Begin|Withdrawal by Subject|5
7847979|NCT00142909|27234514|P2|Medications Begin|Protocol Violation|0
7847980|NCT00142909|27234515|P1|Medications Begin|Protocol Violation|2
7847981|NCT00142909|27234514|P2|Randomization|Various Reasons|10
7847982|NCT00142909|27234515|P1|Randomization|Various Reasons|7
7847983|NCT00142792|27234555|P3|Overall Study|No category|1
7847984|NCT00142792|27234556|P2|Overall Study|No category|2
7847985|NCT00142792|27234557|P1|Overall Study|No category|1
7847986|NCT00142792|27234555|P3|Overall Study|Lost to Follow-up|7
7847987|NCT00142792|27234556|P2|Overall Study|Lost to Follow-up|11
7847988|NCT00142792|27234557|P1|Overall Study|Lost to Follow-up|8
7847989|NCT00142792|27234555|P3|Overall Study|Withdrawal by Subject|3
7847990|NCT00142792|27234556|P2|Overall Study|Withdrawal by Subject|2
7847991|NCT00142792|27234557|P1|Overall Study|Withdrawal by Subject|3
7847992|NCT00142792|27234555|P3|Overall Study|Death|1
7847993|NCT00142792|27234556|P2|Overall Study|Death|0
7847994|NCT00142792|27234557|P1|Overall Study|Death|0
7847995|NCT00142519|27234579|P2|Overall Study|Withdrawal by Subject|7
7847996|NCT00142519|27234580|P1|Overall Study|Withdrawal by Subject|10
7847997|NCT00142519|27234579|P2|Overall Study|Protocol Violation|0
7847998|NCT00142519|27234580|P1|Overall Study|Protocol Violation|1
7847999|NCT00142519|27234579|P2|Overall Study|Not Treated|9
7848000|NCT00142519|27234580|P1|Overall Study|Not Treated|7
7848001|NCT00142415|27234609|P6|Overall Study|Physician Decision|2
7848002|NCT00142415|27234610|P5|Overall Study|Physician Decision|1
7848003|NCT00142415|27234611|P4|Overall Study|Physician Decision|0
7848004|NCT00142415|27234612|P3|Overall Study|Physician Decision|0
7848005|NCT00142415|27234613|P2|Overall Study|Physician Decision|0
7848006|NCT00142415|27234614|P1|Overall Study|Physician Decision|0
7848007|NCT00142298|27234652|P10|Overall Study|Treatment Failure|0
7848008|NCT00142298|27234653|P9|Overall Study|Treatment Failure|0
7848009|NCT00142298|27234654|P8|Overall Study|Treatment Failure|0
7848010|NCT00142298|27234655|P7|Overall Study|Treatment Failure|2
7848011|NCT00142298|27234656|P6|Overall Study|Treatment Failure|2
7848012|NCT00142298|27234657|P5|Overall Study|Treatment Failure|0
7848013|NCT00142298|27234658|P4|Overall Study|Treatment Failure|0
7848014|NCT00142298|27234659|P3|Overall Study|Treatment Failure|0
7848015|NCT00142298|27234660|P2|Overall Study|Treatment Failure|0
7848016|NCT00142298|27234661|P1|Overall Study|Treatment Failure|0
7848017|NCT00142298|27234652|P10|Overall Study|Lost to Follow-up|0
7848018|NCT00142298|27234653|P9|Overall Study|Lost to Follow-up|0
7848019|NCT00142298|27234654|P8|Overall Study|Lost to Follow-up|0
7848020|NCT00142298|27234655|P7|Overall Study|Lost to Follow-up|2
7848021|NCT00142298|27234656|P6|Overall Study|Lost to Follow-up|0
7848022|NCT00142298|27234657|P5|Overall Study|Lost to Follow-up|0
7848023|NCT00142298|27234658|P4|Overall Study|Lost to Follow-up|0
7848024|NCT00142298|27234659|P3|Overall Study|Lost to Follow-up|0
7848025|NCT00142298|27234660|P2|Overall Study|Lost to Follow-up|0
7848026|NCT00142298|27234661|P1|Overall Study|Lost to Follow-up|0
7848027|NCT00142298|27234652|P10|Overall Study|Other- not specified|0
7848028|NCT00142298|27234653|P9|Overall Study|Other- not specified|0
7848029|NCT00142298|27234654|P8|Overall Study|Other- not specified|0
7848030|NCT00142298|27234655|P7|Overall Study|Other- not specified|0
7848031|NCT00142298|27234656|P6|Overall Study|Other- not specified|0
7848032|NCT00142298|27234657|P5|Overall Study|Other- not specified|0
7848033|NCT00142298|27234658|P4|Overall Study|Other- not specified|1
7848034|NCT00142298|27234659|P3|Overall Study|Other- not specified|0
7848035|NCT00142298|27234660|P2|Overall Study|Other- not specified|3
7848036|NCT00142298|27234661|P1|Overall Study|Other- not specified|0
7848037|NCT00142298|27234652|P10|Overall Study|Virologic breakthrough|0
7848038|NCT00142298|27234653|P9|Overall Study|Virologic breakthrough|0
7848039|NCT00142298|27234654|P8|Overall Study|Virologic breakthrough|0
7848040|NCT00142298|27234655|P7|Overall Study|Virologic breakthrough|3
7848041|NCT00142298|27234656|P6|Overall Study|Virologic breakthrough|3
7848042|NCT00142298|27234657|P5|Overall Study|Virologic breakthrough|2
7848043|NCT00142298|27234658|P4|Overall Study|Virologic breakthrough|7
7848044|NCT00142298|27234659|P3|Overall Study|Virologic breakthrough|9
7848045|NCT00142298|27234660|P2|Overall Study|Virologic breakthrough|23
7848046|NCT00142298|27234661|P1|Overall Study|Virologic breakthrough|19
7848047|NCT00142298|27234652|P10|Overall Study|Pregnancy|0
7848048|NCT00142298|27234653|P9|Overall Study|Pregnancy|1
7848049|NCT00142298|27234654|P8|Overall Study|Pregnancy|0
7848050|NCT00142298|27234655|P7|Overall Study|Pregnancy|0
7848051|NCT00142298|27234656|P6|Overall Study|Pregnancy|0
7848052|NCT00142298|27234657|P5|Overall Study|Pregnancy|0
7848053|NCT00142298|27234658|P4|Overall Study|Pregnancy|3
7848054|NCT00142298|27234659|P3|Overall Study|Pregnancy|2
7848055|NCT00142298|27234660|P2|Overall Study|Pregnancy|4
7848056|NCT00142298|27234661|P1|Overall Study|Pregnancy|4
7848057|NCT00142298|27234652|P10|Overall Study|Patient, Investigator,or Sponsor request|0
7848237|NCT00141271|27235323|P1|Overall Study|Lost to Follow-up|15
7848058|NCT00142298|27234653|P9|Overall Study|Patient, Investigator,or Sponsor request|1
7848059|NCT00142298|27234654|P8|Overall Study|Patient, Investigator,or Sponsor request|4
7848060|NCT00142298|27234655|P7|Overall Study|Patient, Investigator,or Sponsor request|1
7848061|NCT00142298|27234656|P6|Overall Study|Patient, Investigator,or Sponsor request|3
7848062|NCT00142298|27234657|P5|Overall Study|Patient, Investigator,or Sponsor request|4
7848063|NCT00142298|27234658|P4|Overall Study|Patient, Investigator,or Sponsor request|51
7848064|NCT00142298|27234659|P3|Overall Study|Patient, Investigator,or Sponsor request|11
7848065|NCT00142298|27234660|P2|Overall Study|Patient, Investigator,or Sponsor request|60
7848066|NCT00142298|27234661|P1|Overall Study|Patient, Investigator,or Sponsor request|66
7848067|NCT00142298|27234652|P10|Overall Study|Non-compliance|0
7848068|NCT00142298|27234653|P9|Overall Study|Non-compliance|3
7848069|NCT00142298|27234654|P8|Overall Study|Non-compliance|3
7848070|NCT00142298|27234655|P7|Overall Study|Non-compliance|0
7848071|NCT00142298|27234656|P6|Overall Study|Non-compliance|0
7848072|NCT00142298|27234657|P5|Overall Study|Non-compliance|1
7848073|NCT00142298|27234658|P4|Overall Study|Non-compliance|6
7848074|NCT00142298|27234659|P3|Overall Study|Non-compliance|0
7848075|NCT00142298|27234660|P2|Overall Study|Non-compliance|13
7848076|NCT00142298|27234661|P1|Overall Study|Non-compliance|15
7848077|NCT00142298|27234652|P10|Overall Study|Lack of Efficacy|0
7848078|NCT00142298|27234653|P9|Overall Study|Lack of Efficacy|0
7848079|NCT00142298|27234654|P8|Overall Study|Lack of Efficacy|1
7848080|NCT00142298|27234655|P7|Overall Study|Lack of Efficacy|0
7848081|NCT00142298|27234656|P6|Overall Study|Lack of Efficacy|0
7848082|NCT00142298|27234657|P5|Overall Study|Lack of Efficacy|1
7848083|NCT00142298|27234658|P4|Overall Study|Lack of Efficacy|12
7848084|NCT00142298|27234659|P3|Overall Study|Lack of Efficacy|9
7848085|NCT00142298|27234660|P2|Overall Study|Lack of Efficacy|62
7848086|NCT00142298|27234661|P1|Overall Study|Lack of Efficacy|44
7848087|NCT00142298|27234652|P10|Overall Study|Death|0
7848088|NCT00142298|27234653|P9|Overall Study|Death|0
7848089|NCT00142298|27234654|P8|Overall Study|Death|0
7848090|NCT00142298|27234655|P7|Overall Study|Death|0
7848091|NCT00142298|27234656|P6|Overall Study|Death|6
7848092|NCT00142298|27234657|P5|Overall Study|Death|0
7848093|NCT00142298|27234658|P4|Overall Study|Death|0
7848094|NCT00142298|27234659|P3|Overall Study|Death|1
7848095|NCT00142298|27234660|P2|Overall Study|Death|1
7848096|NCT00142298|27234661|P1|Overall Study|Death|1
7848097|NCT00142298|27234652|P10|Overall Study|Clinical disease progression|0
7848098|NCT00142298|27234653|P9|Overall Study|Clinical disease progression|0
7848099|NCT00142298|27234654|P8|Overall Study|Clinical disease progression|0
7848100|NCT00142298|27234655|P7|Overall Study|Clinical disease progression|0
7848101|NCT00142298|27234656|P6|Overall Study|Clinical disease progression|0
7848102|NCT00142298|27234657|P5|Overall Study|Clinical disease progression|0
7848103|NCT00142298|27234658|P4|Overall Study|Clinical disease progression|0
7848104|NCT00142298|27234659|P3|Overall Study|Clinical disease progression|0
7848105|NCT00142298|27234660|P2|Overall Study|Clinical disease progression|0
7848106|NCT00142298|27234661|P1|Overall Study|Clinical disease progression|1
7848107|NCT00142298|27234652|P10|Overall Study|Adverse Event|0
7848108|NCT00142298|27234653|P9|Overall Study|Adverse Event|0
7848109|NCT00142298|27234654|P8|Overall Study|Adverse Event|0
7848110|NCT00142298|27234655|P7|Overall Study|Adverse Event|0
7848111|NCT00142298|27234656|P6|Overall Study|Adverse Event|2
7848112|NCT00142298|27234657|P5|Overall Study|Adverse Event|2
7848113|NCT00142298|27234658|P4|Overall Study|Adverse Event|5
7848114|NCT00142298|27234659|P3|Overall Study|Adverse Event|1
7848115|NCT00142298|27234660|P2|Overall Study|Adverse Event|10
7848116|NCT00142298|27234661|P1|Overall Study|Adverse Event|10
7848117|NCT00141921|27234695|P1|Overall Study|Other|8
7848118|NCT00141921|27234695|P1|Overall Study|Ineligibility Determined|2
7848119|NCT00141921|27234695|P1|Overall Study|Pregnancy|4
7848120|NCT00141921|27234695|P1|Overall Study|Administrative Decision|2
7848121|NCT00141921|27234695|P1|Overall Study|Adverse Event|5
7848122|NCT00141921|27234695|P1|Overall Study|Protocol Deviation|7
7848123|NCT00141921|27234695|P1|Overall Study|Disease Progression|7
7848124|NCT00141921|27234695|P1|Overall Study|Noncompliance|17
7848125|NCT00141921|27234695|P1|Overall Study|Lost to Follow-up|19
7848126|NCT00141921|27234695|P1|Overall Study|Withdrawal by Subject|42
7848127|NCT00141921|27234695|P1|Overall Study|Remain on Study|28
7848128|NCT00141817|27234721|P4|Overall Study|Parent request|0
7848129|NCT00141817|27234722|P3|Overall Study|Parent request|0
7848130|NCT00141817|27234723|P2|Overall Study|Parent request|0
7848131|NCT00141817|27234724|P1|Overall Study|Parent request|1
7848132|NCT00141817|27234721|P4|Overall Study|Protocol Violation|0
7848133|NCT00141817|27234722|P3|Overall Study|Protocol Violation|1
7848134|NCT00141817|27234723|P2|Overall Study|Protocol Violation|0
7848135|NCT00141817|27234724|P1|Overall Study|Protocol Violation|0
7848136|NCT00141778|27234765|P3|Started Study Medication|Chest Discomfort|1
7848137|NCT00141778|27234766|P2|Started Study Medication|Chest Discomfort|0
7848138|NCT00141778|27234767|P1|Started Study Medication|Chest Discomfort|0
7848139|NCT00141778|27234765|P3|Started Study Medication|Difficulty Swallowing|0
7848140|NCT00141778|27234766|P2|Started Study Medication|Difficulty Swallowing|1
7848141|NCT00141778|27234767|P1|Started Study Medication|Difficulty Swallowing|0
7848142|NCT00141778|27234765|P3|Started Study Medication|Withdrawal by Subject|0
7848143|NCT00141778|27234766|P2|Started Study Medication|Withdrawal by Subject|2
7848144|NCT00141778|27234767|P1|Started Study Medication|Withdrawal by Subject|0
7848238|NCT00141271|27235321|P3|Overall Study|Lack of Efficacy|3
7848145|NCT00141778|27234765|P3|Started Study Medication|Met safety criteria for discontinuation|3
7848146|NCT00141778|27234766|P2|Started Study Medication|Met safety criteria for discontinuation|4
7848147|NCT00141778|27234767|P1|Started Study Medication|Met safety criteria for discontinuation|2
7848148|NCT00141778|27234765|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
7848149|NCT00141778|27234766|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
7848150|NCT00141778|27234767|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
7848151|NCT00141726|27234820|P1|Overall Study|Completed <50% Scheduled Dosing|3
7848152|NCT00141518|27234828|P3|Overall Study|Lack of Efficacy|0
7848153|NCT00141518|27234829|P2|Overall Study|Lack of Efficacy|0
7848154|NCT00141518|27234830|P1|Overall Study|Lack of Efficacy|5
7848155|NCT00141518|27234828|P3|Overall Study|Protocol Violation|2
7848156|NCT00141518|27234829|P2|Overall Study|Protocol Violation|1
7848157|NCT00141518|27234830|P1|Overall Study|Protocol Violation|1
7848158|NCT00141518|27234828|P3|Overall Study|Withdrawal by Subject|2
7848159|NCT00141518|27234829|P2|Overall Study|Withdrawal by Subject|0
7848160|NCT00141518|27234830|P1|Overall Study|Withdrawal by Subject|2
7848161|NCT00141518|27234828|P3|Overall Study|Adverse Event|2
7848162|NCT00141518|27234829|P2|Overall Study|Adverse Event|5
7848163|NCT00141518|27234830|P1|Overall Study|Adverse Event|7
7848164|NCT00141518|27234828|P3|Overall Study|Withdrew Consent Prior to Treatment|0
7848165|NCT00141518|27234829|P2|Overall Study|Withdrew Consent Prior to Treatment|0
7848166|NCT00141518|27234830|P1|Overall Study|Withdrew Consent Prior to Treatment|1
7848167|NCT00141453|27235019|P2|Overall Study|Protocol Violation|5
7848168|NCT00141453|27235020|P1|Overall Study|Protocol Violation|6
7848169|NCT00141297|27235034|P10|Overall Study|Transitioned|0
7848170|NCT00141297|27235035|P9|Overall Study|Transitioned|0
7848171|NCT00141297|27235036|P8|Overall Study|Transitioned|0
7848172|NCT00141297|27235037|P7|Overall Study|Transitioned|0
7848173|NCT00141297|27235038|P6|Overall Study|Transitioned|0
7848174|NCT00141297|27235039|P5|Overall Study|Transitioned|1
7848175|NCT00141297|27235040|P4|Overall Study|Transitioned|0
7848176|NCT00141297|27235041|P3|Overall Study|Transitioned|0
7848177|NCT00141297|27235042|P2|Overall Study|Transitioned|0
7848178|NCT00141297|27235043|P1|Overall Study|Transitioned|0
7848179|NCT00141297|27235034|P10|Overall Study|Progressive Disease|6
7848180|NCT00141297|27235035|P9|Overall Study|Progressive Disease|15
7848181|NCT00141297|27235036|P8|Overall Study|Progressive Disease|3
7848182|NCT00141297|27235037|P7|Overall Study|Progressive Disease|3
7848183|NCT00141297|27235038|P6|Overall Study|Progressive Disease|2
7848184|NCT00141297|27235039|P5|Overall Study|Progressive Disease|15
7848185|NCT00141297|27235040|P4|Overall Study|Progressive Disease|2
7848186|NCT00141297|27235041|P3|Overall Study|Progressive Disease|6
7848187|NCT00141297|27235042|P2|Overall Study|Progressive Disease|3
7848188|NCT00141297|27235043|P1|Overall Study|Progressive Disease|2
7848189|NCT00141297|27235034|P10|Overall Study|Other|0
7848190|NCT00141297|27235035|P9|Overall Study|Other|2
7848191|NCT00141297|27235036|P8|Overall Study|Other|0
7848192|NCT00141297|27235037|P7|Overall Study|Other|0
7848193|NCT00141297|27235038|P6|Overall Study|Other|0
7848194|NCT00141297|27235039|P5|Overall Study|Other|5
7848195|NCT00141297|27235040|P4|Overall Study|Other|1
7848196|NCT00141297|27235041|P3|Overall Study|Other|0
7848197|NCT00141297|27235042|P2|Overall Study|Other|0
7848198|NCT00141297|27235043|P1|Overall Study|Other|0
7848199|NCT00141297|27235034|P10|Overall Study|Withdrawal by Subject|0
7848200|NCT00141297|27235035|P9|Overall Study|Withdrawal by Subject|1
7848201|NCT00141297|27235036|P8|Overall Study|Withdrawal by Subject|0
7848202|NCT00141297|27235037|P7|Overall Study|Withdrawal by Subject|0
7848203|NCT00141297|27235038|P6|Overall Study|Withdrawal by Subject|0
7848204|NCT00141297|27235039|P5|Overall Study|Withdrawal by Subject|0
7848205|NCT00141297|27235040|P4|Overall Study|Withdrawal by Subject|0
7848206|NCT00141297|27235041|P3|Overall Study|Withdrawal by Subject|0
7848207|NCT00141297|27235042|P2|Overall Study|Withdrawal by Subject|0
7848208|NCT00141297|27235043|P1|Overall Study|Withdrawal by Subject|0
7848209|NCT00141297|27235034|P10|Overall Study|Death|0
7848210|NCT00141297|27235035|P9|Overall Study|Death|1
7848211|NCT00141297|27235036|P8|Overall Study|Death|0
7848212|NCT00141297|27235037|P7|Overall Study|Death|0
7848213|NCT00141297|27235038|P6|Overall Study|Death|0
7848214|NCT00141297|27235039|P5|Overall Study|Death|0
7848215|NCT00141297|27235040|P4|Overall Study|Death|0
7848216|NCT00141297|27235041|P3|Overall Study|Death|0
7848217|NCT00141297|27235042|P2|Overall Study|Death|0
7848218|NCT00141297|27235043|P1|Overall Study|Death|1
7848219|NCT00141297|27235034|P10|Overall Study|Adverse Event|0
7848220|NCT00141297|27235035|P9|Overall Study|Adverse Event|1
7848221|NCT00141297|27235036|P8|Overall Study|Adverse Event|1
7848222|NCT00141297|27235037|P7|Overall Study|Adverse Event|0
7848223|NCT00141297|27235038|P6|Overall Study|Adverse Event|1
7848224|NCT00141297|27235039|P5|Overall Study|Adverse Event|1
7848225|NCT00141297|27235040|P4|Overall Study|Adverse Event|0
7848226|NCT00141297|27235041|P3|Overall Study|Adverse Event|1
7848227|NCT00141297|27235042|P2|Overall Study|Adverse Event|0
7848228|NCT00141297|27235043|P1|Overall Study|Adverse Event|0
7848229|NCT00141271|27235321|P3|Overall Study|Other|5
7848230|NCT00141271|27235322|P2|Overall Study|Other|12
7848231|NCT00141271|27235323|P1|Overall Study|Other|11
7848232|NCT00141271|27235321|P3|Overall Study|Withdrawal by Subject|10
7848233|NCT00141271|27235322|P2|Overall Study|Withdrawal by Subject|9
7848234|NCT00141271|27235323|P1|Overall Study|Withdrawal by Subject|14
7848235|NCT00141271|27235321|P3|Overall Study|Lost to Follow-up|21
7848236|NCT00141271|27235322|P2|Overall Study|Lost to Follow-up|15
7848239|NCT00141271|27235322|P2|Overall Study|Lack of Efficacy|7
7848240|NCT00141271|27235323|P1|Overall Study|Lack of Efficacy|7
7848241|NCT00141271|27235321|P3|Overall Study|Laboratory Abnormality|1
7848242|NCT00141271|27235322|P2|Overall Study|Laboratory Abnormality|1
7848243|NCT00141271|27235323|P1|Overall Study|Laboratory Abnormality|2
7848244|NCT00141271|27235321|P3|Overall Study|Adverse Event|17
7848245|NCT00141271|27235322|P2|Overall Study|Adverse Event|19
7848246|NCT00141271|27235323|P1|Overall Study|Adverse Event|31
7848247|NCT00141219|27235444|P2|Overall Study|Withdrawal by Subject|2
7848248|NCT00141219|27235445|P1|Overall Study|Withdrawal by Subject|6
7848249|NCT00141219|27235444|P2|Overall Study|Lack of Efficacy|4
7848250|NCT00141219|27235445|P1|Overall Study|Lack of Efficacy|5
7848251|NCT00141219|27235444|P2|Overall Study|Adverse Event|6
7848252|NCT00141219|27235445|P1|Overall Study|Adverse Event|8
7848253|NCT00141219|27235444|P2|Overall Study|Protocol violations|4
7848254|NCT00141219|27235445|P1|Overall Study|Protocol violations|5
7848255|NCT00141102|27235502|P2|Overall Study|Death|2
7848256|NCT00141102|27235503|P1|Overall Study|Death|2
7848257|NCT00141102|27235502|P2|Overall Study|Randomized But Did Not Receive Treatment|9
7848258|NCT00141102|27235503|P1|Overall Study|Randomized But Did Not Receive Treatment|15
7848259|NCT00141102|27235502|P2|Overall Study|Withdrawal by Subject|142
7848260|NCT00141102|27235503|P1|Overall Study|Withdrawal by Subject|112
7848261|NCT00141102|27235502|P2|Overall Study|Other|76
7848262|NCT00141102|27235503|P1|Overall Study|Other|87
7848263|NCT00141102|27235502|P2|Overall Study|Lost to Follow-up|32
7848264|NCT00141102|27235503|P1|Overall Study|Lost to Follow-up|29
7848265|NCT00141102|27235502|P2|Overall Study|Lack of Efficacy|26
7848266|NCT00141102|27235503|P1|Overall Study|Lack of Efficacy|21
7848267|NCT00141102|27235502|P2|Overall Study|Laboratory Abnormality|33
7848268|NCT00141102|27235503|P1|Overall Study|Laboratory Abnormality|9
7848269|NCT00141102|27235502|P2|Overall Study|Adverse Event|305
7848270|NCT00141102|27235503|P1|Overall Study|Adverse Event|233
7848271|NCT00141037|27235543|P2|Overall Study|Graft Failure|4
7848272|NCT00141037|27235544|P1|Overall Study|Graft Failure|3
7848273|NCT00141037|27235543|P2|Overall Study|Moved from area|7
7848274|NCT00141037|27235544|P1|Overall Study|Moved from area|1
7848275|NCT00141037|27235543|P2|Overall Study|Other|1
7848276|NCT00141037|27235544|P1|Overall Study|Other|0
7848277|NCT00141037|27235543|P2|Overall Study|Withdrawal by Subject|1
7848278|NCT00141037|27235544|P1|Overall Study|Withdrawal by Subject|2
7848279|NCT00141037|27235543|P2|Overall Study|Protocol Violation|2
7848280|NCT00141037|27235544|P1|Overall Study|Protocol Violation|0
7848281|NCT00141037|27235543|P2|Overall Study|Lost to Follow-up|1
7848282|NCT00141037|27235544|P1|Overall Study|Lost to Follow-up|3
7848283|NCT00141037|27235543|P2|Overall Study|Physician Decision|2
7848284|NCT00141037|27235544|P1|Overall Study|Physician Decision|1
7848285|NCT00140855|27235552|P1|Overall Study|Progressive disease|2
7848286|NCT00140426|27235585|P2|Overall Study|Withdrawal by Subject|3
7848287|NCT00140426|27235586|P1|Overall Study|Withdrawal by Subject|0
7848288|NCT00140413|27235619|P2|Overall Study|Withdrawal by Subject|0
7848289|NCT00140413|27235620|P1|Overall Study|Withdrawal by Subject|2
7848290|NCT00140413|27235619|P2|Overall Study|Lost to Follow-up|0
7848291|NCT00140413|27235620|P1|Overall Study|Lost to Follow-up|1
7848292|NCT00140140|27235751|P3|Overall Study|Physician Decision|0
7848293|NCT00140140|27235752|P2|Overall Study|Physician Decision|1
7848294|NCT00140140|27235753|P1|Overall Study|Physician Decision|1
7848295|NCT00140140|27235751|P3|Overall Study|Unacceptable toxicity|2
7848296|NCT00140140|27235752|P2|Overall Study|Unacceptable toxicity|1
7848297|NCT00140140|27235753|P1|Overall Study|Unacceptable toxicity|1
7848298|NCT00139776|27235803|P4|Period III|Withdrawal by Subject|21
7848299|NCT00139776|27235804|P3|Period III|Withdrawal by Subject|16
7848300|NCT00139776|27235805|P2|Period III|Withdrawal by Subject|0
7848301|NCT00139776|27235806|P1|Period III|Withdrawal by Subject|0
7848302|NCT00139776|27235803|P4|Period III|Lost to Follow-up|4
7848303|NCT00139776|27235804|P3|Period III|Lost to Follow-up|5
7848304|NCT00139776|27235805|P2|Period III|Lost to Follow-up|0
7848305|NCT00139776|27235806|P1|Period III|Lost to Follow-up|0
7848306|NCT00139776|27235803|P4|Period III|Lack of Efficacy|24
7848307|NCT00139776|27235804|P3|Period III|Lack of Efficacy|10
7848308|NCT00139776|27235805|P2|Period III|Lack of Efficacy|0
7848309|NCT00139776|27235806|P1|Period III|Lack of Efficacy|0
7848310|NCT00139776|27235803|P4|Period III|Other|34
7848311|NCT00139776|27235804|P3|Period III|Other|23
7848312|NCT00139776|27235805|P2|Period III|Other|0
7848313|NCT00139776|27235806|P1|Period III|Other|0
7848314|NCT00139776|27235803|P4|Period III|Adverse Event|23
7848315|NCT00139776|27235804|P3|Period III|Adverse Event|22
7848316|NCT00139776|27235805|P2|Period III|Adverse Event|0
7848317|NCT00139776|27235806|P1|Period III|Adverse Event|0
7848318|NCT00139776|27235803|P4|Period II|Not Randomized into Period III|0
7848319|NCT00139776|27235804|P3|Period II|Not Randomized into Period III|0
7848320|NCT00139776|27235805|P2|Period II|Not Randomized into Period III|322
7848321|NCT00139776|27235806|P1|Period II|Not Randomized into Period III|0
7848322|NCT00139776|27235803|P4|Period I|Did not enter Period II|0
7848323|NCT00139776|27235804|P3|Period I|Did not enter Period II|0
7848324|NCT00139776|27235805|P2|Period I|Did not enter Period II|0
7848325|NCT00139776|27235806|P1|Period I|Did not enter Period II|575
7848326|NCT00139737|27235841|P1|Overall Study|Screened, Not Treated|13
7848327|NCT00139737|27235841|P1|Overall Study|Did Not Meet Entrance Criteria|1
7848328|NCT00139737|27235841|P1|Overall Study|Withdrew During Screening Phase|8
7848329|NCT00139737|27235841|P1|Overall Study|Protocol Violation|18
7848330|NCT00139737|27235841|P1|Overall Study|Laboratory Abnormality|2
7848331|NCT00139737|27235841|P1|Overall Study|Death|3
7848332|NCT00139737|27235841|P1|Overall Study|Lost to Follow-up|8
7848333|NCT00139737|27235841|P1|Overall Study|Lack of Efficacy|40
7848334|NCT00139737|27235841|P1|Overall Study|Adverse Event|58
7848335|NCT00139737|27235841|P1|Overall Study|Withdrawal by Subject|190
7848336|NCT00139659|27235847|P2|Overall Study|Withdrawal by Subject|10
7848337|NCT00139659|27235848|P1|Overall Study|Withdrawal by Subject|14
7848338|NCT00139659|27235847|P2|Overall Study|Reason not Specified|3
7848339|NCT00139659|27235848|P1|Overall Study|Reason not Specified|6
7848340|NCT00139659|27235847|P2|Overall Study|Lost to Follow-up|3
7848341|NCT00139659|27235848|P1|Overall Study|Lost to Follow-up|7
7848342|NCT00139659|27235847|P2|Overall Study|Lack of Efficacy|1
7848343|NCT00139659|27235848|P1|Overall Study|Lack of Efficacy|1
7848344|NCT00139659|27235847|P2|Overall Study|Adverse Event|1
7848345|NCT00139659|27235848|P1|Overall Study|Adverse Event|12
7848346|NCT00139477|27235926|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
7848347|NCT00139477|27235927|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
7848348|NCT00139477|27235926|P2|Second Intervention -6Months to 12Months|Relocation|0
7848349|NCT00139477|27235927|P1|Second Intervention -6Months to 12Months|Relocation|1
7848350|NCT00139477|27235926|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
7848351|NCT00139477|27235927|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
7848352|NCT00139477|27235926|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
7848353|NCT00139477|27235927|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
7848354|NCT00139477|27235926|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
7848355|NCT00139477|27235927|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
7848356|NCT00139477|27235926|P2|First Intervention -Baseline to 6Months|Relocation|2
7848357|NCT00139477|27235927|P1|First Intervention -Baseline to 6Months|Relocation|1
7848358|NCT00139477|27235926|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
7848359|NCT00139477|27235927|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
7848360|NCT00138671|27235962|P2|Overall Study|Other|3
7848361|NCT00138671|27235963|P1|Overall Study|Other|3
7848362|NCT00138671|27235962|P2|Overall Study|Withdrawal by Subject|5
7848363|NCT00138671|27235963|P1|Overall Study|Withdrawal by Subject|3
7848364|NCT00138671|27235962|P2|Overall Study|Lost to Follow-up|2
7848365|NCT00138671|27235963|P1|Overall Study|Lost to Follow-up|1
7848366|NCT00138671|27235962|P2|Overall Study|Adverse Event|3
7848367|NCT00138671|27235963|P1|Overall Study|Adverse Event|6
7848368|NCT00138671|27235962|P2|Overall Study|Death|3
7848369|NCT00138671|27235963|P1|Overall Study|Death|0
7848370|NCT00138658|27236013|P1|Overall Study|Withdrawal by Subject|5
7848371|NCT00138658|27236013|P1|Overall Study|Physician Decision|11
7848372|NCT00138658|27236013|P1|Overall Study|Disease Progression|21
7848373|NCT00138658|27236013|P1|Overall Study|Death|1
7848374|NCT00138658|27236013|P1|Overall Study|Adverse Event|23
7848375|NCT00138424|27236036|P4|Overall Study|Physician Decision|0
7848376|NCT00138424|27236037|P3|Overall Study|Physician Decision|0
7848377|NCT00138424|27236038|P2|Overall Study|Physician Decision|1
7848378|NCT00138424|27236039|P1|Overall Study|Physician Decision|0
7848379|NCT00138151|27236122|P1|Overall Study|Physician Decision|1
7848380|NCT00138151|27236122|P1|Overall Study|Withdrawal by Subject|3
7848381|NCT00138073|27236137|P1|Overall Study|lack of resources|55
7848382|NCT00137839|27236176|P1|Overall Study|Prolonged Treatment Delay|1
7848383|NCT00137839|27236176|P1|Overall Study|Not Start Treatment|1
7848384|NCT00137839|27236176|P1|Overall Study|Disease Progression|60
7848385|NCT00137839|27236176|P1|Overall Study|Death|8
7848386|NCT00137839|27236176|P1|Overall Study|Physician Decision|7
7848387|NCT00137839|27236176|P1|Overall Study|Adverse Event|7
7848388|NCT00137631|27236189|P2|Overall Study|Lost to Follow-up|41
7848389|NCT00137631|27236190|P1|Overall Study|Lost to Follow-up|37
7848390|NCT00137449|27236206|P2|Overall Study|Withdrawal by Subject|1
7848391|NCT00137449|27236207|P1|Overall Study|Withdrawal by Subject|1
7848392|NCT00137449|27236206|P2|Overall Study|Adverse Event|1
7848393|NCT00137449|27236207|P1|Overall Study|Adverse Event|3
7848394|NCT00137449|27236206|P2|Overall Study|Death|3
7848395|NCT00137449|27236207|P1|Overall Study|Death|4
7848396|NCT00137449|27236206|P2|Overall Study|Disease Progression|13
7848397|NCT00137449|27236207|P1|Overall Study|Disease Progression|8
7848398|NCT00137436|27236244|P1|Overall Study|Other|5
7848399|NCT00137436|27236244|P1|Overall Study|Withdrawal by Subject|6
7848400|NCT00137436|27236244|P1|Overall Study|Lack of Efficacy|17
7848401|NCT00137436|27236244|P1|Overall Study|Death|2
7848402|NCT00137436|27236244|P1|Overall Study|Adverse Event|13
7848403|NCT00137423|27236263|P2|Overall Study|Death|1
7848404|NCT00137423|27236264|P1|Overall Study|Death|0
7848405|NCT00137423|27236263|P2|Overall Study|Lack of Efficacy|33
7848406|NCT00137423|27236264|P1|Overall Study|Lack of Efficacy|31
7848407|NCT00137423|27236263|P2|Overall Study|consent withdrawn|1
7848408|NCT00137423|27236264|P1|Overall Study|consent withdrawn|1
7848409|NCT00137423|27236263|P2|Overall Study|Adverse Event|9
7848410|NCT00137423|27236264|P1|Overall Study|Adverse Event|7
7848411|NCT00137267|27236301|P2|Overall Study|Lost to Follow-up|21
7848412|NCT00137267|27236302|P1|Overall Study|Lost to Follow-up|15
7848413|NCT00137111|27236314|P4|Total Therapy|Non Compliance|0
7848414|NCT00137111|27236315|P3|Total Therapy|Non Compliance|0
7848415|NCT00137111|27236316|P2|Total Therapy|Non Compliance|0
7848416|NCT00137111|27236317|P1|Total Therapy|Non Compliance|5
7848417|NCT00137111|27236314|P4|Total Therapy|Death|0
7848418|NCT00137111|27236315|P3|Total Therapy|Death|0
7848419|NCT00137111|27236316|P2|Total Therapy|Death|0
7848420|NCT00137111|27236317|P1|Total Therapy|Death|35
7848421|NCT00137046|27236331|P2|Overall Study|Withdrew prior to study treatment|1
7848422|NCT00137046|27236332|P1|Overall Study|Withdrew prior to study treatment|1
7848423|NCT00137046|27236331|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
7848424|NCT00137046|27236332|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
7848425|NCT00137046|27236331|P2|Overall Study|Withdrawal by Subject|42
7848426|NCT00137046|27236332|P1|Overall Study|Withdrawal by Subject|33
7848427|NCT00137046|27236331|P2|Overall Study|Other|19
7848428|NCT00137046|27236332|P1|Overall Study|Other|23
7848429|NCT00137046|27236331|P2|Overall Study|Lost to Follow-up|24
7848430|NCT00137046|27236332|P1|Overall Study|Lost to Follow-up|8
7848431|NCT00137046|27236331|P2|Overall Study|Lack of Efficacy|1
7848432|NCT00137046|27236332|P1|Overall Study|Lack of Efficacy|13
7848433|NCT00137046|27236331|P2|Overall Study|Laboratory Abnormality|0
7848434|NCT00137046|27236332|P1|Overall Study|Laboratory Abnormality|2
7848435|NCT00137046|27236331|P2|Overall Study|Adverse Event|5
7848436|NCT00137046|27236332|P1|Overall Study|Adverse Event|16
7848437|NCT00137046|27236331|P2|Overall Study|Death|1
7848438|NCT00137046|27236332|P1|Overall Study|Death|2
7848439|NCT00136955|27236380|P1|Overall Study|Incl. prog. disease, protocol violation|12
7848440|NCT00136955|27236380|P1|Overall Study|Withdrawal by Subject|2
7848441|NCT00136955|27236380|P1|Overall Study|Lost to Follow-up|1
7848442|NCT00136955|27236380|P1|Overall Study|Adverse Event|8
7848443|NCT00136916|27236389|P2|Overall Study|Discontinued in follow up period|0
7848444|NCT00136916|27236390|P1|Overall Study|Discontinued in follow up period|3
7848445|NCT00136916|27236389|P2|Overall Study|Other|24
7848446|NCT00136916|27236390|P1|Overall Study|Other|22
7848447|NCT00136916|27236389|P2|Overall Study|Withdrawal by Subject|46
7848448|NCT00136916|27236390|P1|Overall Study|Withdrawal by Subject|44
7848449|NCT00136916|27236389|P2|Overall Study|Lost to Follow-up|14
7848450|NCT00136916|27236390|P1|Overall Study|Lost to Follow-up|12
7848451|NCT00136916|27236389|P2|Overall Study|Lack of Efficacy|3
7848452|NCT00136916|27236390|P1|Overall Study|Lack of Efficacy|13
7848453|NCT00136916|27236389|P2|Overall Study|Laboratory abnormality|1
7848454|NCT00136916|27236390|P1|Overall Study|Laboratory abnormality|0
7848455|NCT00136916|27236389|P2|Overall Study|Adverse Event|8
7848456|NCT00136916|27236390|P1|Overall Study|Adverse Event|27
7848457|NCT00136916|27236389|P2|Overall Study|Death|3
7848458|NCT00136916|27236390|P1|Overall Study|Death|1
7848459|NCT00136916|27236389|P2|Overall Study|Never received study treatment|5
7848460|NCT00136916|27236390|P1|Overall Study|Never received study treatment|3
7848461|NCT00136604|27236497|P5|Overall Study|Migrated/moved from study area|0
7848462|NCT00136604|27236498|P4|Overall Study|Migrated/moved from study area|0
7848463|NCT00136604|27236499|P3|Overall Study|Migrated/moved from study area|0
7848464|NCT00136604|27236500|P2|Overall Study|Migrated/moved from study area|1
7848465|NCT00136604|27236501|P1|Overall Study|Migrated/moved from study area|0
7848466|NCT00136604|27236497|P5|Overall Study|Lost to Follow-up|1
7848467|NCT00136604|27236498|P4|Overall Study|Lost to Follow-up|0
7848468|NCT00136604|27236499|P3|Overall Study|Lost to Follow-up|0
7848469|NCT00136604|27236500|P2|Overall Study|Lost to Follow-up|0
7848470|NCT00136604|27236501|P1|Overall Study|Lost to Follow-up|1
7848471|NCT00136357|27236609|P2|Overall Study|Withdrawal by Subject|2
7848472|NCT00136357|27236610|P1|Overall Study|Withdrawal by Subject|3
7848473|NCT00136318|27236618|P2|Overall Study|Withdrawal by Subject|2
7848474|NCT00136318|27236619|P1|Overall Study|Withdrawal by Subject|2
7848475|NCT00136318|27236618|P2|Overall Study|Adverse Event|5
7848476|NCT00136318|27236619|P1|Overall Study|Adverse Event|5
7848477|NCT00136084|27236646|P2|Overall Study|Withdrawal by Subject|1
7848478|NCT00136084|27236647|P1|Overall Study|Withdrawal by Subject|5
7848479|NCT00136084|27236646|P2|Overall Study|No Response|2
7848480|NCT00136084|27236647|P1|Overall Study|No Response|1
7848481|NCT00136084|27236646|P2|Overall Study|Lost to Follow-up|0
7848482|NCT00136084|27236647|P1|Overall Study|Lost to Follow-up|2
7848483|NCT00136084|27236646|P2|Overall Study|Relapse|23
7848484|NCT00136084|27236647|P1|Overall Study|Relapse|20
7848485|NCT00136084|27236646|P2|Overall Study|Unacceptable toxicity|11
7848486|NCT00136084|27236647|P1|Overall Study|Unacceptable toxicity|8
7848487|NCT00136084|27236646|P2|Overall Study|Death|5
7848488|NCT00136084|27236647|P1|Overall Study|Death|12
7848489|NCT00135707|27236683|P2|Overall Study|Institutional review board request|0
7848490|NCT00135707|27236684|P1|Overall Study|Institutional review board request|1
7848491|NCT00135707|27236683|P2|Overall Study|Withdrawal by Subject|1
7848492|NCT00135707|27236684|P1|Overall Study|Withdrawal by Subject|0
7848493|NCT00135707|27236683|P2|Overall Study|Lost to Follow-up|89
7848494|NCT00135707|27236684|P1|Overall Study|Lost to Follow-up|94
7848495|NCT00135694|27236767|P3|Overall Study|Ineligible for Random assignment|0
7848496|NCT00135694|27236768|P2|Overall Study|Ineligible for Random assignment|0
7848497|NCT00135694|27236769|P1|Overall Study|Ineligible for Random assignment|42
7848498|NCT00135694|27236767|P3|Overall Study|Hepatitis C related reasons|0
7848499|NCT00135694|27236768|P2|Overall Study|Hepatitis C related reasons|1
7848500|NCT00135694|27236769|P1|Overall Study|Hepatitis C related reasons|39
7848501|NCT00135694|27236767|P3|Overall Study|Protocol Violation|0
7848502|NCT00135694|27236768|P2|Overall Study|Protocol Violation|1
7848503|NCT00135694|27236769|P1|Overall Study|Protocol Violation|19
7848504|NCT00135694|27236767|P3|Overall Study|Withdrawal by Subject|4
7848505|NCT00135694|27236768|P2|Overall Study|Withdrawal by Subject|7
7848506|NCT00135694|27236769|P1|Overall Study|Withdrawal by Subject|41
7848507|NCT00135694|27236767|P3|Overall Study|Lost to Follow-up|1
7848508|NCT00135694|27236768|P2|Overall Study|Lost to Follow-up|7
7848509|NCT00135694|27236769|P1|Overall Study|Lost to Follow-up|8
7848510|NCT00135694|27236767|P3|Overall Study|Death|2
7848511|NCT00135694|27236768|P2|Overall Study|Death|1
7848512|NCT00135694|27236769|P1|Overall Study|Death|14
7848513|NCT00135694|27236767|P3|Overall Study|Adverse Event|0
7848514|NCT00135694|27236768|P2|Overall Study|Adverse Event|4
7848515|NCT00135694|27236769|P1|Overall Study|Adverse Event|17
7848516|NCT00135512|27236787|P1|Overall Study|Other|42
7848517|NCT00135512|27236787|P1|Overall Study|Lack of Efficacy|25
7848518|NCT00135512|27236787|P1|Overall Study|Adverse Event|56
7848519|NCT00135356|27236799|P2|Overall Study|Withdrawal by Subject|4
7848520|NCT00135356|27236800|P1|Overall Study|Withdrawal by Subject|2
7848521|NCT00135356|27236799|P2|Overall Study|No longer meets study criteria|0
7848522|NCT00135356|27236800|P1|Overall Study|No longer meets study criteria|2
7848523|NCT00135356|27236799|P2|Overall Study|Poor/noncompliance|1
7848524|NCT00135356|27236800|P1|Overall Study|Poor/noncompliance|1
7848525|NCT00135356|27236799|P2|Overall Study|Change in antiviral regimen|1
7848526|NCT00135356|27236800|P1|Overall Study|Change in antiviral regimen|0
7848527|NCT00135356|27236799|P2|Overall Study|Surgery for abdominal fat|0
7848528|NCT00135356|27236800|P1|Overall Study|Surgery for abdominal fat|1
7848529|NCT00135356|27236799|P2|Overall Study|Lost to Follow-up|1
7848530|NCT00135356|27236800|P1|Overall Study|Lost to Follow-up|3
7848531|NCT00135356|27236799|P2|Overall Study|Lack of Efficacy|0
7848532|NCT00135356|27236800|P1|Overall Study|Lack of Efficacy|2
7848533|NCT00135356|27236799|P2|Overall Study|Adverse Event|2
7848534|NCT00135356|27236800|P1|Overall Study|Adverse Event|6
7848535|NCT00135330|27236843|P3|Overall Study|Sponsor Decision|0
7848536|NCT00135330|27236844|P2|Overall Study|Sponsor Decision|1
7848537|NCT00135330|27236845|P1|Overall Study|Sponsor Decision|0
7848538|NCT00135330|27236843|P3|Overall Study|Patient Decision|4
7848539|NCT00135330|27236844|P2|Overall Study|Patient Decision|1
7848540|NCT00135330|27236845|P1|Overall Study|Patient Decision|5
7848541|NCT00135330|27236843|P3|Overall Study|Protocol Violation|3
7848542|NCT00135330|27236844|P2|Overall Study|Protocol Violation|3
7848543|NCT00135330|27236845|P1|Overall Study|Protocol Violation|4
7848544|NCT00135330|27236843|P3|Overall Study|Physician Decision|0
7848545|NCT00135330|27236844|P2|Overall Study|Physician Decision|1
7848546|NCT00135330|27236845|P1|Overall Study|Physician Decision|1
7848547|NCT00135330|27236843|P3|Overall Study|Lost to Follow-up|3
7848548|NCT00135330|27236844|P2|Overall Study|Lost to Follow-up|2
7848549|NCT00135330|27236845|P1|Overall Study|Lost to Follow-up|0
7848550|NCT00135330|27236843|P3|Overall Study|Adverse Event|1
7848551|NCT00135330|27236844|P2|Overall Study|Adverse Event|5
7848552|NCT00135330|27236845|P1|Overall Study|Adverse Event|2
7848553|NCT00134901|27237043|P2|Overall Study|discontinued intervention|10
7848554|NCT00134901|27237044|P1|Overall Study|discontinued intervention|12
7848555|NCT00134901|27237043|P2|Overall Study|Lost to Follow-up|5
7848556|NCT00134901|27237044|P1|Overall Study|Lost to Follow-up|5
7848557|NCT00134784|27237056|P4|Overall Study|Withdrawal by Subject|1
7848558|NCT00134784|27237057|P3|Overall Study|Withdrawal by Subject|2
7848559|NCT00134784|27237058|P2|Overall Study|Withdrawal by Subject|2
7848560|NCT00134784|27237059|P1|Overall Study|Withdrawal by Subject|2
7848561|NCT00134719|27237069|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
7848562|NCT00134719|27237070|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
7848563|NCT00134719|27237071|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
7848564|NCT00134719|27237069|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
7848565|NCT00134719|27237070|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
7848566|NCT00134719|27237071|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
7848567|NCT00134719|27237069|P3|Primary Vaccination Phase|Lost to Follow-up|3
7848568|NCT00134719|27237070|P2|Primary Vaccination Phase|Lost to Follow-up|3
7848569|NCT00134719|27237071|P1|Primary Vaccination Phase|Lost to Follow-up|7
7848570|NCT00134719|27237069|P3|Primary Vaccination Phase|Withdrawal by Subject|2
7848571|NCT00134719|27237070|P2|Primary Vaccination Phase|Withdrawal by Subject|3
7848572|NCT00134719|27237071|P1|Primary Vaccination Phase|Withdrawal by Subject|2
7848573|NCT00134719|27237069|P3|Primary Vaccination Phase|Protocol Violation|0
7848574|NCT00134719|27237070|P2|Primary Vaccination Phase|Protocol Violation|0
7848575|NCT00134719|27237071|P1|Primary Vaccination Phase|Protocol Violation|1
7848576|NCT00134719|27237069|P3|Primary Vaccination Phase|Adverse Event|0
7848577|NCT00134719|27237070|P2|Primary Vaccination Phase|Adverse Event|0
7848578|NCT00134719|27237071|P1|Primary Vaccination Phase|Adverse Event|4
7848579|NCT00134563|27237202|P3|Overall Study|Reason other than above|5
7848580|NCT00134563|27237203|P2|Overall Study|Reason other than above|2
7848581|NCT00134563|27237204|P1|Overall Study|Reason other than above|0
7848582|NCT00134563|27237202|P3|Overall Study|did not wish to continue|26
7848583|NCT00134563|27237203|P2|Overall Study|did not wish to continue|32
7848584|NCT00134563|27237204|P1|Overall Study|did not wish to continue|33
7848585|NCT00134563|27237202|P3|Overall Study|progressive disease|2
7848586|NCT00134563|27237203|P2|Overall Study|progressive disease|4
7848587|NCT00134563|27237204|P1|Overall Study|progressive disease|11
7848588|NCT00134563|27237202|P3|Overall Study|Lost to Follow-up|2
7848589|NCT00134563|27237203|P2|Overall Study|Lost to Follow-up|0
7848590|NCT00134563|27237204|P1|Overall Study|Lost to Follow-up|4
7848591|NCT00134563|27237202|P3|Overall Study|Protocol Violation|5
7848592|NCT00134563|27237203|P2|Overall Study|Protocol Violation|2
7848593|NCT00134563|27237204|P1|Overall Study|Protocol Violation|3
7848594|NCT00134563|27237202|P3|Overall Study|Lack of Efficacy|17
7848595|NCT00134563|27237203|P2|Overall Study|Lack of Efficacy|14
7848596|NCT00134563|27237204|P1|Overall Study|Lack of Efficacy|24
7848597|NCT00134563|27237202|P3|Overall Study|Adverse Event|38
7848598|NCT00134563|27237203|P2|Overall Study|Adverse Event|37
7848599|NCT00134563|27237204|P1|Overall Study|Adverse Event|29
7848600|NCT00134563|27237202|P3|Overall Study|Not treated due to protocol violation|1
7848601|NCT00134563|27237203|P2|Overall Study|Not treated due to protocol violation|1
7848602|NCT00134563|27237204|P1|Overall Study|Not treated due to protocol violation|0
7848603|NCT00134082|27237265|P1|Overall Study|Death|1
7848604|NCT00134082|27237265|P1|Overall Study|Adverse Event|2
7848615|NCT00133991|27237319|P1|Overall Study|Death|4
7848616|NCT00133952|27237358|P2|Overall Study|Sponsor Decision|1
7848617|NCT00133952|27237359|P1|Overall Study|Sponsor Decision|0
7848618|NCT00133952|27237358|P2|Overall Study|Physician Decision|3
7848619|NCT00133952|27237359|P1|Overall Study|Physician Decision|4
7848620|NCT00133952|27237358|P2|Overall Study|Withdrawal by Subject|4
7848621|NCT00133952|27237359|P1|Overall Study|Withdrawal by Subject|20
7848622|NCT00133952|27237358|P2|Overall Study|Protocol Violation|1
7848623|NCT00133952|27237359|P1|Overall Study|Protocol Violation|1
7848624|NCT00133952|27237358|P2|Overall Study|Protocol Entry Criteria Exclusion|1
7848625|NCT00133952|27237359|P1|Overall Study|Protocol Entry Criteria Exclusion|4
7848626|NCT00133952|27237358|P2|Overall Study|Lost to Follow-up|14
7848627|NCT00133952|27237359|P1|Overall Study|Lost to Follow-up|9
7848628|NCT00133952|27237358|P2|Overall Study|Death|2
7848629|NCT00133952|27237359|P1|Overall Study|Death|3
7848630|NCT00133952|27237358|P2|Overall Study|Adverse Event|2
7848631|NCT00133952|27237359|P1|Overall Study|Adverse Event|1
7848632|NCT00133705|27237390|P2|Overall Study|Withdrawal by Subject|3
7848633|NCT00133705|27237391|P1|Overall Study|Withdrawal by Subject|2
7848634|NCT00132873|27237545|P1|Overall Study|Planned Pregnancy|1
7848635|NCT00132873|27237545|P1|Overall Study|Withdrawal by Subject|3
7848636|NCT00132873|27237545|P1|Overall Study|Lack of Efficacy|1
7848637|NCT00132873|27237545|P1|Overall Study|Lost to Follow-up|1
7848638|NCT00132873|27237545|P1|Overall Study|Adverse Event|3
7848639|NCT00132808|27237553|P3|Stratum II|Withdrawal by Subject|6
7848640|NCT00132808|27237554|P2|Stratum II|Withdrawal by Subject|9
7848641|NCT00132808|27237555|P1|Stratum II|Withdrawal by Subject|4
7848642|NCT00132808|27237553|P3|Stratum II|Protocol Violation|1
7848643|NCT00132808|27237554|P2|Stratum II|Protocol Violation|2
7848644|NCT00132808|27237555|P1|Stratum II|Protocol Violation|0
7848645|NCT00132808|27237553|P3|Stratum II|Lost to Follow-up|1
7848646|NCT00132808|27237554|P2|Stratum II|Lost to Follow-up|2
7848647|NCT00132808|27237555|P1|Stratum II|Lost to Follow-up|2
7848648|NCT00132808|27237553|P3|Stratum II|Death|0
7848649|NCT00132808|27237554|P2|Stratum II|Death|0
7848650|NCT00132808|27237555|P1|Stratum II|Death|1
7848651|NCT00132808|27237553|P3|Stratum II|Adverse Event|1
7848652|NCT00132808|27237554|P2|Stratum II|Adverse Event|2
7848653|NCT00132808|27237555|P1|Stratum II|Adverse Event|1
7848654|NCT00132808|27237553|P3|Stratum I|Abnormal test procedure result (s)|1
7848655|NCT00132808|27237554|P2|Stratum I|Abnormal test procedure result (s)|0
7848656|NCT00132808|27237555|P1|Stratum I|Abnormal test procedure result (s)|0
7848657|NCT00132808|27237553|P3|Stratum I|Withdrawal by Subject|3
7848658|NCT00132808|27237554|P2|Stratum I|Withdrawal by Subject|7
7848659|NCT00132808|27237555|P1|Stratum I|Withdrawal by Subject|4
7848660|NCT00132808|27237553|P3|Stratum I|Lost to Follow-up|1
7848661|NCT00132808|27237554|P2|Stratum I|Lost to Follow-up|4
7848662|NCT00132808|27237555|P1|Stratum I|Lost to Follow-up|3
7848663|NCT00132808|27237553|P3|Stratum I|Adverse Event|0
7848664|NCT00132808|27237554|P2|Stratum I|Adverse Event|1
7848665|NCT00132808|27237555|P1|Stratum I|Adverse Event|2
7848666|NCT00132769|27237580|P2|Overall Study|Protocol Violation|1
7848667|NCT00132769|27237581|P1|Overall Study|Protocol Violation|1
7848668|NCT00132769|27237580|P2|Overall Study|Adverse Event|1
7848669|NCT00132769|27237581|P1|Overall Study|Adverse Event|2
7848670|NCT00132769|27237580|P2|Overall Study|Lack of Efficacy|6
7848671|NCT00132769|27237581|P1|Overall Study|Lack of Efficacy|7
7848672|NCT00132769|27237580|P2|Overall Study|Withdrawal by Subject|3
7848673|NCT00132769|27237581|P1|Overall Study|Withdrawal by Subject|1
7848674|NCT00132730|27237607|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
7848675|NCT00132730|27237608|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
7848676|NCT00132730|27237609|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
7848677|NCT00132730|27237610|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
7848746|NCT00132691|27237656|P2|Overall Study|Death|0
7848678|NCT00132730|27237611|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
7848679|NCT00132730|27237612|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
7848680|NCT00132730|27237607|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
7848681|NCT00132730|27237608|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
7848682|NCT00132730|27237609|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
7848683|NCT00132730|27237610|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
7848684|NCT00132730|27237611|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
7848685|NCT00132730|27237612|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
7848686|NCT00132730|27237607|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7848687|NCT00132730|27237608|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
7848688|NCT00132730|27237609|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7848689|NCT00132730|27237610|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7848690|NCT00132730|27237611|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7848691|NCT00132730|27237612|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7848692|NCT00132730|27237607|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7848693|NCT00132730|27237608|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
7848694|NCT00132730|27237609|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7848695|NCT00132730|27237610|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7848696|NCT00132730|27237611|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7848697|NCT00132730|27237612|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7848698|NCT00132730|27237607|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
7848699|NCT00132730|27237608|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
7848700|NCT00132730|27237609|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
7848701|NCT00132730|27237610|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
7848702|NCT00132730|27237611|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
7848703|NCT00132730|27237612|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
7848704|NCT00132730|27237607|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
7848705|NCT00132730|27237608|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
7848706|NCT00132730|27237609|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
7848707|NCT00132730|27237610|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
7848708|NCT00132730|27237611|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
7848709|NCT00132730|27237612|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
7848710|NCT00132730|27237607|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7848711|NCT00132730|27237608|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7848712|NCT00132730|27237609|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
7848713|NCT00132730|27237610|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7848714|NCT00132730|27237611|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7848715|NCT00132730|27237612|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7848716|NCT00132730|27237607|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7848717|NCT00132730|27237608|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7848718|NCT00132730|27237609|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
7848719|NCT00132730|27237610|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
7848720|NCT00132730|27237611|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7848721|NCT00132730|27237612|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7848722|NCT00132730|27237607|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
7848723|NCT00132730|27237608|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
7848724|NCT00132730|27237609|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
7848725|NCT00132730|27237610|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
7848726|NCT00132730|27237611|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
7848727|NCT00132730|27237612|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
7848728|NCT00132730|27237607|P6|Period II - 12-week Treatment (Base)|Other reasons|0
7848729|NCT00132730|27237608|P5|Period II - 12-week Treatment (Base)|Other reasons|0
7848730|NCT00132730|27237609|P4|Period II - 12-week Treatment (Base)|Other reasons|13
7848731|NCT00132730|27237610|P3|Period II - 12-week Treatment (Base)|Other reasons|9
7848732|NCT00132730|27237611|P2|Period II - 12-week Treatment (Base)|Other reasons|10
7848733|NCT00132730|27237612|P1|Period II - 12-week Treatment (Base)|Other reasons|11
7848734|NCT00132730|27237607|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7848735|NCT00132730|27237608|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7848736|NCT00132730|27237609|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7848737|NCT00132730|27237610|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7848738|NCT00132730|27237611|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
7848739|NCT00132730|27237612|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
7848740|NCT00132730|27237607|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
7848741|NCT00132730|27237608|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
7848742|NCT00132730|27237609|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
7848743|NCT00132730|27237610|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
7848744|NCT00132730|27237611|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
7848745|NCT00132730|27237612|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
7848747|NCT00132691|27237657|P1|Overall Study|Death|2
7848748|NCT00132691|27237656|P2|Overall Study|Missed 2-year visit|4
7848749|NCT00132691|27237657|P1|Overall Study|Missed 2-year visit|4
7848750|NCT00132691|27237656|P2|Overall Study|Lost to Follow-up|8
7848751|NCT00132691|27237657|P1|Overall Study|Lost to Follow-up|5
7848752|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
7848753|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
7848754|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
7848755|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
7848756|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
7848757|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
7848758|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
7848759|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
7848760|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
7848761|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
7848762|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
7848763|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
7848764|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
7848765|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
7848766|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
7848767|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
7848768|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
7848769|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
7848770|NCT00132678|27237697|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
7848771|NCT00132678|27237698|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
7848772|NCT00132678|27237699|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
7848773|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Pregnancy|0
7848774|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Pregnancy|0
7848775|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Pregnancy|2
7848776|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Physician Decision|0
7848777|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Physician Decision|0
7848778|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Physician Decision|1
7848779|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
7848780|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
7848781|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
7848782|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
7848783|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
7848784|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
7848785|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
7848786|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
7848787|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
7848788|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
7848789|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
7848790|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
7848791|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Non responder|0
7848792|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Non responder|0
7848793|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Non responder|107
7848794|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Adverse Event|0
7848795|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Adverse Event|0
7848796|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Adverse Event|12
7848797|NCT00132678|27237697|P3|Period III (Open-Label Stabilization)|Death|0
7848798|NCT00132678|27237698|P2|Period III (Open-Label Stabilization)|Death|0
7848799|NCT00132678|27237699|P1|Period III (Open-Label Stabilization)|Death|2
7848800|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
7848801|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
7848802|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
7848803|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
7848804|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
7848805|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
7848806|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
7848807|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
7848808|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
7848809|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
7848810|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
7848811|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
7848812|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
7848813|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
7848814|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
7848815|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
7848816|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
7848817|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
7848818|NCT00132678|27237697|P3|Period II (Open-Label Oral Risperidone)|Death|1
7848819|NCT00132678|27237698|P2|Period II (Open-Label Oral Risperidone)|Death|0
7848820|NCT00132678|27237699|P1|Period II (Open-Label Oral Risperidone)|Death|0
7848821|NCT00132496|27237713|P2|Overall Study|Physician Decision|0
7848822|NCT00132496|27237714|P1|Overall Study|Physician Decision|1
7848823|NCT00132496|27237713|P2|Overall Study|Withdrawal by Subject|2
7848824|NCT00132496|27237714|P1|Overall Study|Withdrawal by Subject|1
7848825|NCT00132314|27237722|P2|Overall Study|Refused intervention at baseline|7
7848826|NCT00132314|27237723|P1|Overall Study|Refused intervention at baseline|2
7848827|NCT00132314|27237722|P2|Overall Study|Lacked SSN|3
7848828|NCT00132314|27237723|P1|Overall Study|Lacked SSN|1
7848829|NCT00132314|27237722|P2|Overall Study|Lost to Follow-up|62
7848830|NCT00132314|27237723|P1|Overall Study|Lost to Follow-up|70
7848831|NCT00132301|27237733|P2|Overall Study|Excluded by Data Monitoring Committee|0
7848832|NCT00132301|27237734|P1|Overall Study|Excluded by Data Monitoring Committee|1
7848833|NCT00132301|27237733|P2|Overall Study|Other|1
7848834|NCT00132301|27237734|P1|Overall Study|Other|1
7848835|NCT00132301|27237733|P2|Overall Study|Lost to Follow-up|3
7848836|NCT00132301|27237734|P1|Overall Study|Lost to Follow-up|5
7848837|NCT00132301|27237733|P2|Overall Study|Physician Decision|1
7848838|NCT00132301|27237734|P1|Overall Study|Physician Decision|1
7848839|NCT00132301|27237733|P2|Overall Study|Withdrawal by Subject|2
7848840|NCT00132301|27237734|P1|Overall Study|Withdrawal by Subject|5
7848841|NCT00132301|27237733|P2|Overall Study|Death|6
7848842|NCT00132301|27237734|P1|Overall Study|Death|7
7848843|NCT00132132|27237742|P2|Overall Study|Lost to Follow-up|2
7848844|NCT00132132|27237743|P1|Overall Study|Lost to Follow-up|7
7848845|NCT00132041|27237751|P1|18 Months Post Ablation|ExtraHepatic tumor|1
7848846|NCT00132041|27237751|P1|18 Months Post Ablation|Non-Protocol Treatment|3
7848847|NCT00132041|27237751|P1|18 Months Post Ablation|Transplant|1
7848848|NCT00132041|27237751|P1|18 Months Post Ablation|Withdrawal by Subject|1
7848849|NCT00132041|27237751|P1|15 Months Post Ablation|Non-Protocol Treatment|1
7848850|NCT00132041|27237751|P1|15 Months Post Ablation|Transplant|5
7848851|NCT00132041|27237751|P1|15 Months Post Ablation|Death|1
7848852|NCT00132041|27237751|P1|15 Months Post Ablation|Withdrawal by Subject|1
7848853|NCT00132041|27237751|P1|12 Months Post Ablation|non-protocol Treatment|1
7848854|NCT00132041|27237751|P1|12 Months Post Ablation|Transplant|1
7848855|NCT00132041|27237751|P1|12 Months Post Ablation|Death|1
7848856|NCT00132041|27237751|P1|12 Months Post Ablation|Withdrawal by Subject|1
7848857|NCT00132041|27237751|P1|9 Months Post Ablation|Transplant|1
7848858|NCT00132041|27237751|P1|9 Months Post Ablation|Death|1
7848859|NCT00132041|27237751|P1|6 Months Post Ablation|Transplant|6
7848860|NCT00132041|27237751|P1|6 Months Post Ablation|Death|2
7848861|NCT00132041|27237751|P1|6 Months Post Ablation|Withdrawal by Subject|2
7848862|NCT00132041|27237751|P1|3 Months Post Ablation|Non-Protocol Treatment|2
7848863|NCT00132041|27237751|P1|3 Months Post Ablation|Transplant|1
7848864|NCT00132041|27237751|P1|Baseline|Ineligible|6
7848865|NCT00132028|27237766|P1|Overall Study|Physician Decision|3
7848866|NCT00132028|27237766|P1|Overall Study|not eligible|2
7848867|NCT00132028|27237766|P1|Overall Study|Withdrawal by Subject|2
7848868|NCT00132028|27237766|P1|Overall Study|Lack of Efficacy|11
7848869|NCT00132028|27237766|P1|Overall Study|Death|2
7848870|NCT00132028|27237766|P1|Overall Study|Adverse Event|7
7848871|NCT00131937|27237778|P1|Overall Study|Alternative therapy|1
7848872|NCT00131937|27237778|P1|Overall Study|Disease Progression|7
7848873|NCT00131937|27237778|P1|Overall Study|Physician Decision|1
7848874|NCT00131937|27237778|P1|Overall Study|Withdrawal by Subject|2
7848875|NCT00131937|27237778|P1|Overall Study|Adverse Event|3
7848876|NCT00131911|27237786|P2|Overall Study|Withdrawal by Subject|0
7848877|NCT00131911|27237787|P1|Overall Study|Withdrawal by Subject|1
7848878|NCT00131664|27237857|P6|Second Period (Additional Drug Added)|Administrative reasons|0
7848879|NCT00131664|27237858|P5|Second Period (Additional Drug Added)|Administrative reasons|1
7848880|NCT00131664|27237859|P4|Second Period (Additional Drug Added)|Administrative reasons|0
7848881|NCT00131664|27237860|P3|Second Period (Additional Drug Added)|Administrative reasons|0
7848882|NCT00131664|27237861|P2|Second Period (Additional Drug Added)|Administrative reasons|2
7848883|NCT00131664|27237862|P1|Second Period (Additional Drug Added)|Administrative reasons|4
7848884|NCT00131664|27237857|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7848885|NCT00131664|27237858|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7848886|NCT00131664|27237859|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
7848887|NCT00131664|27237860|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7848888|NCT00131664|27237861|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7848889|NCT00131664|27237862|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7848890|NCT00131664|27237857|P6|Second Period (Additional Drug Added)|Adverse Event|1
7848891|NCT00131664|27237858|P5|Second Period (Additional Drug Added)|Adverse Event|0
7848892|NCT00131664|27237859|P4|Second Period (Additional Drug Added)|Adverse Event|0
7848893|NCT00131664|27237860|P3|Second Period (Additional Drug Added)|Adverse Event|0
7848894|NCT00131664|27237861|P2|Second Period (Additional Drug Added)|Adverse Event|1
7848895|NCT00131664|27237862|P1|Second Period (Additional Drug Added)|Adverse Event|0
7848896|NCT00131664|27237857|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7848897|NCT00131664|27237858|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7848898|NCT00131664|27237859|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7848899|NCT00131664|27237860|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7848900|NCT00131664|27237861|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7848901|NCT00131664|27237862|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
7848902|NCT00131664|27237857|P6|Second Period (Additional Drug Added)|Protocol Violation|0
7848903|NCT00131664|27237858|P5|Second Period (Additional Drug Added)|Protocol Violation|0
7848904|NCT00131664|27237859|P4|Second Period (Additional Drug Added)|Protocol Violation|0
7848905|NCT00131664|27237860|P3|Second Period (Additional Drug Added)|Protocol Violation|1
7848906|NCT00131664|27237861|P2|Second Period (Additional Drug Added)|Protocol Violation|1
7848907|NCT00131664|27237862|P1|Second Period (Additional Drug Added)|Protocol Violation|0
7848908|NCT00131664|27237857|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
7848909|NCT00131664|27237858|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
7848910|NCT00131664|27237859|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
7848911|NCT00131664|27237860|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
7848912|NCT00131664|27237861|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
7848913|NCT00131664|27237862|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
7848914|NCT00131664|27237857|P6|First Period (First 6 Months)|Administrative reasons|0
7848915|NCT00131664|27237858|P5|First Period (First 6 Months)|Administrative reasons|0
7848916|NCT00131664|27237859|P4|First Period (First 6 Months)|Administrative reasons|0
7848917|NCT00131664|27237860|P3|First Period (First 6 Months)|Administrative reasons|5
7848918|NCT00131664|27237861|P2|First Period (First 6 Months)|Administrative reasons|0
7848919|NCT00131664|27237862|P1|First Period (First 6 Months)|Administrative reasons|2
7848920|NCT00131664|27237857|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7848921|NCT00131664|27237858|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7848922|NCT00131664|27237859|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7848923|NCT00131664|27237860|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7848924|NCT00131664|27237861|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
7848925|NCT00131664|27237862|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
7848926|NCT00131664|27237857|P6|First Period (First 6 Months)|Adverse Event|0
7848927|NCT00131664|27237858|P5|First Period (First 6 Months)|Adverse Event|0
7848928|NCT00131664|27237859|P4|First Period (First 6 Months)|Adverse Event|0
7848929|NCT00131664|27237860|P3|First Period (First 6 Months)|Adverse Event|5
7848930|NCT00131664|27237861|P2|First Period (First 6 Months)|Adverse Event|4
7848931|NCT00131664|27237862|P1|First Period (First 6 Months)|Adverse Event|9
7848932|NCT00131664|27237857|P6|First Period (First 6 Months)|Withdrawal by Subject|0
7848933|NCT00131664|27237858|P5|First Period (First 6 Months)|Withdrawal by Subject|0
7848934|NCT00131664|27237859|P4|First Period (First 6 Months)|Withdrawal by Subject|0
7848935|NCT00131664|27237860|P3|First Period (First 6 Months)|Withdrawal by Subject|2
7848936|NCT00131664|27237861|P2|First Period (First 6 Months)|Withdrawal by Subject|6
7848937|NCT00131664|27237862|P1|First Period (First 6 Months)|Withdrawal by Subject|4
7848938|NCT00131664|27237857|P6|First Period (First 6 Months)|Protocol Violation|0
7848939|NCT00131664|27237858|P5|First Period (First 6 Months)|Protocol Violation|0
7848940|NCT00131664|27237859|P4|First Period (First 6 Months)|Protocol Violation|0
7848941|NCT00131664|27237860|P3|First Period (First 6 Months)|Protocol Violation|1
7848942|NCT00131664|27237861|P2|First Period (First 6 Months)|Protocol Violation|2
7848943|NCT00131664|27237862|P1|First Period (First 6 Months)|Protocol Violation|2
7848944|NCT00131664|27237857|P6|First Period (First 6 Months)|Death|0
7848945|NCT00131664|27237858|P5|First Period (First 6 Months)|Death|0
7848946|NCT00131664|27237859|P4|First Period (First 6 Months)|Death|0
7848947|NCT00131664|27237860|P3|First Period (First 6 Months)|Death|0
7848948|NCT00131664|27237861|P2|First Period (First 6 Months)|Death|1
7848949|NCT00131664|27237862|P1|First Period (First 6 Months)|Death|0
7848950|NCT00131664|27237857|P6|First Period (First 6 Months)|Lost to Follow-up|0
7848951|NCT00131664|27237858|P5|First Period (First 6 Months)|Lost to Follow-up|0
7848952|NCT00131664|27237859|P4|First Period (First 6 Months)|Lost to Follow-up|0
7848953|NCT00131664|27237860|P3|First Period (First 6 Months)|Lost to Follow-up|3
7848954|NCT00131664|27237861|P2|First Period (First 6 Months)|Lost to Follow-up|3
7848955|NCT00131664|27237862|P1|First Period (First 6 Months)|Lost to Follow-up|7
7848956|NCT00131508|27237934|P2|Overall Study|Withdrawal by Subject|2
7848957|NCT00131508|27237935|P1|Overall Study|Withdrawal by Subject|1
7848958|NCT00131508|27237934|P2|Overall Study|Non-Compliance|4
7848959|NCT00131508|27237935|P1|Overall Study|Non-Compliance|2
7848960|NCT00131508|27237934|P2|Overall Study|Disease progression|2
7848961|NCT00131508|27237935|P1|Overall Study|Disease progression|0
7848962|NCT00131469|27237959|P2|Overall Study|scan not analyzable|6
7848963|NCT00131469|27237960|P1|Overall Study|scan not analyzable|3
7848964|NCT00131469|27237959|P2|Overall Study|Lost to Follow-up|1
7848965|NCT00131469|27237960|P1|Overall Study|Lost to Follow-up|0
7848966|NCT00131469|27237959|P2|Overall Study|Death|1
7848967|NCT00131469|27237960|P1|Overall Study|Death|0
7848968|NCT00131469|27237959|P2|Overall Study|Protocol Violation|1
7848969|NCT00131469|27237960|P1|Overall Study|Protocol Violation|3
7848970|NCT00131469|27237959|P2|Overall Study|Withdrawal by Subject|4
7848971|NCT00131469|27237960|P1|Overall Study|Withdrawal by Subject|3
7848972|NCT00131365|27238006|P1|Overall Study|Alternative treatment|3
7848973|NCT00131365|27238006|P1|Overall Study|Withdrawal by Subject|1
7848974|NCT00131352|27238013|P2|Repeat Treatment Period|Other|0
7848975|NCT00131352|27238014|P1|Repeat Treatment Period|Other|1
7848976|NCT00131352|27238013|P2|Repeat Treatment Period|Adverse Event|0
7848977|NCT00131352|27238014|P1|Repeat Treatment Period|Adverse Event|1
7848978|NCT00131352|27238013|P2|Initial Treatment Period|Other|2
7848979|NCT00131352|27238014|P1|Initial Treatment Period|Other|0
7848980|NCT00131352|27238013|P2|Initial Treatment Period|Lack of Efficacy|4
7848981|NCT00131352|27238014|P1|Initial Treatment Period|Lack of Efficacy|6
7848982|NCT00131352|27238013|P2|Initial Treatment Period|Withdrawal by Subject|1
7848983|NCT00131352|27238014|P1|Initial Treatment Period|Withdrawal by Subject|1
7848984|NCT00131352|27238013|P2|Initial Treatment Period|Non-compliant|2
7848985|NCT00131352|27238014|P1|Initial Treatment Period|Non-compliant|1
7848986|NCT00131352|27238013|P2|Initial Treatment Period|Adverse Event|3
7848987|NCT00131352|27238014|P1|Initial Treatment Period|Adverse Event|1
7848988|NCT00131248|27238036|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
7848989|NCT00131248|27238037|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
7848990|NCT00130832|27238064|P2|Overall Study|Other|3
7848991|NCT00130832|27238065|P1|Overall Study|Other|0
7848992|NCT00130832|27238064|P2|Overall Study|Moved|2
7848993|NCT00130832|27238065|P1|Overall Study|Moved|2
7848994|NCT00130832|27238064|P2|Overall Study|Withdrawal by Subject|1
7848995|NCT00130832|27238065|P1|Overall Study|Withdrawal by Subject|6
7848996|NCT00130832|27238064|P2|Overall Study|Protocol Violation|8
7848997|NCT00130832|27238065|P1|Overall Study|Protocol Violation|6
7848998|NCT00130832|27238064|P2|Overall Study|Lost to Follow-up|2
7848999|NCT00130832|27238065|P1|Overall Study|Lost to Follow-up|1
7849000|NCT00130832|27238064|P2|Overall Study|Adverse Event|1
7849001|NCT00130832|27238065|P1|Overall Study|Adverse Event|1
7849002|NCT00130793|27238077|P2|Overall Study|Withdrew consent|0
7849003|NCT00130793|27238078|P1|Overall Study|Withdrew consent|2
7849004|NCT00130793|27238077|P2|Overall Study|Lost to Follow-up|4
7849005|NCT00130793|27238078|P1|Overall Study|Lost to Follow-up|1
7849006|NCT00130728|27238099|P2|Overall Study|Withdrawal by Subject|2
7849007|NCT00130728|27238100|P1|Overall Study|Withdrawal by Subject|0
7849008|NCT00130728|27238099|P2|Overall Study|Lost to Follow-up|0
7849009|NCT00130728|27238100|P1|Overall Study|Lost to Follow-up|4
7849010|NCT00130728|27238099|P2|Overall Study|Death|258
7849011|NCT00130728|27238100|P1|Overall Study|Death|258
7849012|NCT00130689|27238112|P1|Overall Study|Ineligible|6
7849013|NCT00130689|27238112|P1|Overall Study|Withdrawal by Subject|3
7849014|NCT00130689|27238112|P1|Overall Study|Clinical Deterioration|4
7849015|NCT00130689|27238112|P1|Overall Study|Death|1
7849016|NCT00130689|27238112|P1|Overall Study|Progressive Disease|29
7849017|NCT00130637|27238116|P1|Overall Study|Withdrawal by Subject|1
7849018|NCT00130637|27238116|P1|Overall Study|Adverse Event|2
7849019|NCT00130533|27238123|P2|Overall Study|Other|5
7849020|NCT00130533|27238124|P1|Overall Study|Other|12
7849021|NCT00130533|27238123|P2|Overall Study|Second Primary Malignancy|1
7849022|NCT00130533|27238124|P1|Overall Study|Second Primary Malignancy|0
7849023|NCT00130533|27238123|P2|Overall Study|Sponsor´s decision|0
7849024|NCT00130533|27238124|P1|Overall Study|Sponsor´s decision|2
7849025|NCT00130533|27238123|P2|Overall Study|Lost to Follow-up|1
7849026|NCT00130533|27238124|P1|Overall Study|Lost to Follow-up|1
7849027|NCT00130533|27238123|P2|Overall Study|Protocol Violation|1
7849028|NCT00130533|27238124|P1|Overall Study|Protocol Violation|5
7849029|NCT00130533|27238123|P2|Overall Study|Death|2
7849030|NCT00130533|27238124|P1|Overall Study|Death|4
7849031|NCT00130533|27238123|P2|Overall Study|Interruption of treatment > 3 weeks|0
7849032|NCT00130533|27238124|P1|Overall Study|Interruption of treatment > 3 weeks|11
7849033|NCT00130533|27238123|P2|Overall Study|Disease relapse|13
7849034|NCT00130533|27238124|P1|Overall Study|Disease relapse|9
7849035|NCT00130533|27238123|P2|Overall Study|Adverse Event|1
7849036|NCT00130533|27238124|P1|Overall Study|Adverse Event|34
7849037|NCT00130533|27238123|P2|Overall Study|Withdrawal by Subject|6
7849038|NCT00130533|27238124|P1|Overall Study|Withdrawal by Subject|33
7849039|NCT00130520|27238136|P1|Overall Study|Did not meet re-treatment criteria|1
7849040|NCT00130520|27238136|P1|Overall Study|Protocol non-compliance|1
7849041|NCT00130520|27238136|P1|Overall Study|Disease Progression|23
7849042|NCT00130520|27238136|P1|Overall Study|Withdrawal by Subject|1
7849043|NCT00130520|27238136|P1|Overall Study|Physician Decision|1
7849044|NCT00130520|27238136|P1|Overall Study|Death|1
7849045|NCT00130520|27238136|P1|Overall Study|Adverse Event|11
7849046|NCT00130442|27238144|P2|Overall Study|did not meet criteria|1
7849047|NCT00130442|27238145|P1|Overall Study|did not meet criteria|1
7849048|NCT00130442|27238144|P2|Overall Study|Withdrawal by Subject|1
7849049|NCT00130442|27238145|P1|Overall Study|Withdrawal by Subject|0
7849050|NCT00130286|27238163|P4|Overall Study|Missing lab specimens|0
7849051|NCT00130286|27238164|P3|Overall Study|Missing lab specimens|0
7849052|NCT00130286|27238165|P2|Overall Study|Missing lab specimens|2
7849053|NCT00130286|27238166|P1|Overall Study|Missing lab specimens|0
7849054|NCT00130286|27238163|P4|Overall Study|Adverse Event|0
7849055|NCT00130286|27238164|P3|Overall Study|Adverse Event|2
7849056|NCT00130286|27238165|P2|Overall Study|Adverse Event|0
7849057|NCT00130286|27238166|P1|Overall Study|Adverse Event|0
7849058|NCT00130286|27238163|P4|Overall Study|Withdrawal by Subject|2
7849059|NCT00130286|27238164|P3|Overall Study|Withdrawal by Subject|2
7849060|NCT00130286|27238165|P2|Overall Study|Withdrawal by Subject|1
7849061|NCT00130286|27238166|P1|Overall Study|Withdrawal by Subject|0
7849062|NCT00130247|27238186|P2|Overall Study|Not compliant with DOT|2
7849063|NCT00130247|27238187|P1|Overall Study|Not compliant with DOT|0
7849064|NCT00130247|27238186|P2|Overall Study|Post-randomization exclusion|2
7849065|NCT00130247|27238187|P1|Overall Study|Post-randomization exclusion|1
7849066|NCT00130247|27238186|P2|Overall Study|Pregnancy|0
7849067|NCT00130247|27238187|P1|Overall Study|Pregnancy|1
7849068|NCT00130208|27238205|P2|Washout Period (8 Weeks)|Other|1
7849069|NCT00130208|27238206|P1|Washout Period (8 Weeks)|Other|1
7849070|NCT00130208|27238205|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
7849071|NCT00130208|27238206|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
7849072|NCT00130208|27238205|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
7849073|NCT00130208|27238206|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
7849074|NCT00130208|27238205|P2|Washout Period (8 Weeks)|Adverse Event|6
7849075|NCT00130208|27238206|P1|Washout Period (8 Weeks)|Adverse Event|3
7849076|NCT00130208|27238205|P2|Maintenance Period (26 Weeks)|Other|1
7849077|NCT00130208|27238206|P1|Maintenance Period (26 Weeks)|Other|1
7849078|NCT00130208|27238205|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
7849079|NCT00130208|27238206|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
7849080|NCT00130208|27238205|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
7849081|NCT00130208|27238206|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
7849082|NCT00130208|27238205|P2|Maintenance Period (26 Weeks)|Physician Decision|2
7849083|NCT00130208|27238206|P1|Maintenance Period (26 Weeks)|Physician Decision|0
7849084|NCT00130208|27238205|P2|Maintenance Period (26 Weeks)|Adverse Event|12
7849085|NCT00130208|27238206|P1|Maintenance Period (26 Weeks)|Adverse Event|10
7849086|NCT00130039|27238242|P2|Overall Study|clinical events without follow up MRI|4
7849087|NCT00130039|27238243|P1|Overall Study|clinical events without follow up MRI|5
7849088|NCT00130039|27238242|P2|Overall Study|Physician Decision|0
7849089|NCT00130039|27238243|P1|Overall Study|Physician Decision|3
7849090|NCT00130039|27238242|P2|Overall Study|Adverse Event|2
7849091|NCT00130039|27238243|P1|Overall Study|Adverse Event|4
7849092|NCT00130039|27238242|P2|Overall Study|Lost to Follow-up|1
7849093|NCT00130039|27238243|P1|Overall Study|Lost to Follow-up|3
7849094|NCT00130039|27238242|P2|Overall Study|Withdrawal by Subject|11
7849095|NCT00130039|27238243|P1|Overall Study|Withdrawal by Subject|15
7849096|NCT00129987|27238261|P2|1 Year|Withdrawal by Subject|21
7849097|NCT00129987|27238262|P1|1 Year|Withdrawal by Subject|32
7849098|NCT00129987|27238261|P2|1st Educational Session|Withdrawal by Subject|109
7849099|NCT00129987|27238262|P1|1st Educational Session|Withdrawal by Subject|141
7849100|NCT00129974|27238274|P1|Overall Study|Other|1
7849101|NCT00129961|27238281|P2|Overall Study|Missing Record|1
7849102|NCT00129961|27238282|P1|Overall Study|Missing Record|0
7849103|NCT00129961|27238281|P2|Overall Study|Withdrawal by Subject|1
7849104|NCT00129961|27238282|P1|Overall Study|Withdrawal by Subject|2
7849105|NCT00129961|27238281|P2|Overall Study|Physician Decision|0
7849106|NCT00129961|27238282|P1|Overall Study|Physician Decision|1
7849107|NCT00129961|27238281|P2|Overall Study|Withdrawal by Sponsor|20
7849108|NCT00129961|27238282|P1|Overall Study|Withdrawal by Sponsor|14
7849109|NCT00129961|27238281|P2|Overall Study|Death|1
7849110|NCT00129961|27238282|P1|Overall Study|Death|1
7849111|NCT00129961|27238281|P2|Overall Study|Adverse Event|0
7849112|NCT00129961|27238282|P1|Overall Study|Adverse Event|1
7849113|NCT00129935|27238318|P2|Overall Study|Incorrect study treatment|0
7849114|NCT00129935|27238319|P1|Overall Study|Incorrect study treatment|1
7849115|NCT00129935|27238318|P2|Overall Study|Crossed to the other arm|1
7849116|NCT00129935|27238319|P1|Overall Study|Crossed to the other arm|2
7849117|NCT00129935|27238318|P2|Overall Study|Other|2
7849118|NCT00129935|27238319|P1|Overall Study|Other|3
7849119|NCT00129935|27238318|P2|Overall Study|Second primary|1
7849120|NCT00129935|27238319|P1|Overall Study|Second primary|0
7849121|NCT00129935|27238318|P2|Overall Study|Recurrence|3
7849122|NCT00129935|27238319|P1|Overall Study|Recurrence|1
7849123|NCT00129935|27238318|P2|Overall Study|Physician Decision|4
7849124|NCT00129935|27238319|P1|Overall Study|Physician Decision|3
7849125|NCT00129935|27238318|P2|Overall Study|Protocol Violation|4
7849126|NCT00129935|27238319|P1|Overall Study|Protocol Violation|0
7849127|NCT00129935|27238318|P2|Overall Study|Withdrawal by Subject|20
7849128|NCT00129935|27238319|P1|Overall Study|Withdrawal by Subject|7
7849129|NCT00129935|27238318|P2|Overall Study|Death|1
7849130|NCT00129935|27238319|P1|Overall Study|Death|1
7849131|NCT00129935|27238318|P2|Overall Study|Adverse Event|56
7849132|NCT00129935|27238319|P1|Overall Study|Adverse Event|18
7849133|NCT00129766|27238337|P2|Overall Study|Lost to Follow-up|21
7849134|NCT00129766|27238338|P1|Overall Study|Lost to Follow-up|26
7849135|NCT00129766|27238337|P2|Overall Study|Withdrawal of consent|30
7849136|NCT00129766|27238338|P1|Overall Study|Withdrawal of consent|31
7849137|NCT00129766|27238337|P2|Overall Study|Death|8
7849138|NCT00129766|27238338|P1|Overall Study|Death|3
7849139|NCT00129701|27238387|P1|Overall Study|Withdrawal by Subject|33
7849140|NCT00129649|27238396|P2|Overall Study|Withdrawal by Subject|65
7849141|NCT00129649|27238397|P1|Overall Study|Withdrawal by Subject|76
7849142|NCT00129623|27238405|P2|Overall Study|Uncertainty to return|1
7849143|NCT00129623|27238406|P1|Overall Study|Uncertainty to return|0
7849144|NCT00129623|27238405|P2|Overall Study|Relocated job out of state|0
7849145|NCT00129623|27238406|P1|Overall Study|Relocated job out of state|1
7849146|NCT00129623|27238405|P2|Overall Study|Failure to Return|1
7849147|NCT00129623|27238406|P1|Overall Study|Failure to Return|1
7849148|NCT00129623|27238405|P2|Overall Study|Refused Treatment|3
7849149|NCT00129623|27238406|P1|Overall Study|Refused Treatment|5
7849150|NCT00129623|27238405|P2|Overall Study|Adverse Event|7
7849151|NCT00129623|27238406|P1|Overall Study|Adverse Event|3
7849152|NCT00129545|27238431|P3|Overall Study|Device not implanted|0
7849153|NCT00129545|27238432|P2|Overall Study|Device not implanted|61
7849154|NCT00129545|27238433|P1|Overall Study|Device not implanted|16
7849155|NCT00129545|27238431|P3|Overall Study|Physician Decision|10
7849156|NCT00129545|27238432|P2|Overall Study|Physician Decision|3
7849157|NCT00129545|27238433|P1|Overall Study|Physician Decision|0
7849158|NCT00129545|27238431|P3|Overall Study|Lost to Follow-up|13
7849159|NCT00129545|27238432|P2|Overall Study|Lost to Follow-up|22
7849160|NCT00129545|27238433|P1|Overall Study|Lost to Follow-up|2
7849161|NCT00129545|27238431|P3|Overall Study|Withdrawal by Subject|44
7849162|NCT00129545|27238432|P2|Overall Study|Withdrawal by Subject|18
7849163|NCT00129545|27238433|P1|Overall Study|Withdrawal by Subject|3
7849164|NCT00129545|27238431|P3|Overall Study|Death|44
7849165|NCT00129545|27238432|P2|Overall Study|Death|60
7849166|NCT00129545|27238433|P1|Overall Study|Death|5
7849167|NCT00129467|27238462|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
7849168|NCT00129467|27238463|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
7849169|NCT00129467|27238462|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
7849170|NCT00129467|27238463|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
7849171|NCT00129467|27238462|P2|Received Intervention|Dizzyness, fatigue|1
7849172|NCT00129467|27238463|P1|Received Intervention|Dizzyness, fatigue|0
7849173|NCT00129467|27238462|P2|Received Intervention|Intolerance to citalopram|1
7849174|NCT00129467|27238463|P1|Received Intervention|Intolerance to citalopram|0
7849175|NCT00129467|27238462|P2|Received Intervention|Nausea|0
7849176|NCT00129467|27238463|P1|Received Intervention|Nausea|1
7849177|NCT00129467|27238462|P2|Received Intervention|Withdrawal by Subject|0
7849178|NCT00129467|27238463|P1|Received Intervention|Withdrawal by Subject|1
7849179|NCT00129467|27238462|P2|Received Intervention|Delirium|0
7849180|NCT00129467|27238463|P1|Received Intervention|Delirium|2
7849181|NCT00129467|27238462|P2|Received Intervention|Cardiac SAE (hypertension)|1
7849182|NCT00129467|27238463|P1|Received Intervention|Cardiac SAE (hypertension)|1
7849183|NCT00129467|27238462|P2|Received Intervention|Death|1
7849184|NCT00129467|27238463|P1|Received Intervention|Death|1
7849185|NCT00129402|27238494|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
7849186|NCT00129402|27238495|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7849187|NCT00129402|27238496|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7849188|NCT00129402|27238497|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7849189|NCT00129402|27238498|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7849190|NCT00129402|27238499|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7849191|NCT00129402|27238500|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7849192|NCT00129402|27238494|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
7849193|NCT00129402|27238495|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7849194|NCT00129402|27238496|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7849195|NCT00129402|27238497|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7849196|NCT00129402|27238498|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7849197|NCT00129402|27238499|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7849198|NCT00129402|27238500|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7849199|NCT00129402|27238494|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
7849200|NCT00129402|27238495|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7849201|NCT00129402|27238496|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7849202|NCT00129402|27238497|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7849203|NCT00129402|27238498|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7849204|NCT00129402|27238499|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7849205|NCT00129402|27238500|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7849206|NCT00129402|27238494|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
7849207|NCT00129402|27238495|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7849208|NCT00129402|27238496|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7849209|NCT00129402|27238497|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7849210|NCT00129402|27238498|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7849211|NCT00129402|27238499|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7849212|NCT00129402|27238500|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7849213|NCT00129402|27238494|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7849214|NCT00129402|27238495|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
7849215|NCT00129402|27238496|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7849216|NCT00129402|27238497|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7849217|NCT00129402|27238498|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
7849218|NCT00129402|27238499|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7849219|NCT00129402|27238500|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7849220|NCT00129402|27238494|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7849221|NCT00129402|27238495|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
7849222|NCT00129402|27238496|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7849223|NCT00129402|27238497|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7849224|NCT00129402|27238498|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
7849225|NCT00129402|27238499|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7849226|NCT00129402|27238500|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7849227|NCT00129402|27238494|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7849228|NCT00129402|27238495|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7849304|NCT00129259|27238579|P2|Overall Study|Withdrawal by Subject|1
7849229|NCT00129402|27238496|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7849230|NCT00129402|27238497|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7849231|NCT00129402|27238498|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
7849232|NCT00129402|27238499|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7849233|NCT00129402|27238500|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7849234|NCT00129402|27238494|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7849235|NCT00129402|27238495|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
7849236|NCT00129402|27238496|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7849237|NCT00129402|27238497|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7849238|NCT00129402|27238498|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
7849239|NCT00129402|27238499|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7849240|NCT00129402|27238500|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7849241|NCT00129402|27238494|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7849242|NCT00129402|27238495|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7849243|NCT00129402|27238496|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7849244|NCT00129402|27238497|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7849245|NCT00129402|27238498|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
7849246|NCT00129402|27238499|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7849247|NCT00129402|27238500|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7849248|NCT00129402|27238494|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7849249|NCT00129402|27238495|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7849250|NCT00129402|27238496|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7849251|NCT00129402|27238497|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7849252|NCT00129402|27238498|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7849253|NCT00129402|27238499|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7849254|NCT00129402|27238500|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7849255|NCT00129402|27238494|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7849256|NCT00129402|27238495|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7849257|NCT00129402|27238496|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7849258|NCT00129402|27238497|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
7849259|NCT00129402|27238498|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7849260|NCT00129402|27238499|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7849261|NCT00129402|27238500|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7849262|NCT00129402|27238494|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7849263|NCT00129402|27238495|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
7849264|NCT00129402|27238496|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7849265|NCT00129402|27238497|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7849266|NCT00129402|27238498|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7849267|NCT00129402|27238499|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7849268|NCT00129402|27238500|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7849269|NCT00129402|27238494|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7849270|NCT00129402|27238495|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7849271|NCT00129402|27238496|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7849272|NCT00129402|27238497|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7849273|NCT00129402|27238498|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7849274|NCT00129402|27238499|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7849275|NCT00129402|27238500|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7849276|NCT00129389|27238519|P2|Overall Study|Crossed to the other arm|16
7849277|NCT00129389|27238520|P1|Overall Study|Crossed to the other arm|1
7849278|NCT00129389|27238519|P2|Overall Study|Not eligible|2
7849279|NCT00129389|27238520|P1|Overall Study|Not eligible|1
7849280|NCT00129389|27238519|P2|Overall Study|Relapse|0
7849281|NCT00129389|27238520|P1|Overall Study|Relapse|1
7849282|NCT00129389|27238519|P2|Overall Study|Withdrawal by Subject|23
7849283|NCT00129389|27238520|P1|Overall Study|Withdrawal by Subject|9
7849284|NCT00129389|27238519|P2|Overall Study|Protocol Violation|6
7849285|NCT00129389|27238520|P1|Overall Study|Protocol Violation|0
7849286|NCT00129389|27238519|P2|Overall Study|Physician Decision|4
7849287|NCT00129389|27238520|P1|Overall Study|Physician Decision|0
7849288|NCT00129389|27238519|P2|Overall Study|Lost to Follow-up|1
7849289|NCT00129389|27238520|P1|Overall Study|Lost to Follow-up|2
7849290|NCT00129389|27238519|P2|Overall Study|Death|1
7849291|NCT00129389|27238520|P1|Overall Study|Death|0
7849292|NCT00129389|27238519|P2|Overall Study|Adverse Event|87
7849293|NCT00129389|27238520|P1|Overall Study|Adverse Event|19
7849294|NCT00129376|27238528|P1|Overall Study|Lack of Efficacy|1
7849295|NCT00129376|27238528|P1|Overall Study|Adverse Event|1
7849296|NCT00129311|27238538|P2|Overall Study|Withdrawal by Subject|19
7849297|NCT00129311|27238539|P1|Overall Study|Withdrawal by Subject|12
7849298|NCT00129272|27238568|P2|Overall Study|Withdrawal by Subject|11
7849299|NCT00129272|27238569|P1|Overall Study|Withdrawal by Subject|5
7849300|NCT00129272|27238568|P2|Overall Study|Lost to Follow-up|11
7849301|NCT00129272|27238569|P1|Overall Study|Lost to Follow-up|12
7849302|NCT00129259|27238579|P2|Overall Study|Only available minimal phone assessments|1
7849303|NCT00129259|27238580|P1|Overall Study|Only available minimal phone assessments|0
7849305|NCT00129259|27238580|P1|Overall Study|Withdrawal by Subject|2
7849306|NCT00129259|27238579|P2|Overall Study|Lost to Follow-up|1
7849307|NCT00129259|27238580|P1|Overall Study|Lost to Follow-up|1
7849308|NCT00129220|27238608|P3|Study Period III|Reason Not Specified|2
7849309|NCT00129220|27238609|P2|Study Period III|Reason Not Specified|0
7849310|NCT00129220|27238610|P1|Study Period III|Reason Not Specified|9
7849311|NCT00129220|27238608|P3|Study Period III|Sponsor Decision|0
7849312|NCT00129220|27238609|P2|Study Period III|Sponsor Decision|0
7849313|NCT00129220|27238610|P1|Study Period III|Sponsor Decision|1
7849314|NCT00129220|27238608|P3|Study Period III|Withdrawal by Subject|3
7849315|NCT00129220|27238609|P2|Study Period III|Withdrawal by Subject|0
7849316|NCT00129220|27238610|P1|Study Period III|Withdrawal by Subject|1
7849317|NCT00129220|27238608|P3|Study Period III|Protocol Violation|2
7849318|NCT00129220|27238609|P2|Study Period III|Protocol Violation|1
7849319|NCT00129220|27238610|P1|Study Period III|Protocol Violation|1
7849320|NCT00129220|27238608|P3|Study Period III|Adverse Event|3
7849321|NCT00129220|27238609|P2|Study Period III|Adverse Event|0
7849322|NCT00129220|27238610|P1|Study Period III|Adverse Event|1
7849323|NCT00129220|27238608|P3|Study Period II|Reason Not Specified|5
7849324|NCT00129220|27238609|P2|Study Period II|Reason Not Specified|0
7849325|NCT00129220|27238610|P1|Study Period II|Reason Not Specified|2
7849326|NCT00129220|27238608|P3|Study Period II|Withdrawal by Subject|4
7849327|NCT00129220|27238609|P2|Study Period II|Withdrawal by Subject|3
7849328|NCT00129220|27238610|P1|Study Period II|Withdrawal by Subject|1
7849329|NCT00129220|27238608|P3|Study Period II|Physician Decision|0
7849330|NCT00129220|27238609|P2|Study Period II|Physician Decision|1
7849331|NCT00129220|27238610|P1|Study Period II|Physician Decision|0
7849332|NCT00129220|27238608|P3|Study Period II|Protocol Violation|1
7849333|NCT00129220|27238609|P2|Study Period II|Protocol Violation|2
7849334|NCT00129220|27238610|P1|Study Period II|Protocol Violation|4
7849335|NCT00129220|27238608|P3|Study Period II|Entry Criteria Not Met|2
7849336|NCT00129220|27238609|P2|Study Period II|Entry Criteria Not Met|0
7849337|NCT00129220|27238610|P1|Study Period II|Entry Criteria Not Met|2
7849338|NCT00129220|27238608|P3|Study Period II|Lack of Efficacy|28
7849339|NCT00129220|27238609|P2|Study Period II|Lack of Efficacy|1
7849340|NCT00129220|27238610|P1|Study Period II|Lack of Efficacy|15
7849341|NCT00129220|27238608|P3|Study Period II|Adverse Event|7
7849342|NCT00129220|27238609|P2|Study Period II|Adverse Event|5
7849343|NCT00129220|27238610|P1|Study Period II|Adverse Event|9
7849344|NCT00129129|27238650|P5|Fourth Dose Phase|Protocol Violation|0
7849345|NCT00129129|27238651|P4|Fourth Dose Phase|Protocol Violation|1
7849346|NCT00129129|27238652|P3|Fourth Dose Phase|Protocol Violation|0
7849347|NCT00129129|27238653|P2|Fourth Dose Phase|Protocol Violation|0
7849348|NCT00129129|27238654|P1|Fourth Dose Phase|Protocol Violation|0
7849349|NCT00129129|27238650|P5|Fourth Dose Phase|Other|1
7849350|NCT00129129|27238651|P4|Fourth Dose Phase|Other|1
7849351|NCT00129129|27238652|P3|Fourth Dose Phase|Other|0
7849352|NCT00129129|27238653|P2|Fourth Dose Phase|Other|0
7849353|NCT00129129|27238654|P1|Fourth Dose Phase|Other|0
7849354|NCT00129129|27238650|P5|Fourth Dose Phase|Migration from study area|2
7849355|NCT00129129|27238651|P4|Fourth Dose Phase|Migration from study area|0
7849356|NCT00129129|27238652|P3|Fourth Dose Phase|Migration from study area|0
7849357|NCT00129129|27238653|P2|Fourth Dose Phase|Migration from study area|0
7849358|NCT00129129|27238654|P1|Fourth Dose Phase|Migration from study area|0
7849359|NCT00129129|27238650|P5|Fourth Dose Phase|Withdrawal by Subject|1
7849360|NCT00129129|27238651|P4|Fourth Dose Phase|Withdrawal by Subject|0
7849361|NCT00129129|27238652|P3|Fourth Dose Phase|Withdrawal by Subject|0
7849362|NCT00129129|27238653|P2|Fourth Dose Phase|Withdrawal by Subject|0
7849363|NCT00129129|27238654|P1|Fourth Dose Phase|Withdrawal by Subject|0
7849364|NCT00129129|27238650|P5|Fourth Dose Phase|Lost to Follow-up|2
7849365|NCT00129129|27238651|P4|Fourth Dose Phase|Lost to Follow-up|2
7849366|NCT00129129|27238652|P3|Fourth Dose Phase|Lost to Follow-up|0
7849367|NCT00129129|27238653|P2|Fourth Dose Phase|Lost to Follow-up|0
7849368|NCT00129129|27238654|P1|Fourth Dose Phase|Lost to Follow-up|4
7849369|NCT00129129|27238650|P5|Primary Phase|Other|0
7849370|NCT00129129|27238651|P4|Primary Phase|Other|0
7849371|NCT00129129|27238652|P3|Primary Phase|Other|0
7849372|NCT00129129|27238653|P2|Primary Phase|Other|5
7849373|NCT00129129|27238654|P1|Primary Phase|Other|2
7849374|NCT00129129|27238650|P5|Primary Phase|Lost to Follow-up|0
7849375|NCT00129129|27238651|P4|Primary Phase|Lost to Follow-up|0
7849376|NCT00129129|27238652|P3|Primary Phase|Lost to Follow-up|0
7849377|NCT00129129|27238653|P2|Primary Phase|Lost to Follow-up|6
7849378|NCT00129129|27238654|P1|Primary Phase|Lost to Follow-up|8
7849379|NCT00129129|27238650|P5|Primary Phase|Migration from study area|0
7849380|NCT00129129|27238651|P4|Primary Phase|Migration from study area|0
7849381|NCT00129129|27238652|P3|Primary Phase|Migration from study area|0
7849382|NCT00129129|27238653|P2|Primary Phase|Migration from study area|3
7849383|NCT00129129|27238654|P1|Primary Phase|Migration from study area|1
7849384|NCT00129129|27238650|P5|Primary Phase|Withdrawal by Subject|0
7849385|NCT00129129|27238651|P4|Primary Phase|Withdrawal by Subject|0
7849386|NCT00129129|27238652|P3|Primary Phase|Withdrawal by Subject|0
7849387|NCT00129129|27238653|P2|Primary Phase|Withdrawal by Subject|10
7849388|NCT00129129|27238654|P1|Primary Phase|Withdrawal by Subject|12
7849389|NCT00129129|27238650|P5|Primary Phase|Adverse Event|0
7849390|NCT00129129|27238651|P4|Primary Phase|Adverse Event|0
7849391|NCT00129129|27238652|P3|Primary Phase|Adverse Event|0
7849392|NCT00129129|27238653|P2|Primary Phase|Adverse Event|1
7849393|NCT00129129|27238654|P1|Primary Phase|Adverse Event|2
7849394|NCT00129116|27238861|P5|Booster Phase|Lost to Follow-up|1
7849395|NCT00129116|27238862|P4|Booster Phase|Lost to Follow-up|0
7849396|NCT00129116|27238863|P3|Booster Phase|Lost to Follow-up|0
7849397|NCT00129116|27238864|P2|Booster Phase|Lost to Follow-up|0
7849398|NCT00129116|27238865|P1|Booster Phase|Lost to Follow-up|2
7849399|NCT00129116|27238861|P5|Primary Phase|Other|0
7849400|NCT00129116|27238862|P4|Primary Phase|Other|0
7849401|NCT00129116|27238863|P3|Primary Phase|Other|1
7849402|NCT00129116|27238864|P2|Primary Phase|Other|0
7849403|NCT00129116|27238865|P1|Primary Phase|Other|0
7849404|NCT00129116|27238861|P5|Primary Phase|Withdrawal by Subject|0
7849405|NCT00129116|27238862|P4|Primary Phase|Withdrawal by Subject|0
7849406|NCT00129116|27238863|P3|Primary Phase|Withdrawal by Subject|0
7849407|NCT00129116|27238864|P2|Primary Phase|Withdrawal by Subject|1
7849408|NCT00129116|27238865|P1|Primary Phase|Withdrawal by Subject|0
7849409|NCT00129116|27238861|P5|Primary Phase|Adverse Event|0
7849410|NCT00129116|27238862|P4|Primary Phase|Adverse Event|0
7849411|NCT00129116|27238863|P3|Primary Phase|Adverse Event|0
7849412|NCT00129116|27238864|P2|Primary Phase|Adverse Event|1
7849413|NCT00129116|27238865|P1|Primary Phase|Adverse Event|1
7849414|NCT00129116|27238861|P5|Primary Phase|Protocol Violation|0
7849415|NCT00129116|27238862|P4|Primary Phase|Protocol Violation|0
7849416|NCT00129116|27238863|P3|Primary Phase|Protocol Violation|0
7849417|NCT00129116|27238864|P2|Primary Phase|Protocol Violation|1
7849418|NCT00129116|27238865|P1|Primary Phase|Protocol Violation|0
7849419|NCT00129116|27238861|P5|Primary Phase|Lost to Follow-up|1
7849420|NCT00129116|27238862|P4|Primary Phase|Lost to Follow-up|1
7849421|NCT00129116|27238863|P3|Primary Phase|Lost to Follow-up|0
7849422|NCT00129116|27238864|P2|Primary Phase|Lost to Follow-up|1
7849423|NCT00129116|27238865|P1|Primary Phase|Lost to Follow-up|1
7849424|NCT00128830|27239149|P1|Overall Study|Other|9
7849425|NCT00128830|27239149|P1|Overall Study|Discontinued or ineligible for study|2
7849426|NCT00128830|27239149|P1|Overall Study|Non-compliant|4
7849427|NCT00128830|27239149|P1|Overall Study|Reached a virologic endpoint|29
7849428|NCT00128830|27239149|P1|Overall Study|Lost to Follow-up|4
7849429|NCT00128830|27239149|P1|Overall Study|Withdrawal by Subject|14
7849430|NCT00128830|27239149|P1|Overall Study|Adverse Event|10
7849431|NCT00128661|27239191|P2|Overall Study|Other|8
7849432|NCT00128661|27239192|P1|Overall Study|Other|7
7849433|NCT00128661|27239191|P2|Overall Study|Withdrawal by Subject|232
7849434|NCT00128661|27239192|P1|Overall Study|Withdrawal by Subject|243
7849435|NCT00128661|27239191|P2|Overall Study|Lost to Follow-up|7
7849436|NCT00128661|27239192|P1|Overall Study|Lost to Follow-up|10
7849437|NCT00128661|27239191|P2|Overall Study|Adverse Event|11
7849438|NCT00128661|27239192|P1|Overall Study|Adverse Event|14
7849439|NCT00128492|27239238|P2|Overall Study|Pregnancy|1
7849440|NCT00128492|27239239|P1|Overall Study|Pregnancy|0
7849441|NCT00128492|27239238|P2|Overall Study|Withdrawal by Subject|5
7849442|NCT00128492|27239239|P1|Overall Study|Withdrawal by Subject|3
7849443|NCT00128492|27239238|P2|Overall Study|Personal or administrative|22
7849444|NCT00128492|27239239|P1|Overall Study|Personal or administrative|10
7849445|NCT00128492|27239238|P2|Overall Study|Noncompliance|5
7849446|NCT00128492|27239239|P1|Overall Study|Noncompliance|0
7849447|NCT00128492|27239238|P2|Overall Study|Lost to Follow-up|5
7849448|NCT00128492|27239239|P1|Overall Study|Lost to Follow-up|1
7849449|NCT00128492|27239238|P2|Overall Study|Death|0
7849450|NCT00128492|27239239|P1|Overall Study|Death|1
7849451|NCT00128492|27239238|P2|Overall Study|AE related to study|4
7849452|NCT00128492|27239239|P1|Overall Study|AE related to study|1
7849453|NCT00128492|27239238|P2|Overall Study|Study drug intolerance (AE)|8
7849454|NCT00128492|27239239|P1|Overall Study|Study drug intolerance (AE)|2
7849455|NCT00128492|27239238|P2|Overall Study|AE unrelated to study|9
7849456|NCT00128492|27239239|P1|Overall Study|AE unrelated to study|2
7849457|NCT00128206|27239396|P2|Overall Study|Adverse Event|2
7849458|NCT00128206|27239397|P1|Overall Study|Adverse Event|0
7849459|NCT00128206|27239396|P2|Overall Study|Lost to Follow-up|118
7849460|NCT00128206|27239397|P1|Overall Study|Lost to Follow-up|137
7849461|NCT00128102|27239693|P2|Overall Study|Protocol Violation|2
7849462|NCT00128102|27239694|P1|Overall Study|Protocol Violation|2
7849463|NCT00128102|27239693|P2|Overall Study|Withdrawal by Subject|11
7849464|NCT00128102|27239694|P1|Overall Study|Withdrawal by Subject|19
7849465|NCT00128102|27239693|P2|Overall Study|Physician Decision|3
7849466|NCT00128102|27239694|P1|Overall Study|Physician Decision|3
7849467|NCT00128102|27239693|P2|Overall Study|Death|13
7849468|NCT00128102|27239694|P1|Overall Study|Death|12
7849469|NCT00128102|27239693|P2|Overall Study|Adverse Event|11
7849470|NCT00128102|27239694|P1|Overall Study|Adverse Event|34
7849471|NCT00128102|27239693|P2|Overall Study|Progressive Disease|285
7849472|NCT00128102|27239694|P1|Overall Study|Progressive Disease|255
7849473|NCT00128102|27239693|P2|Overall Study|Other|1
7849474|NCT00128102|27239694|P1|Overall Study|Other|0
7849475|NCT00128102|27239693|P2|Overall Study|Site Discontinued|6
7849476|NCT00128102|27239694|P1|Overall Study|Site Discontinued|3
7849477|NCT00127933|27239720|P2|Overall Study|Randomized but not dosed|0
7849478|NCT00127933|27239721|P1|Overall Study|Randomized but not dosed|1
7849479|NCT00127855|27239742|P5|Primary Vaccination Course|Other|1
7849480|NCT00127855|27239743|P4|Primary Vaccination Course|Other|0
7849481|NCT00127855|27239744|P3|Primary Vaccination Course|Other|0
7849482|NCT00127855|27239745|P2|Primary Vaccination Course|Other|0
7849483|NCT00127855|27239746|P1|Primary Vaccination Course|Other|0
7849484|NCT00127855|27239742|P5|Primary Vaccination Course|Lost to Follow-up|2
7849485|NCT00127855|27239743|P4|Primary Vaccination Course|Lost to Follow-up|0
7849486|NCT00127855|27239744|P3|Primary Vaccination Course|Lost to Follow-up|1
7849487|NCT00127855|27239745|P2|Primary Vaccination Course|Lost to Follow-up|1
7849488|NCT00127855|27239746|P1|Primary Vaccination Course|Lost to Follow-up|1
7849489|NCT00127855|27239742|P5|Primary Vaccination Course|Withdrawal by Subject|1
7849490|NCT00127855|27239743|P4|Primary Vaccination Course|Withdrawal by Subject|0
7849491|NCT00127855|27239744|P3|Primary Vaccination Course|Withdrawal by Subject|0
7849492|NCT00127855|27239745|P2|Primary Vaccination Course|Withdrawal by Subject|0
7849493|NCT00127855|27239746|P1|Primary Vaccination Course|Withdrawal by Subject|1
7849494|NCT00127855|27239742|P5|Primary Vaccination Course|Adverse Event|0
7849495|NCT00127855|27239743|P4|Primary Vaccination Course|Adverse Event|0
7849496|NCT00127855|27239744|P3|Primary Vaccination Course|Adverse Event|1
7849497|NCT00127855|27239745|P2|Primary Vaccination Course|Adverse Event|0
7849498|NCT00127855|27239746|P1|Primary Vaccination Course|Adverse Event|0
7849499|NCT00127842|27239928|P1|Overall Study|Other|5
7849500|NCT00127842|27239928|P1|Overall Study|Protocol Violation|1
7849501|NCT00127842|27239928|P1|Overall Study|Noncompliance|2
7849502|NCT00127842|27239928|P1|Overall Study|Lack of Efficacy|12
7849503|NCT00127842|27239928|P1|Overall Study|Lost to Follow-up|1
7849504|NCT00127842|27239928|P1|Overall Study|Withdrawal by Subject|3
7849505|NCT00127842|27239928|P1|Overall Study|Adverse Event|15
7849506|NCT00127803|27239946|P4|Overall Study|Lost to Follow-up|1
7849507|NCT00127803|27239947|P3|Overall Study|Lost to Follow-up|0
7849508|NCT00127803|27239948|P2|Overall Study|Lost to Follow-up|0
7849509|NCT00127803|27239949|P1|Overall Study|Lost to Follow-up|0
7849510|NCT00127803|27239946|P4|Overall Study|Withdrawal by Subject|0
7849511|NCT00127803|27239947|P3|Overall Study|Withdrawal by Subject|0
7849512|NCT00127803|27239948|P2|Overall Study|Withdrawal by Subject|0
7849513|NCT00127803|27239949|P1|Overall Study|Withdrawal by Subject|1
7849514|NCT00127803|27239946|P4|Overall Study|Adverse Event|0
7849515|NCT00127803|27239947|P3|Overall Study|Adverse Event|0
7849516|NCT00127803|27239948|P2|Overall Study|Adverse Event|0
7849517|NCT00127803|27239949|P1|Overall Study|Adverse Event|2
7849518|NCT00127712|27239998|P2|Overall Study|Lack of GI access to continue|0
7849519|NCT00127712|27239999|P1|Overall Study|Lack of GI access to continue|2
7849520|NCT00127712|27239998|P2|Overall Study|Adverse Event|0
7849521|NCT00127712|27239999|P1|Overall Study|Adverse Event|3
7849522|NCT00127660|27240015|P4|Overall Study|Protocol Violation|0
7849523|NCT00127660|27240016|P3|Overall Study|Protocol Violation|5
7849524|NCT00127660|27240017|P2|Overall Study|Protocol Violation|3
7849525|NCT00127660|27240018|P1|Overall Study|Protocol Violation|3
7849526|NCT00127608|27240028|P1|Overall Study|VZV DNA negative|1
7849527|NCT00127413|27240072|P4|Overall Study|Lost to Follow-up|2
7849528|NCT00127413|27240073|P3|Overall Study|Lost to Follow-up|8
7849529|NCT00127413|27240074|P2|Overall Study|Lost to Follow-up|4
7849530|NCT00127413|27240075|P1|Overall Study|Lost to Follow-up|6
7849531|NCT00127205|27240116|P3|Overall Study|Progression|84
7849532|NCT00127205|27240117|P2|Overall Study|Progression|131
7849533|NCT00127205|27240118|P1|Overall Study|Progression|127
7849534|NCT00127205|27240116|P3|Overall Study|Data not reported|1
7849535|NCT00127205|27240117|P2|Overall Study|Data not reported|10
7849536|NCT00127205|27240118|P1|Overall Study|Data not reported|6
7849537|NCT00127205|27240116|P3|Overall Study|Other-non protocol specified|77
7849538|NCT00127205|27240117|P2|Overall Study|Other-non protocol specified|129
7849539|NCT00127205|27240118|P1|Overall Study|Other-non protocol specified|142
7849540|NCT00127205|27240116|P3|Overall Study|Withdrawal by Subject|172
7849541|NCT00127205|27240117|P2|Overall Study|Withdrawal by Subject|310
7849542|NCT00127205|27240118|P1|Overall Study|Withdrawal by Subject|318
7849543|NCT00127205|27240116|P3|Overall Study|Death|5
7849544|NCT00127205|27240117|P2|Overall Study|Death|6
7849545|NCT00127205|27240118|P1|Overall Study|Death|8
7849546|NCT00127205|27240116|P3|Overall Study|Adverse Event|273
7849547|NCT00127205|27240117|P2|Overall Study|Adverse Event|387
7849548|NCT00127205|27240118|P1|Overall Study|Adverse Event|228
7849549|NCT00127192|27240140|P5|Overall Study|Adverse event in pre-treatment period|0
7849550|NCT00127192|27240141|P4|Overall Study|Adverse event in pre-treatment period|0
7849551|NCT00127192|27240142|P3|Overall Study|Adverse event in pre-treatment period|0
7849552|NCT00127192|27240143|P2|Overall Study|Adverse event in pre-treatment period|0
7849553|NCT00127192|27240144|P1|Overall Study|Adverse event in pre-treatment period|1
7849554|NCT00127192|27240140|P5|Overall Study|Withdrawal by Subject|3
7849555|NCT00127192|27240141|P4|Overall Study|Withdrawal by Subject|0
7849556|NCT00127192|27240142|P3|Overall Study|Withdrawal by Subject|1
7849557|NCT00127192|27240143|P2|Overall Study|Withdrawal by Subject|0
7849558|NCT00127192|27240144|P1|Overall Study|Withdrawal by Subject|0
7849559|NCT00127192|27240140|P5|Overall Study|Lack of Efficacy|2
7849560|NCT00127192|27240141|P4|Overall Study|Lack of Efficacy|0
7849561|NCT00127192|27240142|P3|Overall Study|Lack of Efficacy|0
7849562|NCT00127192|27240143|P2|Overall Study|Lack of Efficacy|0
7849563|NCT00127192|27240144|P1|Overall Study|Lack of Efficacy|2
7849564|NCT00127192|27240140|P5|Overall Study|Adverse Event|0
7849565|NCT00127192|27240141|P4|Overall Study|Adverse Event|1
7849566|NCT00127192|27240142|P3|Overall Study|Adverse Event|1
7849567|NCT00127192|27240143|P2|Overall Study|Adverse Event|1
7849568|NCT00127192|27240144|P1|Overall Study|Adverse Event|0
7849569|NCT00127166|27240168|P2|Period II|Patient did not perform Visit 6 exercise|0
7849570|NCT00127166|27240169|P1|Period II|Patient did not perform Visit 6 exercise|1
7849571|NCT00127166|27240168|P2|Period II|Withdrawal by Subject|0
7849572|NCT00127166|27240169|P1|Period II|Withdrawal by Subject|2
7849573|NCT00127166|27240168|P2|Washout Period|Patient did not meet inclusion criteria|1
7849574|NCT00127166|27240169|P1|Washout Period|Patient did not meet inclusion criteria|0
7849575|NCT00127166|27240168|P2|Period I|Patient did not meet inclusion criteria|0
7849576|NCT00127166|27240169|P1|Period I|Patient did not meet inclusion criteria|1
7849577|NCT00127166|27240168|P2|Period I|Withdrawal by Subject|0
7849578|NCT00127166|27240169|P1|Period I|Withdrawal by Subject|2
7849579|NCT00127166|27240168|P2|Period I|Protocol Violation|2
7849580|NCT00127166|27240169|P1|Period I|Protocol Violation|0
7849581|NCT00127101|27240189|P6|Continuation Phase|Withdrawal by Subject|1
7849582|NCT00127101|27240190|P5|Continuation Phase|Withdrawal by Subject|2
7849583|NCT00127101|27240191|P4|Continuation Phase|Withdrawal by Subject|0
7849584|NCT00127101|27240192|P3|Continuation Phase|Withdrawal by Subject|1
7849585|NCT00127101|27240193|P2|Continuation Phase|Withdrawal by Subject|0
7849586|NCT00127101|27240194|P1|Continuation Phase|Withdrawal by Subject|0
7849587|NCT00127101|27240189|P6|Continuation Phase|Lack of Efficacy|1
7849588|NCT00127101|27240190|P5|Continuation Phase|Lack of Efficacy|0
7849589|NCT00127101|27240191|P4|Continuation Phase|Lack of Efficacy|0
7849590|NCT00127101|27240192|P3|Continuation Phase|Lack of Efficacy|0
7849591|NCT00127101|27240193|P2|Continuation Phase|Lack of Efficacy|0
7849592|NCT00127101|27240194|P1|Continuation Phase|Lack of Efficacy|0
7849593|NCT00127101|27240189|P6|Continuation Phase|Adverse Event|1
7849594|NCT00127101|27240190|P5|Continuation Phase|Adverse Event|1
7849595|NCT00127101|27240191|P4|Continuation Phase|Adverse Event|0
7849596|NCT00127101|27240192|P3|Continuation Phase|Adverse Event|0
7849597|NCT00127101|27240193|P2|Continuation Phase|Adverse Event|0
7849598|NCT00127101|27240194|P1|Continuation Phase|Adverse Event|0
7849599|NCT00127101|27240189|P6|Base Protocol|Withdrawal by Subject|1
7849600|NCT00127101|27240190|P5|Base Protocol|Withdrawal by Subject|0
7849601|NCT00127101|27240191|P4|Base Protocol|Withdrawal by Subject|0
7849602|NCT00127101|27240192|P3|Base Protocol|Withdrawal by Subject|1
7849603|NCT00127101|27240193|P2|Base Protocol|Withdrawal by Subject|2
7849604|NCT00127101|27240194|P1|Base Protocol|Withdrawal by Subject|1
7849605|NCT00127101|27240189|P6|Base Protocol|Lack of Efficacy|0
7849606|NCT00127101|27240190|P5|Base Protocol|Lack of Efficacy|2
7849607|NCT00127101|27240191|P4|Base Protocol|Lack of Efficacy|0
7849608|NCT00127101|27240192|P3|Base Protocol|Lack of Efficacy|0
7849609|NCT00127101|27240193|P2|Base Protocol|Lack of Efficacy|0
7849610|NCT00127101|27240194|P1|Base Protocol|Lack of Efficacy|1
7849611|NCT00127101|27240189|P6|Base Protocol|Adverse Event|0
7849612|NCT00127101|27240190|P5|Base Protocol|Adverse Event|0
7849613|NCT00127101|27240191|P4|Base Protocol|Adverse Event|0
7849614|NCT00127101|27240192|P3|Base Protocol|Adverse Event|1
7849615|NCT00127101|27240193|P2|Base Protocol|Adverse Event|2
7849616|NCT00127101|27240194|P1|Base Protocol|Adverse Event|0
7849617|NCT00127036|27240229|P2|Overall Study|Screen Failure|0
7849618|NCT00127036|27240230|P1|Overall Study|Screen Failure|2
7849619|NCT00127036|27240229|P2|Overall Study|Insufficient Data for Analysis|11
7849620|NCT00127036|27240230|P1|Overall Study|Insufficient Data for Analysis|6
7849621|NCT00126776|27240242|P2|Overall Study|follow up complete on all patients|0
7849622|NCT00126776|27240243|P1|Overall Study|follow up complete on all patients|0
7849623|NCT00126659|27240292|P3|Overall Study|Adverse Event|2
7849624|NCT00126659|27240293|P2|Overall Study|Adverse Event|0
7849625|NCT00126659|27240294|P1|Overall Study|Adverse Event|0
7849626|NCT00126594|27240302|P2|Overall Study|Disease Progression|24
7849627|NCT00126594|27240303|P1|Overall Study|Disease Progression|29
7849628|NCT00126594|27240302|P2|Overall Study|Non-compliance|1
7849629|NCT00126594|27240303|P1|Overall Study|Non-compliance|0
7849630|NCT00126594|27240302|P2|Overall Study|Adverse Event|5
7849631|NCT00126594|27240303|P1|Overall Study|Adverse Event|7
7849632|NCT00126594|27240302|P2|Overall Study|Physician Decision|3
7849633|NCT00126594|27240303|P1|Overall Study|Physician Decision|1
7849634|NCT00126594|27240302|P2|Overall Study|Withdrawal by Subject|4
7849635|NCT00126594|27240303|P1|Overall Study|Withdrawal by Subject|0
7849636|NCT00126594|27240302|P2|Overall Study|Ineligible|0
7849637|NCT00126594|27240303|P1|Overall Study|Ineligible|2
7849638|NCT00126581|27240320|P2|Overall Study|Other illness/MD discretion|4
7849639|NCT00126581|27240321|P1|Overall Study|Other illness/MD discretion|3
7849640|NCT00126581|27240320|P2|Overall Study|Alternative therapy|3
7849641|NCT00126581|27240321|P1|Overall Study|Alternative therapy|3
7849642|NCT00126581|27240320|P2|Overall Study|Withdrawal by Subject|4
7849643|NCT00126581|27240321|P1|Overall Study|Withdrawal by Subject|1
7849644|NCT00126581|27240320|P2|Overall Study|Death|2
7849645|NCT00126581|27240321|P1|Overall Study|Death|3
7849646|NCT00126581|27240320|P2|Overall Study|Adverse Event|7
7849647|NCT00126581|27240321|P1|Overall Study|Adverse Event|3
7849648|NCT00126568|27240341|P1|Overall Study|Death|2
7849649|NCT00126555|27240348|P1|Overall Study|Progressive Disease|3
7849650|NCT00126555|27240348|P1|Overall Study|Adverse Event|2
7849651|NCT00126555|27240348|P1|Overall Study|Withdrawal by Subject|1
7849652|NCT00126503|27240370|P2|Overall Study|Physician Decision|1
7849653|NCT00126503|27240371|P1|Overall Study|Physician Decision|2
7849654|NCT00126503|27240370|P2|Overall Study|non-compliant|0
7849655|NCT00126503|27240371|P1|Overall Study|non-compliant|1
7849656|NCT00126503|27240370|P2|Overall Study|Adverse Event|3
7849657|NCT00126503|27240371|P1|Overall Study|Adverse Event|13
7849658|NCT00126503|27240370|P2|Overall Study|Death|0
7849659|NCT00126503|27240371|P1|Overall Study|Death|3
7849660|NCT00126503|27240370|P2|Overall Study|other complicating disease|1
7849661|NCT00126503|27240371|P1|Overall Study|other complicating disease|4
7849662|NCT00126503|27240370|P2|Overall Study|alternative therapy|1
7849663|NCT00126503|27240371|P1|Overall Study|alternative therapy|1
7849664|NCT00126503|27240370|P2|Overall Study|Withdrawal by Subject|1
7849665|NCT00126503|27240371|P1|Overall Study|Withdrawal by Subject|0
7849666|NCT00126503|27240370|P2|Overall Study|disease progression|14
7849667|NCT00126503|27240371|P1|Overall Study|disease progression|23
7849668|NCT00126490|27240383|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
7849669|NCT00126438|27240393|P2|Overall Study|Withdrawal by Subject|2
7849670|NCT00126438|27240394|P1|Overall Study|Withdrawal by Subject|3
7849671|NCT00126438|27240393|P2|Overall Study|Protocol Violation|8
7849672|NCT00126438|27240394|P1|Overall Study|Protocol Violation|8
7849673|NCT00126438|27240393|P2|Overall Study|Lost to Follow-up|0
7849674|NCT00126438|27240394|P1|Overall Study|Lost to Follow-up|22
7849675|NCT00126438|27240393|P2|Overall Study|Withdrawal due to adverse event|0
7849676|NCT00126438|27240394|P1|Overall Study|Withdrawal due to adverse event|1
7849677|NCT00126425|27240402|P2|Overall Study|Other|0
7849678|NCT00126425|27240403|P1|Overall Study|Other|5
7849679|NCT00126425|27240402|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
7849680|NCT00126425|27240403|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
7849681|NCT00126425|27240402|P2|Overall Study|Adverse Event|0
7849682|NCT00126425|27240403|P1|Overall Study|Adverse Event|1
7849683|NCT00126425|27240402|P2|Overall Study|Protocol Violation|6
7849684|NCT00126425|27240403|P1|Overall Study|Protocol Violation|9
7849685|NCT00126425|27240402|P2|Overall Study|Lost to Follow-up|4
7849686|NCT00126425|27240403|P1|Overall Study|Lost to Follow-up|8
7849687|NCT00126425|27240402|P2|Overall Study|Withdrawal by Subject|1
7849688|NCT00126425|27240403|P1|Overall Study|Withdrawal by Subject|17
7849689|NCT00126191|27240411|P2|Overall Study|Death|1
7849690|NCT00126191|27240412|P1|Overall Study|Death|0
7849691|NCT00126191|27240411|P2|Overall Study|Physician Decision|1
7849692|NCT00126191|27240412|P1|Overall Study|Physician Decision|0
7849693|NCT00126126|27240422|P2|Overall Study|Lost to Follow-up|2
7849694|NCT00126126|27240423|P1|Overall Study|Lost to Follow-up|0
7849695|NCT00125853|27240462|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
7849696|NCT00125853|27240463|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
7849697|NCT00125359|27240630|P1|Overall Study|Physician Decision|14
7849698|NCT00125359|27240630|P1|Overall Study|Adverse Event|5
7849699|NCT00125359|27240630|P1|Overall Study|Death|4
7849700|NCT00125268|27240639|P2|Overall Study|Withdrawal by Subject|1
7849701|NCT00125268|27240640|P1|Overall Study|Withdrawal by Subject|1
7849702|NCT00125242|27240652|P2|Overall Study|did not qualify|2
7849703|NCT00125242|27240653|P1|Overall Study|did not qualify|7
7849704|NCT00125190|27240658|P1|Overall Study|Lost to Follow-up|4
7849705|NCT00125190|27240658|P1|Overall Study|Other|1
7849706|NCT00125190|27240658|P1|Overall Study|Adverse Event|1
7849707|NCT00125190|27240658|P1|Overall Study|Non-compliance|2
7849708|NCT00125190|27240658|P1|Overall Study|Subject/Parent Decision|7
7849709|NCT00125164|27240674|P4|Overall Study|Withdrawal by Subject|1
7849710|NCT00125164|27240675|P3|Overall Study|Withdrawal by Subject|1
7849711|NCT00125164|27240676|P2|Overall Study|Withdrawal by Subject|0
7849712|NCT00125164|27240677|P1|Overall Study|Withdrawal by Subject|2
7849713|NCT00125164|27240674|P4|Overall Study|Lost to Follow-up|1
7849714|NCT00125164|27240675|P3|Overall Study|Lost to Follow-up|1
7849715|NCT00125164|27240676|P2|Overall Study|Lost to Follow-up|0
7849716|NCT00125164|27240677|P1|Overall Study|Lost to Follow-up|0
7849717|NCT00125164|27240674|P4|Overall Study|Adverse Event|4
7849718|NCT00125164|27240675|P3|Overall Study|Adverse Event|2
7849719|NCT00125164|27240676|P2|Overall Study|Adverse Event|0
7849720|NCT00125164|27240677|P1|Overall Study|Adverse Event|0
7849721|NCT00125138|27240731|P4|Overall Study|Sponsor decision-pt moved to assist care|1
7849722|NCT00125138|27240732|P3|Overall Study|Sponsor decision-pt moved to assist care|0
7849723|NCT00125138|27240733|P2|Overall Study|Sponsor decision-pt moved to assist care|0
7849724|NCT00125138|27240734|P1|Overall Study|Sponsor decision-pt moved to assist care|0
7849725|NCT00125138|27240731|P4|Overall Study|Lack of Efficacy|1
7849726|NCT00125138|27240732|P3|Overall Study|Lack of Efficacy|0
7849727|NCT00125138|27240733|P2|Overall Study|Lack of Efficacy|0
7849728|NCT00125138|27240734|P1|Overall Study|Lack of Efficacy|0
7849729|NCT00125138|27240731|P4|Overall Study|Withdrawal by Subject|1
7849730|NCT00125138|27240732|P3|Overall Study|Withdrawal by Subject|1
7849731|NCT00125138|27240733|P2|Overall Study|Withdrawal by Subject|3
7849732|NCT00125138|27240734|P1|Overall Study|Withdrawal by Subject|2
7849733|NCT00125138|27240731|P4|Overall Study|Adverse Event|2
7849734|NCT00125138|27240732|P3|Overall Study|Adverse Event|3
7849735|NCT00125138|27240733|P2|Overall Study|Adverse Event|0
7849736|NCT00125138|27240734|P1|Overall Study|Adverse Event|1
7849737|NCT00124982|27240783|P3|Long-term Period|Neurologist Recommendation|1
7849738|NCT00124982|27240784|P2|Long-term Period|Neurologist Recommendation|0
7849739|NCT00124982|27240785|P1|Long-term Period|Neurologist Recommendation|0
7849740|NCT00124982|27240783|P3|Long-term Period|Administrative Reason by Sponsor|1
7849741|NCT00124982|27240784|P2|Long-term Period|Administrative Reason by Sponsor|0
7849742|NCT00124982|27240785|P1|Long-term Period|Administrative Reason by Sponsor|0
7849743|NCT00124982|27240783|P3|Long-term Period|Poor/Non-compliance|2
7849744|NCT00124982|27240784|P2|Long-term Period|Poor/Non-compliance|0
7849745|NCT00124982|27240785|P1|Long-term Period|Poor/Non-compliance|0
7849746|NCT00124982|27240783|P3|Long-term Period|Pregnancy|1
7849747|NCT00124982|27240784|P2|Long-term Period|Pregnancy|0
7849748|NCT00124982|27240785|P1|Long-term Period|Pregnancy|0
7849749|NCT00124982|27240783|P3|Long-term Period|Withdrawal by Subject|16
7849750|NCT00124982|27240784|P2|Long-term Period|Withdrawal by Subject|0
7849751|NCT00124982|27240785|P1|Long-term Period|Withdrawal by Subject|0
7849752|NCT00124982|27240783|P3|Long-term Period|Lost to Follow-up|4
7849753|NCT00124982|27240784|P2|Long-term Period|Lost to Follow-up|0
7849754|NCT00124982|27240785|P1|Long-term Period|Lost to Follow-up|0
7849755|NCT00124982|27240783|P3|Long-term Period|Lack of Efficacy|46
7849756|NCT00124982|27240784|P2|Long-term Period|Lack of Efficacy|0
7849757|NCT00124982|27240785|P1|Long-term Period|Lack of Efficacy|0
7849758|NCT00124982|27240783|P3|Long-term Period|Adverse Event|17
7849759|NCT00124982|27240784|P2|Long-term Period|Adverse Event|0
7849760|NCT00124982|27240785|P1|Long-term Period|Adverse Event|0
7849761|NCT00124982|27240783|P3|Long-term Period|Death|1
7849762|NCT00124982|27240784|P2|Long-term Period|Death|0
7849763|NCT00124982|27240785|P1|Long-term Period|Death|0
7849764|NCT00124982|27240783|P3|Short-term Period|Participant Had Lymphopenia|0
7849765|NCT00124982|27240784|P2|Short-term Period|Participant Had Lymphopenia|0
7849766|NCT00124982|27240785|P1|Short-term Period|Participant Had Lymphopenia|1
7849767|NCT00124982|27240783|P3|Short-term Period|Investigator Decision-No Specific AE|0
7849768|NCT00124982|27240784|P2|Short-term Period|Investigator Decision-No Specific AE|0
7849769|NCT00124982|27240785|P1|Short-term Period|Investigator Decision-No Specific AE|1
7849770|NCT00124982|27240783|P3|Short-term Period|Participant Chose Own Doctor|0
7849771|NCT00124982|27240784|P2|Short-term Period|Participant Chose Own Doctor|1
7849772|NCT00124982|27240785|P1|Short-term Period|Participant Chose Own Doctor|0
7849773|NCT00124982|27240783|P3|Short-term Period|Participant Decision|0
7849774|NCT00124982|27240784|P2|Short-term Period|Participant Decision|0
7849775|NCT00124982|27240785|P1|Short-term Period|Participant Decision|1
7849776|NCT00124982|27240783|P3|Short-term Period|No Longer Meets Study Criteria|0
7849777|NCT00124982|27240784|P2|Short-term Period|No Longer Meets Study Criteria|2
7849778|NCT00124982|27240785|P1|Short-term Period|No Longer Meets Study Criteria|1
7849779|NCT00124982|27240783|P3|Short-term Period|Poor/Non-compliance|0
7849780|NCT00124982|27240784|P2|Short-term Period|Poor/Non-compliance|1
7849781|NCT00124982|27240785|P1|Short-term Period|Poor/Non-compliance|3
7849782|NCT00124982|27240783|P3|Short-term Period|Withdrawal of Consent|0
7849783|NCT00124982|27240784|P2|Short-term Period|Withdrawal of Consent|9
7849784|NCT00124982|27240785|P1|Short-term Period|Withdrawal of Consent|7
7849785|NCT00124982|27240783|P3|Short-term Period|Lost to Follow-up|0
7849786|NCT00124982|27240784|P2|Short-term Period|Lost to Follow-up|5
7849787|NCT00124982|27240785|P1|Short-term Period|Lost to Follow-up|8
7849788|NCT00124982|27240783|P3|Short-term Period|Lack of Efficacy|0
7849789|NCT00124982|27240784|P2|Short-term Period|Lack of Efficacy|73
7849790|NCT00124982|27240785|P1|Short-term Period|Lack of Efficacy|32
7849791|NCT00124982|27240783|P3|Short-term Period|Adverse Event|0
7849792|NCT00124982|27240784|P2|Short-term Period|Adverse Event|22
7849793|NCT00124982|27240785|P1|Short-term Period|Adverse Event|17
7849794|NCT00124982|27240783|P3|Short-term Period|Death|0
7849795|NCT00124982|27240784|P2|Short-term Period|Death|1
7849796|NCT00124982|27240785|P1|Short-term Period|Death|1
7849797|NCT00124943|27240867|P4|Phase II|Withdrawal by Subject|2
7849798|NCT00124943|27240868|P3|Phase II|Withdrawal by Subject|0
7849799|NCT00124943|27240869|P2|Phase II|Withdrawal by Subject|0
7849800|NCT00124943|27240870|P1|Phase II|Withdrawal by Subject|0
7849801|NCT00124943|27240867|P4|Phase II|Lost to Follow-up|1
7849802|NCT00124943|27240868|P3|Phase II|Lost to Follow-up|0
7849803|NCT00124943|27240869|P2|Phase II|Lost to Follow-up|0
7849804|NCT00124943|27240870|P1|Phase II|Lost to Follow-up|0
7849805|NCT00124943|27240867|P4|Phase II|Protocol Violation|1
7849806|NCT00124943|27240868|P3|Phase II|Protocol Violation|0
7849807|NCT00124943|27240869|P2|Phase II|Protocol Violation|0
7849808|NCT00124943|27240870|P1|Phase II|Protocol Violation|0
7849809|NCT00124943|27240867|P4|Phase II|Adverse Event|1
7849810|NCT00124943|27240868|P3|Phase II|Adverse Event|0
7849811|NCT00124943|27240869|P2|Phase II|Adverse Event|2
7849812|NCT00124943|27240870|P1|Phase II|Adverse Event|0
7849813|NCT00124917|27240908|P1|Overall Study|Physician Decision|3
7849814|NCT00124748|27240918|P2|Overall Study|Death|3
7849815|NCT00124748|27240919|P1|Overall Study|Death|1
7849816|NCT00124748|27240918|P2|Overall Study|Administrative Problem(Study Terminated)|174
7849817|NCT00124748|27240919|P1|Overall Study|Administrative Problem(Study Terminated)|101
7849818|NCT00124748|27240918|P2|Overall Study|Lost to Follow-up|7
7849819|NCT00124748|27240919|P1|Overall Study|Lost to Follow-up|2
7849820|NCT00124748|27240918|P2|Overall Study|Withdrawal by Subject|15
7849821|NCT00124748|27240919|P1|Overall Study|Withdrawal by Subject|5
7849822|NCT00124748|27240918|P2|Overall Study|Protocol Violation|1
7849823|NCT00124748|27240919|P1|Overall Study|Protocol Violation|3
7849824|NCT00124748|27240918|P2|Overall Study|No longer requires study drug|1
7849825|NCT00124748|27240919|P1|Overall Study|No longer requires study drug|1
7849826|NCT00124748|27240918|P2|Overall Study|Lack of Efficacy|41
7849827|NCT00124748|27240919|P1|Overall Study|Lack of Efficacy|20
7849828|NCT00124748|27240918|P2|Overall Study|Abnormal Procedure|1
7849829|NCT00124748|27240919|P1|Overall Study|Abnormal Procedure|0
7849830|NCT00124748|27240918|P2|Overall Study|Abnormal laboratory Value|2
7849831|NCT00124748|27240919|P1|Overall Study|Abnormal laboratory Value|2
7849832|NCT00124748|27240918|P2|Overall Study|Adverse Event|39
7849833|NCT00124748|27240919|P1|Overall Study|Adverse Event|8
7849834|NCT00124709|27241026|P2|Overall Study|Lost to Follow-up|120
7849835|NCT00124709|27241027|P1|Overall Study|Lost to Follow-up|114
7849836|NCT00124709|27241026|P2|Overall Study|Withdrawal by Subject|136
7849837|NCT00124709|27241027|P1|Overall Study|Withdrawal by Subject|127
7849838|NCT00124709|27241026|P2|Overall Study|Protocol Violation|5
7849839|NCT00124709|27241027|P1|Overall Study|Protocol Violation|3
7849840|NCT00124709|27241026|P2|Overall Study|Lack of Efficacy|10
7849841|NCT00124709|27241027|P1|Overall Study|Lack of Efficacy|5
7849842|NCT00124709|27241026|P2|Overall Study|Adverse Event|0
7849843|NCT00124709|27241027|P1|Overall Study|Adverse Event|3
7849844|NCT00124709|27241026|P2|Overall Study|Randomized but did not take medication|1
7849845|NCT00124709|27241027|P1|Overall Study|Randomized but did not take medication|3
7849846|NCT00124657|27241044|P3|Overall Study|Intercurrent illness|0
7849847|NCT00124657|27241045|P2|Overall Study|Intercurrent illness|0
7849848|NCT00124657|27241046|P1|Overall Study|Intercurrent illness|1
7849849|NCT00124657|27241044|P3|Overall Study|Progressive disease|27
7849850|NCT00124657|27241045|P2|Overall Study|Progressive disease|5
7849851|NCT00124657|27241046|P1|Overall Study|Progressive disease|14
7849852|NCT00124657|27241044|P3|Overall Study|Non-compliance|4
7849853|NCT00124657|27241045|P2|Overall Study|Non-compliance|0
7849854|NCT00124657|27241046|P1|Overall Study|Non-compliance|1
7849855|NCT00124657|27241044|P3|Overall Study|Toxicity|1
7849856|NCT00124657|27241045|P2|Overall Study|Toxicity|0
7849857|NCT00124657|27241046|P1|Overall Study|Toxicity|0
7849858|NCT00124618|27241081|P1|Overall Study|Ineligible|1
7849859|NCT00124462|27241113|P2|Overall Study|Device fitting, n=2, other hlth issues|1
7849860|NCT00124462|27241114|P1|Overall Study|Device fitting, n=2, other hlth issues|1
7849861|NCT00124462|27241113|P2|Overall Study|Withdrawal by Subject|5
7849862|NCT00124462|27241114|P1|Overall Study|Withdrawal by Subject|4
7849863|NCT00124462|27241113|P2|Overall Study|Physician Decision|4
7849864|NCT00124462|27241114|P1|Overall Study|Physician Decision|3
7849865|NCT00124462|27241113|P2|Overall Study|Lost to Follow-up|3
7849866|NCT00124462|27241114|P1|Overall Study|Lost to Follow-up|3
7849867|NCT00124449|27241124|P2|18-Month Untreated Observation Period|Relocated|0
7849868|NCT00124449|27241125|P1|18-Month Untreated Observation Period|Relocated|1
7849869|NCT00124449|27241124|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
7849870|NCT00124449|27241125|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
7849871|NCT00124449|27241124|P2|18-Month Untreated Observation Period|Pregnancy|0
7849872|NCT00124449|27241125|P1|18-Month Untreated Observation Period|Pregnancy|1
7849873|NCT00124449|27241124|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
7849874|NCT00124449|27241125|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
7849875|NCT00124449|27241124|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
7849876|NCT00124449|27241125|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
7849877|NCT00124449|27241124|P2|18-Month Untreated Observation Period|Adverse Event|1
7849878|NCT00124449|27241125|P1|18-Month Untreated Observation Period|Adverse Event|0
7849879|NCT00124449|27241124|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
7849880|NCT00124449|27241125|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
7849881|NCT00124449|27241124|P2|6-month Double-Blind Treatment Period|Sponsor request|1
7849882|NCT00124449|27241125|P1|6-month Double-Blind Treatment Period|Sponsor request|0
7849883|NCT00124449|27241124|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
7849884|NCT00124449|27241125|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
7849885|NCT00124449|27241124|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7849886|NCT00124449|27241125|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7849887|NCT00124449|27241124|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
7849888|NCT00124449|27241125|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
7849889|NCT00124449|27241124|P2|6-month Double-Blind Treatment Period|Adverse Event|0
7849890|NCT00124449|27241125|P1|6-month Double-Blind Treatment Period|Adverse Event|1
7849891|NCT00124072|27241179|P4|Overall Study|Death|480
7849892|NCT00124072|27241180|P3|Overall Study|Death|471
7849893|NCT00124072|27241181|P2|Overall Study|Death|484
7849894|NCT00124072|27241182|P1|Overall Study|Death|499
7849895|NCT00124072|27241179|P4|Overall Study|Lost to Follow-up for Morbidity|18
7849896|NCT00124072|27241180|P3|Overall Study|Lost to Follow-up for Morbidity|19
7849897|NCT00124072|27241181|P2|Overall Study|Lost to Follow-up for Morbidity|25
7849898|NCT00124072|27241182|P1|Overall Study|Lost to Follow-up for Morbidity|15
7849899|NCT00124072|27241179|P4|Overall Study|Lost to Follow-up for Mortality|2
7849900|NCT00124072|27241180|P3|Overall Study|Lost to Follow-up for Mortality|2
7849901|NCT00124072|27241181|P2|Overall Study|Lost to Follow-up for Mortality|3
7849902|NCT00124072|27241182|P1|Overall Study|Lost to Follow-up for Mortality|0
7849903|NCT00124020|27241194|P2|Overall Study|Transfer to another hospital|0
7849904|NCT00124020|27241195|P1|Overall Study|Transfer to another hospital|2
7849905|NCT00124020|27241194|P2|Overall Study|Other|1
7849906|NCT00124020|27241195|P1|Overall Study|Other|1
7849907|NCT00124020|27241194|P2|Overall Study|Lost to Follow-up|8
7849908|NCT00124020|27241195|P1|Overall Study|Lost to Follow-up|5
7849909|NCT00124020|27241194|P2|Overall Study|Withdrawal by Subject|11
7849910|NCT00124020|27241195|P1|Overall Study|Withdrawal by Subject|13
7849911|NCT00124020|27241194|P2|Overall Study|Death|71
7849912|NCT00124020|27241195|P1|Overall Study|Death|67
7849913|NCT00123955|27241203|P2|Overall Study|Death|1
7849914|NCT00123955|27241204|P1|Overall Study|Death|0
7849915|NCT00123955|27241203|P2|Overall Study|Withdrawal by Subject|3
7849916|NCT00123955|27241204|P1|Overall Study|Withdrawal by Subject|4
7849917|NCT00123955|27241203|P2|Overall Study|Adverse Event|0
7849918|NCT00123955|27241204|P1|Overall Study|Adverse Event|1
7849919|NCT00123734|27241216|P1|Overall Study|Withdrawal by Subject|1
7849920|NCT00123734|27241216|P1|Overall Study|Dropout|1
7849921|NCT00123734|27241216|P1|Overall Study|Lost to Follow-up|3
7849922|NCT00123734|27241216|P1|Overall Study|Death|3
7849923|NCT00123487|27241301|P2|Treated With Study Drug|Unknown (case report form lost)|1
7849924|NCT00123487|27241302|P1|Treated With Study Drug|Unknown (case report form lost)|0
7849925|NCT00123487|27241301|P2|Treated With Study Drug|Withdrawal by Subject|13
7849926|NCT00123487|27241302|P1|Treated With Study Drug|Withdrawal by Subject|11
7849927|NCT00123487|27241301|P2|Treated With Study Drug|Study Drug Toxicity|80
7849928|NCT00123487|27241302|P1|Treated With Study Drug|Study Drug Toxicity|62
7849929|NCT00123487|27241301|P2|Treated With Study Drug|Other|58
7849930|NCT00123487|27241302|P1|Treated With Study Drug|Other|59
7849931|NCT00123487|27241301|P2|Treated With Study Drug|Physician Decision|9
7849932|NCT00123487|27241302|P1|Treated With Study Drug|Physician Decision|8
7849933|NCT00123487|27241301|P2|Treated With Study Drug|Disease Progression|122
7849934|NCT00123487|27241302|P1|Treated With Study Drug|Disease Progression|141
7849935|NCT00123487|27241301|P2|Treated With Study Drug|Adverse Event|22
7849936|NCT00123487|27241302|P1|Treated With Study Drug|Adverse Event|23
7849937|NCT00123487|27241301|P2|Randomized|SAE prior to starting treatment|0
7849938|NCT00123487|27241302|P1|Randomized|SAE prior to starting treatment|1
7849939|NCT00123487|27241301|P2|Randomized|Death prior to starting treatment|1
7849940|NCT00123487|27241302|P1|Randomized|Death prior to starting treatment|0
7849941|NCT00123474|27241346|P4|As Treated at Study Closure|Withdrawal by Subject|16
7849942|NCT00123474|27241347|P3|As Treated at Study Closure|Withdrawal by Subject|18
7849943|NCT00123474|27241348|P2|As Treated at Study Closure|Withdrawal by Subject|19
7849944|NCT00123474|27241349|P1|As Treated at Study Closure|Withdrawal by Subject|14
7849945|NCT00123474|27241346|P4|As Treated at Study Closure|Study Drug Toxicity|51
7849946|NCT00123474|27241347|P3|As Treated at Study Closure|Study Drug Toxicity|45
7849947|NCT00123474|27241348|P2|As Treated at Study Closure|Study Drug Toxicity|45
7849948|NCT00123474|27241349|P1|As Treated at Study Closure|Study Drug Toxicity|39
7849949|NCT00123474|27241346|P4|As Treated at Study Closure|non-specified|60
7849950|NCT00123474|27241347|P3|As Treated at Study Closure|non-specified|57
7849951|NCT00123474|27241348|P2|As Treated at Study Closure|non-specified|47
7849952|NCT00123474|27241349|P1|As Treated at Study Closure|non-specified|54
7849953|NCT00123474|27241346|P4|As Treated at Study Closure|Investigator Request|5
7849954|NCT00123474|27241347|P3|As Treated at Study Closure|Investigator Request|7
7849955|NCT00123474|27241348|P2|As Treated at Study Closure|Investigator Request|6
7849956|NCT00123474|27241349|P1|As Treated at Study Closure|Investigator Request|12
7849957|NCT00123474|27241346|P4|As Treated at Study Closure|Disease Progression|27
7849958|NCT00123474|27241347|P3|As Treated at Study Closure|Disease Progression|29
7849959|NCT00123474|27241348|P2|As Treated at Study Closure|Disease Progression|42
7849960|NCT00123474|27241349|P1|As Treated at Study Closure|Disease Progression|35
7849961|NCT00123474|27241346|P4|As Treated at Study Closure|Adverse Event|8
7849962|NCT00123474|27241347|P3|As Treated at Study Closure|Adverse Event|10
7849963|NCT00123474|27241348|P2|As Treated at Study Closure|Adverse Event|4
7849964|NCT00123474|27241349|P1|As Treated at Study Closure|Adverse Event|10
7849965|NCT00123474|27241346|P4|As Treated at Study Closure|not reported when site closed|0
7849966|NCT00123474|27241347|P3|As Treated at Study Closure|not reported when site closed|1
7849967|NCT00123474|27241348|P2|As Treated at Study Closure|not reported when site closed|0
7849968|NCT00123474|27241349|P1|As Treated at Study Closure|not reported when site closed|1
7849969|NCT00123474|27241346|P4|Randomized to Treatment|Randomized, never treated|1
7849970|NCT00123474|27241347|P3|Randomized to Treatment|Randomized, never treated|2
7849971|NCT00123474|27241348|P2|Randomized to Treatment|Randomized, never treated|4
7849972|NCT00123474|27241349|P1|Randomized to Treatment|Randomized, never treated|1
7849973|NCT00123422|27241443|P3|Overall Study|Lost to Follow-up|2
7849974|NCT00123422|27241444|P2|Overall Study|Lost to Follow-up|2
7849975|NCT00123422|27241445|P1|Overall Study|Lost to Follow-up|1
7849976|NCT00123422|27241443|P3|Overall Study|Withdrawal by Subject|2
7849977|NCT00123422|27241444|P2|Overall Study|Withdrawal by Subject|2
7849978|NCT00123422|27241445|P1|Overall Study|Withdrawal by Subject|1
7849979|NCT00123422|27241443|P3|Overall Study|Physician Decision|6
7849980|NCT00123422|27241444|P2|Overall Study|Physician Decision|2
7849981|NCT00123422|27241445|P1|Overall Study|Physician Decision|2
7849982|NCT00122980|27241533|P2|Overall Study|Study termination|35
7849983|NCT00122980|27241534|P1|Overall Study|Study termination|27
7849984|NCT00122980|27241533|P2|Overall Study|Adjudicated stroke (study endpoint)|0
7849985|NCT00122980|27241534|P1|Overall Study|Adjudicated stroke (study endpoint)|7
7849986|NCT00122980|27241533|P2|Overall Study|Withdrawal by Subject|3
7849987|NCT00122980|27241534|P1|Overall Study|Withdrawal by Subject|2
7849988|NCT00122980|27241533|P2|Overall Study|Protocol Violation|1
7849989|NCT00122980|27241534|P1|Overall Study|Protocol Violation|5
7849990|NCT00122980|27241533|P2|Overall Study|Physician Decision|0
7849991|NCT00122980|27241534|P1|Overall Study|Physician Decision|2
7849992|NCT00122980|27241533|P2|Overall Study|Death|1
7849993|NCT00122980|27241534|P1|Overall Study|Death|0
7849994|NCT00122954|27241558|P2|Overall Study|Protocol Violation|1
7849995|NCT00122954|27241559|P1|Overall Study|Protocol Violation|0
7849996|NCT00122954|27241558|P2|Overall Study|Withdrawal by Subject|2
7849997|NCT00122954|27241559|P1|Overall Study|Withdrawal by Subject|2
7849998|NCT00122681|27241569|P2|Overall Study|Personal reasons|147
7849999|NCT00122681|27241570|P1|Overall Study|Personal reasons|150
7850000|NCT00122681|27241569|P2|Overall Study|Withdrawal by Subject|251
7850001|NCT00122681|27241570|P1|Overall Study|Withdrawal by Subject|257
7850002|NCT00122681|27241569|P2|Overall Study|Protocol Violation|10
7850003|NCT00122681|27241570|P1|Overall Study|Protocol Violation|7
7850004|NCT00122681|27241569|P2|Overall Study|Lost to Follow-up|1097
7850005|NCT00122681|27241570|P1|Overall Study|Lost to Follow-up|1080
7850006|NCT00122681|27241569|P2|Overall Study|Adverse Event|16
7850007|NCT00122681|27241570|P1|Overall Study|Adverse Event|20
7850008|NCT00122460|27241644|P2|Overall Study|investigational study phase ongoing|1
7850009|NCT00122460|27241645|P1|Overall Study|investigational study phase ongoing|7
7850010|NCT00122382|27241694|P3|Open-Label Study|Withdrawal of Consent|4
7850011|NCT00122382|27241695|P2|Open-Label Study|Withdrawal of Consent|0
7850012|NCT00122382|27241696|P1|Open-Label Study|Withdrawal of Consent|0
7850013|NCT00122382|27241694|P3|Open-Label Study|Poor/Non-Compliance|1
7850014|NCT00122382|27241695|P2|Open-Label Study|Poor/Non-Compliance|0
7850015|NCT00122382|27241696|P1|Open-Label Study|Poor/Non-Compliance|0
7850016|NCT00122382|27241694|P3|Open-Label Study|Pregnancy|2
7850017|NCT00122382|27241695|P2|Open-Label Study|Pregnancy|0
7850018|NCT00122382|27241696|P1|Open-Label Study|Pregnancy|0
7850019|NCT00122382|27241694|P3|Open-Label Study|Lost to Follow-up|3
7850020|NCT00122382|27241695|P2|Open-Label Study|Lost to Follow-up|0
7850021|NCT00122382|27241696|P1|Open-Label Study|Lost to Follow-up|0
7850022|NCT00122382|27241694|P3|Open-Label Study|Lack of Efficacy|3
7850023|NCT00122382|27241695|P2|Open-Label Study|Lack of Efficacy|0
7850024|NCT00122382|27241696|P1|Open-Label Study|Lack of Efficacy|0
7850025|NCT00122382|27241694|P3|Open-Label Study|Death|2
7850026|NCT00122382|27241695|P2|Open-Label Study|Death|0
7850027|NCT00122382|27241696|P1|Open-Label Study|Death|0
7850028|NCT00122382|27241694|P3|Open-Label Study|Adverse Event|11
7850029|NCT00122382|27241695|P2|Open-Label Study|Adverse Event|0
7850030|NCT00122382|27241696|P1|Open-Label Study|Adverse Event|0
7850031|NCT00122382|27241694|P3|Double-Blind Study|Randomized but not treated|0
7850032|NCT00122382|27241695|P2|Double-Blind Study|Randomized but not treated|2
7850033|NCT00122382|27241696|P1|Double-Blind Study|Randomized but not treated|0
7850034|NCT00122382|27241694|P3|Double-Blind Study|Methotrexate Discontinued|0
7850035|NCT00122382|27241695|P2|Double-Blind Study|Methotrexate Discontinued|1
7850036|NCT00122382|27241696|P1|Double-Blind Study|Methotrexate Discontinued|0
7850037|NCT00122382|27241694|P3|Double-Blind Study|Protocol Violation|0
7850038|NCT00122382|27241695|P2|Double-Blind Study|Protocol Violation|0
7850039|NCT00122382|27241696|P1|Double-Blind Study|Protocol Violation|1
7850040|NCT00122382|27241694|P3|Double-Blind Study|Withdrawal of Consent|0
7850041|NCT00122382|27241695|P2|Double-Blind Study|Withdrawal of Consent|3
7850042|NCT00122382|27241696|P1|Double-Blind Study|Withdrawal of Consent|7
7850043|NCT00122382|27241694|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
7850044|NCT00122382|27241695|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
7850045|NCT00122382|27241696|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
7850046|NCT00122382|27241694|P3|Double-Blind Study|Pregnancy|0
7850047|NCT00122382|27241695|P2|Double-Blind Study|Pregnancy|0
7850048|NCT00122382|27241696|P1|Double-Blind Study|Pregnancy|2
7850049|NCT00122382|27241694|P3|Double-Blind Study|Lost to Follow-up|0
7850050|NCT00122382|27241695|P2|Double-Blind Study|Lost to Follow-up|1
7850051|NCT00122382|27241696|P1|Double-Blind Study|Lost to Follow-up|2
7850052|NCT00122382|27241694|P3|Double-Blind Study|Lack of Efficacy|0
7850053|NCT00122382|27241695|P2|Double-Blind Study|Lack of Efficacy|8
7850054|NCT00122382|27241696|P1|Double-Blind Study|Lack of Efficacy|0
7850055|NCT00122382|27241694|P3|Double-Blind Study|Death|0
7850056|NCT00122382|27241695|P2|Double-Blind Study|Death|2
7850057|NCT00122382|27241696|P1|Double-Blind Study|Death|2
7850058|NCT00122382|27241694|P3|Double-Blind Study|Adverse Event|0
7850059|NCT00122382|27241695|P2|Double-Blind Study|Adverse Event|11
7850060|NCT00122382|27241696|P1|Double-Blind Study|Adverse Event|9
7850061|NCT00122317|27241840|P1|Overall Study|Withdrawal by Subject|1
7850062|NCT00122317|27241840|P1|Overall Study|patient non-compliance|1
7850063|NCT00122317|27241840|P1|Overall Study|Physician Decision|2
7850064|NCT00122317|27241840|P1|Overall Study|Adverse Event|4
7850065|NCT00122317|27241840|P1|Overall Study|Death|3
7850066|NCT00122278|27241849|P2|Overall Study|Lost to Follow-up|0
7850067|NCT00122278|27241850|P1|Overall Study|Lost to Follow-up|2
7850068|NCT00122187|27241860|P2|Overall Study|Withdrew because of resource limitations|2
7850069|NCT00122187|27241861|P1|Overall Study|Withdrew because of resource limitations|2
7850070|NCT00122135|27241875|P2|Overall Study|Withdrawal by Subject|0
7850071|NCT00122135|27241876|P1|Overall Study|Withdrawal by Subject|3
7850072|NCT00122109|27241884|P2|Overall Study|Did not meet criteria|7
7850073|NCT00122109|27241885|P1|Overall Study|Did not meet criteria|6
7850074|NCT00121992|27241911|P2|Overall Study|Treatment not received|11
7850075|NCT00121992|27241912|P1|Overall Study|Treatment not received|2
7850076|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Death|2
7850077|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Death|0
7850078|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Death|0
7850079|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Death|1
7850080|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7850081|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
7850082|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7850083|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7850084|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
7850085|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
7850086|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
7850087|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
7850088|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
7850089|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
7850090|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
7850091|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
7850092|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
7850093|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
7850094|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
7850095|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
7850096|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
7850097|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
7850098|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
7850099|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
7850100|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
7850101|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
7850102|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
7850103|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
7850104|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
7850105|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
7850106|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
7850107|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
7850108|NCT00121667|27242174|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
7850109|NCT00121667|27242175|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
7850110|NCT00121667|27242176|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
7850111|NCT00121667|27242177|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
7850112|NCT00121667|27242174|P4|Short Term (ST) Period|Pregnancy|1
7850113|NCT00121667|27242175|P3|Short Term (ST) Period|Pregnancy|0
7850114|NCT00121667|27242176|P2|Short Term (ST) Period|Pregnancy|0
7850115|NCT00121667|27242177|P1|Short Term (ST) Period|Pregnancy|0
7850116|NCT00121667|27242174|P4|Short Term (ST) Period|Death|1
7850117|NCT00121667|27242175|P3|Short Term (ST) Period|Death|0
7850118|NCT00121667|27242176|P2|Short Term (ST) Period|Death|0
7850119|NCT00121667|27242177|P1|Short Term (ST) Period|Death|0
7850120|NCT00121667|27242174|P4|Short Term (ST) Period|Other Reason|0
7850121|NCT00121667|27242175|P3|Short Term (ST) Period|Other Reason|0
7850122|NCT00121667|27242176|P2|Short Term (ST) Period|Other Reason|0
7850123|NCT00121667|27242177|P1|Short Term (ST) Period|Other Reason|3
7850124|NCT00121667|27242174|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
7850125|NCT00121667|27242175|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
7850126|NCT00121667|27242176|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
7850127|NCT00121667|27242177|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
7850128|NCT00121667|27242174|P4|Short Term (ST) Period|Poor / Non-compliance|2
7850129|NCT00121667|27242175|P3|Short Term (ST) Period|Poor / Non-compliance|1
7850130|NCT00121667|27242176|P2|Short Term (ST) Period|Poor / Non-compliance|1
7850131|NCT00121667|27242177|P1|Short Term (ST) Period|Poor / Non-compliance|0
7850132|NCT00121667|27242174|P4|Short Term (ST) Period|Lost to Follow-up|3
7850133|NCT00121667|27242175|P3|Short Term (ST) Period|Lost to Follow-up|4
7850134|NCT00121667|27242176|P2|Short Term (ST) Period|Lost to Follow-up|4
7850135|NCT00121667|27242177|P1|Short Term (ST) Period|Lost to Follow-up|3
7850136|NCT00121667|27242174|P4|Short Term (ST) Period|Adverse Event|3
7850137|NCT00121667|27242175|P3|Short Term (ST) Period|Adverse Event|5
7850138|NCT00121667|27242176|P2|Short Term (ST) Period|Adverse Event|6
7850139|NCT00121667|27242177|P1|Short Term (ST) Period|Adverse Event|5
7850140|NCT00121667|27242174|P4|Short Term (ST) Period|Subject Withdrew Consent|11
7850141|NCT00121667|27242175|P3|Short Term (ST) Period|Subject Withdrew Consent|4
7850142|NCT00121667|27242176|P2|Short Term (ST) Period|Subject Withdrew Consent|13
7850143|NCT00121667|27242177|P1|Short Term (ST) Period|Subject Withdrew Consent|8
7850144|NCT00121667|27242174|P4|Short Term (ST) Period|Lack of Efficacy|44
7850145|NCT00121667|27242175|P3|Short Term (ST) Period|Lack of Efficacy|27
7850146|NCT00121667|27242176|P2|Short Term (ST) Period|Lack of Efficacy|22
7850147|NCT00121667|27242177|P1|Short Term (ST) Period|Lack of Efficacy|25
7850148|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Other Reason|1
7850149|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Other Reason|0
7850150|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Other Reason|2
7850151|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Other Reason|3
7850152|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Other Reason|5
7850153|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Missing|0
7850154|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Missing|0
7850155|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Missing|1
7850156|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Missing|0
7850157|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Missing|0
7850158|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Death|0
7850159|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Death|1
7850160|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Death|0
7850161|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Death|0
7850162|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Death|0
7850163|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
7850164|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
7850165|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
7850166|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
7850167|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
7850168|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Pregnancy|0
7850169|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Pregnancy|1
7850170|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Pregnancy|0
7850171|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Pregnancy|1
7850172|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Pregnancy|0
7850173|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
7850174|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
7850175|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
7850176|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
7850177|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
7850178|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
7850179|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
7850180|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
7850181|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
7850182|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
7850183|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
7850184|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
7850185|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
7850186|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
7850187|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
7850188|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Adverse Event|5
7850189|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Adverse Event|5
7850190|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Adverse Event|10
7850191|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Adverse Event|10
7850192|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Adverse Event|9
7850193|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
7850194|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
7850195|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
7850196|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
7850197|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
7850198|NCT00121641|27242275|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
7850199|NCT00121641|27242276|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
7850200|NCT00121641|27242277|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
7850201|NCT00121641|27242278|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
7850202|NCT00121641|27242279|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
7850203|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Other Reason|0
7850204|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Other Reason|0
7850205|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Other Reason|0
7850206|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Other Reason|0
7850207|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Other Reason|1
7850208|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7850209|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
7850210|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
7850211|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7850212|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7850213|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
7850214|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
7850215|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
7850216|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
7850217|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
7850218|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
7850219|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
7850220|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
7850221|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
7850222|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
7850223|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Adverse Event|2
7850224|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Adverse Event|0
7850225|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Adverse Event|4
7850226|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Adverse Event|3
7850227|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Adverse Event|3
7850228|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
7850229|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
7850230|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
7850231|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
7850232|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
7850233|NCT00121641|27242275|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
7850234|NCT00121641|27242276|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
7850235|NCT00121641|27242277|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
7850236|NCT00121641|27242278|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
7850237|NCT00121641|27242279|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
7850238|NCT00121485|27242392|P2|Overall Study|Crossover|2
7850239|NCT00121485|27242393|P1|Overall Study|Crossover|0
7850240|NCT00121485|27242392|P2|Overall Study|Not implanted|5
7850241|NCT00121485|27242393|P1|Overall Study|Not implanted|1
7850242|NCT00121238|27242444|P1|Overall Study|Protocol Violation|2
7850243|NCT00121238|27242444|P1|Overall Study|disease progression before intervention|1
7850244|NCT00121199|27242460|P1|Overall Study|Ineligible|9
7850245|NCT00121199|27242460|P1|Overall Study|Other - Not Protocol Specified|3
7850246|NCT00121199|27242460|P1|Overall Study|Death|3
7850247|NCT00121199|27242460|P1|Overall Study|Progression/Relapse|1
7850248|NCT00121199|27242460|P1|Overall Study|Refusal Unrelated to Adverse Event|1
7850249|NCT00121199|27242460|P1|Overall Study|Adverse Event|11
7850250|NCT00121134|27242504|P4|Overall Study|Patient Personal Reasons|0
7850251|NCT00121134|27242505|P3|Overall Study|Patient Personal Reasons|0
7850252|NCT00121134|27242506|P2|Overall Study|Patient Personal Reasons|1
7850253|NCT00121134|27242507|P1|Overall Study|Patient Personal Reasons|0
7850254|NCT00121134|27242504|P4|Overall Study|Intercurrent Illness|1
7850255|NCT00121134|27242505|P3|Overall Study|Intercurrent Illness|0
7850256|NCT00121134|27242506|P2|Overall Study|Intercurrent Illness|0
7850257|NCT00121134|27242507|P1|Overall Study|Intercurrent Illness|0
7850258|NCT00121134|27242504|P4|Overall Study|Treatment Delay|0
7850259|NCT00121134|27242505|P3|Overall Study|Treatment Delay|0
7850260|NCT00121134|27242506|P2|Overall Study|Treatment Delay|0
7850261|NCT00121134|27242507|P1|Overall Study|Treatment Delay|1
7850262|NCT00121134|27242504|P4|Overall Study|Physician Decision|1
7850263|NCT00121134|27242505|P3|Overall Study|Physician Decision|4
7850264|NCT00121134|27242506|P2|Overall Study|Physician Decision|4
7850265|NCT00121134|27242507|P1|Overall Study|Physician Decision|6
7850266|NCT00121134|27242504|P4|Overall Study|Toxicity|5
7850267|NCT00121134|27242505|P3|Overall Study|Toxicity|13
7850268|NCT00121134|27242506|P2|Overall Study|Toxicity|7
7850269|NCT00121134|27242507|P1|Overall Study|Toxicity|4
7850270|NCT00121134|27242504|P4|Overall Study|Progression of Disease|2
7850271|NCT00121134|27242505|P3|Overall Study|Progression of Disease|4
7850272|NCT00121134|27242506|P2|Overall Study|Progression of Disease|3
7850273|NCT00121134|27242507|P1|Overall Study|Progression of Disease|5
7850274|NCT00120874|27242519|P2|Overall Study|Death|1
7850275|NCT00120874|27242520|P1|Overall Study|Death|0
7850276|NCT00120627|27242558|P2|Overall Study|Withdrawal by Subject|5
7850277|NCT00120627|27242559|P1|Overall Study|Withdrawal by Subject|5
7850278|NCT00120406|27242610|P2|Overall Study|patient moved but has not withdrawn|1
7850279|NCT00120406|27242611|P1|Overall Study|patient moved but has not withdrawn|0
7850280|NCT00120406|27242610|P2|Overall Study|received non-study stent|2
7850281|NCT00120406|27242611|P1|Overall Study|received non-study stent|0
7850282|NCT00120406|27242610|P2|Overall Study|Lost to Follow-up|2
7850283|NCT00120406|27242611|P1|Overall Study|Lost to Follow-up|5
7850284|NCT00120406|27242610|P2|Overall Study|Withdrawal by Subject|7
7850285|NCT00120406|27242611|P1|Overall Study|Withdrawal by Subject|5
7850286|NCT00120406|27242610|P2|Overall Study|Death|4
7850287|NCT00120406|27242611|P1|Overall Study|Death|9
7850288|NCT00120289|27242621|P2|Overall Study|Withdrawal by Subject|13
7850289|NCT00120289|27242622|P1|Overall Study|Withdrawal by Subject|14
7850290|NCT00120289|27242621|P2|Overall Study|Lost to Follow-up|14
7850291|NCT00120289|27242622|P1|Overall Study|Lost to Follow-up|11
7850292|NCT00120289|27242621|P2|Overall Study|Death|82
7850293|NCT00120289|27242622|P1|Overall Study|Death|96
7850294|NCT00120250|27242634|P2|Overall Study|Protocol Violation|1
7850295|NCT00120250|27242635|P1|Overall Study|Protocol Violation|0
7850296|NCT00120250|27242634|P2|Overall Study|Lost to Follow-up|1
7850297|NCT00120250|27242635|P1|Overall Study|Lost to Follow-up|1
7850298|NCT00120042|27242651|P3|Overall Study|all completed protocl|0
7850299|NCT00120042|27242652|P2|Overall Study|all completed protocl|0
7850300|NCT00120042|27242653|P1|Overall Study|all completed protocl|0
7850301|NCT00119678|27242676|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
7850302|NCT00119678|27242677|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
7850303|NCT00119678|27242676|P2|Open-label Treatment Period|Pregnancy|0
7850304|NCT00119678|27242677|P1|Open-label Treatment Period|Pregnancy|1
7850305|NCT00119678|27242676|P2|Open-label Treatment Period|Participants not meeting study criteria|0
7850306|NCT00119678|27242677|P1|Open-label Treatment Period|Participants not meeting study criteria|2
7850307|NCT00119678|27242676|P2|Open-label Treatment Period|Participant withdrew consent|0
7850308|NCT00119678|27242677|P1|Open-label Treatment Period|Participant withdrew consent|4
7850309|NCT00119678|27242676|P2|Open-label Treatment Period|Lost to Follow-up|0
7850310|NCT00119678|27242677|P1|Open-label Treatment Period|Lost to Follow-up|3
7850311|NCT00119678|27242676|P2|Open-label Treatment Period|Lack of Efficacy|0
7850312|NCT00119678|27242677|P1|Open-label Treatment Period|Lack of Efficacy|9
7850313|NCT00119678|27242676|P2|Open-label Treatment Period|Adverse Event|0
7850314|NCT00119678|27242677|P1|Open-label Treatment Period|Adverse Event|3
7850315|NCT00119678|27242676|P2|Open-label Treatment Period|Death|0
7850316|NCT00119678|27242677|P1|Open-label Treatment Period|Death|1
7850317|NCT00119678|27242676|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
7850318|NCT00119678|27242677|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
7850319|NCT00119678|27242676|P2|Double-blind Treatment Period|Not treated|2
7850320|NCT00119678|27242677|P1|Double-blind Treatment Period|Not treated|1
7850321|NCT00119678|27242676|P2|Double-blind Treatment Period|Pregnancy|2
7850322|NCT00119678|27242677|P1|Double-blind Treatment Period|Pregnancy|0
7850323|NCT00119678|27242676|P2|Double-blind Treatment Period|Poor/Non-compliance|0
7850324|NCT00119678|27242677|P1|Double-blind Treatment Period|Poor/Non-compliance|3
7850325|NCT00119678|27242676|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
7850326|NCT00119678|27242677|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
7850327|NCT00119678|27242676|P2|Double-blind Treatment Period|Participant withdrew consent|4
7850328|NCT00119678|27242677|P1|Double-blind Treatment Period|Participant withdrew consent|4
7850329|NCT00119678|27242676|P2|Double-blind Treatment Period|Lost to Follow-up|2
7850330|NCT00119678|27242677|P1|Double-blind Treatment Period|Lost to Follow-up|1
7850331|NCT00119678|27242676|P2|Double-blind Treatment Period|Lack of Efficacy|12
7850332|NCT00119678|27242677|P1|Double-blind Treatment Period|Lack of Efficacy|21
7850333|NCT00119678|27242676|P2|Double-blind Treatment Period|Adverse Event|1
7850334|NCT00119678|27242677|P1|Double-blind Treatment Period|Adverse Event|7
7850335|NCT00119678|27242676|P2|Double-blind Treatment Period|Death|0
7850336|NCT00119678|27242677|P1|Double-blind Treatment Period|Death|1
7850337|NCT00119405|27242723|P1|Overall Study|Withdrawal by Subject|1
7850338|NCT00119379|27242737|P2|Overall Study|Adverse Event|1
7850339|NCT00119379|27242738|P1|Overall Study|Adverse Event|4
7850340|NCT00119262|27242756|P2|Overall Study|others|5
7850341|NCT00119262|27242757|P1|Overall Study|others|0
7850342|NCT00119262|27242756|P2|Overall Study|ineligble|2
7850343|NCT00119262|27242757|P1|Overall Study|ineligble|1
7850344|NCT00119262|27242756|P2|Overall Study|other disease|2
7850345|NCT00119262|27242757|P1|Overall Study|other disease|0
7850346|NCT00119262|27242756|P2|Overall Study|Adverse Event|35
7850347|NCT00119262|27242757|P1|Overall Study|Adverse Event|33
7850348|NCT00119262|27242756|P2|Overall Study|Withdrawal by Subject|11
7850349|NCT00119262|27242757|P1|Overall Study|Withdrawal by Subject|12
7850350|NCT00119262|27242756|P2|Overall Study|Lack of Efficacy|3
7850351|NCT00119262|27242757|P1|Overall Study|Lack of Efficacy|0
7850352|NCT00119106|27242780|P2|Overall Study|HIV infected at baseline|178
7850353|NCT00119106|27242781|P1|Overall Study|HIV infected at baseline|179
7850354|NCT00119015|27242817|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
7850355|NCT00119015|27242818|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
7850356|NCT00119015|27242819|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
7850357|NCT00118911|27242835|P2|Overall Study|Withdrawal by Subject|5
7850358|NCT00118911|27242836|P1|Overall Study|Withdrawal by Subject|2
7850359|NCT00118898|27242848|P4|Overall Study|Not able to get to clinic|40
7850360|NCT00118898|27242849|P3|Overall Study|Not able to get to clinic|31
7850361|NCT00118898|27242850|P2|Overall Study|Not able to get to clinic|43
7850362|NCT00118898|27242851|P1|Overall Study|Not able to get to clinic|34
7850363|NCT00118898|27242848|P4|Overall Study|Not compliant with requirements|11
7850364|NCT00118898|27242849|P3|Overall Study|Not compliant with requirements|11
7850365|NCT00118898|27242850|P2|Overall Study|Not compliant with requirements|13
7850366|NCT00118898|27242851|P1|Overall Study|Not compliant with requirements|11
7850367|NCT00118898|27242848|P4|Overall Study|Severe debilitation|4
7850368|NCT00118898|27242849|P3|Overall Study|Severe debilitation|6
7850369|NCT00118898|27242850|P2|Overall Study|Severe debilitation|4
7850370|NCT00118898|27242851|P1|Overall Study|Severe debilitation|1
7850371|NCT00118898|27242848|P4|Overall Study|Site Closure|37
7850372|NCT00118898|27242849|P3|Overall Study|Site Closure|28
7850373|NCT00118898|27242850|P2|Overall Study|Site Closure|31
7850374|NCT00118898|27242851|P1|Overall Study|Site Closure|33
7850375|NCT00118898|27242848|P4|Overall Study|Withdrawal by Subject|8
7850376|NCT00118898|27242849|P3|Overall Study|Withdrawal by Subject|8
7850377|NCT00118898|27242850|P2|Overall Study|Withdrawal by Subject|5
7850378|NCT00118898|27242851|P1|Overall Study|Withdrawal by Subject|10
7850379|NCT00118898|27242848|P4|Overall Study|Lost to Follow-up|33
7850380|NCT00118898|27242849|P3|Overall Study|Lost to Follow-up|33
7850381|NCT00118898|27242850|P2|Overall Study|Lost to Follow-up|34
7850382|NCT00118898|27242851|P1|Overall Study|Lost to Follow-up|26
7850383|NCT00118898|27242848|P4|Overall Study|Death|8
7850384|NCT00118898|27242849|P3|Overall Study|Death|6
7850385|NCT00118898|27242850|P2|Overall Study|Death|11
7850386|NCT00118898|27242851|P1|Overall Study|Death|6
7850387|NCT00118716|27242977|P2|Overall Study|Investigator discretion|1
7850388|NCT00118716|27242978|P1|Overall Study|Investigator discretion|0
7850389|NCT00118716|27242977|P2|Overall Study|Expired drug use|2
7850390|NCT00118716|27242978|P1|Overall Study|Expired drug use|1
7850391|NCT00118716|27242977|P2|Overall Study|misrandomized|1
7850392|NCT00118716|27242978|P1|Overall Study|misrandomized|1
7850393|NCT00118716|27242977|P2|Overall Study|Non-compliance|3
7850394|NCT00118716|27242978|P1|Overall Study|Non-compliance|1
7850395|NCT00118716|27242977|P2|Overall Study|Discontinued by sponsor|1
7850396|NCT00118716|27242978|P1|Overall Study|Discontinued by sponsor|1
7850397|NCT00118716|27242977|P2|Overall Study|Exacerbation|2
7850398|NCT00118716|27242978|P1|Overall Study|Exacerbation|2
7850399|NCT00118716|27242977|P2|Overall Study|Withdrawal by Subject|1
7850400|NCT00118716|27242978|P1|Overall Study|Withdrawal by Subject|0
7850401|NCT00118716|27242977|P2|Overall Study|Protocol Violation|4
7850402|NCT00118716|27242978|P1|Overall Study|Protocol Violation|5
7850403|NCT00118716|27242977|P2|Overall Study|Adverse Event|7
7850404|NCT00118716|27242978|P1|Overall Study|Adverse Event|2
7850405|NCT00118703|27242998|P2|Overall Study|Lost to Follow-up|2
7850406|NCT00118703|27242999|P1|Overall Study|Lost to Follow-up|1
7850407|NCT00118703|27242998|P2|Overall Study|Withdrawal by Subject|5
7850408|NCT00118703|27242999|P1|Overall Study|Withdrawal by Subject|2
7850409|NCT00118703|27242998|P2|Overall Study|Participant took two different treatment|1
7850410|NCT00118703|27242999|P1|Overall Study|Participant took two different treatment|0
7850411|NCT00118703|27242998|P2|Overall Study|Adverse Event|1
7850412|NCT00118703|27242999|P1|Overall Study|Adverse Event|1
7850413|NCT00118703|27242998|P2|Overall Study|Protocol Violation|0
7850414|NCT00118703|27242999|P1|Overall Study|Protocol Violation|1
7850415|NCT00118482|27243096|P2|Overall Study|Withdrawal by Subject|22
7850416|NCT00118482|27243097|P1|Overall Study|Withdrawal by Subject|23
7850417|NCT00118482|27243096|P2|Overall Study|Lost to Follow-up|7
7850418|NCT00118482|27243097|P1|Overall Study|Lost to Follow-up|7
7850419|NCT00118430|27243112|P3|Overall Study|Lost to Follow-up|28
7850420|NCT00118430|27243113|P2|Overall Study|Lost to Follow-up|22
7850421|NCT00118430|27243114|P1|Overall Study|Lost to Follow-up|15
7850422|NCT00118430|27243112|P3|Overall Study|Withdrawal by Subject|0
7850423|NCT00118430|27243113|P2|Overall Study|Withdrawal by Subject|2
7850424|NCT00118430|27243114|P1|Overall Study|Withdrawal by Subject|6
7850425|NCT00118417|27243129|P2|Phase II (Weeks 6 to 12)|Remission|2
7850426|NCT00118417|27243130|P1|Phase II (Weeks 6 to 12)|Remission|1
7850427|NCT00118417|27243129|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
7850428|NCT00118417|27243130|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
7850429|NCT00118417|27243129|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
7850430|NCT00118417|27243130|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
7850431|NCT00118417|27243129|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
7850432|NCT00118417|27243130|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
7850433|NCT00118417|27243129|P2|Phase I (Weeks 0 to 6)|Remission|0
7850434|NCT00118417|27243130|P1|Phase I (Weeks 0 to 6)|Remission|8
7850435|NCT00118287|27243274|P1|Overall Study|Muscle pain|1
7850436|NCT00118287|27243274|P1|Overall Study|Intracranial haemorrhage|1
7850437|NCT00118157|27243328|P1|Overall Study|Withdrawal by Subject|2
7850438|NCT00118157|27243328|P1|Overall Study|Death|8
7850439|NCT00118157|27243328|P1|Overall Study|Adverse Event|2
7850440|NCT00118092|27243346|P1|Overall Study|Protocol Violation|1
7850441|NCT00118092|27243346|P1|Overall Study|Withdrawal by Subject|1
7850442|NCT00118040|27243364|P3|Overall Study|Other|1
7850443|NCT00118040|27243365|P2|Overall Study|Other|0
7850444|NCT00118040|27243366|P1|Overall Study|Other|0
7850445|NCT00118040|27243364|P3|Overall Study|Non-Compliant Participant|2
7850446|NCT00118040|27243365|P2|Overall Study|Non-Compliant Participant|1
7850447|NCT00118040|27243366|P1|Overall Study|Non-Compliant Participant|1
7850448|NCT00118040|27243364|P3|Overall Study|Medical Contraindication|1
7850449|NCT00118040|27243365|P2|Overall Study|Medical Contraindication|0
7850450|NCT00118040|27243366|P1|Overall Study|Medical Contraindication|0
7850451|NCT00118040|27243364|P3|Overall Study|Withdrawal by Subject|2
7850452|NCT00118040|27243365|P2|Overall Study|Withdrawal by Subject|0
7850453|NCT00118040|27243366|P1|Overall Study|Withdrawal by Subject|0
7850454|NCT00118040|27243364|P3|Overall Study|Adverse Event|0
7850455|NCT00118040|27243365|P2|Overall Study|Adverse Event|1
7850456|NCT00118040|27243366|P1|Overall Study|Adverse Event|0
7850457|NCT00117988|27243427|P1|Overall Study|Adverse Event|1
7850458|NCT00117988|27243427|P1|Overall Study|Death|3
7850459|NCT00117949|27243450|P4|Overall Study|Hepatic abnormalities|1
7850460|NCT00117949|27243451|P3|Overall Study|Hepatic abnormalities|0
7850461|NCT00117949|27243452|P2|Overall Study|Hepatic abnormalities|1
7850462|NCT00117949|27243453|P1|Overall Study|Hepatic abnormalities|0
7850463|NCT00117949|27243450|P4|Overall Study|PSA reduction <=50%|4
7850464|NCT00117949|27243451|P3|Overall Study|PSA reduction <=50%|2
7850465|NCT00117949|27243452|P2|Overall Study|PSA reduction <=50%|2
7850466|NCT00117949|27243453|P1|Overall Study|PSA reduction <=50%|0
7850467|NCT00117949|27243450|P4|Overall Study|PSA increase >=10ng/mL|0
7850468|NCT00117949|27243451|P3|Overall Study|PSA increase >=10ng/mL|1
7850469|NCT00117949|27243452|P2|Overall Study|PSA increase >=10ng/mL|1
7850470|NCT00117949|27243453|P1|Overall Study|PSA increase >=10ng/mL|0
7850471|NCT00117949|27243450|P4|Overall Study|Prostate-specific antigen increase >=25%|2
7850472|NCT00117949|27243451|P3|Overall Study|Prostate-specific antigen increase >=25%|1
7850473|NCT00117949|27243452|P2|Overall Study|Prostate-specific antigen increase >=25%|1
7850474|NCT00117949|27243453|P1|Overall Study|Prostate-specific antigen increase >=25%|0
7850475|NCT00117949|27243450|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
7850476|NCT00117949|27243451|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
7850477|NCT00117949|27243452|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
7850478|NCT00117949|27243453|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
7850479|NCT00117949|27243450|P4|Overall Study|Testosterone >1.0 ng/mL|15
7850480|NCT00117949|27243451|P3|Overall Study|Testosterone >1.0 ng/mL|17
7850481|NCT00117949|27243452|P2|Overall Study|Testosterone >1.0 ng/mL|18
7850482|NCT00117949|27243453|P1|Overall Study|Testosterone >1.0 ng/mL|10
7850483|NCT00117845|27243487|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
7850484|NCT00117793|27243505|P1|Overall Study|Withdrawal by Subject|12
7850485|NCT00117676|27243528|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
7850486|NCT00117676|27243529|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
7850487|NCT00117676|27243528|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
7850488|NCT00117676|27243529|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
7850489|NCT00117676|27243528|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
7850490|NCT00117676|27243529|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
7850491|NCT00117676|27243528|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
7850492|NCT00117676|27243529|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
7850493|NCT00117676|27243528|P2|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
7850494|NCT00117676|27243529|P1|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
7850495|NCT00117676|27243528|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
7850496|NCT00117676|27243529|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
7850497|NCT00117676|27243528|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
7850498|NCT00117676|27243529|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
7850499|NCT00117676|27243528|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
7850500|NCT00117676|27243529|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
7850501|NCT00117676|27243528|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
7850502|NCT00117676|27243529|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
7850503|NCT00117676|27243528|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
7850504|NCT00117676|27243529|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
7850505|NCT00117676|27243528|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
7850506|NCT00117676|27243529|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
7850507|NCT00117676|27243528|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
7850508|NCT00117676|27243529|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
7850509|NCT00117676|27243528|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
7850510|NCT00117676|27243529|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
7850511|NCT00117676|27243528|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
7850512|NCT00117676|27243529|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
7850513|NCT00117676|27243528|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
7850514|NCT00117676|27243529|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
7850515|NCT00117676|27243528|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
7850516|NCT00117676|27243529|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
7850517|NCT00117676|27243528|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
7850518|NCT00117676|27243529|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
7850519|NCT00117676|27243528|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
7850520|NCT00117676|27243529|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
7850521|NCT00117676|27243528|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
7850522|NCT00117676|27243529|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7850523|NCT00117676|27243528|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
7850524|NCT00117676|27243529|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
7850525|NCT00117676|27243528|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
7850526|NCT00117676|27243529|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
7850527|NCT00117676|27243528|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
7850528|NCT00117676|27243529|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
7850529|NCT00117676|27243528|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
7850530|NCT00117676|27243529|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
7850531|NCT00117676|27243528|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
7850532|NCT00117676|27243529|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
7850533|NCT00117676|27243528|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
7850534|NCT00117676|27243529|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
7850535|NCT00117676|27243528|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
7850536|NCT00117676|27243529|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
7850537|NCT00117676|27243528|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
7850538|NCT00117676|27243529|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
7850539|NCT00117676|27243528|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
7850540|NCT00117676|27243529|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
7850541|NCT00117676|27243528|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
7850542|NCT00117676|27243529|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
7850543|NCT00117676|27243528|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
7850544|NCT00117676|27243529|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
7850545|NCT00117676|27243528|P2|Double-blind Period Through Week 48|Withdrew Consent|1
7850546|NCT00117676|27243529|P1|Double-blind Period Through Week 48|Withdrew Consent|0
7850547|NCT00117676|27243528|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
7850548|NCT00117676|27243529|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
7850549|NCT00117676|27243528|P2|Double-blind Period Through Week 48|Protocol Violation|1
7850550|NCT00117676|27243529|P1|Double-blind Period Through Week 48|Protocol Violation|0
7850551|NCT00117676|27243528|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
7850552|NCT00117676|27243529|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
7850553|NCT00117676|27243528|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
7850554|NCT00117676|27243529|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
7850555|NCT00117637|27243618|P2|Second Intervention (Period 2)|reason not reported|0
7850556|NCT00117637|27243619|P1|Second Intervention (Period 2)|reason not reported|1
7850557|NCT00117637|27243618|P2|Second Intervention (Period 2)|non compliant with study medication|1
7850558|NCT00117637|27243619|P1|Second Intervention (Period 2)|non compliant with study medication|1
7850559|NCT00117637|27243618|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
7850560|NCT00117637|27243619|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
7850561|NCT00117637|27243618|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
7850562|NCT00117637|27243619|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
7850563|NCT00117637|27243618|P2|Second Intervention (Period 2)|Protocol Violation|0
7850564|NCT00117637|27243619|P1|Second Intervention (Period 2)|Protocol Violation|1
7850565|NCT00117637|27243618|P2|Second Intervention (Period 2)|Lost to Follow-up|0
7850566|NCT00117637|27243619|P1|Second Intervention (Period 2)|Lost to Follow-up|1
7850567|NCT00117637|27243618|P2|Second Intervention (Period 2)|Adverse Event|9
7850568|NCT00117637|27243619|P1|Second Intervention (Period 2)|Adverse Event|0
7850569|NCT00117637|27243618|P2|First Intervention (Period 1)|reason not reported|1
7850570|NCT00117637|27243619|P1|First Intervention (Period 1)|reason not reported|0
7850571|NCT00117637|27243618|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
7850572|NCT00117637|27243619|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
7850573|NCT00117637|27243618|P2|First Intervention (Period 1)|protocol driven decision point|0
7850574|NCT00117637|27243619|P1|First Intervention (Period 1)|protocol driven decision point|1
7850575|NCT00117637|27243618|P2|First Intervention (Period 1)|study terminated by the sponsor|1
7850576|NCT00117637|27243619|P1|First Intervention (Period 1)|study terminated by the sponsor|3
7850577|NCT00117637|27243618|P2|First Intervention (Period 1)|Withdrawal by Subject|4
7850578|NCT00117637|27243619|P1|First Intervention (Period 1)|Withdrawal by Subject|2
7850579|NCT00117637|27243618|P2|First Intervention (Period 1)|Protocol Violation|0
7850580|NCT00117637|27243619|P1|First Intervention (Period 1)|Protocol Violation|1
7850581|NCT00117637|27243618|P2|First Intervention (Period 1)|Lost to Follow-up|2
7850582|NCT00117637|27243619|P1|First Intervention (Period 1)|Lost to Follow-up|0
7850583|NCT00117637|27243618|P2|First Intervention (Period 1)|Adverse Event|16
7850584|NCT00117637|27243619|P1|First Intervention (Period 1)|Adverse Event|11
7850585|NCT00117598|27243694|P5|After Treament Cross Over|Other|2
7850586|NCT00117598|27243695|P4|After Treament Cross Over|Other|1
7850587|NCT00117598|27243696|P3|After Treament Cross Over|Other|0
7850588|NCT00117598|27243697|P2|After Treament Cross Over|Other|0
7850589|NCT00117598|27243698|P1|After Treament Cross Over|Other|0
7850590|NCT00117598|27243694|P5|After Treament Cross Over|Withdrawal by Subject|0
7850591|NCT00117598|27243695|P4|After Treament Cross Over|Withdrawal by Subject|1
7850592|NCT00117598|27243696|P3|After Treament Cross Over|Withdrawal by Subject|0
7850593|NCT00117598|27243697|P2|After Treament Cross Over|Withdrawal by Subject|0
7850594|NCT00117598|27243698|P1|After Treament Cross Over|Withdrawal by Subject|0
7850595|NCT00117598|27243694|P5|After Treament Cross Over|Death|2
7850596|NCT00117598|27243695|P4|After Treament Cross Over|Death|1
7850597|NCT00117598|27243696|P3|After Treament Cross Over|Death|0
7850598|NCT00117598|27243697|P2|After Treament Cross Over|Death|0
7850599|NCT00117598|27243698|P1|After Treament Cross Over|Death|0
7850600|NCT00117598|27243694|P5|Prior to Treatment Cross Over|Other|0
7850601|NCT00117598|27243695|P4|Prior to Treatment Cross Over|Other|0
7850602|NCT00117598|27243696|P3|Prior to Treatment Cross Over|Other|9
7850603|NCT00117598|27243697|P2|Prior to Treatment Cross Over|Other|9
7850604|NCT00117598|27243698|P1|Prior to Treatment Cross Over|Other|15
7850605|NCT00117598|27243694|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
7850606|NCT00117598|27243695|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
7850607|NCT00117598|27243696|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
7850608|NCT00117598|27243697|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
7850609|NCT00117598|27243698|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
7850610|NCT00117598|27243694|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
7850611|NCT00117598|27243695|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
7850612|NCT00117598|27243696|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
7850613|NCT00117598|27243697|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
7850614|NCT00117598|27243698|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
7850615|NCT00117598|27243694|P5|Prior to Treatment Cross Over|Death|0
7850616|NCT00117598|27243695|P4|Prior to Treatment Cross Over|Death|0
7850617|NCT00117598|27243696|P3|Prior to Treatment Cross Over|Death|37
7850618|NCT00117598|27243697|P2|Prior to Treatment Cross Over|Death|41
7850619|NCT00117598|27243698|P1|Prior to Treatment Cross Over|Death|40
7850620|NCT00117572|27243732|P2|Overall Study|Protocol Violation|0
7850621|NCT00117572|27243733|P1|Overall Study|Protocol Violation|1
7850622|NCT00117572|27243732|P2|Overall Study|Withdrawal by Subject|3
7850623|NCT00117572|27243733|P1|Overall Study|Withdrawal by Subject|3
7850624|NCT00117572|27243732|P2|Overall Study|Site withdrew before starting treatment|3
7850625|NCT00117572|27243733|P1|Overall Study|Site withdrew before starting treatment|2
7850626|NCT00117507|27243772|P1|Overall Study|Death|3
7850627|NCT00117507|27243772|P1|Overall Study|Patient withdrew consent|4
7850628|NCT00117507|27243772|P1|Overall Study|Unsatisfactory therapeutic effect|1
7850629|NCT00117507|27243772|P1|Overall Study|Abnormal laboratory values|3
7850630|NCT00117507|27243772|P1|Overall Study|Adverse Event|4
7850631|NCT00117338|27243785|P2|Overall Study|Lack of Efficacy|1
7850632|NCT00117338|27243786|P1|Overall Study|Lack of Efficacy|0
7850633|NCT00117338|27243785|P2|Overall Study|Did not meet Inclusion Criteria|0
7850634|NCT00117338|27243786|P1|Overall Study|Did not meet Inclusion Criteria|1
7850635|NCT00117338|27243785|P2|Overall Study|Withdrawal by Subject|0
7850636|NCT00117338|27243786|P1|Overall Study|Withdrawal by Subject|1
7850637|NCT00117338|27243785|P2|Overall Study|Protocol Violation|2
7850638|NCT00117338|27243786|P1|Overall Study|Protocol Violation|3
7850639|NCT00117338|27243785|P2|Overall Study|Adverse Event|1
7850640|NCT00117338|27243786|P1|Overall Study|Adverse Event|0
7850641|NCT00117325|27243806|P2|Overall Study|Admisnitrative|0
7850642|NCT00117325|27243807|P1|Overall Study|Admisnitrative|1
7850643|NCT00117325|27243806|P2|Overall Study|Early termination|1
7850644|NCT00117325|27243807|P1|Overall Study|Early termination|1
7850645|NCT00117325|27243806|P2|Overall Study|Use of prohibited medicine|2
7850646|NCT00117325|27243807|P1|Overall Study|Use of prohibited medicine|1
7850647|NCT00117325|27243806|P2|Overall Study|Lack of Efficacy|0
7850648|NCT00117325|27243807|P1|Overall Study|Lack of Efficacy|1
7850649|NCT00117325|27243806|P2|Overall Study|Withdrawal by Subject|2
7850650|NCT00117325|27243807|P1|Overall Study|Withdrawal by Subject|3
7850651|NCT00117325|27243806|P2|Overall Study|Protocol Violation|3
7850652|NCT00117325|27243807|P1|Overall Study|Protocol Violation|2
7850653|NCT00117325|27243806|P2|Overall Study|Lost to Follow-up|1
7850654|NCT00117325|27243807|P1|Overall Study|Lost to Follow-up|1
7850655|NCT00117325|27243806|P2|Overall Study|Adverse Event|3
7850656|NCT00117325|27243807|P1|Overall Study|Adverse Event|3
7850657|NCT00117312|27243839|P4|Overall Study|Withdrawal by Subject|0
7850658|NCT00117312|27243840|P3|Overall Study|Withdrawal by Subject|0
7850659|NCT00117312|27243841|P2|Overall Study|Withdrawal by Subject|2
7850660|NCT00117312|27243842|P1|Overall Study|Withdrawal by Subject|0
7850661|NCT00117312|27243839|P4|Overall Study|Hepatic abnormality|1
7850662|NCT00117312|27243840|P3|Overall Study|Hepatic abnormality|0
7850663|NCT00117312|27243841|P2|Overall Study|Hepatic abnormality|1
7850664|NCT00117312|27243842|P1|Overall Study|Hepatic abnormality|0
7850665|NCT00117312|27243839|P4|Overall Study|PSA increase >= 10ng/mL|0
7850666|NCT00117312|27243840|P3|Overall Study|PSA increase >= 10ng/mL|1
7850667|NCT00117312|27243841|P2|Overall Study|PSA increase >= 10ng/mL|1
7850668|NCT00117312|27243842|P1|Overall Study|PSA increase >= 10ng/mL|0
7850669|NCT00117312|27243839|P4|Overall Study|PSA decrease <=50%|4
7850670|NCT00117312|27243840|P3|Overall Study|PSA decrease <=50%|2
7850671|NCT00117312|27243841|P2|Overall Study|PSA decrease <=50%|2
7850672|NCT00117312|27243842|P1|Overall Study|PSA decrease <=50%|0
7850673|NCT00117312|27243839|P4|Overall Study|Protocol Violation|0
7850674|NCT00117312|27243840|P3|Overall Study|Protocol Violation|3
7850675|NCT00117312|27243841|P2|Overall Study|Protocol Violation|1
7850676|NCT00117312|27243842|P1|Overall Study|Protocol Violation|0
7850677|NCT00117312|27243839|P4|Overall Study|Adverse Event|0
7850678|NCT00117312|27243840|P3|Overall Study|Adverse Event|0
7850679|NCT00117312|27243841|P2|Overall Study|Adverse Event|2
7850680|NCT00117312|27243842|P1|Overall Study|Adverse Event|0
7850681|NCT00117312|27243839|P4|Overall Study|Patient choice|1
7850682|NCT00117312|27243840|P3|Overall Study|Patient choice|2
7850683|NCT00117312|27243841|P2|Overall Study|Patient choice|0
7850684|NCT00117312|27243842|P1|Overall Study|Patient choice|0
7850685|NCT00117312|27243839|P4|Overall Study|Other|1
7850686|NCT00117312|27243840|P3|Overall Study|Other|3
7850687|NCT00117312|27243841|P2|Overall Study|Other|1
7850688|NCT00117312|27243842|P1|Overall Study|Other|0
7850689|NCT00117312|27243839|P4|Overall Study|Prostate-specific antigen increase >=25%|3
7850690|NCT00117312|27243840|P3|Overall Study|Prostate-specific antigen increase >=25%|5
7850691|NCT00117312|27243841|P2|Overall Study|Prostate-specific antigen increase >=25%|1
7850692|NCT00117312|27243842|P1|Overall Study|Prostate-specific antigen increase >=25%|0
7850693|NCT00117312|27243839|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
7850694|NCT00117312|27243840|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
7850695|NCT00117312|27243841|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
7850696|NCT00117312|27243842|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
7850697|NCT00117312|27243839|P4|Overall Study|Testosterone >1.0 ng/mL|9
7850698|NCT00117312|27243840|P3|Overall Study|Testosterone >1.0 ng/mL|5
7850699|NCT00117312|27243841|P2|Overall Study|Testosterone >1.0 ng/mL|9
7850700|NCT00117312|27243842|P1|Overall Study|Testosterone >1.0 ng/mL|9
7850701|NCT00117286|27243858|P2|Overall Study|Research site closing|2
7850702|NCT00117286|27243859|P1|Overall Study|Research site closing|0
7850703|NCT00117286|27243858|P2|Overall Study|Lack of Efficacy|1
7850704|NCT00117286|27243859|P1|Overall Study|Lack of Efficacy|2
7850705|NCT00117286|27243858|P2|Overall Study|Physician Decision|7
7850706|NCT00117286|27243859|P1|Overall Study|Physician Decision|3
7850707|NCT00117286|27243858|P2|Overall Study|Withdrawal by Subject|2
7850708|NCT00117286|27243859|P1|Overall Study|Withdrawal by Subject|6
7850709|NCT00117286|27243858|P2|Overall Study|Protocol Violation|3
7850710|NCT00117286|27243859|P1|Overall Study|Protocol Violation|3
7850711|NCT00117286|27243858|P2|Overall Study|Lost to Follow-up|0
7850712|NCT00117286|27243859|P1|Overall Study|Lost to Follow-up|2
7850713|NCT00117286|27243858|P2|Overall Study|Adverse Event|6
7850714|NCT00117286|27243859|P1|Overall Study|Adverse Event|12
7850715|NCT00117156|27243867|P1|Overall Study|Trt for Pre-Exist Second Primary|1
7850716|NCT00117156|27243867|P1|Overall Study|Physician Decision|1
7850717|NCT00117156|27243867|P1|Overall Study|Adverse Event|9
7850869|NCT00116753|27244163|P1|Overall Study|Disease Progression|3
7850718|NCT00116844|27243935|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
7850719|NCT00116844|27243936|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
7850720|NCT00116844|27243935|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
7850721|NCT00116844|27243936|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
7850722|NCT00116844|27243935|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
7850723|NCT00116844|27243936|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
7850724|NCT00116844|27243935|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
7850725|NCT00116844|27243936|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
7850726|NCT00116844|27243935|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
7850727|NCT00116844|27243936|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
7850728|NCT00116844|27243935|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
7850729|NCT00116844|27243936|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
7850730|NCT00116844|27243935|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
7850731|NCT00116844|27243936|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
7850732|NCT00116844|27243935|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
7850733|NCT00116844|27243936|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
7850734|NCT00116844|27243935|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
7850735|NCT00116844|27243936|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
7850736|NCT00116831|27243954|P2|Overall Study|Missing data for participant|0
7850737|NCT00116831|27243955|P1|Overall Study|Missing data for participant|1
7850738|NCT00116831|27243954|P2|Overall Study|Insufficient therapeutic effect|1
7850739|NCT00116831|27243955|P1|Overall Study|Insufficient therapeutic effect|0
7850740|NCT00116831|27243954|P2|Overall Study|Withdrawal by Subject|32
7850741|NCT00116831|27243955|P1|Overall Study|Withdrawal by Subject|32
7850742|NCT00116831|27243954|P2|Overall Study|Withdrawn investigational product|0
7850743|NCT00116831|27243955|P1|Overall Study|Withdrawn investigational product|1
7850744|NCT00116831|27243954|P2|Overall Study|Low haemoglobin on screening|0
7850745|NCT00116831|27243955|P1|Overall Study|Low haemoglobin on screening|1
7850746|NCT00116831|27243954|P2|Overall Study|Hypoglycaemic events|0
7850747|NCT00116831|27243955|P1|Overall Study|Hypoglycaemic events|1
7850748|NCT00116831|27243954|P2|Overall Study|Protocol Violation|6
7850749|NCT00116831|27243955|P1|Overall Study|Protocol Violation|3
7850750|NCT00116831|27243954|P2|Overall Study|Lost to Follow-up|6
7850751|NCT00116831|27243955|P1|Overall Study|Lost to Follow-up|8
7850752|NCT00116831|27243954|P2|Overall Study|Baseline IVUS determined unevaluable|11
7850753|NCT00116831|27243955|P1|Overall Study|Baseline IVUS determined unevaluable|12
7850754|NCT00116831|27243954|P2|Overall Study|Adverse Event|16
7850755|NCT00116831|27243955|P1|Overall Study|Adverse Event|14
7850756|NCT00116805|27244033|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
7850757|NCT00116805|27244034|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
7850758|NCT00116805|27244033|P2|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
7850759|NCT00116805|27244034|P1|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
7850760|NCT00116805|27244033|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
7850761|NCT00116805|27244034|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
7850762|NCT00116805|27244033|P2|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
7850763|NCT00116805|27244034|P1|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
7850764|NCT00116805|27244033|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
7850765|NCT00116805|27244034|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
7850766|NCT00116805|27244033|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
7850767|NCT00116805|27244034|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
7850768|NCT00116805|27244033|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
7850769|NCT00116805|27244034|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
7850770|NCT00116805|27244033|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
7850771|NCT00116805|27244034|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
7850772|NCT00116805|27244033|P2|Open-label Period Weeks 337 - 384|Completed Study|0
7850773|NCT00116805|27244034|P1|Open-label Period Weeks 337 - 384|Completed Study|1
7850774|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
7850775|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
7850776|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
7850777|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
7850778|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
7850779|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
7850780|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
7850781|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
7850782|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
7850783|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
7850784|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
7850785|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
7850786|NCT00116805|27244033|P2|Open-label Period Weeks 289 - 336|Completed Study|1
7850787|NCT00116805|27244034|P1|Open-label Period Weeks 289 - 336|Completed Study|0
7850788|NCT00116805|27244033|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
7850789|NCT00116805|27244034|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
7850790|NCT00116805|27244033|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
7850791|NCT00116805|27244034|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
7850792|NCT00116805|27244033|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
7850793|NCT00116805|27244034|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
7850794|NCT00116805|27244033|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7850795|NCT00116805|27244034|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7850796|NCT00116805|27244033|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
7850797|NCT00116805|27244034|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
7850798|NCT00116805|27244033|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
7850799|NCT00116805|27244034|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
7850800|NCT00116805|27244033|P2|Open-label Period Weeks 193 - 240|Completed Study|1
7850801|NCT00116805|27244034|P1|Open-label Period Weeks 193 - 240|Completed Study|0
7850802|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
7850803|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
7850804|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
7850805|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
7850806|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
7850807|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
7850808|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
7850809|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
7850810|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
7850811|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
7850812|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
7850813|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
7850814|NCT00116805|27244033|P2|Open-label Period Weeks 145 - 192|Completed Study|1
7850815|NCT00116805|27244034|P1|Open-label Period Weeks 145 - 192|Completed Study|1
7850816|NCT00116805|27244033|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
7850817|NCT00116805|27244034|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
7850818|NCT00116805|27244033|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
7850819|NCT00116805|27244034|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
7850820|NCT00116805|27244033|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
7850821|NCT00116805|27244034|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
7850822|NCT00116805|27244033|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
7850823|NCT00116805|27244034|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
7850824|NCT00116805|27244033|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
7850825|NCT00116805|27244034|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
7850826|NCT00116805|27244033|P2|Open-label Period Weeks 97 - 144|Completed Study|0
7850827|NCT00116805|27244034|P1|Open-label Period Weeks 97 - 144|Completed Study|1
7850828|NCT00116805|27244033|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
7850829|NCT00116805|27244034|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
7850830|NCT00116805|27244033|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
7850831|NCT00116805|27244034|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
7850832|NCT00116805|27244033|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
7850833|NCT00116805|27244034|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
7850834|NCT00116805|27244033|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
7850835|NCT00116805|27244034|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
7850836|NCT00116805|27244033|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
7850837|NCT00116805|27244034|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
7850838|NCT00116805|27244033|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
7850839|NCT00116805|27244034|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
7850840|NCT00116805|27244033|P2|Double-blind Period Through Week 48|Withdrew Consent|2
7850841|NCT00116805|27244034|P1|Double-blind Period Through Week 48|Withdrew Consent|4
7850842|NCT00116805|27244033|P2|Double-blind Period Through Week 48|Protocol Violation|1
7850843|NCT00116805|27244034|P1|Double-blind Period Through Week 48|Protocol Violation|1
7850844|NCT00116805|27244033|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
7850845|NCT00116805|27244034|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
7850846|NCT00116779|27244127|P2|Overall Study|Elevated PSA levels|2
7850847|NCT00116779|27244128|P1|Overall Study|Elevated PSA levels|2
7850848|NCT00116779|27244127|P2|Overall Study|Physician Decision|1
7850849|NCT00116779|27244128|P1|Overall Study|Physician Decision|3
7850850|NCT00116779|27244127|P2|Overall Study|Inadequate testosterone suppression|9
7850851|NCT00116779|27244128|P1|Overall Study|Inadequate testosterone suppression|7
7850852|NCT00116779|27244127|P2|Overall Study|Withdrawal by Subject|1
7850853|NCT00116779|27244128|P1|Overall Study|Withdrawal by Subject|4
7850854|NCT00116779|27244127|P2|Overall Study|Protocol Violation|4
7850855|NCT00116779|27244128|P1|Overall Study|Protocol Violation|1
7850856|NCT00116779|27244127|P2|Overall Study|Adverse Event|2
7850857|NCT00116779|27244128|P1|Overall Study|Adverse Event|4
7850858|NCT00116753|27244161|P3|Overall Study|Dosing Error|0
7850859|NCT00116753|27244162|P2|Overall Study|Dosing Error|1
7850860|NCT00116753|27244163|P1|Overall Study|Dosing Error|0
7850861|NCT00116753|27244161|P3|Overall Study|Progressive Parkinson's Disease|0
7850862|NCT00116753|27244162|P2|Overall Study|Progressive Parkinson's Disease|0
7850863|NCT00116753|27244163|P1|Overall Study|Progressive Parkinson's Disease|1
7850864|NCT00116753|27244161|P3|Overall Study|Abnormal Echocardiogram|1
7850865|NCT00116753|27244162|P2|Overall Study|Abnormal Echocardiogram|0
7850866|NCT00116753|27244163|P1|Overall Study|Abnormal Echocardiogram|0
7850867|NCT00116753|27244161|P3|Overall Study|Disease Progression|3
7850868|NCT00116753|27244162|P2|Overall Study|Disease Progression|4
7850870|NCT00116753|27244161|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
7850871|NCT00116753|27244162|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
7850872|NCT00116753|27244163|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
7850873|NCT00116753|27244161|P3|Overall Study|Protocol Violation|1
7850874|NCT00116753|27244162|P2|Overall Study|Protocol Violation|0
7850875|NCT00116753|27244163|P1|Overall Study|Protocol Violation|0
7850876|NCT00116753|27244161|P3|Overall Study|Lost to Follow-up|1
7850877|NCT00116753|27244162|P2|Overall Study|Lost to Follow-up|2
7850878|NCT00116753|27244163|P1|Overall Study|Lost to Follow-up|0
7850879|NCT00116753|27244161|P3|Overall Study|Withdrawal by Subject|8
7850880|NCT00116753|27244162|P2|Overall Study|Withdrawal by Subject|12
7850881|NCT00116753|27244163|P1|Overall Study|Withdrawal by Subject|11
7850882|NCT00116753|27244161|P3|Overall Study|Adverse Event|7
7850883|NCT00116753|27244162|P2|Overall Study|Adverse Event|10
7850884|NCT00116753|27244163|P1|Overall Study|Adverse Event|16
7850885|NCT00116688|27244185|P2|Overall Study|Other|0
7850886|NCT00116688|27244186|P1|Overall Study|Other|11
7850887|NCT00116688|27244185|P2|Overall Study|Pregnancy|0
7850888|NCT00116688|27244186|P1|Overall Study|Pregnancy|1
7850889|NCT00116688|27244185|P2|Overall Study|Protocol-specified criteria|0
7850890|NCT00116688|27244186|P1|Overall Study|Protocol-specified criteria|3
7850891|NCT00116688|27244185|P2|Overall Study|Death|0
7850892|NCT00116688|27244186|P1|Overall Study|Death|15
7850893|NCT00116688|27244185|P2|Overall Study|Lost to Follow-up|0
7850894|NCT00116688|27244186|P1|Overall Study|Lost to Follow-up|3
7850895|NCT00116688|27244185|P2|Overall Study|Physician Decision|0
7850896|NCT00116688|27244186|P1|Overall Study|Physician Decision|7
7850897|NCT00116688|27244185|P2|Overall Study|Requirement for alternative therapy|1
7850898|NCT00116688|27244186|P1|Overall Study|Requirement for alternative therapy|11
7850899|NCT00116688|27244185|P2|Overall Study|Withdrawal by Subject|2
7850900|NCT00116688|27244186|P1|Overall Study|Withdrawal by Subject|26
7850901|NCT00116688|27244185|P2|Overall Study|Adverse Event|0
7850902|NCT00116688|27244186|P1|Overall Study|Adverse Event|11
7850903|NCT00116688|27244185|P2|Overall Study|Noncompliance|1
7850904|NCT00116688|27244186|P1|Overall Study|Noncompliance|3
7850905|NCT00116688|27244185|P2|Overall Study|Protocol deviation|0
7850906|NCT00116688|27244186|P1|Overall Study|Protocol deviation|1
7850907|NCT00116649|27244201|P1|Overall Study|Protocol Specified|7
7850908|NCT00116649|27244201|P1|Overall Study|Various Reasons|18
7850909|NCT00116649|27244201|P1|Overall Study|Local Skin Reaction|9
7850910|NCT00116649|27244201|P1|Overall Study|Withdrawal by Subject|68
7850911|NCT00116649|27244201|P1|Overall Study|Lost to Follow-up|32
7850912|NCT00116649|27244201|P1|Overall Study|Lack of Efficacy|1
7850913|NCT00116649|27244201|P1|Overall Study|Adverse Event|20
7850914|NCT00116584|27244208|P2|Overall Study|Protocol Violation|1
7850915|NCT00116584|27244209|P1|Overall Study|Protocol Violation|1
7850916|NCT00116584|27244208|P2|Overall Study|Withdrawal by Subject|0
7850917|NCT00116584|27244209|P1|Overall Study|Withdrawal by Subject|1
7850918|NCT00116558|27244222|P3|Overall Study|disease progression|18
7850919|NCT00116558|27244223|P2|Overall Study|disease progression|7
7850920|NCT00116558|27244224|P1|Overall Study|disease progression|3
7850921|NCT00116558|27244222|P3|Overall Study|Withdrawal by Subject|12
7850922|NCT00116558|27244223|P2|Overall Study|Withdrawal by Subject|3
7850923|NCT00116558|27244224|P1|Overall Study|Withdrawal by Subject|17
7850924|NCT00116558|27244222|P3|Overall Study|Death|3
7850925|NCT00116558|27244223|P2|Overall Study|Death|5
7850926|NCT00116558|27244224|P1|Overall Study|Death|11
7850927|NCT00116428|27244235|P2|Overall Study|Did not meet inclusion criteria|0
7850928|NCT00116428|27244236|P1|Overall Study|Did not meet inclusion criteria|1
7850929|NCT00116428|27244235|P2|Overall Study|Withdrawal by Subject|5
7850930|NCT00116428|27244236|P1|Overall Study|Withdrawal by Subject|2
7850931|NCT00116272|27244265|P2|Overall Study|Lost to Follow-up|6
7850932|NCT00116272|27244266|P1|Overall Study|Lost to Follow-up|11
7850933|NCT00116168|27244335|P4|Overall Study|Lost to Follow-up|0
7850934|NCT00116168|27244336|P3|Overall Study|Lost to Follow-up|0
7850935|NCT00116168|27244337|P2|Overall Study|Lost to Follow-up|5
7850936|NCT00116168|27244338|P1|Overall Study|Lost to Follow-up|6
7850937|NCT00116142|27244402|P2|Overall Study|Patient didn't start due to low platelet counts|1
7850938|NCT00116142|27244403|P1|Overall Study|Patient didn't start due to low platelet counts|0
7850939|NCT00116142|27244402|P2|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
7850940|NCT00116142|27244403|P1|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
7850941|NCT00116142|27244402|P2|Overall Study|Patient stopped due to bilateral ruptured tendons|1
7850942|NCT00116142|27244403|P1|Overall Study|Patient stopped due to bilateral ruptured tendons|0
7850943|NCT00116142|27244402|P2|Overall Study|Patient stopped due to depression|1
7850944|NCT00116142|27244403|P1|Overall Study|Patient stopped due to depression|0
7850945|NCT00116142|27244402|P2|Overall Study|Patient could not tolerate docetaxel|2
7850946|NCT00116142|27244403|P1|Overall Study|Patient could not tolerate docetaxel|0
7850947|NCT00116142|27244402|P2|Overall Study|Delayed Radiation Therapy|0
7850948|NCT00116142|27244403|P1|Overall Study|Delayed Radiation Therapy|1
7850949|NCT00116142|27244402|P2|Overall Study|Physician Decision|1
7850950|NCT00116142|27244403|P1|Overall Study|Physician Decision|3
7850951|NCT00116142|27244402|P2|Overall Study|Withdrawal by Subject|5
7850952|NCT00116142|27244403|P1|Overall Study|Withdrawal by Subject|5
7850953|NCT00116142|27244402|P2|Overall Study|Protocol Violation|1
7850954|NCT00116142|27244403|P1|Overall Study|Protocol Violation|2
7850955|NCT00116142|27244402|P2|Overall Study|Adverse Event|7
7850956|NCT00116142|27244403|P1|Overall Study|Adverse Event|8
7850957|NCT00115934|27244419|P2|Overall Study|Did not receive intervention|2
7850958|NCT00115934|27244420|P1|Overall Study|Did not receive intervention|3
7850959|NCT00115934|27244419|P2|Overall Study|Lost to Follow-up|0
7850960|NCT00115934|27244420|P1|Overall Study|Lost to Follow-up|1
7850961|NCT00115804|27244469|P1|Overall Study|Adverse Event|2
7850962|NCT00115778|27244480|P2|Overall Study|Withdrawal by Subject|1
7850963|NCT00115778|27244481|P1|Overall Study|Withdrawal by Subject|0
7850964|NCT00115765|27244501|P4|Overall Study|Other|2
7850965|NCT00115765|27244502|P3|Overall Study|Other|9
7850966|NCT00115765|27244503|P2|Overall Study|Other|12
7850967|NCT00115765|27244504|P1|Overall Study|Other|6
7850968|NCT00115765|27244501|P4|Overall Study|Lost to Follow-up|1
7850969|NCT00115765|27244502|P3|Overall Study|Lost to Follow-up|18
7850970|NCT00115765|27244503|P2|Overall Study|Lost to Follow-up|20
7850971|NCT00115765|27244504|P1|Overall Study|Lost to Follow-up|3
7850972|NCT00115765|27244501|P4|Overall Study|Physician Decision|13
7850973|NCT00115765|27244502|P3|Overall Study|Physician Decision|18
7850974|NCT00115765|27244503|P2|Overall Study|Physician Decision|15
7850975|NCT00115765|27244504|P1|Overall Study|Physician Decision|4
7850976|NCT00115765|27244501|P4|Overall Study|Withdrawal by Subject|15
7850977|NCT00115765|27244502|P3|Overall Study|Withdrawal by Subject|76
7850978|NCT00115765|27244503|P2|Overall Study|Withdrawal by Subject|53
7850979|NCT00115765|27244504|P1|Overall Study|Withdrawal by Subject|22
7850980|NCT00115739|27244542|P1|Overall Study|Lost to Follow-up|3
7850981|NCT00115349|27244551|P2|Overall Study|Study closed due to low enrollment.|9
7850982|NCT00115349|27244552|P1|Overall Study|Study closed due to low enrollment.|11
7850983|NCT00115336|27244560|P2|Overall Study|Hospital discharge before study drug|1
7850984|NCT00115336|27244561|P1|Overall Study|Hospital discharge before study drug|0
7850985|NCT00115063|27244603|P2|Overall Study|Death|0
7850986|NCT00115063|27244604|P1|Overall Study|Death|1
7850987|NCT00115063|27244603|P2|Overall Study|Lost to Follow-up|104
7850988|NCT00115063|27244604|P1|Overall Study|Lost to Follow-up|98
7850989|NCT00115037|27244622|P6|Phase2|Lost to Follow-up|10
7850990|NCT00115037|27244623|P5|Phase2|Lost to Follow-up|4
7850991|NCT00115037|27244624|P4|Phase2|Lost to Follow-up|14
7850992|NCT00115037|27244625|P3|Phase2|Lost to Follow-up|12
7850993|NCT00115037|27244626|P2|Phase2|Lost to Follow-up|0
7850994|NCT00115037|27244627|P1|Phase2|Lost to Follow-up|0
7850995|NCT00115037|27244622|P6|Phase2|Withdrawal by Subject|1
7850996|NCT00115037|27244623|P5|Phase2|Withdrawal by Subject|2
7850997|NCT00115037|27244624|P4|Phase2|Withdrawal by Subject|1
7850998|NCT00115037|27244625|P3|Phase2|Withdrawal by Subject|2
7850999|NCT00115037|27244626|P2|Phase2|Withdrawal by Subject|0
7851000|NCT00115037|27244627|P1|Phase2|Withdrawal by Subject|0
7851001|NCT00115037|27244622|P6|Phase2|Death|1
7851002|NCT00115037|27244623|P5|Phase2|Death|0
7851003|NCT00115037|27244624|P4|Phase2|Death|0
7851004|NCT00115037|27244625|P3|Phase2|Death|1
7851005|NCT00115037|27244626|P2|Phase2|Death|0
7851006|NCT00115037|27244627|P1|Phase2|Death|0
7851007|NCT00115037|27244622|P6|Phase1|Withdrawal by Subject|0
7851008|NCT00115037|27244623|P5|Phase1|Withdrawal by Subject|0
7851009|NCT00115037|27244624|P4|Phase1|Withdrawal by Subject|0
7851010|NCT00115037|27244625|P3|Phase1|Withdrawal by Subject|0
7851011|NCT00115037|27244626|P2|Phase1|Withdrawal by Subject|4
7851012|NCT00115037|27244627|P1|Phase1|Withdrawal by Subject|9
7851013|NCT00115037|27244622|P6|Phase1|Lost to Follow-up|0
7851014|NCT00115037|27244623|P5|Phase1|Lost to Follow-up|0
7851015|NCT00115037|27244624|P4|Phase1|Lost to Follow-up|0
7851016|NCT00115037|27244625|P3|Phase1|Lost to Follow-up|0
7851017|NCT00115037|27244626|P2|Phase1|Lost to Follow-up|23
7851018|NCT00115037|27244627|P1|Phase1|Lost to Follow-up|16
7851019|NCT00114972|27244643|P2|Overall Study|Lost to Follow-up|5
7851020|NCT00114972|27244644|P1|Overall Study|Lost to Follow-up|8
7851021|NCT00114972|27244643|P2|Overall Study|Withdrawal by Subject|7
7851022|NCT00114972|27244644|P1|Overall Study|Withdrawal by Subject|40
7851023|NCT00114959|27244664|P1|Overall Study|Death|1
7851024|NCT00114959|27244664|P1|Overall Study|Physician Decision|1
7851025|NCT00114959|27244664|P1|Overall Study|Lack of Efficacy|6
7851026|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Other|2
7851027|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Other|0
7851028|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Other|2
7851029|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
7851030|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
7851031|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
7851032|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
7851033|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
7851034|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
7851035|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
7851036|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
7851037|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
7851038|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Adverse Event|7
7851039|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Adverse Event|14
7851040|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Adverse Event|15
7851041|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
7851042|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
7851043|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
7851220|NCT00113516|27245222|P1|Part 1|Death|3
7851044|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
7851045|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
7851046|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
7851047|NCT00114777|27244674|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
7851048|NCT00114777|27244675|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
7851049|NCT00114777|27244676|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
7851050|NCT00114777|27244674|P3|Long-Term Extension to Month 84|Death|7
7851051|NCT00114777|27244675|P2|Long-Term Extension to Month 84|Death|13
7851052|NCT00114777|27244676|P1|Long-Term Extension to Month 84|Death|8
7851053|NCT00114777|27244674|P3|Randomization to Month 36|Other|12
7851054|NCT00114777|27244675|P2|Randomization to Month 36|Other|3
7851055|NCT00114777|27244676|P1|Randomization to Month 36|Other|9
7851056|NCT00114777|27244674|P3|Randomization to Month 36|Withdrawal by Subject|5
7851057|NCT00114777|27244675|P2|Randomization to Month 36|Withdrawal by Subject|4
7851058|NCT00114777|27244676|P1|Randomization to Month 36|Withdrawal by Subject|3
7851059|NCT00114777|27244674|P3|Randomization to Month 36|Adverse Event|44
7851060|NCT00114777|27244675|P2|Randomization to Month 36|Adverse Event|35
7851061|NCT00114777|27244676|P1|Randomization to Month 36|Adverse Event|34
7851062|NCT00114777|27244674|P3|Randomization to Month 36|Poor or Non-Compliance|1
7851063|NCT00114777|27244675|P2|Randomization to Month 36|Poor or Non-Compliance|0
7851064|NCT00114777|27244676|P1|Randomization to Month 36|Poor or Non-Compliance|0
7851065|NCT00114777|27244674|P3|Randomization to Month 36|Lack of Efficacy|17
7851066|NCT00114777|27244675|P2|Randomization to Month 36|Lack of Efficacy|15
7851067|NCT00114777|27244676|P1|Randomization to Month 36|Lack of Efficacy|19
7851068|NCT00114777|27244674|P3|Randomization to Month 36|No Longer Met Study Criteria|2
7851069|NCT00114777|27244675|P2|Randomization to Month 36|No Longer Met Study Criteria|0
7851070|NCT00114777|27244676|P1|Randomization to Month 36|No Longer Met Study Criteria|0
7851071|NCT00114777|27244674|P3|Randomization to Month 36|Death|3
7851072|NCT00114777|27244675|P2|Randomization to Month 36|Death|4
7851073|NCT00114777|27244676|P1|Randomization to Month 36|Death|10
7851092|NCT00114634|27244765|P1|Overall Study|failure to return forms|3
7851093|NCT00114530|27244781|P2|Overall Study|Ineligible|0
7851094|NCT00114530|27244782|P1|Overall Study|Ineligible|1
7851095|NCT00114530|27244781|P2|Overall Study|Subject decision after endpoint failure|1
7851096|NCT00114530|27244782|P1|Overall Study|Subject decision after endpoint failure|0
7851097|NCT00114530|27244781|P2|Overall Study|Breast Cancer|0
7851098|NCT00114530|27244782|P1|Overall Study|Breast Cancer|1
7851099|NCT00114530|27244781|P2|Overall Study|Withdrawal by Subject|6
7851100|NCT00114530|27244782|P1|Overall Study|Withdrawal by Subject|2
7851101|NCT00114530|27244781|P2|Overall Study|Physician Decision|1
7851102|NCT00114530|27244782|P1|Overall Study|Physician Decision|1
7851103|NCT00114530|27244781|P2|Overall Study|Lost to Follow-up|1
7851104|NCT00114530|27244782|P1|Overall Study|Lost to Follow-up|1
7851105|NCT00114530|27244781|P2|Overall Study|Death|11
7851106|NCT00114530|27244782|P1|Overall Study|Death|3
7851107|NCT00114244|27244919|P2|Overall Study|Withdrawal by Subject|2
7851108|NCT00114244|27244920|P1|Overall Study|Withdrawal by Subject|0
7851109|NCT00114244|27244919|P2|Overall Study|Adverse Event|5
7851110|NCT00114244|27244920|P1|Overall Study|Adverse Event|2
7851111|NCT00114231|27244932|P2|Overall Study|Biopsy done after registration|0
7851112|NCT00114231|27244933|P1|Overall Study|Biopsy done after registration|1
7851113|NCT00114231|27244932|P2|Overall Study|No Absolute Neutrophil Count|0
7851114|NCT00114231|27244933|P1|Overall Study|No Absolute Neutrophil Count|2
7851115|NCT00114231|27244932|P2|Overall Study|Tumor fixed on digital exam|1
7851116|NCT00114231|27244933|P1|Overall Study|Tumor fixed on digital exam|0
7851117|NCT00114231|27244932|P2|Overall Study|Tumor size > 4cm|0
7851118|NCT00114231|27244933|P1|Overall Study|Tumor size > 4cm|1
7851119|NCT00114231|27244932|P2|Overall Study|Low creatinine clearance|1
7851120|NCT00114231|27244933|P1|Overall Study|Low creatinine clearance|0
7851121|NCT00114231|27244932|P2|Overall Study|No adenocarcinoma|0
7851122|NCT00114231|27244933|P1|Overall Study|No adenocarcinoma|1
7851123|NCT00114231|27244932|P2|Overall Study|Suspected metastatic disease|0
7851124|NCT00114231|27244933|P1|Overall Study|Suspected metastatic disease|1
7851125|NCT00114231|27244932|P2|Overall Study|QARC requirement not met|0
7851126|NCT00114231|27244933|P1|Overall Study|QARC requirement not met|1
7851127|NCT00114231|27244932|P2|Overall Study|No consent|0
7851128|NCT00114231|27244933|P1|Overall Study|No consent|2
7851129|NCT00114218|27244942|P1|Overall Study|Never Treated|1
7851130|NCT00114218|27244942|P1|Overall Study|Wrong Primary|1
7851131|NCT00114218|27244942|P1|Overall Study|Wrong Cell Type|2
7851132|NCT00114166|27244949|P2|Overall Study|Wrong primary|1
7851133|NCT00114166|27244950|P1|Overall Study|Wrong primary|0
7851134|NCT00114140|27244960|P1|Overall Study|Protocol Violation|7
7851135|NCT00114127|27244974|P2|Overall Study|Withdrawal by Subject|3
7851136|NCT00114127|27244975|P1|Overall Study|Withdrawal by Subject|1
7851137|NCT00114127|27244974|P2|Overall Study|Lost to Follow-up|0
7851138|NCT00114127|27244975|P1|Overall Study|Lost to Follow-up|1
7851139|NCT00114127|27244974|P2|Overall Study|Adverse Event|1
7851140|NCT00114127|27244975|P1|Overall Study|Adverse Event|2
7851141|NCT00113919|27245047|P1|Overall Study|Death|6
7851142|NCT00113919|27245047|P1|Overall Study|Physician Decision|8
7851143|NCT00113841|27245115|P2|Overall Study|Non-compliant|0
7851144|NCT00113841|27245116|P1|Overall Study|Non-compliant|1
7851145|NCT00113841|27245115|P2|Overall Study|Disease progression|2
7851146|NCT00113841|27245116|P1|Overall Study|Disease progression|0
7851147|NCT00113763|27245124|P2|Overall Study|Ongoing|0
7851148|NCT00113763|27245125|P1|Overall Study|Ongoing|1
7851149|NCT00113763|27245124|P2|Overall Study|Non-compliance|0
7851150|NCT00113763|27245125|P1|Overall Study|Non-compliance|1
7851151|NCT00113763|27245124|P2|Overall Study|Other|6
7851152|NCT00113763|27245125|P1|Overall Study|Other|27
7851153|NCT00113763|27245124|P2|Overall Study|Withdrawal by Subject|4
7851154|NCT00113763|27245125|P1|Overall Study|Withdrawal by Subject|1
7851155|NCT00113763|27245124|P2|Overall Study|Lost to Follow-up|0
7851156|NCT00113763|27245125|P1|Overall Study|Lost to Follow-up|10
7851157|NCT00113763|27245124|P2|Overall Study|Disease Progression|14
7851158|NCT00113763|27245125|P1|Overall Study|Disease Progression|28
7851159|NCT00113763|27245124|P2|Overall Study|Adverse Event|2
7851160|NCT00113763|27245125|P1|Overall Study|Adverse Event|5
7851161|NCT00113607|27245151|P2|Overall Study|Other|32
7851162|NCT00113607|27245152|P1|Overall Study|Other|43
7851163|NCT00113607|27245151|P2|Overall Study|Complete Response (Confirmed)|24
7851164|NCT00113607|27245152|P1|Overall Study|Complete Response (Confirmed)|14
7851165|NCT00113607|27245151|P2|Overall Study|Disease Progression|142
7851166|NCT00113607|27245152|P1|Overall Study|Disease Progression|180
7851167|NCT00113607|27245151|P2|Overall Study|Lost to Follow-up|2
7851168|NCT00113607|27245152|P1|Overall Study|Lost to Follow-up|0
7851169|NCT00113607|27245151|P2|Overall Study|Withdrawal by Subject|58
7851170|NCT00113607|27245152|P1|Overall Study|Withdrawal by Subject|50
7851171|NCT00113607|27245151|P2|Overall Study|Death|8
7851172|NCT00113607|27245152|P1|Overall Study|Death|8
7851173|NCT00113607|27245151|P2|Overall Study|Adverse Event|71
7851174|NCT00113607|27245152|P1|Overall Study|Adverse Event|40
7851175|NCT00113568|27245166|P1|Overall Study|Other|112
7851176|NCT00113568|27245166|P1|Overall Study|Withdrawal by Subject|117
7851177|NCT00113568|27245166|P1|Overall Study|Protocol Violation|32
7851178|NCT00113568|27245166|P1|Overall Study|Lost to Follow-up|156
7851179|NCT00113568|27245166|P1|Overall Study|Lack of Efficacy|30
7851180|NCT00113568|27245166|P1|Overall Study|Death|1
7851181|NCT00113568|27245166|P1|Overall Study|Adverse Event|97
7851182|NCT00113555|27245178|P1|Overall Study|Lost to Follow-up|8
7851183|NCT00113555|27245178|P1|Overall Study|Missed Followup|4
7851184|NCT00113555|27245178|P1|Overall Study|Death|1
7851185|NCT00113555|27245178|P1|Overall Study|Permanently Explanted|7
7851186|NCT00113555|27245178|P1|Overall Study|Baseline Failure|59
7851187|NCT00113529|27245188|P1|Overall Study|Withdrawal by Subject|4
7851188|NCT00113529|27245188|P1|Overall Study|Decision of sponsor|6
7851189|NCT00113529|27245188|P1|Overall Study|Lack of Efficacy|20
7851190|NCT00113529|27245188|P1|Overall Study|Adverse Event|4
7851191|NCT00113516|27245221|P2|Part 2|Ongoing|1
7851192|NCT00113516|27245222|P1|Part 2|Ongoing|0
7851193|NCT00113516|27245221|P2|Part 2|Laboratory Abnormality|1
7851194|NCT00113516|27245222|P1|Part 2|Laboratory Abnormality|0
7851195|NCT00113516|27245221|P2|Part 2|Other|3
7851196|NCT00113516|27245222|P1|Part 2|Other|0
7851197|NCT00113516|27245221|P2|Part 2|Withdrawal by Subject|3
7851198|NCT00113516|27245222|P1|Part 2|Withdrawal by Subject|0
7851199|NCT00113516|27245221|P2|Part 2|Lack of Efficacy|37
7851200|NCT00113516|27245222|P1|Part 2|Lack of Efficacy|0
7851201|NCT00113516|27245221|P2|Part 2|Death|5
7851202|NCT00113516|27245222|P1|Part 2|Death|0
7851203|NCT00113516|27245221|P2|Part 2|Adverse Event|16
7851204|NCT00113516|27245222|P1|Part 2|Adverse Event|0
7851205|NCT00113516|27245221|P2|Part 1|Missing|0
7851206|NCT00113516|27245222|P1|Part 1|Missing|65
7851207|NCT00113516|27245221|P2|Part 1|Ongoing|0
7851208|NCT00113516|27245222|P1|Part 1|Ongoing|1
7851209|NCT00113516|27245221|P2|Part 1|Laboratory Abnormality|0
7851210|NCT00113516|27245222|P1|Part 1|Laboratory Abnormality|1
7851211|NCT00113516|27245221|P2|Part 1|Did Not Meet Entrance Criteria|0
7851212|NCT00113516|27245222|P1|Part 1|Did Not Meet Entrance Criteria|1
7851213|NCT00113516|27245221|P2|Part 1|Lack of Efficacy|0
7851214|NCT00113516|27245222|P1|Part 1|Lack of Efficacy|2
7851215|NCT00113516|27245221|P2|Part 1|Withdrawal by Subject|0
7851216|NCT00113516|27245222|P1|Part 1|Withdrawal by Subject|2
7851217|NCT00113516|27245221|P2|Part 1|Other|0
7851218|NCT00113516|27245222|P1|Part 1|Other|3
7851219|NCT00113516|27245221|P2|Part 1|Death|0
7851221|NCT00113516|27245221|P2|Part 1|Adverse Event|0
7851222|NCT00113516|27245222|P1|Part 1|Adverse Event|6
7851223|NCT00113490|27245265|P2|Overall Study|Lost to Follow-up|0
7851224|NCT00113490|27245266|P1|Overall Study|Lost to Follow-up|1
7851225|NCT00113490|27245265|P2|Overall Study|Withdrawal by Subject|3
7851226|NCT00113490|27245266|P1|Overall Study|Withdrawal by Subject|1
7851227|NCT00113399|27245299|P2|Overall Study|Other|1
7851228|NCT00113399|27245300|P1|Overall Study|Other|0
7851229|NCT00113399|27245299|P2|Overall Study|Complete Response|1
7851230|NCT00113399|27245300|P1|Overall Study|Complete Response|0
7851231|NCT00113399|27245299|P2|Overall Study|Withdrawal by Subject|2
7851232|NCT00113399|27245300|P1|Overall Study|Withdrawal by Subject|1
7851233|NCT00113399|27245299|P2|Overall Study|Death|1
7851234|NCT00113399|27245300|P1|Overall Study|Death|1
7851235|NCT00113386|27245308|P2|Overall Study|Unknown - Lost to Follow-Up|1
7851236|NCT00113386|27245309|P1|Overall Study|Unknown - Lost to Follow-Up|2
7851237|NCT00113386|27245308|P2|Overall Study|Ineligible|2
7851238|NCT00113386|27245309|P1|Overall Study|Ineligible|1
7851239|NCT00113386|27245308|P2|Overall Study|Toxicity|0
7851240|NCT00113386|27245309|P1|Overall Study|Toxicity|3
7851241|NCT00113386|27245308|P2|Overall Study|Physician Decision|1
7851242|NCT00113386|27245309|P1|Overall Study|Physician Decision|0
7851243|NCT00113386|27245308|P2|Overall Study|Withdrawal by Subject|0
7851244|NCT00113386|27245309|P1|Overall Study|Withdrawal by Subject|1
7851245|NCT00113373|27245315|P1|Overall Study|Never Treated|1
7851246|NCT00113373|27245315|P1|Overall Study|Ineligible: second primary|1
7851247|NCT00113373|27245315|P1|Overall Study|Ineligible: wrong primary|1
7851248|NCT00113360|27245330|P1|Overall Study|Did not meet eligibility criteria|3
7851249|NCT00113360|27245330|P1|Overall Study|Subject required surgery|1
7851250|NCT00113360|27245330|P1|Overall Study|Adverse Event|3
7851251|NCT00113295|27245344|P2|Overall Study|Unrelated Medical Illness|0
7851252|NCT00113295|27245345|P1|Overall Study|Unrelated Medical Illness|1
7851253|NCT00113295|27245344|P2|Overall Study|Adverse Event|1
7851254|NCT00113295|27245345|P1|Overall Study|Adverse Event|4
7851255|NCT00113269|27245364|P4|Overall Study|Unable to return for follow up|0
7851256|NCT00113269|27245365|P3|Overall Study|Unable to return for follow up|0
7851257|NCT00113269|27245366|P2|Overall Study|Unable to return for follow up|1
7851258|NCT00113269|27245367|P1|Overall Study|Unable to return for follow up|2
7851259|NCT00113269|27245364|P4|Overall Study|Did not meet eligibility criteria|1
7851260|NCT00113269|27245365|P3|Overall Study|Did not meet eligibility criteria|0
7851261|NCT00113269|27245366|P2|Overall Study|Did not meet eligibility criteria|0
7851262|NCT00113269|27245367|P1|Overall Study|Did not meet eligibility criteria|1
7851263|NCT00113269|27245364|P4|Overall Study|Withdrew consent, Prednisone initiated|1
7851264|NCT00113269|27245365|P3|Overall Study|Withdrew consent, Prednisone initiated|0
7851265|NCT00113269|27245366|P2|Overall Study|Withdrew consent, Prednisone initiated|0
7851266|NCT00113269|27245367|P1|Overall Study|Withdrew consent, Prednisone initiated|0
7851267|NCT00113269|27245364|P4|Overall Study|Received pancreas transplant|2
7851268|NCT00113269|27245365|P3|Overall Study|Received pancreas transplant|0
7851269|NCT00113269|27245366|P2|Overall Study|Received pancreas transplant|0
7851270|NCT00113269|27245367|P1|Overall Study|Received pancreas transplant|0
7851271|NCT00113269|27245364|P4|Overall Study|Moved|3
7851272|NCT00113269|27245365|P3|Overall Study|Moved|0
7851273|NCT00113269|27245366|P2|Overall Study|Moved|1
7851274|NCT00113269|27245367|P1|Overall Study|Moved|0
7851275|NCT00113269|27245364|P4|Overall Study|Discontinued due to rejection|0
7851276|NCT00113269|27245365|P3|Overall Study|Discontinued due to rejection|1
7851277|NCT00113269|27245366|P2|Overall Study|Discontinued due to rejection|0
7851278|NCT00113269|27245367|P1|Overall Study|Discontinued due to rejection|0
7851279|NCT00113269|27245364|P4|Overall Study|Sponsor elected to discontinue patient|1
7851280|NCT00113269|27245365|P3|Overall Study|Sponsor elected to discontinue patient|0
7851281|NCT00113269|27245366|P2|Overall Study|Sponsor elected to discontinue patient|0
7851282|NCT00113269|27245367|P1|Overall Study|Sponsor elected to discontinue patient|1
7851283|NCT00113269|27245364|P4|Overall Study|Lost to Follow-up|3
7851284|NCT00113269|27245365|P3|Overall Study|Lost to Follow-up|6
7851285|NCT00113269|27245366|P2|Overall Study|Lost to Follow-up|3
7851286|NCT00113269|27245367|P1|Overall Study|Lost to Follow-up|2
7851287|NCT00113269|27245364|P4|Overall Study|Protocol Violation|2
7851288|NCT00113269|27245365|P3|Overall Study|Protocol Violation|4
7851289|NCT00113269|27245366|P2|Overall Study|Protocol Violation|0
7851290|NCT00113269|27245367|P1|Overall Study|Protocol Violation|1
7851291|NCT00113269|27245364|P4|Overall Study|Graft loss|9
7851292|NCT00113269|27245365|P3|Overall Study|Graft loss|4
7851293|NCT00113269|27245366|P2|Overall Study|Graft loss|6
7851294|NCT00113269|27245367|P1|Overall Study|Graft loss|6
7851295|NCT00113269|27245364|P4|Overall Study|Withdrawal by Subject|2
7851296|NCT00113269|27245365|P3|Overall Study|Withdrawal by Subject|4
7851297|NCT00113269|27245366|P2|Overall Study|Withdrawal by Subject|3
7851298|NCT00113269|27245367|P1|Overall Study|Withdrawal by Subject|4
7851299|NCT00113269|27245364|P4|Overall Study|Adverse Event|7
7851300|NCT00113269|27245365|P3|Overall Study|Adverse Event|11
7851301|NCT00113269|27245366|P2|Overall Study|Adverse Event|7
7851302|NCT00113269|27245367|P1|Overall Study|Adverse Event|2
7851303|NCT00113269|27245364|P4|Overall Study|Did not meet eligibility - pre-treatment|2
7851304|NCT00113269|27245365|P3|Overall Study|Did not meet eligibility - pre-treatment|0
7851305|NCT00113269|27245366|P2|Overall Study|Did not meet eligibility - pre-treatment|0
7851306|NCT00113269|27245367|P1|Overall Study|Did not meet eligibility - pre-treatment|0
7851307|NCT00113269|27245364|P4|Overall Study|Death in operating room|1
7851308|NCT00113269|27245365|P3|Overall Study|Death in operating room|0
7851309|NCT00113269|27245366|P2|Overall Study|Death in operating room|0
7851310|NCT00113269|27245367|P1|Overall Study|Death in operating room|0
7851311|NCT00113269|27245364|P4|Overall Study|Early graft loss, technical|0
7851312|NCT00113269|27245365|P3|Overall Study|Early graft loss, technical|2
7851313|NCT00113269|27245366|P2|Overall Study|Early graft loss, technical|0
7851314|NCT00113269|27245367|P1|Overall Study|Early graft loss, technical|0
7851315|NCT00113269|27245364|P4|Overall Study|Not transplanted, recipient issues|4
7851316|NCT00113269|27245365|P3|Overall Study|Not transplanted, recipient issues|7
7851317|NCT00113269|27245366|P2|Overall Study|Not transplanted, recipient issues|1
7851318|NCT00113269|27245367|P1|Overall Study|Not transplanted, recipient issues|2
7851319|NCT00113269|27245364|P4|Overall Study|Not transplanted, donor issues|2
7851320|NCT00113269|27245365|P3|Overall Study|Not transplanted, donor issues|2
7851321|NCT00113269|27245366|P2|Overall Study|Not transplanted, donor issues|0
7851322|NCT00113269|27245367|P1|Overall Study|Not transplanted, donor issues|4
7851323|NCT00113087|27245427|P2|Overall Study|Family or MD withdrew subject|5
7851324|NCT00113087|27245428|P1|Overall Study|Family or MD withdrew subject|10
7851325|NCT00113087|27245427|P2|Overall Study|Death or Transplant|16
7851326|NCT00113087|27245428|P1|Overall Study|Death or Transplant|14
7851327|NCT00112957|27245499|P1|Overall Study|Physician Decision|1
7851328|NCT00112957|27245499|P1|Overall Study|Progressive disease|18
7851329|NCT00112905|27245539|P1|Overall Study|performance status was deteiorating|1
7851330|NCT00112905|27245539|P1|Overall Study|Alternative treatment|1
7851331|NCT00112905|27245539|P1|Overall Study|Ineligibility|5
7851332|NCT00112905|27245539|P1|Overall Study|Death|1
7851333|NCT00112905|27245539|P1|Overall Study|Adverse Event|4
7851334|NCT00112866|27245548|P2|Overall Study|did not start treatment post-op|2
7851335|NCT00112866|27245549|P1|Overall Study|did not start treatment post-op|1
7851336|NCT00112866|27245548|P2|Overall Study|Protocol Violation|0
7851337|NCT00112866|27245549|P1|Overall Study|Protocol Violation|1
7851338|NCT00112840|27245571|P3|Overall Study|Protocol Violation|5
7851339|NCT00112840|27245572|P2|Overall Study|Protocol Violation|0
7851340|NCT00112840|27245573|P1|Overall Study|Protocol Violation|0
7851341|NCT00112840|27245571|P3|Overall Study|Withdrawal by Subject|1
7851342|NCT00112840|27245572|P2|Overall Study|Withdrawal by Subject|0
7851343|NCT00112840|27245573|P1|Overall Study|Withdrawal by Subject|1
7851344|NCT00112840|27245571|P3|Overall Study|Physician Decision|0
7851345|NCT00112840|27245572|P2|Overall Study|Physician Decision|0
7851346|NCT00112840|27245573|P1|Overall Study|Physician Decision|1
7851347|NCT00112736|27245615|P2|Overall Study|1 pt never had had RX due rapid decline|0
7851348|NCT00112736|27245616|P1|Overall Study|1 pt never had had RX due rapid decline|1
7851349|NCT00112580|27245675|P2|Overall Study|Participant withdrew consent|1
7851350|NCT00112580|27245676|P1|Overall Study|Participant withdrew consent|2
7851351|NCT00112580|27245675|P2|Overall Study|Disease progression|16
7851352|NCT00112580|27245676|P1|Overall Study|Disease progression|5
7851353|NCT00112580|27245675|P2|Overall Study|Adverse Event|2
7851354|NCT00112580|27245676|P1|Overall Study|Adverse Event|1
7851355|NCT00112489|27245681|P1|Overall Study|Ineligible|7
7851356|NCT00112489|27245681|P1|Overall Study|Patient never treated|2
7851357|NCT00112489|27245681|P1|Overall Study|Other, Not Specified|9
7851358|NCT00112489|27245681|P1|Overall Study|Death|2
7851359|NCT00112489|27245681|P1|Overall Study|Adverse Event|12
7851360|NCT00112489|27245681|P1|Overall Study|Refused further treatment|8
7851361|NCT00112463|27245691|P1|Overall Study|Never started treatment|2
7851362|NCT00112463|27245691|P1|Overall Study|Withdrawal by Subject|2
7851363|NCT00112463|27245691|P1|Overall Study|Toxicity|3
7851364|NCT00112463|27245691|P1|Overall Study|Second Primary|1
7851365|NCT00112463|27245691|P1|Overall Study|Progression|30
7851366|NCT00112463|27245691|P1|Overall Study|Physician Decision|1
7851367|NCT00112437|27245703|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
7851368|NCT00112437|27245704|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851369|NCT00112437|27245705|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
7851370|NCT00112437|27245706|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
7851371|NCT00112437|27245707|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851372|NCT00112437|27245708|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851373|NCT00112437|27245709|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851374|NCT00112437|27245710|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851375|NCT00112437|27245711|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851376|NCT00112437|27245712|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851377|NCT00112437|27245713|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851378|NCT00112437|27245714|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851379|NCT00112437|27245715|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851380|NCT00112437|27245716|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851381|NCT00112437|27245717|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851382|NCT00112437|27245718|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851383|NCT00112437|27245719|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851384|NCT00112437|27245720|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851385|NCT00112437|27245721|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851386|NCT00112437|27245722|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851387|NCT00112437|27245723|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851388|NCT00112437|27245724|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851389|NCT00112437|27245725|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851390|NCT00112437|27245726|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851391|NCT00112437|27245727|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851392|NCT00112437|27245728|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7851393|NCT00112437|27245703|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
7851394|NCT00112437|27245704|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
7851395|NCT00112437|27245705|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
7851396|NCT00112437|27245706|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
7851397|NCT00112437|27245707|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
7851398|NCT00112437|27245708|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
7851399|NCT00112437|27245709|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
7851400|NCT00112437|27245710|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
7851401|NCT00112437|27245711|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
7851402|NCT00112437|27245712|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
7851403|NCT00112437|27245713|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
7851404|NCT00112437|27245714|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
7851405|NCT00112437|27245715|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
7851406|NCT00112437|27245716|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
7851407|NCT00112437|27245717|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
7851408|NCT00112437|27245718|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
7851409|NCT00112437|27245719|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
7851410|NCT00112437|27245720|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
7851411|NCT00112437|27245721|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
7851412|NCT00112437|27245722|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
7851413|NCT00112437|27245723|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
7851414|NCT00112437|27245724|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
7851415|NCT00112437|27245725|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
7851416|NCT00112437|27245726|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
7851417|NCT00112437|27245727|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
7851418|NCT00112437|27245728|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
7851419|NCT00112437|27245703|P26|Years 6-10 (60-Month Extension)|Other|0
7851420|NCT00112437|27245704|P25|Years 6-10 (60-Month Extension)|Other|1
7851421|NCT00112437|27245705|P24|Years 6-10 (60-Month Extension)|Other|0
7851422|NCT00112437|27245706|P23|Years 6-10 (60-Month Extension)|Other|0
7851423|NCT00112437|27245707|P22|Years 6-10 (60-Month Extension)|Other|0
7851424|NCT00112437|27245708|P21|Years 6-10 (60-Month Extension)|Other|0
7851425|NCT00112437|27245709|P20|Years 6-10 (60-Month Extension)|Other|0
7851426|NCT00112437|27245710|P19|Years 6-10 (60-Month Extension)|Other|0
7851427|NCT00112437|27245711|P18|Years 6-10 (60-Month Extension)|Other|0
7851428|NCT00112437|27245712|P17|Years 6-10 (60-Month Extension)|Other|0
7851429|NCT00112437|27245713|P16|Years 6-10 (60-Month Extension)|Other|0
7851430|NCT00112437|27245714|P15|Years 6-10 (60-Month Extension)|Other|0
7851431|NCT00112437|27245715|P14|Years 6-10 (60-Month Extension)|Other|0
7851432|NCT00112437|27245716|P13|Years 6-10 (60-Month Extension)|Other|0
7851433|NCT00112437|27245717|P12|Years 6-10 (60-Month Extension)|Other|0
7851434|NCT00112437|27245718|P11|Years 6-10 (60-Month Extension)|Other|0
7851435|NCT00112437|27245719|P10|Years 6-10 (60-Month Extension)|Other|0
7851436|NCT00112437|27245720|P9|Years 6-10 (60-Month Extension)|Other|0
7851437|NCT00112437|27245721|P8|Years 6-10 (60-Month Extension)|Other|0
7851438|NCT00112437|27245722|P7|Years 6-10 (60-Month Extension)|Other|0
7851439|NCT00112437|27245723|P6|Years 6-10 (60-Month Extension)|Other|0
7851440|NCT00112437|27245724|P5|Years 6-10 (60-Month Extension)|Other|0
7851441|NCT00112437|27245725|P4|Years 6-10 (60-Month Extension)|Other|0
7851442|NCT00112437|27245726|P3|Years 6-10 (60-Month Extension)|Other|0
7851443|NCT00112437|27245727|P2|Years 6-10 (60-Month Extension)|Other|0
7851444|NCT00112437|27245728|P1|Years 6-10 (60-Month Extension)|Other|0
7851445|NCT00112437|27245703|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
7851446|NCT00112437|27245704|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851447|NCT00112437|27245705|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851448|NCT00112437|27245706|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851449|NCT00112437|27245707|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851450|NCT00112437|27245708|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851451|NCT00112437|27245709|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851452|NCT00112437|27245710|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851453|NCT00112437|27245711|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851454|NCT00112437|27245712|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851455|NCT00112437|27245713|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851456|NCT00112437|27245714|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851457|NCT00112437|27245715|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851458|NCT00112437|27245716|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851459|NCT00112437|27245717|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851460|NCT00112437|27245718|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851461|NCT00112437|27245719|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851462|NCT00112437|27245720|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851463|NCT00112437|27245721|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851464|NCT00112437|27245722|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851465|NCT00112437|27245723|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851466|NCT00112437|27245724|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851467|NCT00112437|27245725|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851468|NCT00112437|27245726|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851469|NCT00112437|27245727|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851470|NCT00112437|27245728|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7851471|NCT00112437|27245703|P26|Years 6-10 (60-Month Extension)|Death|0
7851472|NCT00112437|27245704|P25|Years 6-10 (60-Month Extension)|Death|0
7851473|NCT00112437|27245705|P24|Years 6-10 (60-Month Extension)|Death|2
7851474|NCT00112437|27245706|P23|Years 6-10 (60-Month Extension)|Death|0
7851475|NCT00112437|27245707|P22|Years 6-10 (60-Month Extension)|Death|0
7851476|NCT00112437|27245708|P21|Years 6-10 (60-Month Extension)|Death|0
7851477|NCT00112437|27245709|P20|Years 6-10 (60-Month Extension)|Death|0
7851478|NCT00112437|27245710|P19|Years 6-10 (60-Month Extension)|Death|0
7851479|NCT00112437|27245711|P18|Years 6-10 (60-Month Extension)|Death|0
7851480|NCT00112437|27245712|P17|Years 6-10 (60-Month Extension)|Death|0
7851481|NCT00112437|27245713|P16|Years 6-10 (60-Month Extension)|Death|0
7851482|NCT00112437|27245714|P15|Years 6-10 (60-Month Extension)|Death|0
7851483|NCT00112437|27245715|P14|Years 6-10 (60-Month Extension)|Death|0
7851484|NCT00112437|27245716|P13|Years 6-10 (60-Month Extension)|Death|0
7851485|NCT00112437|27245717|P12|Years 6-10 (60-Month Extension)|Death|0
7851486|NCT00112437|27245718|P11|Years 6-10 (60-Month Extension)|Death|0
7851487|NCT00112437|27245719|P10|Years 6-10 (60-Month Extension)|Death|0
7851488|NCT00112437|27245720|P9|Years 6-10 (60-Month Extension)|Death|0
7851489|NCT00112437|27245721|P8|Years 6-10 (60-Month Extension)|Death|0
7851490|NCT00112437|27245722|P7|Years 6-10 (60-Month Extension)|Death|0
7851491|NCT00112437|27245723|P6|Years 6-10 (60-Month Extension)|Death|0
7851492|NCT00112437|27245724|P5|Years 6-10 (60-Month Extension)|Death|0
7851493|NCT00112437|27245725|P4|Years 6-10 (60-Month Extension)|Death|0
7851494|NCT00112437|27245726|P3|Years 6-10 (60-Month Extension)|Death|0
7851495|NCT00112437|27245727|P2|Years 6-10 (60-Month Extension)|Death|0
7851496|NCT00112437|27245728|P1|Years 6-10 (60-Month Extension)|Death|0
7851497|NCT00112437|27245703|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
7851498|NCT00112437|27245704|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
7851499|NCT00112437|27245705|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
7851500|NCT00112437|27245706|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
7851501|NCT00112437|27245707|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
7851502|NCT00112437|27245708|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
7851503|NCT00112437|27245709|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
7851504|NCT00112437|27245710|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
7851505|NCT00112437|27245711|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
7851506|NCT00112437|27245712|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
7851507|NCT00112437|27245713|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
7851508|NCT00112437|27245714|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
7851509|NCT00112437|27245715|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
7851510|NCT00112437|27245716|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
7851511|NCT00112437|27245717|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
7851512|NCT00112437|27245718|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
7851513|NCT00112437|27245719|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
7851514|NCT00112437|27245720|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
7851515|NCT00112437|27245721|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
7851516|NCT00112437|27245722|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
7851517|NCT00112437|27245723|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
7851518|NCT00112437|27245724|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
7851519|NCT00112437|27245725|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
7851520|NCT00112437|27245726|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
7851521|NCT00112437|27245727|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
7851522|NCT00112437|27245728|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
7851523|NCT00112437|27245703|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851524|NCT00112437|27245704|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851525|NCT00112437|27245705|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851526|NCT00112437|27245706|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851527|NCT00112437|27245707|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
7851528|NCT00112437|27245708|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
7851529|NCT00112437|27245709|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851530|NCT00112437|27245710|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851531|NCT00112437|27245711|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851532|NCT00112437|27245712|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851533|NCT00112437|27245713|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851534|NCT00112437|27245714|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851535|NCT00112437|27245715|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851536|NCT00112437|27245716|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851537|NCT00112437|27245717|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851538|NCT00112437|27245718|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851539|NCT00112437|27245719|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851540|NCT00112437|27245720|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851541|NCT00112437|27245721|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851542|NCT00112437|27245722|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851543|NCT00112437|27245723|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851544|NCT00112437|27245724|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851545|NCT00112437|27245725|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851546|NCT00112437|27245726|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851547|NCT00112437|27245727|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851548|NCT00112437|27245728|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7851549|NCT00112437|27245703|P26|Years 4-5 (24-Month Extension)|Participant moved|0
7851550|NCT00112437|27245704|P25|Years 4-5 (24-Month Extension)|Participant moved|0
7851551|NCT00112437|27245705|P24|Years 4-5 (24-Month Extension)|Participant moved|0
7851552|NCT00112437|27245706|P23|Years 4-5 (24-Month Extension)|Participant moved|0
7851553|NCT00112437|27245707|P22|Years 4-5 (24-Month Extension)|Participant moved|1
7851554|NCT00112437|27245708|P21|Years 4-5 (24-Month Extension)|Participant moved|0
7851555|NCT00112437|27245709|P20|Years 4-5 (24-Month Extension)|Participant moved|0
7851556|NCT00112437|27245710|P19|Years 4-5 (24-Month Extension)|Participant moved|0
7851557|NCT00112437|27245711|P18|Years 4-5 (24-Month Extension)|Participant moved|0
7851558|NCT00112437|27245712|P17|Years 4-5 (24-Month Extension)|Participant moved|0
7851559|NCT00112437|27245713|P16|Years 4-5 (24-Month Extension)|Participant moved|0
7851560|NCT00112437|27245714|P15|Years 4-5 (24-Month Extension)|Participant moved|0
7851561|NCT00112437|27245715|P14|Years 4-5 (24-Month Extension)|Participant moved|0
7851562|NCT00112437|27245716|P13|Years 4-5 (24-Month Extension)|Participant moved|0
7851563|NCT00112437|27245717|P12|Years 4-5 (24-Month Extension)|Participant moved|0
7851564|NCT00112437|27245718|P11|Years 4-5 (24-Month Extension)|Participant moved|0
7851565|NCT00112437|27245719|P10|Years 4-5 (24-Month Extension)|Participant moved|0
7851566|NCT00112437|27245720|P9|Years 4-5 (24-Month Extension)|Participant moved|0
7851567|NCT00112437|27245721|P8|Years 4-5 (24-Month Extension)|Participant moved|0
7851568|NCT00112437|27245722|P7|Years 4-5 (24-Month Extension)|Participant moved|0
7851569|NCT00112437|27245723|P6|Years 4-5 (24-Month Extension)|Participant moved|0
7851570|NCT00112437|27245724|P5|Years 4-5 (24-Month Extension)|Participant moved|0
7851571|NCT00112437|27245725|P4|Years 4-5 (24-Month Extension)|Participant moved|0
7851572|NCT00112437|27245726|P3|Years 4-5 (24-Month Extension)|Participant moved|0
7851573|NCT00112437|27245727|P2|Years 4-5 (24-Month Extension)|Participant moved|0
7851574|NCT00112437|27245728|P1|Years 4-5 (24-Month Extension)|Participant moved|0
7851575|NCT00112437|27245703|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
7851576|NCT00112437|27245704|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
7851577|NCT00112437|27245705|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
7851578|NCT00112437|27245706|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
7851579|NCT00112437|27245707|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
7851580|NCT00112437|27245708|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
7851581|NCT00112437|27245709|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
7851582|NCT00112437|27245710|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
7851583|NCT00112437|27245711|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
7851584|NCT00112437|27245712|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
7851585|NCT00112437|27245713|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
7851586|NCT00112437|27245714|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
7851587|NCT00112437|27245715|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
7851588|NCT00112437|27245716|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
7851589|NCT00112437|27245717|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
7851590|NCT00112437|27245718|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
7851591|NCT00112437|27245719|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
7851592|NCT00112437|27245720|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
7851593|NCT00112437|27245721|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
7851594|NCT00112437|27245722|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
7851595|NCT00112437|27245723|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
7851596|NCT00112437|27245724|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
7851597|NCT00112437|27245725|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
7851598|NCT00112437|27245726|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
7851599|NCT00112437|27245727|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
7851600|NCT00112437|27245728|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
7851601|NCT00112437|27245703|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851602|NCT00112437|27245704|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851603|NCT00112437|27245705|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851604|NCT00112437|27245706|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851605|NCT00112437|27245707|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851606|NCT00112437|27245708|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
7851607|NCT00112437|27245709|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851608|NCT00112437|27245710|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851609|NCT00112437|27245711|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851610|NCT00112437|27245712|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851611|NCT00112437|27245713|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851612|NCT00112437|27245714|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851613|NCT00112437|27245715|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851614|NCT00112437|27245716|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851615|NCT00112437|27245717|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851616|NCT00112437|27245718|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851617|NCT00112437|27245719|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851618|NCT00112437|27245720|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851619|NCT00112437|27245721|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851620|NCT00112437|27245722|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851621|NCT00112437|27245723|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851622|NCT00112437|27245724|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851623|NCT00112437|27245725|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851624|NCT00112437|27245726|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851625|NCT00112437|27245727|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851626|NCT00112437|27245728|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7851627|NCT00112437|27245703|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851628|NCT00112437|27245704|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851629|NCT00112437|27245705|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851630|NCT00112437|27245706|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851631|NCT00112437|27245707|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
7851632|NCT00112437|27245708|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
7851633|NCT00112437|27245709|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851634|NCT00112437|27245710|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851635|NCT00112437|27245711|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851636|NCT00112437|27245712|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851637|NCT00112437|27245713|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851638|NCT00112437|27245714|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851639|NCT00112437|27245715|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851640|NCT00112437|27245716|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851641|NCT00112437|27245717|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851642|NCT00112437|27245718|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851643|NCT00112437|27245719|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851644|NCT00112437|27245720|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851645|NCT00112437|27245721|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851646|NCT00112437|27245722|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851647|NCT00112437|27245723|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851648|NCT00112437|27245724|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851649|NCT00112437|27245725|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851650|NCT00112437|27245726|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851651|NCT00112437|27245727|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851652|NCT00112437|27245728|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7851653|NCT00112437|27245703|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851654|NCT00112437|27245704|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851655|NCT00112437|27245705|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851656|NCT00112437|27245706|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851657|NCT00112437|27245707|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851658|NCT00112437|27245708|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851659|NCT00112437|27245709|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851660|NCT00112437|27245710|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851661|NCT00112437|27245711|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851662|NCT00112437|27245712|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851663|NCT00112437|27245713|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851664|NCT00112437|27245714|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851665|NCT00112437|27245715|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851666|NCT00112437|27245716|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851667|NCT00112437|27245717|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
7851668|NCT00112437|27245718|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
7851669|NCT00112437|27245719|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851670|NCT00112437|27245720|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851671|NCT00112437|27245721|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851672|NCT00112437|27245722|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851673|NCT00112437|27245723|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851674|NCT00112437|27245724|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851675|NCT00112437|27245725|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851676|NCT00112437|27245726|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851677|NCT00112437|27245727|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851678|NCT00112437|27245728|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7851679|NCT00112437|27245703|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851680|NCT00112437|27245704|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851681|NCT00112437|27245705|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851682|NCT00112437|27245706|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851683|NCT00112437|27245707|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851684|NCT00112437|27245708|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851685|NCT00112437|27245709|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851686|NCT00112437|27245710|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851687|NCT00112437|27245711|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851688|NCT00112437|27245712|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851689|NCT00112437|27245713|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851690|NCT00112437|27245714|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
7851691|NCT00112437|27245715|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851692|NCT00112437|27245716|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851693|NCT00112437|27245717|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
7851694|NCT00112437|27245718|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851695|NCT00112437|27245719|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851696|NCT00112437|27245720|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851697|NCT00112437|27245721|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851698|NCT00112437|27245722|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851699|NCT00112437|27245723|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851700|NCT00112437|27245724|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851701|NCT00112437|27245725|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851702|NCT00112437|27245726|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851703|NCT00112437|27245727|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851704|NCT00112437|27245728|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7851705|NCT00112437|27245703|P26|Year 3 (12-Month Extension)|Protocol Violation|0
7851706|NCT00112437|27245704|P25|Year 3 (12-Month Extension)|Protocol Violation|0
7851707|NCT00112437|27245705|P24|Year 3 (12-Month Extension)|Protocol Violation|0
7851708|NCT00112437|27245706|P23|Year 3 (12-Month Extension)|Protocol Violation|0
7851709|NCT00112437|27245707|P22|Year 3 (12-Month Extension)|Protocol Violation|0
7851710|NCT00112437|27245708|P21|Year 3 (12-Month Extension)|Protocol Violation|0
7851711|NCT00112437|27245709|P20|Year 3 (12-Month Extension)|Protocol Violation|0
7851712|NCT00112437|27245710|P19|Year 3 (12-Month Extension)|Protocol Violation|0
7851713|NCT00112437|27245711|P18|Year 3 (12-Month Extension)|Protocol Violation|0
7851714|NCT00112437|27245712|P17|Year 3 (12-Month Extension)|Protocol Violation|0
7851715|NCT00112437|27245713|P16|Year 3 (12-Month Extension)|Protocol Violation|1
7851716|NCT00112437|27245714|P15|Year 3 (12-Month Extension)|Protocol Violation|0
7851717|NCT00112437|27245715|P14|Year 3 (12-Month Extension)|Protocol Violation|0
7851718|NCT00112437|27245716|P13|Year 3 (12-Month Extension)|Protocol Violation|0
7851719|NCT00112437|27245717|P12|Year 3 (12-Month Extension)|Protocol Violation|0
7851720|NCT00112437|27245718|P11|Year 3 (12-Month Extension)|Protocol Violation|0
7851721|NCT00112437|27245719|P10|Year 3 (12-Month Extension)|Protocol Violation|0
7851722|NCT00112437|27245720|P9|Year 3 (12-Month Extension)|Protocol Violation|0
7851723|NCT00112437|27245721|P8|Year 3 (12-Month Extension)|Protocol Violation|0
7851724|NCT00112437|27245722|P7|Year 3 (12-Month Extension)|Protocol Violation|0
7851725|NCT00112437|27245723|P6|Year 3 (12-Month Extension)|Protocol Violation|0
7851726|NCT00112437|27245724|P5|Year 3 (12-Month Extension)|Protocol Violation|0
7851727|NCT00112437|27245725|P4|Year 3 (12-Month Extension)|Protocol Violation|0
7851728|NCT00112437|27245726|P3|Year 3 (12-Month Extension)|Protocol Violation|0
7851729|NCT00112437|27245727|P2|Year 3 (12-Month Extension)|Protocol Violation|0
7851730|NCT00112437|27245728|P1|Year 3 (12-Month Extension)|Protocol Violation|0
7851731|NCT00112437|27245703|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851732|NCT00112437|27245704|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851733|NCT00112437|27245705|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851734|NCT00112437|27245706|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851735|NCT00112437|27245707|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851736|NCT00112437|27245708|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851737|NCT00112437|27245709|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851738|NCT00112437|27245710|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851739|NCT00112437|27245711|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851740|NCT00112437|27245712|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851741|NCT00112437|27245713|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
7851742|NCT00112437|27245714|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851743|NCT00112437|27245715|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851744|NCT00112437|27245716|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851745|NCT00112437|27245717|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851746|NCT00112437|27245718|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851747|NCT00112437|27245719|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851748|NCT00112437|27245720|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851749|NCT00112437|27245721|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851750|NCT00112437|27245722|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851751|NCT00112437|27245723|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851752|NCT00112437|27245724|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851753|NCT00112437|27245725|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851754|NCT00112437|27245726|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851755|NCT00112437|27245727|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851756|NCT00112437|27245728|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
7851757|NCT00112437|27245703|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851758|NCT00112437|27245704|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851759|NCT00112437|27245705|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851760|NCT00112437|27245706|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851761|NCT00112437|27245707|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851762|NCT00112437|27245708|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851763|NCT00112437|27245709|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851764|NCT00112437|27245710|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
7851765|NCT00112437|27245711|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851766|NCT00112437|27245712|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851767|NCT00112437|27245713|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
7851768|NCT00112437|27245714|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851769|NCT00112437|27245715|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
7851770|NCT00112437|27245716|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851771|NCT00112437|27245717|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
7851772|NCT00112437|27245718|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851773|NCT00112437|27245719|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851774|NCT00112437|27245720|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851775|NCT00112437|27245721|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851776|NCT00112437|27245722|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851777|NCT00112437|27245723|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851778|NCT00112437|27245724|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851779|NCT00112437|27245725|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851780|NCT00112437|27245726|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851781|NCT00112437|27245727|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851782|NCT00112437|27245728|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
7851783|NCT00112437|27245703|P26|Year 3 (12-Month Extension)|Adverse Event|0
7851784|NCT00112437|27245704|P25|Year 3 (12-Month Extension)|Adverse Event|0
7851785|NCT00112437|27245705|P24|Year 3 (12-Month Extension)|Adverse Event|0
7851786|NCT00112437|27245706|P23|Year 3 (12-Month Extension)|Adverse Event|0
7851787|NCT00112437|27245707|P22|Year 3 (12-Month Extension)|Adverse Event|0
7851788|NCT00112437|27245708|P21|Year 3 (12-Month Extension)|Adverse Event|0
7851789|NCT00112437|27245709|P20|Year 3 (12-Month Extension)|Adverse Event|1
7851790|NCT00112437|27245710|P19|Year 3 (12-Month Extension)|Adverse Event|0
7851791|NCT00112437|27245711|P18|Year 3 (12-Month Extension)|Adverse Event|1
7851792|NCT00112437|27245712|P17|Year 3 (12-Month Extension)|Adverse Event|3
7851793|NCT00112437|27245713|P16|Year 3 (12-Month Extension)|Adverse Event|1
7851794|NCT00112437|27245714|P15|Year 3 (12-Month Extension)|Adverse Event|0
7851795|NCT00112437|27245715|P14|Year 3 (12-Month Extension)|Adverse Event|0
7851796|NCT00112437|27245716|P13|Year 3 (12-Month Extension)|Adverse Event|0
7851797|NCT00112437|27245717|P12|Year 3 (12-Month Extension)|Adverse Event|0
7851798|NCT00112437|27245718|P11|Year 3 (12-Month Extension)|Adverse Event|1
7851799|NCT00112437|27245719|P10|Year 3 (12-Month Extension)|Adverse Event|0
7851800|NCT00112437|27245720|P9|Year 3 (12-Month Extension)|Adverse Event|0
7851801|NCT00112437|27245721|P8|Year 3 (12-Month Extension)|Adverse Event|0
7851802|NCT00112437|27245722|P7|Year 3 (12-Month Extension)|Adverse Event|0
7851803|NCT00112437|27245723|P6|Year 3 (12-Month Extension)|Adverse Event|0
7851804|NCT00112437|27245724|P5|Year 3 (12-Month Extension)|Adverse Event|0
7851805|NCT00112437|27245725|P4|Year 3 (12-Month Extension)|Adverse Event|0
7851806|NCT00112437|27245726|P3|Year 3 (12-Month Extension)|Adverse Event|0
7851807|NCT00112437|27245727|P2|Year 3 (12-Month Extension)|Adverse Event|0
7851808|NCT00112437|27245728|P1|Year 3 (12-Month Extension)|Adverse Event|0
7851809|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Moved|0
7851810|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Moved|0
7851811|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Moved|0
7851812|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Moved|0
7851813|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Moved|0
7851814|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Moved|0
7851815|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Moved|0
7851816|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Moved|0
7851817|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Moved|0
7851818|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Moved|0
7851819|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Moved|0
7851820|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Moved|0
7851821|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Moved|0
7851822|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Moved|0
7851823|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Moved|0
7851824|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Moved|0
7851825|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Moved|1
7851826|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Moved|0
7851827|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Moved|0
7851828|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Moved|0
7851829|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Moved|0
7851830|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Moved|0
7851831|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Moved|0
7851832|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Moved|0
7851833|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Moved|0
7851834|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Moved|0
7851835|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|patient was out of windows|0
7851836|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|patient was out of windows|0
7851837|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|patient was out of windows|0
7851838|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|patient was out of windows|0
7851839|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|patient was out of windows|0
7851840|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|patient was out of windows|0
7851841|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|patient was out of windows|0
7851842|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|patient was out of windows|0
7851843|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|patient was out of windows|0
7851844|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|patient was out of windows|0
7851845|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|patient was out of windows|0
7851846|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|patient was out of windows|0
7851847|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|patient was out of windows|0
7851848|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|patient was out of windows|0
7851849|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|patient was out of windows|0
7851850|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|patient was out of windows|0
7851851|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|patient was out of windows|1
7851852|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|patient was out of windows|0
7851853|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|patient was out of windows|0
7851854|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|patient was out of windows|0
7851855|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|patient was out of windows|0
7851856|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|patient was out of windows|0
7851857|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|patient was out of windows|0
7851858|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|patient was out of windows|0
7851859|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|patient was out of windows|0
7851860|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|patient was out of windows|0
7851861|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851862|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851863|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851864|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851865|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851866|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851867|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851868|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851869|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851870|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851871|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851872|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851873|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851874|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851875|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851876|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851877|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
7851878|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851879|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851880|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851881|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851882|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851883|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851884|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851885|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851886|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7851887|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851888|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851889|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851890|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851891|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851892|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851893|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851894|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851895|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851896|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851897|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851898|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851899|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851900|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851901|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851902|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851903|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7851904|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
7851905|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
7851906|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7851907|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7851908|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851909|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851910|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851911|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851912|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7851913|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Protocol Violation|0
7851914|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Protocol Violation|0
7851915|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Protocol Violation|0
7851916|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Protocol Violation|0
7851917|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Protocol Violation|0
7851918|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Protocol Violation|0
7851919|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Protocol Violation|0
7851920|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Protocol Violation|0
7851921|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Protocol Violation|0
7851922|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Protocol Violation|0
7851923|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Protocol Violation|0
7851924|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Protocol Violation|0
7851925|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Protocol Violation|0
7851926|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Protocol Violation|0
7851927|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Protocol Violation|0
7851928|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Protocol Violation|0
7851929|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Protocol Violation|0
7851930|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Protocol Violation|1
7851931|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Protocol Violation|0
7851932|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Protocol Violation|0
7851933|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Protocol Violation|0
7851934|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Protocol Violation|0
7851935|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Protocol Violation|0
7851936|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Protocol Violation|0
7851937|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Protocol Violation|0
7851938|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Protocol Violation|0
7851939|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851940|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851941|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851942|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851943|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851944|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851945|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851946|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851947|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851948|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851949|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851950|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851951|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851952|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851953|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851954|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851955|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851956|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
7851957|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851958|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851959|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851960|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851961|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851962|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851963|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851964|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
7851965|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851966|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851967|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851968|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851969|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851970|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851971|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851972|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851973|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851974|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851975|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851976|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851977|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851978|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851979|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851980|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851981|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
7851982|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851983|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851984|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
7851985|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
7851986|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851987|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851988|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851989|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851990|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
7851991|NCT00112437|27245703|P26|Year 2 (12-Month Extension)|Adverse Event|0
7851992|NCT00112437|27245704|P25|Year 2 (12-Month Extension)|Adverse Event|0
7851993|NCT00112437|27245705|P24|Year 2 (12-Month Extension)|Adverse Event|0
7851994|NCT00112437|27245706|P23|Year 2 (12-Month Extension)|Adverse Event|0
7851995|NCT00112437|27245707|P22|Year 2 (12-Month Extension)|Adverse Event|0
7851996|NCT00112437|27245708|P21|Year 2 (12-Month Extension)|Adverse Event|0
7851997|NCT00112437|27245709|P20|Year 2 (12-Month Extension)|Adverse Event|0
7851998|NCT00112437|27245710|P19|Year 2 (12-Month Extension)|Adverse Event|0
7851999|NCT00112437|27245711|P18|Year 2 (12-Month Extension)|Adverse Event|0
7852000|NCT00112437|27245712|P17|Year 2 (12-Month Extension)|Adverse Event|0
7852001|NCT00112437|27245713|P16|Year 2 (12-Month Extension)|Adverse Event|0
7852002|NCT00112437|27245714|P15|Year 2 (12-Month Extension)|Adverse Event|0
7852003|NCT00112437|27245715|P14|Year 2 (12-Month Extension)|Adverse Event|0
7852004|NCT00112437|27245716|P13|Year 2 (12-Month Extension)|Adverse Event|0
7852005|NCT00112437|27245717|P12|Year 2 (12-Month Extension)|Adverse Event|0
7852006|NCT00112437|27245718|P11|Year 2 (12-Month Extension)|Adverse Event|0
7852007|NCT00112437|27245719|P10|Year 2 (12-Month Extension)|Adverse Event|7
7852008|NCT00112437|27245720|P9|Year 2 (12-Month Extension)|Adverse Event|1
7852009|NCT00112437|27245721|P8|Year 2 (12-Month Extension)|Adverse Event|6
7852010|NCT00112437|27245722|P7|Year 2 (12-Month Extension)|Adverse Event|2
7852011|NCT00112437|27245723|P6|Year 2 (12-Month Extension)|Adverse Event|1
7852012|NCT00112437|27245724|P5|Year 2 (12-Month Extension)|Adverse Event|0
7852013|NCT00112437|27245725|P4|Year 2 (12-Month Extension)|Adverse Event|0
7852014|NCT00112437|27245726|P3|Year 2 (12-Month Extension)|Adverse Event|0
7852015|NCT00112437|27245727|P2|Year 2 (12-Month Extension)|Adverse Event|0
7852016|NCT00112437|27245728|P1|Year 2 (12-Month Extension)|Adverse Event|0
7852017|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852018|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852019|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852020|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852021|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852022|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852023|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852024|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852025|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852026|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852027|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852028|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852029|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852030|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852031|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852032|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852033|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852034|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852035|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852036|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852037|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852038|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
7852039|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852040|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852041|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852042|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7852043|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852044|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852045|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852046|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852047|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852048|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852049|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852050|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852051|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852052|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852053|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852054|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852055|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852056|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852057|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852058|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852059|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852060|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852061|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852062|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852063|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852064|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852065|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
7852066|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852067|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852068|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7852069|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|moved|0
7852070|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|moved|0
7852071|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|moved|0
7852072|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|moved|0
7852073|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|moved|0
7852074|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|moved|0
7852075|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|moved|0
7852076|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|moved|0
7852077|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|moved|0
7852078|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|moved|0
7852079|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|moved|0
7852080|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|moved|0
7852081|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|moved|0
7852082|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|moved|0
7852083|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|moved|0
7852084|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|moved|0
7852085|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|moved|0
7852086|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|moved|0
7852087|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|moved|0
7852088|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|moved|0
7852089|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|moved|0
7852090|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|moved|0
7852091|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|moved|0
7852092|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|moved|1
7852093|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|moved|1
7852094|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|moved|0
7852095|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852096|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852097|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852098|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852099|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852100|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852101|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852102|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852103|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852104|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852105|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852106|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852107|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852108|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852109|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852110|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852111|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852112|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852113|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852114|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852115|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7852116|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
7852117|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
7852118|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
7852119|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
7852120|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
7852121|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
7852122|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
7852123|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
7852124|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
7852125|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
7852126|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
7852127|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
7852128|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
7852129|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
7852130|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
7852131|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
7852132|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
7852133|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
7852134|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
7852135|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
7852136|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
7852137|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
7852138|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
7852139|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
7852140|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
7852141|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
7852142|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
7852143|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
7852144|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
7852145|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
7852146|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
7852147|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852148|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852149|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852150|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852151|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852152|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852153|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852154|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852155|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852156|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852157|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852158|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852159|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852160|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852161|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852162|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852163|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852164|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852165|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852166|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852167|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852168|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852169|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852170|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852171|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
7852172|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7852173|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852174|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852175|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852176|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852177|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852178|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852179|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852180|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852181|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852182|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852183|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852184|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852185|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852186|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852187|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852188|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852189|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852190|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852191|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852192|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852193|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852194|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852195|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852196|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852197|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
7852198|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7852199|NCT00112437|27245703|P26|Year 1 (12-Month Base Study)|Adverse Event|0
7852200|NCT00112437|27245704|P25|Year 1 (12-Month Base Study)|Adverse Event|0
7852201|NCT00112437|27245705|P24|Year 1 (12-Month Base Study)|Adverse Event|0
7852202|NCT00112437|27245706|P23|Year 1 (12-Month Base Study)|Adverse Event|0
7852203|NCT00112437|27245707|P22|Year 1 (12-Month Base Study)|Adverse Event|0
7852204|NCT00112437|27245708|P21|Year 1 (12-Month Base Study)|Adverse Event|0
7852205|NCT00112437|27245709|P20|Year 1 (12-Month Base Study)|Adverse Event|0
7852206|NCT00112437|27245710|P19|Year 1 (12-Month Base Study)|Adverse Event|0
7852207|NCT00112437|27245711|P18|Year 1 (12-Month Base Study)|Adverse Event|0
7852208|NCT00112437|27245712|P17|Year 1 (12-Month Base Study)|Adverse Event|0
7852209|NCT00112437|27245713|P16|Year 1 (12-Month Base Study)|Adverse Event|0
7852210|NCT00112437|27245714|P15|Year 1 (12-Month Base Study)|Adverse Event|0
7852211|NCT00112437|27245715|P14|Year 1 (12-Month Base Study)|Adverse Event|0
7852212|NCT00112437|27245716|P13|Year 1 (12-Month Base Study)|Adverse Event|0
7852213|NCT00112437|27245717|P12|Year 1 (12-Month Base Study)|Adverse Event|0
7852214|NCT00112437|27245718|P11|Year 1 (12-Month Base Study)|Adverse Event|0
7852215|NCT00112437|27245719|P10|Year 1 (12-Month Base Study)|Adverse Event|0
7852216|NCT00112437|27245720|P9|Year 1 (12-Month Base Study)|Adverse Event|0
7852217|NCT00112437|27245721|P8|Year 1 (12-Month Base Study)|Adverse Event|0
7852218|NCT00112437|27245722|P7|Year 1 (12-Month Base Study)|Adverse Event|0
7852219|NCT00112437|27245723|P6|Year 1 (12-Month Base Study)|Adverse Event|0
7852220|NCT00112437|27245724|P5|Year 1 (12-Month Base Study)|Adverse Event|3
7852221|NCT00112437|27245725|P4|Year 1 (12-Month Base Study)|Adverse Event|4
7852222|NCT00112437|27245726|P3|Year 1 (12-Month Base Study)|Adverse Event|6
7852223|NCT00112437|27245727|P2|Year 1 (12-Month Base Study)|Adverse Event|10
7852224|NCT00112437|27245728|P1|Year 1 (12-Month Base Study)|Adverse Event|9
7852225|NCT00112385|27246008|P2|Overall Study|Withdrawal by Subject|1
7852226|NCT00112385|27246009|P1|Overall Study|Withdrawal by Subject|0
7852227|NCT00112385|27246008|P2|Overall Study|Lost to Follow-up|0
7852228|NCT00112385|27246009|P1|Overall Study|Lost to Follow-up|1
7852229|NCT00112359|27246099|P2|Overall Study|Other|0
7852230|NCT00112359|27246100|P1|Overall Study|Other|3
7852231|NCT00112359|27246099|P2|Overall Study|Personal/administrative|1
7852232|NCT00112359|27246100|P1|Overall Study|Personal/administrative|1
7852233|NCT00112359|27246099|P2|Overall Study|Lost to Follow-up|1
7852234|NCT00112359|27246100|P1|Overall Study|Lost to Follow-up|0
7852235|NCT00112359|27246099|P2|Overall Study|Related adverse event|3
7852236|NCT00112359|27246100|P1|Overall Study|Related adverse event|5
7852237|NCT00112359|27246099|P2|Overall Study|Trial drug intolerance (adverse event)|0
7852238|NCT00112359|27246100|P1|Overall Study|Trial drug intolerance (adverse event)|2
7852239|NCT00112359|27246099|P2|Overall Study|Unrelated adverse event|8
7852240|NCT00112359|27246100|P1|Overall Study|Unrelated adverse event|16
7852241|NCT00112294|27246126|P2|Overall Study|Still on study|0
7852242|NCT00112294|27246127|P1|Overall Study|Still on study|5
7852243|NCT00112047|27246435|P2|Atripla Phase|Other|1
7852244|NCT00112047|27246436|P1|Atripla Phase|Other|3
7852245|NCT00112047|27246435|P2|Atripla Phase|Non-compliance|0
7852246|NCT00112047|27246436|P1|Atripla Phase|Non-compliance|1
7852247|NCT00112047|27246435|P2|Atripla Phase|Sub-optimal virological response|1
7852248|NCT00112047|27246436|P1|Atripla Phase|Sub-optimal virological response|0
7852249|NCT00112047|27246435|P2|Atripla Phase|Withdrew consent|7
7852250|NCT00112047|27246436|P1|Atripla Phase|Withdrew consent|7
7852251|NCT00112047|27246435|P2|Atripla Phase|Death|2
7852252|NCT00112047|27246436|P1|Atripla Phase|Death|0
7852253|NCT00112047|27246435|P2|Atripla Phase|Pregnancy|1
7852254|NCT00112047|27246436|P1|Atripla Phase|Pregnancy|0
7852255|NCT00112047|27246435|P2|Atripla Phase|Lost to Follow-up|7
7852256|NCT00112047|27246436|P1|Atripla Phase|Lost to Follow-up|5
7852257|NCT00112047|27246435|P2|Atripla Phase|Adverse Event|1
7852258|NCT00112047|27246436|P1|Atripla Phase|Adverse Event|2
7852259|NCT00112047|27246435|P2|Randomized Phase|High Hepatitis B DNA|1
7852260|NCT00112047|27246436|P1|Randomized Phase|High Hepatitis B DNA|0
7852261|NCT00112047|27246435|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
7852262|NCT00112047|27246436|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
7852263|NCT00112047|27246435|P2|Randomized Phase|Moved out of State|1
7852264|NCT00112047|27246436|P1|Randomized Phase|Moved out of State|0
7852265|NCT00112047|27246435|P2|Randomized Phase|Incarceration|2
7852266|NCT00112047|27246436|P1|Randomized Phase|Incarceration|3
7852267|NCT00112047|27246435|P2|Randomized Phase|Inability to swallow pills|1
7852268|NCT00112047|27246436|P1|Randomized Phase|Inability to swallow pills|0
7852269|NCT00112047|27246435|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
7852270|NCT00112047|27246436|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
7852271|NCT00112047|27246435|P2|Randomized Phase|Death|3
7852272|NCT00112047|27246436|P1|Randomized Phase|Death|1
7852273|NCT00112047|27246435|P2|Randomized Phase|Pregnancy|1
7852274|NCT00112047|27246436|P1|Randomized Phase|Pregnancy|3
7852275|NCT00112047|27246435|P2|Randomized Phase|Protocol Violation|0
7852276|NCT00112047|27246436|P1|Randomized Phase|Protocol Violation|2
7852277|NCT00112047|27246435|P2|Randomized Phase|Noncompliance|4
7852278|NCT00112047|27246436|P1|Randomized Phase|Noncompliance|8
7852279|NCT00112047|27246435|P2|Randomized Phase|Sub-optimal virological response|13
7852280|NCT00112047|27246436|P1|Randomized Phase|Sub-optimal virological response|3
7852281|NCT00112047|27246435|P2|Randomized Phase|Withrawal of consent|18
7852282|NCT00112047|27246436|P1|Randomized Phase|Withrawal of consent|10
7852283|NCT00112047|27246435|P2|Randomized Phase|Adverse Event|10
7852284|NCT00112047|27246436|P1|Randomized Phase|Adverse Event|10
7852285|NCT00112047|27246435|P2|Randomized Phase|Lost to Follow-up|33
7852286|NCT00112047|27246436|P1|Randomized Phase|Lost to Follow-up|26
7852287|NCT00111917|27246536|P2|Overall Study|Withdrawal by Subject|1
7852288|NCT00111917|27246537|P1|Overall Study|Withdrawal by Subject|1
7852289|NCT00111839|27246552|P3|Overall Study|Randomized but Not Treated|2
7852290|NCT00111839|27246553|P2|Overall Study|Randomized but Not Treated|0
7852291|NCT00111839|27246554|P1|Overall Study|Randomized but Not Treated|0
7852292|NCT00111839|27246552|P3|Overall Study|Other|3
7852293|NCT00111839|27246553|P2|Overall Study|Other|3
7852294|NCT00111839|27246554|P1|Overall Study|Other|6
7852295|NCT00111839|27246552|P3|Overall Study|Logistical Constraint|0
7852296|NCT00111839|27246553|P2|Overall Study|Logistical Constraint|0
7852297|NCT00111839|27246554|P1|Overall Study|Logistical Constraint|1
7852298|NCT00111839|27246552|P3|Overall Study|Lost to Follow-up|0
7852299|NCT00111839|27246553|P2|Overall Study|Lost to Follow-up|0
7852300|NCT00111839|27246554|P1|Overall Study|Lost to Follow-up|1
7852301|NCT00111839|27246552|P3|Overall Study|Withdrawal by Subject|2
7852302|NCT00111839|27246553|P2|Overall Study|Withdrawal by Subject|2
7852303|NCT00111839|27246554|P1|Overall Study|Withdrawal by Subject|2
7852304|NCT00111839|27246552|P3|Overall Study|Death|6
7852305|NCT00111839|27246553|P2|Overall Study|Death|1
7852306|NCT00111839|27246554|P1|Overall Study|Death|1
7852307|NCT00111839|27246552|P3|Overall Study|Protocol Violation|2
7852308|NCT00111839|27246553|P2|Overall Study|Protocol Violation|4
7852309|NCT00111839|27246554|P1|Overall Study|Protocol Violation|2
7852310|NCT00111839|27246552|P3|Overall Study|Adverse Event|1
7852311|NCT00111839|27246553|P2|Overall Study|Adverse Event|3
7852312|NCT00111839|27246554|P1|Overall Study|Adverse Event|5
7852313|NCT00111839|27246552|P3|Overall Study|Disease Progression|33
7852314|NCT00111839|27246553|P2|Overall Study|Disease Progression|33
7852315|NCT00111839|27246554|P1|Overall Study|Disease Progression|30
7852316|NCT00111813|27246574|P6|Overall Study|Other|0
7852317|NCT00111813|27246575|P5|Overall Study|Other|0
7852318|NCT00111813|27246576|P4|Overall Study|Other|0
7852319|NCT00111813|27246577|P3|Overall Study|Other|1
7852320|NCT00111813|27246578|P2|Overall Study|Other|0
7852321|NCT00111813|27246579|P1|Overall Study|Other|0
7852322|NCT00111813|27246574|P6|Overall Study|Lack of Efficacy|1
7852323|NCT00111813|27246575|P5|Overall Study|Lack of Efficacy|0
7852324|NCT00111813|27246576|P4|Overall Study|Lack of Efficacy|0
7852325|NCT00111813|27246577|P3|Overall Study|Lack of Efficacy|0
7852326|NCT00111813|27246578|P2|Overall Study|Lack of Efficacy|0
7852327|NCT00111813|27246579|P1|Overall Study|Lack of Efficacy|0
7852328|NCT00111813|27246574|P6|Overall Study|Progressive disease|3
7852329|NCT00111813|27246575|P5|Overall Study|Progressive disease|4
7852330|NCT00111813|27246576|P4|Overall Study|Progressive disease|3
7852331|NCT00111813|27246577|P3|Overall Study|Progressive disease|5
7852332|NCT00111813|27246578|P2|Overall Study|Progressive disease|1
7852333|NCT00111813|27246579|P1|Overall Study|Progressive disease|2
7852334|NCT00111813|27246574|P6|Overall Study|Adverse Event|2
7852335|NCT00111813|27246575|P5|Overall Study|Adverse Event|2
7852336|NCT00111813|27246576|P4|Overall Study|Adverse Event|2
7852337|NCT00111813|27246577|P3|Overall Study|Adverse Event|4
7852338|NCT00111813|27246578|P2|Overall Study|Adverse Event|2
7852339|NCT00111813|27246579|P1|Overall Study|Adverse Event|1
7852340|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7852341|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7852342|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7852343|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
7852344|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7852345|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7852346|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7852347|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7852348|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7852349|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
7852350|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7852351|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7852352|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7852353|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7852354|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7852355|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7852356|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
7852357|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7852358|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7852359|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7852360|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7852361|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
7852362|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7852363|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7852364|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7852365|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
7852366|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7852367|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7852368|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
7852369|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7852370|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7852371|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
7852372|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7852373|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
7852374|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
7852375|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7852376|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7852377|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7852378|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7852379|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
7852380|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
7852381|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7852382|NCT00111800|27246618|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7852383|NCT00111800|27246619|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7852384|NCT00111800|27246620|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
7852385|NCT00111800|27246621|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
7852386|NCT00111800|27246622|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
7852387|NCT00111800|27246623|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7852388|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
7852389|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7852390|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7852391|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7852392|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7852393|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7852394|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7852395|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
7852396|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7852397|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7852398|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7852399|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7852400|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7852401|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
7852402|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7852403|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7852404|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7852405|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7852406|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7852407|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7852408|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
7852409|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7852410|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7852411|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7852412|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7852413|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7852414|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
7852415|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7852416|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7852417|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7852418|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7852419|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7852420|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7852421|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7852422|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
7852423|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7852424|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7852425|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7852426|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7852427|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7852428|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
7852429|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7852430|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7852431|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7852432|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7852433|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7852434|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
7852435|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7852436|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7852437|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7852438|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7852439|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7852440|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
7852441|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7852442|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7852443|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7852444|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7852445|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7852446|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7852447|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
7852448|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7852449|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7852450|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7852451|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7852452|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
7852453|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
7852454|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7852455|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7852456|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7852457|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7852458|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7852459|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7852460|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7852461|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7852462|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7852463|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7852464|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7852465|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7852466|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7852467|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7852468|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
7852469|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7852470|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7852471|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
7852472|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
7852473|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
7852474|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
7852475|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
7852476|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
7852477|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
7852478|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
7852479|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
7852480|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
7852481|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
7852482|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
7852483|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
7852484|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
7852485|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7852486|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7852487|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
7852488|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7852489|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
7852490|NCT00111800|27246618|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7852491|NCT00111800|27246619|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
7852492|NCT00111800|27246620|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7852493|NCT00111800|27246621|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7852494|NCT00111800|27246622|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
7852495|NCT00111800|27246623|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
7852496|NCT00111761|27246793|P2|Part 2|Other|0
7852497|NCT00111761|27246794|P1|Part 2|Other|1
7852498|NCT00111761|27246793|P2|Part 2|Protocol-specified criteria|0
7852499|NCT00111761|27246794|P1|Part 2|Protocol-specified criteria|1
7852500|NCT00111761|27246793|P2|Part 2|Disease progression|0
7852501|NCT00111761|27246794|P1|Part 2|Disease progression|3
7852502|NCT00111761|27246793|P2|Part 2|Death|0
7852503|NCT00111761|27246794|P1|Part 2|Death|1
7852504|NCT00111761|27246793|P2|Part 2|Physician Decision|0
7852505|NCT00111761|27246794|P1|Part 2|Physician Decision|1
7852506|NCT00111761|27246793|P2|Part 2|Adverse Event|0
7852507|NCT00111761|27246794|P1|Part 2|Adverse Event|1
7852508|NCT00111761|27246793|P2|Part 1|Withdrawal by Subject|1
7852509|NCT00111761|27246794|P1|Part 1|Withdrawal by Subject|0
7852510|NCT00111761|27246793|P2|Part 1|Other|1
7852511|NCT00111761|27246794|P1|Part 1|Other|0
7852512|NCT00111761|27246793|P2|Part 1|Death|2
7852513|NCT00111761|27246794|P1|Part 1|Death|0
7852514|NCT00111761|27246793|P2|Part 1|Physician Decision|1
7852515|NCT00111761|27246794|P1|Part 1|Physician Decision|0
7852516|NCT00111475|27246831|P10|Overall Study|Lost to Follow-up|0
7852517|NCT00111475|27246832|P9|Overall Study|Lost to Follow-up|0
7852518|NCT00111475|27246833|P8|Overall Study|Lost to Follow-up|0
7852519|NCT00111475|27246834|P7|Overall Study|Lost to Follow-up|0
7852520|NCT00111475|27246835|P6|Overall Study|Lost to Follow-up|1
7852521|NCT00111475|27246836|P5|Overall Study|Lost to Follow-up|0
7852522|NCT00111475|27246837|P4|Overall Study|Lost to Follow-up|0
7852523|NCT00111475|27246838|P3|Overall Study|Lost to Follow-up|0
7852524|NCT00111475|27246839|P2|Overall Study|Lost to Follow-up|0
7852525|NCT00111475|27246840|P1|Overall Study|Lost to Follow-up|0
7852526|NCT00111241|27246958|P2|Overall Study|Adverse Event|0
7852527|NCT00111241|27246959|P1|Overall Study|Adverse Event|1
7852528|NCT00111241|27246958|P2|Overall Study|Protocol Violation|8
7852529|NCT00111241|27246959|P1|Overall Study|Protocol Violation|9
7852530|NCT00111241|27246958|P2|Overall Study|Withdrawal by Subject|0
7852531|NCT00111241|27246959|P1|Overall Study|Withdrawal by Subject|4
7852532|NCT00111241|27246958|P2|Overall Study|Lost to Follow-up|0
7852533|NCT00111241|27246959|P1|Overall Study|Lost to Follow-up|1
7852534|NCT00111228|27246970|P3|Overall Study|Withdrawal by Subject|0
7852535|NCT00111228|27246971|P2|Overall Study|Withdrawal by Subject|1
7852536|NCT00111228|27246972|P1|Overall Study|Withdrawal by Subject|5
7852537|NCT00111007|27246985|P2|Long Term Follow-up|Missing|3
7852538|NCT00111007|27246986|P1|Long Term Follow-up|Missing|10
7852539|NCT00111007|27246985|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
7852540|NCT00111007|27246986|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
7852541|NCT00111007|27246985|P2|Long Term Follow-up|Withdrawal by Subject|1
7852542|NCT00111007|27246986|P1|Long Term Follow-up|Withdrawal by Subject|0
7852543|NCT00111007|27246985|P2|Long Term Follow-up|Lost to Follow-up|1
7852544|NCT00111007|27246986|P1|Long Term Follow-up|Lost to Follow-up|1
7852545|NCT00111007|27246985|P2|Long Term Follow-up|Death|39
7852546|NCT00111007|27246986|P1|Long Term Follow-up|Death|34
7852547|NCT00111007|27246985|P2|Active Follow-up|Disease progression/recurrence/relapse|2
7852548|NCT00111007|27246986|P1|Active Follow-up|Disease progression/recurrence/relapse|3
7852549|NCT00111007|27246985|P2|Active Follow-up|Death|0
7852550|NCT00111007|27246986|P1|Active Follow-up|Death|2
7852551|NCT00111007|27246985|P2|Active Follow-up|Adverse Event|0
7852552|NCT00111007|27246986|P1|Active Follow-up|Adverse Event|1
7852553|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Primary reason with other category|1
7852554|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Primary reason with other category|0
7852555|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
7852556|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
7852557|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
7852558|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
7852559|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Relapse|0
7852560|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Relapse|1
7852561|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
7852562|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
7852563|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
7852564|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
7852565|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Protocol Violation|1
7852566|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Protocol Violation|0
7852567|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Death|2
7852568|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Death|5
7852569|NCT00111007|27246985|P2|Double-blind (DB) Treatment|Adverse Event|4
7852570|NCT00111007|27246986|P1|Double-blind (DB) Treatment|Adverse Event|12
7852571|NCT00110994|27247002|P2|Long Term Follow-up|Death|17
7852572|NCT00110994|27247003|P1|Long Term Follow-up|Death|19
7852573|NCT00110994|27247002|P2|Active Follow-up|Other reasons|2
7852574|NCT00110994|27247003|P1|Active Follow-up|Other reasons|0
7852575|NCT00110994|27247002|P2|Active Follow-up|Disease progression/recurrence/replace|0
7852576|NCT00110994|27247003|P1|Active Follow-up|Disease progression/recurrence/replace|1
7852577|NCT00110994|27247002|P2|Double-blind (DB) Treatment|other reasons|3
7852578|NCT00110994|27247003|P1|Double-blind (DB) Treatment|other reasons|2
7852579|NCT00110994|27247002|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
7852580|NCT00110994|27247003|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
7852581|NCT00110994|27247002|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
7852582|NCT00110994|27247003|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
7852583|NCT00110994|27247002|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
7852584|NCT00110994|27247003|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
7852585|NCT00110994|27247002|P2|Double-blind (DB) Treatment|Death|0
7852586|NCT00110994|27247003|P1|Double-blind (DB) Treatment|Death|1
7852587|NCT00110994|27247002|P2|Double-blind (DB) Treatment|Adverse Event|0
7852588|NCT00110994|27247003|P1|Double-blind (DB) Treatment|Adverse Event|3
7852589|NCT00110890|27247029|P2|Overall Study|Did not enter follow-up phase|4
7852590|NCT00110890|27247030|P1|Overall Study|Did not enter follow-up phase|10
7852591|NCT00110890|27247029|P2|Overall Study|Parathyroidectomy|1
7852592|NCT00110890|27247030|P1|Overall Study|Parathyroidectomy|0
7852593|NCT00110890|27247029|P2|Overall Study|Disease progression|1
7852594|NCT00110890|27247030|P1|Overall Study|Disease progression|0
7852595|NCT00110890|27247029|P2|Overall Study|Requirement for alternative therapy|1
7852596|NCT00110890|27247030|P1|Overall Study|Requirement for alternative therapy|0
7852597|NCT00110890|27247029|P2|Overall Study|Ineligibility determined|0
7852598|NCT00110890|27247030|P1|Overall Study|Ineligibility determined|3
7852599|NCT00110890|27247029|P2|Overall Study|Other|23
7852600|NCT00110890|27247030|P1|Overall Study|Other|34
7852601|NCT00110890|27247029|P2|Overall Study|Invest. Product Commercially Available|110
7852602|NCT00110890|27247030|P1|Overall Study|Invest. Product Commercially Available|217
7852603|NCT00110890|27247029|P2|Overall Study|Kidney Transplant|12
7852604|NCT00110890|27247030|P1|Overall Study|Kidney Transplant|16
7852605|NCT00110890|27247029|P2|Overall Study|Noncompliance|0
7852606|NCT00110890|27247030|P1|Overall Study|Noncompliance|10
7852607|NCT00110890|27247029|P2|Overall Study|Protocol Deviation|0
7852608|NCT00110890|27247030|P1|Overall Study|Protocol Deviation|1
7852609|NCT00110890|27247029|P2|Overall Study|Withdrawal by Subject|5
7852610|NCT00110890|27247030|P1|Overall Study|Withdrawal by Subject|17
7852611|NCT00110890|27247029|P2|Overall Study|Physician Decision|5
7852612|NCT00110890|27247030|P1|Overall Study|Physician Decision|4
7852613|NCT00110890|27247029|P2|Overall Study|Lost to Follow-up|1
7852614|NCT00110890|27247030|P1|Overall Study|Lost to Follow-up|3
7852615|NCT00110890|27247029|P2|Overall Study|Death|9
7852616|NCT00110890|27247030|P1|Overall Study|Death|16
7852617|NCT00110890|27247029|P2|Overall Study|Adverse Event|7
7852618|NCT00110890|27247030|P1|Overall Study|Adverse Event|30
7852619|NCT00110812|27247047|P3|Extended Follow-up|Lost to Follow-up|1
7852620|NCT00110812|27247048|P2|Extended Follow-up|Lost to Follow-up|3
7852621|NCT00110812|27247049|P1|Extended Follow-up|Lost to Follow-up|1
7852622|NCT00110812|27247047|P3|Extended Follow-up|Withdrawal by Subject|0
7852623|NCT00110812|27247048|P2|Extended Follow-up|Withdrawal by Subject|1
7852624|NCT00110812|27247049|P1|Extended Follow-up|Withdrawal by Subject|0
7852625|NCT00110812|27247047|P3|Extended Follow-up|Death|3
7852626|NCT00110812|27247048|P2|Extended Follow-up|Death|0
7852627|NCT00110812|27247049|P1|Extended Follow-up|Death|1
7852628|NCT00110812|27247047|P3|Main Study|Lost to Follow-up|10
7852629|NCT00110812|27247048|P2|Main Study|Lost to Follow-up|11
7852630|NCT00110812|27247049|P1|Main Study|Lost to Follow-up|8
7852631|NCT00110812|27247047|P3|Main Study|Withdrawal by Subject|1
7852632|NCT00110812|27247048|P2|Main Study|Withdrawal by Subject|0
7852633|NCT00110812|27247049|P1|Main Study|Withdrawal by Subject|0
7852634|NCT00110812|27247047|P3|Main Study|Death|2
7852635|NCT00110812|27247048|P2|Main Study|Death|0
7852636|NCT00110812|27247049|P1|Main Study|Death|0
7852637|NCT00110617|27247094|P2|Overall Study|Did not receive study drug|12
7852638|NCT00110617|27247095|P1|Overall Study|Did not receive study drug|0
7852639|NCT00110617|27247094|P2|Overall Study|Death|1
7852640|NCT00110617|27247095|P1|Overall Study|Death|1
7852641|NCT00110617|27247094|P2|Overall Study|Administrative problems|5
7852642|NCT00110617|27247095|P1|Overall Study|Administrative problems|6
7852643|NCT00110617|27247094|P2|Overall Study|Lost to Follow-up|1
7852644|NCT00110617|27247095|P1|Overall Study|Lost to Follow-up|9
7852645|NCT00110617|27247094|P2|Overall Study|Withdrawal by Subject|4
7852646|NCT00110617|27247095|P1|Overall Study|Withdrawal by Subject|10
7852647|NCT00110617|27247094|P2|Overall Study|Protocol Violation|0
7852648|NCT00110617|27247095|P1|Overall Study|Protocol Violation|5
7852649|NCT00110617|27247094|P2|Overall Study|Patient no longer requires study drug|0
7852650|NCT00110617|27247095|P1|Overall Study|Patient no longer requires study drug|1
7852651|NCT00110617|27247094|P2|Overall Study|Lack of Efficacy|0
7852652|NCT00110617|27247095|P1|Overall Study|Lack of Efficacy|1
7852653|NCT00110617|27247094|P2|Overall Study|Abnormal Laboratory Value|2
7852654|NCT00110617|27247095|P1|Overall Study|Abnormal Laboratory Value|4
7852655|NCT00110617|27247094|P2|Overall Study|Adverse Event|4
7852656|NCT00110617|27247095|P1|Overall Study|Adverse Event|2
7852657|NCT00110396|27247212|P1|Overall Study|Patient is to be administered copaxone|1
7852658|NCT00110396|27247212|P1|Overall Study|The patient has refused to visit site|1
7852659|NCT00110396|27247212|P1|Overall Study|The patient has refused|2
7852660|NCT00110396|27247212|P1|Overall Study|Patient refused to come back|1
7852661|NCT00110396|27247212|P1|Overall Study|Protocol Violation|2
7852662|NCT00110396|27247212|P1|Overall Study|Pregnancy (Protocol violation)|2
7852663|NCT00110396|27247212|P1|Overall Study|Pregnancy|1
7852664|NCT00110396|27247212|P1|Overall Study|Participation in MS vaccine study|1
7852665|NCT00110396|27247212|P1|Overall Study|Patient's decision|1
7852666|NCT00110396|27247212|P1|Overall Study|Patient will|1
7852667|NCT00110396|27247212|P1|Overall Study|Patient refused to participate|1
7852668|NCT00110396|27247212|P1|Overall Study|Patient refused to continue|1
7852669|NCT00110396|27247212|P1|Overall Study|Patient non-compliance|1
7852670|NCT00110396|27247212|P1|Overall Study|Decided not to continue treatment|1
7852671|NCT00110396|27247212|P1|Overall Study|Lack of Efficacy|1
7852672|NCT00110396|27247212|P1|Overall Study|Initiated mitoxantrone therapy|1
7852673|NCT00110396|27247212|P1|Overall Study|Administration of plasmapheresis|1
7852674|NCT00110396|27247212|P1|Overall Study|Lost to Follow-up|1
7852675|NCT00110396|27247212|P1|Overall Study|Adverse Event|15
7852676|NCT00110357|27247220|P2|Overall Study|Withdrawal by Subject|1
7852677|NCT00110357|27247221|P1|Overall Study|Withdrawal by Subject|3
7852678|NCT00110357|27247220|P2|Overall Study|Study Drug Toxicity|3
7852679|NCT00110357|27247221|P1|Overall Study|Study Drug Toxicity|1
7852680|NCT00110357|27247220|P2|Overall Study|Study Closure|0
7852681|NCT00110357|27247221|P1|Overall Study|Study Closure|1
7852682|NCT00110357|27247220|P2|Overall Study|Disease progression/relapse|15
7852683|NCT00110357|27247221|P1|Overall Study|Disease progression/relapse|20
7852684|NCT00110357|27247220|P2|Overall Study|Deterioration without progression|0
7852685|NCT00110357|27247221|P1|Overall Study|Deterioration without progression|2
7852686|NCT00110305|27247309|P2|Overall Study|Other|2
7852687|NCT00110305|27247310|P1|Overall Study|Other|8
7852688|NCT00110305|27247309|P2|Overall Study|Lost to Follow-up|3
7852689|NCT00110305|27247310|P1|Overall Study|Lost to Follow-up|20
7852690|NCT00110305|27247309|P2|Overall Study|Withdrawal by Subject|7
7852691|NCT00110305|27247310|P1|Overall Study|Withdrawal by Subject|7
7852692|NCT00110305|27247309|P2|Overall Study|Protocol Violation|1
7852693|NCT00110305|27247310|P1|Overall Study|Protocol Violation|0
7852694|NCT00110305|27247309|P2|Overall Study|Subject Reached A Virologic Endpoint|3
7852695|NCT00110305|27247310|P1|Overall Study|Subject Reached A Virologic Endpoint|21
7852696|NCT00110305|27247309|P2|Overall Study|Subject Ineligible To Continue The Trial|1
7852697|NCT00110305|27247310|P1|Overall Study|Subject Ineligible To Continue The Trial|2
7852698|NCT00110305|27247309|P2|Overall Study|Subject Non-Compliant|2
7852699|NCT00110305|27247310|P1|Overall Study|Subject Non-Compliant|9
7852700|NCT00110305|27247309|P2|Overall Study|Sponsors Decision|0
7852701|NCT00110305|27247310|P1|Overall Study|Sponsors Decision|1
7852702|NCT00110305|27247309|P2|Overall Study|Adverse Event|13
7852703|NCT00110305|27247310|P1|Overall Study|Adverse Event|46
7852704|NCT00110266|27247361|P1|Overall Study|Participant condition no longer requires study drug|1
7852705|NCT00110266|27247361|P1|Overall Study|Unsatisfactory therapeutic effect|2
7852706|NCT00110266|27247361|P1|Overall Study|Death|17
7852707|NCT00110266|27247361|P1|Overall Study|Withdrawal by Subject|16
7852708|NCT00110266|27247361|P1|Overall Study|Abnormal laboratory value|15
7852709|NCT00110266|27247361|P1|Overall Study|Adverse Event|27
7852710|NCT00110214|27247379|P2|Overall Study|Other (not specified)|75
7852711|NCT00110214|27247380|P1|Overall Study|Other (not specified)|61
7852712|NCT00110214|27247379|P2|Overall Study|Refused further treatment|65
7852713|NCT00110214|27247380|P1|Overall Study|Refused further treatment|52
7852714|NCT00110214|27247379|P2|Overall Study|Adverse Event|192
7852715|NCT00110214|27247380|P1|Overall Study|Adverse Event|115
7852716|NCT00110214|27247379|P2|Overall Study|Disease progression or death|151
7852717|NCT00110214|27247380|P1|Overall Study|Disease progression or death|260
7852718|NCT00110214|27247379|P2|Overall Study|Never started treatment|20
7852719|NCT00110214|27247380|P1|Overall Study|Never started treatment|21
7852720|NCT00110149|27247392|P1|Overall Study|Physician Decision|3
7852721|NCT00110084|27247406|P1|Overall Study|Other|2
7852722|NCT00110084|27247406|P1|Overall Study|Intercurrent Illness|1
7852723|NCT00110084|27247406|P1|Overall Study|Alternate Therapy|5
7852724|NCT00110084|27247406|P1|Overall Study|Patient Refusal|10
7852725|NCT00110084|27247406|P1|Overall Study|Death|1
7852726|NCT00110084|27247406|P1|Overall Study|Adverse Event|9
7852727|NCT00110019|27247415|P2|Overall Study|other reasons|30
7852728|NCT00110019|27247416|P1|Overall Study|other reasons|22
7852729|NCT00110019|27247415|P2|Overall Study|Not start protocol therapy|16
7852730|NCT00110019|27247416|P1|Overall Study|Not start protocol therapy|17
7852731|NCT00110019|27247415|P2|Overall Study|symptom deterioration|16
7852732|NCT00110019|27247416|P1|Overall Study|symptom deterioration|13
7852733|NCT00110019|27247415|P2|Overall Study|complicating disease|1
7852734|NCT00110019|27247416|P1|Overall Study|complicating disease|1
7852735|NCT00110019|27247415|P2|Overall Study|alternative therapy|1
7852736|NCT00110019|27247416|P1|Overall Study|alternative therapy|5
7852737|NCT00110019|27247415|P2|Overall Study|Withdrawal by Subject|9
7852738|NCT00110019|27247416|P1|Overall Study|Withdrawal by Subject|21
7852739|NCT00110019|27247415|P2|Overall Study|Death|15
7852740|NCT00110019|27247416|P1|Overall Study|Death|13
7852741|NCT00110019|27247415|P2|Overall Study|Adverse Event|40
7852742|NCT00110019|27247416|P1|Overall Study|Adverse Event|61
7852743|NCT00110019|27247415|P2|Overall Study|Lack of Efficacy|285
7852744|NCT00110019|27247416|P1|Overall Study|Lack of Efficacy|253
7852745|NCT00109967|27247428|P2|Overall Study|Death|2
7852746|NCT00109967|27247429|P1|Overall Study|Death|0
7852747|NCT00109967|27247428|P2|Overall Study|Physician Decision|3
7852748|NCT00109967|27247429|P1|Overall Study|Physician Decision|1
7852749|NCT00109967|27247428|P2|Overall Study|Withdrawal by Subject|0
7852750|NCT00109967|27247429|P1|Overall Study|Withdrawal by Subject|5
7852751|NCT00109967|27247428|P2|Overall Study|Adverse Event|1
7852752|NCT00109967|27247429|P1|Overall Study|Adverse Event|12
7852753|NCT00109967|27247428|P2|Overall Study|Cancel Prior to Treatment|0
7852754|NCT00109967|27247429|P1|Overall Study|Cancel Prior to Treatment|2
7852755|NCT00109928|27247443|P1|Overall Study|not eligible|1
7852756|NCT00109928|27247443|P1|Overall Study|not protocol specified|2
7852757|NCT00109928|27247443|P1|Overall Study|Death|2
7852758|NCT00109928|27247443|P1|Overall Study|Progression|6
7852759|NCT00109928|27247443|P1|Overall Study|Adverse Event|2
7852760|NCT00109850|27247460|P1|Overall Study|Ineligible|1
7852761|NCT00109850|27247460|P1|Overall Study|Death|2
7852762|NCT00109850|27247460|P1|Overall Study|Adverse Event|1
7852763|NCT00109837|27247467|P1|Overall Study|Ineligible|1
7852764|NCT00109837|27247467|P1|Overall Study|Not treated|1
7852765|NCT00109837|27247467|P1|Overall Study|BCR/ABL+ or Ph+|17
7852766|NCT00109837|27247467|P1|Overall Study|Death|1
7852767|NCT00109837|27247467|P1|Overall Study|Refusal unrelated to adverse effects|1
7852768|NCT00109837|27247467|P1|Overall Study|Adverse Event|2
7852769|NCT00109772|27247477|P2|Open-label Extension|Other|10
7852770|NCT00109772|27247478|P1|Open-label Extension|Other|4
7852771|NCT00109772|27247477|P2|Open-label Extension|Protocol Violation|2
7852772|NCT00109772|27247478|P1|Open-label Extension|Protocol Violation|2
7852773|NCT00109772|27247477|P2|Open-label Extension|Death|1
7852774|NCT00109772|27247478|P1|Open-label Extension|Death|0
7852775|NCT00109772|27247477|P2|Open-label Extension|Lost to Follow-up|0
7852776|NCT00109772|27247478|P1|Open-label Extension|Lost to Follow-up|1
7852777|NCT00109772|27247477|P2|Open-label Extension|Withdrawal by Subject|6
7852778|NCT00109772|27247478|P1|Open-label Extension|Withdrawal by Subject|9
7852779|NCT00109772|27247477|P2|Open-label Extension|Lack of Efficacy|11
7852780|NCT00109772|27247478|P1|Open-label Extension|Lack of Efficacy|19
7852781|NCT00109772|27247477|P2|Open-label Extension|Adverse Event|19
7852782|NCT00109772|27247478|P1|Open-label Extension|Adverse Event|10
7852783|NCT00109772|27247477|P2|Double-blind Treatment|Withdrew prior to treatment|1
7852784|NCT00109772|27247478|P1|Double-blind Treatment|Withdrew prior to treatment|3
7852785|NCT00109772|27247477|P2|Double-blind Treatment|Other|4
7852786|NCT00109772|27247478|P1|Double-blind Treatment|Other|0
7852787|NCT00109772|27247477|P2|Double-blind Treatment|Protocol Violation|1
7852788|NCT00109772|27247478|P1|Double-blind Treatment|Protocol Violation|0
7852789|NCT00109772|27247477|P2|Double-blind Treatment|Lost to Follow-up|3
7852790|NCT00109772|27247478|P1|Double-blind Treatment|Lost to Follow-up|2
7852791|NCT00109772|27247477|P2|Double-blind Treatment|Withdrawal by Subject|1
7852792|NCT00109772|27247478|P1|Double-blind Treatment|Withdrawal by Subject|2
7852793|NCT00109772|27247477|P2|Double-blind Treatment|Lack of Efficacy|0
7852794|NCT00109772|27247478|P1|Double-blind Treatment|Lack of Efficacy|1
7852795|NCT00109772|27247477|P2|Double-blind Treatment|Adverse Event|5
7852796|NCT00109772|27247478|P1|Double-blind Treatment|Adverse Event|14
7852797|NCT00109733|27247518|P2|Overall Study|Could not commit time for study|1
7852798|NCT00109733|27247519|P1|Overall Study|Could not commit time for study|1
7852799|NCT00109733|27247518|P2|Overall Study|Non-compliant|1
7852800|NCT00109733|27247519|P1|Overall Study|Non-compliant|0
7852801|NCT00109733|27247518|P2|Overall Study|Stopped taking study drug|1
7852802|NCT00109733|27247519|P1|Overall Study|Stopped taking study drug|1
7852803|NCT00109733|27247518|P2|Overall Study|Protocol Violation|1
7852804|NCT00109733|27247519|P1|Overall Study|Protocol Violation|0
7852805|NCT00109707|27247536|P3|Overall Study|Patient withdrew consent|0
7852806|NCT00109707|27247537|P2|Overall Study|Patient withdrew consent|1
7852807|NCT00109707|27247538|P1|Overall Study|Patient withdrew consent|6
7852808|NCT00109707|27247536|P3|Overall Study|Protocol Violation|0
7852809|NCT00109707|27247537|P2|Overall Study|Protocol Violation|0
7852810|NCT00109707|27247538|P1|Overall Study|Protocol Violation|1
7852811|NCT00109707|27247536|P3|Overall Study|Lost to Follow-up|0
7852812|NCT00109707|27247537|P2|Overall Study|Lost to Follow-up|0
7852813|NCT00109707|27247538|P1|Overall Study|Lost to Follow-up|3
7852814|NCT00109707|27247536|P3|Overall Study|Disease progression|3
7852815|NCT00109707|27247537|P2|Overall Study|Disease progression|4
7852816|NCT00109707|27247538|P1|Overall Study|Disease progression|12
7852817|NCT00109707|27247536|P3|Overall Study|Death|0
7852818|NCT00109707|27247537|P2|Overall Study|Death|0
7852819|NCT00109707|27247538|P1|Overall Study|Death|4
7852820|NCT00109707|27247536|P3|Overall Study|Adverse Event|3
7852821|NCT00109707|27247537|P2|Overall Study|Adverse Event|2
7852822|NCT00109707|27247538|P1|Overall Study|Adverse Event|10
7852823|NCT00109707|27247536|P3|Overall Study|Administrative problems|1
7852824|NCT00109707|27247537|P2|Overall Study|Administrative problems|0
7852825|NCT00109707|27247538|P1|Overall Study|Administrative problems|2
7852826|NCT00109707|27247536|P3|Overall Study|Abnormal laboratory values|0
7852827|NCT00109707|27247537|P2|Overall Study|Abnormal laboratory values|0
7852828|NCT00109707|27247538|P1|Overall Study|Abnormal laboratory values|1
7852829|NCT00109707|27247536|P3|Overall Study|Discontinued in core study without entering the extension study|34
7852830|NCT00109707|27247537|P2|Overall Study|Discontinued in core study without entering the extension study|122
7852831|NCT00109707|27247538|P1|Overall Study|Discontinued in core study without entering the extension study|215
7852832|NCT00109590|27247566|P3|Overall Study|Never Started Treatment|3
7852833|NCT00109590|27247567|P2|Overall Study|Never Started Treatment|2
7852834|NCT00109590|27247568|P1|Overall Study|Never Started Treatment|1
7852835|NCT00109590|27247566|P3|Overall Study|Lost to Follow-up|1
7852836|NCT00109590|27247567|P2|Overall Study|Lost to Follow-up|0
7852837|NCT00109590|27247568|P1|Overall Study|Lost to Follow-up|1
7852838|NCT00109577|27247610|P2|Overall Study|Withdrawal by Subject|3
7852839|NCT00109577|27247611|P1|Overall Study|Withdrawal by Subject|3
7852840|NCT00109343|27247644|P3|Overall Study|Other|1
7852841|NCT00109343|27247645|P2|Overall Study|Other|2
7852842|NCT00109343|27247646|P1|Overall Study|Other|5
7852843|NCT00109343|27247644|P3|Overall Study|Subject Moved|1
7852844|NCT00109343|27247645|P2|Overall Study|Subject Moved|2
7852845|NCT00109343|27247646|P1|Overall Study|Subject Moved|6
7852846|NCT00109343|27247644|P3|Overall Study|Withdrawal by Subject|10
7852847|NCT00109343|27247645|P2|Overall Study|Withdrawal by Subject|11
7852848|NCT00109343|27247646|P1|Overall Study|Withdrawal by Subject|15
7852849|NCT00109343|27247644|P3|Overall Study|Protocol Violation|2
7852850|NCT00109343|27247645|P2|Overall Study|Protocol Violation|2
7852851|NCT00109343|27247646|P1|Overall Study|Protocol Violation|1
7852852|NCT00109343|27247644|P3|Overall Study|Lost to Follow-up|14
7852853|NCT00109343|27247645|P2|Overall Study|Lost to Follow-up|20
7852854|NCT00109343|27247646|P1|Overall Study|Lost to Follow-up|35
7852855|NCT00109343|27247644|P3|Overall Study|Lack of Efficacy|0
7852856|NCT00109343|27247645|P2|Overall Study|Lack of Efficacy|0
7852857|NCT00109343|27247646|P1|Overall Study|Lack of Efficacy|1
7852858|NCT00109343|27247644|P3|Overall Study|Adverse Event|2
7852859|NCT00109343|27247645|P2|Overall Study|Adverse Event|0
7852860|NCT00109343|27247646|P1|Overall Study|Adverse Event|1
7852861|NCT00109031|27247691|P4|Overall Study|Protocol Violation|0
7852862|NCT00109031|27247692|P3|Overall Study|Protocol Violation|1
7852863|NCT00109031|27247693|P2|Overall Study|Protocol Violation|0
7852864|NCT00109031|27247694|P1|Overall Study|Protocol Violation|0
7852865|NCT00109031|27247691|P4|Overall Study|Physician Decision|0
7852866|NCT00109031|27247692|P3|Overall Study|Physician Decision|0
7852867|NCT00109031|27247693|P2|Overall Study|Physician Decision|1
7852868|NCT00109031|27247694|P1|Overall Study|Physician Decision|0
7852869|NCT00109031|27247691|P4|Overall Study|Withdrawal by Subject|0
7852870|NCT00109031|27247692|P3|Overall Study|Withdrawal by Subject|0
7852871|NCT00109031|27247693|P2|Overall Study|Withdrawal by Subject|1
7852872|NCT00109031|27247694|P1|Overall Study|Withdrawal by Subject|0
7852873|NCT00109031|27247691|P4|Overall Study|Adverse Event|0
7852874|NCT00109031|27247692|P3|Overall Study|Adverse Event|1
7852875|NCT00109031|27247693|P2|Overall Study|Adverse Event|0
7852876|NCT00109031|27247694|P1|Overall Study|Adverse Event|0
7852877|NCT00108953|27247745|P2|Follow-up|Study terminated by sponsor|6
7852878|NCT00108953|27247746|P1|Follow-up|Study terminated by sponsor|10
7852879|NCT00108953|27247745|P2|Follow-up|Lost to Follow-up|1
7852880|NCT00108953|27247746|P1|Follow-up|Lost to Follow-up|1
7852881|NCT00108953|27247745|P2|Follow-up|Death|26
7852882|NCT00108953|27247746|P1|Follow-up|Death|18
7852883|NCT00108862|27247768|P2|Overall Study|Lost to Follow-up|19
7852884|NCT00108862|27247769|P1|Overall Study|Lost to Follow-up|27
7852885|NCT00108862|27247768|P2|Overall Study|Withdrawal by Subject|6
7852886|NCT00108862|27247769|P1|Overall Study|Withdrawal by Subject|10
7852887|NCT00108862|27247768|P2|Overall Study|Death|37
7852888|NCT00108862|27247769|P1|Overall Study|Death|31
7852889|NCT00108745|27247800|P3|Overall Study|Ineligible|13
7852890|NCT00108745|27247801|P2|Overall Study|Ineligible|13
7852891|NCT00108745|27247802|P1|Overall Study|Ineligible|7
7852892|NCT00108745|27247800|P3|Overall Study|Never Treated|12
7852893|NCT00108745|27247801|P2|Overall Study|Never Treated|10
7852894|NCT00108745|27247802|P1|Overall Study|Never Treated|8
7852895|NCT00108745|27247800|P3|Overall Study|Withdrawal by Subject|12
7852896|NCT00108745|27247801|P2|Overall Study|Withdrawal by Subject|12
7852897|NCT00108745|27247802|P1|Overall Study|Withdrawal by Subject|19
7852898|NCT00108732|27247822|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
7852899|NCT00108732|27247822|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
7852900|NCT00108732|27247822|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
7852901|NCT00108732|27247822|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
7852902|NCT00108732|27247822|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
7852903|NCT00108732|27247822|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
7852904|NCT00108732|27247822|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
7852905|NCT00108628|27247831|P2|Overall Study|Death|0
7852906|NCT00108628|27247832|P1|Overall Study|Death|1
7852907|NCT00108628|27247831|P2|Overall Study|Lack of Efficacy|1
7852908|NCT00108628|27247832|P1|Overall Study|Lack of Efficacy|2
7852909|NCT00108628|27247831|P2|Overall Study|Withdrawal by Subject|9
7852910|NCT00108628|27247832|P1|Overall Study|Withdrawal by Subject|17
7852911|NCT00108485|27247882|P2|Overall Study|Lost to Follow-up|2
7852912|NCT00108485|27247883|P1|Overall Study|Lost to Follow-up|0
7852913|NCT00108485|27247882|P2|Overall Study|Withdrawal by Subject|0
7852914|NCT00108485|27247883|P1|Overall Study|Withdrawal by Subject|3
7852915|NCT00108433|27247891|P2|Overall Study|Other|14
7852916|NCT00108433|27247892|P1|Overall Study|Other|14
7852917|NCT00108433|27247891|P2|Overall Study|Adverse Event|1
7852918|NCT00108433|27247892|P1|Overall Study|Adverse Event|3
7852919|NCT00108433|27247891|P2|Overall Study|Death|0
7852920|NCT00108433|27247892|P1|Overall Study|Death|3
7852921|NCT00108433|27247891|P2|Overall Study|Lack of Efficacy|2
7852922|NCT00108433|27247892|P1|Overall Study|Lack of Efficacy|1
7852923|NCT00108355|27247908|P2|Overall Study|Loculated ascites, limiting paracentesis|1
7852924|NCT00108355|27247909|P1|Overall Study|Loculated ascites, limiting paracentesis|1
7852925|NCT00108355|27247908|P2|Overall Study|Peritonitis at index paracentesis|1
7852926|NCT00108355|27247909|P1|Overall Study|Peritonitis at index paracentesis|1
7852927|NCT00108160|27247958|P2|Overall Study|Protocol Violation|5
7852928|NCT00108160|27247959|P1|Overall Study|Protocol Violation|9
7852929|NCT00108160|27247958|P2|Overall Study|Withdrawal by Subject|2
7852930|NCT00108160|27247959|P1|Overall Study|Withdrawal by Subject|4
7852931|NCT00108160|27247958|P2|Overall Study|Death|2
7852932|NCT00108160|27247959|P1|Overall Study|Death|1
7852933|NCT00108160|27247958|P2|Overall Study|Lost to Follow-up|12
7852934|NCT00108160|27247959|P1|Overall Study|Lost to Follow-up|25
7852935|NCT00108082|27247972|P3|Overall Study|Blood Pressure Not Controlled|0
7852936|NCT00108082|27247973|P2|Overall Study|Blood Pressure Not Controlled|0
7852937|NCT00108082|27247974|P1|Overall Study|Blood Pressure Not Controlled|1
7852938|NCT00108082|27247972|P3|Overall Study|Investigator Not at Site|0
7852939|NCT00108082|27247973|P2|Overall Study|Investigator Not at Site|0
7852940|NCT00108082|27247974|P1|Overall Study|Investigator Not at Site|1
7852941|NCT00108082|27247972|P3|Overall Study|Subject Left Site Location|0
7852942|NCT00108082|27247973|P2|Overall Study|Subject Left Site Location|0
7852943|NCT00108082|27247974|P1|Overall Study|Subject Left Site Location|1
7852944|NCT00108082|27247972|P3|Overall Study|Study Medication Not Tapered|0
7852945|NCT00108082|27247973|P2|Overall Study|Study Medication Not Tapered|1
7852946|NCT00108082|27247974|P1|Overall Study|Study Medication Not Tapered|0
7852947|NCT00108082|27247972|P3|Overall Study|Protocol Amendment|0
7852948|NCT00108082|27247973|P2|Overall Study|Protocol Amendment|1
7852949|NCT00108082|27247974|P1|Overall Study|Protocol Amendment|0
7852950|NCT00108082|27247972|P3|Overall Study|Site Closed Study|0
7852951|NCT00108082|27247973|P2|Overall Study|Site Closed Study|2
7852952|NCT00108082|27247974|P1|Overall Study|Site Closed Study|0
7852953|NCT00108082|27247972|P3|Overall Study|Stopped Study Medication|1
7852954|NCT00108082|27247973|P2|Overall Study|Stopped Study Medication|0
7852955|NCT00108082|27247974|P1|Overall Study|Stopped Study Medication|0
7852956|NCT00108082|27247972|P3|Overall Study|Non-compliance|2
7852957|NCT00108082|27247973|P2|Overall Study|Non-compliance|0
7852958|NCT00108082|27247974|P1|Overall Study|Non-compliance|1
7852959|NCT00108082|27247972|P3|Overall Study|Incorrectly Randomized|2
7852960|NCT00108082|27247973|P2|Overall Study|Incorrectly Randomized|0
7852961|NCT00108082|27247974|P1|Overall Study|Incorrectly Randomized|0
7852962|NCT00108082|27247972|P3|Overall Study|Woman of Child-bearing Potential|2
7852963|NCT00108082|27247973|P2|Overall Study|Woman of Child-bearing Potential|0
7852964|NCT00108082|27247974|P1|Overall Study|Woman of Child-bearing Potential|2
7852965|NCT00108082|27247972|P3|Overall Study|Amendment 4: > Month 12|5
7852966|NCT00108082|27247973|P2|Overall Study|Amendment 4: > Month 12|7
7852967|NCT00108082|27247974|P1|Overall Study|Amendment 4: > Month 12|5
7852968|NCT00108082|27247972|P3|Overall Study|Lack of Efficacy|2
7852969|NCT00108082|27247973|P2|Overall Study|Lack of Efficacy|1
7852970|NCT00108082|27247974|P1|Overall Study|Lack of Efficacy|3
7852971|NCT00108082|27247972|P3|Overall Study|Protocol Violation|0
7852972|NCT00108082|27247973|P2|Overall Study|Protocol Violation|2
7852973|NCT00108082|27247974|P1|Overall Study|Protocol Violation|1
7852974|NCT00108082|27247972|P3|Overall Study|Consent Withdrawn|5
7852975|NCT00108082|27247973|P2|Overall Study|Consent Withdrawn|3
7852976|NCT00108082|27247974|P1|Overall Study|Consent Withdrawn|3
7852977|NCT00108082|27247972|P3|Overall Study|Lost to Follow-up|7
7852978|NCT00108082|27247973|P2|Overall Study|Lost to Follow-up|3
7852979|NCT00108082|27247974|P1|Overall Study|Lost to Follow-up|6
7852980|NCT00108082|27247972|P3|Overall Study|Adverse Event|17
7852981|NCT00108082|27247973|P2|Overall Study|Adverse Event|12
7852982|NCT00108082|27247974|P1|Overall Study|Adverse Event|14
7852983|NCT00108069|27248023|P2|Overall Study|Progessive disease|11
7852984|NCT00108069|27248024|P1|Overall Study|Progessive disease|27
7852985|NCT00108069|27248023|P2|Overall Study|Death|0
7852986|NCT00108069|27248024|P1|Overall Study|Death|1
7852987|NCT00108069|27248023|P2|Overall Study|Withdrawal by Subject|0
7852988|NCT00108069|27248024|P1|Overall Study|Withdrawal by Subject|1
7852989|NCT00108069|27248023|P2|Overall Study|Adverse Event|1
7852990|NCT00108069|27248024|P1|Overall Study|Adverse Event|1
7852991|NCT00108069|27248023|P2|Overall Study|Never rec'd study drug|1
7852992|NCT00108069|27248024|P1|Overall Study|Never rec'd study drug|0
7852993|NCT00107991|27248038|P1|18-Week Post Treatment Assessment|Adverse Event|2
7852994|NCT00107991|27248038|P1|12 Week Treatment Period|Incarcerated|1
7852995|NCT00107991|27248038|P1|12 Week Treatment Period|Protocol Violation|1
7852996|NCT00107991|27248038|P1|12 Week Treatment Period|Adverse Event|1
7852997|NCT00107991|27248038|P1|12 Week Treatment Period|Lack of Efficacy|2
7852998|NCT00107991|27248038|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
7852999|NCT00107991|27248038|P1|Eligibility Assessment|chronic uncontrolled asthma|1
7853000|NCT00107991|27248038|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
7853001|NCT00107991|27248038|P1|Eligibility Assessment|Abnormal labs|2
7853002|NCT00107991|27248038|P1|Eligibility Assessment|Positive purified protein derivative|4
7853003|NCT00107991|27248038|P1|Eligibility Assessment|Unwilling to participate|7
7853004|NCT00107991|27248038|P1|Eligibility Assessment|Disease not severe enough|7
7853005|NCT00107978|27248048|P2|Overall Study|Other|4
7853006|NCT00107978|27248049|P1|Overall Study|Other|5
7853007|NCT00107978|27248048|P2|Overall Study|Protocol Violation|1
7853008|NCT00107978|27248049|P1|Overall Study|Protocol Violation|0
7853009|NCT00107978|27248048|P2|Overall Study|Withdrawal by Subject|9
7853010|NCT00107978|27248049|P1|Overall Study|Withdrawal by Subject|4
7853011|NCT00107978|27248048|P2|Overall Study|Lost to Follow-up|28
7853012|NCT00107978|27248049|P1|Overall Study|Lost to Follow-up|20
7853013|NCT00107978|27248048|P2|Overall Study|Death|3
7853014|NCT00107978|27248049|P1|Overall Study|Death|3
7853015|NCT00107978|27248048|P2|Overall Study|Adverse Event|5
7853016|NCT00107978|27248049|P1|Overall Study|Adverse Event|1
7853017|NCT00107952|27248057|P2|Overall Study|Never received study treatment|6
7853018|NCT00107952|27248058|P1|Overall Study|Never received study treatment|9
7853019|NCT00107952|27248057|P2|Overall Study|Other|5
7853020|NCT00107952|27248058|P1|Overall Study|Other|2
7853021|NCT00107952|27248057|P2|Overall Study|Withdrawal by Subject|6
7853022|NCT00107952|27248058|P1|Overall Study|Withdrawal by Subject|9
7853023|NCT00107952|27248057|P2|Overall Study|Lost to Follow-up|3
7853024|NCT00107952|27248058|P1|Overall Study|Lost to Follow-up|0
7853025|NCT00107952|27248057|P2|Overall Study|Death|61
7853026|NCT00107952|27248058|P1|Overall Study|Death|75
7853027|NCT00107900|27248070|P6|Overall Study|Administrative Reasons|0
7853028|NCT00107900|27248071|P5|Overall Study|Administrative Reasons|2
7853029|NCT00107900|27248072|P4|Overall Study|Administrative Reasons|2
7853030|NCT00107900|27248073|P3|Overall Study|Administrative Reasons|2
7853031|NCT00107900|27248074|P2|Overall Study|Administrative Reasons|0
7853032|NCT00107900|27248075|P1|Overall Study|Administrative Reasons|1
7853033|NCT00107900|27248070|P6|Overall Study|Withdrawal by Subject|1
7853034|NCT00107900|27248071|P5|Overall Study|Withdrawal by Subject|1
7853035|NCT00107900|27248072|P4|Overall Study|Withdrawal by Subject|0
7853036|NCT00107900|27248073|P3|Overall Study|Withdrawal by Subject|5
7853037|NCT00107900|27248074|P2|Overall Study|Withdrawal by Subject|0
7853038|NCT00107900|27248075|P1|Overall Study|Withdrawal by Subject|1
7853039|NCT00107900|27248070|P6|Overall Study|Protocol Violation|0
7853040|NCT00107900|27248071|P5|Overall Study|Protocol Violation|7
7853041|NCT00107900|27248072|P4|Overall Study|Protocol Violation|5
7853042|NCT00107900|27248073|P3|Overall Study|Protocol Violation|5
7853043|NCT00107900|27248074|P2|Overall Study|Protocol Violation|0
7853044|NCT00107900|27248075|P1|Overall Study|Protocol Violation|1
7853045|NCT00107900|27248070|P6|Overall Study|Lost to Follow-up|5
7853046|NCT00107900|27248071|P5|Overall Study|Lost to Follow-up|5
7853047|NCT00107900|27248072|P4|Overall Study|Lost to Follow-up|2
7853048|NCT00107900|27248073|P3|Overall Study|Lost to Follow-up|3
7853049|NCT00107900|27248074|P2|Overall Study|Lost to Follow-up|1
7853050|NCT00107900|27248075|P1|Overall Study|Lost to Follow-up|4
7853051|NCT00107900|27248070|P6|Overall Study|Death|0
7853052|NCT00107900|27248071|P5|Overall Study|Death|1
7853053|NCT00107900|27248072|P4|Overall Study|Death|0
7853054|NCT00107900|27248073|P3|Overall Study|Death|0
7853055|NCT00107900|27248074|P2|Overall Study|Death|0
7853056|NCT00107900|27248075|P1|Overall Study|Death|0
7853057|NCT00107900|27248070|P6|Overall Study|Adverse Event|3
7853058|NCT00107900|27248071|P5|Overall Study|Adverse Event|5
7853059|NCT00107900|27248072|P4|Overall Study|Adverse Event|3
7853060|NCT00107900|27248073|P3|Overall Study|Adverse Event|10
7853061|NCT00107900|27248074|P2|Overall Study|Adverse Event|2
7853062|NCT00107900|27248075|P1|Overall Study|Adverse Event|3
7853063|NCT00107783|27248109|P2|Overall Study|Second hip replacement|1
7853064|NCT00107783|27248110|P1|Overall Study|Second hip replacement|1
7853065|NCT00107783|27248109|P2|Overall Study|Withdrawal by Subject|0
7853066|NCT00107783|27248110|P1|Overall Study|Withdrawal by Subject|2
7853067|NCT00107783|27248109|P2|Overall Study|Death|1
7853068|NCT00107783|27248110|P1|Overall Study|Death|0
7853069|NCT00107783|27248109|P2|Overall Study|Adverse Event|2
7853070|NCT00107783|27248110|P1|Overall Study|Adverse Event|0
7853071|NCT00107653|27248145|P2|Overall Study|Administrative Reasons|3
7853072|NCT00107653|27248146|P1|Overall Study|Administrative Reasons|3
7853073|NCT00107653|27248145|P2|Overall Study|Lost to Follow-up|5
7853074|NCT00107653|27248146|P1|Overall Study|Lost to Follow-up|13
7853075|NCT00107653|27248145|P2|Overall Study|Withdrawal by Subject|13
7853076|NCT00107653|27248146|P1|Overall Study|Withdrawal by Subject|12
7853077|NCT00107653|27248145|P2|Overall Study|Protocol Violation|0
7853078|NCT00107653|27248146|P1|Overall Study|Protocol Violation|1
7853079|NCT00107653|27248145|P2|Overall Study|Violation of Selection Criteria at Entry|1
7853080|NCT00107653|27248146|P1|Overall Study|Violation of Selection Criteria at Entry|1
7853081|NCT00107653|27248145|P2|Overall Study|Insufficient Therapeutic Response|11
7853082|NCT00107653|27248146|P1|Overall Study|Insufficient Therapeutic Response|25
7853083|NCT00107653|27248145|P2|Overall Study|Adverse Event|43
7853084|NCT00107653|27248146|P1|Overall Study|Adverse Event|24
7853085|NCT00107614|27248192|P1|Overall Study|Death|2
7853086|NCT00107614|27248192|P1|Overall Study|Physician Decision|10
7853087|NCT00107380|27248223|P1|Overall Study|Ineligible|2
7853088|NCT00107380|27248223|P1|Overall Study|Other - not protocol specified|7
7853089|NCT00107380|27248223|P1|Overall Study|Death|3
7853090|NCT00107380|27248223|P1|Overall Study|Progression/relapse|4
7853091|NCT00107380|27248223|P1|Overall Study|Refusal Unrelated to Adverse Event|7
7853092|NCT00107380|27248223|P1|Overall Study|Adverse Event|7
7853093|NCT00107315|27248229|P1|Overall Study|Withdrawal by Subject|2
7853094|NCT00107315|27248229|P1|Overall Study|Adverse Event|4
7853095|NCT00107315|27248229|P1|Overall Study|Disease Progression|9
7853096|NCT00107276|27248236|P1|Overall Study|Ineligible|16
7853097|NCT00107276|27248236|P1|Overall Study|Death|1
7853098|NCT00107276|27248236|P1|Overall Study|Patient refusal|1
7853099|NCT00107276|27248236|P1|Overall Study|M.D. decision|2
7853100|NCT00107276|27248236|P1|Overall Study|Adverse Event|6
7853101|NCT00107276|27248236|P1|Overall Study|Progression|46
7853102|NCT00107198|27248242|P1|Overall Study|Ineligible|5
7853103|NCT00107198|27248242|P1|Overall Study|Withdrawal by Subject|6
7853104|NCT00107198|27248242|P1|Overall Study|Protocol Violation|1
7853105|NCT00107198|27248242|P1|Overall Study|Lost to Follow-up|12
7853106|NCT00107198|27248242|P1|Overall Study|Lack of Efficacy|28
7853107|NCT00107172|27248252|P2|Overall Study|Other Reason|3
7853108|NCT00107172|27248253|P1|Overall Study|Other Reason|4
7853109|NCT00107172|27248252|P2|Overall Study|Death|2
7853110|NCT00107172|27248253|P1|Overall Study|Death|0
7853111|NCT00107172|27248252|P2|Overall Study|Withdrawal by Subject|0
7853112|NCT00107172|27248253|P1|Overall Study|Withdrawal by Subject|1
7853113|NCT00107120|27248283|P2|Overall Study|death of parent|1
7853114|NCT00107120|27248284|P1|Overall Study|death of parent|0
7853115|NCT00107120|27248283|P2|Overall Study|moving away from site|1
7853116|NCT00107120|27248284|P1|Overall Study|moving away from site|1
7853117|NCT00107120|27248283|P2|Overall Study|Pregnancy|1
7853118|NCT00107120|27248284|P1|Overall Study|Pregnancy|0
7853119|NCT00107120|27248283|P2|Overall Study|Lost to Follow-up|6
7853120|NCT00107120|27248284|P1|Overall Study|Lost to Follow-up|8
7853121|NCT00107120|27248283|P2|Overall Study|Withdrawal by Subject|9
7853122|NCT00107120|27248284|P1|Overall Study|Withdrawal by Subject|8
7853123|NCT00107120|27248283|P2|Overall Study|Protocol Violation|0
7853124|NCT00107120|27248284|P1|Overall Study|Protocol Violation|3
7853125|NCT00107120|27248283|P2|Overall Study|Lack of Efficacy|5
7853126|NCT00107120|27248284|P1|Overall Study|Lack of Efficacy|5
7853127|NCT00107120|27248283|P2|Overall Study|Adverse Event|1
7853128|NCT00107120|27248284|P1|Overall Study|Adverse Event|4
7853129|NCT00107042|27248296|P2|Overall Study|Disallowed medications|2
7853130|NCT00107042|27248297|P1|Overall Study|Disallowed medications|0
7853131|NCT00107042|27248296|P2|Overall Study|vaccinated outside window|1
7853132|NCT00107042|27248297|P1|Overall Study|vaccinated outside window|1
7853133|NCT00107042|27248296|P2|Overall Study|Inadvertent enrollment|1
7853134|NCT00107042|27248297|P1|Overall Study|Inadvertent enrollment|0
7853135|NCT00107042|27248296|P2|Overall Study|Pregnancy|1
7853136|NCT00107042|27248297|P1|Overall Study|Pregnancy|1
7853137|NCT00107042|27248296|P2|Overall Study|Moved out of area|3
7853138|NCT00107042|27248297|P1|Overall Study|Moved out of area|5
7853139|NCT00107042|27248296|P2|Overall Study|Withdrawal by Subject|1
7853140|NCT00107042|27248297|P1|Overall Study|Withdrawal by Subject|6
7853141|NCT00107042|27248296|P2|Overall Study|Lost to Follow-up|7
7853142|NCT00107042|27248297|P1|Overall Study|Lost to Follow-up|9
7853143|NCT00106964|27248363|P3|Overall Study|Required disallowed medication|0
7853144|NCT00106964|27248364|P2|Overall Study|Required disallowed medication|1
7853145|NCT00106964|27248365|P1|Overall Study|Required disallowed medication|0
7853146|NCT00106964|27248363|P3|Overall Study|Did not meet eligibility criteria|2
7853147|NCT00106964|27248364|P2|Overall Study|Did not meet eligibility criteria|2
7853148|NCT00106964|27248365|P1|Overall Study|Did not meet eligibility criteria|0
7853149|NCT00106964|27248363|P3|Overall Study|Failure to adhere|0
7853150|NCT00106964|27248364|P2|Overall Study|Failure to adhere|0
7853151|NCT00106964|27248365|P1|Overall Study|Failure to adhere|2
7853152|NCT00106964|27248363|P3|Overall Study|Site Funding Terminated|1
7853153|NCT00106964|27248364|P2|Overall Study|Site Funding Terminated|1
7853154|NCT00106964|27248365|P1|Overall Study|Site Funding Terminated|0
7853155|NCT00106964|27248363|P3|Overall Study|Incarceration|0
7853156|NCT00106964|27248364|P2|Overall Study|Incarceration|1
7853157|NCT00106964|27248365|P1|Overall Study|Incarceration|0
7853158|NCT00106964|27248363|P3|Overall Study|Death|0
7853159|NCT00106964|27248364|P2|Overall Study|Death|1
7853160|NCT00106964|27248365|P1|Overall Study|Death|1
7853161|NCT00106964|27248363|P3|Overall Study|Pregnancy|2
7853162|NCT00106964|27248364|P2|Overall Study|Pregnancy|3
7853163|NCT00106964|27248365|P1|Overall Study|Pregnancy|2
7853164|NCT00106964|27248363|P3|Overall Study|Lost to Follow-up|2
7853165|NCT00106964|27248364|P2|Overall Study|Lost to Follow-up|6
7853166|NCT00106964|27248365|P1|Overall Study|Lost to Follow-up|8
7853167|NCT00106704|27248460|P2|Overall Study|Laboratory test|1
7853168|NCT00106704|27248461|P1|Overall Study|Laboratory test|1
7853169|NCT00106704|27248460|P2|Overall Study|Unable to re-enter US|0
7853170|NCT00106704|27248461|P1|Overall Study|Unable to re-enter US|1
7853171|NCT00106704|27248460|P2|Overall Study|Patient Received Glycemic Medication|41
7853172|NCT00106704|27248461|P1|Overall Study|Patient Received Glycemic Medication|22
7853173|NCT00106704|27248460|P2|Overall Study|Planned major surgery|0
7853174|NCT00106704|27248461|P1|Overall Study|Planned major surgery|1
7853175|NCT00106704|27248460|P2|Overall Study|Site terminated|1
7853176|NCT00106704|27248461|P1|Overall Study|Site terminated|0
7853177|NCT00106704|27248460|P2|Overall Study|Patient moved|0
7853178|NCT00106704|27248461|P1|Overall Study|Patient moved|1
7853179|NCT00106704|27248460|P2|Overall Study|Withdrawal by Subject|21
7853180|NCT00106704|27248461|P1|Overall Study|Withdrawal by Subject|14
7853181|NCT00106704|27248460|P2|Overall Study|Protocol Violation|7
7853182|NCT00106704|27248461|P1|Overall Study|Protocol Violation|4
7853183|NCT00106704|27248460|P2|Overall Study|Pregnancy|0
7853184|NCT00106704|27248461|P1|Overall Study|Pregnancy|1
7853185|NCT00106704|27248460|P2|Overall Study|Lost to Follow-up|3
7853186|NCT00106704|27248461|P1|Overall Study|Lost to Follow-up|7
7853187|NCT00106704|27248460|P2|Overall Study|Lack of Efficacy|69
7853188|NCT00106704|27248461|P1|Overall Study|Lack of Efficacy|67
7853189|NCT00106704|27248460|P2|Overall Study|Death|1
7853190|NCT00106704|27248461|P1|Overall Study|Death|2
7853191|NCT00106704|27248460|P2|Overall Study|Adverse Event|7
7853192|NCT00106704|27248461|P1|Overall Study|Adverse Event|10
7853193|NCT00106639|27248472|P3|Overall Study|Participant defaulted|1
7853194|NCT00106639|27248473|P2|Overall Study|Participant defaulted|1
7853195|NCT00106639|27248474|P1|Overall Study|Participant defaulted|0
7853196|NCT00106639|27248472|P3|Overall Study|Withdrawal by Subject|0
7853197|NCT00106639|27248473|P2|Overall Study|Withdrawal by Subject|1
7853198|NCT00106639|27248474|P1|Overall Study|Withdrawal by Subject|0
7853199|NCT00106639|27248472|P3|Overall Study|Protocol Violation|0
7853200|NCT00106639|27248473|P2|Overall Study|Protocol Violation|1
7853201|NCT00106639|27248474|P1|Overall Study|Protocol Violation|0
7853202|NCT00106639|27248472|P3|Overall Study|Adverse Event|1
7853203|NCT00106639|27248473|P2|Overall Study|Adverse Event|4
7853204|NCT00106639|27248474|P1|Overall Study|Adverse Event|3
7853205|NCT00106626|27248601|P4|Overall Study|> 14 day delay in therapy start|0
7853206|NCT00106626|27248602|P3|Overall Study|> 14 day delay in therapy start|0
7853207|NCT00106626|27248603|P2|Overall Study|> 14 day delay in therapy start|1
7853208|NCT00106626|27248604|P1|Overall Study|> 14 day delay in therapy start|0
7853209|NCT00106626|27248601|P4|Overall Study|Received radiation on new therapy|0
7853210|NCT00106626|27248602|P3|Overall Study|Received radiation on new therapy|0
7853211|NCT00106626|27248603|P2|Overall Study|Received radiation on new therapy|0
7853212|NCT00106626|27248604|P1|Overall Study|Received radiation on new therapy|1
7853213|NCT00106626|27248601|P4|Overall Study|Progressive Disease|10
7853214|NCT00106626|27248602|P3|Overall Study|Progressive Disease|9
7853215|NCT00106626|27248603|P2|Overall Study|Progressive Disease|1
7853216|NCT00106626|27248604|P1|Overall Study|Progressive Disease|4
7853217|NCT00106626|27248601|P4|Overall Study|Adverse Event|3
7853218|NCT00106626|27248602|P3|Overall Study|Adverse Event|3
7853219|NCT00106626|27248603|P2|Overall Study|Adverse Event|4
7853220|NCT00106626|27248604|P1|Overall Study|Adverse Event|5
7853221|NCT00106353|27248949|P7|Part 2|Physician Decision|0
7853222|NCT00106353|27248950|P6|Part 2|Physician Decision|1
7853223|NCT00106353|27248951|P5|Part 2|Physician Decision|0
7853224|NCT00106353|27248952|P4|Part 2|Physician Decision|0
7853225|NCT00106353|27248953|P3|Part 2|Physician Decision|0
7853226|NCT00106353|27248954|P2|Part 2|Physician Decision|0
7853227|NCT00106353|27248955|P1|Part 2|Physician Decision|0
7853228|NCT00106353|27248949|P7|Part 2|Withdrawal by Subject|0
7853229|NCT00106353|27248950|P6|Part 2|Withdrawal by Subject|0
7853230|NCT00106353|27248951|P5|Part 2|Withdrawal by Subject|1
7853231|NCT00106353|27248952|P4|Part 2|Withdrawal by Subject|0
7853232|NCT00106353|27248953|P3|Part 2|Withdrawal by Subject|0
7853233|NCT00106353|27248954|P2|Part 2|Withdrawal by Subject|0
7853234|NCT00106353|27248955|P1|Part 2|Withdrawal by Subject|0
7853235|NCT00106353|27248949|P7|Part 2|Other|1
7853236|NCT00106353|27248950|P6|Part 2|Other|1
7853237|NCT00106353|27248951|P5|Part 2|Other|1
7853238|NCT00106353|27248952|P4|Part 2|Other|0
7853239|NCT00106353|27248953|P3|Part 2|Other|0
7853240|NCT00106353|27248954|P2|Part 2|Other|0
7853241|NCT00106353|27248955|P1|Part 2|Other|0
7853242|NCT00106353|27248949|P7|Part 2|Adverse Event|1
7853243|NCT00106353|27248950|P6|Part 2|Adverse Event|2
7853244|NCT00106353|27248951|P5|Part 2|Adverse Event|0
7853245|NCT00106353|27248952|P4|Part 2|Adverse Event|0
7853246|NCT00106353|27248953|P3|Part 2|Adverse Event|0
7853247|NCT00106353|27248954|P2|Part 2|Adverse Event|0
7853248|NCT00106353|27248955|P1|Part 2|Adverse Event|0
7853249|NCT00106353|27248949|P7|Part 2|Symptomatic deterioration|0
7853250|NCT00106353|27248950|P6|Part 2|Symptomatic deterioration|0
7853251|NCT00106353|27248951|P5|Part 2|Symptomatic deterioration|3
7853252|NCT00106353|27248952|P4|Part 2|Symptomatic deterioration|0
7853253|NCT00106353|27248953|P3|Part 2|Symptomatic deterioration|0
7853254|NCT00106353|27248954|P2|Part 2|Symptomatic deterioration|0
7853255|NCT00106353|27248955|P1|Part 2|Symptomatic deterioration|0
7853256|NCT00106353|27248949|P7|Part 2|Death|1
7853257|NCT00106353|27248950|P6|Part 2|Death|0
7853258|NCT00106353|27248951|P5|Part 2|Death|3
7853259|NCT00106353|27248952|P4|Part 2|Death|0
7853260|NCT00106353|27248953|P3|Part 2|Death|0
7853261|NCT00106353|27248954|P2|Part 2|Death|0
7853262|NCT00106353|27248955|P1|Part 2|Death|0
7853263|NCT00106353|27248949|P7|Part 2|Disease progression|13
7853264|NCT00106353|27248950|P6|Part 2|Disease progression|14
7853265|NCT00106353|27248951|P5|Part 2|Disease progression|8
7853266|NCT00106353|27248952|P4|Part 2|Disease progression|0
7853267|NCT00106353|27248953|P3|Part 2|Disease progression|0
7853268|NCT00106353|27248954|P2|Part 2|Disease progression|0
7853269|NCT00106353|27248955|P1|Part 2|Disease progression|0
7853270|NCT00106353|27248949|P7|Part 1|Adverse Event|0
7853271|NCT00106353|27248950|P6|Part 1|Adverse Event|0
7853272|NCT00106353|27248951|P5|Part 1|Adverse Event|0
7853273|NCT00106353|27248952|P4|Part 1|Adverse Event|1
7853274|NCT00106353|27248953|P3|Part 1|Adverse Event|0
7853275|NCT00106353|27248954|P2|Part 1|Adverse Event|0
7853276|NCT00106353|27248955|P1|Part 1|Adverse Event|0
7853277|NCT00106353|27248949|P7|Part 1|Entered follow-up phase|0
7853278|NCT00106353|27248950|P6|Part 1|Entered follow-up phase|0
7853279|NCT00106353|27248951|P5|Part 1|Entered follow-up phase|0
7853280|NCT00106353|27248952|P4|Part 1|Entered follow-up phase|1
7853281|NCT00106353|27248953|P3|Part 1|Entered follow-up phase|0
7853282|NCT00106353|27248954|P2|Part 1|Entered follow-up phase|1
7853283|NCT00106353|27248955|P1|Part 1|Entered follow-up phase|1
7853284|NCT00106353|27248949|P7|Part 1|Symptomatic deterioration|0
7853285|NCT00106353|27248950|P6|Part 1|Symptomatic deterioration|0
7853286|NCT00106353|27248951|P5|Part 1|Symptomatic deterioration|0
7853287|NCT00106353|27248952|P4|Part 1|Symptomatic deterioration|0
7853288|NCT00106353|27248953|P3|Part 1|Symptomatic deterioration|1
7853289|NCT00106353|27248954|P2|Part 1|Symptomatic deterioration|0
7853290|NCT00106353|27248955|P1|Part 1|Symptomatic deterioration|0
7853291|NCT00106353|27248949|P7|Part 1|Withdrawal by Subject|0
7853292|NCT00106353|27248950|P6|Part 1|Withdrawal by Subject|0
7853293|NCT00106353|27248951|P5|Part 1|Withdrawal by Subject|0
7853294|NCT00106353|27248952|P4|Part 1|Withdrawal by Subject|2
7853295|NCT00106353|27248953|P3|Part 1|Withdrawal by Subject|1
7853296|NCT00106353|27248954|P2|Part 1|Withdrawal by Subject|0
7853297|NCT00106353|27248955|P1|Part 1|Withdrawal by Subject|0
7853298|NCT00106353|27248949|P7|Part 1|Disease progression|0
7853299|NCT00106353|27248950|P6|Part 1|Disease progression|0
7853300|NCT00106353|27248951|P5|Part 1|Disease progression|0
7853301|NCT00106353|27248952|P4|Part 1|Disease progression|3
7853302|NCT00106353|27248953|P3|Part 1|Disease progression|1
7853303|NCT00106353|27248954|P2|Part 1|Disease progression|4
7853304|NCT00106353|27248955|P1|Part 1|Disease progression|3
7853305|NCT00106249|27249082|P2|Overall Study|Lost to Follow-up|2
7853306|NCT00106249|27249083|P1|Overall Study|Lost to Follow-up|3
7853307|NCT00106184|27249095|P2|Overall Study|Withdrawal by Subject|2
7853308|NCT00106184|27249096|P1|Overall Study|Withdrawal by Subject|3
7853309|NCT00106080|27249138|P2|Overall Study|Withdrew/Loss to follow-up|27
7853310|NCT00106080|27249139|P1|Overall Study|Withdrew/Loss to follow-up|43
7853311|NCT00106028|27249149|P2|Overall Study|Lost to Follow-up|1
7853312|NCT00106028|27249150|P1|Overall Study|Lost to Follow-up|0
7853313|NCT00106028|27249149|P2|Overall Study|Withdrawal by Subject|8
7853314|NCT00106028|27249150|P1|Overall Study|Withdrawal by Subject|2
7853315|NCT00106028|27249149|P2|Overall Study|Protocol Violation|1
7853316|NCT00106028|27249150|P1|Overall Study|Protocol Violation|1
7853317|NCT00106028|27249149|P2|Overall Study|Adverse Event|2
7853318|NCT00106028|27249150|P1|Overall Study|Adverse Event|3
7853319|NCT00106002|27249244|P1|Overall Study|Ineligible after Registration|1
7853320|NCT00106002|27249244|P1|Overall Study|Did not take any study drug|1
7853321|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
7853322|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
7853323|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
7853324|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
7853325|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Death|0
7853326|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Death|0
7853327|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
7853328|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
7853329|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
7853330|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
7853331|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
7853332|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
7853333|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
7853334|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
7853335|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
7853336|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
7853337|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
7853338|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
7853339|NCT00105989|27249252|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
7853340|NCT00105989|27249253|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
7853341|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
7853342|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
7853343|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
7853344|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
7853345|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Death|0
7853346|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Death|0
7853347|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
7853348|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
7853349|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
7853350|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
7853351|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
7853352|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
7853353|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
7853354|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
7853355|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
7853356|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
7853357|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
7853358|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
7853359|NCT00105989|27249252|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
7853360|NCT00105989|27249253|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
7853361|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
7853362|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
7853363|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
7853364|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
7853365|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Death|0
7853366|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Death|1
7853367|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Physician Decision|0
7853368|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Physician Decision|0
7853369|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
7853370|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
7853371|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
7853372|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
7853373|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
7853374|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
7853375|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
7853376|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
7853377|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
7853378|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
7853379|NCT00105989|27249252|P2|Acute - Open Label: Week 0-10|Adverse Event|0
7853380|NCT00105989|27249253|P1|Acute - Open Label: Week 0-10|Adverse Event|33
7853381|NCT00105586|27249369|P2|Overall Study|Physician Decision|13
7853382|NCT00105586|27249370|P1|Overall Study|Physician Decision|13
7853383|NCT00105586|27249369|P2|Overall Study|Adverse Event|3
7853384|NCT00105586|27249370|P1|Overall Study|Adverse Event|4
7853385|NCT00105560|27249378|P1|Overall Study|Lost to Follow-up|1
7853386|NCT00105534|27249400|P2|Overall Study|Other Reason|2
7853387|NCT00105534|27249401|P1|Overall Study|Other Reason|0
7853388|NCT00105534|27249400|P2|Overall Study|Treatment unmasked|0
7853389|NCT00105534|27249401|P1|Overall Study|Treatment unmasked|1
7853390|NCT00105534|27249400|P2|Overall Study|Lack of Efficacy|15
7853391|NCT00105534|27249401|P1|Overall Study|Lack of Efficacy|7
7853392|NCT00105534|27249400|P2|Overall Study|Lost to Follow-up|1
7853393|NCT00105534|27249401|P1|Overall Study|Lost to Follow-up|5
7853394|NCT00105534|27249400|P2|Overall Study|Withdrawal by Subject|6
7853395|NCT00105534|27249401|P1|Overall Study|Withdrawal by Subject|6
7853396|NCT00105534|27249400|P2|Overall Study|Protocol Violation|4
7853397|NCT00105534|27249401|P1|Overall Study|Protocol Violation|1
7853398|NCT00105534|27249400|P2|Overall Study|Adverse Event|5
7853399|NCT00105534|27249401|P1|Overall Study|Adverse Event|2
7853400|NCT00105521|27249413|P4|Overall Study|Lost to Follow-up|0
7853401|NCT00105521|27249414|P3|Overall Study|Lost to Follow-up|0
7853402|NCT00105521|27249415|P2|Overall Study|Lost to Follow-up|1
7853403|NCT00105521|27249416|P1|Overall Study|Lost to Follow-up|0
7853404|NCT00105521|27249413|P4|Overall Study|Protocol Violation|4
7853405|NCT00105521|27249414|P3|Overall Study|Protocol Violation|4
7853406|NCT00105521|27249415|P2|Overall Study|Protocol Violation|5
7853407|NCT00105521|27249416|P1|Overall Study|Protocol Violation|3
7853408|NCT00105521|27249413|P4|Overall Study|Lack of Efficacy|1
7853409|NCT00105521|27249414|P3|Overall Study|Lack of Efficacy|0
7853410|NCT00105521|27249415|P2|Overall Study|Lack of Efficacy|0
7853411|NCT00105521|27249416|P1|Overall Study|Lack of Efficacy|0
7853412|NCT00105521|27249413|P4|Overall Study|Withdrawal by Subject|4
7853413|NCT00105521|27249414|P3|Overall Study|Withdrawal by Subject|1
7853414|NCT00105521|27249415|P2|Overall Study|Withdrawal by Subject|0
7853415|NCT00105521|27249416|P1|Overall Study|Withdrawal by Subject|1
7853416|NCT00105521|27249413|P4|Overall Study|Adverse Event|8
7853417|NCT00105521|27249414|P3|Overall Study|Adverse Event|10
7853418|NCT00105521|27249415|P2|Overall Study|Adverse Event|4
7853419|NCT00105521|27249416|P1|Overall Study|Adverse Event|10
7853420|NCT00105521|27249413|P4|Overall Study|Other|0
7853421|NCT00105521|27249414|P3|Overall Study|Other|2
7853422|NCT00105521|27249415|P2|Overall Study|Other|1
7853423|NCT00105521|27249416|P1|Overall Study|Other|1
7853424|NCT00105508|27249440|P2|Overall Study|Other|9
7853425|NCT00105508|27249441|P1|Overall Study|Other|8
7853426|NCT00105508|27249440|P2|Overall Study|Protocol Violation|2
7853427|NCT00105508|27249441|P1|Overall Study|Protocol Violation|1
7853428|NCT00105508|27249440|P2|Overall Study|Lost to Follow-up|0
7853429|NCT00105508|27249441|P1|Overall Study|Lost to Follow-up|3
7853430|NCT00105508|27249440|P2|Overall Study|Withdrawal by Subject|6
7853431|NCT00105508|27249441|P1|Overall Study|Withdrawal by Subject|10
7853432|NCT00105508|27249440|P2|Overall Study|Insufficient Efficacy|0
7853433|NCT00105508|27249441|P1|Overall Study|Insufficient Efficacy|1
7853434|NCT00105508|27249440|P2|Overall Study|Adverse Event|19
7853435|NCT00105508|27249441|P1|Overall Study|Adverse Event|16
7853436|NCT00105508|27249440|P2|Overall Study|Prephase Dropout|0
7853437|NCT00105508|27249441|P1|Overall Study|Prephase Dropout|1
7853438|NCT00105482|27249455|P2|Overall Study|Withdrawn by PI|1
7853439|NCT00105482|27249456|P1|Overall Study|Withdrawn by PI|1
7853440|NCT00105482|27249455|P2|Overall Study|Scheduling Conflict|3
7853441|NCT00105482|27249456|P1|Overall Study|Scheduling Conflict|2
7853442|NCT00105482|27249455|P2|Overall Study|Lost Interest|32
7853443|NCT00105482|27249456|P1|Overall Study|Lost Interest|29
7853444|NCT00105482|27249455|P2|Overall Study|Withdrawal by Subject|1
7853445|NCT00105482|27249456|P1|Overall Study|Withdrawal by Subject|0
7853446|NCT00105482|27249455|P2|Overall Study|Lost to Follow-up|17
7853447|NCT00105482|27249456|P1|Overall Study|Lost to Follow-up|26
7853448|NCT00105482|27249455|P2|Overall Study|Adverse Event|1
7853449|NCT00105482|27249456|P1|Overall Study|Adverse Event|1
7853450|NCT00105469|27249472|P2|Overall Study|Other Reason|0
7853451|NCT00105469|27249473|P1|Overall Study|Other Reason|4
7853452|NCT00105469|27249472|P2|Overall Study|Lack of Efficacy|0
7853453|NCT00105469|27249473|P1|Overall Study|Lack of Efficacy|2
7853454|NCT00105469|27249472|P2|Overall Study|Lost to Follow-up|0
7853455|NCT00105469|27249473|P1|Overall Study|Lost to Follow-up|1
7853456|NCT00105469|27249472|P2|Overall Study|Withdrawal by Subject|3
7853457|NCT00105469|27249473|P1|Overall Study|Withdrawal by Subject|2
7853458|NCT00105469|27249472|P2|Overall Study|Protocol Violation|0
7853459|NCT00105469|27249473|P1|Overall Study|Protocol Violation|4
7853460|NCT00105469|27249472|P2|Overall Study|Adverse Event|8
7853461|NCT00105469|27249473|P1|Overall Study|Adverse Event|9
7853462|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
7853463|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
7853464|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
7853465|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
7853466|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
7853467|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
7853468|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
7853469|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
7853470|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
7853471|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7853472|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7853473|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7853474|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7853475|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7853476|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7853551|NCT00105196|27249526|P2|Overall Study|Lost to Follow-up|2
7853477|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
7853478|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7853479|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
7853480|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7853481|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7853482|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
7853483|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
7853484|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
7853485|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
7853486|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
7853487|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
7853488|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
7853489|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
7853490|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
7853491|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
7853492|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
7853493|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
7853494|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7853495|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7853496|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
7853497|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7853498|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
7853499|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
7853500|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
7853501|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
7853502|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
7853503|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
7853504|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
7853505|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
7853506|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
7853507|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
7853508|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
7853509|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
7853510|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
7853511|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
7853512|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
7853513|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
7853514|NCT00105443|27249483|P4|Follow-up and/or Open Label Nexavar|Death|4
7853515|NCT00105443|27249484|P3|Follow-up and/or Open Label Nexavar|Death|219
7853516|NCT00105443|27249485|P2|Follow-up and/or Open Label Nexavar|Death|7
7853517|NCT00105443|27249486|P1|Follow-up and/or Open Label Nexavar|Death|180
7853518|NCT00105443|27249483|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
7853519|NCT00105443|27249484|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
7853520|NCT00105443|27249485|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
7853521|NCT00105443|27249486|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
7853522|NCT00105443|27249483|P4|Double-Blind Treatment|Physician Decision|0
7853523|NCT00105443|27249484|P3|Double-Blind Treatment|Physician Decision|2
7853524|NCT00105443|27249485|P2|Double-Blind Treatment|Physician Decision|0
7853525|NCT00105443|27249486|P1|Double-Blind Treatment|Physician Decision|1
7853526|NCT00105443|27249483|P4|Double-Blind Treatment|Withdrawal by Subject|0
7853527|NCT00105443|27249484|P3|Double-Blind Treatment|Withdrawal by Subject|7
7853528|NCT00105443|27249485|P2|Double-Blind Treatment|Withdrawal by Subject|0
7853529|NCT00105443|27249486|P1|Double-Blind Treatment|Withdrawal by Subject|8
7853530|NCT00105443|27249483|P4|Double-Blind Treatment|Lost to Follow-up|0
7853531|NCT00105443|27249484|P3|Double-Blind Treatment|Lost to Follow-up|1
7853532|NCT00105443|27249485|P2|Double-Blind Treatment|Lost to Follow-up|0
7853533|NCT00105443|27249486|P1|Double-Blind Treatment|Lost to Follow-up|0
7853534|NCT00105443|27249483|P4|Double-Blind Treatment|Adverse Event|0
7853535|NCT00105443|27249484|P3|Double-Blind Treatment|Adverse Event|0
7853536|NCT00105443|27249485|P2|Double-Blind Treatment|Adverse Event|0
7853537|NCT00105443|27249486|P1|Double-Blind Treatment|Adverse Event|1
7853538|NCT00105235|27249513|P1|Overall Study|Withdrawal by Subject|2
7853539|NCT00105235|27249513|P1|Overall Study|Physician Decision|1
7853540|NCT00105235|27249513|P1|Overall Study|Death|4
7853541|NCT00105196|27249526|P2|Overall Study|Subject became unblinded|1
7853542|NCT00105196|27249527|P1|Overall Study|Subject became unblinded|0
7853543|NCT00105196|27249526|P2|Overall Study|marijuana use|1
7853544|NCT00105196|27249527|P1|Overall Study|marijuana use|0
7853545|NCT00105196|27249526|P2|Overall Study|pending surgery|1
7853546|NCT00105196|27249527|P1|Overall Study|pending surgery|0
7853547|NCT00105196|27249526|P2|Overall Study|Protocol Violation|2
7853548|NCT00105196|27249527|P1|Overall Study|Protocol Violation|5
7853549|NCT00105196|27249526|P2|Overall Study|Poor/noncompliance|4
7853550|NCT00105196|27249527|P1|Overall Study|Poor/noncompliance|3
7853552|NCT00105196|27249527|P1|Overall Study|Lost to Follow-up|3
7853553|NCT00105196|27249526|P2|Overall Study|Withdrawal by Subject|6
7853554|NCT00105196|27249527|P1|Overall Study|Withdrawal by Subject|6
7853555|NCT00105196|27249526|P2|Overall Study|Adverse Event|3
7853556|NCT00105196|27249527|P1|Overall Study|Adverse Event|11
7853557|NCT00105196|27249526|P2|Overall Study|Lack of Efficacy|3
7853558|NCT00105196|27249527|P1|Overall Study|Lack of Efficacy|2
7853559|NCT00105183|27249550|P3|Overall Study|Other reason|0
7853560|NCT00105183|27249551|P2|Overall Study|Other reason|2
7853561|NCT00105183|27249552|P1|Overall Study|Other reason|1
7853562|NCT00105183|27249550|P3|Overall Study|Lost to Follow-up|1
7853563|NCT00105183|27249551|P2|Overall Study|Lost to Follow-up|1
7853564|NCT00105183|27249552|P1|Overall Study|Lost to Follow-up|0
7853565|NCT00105183|27249550|P3|Overall Study|Physician Decision|3
7853566|NCT00105183|27249551|P2|Overall Study|Physician Decision|2
7853567|NCT00105183|27249552|P1|Overall Study|Physician Decision|1
7853568|NCT00105183|27249550|P3|Overall Study|Withdrawal by Subject|4
7853569|NCT00105183|27249551|P2|Overall Study|Withdrawal by Subject|1
7853570|NCT00105183|27249552|P1|Overall Study|Withdrawal by Subject|1
7853571|NCT00105183|27249550|P3|Overall Study|Death|15
7853572|NCT00105183|27249551|P2|Overall Study|Death|13
7853573|NCT00105183|27249552|P1|Overall Study|Death|19
7853574|NCT00105157|27249588|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7853575|NCT00105157|27249589|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7853576|NCT00105157|27249590|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
7853577|NCT00105157|27249591|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7853578|NCT00105157|27249588|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
7853579|NCT00105157|27249589|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7853580|NCT00105157|27249590|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7853581|NCT00105157|27249591|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7853582|NCT00105157|27249588|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
7853583|NCT00105157|27249589|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
7853584|NCT00105157|27249590|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
7853585|NCT00105157|27249591|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
7853586|NCT00105157|27249588|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
7853587|NCT00105157|27249589|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
7853588|NCT00105157|27249590|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
7853589|NCT00105157|27249591|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
7853590|NCT00105157|27249588|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
7853591|NCT00105157|27249589|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7853592|NCT00105157|27249590|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7853593|NCT00105157|27249591|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7853594|NCT00105157|27249588|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
7853595|NCT00105157|27249589|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
7853596|NCT00105157|27249590|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
7853597|NCT00105157|27249591|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
7853598|NCT00105157|27249588|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
7853599|NCT00105157|27249589|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
7853600|NCT00105157|27249590|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
7853601|NCT00105157|27249591|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
7853602|NCT00105157|27249588|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
7853603|NCT00105157|27249589|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
7853604|NCT00105157|27249590|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
7853605|NCT00105157|27249591|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
7853606|NCT00105157|27249588|P4|Open-Label Continuation of DB|Lost to Follow-up|0
7853607|NCT00105157|27249589|P3|Open-Label Continuation of DB|Lost to Follow-up|1
7853608|NCT00105157|27249590|P2|Open-Label Continuation of DB|Lost to Follow-up|1
7853609|NCT00105157|27249591|P1|Open-Label Continuation of DB|Lost to Follow-up|1
7853610|NCT00105157|27249588|P4|Open-Label Continuation of DB|Lack of Efficacy|1
7853611|NCT00105157|27249589|P3|Open-Label Continuation of DB|Lack of Efficacy|3
7853612|NCT00105157|27249590|P2|Open-Label Continuation of DB|Lack of Efficacy|4
7853613|NCT00105157|27249591|P1|Open-Label Continuation of DB|Lack of Efficacy|1
7853614|NCT00105157|27249588|P4|Open-Label Continuation of DB|Adverse Event|0
7853615|NCT00105157|27249589|P3|Open-Label Continuation of DB|Adverse Event|0
7853616|NCT00105157|27249590|P2|Open-Label Continuation of DB|Adverse Event|1
7853617|NCT00105157|27249591|P1|Open-Label Continuation of DB|Adverse Event|3
7853618|NCT00105157|27249588|P4|Double-Blind (DB)|Lack of Efficacy|38
7853619|NCT00105157|27249589|P3|Double-Blind (DB)|Lack of Efficacy|11
7853620|NCT00105157|27249590|P2|Double-Blind (DB)|Lack of Efficacy|14
7853621|NCT00105157|27249591|P1|Double-Blind (DB)|Lack of Efficacy|11
7853622|NCT00105157|27249588|P4|Double-Blind (DB)|Adverse Event|1
7853623|NCT00105157|27249589|P3|Double-Blind (DB)|Adverse Event|1
7853624|NCT00105157|27249590|P2|Double-Blind (DB)|Adverse Event|0
7853625|NCT00105157|27249591|P1|Double-Blind (DB)|Adverse Event|2
7853626|NCT00105157|27249588|P4|Double-Blind (DB)|Never Treated|0
7853627|NCT00105157|27249589|P3|Double-Blind (DB)|Never Treated|0
7853628|NCT00105157|27249590|P2|Double-Blind (DB)|Never Treated|0
7853629|NCT00105157|27249591|P1|Double-Blind (DB)|Never Treated|1
7853630|NCT00105079|27249785|P2|Overall Study|Other|1
7853631|NCT00105079|27249786|P1|Overall Study|Other|3
7853632|NCT00105079|27249785|P2|Overall Study|Protocol Violation|0
7853633|NCT00105079|27249786|P1|Overall Study|Protocol Violation|1
7853634|NCT00105079|27249785|P2|Overall Study|Violation of selection criteria at entry|2
7853635|NCT00105079|27249786|P1|Overall Study|Violation of selection criteria at entry|0
7853636|NCT00105079|27249785|P2|Overall Study|Refused treatment|4
7853637|NCT00105079|27249786|P1|Overall Study|Refused treatment|6
7853638|NCT00105079|27249785|P2|Overall Study|Lack of Efficacy|3
7853639|NCT00105079|27249786|P1|Overall Study|Lack of Efficacy|9
7853640|NCT00105079|27249785|P2|Overall Study|Lost to Follow-up|12
7853641|NCT00105079|27249786|P1|Overall Study|Lost to Follow-up|12
7853642|NCT00105079|27249785|P2|Overall Study|Death|1
7853643|NCT00105079|27249786|P1|Overall Study|Death|3
7853644|NCT00105079|27249785|P2|Overall Study|Adverse Event|12
7853645|NCT00105079|27249786|P1|Overall Study|Adverse Event|5
7853646|NCT00105066|27249804|P2|Overall Study|Adverse Event|5
7853647|NCT00105066|27249805|P1|Overall Study|Adverse Event|2
7853648|NCT00104884|27249883|P1|Overall Study|Disease progression|4
7853649|NCT00104871|27249887|P1|Overall Study|Not evaluable|1
7853650|NCT00104728|27249908|P1|Overall Study|screen failures|19
7853651|NCT00104676|27249915|P2|Overall Study|treatment interruption|10
7853652|NCT00104676|27249916|P1|Overall Study|treatment interruption|4
7853653|NCT00104676|27249915|P2|Overall Study|Withdrawal by Subject|2
7853654|NCT00104676|27249916|P1|Overall Study|Withdrawal by Subject|0
7853655|NCT00104676|27249915|P2|Overall Study|Death|2
7853656|NCT00104676|27249916|P1|Overall Study|Death|3
7853657|NCT00104650|27249927|P3|Follow-up Period|Other|0
7853658|NCT00104650|27249928|P2|Follow-up Period|Other|1
7853659|NCT00104650|27249929|P1|Follow-up Period|Other|0
7853660|NCT00104650|27249927|P3|Follow-up Period|Lost to Follow-up|2
7853661|NCT00104650|27249928|P2|Follow-up Period|Lost to Follow-up|1
7853662|NCT00104650|27249929|P1|Follow-up Period|Lost to Follow-up|0
7853663|NCT00104650|27249927|P3|Follow-up Period|Disease progression|0
7853664|NCT00104650|27249928|P2|Follow-up Period|Disease progression|1
7853665|NCT00104650|27249929|P1|Follow-up Period|Disease progression|3
7853666|NCT00104650|27249927|P3|Follow-up Period|Death|4
7853667|NCT00104650|27249928|P2|Follow-up Period|Death|6
7853668|NCT00104650|27249929|P1|Follow-up Period|Death|6
7853669|NCT00104650|27249927|P3|Follow-up Period|Withdrawal by Subject|3
7853670|NCT00104650|27249928|P2|Follow-up Period|Withdrawal by Subject|3
7853671|NCT00104650|27249929|P1|Follow-up Period|Withdrawal by Subject|0
7853672|NCT00104650|27249927|P3|Follow-up Period|Adverse Event|1
7853673|NCT00104650|27249928|P2|Follow-up Period|Adverse Event|0
7853674|NCT00104650|27249929|P1|Follow-up Period|Adverse Event|1
7853675|NCT00104650|27249927|P3|Follow-up Period|Physician Decision|0
7853676|NCT00104650|27249928|P2|Follow-up Period|Physician Decision|1
7853677|NCT00104650|27249929|P1|Follow-up Period|Physician Decision|1
7853678|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Protocol deviation|0
7853679|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Protocol deviation|1
7853680|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Protocol deviation|0
7853681|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Other|0
7853682|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Other|0
7853683|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Other|1
7853684|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
7853685|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
7853686|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
7853687|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Disease progression|2
7853688|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Disease progression|3
7853689|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Disease progression|2
7853690|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Death|6
7853691|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Death|5
7853692|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Death|7
7853693|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
7853694|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
7853695|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
7853696|NCT00104650|27249927|P3|Treatment Period (25 Weeks)|Physician Decision|1
7853697|NCT00104650|27249928|P2|Treatment Period (25 Weeks)|Physician Decision|0
7853698|NCT00104650|27249929|P1|Treatment Period (25 Weeks)|Physician Decision|0
7853699|NCT00104637|27249961|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
7853700|NCT00104637|27249962|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
7853701|NCT00104572|27249991|P3|Overall Study|Withdrawal by Subject|0
7853702|NCT00104572|27249992|P2|Overall Study|Withdrawal by Subject|3
7853703|NCT00104572|27249993|P1|Overall Study|Withdrawal by Subject|3
7853704|NCT00104520|27250012|P2|Overall Study|Other|5
7853705|NCT00104520|27250013|P1|Overall Study|Other|1
7853706|NCT00104520|27250012|P2|Overall Study|Personal/administrative|1
7853707|NCT00104520|27250013|P1|Overall Study|Personal/administrative|1
7853708|NCT00104520|27250012|P2|Overall Study|Noncompliance|2
7853709|NCT00104520|27250013|P1|Overall Study|Noncompliance|0
7853710|NCT00104520|27250012|P2|Overall Study|Lost to Follow-up|0
7853711|NCT00104520|27250013|P1|Overall Study|Lost to Follow-up|1
7853712|NCT00104520|27250012|P2|Overall Study|Related adverse event|15
7853713|NCT00104520|27250013|P1|Overall Study|Related adverse event|13
7853714|NCT00104520|27250012|P2|Overall Study|Study drug intolerance|1
7853715|NCT00104520|27250013|P1|Overall Study|Study drug intolerance|0
7853716|NCT00104520|27250012|P2|Overall Study|Unrelated adverse event|47
7853717|NCT00104520|27250013|P1|Overall Study|Unrelated adverse event|34
7853718|NCT00104416|27250033|P5|Continuation Phase|Non-compliance|1
7853719|NCT00104416|27250034|P4|Continuation Phase|Non-compliance|0
7853720|NCT00104416|27250035|P3|Continuation Phase|Non-compliance|0
7853721|NCT00104416|27250036|P2|Continuation Phase|Non-compliance|0
7853722|NCT00104416|27250037|P1|Continuation Phase|Non-compliance|0
7853723|NCT00104416|27250033|P5|Continuation Phase|Pregnancy|0
7853724|NCT00104416|27250034|P4|Continuation Phase|Pregnancy|1
7853725|NCT00104416|27250035|P3|Continuation Phase|Pregnancy|1
7853726|NCT00104416|27250036|P2|Continuation Phase|Pregnancy|0
7853727|NCT00104416|27250037|P1|Continuation Phase|Pregnancy|0
7853728|NCT00104416|27250033|P5|Continuation Phase|Withdrawal by Subject|1
7853729|NCT00104416|27250034|P4|Continuation Phase|Withdrawal by Subject|1
7853730|NCT00104416|27250035|P3|Continuation Phase|Withdrawal by Subject|2
7853731|NCT00104416|27250036|P2|Continuation Phase|Withdrawal by Subject|0
7853732|NCT00104416|27250037|P1|Continuation Phase|Withdrawal by Subject|0
7853733|NCT00104416|27250033|P5|Continuation Phase|Lost to Follow-up|1
7853734|NCT00104416|27250034|P4|Continuation Phase|Lost to Follow-up|0
7853735|NCT00104416|27250035|P3|Continuation Phase|Lost to Follow-up|1
7853736|NCT00104416|27250036|P2|Continuation Phase|Lost to Follow-up|0
7853737|NCT00104416|27250037|P1|Continuation Phase|Lost to Follow-up|0
7853738|NCT00104416|27250033|P5|Continuation Phase|Adverse Event|2
7853739|NCT00104416|27250034|P4|Continuation Phase|Adverse Event|0
7853740|NCT00104416|27250035|P3|Continuation Phase|Adverse Event|2
7853741|NCT00104416|27250036|P2|Continuation Phase|Adverse Event|0
7853742|NCT00104416|27250037|P1|Continuation Phase|Adverse Event|0
7853743|NCT00104416|27250033|P5|Double-Blind Phase|Participant Did Not Take Drug|0
7853744|NCT00104416|27250034|P4|Double-Blind Phase|Participant Did Not Take Drug|0
7853745|NCT00104416|27250035|P3|Double-Blind Phase|Participant Did Not Take Drug|0
7853746|NCT00104416|27250036|P2|Double-Blind Phase|Participant Did Not Take Drug|4
7853747|NCT00104416|27250037|P1|Double-Blind Phase|Participant Did Not Take Drug|3
7853748|NCT00104416|27250033|P5|Double-Blind Phase|Pregnancy|0
7853749|NCT00104416|27250034|P4|Double-Blind Phase|Pregnancy|0
7853750|NCT00104416|27250035|P3|Double-Blind Phase|Pregnancy|0
7853751|NCT00104416|27250036|P2|Double-Blind Phase|Pregnancy|0
7853752|NCT00104416|27250037|P1|Double-Blind Phase|Pregnancy|1
7853753|NCT00104416|27250033|P5|Double-Blind Phase|Withdrawal by Subject|0
7853754|NCT00104416|27250034|P4|Double-Blind Phase|Withdrawal by Subject|0
7853755|NCT00104416|27250035|P3|Double-Blind Phase|Withdrawal by Subject|0
7853756|NCT00104416|27250036|P2|Double-Blind Phase|Withdrawal by Subject|3
7853757|NCT00104416|27250037|P1|Double-Blind Phase|Withdrawal by Subject|2
7853758|NCT00104416|27250033|P5|Double-Blind Phase|Protocol Violation|0
7853759|NCT00104416|27250034|P4|Double-Blind Phase|Protocol Violation|0
7853760|NCT00104416|27250035|P3|Double-Blind Phase|Protocol Violation|0
7853761|NCT00104416|27250036|P2|Double-Blind Phase|Protocol Violation|1
7853762|NCT00104416|27250037|P1|Double-Blind Phase|Protocol Violation|0
7853763|NCT00104416|27250033|P5|Double-Blind Phase|Lost to Follow-up|0
7853764|NCT00104416|27250034|P4|Double-Blind Phase|Lost to Follow-up|0
7853765|NCT00104416|27250035|P3|Double-Blind Phase|Lost to Follow-up|0
7853766|NCT00104416|27250036|P2|Double-Blind Phase|Lost to Follow-up|1
7853767|NCT00104416|27250037|P1|Double-Blind Phase|Lost to Follow-up|0
7853768|NCT00104416|27250033|P5|Double-Blind Phase|Adverse Event|0
7853769|NCT00104416|27250034|P4|Double-Blind Phase|Adverse Event|0
7853770|NCT00104416|27250035|P3|Double-Blind Phase|Adverse Event|0
7853771|NCT00104416|27250036|P2|Double-Blind Phase|Adverse Event|1
7853772|NCT00104416|27250037|P1|Double-Blind Phase|Adverse Event|2
7853773|NCT00104299|27250082|P2|Overall Study|To have renal transplant|0
7853774|NCT00104299|27250083|P1|Overall Study|To have renal transplant|1
7853775|NCT00104299|27250082|P2|Overall Study|Physician Decision|1
7853776|NCT00104299|27250083|P1|Overall Study|Physician Decision|1
7853777|NCT00104299|27250082|P2|Overall Study|Withdrawal by Subject|6
7853778|NCT00104299|27250083|P1|Overall Study|Withdrawal by Subject|2
7853779|NCT00104299|27250082|P2|Overall Study|Death|2
7853780|NCT00104299|27250083|P1|Overall Study|Death|2
7853781|NCT00104299|27250082|P2|Overall Study|Adverse Event|1
7853782|NCT00104299|27250083|P1|Overall Study|Adverse Event|3
7853783|NCT00104247|27250105|P2|Overall Study|Noncompliant with dosing|1
7853784|NCT00104247|27250106|P1|Overall Study|Noncompliant with dosing|0
7853785|NCT00104247|27250105|P2|Overall Study|Withdrawal by Subject|0
7853786|NCT00104247|27250106|P1|Overall Study|Withdrawal by Subject|1
7853787|NCT00104104|27250125|P2|Overall Study|Death|6
7853788|NCT00104104|27250126|P1|Overall Study|Death|9
7853789|NCT00104104|27250125|P2|Overall Study|Administrative problems|13
7853790|NCT00104104|27250126|P1|Overall Study|Administrative problems|12
7853791|NCT00104104|27250125|P2|Overall Study|Lost to Follow-up|7
7853792|NCT00104104|27250126|P1|Overall Study|Lost to Follow-up|3
7853793|NCT00104104|27250125|P2|Overall Study|Withdrawal by Subject|15
7853794|NCT00104104|27250126|P1|Overall Study|Withdrawal by Subject|11
7853795|NCT00104104|27250125|P2|Overall Study|Protocol Violation|2
7853796|NCT00104104|27250126|P1|Overall Study|Protocol Violation|5
7853797|NCT00104104|27250125|P2|Overall Study|Condition no longer requires study drug|4
7853798|NCT00104104|27250126|P1|Overall Study|Condition no longer requires study drug|7
7853799|NCT00104104|27250125|P2|Overall Study|Lack of Efficacy|3
7853800|NCT00104104|27250126|P1|Overall Study|Lack of Efficacy|0
7853801|NCT00104104|27250125|P2|Overall Study|Abnormal laboratory value(s)|14
7853802|NCT00104104|27250126|P1|Overall Study|Abnormal laboratory value(s)|20
7853803|NCT00104104|27250125|P2|Overall Study|Adverse Event|8
7853804|NCT00104104|27250126|P1|Overall Study|Adverse Event|8
7853805|NCT00104052|27250140|P1|Overall Study|Discontinuation unrelated to treatment|2
7853806|NCT00104052|27250140|P1|Overall Study|Lack of Efficacy|26
7853807|NCT00104052|27250140|P1|Overall Study|Adverse Event|1
7853808|NCT00103857|27250151|P7|50-Week Extension Study|reason unspecified|0
7853809|NCT00103857|27250152|P6|50-Week Extension Study|reason unspecified|0
7853810|NCT00103857|27250153|P5|50-Week Extension Study|reason unspecified|1
7853811|NCT00103857|27250154|P4|50-Week Extension Study|reason unspecified|0
7853812|NCT00103857|27250155|P3|50-Week Extension Study|reason unspecified|0
7853813|NCT00103857|27250156|P2|50-Week Extension Study|reason unspecified|0
7853814|NCT00103857|27250157|P1|50-Week Extension Study|reason unspecified|0
7853815|NCT00103857|27250151|P7|50-Week Extension Study|patient scheduled for elective surgery|0
7853816|NCT00103857|27250152|P6|50-Week Extension Study|patient scheduled for elective surgery|0
7853817|NCT00103857|27250153|P5|50-Week Extension Study|patient scheduled for elective surgery|0
7853818|NCT00103857|27250154|P4|50-Week Extension Study|patient scheduled for elective surgery|0
7853819|NCT00103857|27250155|P3|50-Week Extension Study|patient scheduled for elective surgery|1
7853820|NCT00103857|27250156|P2|50-Week Extension Study|patient scheduled for elective surgery|0
7853821|NCT00103857|27250157|P1|50-Week Extension Study|patient scheduled for elective surgery|0
7853822|NCT00103857|27250151|P7|50-Week Extension Study|patient moved|0
7853823|NCT00103857|27250152|P6|50-Week Extension Study|patient moved|0
7853824|NCT00103857|27250153|P5|50-Week Extension Study|patient moved|0
7853825|NCT00103857|27250154|P4|50-Week Extension Study|patient moved|2
7853826|NCT00103857|27250155|P3|50-Week Extension Study|patient moved|1
7853827|NCT00103857|27250156|P2|50-Week Extension Study|patient moved|0
7853828|NCT00103857|27250157|P1|50-Week Extension Study|patient moved|0
7853829|NCT00103857|27250151|P7|50-Week Extension Study|non-compliance with study procedures|0
7853830|NCT00103857|27250152|P6|50-Week Extension Study|non-compliance with study procedures|0
7853831|NCT00103857|27250153|P5|50-Week Extension Study|non-compliance with study procedures|1
7853832|NCT00103857|27250154|P4|50-Week Extension Study|non-compliance with study procedures|1
7853833|NCT00103857|27250155|P3|50-Week Extension Study|non-compliance with study procedures|0
7853834|NCT00103857|27250156|P2|50-Week Extension Study|non-compliance with study procedures|0
7853835|NCT00103857|27250157|P1|50-Week Extension Study|non-compliance with study procedures|1
7853836|NCT00103857|27250151|P7|50-Week Extension Study|protocol discontinuation criteria|0
7853837|NCT00103857|27250152|P6|50-Week Extension Study|protocol discontinuation criteria|3
7853838|NCT00103857|27250153|P5|50-Week Extension Study|protocol discontinuation criteria|3
7853839|NCT00103857|27250154|P4|50-Week Extension Study|protocol discontinuation criteria|2
7853840|NCT00103857|27250155|P3|50-Week Extension Study|protocol discontinuation criteria|3
7853841|NCT00103857|27250156|P2|50-Week Extension Study|protocol discontinuation criteria|2
7853842|NCT00103857|27250157|P1|50-Week Extension Study|protocol discontinuation criteria|2
7853843|NCT00103857|27250151|P7|50-Week Extension Study|Withdrawal by Subject|0
7853844|NCT00103857|27250152|P6|50-Week Extension Study|Withdrawal by Subject|3
7853845|NCT00103857|27250153|P5|50-Week Extension Study|Withdrawal by Subject|3
7853846|NCT00103857|27250154|P4|50-Week Extension Study|Withdrawal by Subject|8
7853847|NCT00103857|27250155|P3|50-Week Extension Study|Withdrawal by Subject|2
7853848|NCT00103857|27250156|P2|50-Week Extension Study|Withdrawal by Subject|5
7853849|NCT00103857|27250157|P1|50-Week Extension Study|Withdrawal by Subject|2
7853850|NCT00103857|27250151|P7|50-Week Extension Study|Protocol Violation|0
7853851|NCT00103857|27250152|P6|50-Week Extension Study|Protocol Violation|1
7853852|NCT00103857|27250153|P5|50-Week Extension Study|Protocol Violation|0
7853853|NCT00103857|27250154|P4|50-Week Extension Study|Protocol Violation|2
7853854|NCT00103857|27250155|P3|50-Week Extension Study|Protocol Violation|1
7853855|NCT00103857|27250156|P2|50-Week Extension Study|Protocol Violation|1
7853856|NCT00103857|27250157|P1|50-Week Extension Study|Protocol Violation|1
7853857|NCT00103857|27250151|P7|50-Week Extension Study|Pregnancy|0
7853858|NCT00103857|27250152|P6|50-Week Extension Study|Pregnancy|0
7853859|NCT00103857|27250153|P5|50-Week Extension Study|Pregnancy|1
7853860|NCT00103857|27250154|P4|50-Week Extension Study|Pregnancy|0
7853861|NCT00103857|27250155|P3|50-Week Extension Study|Pregnancy|1
7853862|NCT00103857|27250156|P2|50-Week Extension Study|Pregnancy|0
7853863|NCT00103857|27250157|P1|50-Week Extension Study|Pregnancy|0
7853864|NCT00103857|27250151|P7|50-Week Extension Study|Physician Decision|0
7853865|NCT00103857|27250152|P6|50-Week Extension Study|Physician Decision|0
7853866|NCT00103857|27250153|P5|50-Week Extension Study|Physician Decision|0
7853867|NCT00103857|27250154|P4|50-Week Extension Study|Physician Decision|0
7853868|NCT00103857|27250155|P3|50-Week Extension Study|Physician Decision|1
7853869|NCT00103857|27250156|P2|50-Week Extension Study|Physician Decision|1
7853870|NCT00103857|27250157|P1|50-Week Extension Study|Physician Decision|0
7853871|NCT00103857|27250151|P7|50-Week Extension Study|Lost to Follow-up|0
7853872|NCT00103857|27250152|P6|50-Week Extension Study|Lost to Follow-up|3
7853873|NCT00103857|27250153|P5|50-Week Extension Study|Lost to Follow-up|3
7853874|NCT00103857|27250154|P4|50-Week Extension Study|Lost to Follow-up|4
7853875|NCT00103857|27250155|P3|50-Week Extension Study|Lost to Follow-up|1
7853876|NCT00103857|27250156|P2|50-Week Extension Study|Lost to Follow-up|0
7853877|NCT00103857|27250157|P1|50-Week Extension Study|Lost to Follow-up|4
7853878|NCT00103857|27250151|P7|50-Week Extension Study|Lack of Efficacy|0
7853879|NCT00103857|27250152|P6|50-Week Extension Study|Lack of Efficacy|8
7853880|NCT00103857|27250153|P5|50-Week Extension Study|Lack of Efficacy|8
7853881|NCT00103857|27250154|P4|50-Week Extension Study|Lack of Efficacy|16
7853882|NCT00103857|27250155|P3|50-Week Extension Study|Lack of Efficacy|13
7853883|NCT00103857|27250156|P2|50-Week Extension Study|Lack of Efficacy|15
7853884|NCT00103857|27250157|P1|50-Week Extension Study|Lack of Efficacy|26
7853885|NCT00103857|27250151|P7|50-Week Extension Study|Death|0
7853886|NCT00103857|27250152|P6|50-Week Extension Study|Death|1
7853887|NCT00103857|27250153|P5|50-Week Extension Study|Death|0
7853888|NCT00103857|27250154|P4|50-Week Extension Study|Death|1
7853889|NCT00103857|27250155|P3|50-Week Extension Study|Death|0
7853890|NCT00103857|27250156|P2|50-Week Extension Study|Death|0
7853891|NCT00103857|27250157|P1|50-Week Extension Study|Death|0
7853892|NCT00103857|27250151|P7|50-Week Extension Study|Adverse Event|0
7853893|NCT00103857|27250152|P6|50-Week Extension Study|Adverse Event|1
7853894|NCT00103857|27250153|P5|50-Week Extension Study|Adverse Event|1
7853895|NCT00103857|27250154|P4|50-Week Extension Study|Adverse Event|0
7853896|NCT00103857|27250155|P3|50-Week Extension Study|Adverse Event|2
7853897|NCT00103857|27250156|P2|50-Week Extension Study|Adverse Event|3
7853898|NCT00103857|27250157|P1|50-Week Extension Study|Adverse Event|2
7853899|NCT00103857|27250151|P7|54-Week Base Study|patient intolerance to rescue therapy|0
7853900|NCT00103857|27250152|P6|54-Week Base Study|patient intolerance to rescue therapy|0
7853901|NCT00103857|27250153|P5|54-Week Base Study|patient intolerance to rescue therapy|0
7853902|NCT00103857|27250154|P4|54-Week Base Study|patient intolerance to rescue therapy|0
7853903|NCT00103857|27250155|P3|54-Week Base Study|patient intolerance to rescue therapy|0
7853904|NCT00103857|27250156|P2|54-Week Base Study|patient intolerance to rescue therapy|0
7853905|NCT00103857|27250157|P1|54-Week Base Study|patient intolerance to rescue therapy|1
7853906|NCT00103857|27250151|P7|54-Week Base Study|site error|0
7853907|NCT00103857|27250152|P6|54-Week Base Study|site error|1
7853908|NCT00103857|27250153|P5|54-Week Base Study|site error|0
7853909|NCT00103857|27250154|P4|54-Week Base Study|site error|0
7853910|NCT00103857|27250155|P3|54-Week Base Study|site error|0
7853911|NCT00103857|27250156|P2|54-Week Base Study|site error|0
7853912|NCT00103857|27250157|P1|54-Week Base Study|site error|0
7853913|NCT00103857|27250151|P7|54-Week Base Study|laboratory reporting error|0
7853914|NCT00103857|27250152|P6|54-Week Base Study|laboratory reporting error|0
7853915|NCT00103857|27250153|P5|54-Week Base Study|laboratory reporting error|1
7853916|NCT00103857|27250154|P4|54-Week Base Study|laboratory reporting error|0
7853917|NCT00103857|27250155|P3|54-Week Base Study|laboratory reporting error|0
7853918|NCT00103857|27250156|P2|54-Week Base Study|laboratory reporting error|0
7853919|NCT00103857|27250157|P1|54-Week Base Study|laboratory reporting error|0
7853920|NCT00103857|27250151|P7|54-Week Base Study|patient incarcerated|0
7853921|NCT00103857|27250152|P6|54-Week Base Study|patient incarcerated|1
7853922|NCT00103857|27250153|P5|54-Week Base Study|patient incarcerated|1
7853923|NCT00103857|27250154|P4|54-Week Base Study|patient incarcerated|0
7853924|NCT00103857|27250155|P3|54-Week Base Study|patient incarcerated|0
7853925|NCT00103857|27250156|P2|54-Week Base Study|patient incarcerated|0
7853926|NCT00103857|27250157|P1|54-Week Base Study|patient incarcerated|0
7853927|NCT00103857|27250151|P7|54-Week Base Study|non-compliance with study procedures|0
7853928|NCT00103857|27250152|P6|54-Week Base Study|non-compliance with study procedures|2
7853929|NCT00103857|27250153|P5|54-Week Base Study|non-compliance with study procedures|0
7853930|NCT00103857|27250154|P4|54-Week Base Study|non-compliance with study procedures|0
7853931|NCT00103857|27250155|P3|54-Week Base Study|non-compliance with study procedures|0
7853932|NCT00103857|27250156|P2|54-Week Base Study|non-compliance with study procedures|2
7853933|NCT00103857|27250157|P1|54-Week Base Study|non-compliance with study procedures|1
7853934|NCT00103857|27250151|P7|54-Week Base Study|patient moved|0
7853935|NCT00103857|27250152|P6|54-Week Base Study|patient moved|1
7853936|NCT00103857|27250153|P5|54-Week Base Study|patient moved|3
7853937|NCT00103857|27250154|P4|54-Week Base Study|patient moved|2
7853938|NCT00103857|27250155|P3|54-Week Base Study|patient moved|1
7853939|NCT00103857|27250156|P2|54-Week Base Study|patient moved|1
7853940|NCT00103857|27250157|P1|54-Week Base Study|patient moved|0
7853941|NCT00103857|27250151|P7|54-Week Base Study|protocol discontinuation criteria|5
7853942|NCT00103857|27250152|P6|54-Week Base Study|protocol discontinuation criteria|3
7853943|NCT00103857|27250153|P5|54-Week Base Study|protocol discontinuation criteria|5
7853944|NCT00103857|27250154|P4|54-Week Base Study|protocol discontinuation criteria|6
7853945|NCT00103857|27250155|P3|54-Week Base Study|protocol discontinuation criteria|2
7853946|NCT00103857|27250156|P2|54-Week Base Study|protocol discontinuation criteria|5
7853947|NCT00103857|27250157|P1|54-Week Base Study|protocol discontinuation criteria|2
7853948|NCT00103857|27250151|P7|54-Week Base Study|Withdrawal by Subject|4
7853949|NCT00103857|27250152|P6|54-Week Base Study|Withdrawal by Subject|15
7853950|NCT00103857|27250153|P5|54-Week Base Study|Withdrawal by Subject|10
7853951|NCT00103857|27250154|P4|54-Week Base Study|Withdrawal by Subject|15
7853952|NCT00103857|27250155|P3|54-Week Base Study|Withdrawal by Subject|16
7853953|NCT00103857|27250156|P2|54-Week Base Study|Withdrawal by Subject|16
7853954|NCT00103857|27250157|P1|54-Week Base Study|Withdrawal by Subject|17
7853955|NCT00103857|27250151|P7|54-Week Base Study|Protocol Violation|3
7853956|NCT00103857|27250152|P6|54-Week Base Study|Protocol Violation|3
7853957|NCT00103857|27250153|P5|54-Week Base Study|Protocol Violation|0
7853958|NCT00103857|27250154|P4|54-Week Base Study|Protocol Violation|4
7853959|NCT00103857|27250155|P3|54-Week Base Study|Protocol Violation|2
7853960|NCT00103857|27250156|P2|54-Week Base Study|Protocol Violation|4
7853961|NCT00103857|27250157|P1|54-Week Base Study|Protocol Violation|6
7853962|NCT00103857|27250151|P7|54-Week Base Study|Pregnancy|1
7853963|NCT00103857|27250152|P6|54-Week Base Study|Pregnancy|0
7853964|NCT00103857|27250153|P5|54-Week Base Study|Pregnancy|1
7853965|NCT00103857|27250154|P4|54-Week Base Study|Pregnancy|0
7853966|NCT00103857|27250155|P3|54-Week Base Study|Pregnancy|0
7853967|NCT00103857|27250156|P2|54-Week Base Study|Pregnancy|0
7853968|NCT00103857|27250157|P1|54-Week Base Study|Pregnancy|1
7853969|NCT00103857|27250151|P7|54-Week Base Study|Physician Decision|0
7853970|NCT00103857|27250152|P6|54-Week Base Study|Physician Decision|0
7853971|NCT00103857|27250153|P5|54-Week Base Study|Physician Decision|1
7853972|NCT00103857|27250154|P4|54-Week Base Study|Physician Decision|0
7853973|NCT00103857|27250155|P3|54-Week Base Study|Physician Decision|0
7853974|NCT00103857|27250156|P2|54-Week Base Study|Physician Decision|1
7853975|NCT00103857|27250157|P1|54-Week Base Study|Physician Decision|1
7853976|NCT00103857|27250151|P7|54-Week Base Study|Lost to Follow-up|3
7853977|NCT00103857|27250152|P6|54-Week Base Study|Lost to Follow-up|9
7853978|NCT00103857|27250153|P5|54-Week Base Study|Lost to Follow-up|10
7853979|NCT00103857|27250154|P4|54-Week Base Study|Lost to Follow-up|5
7853980|NCT00103857|27250155|P3|54-Week Base Study|Lost to Follow-up|7
7853981|NCT00103857|27250156|P2|54-Week Base Study|Lost to Follow-up|4
7853982|NCT00103857|27250157|P1|54-Week Base Study|Lost to Follow-up|5
7853983|NCT00103857|27250151|P7|54-Week Base Study|Lack of Efficacy|19
7853984|NCT00103857|27250152|P6|54-Week Base Study|Lack of Efficacy|14
7853985|NCT00103857|27250153|P5|54-Week Base Study|Lack of Efficacy|3
7853986|NCT00103857|27250154|P4|54-Week Base Study|Lack of Efficacy|4
7853987|NCT00103857|27250155|P3|54-Week Base Study|Lack of Efficacy|8
7853988|NCT00103857|27250156|P2|54-Week Base Study|Lack of Efficacy|14
7853989|NCT00103857|27250157|P1|54-Week Base Study|Lack of Efficacy|11
7853990|NCT00103857|27250151|P7|54-Week Base Study|Death|0
7853991|NCT00103857|27250152|P6|54-Week Base Study|Death|1
7853992|NCT00103857|27250153|P5|54-Week Base Study|Death|1
7853993|NCT00103857|27250154|P4|54-Week Base Study|Death|0
7853994|NCT00103857|27250155|P3|54-Week Base Study|Death|0
7853995|NCT00103857|27250156|P2|54-Week Base Study|Death|0
7853996|NCT00103857|27250157|P1|54-Week Base Study|Death|0
7853997|NCT00103857|27250151|P7|54-Week Base Study|Adverse Event|3
7853998|NCT00103857|27250152|P6|54-Week Base Study|Adverse Event|11
7853999|NCT00103857|27250153|P5|54-Week Base Study|Adverse Event|5
7854000|NCT00103857|27250154|P4|54-Week Base Study|Adverse Event|6
7854001|NCT00103857|27250155|P3|54-Week Base Study|Adverse Event|11
7854002|NCT00103857|27250156|P2|54-Week Base Study|Adverse Event|9
7854003|NCT00103857|27250157|P1|54-Week Base Study|Adverse Event|12
7854004|NCT00103740|27250256|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
7854005|NCT00103740|27250257|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
7854006|NCT00103740|27250256|P2|Period 2 - Extended Observation Period|Death|2
7854007|NCT00103740|27250257|P1|Period 2 - Extended Observation Period|Death|6
7854008|NCT00103740|27250256|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
7854009|NCT00103740|27250257|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
7854010|NCT00103740|27250256|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
7854011|NCT00103740|27250257|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
7854012|NCT00103740|27250256|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
7854013|NCT00103740|27250257|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
7854014|NCT00103740|27250256|P2|Period 1 - Core|Patient withdrew consent|2
7854015|NCT00103740|27250257|P1|Period 1 - Core|Patient withdrew consent|3
7854016|NCT00103740|27250256|P2|Period 1 - Core|Protocol Violation|2
7854017|NCT00103740|27250257|P1|Period 1 - Core|Protocol Violation|3
7854018|NCT00103740|27250256|P2|Period 1 - Core|Adverse Event|0
7854019|NCT00103740|27250257|P1|Period 1 - Core|Adverse Event|1
7854020|NCT00103662|27250285|P2|Overall Study|Intercurrent illness|0
7854021|NCT00103662|27250286|P1|Overall Study|Intercurrent illness|1
7854022|NCT00103662|27250285|P2|Overall Study|Failed mobilization|4
7854023|NCT00103662|27250286|P1|Overall Study|Failed mobilization|0
7854024|NCT00103662|27250285|P2|Overall Study|Other|9
7854025|NCT00103662|27250286|P1|Overall Study|Other|6
7854026|NCT00103662|27250285|P2|Overall Study|Lost to Follow-up|1
7854027|NCT00103662|27250286|P1|Overall Study|Lost to Follow-up|0
7854028|NCT00103662|27250285|P2|Overall Study|Elective Withdrawal|5
7854029|NCT00103662|27250286|P1|Overall Study|Elective Withdrawal|5
7854030|NCT00103662|27250285|P2|Overall Study|Death|7
7854031|NCT00103662|27250286|P1|Overall Study|Death|7
7854032|NCT00103662|27250285|P2|Overall Study|Entered Rescue Procedure|7
7854033|NCT00103662|27250286|P1|Overall Study|Entered Rescue Procedure|0
7854034|NCT00103610|27250312|P2|Overall Study|Noncompliance|1
7854035|NCT00103610|27250313|P1|Overall Study|Noncompliance|0
7854036|NCT00103610|27250312|P2|Overall Study|Failed mobilization|5
7854037|NCT00103610|27250313|P1|Overall Study|Failed mobilization|1
7854038|NCT00103610|27250312|P2|Overall Study|Other|7
7854039|NCT00103610|27250313|P1|Overall Study|Other|2
7854040|NCT00103610|27250312|P2|Overall Study|Adverse Event|2
7854041|NCT00103610|27250313|P1|Overall Study|Adverse Event|2
7854042|NCT00103610|27250312|P2|Overall Study|Lost to Follow-up|1
7854043|NCT00103610|27250313|P1|Overall Study|Lost to Follow-up|3
7854044|NCT00103610|27250312|P2|Overall Study|Elective Withdrawal|0
7854045|NCT00103610|27250313|P1|Overall Study|Elective Withdrawal|4
7854046|NCT00103610|27250312|P2|Overall Study|Death|12
7854047|NCT00103610|27250313|P1|Overall Study|Death|16
7854048|NCT00103610|27250312|P2|Overall Study|Entered Rescue Procedure|52
7854049|NCT00103610|27250313|P1|Overall Study|Entered Rescue Procedure|10
7854050|NCT00103506|27250337|P2|Overall Study|Withdrawal by Subject|21
7854051|NCT00103506|27250338|P1|Overall Study|Withdrawal by Subject|18
7854052|NCT00103506|27250337|P2|Overall Study|Lost to Follow-up|13
7854053|NCT00103506|27250338|P1|Overall Study|Lost to Follow-up|13
7854054|NCT00103506|27250337|P2|Overall Study|Death|253
7854055|NCT00103506|27250338|P1|Overall Study|Death|257
7854056|NCT00103506|27250337|P2|Overall Study|Study closed by sponsor|37
7854057|NCT00103506|27250338|P1|Overall Study|Study closed by sponsor|34
7854058|NCT00103402|27250350|P2|Overall Study|Personal constraints/Other|0
7854059|NCT00103402|27250351|P1|Overall Study|Personal constraints/Other|5
7854060|NCT00103402|27250350|P2|Overall Study|Dissatisfied/No longer interested|6
7854061|NCT00103402|27250351|P1|Overall Study|Dissatisfied/No longer interested|6
7854062|NCT00103402|27250350|P2|Overall Study|Lost to Follow-up|7
7854063|NCT00103402|27250351|P1|Overall Study|Lost to Follow-up|8
7854064|NCT00103402|27250350|P2|Overall Study|Adverse Event|4
7854065|NCT00103402|27250351|P1|Overall Study|Adverse Event|3
7854066|NCT00103311|27250392|P2|Overall Study|Adverse Event|0
7854067|NCT00103311|27250393|P1|Overall Study|Adverse Event|1
7854068|NCT00103311|27250392|P2|Overall Study|Withdrawal by Subject|1
7854069|NCT00103311|27250393|P1|Overall Study|Withdrawal by Subject|2
7854070|NCT00103311|27250392|P2|Overall Study|Lost to Follow-up|0
7854071|NCT00103311|27250393|P1|Overall Study|Lost to Follow-up|1
7854072|NCT00103285|27250403|P8|Response Assignment|Other|53
7854073|NCT00103285|27250404|P7|Response Assignment|Other|11
7854074|NCT00103285|27250405|P6|Response Assignment|Other|17
7854075|NCT00103285|27250406|P5|Response Assignment|Other|37
7854076|NCT00103285|27250407|P4|Response Assignment|Other|38
7854077|NCT00103285|27250408|P3|Response Assignment|Other|48
7854078|NCT00103285|27250409|P2|Response Assignment|Other|30
7854079|NCT00103285|27250410|P1|Response Assignment|Other|0
7854080|NCT00103285|27250403|P8|Response Assignment|Refusal|10
7854081|NCT00103285|27250404|P7|Response Assignment|Refusal|30
7854082|NCT00103285|27250405|P6|Response Assignment|Refusal|15
7854083|NCT00103285|27250406|P5|Response Assignment|Refusal|25
7854084|NCT00103285|27250407|P4|Response Assignment|Refusal|3
7854085|NCT00103285|27250408|P3|Response Assignment|Refusal|5
7854086|NCT00103285|27250409|P2|Response Assignment|Refusal|53
7854087|NCT00103285|27250410|P1|Response Assignment|Refusal|0
7854088|NCT00103285|27250403|P8|Response Assignment|Ineligible|5
7854089|NCT00103285|27250404|P7|Response Assignment|Ineligible|1
7854090|NCT00103285|27250405|P6|Response Assignment|Ineligible|3
7854091|NCT00103285|27250406|P5|Response Assignment|Ineligible|0
7854092|NCT00103285|27250407|P4|Response Assignment|Ineligible|2
7854093|NCT00103285|27250408|P3|Response Assignment|Ineligible|6
7854094|NCT00103285|27250409|P2|Response Assignment|Ineligible|8
7854095|NCT00103285|27250410|P1|Response Assignment|Ineligible|0
7854096|NCT00103285|27250403|P8|Response Assignment|Withdrawal by Subject|2
7854097|NCT00103285|27250404|P7|Response Assignment|Withdrawal by Subject|0
7854098|NCT00103285|27250405|P6|Response Assignment|Withdrawal by Subject|2
7854099|NCT00103285|27250406|P5|Response Assignment|Withdrawal by Subject|2
7854100|NCT00103285|27250407|P4|Response Assignment|Withdrawal by Subject|1
7854101|NCT00103285|27250408|P3|Response Assignment|Withdrawal by Subject|1
7854102|NCT00103285|27250409|P2|Response Assignment|Withdrawal by Subject|4
7854103|NCT00103285|27250410|P1|Response Assignment|Withdrawal by Subject|0
7854104|NCT00103285|27250403|P8|Response Assignment|Protocol Violation|0
7854105|NCT00103285|27250404|P7|Response Assignment|Protocol Violation|0
7854106|NCT00103285|27250405|P6|Response Assignment|Protocol Violation|0
7854107|NCT00103285|27250406|P5|Response Assignment|Protocol Violation|0
7854108|NCT00103285|27250407|P4|Response Assignment|Protocol Violation|0
7854109|NCT00103285|27250408|P3|Response Assignment|Protocol Violation|0
7854110|NCT00103285|27250409|P2|Response Assignment|Protocol Violation|2
7854111|NCT00103285|27250410|P1|Response Assignment|Protocol Violation|0
7854112|NCT00103285|27250403|P8|Response Assignment|Physician Decision|35
7854113|NCT00103285|27250404|P7|Response Assignment|Physician Decision|4
7854114|NCT00103285|27250405|P6|Response Assignment|Physician Decision|7
7854115|NCT00103285|27250406|P5|Response Assignment|Physician Decision|13
7854116|NCT00103285|27250407|P4|Response Assignment|Physician Decision|9
7854117|NCT00103285|27250408|P3|Response Assignment|Physician Decision|14
7854118|NCT00103285|27250409|P2|Response Assignment|Physician Decision|13
7854119|NCT00103285|27250410|P1|Response Assignment|Physician Decision|0
7854120|NCT00103285|27250403|P8|Response Assignment|Lost to Follow-up|5
7854121|NCT00103285|27250404|P7|Response Assignment|Lost to Follow-up|2
7854122|NCT00103285|27250405|P6|Response Assignment|Lost to Follow-up|2
7854123|NCT00103285|27250406|P5|Response Assignment|Lost to Follow-up|1
7854124|NCT00103285|27250407|P4|Response Assignment|Lost to Follow-up|5
7854125|NCT00103285|27250408|P3|Response Assignment|Lost to Follow-up|5
7854126|NCT00103285|27250409|P2|Response Assignment|Lost to Follow-up|9
7854127|NCT00103285|27250410|P1|Response Assignment|Lost to Follow-up|0
7854128|NCT00103285|27250403|P8|Response Assignment|Death|8
7854129|NCT00103285|27250404|P7|Response Assignment|Death|0
7854130|NCT00103285|27250405|P6|Response Assignment|Death|1
7854131|NCT00103285|27250406|P5|Response Assignment|Death|3
7854132|NCT00103285|27250407|P4|Response Assignment|Death|2
7854133|NCT00103285|27250408|P3|Response Assignment|Death|2
7854134|NCT00103285|27250409|P2|Response Assignment|Death|5
7854135|NCT00103285|27250410|P1|Response Assignment|Death|0
7854136|NCT00103285|27250403|P8|Response Assignment|Adverse Event|2
7854137|NCT00103285|27250404|P7|Response Assignment|Adverse Event|1
7854138|NCT00103285|27250405|P6|Response Assignment|Adverse Event|1
7854139|NCT00103285|27250406|P5|Response Assignment|Adverse Event|3
7854140|NCT00103285|27250407|P4|Response Assignment|Adverse Event|2
7854141|NCT00103285|27250408|P3|Response Assignment|Adverse Event|3
7854142|NCT00103285|27250409|P2|Response Assignment|Adverse Event|8
7854143|NCT00103285|27250410|P1|Response Assignment|Adverse Event|0
7854144|NCT00103285|27250403|P8|Induction|Other|0
7854145|NCT00103285|27250404|P7|Induction|Other|0
7854146|NCT00103285|27250405|P6|Induction|Other|0
7854147|NCT00103285|27250406|P5|Induction|Other|0
7854148|NCT00103285|27250407|P4|Induction|Other|0
7854149|NCT00103285|27250408|P3|Induction|Other|0
7854150|NCT00103285|27250409|P2|Induction|Other|0
7854151|NCT00103285|27250410|P1|Induction|Other|258
7854152|NCT00103285|27250403|P8|Induction|Refusal|0
7854153|NCT00103285|27250404|P7|Induction|Refusal|0
7854154|NCT00103285|27250405|P6|Induction|Refusal|0
7854155|NCT00103285|27250406|P5|Induction|Refusal|0
7854156|NCT00103285|27250407|P4|Induction|Refusal|0
7854157|NCT00103285|27250408|P3|Induction|Refusal|0
7854158|NCT00103285|27250409|P2|Induction|Refusal|0
7854159|NCT00103285|27250410|P1|Induction|Refusal|906
7854160|NCT00103285|27250403|P8|Induction|Ineligible|0
7854161|NCT00103285|27250404|P7|Induction|Ineligible|0
7854162|NCT00103285|27250405|P6|Induction|Ineligible|0
7854163|NCT00103285|27250406|P5|Induction|Ineligible|0
7854164|NCT00103285|27250407|P4|Induction|Ineligible|0
7854165|NCT00103285|27250408|P3|Induction|Ineligible|0
7854166|NCT00103285|27250409|P2|Induction|Ineligible|0
7854167|NCT00103285|27250410|P1|Induction|Ineligible|43
7854168|NCT00103285|27250403|P8|Induction|Withdrawal by Subject|0
7854169|NCT00103285|27250404|P7|Induction|Withdrawal by Subject|0
7854170|NCT00103285|27250405|P6|Induction|Withdrawal by Subject|0
7854171|NCT00103285|27250406|P5|Induction|Withdrawal by Subject|0
7854172|NCT00103285|27250407|P4|Induction|Withdrawal by Subject|0
7854173|NCT00103285|27250408|P3|Induction|Withdrawal by Subject|0
7854174|NCT00103285|27250409|P2|Induction|Withdrawal by Subject|0
7854175|NCT00103285|27250410|P1|Induction|Withdrawal by Subject|1
7854176|NCT00103285|27250403|P8|Induction|Physician Decision|0
7854177|NCT00103285|27250404|P7|Induction|Physician Decision|0
7854178|NCT00103285|27250405|P6|Induction|Physician Decision|0
7854179|NCT00103285|27250406|P5|Induction|Physician Decision|0
7854180|NCT00103285|27250407|P4|Induction|Physician Decision|0
7854181|NCT00103285|27250408|P3|Induction|Physician Decision|0
7854182|NCT00103285|27250409|P2|Induction|Physician Decision|0
7854183|NCT00103285|27250410|P1|Induction|Physician Decision|103
7854184|NCT00103285|27250403|P8|Induction|Death|0
7854185|NCT00103285|27250404|P7|Induction|Death|0
7854186|NCT00103285|27250405|P6|Induction|Death|0
7854187|NCT00103285|27250406|P5|Induction|Death|0
7854188|NCT00103285|27250407|P4|Induction|Death|0
7854189|NCT00103285|27250408|P3|Induction|Death|0
7854190|NCT00103285|27250409|P2|Induction|Death|0
7854191|NCT00103285|27250410|P1|Induction|Death|24
7854192|NCT00103285|27250403|P8|Induction|Adverse Event|0
7854193|NCT00103285|27250404|P7|Induction|Adverse Event|0
7854194|NCT00103285|27250405|P6|Induction|Adverse Event|0
7854195|NCT00103285|27250406|P5|Induction|Adverse Event|0
7854196|NCT00103285|27250407|P4|Induction|Adverse Event|0
7854197|NCT00103285|27250408|P3|Induction|Adverse Event|0
7854198|NCT00103285|27250409|P2|Induction|Adverse Event|0
7854199|NCT00103285|27250410|P1|Induction|Adverse Event|14
7854200|NCT00103259|27250439|P2|Overall Study|ineligible/no protocol therapy|6
7854201|NCT00103259|27250440|P1|Overall Study|ineligible/no protocol therapy|4
7854202|NCT00103259|27250439|P2|Overall Study|other (reasons were not specified)|1
7854203|NCT00103259|27250440|P1|Overall Study|other (reasons were not specified)|2
7854204|NCT00103259|27250439|P2|Overall Study|alternative therapy|0
7854205|NCT00103259|27250440|P1|Overall Study|alternative therapy|1
7854206|NCT00103259|27250439|P2|Overall Study|Withdrawal by Subject|3
7854207|NCT00103259|27250440|P1|Overall Study|Withdrawal by Subject|2
7854208|NCT00103259|27250439|P2|Overall Study|Death|2
7854209|NCT00103259|27250440|P1|Overall Study|Death|3
7854210|NCT00103207|27250452|P1|Overall Study|Diagnosis of BAC not confirmed|27
7854211|NCT00103207|27250452|P1|Overall Study|Ineligible|4
7854212|NCT00103207|27250452|P1|Overall Study|Other complicating disease|1
7854213|NCT00103207|27250452|P1|Overall Study|Withdrawal by Subject|2
7854214|NCT00103207|27250452|P1|Overall Study|Death|1
7854215|NCT00103207|27250452|P1|Overall Study|Adverse Event|3
7854216|NCT00103142|27250471|P2|Overall Study|Progression of disease|1
7854217|NCT00103142|27250472|P1|Overall Study|Progression of disease|2
7854218|NCT00103142|27250471|P2|Overall Study|Adverse Event|0
7854219|NCT00103142|27250472|P1|Overall Study|Adverse Event|1
7854220|NCT00103012|27250488|P3|Overall Study|Subject non-compliant with medications|1
7854221|NCT00103012|27250489|P2|Overall Study|Subject non-compliant with medications|0
7854222|NCT00103012|27250490|P1|Overall Study|Subject non-compliant with medications|0
7854223|NCT00103012|27250488|P3|Overall Study|Adverse Event|1
7854224|NCT00103012|27250489|P2|Overall Study|Adverse Event|0
7854225|NCT00103012|27250490|P1|Overall Study|Adverse Event|0
7854226|NCT00103012|27250488|P3|Overall Study|Pregnancy|0
7854227|NCT00103012|27250489|P2|Overall Study|Pregnancy|0
7854228|NCT00103012|27250490|P1|Overall Study|Pregnancy|1
7854229|NCT00103012|27250488|P3|Overall Study|Withdrawal by Subject|2
7854230|NCT00103012|27250489|P2|Overall Study|Withdrawal by Subject|1
7854231|NCT00103012|27250490|P1|Overall Study|Withdrawal by Subject|2
7854232|NCT00102960|27250501|P3|Overall Study|Withdrawal by Subject|1
7854233|NCT00102960|27250502|P2|Overall Study|Withdrawal by Subject|0
7854234|NCT00102960|27250503|P1|Overall Study|Withdrawal by Subject|1
7854235|NCT00102960|27250501|P3|Overall Study|Lost to Follow-up|16
7854236|NCT00102960|27250502|P2|Overall Study|Lost to Follow-up|12
7854237|NCT00102960|27250503|P1|Overall Study|Lost to Follow-up|6
7854238|NCT00102960|27250501|P3|Overall Study|Death|11
7854239|NCT00102960|27250502|P2|Overall Study|Death|11
7854240|NCT00102960|27250503|P1|Overall Study|Death|23
7854241|NCT00102804|27250552|P2|Overall Study|Alive, Receiving Treatment|2
7854242|NCT00102804|27250553|P1|Overall Study|Alive, Receiving Treatment|7
7854243|NCT00102804|27250552|P2|Overall Study|Sponsor Decision|0
7854244|NCT00102804|27250553|P1|Overall Study|Sponsor Decision|1
7854245|NCT00102804|27250552|P2|Overall Study|Satisfactory Response|0
7854246|NCT00102804|27250553|P1|Overall Study|Satisfactory Response|2
7854247|NCT00102804|27250552|P2|Overall Study|Protocol Violation|1
7854248|NCT00102804|27250553|P1|Overall Study|Protocol Violation|2
7854249|NCT00102804|27250552|P2|Overall Study|Lost to Follow-up|1
7854250|NCT00102804|27250553|P1|Overall Study|Lost to Follow-up|4
7854251|NCT00102804|27250552|P2|Overall Study|Enrollment Criteria Not Met|0
7854252|NCT00102804|27250553|P1|Overall Study|Enrollment Criteria Not Met|6
7854253|NCT00102804|27250552|P2|Overall Study|Death|6
7854254|NCT00102804|27250553|P1|Overall Study|Death|5
7854255|NCT00102804|27250552|P2|Overall Study|Physician Decision|6
7854256|NCT00102804|27250553|P1|Overall Study|Physician Decision|24
7854257|NCT00102804|27250552|P2|Overall Study|Adverse Event|3
7854258|NCT00102804|27250553|P1|Overall Study|Adverse Event|37
7854259|NCT00102804|27250552|P2|Overall Study|Withdrawal by Subject|7
7854260|NCT00102804|27250553|P1|Overall Study|Withdrawal by Subject|46
7854261|NCT00102804|27250552|P2|Overall Study|Progressive Disease (PD)|196
7854262|NCT00102804|27250553|P1|Overall Study|Progressive Disease (PD)|307
7854263|NCT00102687|27250574|P5|Maintenance Period|Physician Decision|4
7854264|NCT00102687|27250575|P4|Maintenance Period|Physician Decision|0
7854265|NCT00102687|27250576|P3|Maintenance Period|Physician Decision|3
7854266|NCT00102687|27250577|P2|Maintenance Period|Physician Decision|2
7854267|NCT00102687|27250578|P1|Maintenance Period|Physician Decision|1
7854268|NCT00102687|27250574|P5|Maintenance Period|Death|1
7854269|NCT00102687|27250575|P4|Maintenance Period|Death|1
7854270|NCT00102687|27250576|P3|Maintenance Period|Death|0
7854271|NCT00102687|27250577|P2|Maintenance Period|Death|0
7854272|NCT00102687|27250578|P1|Maintenance Period|Death|0
7854273|NCT00102687|27250574|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
7854274|NCT00102687|27250575|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
7854275|NCT00102687|27250576|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7854276|NCT00102687|27250577|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7854277|NCT00102687|27250578|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7854278|NCT00102687|27250574|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
7854279|NCT00102687|27250575|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
7854280|NCT00102687|27250576|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
7854281|NCT00102687|27250577|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
7854282|NCT00102687|27250578|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
7854283|NCT00102687|27250574|P5|Maintenance Period|Adverse Event|3
7854284|NCT00102687|27250575|P4|Maintenance Period|Adverse Event|1
7854285|NCT00102687|27250576|P3|Maintenance Period|Adverse Event|0
7854286|NCT00102687|27250577|P2|Maintenance Period|Adverse Event|0
7854287|NCT00102687|27250578|P1|Maintenance Period|Adverse Event|1
7854288|NCT00102687|27250574|P5|Maintenance Period|Withdrawal by Subject|1
7854289|NCT00102687|27250575|P4|Maintenance Period|Withdrawal by Subject|3
7854290|NCT00102687|27250576|P3|Maintenance Period|Withdrawal by Subject|2
7854291|NCT00102687|27250577|P2|Maintenance Period|Withdrawal by Subject|0
7854292|NCT00102687|27250578|P1|Maintenance Period|Withdrawal by Subject|4
7854293|NCT00102687|27250574|P5|Initial Period|Death|0
7854294|NCT00102687|27250575|P4|Initial Period|Death|0
7854295|NCT00102687|27250576|P3|Initial Period|Death|1
7854296|NCT00102687|27250577|P2|Initial Period|Death|1
7854297|NCT00102687|27250578|P1|Initial Period|Death|1
7854298|NCT00102687|27250574|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
7854299|NCT00102687|27250575|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
7854300|NCT00102687|27250576|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
7854301|NCT00102687|27250577|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
7854302|NCT00102687|27250578|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
7854303|NCT00102687|27250574|P5|Initial Period|Sponsor's decision|0
7854304|NCT00102687|27250575|P4|Initial Period|Sponsor's decision|0
7854305|NCT00102687|27250576|P3|Initial Period|Sponsor's decision|1
7854306|NCT00102687|27250577|P2|Initial Period|Sponsor's decision|1
7854307|NCT00102687|27250578|P1|Initial Period|Sponsor's decision|0
7854308|NCT00102687|27250574|P5|Initial Period|Physician Decision|0
7854309|NCT00102687|27250575|P4|Initial Period|Physician Decision|0
7854310|NCT00102687|27250576|P3|Initial Period|Physician Decision|6
7854311|NCT00102687|27250577|P2|Initial Period|Physician Decision|9
7854312|NCT00102687|27250578|P1|Initial Period|Physician Decision|2
7854313|NCT00102687|27250574|P5|Initial Period|Protocol Violation|0
7854314|NCT00102687|27250575|P4|Initial Period|Protocol Violation|0
7854315|NCT00102687|27250576|P3|Initial Period|Protocol Violation|2
7854316|NCT00102687|27250577|P2|Initial Period|Protocol Violation|0
7854317|NCT00102687|27250578|P1|Initial Period|Protocol Violation|0
7854318|NCT00102687|27250574|P5|Initial Period|Transformation to AML (blast > 30%)|0
7854319|NCT00102687|27250575|P4|Initial Period|Transformation to AML (blast > 30%)|0
7854320|NCT00102687|27250576|P3|Initial Period|Transformation to AML (blast > 30%)|0
7854321|NCT00102687|27250577|P2|Initial Period|Transformation to AML (blast > 30%)|3
7854322|NCT00102687|27250578|P1|Initial Period|Transformation to AML (blast > 30%)|1
7854323|NCT00102687|27250574|P5|Initial Period|Adverse Event|0
7854324|NCT00102687|27250575|P4|Initial Period|Adverse Event|0
7854325|NCT00102687|27250576|P3|Initial Period|Adverse Event|9
7854326|NCT00102687|27250577|P2|Initial Period|Adverse Event|7
7854327|NCT00102687|27250578|P1|Initial Period|Adverse Event|4
7854328|NCT00102687|27250574|P5|Initial Period|Withdrawal by Subject|0
7854329|NCT00102687|27250575|P4|Initial Period|Withdrawal by Subject|0
7854330|NCT00102687|27250576|P3|Initial Period|Withdrawal by Subject|5
7854331|NCT00102687|27250577|P2|Initial Period|Withdrawal by Subject|3
7854332|NCT00102687|27250578|P1|Initial Period|Withdrawal by Subject|6
7854333|NCT00102596|27250642|P2|Part A|Adverse Event|0
7854334|NCT00102596|27250643|P1|Part A|Adverse Event|1
7854335|NCT00102596|27250642|P2|Part A|Screen failures|0
7854336|NCT00102596|27250643|P1|Part A|Screen failures|6
7854337|NCT00102531|27250654|P2|Overall Study|Physician Decision|1
7854338|NCT00102531|27250655|P1|Overall Study|Physician Decision|0
7854339|NCT00102531|27250654|P2|Overall Study|Disease Progression|9
7854340|NCT00102531|27250655|P1|Overall Study|Disease Progression|5
7854341|NCT00102531|27250654|P2|Overall Study|Adverse Event|1
7854342|NCT00102531|27250655|P1|Overall Study|Adverse Event|0
7854343|NCT00102440|27250670|P3|Overall Study|Protocol Violation|1
7854344|NCT00102440|27250671|P2|Overall Study|Protocol Violation|2
7854345|NCT00102440|27250672|P1|Overall Study|Protocol Violation|7
7854346|NCT00102440|27250670|P3|Overall Study|Other|14
7854347|NCT00102440|27250671|P2|Overall Study|Other|14
7854348|NCT00102440|27250672|P1|Overall Study|Other|11
7854349|NCT00102440|27250670|P3|Overall Study|Personal Reason(s)|13
7854350|NCT00102440|27250671|P2|Overall Study|Personal Reason(s)|13
7854351|NCT00102440|27250672|P1|Overall Study|Personal Reason(s)|19
7854352|NCT00102440|27250670|P3|Overall Study|Gout Flare|9
7854353|NCT00102440|27250671|P2|Overall Study|Gout Flare|28
7854354|NCT00102440|27250672|P1|Overall Study|Gout Flare|10
7854355|NCT00102440|27250670|P3|Overall Study|Adverse Event|8
7854356|NCT00102440|27250671|P2|Overall Study|Adverse Event|23
7854357|NCT00102440|27250672|P1|Overall Study|Adverse Event|16
7854358|NCT00102440|27250670|P3|Overall Study|Lost to Follow-up|21
7854359|NCT00102440|27250671|P2|Overall Study|Lost to Follow-up|18
7854360|NCT00102440|27250672|P1|Overall Study|Lost to Follow-up|25
7854361|NCT00102063|27250722|P3|Overall Study|Protocol Violation|1
7854362|NCT00102063|27250723|P2|Overall Study|Protocol Violation|1
7854363|NCT00102063|27250724|P1|Overall Study|Protocol Violation|0
7854364|NCT00102063|27250722|P3|Overall Study|Lost to Follow-up|1
7854365|NCT00102063|27250723|P2|Overall Study|Lost to Follow-up|0
7854366|NCT00102063|27250724|P1|Overall Study|Lost to Follow-up|0
7854367|NCT00102063|27250722|P3|Overall Study|Withdrawal by Subject|5
7854368|NCT00102063|27250723|P2|Overall Study|Withdrawal by Subject|12
7854369|NCT00102063|27250724|P1|Overall Study|Withdrawal by Subject|4
7854370|NCT00102063|27250722|P3|Overall Study|Adverse Event|2
7854371|NCT00102063|27250723|P2|Overall Study|Adverse Event|4
7854372|NCT00102063|27250724|P1|Overall Study|Adverse Event|7
7854373|NCT00102063|27250722|P3|Overall Study|Lack of Efficacy|1
7854374|NCT00102063|27250723|P2|Overall Study|Lack of Efficacy|1
7854375|NCT00102063|27250724|P1|Overall Study|Lack of Efficacy|5
7854376|NCT00101907|27250782|P6|Overall Study|Withdrawal by Subject|0
7854377|NCT00101907|27250783|P5|Overall Study|Withdrawal by Subject|1
7854378|NCT00101907|27250784|P4|Overall Study|Withdrawal by Subject|0
7854379|NCT00101907|27250785|P3|Overall Study|Withdrawal by Subject|1
7854380|NCT00101907|27250786|P2|Overall Study|Withdrawal by Subject|0
7854381|NCT00101907|27250787|P1|Overall Study|Withdrawal by Subject|1
7854382|NCT00101907|27250782|P6|Overall Study|Physician Decision|0
7854383|NCT00101907|27250783|P5|Overall Study|Physician Decision|1
7854384|NCT00101907|27250784|P4|Overall Study|Physician Decision|1
7854385|NCT00101907|27250785|P3|Overall Study|Physician Decision|0
7854386|NCT00101907|27250786|P2|Overall Study|Physician Decision|0
7854387|NCT00101907|27250787|P1|Overall Study|Physician Decision|0
7854388|NCT00101907|27250782|P6|Overall Study|Death|0
7854389|NCT00101907|27250783|P5|Overall Study|Death|3
7854390|NCT00101907|27250784|P4|Overall Study|Death|0
7854391|NCT00101907|27250785|P3|Overall Study|Death|0
7854392|NCT00101907|27250786|P2|Overall Study|Death|1
7854393|NCT00101907|27250787|P1|Overall Study|Death|0
7854394|NCT00101907|27250782|P6|Overall Study|Adverse Event|0
7854395|NCT00101907|27250783|P5|Overall Study|Adverse Event|0
7854396|NCT00101907|27250784|P4|Overall Study|Adverse Event|0
7854397|NCT00101907|27250785|P3|Overall Study|Adverse Event|0
7854398|NCT00101907|27250786|P2|Overall Study|Adverse Event|0
7854399|NCT00101907|27250787|P1|Overall Study|Adverse Event|1
7854400|NCT00101868|27250829|P2|Overall Study|Lost to Follow-up|13
7854401|NCT00101868|27250830|P1|Overall Study|Lost to Follow-up|8
7854402|NCT00101868|27250829|P2|Overall Study|Protocol Violation|0
7854403|NCT00101868|27250830|P1|Overall Study|Protocol Violation|3
7854404|NCT00101868|27250829|P2|Overall Study|Withdrawal by Subject|9
7854405|NCT00101868|27250830|P1|Overall Study|Withdrawal by Subject|8
7854406|NCT00101868|27250829|P2|Overall Study|Death|10
7854407|NCT00101868|27250830|P1|Overall Study|Death|10
7854408|NCT00101686|27250900|P10|Overall Study|Withdrawal by Subject|9
7854409|NCT00101686|27250901|P9|Overall Study|Withdrawal by Subject|8
7854410|NCT00101686|27250902|P8|Overall Study|Withdrawal by Subject|7
7854411|NCT00101686|27250903|P7|Overall Study|Withdrawal by Subject|7
7854412|NCT00101686|27250904|P6|Overall Study|Withdrawal by Subject|7
7854413|NCT00101686|27250905|P5|Overall Study|Withdrawal by Subject|8
7854414|NCT00101686|27250906|P4|Overall Study|Withdrawal by Subject|8
7854415|NCT00101686|27250907|P3|Overall Study|Withdrawal by Subject|6
7854416|NCT00101686|27250908|P2|Overall Study|Withdrawal by Subject|8
7854417|NCT00101686|27250909|P1|Overall Study|Withdrawal by Subject|9
7854418|NCT00101686|27250900|P10|Overall Study|Other|3
7854419|NCT00101686|27250901|P9|Overall Study|Other|3
7854420|NCT00101686|27250902|P8|Overall Study|Other|5
7854421|NCT00101686|27250903|P7|Overall Study|Other|1
7854422|NCT00101686|27250904|P6|Overall Study|Other|12
7854423|NCT00101686|27250905|P5|Overall Study|Other|2
7854424|NCT00101686|27250906|P4|Overall Study|Other|6
7854425|NCT00101686|27250907|P3|Overall Study|Other|1
7854426|NCT00101686|27250908|P2|Overall Study|Other|4
7854427|NCT00101686|27250909|P1|Overall Study|Other|1
7854428|NCT00101686|27250900|P10|Overall Study|Physician Decision|1
7854429|NCT00101686|27250901|P9|Overall Study|Physician Decision|1
7854430|NCT00101686|27250902|P8|Overall Study|Physician Decision|5
7854431|NCT00101686|27250903|P7|Overall Study|Physician Decision|5
7854432|NCT00101686|27250904|P6|Overall Study|Physician Decision|9
7854433|NCT00101686|27250905|P5|Overall Study|Physician Decision|8
7854434|NCT00101686|27250906|P4|Overall Study|Physician Decision|7
7854435|NCT00101686|27250907|P3|Overall Study|Physician Decision|6
7854436|NCT00101686|27250908|P2|Overall Study|Physician Decision|13
7854437|NCT00101686|27250909|P1|Overall Study|Physician Decision|10
7854438|NCT00101686|27250900|P10|Overall Study|intercurrent non-cancer related illness|1
7854439|NCT00101686|27250901|P9|Overall Study|intercurrent non-cancer related illness|1
7854440|NCT00101686|27250902|P8|Overall Study|intercurrent non-cancer related illness|0
7854441|NCT00101686|27250903|P7|Overall Study|intercurrent non-cancer related illness|1
7854442|NCT00101686|27250904|P6|Overall Study|intercurrent non-cancer related illness|3
7854443|NCT00101686|27250905|P5|Overall Study|intercurrent non-cancer related illness|1
7854444|NCT00101686|27250906|P4|Overall Study|intercurrent non-cancer related illness|0
7854445|NCT00101686|27250907|P3|Overall Study|intercurrent non-cancer related illness|2
7854446|NCT00101686|27250908|P2|Overall Study|intercurrent non-cancer related illness|0
7854447|NCT00101686|27250909|P1|Overall Study|intercurrent non-cancer related illness|0
7854448|NCT00101686|27250900|P10|Overall Study|Randomized but did not receive treament|1
7854449|NCT00101686|27250901|P9|Overall Study|Randomized but did not receive treament|0
7854450|NCT00101686|27250902|P8|Overall Study|Randomized but did not receive treament|1
7854451|NCT00101686|27250903|P7|Overall Study|Randomized but did not receive treament|0
7854452|NCT00101686|27250904|P6|Overall Study|Randomized but did not receive treament|2
7854453|NCT00101686|27250905|P5|Overall Study|Randomized but did not receive treament|2
7854454|NCT00101686|27250906|P4|Overall Study|Randomized but did not receive treament|2
7854455|NCT00101686|27250907|P3|Overall Study|Randomized but did not receive treament|2
7854456|NCT00101686|27250908|P2|Overall Study|Randomized but did not receive treament|6
7854457|NCT00101686|27250909|P1|Overall Study|Randomized but did not receive treament|1
7854458|NCT00101686|27250900|P10|Overall Study|unacceptable toxicity|4
7854459|NCT00101686|27250901|P9|Overall Study|unacceptable toxicity|1
7854460|NCT00101686|27250902|P8|Overall Study|unacceptable toxicity|2
7854461|NCT00101686|27250903|P7|Overall Study|unacceptable toxicity|4
7854462|NCT00101686|27250904|P6|Overall Study|unacceptable toxicity|10
7854463|NCT00101686|27250905|P5|Overall Study|unacceptable toxicity|16
7854464|NCT00101686|27250906|P4|Overall Study|unacceptable toxicity|6
7854465|NCT00101686|27250907|P3|Overall Study|unacceptable toxicity|10
7854466|NCT00101686|27250908|P2|Overall Study|unacceptable toxicity|9
7854467|NCT00101686|27250909|P1|Overall Study|unacceptable toxicity|3
7854468|NCT00101686|27250900|P10|Overall Study|>3 week delay treatment due toxicity|0
7854469|NCT00101686|27250901|P9|Overall Study|>3 week delay treatment due toxicity|3
7854470|NCT00101686|27250902|P8|Overall Study|>3 week delay treatment due toxicity|1
7854471|NCT00101686|27250903|P7|Overall Study|>3 week delay treatment due toxicity|2
7854472|NCT00101686|27250904|P6|Overall Study|>3 week delay treatment due toxicity|3
7854473|NCT00101686|27250905|P5|Overall Study|>3 week delay treatment due toxicity|7
7854474|NCT00101686|27250906|P4|Overall Study|>3 week delay treatment due toxicity|2
7854475|NCT00101686|27250907|P3|Overall Study|>3 week delay treatment due toxicity|1
7854476|NCT00101686|27250908|P2|Overall Study|>3 week delay treatment due toxicity|2
7854477|NCT00101686|27250909|P1|Overall Study|>3 week delay treatment due toxicity|6
7854478|NCT00101686|27250900|P10|Overall Study|initiation other anti-cancer treatment|3
7854479|NCT00101686|27250901|P9|Overall Study|initiation other anti-cancer treatment|3
7854480|NCT00101686|27250902|P8|Overall Study|initiation other anti-cancer treatment|2
7854481|NCT00101686|27250903|P7|Overall Study|initiation other anti-cancer treatment|2
7854482|NCT00101686|27250904|P6|Overall Study|initiation other anti-cancer treatment|1
7854483|NCT00101686|27250905|P5|Overall Study|initiation other anti-cancer treatment|1
7854484|NCT00101686|27250906|P4|Overall Study|initiation other anti-cancer treatment|3
7854485|NCT00101686|27250907|P3|Overall Study|initiation other anti-cancer treatment|4
7854486|NCT00101686|27250908|P2|Overall Study|initiation other anti-cancer treatment|3
7854487|NCT00101686|27250909|P1|Overall Study|initiation other anti-cancer treatment|4
7854488|NCT00101686|27250900|P10|Overall Study|Progressive Disease|8
7854489|NCT00101686|27250901|P9|Overall Study|Progressive Disease|10
7854490|NCT00101686|27250902|P8|Overall Study|Progressive Disease|7
7854491|NCT00101686|27250903|P7|Overall Study|Progressive Disease|5
7854492|NCT00101686|27250904|P6|Overall Study|Progressive Disease|25
7854493|NCT00101686|27250905|P5|Overall Study|Progressive Disease|28
7854494|NCT00101686|27250906|P4|Overall Study|Progressive Disease|38
7854495|NCT00101686|27250907|P3|Overall Study|Progressive Disease|37
7854496|NCT00101686|27250908|P2|Overall Study|Progressive Disease|28
7854497|NCT00101686|27250909|P1|Overall Study|Progressive Disease|37
7854498|NCT00101582|27251026|P2|Overall Study|Other|1
7854499|NCT00101582|27251027|P1|Overall Study|Other|0
7854500|NCT00101582|27251026|P2|Overall Study|Death|5
7854501|NCT00101582|27251027|P1|Overall Study|Death|3
7854502|NCT00101582|27251026|P2|Overall Study|Physician Decision|0
7854503|NCT00101582|27251027|P1|Overall Study|Physician Decision|1
7854504|NCT00101582|27251026|P2|Overall Study|Withdrawal by Subject|4
7854505|NCT00101582|27251027|P1|Overall Study|Withdrawal by Subject|6
7854506|NCT00101582|27251026|P2|Overall Study|Adverse Event|4
7854507|NCT00101582|27251027|P1|Overall Study|Adverse Event|1
7854508|NCT00101582|27251026|P2|Overall Study|Ineligibility determined|1
7854509|NCT00101582|27251027|P1|Overall Study|Ineligibility determined|0
7854510|NCT00101452|27251050|P3|Overall Study|Other|12
7854511|NCT00101452|27251051|P2|Overall Study|Other|16
7854512|NCT00101452|27251052|P1|Overall Study|Other|15
7854513|NCT00101452|27251050|P3|Overall Study|Protocol Violation|3
7854514|NCT00101452|27251051|P2|Overall Study|Protocol Violation|1
7854515|NCT00101452|27251052|P1|Overall Study|Protocol Violation|2
7854516|NCT00101452|27251050|P3|Overall Study|Physician Decision|2
7854517|NCT00101452|27251051|P2|Overall Study|Physician Decision|3
7854518|NCT00101452|27251052|P1|Overall Study|Physician Decision|0
7854519|NCT00101452|27251050|P3|Overall Study|Baseline Fail|2
7854520|NCT00101452|27251051|P2|Overall Study|Baseline Fail|1
7854521|NCT00101452|27251052|P1|Overall Study|Baseline Fail|2
7854522|NCT00101452|27251050|P3|Overall Study|Withdrawal by Subject|9
7854523|NCT00101452|27251051|P2|Overall Study|Withdrawal by Subject|14
7854524|NCT00101452|27251052|P1|Overall Study|Withdrawal by Subject|10
7854525|NCT00101452|27251050|P3|Overall Study|Lost to Follow-up|14
7854526|NCT00101452|27251051|P2|Overall Study|Lost to Follow-up|8
7854527|NCT00101452|27251052|P1|Overall Study|Lost to Follow-up|13
7854528|NCT00101452|27251050|P3|Overall Study|Adverse Event|1
7854529|NCT00101452|27251051|P2|Overall Study|Adverse Event|0
7854530|NCT00101452|27251052|P1|Overall Study|Adverse Event|2
7854531|NCT00101439|27251066|P2|Period 2|Withdrawal by Subject|2
7854532|NCT00101439|27251067|P1|Period 2|Withdrawal by Subject|0
7854533|NCT00101400|27251083|P1|Survival Follow-Up|Alive|7
7854534|NCT00101283|27251103|P2|Overall Study|Prostate Cancer Recurrence|1
7854535|NCT00101283|27251104|P1|Overall Study|Prostate Cancer Recurrence|0
7854536|NCT00101283|27251103|P2|Overall Study|Insurance Refusal|1
7854537|NCT00101283|27251104|P1|Overall Study|Insurance Refusal|0
7854538|NCT00101283|27251103|P2|Overall Study|Withdrawal by Subject|1
7854539|NCT00101283|27251104|P1|Overall Study|Withdrawal by Subject|0
7854540|NCT00101192|27251114|P1|Overall Study|Inevaluable|1
7854541|NCT00101192|27251114|P1|Overall Study|Ineligible|6
7854542|NCT00101166|27251118|P1|Overall Study|progressive disease|10
7854543|NCT00101101|27251126|P1|Overall Study|never received vaccine|20
7854544|NCT00101010|27251147|P1|Overall Study|Physician Decision|1
7854545|NCT00100932|27251154|P2|Overall Study|Other|2
7854546|NCT00100932|27251155|P1|Overall Study|Other|5
7854547|NCT00100932|27251154|P2|Overall Study|Physician Decision|5
7854548|NCT00100932|27251155|P1|Overall Study|Physician Decision|7
7854549|NCT00100932|27251154|P2|Overall Study|Progressive Disease|18
7854550|NCT00100932|27251155|P1|Overall Study|Progressive Disease|44
7854551|NCT00100932|27251154|P2|Overall Study|Withdrawal by Subject|0
7854552|NCT00100932|27251155|P1|Overall Study|Withdrawal by Subject|6
7854553|NCT00100932|27251154|P2|Overall Study|Adverse Event|2
7854554|NCT00100932|27251155|P1|Overall Study|Adverse Event|11
7854555|NCT00100828|27251170|P1|Overall Study|Physician Decision|6
7854556|NCT00100815|27251174|P1|Overall Study|Other|3
7854557|NCT00100815|27251174|P1|Overall Study|Death|4
7854558|NCT00100815|27251174|P1|Overall Study|Adverse Event|18
7854559|NCT00100815|27251174|P1|Overall Study|Progression|24
7854560|NCT00100802|27251182|P1|Overall Study|Ineligible|12
7854561|NCT00100802|27251182|P1|Overall Study|Withdrawal by Subject|5
7854562|NCT00100802|27251182|P1|Overall Study|Protocol Violation|1
7854563|NCT00100802|27251182|P1|Overall Study|Physician Decision|5
7854564|NCT00100802|27251182|P1|Overall Study|Lack of Efficacy|47
7854565|NCT00100802|27251182|P1|Overall Study|Death|1
7854566|NCT00100802|27251182|P1|Overall Study|Adverse Event|9
7854567|NCT00100789|27251187|P1|Overall Study|Never received treatment|1
7854568|NCT00100789|27251187|P1|Overall Study|Ineligible|3
7854569|NCT00100789|27251187|P1|Overall Study|Not protocol specified|5
7854570|NCT00100789|27251187|P1|Overall Study|Death|2
7854571|NCT00100789|27251187|P1|Overall Study|Progression/relapse|42
7854572|NCT00100789|27251187|P1|Overall Study|Withdrawal by Subject|1
7854573|NCT00100789|27251187|P1|Overall Study|Adverse Event|10
7854574|NCT00100178|27251264|P3|Overall Study|Physician Decision|3
7854575|NCT00100178|27251265|P2|Overall Study|Physician Decision|1
7854576|NCT00100178|27251266|P1|Overall Study|Physician Decision|6
7854577|NCT00100178|27251264|P3|Overall Study|Withdrawal by Subject|1
7854578|NCT00100178|27251265|P2|Overall Study|Withdrawal by Subject|1
7854579|NCT00100178|27251266|P1|Overall Study|Withdrawal by Subject|1
7854580|NCT00100178|27251264|P3|Overall Study|Adverse Event|1
7854581|NCT00100178|27251265|P2|Overall Study|Adverse Event|2
7854582|NCT00100178|27251266|P1|Overall Study|Adverse Event|2
7854583|NCT00100178|27251264|P3|Overall Study|Lost to Follow-up|5
7854584|NCT00100178|27251265|P2|Overall Study|Lost to Follow-up|6
7854585|NCT00100178|27251266|P1|Overall Study|Lost to Follow-up|0
7854586|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7854587|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7854588|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
7854589|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7854590|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7854591|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7854592|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
7854593|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
7854594|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
7854595|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
7854596|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
7854597|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
7854598|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
7854599|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
7854600|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
7854601|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
7854602|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
7854603|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
7854604|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
7854605|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
7854606|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
7854607|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
7854608|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
7854609|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
7854610|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
7854611|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
7854612|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
7854613|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
7854614|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
7854615|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
7854616|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
7854617|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7854618|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7854619|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7854620|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
7854621|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
7854622|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
7854623|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7854624|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7854625|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
7854626|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
7854627|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7854628|NCT00100048|27251295|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
7854629|NCT00100048|27251296|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
7854630|NCT00100048|27251297|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
7854631|NCT00100048|27251298|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
7854632|NCT00100048|27251299|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
7854633|NCT00100048|27251300|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
7854634|NCT00099983|27251409|P2|Overall Study|Other issue|0
7854635|NCT00099983|27251410|P1|Overall Study|Other issue|1
7854636|NCT00099983|27251409|P2|Overall Study|Intolerant of burden of visits|1
7854637|NCT00099983|27251410|P1|Overall Study|Intolerant of burden of visits|0
7854638|NCT00099983|27251409|P2|Overall Study|Incarcerated|1
7854639|NCT00099983|27251410|P1|Overall Study|Incarcerated|0
7854640|NCT00099983|27251409|P2|Overall Study|Other psychiatric problem|0
7854641|NCT00099983|27251410|P1|Overall Study|Other psychiatric problem|1
7854642|NCT00099983|27251409|P2|Overall Study|Moved|0
7854643|NCT00099983|27251410|P1|Overall Study|Moved|1
7854644|NCT00099983|27251409|P2|Overall Study|Unable to return for appointments|1
7854645|NCT00099983|27251410|P1|Overall Study|Unable to return for appointments|1
7854646|NCT00099983|27251409|P2|Overall Study|Lack of Efficacy|1
7854647|NCT00099983|27251410|P1|Overall Study|Lack of Efficacy|0
7854648|NCT00099983|27251409|P2|Overall Study|Adverse Event|1
7854649|NCT00099983|27251410|P1|Overall Study|Adverse Event|1
7854650|NCT00099983|27251409|P2|Overall Study|Withdrawal by Subject|2
7854651|NCT00099983|27251410|P1|Overall Study|Withdrawal by Subject|3
7854652|NCT00099983|27251409|P2|Overall Study|Missing Source Documents|15
7854653|NCT00099983|27251410|P1|Overall Study|Missing Source Documents|14
7854654|NCT00099983|27251409|P2|Overall Study|Lost to Follow-up|3
7854655|NCT00099983|27251410|P1|Overall Study|Lost to Follow-up|2
7854656|NCT00099632|27251422|P6|Overall Study|Protocol Violation|1
7854657|NCT00099632|27251423|P5|Overall Study|Protocol Violation|0
7854658|NCT00099632|27251424|P4|Overall Study|Protocol Violation|0
7854659|NCT00099632|27251425|P3|Overall Study|Protocol Violation|0
7854660|NCT00099632|27251426|P2|Overall Study|Protocol Violation|0
7854661|NCT00099632|27251427|P1|Overall Study|Protocol Violation|0
7854662|NCT00099632|27251422|P6|Overall Study|Withdrawal by Subject|1
7854663|NCT00099632|27251423|P5|Overall Study|Withdrawal by Subject|0
7854664|NCT00099632|27251424|P4|Overall Study|Withdrawal by Subject|0
7854665|NCT00099632|27251425|P3|Overall Study|Withdrawal by Subject|0
7854666|NCT00099632|27251426|P2|Overall Study|Withdrawal by Subject|1
7854667|NCT00099632|27251427|P1|Overall Study|Withdrawal by Subject|0
7854668|NCT00099632|27251422|P6|Overall Study|Lost to Follow-up|0
7854669|NCT00099632|27251423|P5|Overall Study|Lost to Follow-up|1
7854670|NCT00099632|27251424|P4|Overall Study|Lost to Follow-up|1
7854671|NCT00099632|27251425|P3|Overall Study|Lost to Follow-up|3
7854672|NCT00099632|27251426|P2|Overall Study|Lost to Follow-up|0
7854673|NCT00099632|27251427|P1|Overall Study|Lost to Follow-up|1
7854674|NCT00099437|27251467|P2|Overall Study|Ongoing in FU but not on treatment|45
7854675|NCT00099437|27251468|P1|Overall Study|Ongoing in FU but not on treatment|37
7854676|NCT00099437|27251467|P2|Overall Study|Withdrawal by Subject|10
7854677|NCT00099437|27251468|P1|Overall Study|Withdrawal by Subject|6
7854678|NCT00099437|27251467|P2|Overall Study|Death|261
7854679|NCT00099437|27251468|P1|Overall Study|Death|293
7854680|NCT00099437|27251467|P2|Overall Study|Lost to Follow-up|33
7854681|NCT00099437|27251468|P1|Overall Study|Lost to Follow-up|30
7854682|NCT00099359|27251582|P3|Overall Study|moved out of area|4
7854683|NCT00099359|27251583|P2|Overall Study|moved out of area|7
7854684|NCT00099359|27251584|P1|Overall Study|moved out of area|9
7854685|NCT00099359|27251582|P3|Overall Study|Lost to Follow-up|24
7854686|NCT00099359|27251583|P2|Overall Study|Lost to Follow-up|24
7854687|NCT00099359|27251584|P1|Overall Study|Lost to Follow-up|15
7854688|NCT00099359|27251582|P3|Overall Study|Withdrawal by Subject|23
7854689|NCT00099359|27251583|P2|Overall Study|Withdrawal by Subject|19
7854690|NCT00099359|27251584|P1|Overall Study|Withdrawal by Subject|19
7854691|NCT00099359|27251582|P3|Overall Study|Death|17
7854692|NCT00099359|27251583|P2|Overall Study|Death|15
7854693|NCT00099359|27251584|P1|Overall Study|Death|11
7854694|NCT00099268|27251607|P2|Overall Study|Death|1
7854695|NCT00099268|27251608|P1|Overall Study|Death|3
7854696|NCT00099268|27251607|P2|Overall Study|Administrative problems|4
7854697|NCT00099268|27251608|P1|Overall Study|Administrative problems|4
7854698|NCT00099268|27251607|P2|Overall Study|Lack of Efficacy|18
7854699|NCT00099268|27251608|P1|Overall Study|Lack of Efficacy|5
7854700|NCT00099268|27251607|P2|Overall Study|Lost to Follow-up|4
7854701|NCT00099268|27251608|P1|Overall Study|Lost to Follow-up|6
7854702|NCT00099268|27251607|P2|Overall Study|Protocol Violation|8
7854703|NCT00099268|27251608|P1|Overall Study|Protocol Violation|9
7854704|NCT00099268|27251607|P2|Overall Study|Adverse Event|19
7854705|NCT00099268|27251608|P1|Overall Study|Adverse Event|19
7854706|NCT00099268|27251607|P2|Overall Study|Withdrawal by Subject|28
7854707|NCT00099268|27251608|P1|Overall Study|Withdrawal by Subject|46
7854708|NCT00098865|27251648|P1|Overall Study|Alternative Therapy|1
7854709|NCT00098865|27251648|P1|Overall Study|Adverse Event|2
7854710|NCT00098865|27251648|P1|Overall Study|Progressive Disease|6
7854711|NCT00098839|27251656|P2|Overall Study|Ineligible|0
7854712|NCT00098839|27251657|P1|Overall Study|Ineligible|2
7854713|NCT00098839|27251656|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
7854714|NCT00098839|27251657|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
7854715|NCT00098839|27251656|P2|Overall Study|Relapse|3
7854716|NCT00098839|27251657|P1|Overall Study|Relapse|6
7854717|NCT00098839|27251656|P2|Overall Study|Refusal of further protocol therapy|1
7854718|NCT00098839|27251657|P1|Overall Study|Refusal of further protocol therapy|3
7854719|NCT00098839|27251656|P2|Overall Study|Withdrawal by Subject|0
7854720|NCT00098839|27251657|P1|Overall Study|Withdrawal by Subject|1
7854721|NCT00098839|27251656|P2|Overall Study|Physician Decision|14
7854722|NCT00098839|27251657|P1|Overall Study|Physician Decision|4
7854723|NCT00098839|27251656|P2|Overall Study|Death|2
7854724|NCT00098839|27251657|P1|Overall Study|Death|1
7854725|NCT00098839|27251656|P2|Overall Study|Adverse Event|2
7854726|NCT00098839|27251657|P1|Overall Study|Adverse Event|5
7854727|NCT00098813|27251668|P1|Overall Study|Reversal of RAI resistance|1
7854728|NCT00098813|27251668|P1|Overall Study|Other complicating disease|1
7854729|NCT00098813|27251668|P1|Overall Study|Progression of Disease|1
7854730|NCT00098813|27251668|P1|Overall Study|Withdrawal by Subject|7
7854731|NCT00098813|27251668|P1|Overall Study|Protocol Violation|1
7854732|NCT00098813|27251668|P1|Overall Study|Death|8
7854733|NCT00098787|27251675|P3|Overall Study|Other|9
7854734|NCT00098787|27251676|P2|Overall Study|Other|6
7854735|NCT00098787|27251677|P1|Overall Study|Other|7
7854736|NCT00098787|27251675|P3|Overall Study|Alternative therapy|13
7854737|NCT00098787|27251676|P2|Overall Study|Alternative therapy|13
7854738|NCT00098787|27251677|P1|Overall Study|Alternative therapy|8
7854739|NCT00098787|27251675|P3|Overall Study|Withdrawal by Subject|6
7854740|NCT00098787|27251676|P2|Overall Study|Withdrawal by Subject|12
7854741|NCT00098787|27251677|P1|Overall Study|Withdrawal by Subject|4
7854742|NCT00098787|27251675|P3|Overall Study|Death|0
7854743|NCT00098787|27251676|P2|Overall Study|Death|1
7854744|NCT00098787|27251677|P1|Overall Study|Death|6
7854745|NCT00098787|27251675|P3|Overall Study|Adverse Event|8
7854746|NCT00098787|27251676|P2|Overall Study|Adverse Event|17
7854747|NCT00098787|27251677|P1|Overall Study|Adverse Event|8
7854748|NCT00098787|27251675|P3|Overall Study|Disease progression|23
7854749|NCT00098787|27251676|P2|Overall Study|Disease progression|17
7854750|NCT00098787|27251677|P1|Overall Study|Disease progression|28
7854751|NCT00098787|27251675|P3|Overall Study|Ineligible|3
7854752|NCT00098787|27251676|P2|Overall Study|Ineligible|7
7854753|NCT00098787|27251677|P1|Overall Study|Ineligible|9
7854754|NCT00098787|27251675|P3|Overall Study|Never started treatment|1
7854755|NCT00098787|27251676|P2|Overall Study|Never started treatment|2
7854756|NCT00098787|27251677|P1|Overall Study|Never started treatment|3
7854757|NCT00098774|27251691|P1|Overall Study|Physician Decision|2
7854758|NCT00098774|27251691|P1|Overall Study|Failed (to respond) during induction|4
7854759|NCT00098774|27251691|P1|Overall Study|Withdrawal by Subject|1
7854760|NCT00098774|27251691|P1|Overall Study|Disease Progression|9
7854761|NCT00098774|27251691|P1|Overall Study|Adverse Event|2
7854762|NCT00098748|27251701|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
7854763|NCT00098748|27251702|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
7854764|NCT00098748|27251703|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
7854765|NCT00098748|27251701|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
7854766|NCT00098748|27251702|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
7854767|NCT00098748|27251703|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
7854768|NCT00098748|27251701|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
7854769|NCT00098748|27251702|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
7854770|NCT00098748|27251703|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
7854771|NCT00098748|27251701|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
7854772|NCT00098748|27251702|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
7854773|NCT00098748|27251703|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
7854774|NCT00098748|27251701|P3|Continued on Open-Label Treatment|Adverse Event|0
7854775|NCT00098748|27251702|P2|Continued on Open-Label Treatment|Adverse Event|1
7854776|NCT00098748|27251703|P1|Continued on Open-Label Treatment|Adverse Event|0
7854777|NCT00098748|27251701|P3|Received Study Treatment|Subject defaulted|4
7854778|NCT00098748|27251702|P2|Received Study Treatment|Subject defaulted|4
7854779|NCT00098748|27251703|P1|Received Study Treatment|Subject defaulted|3
7854780|NCT00098748|27251701|P3|Received Study Treatment|Other|6
7854781|NCT00098748|27251702|P2|Received Study Treatment|Other|2
7854782|NCT00098748|27251703|P1|Received Study Treatment|Other|2
7854783|NCT00098748|27251701|P3|Received Study Treatment|Lack of Efficacy|27
7854784|NCT00098748|27251702|P2|Received Study Treatment|Lack of Efficacy|27
7854785|NCT00098748|27251703|P1|Received Study Treatment|Lack of Efficacy|40
7854786|NCT00098748|27251701|P3|Received Study Treatment|Adverse Event|5
7854787|NCT00098748|27251702|P2|Received Study Treatment|Adverse Event|2
7854788|NCT00098748|27251703|P1|Received Study Treatment|Adverse Event|1
7854789|NCT00098748|27251701|P3|Received Study Treatment|Death|2
7854790|NCT00098748|27251702|P2|Received Study Treatment|Death|1
7854791|NCT00098748|27251703|P1|Received Study Treatment|Death|2
7854792|NCT00098748|27251701|P3|Assigned to Study Treatment|Randomized, but not treated|2
7854793|NCT00098748|27251702|P2|Assigned to Study Treatment|Randomized, but not treated|2
7854794|NCT00098748|27251703|P1|Assigned to Study Treatment|Randomized, but not treated|0
7854795|NCT00098722|27251759|P7|Observation Phase|Other|10
7854796|NCT00098722|27251760|P6|Observation Phase|Other|21
7854797|NCT00098722|27251761|P5|Observation Phase|Other|0
7854798|NCT00098722|27251762|P4|Observation Phase|Other|0
7854799|NCT00098722|27251763|P3|Observation Phase|Other|0
7854800|NCT00098722|27251764|P2|Observation Phase|Other|0
7854801|NCT00098722|27251765|P1|Observation Phase|Other|0
7854802|NCT00098722|27251759|P7|Observation Phase|Participant defaulted|4
7854803|NCT00098722|27251760|P6|Observation Phase|Participant defaulted|17
7854804|NCT00098722|27251761|P5|Observation Phase|Participant defaulted|0
7854805|NCT00098722|27251762|P4|Observation Phase|Participant defaulted|0
7854806|NCT00098722|27251763|P3|Observation Phase|Participant defaulted|0
7854807|NCT00098722|27251764|P2|Observation Phase|Participant defaulted|0
7854808|NCT00098722|27251765|P1|Observation Phase|Participant defaulted|0
7854809|NCT00098722|27251759|P7|Observation Phase|Lack of Efficacy|0
7854810|NCT00098722|27251760|P6|Observation Phase|Lack of Efficacy|2
7854811|NCT00098722|27251761|P5|Observation Phase|Lack of Efficacy|0
7854812|NCT00098722|27251762|P4|Observation Phase|Lack of Efficacy|0
7854813|NCT00098722|27251763|P3|Observation Phase|Lack of Efficacy|0
7854814|NCT00098722|27251764|P2|Observation Phase|Lack of Efficacy|0
7854815|NCT00098722|27251765|P1|Observation Phase|Lack of Efficacy|0
7854816|NCT00098722|27251759|P7|Observation Phase|Death|3
7854817|NCT00098722|27251760|P6|Observation Phase|Death|5
7854818|NCT00098722|27251761|P5|Observation Phase|Death|0
7854819|NCT00098722|27251762|P4|Observation Phase|Death|0
7854820|NCT00098722|27251763|P3|Observation Phase|Death|0
7854821|NCT00098722|27251764|P2|Observation Phase|Death|0
7854822|NCT00098722|27251765|P1|Observation Phase|Death|0
7854823|NCT00098722|27251759|P7|Open Label Phase|Other|0
7854824|NCT00098722|27251760|P6|Open Label Phase|Other|0
7854825|NCT00098722|27251761|P5|Open Label Phase|Other|0
7854826|NCT00098722|27251762|P4|Open Label Phase|Other|18
7854827|NCT00098722|27251763|P3|Open Label Phase|Other|0
7854828|NCT00098722|27251764|P2|Open Label Phase|Other|0
7854829|NCT00098722|27251765|P1|Open Label Phase|Other|0
7854830|NCT00098722|27251759|P7|Open Label Phase|Ongoing at cut-off date|0
7854831|NCT00098722|27251760|P6|Open Label Phase|Ongoing at cut-off date|0
7854832|NCT00098722|27251761|P5|Open Label Phase|Ongoing at cut-off date|50
7854833|NCT00098722|27251762|P4|Open Label Phase|Ongoing at cut-off date|220
7854834|NCT00098722|27251763|P3|Open Label Phase|Ongoing at cut-off date|0
7854835|NCT00098722|27251764|P2|Open Label Phase|Ongoing at cut-off date|0
7854836|NCT00098722|27251765|P1|Open Label Phase|Ongoing at cut-off date|0
7854837|NCT00098722|27251759|P7|Open Label Phase|Participant defaulted|0
7854838|NCT00098722|27251760|P6|Open Label Phase|Participant defaulted|0
7854839|NCT00098722|27251761|P5|Open Label Phase|Participant defaulted|0
7854840|NCT00098722|27251762|P4|Open Label Phase|Participant defaulted|18
7854841|NCT00098722|27251763|P3|Open Label Phase|Participant defaulted|0
7854842|NCT00098722|27251764|P2|Open Label Phase|Participant defaulted|0
7854843|NCT00098722|27251765|P1|Open Label Phase|Participant defaulted|0
7854844|NCT00098722|27251759|P7|Open Label Phase|Pregnancy|0
7854845|NCT00098722|27251760|P6|Open Label Phase|Pregnancy|0
7854846|NCT00098722|27251761|P5|Open Label Phase|Pregnancy|0
7854847|NCT00098722|27251762|P4|Open Label Phase|Pregnancy|1
7854848|NCT00098722|27251763|P3|Open Label Phase|Pregnancy|0
7854849|NCT00098722|27251764|P2|Open Label Phase|Pregnancy|0
7854850|NCT00098722|27251765|P1|Open Label Phase|Pregnancy|0
7854851|NCT00098722|27251759|P7|Open Label Phase|Lack of Efficacy|0
7854852|NCT00098722|27251760|P6|Open Label Phase|Lack of Efficacy|0
7854853|NCT00098722|27251761|P5|Open Label Phase|Lack of Efficacy|0
7854854|NCT00098722|27251762|P4|Open Label Phase|Lack of Efficacy|8
7854855|NCT00098722|27251763|P3|Open Label Phase|Lack of Efficacy|0
7854856|NCT00098722|27251764|P2|Open Label Phase|Lack of Efficacy|0
7854857|NCT00098722|27251765|P1|Open Label Phase|Lack of Efficacy|0
7854858|NCT00098722|27251759|P7|Open Label Phase|Death|0
7854859|NCT00098722|27251760|P6|Open Label Phase|Death|0
7854860|NCT00098722|27251761|P5|Open Label Phase|Death|0
7854861|NCT00098722|27251762|P4|Open Label Phase|Death|2
7854862|NCT00098722|27251763|P3|Open Label Phase|Death|0
7854863|NCT00098722|27251764|P2|Open Label Phase|Death|0
7854864|NCT00098722|27251765|P1|Open Label Phase|Death|0
7854865|NCT00098722|27251759|P7|Open Label Phase|Adverse Event|0
7854866|NCT00098722|27251760|P6|Open Label Phase|Adverse Event|0
7854867|NCT00098722|27251761|P5|Open Label Phase|Adverse Event|0
7854868|NCT00098722|27251762|P4|Open Label Phase|Adverse Event|5
7854869|NCT00098722|27251763|P3|Open Label Phase|Adverse Event|0
7854870|NCT00098722|27251764|P2|Open Label Phase|Adverse Event|0
7854871|NCT00098722|27251765|P1|Open Label Phase|Adverse Event|0
7854872|NCT00098722|27251759|P7|Double Blind Phase|Other|0
7854873|NCT00098722|27251760|P6|Double Blind Phase|Other|0
7854874|NCT00098722|27251761|P5|Double Blind Phase|Other|0
7854875|NCT00098722|27251762|P4|Double Blind Phase|Other|0
7854876|NCT00098722|27251763|P3|Double Blind Phase|Other|7
7854877|NCT00098722|27251764|P2|Double Blind Phase|Other|8
7854878|NCT00098722|27251765|P1|Double Blind Phase|Other|7
7854879|NCT00098722|27251759|P7|Double Blind Phase|Ongoing at cut-off date|0
7854880|NCT00098722|27251760|P6|Double Blind Phase|Ongoing at cut-off date|0
7854881|NCT00098722|27251761|P5|Double Blind Phase|Ongoing at cut-off date|0
7854882|NCT00098722|27251762|P4|Double Blind Phase|Ongoing at cut-off date|0
7854883|NCT00098722|27251763|P3|Double Blind Phase|Ongoing at cut-off date|57
7854884|NCT00098722|27251764|P2|Double Blind Phase|Ongoing at cut-off date|137
7854885|NCT00098722|27251765|P1|Double Blind Phase|Ongoing at cut-off date|128
7854886|NCT00098722|27251759|P7|Double Blind Phase|Randomized, not treated|0
7854887|NCT00098722|27251760|P6|Double Blind Phase|Randomized, not treated|0
7854888|NCT00098722|27251761|P5|Double Blind Phase|Randomized, not treated|0
7854889|NCT00098722|27251762|P4|Double Blind Phase|Randomized, not treated|0
7854890|NCT00098722|27251763|P3|Double Blind Phase|Randomized, not treated|3
7854891|NCT00098722|27251764|P2|Double Blind Phase|Randomized, not treated|3
7854892|NCT00098722|27251765|P1|Double Blind Phase|Randomized, not treated|4
7854893|NCT00098722|27251759|P7|Double Blind Phase|Pregnancy|0
7854894|NCT00098722|27251760|P6|Double Blind Phase|Pregnancy|0
7854895|NCT00098722|27251761|P5|Double Blind Phase|Pregnancy|0
7854896|NCT00098722|27251762|P4|Double Blind Phase|Pregnancy|0
7854897|NCT00098722|27251763|P3|Double Blind Phase|Pregnancy|0
7854898|NCT00098722|27251764|P2|Double Blind Phase|Pregnancy|0
7854899|NCT00098722|27251765|P1|Double Blind Phase|Pregnancy|1
7854900|NCT00098722|27251759|P7|Double Blind Phase|Participant defaulted|0
7854901|NCT00098722|27251760|P6|Double Blind Phase|Participant defaulted|0
7854902|NCT00098722|27251761|P5|Double Blind Phase|Participant defaulted|0
7854903|NCT00098722|27251762|P4|Double Blind Phase|Participant defaulted|0
7854904|NCT00098722|27251763|P3|Double Blind Phase|Participant defaulted|9
7854905|NCT00098722|27251764|P2|Double Blind Phase|Participant defaulted|11
7854906|NCT00098722|27251765|P1|Double Blind Phase|Participant defaulted|16
7854907|NCT00098722|27251759|P7|Double Blind Phase|Lack of Efficacy|0
7854908|NCT00098722|27251760|P6|Double Blind Phase|Lack of Efficacy|0
7854909|NCT00098722|27251761|P5|Double Blind Phase|Lack of Efficacy|0
7854910|NCT00098722|27251762|P4|Double Blind Phase|Lack of Efficacy|0
7854911|NCT00098722|27251763|P3|Double Blind Phase|Lack of Efficacy|15
7854912|NCT00098722|27251764|P2|Double Blind Phase|Lack of Efficacy|23
7854913|NCT00098722|27251765|P1|Double Blind Phase|Lack of Efficacy|21
7854914|NCT00098722|27251759|P7|Double Blind Phase|Death|0
7854915|NCT00098722|27251760|P6|Double Blind Phase|Death|0
7854916|NCT00098722|27251761|P5|Double Blind Phase|Death|0
7854917|NCT00098722|27251762|P4|Double Blind Phase|Death|0
7854918|NCT00098722|27251763|P3|Double Blind Phase|Death|0
7854919|NCT00098722|27251764|P2|Double Blind Phase|Death|5
7854920|NCT00098722|27251765|P1|Double Blind Phase|Death|2
7854921|NCT00098722|27251759|P7|Double Blind Phase|Adverse Event|0
7854922|NCT00098722|27251760|P6|Double Blind Phase|Adverse Event|0
7854923|NCT00098722|27251761|P5|Double Blind Phase|Adverse Event|0
7854924|NCT00098722|27251762|P4|Double Blind Phase|Adverse Event|0
7854925|NCT00098722|27251763|P3|Double Blind Phase|Adverse Event|3
7854926|NCT00098722|27251764|P2|Double Blind Phase|Adverse Event|7
7854927|NCT00098722|27251765|P1|Double Blind Phase|Adverse Event|7
7854928|NCT00098475|27251839|P4|Step 2|Never started treatment|0
7854929|NCT00098475|27251840|P3|Step 2|Never started treatment|0
7854930|NCT00098475|27251841|P2|Step 2|Never started treatment|1
7854931|NCT00098475|27251842|P1|Step 2|Never started treatment|1
7854932|NCT00098475|27251839|P4|Step 2|Alternative therapy|0
7854933|NCT00098475|27251840|P3|Step 2|Alternative therapy|0
7854934|NCT00098475|27251841|P2|Step 2|Alternative therapy|2
7854935|NCT00098475|27251842|P1|Step 2|Alternative therapy|1
7854936|NCT00098475|27251839|P4|Step 2|Physician Decision|0
7854937|NCT00098475|27251840|P3|Step 2|Physician Decision|0
7854938|NCT00098475|27251841|P2|Step 2|Physician Decision|1
7854939|NCT00098475|27251842|P1|Step 2|Physician Decision|0
7854940|NCT00098475|27251839|P4|Step 2|Withdrawal by Subject|0
7854941|NCT00098475|27251840|P3|Step 2|Withdrawal by Subject|0
7854942|NCT00098475|27251841|P2|Step 2|Withdrawal by Subject|2
7854943|NCT00098475|27251842|P1|Step 2|Withdrawal by Subject|0
7854944|NCT00098475|27251839|P4|Step 2|Adverse Event|0
7854945|NCT00098475|27251840|P3|Step 2|Adverse Event|0
7854946|NCT00098475|27251841|P2|Step 2|Adverse Event|0
7854947|NCT00098475|27251842|P1|Step 2|Adverse Event|2
7854948|NCT00098475|27251839|P4|Step 2|Disease progression|0
7854949|NCT00098475|27251840|P3|Step 2|Disease progression|0
7854950|NCT00098475|27251841|P2|Step 2|Disease progression|4
7854951|NCT00098475|27251842|P1|Step 2|Disease progression|1
7854952|NCT00098475|27251839|P4|Step 1|Not documented|0
7854953|NCT00098475|27251840|P3|Step 1|Not documented|0
7854954|NCT00098475|27251841|P2|Step 1|Not documented|1
7854955|NCT00098475|27251842|P1|Step 1|Not documented|0
7854956|NCT00098475|27251839|P4|Step 1|Patient fell with fracture|0
7854957|NCT00098475|27251840|P3|Step 1|Patient fell with fracture|0
7854958|NCT00098475|27251841|P2|Step 1|Patient fell with fracture|0
7854959|NCT00098475|27251842|P1|Step 1|Patient fell with fracture|1
7854960|NCT00098475|27251839|P4|Step 1|Misinterpretation of lab data|0
7854961|NCT00098475|27251840|P3|Step 1|Misinterpretation of lab data|0
7854962|NCT00098475|27251841|P2|Step 1|Misinterpretation of lab data|1
7854963|NCT00098475|27251842|P1|Step 1|Misinterpretation of lab data|0
7854964|NCT00098475|27251839|P4|Step 1|Criteria to continue treatment not met|0
7854965|NCT00098475|27251840|P3|Step 1|Criteria to continue treatment not met|0
7854966|NCT00098475|27251841|P2|Step 1|Criteria to continue treatment not met|1
7854967|NCT00098475|27251842|P1|Step 1|Criteria to continue treatment not met|0
7854968|NCT00098475|27251839|P4|Step 1|Referred to other physicians|0
7854969|NCT00098475|27251840|P3|Step 1|Referred to other physicians|0
7854970|NCT00098475|27251841|P2|Step 1|Referred to other physicians|1
7854971|NCT00098475|27251842|P1|Step 1|Referred to other physicians|0
7854972|NCT00098475|27251839|P4|Step 1|Rising paraprotein|0
7854973|NCT00098475|27251840|P3|Step 1|Rising paraprotein|0
7854974|NCT00098475|27251841|P2|Step 1|Rising paraprotein|1
7854975|NCT00098475|27251842|P1|Step 1|Rising paraprotein|0
7854976|NCT00098475|27251839|P4|Step 1|Insurance issue|0
7854977|NCT00098475|27251840|P3|Step 1|Insurance issue|0
7854978|NCT00098475|27251841|P2|Step 1|Insurance issue|1
7854979|NCT00098475|27251842|P1|Step 1|Insurance issue|0
7854980|NCT00098475|27251839|P4|Step 1|Declining performance status|0
7854981|NCT00098475|27251840|P3|Step 1|Declining performance status|0
7854982|NCT00098475|27251841|P2|Step 1|Declining performance status|1
7854983|NCT00098475|27251842|P1|Step 1|Declining performance status|0
7854984|NCT00098475|27251839|P4|Step 1|Off treatment for > specified timeframe|0
7854985|NCT00098475|27251840|P3|Step 1|Off treatment for > specified timeframe|0
7854986|NCT00098475|27251841|P2|Step 1|Off treatment for > specified timeframe|1
7854987|NCT00098475|27251842|P1|Step 1|Off treatment for > specified timeframe|1
7854988|NCT00098475|27251839|P4|Step 1|Incorrect disease assessment|0
7854989|NCT00098475|27251840|P3|Step 1|Incorrect disease assessment|0
7854990|NCT00098475|27251841|P2|Step 1|Incorrect disease assessment|0
7854991|NCT00098475|27251842|P1|Step 1|Incorrect disease assessment|2
7854992|NCT00098475|27251839|P4|Step 1|Both patient and physician's decision|0
7854993|NCT00098475|27251840|P3|Step 1|Both patient and physician's decision|0
7854994|NCT00098475|27251841|P2|Step 1|Both patient and physician's decision|1
7854995|NCT00098475|27251842|P1|Step 1|Both patient and physician's decision|2
7854996|NCT00098475|27251839|P4|Step 1|Cannot comply due to other tx|0
7854997|NCT00098475|27251840|P3|Step 1|Cannot comply due to other tx|0
7854998|NCT00098475|27251841|P2|Step 1|Cannot comply due to other tx|1
7854999|NCT00098475|27251842|P1|Step 1|Cannot comply due to other tx|0
7855000|NCT00098475|27251839|P4|Step 1|Complications|0
7855001|NCT00098475|27251840|P3|Step 1|Complications|0
7855002|NCT00098475|27251841|P2|Step 1|Complications|0
7855003|NCT00098475|27251842|P1|Step 1|Complications|1
7855004|NCT00098475|27251839|P4|Step 1|Knee surgery|0
7855005|NCT00098475|27251840|P3|Step 1|Knee surgery|0
7855006|NCT00098475|27251841|P2|Step 1|Knee surgery|0
7855007|NCT00098475|27251842|P1|Step 1|Knee surgery|1
7855008|NCT00098475|27251839|P4|Step 1|Still on treatment as of this analysis|0
7855009|NCT00098475|27251840|P3|Step 1|Still on treatment as of this analysis|0
7855010|NCT00098475|27251841|P2|Step 1|Still on treatment as of this analysis|27
7855011|NCT00098475|27251842|P1|Step 1|Still on treatment as of this analysis|14
7855012|NCT00098475|27251839|P4|Step 1|Never started treatment|0
7855013|NCT00098475|27251840|P3|Step 1|Never started treatment|0
7855014|NCT00098475|27251841|P2|Step 1|Never started treatment|2
7855015|NCT00098475|27251842|P1|Step 1|Never started treatment|0
7855016|NCT00098475|27251839|P4|Step 1|Other disease|0
7855017|NCT00098475|27251840|P3|Step 1|Other disease|1
7855018|NCT00098475|27251841|P2|Step 1|Other disease|1
7855019|NCT00098475|27251842|P1|Step 1|Other disease|2
7855020|NCT00098475|27251839|P4|Step 1|Alternative therapy|0
7855021|NCT00098475|27251840|P3|Step 1|Alternative therapy|1
7855022|NCT00098475|27251841|P2|Step 1|Alternative therapy|43
7855023|NCT00098475|27251842|P1|Step 1|Alternative therapy|31
7855024|NCT00098475|27251839|P4|Step 1|Physician Decision|0
7855025|NCT00098475|27251840|P3|Step 1|Physician Decision|0
7855026|NCT00098475|27251841|P2|Step 1|Physician Decision|2
7855027|NCT00098475|27251842|P1|Step 1|Physician Decision|5
7855028|NCT00098475|27251839|P4|Step 1|Withdrawal by Subject|0
7855029|NCT00098475|27251840|P3|Step 1|Withdrawal by Subject|0
7855030|NCT00098475|27251841|P2|Step 1|Withdrawal by Subject|11
7855031|NCT00098475|27251842|P1|Step 1|Withdrawal by Subject|14
7855032|NCT00098475|27251839|P4|Step 1|Death|1
7855033|NCT00098475|27251840|P3|Step 1|Death|0
7855034|NCT00098475|27251841|P2|Step 1|Death|5
7855035|NCT00098475|27251842|P1|Step 1|Death|8
7855036|NCT00098475|27251839|P4|Step 1|Adverse Event|1
7855037|NCT00098475|27251840|P3|Step 1|Adverse Event|0
7855038|NCT00098475|27251841|P2|Step 1|Adverse Event|37
7855039|NCT00098475|27251842|P1|Step 1|Adverse Event|56
7855040|NCT00098475|27251839|P4|Step 1|Progressive disease|1
7855041|NCT00098475|27251840|P3|Step 1|Progressive disease|2
7855042|NCT00098475|27251841|P2|Step 1|Progressive disease|35
7855043|NCT00098475|27251842|P1|Step 1|Progressive disease|33
7855044|NCT00098345|27251879|P1|Overall Study|progression|4
7855045|NCT00098345|27251879|P1|Overall Study|Withdrawal by Subject|2
7855046|NCT00098345|27251879|P1|Overall Study|Adverse Event|7
7855047|NCT00098306|27251892|P7|Observational Phase|Un-specified|4
7855048|NCT00098306|27251893|P6|Observational Phase|Un-specified|7
7855049|NCT00098306|27251894|P5|Observational Phase|Un-specified|0
7855050|NCT00098306|27251895|P4|Observational Phase|Un-specified|0
7855051|NCT00098306|27251896|P3|Observational Phase|Un-specified|0
7855052|NCT00098306|27251897|P2|Observational Phase|Un-specified|0
7855053|NCT00098306|27251898|P1|Observational Phase|Un-specified|0
7855054|NCT00098306|27251892|P7|Observational Phase|Participant defaulted|18
7855055|NCT00098306|27251893|P6|Observational Phase|Participant defaulted|34
7855056|NCT00098306|27251894|P5|Observational Phase|Participant defaulted|0
7855057|NCT00098306|27251895|P4|Observational Phase|Participant defaulted|0
7855058|NCT00098306|27251896|P3|Observational Phase|Participant defaulted|0
7855059|NCT00098306|27251897|P2|Observational Phase|Participant defaulted|0
7855060|NCT00098306|27251898|P1|Observational Phase|Participant defaulted|0
7855061|NCT00098306|27251892|P7|Observational Phase|Death|4
7855062|NCT00098306|27251893|P6|Observational Phase|Death|5
7855063|NCT00098306|27251894|P5|Observational Phase|Death|0
7855064|NCT00098306|27251895|P4|Observational Phase|Death|0
7855065|NCT00098306|27251896|P3|Observational Phase|Death|0
7855066|NCT00098306|27251897|P2|Observational Phase|Death|0
7855067|NCT00098306|27251898|P1|Observational Phase|Death|0
7855068|NCT00098306|27251892|P7|Open Label|Ongoing at cut-off date|0
7855069|NCT00098306|27251893|P6|Open Label|Ongoing at cut-off date|0
7855070|NCT00098306|27251894|P5|Open Label|Ongoing at cut-off date|62
7855071|NCT00098306|27251895|P4|Open Label|Ongoing at cut-off date|269
7855072|NCT00098306|27251896|P3|Open Label|Ongoing at cut-off date|0
7855073|NCT00098306|27251897|P2|Open Label|Ongoing at cut-off date|0
7855074|NCT00098306|27251898|P1|Open Label|Ongoing at cut-off date|0
7855075|NCT00098306|27251892|P7|Open Label|Un-specified|0
7855076|NCT00098306|27251893|P6|Open Label|Un-specified|0
7855077|NCT00098306|27251894|P5|Open Label|Un-specified|0
7855078|NCT00098306|27251895|P4|Open Label|Un-specified|15
7855079|NCT00098306|27251896|P3|Open Label|Un-specified|0
7855080|NCT00098306|27251897|P2|Open Label|Un-specified|0
7855081|NCT00098306|27251898|P1|Open Label|Un-specified|0
7855082|NCT00098306|27251892|P7|Open Label|Participant defaulted|0
7855083|NCT00098306|27251893|P6|Open Label|Participant defaulted|0
7855084|NCT00098306|27251894|P5|Open Label|Participant defaulted|0
7855085|NCT00098306|27251895|P4|Open Label|Participant defaulted|24
7855086|NCT00098306|27251896|P3|Open Label|Participant defaulted|0
7855087|NCT00098306|27251897|P2|Open Label|Participant defaulted|0
7855088|NCT00098306|27251898|P1|Open Label|Participant defaulted|0
7855089|NCT00098306|27251892|P7|Open Label|Death|0
7855090|NCT00098306|27251893|P6|Open Label|Death|0
7855091|NCT00098306|27251894|P5|Open Label|Death|0
7855092|NCT00098306|27251895|P4|Open Label|Death|4
7855093|NCT00098306|27251896|P3|Open Label|Death|0
7855094|NCT00098306|27251897|P2|Open Label|Death|0
7855095|NCT00098306|27251898|P1|Open Label|Death|0
7855096|NCT00098306|27251892|P7|Open Label|Adverse Event|0
7855097|NCT00098306|27251893|P6|Open Label|Adverse Event|0
7855098|NCT00098306|27251894|P5|Open Label|Adverse Event|0
7855099|NCT00098306|27251895|P4|Open Label|Adverse Event|2
7855100|NCT00098306|27251896|P3|Open Label|Adverse Event|0
7855101|NCT00098306|27251897|P2|Open Label|Adverse Event|0
7855102|NCT00098306|27251898|P1|Open Label|Adverse Event|0
7855103|NCT00098306|27251892|P7|Open Label|Lack of Efficacy|0
7855104|NCT00098306|27251893|P6|Open Label|Lack of Efficacy|0
7855105|NCT00098306|27251894|P5|Open Label|Lack of Efficacy|0
7855106|NCT00098306|27251895|P4|Open Label|Lack of Efficacy|13
7855107|NCT00098306|27251896|P3|Open Label|Lack of Efficacy|0
7855108|NCT00098306|27251897|P2|Open Label|Lack of Efficacy|0
7855109|NCT00098306|27251898|P1|Open Label|Lack of Efficacy|0
7855110|NCT00098306|27251892|P7|Double Blind|Un-specified|0
7855111|NCT00098306|27251893|P6|Double Blind|Un-specified|0
7855112|NCT00098306|27251894|P5|Double Blind|Un-specified|0
7855113|NCT00098306|27251895|P4|Double Blind|Un-specified|0
7855114|NCT00098306|27251896|P3|Double Blind|Un-specified|11
7855115|NCT00098306|27251897|P2|Double Blind|Un-specified|3
7855116|NCT00098306|27251898|P1|Double Blind|Un-specified|7
7855117|NCT00098306|27251892|P7|Double Blind|Participant defaulted|0
7855118|NCT00098306|27251893|P6|Double Blind|Participant defaulted|0
7855119|NCT00098306|27251894|P5|Double Blind|Participant defaulted|0
7855120|NCT00098306|27251895|P4|Double Blind|Participant defaulted|0
7855121|NCT00098306|27251896|P3|Double Blind|Participant defaulted|11
7855122|NCT00098306|27251897|P2|Double Blind|Participant defaulted|18
7855123|NCT00098306|27251898|P1|Double Blind|Participant defaulted|19
7855124|NCT00098306|27251892|P7|Double Blind|Death|0
7855125|NCT00098306|27251893|P6|Double Blind|Death|0
7855126|NCT00098306|27251894|P5|Double Blind|Death|0
7855127|NCT00098306|27251895|P4|Double Blind|Death|0
7855128|NCT00098306|27251896|P3|Double Blind|Death|1
7855129|NCT00098306|27251897|P2|Double Blind|Death|4
7855130|NCT00098306|27251898|P1|Double Blind|Death|1
7855131|NCT00098306|27251892|P7|Double Blind|Lack of Efficacy|0
7855132|NCT00098306|27251893|P6|Double Blind|Lack of Efficacy|0
7855133|NCT00098306|27251894|P5|Double Blind|Lack of Efficacy|0
7855134|NCT00098306|27251895|P4|Double Blind|Lack of Efficacy|0
7855135|NCT00098306|27251896|P3|Double Blind|Lack of Efficacy|17
7855136|NCT00098306|27251897|P2|Double Blind|Lack of Efficacy|34
7855137|NCT00098306|27251898|P1|Double Blind|Lack of Efficacy|43
7855138|NCT00098306|27251892|P7|Double Blind|Adverse Event|0
7855139|NCT00098306|27251893|P6|Double Blind|Adverse Event|0
7855140|NCT00098306|27251894|P5|Double Blind|Adverse Event|0
7855141|NCT00098306|27251895|P4|Double Blind|Adverse Event|0
7855142|NCT00098306|27251896|P3|Double Blind|Adverse Event|6
7855143|NCT00098306|27251897|P2|Double Blind|Adverse Event|10
7855144|NCT00098306|27251898|P1|Double Blind|Adverse Event|11
7855145|NCT00098306|27251892|P7|Double Blind|Ongoing at cut-off date|0
7855146|NCT00098306|27251893|P6|Double Blind|Ongoing at cut-off date|0
7855147|NCT00098306|27251894|P5|Double Blind|Ongoing at cut-off date|0
7855148|NCT00098306|27251895|P4|Double Blind|Ongoing at cut-off date|0
7855149|NCT00098306|27251896|P3|Double Blind|Ongoing at cut-off date|72
7855150|NCT00098306|27251897|P2|Double Blind|Ongoing at cut-off date|166
7855151|NCT00098306|27251898|P1|Double Blind|Ongoing at cut-off date|151
7855152|NCT00098306|27251892|P7|Double Blind|Randomized, not treated|0
7855153|NCT00098306|27251893|P6|Double Blind|Randomized, not treated|0
7855154|NCT00098306|27251894|P5|Double Blind|Randomized, not treated|0
7855155|NCT00098306|27251895|P4|Double Blind|Randomized, not treated|0
7855156|NCT00098306|27251896|P3|Double Blind|Randomized, not treated|2
7855157|NCT00098306|27251897|P2|Double Blind|Randomized, not treated|5
7855158|NCT00098306|27251898|P1|Double Blind|Randomized, not treated|9
7855159|NCT00098293|27251964|P5|Supplemental Phase (SP)|Other|22
7855160|NCT00098293|27251965|P4|Supplemental Phase (SP)|Other|0
7855161|NCT00098293|27251966|P3|Supplemental Phase (SP)|Other|0
7855162|NCT00098293|27251967|P2|Supplemental Phase (SP)|Other|0
7855163|NCT00098293|27251968|P1|Supplemental Phase (SP)|Other|0
7855164|NCT00098293|27251964|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
7855165|NCT00098293|27251965|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
7855166|NCT00098293|27251966|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
7855167|NCT00098293|27251967|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
7855168|NCT00098293|27251968|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
7855169|NCT00098293|27251964|P5|Supplemental Phase (SP)|Lost to Follow-up|2
7855170|NCT00098293|27251965|P4|Supplemental Phase (SP)|Lost to Follow-up|0
7855171|NCT00098293|27251966|P3|Supplemental Phase (SP)|Lost to Follow-up|0
7855172|NCT00098293|27251967|P2|Supplemental Phase (SP)|Lost to Follow-up|0
7855173|NCT00098293|27251968|P1|Supplemental Phase (SP)|Lost to Follow-up|0
7855174|NCT00098293|27251964|P5|Supplemental Phase (SP)|Death|1
7855175|NCT00098293|27251965|P4|Supplemental Phase (SP)|Death|0
7855176|NCT00098293|27251966|P3|Supplemental Phase (SP)|Death|0
7855177|NCT00098293|27251967|P2|Supplemental Phase (SP)|Death|0
7855178|NCT00098293|27251968|P1|Supplemental Phase (SP)|Death|0
7855179|NCT00098293|27251964|P5|Open-label (OL) Phase|Death|0
7855180|NCT00098293|27251965|P4|Open-label (OL) Phase|Death|0
7855181|NCT00098293|27251966|P3|Open-label (OL) Phase|Death|3
7855182|NCT00098293|27251967|P2|Open-label (OL) Phase|Death|2
7855183|NCT00098293|27251968|P1|Open-label (OL) Phase|Death|0
7855184|NCT00098293|27251964|P5|Open-label (OL) Phase|Participant Defaulted|0
7855185|NCT00098293|27251965|P4|Open-label (OL) Phase|Participant Defaulted|20
7855186|NCT00098293|27251966|P3|Open-label (OL) Phase|Participant Defaulted|16
7855187|NCT00098293|27251967|P2|Open-label (OL) Phase|Participant Defaulted|6
7855188|NCT00098293|27251968|P1|Open-label (OL) Phase|Participant Defaulted|0
7855189|NCT00098293|27251964|P5|Open-label (OL) Phase|Protocol Violation|0
7855190|NCT00098293|27251965|P4|Open-label (OL) Phase|Protocol Violation|16
7855191|NCT00098293|27251966|P3|Open-label (OL) Phase|Protocol Violation|13
7855192|NCT00098293|27251967|P2|Open-label (OL) Phase|Protocol Violation|6
7855193|NCT00098293|27251968|P1|Open-label (OL) Phase|Protocol Violation|0
7855194|NCT00098293|27251964|P5|Open-label (OL) Phase|Pregnancy|0
7855195|NCT00098293|27251965|P4|Open-label (OL) Phase|Pregnancy|3
7855196|NCT00098293|27251966|P3|Open-label (OL) Phase|Pregnancy|0
7855197|NCT00098293|27251967|P2|Open-label (OL) Phase|Pregnancy|1
7855198|NCT00098293|27251968|P1|Open-label (OL) Phase|Pregnancy|0
7855199|NCT00098293|27251964|P5|Open-label (OL) Phase|Lack of Efficacy|0
7855200|NCT00098293|27251965|P4|Open-label (OL) Phase|Lack of Efficacy|20
7855201|NCT00098293|27251966|P3|Open-label (OL) Phase|Lack of Efficacy|2
7855202|NCT00098293|27251967|P2|Open-label (OL) Phase|Lack of Efficacy|7
7855203|NCT00098293|27251968|P1|Open-label (OL) Phase|Lack of Efficacy|0
7855204|NCT00098293|27251964|P5|Open-label (OL) Phase|Adverse Event|0
7855205|NCT00098293|27251965|P4|Open-label (OL) Phase|Adverse Event|6
7855206|NCT00098293|27251966|P3|Open-label (OL) Phase|Adverse Event|7
7855207|NCT00098293|27251967|P2|Open-label (OL) Phase|Adverse Event|3
7855208|NCT00098293|27251968|P1|Open-label (OL) Phase|Adverse Event|0
7855209|NCT00098293|27251964|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7855210|NCT00098293|27251965|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7855211|NCT00098293|27251966|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
7855212|NCT00098293|27251967|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7855213|NCT00098293|27251968|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7855214|NCT00098293|27251964|P5|Double-blind (DB) Phase|Terminated by sponsor|0
7855215|NCT00098293|27251965|P4|Double-blind (DB) Phase|Terminated by sponsor|0
7855216|NCT00098293|27251966|P3|Double-blind (DB) Phase|Terminated by sponsor|0
7855217|NCT00098293|27251967|P2|Double-blind (DB) Phase|Terminated by sponsor|0
7855218|NCT00098293|27251968|P1|Double-blind (DB) Phase|Terminated by sponsor|135
7855219|NCT00098293|27251964|P5|Double-blind (DB) Phase|Protocol Violation|0
7855220|NCT00098293|27251965|P4|Double-blind (DB) Phase|Protocol Violation|0
7855221|NCT00098293|27251966|P3|Double-blind (DB) Phase|Protocol Violation|22
7855222|NCT00098293|27251967|P2|Double-blind (DB) Phase|Protocol Violation|18
7855223|NCT00098293|27251968|P1|Double-blind (DB) Phase|Protocol Violation|2
7855224|NCT00098293|27251964|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
7855225|NCT00098293|27251965|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
7855226|NCT00098293|27251966|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
7855227|NCT00098293|27251967|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
7855228|NCT00098293|27251968|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
7855229|NCT00098293|27251964|P5|Double-blind (DB) Phase|Death|0
7855230|NCT00098293|27251965|P4|Double-blind (DB) Phase|Death|0
7855231|NCT00098293|27251966|P3|Double-blind (DB) Phase|Death|2
7855232|NCT00098293|27251967|P2|Double-blind (DB) Phase|Death|2
7855233|NCT00098293|27251968|P1|Double-blind (DB) Phase|Death|1
7855234|NCT00098293|27251964|P5|Double-blind (DB) Phase|Lack of Efficacy|0
7855235|NCT00098293|27251965|P4|Double-blind (DB) Phase|Lack of Efficacy|0
7855236|NCT00098293|27251966|P3|Double-blind (DB) Phase|Lack of Efficacy|30
7855237|NCT00098293|27251967|P2|Double-blind (DB) Phase|Lack of Efficacy|64
7855238|NCT00098293|27251968|P1|Double-blind (DB) Phase|Lack of Efficacy|11
7855239|NCT00098293|27251964|P5|Double-blind (DB) Phase|Participant Defaulted|0
7855240|NCT00098293|27251965|P4|Double-blind (DB) Phase|Participant Defaulted|0
7855241|NCT00098293|27251966|P3|Double-blind (DB) Phase|Participant Defaulted|36
7855242|NCT00098293|27251967|P2|Double-blind (DB) Phase|Participant Defaulted|40
7855243|NCT00098293|27251968|P1|Double-blind (DB) Phase|Participant Defaulted|11
7855244|NCT00098293|27251964|P5|Double-blind (DB) Phase|Pregnancy|0
7855245|NCT00098293|27251965|P4|Double-blind (DB) Phase|Pregnancy|0
7855246|NCT00098293|27251966|P3|Double-blind (DB) Phase|Pregnancy|9
7855247|NCT00098293|27251967|P2|Double-blind (DB) Phase|Pregnancy|7
7855248|NCT00098293|27251968|P1|Double-blind (DB) Phase|Pregnancy|0
7855249|NCT00098293|27251964|P5|Double-blind (DB) Phase|Adverse Event|0
7855250|NCT00098293|27251965|P4|Double-blind (DB) Phase|Adverse Event|0
7855251|NCT00098293|27251966|P3|Double-blind (DB) Phase|Adverse Event|60
7855252|NCT00098293|27251967|P2|Double-blind (DB) Phase|Adverse Event|27
7855253|NCT00098293|27251968|P1|Double-blind (DB) Phase|Adverse Event|14
7855254|NCT00098254|27252021|P1|Overall Study|Death|1
7855255|NCT00098254|27252021|P1|Overall Study|Adverse Event|2
7855256|NCT00098020|27252087|P1|Overall Study|Low epidermal growth factor receptor|1
7855257|NCT00098020|27252087|P1|Overall Study|Low urine PCR|1
7855258|NCT00098020|27252087|P1|Overall Study|elevated liver enzymes|1
7855259|NCT00098020|27252087|P1|Overall Study|Lost to Follow-up|1
7855260|NCT00098020|27252087|P1|Overall Study|Adverse Event|2
7855261|NCT00097981|27252094|P2|Overall Study|Other|13
7855262|NCT00097981|27252095|P1|Overall Study|Other|19
7855263|NCT00097981|27252094|P2|Overall Study|Transplant planned|27
7855264|NCT00097981|27252095|P1|Overall Study|Transplant planned|28
7855265|NCT00097981|27252094|P2|Overall Study|Disease Progression|2
7855266|NCT00097981|27252095|P1|Overall Study|Disease Progression|8
7855267|NCT00097981|27252094|P2|Overall Study|Physician Decision|1
7855268|NCT00097981|27252095|P1|Overall Study|Physician Decision|7
7855269|NCT00097981|27252094|P2|Overall Study|Death|4
7855270|NCT00097981|27252095|P1|Overall Study|Death|2
7855271|NCT00097981|27252094|P2|Overall Study|Protocol Violation|1
7855272|NCT00097981|27252095|P1|Overall Study|Protocol Violation|1
7855273|NCT00097981|27252094|P2|Overall Study|Withdrawal by Subject|8
7855274|NCT00097981|27252095|P1|Overall Study|Withdrawal by Subject|10
7855275|NCT00097981|27252094|P2|Overall Study|Adverse Event|44
7855276|NCT00097981|27252095|P1|Overall Study|Adverse Event|31
7855277|NCT00097786|27252117|P4|Overall Study|lost to follow-up for all-cause death|310
7855278|NCT00097786|27252118|P3|Overall Study|lost to follow-up for all-cause death|313
7855279|NCT00097786|27252119|P2|Overall Study|lost to follow-up for all-cause death|292
7855280|NCT00097786|27252120|P1|Overall Study|lost to follow-up for all-cause death|296
7855281|NCT00097773|27252142|P4|Overall Study|Other|0
7855282|NCT00097773|27252143|P3|Overall Study|Other|2
7855283|NCT00097773|27252144|P2|Overall Study|Other|0
7855284|NCT00097773|27252145|P1|Overall Study|Other|1
7855285|NCT00097773|27252142|P4|Overall Study|Adverse Event|0
7855286|NCT00097773|27252143|P3|Overall Study|Adverse Event|0
7855287|NCT00097773|27252144|P2|Overall Study|Adverse Event|1
7855288|NCT00097773|27252145|P1|Overall Study|Adverse Event|0
7855289|NCT00097773|27252142|P4|Overall Study|Withdrawal by Subject|1
7855290|NCT00097773|27252143|P3|Overall Study|Withdrawal by Subject|3
7855291|NCT00097773|27252144|P2|Overall Study|Withdrawal by Subject|3
7855292|NCT00097773|27252145|P1|Overall Study|Withdrawal by Subject|3
7855293|NCT00097773|27252142|P4|Overall Study|Physician Decision|1
7855294|NCT00097773|27252143|P3|Overall Study|Physician Decision|3
7855295|NCT00097773|27252144|P2|Overall Study|Physician Decision|2
7855296|NCT00097773|27252145|P1|Overall Study|Physician Decision|2
7855297|NCT00097773|27252142|P4|Overall Study|Lost to Follow-up|1
7855298|NCT00097773|27252143|P3|Overall Study|Lost to Follow-up|0
7855299|NCT00097773|27252144|P2|Overall Study|Lost to Follow-up|2
7855300|NCT00097773|27252145|P1|Overall Study|Lost to Follow-up|2
7855301|NCT00097721|27252165|P2|Overall Study|Reason not given|1
7855302|NCT00097721|27252166|P1|Overall Study|Reason not given|1
7855303|NCT00097721|27252165|P2|Overall Study|Physician Decision|3
7855304|NCT00097721|27252166|P1|Overall Study|Physician Decision|1
7855305|NCT00097721|27252165|P2|Overall Study|Progressive Disease|27
7855306|NCT00097721|27252166|P1|Overall Study|Progressive Disease|55
7855307|NCT00097721|27252165|P2|Overall Study|Withdrawal by Subject|1
7855308|NCT00097721|27252166|P1|Overall Study|Withdrawal by Subject|6
7855309|NCT00097721|27252165|P2|Overall Study|Adverse Event|1
7855310|NCT00097721|27252166|P1|Overall Study|Adverse Event|8
7855311|NCT00097591|27252225|P2|Overall Study|Other|3
7855312|NCT00097591|27252226|P1|Overall Study|Other|0
7855313|NCT00097591|27252225|P2|Overall Study|Lost to follow up|10
7855314|NCT00097591|27252226|P1|Overall Study|Lost to follow up|6
7855315|NCT00097591|27252225|P2|Overall Study|Unable to attend termination visit|51
7855316|NCT00097591|27252226|P1|Overall Study|Unable to attend termination visit|53
7855317|NCT00097591|27252225|P2|Overall Study|Less than 6 months on study drug|7
7855318|NCT00097591|27252226|P1|Overall Study|Less than 6 months on study drug|9
7855319|NCT00097591|27252225|P2|Overall Study|Withdrawal of consent|323
7855320|NCT00097591|27252226|P1|Overall Study|Withdrawal of consent|342
7855321|NCT00097539|27252249|P7|Overall Study|Reason not Specified|2
7855322|NCT00097539|27252250|P6|Overall Study|Reason not Specified|40
7855323|NCT00097539|27252251|P5|Overall Study|Reason not Specified|11
7855324|NCT00097539|27252252|P4|Overall Study|Reason not Specified|21
7855325|NCT00097539|27252253|P3|Overall Study|Reason not Specified|53
7855326|NCT00097539|27252254|P2|Overall Study|Reason not Specified|49
7855327|NCT00097539|27252255|P1|Overall Study|Reason not Specified|111
7855328|NCT00097539|27252249|P7|Overall Study|Reasons Other Than Above|34
7855329|NCT00097539|27252250|P6|Overall Study|Reasons Other Than Above|1244
7855330|NCT00097539|27252251|P5|Overall Study|Reasons Other Than Above|361
7855331|NCT00097539|27252252|P4|Overall Study|Reasons Other Than Above|692
7855332|NCT00097539|27252253|P3|Overall Study|Reasons Other Than Above|1757
7855333|NCT00097539|27252254|P2|Overall Study|Reasons Other Than Above|1382
7855334|NCT00097539|27252255|P1|Overall Study|Reasons Other Than Above|3602
7855335|NCT00097539|27252249|P7|Overall Study|Death|0
7855336|NCT00097539|27252250|P6|Overall Study|Death|3
7855337|NCT00097539|27252251|P5|Overall Study|Death|1
7855338|NCT00097539|27252252|P4|Overall Study|Death|0
7855339|NCT00097539|27252253|P3|Overall Study|Death|0
7855340|NCT00097539|27252254|P2|Overall Study|Death|7
7855341|NCT00097539|27252255|P1|Overall Study|Death|2
7855342|NCT00097539|27252249|P7|Overall Study|Adverse Event|1
7855343|NCT00097539|27252250|P6|Overall Study|Adverse Event|59
7855344|NCT00097539|27252251|P5|Overall Study|Adverse Event|30
7855345|NCT00097539|27252252|P4|Overall Study|Adverse Event|27
7855346|NCT00097539|27252253|P3|Overall Study|Adverse Event|37
7855347|NCT00097539|27252254|P2|Overall Study|Adverse Event|133
7855348|NCT00097539|27252255|P1|Overall Study|Adverse Event|78
7855349|NCT00097539|27252249|P7|Overall Study|Lack of Efficacy|5
7855350|NCT00097539|27252250|P6|Overall Study|Lack of Efficacy|228
7855351|NCT00097539|27252251|P5|Overall Study|Lack of Efficacy|45
7855352|NCT00097539|27252252|P4|Overall Study|Lack of Efficacy|105
7855353|NCT00097539|27252253|P3|Overall Study|Lack of Efficacy|202
7855354|NCT00097539|27252254|P2|Overall Study|Lack of Efficacy|122
7855355|NCT00097539|27252255|P1|Overall Study|Lack of Efficacy|249
7855356|NCT00097539|27252249|P7|Overall Study|Participant Non-compliant|18
7855357|NCT00097539|27252250|P6|Overall Study|Participant Non-compliant|543
7855358|NCT00097539|27252251|P5|Overall Study|Participant Non-compliant|136
7855359|NCT00097539|27252252|P4|Overall Study|Participant Non-compliant|353
7855360|NCT00097539|27252253|P3|Overall Study|Participant Non-compliant|1067
7855361|NCT00097539|27252254|P2|Overall Study|Participant Non-compliant|567
7855362|NCT00097539|27252255|P1|Overall Study|Participant Non-compliant|2140
7855363|NCT00097539|27252249|P7|Overall Study|Withdrawal by Subject|3
7855364|NCT00097539|27252250|P6|Overall Study|Withdrawal by Subject|229
7855365|NCT00097539|27252251|P5|Overall Study|Withdrawal by Subject|68
7855366|NCT00097539|27252252|P4|Overall Study|Withdrawal by Subject|217
7855367|NCT00097539|27252253|P3|Overall Study|Withdrawal by Subject|346
7855368|NCT00097539|27252254|P2|Overall Study|Withdrawal by Subject|323
7855369|NCT00097539|27252255|P1|Overall Study|Withdrawal by Subject|925
7855370|NCT00097539|27252249|P7|Overall Study|Status Unknown (Or no final evaluation)|108
7855371|NCT00097539|27252250|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
7855372|NCT00097539|27252251|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
7855373|NCT00097539|27252252|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
7855374|NCT00097539|27252253|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
7855375|NCT00097539|27252254|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
7855376|NCT00097539|27252255|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
7855377|NCT00097500|27252301|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
7855378|NCT00097500|27252302|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
7855379|NCT00097500|27252301|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
7855380|NCT00097500|27252302|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
7855381|NCT00097500|27252301|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
7855382|NCT00097500|27252302|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
7855383|NCT00097500|27252301|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
7855384|NCT00097500|27252302|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
7855385|NCT00097500|27252301|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
7855386|NCT00097500|27252302|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
7855387|NCT00097500|27252301|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
7855388|NCT00097500|27252302|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
7855389|NCT00097500|27252301|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
7855390|NCT00097500|27252302|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
7855391|NCT00097370|27252333|P1|Stage 3|Lost to Follow-up|1
7855392|NCT00097370|27252333|P1|Stage 3|Sponsor Terminated Study|52
7855393|NCT00097370|27252333|P1|Stage 3|Lack of Efficacy|1
7855394|NCT00097370|27252333|P1|Stage 3|Withdrawal by Subject|3
7855395|NCT00097370|27252333|P1|Stage 3|Adverse Event|2
7855396|NCT00097370|27252333|P1|Stage 2|Lost to Follow-up|1
7855397|NCT00097370|27252333|P1|Stage 2|Sponsor Terminated Study|2
7855398|NCT00097370|27252333|P1|Stage 2|Pregnancy|1
7855399|NCT00097370|27252333|P1|Stage 2|Lack of Efficacy|3
7855400|NCT00097370|27252333|P1|Stage 2|Withdrawal by Subject|1
7855401|NCT00097370|27252333|P1|Stage 2|Adverse Event|5
7855402|NCT00097370|27252333|P1|Stage 1|Lack of Efficacy|2
7855403|NCT00097370|27252333|P1|Stage 1|Withdrawal by Subject|1
7855404|NCT00097370|27252333|P1|Stage 1|Adverse Event|3
7855405|NCT00096993|27252367|P2|Overall Study|Other unspecified|1
7855406|NCT00096993|27252368|P1|Overall Study|Other unspecified|1
7855407|NCT00096993|27252367|P2|Overall Study|Non-compliance|1
7855408|NCT00096993|27252368|P1|Overall Study|Non-compliance|0
7855409|NCT00096993|27252367|P2|Overall Study|Physician Decision|1
7855410|NCT00096993|27252368|P1|Overall Study|Physician Decision|2
7855411|NCT00096993|27252367|P2|Overall Study|Subject's decision|1
7855412|NCT00096993|27252368|P1|Overall Study|Subject's decision|3
7855413|NCT00096993|27252367|P2|Overall Study|Adverse Event|8
7855414|NCT00096993|27252368|P1|Overall Study|Adverse Event|2
7855415|NCT00096993|27252367|P2|Overall Study|Disease progression|53
7855416|NCT00096993|27252368|P1|Overall Study|Disease progression|56
7855417|NCT00096993|27252367|P2|Overall Study|Death|0
7855418|NCT00096993|27252368|P1|Overall Study|Death|1
7855419|NCT00096954|27252384|P2|Overall Study|Lost to Follow-up|5
7855420|NCT00096954|27252385|P1|Overall Study|Lost to Follow-up|8
7855421|NCT00096954|27252384|P2|Overall Study|Non-compliance|3
7855422|NCT00096954|27252385|P1|Overall Study|Non-compliance|0
7855423|NCT00096954|27252384|P2|Overall Study|Initiation of immunotherapy|0
7855424|NCT00096954|27252385|P1|Overall Study|Initiation of immunotherapy|1
7855425|NCT00096954|27252384|P2|Overall Study|Pregnancy|1
7855426|NCT00096954|27252385|P1|Overall Study|Pregnancy|1
7855427|NCT00096954|27252384|P2|Overall Study|Sponsors Decision|1
7855428|NCT00096954|27252385|P1|Overall Study|Sponsors Decision|1
7855429|NCT00096954|27252384|P2|Overall Study|Physician Decision|1
7855430|NCT00096954|27252385|P1|Overall Study|Physician Decision|1
7855431|NCT00096954|27252384|P2|Overall Study|Withdrawal by Subject|8
7855432|NCT00096954|27252385|P1|Overall Study|Withdrawal by Subject|9
7855433|NCT00096954|27252384|P2|Overall Study|Adverse Event|1
7855434|NCT00096954|27252385|P1|Overall Study|Adverse Event|3
7855435|NCT00096941|27252397|P1|Overall Study|disease progression|3
7855436|NCT00096785|27252404|P2|Overall Study|Relocated|0
7855437|NCT00096785|27252405|P1|Overall Study|Relocated|1
7855438|NCT00096785|27252404|P2|Overall Study|Withdrawal by Subject|1
7855439|NCT00096785|27252405|P1|Overall Study|Withdrawal by Subject|0
7855440|NCT00096785|27252404|P2|Overall Study|Lost to Follow-up|0
7855441|NCT00096785|27252405|P1|Overall Study|Lost to Follow-up|1
7855442|NCT00096538|27252434|P1|Overall Study|Withdrawal by Subject|1
7855443|NCT00096486|27252442|P4|Overall Study|Not Treated|1
7855444|NCT00096486|27252443|P3|Overall Study|Not Treated|1
7855445|NCT00096486|27252444|P2|Overall Study|Not Treated|0
7855446|NCT00096486|27252445|P1|Overall Study|Not Treated|0
7855447|NCT00096486|27252442|P4|Overall Study|Withdrawal by Subject|1
7855448|NCT00096486|27252443|P3|Overall Study|Withdrawal by Subject|1
7855449|NCT00096486|27252444|P2|Overall Study|Withdrawal by Subject|0
7855450|NCT00096486|27252445|P1|Overall Study|Withdrawal by Subject|0
7855451|NCT00096447|27252464|P1|Overall Study|Never treated|1
7855452|NCT00096382|27252480|P2|Overall Study|Death during treatment|0
7855453|NCT00096382|27252481|P1|Overall Study|Death during treatment|1
7855454|NCT00096382|27252480|P2|Overall Study|Not treated|0
7855455|NCT00096382|27252481|P1|Overall Study|Not treated|1
7855456|NCT00096356|27252491|P2|Overall Study|multiple reasons|18
7855457|NCT00096356|27252492|P1|Overall Study|multiple reasons|10
7855458|NCT00096356|27252491|P2|Overall Study|Lack of Efficacy|0
7855459|NCT00096356|27252492|P1|Overall Study|Lack of Efficacy|1
7855460|NCT00096356|27252491|P2|Overall Study|Withdrawal by Subject|23
7855461|NCT00096356|27252492|P1|Overall Study|Withdrawal by Subject|17
7855462|NCT00096356|27252491|P2|Overall Study|Physician Decision|3
7855463|NCT00096356|27252492|P1|Overall Study|Physician Decision|5
7855464|NCT00096356|27252491|P2|Overall Study|Adverse Event|9
7855465|NCT00096356|27252492|P1|Overall Study|Adverse Event|11
7855466|NCT00096278|27252504|P2|Overall Study|Patient not at risk for primary endpoint|2
7855467|NCT00096278|27252505|P1|Overall Study|Patient not at risk for primary endpoint|3
7855468|NCT00096278|27252504|P2|Overall Study|No follow-up data|18
7855469|NCT00096278|27252505|P1|Overall Study|No follow-up data|15
7855470|NCT00096265|27252524|P3|Overall Study|Ineligible|0
7855471|NCT00096265|27252525|P2|Overall Study|Ineligible|0
7855472|NCT00096265|27252526|P1|Overall Study|Ineligible|1
7855473|NCT00096226|27252552|P1|Overall Study|Protocol treatment not started|1
7855474|NCT00096226|27252552|P1|Overall Study|Ineligible|2
7855475|NCT00096200|27252566|P3|Overall Study|Ineligible pathology|0
7855476|NCT00096200|27252567|P2|Overall Study|Ineligible pathology|1
7855477|NCT00096200|27252568|P1|Overall Study|Ineligible pathology|0
7855478|NCT00096200|27252566|P3|Overall Study|Withdrawal by Subject|0
7855479|NCT00096200|27252567|P2|Overall Study|Withdrawal by Subject|2
7855480|NCT00096200|27252568|P1|Overall Study|Withdrawal by Subject|1
7855481|NCT00096200|27252566|P3|Overall Study|Adverse Event|0
7855482|NCT00096200|27252567|P2|Overall Study|Adverse Event|4
7855483|NCT00096200|27252568|P1|Overall Study|Adverse Event|0
7855484|NCT00096174|27252582|P1|Overall Study|other reason|8
7855485|NCT00096174|27252582|P1|Overall Study|Ineligible|6
7855486|NCT00096174|27252582|P1|Overall Study|Not started protocol therapy|3
7855487|NCT00096174|27252582|P1|Overall Study|Withdrawal by Subject|15
7855488|NCT00096174|27252582|P1|Overall Study|Death|6
7855489|NCT00096174|27252582|P1|Overall Study|Adverse Event|15
7855490|NCT00096174|27252582|P1|Overall Study|Lack of Efficacy|9
7855491|NCT00096135|27252627|P2|Overall Study|Ineligible|0
7855492|NCT00096135|27252628|P1|Overall Study|Ineligible|2
7855493|NCT00096135|27252627|P2|Overall Study|Other, specify|3
7855494|NCT00096135|27252628|P1|Overall Study|Other, specify|15
7855495|NCT00096135|27252627|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
7855496|NCT00096135|27252628|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
7855497|NCT00096135|27252627|P2|Overall Study|Refusal of further protocol therapy|1
7855498|NCT00096135|27252628|P1|Overall Study|Refusal of further protocol therapy|4
7855499|NCT00096135|27252627|P2|Overall Study|Physician Decision|4
7855500|NCT00096135|27252628|P1|Overall Study|Physician Decision|20
7855501|NCT00096044|27252644|P1|Overall Study|Disease Progression|4
7855502|NCT00096044|27252644|P1|Overall Study|Adverse Event|21
7855503|NCT00096044|27252644|P1|Overall Study|Withdrawal by Subject|9
7855504|NCT00096031|27252653|P1|Overall Study|Not protocol specified|5
7855505|NCT00096031|27252653|P1|Overall Study|Ineligible|8
7855506|NCT00096031|27252653|P1|Overall Study|Withdrawal by Subject|1
7855507|NCT00096031|27252653|P1|Overall Study|Death|4
7855508|NCT00096031|27252653|P1|Overall Study|Lack of Efficacy|42
7855509|NCT00096031|27252653|P1|Overall Study|Adverse Event|3
7855510|NCT00096018|27252661|P2|Overall Study|Miscellaneous|1
7855511|NCT00096018|27252662|P1|Overall Study|Miscellaneous|2
7855512|NCT00096018|27252661|P2|Overall Study|Withdrawal by Subject|2
7855513|NCT00096018|27252662|P1|Overall Study|Withdrawal by Subject|0
7855514|NCT00096018|27252661|P2|Overall Study|Death|1
7855515|NCT00096018|27252662|P1|Overall Study|Death|0
7855516|NCT00096018|27252661|P2|Overall Study|Adverse Event|5
7855517|NCT00096018|27252662|P1|Overall Study|Adverse Event|0
7855518|NCT00096018|27252661|P2|Overall Study|Miscellaneous (not treated)|2
7855519|NCT00096018|27252662|P1|Overall Study|Miscellaneous (not treated)|0
7855520|NCT00096018|27252661|P2|Overall Study|Became Ineligible (not treated)|3
7855521|NCT00096018|27252662|P1|Overall Study|Became Ineligible (not treated)|0
7855522|NCT00095979|27252670|P1|Overall Study|Ineligible: Second primary cancer site|2
7855523|NCT00095940|27252688|P9|Lapatinib Continuation/Phase II|Adverse Event|0
7855524|NCT00095940|27252689|P8|Lapatinib Continuation/Phase II|Adverse Event|1
7855525|NCT00095940|27252690|P7|Lapatinib Continuation/Phase II|Adverse Event|0
7855526|NCT00095940|27252691|P6|Lapatinib Continuation/Phase II|Adverse Event|0
7855527|NCT00095940|27252692|P5|Lapatinib Continuation/Phase II|Adverse Event|0
7855528|NCT00095940|27252693|P4|Lapatinib Continuation/Phase II|Adverse Event|0
7855529|NCT00095940|27252694|P3|Lapatinib Continuation/Phase II|Adverse Event|0
7855530|NCT00095940|27252695|P2|Lapatinib Continuation/Phase II|Adverse Event|0
7855531|NCT00095940|27252696|P1|Lapatinib Continuation/Phase II|Adverse Event|0
7855532|NCT00095940|27252688|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7855533|NCT00095940|27252689|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7855534|NCT00095940|27252690|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7855535|NCT00095940|27252691|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7855536|NCT00095940|27252692|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7855537|NCT00095940|27252693|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7855538|NCT00095940|27252694|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7855539|NCT00095940|27252695|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7855540|NCT00095940|27252696|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7855541|NCT00095940|27252688|P9|Lapatinib Continuation/Phase II|Disease Progression|12
7855542|NCT00095940|27252689|P8|Lapatinib Continuation/Phase II|Disease Progression|1
7855543|NCT00095940|27252690|P7|Lapatinib Continuation/Phase II|Disease Progression|2
7855544|NCT00095940|27252691|P6|Lapatinib Continuation/Phase II|Disease Progression|13
7855545|NCT00095940|27252692|P5|Lapatinib Continuation/Phase II|Disease Progression|0
7855546|NCT00095940|27252693|P4|Lapatinib Continuation/Phase II|Disease Progression|0
7855547|NCT00095940|27252694|P3|Lapatinib Continuation/Phase II|Disease Progression|15
7855548|NCT00095940|27252695|P2|Lapatinib Continuation/Phase II|Disease Progression|1
7855549|NCT00095940|27252696|P1|Lapatinib Continuation/Phase II|Disease Progression|1
7855550|NCT00095836|27252729|P1|Overall Study|Death|2
7855551|NCT00095836|27252729|P1|Overall Study|Adverse Event|1
7855552|NCT00095836|27252729|P1|Overall Study|Lost to Follow-up|1
7855553|NCT00095628|27252759|P1|Overall Study|Disease progression prior to treatment|1
7855554|NCT00095576|27252770|P2|Overall Study|Subject moved|36
7855555|NCT00095576|27252771|P1|Overall Study|Subject moved|30
7855556|NCT00095576|27252770|P2|Overall Study|Site terminated|67
7855557|NCT00095576|27252771|P1|Overall Study|Site terminated|75
7855558|NCT00095576|27252770|P2|Overall Study|Option to switch to a rollover study|1099
7855559|NCT00095576|27252771|P1|Overall Study|Option to switch to a rollover study|1097
7855560|NCT00095576|27252770|P2|Overall Study|Withdrawal by Subject|47
7855561|NCT00095576|27252771|P1|Overall Study|Withdrawal by Subject|34
7855562|NCT00095576|27252770|P2|Overall Study|Protocol Violation|0
7855563|NCT00095576|27252771|P1|Overall Study|Protocol Violation|1
7855564|NCT00095576|27252770|P2|Overall Study|Lost to Follow-up|229
7855565|NCT00095576|27252771|P1|Overall Study|Lost to Follow-up|233
7855566|NCT00095576|27252770|P2|Overall Study|Adverse Event|3
7855567|NCT00095576|27252771|P1|Overall Study|Adverse Event|5
7855598|NCT00095303|27253224|P2|Follow Up Study|Lost to Follow-up|58
7855599|NCT00095303|27253225|P1|Follow Up Study|Lost to Follow-up|59
7855600|NCT00095303|27253224|P2|Main Study|Lost to Follow-up|87
7855601|NCT00095303|27253225|P1|Main Study|Lost to Follow-up|91
7855602|NCT00095238|27253293|P2|Overall Study|Other Reasons|88
7855603|NCT00095238|27253294|P1|Overall Study|Other Reasons|87
7855604|NCT00095238|27253293|P2|Overall Study|Missing|0
7855605|NCT00095238|27253294|P1|Overall Study|Missing|1
7855606|NCT00095238|27253293|P2|Overall Study|Study terminated by sponsor|1
7855607|NCT00095238|27253294|P1|Overall Study|Study terminated by sponsor|0
7855608|NCT00095238|27253293|P2|Overall Study|No longer met study criteria|5
7855609|NCT00095238|27253294|P1|Overall Study|No longer met study criteria|4
7855610|NCT00095238|27253293|P2|Overall Study|Noncompliance|45
7855611|NCT00095238|27253294|P1|Overall Study|Noncompliance|44
7855612|NCT00095238|27253293|P2|Overall Study|Lost to Follow-up|24
7855613|NCT00095238|27253294|P1|Overall Study|Lost to Follow-up|19
7855614|NCT00095238|27253293|P2|Overall Study|Death|170
7855615|NCT00095238|27253294|P1|Overall Study|Death|154
7855616|NCT00095238|27253293|P2|Overall Study|Subject Withdrew Consent|223
7855617|NCT00095238|27253294|P1|Overall Study|Subject Withdrew Consent|208
7855618|NCT00095238|27253293|P2|Overall Study|Adverse Event|287
7855619|NCT00095238|27253294|P1|Overall Study|Adverse Event|331
7855620|NCT00095238|27253293|P2|Overall Study|Lack of Efficacy|9
7855621|NCT00095238|27253294|P1|Overall Study|Lack of Efficacy|9
7855622|NCT00095212|27253356|P2|Overall Study|Withdrawal by Subject|3
7855623|NCT00095212|27253357|P1|Overall Study|Withdrawal by Subject|1
7855624|NCT00095199|27253387|P4|Overall Study|Data inadvertently lost by site|0
7855625|NCT00095199|27253388|P3|Overall Study|Data inadvertently lost by site|0
7855626|NCT00095199|27253389|P2|Overall Study|Data inadvertently lost by site|0
7855627|NCT00095199|27253390|P1|Overall Study|Data inadvertently lost by site|1
7855628|NCT00095199|27253387|P4|Overall Study|Primary tumor removed in other surgery|0
7855629|NCT00095199|27253388|P3|Overall Study|Primary tumor removed in other surgery|0
7855630|NCT00095199|27253389|P2|Overall Study|Primary tumor removed in other surgery|1
7855631|NCT00095199|27253390|P1|Overall Study|Primary tumor removed in other surgery|0
7855632|NCT00095199|27253387|P4|Overall Study|Started radiotherapy regimen|0
7855633|NCT00095199|27253388|P3|Overall Study|Started radiotherapy regimen|0
7855634|NCT00095199|27253389|P2|Overall Study|Started radiotherapy regimen|1
7855635|NCT00095199|27253390|P1|Overall Study|Started radiotherapy regimen|0
7855636|NCT00095199|27253387|P4|Overall Study|Started Palliative Radiotherapy|0
7855637|NCT00095199|27253388|P3|Overall Study|Started Palliative Radiotherapy|0
7855638|NCT00095199|27253389|P2|Overall Study|Started Palliative Radiotherapy|0
7855639|NCT00095199|27253390|P1|Overall Study|Started Palliative Radiotherapy|1
7855640|NCT00095199|27253387|P4|Overall Study|Not eligible|1
7855641|NCT00095199|27253388|P3|Overall Study|Not eligible|0
7855642|NCT00095199|27253389|P2|Overall Study|Not eligible|7
7855643|NCT00095199|27253390|P1|Overall Study|Not eligible|1
7855644|NCT00095199|27253387|P4|Overall Study|Physician Decision|1
7855645|NCT00095199|27253388|P3|Overall Study|Physician Decision|1
7855646|NCT00095199|27253389|P2|Overall Study|Physician Decision|6
7855647|NCT00095199|27253390|P1|Overall Study|Physician Decision|5
7855648|NCT00095199|27253387|P4|Overall Study|Surgery needed could not start in 7 days|0
7855649|NCT00095199|27253388|P3|Overall Study|Surgery needed could not start in 7 days|1
7855650|NCT00095199|27253389|P2|Overall Study|Surgery needed could not start in 7 days|0
7855651|NCT00095199|27253390|P1|Overall Study|Surgery needed could not start in 7 days|0
7855652|NCT00095199|27253387|P4|Overall Study|Liver function test results elevated|1
7855653|NCT00095199|27253388|P3|Overall Study|Liver function test results elevated|1
7855654|NCT00095199|27253389|P2|Overall Study|Liver function test results elevated|0
7855655|NCT00095199|27253390|P1|Overall Study|Liver function test results elevated|0
7855656|NCT00095199|27253387|P4|Overall Study|Protocol Violation|0
7855657|NCT00095199|27253388|P3|Overall Study|Protocol Violation|2
7855658|NCT00095199|27253389|P2|Overall Study|Protocol Violation|4
7855659|NCT00095199|27253390|P1|Overall Study|Protocol Violation|4
7855660|NCT00095199|27253387|P4|Overall Study|Withdrawal by Subject|22
7855661|NCT00095199|27253388|P3|Overall Study|Withdrawal by Subject|13
7855662|NCT00095199|27253389|P2|Overall Study|Withdrawal by Subject|16
7855663|NCT00095199|27253390|P1|Overall Study|Withdrawal by Subject|21
7855664|NCT00095199|27253387|P4|Overall Study|Death|9
7855665|NCT00095199|27253388|P3|Overall Study|Death|11
7855666|NCT00095199|27253389|P2|Overall Study|Death|6
7855667|NCT00095199|27253390|P1|Overall Study|Death|10
7855668|NCT00095199|27253387|P4|Overall Study|Progressive disease|98
7855669|NCT00095199|27253388|P3|Overall Study|Progressive disease|105
7855670|NCT00095199|27253389|P2|Overall Study|Progressive disease|179
7855671|NCT00095199|27253390|P1|Overall Study|Progressive disease|213
7855672|NCT00095199|27253387|P4|Overall Study|Adverse Event|11
7855673|NCT00095199|27253388|P3|Overall Study|Adverse Event|26
7855674|NCT00095199|27253389|P2|Overall Study|Adverse Event|22
7855675|NCT00095199|27253390|P1|Overall Study|Adverse Event|40
7855676|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Other|8
7855677|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Other|6
7855678|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Other|4
7855679|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Other|0
7855680|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Other|0
7855681|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Other|0
7855682|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
7855683|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
7855684|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
7855685|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
7855686|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
7855687|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
7855688|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
7855689|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
7855690|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7855691|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7855692|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7855693|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7855694|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
7855695|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
7855696|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7855697|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7855698|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7855699|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7855700|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7855701|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
7855702|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
7855703|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7855704|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7855705|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7855706|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
7855707|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
7855708|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
7855709|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7855710|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7855711|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7855712|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
7855713|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
7855714|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
7855715|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7855716|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7855717|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7855718|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
7855719|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
7855720|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
7855721|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
7855722|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
7855723|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
7855724|NCT00095173|27253428|P6|Open-Label Extension Phase (Period C)|Death|1
7855725|NCT00095173|27253429|P5|Open-Label Extension Phase (Period C)|Death|0
7855726|NCT00095173|27253430|P4|Open-Label Extension Phase (Period C)|Death|0
7855727|NCT00095173|27253431|P3|Open-Label Extension Phase (Period C)|Death|0
7855728|NCT00095173|27253432|P2|Open-Label Extension Phase (Period C)|Death|0
7855729|NCT00095173|27253433|P1|Open-Label Extension Phase (Period C)|Death|0
7855730|NCT00095173|27253428|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7855731|NCT00095173|27253429|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7855732|NCT00095173|27253430|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7855733|NCT00095173|27253431|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7855734|NCT00095173|27253432|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
7855735|NCT00095173|27253433|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7855736|NCT00095173|27253428|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
7855737|NCT00095173|27253429|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
7855738|NCT00095173|27253430|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
7855739|NCT00095173|27253431|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
7855740|NCT00095173|27253432|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
7855741|NCT00095173|27253433|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
7855742|NCT00095173|27253428|P6|Open-Label Lead-In Phase (Period A)|Other|0
7855743|NCT00095173|27253429|P5|Open-Label Lead-In Phase (Period A)|Other|0
7855744|NCT00095173|27253430|P4|Open-Label Lead-In Phase (Period A)|Other|0
7855745|NCT00095173|27253431|P3|Open-Label Lead-In Phase (Period A)|Other|0
7855746|NCT00095173|27253432|P2|Open-Label Lead-In Phase (Period A)|Other|0
7855747|NCT00095173|27253433|P1|Open-Label Lead-In Phase (Period A)|Other|1
7855748|NCT00095173|27253428|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7855749|NCT00095173|27253429|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7855750|NCT00095173|27253430|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7855751|NCT00095173|27253431|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7855752|NCT00095173|27253432|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7855753|NCT00095173|27253433|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
7855754|NCT00095173|27253428|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7855755|NCT00095173|27253429|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7855756|NCT00095173|27253430|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7855757|NCT00095173|27253431|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7855758|NCT00095173|27253432|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7855759|NCT00095173|27253433|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
7855760|NCT00095173|27253428|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7855761|NCT00095173|27253429|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7855762|NCT00095173|27253430|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7855763|NCT00095173|27253431|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7855764|NCT00095173|27253432|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7855765|NCT00095173|27253433|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
7855766|NCT00095147|27253471|P5|Long-term Extension Period|Leaving country|1
7855767|NCT00095147|27253472|P4|Long-term Extension Period|Leaving country|0
7855768|NCT00095147|27253473|P3|Long-term Extension Period|Leaving country|0
7855769|NCT00095147|27253474|P2|Long-term Extension Period|Leaving country|0
7855770|NCT00095147|27253475|P1|Long-term Extension Period|Leaving country|0
7855771|NCT00095147|27253471|P5|Long-term Extension Period|Participant chose to use Revellex|1
7855772|NCT00095147|27253472|P4|Long-term Extension Period|Participant chose to use Revellex|0
7855773|NCT00095147|27253473|P3|Long-term Extension Period|Participant chose to use Revellex|0
7855774|NCT00095147|27253474|P2|Long-term Extension Period|Participant chose to use Revellex|0
7855775|NCT00095147|27253475|P1|Long-term Extension Period|Participant chose to use Revellex|0
7855776|NCT00095147|27253471|P5|Long-term Extension Period|No longer meets study criteria|1
7855777|NCT00095147|27253472|P4|Long-term Extension Period|No longer meets study criteria|0
7855778|NCT00095147|27253473|P3|Long-term Extension Period|No longer meets study criteria|0
7855779|NCT00095147|27253474|P2|Long-term Extension Period|No longer meets study criteria|0
7855780|NCT00095147|27253475|P1|Long-term Extension Period|No longer meets study criteria|0
7855781|NCT00095147|27253471|P5|Long-term Extension Period|Pregnancy|1
7855782|NCT00095147|27253472|P4|Long-term Extension Period|Pregnancy|0
7855783|NCT00095147|27253473|P3|Long-term Extension Period|Pregnancy|0
7855784|NCT00095147|27253474|P2|Long-term Extension Period|Pregnancy|0
7855785|NCT00095147|27253475|P1|Long-term Extension Period|Pregnancy|0
7855786|NCT00095147|27253471|P5|Long-term Extension Period|Withdrawal of consent|12
7855787|NCT00095147|27253472|P4|Long-term Extension Period|Withdrawal of consent|0
7855788|NCT00095147|27253473|P3|Long-term Extension Period|Withdrawal of consent|0
7855789|NCT00095147|27253474|P2|Long-term Extension Period|Withdrawal of consent|0
7855790|NCT00095147|27253475|P1|Long-term Extension Period|Withdrawal of consent|0
7855791|NCT00095147|27253471|P5|Long-term Extension Period|Lost to Follow-up|6
7855792|NCT00095147|27253472|P4|Long-term Extension Period|Lost to Follow-up|0
7855793|NCT00095147|27253473|P3|Long-term Extension Period|Lost to Follow-up|0
7855794|NCT00095147|27253474|P2|Long-term Extension Period|Lost to Follow-up|0
7855795|NCT00095147|27253475|P1|Long-term Extension Period|Lost to Follow-up|0
7855796|NCT00095147|27253471|P5|Long-term Extension Period|Lack of Efficacy|9
7855797|NCT00095147|27253472|P4|Long-term Extension Period|Lack of Efficacy|0
7855798|NCT00095147|27253473|P3|Long-term Extension Period|Lack of Efficacy|0
7855799|NCT00095147|27253474|P2|Long-term Extension Period|Lack of Efficacy|0
7855800|NCT00095147|27253475|P1|Long-term Extension Period|Lack of Efficacy|0
7855801|NCT00095147|27253471|P5|Long-term Extension Period|Adverse Event|11
7855802|NCT00095147|27253472|P4|Long-term Extension Period|Adverse Event|0
7855803|NCT00095147|27253473|P3|Long-term Extension Period|Adverse Event|0
7855804|NCT00095147|27253474|P2|Long-term Extension Period|Adverse Event|0
7855805|NCT00095147|27253475|P1|Long-term Extension Period|Adverse Event|0
7855806|NCT00095147|27253471|P5|Long-term Extension Period|Death|3
7855807|NCT00095147|27253472|P4|Long-term Extension Period|Death|0
7855808|NCT00095147|27253473|P3|Long-term Extension Period|Death|0
7855809|NCT00095147|27253474|P2|Long-term Extension Period|Death|0
7855810|NCT00095147|27253475|P1|Long-term Extension Period|Death|0
7855811|NCT00095147|27253471|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7855812|NCT00095147|27253472|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
7855813|NCT00095147|27253473|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7855814|NCT00095147|27253474|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7855815|NCT00095147|27253475|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
7855816|NCT00095147|27253471|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7855817|NCT00095147|27253472|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7855818|NCT00095147|27253473|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7855819|NCT00095147|27253474|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
7855820|NCT00095147|27253475|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
7855821|NCT00095147|27253471|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
7855822|NCT00095147|27253472|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
7855823|NCT00095147|27253473|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
7855824|NCT00095147|27253474|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
7855825|NCT00095147|27253475|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
7855826|NCT00095147|27253471|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7855827|NCT00095147|27253472|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7855828|NCT00095147|27253473|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7855829|NCT00095147|27253474|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
7855830|NCT00095147|27253475|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
7855831|NCT00095147|27253471|P5|Double-blind Period 2 (Days 198-365)|Death|0
7855832|NCT00095147|27253472|P4|Double-blind Period 2 (Days 198-365)|Death|1
7855833|NCT00095147|27253473|P3|Double-blind Period 2 (Days 198-365)|Death|0
7855834|NCT00095147|27253474|P2|Double-blind Period 2 (Days 198-365)|Death|1
7855835|NCT00095147|27253475|P1|Double-blind Period 2 (Days 198-365)|Death|0
7855836|NCT00095147|27253471|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7855837|NCT00095147|27253472|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7855838|NCT00095147|27253473|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7855839|NCT00095147|27253474|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
7855840|NCT00095147|27253475|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
7855841|NCT00095147|27253471|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7855842|NCT00095147|27253472|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7855843|NCT00095147|27253473|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
7855844|NCT00095147|27253474|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7855845|NCT00095147|27253475|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
7855846|NCT00095147|27253471|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7855847|NCT00095147|27253472|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7855848|NCT00095147|27253473|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7855849|NCT00095147|27253474|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
7855850|NCT00095147|27253475|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
7855851|NCT00095147|27253471|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
7855852|NCT00095147|27253472|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
7855853|NCT00095147|27253473|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
7855854|NCT00095147|27253474|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
7855855|NCT00095147|27253475|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
7855856|NCT00095147|27253471|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
7855857|NCT00095147|27253472|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
7855858|NCT00095147|27253473|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
7855859|NCT00095147|27253474|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
7855860|NCT00095147|27253475|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
7855861|NCT00095147|27253471|P5|Double-blind Period 1 (Days 1-197)|Death|0
7855862|NCT00095147|27253472|P4|Double-blind Period 1 (Days 1-197)|Death|0
7855863|NCT00095147|27253473|P3|Double-blind Period 1 (Days 1-197)|Death|0
7855864|NCT00095147|27253474|P2|Double-blind Period 1 (Days 1-197)|Death|0
7855865|NCT00095147|27253475|P1|Double-blind Period 1 (Days 1-197)|Death|1
7855866|NCT00095121|27253670|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
7855867|NCT00095121|27253671|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
7855868|NCT00095121|27253670|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
7855869|NCT00095121|27253671|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
7855870|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Protocol Violation|1
7855871|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Protocol Violation|0
7855872|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
7855873|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
7855874|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Death|1
7855875|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Death|3
7855876|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Patient Moved|0
7855877|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Patient Moved|1
7855878|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
7855879|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
7855880|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
7855881|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
7855882|NCT00095056|27253717|P2|Phase B (Weeks 12-54)|Adverse Event|2
7855883|NCT00095056|27253718|P1|Phase B (Weeks 12-54)|Adverse Event|2
7855884|NCT00095056|27253717|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
7855885|NCT00095056|27253718|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
7855886|NCT00095056|27253717|P2|Phase A (Weeks 0-12)|Death|0
7855887|NCT00095056|27253718|P1|Phase A (Weeks 0-12)|Death|1
7855888|NCT00095056|27253717|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
7855889|NCT00095056|27253718|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
7855890|NCT00095056|27253717|P2|Phase A (Weeks 0-12)|Adverse Event|1
7855891|NCT00095056|27253718|P1|Phase A (Weeks 0-12)|Adverse Event|1
7855892|NCT00094861|27253847|P2|Overall Study|Other|0
7855893|NCT00094861|27253848|P1|Overall Study|Other|3
7855894|NCT00094861|27253847|P2|Overall Study|Death|2
7855895|NCT00094861|27253848|P1|Overall Study|Death|4
7855896|NCT00094861|27253847|P2|Overall Study|Lost to Follow-up|1
7855897|NCT00094861|27253848|P1|Overall Study|Lost to Follow-up|0
7855898|NCT00094861|27253847|P2|Overall Study|Physician Decision|1
7855899|NCT00094861|27253848|P1|Overall Study|Physician Decision|1
7855900|NCT00094861|27253847|P2|Overall Study|Withdrawal by Subject|3
7855901|NCT00094861|27253848|P1|Overall Study|Withdrawal by Subject|5
7855902|NCT00094861|27253847|P2|Overall Study|Adverse Event|2
7855903|NCT00094861|27253848|P1|Overall Study|Adverse Event|5
7855904|NCT00094835|27253875|P7|Overall Study|Other|0
7855905|NCT00094835|27253876|P6|Overall Study|Other|0
7855906|NCT00094835|27253877|P5|Overall Study|Other|0
7855907|NCT00094835|27253878|P4|Overall Study|Other|1
7855908|NCT00094835|27253879|P3|Overall Study|Other|1
7855909|NCT00094835|27253880|P2|Overall Study|Other|1
7855910|NCT00094835|27253881|P1|Overall Study|Other|1
7855911|NCT00094835|27253875|P7|Overall Study|Non-compliance|1
7855912|NCT00094835|27253876|P6|Overall Study|Non-compliance|2
7855913|NCT00094835|27253877|P5|Overall Study|Non-compliance|2
7855914|NCT00094835|27253878|P4|Overall Study|Non-compliance|0
7855915|NCT00094835|27253879|P3|Overall Study|Non-compliance|2
7855916|NCT00094835|27253880|P2|Overall Study|Non-compliance|2
7855917|NCT00094835|27253881|P1|Overall Study|Non-compliance|1
7855918|NCT00094835|27253875|P7|Overall Study|Death|0
7855919|NCT00094835|27253876|P6|Overall Study|Death|0
7855920|NCT00094835|27253877|P5|Overall Study|Death|1
7855921|NCT00094835|27253878|P4|Overall Study|Death|0
7855922|NCT00094835|27253879|P3|Overall Study|Death|0
7855923|NCT00094835|27253880|P2|Overall Study|Death|0
7855924|NCT00094835|27253881|P1|Overall Study|Death|1
7855925|NCT00094835|27253875|P7|Overall Study|Lost to Follow-up|0
7855926|NCT00094835|27253876|P6|Overall Study|Lost to Follow-up|0
7855927|NCT00094835|27253877|P5|Overall Study|Lost to Follow-up|1
7855928|NCT00094835|27253878|P4|Overall Study|Lost to Follow-up|0
7855929|NCT00094835|27253879|P3|Overall Study|Lost to Follow-up|0
7855930|NCT00094835|27253880|P2|Overall Study|Lost to Follow-up|0
7855931|NCT00094835|27253881|P1|Overall Study|Lost to Follow-up|0
7855932|NCT00094835|27253875|P7|Overall Study|Withdrawal by Subject|1
7855933|NCT00094835|27253876|P6|Overall Study|Withdrawal by Subject|0
7855934|NCT00094835|27253877|P5|Overall Study|Withdrawal by Subject|0
7855935|NCT00094835|27253878|P4|Overall Study|Withdrawal by Subject|0
7855936|NCT00094835|27253879|P3|Overall Study|Withdrawal by Subject|0
7855937|NCT00094835|27253880|P2|Overall Study|Withdrawal by Subject|0
7855938|NCT00094835|27253881|P1|Overall Study|Withdrawal by Subject|0
7855939|NCT00094835|27253875|P7|Overall Study|Physician Decision|0
7855940|NCT00094835|27253876|P6|Overall Study|Physician Decision|1
7855941|NCT00094835|27253877|P5|Overall Study|Physician Decision|0
7855942|NCT00094835|27253878|P4|Overall Study|Physician Decision|0
7855943|NCT00094835|27253879|P3|Overall Study|Physician Decision|0
7855944|NCT00094835|27253880|P2|Overall Study|Physician Decision|0
7855945|NCT00094835|27253881|P1|Overall Study|Physician Decision|1
7855946|NCT00094809|27253959|P2|Overall Study|Other|1
7855947|NCT00094809|27253960|P1|Overall Study|Other|1
7855948|NCT00094809|27253959|P2|Overall Study|Study drug not received|8
7855949|NCT00094809|27253960|P1|Overall Study|Study drug not received|2
7855950|NCT00094809|27253959|P2|Overall Study|Informed consent signed after treatment|0
7855951|NCT00094809|27253960|P1|Overall Study|Informed consent signed after treatment|1
7855952|NCT00094809|27253959|P2|Overall Study|Other|4
7855953|NCT00094809|27253960|P1|Overall Study|Other|2
7855954|NCT00094809|27253959|P2|Overall Study|Protocol-specified criteria|1
7855955|NCT00094809|27253960|P1|Overall Study|Protocol-specified criteria|1
7855956|NCT00094809|27253959|P2|Overall Study|Death|25
7855957|NCT00094809|27253960|P1|Overall Study|Death|19
7855958|NCT00094809|27253959|P2|Overall Study|Lost to Follow-up|6
7855959|NCT00094809|27253960|P1|Overall Study|Lost to Follow-up|6
7855960|NCT00094809|27253959|P2|Overall Study|Physician Decision|5
7855961|NCT00094809|27253960|P1|Overall Study|Physician Decision|3
7855962|NCT00094809|27253959|P2|Overall Study|Disease progression|3
7855963|NCT00094809|27253960|P1|Overall Study|Disease progression|3
7855964|NCT00094809|27253959|P2|Overall Study|Withdrawal by Subject|9
7855965|NCT00094809|27253960|P1|Overall Study|Withdrawal by Subject|8
7855966|NCT00094809|27253959|P2|Overall Study|Adverse Event|1
7855967|NCT00094809|27253960|P1|Overall Study|Adverse Event|3
7855968|NCT00094809|27253959|P2|Overall Study|Noncompliance|0
7855969|NCT00094809|27253960|P1|Overall Study|Noncompliance|1
7855970|NCT00094809|27253959|P2|Overall Study|Protocol deviation|2
7855971|NCT00094809|27253960|P1|Overall Study|Protocol deviation|2
7855972|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Other|23
7855973|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Other|15
7855974|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
7855975|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
7855976|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
7855977|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
7855978|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
7855979|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
7855980|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
7855981|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
7855982|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
7855983|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
7855984|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
7855985|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
7855986|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
7855987|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
7855988|NCT00094770|27253986|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
7855989|NCT00094770|27253987|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
7855990|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Other|11
7855991|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Other|10
7855992|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
7855993|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
7855994|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
7855995|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
7855996|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
7855997|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
7855998|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
7855999|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
7856000|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
7856001|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
7856002|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
7856003|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
7856004|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
7856005|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
7856006|NCT00094770|27253986|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
7856007|NCT00094770|27253987|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
7856008|NCT00094757|27254018|P3|Overall Study|Protocol specified discontinuation|0
7856009|NCT00094757|27254019|P2|Overall Study|Protocol specified discontinuation|3
7856010|NCT00094757|27254020|P1|Overall Study|Protocol specified discontinuation|1
7856011|NCT00094757|27254018|P3|Overall Study|Other|1
7856012|NCT00094757|27254019|P2|Overall Study|Other|3
7856013|NCT00094757|27254020|P1|Overall Study|Other|3
7856014|NCT00094757|27254018|P3|Overall Study|Withdrawal by Subject|5
7856015|NCT00094757|27254019|P2|Overall Study|Withdrawal by Subject|21
7856016|NCT00094757|27254020|P1|Overall Study|Withdrawal by Subject|14
7856017|NCT00094757|27254018|P3|Overall Study|Protocol Violation|3
7856018|NCT00094757|27254019|P2|Overall Study|Protocol Violation|5
7856019|NCT00094757|27254020|P1|Overall Study|Protocol Violation|8
7856020|NCT00094757|27254018|P3|Overall Study|Patient Moved|1
7856021|NCT00094757|27254019|P2|Overall Study|Patient Moved|1
7856022|NCT00094757|27254020|P1|Overall Study|Patient Moved|2
7856023|NCT00094757|27254018|P3|Overall Study|Lost to Follow-up|6
7856024|NCT00094757|27254019|P2|Overall Study|Lost to Follow-up|5
7856025|NCT00094757|27254020|P1|Overall Study|Lost to Follow-up|3
7856026|NCT00094757|27254018|P3|Overall Study|Lack of Efficacy|8
7856027|NCT00094757|27254019|P2|Overall Study|Lack of Efficacy|15
7856028|NCT00094757|27254020|P1|Overall Study|Lack of Efficacy|11
7856029|NCT00094757|27254018|P3|Overall Study|Adverse Event|6
7856030|NCT00094757|27254019|P2|Overall Study|Adverse Event|9
7856031|NCT00094757|27254020|P1|Overall Study|Adverse Event|11
7856032|NCT00094653|27254040|P3|Overall Study|Protocol Violation|1
7856033|NCT00094653|27254041|P2|Overall Study|Protocol Violation|0
7856034|NCT00094653|27254042|P1|Overall Study|Protocol Violation|0
7856035|NCT00094653|27254040|P3|Overall Study|Lost to Follow-up|1
7856036|NCT00094653|27254041|P2|Overall Study|Lost to Follow-up|2
7856037|NCT00094653|27254042|P1|Overall Study|Lost to Follow-up|3
7856038|NCT00094653|27254040|P3|Overall Study|Other|2
7856039|NCT00094653|27254041|P2|Overall Study|Other|2
7856040|NCT00094653|27254042|P1|Overall Study|Other|2
7856041|NCT00094653|27254040|P3|Overall Study|Subject Withdrew Consent|3
7856042|NCT00094653|27254041|P2|Overall Study|Subject Withdrew Consent|2
7856043|NCT00094653|27254042|P1|Overall Study|Subject Withdrew Consent|10
7856044|NCT00094653|27254040|P3|Overall Study|Death|119
7856045|NCT00094653|27254041|P2|Overall Study|Death|100
7856046|NCT00094653|27254042|P1|Overall Study|Death|306
7856047|NCT00094575|27254105|P2|Overall Study|Death|146
7856048|NCT00094575|27254106|P1|Overall Study|Death|146
7856049|NCT00094536|27254126|P1|Treatment and Follow-up|Unable to attend visits|1
7856050|NCT00094536|27254126|P1|Treatment and Follow-up|Subject non-compliance|9
7856051|NCT00094536|27254126|P1|Treatment and Follow-up|Withdrawal by Subject|1
7856052|NCT00094536|27254126|P1|Treatment and Follow-up|Lost to Follow-up|7
7856053|NCT00094536|27254126|P1|Treatment and Follow-up|Lack of Efficacy|9
7856054|NCT00094536|27254126|P1|Treatment and Follow-up|Adverse Event|4
7856055|NCT00094536|27254126|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
7856056|NCT00094458|27254150|P6|OLE: Open-Label Extension|Patient decision|0
7856057|NCT00094458|27254151|P5|OLE: Open-Label Extension|Patient decision|1
7856058|NCT00094458|27254152|P4|OLE: Open-Label Extension|Patient decision|0
7856059|NCT00094458|27254153|P3|OLE: Open-Label Extension|Patient decision|0
7856060|NCT00094458|27254154|P2|OLE: Open-Label Extension|Patient decision|0
7856061|NCT00094458|27254155|P1|OLE: Open-Label Extension|Patient decision|0
7856062|NCT00094458|27254150|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7856063|NCT00094458|27254151|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
7856064|NCT00094458|27254152|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
7856065|NCT00094458|27254153|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7856066|NCT00094458|27254154|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7856067|NCT00094458|27254155|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7856068|NCT00094458|27254150|P6|OLE: Open-Label Extension|Adverse Event|4
7856069|NCT00094458|27254151|P5|OLE: Open-Label Extension|Adverse Event|3
7856070|NCT00094458|27254152|P4|OLE: Open-Label Extension|Adverse Event|0
7856071|NCT00094458|27254153|P3|OLE: Open-Label Extension|Adverse Event|0
7856072|NCT00094458|27254154|P2|OLE: Open-Label Extension|Adverse Event|0
7856073|NCT00094458|27254155|P1|OLE: Open-Label Extension|Adverse Event|0
7856074|NCT00094458|27254150|P6|Study Extension: Week 30 Through Week 50|Other|0
7856075|NCT00094458|27254151|P5|Study Extension: Week 30 Through Week 50|Other|0
7856076|NCT00094458|27254152|P4|Study Extension: Week 30 Through Week 50|Other|0
7856077|NCT00094458|27254153|P3|Study Extension: Week 30 Through Week 50|Other|3
7856078|NCT00094458|27254154|P2|Study Extension: Week 30 Through Week 50|Other|2
7856079|NCT00094458|27254155|P1|Study Extension: Week 30 Through Week 50|Other|1
7856080|NCT00094458|27254150|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
7856081|NCT00094458|27254151|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
7856082|NCT00094458|27254152|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
7856083|NCT00094458|27254153|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
7856084|NCT00094458|27254154|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
7856085|NCT00094458|27254155|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
7856086|NCT00094458|27254150|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7856087|NCT00094458|27254151|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7856088|NCT00094458|27254152|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7856089|NCT00094458|27254153|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
7856090|NCT00094458|27254154|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7856091|NCT00094458|27254155|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
7856092|NCT00094458|27254150|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7856093|NCT00094458|27254151|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7856094|NCT00094458|27254152|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7856095|NCT00094458|27254153|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
7856096|NCT00094458|27254154|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
7856097|NCT00094458|27254155|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
7856098|NCT00094458|27254150|P6|Main Study: Through Week 30|Other|0
7856099|NCT00094458|27254151|P5|Main Study: Through Week 30|Other|0
7856100|NCT00094458|27254152|P4|Main Study: Through Week 30|Other|0
7856101|NCT00094458|27254153|P3|Main Study: Through Week 30|Other|9
7856102|NCT00094458|27254154|P2|Main Study: Through Week 30|Other|16
7856103|NCT00094458|27254155|P1|Main Study: Through Week 30|Other|19
7856104|NCT00094458|27254150|P6|Main Study: Through Week 30|Death|0
7856105|NCT00094458|27254151|P5|Main Study: Through Week 30|Death|0
7856106|NCT00094458|27254152|P4|Main Study: Through Week 30|Death|0
7856107|NCT00094458|27254153|P3|Main Study: Through Week 30|Death|0
7856108|NCT00094458|27254154|P2|Main Study: Through Week 30|Death|0
7856109|NCT00094458|27254155|P1|Main Study: Through Week 30|Death|1
7856110|NCT00094458|27254150|P6|Main Study: Through Week 30|Adverse Event|0
7856111|NCT00094458|27254151|P5|Main Study: Through Week 30|Adverse Event|0
7856112|NCT00094458|27254152|P4|Main Study: Through Week 30|Adverse Event|0
7856113|NCT00094458|27254153|P3|Main Study: Through Week 30|Adverse Event|28
7856114|NCT00094458|27254154|P2|Main Study: Through Week 30|Adverse Event|20
7856115|NCT00094458|27254155|P1|Main Study: Through Week 30|Adverse Event|38
7856116|NCT00094458|27254150|P6|Main Study: Through Week 30|Withdrawal by Subject|0
7856117|NCT00094458|27254151|P5|Main Study: Through Week 30|Withdrawal by Subject|0
7856118|NCT00094458|27254152|P4|Main Study: Through Week 30|Withdrawal by Subject|0
7856119|NCT00094458|27254153|P3|Main Study: Through Week 30|Withdrawal by Subject|7
7856120|NCT00094458|27254154|P2|Main Study: Through Week 30|Withdrawal by Subject|9
7856121|NCT00094458|27254155|P1|Main Study: Through Week 30|Withdrawal by Subject|18
7856122|NCT00094458|27254150|P6|Main Study: Through Week 30|Lost to Follow-up|0
7856123|NCT00094458|27254151|P5|Main Study: Through Week 30|Lost to Follow-up|0
7856124|NCT00094458|27254152|P4|Main Study: Through Week 30|Lost to Follow-up|0
7856125|NCT00094458|27254153|P3|Main Study: Through Week 30|Lost to Follow-up|2
7856126|NCT00094458|27254154|P2|Main Study: Through Week 30|Lost to Follow-up|5
7856127|NCT00094458|27254155|P1|Main Study: Through Week 30|Lost to Follow-up|5
7856128|NCT00094458|27254150|P6|Main Study: Through Week 30|Eligibility criteria not met|0
7856129|NCT00094458|27254151|P5|Main Study: Through Week 30|Eligibility criteria not met|0
7856130|NCT00094458|27254152|P4|Main Study: Through Week 30|Eligibility criteria not met|0
7856131|NCT00094458|27254153|P3|Main Study: Through Week 30|Eligibility criteria not met|2
7856132|NCT00094458|27254154|P2|Main Study: Through Week 30|Eligibility criteria not met|8
7856133|NCT00094458|27254155|P1|Main Study: Through Week 30|Eligibility criteria not met|3
7856134|NCT00094445|27254193|P1|Overall Study|Progressive Disease|2
7856135|NCT00094445|27254193|P1|Overall Study|Lost to Follow-up|1
7856136|NCT00094445|27254193|P1|Overall Study|Withdrawal by Subject|3
7856137|NCT00094328|27254197|P1|Overall Study|Lost to Follow-up|1
7856138|NCT00094302|27254211|P2|Overall Study|Death|246
7856139|NCT00094302|27254212|P1|Overall Study|Death|266
7856140|NCT00094302|27254211|P2|Overall Study|Withdrawal by Subject|111
7856141|NCT00094302|27254212|P1|Overall Study|Withdrawal by Subject|103
7856142|NCT00094302|27254211|P2|Overall Study|Physician Decision|8
7856143|NCT00094302|27254212|P1|Overall Study|Physician Decision|5
7856144|NCT00094302|27254211|P2|Overall Study|Lost to Follow-up|41
7856145|NCT00094302|27254212|P1|Overall Study|Lost to Follow-up|43
7856146|NCT00094172|27254301|P2|Overall Study|Started other MS therapy due to disease|0
7856147|NCT00094172|27254302|P1|Overall Study|Started other MS therapy due to disease|1
7856148|NCT00094172|27254301|P2|Overall Study|Primary endpoint met.|0
7856149|NCT00094172|27254302|P1|Overall Study|Primary endpoint met.|1
7856150|NCT00094172|27254301|P2|Overall Study|Withdrawal by Subject|5
7856151|NCT00094172|27254302|P1|Overall Study|Withdrawal by Subject|10
7856152|NCT00094172|27254301|P2|Overall Study|Protocol Violation|1
7856153|NCT00094172|27254302|P1|Overall Study|Protocol Violation|0
7856154|NCT00094172|27254301|P2|Overall Study|Lost to Follow-up|0
7856155|NCT00094172|27254302|P1|Overall Study|Lost to Follow-up|2
7856156|NCT00094172|27254301|P2|Overall Study|Adverse Event|1
7856157|NCT00094172|27254302|P1|Overall Study|Adverse Event|0
7856158|NCT00094107|27254312|P1|Overall Study|Withdrawal due to Disease Progression|1
7856159|NCT00094107|27254312|P1|Overall Study|Adverse Event|3
7856160|NCT00094107|27254312|P1|Overall Study|Death|5
7856161|NCT00094107|27254312|P1|Overall Study|Lack of Efficacy|23
7856162|NCT00094094|27254321|P1|Overall Study|Adverse Event|7
7856163|NCT00094094|27254321|P1|Overall Study|Lack of Efficacy|23
7856164|NCT00094094|27254321|P1|Overall Study|Death|2
7856165|NCT00094055|27254330|P1|Overall Study|Withdrawal by Subject|9
7856166|NCT00094055|27254330|P1|Overall Study|roll-over to another study|14
7856167|NCT00094055|27254330|P1|Overall Study|clinical progression|1
7856168|NCT00094055|27254330|P1|Overall Study|progressive disease|2
7856169|NCT00094055|27254330|P1|Overall Study|Lost to Follow-up|2
7856170|NCT00094055|27254330|P1|Overall Study|Lack of Efficacy|17
7856171|NCT00094055|27254330|P1|Overall Study|Death|4
7856172|NCT00094055|27254330|P1|Overall Study|Adverse Event|11
7856173|NCT00093808|27254387|P1|Overall Study|Protocol Violation|1
7856174|NCT00093808|27254387|P1|Overall Study|Cancel participation before receiving tx|1
7856175|NCT00093795|27254397|P3|Overall Study|No follow up data|17
7856176|NCT00093795|27254398|P2|Overall Study|No follow up data|16
7856177|NCT00093795|27254399|P1|Overall Study|No follow up data|20
7856178|NCT00093496|27254444|P2|Overall Study|Protocol Violation|3
7856179|NCT00093496|27254445|P1|Overall Study|Protocol Violation|1
7856180|NCT00093470|27254458|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
7856181|NCT00093470|27254459|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
7856182|NCT00093470|27254458|P2|Overall Study|Never started treatment|0
7856183|NCT00093470|27254459|P1|Overall Study|Never started treatment|1
7856184|NCT00093470|27254458|P2|Overall Study|Physician Decision|0
7856185|NCT00093470|27254459|P1|Overall Study|Physician Decision|2
7856186|NCT00093470|27254458|P2|Overall Study|Other complicating disease|0
7856187|NCT00093470|27254459|P1|Overall Study|Other complicating disease|3
7856188|NCT00093470|27254458|P2|Overall Study|Alternative therapy|0
7856189|NCT00093470|27254459|P1|Overall Study|Alternative therapy|2
7856190|NCT00093470|27254458|P2|Overall Study|Withdrawal by Subject|0
7856191|NCT00093470|27254459|P1|Overall Study|Withdrawal by Subject|8
7856192|NCT00093470|27254458|P2|Overall Study|Death|0
7856193|NCT00093470|27254459|P1|Overall Study|Death|2
7856194|NCT00093470|27254458|P2|Overall Study|Adverse Event|0
7856195|NCT00093470|27254459|P1|Overall Study|Adverse Event|15
7856196|NCT00093470|27254458|P2|Overall Study|Disease progression|0
7856197|NCT00093470|27254459|P1|Overall Study|Disease progression|39
7856198|NCT00093145|27254473|P1|Overall Study|Other|1
7856199|NCT00093145|27254473|P1|Overall Study|Withdrawal by Subject|9
7856200|NCT00093145|27254473|P1|Overall Study|Physician Decision|5
7856201|NCT00093145|27254473|P1|Overall Study|Unacceptable Toxicity Only|2
7856202|NCT00093015|27254515|P2|Overall Study|Death|385
7856203|NCT00093015|27254516|P1|Overall Study|Death|375
7856204|NCT00093015|27254515|P2|Overall Study|Lost to Follow-up|108
7856205|NCT00093015|27254516|P1|Overall Study|Lost to Follow-up|96
7856206|NCT00093015|27254515|P2|Overall Study|Withdrawal by Subject|171
7856207|NCT00093015|27254516|P1|Overall Study|Withdrawal by Subject|194
7856208|NCT00092677|27254544|P2|Overall Study|Adminstrative|9
7856209|NCT00092677|27254545|P1|Overall Study|Adminstrative|5
7856210|NCT00092677|27254544|P2|Overall Study|Lost to Follow-up|2
7856211|NCT00092677|27254545|P1|Overall Study|Lost to Follow-up|0
7856212|NCT00092547|27254589|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
7856213|NCT00092547|27254590|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
7856214|NCT00092547|27254591|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
7856215|NCT00092547|27254589|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
7856216|NCT00092547|27254590|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
7856217|NCT00092547|27254591|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
7856218|NCT00092547|27254589|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
7856219|NCT00092547|27254590|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
7856220|NCT00092547|27254591|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
7856221|NCT00092547|27254589|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
7856222|NCT00092547|27254590|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
7856223|NCT00092547|27254591|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
7856224|NCT00092547|27254589|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
7856225|NCT00092547|27254590|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
7856226|NCT00092547|27254591|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
7856227|NCT00092547|27254589|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
7856228|NCT00092547|27254590|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
7856229|NCT00092547|27254591|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
7856230|NCT00092547|27254589|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
7856231|NCT00092547|27254590|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
7856232|NCT00092547|27254591|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
7856233|NCT00092547|27254589|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
7856234|NCT00092547|27254590|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
7856235|NCT00092547|27254591|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
7856236|NCT00092547|27254589|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
7856237|NCT00092547|27254590|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
7856238|NCT00092547|27254591|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
7856239|NCT00092547|27254589|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
7856240|NCT00092547|27254590|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
7856241|NCT00092547|27254591|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
7856242|NCT00092547|27254589|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
7856243|NCT00092547|27254590|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
7856244|NCT00092547|27254591|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
7856245|NCT00092547|27254589|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
7856246|NCT00092547|27254590|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
7856247|NCT00092547|27254591|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
7856248|NCT00092547|27254589|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
7856249|NCT00092547|27254590|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
7856250|NCT00092547|27254591|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
7856251|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
7856252|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
7856253|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
7856254|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
7856255|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
7856256|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
7856257|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
7856258|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
7856259|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
7856260|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
7856261|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
7856262|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
7856263|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
7856264|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
7856265|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
7856266|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
7856267|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
7856268|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
7856269|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
7856270|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
7856271|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
7856272|NCT00092547|27254589|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
7856273|NCT00092547|27254590|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
7856274|NCT00092547|27254591|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
7856275|NCT00092534|27254635|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7856276|NCT00092534|27254636|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
7856277|NCT00092534|27254637|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7856278|NCT00092534|27254638|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7856279|NCT00092534|27254639|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7856280|NCT00092534|27254635|P5|Base Study EXT|Protocol Violation|0
7856281|NCT00092534|27254636|P4|Base Study EXT|Protocol Violation|0
7856282|NCT00092534|27254637|P3|Base Study EXT|Protocol Violation|15
7856283|NCT00092534|27254638|P2|Base Study EXT|Protocol Violation|0
7856284|NCT00092534|27254639|P1|Base Study EXT|Protocol Violation|0
7856285|NCT00092534|27254635|P5|Base Study EXT|Study ended|0
7856286|NCT00092534|27254636|P4|Base Study EXT|Study ended|0
7856287|NCT00092534|27254637|P3|Base Study EXT|Study ended|29
7856288|NCT00092534|27254638|P2|Base Study EXT|Study ended|0
7856289|NCT00092534|27254639|P1|Base Study EXT|Study ended|0
7856290|NCT00092534|27254635|P5|Base Study EXT|Site closed|0
7856291|NCT00092534|27254636|P4|Base Study EXT|Site closed|0
7856292|NCT00092534|27254637|P3|Base Study EXT|Site closed|21
7856293|NCT00092534|27254638|P2|Base Study EXT|Site closed|0
7856294|NCT00092534|27254639|P1|Base Study EXT|Site closed|0
7856295|NCT00092534|27254635|P5|Base Study EXT|Travel|0
7856296|NCT00092534|27254636|P4|Base Study EXT|Travel|0
7856297|NCT00092534|27254637|P3|Base Study EXT|Travel|2
7856298|NCT00092534|27254638|P2|Base Study EXT|Travel|0
7856299|NCT00092534|27254639|P1|Base Study EXT|Travel|0
7856300|NCT00092534|27254635|P5|Base Study EXT|Participant moved|0
7856301|NCT00092534|27254636|P4|Base Study EXT|Participant moved|0
7856302|NCT00092534|27254637|P3|Base Study EXT|Participant moved|6
7856303|NCT00092534|27254638|P2|Base Study EXT|Participant moved|0
7856304|NCT00092534|27254639|P1|Base Study EXT|Participant moved|0
7856305|NCT00092534|27254635|P5|Base Study EXT|Withdrawal by Subject|0
7856306|NCT00092534|27254636|P4|Base Study EXT|Withdrawal by Subject|0
7856307|NCT00092534|27254637|P3|Base Study EXT|Withdrawal by Subject|18
7856308|NCT00092534|27254638|P2|Base Study EXT|Withdrawal by Subject|0
7856309|NCT00092534|27254639|P1|Base Study EXT|Withdrawal by Subject|0
7856310|NCT00092534|27254635|P5|Base Study EXT|Pregnancy|0
7856311|NCT00092534|27254636|P4|Base Study EXT|Pregnancy|0
7856312|NCT00092534|27254637|P3|Base Study EXT|Pregnancy|12
7856313|NCT00092534|27254638|P2|Base Study EXT|Pregnancy|0
7856314|NCT00092534|27254639|P1|Base Study EXT|Pregnancy|0
7856315|NCT00092534|27254635|P5|Base Study EXT|Physician Decision|0
7856316|NCT00092534|27254636|P4|Base Study EXT|Physician Decision|0
7856317|NCT00092534|27254637|P3|Base Study EXT|Physician Decision|1
7856318|NCT00092534|27254638|P2|Base Study EXT|Physician Decision|0
7856319|NCT00092534|27254639|P1|Base Study EXT|Physician Decision|0
7856320|NCT00092534|27254635|P5|Base Study EXT|Lost to Follow-up|0
7856321|NCT00092534|27254636|P4|Base Study EXT|Lost to Follow-up|0
7856322|NCT00092534|27254637|P3|Base Study EXT|Lost to Follow-up|41
7856323|NCT00092534|27254638|P2|Base Study EXT|Lost to Follow-up|0
7856324|NCT00092534|27254639|P1|Base Study EXT|Lost to Follow-up|0
7856325|NCT00092534|27254635|P5|Base Study Follow-Up Period|Subjects in extension|0
7856326|NCT00092534|27254636|P4|Base Study Follow-Up Period|Subjects in extension|0
7856327|NCT00092534|27254637|P3|Base Study Follow-Up Period|Subjects in extension|0
7856328|NCT00092534|27254638|P2|Base Study Follow-Up Period|Subjects in extension|371
7856329|NCT00092534|27254639|P1|Base Study Follow-Up Period|Subjects in extension|15
7856330|NCT00092534|27254635|P5|Base Study Follow-Up Period|Subjects continuing|0
7856331|NCT00092534|27254636|P4|Base Study Follow-Up Period|Subjects continuing|0
7856332|NCT00092534|27254637|P3|Base Study Follow-Up Period|Subjects continuing|0
7856333|NCT00092534|27254638|P2|Base Study Follow-Up Period|Subjects continuing|31
7856334|NCT00092534|27254639|P1|Base Study Follow-Up Period|Subjects continuing|27
7856335|NCT00092534|27254635|P5|Base Study Follow-Up Period|Site Closed|0
7856336|NCT00092534|27254636|P4|Base Study Follow-Up Period|Site Closed|0
7856337|NCT00092534|27254637|P3|Base Study Follow-Up Period|Site Closed|0
7856338|NCT00092534|27254638|P2|Base Study Follow-Up Period|Site Closed|2
7856339|NCT00092534|27254639|P1|Base Study Follow-Up Period|Site Closed|0
7856340|NCT00092534|27254635|P5|Base Study Follow-Up Period|Travel|0
7856341|NCT00092534|27254636|P4|Base Study Follow-Up Period|Travel|0
7856342|NCT00092534|27254637|P3|Base Study Follow-Up Period|Travel|0
7856343|NCT00092534|27254638|P2|Base Study Follow-Up Period|Travel|7
7856344|NCT00092534|27254639|P1|Base Study Follow-Up Period|Travel|10
7856345|NCT00092534|27254635|P5|Base Study Follow-Up Period|Moved|0
7856346|NCT00092534|27254636|P4|Base Study Follow-Up Period|Moved|0
7856347|NCT00092534|27254637|P3|Base Study Follow-Up Period|Moved|0
7856348|NCT00092534|27254638|P2|Base Study Follow-Up Period|Moved|58
7856349|NCT00092534|27254639|P1|Base Study Follow-Up Period|Moved|62
7856350|NCT00092534|27254635|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
7856351|NCT00092534|27254636|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
7856352|NCT00092534|27254637|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
7856353|NCT00092534|27254638|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
7856354|NCT00092534|27254639|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
7856355|NCT00092534|27254635|P5|Base Study Follow-Up Period|Protocol Violation|0
7856356|NCT00092534|27254636|P4|Base Study Follow-Up Period|Protocol Violation|0
7856357|NCT00092534|27254637|P3|Base Study Follow-Up Period|Protocol Violation|0
7856358|NCT00092534|27254638|P2|Base Study Follow-Up Period|Protocol Violation|2
7856359|NCT00092534|27254639|P1|Base Study Follow-Up Period|Protocol Violation|1
7856360|NCT00092534|27254635|P5|Base Study Follow-Up Period|Pregnancy|0
7856361|NCT00092534|27254636|P4|Base Study Follow-Up Period|Pregnancy|0
7856362|NCT00092534|27254637|P3|Base Study Follow-Up Period|Pregnancy|0
7856363|NCT00092534|27254638|P2|Base Study Follow-Up Period|Pregnancy|10
7856364|NCT00092534|27254639|P1|Base Study Follow-Up Period|Pregnancy|6
7856365|NCT00092534|27254635|P5|Base Study Follow-Up Period|Lost to Follow-up|0
7856366|NCT00092534|27254636|P4|Base Study Follow-Up Period|Lost to Follow-up|0
7856367|NCT00092534|27254637|P3|Base Study Follow-Up Period|Lost to Follow-up|0
7856368|NCT00092534|27254638|P2|Base Study Follow-Up Period|Lost to Follow-up|146
7856369|NCT00092534|27254639|P1|Base Study Follow-Up Period|Lost to Follow-up|120
7856370|NCT00092534|27254635|P5|Base Study Follow-Up Period|Death|0
7856371|NCT00092534|27254636|P4|Base Study Follow-Up Period|Death|0
7856372|NCT00092534|27254637|P3|Base Study Follow-Up Period|Death|0
7856373|NCT00092534|27254638|P2|Base Study Follow-Up Period|Death|1
7856374|NCT00092534|27254639|P1|Base Study Follow-Up Period|Death|2
7856375|NCT00092534|27254635|P5|Base Study Follow-Up Period|Adverse Event|0
7856376|NCT00092534|27254636|P4|Base Study Follow-Up Period|Adverse Event|0
7856377|NCT00092534|27254637|P3|Base Study Follow-Up Period|Adverse Event|0
7856378|NCT00092534|27254638|P2|Base Study Follow-Up Period|Adverse Event|4
7856379|NCT00092534|27254639|P1|Base Study Follow-Up Period|Adverse Event|2
7856380|NCT00092534|27254635|P5|Base Study Vaccination Period|Site Closed|0
7856381|NCT00092534|27254636|P4|Base Study Vaccination Period|Site Closed|0
7856382|NCT00092534|27254637|P3|Base Study Vaccination Period|Site Closed|0
7856383|NCT00092534|27254638|P2|Base Study Vaccination Period|Site Closed|1
7856384|NCT00092534|27254639|P1|Base Study Vaccination Period|Site Closed|0
7856385|NCT00092534|27254635|P5|Base Study Vaccination Period|Travel|0
7856386|NCT00092534|27254636|P4|Base Study Vaccination Period|Travel|0
7856387|NCT00092534|27254637|P3|Base Study Vaccination Period|Travel|0
7856388|NCT00092534|27254638|P2|Base Study Vaccination Period|Travel|0
7856389|NCT00092534|27254639|P1|Base Study Vaccination Period|Travel|1
7856390|NCT00092534|27254635|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
7856391|NCT00092534|27254636|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
7856392|NCT00092534|27254637|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
7856393|NCT00092534|27254638|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
7856394|NCT00092534|27254639|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
7856395|NCT00092534|27254635|P5|Base Study Vaccination Period|Moved|0
7856396|NCT00092534|27254636|P4|Base Study Vaccination Period|Moved|0
7856397|NCT00092534|27254637|P3|Base Study Vaccination Period|Moved|0
7856398|NCT00092534|27254638|P2|Base Study Vaccination Period|Moved|12
7856399|NCT00092534|27254639|P1|Base Study Vaccination Period|Moved|14
7856400|NCT00092534|27254635|P5|Base Study Vaccination Period|Withdrawal by Subject|0
7856401|NCT00092534|27254636|P4|Base Study Vaccination Period|Withdrawal by Subject|0
7856402|NCT00092534|27254637|P3|Base Study Vaccination Period|Withdrawal by Subject|0
7856403|NCT00092534|27254638|P2|Base Study Vaccination Period|Withdrawal by Subject|58
7856404|NCT00092534|27254639|P1|Base Study Vaccination Period|Withdrawal by Subject|85
7856405|NCT00092534|27254635|P5|Base Study Vaccination Period|Protocol Violation|0
7856406|NCT00092534|27254636|P4|Base Study Vaccination Period|Protocol Violation|0
7856407|NCT00092534|27254637|P3|Base Study Vaccination Period|Protocol Violation|0
7856408|NCT00092534|27254638|P2|Base Study Vaccination Period|Protocol Violation|1
7856409|NCT00092534|27254639|P1|Base Study Vaccination Period|Protocol Violation|2
7856410|NCT00092534|27254635|P5|Base Study Vaccination Period|Pregnancy|0
7856411|NCT00092534|27254636|P4|Base Study Vaccination Period|Pregnancy|0
7856412|NCT00092534|27254637|P3|Base Study Vaccination Period|Pregnancy|0
7856413|NCT00092534|27254638|P2|Base Study Vaccination Period|Pregnancy|7
7856414|NCT00092534|27254639|P1|Base Study Vaccination Period|Pregnancy|9
7856415|NCT00092534|27254635|P5|Base Study Vaccination Period|Physician Decision|0
7856416|NCT00092534|27254636|P4|Base Study Vaccination Period|Physician Decision|0
7856417|NCT00092534|27254637|P3|Base Study Vaccination Period|Physician Decision|0
7856418|NCT00092534|27254638|P2|Base Study Vaccination Period|Physician Decision|0
7856419|NCT00092534|27254639|P1|Base Study Vaccination Period|Physician Decision|1
7856420|NCT00092534|27254635|P5|Base Study Vaccination Period|Lost to Follow-up|0
7856421|NCT00092534|27254636|P4|Base Study Vaccination Period|Lost to Follow-up|0
7856422|NCT00092534|27254637|P3|Base Study Vaccination Period|Lost to Follow-up|0
7856423|NCT00092534|27254638|P2|Base Study Vaccination Period|Lost to Follow-up|37
7856424|NCT00092534|27254639|P1|Base Study Vaccination Period|Lost to Follow-up|41
7856425|NCT00092534|27254635|P5|Base Study Vaccination Period|Death|0
7856426|NCT00092534|27254636|P4|Base Study Vaccination Period|Death|0
7856427|NCT00092534|27254637|P3|Base Study Vaccination Period|Death|0
7856428|NCT00092534|27254638|P2|Base Study Vaccination Period|Death|4
7856429|NCT00092534|27254639|P1|Base Study Vaccination Period|Death|5
7856430|NCT00092534|27254635|P5|Base Study Vaccination Period|Adverse Event|0
7856431|NCT00092534|27254636|P4|Base Study Vaccination Period|Adverse Event|0
7856432|NCT00092534|27254637|P3|Base Study Vaccination Period|Adverse Event|0
7856433|NCT00092534|27254638|P2|Base Study Vaccination Period|Adverse Event|1
7856434|NCT00092534|27254639|P1|Base Study Vaccination Period|Adverse Event|3
7856435|NCT00092534|27254635|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
7856436|NCT00092534|27254636|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
7856437|NCT00092534|27254637|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
7856438|NCT00092534|27254638|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
7856439|NCT00092534|27254639|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
7856440|NCT00092521|27254670|P4|Extension Study (Group 4)|Unable/unwilling to return|25
7856441|NCT00092521|27254671|P3|Extension Study (Group 4)|Unable/unwilling to return|0
7856442|NCT00092521|27254672|P2|Extension Study (Group 4)|Unable/unwilling to return|0
7856443|NCT00092521|27254673|P1|Extension Study (Group 4)|Unable/unwilling to return|0
7856444|NCT00092521|27254670|P4|Extension Study (Group 4)|Site Terminated|4
7856445|NCT00092521|27254671|P3|Extension Study (Group 4)|Site Terminated|0
7856446|NCT00092521|27254672|P2|Extension Study (Group 4)|Site Terminated|0
7856447|NCT00092521|27254673|P1|Extension Study (Group 4)|Site Terminated|0
7856448|NCT00092521|27254670|P4|Extension Study (Group 4)|Moved|16
7856449|NCT00092521|27254671|P3|Extension Study (Group 4)|Moved|0
7856450|NCT00092521|27254672|P2|Extension Study (Group 4)|Moved|0
7856451|NCT00092521|27254673|P1|Extension Study (Group 4)|Moved|0
7856452|NCT00092521|27254670|P4|Extension Study (Group 4)|Withdrawal by Subject|46
7856453|NCT00092521|27254671|P3|Extension Study (Group 4)|Withdrawal by Subject|0
7856454|NCT00092521|27254672|P2|Extension Study (Group 4)|Withdrawal by Subject|0
7856455|NCT00092521|27254673|P1|Extension Study (Group 4)|Withdrawal by Subject|0
7856456|NCT00092521|27254670|P4|Extension Study (Group 4)|Protocol Violation|2
7856457|NCT00092521|27254671|P3|Extension Study (Group 4)|Protocol Violation|0
7856458|NCT00092521|27254672|P2|Extension Study (Group 4)|Protocol Violation|0
7856459|NCT00092521|27254673|P1|Extension Study (Group 4)|Protocol Violation|0
7856460|NCT00092521|27254670|P4|Extension Study (Group 4)|Pregnancy|4
7856461|NCT00092521|27254671|P3|Extension Study (Group 4)|Pregnancy|0
7856462|NCT00092521|27254672|P2|Extension Study (Group 4)|Pregnancy|0
7856463|NCT00092521|27254673|P1|Extension Study (Group 4)|Pregnancy|0
7856464|NCT00092521|27254670|P4|Extension Study (Group 4)|Lost to Follow-up|87
7856465|NCT00092521|27254671|P3|Extension Study (Group 4)|Lost to Follow-up|0
7856466|NCT00092521|27254672|P2|Extension Study (Group 4)|Lost to Follow-up|0
7856467|NCT00092521|27254673|P1|Extension Study (Group 4)|Lost to Follow-up|0
7856468|NCT00092521|27254670|P4|Extension Study (Group 4)|Adverse Event|2
7856469|NCT00092521|27254671|P3|Extension Study (Group 4)|Adverse Event|0
7856470|NCT00092521|27254672|P2|Extension Study (Group 4)|Adverse Event|0
7856471|NCT00092521|27254673|P1|Extension Study (Group 4)|Adverse Event|0
7856472|NCT00092521|27254670|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
7856473|NCT00092521|27254671|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
7856474|NCT00092521|27254672|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
7856475|NCT00092521|27254673|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
7856476|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Visits Compressed|0
7856477|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Visits Compressed|5
7856478|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Visits Compressed|0
7856479|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Visits Compressed|5
7856480|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Travel|0
7856481|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Travel|0
7856482|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Travel|0
7856483|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Travel|2
7856484|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Site Terminated|0
7856485|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Site Terminated|3
7856486|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Site Terminated|0
7856487|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Site Terminated|3
7856488|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Moved|0
7856489|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Moved|28
7856490|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Moved|2
7856491|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Moved|32
7856492|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
7856493|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
7856494|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
7856495|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
7856496|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Protocol Violation|0
7856497|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Protocol Violation|5
7856498|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Protocol Violation|1
7856499|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Protocol Violation|1
7856500|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
7856501|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
7856502|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
7856503|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
7856504|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Death|0
7856505|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Death|1
7856506|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Death|0
7856507|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Death|2
7856508|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Adverse Event|0
7856509|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Adverse Event|0
7856510|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Adverse Event|0
7856511|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Adverse Event|1
7856512|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Subjects in Extension|0
7856513|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Subjects in Extension|412
7856514|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Subjects in Extension|109
7856515|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Subjects in Extension|13
7856516|NCT00092521|27254670|P4|Follow-Up (After Month 7)|Subjects Continuing|0
7856517|NCT00092521|27254671|P3|Follow-Up (After Month 7)|Subjects Continuing|35
7856518|NCT00092521|27254672|P2|Follow-Up (After Month 7)|Subjects Continuing|4
7856519|NCT00092521|27254673|P1|Follow-Up (After Month 7)|Subjects Continuing|34
7856520|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7856521|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7856522|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7856523|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
7856524|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
7856525|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
7856526|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
7856527|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
7856528|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Moved|0
7856529|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Moved|18
7856530|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Moved|1
7856531|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Moved|14
7856532|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
7856533|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
7856534|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
7856535|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
7856536|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
7856537|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
7856538|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
7856539|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
7856540|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
7856541|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
7856542|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
7856543|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
7856544|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Death|0
7856545|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Death|1
7856546|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Death|0
7856547|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Death|0
7856548|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
7856549|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
7856550|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
7856551|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
7856552|NCT00092521|27254670|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
7856553|NCT00092521|27254671|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
7856554|NCT00092521|27254672|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
7856555|NCT00092521|27254673|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
7856556|NCT00092495|27254687|P5|Base Study Follow-up Period|Withdrawal by Subject|0
7856557|NCT00092495|27254688|P4|Base Study Follow-up Period|Withdrawal by Subject|0
7856558|NCT00092495|27254689|P3|Base Study Follow-up Period|Withdrawal by Subject|0
7856559|NCT00092495|27254690|P2|Base Study Follow-up Period|Withdrawal by Subject|0
7856560|NCT00092495|27254691|P1|Base Study Follow-up Period|Withdrawal by Subject|2
7856561|NCT00092495|27254687|P5|Base Study Follow-up Period|Lost to Follow-up|0
7856562|NCT00092495|27254688|P4|Base Study Follow-up Period|Lost to Follow-up|12
7856563|NCT00092495|27254689|P3|Base Study Follow-up Period|Lost to Follow-up|3
7856564|NCT00092495|27254690|P2|Base Study Follow-up Period|Lost to Follow-up|3
7856565|NCT00092495|27254691|P1|Base Study Follow-up Period|Lost to Follow-up|1
7856566|NCT00092495|27254687|P5|Base Study Follow-up Period|Extended|0
7856567|NCT00092495|27254688|P4|Base Study Follow-up Period|Extended|2
7856568|NCT00092495|27254689|P3|Base Study Follow-up Period|Extended|1
7856569|NCT00092495|27254690|P2|Base Study Follow-up Period|Extended|0
7856570|NCT00092495|27254691|P1|Base Study Follow-up Period|Extended|0
7856571|NCT00092495|27254687|P5|Base Study Vaccination Period|Withdrawal by Subject|0
7856572|NCT00092495|27254688|P4|Base Study Vaccination Period|Withdrawal by Subject|25
7856573|NCT00092495|27254689|P3|Base Study Vaccination Period|Withdrawal by Subject|14
7856574|NCT00092495|27254690|P2|Base Study Vaccination Period|Withdrawal by Subject|10
7856575|NCT00092495|27254691|P1|Base Study Vaccination Period|Withdrawal by Subject|9
7856576|NCT00092495|27254687|P5|Base Study Vaccination Period|Protocol Violation|0
7856577|NCT00092495|27254688|P4|Base Study Vaccination Period|Protocol Violation|0
7856578|NCT00092495|27254689|P3|Base Study Vaccination Period|Protocol Violation|0
7856579|NCT00092495|27254690|P2|Base Study Vaccination Period|Protocol Violation|0
7856580|NCT00092495|27254691|P1|Base Study Vaccination Period|Protocol Violation|1
7856581|NCT00092495|27254687|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
7856582|NCT00092495|27254688|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
7856583|NCT00092495|27254689|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
7856584|NCT00092495|27254690|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
7856671|NCT00092443|27254809|P1|Overall Study|Adverse Event|9
7856585|NCT00092495|27254691|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
7856586|NCT00092495|27254687|P5|Base Study Vaccination Period|Pregnancy|0
7856587|NCT00092495|27254688|P4|Base Study Vaccination Period|Pregnancy|0
7856588|NCT00092495|27254689|P3|Base Study Vaccination Period|Pregnancy|0
7856589|NCT00092495|27254690|P2|Base Study Vaccination Period|Pregnancy|0
7856590|NCT00092495|27254691|P1|Base Study Vaccination Period|Pregnancy|2
7856591|NCT00092495|27254687|P5|Base Study Vaccination Period|Other|0
7856592|NCT00092495|27254688|P4|Base Study Vaccination Period|Other|2
7856593|NCT00092495|27254689|P3|Base Study Vaccination Period|Other|0
7856594|NCT00092495|27254690|P2|Base Study Vaccination Period|Other|1
7856595|NCT00092495|27254691|P1|Base Study Vaccination Period|Other|1
7856596|NCT00092495|27254687|P5|Base Study Vaccination Period|Moved|0
7856597|NCT00092495|27254688|P4|Base Study Vaccination Period|Moved|2
7856598|NCT00092495|27254689|P3|Base Study Vaccination Period|Moved|2
7856599|NCT00092495|27254690|P2|Base Study Vaccination Period|Moved|1
7856600|NCT00092495|27254691|P1|Base Study Vaccination Period|Moved|3
7856601|NCT00092495|27254687|P5|Base Study Vaccination Period|Lost to Follow-up|0
7856602|NCT00092495|27254688|P4|Base Study Vaccination Period|Lost to Follow-up|36
7856603|NCT00092495|27254689|P3|Base Study Vaccination Period|Lost to Follow-up|11
7856604|NCT00092495|27254690|P2|Base Study Vaccination Period|Lost to Follow-up|6
7856605|NCT00092495|27254691|P1|Base Study Vaccination Period|Lost to Follow-up|16
7856606|NCT00092495|27254687|P5|Base Study Vaccination Period|Adverse Event|0
7856607|NCT00092495|27254688|P4|Base Study Vaccination Period|Adverse Event|3
7856608|NCT00092495|27254689|P3|Base Study Vaccination Period|Adverse Event|0
7856609|NCT00092495|27254690|P2|Base Study Vaccination Period|Adverse Event|0
7856610|NCT00092495|27254691|P1|Base Study Vaccination Period|Adverse Event|1
7856611|NCT00092495|27254687|P5|Base Study Vaccination Period|*Pregnancy|0
7856612|NCT00092495|27254688|P4|Base Study Vaccination Period|*Pregnancy|7
7856613|NCT00092495|27254689|P3|Base Study Vaccination Period|*Pregnancy|5
7856614|NCT00092495|27254690|P2|Base Study Vaccination Period|*Pregnancy|2
7856615|NCT00092495|27254691|P1|Base Study Vaccination Period|*Pregnancy|0
7856616|NCT00092495|27254687|P5|Base Study Vaccination Period|*Other reasons|0
7856617|NCT00092495|27254688|P4|Base Study Vaccination Period|*Other reasons|1
7856618|NCT00092495|27254689|P3|Base Study Vaccination Period|*Other reasons|0
7856619|NCT00092495|27254690|P2|Base Study Vaccination Period|*Other reasons|0
7856620|NCT00092495|27254691|P1|Base Study Vaccination Period|*Other reasons|1
7856621|NCT00092495|27254687|P5|Base Study Vaccination Period|*Clinical AE|0
7856622|NCT00092495|27254688|P4|Base Study Vaccination Period|*Clinical AE|2
7856623|NCT00092495|27254689|P3|Base Study Vaccination Period|*Clinical AE|1
7856624|NCT00092495|27254690|P2|Base Study Vaccination Period|*Clinical AE|0
7856625|NCT00092495|27254691|P1|Base Study Vaccination Period|*Clinical AE|1
7856626|NCT00092495|27254687|P5|Base Study Vaccination Period|Extended|0
7856627|NCT00092495|27254688|P4|Base Study Vaccination Period|Extended|1
7856628|NCT00092495|27254689|P3|Base Study Vaccination Period|Extended|0
7856629|NCT00092495|27254690|P2|Base Study Vaccination Period|Extended|0
7856630|NCT00092495|27254691|P1|Base Study Vaccination Period|Extended|0
7856631|NCT00092495|27254687|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
7856632|NCT00092495|27254688|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
7856633|NCT00092495|27254689|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
7856634|NCT00092495|27254690|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
7856635|NCT00092495|27254691|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
7856636|NCT00092456|27254757|P4|Overall Study|Other|0
7856637|NCT00092456|27254758|P3|Overall Study|Other|3
7856638|NCT00092456|27254759|P2|Overall Study|Other|2
7856639|NCT00092456|27254760|P1|Overall Study|Other|4
7856640|NCT00092456|27254757|P4|Overall Study|Moved|1
7856641|NCT00092456|27254758|P3|Overall Study|Moved|0
7856642|NCT00092456|27254759|P2|Overall Study|Moved|1
7856643|NCT00092456|27254760|P1|Overall Study|Moved|1
7856644|NCT00092456|27254757|P4|Overall Study|Withdrawal by Subject|6
7856645|NCT00092456|27254758|P3|Overall Study|Withdrawal by Subject|16
7856646|NCT00092456|27254759|P2|Overall Study|Withdrawal by Subject|5
7856647|NCT00092456|27254760|P1|Overall Study|Withdrawal by Subject|13
7856648|NCT00092456|27254757|P4|Overall Study|Protocol Violation|6
7856649|NCT00092456|27254758|P3|Overall Study|Protocol Violation|8
7856650|NCT00092456|27254759|P2|Overall Study|Protocol Violation|7
7856651|NCT00092456|27254760|P1|Overall Study|Protocol Violation|5
7856652|NCT00092456|27254757|P4|Overall Study|Lost to Follow-up|2
7856653|NCT00092456|27254758|P3|Overall Study|Lost to Follow-up|1
7856654|NCT00092456|27254759|P2|Overall Study|Lost to Follow-up|2
7856655|NCT00092456|27254760|P1|Overall Study|Lost to Follow-up|2
7856656|NCT00092456|27254757|P4|Overall Study|Adverse Event|1
7856657|NCT00092456|27254758|P3|Overall Study|Adverse Event|1
7856658|NCT00092456|27254759|P2|Overall Study|Adverse Event|0
7856659|NCT00092456|27254760|P1|Overall Study|Adverse Event|0
7856660|NCT00092443|27254808|P2|Overall Study|Other|13
7856661|NCT00092443|27254809|P1|Overall Study|Other|17
7856662|NCT00092443|27254808|P2|Overall Study|Moved|5
7856663|NCT00092443|27254809|P1|Overall Study|Moved|5
7856664|NCT00092443|27254808|P2|Overall Study|Withdrawal by Subject|11
7856665|NCT00092443|27254809|P1|Overall Study|Withdrawal by Subject|9
7856666|NCT00092443|27254808|P2|Overall Study|Protocol Violation|9
7856667|NCT00092443|27254809|P1|Overall Study|Protocol Violation|11
7856668|NCT00092443|27254808|P2|Overall Study|Lost to Follow-up|3
7856669|NCT00092443|27254809|P1|Overall Study|Lost to Follow-up|7
7856670|NCT00092443|27254808|P2|Overall Study|Adverse Event|13
7856672|NCT00092417|27254827|P2|Overall Study|Other|0
7856673|NCT00092417|27254828|P1|Overall Study|Other|1
7856674|NCT00092417|27254827|P2|Overall Study|Withdrawal by Subject|1
7856675|NCT00092417|27254828|P1|Overall Study|Withdrawal by Subject|2
7856676|NCT00092417|27254827|P2|Overall Study|Lost to Follow-up|0
7856677|NCT00092417|27254828|P1|Overall Study|Lost to Follow-up|2
7856678|NCT00092131|27254842|P2|Treatment Period II|Adverse Event|1
7856679|NCT00092131|27254843|P1|Treatment Period II|Adverse Event|0
7856680|NCT00092131|27254842|P2|Treatment Period I|Adverse Event|0
7856681|NCT00092131|27254843|P1|Treatment Period I|Adverse Event|1
7856682|NCT00092118|27254873|P2|Overall Study|Other|5
7856683|NCT00092118|27254874|P1|Overall Study|Other|6
7856684|NCT00092118|27254873|P2|Overall Study|Withdrawal by Subject|10
7856685|NCT00092118|27254874|P1|Overall Study|Withdrawal by Subject|4
7856686|NCT00092118|27254873|P2|Overall Study|Protocol Violation|25
7856687|NCT00092118|27254874|P1|Overall Study|Protocol Violation|23
7856688|NCT00092118|27254873|P2|Overall Study|Lost to Follow-up|3
7856689|NCT00092118|27254874|P1|Overall Study|Lost to Follow-up|4
7856690|NCT00092118|27254873|P2|Overall Study|Lack of Efficacy|14
7856691|NCT00092118|27254874|P1|Overall Study|Lack of Efficacy|12
7856692|NCT00092118|27254873|P2|Overall Study|Adverse Event|32
7856693|NCT00092118|27254874|P1|Overall Study|Adverse Event|35
7856694|NCT00091949|27254908|P2|Overall Study|Lost to Follow-up|41
7856695|NCT00091949|27254909|P1|Overall Study|Lost to Follow-up|58
7856696|NCT00091949|27254908|P2|Overall Study|Withdrawal by Subject|110
7856697|NCT00091949|27254909|P1|Overall Study|Withdrawal by Subject|117
7856698|NCT00091832|27254933|P6|Overall Study|Protocol Violation|1
7856699|NCT00091832|27254934|P5|Overall Study|Protocol Violation|0
7856700|NCT00091832|27254935|P4|Overall Study|Protocol Violation|0
7856701|NCT00091832|27254936|P3|Overall Study|Protocol Violation|1
7856702|NCT00091832|27254937|P2|Overall Study|Protocol Violation|0
7856703|NCT00091832|27254938|P1|Overall Study|Protocol Violation|0
7856704|NCT00091832|27254933|P6|Overall Study|Other|0
7856705|NCT00091832|27254934|P5|Overall Study|Other|0
7856706|NCT00091832|27254935|P4|Overall Study|Other|0
7856707|NCT00091832|27254936|P3|Overall Study|Other|2
7856708|NCT00091832|27254937|P2|Overall Study|Other|1
7856709|NCT00091832|27254938|P1|Overall Study|Other|0
7856710|NCT00091832|27254933|P6|Overall Study|Noncompliance|0
7856711|NCT00091832|27254934|P5|Overall Study|Noncompliance|0
7856712|NCT00091832|27254935|P4|Overall Study|Noncompliance|0
7856713|NCT00091832|27254936|P3|Overall Study|Noncompliance|0
7856714|NCT00091832|27254937|P2|Overall Study|Noncompliance|1
7856715|NCT00091832|27254938|P1|Overall Study|Noncompliance|0
7856716|NCT00091832|27254933|P6|Overall Study|Lost to Follow-up|1
7856717|NCT00091832|27254934|P5|Overall Study|Lost to Follow-up|2
7856718|NCT00091832|27254935|P4|Overall Study|Lost to Follow-up|3
7856719|NCT00091832|27254936|P3|Overall Study|Lost to Follow-up|3
7856720|NCT00091832|27254937|P2|Overall Study|Lost to Follow-up|0
7856721|NCT00091832|27254938|P1|Overall Study|Lost to Follow-up|1
7856722|NCT00091832|27254933|P6|Overall Study|Ineligibility Determined|0
7856723|NCT00091832|27254934|P5|Overall Study|Ineligibility Determined|1
7856724|NCT00091832|27254935|P4|Overall Study|Ineligibility Determined|0
7856725|NCT00091832|27254936|P3|Overall Study|Ineligibility Determined|1
7856726|NCT00091832|27254937|P2|Overall Study|Ineligibility Determined|0
7856727|NCT00091832|27254938|P1|Overall Study|Ineligibility Determined|0
7856728|NCT00091832|27254933|P6|Overall Study|Disease Progression|2
7856729|NCT00091832|27254934|P5|Overall Study|Disease Progression|1
7856730|NCT00091832|27254935|P4|Overall Study|Disease Progression|1
7856731|NCT00091832|27254936|P3|Overall Study|Disease Progression|0
7856732|NCT00091832|27254937|P2|Overall Study|Disease Progression|0
7856733|NCT00091832|27254938|P1|Overall Study|Disease Progression|2
7856734|NCT00091832|27254933|P6|Overall Study|Death|6
7856735|NCT00091832|27254934|P5|Overall Study|Death|5
7856736|NCT00091832|27254935|P4|Overall Study|Death|8
7856737|NCT00091832|27254936|P3|Overall Study|Death|5
7856738|NCT00091832|27254937|P2|Overall Study|Death|4
7856739|NCT00091832|27254938|P1|Overall Study|Death|6
7856740|NCT00091832|27254933|P6|Overall Study|Withdrawal by Subject|1
7856741|NCT00091832|27254934|P5|Overall Study|Withdrawal by Subject|3
7856742|NCT00091832|27254935|P4|Overall Study|Withdrawal by Subject|1
7856743|NCT00091832|27254936|P3|Overall Study|Withdrawal by Subject|0
7856744|NCT00091832|27254937|P2|Overall Study|Withdrawal by Subject|5
7856745|NCT00091832|27254938|P1|Overall Study|Withdrawal by Subject|4
7856746|NCT00091832|27254933|P6|Overall Study|Adverse Event|0
7856747|NCT00091832|27254934|P5|Overall Study|Adverse Event|3
7856748|NCT00091832|27254935|P4|Overall Study|Adverse Event|1
7856749|NCT00091832|27254936|P3|Overall Study|Adverse Event|0
7856750|NCT00091832|27254937|P2|Overall Study|Adverse Event|0
7856751|NCT00091832|27254938|P1|Overall Study|Adverse Event|0
7856752|NCT00091832|27254933|P6|Overall Study|Physician Decision|0
7856753|NCT00091832|27254934|P5|Overall Study|Physician Decision|0
7856754|NCT00091832|27254935|P4|Overall Study|Physician Decision|0
7856755|NCT00091832|27254936|P3|Overall Study|Physician Decision|0
7856756|NCT00091832|27254937|P2|Overall Study|Physician Decision|0
7856757|NCT00091832|27254938|P1|Overall Study|Physician Decision|1
7856758|NCT00091819|27255056|P2|Overall Study|Never received study treatment|4
7856759|NCT00091819|27255057|P1|Overall Study|Never received study treatment|3
7856760|NCT00091819|27255056|P2|Overall Study|Other|3
7856761|NCT00091819|27255057|P1|Overall Study|Other|2
7856762|NCT00091819|27255056|P2|Overall Study|Protocol Violation|2
7856763|NCT00091819|27255057|P1|Overall Study|Protocol Violation|1
7856764|NCT00091819|27255056|P2|Overall Study|Withdrawal by Subject|8
7856765|NCT00091819|27255057|P1|Overall Study|Withdrawal by Subject|5
7856766|NCT00091819|27255056|P2|Overall Study|Lost to Follow-up|23
7856767|NCT00091819|27255057|P1|Overall Study|Lost to Follow-up|26
7856768|NCT00091819|27255056|P2|Overall Study|Death|5
7856769|NCT00091819|27255057|P1|Overall Study|Death|4
7856770|NCT00091819|27255056|P2|Overall Study|Adverse Event|1
7856771|NCT00091819|27255057|P1|Overall Study|Adverse Event|1
7856772|NCT00091793|27255065|P2|Overall Study|Other|0
7856773|NCT00091793|27255066|P1|Overall Study|Other|2
7856774|NCT00091793|27255065|P2|Overall Study|Noncompliance|0
7856775|NCT00091793|27255066|P1|Overall Study|Noncompliance|2
7856776|NCT00091793|27255065|P2|Overall Study|Lost to Follow-up|5
7856777|NCT00091793|27255066|P1|Overall Study|Lost to Follow-up|7
7856778|NCT00091793|27255065|P2|Overall Study|Ineligibility determined|0
7856779|NCT00091793|27255066|P1|Overall Study|Ineligibility determined|2
7856780|NCT00091793|27255065|P2|Overall Study|Withdrawal by Subject|15
7856781|NCT00091793|27255066|P1|Overall Study|Withdrawal by Subject|10
7856782|NCT00091793|27255065|P2|Overall Study|Adverse Event|2
7856783|NCT00091793|27255066|P1|Overall Study|Adverse Event|1
7856784|NCT00091572|27255090|P2|Overall Study|Toxicity (Related AE)|9
7856785|NCT00091572|27255091|P1|Overall Study|Toxicity (Related AE)|53
7856786|NCT00091572|27255090|P2|Overall Study|Major Protocol Violation|0
7856787|NCT00091572|27255091|P1|Overall Study|Major Protocol Violation|2
7856788|NCT00091572|27255090|P2|Overall Study|Ongoing (still on treatment)|12
7856789|NCT00091572|27255091|P1|Overall Study|Ongoing (still on treatment)|8
7856790|NCT00091572|27255090|P2|Overall Study|Other Reason|13
7856791|NCT00091572|27255091|P1|Overall Study|Other Reason|6
7856792|NCT00091572|27255090|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
7856793|NCT00091572|27255091|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
7856794|NCT00091572|27255090|P2|Overall Study|Death not due to malignancy/toxicity|3
7856795|NCT00091572|27255091|P1|Overall Study|Death not due to malignancy/toxicity|1
7856796|NCT00091572|27255090|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
7856797|NCT00091572|27255091|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
7856798|NCT00091572|27255090|P2|Overall Study|Lost to Follow-up|1
7856799|NCT00091572|27255091|P1|Overall Study|Lost to Follow-up|1
7856800|NCT00091442|27255122|P2|Overall Study|Other|6
7856801|NCT00091442|27255123|P1|Overall Study|Other|2
7856802|NCT00091442|27255122|P2|Overall Study|Lost to Follow-up|3
7856803|NCT00091442|27255123|P1|Overall Study|Lost to Follow-up|1
7856804|NCT00091442|27255122|P2|Overall Study|Death|7
7856805|NCT00091442|27255123|P1|Overall Study|Death|9
7856806|NCT00091442|27255122|P2|Overall Study|2cycles therapy beyond Complete response|16
7856807|NCT00091442|27255123|P1|Overall Study|2cycles therapy beyond Complete response|9
7856808|NCT00091442|27255122|P2|Overall Study|Adverse Event|48
7856809|NCT00091442|27255123|P1|Overall Study|Adverse Event|29
7856810|NCT00091442|27255122|P2|Overall Study|Withdrawal by Subject|46
7856811|NCT00091442|27255123|P1|Overall Study|Withdrawal by Subject|38
7856812|NCT00091442|27255122|P2|Overall Study|Physician Decision|58
7856813|NCT00091442|27255123|P1|Overall Study|Physician Decision|61
7856814|NCT00091442|27255122|P2|Overall Study|Progressive Disease|189
7856815|NCT00091442|27255123|P1|Overall Study|Progressive Disease|220
7856816|NCT00091390|27255133|P1|Overall Study|No protocol treatment|3
7856817|NCT00091390|27255133|P1|Overall Study|Protocol Violation|1
7856818|NCT00091169|27255158|P2|Overall Study|Not start protocol therapy|17
7856819|NCT00091169|27255159|P1|Overall Study|Not start protocol therapy|26
7856820|NCT00091169|27255158|P2|Overall Study|Other|4
7856821|NCT00091169|27255159|P1|Overall Study|Other|3
7856822|NCT00091169|27255158|P2|Overall Study|Withdrawal by Subject|13
7856823|NCT00091169|27255159|P1|Overall Study|Withdrawal by Subject|10
7856824|NCT00091169|27255158|P2|Overall Study|Death|1
7856825|NCT00091169|27255159|P1|Overall Study|Death|4
7856826|NCT00091169|27255158|P2|Overall Study|Adverse Event|17
7856827|NCT00091169|27255159|P1|Overall Study|Adverse Event|11
7856828|NCT00091169|27255158|P2|Overall Study|Disease progression|1
7856829|NCT00091169|27255159|P1|Overall Study|Disease progression|3
7856830|NCT00091026|27255177|P2|Overall Study|Unknown-never received treatment|1
7856831|NCT00091026|27255178|P1|Overall Study|Unknown-never received treatment|0
7856832|NCT00091026|27255177|P2|Overall Study|Patient withdrew and never received trea|2
7856833|NCT00091026|27255178|P1|Overall Study|Patient withdrew and never received trea|0
7856834|NCT00091026|27255177|P2|Overall Study|Patient deemed non eligible-never receiv|0
7856835|NCT00091026|27255178|P1|Overall Study|Patient deemed non eligible-never receiv|1
7856836|NCT00090987|27255188|P1|Overall Study|Incarcerated|1
7856837|NCT00090987|27255188|P1|Overall Study|Non-compliance|4
7856838|NCT00090987|27255188|P1|Overall Study|alternative therapy|1
7856839|NCT00090987|27255188|P1|Overall Study|Withdrawal by Subject|3
7856840|NCT00090987|27255188|P1|Overall Study|Lack of Efficacy|7
7856841|NCT00090987|27255188|P1|Overall Study|Adverse Event|5
7856842|NCT00090857|27255201|P2|Overall Study|Adverse Event|2
7856843|NCT00090857|27255202|P1|Overall Study|Adverse Event|2
7856844|NCT00090857|27255201|P2|Overall Study|Withdrawal by Subject|0
7856845|NCT00090857|27255202|P1|Overall Study|Withdrawal by Subject|2
7856846|NCT00090857|27255201|P2|Overall Study|Lost to Follow-up|1
7856847|NCT00090857|27255202|P1|Overall Study|Lost to Follow-up|0
7856848|NCT00090779|27255243|P2|Step 3|Off extended study due to study closure|3
7856849|NCT00090779|27255244|P1|Step 3|Off extended study due to study closure|4
7856850|NCT00090779|27255243|P2|Step 3|Initiation of ART and off extended study|2
7856851|NCT00090779|27255244|P1|Step 3|Initiation of ART and off extended study|3
7856852|NCT00090779|27255243|P2|Step 2|Non-compliance to study requirements|1
7856853|NCT00090779|27255244|P1|Step 2|Non-compliance to study requirements|0
7856854|NCT00090779|27255243|P2|Step 2|Subject relocated|1
7856855|NCT00090779|27255244|P1|Step 2|Subject relocated|0
7856856|NCT00090779|27255243|P2|Step 2|Off study per study closure|16
7856857|NCT00090779|27255244|P1|Step 2|Off study per study closure|6
7856858|NCT00090779|27255243|P2|Step 1|Subject relocated|8
7856859|NCT00090779|27255244|P1|Step 1|Subject relocated|2
7856860|NCT00090779|27255243|P2|Step 1|Non-compliance to study requirements|1
7856861|NCT00090779|27255244|P1|Step 1|Non-compliance to study requirements|0
7856862|NCT00090779|27255243|P2|Step 1|Pregnancy|0
7856863|NCT00090779|27255244|P1|Step 1|Pregnancy|1
7856864|NCT00090779|27255243|P2|Step 1|Physician Decision|0
7856865|NCT00090779|27255244|P1|Step 1|Physician Decision|1
7856866|NCT00090779|27255243|P2|Step 1|Death|2
7856867|NCT00090779|27255244|P1|Step 1|Death|0
7856868|NCT00090779|27255243|P2|Step 1|Lost to Follow-up|2
7856869|NCT00090779|27255244|P1|Step 1|Lost to Follow-up|3
7856870|NCT00090779|27255243|P2|Step 1|Withdrawal by Subject|2
7856871|NCT00090779|27255244|P1|Step 1|Withdrawal by Subject|4
7856872|NCT00090766|27255268|P3|Overall Study|Lost to Follow-up|2
7856873|NCT00090766|27255269|P2|Overall Study|Lost to Follow-up|0
7856874|NCT00090766|27255270|P1|Overall Study|Lost to Follow-up|2
7856875|NCT00090766|27255268|P3|Overall Study|Admin|0
7856876|NCT00090766|27255269|P2|Overall Study|Admin|2
7856877|NCT00090766|27255270|P1|Overall Study|Admin|0
7856878|NCT00090766|27255268|P3|Overall Study|Death|0
7856879|NCT00090766|27255269|P2|Overall Study|Death|0
7856880|NCT00090766|27255270|P1|Overall Study|Death|1
7856881|NCT00090766|27255268|P3|Overall Study|Nephrectomy Planned|1
7856882|NCT00090766|27255269|P2|Overall Study|Nephrectomy Planned|0
7856883|NCT00090766|27255270|P1|Overall Study|Nephrectomy Planned|0
7856884|NCT00090753|27255312|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
7856885|NCT00090753|27255313|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
7856886|NCT00090753|27255312|P2|Extended Treatment Period|Mircera Commercialization|93
7856887|NCT00090753|27255313|P1|Extended Treatment Period|Mircera Commercialization|188
7856888|NCT00090753|27255312|P2|Extended Treatment Period|Renal Transplant|12
7856889|NCT00090753|27255313|P1|Extended Treatment Period|Renal Transplant|15
7856890|NCT00090753|27255312|P2|Extended Treatment Period|Lost to Follow-up|1
7856891|NCT00090753|27255313|P1|Extended Treatment Period|Lost to Follow-up|3
7856892|NCT00090753|27255312|P2|Extended Treatment Period|Refused Treatment|12
7856893|NCT00090753|27255313|P1|Extended Treatment Period|Refused Treatment|18
7856894|NCT00090753|27255312|P2|Extended Treatment Period|Lack of Efficacy|0
7856895|NCT00090753|27255313|P1|Extended Treatment Period|Lack of Efficacy|1
7856896|NCT00090753|27255312|P2|Extended Treatment Period|Death|30
7856897|NCT00090753|27255313|P1|Extended Treatment Period|Death|58
7856898|NCT00090753|27255312|P2|Extended Treatment Period|Adverse Event|0
7856899|NCT00090753|27255313|P1|Extended Treatment Period|Adverse Event|11
7856900|NCT00090753|27255312|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
7856901|NCT00090753|27255313|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
7856902|NCT00090753|27255312|P2|First Treatment Period|Mircera Commercialization|0
7856903|NCT00090753|27255313|P1|First Treatment Period|Mircera Commercialization|1
7856904|NCT00090753|27255312|P2|First Treatment Period|Renal Transplant|50
7856905|NCT00090753|27255313|P1|First Treatment Period|Renal Transplant|70
7856906|NCT00090753|27255312|P2|First Treatment Period|Lost to Follow-up|4
7856907|NCT00090753|27255313|P1|First Treatment Period|Lost to Follow-up|4
7856908|NCT00090753|27255312|P2|First Treatment Period|Refused Treatment|25
7856909|NCT00090753|27255313|P1|First Treatment Period|Refused Treatment|32
7856910|NCT00090753|27255312|P2|First Treatment Period|Lack of Efficacy|1
7856911|NCT00090753|27255313|P1|First Treatment Period|Lack of Efficacy|2
7856912|NCT00090753|27255312|P2|First Treatment Period|Death|62
7856913|NCT00090753|27255313|P1|First Treatment Period|Death|88
7856914|NCT00090753|27255312|P2|First Treatment Period|Adverse Event|8
7856915|NCT00090753|27255313|P1|First Treatment Period|Adverse Event|20
7856916|NCT00090610|27255323|P2|Overall Study|Withdrawal by Subject|1
7856917|NCT00090610|27255324|P1|Overall Study|Withdrawal by Subject|1
7856918|NCT00090584|27255340|P2|Baseline to 8 Months|Lost to Follow-up|41
7856919|NCT00090584|27255341|P1|Baseline to 8 Months|Lost to Follow-up|44
7856920|NCT00090584|27255340|P2|Baseline to 10 Weeks|Lost to Follow-up|12
7856921|NCT00090584|27255341|P1|Baseline to 10 Weeks|Lost to Follow-up|15
7856922|NCT00090519|27255373|P2|Overall Study|Sponsor Decision|1
7856923|NCT00090519|27255374|P1|Overall Study|Sponsor Decision|3
7856924|NCT00090519|27255373|P2|Overall Study|Physician Decision|3
7856925|NCT00090519|27255374|P1|Overall Study|Physician Decision|2
7856926|NCT00090519|27255373|P2|Overall Study|Withdrawal by Subject|29
7856927|NCT00090519|27255374|P1|Overall Study|Withdrawal by Subject|28
7856928|NCT00090519|27255373|P2|Overall Study|Lost to Follow-up|29
7856929|NCT00090519|27255374|P1|Overall Study|Lost to Follow-up|26
7856930|NCT00090519|27255373|P2|Overall Study|Death|9
7856931|NCT00090519|27255374|P1|Overall Study|Death|9
7856932|NCT00090519|27255373|P2|Overall Study|Adverse Event|4
7856933|NCT00090519|27255374|P1|Overall Study|Adverse Event|5
7856934|NCT00090493|27255398|P1|Overall Study|Physician Decision|2
7856935|NCT00090363|27255405|P3|Overall Study|Continuing on study off treatment|16
7856936|NCT00090363|27255406|P2|Overall Study|Continuing on study off treatment|13
7856937|NCT00090363|27255407|P1|Overall Study|Continuing on study off treatment|14
7856938|NCT00090363|27255405|P3|Overall Study|Reasons not specified|1
7856939|NCT00090363|27255406|P2|Overall Study|Reasons not specified|1
7856940|NCT00090363|27255407|P1|Overall Study|Reasons not specified|2
7856941|NCT00090363|27255405|P3|Overall Study|Consent expired|9
7856942|NCT00090363|27255406|P2|Overall Study|Consent expired|10
7856943|NCT00090363|27255407|P1|Overall Study|Consent expired|7
7856944|NCT00090363|27255405|P3|Overall Study|Eligibility criteria not fulfilled|1
7856945|NCT00090363|27255406|P2|Overall Study|Eligibility criteria not fulfilled|0
7856946|NCT00090363|27255407|P1|Overall Study|Eligibility criteria not fulfilled|0
7856947|NCT00090363|27255405|P3|Overall Study|Study-specific discontinuation criteria|62
7856948|NCT00090363|27255406|P2|Overall Study|Study-specific discontinuation criteria|74
7856949|NCT00090363|27255407|P1|Overall Study|Study-specific discontinuation criteria|75
7856950|NCT00090363|27255405|P3|Overall Study|Withdrawal by Subject|6
7856951|NCT00090363|27255406|P2|Overall Study|Withdrawal by Subject|7
7856952|NCT00090363|27255407|P1|Overall Study|Withdrawal by Subject|7
7856953|NCT00090363|27255405|P3|Overall Study|Lost to Follow-up|1
7856954|NCT00090363|27255406|P2|Overall Study|Lost to Follow-up|2
7856955|NCT00090363|27255407|P1|Overall Study|Lost to Follow-up|1
7856956|NCT00090545|27255429|P2|Overall Study|Adverse Event|2
7856957|NCT00090545|27255430|P1|Overall Study|Adverse Event|0
7856958|NCT00090545|27255429|P2|Overall Study|Death|1
7856959|NCT00090545|27255430|P1|Overall Study|Death|0
7856960|NCT00090545|27255429|P2|Overall Study|Refused further treatment|4
7856961|NCT00090545|27255430|P1|Overall Study|Refused further treatment|1
7856962|NCT00090545|27255429|P2|Overall Study|Disease progression on study|17
7856963|NCT00090545|27255430|P1|Overall Study|Disease progression on study|21
7856964|NCT00090285|27255450|P6|Long-term Follow-up (EXT2)|Physician Decision|5
7856965|NCT00090285|27255451|P5|Long-term Follow-up (EXT2)|Physician Decision|6
7856966|NCT00090285|27255452|P4|Long-term Follow-up (EXT2)|Physician Decision|0
7856967|NCT00090285|27255453|P3|Long-term Follow-up (EXT2)|Physician Decision|0
7856968|NCT00090285|27255454|P2|Long-term Follow-up (EXT2)|Physician Decision|0
7856969|NCT00090285|27255455|P1|Long-term Follow-up (EXT2)|Physician Decision|0
7856970|NCT00090285|27255450|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
7856971|NCT00090285|27255451|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
7856972|NCT00090285|27255452|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7856973|NCT00090285|27255453|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7856974|NCT00090285|27255454|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7856975|NCT00090285|27255455|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7856976|NCT00090285|27255450|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
7856977|NCT00090285|27255451|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
7856978|NCT00090285|27255452|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7856979|NCT00090285|27255453|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7856980|NCT00090285|27255454|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7856981|NCT00090285|27255455|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7856982|NCT00090285|27255450|P6|Long-term Follow-up (EXT2)|Adverse Event|2
7856983|NCT00090285|27255451|P5|Long-term Follow-up (EXT2)|Adverse Event|5
7856984|NCT00090285|27255452|P4|Long-term Follow-up (EXT2)|Adverse Event|0
7856985|NCT00090285|27255453|P3|Long-term Follow-up (EXT2)|Adverse Event|0
7856986|NCT00090285|27255454|P2|Long-term Follow-up (EXT2)|Adverse Event|0
7856987|NCT00090285|27255455|P1|Long-term Follow-up (EXT2)|Adverse Event|0
7856988|NCT00090285|27255450|P6|Extension 1|Moved|0
7856989|NCT00090285|27255451|P5|Extension 1|Moved|0
7856990|NCT00090285|27255452|P4|Extension 1|Moved|0
7856991|NCT00090285|27255453|P3|Extension 1|Moved|3
7856992|NCT00090285|27255454|P2|Extension 1|Moved|0
7856993|NCT00090285|27255455|P1|Extension 1|Moved|0
7856994|NCT00090285|27255450|P6|Extension 1|Other|0
7856995|NCT00090285|27255451|P5|Extension 1|Other|0
7856996|NCT00090285|27255452|P4|Extension 1|Other|0
7856997|NCT00090285|27255453|P3|Extension 1|Other|4
7856998|NCT00090285|27255454|P2|Extension 1|Other|0
7856999|NCT00090285|27255455|P1|Extension 1|Other|0
7857000|NCT00090285|27255450|P6|Extension 1|Withdrawal by Subject|0
7857001|NCT00090285|27255451|P5|Extension 1|Withdrawal by Subject|0
7857002|NCT00090285|27255452|P4|Extension 1|Withdrawal by Subject|1
7857003|NCT00090285|27255453|P3|Extension 1|Withdrawal by Subject|13
7857004|NCT00090285|27255454|P2|Extension 1|Withdrawal by Subject|0
7857005|NCT00090285|27255455|P1|Extension 1|Withdrawal by Subject|0
7857006|NCT00090285|27255450|P6|Extension 1|Lost to Follow-up|0
7857007|NCT00090285|27255451|P5|Extension 1|Lost to Follow-up|0
7857008|NCT00090285|27255452|P4|Extension 1|Lost to Follow-up|0
7857009|NCT00090285|27255453|P3|Extension 1|Lost to Follow-up|35
7857010|NCT00090285|27255454|P2|Extension 1|Lost to Follow-up|0
7857011|NCT00090285|27255455|P1|Extension 1|Lost to Follow-up|0
7857012|NCT00090285|27255450|P6|Extension 1|Adverse Event|0
7857013|NCT00090285|27255451|P5|Extension 1|Adverse Event|0
7857014|NCT00090285|27255452|P4|Extension 1|Adverse Event|0
7857015|NCT00090285|27255453|P3|Extension 1|Adverse Event|2
7857016|NCT00090285|27255454|P2|Extension 1|Adverse Event|0
7857017|NCT00090285|27255455|P1|Extension 1|Adverse Event|0
7857018|NCT00090285|27255450|P6|Base Study Follow-up Period|Subject Incarcerated|0
7857019|NCT00090285|27255451|P5|Base Study Follow-up Period|Subject Incarcerated|0
7857020|NCT00090285|27255452|P4|Base Study Follow-up Period|Subject Incarcerated|0
7857021|NCT00090285|27255453|P3|Base Study Follow-up Period|Subject Incarcerated|0
7857022|NCT00090285|27255454|P2|Base Study Follow-up Period|Subject Incarcerated|2
7857023|NCT00090285|27255455|P1|Base Study Follow-up Period|Subject Incarcerated|0
7857024|NCT00090285|27255450|P6|Base Study Follow-up Period|Uncooperative|0
7857025|NCT00090285|27255451|P5|Base Study Follow-up Period|Uncooperative|0
7857026|NCT00090285|27255452|P4|Base Study Follow-up Period|Uncooperative|0
7857027|NCT00090285|27255453|P3|Base Study Follow-up Period|Uncooperative|0
7857028|NCT00090285|27255454|P2|Base Study Follow-up Period|Uncooperative|4
7857029|NCT00090285|27255455|P1|Base Study Follow-up Period|Uncooperative|3
7857030|NCT00090285|27255450|P6|Base Study Follow-up Period|Protocol Violation|0
7857031|NCT00090285|27255451|P5|Base Study Follow-up Period|Protocol Violation|0
7857032|NCT00090285|27255452|P4|Base Study Follow-up Period|Protocol Violation|0
7857033|NCT00090285|27255453|P3|Base Study Follow-up Period|Protocol Violation|0
7857034|NCT00090285|27255454|P2|Base Study Follow-up Period|Protocol Violation|0
7857035|NCT00090285|27255455|P1|Base Study Follow-up Period|Protocol Violation|1
7857036|NCT00090285|27255450|P6|Base Study Follow-up Period|Other|0
7857037|NCT00090285|27255451|P5|Base Study Follow-up Period|Other|0
7857038|NCT00090285|27255452|P4|Base Study Follow-up Period|Other|0
7857039|NCT00090285|27255453|P3|Base Study Follow-up Period|Other|0
7857040|NCT00090285|27255454|P2|Base Study Follow-up Period|Other|0
7857041|NCT00090285|27255455|P1|Base Study Follow-up Period|Other|2
7857042|NCT00090285|27255450|P6|Base Study Follow-up Period|Moved|0
7857043|NCT00090285|27255451|P5|Base Study Follow-up Period|Moved|0
7857044|NCT00090285|27255452|P4|Base Study Follow-up Period|Moved|0
7857045|NCT00090285|27255453|P3|Base Study Follow-up Period|Moved|0
7857046|NCT00090285|27255454|P2|Base Study Follow-up Period|Moved|36
7857047|NCT00090285|27255455|P1|Base Study Follow-up Period|Moved|41
7857048|NCT00090285|27255450|P6|Base Study Follow-up Period|Withdrawal by Subject|0
7857049|NCT00090285|27255451|P5|Base Study Follow-up Period|Withdrawal by Subject|0
7857050|NCT00090285|27255452|P4|Base Study Follow-up Period|Withdrawal by Subject|0
7857051|NCT00090285|27255453|P3|Base Study Follow-up Period|Withdrawal by Subject|0
7857052|NCT00090285|27255454|P2|Base Study Follow-up Period|Withdrawal by Subject|64
7857053|NCT00090285|27255455|P1|Base Study Follow-up Period|Withdrawal by Subject|53
7857054|NCT00090285|27255450|P6|Base Study Follow-up Period|Lost to Follow-up|0
7857055|NCT00090285|27255451|P5|Base Study Follow-up Period|Lost to Follow-up|0
7857056|NCT00090285|27255452|P4|Base Study Follow-up Period|Lost to Follow-up|0
7857057|NCT00090285|27255453|P3|Base Study Follow-up Period|Lost to Follow-up|0
7857058|NCT00090285|27255454|P2|Base Study Follow-up Period|Lost to Follow-up|226
7857059|NCT00090285|27255455|P1|Base Study Follow-up Period|Lost to Follow-up|232
7857060|NCT00090285|27255450|P6|Base Study Follow-up Period|Adverse Event|0
7857061|NCT00090285|27255451|P5|Base Study Follow-up Period|Adverse Event|0
7857062|NCT00090285|27255452|P4|Base Study Follow-up Period|Adverse Event|0
7857063|NCT00090285|27255453|P3|Base Study Follow-up Period|Adverse Event|0
7857064|NCT00090285|27255454|P2|Base Study Follow-up Period|Adverse Event|10
7857065|NCT00090285|27255455|P1|Base Study Follow-up Period|Adverse Event|3
7857066|NCT00090285|27255450|P6|Base Study Vaccination Period|HIV positive|0
7857067|NCT00090285|27255451|P5|Base Study Vaccination Period|HIV positive|0
7857068|NCT00090285|27255452|P4|Base Study Vaccination Period|HIV positive|0
7857069|NCT00090285|27255453|P3|Base Study Vaccination Period|HIV positive|0
7857070|NCT00090285|27255454|P2|Base Study Vaccination Period|HIV positive|1
7857071|NCT00090285|27255455|P1|Base Study Vaccination Period|HIV positive|1
7857072|NCT00090285|27255450|P6|Base Study Vaccination Period|Subject Incarcerated|0
7857073|NCT00090285|27255451|P5|Base Study Vaccination Period|Subject Incarcerated|0
7857074|NCT00090285|27255452|P4|Base Study Vaccination Period|Subject Incarcerated|0
7857075|NCT00090285|27255453|P3|Base Study Vaccination Period|Subject Incarcerated|0
7857076|NCT00090285|27255454|P2|Base Study Vaccination Period|Subject Incarcerated|2
7857077|NCT00090285|27255455|P1|Base Study Vaccination Period|Subject Incarcerated|2
7857078|NCT00090285|27255450|P6|Base Study Vaccination Period|Other|0
7857079|NCT00090285|27255451|P5|Base Study Vaccination Period|Other|0
7857080|NCT00090285|27255452|P4|Base Study Vaccination Period|Other|0
7857081|NCT00090285|27255453|P3|Base Study Vaccination Period|Other|0
7857082|NCT00090285|27255454|P2|Base Study Vaccination Period|Other|2
7857083|NCT00090285|27255455|P1|Base Study Vaccination Period|Other|2
7857084|NCT00090285|27255450|P6|Base Study Vaccination Period|Site Terminated|0
7857085|NCT00090285|27255451|P5|Base Study Vaccination Period|Site Terminated|0
7857086|NCT00090285|27255452|P4|Base Study Vaccination Period|Site Terminated|0
7857087|NCT00090285|27255453|P3|Base Study Vaccination Period|Site Terminated|0
7857088|NCT00090285|27255454|P2|Base Study Vaccination Period|Site Terminated|0
7857089|NCT00090285|27255455|P1|Base Study Vaccination Period|Site Terminated|1
7857090|NCT00090285|27255450|P6|Base Study Vaccination Period|Moved|0
7857091|NCT00090285|27255451|P5|Base Study Vaccination Period|Moved|0
7857092|NCT00090285|27255452|P4|Base Study Vaccination Period|Moved|0
7857093|NCT00090285|27255453|P3|Base Study Vaccination Period|Moved|0
7857094|NCT00090285|27255454|P2|Base Study Vaccination Period|Moved|21
7857095|NCT00090285|27255455|P1|Base Study Vaccination Period|Moved|20
7857096|NCT00090285|27255450|P6|Base Study Vaccination Period|Uncooperative|0
7857097|NCT00090285|27255451|P5|Base Study Vaccination Period|Uncooperative|0
7857098|NCT00090285|27255452|P4|Base Study Vaccination Period|Uncooperative|0
7857099|NCT00090285|27255453|P3|Base Study Vaccination Period|Uncooperative|0
7857100|NCT00090285|27255454|P2|Base Study Vaccination Period|Uncooperative|2
7857101|NCT00090285|27255455|P1|Base Study Vaccination Period|Uncooperative|2
7857102|NCT00090285|27255450|P6|Base Study Vaccination Period|Withdrawal by Subject|0
7857103|NCT00090285|27255451|P5|Base Study Vaccination Period|Withdrawal by Subject|0
7857186|NCT00090220|27255536|P4|Extension 1 (EXT1)|Protocol Violation|1
7857104|NCT00090285|27255452|P4|Base Study Vaccination Period|Withdrawal by Subject|0
7857105|NCT00090285|27255453|P3|Base Study Vaccination Period|Withdrawal by Subject|0
7857106|NCT00090285|27255454|P2|Base Study Vaccination Period|Withdrawal by Subject|69
7857107|NCT00090285|27255455|P1|Base Study Vaccination Period|Withdrawal by Subject|64
7857108|NCT00090285|27255450|P6|Base Study Vaccination Period|Protocol Violation|0
7857109|NCT00090285|27255451|P5|Base Study Vaccination Period|Protocol Violation|0
7857110|NCT00090285|27255452|P4|Base Study Vaccination Period|Protocol Violation|0
7857111|NCT00090285|27255453|P3|Base Study Vaccination Period|Protocol Violation|0
7857112|NCT00090285|27255454|P2|Base Study Vaccination Period|Protocol Violation|3
7857113|NCT00090285|27255455|P1|Base Study Vaccination Period|Protocol Violation|2
7857114|NCT00090285|27255450|P6|Base Study Vaccination Period|Lost to Follow-up|0
7857115|NCT00090285|27255451|P5|Base Study Vaccination Period|Lost to Follow-up|0
7857116|NCT00090285|27255452|P4|Base Study Vaccination Period|Lost to Follow-up|0
7857117|NCT00090285|27255453|P3|Base Study Vaccination Period|Lost to Follow-up|0
7857118|NCT00090285|27255454|P2|Base Study Vaccination Period|Lost to Follow-up|112
7857119|NCT00090285|27255455|P1|Base Study Vaccination Period|Lost to Follow-up|111
7857120|NCT00090285|27255450|P6|Base Study Vaccination Period|Adverse Event|0
7857121|NCT00090285|27255451|P5|Base Study Vaccination Period|Adverse Event|0
7857122|NCT00090285|27255452|P4|Base Study Vaccination Period|Adverse Event|0
7857123|NCT00090285|27255453|P3|Base Study Vaccination Period|Adverse Event|0
7857124|NCT00090285|27255454|P2|Base Study Vaccination Period|Adverse Event|4
7857125|NCT00090285|27255455|P1|Base Study Vaccination Period|Adverse Event|2
7857126|NCT00090285|27255450|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
7857127|NCT00090285|27255451|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
7857128|NCT00090285|27255452|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
7857129|NCT00090285|27255453|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
7857130|NCT00090285|27255454|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
7857131|NCT00090285|27255455|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
7857132|NCT00090259|27255492|P2|Overall Study|Investigator site closed|7
7857133|NCT00090259|27255493|P1|Overall Study|Investigator site closed|11
7857134|NCT00090259|27255492|P2|Overall Study|Withdrawal by Subject|15
7857135|NCT00090259|27255493|P1|Overall Study|Withdrawal by Subject|21
7857136|NCT00090259|27255492|P2|Overall Study|Lost to Follow-up|26
7857137|NCT00090259|27255493|P1|Overall Study|Lost to Follow-up|30
7857138|NCT00090233|27255509|P2|Overall Study|Data not available at data cut-off point|1563
7857139|NCT00090233|27255510|P1|Overall Study|Data not available at data cut-off point|1552
7857140|NCT00090233|27255509|P2|Overall Study|Other|1160
7857141|NCT00090233|27255510|P1|Overall Study|Other|1211
7857142|NCT00090233|27255509|P2|Overall Study|Moved|189
7857143|NCT00090233|27255510|P1|Overall Study|Moved|203
7857144|NCT00090233|27255509|P2|Overall Study|Withdrawal by Subject|211
7857145|NCT00090233|27255510|P1|Overall Study|Withdrawal by Subject|182
7857146|NCT00090233|27255509|P2|Overall Study|Protocol Violation|1022
7857147|NCT00090233|27255510|P1|Overall Study|Protocol Violation|960
7857148|NCT00090233|27255509|P2|Overall Study|Lost to Follow-up|95
7857149|NCT00090233|27255510|P1|Overall Study|Lost to Follow-up|68
7857150|NCT00090233|27255509|P2|Overall Study|Adverse Event|198
7857151|NCT00090233|27255510|P1|Overall Study|Adverse Event|214
7857152|NCT00090233|27255509|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
7857153|NCT00090233|27255510|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
7857154|NCT00090220|27255534|P6|Long-term Follow-up (EXT2)|Other|0
7857155|NCT00090220|27255535|P5|Long-term Follow-up (EXT2)|Other|1
7857156|NCT00090220|27255536|P4|Long-term Follow-up (EXT2)|Other|0
7857157|NCT00090220|27255537|P3|Long-term Follow-up (EXT2)|Other|0
7857158|NCT00090220|27255538|P2|Long-term Follow-up (EXT2)|Other|0
7857159|NCT00090220|27255539|P1|Long-term Follow-up (EXT2)|Other|0
7857160|NCT00090220|27255534|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
7857161|NCT00090220|27255535|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
7857162|NCT00090220|27255536|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7857163|NCT00090220|27255537|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7857164|NCT00090220|27255538|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7857165|NCT00090220|27255539|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7857166|NCT00090220|27255534|P6|Long-term Follow-up (EXT2)|Death|1
7857167|NCT00090220|27255535|P5|Long-term Follow-up (EXT2)|Death|1
7857168|NCT00090220|27255536|P4|Long-term Follow-up (EXT2)|Death|0
7857169|NCT00090220|27255537|P3|Long-term Follow-up (EXT2)|Death|0
7857170|NCT00090220|27255538|P2|Long-term Follow-up (EXT2)|Death|0
7857171|NCT00090220|27255539|P1|Long-term Follow-up (EXT2)|Death|0
7857172|NCT00090220|27255534|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
7857173|NCT00090220|27255535|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
7857174|NCT00090220|27255536|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7857175|NCT00090220|27255537|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7857176|NCT00090220|27255538|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7857177|NCT00090220|27255539|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7857178|NCT00090220|27255534|P6|Extension 1 (EXT1)|Other reason|0
7857179|NCT00090220|27255535|P5|Extension 1 (EXT1)|Other reason|0
7857180|NCT00090220|27255536|P4|Extension 1 (EXT1)|Other reason|0
7857181|NCT00090220|27255537|P3|Extension 1 (EXT1)|Other reason|2
7857182|NCT00090220|27255538|P2|Extension 1 (EXT1)|Other reason|0
7857183|NCT00090220|27255539|P1|Extension 1 (EXT1)|Other reason|0
7857184|NCT00090220|27255534|P6|Extension 1 (EXT1)|Protocol Violation|0
7857185|NCT00090220|27255535|P5|Extension 1 (EXT1)|Protocol Violation|0
7857187|NCT00090220|27255537|P3|Extension 1 (EXT1)|Protocol Violation|0
7857188|NCT00090220|27255538|P2|Extension 1 (EXT1)|Protocol Violation|0
7857189|NCT00090220|27255539|P1|Extension 1 (EXT1)|Protocol Violation|0
7857190|NCT00090220|27255534|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
7857191|NCT00090220|27255535|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
7857192|NCT00090220|27255536|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
7857193|NCT00090220|27255537|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
7857194|NCT00090220|27255538|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
7857195|NCT00090220|27255539|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
7857196|NCT00090220|27255534|P6|Extension 1 (EXT1)|Moved|0
7857197|NCT00090220|27255535|P5|Extension 1 (EXT1)|Moved|0
7857198|NCT00090220|27255536|P4|Extension 1 (EXT1)|Moved|1
7857199|NCT00090220|27255537|P3|Extension 1 (EXT1)|Moved|2
7857200|NCT00090220|27255538|P2|Extension 1 (EXT1)|Moved|0
7857201|NCT00090220|27255539|P1|Extension 1 (EXT1)|Moved|0
7857202|NCT00090220|27255534|P6|Extension 1 (EXT1)|Lost to Follow-up|0
7857203|NCT00090220|27255535|P5|Extension 1 (EXT1)|Lost to Follow-up|0
7857204|NCT00090220|27255536|P4|Extension 1 (EXT1)|Lost to Follow-up|0
7857205|NCT00090220|27255537|P3|Extension 1 (EXT1)|Lost to Follow-up|22
7857206|NCT00090220|27255538|P2|Extension 1 (EXT1)|Lost to Follow-up|0
7857207|NCT00090220|27255539|P1|Extension 1 (EXT1)|Lost to Follow-up|0
7857208|NCT00090220|27255534|P6|Extension 1 (EXT1)|Adverse Event|0
7857209|NCT00090220|27255535|P5|Extension 1 (EXT1)|Adverse Event|0
7857210|NCT00090220|27255536|P4|Extension 1 (EXT1)|Adverse Event|0
7857211|NCT00090220|27255537|P3|Extension 1 (EXT1)|Adverse Event|4
7857212|NCT00090220|27255538|P2|Extension 1 (EXT1)|Adverse Event|0
7857213|NCT00090220|27255539|P1|Extension 1 (EXT1)|Adverse Event|0
7857214|NCT00090220|27255534|P6|Base Study Follow-up Period|Other|0
7857215|NCT00090220|27255535|P5|Base Study Follow-up Period|Other|0
7857216|NCT00090220|27255536|P4|Base Study Follow-up Period|Other|0
7857217|NCT00090220|27255537|P3|Base Study Follow-up Period|Other|0
7857218|NCT00090220|27255538|P2|Base Study Follow-up Period|Other|21
7857219|NCT00090220|27255539|P1|Base Study Follow-up Period|Other|19
7857220|NCT00090220|27255534|P6|Base Study Follow-up Period|Patient Moved|0
7857221|NCT00090220|27255535|P5|Base Study Follow-up Period|Patient Moved|0
7857222|NCT00090220|27255536|P4|Base Study Follow-up Period|Patient Moved|0
7857223|NCT00090220|27255537|P3|Base Study Follow-up Period|Patient Moved|0
7857224|NCT00090220|27255538|P2|Base Study Follow-up Period|Patient Moved|28
7857225|NCT00090220|27255539|P1|Base Study Follow-up Period|Patient Moved|20
7857226|NCT00090220|27255534|P6|Base Study Follow-up Period|Withdrawal by Subject|0
7857227|NCT00090220|27255535|P5|Base Study Follow-up Period|Withdrawal by Subject|0
7857228|NCT00090220|27255536|P4|Base Study Follow-up Period|Withdrawal by Subject|0
7857229|NCT00090220|27255537|P3|Base Study Follow-up Period|Withdrawal by Subject|0
7857230|NCT00090220|27255538|P2|Base Study Follow-up Period|Withdrawal by Subject|36
7857231|NCT00090220|27255539|P1|Base Study Follow-up Period|Withdrawal by Subject|27
7857232|NCT00090220|27255534|P6|Base Study Follow-up Period|Lost to Follow-up|0
7857233|NCT00090220|27255535|P5|Base Study Follow-up Period|Lost to Follow-up|0
7857234|NCT00090220|27255536|P4|Base Study Follow-up Period|Lost to Follow-up|0
7857235|NCT00090220|27255537|P3|Base Study Follow-up Period|Lost to Follow-up|0
7857236|NCT00090220|27255538|P2|Base Study Follow-up Period|Lost to Follow-up|78
7857237|NCT00090220|27255539|P1|Base Study Follow-up Period|Lost to Follow-up|88
7857238|NCT00090220|27255534|P6|Base Study Follow-up Period|Adverse Event|0
7857239|NCT00090220|27255535|P5|Base Study Follow-up Period|Adverse Event|0
7857240|NCT00090220|27255536|P4|Base Study Follow-up Period|Adverse Event|0
7857241|NCT00090220|27255537|P3|Base Study Follow-up Period|Adverse Event|0
7857242|NCT00090220|27255538|P2|Base Study Follow-up Period|Adverse Event|1
7857243|NCT00090220|27255539|P1|Base Study Follow-up Period|Adverse Event|6
7857244|NCT00090220|27255534|P6|Base Study Vaccination Period|Other|0
7857245|NCT00090220|27255535|P5|Base Study Vaccination Period|Other|0
7857246|NCT00090220|27255536|P4|Base Study Vaccination Period|Other|0
7857247|NCT00090220|27255537|P3|Base Study Vaccination Period|Other|0
7857248|NCT00090220|27255538|P2|Base Study Vaccination Period|Other|4
7857249|NCT00090220|27255539|P1|Base Study Vaccination Period|Other|4
7857250|NCT00090220|27255534|P6|Base Study Vaccination Period|Patient Moved|0
7857251|NCT00090220|27255535|P5|Base Study Vaccination Period|Patient Moved|0
7857252|NCT00090220|27255536|P4|Base Study Vaccination Period|Patient Moved|0
7857253|NCT00090220|27255537|P3|Base Study Vaccination Period|Patient Moved|0
7857254|NCT00090220|27255538|P2|Base Study Vaccination Period|Patient Moved|2
7857255|NCT00090220|27255539|P1|Base Study Vaccination Period|Patient Moved|6
7857256|NCT00090220|27255534|P6|Base Study Vaccination Period|Withdrawal by Subject|0
7857257|NCT00090220|27255535|P5|Base Study Vaccination Period|Withdrawal by Subject|0
7857258|NCT00090220|27255536|P4|Base Study Vaccination Period|Withdrawal by Subject|0
7857259|NCT00090220|27255537|P3|Base Study Vaccination Period|Withdrawal by Subject|0
7857260|NCT00090220|27255538|P2|Base Study Vaccination Period|Withdrawal by Subject|27
7857261|NCT00090220|27255539|P1|Base Study Vaccination Period|Withdrawal by Subject|23
7857262|NCT00090220|27255534|P6|Base Study Vaccination Period|Lost to Follow-up|0
7857263|NCT00090220|27255535|P5|Base Study Vaccination Period|Lost to Follow-up|0
7857264|NCT00090220|27255536|P4|Base Study Vaccination Period|Lost to Follow-up|0
7857265|NCT00090220|27255537|P3|Base Study Vaccination Period|Lost to Follow-up|0
7857266|NCT00090220|27255538|P2|Base Study Vaccination Period|Lost to Follow-up|28
7857267|NCT00090220|27255539|P1|Base Study Vaccination Period|Lost to Follow-up|24
7857268|NCT00090220|27255534|P6|Base Study Vaccination Period|Adverse Event|0
7857269|NCT00090220|27255535|P5|Base Study Vaccination Period|Adverse Event|0
7857270|NCT00090220|27255536|P4|Base Study Vaccination Period|Adverse Event|0
7857271|NCT00090220|27255537|P3|Base Study Vaccination Period|Adverse Event|0
7857272|NCT00090220|27255538|P2|Base Study Vaccination Period|Adverse Event|1
7857273|NCT00090220|27255539|P1|Base Study Vaccination Period|Adverse Event|6
7857274|NCT00090220|27255534|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
7857275|NCT00090220|27255535|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
7857276|NCT00090220|27255536|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
7857277|NCT00090220|27255537|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
7857278|NCT00090220|27255538|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
7857279|NCT00090220|27255539|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
7857280|NCT00090402|27255634|P3|Overall Study|stopped taking study medication|1
7857281|NCT00090402|27255635|P2|Overall Study|stopped taking study medication|0
7857282|NCT00090402|27255636|P1|Overall Study|stopped taking study medication|1
7857283|NCT00090402|27255634|P3|Overall Study|subject moved|0
7857284|NCT00090402|27255635|P2|Overall Study|subject moved|1
7857285|NCT00090402|27255636|P1|Overall Study|subject moved|0
7857286|NCT00090402|27255634|P3|Overall Study|Death|0
7857287|NCT00090402|27255635|P2|Overall Study|Death|1
7857288|NCT00090402|27255636|P1|Overall Study|Death|1
7857289|NCT00090142|27255650|P2|Treatment Period II|Other|0
7857290|NCT00090142|27255651|P1|Treatment Period II|Other|1
7857291|NCT00090142|27255650|P2|Treatment Period I|Other|1
7857292|NCT00090142|27255651|P1|Treatment Period I|Other|0
7857293|NCT00090142|27255650|P2|Treatment Period I|Withdrawal by Subject|0
7857294|NCT00090142|27255651|P1|Treatment Period I|Withdrawal by Subject|2
7857295|NCT00090142|27255650|P2|Treatment Period I|Protocol Violation|0
7857296|NCT00090142|27255651|P1|Treatment Period I|Protocol Violation|2
7857297|NCT00090142|27255650|P2|Treatment Period I|Lost to Follow-up|2
7857298|NCT00090142|27255651|P1|Treatment Period I|Lost to Follow-up|1
7857299|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Other|0
7857300|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Other|1
7857301|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Other|0
7857302|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Jailed|0
7857303|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Jailed|1
7857304|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Jailed|0
7857305|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
7857306|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
7857307|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
7857308|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Depression|0
7857309|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Depression|1
7857310|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Depression|0
7857311|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
7857312|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
7857313|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
7857314|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
7857315|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
7857316|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
7857317|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Back Pain|0
7857318|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Back Pain|1
7857319|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Back Pain|0
7857320|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
7857321|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
7857322|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
7857323|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
7857324|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
7857325|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
7857326|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
7857327|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
7857328|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
7857329|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Gyneomastia|0
7857330|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Gyneomastia|0
7857331|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Gyneomastia|1
7857332|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Death|1
7857333|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Death|0
7857334|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Death|1
7857335|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
7857336|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
7857337|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
7857338|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Enrollment Error|2
7857339|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Enrollment Error|0
7857340|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Enrollment Error|1
7857341|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Loss of Libido|0
7857342|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Loss of Libido|0
7857343|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Loss of Libido|1
7857344|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
7857345|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
7857346|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
7857347|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
7857348|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
7857349|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
7857350|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
7857351|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
7857352|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
7857353|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
7857354|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
7857355|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
7857356|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Participant relocated|1
7857357|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Participant relocated|3
7857358|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Participant relocated|2
7857359|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
7857360|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
7857361|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
7857362|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Loss of Contact|2
7857363|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Loss of Contact|0
7857364|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Loss of Contact|4
7857365|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
7857366|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
7857367|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
7857368|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
7857369|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
7857370|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
7857371|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Protocol Violation|17
7857372|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Protocol Violation|18
7857373|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Protocol Violation|18
7857374|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
7857375|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
7857376|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
7857377|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
7857378|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
7857379|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
7857380|NCT00090103|27255682|P3|16-Week Safety Follow-up Period|Adverse Event|44
7857381|NCT00090103|27255683|P2|16-Week Safety Follow-up Period|Adverse Event|39
7857382|NCT00090103|27255684|P1|16-Week Safety Follow-up Period|Adverse Event|34
7857383|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
7857384|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
7857385|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
7857386|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
7857387|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
7857388|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
7857389|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
7857390|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
7857391|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
7857392|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
7857393|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
7857394|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
7857395|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
7857396|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
7857397|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
7857398|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
7857399|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
7857400|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
7857401|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
7857402|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
7857403|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
7857404|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
7857405|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
7857406|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
7857407|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
7857408|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
7857409|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
7857410|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
7857411|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
7857412|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
7857413|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
7857414|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
7857415|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
7857416|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
7857417|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
7857418|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
7857419|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
7857420|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
7857421|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
7857422|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
7857423|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
7857424|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
7857425|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
7857426|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
7857427|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
7857428|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
7857429|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
7857430|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
7857431|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
7857432|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
7857433|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
7857434|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
7857435|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
7857436|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
7857437|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
7857438|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
7857439|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
7857440|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
7857441|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
7857442|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
7857443|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
7857444|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
7857445|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
7857446|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
7857447|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
7857448|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
7857449|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
7857450|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
7857451|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
7857452|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
7857453|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
7857454|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
7857455|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
7857456|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
7857457|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
7857458|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
7857459|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
7857460|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
7857461|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
7857462|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
7857463|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
7857464|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
7857465|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
7857466|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
7857467|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
7857468|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
7857469|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
7857470|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
7857471|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
7857472|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
7857473|NCT00090103|27255682|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
7857474|NCT00090103|27255683|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
7857475|NCT00090103|27255684|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
7857476|NCT00089999|27255850|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
7857477|NCT00089999|27255851|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
7857478|NCT00089999|27255850|P2|Overall Study|Patient Underwent Surgery|0
7857479|NCT00089999|27255851|P1|Overall Study|Patient Underwent Surgery|2
7857480|NCT00089999|27255850|P2|Overall Study|Physician Decision|2
7857481|NCT00089999|27255851|P1|Overall Study|Physician Decision|2
7857482|NCT00089999|27255850|P2|Overall Study|Clinical Progression|2
7857483|NCT00089999|27255851|P1|Overall Study|Clinical Progression|1
7857484|NCT00089999|27255850|P2|Overall Study|Poor General Condition|0
7857485|NCT00089999|27255851|P1|Overall Study|Poor General Condition|1
7857486|NCT00089999|27255850|P2|Overall Study|Death|3
7857487|NCT00089999|27255851|P1|Overall Study|Death|3
7857488|NCT00089999|27255850|P2|Overall Study|Symptomatic Progression of Cancer|5
7857489|NCT00089999|27255851|P1|Overall Study|Symptomatic Progression of Cancer|2
7857490|NCT00089999|27255850|P2|Overall Study|Radiological Progression of Cancer|44
7857491|NCT00089999|27255851|P1|Overall Study|Radiological Progression of Cancer|52
7857492|NCT00089999|27255850|P2|Overall Study|Lost to Follow-up|1
7857493|NCT00089999|27255851|P1|Overall Study|Lost to Follow-up|2
7857494|NCT00089999|27255850|P2|Overall Study|Withdrawal by Subject|4
7857495|NCT00089999|27255851|P1|Overall Study|Withdrawal by Subject|0
7857496|NCT00089999|27255850|P2|Overall Study|Adverse Event|7
7857497|NCT00089999|27255851|P1|Overall Study|Adverse Event|4
7857498|NCT00089986|27255874|P3|Overall Study|Withdrawal by Subject|2
7857499|NCT00089986|27255875|P2|Overall Study|Withdrawal by Subject|6
7857500|NCT00089986|27255876|P1|Overall Study|Withdrawal by Subject|3
7857501|NCT00089986|27255874|P3|Overall Study|Do not resuscitate (DNR)|1
7857502|NCT00089986|27255875|P2|Overall Study|Do not resuscitate (DNR)|0
7857503|NCT00089986|27255876|P1|Overall Study|Do not resuscitate (DNR)|0
7857504|NCT00089986|27255874|P3|Overall Study|Family decision|0
7857505|NCT00089986|27255875|P2|Overall Study|Family decision|1
7857506|NCT00089986|27255876|P1|Overall Study|Family decision|0
7857507|NCT00089986|27255874|P3|Overall Study|Enrollment in another study|0
7857508|NCT00089986|27255875|P2|Overall Study|Enrollment in another study|1
7857509|NCT00089986|27255876|P1|Overall Study|Enrollment in another study|0
7857510|NCT00089986|27255874|P3|Overall Study|Investigator decision to withdrew|0
7857511|NCT00089986|27255875|P2|Overall Study|Investigator decision to withdrew|1
7857512|NCT00089986|27255876|P1|Overall Study|Investigator decision to withdrew|0
7857513|NCT00089986|27255874|P3|Overall Study|Hemohlobin stopping rule|0
7857514|NCT00089986|27255875|P2|Overall Study|Hemohlobin stopping rule|1
7857515|NCT00089986|27255876|P1|Overall Study|Hemohlobin stopping rule|0
7857516|NCT00089986|27255874|P3|Overall Study|Subject withdrew but agreed follow up|0
7857517|NCT00089986|27255875|P2|Overall Study|Subject withdrew but agreed follow up|2
7857518|NCT00089986|27255876|P1|Overall Study|Subject withdrew but agreed follow up|1
7857519|NCT00089986|27255874|P3|Overall Study|Patient transferred to another hospital|0
7857520|NCT00089986|27255875|P2|Overall Study|Patient transferred to another hospital|1
7857521|NCT00089986|27255876|P1|Overall Study|Patient transferred to another hospital|2
7857522|NCT00089986|27255874|P3|Overall Study|Protocol Violation|0
7857523|NCT00089986|27255875|P2|Overall Study|Protocol Violation|1
7857524|NCT00089986|27255876|P1|Overall Study|Protocol Violation|0
7857525|NCT00089986|27255874|P3|Overall Study|Lost to Follow-up|1
7857526|NCT00089986|27255875|P2|Overall Study|Lost to Follow-up|1
7857527|NCT00089986|27255876|P1|Overall Study|Lost to Follow-up|3
7857528|NCT00089986|27255874|P3|Overall Study|Adverse Event|6
7857529|NCT00089986|27255875|P2|Overall Study|Adverse Event|9
7857530|NCT00089986|27255876|P1|Overall Study|Adverse Event|6
7857531|NCT00089973|27255893|P1|Overall Study|Death|1
7857532|NCT00089973|27255893|P1|Overall Study|Disease progression|45
7857533|NCT00089973|27255893|P1|Overall Study|Withdrawal by Subject|1
7857534|NCT00089973|27255893|P1|Overall Study|Adverse Event|3
7857535|NCT00089895|27255908|P2|Overall Study|Missing|2
7857536|NCT00089895|27255909|P1|Overall Study|Missing|4
7857537|NCT00089895|27255908|P2|Overall Study|Not otherwise specified|8
7857538|NCT00089895|27255909|P1|Overall Study|Not otherwise specified|4
7857539|NCT00089895|27255908|P2|Overall Study|Exclusion criteria met|6
7857540|NCT00089895|27255909|P1|Overall Study|Exclusion criteria met|6
7857541|NCT00089895|27255908|P2|Overall Study|Physician Decision|7
7857542|NCT00089895|27255909|P1|Overall Study|Physician Decision|3
7857543|NCT00089895|27255908|P2|Overall Study|Bleeding|2
7857544|NCT00089895|27255909|P1|Overall Study|Bleeding|0
7857545|NCT00089895|27255908|P2|Overall Study|Surgery|1
7857546|NCT00089895|27255909|P1|Overall Study|Surgery|0
7857547|NCT00089895|27255908|P2|Overall Study|Technical reason|2
7857548|NCT00089895|27255909|P1|Overall Study|Technical reason|7
7857549|NCT00089895|27255908|P2|Overall Study|Consent Withdrawn|14
7857550|NCT00089895|27255909|P1|Overall Study|Consent Withdrawn|11
7857551|NCT00089843|27255921|P4|Overall Study|Physician Decision|1
7857552|NCT00089843|27255922|P3|Overall Study|Physician Decision|0
7857553|NCT00089843|27255923|P2|Overall Study|Physician Decision|0
7857554|NCT00089843|27255924|P1|Overall Study|Physician Decision|1
7857555|NCT00089843|27255921|P4|Overall Study|Withdrawal by Subject|6
7857556|NCT00089843|27255922|P3|Overall Study|Withdrawal by Subject|5
7857557|NCT00089843|27255923|P2|Overall Study|Withdrawal by Subject|4
7857558|NCT00089843|27255924|P1|Overall Study|Withdrawal by Subject|1
7857559|NCT00089791|27255936|P2|Overall Study|Requirement for alternative therapy|4
7857560|NCT00089791|27255937|P1|Overall Study|Requirement for alternative therapy|7
7857561|NCT00089791|27255936|P2|Overall Study|Protocol deviation|10
7857562|NCT00089791|27255937|P1|Overall Study|Protocol deviation|12
7857563|NCT00089791|27255936|P2|Overall Study|Other|32
7857564|NCT00089791|27255937|P1|Overall Study|Other|20
7857565|NCT00089791|27255936|P2|Overall Study|Noncompliance|13
7857566|NCT00089791|27255937|P1|Overall Study|Noncompliance|17
7857567|NCT00089791|27255936|P2|Overall Study|Lost to Follow-up|57
7857568|NCT00089791|27255937|P1|Overall Study|Lost to Follow-up|57
7857569|NCT00089791|27255936|P2|Overall Study|Ineligibility determined|9
7857570|NCT00089791|27255937|P1|Overall Study|Ineligibility determined|12
7857571|NCT00089791|27255936|P2|Overall Study|Disease progression|3
7857572|NCT00089791|27255937|P1|Overall Study|Disease progression|7
7857573|NCT00089791|27255936|P2|Overall Study|Death|62
7857574|NCT00089791|27255937|P1|Overall Study|Death|78
7857575|NCT00089791|27255936|P2|Overall Study|Withdrawal by Subject|344
7857576|NCT00089791|27255937|P1|Overall Study|Withdrawal by Subject|403
7857577|NCT00089791|27255936|P2|Overall Study|Adverse Event|93
7857578|NCT00089791|27255937|P1|Overall Study|Adverse Event|81
7857579|NCT00089791|27255936|P2|Overall Study|Physician Decision|3
7857580|NCT00089791|27255937|P1|Overall Study|Physician Decision|6
7857581|NCT00089778|27255971|P3|Overall Study|Protocol Violation|1
7857582|NCT00089778|27255972|P2|Overall Study|Protocol Violation|0
7857583|NCT00089778|27255973|P1|Overall Study|Protocol Violation|0
7857584|NCT00089674|27255986|P2|Overall Study|Requirement for alternative therapy|4
7857585|NCT00089674|27255987|P1|Overall Study|Requirement for alternative therapy|14
7857586|NCT00089674|27255986|P2|Overall Study|Other|9
7857587|NCT00089674|27255987|P1|Overall Study|Other|5
7857588|NCT00089674|27255986|P2|Overall Study|Noncompliance|3
7857589|NCT00089674|27255987|P1|Overall Study|Noncompliance|7
7857590|NCT00089674|27255986|P2|Overall Study|Lost to Follow-up|17
7857591|NCT00089674|27255987|P1|Overall Study|Lost to Follow-up|21
7857592|NCT00089674|27255986|P2|Overall Study|Ineligibility determined|10
7857593|NCT00089674|27255987|P1|Overall Study|Ineligibility determined|8
7857594|NCT00089674|27255986|P2|Overall Study|Disease progression|23
7857595|NCT00089674|27255987|P1|Overall Study|Disease progression|21
7857596|NCT00089674|27255986|P2|Overall Study|Death|43
7857597|NCT00089674|27255987|P1|Overall Study|Death|43
7857598|NCT00089674|27255986|P2|Overall Study|Withdrawal by Subject|127
7857599|NCT00089674|27255987|P1|Overall Study|Withdrawal by Subject|143
7857600|NCT00089674|27255986|P2|Overall Study|Adverse Event|29
7857601|NCT00089674|27255987|P1|Overall Study|Adverse Event|23
7857602|NCT00089674|27255986|P2|Overall Study|Physician Decision|2
7857603|NCT00089674|27255987|P1|Overall Study|Physician Decision|4
7857604|NCT00089661|27256013|P2|Overall Study|Other|1
7857605|NCT00089661|27256014|P1|Overall Study|Other|2
7857606|NCT00089661|27256013|P2|Overall Study|Noncompliance|4
7857607|NCT00089661|27256014|P1|Overall Study|Noncompliance|2
7857608|NCT00089661|27256013|P2|Overall Study|Ineligibility determined|4
7857609|NCT00089661|27256014|P1|Overall Study|Ineligibility determined|4
7857610|NCT00089661|27256013|P2|Overall Study|Disease progression|3
7857611|NCT00089661|27256014|P1|Overall Study|Disease progression|1
7857612|NCT00089661|27256013|P2|Overall Study|Withdrawal by Subject|9
7857613|NCT00089661|27256014|P1|Overall Study|Withdrawal by Subject|11
7857614|NCT00089661|27256013|P2|Overall Study|Lost to Follow-up|3
7857615|NCT00089661|27256014|P1|Overall Study|Lost to Follow-up|0
7857616|NCT00089661|27256013|P2|Overall Study|Death|0
7857617|NCT00089661|27256014|P1|Overall Study|Death|1
7857618|NCT00089661|27256013|P2|Overall Study|Adverse Event|2
7857619|NCT00089661|27256014|P1|Overall Study|Adverse Event|0
7857620|NCT00089648|27256030|P1|Overall Study|Lack of Efficacy|33
7857621|NCT00089648|27256030|P1|Overall Study|Withdrawal by Subject|1
7857622|NCT00089648|27256030|P1|Overall Study|Adverse Event|7
7857623|NCT00089635|27256046|P1|Overall Study|Other|2
7857624|NCT00089635|27256046|P1|Overall Study|Ineligibility determined|1
7857625|NCT00089635|27256046|P1|Overall Study|Withdrawal by Subject|6
7857626|NCT00089635|27256046|P1|Overall Study|Lost to Follow-up|3
7857627|NCT00089635|27256046|P1|Overall Study|Disease Progression|12
7857628|NCT00089635|27256046|P1|Overall Study|Death|17
7857629|NCT00089635|27256046|P1|Overall Study|Adverse Event|2
7857630|NCT00089583|27256060|P2|Overall Study|Participant Incarcerated|1
7857631|NCT00089583|27256061|P1|Overall Study|Participant Incarcerated|0
7857632|NCT00089583|27256060|P2|Overall Study|Necessity to Use Prohibited Drug|0
7857633|NCT00089583|27256061|P1|Overall Study|Necessity to Use Prohibited Drug|1
7857634|NCT00089583|27256060|P2|Overall Study|Start of Disallowed Medication|1
7857635|NCT00089583|27256061|P1|Overall Study|Start of Disallowed Medication|0
7857636|NCT00089583|27256060|P2|Overall Study|Principal Investigator Decision|10
7857637|NCT00089583|27256061|P1|Overall Study|Principal Investigator Decision|0
7857638|NCT00089583|27256060|P2|Overall Study|Protocol Violation|3
7857639|NCT00089583|27256061|P1|Overall Study|Protocol Violation|0
7857640|NCT00089583|27256060|P2|Overall Study|Reason Not Provided|1
7857641|NCT00089583|27256061|P1|Overall Study|Reason Not Provided|0
7857642|NCT00089583|27256060|P2|Overall Study|Participant Management Criteria Met|1
7857643|NCT00089583|27256061|P1|Overall Study|Participant Management Criteria Met|0
7857644|NCT00089583|27256060|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
7857645|NCT00089583|27256061|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
7857646|NCT00089583|27256060|P2|Overall Study|Non-Compliance|4
7857647|NCT00089583|27256061|P1|Overall Study|Non-Compliance|0
7857648|NCT00089583|27256060|P2|Overall Study|Participant Refused Study Medication|2
7857649|NCT00089583|27256061|P1|Overall Study|Participant Refused Study Medication|0
7857650|NCT00089583|27256060|P2|Overall Study|Participant (Par) Didn't Take Medication|0
7857651|NCT00089583|27256061|P1|Overall Study|Participant (Par) Didn't Take Medication|1
7857652|NCT00089583|27256060|P2|Overall Study|Withdrawal by Subject|4
7857653|NCT00089583|27256061|P1|Overall Study|Withdrawal by Subject|0
7857654|NCT00089583|27256060|P2|Overall Study|Insufficient Viral Load Response|5
7857655|NCT00089583|27256061|P1|Overall Study|Insufficient Viral Load Response|5
7857656|NCT00089583|27256060|P2|Overall Study|Adverse Event|3
7857657|NCT00089583|27256061|P1|Overall Study|Adverse Event|0
7857658|NCT00089609|27256155|P2|Overall Study|Withdrawal by Subject|1
7857659|NCT00089609|27256156|P1|Overall Study|Withdrawal by Subject|3
7857660|NCT00089544|27256175|P2|Overall Study|Ineligible|0
7857661|NCT00089544|27256176|P1|Overall Study|Ineligible|1
7857662|NCT00089505|27256190|P4|Overall Study|Protocol Violation|0
7857663|NCT00089505|27256191|P3|Overall Study|Protocol Violation|1
7857664|NCT00089505|27256192|P2|Overall Study|Protocol Violation|0
7857665|NCT00089505|27256193|P1|Overall Study|Protocol Violation|0
7857666|NCT00089505|27256190|P4|Overall Study|Physician Decision|0
7857667|NCT00089505|27256191|P3|Overall Study|Physician Decision|0
7857668|NCT00089505|27256192|P2|Overall Study|Physician Decision|0
7857669|NCT00089505|27256193|P1|Overall Study|Physician Decision|1
7857670|NCT00089505|27256190|P4|Overall Study|Lost to Follow-up|7
7857671|NCT00089505|27256191|P3|Overall Study|Lost to Follow-up|9
7857672|NCT00089505|27256192|P2|Overall Study|Lost to Follow-up|1
7857673|NCT00089505|27256193|P1|Overall Study|Lost to Follow-up|1
7857674|NCT00089505|27256190|P4|Overall Study|Withdrawal by Subject|6
7857675|NCT00089505|27256191|P3|Overall Study|Withdrawal by Subject|6
7857676|NCT00089505|27256192|P2|Overall Study|Withdrawal by Subject|0
7857677|NCT00089505|27256193|P1|Overall Study|Withdrawal by Subject|3
7857678|NCT00089505|27256190|P4|Overall Study|Death|8
7857679|NCT00089505|27256191|P3|Overall Study|Death|5
7857680|NCT00089505|27256192|P2|Overall Study|Death|1
7857681|NCT00089505|27256193|P1|Overall Study|Death|4
7857682|NCT00089479|27256237|P2|Overall Study|Lost to Follow-up|107
7857683|NCT00089479|27256238|P1|Overall Study|Lost to Follow-up|137
7857684|NCT00089479|27256237|P2|Overall Study|Withdrawal by Subject|107
7857685|NCT00089479|27256238|P1|Overall Study|Withdrawal by Subject|86
7857686|NCT00089479|27256237|P2|Overall Study|Death|75
7857687|NCT00089479|27256238|P1|Overall Study|Death|108
7857688|NCT00089297|27256281|P1|Overall Study|Non-compliance|1
7857689|NCT00089297|27256281|P1|Overall Study|IRB approval not ready|1
7857690|NCT00089297|27256281|P1|Overall Study|Secondary malignancy|1
7857691|NCT00089297|27256281|P1|Overall Study|Ineligible|11
7857692|NCT00089297|27256281|P1|Overall Study|Disease progression|2
7857693|NCT00089297|27256281|P1|Overall Study|Withdrawal by Subject|12
7857694|NCT00089297|27256281|P1|Overall Study|Death|1
7857695|NCT00089297|27256281|P1|Overall Study|Adverse Event|9
7857696|NCT00089284|27256293|P7|Overall Study|Adverse event before starting treatment|1
7857697|NCT00089284|27256294|P6|Overall Study|Adverse event before starting treatment|0
7857698|NCT00089284|27256295|P5|Overall Study|Adverse event before starting treatment|0
7857699|NCT00089284|27256296|P4|Overall Study|Adverse event before starting treatment|0
7857700|NCT00089284|27256297|P3|Overall Study|Adverse event before starting treatment|0
7857701|NCT00089284|27256298|P2|Overall Study|Adverse event before starting treatment|0
7857702|NCT00089284|27256299|P1|Overall Study|Adverse event before starting treatment|0
7857703|NCT00089141|27256336|P2|Overall Study|Termination of trial|24
7857704|NCT00089141|27256337|P1|Overall Study|Termination of trial|18
7857705|NCT00089076|27256373|P1|Overall Study|Progression|7
7857706|NCT00089076|27256373|P1|Overall Study|Withdrawal by Subject|2
7857707|NCT00089076|27256373|P1|Overall Study|Alternate Therapy|1
7857708|NCT00088907|27256430|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
7857709|NCT00088907|27256431|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
7857710|NCT00088907|27256430|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
7857711|NCT00088907|27256431|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
7857712|NCT00088907|27256430|P2|Single Gefitinib Treatment (Step 2)|Death|0
7857713|NCT00088907|27256431|P1|Single Gefitinib Treatment (Step 2)|Death|1
7857714|NCT00088907|27256430|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
7857715|NCT00088907|27256431|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
7857716|NCT00088907|27256430|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
7857717|NCT00088907|27256431|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
7857718|NCT00088907|27256430|P2|Randomized Study (Step 1)|unknown/not specify|13
7857719|NCT00088907|27256431|P1|Randomized Study (Step 1)|unknown/not specify|24
7857720|NCT00088907|27256430|P2|Randomized Study (Step 1)|complicating disease|1
7857721|NCT00088907|27256431|P1|Randomized Study (Step 1)|complicating disease|3
7857722|NCT00088907|27256430|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
7857723|NCT00088907|27256431|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
7857724|NCT00088907|27256430|P2|Randomized Study (Step 1)|Death|12
7857725|NCT00088907|27256431|P1|Randomized Study (Step 1)|Death|11
7857726|NCT00088907|27256430|P2|Randomized Study (Step 1)|Adverse Event|19
7857727|NCT00088907|27256431|P1|Randomized Study (Step 1)|Adverse Event|14
7857728|NCT00088907|27256430|P2|Randomized Study (Step 1)|Lack of Efficacy|62
7857729|NCT00088907|27256431|P1|Randomized Study (Step 1)|Lack of Efficacy|55
7857730|NCT00088881|27256442|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
7857731|NCT00088881|27256442|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
7857732|NCT00088881|27256442|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
7857733|NCT00088881|27256442|P1|Step 1 - R-CHOP|Physician Decision|1
7857734|NCT00088881|27256442|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
7857735|NCT00088881|27256442|P1|Step 1 - R-CHOP|Adverse Event|1
7857736|NCT00088881|27256442|P1|Step 1 - R-CHOP|Patient ineligible|9
7857737|NCT00088829|27256451|P1|Overall Study|PI left institution and study was close|22
7857738|NCT00088595|27256493|P1|Overall Study|New Cancer Therapy|2
7857739|NCT00088595|27256493|P1|Overall Study|Ongoing (After Core)|7
7857740|NCT00088595|27256493|P1|Overall Study|Withdrawal by Subject|8
7857741|NCT00088595|27256493|P1|Overall Study|Adverse Event|11
7857742|NCT00088530|27256511|P2|Overall Study|Patient never treated|0
7857743|NCT00088530|27256512|P1|Overall Study|Patient never treated|1
7857744|NCT00088530|27256511|P2|Overall Study|Sponsor decision|1
7857745|NCT00088530|27256512|P1|Overall Study|Sponsor decision|0
7857746|NCT00088530|27256511|P2|Overall Study|Physician Decision|0
7857747|NCT00088530|27256512|P1|Overall Study|Physician Decision|2
7857748|NCT00088530|27256511|P2|Overall Study|Lost to Follow-up|0
7857749|NCT00088530|27256512|P1|Overall Study|Lost to Follow-up|2
7857750|NCT00088530|27256511|P2|Overall Study|Withdrawal by Subject|5
7857751|NCT00088530|27256512|P1|Overall Study|Withdrawal by Subject|2
7857752|NCT00088530|27256511|P2|Overall Study|Adverse Event|9
7857753|NCT00088530|27256512|P1|Overall Study|Adverse Event|15
7857754|NCT00088530|27256511|P2|Overall Study|Progressive/Relapsed Disease|39
7857755|NCT00088530|27256512|P1|Overall Study|Progressive/Relapsed Disease|28
7857756|NCT00088465|27256524|P1|Overall Study|Death|11
7857757|NCT00088465|27256524|P1|Overall Study|Protocol Violation|17
7857758|NCT00088465|27256524|P1|Overall Study|Lack of Efficacy|27
7857759|NCT00088465|27256524|P1|Overall Study|Sponsor Decision|37
7857760|NCT00088465|27256524|P1|Overall Study|Physician Decision|45
7857761|NCT00088465|27256524|P1|Overall Study|Lost to Follow-up|57
7857762|NCT00088465|27256524|P1|Overall Study|Adverse Event|77
7857763|NCT00088465|27256524|P1|Overall Study|Withdrawal by Subject|290
7857764|NCT00088452|27256550|P3|Overall Study|Did not receive intervention|1
7857765|NCT00088452|27256551|P2|Overall Study|Did not receive intervention|0
7857766|NCT00088452|27256552|P1|Overall Study|Did not receive intervention|1
7857767|NCT00088413|27256570|P4|Overall Study|Patient unevaluable due to adverse event|0
7857768|NCT00088413|27256571|P3|Overall Study|Patient unevaluable due to adverse event|1
7857769|NCT00088413|27256572|P2|Overall Study|Patient unevaluable due to adverse event|0
7857770|NCT00088413|27256573|P1|Overall Study|Patient unevaluable due to adverse event|0
7857771|NCT00088413|27256570|P4|Overall Study|Other|0
7857772|NCT00088413|27256571|P3|Overall Study|Other|0
7857773|NCT00088413|27256572|P2|Overall Study|Other|1
7857774|NCT00088413|27256573|P1|Overall Study|Other|0
7857775|NCT00088413|27256570|P4|Overall Study|Progressive disease|14
7857776|NCT00088413|27256571|P3|Overall Study|Progressive disease|8
7857777|NCT00088413|27256572|P2|Overall Study|Progressive disease|11
7857778|NCT00088413|27256573|P1|Overall Study|Progressive disease|9
7857779|NCT00088413|27256570|P4|Overall Study|Death|0
7857780|NCT00088413|27256571|P3|Overall Study|Death|0
7857781|NCT00088413|27256572|P2|Overall Study|Death|1
7857782|NCT00088413|27256573|P1|Overall Study|Death|0
7857783|NCT00088413|27256570|P4|Overall Study|Off study due to missing a vaccine dose|0
7857784|NCT00088413|27256571|P3|Overall Study|Off study due to missing a vaccine dose|0
7857785|NCT00088413|27256572|P2|Overall Study|Off study due to missing a vaccine dose|0
7857786|NCT00088413|27256573|P1|Overall Study|Off study due to missing a vaccine dose|1
7857787|NCT00088413|27256570|P4|Overall Study|Refused trmt Off-study per pt wishes|0
7857788|NCT00088413|27256571|P3|Overall Study|Refused trmt Off-study per pt wishes|1
7857789|NCT00088413|27256572|P2|Overall Study|Refused trmt Off-study per pt wishes|1
7857790|NCT00088413|27256573|P1|Overall Study|Refused trmt Off-study per pt wishes|0
7857791|NCT00088413|27256570|P4|Overall Study|Adverse Events/Side Effects|0
7857792|NCT00088413|27256571|P3|Overall Study|Adverse Events/Side Effects|1
7857793|NCT00088413|27256572|P2|Overall Study|Adverse Events/Side Effects|1
7857794|NCT00088413|27256573|P1|Overall Study|Adverse Events/Side Effects|0
7857795|NCT00088413|27256570|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7857796|NCT00088413|27256571|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
7857797|NCT00088413|27256572|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7857798|NCT00088413|27256573|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7857799|NCT00088374|27256587|P1|Overall Study|patient received <1 cycle only of 17AAG|1
7857800|NCT00088374|27256587|P1|Overall Study|patient did not receive any 17AAG|1
7857801|NCT00088205|27256605|P1|Overall Study|Death Due to Study Disease|4
7857802|NCT00088205|27256605|P1|Overall Study|Physician Decision|1
7857803|NCT00088205|27256605|P1|Overall Study|Progressive Disease|51
7857804|NCT00088205|27256605|P1|Overall Study|Adverse Event|4
7857805|NCT00088166|27256622|P2|Overall Study|Withdrawal by Subject|5
7857806|NCT00088166|27256623|P1|Overall Study|Withdrawal by Subject|5
7857807|NCT00088166|27256622|P2|Overall Study|Patient deterioration|39
7857808|NCT00088166|27256623|P1|Overall Study|Patient deterioration|29
7857809|NCT00088166|27256622|P2|Overall Study|Protocol Violation|5
7857810|NCT00088166|27256623|P1|Overall Study|Protocol Violation|1
7857811|NCT00088166|27256622|P2|Overall Study|Physician Decision|1
7857812|NCT00088166|27256623|P1|Overall Study|Physician Decision|4
7857813|NCT00088166|27256622|P2|Overall Study|Lost to Follow-up|1
7857814|NCT00088166|27256623|P1|Overall Study|Lost to Follow-up|0
7857815|NCT00088166|27256622|P2|Overall Study|Death|1
7857816|NCT00088166|27256623|P1|Overall Study|Death|3
7857817|NCT00088166|27256622|P2|Overall Study|Adverse Event|9
7857818|NCT00088166|27256623|P1|Overall Study|Adverse Event|11
7857819|NCT00088153|27256647|P2|Overall Study|Lost to Follow-up|12
7857820|NCT00088153|27256648|P1|Overall Study|Lost to Follow-up|11
7857821|NCT00088153|27256647|P2|Overall Study|Withdrawal by Subject|10
7857822|NCT00088153|27256648|P1|Overall Study|Withdrawal by Subject|10
7857823|NCT00088153|27256647|P2|Overall Study|Physician Decision|3
7857824|NCT00088153|27256648|P1|Overall Study|Physician Decision|3
7857825|NCT00087698|27256658|P1|Overall Study|Protocol Violation|1
7857826|NCT00087698|27256658|P1|Overall Study|Death from Study Drug Toxicity|2
7857827|NCT00087698|27256658|P1|Overall Study|Death from Study Disease|2
7857828|NCT00087698|27256658|P1|Overall Study|Clinical Relapse|1
7857829|NCT00087698|27256658|P1|Overall Study|Protocol Entry Criteria Not Met|2
7857830|NCT00087698|27256658|P1|Overall Study|Lack of Efficacy, Physician Perception|3
7857831|NCT00087698|27256658|P1|Overall Study|Withdrawal by Subject|4
7857832|NCT00087698|27256658|P1|Overall Study|Adverse Event|4
7857833|NCT00087698|27256658|P1|Overall Study|Death from Other Causes|3
7857834|NCT00087698|27256658|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
7857835|NCT00087685|27256667|P1|Overall Study|Withdrawal by Subject|3
7857836|NCT00087685|27256667|P1|Overall Study|Progressive Disease|5
7857837|NCT00087685|27256667|P1|Overall Study|Non-Compliance|1
7857838|NCT00087685|27256667|P1|Overall Study|Adverse Event|5
7857839|NCT00087646|27256680|P4|Overall Study|Violation of Selection Criteria at Entry|1
7857840|NCT00087646|27256681|P3|Overall Study|Violation of Selection Criteria at Entry|0
7857841|NCT00087646|27256682|P2|Overall Study|Violation of Selection Criteria at Entry|0
7857842|NCT00087646|27256683|P1|Overall Study|Violation of Selection Criteria at Entry|1
7857843|NCT00087646|27256680|P4|Overall Study|Other Protocol Violation|0
7857844|NCT00087646|27256681|P3|Overall Study|Other Protocol Violation|0
7857845|NCT00087646|27256682|P2|Overall Study|Other Protocol Violation|1
7857846|NCT00087646|27256683|P1|Overall Study|Other Protocol Violation|3
7857847|NCT00087646|27256680|P4|Overall Study|Administrative/Other|2
7857848|NCT00087646|27256681|P3|Overall Study|Administrative/Other|1
7857849|NCT00087646|27256682|P2|Overall Study|Administrative/Other|1
7857850|NCT00087646|27256683|P1|Overall Study|Administrative/Other|6
7857851|NCT00087646|27256680|P4|Overall Study|Failure to Return|3
7857852|NCT00087646|27256681|P3|Overall Study|Failure to Return|2
7857853|NCT00087646|27256682|P2|Overall Study|Failure to Return|2
7857854|NCT00087646|27256683|P1|Overall Study|Failure to Return|5
7857855|NCT00087646|27256680|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
7857856|NCT00087646|27256681|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
7857857|NCT00087646|27256682|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
7857858|NCT00087646|27256683|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
7857859|NCT00087646|27256680|P4|Overall Study|Insufficient therapeutic response|51
7857860|NCT00087646|27256681|P3|Overall Study|Insufficient therapeutic response|38
7857861|NCT00087646|27256682|P2|Overall Study|Insufficient therapeutic response|24
7857862|NCT00087646|27256683|P1|Overall Study|Insufficient therapeutic response|64
7857863|NCT00087646|27256680|P4|Overall Study|Withdrawal by Subject|2
7857864|NCT00087646|27256681|P3|Overall Study|Withdrawal by Subject|2
7857865|NCT00087646|27256682|P2|Overall Study|Withdrawal by Subject|1
7857866|NCT00087646|27256683|P1|Overall Study|Withdrawal by Subject|6
7857867|NCT00087646|27256680|P4|Overall Study|Death|0
7857868|NCT00087646|27256681|P3|Overall Study|Death|0
7857869|NCT00087646|27256682|P2|Overall Study|Death|1
7857870|NCT00087646|27256683|P1|Overall Study|Death|0
7857871|NCT00087646|27256680|P4|Overall Study|Adverse Event|20
7857872|NCT00087646|27256681|P3|Overall Study|Adverse Event|18
7857873|NCT00087646|27256682|P2|Overall Study|Adverse Event|6
7857874|NCT00087646|27256683|P1|Overall Study|Adverse Event|37
7857875|NCT00087607|27256722|P2|Overall Study|Violation of Selection Criteria at Entry|1
7857876|NCT00087607|27256723|P1|Overall Study|Violation of Selection Criteria at Entry|0
7857877|NCT00087607|27256722|P2|Overall Study|Other Protocol Violation|2
7857878|NCT00087607|27256723|P1|Overall Study|Other Protocol Violation|5
7857879|NCT00087607|27256722|P2|Overall Study|Refused Treatment|7
7857880|NCT00087607|27256723|P1|Overall Study|Refused Treatment|5
7857881|NCT00087607|27256722|P2|Overall Study|Administrative|12
7857882|NCT00087607|27256723|P1|Overall Study|Administrative|12
7857883|NCT00087607|27256722|P2|Overall Study|Withdrew Consent|16
7857884|NCT00087607|27256723|P1|Overall Study|Withdrew Consent|12
7857885|NCT00087607|27256722|P2|Overall Study|Failure to return|17
7857886|NCT00087607|27256723|P1|Overall Study|Failure to return|21
7857887|NCT00087607|27256722|P2|Overall Study|Insufficient Therapeutic Response|42
7857888|NCT00087607|27256723|P1|Overall Study|Insufficient Therapeutic Response|53
7857889|NCT00087607|27256722|P2|Overall Study|Death|1
7857890|NCT00087607|27256723|P1|Overall Study|Death|0
7857891|NCT00087607|27256722|P2|Overall Study|Adverse Event|24
7857892|NCT00087607|27256723|P1|Overall Study|Adverse Event|14
7857893|NCT00087594|27256763|P2|Overall Study|Lack of Efficacy|5
7857894|NCT00087594|27256764|P1|Overall Study|Lack of Efficacy|2
7857895|NCT00087594|27256763|P2|Overall Study|Withdrawal by Subject|2
7857896|NCT00087594|27256764|P1|Overall Study|Withdrawal by Subject|4
7857897|NCT00087594|27256763|P2|Overall Study|Lost to Follow-up|2
7857898|NCT00087594|27256764|P1|Overall Study|Lost to Follow-up|0
7857899|NCT00087594|27256763|P2|Overall Study|Adverse Event|3
7857900|NCT00087594|27256764|P1|Overall Study|Adverse Event|2
7857901|NCT00087568|27256798|P2|Overall Study|Lack of Efficacy|1
7857902|NCT00087568|27256799|P1|Overall Study|Lack of Efficacy|24
7857903|NCT00087568|27256798|P2|Overall Study|Lost to Follow-up|0
7857904|NCT00087568|27256799|P1|Overall Study|Lost to Follow-up|1
7857905|NCT00087568|27256798|P2|Overall Study|Withdrawal by Subject|1
7857906|NCT00087568|27256799|P1|Overall Study|Withdrawal by Subject|1
7857907|NCT00087568|27256798|P2|Overall Study|Adverse Event|0
7857908|NCT00087568|27256799|P1|Overall Study|Adverse Event|4
7857909|NCT00087555|27256826|P3|Overall Study|Patient wanted to go back on Med|0
7857910|NCT00087555|27256827|P2|Overall Study|Patient wanted to go back on Med|0
7857911|NCT00087555|27256828|P1|Overall Study|Patient wanted to go back on Med|1
7857912|NCT00087555|27256826|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
7857913|NCT00087555|27256827|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
7857914|NCT00087555|27256828|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
7857915|NCT00087555|27256826|P3|Overall Study|Non Compliance|1
7857916|NCT00087555|27256827|P2|Overall Study|Non Compliance|0
7857917|NCT00087555|27256828|P1|Overall Study|Non Compliance|0
7857918|NCT00087555|27256826|P3|Overall Study|Lack of Efficacy|1
7857919|NCT00087555|27256827|P2|Overall Study|Lack of Efficacy|0
7857920|NCT00087555|27256828|P1|Overall Study|Lack of Efficacy|2
7857921|NCT00087555|27256826|P3|Overall Study|Withdrawal by Subject|1
7857922|NCT00087555|27256827|P2|Overall Study|Withdrawal by Subject|2
7857923|NCT00087555|27256828|P1|Overall Study|Withdrawal by Subject|3
7857924|NCT00087555|27256826|P3|Overall Study|Pregnancy|1
7857925|NCT00087555|27256827|P2|Overall Study|Pregnancy|1
7857926|NCT00087555|27256828|P1|Overall Study|Pregnancy|0
7857927|NCT00087555|27256826|P3|Overall Study|Screen Failure|0
7857928|NCT00087555|27256827|P2|Overall Study|Screen Failure|1
7857929|NCT00087555|27256828|P1|Overall Study|Screen Failure|1
7857930|NCT00087555|27256826|P3|Overall Study|Protocol Violation|2
7857931|NCT00087555|27256827|P2|Overall Study|Protocol Violation|0
7857932|NCT00087555|27256828|P1|Overall Study|Protocol Violation|0
7857933|NCT00087555|27256826|P3|Overall Study|Non - Compliance|0
7857934|NCT00087555|27256827|P2|Overall Study|Non - Compliance|0
7857935|NCT00087555|27256828|P1|Overall Study|Non - Compliance|1
7857936|NCT00087555|27256826|P3|Overall Study|Lost to Follow-up|1
7857937|NCT00087555|27256827|P2|Overall Study|Lost to Follow-up|1
7857938|NCT00087555|27256828|P1|Overall Study|Lost to Follow-up|0
7857939|NCT00087555|27256826|P3|Overall Study|Adverse Event|14
7857940|NCT00087555|27256827|P2|Overall Study|Adverse Event|6
7857941|NCT00087555|27256828|P1|Overall Study|Adverse Event|3
7857942|NCT00087529|27256838|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
7857943|NCT00087529|27256839|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
7857944|NCT00087529|27256838|P2|Overall Study|Disease Progression|4
7857945|NCT00087529|27256839|P1|Overall Study|Disease Progression|5
7857946|NCT00087529|27256838|P2|Overall Study|Participant Noncompliance|1
7857947|NCT00087529|27256839|P1|Overall Study|Participant Noncompliance|0
7857948|NCT00087529|27256838|P2|Overall Study|Initiation of Excluded Therapy|1
7857949|NCT00087529|27256839|P1|Overall Study|Initiation of Excluded Therapy|0
7857950|NCT00087529|27256838|P2|Overall Study|Physician Decision|8
7857951|NCT00087529|27256839|P1|Overall Study|Physician Decision|4
7857952|NCT00087529|27256838|P2|Overall Study|Participant Decision|37
7857953|NCT00087529|27256839|P1|Overall Study|Participant Decision|14
7857954|NCT00087529|27256838|P2|Overall Study|Lost to Follow-up|3
7857955|NCT00087529|27256839|P1|Overall Study|Lost to Follow-up|2
7857956|NCT00087529|27256838|P2|Overall Study|Pregnancy|1
7857957|NCT00087529|27256839|P1|Overall Study|Pregnancy|0
7857958|NCT00087529|27256838|P2|Overall Study|Adverse Event|8
7857959|NCT00087529|27256839|P1|Overall Study|Adverse Event|0
7857960|NCT00087529|27256838|P2|Overall Study|Death|0
7857961|NCT00087529|27256839|P1|Overall Study|Death|1
7857962|NCT00087516|27256854|P4|Overall Study|Other|0
7857963|NCT00087516|27256855|P3|Overall Study|Other|1
7857964|NCT00087516|27256856|P2|Overall Study|Other|0
7857965|NCT00087516|27256857|P1|Overall Study|Other|0
7857966|NCT00087516|27256854|P4|Overall Study|Recommendation of Primary Care Physician|1
7857967|NCT00087516|27256855|P3|Overall Study|Recommendation of Primary Care Physician|0
7857968|NCT00087516|27256856|P2|Overall Study|Recommendation of Primary Care Physician|0
7857969|NCT00087516|27256857|P1|Overall Study|Recommendation of Primary Care Physician|0
7857970|NCT00087516|27256854|P4|Overall Study|Patient was non-compliant|0
7857971|NCT00087516|27256855|P3|Overall Study|Patient was non-compliant|0
7857972|NCT00087516|27256856|P2|Overall Study|Patient was non-compliant|1
7857973|NCT00087516|27256857|P1|Overall Study|Patient was non-compliant|3
7857974|NCT00087516|27256854|P4|Overall Study|Patient moved|0
7857975|NCT00087516|27256855|P3|Overall Study|Patient moved|1
7857976|NCT00087516|27256856|P2|Overall Study|Patient moved|2
7857977|NCT00087516|27256857|P1|Overall Study|Patient moved|3
7857978|NCT00087516|27256854|P4|Overall Study|Protocol specified discontinuation|26
7857979|NCT00087516|27256855|P3|Overall Study|Protocol specified discontinuation|33
7857980|NCT00087516|27256856|P2|Overall Study|Protocol specified discontinuation|33
7857981|NCT00087516|27256857|P1|Overall Study|Protocol specified discontinuation|35
7857982|NCT00087516|27256854|P4|Overall Study|Site terminated|0
7857983|NCT00087516|27256855|P3|Overall Study|Site terminated|1
7857984|NCT00087516|27256856|P2|Overall Study|Site terminated|2
7857985|NCT00087516|27256857|P1|Overall Study|Site terminated|0
7857986|NCT00087516|27256854|P4|Overall Study|Withdrawal by Subject|12
7857987|NCT00087516|27256855|P3|Overall Study|Withdrawal by Subject|11
7857988|NCT00087516|27256856|P2|Overall Study|Withdrawal by Subject|27
7857989|NCT00087516|27256857|P1|Overall Study|Withdrawal by Subject|16
7857990|NCT00087516|27256854|P4|Overall Study|Protocol Violation|6
7857991|NCT00087516|27256855|P3|Overall Study|Protocol Violation|3
7857992|NCT00087516|27256856|P2|Overall Study|Protocol Violation|8
7857993|NCT00087516|27256857|P1|Overall Study|Protocol Violation|4
7857994|NCT00087516|27256854|P4|Overall Study|Lost to Follow-up|5
7857995|NCT00087516|27256855|P3|Overall Study|Lost to Follow-up|5
7857996|NCT00087516|27256856|P2|Overall Study|Lost to Follow-up|6
7857997|NCT00087516|27256857|P1|Overall Study|Lost to Follow-up|8
7857998|NCT00087516|27256854|P4|Overall Study|Lack of Efficacy|29
7857999|NCT00087516|27256855|P3|Overall Study|Lack of Efficacy|39
7858000|NCT00087516|27256856|P2|Overall Study|Lack of Efficacy|80
7858001|NCT00087516|27256857|P1|Overall Study|Lack of Efficacy|82
7858002|NCT00087516|27256854|P4|Overall Study|Adverse Event|6
7858003|NCT00087516|27256855|P3|Overall Study|Adverse Event|3
7858004|NCT00087516|27256856|P2|Overall Study|Adverse Event|10
7858005|NCT00087516|27256857|P1|Overall Study|Adverse Event|10
7858006|NCT00087490|27256886|P2|Overall Study|Randomized but not treated|18
7858007|NCT00087490|27256887|P1|Overall Study|Randomized but not treated|7
7858008|NCT00087490|27256886|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
7858009|NCT00087490|27256887|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
7858010|NCT00087490|27256886|P2|Overall Study|Protocol Violation or (/) Unspecified|201
7858011|NCT00087490|27256887|P1|Overall Study|Protocol Violation or (/) Unspecified|214
7858012|NCT00087490|27256886|P2|Overall Study|Lack of Efficacy|2
7858013|NCT00087490|27256887|P1|Overall Study|Lack of Efficacy|0
7858014|NCT00087490|27256886|P2|Overall Study|Adverse Event|8
7858015|NCT00087490|27256887|P1|Overall Study|Adverse Event|3
7858016|NCT00087490|27256886|P2|Overall Study|Death|4
7858017|NCT00087490|27256887|P1|Overall Study|Death|6
7858018|NCT00087438|27256921|P1|Overall Study|Ineligible / No protocol treatment|4
7858019|NCT00087152|27256931|P1|Overall Study|Ineligible|6
7858020|NCT00087139|27256940|P3|Overall Study|Extradural disease|1
7858021|NCT00087139|27256941|P2|Overall Study|Extradural disease|0
7858022|NCT00087139|27256942|P1|Overall Study|Extradural disease|0
7858023|NCT00087139|27256940|P3|Overall Study|Response achieved|0
7858024|NCT00087139|27256941|P2|Overall Study|Response achieved|1
7858025|NCT00087139|27256942|P1|Overall Study|Response achieved|0
7858026|NCT00087139|27256940|P3|Overall Study|Use of coumadin|0
7858027|NCT00087139|27256941|P2|Overall Study|Use of coumadin|0
7858028|NCT00087139|27256942|P1|Overall Study|Use of coumadin|1
7858029|NCT00087139|27256940|P3|Overall Study|Symptomatic deterioration|3
7858030|NCT00087139|27256941|P2|Overall Study|Symptomatic deterioration|1
7858031|NCT00087139|27256942|P1|Overall Study|Symptomatic deterioration|1
7858032|NCT00087139|27256940|P3|Overall Study|Ineligible|4
7858033|NCT00087139|27256941|P2|Overall Study|Ineligible|7
7858034|NCT00087139|27256942|P1|Overall Study|Ineligible|4
7858035|NCT00087139|27256940|P3|Overall Study|Disease progression|12
7858036|NCT00087139|27256941|P2|Overall Study|Disease progression|19
7858037|NCT00087139|27256942|P1|Overall Study|Disease progression|9
7858038|NCT00087139|27256940|P3|Overall Study|Physician Decision|1
7858039|NCT00087139|27256941|P2|Overall Study|Physician Decision|1
7858040|NCT00087139|27256942|P1|Overall Study|Physician Decision|1
7858041|NCT00087139|27256940|P3|Overall Study|Withdrawal by Subject|2
7858042|NCT00087139|27256941|P2|Overall Study|Withdrawal by Subject|2
7858043|NCT00087139|27256942|P1|Overall Study|Withdrawal by Subject|3
7858044|NCT00087139|27256940|P3|Overall Study|Death|0
7858045|NCT00087139|27256941|P2|Overall Study|Death|1
7858046|NCT00087139|27256942|P1|Overall Study|Death|2
7858047|NCT00087139|27256940|P3|Overall Study|Adverse Event|13
7858048|NCT00087139|27256941|P2|Overall Study|Adverse Event|17
7858049|NCT00087139|27256942|P1|Overall Study|Adverse Event|18
7858050|NCT00087126|27256957|P1|Overall Study|Never treated|1
7858051|NCT00087126|27256957|P1|Overall Study|Ineligible - second primary|1
7858052|NCT00086996|27256982|P1|Overall Study|not eligible|5
7858053|NCT00086996|27256982|P1|Overall Study|Other|6
7858054|NCT00086996|27256982|P1|Overall Study|Withdrawal by Subject|13
7858055|NCT00086996|27256982|P1|Overall Study|progression/relapse|7
7858056|NCT00086996|27256982|P1|Overall Study|Death|4
7858057|NCT00086996|27256982|P1|Overall Study|Adverse Event|29
7858058|NCT00086684|27257004|P3|Overall Study|Other|3
7858059|NCT00086684|27257005|P2|Overall Study|Other|2
7858060|NCT00086684|27257006|P1|Overall Study|Other|4
7858061|NCT00086684|27257004|P3|Overall Study|WITHDRAWAL OF CONSENT|5
7858062|NCT00086684|27257005|P2|Overall Study|WITHDRAWAL OF CONSENT|7
7858063|NCT00086684|27257006|P1|Overall Study|WITHDRAWAL OF CONSENT|5
7858064|NCT00086684|27257004|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
7858065|NCT00086684|27257005|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
7858066|NCT00086684|27257006|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
7858067|NCT00086684|27257004|P3|Overall Study|NONCOMPLIANCE|6
7858068|NCT00086684|27257005|P2|Overall Study|NONCOMPLIANCE|7
7858069|NCT00086684|27257006|P1|Overall Study|NONCOMPLIANCE|5
7858070|NCT00086684|27257004|P3|Overall Study|Withdrawal by Subject|10
7858071|NCT00086684|27257005|P2|Overall Study|Withdrawal by Subject|4
7858072|NCT00086684|27257006|P1|Overall Study|Withdrawal by Subject|0
7858073|NCT00086684|27257004|P3|Overall Study|Protocol Violation|0
7858074|NCT00086684|27257005|P2|Overall Study|Protocol Violation|3
7858075|NCT00086684|27257006|P1|Overall Study|Protocol Violation|8
7858076|NCT00086684|27257004|P3|Overall Study|Lost to Follow-up|10
7858077|NCT00086684|27257005|P2|Overall Study|Lost to Follow-up|8
7858078|NCT00086684|27257006|P1|Overall Study|Lost to Follow-up|15
7858079|NCT00086684|27257004|P3|Overall Study|Lack of Efficacy|5
7858080|NCT00086684|27257005|P2|Overall Study|Lack of Efficacy|6
7858081|NCT00086684|27257006|P1|Overall Study|Lack of Efficacy|6
7858082|NCT00086684|27257004|P3|Overall Study|Adverse Event|14
7858083|NCT00086684|27257005|P2|Overall Study|Adverse Event|17
7858084|NCT00086684|27257006|P1|Overall Study|Adverse Event|12
7858085|NCT00086619|27257019|P2|Overall Study|Protocol Violation|1
7858086|NCT00086619|27257020|P1|Overall Study|Protocol Violation|1
7858087|NCT00086619|27257019|P2|Overall Study|Adverse Event|10
7858088|NCT00086619|27257020|P1|Overall Study|Adverse Event|8
7858089|NCT00086619|27257019|P2|Overall Study|Withdrawal by Subject|6
7858090|NCT00086619|27257020|P1|Overall Study|Withdrawal by Subject|6
7858091|NCT00086580|27257030|P2|Observation Period|Other|7
7858092|NCT00086580|27257031|P1|Observation Period|Other|8
7858093|NCT00086580|27257030|P2|Observation Period|Death|55
7858094|NCT00086580|27257031|P1|Observation Period|Death|33
7858095|NCT00086580|27257030|P2|Observation Period|Withdrawal by Subject|2
7858096|NCT00086580|27257031|P1|Observation Period|Withdrawal by Subject|4
7858097|NCT00086580|27257030|P2|Observation Period|Unable to comply with protocol|1
7858098|NCT00086580|27257031|P1|Observation Period|Unable to comply with protocol|1
7858099|NCT00086580|27257030|P2|Follow-up Period|Other|6
7858100|NCT00086580|27257031|P1|Follow-up Period|Other|7
7858101|NCT00086580|27257030|P2|Follow-up Period|Death|7
7858102|NCT00086580|27257031|P1|Follow-up Period|Death|13
7858103|NCT00086580|27257030|P2|Follow-up Period|AE - not related|0
7858104|NCT00086580|27257031|P1|Follow-up Period|AE - not related|1
7858105|NCT00086580|27257030|P2|Follow-up Period|Physician Decision|1
7858106|NCT00086580|27257031|P1|Follow-up Period|Physician Decision|0
7858107|NCT00086580|27257030|P2|Follow-up Period|Withdrawal by Subject|6
7858108|NCT00086580|27257031|P1|Follow-up Period|Withdrawal by Subject|6
7858109|NCT00086580|27257030|P2|Follow-up Period|Unable to comply with protocol|0
7858110|NCT00086580|27257031|P1|Follow-up Period|Unable to comply with protocol|5
7858111|NCT00086580|27257030|P2|Follow-up Period|Disease progression|99
7858112|NCT00086580|27257031|P1|Follow-up Period|Disease progression|72
7858113|NCT00086580|27257030|P2|Treatment Period|Other|3
7858114|NCT00086580|27257031|P1|Treatment Period|Other|5
7858115|NCT00086580|27257030|P2|Treatment Period|Death|7
7858116|NCT00086580|27257031|P1|Treatment Period|Death|5
7858117|NCT00086580|27257030|P2|Treatment Period|Anemia or thrombocytopenia|4
7858118|NCT00086580|27257031|P1|Treatment Period|Anemia or thrombocytopenia|1
7858119|NCT00086580|27257030|P2|Treatment Period|Toxicity - treatment related|15
7858120|NCT00086580|27257031|P1|Treatment Period|Toxicity - treatment related|15
7858121|NCT00086580|27257030|P2|Treatment Period|AE - not treatment related|7
7858122|NCT00086580|27257031|P1|Treatment Period|AE - not treatment related|7
7858123|NCT00086580|27257030|P2|Treatment Period|Physician Decision|7
7858124|NCT00086580|27257031|P1|Treatment Period|Physician Decision|13
7858125|NCT00086580|27257030|P2|Treatment Period|Withdrawal by Subject|8
7858126|NCT00086580|27257031|P1|Treatment Period|Withdrawal by Subject|7
7858127|NCT00086580|27257030|P2|Treatment Period|Unable to comply with protocol|1
7858128|NCT00086580|27257031|P1|Treatment Period|Unable to comply with protocol|3
7858129|NCT00086580|27257030|P2|Treatment Period|Disease progression|8
7858130|NCT00086580|27257031|P1|Treatment Period|Disease progression|9
7858131|NCT00086411|27257079|P4|Overall Study|Lost to Follow-up|12
7858132|NCT00086411|27257080|P3|Overall Study|Lost to Follow-up|13
7858133|NCT00086411|27257081|P2|Overall Study|Lost to Follow-up|11
7858134|NCT00086411|27257082|P1|Overall Study|Lost to Follow-up|11
7858135|NCT00086385|27257100|P4|Overall Study|Death|1
7858136|NCT00086385|27257101|P3|Overall Study|Death|1
7858137|NCT00086385|27257102|P2|Overall Study|Death|2
7858138|NCT00086385|27257103|P1|Overall Study|Death|2
7858139|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Discontinued in error|0
7858140|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Discontinued in error|1
7858141|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
7858142|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
7858143|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
7858144|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
7858145|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Patient Died|1
7858146|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Patient Died|3
7858147|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
7858148|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
7858149|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
7858150|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
7858151|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Patient Moved|2
7858152|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Patient Moved|2
7858153|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
7858154|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
7858155|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Protocol Violation|0
7858156|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Protocol Violation|1
7858157|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Physician Decision|0
7858158|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Physician Decision|3
7858159|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
7858160|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
7858161|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
7858162|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
7858163|NCT00086515|27257115|P2|Phase B (Weeks 24-104)|Adverse Event|10
7858164|NCT00086515|27257116|P1|Phase B (Weeks 24-104)|Adverse Event|16
7858165|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
7858166|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
7858167|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Poor compliance|0
7858168|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Poor compliance|1
7858169|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
7858170|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
7858171|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
7858172|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
7858173|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Protocol Violation|1
7858174|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Protocol Violation|0
7858175|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
7858176|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
7858177|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
7858178|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
7858179|NCT00086515|27257115|P2|Phase A to Phase B Transition Period|Adverse Event|1
7858180|NCT00086515|27257116|P1|Phase A to Phase B Transition Period|Adverse Event|2
7858181|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
7858182|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
7858183|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
7858184|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
7858185|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Poor compliance|0
7858186|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Poor compliance|1
7858187|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
7858188|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
7858189|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Patient Moved|3
7858190|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Patient Moved|2
7858191|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
7858192|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
7858193|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Protocol Violation|1
7858194|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Protocol Violation|3
7858195|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
7858196|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
7858197|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
7858198|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
7858199|NCT00086515|27257115|P2|Phase A (Weeks 0-24)|Adverse Event|9
7858200|NCT00086515|27257116|P1|Phase A (Weeks 0-24)|Adverse Event|17
7858201|NCT00086502|27257128|P2|Overall Study|Patient Accidentally Unblinded|0
7858202|NCT00086502|27257129|P1|Overall Study|Patient Accidentally Unblinded|1
7858203|NCT00086502|27257128|P2|Overall Study|Protocol Discontinuation Criteria|3
7858204|NCT00086502|27257129|P1|Overall Study|Protocol Discontinuation Criteria|1
7858205|NCT00086502|27257128|P2|Overall Study|Patient Moved|1
7858206|NCT00086502|27257129|P1|Overall Study|Patient Moved|1
7858207|NCT00086502|27257128|P2|Overall Study|Withdrawal by Subject|6
7858208|NCT00086502|27257129|P1|Overall Study|Withdrawal by Subject|5
7858209|NCT00086502|27257128|P2|Overall Study|Protocol Violation|3
7858210|NCT00086502|27257129|P1|Overall Study|Protocol Violation|3
7858211|NCT00086502|27257128|P2|Overall Study|Pregnancy|1
7858212|NCT00086502|27257129|P1|Overall Study|Pregnancy|0
7858213|NCT00086502|27257128|P2|Overall Study|Physician Decision|1
7858214|NCT00086502|27257129|P1|Overall Study|Physician Decision|1
7858215|NCT00086502|27257128|P2|Overall Study|Lost to Follow-up|1
7858216|NCT00086502|27257129|P1|Overall Study|Lost to Follow-up|3
7858217|NCT00086502|27257128|P2|Overall Study|Lack of Efficacy|2
7858218|NCT00086502|27257129|P1|Overall Study|Lack of Efficacy|0
7858219|NCT00086502|27257128|P2|Overall Study|Adverse Event|2
7858220|NCT00086502|27257129|P1|Overall Study|Adverse Event|11
7858221|NCT00086346|27257154|P2|Patients Dosed With Test Article|Lack of Efficacy|0
7858222|NCT00086346|27257155|P1|Patients Dosed With Test Article|Lack of Efficacy|11
7858223|NCT00086346|27257154|P2|Patients Dosed With Test Article|Protocol Violation|3
7858224|NCT00086346|27257155|P1|Patients Dosed With Test Article|Protocol Violation|11
7858225|NCT00086346|27257154|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
7858226|NCT00086346|27257155|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
7858227|NCT00086346|27257154|P2|Patients Dosed With Test Article|Nonmedical event|3
7858228|NCT00086346|27257155|P1|Patients Dosed With Test Article|Nonmedical event|7
7858229|NCT00086346|27257154|P2|Patients Dosed With Test Article|Lost to Follow-up|3
7858230|NCT00086346|27257155|P1|Patients Dosed With Test Article|Lost to Follow-up|1
7858231|NCT00086346|27257154|P2|Patients Dosed With Test Article|Adverse Event|11
7858232|NCT00086346|27257155|P1|Patients Dosed With Test Article|Adverse Event|94
7858233|NCT00086346|27257154|P2|Randomization|Did not receive test article|4
7858234|NCT00086346|27257155|P1|Randomization|Did not receive test article|4
7858235|NCT00086281|27257182|P15|Phase 2|Adverse Event|0
7858236|NCT00086281|27257183|P14|Phase 2|Adverse Event|1
7858237|NCT00086281|27257184|P13|Phase 2|Adverse Event|1
7858238|NCT00086281|27257185|P12|Phase 2|Adverse Event|0
7858239|NCT00086281|27257186|P11|Phase 2|Adverse Event|0
7858240|NCT00086281|27257187|P10|Phase 2|Adverse Event|0
7858241|NCT00086281|27257188|P9|Phase 2|Adverse Event|0
7858242|NCT00086281|27257189|P8|Phase 2|Adverse Event|0
7858243|NCT00086281|27257190|P7|Phase 2|Adverse Event|0
7858244|NCT00086281|27257191|P6|Phase 2|Adverse Event|0
7858245|NCT00086281|27257192|P5|Phase 2|Adverse Event|0
7858246|NCT00086281|27257193|P4|Phase 2|Adverse Event|0
7858247|NCT00086281|27257194|P3|Phase 2|Adverse Event|0
7858248|NCT00086281|27257195|P2|Phase 2|Adverse Event|0
7858249|NCT00086281|27257196|P1|Phase 2|Adverse Event|0
7858250|NCT00086281|27257182|P15|Phase 1|Serious Adverse Event|1
7858251|NCT00086281|27257183|P14|Phase 1|Serious Adverse Event|0
7858252|NCT00086281|27257184|P13|Phase 1|Serious Adverse Event|0
7858253|NCT00086281|27257185|P12|Phase 1|Serious Adverse Event|0
7858254|NCT00086281|27257186|P11|Phase 1|Serious Adverse Event|0
7858255|NCT00086281|27257187|P10|Phase 1|Serious Adverse Event|0
7858256|NCT00086281|27257188|P9|Phase 1|Serious Adverse Event|0
7858257|NCT00086281|27257189|P8|Phase 1|Serious Adverse Event|0
7858258|NCT00086281|27257190|P7|Phase 1|Serious Adverse Event|0
7858259|NCT00086281|27257191|P6|Phase 1|Serious Adverse Event|0
7858260|NCT00086281|27257192|P5|Phase 1|Serious Adverse Event|0
7858261|NCT00086281|27257193|P4|Phase 1|Serious Adverse Event|0
7858262|NCT00086281|27257194|P3|Phase 1|Serious Adverse Event|0
7858263|NCT00086281|27257195|P2|Phase 1|Serious Adverse Event|0
7858264|NCT00086281|27257196|P1|Phase 1|Serious Adverse Event|0
7858265|NCT00086281|27257182|P15|Phase 1|Protocol Violation|0
7858266|NCT00086281|27257183|P14|Phase 1|Protocol Violation|0
7858267|NCT00086281|27257184|P13|Phase 1|Protocol Violation|0
7858268|NCT00086281|27257185|P12|Phase 1|Protocol Violation|0
7858269|NCT00086281|27257186|P11|Phase 1|Protocol Violation|1
7858270|NCT00086281|27257187|P10|Phase 1|Protocol Violation|0
7858271|NCT00086281|27257188|P9|Phase 1|Protocol Violation|0
7858272|NCT00086281|27257189|P8|Phase 1|Protocol Violation|0
7858273|NCT00086281|27257190|P7|Phase 1|Protocol Violation|0
7858274|NCT00086281|27257191|P6|Phase 1|Protocol Violation|0
7858275|NCT00086281|27257192|P5|Phase 1|Protocol Violation|0
7858276|NCT00086281|27257193|P4|Phase 1|Protocol Violation|0
7858277|NCT00086281|27257194|P3|Phase 1|Protocol Violation|0
7858278|NCT00086281|27257195|P2|Phase 1|Protocol Violation|0
7858279|NCT00086281|27257196|P1|Phase 1|Protocol Violation|0
7858280|NCT00086281|27257182|P15|Phase 1|Adverse Event|2
7858281|NCT00086281|27257183|P14|Phase 1|Adverse Event|1
7858282|NCT00086281|27257184|P13|Phase 1|Adverse Event|1
7858283|NCT00086281|27257185|P12|Phase 1|Adverse Event|1
7858284|NCT00086281|27257186|P11|Phase 1|Adverse Event|2
7858285|NCT00086281|27257187|P10|Phase 1|Adverse Event|1
7858286|NCT00086281|27257188|P9|Phase 1|Adverse Event|0
7858287|NCT00086281|27257189|P8|Phase 1|Adverse Event|0
7858288|NCT00086281|27257190|P7|Phase 1|Adverse Event|0
7858289|NCT00086281|27257191|P6|Phase 1|Adverse Event|0
7858290|NCT00086281|27257192|P5|Phase 1|Adverse Event|0
7858291|NCT00086281|27257193|P4|Phase 1|Adverse Event|0
7858292|NCT00086281|27257194|P3|Phase 1|Adverse Event|0
7858293|NCT00086281|27257195|P2|Phase 1|Adverse Event|0
7858294|NCT00086281|27257196|P1|Phase 1|Adverse Event|0
7858295|NCT00086307|27257209|P3|Overall Study|Withdrawal by Subject|2
7858296|NCT00086307|27257210|P2|Overall Study|Withdrawal by Subject|0
7858297|NCT00086307|27257211|P1|Overall Study|Withdrawal by Subject|0
7858298|NCT00086307|27257209|P3|Overall Study|Fatigue and difficulty falling asleep|1
7858299|NCT00086307|27257210|P2|Overall Study|Fatigue and difficulty falling asleep|0
7858300|NCT00086307|27257211|P1|Overall Study|Fatigue and difficulty falling asleep|0
7858301|NCT00086307|27257209|P3|Overall Study|Suicidal ideation|1
7858302|NCT00086307|27257210|P2|Overall Study|Suicidal ideation|0
7858303|NCT00086307|27257211|P1|Overall Study|Suicidal ideation|0
7858304|NCT00086307|27257209|P3|Overall Study|Constipation and sleepiness|1
7858305|NCT00086307|27257210|P2|Overall Study|Constipation and sleepiness|0
7858306|NCT00086307|27257211|P1|Overall Study|Constipation and sleepiness|0
7858307|NCT00086307|27257209|P3|Overall Study|Nausea and headaches|1
7858308|NCT00086307|27257210|P2|Overall Study|Nausea and headaches|0
7858309|NCT00086307|27257211|P1|Overall Study|Nausea and headaches|0
7858310|NCT00086307|27257209|P3|Overall Study|Shortness of breath and muscle spasms|0
7858311|NCT00086307|27257210|P2|Overall Study|Shortness of breath and muscle spasms|0
7858312|NCT00086307|27257211|P1|Overall Study|Shortness of breath and muscle spasms|1
7858313|NCT00086307|27257209|P3|Overall Study|Lack of Efficacy|2
7858314|NCT00086307|27257210|P2|Overall Study|Lack of Efficacy|1
7858315|NCT00086307|27257211|P1|Overall Study|Lack of Efficacy|1
7858316|NCT00086190|27257222|P3|Overall Study|Worsening depression|2
7858317|NCT00086190|27257223|P2|Overall Study|Worsening depression|0
7858318|NCT00086190|27257224|P1|Overall Study|Worsening depression|0
7858319|NCT00086190|27257222|P3|Overall Study|Moved|0
7858320|NCT00086190|27257223|P2|Overall Study|Moved|0
7858321|NCT00086190|27257224|P1|Overall Study|Moved|1
7858322|NCT00086190|27257222|P3|Overall Study|Protocol Violation|0
7858323|NCT00086190|27257223|P2|Overall Study|Protocol Violation|0
7858324|NCT00086190|27257224|P1|Overall Study|Protocol Violation|1
7858325|NCT00086190|27257222|P3|Overall Study|Withdrawal by Subject|2
7858326|NCT00086190|27257223|P2|Overall Study|Withdrawal by Subject|2
7858327|NCT00086190|27257224|P1|Overall Study|Withdrawal by Subject|0
7858328|NCT00086190|27257222|P3|Overall Study|Adverse Event|2
7858329|NCT00086190|27257223|P2|Overall Study|Adverse Event|2
7858330|NCT00086190|27257224|P1|Overall Study|Adverse Event|6
7858331|NCT00086047|27257293|P2|Overall Study|Physician Decision|1
7858332|NCT00086047|27257294|P1|Overall Study|Physician Decision|0
7858333|NCT00086047|27257293|P2|Overall Study|Lost to Follow-up|6
7858334|NCT00086047|27257294|P1|Overall Study|Lost to Follow-up|7
7858335|NCT00085917|27257302|P2|Overall Study|Adverse Event|3
7858336|NCT00085917|27257303|P1|Overall Study|Adverse Event|4
7858337|NCT00085735|27257332|P6|Overall Study|Pt transferred to inst w/out study open|0
7858338|NCT00085735|27257333|P5|Overall Study|Pt transferred to inst w/out study open|0
7858339|NCT00085735|27257334|P4|Overall Study|Pt transferred to inst w/out study open|0
7858340|NCT00085735|27257335|P3|Overall Study|Pt transferred to inst w/out study open|0
7858341|NCT00085735|27257336|P2|Overall Study|Pt transferred to inst w/out study open|0
7858342|NCT00085735|27257337|P1|Overall Study|Pt transferred to inst w/out study open|1
7858343|NCT00085735|27257332|P6|Overall Study|Reason not documented|0
7858344|NCT00085735|27257333|P5|Overall Study|Reason not documented|1
7858345|NCT00085735|27257334|P4|Overall Study|Reason not documented|0
7858346|NCT00085735|27257335|P3|Overall Study|Reason not documented|1
7858347|NCT00085735|27257336|P2|Overall Study|Reason not documented|0
7858348|NCT00085735|27257337|P1|Overall Study|Reason not documented|1
7858349|NCT00085735|27257332|P6|Overall Study|Excess residual disease|4
7858350|NCT00085735|27257333|P5|Overall Study|Excess residual disease|1
7858351|NCT00085735|27257334|P4|Overall Study|Excess residual disease|1
7858352|NCT00085735|27257335|P3|Overall Study|Excess residual disease|1
7858353|NCT00085735|27257336|P2|Overall Study|Excess residual disease|2
7858354|NCT00085735|27257337|P1|Overall Study|Excess residual disease|2
7858355|NCT00085735|27257332|P6|Overall Study|Patient ineligible|8
7858356|NCT00085735|27257333|P5|Overall Study|Patient ineligible|17
7858357|NCT00085735|27257334|P4|Overall Study|Patient ineligible|7
7858358|NCT00085735|27257335|P3|Overall Study|Patient ineligible|3
7858359|NCT00085735|27257336|P2|Overall Study|Patient ineligible|0
7858360|NCT00085735|27257337|P1|Overall Study|Patient ineligible|1
7858361|NCT00085735|27257332|P6|Overall Study|Withdrawal by Subject|8
7858362|NCT00085735|27257333|P5|Overall Study|Withdrawal by Subject|7
7858363|NCT00085735|27257334|P4|Overall Study|Withdrawal by Subject|5
7858364|NCT00085735|27257335|P3|Overall Study|Withdrawal by Subject|4
7858365|NCT00085735|27257336|P2|Overall Study|Withdrawal by Subject|0
7858366|NCT00085735|27257337|P1|Overall Study|Withdrawal by Subject|1
7858367|NCT00085735|27257332|P6|Overall Study|Protocol Violation|0
7858368|NCT00085735|27257333|P5|Overall Study|Protocol Violation|0
7858369|NCT00085735|27257334|P4|Overall Study|Protocol Violation|0
7858370|NCT00085735|27257335|P3|Overall Study|Protocol Violation|0
7858371|NCT00085735|27257336|P2|Overall Study|Protocol Violation|0
7858372|NCT00085735|27257337|P1|Overall Study|Protocol Violation|1
7858373|NCT00085735|27257332|P6|Overall Study|Physician Decision|8
7858374|NCT00085735|27257333|P5|Overall Study|Physician Decision|11
7858375|NCT00085735|27257334|P4|Overall Study|Physician Decision|3
7858376|NCT00085735|27257335|P3|Overall Study|Physician Decision|2
7858377|NCT00085735|27257336|P2|Overall Study|Physician Decision|3
7858378|NCT00085735|27257337|P1|Overall Study|Physician Decision|2
7858379|NCT00085735|27257332|P6|Overall Study|Lost to Follow-up|0
7858380|NCT00085735|27257333|P5|Overall Study|Lost to Follow-up|1
7858381|NCT00085735|27257334|P4|Overall Study|Lost to Follow-up|0
7858382|NCT00085735|27257335|P3|Overall Study|Lost to Follow-up|0
7858383|NCT00085735|27257336|P2|Overall Study|Lost to Follow-up|1
7858384|NCT00085735|27257337|P1|Overall Study|Lost to Follow-up|0
7858385|NCT00085735|27257332|P6|Overall Study|Lack of Efficacy|3
7858386|NCT00085735|27257333|P5|Overall Study|Lack of Efficacy|4
7858387|NCT00085735|27257334|P4|Overall Study|Lack of Efficacy|3
7858388|NCT00085735|27257335|P3|Overall Study|Lack of Efficacy|6
7858389|NCT00085735|27257336|P2|Overall Study|Lack of Efficacy|4
7858390|NCT00085735|27257337|P1|Overall Study|Lack of Efficacy|2
7858391|NCT00085735|27257332|P6|Overall Study|Adverse Event|0
7858392|NCT00085735|27257333|P5|Overall Study|Adverse Event|0
7858393|NCT00085735|27257334|P4|Overall Study|Adverse Event|0
7858394|NCT00085735|27257335|P3|Overall Study|Adverse Event|0
7858395|NCT00085735|27257336|P2|Overall Study|Adverse Event|0
7858396|NCT00085735|27257337|P1|Overall Study|Adverse Event|1
7858397|NCT00085709|27257392|P2|Overall Study|Withdrawal by Subject|1
7858398|NCT00085709|27257393|P1|Overall Study|Withdrawal by Subject|2
7858399|NCT00085709|27257392|P2|Overall Study|Not eligible|19
7858400|NCT00085709|27257393|P1|Overall Study|Not eligible|19
7858401|NCT00085709|27257392|P2|Overall Study|Not protocol specified|22
7858402|NCT00085709|27257393|P1|Overall Study|Not protocol specified|12
7858403|NCT00085709|27257392|P2|Overall Study|Progression|4
7858404|NCT00085709|27257393|P1|Overall Study|Progression|3
7858405|NCT00085709|27257392|P2|Overall Study|Refusal unrelated to adverse events|2
7858406|NCT00085709|27257393|P1|Overall Study|Refusal unrelated to adverse events|1
7858407|NCT00085709|27257392|P2|Overall Study|Death|2
7858408|NCT00085709|27257393|P1|Overall Study|Death|8
7858409|NCT00085709|27257392|P2|Overall Study|Adverse Event|0
7858410|NCT00085709|27257393|P1|Overall Study|Adverse Event|8
7858411|NCT00085644|27257409|P3|Open-Label Period|Personal reason|4
7858412|NCT00085644|27257410|P2|Open-Label Period|Personal reason|0
7858413|NCT00085644|27257411|P1|Open-Label Period|Personal reason|0
7858414|NCT00085644|27257409|P3|Open-Label Period|Protocol Violation|4
7858415|NCT00085644|27257410|P2|Open-Label Period|Protocol Violation|0
7858416|NCT00085644|27257411|P1|Open-Label Period|Protocol Violation|0
7858417|NCT00085644|27257409|P3|Open-Label Period|Contemplating pregnancy|3
7858418|NCT00085644|27257410|P2|Open-Label Period|Contemplating pregnancy|0
7858419|NCT00085644|27257411|P1|Open-Label Period|Contemplating pregnancy|0
7858420|NCT00085644|27257409|P3|Open-Label Period|Pregnancy|3
7858421|NCT00085644|27257410|P2|Open-Label Period|Pregnancy|0
7858422|NCT00085644|27257411|P1|Open-Label Period|Pregnancy|0
7858423|NCT00085644|27257409|P3|Open-Label Period|Lack of Efficacy|15
7858424|NCT00085644|27257410|P2|Open-Label Period|Lack of Efficacy|0
7858425|NCT00085644|27257411|P1|Open-Label Period|Lack of Efficacy|0
7858426|NCT00085644|27257409|P3|Open-Label Period|Lost to Follow-up|13
7858427|NCT00085644|27257410|P2|Open-Label Period|Lost to Follow-up|0
7858428|NCT00085644|27257411|P1|Open-Label Period|Lost to Follow-up|0
7858429|NCT00085644|27257409|P3|Open-Label Period|Withdrawal by Subject|29
7858430|NCT00085644|27257410|P2|Open-Label Period|Withdrawal by Subject|0
7858431|NCT00085644|27257411|P1|Open-Label Period|Withdrawal by Subject|0
7858432|NCT00085644|27257409|P3|Open-Label Period|Adverse Event|38
7858433|NCT00085644|27257410|P2|Open-Label Period|Adverse Event|0
7858434|NCT00085644|27257411|P1|Open-Label Period|Adverse Event|0
7858435|NCT00085644|27257409|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
7858436|NCT00085644|27257410|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
7858437|NCT00085644|27257411|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
7858438|NCT00085644|27257409|P3|Double-Blind Period|Contemplating pregnancy|0
7858439|NCT00085644|27257410|P2|Double-Blind Period|Contemplating pregnancy|0
7858440|NCT00085644|27257411|P1|Double-Blind Period|Contemplating pregnancy|1
7858441|NCT00085644|27257409|P3|Double-Blind Period|Lack/loss of efficacy|0
7858442|NCT00085644|27257410|P2|Double-Blind Period|Lack/loss of efficacy|2
7858443|NCT00085644|27257411|P1|Double-Blind Period|Lack/loss of efficacy|2
7858444|NCT00085644|27257409|P3|Double-Blind Period|Lost to Follow-up|0
7858445|NCT00085644|27257410|P2|Double-Blind Period|Lost to Follow-up|1
7858446|NCT00085644|27257411|P1|Double-Blind Period|Lost to Follow-up|2
7858447|NCT00085644|27257409|P3|Double-Blind Period|Withdrawal by Subject|0
7858448|NCT00085644|27257410|P2|Double-Blind Period|Withdrawal by Subject|0
7858449|NCT00085644|27257411|P1|Double-Blind Period|Withdrawal by Subject|3
7858450|NCT00085644|27257409|P3|Double-Blind Period|Adverse Event|0
7858451|NCT00085644|27257410|P2|Double-Blind Period|Adverse Event|2
7858452|NCT00085644|27257411|P1|Double-Blind Period|Adverse Event|5
7858453|NCT00085631|27257452|P3|Overall Study|Missing Data|7
7858454|NCT00085631|27257453|P2|Overall Study|Missing Data|11
7858455|NCT00085631|27257454|P1|Overall Study|Missing Data|4
7858456|NCT00085566|27257464|P3|Overall Study|Clinical progression|1
7858457|NCT00085566|27257465|P2|Overall Study|Clinical progression|0
7858458|NCT00085566|27257466|P1|Overall Study|Clinical progression|0
7858459|NCT00085566|27257464|P3|Overall Study|Patient Not treated|3
7858460|NCT00085566|27257465|P2|Overall Study|Patient Not treated|0
7858461|NCT00085566|27257466|P1|Overall Study|Patient Not treated|0
7858462|NCT00085566|27257464|P3|Overall Study|Adverse Event|10
7858463|NCT00085566|27257465|P2|Overall Study|Adverse Event|0
7858464|NCT00085566|27257466|P1|Overall Study|Adverse Event|0
7858465|NCT00085540|27257476|P2|Overall Study|Protocol Violation|1
7858466|NCT00085540|27257477|P1|Overall Study|Protocol Violation|0
7858467|NCT00085540|27257476|P2|Overall Study|Withdrawal by Subject|1
7858468|NCT00085540|27257477|P1|Overall Study|Withdrawal by Subject|0
7858469|NCT00085423|27257489|P1|Overall Study|screen failure|1
7858470|NCT00085423|27257489|P1|Overall Study|Withdrawal by Subject|1
7858471|NCT00085202|27257540|P2|Overall Study|Progressive disease|11
7858472|NCT00085202|27257541|P1|Overall Study|Progressive disease|1
7858473|NCT00085202|27257540|P2|Overall Study|Physician Decision|1
7858474|NCT00085202|27257541|P1|Overall Study|Physician Decision|4
7858475|NCT00085202|27257540|P2|Overall Study|Withdrawal by Subject|1
7858476|NCT00085202|27257541|P1|Overall Study|Withdrawal by Subject|2
7858477|NCT00085202|27257540|P2|Overall Study|Non-specified|5
7858478|NCT00085202|27257541|P1|Overall Study|Non-specified|3
7858479|NCT00085202|27257540|P2|Overall Study|Excessive toxicity|5
7858480|NCT00085202|27257541|P1|Overall Study|Excessive toxicity|6
7858481|NCT00085202|27257540|P2|Overall Study|Bone involvement confirmed by bone scan|1
7858482|NCT00085202|27257541|P1|Overall Study|Bone involvement confirmed by bone scan|0
7858483|NCT00085202|27257540|P2|Overall Study|Still on therapy|0
7858484|NCT00085202|27257541|P1|Overall Study|Still on therapy|2
7858485|NCT00085098|27257562|P2|Overall Study|Ineligible|1
7858486|NCT00085098|27257563|P1|Overall Study|Ineligible|1
7858487|NCT00085098|27257562|P2|Overall Study|Withdrawal by Subject|1
7858488|NCT00085098|27257563|P1|Overall Study|Withdrawal by Subject|0
7858489|NCT00084929|27257573|P1|Overall Study|Missing Reference Standard (Colonoscopy)|42
7858490|NCT00084929|27257573|P1|Overall Study|Missing/incomplete CTC exam|9
7858491|NCT00084929|27257573|P1|Overall Study|Withdrawal by Subject|10
7858492|NCT00084929|27257573|P1|Overall Study|Ineligible - Medical history|6
7858493|NCT00084929|27257573|P1|Overall Study|ineligible - Pre-scheduled procedure not|1
7858494|NCT00084929|27257573|P1|Overall Study|ineligible - medical contraindication|1
7858495|NCT00084864|27257595|P4|Overall Study|Adverse Event|0
7858496|NCT00084864|27257596|P3|Overall Study|Adverse Event|0
7858497|NCT00084864|27257597|P2|Overall Study|Adverse Event|0
7858498|NCT00084864|27257598|P1|Overall Study|Adverse Event|1
7858499|NCT00084838|27257624|P1|Overall Study|Ineligible|4
7858500|NCT00084838|27257624|P1|Overall Study|Pt Non-Compliance|1
7858501|NCT00084838|27257624|P1|Overall Study|Progressive Disease|4
7858502|NCT00084838|27257624|P1|Overall Study|Withdrawal by Subject|1
7858503|NCT00084838|27257624|P1|Overall Study|Adverse Event|2
7858504|NCT00084838|27257624|P1|Overall Study|Death|1
7858505|NCT00084747|27257646|P1|Overall Study|Withdrawal by Subject|2
7858506|NCT00084747|27257646|P1|Overall Study|Death|3
7858507|NCT00084747|27257646|P1|Overall Study|Relapsed|8
7858508|NCT00084682|27257651|P1|Overall Study|Withdrawal by Subject|1
7858509|NCT00084617|27257658|P1|Overall Study|Protocol Violation|1
7858510|NCT00084617|27257658|P1|Overall Study|Lack of Efficacy|1
7858511|NCT00084617|27257658|P1|Overall Study|Withdrawal by Subject|7
7858512|NCT00084487|27257679|P1|Overall Study|Death|1
7858513|NCT00084318|27257723|P2|Overall Study|No protocol treatment|0
7858514|NCT00084318|27257724|P1|Overall Study|No protocol treatment|2
7858515|NCT00084318|27257723|P2|Overall Study|Protocol Violation|11
7858516|NCT00084318|27257724|P1|Overall Study|Protocol Violation|15
7858517|NCT00084318|27257723|P2|Overall Study|Withdrawal by Subject|2
7858518|NCT00084318|27257724|P1|Overall Study|Withdrawal by Subject|5
7858519|NCT00084266|27257744|P2|Overall Study|Randomized not treated|20
7858520|NCT00084266|27257745|P1|Overall Study|Randomized not treated|21
7858521|NCT00084266|27257744|P2|Overall Study|Other|344
7858522|NCT00084266|27257745|P1|Overall Study|Other|360
7858523|NCT00084266|27257744|P2|Overall Study|Participant not willing to participate|8
7858524|NCT00084266|27257745|P1|Overall Study|Participant not willing to participate|3
7858525|NCT00084266|27257744|P2|Overall Study|Lost to Follow-up|3
7858526|NCT00084266|27257745|P1|Overall Study|Lost to Follow-up|5
7858527|NCT00084266|27257744|P2|Overall Study|Lack of Efficacy|4
7858528|NCT00084266|27257745|P1|Overall Study|Lack of Efficacy|2
7858529|NCT00084266|27257744|P2|Overall Study|Adverse Event|5
7858530|NCT00084266|27257745|P1|Overall Study|Adverse Event|8
7858531|NCT00084266|27257744|P2|Overall Study|Death|39
7858532|NCT00084266|27257745|P1|Overall Study|Death|42
7858533|NCT00084136|27257803|P3|NRTI Comparison|Not reason above|0
7858534|NCT00084136|27257804|P2|NRTI Comparison|Not reason above|0
7858535|NCT00084136|27257805|P1|NRTI Comparison|Not reason above|1
7858536|NCT00084136|27257803|P3|NRTI Comparison|Clinic site closed|14
7858537|NCT00084136|27257804|P2|NRTI Comparison|Clinic site closed|0
7858538|NCT00084136|27257805|P1|NRTI Comparison|Clinic site closed|12
7858539|NCT00084136|27257803|P3|NRTI Comparison|Withdrawal by Subject|38
7858540|NCT00084136|27257804|P2|NRTI Comparison|Withdrawal by Subject|0
7858541|NCT00084136|27257805|P1|NRTI Comparison|Withdrawal by Subject|54
7858542|NCT00084136|27257803|P3|NRTI Comparison|Lost to Follow-up|12
7858543|NCT00084136|27257804|P2|NRTI Comparison|Lost to Follow-up|0
7858544|NCT00084136|27257805|P1|NRTI Comparison|Lost to Follow-up|14
7858545|NCT00084136|27257803|P3|NRTI Comparison|Death|18
7858546|NCT00084136|27257804|P2|NRTI Comparison|Death|0
7858547|NCT00084136|27257805|P1|NRTI Comparison|Death|20
7858548|NCT00084136|27257803|P3|PI Comparison|Clinic site closed|0
7858549|NCT00084136|27257804|P2|PI Comparison|Clinic site closed|0
7858550|NCT00084136|27257805|P1|PI Comparison|Clinic site closed|1
7858551|NCT00084136|27257803|P3|PI Comparison|Withdrawal by Subject|0
7858552|NCT00084136|27257804|P2|PI Comparison|Withdrawal by Subject|30
7858553|NCT00084136|27257805|P1|PI Comparison|Withdrawal by Subject|33
7858554|NCT00084136|27257803|P3|PI Comparison|Lost to Follow-up|0
7858555|NCT00084136|27257804|P2|PI Comparison|Lost to Follow-up|8
7858556|NCT00084136|27257805|P1|PI Comparison|Lost to Follow-up|11
7858557|NCT00084136|27257803|P3|PI Comparison|Death|0
7858558|NCT00084136|27257804|P2|PI Comparison|Death|9
7858559|NCT00084136|27257805|P1|PI Comparison|Death|10
7858560|NCT00084084|27257864|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
7858561|NCT00084084|27257864|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
7858562|NCT00083915|27257880|P2|Overall Study|Insurance issues|1
7858563|NCT00083915|27257881|P1|Overall Study|Insurance issues|1
7858564|NCT00083915|27257880|P2|Overall Study|No response|1
7858565|NCT00083915|27257881|P1|Overall Study|No response|3
7858566|NCT00083915|27257880|P2|Overall Study|Failure to collect|0
7858567|NCT00083915|27257881|P1|Overall Study|Failure to collect|3
7858568|NCT00083915|27257880|P2|Overall Study|disease progression|23
7858569|NCT00083915|27257881|P1|Overall Study|disease progression|18
7858570|NCT00083915|27257880|P2|Overall Study|Withdrawal by Subject|3
7858571|NCT00083915|27257881|P1|Overall Study|Withdrawal by Subject|8
7858572|NCT00083915|27257880|P2|Overall Study|Physician Decision|6
7858573|NCT00083915|27257881|P1|Overall Study|Physician Decision|11
7858574|NCT00083915|27257880|P2|Overall Study|Death|3
7858575|NCT00083915|27257881|P1|Overall Study|Death|6
7858576|NCT00083889|27257889|P2|Overall Study|Crossover to SU011248|25
7858577|NCT00083889|27257890|P1|Overall Study|Crossover to SU011248|0
7858578|NCT00083889|27257889|P2|Overall Study|Completed on marketed sunitinub|0
7858579|NCT00083889|27257890|P1|Overall Study|Completed on marketed sunitinub|3
7858580|NCT00083889|27257889|P2|Overall Study|Randomized: did not take study drug|15
7858581|NCT00083889|27257890|P1|Overall Study|Randomized: did not take study drug|0
7858582|NCT00083889|27257889|P2|Overall Study|Decision of sponsor|4
7858583|NCT00083889|27257890|P1|Overall Study|Decision of sponsor|32
7858584|NCT00083889|27257889|P2|Overall Study|Lack of Efficacy|219
7858585|NCT00083889|27257890|P1|Overall Study|Lack of Efficacy|240
7858586|NCT00083889|27257889|P2|Overall Study|Withdrawal by Subject|24
7858587|NCT00083889|27257890|P1|Overall Study|Withdrawal by Subject|22
7858588|NCT00083889|27257889|P2|Overall Study|Protocol Violation|2
7858589|NCT00083889|27257890|P1|Overall Study|Protocol Violation|2
7858590|NCT00083889|27257889|P2|Overall Study|Adverse Event|86
7858591|NCT00083889|27257890|P1|Overall Study|Adverse Event|76
7858592|NCT00083759|27257948|P2|Overall Study|Other|13
7858593|NCT00083759|27257949|P1|Overall Study|Other|14
7858594|NCT00083759|27257948|P2|Overall Study|Sponsor's Discretion|29
7858595|NCT00083759|27257949|P1|Overall Study|Sponsor's Discretion|28
7858596|NCT00083759|27257948|P2|Overall Study|Non-Compliance|0
7858597|NCT00083759|27257949|P1|Overall Study|Non-Compliance|1
7858598|NCT00083759|27257948|P2|Overall Study|Subject Withdrew Consent|2
7858599|NCT00083759|27257949|P1|Overall Study|Subject Withdrew Consent|2
7858600|NCT00083759|27257948|P2|Overall Study|Inadequate Therapeutic Response|35
7858601|NCT00083759|27257949|P1|Overall Study|Inadequate Therapeutic Response|32
7858602|NCT00083759|27257948|P2|Overall Study|Death|1
7858603|NCT00083759|27257949|P1|Overall Study|Death|1
7858604|NCT00083759|27257948|P2|Overall Study|Lost to Follow-up|0
7858605|NCT00083759|27257949|P1|Overall Study|Lost to Follow-up|1
7858606|NCT00083759|27257948|P2|Overall Study|Adverse Event|3
7858607|NCT00083759|27257949|P1|Overall Study|Adverse Event|5
7858608|NCT00083616|27257967|P1|Overall Study|Other|6
7858609|NCT00083616|27257967|P1|Overall Study|Non-compliance|1
7858610|NCT00083616|27257967|P1|Overall Study|Ineligibility determined|2
7858611|NCT00083616|27257967|P1|Overall Study|Withdrawal by Subject|3
7858612|NCT00083616|27257967|P1|Overall Study|Physician Decision|2
7858613|NCT00083616|27257967|P1|Overall Study|Lost to Follow-up|1
7858614|NCT00083616|27257967|P1|Overall Study|Disease Progression|16
7858615|NCT00082888|27257995|P3|Overall Study|Ineligible|0
7858616|NCT00082888|27257996|P2|Overall Study|Ineligible|0
7858617|NCT00082888|27257997|P1|Overall Study|Ineligible|1
7858618|NCT00082810|27258017|P1|Overall Study|Withdrawal by Subject|4
7858619|NCT00082810|27258017|P1|Overall Study|Progressive disease|24
7858620|NCT00082810|27258017|P1|Overall Study|Adverse Event|3
7858621|NCT00082758|27258028|P3|Overall Study|Protocol Violation|0
7858622|NCT00082758|27258029|P2|Overall Study|Protocol Violation|1
7858623|NCT00082758|27258030|P1|Overall Study|Protocol Violation|0
7858624|NCT00082758|27258028|P3|Overall Study|Withdrawal by Subject|0
7858625|NCT00082758|27258029|P2|Overall Study|Withdrawal by Subject|0
7858626|NCT00082758|27258030|P1|Overall Study|Withdrawal by Subject|3
7858627|NCT00082758|27258028|P3|Overall Study|Physician Decision|0
7858628|NCT00082758|27258029|P2|Overall Study|Physician Decision|1
7858629|NCT00082758|27258030|P1|Overall Study|Physician Decision|0
7858630|NCT00082758|27258028|P3|Overall Study|Lack of Efficacy|0
7858631|NCT00082758|27258029|P2|Overall Study|Lack of Efficacy|13
7858632|NCT00082758|27258030|P1|Overall Study|Lack of Efficacy|12
7858633|NCT00082758|27258028|P3|Overall Study|Adverse Event|0
7858634|NCT00082758|27258029|P2|Overall Study|Adverse Event|2
7858635|NCT00082758|27258030|P1|Overall Study|Adverse Event|0
7858636|NCT00083226|27258050|P1|Overall Study|ineligible or not receiving treatment|4
7858637|NCT00083226|27258050|P1|Overall Study|Other|2
7858638|NCT00083226|27258050|P1|Overall Study|Withdrawal by Subject|4
7858639|NCT00083226|27258050|P1|Overall Study|Death|4
7858640|NCT00083226|27258050|P1|Overall Study|Adverse Event|9
7858641|NCT00083226|27258050|P1|Overall Study|Lack of Efficacy|19
7858642|NCT00082628|27258094|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
7858643|NCT00082628|27258095|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
7858644|NCT00082628|27258096|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
7858645|NCT00082628|27258097|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
7858646|NCT00082628|27258098|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
7858647|NCT00082628|27258094|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7858648|NCT00082628|27258095|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
7858649|NCT00082628|27258096|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7858650|NCT00082628|27258097|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7858651|NCT00082628|27258098|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7858652|NCT00082628|27258094|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
7858653|NCT00082628|27258095|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7858654|NCT00082628|27258096|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7858655|NCT00082628|27258097|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7858656|NCT00082628|27258098|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7858657|NCT00082628|27258094|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7858658|NCT00082628|27258095|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7858659|NCT00082628|27258096|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7858660|NCT00082628|27258097|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
7858661|NCT00082628|27258098|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
7858662|NCT00082628|27258094|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7858663|NCT00082628|27258095|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7858664|NCT00082628|27258096|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7858665|NCT00082628|27258097|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
7858666|NCT00082628|27258098|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
7858667|NCT00082628|27258094|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7858668|NCT00082628|27258095|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7858669|NCT00082628|27258096|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7858670|NCT00082628|27258097|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
7858671|NCT00082628|27258098|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
7858672|NCT00082628|27258094|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7858673|NCT00082628|27258095|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7858674|NCT00082628|27258096|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7858675|NCT00082628|27258097|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
7858676|NCT00082628|27258098|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7858677|NCT00082433|27258118|P2|Overall Study|Impending surgery|1
7858678|NCT00082433|27258119|P1|Overall Study|Impending surgery|0
7858679|NCT00082433|27258118|P2|Overall Study|New primary cancer|0
7858680|NCT00082433|27258119|P1|Overall Study|New primary cancer|1
7858681|NCT00082433|27258118|P2|Overall Study|Noncompliance|1
7858682|NCT00082433|27258119|P1|Overall Study|Noncompliance|2
7858683|NCT00082433|27258118|P2|Overall Study|Ineligible|1
7858684|NCT00082433|27258119|P1|Overall Study|Ineligible|2
7858685|NCT00082433|27258118|P2|Overall Study|Not Treated|11
7858686|NCT00082433|27258119|P1|Overall Study|Not Treated|12
7858687|NCT00082433|27258118|P2|Overall Study|Still On Treatment|1
7858688|NCT00082433|27258119|P1|Overall Study|Still On Treatment|2
7858689|NCT00082433|27258118|P2|Overall Study|Withdrawal by Subject|30
7858690|NCT00082433|27258119|P1|Overall Study|Withdrawal by Subject|55
7858691|NCT00082433|27258118|P2|Overall Study|Study Drug Toxicity|66
7858692|NCT00082433|27258119|P1|Overall Study|Study Drug Toxicity|179
7858693|NCT00082433|27258118|P2|Overall Study|Lost to Follow-up|2
7858694|NCT00082433|27258119|P1|Overall Study|Lost to Follow-up|1
7858695|NCT00082433|27258118|P2|Overall Study|Physician Decision|61
7858696|NCT00082433|27258119|P1|Overall Study|Physician Decision|50
7858697|NCT00082433|27258118|P2|Overall Study|Disease Progression/Relapse|388
7858698|NCT00082433|27258119|P1|Overall Study|Disease Progression/Relapse|270
7858699|NCT00082433|27258118|P2|Overall Study|Death|18
7858700|NCT00082433|27258119|P1|Overall Study|Death|8
7858701|NCT00082433|27258118|P2|Overall Study|Adverse Event|17
7858702|NCT00082433|27258119|P1|Overall Study|Adverse Event|12
7858703|NCT00082381|27258139|P2|Overall Study|Loss of Glucose Control|0
7858704|NCT00082381|27258140|P1|Overall Study|Loss of Glucose Control|4
7858705|NCT00082381|27258139|P2|Overall Study|Protocol Violation|11
7858706|NCT00082381|27258140|P1|Overall Study|Protocol Violation|10
7858707|NCT00082381|27258139|P2|Overall Study|Physician Decision|2
7858708|NCT00082381|27258140|P1|Overall Study|Physician Decision|1
7858709|NCT00082381|27258139|P2|Overall Study|Patient Decision|4
7858710|NCT00082381|27258140|P1|Overall Study|Patient Decision|8
7858711|NCT00082381|27258139|P2|Overall Study|Lost to Follow-up|7
7858712|NCT00082381|27258140|P1|Overall Study|Lost to Follow-up|5
7858713|NCT00082381|27258139|P2|Overall Study|Adverse Event|2
7858714|NCT00082381|27258140|P1|Overall Study|Adverse Event|27
7858715|NCT00082407|27258160|P2|Overall Study|Lost to Follow-up|3
7858716|NCT00082407|27258161|P1|Overall Study|Lost to Follow-up|0
7858717|NCT00082407|27258160|P2|Overall Study|Death|1
7858718|NCT00082407|27258161|P1|Overall Study|Death|2
7858719|NCT00082407|27258160|P2|Overall Study|Loss of Glucose Control|2
7858720|NCT00082407|27258161|P1|Overall Study|Loss of Glucose Control|2
7858721|NCT00082407|27258160|P2|Overall Study|Physician Decision|3
7858722|NCT00082407|27258161|P1|Overall Study|Physician Decision|5
7858723|NCT00082407|27258160|P2|Overall Study|Patient Decision|6
7858724|NCT00082407|27258161|P1|Overall Study|Patient Decision|13
7858725|NCT00082407|27258160|P2|Overall Study|Protocol Violation|12
7858726|NCT00082407|27258161|P1|Overall Study|Protocol Violation|14
7858727|NCT00082407|27258160|P2|Overall Study|Adverse Event|0
7858728|NCT00082407|27258161|P1|Overall Study|Adverse Event|20
7858729|NCT00082368|27258179|P1|Overall Study|Not treated-pt had poor IV access|1
7858730|NCT00082355|27258184|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
7858731|NCT00082355|27258184|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
7858732|NCT00082355|27258184|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
7858733|NCT00082173|27258220|P2|Overall Study|Culture negative or resistant at baselin|6
7858734|NCT00082173|27258221|P1|Overall Study|Culture negative or resistant at baselin|5
7858735|NCT00082173|27258220|P2|Overall Study|Adverse Event|0
7858736|NCT00082173|27258221|P1|Overall Study|Adverse Event|1
7858737|NCT00082173|27258220|P2|Overall Study|Lost to Follow-up|0
7858738|NCT00082173|27258221|P1|Overall Study|Lost to Follow-up|1
7858739|NCT00082173|27258220|P2|Overall Study|Withdrawal by Subject|5
7858740|NCT00082173|27258221|P1|Overall Study|Withdrawal by Subject|3
7858741|NCT00081770|27258266|P3|Overall Study|Other|8
7858742|NCT00081770|27258267|P2|Overall Study|Other|7
7858743|NCT00081770|27258268|P1|Overall Study|Other|2
7858744|NCT00081770|27258266|P3|Overall Study|Administrative|1
7858745|NCT00081770|27258267|P2|Overall Study|Administrative|0
7858746|NCT00081770|27258268|P1|Overall Study|Administrative|1
7858747|NCT00081770|27258266|P3|Overall Study|Did not meet protocol eligibility|3
7858748|NCT00081770|27258267|P2|Overall Study|Did not meet protocol eligibility|0
7858749|NCT00081770|27258268|P1|Overall Study|Did not meet protocol eligibility|2
7858750|NCT00081770|27258266|P3|Overall Study|Withdrawal by Subject|42
7858751|NCT00081770|27258267|P2|Overall Study|Withdrawal by Subject|40
7858752|NCT00081770|27258268|P1|Overall Study|Withdrawal by Subject|45
7858753|NCT00081770|27258266|P3|Overall Study|Protocol Violation|10
7858754|NCT00081770|27258267|P2|Overall Study|Protocol Violation|10
7858755|NCT00081770|27258268|P1|Overall Study|Protocol Violation|15
7858756|NCT00081770|27258266|P3|Overall Study|Lost to Follow-up|45
7858757|NCT00081770|27258267|P2|Overall Study|Lost to Follow-up|34
7858758|NCT00081770|27258268|P1|Overall Study|Lost to Follow-up|45
7858759|NCT00081770|27258266|P3|Overall Study|Lack of Efficacy|211
7858760|NCT00081770|27258267|P2|Overall Study|Lack of Efficacy|357
7858761|NCT00081770|27258268|P1|Overall Study|Lack of Efficacy|262
7858762|NCT00081770|27258266|P3|Overall Study|Adverse Event|136
7858763|NCT00081770|27258267|P2|Overall Study|Adverse Event|98
7858764|NCT00081770|27258268|P1|Overall Study|Adverse Event|130
7858765|NCT00081731|27258287|P2|Overall Study|scientific integrity issue|8
7858766|NCT00081731|27258288|P1|Overall Study|scientific integrity issue|8
7858767|NCT00081653|27258308|P2|Overall Study|Loss of bone mass|2
7858768|NCT00081653|27258309|P1|Overall Study|Loss of bone mass|0
7858769|NCT00081653|27258308|P2|Overall Study|Participant leaving country|0
7858770|NCT00081653|27258309|P1|Overall Study|Participant leaving country|1
7858771|NCT00081653|27258308|P2|Overall Study|Bone loss|0
7858772|NCT00081653|27258309|P1|Overall Study|Bone loss|2
7858773|NCT00081653|27258308|P2|Overall Study|Low bone mineral density|0
7858774|NCT00081653|27258309|P1|Overall Study|Low bone mineral density|1
7858775|NCT00081653|27258308|P2|Overall Study|Refused Treatment|14
7858776|NCT00081653|27258309|P1|Overall Study|Refused Treatment|18
7858777|NCT00081653|27258308|P2|Overall Study|Lost to Follow-up|4
7858778|NCT00081653|27258309|P1|Overall Study|Lost to Follow-up|2
7858779|NCT00081653|27258308|P2|Overall Study|Adverse Event|17
7858780|NCT00081653|27258309|P1|Overall Study|Adverse Event|23
7858781|NCT00081497|27258327|P2|Overall Study|Non-compliance|1
7858782|NCT00081497|27258328|P1|Overall Study|Non-compliance|0
7858783|NCT00081497|27258327|P2|Overall Study|Withdrawal by Subject|0
7858784|NCT00081497|27258328|P1|Overall Study|Withdrawal by Subject|1
7858785|NCT00081497|27258327|P2|Overall Study|Death|1
7858786|NCT00081497|27258328|P1|Overall Study|Death|0
7858787|NCT00081497|27258327|P2|Overall Study|Adverse Event|0
7858788|NCT00081497|27258328|P1|Overall Study|Adverse Event|2
7858789|NCT00081458|27258346|P3|Overall Study|Randomized but not dosed|1
7858790|NCT00081458|27258347|P2|Overall Study|Randomized but not dosed|0
7858791|NCT00081458|27258348|P1|Overall Study|Randomized but not dosed|0
7858792|NCT00081458|27258346|P3|Overall Study|Withdrawal by Subject|1
7858793|NCT00081458|27258347|P2|Overall Study|Withdrawal by Subject|3
7858794|NCT00081458|27258348|P1|Overall Study|Withdrawal by Subject|0
7858795|NCT00081458|27258346|P3|Overall Study|Adverse Event|2
7858796|NCT00081458|27258347|P2|Overall Study|Adverse Event|5
7858797|NCT00081458|27258348|P1|Overall Study|Adverse Event|1
7858798|NCT00081289|27258404|P2|Overall Study|Ineligible / no protocol treatment|4
7858799|NCT00081289|27258405|P1|Overall Study|Ineligible / no protocol treatment|3
7858800|NCT00081289|27258404|P2|Overall Study|Accrued prior to chemotherapy amendment|17
7858801|NCT00081289|27258405|P1|Overall Study|Accrued prior to chemotherapy amendment|18
7858802|NCT00081263|27258449|P2|Overall Study|Inadequate data|10
7858803|NCT00081263|27258450|P1|Overall Study|Inadequate data|5
7858804|NCT00081263|27258449|P2|Overall Study|Never treated|5
7858805|NCT00081263|27258450|P1|Overall Study|Never treated|4
7858806|NCT00081263|27258449|P2|Overall Study|Inadequate pathology|1
7858807|NCT00081263|27258450|P1|Overall Study|Inadequate pathology|0
7858808|NCT00081263|27258449|P2|Overall Study|improper pre-protocol therapy|1
7858809|NCT00081263|27258450|P1|Overall Study|improper pre-protocol therapy|0
7858810|NCT00081263|27258449|P2|Overall Study|wrong cell type|5
7858811|NCT00081263|27258450|P1|Overall Study|wrong cell type|7
7858812|NCT00081263|27258449|P2|Overall Study|clerical error|0
7858813|NCT00081263|27258450|P1|Overall Study|clerical error|1
7858814|NCT00081159|27258460|P2|Overall Study|Lost to Follow-up|1
7858815|NCT00081159|27258461|P1|Overall Study|Lost to Follow-up|2
7858816|NCT00081159|27258460|P2|Overall Study|Myelosuppression prior to treatment|1
7858817|NCT00081159|27258461|P1|Overall Study|Myelosuppression prior to treatment|0
7858818|NCT00081159|27258460|P2|Overall Study|Withdrawal by Subject|3
7858819|NCT00081159|27258461|P1|Overall Study|Withdrawal by Subject|0
7858820|NCT00080938|27258471|P1|Overall Study|Ineligible|4
7858821|NCT00080938|27258471|P1|Overall Study|Not started protocol therapy|1
7858822|NCT00080938|27258471|P1|Overall Study|other disease|1
7858823|NCT00080938|27258471|P1|Overall Study|Lack of Efficacy|7
7858824|NCT00080938|27258471|P1|Overall Study|Death|2
7858825|NCT00080938|27258471|P1|Overall Study|Withdrawal by Subject|6
7858826|NCT00080938|27258471|P1|Overall Study|Adverse Event|3
7858827|NCT00080899|27258487|P1|Overall Study|Adverse Event|1
7858828|NCT00080483|27258499|P2|Overall Study|Physician Decision|1
7858829|NCT00080483|27258500|P1|Overall Study|Physician Decision|1
7858830|NCT00080483|27258499|P2|Overall Study|Lost to Follow-up|1
7858831|NCT00080483|27258500|P1|Overall Study|Lost to Follow-up|1
7858832|NCT00002525|27258508|P2|Overall Study|Never start protocol therapy|0
7858833|NCT00002525|27258509|P1|Overall Study|Never start protocol therapy|8
7858834|NCT00002525|27258508|P2|Overall Study|Other|0
7858835|NCT00002525|27258509|P1|Overall Study|Other|26
7858836|NCT00002525|27258508|P2|Overall Study|Error|0
7858837|NCT00002525|27258509|P1|Overall Study|Error|6
7858838|NCT00002525|27258508|P2|Overall Study|Duke's A, B1, D disease|0
7858839|NCT00002525|27258509|P1|Overall Study|Duke's A, B1, D disease|92
7858840|NCT00002525|27258508|P2|Overall Study|Other complicating disease|0
7858841|NCT00002525|27258509|P1|Overall Study|Other complicating disease|1
7858842|NCT00002525|27258508|P2|Overall Study|Start non-protocol therapy|0
7858843|NCT00002525|27258509|P1|Overall Study|Start non-protocol therapy|1
7858844|NCT00002525|27258508|P2|Overall Study|Withdrawal by Subject|0
7858845|NCT00002525|27258509|P1|Overall Study|Withdrawal by Subject|11
7858846|NCT00002525|27258508|P2|Overall Study|Death|0
7858847|NCT00002525|27258509|P1|Overall Study|Death|5
7858848|NCT00002525|27258508|P2|Overall Study|Adverse Event|0
7858849|NCT00002525|27258509|P1|Overall Study|Adverse Event|36
7858850|NCT00080301|27258536|P2|Overall Study|Still on Treatment as of CSR date|1
7858851|NCT00080301|27258537|P1|Overall Study|Still on Treatment as of CSR date|0
7858852|NCT00080301|27258536|P2|Overall Study|Randomized but Never Treated|10
7858853|NCT00080301|27258537|P1|Overall Study|Randomized but Never Treated|5
7858854|NCT00080288|27258557|P2|Overall Study|Miscellaneous|11
7858855|NCT00080288|27258558|P1|Overall Study|Miscellaneous|11
7858856|NCT00080288|27258557|P2|Overall Study|Withdrawal by Subject|16
7858857|NCT00080288|27258558|P1|Overall Study|Withdrawal by Subject|3
7858858|NCT00080288|27258557|P2|Overall Study|Physician Decision|2
7858859|NCT00080288|27258558|P1|Overall Study|Physician Decision|6
7858860|NCT00080288|27258557|P2|Overall Study|Lost to Follow-up|5
7858861|NCT00080288|27258558|P1|Overall Study|Lost to Follow-up|3
7858862|NCT00080288|27258557|P2|Overall Study|Adverse Event|4
7858863|NCT00080288|27258558|P1|Overall Study|Adverse Event|7
7858864|NCT00080223|27258566|P1|Overall Study|Physician Decision|1
7858865|NCT00080223|27258566|P1|Overall Study|Participant unwilling to continue|2
7858866|NCT00080223|27258566|P1|Overall Study|Non-compliance With Study Treatment|7
7858867|NCT00080223|27258566|P1|Overall Study|Lung Transplantation|9
7858868|NCT00080223|27258566|P1|Overall Study|Withdrawal by Subject|13
7858869|NCT00080223|27258566|P1|Overall Study|Death|21
7858870|NCT00080223|27258566|P1|Overall Study|Adverse Event|23
7858871|NCT00002540|27258576|P2|Overall Study|Refused Screen (Prostate Screening)|2433
7858872|NCT00002540|27258577|P1|Overall Study|Refused Screen (Prostate Screening)|0
7858873|NCT00002540|27258576|P2|Overall Study|Refused ASU (Control)|0
7858874|NCT00002540|27258577|P1|Overall Study|Refused ASU (Control)|597
7858875|NCT00002540|27258576|P2|Overall Study|Died Before ASU (Control)|0
7858876|NCT00002540|27258577|P1|Overall Study|Died Before ASU (Control)|202
7858877|NCT00002540|27258576|P2|Overall Study|Died Before Randomization|6
7858878|NCT00002540|27258577|P1|Overall Study|Died Before Randomization|2
7858879|NCT00002540|27258576|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
7858880|NCT00002540|27258577|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
7858881|NCT00080119|27258607|P4|Overall Study|Lost to Follow-up|14
7858882|NCT00080119|27258608|P3|Overall Study|Lost to Follow-up|19
7858883|NCT00080119|27258609|P2|Overall Study|Lost to Follow-up|19
7858884|NCT00080119|27258610|P1|Overall Study|Lost to Follow-up|16
7858885|NCT00080119|27258607|P4|Overall Study|Unwilling to adhere to study requirement|1
7858886|NCT00080119|27258608|P3|Overall Study|Unwilling to adhere to study requirement|5
7858887|NCT00080119|27258609|P2|Overall Study|Unwilling to adhere to study requirement|2
7858888|NCT00080119|27258610|P1|Overall Study|Unwilling to adhere to study requirement|3
7858889|NCT00080119|27258607|P4|Overall Study|Consent withdrawn|6
7858890|NCT00080119|27258608|P3|Overall Study|Consent withdrawn|4
7858891|NCT00080119|27258609|P2|Overall Study|Consent withdrawn|17
7858892|NCT00080119|27258610|P1|Overall Study|Consent withdrawn|13
7858893|NCT00080119|27258607|P4|Overall Study|Unable to get to clinic|1
7858894|NCT00080119|27258608|P3|Overall Study|Unable to get to clinic|7
7858895|NCT00080119|27258609|P2|Overall Study|Unable to get to clinic|24
7858896|NCT00080119|27258610|P1|Overall Study|Unable to get to clinic|24
7858897|NCT00080119|27258607|P4|Overall Study|Discontinued because of study closure|141
7858898|NCT00080119|27258608|P3|Overall Study|Discontinued because of study closure|130
7858899|NCT00080119|27258609|P2|Overall Study|Discontinued because of study closure|0
7858900|NCT00080119|27258610|P1|Overall Study|Discontinued because of study closure|0
7858901|NCT00079937|27258644|P2|Overall Study|Administrative problems|11
7858902|NCT00079937|27258645|P1|Overall Study|Administrative problems|22
7858903|NCT00079937|27258644|P2|Overall Study|Lost to Follow-up|5
7858904|NCT00079937|27258645|P1|Overall Study|Lost to Follow-up|12
7858905|NCT00079937|27258644|P2|Overall Study|Withdrawal by Subject|7
7858906|NCT00079937|27258645|P1|Overall Study|Withdrawal by Subject|21
7858907|NCT00079937|27258644|P2|Overall Study|Protocol Violation|6
7858908|NCT00079937|27258645|P1|Overall Study|Protocol Violation|8
7858909|NCT00079937|27258644|P2|Overall Study|Subject no longer requires study drug|0
7858910|NCT00079937|27258645|P1|Overall Study|Subject no longer requires study drug|3
7858911|NCT00079937|27258644|P2|Overall Study|Unsatisfactory therapeutic effect|2
7858912|NCT00079937|27258645|P1|Overall Study|Unsatisfactory therapeutic effect|1
7858913|NCT00079937|27258644|P2|Overall Study|Adverse Event|1
7858914|NCT00079937|27258645|P1|Overall Study|Adverse Event|2
7858915|NCT00009737|27258663|P2|Overall Study|Administrative/Other Reasons|1
7858916|NCT00009737|27258664|P1|Overall Study|Administrative/Other Reasons|7
7858917|NCT00009737|27258663|P2|Overall Study|Lost to Follow-up|1
7858918|NCT00009737|27258664|P1|Overall Study|Lost to Follow-up|1
7858919|NCT00009737|27258663|P2|Overall Study|Refused Treatment|16
7858920|NCT00009737|27258664|P1|Overall Study|Refused Treatment|15
7858921|NCT00009737|27258663|P2|Overall Study|Other Protocol Violation|0
7858922|NCT00009737|27258664|P1|Overall Study|Other Protocol Violation|1
7858923|NCT00009737|27258663|P2|Overall Study|Violation of Selection Criteria at Entry|9
7858924|NCT00009737|27258664|P1|Overall Study|Violation of Selection Criteria at Entry|13
7858925|NCT00009737|27258663|P2|Overall Study|Lack of Efficacy|15
7858926|NCT00009737|27258664|P1|Overall Study|Lack of Efficacy|17
7858927|NCT00009737|27258663|P2|Overall Study|Death|6
7858928|NCT00009737|27258664|P1|Overall Study|Death|4
7858929|NCT00009737|27258663|P2|Overall Study|Adverse Event|75
7858930|NCT00009737|27258664|P1|Overall Study|Adverse Event|112
7858931|NCT00079781|27258683|P3|Follow-up Period|Death|1
7858932|NCT00079781|27258684|P2|Follow-up Period|Death|0
7858933|NCT00079781|27258685|P1|Follow-up Period|Death|0
7858934|NCT00079781|27258683|P3|Follow-up Period|Lost to Follow-up|0
7858935|NCT00079781|27258684|P2|Follow-up Period|Lost to Follow-up|0
7858936|NCT00079781|27258685|P1|Follow-up Period|Lost to Follow-up|1
7858937|NCT00079781|27258683|P3|Follow-up Period|Withdrawal by Subject|1
7858938|NCT00079781|27258684|P2|Follow-up Period|Withdrawal by Subject|0
7858939|NCT00079781|27258685|P1|Follow-up Period|Withdrawal by Subject|3
7858940|NCT00079781|27258683|P3|Pre-implant Period|Did not meet I/E criteria|1
7858941|NCT00079781|27258684|P2|Pre-implant Period|Did not meet I/E criteria|1
7858942|NCT00079781|27258685|P1|Pre-implant Period|Did not meet I/E criteria|1
7858943|NCT00079781|27258683|P3|Pre-implant Period|Withdrawal by Subject|0
7858944|NCT00079781|27258684|P2|Pre-implant Period|Withdrawal by Subject|0
7858945|NCT00079781|27258685|P1|Pre-implant Period|Withdrawal by Subject|2
7858946|NCT00079677|27258694|P2|Overall Study|Miscellaneous|0
7858947|NCT00079677|27258695|P1|Overall Study|Miscellaneous|2
7858948|NCT00079677|27258694|P2|Overall Study|Withdrawal by Subject|3
7858949|NCT00079677|27258695|P1|Overall Study|Withdrawal by Subject|5
7858950|NCT00079677|27258694|P2|Overall Study|Protocol Violation|3
7858951|NCT00079677|27258695|P1|Overall Study|Protocol Violation|2
7858952|NCT00079677|27258694|P2|Overall Study|Physician Decision|0
7858953|NCT00079677|27258695|P1|Overall Study|Physician Decision|3
7858954|NCT00079677|27258694|P2|Overall Study|Lost to Follow-up|2
7858955|NCT00079677|27258695|P1|Overall Study|Lost to Follow-up|2
7858956|NCT00079677|27258694|P2|Overall Study|Lack of Efficacy|0
7858957|NCT00079677|27258695|P1|Overall Study|Lack of Efficacy|1
7858958|NCT00079677|27258694|P2|Overall Study|Adverse Event|6
7858959|NCT00079677|27258695|P1|Overall Study|Adverse Event|5
7858960|NCT00079417|27258711|P1|Overall Study|Ineligible|7
7858961|NCT00079417|27258711|P1|Overall Study|Physician Decision|2
7858962|NCT00079391|27258719|P1|Overall Study|Withdrawal by Subject|1
7858963|NCT00079339|27258731|P3|Overall Study|Disease progression|2
7858964|NCT00079339|27258732|P2|Overall Study|Disease progression|28
7858965|NCT00079339|27258733|P1|Overall Study|Disease progression|3
7858966|NCT00079339|27258731|P3|Overall Study|Withdrawal by Subject|1
7858967|NCT00079339|27258732|P2|Overall Study|Withdrawal by Subject|4
7858968|NCT00079339|27258733|P1|Overall Study|Withdrawal by Subject|0
7858969|NCT00079339|27258731|P3|Overall Study|Non-compliance|1
7858970|NCT00079339|27258732|P2|Overall Study|Non-compliance|0
7858971|NCT00079339|27258733|P1|Overall Study|Non-compliance|0
7858972|NCT00079339|27258731|P3|Overall Study|Death|0
7858973|NCT00079339|27258732|P2|Overall Study|Death|0
7858974|NCT00079339|27258733|P1|Overall Study|Death|1
7858975|NCT00079339|27258731|P3|Overall Study|Adverse Event|2
7858976|NCT00079339|27258732|P2|Overall Study|Adverse Event|7
7858977|NCT00079339|27258733|P1|Overall Study|Adverse Event|1
7858978|NCT00079274|27258764|P7|Overall Study|Other|0
7858979|NCT00079274|27258765|P6|Overall Study|Other|2
7858980|NCT00079274|27258766|P5|Overall Study|Other|1
7858981|NCT00079274|27258767|P4|Overall Study|Other|55
7858982|NCT00079274|27258768|P3|Overall Study|Other|5
7858983|NCT00079274|27258769|P2|Overall Study|Other|7
7858984|NCT00079274|27258770|P1|Overall Study|Other|43
7858985|NCT00079274|27258764|P7|Overall Study|Cytogenetic resistance|0
7858986|NCT00079274|27258765|P6|Overall Study|Cytogenetic resistance|0
7858987|NCT00079274|27258766|P5|Overall Study|Cytogenetic resistance|0
7858988|NCT00079274|27258767|P4|Overall Study|Cytogenetic resistance|2
7858989|NCT00079274|27258768|P3|Overall Study|Cytogenetic resistance|0
7858990|NCT00079274|27258769|P2|Overall Study|Cytogenetic resistance|0
7858991|NCT00079274|27258770|P1|Overall Study|Cytogenetic resistance|0
7858992|NCT00079274|27258764|P7|Overall Study|Death|0
7858993|NCT00079274|27258765|P6|Overall Study|Death|0
7858994|NCT00079274|27258766|P5|Overall Study|Death|0
7858995|NCT00079274|27258767|P4|Overall Study|Death|15
7858996|NCT00079274|27258768|P3|Overall Study|Death|1
7858997|NCT00079274|27258769|P2|Overall Study|Death|0
7858998|NCT00079274|27258770|P1|Overall Study|Death|4
7858999|NCT00079274|27258764|P7|Overall Study|Other Medical Problems|0
7859000|NCT00079274|27258765|P6|Overall Study|Other Medical Problems|0
7859001|NCT00079274|27258766|P5|Overall Study|Other Medical Problems|0
7859002|NCT00079274|27258767|P4|Overall Study|Other Medical Problems|7
7859003|NCT00079274|27258768|P3|Overall Study|Other Medical Problems|0
7859004|NCT00079274|27258769|P2|Overall Study|Other Medical Problems|1
7859005|NCT00079274|27258770|P1|Overall Study|Other Medical Problems|6
7859006|NCT00079274|27258764|P7|Overall Study|Alternate Treatment|0
7859007|NCT00079274|27258765|P6|Overall Study|Alternate Treatment|0
7859008|NCT00079274|27258766|P5|Overall Study|Alternate Treatment|0
7859009|NCT00079274|27258767|P4|Overall Study|Alternate Treatment|3
7859010|NCT00079274|27258768|P3|Overall Study|Alternate Treatment|0
7859011|NCT00079274|27258769|P2|Overall Study|Alternate Treatment|1
7859012|NCT00079274|27258770|P1|Overall Study|Alternate Treatment|6
7859013|NCT00079274|27258764|P7|Overall Study|Recurrence|0
7859014|NCT00079274|27258765|P6|Overall Study|Recurrence|2
7859015|NCT00079274|27258766|P5|Overall Study|Recurrence|0
7859016|NCT00079274|27258767|P4|Overall Study|Recurrence|15
7859017|NCT00079274|27258768|P3|Overall Study|Recurrence|1
7859018|NCT00079274|27258769|P2|Overall Study|Recurrence|0
7859019|NCT00079274|27258770|P1|Overall Study|Recurrence|21
7859020|NCT00079274|27258764|P7|Overall Study|Adverse Event|0
7859021|NCT00079274|27258765|P6|Overall Study|Adverse Event|8
7859022|NCT00079274|27258766|P5|Overall Study|Adverse Event|7
7859023|NCT00079274|27258767|P4|Overall Study|Adverse Event|184
7859024|NCT00079274|27258768|P3|Overall Study|Adverse Event|8
7859025|NCT00079274|27258769|P2|Overall Study|Adverse Event|8
7859026|NCT00079274|27258770|P1|Overall Study|Adverse Event|130
7859027|NCT00079274|27258764|P7|Overall Study|Withdrawal by Subject|0
7859028|NCT00079274|27258765|P6|Overall Study|Withdrawal by Subject|8
7859029|NCT00079274|27258766|P5|Overall Study|Withdrawal by Subject|7
7859030|NCT00079274|27258767|P4|Overall Study|Withdrawal by Subject|163
7859031|NCT00079274|27258768|P3|Overall Study|Withdrawal by Subject|12
7859032|NCT00079274|27258769|P2|Overall Study|Withdrawal by Subject|10
7859033|NCT00079274|27258770|P1|Overall Study|Withdrawal by Subject|111
7859034|NCT00079183|27258791|P1|Overall Study|Specimen collection non-compliance|1
7859035|NCT00079183|27258791|P1|Overall Study|Study medication non-compliance|2
7859036|NCT00079183|27258791|P1|Overall Study|Withdrawal by Subject|4
7859037|NCT00079040|27258806|P1|Overall Study|Ineligible|1
7859038|NCT00079040|27258806|P1|Overall Study|Withdrew before treatment|1
7859039|NCT00078949|27258829|P4|Overall Study|No treated|3
7859040|NCT00078949|27258830|P3|Overall Study|No treated|3
7859041|NCT00078949|27258831|P2|Overall Study|No treated|5
7859042|NCT00078949|27258832|P1|Overall Study|No treated|4
7859043|NCT00078819|27258861|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
7859044|NCT00078819|27258862|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7859045|NCT00078819|27258863|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7859046|NCT00078819|27258864|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7859047|NCT00078819|27258861|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
7859048|NCT00078819|27258862|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
7859049|NCT00078819|27258863|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
7859050|NCT00078819|27258864|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
7859051|NCT00078819|27258861|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
7859052|NCT00078819|27258862|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
7859053|NCT00078819|27258863|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
7859054|NCT00078819|27258864|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
7859055|NCT00078819|27258861|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
7859056|NCT00078819|27258862|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
7859057|NCT00078819|27258863|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
7859058|NCT00078819|27258864|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
7859059|NCT00078819|27258861|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
7859060|NCT00078819|27258862|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
7859061|NCT00078819|27258863|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
7859062|NCT00078819|27258864|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
7859063|NCT00078819|27258861|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
7859064|NCT00078819|27258862|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
7859065|NCT00078819|27258863|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
7859066|NCT00078819|27258864|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
7859067|NCT00078819|27258861|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7859068|NCT00078819|27258862|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7859069|NCT00078819|27258863|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7859070|NCT00078819|27258864|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
7859071|NCT00078819|27258861|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7859072|NCT00078819|27258862|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7859073|NCT00078819|27258863|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
7859074|NCT00078819|27258864|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7859075|NCT00078806|27258889|P4|Part 2|Adverse Event|0
7859076|NCT00078806|27258890|P3|Part 2|Adverse Event|0
7859077|NCT00078806|27258891|P2|Part 2|Adverse Event|1
7859078|NCT00078806|27258892|P1|Part 2|Adverse Event|0
7859079|NCT00078806|27258889|P4|Part 1B|Lack of Efficacy|0
7859080|NCT00078806|27258890|P3|Part 1B|Lack of Efficacy|0
7859081|NCT00078806|27258891|P2|Part 1B|Lack of Efficacy|0
7859082|NCT00078806|27258892|P1|Part 1B|Lack of Efficacy|7
7859083|NCT00078806|27258889|P4|Part 1B|Adverse Event|0
7859084|NCT00078806|27258890|P3|Part 1B|Adverse Event|0
7859085|NCT00078806|27258891|P2|Part 1B|Adverse Event|0
7859086|NCT00078806|27258892|P1|Part 1B|Adverse Event|1
7859087|NCT00078806|27258889|P4|Part 1A|Other|0
7859088|NCT00078806|27258890|P3|Part 1A|Other|0
7859089|NCT00078806|27258891|P2|Part 1A|Other|0
7859090|NCT00078806|27258892|P1|Part 1A|Other|1
7859091|NCT00078806|27258889|P4|Part 1A|Lack of Efficacy|0
7859092|NCT00078806|27258890|P3|Part 1A|Lack of Efficacy|0
7859093|NCT00078806|27258891|P2|Part 1A|Lack of Efficacy|0
7859094|NCT00078806|27258892|P1|Part 1A|Lack of Efficacy|7
7859095|NCT00078806|27258889|P4|Part 1A|Adverse Event|0
7859096|NCT00078806|27258890|P3|Part 1A|Adverse Event|0
7859097|NCT00078806|27258891|P2|Part 1A|Adverse Event|0
7859098|NCT00078806|27258892|P1|Part 1A|Adverse Event|2
7859099|NCT00078767|27258928|P2|Overall Study|Withdrawal by Subject|1
7859100|NCT00078767|27258929|P1|Overall Study|Withdrawal by Subject|1
7859101|NCT00005947|27258979|P2|Overall Study|Site Closure|0
7859102|NCT00005947|27258980|P1|Overall Study|Site Closure|1
7859103|NCT00005947|27258979|P2|Overall Study|Patient Refused to Continue|1
7859104|NCT00005947|27258980|P1|Overall Study|Patient Refused to Continue|2
7859105|NCT00005947|27258979|P2|Overall Study|Death|40
7859106|NCT00005947|27258980|P1|Overall Study|Death|54
7859107|NCT00002597|27259016|P2|Overall Study|Withdrawal by Subject|6
7859108|NCT00002597|27259017|P1|Overall Study|Withdrawal by Subject|7
7859109|NCT00002597|27259016|P2|Overall Study|Protocol Violation|17
7859110|NCT00002597|27259017|P1|Overall Study|Protocol Violation|19
7859111|NCT00078377|27259042|P3|Overall Study|Miscellaneous|1
7859112|NCT00078377|27259043|P2|Overall Study|Miscellaneous|6
7859113|NCT00078377|27259044|P1|Overall Study|Miscellaneous|2
7859114|NCT00078377|27259042|P3|Overall Study|Withdrawal by Subject|4
7859115|NCT00078377|27259043|P2|Overall Study|Withdrawal by Subject|4
7859116|NCT00078377|27259044|P1|Overall Study|Withdrawal by Subject|3
7859117|NCT00078377|27259042|P3|Overall Study|Physician Decision|0
7859118|NCT00078377|27259043|P2|Overall Study|Physician Decision|0
7859119|NCT00078377|27259044|P1|Overall Study|Physician Decision|2
7859120|NCT00078377|27259042|P3|Overall Study|Lost to Follow-up|1
7859121|NCT00078377|27259043|P2|Overall Study|Lost to Follow-up|1
7859122|NCT00078377|27259044|P1|Overall Study|Lost to Follow-up|0
7859123|NCT00078377|27259042|P3|Overall Study|Lack of Efficacy|2
7859124|NCT00078377|27259043|P2|Overall Study|Lack of Efficacy|0
7859125|NCT00078377|27259044|P1|Overall Study|Lack of Efficacy|2
7859126|NCT00078377|27259042|P3|Overall Study|Adverse Event|1
7859127|NCT00078377|27259043|P2|Overall Study|Adverse Event|5
7859128|NCT00078377|27259044|P1|Overall Study|Adverse Event|2
7859129|NCT00078338|27259059|P2|Overall Study|Subjects randomized, but not treated|3
7859130|NCT00078338|27259060|P1|Overall Study|Subjects randomized, but not treated|3
7859131|NCT00078338|27259059|P2|Overall Study|Other|16
7859132|NCT00078338|27259060|P1|Overall Study|Other|28
7859133|NCT00078338|27259059|P2|Overall Study|Disease Progression|7
7859134|NCT00078338|27259060|P1|Overall Study|Disease Progression|4
7859135|NCT00078338|27259059|P2|Overall Study|Protocol Violation|2
7859136|NCT00078338|27259060|P1|Overall Study|Protocol Violation|2
7859137|NCT00078338|27259059|P2|Overall Study|Lost to Follow-up|2
7859138|NCT00078338|27259060|P1|Overall Study|Lost to Follow-up|17
7859139|NCT00078338|27259059|P2|Overall Study|Adverse Event|24
7859140|NCT00078338|27259060|P1|Overall Study|Adverse Event|31
7859141|NCT00078325|27259153|P3|Overall Study|Miscellaneous|1
7859142|NCT00078325|27259154|P2|Overall Study|Miscellaneous|1
7859143|NCT00078325|27259155|P1|Overall Study|Miscellaneous|1
7859144|NCT00078325|27259153|P3|Overall Study|Physician Decision|1
7859145|NCT00078325|27259154|P2|Overall Study|Physician Decision|0
7859146|NCT00078325|27259155|P1|Overall Study|Physician Decision|2
7859147|NCT00078325|27259153|P3|Overall Study|Lost to Follow-up|1
7859148|NCT00078325|27259154|P2|Overall Study|Lost to Follow-up|1
7859149|NCT00078325|27259155|P1|Overall Study|Lost to Follow-up|0
7859150|NCT00078325|27259153|P3|Overall Study|Withdrawal by Subject|3
7859151|NCT00078325|27259154|P2|Overall Study|Withdrawal by Subject|5
7859152|NCT00078325|27259155|P1|Overall Study|Withdrawal by Subject|1
7859153|NCT00078325|27259153|P3|Overall Study|Protocol Violation|0
7859154|NCT00078325|27259154|P2|Overall Study|Protocol Violation|2
7859155|NCT00078325|27259155|P1|Overall Study|Protocol Violation|2
7859156|NCT00078325|27259153|P3|Overall Study|Adverse Event|5
7859157|NCT00078325|27259154|P2|Overall Study|Adverse Event|10
7859158|NCT00078325|27259155|P1|Overall Study|Adverse Event|15
7859159|NCT00078312|27259166|P1|Overall Study|Miscellaneous|33
7859160|NCT00078312|27259166|P1|Overall Study|Withdrawal by Subject|33
7859161|NCT00078312|27259166|P1|Overall Study|Protocol Violation|3
7859162|NCT00078312|27259166|P1|Overall Study|Physician Decision|9
7859163|NCT00078312|27259166|P1|Overall Study|Lost to Follow-up|41
7859164|NCT00078312|27259166|P1|Overall Study|Lack of Efficacy|15
7859165|NCT00078312|27259166|P1|Overall Study|Adverse Event|43
7859166|NCT00077974|27259181|P1|Overall Study|Decision of Sponsor|2
7859167|NCT00077974|27259181|P1|Overall Study|Lack of Efficacy|76
7859168|NCT00077974|27259181|P1|Overall Study|Withdrawal by Subject|3
7859169|NCT00077974|27259181|P1|Overall Study|Protocol Violation|1
7859170|NCT00077974|27259181|P1|Overall Study|Adverse Event|22
7859171|NCT00077857|27259198|P2|Overall Study|Other|13
7859172|NCT00077857|27259199|P1|Overall Study|Other|15
7859173|NCT00077857|27259198|P2|Overall Study|Failure to return|5
7859174|NCT00077857|27259199|P1|Overall Study|Failure to return|5
7859175|NCT00077857|27259198|P2|Overall Study|Refused treatment|21
7859176|NCT00077857|27259199|P1|Overall Study|Refused treatment|29
7859177|NCT00077857|27259198|P2|Overall Study|Other protocol violation|1
7859178|NCT00077857|27259199|P1|Overall Study|Other protocol violation|0
7859179|NCT00077857|27259198|P2|Overall Study|Violation of selection criteria at entry|1
7859180|NCT00077857|27259199|P1|Overall Study|Violation of selection criteria at entry|3
7859181|NCT00077857|27259198|P2|Overall Study|Insufficient therapeutic response|128
7859182|NCT00077857|27259199|P1|Overall Study|Insufficient therapeutic response|112
7859183|NCT00077857|27259198|P2|Overall Study|Death|3
7859184|NCT00077857|27259199|P1|Overall Study|Death|7
7859185|NCT00077857|27259198|P2|Overall Study|Adverse Event|32
7859186|NCT00077857|27259199|P1|Overall Study|Adverse Event|30
7859187|NCT00077766|27259219|P2|Overall Study|Participants Vacation|1
7859188|NCT00077766|27259220|P1|Overall Study|Participants Vacation|2
7859189|NCT00077766|27259219|P2|Overall Study|Stop Dialysis|1
7859190|NCT00077766|27259220|P1|Overall Study|Stop Dialysis|0
7859191|NCT00077766|27259219|P2|Overall Study|Started Nocturnal Dialysis|1
7859192|NCT00077766|27259220|P1|Overall Study|Started Nocturnal Dialysis|0
7859193|NCT00077766|27259219|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
7859194|NCT00077766|27259220|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
7859195|NCT00077766|27259219|P2|Overall Study|Dialysis|1
7859196|NCT00077766|27259220|P1|Overall Study|Dialysis|0
7859197|NCT00077766|27259219|P2|Overall Study|Dialysis Discontinued|0
7859198|NCT00077766|27259220|P1|Overall Study|Dialysis Discontinued|1
7859199|NCT00077766|27259219|P2|Overall Study|Participant's decision|0
7859200|NCT00077766|27259220|P1|Overall Study|Participant's decision|1
7859201|NCT00077766|27259219|P2|Overall Study|Investigators Discretion|0
7859202|NCT00077766|27259220|P1|Overall Study|Investigators Discretion|1
7859203|NCT00077766|27259219|P2|Overall Study|Transplantation|1
7859204|NCT00077766|27259220|P1|Overall Study|Transplantation|5
7859205|NCT00077766|27259219|P2|Overall Study|Kidney Transplantation|5
7859206|NCT00077766|27259220|P1|Overall Study|Kidney Transplantation|9
7859207|NCT00077766|27259219|P2|Overall Study|Protocol Violation|0
7859208|NCT00077766|27259220|P1|Overall Study|Protocol Violation|1
7859209|NCT00077766|27259219|P2|Overall Study|Lost to Follow-up|0
7859210|NCT00077766|27259220|P1|Overall Study|Lost to Follow-up|2
7859211|NCT00077766|27259219|P2|Overall Study|Death|10
7859212|NCT00077766|27259220|P1|Overall Study|Death|12
7859213|NCT00077766|27259219|P2|Overall Study|Withdrawal by Subject|3
7859214|NCT00077766|27259220|P1|Overall Study|Withdrawal by Subject|4
7859215|NCT00077766|27259219|P2|Overall Study|Adverse Event|1
7859216|NCT00077766|27259220|P1|Overall Study|Adverse Event|1
7859217|NCT00077675|27259245|P2|Overall Study|Never received study treatment|3
7859218|NCT00077675|27259246|P1|Overall Study|Never received study treatment|3
7859219|NCT00077675|27259245|P2|Overall Study|Other|1
7859220|NCT00077675|27259246|P1|Overall Study|Other|0
7859221|NCT00077675|27259245|P2|Overall Study|Withdrawal by Subject|0
7859222|NCT00077675|27259246|P1|Overall Study|Withdrawal by Subject|1
7859223|NCT00077675|27259245|P2|Overall Study|Lost to Follow-up|3
7859224|NCT00077675|27259246|P1|Overall Study|Lost to Follow-up|6
7859225|NCT00077675|27259245|P2|Overall Study|Adverse Event|2
7859226|NCT00077675|27259246|P1|Overall Study|Adverse Event|1
7859227|NCT00077649|27259256|P4|Overall Study|Randomized but never dosed|0
7859228|NCT00077649|27259257|P3|Overall Study|Randomized but never dosed|0
7859229|NCT00077649|27259258|P2|Overall Study|Randomized but never dosed|0
7859230|NCT00077649|27259259|P1|Overall Study|Randomized but never dosed|1
7859231|NCT00077649|27259256|P4|Overall Study|Abnormality of Laboratory Test|2
7859232|NCT00077649|27259257|P3|Overall Study|Abnormality of Laboratory Test|1
7859233|NCT00077649|27259258|P2|Overall Study|Abnormality of Laboratory Test|2
7859234|NCT00077649|27259259|P1|Overall Study|Abnormality of Laboratory Test|1
7859235|NCT00077649|27259256|P4|Overall Study|Lost to Follow-up|2
7859236|NCT00077649|27259257|P3|Overall Study|Lost to Follow-up|3
7859237|NCT00077649|27259258|P2|Overall Study|Lost to Follow-up|2
7859238|NCT00077649|27259259|P1|Overall Study|Lost to Follow-up|2
7859239|NCT00077649|27259256|P4|Overall Study|Withdrawal by Subject|2
7859240|NCT00077649|27259257|P3|Overall Study|Withdrawal by Subject|1
7859241|NCT00077649|27259258|P2|Overall Study|Withdrawal by Subject|1
7859242|NCT00077649|27259259|P1|Overall Study|Withdrawal by Subject|0
7859243|NCT00077649|27259256|P4|Overall Study|Lack of Efficacy|2
7859244|NCT00077649|27259257|P3|Overall Study|Lack of Efficacy|3
7859245|NCT00077649|27259258|P2|Overall Study|Lack of Efficacy|3
7859246|NCT00077649|27259259|P1|Overall Study|Lack of Efficacy|5
7859247|NCT00077649|27259256|P4|Overall Study|Adverse Event|9
7859248|NCT00077649|27259257|P3|Overall Study|Adverse Event|7
7859249|NCT00077649|27259258|P2|Overall Study|Adverse Event|1
7859250|NCT00077649|27259259|P1|Overall Study|Adverse Event|5
7859251|NCT00077636|27259307|P2|Overall Study|Abnormality Of Laboratory Test|2
7859252|NCT00077636|27259308|P1|Overall Study|Abnormality Of Laboratory Test|3
7859253|NCT00077636|27259307|P2|Overall Study|Lost to Follow-up|18
7859254|NCT00077636|27259308|P1|Overall Study|Lost to Follow-up|10
7859255|NCT00077636|27259307|P2|Overall Study|Protocol Violation|2
7859256|NCT00077636|27259308|P1|Overall Study|Protocol Violation|0
7859257|NCT00077636|27259307|P2|Overall Study|Adverse Event|34
7859258|NCT00077636|27259308|P1|Overall Study|Adverse Event|17
7859259|NCT00077636|27259307|P2|Overall Study|Withdrawal by Subject|2
7859260|NCT00077636|27259308|P1|Overall Study|Withdrawal by Subject|2
7859261|NCT00077636|27259307|P2|Overall Study|Admin|3
7859262|NCT00077636|27259308|P1|Overall Study|Admin|3
7859263|NCT00077636|27259307|P2|Overall Study|Refused Treatment|31
7859264|NCT00077636|27259308|P1|Overall Study|Refused Treatment|9
7859265|NCT00077623|27259329|P3|Overall Study|Failure to return|0
7859266|NCT00077623|27259330|P2|Overall Study|Failure to return|0
7859267|NCT00077623|27259331|P1|Overall Study|Failure to return|1
7859268|NCT00077623|27259329|P3|Overall Study|Death|11
7859269|NCT00077623|27259330|P2|Overall Study|Death|18
7859270|NCT00077623|27259331|P1|Overall Study|Death|12
7859271|NCT00077623|27259329|P3|Overall Study|Insufficient therapeutic response|0
7859272|NCT00077623|27259330|P2|Overall Study|Insufficient therapeutic response|0
7859273|NCT00077623|27259331|P1|Overall Study|Insufficient therapeutic response|2
7859274|NCT00077623|27259329|P3|Overall Study|Other-Non safety reason|19
7859275|NCT00077623|27259330|P2|Overall Study|Other-Non safety reason|15
7859276|NCT00077623|27259331|P1|Overall Study|Other-Non safety reason|18
7859277|NCT00077623|27259329|P3|Overall Study|Withdrawal by Subject|1
7859278|NCT00077623|27259330|P2|Overall Study|Withdrawal by Subject|10
7859279|NCT00077623|27259331|P1|Overall Study|Withdrawal by Subject|2
7859280|NCT00077623|27259329|P3|Overall Study|Adverse Event|1
7859281|NCT00077623|27259330|P2|Overall Study|Adverse Event|0
7859282|NCT00077623|27259331|P1|Overall Study|Adverse Event|1
7859283|NCT00077610|27259366|P3|Overall Study|Sponsors decision to withdraw|1
7859284|NCT00077610|27259367|P2|Overall Study|Sponsors decision to withdraw|0
7859285|NCT00077610|27259368|P1|Overall Study|Sponsors decision to withdraw|0
7859286|NCT00077610|27259366|P3|Overall Study|Financial issues|0
7859287|NCT00077610|27259367|P2|Overall Study|Financial issues|1
7859288|NCT00077610|27259368|P1|Overall Study|Financial issues|0
7859289|NCT00077610|27259366|P3|Overall Study|Relocation|5
7859290|NCT00077610|27259367|P2|Overall Study|Relocation|8
7859291|NCT00077610|27259368|P1|Overall Study|Relocation|0
7859292|NCT00077610|27259366|P3|Overall Study|Change in dialysis modality|0
7859293|NCT00077610|27259367|P2|Overall Study|Change in dialysis modality|0
7859294|NCT00077610|27259368|P1|Overall Study|Change in dialysis modality|1
7859295|NCT00077610|27259366|P3|Overall Study|Transfer to other center for surgery|0
7859296|NCT00077610|27259367|P2|Overall Study|Transfer to other center for surgery|0
7859297|NCT00077610|27259368|P1|Overall Study|Transfer to other center for surgery|1
7859298|NCT00077610|27259366|P3|Overall Study|Transfer to satellite unit|0
7859299|NCT00077610|27259367|P2|Overall Study|Transfer to satellite unit|0
7859300|NCT00077610|27259368|P1|Overall Study|Transfer to satellite unit|1
7859301|NCT00077610|27259366|P3|Overall Study|Transferred to nursing home|1
7859302|NCT00077610|27259367|P2|Overall Study|Transferred to nursing home|0
7859303|NCT00077610|27259368|P1|Overall Study|Transferred to nursing home|0
7859304|NCT00077610|27259366|P3|Overall Study|Transferred to other unit|1
7859305|NCT00077610|27259367|P2|Overall Study|Transferred to other unit|0
7859306|NCT00077610|27259368|P1|Overall Study|Transferred to other unit|0
7859307|NCT00077610|27259366|P3|Overall Study|Given Epogen in hospital|0
7859308|NCT00077610|27259367|P2|Overall Study|Given Epogen in hospital|0
7859309|NCT00077610|27259368|P1|Overall Study|Given Epogen in hospital|1
7859310|NCT00077610|27259366|P3|Overall Study|Worsening of health condition|0
7859311|NCT00077610|27259367|P2|Overall Study|Worsening of health condition|1
7859312|NCT00077610|27259368|P1|Overall Study|Worsening of health condition|1
7859313|NCT00077610|27259366|P3|Overall Study|Principal Investigator's decision|1
7859314|NCT00077610|27259367|P2|Overall Study|Principal Investigator's decision|0
7859315|NCT00077610|27259368|P1|Overall Study|Principal Investigator's decision|1
7859316|NCT00077610|27259366|P3|Overall Study|Multiple blood transfusions|1
7859317|NCT00077610|27259367|P2|Overall Study|Multiple blood transfusions|0
7859318|NCT00077610|27259368|P1|Overall Study|Multiple blood transfusions|0
7859319|NCT00077610|27259366|P3|Overall Study|Insufficient Therapeutic Response|0
7859320|NCT00077610|27259367|P2|Overall Study|Insufficient Therapeutic Response|0
7859321|NCT00077610|27259368|P1|Overall Study|Insufficient Therapeutic Response|1
7859322|NCT00077610|27259366|P3|Overall Study|Withdrew from dialysis care|3
7859323|NCT00077610|27259367|P2|Overall Study|Withdrew from dialysis care|0
7859324|NCT00077610|27259368|P1|Overall Study|Withdrew from dialysis care|5
7859325|NCT00077610|27259366|P3|Overall Study|Renal transplant|11
7859326|NCT00077610|27259367|P2|Overall Study|Renal transplant|15
7859327|NCT00077610|27259368|P1|Overall Study|Renal transplant|12
7859328|NCT00077610|27259366|P3|Overall Study|Death|13
7859329|NCT00077610|27259367|P2|Overall Study|Death|13
7859330|NCT00077610|27259368|P1|Overall Study|Death|17
7859331|NCT00077610|27259366|P3|Overall Study|Withdrawal by Subject|6
7859332|NCT00077610|27259367|P2|Overall Study|Withdrawal by Subject|10
7859333|NCT00077610|27259368|P1|Overall Study|Withdrawal by Subject|4
7859334|NCT00077610|27259366|P3|Overall Study|Lost to Follow-up|2
7859335|NCT00077610|27259367|P2|Overall Study|Lost to Follow-up|1
7859336|NCT00077610|27259368|P1|Overall Study|Lost to Follow-up|0
7859337|NCT00077610|27259366|P3|Overall Study|Adverse Event|1
7859338|NCT00077610|27259367|P2|Overall Study|Adverse Event|7
7859339|NCT00077610|27259368|P1|Overall Study|Adverse Event|9
7859340|NCT00077376|27259397|P1|Overall Study|Insurance ran out|1
7859341|NCT00077376|27259397|P1|Overall Study|Surgery|1
7859342|NCT00077376|27259397|P1|Overall Study|Symptomatic deterioration|1
7859343|NCT00077376|27259397|P1|Overall Study|Still on treatment|1
7859344|NCT00077376|27259397|P1|Overall Study|Complicating disease|1
7859345|NCT00077376|27259397|P1|Overall Study|Alternative therapy|5
7859346|NCT00077376|27259397|P1|Overall Study|Physician Decision|1
7859347|NCT00077376|27259397|P1|Overall Study|Death|1
7859348|NCT00077376|27259397|P1|Overall Study|Withdrawal by Subject|2
7859349|NCT00077376|27259397|P1|Overall Study|Adverse Event|8
7859350|NCT00077207|27259408|P1|Overall Study|Ineligible|1
7859351|NCT00077207|27259408|P1|Overall Study|Withdrawal by Subject|6
7859352|NCT00077207|27259408|P1|Overall Study|Physician Decision|6
7859353|NCT00077207|27259408|P1|Overall Study|Lack of Efficacy|12
7859354|NCT00077207|27259408|P1|Overall Study|Adverse Event|5
7859355|NCT00077064|27259420|P2|Overall Study|Patient refusal|2
7859356|NCT00077064|27259421|P1|Overall Study|Patient refusal|0
7859357|NCT00077064|27259420|P2|Overall Study|Adverse Event|4
7859358|NCT00077064|27259421|P1|Overall Study|Adverse Event|0
7859359|NCT00076999|27259437|P5|Overall Study|Other reason (not specified)|13
7859360|NCT00076999|27259438|P4|Overall Study|Other reason (not specified)|1
7859361|NCT00076999|27259439|P3|Overall Study|Other reason (not specified)|4
7859362|NCT00076999|27259440|P2|Overall Study|Other reason (not specified)|8
7859363|NCT00076999|27259441|P1|Overall Study|Other reason (not specified)|8
7859364|NCT00076999|27259437|P5|Overall Study|Withdrawal by Subject|1
7859365|NCT00076999|27259438|P4|Overall Study|Withdrawal by Subject|0
7859366|NCT00076999|27259439|P3|Overall Study|Withdrawal by Subject|3
7859367|NCT00076999|27259440|P2|Overall Study|Withdrawal by Subject|4
7859368|NCT00076999|27259441|P1|Overall Study|Withdrawal by Subject|0
7859369|NCT00076999|27259437|P5|Overall Study|Lost to Follow-up|0
7859370|NCT00076999|27259438|P4|Overall Study|Lost to Follow-up|0
7859371|NCT00076999|27259439|P3|Overall Study|Lost to Follow-up|0
7859372|NCT00076999|27259440|P2|Overall Study|Lost to Follow-up|1
7859373|NCT00076999|27259441|P1|Overall Study|Lost to Follow-up|2
7859374|NCT00076999|27259437|P5|Overall Study|Protocol Violation|9
7859375|NCT00076999|27259438|P4|Overall Study|Protocol Violation|0
7859376|NCT00076999|27259439|P3|Overall Study|Protocol Violation|4
7859377|NCT00076999|27259440|P2|Overall Study|Protocol Violation|3
7859378|NCT00076999|27259441|P1|Overall Study|Protocol Violation|0
7859379|NCT00076999|27259437|P5|Overall Study|Adverse Event|2
7859380|NCT00076999|27259438|P4|Overall Study|Adverse Event|0
7859381|NCT00076999|27259439|P3|Overall Study|Adverse Event|6
7859382|NCT00076999|27259440|P2|Overall Study|Adverse Event|8
7859383|NCT00076999|27259441|P1|Overall Study|Adverse Event|2
7859384|NCT00003222|27259560|P2|Overall Study|Physician Decision|1
7859385|NCT00003222|27259561|P1|Overall Study|Physician Decision|0
7859386|NCT00076804|27259573|P2|Overall Study|Early study Closure|32
7859387|NCT00076804|27259574|P1|Overall Study|Early study Closure|32
7859388|NCT00076804|27259573|P2|Overall Study|Withdrawal by Subject|8
7859389|NCT00076804|27259574|P1|Overall Study|Withdrawal by Subject|10
7859390|NCT00076804|27259573|P2|Overall Study|Lost to Follow-up|9
7859391|NCT00076804|27259574|P1|Overall Study|Lost to Follow-up|9
7859392|NCT00076804|27259573|P2|Overall Study|Death|20
7859393|NCT00076804|27259574|P1|Overall Study|Death|9
7859394|NCT00076752|27259586|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
7859395|NCT00076752|27259586|P1|Overall Study|Death|2
7859396|NCT00076570|27259632|P2|Overall Study|Drug intolerance|8
7859397|NCT00076570|27259633|P1|Overall Study|Drug intolerance|8
7859398|NCT00003298|27259641|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
7859399|NCT00003298|27259641|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
7859400|NCT00003298|27259641|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
7859401|NCT00003298|27259641|P1|Step 2 (Adjuvant Therapy)|Death|1
7859402|NCT00003298|27259641|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
7859403|NCT00003298|27259641|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
7859404|NCT00003298|27259641|P1|Re-register to Step 2 After Surgery|Reason unknown|1
7859405|NCT00003298|27259641|P1|Re-register to Step 2 After Surgery|Other complications|2
7859406|NCT00003298|27259641|P1|Re-register to Step 2 After Surgery|Positive margins|5
7859407|NCT00003298|27259641|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
7859408|NCT00003298|27259641|P1|Surgery|Unevaluable and off study|2
7859409|NCT00003298|27259641|P1|Surgery|Progression before surgery|2
7859410|NCT00003298|27259641|P1|Surgery|Unresectable at surgery|3
7859411|NCT00003298|27259641|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
7859412|NCT00003298|27259641|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
7859413|NCT00076336|27259651|P2|Overall Study|Treatment failure|5
7859414|NCT00076336|27259652|P1|Overall Study|Treatment failure|4
7859415|NCT00076336|27259651|P2|Overall Study|Virologic Breakthrough|16
7859416|NCT00076336|27259652|P1|Overall Study|Virologic Breakthrough|14
7859417|NCT00076336|27259651|P2|Overall Study|Liver Transplantation|3
7859418|NCT00076336|27259652|P1|Overall Study|Liver Transplantation|3
7859419|NCT00076336|27259651|P2|Overall Study|Patient, Investigator, Sponsor request|6
7859420|NCT00076336|27259652|P1|Overall Study|Patient, Investigator, Sponsor request|8
7859421|NCT00076336|27259651|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
7859422|NCT00076336|27259652|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
7859423|NCT00076336|27259651|P2|Overall Study|Non-Compliance|0
7859424|NCT00076336|27259652|P1|Overall Study|Non-Compliance|2
7859425|NCT00076336|27259651|P2|Overall Study|Lost to Follow-up|4
7859426|NCT00076336|27259652|P1|Overall Study|Lost to Follow-up|4
7859427|NCT00076336|27259651|P2|Overall Study|Adverse Event|4
7859428|NCT00076336|27259652|P1|Overall Study|Adverse Event|4
7859429|NCT00076336|27259651|P2|Overall Study|Death|17
7859430|NCT00076336|27259652|P1|Overall Study|Death|13
7859431|NCT00076102|27259705|P1|Overall Study|refusal of further therapy|2
7859432|NCT00076102|27259705|P1|Overall Study|plexiform neurofibroma surgery|1
7859433|NCT00076102|27259705|P1|Overall Study|Progression in pre-existing brain tumor|1
7859434|NCT00076102|27259705|P1|Overall Study|Clinical progression|1
7859435|NCT00076024|27259733|P4|Phase 2, Open-label|Other|2
7859436|NCT00076024|27259734|P3|Phase 2, Open-label|Other|0
7859437|NCT00076024|27259735|P2|Phase 2, Open-label|Other|0
7859438|NCT00076024|27259736|P1|Phase 2, Open-label|Other|0
7859439|NCT00076024|27259733|P4|Phase 2, Open-label|Withdrawal by Subject|1
7859440|NCT00076024|27259734|P3|Phase 2, Open-label|Withdrawal by Subject|0
7859441|NCT00076024|27259735|P2|Phase 2, Open-label|Withdrawal by Subject|0
7859442|NCT00076024|27259736|P1|Phase 2, Open-label|Withdrawal by Subject|0
7859443|NCT00076024|27259733|P4|Phase 2, Open-label|Lack of Efficacy|11
7859444|NCT00076024|27259734|P3|Phase 2, Open-label|Lack of Efficacy|0
7859445|NCT00076024|27259735|P2|Phase 2, Open-label|Lack of Efficacy|0
7859446|NCT00076024|27259736|P1|Phase 2, Open-label|Lack of Efficacy|0
7859447|NCT00076024|27259733|P4|Phase 2, Open-label|Adverse Event|2
7859448|NCT00076024|27259734|P3|Phase 2, Open-label|Adverse Event|0
7859449|NCT00076024|27259735|P2|Phase 2, Open-label|Adverse Event|0
7859450|NCT00076024|27259736|P1|Phase 2, Open-label|Adverse Event|0
7859451|NCT00076024|27259733|P4|Phase 2, Double-blind|Randomized but not treated|0
7859452|NCT00076024|27259734|P3|Phase 2, Double-blind|Randomized but not treated|0
7859453|NCT00076024|27259735|P2|Phase 2, Double-blind|Randomized but not treated|1
7859454|NCT00076024|27259736|P1|Phase 2, Double-blind|Randomized but not treated|0
7859455|NCT00076024|27259733|P4|Phase 2, Double-blind|Un-specified|0
7859456|NCT00076024|27259734|P3|Phase 2, Double-blind|Un-specified|6
7859457|NCT00076024|27259735|P2|Phase 2, Double-blind|Un-specified|14
7859458|NCT00076024|27259736|P1|Phase 2, Double-blind|Un-specified|0
7859459|NCT00076024|27259733|P4|Phase 2, Double-blind|Adverse Event|0
7859460|NCT00076024|27259734|P3|Phase 2, Double-blind|Adverse Event|6
7859461|NCT00076024|27259735|P2|Phase 2, Double-blind|Adverse Event|25
7859462|NCT00076024|27259736|P1|Phase 2, Double-blind|Adverse Event|0
7859463|NCT00076024|27259733|P4|Phase 2, Double-blind|Withdrawal by Subject|0
7859464|NCT00076024|27259734|P3|Phase 2, Double-blind|Withdrawal by Subject|4
7859465|NCT00076024|27259735|P2|Phase 2, Double-blind|Withdrawal by Subject|13
7859466|NCT00076024|27259736|P1|Phase 2, Double-blind|Withdrawal by Subject|0
7859467|NCT00076024|27259733|P4|Phase 2, Double-blind|Lack of Efficacy|0
7859468|NCT00076024|27259734|P3|Phase 2, Double-blind|Lack of Efficacy|40
7859469|NCT00076024|27259735|P2|Phase 2, Double-blind|Lack of Efficacy|59
7859470|NCT00076024|27259736|P1|Phase 2, Double-blind|Lack of Efficacy|0
7859471|NCT00076024|27259733|P4|Phase 1, Lead-in|Clinical progression|0
7859472|NCT00076024|27259734|P3|Phase 1, Lead-in|Clinical progression|0
7859473|NCT00076024|27259735|P2|Phase 1, Lead-in|Clinical progression|0
7859474|NCT00076024|27259736|P1|Phase 1, Lead-in|Clinical progression|1
7859475|NCT00076024|27259733|P4|Phase 1, Lead-in|Adverse Event|0
7859476|NCT00076024|27259734|P3|Phase 1, Lead-in|Adverse Event|0
7859477|NCT00076024|27259735|P2|Phase 1, Lead-in|Adverse Event|0
7859478|NCT00076024|27259736|P1|Phase 1, Lead-in|Adverse Event|1
7859479|NCT00076024|27259733|P4|Phase 1, Lead-in|Lack of Efficacy|0
7859480|NCT00076024|27259734|P3|Phase 1, Lead-in|Lack of Efficacy|0
7859481|NCT00076024|27259735|P2|Phase 1, Lead-in|Lack of Efficacy|0
7859482|NCT00076024|27259736|P1|Phase 1, Lead-in|Lack of Efficacy|4
7859483|NCT00076011|27259750|P1|Overall Study|Ongoing|1
7859484|NCT00076011|27259750|P1|Overall Study|Other|11
7859485|NCT00076011|27259750|P1|Overall Study|Study terminated by sponsor|3
7859486|NCT00076011|27259750|P1|Overall Study|Withdrawal by Subject|1
7859487|NCT00076011|27259750|P1|Overall Study|Lack of Efficacy|25
7859488|NCT00076011|27259750|P1|Overall Study|Adverse Event|10
7859489|NCT00076011|27259750|P1|Overall Study|Death|1
7859490|NCT00075946|27259762|P5|Overall Study|Other|0
7859491|NCT00075946|27259763|P4|Overall Study|Other|2
7859492|NCT00075946|27259764|P3|Overall Study|Other|0
7859493|NCT00075946|27259765|P2|Overall Study|Other|13
7859494|NCT00075946|27259766|P1|Overall Study|Other|5
7859495|NCT00075946|27259762|P5|Overall Study|Time to progression less than 6 months|0
7859496|NCT00075946|27259763|P4|Overall Study|Time to progression less than 6 months|3
7859497|NCT00075946|27259764|P3|Overall Study|Time to progression less than 6 months|8
7859498|NCT00075946|27259765|P2|Overall Study|Time to progression less than 6 months|30
7859499|NCT00075946|27259766|P1|Overall Study|Time to progression less than 6 months|15
7859500|NCT00075946|27259762|P5|Overall Study|No response to retreatment|0
7859501|NCT00075946|27259763|P4|Overall Study|No response to retreatment|0
7859502|NCT00075946|27259764|P3|Overall Study|No response to retreatment|2
7859503|NCT00075946|27259765|P2|Overall Study|No response to retreatment|0
7859504|NCT00075946|27259766|P1|Overall Study|No response to retreatment|23
7859505|NCT00075946|27259762|P5|Overall Study|Other complicating disease|0
7859506|NCT00075946|27259763|P4|Overall Study|Other complicating disease|4
7859507|NCT00075946|27259764|P3|Overall Study|Other complicating disease|1
7859508|NCT00075946|27259765|P2|Overall Study|Other complicating disease|13
7859509|NCT00075946|27259766|P1|Overall Study|Other complicating disease|7
7859510|NCT00075946|27259762|P5|Overall Study|Alternative therapy|0
7859511|NCT00075946|27259763|P4|Overall Study|Alternative therapy|0
7859512|NCT00075946|27259764|P3|Overall Study|Alternative therapy|5
7859513|NCT00075946|27259765|P2|Overall Study|Alternative therapy|2
7859514|NCT00075946|27259766|P1|Overall Study|Alternative therapy|16
7859515|NCT00075946|27259762|P5|Overall Study|Withdrawal by Subject|0
7859516|NCT00075946|27259763|P4|Overall Study|Withdrawal by Subject|9
7859517|NCT00075946|27259764|P3|Overall Study|Withdrawal by Subject|4
7859518|NCT00075946|27259765|P2|Overall Study|Withdrawal by Subject|58
7859519|NCT00075946|27259766|P1|Overall Study|Withdrawal by Subject|23
7859520|NCT00075946|27259762|P5|Overall Study|Death|0
7859521|NCT00075946|27259763|P4|Overall Study|Death|0
7859522|NCT00075946|27259764|P3|Overall Study|Death|0
7859523|NCT00075946|27259765|P2|Overall Study|Death|1
7859524|NCT00075946|27259766|P1|Overall Study|Death|0
7859525|NCT00075946|27259762|P5|Overall Study|Adverse Event|0
7859526|NCT00075946|27259763|P4|Overall Study|Adverse Event|2
7859527|NCT00075946|27259764|P3|Overall Study|Adverse Event|0
7859528|NCT00075946|27259765|P2|Overall Study|Adverse Event|10
7859529|NCT00075946|27259766|P1|Overall Study|Adverse Event|2
7859530|NCT00075946|27259762|P5|Overall Study|Still on treatment at time of analysis|0
7859531|NCT00075946|27259763|P4|Overall Study|Still on treatment at time of analysis|9
7859532|NCT00075946|27259764|P3|Overall Study|Still on treatment at time of analysis|3
7859533|NCT00075946|27259765|P2|Overall Study|Still on treatment at time of analysis|19
7859534|NCT00075946|27259766|P1|Overall Study|Still on treatment at time of analysis|52
7859535|NCT00075946|27259762|P5|Overall Study|Incorrectly randomized (no response)|0
7859536|NCT00075946|27259763|P4|Overall Study|Incorrectly randomized (no response)|1
7859537|NCT00075946|27259764|P3|Overall Study|Incorrectly randomized (no response)|5
7859538|NCT00075946|27259765|P2|Overall Study|Incorrectly randomized (no response)|5
7859539|NCT00075946|27259766|P1|Overall Study|Incorrectly randomized (no response)|5
7859540|NCT00075946|27259762|P5|Overall Study|Did not achieve response after induction|182
7859541|NCT00075946|27259763|P4|Overall Study|Did not achieve response after induction|0
7859542|NCT00075946|27259764|P3|Overall Study|Did not achieve response after induction|0
7859543|NCT00075946|27259765|P2|Overall Study|Did not achieve response after induction|0
7859544|NCT00075946|27259766|P1|Overall Study|Did not achieve response after induction|0
7859545|NCT00075946|27259762|P5|Overall Study|Path ineligible: undetermined histology|6
7859546|NCT00075946|27259763|P4|Overall Study|Path ineligible: undetermined histology|0
7859547|NCT00075946|27259764|P3|Overall Study|Path ineligible: undetermined histology|0
7859548|NCT00075946|27259765|P2|Overall Study|Path ineligible: undetermined histology|0
7859549|NCT00075946|27259766|P1|Overall Study|Path ineligible: undetermined histology|0
7859550|NCT00075881|27259781|P1|Overall Study|never start protocol therapy|1
7859551|NCT00075881|27259781|P1|Overall Study|Ineligible|1
7859552|NCT00075881|27259781|P1|Overall Study|missing data|2
7859553|NCT00075881|27259781|P1|Overall Study|other|4
7859554|NCT00075881|27259781|P1|Overall Study|other complicating disease|3
7859555|NCT00075881|27259781|P1|Overall Study|Protocol Violation|4
7859556|NCT00075881|27259781|P1|Overall Study|Withdrawal by Subject|2
7859557|NCT00075881|27259781|P1|Overall Study|Death|1
7859558|NCT00075881|27259781|P1|Overall Study|Adverse Event|7
7859559|NCT00075881|27259781|P1|Overall Study|Lack of Efficacy|18
7859560|NCT00075816|27259825|P2|Overall Study|Did not undergo transplantation|11
7859561|NCT00075816|27259826|P1|Overall Study|Did not undergo transplantation|14
7859562|NCT00075764|27259895|P2|Overall Study|Under review|1
7859563|NCT00075764|27259896|P1|Overall Study|Under review|0
7859564|NCT00075764|27259895|P2|Overall Study|Not protocol specified|19
7859565|NCT00075764|27259896|P1|Overall Study|Not protocol specified|27
7859566|NCT00075764|27259895|P2|Overall Study|Delinquent|2
7859567|NCT00075764|27259896|P1|Overall Study|Delinquent|4
7859568|NCT00075764|27259895|P2|Overall Study|Still on treatment|15
7859569|NCT00075764|27259896|P1|Overall Study|Still on treatment|8
7859570|NCT00075764|27259895|P2|Overall Study|Progression|274
7859571|NCT00075764|27259896|P1|Overall Study|Progression|269
7859572|NCT00075764|27259895|P2|Overall Study|Withdrawal by Subject|18
7859573|NCT00075764|27259896|P1|Overall Study|Withdrawal by Subject|28
7859574|NCT00075764|27259895|P2|Overall Study|Death|8
7859575|NCT00075764|27259896|P1|Overall Study|Death|4
7859576|NCT00075764|27259895|P2|Overall Study|Adverse Event|12
7859577|NCT00075764|27259896|P1|Overall Study|Adverse Event|5
7859578|NCT00075725|27259920|P12|Overall Study|Pt incarcerated|0
7859579|NCT00075725|27259921|P11|Overall Study|Pt incarcerated|0
7859580|NCT00075725|27259922|P10|Overall Study|Pt incarcerated|0
7859581|NCT00075725|27259923|P9|Overall Study|Pt incarcerated|0
7859582|NCT00075725|27259924|P8|Overall Study|Pt incarcerated|1
7859583|NCT00075725|27259925|P7|Overall Study|Pt incarcerated|0
7859584|NCT00075725|27259926|P6|Overall Study|Pt incarcerated|0
7859585|NCT00075725|27259927|P5|Overall Study|Pt incarcerated|0
7859586|NCT00075725|27259928|P4|Overall Study|Pt incarcerated|0
7859587|NCT00075725|27259929|P3|Overall Study|Pt incarcerated|0
7859588|NCT00075725|27259930|P2|Overall Study|Pt incarcerated|0
7859589|NCT00075725|27259931|P1|Overall Study|Pt incarcerated|0
7859590|NCT00075725|27259920|P12|Overall Study|Pt care terminated due to pt behavior|0
7859591|NCT00075725|27259921|P11|Overall Study|Pt care terminated due to pt behavior|0
7859592|NCT00075725|27259922|P10|Overall Study|Pt care terminated due to pt behavior|0
7859593|NCT00075725|27259923|P9|Overall Study|Pt care terminated due to pt behavior|0
7859594|NCT00075725|27259924|P8|Overall Study|Pt care terminated due to pt behavior|1
7859595|NCT00075725|27259925|P7|Overall Study|Pt care terminated due to pt behavior|0
7859596|NCT00075725|27259926|P6|Overall Study|Pt care terminated due to pt behavior|0
7859597|NCT00075725|27259927|P5|Overall Study|Pt care terminated due to pt behavior|0
7859598|NCT00075725|27259928|P4|Overall Study|Pt care terminated due to pt behavior|0
7859599|NCT00075725|27259929|P3|Overall Study|Pt care terminated due to pt behavior|0
7859600|NCT00075725|27259930|P2|Overall Study|Pt care terminated due to pt behavior|0
7859601|NCT00075725|27259931|P1|Overall Study|Pt care terminated due to pt behavior|0
7859602|NCT00075725|27259920|P12|Overall Study|Other complications|0
7859603|NCT00075725|27259921|P11|Overall Study|Other complications|0
7859604|NCT00075725|27259922|P10|Overall Study|Other complications|0
7859605|NCT00075725|27259923|P9|Overall Study|Other complications|0
7859606|NCT00075725|27259924|P8|Overall Study|Other complications|0
7859607|NCT00075725|27259925|P7|Overall Study|Other complications|0
7859608|NCT00075725|27259926|P6|Overall Study|Other complications|1
7859609|NCT00075725|27259927|P5|Overall Study|Other complications|0
7859610|NCT00075725|27259928|P4|Overall Study|Other complications|0
7859611|NCT00075725|27259929|P3|Overall Study|Other complications|0
7859612|NCT00075725|27259930|P2|Overall Study|Other complications|0
7859613|NCT00075725|27259931|P1|Overall Study|Other complications|0
7859614|NCT00075725|27259920|P12|Overall Study|Study Closure|0
7859615|NCT00075725|27259921|P11|Overall Study|Study Closure|0
7859616|NCT00075725|27259922|P10|Overall Study|Study Closure|0
7859617|NCT00075725|27259923|P9|Overall Study|Study Closure|0
7859618|NCT00075725|27259924|P8|Overall Study|Study Closure|1
7859619|NCT00075725|27259925|P7|Overall Study|Study Closure|0
7859620|NCT00075725|27259926|P6|Overall Study|Study Closure|3
7859621|NCT00075725|27259927|P5|Overall Study|Study Closure|1
7859622|NCT00075725|27259928|P4|Overall Study|Study Closure|0
7859623|NCT00075725|27259929|P3|Overall Study|Study Closure|0
7859624|NCT00075725|27259930|P2|Overall Study|Study Closure|0
7859625|NCT00075725|27259931|P1|Overall Study|Study Closure|1
7859626|NCT00075725|27259920|P12|Overall Study|Institution Terminated|0
7859627|NCT00075725|27259921|P11|Overall Study|Institution Terminated|0
7859628|NCT00075725|27259922|P10|Overall Study|Institution Terminated|0
7859629|NCT00075725|27259923|P9|Overall Study|Institution Terminated|0
7859630|NCT00075725|27259924|P8|Overall Study|Institution Terminated|3
7859631|NCT00075725|27259925|P7|Overall Study|Institution Terminated|0
7859632|NCT00075725|27259926|P6|Overall Study|Institution Terminated|0
7859633|NCT00075725|27259927|P5|Overall Study|Institution Terminated|1
7859634|NCT00075725|27259928|P4|Overall Study|Institution Terminated|0
7859635|NCT00075725|27259929|P3|Overall Study|Institution Terminated|0
7859636|NCT00075725|27259930|P2|Overall Study|Institution Terminated|0
7859637|NCT00075725|27259931|P1|Overall Study|Institution Terminated|0
7859638|NCT00075725|27259920|P12|Overall Study|Pt relocated|0
7859639|NCT00075725|27259921|P11|Overall Study|Pt relocated|0
7859640|NCT00075725|27259922|P10|Overall Study|Pt relocated|0
7859641|NCT00075725|27259923|P9|Overall Study|Pt relocated|1
7859642|NCT00075725|27259924|P8|Overall Study|Pt relocated|2
7859643|NCT00075725|27259925|P7|Overall Study|Pt relocated|1
7859644|NCT00075725|27259926|P6|Overall Study|Pt relocated|1
7859645|NCT00075725|27259927|P5|Overall Study|Pt relocated|0
7859646|NCT00075725|27259928|P4|Overall Study|Pt relocated|2
7859647|NCT00075725|27259929|P3|Overall Study|Pt relocated|0
7859648|NCT00075725|27259930|P2|Overall Study|Pt relocated|0
7859649|NCT00075725|27259931|P1|Overall Study|Pt relocated|0
7859650|NCT00075725|27259920|P12|Overall Study|Pt received additional steroids|0
7859651|NCT00075725|27259921|P11|Overall Study|Pt received additional steroids|0
7859652|NCT00075725|27259922|P10|Overall Study|Pt received additional steroids|0
7859653|NCT00075725|27259923|P9|Overall Study|Pt received additional steroids|0
7859654|NCT00075725|27259924|P8|Overall Study|Pt received additional steroids|0
7859655|NCT00075725|27259925|P7|Overall Study|Pt received additional steroids|0
7859656|NCT00075725|27259926|P6|Overall Study|Pt received additional steroids|0
7859657|NCT00075725|27259927|P5|Overall Study|Pt received additional steroids|0
7859658|NCT00075725|27259928|P4|Overall Study|Pt received additional steroids|1
7859659|NCT00075725|27259929|P3|Overall Study|Pt received additional steroids|0
7859660|NCT00075725|27259930|P2|Overall Study|Pt received additional steroids|0
7859661|NCT00075725|27259931|P1|Overall Study|Pt received additional steroids|0
7859662|NCT00075725|27259920|P12|Overall Study|Pt went to transplant|0
7859663|NCT00075725|27259921|P11|Overall Study|Pt went to transplant|0
7859664|NCT00075725|27259922|P10|Overall Study|Pt went to transplant|0
7859665|NCT00075725|27259923|P9|Overall Study|Pt went to transplant|0
7859666|NCT00075725|27259924|P8|Overall Study|Pt went to transplant|0
7859667|NCT00075725|27259925|P7|Overall Study|Pt went to transplant|0
7859668|NCT00075725|27259926|P6|Overall Study|Pt went to transplant|1
7859669|NCT00075725|27259927|P5|Overall Study|Pt went to transplant|0
7859670|NCT00075725|27259928|P4|Overall Study|Pt went to transplant|1
7859671|NCT00075725|27259929|P3|Overall Study|Pt went to transplant|0
7859672|NCT00075725|27259930|P2|Overall Study|Pt went to transplant|0
7859673|NCT00075725|27259931|P1|Overall Study|Pt went to transplant|0
7859674|NCT00075725|27259920|P12|Overall Study|specimen(s) not submitted|0
7859675|NCT00075725|27259921|P11|Overall Study|specimen(s) not submitted|0
7859676|NCT00075725|27259922|P10|Overall Study|specimen(s) not submitted|0
7859677|NCT00075725|27259923|P9|Overall Study|specimen(s) not submitted|0
7859678|NCT00075725|27259924|P8|Overall Study|specimen(s) not submitted|0
7859679|NCT00075725|27259925|P7|Overall Study|specimen(s) not submitted|0
7859680|NCT00075725|27259926|P6|Overall Study|specimen(s) not submitted|0
7859681|NCT00075725|27259927|P5|Overall Study|specimen(s) not submitted|0
7859682|NCT00075725|27259928|P4|Overall Study|specimen(s) not submitted|0
7859683|NCT00075725|27259929|P3|Overall Study|specimen(s) not submitted|2
7859684|NCT00075725|27259930|P2|Overall Study|specimen(s) not submitted|0
7859685|NCT00075725|27259931|P1|Overall Study|specimen(s) not submitted|0
7859686|NCT00075725|27259920|P12|Overall Study|Unsuccessful institutional transfer|0
7859687|NCT00075725|27259921|P11|Overall Study|Unsuccessful institutional transfer|0
7859688|NCT00075725|27259922|P10|Overall Study|Unsuccessful institutional transfer|1
7859689|NCT00075725|27259923|P9|Overall Study|Unsuccessful institutional transfer|0
7859690|NCT00075725|27259924|P8|Overall Study|Unsuccessful institutional transfer|0
7859691|NCT00075725|27259925|P7|Overall Study|Unsuccessful institutional transfer|0
7859692|NCT00075725|27259926|P6|Overall Study|Unsuccessful institutional transfer|0
7859693|NCT00075725|27259927|P5|Overall Study|Unsuccessful institutional transfer|0
7859694|NCT00075725|27259928|P4|Overall Study|Unsuccessful institutional transfer|0
7859695|NCT00075725|27259929|P3|Overall Study|Unsuccessful institutional transfer|2
7859696|NCT00075725|27259930|P2|Overall Study|Unsuccessful institutional transfer|0
7859697|NCT00075725|27259931|P1|Overall Study|Unsuccessful institutional transfer|0
7859698|NCT00075725|27259920|P12|Overall Study|Clinic chart lost unable to recreate|0
7859699|NCT00075725|27259921|P11|Overall Study|Clinic chart lost unable to recreate|0
7859700|NCT00075725|27259922|P10|Overall Study|Clinic chart lost unable to recreate|0
7859701|NCT00075725|27259923|P9|Overall Study|Clinic chart lost unable to recreate|0
7859702|NCT00075725|27259924|P8|Overall Study|Clinic chart lost unable to recreate|0
7859703|NCT00075725|27259925|P7|Overall Study|Clinic chart lost unable to recreate|0
7859704|NCT00075725|27259926|P6|Overall Study|Clinic chart lost unable to recreate|0
7859705|NCT00075725|27259927|P5|Overall Study|Clinic chart lost unable to recreate|0
7859706|NCT00075725|27259928|P4|Overall Study|Clinic chart lost unable to recreate|0
7859707|NCT00075725|27259929|P3|Overall Study|Clinic chart lost unable to recreate|1
7859708|NCT00075725|27259930|P2|Overall Study|Clinic chart lost unable to recreate|0
7859709|NCT00075725|27259931|P1|Overall Study|Clinic chart lost unable to recreate|0
7859710|NCT00075725|27259920|P12|Overall Study|Pt trying to find a BM donor|0
7859711|NCT00075725|27259921|P11|Overall Study|Pt trying to find a BM donor|0
7859712|NCT00075725|27259922|P10|Overall Study|Pt trying to find a BM donor|0
7859713|NCT00075725|27259923|P9|Overall Study|Pt trying to find a BM donor|0
7859714|NCT00075725|27259924|P8|Overall Study|Pt trying to find a BM donor|0
7859715|NCT00075725|27259925|P7|Overall Study|Pt trying to find a BM donor|0
7859716|NCT00075725|27259926|P6|Overall Study|Pt trying to find a BM donor|0
7859717|NCT00075725|27259927|P5|Overall Study|Pt trying to find a BM donor|0
7859718|NCT00075725|27259928|P4|Overall Study|Pt trying to find a BM donor|0
7859719|NCT00075725|27259929|P3|Overall Study|Pt trying to find a BM donor|0
7859720|NCT00075725|27259930|P2|Overall Study|Pt trying to find a BM donor|1
7859721|NCT00075725|27259931|P1|Overall Study|Pt trying to find a BM donor|0
7859722|NCT00075725|27259920|P12|Overall Study|Other|3
7859723|NCT00075725|27259921|P11|Overall Study|Other|0
7859724|NCT00075725|27259922|P10|Overall Study|Other|1
7859725|NCT00075725|27259923|P9|Overall Study|Other|2
7859726|NCT00075725|27259924|P8|Overall Study|Other|9
7859727|NCT00075725|27259925|P7|Overall Study|Other|2
7859728|NCT00075725|27259926|P6|Overall Study|Other|4
7859729|NCT00075725|27259927|P5|Overall Study|Other|1
7859730|NCT00075725|27259928|P4|Overall Study|Other|1
7859731|NCT00075725|27259929|P3|Overall Study|Other|1
7859732|NCT00075725|27259930|P2|Overall Study|Other|2
7859733|NCT00075725|27259931|P1|Overall Study|Other|4
7859734|NCT00075725|27259920|P12|Overall Study|Inevaluable|0
7859735|NCT00075725|27259921|P11|Overall Study|Inevaluable|1
7859736|NCT00075725|27259922|P10|Overall Study|Inevaluable|0
7859737|NCT00075725|27259923|P9|Overall Study|Inevaluable|2
7859738|NCT00075725|27259924|P8|Overall Study|Inevaluable|11
7859739|NCT00075725|27259925|P7|Overall Study|Inevaluable|1
7859740|NCT00075725|27259926|P6|Overall Study|Inevaluable|9
7859741|NCT00075725|27259927|P5|Overall Study|Inevaluable|2
7859742|NCT00075725|27259928|P4|Overall Study|Inevaluable|2
7859743|NCT00075725|27259929|P3|Overall Study|Inevaluable|4
7859744|NCT00075725|27259930|P2|Overall Study|Inevaluable|1
7859745|NCT00075725|27259931|P1|Overall Study|Inevaluable|1
7859746|NCT00075725|27259920|P12|Overall Study|Pt has very high risk ALL characteristic|3
7859747|NCT00075725|27259921|P11|Overall Study|Pt has very high risk ALL characteristic|0
7859748|NCT00075725|27259922|P10|Overall Study|Pt has very high risk ALL characteristic|1
7859749|NCT00075725|27259923|P9|Overall Study|Pt has very high risk ALL characteristic|29
7859750|NCT00075725|27259924|P8|Overall Study|Pt has very high risk ALL characteristic|74
7859751|NCT00075725|27259925|P7|Overall Study|Pt has very high risk ALL characteristic|23
7859752|NCT00075725|27259926|P6|Overall Study|Pt has very high risk ALL characteristic|75
7859753|NCT00075725|27259927|P5|Overall Study|Pt has very high risk ALL characteristic|11
7859754|NCT00075725|27259928|P4|Overall Study|Pt has very high risk ALL characteristic|18
7859755|NCT00075725|27259929|P3|Overall Study|Pt has very high risk ALL characteristic|26
7859756|NCT00075725|27259930|P2|Overall Study|Pt has very high risk ALL characteristic|11
7859757|NCT00075725|27259931|P1|Overall Study|Pt has very high risk ALL characteristic|15
7859758|NCT00075725|27259920|P12|Overall Study|MRD positive after extended ind|0
7859759|NCT00075725|27259921|P11|Overall Study|MRD positive after extended ind|0
7859760|NCT00075725|27259922|P10|Overall Study|MRD positive after extended ind|0
7859761|NCT00075725|27259923|P9|Overall Study|MRD positive after extended ind|0
7859762|NCT00075725|27259924|P8|Overall Study|MRD positive after extended ind|1
7859763|NCT00075725|27259925|P7|Overall Study|MRD positive after extended ind|0
7859764|NCT00075725|27259926|P6|Overall Study|MRD positive after extended ind|2
7859765|NCT00075725|27259927|P5|Overall Study|MRD positive after extended ind|1
7859766|NCT00075725|27259928|P4|Overall Study|MRD positive after extended ind|0
7859767|NCT00075725|27259929|P3|Overall Study|MRD positive after extended ind|1
7859768|NCT00075725|27259930|P2|Overall Study|MRD positive after extended ind|1
7859769|NCT00075725|27259931|P1|Overall Study|MRD positive after extended ind|0
7859770|NCT00075725|27259920|P12|Overall Study|Insurance issues|0
7859771|NCT00075725|27259921|P11|Overall Study|Insurance issues|0
7859772|NCT00075725|27259922|P10|Overall Study|Insurance issues|0
7859773|NCT00075725|27259923|P9|Overall Study|Insurance issues|0
7859774|NCT00075725|27259924|P8|Overall Study|Insurance issues|1
7859775|NCT00075725|27259925|P7|Overall Study|Insurance issues|0
7859776|NCT00075725|27259926|P6|Overall Study|Insurance issues|1
7859777|NCT00075725|27259927|P5|Overall Study|Insurance issues|1
7859778|NCT00075725|27259928|P4|Overall Study|Insurance issues|1
7859779|NCT00075725|27259929|P3|Overall Study|Insurance issues|0
7859780|NCT00075725|27259930|P2|Overall Study|Insurance issues|1
7859781|NCT00075725|27259931|P1|Overall Study|Insurance issues|0
7859782|NCT00075725|27259920|P12|Overall Study|Pt age out of range for treatment|0
7859783|NCT00075725|27259921|P11|Overall Study|Pt age out of range for treatment|0
7859784|NCT00075725|27259922|P10|Overall Study|Pt age out of range for treatment|0
7859785|NCT00075725|27259923|P9|Overall Study|Pt age out of range for treatment|0
7859786|NCT00075725|27259924|P8|Overall Study|Pt age out of range for treatment|1
7859787|NCT00075725|27259925|P7|Overall Study|Pt age out of range for treatment|0
7859788|NCT00075725|27259926|P6|Overall Study|Pt age out of range for treatment|1
7859789|NCT00075725|27259927|P5|Overall Study|Pt age out of range for treatment|0
7859790|NCT00075725|27259928|P4|Overall Study|Pt age out of range for treatment|0
7859791|NCT00075725|27259929|P3|Overall Study|Pt age out of range for treatment|0
7859792|NCT00075725|27259930|P2|Overall Study|Pt age out of range for treatment|1
7859793|NCT00075725|27259931|P1|Overall Study|Pt age out of range for treatment|0
7859794|NCT00075725|27259920|P12|Overall Study|Pt non compliant with therapy|0
7859795|NCT00075725|27259921|P11|Overall Study|Pt non compliant with therapy|0
7859796|NCT00075725|27259922|P10|Overall Study|Pt non compliant with therapy|0
7859797|NCT00075725|27259923|P9|Overall Study|Pt non compliant with therapy|3
7859798|NCT00075725|27259924|P8|Overall Study|Pt non compliant with therapy|5
7859799|NCT00075725|27259925|P7|Overall Study|Pt non compliant with therapy|2
7859800|NCT00075725|27259926|P6|Overall Study|Pt non compliant with therapy|14
7859801|NCT00075725|27259927|P5|Overall Study|Pt non compliant with therapy|2
7859802|NCT00075725|27259928|P4|Overall Study|Pt non compliant with therapy|0
7859803|NCT00075725|27259929|P3|Overall Study|Pt non compliant with therapy|1
7859804|NCT00075725|27259930|P2|Overall Study|Pt non compliant with therapy|1
7859805|NCT00075725|27259931|P1|Overall Study|Pt non compliant with therapy|2
7859806|NCT00075725|27259920|P12|Overall Study|Pt/Guardian refused RT therapy|0
7859807|NCT00075725|27259921|P11|Overall Study|Pt/Guardian refused RT therapy|0
7859808|NCT00075725|27259922|P10|Overall Study|Pt/Guardian refused RT therapy|0
7859809|NCT00075725|27259923|P9|Overall Study|Pt/Guardian refused RT therapy|0
7859810|NCT00075725|27259924|P8|Overall Study|Pt/Guardian refused RT therapy|0
7859811|NCT00075725|27259925|P7|Overall Study|Pt/Guardian refused RT therapy|0
7859812|NCT00075725|27259926|P6|Overall Study|Pt/Guardian refused RT therapy|0
7859813|NCT00075725|27259927|P5|Overall Study|Pt/Guardian refused RT therapy|1
7859814|NCT00075725|27259928|P4|Overall Study|Pt/Guardian refused RT therapy|2
7859815|NCT00075725|27259929|P3|Overall Study|Pt/Guardian refused RT therapy|1
7859816|NCT00075725|27259930|P2|Overall Study|Pt/Guardian refused RT therapy|0
7859817|NCT00075725|27259931|P1|Overall Study|Pt/Guardian refused RT therapy|1
7859818|NCT00075725|27259920|P12|Overall Study|Ineligible or wrong diagnosis|4
7859819|NCT00075725|27259921|P11|Overall Study|Ineligible or wrong diagnosis|2
7859820|NCT00075725|27259922|P10|Overall Study|Ineligible or wrong diagnosis|1
7859821|NCT00075725|27259923|P9|Overall Study|Ineligible or wrong diagnosis|10
7859822|NCT00075725|27259924|P8|Overall Study|Ineligible or wrong diagnosis|9
7859823|NCT00075725|27259925|P7|Overall Study|Ineligible or wrong diagnosis|6
7859824|NCT00075725|27259926|P6|Overall Study|Ineligible or wrong diagnosis|17
7859825|NCT00075725|27259927|P5|Overall Study|Ineligible or wrong diagnosis|3
7859826|NCT00075725|27259928|P4|Overall Study|Ineligible or wrong diagnosis|10
7859827|NCT00075725|27259929|P3|Overall Study|Ineligible or wrong diagnosis|3
7859828|NCT00075725|27259930|P2|Overall Study|Ineligible or wrong diagnosis|3
7859829|NCT00075725|27259931|P1|Overall Study|Ineligible or wrong diagnosis|8
7859830|NCT00075725|27259920|P12|Overall Study|Patient off treatment|0
7859831|NCT00075725|27259921|P11|Overall Study|Patient off treatment|0
7859832|NCT00075725|27259922|P10|Overall Study|Patient off treatment|0
7859833|NCT00075725|27259923|P9|Overall Study|Patient off treatment|1
7859834|NCT00075725|27259924|P8|Overall Study|Patient off treatment|2
7859835|NCT00075725|27259925|P7|Overall Study|Patient off treatment|0
7859836|NCT00075725|27259926|P6|Overall Study|Patient off treatment|0
7859837|NCT00075725|27259927|P5|Overall Study|Patient off treatment|1
7859838|NCT00075725|27259928|P4|Overall Study|Patient off treatment|2
7859839|NCT00075725|27259929|P3|Overall Study|Patient off treatment|1
7859840|NCT00075725|27259930|P2|Overall Study|Patient off treatment|0
7859841|NCT00075725|27259931|P1|Overall Study|Patient off treatment|0
7859842|NCT00075725|27259920|P12|Overall Study|Disease Progression, all other reasons|5
7859843|NCT00075725|27259921|P11|Overall Study|Disease Progression, all other reasons|0
7859844|NCT00075725|27259922|P10|Overall Study|Disease Progression, all other reasons|4
7859845|NCT00075725|27259923|P9|Overall Study|Disease Progression, all other reasons|21
7859846|NCT00075725|27259924|P8|Overall Study|Disease Progression, all other reasons|46
7859847|NCT00075725|27259925|P7|Overall Study|Disease Progression, all other reasons|20
7859848|NCT00075725|27259926|P6|Overall Study|Disease Progression, all other reasons|59
7859849|NCT00075725|27259927|P5|Overall Study|Disease Progression, all other reasons|21
7859850|NCT00075725|27259928|P4|Overall Study|Disease Progression, all other reasons|6
7859851|NCT00075725|27259929|P3|Overall Study|Disease Progression, all other reasons|33
7859852|NCT00075725|27259930|P2|Overall Study|Disease Progression, all other reasons|5
7859853|NCT00075725|27259931|P1|Overall Study|Disease Progression, all other reasons|17
7859854|NCT00075725|27259920|P12|Overall Study|Withdrawal by Subject|0
7859855|NCT00075725|27259921|P11|Overall Study|Withdrawal by Subject|0
7859856|NCT00075725|27259922|P10|Overall Study|Withdrawal by Subject|2
7859857|NCT00075725|27259923|P9|Overall Study|Withdrawal by Subject|10
7859858|NCT00075725|27259924|P8|Overall Study|Withdrawal by Subject|31
7859859|NCT00075725|27259925|P7|Overall Study|Withdrawal by Subject|7
7859860|NCT00075725|27259926|P6|Overall Study|Withdrawal by Subject|27
7859861|NCT00075725|27259927|P5|Overall Study|Withdrawal by Subject|6
7859862|NCT00075725|27259928|P4|Overall Study|Withdrawal by Subject|10
7859863|NCT00075725|27259929|P3|Overall Study|Withdrawal by Subject|6
7859864|NCT00075725|27259930|P2|Overall Study|Withdrawal by Subject|3
7859865|NCT00075725|27259931|P1|Overall Study|Withdrawal by Subject|12
7859866|NCT00075725|27259920|P12|Overall Study|Protocol Violation|1
7859867|NCT00075725|27259921|P11|Overall Study|Protocol Violation|0
7859868|NCT00075725|27259922|P10|Overall Study|Protocol Violation|0
7859869|NCT00075725|27259923|P9|Overall Study|Protocol Violation|3
7859870|NCT00075725|27259924|P8|Overall Study|Protocol Violation|2
7859871|NCT00075725|27259925|P7|Overall Study|Protocol Violation|1
7859872|NCT00075725|27259926|P6|Overall Study|Protocol Violation|2
7859873|NCT00075725|27259927|P5|Overall Study|Protocol Violation|3
7859874|NCT00075725|27259928|P4|Overall Study|Protocol Violation|3
7859875|NCT00075725|27259929|P3|Overall Study|Protocol Violation|0
7859876|NCT00075725|27259930|P2|Overall Study|Protocol Violation|1
7859877|NCT00075725|27259931|P1|Overall Study|Protocol Violation|1
7859878|NCT00075725|27259920|P12|Overall Study|Pregnancy|0
7859879|NCT00075725|27259921|P11|Overall Study|Pregnancy|0
7859880|NCT00075725|27259922|P10|Overall Study|Pregnancy|0
7859881|NCT00075725|27259923|P9|Overall Study|Pregnancy|0
7859882|NCT00075725|27259924|P8|Overall Study|Pregnancy|1
7859883|NCT00075725|27259925|P7|Overall Study|Pregnancy|0
7859884|NCT00075725|27259926|P6|Overall Study|Pregnancy|1
7859885|NCT00075725|27259927|P5|Overall Study|Pregnancy|0
7859886|NCT00075725|27259928|P4|Overall Study|Pregnancy|0
7859887|NCT00075725|27259929|P3|Overall Study|Pregnancy|0
7859888|NCT00075725|27259930|P2|Overall Study|Pregnancy|0
7859889|NCT00075725|27259931|P1|Overall Study|Pregnancy|0
7859890|NCT00075725|27259920|P12|Overall Study|Physician Decision|0
7859891|NCT00075725|27259921|P11|Overall Study|Physician Decision|1
7859892|NCT00075725|27259922|P10|Overall Study|Physician Decision|0
7859893|NCT00075725|27259923|P9|Overall Study|Physician Decision|5
7859894|NCT00075725|27259924|P8|Overall Study|Physician Decision|17
7859895|NCT00075725|27259925|P7|Overall Study|Physician Decision|3
7859896|NCT00075725|27259926|P6|Overall Study|Physician Decision|19
7859897|NCT00075725|27259927|P5|Overall Study|Physician Decision|4
7859898|NCT00075725|27259928|P4|Overall Study|Physician Decision|8
7859899|NCT00075725|27259929|P3|Overall Study|Physician Decision|5
7859900|NCT00075725|27259930|P2|Overall Study|Physician Decision|6
7859901|NCT00075725|27259931|P1|Overall Study|Physician Decision|2
7859902|NCT00075725|27259920|P12|Overall Study|Lost to Follow-up|0
7859903|NCT00075725|27259921|P11|Overall Study|Lost to Follow-up|0
7859904|NCT00075725|27259922|P10|Overall Study|Lost to Follow-up|0
7859905|NCT00075725|27259923|P9|Overall Study|Lost to Follow-up|1
7859906|NCT00075725|27259924|P8|Overall Study|Lost to Follow-up|4
7859907|NCT00075725|27259925|P7|Overall Study|Lost to Follow-up|2
7859908|NCT00075725|27259926|P6|Overall Study|Lost to Follow-up|13
7859909|NCT00075725|27259927|P5|Overall Study|Lost to Follow-up|0
7859910|NCT00075725|27259928|P4|Overall Study|Lost to Follow-up|1
7859911|NCT00075725|27259929|P3|Overall Study|Lost to Follow-up|4
7859912|NCT00075725|27259930|P2|Overall Study|Lost to Follow-up|1
7859913|NCT00075725|27259931|P1|Overall Study|Lost to Follow-up|1
7859914|NCT00075725|27259920|P12|Overall Study|Death|0
7859915|NCT00075725|27259921|P11|Overall Study|Death|3
7859916|NCT00075725|27259922|P10|Overall Study|Death|4
7859917|NCT00075725|27259923|P9|Overall Study|Death|14
7859918|NCT00075725|27259924|P8|Overall Study|Death|22
7859919|NCT00075725|27259925|P7|Overall Study|Death|4
7859920|NCT00075725|27259926|P6|Overall Study|Death|25
7859921|NCT00075725|27259927|P5|Overall Study|Death|3
7859922|NCT00075725|27259928|P4|Overall Study|Death|2
7859923|NCT00075725|27259929|P3|Overall Study|Death|10
7859924|NCT00075725|27259930|P2|Overall Study|Death|5
7859925|NCT00075725|27259931|P1|Overall Study|Death|3
7859926|NCT00075725|27259920|P12|Overall Study|Adverse Event|2
7859927|NCT00075725|27259921|P11|Overall Study|Adverse Event|2
7859928|NCT00075725|27259922|P10|Overall Study|Adverse Event|4
7859929|NCT00075725|27259923|P9|Overall Study|Adverse Event|15
7859930|NCT00075725|27259924|P8|Overall Study|Adverse Event|51
7859931|NCT00075725|27259925|P7|Overall Study|Adverse Event|3
7859932|NCT00075725|27259926|P6|Overall Study|Adverse Event|38
7859933|NCT00075725|27259927|P5|Overall Study|Adverse Event|4
7859934|NCT00075725|27259928|P4|Overall Study|Adverse Event|8
7859935|NCT00075725|27259929|P3|Overall Study|Adverse Event|20
7859936|NCT00075725|27259930|P2|Overall Study|Adverse Event|6
7859937|NCT00075725|27259931|P1|Overall Study|Adverse Event|6
7859938|NCT00075582|27260028|P2|Overall Study|Ineligible for study|16
7859939|NCT00075582|27260029|P1|Overall Study|Ineligible for study|36
7859940|NCT00075582|27260028|P2|Overall Study|Withdrawal by Subject|2
7859941|NCT00075582|27260029|P1|Overall Study|Withdrawal by Subject|2
7859942|NCT00075582|27260028|P2|Overall Study|Physician Decision|8
7859943|NCT00075582|27260029|P1|Overall Study|Physician Decision|5
7859944|NCT00075582|27260028|P2|Overall Study|Lack of Efficacy|8
7859945|NCT00075582|27260029|P1|Overall Study|Lack of Efficacy|4
7859946|NCT00075582|27260028|P2|Overall Study|Adverse Event|1
7859947|NCT00075582|27260029|P1|Overall Study|Adverse Event|3
7859948|NCT00075504|27260043|P2|Overall Study|Withdrawal by Subject|7
7859949|NCT00075504|27260044|P1|Overall Study|Withdrawal by Subject|9
7859950|NCT00075478|27260056|P2|Overall Study|Physician Decision|1
7859951|NCT00075478|27260057|P1|Overall Study|Physician Decision|0
7859952|NCT00075478|27260056|P2|Overall Study|not eligible|0
7859953|NCT00075478|27260057|P1|Overall Study|not eligible|1
7859954|NCT00075400|27260077|P1|Overall Study|Never treated|2
7859955|NCT00075400|27260077|P1|Overall Study|Ineligible: wrong primary|1
7859956|NCT00075270|27260098|P2|Overall Study|Missing|13
7859957|NCT00075270|27260099|P1|Overall Study|Missing|26
7859958|NCT00075270|27260098|P2|Overall Study|Other/Unknown|5
7859959|NCT00075270|27260099|P1|Overall Study|Other/Unknown|9
7859960|NCT00075270|27260098|P2|Overall Study|Death|215
7859961|NCT00075270|27260099|P1|Overall Study|Death|198
7859962|NCT00075270|27260098|P2|Overall Study|Protocol Violation|2
7859963|NCT00075270|27260099|P1|Overall Study|Protocol Violation|0
7859964|NCT00075270|27260098|P2|Overall Study|Lost to Follow-up|28
7859965|NCT00075270|27260099|P1|Overall Study|Lost to Follow-up|25
7859966|NCT00075270|27260098|P2|Overall Study|Withdrawal by Subject|21
7859967|NCT00075270|27260099|P1|Overall Study|Withdrawal by Subject|28
7859968|NCT00075218|27260145|P3|Open-Label Treatment|enrolled in a separate continuation|9
7859969|NCT00075218|27260146|P2|Open-Label Treatment|enrolled in a separate continuation|0
7859970|NCT00075218|27260147|P1|Open-Label Treatment|enrolled in a separate continuation|0
7859971|NCT00075218|27260145|P3|Open-Label Treatment|Protocol Violation|1
7859972|NCT00075218|27260146|P2|Open-Label Treatment|Protocol Violation|0
7859973|NCT00075218|27260147|P1|Open-Label Treatment|Protocol Violation|0
7859974|NCT00075218|27260145|P3|Open-Label Treatment|Decision of Sponsor|8
7859975|NCT00075218|27260146|P2|Open-Label Treatment|Decision of Sponsor|0
7859976|NCT00075218|27260147|P1|Open-Label Treatment|Decision of Sponsor|0
7859977|NCT00075218|27260145|P3|Open-Label Treatment|Withdrawal by Subject|12
7859978|NCT00075218|27260146|P2|Open-Label Treatment|Withdrawal by Subject|0
7859979|NCT00075218|27260147|P1|Open-Label Treatment|Withdrawal by Subject|0
7859980|NCT00075218|27260145|P3|Open-Label Treatment|Adverse Event|51
7859981|NCT00075218|27260146|P2|Open-Label Treatment|Adverse Event|0
7859982|NCT00075218|27260147|P1|Open-Label Treatment|Adverse Event|0
7859983|NCT00075218|27260145|P3|Open-Label Treatment|Lack of Efficacy|174
7859984|NCT00075218|27260146|P2|Open-Label Treatment|Lack of Efficacy|0
7859985|NCT00075218|27260147|P1|Open-Label Treatment|Lack of Efficacy|0
7859986|NCT00075218|27260145|P3|Double-Blind Treatment|No study medication taken|0
7859987|NCT00075218|27260146|P2|Double-Blind Treatment|No study medication taken|0
7859988|NCT00075218|27260147|P1|Double-Blind Treatment|No study medication taken|2
7859989|NCT00075218|27260145|P3|Double-Blind Treatment|Decision of Sponsor|0
7859990|NCT00075218|27260146|P2|Double-Blind Treatment|Decision of Sponsor|1
7859991|NCT00075218|27260147|P1|Double-Blind Treatment|Decision of Sponsor|0
7859992|NCT00075218|27260145|P3|Double-Blind Treatment|Lack of Efficacy|0
7859993|NCT00075218|27260146|P2|Double-Blind Treatment|Lack of Efficacy|6
7859994|NCT00075218|27260147|P1|Double-Blind Treatment|Lack of Efficacy|58
7859995|NCT00075218|27260145|P3|Double-Blind Treatment|Lost to Follow-up|0
7859996|NCT00075218|27260146|P2|Double-Blind Treatment|Lost to Follow-up|0
7859997|NCT00075218|27260147|P1|Double-Blind Treatment|Lost to Follow-up|1
7859998|NCT00075218|27260145|P3|Double-Blind Treatment|Withdrawal by Subject|0
7859999|NCT00075218|27260146|P2|Double-Blind Treatment|Withdrawal by Subject|4
7860000|NCT00075218|27260147|P1|Double-Blind Treatment|Withdrawal by Subject|7
7860001|NCT00075218|27260145|P3|Double-Blind Treatment|Adverse Event|0
7860002|NCT00075218|27260146|P2|Double-Blind Treatment|Adverse Event|4
7860003|NCT00075218|27260147|P1|Double-Blind Treatment|Adverse Event|23
7860004|NCT00075023|27260196|P2|Pilot Study|Withdrawal by Subject|0
7860005|NCT00075023|27260197|P1|Pilot Study|Withdrawal by Subject|1
7860006|NCT00075023|27260196|P2|Pilot Study|Physician Decision|2
7860007|NCT00075023|27260197|P1|Pilot Study|Physician Decision|1
7860008|NCT00074984|27260206|P2|Overall Study|Patient Withdrawn Per Protocol|3
7860009|NCT00074984|27260207|P1|Overall Study|Patient Withdrawn Per Protocol|0
7860010|NCT00074984|27260206|P2|Overall Study|Withdrawal by Subject|3
7860011|NCT00074984|27260207|P1|Overall Study|Withdrawal by Subject|2
7860012|NCT00074984|27260206|P2|Overall Study|Death|2
7860013|NCT00074984|27260207|P1|Overall Study|Death|1
7860014|NCT00074958|27260222|P1|Overall Study|Adverse Event|1
7860015|NCT00074711|27260283|P2|Overall Study|Participant stopped study drug|6
7860016|NCT00074711|27260284|P1|Overall Study|Participant stopped study drug|4
7860017|NCT00074711|27260283|P2|Overall Study|Lost to Follow-up|8
7860018|NCT00074711|27260284|P1|Overall Study|Lost to Follow-up|10
7860019|NCT00074711|27260283|P2|Overall Study|Withdrawal by Subject|1
7860020|NCT00074711|27260284|P1|Overall Study|Withdrawal by Subject|1
7860021|NCT00074581|27260302|P2|Overall Study|Other|19
7860022|NCT00074581|27260303|P1|Overall Study|Other|14
7860023|NCT00074581|27260302|P2|Overall Study|Ended relationship w. index participant|106
7860024|NCT00074581|27260303|P1|Overall Study|Ended relationship w. index participant|117
7860025|NCT00074581|27260302|P2|Overall Study|Lost to Follow-up|11
7860026|NCT00074581|27260303|P1|Overall Study|Lost to Follow-up|16
7860027|NCT00074581|27260302|P2|Overall Study|Were withdrawn by investigator|2
7860028|NCT00074581|27260303|P1|Overall Study|Were withdrawn by investigator|5
7860029|NCT00074581|27260302|P2|Overall Study|Relocated|9
7860030|NCT00074581|27260303|P1|Overall Study|Relocated|14
7860031|NCT00074581|27260302|P2|Overall Study|Unable to adhere to visit schedule|14
7860032|NCT00074581|27260303|P1|Overall Study|Unable to adhere to visit schedule|13
7860033|NCT00074581|27260302|P2|Overall Study|Withdrawal by Subject|49
7860034|NCT00074581|27260303|P1|Overall Study|Withdrawal by Subject|50
7860035|NCT00074581|27260302|P2|Overall Study|Death|16
7860036|NCT00074581|27260303|P1|Overall Study|Death|15
7860037|NCT00074490|27260316|P6|Overall Study|Progressive malignancy|0
7860038|NCT00074490|27260317|P5|Overall Study|Progressive malignancy|3
7860039|NCT00074490|27260318|P4|Overall Study|Progressive malignancy|0
7860040|NCT00074490|27260319|P3|Overall Study|Progressive malignancy|0
7860041|NCT00074490|27260320|P2|Overall Study|Progressive malignancy|7
7860042|NCT00074490|27260321|P1|Overall Study|Progressive malignancy|0
7860043|NCT00074412|27260355|P2|Overall Study|Lost to Follow-up|58
7860044|NCT00074412|27260356|P1|Overall Study|Lost to Follow-up|52
7860045|NCT00074412|27260355|P2|Overall Study|Death|26
7860046|NCT00074412|27260356|P1|Overall Study|Death|30
7860047|NCT00074282|27260387|P3|Step 2|Ineligible|1
7860048|NCT00074282|27260388|P2|Step 2|Ineligible|0
7860049|NCT00074282|27260389|P1|Step 2|Ineligible|0
7860050|NCT00074282|27260387|P3|Step 2|Physician Decision|1
7860051|NCT00074282|27260388|P2|Step 2|Physician Decision|0
7860052|NCT00074282|27260389|P1|Step 2|Physician Decision|0
7860053|NCT00074282|27260387|P3|Step 2|Withdrawal by Subject|2
7860054|NCT00074282|27260388|P2|Step 2|Withdrawal by Subject|0
7860055|NCT00074282|27260389|P1|Step 2|Withdrawal by Subject|0
7860056|NCT00074282|27260387|P3|Step 2|Death|3
7860057|NCT00074282|27260388|P2|Step 2|Death|0
7860058|NCT00074282|27260389|P1|Step 2|Death|0
7860059|NCT00074282|27260387|P3|Step 2|Disease progression|5
7860060|NCT00074282|27260388|P2|Step 2|Disease progression|0
7860061|NCT00074282|27260389|P1|Step 2|Disease progression|0
7860062|NCT00074282|27260387|P3|Step 2|Adverse Event|12
7860063|NCT00074282|27260388|P2|Step 2|Adverse Event|2
7860064|NCT00074282|27260389|P1|Step 2|Adverse Event|0
7860065|NCT00074282|27260387|P3|Step 1|Never started treatment|0
7860066|NCT00074282|27260388|P2|Step 1|Never started treatment|0
7860067|NCT00074282|27260389|P1|Step 1|Never started treatment|2
7860068|NCT00074282|27260387|P3|Step 1|Ineligible|0
7860069|NCT00074282|27260388|P2|Step 1|Ineligible|0
7860070|NCT00074282|27260389|P1|Step 1|Ineligible|4
7860071|NCT00074282|27260387|P3|Step 1|Physician Decision|0
7860072|NCT00074282|27260388|P2|Step 1|Physician Decision|0
7860073|NCT00074282|27260389|P1|Step 1|Physician Decision|1
7860074|NCT00074282|27260387|P3|Step 1|Other complicating disease|0
7860075|NCT00074282|27260388|P2|Step 1|Other complicating disease|0
7860076|NCT00074282|27260389|P1|Step 1|Other complicating disease|2
7860077|NCT00074282|27260387|P3|Step 1|Alternative therapy|0
7860078|NCT00074282|27260388|P2|Step 1|Alternative therapy|0
7860079|NCT00074282|27260389|P1|Step 1|Alternative therapy|2
7860080|NCT00074282|27260387|P3|Step 1|Disease progression|0
7860081|NCT00074282|27260388|P2|Step 1|Disease progression|0
7860082|NCT00074282|27260389|P1|Step 1|Disease progression|2
7860083|NCT00074282|27260387|P3|Step 1|Withdrawal by Subject|0
7860084|NCT00074282|27260388|P2|Step 1|Withdrawal by Subject|0
7860085|NCT00074282|27260389|P1|Step 1|Withdrawal by Subject|7
7860086|NCT00074282|27260387|P3|Step 1|Death|0
7860087|NCT00074282|27260388|P2|Step 1|Death|0
7860088|NCT00074282|27260389|P1|Step 1|Death|6
7860089|NCT00074282|27260387|P3|Step 1|Adverse Event|0
7860090|NCT00074282|27260388|P2|Step 1|Adverse Event|0
7860091|NCT00074282|27260389|P1|Step 1|Adverse Event|32
7860092|NCT00074152|27260416|P2|Overall Study|Lack of Efficacy|24
7860093|NCT00074152|27260417|P1|Overall Study|Lack of Efficacy|34
7860094|NCT00074152|27260416|P2|Overall Study|Death|9
7860095|NCT00074152|27260417|P1|Overall Study|Death|21
7860096|NCT00073983|27260434|P1|Overall Study|not evaluable|1
7860097|NCT00073918|27260455|P1|Overall Study|Eligibility requirement not met-low CD20|1
7860098|NCT00073918|27260455|P1|Overall Study|Rapid disease progression|2
7860099|NCT00073918|27260455|P1|Overall Study|Eligibility requirement not met - HAMA+|1
7860100|NCT00073749|27260469|P7|Overall Study|Other|0
7860101|NCT00073749|27260470|P6|Overall Study|Other|2
7860102|NCT00073749|27260471|P5|Overall Study|Other|0
7860103|NCT00073749|27260472|P4|Overall Study|Other|0
7860104|NCT00073749|27260473|P3|Overall Study|Other|0
7860105|NCT00073749|27260474|P2|Overall Study|Other|0
7860106|NCT00073749|27260475|P1|Overall Study|Other|0
7860107|NCT00073749|27260469|P7|Overall Study|Lost to Follow-up|2
7860108|NCT00073749|27260470|P6|Overall Study|Lost to Follow-up|0
7860109|NCT00073749|27260471|P5|Overall Study|Lost to Follow-up|0
7860110|NCT00073749|27260472|P4|Overall Study|Lost to Follow-up|0
7860111|NCT00073749|27260473|P3|Overall Study|Lost to Follow-up|0
7860112|NCT00073749|27260474|P2|Overall Study|Lost to Follow-up|0
7860113|NCT00073749|27260475|P1|Overall Study|Lost to Follow-up|0
7860114|NCT00073749|27260469|P7|Overall Study|Discontinuation of Study by Sponsor|4
7860115|NCT00073749|27260470|P6|Overall Study|Discontinuation of Study by Sponsor|0
7860116|NCT00073749|27260471|P5|Overall Study|Discontinuation of Study by Sponsor|0
7860117|NCT00073749|27260472|P4|Overall Study|Discontinuation of Study by Sponsor|0
7860118|NCT00073749|27260473|P3|Overall Study|Discontinuation of Study by Sponsor|0
7860119|NCT00073749|27260474|P2|Overall Study|Discontinuation of Study by Sponsor|0
7860120|NCT00073749|27260475|P1|Overall Study|Discontinuation of Study by Sponsor|0
7860121|NCT00073749|27260469|P7|Overall Study|Withdrawal by Subject|2
7860122|NCT00073749|27260470|P6|Overall Study|Withdrawal by Subject|0
7860123|NCT00073749|27260471|P5|Overall Study|Withdrawal by Subject|1
7860124|NCT00073749|27260472|P4|Overall Study|Withdrawal by Subject|0
7860125|NCT00073749|27260473|P3|Overall Study|Withdrawal by Subject|0
7860126|NCT00073749|27260474|P2|Overall Study|Withdrawal by Subject|1
7860127|NCT00073749|27260475|P1|Overall Study|Withdrawal by Subject|0
7860128|NCT00073749|27260469|P7|Overall Study|Physician Decision|0
7860129|NCT00073749|27260470|P6|Overall Study|Physician Decision|2
7860130|NCT00073749|27260471|P5|Overall Study|Physician Decision|0
7860131|NCT00073749|27260472|P4|Overall Study|Physician Decision|0
7860132|NCT00073749|27260473|P3|Overall Study|Physician Decision|1
7860133|NCT00073749|27260474|P2|Overall Study|Physician Decision|0
7860134|NCT00073749|27260475|P1|Overall Study|Physician Decision|0
7860135|NCT00073749|27260469|P7|Overall Study|Adverse Event|0
7860136|NCT00073749|27260470|P6|Overall Study|Adverse Event|1
7860137|NCT00073749|27260471|P5|Overall Study|Adverse Event|2
7860138|NCT00073749|27260472|P4|Overall Study|Adverse Event|4
7860139|NCT00073749|27260473|P3|Overall Study|Adverse Event|6
7860140|NCT00073749|27260474|P2|Overall Study|Adverse Event|3
7860141|NCT00073749|27260475|P1|Overall Study|Adverse Event|0
7860142|NCT00073749|27260469|P7|Overall Study|Death|29
7860143|NCT00073749|27260470|P6|Overall Study|Death|0
7860144|NCT00073749|27260471|P5|Overall Study|Death|0
7860145|NCT00073749|27260472|P4|Overall Study|Death|0
7860146|NCT00073749|27260473|P3|Overall Study|Death|1
7860147|NCT00073749|27260474|P2|Overall Study|Death|1
7860148|NCT00073749|27260475|P1|Overall Study|Death|0
7860149|NCT00073749|27260469|P7|Overall Study|Disease Progression|3
7860150|NCT00073749|27260470|P6|Overall Study|Disease Progression|1
7860151|NCT00073749|27260471|P5|Overall Study|Disease Progression|3
7860152|NCT00073749|27260472|P4|Overall Study|Disease Progression|2
7860153|NCT00073749|27260473|P3|Overall Study|Disease Progression|3
7860154|NCT00073749|27260474|P2|Overall Study|Disease Progression|0
7860155|NCT00073749|27260475|P1|Overall Study|Disease Progression|2
7860156|NCT00073528|27260506|P2|Overall Study|Protocol Violation|5
7860157|NCT00073528|27260507|P1|Overall Study|Protocol Violation|3
7860158|NCT00073528|27260506|P2|Overall Study|Other|12
7860159|NCT00073528|27260507|P1|Overall Study|Other|9
7860160|NCT00073528|27260506|P2|Overall Study|Other|19
7860161|NCT00073528|27260507|P1|Overall Study|Other|18
7860162|NCT00073528|27260506|P2|Overall Study|Study terminated by Sponsor|29
7860163|NCT00073528|27260507|P1|Overall Study|Study terminated by Sponsor|10
7860164|NCT00073528|27260506|P2|Overall Study|Withdrawal by Subject|45
7860165|NCT00073528|27260507|P1|Overall Study|Withdrawal by Subject|50
7860166|NCT00073528|27260506|P2|Overall Study|Lost to Follow-up|45
7860167|NCT00073528|27260507|P1|Overall Study|Lost to Follow-up|52
7860168|NCT00073528|27260506|P2|Overall Study|Death|473
7860169|NCT00073528|27260507|P1|Overall Study|Death|488
7860170|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
7860171|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
7860172|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
7860173|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
7860174|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
7860175|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
7860176|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
7860177|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
7860178|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
7860179|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
7860180|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
7860181|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
7860182|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
7860183|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
7860184|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
7860185|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
7860186|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
7860187|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
7860188|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
7860189|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
7860190|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
7860191|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
7860192|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
7860193|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
7860194|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
7860195|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
7860196|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
7860197|NCT00073307|27260594|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
7860198|NCT00073307|27260595|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
7860199|NCT00073307|27260596|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
7860200|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
7860201|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
7860202|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
7860203|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
7860204|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
7860205|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
7860206|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
7860207|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
7860208|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
7860209|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
7860210|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
7860211|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
7860212|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
7860213|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
7860214|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
7860215|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
7860216|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
7860217|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
7860218|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
7860219|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
7860220|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
7860221|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
7860222|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
7860223|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
7860224|NCT00073307|27260594|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
7860225|NCT00073307|27260595|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
7860226|NCT00073307|27260596|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
7860227|NCT00073021|27260627|P2|Overall Study|Lack of Efficacy|5
7860228|NCT00073021|27260628|P1|Overall Study|Lack of Efficacy|11
7860229|NCT00073021|27260627|P2|Overall Study|Physician Decision|1
7860230|NCT00073021|27260628|P1|Overall Study|Physician Decision|3
7860231|NCT00073021|27260627|P2|Overall Study|Withdrawal by Subject|5
7860232|NCT00073021|27260628|P1|Overall Study|Withdrawal by Subject|6
7860233|NCT00073021|27260627|P2|Overall Study|Adverse Event|4
7860234|NCT00073021|27260628|P1|Overall Study|Adverse Event|4
7860235|NCT00073021|27260627|P2|Overall Study|Protocol Violation|1
7860236|NCT00073021|27260628|P1|Overall Study|Protocol Violation|2
7860237|NCT00073008|27260658|P2|Overall Study|"Other selected on Case Report Form"|5
7860238|NCT00073008|27260659|P1|Overall Study|"Other selected on Case Report Form"|7
7860239|NCT00073008|27260658|P2|Overall Study|Death|47
7860240|NCT00073008|27260659|P1|Overall Study|Death|46
7860241|NCT00073008|27260658|P2|Overall Study|Lost to Follow-up|3
7860242|NCT00073008|27260659|P1|Overall Study|Lost to Follow-up|1
7860243|NCT00073008|27260658|P2|Overall Study|Withdrawal by Subject|2
7860244|NCT00073008|27260659|P1|Overall Study|Withdrawal by Subject|2
7860245|NCT00073008|27260658|P2|Overall Study|Missing|6
7860246|NCT00073008|27260659|P1|Overall Study|Missing|6
7860247|NCT00072475|27260698|P1|Overall Study|Patient/Investigator Decision|4
7860248|NCT00072475|27260698|P1|Overall Study|Withdrawal by Subject|46
7860249|NCT00072475|27260698|P1|Overall Study|Death|3
7860250|NCT00072475|27260698|P1|Overall Study|Adverse Event|44
7860251|NCT00072384|27260713|P1|Overall Study|Ineligible|8
7860252|NCT00072384|27260713|P1|Overall Study|Physician Decision|1
7860253|NCT00072293|27260726|P2|Overall Study|Withdrawal by Subject|1
7860254|NCT00072293|27260727|P1|Overall Study|Withdrawal by Subject|0
7860255|NCT00072293|27260726|P2|Overall Study|Lost to Follow-up|1
7860256|NCT00072293|27260727|P1|Overall Study|Lost to Follow-up|1
7860257|NCT00072280|27260739|P2|Follow-up|Early termination of study|2
7860258|NCT00072280|27260740|P1|Follow-up|Early termination of study|2
7860259|NCT00072280|27260739|P2|Treatment|Found ineligible|2
7860260|NCT00072280|27260740|P1|Treatment|Found ineligible|1
7860261|NCT00072189|27260745|P1|Overall Study|Withdrawal by Subject|1
7860262|NCT00072176|27260753|P2|Overall Study|Protocol Violation|1
7860263|NCT00072176|27260754|P1|Overall Study|Protocol Violation|0
7860264|NCT00072176|27260753|P2|Overall Study|Withdrawal by Subject|0
7860265|NCT00072176|27260754|P1|Overall Study|Withdrawal by Subject|1
7860266|NCT00071981|27260766|P4|Overall Study|others (not specified in the study)|0
7860267|NCT00071981|27260767|P3|Overall Study|others (not specified in the study)|2
7860268|NCT00071981|27260768|P2|Overall Study|others (not specified in the study)|2
7860269|NCT00071981|27260769|P1|Overall Study|others (not specified in the study)|0
7860270|NCT00071981|27260766|P4|Overall Study|No protocol therapy|0
7860271|NCT00071981|27260767|P3|Overall Study|No protocol therapy|1
7860272|NCT00071981|27260768|P2|Overall Study|No protocol therapy|5
7860273|NCT00071981|27260769|P1|Overall Study|No protocol therapy|2
7860274|NCT00071981|27260766|P4|Overall Study|Withdrawal by Subject|0
7860275|NCT00071981|27260767|P3|Overall Study|Withdrawal by Subject|0
7860276|NCT00071981|27260768|P2|Overall Study|Withdrawal by Subject|1
7860277|NCT00071981|27260769|P1|Overall Study|Withdrawal by Subject|3
7860278|NCT00071981|27260766|P4|Overall Study|Death|1
7860279|NCT00071981|27260767|P3|Overall Study|Death|1
7860280|NCT00071981|27260768|P2|Overall Study|Death|0
7860281|NCT00071981|27260769|P1|Overall Study|Death|0
7860282|NCT00071981|27260766|P4|Overall Study|Adverse Event|1
7860283|NCT00071981|27260767|P3|Overall Study|Adverse Event|3
7860284|NCT00071981|27260768|P2|Overall Study|Adverse Event|4
7860285|NCT00071981|27260769|P1|Overall Study|Adverse Event|4
7860286|NCT00071981|27260766|P4|Overall Study|Lack of Efficacy|43
7860287|NCT00071981|27260767|P3|Overall Study|Lack of Efficacy|30
7860288|NCT00071981|27260768|P2|Overall Study|Lack of Efficacy|29
7860289|NCT00071981|27260769|P1|Overall Study|Lack of Efficacy|37
7860290|NCT00071812|27260812|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
7860291|NCT00071812|27260813|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
7860292|NCT00071812|27260814|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
7860293|NCT00071812|27260815|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
7860294|NCT00071812|27260812|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
7860295|NCT00071812|27260813|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7860296|NCT00071812|27260814|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7860297|NCT00071812|27260815|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7860298|NCT00071812|27260812|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
7860299|NCT00071812|27260813|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
7860300|NCT00071812|27260814|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
7860301|NCT00071812|27260815|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
7860302|NCT00071812|27260812|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
7860303|NCT00071812|27260813|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
7860304|NCT00071812|27260814|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
7860305|NCT00071812|27260815|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
7860306|NCT00071812|27260812|P4|24-Week Open-Label Extension Period|Adverse Event|7
7860307|NCT00071812|27260813|P3|24-Week Open-Label Extension Period|Adverse Event|0
7860308|NCT00071812|27260814|P2|24-Week Open-Label Extension Period|Adverse Event|0
7860309|NCT00071812|27260815|P1|24-Week Open-Label Extension Period|Adverse Event|0
7860310|NCT00071812|27260812|P4|24-Week Double-Blind Period|Protocol Violation|1
7860311|NCT00071812|27260813|P3|24-Week Double-Blind Period|Protocol Violation|0
7860312|NCT00071812|27260814|P2|24-Week Double-Blind Period|Protocol Violation|0
7860313|NCT00071812|27260815|P1|24-Week Double-Blind Period|Protocol Violation|0
7860314|NCT00071812|27260812|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
7860315|NCT00071812|27260813|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
7860316|NCT00071812|27260814|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
7860317|NCT00071812|27260815|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
7860318|NCT00071812|27260812|P4|24-Week Double-Blind Period|Lost to Follow-up|0
7860319|NCT00071812|27260813|P3|24-Week Double-Blind Period|Lost to Follow-up|1
7860320|NCT00071812|27260814|P2|24-Week Double-Blind Period|Lost to Follow-up|1
7860321|NCT00071812|27260815|P1|24-Week Double-Blind Period|Lost to Follow-up|0
7860322|NCT00071812|27260812|P4|24-Week Double-Blind Period|Lack of Efficacy|1
7860323|NCT00071812|27260813|P3|24-Week Double-Blind Period|Lack of Efficacy|2
7860324|NCT00071812|27260814|P2|24-Week Double-Blind Period|Lack of Efficacy|1
7860325|NCT00071812|27260815|P1|24-Week Double-Blind Period|Lack of Efficacy|3
7860326|NCT00071812|27260812|P4|24-Week Double-Blind Period|Adverse Event|4
7860327|NCT00071812|27260813|P3|24-Week Double-Blind Period|Adverse Event|4
7860328|NCT00071812|27260814|P2|24-Week Double-Blind Period|Adverse Event|3
7860329|NCT00071812|27260815|P1|24-Week Double-Blind Period|Adverse Event|2
7860330|NCT00071799|27260857|P2|Overall Study|Not Documented|2
7860331|NCT00071799|27260858|P1|Overall Study|Not Documented|0
7860332|NCT00071799|27260857|P2|Overall Study|Different Central+Local Pathology Review|1
7860333|NCT00071799|27260858|P1|Overall Study|Different Central+Local Pathology Review|0
7860334|NCT00071799|27260857|P2|Overall Study|Disease Progression|20
7860335|NCT00071799|27260858|P1|Overall Study|Disease Progression|23
7860336|NCT00071799|27260857|P2|Overall Study|Lack of Efficacy|18
7860337|NCT00071799|27260858|P1|Overall Study|Lack of Efficacy|11
7860338|NCT00071799|27260857|P2|Overall Study|Physician Decision|2
7860339|NCT00071799|27260858|P1|Overall Study|Physician Decision|0
7860340|NCT00071799|27260857|P2|Overall Study|Withdrawal by Subject|37
7860341|NCT00071799|27260858|P1|Overall Study|Withdrawal by Subject|15
7860342|NCT00071799|27260857|P2|Overall Study|Lost to Follow-up|1
7860343|NCT00071799|27260858|P1|Overall Study|Lost to Follow-up|1
7860344|NCT00071799|27260857|P2|Overall Study|Protocol Violation|7
7860345|NCT00071799|27260858|P1|Overall Study|Protocol Violation|1
7860346|NCT00071799|27260857|P2|Overall Study|Adverse Event|10
7860347|NCT00071799|27260858|P1|Overall Study|Adverse Event|19
7860348|NCT00071760|27260911|P1|Overall Study|Ongoing|25
7860349|NCT00071760|27260911|P1|Overall Study|Study Team Rec./Resistance|1
7860350|NCT00071760|27260911|P1|Overall Study|Investigator's Recommendation (Rec.)|4
7860351|NCT00071760|27260911|P1|Overall Study|Relocation|1
7860352|NCT00071760|27260911|P1|Overall Study|Unavailability of RTV|8
7860353|NCT00071760|27260911|P1|Overall Study|Pulmonary Tuberculosis|1
7860354|NCT00071760|27260911|P1|Overall Study|Insufficient Viral Load Response|3
7860355|NCT00071760|27260911|P1|Overall Study|Withdrawal by Subject|3
7860356|NCT00071760|27260911|P1|Overall Study|Protocol Violation|1
7860357|NCT00071760|27260911|P1|Overall Study|Lost to Follow-up|4
7860358|NCT00071760|27260911|P1|Overall Study|Adverse Event|3
7860359|NCT00071513|27260991|P2|Follow-up Assessment|Withdrawal by Subject|6
7860360|NCT00071513|27260992|P1|Follow-up Assessment|Withdrawal by Subject|6
7860361|NCT00071513|27260991|P2|Intervention Component|Withdrawal by Subject|3
7860362|NCT00071513|27260992|P1|Intervention Component|Withdrawal by Subject|2
7860363|NCT00071487|27261004|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
7860364|NCT00071487|27261005|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
7860365|NCT00071487|27261006|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
7860366|NCT00071487|27261007|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
7860367|NCT00071487|27261004|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
7860368|NCT00071487|27261005|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
7860369|NCT00071487|27261006|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
7860370|NCT00071487|27261007|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
7860371|NCT00071487|27261004|P4|24-Week Open-Label Extension Period|Pregnancy|1
7860372|NCT00071487|27261005|P3|24-Week Open-Label Extension Period|Pregnancy|0
7860373|NCT00071487|27261006|P2|24-Week Open-Label Extension Period|Pregnancy|0
7860374|NCT00071487|27261007|P1|24-Week Open-Label Extension Period|Pregnancy|0
7860375|NCT00071487|27261004|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
7860376|NCT00071487|27261005|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7860377|NCT00071487|27261006|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7860378|NCT00071487|27261007|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7860379|NCT00071487|27261004|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
7860380|NCT00071487|27261005|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
7860381|NCT00071487|27261006|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
7860382|NCT00071487|27261007|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
7860383|NCT00071487|27261004|P4|24-Week Open-Label Extension Period|Adverse Event|6
7860384|NCT00071487|27261005|P3|24-Week Open-Label Extension Period|Adverse Event|1
7860385|NCT00071487|27261006|P2|24-Week Open-Label Extension Period|Adverse Event|0
7860386|NCT00071487|27261007|P1|24-Week Open-Label Extension Period|Adverse Event|0
7860387|NCT00071487|27261004|P4|52-Week Double-Blind Period|Lack of Compliance|3
7860388|NCT00071487|27261005|P3|52-Week Double-Blind Period|Lack of Compliance|3
7860389|NCT00071487|27261006|P2|52-Week Double-Blind Period|Lack of Compliance|3
7860390|NCT00071487|27261007|P1|52-Week Double-Blind Period|Lack of Compliance|6
7860391|NCT00071487|27261004|P4|52-Week Double-Blind Period|Death|0
7860392|NCT00071487|27261005|P3|52-Week Double-Blind Period|Death|0
7860393|NCT00071487|27261006|P2|52-Week Double-Blind Period|Death|1
7860394|NCT00071487|27261007|P1|52-Week Double-Blind Period|Death|0
7860395|NCT00071487|27261004|P4|52-Week Double-Blind Period|Protocol Violation|0
7860396|NCT00071487|27261005|P3|52-Week Double-Blind Period|Protocol Violation|1
7860397|NCT00071487|27261006|P2|52-Week Double-Blind Period|Protocol Violation|1
7860398|NCT00071487|27261007|P1|52-Week Double-Blind Period|Protocol Violation|0
7860399|NCT00071487|27261004|P4|52-Week Double-Blind Period|Pregnancy|0
7860400|NCT00071487|27261005|P3|52-Week Double-Blind Period|Pregnancy|0
7860401|NCT00071487|27261006|P2|52-Week Double-Blind Period|Pregnancy|1
7860402|NCT00071487|27261007|P1|52-Week Double-Blind Period|Pregnancy|0
7860403|NCT00071487|27261004|P4|52-Week Double-Blind Period|Lost to Follow-up|2
7860404|NCT00071487|27261005|P3|52-Week Double-Blind Period|Lost to Follow-up|2
7860405|NCT00071487|27261006|P2|52-Week Double-Blind Period|Lost to Follow-up|0
7860406|NCT00071487|27261007|P1|52-Week Double-Blind Period|Lost to Follow-up|0
7860407|NCT00071487|27261004|P4|52-Week Double-Blind Period|Physician Decision|0
7860408|NCT00071487|27261005|P3|52-Week Double-Blind Period|Physician Decision|0
7860409|NCT00071487|27261006|P2|52-Week Double-Blind Period|Physician Decision|0
7860410|NCT00071487|27261007|P1|52-Week Double-Blind Period|Physician Decision|1
7860411|NCT00071487|27261004|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
7860412|NCT00071487|27261005|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
7860413|NCT00071487|27261006|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
7860414|NCT00071487|27261007|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
7860415|NCT00071487|27261004|P4|52-Week Double-Blind Period|Lack of Efficacy|1
7860416|NCT00071487|27261005|P3|52-Week Double-Blind Period|Lack of Efficacy|0
7860417|NCT00071487|27261006|P2|52-Week Double-Blind Period|Lack of Efficacy|2
7860418|NCT00071487|27261007|P1|52-Week Double-Blind Period|Lack of Efficacy|1
7860419|NCT00071487|27261004|P4|52-Week Double-Blind Period|Adverse Event|8
7860420|NCT00071487|27261005|P3|52-Week Double-Blind Period|Adverse Event|4
7860421|NCT00071487|27261006|P2|52-Week Double-Blind Period|Adverse Event|8
7860422|NCT00071487|27261007|P1|52-Week Double-Blind Period|Adverse Event|5
7860423|NCT00071396|27261051|P1|Overall Study|Physician Decision|2
7860424|NCT00071396|27261051|P1|Overall Study|Withdrawal by Subject|1
7860425|NCT00071110|27261057|P2|Overall Study|Protocol Violation|4
7860426|NCT00071110|27261058|P1|Overall Study|Protocol Violation|0
7860427|NCT00071032|27261072|P2|Overall Study|Missing Primary Outcome|1
7860428|NCT00071032|27261073|P1|Overall Study|Missing Primary Outcome|0
7860429|NCT00071032|27261072|P2|Overall Study|Withdrawal by Subject|6
7860430|NCT00071032|27261073|P1|Overall Study|Withdrawal by Subject|8
7860431|NCT00071032|27261072|P2|Overall Study|Lost to Follow-up|1
7860432|NCT00071032|27261073|P1|Overall Study|Lost to Follow-up|1
7860433|NCT00071006|27261109|P1|Overall Study|Other|3
7860434|NCT00071006|27261109|P1|Overall Study|Withdrawal by Subject|1
7860435|NCT00071006|27261109|P1|Overall Study|Adverse Event|1
7860436|NCT00071006|27261109|P1|Overall Study|Lack of Efficacy|7
7860437|NCT00070941|27261122|P3|Overall Study|Adverse Event|4
7860438|NCT00070941|27261123|P2|Overall Study|Adverse Event|8
7860439|NCT00070941|27261124|P1|Overall Study|Adverse Event|10
7860440|NCT00071058|27261132|P1|Overall Study|brain tumor-removed from study|1
7860441|NCT00070707|27261139|P2|Overall Study|Unrelated to Study Medication|0
7860442|NCT00070707|27261140|P1|Overall Study|Unrelated to Study Medication|1
7860443|NCT00070707|27261139|P2|Overall Study|Protocol Violation|4
7860444|NCT00070707|27261140|P1|Overall Study|Protocol Violation|8
7860445|NCT00070707|27261139|P2|Overall Study|Lack of Efficacy|1
7860446|NCT00070707|27261140|P1|Overall Study|Lack of Efficacy|4
7860447|NCT00070707|27261139|P2|Overall Study|Adverse Event|2
7860448|NCT00070707|27261140|P1|Overall Study|Adverse Event|1
7860449|NCT00003907|27261188|P2|Overall Study|ineligible or not treated|2
7860450|NCT00003907|27261189|P1|Overall Study|ineligible or not treated|2
7860451|NCT00003907|27261188|P2|Overall Study|Other|3
7860452|NCT00003907|27261189|P1|Overall Study|Other|1
7860453|NCT00003907|27261188|P2|Overall Study|Complicating disease|0
7860454|NCT00003907|27261189|P1|Overall Study|Complicating disease|1
7860455|NCT00003907|27261188|P2|Overall Study|Progressive disease|4
7860456|NCT00003907|27261189|P1|Overall Study|Progressive disease|4
7860457|NCT00003907|27261188|P2|Overall Study|Withdrawal by Subject|3
7860458|NCT00003907|27261189|P1|Overall Study|Withdrawal by Subject|1
7860459|NCT00003907|27261188|P2|Overall Study|Death|0
7860460|NCT00003907|27261189|P1|Overall Study|Death|2
7860461|NCT00003907|27261188|P2|Overall Study|Adverse Event|11
7860462|NCT00003907|27261189|P1|Overall Study|Adverse Event|2
7860463|NCT00070564|27261205|P6|Overall Study|Not reported|0
7860464|NCT00070564|27261206|P5|Overall Study|Not reported|1
7860465|NCT00070564|27261207|P4|Overall Study|Not reported|0
7860466|NCT00070564|27261208|P3|Overall Study|Not reported|0
7860467|NCT00070564|27261209|P2|Overall Study|Not reported|0
7860468|NCT00070564|27261210|P1|Overall Study|Not reported|0
7860469|NCT00070564|27261205|P6|Overall Study|Withdrawal by Subject|8
7860470|NCT00070564|27261206|P5|Overall Study|Withdrawal by Subject|8
7860471|NCT00070564|27261207|P4|Overall Study|Withdrawal by Subject|30
7860472|NCT00070564|27261208|P3|Overall Study|Withdrawal by Subject|23
7860473|NCT00070564|27261209|P2|Overall Study|Withdrawal by Subject|37
7860474|NCT00070564|27261210|P1|Overall Study|Withdrawal by Subject|26
7860475|NCT00070564|27261205|P6|Overall Study|Other, not protocol specified|7
7860476|NCT00070564|27261206|P5|Overall Study|Other, not protocol specified|6
7860477|NCT00070564|27261207|P4|Overall Study|Other, not protocol specified|19
7860478|NCT00070564|27261208|P3|Overall Study|Other, not protocol specified|14
7860479|NCT00070564|27261209|P2|Overall Study|Other, not protocol specified|15
7860480|NCT00070564|27261210|P1|Overall Study|Other, not protocol specified|17
7860481|NCT00070564|27261205|P6|Overall Study|Death|1
7860482|NCT00070564|27261206|P5|Overall Study|Death|0
7860483|NCT00070564|27261207|P4|Overall Study|Death|3
7860484|NCT00070564|27261208|P3|Overall Study|Death|5
7860485|NCT00070564|27261209|P2|Overall Study|Death|1
7860486|NCT00070564|27261210|P1|Overall Study|Death|4
7860487|NCT00070564|27261205|P6|Overall Study|Adverse Event|36
7860488|NCT00070564|27261206|P5|Overall Study|Adverse Event|63
7860489|NCT00070564|27261207|P4|Overall Study|Adverse Event|108
7860490|NCT00070564|27261208|P3|Overall Study|Adverse Event|120
7860491|NCT00070564|27261209|P2|Overall Study|Adverse Event|142
7860492|NCT00070564|27261210|P1|Overall Study|Adverse Event|150
7860493|NCT00070564|27261205|P6|Overall Study|Delinquent|0
7860494|NCT00070564|27261206|P5|Overall Study|Delinquent|0
7860495|NCT00070564|27261207|P4|Overall Study|Delinquent|0
7860496|NCT00070564|27261208|P3|Overall Study|Delinquent|2
7860497|NCT00070564|27261209|P2|Overall Study|Delinquent|4
7860498|NCT00070564|27261210|P1|Overall Study|Delinquent|1
7860499|NCT00070564|27261205|P6|Overall Study|Progression|0
7860500|NCT00070564|27261206|P5|Overall Study|Progression|1
7860501|NCT00070564|27261207|P4|Overall Study|Progression|7
7860502|NCT00070564|27261208|P3|Overall Study|Progression|7
7860503|NCT00070564|27261209|P2|Overall Study|Progression|4
7860504|NCT00070564|27261210|P1|Overall Study|Progression|2
7860505|NCT00070499|27261264|P4|Overall Study|Not eligible|2
7860506|NCT00070499|27261265|P3|Overall Study|Not eligible|3
7860507|NCT00070499|27261266|P2|Overall Study|Not eligible|5
7860508|NCT00070499|27261267|P1|Overall Study|Not eligible|2
7860509|NCT00070499|27261264|P4|Overall Study|Did not start treatment|2
7860510|NCT00070499|27261265|P3|Overall Study|Did not start treatment|0
7860511|NCT00070499|27261266|P2|Overall Study|Did not start treatment|0
7860512|NCT00070499|27261267|P1|Overall Study|Did not start treatment|1
7860513|NCT00070499|27261264|P4|Overall Study|Still on protocol treatment|57
7860514|NCT00070499|27261265|P3|Overall Study|Still on protocol treatment|79
7860515|NCT00070499|27261266|P2|Overall Study|Still on protocol treatment|4
7860516|NCT00070499|27261267|P1|Overall Study|Still on protocol treatment|10
7860517|NCT00070499|27261264|P4|Overall Study|Other - not protocol specified|20
7860518|NCT00070499|27261265|P3|Overall Study|Other - not protocol specified|12
7860519|NCT00070499|27261266|P2|Overall Study|Other - not protocol specified|3
7860520|NCT00070499|27261267|P1|Overall Study|Other - not protocol specified|7
7860521|NCT00070499|27261264|P4|Overall Study|Death|2
7860522|NCT00070499|27261265|P3|Overall Study|Death|1
7860523|NCT00070499|27261266|P2|Overall Study|Death|1
7860524|NCT00070499|27261267|P1|Overall Study|Death|1
7860525|NCT00070499|27261264|P4|Overall Study|Progression/relapse|4
7860526|NCT00070499|27261265|P3|Overall Study|Progression/relapse|1
7860527|NCT00070499|27261266|P2|Overall Study|Progression/relapse|2
7860528|NCT00070499|27261267|P1|Overall Study|Progression/relapse|4
7860529|NCT00070499|27261264|P4|Overall Study|Refusal unrelated to adverse effects|8
7860530|NCT00070499|27261265|P3|Overall Study|Refusal unrelated to adverse effects|5
7860531|NCT00070499|27261266|P2|Overall Study|Refusal unrelated to adverse effects|5
7860532|NCT00070499|27261267|P1|Overall Study|Refusal unrelated to adverse effects|7
7860533|NCT00070499|27261264|P4|Overall Study|Adverse Event|15
7860534|NCT00070499|27261265|P3|Overall Study|Adverse Event|19
7860535|NCT00070499|27261266|P2|Overall Study|Adverse Event|6
7860536|NCT00070499|27261267|P1|Overall Study|Adverse Event|6
7860537|NCT00070317|27261293|P1|Overall Study|Ineligible-Inadequate pathology|6
7860538|NCT00070317|27261293|P1|Overall Study|Ineligible-Improper prior treatment|2
7860539|NCT00070317|27261293|P1|Overall Study|Ineligible required test not done|1
7860540|NCT00070317|27261293|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
7860541|NCT00070317|27261293|P1|Overall Study|Inevaluable (Never Treated)|1
7860542|NCT00070291|27261298|P1|Step 2|Adverse Event|1
7860543|NCT00070291|27261298|P1|Step 1|Adverse Event|1
7860544|NCT00070291|27261298|P1|Step 1|Withdrawal by Subject|1
7860545|NCT00070109|27261314|P5|Overall Study|removed from prot thpy prior to chemo|0
7860546|NCT00070109|27261315|P4|Overall Study|removed from prot thpy prior to chemo|1
7860547|NCT00070109|27261316|P3|Overall Study|removed from prot thpy prior to chemo|0
7860548|NCT00070109|27261317|P2|Overall Study|removed from prot thpy prior to chemo|0
7860549|NCT00070109|27261318|P1|Overall Study|removed from prot thpy prior to chemo|0
7860550|NCT00070109|27261314|P5|Overall Study|Adverse Event|2
7860551|NCT00070109|27261315|P4|Overall Study|Adverse Event|4
7860552|NCT00070109|27261316|P3|Overall Study|Adverse Event|2
7860553|NCT00070109|27261317|P2|Overall Study|Adverse Event|0
7860554|NCT00070109|27261318|P1|Overall Study|Adverse Event|0
7860555|NCT00070109|27261314|P5|Overall Study|Withdrawal by Subject|0
7860556|NCT00070109|27261315|P4|Overall Study|Withdrawal by Subject|0
7860557|NCT00070109|27261316|P3|Overall Study|Withdrawal by Subject|1
7860558|NCT00070109|27261317|P2|Overall Study|Withdrawal by Subject|1
7860559|NCT00070109|27261318|P1|Overall Study|Withdrawal by Subject|0
7860560|NCT00070109|27261314|P5|Overall Study|Physician Decision|0
7860561|NCT00070109|27261315|P4|Overall Study|Physician Decision|0
7860562|NCT00070109|27261316|P3|Overall Study|Physician Decision|0
7860563|NCT00070109|27261317|P2|Overall Study|Physician Decision|0
7860564|NCT00070109|27261318|P1|Overall Study|Physician Decision|1
7860565|NCT00070109|27261314|P5|Overall Study|Lack of Efficacy|5
7860566|NCT00070109|27261315|P4|Overall Study|Lack of Efficacy|15
7860567|NCT00070109|27261316|P3|Overall Study|Lack of Efficacy|5
7860568|NCT00070109|27261317|P2|Overall Study|Lack of Efficacy|4
7860569|NCT00070109|27261318|P1|Overall Study|Lack of Efficacy|6
7860570|NCT00070109|27261314|P5|Overall Study|Death|1
7860571|NCT00070109|27261315|P4|Overall Study|Death|0
7860572|NCT00070109|27261316|P3|Overall Study|Death|0
7860573|NCT00070109|27261317|P2|Overall Study|Death|1
7860574|NCT00070109|27261318|P1|Overall Study|Death|1
7860575|NCT00070018|27261375|P1|Overall Study|Withdrawal by Subject|1
7860576|NCT00070018|27261375|P1|Overall Study|Lack of Efficacy|1
7860577|NCT00070018|27261375|P1|Overall Study|Adverse Event|2
7860578|NCT00069953|27261379|P1|Overall Study|Protocol Violation|2
7860579|NCT00069784|27261385|P2|Overall Study|Other|0
7860580|NCT00069784|27261386|P1|Overall Study|Other|17
7860581|NCT00069784|27261385|P2|Overall Study|Withdrawal by Subject|0
7860582|NCT00069784|27261386|P1|Overall Study|Withdrawal by Subject|1090
7860583|NCT00069784|27261385|P2|Overall Study|Adverse Event|0
7860584|NCT00069784|27261386|P1|Overall Study|Adverse Event|105
7860585|NCT00069823|27261406|P2|Overall Study|Did not have follow-up diary cards|3
7860586|NCT00069823|27261407|P1|Overall Study|Did not have follow-up diary cards|6
7860587|NCT00069641|27261450|P3|Overall Study|Death|1
7860588|NCT00069641|27261451|P2|Overall Study|Death|0
7860589|NCT00069641|27261452|P1|Overall Study|Death|1
7860590|NCT00069576|27261479|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
7860591|NCT00069576|27261480|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
7860592|NCT00069576|27261479|P2|Original Trial|Lost to Follow-up|33
7860593|NCT00069576|27261480|P1|Original Trial|Lost to Follow-up|25
7860594|NCT00069277|27261530|P1|Overall Study|Physician Decision|2
7860595|NCT00069277|27261530|P1|Overall Study|Progressive Disease|15
7860596|NCT00069277|27261530|P1|Overall Study|Withdrawal by Subject|1
7860597|NCT00069277|27261530|P1|Overall Study|Adverse Event|3
7860598|NCT00069264|27261534|P1|Overall Study|Discon Therapy|3
7860599|NCT00069264|27261534|P1|Overall Study|Withdrawal by Subject|3
7860600|NCT00069264|27261534|P1|Overall Study|Progressive Disease|23
7860601|NCT00069264|27261534|P1|Overall Study|Adverse Event|3
7860602|NCT00069238|27261562|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
7860603|NCT00069238|27261563|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
7860604|NCT00069238|27261564|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
7860605|NCT00069238|27261562|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
7860606|NCT00069238|27261563|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
7860607|NCT00069238|27261564|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
7860608|NCT00069238|27261562|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
7860609|NCT00069238|27261563|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
7860610|NCT00069238|27261564|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
7860611|NCT00069121|27261572|P2|Overall Study|Lost to Follow-up|63
7860612|NCT00069121|27261573|P1|Overall Study|Lost to Follow-up|63
7860613|NCT00069121|27261572|P2|Overall Study|Withdrawal by Subject|20
7860614|NCT00069121|27261573|P1|Overall Study|Withdrawal by Subject|18
7860615|NCT00069121|27261572|P2|Overall Study|Death|242
7860616|NCT00069121|27261573|P1|Overall Study|Death|286
7860617|NCT00069108|27261595|P2|Overall Study|Refused treatment|10
7860618|NCT00069108|27261596|P1|Overall Study|Refused treatment|5
7860619|NCT00069108|27261595|P2|Overall Study|Violation criteria|4
7860620|NCT00069108|27261596|P1|Overall Study|Violation criteria|1
7860621|NCT00069108|27261595|P2|Overall Study|Insufficient therapy|144
7860622|NCT00069108|27261596|P1|Overall Study|Insufficient therapy|117
7860623|NCT00069108|27261595|P2|Overall Study|Administration|4
7860624|NCT00069108|27261596|P1|Overall Study|Administration|15
7860625|NCT00069108|27261595|P2|Overall Study|Death|6
7860626|NCT00069108|27261596|P1|Overall Study|Death|6
7860627|NCT00069108|27261595|P2|Overall Study|Adverse Event|42
7860628|NCT00069108|27261596|P1|Overall Study|Adverse Event|64
7860629|NCT00069108|27261595|P2|Overall Study|Withdrawal by Subject|9
7860630|NCT00069108|27261596|P1|Overall Study|Withdrawal by Subject|5
7860631|NCT00069095|27261628|P6|Follow-up Phase|Death|101
7860632|NCT00069095|27261629|P5|Follow-up Phase|Death|92
7860633|NCT00069095|27261630|P4|Follow-up Phase|Death|112
7860634|NCT00069095|27261631|P3|Follow-up Phase|Death|120
7860635|NCT00069095|27261632|P2|Follow-up Phase|Death|206
7860636|NCT00069095|27261633|P1|Follow-up Phase|Death|174
7860637|NCT00069095|27261628|P6|Post-study Treatment Phase|Investigator decision|1
7860638|NCT00069095|27261629|P5|Post-study Treatment Phase|Investigator decision|0
7860639|NCT00069095|27261630|P4|Post-study Treatment Phase|Investigator decision|0
7860640|NCT00069095|27261631|P3|Post-study Treatment Phase|Investigator decision|0
7860641|NCT00069095|27261632|P2|Post-study Treatment Phase|Investigator decision|0
7860642|NCT00069095|27261633|P1|Post-study Treatment Phase|Investigator decision|0
7860643|NCT00069095|27261628|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7860644|NCT00069095|27261629|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
7860645|NCT00069095|27261630|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7860646|NCT00069095|27261631|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7860647|NCT00069095|27261632|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7860648|NCT00069095|27261633|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7860649|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
7860650|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
7860651|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
7860652|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
7860653|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
7860654|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
7860655|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant had progressive disease|0
7860656|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant had progressive disease|1
7860657|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant had progressive disease|0
7860658|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant had progressive disease|0
7860659|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant had progressive disease|0
7860660|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant had progressive disease|0
7860661|NCT00069095|27261628|P6|Post-study Treatment Phase|Death|0
7860662|NCT00069095|27261629|P5|Post-study Treatment Phase|Death|1
7860663|NCT00069095|27261630|P4|Post-study Treatment Phase|Death|0
7860664|NCT00069095|27261631|P3|Post-study Treatment Phase|Death|0
7860665|NCT00069095|27261632|P2|Post-study Treatment Phase|Death|0
7860666|NCT00069095|27261633|P1|Post-study Treatment Phase|Death|0
7860667|NCT00069095|27261628|P6|Post-study Treatment Phase|Surgery|0
7860668|NCT00069095|27261629|P5|Post-study Treatment Phase|Surgery|1
7860669|NCT00069095|27261630|P4|Post-study Treatment Phase|Surgery|1
7860670|NCT00069095|27261631|P3|Post-study Treatment Phase|Surgery|0
7860671|NCT00069095|27261632|P2|Post-study Treatment Phase|Surgery|0
7860672|NCT00069095|27261633|P1|Post-study Treatment Phase|Surgery|0
7860673|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant completed treatment|0
7860674|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant completed treatment|0
7860675|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant completed treatment|1
7860676|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant completed treatment|0
7860677|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant completed treatment|0
7860678|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant completed treatment|0
7860679|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
7860680|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
7860681|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
7860682|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
7860683|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
7860684|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
7860685|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant will start new treatment|0
7860686|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant will start new treatment|0
7860687|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant will start new treatment|0
7860688|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant will start new treatment|1
7860689|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant will start new treatment|0
7860690|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant will start new treatment|0
7860691|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant withdrew consent|0
7860692|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant withdrew consent|0
7860693|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant withdrew consent|0
7860694|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant withdrew consent|1
7860695|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant withdrew consent|0
7860696|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant withdrew consent|0
7860697|NCT00069095|27261628|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7860698|NCT00069095|27261629|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7860699|NCT00069095|27261630|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7860700|NCT00069095|27261631|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7860701|NCT00069095|27261632|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7860702|NCT00069095|27261633|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7860703|NCT00069095|27261628|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
7860704|NCT00069095|27261629|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
7860705|NCT00069095|27261630|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
7860706|NCT00069095|27261631|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
7860707|NCT00069095|27261632|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
7860708|NCT00069095|27261633|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
7860709|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant had complete response|0
7860710|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant had complete response|0
7860711|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant had complete response|0
7860712|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant had complete response|0
7860713|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant had complete response|1
7860714|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant had complete response|1
7860715|NCT00069095|27261628|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
7860716|NCT00069095|27261629|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7860717|NCT00069095|27261630|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7860718|NCT00069095|27261631|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7860719|NCT00069095|27261632|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7860720|NCT00069095|27261633|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
7860721|NCT00069095|27261628|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
7860722|NCT00069095|27261629|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
7860723|NCT00069095|27261630|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
7860724|NCT00069095|27261631|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
7860725|NCT00069095|27261632|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
7860726|NCT00069095|27261633|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
7860727|NCT00069095|27261628|P6|Post-study Treatment Phase|Eligible for surgery|0
7860728|NCT00069095|27261629|P5|Post-study Treatment Phase|Eligible for surgery|0
7860729|NCT00069095|27261630|P4|Post-study Treatment Phase|Eligible for surgery|0
7860730|NCT00069095|27261631|P3|Post-study Treatment Phase|Eligible for surgery|0
7860731|NCT00069095|27261632|P2|Post-study Treatment Phase|Eligible for surgery|0
7860732|NCT00069095|27261633|P1|Post-study Treatment Phase|Eligible for surgery|2
7860733|NCT00069095|27261628|P6|Post-study Treatment Phase|Adverse Event|1
7860734|NCT00069095|27261629|P5|Post-study Treatment Phase|Adverse Event|5
7860735|NCT00069095|27261630|P4|Post-study Treatment Phase|Adverse Event|0
7860736|NCT00069095|27261631|P3|Post-study Treatment Phase|Adverse Event|1
7860737|NCT00069095|27261632|P2|Post-study Treatment Phase|Adverse Event|3
7860738|NCT00069095|27261633|P1|Post-study Treatment Phase|Adverse Event|2
7860739|NCT00069095|27261628|P6|Post-study Treatment Phase|Missing reason|17
7860740|NCT00069095|27261629|P5|Post-study Treatment Phase|Missing reason|18
7860741|NCT00069095|27261630|P4|Post-study Treatment Phase|Missing reason|8
7860742|NCT00069095|27261631|P3|Post-study Treatment Phase|Missing reason|12
7860743|NCT00069095|27261632|P2|Post-study Treatment Phase|Missing reason|3
7860744|NCT00069095|27261633|P1|Post-study Treatment Phase|Missing reason|1
7860745|NCT00069095|27261628|P6|Primary Treatment Phase|Violation criteria|5
7860746|NCT00069095|27261629|P5|Primary Treatment Phase|Violation criteria|1
7860747|NCT00069095|27261630|P4|Primary Treatment Phase|Violation criteria|3
7860748|NCT00069095|27261631|P3|Primary Treatment Phase|Violation criteria|4
7860749|NCT00069095|27261632|P2|Primary Treatment Phase|Violation criteria|2
7860750|NCT00069095|27261633|P1|Primary Treatment Phase|Violation criteria|0
7860751|NCT00069095|27261628|P6|Primary Treatment Phase|Other Violation|1
7860752|NCT00069095|27261629|P5|Primary Treatment Phase|Other Violation|0
7860753|NCT00069095|27261630|P4|Primary Treatment Phase|Other Violation|1
7860754|NCT00069095|27261631|P3|Primary Treatment Phase|Other Violation|1
7860755|NCT00069095|27261632|P2|Primary Treatment Phase|Other Violation|1
7860756|NCT00069095|27261633|P1|Primary Treatment Phase|Other Violation|0
7860757|NCT00069095|27261628|P6|Primary Treatment Phase|Withdrew|9
7860758|NCT00069095|27261629|P5|Primary Treatment Phase|Withdrew|4
7860759|NCT00069095|27261630|P4|Primary Treatment Phase|Withdrew|2
7860760|NCT00069095|27261631|P3|Primary Treatment Phase|Withdrew|8
7860761|NCT00069095|27261632|P2|Primary Treatment Phase|Withdrew|3
7860762|NCT00069095|27261633|P1|Primary Treatment Phase|Withdrew|2
7860763|NCT00069095|27261628|P6|Primary Treatment Phase|Refused treatment|27
7860764|NCT00069095|27261629|P5|Primary Treatment Phase|Refused treatment|24
7860765|NCT00069095|27261630|P4|Primary Treatment Phase|Refused treatment|31
7860766|NCT00069095|27261631|P3|Primary Treatment Phase|Refused treatment|17
7860767|NCT00069095|27261632|P2|Primary Treatment Phase|Refused treatment|26
7860768|NCT00069095|27261633|P1|Primary Treatment Phase|Refused treatment|15
7860769|NCT00069095|27261628|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
7860770|NCT00069095|27261629|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
7860771|NCT00069095|27261630|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
7860772|NCT00069095|27261631|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
7860773|NCT00069095|27261632|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
7860774|NCT00069095|27261633|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
7860775|NCT00069095|27261628|P6|Primary Treatment Phase|Failure to return|2
7860776|NCT00069095|27261629|P5|Primary Treatment Phase|Failure to return|0
7860777|NCT00069095|27261630|P4|Primary Treatment Phase|Failure to return|0
7860778|NCT00069095|27261631|P3|Primary Treatment Phase|Failure to return|0
7860779|NCT00069095|27261632|P2|Primary Treatment Phase|Failure to return|5
7860780|NCT00069095|27261633|P1|Primary Treatment Phase|Failure to return|5
7860781|NCT00069095|27261628|P6|Primary Treatment Phase|Death|8
7860782|NCT00069095|27261629|P5|Primary Treatment Phase|Death|8
7860783|NCT00069095|27261630|P4|Primary Treatment Phase|Death|5
7860784|NCT00069095|27261631|P3|Primary Treatment Phase|Death|2
7860785|NCT00069095|27261632|P2|Primary Treatment Phase|Death|8
7860786|NCT00069095|27261633|P1|Primary Treatment Phase|Death|14
7860787|NCT00069095|27261628|P6|Primary Treatment Phase|Adverse Event|101
7860788|NCT00069095|27261629|P5|Primary Treatment Phase|Adverse Event|109
7860789|NCT00069095|27261630|P4|Primary Treatment Phase|Adverse Event|72
7860790|NCT00069095|27261631|P3|Primary Treatment Phase|Adverse Event|71
7860791|NCT00069095|27261632|P2|Primary Treatment Phase|Adverse Event|92
7860792|NCT00069095|27261633|P1|Primary Treatment Phase|Adverse Event|99
7860793|NCT00069095|27261628|P6|Primary Treatment Phase|Admin/Other|42
7860794|NCT00069095|27261629|P5|Primary Treatment Phase|Admin/Other|48
7860795|NCT00069095|27261630|P4|Primary Treatment Phase|Admin/Other|45
7860796|NCT00069095|27261631|P3|Primary Treatment Phase|Admin/Other|31
7860797|NCT00069095|27261632|P2|Primary Treatment Phase|Admin/Other|38
7860798|NCT00069095|27261633|P1|Primary Treatment Phase|Admin/Other|29
7860799|NCT00069095|27261628|P6|Primary Treatment Phase|Ongoing|4
7860800|NCT00069095|27261629|P5|Primary Treatment Phase|Ongoing|7
7860801|NCT00069095|27261630|P4|Primary Treatment Phase|Ongoing|7
7860802|NCT00069095|27261631|P3|Primary Treatment Phase|Ongoing|5
7860803|NCT00069095|27261632|P2|Primary Treatment Phase|Ongoing|0
7860804|NCT00069095|27261633|P1|Primary Treatment Phase|Ongoing|0
7860805|NCT00068822|27261703|P2|First Randomized Intervention|Lost to Follow-up|2
7860806|NCT00068822|27261704|P1|First Randomized Intervention|Lost to Follow-up|1
7860807|NCT00068692|27261738|P8|Step 2: Randomization|never start protocol therapy|0
7860808|NCT00068692|27261739|P7|Step 2: Randomization|never start protocol therapy|0
7860809|NCT00068692|27261740|P6|Step 2: Randomization|never start protocol therapy|0
7860810|NCT00068692|27261741|P5|Step 2: Randomization|never start protocol therapy|1
7860811|NCT00068692|27261742|P4|Step 2: Randomization|never start protocol therapy|0
7860812|NCT00068692|27261743|P3|Step 2: Randomization|never start protocol therapy|1
7860813|NCT00068692|27261744|P2|Step 2: Randomization|never start protocol therapy|0
7860814|NCT00068692|27261745|P1|Step 2: Randomization|never start protocol therapy|0
7860815|NCT00068692|27261738|P8|Step 2: Randomization|Other|0
7860816|NCT00068692|27261739|P7|Step 2: Randomization|Other|0
7860817|NCT00068692|27261740|P6|Step 2: Randomization|Other|1
7860818|NCT00068692|27261741|P5|Step 2: Randomization|Other|0
7860819|NCT00068692|27261742|P4|Step 2: Randomization|Other|1
7860820|NCT00068692|27261743|P3|Step 2: Randomization|Other|0
7860821|NCT00068692|27261744|P2|Step 2: Randomization|Other|0
7860822|NCT00068692|27261745|P1|Step 2: Randomization|Other|0
7860823|NCT00068692|27261738|P8|Step 2: Randomization|Physician Decision|0
7860824|NCT00068692|27261739|P7|Step 2: Randomization|Physician Decision|0
7860825|NCT00068692|27261740|P6|Step 2: Randomization|Physician Decision|0
7860826|NCT00068692|27261741|P5|Step 2: Randomization|Physician Decision|1
7860827|NCT00068692|27261742|P4|Step 2: Randomization|Physician Decision|1
7860828|NCT00068692|27261743|P3|Step 2: Randomization|Physician Decision|0
7860829|NCT00068692|27261744|P2|Step 2: Randomization|Physician Decision|0
7860830|NCT00068692|27261745|P1|Step 2: Randomization|Physician Decision|0
7860831|NCT00068692|27261738|P8|Step 2: Randomization|alternative therapy|0
7860832|NCT00068692|27261739|P7|Step 2: Randomization|alternative therapy|0
7860833|NCT00068692|27261740|P6|Step 2: Randomization|alternative therapy|0
7860834|NCT00068692|27261741|P5|Step 2: Randomization|alternative therapy|1
7860835|NCT00068692|27261742|P4|Step 2: Randomization|alternative therapy|1
7860836|NCT00068692|27261743|P3|Step 2: Randomization|alternative therapy|0
7860837|NCT00068692|27261744|P2|Step 2: Randomization|alternative therapy|0
7860838|NCT00068692|27261745|P1|Step 2: Randomization|alternative therapy|0
7860839|NCT00068692|27261738|P8|Step 2: Randomization|Withdrawal by Subject|3
7860840|NCT00068692|27261739|P7|Step 2: Randomization|Withdrawal by Subject|0
7860841|NCT00068692|27261740|P6|Step 2: Randomization|Withdrawal by Subject|2
7860842|NCT00068692|27261741|P5|Step 2: Randomization|Withdrawal by Subject|3
7860843|NCT00068692|27261742|P4|Step 2: Randomization|Withdrawal by Subject|6
7860844|NCT00068692|27261743|P3|Step 2: Randomization|Withdrawal by Subject|4
7860845|NCT00068692|27261744|P2|Step 2: Randomization|Withdrawal by Subject|0
7860846|NCT00068692|27261745|P1|Step 2: Randomization|Withdrawal by Subject|0
7860847|NCT00068692|27261738|P8|Step 2: Randomization|Death|1
7860848|NCT00068692|27261739|P7|Step 2: Randomization|Death|0
7860849|NCT00068692|27261740|P6|Step 2: Randomization|Death|0
7860850|NCT00068692|27261741|P5|Step 2: Randomization|Death|1
7860851|NCT00068692|27261742|P4|Step 2: Randomization|Death|0
7860852|NCT00068692|27261743|P3|Step 2: Randomization|Death|0
7860853|NCT00068692|27261744|P2|Step 2: Randomization|Death|0
7860854|NCT00068692|27261745|P1|Step 2: Randomization|Death|0
7860855|NCT00068692|27261738|P8|Step 2: Randomization|Adverse Event|4
7860856|NCT00068692|27261739|P7|Step 2: Randomization|Adverse Event|4
7860857|NCT00068692|27261740|P6|Step 2: Randomization|Adverse Event|3
7860858|NCT00068692|27261741|P5|Step 2: Randomization|Adverse Event|2
7860859|NCT00068692|27261742|P4|Step 2: Randomization|Adverse Event|2
7860860|NCT00068692|27261743|P3|Step 2: Randomization|Adverse Event|4
7860861|NCT00068692|27261744|P2|Step 2: Randomization|Adverse Event|0
7860862|NCT00068692|27261745|P1|Step 2: Randomization|Adverse Event|0
7860863|NCT00068692|27261738|P8|Step 2: Randomization|Disesae progression/replase|0
7860864|NCT00068692|27261739|P7|Step 2: Randomization|Disesae progression/replase|0
7860865|NCT00068692|27261740|P6|Step 2: Randomization|Disesae progression/replase|0
7860866|NCT00068692|27261741|P5|Step 2: Randomization|Disesae progression/replase|0
7860867|NCT00068692|27261742|P4|Step 2: Randomization|Disesae progression/replase|1
7860868|NCT00068692|27261743|P3|Step 2: Randomization|Disesae progression/replase|1
7860869|NCT00068692|27261744|P2|Step 2: Randomization|Disesae progression/replase|0
7860870|NCT00068692|27261745|P1|Step 2: Randomization|Disesae progression/replase|0
7860871|NCT00068692|27261738|P8|Step 1: Registration|Registered but not randomized|0
7860872|NCT00068692|27261739|P7|Step 1: Registration|Registered but not randomized|0
7860873|NCT00068692|27261740|P6|Step 1: Registration|Registered but not randomized|0
7860874|NCT00068692|27261741|P5|Step 1: Registration|Registered but not randomized|0
7860875|NCT00068692|27261742|P4|Step 1: Registration|Registered but not randomized|0
7860876|NCT00068692|27261743|P3|Step 1: Registration|Registered but not randomized|0
7860877|NCT00068692|27261744|P2|Step 1: Registration|Registered but not randomized|1
7860878|NCT00068692|27261745|P1|Step 1: Registration|Registered but not randomized|0
7860879|NCT00068692|27261738|P8|Step 1: Registration|Not start protocol therapy|0
7860880|NCT00068692|27261739|P7|Step 1: Registration|Not start protocol therapy|0
7860881|NCT00068692|27261740|P6|Step 1: Registration|Not start protocol therapy|0
7860882|NCT00068692|27261741|P5|Step 1: Registration|Not start protocol therapy|0
7860883|NCT00068692|27261742|P4|Step 1: Registration|Not start protocol therapy|0
7860884|NCT00068692|27261743|P3|Step 1: Registration|Not start protocol therapy|0
7860885|NCT00068692|27261744|P2|Step 1: Registration|Not start protocol therapy|0
7860886|NCT00068692|27261745|P1|Step 1: Registration|Not start protocol therapy|3
7860887|NCT00068692|27261738|P8|Step 1: Registration|Other|0
7860888|NCT00068692|27261739|P7|Step 1: Registration|Other|0
7860889|NCT00068692|27261740|P6|Step 1: Registration|Other|0
7860890|NCT00068692|27261741|P5|Step 1: Registration|Other|0
7860891|NCT00068692|27261742|P4|Step 1: Registration|Other|0
7860892|NCT00068692|27261743|P3|Step 1: Registration|Other|0
7860893|NCT00068692|27261744|P2|Step 1: Registration|Other|0
7860894|NCT00068692|27261745|P1|Step 1: Registration|Other|2
7860895|NCT00068692|27261738|P8|Step 1: Registration|Not eligible|0
7860896|NCT00068692|27261739|P7|Step 1: Registration|Not eligible|0
7860897|NCT00068692|27261740|P6|Step 1: Registration|Not eligible|0
7860898|NCT00068692|27261741|P5|Step 1: Registration|Not eligible|0
7860899|NCT00068692|27261742|P4|Step 1: Registration|Not eligible|0
7860900|NCT00068692|27261743|P3|Step 1: Registration|Not eligible|0
7860901|NCT00068692|27261744|P2|Step 1: Registration|Not eligible|0
7860902|NCT00068692|27261745|P1|Step 1: Registration|Not eligible|6
7860903|NCT00068692|27261738|P8|Step 1: Registration|Protocol Violation|0
7860904|NCT00068692|27261739|P7|Step 1: Registration|Protocol Violation|0
7860905|NCT00068692|27261740|P6|Step 1: Registration|Protocol Violation|0
7860906|NCT00068692|27261741|P5|Step 1: Registration|Protocol Violation|0
7860907|NCT00068692|27261742|P4|Step 1: Registration|Protocol Violation|0
7860908|NCT00068692|27261743|P3|Step 1: Registration|Protocol Violation|0
7860909|NCT00068692|27261744|P2|Step 1: Registration|Protocol Violation|0
7860910|NCT00068692|27261745|P1|Step 1: Registration|Protocol Violation|1
7860911|NCT00068692|27261738|P8|Step 1: Registration|Complicating disease|0
7860912|NCT00068692|27261739|P7|Step 1: Registration|Complicating disease|0
7860913|NCT00068692|27261740|P6|Step 1: Registration|Complicating disease|0
7860914|NCT00068692|27261741|P5|Step 1: Registration|Complicating disease|0
7860915|NCT00068692|27261742|P4|Step 1: Registration|Complicating disease|0
7860916|NCT00068692|27261743|P3|Step 1: Registration|Complicating disease|0
7860917|NCT00068692|27261744|P2|Step 1: Registration|Complicating disease|0
7860918|NCT00068692|27261745|P1|Step 1: Registration|Complicating disease|2
7860919|NCT00068692|27261738|P8|Step 1: Registration|Alternative therapy|0
7860920|NCT00068692|27261739|P7|Step 1: Registration|Alternative therapy|0
7860921|NCT00068692|27261740|P6|Step 1: Registration|Alternative therapy|0
7860922|NCT00068692|27261741|P5|Step 1: Registration|Alternative therapy|0
7860923|NCT00068692|27261742|P4|Step 1: Registration|Alternative therapy|0
7860924|NCT00068692|27261743|P3|Step 1: Registration|Alternative therapy|0
7860925|NCT00068692|27261744|P2|Step 1: Registration|Alternative therapy|0
7860926|NCT00068692|27261745|P1|Step 1: Registration|Alternative therapy|2
7860927|NCT00068692|27261738|P8|Step 1: Registration|Withdrawal by Subject|0
7860928|NCT00068692|27261739|P7|Step 1: Registration|Withdrawal by Subject|0
7860929|NCT00068692|27261740|P6|Step 1: Registration|Withdrawal by Subject|0
7860930|NCT00068692|27261741|P5|Step 1: Registration|Withdrawal by Subject|0
7860931|NCT00068692|27261742|P4|Step 1: Registration|Withdrawal by Subject|0
7860932|NCT00068692|27261743|P3|Step 1: Registration|Withdrawal by Subject|0
7860933|NCT00068692|27261744|P2|Step 1: Registration|Withdrawal by Subject|0
7860934|NCT00068692|27261745|P1|Step 1: Registration|Withdrawal by Subject|11
7860935|NCT00068692|27261738|P8|Step 1: Registration|Death|0
7860936|NCT00068692|27261739|P7|Step 1: Registration|Death|0
7860937|NCT00068692|27261740|P6|Step 1: Registration|Death|0
7860938|NCT00068692|27261741|P5|Step 1: Registration|Death|0
7860939|NCT00068692|27261742|P4|Step 1: Registration|Death|0
7860940|NCT00068692|27261743|P3|Step 1: Registration|Death|0
7860941|NCT00068692|27261744|P2|Step 1: Registration|Death|0
7860942|NCT00068692|27261745|P1|Step 1: Registration|Death|1
7860943|NCT00068692|27261738|P8|Step 1: Registration|Adverse Event|0
7860944|NCT00068692|27261739|P7|Step 1: Registration|Adverse Event|0
7860945|NCT00068692|27261740|P6|Step 1: Registration|Adverse Event|0
7860946|NCT00068692|27261741|P5|Step 1: Registration|Adverse Event|0
7860947|NCT00068692|27261742|P4|Step 1: Registration|Adverse Event|0
7860948|NCT00068692|27261743|P3|Step 1: Registration|Adverse Event|0
7860949|NCT00068692|27261744|P2|Step 1: Registration|Adverse Event|0
7860950|NCT00068692|27261745|P1|Step 1: Registration|Adverse Event|7
7860951|NCT00068692|27261738|P8|Step 1: Registration|Disese progression/relapse|0
7860952|NCT00068692|27261739|P7|Step 1: Registration|Disese progression/relapse|0
7860953|NCT00068692|27261740|P6|Step 1: Registration|Disese progression/relapse|0
7860954|NCT00068692|27261741|P5|Step 1: Registration|Disese progression/relapse|0
7860955|NCT00068692|27261742|P4|Step 1: Registration|Disese progression/relapse|0
7860956|NCT00068692|27261743|P3|Step 1: Registration|Disese progression/relapse|0
7860957|NCT00068692|27261744|P2|Step 1: Registration|Disese progression/relapse|0
7860958|NCT00068692|27261745|P1|Step 1: Registration|Disese progression/relapse|5
7860959|NCT00068601|27261768|P2|Overall Study|Missing primary outcome data|34
7860960|NCT00068601|27261769|P1|Overall Study|Missing primary outcome data|30
7860961|NCT00068601|27261768|P2|Overall Study|Lost to Follow-up|2
7860962|NCT00068601|27261769|P1|Overall Study|Lost to Follow-up|3
7860963|NCT00068601|27261768|P2|Overall Study|Death|3
7860964|NCT00068601|27261769|P1|Overall Study|Death|11
7860965|NCT00068601|27261768|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
7860966|NCT00068601|27261769|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
7860967|NCT00068601|27261768|P2|Overall Study|Not evaluable: withdrew consent|4
7860968|NCT00068601|27261769|P1|Overall Study|Not evaluable: withdrew consent|5
7860969|NCT00068601|27261768|P2|Overall Study|Ineligible|13
7860970|NCT00068601|27261769|P1|Overall Study|Ineligible|11
7860971|NCT00068588|27261782|P3|Overall Study|Poor KPS|1
7860972|NCT00068588|27261783|P2|Overall Study|Poor KPS|0
7860973|NCT00068588|27261784|P1|Overall Study|Poor KPS|0
7860974|NCT00068588|27261782|P3|Overall Study|Withdrawal by Subject|1
7860975|NCT00068588|27261783|P2|Overall Study|Withdrawal by Subject|0
7860976|NCT00068588|27261784|P1|Overall Study|Withdrawal by Subject|0
7860977|NCT00068588|27261782|P3|Overall Study|Adverse Event|2
7860978|NCT00068588|27261783|P2|Overall Study|Adverse Event|0
7860979|NCT00068588|27261784|P1|Overall Study|Adverse Event|0
7860980|NCT00068445|27261800|P2|Treatment|Other (Specifics not available)|5
7860981|NCT00068445|27261801|P1|Treatment|Other (Specifics not available)|9
7860982|NCT00068445|27261800|P2|Treatment|Adverse Event|1
7860983|NCT00068445|27261801|P1|Treatment|Adverse Event|7
7860984|NCT00068445|27261800|P2|Treatment|Refused Further Treatment|10
7860985|NCT00068445|27261801|P1|Treatment|Refused Further Treatment|13
7860986|NCT00068445|27261800|P2|Randomization|Ineligible|1
7860987|NCT00068445|27261801|P1|Randomization|Ineligible|1
7860988|NCT00068445|27261800|P2|Randomization|Cancel|3
7860989|NCT00068445|27261801|P1|Randomization|Cancel|1
7860990|NCT00068419|27261825|P1|Overall Study|Ineligible|11
7860991|NCT00068419|27261825|P1|Overall Study|Withdrawal by Subject|14
7860992|NCT00068419|27261825|P1|Overall Study|Physician Decision|7
7860993|NCT00068419|27261825|P1|Overall Study|Lost to Follow-up|1
7860994|NCT00068419|27261825|P1|Overall Study|Lack of Efficacy|24
7860995|NCT00068419|27261825|P1|Overall Study|Adverse Event|3
7860996|NCT00068406|27261834|P1|Overall Study|Ineligible-Inadequate Pathology|2
7860997|NCT00068406|27261834|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
7860998|NCT00068393|27261839|P1|Overall Study|Quality of life worsening|1
7860999|NCT00068393|27261839|P1|Overall Study|Alternative treatment|1
7861000|NCT00068393|27261839|P1|Overall Study|Withdrawal by Subject|3
7861001|NCT00068393|27261839|P1|Overall Study|Death|3
7861002|NCT00068393|27261839|P1|Overall Study|Adverse Event|2
7861003|NCT00068380|27261845|P1|Overall Study|Adverse Event|2
7861004|NCT00068380|27261845|P1|Overall Study|Withdrawal by Subject|3
7861005|NCT00068250|27261889|P4|Phase I: Dose Level 2|Protocol Violation|0
7861006|NCT00068250|27261890|P3|Phase I: Dose Level 2|Protocol Violation|0
7861007|NCT00068250|27261891|P2|Phase I: Dose Level 2|Protocol Violation|1
7861008|NCT00068250|27261892|P1|Phase I: Dose Level 2|Protocol Violation|0
7861009|NCT00068237|27261902|P1|Overall Study|No protocol treatment received|2
7861010|NCT00068237|27261902|P1|Overall Study|Ineligible|3
7861011|NCT00068107|27261914|P1|Overall Study|Withdrawal by Subject|1
7861012|NCT00068107|27261914|P1|Overall Study|Death|2
7861013|NCT00068107|27261914|P1|Overall Study|end-stage renal disease|6
7861014|NCT00067990|27261927|P2|Overall Study|Withdrawal by Subject|12
7861015|NCT00067990|27261928|P1|Overall Study|Withdrawal by Subject|4
7861016|NCT00067990|27261927|P2|Overall Study|ESRD, Non IF/TA|3
7861017|NCT00067990|27261928|P1|Overall Study|ESRD, Non IF/TA|1
7861018|NCT00067990|27261927|P2|Overall Study|Death|7
7861019|NCT00067990|27261928|P1|Overall Study|Death|5
7861020|NCT00067470|27261951|P2|Overall Study|Withdrawal by Subject|1
7861021|NCT00067470|27261952|P1|Overall Study|Withdrawal by Subject|0
7861022|NCT00067002|27261989|P2|Overall Study|Graft Failure|6
7861023|NCT00067002|27261990|P1|Overall Study|Graft Failure|5
7861024|NCT00067002|27261989|P2|Overall Study|Delayed|1
7861025|NCT00067002|27261990|P1|Overall Study|Delayed|1
7861026|NCT00067002|27261989|P2|Overall Study|Early Death|2
7861027|NCT00067002|27261990|P1|Overall Study|Early Death|1
7861028|NCT00066807|27262048|P2|Overall Study|Study was terminated early|15
7861029|NCT00066807|27262049|P1|Overall Study|Study was terminated early|14
7861030|NCT00066742|27262074|P1|Consolidation Chemotherapy|Ineligible|2
7861031|NCT00066742|27262074|P1|Consolidation Chemotherapy|not protocol specified|1
7861032|NCT00066742|27262074|P1|Induction Chemoradiotherapy|Ineligible|3
7861033|NCT00066742|27262074|P1|Induction Chemoradiotherapy|not protocol specified|2
7861034|NCT00066742|27262074|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
7861035|NCT00066742|27262074|P1|Induction Chemoradiotherapy|Adverse Event|21
7861036|NCT00066742|27262074|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
7861037|NCT00066729|27262081|P1|Overall Study|Disease progression|1
7861038|NCT00066729|27262081|P1|Overall Study|Lost to Follow-up|1
7861039|NCT00066703|27262092|P2|Overall Study|Treatment ongoing|311
7861040|NCT00066703|27262093|P1|Overall Study|Treatment ongoing|346
7861041|NCT00066703|27262092|P2|Overall Study|Withdrawal by Subject|63
7861042|NCT00066703|27262093|P1|Overall Study|Withdrawal by Subject|38
7861043|NCT00066703|27262092|P2|Overall Study|Lost to Follow-up|28
7861044|NCT00066703|27262093|P1|Overall Study|Lost to Follow-up|31
7861045|NCT00066703|27262092|P2|Overall Study|Lack of Efficacy|69
7861046|NCT00066703|27262093|P1|Overall Study|Lack of Efficacy|114
7861047|NCT00066703|27262092|P2|Overall Study|Death|0
7861048|NCT00066703|27262093|P1|Overall Study|Death|3
7861049|NCT00066703|27262092|P2|Overall Study|Adverse Event|111
7861050|NCT00066703|27262093|P1|Overall Study|Adverse Event|80
7861051|NCT00066690|27262108|P3|Overall Study|Treatment Ongoing|282
7861052|NCT00066690|27262109|P2|Overall Study|Treatment Ongoing|278
7861053|NCT00066690|27262110|P1|Overall Study|Treatment Ongoing|246
7861054|NCT00066690|27262108|P3|Overall Study|Withdrawal by Subject|49
7861055|NCT00066690|27262109|P2|Overall Study|Withdrawal by Subject|55
7861056|NCT00066690|27262110|P1|Overall Study|Withdrawal by Subject|50
7861057|NCT00066690|27262108|P3|Overall Study|Lost to Follow-up|29
7861058|NCT00066690|27262109|P2|Overall Study|Lost to Follow-up|21
7861059|NCT00066690|27262110|P1|Overall Study|Lost to Follow-up|40
7861060|NCT00066690|27262108|P3|Overall Study|Lack of Efficacy|76
7861061|NCT00066690|27262109|P2|Overall Study|Lack of Efficacy|110
7861062|NCT00066690|27262110|P1|Overall Study|Lack of Efficacy|114
7861063|NCT00066690|27262108|P3|Overall Study|Death|2
7861064|NCT00066690|27262109|P2|Overall Study|Death|0
7861065|NCT00066690|27262110|P1|Overall Study|Death|3
7861066|NCT00066690|27262108|P3|Overall Study|Adverse Event|126
7861067|NCT00066690|27262109|P2|Overall Study|Adverse Event|58
7861068|NCT00066690|27262110|P1|Overall Study|Adverse Event|145
7861069|NCT00066573|27262144|P2|Overall Study|Did not received protocol treatment|28
7861070|NCT00066573|27262145|P1|Overall Study|Did not received protocol treatment|28
7861071|NCT00066469|27262157|P1|Overall Study|ineligible|1
7861072|NCT00066469|27262157|P1|Overall Study|Withdrawal by Subject|1
7861073|NCT00066469|27262157|P1|Overall Study|Physician Decision|1
7861074|NCT00066469|27262157|P1|Overall Study|Lost to Follow-up|1
7861075|NCT00066469|27262157|P1|Overall Study|Lack of Efficacy|9
7861076|NCT00066469|27262157|P1|Overall Study|Death|3
7861077|NCT00066365|27262163|P2|Overall Study|Ineligible|2
7861078|NCT00066365|27262164|P1|Overall Study|Ineligible|4
7861079|NCT00066365|27262163|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
7861080|NCT00066365|27262164|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
7861081|NCT00066365|27262163|P2|Overall Study|Physician Decision|0
7861082|NCT00066365|27262164|P1|Overall Study|Physician Decision|1
7861083|NCT00066365|27262163|P2|Overall Study|Lack of Efficacy|12
7861084|NCT00066365|27262164|P1|Overall Study|Lack of Efficacy|15
7861085|NCT00066365|27262163|P2|Overall Study|Adverse Event|0
7861086|NCT00066365|27262164|P1|Overall Study|Adverse Event|1
7861087|NCT00066222|27262192|P1|Overall Study|No protocol treatment received|1
7861088|NCT00066170|27262205|P4|Overall Study|Other|0
7861089|NCT00066170|27262206|P3|Overall Study|Other|2
7861090|NCT00066170|27262207|P2|Overall Study|Other|5
7861091|NCT00066170|27262208|P1|Overall Study|Other|1
7861092|NCT00066170|27262205|P4|Overall Study|Protocol Violation|0
7861093|NCT00066170|27262206|P3|Overall Study|Protocol Violation|0
7861094|NCT00066170|27262207|P2|Overall Study|Protocol Violation|0
7861095|NCT00066170|27262208|P1|Overall Study|Protocol Violation|3
7861096|NCT00066170|27262205|P4|Overall Study|Non-Compliance with Trial Medicine|1
7861097|NCT00066170|27262206|P3|Overall Study|Non-Compliance with Trial Medicine|0
7861098|NCT00066170|27262207|P2|Overall Study|Non-Compliance with Trial Medicine|0
7861099|NCT00066170|27262208|P1|Overall Study|Non-Compliance with Trial Medicine|1
7861100|NCT00066170|27262205|P4|Overall Study|Lost to Follow-up|0
7861101|NCT00066170|27262206|P3|Overall Study|Lost to Follow-up|0
7861102|NCT00066170|27262207|P2|Overall Study|Lost to Follow-up|1
7861103|NCT00066170|27262208|P1|Overall Study|Lost to Follow-up|0
7861104|NCT00066170|27262205|P4|Overall Study|Serious Adverse Event|1
7861105|NCT00066170|27262206|P3|Overall Study|Serious Adverse Event|1
7861106|NCT00066170|27262207|P2|Overall Study|Serious Adverse Event|0
7861107|NCT00066170|27262208|P1|Overall Study|Serious Adverse Event|0
7861108|NCT00066170|27262205|P4|Overall Study|Adverse Event|7
7861109|NCT00066170|27262206|P3|Overall Study|Adverse Event|1
7861110|NCT00066170|27262207|P2|Overall Study|Adverse Event|4
7861111|NCT00066170|27262208|P1|Overall Study|Adverse Event|2
7861112|NCT00066066|27262221|P6|Overall Study|Lost to Follow-up|5
7861113|NCT00066066|27262222|P5|Overall Study|Lost to Follow-up|3
7861114|NCT00066066|27262223|P4|Overall Study|Lost to Follow-up|4
7861115|NCT00066066|27262224|P3|Overall Study|Lost to Follow-up|7
7861116|NCT00066066|27262225|P2|Overall Study|Lost to Follow-up|4
7861117|NCT00066066|27262226|P1|Overall Study|Lost to Follow-up|6
7861118|NCT00065507|27262304|P2|Overall Study|Subject No Longer Meets Study Criteria|0
7861119|NCT00065507|27262305|P1|Overall Study|Subject No Longer Meets Study Criteria|1
7861120|NCT00065507|27262304|P2|Overall Study|Subject Withdrew Consent|1
7861121|NCT00065507|27262305|P1|Overall Study|Subject Withdrew Consent|2
7861122|NCT00065507|27262304|P2|Overall Study|Lost to Follow-up|0
7861123|NCT00065507|27262305|P1|Overall Study|Lost to Follow-up|3
7861124|NCT00065507|27262304|P2|Overall Study|Poor/Non-compliance|2
7861125|NCT00065507|27262305|P1|Overall Study|Poor/Non-compliance|3
7861126|NCT00065507|27262304|P2|Overall Study|Lack of Efficacy|6
7861127|NCT00065507|27262305|P1|Overall Study|Lack of Efficacy|0
7861128|NCT00065507|27262304|P2|Overall Study|Adverse Event|3
7861129|NCT00065507|27262305|P1|Overall Study|Adverse Event|4
7861130|NCT00065507|27262304|P2|Overall Study|Death|17
7861131|NCT00065507|27262305|P1|Overall Study|Death|16
7861132|NCT00065468|27262370|P3|Overall Study|Other|18
7861133|NCT00065468|27262371|P2|Overall Study|Other|24
7861134|NCT00065468|27262372|P1|Overall Study|Other|14
7861135|NCT00065468|27262370|P3|Overall Study|Disease progression|1
7861136|NCT00065468|27262371|P2|Overall Study|Disease progression|0
7861137|NCT00065468|27262372|P1|Overall Study|Disease progression|0
7861138|NCT00065468|27262370|P3|Overall Study|Discontinuation of study by Sponsor|13
7861139|NCT00065468|27262371|P2|Overall Study|Discontinuation of study by Sponsor|9
7861140|NCT00065468|27262372|P1|Overall Study|Discontinuation of study by Sponsor|13
7861141|NCT00065468|27262370|P3|Overall Study|Lost to Follow-up|2
7861142|NCT00065468|27262371|P2|Overall Study|Lost to Follow-up|3
7861143|NCT00065468|27262372|P1|Overall Study|Lost to Follow-up|5
7861144|NCT00065468|27262370|P3|Overall Study|Withdrawal by Subject|5
7861145|NCT00065468|27262371|P2|Overall Study|Withdrawal by Subject|4
7861146|NCT00065468|27262372|P1|Overall Study|Withdrawal by Subject|3
7861147|NCT00065468|27262370|P3|Overall Study|Death|171
7861148|NCT00065468|27262371|P2|Overall Study|Death|169
7861149|NCT00065468|27262372|P1|Overall Study|Death|172
7861150|NCT00065442|27262403|P2|Overall Study|Withdrawal by Subject|9
7861151|NCT00065442|27262404|P1|Overall Study|Withdrawal by Subject|3
7861152|NCT00065442|27262403|P2|Overall Study|Death|210
7861153|NCT00065442|27262404|P1|Overall Study|Death|121
7861154|NCT00065442|27262403|P2|Overall Study|Lost to Follow-up|1
7861155|NCT00065442|27262404|P1|Overall Study|Lost to Follow-up|1
7861156|NCT00065429|27262419|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7861157|NCT00065429|27262420|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7861158|NCT00065429|27262421|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
7861159|NCT00065429|27262422|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7861160|NCT00065429|27262423|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7861161|NCT00065429|27262424|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7861162|NCT00065429|27262425|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7861163|NCT00065429|27262419|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7861164|NCT00065429|27262420|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7861165|NCT00065429|27262421|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
7861166|NCT00065429|27262422|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7861167|NCT00065429|27262423|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7861168|NCT00065429|27262424|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7861169|NCT00065429|27262425|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7861170|NCT00065429|27262419|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
7861171|NCT00065429|27262420|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
7861172|NCT00065429|27262421|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
7861173|NCT00065429|27262422|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
7861174|NCT00065429|27262423|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
7861175|NCT00065429|27262424|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
7861176|NCT00065429|27262425|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
7861177|NCT00065429|27262419|P7|Phase I - May 2001 - Oct 2002|Death|0
7861178|NCT00065429|27262420|P6|Phase I - May 2001 - Oct 2002|Death|0
7861179|NCT00065429|27262421|P5|Phase I - May 2001 - Oct 2002|Death|1
7861180|NCT00065429|27262422|P4|Phase I - May 2001 - Oct 2002|Death|0
7861181|NCT00065429|27262423|P3|Phase I - May 2001 - Oct 2002|Death|0
7861182|NCT00065429|27262424|P2|Phase I - May 2001 - Oct 2002|Death|0
7861183|NCT00065429|27262425|P1|Phase I - May 2001 - Oct 2002|Death|0
7861184|NCT00065429|27262419|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
7861185|NCT00065429|27262420|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
7861186|NCT00065429|27262421|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
7861187|NCT00065429|27262422|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
7861188|NCT00065429|27262423|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
7861189|NCT00065429|27262424|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
7861190|NCT00065429|27262425|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
7861191|NCT00065429|27262419|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7861192|NCT00065429|27262420|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7861193|NCT00065429|27262421|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7861194|NCT00065429|27262422|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7861195|NCT00065429|27262423|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
7861196|NCT00065429|27262424|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7861197|NCT00065429|27262425|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7861198|NCT00065429|27262419|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7861199|NCT00065429|27262420|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
7861200|NCT00065429|27262421|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7861201|NCT00065429|27262422|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7861202|NCT00065429|27262423|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7861203|NCT00065429|27262424|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7861204|NCT00065429|27262425|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7861205|NCT00065260|27262439|P2|Overall Study|Death|1
7861206|NCT00065260|27262440|P1|Overall Study|Death|0
7861207|NCT00065182|27262456|P2|Overall Study|Decline in Status|1
7861208|NCT00065182|27262457|P1|Overall Study|Decline in Status|0
7861209|NCT00065182|27262456|P2|Overall Study|Death|1
7861210|NCT00065182|27262457|P1|Overall Study|Death|0
7861211|NCT00065182|27262456|P2|Overall Study|No clinical benefit|0
7861212|NCT00065182|27262457|P1|Overall Study|No clinical benefit|1
7861213|NCT00065182|27262456|P2|Overall Study|Withdrawal by Subject|3
7861214|NCT00065182|27262457|P1|Overall Study|Withdrawal by Subject|8
7861215|NCT00065182|27262456|P2|Overall Study|Sponsor Decision|7
7861216|NCT00065182|27262457|P1|Overall Study|Sponsor Decision|11
7861217|NCT00065182|27262456|P2|Overall Study|Serious adverse events (SAE)|0
7861218|NCT00065182|27262457|P1|Overall Study|Serious adverse events (SAE)|1
7861219|NCT00065182|27262456|P2|Overall Study|Protocol Violation|4
7861220|NCT00065182|27262457|P1|Overall Study|Protocol Violation|3
7861221|NCT00065182|27262456|P2|Overall Study|Lost to Follow-up|4
7861222|NCT00065182|27262457|P1|Overall Study|Lost to Follow-up|0
7861223|NCT00065182|27262456|P2|Overall Study|Adverse Event|17
7861224|NCT00065182|27262457|P1|Overall Study|Adverse Event|24
7861225|NCT00065156|27262483|P1|Overall Study|Secondary Malign Disease|1
7861226|NCT00065156|27262483|P1|Overall Study|Loss of Response|1
7861227|NCT00065156|27262483|P1|Overall Study|Non-Compliance|2
7861228|NCT00065156|27262483|P1|Overall Study|Investigator Decision|2
7861229|NCT00065156|27262483|P1|Overall Study|Disease Progression|7
7861230|NCT00065156|27262483|P1|Overall Study|Study Closed by Sponsor|2
7861231|NCT00065156|27262483|P1|Overall Study|Death|11
7861232|NCT00065156|27262483|P1|Overall Study|Lost to Follow-up|1
7861233|NCT00065156|27262483|P1|Overall Study|Withdrawal by Subject|8
7861234|NCT00065156|27262483|P1|Overall Study|Lack of Efficacy|52
7861235|NCT00065156|27262483|P1|Overall Study|Adverse Event|37
7861236|NCT00065065|27262500|P2|Overall Study|Other|2
7861237|NCT00065065|27262501|P1|Overall Study|Other|2
7861238|NCT00065065|27262500|P2|Overall Study|Lack of Efficacy|11
7861239|NCT00065065|27262501|P1|Overall Study|Lack of Efficacy|4
7861240|NCT00065065|27262500|P2|Overall Study|Withdrawal by Subject|5
7861241|NCT00065065|27262501|P1|Overall Study|Withdrawal by Subject|1
7861242|NCT00065065|27262500|P2|Overall Study|Adverse Event|2
7861243|NCT00065065|27262501|P1|Overall Study|Adverse Event|3
7861244|NCT00003895|27262513|P2|Overall Study|Withdrawal by Subject|3
7861245|NCT00003895|27262514|P1|Overall Study|Withdrawal by Subject|0
7861246|NCT00003895|27262513|P2|Overall Study|Patient Vacation|0
7861247|NCT00003895|27262514|P1|Overall Study|Patient Vacation|2
7861248|NCT00003895|27262513|P2|Overall Study|Lack of Efficacy|1
7861249|NCT00003895|27262514|P1|Overall Study|Lack of Efficacy|1
7861250|NCT00003895|27262513|P2|Overall Study|Adverse Event|0
7861251|NCT00003895|27262514|P1|Overall Study|Adverse Event|4
7861252|NCT00064987|27262522|P2|Overall Study|Physician Decision|0
7861253|NCT00064987|27262523|P1|Overall Study|Physician Decision|3
7861254|NCT00064753|27262554|P2|Overall Study|Lost to Follow-up|235
7861255|NCT00064753|27262555|P1|Overall Study|Lost to Follow-up|225
7861256|NCT00064753|27262554|P2|Overall Study|Withdrawal by Subject|171
7861257|NCT00064753|27262555|P1|Overall Study|Withdrawal by Subject|198
7861258|NCT00064753|27262554|P2|Overall Study|Death|242
7861259|NCT00064753|27262555|P1|Overall Study|Death|251
7861260|NCT00003645|27262585|P2|Overall Study|Withdrawal by Subject|3
7861261|NCT00003645|27262586|P1|Overall Study|Withdrawal by Subject|1
7861262|NCT00003645|27262585|P2|Overall Study|Lost to Follow-up|8
7861263|NCT00003645|27262586|P1|Overall Study|Lost to Follow-up|7
7861264|NCT00003645|27262585|P2|Overall Study|Death|1
7861265|NCT00003645|27262586|P1|Overall Study|Death|4
7861266|NCT00064792|27262600|P2|Overall Study|Adverse Event|0
7861267|NCT00064792|27262601|P1|Overall Study|Adverse Event|3
7861268|NCT00064792|27262600|P2|Overall Study|Withdrawal by Subject|0
7861269|NCT00064792|27262601|P1|Overall Study|Withdrawal by Subject|2
7861270|NCT00064701|27262612|P3|Clinical Continuation Phase|Patient opted out|1
7861271|NCT00064701|27262613|P2|Clinical Continuation Phase|Patient opted out|0
7861272|NCT00064701|27262614|P1|Clinical Continuation Phase|Patient opted out|0
7861273|NCT00064701|27262612|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
7861274|NCT00064701|27262613|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
7861275|NCT00064701|27262614|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
7861276|NCT00064701|27262612|P3|Clinical Continuation Phase|Discharged to nursing home|0
7861277|NCT00064701|27262613|P2|Clinical Continuation Phase|Discharged to nursing home|1
7861278|NCT00064701|27262614|P1|Clinical Continuation Phase|Discharged to nursing home|0
7861279|NCT00064701|27262612|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7861280|NCT00064701|27262613|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
7861281|NCT00064701|27262614|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7861282|NCT00064701|27262612|P3|Clinical Continuation Phase|Pancreas transplant|0
7861283|NCT00064701|27262613|P2|Clinical Continuation Phase|Pancreas transplant|0
7861284|NCT00064701|27262614|P1|Clinical Continuation Phase|Pancreas transplant|1
7861285|NCT00064701|27262612|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
7861286|NCT00064701|27262613|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
7861287|NCT00064701|27262614|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
7861288|NCT00064701|27262612|P3|Clinical Continuation Phase|Physician Decision|0
7861289|NCT00064701|27262613|P2|Clinical Continuation Phase|Physician Decision|3
7861290|NCT00064701|27262614|P1|Clinical Continuation Phase|Physician Decision|1
7861291|NCT00064701|27262612|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
7861292|NCT00064701|27262613|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
7861293|NCT00064701|27262614|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
7861294|NCT00064701|27262612|P3|Clinical Continuation Phase|Sponsor discontinued study|79
7861295|NCT00064701|27262613|P2|Clinical Continuation Phase|Sponsor discontinued study|129
7861296|NCT00064701|27262614|P1|Clinical Continuation Phase|Sponsor discontinued study|113
7861297|NCT00064701|27262612|P3|Clinical Continuation Phase|Rejection|2
7861298|NCT00064701|27262613|P2|Clinical Continuation Phase|Rejection|2
7861299|NCT00064701|27262614|P1|Clinical Continuation Phase|Rejection|1
7861300|NCT00064701|27262612|P3|Clinical Continuation Phase|Graft Failure|2
7861301|NCT00064701|27262613|P2|Clinical Continuation Phase|Graft Failure|5
7861302|NCT00064701|27262614|P1|Clinical Continuation Phase|Graft Failure|5
7861303|NCT00064701|27262612|P3|Clinical Continuation Phase|Lost to Follow-up|6
7861304|NCT00064701|27262613|P2|Clinical Continuation Phase|Lost to Follow-up|3
7861305|NCT00064701|27262614|P1|Clinical Continuation Phase|Lost to Follow-up|6
7861306|NCT00064701|27262612|P3|Clinical Continuation Phase|Withdrawal by Subject|22
7861307|NCT00064701|27262613|P2|Clinical Continuation Phase|Withdrawal by Subject|3
7861308|NCT00064701|27262614|P1|Clinical Continuation Phase|Withdrawal by Subject|22
7861309|NCT00064701|27262612|P3|Clinical Continuation Phase|Non-compliance|7
7861310|NCT00064701|27262613|P2|Clinical Continuation Phase|Non-compliance|6
7861311|NCT00064701|27262614|P1|Clinical Continuation Phase|Non-compliance|8
7861312|NCT00064701|27262612|P3|Clinical Continuation Phase|Adverse Event|14
7861313|NCT00064701|27262613|P2|Clinical Continuation Phase|Adverse Event|21
7861314|NCT00064701|27262614|P1|Clinical Continuation Phase|Adverse Event|12
7861315|NCT00064701|27262612|P3|One Year Post-transplant|Pancreas transplant|1
7861316|NCT00064701|27262613|P2|One Year Post-transplant|Pancreas transplant|0
7861317|NCT00064701|27262614|P1|One Year Post-transplant|Pancreas transplant|0
7861318|NCT00064701|27262612|P3|One Year Post-transplant|Poor absorption|0
7861319|NCT00064701|27262613|P2|One Year Post-transplant|Poor absorption|1
7861320|NCT00064701|27262614|P1|One Year Post-transplant|Poor absorption|0
7861321|NCT00064701|27262612|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
7861322|NCT00064701|27262613|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
7861323|NCT00064701|27262614|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
7861324|NCT00064701|27262612|P3|One Year Post-transplant|Incorrect study drug dispensed|0
7861325|NCT00064701|27262613|P2|One Year Post-transplant|Incorrect study drug dispensed|1
7861326|NCT00064701|27262614|P1|One Year Post-transplant|Incorrect study drug dispensed|0
7861327|NCT00064701|27262612|P3|One Year Post-transplant|Acute tubular necrosis|0
7861328|NCT00064701|27262613|P2|One Year Post-transplant|Acute tubular necrosis|0
7861329|NCT00064701|27262614|P1|One Year Post-transplant|Acute tubular necrosis|1
7861330|NCT00064701|27262612|P3|One Year Post-transplant|Converted to rapamycin|0
7861331|NCT00064701|27262613|P2|One Year Post-transplant|Converted to rapamycin|0
7861332|NCT00064701|27262614|P1|One Year Post-transplant|Converted to rapamycin|1
7861333|NCT00064701|27262612|P3|One Year Post-transplant|Lost to Follow-up|0
7861334|NCT00064701|27262613|P2|One Year Post-transplant|Lost to Follow-up|0
7861335|NCT00064701|27262614|P1|One Year Post-transplant|Lost to Follow-up|1
7861336|NCT00064701|27262612|P3|One Year Post-transplant|Withdrawal by Subject|1
7861337|NCT00064701|27262613|P2|One Year Post-transplant|Withdrawal by Subject|4
7861338|NCT00064701|27262614|P1|One Year Post-transplant|Withdrawal by Subject|0
7861339|NCT00064701|27262612|P3|One Year Post-transplant|Graft Failure|1
7861340|NCT00064701|27262613|P2|One Year Post-transplant|Graft Failure|2
7861341|NCT00064701|27262614|P1|One Year Post-transplant|Graft Failure|3
7861342|NCT00064701|27262612|P3|One Year Post-transplant|Non-compliance|5
7861343|NCT00064701|27262613|P2|One Year Post-transplant|Non-compliance|2
7861344|NCT00064701|27262614|P1|One Year Post-transplant|Non-compliance|4
7861345|NCT00064701|27262612|P3|One Year Post-transplant|Rejection|16
7861346|NCT00064701|27262613|P2|One Year Post-transplant|Rejection|1
7861347|NCT00064701|27262614|P1|One Year Post-transplant|Rejection|0
7861348|NCT00064701|27262612|P3|One Year Post-transplant|Adverse Event|37
7861349|NCT00064701|27262613|P2|One Year Post-transplant|Adverse Event|19
7861350|NCT00064701|27262614|P1|One Year Post-transplant|Adverse Event|23
7861351|NCT00064701|27262612|P3|One Year Post-transplant|Did not receive study drug|11
7861352|NCT00064701|27262613|P2|One Year Post-transplant|Did not receive study drug|12
7861353|NCT00064701|27262614|P1|One Year Post-transplant|Did not receive study drug|7
7861354|NCT00064662|27262666|P2|Overall Study|Administratively withdrawn|2
7861355|NCT00064662|27262667|P1|Overall Study|Administratively withdrawn|2
7861356|NCT00064662|27262666|P2|Overall Study|Withdrawal by Subject|14
7861357|NCT00064662|27262667|P1|Overall Study|Withdrawal by Subject|14
7861358|NCT00064662|27262666|P2|Overall Study|Lost to Follow-up|44
7861359|NCT00064662|27262667|P1|Overall Study|Lost to Follow-up|57
7861360|NCT00064662|27262666|P2|Overall Study|Death|1
7861361|NCT00064662|27262667|P1|Overall Study|Death|1
7861362|NCT00064350|27262678|P3|Cross-Over|Other|0
7861363|NCT00064350|27262679|P2|Cross-Over|Other|2
7861364|NCT00064350|27262680|P1|Cross-Over|Other|0
7861365|NCT00064350|27262678|P3|Cross-Over|Ineligible or never started treatment|0
7861366|NCT00064350|27262679|P2|Cross-Over|Ineligible or never started treatment|6
7861367|NCT00064350|27262680|P1|Cross-Over|Ineligible or never started treatment|3
7861368|NCT00064350|27262678|P3|Cross-Over|Withdrawal by Subject|0
7861369|NCT00064350|27262679|P2|Cross-Over|Withdrawal by Subject|2
7861370|NCT00064350|27262680|P1|Cross-Over|Withdrawal by Subject|2
7861371|NCT00064350|27262678|P3|Cross-Over|Death|0
7861372|NCT00064350|27262679|P2|Cross-Over|Death|3
7861373|NCT00064350|27262680|P1|Cross-Over|Death|1
7861374|NCT00064350|27262678|P3|Cross-Over|Adverse Event|0
7861375|NCT00064350|27262679|P2|Cross-Over|Adverse Event|1
7861376|NCT00064350|27262680|P1|Cross-Over|Adverse Event|0
7861377|NCT00064350|27262678|P3|Randomization|Other|0
7861378|NCT00064350|27262679|P2|Randomization|Other|0
7861379|NCT00064350|27262680|P1|Randomization|Other|5
7861380|NCT00064350|27262678|P3|Randomization|Ineligible or never started treatment|0
7861381|NCT00064350|27262679|P2|Randomization|Ineligible or never started treatment|15
7861382|NCT00064350|27262680|P1|Randomization|Ineligible or never started treatment|9
7861383|NCT00064350|27262678|P3|Randomization|Withdrawal by Subject|0
7861384|NCT00064350|27262679|P2|Randomization|Withdrawal by Subject|0
7861385|NCT00064350|27262680|P1|Randomization|Withdrawal by Subject|1
7861386|NCT00064350|27262678|P3|Randomization|Death|0
7861387|NCT00064350|27262679|P2|Randomization|Death|0
7861388|NCT00064350|27262680|P1|Randomization|Death|3
7861389|NCT00064350|27262678|P3|Randomization|Adverse Event|0
7861390|NCT00064350|27262679|P2|Randomization|Adverse Event|3
7861391|NCT00064350|27262680|P1|Randomization|Adverse Event|8
7861392|NCT00064350|27262678|P3|Induction Treatment|Other|13
7861393|NCT00064350|27262679|P2|Induction Treatment|Other|0
7861394|NCT00064350|27262680|P1|Induction Treatment|Other|0
7861395|NCT00064350|27262678|P3|Induction Treatment|Ineligible or never started treatment|34
7861396|NCT00064350|27262679|P2|Induction Treatment|Ineligible or never started treatment|6
7861397|NCT00064350|27262680|P1|Induction Treatment|Ineligible or never started treatment|3
7861398|NCT00064350|27262678|P3|Induction Treatment|Withdrawal by Subject|21
7861399|NCT00064350|27262679|P2|Induction Treatment|Withdrawal by Subject|0
7861400|NCT00064350|27262680|P1|Induction Treatment|Withdrawal by Subject|0
7861401|NCT00064350|27262678|P3|Induction Treatment|Death|9
7861402|NCT00064350|27262679|P2|Induction Treatment|Death|0
7861403|NCT00064350|27262680|P1|Induction Treatment|Death|0
7861404|NCT00064350|27262678|P3|Induction Treatment|Adverse Event|49
7861405|NCT00064350|27262679|P2|Induction Treatment|Adverse Event|2
7861406|NCT00064350|27262680|P1|Induction Treatment|Adverse Event|0
7861407|NCT00064350|27262678|P3|Induction Treatment|Disease Progression|110
7861408|NCT00064350|27262679|P2|Induction Treatment|Disease Progression|1
7861409|NCT00064350|27262680|P1|Induction Treatment|Disease Progression|5
7861410|NCT00064337|27262695|P1|Maintenance|Death|1
7861411|NCT00064337|27262695|P1|Maintenance|Not protocol-specified|2
7861412|NCT00064337|27262695|P1|Maintenance|On treatment at time of analysis|2
7861413|NCT00064337|27262695|P1|Maintenance|Progression|2
7861414|NCT00064337|27262695|P1|Maintenance|Adverse Event|3
7861415|NCT00064337|27262695|P1|Transplant|Progression|2
7861416|NCT00064337|27262695|P1|Transplant|Patient Refusal|2
7861417|NCT00064337|27262695|P1|Transplant|Death|3
7861418|NCT00064337|27262695|P1|Transplant|Not protocol-specified|5
7861419|NCT00064337|27262695|P1|Transplant|Adverse Event|9
7861420|NCT00064337|27262695|P1|PBSCC or Induction/PBSCC|Death|2
7861421|NCT00064337|27262695|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
7861422|NCT00064337|27262695|P1|PBSCC or Induction/PBSCC|Progression|3
7861423|NCT00064337|27262695|P1|PBSCC or Induction/PBSCC|Adverse Event|6
7861424|NCT00064337|27262695|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
7861425|NCT00064298|27262704|P2|Overall Study|Disease Progression|1
7861426|NCT00064298|27262705|P1|Overall Study|Disease Progression|2
7861427|NCT00064298|27262704|P2|Overall Study|Death|1
7861428|NCT00064298|27262705|P1|Overall Study|Death|0
7861429|NCT00064298|27262704|P2|Overall Study|Lost to Follow-up|2
7861430|NCT00064298|27262705|P1|Overall Study|Lost to Follow-up|2
7861431|NCT00064298|27262704|P2|Overall Study|Withdrawal by Subject|1
7861432|NCT00064298|27262705|P1|Overall Study|Withdrawal by Subject|2
7861433|NCT00064259|27262713|P4|Overall Study|Adverse Event|1
7861434|NCT00064259|27262714|P3|Overall Study|Adverse Event|0
7861435|NCT00064259|27262715|P2|Overall Study|Adverse Event|0
7861436|NCT00064259|27262716|P1|Overall Study|Adverse Event|1
7861437|NCT00064077|27262725|P4|Overall Study|Other reasons|2
7861438|NCT00064077|27262726|P3|Overall Study|Other reasons|1
7861439|NCT00064077|27262727|P2|Overall Study|Other reasons|2
7861440|NCT00064077|27262728|P1|Overall Study|Other reasons|2
7861441|NCT00064077|27262725|P4|Overall Study|No tumor|0
7861442|NCT00064077|27262726|P3|Overall Study|No tumor|1
7861443|NCT00064077|27262727|P2|Overall Study|No tumor|0
7861444|NCT00064077|27262728|P1|Overall Study|No tumor|0
7861445|NCT00064077|27262725|P4|Overall Study|No surgery|0
7861446|NCT00064077|27262726|P3|Overall Study|No surgery|1
7861447|NCT00064077|27262727|P2|Overall Study|No surgery|0
7861448|NCT00064077|27262728|P1|Overall Study|No surgery|0
7861449|NCT00064077|27262725|P4|Overall Study|Pathology|4
7861450|NCT00064077|27262726|P3|Overall Study|Pathology|3
7861451|NCT00064077|27262727|P2|Overall Study|Pathology|7
7861452|NCT00064077|27262728|P1|Overall Study|Pathology|10
7861453|NCT00064077|27262725|P4|Overall Study|Poor risk|1
7861454|NCT00064077|27262726|P3|Overall Study|Poor risk|1
7861455|NCT00064077|27262727|P2|Overall Study|Poor risk|0
7861456|NCT00064077|27262728|P1|Overall Study|Poor risk|2
7861457|NCT00064077|27262725|P4|Overall Study|Improper prior treatment|0
7861458|NCT00064077|27262726|P3|Overall Study|Improper prior treatment|0
7861459|NCT00064077|27262727|P2|Overall Study|Improper prior treatment|0
7861460|NCT00064077|27262728|P1|Overall Study|Improper prior treatment|1
7861461|NCT00064025|27262772|P1|Overall Study|Inevaluable|3
7861462|NCT00064025|27262772|P1|Overall Study|Ineligible|4
7861467|NCT00063986|27262798|P1|Overall Study|Intra-operatively ineligible|4
7861468|NCT00063986|27262798|P1|Overall Study|Ineligible|1
7861469|NCT00063986|27262798|P1|Overall Study|Withdrawal by Subject|1
7861470|NCT00063934|27262810|P1|Overall Study|Ineligible|1
7861471|NCT00063882|27262819|P2|Overall Study|Withdrawal by Subject|1
7861472|NCT00063882|27262820|P1|Overall Study|Withdrawal by Subject|2
7861473|NCT00063882|27262819|P2|Overall Study|Protocol Violation|3
7861474|NCT00063882|27262820|P1|Overall Study|Protocol Violation|3
7861475|NCT00063258|27262947|P2|Overall Study|Lack of Efficacy|0
7861476|NCT00063258|27262948|P1|Overall Study|Lack of Efficacy|2
7861477|NCT00063258|27262947|P2|Overall Study|Physician Decision|0
7861478|NCT00063258|27262948|P1|Overall Study|Physician Decision|2
7861479|NCT00063154|27262954|P1|Overall Study|Did not receive treatment|8
7861480|NCT00063154|27262954|P1|Overall Study|Reason unspecified|1
7861481|NCT00063154|27262954|P1|Overall Study|Death|3
7861482|NCT00063154|27262954|P1|Overall Study|Physician Decision|10
7861483|NCT00063154|27262954|P1|Overall Study|Adverse Event|2
7861484|NCT00063154|27262954|P1|Overall Study|Disease progression|27
7861485|NCT00062868|27262988|P21|Dose Level 3|Withdrew|0
7861486|NCT00062868|27262989|P20|Dose Level 3|Withdrew|0
7861487|NCT00062868|27262990|P19|Dose Level 3|Withdrew|0
7861488|NCT00062868|27262991|P18|Dose Level 3|Withdrew|0
7861489|NCT00062868|27262992|P17|Dose Level 3|Withdrew|0
7861490|NCT00062868|27262993|P16|Dose Level 3|Withdrew|0
7861491|NCT00062868|27262994|P15|Dose Level 3|Withdrew|0
7861492|NCT00062868|27262995|P14|Dose Level 3|Withdrew|0
7861493|NCT00062868|27262996|P13|Dose Level 3|Withdrew|0
7861494|NCT00062868|27262997|P12|Dose Level 3|Withdrew|0
7861495|NCT00062868|27262998|P11|Dose Level 3|Withdrew|0
7861496|NCT00062868|27262999|P10|Dose Level 3|Withdrew|0
7861497|NCT00062868|27263000|P9|Dose Level 3|Withdrew|0
7861498|NCT00062868|27263001|P8|Dose Level 3|Withdrew|0
7861499|NCT00062868|27263002|P7|Dose Level 3|Withdrew|0
7861500|NCT00062868|27263003|P6|Dose Level 3|Withdrew|0
7861501|NCT00062868|27263004|P5|Dose Level 3|Withdrew|0
7861502|NCT00062868|27263005|P4|Dose Level 3|Withdrew|0
7861503|NCT00062868|27263006|P3|Dose Level 3|Withdrew|2
7861504|NCT00062868|27263007|P2|Dose Level 3|Withdrew|0
7861505|NCT00062868|27263008|P1|Dose Level 3|Withdrew|0
7861506|NCT00062868|27262988|P21|Dose Level 3|Lost to Follow-up|0
7861507|NCT00062868|27262989|P20|Dose Level 3|Lost to Follow-up|0
7861508|NCT00062868|27262990|P19|Dose Level 3|Lost to Follow-up|0
7861509|NCT00062868|27262991|P18|Dose Level 3|Lost to Follow-up|0
7861510|NCT00062868|27262992|P17|Dose Level 3|Lost to Follow-up|0
7861511|NCT00062868|27262993|P16|Dose Level 3|Lost to Follow-up|0
7861512|NCT00062868|27262994|P15|Dose Level 3|Lost to Follow-up|1
7861513|NCT00062868|27262995|P14|Dose Level 3|Lost to Follow-up|0
7861514|NCT00062868|27262996|P13|Dose Level 3|Lost to Follow-up|0
7861515|NCT00062868|27262997|P12|Dose Level 3|Lost to Follow-up|0
7861516|NCT00062868|27262998|P11|Dose Level 3|Lost to Follow-up|0
7861517|NCT00062868|27262999|P10|Dose Level 3|Lost to Follow-up|0
7861518|NCT00062868|27263000|P9|Dose Level 3|Lost to Follow-up|0
7861519|NCT00062868|27263001|P8|Dose Level 3|Lost to Follow-up|0
7861520|NCT00062868|27263002|P7|Dose Level 3|Lost to Follow-up|0
7861521|NCT00062868|27263003|P6|Dose Level 3|Lost to Follow-up|0
7861522|NCT00062868|27263004|P5|Dose Level 3|Lost to Follow-up|0
7861523|NCT00062868|27263005|P4|Dose Level 3|Lost to Follow-up|0
7861524|NCT00062868|27263006|P3|Dose Level 3|Lost to Follow-up|0
7861525|NCT00062868|27263007|P2|Dose Level 3|Lost to Follow-up|0
7861526|NCT00062868|27263008|P1|Dose Level 3|Lost to Follow-up|0
7861527|NCT00062868|27262988|P21|Dose Level 3|Death|0
7861528|NCT00062868|27262989|P20|Dose Level 3|Death|0
7861529|NCT00062868|27262990|P19|Dose Level 3|Death|0
7861530|NCT00062868|27262991|P18|Dose Level 3|Death|1
7861531|NCT00062868|27262992|P17|Dose Level 3|Death|0
7861532|NCT00062868|27262993|P16|Dose Level 3|Death|0
7861533|NCT00062868|27262994|P15|Dose Level 3|Death|0
7861534|NCT00062868|27262995|P14|Dose Level 3|Death|0
7861535|NCT00062868|27262996|P13|Dose Level 3|Death|0
7861536|NCT00062868|27262997|P12|Dose Level 3|Death|1
7861537|NCT00062868|27262998|P11|Dose Level 3|Death|0
7861538|NCT00062868|27262999|P10|Dose Level 3|Death|0
7861539|NCT00062868|27263000|P9|Dose Level 3|Death|0
7861540|NCT00062868|27263001|P8|Dose Level 3|Death|0
7861541|NCT00062868|27263002|P7|Dose Level 3|Death|0
7861542|NCT00062868|27263003|P6|Dose Level 3|Death|0
7861543|NCT00062868|27263004|P5|Dose Level 3|Death|0
7861544|NCT00062868|27263005|P4|Dose Level 3|Death|0
7861545|NCT00062868|27263006|P3|Dose Level 3|Death|0
7861546|NCT00062868|27263007|P2|Dose Level 3|Death|0
7861547|NCT00062868|27263008|P1|Dose Level 3|Death|0
7861548|NCT00062868|27262988|P21|Dose Level 2|Lost to Follow-up|0
7861549|NCT00062868|27262989|P20|Dose Level 2|Lost to Follow-up|0
7861550|NCT00062868|27262990|P19|Dose Level 2|Lost to Follow-up|0
7861551|NCT00062868|27262991|P18|Dose Level 2|Lost to Follow-up|0
7861552|NCT00062868|27262992|P17|Dose Level 2|Lost to Follow-up|1
7861553|NCT00062868|27262993|P16|Dose Level 2|Lost to Follow-up|0
7861554|NCT00062868|27262994|P15|Dose Level 2|Lost to Follow-up|0
7861555|NCT00062868|27262995|P14|Dose Level 2|Lost to Follow-up|1
7861556|NCT00062868|27262996|P13|Dose Level 2|Lost to Follow-up|0
7861557|NCT00062868|27262997|P12|Dose Level 2|Lost to Follow-up|0
7861558|NCT00062868|27262998|P11|Dose Level 2|Lost to Follow-up|0
7861559|NCT00062868|27262999|P10|Dose Level 2|Lost to Follow-up|0
7861560|NCT00062868|27263000|P9|Dose Level 2|Lost to Follow-up|0
7861561|NCT00062868|27263001|P8|Dose Level 2|Lost to Follow-up|0
7861562|NCT00062868|27263002|P7|Dose Level 2|Lost to Follow-up|0
7861563|NCT00062868|27263003|P6|Dose Level 2|Lost to Follow-up|0
7861564|NCT00062868|27263004|P5|Dose Level 2|Lost to Follow-up|0
7861565|NCT00062868|27263005|P4|Dose Level 2|Lost to Follow-up|0
7861566|NCT00062868|27263006|P3|Dose Level 2|Lost to Follow-up|0
7861567|NCT00062868|27263007|P2|Dose Level 2|Lost to Follow-up|0
7861568|NCT00062868|27263008|P1|Dose Level 2|Lost to Follow-up|0
7861569|NCT00062868|27262988|P21|Dose Level 2|Death|0
7861570|NCT00062868|27262989|P20|Dose Level 2|Death|0
7861571|NCT00062868|27262990|P19|Dose Level 2|Death|0
7861572|NCT00062868|27262991|P18|Dose Level 2|Death|0
7861573|NCT00062868|27262992|P17|Dose Level 2|Death|2
7861574|NCT00062868|27262993|P16|Dose Level 2|Death|0
7861575|NCT00062868|27262994|P15|Dose Level 2|Death|0
7861576|NCT00062868|27262995|P14|Dose Level 2|Death|0
7861577|NCT00062868|27262996|P13|Dose Level 2|Death|0
7861578|NCT00062868|27262997|P12|Dose Level 2|Death|0
7861579|NCT00062868|27262998|P11|Dose Level 2|Death|1
7861580|NCT00062868|27262999|P10|Dose Level 2|Death|0
7861581|NCT00062868|27263000|P9|Dose Level 2|Death|0
7861582|NCT00062868|27263001|P8|Dose Level 2|Death|0
7861583|NCT00062868|27263002|P7|Dose Level 2|Death|0
7861584|NCT00062868|27263003|P6|Dose Level 2|Death|0
7861585|NCT00062868|27263004|P5|Dose Level 2|Death|2
7861586|NCT00062868|27263005|P4|Dose Level 2|Death|0
7861587|NCT00062868|27263006|P3|Dose Level 2|Death|0
7861588|NCT00062868|27263007|P2|Dose Level 2|Death|3
7861589|NCT00062868|27263008|P1|Dose Level 2|Death|0
7861590|NCT00062868|27262988|P21|Dose Level 1|Lost to Follow-up|1
7861591|NCT00062868|27262989|P20|Dose Level 1|Lost to Follow-up|0
7861592|NCT00062868|27262990|P19|Dose Level 1|Lost to Follow-up|2
7861593|NCT00062868|27262991|P18|Dose Level 1|Lost to Follow-up|0
7861594|NCT00062868|27262992|P17|Dose Level 1|Lost to Follow-up|0
7861595|NCT00062868|27262993|P16|Dose Level 1|Lost to Follow-up|0
7861596|NCT00062868|27262994|P15|Dose Level 1|Lost to Follow-up|0
7861597|NCT00062868|27262995|P14|Dose Level 1|Lost to Follow-up|0
7861598|NCT00062868|27262996|P13|Dose Level 1|Lost to Follow-up|1
7861599|NCT00062868|27262997|P12|Dose Level 1|Lost to Follow-up|0
7861600|NCT00062868|27262998|P11|Dose Level 1|Lost to Follow-up|0
7861601|NCT00062868|27262999|P10|Dose Level 1|Lost to Follow-up|0
7861602|NCT00062868|27263000|P9|Dose Level 1|Lost to Follow-up|0
7861603|NCT00062868|27263001|P8|Dose Level 1|Lost to Follow-up|0
7861604|NCT00062868|27263002|P7|Dose Level 1|Lost to Follow-up|0
7861605|NCT00062868|27263003|P6|Dose Level 1|Lost to Follow-up|0
7861606|NCT00062868|27263004|P5|Dose Level 1|Lost to Follow-up|0
7861607|NCT00062868|27263005|P4|Dose Level 1|Lost to Follow-up|0
7861608|NCT00062868|27263006|P3|Dose Level 1|Lost to Follow-up|0
7861609|NCT00062868|27263007|P2|Dose Level 1|Lost to Follow-up|0
7861610|NCT00062868|27263008|P1|Dose Level 1|Lost to Follow-up|0
7861611|NCT00062868|27262988|P21|Dose Level 1|Death|1
7861612|NCT00062868|27262989|P20|Dose Level 1|Death|0
7861613|NCT00062868|27262990|P19|Dose Level 1|Death|7
7861614|NCT00062868|27262991|P18|Dose Level 1|Death|0
7861615|NCT00062868|27262992|P17|Dose Level 1|Death|0
7861616|NCT00062868|27262993|P16|Dose Level 1|Death|0
7861617|NCT00062868|27262994|P15|Dose Level 1|Death|0
7861618|NCT00062868|27262995|P14|Dose Level 1|Death|0
7861619|NCT00062868|27262996|P13|Dose Level 1|Death|0
7861620|NCT00062868|27262997|P12|Dose Level 1|Death|0
7861621|NCT00062868|27262998|P11|Dose Level 1|Death|0
7861622|NCT00062868|27262999|P10|Dose Level 1|Death|0
7861623|NCT00062868|27263000|P9|Dose Level 1|Death|0
7861624|NCT00062868|27263001|P8|Dose Level 1|Death|0
7861625|NCT00062868|27263002|P7|Dose Level 1|Death|3
7861626|NCT00062868|27263003|P6|Dose Level 1|Death|0
7861627|NCT00062868|27263004|P5|Dose Level 1|Death|0
7861628|NCT00062868|27263005|P4|Dose Level 1|Death|2
7861629|NCT00062868|27263006|P3|Dose Level 1|Death|0
7861630|NCT00062868|27263007|P2|Dose Level 1|Death|0
7861631|NCT00062868|27263008|P1|Dose Level 1|Death|2
7861632|NCT00062751|27263107|P5|Overall Study|Death|0
7861633|NCT00062751|27263108|P4|Overall Study|Death|0
7861634|NCT00062751|27263109|P3|Overall Study|Death|1
7861635|NCT00062751|27263110|P2|Overall Study|Death|0
7861636|NCT00062751|27263111|P1|Overall Study|Death|1
7861637|NCT00062751|27263107|P5|Overall Study|Symptomatic deterioration|1
7861638|NCT00062751|27263108|P4|Overall Study|Symptomatic deterioration|0
7861639|NCT00062751|27263109|P3|Overall Study|Symptomatic deterioration|0
7861640|NCT00062751|27263110|P2|Overall Study|Symptomatic deterioration|1
7861641|NCT00062751|27263111|P1|Overall Study|Symptomatic deterioration|1
7861642|NCT00062751|27263107|P5|Overall Study|Withdrawal by Subject|0
7861643|NCT00062751|27263108|P4|Overall Study|Withdrawal by Subject|1
7861644|NCT00062751|27263109|P3|Overall Study|Withdrawal by Subject|2
7861645|NCT00062751|27263110|P2|Overall Study|Withdrawal by Subject|2
7861646|NCT00062751|27263111|P1|Overall Study|Withdrawal by Subject|1
7861647|NCT00062751|27263107|P5|Overall Study|Other|1
7861648|NCT00062751|27263108|P4|Overall Study|Other|0
7861649|NCT00062751|27263109|P3|Overall Study|Other|1
7861650|NCT00062751|27263110|P2|Overall Study|Other|3
7861651|NCT00062751|27263111|P1|Overall Study|Other|2
7861652|NCT00062751|27263107|P5|Overall Study|Adverse Event|2
7861653|NCT00062751|27263108|P4|Overall Study|Adverse Event|2
7861654|NCT00062751|27263109|P3|Overall Study|Adverse Event|2
7861655|NCT00062751|27263110|P2|Overall Study|Adverse Event|7
7861656|NCT00062751|27263111|P1|Overall Study|Adverse Event|4
7861657|NCT00062751|27263107|P5|Overall Study|Disease progression|2
7861658|NCT00062751|27263108|P4|Overall Study|Disease progression|2
7861659|NCT00062751|27263109|P3|Overall Study|Disease progression|24
7861660|NCT00062751|27263110|P2|Overall Study|Disease progression|17
7861661|NCT00062751|27263111|P1|Overall Study|Disease progression|24
7861662|NCT00062647|27263197|P2|Overall Study|Never received study treatment|1
7861663|NCT00062647|27263198|P1|Overall Study|Never received study treatment|1
7861664|NCT00062647|27263197|P2|Overall Study|Other|4
7861665|NCT00062647|27263198|P1|Overall Study|Other|4
7861666|NCT00062647|27263197|P2|Overall Study|Failed continuation criteria|2
7861667|NCT00062647|27263198|P1|Overall Study|Failed continuation criteria|4
7861668|NCT00062647|27263197|P2|Overall Study|Lost to Follow-up|2
7861669|NCT00062647|27263198|P1|Overall Study|Lost to Follow-up|1
7861670|NCT00062647|27263197|P2|Overall Study|Protocol Violation|0
7861671|NCT00062647|27263198|P1|Overall Study|Protocol Violation|1
7861672|NCT00062647|27263197|P2|Overall Study|Withdrawal by Subject|1
7861673|NCT00062647|27263198|P1|Overall Study|Withdrawal by Subject|2
7861674|NCT00062647|27263197|P2|Overall Study|Adverse Event|1
7861675|NCT00062647|27263198|P1|Overall Study|Adverse Event|1
7861676|NCT00062647|27263197|P2|Overall Study|Death|2
7861677|NCT00062647|27263198|P1|Overall Study|Death|2
7861678|NCT00062439|27263204|P1|Consolidation Chemotherapy|Adverse Event|2
7861679|NCT00062439|27263204|P1|Surgery|Adverse Event|2
7861680|NCT00062439|27263204|P1|Surgery|Death|1
7861681|NCT00062439|27263204|P1|Surgery|Physician Decision|4
7861682|NCT00062439|27263204|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
7861683|NCT00062439|27263204|P1|Post Chemoradiation Assessment|Physician Decision|1
7861684|NCT00062439|27263204|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
7861685|NCT00062439|27263204|P1|Post Chemoradiation Assessment|Disease progression|2
7861686|NCT00062439|27263204|P1|Post Chemoradiation Assessment|Death|1
7861687|NCT00062439|27263204|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
7861688|NCT00062439|27263204|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
7861689|NCT00062439|27263204|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
7861690|NCT00062439|27263204|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
7861691|NCT00062374|27263216|P1|Overall Study|Not treated|12
7861692|NCT00062166|27263221|P1|Overall Study|Withdrawal by Subject|6
7861693|NCT00062010|27263229|P1|Overall Study|Ineligible|3
7861694|NCT00061945|27263237|P2|Course IV: Alemtuzumab|Early exits|15
7861695|NCT00061945|27263238|P1|Course IV: Alemtuzumab|Early exits|6
7861696|NCT00061945|27263237|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
7861697|NCT00061945|27263238|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
7861698|NCT00061945|27263237|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
7861699|NCT00061945|27263238|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
7861700|NCT00061945|27263237|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
7861701|NCT00061945|27263238|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
7861702|NCT00061932|27263248|P2|Overall Study|Withdrawal by Subject|4
7861703|NCT00061932|27263249|P1|Overall Study|Withdrawal by Subject|13
7861704|NCT00061633|27263264|P2|Overall Study|Never received study treatment|2
7861705|NCT00061633|27263265|P1|Overall Study|Never received study treatment|0
7861706|NCT00061633|27263264|P2|Overall Study|Other|1
7861707|NCT00061633|27263265|P1|Overall Study|Other|1
7861708|NCT00061633|27263264|P2|Overall Study|Lost to Follow-up|4
7861709|NCT00061633|27263265|P1|Overall Study|Lost to Follow-up|1
7861710|NCT00061633|27263264|P2|Overall Study|Withdrawal by Subject|2
7861711|NCT00061633|27263265|P1|Overall Study|Withdrawal by Subject|2
7861712|NCT00061633|27263264|P2|Overall Study|Adverse Event|2
7861713|NCT00061633|27263265|P1|Overall Study|Adverse Event|1
7861714|NCT00061048|27263290|P1|Overall Study|disease progression|20
7861715|NCT00061048|27263290|P1|Overall Study|Adverse Event|2
7861716|NCT00006046|27263303|P5|Overall Study|Disease Progression|0
7861717|NCT00006046|27263304|P4|Overall Study|Disease Progression|0
7861718|NCT00006046|27263305|P3|Overall Study|Disease Progression|0
7861719|NCT00006046|27263306|P2|Overall Study|Disease Progression|0
7861720|NCT00006046|27263307|P1|Overall Study|Disease Progression|2
7861721|NCT00006046|27263303|P5|Overall Study|Adverse Event|0
7861722|NCT00006046|27263304|P4|Overall Study|Adverse Event|0
7861723|NCT00006046|27263305|P3|Overall Study|Adverse Event|0
7861724|NCT00006046|27263306|P2|Overall Study|Adverse Event|0
7861725|NCT00006046|27263307|P1|Overall Study|Adverse Event|3
7861726|NCT00060944|27263326|P2|Overall Study|randomized but not treated|4
7861727|NCT00060944|27263327|P1|Overall Study|randomized but not treated|6
7861728|NCT00060944|27263326|P2|Overall Study|Other|4
7861729|NCT00060944|27263327|P1|Overall Study|Other|2
7861730|NCT00060944|27263326|P2|Overall Study|Treatment Switch|13
7861731|NCT00060944|27263327|P1|Overall Study|Treatment Switch|0
7861732|NCT00060944|27263326|P2|Overall Study|Subject Ineligible To Continue|1
7861733|NCT00060944|27263327|P1|Overall Study|Subject Ineligible To Continue|2
7861734|NCT00060944|27263326|P2|Overall Study|Lost to Follow-up|0
7861735|NCT00060944|27263327|P1|Overall Study|Lost to Follow-up|1
7861736|NCT00060944|27263326|P2|Overall Study|Disease Progression|94
7861737|NCT00060944|27263327|P1|Overall Study|Disease Progression|93
7861738|NCT00060944|27263326|P2|Overall Study|Withdrawal by Subject|5
7861739|NCT00060944|27263327|P1|Overall Study|Withdrawal by Subject|18
7861740|NCT00060944|27263326|P2|Overall Study|Death|3
7861741|NCT00060944|27263327|P1|Overall Study|Death|2
7861742|NCT00060944|27263326|P2|Overall Study|Adverse Event|10
7861743|NCT00060944|27263327|P1|Overall Study|Adverse Event|12
7861744|NCT00060840|27263343|P2|Overall Study|Other|0
7861745|NCT00060840|27263344|P1|Overall Study|Other|1
7861746|NCT00060840|27263343|P2|Overall Study|Physician Decision|0
7861747|NCT00060840|27263344|P1|Overall Study|Physician Decision|1
7861748|NCT00060840|27263343|P2|Overall Study|Subinvestigator unavailable|1
7861749|NCT00060840|27263344|P1|Overall Study|Subinvestigator unavailable|0
7861750|NCT00060840|27263343|P2|Overall Study|Withdrawal by Subject|1
7861751|NCT00060840|27263344|P1|Overall Study|Withdrawal by Subject|0
7861752|NCT00060840|27263343|P2|Overall Study|Death|1
7861753|NCT00060840|27263344|P1|Overall Study|Death|0
7861754|NCT00060840|27263343|P2|Overall Study|Change in surgical plan|6
7861755|NCT00060840|27263344|P1|Overall Study|Change in surgical plan|2
7861756|NCT00059839|27263410|P2|Overall Study|Ineligible|3
7861757|NCT00059839|27263411|P1|Overall Study|Ineligible|1
7861758|NCT00059839|27263410|P2|Overall Study|Withdrawal by Subject|6
7861759|NCT00059839|27263411|P1|Overall Study|Withdrawal by Subject|1
7861760|NCT00059839|27263410|P2|Overall Study|Physician Decision|2
7861761|NCT00059839|27263411|P1|Overall Study|Physician Decision|1
7861762|NCT00059839|27263410|P2|Overall Study|Lost to Follow-up|0
7861763|NCT00059839|27263411|P1|Overall Study|Lost to Follow-up|2
7861764|NCT00059839|27263410|P2|Overall Study|Lack of Efficacy|5
7861765|NCT00059839|27263411|P1|Overall Study|Lack of Efficacy|6
7861766|NCT00059839|27263410|P2|Overall Study|Death|1
7861767|NCT00059839|27263411|P1|Overall Study|Death|1
7861768|NCT00059787|27263417|P1|Overall Study|Other|4
7861769|NCT00059787|27263417|P1|Overall Study|ineligible|1
7861770|NCT00059787|27263417|P1|Overall Study|disease progression|2
7861771|NCT00059787|27263417|P1|Overall Study|Adverse Event|13
7861772|NCT00059332|27263468|P2|Overall Study|Lost to Follow-up|1
7861773|NCT00059332|27263469|P1|Overall Study|Lost to Follow-up|1
7861774|NCT00059332|27263468|P2|Overall Study|Withdrawal by Subject|1
7861775|NCT00059332|27263469|P1|Overall Study|Withdrawal by Subject|2
7861776|NCT00059215|27263495|P4|Overall Study|Physician Decision|1
7861777|NCT00059215|27263496|P3|Overall Study|Physician Decision|1
7861778|NCT00059215|27263497|P2|Overall Study|Physician Decision|2
7861779|NCT00059215|27263498|P1|Overall Study|Physician Decision|1
7861780|NCT00059215|27263495|P4|Overall Study|Protocol entry criteria not met|2
7861781|NCT00059215|27263496|P3|Overall Study|Protocol entry criteria not met|0
7861782|NCT00059215|27263497|P2|Overall Study|Protocol entry criteria not met|1
7861783|NCT00059215|27263498|P1|Overall Study|Protocol entry criteria not met|1
7861784|NCT00059215|27263495|P4|Overall Study|Protocol Violation|0
7861785|NCT00059215|27263496|P3|Overall Study|Protocol Violation|1
7861786|NCT00059215|27263497|P2|Overall Study|Protocol Violation|0
7861787|NCT00059215|27263498|P1|Overall Study|Protocol Violation|1
7861788|NCT00059215|27263495|P4|Overall Study|Withdrawal by Subject|3
7861789|NCT00059215|27263496|P3|Overall Study|Withdrawal by Subject|1
7861790|NCT00059215|27263497|P2|Overall Study|Withdrawal by Subject|4
7861791|NCT00059215|27263498|P1|Overall Study|Withdrawal by Subject|4
7861792|NCT00059215|27263495|P4|Overall Study|Lost to Follow-up|0
7861793|NCT00059215|27263496|P3|Overall Study|Lost to Follow-up|0
7861794|NCT00059215|27263497|P2|Overall Study|Lost to Follow-up|2
7861795|NCT00059215|27263498|P1|Overall Study|Lost to Follow-up|1
7861796|NCT00059215|27263495|P4|Overall Study|Death|0
7861797|NCT00059215|27263496|P3|Overall Study|Death|3
7861798|NCT00059215|27263497|P2|Overall Study|Death|0
7861799|NCT00059215|27263498|P1|Overall Study|Death|0
7861800|NCT00059215|27263495|P4|Overall Study|Adverse Event|9
7861801|NCT00059215|27263496|P3|Overall Study|Adverse Event|9
7861802|NCT00059215|27263497|P2|Overall Study|Adverse Event|5
7861803|NCT00059215|27263498|P1|Overall Study|Adverse Event|5
7861804|NCT00059202|27263537|P2|Overall Study|drug toxicity|3
7861805|NCT00059202|27263538|P1|Overall Study|drug toxicity|0
7861806|NCT00059202|27263537|P2|Overall Study|Protocol Violation|3
7861807|NCT00059202|27263538|P1|Overall Study|Protocol Violation|1
7861808|NCT00059202|27263537|P2|Overall Study|Withdrawal by Subject|9
7861809|NCT00059202|27263538|P1|Overall Study|Withdrawal by Subject|5
7861810|NCT00058825|27263574|P1|Overall Study|Death|3
7861811|NCT00058825|27263574|P1|Overall Study|Graft Failure|5
7861812|NCT00058825|27263574|P1|Overall Study|Progressive Disease|5
7861813|NCT00058825|27263574|P1|Overall Study|Relapse|9
7861814|NCT00058552|27263590|P2|Overall Study|Clinical disease progression|4
7861815|NCT00058552|27263591|P1|Overall Study|Clinical disease progression|0
7861816|NCT00058552|27263590|P2|Overall Study|Physician Decision|5
7861817|NCT00058552|27263591|P1|Overall Study|Physician Decision|2
7861818|NCT00058552|27263590|P2|Overall Study|Withdrawal by Subject|5
7861819|NCT00058552|27263591|P1|Overall Study|Withdrawal by Subject|3
7861820|NCT00058552|27263590|P2|Overall Study|Adverse Event|2
7861821|NCT00058552|27263591|P1|Overall Study|Adverse Event|4
7861822|NCT00058552|27263590|P2|Overall Study|Disease progression|44
7861823|NCT00058552|27263591|P1|Overall Study|Disease progression|52
7861824|NCT00058552|27263590|P2|Overall Study|Died prior to receiving treatment|2
7861825|NCT00058552|27263591|P1|Overall Study|Died prior to receiving treatment|4
7861826|NCT00058539|27263609|P1|Overall Study|Death|1
7861827|NCT00058539|27263609|P1|Overall Study|Physician Decision|9
7861828|NCT00058539|27263609|P1|Overall Study|Withdrawal by Subject|5
7861829|NCT00058539|27263609|P1|Overall Study|Adverse Event|3
7861830|NCT00058539|27263609|P1|Overall Study|Disease progression|24
7861831|NCT00058422|27263619|P1|Overall Study|Not treated|2
7861832|NCT00058214|27263650|P1|Overall Study|Adverse Event|1
7861833|NCT00058123|27263672|P1|Overall Study|Received >3 prior treatments|1
7861834|NCT00058123|27263672|P1|Overall Study|Wrong histology|9
7861835|NCT00058058|27263679|P1|Overall Study|Poor positioning, illness,pain|3
7861836|NCT00058058|27263679|P1|Overall Study|technical issues|6
7861837|NCT00058058|27263679|P1|Overall Study|Claustrophobic|5
7861838|NCT00058058|27263679|P1|Overall Study|Ineligible|20
7861839|NCT00058058|27263679|P1|Overall Study|Withdrawal by Subject|4
7861840|NCT00057954|27263704|P1|Overall Study|Disease progression|1
7861841|NCT00057954|27263704|P1|Overall Study|Death|1
7861842|NCT00057941|27263712|P2|Overall Study|Ineligible|5
7861843|NCT00057941|27263713|P1|Overall Study|Ineligible|2
7861844|NCT00057941|27263712|P2|Overall Study|insurance, symptomatic deterioration|3
7861845|NCT00057941|27263713|P1|Overall Study|insurance, symptomatic deterioration|1
7861846|NCT00057941|27263712|P2|Overall Study|still on treatment|1
7861847|NCT00057941|27263713|P1|Overall Study|still on treatment|3
7861848|NCT00057941|27263712|P2|Overall Study|Withdrawal by Subject|1
7861849|NCT00057941|27263713|P1|Overall Study|Withdrawal by Subject|6
7861850|NCT00057941|27263712|P2|Overall Study|Lack of Efficacy|53
7861851|NCT00057941|27263713|P1|Overall Study|Lack of Efficacy|54
7861852|NCT00057941|27263712|P2|Overall Study|Adverse Event|9
7861853|NCT00057941|27263713|P1|Overall Study|Adverse Event|7
7861854|NCT00057941|27263712|P2|Overall Study|Death|2
7861855|NCT00057941|27263713|P1|Overall Study|Death|1
7861856|NCT00057876|27263721|P2|Overall Study|other complicating disease|0
7861857|NCT00057876|27263722|P1|Overall Study|other complicating disease|1
7861858|NCT00057876|27263721|P2|Overall Study|other reason|2
7861859|NCT00057876|27263722|P1|Overall Study|other reason|2
7861860|NCT00057876|27263721|P2|Overall Study|Ineligible|2
7861861|NCT00057876|27263722|P1|Overall Study|Ineligible|1
7861862|NCT00057876|27263721|P2|Overall Study|Lack of Efficacy|8
7861863|NCT00057876|27263722|P1|Overall Study|Lack of Efficacy|10
7861864|NCT00057876|27263721|P2|Overall Study|Withdrawal by Subject|6
7861865|NCT00057876|27263722|P1|Overall Study|Withdrawal by Subject|5
7861866|NCT00057876|27263721|P2|Overall Study|Death|1
7861867|NCT00057876|27263722|P1|Overall Study|Death|2
7861868|NCT00057876|27263721|P2|Overall Study|Adverse Event|8
7861869|NCT00057876|27263722|P1|Overall Study|Adverse Event|8
7861870|NCT00057863|27263732|P1|Overall Study|Withdrawal by Subject|2
7861871|NCT00057863|27263732|P1|Overall Study|Death|1
7861872|NCT00057837|27263741|P2|Overall Study|Never started treatment|1
7861873|NCT00057837|27263742|P1|Overall Study|Never started treatment|1
7861874|NCT00057837|27263741|P2|Overall Study|Ineligible|3
7861875|NCT00057837|27263742|P1|Overall Study|Ineligible|3
7861876|NCT00057837|27263741|P2|Overall Study|Physician Decision|0
7861877|NCT00057837|27263742|P1|Overall Study|Physician Decision|1
7861878|NCT00057837|27263741|P2|Overall Study|Other complicating disease|1
7861879|NCT00057837|27263742|P1|Overall Study|Other complicating disease|2
7861880|NCT00057837|27263741|P2|Overall Study|Alternative therapy|1
7861881|NCT00057837|27263742|P1|Overall Study|Alternative therapy|0
7861882|NCT00057837|27263741|P2|Overall Study|Withdrawal by Subject|3
7861883|NCT00057837|27263742|P1|Overall Study|Withdrawal by Subject|5
7861884|NCT00057837|27263741|P2|Overall Study|Death|4
7861885|NCT00057837|27263742|P1|Overall Study|Death|5
7861886|NCT00057837|27263741|P2|Overall Study|Adverse Event|12
7861887|NCT00057837|27263742|P1|Overall Study|Adverse Event|2
7861888|NCT00057837|27263741|P2|Overall Study|Progression/relapse|14
7861889|NCT00057837|27263742|P1|Overall Study|Progression/relapse|12
7861890|NCT00057811|27263754|P2|Overall Study|Inevaluable|2
7861891|NCT00057811|27263755|P1|Overall Study|Inevaluable|1
7861892|NCT00057811|27263754|P2|Overall Study|Ineligible|2
7861893|NCT00057811|27263755|P1|Overall Study|Ineligible|4
7861894|NCT00057811|27263754|P2|Overall Study|Withdrawal by Subject|4
7861895|NCT00057811|27263755|P1|Overall Study|Withdrawal by Subject|3
7861896|NCT00057811|27263754|P2|Overall Study|Physician Decision|0
7861897|NCT00057811|27263755|P1|Overall Study|Physician Decision|1
7861898|NCT00057811|27263754|P2|Overall Study|Lack of Efficacy|4
7861899|NCT00057811|27263755|P1|Overall Study|Lack of Efficacy|1
7861900|NCT00057746|27263774|P3|Overall Study|Withdrawal by Subject|1
7861901|NCT00057746|27263775|P2|Overall Study|Withdrawal by Subject|0
7861902|NCT00057746|27263776|P1|Overall Study|Withdrawal by Subject|0
7861903|NCT00023673|27263787|P4|Overall Study|Patient withdrew consent|1
7861904|NCT00023673|27263788|P3|Overall Study|Patient withdrew consent|0
7861905|NCT00023673|27263789|P2|Overall Study|Patient withdrew consent|0
7861906|NCT00023673|27263790|P1|Overall Study|Patient withdrew consent|0
7861907|NCT00023673|27263787|P4|Overall Study|Ineligible / no protocol treatment|1
7861908|NCT00023673|27263788|P3|Overall Study|Ineligible / no protocol treatment|0
7861909|NCT00023673|27263789|P2|Overall Study|Ineligible / no protocol treatment|0
7861910|NCT00023673|27263790|P1|Overall Study|Ineligible / no protocol treatment|0
7861911|NCT00057330|27263854|P2|Overall Study|Other|206
7861912|NCT00057330|27263855|P1|Overall Study|Other|260
7861913|NCT00057330|27263854|P2|Overall Study|Physician Decision|0
7861914|NCT00057330|27263855|P1|Overall Study|Physician Decision|1
7861915|NCT00057330|27263854|P2|Overall Study|Lost to Follow-up|617
7861916|NCT00057330|27263855|P1|Overall Study|Lost to Follow-up|745
7861917|NCT00057330|27263854|P2|Overall Study|Withdrawal by Subject|84
7861918|NCT00057330|27263855|P1|Overall Study|Withdrawal by Subject|115
7861919|NCT00057330|27263854|P2|Overall Study|Protocol Violation|1
7861920|NCT00057330|27263855|P1|Overall Study|Protocol Violation|1
7861921|NCT00057330|27263854|P2|Overall Study|Death|0
7861922|NCT00057330|27263855|P1|Overall Study|Death|1
7861923|NCT00057330|27263854|P2|Overall Study|Adverse Event|12
7861924|NCT00057330|27263855|P1|Overall Study|Adverse Event|9
7861925|NCT00056862|27263885|P2|Overall Study|Protocol Violation|0
7861926|NCT00056862|27263886|P1|Overall Study|Protocol Violation|1
7861927|NCT00056407|27263944|P2|Overall Study|Missing|34
7861928|NCT00056407|27263945|P1|Overall Study|Missing|25
7861929|NCT00056407|27263944|P2|Overall Study|"Listed as Other on Case Report Form"|60
7861930|NCT00056407|27263945|P1|Overall Study|"Listed as Other on Case Report Form"|98
7861931|NCT00056407|27263944|P2|Overall Study|Diagnosed with Prostate Cancer|166
7861932|NCT00056407|27263945|P1|Overall Study|Diagnosed with Prostate Cancer|202
7861933|NCT00056407|27263944|P2|Overall Study|Protocol Violation|95
7861934|NCT00056407|27263945|P1|Overall Study|Protocol Violation|104
7861935|NCT00056407|27263944|P2|Overall Study|Lost to Follow-up|113
7861936|NCT00056407|27263945|P1|Overall Study|Lost to Follow-up|123
7861937|NCT00056407|27263944|P2|Overall Study|Withdrawal by Subject|361
7861938|NCT00056407|27263945|P1|Overall Study|Withdrawal by Subject|377
7861939|NCT00056407|27263944|P2|Overall Study|Adverse Event|364
7861940|NCT00056407|27263945|P1|Overall Study|Adverse Event|282
7861941|NCT00056316|27264003|P2|Overall Study|Death/NH placement of pt|1
7861942|NCT00056316|27264004|P1|Overall Study|Death/NH placement of pt|1
7861943|NCT00056316|27264003|P2|Overall Study|Withdrawal by Subject|2
7861944|NCT00056316|27264004|P1|Overall Study|Withdrawal by Subject|2
7861945|NCT00056160|27264018|P2|Final Follow-up|Adverse Event|0
7861946|NCT00056160|27264019|P1|Final Follow-up|Adverse Event|1
7861947|NCT00056160|27264018|P2|Final Follow-up|Transferred into RevAssist Program|0
7861948|NCT00056160|27264019|P1|Final Follow-up|Transferred into RevAssist Program|2
7861949|NCT00056160|27264018|P2|Final Follow-up|Transferred into expanded access study.|0
7861950|NCT00056160|27264019|P1|Final Follow-up|Transferred into expanded access study.|3
7861951|NCT00056160|27264018|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
7861952|NCT00056160|27264019|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
7861953|NCT00056160|27264018|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
7862037|NCT00054639|27264372|P1|Overall Study|Lack of Efficacy|1
7861954|NCT00056160|27264019|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
7861955|NCT00056160|27264018|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
7861956|NCT00056160|27264019|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
7861957|NCT00056160|27264018|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
7861958|NCT00056160|27264019|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
7861959|NCT00056160|27264018|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
7861960|NCT00056160|27264019|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
7861961|NCT00056160|27264018|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
7861962|NCT00056160|27264019|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
7861963|NCT00056160|27264018|P2|Up to Unblinding (07 Jun 2005)|Other|7
7861964|NCT00056160|27264019|P1|Up to Unblinding (07 Jun 2005)|Other|8
7861965|NCT00056160|27264018|P2|Up to Unblinding (07 Jun 2005)|Death|1
7861966|NCT00056160|27264019|P1|Up to Unblinding (07 Jun 2005)|Death|2
7861967|NCT00056160|27264018|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
7861968|NCT00056160|27264019|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
7861969|NCT00056160|27264018|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
7861970|NCT00056160|27264019|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
7861971|NCT00056160|27264018|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
7861972|NCT00056160|27264019|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
7861973|NCT00056160|27264018|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
7861974|NCT00056160|27264019|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
7861975|NCT00055601|27264042|P2|Overall Study|No protocol treatment received|1
7861976|NCT00055601|27264043|P1|Overall Study|No protocol treatment received|1
7861977|NCT00055601|27264042|P2|Overall Study|Protocol Violation|1
7861978|NCT00055601|27264043|P1|Overall Study|Protocol Violation|1
7861979|NCT00055497|27264057|P4|Overall Study|Other|11
7861980|NCT00055497|27264058|P3|Overall Study|Other|0
7861981|NCT00055497|27264059|P2|Overall Study|Other|0
7861982|NCT00055497|27264060|P1|Overall Study|Other|0
7861983|NCT00055497|27264057|P4|Overall Study|Administrative Reasons|1
7861984|NCT00055497|27264058|P3|Overall Study|Administrative Reasons|0
7861985|NCT00055497|27264059|P2|Overall Study|Administrative Reasons|0
7861986|NCT00055497|27264060|P1|Overall Study|Administrative Reasons|0
7861987|NCT00055497|27264057|P4|Overall Study|Lack of Efficacy|27
7861988|NCT00055497|27264058|P3|Overall Study|Lack of Efficacy|0
7861989|NCT00055497|27264059|P2|Overall Study|Lack of Efficacy|0
7861990|NCT00055497|27264060|P1|Overall Study|Lack of Efficacy|1
7861991|NCT00055497|27264057|P4|Overall Study|Protocol Violation|3
7861992|NCT00055497|27264058|P3|Overall Study|Protocol Violation|0
7861993|NCT00055497|27264059|P2|Overall Study|Protocol Violation|0
7861994|NCT00055497|27264060|P1|Overall Study|Protocol Violation|0
7861995|NCT00055497|27264057|P4|Overall Study|Lost to Follow-up|5
7861996|NCT00055497|27264058|P3|Overall Study|Lost to Follow-up|0
7861997|NCT00055497|27264059|P2|Overall Study|Lost to Follow-up|1
7861998|NCT00055497|27264060|P1|Overall Study|Lost to Follow-up|0
7861999|NCT00055497|27264057|P4|Overall Study|Withdrawal by Subject|15
7862000|NCT00055497|27264058|P3|Overall Study|Withdrawal by Subject|1
7862001|NCT00055497|27264059|P2|Overall Study|Withdrawal by Subject|1
7862002|NCT00055497|27264060|P1|Overall Study|Withdrawal by Subject|3
7862003|NCT00055497|27264057|P4|Overall Study|Adverse Event|28
7862004|NCT00055497|27264058|P3|Overall Study|Adverse Event|1
7862005|NCT00055497|27264059|P2|Overall Study|Adverse Event|1
7862006|NCT00055497|27264060|P1|Overall Study|Adverse Event|1
7862007|NCT00055471|27264105|P3|Period 1: Dose Escalation Period|Disease progression|0
7862008|NCT00055471|27264106|P2|Period 1: Dose Escalation Period|Disease progression|1
7862009|NCT00055471|27264107|P1|Period 1: Dose Escalation Period|Disease progression|0
7862010|NCT00055471|27264105|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
7862011|NCT00055471|27264106|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
7862012|NCT00055471|27264107|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
7862013|NCT00055471|27264105|P3|Period 1: Dose Escalation Period|Adverse Event|2
7862014|NCT00055471|27264106|P2|Period 1: Dose Escalation Period|Adverse Event|1
7862015|NCT00055471|27264107|P1|Period 1: Dose Escalation Period|Adverse Event|0
7862016|NCT00054717|27264162|P2|Overall Study|Other reason not defined above|217
7862017|NCT00054717|27264163|P1|Overall Study|Other reason not defined above|117
7862018|NCT00054717|27264162|P2|Overall Study|Withdrawal by Subject|20
7862019|NCT00054717|27264163|P1|Overall Study|Withdrawal by Subject|32
7862020|NCT00054717|27264162|P2|Overall Study|Lost to Follow-up|13
7862021|NCT00054717|27264163|P1|Overall Study|Lost to Follow-up|23
7862022|NCT00054717|27264162|P2|Overall Study|Protocol Violation|19
7862023|NCT00054717|27264163|P1|Overall Study|Protocol Violation|18
7862024|NCT00054717|27264162|P2|Overall Study|Adverse Event|22
7862025|NCT00054717|27264163|P1|Overall Study|Adverse Event|70
7862026|NCT00054717|27264162|P2|Overall Study|Randomized but not treated|8
7862027|NCT00054717|27264163|P1|Overall Study|Randomized but not treated|2
7862028|NCT00054704|27264351|P2|Overall Study|Lost to Follow-up|1
7862029|NCT00054704|27264352|P1|Overall Study|Lost to Follow-up|0
7862030|NCT00054704|27264351|P2|Overall Study|Adverse Event|1
7862031|NCT00054704|27264352|P1|Overall Study|Adverse Event|3
7862032|NCT00054704|27264351|P2|Overall Study|Lack of Efficacy|3
7862033|NCT00054704|27264352|P1|Overall Study|Lack of Efficacy|2
7862034|NCT00054691|27264358|P1|Overall Study|Noncompliant|1
7862035|NCT00054691|27264358|P1|Overall Study|Unmeasurable Disease|2
7862036|NCT00054639|27264372|P1|Overall Study|Physician Decision|1
7862038|NCT00054327|27264405|P6|Overall Study|Engraftment failure|0
7862039|NCT00054327|27264406|P5|Overall Study|Engraftment failure|0
7862040|NCT00054327|27264407|P4|Overall Study|Engraftment failure|0
7862041|NCT00054327|27264408|P3|Overall Study|Engraftment failure|0
7862042|NCT00054327|27264409|P2|Overall Study|Engraftment failure|0
7862043|NCT00054327|27264410|P1|Overall Study|Engraftment failure|1
7862044|NCT00054275|27264448|P1|Overall Study|Physician Decision|1
7862045|NCT00054275|27264448|P1|Overall Study|Progressive disease in cycle 1|1
7862046|NCT00054275|27264448|P1|Overall Study|Adverse Event|5
7862047|NCT00054275|27264448|P1|Overall Study|Withdrawal by Subject|4
7862048|NCT00054132|27264454|P1|Overall Study|Not Treated|1
7862049|NCT00053898|27264481|P2|Overall Study|Follow-up from telephone contact only|1
7862050|NCT00053898|27264482|P1|Overall Study|Follow-up from telephone contact only|5
7862051|NCT00053898|27264481|P2|Overall Study|No follow-up data from any source|12
7862052|NCT00053898|27264482|P1|Overall Study|No follow-up data from any source|9
7862053|NCT00053846|27264508|P2|Overall Study|Pills too large|1
7862054|NCT00053846|27264509|P1|Overall Study|Pills too large|0
7862055|NCT00053846|27264508|P2|Overall Study|Quit due to side effects|3
7862056|NCT00053846|27264509|P1|Overall Study|Quit due to side effects|1
7862057|NCT00053846|27264508|P2|Overall Study|Did not return data|2
7862058|NCT00053846|27264509|P1|Overall Study|Did not return data|1
7862059|NCT00053846|27264508|P2|Overall Study|Became ineligible|1
7862060|NCT00053846|27264509|P1|Overall Study|Became ineligible|3
7862061|NCT00053846|27264508|P2|Overall Study|Expired|0
7862062|NCT00053846|27264509|P1|Overall Study|Expired|5
7862063|NCT00053846|27264508|P2|Overall Study|Became too ill|7
7862064|NCT00053846|27264509|P1|Overall Study|Became too ill|8
7862065|NCT00053846|27264508|P2|Overall Study|Changed mind|13
7862066|NCT00053846|27264509|P1|Overall Study|Changed mind|8
7862067|NCT00053417|27264668|P4|Overall Study|Lost to Follow-up|0
7862068|NCT00053417|27264669|P3|Overall Study|Lost to Follow-up|0
7862069|NCT00053417|27264670|P2|Overall Study|Lost to Follow-up|1
7862070|NCT00053417|27264671|P1|Overall Study|Lost to Follow-up|1
7862071|NCT00053417|27264668|P4|Overall Study|Withdrawal by Subject|0
7862072|NCT00053417|27264669|P3|Overall Study|Withdrawal by Subject|0
7862073|NCT00053417|27264670|P2|Overall Study|Withdrawal by Subject|1
7862074|NCT00053417|27264671|P1|Overall Study|Withdrawal by Subject|0
7862075|NCT00053417|27264668|P4|Overall Study|Non-Compliance|1
7862076|NCT00053417|27264669|P3|Overall Study|Non-Compliance|0
7862077|NCT00053417|27264670|P2|Overall Study|Non-Compliance|0
7862078|NCT00053417|27264671|P1|Overall Study|Non-Compliance|0
7862079|NCT00053417|27264668|P4|Overall Study|Adverse Event|5
7862080|NCT00053417|27264669|P3|Overall Study|Adverse Event|1
7862081|NCT00053417|27264670|P2|Overall Study|Adverse Event|0
7862082|NCT00053417|27264671|P1|Overall Study|Adverse Event|1
7862083|NCT00053365|27264681|P1|Overall Study|Never treated|4
7862084|NCT00053365|27264681|P1|Overall Study|Platinum-sensitive interval >12 months|1
7862085|NCT00053365|27264681|P1|Overall Study|Incorrect cell type|1
7862086|NCT00053352|27264690|P2|Overall Study|Disease at new site|0
7862087|NCT00053352|27264691|P1|Overall Study|Disease at new site|1
7862088|NCT00053352|27264690|P2|Overall Study|Ineligible|8
7862089|NCT00053352|27264691|P1|Overall Study|Ineligible|8
7862090|NCT00053352|27264690|P2|Overall Study|Withdrawal by Subject|0
7862091|NCT00053352|27264691|P1|Overall Study|Withdrawal by Subject|1
7862092|NCT00053352|27264690|P2|Overall Study|Physician Decision|1
7862093|NCT00053352|27264691|P1|Overall Study|Physician Decision|11
7862094|NCT00053352|27264690|P2|Overall Study|Lost to Follow-up|1
7862095|NCT00053352|27264691|P1|Overall Study|Lost to Follow-up|0
7862096|NCT00003830|27264707|P2|Overall Study|Sentinel node positive patients|793
7862097|NCT00003830|27264708|P1|Overall Study|Sentinel node positive patients|829
7862098|NCT00003830|27264707|P2|Overall Study|No follow up data|0
7862099|NCT00003830|27264708|P1|Overall Study|No follow up data|3
7862100|NCT00052962|27264734|P2|Overall Study|Not randomized/not evaluable|0
7862101|NCT00052962|27264735|P1|Overall Study|Not randomized/not evaluable|1
7862102|NCT00052962|27264734|P2|Overall Study|Not evaluable|2
7862103|NCT00052962|27264735|P1|Overall Study|Not evaluable|0
7862104|NCT00052715|27264754|P1|Overall Study|wrong histology|1
7862105|NCT00049673|27264796|P2|Overall Study|No receive treatment/lost to follow-up|3
7862106|NCT00049673|27264797|P1|Overall Study|No receive treatment/lost to follow-up|1
7862107|NCT00049543|27264807|P2|Overall Study|still on treatment|9
7862108|NCT00049543|27264808|P1|Overall Study|still on treatment|2
7862109|NCT00049530|27264818|P1|Overall Study|ineligible|3
7862110|NCT00049530|27264818|P1|Overall Study|symptomatic deterioration|1
7862111|NCT00049530|27264818|P1|Overall Study|Death|1
7862112|NCT00049530|27264818|P1|Overall Study|Adverse Event|2
7862113|NCT00049530|27264818|P1|Overall Study|Lack of Efficacy|25
7862114|NCT00049517|27264827|P6|Conditioning/Transplant|Reasons not reported|5
7862115|NCT00049517|27264828|P5|Conditioning/Transplant|Reasons not reported|5
7862116|NCT00049517|27264829|P4|Conditioning/Transplant|Reasons not reported|15
7862117|NCT00049517|27264830|P3|Conditioning/Transplant|Reasons not reported|18
7862118|NCT00049517|27264831|P2|Conditioning/Transplant|Reasons not reported|31
7862119|NCT00049517|27264832|P1|Conditioning/Transplant|Reasons not reported|25
7862120|NCT00049517|27264827|P6|Conditioning/Transplant|Other complicating disease|1
7862121|NCT00049517|27264828|P5|Conditioning/Transplant|Other complicating disease|0
7862122|NCT00049517|27264829|P4|Conditioning/Transplant|Other complicating disease|4
7862123|NCT00049517|27264830|P3|Conditioning/Transplant|Other complicating disease|0
7862124|NCT00049517|27264831|P2|Conditioning/Transplant|Other complicating disease|0
7862125|NCT00049517|27264832|P1|Conditioning/Transplant|Other complicating disease|2
7862126|NCT00049517|27264827|P6|Conditioning/Transplant|Alternative therapy|0
7862127|NCT00049517|27264828|P5|Conditioning/Transplant|Alternative therapy|1
7862128|NCT00049517|27264829|P4|Conditioning/Transplant|Alternative therapy|1
7862129|NCT00049517|27264830|P3|Conditioning/Transplant|Alternative therapy|2
7862130|NCT00049517|27264831|P2|Conditioning/Transplant|Alternative therapy|4
7862131|NCT00049517|27264832|P1|Conditioning/Transplant|Alternative therapy|4
7862132|NCT00049517|27264827|P6|Conditioning/Transplant|Withdrawal by Subject|0
7862133|NCT00049517|27264828|P5|Conditioning/Transplant|Withdrawal by Subject|0
7862134|NCT00049517|27264829|P4|Conditioning/Transplant|Withdrawal by Subject|7
7862135|NCT00049517|27264830|P3|Conditioning/Transplant|Withdrawal by Subject|4
7862136|NCT00049517|27264831|P2|Conditioning/Transplant|Withdrawal by Subject|8
7862137|NCT00049517|27264832|P1|Conditioning/Transplant|Withdrawal by Subject|4
7862138|NCT00049517|27264827|P6|Conditioning/Transplant|Death|0
7862139|NCT00049517|27264828|P5|Conditioning/Transplant|Death|0
7862140|NCT00049517|27264829|P4|Conditioning/Transplant|Death|2
7862141|NCT00049517|27264830|P3|Conditioning/Transplant|Death|0
7862142|NCT00049517|27264831|P2|Conditioning/Transplant|Death|0
7862143|NCT00049517|27264832|P1|Conditioning/Transplant|Death|1
7862144|NCT00049517|27264827|P6|Conditioning/Transplant|Adverse Event|0
7862145|NCT00049517|27264828|P5|Conditioning/Transplant|Adverse Event|0
7862146|NCT00049517|27264829|P4|Conditioning/Transplant|Adverse Event|8
7862147|NCT00049517|27264830|P3|Conditioning/Transplant|Adverse Event|4
7862148|NCT00049517|27264831|P2|Conditioning/Transplant|Adverse Event|1
7862149|NCT00049517|27264832|P1|Conditioning/Transplant|Adverse Event|2
7862150|NCT00049517|27264827|P6|Conditioning/Transplant|Disease progression|0
7862151|NCT00049517|27264828|P5|Conditioning/Transplant|Disease progression|0
7862152|NCT00049517|27264829|P4|Conditioning/Transplant|Disease progression|6
7862153|NCT00049517|27264830|P3|Conditioning/Transplant|Disease progression|10
7862154|NCT00049517|27264831|P2|Conditioning/Transplant|Disease progression|6
7862155|NCT00049517|27264832|P1|Conditioning/Transplant|Disease progression|14
7862156|NCT00049517|27264827|P6|Induction|Reasons not reported|25
7862157|NCT00049517|27264828|P5|Induction|Reasons not reported|22
7862158|NCT00049517|27264829|P4|Induction|Reasons not reported|0
7862159|NCT00049517|27264830|P3|Induction|Reasons not reported|0
7862160|NCT00049517|27264831|P2|Induction|Reasons not reported|0
7862161|NCT00049517|27264832|P1|Induction|Reasons not reported|0
7862162|NCT00049517|27264827|P6|Induction|Other complicating disease|0
7862163|NCT00049517|27264828|P5|Induction|Other complicating disease|3
7862164|NCT00049517|27264829|P4|Induction|Other complicating disease|0
7862165|NCT00049517|27264830|P3|Induction|Other complicating disease|0
7862166|NCT00049517|27264831|P2|Induction|Other complicating disease|0
7862167|NCT00049517|27264832|P1|Induction|Other complicating disease|0
7862168|NCT00049517|27264827|P6|Induction|Alternative therapy|2
7862169|NCT00049517|27264828|P5|Induction|Alternative therapy|2
7862170|NCT00049517|27264829|P4|Induction|Alternative therapy|0
7862171|NCT00049517|27264830|P3|Induction|Alternative therapy|0
7862172|NCT00049517|27264831|P2|Induction|Alternative therapy|0
7862173|NCT00049517|27264832|P1|Induction|Alternative therapy|0
7862174|NCT00049517|27264827|P6|Induction|Withdrawal by Subject|3
7862175|NCT00049517|27264828|P5|Induction|Withdrawal by Subject|1
7862176|NCT00049517|27264829|P4|Induction|Withdrawal by Subject|0
7862177|NCT00049517|27264830|P3|Induction|Withdrawal by Subject|0
7862178|NCT00049517|27264831|P2|Induction|Withdrawal by Subject|0
7862179|NCT00049517|27264832|P1|Induction|Withdrawal by Subject|0
7862180|NCT00049517|27264827|P6|Induction|Death|6
7862181|NCT00049517|27264828|P5|Induction|Death|9
7862182|NCT00049517|27264829|P4|Induction|Death|0
7862183|NCT00049517|27264830|P3|Induction|Death|0
7862184|NCT00049517|27264831|P2|Induction|Death|0
7862185|NCT00049517|27264832|P1|Induction|Death|0
7862186|NCT00049517|27264827|P6|Induction|Adverse Event|7
7862187|NCT00049517|27264828|P5|Induction|Adverse Event|5
7862188|NCT00049517|27264829|P4|Induction|Adverse Event|0
7862189|NCT00049517|27264830|P3|Induction|Adverse Event|0
7862190|NCT00049517|27264831|P2|Induction|Adverse Event|0
7862191|NCT00049517|27264832|P1|Induction|Adverse Event|0
7862192|NCT00049517|27264827|P6|Induction|Disease progression|11
7862193|NCT00049517|27264828|P5|Induction|Disease progression|18
7862194|NCT00049517|27264829|P4|Induction|Disease progression|0
7862195|NCT00049517|27264830|P3|Induction|Disease progression|0
7862196|NCT00049517|27264831|P2|Induction|Disease progression|0
7862197|NCT00049517|27264832|P1|Induction|Disease progression|0
7862198|NCT00049322|27264850|P2|Overall Study|refused angio|3
7862199|NCT00049322|27264851|P1|Overall Study|refused angio|0
7862200|NCT00049322|27264850|P2|Overall Study|Adverse Event|0
7862201|NCT00049322|27264851|P1|Overall Study|Adverse Event|1
7862202|NCT00049322|27264850|P2|Overall Study|disease burden|3
7862203|NCT00049322|27264851|P1|Overall Study|disease burden|0
7862204|NCT00049257|27264863|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
7862205|NCT00049257|27264863|P1|Carboplatin, Paclitaxel|Death|2
7862206|NCT00049257|27264863|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
7862207|NCT00049257|27264863|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
7862208|NCT00049127|27264875|P5|Overall Study|Withdrawal by Subject|0
7862209|NCT00049127|27264876|P4|Overall Study|Withdrawal by Subject|0
7862210|NCT00049127|27264877|P3|Overall Study|Withdrawal by Subject|1
7862211|NCT00049127|27264878|P2|Overall Study|Withdrawal by Subject|0
7862212|NCT00049127|27264879|P1|Overall Study|Withdrawal by Subject|0
7862213|NCT00048997|27264917|P2|Overall Study|Withdrawal by Subject|1
7862214|NCT00048997|27264918|P1|Overall Study|Withdrawal by Subject|6
7862215|NCT00048997|27264917|P2|Overall Study|Protocol Violation|2
7862216|NCT00048997|27264918|P1|Overall Study|Protocol Violation|7
7862217|NCT00047385|27264941|P2|Overall Study|Eligible for screening but had no screen|492
7862218|NCT00047385|27264942|P1|Overall Study|Eligible for screening but had no screen|260
7862219|NCT00047385|27264941|P2|Overall Study|Lung Cancer diagnosed before screening|3
7862220|NCT00047385|27264942|P1|Overall Study|Lung Cancer diagnosed before screening|5
7862221|NCT00047385|27264941|P2|Overall Study|Death before any screening|5
7862222|NCT00047385|27264942|P1|Overall Study|Death before any screening|2
7862223|NCT00047320|27264960|P1|Overall Study|Ineligible|2
7862224|NCT00047320|27264960|P1|Overall Study|Withdrawal by Subject|9
7862225|NCT00047320|27264960|P1|Overall Study|Physician Decision|8
7862226|NCT00047320|27264960|P1|Overall Study|Lost to Follow-up|1
7862227|NCT00047320|27264960|P1|Overall Study|Lack of Efficacy|8
7862228|NCT00047008|27264975|P2|Overall Study|Ineligible|8
7862229|NCT00047008|27264976|P1|Overall Study|Ineligible|9
7862230|NCT00047008|27264975|P2|Overall Study|Withdrawn consent|3
7862231|NCT00047008|27264976|P1|Overall Study|Withdrawn consent|2
7862232|NCT00046930|27264984|P2|Overall Study|Ineligible|4
7862233|NCT00046930|27264985|P1|Overall Study|Ineligible|12
7862234|NCT00046891|27265000|P2|Overall Study|Adverse Event|5
7862235|NCT00046891|27265001|P1|Overall Study|Adverse Event|5
7862236|NCT00046891|27265000|P2|Overall Study|Withdrawal by Subject|15
7862237|NCT00046891|27265001|P1|Overall Study|Withdrawal by Subject|18
7862238|NCT00046891|27265000|P2|Overall Study|Ineligible|1
7862239|NCT00046891|27265001|P1|Overall Study|Ineligible|1
7862240|NCT00046891|27265000|P2|Overall Study|Cancels|9
7862241|NCT00046891|27265001|P1|Overall Study|Cancels|5
7862242|NCT00046839|27265021|P2|Overall Study|Withdrawal of consent|0
7862243|NCT00046839|27265022|P1|Overall Study|Withdrawal of consent|1
7862244|NCT00046839|27265021|P2|Overall Study|Ineligible / No protocol treatment|2
7862245|NCT00046839|27265022|P1|Overall Study|Ineligible / No protocol treatment|0
7862246|NCT00045734|27265029|P1|Overall Study|Protocol Violation|1
7862247|NCT00045708|27265044|P3|Phase 1|early progressive disease|0
7862248|NCT00045708|27265045|P2|Phase 1|early progressive disease|1
7862249|NCT00045708|27265046|P1|Phase 1|early progressive disease|0
7862250|NCT00045630|27265071|P1|Overall Study|Ineligible|2
7862251|NCT00045630|27265071|P1|Overall Study|Death|1
7862252|NCT00045630|27265071|P1|Overall Study|Progression/relapse|1
7862253|NCT00045630|27265071|P1|Overall Study|Refusal unrelated to adverse event|1
7862254|NCT00045630|27265071|P1|Overall Study|Adverse Event|1
7862255|NCT00045305|27265090|P1|Overall Study|site error|2
7862256|NCT00045305|27265090|P1|Overall Study|Death|3
7862257|NCT00045305|27265090|P1|Overall Study|Adverse Event|3
7862258|NCT00045305|27265090|P1|Overall Study|Lack of Efficacy|6
7862259|NCT00045162|27265101|P2|Overall Study|Other|16
7862260|NCT00045162|27265102|P1|Overall Study|Other|21
7862261|NCT00045162|27265101|P2|Overall Study|Withdrawal by Subject|3
7862262|NCT00045162|27265102|P1|Overall Study|Withdrawal by Subject|5
7862263|NCT00045162|27265101|P2|Overall Study|Death|10
7862264|NCT00045162|27265102|P1|Overall Study|Death|10
7862265|NCT00045162|27265101|P2|Overall Study|Lack of Efficacy|29
7862266|NCT00045162|27265102|P1|Overall Study|Lack of Efficacy|32
7862267|NCT00045162|27265101|P2|Overall Study|Adverse Event|50
7862268|NCT00045162|27265102|P1|Overall Study|Adverse Event|55
7862269|NCT00045162|27265101|P2|Overall Study|Not treated|2
7862270|NCT00045162|27265102|P1|Overall Study|Not treated|7
7862271|NCT00045162|27265101|P2|Overall Study|Ineligible|8
7862272|NCT00045162|27265102|P1|Overall Study|Ineligible|12
7862273|NCT00045110|27265117|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
7862274|NCT00045110|27265118|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
7862275|NCT00045110|27265119|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
7862276|NCT00045110|27265117|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
7862277|NCT00045110|27265118|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
7862278|NCT00045110|27265119|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
7862279|NCT00045110|27265117|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
7862280|NCT00045110|27265118|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
7862281|NCT00045110|27265119|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
7862282|NCT00045032|27265168|P3|Overall Study|Other|105
7862283|NCT00045032|27265169|P2|Overall Study|Other|84
7862284|NCT00045032|27265170|P1|Overall Study|Other|93
7862285|NCT00045032|27265168|P3|Overall Study|Failure to Return|61
7862286|NCT00045032|27265169|P2|Overall Study|Failure to Return|62
7862287|NCT00045032|27265170|P1|Overall Study|Failure to Return|57
7862288|NCT00045032|27265168|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
7862289|NCT00045032|27265169|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
7862290|NCT00045032|27265170|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
7862291|NCT00045032|27265168|P3|Overall Study|Other Protocol Violation|1
7862292|NCT00045032|27265169|P2|Overall Study|Other Protocol Violation|0
7862293|NCT00045032|27265170|P1|Overall Study|Other Protocol Violation|2
7862294|NCT00045032|27265168|P3|Overall Study|Violation of Selection Criteria at Entry|6
7862295|NCT00045032|27265169|P2|Overall Study|Violation of Selection Criteria at Entry|6
7862296|NCT00045032|27265170|P1|Overall Study|Violation of Selection Criteria at Entry|3
7862297|NCT00045032|27265168|P3|Overall Study|Insufficient Therapeutic Response|445
7862298|NCT00045032|27265169|P2|Overall Study|Insufficient Therapeutic Response|437
7862299|NCT00045032|27265170|P1|Overall Study|Insufficient Therapeutic Response|542
7862300|NCT00045032|27265168|P3|Overall Study|Death|17
7862301|NCT00045032|27265169|P2|Overall Study|Death|24
7862302|NCT00045032|27265170|P1|Overall Study|Death|22
7862303|NCT00045032|27265168|P3|Overall Study|Adverse Event/Intercurrent Illness|7
7862304|NCT00045032|27265169|P2|Overall Study|Adverse Event/Intercurrent Illness|2
7862305|NCT00045032|27265170|P1|Overall Study|Adverse Event/Intercurrent Illness|2
7862306|NCT00042991|27265304|P7|Overall Study|Alternative Therapy|0
7862307|NCT00042991|27265305|P6|Overall Study|Alternative Therapy|0
7862308|NCT00042991|27265306|P5|Overall Study|Alternative Therapy|1
7862309|NCT00042991|27265307|P4|Overall Study|Alternative Therapy|0
7862310|NCT00042991|27265308|P3|Overall Study|Alternative Therapy|0
7862311|NCT00042991|27265309|P2|Overall Study|Alternative Therapy|0
7862312|NCT00042991|27265310|P1|Overall Study|Alternative Therapy|0
7862313|NCT00042991|27265304|P7|Overall Study|Disease Progression|2
7862314|NCT00042991|27265305|P6|Overall Study|Disease Progression|4
7862315|NCT00042991|27265306|P5|Overall Study|Disease Progression|1
7862316|NCT00042991|27265307|P4|Overall Study|Disease Progression|2
7862317|NCT00042991|27265308|P3|Overall Study|Disease Progression|2
7862318|NCT00042991|27265309|P2|Overall Study|Disease Progression|29
7862319|NCT00042991|27265310|P1|Overall Study|Disease Progression|5
7862320|NCT00042991|27265304|P7|Overall Study|Withdrawal by Subject|0
7862321|NCT00042991|27265305|P6|Overall Study|Withdrawal by Subject|0
7862322|NCT00042991|27265306|P5|Overall Study|Withdrawal by Subject|1
7862323|NCT00042991|27265307|P4|Overall Study|Withdrawal by Subject|0
7862324|NCT00042991|27265308|P3|Overall Study|Withdrawal by Subject|2
7862325|NCT00042991|27265309|P2|Overall Study|Withdrawal by Subject|7
7862326|NCT00042991|27265310|P1|Overall Study|Withdrawal by Subject|0
7862327|NCT00042991|27265304|P7|Overall Study|Adverse Event|0
7862328|NCT00042991|27265305|P6|Overall Study|Adverse Event|1
7862329|NCT00042991|27265306|P5|Overall Study|Adverse Event|0
7862330|NCT00042991|27265307|P4|Overall Study|Adverse Event|0
7862331|NCT00042991|27265308|P3|Overall Study|Adverse Event|2
7862332|NCT00042991|27265309|P2|Overall Study|Adverse Event|4
7862333|NCT00042991|27265310|P1|Overall Study|Adverse Event|1
7862334|NCT00042939|27265353|P2|Overall Study|Did not start treatment|1
7862335|NCT00042939|27265354|P1|Overall Study|Did not start treatment|2
7862336|NCT00042939|27265353|P2|Overall Study|Treatment break > 4 weeks|1
7862337|NCT00042939|27265354|P1|Overall Study|Treatment break > 4 weeks|0
7862338|NCT00042939|27265353|P2|Overall Study|Still on treatment|0
7862339|NCT00042939|27265354|P1|Overall Study|Still on treatment|1
7862340|NCT00042939|27265353|P2|Overall Study|Patient non-compliance|0
7862341|NCT00042939|27265354|P1|Overall Study|Patient non-compliance|1
7862342|NCT00042939|27265353|P2|Overall Study|Rising ca 19-9|0
7862343|NCT00042939|27265354|P1|Overall Study|Rising ca 19-9|1
7862344|NCT00042939|27265353|P2|Overall Study|QOL diminished|0
7862345|NCT00042939|27265354|P1|Overall Study|QOL diminished|1
7862346|NCT00042939|27265353|P2|Overall Study|Deterioration of health|4
7862347|NCT00042939|27265354|P1|Overall Study|Deterioration of health|3
7862348|NCT00042939|27265353|P2|Overall Study|Ineligible|2
7862349|NCT00042939|27265354|P1|Overall Study|Ineligible|2
7862350|NCT00042939|27265353|P2|Overall Study|Other disease|0
7862351|NCT00042939|27265354|P1|Overall Study|Other disease|1
7862352|NCT00042939|27265353|P2|Overall Study|Withdrawal by Subject|4
7862353|NCT00042939|27265354|P1|Overall Study|Withdrawal by Subject|3
7862354|NCT00042939|27265353|P2|Overall Study|Death|2
7862355|NCT00042939|27265354|P1|Overall Study|Death|3
7862356|NCT00042939|27265353|P2|Overall Study|Adverse Event|7
7862357|NCT00042939|27265354|P1|Overall Study|Adverse Event|6
7862358|NCT00041132|27265368|P1|Overall Study|Physician Decision|2
7862359|NCT00041132|27265368|P1|Overall Study|Withdrawal by Subject|1
7862360|NCT00041132|27265368|P1|Overall Study|Not Eligible|7
7862361|NCT00041132|27265368|P1|Overall Study|Death|1
7862362|NCT00041132|27265368|P1|Overall Study|Adverse Event|19
7862363|NCT00041080|27265403|P2|Overall Study|Ineligible|0
7862364|NCT00041080|27265404|P1|Overall Study|Ineligible|1
7862365|NCT00041080|27265403|P2|Overall Study|Did not start therapy|1
7862366|NCT00041080|27265404|P1|Overall Study|Did not start therapy|1
7862367|NCT00041080|27265403|P2|Overall Study|Concommitant Illness/Other|2
7862368|NCT00041080|27265404|P1|Overall Study|Concommitant Illness/Other|1
7862369|NCT00041080|27265403|P2|Overall Study|Withdrawal by Subject|6
7862370|NCT00041080|27265404|P1|Overall Study|Withdrawal by Subject|6
7862371|NCT00041080|27265403|P2|Overall Study|Adverse Event|1
7862372|NCT00041080|27265404|P1|Overall Study|Adverse Event|21
7862373|NCT00041067|27265410|P1|Overall Study|Ineligible|2
7862374|NCT00041067|27265410|P1|Overall Study|Other reasons|23
7862375|NCT00041067|27265410|P1|Overall Study|Patient refusal|12
7862376|NCT00041067|27265410|P1|Overall Study|Progression|19
7862377|NCT00041067|27265410|P1|Overall Study|Adverse Event|20
7862378|NCT00040742|27265477|P4|Overall Study|Other medical|5
7862379|NCT00040742|27265478|P3|Overall Study|Other medical|5
7862380|NCT00040742|27265479|P2|Overall Study|Other medical|5
7862381|NCT00040742|27265480|P1|Overall Study|Other medical|7
7862382|NCT00040742|27265477|P4|Overall Study|Incomplete Forms|5
7862383|NCT00040742|27265478|P3|Overall Study|Incomplete Forms|4
7862384|NCT00040742|27265479|P2|Overall Study|Incomplete Forms|10
7862385|NCT00040742|27265480|P1|Overall Study|Incomplete Forms|6
7862386|NCT00040742|27265477|P4|Overall Study|Chemotoxicity|2
7862387|NCT00040742|27265478|P3|Overall Study|Chemotoxicity|5
7862388|NCT00040742|27265479|P2|Overall Study|Chemotoxicity|3
7862389|NCT00040742|27265480|P1|Overall Study|Chemotoxicity|4
7862390|NCT00040742|27265477|P4|Overall Study|Withdrawal by Subject|13
7862391|NCT00040742|27265478|P3|Overall Study|Withdrawal by Subject|10
7862392|NCT00040742|27265479|P2|Overall Study|Withdrawal by Subject|15
7862393|NCT00040742|27265480|P1|Overall Study|Withdrawal by Subject|7
7862394|NCT00040742|27265477|P4|Overall Study|Adverse Event|9
7862395|NCT00040742|27265478|P3|Overall Study|Adverse Event|21
7862396|NCT00040742|27265479|P2|Overall Study|Adverse Event|16
7862397|NCT00040742|27265480|P1|Overall Study|Adverse Event|15
7862398|NCT00040742|27265477|P4|Overall Study|Death|0
7862399|NCT00040742|27265478|P3|Overall Study|Death|1
7862400|NCT00040742|27265479|P2|Overall Study|Death|0
7862401|NCT00040742|27265480|P1|Overall Study|Death|0
7862402|NCT00039377|27265494|P4|Initial Registration|Withdrawal by Subject|0
7862403|NCT00039377|27265495|P3|Initial Registration|Withdrawal by Subject|0
7862404|NCT00039377|27265496|P2|Initial Registration|Withdrawal by Subject|0
7862405|NCT00039377|27265497|P1|Initial Registration|Withdrawal by Subject|3
7862406|NCT00039377|27265494|P4|Initial Registration|Received non-protocol therapy|0
7862407|NCT00039377|27265495|P3|Initial Registration|Received non-protocol therapy|0
7862408|NCT00039377|27265496|P2|Initial Registration|Received non-protocol therapy|0
7862409|NCT00039377|27265497|P1|Initial Registration|Received non-protocol therapy|11
7862410|NCT00039377|27265494|P4|Initial Registration|Relapsed|0
7862411|NCT00039377|27265495|P3|Initial Registration|Relapsed|0
7862412|NCT00039377|27265496|P2|Initial Registration|Relapsed|0
7862413|NCT00039377|27265497|P1|Initial Registration|Relapsed|6
7862414|NCT00039377|27265494|P4|Initial Registration|Adverse Event|0
7862415|NCT00039377|27265495|P3|Initial Registration|Adverse Event|0
7862416|NCT00039377|27265496|P2|Initial Registration|Adverse Event|0
7862417|NCT00039377|27265497|P1|Initial Registration|Adverse Event|2
7862418|NCT00039130|27265513|P1|Overall Study|Physician Decision|3
7862419|NCT00039130|27265513|P1|Overall Study|Subsequent treatment|2
7862420|NCT00039130|27265513|P1|Overall Study|Progression|2
7862421|NCT00039130|27265513|P1|Overall Study|Withdrawal by Subject|3
7862422|NCT00039130|27265513|P1|Overall Study|Death|9
7862423|NCT00039130|27265513|P1|Overall Study|Adverse Event|11
7862424|NCT00033657|27265529|P2|Adjuvant Chemotherapy|Other|2
7862425|NCT00033657|27265530|P1|Adjuvant Chemotherapy|Other|0
7862426|NCT00033657|27265529|P2|Adjuvant Chemotherapy|alternative therapy|0
7862427|NCT00033657|27265530|P1|Adjuvant Chemotherapy|alternative therapy|1
7862428|NCT00033657|27265529|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
7862429|NCT00033657|27265530|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
7862430|NCT00033657|27265529|P2|Adjuvant Chemotherapy|Death|1
7862431|NCT00033657|27265530|P1|Adjuvant Chemotherapy|Death|2
7862432|NCT00033657|27265529|P2|Adjuvant Chemotherapy|Adverse Event|10
7862433|NCT00033657|27265530|P1|Adjuvant Chemotherapy|Adverse Event|7
7862434|NCT00033657|27265529|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
7862435|NCT00033657|27265530|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
7862436|NCT00033657|27265529|P2|Surgical Resection|not complete resection|3
7862437|NCT00033657|27265530|P1|Surgical Resection|not complete resection|0
7862438|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
7862439|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
7862440|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|Ineligible|4
7862441|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|Ineligible|8
7862442|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|other complicating disease|1
7862443|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|other complicating disease|0
7862444|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
7862445|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7862446|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|Death|1
7862447|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|Death|1
7862448|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|Adverse Event|2
7862449|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|Adverse Event|0
7862450|NCT00033657|27265529|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
7862451|NCT00033657|27265530|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
7862452|NCT00033631|27265544|P2|Overall Study|Withdrawal by Subject|4
7862453|NCT00033631|27265545|P1|Overall Study|Withdrawal by Subject|4
7862454|NCT00033631|27265544|P2|Overall Study|Protocol Violation|11
7862455|NCT00033631|27265545|P1|Overall Study|Protocol Violation|14
7862456|NCT00033540|27265567|P1|Overall Study|Never received treatment|2
7862457|NCT00033540|27265567|P1|Overall Study|Ineligible|3
7862458|NCT00033540|27265567|P1|Overall Study|Other|5
7862459|NCT00033540|27265567|P1|Overall Study|Withdrawal by Subject|6
7862460|NCT00033540|27265567|P1|Overall Study|Progression|26
7862461|NCT00033540|27265567|P1|Overall Study|Death|1
7862462|NCT00033540|27265567|P1|Overall Study|Adverse Event|14
7862463|NCT00033514|27265577|P2|Overall Study|Withdrawal by Subject|3
7862464|NCT00033514|27265578|P1|Overall Study|Withdrawal by Subject|0
7862465|NCT00033514|27265577|P2|Overall Study|Lost to Follow-up|1
7862466|NCT00033514|27265578|P1|Overall Study|Lost to Follow-up|1
7862467|NCT00033371|27265588|P2|Overall Study|Disease Progression|1
7862468|NCT00033371|27265589|P1|Overall Study|Disease Progression|0
7862469|NCT00033371|27265588|P2|Overall Study|Withdrawal by Subject|3
7862470|NCT00033371|27265589|P1|Overall Study|Withdrawal by Subject|3
7862471|NCT00033371|27265588|P2|Overall Study|Lost to Follow-up|1
7862472|NCT00033371|27265589|P1|Overall Study|Lost to Follow-up|2
7862473|NCT00033371|27265588|P2|Overall Study|Adverse Event|5
7862474|NCT00033371|27265589|P1|Overall Study|Adverse Event|1
7862475|NCT00033293|27265607|P2|Overall Study|Treatment refused|6
7862476|NCT00033293|27265608|P1|Overall Study|Treatment refused|0
7862477|NCT00033293|27265607|P2|Overall Study|Could not be weaned from steroid therapy|1
7862478|NCT00033293|27265608|P1|Overall Study|Could not be weaned from steroid therapy|1
7862479|NCT00033293|27265607|P2|Overall Study|Withdrawal by Subject|0
7862480|NCT00033293|27265608|P1|Overall Study|Withdrawal by Subject|1
7862481|NCT00033293|27265607|P2|Overall Study|Physician Decision|1
7862482|NCT00033293|27265608|P1|Overall Study|Physician Decision|3
7862483|NCT00033293|27265607|P2|Overall Study|Lost to Follow-up|1
7862484|NCT00033293|27265608|P1|Overall Study|Lost to Follow-up|0
7862485|NCT00033293|27265607|P2|Overall Study|Lack of Efficacy|8
7862486|NCT00033293|27265608|P1|Overall Study|Lack of Efficacy|5
7862487|NCT00033293|27265607|P2|Overall Study|Death|1
7862488|NCT00033293|27265608|P1|Overall Study|Death|0
7862489|NCT00031694|27265626|P1|Overall Study|Withdrawal by Subject|5
7862490|NCT00031694|27265626|P1|Overall Study|Death|2
7862491|NCT00031694|27265626|P1|Overall Study|Adverse Event|12
7862492|NCT00031590|27265632|P1|Overall Study|Withdrawal by parents|2
7862493|NCT00031590|27265632|P1|Overall Study|Adverse Event|1
7862494|NCT00030901|27265639|P3|Randomization|Ineligible|14
7862495|NCT00030901|27265640|P2|Randomization|Ineligible|15
7862496|NCT00030901|27265641|P1|Randomization|Ineligible|0
7862497|NCT00030901|27265639|P3|Randomization|Other|33
7862498|NCT00030901|27265640|P2|Randomization|Other|36
7862499|NCT00030901|27265641|P1|Randomization|Other|0
7862500|NCT00030901|27265639|P3|Randomization|Death|3
7862501|NCT00030901|27265640|P2|Randomization|Death|1
7862502|NCT00030901|27265641|P1|Randomization|Death|0
7862503|NCT00030901|27265639|P3|Randomization|Progression/Relapse|21
7862504|NCT00030901|27265640|P2|Randomization|Progression/Relapse|22
7862505|NCT00030901|27265641|P1|Randomization|Progression/Relapse|0
7862506|NCT00030901|27265639|P3|Randomization|Refusal Unrelated to Adverse Event|10
7862507|NCT00030901|27265640|P2|Randomization|Refusal Unrelated to Adverse Event|16
7862508|NCT00030901|27265641|P1|Randomization|Refusal Unrelated to Adverse Event|0
7862509|NCT00030901|27265639|P3|Randomization|Adverse Event|7
7862510|NCT00030901|27265640|P2|Randomization|Adverse Event|11
7862511|NCT00030901|27265641|P1|Randomization|Adverse Event|0
7862512|NCT00030901|27265639|P3|Initial Registration|Ineligible|0
7862513|NCT00030901|27265640|P2|Initial Registration|Ineligible|0
7862514|NCT00030901|27265641|P1|Initial Registration|Ineligible|167
7862515|NCT00030823|27265649|P1|Overall Study|Withdrawal by Subject|1
7862516|NCT00028769|27265657|P1|Overall Study|Not Analyzable|1
7862517|NCT00028769|27265657|P1|Overall Study|Ineligible|5
7862518|NCT00028769|27265657|P1|Overall Study|Other - Not Protocol Specified|1
7862519|NCT00028769|27265657|P1|Overall Study|Progression or Death|31
7862520|NCT00028769|27265657|P1|Overall Study|Refusal Unrelated to Adverse Events|1
7862521|NCT00028769|27265657|P1|Overall Study|Adverse Event|2
7862522|NCT00028002|27265663|P1|Overall Study|Ineligible|8
7862523|NCT00028002|27265663|P1|Overall Study|Withdrawal by Subject|3
7862524|NCT00027846|27265673|P3|Overall Study|Neuraxis dissemination during/after ther|5
7862525|NCT00027846|27265674|P2|Overall Study|Neuraxis dissemination during/after ther|2
7862526|NCT00027846|27265675|P1|Overall Study|Neuraxis dissemination during/after ther|0
7862527|NCT00027846|27265673|P3|Overall Study|Entry into another COG therapeutic study|2
7862528|NCT00027846|27265674|P2|Overall Study|Entry into another COG therapeutic study|5
7862529|NCT00027846|27265675|P1|Overall Study|Entry into another COG therapeutic study|0
7862530|NCT00027846|27265673|P3|Overall Study|Ineligible for study|14
7862531|NCT00027846|27265674|P2|Overall Study|Ineligible for study|6
7862532|NCT00027846|27265675|P1|Overall Study|Ineligible for study|2
7862533|NCT00027846|27265673|P3|Overall Study|Withdrawal by Subject|7
7862534|NCT00027846|27265674|P2|Overall Study|Withdrawal by Subject|14
7862535|NCT00027846|27265675|P1|Overall Study|Withdrawal by Subject|0
7862536|NCT00027846|27265673|P3|Overall Study|Lost to Follow-up|9
7862537|NCT00027846|27265674|P2|Overall Study|Lost to Follow-up|41
7862538|NCT00027846|27265675|P1|Overall Study|Lost to Follow-up|0
7862539|NCT00027560|27265693|P1|Overall Study|Withdrawal by Subject|1
7862540|NCT00026494|27265706|P4|Overall Study|Clinical progression|0
7862541|NCT00026494|27265707|P3|Overall Study|Clinical progression|3
7862542|NCT00026494|27265708|P2|Overall Study|Clinical progression|0
7862543|NCT00026494|27265709|P1|Overall Study|Clinical progression|0
7862544|NCT00026494|27265706|P4|Overall Study|Patient not treated|0
7862545|NCT00026494|27265707|P3|Overall Study|Patient not treated|2
7862546|NCT00026494|27265708|P2|Overall Study|Patient not treated|0
7862547|NCT00026494|27265709|P1|Overall Study|Patient not treated|0
7862548|NCT00026494|27265706|P4|Overall Study|Patient non-compliance|0
7862549|NCT00026494|27265707|P3|Overall Study|Patient non-compliance|0
7862550|NCT00026494|27265708|P2|Overall Study|Patient non-compliance|0
7862551|NCT00026494|27265709|P1|Overall Study|Patient non-compliance|1
7862552|NCT00026494|27265706|P4|Overall Study|Withdrawal by Subject|0
7862553|NCT00026494|27265707|P3|Overall Study|Withdrawal by Subject|1
7862554|NCT00026494|27265708|P2|Overall Study|Withdrawal by Subject|0
7862555|NCT00026494|27265709|P1|Overall Study|Withdrawal by Subject|1
7862556|NCT00026312|27265721|P2|Overall Study|Refusal by patient/parent/guardian|59
7862557|NCT00026312|27265722|P1|Overall Study|Refusal by patient/parent/guardian|8
7862558|NCT00026312|27265721|P2|Overall Study|Entry onto another COG study|1
7862559|NCT00026312|27265722|P1|Overall Study|Entry onto another COG study|0
7862560|NCT00026312|27265721|P2|Overall Study|Ineligible|5
7862561|NCT00026312|27265722|P1|Overall Study|Ineligible|4
7862562|NCT00026312|27265721|P2|Overall Study|Withdrawal by Subject|6
7862563|NCT00026312|27265722|P1|Overall Study|Withdrawal by Subject|1
7862564|NCT00026312|27265721|P2|Overall Study|Protocol Violation|3
7862565|NCT00026312|27265722|P1|Overall Study|Protocol Violation|0
7862566|NCT00026312|27265721|P2|Overall Study|Physician Decision|37
7862567|NCT00026312|27265722|P1|Overall Study|Physician Decision|1
7862568|NCT00026312|27265721|P2|Overall Study|Lost to Follow-up|5
7862569|NCT00026312|27265722|P1|Overall Study|Lost to Follow-up|0
7862570|NCT00026312|27265721|P2|Overall Study|Lack of Efficacy|114
7862571|NCT00026312|27265722|P1|Overall Study|Lack of Efficacy|19
7862572|NCT00026312|27265721|P2|Overall Study|Death|7
7862573|NCT00026312|27265722|P1|Overall Study|Death|1
7862574|NCT00026312|27265721|P2|Overall Study|Adverse Event|32
7862575|NCT00026312|27265722|P1|Overall Study|Adverse Event|0
7862576|NCT00026208|27265761|P2|Overall Study|Complications of auto accident|0
7862577|NCT00026208|27265762|P1|Overall Study|Complications of auto accident|1
7862578|NCT00025662|27265780|P1|Overall Study|Technical failure of manipulation|1
7862579|NCT00025662|27265780|P1|Overall Study|Withdrawal by Subject|2
7862580|NCT00025506|27265788|P1|Overall Study|Never Treated|2
7862581|NCT00025506|27265788|P1|Overall Study|Ineligible: inadequate pathology|2
7862582|NCT00025506|27265788|P1|Overall Study|Ineligible: wrong cell type|5
7862583|NCT00025506|27265788|P1|Overall Study|Ineligible: clerical error|1
7862584|NCT00025259|27265809|P7|Overall Study|Adverse Event|0
7862585|NCT00025259|27265810|P6|Overall Study|Adverse Event|0
7862586|NCT00025259|27265811|P5|Overall Study|Adverse Event|0
7862587|NCT00025259|27265812|P4|Overall Study|Adverse Event|0
7862588|NCT00025259|27265813|P3|Overall Study|Adverse Event|0
7862589|NCT00025259|27265814|P2|Overall Study|Adverse Event|0
7862590|NCT00025259|27265815|P1|Overall Study|Adverse Event|1
7862591|NCT00025259|27265809|P7|Overall Study|Randomization error|2
7862592|NCT00025259|27265810|P6|Overall Study|Randomization error|7
7862593|NCT00025259|27265811|P5|Overall Study|Randomization error|1
7862594|NCT00025259|27265812|P4|Overall Study|Randomization error|0
7862595|NCT00025259|27265813|P3|Overall Study|Randomization error|0
7862596|NCT00025259|27265814|P2|Overall Study|Randomization error|0
7862597|NCT00025259|27265815|P1|Overall Study|Randomization error|1
7862598|NCT00025259|27265809|P7|Overall Study|Ineligible|1
7862599|NCT00025259|27265810|P6|Overall Study|Ineligible|0
7862600|NCT00025259|27265811|P5|Overall Study|Ineligible|6
7862601|NCT00025259|27265812|P4|Overall Study|Ineligible|0
7862602|NCT00025259|27265813|P3|Overall Study|Ineligible|0
7862603|NCT00025259|27265814|P2|Overall Study|Ineligible|1
7862604|NCT00025259|27265815|P1|Overall Study|Ineligible|14
7862605|NCT00025259|27265809|P7|Overall Study|Withdrawal by Subject|3
7862606|NCT00025259|27265810|P6|Overall Study|Withdrawal by Subject|8
7862607|NCT00025259|27265811|P5|Overall Study|Withdrawal by Subject|11
7862608|NCT00025259|27265812|P4|Overall Study|Withdrawal by Subject|14
7862609|NCT00025259|27265813|P3|Overall Study|Withdrawal by Subject|6
7862610|NCT00025259|27265814|P2|Overall Study|Withdrawal by Subject|27
7862611|NCT00025259|27265815|P1|Overall Study|Withdrawal by Subject|9
7862612|NCT00025259|27265809|P7|Overall Study|Protocol Violation|3
7862613|NCT00025259|27265810|P6|Overall Study|Protocol Violation|1
7862614|NCT00025259|27265811|P5|Overall Study|Protocol Violation|2
7862615|NCT00025259|27265812|P4|Overall Study|Protocol Violation|1
7862616|NCT00025259|27265813|P3|Overall Study|Protocol Violation|2
7862617|NCT00025259|27265814|P2|Overall Study|Protocol Violation|2
7862618|NCT00025259|27265815|P1|Overall Study|Protocol Violation|3
7862619|NCT00025259|27265809|P7|Overall Study|Physician Decision|1
7862620|NCT00025259|27265810|P6|Overall Study|Physician Decision|2
7862621|NCT00025259|27265811|P5|Overall Study|Physician Decision|4
7862622|NCT00025259|27265812|P4|Overall Study|Physician Decision|5
7862623|NCT00025259|27265813|P3|Overall Study|Physician Decision|0
7862624|NCT00025259|27265814|P2|Overall Study|Physician Decision|1
7862625|NCT00025259|27265815|P1|Overall Study|Physician Decision|12
7862626|NCT00025259|27265809|P7|Overall Study|Lost to Follow-up|1
7862627|NCT00025259|27265810|P6|Overall Study|Lost to Follow-up|3
7862628|NCT00025259|27265811|P5|Overall Study|Lost to Follow-up|1
7862629|NCT00025259|27265812|P4|Overall Study|Lost to Follow-up|13
7862630|NCT00025259|27265813|P3|Overall Study|Lost to Follow-up|13
7862631|NCT00025259|27265814|P2|Overall Study|Lost to Follow-up|9
7862632|NCT00025259|27265815|P1|Overall Study|Lost to Follow-up|2
7862633|NCT00025259|27265809|P7|Overall Study|Lack of Efficacy|38
7862634|NCT00025259|27265810|P6|Overall Study|Lack of Efficacy|30
7862635|NCT00025259|27265811|P5|Overall Study|Lack of Efficacy|11
7862636|NCT00025259|27265812|P4|Overall Study|Lack of Efficacy|78
7862637|NCT00025259|27265813|P3|Overall Study|Lack of Efficacy|60
7862638|NCT00025259|27265814|P2|Overall Study|Lack of Efficacy|46
7862639|NCT00025259|27265815|P1|Overall Study|Lack of Efficacy|2
7862640|NCT00025259|27265809|P7|Overall Study|Death|2
7862641|NCT00025259|27265810|P6|Overall Study|Death|1
7862642|NCT00025259|27265811|P5|Overall Study|Death|0
7862643|NCT00025259|27265812|P4|Overall Study|Death|3
7862644|NCT00025259|27265813|P3|Overall Study|Death|0
7862645|NCT00025259|27265814|P2|Overall Study|Death|3
7862646|NCT00025259|27265815|P1|Overall Study|Death|1
7862647|NCT00025233|27265851|P1|Overall Study|Never treated|1
7862648|NCT00025233|27265851|P1|Overall Study|Ineligible: improper prior treatment|1
7862649|NCT00025233|27265851|P1|Overall Study|Ineligible: wrong primary|1
7862650|NCT00025233|27265851|P1|Overall Study|Ineligible: wrong cell type|1
7862651|NCT00025155|27265866|P1|Overall Study|Ineligible: Second primary cancer site|1
7862652|NCT00025155|27265866|P1|Overall Study|Ineligible: Wrong primary cancer site|1
7862653|NCT00024258|27265877|P1|Overall Study|Disease Progression|8
7862654|NCT00024258|27265877|P1|Overall Study|Withdrawal by Subject|1
7862655|NCT00024167|27265884|P2|Overall Study|Death|47
7862656|NCT00024167|27265885|P1|Overall Study|Death|53
7862657|NCT00023764|27265909|P1|Overall Study|delay in obtaining staging images|1
7862658|NCT00023764|27265909|P1|Overall Study|patient received other treatment|1
7862659|NCT00023764|27265909|P1|Overall Study|Progression of disease|6
7862660|NCT00023764|27265909|P1|Overall Study|Withdrawal by Subject|1
7862661|NCT00023764|27265909|P1|Overall Study|Adverse Event|4
7862662|NCT00023764|27265909|P1|Overall Study|Other|1
7862663|NCT00023712|27265916|P2|Overall Study|Never treated|1
7862664|NCT00023712|27265917|P1|Overall Study|Never treated|1
7862665|NCT00023712|27265916|P2|Overall Study|Not platinum sensitive|0
7862666|NCT00023712|27265917|P1|Overall Study|Not platinum sensitive|1
7862667|NCT00022698|27265941|P2|Overall Study|Administrative /other|7
7862668|NCT00022698|27265942|P1|Overall Study|Administrative /other|1
7862669|NCT00022698|27265941|P2|Overall Study|Insufficient therapeutic response|14
7862670|NCT00022698|27265942|P1|Overall Study|Insufficient therapeutic response|2
7862671|NCT00022698|27265941|P2|Overall Study|Refused treatment|2
7862672|NCT00022698|27265942|P1|Overall Study|Refused treatment|0
7862673|NCT00022698|27265941|P2|Overall Study|Failure to return|1
7862674|NCT00022698|27265942|P1|Overall Study|Failure to return|0
7862675|NCT00022698|27265941|P2|Overall Study|Death|2
7862676|NCT00022698|27265942|P1|Overall Study|Death|0
7862677|NCT00022698|27265941|P2|Overall Study|Adverse Event|9
7862678|NCT00022698|27265942|P1|Overall Study|Adverse Event|5
7862679|NCT00022672|27265967|P2|Extension Phase|Other|1
7862680|NCT00022672|27265968|P1|Extension Phase|Other|1
7862681|NCT00022672|27265967|P2|Extension Phase|Refused Treatment|2
7862682|NCT00022672|27265968|P1|Extension Phase|Refused Treatment|0
7862683|NCT00022672|27265967|P2|Extension Phase|Insufficient Therapeutic Response|44
7862684|NCT00022672|27265968|P1|Extension Phase|Insufficient Therapeutic Response|1
7862685|NCT00022672|27265967|P2|Extension Phase|Death|1
7862686|NCT00022672|27265968|P1|Extension Phase|Death|0
7862687|NCT00022672|27265967|P2|Extension Phase|Adverse Event|3
7862688|NCT00022672|27265968|P1|Extension Phase|Adverse Event|1
7862689|NCT00022672|27265967|P2|Main Phase: 24 Months|Other|0
7862690|NCT00022672|27265968|P1|Main Phase: 24 Months|Other|1
7862691|NCT00022672|27265967|P2|Main Phase: 24 Months|Failure to Return|1
7862692|NCT00022672|27265968|P1|Main Phase: 24 Months|Failure to Return|1
7862693|NCT00022672|27265967|P2|Main Phase: 24 Months|Refused Treatment|4
7862694|NCT00022672|27265968|P1|Main Phase: 24 Months|Refused Treatment|3
7862695|NCT00022672|27265967|P2|Main Phase: 24 Months|Other Protocol Violation|0
7862696|NCT00022672|27265968|P1|Main Phase: 24 Months|Other Protocol Violation|1
7862697|NCT00022672|27265967|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
7862698|NCT00022672|27265968|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
7862699|NCT00022672|27265967|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
7862700|NCT00022672|27265968|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
7862701|NCT00022672|27265967|P2|Main Phase: 24 Months|Death|3
7862702|NCT00022672|27265968|P1|Main Phase: 24 Months|Death|0
7862703|NCT00022672|27265967|P2|Main Phase: 24 Months|Adverse Event|0
7862704|NCT00022672|27265968|P1|Main Phase: 24 Months|Adverse Event|6
7862705|NCT00022659|27266001|P1|Overall Study|Never treated|1
7862706|NCT00022659|27266001|P1|Overall Study|Ineligible: wrong primary|1
7862707|NCT00022633|27266014|P2|Overall Study|Ineligible|0
7862708|NCT00022633|27266015|P1|Overall Study|Ineligible|4
7862709|NCT00022633|27266014|P2|Overall Study|Other - not protocol specified|2
7862710|NCT00022633|27266015|P1|Overall Study|Other - not protocol specified|3
7862711|NCT00022633|27266014|P2|Overall Study|Death|0
7862712|NCT00022633|27266015|P1|Overall Study|Death|4
7862713|NCT00022633|27266014|P2|Overall Study|Progression/relapse|2
7862714|NCT00022633|27266015|P1|Overall Study|Progression/relapse|9
7862715|NCT00022633|27266014|P2|Overall Study|Refusal unrelated to adverse event|0
7862716|NCT00022633|27266015|P1|Overall Study|Refusal unrelated to adverse event|1
7862717|NCT00022633|27266014|P2|Overall Study|Adverse Event|1
7862718|NCT00022633|27266015|P1|Overall Study|Adverse Event|11
7862719|NCT00022516|27266028|P2|Overall Study|Incomplete documentation|27
7862720|NCT00022516|27266029|P1|Overall Study|Incomplete documentation|0
7862721|NCT00022516|27266028|P2|Overall Study|Withdrawal by Subject|113
7862722|NCT00022516|27266029|P1|Overall Study|Withdrawal by Subject|2
7862723|NCT00022516|27266028|P2|Overall Study|Protocol Violation|3
7862724|NCT00022516|27266029|P1|Overall Study|Protocol Violation|1
7862725|NCT00022516|27266028|P2|Overall Study|Physician Decision|1
7862726|NCT00022516|27266029|P1|Overall Study|Physician Decision|0
7862727|NCT00022516|27266028|P2|Overall Study|Lack of Efficacy|27
7862728|NCT00022516|27266029|P1|Overall Study|Lack of Efficacy|0
7862729|NCT00022516|27266028|P2|Overall Study|Adverse Event|59
7862730|NCT00022516|27266029|P1|Overall Study|Adverse Event|0
7862731|NCT00021255|27266048|P3|Overall Study|Randomized but not treated|18
7862732|NCT00021255|27266049|P2|Overall Study|Randomized but not treated|2
7862733|NCT00021255|27266050|P1|Overall Study|Randomized but not treated|28
7862734|NCT00021255|27266048|P3|Overall Study|Missing|13
7862735|NCT00021255|27266049|P2|Overall Study|Missing|27
7862736|NCT00021255|27266050|P1|Overall Study|Missing|0
7862737|NCT00021255|27266048|P3|Overall Study|Other than specified above|19
7862738|NCT00021255|27266049|P2|Overall Study|Other than specified above|38
7862739|NCT00021255|27266050|P1|Overall Study|Other than specified above|0
7862740|NCT00021255|27266048|P3|Overall Study|Protocol Violation|0
7862741|NCT00021255|27266049|P2|Overall Study|Protocol Violation|2
7862742|NCT00021255|27266050|P1|Overall Study|Protocol Violation|0
7862743|NCT00021255|27266048|P3|Overall Study|Adverse Event|18
7862744|NCT00021255|27266049|P2|Overall Study|Adverse Event|30
7862745|NCT00021255|27266050|P1|Overall Study|Adverse Event|46
7862746|NCT00021255|27266048|P3|Overall Study|Herceptin toxicity|6
7862747|NCT00021255|27266049|P2|Overall Study|Herceptin toxicity|22
7862748|NCT00021255|27266050|P1|Overall Study|Herceptin toxicity|0
7862749|NCT00021255|27266048|P3|Overall Study|Cardiac toxicity|32
7862750|NCT00021255|27266049|P2|Overall Study|Cardiac toxicity|61
7862751|NCT00021255|27266050|P1|Overall Study|Cardiac toxicity|0
7862752|NCT00021255|27266048|P3|Overall Study|Lost to Follow-up|3
7862753|NCT00021255|27266049|P2|Overall Study|Lost to Follow-up|2
7862754|NCT00021255|27266050|P1|Overall Study|Lost to Follow-up|0
7862755|NCT00021255|27266048|P3|Overall Study|Withdrawal by Subject|26
7862756|NCT00021255|27266049|P2|Overall Study|Withdrawal by Subject|64
7862757|NCT00021255|27266050|P1|Overall Study|Withdrawal by Subject|41
7862758|NCT00021255|27266048|P3|Overall Study|Second primary malignancy|1
7862759|NCT00021255|27266049|P2|Overall Study|Second primary malignancy|4
7862760|NCT00021255|27266050|P1|Overall Study|Second primary malignancy|0
7862761|NCT00021255|27266048|P3|Overall Study|Breast cancer relapse|11
7862762|NCT00021255|27266049|P2|Overall Study|Breast cancer relapse|18
7862763|NCT00021255|27266050|P1|Overall Study|Breast cancer relapse|5
7862764|NCT00021255|27266048|P3|Overall Study|Death|2
7862765|NCT00021255|27266049|P2|Overall Study|Death|0
7862766|NCT00021255|27266050|P1|Overall Study|Death|1
7862767|NCT00021229|27266067|P3|Overall Study|Punctate hemmorrhage post RT|0
7862768|NCT00021229|27266068|P2|Overall Study|Punctate hemmorrhage post RT|0
7862769|NCT00021229|27266069|P1|Overall Study|Punctate hemmorrhage post RT|2
7862770|NCT00021229|27266067|P3|Overall Study|Physician Decision|1
7862771|NCT00021229|27266068|P2|Overall Study|Physician Decision|0
7862772|NCT00021229|27266069|P1|Overall Study|Physician Decision|0
7862773|NCT00021229|27266067|P3|Overall Study|Protocol Violation|0
7862774|NCT00021229|27266068|P2|Overall Study|Protocol Violation|1
7862775|NCT00021229|27266069|P1|Overall Study|Protocol Violation|1
7862776|NCT00021229|27266067|P3|Overall Study|Progressive Disease|12
7862777|NCT00021229|27266068|P2|Overall Study|Progressive Disease|19
7862778|NCT00021229|27266069|P1|Overall Study|Progressive Disease|15
7862779|NCT00021229|27266067|P3|Overall Study|Withdrawal by Subject|1
7862780|NCT00021229|27266068|P2|Overall Study|Withdrawal by Subject|7
7862781|NCT00021229|27266069|P1|Overall Study|Withdrawal by Subject|7
7862782|NCT00021229|27266067|P3|Overall Study|Death|0
7862783|NCT00021229|27266068|P2|Overall Study|Death|1
7862784|NCT00021229|27266069|P1|Overall Study|Death|0
7862785|NCT00021229|27266067|P3|Overall Study|Adverse Event|2
7862786|NCT00021229|27266068|P2|Overall Study|Adverse Event|5
7862787|NCT00021229|27266069|P1|Overall Study|Adverse Event|10
7862788|NCT00019604|27266124|P1|Overall Study|Details for other not available|4
7862789|NCT00019604|27266124|P1|Overall Study|Unable to evaluate|1
7862790|NCT00019604|27266124|P1|Overall Study|Too much disease|1
7862791|NCT00019604|27266124|P1|Overall Study|Pt going to immunotherapy study|1
7862792|NCT00019604|27266124|P1|Overall Study|Started new chemo regimen|1
7862793|NCT00019604|27266124|P1|Overall Study|Resectable disease|1
7862794|NCT00019604|27266124|P1|Overall Study|Non compliant|1
7862795|NCT00019604|27266124|P1|Overall Study|Non compliant on systemic CH|1
7862796|NCT00019604|27266124|P1|Overall Study|Move to a different study|1
7862797|NCT00019604|27266124|P1|Overall Study|Going to have liver transplant|1
7862798|NCT00019604|27266124|P1|Overall Study|Carcinoid tumor, not treatable|1
7862799|NCT00019604|27266124|P1|Overall Study|Refused treatment|1
7862800|NCT00019604|27266124|P1|Overall Study|Progressive disease|23
7862801|NCT00019604|27266124|P1|Overall Study|Death|1
7862802|NCT00016354|27266147|P8|Overall Study|Lack of Efficacy|1
7862803|NCT00016354|27266148|P7|Overall Study|Lack of Efficacy|0
7862804|NCT00016354|27266149|P6|Overall Study|Lack of Efficacy|0
7862805|NCT00016354|27266150|P5|Overall Study|Lack of Efficacy|0
7862806|NCT00016354|27266151|P4|Overall Study|Lack of Efficacy|0
7862807|NCT00016354|27266152|P3|Overall Study|Lack of Efficacy|0
7862808|NCT00016354|27266153|P2|Overall Study|Lack of Efficacy|0
7862809|NCT00016354|27266154|P1|Overall Study|Lack of Efficacy|0
7862810|NCT00014495|27266168|P4|Overall Study|Clinical deterioration|1
7862811|NCT00014495|27266169|P3|Overall Study|Clinical deterioration|0
7862812|NCT00014495|27266170|P2|Overall Study|Clinical deterioration|0
7862813|NCT00014495|27266171|P1|Overall Study|Clinical deterioration|0
7862814|NCT00014495|27266168|P4|Overall Study|Death|0
7862815|NCT00014495|27266169|P3|Overall Study|Death|1
7862816|NCT00014495|27266170|P2|Overall Study|Death|0
7862817|NCT00014495|27266171|P1|Overall Study|Death|0
7862818|NCT00012012|27266237|P2|Overall Study|Withdrawal by Subject|2
7862819|NCT00012012|27266238|P1|Overall Study|Withdrawal by Subject|0
7862820|NCT00012012|27266237|P2|Overall Study|Protocol Violation|1
7862821|NCT00012012|27266238|P1|Overall Study|Protocol Violation|1
7862822|NCT00010257|27266277|P2|Overall Study|Withdrawal by Subject|0
7862823|NCT00010257|27266278|P1|Overall Study|Withdrawal by Subject|1
7862824|NCT00009945|27266288|P2|Overall Study|no follow up data|5
7862825|NCT00009945|27266289|P1|Overall Study|no follow up data|7
7862826|NCT00008385|27266305|P2|Overall Study|Not start protocol therapy|175
7862827|NCT00008385|27266306|P1|Overall Study|Not start protocol therapy|44
7862828|NCT00008385|27266305|P2|Overall Study|Other|212
7862829|NCT00008385|27266306|P1|Overall Study|Other|105
7862830|NCT00008385|27266305|P2|Overall Study|Maximum dose reached|2
7862831|NCT00008385|27266306|P1|Overall Study|Maximum dose reached|0
7862832|NCT00008385|27266305|P2|Overall Study|Other complicating disease|30
7862833|NCT00008385|27266306|P1|Overall Study|Other complicating disease|17
7862834|NCT00008385|27266305|P2|Overall Study|Start non-protocol therapy|1
7862835|NCT00008385|27266306|P1|Overall Study|Start non-protocol therapy|3
7862836|NCT00008385|27266305|P2|Overall Study|Withdrawal by Subject|157
7862837|NCT00008385|27266306|P1|Overall Study|Withdrawal by Subject|67
7862838|NCT00008385|27266305|P2|Overall Study|Death|18
7862839|NCT00008385|27266306|P1|Overall Study|Death|12
7862840|NCT00008385|27266305|P2|Overall Study|Adverse Event|20
7862841|NCT00008385|27266306|P1|Overall Study|Adverse Event|8
7862842|NCT00008385|27266305|P2|Overall Study|Progressive disease|117
7862843|NCT00008385|27266306|P1|Overall Study|Progressive disease|52
7862844|NCT00008385|27266305|P2|Overall Study|Off treatment reasons not reported|70
7862845|NCT00008385|27266306|P1|Overall Study|Off treatment reasons not reported|79
7862846|NCT00008138|27266316|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
7862847|NCT00008138|27266316|P1|Post-Cytoreduction Chemotherapy|Progression|1
7862848|NCT00008138|27266316|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
7862849|NCT00008138|27266316|P1|Interval Debulking|Withdrawal by Subject|2
7862850|NCT00008138|27266316|P1|Neoadjuvant Chemotherapy|not protocol specified|8
7862851|NCT00008138|27266316|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
7862852|NCT00008138|27266316|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
7862853|NCT00008138|27266316|P1|Neoadjuvant Chemotherapy|Adverse Event|3
7862854|NCT00006916|27266322|P1|Overall Study|Complication of device insertion|1
7862855|NCT00006916|27266322|P1|Overall Study|Device not inserted|4
7862856|NCT00006903|27266328|P3|Overall Study|Ineligible|2
7862857|NCT00006903|27266329|P2|Overall Study|Ineligible|1
7862858|NCT00006903|27266330|P1|Overall Study|Ineligible|10
7862859|NCT00006903|27266328|P3|Overall Study|Patient never treated|1
7862860|NCT00006903|27266329|P2|Overall Study|Patient never treated|0
7862861|NCT00006903|27266330|P1|Overall Study|Patient never treated|0
7862862|NCT00006903|27266328|P3|Overall Study|Death|0
7862863|NCT00006903|27266329|P2|Overall Study|Death|1
7862864|NCT00006903|27266330|P1|Overall Study|Death|0
7862865|NCT00006903|27266328|P3|Overall Study|Adverse Event|1
7862866|NCT00006903|27266329|P2|Overall Study|Adverse Event|0
7862867|NCT00006903|27266330|P1|Overall Study|Adverse Event|0
7862868|NCT00006903|27266328|P3|Overall Study|Refused further treatment|1
7862869|NCT00006903|27266329|P2|Overall Study|Refused further treatment|2
7862870|NCT00006903|27266330|P1|Overall Study|Refused further treatment|0
7862871|NCT00006903|27266328|P3|Overall Study|Still receiving treatment|1
7862872|NCT00006903|27266329|P2|Overall Study|Still receiving treatment|0
7862873|NCT00006903|27266330|P1|Overall Study|Still receiving treatment|0
7862874|NCT00006721|27266343|P3|Overall Study|Eligible but no Treatment Received|0
7862875|NCT00006721|27266344|P2|Overall Study|Eligible but no Treatment Received|0
7862876|NCT00006721|27266345|P1|Overall Study|Eligible but no Treatment Received|1
7862877|NCT00006721|27266343|P3|Overall Study|Ineligible|10
7862878|NCT00006721|27266344|P2|Overall Study|Ineligible|12
7862879|NCT00006721|27266345|P1|Overall Study|Ineligible|2
7862880|NCT00006721|27266343|P3|Overall Study|Other - Not Protocol Specified|7
7862881|NCT00006721|27266344|P2|Overall Study|Other - Not Protocol Specified|7
7862882|NCT00006721|27266345|P1|Overall Study|Other - Not Protocol Specified|0
7862883|NCT00006721|27266343|P3|Overall Study|Death|2
7862884|NCT00006721|27266344|P2|Overall Study|Death|1
7862885|NCT00006721|27266345|P1|Overall Study|Death|0
7862886|NCT00006721|27266343|P3|Overall Study|Progression/Relapse|2
7862887|NCT00006721|27266344|P2|Overall Study|Progression/Relapse|1
7862888|NCT00006721|27266345|P1|Overall Study|Progression/Relapse|0
7862889|NCT00006721|27266343|P3|Overall Study|Refusal Unrelated to Adverse Event|8
7862890|NCT00006721|27266344|P2|Overall Study|Refusal Unrelated to Adverse Event|0
7862891|NCT00006721|27266345|P1|Overall Study|Refusal Unrelated to Adverse Event|1
7862892|NCT00006721|27266343|P3|Overall Study|Adverse Event|4
7862893|NCT00006721|27266344|P2|Overall Study|Adverse Event|4
7862894|NCT00006721|27266345|P1|Overall Study|Adverse Event|0
7862895|NCT00006478|27266363|P1|Overall Study|Physician Decision|6
7862896|NCT00006478|27266363|P1|Overall Study|Vaccine could not be produced|1
7862897|NCT00006392|27266374|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7862898|NCT00006392|27266375|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7862899|NCT00006392|27266376|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7862900|NCT00006392|27266377|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
7862901|NCT00006392|27266374|P4|Overall Study|Ineligible|5
7862902|NCT00006392|27266375|P3|Overall Study|Ineligible|5
7862903|NCT00006392|27266376|P2|Overall Study|Ineligible|3
7862904|NCT00006392|27266377|P1|Overall Study|Ineligible|11
7862905|NCT00006389|27266407|P1|Overall Study|Adverse Event|1
7862906|NCT00006237|27266424|P2|Overall Study|Not protocol specified|5
7862907|NCT00006237|27266425|P1|Overall Study|Not protocol specified|14
7862908|NCT00006237|27266424|P2|Overall Study|Withdrawal by Subject|1
7862909|NCT00006237|27266425|P1|Overall Study|Withdrawal by Subject|0
7862910|NCT00006237|27266424|P2|Overall Study|Not eligible|20
7862911|NCT00006237|27266425|P1|Overall Study|Not eligible|9
7862912|NCT00006237|27266424|P2|Overall Study|Progression/relapse|2
7862913|NCT00006237|27266425|P1|Overall Study|Progression/relapse|54
7862914|NCT00006237|27266424|P2|Overall Study|Refusal unrelated to adverse effects|4
7862915|NCT00006237|27266425|P1|Overall Study|Refusal unrelated to adverse effects|8
7862916|NCT00006237|27266424|P2|Overall Study|Death|0
7862917|NCT00006237|27266425|P1|Overall Study|Death|1
7862918|NCT00006237|27266424|P2|Overall Study|Adverse Event|29
7862919|NCT00006237|27266425|P1|Overall Study|Adverse Event|39
7862920|NCT00006011|27266468|P3|Overall Study|Ineligible|9
7862921|NCT00006011|27266469|P2|Overall Study|Ineligible|16
7862922|NCT00006011|27266470|P1|Overall Study|Ineligible|18
7862923|NCT00006011|27266468|P3|Overall Study|Other|5
7862924|NCT00006011|27266469|P2|Overall Study|Other|2
7862925|NCT00006011|27266470|P1|Overall Study|Other|4
7862926|NCT00006011|27266468|P3|Overall Study|Death|2
7862927|NCT00006011|27266469|P2|Overall Study|Death|1
7862928|NCT00006011|27266470|P1|Overall Study|Death|0
7862929|NCT00006011|27266468|P3|Overall Study|Adverse Event|5
7862930|NCT00006011|27266469|P2|Overall Study|Adverse Event|39
7862931|NCT00006011|27266470|P1|Overall Study|Adverse Event|15
7862932|NCT00006011|27266468|P3|Overall Study|Refused further treatment|26
7862933|NCT00006011|27266469|P2|Overall Study|Refused further treatment|13
7862934|NCT00006011|27266470|P1|Overall Study|Refused further treatment|15
7862935|NCT00006011|27266468|P3|Overall Study|Disease progression|26
7862936|NCT00006011|27266469|P2|Overall Study|Disease progression|6
7862937|NCT00006011|27266470|P1|Overall Study|Disease progression|13
7862938|NCT00005957|27266478|P2|Overall Study|Crossover to the other arm|19
7862939|NCT00005957|27266479|P1|Overall Study|Crossover to the other arm|5
7862940|NCT00005957|27266478|P2|Overall Study|No treated|9
7862941|NCT00005957|27266479|P1|Overall Study|No treated|3
7862942|NCT00005879|27266489|P2|Overall Study|Withdrawal by Subject|10
7862943|NCT00005879|27266490|P1|Overall Study|Withdrawal by Subject|8
7862944|NCT00005047|27266513|P4|Overall Study|Lack of Efficacy|0
7862945|NCT00005047|27266514|P3|Overall Study|Lack of Efficacy|0
7862946|NCT00005047|27266515|P2|Overall Study|Lack of Efficacy|0
7862947|NCT00005047|27266516|P1|Overall Study|Lack of Efficacy|1
7862948|NCT00005047|27266513|P4|Overall Study|Lost to Follow-up|0
7862949|NCT00005047|27266514|P3|Overall Study|Lost to Follow-up|0
7862950|NCT00005047|27266515|P2|Overall Study|Lost to Follow-up|0
7862951|NCT00005047|27266516|P1|Overall Study|Lost to Follow-up|1
7862952|NCT00005047|27266513|P4|Overall Study|Adverse Event|0
7862953|NCT00005047|27266514|P3|Overall Study|Adverse Event|0
7862954|NCT00005047|27266515|P2|Overall Study|Adverse Event|0
7862955|NCT00005047|27266516|P1|Overall Study|Adverse Event|5
7862956|NCT00005047|27266513|P4|Overall Study|Withdrawal by Subject|0
7862957|NCT00005047|27266514|P3|Overall Study|Withdrawal by Subject|0
7862958|NCT00005047|27266515|P2|Overall Study|Withdrawal by Subject|0
7862959|NCT00005047|27266516|P1|Overall Study|Withdrawal by Subject|12
7862960|NCT00005044|27266532|P2|Overall Study|No protocol treatment|1
7862961|NCT00005044|27266533|P1|Overall Study|No protocol treatment|0
7862962|NCT00005044|27266532|P2|Overall Study|Withdrawal by Subject|5
7862963|NCT00005044|27266533|P1|Overall Study|Withdrawal by Subject|1
7862964|NCT00005044|27266532|P2|Overall Study|Protocol Violation|46
7862965|NCT00005044|27266533|P1|Overall Study|Protocol Violation|37
7862966|NCT00004888|27266553|P2|Overall Study|Toxic death|0
7862967|NCT00004888|27266554|P1|Overall Study|Toxic death|1
7862968|NCT00004888|27266553|P2|Overall Study|Death without progressive disease|1
7862969|NCT00004888|27266554|P1|Overall Study|Death without progressive disease|0
7862970|NCT00004888|27266553|P2|Overall Study|Progressive Disease|9
7862971|NCT00004888|27266554|P1|Overall Study|Progressive Disease|4
7862972|NCT00004888|27266553|P2|Overall Study|Physician Decision|1
7862973|NCT00004888|27266554|P1|Overall Study|Physician Decision|1
7862974|NCT00004888|27266553|P2|Overall Study|Withdrawal by Subject|3
7862975|NCT00004888|27266554|P1|Overall Study|Withdrawal by Subject|0
7862976|NCT00004888|27266553|P2|Overall Study|Adverse Event|10
7862977|NCT00004888|27266554|P1|Overall Study|Adverse Event|5
7862978|NCT00004859|27266572|P2|Overall Study|Other|21
7862979|NCT00004859|27266573|P1|Overall Study|Other|13
7862980|NCT00004859|27266572|P2|Overall Study|missing data|11
7862981|NCT00004859|27266573|P1|Overall Study|missing data|14
7862982|NCT00004859|27266572|P2|Overall Study|error|1
7862983|NCT00004859|27266573|P1|Overall Study|error|3
7862984|NCT00004859|27266572|P2|Overall Study|other disease|3
7862985|NCT00004859|27266573|P1|Overall Study|other disease|0
7862986|NCT00004859|27266572|P2|Overall Study|Protocol Violation|2
7862987|NCT00004859|27266573|P1|Overall Study|Protocol Violation|2
7862988|NCT00004859|27266572|P2|Overall Study|Withdrawal by Subject|33
7862989|NCT00004859|27266573|P1|Overall Study|Withdrawal by Subject|7
7862990|NCT00004859|27266572|P2|Overall Study|Death|5
7862991|NCT00004859|27266573|P1|Overall Study|Death|5
7862992|NCT00004859|27266572|P2|Overall Study|Adverse Event|93
7862993|NCT00004859|27266573|P1|Overall Study|Adverse Event|31
7862994|NCT00004859|27266572|P2|Overall Study|Lack of Efficacy|113
7862995|NCT00004859|27266573|P1|Overall Study|Lack of Efficacy|43
7862996|NCT00004259|27266587|P4|Overall Study|Withdrawal by Subject|0
7862997|NCT00004259|27266588|P3|Overall Study|Withdrawal by Subject|0
7862998|NCT00004259|27266589|P2|Overall Study|Withdrawal by Subject|2
7862999|NCT00004259|27266590|P1|Overall Study|Withdrawal by Subject|0
7863000|NCT00004259|27266587|P4|Overall Study|Protocol Violation|0
7863001|NCT00004259|27266588|P3|Overall Study|Protocol Violation|0
7863002|NCT00004259|27266589|P2|Overall Study|Protocol Violation|2
7863003|NCT00004259|27266590|P1|Overall Study|Protocol Violation|1
7863004|NCT00004228|27266615|P7|Overall Study|ineligible|5
7863005|NCT00004228|27266616|P6|Overall Study|ineligible|2
7863006|NCT00004228|27266617|P5|Overall Study|ineligible|1
7863007|NCT00004228|27266618|P4|Overall Study|ineligible|1
7863008|NCT00004228|27266619|P3|Overall Study|ineligible|4
7863009|NCT00004228|27266620|P2|Overall Study|ineligible|2
7863010|NCT00004228|27266621|P1|Overall Study|ineligible|4
7863011|NCT00004228|27266615|P7|Overall Study|Other|0
7863012|NCT00004228|27266616|P6|Overall Study|Other|0
7863013|NCT00004228|27266617|P5|Overall Study|Other|0
7863014|NCT00004228|27266618|P4|Overall Study|Other|0
7863015|NCT00004228|27266619|P3|Overall Study|Other|1
7863016|NCT00004228|27266620|P2|Overall Study|Other|0
7863017|NCT00004228|27266621|P1|Overall Study|Other|0
7863018|NCT00004228|27266615|P7|Overall Study|Withdrawal by Subject|2
7863019|NCT00004228|27266616|P6|Overall Study|Withdrawal by Subject|1
7863020|NCT00004228|27266617|P5|Overall Study|Withdrawal by Subject|2
7863021|NCT00004228|27266618|P4|Overall Study|Withdrawal by Subject|0
7863022|NCT00004228|27266619|P3|Overall Study|Withdrawal by Subject|1
7863023|NCT00004228|27266620|P2|Overall Study|Withdrawal by Subject|0
7863024|NCT00004228|27266621|P1|Overall Study|Withdrawal by Subject|3
7863025|NCT00004228|27266615|P7|Overall Study|Protocol Violation|0
7863026|NCT00004228|27266616|P6|Overall Study|Protocol Violation|2
7863027|NCT00004228|27266617|P5|Overall Study|Protocol Violation|1
7863028|NCT00004228|27266618|P4|Overall Study|Protocol Violation|1
7863029|NCT00004228|27266619|P3|Overall Study|Protocol Violation|2
7863030|NCT00004228|27266620|P2|Overall Study|Protocol Violation|5
7863031|NCT00004228|27266621|P1|Overall Study|Protocol Violation|0
7863032|NCT00004228|27266615|P7|Overall Study|Physician Decision|1
7863033|NCT00004228|27266616|P6|Overall Study|Physician Decision|1
7863034|NCT00004228|27266617|P5|Overall Study|Physician Decision|1
7863035|NCT00004228|27266618|P4|Overall Study|Physician Decision|2
7863036|NCT00004228|27266619|P3|Overall Study|Physician Decision|3
7863037|NCT00004228|27266620|P2|Overall Study|Physician Decision|0
7863038|NCT00004228|27266621|P1|Overall Study|Physician Decision|1
7863039|NCT00004228|27266615|P7|Overall Study|Lost to Follow-up|0
7863040|NCT00004228|27266616|P6|Overall Study|Lost to Follow-up|0
7863041|NCT00004228|27266617|P5|Overall Study|Lost to Follow-up|0
7863042|NCT00004228|27266618|P4|Overall Study|Lost to Follow-up|0
7863043|NCT00004228|27266619|P3|Overall Study|Lost to Follow-up|1
7863044|NCT00004228|27266620|P2|Overall Study|Lost to Follow-up|0
7863045|NCT00004228|27266621|P1|Overall Study|Lost to Follow-up|0
7863046|NCT00004228|27266615|P7|Overall Study|Lack of Efficacy|4
7863047|NCT00004228|27266616|P6|Overall Study|Lack of Efficacy|8
7863048|NCT00004228|27266617|P5|Overall Study|Lack of Efficacy|9
7863049|NCT00004228|27266618|P4|Overall Study|Lack of Efficacy|3
7863050|NCT00004228|27266619|P3|Overall Study|Lack of Efficacy|5
7863051|NCT00004228|27266620|P2|Overall Study|Lack of Efficacy|6
7863052|NCT00004228|27266621|P1|Overall Study|Lack of Efficacy|1
7863053|NCT00004228|27266615|P7|Overall Study|Death|0
7863054|NCT00004228|27266616|P6|Overall Study|Death|0
7863055|NCT00004228|27266617|P5|Overall Study|Death|1
7863056|NCT00004228|27266618|P4|Overall Study|Death|0
7863057|NCT00004228|27266619|P3|Overall Study|Death|2
7863058|NCT00004228|27266620|P2|Overall Study|Death|1
7863059|NCT00004228|27266621|P1|Overall Study|Death|0
7863060|NCT00004228|27266615|P7|Overall Study|Adverse Event|0
7863061|NCT00004228|27266616|P6|Overall Study|Adverse Event|0
7863062|NCT00004228|27266617|P5|Overall Study|Adverse Event|1
7863063|NCT00004228|27266618|P4|Overall Study|Adverse Event|0
7863064|NCT00004228|27266619|P3|Overall Study|Adverse Event|0
7863065|NCT00004228|27266620|P2|Overall Study|Adverse Event|1
7863066|NCT00004228|27266621|P1|Overall Study|Adverse Event|0
7863067|NCT00004124|27266655|P2|Overall Study|Received no protocol therapy|20
7863068|NCT00004124|27266656|P1|Overall Study|Received no protocol therapy|12
7863069|NCT00004088|27266681|P1|Overall Study|Physician Decision|1
7863070|NCT00004088|27266681|P1|Overall Study|Protocol Violation|3
7863071|NCT00004088|27266681|P1|Overall Study|Withdrawal by Subject|1
7863072|NCT00004088|27266681|P1|Overall Study|No C2 given due to study on hold by IRB|4
7863073|NCT00004031|27266709|P2|Overall Study|Reason under review|2
7863074|NCT00004031|27266710|P1|Overall Study|Reason under review|3
7863075|NCT00004031|27266709|P2|Overall Study|Other- not protocol specified|3
7863076|NCT00004031|27266710|P1|Overall Study|Other- not protocol specified|3
7863077|NCT00004031|27266709|P2|Overall Study|Death|1
7863078|NCT00004031|27266710|P1|Overall Study|Death|3
7863079|NCT00004031|27266709|P2|Overall Study|Progression/relapse|4
7863080|NCT00004031|27266710|P1|Overall Study|Progression/relapse|9
7863081|NCT00004031|27266709|P2|Overall Study|Refusal unrelated to adverse events|11
7863082|NCT00004031|27266710|P1|Overall Study|Refusal unrelated to adverse events|2
7863083|NCT00004031|27266709|P2|Overall Study|Adverse Event|0
7863084|NCT00004031|27266710|P1|Overall Study|Adverse Event|5
7863085|NCT00003901|27266727|P1|Overall Study|Medical problems|6
7863086|NCT00003901|27266727|P1|Overall Study|Chest X-Ray not done prior registration|1
7863087|NCT00003901|27266727|P1|Overall Study|CT Scan not within protocol requirement|2
7863088|NCT00003901|27266727|P1|Overall Study|Ineligible|6
7863089|NCT00003901|27266727|P1|Overall Study|Withdrawal by Subject|1
7863090|NCT00003901|27266727|P1|Overall Study|Adverse Event|1
7863091|NCT00003896|27266738|P1|Overall Study|ineligible|5
7863092|NCT00003896|27266738|P1|Overall Study|not protocol specified|3
7863093|NCT00003896|27266738|P1|Overall Study|Death|3
7863094|NCT00003896|27266738|P1|Overall Study|Lack of Efficacy|1
7863095|NCT00003896|27266738|P1|Overall Study|Withdrawal by Subject|1
7863096|NCT00003896|27266738|P1|Overall Study|Adverse Event|16
7863097|NCT00003875|27266744|P1|Overall Study|Screen Failed|1
7863098|NCT00003869|27266753|P2|Overall Study|Alternative treatmnt, medical problems|4
7863099|NCT00003869|27266754|P1|Overall Study|Alternative treatmnt, medical problems|5
7863100|NCT00003869|27266753|P2|Overall Study|Death|2
7863101|NCT00003869|27266754|P1|Overall Study|Death|1
7863102|NCT00003869|27266753|P2|Overall Study|Withdrawal by Subject|3
7863103|NCT00003869|27266754|P1|Overall Study|Withdrawal by Subject|21
7863104|NCT00003869|27266753|P2|Overall Study|Adverse Event|3
7863105|NCT00003869|27266754|P1|Overall Study|Adverse Event|14
7863106|NCT00003782|27266816|P3|Overall Study|No follow up data|26
7863107|NCT00003782|27266817|P2|Overall Study|No follow up data|31
7863108|NCT00003782|27266818|P1|Overall Study|No follow up data|30
7863109|NCT00003702|27266828|P2|Overall Study|Inadequate documentation of disease|3
7863110|NCT00003702|27266829|P1|Overall Study|Inadequate documentation of disease|1
7863111|NCT00003702|27266828|P2|Overall Study|WHO score > 6|1
7863112|NCT00003702|27266829|P1|Overall Study|WHO score > 6|2
7863113|NCT00003702|27266828|P2|Overall Study|Did not meet criteria for persistence|5
7863114|NCT00003702|27266829|P1|Overall Study|Did not meet criteria for persistence|8
7863115|NCT00003702|27266828|P2|Overall Study|Ineligible cell types|2
7863116|NCT00003702|27266829|P1|Overall Study|Ineligible cell types|2
7863117|NCT00003659|27266838|P1|Overall Study|Withdrawal by Subject|3
7863118|NCT00003641|27266859|P2|Overall Study|Never started interferon|12
7863119|NCT00003641|27266860|P1|Overall Study|Never started interferon|567
7863120|NCT00003641|27266859|P2|Overall Study|Should not receive interferon therapy|0
7863121|NCT00003641|27266860|P1|Overall Study|Should not receive interferon therapy|2
7863122|NCT00003641|27266859|P2|Overall Study|Unknown/missing|22
7863123|NCT00003641|27266860|P1|Overall Study|Unknown/missing|0
7863124|NCT00003641|27266859|P2|Overall Study|Disease progression|2
7863125|NCT00003641|27266860|P1|Overall Study|Disease progression|0
7863126|NCT00003641|27266859|P2|Overall Study|Adverse Event|38
7863127|NCT00003641|27266860|P1|Overall Study|Adverse Event|0
7863128|NCT00003641|27266859|P2|Overall Study|Withdrawal by Subject|100
7863129|NCT00003641|27266860|P1|Overall Study|Withdrawal by Subject|0
7863130|NCT00003631|27266871|P3|Overall Study|Evaluable for toxicity only|2
7863131|NCT00003631|27266872|P2|Overall Study|Evaluable for toxicity only|0
7863132|NCT00003631|27266873|P1|Overall Study|Evaluable for toxicity only|0
7863133|NCT00003631|27266871|P3|Overall Study|Death|1
7863134|NCT00003631|27266872|P2|Overall Study|Death|0
7863135|NCT00003631|27266873|P1|Overall Study|Death|0
7863136|NCT00003631|27266871|P3|Overall Study|Adverse Event|5
7863137|NCT00003631|27266872|P2|Overall Study|Adverse Event|1
7863138|NCT00003631|27266873|P1|Overall Study|Adverse Event|1
7863139|NCT00003631|27266871|P3|Overall Study|Protocol Violation|0
7863140|NCT00003631|27266872|P2|Overall Study|Protocol Violation|0
7863141|NCT00003631|27266873|P1|Overall Study|Protocol Violation|1
7863142|NCT00003631|27266871|P3|Overall Study|Patient not treated|1
7863143|NCT00003631|27266872|P2|Overall Study|Patient not treated|0
7863144|NCT00003631|27266873|P1|Overall Study|Patient not treated|1
7863145|NCT00003590|27266881|P1|Overall Study|Physician Decision|1
7863146|NCT00003590|27266881|P1|Overall Study|Death|1
7863147|NCT00003590|27266881|P1|Overall Study|Lack of Efficacy|11
7863148|NCT00003590|27266881|P1|Overall Study|Withdrawal by Subject|1
7863149|NCT00003590|27266881|P1|Overall Study|Adverse Event|7
7863150|NCT00003590|27266881|P1|Overall Study|Ineligible Patient|1
7863151|NCT00003537|27266886|P1|Overall Study|Not evalauable|1
7863152|NCT00003535|27266891|P1|Overall Study|Not evaluable|5
7863153|NCT00003531|27266896|P1|Overall Study|Not evaluable|10
7863154|NCT00003526|27266900|P1|Overall Study|Not evaluable|6
7863155|NCT00003511|27266904|P1|Overall Study|Not evaluable|4
7863156|NCT00003509|27266908|P1|Overall Study|Not evaluable|5
7863157|NCT00003508|27266912|P1|Overall Study|Not evaluable|5
7863158|NCT00003499|27266916|P1|Overall Study|Not evaluable|8
7863159|NCT00003498|27266921|P1|Overall Study|Not evaluable.|4
7863160|NCT00003492|27266925|P1|Overall Study|Not evaluable|6
7863161|NCT00003487|27266929|P1|Overall Study|Not evaluable|2
7863162|NCT00003483|27266933|P1|Overall Study|Not evaluable|1
7863163|NCT00003479|27266938|P1|Overall Study|Not evaluable|3
7863164|NCT00003477|27266943|P1|Overall Study|Not evalauable|4
7863165|NCT00003476|27266948|P1|Overall Study|Not evaluable|1
7863166|NCT00003475|27266953|P1|Overall Study|Not evaluable|13
7863167|NCT00003474|27266958|P1|Overall Study|Not Evaluable|14
7863168|NCT00003473|27266963|P1|Overall Study|Three patients were not evaluable.|3
7863169|NCT00003472|27266968|P1|Overall Study|Not evaluable|3
7863170|NCT00003471|27266973|P1|Overall Study|Not evaluable|4
7863171|NCT00003470|27266978|P1|Overall Study|Not evaluable|6
7863172|NCT00003458|27267003|P1|Overall Study|Not evaluable|4
7863173|NCT00003457|27267008|P1|Overall Study|Not evaluable|9
7863174|NCT00003456|27267013|P1|Overall Study|Not evaluable|8
7863175|NCT00003389|27267030|P2|Overall Study|Ineligible|27
7863176|NCT00003389|27267031|P1|Overall Study|Ineligible|33
7863177|NCT00003389|27267030|P2|Overall Study|Off-treatment reason missing|21
7863178|NCT00003389|27267031|P1|Overall Study|Off-treatment reason missing|31
7863179|NCT00003389|27267030|P2|Overall Study|Complicating disease|0
7863180|NCT00003389|27267031|P1|Overall Study|Complicating disease|1
7863181|NCT00003389|27267030|P2|Overall Study|Alternative therapy|1
7863182|NCT00003389|27267031|P1|Overall Study|Alternative therapy|2
7863183|NCT00003389|27267030|P2|Overall Study|Withdrawal by Subject|5
7863184|NCT00003389|27267031|P1|Overall Study|Withdrawal by Subject|12
7863185|NCT00003389|27267030|P2|Overall Study|Death|3
7863186|NCT00003389|27267031|P1|Overall Study|Death|0
7863187|NCT00003389|27267030|P2|Overall Study|Adverse Event|2
7863188|NCT00003389|27267031|P1|Overall Study|Adverse Event|13
7863189|NCT00003389|27267030|P2|Overall Study|Disease progression|1
7863190|NCT00003389|27267031|P1|Overall Study|Disease progression|6
7863191|NCT00003377|27267046|P5|Period II|Ureteral stent complications|1
7863192|NCT00003377|27267047|P4|Period II|Ureteral stent complications|0
7863193|NCT00003377|27267048|P3|Period II|Ureteral stent complications|0
7863194|NCT00003377|27267049|P2|Period II|Ureteral stent complications|0
7863195|NCT00003377|27267050|P1|Period II|Ureteral stent complications|0
7863196|NCT00003377|27267046|P5|Period I|Dose Limiting Toxicity(DLT)|0
7863197|NCT00003377|27267047|P4|Period I|Dose Limiting Toxicity(DLT)|1
7863198|NCT00003377|27267048|P3|Period I|Dose Limiting Toxicity(DLT)|1
7863199|NCT00003377|27267049|P2|Period I|Dose Limiting Toxicity(DLT)|0
7863200|NCT00003377|27267050|P1|Period I|Dose Limiting Toxicity(DLT)|0
7863201|NCT00003199|27267064|P1|Overall Study|Screen fail|15
7863202|NCT00003199|27267064|P1|Overall Study|Lack of insurance clearance|2
7863203|NCT00003199|27267064|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
7863204|NCT00003138|27267072|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
7863205|NCT00003138|27267073|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
7863206|NCT00003138|27267072|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
7863207|NCT00003138|27267073|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
7863208|NCT00003138|27267072|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
7863209|NCT00003138|27267073|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
7863210|NCT00003138|27267072|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
7863211|NCT00003138|27267073|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
7863212|NCT00003138|27267072|P2|Step 1|Never started treatment|0
7863213|NCT00003138|27267073|P1|Step 1|Never started treatment|1
7863214|NCT00003138|27267072|P2|Step 1|Reasons off treatment not documented|57
7863215|NCT00003138|27267073|P1|Step 1|Reasons off treatment not documented|60
7863216|NCT00002931|27267101|P1|Overall Study|rapidly progressing disease during|2
7863217|NCT00002874|27267109|P2|Overall Study|Protocol Violation|34
7863218|NCT00002874|27267110|P1|Overall Study|Protocol Violation|44
7863219|NCT00002874|27267109|P2|Overall Study|Withdrawal by Subject|1
7863220|NCT00002874|27267110|P1|Overall Study|Withdrawal by Subject|1
7863221|NCT00002850|27267135|P3|Overall Study|Withdrawal by Subject|0
7863222|NCT00002850|27267136|P2|Overall Study|Withdrawal by Subject|1
7863223|NCT00002850|27267137|P1|Overall Study|Withdrawal by Subject|0
7863224|NCT00002850|27267135|P3|Overall Study|Protocol Violation|1
7863225|NCT00002850|27267136|P2|Overall Study|Protocol Violation|0
7863226|NCT00002850|27267137|P1|Overall Study|Protocol Violation|1
7863227|NCT00002850|27267135|P3|Overall Study|Death|3
7863228|NCT00002850|27267136|P2|Overall Study|Death|1
7863229|NCT00002850|27267137|P1|Overall Study|Death|4
7863230|NCT00002842|27267145|P1|Overall Study|ineligible for surgical resection|27
7863231|NCT00002766|27267151|P2|Overall Study|Protocol Violation|0
7863232|NCT00002766|27267152|P1|Overall Study|Protocol Violation|1
7863233|NCT00002766|27267151|P2|Overall Study|Adverse Event|1
7863234|NCT00002766|27267152|P1|Overall Study|Adverse Event|1
7863235|NCT00002766|27267151|P2|Overall Study|Patient Not Treated|2
7863236|NCT00002766|27267152|P1|Overall Study|Patient Not Treated|1
7863237|NCT00002766|27267151|P2|Overall Study|Withdrawal by Subject|1
7863238|NCT00002766|27267152|P1|Overall Study|Withdrawal by Subject|0
7863239|NCT00002651|27267160|P3|Consolidation and Randomization|not eligible|112
7863240|NCT00002651|27267161|P2|Consolidation and Randomization|not eligible|102
7863241|NCT00002651|27267162|P1|Consolidation and Randomization|not eligible|0
7863242|NCT00002651|27267160|P3|Consolidation and Randomization|Other|313
7863243|NCT00002651|27267161|P2|Consolidation and Randomization|Other|314
7863244|NCT00002651|27267162|P1|Consolidation and Randomization|Other|0
7863245|NCT00002651|27267160|P3|Consolidation and Randomization|Death|48
7863246|NCT00002651|27267161|P2|Consolidation and Randomization|Death|38
7863247|NCT00002651|27267162|P1|Consolidation and Randomization|Death|0
7863248|NCT00002651|27267160|P3|Consolidation and Randomization|Progression/relapse|298
7863249|NCT00002651|27267161|P2|Consolidation and Randomization|Progression/relapse|295
7863250|NCT00002651|27267162|P1|Consolidation and Randomization|Progression/relapse|0
7863251|NCT00002651|27267160|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
7863252|NCT00002651|27267161|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
7863253|NCT00002651|27267162|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
7863254|NCT00002651|27267160|P3|Consolidation and Randomization|Adverse Event|14
7863255|NCT00002651|27267161|P2|Consolidation and Randomization|Adverse Event|36
7863256|NCT00002651|27267162|P1|Consolidation and Randomization|Adverse Event|0
7863257|NCT00002651|27267160|P3|Induction|not eligible|0
7863258|NCT00002651|27267161|P2|Induction|not eligible|0
7863259|NCT00002651|27267162|P1|Induction|not eligible|90
7863260|NCT00002651|27267160|P3|Induction|Other|0
7863261|NCT00002651|27267161|P2|Induction|Other|0
7863262|NCT00002651|27267162|P1|Induction|Other|823
7863263|NCT00002651|27267160|P3|Induction|Death|0
7863264|NCT00002651|27267161|P2|Induction|Death|0
7863265|NCT00002651|27267162|P1|Induction|Death|62
7863266|NCT00002651|27267160|P3|Induction|Progression/relapse|0
7863267|NCT00002651|27267161|P2|Induction|Progression/relapse|0
7863268|NCT00002651|27267162|P1|Induction|Progression/relapse|274
7863269|NCT00002651|27267160|P3|Induction|Refusal unrelated to adverse event|0
7863270|NCT00002651|27267161|P2|Induction|Refusal unrelated to adverse event|0
7863271|NCT00002651|27267162|P1|Induction|Refusal unrelated to adverse event|50
7863272|NCT00002651|27267160|P3|Induction|Adverse Event|0
7863273|NCT00002651|27267161|P2|Induction|Adverse Event|0
7863274|NCT00002651|27267162|P1|Induction|Adverse Event|44
7863275|NCT00002558|27267180|P2|Overall Study|Withdrawal by Subject|1
7863276|NCT00002558|27267181|P1|Overall Study|Withdrawal by Subject|0
7863277|NCT00051636|27267206|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
7863278|NCT00051636|27267207|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
7863279|NCT00051636|27267206|P2|Period 2- Extended Observation Period|Death|5
7863280|NCT00051636|27267207|P1|Period 2- Extended Observation Period|Death|4
7863281|NCT00051636|27267206|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
7863282|NCT00051636|27267207|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
7863283|NCT00051636|27267206|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
7863284|NCT00051636|27267207|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
7863285|NCT00051636|27267206|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
7863286|NCT00051636|27267207|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
7863287|NCT00051636|27267206|P2|Period 1 - Core|Lost to Follow-up|2
7863288|NCT00051636|27267207|P1|Period 1 - Core|Lost to Follow-up|0
7863289|NCT00051636|27267206|P2|Period 1 - Core|Withdrawal by Subject|2
7863290|NCT00051636|27267207|P1|Period 1 - Core|Withdrawal by Subject|1
7863291|NCT00051636|27267206|P2|Period 1 - Core|Protocol Violation|0
7863292|NCT00051636|27267207|P1|Period 1 - Core|Protocol Violation|1
7863293|NCT00051636|27267206|P2|Period 1 - Core|Adverse Event|2
7863294|NCT00051636|27267207|P1|Period 1 - Core|Adverse Event|2
7863295|NCT00051558|27267235|P2|Overall Study|Physician Decision|0
7863296|NCT00051558|27267236|P1|Overall Study|Physician Decision|5
7863297|NCT00051558|27267235|P2|Overall Study|Significant Lab Value|0
7863298|NCT00051558|27267236|P1|Overall Study|Significant Lab Value|2
7863299|NCT00051558|27267235|P2|Overall Study|Other|1
7863300|NCT00051558|27267236|P1|Overall Study|Other|2
7863301|NCT00051558|27267235|P2|Overall Study|Sponsor Decision|1
7863302|NCT00051558|27267236|P1|Overall Study|Sponsor Decision|6
7863303|NCT00051558|27267235|P2|Overall Study|Protocol Entry Criteria Unmet|2
7863304|NCT00051558|27267236|P1|Overall Study|Protocol Entry Criteria Unmet|1
7863305|NCT00051558|27267235|P2|Overall Study|Protocol Violation|4
7863306|NCT00051558|27267236|P1|Overall Study|Protocol Violation|3
7863307|NCT00051558|27267235|P2|Overall Study|Lost to Follow-up|13
7863308|NCT00051558|27267236|P1|Overall Study|Lost to Follow-up|4
7863309|NCT00051558|27267235|P2|Overall Study|Death|15
7863310|NCT00051558|27267236|P1|Overall Study|Death|9
7863311|NCT00051558|27267235|P2|Overall Study|Withdrawal by Subject|42
7863312|NCT00051558|27267236|P1|Overall Study|Withdrawal by Subject|29
7863313|NCT00051558|27267235|P2|Overall Study|Adverse Event|18
7863314|NCT00051558|27267236|P1|Overall Study|Adverse Event|30
7863315|NCT00051363|27267272|P2|Overall Study|Excluded Pre-Randomization|5
7863316|NCT00051363|27267273|P1|Overall Study|Excluded Pre-Randomization|2
7863317|NCT00051363|27267272|P2|Overall Study|Death|2
7863318|NCT00051363|27267273|P1|Overall Study|Death|2
7863319|NCT00051363|27267272|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
7863320|NCT00051363|27267273|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
7863321|NCT00051363|27267272|P2|Overall Study|Dropped Post-Rand for Any Reason|126
7863322|NCT00051363|27267273|P1|Overall Study|Dropped Post-Rand for Any Reason|102
7863323|NCT00051311|27267309|P2|Overall Study|Recipient taken off study|4
7863324|NCT00051311|27267310|P1|Overall Study|Recipient taken off study|4
7863325|NCT00051311|27267309|P2|Overall Study|Death of recipient|8
7863326|NCT00051311|27267310|P1|Overall Study|Death of recipient|8
7863327|NCT00051311|27267309|P2|Overall Study|Pt. to pursue treatment for progressive disease|1
7863328|NCT00051311|27267310|P1|Overall Study|Pt. to pursue treatment for progressive disease|0
7863329|NCT00051311|27267309|P2|Overall Study|Starting new study|1
7863330|NCT00051311|27267310|P1|Overall Study|Starting new study|0
7863331|NCT00051025|27267328|P2|Overall Study|Death|1
7863332|NCT00051025|27267329|P1|Overall Study|Death|0
7863333|NCT00051025|27267328|P2|Overall Study|Withdrawal by Subject|1
7863334|NCT00051025|27267329|P1|Overall Study|Withdrawal by Subject|0
7863335|NCT00051025|27267328|P2|Overall Study|Adverse Event|1
7863336|NCT00051025|27267329|P1|Overall Study|Adverse Event|1
7863337|NCT00051025|27267328|P2|Overall Study|Progressive Disease|1
7863338|NCT00051025|27267329|P1|Overall Study|Progressive Disease|1
7863339|NCT00050960|27267343|P2|Overall Study|Death|15
7863340|NCT00050960|27267344|P1|Overall Study|Death|13
7863341|NCT00050960|27267343|P2|Overall Study|Non-compliance|1
7863342|NCT00050960|27267344|P1|Overall Study|Non-compliance|3
7863343|NCT00050960|27267343|P2|Overall Study|Administrative|46
7863344|NCT00050960|27267344|P1|Overall Study|Administrative|31
7863345|NCT00050960|27267343|P2|Overall Study|Withdrawal by Subject|18
7863346|NCT00050960|27267344|P1|Overall Study|Withdrawal by Subject|23
7863347|NCT00050960|27267343|P2|Overall Study|Lost to Follow-up|1
7863348|NCT00050960|27267344|P1|Overall Study|Lost to Follow-up|0
7863349|NCT00050960|27267343|P2|Overall Study|Adverse Event|61
7863350|NCT00050960|27267344|P1|Overall Study|Adverse Event|62
7863351|NCT00050960|27267343|P2|Overall Study|Complete Response|2
7863352|NCT00050960|27267344|P1|Overall Study|Complete Response|0
7863353|NCT00050960|27267343|P2|Overall Study|Partial Response|19
7863354|NCT00050960|27267344|P1|Overall Study|Partial Response|14
7863355|NCT00050960|27267343|P2|Overall Study|Stable Disease|48
7863356|NCT00050960|27267344|P1|Overall Study|Stable Disease|19
7863357|NCT00050960|27267343|P2|Overall Study|Progressive Disease|93
7863358|NCT00050960|27267344|P1|Overall Study|Progressive Disease|137
7863359|NCT00050778|27267353|P3|Overall Study|Familial and personal reasons|0
7863360|NCT00050778|27267354|P2|Overall Study|Familial and personal reasons|0
7863361|NCT00050778|27267355|P1|Overall Study|Familial and personal reasons|1
7863362|NCT00050778|27267353|P3|Overall Study|Randomized but not treated|2
7863363|NCT00050778|27267354|P2|Overall Study|Randomized but not treated|5
7863364|NCT00050778|27267355|P1|Overall Study|Randomized but not treated|4
7863365|NCT00050778|27267353|P3|Overall Study|Withdrawal by Subject|4
7863366|NCT00050778|27267354|P2|Overall Study|Withdrawal by Subject|8
7863367|NCT00050778|27267355|P1|Overall Study|Withdrawal by Subject|6
7863368|NCT00050778|27267353|P3|Overall Study|Protocol Violation|1
7863369|NCT00050778|27267354|P2|Overall Study|Protocol Violation|0
7863370|NCT00050778|27267355|P1|Overall Study|Protocol Violation|2
7863371|NCT00050778|27267353|P3|Overall Study|Physician Decision|2
7863372|NCT00050778|27267354|P2|Overall Study|Physician Decision|0
7863373|NCT00050778|27267355|P1|Overall Study|Physician Decision|3
7863374|NCT00050778|27267353|P3|Overall Study|Lost to Follow-up|4
7863375|NCT00050778|27267354|P2|Overall Study|Lost to Follow-up|2
7863376|NCT00050778|27267355|P1|Overall Study|Lost to Follow-up|0
7863377|NCT00050778|27267353|P3|Overall Study|Lack of Efficacy|2
7863378|NCT00050778|27267354|P2|Overall Study|Lack of Efficacy|2
7863379|NCT00050778|27267355|P1|Overall Study|Lack of Efficacy|16
7863380|NCT00050778|27267353|P3|Overall Study|Death|1
7863381|NCT00050778|27267354|P2|Overall Study|Death|1
7863382|NCT00050778|27267355|P1|Overall Study|Death|0
7863383|NCT00050778|27267353|P3|Overall Study|Adverse Event|2
7863384|NCT00050778|27267354|P2|Overall Study|Adverse Event|3
7863385|NCT00050778|27267355|P1|Overall Study|Adverse Event|13
7863386|NCT00050622|27267381|P1|Overall Study|Adverse Event|1
7863387|NCT00050167|27267419|P2|Overall Study|not eligible not invasive|1
7863388|NCT00050167|27267420|P1|Overall Study|not eligible not invasive|1
7863389|NCT00050011|27267453|P2|Overall Study|Unknown - Reason is missing|2
7863390|NCT00050011|27267454|P1|Overall Study|Unknown - Reason is missing|0
7863391|NCT00050011|27267453|P2|Overall Study|Death|4
7863392|NCT00050011|27267454|P1|Overall Study|Death|7
7863393|NCT00050011|27267453|P2|Overall Study|Administrative problems|6
7863394|NCT00050011|27267454|P1|Overall Study|Administrative problems|10
7863395|NCT00050011|27267453|P2|Overall Study|Lost to Follow-up|9
7863396|NCT00050011|27267454|P1|Overall Study|Lost to Follow-up|7
7863397|NCT00050011|27267453|P2|Overall Study|Withdrawal by Subject|26
7863398|NCT00050011|27267454|P1|Overall Study|Withdrawal by Subject|34
7863399|NCT00050011|27267453|P2|Overall Study|Protocol Violation|10
7863400|NCT00050011|27267454|P1|Overall Study|Protocol Violation|4
7863401|NCT00050011|27267453|P2|Overall Study|Participant condition no longer required|0
7863402|NCT00050011|27267454|P1|Overall Study|Participant condition no longer required|1
7863403|NCT00050011|27267453|P2|Overall Study|Lack of Efficacy|21
7863404|NCT00050011|27267454|P1|Overall Study|Lack of Efficacy|16
7863405|NCT00050011|27267453|P2|Overall Study|Abnormal test procedure results|1
7863406|NCT00050011|27267454|P1|Overall Study|Abnormal test procedure results|0
7863407|NCT00050011|27267453|P2|Overall Study|Abnormal laboratory value(s)|1
7863408|NCT00050011|27267454|P1|Overall Study|Abnormal laboratory value(s)|1
7863409|NCT00050011|27267453|P2|Overall Study|Adverse Event|46
7863410|NCT00050011|27267454|P1|Overall Study|Adverse Event|41
7863411|NCT00049842|27267476|P2|Follow-up Phase|Other|4
7863412|NCT00049842|27267477|P1|Follow-up Phase|Other|1
7863413|NCT00049842|27267476|P2|Follow-up Phase|Adverse Event|1
7863414|NCT00049842|27267477|P1|Follow-up Phase|Adverse Event|6
7863415|NCT00049842|27267476|P2|Treatment Phase|Did not meet protocol eligibility|1
7863416|NCT00049842|27267477|P1|Treatment Phase|Did not meet protocol eligibility|0
7863417|NCT00049842|27267476|P2|Treatment Phase|Administrative|3
7863418|NCT00049842|27267477|P1|Treatment Phase|Administrative|0
7863419|NCT00049842|27267476|P2|Treatment Phase|Lost to Follow-up|8
7863420|NCT00049842|27267477|P1|Treatment Phase|Lost to Follow-up|4
7863421|NCT00049842|27267476|P2|Treatment Phase|Non-compliance with protocol|8
7863422|NCT00049842|27267477|P1|Treatment Phase|Non-compliance with protocol|7
7863423|NCT00049842|27267476|P2|Treatment Phase|Withdrawal by Subject|46
7863424|NCT00049842|27267477|P1|Treatment Phase|Withdrawal by Subject|35
7863425|NCT00049842|27267476|P2|Treatment Phase|Adverse Event|12
7863426|NCT00049842|27267477|P1|Treatment Phase|Adverse Event|47
7863427|NCT00048932|27267495|P3|Open Label Period (OL)|Participant Surgery|1
7863428|NCT00048932|27267496|P2|Open Label Period (OL)|Participant Surgery|0
7863429|NCT00048932|27267497|P1|Open Label Period (OL)|Participant Surgery|0
7863430|NCT00048932|27267495|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
7863431|NCT00048932|27267496|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
7863432|NCT00048932|27267497|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
7863433|NCT00048932|27267495|P3|Open Label Period (OL)|Site Staff Issues|2
7863434|NCT00048932|27267496|P2|Open Label Period (OL)|Site Staff Issues|0
7863435|NCT00048932|27267497|P1|Open Label Period (OL)|Site Staff Issues|0
7863436|NCT00048932|27267495|P3|Open Label Period (OL)|Investigator Decision|4
7863437|NCT00048932|27267496|P2|Open Label Period (OL)|Investigator Decision|0
7863438|NCT00048932|27267497|P1|Open Label Period (OL)|Investigator Decision|0
7863439|NCT00048932|27267495|P3|Open Label Period (OL)|Medication Lost Efficacy|1
7863440|NCT00048932|27267496|P2|Open Label Period (OL)|Medication Lost Efficacy|0
7863441|NCT00048932|27267497|P1|Open Label Period (OL)|Medication Lost Efficacy|0
7863442|NCT00048932|27267495|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
7863443|NCT00048932|27267496|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
7863444|NCT00048932|27267497|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
7863445|NCT00048932|27267495|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
7863446|NCT00048932|27267496|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
7863447|NCT00048932|27267497|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
7863448|NCT00048932|27267495|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
7863449|NCT00048932|27267496|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
7863450|NCT00048932|27267497|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
7863451|NCT00048932|27267495|P3|Open Label Period (OL)|Patient Decision|4
7863452|NCT00048932|27267496|P2|Open Label Period (OL)|Patient Decision|0
7863453|NCT00048932|27267497|P1|Open Label Period (OL)|Patient Decision|0
7863454|NCT00048932|27267495|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
7863455|NCT00048932|27267496|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
7863456|NCT00048932|27267497|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
7863457|NCT00048932|27267495|P3|Open Label Period (OL)|Trial Terminated|1
7863458|NCT00048932|27267496|P2|Open Label Period (OL)|Trial Terminated|0
7863459|NCT00048932|27267497|P1|Open Label Period (OL)|Trial Terminated|0
7863460|NCT00048932|27267495|P3|Open Label Period (OL)|Site Closure|3
7863461|NCT00048932|27267496|P2|Open Label Period (OL)|Site Closure|0
7863462|NCT00048932|27267497|P1|Open Label Period (OL)|Site Closure|0
7863463|NCT00048932|27267495|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
7863464|NCT00048932|27267496|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
7863465|NCT00048932|27267497|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
7863466|NCT00048932|27267495|P3|Open Label Period (OL)|Participant Relocated|6
7863467|NCT00048932|27267496|P2|Open Label Period (OL)|Participant Relocated|0
7863468|NCT00048932|27267497|P1|Open Label Period (OL)|Participant Relocated|0
7863469|NCT00048932|27267495|P3|Open Label Period (OL)|Participant Transportation Issues|1
7863470|NCT00048932|27267496|P2|Open Label Period (OL)|Participant Transportation Issues|0
7863471|NCT00048932|27267497|P1|Open Label Period (OL)|Participant Transportation Issues|0
7863472|NCT00048932|27267495|P3|Open Label Period (OL)|Investigator Retiring|2
7863473|NCT00048932|27267496|P2|Open Label Period (OL)|Investigator Retiring|0
7863474|NCT00048932|27267497|P1|Open Label Period (OL)|Investigator Retiring|0
7863475|NCT00048932|27267495|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
7863476|NCT00048932|27267496|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
7863477|NCT00048932|27267497|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
7863478|NCT00048932|27267495|P3|Open Label Period (OL)|Pregnancy|6
7863479|NCT00048932|27267496|P2|Open Label Period (OL)|Pregnancy|0
7863480|NCT00048932|27267497|P1|Open Label Period (OL)|Pregnancy|0
7863481|NCT00048932|27267495|P3|Open Label Period (OL)|Poor/Non-Compliance|13
7863482|NCT00048932|27267496|P2|Open Label Period (OL)|Poor/Non-Compliance|0
7863483|NCT00048932|27267497|P1|Open Label Period (OL)|Poor/Non-Compliance|0
7863484|NCT00048932|27267495|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
7863485|NCT00048932|27267496|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
7863486|NCT00048932|27267497|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
7863487|NCT00048932|27267495|P3|Open Label Period (OL)|Withdrawal by Subject|117
7863488|NCT00048932|27267496|P2|Open Label Period (OL)|Withdrawal by Subject|0
7863489|NCT00048932|27267497|P1|Open Label Period (OL)|Withdrawal by Subject|0
7863490|NCT00048932|27267495|P3|Open Label Period (OL)|Lost to Follow-up|27
7863491|NCT00048932|27267496|P2|Open Label Period (OL)|Lost to Follow-up|0
7863492|NCT00048932|27267497|P1|Open Label Period (OL)|Lost to Follow-up|0
7863493|NCT00048932|27267495|P3|Open Label Period (OL)|Lack of Efficacy|81
7863494|NCT00048932|27267496|P2|Open Label Period (OL)|Lack of Efficacy|0
7863495|NCT00048932|27267497|P1|Open Label Period (OL)|Lack of Efficacy|0
7863496|NCT00048932|27267495|P3|Open Label Period (OL)|Adverse Event|103
7863497|NCT00048932|27267496|P2|Open Label Period (OL)|Adverse Event|0
7863498|NCT00048932|27267497|P1|Open Label Period (OL)|Adverse Event|0
7863499|NCT00048932|27267495|P3|Open Label Period (OL)|Death|25
7863500|NCT00048932|27267496|P2|Open Label Period (OL)|Death|0
7863501|NCT00048932|27267497|P1|Open Label Period (OL)|Death|0
7863502|NCT00048932|27267495|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
7863503|NCT00048932|27267496|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
7863504|NCT00048932|27267497|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
7863505|NCT00048932|27267495|P3|Double Blind Period (DB)|Withdrawal by Subject|0
7863506|NCT00048932|27267496|P2|Double Blind Period (DB)|Withdrawal by Subject|10
7863507|NCT00048932|27267497|P1|Double Blind Period (DB)|Withdrawal by Subject|24
7863508|NCT00048932|27267495|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
7863509|NCT00048932|27267496|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
7863510|NCT00048932|27267497|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
7863511|NCT00048932|27267495|P3|Double Blind Period (DB)|Pregnancy|0
7863512|NCT00048932|27267496|P2|Double Blind Period (DB)|Pregnancy|0
7863513|NCT00048932|27267497|P1|Double Blind Period (DB)|Pregnancy|1
7863514|NCT00048932|27267495|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
7863515|NCT00048932|27267496|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
7863516|NCT00048932|27267497|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
7863517|NCT00048932|27267495|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
7863518|NCT00048932|27267496|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
7863519|NCT00048932|27267497|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
7863520|NCT00048932|27267495|P3|Double Blind Period (DB)|Relocation|0
7863521|NCT00048932|27267496|P2|Double Blind Period (DB)|Relocation|0
7863522|NCT00048932|27267497|P1|Double Blind Period (DB)|Relocation|1
7863523|NCT00048932|27267495|P3|Double Blind Period (DB)|Lost to Follow-up|0
7863524|NCT00048932|27267496|P2|Double Blind Period (DB)|Lost to Follow-up|4
7863525|NCT00048932|27267497|P1|Double Blind Period (DB)|Lost to Follow-up|3
7863526|NCT00048932|27267495|P3|Double Blind Period (DB)|Lack of Efficacy|0
7863527|NCT00048932|27267496|P2|Double Blind Period (DB)|Lack of Efficacy|44
7863528|NCT00048932|27267497|P1|Double Blind Period (DB)|Lack of Efficacy|26
7863529|NCT00048932|27267495|P3|Double Blind Period (DB)|Death|0
7863530|NCT00048932|27267496|P2|Double Blind Period (DB)|Death|3
7863531|NCT00048932|27267497|P1|Double Blind Period (DB)|Death|5
7863532|NCT00048932|27267495|P3|Double Blind Period (DB)|Adverse Event|0
7863533|NCT00048932|27267496|P2|Double Blind Period (DB)|Adverse Event|19
7863534|NCT00048932|27267497|P1|Double Blind Period (DB)|Adverse Event|51
7863535|NCT00048932|27267495|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
7863536|NCT00048932|27267496|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
7863537|NCT00048932|27267497|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
7863538|NCT00048581|27267539|P3|Open-Label Period|Study Ended By Sponsor|1
7863539|NCT00048581|27267540|P2|Open-Label Period|Study Ended By Sponsor|0
7863540|NCT00048581|27267541|P1|Open-Label Period|Study Ended By Sponsor|0
7863541|NCT00048581|27267539|P3|Open-Label Period|Primary Investigator Retired|2
7863542|NCT00048581|27267540|P2|Open-Label Period|Primary Investigator Retired|0
7863543|NCT00048581|27267541|P1|Open-Label Period|Primary Investigator Retired|0
7863544|NCT00048581|27267539|P3|Open-Label Period|Problem With Transportation To Site|1
7863545|NCT00048581|27267540|P2|Open-Label Period|Problem With Transportation To Site|0
7863546|NCT00048581|27267541|P1|Open-Label Period|Problem With Transportation To Site|0
7863547|NCT00048581|27267539|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
7863548|NCT00048581|27267540|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
7863549|NCT00048581|27267541|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
7863550|NCT00048581|27267539|P3|Open-Label Period|Study Site Closure|2
7863551|NCT00048581|27267540|P2|Open-Label Period|Study Site Closure|0
7863552|NCT00048581|27267541|P1|Open-Label Period|Study Site Closure|0
7863553|NCT00048581|27267539|P3|Open-Label Period|Pregnancy|7
7863554|NCT00048581|27267540|P2|Open-Label Period|Pregnancy|0
7863555|NCT00048581|27267541|P1|Open-Label Period|Pregnancy|0
7863556|NCT00048581|27267539|P3|Open-Label Period|Poor/Non-compliance|5
7863557|NCT00048581|27267540|P2|Open-Label Period|Poor/Non-compliance|0
7863558|NCT00048581|27267541|P1|Open-Label Period|Poor/Non-compliance|0
7863559|NCT00048581|27267539|P3|Open-Label Period|No Longer Meets Study Criteria|2
7863560|NCT00048581|27267540|P2|Open-Label Period|No Longer Meets Study Criteria|0
7863561|NCT00048581|27267541|P1|Open-Label Period|No Longer Meets Study Criteria|0
7863562|NCT00048581|27267539|P3|Open-Label Period|Withdrawal by Subject|20
7863563|NCT00048581|27267540|P2|Open-Label Period|Withdrawal by Subject|0
7863564|NCT00048581|27267541|P1|Open-Label Period|Withdrawal by Subject|0
7863565|NCT00048581|27267539|P3|Open-Label Period|Lost to Follow-up|14
7863566|NCT00048581|27267540|P2|Open-Label Period|Lost to Follow-up|0
7863567|NCT00048581|27267541|P1|Open-Label Period|Lost to Follow-up|0
7863568|NCT00048581|27267539|P3|Open-Label Period|Lack of Efficacy|69
7863569|NCT00048581|27267540|P2|Open-Label Period|Lack of Efficacy|0
7863570|NCT00048581|27267541|P1|Open-Label Period|Lack of Efficacy|0
7863571|NCT00048581|27267539|P3|Open-Label Period|Adverse Event|37
7863572|NCT00048581|27267540|P2|Open-Label Period|Adverse Event|0
7863573|NCT00048581|27267541|P1|Open-Label Period|Adverse Event|0
7863574|NCT00048581|27267539|P3|Open-Label Period|Death|4
7863575|NCT00048581|27267540|P2|Open-Label Period|Death|0
7863576|NCT00048581|27267541|P1|Open-Label Period|Death|0
7863577|NCT00048581|27267539|P3|Double-Blind Period|Investigator Decision|0
7863578|NCT00048581|27267540|P2|Double-Blind Period|Investigator Decision|0
7863579|NCT00048581|27267541|P1|Double-Blind Period|Investigator Decision|1
7863580|NCT00048581|27267539|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
7863581|NCT00048581|27267540|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
7863582|NCT00048581|27267541|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
7863583|NCT00048581|27267539|P3|Double-Blind Period|Withdrawal by Subject|0
7863584|NCT00048581|27267540|P2|Double-Blind Period|Withdrawal by Subject|2
7863585|NCT00048581|27267541|P1|Double-Blind Period|Withdrawal by Subject|5
7863586|NCT00048581|27267539|P3|Double-Blind Period|Lost to Follow-up|0
7863587|NCT00048581|27267540|P2|Double-Blind Period|Lost to Follow-up|0
7863588|NCT00048581|27267541|P1|Double-Blind Period|Lost to Follow-up|5
7863589|NCT00048581|27267539|P3|Double-Blind Period|Lack of Efficacy|0
7863590|NCT00048581|27267540|P2|Double-Blind Period|Lack of Efficacy|27
7863591|NCT00048581|27267541|P1|Double-Blind Period|Lack of Efficacy|14
7863592|NCT00048581|27267539|P3|Double-Blind Period|Adverse Event|0
7863593|NCT00048581|27267540|P2|Double-Blind Period|Adverse Event|5
7863594|NCT00048581|27267541|P1|Double-Blind Period|Adverse Event|9
7863595|NCT00048568|27267708|P3|Open-Label Period|Lost to Follow-up|7
7863596|NCT00048568|27267709|P2|Open-Label Period|Lost to Follow-up|0
7863597|NCT00048568|27267710|P1|Open-Label Period|Lost to Follow-up|0
7863598|NCT00048568|27267708|P3|Open-Label Period|Unknown Reasons|25
7863599|NCT00048568|27267709|P2|Open-Label Period|Unknown Reasons|0
7863600|NCT00048568|27267710|P1|Open-Label Period|Unknown Reasons|0
7863601|NCT00048568|27267708|P3|Open-Label Period|Administrative Decision By Sponsor|1
7863602|NCT00048568|27267709|P2|Open-Label Period|Administrative Decision By Sponsor|0
7863603|NCT00048568|27267710|P1|Open-Label Period|Administrative Decision By Sponsor|0
7863604|NCT00048568|27267708|P3|Open-Label Period|No Longer Met Study Criteria|2
7863605|NCT00048568|27267709|P2|Open-Label Period|No Longer Met Study Criteria|0
7863606|NCT00048568|27267710|P1|Open-Label Period|No Longer Met Study Criteria|0
7863607|NCT00048568|27267708|P3|Open-Label Period|Pregnancy|5
7863608|NCT00048568|27267709|P2|Open-Label Period|Pregnancy|0
7863609|NCT00048568|27267710|P1|Open-Label Period|Pregnancy|0
7863610|NCT00048568|27267708|P3|Open-Label Period|Withdrawal by Subject|26
7863611|NCT00048568|27267709|P2|Open-Label Period|Withdrawal by Subject|0
7863612|NCT00048568|27267710|P1|Open-Label Period|Withdrawal by Subject|0
7863613|NCT00048568|27267708|P3|Open-Label Period|Lack of Efficacy|32
7863614|NCT00048568|27267709|P2|Open-Label Period|Lack of Efficacy|0
7863615|NCT00048568|27267710|P1|Open-Label Period|Lack of Efficacy|0
7863616|NCT00048568|27267708|P3|Open-Label Period|Adverse Event|49
7863617|NCT00048568|27267709|P2|Open-Label Period|Adverse Event|0
7863618|NCT00048568|27267710|P1|Open-Label Period|Adverse Event|0
7863619|NCT00048568|27267708|P3|Open-Label Period|Death|13
7863620|NCT00048568|27267709|P2|Open-Label Period|Death|0
7863621|NCT00048568|27267710|P1|Open-Label Period|Death|0
7863622|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
7863623|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
7863624|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
7863625|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
7863626|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
7863627|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
7863628|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
7863629|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
7863630|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
7863631|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
7863632|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
7863633|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
7863634|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
7863635|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
7863636|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
7863637|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
7863638|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
7863639|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
7863640|NCT00048568|27267708|P3|Double-Blind Period Days 170 to 365|Death|0
7863641|NCT00048568|27267709|P2|Double-Blind Period Days 170 to 365|Death|1
7863642|NCT00048568|27267710|P1|Double-Blind Period Days 170 to 365|Death|1
7863643|NCT00048568|27267708|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
7863644|NCT00048568|27267709|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
7863645|NCT00048568|27267710|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
7863646|NCT00048568|27267708|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
7863647|NCT00048568|27267709|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
7863648|NCT00048568|27267710|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
7863649|NCT00048568|27267708|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
7863650|NCT00048568|27267709|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
7863651|NCT00048568|27267710|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
7863652|NCT00048568|27267708|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
7863653|NCT00048568|27267709|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
7863654|NCT00048568|27267710|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
7863655|NCT00048568|27267708|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
7863656|NCT00048568|27267709|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
7863657|NCT00048568|27267710|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
7863658|NCT00048724|27268015|P2|Overall Study|Administrative|1
7863659|NCT00048724|27268016|P1|Overall Study|Administrative|1
7863660|NCT00048724|27268015|P2|Overall Study|Did Not Meet Protocol Eligibility|2
7863661|NCT00048724|27268016|P1|Overall Study|Did Not Meet Protocol Eligibility|2
7863662|NCT00048724|27268015|P2|Overall Study|Noncompliance With Protocol|12
7863663|NCT00048724|27268016|P1|Overall Study|Noncompliance With Protocol|4
7863664|NCT00048724|27268015|P2|Overall Study|Protocol-defined Clinical Event|32
7863665|NCT00048724|27268016|P1|Overall Study|Protocol-defined Clinical Event|17
7863666|NCT00048724|27268015|P2|Overall Study|Lost to Follow-up|5
7863667|NCT00048724|27268016|P1|Overall Study|Lost to Follow-up|5
7863668|NCT00048724|27268015|P2|Overall Study|Withdrawal by Subject|54
7863669|NCT00048724|27268016|P1|Overall Study|Withdrawal by Subject|34
7863670|NCT00048724|27268015|P2|Overall Study|Adverse Event|12
7863671|NCT00048724|27268016|P1|Overall Study|Adverse Event|53
7863672|NCT00048542|27268028|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
7863673|NCT00048542|27268029|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
7863674|NCT00048542|27268030|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7863675|NCT00048542|27268031|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7863676|NCT00048542|27268032|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7863677|NCT00048542|27268033|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7863678|NCT00048542|27268034|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7863679|NCT00048542|27268035|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7863680|NCT00048542|27268028|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
7863681|NCT00048542|27268029|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
7863682|NCT00048542|27268030|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7863836|NCT00048074|27268144|P2|Overall Study|Withdrawal by Subject|30
7863683|NCT00048542|27268031|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7863684|NCT00048542|27268032|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7863685|NCT00048542|27268033|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7863686|NCT00048542|27268034|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7863687|NCT00048542|27268035|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7863688|NCT00048542|27268028|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
7863689|NCT00048542|27268029|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
7863690|NCT00048542|27268030|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7863691|NCT00048542|27268031|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7863692|NCT00048542|27268032|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7863693|NCT00048542|27268033|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7863694|NCT00048542|27268034|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7863695|NCT00048542|27268035|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7863696|NCT00048542|27268028|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
7863697|NCT00048542|27268029|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
7863698|NCT00048542|27268030|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7863699|NCT00048542|27268031|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7863700|NCT00048542|27268032|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7863701|NCT00048542|27268033|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7863702|NCT00048542|27268034|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7863703|NCT00048542|27268035|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7863704|NCT00048542|27268028|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
7863705|NCT00048542|27268029|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
7863706|NCT00048542|27268030|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7863707|NCT00048542|27268031|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7863708|NCT00048542|27268032|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7863709|NCT00048542|27268033|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7863710|NCT00048542|27268034|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7863711|NCT00048542|27268035|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7863712|NCT00048542|27268028|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
7863713|NCT00048542|27268029|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
7863714|NCT00048542|27268030|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7863715|NCT00048542|27268031|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7863716|NCT00048542|27268032|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7863717|NCT00048542|27268033|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7863718|NCT00048542|27268034|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7863719|NCT00048542|27268035|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7863720|NCT00048542|27268028|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
7863721|NCT00048542|27268029|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
7863722|NCT00048542|27268030|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
7863723|NCT00048542|27268031|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
7863724|NCT00048542|27268032|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
7863725|NCT00048542|27268033|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
7863726|NCT00048542|27268034|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
7863727|NCT00048542|27268035|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
7863728|NCT00048542|27268028|P8|Open-Label Extension BSA Phase|Adverse Event|0
7863729|NCT00048542|27268029|P7|Open-Label Extension BSA Phase|Adverse Event|0
7863730|NCT00048542|27268030|P6|Open-Label Extension BSA Phase|Adverse Event|1
7863731|NCT00048542|27268031|P5|Open-Label Extension BSA Phase|Adverse Event|1
7863732|NCT00048542|27268032|P4|Open-Label Extension BSA Phase|Adverse Event|0
7863733|NCT00048542|27268033|P3|Open-Label Extension BSA Phase|Adverse Event|0
7863734|NCT00048542|27268034|P2|Open-Label Extension BSA Phase|Adverse Event|0
7863735|NCT00048542|27268035|P1|Open-Label Extension BSA Phase|Adverse Event|0
7863736|NCT00048542|27268028|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
7863737|NCT00048542|27268029|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
7863738|NCT00048542|27268030|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
7863739|NCT00048542|27268031|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
7863740|NCT00048542|27268032|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
7863741|NCT00048542|27268033|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
7863742|NCT00048542|27268034|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
7863743|NCT00048542|27268035|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
7863744|NCT00048542|27268028|P8|Open-Label Extension BSA Phase|Protocol Violation|0
7863745|NCT00048542|27268029|P7|Open-Label Extension BSA Phase|Protocol Violation|0
7863746|NCT00048542|27268030|P6|Open-Label Extension BSA Phase|Protocol Violation|1
7863747|NCT00048542|27268031|P5|Open-Label Extension BSA Phase|Protocol Violation|0
7863748|NCT00048542|27268032|P4|Open-Label Extension BSA Phase|Protocol Violation|0
7863749|NCT00048542|27268033|P3|Open-Label Extension BSA Phase|Protocol Violation|0
7863750|NCT00048542|27268034|P2|Open-Label Extension BSA Phase|Protocol Violation|0
7863751|NCT00048542|27268035|P1|Open-Label Extension BSA Phase|Protocol Violation|0
7863752|NCT00048542|27268028|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7863753|NCT00048542|27268029|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7863754|NCT00048542|27268030|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
7863755|NCT00048542|27268031|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
7863756|NCT00048542|27268032|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7863757|NCT00048542|27268033|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7863758|NCT00048542|27268034|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7863759|NCT00048542|27268035|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7863760|NCT00048542|27268028|P8|Double-Blind Phase|Randomized in error|0
7863761|NCT00048542|27268029|P7|Double-Blind Phase|Randomized in error|0
7863762|NCT00048542|27268030|P6|Double-Blind Phase|Randomized in error|0
7863763|NCT00048542|27268031|P5|Double-Blind Phase|Randomized in error|0
7863764|NCT00048542|27268032|P4|Double-Blind Phase|Randomized in error|0
7863765|NCT00048542|27268033|P3|Double-Blind Phase|Randomized in error|0
7863766|NCT00048542|27268034|P2|Double-Blind Phase|Randomized in error|0
7863767|NCT00048542|27268035|P1|Double-Blind Phase|Randomized in error|1
7863768|NCT00048542|27268028|P8|Double-Blind Phase|Sponsor request or decision|0
7863769|NCT00048542|27268029|P7|Double-Blind Phase|Sponsor request or decision|0
7863770|NCT00048542|27268030|P6|Double-Blind Phase|Sponsor request or decision|0
7863771|NCT00048542|27268031|P5|Double-Blind Phase|Sponsor request or decision|0
7863772|NCT00048542|27268032|P4|Double-Blind Phase|Sponsor request or decision|0
7863773|NCT00048542|27268033|P3|Double-Blind Phase|Sponsor request or decision|0
7863774|NCT00048542|27268034|P2|Double-Blind Phase|Sponsor request or decision|0
7863775|NCT00048542|27268035|P1|Double-Blind Phase|Sponsor request or decision|2
7863776|NCT00048542|27268028|P8|Double-Blind Phase|Protocol Violation|0
7863777|NCT00048542|27268029|P7|Double-Blind Phase|Protocol Violation|0
7863778|NCT00048542|27268030|P6|Double-Blind Phase|Protocol Violation|0
7863779|NCT00048542|27268031|P5|Double-Blind Phase|Protocol Violation|0
7863780|NCT00048542|27268032|P4|Double-Blind Phase|Protocol Violation|0
7863781|NCT00048542|27268033|P3|Double-Blind Phase|Protocol Violation|1
7863782|NCT00048542|27268034|P2|Double-Blind Phase|Protocol Violation|0
7863783|NCT00048542|27268035|P1|Double-Blind Phase|Protocol Violation|0
7863784|NCT00048542|27268028|P8|Double-Blind Phase|Withdrawal by Subject|0
7863785|NCT00048542|27268029|P7|Double-Blind Phase|Withdrawal by Subject|0
7863786|NCT00048542|27268030|P6|Double-Blind Phase|Withdrawal by Subject|0
7863787|NCT00048542|27268031|P5|Double-Blind Phase|Withdrawal by Subject|0
7863788|NCT00048542|27268032|P4|Double-Blind Phase|Withdrawal by Subject|0
7863789|NCT00048542|27268033|P3|Double-Blind Phase|Withdrawal by Subject|0
7863790|NCT00048542|27268034|P2|Double-Blind Phase|Withdrawal by Subject|1
7863791|NCT00048542|27268035|P1|Double-Blind Phase|Withdrawal by Subject|0
7863792|NCT00048347|27268101|P1|Overall Study|Screen failure|2
7863793|NCT00048165|27268107|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
7863794|NCT00048165|27268108|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
7863795|NCT00048165|27268107|P2|Completed 12 Months Study|Death|1
7863796|NCT00048165|27268108|P1|Completed 12 Months Study|Death|2
7863797|NCT00048165|27268107|P2|Completed 12 Months Study|Administration/Other|2
7863798|NCT00048165|27268108|P1|Completed 12 Months Study|Administration/Other|0
7863799|NCT00048165|27268107|P2|Completed 6 Months Study|Did not receive study drug|6
7863800|NCT00048165|27268108|P1|Completed 6 Months Study|Did not receive study drug|6
7863801|NCT00048165|27268107|P2|Completed 6 Months Study|Violation criteria|2
7863802|NCT00048165|27268108|P1|Completed 6 Months Study|Violation criteria|0
7863803|NCT00048165|27268107|P2|Completed 6 Months Study|Refused treatment|5
7863804|NCT00048165|27268108|P1|Completed 6 Months Study|Refused treatment|5
7863805|NCT00048165|27268107|P2|Completed 6 Months Study|Other violation|6
7863806|NCT00048165|27268108|P1|Completed 6 Months Study|Other violation|4
7863807|NCT00048165|27268107|P2|Completed 6 Months Study|Insufficient therapy|4
7863808|NCT00048165|27268108|P1|Completed 6 Months Study|Insufficient therapy|1
7863809|NCT00048165|27268107|P2|Completed 6 Months Study|Death|6
7863810|NCT00048165|27268108|P1|Completed 6 Months Study|Death|12
7863811|NCT00048165|27268107|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
7863812|NCT00048165|27268108|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
7863813|NCT00048165|27268107|P2|Completed 6 Months Study|Abnormality of laboratory test|0
7863814|NCT00048165|27268108|P1|Completed 6 Months Study|Abnormality of laboratory test|1
7863815|NCT00048165|27268107|P2|Completed 6 Months Study|Administration/Other|8
7863816|NCT00048165|27268108|P1|Completed 6 Months Study|Administration/Other|8
7863817|NCT00048074|27268143|P3|Overall Study|Social reasons|0
7863818|NCT00048074|27268144|P2|Overall Study|Social reasons|0
7863819|NCT00048074|27268145|P1|Overall Study|Social reasons|1
7863820|NCT00048074|27268143|P3|Overall Study|Out of station|1
7863821|NCT00048074|27268144|P2|Overall Study|Out of station|1
7863822|NCT00048074|27268145|P1|Overall Study|Out of station|0
7863823|NCT00048074|27268143|P3|Overall Study|Poor compliance|0
7863824|NCT00048074|27268144|P2|Overall Study|Poor compliance|1
7863825|NCT00048074|27268145|P1|Overall Study|Poor compliance|0
7863826|NCT00048074|27268143|P3|Overall Study|Husband ill|0
7863827|NCT00048074|27268144|P2|Overall Study|Husband ill|1
7863828|NCT00048074|27268145|P1|Overall Study|Husband ill|0
7863829|NCT00048074|27268143|P3|Overall Study|Study participation was terminated|0
7863830|NCT00048074|27268144|P2|Overall Study|Study participation was terminated|1
7863831|NCT00048074|27268145|P1|Overall Study|Study participation was terminated|0
7863832|NCT00048074|27268143|P3|Overall Study|Protocol Violation|0
7863833|NCT00048074|27268144|P2|Overall Study|Protocol Violation|3
7863834|NCT00048074|27268145|P1|Overall Study|Protocol Violation|1
7863835|NCT00048074|27268143|P3|Overall Study|Withdrawal by Subject|35
7863837|NCT00048074|27268145|P1|Overall Study|Withdrawal by Subject|28
7863838|NCT00048074|27268143|P3|Overall Study|Lost to Follow-up|6
7863839|NCT00048074|27268144|P2|Overall Study|Lost to Follow-up|6
7863840|NCT00048074|27268145|P1|Overall Study|Lost to Follow-up|2
7863841|NCT00048074|27268143|P3|Overall Study|Death|2
7863842|NCT00048074|27268144|P2|Overall Study|Death|3
7863843|NCT00048074|27268145|P1|Overall Study|Death|3
7863844|NCT00048074|27268143|P3|Overall Study|Adverse Event|53
7863845|NCT00048074|27268144|P2|Overall Study|Adverse Event|41
7863846|NCT00048074|27268145|P1|Overall Study|Adverse Event|46
7863847|NCT00048061|27268202|P4|Overall Study|Early improvement|0
7863848|NCT00048061|27268203|P3|Overall Study|Early improvement|3
7863849|NCT00048061|27268204|P2|Overall Study|Early improvement|5
7863850|NCT00048061|27268205|P1|Overall Study|Early improvement|6
7863851|NCT00048061|27268202|P4|Overall Study|Did not follow-up|5
7863852|NCT00048061|27268203|P3|Overall Study|Did not follow-up|4
7863853|NCT00048061|27268204|P2|Overall Study|Did not follow-up|5
7863854|NCT00048061|27268205|P1|Overall Study|Did not follow-up|5
7863855|NCT00048061|27268202|P4|Overall Study|Withdrawal by Subject|32
7863856|NCT00048061|27268203|P3|Overall Study|Withdrawal by Subject|29
7863857|NCT00048061|27268204|P2|Overall Study|Withdrawal by Subject|29
7863858|NCT00048061|27268205|P1|Overall Study|Withdrawal by Subject|20
7863859|NCT00048061|27268202|P4|Overall Study|Lost to Follow-up|5
7863860|NCT00048061|27268203|P3|Overall Study|Lost to Follow-up|4
7863861|NCT00048061|27268204|P2|Overall Study|Lost to Follow-up|2
7863862|NCT00048061|27268205|P1|Overall Study|Lost to Follow-up|3
7863863|NCT00048061|27268202|P4|Overall Study|Adverse Event|37
7863864|NCT00048061|27268203|P3|Overall Study|Adverse Event|44
7863865|NCT00048061|27268204|P2|Overall Study|Adverse Event|32
7863866|NCT00048061|27268205|P1|Overall Study|Adverse Event|41
7863867|NCT00048048|27268284|P12|Extension Year 2|Early withdrawals|2
7863868|NCT00048048|27268285|P11|Extension Year 2|Early withdrawals|4
7863869|NCT00048048|27268286|P10|Extension Year 2|Early withdrawals|0
7863870|NCT00048048|27268287|P9|Extension Year 2|Early withdrawals|0
7863871|NCT00048048|27268288|P8|Extension Year 2|Early withdrawals|0
7863872|NCT00048048|27268289|P7|Extension Year 2|Early withdrawals|0
7863873|NCT00048048|27268290|P6|Extension Year 2|Early withdrawals|0
7863874|NCT00048048|27268291|P5|Extension Year 2|Early withdrawals|0
7863875|NCT00048048|27268292|P4|Extension Year 2|Early withdrawals|0
7863876|NCT00048048|27268293|P3|Extension Year 2|Early withdrawals|0
7863877|NCT00048048|27268294|P2|Extension Year 2|Early withdrawals|0
7863878|NCT00048048|27268295|P1|Extension Year 2|Early withdrawals|0
7863879|NCT00048048|27268284|P12|Extension Year 1|Early withdrawals|4
7863880|NCT00048048|27268285|P11|Extension Year 1|Early withdrawals|2
7863881|NCT00048048|27268286|P10|Extension Year 1|Early withdrawals|2
7863882|NCT00048048|27268287|P9|Extension Year 1|Early withdrawals|0
7863883|NCT00048048|27268288|P8|Extension Year 1|Early withdrawals|0
7863884|NCT00048048|27268289|P7|Extension Year 1|Early withdrawals|0
7863885|NCT00048048|27268290|P6|Extension Year 1|Early withdrawals|0
7863886|NCT00048048|27268291|P5|Extension Year 1|Early withdrawals|0
7863887|NCT00048048|27268292|P4|Extension Year 1|Early withdrawals|0
7863888|NCT00048048|27268293|P3|Extension Year 1|Early withdrawals|0
7863889|NCT00048048|27268294|P2|Extension Year 1|Early withdrawals|0
7863890|NCT00048048|27268295|P1|Extension Year 1|Early withdrawals|0
7863891|NCT00048048|27268284|P12|Core Treatment|Adverse Event|0
7863892|NCT00048048|27268285|P11|Core Treatment|Adverse Event|0
7863893|NCT00048048|27268286|P10|Core Treatment|Adverse Event|0
7863894|NCT00048048|27268287|P9|Core Treatment|Adverse Event|0
7863895|NCT00048048|27268288|P8|Core Treatment|Adverse Event|1
7863896|NCT00048048|27268289|P7|Core Treatment|Adverse Event|0
7863897|NCT00048048|27268290|P6|Core Treatment|Adverse Event|0
7863898|NCT00048048|27268291|P5|Core Treatment|Adverse Event|0
7863899|NCT00048048|27268292|P4|Core Treatment|Adverse Event|0
7863900|NCT00048048|27268293|P3|Core Treatment|Adverse Event|0
7863901|NCT00048048|27268294|P2|Core Treatment|Adverse Event|0
7863902|NCT00048048|27268295|P1|Core Treatment|Adverse Event|0
7863903|NCT00048048|27268284|P12|Core Treatment|Withdrawal by Subject|0
7863904|NCT00048048|27268285|P11|Core Treatment|Withdrawal by Subject|0
7863905|NCT00048048|27268286|P10|Core Treatment|Withdrawal by Subject|0
7863906|NCT00048048|27268287|P9|Core Treatment|Withdrawal by Subject|0
7863907|NCT00048048|27268288|P8|Core Treatment|Withdrawal by Subject|0
7863908|NCT00048048|27268289|P7|Core Treatment|Withdrawal by Subject|0
7863909|NCT00048048|27268290|P6|Core Treatment|Withdrawal by Subject|0
7863910|NCT00048048|27268291|P5|Core Treatment|Withdrawal by Subject|0
7863911|NCT00048048|27268292|P4|Core Treatment|Withdrawal by Subject|0
7863912|NCT00048048|27268293|P3|Core Treatment|Withdrawal by Subject|1
7863913|NCT00048048|27268294|P2|Core Treatment|Withdrawal by Subject|0
7863914|NCT00048048|27268295|P1|Core Treatment|Withdrawal by Subject|0
7863915|NCT00048035|27268351|P8|Extension Year 2|Early Withdrawals|3
7863916|NCT00048035|27268352|P7|Extension Year 2|Early Withdrawals|3
7863917|NCT00048035|27268353|P6|Extension Year 2|Early Withdrawals|0
7863918|NCT00048035|27268354|P5|Extension Year 2|Early Withdrawals|0
7863919|NCT00048035|27268355|P4|Extension Year 2|Early Withdrawals|0
7863920|NCT00048035|27268356|P3|Extension Year 2|Early Withdrawals|0
7863921|NCT00048035|27268357|P2|Extension Year 2|Early Withdrawals|0
7863922|NCT00048035|27268358|P1|Extension Year 2|Early Withdrawals|0
7863923|NCT00048035|27268351|P8|Extension Year 1|Early Withdrawals|11
7863924|NCT00048035|27268352|P7|Extension Year 1|Early Withdrawals|11
7863925|NCT00048035|27268353|P6|Extension Year 1|Early Withdrawals|0
7863926|NCT00048035|27268354|P5|Extension Year 1|Early Withdrawals|0
7863927|NCT00048035|27268355|P4|Extension Year 1|Early Withdrawals|0
7863928|NCT00048035|27268356|P3|Extension Year 1|Early Withdrawals|0
7863929|NCT00048035|27268357|P2|Extension Year 1|Early Withdrawals|0
7863930|NCT00048035|27268358|P1|Extension Year 1|Early Withdrawals|0
7863931|NCT00048035|27268351|P8|Core Period|Early Withdrawals|0
7863932|NCT00048035|27268352|P7|Core Period|Early Withdrawals|0
7863933|NCT00048035|27268353|P6|Core Period|Early Withdrawals|1
7863934|NCT00048035|27268354|P5|Core Period|Early Withdrawals|1
7863935|NCT00048035|27268355|P4|Core Period|Early Withdrawals|1
7863936|NCT00048035|27268356|P3|Core Period|Early Withdrawals|1
7863937|NCT00048035|27268357|P2|Core Period|Early Withdrawals|2
7863938|NCT00048035|27268358|P1|Core Period|Early Withdrawals|4
7863939|NCT00047879|27268396|P2|Overall Study|Progressive disease|3
7863940|NCT00047879|27268397|P1|Overall Study|Progressive disease|4
7863941|NCT00047463|27268433|P2|Overall Study|Withdrawal by Subject|3
7863942|NCT00047463|27268434|P1|Overall Study|Withdrawal by Subject|0
7863943|NCT00045942|27268551|P9|PKC412A2104E2|Death|0
7863944|NCT00045942|27268552|P8|PKC412A2104E2|Death|0
7863945|NCT00045942|27268553|P7|PKC412A2104E2|Death|2
7863946|NCT00045942|27268554|P6|PKC412A2104E2|Death|1
7863947|NCT00045942|27268555|P5|PKC412A2104E2|Death|0
7863948|NCT00045942|27268556|P4|PKC412A2104E2|Death|0
7863949|NCT00045942|27268557|P3|PKC412A2104E2|Death|0
7863950|NCT00045942|27268558|P2|PKC412A2104E2|Death|0
7863951|NCT00045942|27268559|P1|PKC412A2104E2|Death|0
7863952|NCT00045942|27268551|P9|PKC412A2104E2|Adverse Event|0
7863953|NCT00045942|27268552|P8|PKC412A2104E2|Adverse Event|1
7863954|NCT00045942|27268553|P7|PKC412A2104E2|Adverse Event|3
7863955|NCT00045942|27268554|P6|PKC412A2104E2|Adverse Event|4
7863956|NCT00045942|27268555|P5|PKC412A2104E2|Adverse Event|0
7863957|NCT00045942|27268556|P4|PKC412A2104E2|Adverse Event|0
7863958|NCT00045942|27268557|P3|PKC412A2104E2|Adverse Event|0
7863959|NCT00045942|27268558|P2|PKC412A2104E2|Adverse Event|0
7863960|NCT00045942|27268559|P1|PKC412A2104E2|Adverse Event|0
7863961|NCT00045942|27268551|P9|PKC412A2104E2|Lack of Efficacy|6
7863962|NCT00045942|27268552|P8|PKC412A2104E2|Lack of Efficacy|2
7863963|NCT00045942|27268553|P7|PKC412A2104E2|Lack of Efficacy|2
7863964|NCT00045942|27268554|P6|PKC412A2104E2|Lack of Efficacy|3
7863965|NCT00045942|27268555|P5|PKC412A2104E2|Lack of Efficacy|0
7863966|NCT00045942|27268556|P4|PKC412A2104E2|Lack of Efficacy|0
7863967|NCT00045942|27268557|P3|PKC412A2104E2|Lack of Efficacy|0
7863968|NCT00045942|27268558|P2|PKC412A2104E2|Lack of Efficacy|0
7863969|NCT00045942|27268559|P1|PKC412A2104E2|Lack of Efficacy|0
7863970|NCT00045942|27268551|P9|PKC412A2104E2|Withdrawal by Subject|0
7863971|NCT00045942|27268552|P8|PKC412A2104E2|Withdrawal by Subject|1
7863972|NCT00045942|27268553|P7|PKC412A2104E2|Withdrawal by Subject|0
7863973|NCT00045942|27268554|P6|PKC412A2104E2|Withdrawal by Subject|1
7863974|NCT00045942|27268555|P5|PKC412A2104E2|Withdrawal by Subject|0
7863975|NCT00045942|27268556|P4|PKC412A2104E2|Withdrawal by Subject|0
7863976|NCT00045942|27268557|P3|PKC412A2104E2|Withdrawal by Subject|0
7863977|NCT00045942|27268558|P2|PKC412A2104E2|Withdrawal by Subject|0
7863978|NCT00045942|27268559|P1|PKC412A2104E2|Withdrawal by Subject|0
7863979|NCT00045942|27268551|P9|PKC412A2104E2|Lost to Follow-up|0
7863980|NCT00045942|27268552|P8|PKC412A2104E2|Lost to Follow-up|3
7863981|NCT00045942|27268553|P7|PKC412A2104E2|Lost to Follow-up|0
7863982|NCT00045942|27268554|P6|PKC412A2104E2|Lost to Follow-up|0
7863983|NCT00045942|27268555|P5|PKC412A2104E2|Lost to Follow-up|0
7863984|NCT00045942|27268556|P4|PKC412A2104E2|Lost to Follow-up|0
7863985|NCT00045942|27268557|P3|PKC412A2104E2|Lost to Follow-up|0
7863986|NCT00045942|27268558|P2|PKC412A2104E2|Lost to Follow-up|0
7863987|NCT00045942|27268559|P1|PKC412A2104E2|Lost to Follow-up|0
7863988|NCT00045942|27268551|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863989|NCT00045942|27268552|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863990|NCT00045942|27268553|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863991|NCT00045942|27268554|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863992|NCT00045942|27268555|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863993|NCT00045942|27268556|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
7863994|NCT00045942|27268557|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
7863995|NCT00045942|27268558|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863996|NCT00045942|27268559|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7863997|NCT00045942|27268551|P9|PKC412A2104E1|Death|0
7863998|NCT00045942|27268552|P8|PKC412A2104E1|Death|0
7863999|NCT00045942|27268553|P7|PKC412A2104E1|Death|0
7864000|NCT00045942|27268554|P6|PKC412A2104E1|Death|0
7864001|NCT00045942|27268555|P5|PKC412A2104E1|Death|1
7864002|NCT00045942|27268556|P4|PKC412A2104E1|Death|1
7864003|NCT00045942|27268557|P3|PKC412A2104E1|Death|1
7864004|NCT00045942|27268558|P2|PKC412A2104E1|Death|4
7864005|NCT00045942|27268559|P1|PKC412A2104E1|Death|0
7864006|NCT00045942|27268551|P9|PKC412A2104E1|Adverse Event|0
7864007|NCT00045942|27268552|P8|PKC412A2104E1|Adverse Event|0
7864008|NCT00045942|27268553|P7|PKC412A2104E1|Adverse Event|0
7864009|NCT00045942|27268554|P6|PKC412A2104E1|Adverse Event|0
7864010|NCT00045942|27268555|P5|PKC412A2104E1|Adverse Event|6
7864011|NCT00045942|27268556|P4|PKC412A2104E1|Adverse Event|3
7864012|NCT00045942|27268557|P3|PKC412A2104E1|Adverse Event|1
7864013|NCT00045942|27268558|P2|PKC412A2104E1|Adverse Event|1
7864014|NCT00045942|27268559|P1|PKC412A2104E1|Adverse Event|0
7864015|NCT00045942|27268551|P9|PKC412A2104E1|Abnormal laboratory value|0
7864016|NCT00045942|27268552|P8|PKC412A2104E1|Abnormal laboratory value|0
7864017|NCT00045942|27268553|P7|PKC412A2104E1|Abnormal laboratory value|0
7864018|NCT00045942|27268554|P6|PKC412A2104E1|Abnormal laboratory value|0
7864019|NCT00045942|27268555|P5|PKC412A2104E1|Abnormal laboratory value|0
7864020|NCT00045942|27268556|P4|PKC412A2104E1|Abnormal laboratory value|0
7864021|NCT00045942|27268557|P3|PKC412A2104E1|Abnormal laboratory value|0
7864022|NCT00045942|27268558|P2|PKC412A2104E1|Abnormal laboratory value|1
7864023|NCT00045942|27268559|P1|PKC412A2104E1|Abnormal laboratory value|0
7864024|NCT00045942|27268551|P9|PKC412A2104E1|Lack of Efficacy|0
7864025|NCT00045942|27268552|P8|PKC412A2104E1|Lack of Efficacy|0
7864026|NCT00045942|27268553|P7|PKC412A2104E1|Lack of Efficacy|0
7864027|NCT00045942|27268554|P6|PKC412A2104E1|Lack of Efficacy|0
7864028|NCT00045942|27268555|P5|PKC412A2104E1|Lack of Efficacy|17
7864029|NCT00045942|27268556|P4|PKC412A2104E1|Lack of Efficacy|23
7864030|NCT00045942|27268557|P3|PKC412A2104E1|Lack of Efficacy|11
7864031|NCT00045942|27268558|P2|PKC412A2104E1|Lack of Efficacy|11
7864032|NCT00045942|27268559|P1|PKC412A2104E1|Lack of Efficacy|0
7864033|NCT00045942|27268551|P9|PKC412A2104E1|Condition no longer requires study drug|0
7864034|NCT00045942|27268552|P8|PKC412A2104E1|Condition no longer requires study drug|0
7864035|NCT00045942|27268553|P7|PKC412A2104E1|Condition no longer requires study drug|0
7864036|NCT00045942|27268554|P6|PKC412A2104E1|Condition no longer requires study drug|0
7864037|NCT00045942|27268555|P5|PKC412A2104E1|Condition no longer requires study drug|1
7864038|NCT00045942|27268556|P4|PKC412A2104E1|Condition no longer requires study drug|0
7864039|NCT00045942|27268557|P3|PKC412A2104E1|Condition no longer requires study drug|1
7864040|NCT00045942|27268558|P2|PKC412A2104E1|Condition no longer requires study drug|1
7864041|NCT00045942|27268559|P1|PKC412A2104E1|Condition no longer requires study drug|0
7864042|NCT00045942|27268551|P9|PKC412A2104E1|Withdrawal by Subject|0
7864043|NCT00045942|27268552|P8|PKC412A2104E1|Withdrawal by Subject|0
7864044|NCT00045942|27268553|P7|PKC412A2104E1|Withdrawal by Subject|0
7864045|NCT00045942|27268554|P6|PKC412A2104E1|Withdrawal by Subject|0
7864046|NCT00045942|27268555|P5|PKC412A2104E1|Withdrawal by Subject|2
7864047|NCT00045942|27268556|P4|PKC412A2104E1|Withdrawal by Subject|5
7864048|NCT00045942|27268557|P3|PKC412A2104E1|Withdrawal by Subject|2
7864049|NCT00045942|27268558|P2|PKC412A2104E1|Withdrawal by Subject|0
7864050|NCT00045942|27268559|P1|PKC412A2104E1|Withdrawal by Subject|0
7864051|NCT00045942|27268551|P9|PKC412A2104 (Core)|Death|0
7864052|NCT00045942|27268552|P8|PKC412A2104 (Core)|Death|0
7864053|NCT00045942|27268553|P7|PKC412A2104 (Core)|Death|0
7864054|NCT00045942|27268554|P6|PKC412A2104 (Core)|Death|0
7864055|NCT00045942|27268555|P5|PKC412A2104 (Core)|Death|0
7864056|NCT00045942|27268556|P4|PKC412A2104 (Core)|Death|0
7864057|NCT00045942|27268557|P3|PKC412A2104 (Core)|Death|0
7864058|NCT00045942|27268558|P2|PKC412A2104 (Core)|Death|0
7864059|NCT00045942|27268559|P1|PKC412A2104 (Core)|Death|1
7864060|NCT00045942|27268551|P9|PKC412A2104 (Core)|Lack of Efficacy|0
7864061|NCT00045942|27268552|P8|PKC412A2104 (Core)|Lack of Efficacy|0
7864062|NCT00045942|27268553|P7|PKC412A2104 (Core)|Lack of Efficacy|0
7864063|NCT00045942|27268554|P6|PKC412A2104 (Core)|Lack of Efficacy|0
7864064|NCT00045942|27268555|P5|PKC412A2104 (Core)|Lack of Efficacy|0
7864065|NCT00045942|27268556|P4|PKC412A2104 (Core)|Lack of Efficacy|0
7864066|NCT00045942|27268557|P3|PKC412A2104 (Core)|Lack of Efficacy|0
7864067|NCT00045942|27268558|P2|PKC412A2104 (Core)|Lack of Efficacy|0
7864068|NCT00045942|27268559|P1|PKC412A2104 (Core)|Lack of Efficacy|13
7864069|NCT00045942|27268551|P9|PKC412A2104 (Core)|Adverse Event|0
7864070|NCT00045942|27268552|P8|PKC412A2104 (Core)|Adverse Event|0
7864071|NCT00045942|27268553|P7|PKC412A2104 (Core)|Adverse Event|0
7864072|NCT00045942|27268554|P6|PKC412A2104 (Core)|Adverse Event|0
7864073|NCT00045942|27268555|P5|PKC412A2104 (Core)|Adverse Event|0
7864074|NCT00045942|27268556|P4|PKC412A2104 (Core)|Adverse Event|0
7864075|NCT00045942|27268557|P3|PKC412A2104 (Core)|Adverse Event|0
7864076|NCT00045942|27268558|P2|PKC412A2104 (Core)|Adverse Event|0
7864077|NCT00045942|27268559|P1|PKC412A2104 (Core)|Adverse Event|5
7864078|NCT00045942|27268551|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
7864079|NCT00045942|27268552|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
7864080|NCT00045942|27268553|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
7864081|NCT00045942|27268554|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
7864082|NCT00045942|27268555|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
7864083|NCT00045942|27268556|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
7864084|NCT00045942|27268557|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
7864085|NCT00045942|27268558|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
7864086|NCT00045942|27268559|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
7864087|NCT00044512|27268648|P1|Follow Up|Lost to Follow-up|2
7864088|NCT00044213|27268663|P4|Overall Study|Lost to Follow-up|4
7864089|NCT00044213|27268664|P3|Overall Study|Lost to Follow-up|5
7864090|NCT00044213|27268665|P2|Overall Study|Lost to Follow-up|5
7864091|NCT00044213|27268666|P1|Overall Study|Lost to Follow-up|8
7864092|NCT00044213|27268663|P4|Overall Study|Death|49
7864093|NCT00044213|27268664|P3|Overall Study|Death|42
7864094|NCT00044213|27268665|P2|Overall Study|Death|42
7864095|NCT00044213|27268666|P1|Overall Study|Death|42
7864096|NCT00044213|27268663|P4|Overall Study|Withdrawal by Subject|83
7864097|NCT00044213|27268664|P3|Overall Study|Withdrawal by Subject|91
7864098|NCT00044213|27268665|P2|Overall Study|Withdrawal by Subject|65
7864099|NCT00044213|27268666|P1|Overall Study|Withdrawal by Subject|50
7864100|NCT00044083|27268731|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
7864101|NCT00044083|27268732|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
7864102|NCT00044083|27268731|P2|First Intervention (One Week) Patients|Used illegal drug|0
7864103|NCT00044083|27268732|P1|First Intervention (One Week) Patients|Used illegal drug|1
7864104|NCT00044083|27268731|P2|First Intervention (One Week) Patients|Not follow directions|2
7864105|NCT00044083|27268732|P1|First Intervention (One Week) Patients|Not follow directions|0
7864106|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
7864107|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
7864108|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
7864109|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
7864110|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
7864111|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
7864112|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Pregnancy|0
7864113|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Pregnancy|1
7864114|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
7864115|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
7864116|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Not follow directions|2
7864117|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Not follow directions|2
7864118|NCT00044083|27268731|P2|First Intervention (One Week)- HV's|Adverse Event|0
7864119|NCT00044083|27268732|P1|First Intervention (One Week)- HV's|Adverse Event|1
7864120|NCT00043979|27268770|P3|Period 1|recipient with progressive disease|3
7864121|NCT00043979|27268771|P2|Period 1|recipient with progressive disease|4
7864122|NCT00043979|27268772|P1|Period 1|recipient with progressive disease|7
7864123|NCT00043550|27268793|P3|Overall Study|Withdrawal by Subject|20
7864124|NCT00043550|27268794|P2|Overall Study|Withdrawal by Subject|12
7864125|NCT00043550|27268795|P1|Overall Study|Withdrawal by Subject|22
7864126|NCT00043186|27268812|P9|Overall Study|Other|0
7864127|NCT00043186|27268813|P8|Overall Study|Other|0
7864128|NCT00043186|27268814|P7|Overall Study|Other|0
7864129|NCT00043186|27268815|P6|Overall Study|Other|0
7864130|NCT00043186|27268816|P5|Overall Study|Other|0
7864131|NCT00043186|27268817|P4|Overall Study|Other|1
7864132|NCT00043186|27268818|P3|Overall Study|Other|1
7864133|NCT00043186|27268819|P2|Overall Study|Other|0
7864134|NCT00043186|27268820|P1|Overall Study|Other|0
7864135|NCT00043186|27268812|P9|Overall Study|Noncompliance|0
7864136|NCT00043186|27268813|P8|Overall Study|Noncompliance|0
7864137|NCT00043186|27268814|P7|Overall Study|Noncompliance|0
7864138|NCT00043186|27268815|P6|Overall Study|Noncompliance|0
7864139|NCT00043186|27268816|P5|Overall Study|Noncompliance|0
7864140|NCT00043186|27268817|P4|Overall Study|Noncompliance|1
7864141|NCT00043186|27268818|P3|Overall Study|Noncompliance|1
7864142|NCT00043186|27268819|P2|Overall Study|Noncompliance|0
7864143|NCT00043186|27268820|P1|Overall Study|Noncompliance|0
7864144|NCT00043186|27268812|P9|Overall Study|Lost to Follow-up|2
7864145|NCT00043186|27268813|P8|Overall Study|Lost to Follow-up|1
7864146|NCT00043186|27268814|P7|Overall Study|Lost to Follow-up|1
7864147|NCT00043186|27268815|P6|Overall Study|Lost to Follow-up|1
7864148|NCT00043186|27268816|P5|Overall Study|Lost to Follow-up|1
7864149|NCT00043186|27268817|P4|Overall Study|Lost to Follow-up|1
7864150|NCT00043186|27268818|P3|Overall Study|Lost to Follow-up|1
7864151|NCT00043186|27268819|P2|Overall Study|Lost to Follow-up|5
7864152|NCT00043186|27268820|P1|Overall Study|Lost to Follow-up|3
7864153|NCT00043186|27268812|P9|Overall Study|Ineligibility determined|1
7864154|NCT00043186|27268813|P8|Overall Study|Ineligibility determined|0
7864155|NCT00043186|27268814|P7|Overall Study|Ineligibility determined|0
7864156|NCT00043186|27268815|P6|Overall Study|Ineligibility determined|0
7864157|NCT00043186|27268816|P5|Overall Study|Ineligibility determined|0
7864158|NCT00043186|27268817|P4|Overall Study|Ineligibility determined|0
7864159|NCT00043186|27268818|P3|Overall Study|Ineligibility determined|0
7864160|NCT00043186|27268819|P2|Overall Study|Ineligibility determined|0
7864161|NCT00043186|27268820|P1|Overall Study|Ineligibility determined|0
7864162|NCT00043186|27268812|P9|Overall Study|Disease progression|0
7864163|NCT00043186|27268813|P8|Overall Study|Disease progression|4
7864164|NCT00043186|27268814|P7|Overall Study|Disease progression|0
7864165|NCT00043186|27268815|P6|Overall Study|Disease progression|0
7864166|NCT00043186|27268816|P5|Overall Study|Disease progression|0
7864167|NCT00043186|27268817|P4|Overall Study|Disease progression|3
7864168|NCT00043186|27268818|P3|Overall Study|Disease progression|0
7864169|NCT00043186|27268819|P2|Overall Study|Disease progression|0
7864170|NCT00043186|27268820|P1|Overall Study|Disease progression|1
7864171|NCT00043186|27268812|P9|Overall Study|Death|0
7864172|NCT00043186|27268813|P8|Overall Study|Death|0
7864173|NCT00043186|27268814|P7|Overall Study|Death|2
7864174|NCT00043186|27268815|P6|Overall Study|Death|0
7864175|NCT00043186|27268816|P5|Overall Study|Death|0
7864176|NCT00043186|27268817|P4|Overall Study|Death|0
7864177|NCT00043186|27268818|P3|Overall Study|Death|1
7864178|NCT00043186|27268819|P2|Overall Study|Death|0
7864179|NCT00043186|27268820|P1|Overall Study|Death|0
7864180|NCT00043186|27268812|P9|Overall Study|Withdrawal by Subject|10
7864181|NCT00043186|27268813|P8|Overall Study|Withdrawal by Subject|9
7864182|NCT00043186|27268814|P7|Overall Study|Withdrawal by Subject|12
7864183|NCT00043186|27268815|P6|Overall Study|Withdrawal by Subject|6
7864184|NCT00043186|27268816|P5|Overall Study|Withdrawal by Subject|14
7864185|NCT00043186|27268817|P4|Overall Study|Withdrawal by Subject|13
7864186|NCT00043186|27268818|P3|Overall Study|Withdrawal by Subject|11
7864187|NCT00043186|27268819|P2|Overall Study|Withdrawal by Subject|8
7864188|NCT00043186|27268820|P1|Overall Study|Withdrawal by Subject|11
7864189|NCT00043186|27268812|P9|Overall Study|Adverse Event|3
7864190|NCT00043186|27268813|P8|Overall Study|Adverse Event|1
7864191|NCT00043186|27268814|P7|Overall Study|Adverse Event|2
7864192|NCT00043186|27268815|P6|Overall Study|Adverse Event|1
7864193|NCT00043186|27268816|P5|Overall Study|Adverse Event|2
7864194|NCT00043186|27268817|P4|Overall Study|Adverse Event|3
7864195|NCT00043186|27268818|P3|Overall Study|Adverse Event|2
7864196|NCT00043186|27268819|P2|Overall Study|Adverse Event|2
7864197|NCT00043186|27268820|P1|Overall Study|Adverse Event|2
7864198|NCT00043186|27268812|P9|Overall Study|Physician Decision|1
7864199|NCT00043186|27268813|P8|Overall Study|Physician Decision|1
7864200|NCT00043186|27268814|P7|Overall Study|Physician Decision|0
7864201|NCT00043186|27268815|P6|Overall Study|Physician Decision|0
7864202|NCT00043186|27268816|P5|Overall Study|Physician Decision|1
7864203|NCT00043186|27268817|P4|Overall Study|Physician Decision|0
7864204|NCT00043186|27268818|P3|Overall Study|Physician Decision|3
7864205|NCT00043186|27268819|P2|Overall Study|Physician Decision|0
7864206|NCT00043186|27268820|P1|Overall Study|Physician Decision|0
7864207|NCT00042666|27269146|P1|Overall Study|Other|4
7864208|NCT00042666|27269146|P1|Overall Study|Other|1
7864209|NCT00042666|27269146|P1|Overall Study|Progressive Disease|41
7864210|NCT00042666|27269146|P1|Overall Study|Participant/Physician Perception|1
7864211|NCT00042666|27269146|P1|Overall Study|Protocol Violation|1
7864212|NCT00042666|27269146|P1|Overall Study|Death|4
7864213|NCT00042666|27269146|P1|Overall Study|Adverse Event|2
7864214|NCT00042432|27269158|P2|Overall Study|Other|0
7864215|NCT00042432|27269159|P1|Overall Study|Other|2
7864216|NCT00042432|27269158|P2|Overall Study|Initiation of maintenance dialysis|1
7864217|NCT00042432|27269159|P1|Overall Study|Initiation of maintenance dialysis|1
7864218|NCT00042432|27269158|P2|Overall Study|Ineligibility determined|0
7864219|NCT00042432|27269159|P1|Overall Study|Ineligibility determined|1
7864220|NCT00042432|27269158|P2|Overall Study|Death|2
7864221|NCT00042432|27269159|P1|Overall Study|Death|0
7864222|NCT00042432|27269158|P2|Overall Study|Withdrawal by Subject|3
7864223|NCT00042432|27269159|P1|Overall Study|Withdrawal by Subject|1
7864224|NCT00042432|27269158|P2|Overall Study|Adverse Event|1
7864225|NCT00042432|27269159|P1|Overall Study|Adverse Event|4
7864226|NCT00041756|27269212|P5|Overall Study|Data Monitoring Committee Recommendation|21
7864227|NCT00041756|27269213|P4|Overall Study|Data Monitoring Committee Recommendation|0
7864228|NCT00041756|27269214|P3|Overall Study|Data Monitoring Committee Recommendation|0
7864229|NCT00041756|27269215|P2|Overall Study|Data Monitoring Committee Recommendation|0
7864230|NCT00041756|27269216|P1|Overall Study|Data Monitoring Committee Recommendation|0
7864231|NCT00041756|27269212|P5|Overall Study|Unable to meet protocol criteria|1
7864232|NCT00041756|27269213|P4|Overall Study|Unable to meet protocol criteria|0
7864233|NCT00041756|27269214|P3|Overall Study|Unable to meet protocol criteria|1
7864234|NCT00041756|27269215|P2|Overall Study|Unable to meet protocol criteria|0
7864235|NCT00041756|27269216|P1|Overall Study|Unable to meet protocol criteria|0
7864236|NCT00041756|27269212|P5|Overall Study|Lost to Follow-up|0
7864237|NCT00041756|27269213|P4|Overall Study|Lost to Follow-up|1
7864238|NCT00041756|27269214|P3|Overall Study|Lost to Follow-up|0
7864239|NCT00041756|27269215|P2|Overall Study|Lost to Follow-up|1
7864240|NCT00041756|27269216|P1|Overall Study|Lost to Follow-up|0
7864241|NCT00041756|27269212|P5|Overall Study|Withdrawal by Subject|3
7864242|NCT00041756|27269213|P4|Overall Study|Withdrawal by Subject|2
7864243|NCT00041756|27269214|P3|Overall Study|Withdrawal by Subject|4
7864244|NCT00041756|27269215|P2|Overall Study|Withdrawal by Subject|3
7864245|NCT00041756|27269216|P1|Overall Study|Withdrawal by Subject|3
7864246|NCT00041756|27269212|P5|Overall Study|Protocol Violation|1
7864247|NCT00041756|27269213|P4|Overall Study|Protocol Violation|2
7864248|NCT00041756|27269214|P3|Overall Study|Protocol Violation|2
7864249|NCT00041756|27269215|P2|Overall Study|Protocol Violation|1
7864250|NCT00041756|27269216|P1|Overall Study|Protocol Violation|1
7864251|NCT00041756|27269212|P5|Overall Study|Adverse Event|34
7864252|NCT00041756|27269213|P4|Overall Study|Adverse Event|11
7864253|NCT00041756|27269214|P3|Overall Study|Adverse Event|6
7864254|NCT00041756|27269215|P2|Overall Study|Adverse Event|10
7864255|NCT00041756|27269216|P1|Overall Study|Adverse Event|4
7864256|NCT00041470|27269244|P1|Overall Study|Loss of Funding|38
7864257|NCT00040664|27269249|P4|Overall Study|Non-viability of oral suspension|0
7864258|NCT00040664|27269250|P3|Overall Study|Non-viability of oral suspension|1
7864259|NCT00040664|27269251|P2|Overall Study|Non-viability of oral suspension|0
7864260|NCT00040664|27269252|P1|Overall Study|Non-viability of oral suspension|1
7864261|NCT00040664|27269249|P4|Overall Study|Change of formulation|0
7864262|NCT00040664|27269250|P3|Overall Study|Change of formulation|0
7864263|NCT00040664|27269251|P2|Overall Study|Change of formulation|2
7864264|NCT00040664|27269252|P1|Overall Study|Change of formulation|2
7864265|NCT00040664|27269249|P4|Overall Study|Pharmacokinetic target not achieved|1
7864266|NCT00040664|27269250|P3|Overall Study|Pharmacokinetic target not achieved|0
7864267|NCT00040664|27269251|P2|Overall Study|Pharmacokinetic target not achieved|1
7864268|NCT00040664|27269252|P1|Overall Study|Pharmacokinetic target not achieved|2
7864269|NCT00040664|27269249|P4|Overall Study|Poor taste|0
7864270|NCT00040664|27269250|P3|Overall Study|Poor taste|2
7864271|NCT00040664|27269251|P2|Overall Study|Poor taste|0
7864272|NCT00040664|27269252|P1|Overall Study|Poor taste|2
7864273|NCT00040664|27269249|P4|Overall Study|Medication adherence/compliance problems|5
7864274|NCT00040664|27269250|P3|Overall Study|Medication adherence/compliance problems|1
7864275|NCT00040664|27269251|P2|Overall Study|Medication adherence/compliance problems|2
7864276|NCT00040664|27269252|P1|Overall Study|Medication adherence/compliance problems|8
7864277|NCT00040664|27269249|P4|Overall Study|Pregnancy|3
7864278|NCT00040664|27269250|P3|Overall Study|Pregnancy|0
7864279|NCT00040664|27269251|P2|Overall Study|Pregnancy|0
7864280|NCT00040664|27269252|P1|Overall Study|Pregnancy|3
7864281|NCT00040664|27269249|P4|Overall Study|Withdrawal by Subject|4
7864282|NCT00040664|27269250|P3|Overall Study|Withdrawal by Subject|3
7864283|NCT00040664|27269251|P2|Overall Study|Withdrawal by Subject|0
7864284|NCT00040664|27269252|P1|Overall Study|Withdrawal by Subject|7
7864285|NCT00040664|27269249|P4|Overall Study|Protocol Violation|1
7864286|NCT00040664|27269250|P3|Overall Study|Protocol Violation|0
7864287|NCT00040664|27269251|P2|Overall Study|Protocol Violation|1
7864288|NCT00040664|27269252|P1|Overall Study|Protocol Violation|2
7864289|NCT00040664|27269249|P4|Overall Study|Lost to Follow-up|2
7864290|NCT00040664|27269250|P3|Overall Study|Lost to Follow-up|0
7864291|NCT00040664|27269251|P2|Overall Study|Lost to Follow-up|2
7864292|NCT00040664|27269252|P1|Overall Study|Lost to Follow-up|4
7864293|NCT00040664|27269249|P4|Overall Study|Insufficient CD4 response|0
7864294|NCT00040664|27269250|P3|Overall Study|Insufficient CD4 response|1
7864295|NCT00040664|27269251|P2|Overall Study|Insufficient CD4 response|0
7864296|NCT00040664|27269252|P1|Overall Study|Insufficient CD4 response|1
7864297|NCT00040664|27269249|P4|Overall Study|Lack of Efficacy|4
7864298|NCT00040664|27269250|P3|Overall Study|Lack of Efficacy|3
7864299|NCT00040664|27269251|P2|Overall Study|Lack of Efficacy|2
7864300|NCT00040664|27269252|P1|Overall Study|Lack of Efficacy|9
7864301|NCT00040664|27269249|P4|Overall Study|Adverse Event|7
7864302|NCT00040664|27269250|P3|Overall Study|Adverse Event|2
7864303|NCT00040664|27269251|P2|Overall Study|Adverse Event|3
7864304|NCT00040664|27269252|P1|Overall Study|Adverse Event|12
7864305|NCT00040365|27269318|P1|Overall Study|Lost to Follow-up|3
7864306|NCT00040365|27269318|P1|Overall Study|Progressive disease|7
7864307|NCT00040365|27269318|P1|Overall Study|Death|1
7864308|NCT00039871|27269327|P1|Overall Study|Never entered follow-up|7
7864309|NCT00039871|27269327|P1|Overall Study|Discontinued at Week 12 per protocol|1061
7864310|NCT00039871|27269327|P1|Overall Study|Administrative|1
7864311|NCT00039871|27269327|P1|Overall Study|Did not meet eligibility criteria|11
7864312|NCT00039871|27269327|P1|Overall Study|Withdrawal by Subject|97
7864313|NCT00039871|27269327|P1|Overall Study|Protocol Violation|24
7864314|NCT00039871|27269327|P1|Overall Study|Lost to Follow-up|18
7864315|NCT00039871|27269327|P1|Overall Study|Adverse Event|165
7864316|NCT00039741|27269337|P4|Overall Study|Missed final visit|2
7864317|NCT00039741|27269338|P3|Overall Study|Missed final visit|2
7864318|NCT00039741|27269339|P2|Overall Study|Missed final visit|1
7864319|NCT00039741|27269340|P1|Overall Study|Missed final visit|2
7864320|NCT00039741|27269337|P4|Overall Study|Withdrew consent|1
7864321|NCT00039741|27269338|P3|Overall Study|Withdrew consent|0
7864322|NCT00039741|27269339|P2|Overall Study|Withdrew consent|5
7864323|NCT00039741|27269340|P1|Overall Study|Withdrew consent|0
7864324|NCT00039741|27269337|P4|Overall Study|Non-compliance with protocol|0
7864325|NCT00039741|27269338|P3|Overall Study|Non-compliance with protocol|1
7864326|NCT00039741|27269339|P2|Overall Study|Non-compliance with protocol|0
7864327|NCT00039741|27269340|P1|Overall Study|Non-compliance with protocol|1
7864328|NCT00039741|27269337|P4|Overall Study|Moved|6
7864329|NCT00039741|27269338|P3|Overall Study|Moved|3
7864330|NCT00039741|27269339|P2|Overall Study|Moved|2
7864331|NCT00039741|27269340|P1|Overall Study|Moved|3
7864332|NCT00039741|27269337|P4|Overall Study|Not able to get to clinic|3
7864333|NCT00039741|27269338|P3|Overall Study|Not able to get to clinic|0
7864334|NCT00039741|27269339|P2|Overall Study|Not able to get to clinic|2
7864335|NCT00039741|27269340|P1|Overall Study|Not able to get to clinic|5
7864336|NCT00039741|27269337|P4|Overall Study|Confounding medical condition|0
7864337|NCT00039741|27269338|P3|Overall Study|Confounding medical condition|0
7864338|NCT00039741|27269339|P2|Overall Study|Confounding medical condition|0
7864339|NCT00039741|27269340|P1|Overall Study|Confounding medical condition|1
7864340|NCT00039741|27269337|P4|Overall Study|Lost to Follow-up|2
7864341|NCT00039741|27269338|P3|Overall Study|Lost to Follow-up|5
7864342|NCT00039741|27269339|P2|Overall Study|Lost to Follow-up|1
7864343|NCT00039741|27269340|P1|Overall Study|Lost to Follow-up|3
7864344|NCT00039741|27269337|P4|Overall Study|Death|0
7864345|NCT00039741|27269338|P3|Overall Study|Death|0
7864346|NCT00039741|27269339|P2|Overall Study|Death|1
7864347|NCT00039741|27269340|P1|Overall Study|Death|0
7864348|NCT00038948|27269384|P2|Overall Study|Lack of Efficacy|6
7864349|NCT00038948|27269385|P1|Overall Study|Lack of Efficacy|3
7864350|NCT00038948|27269384|P2|Overall Study|Protocol Violation|7
7864351|NCT00038948|27269385|P1|Overall Study|Protocol Violation|3
7864352|NCT00038948|27269384|P2|Overall Study|Withdrawal by Subject|10
7864353|NCT00038948|27269385|P1|Overall Study|Withdrawal by Subject|23
7864354|NCT00038948|27269384|P2|Overall Study|Nonmedical event|7
7864355|NCT00038948|27269385|P1|Overall Study|Nonmedical event|5
7864356|NCT00038948|27269384|P2|Overall Study|Lost to Follow-up|4
7864357|NCT00038948|27269385|P1|Overall Study|Lost to Follow-up|4
7864358|NCT00038948|27269384|P2|Overall Study|Adverse Event|43
7864359|NCT00038948|27269385|P1|Overall Study|Adverse Event|131
7864360|NCT00038649|27269420|P1|Overall Study|Adverse Event|9
7864361|NCT00038467|27269433|P2|Overall Study|Other|28
7864362|NCT00038467|27269434|P1|Overall Study|Other|26
7864363|NCT00038467|27269433|P2|Overall Study|Randomized, but not treated|35
7864364|NCT00038467|27269434|P1|Overall Study|Randomized, but not treated|31
7864365|NCT00038467|27269433|P2|Overall Study|Recurrence|179
7864366|NCT00038467|27269434|P1|Overall Study|Recurrence|109
7864367|NCT00038467|27269433|P2|Overall Study|Lost to Follow-up|10
7864368|NCT00038467|27269434|P1|Overall Study|Lost to Follow-up|15
7864369|NCT00038467|27269433|P2|Overall Study|Death|16
7864370|NCT00038467|27269434|P1|Overall Study|Death|22
7864371|NCT00038467|27269433|P2|Overall Study|Protocol Violation|22
7864372|NCT00038467|27269434|P1|Overall Study|Protocol Violation|19
7864373|NCT00038467|27269433|P2|Overall Study|Withdrawal by Subject|107
7864374|NCT00038467|27269434|P1|Overall Study|Withdrawal by Subject|150
7864375|NCT00038467|27269433|P2|Overall Study|Adverse Event|145
7864376|NCT00038467|27269434|P1|Overall Study|Adverse Event|170
7864377|NCT00038142|27269496|P2|Overall Study|Unknown Reason|0
7864378|NCT00038142|27269497|P1|Overall Study|Unknown Reason|8
7864379|NCT00038142|27269496|P2|Overall Study|Adverse Event|0
7864380|NCT00038142|27269497|P1|Overall Study|Adverse Event|1
7864381|NCT00038142|27269496|P2|Overall Study|Death|0
7864382|NCT00038142|27269497|P1|Overall Study|Death|1
7864383|NCT00038142|27269496|P2|Overall Study|Progressive Disease|7
7864384|NCT00038142|27269497|P1|Overall Study|Progressive Disease|11
7864385|NCT00038142|27269496|P2|Overall Study|Ineligible|0
7864386|NCT00038142|27269497|P1|Overall Study|Ineligible|1
7864387|NCT00038103|27269505|P2|Overall Study|Randomized/never treated|0
7864388|NCT00038103|27269506|P1|Overall Study|Randomized/never treated|2
7864389|NCT00038103|27269505|P2|Overall Study|Sponsor Decision|1
7864390|NCT00038103|27269506|P1|Overall Study|Sponsor Decision|0
7864391|NCT00038103|27269505|P2|Overall Study|Protocol Violation|2
7864392|NCT00038103|27269506|P1|Overall Study|Protocol Violation|0
7864393|NCT00038103|27269505|P2|Overall Study|Lost to Follow-up|3
7864394|NCT00038103|27269506|P1|Overall Study|Lost to Follow-up|0
7864395|NCT00038103|27269505|P2|Overall Study|Withdrawal by Subject|3
7864396|NCT00038103|27269506|P1|Overall Study|Withdrawal by Subject|0
7864397|NCT00038103|27269505|P2|Overall Study|Lack of Efficacy|41
7864398|NCT00038103|27269506|P1|Overall Study|Lack of Efficacy|48
7864399|NCT00038103|27269505|P2|Overall Study|Adverse Event|6
7864400|NCT00038103|27269506|P1|Overall Study|Adverse Event|5
7864401|NCT00037830|27269529|P3|Overall Study|Unrelated Medical Problem|0
7864402|NCT00037830|27269530|P2|Overall Study|Unrelated Medical Problem|0
7864403|NCT00037830|27269531|P1|Overall Study|Unrelated Medical Problem|2
7864404|NCT00037830|27269529|P3|Overall Study|Protocol Violation|0
7864405|NCT00037830|27269530|P2|Overall Study|Protocol Violation|2
7864406|NCT00037830|27269531|P1|Overall Study|Protocol Violation|2
7864407|NCT00037830|27269529|P3|Overall Study|Withdrawal by Subject|1
7864408|NCT00037830|27269530|P2|Overall Study|Withdrawal by Subject|5
7864409|NCT00037830|27269531|P1|Overall Study|Withdrawal by Subject|4
7864410|NCT00037830|27269529|P3|Overall Study|Adverse Event|0
7864411|NCT00037830|27269530|P2|Overall Study|Adverse Event|0
7864412|NCT00037830|27269531|P1|Overall Study|Adverse Event|2
7864413|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
7864414|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
7864415|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Too early switch|103
7864416|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Too early switch|0
7864417|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
7864418|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
7864419|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Protocol Violation|91
7864420|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Protocol Violation|23
7864421|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
7864422|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
7864423|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Treatment refusal|208
7864424|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Treatment refusal|113
7864425|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Other|288
7864426|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Other|277
7864427|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Adverse Event|782
7864428|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Adverse Event|501
7864429|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
7864430|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
7864431|NCT00036270|27269563|P2|Study Treatment to 5 Year Report|Ongoing|736
7864432|NCT00036270|27269564|P1|Study Treatment to 5 Year Report|Ongoing|1081
7864433|NCT00036270|27269563|P2|Randomized to Study Treatment|Withdrawal by Subject|7
7864434|NCT00036270|27269564|P1|Randomized to Study Treatment|Withdrawal by Subject|6
7864435|NCT00035932|27269583|P3|Overall Study|Lack of Efficacy|28
7864436|NCT00035932|27269584|P2|Overall Study|Lack of Efficacy|33
7864437|NCT00035932|27269585|P1|Overall Study|Lack of Efficacy|33
7864438|NCT00035932|27269583|P3|Overall Study|Study Termination by Sponsor|0
7864439|NCT00035932|27269584|P2|Overall Study|Study Termination by Sponsor|0
7864440|NCT00035932|27269585|P1|Overall Study|Study Termination by Sponsor|1
7864441|NCT00035932|27269583|P3|Overall Study|Withdrawal by Subject|0
7864442|NCT00035932|27269584|P2|Overall Study|Withdrawal by Subject|5
7864443|NCT00035932|27269585|P1|Overall Study|Withdrawal by Subject|1
7864444|NCT00035932|27269583|P3|Overall Study|Protocol Violation While on Study|2
7864445|NCT00035932|27269584|P2|Overall Study|Protocol Violation While on Study|1
7864446|NCT00035932|27269585|P1|Overall Study|Protocol Violation While on Study|0
7864447|NCT00035932|27269583|P3|Overall Study|Noncompliance|6
7864448|NCT00035932|27269584|P2|Overall Study|Noncompliance|7
7864449|NCT00035932|27269585|P1|Overall Study|Noncompliance|6
7864450|NCT00035932|27269583|P3|Overall Study|Lost to Follow-up|3
7864451|NCT00035932|27269584|P2|Overall Study|Lost to Follow-up|4
7864452|NCT00035932|27269585|P1|Overall Study|Lost to Follow-up|4
7864453|NCT00035932|27269583|P3|Overall Study|Disease Progression / Relapse|0
7864454|NCT00035932|27269584|P2|Overall Study|Disease Progression / Relapse|1
7864455|NCT00035932|27269585|P1|Overall Study|Disease Progression / Relapse|1
7864456|NCT00035932|27269583|P3|Overall Study|Death|1
7864457|NCT00035932|27269584|P2|Overall Study|Death|0
7864458|NCT00035932|27269585|P1|Overall Study|Death|0
7864459|NCT00035932|27269583|P3|Overall Study|Adverse Event|9
7864460|NCT00035932|27269584|P2|Overall Study|Adverse Event|9
7864461|NCT00035932|27269585|P1|Overall Study|Adverse Event|10
7864462|NCT00035815|27269711|P2|Overall Study|Withdrawal by Subject|11
7864463|NCT00035815|27269712|P1|Overall Study|Withdrawal by Subject|17
7864464|NCT00035555|27269725|P3|Overall Study|Received cyclosporin in error|1
7864465|NCT00035555|27269726|P2|Overall Study|Received cyclosporin in error|0
7864466|NCT00035555|27269727|P1|Overall Study|Received cyclosporin in error|0
7864467|NCT00035555|27269725|P3|Overall Study|Investigator deemed not a good candidate|1
7864468|NCT00035555|27269726|P2|Overall Study|Investigator deemed not a good candidate|0
7864469|NCT00035555|27269727|P1|Overall Study|Investigator deemed not a good candidate|0
7864470|NCT00035555|27269725|P3|Overall Study|Withdrawal by Subject|2
7864471|NCT00035555|27269726|P2|Overall Study|Withdrawal by Subject|0
7864472|NCT00035555|27269727|P1|Overall Study|Withdrawal by Subject|2
7864473|NCT00035555|27269725|P3|Overall Study|Treatment failure/lack of efficacy|3
7864474|NCT00035555|27269726|P2|Overall Study|Treatment failure/lack of efficacy|5
7864475|NCT00035555|27269727|P1|Overall Study|Treatment failure/lack of efficacy|7
7864476|NCT00035555|27269725|P3|Overall Study|Prohibited medication|0
7864477|NCT00035555|27269726|P2|Overall Study|Prohibited medication|1
7864478|NCT00035555|27269727|P1|Overall Study|Prohibited medication|1
7864479|NCT00035555|27269725|P3|Overall Study|Noncompliance|1
7864480|NCT00035555|27269726|P2|Overall Study|Noncompliance|1
7864481|NCT00035555|27269727|P1|Overall Study|Noncompliance|0
7864482|NCT00035555|27269725|P3|Overall Study|Lost to Follow-up|1
7864483|NCT00035555|27269726|P2|Overall Study|Lost to Follow-up|0
7864484|NCT00035555|27269727|P1|Overall Study|Lost to Follow-up|0
7864485|NCT00035555|27269725|P3|Overall Study|Death|2
7864486|NCT00035555|27269726|P2|Overall Study|Death|0
7864487|NCT00035555|27269727|P1|Overall Study|Death|0
7864488|NCT00035555|27269725|P3|Overall Study|Allograft loss|2
7864489|NCT00035555|27269726|P2|Overall Study|Allograft loss|1
7864490|NCT00035555|27269727|P1|Overall Study|Allograft loss|1
7864491|NCT00035555|27269725|P3|Overall Study|Adverse Event|9
7864492|NCT00035555|27269726|P2|Overall Study|Adverse Event|8
7864493|NCT00035555|27269727|P1|Overall Study|Adverse Event|5
7864494|NCT00032487|27269811|P2|Overall Study|Had other reason|12
7864495|NCT00032487|27269812|P1|Overall Study|Had other reason|12
7864496|NCT00032487|27269811|P2|Overall Study|Lost to Follow-up|58
7864497|NCT00032487|27269812|P1|Overall Study|Lost to Follow-up|57
7864498|NCT00032487|27269811|P2|Overall Study|Adverse Event|7
7864499|NCT00032487|27269812|P1|Overall Study|Adverse Event|3
7864500|NCT00032487|27269811|P2|Overall Study|Withdrawal by Subject|43
7864501|NCT00032487|27269812|P1|Overall Study|Withdrawal by Subject|67
7864502|NCT00031551|27269822|P2|Overall Study|Withdrew due to chemotherapy effects|0
7864503|NCT00031551|27269823|P1|Overall Study|Withdrew due to chemotherapy effects|2
7864504|NCT00031486|27269835|P2|Overall Study|Other|1
7864505|NCT00031486|27269836|P1|Overall Study|Other|1
7864506|NCT00031486|27269835|P2|Overall Study|Did not meet eligibility requirement|1
7864507|NCT00031486|27269836|P1|Overall Study|Did not meet eligibility requirement|2
7864508|NCT00031486|27269835|P2|Overall Study|Non-compliant|4
7864509|NCT00031486|27269836|P1|Overall Study|Non-compliant|0
7864510|NCT00031486|27269835|P2|Overall Study|Death|3
7864511|NCT00031486|27269836|P1|Overall Study|Death|0
7864512|NCT00031486|27269835|P2|Overall Study|Withdrawal by Subject|2
7864513|NCT00031486|27269836|P1|Overall Study|Withdrawal by Subject|3
7864514|NCT00031486|27269835|P2|Overall Study|Lost to Follow-up|1
7864515|NCT00031486|27269836|P1|Overall Study|Lost to Follow-up|0
7864516|NCT00031486|27269835|P2|Overall Study|Adverse Event|0
7864517|NCT00031486|27269836|P1|Overall Study|Adverse Event|1
7864518|NCT00031460|27269862|P2|Overall Study|Confirmed unevaluable|1
7864519|NCT00031460|27269863|P1|Overall Study|Confirmed unevaluable|0
7864520|NCT00031460|27269862|P2|Overall Study|Disruption of blinded drug supply|0
7864521|NCT00031460|27269863|P1|Overall Study|Disruption of blinded drug supply|2
7864522|NCT00031460|27269862|P2|Overall Study|Reactivation of Disease|9
7864523|NCT00031460|27269863|P1|Overall Study|Reactivation of Disease|5
7864524|NCT00031460|27269862|P2|Overall Study|Death|1
7864525|NCT00031460|27269863|P1|Overall Study|Death|0
7864526|NCT00031460|27269862|P2|Overall Study|Non-Compliant|1
7864527|NCT00031460|27269863|P1|Overall Study|Non-Compliant|1
7864528|NCT00031460|27269862|P2|Overall Study|Withdrawal by Subject|1
7864529|NCT00031460|27269863|P1|Overall Study|Withdrawal by Subject|1
7864530|NCT00031460|27269862|P2|Overall Study|Lost to Follow-up|1
7864531|NCT00031460|27269863|P1|Overall Study|Lost to Follow-up|0
7864532|NCT00031447|27269877|P2|Overall Study|Disruption of blinded study drug supply|4
7864533|NCT00031447|27269878|P1|Overall Study|Disruption of blinded study drug supply|7
7864534|NCT00031447|27269877|P2|Overall Study|Re-activation of Disease|1
7864535|NCT00031447|27269878|P1|Overall Study|Re-activation of Disease|2
7864536|NCT00031447|27269877|P2|Overall Study|Non-compliant|1
7864537|NCT00031447|27269878|P1|Overall Study|Non-compliant|1
7864538|NCT00031447|27269877|P2|Overall Study|Lost to Follow-up|1
7864539|NCT00031447|27269878|P1|Overall Study|Lost to Follow-up|0
7864540|NCT00029146|27269953|P2|Overall Study|Lost to Follow-up|1
7864541|NCT00029146|27269954|P1|Overall Study|Lost to Follow-up|2
7864542|NCT00027378|27270005|P2|Overall Study|Physician Decision|3
7864543|NCT00027378|27270006|P1|Overall Study|Physician Decision|0
7864544|NCT00027027|27270019|P5|Overall Study|Withdrawal by Subject|1
7864545|NCT00027027|27270020|P4|Overall Study|Withdrawal by Subject|0
7864546|NCT00027027|27270021|P3|Overall Study|Withdrawal by Subject|0
7864547|NCT00027027|27270022|P2|Overall Study|Withdrawal by Subject|0
7864548|NCT00027027|27270023|P1|Overall Study|Withdrawal by Subject|0
7864549|NCT00027027|27270019|P5|Overall Study|Physician Decision Due To PD|5
7864550|NCT00027027|27270020|P4|Overall Study|Physician Decision Due To PD|3
7864551|NCT00027027|27270021|P3|Overall Study|Physician Decision Due To PD|2
7864552|NCT00027027|27270022|P2|Overall Study|Physician Decision Due To PD|3
7864553|NCT00027027|27270023|P1|Overall Study|Physician Decision Due To PD|2
7864554|NCT00027027|27270019|P5|Overall Study|PD Requiring Surgery|0
7864555|NCT00027027|27270020|P4|Overall Study|PD Requiring Surgery|0
7864556|NCT00027027|27270021|P3|Overall Study|PD Requiring Surgery|1
7864557|NCT00027027|27270022|P2|Overall Study|PD Requiring Surgery|0
7864558|NCT00027027|27270023|P1|Overall Study|PD Requiring Surgery|0
7864559|NCT00027027|27270019|P5|Overall Study|Clinical Symptoms Progression not PD|0
7864560|NCT00027027|27270020|P4|Overall Study|Clinical Symptoms Progression not PD|0
7864561|NCT00027027|27270021|P3|Overall Study|Clinical Symptoms Progression not PD|0
7864562|NCT00027027|27270022|P2|Overall Study|Clinical Symptoms Progression not PD|0
7864563|NCT00027027|27270023|P1|Overall Study|Clinical Symptoms Progression not PD|1
7864564|NCT00027027|27270019|P5|Overall Study|Admitted for Signs of PD|1
7864565|NCT00027027|27270020|P4|Overall Study|Admitted for Signs of PD|0
7864566|NCT00027027|27270021|P3|Overall Study|Admitted for Signs of PD|0
7864567|NCT00027027|27270022|P2|Overall Study|Admitted for Signs of PD|0
7864568|NCT00027027|27270023|P1|Overall Study|Admitted for Signs of PD|0
7864569|NCT00027027|27270019|P5|Overall Study|Adverse Event|1
7864570|NCT00027027|27270020|P4|Overall Study|Adverse Event|0
7864571|NCT00027027|27270021|P3|Overall Study|Adverse Event|1
7864572|NCT00027027|27270022|P2|Overall Study|Adverse Event|0
7864573|NCT00027027|27270023|P1|Overall Study|Adverse Event|0
7864574|NCT00026793|27270068|P1|Overall Study|Off study|2
7864575|NCT00026793|27270068|P1|Overall Study|Physician Decision|2
7864576|NCT00026793|27270068|P1|Overall Study|Death on study due to underlying disease|4
7864577|NCT00025883|27270078|P1|Overall Study|didn't reach 6 months of Metreleptin|10
7864578|NCT00025883|27270078|P1|Overall Study|Adverse Event|1
7864579|NCT00025883|27270078|P1|Overall Study|Death|1
7864580|NCT00025883|27270078|P1|Overall Study|no baseline data|1
7864581|NCT00025883|27270078|P1|Overall Study|had atypical progeriod lipodystrophy|4
7864582|NCT00023595|27270090|P5|10 Year Follow up|Lost to Follow-up|0
7864583|NCT00023595|27270091|P4|10 Year Follow up|Lost to Follow-up|0
7864584|NCT00023595|27270092|P3|10 Year Follow up|Lost to Follow-up|3
7864585|NCT00023595|27270093|P2|10 Year Follow up|Lost to Follow-up|10
7864586|NCT00023595|27270094|P1|10 Year Follow up|Lost to Follow-up|12
7864587|NCT00023595|27270090|P5|5 Year Follow up|Lost to Follow-up|3
7864588|NCT00023595|27270091|P4|5 Year Follow up|Lost to Follow-up|7
7864589|NCT00023595|27270092|P3|5 Year Follow up|Lost to Follow-up|1
7864590|NCT00023595|27270093|P2|5 Year Follow up|Lost to Follow-up|2
7864591|NCT00023595|27270094|P1|5 Year Follow up|Lost to Follow-up|2
7864592|NCT00023452|27270305|P2|Overall Study|Other|69
7864593|NCT00023452|27270306|P1|Overall Study|Other|204
7864594|NCT00023452|27270305|P2|Overall Study|Pregnant|20
7864595|NCT00023452|27270306|P1|Overall Study|Pregnant|53
7864596|NCT00023452|27270305|P2|Overall Study|Refused Treatment (continued follow-up)|224
7864597|NCT00023452|27270306|P1|Overall Study|Refused Treatment (continued follow-up)|225
7864598|NCT00023452|27270305|P2|Overall Study|Physician Decision|21
7864599|NCT00023452|27270306|P1|Overall Study|Physician Decision|49
7864600|NCT00023452|27270305|P2|Overall Study|Lost to Follow-up|60
7864601|NCT00023452|27270306|P1|Overall Study|Lost to Follow-up|293
7864602|NCT00023452|27270305|P2|Overall Study|Adverse Event|196
7864603|NCT00023452|27270306|P1|Overall Study|Adverse Event|139
7864604|NCT00023452|27270305|P2|Overall Study|Withdrawal by Subject|54
7864605|NCT00023452|27270306|P1|Overall Study|Withdrawal by Subject|66
7864606|NCT00023452|27270305|P2|Overall Study|Death|0
7864607|NCT00023452|27270306|P1|Overall Study|Death|2
7864608|NCT00023452|27270305|P2|Overall Study|Out of Window|69
7864609|NCT00023452|27270306|P1|Overall Study|Out of Window|129
7864610|NCT00023452|27270305|P2|Overall Study|Ineligible for Study|159
7864611|NCT00023452|27270306|P1|Overall Study|Ineligible for Study|163
7864612|NCT00023322|27270330|P1|Overall Study|Lost to Follow-up|1
7864613|NCT00022763|27270354|P2|Overall Study|Admin|2
7864614|NCT00022763|27270355|P1|Overall Study|Admin|3
7864615|NCT00022763|27270354|P2|Overall Study|Insufficient Therapy|0
7864616|NCT00022763|27270355|P1|Overall Study|Insufficient Therapy|1
7864617|NCT00022763|27270354|P2|Overall Study|Withdrawal by Subject|7
7864618|NCT00022763|27270355|P1|Overall Study|Withdrawal by Subject|4
7864619|NCT00022763|27270354|P2|Overall Study|Lost to Follow-up|3
7864620|NCT00022763|27270355|P1|Overall Study|Lost to Follow-up|0
7864621|NCT00022763|27270354|P2|Overall Study|Death|1
7864622|NCT00022763|27270355|P1|Overall Study|Death|0
7864623|NCT00022763|27270354|P2|Overall Study|Injection Site Reactions|2
7864624|NCT00022763|27270355|P1|Overall Study|Injection Site Reactions|0
7864625|NCT00022763|27270354|P2|Overall Study|Adverse Event|2
7864626|NCT00022763|27270355|P1|Overall Study|Adverse Event|1
7864627|NCT00014911|27270397|P1|Overall Study|Immunosuppression-related Side Effects|1
7864628|NCT00014911|27270397|P1|Overall Study|Unknown Reasons|2
7864629|NCT00014911|27270397|P1|Overall Study|Withdrawal by Subject|6
7864630|NCT00014911|27270397|P1|Overall Study|Lost to Follow-up|1
7864631|NCT00014911|27270397|P1|Overall Study|Adverse Event|1
7864632|NCT00006604|27270413|P17|Overall Study|Other Reason|0
7864633|NCT00006604|27270414|P16|Overall Study|Other Reason|0
7864634|NCT00006604|27270415|P15|Overall Study|Other Reason|0
7864635|NCT00006604|27270416|P14|Overall Study|Other Reason|0
7864636|NCT00006604|27270417|P13|Overall Study|Other Reason|0
7864637|NCT00006604|27270418|P12|Overall Study|Other Reason|0
7864638|NCT00006604|27270419|P11|Overall Study|Other Reason|0
7864639|NCT00006604|27270420|P10|Overall Study|Other Reason|1
7864640|NCT00006604|27270421|P9|Overall Study|Other Reason|0
7864641|NCT00006604|27270422|P8|Overall Study|Other Reason|0
7864642|NCT00006604|27270423|P7|Overall Study|Other Reason|0
7864643|NCT00006604|27270424|P6|Overall Study|Other Reason|1
7864644|NCT00006604|27270425|P5|Overall Study|Other Reason|0
7864645|NCT00006604|27270426|P4|Overall Study|Other Reason|0
7864646|NCT00006604|27270427|P3|Overall Study|Other Reason|0
7864647|NCT00006604|27270428|P2|Overall Study|Other Reason|0
7864648|NCT00006604|27270429|P1|Overall Study|Other Reason|0
7864649|NCT00006604|27270413|P17|Overall Study|Lost to Follow-up|3
7864650|NCT00006604|27270414|P16|Overall Study|Lost to Follow-up|1
7864651|NCT00006604|27270415|P15|Overall Study|Lost to Follow-up|0
7864652|NCT00006604|27270416|P14|Overall Study|Lost to Follow-up|0
7864653|NCT00006604|27270417|P13|Overall Study|Lost to Follow-up|0
7864654|NCT00006604|27270418|P12|Overall Study|Lost to Follow-up|0
7864655|NCT00006604|27270419|P11|Overall Study|Lost to Follow-up|0
7864656|NCT00006604|27270420|P10|Overall Study|Lost to Follow-up|2
7864657|NCT00006604|27270421|P9|Overall Study|Lost to Follow-up|0
7864658|NCT00006604|27270422|P8|Overall Study|Lost to Follow-up|1
7864659|NCT00006604|27270423|P7|Overall Study|Lost to Follow-up|0
7864660|NCT00006604|27270424|P6|Overall Study|Lost to Follow-up|0
7864661|NCT00006604|27270425|P5|Overall Study|Lost to Follow-up|0
7864662|NCT00006604|27270426|P4|Overall Study|Lost to Follow-up|0
7864663|NCT00006604|27270427|P3|Overall Study|Lost to Follow-up|0
7864664|NCT00006604|27270428|P2|Overall Study|Lost to Follow-up|0
7864665|NCT00006604|27270429|P1|Overall Study|Lost to Follow-up|0
7864666|NCT00006604|27270413|P17|Overall Study|Subj/parent not willing to adhere to req|4
7864667|NCT00006604|27270414|P16|Overall Study|Subj/parent not willing to adhere to req|3
7864668|NCT00006604|27270415|P15|Overall Study|Subj/parent not willing to adhere to req|3
7864669|NCT00006604|27270416|P14|Overall Study|Subj/parent not willing to adhere to req|2
7864670|NCT00006604|27270417|P13|Overall Study|Subj/parent not willing to adhere to req|0
7864671|NCT00006604|27270418|P12|Overall Study|Subj/parent not willing to adhere to req|0
7864672|NCT00006604|27270419|P11|Overall Study|Subj/parent not willing to adhere to req|3
7864673|NCT00006604|27270420|P10|Overall Study|Subj/parent not willing to adhere to req|6
7864674|NCT00006604|27270421|P9|Overall Study|Subj/parent not willing to adhere to req|0
7864675|NCT00006604|27270422|P8|Overall Study|Subj/parent not willing to adhere to req|1
7864676|NCT00006604|27270423|P7|Overall Study|Subj/parent not willing to adhere to req|3
7864677|NCT00006604|27270424|P6|Overall Study|Subj/parent not willing to adhere to req|0
7864678|NCT00006604|27270425|P5|Overall Study|Subj/parent not willing to adhere to req|0
7864679|NCT00006604|27270426|P4|Overall Study|Subj/parent not willing to adhere to req|3
7864680|NCT00006604|27270427|P3|Overall Study|Subj/parent not willing to adhere to req|1
7864681|NCT00006604|27270428|P2|Overall Study|Subj/parent not willing to adhere to req|0
7864682|NCT00006604|27270429|P1|Overall Study|Subj/parent not willing to adhere to req|0
7864683|NCT00006604|27270413|P17|Overall Study|Withdrawal by Subject|1
7864684|NCT00006604|27270414|P16|Overall Study|Withdrawal by Subject|0
7864685|NCT00006604|27270415|P15|Overall Study|Withdrawal by Subject|1
7864686|NCT00006604|27270416|P14|Overall Study|Withdrawal by Subject|2
7864687|NCT00006604|27270417|P13|Overall Study|Withdrawal by Subject|1
7864688|NCT00006604|27270418|P12|Overall Study|Withdrawal by Subject|0
7864689|NCT00006604|27270419|P11|Overall Study|Withdrawal by Subject|2
7864690|NCT00006604|27270420|P10|Overall Study|Withdrawal by Subject|3
7864691|NCT00006604|27270421|P9|Overall Study|Withdrawal by Subject|1
7864692|NCT00006604|27270422|P8|Overall Study|Withdrawal by Subject|0
7864693|NCT00006604|27270423|P7|Overall Study|Withdrawal by Subject|2
7864694|NCT00006604|27270424|P6|Overall Study|Withdrawal by Subject|2
7864695|NCT00006604|27270425|P5|Overall Study|Withdrawal by Subject|1
7864696|NCT00006604|27270426|P4|Overall Study|Withdrawal by Subject|0
7864697|NCT00006604|27270427|P3|Overall Study|Withdrawal by Subject|2
7864698|NCT00006604|27270428|P2|Overall Study|Withdrawal by Subject|0
7864699|NCT00006604|27270429|P1|Overall Study|Withdrawal by Subject|1
7864700|NCT00006604|27270413|P17|Overall Study|Site closing|1
7864701|NCT00006604|27270414|P16|Overall Study|Site closing|0
7864702|NCT00006604|27270415|P15|Overall Study|Site closing|0
7864703|NCT00006604|27270416|P14|Overall Study|Site closing|1
7864704|NCT00006604|27270417|P13|Overall Study|Site closing|1
7864705|NCT00006604|27270418|P12|Overall Study|Site closing|1
7864706|NCT00006604|27270419|P11|Overall Study|Site closing|0
7864707|NCT00006604|27270420|P10|Overall Study|Site closing|0
7864708|NCT00006604|27270421|P9|Overall Study|Site closing|0
7864709|NCT00006604|27270422|P8|Overall Study|Site closing|1
7864710|NCT00006604|27270423|P7|Overall Study|Site closing|0
7864711|NCT00006604|27270424|P6|Overall Study|Site closing|0
7864712|NCT00006604|27270425|P5|Overall Study|Site closing|0
7864713|NCT00006604|27270426|P4|Overall Study|Site closing|1
7864714|NCT00006604|27270427|P3|Overall Study|Site closing|1
7864715|NCT00006604|27270428|P2|Overall Study|Site closing|0
7864716|NCT00006604|27270429|P1|Overall Study|Site closing|0
7864717|NCT00006604|27270413|P17|Overall Study|Subj/Parent not able to get to clinic|0
7864718|NCT00006604|27270414|P16|Overall Study|Subj/Parent not able to get to clinic|0
7864719|NCT00006604|27270415|P15|Overall Study|Subj/Parent not able to get to clinic|3
7864720|NCT00006604|27270416|P14|Overall Study|Subj/Parent not able to get to clinic|1
7864721|NCT00006604|27270417|P13|Overall Study|Subj/Parent not able to get to clinic|1
7864722|NCT00006604|27270418|P12|Overall Study|Subj/Parent not able to get to clinic|1
7864723|NCT00006604|27270419|P11|Overall Study|Subj/Parent not able to get to clinic|2
7864724|NCT00006604|27270420|P10|Overall Study|Subj/Parent not able to get to clinic|1
7864725|NCT00006604|27270421|P9|Overall Study|Subj/Parent not able to get to clinic|0
7864726|NCT00006604|27270422|P8|Overall Study|Subj/Parent not able to get to clinic|0
7864727|NCT00006604|27270423|P7|Overall Study|Subj/Parent not able to get to clinic|1
7864728|NCT00006604|27270424|P6|Overall Study|Subj/Parent not able to get to clinic|0
7864729|NCT00006604|27270425|P5|Overall Study|Subj/Parent not able to get to clinic|1
7864730|NCT00006604|27270426|P4|Overall Study|Subj/Parent not able to get to clinic|1
7864731|NCT00006604|27270427|P3|Overall Study|Subj/Parent not able to get to clinic|0
7864732|NCT00006604|27270428|P2|Overall Study|Subj/Parent not able to get to clinic|0
7864733|NCT00006604|27270429|P1|Overall Study|Subj/Parent not able to get to clinic|0
7864734|NCT00006604|27270413|P17|Overall Study|Severe debilitation, unable to continue|0
7864735|NCT00006604|27270414|P16|Overall Study|Severe debilitation, unable to continue|0
7864736|NCT00006604|27270415|P15|Overall Study|Severe debilitation, unable to continue|2
7864737|NCT00006604|27270416|P14|Overall Study|Severe debilitation, unable to continue|0
7864738|NCT00006604|27270417|P13|Overall Study|Severe debilitation, unable to continue|1
7864739|NCT00006604|27270418|P12|Overall Study|Severe debilitation, unable to continue|2
7864740|NCT00006604|27270419|P11|Overall Study|Severe debilitation, unable to continue|0
7864741|NCT00006604|27270420|P10|Overall Study|Severe debilitation, unable to continue|5
7864742|NCT00006604|27270421|P9|Overall Study|Severe debilitation, unable to continue|0
7864743|NCT00006604|27270422|P8|Overall Study|Severe debilitation, unable to continue|0
7864744|NCT00006604|27270423|P7|Overall Study|Severe debilitation, unable to continue|3
7864745|NCT00006604|27270424|P6|Overall Study|Severe debilitation, unable to continue|0
7864746|NCT00006604|27270425|P5|Overall Study|Severe debilitation, unable to continue|0
7864747|NCT00006604|27270426|P4|Overall Study|Severe debilitation, unable to continue|0
7864748|NCT00006604|27270427|P3|Overall Study|Severe debilitation, unable to continue|0
7864749|NCT00006604|27270428|P2|Overall Study|Severe debilitation, unable to continue|0
7864750|NCT00006604|27270429|P1|Overall Study|Severe debilitation, unable to continue|0
7864751|NCT00006604|27270413|P17|Overall Study|Death|0
7864752|NCT00006604|27270414|P16|Overall Study|Death|0
7864753|NCT00006604|27270415|P15|Overall Study|Death|0
7864754|NCT00006604|27270416|P14|Overall Study|Death|0
7864755|NCT00006604|27270417|P13|Overall Study|Death|0
7864756|NCT00006604|27270418|P12|Overall Study|Death|1
7864757|NCT00006604|27270419|P11|Overall Study|Death|1
7864758|NCT00006604|27270420|P10|Overall Study|Death|1
7864759|NCT00006604|27270421|P9|Overall Study|Death|0
7864760|NCT00006604|27270422|P8|Overall Study|Death|0
7864761|NCT00006604|27270423|P7|Overall Study|Death|0
7864762|NCT00006604|27270424|P6|Overall Study|Death|0
7864763|NCT00006604|27270425|P5|Overall Study|Death|0
7864764|NCT00006604|27270426|P4|Overall Study|Death|0
7864765|NCT00006604|27270427|P3|Overall Study|Death|0
7864766|NCT00006604|27270428|P2|Overall Study|Death|0
7864767|NCT00006604|27270429|P1|Overall Study|Death|0
7864768|NCT00006604|27270413|P17|Overall Study|Randomization entry error-no RX, no FU|0
7864769|NCT00006604|27270414|P16|Overall Study|Randomization entry error-no RX, no FU|0
7864770|NCT00006604|27270415|P15|Overall Study|Randomization entry error-no RX, no FU|0
7864771|NCT00006604|27270416|P14|Overall Study|Randomization entry error-no RX, no FU|0
7864772|NCT00006604|27270417|P13|Overall Study|Randomization entry error-no RX, no FU|0
7864773|NCT00006604|27270418|P12|Overall Study|Randomization entry error-no RX, no FU|1
7864774|NCT00006604|27270419|P11|Overall Study|Randomization entry error-no RX, no FU|0
7864775|NCT00006604|27270420|P10|Overall Study|Randomization entry error-no RX, no FU|0
7864776|NCT00006604|27270421|P9|Overall Study|Randomization entry error-no RX, no FU|0
7864777|NCT00006604|27270422|P8|Overall Study|Randomization entry error-no RX, no FU|0
7864778|NCT00006604|27270423|P7|Overall Study|Randomization entry error-no RX, no FU|0
7864779|NCT00006604|27270424|P6|Overall Study|Randomization entry error-no RX, no FU|0
7864780|NCT00006604|27270425|P5|Overall Study|Randomization entry error-no RX, no FU|0
7864781|NCT00006604|27270426|P4|Overall Study|Randomization entry error-no RX, no FU|0
7864782|NCT00006604|27270427|P3|Overall Study|Randomization entry error-no RX, no FU|0
7864783|NCT00006604|27270428|P2|Overall Study|Randomization entry error-no RX, no FU|0
7864784|NCT00006604|27270429|P1|Overall Study|Randomization entry error-no RX, no FU|0
7864785|NCT00006604|27270413|P17|Overall Study|Met study objective - no further FU|0
7864786|NCT00006604|27270414|P16|Overall Study|Met study objective - no further FU|1
7864787|NCT00006604|27270415|P15|Overall Study|Met study objective - no further FU|1
7864788|NCT00006604|27270416|P14|Overall Study|Met study objective - no further FU|0
7864789|NCT00006604|27270417|P13|Overall Study|Met study objective - no further FU|0
7864790|NCT00006604|27270418|P12|Overall Study|Met study objective - no further FU|0
7864791|NCT00006604|27270419|P11|Overall Study|Met study objective - no further FU|0
7864792|NCT00006604|27270420|P10|Overall Study|Met study objective - no further FU|0
7864793|NCT00006604|27270421|P9|Overall Study|Met study objective - no further FU|0
7864794|NCT00006604|27270422|P8|Overall Study|Met study objective - no further FU|0
7864795|NCT00006604|27270423|P7|Overall Study|Met study objective - no further FU|0
7864796|NCT00006604|27270424|P6|Overall Study|Met study objective - no further FU|0
7864797|NCT00006604|27270425|P5|Overall Study|Met study objective - no further FU|0
7864798|NCT00006604|27270426|P4|Overall Study|Met study objective - no further FU|0
7864799|NCT00006604|27270427|P3|Overall Study|Met study objective - no further FU|0
7864800|NCT00006604|27270428|P2|Overall Study|Met study objective - no further FU|0
7864801|NCT00006604|27270429|P1|Overall Study|Met study objective - no further FU|1
7864802|NCT00004978|27270545|P2|Overall Study|site closure - not in analysis cohort|20
7864803|NCT00004978|27270546|P1|Overall Study|site closure - not in analysis cohort|19
7864804|NCT00004978|27270545|P2|Overall Study|Withdrawal by Subject|26
7864805|NCT00004978|27270546|P1|Overall Study|Withdrawal by Subject|17
7864806|NCT00004978|27270545|P2|Overall Study|Lost to Follow-up|108
7864807|NCT00004978|27270546|P1|Overall Study|Lost to Follow-up|101
7864808|NCT00004978|27270545|P2|Overall Study|Death|116
7864809|NCT00004978|27270546|P1|Overall Study|Death|107
7864810|NCT00021541|27270572|P2|Period 2-crossover|Pts that did not progress|3
7864811|NCT00021541|27270573|P1|Period 2-crossover|Pts that did not progress|2
7864812|NCT00021541|27270572|P2|Period 2-crossover|non-adherence|0
7864813|NCT00021541|27270573|P1|Period 2-crossover|non-adherence|1
7864814|NCT00021541|27270572|P2|Period 2-crossover|Adverse Event|2
7864815|NCT00021541|27270573|P1|Period 2-crossover|Adverse Event|2
7864816|NCT00021541|27270572|P2|Period 2-crossover|Withdrawal by Subject|4
7864817|NCT00021541|27270573|P1|Period 2-crossover|Withdrawal by Subject|3
7864818|NCT00021541|27270572|P2|Period 2-crossover|refused phase B|2
7864819|NCT00021541|27270573|P1|Period 2-crossover|refused phase B|2
7864820|NCT00021541|27270572|P2|Period 1-First Treatment|Ineligible|2
7864821|NCT00021541|27270573|P1|Period 1-First Treatment|Ineligible|0
7864822|NCT00021541|27270572|P2|Period 1-First Treatment|Pts that did not progress|2
7864823|NCT00021541|27270573|P1|Period 1-First Treatment|Pts that did not progress|2
7864824|NCT00021541|27270572|P2|Period 1-First Treatment|Death|0
7864825|NCT00021541|27270573|P1|Period 1-First Treatment|Death|1
7864826|NCT00021541|27270572|P2|Period 1-First Treatment|non-adherence|0
7864827|NCT00021541|27270573|P1|Period 1-First Treatment|non-adherence|3
7864828|NCT00021541|27270572|P2|Period 1-First Treatment|Adverse Event|1
7864829|NCT00021541|27270573|P1|Period 1-First Treatment|Adverse Event|2
7864830|NCT00021541|27270572|P2|Period 1-First Treatment|Withdrawal by Subject|3
7864831|NCT00021541|27270573|P1|Period 1-First Treatment|Withdrawal by Subject|3
7864832|NCT00015457|27270587|P2|Second Intervention|Withdrawal by Subject|0
7864833|NCT00015457|27270588|P1|Second Intervention|Withdrawal by Subject|1
7864834|NCT00015457|27270587|P2|First Intervention|Lack of Efficacy|1
7864835|NCT00015457|27270588|P1|First Intervention|Lack of Efficacy|0
7864836|NCT00015457|27270587|P2|First Intervention|Adverse Event|2
7864837|NCT00015457|27270588|P1|First Intervention|Adverse Event|0
7864838|NCT00013611|27270598|P2|Overall Study|Lost to Follow-up|100
7864839|NCT00013611|27270599|P1|Overall Study|Lost to Follow-up|91
7864840|NCT00010803|27270617|P2|Overall Study|Withdrawal by Subject|98
7864841|NCT00010803|27270618|P1|Overall Study|Withdrawal by Subject|97
7864842|NCT00010374|27270633|P1|Overall Study|False positive phrenic nerve test|1
7864843|NCT00007475|27270651|P4|Overall Study|Adverse Event|0
7864844|NCT00007475|27270652|P3|Overall Study|Adverse Event|0
7864845|NCT00007475|27270653|P2|Overall Study|Adverse Event|0
7864846|NCT00007475|27270654|P1|Overall Study|Adverse Event|3
7864847|NCT00007475|27270651|P4|Overall Study|Withdrawal by Subject|0
7864848|NCT00007475|27270652|P3|Overall Study|Withdrawal by Subject|0
7864849|NCT00007475|27270653|P2|Overall Study|Withdrawal by Subject|0
7864850|NCT00007475|27270654|P1|Overall Study|Withdrawal by Subject|1
7864851|NCT00007345|27270676|P2|Overall Study|Death on study|1
7864852|NCT00007345|27270677|P1|Overall Study|Death on study|1
7864853|NCT00007345|27270676|P2|Overall Study|Intercurrent illness|0
7864854|NCT00007345|27270677|P1|Overall Study|Intercurrent illness|1
7864855|NCT00007345|27270676|P2|Overall Study|Switched to alternative treatment|3
7864856|NCT00007345|27270677|P1|Overall Study|Switched to alternative treatment|0
7864857|NCT00007345|27270676|P2|Overall Study|Refused further treatment|7
7864858|NCT00007345|27270677|P1|Overall Study|Refused further treatment|0
7864859|NCT00007020|27270695|P1|Overall Study|No evidence of treatment|6
7864860|NCT00007020|27270695|P1|Overall Study|Pt cared for by outside physician|4
7864861|NCT00007020|27270695|P1|Overall Study|Pt withdrawn (liver transplant)|4
7864862|NCT00007020|27270695|P1|Overall Study|Pt withdrawn (worsening cholestasis)|1
7864863|NCT00007020|27270695|P1|Overall Study|Lost to Follow-up|13
7864864|NCT00007020|27270695|P1|Overall Study|Death|16
7864865|NCT00006489|27270708|P4|Overall Study|Death|1
7864866|NCT00006489|27270709|P3|Overall Study|Death|0
7864867|NCT00006489|27270710|P2|Overall Study|Death|0
7864868|NCT00006489|27270711|P1|Overall Study|Death|0
7864869|NCT00006489|27270708|P4|Overall Study|Scheduling Conflict|1
7864870|NCT00006489|27270709|P3|Overall Study|Scheduling Conflict|2
7864871|NCT00006489|27270710|P2|Overall Study|Scheduling Conflict|3
7864872|NCT00006489|27270711|P1|Overall Study|Scheduling Conflict|0
7864873|NCT00006489|27270708|P4|Overall Study|Withdrawal by Subject|6
7864874|NCT00006489|27270709|P3|Overall Study|Withdrawal by Subject|9
7864875|NCT00006489|27270710|P2|Overall Study|Withdrawal by Subject|9
7864876|NCT00006489|27270711|P1|Overall Study|Withdrawal by Subject|10
7864877|NCT00006489|27270708|P4|Overall Study|Adverse Event|3
7864878|NCT00006489|27270709|P3|Overall Study|Adverse Event|4
7864879|NCT00006489|27270710|P2|Overall Study|Adverse Event|2
7864880|NCT00006489|27270711|P1|Overall Study|Adverse Event|3
7864881|NCT00006409|27270746|P6|Post-3 Year Intervention|Protocol Violation|62
7864882|NCT00006409|27270747|P5|Post-3 Year Intervention|Protocol Violation|62
7864883|NCT00006409|27270748|P4|Post-3 Year Intervention|Protocol Violation|0
7864884|NCT00006409|27270749|P3|Post-3 Year Intervention|Protocol Violation|0
7864885|NCT00006409|27270750|P2|Post-3 Year Intervention|Protocol Violation|0
7864886|NCT00006409|27270751|P1|Post-3 Year Intervention|Protocol Violation|0
7864887|NCT00006409|27270746|P6|Post-2 Year Intervention|Protocol Violation|0
7864888|NCT00006409|27270747|P5|Post-2 Year Intervention|Protocol Violation|0
7864889|NCT00006409|27270748|P4|Post-2 Year Intervention|Protocol Violation|168
7864890|NCT00006409|27270749|P3|Post-2 Year Intervention|Protocol Violation|251
7864891|NCT00006409|27270750|P2|Post-2 Year Intervention|Protocol Violation|0
7864892|NCT00006409|27270751|P1|Post-2 Year Intervention|Protocol Violation|0
7864893|NCT00006409|27270746|P6|Baseline|Protocol Violation|0
7864894|NCT00006409|27270747|P5|Baseline|Protocol Violation|0
7864895|NCT00006409|27270748|P4|Baseline|Protocol Violation|0
7864896|NCT00006409|27270749|P3|Baseline|Protocol Violation|0
7864897|NCT00006409|27270750|P2|Baseline|Protocol Violation|70
7864898|NCT00006409|27270751|P1|Baseline|Protocol Violation|48
7864899|NCT00006305|27270790|P4|Overall Study|Withdrawal by Subject|14
7864900|NCT00006305|27270791|P3|Overall Study|Withdrawal by Subject|15
7864901|NCT00006305|27270792|P2|Overall Study|Withdrawal by Subject|10
7864902|NCT00006305|27270793|P1|Overall Study|Withdrawal by Subject|17
7864903|NCT00006289|27270809|P2|Second Intervention (5 Weeks)|Protocol Violation|1
7864904|NCT00006289|27270810|P1|Second Intervention (5 Weeks)|Protocol Violation|1
7864905|NCT00006289|27270809|P2|First Intervention (5 Weeks)|Adverse Event|0
7864906|NCT00006289|27270810|P1|First Intervention (5 Weeks)|Adverse Event|1
7864907|NCT00006184|27270828|P2|Overall Study|Death|0
7864908|NCT00006184|27270829|P1|Overall Study|Death|1
7864909|NCT00006164|27270880|P2|Overall Study|Withdrew or lost to follow-up|81
7864910|NCT00006164|27270881|P1|Overall Study|Withdrew or lost to follow-up|70
7864911|NCT00005937|27270924|P1|Overall Study|Lack of Efficacy|5
7864912|NCT00005908|27270928|P2|Overall Study|Withdrawal by Subject|0
7864913|NCT00005908|27270929|P1|Overall Study|Withdrawal by Subject|1
7864914|NCT00005906|27270938|P1|Overall Study|Lack of Efficacy|3
7864915|NCT00004980|27270982|P2|Overall Study|Physician Decision|1
7864916|NCT00004980|27270983|P1|Overall Study|Physician Decision|0
7864917|NCT00004980|27270982|P2|Overall Study|memory difficulties|1
7864918|NCT00004980|27270983|P1|Overall Study|memory difficulties|1
7864919|NCT00004980|27270982|P2|Overall Study|Withdrawal by Subject|0
7864920|NCT00004980|27270983|P1|Overall Study|Withdrawal by Subject|1
7864921|NCT00004732|27270997|P2|Overall Study|Lost to Follow-up|47
7864922|NCT00004732|27270998|P1|Overall Study|Lost to Follow-up|33
7864923|NCT00004732|27270997|P2|Overall Study|Withdrawal by Subject|64
7864924|NCT00004732|27270998|P1|Overall Study|Withdrawal by Subject|36
7864925|NCT00004635|27271008|P2|Period Two|discrepancy in data entry|1
7864926|NCT00004635|27271009|P1|Period Two|discrepancy in data entry|0
7864927|NCT00004635|27271008|P2|Period Two|Lost to Follow-up|0
7864928|NCT00004635|27271009|P1|Period Two|Lost to Follow-up|1
7864929|NCT00004635|27271008|P2|Period Two|secondary malignancy|1
7864930|NCT00004635|27271009|P1|Period Two|secondary malignancy|1
7864931|NCT00004635|27271008|P2|Period Two|travel issues|1
7864932|NCT00004635|27271009|P1|Period Two|travel issues|0
7864933|NCT00004635|27271008|P2|Period Two|health problem|1
7864934|NCT00004635|27271009|P1|Period Two|health problem|1
7864935|NCT00004635|27271008|P2|Period Two|refused|2
7864936|NCT00004635|27271009|P1|Period Two|refused|0
7864937|NCT00004635|27271008|P2|Period Two|Adverse Event|0
7864938|NCT00004635|27271009|P1|Period Two|Adverse Event|1
7864939|NCT00004635|27271008|P2|Period Two|progression|3
7864940|NCT00004635|27271009|P1|Period Two|progression|2
7864941|NCT00004635|27271008|P2|Period One|discrepancy in data entry|1
7864942|NCT00004635|27271009|P1|Period One|discrepancy in data entry|0
7864943|NCT00004635|27271008|P2|Period One|health problem|1
7864944|NCT00004635|27271009|P1|Period One|health problem|0
7864945|NCT00004635|27271008|P2|Period One|progressed|2
7864946|NCT00004635|27271009|P1|Period One|progressed|0
7864947|NCT00004635|27271008|P2|Period One|second malignancy|0
7864948|NCT00004635|27271009|P1|Period One|second malignancy|1
7864949|NCT00004635|27271008|P2|Period One|PSA did not go <5 ng/mL|0
7864950|NCT00004635|27271009|P1|Period One|PSA did not go <5 ng/mL|1
7864951|NCT00004635|27271008|P2|Period One|Protocol Violation|0
7864952|NCT00004635|27271009|P1|Period One|Protocol Violation|1
7864953|NCT00004635|27271008|P2|Period One|Withdrawal by Subject|1
7864954|NCT00004635|27271009|P1|Period One|Withdrawal by Subject|1
7864955|NCT00004635|27271008|P2|Period One|refused|1
7864956|NCT00004635|27271009|P1|Period One|refused|2
7864957|NCT00004563|27271021|P2|Overall Study|Death|3
7864958|NCT00004563|27271022|P1|Overall Study|Death|2
7864959|NCT00004563|27271021|P2|Overall Study|Lack of Efficacy|5
7864960|NCT00004563|27271022|P1|Overall Study|Lack of Efficacy|3
7864961|NCT00004563|27271021|P2|Overall Study|Withdrawal by Subject|16
7864962|NCT00004563|27271022|P1|Overall Study|Withdrawal by Subject|20
7864963|NCT00004562|27271034|P2|Overall Study|Lost to Follow-up|91
7864964|NCT00004562|27271035|P1|Overall Study|Lost to Follow-up|102
7864965|NCT00001962|27271076|P1|Overall Study|Adverse Event|1
7864966|NCT00001962|27271076|P1|Overall Study|Lost to Follow-up|2
7864967|NCT00001962|27271076|P1|Overall Study|Death|1
7864968|NCT00001962|27271076|P1|Overall Study|Lack of Accrual|6
7864969|NCT00001962|27271076|P1|Overall Study|Lack of Efficacy|18
7864970|NCT00001959|27271082|P1|Overall Study|non-compliance|1
7864971|NCT00001959|27271082|P1|Overall Study|disabling sedation|1
7864972|NCT00001959|27271082|P1|Overall Study|newly diagnosed colon cancer|1
7864973|NCT00001941|27271088|P5|Overall Study|not treated- rapidly progressing disease|1
7864974|NCT00001941|27271089|P4|Overall Study|not treated- rapidly progressing disease|0
7864975|NCT00001941|27271090|P3|Overall Study|not treated- rapidly progressing disease|0
7864976|NCT00001941|27271091|P2|Overall Study|not treated- rapidly progressing disease|0
7864977|NCT00001941|27271092|P1|Overall Study|not treated- rapidly progressing disease|0
7864978|NCT00001849|27271110|P1|Overall Study|tumor remained occult|6
7864979|NCT00001849|27271110|P1|Overall Study|Withdrawal by Subject|2
7864980|NCT00001849|27271110|P1|Overall Study|Lost to Follow-up|2
7864981|NCT00001849|27271110|P1|Overall Study|Death|4
7864982|NCT00001832|27271139|P15|Treatment Period|Not treated|0
7864983|NCT00001832|27271140|P14|Treatment Period|Not treated|0
7864984|NCT00001832|27271141|P13|Treatment Period|Not treated|0
7864985|NCT00001832|27271142|P12|Treatment Period|Not treated|0
7864986|NCT00001832|27271143|P11|Treatment Period|Not treated|0
7864987|NCT00001832|27271144|P10|Treatment Period|Not treated|0
7864988|NCT00001832|27271145|P9|Treatment Period|Not treated|0
7864989|NCT00001832|27271146|P8|Treatment Period|Not treated|1
7864990|NCT00001832|27271147|P7|Treatment Period|Not treated|0
7864991|NCT00001832|27271148|P6|Treatment Period|Not treated|0
7864992|NCT00001832|27271149|P5|Treatment Period|Not treated|0
7864993|NCT00001832|27271150|P4|Treatment Period|Not treated|0
7864994|NCT00001832|27271151|P3|Treatment Period|Not treated|0
7864995|NCT00001832|27271152|P2|Treatment Period|Not treated|0
7864996|NCT00001832|27271153|P1|Treatment Period|Not treated|0
7864997|NCT00001832|27271139|P15|Treatment Period|Death during treatment|0
7864998|NCT00001832|27271140|P14|Treatment Period|Death during treatment|0
7864999|NCT00001832|27271141|P13|Treatment Period|Death during treatment|0
7865000|NCT00001832|27271142|P12|Treatment Period|Death during treatment|0
7865001|NCT00001832|27271143|P11|Treatment Period|Death during treatment|0
7865002|NCT00001832|27271144|P10|Treatment Period|Death during treatment|0
7865003|NCT00001832|27271145|P9|Treatment Period|Death during treatment|0
7865004|NCT00001832|27271146|P8|Treatment Period|Death during treatment|0
7865005|NCT00001832|27271147|P7|Treatment Period|Death during treatment|0
7865006|NCT00001832|27271148|P6|Treatment Period|Death during treatment|1
7865007|NCT00001832|27271149|P5|Treatment Period|Death during treatment|0
7865008|NCT00001832|27271150|P4|Treatment Period|Death during treatment|0
7865009|NCT00001832|27271151|P3|Treatment Period|Death during treatment|0
7865010|NCT00001832|27271152|P2|Treatment Period|Death during treatment|0
7865011|NCT00001832|27271153|P1|Treatment Period|Death during treatment|0
7865012|NCT00001832|27271139|P15|Apheresis Period|not able to manufacture treatment cells|0
7865013|NCT00001832|27271140|P14|Apheresis Period|not able to manufacture treatment cells|0
7865014|NCT00001832|27271141|P13|Apheresis Period|not able to manufacture treatment cells|0
7865015|NCT00001832|27271142|P12|Apheresis Period|not able to manufacture treatment cells|0
7865016|NCT00001832|27271143|P11|Apheresis Period|not able to manufacture treatment cells|0
7865017|NCT00001832|27271144|P10|Apheresis Period|not able to manufacture treatment cells|0
7865018|NCT00001832|27271145|P9|Apheresis Period|not able to manufacture treatment cells|0
7865019|NCT00001832|27271146|P8|Apheresis Period|not able to manufacture treatment cells|0
7865020|NCT00001832|27271147|P7|Apheresis Period|not able to manufacture treatment cells|0
7865021|NCT00001832|27271148|P6|Apheresis Period|not able to manufacture treatment cells|0
7865022|NCT00001832|27271149|P5|Apheresis Period|not able to manufacture treatment cells|0
7865023|NCT00001832|27271150|P4|Apheresis Period|not able to manufacture treatment cells|0
7865024|NCT00001832|27271151|P3|Apheresis Period|not able to manufacture treatment cells|0
7865025|NCT00001832|27271152|P2|Apheresis Period|not able to manufacture treatment cells|0
7865026|NCT00001832|27271153|P1|Apheresis Period|not able to manufacture treatment cells|60
7865027|NCT00001723|27271199|P2|Overall Study|medication intolerance|2
7865028|NCT00001723|27271200|P1|Overall Study|medication intolerance|1
7865029|NCT00001723|27271199|P2|Overall Study|Lost to Follow-up|2
7865030|NCT00001723|27271200|P1|Overall Study|Lost to Follow-up|2
7865031|NCT00001723|27271199|P2|Overall Study|Lack of family interest|5
7865032|NCT00001723|27271200|P1|Overall Study|Lack of family interest|4
7865033|NCT00001723|27271199|P2|Overall Study|Lack of Efficacy|7
7865034|NCT00001723|27271200|P1|Overall Study|Lack of Efficacy|6
7865035|NCT00001703|27271216|P1|Overall Study|recurrent disease|2
7865036|NCT00001703|27271216|P1|Overall Study|No evidence of disease|1
7865037|NCT00001703|27271216|P1|Overall Study|progressed disease|2
7865038|NCT00001596|27271254|P2|Overall Study|Adverse Event|0
7865039|NCT00001596|27271255|P1|Overall Study|Adverse Event|1
7865040|NCT00001596|27271254|P2|Overall Study|Study Termination|9
7865041|NCT00001596|27271255|P1|Overall Study|Study Termination|12
7865042|NCT00001596|27271254|P2|Overall Study|Withdrawal by Subject|1
7865043|NCT00001596|27271255|P1|Overall Study|Withdrawal by Subject|3
7865044|NCT00001596|27271254|P2|Overall Study|Death|0
7865045|NCT00001596|27271255|P1|Overall Study|Death|1
7865046|NCT00001575|27271286|P1|Overall Study|Withdrawn/deaths|23
7865047|NCT00001575|27271286|P1|Overall Study|Screening failures-Ph I portion|22
7865048|NCT00001566|27271292|P1|Overall Study|unable to complete initial apheresis|1
7865049|NCT00001566|27271292|P1|Overall Study|Lost to Follow-up|1
7865050|NCT00001566|27271292|P1|Overall Study|Death|13
7865051|NCT00001566|27271292|P1|Overall Study|stopped after C3 due to symptomatic PD|1
7865203|NCT03384940|27271688|P3|Overall Study|Other|1
7865052|NCT00001566|27271292|P1|Overall Study|patients' choice to discontinue protocol|3
7865053|NCT00001262|27271332|P3|Overall Study|Withdrawal by Subject|0
7865054|NCT00001262|27271333|P2|Overall Study|Withdrawal by Subject|3
7865055|NCT00001262|27271334|P1|Overall Study|Withdrawal by Subject|0
7865056|NCT00001262|27271332|P3|Overall Study|Death|0
7865057|NCT00001262|27271333|P2|Overall Study|Death|11
7865058|NCT00001262|27271334|P1|Overall Study|Death|10
7865059|NCT00001213|27271360|P1|Overall Study|Death|18
7865060|NCT00000378|27271371|P2|Overall Study|Lack of Efficacy|14
7865061|NCT00000378|27271372|P1|Overall Study|Lack of Efficacy|16
7865062|NCT00000620|27271389|P8|Overall Study|missed closeout visit|16
7865063|NCT00000620|27271390|P7|Overall Study|missed closeout visit|13
7865064|NCT00000620|27271391|P6|Overall Study|missed closeout visit|28
7865065|NCT00000620|27271392|P5|Overall Study|missed closeout visit|26
7865066|NCT00000620|27271393|P4|Overall Study|missed closeout visit|11
7865067|NCT00000620|27271394|P3|Overall Study|missed closeout visit|16
7865068|NCT00000620|27271395|P2|Overall Study|missed closeout visit|28
7865069|NCT00000620|27271396|P1|Overall Study|missed closeout visit|22
7865070|NCT00000620|27271389|P8|Overall Study|Withdrawal by Subject|21
7865071|NCT00000620|27271390|P7|Overall Study|Withdrawal by Subject|32
7865072|NCT00000620|27271391|P6|Overall Study|Withdrawal by Subject|32
7865073|NCT00000620|27271392|P5|Overall Study|Withdrawal by Subject|30
7865074|NCT00000620|27271393|P4|Overall Study|Withdrawal by Subject|27
7865075|NCT00000620|27271394|P3|Overall Study|Withdrawal by Subject|28
7865076|NCT00000620|27271395|P2|Overall Study|Withdrawal by Subject|27
7865077|NCT00000620|27271396|P1|Overall Study|Withdrawal by Subject|40
7865078|NCT00000620|27271389|P8|Overall Study|Lost to Follow-up|14
7865079|NCT00000620|27271390|P7|Overall Study|Lost to Follow-up|13
7865080|NCT00000620|27271391|P6|Overall Study|Lost to Follow-up|15
7865081|NCT00000620|27271392|P5|Overall Study|Lost to Follow-up|15
7865082|NCT00000620|27271393|P4|Overall Study|Lost to Follow-up|14
7865083|NCT00000620|27271394|P3|Overall Study|Lost to Follow-up|14
7865084|NCT00000620|27271395|P2|Overall Study|Lost to Follow-up|14
7865085|NCT00000620|27271396|P1|Overall Study|Lost to Follow-up|14
7865086|NCT00000620|27271389|P8|Overall Study|Death|95
7865087|NCT00000620|27271390|P7|Overall Study|Death|91
7865088|NCT00000620|27271391|P6|Overall Study|Death|77
7865089|NCT00000620|27271392|P5|Overall Study|Death|64
7865090|NCT00000620|27271393|P4|Overall Study|Death|126
7865091|NCT00000620|27271394|P3|Overall Study|Death|112
7865092|NCT00000620|27271395|P2|Overall Study|Death|67
7865093|NCT00000620|27271396|P1|Overall Study|Death|86
7865094|NCT00004445|27271477|P1|Overall Study|Withdrawal by Subject|1
7865095|NCT00004445|27271477|P1|Overall Study|Physician Decision|2
7865096|NCT00004412|27271490|P3|Randomized Period|Moved to Crossover Period|0
7865097|NCT00004412|27271491|P2|Randomized Period|Moved to Crossover Period|0
7865098|NCT00004412|27271492|P1|Randomized Period|Moved to Crossover Period|3
7865099|NCT00000135|27271533|P2|Overall Study|Death|14
7865100|NCT00000135|27271534|P1|Overall Study|Death|27
7865101|NCT03905694|27271587|P1|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
7865102|NCT03723915|27271591|P1|On Treatment|Failed to meet treatment requirements|2
7865103|NCT03723915|27271591|P1|Screening|Failed to meet screening requirements.|2
7865104|NCT03681184|27271597|P2|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
7865105|NCT03681184|27271598|P1|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
7865106|NCT03681184|27271597|P2|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
7865107|NCT03681184|27271598|P1|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
7865108|NCT03681184|27271597|P2|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
7865109|NCT03681184|27271598|P1|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
7865110|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
7865111|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
7865112|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7865113|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7865114|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
7865115|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
7865116|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
7865117|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
7865118|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7865119|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
7865120|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
7865121|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7865122|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
7865123|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
7865124|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
7865125|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
7865126|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7865127|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7865128|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
7865129|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
7865130|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7865131|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7865132|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
7865133|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7865134|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
7865135|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7865136|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
7865137|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7865138|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
7865139|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
7865140|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
7865141|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
7865142|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
7865143|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
7865144|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7865145|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7865146|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7865147|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
7865148|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
7865149|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7865150|NCT03605836|27271640|P4|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7865151|NCT03605836|27271641|P3|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7865152|NCT03605836|27271642|P2|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
7865153|NCT03605836|27271643|P1|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
7865154|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7865155|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7865156|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7865157|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
7865158|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7865159|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7865160|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7865161|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
7865162|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7865163|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7865164|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7865165|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
7865166|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7865167|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7865168|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7865169|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Physician Decision|7
7865170|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7865171|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7865172|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7865173|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
7865174|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7865175|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7865176|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7865177|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
7865178|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7865179|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7865180|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7865181|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
7865182|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7865183|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7865184|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7865185|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
7865186|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7865187|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7865188|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7865189|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
7865190|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7865191|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7865192|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7865193|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
7865194|NCT03605836|27271640|P4|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7865195|NCT03605836|27271641|P3|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7865196|NCT03605836|27271642|P2|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7865197|NCT03605836|27271643|P1|OL Placebo Run-in Period [1 Week]|Adverse Event|2
7865198|NCT03574753|27271655|P1|Overall Study|Death|1
7865199|NCT03574753|27271655|P1|Overall Study|Progression/relapse|19
7865200|NCT03574753|27271655|P1|Overall Study|Adverse Event|3
7865204|NCT03384940|27271689|P2|Overall Study|Other|0
7865205|NCT03384940|27271690|P1|Overall Study|Other|0
7865206|NCT03384940|27271688|P3|Overall Study|Death|0
7865207|NCT03384940|27271689|P2|Overall Study|Death|1
7865208|NCT03384940|27271690|P1|Overall Study|Death|2
7865209|NCT03384940|27271688|P3|Overall Study|Physician Decision|0
7865210|NCT03384940|27271689|P2|Overall Study|Physician Decision|1
7865211|NCT03384940|27271690|P1|Overall Study|Physician Decision|1
7865212|NCT03384940|27271688|P3|Overall Study|Withdrawal by Subject|0
7865213|NCT03384940|27271689|P2|Overall Study|Withdrawal by Subject|1
7865214|NCT03384940|27271690|P1|Overall Study|Withdrawal by Subject|3
7865215|NCT03384940|27271688|P3|Overall Study|Adverse Event|1
7865216|NCT03384940|27271689|P2|Overall Study|Adverse Event|1
7865217|NCT03384940|27271690|P1|Overall Study|Adverse Event|7
7865218|NCT03384940|27271688|P3|Overall Study|Clinical progression|3
7865219|NCT03384940|27271689|P2|Overall Study|Clinical progression|0
7865220|NCT03384940|27271690|P1|Overall Study|Clinical progression|4
7865221|NCT03384940|27271688|P3|Overall Study|Progressive disease|13
7865222|NCT03384940|27271689|P2|Overall Study|Progressive disease|11
7865223|NCT03384940|27271690|P1|Overall Study|Progressive disease|36
7865228|NCT03052920|27271787|P1|Overall Study|Withdrawal by Subject|1
7865259|NCT02544217|27271859|P6|Overall Study|Withdrawal by Subject|0
7865260|NCT02544217|27271860|P5|Overall Study|Withdrawal by Subject|0
7865261|NCT02544217|27271861|P4|Overall Study|Withdrawal by Subject|0
7865262|NCT02544217|27271862|P3|Overall Study|Withdrawal by Subject|0
7865263|NCT02544217|27271863|P2|Overall Study|Withdrawal by Subject|1
7865264|NCT02544217|27271864|P1|Overall Study|Withdrawal by Subject|1
7865265|NCT02527343|27272659|P6|PT Follow-up: Weeks 104 to 169|Other|1
7865266|NCT02527343|27272660|P5|PT Follow-up: Weeks 104 to 169|Other|0
7865267|NCT02527343|27272661|P4|PT Follow-up: Weeks 104 to 169|Other|0
7865268|NCT02527343|27272662|P3|PT Follow-up: Weeks 104 to 169|Other|0
7865269|NCT02527343|27272663|P2|PT Follow-up: Weeks 104 to 169|Other|0
7865270|NCT02527343|27272664|P1|PT Follow-up: Weeks 104 to 169|Other|0
7865271|NCT02527343|27272659|P6|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7865272|NCT02527343|27272660|P5|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
7865273|NCT02527343|27272661|P4|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7865274|NCT02527343|27272662|P3|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7865275|NCT02527343|27272663|P2|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7865276|NCT02527343|27272664|P1|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7865277|NCT02527343|27272659|P6|OLE Period-Year 2: Week 105 to 156|Other|2
7865278|NCT02527343|27272660|P5|OLE Period-Year 2: Week 105 to 156|Other|1
7865279|NCT02527343|27272661|P4|OLE Period-Year 2: Week 105 to 156|Other|0
7865280|NCT02527343|27272662|P3|OLE Period-Year 2: Week 105 to 156|Other|0
7865281|NCT02527343|27272663|P2|OLE Period-Year 2: Week 105 to 156|Other|0
7865282|NCT02527343|27272664|P1|OLE Period-Year 2: Week 105 to 156|Other|0
7865283|NCT02527343|27272659|P6|OLE Period-Year 1: Week 53 to 104|Other|7
7865284|NCT02527343|27272660|P5|OLE Period-Year 1: Week 53 to 104|Other|5
7865285|NCT02527343|27272661|P4|OLE Period-Year 1: Week 53 to 104|Other|0
7865286|NCT02527343|27272662|P3|OLE Period-Year 1: Week 53 to 104|Other|0
7865287|NCT02527343|27272663|P2|OLE Period-Year 1: Week 53 to 104|Other|0
7865288|NCT02527343|27272664|P1|OLE Period-Year 1: Week 53 to 104|Other|0
7865289|NCT02527343|27272659|P6|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
7865290|NCT02527343|27272660|P5|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
7865291|NCT02527343|27272661|P4|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7865292|NCT02527343|27272662|P3|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7865293|NCT02527343|27272663|P2|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7865294|NCT02527343|27272664|P1|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7865295|NCT02527343|27272659|P6|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
7865296|NCT02527343|27272660|P5|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
7865297|NCT02527343|27272661|P4|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7865298|NCT02527343|27272662|P3|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7865299|NCT02527343|27272663|P2|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7865300|NCT02527343|27272664|P1|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7865301|NCT02527343|27272659|P6|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7865302|NCT02527343|27272660|P5|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
7865303|NCT02527343|27272661|P4|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7865304|NCT02527343|27272662|P3|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7865305|NCT02527343|27272663|P2|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7865306|NCT02527343|27272664|P1|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7865307|NCT02527343|27272659|P6|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7865308|NCT02527343|27272660|P5|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7865309|NCT02527343|27272661|P4|RT Post Treatment Follow-up: Weeks 54-65|Other|2
7865310|NCT02527343|27272662|P3|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7865311|NCT02527343|27272663|P2|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7865312|NCT02527343|27272664|P1|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7865313|NCT02527343|27272659|P6|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7865314|NCT02527343|27272660|P5|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7865315|NCT02527343|27272661|P4|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7865316|NCT02527343|27272662|P3|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
7865317|NCT02527343|27272663|P2|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7865318|NCT02527343|27272664|P1|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7865319|NCT02527343|27272659|P6|RT Period: Weeks 1 to 52|Other|0
7865320|NCT02527343|27272660|P5|RT Period: Weeks 1 to 52|Other|0
7865321|NCT02527343|27272661|P4|RT Period: Weeks 1 to 52|Other|0
7865322|NCT02527343|27272662|P3|RT Period: Weeks 1 to 52|Other|0
7865323|NCT02527343|27272663|P2|RT Period: Weeks 1 to 52|Other|3
7865324|NCT02527343|27272664|P1|RT Period: Weeks 1 to 52|Other|4
7865325|NCT02527343|27272659|P6|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7865326|NCT02527343|27272660|P5|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7865327|NCT02527343|27272661|P4|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7865328|NCT02527343|27272662|P3|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7865329|NCT02527343|27272663|P2|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
7865330|NCT02527343|27272664|P1|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7865331|NCT02527343|27272659|P6|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7865332|NCT02527343|27272660|P5|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7865333|NCT02527343|27272661|P4|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7865334|NCT02527343|27272662|P3|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7865335|NCT02527343|27272663|P2|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7865336|NCT02527343|27272664|P1|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
7865337|NCT02527343|27272659|P6|RT Period: Weeks 1 to 52|Investigator Judgement|0
7865338|NCT02527343|27272660|P5|RT Period: Weeks 1 to 52|Investigator Judgement|0
7865339|NCT02527343|27272661|P4|RT Period: Weeks 1 to 52|Investigator Judgement|0
7865340|NCT02527343|27272662|P3|RT Period: Weeks 1 to 52|Investigator Judgement|0
7865341|NCT02527343|27272663|P2|RT Period: Weeks 1 to 52|Investigator Judgement|0
7865342|NCT02527343|27272664|P1|RT Period: Weeks 1 to 52|Investigator Judgement|1
7865343|NCT02425891|27272706|P2|Overall Study|Not treated|6
7865344|NCT02425891|27272707|P1|Overall Study|Not treated|6
7865345|NCT02425891|27272706|P2|Overall Study|On-going in Study|90
7865346|NCT02425891|27272707|P1|Overall Study|On-going in Study|79
7865347|NCT02425891|27272706|P2|Overall Study|Withdrawal by Subject|32
7865348|NCT02425891|27272707|P1|Overall Study|Withdrawal by Subject|27
7865349|NCT02425891|27272706|P2|Overall Study|Study Terminated By Sponsor|0
7865350|NCT02425891|27272707|P1|Overall Study|Study Terminated By Sponsor|1
7865351|NCT02425891|27272706|P2|Overall Study|Protocol Violation|1
7865352|NCT02425891|27272707|P1|Overall Study|Protocol Violation|1
7865353|NCT02425891|27272706|P2|Overall Study|Physician Decision|1
7865354|NCT02425891|27272707|P1|Overall Study|Physician Decision|0
7865355|NCT02425891|27272706|P2|Overall Study|Accidentally randomized screen failure participant|1
7865356|NCT02425891|27272707|P1|Overall Study|Accidentally randomized screen failure participant|0
7865357|NCT02425891|27272706|P2|Overall Study|Non-Compliance|0
7865358|NCT02425891|27272707|P1|Overall Study|Non-Compliance|1
7865359|NCT02425891|27272706|P2|Overall Study|Lost to Follow-up|6
7865360|NCT02425891|27272707|P1|Overall Study|Lost to Follow-up|4
7865361|NCT02425891|27272706|P2|Overall Study|Death|314
7865362|NCT02425891|27272707|P1|Overall Study|Death|332
7865363|NCT02108652|27272802|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
7865364|NCT02108652|27272802|P1|Overall Study|Withdrawal by Subject|8
7865365|NCT02108652|27272802|P1|Overall Study|Lost to Follow-up|2
7865366|NCT02108652|27272802|P1|Overall Study|Death|226
7865367|NCT02085460|27272826|P3|Overall Study|Withdrawal by Subject|7
7865368|NCT02085460|27272827|P2|Overall Study|Withdrawal by Subject|5
7865369|NCT02085460|27272828|P1|Overall Study|Withdrawal by Subject|11
7865370|NCT02085460|27272826|P3|Overall Study|Physician Decision|2
7865371|NCT02085460|27272827|P2|Overall Study|Physician Decision|1
7865372|NCT02085460|27272828|P1|Overall Study|Physician Decision|1
7865373|NCT02085460|27272826|P3|Overall Study|Adverse Event|1
7865374|NCT02085460|27272827|P2|Overall Study|Adverse Event|2
7865375|NCT02085460|27272828|P1|Overall Study|Adverse Event|2
7865376|NCT02043678|27272841|P2|Overall Study|Ongoing with treatment|38
7865377|NCT02043678|27272842|P1|Overall Study|Ongoing with treatment|34
7865378|NCT02043678|27272841|P2|Overall Study|Withdrawal by Subject|15
7865379|NCT02043678|27272842|P1|Overall Study|Withdrawal by Subject|12
7865380|NCT02043678|27272841|P2|Overall Study|Protocol-driven decision point|56
7865381|NCT02043678|27272842|P1|Overall Study|Protocol-driven decision point|56
7865382|NCT02043678|27272841|P2|Overall Study|Radiological PD|80
7865383|NCT02043678|27272842|P1|Overall Study|Radiological PD|91
7865384|NCT02043678|27272841|P2|Overall Study|Clinical PD|138
7865385|NCT02043678|27272842|P1|Overall Study|Clinical PD|108
7865386|NCT02043678|27272841|P2|Overall Study|Other|16
7865387|NCT02043678|27272842|P1|Overall Study|Other|19
7865388|NCT02043678|27272841|P2|Overall Study|Lost to Follow-up|1
7865389|NCT02043678|27272842|P1|Overall Study|Lost to Follow-up|1
7865390|NCT02043678|27272841|P2|Overall Study|AE without clinical PD|34
7865391|NCT02043678|27272842|P1|Overall Study|AE without clinical PD|51
7865392|NCT02043678|27272841|P2|Overall Study|AE with clinical progressive disease(PD)|18
7865393|NCT02043678|27272842|P1|Overall Study|AE with clinical progressive disease(PD)|18
7865394|NCT02043678|27272841|P2|Overall Study|Never treated|9
7865395|NCT02043678|27272842|P1|Overall Study|Never treated|11
7865396|NCT02034409|27272891|P2|Sham-Controlled Treatment Period|misrandomized|2
7865397|NCT02034409|27272892|P1|Sham-Controlled Treatment Period|misrandomized|2
7865398|NCT02034409|27272891|P2|Sham-Controlled Treatment Period|Physician Decision|3
7865399|NCT02034409|27272892|P1|Sham-Controlled Treatment Period|Physician Decision|1
7865400|NCT02034409|27272891|P2|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7865401|NCT02034409|27272892|P1|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7865402|NCT02034409|27272891|P2|Sham-Controlled Treatment Period|Lost to Follow-up|1
7865403|NCT02034409|27272892|P1|Sham-Controlled Treatment Period|Lost to Follow-up|0
7865404|NCT02034409|27272891|P2|Sham-Controlled Treatment Period|Adverse Event|1
7865405|NCT02034409|27272892|P1|Sham-Controlled Treatment Period|Adverse Event|1
7865406|NCT02034409|27272891|P2|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
7865407|NCT02034409|27272892|P1|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
7865408|NCT01985360|27272922|P2|Overall Study|Lost to Follow-up|3
7865409|NCT01985360|27272923|P1|Overall Study|Lost to Follow-up|5
7865410|NCT01985360|27272922|P2|Overall Study|Withdrawal by Subject|0
7865411|NCT01985360|27272923|P1|Overall Study|Withdrawal by Subject|4
7865412|NCT01972217|27272935|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
7865413|NCT01972217|27272936|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7865414|NCT01972217|27272937|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7865415|NCT01972217|27272938|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7865416|NCT01972217|27272935|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
7865417|NCT01972217|27272936|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
7865418|NCT01972217|27272937|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7865419|NCT01972217|27272938|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7865420|NCT01972217|27272935|P4|Part B Double-blind, Randomised Period|Screen failure|1
7865421|NCT01972217|27272936|P3|Part B Double-blind, Randomised Period|Screen failure|0
7865422|NCT01972217|27272937|P2|Part B Double-blind, Randomised Period|Screen failure|0
7865423|NCT01972217|27272938|P1|Part B Double-blind, Randomised Period|Screen failure|0
7865424|NCT01972217|27272935|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
7865425|NCT01972217|27272936|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
7865426|NCT01972217|27272937|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
7865427|NCT01972217|27272938|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
7865428|NCT01972217|27272935|P4|Part B Double-blind, Randomised Period|Death|44
7865429|NCT01972217|27272936|P3|Part B Double-blind, Randomised Period|Death|43
7865430|NCT01972217|27272937|P2|Part B Double-blind, Randomised Period|Death|0
7865431|NCT01972217|27272938|P1|Part B Double-blind, Randomised Period|Death|0
7865432|NCT01972217|27272935|P4|Part A: Open-label Safety Run-in Period|Death|0
7865433|NCT01972217|27272936|P3|Part A: Open-label Safety Run-in Period|Death|0
7865434|NCT01972217|27272937|P2|Part A: Open-label Safety Run-in Period|Death|1
7865435|NCT01972217|27272938|P1|Part A: Open-label Safety Run-in Period|Death|0
7865436|NCT01972217|27272935|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
7865437|NCT01972217|27272936|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
7865438|NCT01972217|27272937|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
7865439|NCT01972217|27272938|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
7865440|NCT01972217|27272935|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7865441|NCT01972217|27272936|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7865442|NCT01972217|27272937|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
7865443|NCT01972217|27272938|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
7865444|NCT01972217|27272935|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7865445|NCT01972217|27272936|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7865446|NCT01972217|27272937|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
7865447|NCT01972217|27272938|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7865448|NCT01939353|27272984|P1|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
7865449|NCT01939353|27272984|P1|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
7865450|NCT01939353|27272984|P1|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
7865451|NCT01939353|27272984|P1|Placebo Run-in (1 Week)|Lost to Follow-up|1
7865452|NCT01939353|27272984|P1|Placebo Run-in (1 Week)|Withdrew Consent|3
7865453|NCT01909453|27273006|P5|Overall Study|Withdrawal by Subject|4
7865454|NCT01909453|27273007|P4|Overall Study|Withdrawal by Subject|5
7865455|NCT01909453|27273008|P3|Overall Study|Withdrawal by Subject|16
7865456|NCT01909453|27273009|P2|Overall Study|Withdrawal by Subject|13
7865457|NCT01909453|27273010|P1|Overall Study|Withdrawal by Subject|2
7865458|NCT01909453|27273006|P5|Overall Study|Lost to Follow-up|3
7865459|NCT01909453|27273007|P4|Overall Study|Lost to Follow-up|3
7865460|NCT01909453|27273008|P3|Overall Study|Lost to Follow-up|4
7865461|NCT01909453|27273009|P2|Overall Study|Lost to Follow-up|4
7865462|NCT01909453|27273010|P1|Overall Study|Lost to Follow-up|3
7865463|NCT01909453|27273006|P5|Overall Study|Death|29
7865464|NCT01909453|27273007|P4|Overall Study|Death|86
7865465|NCT01909453|27273008|P3|Overall Study|Death|88
7865466|NCT01909453|27273009|P2|Overall Study|Death|74
7865467|NCT01909453|27273010|P1|Overall Study|Death|69
7865468|NCT01909453|27273006|P5|Overall Study|Ongoing|50
7865469|NCT01909453|27273007|P4|Overall Study|Ongoing|164
7865470|NCT01909453|27273008|P3|Overall Study|Ongoing|83
7865471|NCT01909453|27273009|P2|Overall Study|Ongoing|103
7865472|NCT01909453|27273010|P1|Overall Study|Ongoing|118
7865473|NCT01904019|27273157|P1|5 Year Follow-up|Impossibility to contact patient|4
7865474|NCT01904019|27273157|P1|5 Year Follow-up|Withdrawal by Subject|2
7865475|NCT01904019|27273157|P1|3 Year Follow-up|Impossibility to contact patient|14
7865476|NCT01904019|27273157|P1|3 Year Follow-up|Withdrawal by Subject|1
7865477|NCT01904019|27273157|P1|1 Year Follow-up|Impossibility to contact patient|5
7865478|NCT01904019|27273157|P1|1 Year Follow-up|Withdrawal by Subject|4
7865479|NCT01660451|27273189|P3|Overall Study|Ongoing with treatment|46
7865480|NCT01660451|27273190|P2|Overall Study|Ongoing with treatment|3
7865481|NCT01660451|27273191|P1|Overall Study|Ongoing with treatment|3
7865482|NCT01660451|27273189|P3|Overall Study|Withdrawal by Subject|16
7865483|NCT01660451|27273190|P2|Overall Study|Withdrawal by Subject|0
7865484|NCT01660451|27273191|P1|Overall Study|Withdrawal by Subject|1
7865485|NCT01660451|27273189|P3|Overall Study|Physician Decision|5
7865486|NCT01660451|27273190|P2|Overall Study|Physician Decision|2
7865487|NCT01660451|27273191|P1|Overall Study|Physician Decision|1
7865488|NCT01660451|27273189|P3|Overall Study|Protocol Deviation|1
7865489|NCT01660451|27273190|P2|Overall Study|Protocol Deviation|0
7865490|NCT01660451|27273191|P1|Overall Study|Protocol Deviation|0
7865491|NCT01660451|27273189|P3|Overall Study|Sponsor Decision|1
7865492|NCT01660451|27273190|P2|Overall Study|Sponsor Decision|0
7865493|NCT01660451|27273191|P1|Overall Study|Sponsor Decision|0
7865494|NCT01660451|27273189|P3|Overall Study|AE with Clinical PD|9
7865495|NCT01660451|27273190|P2|Overall Study|AE with Clinical PD|3
7865496|NCT01660451|27273191|P1|Overall Study|AE with Clinical PD|1
7865497|NCT01660451|27273189|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
7865498|NCT01660451|27273190|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
7865499|NCT01660451|27273191|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
7865500|NCT01660451|27273189|P3|Overall Study|Protocol Violation|1
7865501|NCT01660451|27273190|P2|Overall Study|Protocol Violation|1
7865502|NCT01660451|27273191|P1|Overall Study|Protocol Violation|0
7865503|NCT01419080|27273219|P1|Overall Study|Too Ill|3
7865504|NCT01419080|27273219|P1|Overall Study|Lost to Follow-up|23
7865505|NCT01419080|27273219|P1|Overall Study|Death|30
7865506|NCT01419080|27273219|P1|Overall Study|Withdrawal by Subject|75
7865507|NCT01065454|27273234|P4|Follow up|study ongoing|41
7865508|NCT01065454|27273235|P3|Follow up|study ongoing|15
7865509|NCT01065454|27273236|P2|Follow up|study ongoing|22
7865510|NCT01065454|27273237|P1|Follow up|study ongoing|37
7865511|NCT01065454|27273234|P4|Follow up|Withdrawal by Subject|0
7865512|NCT01065454|27273235|P3|Follow up|Withdrawal by Subject|1
7865513|NCT01065454|27273236|P2|Follow up|Withdrawal by Subject|1
7865514|NCT01065454|27273237|P1|Follow up|Withdrawal by Subject|1
7865515|NCT01065454|27273234|P4|Follow up|Progressive disease|1
7865516|NCT01065454|27273235|P3|Follow up|Progressive disease|0
7865517|NCT01065454|27273236|P2|Follow up|Progressive disease|0
7865518|NCT01065454|27273237|P1|Follow up|Progressive disease|0
7865519|NCT01065454|27273234|P4|Follow up|Lost to Follow-up|1
7865520|NCT01065454|27273235|P3|Follow up|Lost to Follow-up|0
7865521|NCT01065454|27273236|P2|Follow up|Lost to Follow-up|0
7865522|NCT01065454|27273237|P1|Follow up|Lost to Follow-up|0
7865523|NCT01065454|27273234|P4|Follow up|Death|0
7865524|NCT01065454|27273235|P3|Follow up|Death|1
7865525|NCT01065454|27273236|P2|Follow up|Death|1
7865526|NCT01065454|27273237|P1|Follow up|Death|0
7865527|NCT01065454|27273234|P4|Follow up|Adverse Event|1
7865528|NCT01065454|27273235|P3|Follow up|Adverse Event|0
7865529|NCT01065454|27273236|P2|Follow up|Adverse Event|0
7865530|NCT01065454|27273237|P1|Follow up|Adverse Event|1
7865531|NCT01065454|27273234|P4|Treatment|Withdrawal by Subject|3
7865532|NCT01065454|27273235|P3|Treatment|Withdrawal by Subject|2
7865533|NCT01065454|27273236|P2|Treatment|Withdrawal by Subject|1
7865534|NCT01065454|27273237|P1|Treatment|Withdrawal by Subject|3
7865535|NCT01065454|27273234|P4|Treatment|Protocol Violation|0
7865536|NCT01065454|27273235|P3|Treatment|Protocol Violation|1
7865537|NCT01065454|27273236|P2|Treatment|Protocol Violation|0
7865538|NCT01065454|27273237|P1|Treatment|Protocol Violation|1
7865539|NCT01065454|27273234|P4|Treatment|Protocol Decision|2
7865540|NCT01065454|27273235|P3|Treatment|Protocol Decision|3
7865541|NCT01065454|27273236|P2|Treatment|Protocol Decision|0
7865542|NCT01065454|27273237|P1|Treatment|Protocol Decision|0
7865543|NCT01065454|27273234|P4|Treatment|Non-compliance|1
7865544|NCT01065454|27273235|P3|Treatment|Non-compliance|0
7865545|NCT01065454|27273236|P2|Treatment|Non-compliance|0
7865546|NCT01065454|27273237|P1|Treatment|Non-compliance|1
7865547|NCT01065454|27273234|P4|Treatment|Death|0
7865548|NCT01065454|27273235|P3|Treatment|Death|0
7865549|NCT01065454|27273236|P2|Treatment|Death|0
7865550|NCT01065454|27273237|P1|Treatment|Death|1
7865551|NCT01065454|27273234|P4|Treatment|Adverse Event|6
7865552|NCT01065454|27273235|P3|Treatment|Adverse Event|3
7865553|NCT01065454|27273236|P2|Treatment|Adverse Event|4
7865554|NCT01065454|27273237|P1|Treatment|Adverse Event|7
7865555|NCT01063517|27273349|P2|Overall Study|Death|48
7865556|NCT01063517|27273350|P1|Overall Study|Death|33
7865557|NCT01063517|27273349|P2|Overall Study|Withdrawal by Subject|2
7865558|NCT01063517|27273350|P1|Overall Study|Withdrawal by Subject|1
7865559|NCT01063517|27273349|P2|Overall Study|Lost to Follow-up|3
7865560|NCT01063517|27273350|P1|Overall Study|Lost to Follow-up|4
7865561|NCT01063517|27273349|P2|Overall Study|Study reached data cut-off|7
7865562|NCT01063517|27273350|P1|Overall Study|Study reached data cut-off|19
7865563|NCT01063517|27273349|P2|Overall Study|Consent withdrawal|0
7865564|NCT01063517|27273350|P1|Overall Study|Consent withdrawal|1
7865565|NCT00982111|27273390|P2|Overall Study|Withdrawal by Subject|17
7865566|NCT00982111|27273391|P1|Overall Study|Withdrawal by Subject|16
7865567|NCT00982111|27273390|P2|Overall Study|On Study Treatment at Conclusion|0
7865568|NCT00982111|27273391|P1|Overall Study|On Study Treatment at Conclusion|7
7865569|NCT00982111|27273390|P2|Overall Study|New Anti-Cancer Therapy|5
7865570|NCT00982111|27273391|P1|Overall Study|New Anti-Cancer Therapy|5
7865571|NCT00982111|27273390|P2|Overall Study|Lost to Follow-up|6
7865572|NCT00982111|27273391|P1|Overall Study|Lost to Follow-up|9
7865573|NCT00982111|27273390|P2|Overall Study|Progressive Disease|37
7865574|NCT00982111|27273391|P1|Overall Study|Progressive Disease|37
7865575|NCT00982111|27273390|P2|Overall Study|Adverse Event|1
7865576|NCT00982111|27273391|P1|Overall Study|Adverse Event|1
7865577|NCT00697073|27273413|P1|Overall Study|non compliance and other|6
7865578|NCT00697073|27273413|P1|Overall Study|Pregnancy|1
7865579|NCT00697073|27273413|P1|Overall Study|Withdrawal by Subject|2
7865580|NCT00114738|27273432|P3|Screening for Randomization|Other|0
7865581|NCT00114738|27273433|P2|Screening for Randomization|Other|0
7865582|NCT00114738|27273434|P1|Screening for Randomization|Other|1
7865583|NCT00114738|27273432|P3|Screening for Randomization|CNS Hemorrhage|0
7865584|NCT00114738|27273433|P2|Screening for Randomization|CNS Hemorrhage|0
7865585|NCT00114738|27273434|P1|Screening for Randomization|CNS Hemorrhage|1
7865586|NCT00114738|27273432|P3|Screening for Randomization|Progressive disease|0
7865587|NCT00114738|27273433|P2|Screening for Randomization|Progressive disease|0
7865588|NCT00114738|27273434|P1|Screening for Randomization|Progressive disease|2
7865589|NCT00114738|27273432|P3|Screening for Randomization|Neuropathy|0
7865590|NCT00114738|27273433|P2|Screening for Randomization|Neuropathy|0
7865591|NCT00114738|27273434|P1|Screening for Randomization|Neuropathy|17
7865592|NCT00114738|27273432|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
7865593|NCT00114738|27273433|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
7865594|NCT00114738|27273434|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
7865595|NCT00114738|27273432|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
7865596|NCT00114738|27273433|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
7865597|NCT00114738|27273434|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
7865598|NCT00112502|27273455|P8|Overall Study|Withdrawal by Subject|7
7865599|NCT00112502|27273456|P7|Overall Study|Withdrawal by Subject|3
7865600|NCT00112502|27273457|P6|Overall Study|Withdrawal by Subject|5
7865601|NCT00112502|27273458|P5|Overall Study|Withdrawal by Subject|2
7865602|NCT00112502|27273459|P4|Overall Study|Withdrawal by Subject|4
7865603|NCT00112502|27273460|P3|Overall Study|Withdrawal by Subject|1
7865604|NCT00112502|27273461|P2|Overall Study|Withdrawal by Subject|1
7865605|NCT00112502|27273462|P1|Overall Study|Withdrawal by Subject|0
7865606|NCT04355767|27273506|P2|Overall Study|Death|1
7865607|NCT04355767|27273507|P1|Overall Study|Death|5
7865608|NCT04355767|27273506|P2|Overall Study|Withdrawal by Subject|2
7865609|NCT04355767|27273507|P1|Overall Study|Withdrawal by Subject|2
7865610|NCT04353037|27273527|P4|Overall Study|Exposure Change|2
7865611|NCT04353037|27273528|P3|Overall Study|Exposure Change|0
7865612|NCT04353037|27273529|P2|Overall Study|Exposure Change|0
7865613|NCT04353037|27273530|P1|Overall Study|Exposure Change|0
7865614|NCT04353037|27273527|P4|Overall Study|Adverse Event|0
7865615|NCT04353037|27273528|P3|Overall Study|Adverse Event|2
7865616|NCT04353037|27273529|P2|Overall Study|Adverse Event|0
7865617|NCT04353037|27273530|P1|Overall Study|Adverse Event|0
7865618|NCT04353037|27273527|P4|Overall Study|Withdrawal by Subject|5
7865619|NCT04353037|27273528|P3|Overall Study|Withdrawal by Subject|3
7865620|NCT04353037|27273529|P2|Overall Study|Withdrawal by Subject|2
7865621|NCT04353037|27273530|P1|Overall Study|Withdrawal by Subject|0
7865622|NCT04353037|27273527|P4|Overall Study|Lost to Follow-up|3
7865623|NCT04353037|27273528|P3|Overall Study|Lost to Follow-up|2
7865624|NCT04353037|27273529|P2|Overall Study|Lost to Follow-up|1
7865625|NCT04353037|27273530|P1|Overall Study|Lost to Follow-up|0
7865626|NCT04178720|27273591|P2|Overall Study|Relocation|1
7865627|NCT04178720|27273592|P1|Overall Study|Relocation|0
7865628|NCT04178720|27273591|P2|Overall Study|Withdrawal by Subject|0
7865629|NCT04178720|27273592|P1|Overall Study|Withdrawal by Subject|2
7865630|NCT03799198|27273652|P2|Overall Study|Death|1
7865631|NCT03799198|27273653|P1|Overall Study|Death|0
7865632|NCT03799198|27273652|P2|Overall Study|Lost to Follow-up|8
7865633|NCT03799198|27273653|P1|Overall Study|Lost to Follow-up|4
7865634|NCT03707587|27273695|P2|Overall Study|Death|1
7865635|NCT03707587|27273696|P1|Overall Study|Death|0
7865636|NCT03676634|27273708|P1|Overall Study|Out-of-limit pulse|2
7865637|NCT03676634|27273708|P1|Overall Study|Red blood cell loss|1
7865638|NCT03599362|27273733|P1|Overall Study|Screen Failure|3
7865639|NCT03521193|27273740|P2|Overall Study|non compliant to ASA treatment|0
7865640|NCT03521193|27273741|P1|Overall Study|non compliant to ASA treatment|8
7865641|NCT03521193|27273740|P2|Overall Study|Withdrawal by Subject|0
7865642|NCT03521193|27273741|P1|Overall Study|Withdrawal by Subject|8
7865643|NCT03431857|27273767|P1|Overall Study|Withdrawal by Subject|1
7865644|NCT03431857|27273767|P1|Overall Study|Adverse Event|6
7865645|NCT03431857|27273767|P1|Overall Study|Lost to Follow-up|41
7865646|NCT03431857|27273767|P1|Overall Study|Death|6
7865647|NCT03356145|27273781|P2|Overall Study|Did not meet inclusion criteria|0
7865648|NCT03356145|27273782|P1|Overall Study|Did not meet inclusion criteria|1
7865649|NCT03356145|27273781|P2|Overall Study|Withdrawal by Subject|1
7865650|NCT03356145|27273782|P1|Overall Study|Withdrawal by Subject|2
7865651|NCT03263442|27273821|P2|6-month Follow-Up|Lost to Follow-up|2
7865652|NCT03263442|27273822|P1|6-month Follow-Up|Lost to Follow-up|2
7865653|NCT03263442|27273821|P2|3-month Follow-Up|Lost to Follow-up|3
7865654|NCT03263442|27273822|P1|3-month Follow-Up|Lost to Follow-up|1
7865655|NCT03263442|27273821|P2|1-month Follow-Up|Lost to Follow-up|0
7865656|NCT03263442|27273822|P1|1-month Follow-Up|Lost to Follow-up|1
7865657|NCT03263442|27273821|P2|Inpatient Phase|Inadequate Drug Exposure|1
7865658|NCT03263442|27273822|P1|Inpatient Phase|Inadequate Drug Exposure|0
7865659|NCT03263442|27273821|P2|Inpatient Phase|Withdrawal by Subject|0
7865660|NCT03263442|27273822|P1|Inpatient Phase|Withdrawal by Subject|1
7865661|NCT03263442|27273821|P2|Inpatient Phase|Death|0
7865662|NCT03263442|27273822|P1|Inpatient Phase|Death|1
7865663|NCT03248492|27273869|P5|Overall Study|Other|0
7865664|NCT03248492|27273870|P4|Overall Study|Other|4
7865665|NCT03248492|27273871|P3|Overall Study|Other|0
7865666|NCT03248492|27273872|P2|Overall Study|Other|1
7865667|NCT03248492|27273873|P1|Overall Study|Other|0
7865668|NCT03248492|27273869|P5|Overall Study|Death|0
7865669|NCT03248492|27273870|P4|Overall Study|Death|6
7865670|NCT03248492|27273871|P3|Overall Study|Death|0
7865671|NCT03248492|27273872|P2|Overall Study|Death|0
7865672|NCT03248492|27273873|P1|Overall Study|Death|1
7865673|NCT03248492|27273869|P5|Overall Study|Physician Decision|0
7865674|NCT03248492|27273870|P4|Overall Study|Physician Decision|2
7865675|NCT03248492|27273871|P3|Overall Study|Physician Decision|1
7865676|NCT03248492|27273872|P2|Overall Study|Physician Decision|0
7865677|NCT03248492|27273873|P1|Overall Study|Physician Decision|1
7865678|NCT03248492|27273869|P5|Overall Study|Withdrawal by Subject|1
7865679|NCT03248492|27273870|P4|Overall Study|Withdrawal by Subject|3
7865680|NCT03248492|27273871|P3|Overall Study|Withdrawal by Subject|0
7865681|NCT03248492|27273872|P2|Overall Study|Withdrawal by Subject|3
7865682|NCT03248492|27273873|P1|Overall Study|Withdrawal by Subject|3
7865683|NCT03248492|27273869|P5|Overall Study|Adverse Event|1
7865684|NCT03248492|27273870|P4|Overall Study|Adverse Event|8
7865685|NCT03248492|27273871|P3|Overall Study|Adverse Event|8
7865686|NCT03248492|27273872|P2|Overall Study|Adverse Event|6
7865687|NCT03248492|27273873|P1|Overall Study|Adverse Event|6
7865688|NCT03248492|27273869|P5|Overall Study|Progressive disease per RECIST v1.1|0
7865689|NCT03248492|27273870|P4|Overall Study|Progressive disease per RECIST v1.1|22
7865690|NCT03248492|27273871|P3|Overall Study|Progressive disease per RECIST v1.1|9
7865691|NCT03248492|27273872|P2|Overall Study|Progressive disease per RECIST v1.1|12
7865692|NCT03248492|27273873|P1|Overall Study|Progressive disease per RECIST v1.1|16
7865693|NCT03248492|27273869|P5|Overall Study|Ongoing|2
7865694|NCT03248492|27273870|P4|Overall Study|Ongoing|85
7865695|NCT03248492|27273871|P3|Overall Study|Ongoing|3
7865696|NCT03248492|27273872|P2|Overall Study|Ongoing|26
7865697|NCT03248492|27273873|P1|Overall Study|Ongoing|23
7865698|NCT03239483|27273913|P2|Overall Study|Withdrawal by Subject|0
7865699|NCT03239483|27273914|P1|Overall Study|Withdrawal by Subject|1
7865700|NCT03239483|27273913|P2|Overall Study|Lost to Follow-up|0
7865701|NCT03239483|27273914|P1|Overall Study|Lost to Follow-up|1
7865702|NCT03194646|27273972|P4|Overall Study|Missing|12
7865703|NCT03194646|27273973|P3|Overall Study|Missing|1
7865704|NCT03194646|27273974|P2|Overall Study|Missing|0
7865705|NCT03194646|27273975|P1|Overall Study|Missing|4
7865706|NCT03194646|27273972|P4|Overall Study|Withdrawal by Subject|131
7865707|NCT03194646|27273973|P3|Overall Study|Withdrawal by Subject|36
7865708|NCT03194646|27273974|P2|Overall Study|Withdrawal by Subject|75
7865709|NCT03194646|27273975|P1|Overall Study|Withdrawal by Subject|74
7865710|NCT03194646|27273972|P4|Overall Study|Study terminated by sponsor|34
7865711|NCT03194646|27273973|P3|Overall Study|Study terminated by sponsor|30
7865712|NCT03194646|27273974|P2|Overall Study|Study terminated by sponsor|61
7865713|NCT03194646|27273975|P1|Overall Study|Study terminated by sponsor|60
7865714|NCT03194646|27273972|P4|Overall Study|Site terminated by sponsor|0
7865715|NCT03194646|27273973|P3|Overall Study|Site terminated by sponsor|2
7865716|NCT03194646|27273974|P2|Overall Study|Site terminated by sponsor|0
7865717|NCT03194646|27273975|P1|Overall Study|Site terminated by sponsor|0
7865718|NCT03194646|27273972|P4|Overall Study|Protocol Violation|1
7865719|NCT03194646|27273973|P3|Overall Study|Protocol Violation|1
7865720|NCT03194646|27273974|P2|Overall Study|Protocol Violation|2
7865721|NCT03194646|27273975|P1|Overall Study|Protocol Violation|4
7865722|NCT03194646|27273972|P4|Overall Study|Pregnancy|2
7865723|NCT03194646|27273973|P3|Overall Study|Pregnancy|1
7865724|NCT03194646|27273974|P2|Overall Study|Pregnancy|5
7865725|NCT03194646|27273975|P1|Overall Study|Pregnancy|4
7865726|NCT03194646|27273972|P4|Overall Study|Physician Decision|4
7865727|NCT03194646|27273973|P3|Overall Study|Physician Decision|5
7865728|NCT03194646|27273974|P2|Overall Study|Physician Decision|9
7865729|NCT03194646|27273975|P1|Overall Study|Physician Decision|7
7865730|NCT03194646|27273972|P4|Overall Study|Other|31
7865731|NCT03194646|27273973|P3|Overall Study|Other|34
7865732|NCT03194646|27273974|P2|Overall Study|Other|67
7865733|NCT03194646|27273975|P1|Overall Study|Other|87
7865734|NCT03194646|27273972|P4|Overall Study|Non-compliance with study drug|1
7865735|NCT03194646|27273973|P3|Overall Study|Non-compliance with study drug|1
7865736|NCT03194646|27273974|P2|Overall Study|Non-compliance with study drug|0
7865737|NCT03194646|27273975|P1|Overall Study|Non-compliance with study drug|4
7865738|NCT03194646|27273972|P4|Overall Study|Lost to Follow-up|35
7865739|NCT03194646|27273973|P3|Overall Study|Lost to Follow-up|12
7865740|NCT03194646|27273974|P2|Overall Study|Lost to Follow-up|22
7865741|NCT03194646|27273975|P1|Overall Study|Lost to Follow-up|30
7865742|NCT03194646|27273972|P4|Overall Study|Lack of Efficacy|12
7865743|NCT03194646|27273973|P3|Overall Study|Lack of Efficacy|2
7865744|NCT03194646|27273974|P2|Overall Study|Lack of Efficacy|2
7865745|NCT03194646|27273975|P1|Overall Study|Lack of Efficacy|4
7865746|NCT03194646|27273972|P4|Overall Study|Adverse Event|17
7865747|NCT03194646|27273973|P3|Overall Study|Adverse Event|14
7865748|NCT03194646|27273974|P2|Overall Study|Adverse Event|25
7865749|NCT03194646|27273975|P1|Overall Study|Adverse Event|24
7865750|NCT03100149|27274008|P3|Overall Study|Withdrawal by Subject|1
7865751|NCT03100149|27274009|P2|Overall Study|Withdrawal by Subject|3
7865752|NCT03100149|27274010|P1|Overall Study|Withdrawal by Subject|0
7865753|NCT03100149|27274008|P3|Overall Study|Participant Moved out of Country|1
7865754|NCT03100149|27274009|P2|Overall Study|Participant Moved out of Country|0
7865755|NCT03100149|27274010|P1|Overall Study|Participant Moved out of Country|0
7865756|NCT03100149|27274008|P3|Overall Study|Adverse Event|0
7865757|NCT03100149|27274009|P2|Overall Study|Adverse Event|1
7865758|NCT03100149|27274010|P1|Overall Study|Adverse Event|0
7865759|NCT03066778|27274047|P2|Overall Study|Ongoing in Study|37
7865760|NCT03066778|27274048|P1|Overall Study|Ongoing in Study|57
7865761|NCT03066778|27274047|P2|Overall Study|Withdrawal by Subject|5
7865762|NCT03066778|27274048|P1|Overall Study|Withdrawal by Subject|4
7865763|NCT03066778|27274047|P2|Overall Study|Death|183
7865764|NCT03066778|27274048|P1|Overall Study|Death|167
7865765|NCT03006926|27274076|P2|Overall Study|Withdrawal by Subject|2
7865766|NCT03006926|27274077|P1|Overall Study|Withdrawal by Subject|0
7865767|NCT03006926|27274076|P2|Overall Study|Lost to Follow-up|1
7865768|NCT03006926|27274077|P1|Overall Study|Lost to Follow-up|0
7865769|NCT03006926|27274076|P2|Overall Study|Ongoing-on Treatment|36
7865770|NCT03006926|27274077|P1|Overall Study|Ongoing-on Treatment|0
7865771|NCT03006926|27274076|P2|Overall Study|Ongoing Survival Follow-up|26
7865772|NCT03006926|27274077|P1|Overall Study|Ongoing Survival Follow-up|0
7865773|NCT03006926|27274076|P2|Overall Study|Death|33
7865774|NCT03006926|27274077|P1|Overall Study|Death|0
7865775|NCT03006393|27274097|P2|Overall Study|Lost to Follow-up|1
7865776|NCT03006393|27274098|P1|Overall Study|Lost to Follow-up|0
7865777|NCT03006393|27274097|P2|Overall Study|Pregnancy|1
7865778|NCT03006393|27274098|P1|Overall Study|Pregnancy|0
7865779|NCT03006393|27274097|P2|Overall Study|Withdrawal by Subject|1
7865780|NCT03006393|27274098|P1|Overall Study|Withdrawal by Subject|1
7865781|NCT02903914|27274180|P8|Overall Study|Reasoning not specified|0
7865782|NCT02903914|27274181|P7|Overall Study|Reasoning not specified|20
7865783|NCT02903914|27274182|P6|Overall Study|Reasoning not specified|3
7865784|NCT02903914|27274183|P5|Overall Study|Reasoning not specified|3
7865785|NCT02903914|27274184|P4|Overall Study|Reasoning not specified|3
7865786|NCT02903914|27274185|P3|Overall Study|Reasoning not specified|20
7865787|NCT02903914|27274186|P2|Overall Study|Reasoning not specified|3
7865788|NCT02903914|27274187|P1|Overall Study|Reasoning not specified|2
7865789|NCT02903914|27274180|P8|Overall Study|New Cancer Therapy|0
7865790|NCT02903914|27274181|P7|Overall Study|New Cancer Therapy|55
7865791|NCT02903914|27274182|P6|Overall Study|New Cancer Therapy|6
7865792|NCT02903914|27274183|P5|Overall Study|New Cancer Therapy|3
7865793|NCT02903914|27274184|P4|Overall Study|New Cancer Therapy|4
7865794|NCT02903914|27274185|P3|Overall Study|New Cancer Therapy|21
7865795|NCT02903914|27274186|P2|Overall Study|New Cancer Therapy|2
7865796|NCT02903914|27274187|P1|Overall Study|New Cancer Therapy|2
7865797|NCT02903914|27274180|P8|Overall Study|Symptomatic Deterioration|0
7865798|NCT02903914|27274181|P7|Overall Study|Symptomatic Deterioration|0
7865799|NCT02903914|27274182|P6|Overall Study|Symptomatic Deterioration|0
7865800|NCT02903914|27274183|P5|Overall Study|Symptomatic Deterioration|0
7865801|NCT02903914|27274184|P4|Overall Study|Symptomatic Deterioration|0
7865802|NCT02903914|27274185|P3|Overall Study|Symptomatic Deterioration|1
7865803|NCT02903914|27274186|P2|Overall Study|Symptomatic Deterioration|0
7865804|NCT02903914|27274187|P1|Overall Study|Symptomatic Deterioration|0
7865805|NCT02903914|27274180|P8|Overall Study|Physician Decision|0
7865806|NCT02903914|27274181|P7|Overall Study|Physician Decision|1
7865807|NCT02903914|27274182|P6|Overall Study|Physician Decision|0
7865808|NCT02903914|27274183|P5|Overall Study|Physician Decision|0
7865809|NCT02903914|27274184|P4|Overall Study|Physician Decision|0
7865810|NCT02903914|27274185|P3|Overall Study|Physician Decision|1
7865811|NCT02903914|27274186|P2|Overall Study|Physician Decision|0
7865812|NCT02903914|27274187|P1|Overall Study|Physician Decision|0
7865813|NCT02903914|27274180|P8|Overall Study|Lost to Follow-up|0
7865814|NCT02903914|27274181|P7|Overall Study|Lost to Follow-up|1
7865815|NCT02903914|27274182|P6|Overall Study|Lost to Follow-up|0
7865816|NCT02903914|27274183|P5|Overall Study|Lost to Follow-up|2
7865817|NCT02903914|27274184|P4|Overall Study|Lost to Follow-up|0
7865818|NCT02903914|27274185|P3|Overall Study|Lost to Follow-up|0
7865819|NCT02903914|27274186|P2|Overall Study|Lost to Follow-up|1
7865820|NCT02903914|27274187|P1|Overall Study|Lost to Follow-up|0
7865821|NCT02903914|27274180|P8|Overall Study|Death|0
7865822|NCT02903914|27274181|P7|Overall Study|Death|24
7865823|NCT02903914|27274182|P6|Overall Study|Death|3
7865824|NCT02903914|27274183|P5|Overall Study|Death|1
7865825|NCT02903914|27274184|P4|Overall Study|Death|0
7865826|NCT02903914|27274185|P3|Overall Study|Death|9
7865827|NCT02903914|27274186|P2|Overall Study|Death|0
7865828|NCT02903914|27274187|P1|Overall Study|Death|0
7865829|NCT02903914|27274180|P8|Overall Study|Progressive Disease|4
7865830|NCT02903914|27274181|P7|Overall Study|Progressive Disease|2
7865831|NCT02903914|27274182|P6|Overall Study|Progressive Disease|0
7865832|NCT02903914|27274183|P5|Overall Study|Progressive Disease|0
7865833|NCT02903914|27274184|P4|Overall Study|Progressive Disease|0
7865834|NCT02903914|27274185|P3|Overall Study|Progressive Disease|4
7865835|NCT02903914|27274186|P2|Overall Study|Progressive Disease|0
7865836|NCT02903914|27274187|P1|Overall Study|Progressive Disease|1
7865837|NCT02903914|27274180|P8|Overall Study|Withdrawal by Subject|0
7865838|NCT02903914|27274181|P7|Overall Study|Withdrawal by Subject|12
7865839|NCT02903914|27274182|P6|Overall Study|Withdrawal by Subject|1
7865840|NCT02903914|27274183|P5|Overall Study|Withdrawal by Subject|1
7865841|NCT02903914|27274184|P4|Overall Study|Withdrawal by Subject|0
7865842|NCT02903914|27274185|P3|Overall Study|Withdrawal by Subject|28
7865843|NCT02903914|27274186|P2|Overall Study|Withdrawal by Subject|1
7865844|NCT02903914|27274187|P1|Overall Study|Withdrawal by Subject|3
7865845|NCT02903914|27274180|P8|Overall Study|Adverse Event|1
7865846|NCT02903914|27274181|P7|Overall Study|Adverse Event|2
7865847|NCT02903914|27274182|P6|Overall Study|Adverse Event|1
7865848|NCT02903914|27274183|P5|Overall Study|Adverse Event|0
7865849|NCT02903914|27274184|P4|Overall Study|Adverse Event|0
7865850|NCT02903914|27274185|P3|Overall Study|Adverse Event|1
7865851|NCT02903914|27274186|P2|Overall Study|Adverse Event|0
7865852|NCT02903914|27274187|P1|Overall Study|Adverse Event|0
7865853|NCT02852967|27274212|P5|Overall Study|Inclusion/Exclusion Violation|0
7865854|NCT02852967|27274213|P4|Overall Study|Inclusion/Exclusion Violation|0
7865855|NCT02852967|27274214|P3|Overall Study|Inclusion/Exclusion Violation|0
7865856|NCT02852967|27274215|P2|Overall Study|Inclusion/Exclusion Violation|0
7865857|NCT02852967|27274216|P1|Overall Study|Inclusion/Exclusion Violation|1
7865858|NCT02852967|27274212|P5|Overall Study|Dispensing Drug Violation|0
7865859|NCT02852967|27274213|P4|Overall Study|Dispensing Drug Violation|0
7865860|NCT02852967|27274214|P3|Overall Study|Dispensing Drug Violation|1
7865861|NCT02852967|27274215|P2|Overall Study|Dispensing Drug Violation|0
7865862|NCT02852967|27274216|P1|Overall Study|Dispensing Drug Violation|0
7865863|NCT02852967|27274212|P5|Overall Study|Non-compliance|0
7865864|NCT02852967|27274213|P4|Overall Study|Non-compliance|1
7865865|NCT02852967|27274214|P3|Overall Study|Non-compliance|1
7865866|NCT02852967|27274215|P2|Overall Study|Non-compliance|0
7865867|NCT02852967|27274216|P1|Overall Study|Non-compliance|0
7865868|NCT02852967|27274212|P5|Overall Study|Lack of Efficacy|0
7865869|NCT02852967|27274213|P4|Overall Study|Lack of Efficacy|0
7865870|NCT02852967|27274214|P3|Overall Study|Lack of Efficacy|0
7865871|NCT02852967|27274215|P2|Overall Study|Lack of Efficacy|1
7865872|NCT02852967|27274216|P1|Overall Study|Lack of Efficacy|0
7865873|NCT02852967|27274212|P5|Overall Study|Physician Decision|0
7865874|NCT02852967|27274213|P4|Overall Study|Physician Decision|1
7865875|NCT02852967|27274214|P3|Overall Study|Physician Decision|0
7865876|NCT02852967|27274215|P2|Overall Study|Physician Decision|0
7865877|NCT02852967|27274216|P1|Overall Study|Physician Decision|0
7865878|NCT02852967|27274212|P5|Overall Study|Elevated Liver Enzymes|2
7865879|NCT02852967|27274213|P4|Overall Study|Elevated Liver Enzymes|2
7865880|NCT02852967|27274214|P3|Overall Study|Elevated Liver Enzymes|0
7865881|NCT02852967|27274215|P2|Overall Study|Elevated Liver Enzymes|0
7865882|NCT02852967|27274216|P1|Overall Study|Elevated Liver Enzymes|2
7865883|NCT02852967|27274212|P5|Overall Study|SAE|0
7865884|NCT02852967|27274213|P4|Overall Study|SAE|3
7865885|NCT02852967|27274214|P3|Overall Study|SAE|0
7865886|NCT02852967|27274215|P2|Overall Study|SAE|0
7865887|NCT02852967|27274216|P1|Overall Study|SAE|0
7865888|NCT02852967|27274212|P5|Overall Study|Withdrawal by Subject|10
7865889|NCT02852967|27274213|P4|Overall Study|Withdrawal by Subject|10
7865890|NCT02852967|27274214|P3|Overall Study|Withdrawal by Subject|7
7865891|NCT02852967|27274215|P2|Overall Study|Withdrawal by Subject|12
7865892|NCT02852967|27274216|P1|Overall Study|Withdrawal by Subject|6
7865893|NCT02852967|27274212|P5|Overall Study|Lost to Follow-up|4
7865894|NCT02852967|27274213|P4|Overall Study|Lost to Follow-up|4
7865895|NCT02852967|27274214|P3|Overall Study|Lost to Follow-up|3
7865896|NCT02852967|27274215|P2|Overall Study|Lost to Follow-up|2
7865897|NCT02852967|27274216|P1|Overall Study|Lost to Follow-up|1
7865898|NCT02852967|27274212|P5|Overall Study|Death|0
7865899|NCT02852967|27274213|P4|Overall Study|Death|0
7865900|NCT02852967|27274214|P3|Overall Study|Death|0
7865901|NCT02852967|27274215|P2|Overall Study|Death|0
7865902|NCT02852967|27274216|P1|Overall Study|Death|1
7865903|NCT02852967|27274212|P5|Overall Study|Adverse Event|0
7865904|NCT02852967|27274213|P4|Overall Study|Adverse Event|1
7865905|NCT02852967|27274214|P3|Overall Study|Adverse Event|0
7865906|NCT02852967|27274215|P2|Overall Study|Adverse Event|1
7865907|NCT02852967|27274216|P1|Overall Study|Adverse Event|3
7865908|NCT02810951|27274265|P1|Overall Study|Adverse Event|1
7865909|NCT02698189|27274273|P2|Overall Study|Still ongoing in the study|1
7865910|NCT02698189|27274274|P1|Overall Study|Still ongoing in the study|0
7865911|NCT02698189|27274273|P2|Overall Study|Progressive disease|5
7865912|NCT02698189|27274274|P1|Overall Study|Progressive disease|3
7865913|NCT02697734|27274303|P2|Optional Extension Phase|Physician Decision|1
7865914|NCT02697734|27274304|P1|Optional Extension Phase|Physician Decision|0
7865915|NCT02697734|27274303|P2|Optional Extension Phase|Adverse Event|1
7865916|NCT02697734|27274304|P1|Optional Extension Phase|Adverse Event|5
7865917|NCT02697734|27274303|P2|Core Phase - up to Week 48|Physician Decision|0
7865918|NCT02697734|27274304|P1|Core Phase - up to Week 48|Physician Decision|1
7865919|NCT02697734|27274303|P2|Core Phase - up to Week 48|Adverse Event|2
7865920|NCT02697734|27274304|P1|Core Phase - up to Week 48|Adverse Event|1
7865921|NCT02697734|27274303|P2|Core Phase - up to Week 48|Withdrawal by Subject|0
7865922|NCT02697734|27274304|P1|Core Phase - up to Week 48|Withdrawal by Subject|4
7865923|NCT02655016|27274388|P2|Overall Study|Withdrawal by Subject|36
7865924|NCT02655016|27274389|P1|Overall Study|Withdrawal by Subject|18
7865925|NCT02655016|27274388|P2|Overall Study|Lost to Follow-up|1
7865926|NCT02655016|27274389|P1|Overall Study|Lost to Follow-up|1
7865927|NCT02655016|27274388|P2|Overall Study|Death|48
7865928|NCT02655016|27274389|P1|Overall Study|Death|30
7865929|NCT02655016|27274388|P2|Overall Study|Site closed|1
7865930|NCT02655016|27274389|P1|Overall Study|Site closed|0
7865931|NCT02655016|27274388|P2|Overall Study|Disease progression|4
7865932|NCT02655016|27274389|P1|Overall Study|Disease progression|6
7865933|NCT02576990|27274423|P2|Overall Study|Withdrawal by Subject|2
7865934|NCT02576990|27274424|P1|Overall Study|Withdrawal by Subject|0
7865935|NCT02576990|27274423|P2|Overall Study|Sponsor's decision|4
7865936|NCT02576990|27274424|P1|Overall Study|Sponsor's decision|24
7865937|NCT02576990|27274423|P2|Overall Study|Screen failure|0
7865938|NCT02576990|27274424|P1|Overall Study|Screen failure|2
7865939|NCT02576990|27274423|P2|Overall Study|Physician Decision|0
7865940|NCT02576990|27274424|P1|Overall Study|Physician Decision|1
7865941|NCT02576990|27274423|P2|Overall Study|Death|18
7865942|NCT02576990|27274424|P1|Overall Study|Death|29
7865943|NCT02562235|27274450|P1|Overall Study|Adverse Event|3
7865944|NCT02366195|27274542|P1|Overall Study|Death|41
7865945|NCT02366195|27274542|P1|Overall Study|Lost to Follow-up|1
7865946|NCT02366195|27274542|P1|Overall Study|Withdrawal by Subject|9
7865947|NCT02366195|27274542|P1|Overall Study|Protocol-specified criteria|3
7865948|NCT02343549|27274560|P1|Overall Study|Withdrawal by Subject|2
7865949|NCT02343549|27274560|P1|Overall Study|Death|11
7865950|NCT02326883|27274573|P3|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
7865951|NCT02326883|27274574|P2|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
7865952|NCT02326883|27274575|P1|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
7865953|NCT02308124|27274586|P3|Overall Study|Adverse Event|2
7865954|NCT02308124|27274587|P2|Overall Study|Adverse Event|2
7865955|NCT02308124|27274588|P1|Overall Study|Adverse Event|0
7865956|NCT02308124|27274586|P3|Overall Study|Lost to Follow-up|6
7865957|NCT02308124|27274587|P2|Overall Study|Lost to Follow-up|6
7865958|NCT02308124|27274588|P1|Overall Study|Lost to Follow-up|6
7865959|NCT02298023|27274611|P3|Overall Study|Withdrawal by Subject|0
7865960|NCT02298023|27274612|P2|Overall Study|Withdrawal by Subject|0
7865961|NCT02298023|27274613|P1|Overall Study|Withdrawal by Subject|1
7865962|NCT01967888|27274663|P2|Overall Study|Subject Unable To Comply With Final Day|1
7865963|NCT01967888|27274664|P1|Overall Study|Subject Unable To Comply With Final Day|0
7865964|NCT01967888|27274663|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
7865965|NCT01967888|27274664|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
7865966|NCT01967888|27274663|P2|Overall Study|Subject excluded after randomization|0
7865967|NCT01967888|27274664|P1|Overall Study|Subject excluded after randomization|1
7865968|NCT01967888|27274663|P2|Overall Study|Research visit not done, data recorded|0
7865969|NCT01967888|27274664|P1|Overall Study|Research visit not done, data recorded|1
7865970|NCT01967888|27274663|P2|Overall Study|Did Not Have Transplant|0
7865971|NCT01967888|27274664|P1|Overall Study|Did Not Have Transplant|1
7865972|NCT01967888|27274663|P2|Overall Study|Withdrawal by Subject|1
7865973|NCT01967888|27274664|P1|Overall Study|Withdrawal by Subject|1
7865974|NCT01967888|27274663|P2|Overall Study|Lost to Follow-up|4
7865975|NCT01967888|27274664|P1|Overall Study|Lost to Follow-up|6
7865976|NCT01551745|27274745|P1|Overall Study|Disease Progression|2
7865977|NCT01551745|27274745|P1|Overall Study|Withdrawal by Subject|1
7865978|NCT01252953|27274754|P2|Overall Study|Lost to Follow-up|21
7865979|NCT01252953|27274755|P1|Overall Study|Lost to Follow-up|22
7865980|NCT01252953|27274754|P2|Overall Study|Withdrawal by Subject|17
7865981|NCT01252953|27274755|P1|Overall Study|Withdrawal by Subject|16
7865982|NCT01092182|27274770|P3|Overall Study|Participant refused follow-up|0
7865983|NCT01092182|27274771|P2|Overall Study|Participant refused follow-up|2
7865984|NCT01092182|27274772|P1|Overall Study|Participant refused follow-up|0
7865985|NCT01092182|27274770|P3|Overall Study|Non-compliance|0
7865986|NCT01092182|27274771|P2|Overall Study|Non-compliance|3
7865987|NCT01092182|27274772|P1|Overall Study|Non-compliance|0
7865988|NCT01092182|27274770|P3|Overall Study|Did not meet criteria|25
7865989|NCT01092182|27274771|P2|Overall Study|Did not meet criteria|0
7865990|NCT01092182|27274772|P1|Overall Study|Did not meet criteria|0
7865991|NCT01092182|27274770|P3|Overall Study|Physician Decision|0
7865992|NCT01092182|27274771|P2|Overall Study|Physician Decision|6
7865993|NCT01092182|27274772|P1|Overall Study|Physician Decision|0
7865994|NCT01092182|27274770|P3|Overall Study|participant safety|0
7865995|NCT01092182|27274771|P2|Overall Study|participant safety|2
7865996|NCT01092182|27274772|P1|Overall Study|participant safety|1
7865997|NCT01092182|27274770|P3|Overall Study|Death|3
7865998|NCT01092182|27274771|P2|Overall Study|Death|5
7865999|NCT01092182|27274772|P1|Overall Study|Death|0
7866000|NCT00942357|27274794|P2|Overall Study|Ineligible|40
7866001|NCT00942357|27274795|P1|Overall Study|Ineligible|37
7866002|NCT00344487|27274890|P1|Overall Study|immunologic failure|1
7866003|NCT00063999|27274922|P2|Overall Study|Ineligible|24
7866004|NCT00063999|27274923|P1|Overall Study|Ineligible|44
7866005|NCT00063999|27274922|P2|Overall Study|Withdrawal by Subject|0
7866006|NCT00063999|27274923|P1|Overall Study|Withdrawal by Subject|1
7866007|NCT04150068|27275034|P3|Overall Study|Still on study|16
7866008|NCT04150068|27275035|P2|Overall Study|Still on study|12
7866009|NCT04150068|27275036|P1|Overall Study|Still on study|24
7866010|NCT04147715|27275055|P12|Overall Study|Adverse Event|0
7866011|NCT04147715|27275056|P11|Overall Study|Adverse Event|0
7866012|NCT04147715|27275057|P10|Overall Study|Adverse Event|0
7866013|NCT04147715|27275058|P9|Overall Study|Adverse Event|1
7866014|NCT04147715|27275059|P8|Overall Study|Adverse Event|2
7866015|NCT04147715|27275060|P7|Overall Study|Adverse Event|0
7866016|NCT04147715|27275061|P6|Overall Study|Adverse Event|0
7866017|NCT04147715|27275062|P5|Overall Study|Adverse Event|0
7866018|NCT04147715|27275063|P4|Overall Study|Adverse Event|0
7866019|NCT04147715|27275064|P3|Overall Study|Adverse Event|0
7866020|NCT04147715|27275065|P2|Overall Study|Adverse Event|0
7866021|NCT04147715|27275066|P1|Overall Study|Adverse Event|0
7866022|NCT03954834|27275345|P4|Overall Study|Lost to Follow-up|5
7866023|NCT03954834|27275346|P3|Overall Study|Lost to Follow-up|3
7866024|NCT03954834|27275347|P2|Overall Study|Lost to Follow-up|2
7866025|NCT03954834|27275348|P1|Overall Study|Lost to Follow-up|3
7866026|NCT03954834|27275345|P4|Overall Study|Participant left the country|0
7866027|NCT03954834|27275346|P3|Overall Study|Participant left the country|1
7866028|NCT03954834|27275347|P2|Overall Study|Participant left the country|0
7866029|NCT03954834|27275348|P1|Overall Study|Participant left the country|0
7866030|NCT03954834|27275345|P4|Overall Study|Withdrawal by Subject|6
7866031|NCT03954834|27275346|P3|Overall Study|Withdrawal by Subject|13
7866032|NCT03954834|27275347|P2|Overall Study|Withdrawal by Subject|3
7866033|NCT03954834|27275348|P1|Overall Study|Withdrawal by Subject|2
7866034|NCT03954834|27275345|P4|Overall Study|Protocol Violation|1
7866035|NCT03954834|27275346|P3|Overall Study|Protocol Violation|0
7866036|NCT03954834|27275347|P2|Overall Study|Protocol Violation|0
7866037|NCT03954834|27275348|P1|Overall Study|Protocol Violation|1
7866038|NCT03954834|27275345|P4|Overall Study|Physician Decision|2
7866039|NCT03954834|27275346|P3|Overall Study|Physician Decision|0
7866040|NCT03954834|27275347|P2|Overall Study|Physician Decision|1
7866041|NCT03954834|27275348|P1|Overall Study|Physician Decision|0
7866042|NCT03954834|27275345|P4|Overall Study|Death|1
7866043|NCT03954834|27275346|P3|Overall Study|Death|0
7866044|NCT03954834|27275347|P2|Overall Study|Death|0
7866045|NCT03954834|27275348|P1|Overall Study|Death|0
7866046|NCT03954834|27275345|P4|Overall Study|Adverse Event|1
7866047|NCT03954834|27275346|P3|Overall Study|Adverse Event|1
7866048|NCT03954834|27275347|P2|Overall Study|Adverse Event|3
7866049|NCT03954834|27275348|P1|Overall Study|Adverse Event|1
7866050|NCT03875092|27275391|P2|Overall Study|Ongoing in Study|14
7866051|NCT03875092|27275392|P1|Overall Study|Ongoing in Study|35
7866052|NCT03875092|27275391|P2|Overall Study|Death|41
7866053|NCT03875092|27275392|P1|Overall Study|Death|28
7866054|NCT03875092|27275391|P2|Overall Study|Adverse Event|5
7866055|NCT03875092|27275392|P1|Overall Study|Adverse Event|2
7866056|NCT03862625|27275410|P2|Overall Study|Lost to Follow-up|1
7866057|NCT03862625|27275411|P1|Overall Study|Lost to Follow-up|0
7866058|NCT03721276|27275441|P2|Overall Study|Adverse Event|1
7866059|NCT03721276|27275442|P1|Overall Study|Adverse Event|0
7866060|NCT03721276|27275441|P2|Overall Study|Lost to Follow-up|3
7866061|NCT03721276|27275442|P1|Overall Study|Lost to Follow-up|5
7866077|NCT03595280|27275569|P3|Overall Study|Lost to Follow-up|15
7866078|NCT03595280|27275570|P2|Overall Study|Lost to Follow-up|9
7866079|NCT03595280|27275571|P1|Overall Study|Lost to Follow-up|6
7866080|NCT03500419|27275599|P2|Overall Study|Withdrawal by Subject|25
7866081|NCT03500419|27275600|P1|Overall Study|Withdrawal by Subject|2
7866082|NCT03029208|27275660|P2|Overall Study|Lost to Follow-up|1
7866083|NCT03029208|27275661|P1|Overall Study|Lost to Follow-up|0
7866084|NCT03029208|27275660|P2|Overall Study|Withdrawal by Subject|3
7866085|NCT03029208|27275661|P1|Overall Study|Withdrawal by Subject|2
7866086|NCT02948959|27275768|P2|12 Weeks Follow-up Period|Study site closure|0
7866087|NCT02948959|27275769|P1|12 Weeks Follow-up Period|Study site closure|1
7866088|NCT02948959|27275768|P2|12 Weeks Follow-up Period|Change of residence location|2
7866089|NCT02948959|27275769|P1|12 Weeks Follow-up Period|Change of residence location|0
7866090|NCT02948959|27275768|P2|12 Weeks Follow-up Period|Randomized by error|3
7866091|NCT02948959|27275769|P1|12 Weeks Follow-up Period|Randomized by error|0
7866092|NCT02948959|27275768|P2|12 Weeks Follow-up Period|Withdrawal by Subject|3
7866093|NCT02948959|27275769|P1|12 Weeks Follow-up Period|Withdrawal by Subject|3
7866094|NCT02948959|27275768|P2|12 Weeks Follow-up Period|Poor compliance to protocol|2
7866095|NCT02948959|27275769|P1|12 Weeks Follow-up Period|Poor compliance to protocol|1
7866096|NCT02948959|27275768|P2|12 Weeks Follow-up Period|Adverse Event|2
7866097|NCT02948959|27275769|P1|12 Weeks Follow-up Period|Adverse Event|0
7866098|NCT02948959|27275768|P2|52 Weeks Treatment Period|Change of residence location|1
7866099|NCT02948959|27275769|P1|52 Weeks Treatment Period|Change of residence location|0
7866100|NCT02948959|27275768|P2|52 Weeks Treatment Period|Non-compliant to study treatment|1
7866101|NCT02948959|27275769|P1|52 Weeks Treatment Period|Non-compliant to study treatment|0
7866102|NCT02948959|27275768|P2|52 Weeks Treatment Period|Randomized and not treated|3
7866103|NCT02948959|27275769|P1|52 Weeks Treatment Period|Randomized and not treated|0
7866104|NCT02948959|27275768|P2|52 Weeks Treatment Period|Randomized by error|5
7866105|NCT02948959|27275769|P1|52 Weeks Treatment Period|Randomized by error|0
7866106|NCT02948959|27275768|P2|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
7866107|NCT02948959|27275769|P1|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
7866108|NCT02948959|27275768|P2|52 Weeks Treatment Period|Withdrawal by Subject|2
7866109|NCT02948959|27275769|P1|52 Weeks Treatment Period|Withdrawal by Subject|2
7866110|NCT02948959|27275768|P2|52 Weeks Treatment Period|Adverse Event|5
7866111|NCT02948959|27275769|P1|52 Weeks Treatment Period|Adverse Event|2
7866112|NCT02948959|27275768|P2|52 Weeks Treatment Period|Poor compliance to protocol|2
7866113|NCT02948959|27275769|P1|52 Weeks Treatment Period|Poor compliance to protocol|0
7866114|NCT02895945|27275889|P2|Overall Study|Physician Decision|1
7866115|NCT02895945|27275890|P1|Overall Study|Physician Decision|2
7866116|NCT02557139|27275943|P3|Overall Study|Illness of prohibited medication|1
7866117|NCT02557139|27275944|P2|Overall Study|Illness of prohibited medication|0
7866118|NCT02557139|27275945|P1|Overall Study|Illness of prohibited medication|0
7866119|NCT02557139|27275943|P3|Overall Study|Withdrawal by Subject|0
7866120|NCT02557139|27275944|P2|Overall Study|Withdrawal by Subject|0
7866121|NCT02557139|27275945|P1|Overall Study|Withdrawal by Subject|1
7866122|NCT02557139|27275943|P3|Overall Study|Significant liver elevation|1
7866123|NCT02557139|27275944|P2|Overall Study|Significant liver elevation|0
7866124|NCT02557139|27275945|P1|Overall Study|Significant liver elevation|1
7866125|NCT02511106|27275972|P2|Overall Study|Missing|0
7866126|NCT02511106|27275973|P1|Overall Study|Missing|1
7866127|NCT02511106|27275972|P2|Overall Study|Without specified reason|0
7866128|NCT02511106|27275973|P1|Overall Study|Without specified reason|1
7866129|NCT02511106|27275972|P2|Overall Study|Ongoing study at data cut-off|307
7866130|NCT02511106|27275973|P1|Overall Study|Ongoing study at data cut-off|309
7866131|NCT02511106|27275972|P2|Overall Study|Withdrawal by Subject|14
7866132|NCT02511106|27275973|P1|Overall Study|Withdrawal by Subject|19
7866133|NCT02511106|27275972|P2|Overall Study|Lost to Follow-up|2
7866134|NCT02511106|27275973|P1|Overall Study|Lost to Follow-up|1
7866135|NCT02015819|27276053|P4|Overall Study|Rickham catheter was misaligned|1
7866136|NCT02015819|27276054|P3|Overall Study|Rickham catheter was misaligned|0
7866137|NCT02015819|27276055|P2|Overall Study|Rickham catheter was misaligned|0
7866138|NCT02015819|27276056|P1|Overall Study|Rickham catheter was misaligned|0
7866139|NCT01809132|27276090|P3|Overall Study|Withdrawal by Subject|1
7866140|NCT01809132|27276091|P2|Overall Study|Withdrawal by Subject|0
7866141|NCT01809132|27276092|P1|Overall Study|Withdrawal by Subject|0
7866142|NCT01665144|27276119|P2|Overall Study|Withdrawal by Subject|77
7866143|NCT01665144|27276120|P1|Overall Study|Withdrawal by Subject|96
7866144|NCT01665144|27276119|P2|Overall Study|Adverse Event|18
7866145|NCT01665144|27276120|P1|Overall Study|Adverse Event|45
7866146|NCT01665144|27276119|P2|Overall Study|Lack of Efficacy|11
7866147|NCT01665144|27276120|P1|Overall Study|Lack of Efficacy|16
7866148|NCT01665144|27276119|P2|Overall Study|Physician Decision|1
7866149|NCT01665144|27276120|P1|Overall Study|Physician Decision|13
7866150|NCT01665144|27276119|P2|Overall Study|Lost to Follow-up|8
7866151|NCT01665144|27276120|P1|Overall Study|Lost to Follow-up|9
7866152|NCT01665144|27276119|P2|Overall Study|Progressive disease|4
7866153|NCT01665144|27276120|P1|Overall Study|Progressive disease|8
7866154|NCT01665144|27276119|P2|Overall Study|Non-compliance w/study treatment|0
7866155|NCT01665144|27276120|P1|Overall Study|Non-compliance w/study treatment|5
7866156|NCT01665144|27276119|P2|Overall Study|Protocol deviation|1
7866157|NCT01665144|27276120|P1|Overall Study|Protocol deviation|3
7866158|NCT01665144|27276119|P2|Overall Study|Death|1
7866159|NCT01665144|27276120|P1|Overall Study|Death|3
7866160|NCT01665144|27276119|P2|Overall Study|Technical problems|0
7866161|NCT01665144|27276120|P1|Overall Study|Technical problems|2
7866162|NCT01665144|27276119|P2|Overall Study|New therapy for study indication|1
7866163|NCT01665144|27276120|P1|Overall Study|New therapy for study indication|2
7866164|NCT01535053|27276128|P2|Overall Study|Ineligible|2
7866165|NCT01535053|27276129|P1|Overall Study|Ineligible|1
7866166|NCT01466270|27276147|P2|Overall Study|Multiple|1
7866167|NCT01466270|27276148|P1|Overall Study|Multiple|1
7866168|NCT01466270|27276147|P2|Overall Study|Toxicity|1
7866169|NCT01466270|27276148|P1|Overall Study|Toxicity|4
7866170|NCT01466270|27276147|P2|Overall Study|Progression|0
7866171|NCT01466270|27276148|P1|Overall Study|Progression|1
7866172|NCT01466270|27276147|P2|Overall Study|Lost to Follow-up|3
7866173|NCT01466270|27276148|P1|Overall Study|Lost to Follow-up|1
7866174|NCT01466270|27276147|P2|Overall Study|Physician Decision|0
7866175|NCT01466270|27276148|P1|Overall Study|Physician Decision|1
7866176|NCT01466270|27276147|P2|Overall Study|Withdrawal by Subject|1
7866177|NCT01466270|27276148|P1|Overall Study|Withdrawal by Subject|4
7866178|NCT01435018|27276163|P3|Overall Study|Never started chemotherapy|1
7866179|NCT01435018|27276164|P2|Overall Study|Never started chemotherapy|0
7866180|NCT01435018|27276165|P1|Overall Study|Never started chemotherapy|3
7866181|NCT01435018|27276163|P3|Overall Study|Enrollment Violation|0
7866182|NCT01435018|27276164|P2|Overall Study|Enrollment Violation|1
7866183|NCT01435018|27276165|P1|Overall Study|Enrollment Violation|0
7866184|NCT01435018|27276163|P3|Overall Study|Unable to contact participant/parent|1
7866185|NCT01435018|27276164|P2|Overall Study|Unable to contact participant/parent|1
7866186|NCT01435018|27276165|P1|Overall Study|Unable to contact participant/parent|1
7866187|NCT01435018|27276163|P3|Overall Study|Severe debilitation, unable to continue|1
7866188|NCT01435018|27276164|P2|Overall Study|Severe debilitation, unable to continue|0
7866189|NCT01435018|27276165|P1|Overall Study|Severe debilitation, unable to continue|0
7866190|NCT01435018|27276163|P3|Overall Study|Not able to get to clinic|2
7866191|NCT01435018|27276164|P2|Overall Study|Not able to get to clinic|0
7866192|NCT01435018|27276165|P1|Overall Study|Not able to get to clinic|2
7866193|NCT01435018|27276163|P3|Overall Study|Not willing to adhere to requirements|3
7866194|NCT01435018|27276164|P2|Overall Study|Not willing to adhere to requirements|2
7866195|NCT01435018|27276165|P1|Overall Study|Not willing to adhere to requirements|0
7866196|NCT01435018|27276163|P3|Overall Study|Withdrew consent|1
7866197|NCT01435018|27276164|P2|Overall Study|Withdrew consent|3
7866198|NCT01435018|27276165|P1|Overall Study|Withdrew consent|0
7866199|NCT01435018|27276163|P3|Overall Study|Site is closing|7
7866200|NCT01435018|27276164|P2|Overall Study|Site is closing|9
7866201|NCT01435018|27276165|P1|Overall Study|Site is closing|4
7866202|NCT01435018|27276163|P3|Overall Study|Death|25
7866203|NCT01435018|27276164|P2|Overall Study|Death|18
7866204|NCT01435018|27276165|P1|Overall Study|Death|37
7866205|NCT01332968|27276258|P8|Follow-Up Period|Lost to Follow-up|2
7866206|NCT01332968|27276259|P7|Follow-Up Period|Lost to Follow-up|1
7866207|NCT01332968|27276260|P6|Follow-Up Period|Lost to Follow-up|0
7866208|NCT01332968|27276261|P5|Follow-Up Period|Lost to Follow-up|0
7866209|NCT01332968|27276262|P4|Follow-Up Period|Lost to Follow-up|0
7866210|NCT01332968|27276263|P3|Follow-Up Period|Lost to Follow-up|0
7866211|NCT01332968|27276264|P2|Follow-Up Period|Lost to Follow-up|0
7866212|NCT01332968|27276265|P1|Follow-Up Period|Lost to Follow-up|0
7866213|NCT01332968|27276258|P8|Follow-Up Period|Withdrawal by Subject|2
7866214|NCT01332968|27276259|P7|Follow-Up Period|Withdrawal by Subject|1
7866215|NCT01332968|27276260|P6|Follow-Up Period|Withdrawal by Subject|0
7866216|NCT01332968|27276261|P5|Follow-Up Period|Withdrawal by Subject|0
7866217|NCT01332968|27276262|P4|Follow-Up Period|Withdrawal by Subject|0
7866218|NCT01332968|27276263|P3|Follow-Up Period|Withdrawal by Subject|0
7866219|NCT01332968|27276264|P2|Follow-Up Period|Withdrawal by Subject|0
7866220|NCT01332968|27276265|P1|Follow-Up Period|Withdrawal by Subject|0
7866221|NCT01332968|27276258|P8|Follow-Up Period|Follow-up ongoing|505
7866222|NCT01332968|27276259|P7|Follow-Up Period|Follow-up ongoing|502
7866223|NCT01332968|27276260|P6|Follow-Up Period|Follow-up ongoing|0
7866224|NCT01332968|27276261|P5|Follow-Up Period|Follow-up ongoing|0
7866225|NCT01332968|27276262|P4|Follow-Up Period|Follow-up ongoing|0
7866226|NCT01332968|27276263|P3|Follow-Up Period|Follow-up ongoing|0
7866227|NCT01332968|27276264|P2|Follow-Up Period|Follow-up ongoing|0
7866228|NCT01332968|27276265|P1|Follow-Up Period|Follow-up ongoing|0
7866229|NCT01332968|27276258|P8|Follow-Up Period|Death|22
7866230|NCT01332968|27276259|P7|Follow-Up Period|Death|38
7866231|NCT01332968|27276260|P6|Follow-Up Period|Death|0
7866232|NCT01332968|27276261|P5|Follow-Up Period|Death|0
7866233|NCT01332968|27276262|P4|Follow-Up Period|Death|0
7866234|NCT01332968|27276263|P3|Follow-Up Period|Death|0
7866235|NCT01332968|27276264|P2|Follow-Up Period|Death|0
7866236|NCT01332968|27276265|P1|Follow-Up Period|Death|0
7866237|NCT01332968|27276258|P8|Maintenance/Observation Period|Treatment ongoing|0
7866238|NCT01332968|27276259|P7|Maintenance/Observation Period|Treatment ongoing|0
7866239|NCT01332968|27276260|P6|Maintenance/Observation Period|Treatment ongoing|8
7866240|NCT01332968|27276261|P5|Maintenance/Observation Period|Treatment ongoing|10
7866241|NCT01332968|27276262|P4|Maintenance/Observation Period|Treatment ongoing|62
7866242|NCT01332968|27276263|P3|Maintenance/Observation Period|Treatment ongoing|54
7866243|NCT01332968|27276264|P2|Maintenance/Observation Period|Treatment ongoing|0
7866244|NCT01332968|27276265|P1|Maintenance/Observation Period|Treatment ongoing|0
7866245|NCT01332968|27276258|P8|Maintenance/Observation Period|Adverse Event|0
7866246|NCT01332968|27276259|P7|Maintenance/Observation Period|Adverse Event|0
7866247|NCT01332968|27276260|P6|Maintenance/Observation Period|Adverse Event|0
7866248|NCT01332968|27276261|P5|Maintenance/Observation Period|Adverse Event|0
7866249|NCT01332968|27276262|P4|Maintenance/Observation Period|Adverse Event|65
7866250|NCT01332968|27276263|P3|Maintenance/Observation Period|Adverse Event|50
7866251|NCT01332968|27276264|P2|Maintenance/Observation Period|Adverse Event|0
7866252|NCT01332968|27276265|P1|Maintenance/Observation Period|Adverse Event|0
7866253|NCT01332968|27276258|P8|Maintenance/Observation Period|Death|0
7866254|NCT01332968|27276259|P7|Maintenance/Observation Period|Death|0
7866255|NCT01332968|27276260|P6|Maintenance/Observation Period|Death|0
7866256|NCT01332968|27276261|P5|Maintenance/Observation Period|Death|0
7866257|NCT01332968|27276262|P4|Maintenance/Observation Period|Death|6
7866258|NCT01332968|27276263|P3|Maintenance/Observation Period|Death|5
7866259|NCT01332968|27276264|P2|Maintenance/Observation Period|Death|0
7866260|NCT01332968|27276265|P1|Maintenance/Observation Period|Death|0
7866261|NCT01332968|27276258|P8|Maintenance/Observation Period|Lost to Follow-up|0
7866262|NCT01332968|27276259|P7|Maintenance/Observation Period|Lost to Follow-up|0
7866263|NCT01332968|27276260|P6|Maintenance/Observation Period|Lost to Follow-up|0
7866264|NCT01332968|27276261|P5|Maintenance/Observation Period|Lost to Follow-up|0
7866265|NCT01332968|27276262|P4|Maintenance/Observation Period|Lost to Follow-up|2
7866266|NCT01332968|27276263|P3|Maintenance/Observation Period|Lost to Follow-up|1
7866267|NCT01332968|27276264|P2|Maintenance/Observation Period|Lost to Follow-up|0
7866268|NCT01332968|27276265|P1|Maintenance/Observation Period|Lost to Follow-up|0
7866269|NCT01332968|27276258|P8|Maintenance/Observation Period|Non-compliance|0
7866270|NCT01332968|27276259|P7|Maintenance/Observation Period|Non-compliance|0
7866271|NCT01332968|27276260|P6|Maintenance/Observation Period|Non-compliance|1
7866272|NCT01332968|27276261|P5|Maintenance/Observation Period|Non-compliance|0
7866273|NCT01332968|27276262|P4|Maintenance/Observation Period|Non-compliance|3
7866274|NCT01332968|27276263|P3|Maintenance/Observation Period|Non-compliance|2
7866275|NCT01332968|27276264|P2|Maintenance/Observation Period|Non-compliance|0
7866276|NCT01332968|27276265|P1|Maintenance/Observation Period|Non-compliance|0
7866277|NCT01332968|27276258|P8|Maintenance/Observation Period|Other|0
7866278|NCT01332968|27276259|P7|Maintenance/Observation Period|Other|0
7866279|NCT01332968|27276260|P6|Maintenance/Observation Period|Other|0
7866280|NCT01332968|27276261|P5|Maintenance/Observation Period|Other|0
7866281|NCT01332968|27276262|P4|Maintenance/Observation Period|Other|5
7866282|NCT01332968|27276263|P3|Maintenance/Observation Period|Other|4
7866283|NCT01332968|27276264|P2|Maintenance/Observation Period|Other|0
7866284|NCT01332968|27276265|P1|Maintenance/Observation Period|Other|0
7866285|NCT01332968|27276258|P8|Maintenance/Observation Period|Physician Decision|0
7866286|NCT01332968|27276259|P7|Maintenance/Observation Period|Physician Decision|0
7866287|NCT01332968|27276260|P6|Maintenance/Observation Period|Physician Decision|0
7866288|NCT01332968|27276261|P5|Maintenance/Observation Period|Physician Decision|0
7866289|NCT01332968|27276262|P4|Maintenance/Observation Period|Physician Decision|19
7866290|NCT01332968|27276263|P3|Maintenance/Observation Period|Physician Decision|14
7866291|NCT01332968|27276264|P2|Maintenance/Observation Period|Physician Decision|0
7866292|NCT01332968|27276265|P1|Maintenance/Observation Period|Physician Decision|0
7866293|NCT01332968|27276258|P8|Maintenance/Observation Period|Progressive disease|0
7866294|NCT01332968|27276259|P7|Maintenance/Observation Period|Progressive disease|0
7866295|NCT01332968|27276260|P6|Maintenance/Observation Period|Progressive disease|0
7866296|NCT01332968|27276261|P5|Maintenance/Observation Period|Progressive disease|0
7866297|NCT01332968|27276262|P4|Maintenance/Observation Period|Progressive disease|39
7866298|NCT01332968|27276263|P3|Maintenance/Observation Period|Progressive disease|72
7866299|NCT01332968|27276264|P2|Maintenance/Observation Period|Progressive disease|0
7866300|NCT01332968|27276265|P1|Maintenance/Observation Period|Progressive disease|0
7866301|NCT01332968|27276258|P8|Maintenance/Observation Period|Protocol Violation|0
7866302|NCT01332968|27276259|P7|Maintenance/Observation Period|Protocol Violation|0
7866303|NCT01332968|27276260|P6|Maintenance/Observation Period|Protocol Violation|0
7866304|NCT01332968|27276261|P5|Maintenance/Observation Period|Protocol Violation|0
7866305|NCT01332968|27276262|P4|Maintenance/Observation Period|Protocol Violation|1
7866306|NCT01332968|27276263|P3|Maintenance/Observation Period|Protocol Violation|1
7866307|NCT01332968|27276264|P2|Maintenance/Observation Period|Protocol Violation|0
7866308|NCT01332968|27276265|P1|Maintenance/Observation Period|Protocol Violation|0
7866309|NCT01332968|27276258|P8|Maintenance/Observation Period|Withdrawal by Subject|0
7866310|NCT01332968|27276259|P7|Maintenance/Observation Period|Withdrawal by Subject|0
7866311|NCT01332968|27276260|P6|Maintenance/Observation Period|Withdrawal by Subject|0
7866312|NCT01332968|27276261|P5|Maintenance/Observation Period|Withdrawal by Subject|0
7866313|NCT01332968|27276262|P4|Maintenance/Observation Period|Withdrawal by Subject|5
7866314|NCT01332968|27276263|P3|Maintenance/Observation Period|Withdrawal by Subject|10
7866315|NCT01332968|27276264|P2|Maintenance/Observation Period|Withdrawal by Subject|0
7866316|NCT01332968|27276265|P1|Maintenance/Observation Period|Withdrawal by Subject|0
7866317|NCT01332968|27276258|P8|Induction Period|Randomized, but not treated|0
7866318|NCT01332968|27276259|P7|Induction Period|Randomized, but not treated|0
7866319|NCT01332968|27276260|P6|Induction Period|Randomized, but not treated|0
7866320|NCT01332968|27276261|P5|Induction Period|Randomized, but not treated|0
7866321|NCT01332968|27276262|P4|Induction Period|Randomized, but not treated|0
7866322|NCT01332968|27276263|P3|Induction Period|Randomized, but not treated|0
7866323|NCT01332968|27276264|P2|Induction Period|Randomized, but not treated|7
7866324|NCT01332968|27276265|P1|Induction Period|Randomized, but not treated|4
7866325|NCT01332968|27276258|P8|Induction Period|Adverse Event|0
7866326|NCT01332968|27276259|P7|Induction Period|Adverse Event|0
7866327|NCT01332968|27276260|P6|Induction Period|Adverse Event|0
7866328|NCT01332968|27276261|P5|Induction Period|Adverse Event|0
7866329|NCT01332968|27276262|P4|Induction Period|Adverse Event|0
7866330|NCT01332968|27276263|P3|Induction Period|Adverse Event|0
7866331|NCT01332968|27276264|P2|Induction Period|Adverse Event|26
7866332|NCT01332968|27276265|P1|Induction Period|Adverse Event|23
7866333|NCT01332968|27276258|P8|Induction Period|Death|0
7866334|NCT01332968|27276259|P7|Induction Period|Death|0
7866335|NCT01332968|27276260|P6|Induction Period|Death|0
7866336|NCT01332968|27276261|P5|Induction Period|Death|0
7866337|NCT01332968|27276262|P4|Induction Period|Death|0
7866338|NCT01332968|27276263|P3|Induction Period|Death|0
7866339|NCT01332968|27276264|P2|Induction Period|Death|4
7866340|NCT01332968|27276265|P1|Induction Period|Death|1
7866341|NCT01332968|27276258|P8|Induction Period|Non-compliance|0
7866342|NCT01332968|27276259|P7|Induction Period|Non-compliance|0
7866343|NCT01332968|27276260|P6|Induction Period|Non-compliance|0
7866344|NCT01332968|27276261|P5|Induction Period|Non-compliance|0
7866345|NCT01332968|27276262|P4|Induction Period|Non-compliance|0
7866346|NCT01332968|27276263|P3|Induction Period|Non-compliance|0
7866347|NCT01332968|27276264|P2|Induction Period|Non-compliance|0
7866348|NCT01332968|27276265|P1|Induction Period|Non-compliance|1
7866349|NCT01332968|27276258|P8|Induction Period|Other|0
7866350|NCT01332968|27276259|P7|Induction Period|Other|0
7866351|NCT01332968|27276260|P6|Induction Period|Other|0
7866352|NCT01332968|27276261|P5|Induction Period|Other|0
7866353|NCT01332968|27276262|P4|Induction Period|Other|0
7866354|NCT01332968|27276263|P3|Induction Period|Other|0
7866355|NCT01332968|27276264|P2|Induction Period|Other|2
7866356|NCT01332968|27276265|P1|Induction Period|Other|2
7866357|NCT01332968|27276258|P8|Induction Period|Physician Decision|0
7866358|NCT01332968|27276259|P7|Induction Period|Physician Decision|0
7866359|NCT01332968|27276260|P6|Induction Period|Physician Decision|0
7866360|NCT01332968|27276261|P5|Induction Period|Physician Decision|0
7866361|NCT01332968|27276262|P4|Induction Period|Physician Decision|0
7866362|NCT01332968|27276263|P3|Induction Period|Physician Decision|0
7866363|NCT01332968|27276264|P2|Induction Period|Physician Decision|1
7866364|NCT01332968|27276265|P1|Induction Period|Physician Decision|6
7866365|NCT01332968|27276258|P8|Induction Period|Progressive disease|0
7866366|NCT01332968|27276259|P7|Induction Period|Progressive disease|0
7866367|NCT01332968|27276260|P6|Induction Period|Progressive disease|0
7866368|NCT01332968|27276261|P5|Induction Period|Progressive disease|0
7866369|NCT01332968|27276262|P4|Induction Period|Progressive disease|0
7866370|NCT01332968|27276263|P3|Induction Period|Progressive disease|0
7866371|NCT01332968|27276264|P2|Induction Period|Progressive disease|7
7866372|NCT01332968|27276265|P1|Induction Period|Progressive disease|15
7866373|NCT01332968|27276258|P8|Induction Period|Protocol Violation|0
7866374|NCT01332968|27276259|P7|Induction Period|Protocol Violation|0
7866375|NCT01332968|27276260|P6|Induction Period|Protocol Violation|0
7866376|NCT01332968|27276261|P5|Induction Period|Protocol Violation|0
7866377|NCT01332968|27276262|P4|Induction Period|Protocol Violation|0
7866378|NCT01332968|27276263|P3|Induction Period|Protocol Violation|0
7866379|NCT01332968|27276264|P2|Induction Period|Protocol Violation|4
7866380|NCT01332968|27276265|P1|Induction Period|Protocol Violation|3
7866381|NCT01332968|27276258|P8|Induction Period|Withdrawal by Subject|0
7866382|NCT01332968|27276259|P7|Induction Period|Withdrawal by Subject|0
7866383|NCT01332968|27276260|P6|Induction Period|Withdrawal by Subject|0
7866384|NCT01332968|27276261|P5|Induction Period|Withdrawal by Subject|0
7866385|NCT01332968|27276262|P4|Induction Period|Withdrawal by Subject|0
7866386|NCT01332968|27276263|P3|Induction Period|Withdrawal by Subject|0
7866387|NCT01332968|27276264|P2|Induction Period|Withdrawal by Subject|5
7866388|NCT01332968|27276265|P1|Induction Period|Withdrawal by Subject|3
7866389|NCT01239797|27276331|P2|Treated Participants|Poor/Non-compliance|1
7866390|NCT01239797|27276332|P1|Treated Participants|Poor/Non-compliance|0
7866391|NCT01239797|27276331|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
7866392|NCT01239797|27276332|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
7866393|NCT01239797|27276331|P2|Treated Participants|Death|1
7866394|NCT01239797|27276332|P1|Treated Participants|Death|1
7866395|NCT01239797|27276331|P2|Treated Participants|Non-specified|11
7866396|NCT01239797|27276332|P1|Treated Participants|Non-specified|1
7866397|NCT01239797|27276331|P2|Treated Participants|Withdrawal by Subject|23
7866398|NCT01239797|27276332|P1|Treated Participants|Withdrawal by Subject|27
7866399|NCT01239797|27276331|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
7866400|NCT01239797|27276332|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
7866401|NCT01239797|27276331|P2|Treated Participants|Study Drug Toxicity|44
7866402|NCT01239797|27276332|P1|Treated Participants|Study Drug Toxicity|30
7866403|NCT01239797|27276331|P2|Treated Participants|Disease Progression|161
7866404|NCT01239797|27276332|P1|Treated Participants|Disease Progression|153
7866405|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
7866406|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7866407|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7866408|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7866409|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7866410|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7866411|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
7866412|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7866413|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7866414|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7866415|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7866416|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
7866417|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7866418|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7866419|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7866420|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
7866421|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7866422|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7866423|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7866424|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7866425|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7866426|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7866427|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
7866428|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
7866429|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7866430|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
7866431|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7866432|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
7866433|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7866434|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7866435|NCT01111539|27276340|P5|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7866436|NCT01111539|27276341|P4|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7866437|NCT01111539|27276342|P3|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7866438|NCT01111539|27276343|P2|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7866439|NCT01111539|27276344|P1|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7866440|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7866441|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7866442|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7866443|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7866444|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
7866445|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7866446|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7866447|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7866448|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7866449|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Protocol Deviation|2
7866450|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7866451|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7866452|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7866453|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7866454|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
7866455|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7866456|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7866457|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7866458|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7866459|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
7866460|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7866461|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7866462|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7866463|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7866464|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
7866465|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Adverse Event|0
7866466|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Adverse Event|0
7866467|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Adverse Event|0
7866468|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Adverse Event|0
7866469|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Adverse Event|5
7866470|NCT01111539|27276340|P5|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7866471|NCT01111539|27276341|P4|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7866472|NCT01111539|27276342|P3|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7866473|NCT01111539|27276343|P2|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7866474|NCT01111539|27276344|P1|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
7866475|NCT01001910|27276419|P1|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
7866476|NCT00994279|27276428|P2|Overall Study|Multiple reasons|3
7866477|NCT00994279|27276429|P1|Overall Study|Multiple reasons|1
7866478|NCT00994279|27276428|P2|Overall Study|Toxicity|0
7866479|NCT00994279|27276429|P1|Overall Study|Toxicity|1
7866480|NCT00994279|27276428|P2|Overall Study|Withdrawal by Subject|2
7866481|NCT00994279|27276429|P1|Overall Study|Withdrawal by Subject|2
7866482|NCT00888615|27276441|P1|Overall Study|No treatment|2
7866483|NCT00695786|27276467|P4|Overall Study|Lack of Efficacy|4
7866484|NCT00695786|27276468|P3|Overall Study|Lack of Efficacy|0
7866485|NCT00695786|27276469|P2|Overall Study|Lack of Efficacy|0
7866486|NCT00695786|27276470|P1|Overall Study|Lack of Efficacy|0
7866487|NCT00695786|27276467|P4|Overall Study|Deemed Ineligible|0
7866488|NCT00695786|27276468|P3|Overall Study|Deemed Ineligible|0
7866489|NCT00695786|27276469|P2|Overall Study|Deemed Ineligible|0
7866490|NCT00695786|27276470|P1|Overall Study|Deemed Ineligible|1
7866491|NCT00695786|27276467|P4|Overall Study|Withdrawal by Subject|1
7866492|NCT00695786|27276468|P3|Overall Study|Withdrawal by Subject|3
7866493|NCT00695786|27276469|P2|Overall Study|Withdrawal by Subject|4
7866494|NCT00695786|27276470|P1|Overall Study|Withdrawal by Subject|0
7866495|NCT00695786|27276467|P4|Overall Study|Lost to Follow-up|1
7866496|NCT00695786|27276468|P3|Overall Study|Lost to Follow-up|1
7866497|NCT00695786|27276469|P2|Overall Study|Lost to Follow-up|5
7866498|NCT00695786|27276470|P1|Overall Study|Lost to Follow-up|0
7866499|NCT00695786|27276467|P4|Overall Study|Adverse Event|2
7866500|NCT00695786|27276468|P3|Overall Study|Adverse Event|4
7866501|NCT00695786|27276469|P2|Overall Study|Adverse Event|3
7866502|NCT00695786|27276470|P1|Overall Study|Adverse Event|0
7866503|NCT00674817|27276480|P1|Period 4|Adverse Event|1
7866504|NCT00674817|27276480|P1|Period 3|Protocol Violation|1
7866505|NCT00674817|27276480|P1|Period 3|Adverse Event|1
7866506|NCT00674817|27276480|P1|Period 1|Protocol Violation|1
7866507|NCT00674817|27276480|P1|Period 1|Withdrawal by Subject|2
7866508|NCT00369785|27276628|P2|Overall Study|Multiple reasons|5
7866509|NCT00369785|27276629|P1|Overall Study|Multiple reasons|6
7866510|NCT00369785|27276628|P2|Overall Study|Progression|4
7866511|NCT00369785|27276629|P1|Overall Study|Progression|4
7866512|NCT00369785|27276628|P2|Overall Study|Never started|2
7866513|NCT00369785|27276629|P1|Overall Study|Never started|0
7866514|NCT00369785|27276628|P2|Overall Study|Toxicity|4
7866515|NCT00369785|27276629|P1|Overall Study|Toxicity|6
7866516|NCT00369785|27276628|P2|Overall Study|Withdrawal by Subject|6
7866517|NCT00369785|27276629|P1|Overall Study|Withdrawal by Subject|7
7866518|NCT00369785|27276628|P2|Overall Study|Death|2
7866519|NCT00369785|27276629|P1|Overall Study|Death|1
7866520|NCT00369785|27276628|P2|Overall Study|Physician Decision|2
7866521|NCT00369785|27276629|P1|Overall Study|Physician Decision|3
7866522|NCT00326625|27276639|P2|Overall Study|prescheduled medical intervention|1
7866523|NCT00326625|27276640|P1|Overall Study|prescheduled medical intervention|0
7866524|NCT00326625|27276639|P2|Overall Study|Lost to Follow-up|0
7866525|NCT00326625|27276640|P1|Overall Study|Lost to Follow-up|1
7866526|NCT00326625|27276639|P2|Overall Study|Death|16
7866527|NCT00326625|27276640|P1|Overall Study|Death|18
7866528|NCT00326625|27276639|P2|Overall Study|Withdrawal by Subject|12
7866529|NCT00326625|27276640|P1|Overall Study|Withdrawal by Subject|15
7866530|NCT00326625|27276639|P2|Overall Study|Adverse Event|9
7866531|NCT00326625|27276640|P1|Overall Study|Adverse Event|20
7866532|NCT04347954|27276676|P3|Overall Study|Lost to Follow-up|0
7866533|NCT04347954|27276677|P2|Overall Study|Lost to Follow-up|1
7866534|NCT04347954|27276678|P1|Overall Study|Lost to Follow-up|0
7866535|NCT04347954|27276676|P3|Overall Study|Did not present to study site for allocated intervention|3
7866536|NCT04347954|27276677|P2|Overall Study|Did not present to study site for allocated intervention|0
7866537|NCT04347954|27276678|P1|Overall Study|Did not present to study site for allocated intervention|3
7866538|NCT03945981|27276740|P1|Overall Study|Protocol Violation|1
7866539|NCT03945981|27276740|P1|Overall Study|Withdrawal by Subject|6
7866540|NCT03945981|27276740|P1|Overall Study|Physician Decision|4
7866541|NCT03945981|27276740|P1|Overall Study|Lost to Follow-up|12
7866542|NCT03467217|27276963|P2|Overall Study|Lost to Follow-up|2
7866543|NCT03467217|27276964|P1|Overall Study|Lost to Follow-up|0
7866544|NCT03467217|27276963|P2|Overall Study|Clinic closed due to COVID-19 pandemic|2
7866545|NCT03467217|27276964|P1|Overall Study|Clinic closed due to COVID-19 pandemic|5
7866546|NCT03467217|27276963|P2|Overall Study|Trial stopped early|2
7866547|NCT03467217|27276964|P1|Overall Study|Trial stopped early|5
7866548|NCT03353740|27277002|P1|Overall Study|Images for these participants not viable|52
7866549|NCT03308942|27277032|P5|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7866550|NCT03308942|27277033|P4|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|5
7866551|NCT03308942|27277034|P3|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7866552|NCT03308942|27277035|P2|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7866553|NCT03308942|27277036|P1|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
7866554|NCT03308942|27277032|P5|Stage 2 (up to a Maximum of 17 Months)|Death|0
7866555|NCT03308942|27277033|P4|Stage 2 (up to a Maximum of 17 Months)|Death|4
7866556|NCT03308942|27277034|P3|Stage 2 (up to a Maximum of 17 Months)|Death|0
7866557|NCT03308942|27277035|P2|Stage 2 (up to a Maximum of 17 Months)|Death|0
7866558|NCT03308942|27277036|P1|Stage 2 (up to a Maximum of 17 Months)|Death|0
7866559|NCT03308942|27277032|P5|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
7866560|NCT03308942|27277033|P4|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|3
7866561|NCT03308942|27277034|P3|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
7866562|NCT03308942|27277035|P2|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
7866563|NCT03308942|27277036|P1|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
7866564|NCT03308942|27277032|P5|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
7866565|NCT03308942|27277033|P4|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
7866566|NCT03308942|27277034|P3|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
7866567|NCT03308942|27277035|P2|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|4
7866568|NCT03308942|27277036|P1|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|7
7866569|NCT03308942|27277032|P5|Stage 1 (up to a Maximum of 29 Months)|Death|0
7866570|NCT03308942|27277033|P4|Stage 1 (up to a Maximum of 29 Months)|Death|0
7866571|NCT03308942|27277034|P3|Stage 1 (up to a Maximum of 29 Months)|Death|1
7866572|NCT03308942|27277035|P2|Stage 1 (up to a Maximum of 29 Months)|Death|15
7866573|NCT03308942|27277036|P1|Stage 1 (up to a Maximum of 29 Months)|Death|8
7866574|NCT03308942|27277032|P5|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
7866575|NCT03308942|27277033|P4|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
7866576|NCT03308942|27277034|P3|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
7866577|NCT03308942|27277035|P2|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
7866578|NCT03308942|27277036|P1|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
7866579|NCT03259425|27277083|P1|Overall Study|Disease progression to an extent that didn't allow surgery|1
7866580|NCT03234608|27277095|P2|Overall Study|Lost to Follow-up|21
7866581|NCT03234608|27277096|P1|Overall Study|Lost to Follow-up|23
7866582|NCT02990338|27277112|P2|Overall Study|Randomized but not treated|2
7866583|NCT02990338|27277113|P1|Overall Study|Randomized but not treated|4
7866584|NCT02990338|27277112|P2|Overall Study|Other|4
7866585|NCT02990338|27277113|P1|Overall Study|Other|1
7866586|NCT02990338|27277112|P2|Overall Study|Withdrawal by Subject|5
7866587|NCT02990338|27277113|P1|Overall Study|Withdrawal by Subject|6
7866588|NCT02990338|27277112|P2|Overall Study|Poor compliance to protocol|1
7866589|NCT02990338|27277113|P1|Overall Study|Poor compliance to protocol|0
7866590|NCT02990338|27277112|P2|Overall Study|Progressive disease|66
7866591|NCT02990338|27277113|P1|Overall Study|Progressive disease|88
7866592|NCT02990338|27277112|P2|Overall Study|Adverse Event|11
7866593|NCT02990338|27277113|P1|Overall Study|Adverse Event|19
7866594|NCT02962765|27277168|P1|Overall Study|Limited access to study medication|3
7866595|NCT02962765|27277168|P1|Overall Study|Death|1
7866596|NCT02962765|27277168|P1|Overall Study|Lost to Follow-up|1
7866597|NCT02962765|27277168|P1|Overall Study|Withdrawal by Subject|3
7866598|NCT02962765|27277168|P1|Overall Study|Protocol Violation|9
7866599|NCT02831764|27277187|P2|Overall Study|Ongoing at the time of the analysis|335
7866600|NCT02831764|27277188|P1|Overall Study|Ongoing at the time of the analysis|330
7866601|NCT02831764|27277187|P2|Overall Study|Protocol Violation|2
7866602|NCT02831764|27277188|P1|Overall Study|Protocol Violation|5
7866603|NCT02831764|27277187|P2|Overall Study|Lack of Efficacy|2
7866604|NCT02831764|27277188|P1|Overall Study|Lack of Efficacy|2
7866605|NCT02831764|27277187|P2|Overall Study|Adverse Event|5
7866606|NCT02831764|27277188|P1|Overall Study|Adverse Event|8
7866607|NCT02831764|27277187|P2|Overall Study|Lost to Follow-up|5
7866608|NCT02831764|27277188|P1|Overall Study|Lost to Follow-up|6
7866609|NCT02831764|27277187|P2|Overall Study|Physician Decision|2
7866610|NCT02831764|27277188|P1|Overall Study|Physician Decision|2
7866611|NCT02831764|27277187|P2|Overall Study|Withdrawal by Subject|6
7866612|NCT02831764|27277188|P1|Overall Study|Withdrawal by Subject|7
7866613|NCT02831764|27277187|P2|Overall Study|Protocol specific withdrawal criteria|2
7866614|NCT02831764|27277188|P1|Overall Study|Protocol specific withdrawal criteria|0
7866615|NCT02831673|27277252|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
7866616|NCT02831673|27277253|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
7866617|NCT02831673|27277252|P2|Overall Study|Withdrawal by Subject|4
7866618|NCT02831673|27277253|P1|Overall Study|Withdrawal by Subject|6
7866619|NCT02831673|27277252|P2|Overall Study|Physician Decision|3
7866620|NCT02831673|27277253|P1|Overall Study|Physician Decision|6
7866621|NCT02831673|27277252|P2|Overall Study|Lost to Follow-up|6
7866622|NCT02831673|27277253|P1|Overall Study|Lost to Follow-up|9
7866623|NCT02831673|27277252|P2|Overall Study|Protocol Withdrawal Criterion Met|6
7866624|NCT02831673|27277253|P1|Overall Study|Protocol Withdrawal Criterion Met|1
7866625|NCT02831673|27277252|P2|Overall Study|Protocol Violation|4
7866626|NCT02831673|27277253|P1|Overall Study|Protocol Violation|5
7866627|NCT02831673|27277252|P2|Overall Study|Lack of Efficacy|1
7866628|NCT02831673|27277253|P1|Overall Study|Lack of Efficacy|3
7866629|NCT02831673|27277252|P2|Overall Study|Adverse Event|4
7866630|NCT02831673|27277253|P1|Overall Study|Adverse Event|6
7866631|NCT02764762|27277315|P1|Overall Study|Significant Deviation|1
7866632|NCT02764762|27277315|P1|Overall Study|Voluntary Withdrawal|3
7866633|NCT02764762|27277315|P1|Overall Study|Adverse Event|5
7866634|NCT02682784|27277334|P4|Overall Study|Physician Decision|1
7866635|NCT02682784|27277335|P3|Overall Study|Physician Decision|1
7866636|NCT02682784|27277336|P2|Overall Study|Physician Decision|0
7866637|NCT02682784|27277337|P1|Overall Study|Physician Decision|1
7866638|NCT02682784|27277334|P4|Overall Study|Withdrawal by Subject|2
7866639|NCT02682784|27277335|P3|Overall Study|Withdrawal by Subject|1
7866640|NCT02682784|27277336|P2|Overall Study|Withdrawal by Subject|2
7866641|NCT02682784|27277337|P1|Overall Study|Withdrawal by Subject|0
7866642|NCT02660827|27277351|P1|Overall Study|Finished study period, then left.|5
7866643|NCT02660827|27277351|P1|Overall Study|Adverse Event|3
7866644|NCT02660827|27277351|P1|Overall Study|Withdrawal by Sponsor|2
7866645|NCT02660827|27277351|P1|Overall Study|Withdrawal by Subject|21
7866646|NCT02527421|27277389|P2|Overall Study|Withdrawal by Subject|0
7866647|NCT02527421|27277390|P1|Overall Study|Withdrawal by Subject|1
7866648|NCT02484443|27277398|P1|Overall Study|Ineligible|2
7866649|NCT02484443|27277398|P1|Overall Study|Physician Decision|2
7866650|NCT02484443|27277398|P1|Overall Study|Lack of Efficacy|28
7866651|NCT02454933|27277409|P2|Overall Study|Withdrawal by Subject|2
7866652|NCT02454933|27277410|P1|Overall Study|Withdrawal by Subject|0
7866653|NCT02454933|27277409|P2|Overall Study|Adverse Event|1
7866654|NCT02454933|27277410|P1|Overall Study|Adverse Event|1
7866655|NCT02454933|27277409|P2|Overall Study|Progressive disease|5
7866656|NCT02454933|27277410|P1|Overall Study|Progressive disease|7
7866657|NCT02420821|27277417|P2|Overall Study|Death|116
7866658|NCT02420821|27277418|P1|Overall Study|Death|129
7866659|NCT02420821|27277417|P2|Overall Study|Withdrawal by Subject|17
7866660|NCT02420821|27277418|P1|Overall Study|Withdrawal by Subject|31
7866661|NCT02420821|27277417|P2|Overall Study|Physician Decision|2
7866662|NCT02420821|27277418|P1|Overall Study|Physician Decision|5
7866663|NCT02420821|27277417|P2|Overall Study|Non-compliance|2
7866664|NCT02420821|27277418|P1|Overall Study|Non-compliance|1
7866665|NCT02420821|27277417|P2|Overall Study|Lost to Follow-up|0
7866666|NCT02420821|27277418|P1|Overall Study|Lost to Follow-up|2
7866667|NCT02366091|27277490|P4|Overall Study|Withdrawal by Subject|1
7866668|NCT02366091|27277491|P3|Overall Study|Withdrawal by Subject|3
7866669|NCT02366091|27277492|P2|Overall Study|Withdrawal by Subject|7
7866670|NCT02366091|27277493|P1|Overall Study|Withdrawal by Subject|3
7866671|NCT02354586|27277523|P1|Overall Study|Disease progression|116
7866672|NCT02354586|27277523|P1|Overall Study|Lost to Follow-up|6
7866673|NCT02354586|27277523|P1|Overall Study|Withdrawal by Subject|51
7866674|NCT02354586|27277523|P1|Overall Study|Death|168
7866675|NCT02294461|27277560|P2|Overall Study|Miscellaneous|32
7866676|NCT02294461|27277561|P1|Overall Study|Miscellaneous|11
7866677|NCT02294461|27277560|P2|Overall Study|Adverse Event|10
7866678|NCT02294461|27277561|P1|Overall Study|Adverse Event|11
7866679|NCT02294461|27277560|P2|Overall Study|Disease Progression|39
7866680|NCT02294461|27277561|P1|Overall Study|Disease Progression|23
7866681|NCT02294461|27277560|P2|Overall Study|Withdrawal by Subject|45
7866682|NCT02294461|27277561|P1|Overall Study|Withdrawal by Subject|14
7866683|NCT02294461|27277560|P2|Overall Study|Protocol Violation|2
7866684|NCT02294461|27277561|P1|Overall Study|Protocol Violation|0
7866685|NCT02294461|27277560|P2|Overall Study|Death|3
7866686|NCT02294461|27277561|P1|Overall Study|Death|3
7866687|NCT01958021|27277615|P2|Overall Study|Death|0
7866688|NCT01958021|27277616|P1|Overall Study|Death|2
7866689|NCT01958021|27277615|P2|Overall Study|Protocol Violation|1
7866690|NCT01958021|27277616|P1|Overall Study|Protocol Violation|3
7866691|NCT01958021|27277615|P2|Overall Study|Physician Decision|13
7866692|NCT01958021|27277616|P1|Overall Study|Physician Decision|10
7866693|NCT01958021|27277615|P2|Overall Study|Subject/guardian decision|13
7866694|NCT01958021|27277616|P1|Overall Study|Subject/guardian decision|12
7866695|NCT01958021|27277615|P2|Overall Study|Adverse Event|7
7866696|NCT01958021|27277616|P1|Overall Study|Adverse Event|25
7866697|NCT01958021|27277615|P2|Overall Study|Progressive disease|146
7866698|NCT01958021|27277616|P1|Overall Study|Progressive disease|87
7866699|NCT01843374|27277626|P2|Overall Study|Withdrawing due to Other reason|46
7866700|NCT01843374|27277627|P1|Overall Study|Withdrawing due to Other reason|20
7866701|NCT01843374|27277626|P2|Overall Study|Withdrawal by Subject|20
7866702|NCT01843374|27277627|P1|Overall Study|Withdrawal by Subject|14
7866703|NCT01843374|27277626|P2|Overall Study|Death|313
7866704|NCT01843374|27277627|P1|Overall Study|Death|155
7866705|NCT01828112|27277653|P2|Overall Study|Subject/guardian decision|8
7866706|NCT01828112|27277654|P1|Overall Study|Subject/guardian decision|6
7866707|NCT01828112|27277653|P2|Overall Study|Progressive disease|82
7866708|NCT01828112|27277654|P1|Overall Study|Progressive disease|56
7866709|NCT01828112|27277653|P2|Overall Study|Physician Decision|5
7866710|NCT01828112|27277654|P1|Overall Study|Physician Decision|5
7866711|NCT01828112|27277653|P2|Overall Study|Death|5
7866712|NCT01828112|27277654|P1|Overall Study|Death|9
7866713|NCT01828112|27277653|P2|Overall Study|Adverse Event|8
7866714|NCT01828112|27277654|P1|Overall Study|Adverse Event|6
7866715|NCT01708954|27277663|P3|Step 2|Withdrawal by Subject|0
7866716|NCT01708954|27277664|P2|Step 2|Withdrawal by Subject|1
7866717|NCT01708954|27277665|P1|Step 2|Withdrawal by Subject|1
7866718|NCT01708954|27277663|P3|Step 2|Adverse Event|0
7866719|NCT01708954|27277664|P2|Step 2|Adverse Event|2
7866720|NCT01708954|27277665|P1|Step 2|Adverse Event|3
7866721|NCT01708954|27277663|P3|Step 2|Disease progression|0
7866722|NCT01708954|27277664|P2|Step 2|Disease progression|4
7866723|NCT01708954|27277665|P1|Step 2|Disease progression|9
7866724|NCT01708954|27277663|P3|Step 1|Ineligible or never received treatment|8
7866725|NCT01708954|27277664|P2|Step 1|Ineligible or never received treatment|2
7866726|NCT01708954|27277665|P1|Step 1|Ineligible or never received treatment|4
7866727|NCT01708954|27277663|P3|Step 1|Off-treatment reason not submitted|1
7866728|NCT01708954|27277664|P2|Step 1|Off-treatment reason not submitted|1
7866729|NCT01708954|27277665|P1|Step 1|Off-treatment reason not submitted|1
7866730|NCT01708954|27277663|P3|Step 1|Symptomatic deterioration|1
7866731|NCT01708954|27277664|P2|Step 1|Symptomatic deterioration|0
7866732|NCT01708954|27277665|P1|Step 1|Symptomatic deterioration|1
7866733|NCT01708954|27277663|P3|Step 1|Crossed over to Step 2|0
7866734|NCT01708954|27277664|P2|Step 1|Crossed over to Step 2|0
7866735|NCT01708954|27277665|P1|Step 1|Crossed over to Step 2|2
7866736|NCT01708954|27277663|P3|Step 1|Other complicating disease|0
7866737|NCT01708954|27277664|P2|Step 1|Other complicating disease|2
7866738|NCT01708954|27277665|P1|Step 1|Other complicating disease|0
7866739|NCT01708954|27277663|P3|Step 1|Withdrawal by Subject|3
7866740|NCT01708954|27277664|P2|Step 1|Withdrawal by Subject|5
7866741|NCT01708954|27277665|P1|Step 1|Withdrawal by Subject|2
7866742|NCT01708954|27277663|P3|Step 1|Death|3
7866743|NCT01708954|27277664|P2|Step 1|Death|2
7866744|NCT01708954|27277665|P1|Step 1|Death|3
7866745|NCT01708954|27277663|P3|Step 1|Adverse Event|13
7866746|NCT01708954|27277664|P2|Step 1|Adverse Event|11
7866747|NCT01708954|27277665|P1|Step 1|Adverse Event|3
7866748|NCT01708954|27277663|P3|Step 1|Disease progression|14
7866749|NCT01708954|27277664|P2|Step 1|Disease progression|17
7866750|NCT01708954|27277665|P1|Step 1|Disease progression|26
7866751|NCT01236547|27277713|P5|Overall Study|Protocol Violation|12
7866752|NCT01236547|27277714|P4|Overall Study|Protocol Violation|6
7866753|NCT01236547|27277715|P3|Overall Study|Protocol Violation|1
7866754|NCT01236547|27277716|P2|Overall Study|Protocol Violation|1
7866755|NCT01236547|27277717|P1|Overall Study|Protocol Violation|0
7866756|NCT01142388|27277751|P2|Overall Study|Never started therapy|3
7866757|NCT01142388|27277752|P1|Overall Study|Never started therapy|7
7866758|NCT01142388|27277751|P2|Overall Study|Other|1
7866759|NCT01142388|27277752|P1|Overall Study|Other|1
7866760|NCT01142388|27277751|P2|Overall Study|Other complications|2
7866761|NCT01142388|27277752|P1|Overall Study|Other complications|0
7866762|NCT01142388|27277751|P2|Overall Study|Alternative therapy|0
7866763|NCT01142388|27277752|P1|Overall Study|Alternative therapy|1
7866764|NCT01142388|27277751|P2|Overall Study|Withdrawal by Subject|3
7866765|NCT01142388|27277752|P1|Overall Study|Withdrawal by Subject|5
7866766|NCT01142388|27277751|P2|Overall Study|Death|2
7866767|NCT01142388|27277752|P1|Overall Study|Death|3
7866768|NCT01142388|27277751|P2|Overall Study|Adverse Event|5
7866769|NCT01142388|27277752|P1|Overall Study|Adverse Event|9
7866770|NCT01142388|27277751|P2|Overall Study|Lack of Efficacy|31
7866771|NCT01142388|27277752|P1|Overall Study|Lack of Efficacy|21
7866772|NCT00972478|27277764|P2|Overall Study|Not start protocol treatment|2
7866773|NCT00972478|27277765|P1|Overall Study|Not start protocol treatment|1
7866774|NCT00972478|27277764|P2|Overall Study|Ineligible|7
7866775|NCT00972478|27277765|P1|Overall Study|Ineligible|1
7866776|NCT00972478|27277764|P2|Overall Study|Not protocol specified|1
7866777|NCT00972478|27277765|P1|Overall Study|Not protocol specified|1
7866778|NCT00972478|27277764|P2|Overall Study|Death|2
7866779|NCT00972478|27277765|P1|Overall Study|Death|0
7866780|NCT00972478|27277764|P2|Overall Study|Progression/Relapse|2
7866781|NCT00972478|27277765|P1|Overall Study|Progression/Relapse|0
7866782|NCT00972478|27277764|P2|Overall Study|Withdrawal by Subject|8
7866783|NCT00972478|27277765|P1|Overall Study|Withdrawal by Subject|1
7866784|NCT00972478|27277764|P2|Overall Study|Adverse Event|16
7866785|NCT00972478|27277765|P1|Overall Study|Adverse Event|3
7866786|NCT00785291|27277778|P3|Overall Study|Other Medical Reasons|15
7866787|NCT00785291|27277779|P2|Overall Study|Other Medical Reasons|25
7866788|NCT00785291|27277780|P1|Overall Study|Other Medical Reasons|29
7866789|NCT00785291|27277778|P3|Overall Study|Complicating illness|4
7866790|NCT00785291|27277779|P2|Overall Study|Complicating illness|4
7866791|NCT00785291|27277780|P1|Overall Study|Complicating illness|6
7866792|NCT00785291|27277778|P3|Overall Study|Alternative Therapy|7
7866793|NCT00785291|27277779|P2|Overall Study|Alternative Therapy|6
7866794|NCT00785291|27277780|P1|Overall Study|Alternative Therapy|12
7866795|NCT00785291|27277778|P3|Overall Study|Withdrawal by Subject|17
7866796|NCT00785291|27277779|P2|Overall Study|Withdrawal by Subject|36
7866797|NCT00785291|27277780|P1|Overall Study|Withdrawal by Subject|35
7866798|NCT00785291|27277778|P3|Overall Study|Death|3
7866799|NCT00785291|27277779|P2|Overall Study|Death|4
7866800|NCT00785291|27277780|P1|Overall Study|Death|7
7866801|NCT00785291|27277778|P3|Overall Study|Adverse Event|56
7866802|NCT00785291|27277779|P2|Overall Study|Adverse Event|70
7866803|NCT00785291|27277780|P1|Overall Study|Adverse Event|39
7866804|NCT00785291|27277778|P3|Overall Study|Never began treatment|4
7866805|NCT00785291|27277779|P2|Overall Study|Never began treatment|4
7866806|NCT00785291|27277780|P1|Overall Study|Never began treatment|8
7866807|NCT00770809|27277803|P3|Overall Study|Other Medical Reasons|3
7866808|NCT00770809|27277804|P2|Overall Study|Other Medical Reasons|4
7866809|NCT00770809|27277805|P1|Overall Study|Other Medical Reasons|2
7866810|NCT00770809|27277803|P3|Overall Study|Complicating illness|1
7866811|NCT00770809|27277804|P2|Overall Study|Complicating illness|0
7866812|NCT00770809|27277805|P1|Overall Study|Complicating illness|0
7866813|NCT00770809|27277803|P3|Overall Study|Progression|0
7866814|NCT00770809|27277804|P2|Overall Study|Progression|2
7866815|NCT00770809|27277805|P1|Overall Study|Progression|2
7866816|NCT00770809|27277803|P3|Overall Study|Withdrawal by Subject|7
7866817|NCT00770809|27277804|P2|Overall Study|Withdrawal by Subject|3
7866818|NCT00770809|27277805|P1|Overall Study|Withdrawal by Subject|3
7866819|NCT00770809|27277803|P3|Overall Study|Death|0
7866820|NCT00770809|27277804|P2|Overall Study|Death|0
7866821|NCT00770809|27277805|P1|Overall Study|Death|1
7866822|NCT00770809|27277803|P3|Overall Study|Adverse Event|12
7866823|NCT00770809|27277804|P2|Overall Study|Adverse Event|1
7866824|NCT00770809|27277805|P1|Overall Study|Adverse Event|9
7866825|NCT00588770|27277815|P2|Overall Study|Patient non-compliance|2
7866826|NCT00588770|27277816|P1|Overall Study|Patient non-compliance|2
7866827|NCT00588770|27277815|P2|Overall Study|Physician discretion|0
7866828|NCT00588770|27277816|P1|Overall Study|Physician discretion|2
7866829|NCT00588770|27277815|P2|Overall Study|Lack of Efficacy|10
7866830|NCT00588770|27277816|P1|Overall Study|Lack of Efficacy|8
7866831|NCT00588770|27277815|P2|Overall Study|Not start protocol therapy|9
7866832|NCT00588770|27277816|P1|Overall Study|Not start protocol therapy|0
7866833|NCT00588770|27277815|P2|Overall Study|Other complicating disease|2
7866834|NCT00588770|27277816|P1|Overall Study|Other complicating disease|3
7866835|NCT00588770|27277815|P2|Overall Study|Alternative therapy|4
7866836|NCT00588770|27277816|P1|Overall Study|Alternative therapy|2
7866837|NCT00588770|27277815|P2|Overall Study|Withdrawal by Subject|25
7866838|NCT00588770|27277816|P1|Overall Study|Withdrawal by Subject|15
7866839|NCT00588770|27277815|P2|Overall Study|Death|22
7866840|NCT00588770|27277816|P1|Overall Study|Death|13
7866841|NCT00588770|27277815|P2|Overall Study|Adverse Event|58
7866842|NCT00588770|27277816|P1|Overall Study|Adverse Event|29
7866843|NCT00588770|27277815|P2|Overall Study|Disease progression|68
7866844|NCT00588770|27277816|P1|Overall Study|Disease progression|85
7866845|NCT04854707|27277880|P3|Overall Study|Lack of Efficacy|30
7866846|NCT04854707|27277881|P2|Overall Study|Lack of Efficacy|59
7866847|NCT04854707|27277882|P1|Overall Study|Lack of Efficacy|78
7866848|NCT04504032|27277931|P2|Overall Study|Progressed to moderate/severe COVID-19|0
7866849|NCT04504032|27277932|P1|Overall Study|Progressed to moderate/severe COVID-19|1
7866850|NCT04504032|27277931|P2|Overall Study|Drug supply issues|1
7866851|NCT04504032|27277932|P1|Overall Study|Drug supply issues|1
7866852|NCT04504032|27277931|P2|Overall Study|Disease progression prior to dosing|3
7866853|NCT04504032|27277932|P1|Overall Study|Disease progression prior to dosing|15
7866854|NCT04504032|27277931|P2|Overall Study|Withdrawal by Subject|11
7866855|NCT04504032|27277932|P1|Overall Study|Withdrawal by Subject|9
7866856|NCT04504032|27277931|P2|Overall Study|Study terminated by sponsor|2
7866857|NCT04504032|27277932|P1|Overall Study|Study terminated by sponsor|1
7866858|NCT04504032|27277931|P2|Overall Study|Protocol Violation|0
7866859|NCT04504032|27277932|P1|Overall Study|Protocol Violation|2
7866860|NCT04504032|27277931|P2|Overall Study|Lost to Follow-up|9
7866861|NCT04504032|27277932|P1|Overall Study|Lost to Follow-up|6
7866862|NCT04504032|27277931|P2|Overall Study|Adverse Event|2
7866863|NCT04504032|27277932|P1|Overall Study|Adverse Event|1
7866864|NCT04218110|27277970|P4|Overall Study|Withdrawal by Subject|1
7866865|NCT04218110|27277971|P3|Overall Study|Withdrawal by Subject|0
7866866|NCT04218110|27277972|P2|Overall Study|Withdrawal by Subject|0
7866867|NCT04218110|27277973|P1|Overall Study|Withdrawal by Subject|0
7866868|NCT03989232|27277998|P2|Overall Study|Death|2
7866869|NCT03989232|27277999|P1|Overall Study|Death|1
7866870|NCT03989232|27277998|P2|Overall Study|Withdrawal by Subject|6
7866871|NCT03989232|27277999|P1|Overall Study|Withdrawal by Subject|6
7866872|NCT03989232|27277998|P2|Overall Study|Lost to Follow-up|10
7866873|NCT03989232|27277999|P1|Overall Study|Lost to Follow-up|3
7866874|NCT03830333|27278075|P2|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
7866875|NCT03830333|27278076|P1|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
7866876|NCT03830333|27278075|P2|Overall Study|Withdrawal by Subject|1
7866877|NCT03830333|27278076|P1|Overall Study|Withdrawal by Subject|5
7866878|NCT03830333|27278075|P2|Overall Study|Death|1
7866879|NCT03830333|27278076|P1|Overall Study|Death|0
7866880|NCT03691779|27278171|P2|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
7866881|NCT03691779|27278172|P1|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
7866882|NCT03691779|27278171|P2|Part B (24 Weeks)|Adverse Event|1
7866883|NCT03691779|27278172|P1|Part B (24 Weeks)|Adverse Event|0
7866884|NCT03635086|27278204|P5|Overall Study|Lost to Follow-up|0
7866885|NCT03635086|27278205|P4|Overall Study|Lost to Follow-up|0
7866886|NCT03635086|27278206|P3|Overall Study|Lost to Follow-up|0
7866887|NCT03635086|27278207|P2|Overall Study|Lost to Follow-up|0
7866888|NCT03635086|27278208|P1|Overall Study|Lost to Follow-up|1
7866889|NCT03635086|27278204|P5|Overall Study|Adverse Event|0
7866890|NCT03635086|27278205|P4|Overall Study|Adverse Event|0
7866891|NCT03635086|27278206|P3|Overall Study|Adverse Event|0
7866892|NCT03635086|27278207|P2|Overall Study|Adverse Event|1
7866893|NCT03635086|27278208|P1|Overall Study|Adverse Event|0
7866894|NCT03635086|27278204|P5|Overall Study|Withdrawal of consent|0
7866895|NCT03635086|27278205|P4|Overall Study|Withdrawal of consent|0
7866896|NCT03635086|27278206|P3|Overall Study|Withdrawal of consent|1
7866897|NCT03635086|27278207|P2|Overall Study|Withdrawal of consent|0
7866898|NCT03635086|27278208|P1|Overall Study|Withdrawal of consent|0
7866899|NCT03552198|27278273|P4|Overall Study|Did not receive air alerts|1
7866900|NCT03552198|27278274|P3|Overall Study|Did not receive air alerts|0
7866901|NCT03552198|27278275|P2|Overall Study|Did not receive air alerts|0
7866902|NCT03552198|27278276|P1|Overall Study|Did not receive air alerts|1
7866903|NCT03552198|27278273|P4|Overall Study|Incomplete/unmatched questionnaire|2
7866904|NCT03552198|27278274|P3|Overall Study|Incomplete/unmatched questionnaire|2
7866905|NCT03552198|27278275|P2|Overall Study|Incomplete/unmatched questionnaire|7
7866906|NCT03552198|27278276|P1|Overall Study|Incomplete/unmatched questionnaire|6
7866907|NCT03552198|27278273|P4|Overall Study|Lost to Follow-up|19
7866908|NCT03552198|27278274|P3|Overall Study|Lost to Follow-up|15
7866909|NCT03552198|27278275|P2|Overall Study|Lost to Follow-up|48
7866910|NCT03552198|27278276|P1|Overall Study|Lost to Follow-up|42
7866911|NCT03484273|27278313|P1|Overall Study|Data excluded from analysis|1
7866912|NCT03484273|27278313|P1|Overall Study|Equipment Malfunction|1
7866913|NCT03442569|27278347|P1|Overall Study|Subject was ineligible after enrolment|1
7866914|NCT03318861|27278374|P5|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7866915|NCT03318861|27278375|P4|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7866916|NCT03318861|27278376|P3|Overall Study|Enrolled But Did Not Initiate KITE-585|0
7866917|NCT03318861|27278377|P2|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7866918|NCT03318861|27278378|P1|Overall Study|Enrolled But Did Not Initiate KITE-585|0
7866919|NCT03318861|27278374|P5|Overall Study|Still on Study|1
7866920|NCT03318861|27278375|P4|Overall Study|Still on Study|2
7866921|NCT03318861|27278376|P3|Overall Study|Still on Study|1
7866922|NCT03318861|27278377|P2|Overall Study|Still on Study|1
7866923|NCT03318861|27278378|P1|Overall Study|Still on Study|2
7866924|NCT03318861|27278374|P5|Overall Study|Death|1
7866925|NCT03318861|27278375|P4|Overall Study|Death|1
7866926|NCT03318861|27278376|P3|Overall Study|Death|2
7866927|NCT03318861|27278377|P2|Overall Study|Death|2
7866928|NCT03318861|27278378|P1|Overall Study|Death|1
7866929|NCT03196284|27278426|P3|Extension Part|Physician Decision|1
7866930|NCT03196284|27278427|P2|Extension Part|Physician Decision|0
7866931|NCT03196284|27278428|P1|Extension Part|Physician Decision|0
7866932|NCT03196284|27278426|P3|Extension Part|Withdrawal by Subject|1
7866933|NCT03196284|27278427|P2|Extension Part|Withdrawal by Subject|0
7866934|NCT03196284|27278428|P1|Extension Part|Withdrawal by Subject|0
7866935|NCT03196284|27278426|P3|Extension Part|Lack of Efficacy|1
7866936|NCT03196284|27278427|P2|Extension Part|Lack of Efficacy|0
7866937|NCT03196284|27278428|P1|Extension Part|Lack of Efficacy|0
7866938|NCT03196284|27278426|P3|Main Part|Withdrawal by Subject|0
7866939|NCT03196284|27278427|P2|Main Part|Withdrawal by Subject|1
7866940|NCT03196284|27278428|P1|Main Part|Withdrawal by Subject|0
7866941|NCT03189524|27278522|P3|Overall Study|Progressive Disease|0
7866942|NCT03189524|27278523|P2|Overall Study|Progressive Disease|2
7866943|NCT03189524|27278524|P1|Overall Study|Progressive Disease|0
7866944|NCT03189524|27278522|P3|Overall Study|Withdrawal by Subject|3
7866945|NCT03189524|27278523|P2|Overall Study|Withdrawal by Subject|1
7866946|NCT03189524|27278524|P1|Overall Study|Withdrawal by Subject|1
7866947|NCT03189524|27278522|P3|Overall Study|Lost to Follow-up|8
7866948|NCT03189524|27278523|P2|Overall Study|Lost to Follow-up|0
7866949|NCT03189524|27278524|P1|Overall Study|Lost to Follow-up|1
7866950|NCT03189524|27278522|P3|Overall Study|Death|1
7866951|NCT03189524|27278523|P2|Overall Study|Death|2
7866952|NCT03189524|27278524|P1|Overall Study|Death|2
7866953|NCT03189524|27278522|P3|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
7866954|NCT03189524|27278523|P2|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
7866955|NCT03189524|27278524|P1|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
7866956|NCT03119610|27278583|P2|Overall Study|Lost to Follow-up|1
7866957|NCT03119610|27278584|P1|Overall Study|Lost to Follow-up|0
7866958|NCT03119610|27278583|P2|Overall Study|Adverse Event|0
7866959|NCT03119610|27278584|P1|Overall Study|Adverse Event|1
7866960|NCT03101241|27278616|P2|Overall Study|Lack of efficacy/subject withdrew consent|1
7866961|NCT03101241|27278617|P1|Overall Study|Lack of efficacy/subject withdrew consent|0
7866962|NCT03101241|27278616|P2|Overall Study|Lack of Efficacy|1
7866963|NCT03101241|27278617|P1|Overall Study|Lack of Efficacy|0
7866964|NCT03101241|27278616|P2|Overall Study|Lost to Follow-up|0
7866965|NCT03101241|27278617|P1|Overall Study|Lost to Follow-up|2
7866966|NCT03101241|27278616|P2|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
7866967|NCT03101241|27278617|P1|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
7866968|NCT03101241|27278616|P2|Overall Study|Participant withdrew consent|1
7866969|NCT03101241|27278617|P1|Overall Study|Participant withdrew consent|3
7866970|NCT03101241|27278616|P2|Overall Study|Intercurrent condition necessitating discontinuation|2
7866971|NCT03101241|27278617|P1|Overall Study|Intercurrent condition necessitating discontinuation|4
7866972|NCT02736474|27278682|P2|Overall Study|Lost to Follow-up|1
7866973|NCT02736474|27278683|P1|Overall Study|Lost to Follow-up|0
7866974|NCT02649946|27278719|P2|Overall Study|Missed 6-month follow-up visit|4
7866975|NCT02649946|27278720|P1|Overall Study|Missed 6-month follow-up visit|0
7866976|NCT02649946|27278719|P2|Overall Study|Erroneously enrolled|0
7866977|NCT02649946|27278720|P1|Overall Study|Erroneously enrolled|1
7866978|NCT02649946|27278719|P2|Overall Study|Lost to Follow-up|1
7866979|NCT02649946|27278720|P1|Overall Study|Lost to Follow-up|2
7866980|NCT02649946|27278719|P2|Overall Study|Physician Decision|0
7866981|NCT02649946|27278720|P1|Overall Study|Physician Decision|1
7866982|NCT02649946|27278719|P2|Overall Study|Death|9
7866983|NCT02649946|27278720|P1|Overall Study|Death|7
7866984|NCT02649946|27278719|P2|Overall Study|Withdrawal by Subject|1
7866985|NCT02649946|27278720|P1|Overall Study|Withdrawal by Subject|1
7866986|NCT02564900|27278774|P15|Dose Expansion|Did not receive treatment|1
7866987|NCT02564900|27278775|P14|Dose Expansion|Did not receive treatment|0
7866988|NCT02564900|27278776|P13|Dose Expansion|Did not receive treatment|0
7866989|NCT02564900|27278777|P12|Dose Expansion|Did not receive treatment|0
7866990|NCT02564900|27278778|P11|Dose Expansion|Did not receive treatment|0
7866991|NCT02564900|27278779|P10|Dose Expansion|Did not receive treatment|0
7866992|NCT02564900|27278780|P9|Dose Expansion|Did not receive treatment|0
7866993|NCT02564900|27278781|P8|Dose Expansion|Did not receive treatment|1
7866994|NCT02564900|27278782|P7|Dose Expansion|Did not receive treatment|1
7866995|NCT02564900|27278783|P6|Dose Expansion|Did not receive treatment|0
7866996|NCT02564900|27278784|P5|Dose Expansion|Did not receive treatment|0
7866997|NCT02564900|27278785|P4|Dose Expansion|Did not receive treatment|0
7866998|NCT02564900|27278786|P3|Dose Expansion|Did not receive treatment|0
7866999|NCT02564900|27278787|P2|Dose Expansion|Did not receive treatment|0
7867000|NCT02564900|27278788|P1|Dose Expansion|Did not receive treatment|0
7867001|NCT02564900|27278774|P15|Dose Expansion|Other|1
7867002|NCT02564900|27278775|P14|Dose Expansion|Other|0
7867003|NCT02564900|27278776|P13|Dose Expansion|Other|0
7867004|NCT02564900|27278777|P12|Dose Expansion|Other|0
7867005|NCT02564900|27278778|P11|Dose Expansion|Other|0
7867006|NCT02564900|27278779|P10|Dose Expansion|Other|0
7867007|NCT02564900|27278780|P9|Dose Expansion|Other|1
7867008|NCT02564900|27278781|P8|Dose Expansion|Other|0
7867009|NCT02564900|27278782|P7|Dose Expansion|Other|1
7867010|NCT02564900|27278783|P6|Dose Expansion|Other|0
7867011|NCT02564900|27278784|P5|Dose Expansion|Other|0
7867012|NCT02564900|27278785|P4|Dose Expansion|Other|0
7867013|NCT02564900|27278786|P3|Dose Expansion|Other|0
7867014|NCT02564900|27278787|P2|Dose Expansion|Other|0
7867015|NCT02564900|27278788|P1|Dose Expansion|Other|0
7867016|NCT02564900|27278774|P15|Dose Expansion|Withdrawal by Subject|1
7867017|NCT02564900|27278775|P14|Dose Expansion|Withdrawal by Subject|1
7867018|NCT02564900|27278776|P13|Dose Expansion|Withdrawal by Subject|0
7867019|NCT02564900|27278777|P12|Dose Expansion|Withdrawal by Subject|0
7867020|NCT02564900|27278778|P11|Dose Expansion|Withdrawal by Subject|1
7867021|NCT02564900|27278779|P10|Dose Expansion|Withdrawal by Subject|0
7867022|NCT02564900|27278780|P9|Dose Expansion|Withdrawal by Subject|0
7867023|NCT02564900|27278781|P8|Dose Expansion|Withdrawal by Subject|0
7867024|NCT02564900|27278782|P7|Dose Expansion|Withdrawal by Subject|4
7867025|NCT02564900|27278783|P6|Dose Expansion|Withdrawal by Subject|0
7867026|NCT02564900|27278784|P5|Dose Expansion|Withdrawal by Subject|0
7867027|NCT02564900|27278785|P4|Dose Expansion|Withdrawal by Subject|0
7867028|NCT02564900|27278786|P3|Dose Expansion|Withdrawal by Subject|0
7867029|NCT02564900|27278787|P2|Dose Expansion|Withdrawal by Subject|0
7867030|NCT02564900|27278788|P1|Dose Expansion|Withdrawal by Subject|0
7867031|NCT02564900|27278774|P15|Dose Expansion|Death|0
7867032|NCT02564900|27278775|P14|Dose Expansion|Death|1
7867033|NCT02564900|27278776|P13|Dose Expansion|Death|1
7867034|NCT02564900|27278777|P12|Dose Expansion|Death|0
7867035|NCT02564900|27278778|P11|Dose Expansion|Death|1
7867036|NCT02564900|27278779|P10|Dose Expansion|Death|0
7867037|NCT02564900|27278780|P9|Dose Expansion|Death|0
7867038|NCT02564900|27278781|P8|Dose Expansion|Death|0
7867039|NCT02564900|27278782|P7|Dose Expansion|Death|1
7867040|NCT02564900|27278783|P6|Dose Expansion|Death|0
7867041|NCT02564900|27278784|P5|Dose Expansion|Death|0
7867042|NCT02564900|27278785|P4|Dose Expansion|Death|0
7867043|NCT02564900|27278786|P3|Dose Expansion|Death|0
7867044|NCT02564900|27278787|P2|Dose Expansion|Death|0
7867045|NCT02564900|27278788|P1|Dose Expansion|Death|0
7867046|NCT02564900|27278774|P15|Dose Expansion|Ongoing|6
7867047|NCT02564900|27278775|P14|Dose Expansion|Ongoing|0
7867048|NCT02564900|27278776|P13|Dose Expansion|Ongoing|4
7867049|NCT02564900|27278777|P12|Dose Expansion|Ongoing|0
7867050|NCT02564900|27278778|P11|Dose Expansion|Ongoing|0
7867051|NCT02564900|27278779|P10|Dose Expansion|Ongoing|3
7867052|NCT02564900|27278780|P9|Dose Expansion|Ongoing|11
7867053|NCT02564900|27278781|P8|Dose Expansion|Ongoing|10
7867054|NCT02564900|27278782|P7|Dose Expansion|Ongoing|9
7867055|NCT02564900|27278783|P6|Dose Expansion|Ongoing|0
7867056|NCT02564900|27278784|P5|Dose Expansion|Ongoing|0
7867057|NCT02564900|27278785|P4|Dose Expansion|Ongoing|0
7867058|NCT02564900|27278786|P3|Dose Expansion|Ongoing|0
7867059|NCT02564900|27278787|P2|Dose Expansion|Ongoing|0
7867060|NCT02564900|27278788|P1|Dose Expansion|Ongoing|0
7867061|NCT02564900|27278774|P15|Dose Expansion|Adverse Event|1
7867062|NCT02564900|27278775|P14|Dose Expansion|Adverse Event|2
7867063|NCT02564900|27278776|P13|Dose Expansion|Adverse Event|2
7867064|NCT02564900|27278777|P12|Dose Expansion|Adverse Event|5
7867065|NCT02564900|27278778|P11|Dose Expansion|Adverse Event|0
7867066|NCT02564900|27278779|P10|Dose Expansion|Adverse Event|11
7867067|NCT02564900|27278780|P9|Dose Expansion|Adverse Event|0
7867068|NCT02564900|27278781|P8|Dose Expansion|Adverse Event|22
7867069|NCT02564900|27278782|P7|Dose Expansion|Adverse Event|9
7867070|NCT02564900|27278783|P6|Dose Expansion|Adverse Event|0
7867071|NCT02564900|27278784|P5|Dose Expansion|Adverse Event|0
7867072|NCT02564900|27278785|P4|Dose Expansion|Adverse Event|0
7867073|NCT02564900|27278786|P3|Dose Expansion|Adverse Event|0
7867074|NCT02564900|27278787|P2|Dose Expansion|Adverse Event|0
7867075|NCT02564900|27278788|P1|Dose Expansion|Adverse Event|0
7867076|NCT02564900|27278774|P15|Dose Expansion|Clinical progression|1
7867077|NCT02564900|27278775|P14|Dose Expansion|Clinical progression|3
7867078|NCT02564900|27278776|P13|Dose Expansion|Clinical progression|1
7867079|NCT02564900|27278777|P12|Dose Expansion|Clinical progression|0
7867080|NCT02564900|27278778|P11|Dose Expansion|Clinical progression|2
7867081|NCT02564900|27278779|P10|Dose Expansion|Clinical progression|3
7867082|NCT02564900|27278780|P9|Dose Expansion|Clinical progression|0
7867083|NCT02564900|27278781|P8|Dose Expansion|Clinical progression|12
7867084|NCT02564900|27278782|P7|Dose Expansion|Clinical progression|5
7867085|NCT02564900|27278783|P6|Dose Expansion|Clinical progression|0
7867086|NCT02564900|27278784|P5|Dose Expansion|Clinical progression|0
7867087|NCT02564900|27278785|P4|Dose Expansion|Clinical progression|0
7867088|NCT02564900|27278786|P3|Dose Expansion|Clinical progression|0
7867089|NCT02564900|27278787|P2|Dose Expansion|Clinical progression|0
7867090|NCT02564900|27278788|P1|Dose Expansion|Clinical progression|0
7867091|NCT02564900|27278774|P15|Dose Expansion|Progressive disease per RECIST|11
7867092|NCT02564900|27278775|P14|Dose Expansion|Progressive disease per RECIST|13
7867093|NCT02564900|27278776|P13|Dose Expansion|Progressive disease per RECIST|10
7867094|NCT02564900|27278777|P12|Dose Expansion|Progressive disease per RECIST|19
7867095|NCT02564900|27278778|P11|Dose Expansion|Progressive disease per RECIST|13
7867096|NCT02564900|27278779|P10|Dose Expansion|Progressive disease per RECIST|16
7867097|NCT02564900|27278780|P9|Dose Expansion|Progressive disease per RECIST|8
7867098|NCT02564900|27278781|P8|Dose Expansion|Progressive disease per RECIST|17
7867099|NCT02564900|27278782|P7|Dose Expansion|Progressive disease per RECIST|19
7867100|NCT02564900|27278783|P6|Dose Expansion|Progressive disease per RECIST|0
7867101|NCT02564900|27278784|P5|Dose Expansion|Progressive disease per RECIST|0
7867102|NCT02564900|27278785|P4|Dose Expansion|Progressive disease per RECIST|0
7867103|NCT02564900|27278786|P3|Dose Expansion|Progressive disease per RECIST|0
7867104|NCT02564900|27278787|P2|Dose Expansion|Progressive disease per RECIST|0
7867105|NCT02564900|27278788|P1|Dose Expansion|Progressive disease per RECIST|0
7867106|NCT02564900|27278774|P15|Dose Escalation|Adverse Event|0
7867107|NCT02564900|27278775|P14|Dose Escalation|Adverse Event|0
7867108|NCT02564900|27278776|P13|Dose Escalation|Adverse Event|0
7867109|NCT02564900|27278777|P12|Dose Escalation|Adverse Event|0
7867110|NCT02564900|27278778|P11|Dose Escalation|Adverse Event|0
7867111|NCT02564900|27278779|P10|Dose Escalation|Adverse Event|0
7867112|NCT02564900|27278780|P9|Dose Escalation|Adverse Event|0
7867113|NCT02564900|27278781|P8|Dose Escalation|Adverse Event|0
7867114|NCT02564900|27278782|P7|Dose Escalation|Adverse Event|0
7867115|NCT02564900|27278783|P6|Dose Escalation|Adverse Event|3
7867116|NCT02564900|27278784|P5|Dose Escalation|Adverse Event|1
7867117|NCT02564900|27278785|P4|Dose Escalation|Adverse Event|1
7867118|NCT02564900|27278786|P3|Dose Escalation|Adverse Event|0
7867119|NCT02564900|27278787|P2|Dose Escalation|Adverse Event|0
7867120|NCT02564900|27278788|P1|Dose Escalation|Adverse Event|0
7867121|NCT02564900|27278774|P15|Dose Escalation|Ongoing|0
7867122|NCT02564900|27278775|P14|Dose Escalation|Ongoing|0
7867123|NCT02564900|27278776|P13|Dose Escalation|Ongoing|0
7867124|NCT02564900|27278777|P12|Dose Escalation|Ongoing|0
7867125|NCT02564900|27278778|P11|Dose Escalation|Ongoing|0
7867126|NCT02564900|27278779|P10|Dose Escalation|Ongoing|0
7867127|NCT02564900|27278780|P9|Dose Escalation|Ongoing|0
7867128|NCT02564900|27278781|P8|Dose Escalation|Ongoing|0
7867129|NCT02564900|27278782|P7|Dose Escalation|Ongoing|0
7867130|NCT02564900|27278783|P6|Dose Escalation|Ongoing|2
7867131|NCT02564900|27278784|P5|Dose Escalation|Ongoing|2
7867132|NCT02564900|27278785|P4|Dose Escalation|Ongoing|2
7867133|NCT02564900|27278786|P3|Dose Escalation|Ongoing|0
7867134|NCT02564900|27278787|P2|Dose Escalation|Ongoing|0
7867135|NCT02564900|27278788|P1|Dose Escalation|Ongoing|1
7867136|NCT02564900|27278774|P15|Dose Escalation|Progressive disease per RECIST|0
7867137|NCT02564900|27278775|P14|Dose Escalation|Progressive disease per RECIST|0
7867138|NCT02564900|27278776|P13|Dose Escalation|Progressive disease per RECIST|0
7867139|NCT02564900|27278777|P12|Dose Escalation|Progressive disease per RECIST|0
7867140|NCT02564900|27278778|P11|Dose Escalation|Progressive disease per RECIST|0
7867141|NCT02564900|27278779|P10|Dose Escalation|Progressive disease per RECIST|0
7867142|NCT02564900|27278780|P9|Dose Escalation|Progressive disease per RECIST|0
7867143|NCT02564900|27278781|P8|Dose Escalation|Progressive disease per RECIST|0
7867144|NCT02564900|27278782|P7|Dose Escalation|Progressive disease per RECIST|0
7867145|NCT02564900|27278783|P6|Dose Escalation|Progressive disease per RECIST|1
7867146|NCT02564900|27278784|P5|Dose Escalation|Progressive disease per RECIST|3
7867147|NCT02564900|27278785|P4|Dose Escalation|Progressive disease per RECIST|3
7867148|NCT02564900|27278786|P3|Dose Escalation|Progressive disease per RECIST|3
7867149|NCT02564900|27278787|P2|Dose Escalation|Progressive disease per RECIST|3
7867150|NCT02564900|27278788|P1|Dose Escalation|Progressive disease per RECIST|2
7867151|NCT02155712|27279006|P2|Primary Objective|Withdrawal by Subject|0
7867152|NCT02155712|27279007|P1|Primary Objective|Withdrawal by Subject|21
7867153|NCT02155712|27279006|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
7867154|NCT02155712|27279007|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
7867155|NCT02155712|27279006|P2|Primary Objective|No 2-Year Forms but not Terminated|0
7867156|NCT02155712|27279007|P1|Primary Objective|No 2-Year Forms but not Terminated|13
7867157|NCT02155712|27279006|P2|Primary Objective|Lost to Follow-up|0
7867158|NCT02155712|27279007|P1|Primary Objective|Lost to Follow-up|22
7867159|NCT02155712|27279006|P2|Primary Objective|Death|0
7867160|NCT02155712|27279007|P1|Primary Objective|Death|3
7867161|NCT01942135|27279015|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
7867162|NCT01942135|27279016|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
7867163|NCT01942135|27279015|P2|Overall Study|Withdrawal by Subject|2
7867164|NCT01942135|27279016|P1|Overall Study|Withdrawal by Subject|4
7867165|NCT01942135|27279015|P2|Overall Study|Participant Refused toContinue Treatment|1
7867166|NCT01942135|27279016|P1|Overall Study|Participant Refused toContinue Treatment|1
7867167|NCT01942135|27279015|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
7867168|NCT01942135|27279016|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
7867169|NCT01942135|27279015|P2|Overall Study|Death|1
7867170|NCT01942135|27279016|P1|Overall Study|Death|0
7867171|NCT01942135|27279015|P2|Overall Study|Randomized Not Treated|2
7867172|NCT01942135|27279016|P1|Overall Study|Randomized Not Treated|2
7867173|NCT01942135|27279015|P2|Overall Study|Global deterioration of health status|3
7867174|NCT01942135|27279016|P1|Overall Study|Global deterioration of health status|8
7867175|NCT01942135|27279015|P2|Overall Study|Adverse Event|3
7867176|NCT01942135|27279016|P1|Overall Study|Adverse Event|9
7867177|NCT01874353|27279055|P4|Overall Study|Withdrawal by Subject|0
7867178|NCT01874353|27279056|P3|Overall Study|Withdrawal by Subject|0
7867179|NCT01874353|27279057|P2|Overall Study|Withdrawal by Subject|11
7867180|NCT01874353|27279058|P1|Overall Study|Withdrawal by Subject|13
7867181|NCT01874353|27279055|P4|Overall Study|Death|7
7867182|NCT01874353|27279056|P3|Overall Study|Death|13
7867183|NCT01874353|27279057|P2|Overall Study|Death|60
7867184|NCT01874353|27279058|P1|Overall Study|Death|110
7867185|NCT01874353|27279055|P4|Overall Study|Lost to Follow-up|0
7867186|NCT01874353|27279056|P3|Overall Study|Lost to Follow-up|2
7867187|NCT01874353|27279057|P2|Overall Study|Lost to Follow-up|2
7867188|NCT01874353|27279058|P1|Overall Study|Lost to Follow-up|2
7867189|NCT01874353|27279055|P4|Overall Study|One patient was unblinded and one patient was randomised in error|0
7867190|NCT01874353|27279056|P3|Overall Study|One patient was unblinded and one patient was randomised in error|0
7867191|NCT01874353|27279057|P2|Overall Study|One patient was unblinded and one patient was randomised in error|0
7867192|NCT01874353|27279058|P1|Overall Study|One patient was unblinded and one patient was randomised in error|2
7867193|NCT00958789|27279127|P1|Overall Study|Revision|7
7867194|NCT00958789|27279127|P1|Overall Study|Subject terminated|2
7867195|NCT00958789|27279127|P1|Overall Study|2 yr. Knee Society Score not calculable|1
7867196|NCT00958789|27279127|P1|Overall Study|No 2 yr. Knee Society Score data|4
7867197|NCT00958789|27279127|P1|Overall Study|Withdrawal by Subject|17
7867198|NCT00958789|27279127|P1|Overall Study|Lost to Follow-up|14
7867199|NCT00958789|27279127|P1|Overall Study|Death|5
7867200|NCT00936858|27279145|P1|Overall Study|Lost to Follow-up|1
7867201|NCT00936858|27279145|P1|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
7867202|NCT00936858|27279145|P1|Overall Study|Physician Decision|7
7867203|NCT00936858|27279145|P1|Overall Study|Adverse Event|1
7867204|NCT00936858|27279145|P1|Overall Study|Withdrawal by Subject|5
7867205|NCT00936858|27279145|P1|Overall Study|Progression|29
7867206|NCT00936858|27279145|P1|Overall Study|Death|3
7867207|NCT04428411|27279152|P1|Overall Study|Lost to Follow-up|114
7867208|NCT03984812|27279190|P11|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867209|NCT03984812|27279191|P10|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867210|NCT03984812|27279192|P9|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867211|NCT03984812|27279193|P8|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867212|NCT03984812|27279194|P7|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867213|NCT03984812|27279195|P6|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867214|NCT03984812|27279196|P5|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867215|NCT03984812|27279197|P4|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867216|NCT03984812|27279198|P3|Part 1 (Up to Day 28)|Withdrawal by Subject|1
7867217|NCT03984812|27279199|P2|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867218|NCT03984812|27279200|P1|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7867219|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7867220|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
7867221|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7867222|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7867223|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Early Study Closure|0
7867224|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Early Study Closure|1
7867225|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Early Study Closure|0
7867226|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Early Study Closure|0
7867227|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7867228|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
7867229|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7867230|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7867231|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7867232|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7867233|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
7867234|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7867235|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7867236|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7867237|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
7867238|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7867239|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7867240|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7867241|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7867242|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
7867243|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
7867244|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7867245|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7867246|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7867247|NCT03739840|27279495|P4|Post-Treatment Period: Wk16-23|Adverse Event|0
7867248|NCT03739840|27279496|P3|Post-Treatment Period: Wk16-23|Adverse Event|0
7867249|NCT03739840|27279497|P2|Post-Treatment Period: Wk16-23|Adverse Event|0
7867250|NCT03739840|27279498|P1|Post-Treatment Period: Wk16-23|Adverse Event|3
7867251|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
7867252|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7867253|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7867254|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7867255|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
7867256|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7867257|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7867258|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7867259|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
7867260|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7867261|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7867262|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7867263|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7867264|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Premature Closure Of The Study|1
7867265|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7867266|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7867267|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7867268|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
7867269|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7867270|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7867271|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Study Early Closure|0
7867272|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Study Early Closure|1
7867273|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Study Early Closure|0
7867274|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Study Early Closure|0
7867275|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7867276|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7867277|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
7867278|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7867279|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Premature Program Termination|0
7867280|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Premature Program Termination|0
7867281|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Premature Program Termination|1
7867282|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Premature Program Termination|0
7867283|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7867284|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7867285|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
7867286|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7867287|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Promotor Decision|0
7867288|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Promotor Decision|0
7867289|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Promotor Decision|1
7867290|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Promotor Decision|0
7867291|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Sponsors Decision|3
7867292|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Sponsors Decision|1
7867293|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Sponsors Decision|2
7867294|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Sponsors Decision|3
7867295|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7867296|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7867297|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7867298|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
7867299|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Program Termination|1
7867300|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Program Termination|1
7867301|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Program Termination|0
7867302|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Program Termination|3
7867303|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Consent Withdrawn|1
7867304|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Consent Withdrawn|1
7867305|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Consent Withdrawn|3
7867306|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Consent Withdrawn|1
7867307|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Protocol Violation|0
7867308|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Protocol Violation|1
7867309|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Protocol Violation|0
7867310|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Protocol Violation|0
7867311|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Lack of Efficacy|3
7867312|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Lack of Efficacy|0
7867313|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Lack of Efficacy|1
7867314|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Lack of Efficacy|0
7867315|NCT03739840|27279495|P4|Treatment Period: Wk0-16|Adverse Event|12
7867316|NCT03739840|27279496|P3|Treatment Period: Wk0-16|Adverse Event|6
7867317|NCT03739840|27279497|P2|Treatment Period: Wk0-16|Adverse Event|6
7867318|NCT03739840|27279498|P1|Treatment Period: Wk0-16|Adverse Event|2
7867319|NCT03695367|27279542|P2|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
7867320|NCT03695367|27279543|P1|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
7867321|NCT03695367|27279542|P2|Overall Study|Withdrawal by Subject|1
7867322|NCT03695367|27279543|P1|Overall Study|Withdrawal by Subject|0
7867323|NCT03695367|27279542|P2|Overall Study|Lost to Follow-up|1
7867324|NCT03695367|27279543|P1|Overall Study|Lost to Follow-up|0
7867325|NCT03695367|27279542|P2|Overall Study|Missed the Day 28 visit.|0
7867326|NCT03695367|27279543|P1|Overall Study|Missed the Day 28 visit.|1
7867327|NCT03647488|27279579|P3|Overall Study|Participant refused to take investigational product|0
7867328|NCT03647488|27279580|P2|Overall Study|Participant refused to take investigational product|0
7867329|NCT03647488|27279581|P1|Overall Study|Participant refused to take investigational product|1
7867330|NCT03647488|27279579|P3|Overall Study|Clinical progression|0
7867331|NCT03647488|27279580|P2|Overall Study|Clinical progression|0
7867332|NCT03647488|27279581|P1|Overall Study|Clinical progression|2
7867333|NCT03647488|27279579|P3|Overall Study|Adverse Event|0
7867334|NCT03647488|27279580|P2|Overall Study|Adverse Event|0
7867335|NCT03647488|27279581|P1|Overall Study|Adverse Event|5
7867336|NCT03647488|27279579|P3|Overall Study|Progressive disease|0
7867337|NCT03647488|27279580|P2|Overall Study|Progressive disease|0
7867338|NCT03647488|27279581|P1|Overall Study|Progressive disease|10
7867339|NCT03535740|27279632|P1|Overall Study|Withdrawal by Subject|13
7867340|NCT03535740|27279632|P1|Overall Study|Lost to Follow-up|1
7867341|NCT03535740|27279632|P1|Overall Study|Death|34
7867342|NCT03535740|27279632|P1|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
7867343|NCT03414047|27279641|P4|Overall Study|Withdrawal by Subject|0
7867344|NCT03414047|27279642|P3|Overall Study|Withdrawal by Subject|2
7867345|NCT03414047|27279643|P2|Overall Study|Withdrawal by Subject|0
7867346|NCT03414047|27279644|P1|Overall Study|Withdrawal by Subject|1
7867347|NCT03414047|27279641|P4|Overall Study|Physician Decision|1
7867348|NCT03414047|27279642|P3|Overall Study|Physician Decision|0
7867349|NCT03414047|27279643|P2|Overall Study|Physician Decision|0
7867350|NCT03414047|27279644|P1|Overall Study|Physician Decision|1
7867351|NCT03414047|27279641|P4|Overall Study|Adverse Event|1
7867352|NCT03414047|27279642|P3|Overall Study|Adverse Event|1
7867353|NCT03414047|27279643|P2|Overall Study|Adverse Event|0
7867354|NCT03414047|27279644|P1|Overall Study|Adverse Event|0
7867355|NCT03367793|27279681|P6|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7867356|NCT03367793|27279682|P5|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7867357|NCT03367793|27279683|P4|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7867358|NCT03367793|27279684|P3|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
7867359|NCT03367793|27279685|P2|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7867360|NCT03367793|27279686|P1|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7867361|NCT03301831|27279729|P2|Overall Study|Withdrawal by Subject|0
7867362|NCT03301831|27279730|P1|Overall Study|Withdrawal by Subject|11
7867363|NCT03301831|27279729|P2|Overall Study|Protocol Violation|0
7867364|NCT03301831|27279730|P1|Overall Study|Protocol Violation|4
7867365|NCT03301831|27279729|P2|Overall Study|Lost to Follow-up|3
7867366|NCT03301831|27279730|P1|Overall Study|Lost to Follow-up|5
7867367|NCT03278106|27279744|P1|Overall Study|No protocol treatment|1
7867392|NCT02901548|27279802|P1|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
7867393|NCT02728102|27279820|P3|Overall Study|Withdrawal by Subject|2
7867394|NCT02728102|27279821|P2|Overall Study|Withdrawal by Subject|2
7867395|NCT02728102|27279822|P1|Overall Study|Withdrawal by Subject|0
7867396|NCT02728102|27279820|P3|Overall Study|Death|0
7867397|NCT02728102|27279821|P2|Overall Study|Death|0
7867398|NCT02728102|27279822|P1|Overall Study|Death|1
7867399|NCT02667912|27279970|P2|Overall Study|Withdrawal by Subject|0
7867400|NCT02667912|27279971|P1|Overall Study|Withdrawal by Subject|1
7867401|NCT02667912|27279970|P2|Overall Study|Withdrawal by Subject|2
7867402|NCT02667912|27279971|P1|Overall Study|Withdrawal by Subject|1
7867403|NCT02667912|27279970|P2|Overall Study|Death|1
7867404|NCT02667912|27279971|P1|Overall Study|Death|3
7867405|NCT02633501|27280029|P6|Overall Study|Lost to Follow-up|0
7867406|NCT02633501|27280030|P5|Overall Study|Lost to Follow-up|2
7867407|NCT02633501|27280031|P4|Overall Study|Lost to Follow-up|1
7867408|NCT02633501|27280032|P3|Overall Study|Lost to Follow-up|0
7867409|NCT02633501|27280033|P2|Overall Study|Lost to Follow-up|0
7867410|NCT02633501|27280034|P1|Overall Study|Lost to Follow-up|0
7867411|NCT02633501|27280029|P6|Overall Study|Various other reasons|11
7867412|NCT02633501|27280030|P5|Overall Study|Various other reasons|7
7867413|NCT02633501|27280031|P4|Overall Study|Various other reasons|1
7867414|NCT02633501|27280032|P3|Overall Study|Various other reasons|4
7867415|NCT02633501|27280033|P2|Overall Study|Various other reasons|2
7867416|NCT02633501|27280034|P1|Overall Study|Various other reasons|0
7867417|NCT02633501|27280029|P6|Overall Study|Withdrawal by Subject|3
7867418|NCT02633501|27280030|P5|Overall Study|Withdrawal by Subject|1
7867419|NCT02633501|27280031|P4|Overall Study|Withdrawal by Subject|2
7867420|NCT02633501|27280032|P3|Overall Study|Withdrawal by Subject|2
7867421|NCT02633501|27280033|P2|Overall Study|Withdrawal by Subject|1
7867422|NCT02633501|27280034|P1|Overall Study|Withdrawal by Subject|2
7867423|NCT02633501|27280029|P6|Overall Study|Adverse Event|1
7867424|NCT02633501|27280030|P5|Overall Study|Adverse Event|1
7867425|NCT02633501|27280031|P4|Overall Study|Adverse Event|0
7867426|NCT02633501|27280032|P3|Overall Study|Adverse Event|1
7867427|NCT02633501|27280033|P2|Overall Study|Adverse Event|0
7867428|NCT02633501|27280034|P1|Overall Study|Adverse Event|0
7867429|NCT02474355|27280053|P1|Overall Study|Death|1361
7867430|NCT02474355|27280053|P1|Overall Study|Withdrawal by Subject|124
7867431|NCT02474355|27280053|P1|Overall Study|Lost to Follow-up|98
7867432|NCT02474355|27280053|P1|Overall Study|Eligibility Criteria not Fulfilled|2
7867433|NCT02474355|27280053|P1|Overall Study|Other|43
7867434|NCT02434081|27280061|P1|Overall Study|Patient did not receive treatment for more than six weeks|1
7867435|NCT02434081|27280061|P1|Overall Study|Withdrawal by Subject|1
7867436|NCT02434081|27280061|P1|Overall Study|Physician Decision|2
7867437|NCT02434081|27280061|P1|Overall Study|Adverse Event|20
7867438|NCT02434081|27280061|P1|Overall Study|Progression|20
7867439|NCT02434081|27280061|P1|Overall Study|Death|2
7867440|NCT02434081|27280061|P1|Overall Study|Death (never started treatment)|2
7867441|NCT02337829|27280083|P4|Overall Study|discontinued for other reasons|4
7867442|NCT02337829|27280084|P3|Overall Study|discontinued for other reasons|1
7867443|NCT02337829|27280085|P2|Overall Study|discontinued for other reasons|3
7867444|NCT02337829|27280086|P1|Overall Study|discontinued for other reasons|6
7867445|NCT02337829|27280083|P4|Overall Study|Study terminated by sponsor|6
7867446|NCT02337829|27280084|P3|Overall Study|Study terminated by sponsor|5
7867447|NCT02337829|27280085|P2|Overall Study|Study terminated by sponsor|10
7867448|NCT02337829|27280086|P1|Overall Study|Study terminated by sponsor|12
7867449|NCT02337829|27280083|P4|Overall Study|Death|0
7867450|NCT02337829|27280084|P3|Overall Study|Death|0
7867451|NCT02337829|27280085|P2|Overall Study|Death|1
7867452|NCT02337829|27280086|P1|Overall Study|Death|0
7867453|NCT02332798|27280101|P3|Overall Study|Abnormal Laboratory Findings|0
7867454|NCT02332798|27280102|P2|Overall Study|Abnormal Laboratory Findings|0
7867455|NCT02332798|27280103|P1|Overall Study|Abnormal Laboratory Findings|1
7867456|NCT02332798|27280101|P3|Overall Study|Positive Urine Drug Test|0
7867457|NCT02332798|27280102|P2|Overall Study|Positive Urine Drug Test|1
7867458|NCT02332798|27280103|P1|Overall Study|Positive Urine Drug Test|0
7867459|NCT02332798|27280101|P3|Overall Study|Unwilling to Participate in Study|1
7867460|NCT02332798|27280102|P2|Overall Study|Unwilling to Participate in Study|1
7867461|NCT02332798|27280103|P1|Overall Study|Unwilling to Participate in Study|0
7867462|NCT02254278|27280159|P2|Overall Study|Protocol Violation|1
7867463|NCT02254278|27280160|P1|Overall Study|Protocol Violation|1
7867464|NCT02009384|27280183|P1|Overall Study|Death|2
7867465|NCT01995175|27280187|P1|Overall Study|Migrated / moved from the study area|49
7867466|NCT01995175|27280187|P1|Overall Study|Other|67
7867467|NCT01995175|27280187|P1|Overall Study|Lost to Follow-up|102
7867468|NCT01995175|27280187|P1|Overall Study|Withdrawal by Subject|35
7867469|NCT01951586|27280233|P2|Overall Study|Sponsor Decision|10
7867470|NCT01951586|27280234|P1|Overall Study|Sponsor Decision|9
7867471|NCT01951586|27280233|P2|Overall Study|Lost to Follow-up|1
7867472|NCT01951586|27280234|P1|Overall Study|Lost to Follow-up|0
7867473|NCT01951586|27280233|P2|Overall Study|Withdrawal by Subject|17
7867474|NCT01951586|27280234|P1|Overall Study|Withdrawal by Subject|8
7867475|NCT01951586|27280233|P2|Overall Study|Death|120
7867476|NCT01951586|27280234|P1|Overall Study|Death|61
7867477|NCT01889238|27280258|P1|Overall Study|Treatment ongoing|9
7867478|NCT01847274|27280279|P4|Overall Study|Non Compliance|0
7867479|NCT01847274|27280280|P3|Overall Study|Non Compliance|2
7867480|NCT01847274|27280281|P2|Overall Study|Non Compliance|0
7867481|NCT01847274|27280282|P1|Overall Study|Non Compliance|0
7867482|NCT01847274|27280279|P4|Overall Study|Other Reasons|3
7867483|NCT01847274|27280280|P3|Overall Study|Other Reasons|11
7867484|NCT01847274|27280281|P2|Overall Study|Other Reasons|1
7867485|NCT01847274|27280282|P1|Overall Study|Other Reasons|3
7867486|NCT01847274|27280279|P4|Overall Study|Treatment Associated Risk|0
7867487|NCT01847274|27280280|P3|Overall Study|Treatment Associated Risk|2
7867488|NCT01847274|27280281|P2|Overall Study|Treatment Associated Risk|2
7867489|NCT01847274|27280282|P1|Overall Study|Treatment Associated Risk|0
7867490|NCT01847274|27280279|P4|Overall Study|Disease Progression|98
7867491|NCT01847274|27280280|P3|Overall Study|Disease Progression|129
7867492|NCT01847274|27280281|P2|Overall Study|Disease Progression|49
7867493|NCT01847274|27280282|P1|Overall Study|Disease Progression|63
7867494|NCT01847274|27280279|P4|Overall Study|Withdrawal by Subject|1
7867495|NCT01847274|27280280|P3|Overall Study|Withdrawal by Subject|11
7867496|NCT01847274|27280281|P2|Overall Study|Withdrawal by Subject|8
7867497|NCT01847274|27280282|P1|Overall Study|Withdrawal by Subject|8
7867498|NCT01847274|27280279|P4|Overall Study|Adverse Event|2
7867499|NCT01847274|27280280|P3|Overall Study|Adverse Event|33
7867500|NCT01847274|27280281|P2|Overall Study|Adverse Event|1
7867501|NCT01847274|27280282|P1|Overall Study|Adverse Event|17
7867502|NCT01506609|27280342|P6|Overall Study|Missing / Unknown Reason|2
7867503|NCT01506609|27280343|P5|Overall Study|Missing / Unknown Reason|4
7867504|NCT01506609|27280344|P4|Overall Study|Missing / Unknown Reason|4
7867505|NCT01506609|27280345|P3|Overall Study|Missing / Unknown Reason|1
7867506|NCT01506609|27280346|P2|Overall Study|Missing / Unknown Reason|0
7867507|NCT01506609|27280347|P1|Overall Study|Missing / Unknown Reason|1
7867508|NCT01506609|27280342|P6|Overall Study|Other, Not Specified|3
7867509|NCT01506609|27280343|P5|Overall Study|Other, Not Specified|7
7867510|NCT01506609|27280344|P4|Overall Study|Other, Not Specified|10
7867511|NCT01506609|27280345|P3|Overall Study|Other, Not Specified|0
7867512|NCT01506609|27280346|P2|Overall Study|Other, Not Specified|0
7867513|NCT01506609|27280347|P1|Overall Study|Other, Not Specified|0
7867514|NCT01506609|27280342|P6|Overall Study|Progressive Disease per Protocol|74
7867515|NCT01506609|27280343|P5|Overall Study|Progressive Disease per Protocol|57
7867516|NCT01506609|27280344|P4|Overall Study|Progressive Disease per Protocol|64
7867517|NCT01506609|27280345|P3|Overall Study|Progressive Disease per Protocol|0
7867518|NCT01506609|27280346|P2|Overall Study|Progressive Disease per Protocol|0
7867519|NCT01506609|27280347|P1|Overall Study|Progressive Disease per Protocol|1
7867520|NCT01506609|27280342|P6|Overall Study|Sponsor Discontinued Study|0
7867521|NCT01506609|27280343|P5|Overall Study|Sponsor Discontinued Study|2
7867522|NCT01506609|27280344|P4|Overall Study|Sponsor Discontinued Study|2
7867523|NCT01506609|27280345|P3|Overall Study|Sponsor Discontinued Study|0
7867524|NCT01506609|27280346|P2|Overall Study|Sponsor Discontinued Study|0
7867525|NCT01506609|27280347|P1|Overall Study|Sponsor Discontinued Study|0
7867526|NCT01506609|27280342|P6|Overall Study|Lost to Follow-up|0
7867527|NCT01506609|27280343|P5|Overall Study|Lost to Follow-up|2
7867528|NCT01506609|27280344|P4|Overall Study|Lost to Follow-up|1
7867529|NCT01506609|27280345|P3|Overall Study|Lost to Follow-up|0
7867530|NCT01506609|27280346|P2|Overall Study|Lost to Follow-up|0
7867531|NCT01506609|27280347|P1|Overall Study|Lost to Follow-up|0
7867532|NCT01506609|27280342|P6|Overall Study|Withdrawal by Subject|7
7867533|NCT01506609|27280343|P5|Overall Study|Withdrawal by Subject|7
7867534|NCT01506609|27280344|P4|Overall Study|Withdrawal by Subject|9
7867535|NCT01506609|27280345|P3|Overall Study|Withdrawal by Subject|0
7867536|NCT01506609|27280346|P2|Overall Study|Withdrawal by Subject|0
7867537|NCT01506609|27280347|P1|Overall Study|Withdrawal by Subject|0
7867538|NCT01506609|27280342|P6|Overall Study|Adverse Event Not Related to Progression|5
7867539|NCT01506609|27280343|P5|Overall Study|Adverse Event Not Related to Progression|10
7867540|NCT01506609|27280344|P4|Overall Study|Adverse Event Not Related to Progression|6
7867541|NCT01506609|27280345|P3|Overall Study|Adverse Event Not Related to Progression|0
7867542|NCT01506609|27280346|P2|Overall Study|Adverse Event Not Related to Progression|1
7867543|NCT01506609|27280347|P1|Overall Study|Adverse Event Not Related to Progression|0
7867544|NCT01506609|27280342|P6|Overall Study|Adverse Event Related to Progression|3
7867545|NCT01506609|27280343|P5|Overall Study|Adverse Event Related to Progression|7
7867546|NCT01506609|27280344|P4|Overall Study|Adverse Event Related to Progression|3
7867547|NCT01506609|27280345|P3|Overall Study|Adverse Event Related to Progression|0
7867548|NCT01506609|27280346|P2|Overall Study|Adverse Event Related to Progression|0
7867549|NCT01506609|27280347|P1|Overall Study|Adverse Event Related to Progression|0
7867550|NCT01214421|27280398|P4|Overall Study|Withdrawal by Subject|2
7867551|NCT01214421|27280399|P3|Overall Study|Withdrawal by Subject|11
7867552|NCT01214421|27280400|P2|Overall Study|Withdrawal by Subject|18
7867553|NCT01214421|27280401|P1|Overall Study|Withdrawal by Subject|21
7867554|NCT01214421|27280398|P4|Overall Study|Physician Decision|0
7867555|NCT01214421|27280399|P3|Overall Study|Physician Decision|4
7867556|NCT01214421|27280400|P2|Overall Study|Physician Decision|0
7867557|NCT01214421|27280401|P1|Overall Study|Physician Decision|2
7867558|NCT01214421|27280398|P4|Overall Study|Withdrawal Criteria Met|1
7867559|NCT01214421|27280399|P3|Overall Study|Withdrawal Criteria Met|2
7867560|NCT01214421|27280400|P2|Overall Study|Withdrawal Criteria Met|0
7867561|NCT01214421|27280401|P1|Overall Study|Withdrawal Criteria Met|3
7867562|NCT01214421|27280398|P4|Overall Study|Sponsor Discontinued Site|0
7867563|NCT01214421|27280399|P3|Overall Study|Sponsor Discontinued Site|0
7867564|NCT01214421|27280400|P2|Overall Study|Sponsor Discontinued Site|2
7867565|NCT01214421|27280401|P1|Overall Study|Sponsor Discontinued Site|1
7867566|NCT01214421|27280398|P4|Overall Study|Adverse Event|3
7867567|NCT01214421|27280399|P3|Overall Study|Adverse Event|14
7867568|NCT01214421|27280400|P2|Overall Study|Adverse Event|35
7867569|NCT01214421|27280401|P1|Overall Study|Adverse Event|16
7867570|NCT01214421|27280398|P4|Overall Study|Lost to Follow-up|3
7867571|NCT01214421|27280399|P3|Overall Study|Lost to Follow-up|7
7867572|NCT01214421|27280400|P2|Overall Study|Lost to Follow-up|3
7867573|NCT01214421|27280401|P1|Overall Study|Lost to Follow-up|7
7867574|NCT01008150|27280423|P4|Overall Study|did not receive study drug|0
7867575|NCT01008150|27280424|P3|Overall Study|did not receive study drug|1
7867576|NCT01008150|27280425|P2|Overall Study|did not receive study drug|1
7867577|NCT01008150|27280426|P1|Overall Study|did not receive study drug|1
7867578|NCT00975676|27280458|P2|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
7867579|NCT00975676|27280459|P1|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
7867580|NCT00444535|27280497|P1|Overall Study|Adverse Event|2
7867581|NCT00444535|27280497|P1|Overall Study|progressive disease|1
7867582|NCT00444535|27280497|P1|Overall Study|Physician Decision|5
7867583|NCT00444535|27280497|P1|Overall Study|Withdrawal by Subject|5
7867584|NCT00095498|27280510|P3|Overall Study|Requirement for alternative therapy|2
7867585|NCT00095498|27280511|P2|Overall Study|Requirement for alternative therapy|0
7867586|NCT00095498|27280512|P1|Overall Study|Requirement for alternative therapy|1
7867587|NCT00095498|27280510|P3|Overall Study|Protocol Violation|1
7867588|NCT00095498|27280511|P2|Overall Study|Protocol Violation|0
7867589|NCT00095498|27280512|P1|Overall Study|Protocol Violation|0
7867590|NCT00095498|27280510|P3|Overall Study|Other|6
7867591|NCT00095498|27280511|P2|Overall Study|Other|7
7867592|NCT00095498|27280512|P1|Overall Study|Other|6
7867593|NCT00095498|27280510|P3|Overall Study|Noncompliance|1
7867594|NCT00095498|27280511|P2|Overall Study|Noncompliance|0
7867595|NCT00095498|27280512|P1|Overall Study|Noncompliance|1
7867596|NCT00095498|27280510|P3|Overall Study|Lost to Follow-up|2
7867597|NCT00095498|27280511|P2|Overall Study|Lost to Follow-up|1
7867598|NCT00095498|27280512|P1|Overall Study|Lost to Follow-up|1
7867599|NCT00095498|27280510|P3|Overall Study|Ineligibility determined|2
7867600|NCT00095498|27280511|P2|Overall Study|Ineligibility determined|0
7867601|NCT00095498|27280512|P1|Overall Study|Ineligibility determined|3
7867602|NCT00095498|27280510|P3|Overall Study|Disease progression|1
7867603|NCT00095498|27280511|P2|Overall Study|Disease progression|1
7867604|NCT00095498|27280512|P1|Overall Study|Disease progression|0
7867605|NCT00095498|27280510|P3|Overall Study|Withdrawal by Subject|15
7867606|NCT00095498|27280511|P2|Overall Study|Withdrawal by Subject|16
7867607|NCT00095498|27280512|P1|Overall Study|Withdrawal by Subject|15
7867608|NCT00095498|27280510|P3|Overall Study|Adverse Event|1
7867609|NCT00095498|27280511|P2|Overall Study|Adverse Event|0
7867610|NCT00095498|27280512|P1|Overall Study|Adverse Event|1
7867611|NCT00095498|27280510|P3|Overall Study|Physician Decision|8
7867612|NCT00095498|27280511|P2|Overall Study|Physician Decision|10
7867613|NCT00095498|27280512|P1|Overall Study|Physician Decision|9
7867614|NCT04558125|27280983|P1|Overall Study|Death|1
7867615|NCT04476784|27280990|P2|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
7867616|NCT04476784|27280991|P1|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
7867617|NCT03909971|27281015|P2|Overall Study|Death|6
7867618|NCT03909971|27281016|P1|Overall Study|Death|2
7867619|NCT03909971|27281015|P2|Overall Study|Progressive Disease|14
7867620|NCT03909971|27281016|P1|Overall Study|Progressive Disease|6
7867621|NCT03909971|27281015|P2|Overall Study|Global Deterioration of Health Status|1
7867622|NCT03909971|27281016|P1|Overall Study|Global Deterioration of Health Status|2
7867623|NCT03909971|27281015|P2|Overall Study|Other Reasons Not Specified|1
7867624|NCT03909971|27281016|P1|Overall Study|Other Reasons Not Specified|0
7867625|NCT03685344|27281097|P4|Overall Study|Death|0
7867626|NCT03685344|27281098|P3|Overall Study|Death|0
7867627|NCT03685344|27281099|P2|Overall Study|Death|1
7867628|NCT03685344|27281100|P1|Overall Study|Death|1
7867629|NCT03685344|27281097|P4|Overall Study|Physician Decision|0
7867630|NCT03685344|27281098|P3|Overall Study|Physician Decision|5
7867631|NCT03685344|27281099|P2|Overall Study|Physician Decision|1
7867632|NCT03685344|27281100|P1|Overall Study|Physician Decision|1
7867633|NCT03685344|27281097|P4|Overall Study|Withdrawal by Subject|0
7867634|NCT03685344|27281098|P3|Overall Study|Withdrawal by Subject|2
7867635|NCT03685344|27281099|P2|Overall Study|Withdrawal by Subject|1
7867636|NCT03685344|27281100|P1|Overall Study|Withdrawal by Subject|1
7867637|NCT03465722|27281185|P2|End of Study|On Treatment or in Follow Up|168
7867638|NCT03465722|27281186|P1|End of Study|On Treatment or in Follow Up|157
7867639|NCT03465722|27281185|P2|End of Study|Administrative/Other|2
7867640|NCT03465722|27281186|P1|End of Study|Administrative/Other|4
7867641|NCT03465722|27281185|P2|End of Study|Lost to Follow-up|2
7867642|NCT03465722|27281186|P1|End of Study|Lost to Follow-up|5
7867643|NCT03465722|27281185|P2|End of Study|Death|57
7867644|NCT03465722|27281186|P1|End of Study|Death|57
7867645|NCT03465722|27281185|P2|End of Study|Withdrawal by Subject|7
7867646|NCT03465722|27281186|P1|End of Study|Withdrawal by Subject|17
7867647|NCT03465722|27281185|P2|End of Treatment|Randomized But Not Treated|2
7867648|NCT03465722|27281186|P1|End of Treatment|Randomized But Not Treated|1
7867649|NCT03465722|27281185|P2|End of Treatment|Treatment Ongoing|94
7867650|NCT03465722|27281186|P1|End of Treatment|Treatment Ongoing|68
7867651|NCT03465722|27281185|P2|End of Treatment|Administrative/Other|3
7867652|NCT03465722|27281186|P1|End of Treatment|Administrative/Other|6
7867653|NCT03465722|27281185|P2|End of Treatment|Lost to Follow-up|1
7867654|NCT03465722|27281186|P1|End of Treatment|Lost to Follow-up|3
7867655|NCT03465722|27281185|P2|End of Treatment|Physician Decision|5
7867656|NCT03465722|27281186|P1|End of Treatment|Physician Decision|4
7867657|NCT03465722|27281185|P2|End of Treatment|Clinical Progression|5
7867658|NCT03465722|27281186|P1|End of Treatment|Clinical Progression|17
7867659|NCT03465722|27281185|P2|End of Treatment|Disease Progression (Confirmed by Central Review)|101
7867660|NCT03465722|27281186|P1|End of Treatment|Disease Progression (Confirmed by Central Review)|102
7867661|NCT03465722|27281185|P2|End of Treatment|Adverse Event|23
7867662|NCT03465722|27281186|P1|End of Treatment|Adverse Event|30
7867663|NCT03465722|27281185|P2|End of Treatment|Withdrawal by Subject|1
7867664|NCT03465722|27281186|P1|End of Treatment|Withdrawal by Subject|6
7867665|NCT03465722|27281185|P2|End of Treatment|Patient Refused Treatment|1
7867666|NCT03465722|27281186|P1|End of Treatment|Patient Refused Treatment|3
7867667|NCT03227757|27281257|P1|Overall Study|Missed visits|4
7867668|NCT03227757|27281257|P1|Overall Study|Withdrawal|5
7867669|NCT03227757|27281257|P1|Overall Study|Death|7
7867670|NCT03206073|27281266|P4|Overall Study|Taken off active treatment|0
7867671|NCT03206073|27281267|P3|Overall Study|Taken off active treatment|3
7867672|NCT03206073|27281268|P2|Overall Study|Taken off active treatment|0
7867673|NCT03206073|27281269|P1|Overall Study|Taken off active treatment|0
7867674|NCT03206073|27281266|P4|Overall Study|Death|0
7867675|NCT03206073|27281267|P3|Overall Study|Death|1
7867676|NCT03206073|27281268|P2|Overall Study|Death|0
7867677|NCT03206073|27281269|P1|Overall Study|Death|0
7867678|NCT03206073|27281266|P4|Overall Study|Unable to complete the dose limiting toxicity period|0
7867679|NCT03206073|27281267|P3|Overall Study|Unable to complete the dose limiting toxicity period|0
7867680|NCT03206073|27281268|P2|Overall Study|Unable to complete the dose limiting toxicity period|0
7867681|NCT03206073|27281269|P1|Overall Study|Unable to complete the dose limiting toxicity period|1
7867682|NCT03206073|27281266|P4|Overall Study|Participant Noncompliance|0
7867683|NCT03206073|27281267|P3|Overall Study|Participant Noncompliance|0
7867684|NCT03206073|27281268|P2|Overall Study|Participant Noncompliance|1
7867685|NCT03206073|27281269|P1|Overall Study|Participant Noncompliance|0
7867686|NCT03158688|27281301|P2|Overall Study|Lost to Follow-up|3
7867687|NCT03158688|27281302|P1|Overall Study|Lost to Follow-up|0
7867688|NCT03158688|27281301|P2|Overall Study|Decision by sponsor|3
7867689|NCT03158688|27281302|P1|Overall Study|Decision by sponsor|2
7867690|NCT03158688|27281301|P2|Overall Study|Withdrawal by Subject|14
7867691|NCT03158688|27281302|P1|Overall Study|Withdrawal by Subject|9
7867692|NCT03158688|27281301|P2|Overall Study|Death|59
7867693|NCT03158688|27281302|P1|Overall Study|Death|36
7867694|NCT03158688|27281301|P2|Overall Study|Continuing in study|233
7867695|NCT03158688|27281302|P1|Overall Study|Continuing in study|107
7867696|NCT03150056|27281338|P6|Overall Study|Ongoing in the study|0
7867697|NCT03150056|27281339|P5|Overall Study|Ongoing in the study|3
7867698|NCT03150056|27281340|P4|Overall Study|Ongoing in the study|1
7867699|NCT03150056|27281341|P3|Overall Study|Ongoing in the study|1
7867700|NCT03150056|27281342|P2|Overall Study|Ongoing in the study|0
7867701|NCT03150056|27281343|P1|Overall Study|Ongoing in the study|0
7867702|NCT03150056|27281338|P6|Overall Study|Death|10
7867703|NCT03150056|27281339|P5|Overall Study|Death|8
7867704|NCT03150056|27281340|P4|Overall Study|Death|7
7867705|NCT03150056|27281341|P3|Overall Study|Death|2
7867706|NCT03150056|27281342|P2|Overall Study|Death|2
7867707|NCT03150056|27281343|P1|Overall Study|Death|9
7867708|NCT03150056|27281338|P6|Overall Study|Study terminated by Sponsor|6
7867709|NCT03150056|27281339|P5|Overall Study|Study terminated by Sponsor|5
7867710|NCT03150056|27281340|P4|Overall Study|Study terminated by Sponsor|1
7867711|NCT03150056|27281341|P3|Overall Study|Study terminated by Sponsor|1
7867712|NCT03150056|27281342|P2|Overall Study|Study terminated by Sponsor|3
7867713|NCT03150056|27281343|P1|Overall Study|Study terminated by Sponsor|1
7867714|NCT03150056|27281338|P6|Overall Study|Withdrawal by Subject|2
7867715|NCT03150056|27281339|P5|Overall Study|Withdrawal by Subject|0
7867716|NCT03150056|27281340|P4|Overall Study|Withdrawal by Subject|0
7867717|NCT03150056|27281341|P3|Overall Study|Withdrawal by Subject|0
7867718|NCT03150056|27281342|P2|Overall Study|Withdrawal by Subject|0
7867719|NCT03150056|27281343|P1|Overall Study|Withdrawal by Subject|0
7867720|NCT02829918|27281544|P1|Overall Study|Progression|1
7867721|NCT02829918|27281544|P1|Overall Study|Adverse Event|1
7867722|NCT02829918|27281544|P1|Overall Study|Withdrawal by Subject|4
7867723|NCT02829918|27281544|P1|Overall Study|Death|2
7867724|NCT02828358|27281551|P2|Overall Study|Still on therapy|0
7867725|NCT02828358|27281552|P1|Overall Study|Still on therapy|5
7867726|NCT02828358|27281551|P2|Overall Study|Relapse|0
7867727|NCT02828358|27281552|P1|Overall Study|Relapse|25
7867728|NCT02828358|27281551|P2|Overall Study|Refusal of further protocol therapy|0
7867729|NCT02828358|27281552|P1|Overall Study|Refusal of further protocol therapy|2
7867730|NCT02828358|27281551|P2|Overall Study|Patients without KMT2A rearrangement|21
7867731|NCT02828358|27281552|P1|Overall Study|Patients without KMT2A rearrangement|0
7867732|NCT02828358|27281551|P2|Overall Study|Treatment Failure|0
7867733|NCT02828358|27281552|P1|Overall Study|Treatment Failure|6
7867734|NCT02828358|27281551|P2|Overall Study|Physician Decision|1
7867735|NCT02828358|27281552|P1|Overall Study|Physician Decision|7
7867736|NCT02687451|27281569|P6|Overall Study|Withdrawal by Subject|1
7867737|NCT02687451|27281570|P5|Overall Study|Withdrawal by Subject|0
7867738|NCT02687451|27281571|P4|Overall Study|Withdrawal by Subject|0
7867739|NCT02687451|27281572|P3|Overall Study|Withdrawal by Subject|0
7867740|NCT02687451|27281573|P2|Overall Study|Withdrawal by Subject|0
7867741|NCT02687451|27281574|P1|Overall Study|Withdrawal by Subject|1
7867742|NCT02629822|27281623|P1|Extension Study|Lost to Follow-up|1
7867743|NCT02629822|27281623|P1|Extension Study|Adverse Event|1
7867744|NCT02629822|27281623|P1|Base Study|Non-Compliance With Study Drug|1
7867745|NCT02629822|27281623|P1|Base Study|Lost to Follow-up|2
7867746|NCT02608684|27281641|P1|Overall Study|Withdrawal by Subject|1
7867747|NCT02608684|27281641|P1|Overall Study|Physician Decision|2
7867748|NCT02493712|27281654|P3|Overall Study|Lack of Efficacy|3
7867749|NCT02493712|27281655|P2|Overall Study|Lack of Efficacy|5
7867750|NCT02493712|27281656|P1|Overall Study|Lack of Efficacy|0
7867751|NCT02493712|27281654|P3|Overall Study|Physician Decision|0
7867752|NCT02493712|27281655|P2|Overall Study|Physician Decision|1
7867753|NCT02493712|27281656|P1|Overall Study|Physician Decision|0
7867754|NCT02493712|27281654|P3|Overall Study|Lost to Follow-up|0
7867755|NCT02493712|27281655|P2|Overall Study|Lost to Follow-up|0
7867756|NCT02493712|27281656|P1|Overall Study|Lost to Follow-up|1
7867757|NCT02493712|27281654|P3|Overall Study|Protocol Violation|1
7867758|NCT02493712|27281655|P2|Overall Study|Protocol Violation|0
7867759|NCT02493712|27281656|P1|Overall Study|Protocol Violation|0
7867760|NCT02493712|27281654|P3|Overall Study|Withdrawal by Subject|2
7867761|NCT02493712|27281655|P2|Overall Study|Withdrawal by Subject|0
7867762|NCT02493712|27281656|P1|Overall Study|Withdrawal by Subject|1
7867763|NCT02401308|27281669|P2|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
7867764|NCT02401308|27281670|P1|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
7867765|NCT02394275|27281680|P1|Overall Study|Lost to Follow-up|7
7867766|NCT02394275|27281680|P1|Overall Study|Adverse Event|22
7867767|NCT02291432|27281685|P1|Overall Study|Withdrawal by Subject|2
7867768|NCT02266888|27281700|P4|Overall Study|Transfer of care|0
7867769|NCT02266888|27281701|P3|Overall Study|Transfer of care|1
7867770|NCT02266888|27281702|P2|Overall Study|Transfer of care|0
7867771|NCT02266888|27281703|P1|Overall Study|Transfer of care|0
7867772|NCT02266888|27281700|P4|Overall Study|Personnel unavailable at transplant|1
7867773|NCT02266888|27281701|P3|Overall Study|Personnel unavailable at transplant|0
7867774|NCT02266888|27281702|P2|Overall Study|Personnel unavailable at transplant|0
7867775|NCT02266888|27281703|P1|Overall Study|Personnel unavailable at transplant|0
7867776|NCT02266888|27281700|P4|Overall Study|Randomization Closed|0
7867777|NCT02266888|27281701|P3|Overall Study|Randomization Closed|4
7867778|NCT02266888|27281702|P2|Overall Study|Randomization Closed|0
7867779|NCT02266888|27281703|P1|Overall Study|Randomization Closed|0
7867780|NCT02266888|27281700|P4|Overall Study|No Longer Eligible|2
7867781|NCT02266888|27281701|P3|Overall Study|No Longer Eligible|0
7867782|NCT02266888|27281702|P2|Overall Study|No Longer Eligible|0
7867783|NCT02266888|27281703|P1|Overall Study|No Longer Eligible|0
7867784|NCT02266888|27281700|P4|Overall Study|Study Terminated|0
7867785|NCT02266888|27281701|P3|Overall Study|Study Terminated|0
7867786|NCT02266888|27281702|P2|Overall Study|Study Terminated|1
7867787|NCT02266888|27281703|P1|Overall Study|Study Terminated|5
7867788|NCT02266888|27281700|P4|Overall Study|Physician Decision|2
7867789|NCT02266888|27281701|P3|Overall Study|Physician Decision|2
7867790|NCT02266888|27281702|P2|Overall Study|Physician Decision|1
7867791|NCT02266888|27281703|P1|Overall Study|Physician Decision|0
7867792|NCT02266888|27281700|P4|Overall Study|Death|2
7867793|NCT02266888|27281701|P3|Overall Study|Death|4
7867794|NCT02266888|27281702|P2|Overall Study|Death|2
7867795|NCT02266888|27281703|P1|Overall Study|Death|2
7867796|NCT02068118|27281742|P2|Extension Period|Wrong device use|1
7867797|NCT02068118|27281743|P1|Extension Period|Wrong device use|0
7867798|NCT02068118|27281742|P2|Extension Period|Heart transplant|0
7867799|NCT02068118|27281743|P1|Extension Period|Heart transplant|1
7867800|NCT02068118|27281742|P2|Extension Period|Withdrawal by Subject|0
7867801|NCT02068118|27281743|P1|Extension Period|Withdrawal by Subject|1
7867802|NCT02068118|27281742|P2|Extension Period|Death|2
7867803|NCT02068118|27281743|P1|Extension Period|Death|0
7867804|NCT02068118|27281742|P2|18-month Comparative Study Period|Hearing loss|1
7867805|NCT02068118|27281743|P1|18-month Comparative Study Period|Hearing loss|0
7867806|NCT02068118|27281742|P2|18-month Comparative Study Period|Move|1
7867807|NCT02068118|27281743|P1|18-month Comparative Study Period|Move|0
7867808|NCT02068118|27281742|P2|18-month Comparative Study Period|Alzheimer's disease|1
7867809|NCT02068118|27281743|P1|18-month Comparative Study Period|Alzheimer's disease|0
7867810|NCT02068118|27281742|P2|18-month Comparative Study Period|Hemiplegia|1
7867811|NCT02068118|27281743|P1|18-month Comparative Study Period|Hemiplegia|0
7867812|NCT02068118|27281742|P2|18-month Comparative Study Period|Inclusion in another protocol|2
7867813|NCT02068118|27281743|P1|18-month Comparative Study Period|Inclusion in another protocol|0
7867814|NCT02068118|27281742|P2|18-month Comparative Study Period|Heart transplant|15
7867815|NCT02068118|27281743|P1|18-month Comparative Study Period|Heart transplant|9
7867816|NCT02068118|27281742|P2|18-month Comparative Study Period|Lost to Follow-up|7
7867817|NCT02068118|27281743|P1|18-month Comparative Study Period|Lost to Follow-up|6
7867818|NCT02068118|27281742|P2|18-month Comparative Study Period|Withdrawal by Subject|52
7867819|NCT02068118|27281743|P1|18-month Comparative Study Period|Withdrawal by Subject|23
7867820|NCT02068118|27281742|P2|18-month Comparative Study Period|Death|97
7867821|NCT02068118|27281743|P1|18-month Comparative Study Period|Death|90
7867822|NCT01665768|27281789|P1|Overall Study|Withdrawal by Subject|1
7867823|NCT01665768|27281789|P1|Overall Study|Lack of Efficacy|19
7867824|NCT01665768|27281789|P1|Overall Study|Adverse Event|3
7867825|NCT01615029|27281801|P5|Overall Study|Ongoing|23
7867826|NCT01615029|27281802|P4|Overall Study|Ongoing|2
7867827|NCT01615029|27281803|P3|Overall Study|Ongoing|3
7867828|NCT01615029|27281804|P2|Overall Study|Ongoing|2
7867829|NCT01615029|27281805|P1|Overall Study|Ongoing|1
7867830|NCT01615029|27281801|P5|Overall Study|Physician Decision|1
7867831|NCT01615029|27281802|P4|Overall Study|Physician Decision|0
7867832|NCT01615029|27281803|P3|Overall Study|Physician Decision|0
7867833|NCT01615029|27281804|P2|Overall Study|Physician Decision|0
7867834|NCT01615029|27281805|P1|Overall Study|Physician Decision|0
7867835|NCT01615029|27281801|P5|Overall Study|Progressive disease|5
7867836|NCT01615029|27281802|P4|Overall Study|Progressive disease|1
7867837|NCT01615029|27281803|P3|Overall Study|Progressive disease|1
7867838|NCT01615029|27281804|P2|Overall Study|Progressive disease|1
7867839|NCT01615029|27281805|P1|Overall Study|Progressive disease|2
7867840|NCT01615029|27281801|P5|Overall Study|Lost to Follow-up|1
7867841|NCT01615029|27281802|P4|Overall Study|Lost to Follow-up|0
7867842|NCT01615029|27281803|P3|Overall Study|Lost to Follow-up|0
7867843|NCT01615029|27281804|P2|Overall Study|Lost to Follow-up|0
7867844|NCT01615029|27281805|P1|Overall Study|Lost to Follow-up|0
7867845|NCT01615029|27281801|P5|Overall Study|Death|1
7867846|NCT01615029|27281802|P4|Overall Study|Death|0
7867847|NCT01615029|27281803|P3|Overall Study|Death|0
7867848|NCT01615029|27281804|P2|Overall Study|Death|0
7867849|NCT01615029|27281805|P1|Overall Study|Death|0
7867850|NCT01615029|27281801|P5|Overall Study|Adverse Event|1
7867851|NCT01615029|27281802|P4|Overall Study|Adverse Event|0
7867852|NCT01615029|27281803|P3|Overall Study|Adverse Event|0
7867853|NCT01615029|27281804|P2|Overall Study|Adverse Event|0
7867854|NCT01615029|27281805|P1|Overall Study|Adverse Event|0
7867855|NCT01393821|27281828|P2|Overall Study|not evaluable for primary endpoint|2
7867856|NCT01393821|27281829|P1|Overall Study|not evaluable for primary endpoint|4
7867857|NCT01393821|27281828|P2|Overall Study|Cancel|1
7867858|NCT01393821|27281829|P1|Overall Study|Cancel|1
7867859|NCT01261247|27281856|P1|Overall Study|Ineligible|2
7867860|NCT01111552|27281869|P5|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7867861|NCT01111552|27281870|P4|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7867862|NCT01111552|27281871|P3|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
7867863|NCT01111552|27281872|P2|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7867864|NCT01111552|27281873|P1|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7867865|NCT01111552|27281869|P5|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7867866|NCT01111552|27281870|P4|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7867867|NCT01111552|27281871|P3|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7867868|NCT01111552|27281872|P2|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
7867869|NCT01111552|27281873|P1|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7867870|NCT01111552|27281869|P5|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7867871|NCT01111552|27281870|P4|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7867872|NCT01111552|27281871|P3|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7867873|NCT01111552|27281872|P2|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
7867874|NCT01111552|27281873|P1|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7867875|NCT01111552|27281869|P5|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7867876|NCT01111552|27281870|P4|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7867877|NCT01111552|27281871|P3|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7867878|NCT01111552|27281872|P2|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
7867879|NCT01111552|27281873|P1|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7867880|NCT01111552|27281869|P5|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7867881|NCT01111552|27281870|P4|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7867882|NCT01111552|27281871|P3|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
7867883|NCT01111552|27281872|P2|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7867884|NCT01111552|27281873|P1|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7867885|NCT01111552|27281869|P5|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7867886|NCT01111552|27281870|P4|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
7867887|NCT01111552|27281871|P3|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7867888|NCT01111552|27281872|P2|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7867889|NCT01111552|27281873|P1|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7867890|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7867891|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7867892|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7867893|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7867894|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
7867895|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7867896|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7867897|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7867898|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7867899|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Protocol Deviation|1
7867900|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7867901|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7867902|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7867903|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7867904|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
7867905|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7867906|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7867907|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7867908|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7867993|NCT04381988|27282108|P1|Overall Study|The study was terminated|4
7867909|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
7867910|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7867911|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7867912|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7867913|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7867914|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
7867915|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7867916|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7867917|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7867918|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7867919|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
7867920|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Adverse Event|0
7867921|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Adverse Event|0
7867922|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Adverse Event|0
7867923|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Adverse Event|0
7867924|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Adverse Event|4
7867925|NCT01111552|27281869|P5|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7867926|NCT01111552|27281870|P4|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7867927|NCT01111552|27281871|P3|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7867928|NCT01111552|27281872|P2|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7867929|NCT01111552|27281873|P1|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
7867930|NCT00887432|27281891|P2|Overall Study|No reason provided|1
7867931|NCT00887432|27281892|P1|Overall Study|No reason provided|0
7867932|NCT00887432|27281891|P2|Overall Study|Lost to Follow-up|0
7867933|NCT00887432|27281892|P1|Overall Study|Lost to Follow-up|1
7867934|NCT00887432|27281891|P2|Overall Study|Withdrawal by Subject|2
7867935|NCT00887432|27281892|P1|Overall Study|Withdrawal by Subject|3
7867936|NCT00887432|27281891|P2|Overall Study|Protocol Violation|3
7867937|NCT00887432|27281892|P1|Overall Study|Protocol Violation|2
7867938|NCT00887432|27281891|P2|Overall Study|Did not complete treatment|8
7867939|NCT00887432|27281892|P1|Overall Study|Did not complete treatment|6
7867940|NCT00887432|27281891|P2|Overall Study|Start Excluded Therapy|0
7867941|NCT00887432|27281892|P1|Overall Study|Start Excluded Therapy|3
7867942|NCT00612352|27281904|P2|Overall Study|didn't return calls/show up on test date|1
7867943|NCT00612352|27281905|P1|Overall Study|didn't return calls/show up on test date|4
7867944|NCT00612352|27281904|P2|Overall Study|moved out of state|0
7867945|NCT00612352|27281905|P1|Overall Study|moved out of state|1
7867946|NCT00612352|27281904|P2|Overall Study|Withdrawal by Subject|5
7867947|NCT00612352|27281905|P1|Overall Study|Withdrawal by Subject|3
7867948|NCT00612352|27281904|P2|Overall Study|Adverse Event|0
7867949|NCT00612352|27281905|P1|Overall Study|Adverse Event|1
7867950|NCT00592501|27282019|P1|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
7867951|NCT00592501|27282019|P1|Overall Study|Withdrawal by Subject|1
7867952|NCT00504582|27282035|P3|Overall Study|Lost to Follow-up|0
7867953|NCT00504582|27282036|P2|Overall Study|Lost to Follow-up|0
7867954|NCT00504582|27282037|P1|Overall Study|Lost to Follow-up|1
7867955|NCT00381641|27282050|P2|Overall Study|Withdrawal by Subject|2
7867956|NCT00381641|27282051|P1|Overall Study|Withdrawal by Subject|0
7867957|NCT00334815|27282065|P2|Overall Study|Physician Decision|4
7867958|NCT00334815|27282066|P1|Overall Study|Physician Decision|2
7867959|NCT00334815|27282065|P2|Overall Study|patient refused treatment|1
7867960|NCT00334815|27282066|P1|Overall Study|patient refused treatment|0
7867961|NCT00334815|27282065|P2|Overall Study|ineligible|1
7867962|NCT00334815|27282066|P1|Overall Study|ineligible|1
7867963|NCT00334815|27282065|P2|Overall Study|Progression|0
7867964|NCT00334815|27282066|P1|Overall Study|Progression|1
7867965|NCT00334815|27282065|P2|Overall Study|Death|2
7867966|NCT00334815|27282066|P1|Overall Study|Death|0
7867967|NCT00334815|27282065|P2|Overall Study|Adverse Event|2
7867968|NCT00334815|27282066|P1|Overall Study|Adverse Event|3
7867969|NCT00286234|27282082|P4|Overall Study|Adverse Event|1
7867970|NCT00286234|27282083|P3|Overall Study|Adverse Event|0
7867971|NCT00286234|27282084|P2|Overall Study|Adverse Event|0
7867972|NCT00286234|27282085|P1|Overall Study|Adverse Event|0
7867973|NCT00286234|27282082|P4|Overall Study|Adverse Event|1
7867974|NCT00286234|27282083|P3|Overall Study|Adverse Event|0
7867975|NCT00286234|27282084|P2|Overall Study|Adverse Event|0
7867976|NCT00286234|27282085|P1|Overall Study|Adverse Event|0
7867977|NCT00286234|27282082|P4|Overall Study|Physician Decision|1
7867978|NCT00286234|27282083|P3|Overall Study|Physician Decision|0
7867979|NCT00286234|27282084|P2|Overall Study|Physician Decision|0
7867980|NCT00286234|27282085|P1|Overall Study|Physician Decision|1
7867981|NCT00286234|27282082|P4|Overall Study|Protocol Violation|1
7867982|NCT00286234|27282083|P3|Overall Study|Protocol Violation|0
7867983|NCT00286234|27282084|P2|Overall Study|Protocol Violation|2
7867984|NCT00286234|27282085|P1|Overall Study|Protocol Violation|1
7867985|NCT00193050|27282099|P1|Adjuvant|Lack of Efficacy|2
7867986|NCT00193050|27282099|P1|Adjuvant|Intercurrent Hospitalization|3
7867987|NCT00193050|27282099|P1|Adjuvant|Physician Decision|5
7867988|NCT00193050|27282099|P1|Neoadjuvant Treatment|Adverse Event|2
7867989|NCT00193050|27282099|P1|Neoadjuvant Treatment|Physician Decision|2
7867990|NCT00193050|27282099|P1|Neoadjuvant Treatment|Intercurrent Illness|3
7867991|NCT00193050|27282099|P1|Neoadjuvant Treatment|Lack of Efficacy|2
7867992|NCT04381988|27282107|P2|Overall Study|The study was terminated|0
7867994|NCT04043143|27282144|P2|Overall Study|screen failure|0
7867995|NCT04043143|27282145|P1|Overall Study|screen failure|1
7867996|NCT04043143|27282144|P2|Overall Study|Lost to Follow-up|5
7867997|NCT04043143|27282145|P1|Overall Study|Lost to Follow-up|5
7867998|NCT04013529|27282169|P2|Overall Study|Withdrawal by Subject|1
7867999|NCT04013529|27282170|P1|Overall Study|Withdrawal by Subject|1
7868000|NCT03885596|27282214|P4|Overall Study|Withdrawal by Subject|0
7868001|NCT03885596|27282215|P3|Overall Study|Withdrawal by Subject|0
7868002|NCT03885596|27282216|P2|Overall Study|Withdrawal by Subject|1
7868003|NCT03885596|27282217|P1|Overall Study|Withdrawal by Subject|2
7868004|NCT03829228|27282258|P1|Overall Study|Protocol Violation|1
7868005|NCT03772587|27282270|P5|Overall Study|Withdrawal by Subject|0
7868006|NCT03772587|27282271|P4|Overall Study|Withdrawal by Subject|0
7868007|NCT03772587|27282272|P3|Overall Study|Withdrawal by Subject|0
7868008|NCT03772587|27282273|P2|Overall Study|Withdrawal by Subject|0
7868009|NCT03772587|27282274|P1|Overall Study|Withdrawal by Subject|1
7868010|NCT03772587|27282270|P5|Overall Study|COVID-19|0
7868011|NCT03772587|27282271|P4|Overall Study|COVID-19|1
7868012|NCT03772587|27282272|P3|Overall Study|COVID-19|1
7868013|NCT03772587|27282273|P2|Overall Study|COVID-19|0
7868014|NCT03772587|27282274|P1|Overall Study|COVID-19|0
7868015|NCT03607994|27282387|P2|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
7868016|NCT03607994|27282388|P1|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
7868017|NCT03607695|27282396|P1|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
7868018|NCT03607695|27282396|P1|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
7868019|NCT03597347|27282404|P3|Overall Study|Sponsor decision to terminate study|4
7868020|NCT03597347|27282405|P2|Overall Study|Sponsor decision to terminate study|2
7868021|NCT03597347|27282406|P1|Overall Study|Sponsor decision to terminate study|3
7868022|NCT03597347|27282404|P3|Overall Study|Withdrawal due to Covid-19|0
7868023|NCT03597347|27282405|P2|Overall Study|Withdrawal due to Covid-19|0
7868024|NCT03597347|27282406|P1|Overall Study|Withdrawal due to Covid-19|3
7868025|NCT03597347|27282404|P3|Overall Study|Withdrawal by Subject|0
7868026|NCT03597347|27282405|P2|Overall Study|Withdrawal by Subject|1
7868027|NCT03597347|27282406|P1|Overall Study|Withdrawal by Subject|1
7868028|NCT03504917|27282434|P2|Open Label Extension Treatment Period|Study terminated by sponsor|88
7868029|NCT03504917|27282435|P1|Open Label Extension Treatment Period|Study terminated by sponsor|81
7868030|NCT03504917|27282434|P2|Open Label Extension Treatment Period|Non-compliance with study drug|1
7868031|NCT03504917|27282435|P1|Open Label Extension Treatment Period|Non-compliance with study drug|0
7868032|NCT03504917|27282434|P2|Open Label Extension Treatment Period|Adverse Event|0
7868033|NCT03504917|27282435|P1|Open Label Extension Treatment Period|Adverse Event|7
7868034|NCT03504917|27282434|P2|Open Label Extension Treatment Period|Lack of Efficacy|1
7868035|NCT03504917|27282435|P1|Open Label Extension Treatment Period|Lack of Efficacy|3
7868036|NCT03504917|27282434|P2|Open Label Extension Treatment Period|Lost to Follow-up|4
7868037|NCT03504917|27282435|P1|Open Label Extension Treatment Period|Lost to Follow-up|1
7868038|NCT03504917|27282434|P2|Open Label Extension Treatment Period|Withdrawal by Subject|2
7868039|NCT03504917|27282435|P1|Open Label Extension Treatment Period|Withdrawal by Subject|8
7868040|NCT03504917|27282434|P2|Open Label Extension Treatment Period|The participant left the study site|1
7868041|NCT03504917|27282435|P1|Open Label Extension Treatment Period|The participant left the study site|0
7868042|NCT03504917|27282434|P2|Blinded Treatment Period|Non-compliance with study drug|1
7868043|NCT03504917|27282435|P1|Blinded Treatment Period|Non-compliance with study drug|0
7868044|NCT03504917|27282434|P2|Blinded Treatment Period|Study terminated by sponsor|34
7868045|NCT03504917|27282435|P1|Blinded Treatment Period|Study terminated by sponsor|39
7868046|NCT03504917|27282434|P2|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
7868047|NCT03504917|27282435|P1|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
7868048|NCT03504917|27282434|P2|Blinded Treatment Period|Physician Decision|0
7868049|NCT03504917|27282435|P1|Blinded Treatment Period|Physician Decision|1
7868050|NCT03504917|27282434|P2|Blinded Treatment Period|Adverse Event|4
7868051|NCT03504917|27282435|P1|Blinded Treatment Period|Adverse Event|4
7868052|NCT03504917|27282434|P2|Blinded Treatment Period|Lost to Follow-up|4
7868053|NCT03504917|27282435|P1|Blinded Treatment Period|Lost to Follow-up|1
7868054|NCT03504917|27282434|P2|Blinded Treatment Period|Lack of Efficacy|1
7868055|NCT03504917|27282435|P1|Blinded Treatment Period|Lack of Efficacy|1
7868056|NCT03504917|27282434|P2|Blinded Treatment Period|Withdrawal by Subject|9
7868057|NCT03504917|27282435|P1|Blinded Treatment Period|Withdrawal by Subject|12
7868058|NCT03504917|27282434|P2|Blinded Treatment Period|Protocol Violation|0
7868059|NCT03504917|27282435|P1|Blinded Treatment Period|Protocol Violation|1
7868060|NCT03387462|27282500|P1|Overall Study|Lost to Follow-up|1
7868061|NCT03295721|27282510|P3|Overall Study|Death|1
7868062|NCT03295721|27282511|P2|Overall Study|Death|0
7868063|NCT03295721|27282512|P1|Overall Study|Death|0
7868064|NCT03295721|27282510|P3|Overall Study|Withdrawal by Subject|1
7868065|NCT03295721|27282511|P2|Overall Study|Withdrawal by Subject|0
7868066|NCT03295721|27282512|P1|Overall Study|Withdrawal by Subject|1
7868067|NCT03295721|27282510|P3|Overall Study|Lost to Follow-up|1
7868068|NCT03295721|27282511|P2|Overall Study|Lost to Follow-up|1
7868069|NCT03295721|27282512|P1|Overall Study|Lost to Follow-up|1
7868070|NCT03295721|27282510|P3|Overall Study|Adverse Event|0
7868071|NCT03295721|27282511|P2|Overall Study|Adverse Event|0
7868072|NCT03295721|27282512|P1|Overall Study|Adverse Event|1
7868073|NCT03287245|27282531|P4|Overall Study|Physician Decision|0
7868074|NCT03287245|27282532|P3|Overall Study|Physician Decision|0
7868075|NCT03287245|27282533|P2|Overall Study|Physician Decision|2
7868076|NCT03287245|27282534|P1|Overall Study|Physician Decision|3
7868077|NCT03287245|27282531|P4|Overall Study|Withdrawal by Subject|0
7868078|NCT03287245|27282532|P3|Overall Study|Withdrawal by Subject|3
7868079|NCT03287245|27282533|P2|Overall Study|Withdrawal by Subject|3
7868080|NCT03287245|27282534|P1|Overall Study|Withdrawal by Subject|8
7868081|NCT03287245|27282531|P4|Overall Study|Adverse Event|0
7868082|NCT03287245|27282532|P3|Overall Study|Adverse Event|0
7868083|NCT03287245|27282533|P2|Overall Study|Adverse Event|0
7868084|NCT03287245|27282534|P1|Overall Study|Adverse Event|1
7868085|NCT03287245|27282531|P4|Overall Study|Study terminated by sponsor|1
7868086|NCT03287245|27282532|P3|Overall Study|Study terminated by sponsor|3
7868087|NCT03287245|27282533|P2|Overall Study|Study terminated by sponsor|0
7868088|NCT03287245|27282534|P1|Overall Study|Study terminated by sponsor|3
7868089|NCT03237481|27282655|P3|Overall Study|Withdrawal by Subject|1
7868090|NCT03237481|27282656|P2|Overall Study|Withdrawal by Subject|2
7868091|NCT03237481|27282657|P1|Overall Study|Withdrawal by Subject|3
7868092|NCT03237481|27282655|P3|Overall Study|Protocol Violation|0
7868093|NCT03237481|27282656|P2|Overall Study|Protocol Violation|0
7868094|NCT03237481|27282657|P1|Overall Study|Protocol Violation|1
7868095|NCT03237481|27282655|P3|Overall Study|Lost to Follow-up|0
7868096|NCT03237481|27282656|P2|Overall Study|Lost to Follow-up|0
7868097|NCT03237481|27282657|P1|Overall Study|Lost to Follow-up|1
7868098|NCT03170882|27282674|P2|Overall Study|Reason not Specified|1
7868099|NCT03170882|27282675|P1|Overall Study|Reason not Specified|0
7868100|NCT03170882|27282674|P2|Overall Study|Withdrawal by Subject|6
7868101|NCT03170882|27282675|P1|Overall Study|Withdrawal by Subject|4
7868102|NCT03170882|27282674|P2|Overall Study|Lost to Follow-up|1
7868103|NCT03170882|27282675|P1|Overall Study|Lost to Follow-up|0
7868104|NCT03170882|27282674|P2|Overall Study|Death|29
7868105|NCT03170882|27282675|P1|Overall Study|Death|15
7868106|NCT03170882|27282674|P2|Overall Study|Ongoing|14
7868107|NCT03170882|27282675|P1|Overall Study|Ongoing|10
7868108|NCT03083132|27282856|P2|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
7868109|NCT03083132|27282857|P1|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
7868110|NCT03083132|27282856|P2|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
7868111|NCT03083132|27282857|P1|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
7868112|NCT03083132|27282856|P2|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
7868113|NCT03083132|27282857|P1|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
7868114|NCT03064126|27282877|P4|Overall Study|Protocol Violation|0
7868115|NCT03064126|27282878|P3|Overall Study|Protocol Violation|1
7868116|NCT03064126|27282879|P2|Overall Study|Protocol Violation|1
7868117|NCT03064126|27282880|P1|Overall Study|Protocol Violation|11
7868118|NCT03064126|27282877|P4|Overall Study|Subject moved|0
7868119|NCT03064126|27282878|P3|Overall Study|Subject moved|0
7868120|NCT03064126|27282879|P2|Overall Study|Subject moved|0
7868121|NCT03064126|27282880|P1|Overall Study|Subject moved|1
7868122|NCT03064126|27282877|P4|Overall Study|Withdrawal by Subject|0
7868123|NCT03064126|27282878|P3|Overall Study|Withdrawal by Subject|0
7868124|NCT03064126|27282879|P2|Overall Study|Withdrawal by Subject|4
7868125|NCT03064126|27282880|P1|Overall Study|Withdrawal by Subject|7
7868126|NCT03064126|27282877|P4|Overall Study|Investigator Discretion|0
7868127|NCT03064126|27282878|P3|Overall Study|Investigator Discretion|0
7868128|NCT03064126|27282879|P2|Overall Study|Investigator Discretion|0
7868129|NCT03064126|27282880|P1|Overall Study|Investigator Discretion|1
7868130|NCT03064126|27282877|P4|Overall Study|Death|1
7868131|NCT03064126|27282878|P3|Overall Study|Death|2
7868132|NCT03064126|27282879|P2|Overall Study|Death|2
7868133|NCT03064126|27282880|P1|Overall Study|Death|6
7868134|NCT03015532|27282933|P8|Overall Study|Withdrawal by Subject|0
7868135|NCT03015532|27282934|P7|Overall Study|Withdrawal by Subject|1
7868136|NCT03015532|27282935|P6|Overall Study|Withdrawal by Subject|0
7868137|NCT03015532|27282936|P5|Overall Study|Withdrawal by Subject|0
7868138|NCT03015532|27282937|P4|Overall Study|Withdrawal by Subject|0
7868139|NCT03015532|27282938|P3|Overall Study|Withdrawal by Subject|0
7868140|NCT03015532|27282939|P2|Overall Study|Withdrawal by Subject|0
7868141|NCT03015532|27282940|P1|Overall Study|Withdrawal by Subject|0
7868142|NCT03015532|27282933|P8|Overall Study|Adverse Event|0
7868143|NCT03015532|27282934|P7|Overall Study|Adverse Event|1
7868144|NCT03015532|27282935|P6|Overall Study|Adverse Event|2
7868145|NCT03015532|27282936|P5|Overall Study|Adverse Event|0
7868146|NCT03015532|27282937|P4|Overall Study|Adverse Event|0
7868147|NCT03015532|27282938|P3|Overall Study|Adverse Event|0
7868148|NCT03015532|27282939|P2|Overall Study|Adverse Event|0
7868149|NCT03015532|27282940|P1|Overall Study|Adverse Event|0
7868150|NCT02930122|27282976|P2|Overall Study|An insufficient number of participants were consented to generate meaningful data for this study.|3
7868151|NCT02930122|27282977|P1|Overall Study|An insufficient number of participants were consented to generate meaningful data for this study.|3
7868152|NCT02763566|27282987|P4|Overall Study|Withdrawal by Subject|0
7868153|NCT02763566|27282988|P3|Overall Study|Withdrawal by Subject|0
7868154|NCT02763566|27282989|P2|Overall Study|Withdrawal by Subject|1
7868155|NCT02763566|27282990|P1|Overall Study|Withdrawal by Subject|3
7868156|NCT02763566|27282987|P4|Overall Study|On study treatment at study conclusion|13
7868157|NCT02763566|27282988|P3|Overall Study|On study treatment at study conclusion|54
7868248|NCT02633527|27283236|P5|Overall Study|Withdrawal by Subject|4
7868158|NCT02763566|27282989|P2|Overall Study|On study treatment at study conclusion|34
7868159|NCT02763566|27282990|P1|Overall Study|On study treatment at study conclusion|114
7868160|NCT02763566|27282987|P4|Overall Study|Lost to Follow-up|1
7868161|NCT02763566|27282988|P3|Overall Study|Lost to Follow-up|0
7868162|NCT02763566|27282989|P2|Overall Study|Lost to Follow-up|4
7868163|NCT02763566|27282990|P1|Overall Study|Lost to Follow-up|1
7868164|NCT02718131|27283020|P2|Overall Study|Data was incomplete. Patient was inevaluable|0
7868165|NCT02718131|27283021|P1|Overall Study|Data was incomplete. Patient was inevaluable|1
7868166|NCT02718131|27283020|P2|Overall Study|Adverse Event|0
7868167|NCT02718131|27283021|P1|Overall Study|Adverse Event|1
7868168|NCT02718131|27283020|P2|Overall Study|Withdrawal by Subject|0
7868169|NCT02718131|27283021|P1|Overall Study|Withdrawal by Subject|1
7868170|NCT02659020|27283066|P7|Overall Study|On Treatment|1
7868171|NCT02659020|27283067|P6|Overall Study|On Treatment|0
7868172|NCT02659020|27283068|P5|Overall Study|On Treatment|0
7868173|NCT02659020|27283069|P4|Overall Study|On Treatment|0
7868174|NCT02659020|27283070|P3|Overall Study|On Treatment|0
7868175|NCT02659020|27283071|P2|Overall Study|On Treatment|0
7868176|NCT02659020|27283072|P1|Overall Study|On Treatment|0
7868177|NCT02659020|27283066|P7|Overall Study|Progressive Disease|6
7868178|NCT02659020|27283067|P6|Overall Study|Progressive Disease|7
7868179|NCT02659020|27283068|P5|Overall Study|Progressive Disease|6
7868180|NCT02659020|27283069|P4|Overall Study|Progressive Disease|15
7868181|NCT02659020|27283070|P3|Overall Study|Progressive Disease|2
7868182|NCT02659020|27283071|P2|Overall Study|Progressive Disease|2
7868183|NCT02659020|27283072|P1|Overall Study|Progressive Disease|2
7868184|NCT02659020|27283066|P7|Overall Study|Withdrawal by Subject|3
7868185|NCT02659020|27283067|P6|Overall Study|Withdrawal by Subject|9
7868186|NCT02659020|27283068|P5|Overall Study|Withdrawal by Subject|4
7868187|NCT02659020|27283069|P4|Overall Study|Withdrawal by Subject|4
7868188|NCT02659020|27283070|P3|Overall Study|Withdrawal by Subject|1
7868189|NCT02659020|27283071|P2|Overall Study|Withdrawal by Subject|3
7868190|NCT02659020|27283072|P1|Overall Study|Withdrawal by Subject|2
7868191|NCT02659020|27283066|P7|Overall Study|Physician Decision|1
7868192|NCT02659020|27283067|P6|Overall Study|Physician Decision|3
7868193|NCT02659020|27283068|P5|Overall Study|Physician Decision|6
7868194|NCT02659020|27283069|P4|Overall Study|Physician Decision|1
7868195|NCT02659020|27283070|P3|Overall Study|Physician Decision|1
7868196|NCT02659020|27283071|P2|Overall Study|Physician Decision|0
7868197|NCT02659020|27283072|P1|Overall Study|Physician Decision|0
7868198|NCT02659020|27283066|P7|Overall Study|Lost to Follow-up|0
7868199|NCT02659020|27283067|P6|Overall Study|Lost to Follow-up|5
7868200|NCT02659020|27283068|P5|Overall Study|Lost to Follow-up|1
7868201|NCT02659020|27283069|P4|Overall Study|Lost to Follow-up|4
7868202|NCT02659020|27283070|P3|Overall Study|Lost to Follow-up|1
7868203|NCT02659020|27283071|P2|Overall Study|Lost to Follow-up|2
7868204|NCT02659020|27283072|P1|Overall Study|Lost to Follow-up|1
7868205|NCT02659020|27283066|P7|Overall Study|Adverse Event|4
7868206|NCT02659020|27283067|P6|Overall Study|Adverse Event|4
7868207|NCT02659020|27283068|P5|Overall Study|Adverse Event|3
7868208|NCT02659020|27283069|P4|Overall Study|Adverse Event|6
7868209|NCT02659020|27283070|P3|Overall Study|Adverse Event|0
7868210|NCT02659020|27283071|P2|Overall Study|Adverse Event|0
7868211|NCT02659020|27283072|P1|Overall Study|Adverse Event|1
7868212|NCT02657889|27283142|P4|Overall Study|Ongoing in Study|19
7868213|NCT02657889|27283143|P3|Overall Study|Ongoing in Study|24
7868214|NCT02657889|27283144|P2|Overall Study|Ongoing in Study|5
7868215|NCT02657889|27283145|P1|Overall Study|Ongoing in Study|0
7868216|NCT02657889|27283142|P4|Overall Study|Withdrawal by Subject|0
7868217|NCT02657889|27283143|P3|Overall Study|Withdrawal by Subject|8
7868218|NCT02657889|27283144|P2|Overall Study|Withdrawal by Subject|0
7868219|NCT02657889|27283145|P1|Overall Study|Withdrawal by Subject|0
7868220|NCT02657889|27283142|P4|Overall Study|Lost to Follow-up|2
7868221|NCT02657889|27283143|P3|Overall Study|Lost to Follow-up|1
7868222|NCT02657889|27283144|P2|Overall Study|Lost to Follow-up|0
7868223|NCT02657889|27283145|P1|Overall Study|Lost to Follow-up|2
7868224|NCT02657889|27283142|P4|Overall Study|Death|34
7868225|NCT02657889|27283143|P3|Overall Study|Death|20
7868226|NCT02657889|27283144|P2|Overall Study|Death|2
7868227|NCT02657889|27283145|P1|Overall Study|Death|5
7868228|NCT02633527|27283236|P5|Overall Study|Multiple reasons|1
7868229|NCT02633527|27283237|P4|Overall Study|Multiple reasons|2
7868230|NCT02633527|27283238|P3|Overall Study|Multiple reasons|2
7868231|NCT02633527|27283239|P2|Overall Study|Multiple reasons|0
7868232|NCT02633527|27283240|P1|Overall Study|Multiple reasons|1
7868233|NCT02633527|27283236|P5|Overall Study|Administrative reason|0
7868234|NCT02633527|27283237|P4|Overall Study|Administrative reason|1
7868235|NCT02633527|27283238|P3|Overall Study|Administrative reason|0
7868236|NCT02633527|27283239|P2|Overall Study|Administrative reason|0
7868237|NCT02633527|27283240|P1|Overall Study|Administrative reason|1
7868238|NCT02633527|27283236|P5|Overall Study|Physician Decision|1
7868239|NCT02633527|27283237|P4|Overall Study|Physician Decision|0
7868240|NCT02633527|27283238|P3|Overall Study|Physician Decision|0
7868241|NCT02633527|27283239|P2|Overall Study|Physician Decision|0
7868242|NCT02633527|27283240|P1|Overall Study|Physician Decision|0
7868243|NCT02633527|27283236|P5|Overall Study|Protocol Violation|1
7868244|NCT02633527|27283237|P4|Overall Study|Protocol Violation|1
7868245|NCT02633527|27283238|P3|Overall Study|Protocol Violation|1
7868246|NCT02633527|27283239|P2|Overall Study|Protocol Violation|1
7868247|NCT02633527|27283240|P1|Overall Study|Protocol Violation|0
7868249|NCT02633527|27283237|P4|Overall Study|Withdrawal by Subject|4
7868250|NCT02633527|27283238|P3|Overall Study|Withdrawal by Subject|5
7868251|NCT02633527|27283239|P2|Overall Study|Withdrawal by Subject|3
7868252|NCT02633527|27283240|P1|Overall Study|Withdrawal by Subject|0
7868253|NCT02633527|27283236|P5|Overall Study|Lost to Follow-up|4
7868254|NCT02633527|27283237|P4|Overall Study|Lost to Follow-up|5
7868255|NCT02633527|27283238|P3|Overall Study|Lost to Follow-up|5
7868256|NCT02633527|27283239|P2|Overall Study|Lost to Follow-up|2
7868257|NCT02633527|27283240|P1|Overall Study|Lost to Follow-up|1
7868258|NCT02633527|27283236|P5|Overall Study|Adverse Event|5
7868259|NCT02633527|27283237|P4|Overall Study|Adverse Event|1
7868260|NCT02633527|27283238|P3|Overall Study|Adverse Event|3
7868261|NCT02633527|27283239|P2|Overall Study|Adverse Event|4
7868262|NCT02633527|27283240|P1|Overall Study|Adverse Event|0
7868263|NCT02633527|27283236|P5|Overall Study|Failed to meet eligibility|1
7868264|NCT02633527|27283237|P4|Overall Study|Failed to meet eligibility|0
7868265|NCT02633527|27283238|P3|Overall Study|Failed to meet eligibility|1
7868266|NCT02633527|27283239|P2|Overall Study|Failed to meet eligibility|1
7868267|NCT02633527|27283240|P1|Overall Study|Failed to meet eligibility|0
7868268|NCT02574481|27283283|P4|Overall Study|Death|0
7868269|NCT02574481|27283284|P3|Overall Study|Death|0
7868270|NCT02574481|27283285|P2|Overall Study|Death|6
7868271|NCT02574481|27283286|P1|Overall Study|Death|6
7868272|NCT02574481|27283283|P4|Overall Study|Other|0
7868273|NCT02574481|27283284|P3|Overall Study|Other|0
7868274|NCT02574481|27283285|P2|Overall Study|Other|0
7868275|NCT02574481|27283286|P1|Overall Study|Other|1
7868276|NCT02574481|27283283|P4|Overall Study|Visit Missed|0
7868277|NCT02574481|27283284|P3|Overall Study|Visit Missed|2
7868278|NCT02574481|27283285|P2|Overall Study|Visit Missed|4
7868279|NCT02574481|27283286|P1|Overall Study|Visit Missed|12
7868280|NCT02574481|27283283|P4|Overall Study|Adverse Event|0
7868281|NCT02574481|27283284|P3|Overall Study|Adverse Event|0
7868282|NCT02574481|27283285|P2|Overall Study|Adverse Event|0
7868283|NCT02574481|27283286|P1|Overall Study|Adverse Event|2
7868284|NCT02574481|27283283|P4|Overall Study|Withdrawal by Subject|0
7868285|NCT02574481|27283284|P3|Overall Study|Withdrawal by Subject|1
7868286|NCT02574481|27283285|P2|Overall Study|Withdrawal by Subject|4
7868287|NCT02574481|27283286|P1|Overall Study|Withdrawal by Subject|6
7868288|NCT02563561|27283327|P3|Overall Study|Other|2
7868289|NCT02563561|27283328|P2|Overall Study|Other|5
7868290|NCT02563561|27283329|P1|Overall Study|Other|1
7868291|NCT02563561|27283327|P3|Overall Study|Sponsor Decision|4
7868292|NCT02563561|27283328|P2|Overall Study|Sponsor Decision|2
7868293|NCT02563561|27283329|P1|Overall Study|Sponsor Decision|5
7868294|NCT02563561|27283327|P3|Overall Study|Investigator Decision|2
7868295|NCT02563561|27283328|P2|Overall Study|Investigator Decision|4
7868296|NCT02563561|27283329|P1|Overall Study|Investigator Decision|3
7868297|NCT02563561|27283327|P3|Overall Study|Participant Had Recurrence and Received Therapy|1
7868298|NCT02563561|27283328|P2|Overall Study|Participant Had Recurrence and Received Therapy|2
7868299|NCT02563561|27283329|P1|Overall Study|Participant Had Recurrence and Received Therapy|4
7868300|NCT02563561|27283327|P3|Overall Study|Lost to Follow-up|0
7868301|NCT02563561|27283328|P2|Overall Study|Lost to Follow-up|1
7868302|NCT02563561|27283329|P1|Overall Study|Lost to Follow-up|1
7868303|NCT02563561|27283327|P3|Overall Study|Withdrew of Consent|2
7868304|NCT02563561|27283328|P2|Overall Study|Withdrew of Consent|1
7868305|NCT02563561|27283329|P1|Overall Study|Withdrew of Consent|1
7868306|NCT02563561|27283327|P3|Overall Study|Histology Other than Ta, G1-G2|6
7868307|NCT02563561|27283328|P2|Overall Study|Histology Other than Ta, G1-G2|6
7868308|NCT02563561|27283329|P1|Overall Study|Histology Other than Ta, G1-G2|3
7868309|NCT02501642|27283351|P2|Overall Study|Lost to Follow-up|11
7868310|NCT02501642|27283352|P1|Overall Study|Lost to Follow-up|7
7868311|NCT02453282|27283361|P3|Overall Study|Other|1
7868312|NCT02453282|27283362|P2|Overall Study|Other|1
7868313|NCT02453282|27283363|P1|Overall Study|Other|1
7868314|NCT02453282|27283361|P3|Overall Study|Participants ongoing at data cut-off|62
7868315|NCT02453282|27283362|P2|Overall Study|Participants ongoing at data cut-off|84
7868316|NCT02453282|27283363|P1|Overall Study|Participants ongoing at data cut-off|85
7868317|NCT02453282|27283361|P3|Overall Study|Withdrawal by Subject|11
7868318|NCT02453282|27283362|P2|Overall Study|Withdrawal by Subject|10
7868319|NCT02453282|27283363|P1|Overall Study|Withdrawal by Subject|12
7868320|NCT02453282|27283361|P3|Overall Study|Lost to Follow-up|2
7868321|NCT02453282|27283362|P2|Overall Study|Lost to Follow-up|0
7868322|NCT02453282|27283363|P1|Overall Study|Lost to Follow-up|1
7868323|NCT02453282|27283361|P3|Overall Study|Death|296
7868324|NCT02453282|27283362|P2|Overall Study|Death|277
7868325|NCT02453282|27283363|P1|Overall Study|Death|275
7868326|NCT02429791|27283444|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
7868327|NCT02429791|27283445|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
7868328|NCT02429791|27283444|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7868329|NCT02429791|27283445|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7868330|NCT02429791|27283444|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
7868331|NCT02429791|27283445|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
7868332|NCT02429791|27283444|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7868333|NCT02429791|27283445|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
7868334|NCT02429791|27283444|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
7868335|NCT02429791|27283445|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7868336|NCT02429791|27283444|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
7868337|NCT02429791|27283445|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
7868338|NCT02429791|27283444|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7868339|NCT02429791|27283445|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
7868340|NCT02429791|27283444|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
7868341|NCT02429791|27283445|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
7868342|NCT02429791|27283444|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
7868343|NCT02429791|27283445|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7868344|NCT02429791|27283444|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7868345|NCT02429791|27283445|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7868346|NCT02429791|27283444|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
7868347|NCT02429791|27283445|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
7868348|NCT02429791|27283444|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
7868349|NCT02429791|27283445|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
7868350|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
7868351|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7868352|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
7868353|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
7868354|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
7868355|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
7868356|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7868357|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7868358|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7868359|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
7868360|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
7868361|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
7868362|NCT02422797|27283533|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
7868363|NCT02422797|27283534|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7868364|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7868365|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
7868366|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7868367|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7868368|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
7868369|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
7868370|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7868371|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7868372|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7868373|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7868374|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
7868375|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
7868376|NCT02422797|27283533|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
7868377|NCT02422797|27283534|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
7868378|NCT02172950|27283622|P2|Overall Study|Patient moving|0
7868379|NCT02172950|27283623|P1|Overall Study|Patient moving|1
7868380|NCT02172950|27283622|P2|Overall Study|Patient relocated overseas|1
7868381|NCT02172950|27283623|P1|Overall Study|Patient relocated overseas|1
7868382|NCT02172950|27283622|P2|Overall Study|Patient went to other country|0
7868383|NCT02172950|27283623|P1|Overall Study|Patient went to other country|1
7868384|NCT02172950|27283622|P2|Overall Study|Patient traveling|0
7868385|NCT02172950|27283623|P1|Overall Study|Patient traveling|1
7868386|NCT02172950|27283622|P2|Overall Study|Death|0
7868387|NCT02172950|27283623|P1|Overall Study|Death|1
7868388|NCT02172950|27283622|P2|Overall Study|Lost to Follow-up|0
7868389|NCT02172950|27283623|P1|Overall Study|Lost to Follow-up|1
7868390|NCT02172950|27283622|P2|Overall Study|Protocol Violation|0
7868391|NCT02172950|27283623|P1|Overall Study|Protocol Violation|1
7868392|NCT02172950|27283622|P2|Overall Study|Withdrawal by Subject|0
7868393|NCT02172950|27283623|P1|Overall Study|Withdrawal by Subject|10
7868394|NCT02172950|27283622|P2|Overall Study|Adverse Event|1
7868395|NCT02172950|27283623|P1|Overall Study|Adverse Event|4
7868396|NCT02172950|27283622|P2|Overall Study|Lack of Efficacy|0
7868397|NCT02172950|27283623|P1|Overall Study|Lack of Efficacy|1
7868398|NCT02172950|27283622|P2|Overall Study|Physician Decision|3
7868399|NCT02172950|27283623|P1|Overall Study|Physician Decision|3
7868400|NCT02017444|27283659|P2|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
7868401|NCT02017444|27283660|P1|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
7868402|NCT02017444|27283659|P2|Overall Study|Physician Decision|0
7868403|NCT02017444|27283660|P1|Overall Study|Physician Decision|1
7868404|NCT01675882|27283717|P4|Overall Study|Non-compliance|1
7868405|NCT01675882|27283718|P3|Overall Study|Non-compliance|0
7868406|NCT01675882|27283719|P2|Overall Study|Non-compliance|0
7868407|NCT01675882|27283720|P1|Overall Study|Non-compliance|0
7868408|NCT01675882|27283717|P4|Overall Study|Lost to Follow-up|0
7868409|NCT01675882|27283718|P3|Overall Study|Lost to Follow-up|0
7868410|NCT01675882|27283719|P2|Overall Study|Lost to Follow-up|1
7868411|NCT01675882|27283720|P1|Overall Study|Lost to Follow-up|0
7868412|NCT01675882|27283717|P4|Overall Study|Participant unwilling to continue|1
7868413|NCT01675882|27283718|P3|Overall Study|Participant unwilling to continue|2
7868414|NCT01675882|27283719|P2|Overall Study|Participant unwilling to continue|4
7868415|NCT01675882|27283720|P1|Overall Study|Participant unwilling to continue|2
7868416|NCT01675882|27283717|P4|Overall Study|Adverse Event|0
7868417|NCT01675882|27283718|P3|Overall Study|Adverse Event|1
7868418|NCT01675882|27283719|P2|Overall Study|Adverse Event|2
7868419|NCT01675882|27283720|P1|Overall Study|Adverse Event|0
7868420|NCT01668719|27283805|P3|Phase II|not protocol specified|7
7868421|NCT01668719|27283806|P2|Phase II|not protocol specified|13
7868422|NCT01668719|27283807|P1|Phase II|not protocol specified|0
7868423|NCT01668719|27283805|P3|Phase II|Death|2
7868424|NCT01668719|27283806|P2|Phase II|Death|0
7868425|NCT01668719|27283807|P1|Phase II|Death|0
7868426|NCT01668719|27283805|P3|Phase II|Progression/relapse|17
7868427|NCT01668719|27283806|P2|Phase II|Progression/relapse|13
7868428|NCT01668719|27283807|P1|Phase II|Progression/relapse|0
7868429|NCT01668719|27283805|P3|Phase II|Refusal unrelated to adverse event|1
7868430|NCT01668719|27283806|P2|Phase II|Refusal unrelated to adverse event|4
7868431|NCT01668719|27283807|P1|Phase II|Refusal unrelated to adverse event|0
7868432|NCT01668719|27283805|P3|Phase II|Adverse Event|18
7868433|NCT01668719|27283806|P2|Phase II|Adverse Event|18
7868434|NCT01668719|27283807|P1|Phase II|Adverse Event|0
7868435|NCT01668719|27283805|P3|Phase II|On treatment|3
7868436|NCT01668719|27283806|P2|Phase II|On treatment|4
7868437|NCT01668719|27283807|P1|Phase II|On treatment|0
7868438|NCT01668719|27283805|P3|Phase I|not protocol specified|0
7868439|NCT01668719|27283806|P2|Phase I|not protocol specified|0
7868440|NCT01668719|27283807|P1|Phase I|not protocol specified|2
7868441|NCT01668719|27283805|P3|Phase I|Progression/relapse|0
7868442|NCT01668719|27283806|P2|Phase I|Progression/relapse|0
7868443|NCT01668719|27283807|P1|Phase I|Progression/relapse|1
7868444|NCT01668719|27283805|P3|Phase I|Adverse Event|0
7868445|NCT01668719|27283806|P2|Phase I|Adverse Event|0
7868446|NCT01668719|27283807|P1|Phase I|Adverse Event|2
7868447|NCT01668719|27283805|P3|Phase I|On treatment|0
7868448|NCT01668719|27283806|P2|Phase I|On treatment|0
7868449|NCT01668719|27283807|P1|Phase I|On treatment|1
7868450|NCT01515748|27283823|P2|Overall Study|Ongoing|90
7868451|NCT01515748|27283824|P1|Overall Study|Ongoing|86
7868452|NCT01515748|27283823|P2|Overall Study|Lost to Follow-up|4
7868453|NCT01515748|27283824|P1|Overall Study|Lost to Follow-up|2
7868454|NCT01515748|27283823|P2|Overall Study|Withdrawal by Subject|41
7868455|NCT01515748|27283824|P1|Overall Study|Withdrawal by Subject|32
7868456|NCT01176916|27283871|P1|Overall Study|Withdrawal prior to Treatment|6
7868457|NCT01176916|27283871|P1|Overall Study|Other|6
7868458|NCT01176916|27283871|P1|Overall Study|Withdrawal by Subject|37
7868459|NCT01176916|27283871|P1|Overall Study|Protocol Violation|24
7868460|NCT01176916|27283871|P1|Overall Study|Objective progression or relapse|17
7868461|NCT01176916|27283871|P1|Overall Study|Lost to Follow-up|15
7868462|NCT01176916|27283871|P1|Overall Study|Death|1
7868463|NCT01176916|27283871|P1|Overall Study|Adverse Event|61
7868464|NCT00804193|27283884|P3|Overall Study|Withdrawal by Subject|2
7868465|NCT00804193|27283885|P2|Overall Study|Withdrawal by Subject|1
7868466|NCT00804193|27283886|P1|Overall Study|Withdrawal by Subject|3
7868467|NCT00804193|27283884|P3|Overall Study|Lost to Follow-up|4
7868468|NCT00804193|27283885|P2|Overall Study|Lost to Follow-up|3
7868469|NCT00804193|27283886|P1|Overall Study|Lost to Follow-up|3
7868470|NCT00804193|27283884|P3|Overall Study|Protocol Violation|2
7868471|NCT00804193|27283885|P2|Overall Study|Protocol Violation|8
7868472|NCT00804193|27283886|P1|Overall Study|Protocol Violation|0
7868473|NCT00804193|27283884|P3|Overall Study|Lack of Efficacy|3
7868474|NCT00804193|27283885|P2|Overall Study|Lack of Efficacy|1
7868475|NCT00804193|27283886|P1|Overall Study|Lack of Efficacy|1
7868476|NCT00804193|27283884|P3|Overall Study|Adverse Event|2
7868477|NCT00804193|27283885|P2|Overall Study|Adverse Event|0
7868478|NCT00804193|27283886|P1|Overall Study|Adverse Event|0
7868479|NCT00804193|27283884|P3|Overall Study|Lack of baseline fungus|19
7868480|NCT00804193|27283885|P2|Overall Study|Lack of baseline fungus|31
7868481|NCT00804193|27283886|P1|Overall Study|Lack of baseline fungus|32
7868482|NCT00324805|27283902|P2|Overall Study|Did not start therapy|17
7868483|NCT00324805|27283903|P1|Overall Study|Did not start therapy|12
7868484|NCT00324805|27283902|P2|Overall Study|Other|2
7868485|NCT00324805|27283903|P1|Overall Study|Other|0
7868486|NCT00324805|27283902|P2|Overall Study|Other reasons|26
7868487|NCT00324805|27283903|P1|Overall Study|Other reasons|7
7868488|NCT00324805|27283902|P2|Overall Study|Other complicating disease|9
7868489|NCT00324805|27283903|P1|Overall Study|Other complicating disease|1
7868490|NCT00324805|27283902|P2|Overall Study|Alternative therapy|8
7868491|NCT00324805|27283903|P1|Overall Study|Alternative therapy|4
7868492|NCT00324805|27283902|P2|Overall Study|Death|9
7868493|NCT00324805|27283903|P1|Overall Study|Death|6
7868494|NCT00324805|27283902|P2|Overall Study|Withdrawal by Subject|174
7868495|NCT00324805|27283903|P1|Overall Study|Withdrawal by Subject|51
7868496|NCT00324805|27283902|P2|Overall Study|Progression|35
7868497|NCT00324805|27283903|P1|Overall Study|Progression|7
7868498|NCT00324805|27283902|P2|Overall Study|Adverse Event|203
7868499|NCT00324805|27283903|P1|Overall Study|Adverse Event|62
7868500|NCT00278915|27283915|P1|Overall Study|Lack of Efficacy|1
7868501|NCT00134056|27283950|P2|Eligible for Protocol Assigned Treatment|Other|56
7868502|NCT00134056|27283951|P1|Eligible for Protocol Assigned Treatment|Other|55
7868503|NCT00134056|27283950|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
7868504|NCT00134056|27283951|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
7868505|NCT00134056|27283950|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
7868506|NCT00134056|27283951|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
7868507|NCT00134056|27283950|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
7868508|NCT00134056|27283951|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
7868509|NCT00134056|27283950|P2|Randomization|Not eligible for assigned treatment|20
7868510|NCT00134056|27283951|P1|Randomization|Not eligible for assigned treatment|22
7868511|NCT04507763|27283971|P1|Overall Study|Participants did not meet entrance criteria|201
7868512|NCT04358068|27284040|P2|Overall Study|Did not initiate study treatment|2
7868513|NCT04358068|27284041|P1|Overall Study|Did not initiate study treatment|2
7868514|NCT04231825|27284126|P2|Overall Study|Lost to Follow-up|1
7868515|NCT04231825|27284127|P1|Overall Study|Lost to Follow-up|0
7868516|NCT04231825|27284126|P2|Overall Study|Protocol Violation|3
7868517|NCT04231825|27284127|P1|Overall Study|Protocol Violation|3
7868518|NCT03817853|27284226|P3|Maintenance/ Follow-up Phase|Continuing on Study|2
7868519|NCT03817853|27284227|P2|Maintenance/ Follow-up Phase|Continuing on Study|52
7868520|NCT03817853|27284228|P1|Maintenance/ Follow-up Phase|Continuing on Study|0
7868521|NCT03817853|27284226|P3|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
7868522|NCT03817853|27284227|P2|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
7868523|NCT03817853|27284228|P1|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
7868524|NCT03817853|27284226|P3|Maintenance/ Follow-up Phase|Progressive Disease|3
7868525|NCT03817853|27284227|P2|Maintenance/ Follow-up Phase|Progressive Disease|1
7868526|NCT03817853|27284228|P1|Maintenance/ Follow-up Phase|Progressive Disease|0
7868527|NCT03817853|27284226|P3|Maintenance/ Follow-up Phase|Death|1
7868528|NCT03817853|27284227|P2|Maintenance/ Follow-up Phase|Death|1
7868529|NCT03817853|27284228|P1|Maintenance/ Follow-up Phase|Death|0
7868530|NCT03817853|27284226|P3|Maintenance/ Follow-up Phase|Adverse Event|0
7868531|NCT03817853|27284227|P2|Maintenance/ Follow-up Phase|Adverse Event|1
7868532|NCT03817853|27284228|P1|Maintenance/ Follow-up Phase|Adverse Event|0
7868533|NCT03817853|27284226|P3|Induction Phase|Continuing on Study|0
7868534|NCT03817853|27284227|P2|Induction Phase|Continuing on Study|0
7868535|NCT03817853|27284228|P1|Induction Phase|Continuing on Study|34
7868536|NCT03817853|27284226|P3|Induction Phase|Withdrawal by Subject|0
7868537|NCT03817853|27284227|P2|Induction Phase|Withdrawal by Subject|0
7868538|NCT03817853|27284228|P1|Induction Phase|Withdrawal by Subject|3
7868539|NCT03817853|27284226|P3|Induction Phase|Progressive Disease|0
7868540|NCT03817853|27284227|P2|Induction Phase|Progressive Disease|0
7868541|NCT03817853|27284228|P1|Induction Phase|Progressive Disease|4
7868542|NCT03817853|27284226|P3|Induction Phase|Physician Decision|0
7868543|NCT03817853|27284227|P2|Induction Phase|Physician Decision|0
7868544|NCT03817853|27284228|P1|Induction Phase|Physician Decision|2
7868545|NCT03817853|27284226|P3|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
7868546|NCT03817853|27284227|P2|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
7868547|NCT03817853|27284228|P1|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
7868548|NCT03817853|27284226|P3|Induction Phase|Adverse Event|0
7868549|NCT03817853|27284227|P2|Induction Phase|Adverse Event|0
7868550|NCT03817853|27284228|P1|Induction Phase|Adverse Event|5
7868551|NCT03763877|27284276|P4|Overall Study|Lost to Follow-up|0
7868552|NCT03763877|27284277|P3|Overall Study|Lost to Follow-up|1
7868553|NCT03763877|27284278|P2|Overall Study|Lost to Follow-up|1
7868554|NCT03763877|27284279|P1|Overall Study|Lost to Follow-up|0
7868555|NCT03763877|27284276|P4|Overall Study|Protocol Violation|0
7868556|NCT03763877|27284277|P3|Overall Study|Protocol Violation|0
7868557|NCT03763877|27284278|P2|Overall Study|Protocol Violation|1
7868558|NCT03763877|27284279|P1|Overall Study|Protocol Violation|1
7868559|NCT03763877|27284276|P4|Overall Study|Adverse Event|1
7868560|NCT03763877|27284277|P3|Overall Study|Adverse Event|3
7868561|NCT03763877|27284278|P2|Overall Study|Adverse Event|1
7868562|NCT03763877|27284279|P1|Overall Study|Adverse Event|1
7868563|NCT03763877|27284276|P4|Overall Study|Withdrawal by Subject|4
7868564|NCT03763877|27284277|P3|Overall Study|Withdrawal by Subject|3
7868565|NCT03763877|27284278|P2|Overall Study|Withdrawal by Subject|1
7868566|NCT03763877|27284279|P1|Overall Study|Withdrawal by Subject|3
7868567|NCT03647267|27284371|P2|Overall Study|Lost to Follow-up|0
7868568|NCT03647267|27284372|P1|Overall Study|Lost to Follow-up|1
7868569|NCT03520920|27284396|P3|Overall Study|Study Terminated by the Sponsor|5
7868570|NCT03520920|27284397|P2|Overall Study|Study Terminated by the Sponsor|14
7868571|NCT03520920|27284398|P1|Overall Study|Study Terminated by the Sponsor|5
7868572|NCT03520920|27284396|P3|Overall Study|Withdrawal by Subject|0
7868573|NCT03520920|27284397|P2|Overall Study|Withdrawal by Subject|1
7868574|NCT03520920|27284398|P1|Overall Study|Withdrawal by Subject|2
7868575|NCT03520920|27284396|P3|Overall Study|Death|0
7868576|NCT03520920|27284397|P2|Overall Study|Death|1
7868577|NCT03520920|27284398|P1|Overall Study|Death|13
7868578|NCT03456856|27284436|P1|Overall Study|Withdrawal by Subject|1
7868579|NCT03456856|27284436|P1|Overall Study|Lost to Follow-up|2
7868580|NCT03446573|27284442|P2|Overall Study|Ongoing at the time of interim analysis|343
7868581|NCT03446573|27284443|P1|Overall Study|Ongoing at the time of interim analysis|342
7868582|NCT03446573|27284442|P2|Overall Study|Adverse Event|2
7868583|NCT03446573|27284443|P1|Overall Study|Adverse Event|13
7868584|NCT03446573|27284442|P2|Overall Study|Lack of Efficacy|3
7868585|NCT03446573|27284443|P1|Overall Study|Lack of Efficacy|0
7868586|NCT03446573|27284442|P2|Overall Study|Protocol Violation|2
7868587|NCT03446573|27284443|P1|Overall Study|Protocol Violation|3
7868588|NCT03446573|27284442|P2|Overall Study|Lost to Follow-up|5
7868589|NCT03446573|27284443|P1|Overall Study|Lost to Follow-up|3
7868590|NCT03446573|27284442|P2|Overall Study|Physician Decision|1
7868591|NCT03446573|27284443|P1|Overall Study|Physician Decision|1
7868592|NCT03446573|27284442|P2|Overall Study|Withdrawal by Subject|16
7868593|NCT03446573|27284443|P1|Overall Study|Withdrawal by Subject|7
7868594|NCT03427619|27284515|P1|Overall Study|Unknown or Missing Completion Status|48
7868595|NCT03427619|27284515|P1|Overall Study|Other|2
7868596|NCT03427619|27284515|P1|Overall Study|Administrative|4
7868597|NCT03427619|27284515|P1|Overall Study|Lost to Follow-up|5
7868598|NCT03427619|27284515|P1|Overall Study|Withdrawal by Subject|4
7868599|NCT03427619|27284515|P1|Overall Study|Physician Decision|3
7868600|NCT03406962|27284522|P1|Overall Study|Adverse Event|1
7868601|NCT03406962|27284522|P1|Overall Study|Death|2
7868602|NCT03400943|27284533|P4|Follow-up Period|Withdrawal by Subject|0
7868603|NCT03400943|27284534|P3|Follow-up Period|Withdrawal by Subject|0
7868604|NCT03400943|27284535|P2|Follow-up Period|Withdrawal by Subject|0
7868605|NCT03400943|27284536|P1|Follow-up Period|Withdrawal by Subject|1
7868606|NCT03400943|27284533|P4|Treatment Period 2|Other|0
7868607|NCT03400943|27284534|P3|Treatment Period 2|Other|0
7868608|NCT03400943|27284535|P2|Treatment Period 2|Other|6
7868609|NCT03400943|27284536|P1|Treatment Period 2|Other|1
7868610|NCT03400943|27284533|P4|Treatment Period 2|Withdrawal by Subject|0
7868611|NCT03400943|27284534|P3|Treatment Period 2|Withdrawal by Subject|0
7868612|NCT03400943|27284535|P2|Treatment Period 2|Withdrawal by Subject|1
7868613|NCT03400943|27284536|P1|Treatment Period 2|Withdrawal by Subject|0
7868614|NCT03400943|27284533|P4|Treatment Period 2|Study terminated by sponsor|0
7868615|NCT03400943|27284534|P3|Treatment Period 2|Study terminated by sponsor|0
7868616|NCT03400943|27284535|P2|Treatment Period 2|Study terminated by sponsor|1
7868617|NCT03400943|27284536|P1|Treatment Period 2|Study terminated by sponsor|0
7868618|NCT03400943|27284533|P4|Post-treatment Period 1|Other|5
7868619|NCT03400943|27284534|P3|Post-treatment Period 1|Other|4
7868620|NCT03400943|27284535|P2|Post-treatment Period 1|Other|0
7868621|NCT03400943|27284536|P1|Post-treatment Period 1|Other|2
7868622|NCT03400943|27284533|P4|Post-treatment Period 1|Withdrawal by Subject|2
7868623|NCT03400943|27284534|P3|Post-treatment Period 1|Withdrawal by Subject|2
7868624|NCT03400943|27284535|P2|Post-treatment Period 1|Withdrawal by Subject|0
7868625|NCT03400943|27284536|P1|Post-treatment Period 1|Withdrawal by Subject|1
7868626|NCT03400943|27284533|P4|Post-treatment Period 1|Study terminated by sponsor|6
7868627|NCT03400943|27284534|P3|Post-treatment Period 1|Study terminated by sponsor|5
7868628|NCT03400943|27284535|P2|Post-treatment Period 1|Study terminated by sponsor|0
7868629|NCT03400943|27284536|P1|Post-treatment Period 1|Study terminated by sponsor|5
7868630|NCT03400943|27284533|P4|Post-treatment Period 1|Protocol Violation|0
7868631|NCT03400943|27284534|P3|Post-treatment Period 1|Protocol Violation|0
7868632|NCT03400943|27284535|P2|Post-treatment Period 1|Protocol Violation|0
7868633|NCT03400943|27284536|P1|Post-treatment Period 1|Protocol Violation|1
7868634|NCT03400943|27284533|P4|Post-treatment Period 1|Adverse Event|0
7868635|NCT03400943|27284534|P3|Post-treatment Period 1|Adverse Event|0
7868636|NCT03400943|27284535|P2|Post-treatment Period 1|Adverse Event|0
7868637|NCT03400943|27284536|P1|Post-treatment Period 1|Adverse Event|2
7868638|NCT03400943|27284533|P4|Treatment Period 1|Other|2
7868639|NCT03400943|27284534|P3|Treatment Period 1|Other|2
7868640|NCT03400943|27284535|P2|Treatment Period 1|Other|1
7868641|NCT03400943|27284536|P1|Treatment Period 1|Other|2
7868642|NCT03400943|27284533|P4|Treatment Period 1|Withdrawal by Subject|1
7868643|NCT03400943|27284534|P3|Treatment Period 1|Withdrawal by Subject|3
7868644|NCT03400943|27284535|P2|Treatment Period 1|Withdrawal by Subject|0
7868645|NCT03400943|27284536|P1|Treatment Period 1|Withdrawal by Subject|0
7868646|NCT03400943|27284533|P4|Treatment Period 1|Study terminated by sponsor|1
7868647|NCT03400943|27284534|P3|Treatment Period 1|Study terminated by sponsor|0
7868648|NCT03400943|27284535|P2|Treatment Period 1|Study terminated by sponsor|0
7868649|NCT03400943|27284536|P1|Treatment Period 1|Study terminated by sponsor|2
7868650|NCT03400943|27284533|P4|Treatment Period 1|Protocol Violation|0
7868651|NCT03400943|27284534|P3|Treatment Period 1|Protocol Violation|1
7868652|NCT03400943|27284535|P2|Treatment Period 1|Protocol Violation|1
7868653|NCT03400943|27284536|P1|Treatment Period 1|Protocol Violation|0
7868654|NCT03400943|27284533|P4|Treatment Period 1|Lost to Follow-up|0
7868655|NCT03400943|27284534|P3|Treatment Period 1|Lost to Follow-up|0
7868656|NCT03400943|27284535|P2|Treatment Period 1|Lost to Follow-up|0
7868657|NCT03400943|27284536|P1|Treatment Period 1|Lost to Follow-up|1
7868658|NCT03400943|27284533|P4|Treatment Period 1|Adverse Event|1
7868659|NCT03400943|27284534|P3|Treatment Period 1|Adverse Event|0
7868660|NCT03400943|27284535|P2|Treatment Period 1|Adverse Event|0
7868661|NCT03400943|27284536|P1|Treatment Period 1|Adverse Event|0
7868662|NCT03173560|27284566|P2|Overall Study|Other|1
7868663|NCT03173560|27284567|P1|Overall Study|Other|0
7868664|NCT03173560|27284566|P2|Overall Study|Withdrawal by Subject|5
7868665|NCT03173560|27284567|P1|Overall Study|Withdrawal by Subject|10
7868666|NCT03173560|27284566|P2|Overall Study|Lost to Follow-up|4
7868667|NCT03173560|27284567|P1|Overall Study|Lost to Follow-up|1
7868668|NCT03173560|27284566|P2|Overall Study|Ongoing Survival Follow-up|57
7868669|NCT03173560|27284567|P1|Overall Study|Ongoing Survival Follow-up|56
7868670|NCT03173560|27284566|P2|Overall Study|Ongoing on Treatment|50
7868671|NCT03173560|27284567|P1|Overall Study|Ongoing on Treatment|38
7868672|NCT03125902|27284605|P2|Overall Study|Study is ongoing|282
7868673|NCT03125902|27284606|P1|Overall Study|Study is ongoing|153
7868674|NCT03125902|27284605|P2|Overall Study|Withdrawal by Subject|25
7868675|NCT03125902|27284606|P1|Overall Study|Withdrawal by Subject|13
7868676|NCT03125902|27284605|P2|Overall Study|Physician Decision|0
7868677|NCT03125902|27284606|P1|Overall Study|Physician Decision|1
7868678|NCT03125902|27284605|P2|Overall Study|Mastectomy|1
7868679|NCT03125902|27284606|P1|Overall Study|Mastectomy|0
7868680|NCT03125902|27284605|P2|Overall Study|Lost to Follow-up|0
7868681|NCT03125902|27284606|P1|Overall Study|Lost to Follow-up|1
7868682|NCT03125902|27284605|P2|Overall Study|Death|123
7868683|NCT03125902|27284606|P1|Overall Study|Death|52
7868684|NCT03023722|27284657|P1|Overall Study|No follow-up assessment|4
7868685|NCT03016312|27284665|P2|Overall Study|Withdrawal by Subject|39
7868686|NCT03016312|27284666|P1|Overall Study|Withdrawal by Subject|34
7868687|NCT03016312|27284665|P2|Overall Study|Physician Decision|2
7868688|NCT03016312|27284666|P1|Overall Study|Physician Decision|0
7868689|NCT03016312|27284665|P2|Overall Study|Started new therapy, loss of contact|1
7868690|NCT03016312|27284666|P1|Overall Study|Started new therapy, loss of contact|2
7868691|NCT03016312|27284665|P2|Overall Study|Lost to Follow-up|12
7868692|NCT03016312|27284666|P1|Overall Study|Lost to Follow-up|11
7868693|NCT03016312|27284665|P2|Overall Study|Death|164
7868694|NCT03016312|27284666|P1|Overall Study|Death|194
7868695|NCT02948777|27284686|P1|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
7868696|NCT02927873|27284720|P6|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7868697|NCT02927873|27284721|P5|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7868698|NCT02927873|27284722|P4|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7868699|NCT02927873|27284723|P3|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7868700|NCT02927873|27284724|P2|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7868701|NCT02927873|27284725|P1|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
7868702|NCT02927873|27284720|P6|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7868703|NCT02927873|27284721|P5|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7868704|NCT02927873|27284722|P4|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7868705|NCT02927873|27284723|P3|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7868706|NCT02927873|27284724|P2|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7868707|NCT02927873|27284725|P1|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
7868708|NCT02927873|27284720|P6|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7868709|NCT02927873|27284721|P5|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7868710|NCT02927873|27284722|P4|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7868711|NCT02927873|27284723|P3|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7868712|NCT02927873|27284724|P2|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
7868713|NCT02927873|27284725|P1|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7868714|NCT02927873|27284720|P6|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7868715|NCT02927873|27284721|P5|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7868716|NCT02927873|27284722|P4|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7868717|NCT02927873|27284723|P3|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7868718|NCT02927873|27284724|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7868719|NCT02927873|27284725|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7868720|NCT02927873|27284720|P6|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7868721|NCT02927873|27284721|P5|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7868722|NCT02927873|27284722|P4|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7868723|NCT02927873|27284723|P3|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7868724|NCT02927873|27284724|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7868725|NCT02927873|27284725|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7868726|NCT02927873|27284720|P6|Overall Study|Lost to Follow-up|0
7868727|NCT02927873|27284721|P5|Overall Study|Lost to Follow-up|0
7868728|NCT02927873|27284722|P4|Overall Study|Lost to Follow-up|0
7868729|NCT02927873|27284723|P3|Overall Study|Lost to Follow-up|0
7868730|NCT02927873|27284724|P2|Overall Study|Lost to Follow-up|1
7868731|NCT02927873|27284725|P1|Overall Study|Lost to Follow-up|0
7868732|NCT02792192|27284884|P4|Overall Study|Study Terminated By Sponsor|0
7868733|NCT02792192|27284885|P3|Overall Study|Study Terminated By Sponsor|0
7868734|NCT02792192|27284886|P2|Overall Study|Study Terminated By Sponsor|10
7868735|NCT02792192|27284887|P1|Overall Study|Study Terminated By Sponsor|6
7868736|NCT02792192|27284884|P4|Overall Study|Progressive Disease|0
7868737|NCT02792192|27284885|P3|Overall Study|Progressive Disease|0
7868738|NCT02792192|27284886|P2|Overall Study|Progressive Disease|1
7868739|NCT02792192|27284887|P1|Overall Study|Progressive Disease|0
7868740|NCT02792192|27284884|P4|Overall Study|Physician Decision|0
7868741|NCT02792192|27284885|P3|Overall Study|Physician Decision|0
7868742|NCT02792192|27284886|P2|Overall Study|Physician Decision|0
7868743|NCT02792192|27284887|P1|Overall Study|Physician Decision|1
7868744|NCT02792192|27284884|P4|Overall Study|Informed Consent Withdrawn|0
7868745|NCT02792192|27284885|P3|Overall Study|Informed Consent Withdrawn|0
7868746|NCT02792192|27284886|P2|Overall Study|Informed Consent Withdrawn|0
7868747|NCT02792192|27284887|P1|Overall Study|Informed Consent Withdrawn|4
7868748|NCT02792192|27284884|P4|Overall Study|Death|0
7868749|NCT02792192|27284885|P3|Overall Study|Death|0
7868750|NCT02792192|27284886|P2|Overall Study|Death|0
7868751|NCT02792192|27284887|P1|Overall Study|Death|1
7868752|NCT02779855|27284946|P3|Overall Study|Withdrawal by patient prior to treatment|0
7868753|NCT02779855|27284947|P2|Overall Study|Withdrawal by patient prior to treatment|0
7868754|NCT02779855|27284948|P1|Overall Study|Withdrawal by patient prior to treatment|1
7868755|NCT02696031|27284960|P3|Week 52|Withdrawal by Subject|9
7868756|NCT02696031|27284961|P2|Week 52|Withdrawal by Subject|3
7868757|NCT02696031|27284962|P1|Week 52|Withdrawal by Subject|12
7868758|NCT02696031|27284960|P3|Week 52|Protocol Violation|0
7868759|NCT02696031|27284961|P2|Week 52|Protocol Violation|0
7868760|NCT02696031|27284962|P1|Week 52|Protocol Violation|1
7868761|NCT02696031|27284960|P3|Week 52|Pregnancy|0
7868762|NCT02696031|27284961|P2|Week 52|Pregnancy|2
7868763|NCT02696031|27284962|P1|Week 52|Pregnancy|0
7868764|NCT02696031|27284960|P3|Week 52|Physician Decision|2
7868765|NCT02696031|27284961|P2|Week 52|Physician Decision|1
7868766|NCT02696031|27284962|P1|Week 52|Physician Decision|1
7868767|NCT02696031|27284960|P3|Week 52|Lost to Follow-up|1
7868768|NCT02696031|27284961|P2|Week 52|Lost to Follow-up|1
7868769|NCT02696031|27284962|P1|Week 52|Lost to Follow-up|1
7868770|NCT02696031|27284960|P3|Week 52|Lack of Efficacy|11
7868771|NCT02696031|27284961|P2|Week 52|Lack of Efficacy|7
7868772|NCT02696031|27284962|P1|Week 52|Lack of Efficacy|10
7868773|NCT02696031|27284960|P3|Week 52|Adverse Event|3
7868774|NCT02696031|27284961|P2|Week 52|Adverse Event|5
7868775|NCT02696031|27284962|P1|Week 52|Adverse Event|4
7868776|NCT02696031|27284960|P3|Week 24|Withdrawal by Subject|5
7868777|NCT02696031|27284961|P2|Week 24|Withdrawal by Subject|1
7868778|NCT02696031|27284962|P1|Week 24|Withdrawal by Subject|4
7868779|NCT02696031|27284960|P3|Week 24|Protocol Violation|0
7868780|NCT02696031|27284961|P2|Week 24|Protocol Violation|0
7868781|NCT02696031|27284962|P1|Week 24|Protocol Violation|1
7868782|NCT02696031|27284960|P3|Week 24|Physician Decision|1
7868783|NCT02696031|27284961|P2|Week 24|Physician Decision|0
7868784|NCT02696031|27284962|P1|Week 24|Physician Decision|1
7868785|NCT02696031|27284960|P3|Week 24|Lost to Follow-up|1
7868786|NCT02696031|27284961|P2|Week 24|Lost to Follow-up|1
7868787|NCT02696031|27284962|P1|Week 24|Lost to Follow-up|0
7868788|NCT02696031|27284960|P3|Week 24|Lack of Efficacy|2
7868789|NCT02696031|27284961|P2|Week 24|Lack of Efficacy|1
7868790|NCT02696031|27284962|P1|Week 24|Lack of Efficacy|2
7868791|NCT02696031|27284960|P3|Week 24|Adverse Event|2
7868792|NCT02696031|27284961|P2|Week 24|Adverse Event|4
7868793|NCT02696031|27284962|P1|Week 24|Adverse Event|2
7868794|NCT02690649|27284976|P2|Overall Study|Protocol Violation|3
7868795|NCT02690649|27284977|P1|Overall Study|Protocol Violation|0
7868796|NCT02690649|27284976|P2|Overall Study|Withdrawal by Subject|1
7868797|NCT02690649|27284977|P1|Overall Study|Withdrawal by Subject|1
7868798|NCT02631577|27284991|P2|Overall Study|Withdrawal by Subject|3
7868799|NCT02631577|27284992|P1|Overall Study|Withdrawal by Subject|0
7868800|NCT02631577|27284991|P2|Overall Study|Death|7
7868801|NCT02631577|27284992|P1|Overall Study|Death|1
7868802|NCT02576509|27285024|P2|Follow-up Period|Other reason|2
7868803|NCT02576509|27285025|P1|Follow-up Period|Other reason|1
7868804|NCT02576509|27285024|P2|Follow-up Period|Lost to Follow-up|1
7868805|NCT02576509|27285025|P1|Follow-up Period|Lost to Follow-up|0
7868806|NCT02576509|27285024|P2|Follow-up Period|Participant withdrew consent|14
7868807|NCT02576509|27285025|P1|Follow-up Period|Participant withdrew consent|7
7868808|NCT02576509|27285024|P2|Follow-up Period|Death|35
7868809|NCT02576509|27285025|P1|Follow-up Period|Death|41
7868810|NCT02576509|27285024|P2|Treatment Period|Other reason|7
7868811|NCT02576509|27285025|P1|Treatment Period|Other reason|2
7868812|NCT02576509|27285024|P2|Treatment Period|Participant no longer meets criteria|0
7868813|NCT02576509|27285025|P1|Treatment Period|Participant no longer meets criteria|1
7868814|NCT02576509|27285024|P2|Treatment Period|Poor/non-compliance|1
7868815|NCT02576509|27285025|P1|Treatment Period|Poor/non-compliance|0
7868816|NCT02576509|27285024|P2|Treatment Period|Maximum clinical benefit|0
7868817|NCT02576509|27285025|P1|Treatment Period|Maximum clinical benefit|1
7868818|NCT02576509|27285024|P2|Treatment Period|Lost to Follow-up|1
7868819|NCT02576509|27285025|P1|Treatment Period|Lost to Follow-up|0
7868820|NCT02576509|27285024|P2|Treatment Period|Participant withdrew consent|7
7868821|NCT02576509|27285025|P1|Treatment Period|Participant withdrew consent|2
7868822|NCT02576509|27285024|P2|Treatment Period|Participant request to stop treatment|17
7868823|NCT02576509|27285025|P1|Treatment Period|Participant request to stop treatment|8
7868824|NCT02576509|27285024|P2|Treatment Period|Adverse event unrelated to study drug|40
7868825|NCT02576509|27285025|P1|Treatment Period|Adverse event unrelated to study drug|37
7868826|NCT02576509|27285024|P2|Treatment Period|Death|1
7868827|NCT02576509|27285025|P1|Treatment Period|Death|1
7868828|NCT02576509|27285024|P2|Treatment Period|Study drug toxicity|41
7868829|NCT02576509|27285025|P1|Treatment Period|Study drug toxicity|32
7868830|NCT02576509|27285024|P2|Treatment Period|Disease progression|240
7868831|NCT02576509|27285025|P1|Treatment Period|Disease progression|245
7868832|NCT02576509|27285024|P2|Pre-Treatment Period|Participant no longer meets criteria|2
7868833|NCT02576509|27285025|P1|Pre-Treatment Period|Participant no longer meets criteria|3
7868834|NCT02576509|27285024|P2|Pre-Treatment Period|Participant withdrew consent|5
7868835|NCT02576509|27285025|P1|Pre-Treatment Period|Participant withdrew consent|1
7868836|NCT02576509|27285024|P2|Pre-Treatment Period|Participant request to stop therapy|2
7868837|NCT02576509|27285025|P1|Pre-Treatment Period|Participant request to stop therapy|0
7868838|NCT02566993|27285052|P2|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
7868839|NCT02566993|27285053|P1|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
7868840|NCT02566993|27285052|P2|Overall Study|Lost to Follow-up|1
7868841|NCT02566993|27285053|P1|Overall Study|Lost to Follow-up|0
7868842|NCT02566993|27285052|P2|Overall Study|Screening failure|0
7868843|NCT02566993|27285053|P1|Overall Study|Screening failure|2
7868844|NCT02566993|27285052|P2|Overall Study|Sponsor's decision after incorrect treatment at site|1
7868845|NCT02566993|27285053|P1|Overall Study|Sponsor's decision after incorrect treatment at site|1
7868846|NCT02566993|27285052|P2|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
7868847|NCT02566993|27285053|P1|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
7868848|NCT02566993|27285052|P2|Overall Study|Symptomatic deterioration|16
7868849|NCT02566993|27285053|P1|Overall Study|Symptomatic deterioration|9
7868850|NCT02566993|27285052|P2|Overall Study|Non study drug-related adverse event|9
7868851|NCT02566993|27285053|P1|Overall Study|Non study drug-related adverse event|9
7868852|NCT02566993|27285052|P2|Overall Study|Study drug-related adverse event|41
7868853|NCT02566993|27285053|P1|Overall Study|Study drug-related adverse event|20
7868854|NCT02566993|27285052|P2|Overall Study|Physician Decision|17
7868855|NCT02566993|27285053|P1|Overall Study|Physician Decision|10
7868856|NCT02566993|27285052|P2|Overall Study|Death|23
7868857|NCT02566993|27285053|P1|Overall Study|Death|17
7868858|NCT02566993|27285052|P2|Overall Study|Withdrawal by Subject|28
7868859|NCT02566993|27285053|P1|Overall Study|Withdrawal by Subject|12
7868860|NCT02566993|27285052|P2|Overall Study|Progressive disease|152
7868861|NCT02566993|27285053|P1|Overall Study|Progressive disease|213
7868862|NCT02566993|27285052|P2|Overall Study|Randomized but not treated|16
7868863|NCT02566993|27285053|P1|Overall Study|Randomized but not treated|5
7868864|NCT02436759|27285120|P2|Overall Study|Withdrawal by Subject|1
7868865|NCT02436759|27285121|P1|Overall Study|Withdrawal by Subject|0
7868866|NCT02436759|27285120|P2|Overall Study|Protocol Violation|0
7868867|NCT02436759|27285121|P1|Overall Study|Protocol Violation|1
7868868|NCT02436759|27285120|P2|Overall Study|Adverse Event|0
7868869|NCT02436759|27285121|P1|Overall Study|Adverse Event|3
7868870|NCT02436408|27285129|P1|Overall Study|Death|1
7868871|NCT02407236|27285144|P8|Maintenance Study (44 Weeks)|Other|1
7868872|NCT02407236|27285145|P7|Maintenance Study (44 Weeks)|Other|2
7868873|NCT02407236|27285146|P6|Maintenance Study (44 Weeks)|Other|1
7868874|NCT02407236|27285147|P5|Maintenance Study (44 Weeks)|Other|1
7868875|NCT02407236|27285148|P4|Maintenance Study (44 Weeks)|Other|0
7868876|NCT02407236|27285149|P3|Maintenance Study (44 Weeks)|Other|0
7868877|NCT02407236|27285150|P2|Maintenance Study (44 Weeks)|Other|0
7868878|NCT02407236|27285151|P1|Maintenance Study (44 Weeks)|Other|0
7868879|NCT02407236|27285144|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
7868880|NCT02407236|27285145|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
7868881|NCT02407236|27285146|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
7868882|NCT02407236|27285147|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
7868883|NCT02407236|27285148|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
7868884|NCT02407236|27285149|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
7868885|NCT02407236|27285150|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
7868886|NCT02407236|27285151|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
7868887|NCT02407236|27285144|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
7868888|NCT02407236|27285145|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
7868889|NCT02407236|27285146|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
7868890|NCT02407236|27285147|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
7868891|NCT02407236|27285148|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
7868892|NCT02407236|27285149|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
7868893|NCT02407236|27285150|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
7868894|NCT02407236|27285151|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
7868895|NCT02407236|27285144|P8|Maintenance Study (44 Weeks)|Death|1
7868896|NCT02407236|27285145|P7|Maintenance Study (44 Weeks)|Death|0
7868897|NCT02407236|27285146|P6|Maintenance Study (44 Weeks)|Death|0
7868898|NCT02407236|27285147|P5|Maintenance Study (44 Weeks)|Death|0
7868899|NCT02407236|27285148|P4|Maintenance Study (44 Weeks)|Death|0
7868900|NCT02407236|27285149|P3|Maintenance Study (44 Weeks)|Death|0
7868901|NCT02407236|27285150|P2|Maintenance Study (44 Weeks)|Death|0
7868902|NCT02407236|27285151|P1|Maintenance Study (44 Weeks)|Death|0
7868903|NCT02407236|27285144|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7868904|NCT02407236|27285145|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7868905|NCT02407236|27285146|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7868906|NCT02407236|27285147|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7868907|NCT02407236|27285148|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7868908|NCT02407236|27285149|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7868909|NCT02407236|27285150|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7868910|NCT02407236|27285151|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7868911|NCT02407236|27285144|P8|Induction Study (8 Weeks)|Other|0
7868912|NCT02407236|27285145|P7|Induction Study (8 Weeks)|Other|0
7868913|NCT02407236|27285146|P6|Induction Study (8 Weeks)|Other|0
7868914|NCT02407236|27285147|P5|Induction Study (8 Weeks)|Other|0
7868915|NCT02407236|27285148|P4|Induction Study (8 Weeks)|Other|0
7868916|NCT02407236|27285149|P3|Induction Study (8 Weeks)|Other|5
7868917|NCT02407236|27285150|P2|Induction Study (8 Weeks)|Other|1
7868918|NCT02407236|27285151|P1|Induction Study (8 Weeks)|Other|2
7868919|NCT02407236|27285144|P8|Induction Study (8 Weeks)|Physician Decision|0
7868920|NCT02407236|27285145|P7|Induction Study (8 Weeks)|Physician Decision|0
7868921|NCT02407236|27285146|P6|Induction Study (8 Weeks)|Physician Decision|0
7868922|NCT02407236|27285147|P5|Induction Study (8 Weeks)|Physician Decision|0
7868923|NCT02407236|27285148|P4|Induction Study (8 Weeks)|Physician Decision|0
7868924|NCT02407236|27285149|P3|Induction Study (8 Weeks)|Physician Decision|0
7868925|NCT02407236|27285150|P2|Induction Study (8 Weeks)|Physician Decision|1
7868926|NCT02407236|27285151|P1|Induction Study (8 Weeks)|Physician Decision|1
7868927|NCT02407236|27285144|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
7868928|NCT02407236|27285145|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
7868929|NCT02407236|27285146|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
7868930|NCT02407236|27285147|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
7868931|NCT02407236|27285148|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
7868932|NCT02407236|27285149|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
7868933|NCT02407236|27285150|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
7868934|NCT02407236|27285151|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
7868935|NCT02407236|27285144|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
7868936|NCT02407236|27285145|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
7868937|NCT02407236|27285146|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
7868938|NCT02407236|27285147|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
7868939|NCT02407236|27285148|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
7868940|NCT02407236|27285149|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
7868941|NCT02407236|27285150|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
7868942|NCT02407236|27285151|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
7868943|NCT02407236|27285144|P8|Induction Study (8 Weeks)|Death|0
7868944|NCT02407236|27285145|P7|Induction Study (8 Weeks)|Death|0
7868945|NCT02407236|27285146|P6|Induction Study (8 Weeks)|Death|0
7868946|NCT02407236|27285147|P5|Induction Study (8 Weeks)|Death|0
7868947|NCT02407236|27285148|P4|Induction Study (8 Weeks)|Death|0
7868948|NCT02407236|27285149|P3|Induction Study (8 Weeks)|Death|1
7868949|NCT02407236|27285150|P2|Induction Study (8 Weeks)|Death|0
7868950|NCT02407236|27285151|P1|Induction Study (8 Weeks)|Death|0
7868951|NCT02407236|27285144|P8|Induction Study (8 Weeks)|Adverse Event|0
7868952|NCT02407236|27285145|P7|Induction Study (8 Weeks)|Adverse Event|0
7868953|NCT02407236|27285146|P6|Induction Study (8 Weeks)|Adverse Event|0
7868954|NCT02407236|27285147|P5|Induction Study (8 Weeks)|Adverse Event|0
7868955|NCT02407236|27285148|P4|Induction Study (8 Weeks)|Adverse Event|0
7868956|NCT02407236|27285149|P3|Induction Study (8 Weeks)|Adverse Event|1
7868957|NCT02407236|27285150|P2|Induction Study (8 Weeks)|Adverse Event|0
7868958|NCT02407236|27285151|P1|Induction Study (8 Weeks)|Adverse Event|3
7868959|NCT02367456|27285391|P3|Overall Study|Other reason|0
7868960|NCT02367456|27285392|P2|Overall Study|Other reason|0
7868961|NCT02367456|27285393|P1|Overall Study|Other reason|3
7868962|NCT02367456|27285391|P3|Overall Study|Ongoing|15
7868963|NCT02367456|27285392|P2|Overall Study|Ongoing|6
7868964|NCT02367456|27285393|P1|Overall Study|Ongoing|0
7868965|NCT02367456|27285391|P3|Overall Study|Lost to Follow-up|1
7868966|NCT02367456|27285392|P2|Overall Study|Lost to Follow-up|3
7868967|NCT02367456|27285393|P1|Overall Study|Lost to Follow-up|1
7868968|NCT02367456|27285391|P3|Overall Study|Death|14
7868969|NCT02367456|27285392|P2|Overall Study|Death|21
7868970|NCT02367456|27285393|P1|Overall Study|Death|8
7868971|NCT02315703|27285438|P8|Overall Study|Other|2
7868972|NCT02315703|27285439|P7|Overall Study|Other|8
7868973|NCT02315703|27285440|P6|Overall Study|Other|2
7868974|NCT02315703|27285441|P5|Overall Study|Other|1
7868975|NCT02315703|27285442|P4|Overall Study|Other|2
7868976|NCT02315703|27285443|P3|Overall Study|Other|2
7868977|NCT02315703|27285444|P2|Overall Study|Other|2
7868978|NCT02315703|27285445|P1|Overall Study|Other|4
7868979|NCT02315703|27285438|P8|Overall Study|Physician Decision|0
7868980|NCT02315703|27285439|P7|Overall Study|Physician Decision|1
7868981|NCT02315703|27285440|P6|Overall Study|Physician Decision|2
7868982|NCT02315703|27285441|P5|Overall Study|Physician Decision|0
7868983|NCT02315703|27285442|P4|Overall Study|Physician Decision|0
7868984|NCT02315703|27285443|P3|Overall Study|Physician Decision|0
7868985|NCT02315703|27285444|P2|Overall Study|Physician Decision|0
7868986|NCT02315703|27285445|P1|Overall Study|Physician Decision|0
7868987|NCT02315703|27285438|P8|Overall Study|Withdrawal by Subject|2
7868988|NCT02315703|27285439|P7|Overall Study|Withdrawal by Subject|1
7868989|NCT02315703|27285440|P6|Overall Study|Withdrawal by Subject|1
7868990|NCT02315703|27285441|P5|Overall Study|Withdrawal by Subject|4
7868991|NCT02315703|27285442|P4|Overall Study|Withdrawal by Subject|3
7868992|NCT02315703|27285443|P3|Overall Study|Withdrawal by Subject|0
7868993|NCT02315703|27285444|P2|Overall Study|Withdrawal by Subject|3
7868994|NCT02315703|27285445|P1|Overall Study|Withdrawal by Subject|1
7868995|NCT02315703|27285438|P8|Overall Study|Pregnancy|1
7868996|NCT02315703|27285439|P7|Overall Study|Pregnancy|0
7868997|NCT02315703|27285440|P6|Overall Study|Pregnancy|0
7868998|NCT02315703|27285441|P5|Overall Study|Pregnancy|0
7868999|NCT02315703|27285442|P4|Overall Study|Pregnancy|0
7869000|NCT02315703|27285443|P3|Overall Study|Pregnancy|0
7869001|NCT02315703|27285444|P2|Overall Study|Pregnancy|0
7869002|NCT02315703|27285445|P1|Overall Study|Pregnancy|0
7869003|NCT02315703|27285438|P8|Overall Study|Lost to Follow-up|2
7869004|NCT02315703|27285439|P7|Overall Study|Lost to Follow-up|2
7869005|NCT02315703|27285440|P6|Overall Study|Lost to Follow-up|1
7869006|NCT02315703|27285441|P5|Overall Study|Lost to Follow-up|2
7869007|NCT02315703|27285442|P4|Overall Study|Lost to Follow-up|3
7869008|NCT02315703|27285443|P3|Overall Study|Lost to Follow-up|3
7869009|NCT02315703|27285444|P2|Overall Study|Lost to Follow-up|5
7869010|NCT02315703|27285445|P1|Overall Study|Lost to Follow-up|1
7869011|NCT02315703|27285438|P8|Overall Study|Adverse Event|0
7869012|NCT02315703|27285439|P7|Overall Study|Adverse Event|1
7869013|NCT02315703|27285440|P6|Overall Study|Adverse Event|0
7869014|NCT02315703|27285441|P5|Overall Study|Adverse Event|1
7869015|NCT02315703|27285442|P4|Overall Study|Adverse Event|1
7869016|NCT02315703|27285443|P3|Overall Study|Adverse Event|0
7869017|NCT02315703|27285444|P2|Overall Study|Adverse Event|0
7869018|NCT02315703|27285445|P1|Overall Study|Adverse Event|0
7869019|NCT02277444|27285543|P1|Overall Study|Ongoing|113
7869020|NCT02277444|27285543|P1|Overall Study|Enrolled and not Treated|3
7869021|NCT02277444|27285543|P1|Overall Study|Other|1
7869022|NCT02277444|27285543|P1|Overall Study|Withdrawal by Subject|3
7869023|NCT02277444|27285543|P1|Overall Study|Adverse Event|10
7869024|NCT02231749|27285552|P2|Overall Study|No longer meets Study Criteria|0
7869025|NCT02231749|27285553|P1|Overall Study|No longer meets Study Criteria|1
7869026|NCT02231749|27285552|P2|Overall Study|other|8
7869027|NCT02231749|27285553|P1|Overall Study|other|0
7869028|NCT02231749|27285552|P2|Overall Study|Pregnancy|0
7869029|NCT02231749|27285553|P1|Overall Study|Pregnancy|1
7869030|NCT02231749|27285552|P2|Overall Study|Poor/Non-Compliance|3
7869031|NCT02231749|27285553|P1|Overall Study|Poor/Non-Compliance|0
7869032|NCT02231749|27285552|P2|Overall Study|Maximum Clinical Benefit|8
7869033|NCT02231749|27285553|P1|Overall Study|Maximum Clinical Benefit|5
7869034|NCT02231749|27285552|P2|Overall Study|Lost to Follow-up|2
7869035|NCT02231749|27285553|P1|Overall Study|Lost to Follow-up|1
7869036|NCT02231749|27285552|P2|Overall Study|Participant withdrew Consent|15
7869037|NCT02231749|27285553|P1|Overall Study|Participant withdrew Consent|8
7869038|NCT02231749|27285552|P2|Overall Study|Participant's request to discontinue|21
7869039|NCT02231749|27285553|P1|Overall Study|Participant's request to discontinue|10
7869040|NCT02231749|27285552|P2|Overall Study|AE unrelated to Study drug|31
7869041|NCT02231749|27285553|P1|Overall Study|AE unrelated to Study drug|32
7869042|NCT02231749|27285552|P2|Overall Study|Death|1
7869043|NCT02231749|27285553|P1|Overall Study|Death|1
7869044|NCT02231749|27285552|P2|Overall Study|Study Drug Toxicity|63
7869045|NCT02231749|27285553|P1|Overall Study|Study Drug Toxicity|134
7869046|NCT02231749|27285552|P2|Overall Study|Disease progression|297
7869047|NCT02231749|27285553|P1|Overall Study|Disease progression|229
7869048|NCT02227238|27285571|P2|Overall Study|Lost to Follow-up|5
7869049|NCT02227238|27285572|P1|Overall Study|Lost to Follow-up|7
7869050|NCT02227238|27285571|P2|Overall Study|Physician Decision|9
7869051|NCT02227238|27285572|P1|Overall Study|Physician Decision|0
7869052|NCT02227238|27285571|P2|Overall Study|Withdrawal by Subject|4
7869053|NCT02227238|27285572|P1|Overall Study|Withdrawal by Subject|5
7869054|NCT02227238|27285571|P2|Overall Study|Protocol Violation|8
7869055|NCT02227238|27285572|P1|Overall Study|Protocol Violation|7
7869056|NCT02227238|27285571|P2|Overall Study|Lack of Efficacy|22
7869057|NCT02227238|27285572|P1|Overall Study|Lack of Efficacy|10
7869058|NCT02227238|27285571|P2|Overall Study|Adverse Event|18
7869059|NCT02227238|27285572|P1|Overall Study|Adverse Event|8
7869060|NCT02227238|27285571|P2|Overall Study|Other: Reached stopping criteria|1
7869061|NCT02227238|27285572|P1|Overall Study|Other: Reached stopping criteria|0
7869062|NCT02195479|27285699|P2|Overall Study|Ongoing|297
7869063|NCT02195479|27285700|P1|Overall Study|Ongoing|291
7869064|NCT02195479|27285699|P2|Overall Study|Other|2
7869065|NCT02195479|27285700|P1|Overall Study|Other|2
7869066|NCT02195479|27285699|P2|Overall Study|Withdrawal by Subject|6
7869067|NCT02195479|27285700|P1|Overall Study|Withdrawal by Subject|11
7869068|NCT02195479|27285699|P2|Overall Study|Physician Decision|0
7869069|NCT02195479|27285700|P1|Overall Study|Physician Decision|1
7869070|NCT02195479|27285699|P2|Overall Study|Death|45
7869071|NCT02195479|27285700|P1|Overall Study|Death|48
7869072|NCT02195479|27285699|P2|Overall Study|Lost to Follow-up|0
7869073|NCT02195479|27285700|P1|Overall Study|Lost to Follow-up|3
7869074|NCT02076009|27285738|P2|Overall Study|Subjects randomized but not treated|3
7869075|NCT02076009|27285739|P1|Overall Study|Subjects randomized but not treated|2
7869076|NCT02076009|27285738|P2|Overall Study|Ongoing|249
7869077|NCT02076009|27285739|P1|Overall Study|Ongoing|226
7869078|NCT02076009|27285738|P2|Overall Study|Progressive disease|0
7869079|NCT02076009|27285739|P1|Overall Study|Progressive disease|1
7869080|NCT02076009|27285738|P2|Overall Study|Lost to Follow-up|1
7869081|NCT02076009|27285739|P1|Overall Study|Lost to Follow-up|1
7869082|NCT02076009|27285738|P2|Overall Study|Withdrawal by Subject|3
7869083|NCT02076009|27285739|P1|Overall Study|Withdrawal by Subject|9
7869084|NCT02076009|27285738|P2|Overall Study|Death|30
7869085|NCT02076009|27285739|P1|Overall Study|Death|44
7869086|NCT01928394|27285782|P23|Follow-up Period|Lost to Follow-up|1
7869087|NCT01928394|27285783|P22|Follow-up Period|Lost to Follow-up|0
7869088|NCT01928394|27285784|P21|Follow-up Period|Lost to Follow-up|0
7869089|NCT01928394|27285785|P20|Follow-up Period|Lost to Follow-up|0
7869090|NCT01928394|27285786|P19|Follow-up Period|Lost to Follow-up|0
7869091|NCT01928394|27285787|P18|Follow-up Period|Lost to Follow-up|0
7869092|NCT01928394|27285788|P17|Follow-up Period|Lost to Follow-up|1
7869093|NCT01928394|27285789|P16|Follow-up Period|Lost to Follow-up|0
7869094|NCT01928394|27285790|P15|Follow-up Period|Lost to Follow-up|1
7869095|NCT01928394|27285791|P14|Follow-up Period|Lost to Follow-up|0
7869096|NCT01928394|27285792|P13|Follow-up Period|Lost to Follow-up|1
7869097|NCT01928394|27285793|P12|Follow-up Period|Lost to Follow-up|1
7869098|NCT01928394|27285794|P11|Follow-up Period|Lost to Follow-up|0
7869099|NCT01928394|27285795|P10|Follow-up Period|Lost to Follow-up|0
7869100|NCT01928394|27285796|P9|Follow-up Period|Lost to Follow-up|0
7869101|NCT01928394|27285797|P8|Follow-up Period|Lost to Follow-up|0
7869102|NCT01928394|27285798|P7|Follow-up Period|Lost to Follow-up|0
7869103|NCT01928394|27285799|P6|Follow-up Period|Lost to Follow-up|0
7869104|NCT01928394|27285800|P5|Follow-up Period|Lost to Follow-up|0
7869105|NCT01928394|27285801|P4|Follow-up Period|Lost to Follow-up|0
7869106|NCT01928394|27285802|P3|Follow-up Period|Lost to Follow-up|0
7869107|NCT01928394|27285803|P2|Follow-up Period|Lost to Follow-up|0
7869108|NCT01928394|27285804|P1|Follow-up Period|Lost to Follow-up|0
7869109|NCT01928394|27285782|P23|Follow-up Period|other reason|1
7869110|NCT01928394|27285783|P22|Follow-up Period|other reason|0
7869111|NCT01928394|27285784|P21|Follow-up Period|other reason|0
7869112|NCT01928394|27285785|P20|Follow-up Period|other reason|1
7869113|NCT01928394|27285786|P19|Follow-up Period|other reason|1
7869114|NCT01928394|27285787|P18|Follow-up Period|other reason|0
7869115|NCT01928394|27285788|P17|Follow-up Period|other reason|2
7869116|NCT01928394|27285789|P16|Follow-up Period|other reason|0
7869117|NCT01928394|27285790|P15|Follow-up Period|other reason|4
7869118|NCT01928394|27285791|P14|Follow-up Period|other reason|1
7869119|NCT01928394|27285792|P13|Follow-up Period|other reason|0
7869120|NCT01928394|27285793|P12|Follow-up Period|other reason|1
7869121|NCT01928394|27285794|P11|Follow-up Period|other reason|2
7869122|NCT01928394|27285795|P10|Follow-up Period|other reason|0
7869123|NCT01928394|27285796|P9|Follow-up Period|other reason|0
7869124|NCT01928394|27285797|P8|Follow-up Period|other reason|3
7869125|NCT01928394|27285798|P7|Follow-up Period|other reason|1
7869126|NCT01928394|27285799|P6|Follow-up Period|other reason|0
7869127|NCT01928394|27285800|P5|Follow-up Period|other reason|0
7869128|NCT01928394|27285801|P4|Follow-up Period|other reason|0
7869129|NCT01928394|27285802|P3|Follow-up Period|other reason|0
7869130|NCT01928394|27285803|P2|Follow-up Period|other reason|0
7869131|NCT01928394|27285804|P1|Follow-up Period|other reason|0
7869132|NCT01928394|27285782|P23|Follow-up Period|Death|2
7869133|NCT01928394|27285783|P22|Follow-up Period|Death|3
7869134|NCT01928394|27285784|P21|Follow-up Period|Death|5
7869135|NCT01928394|27285785|P20|Follow-up Period|Death|13
7869136|NCT01928394|27285786|P19|Follow-up Period|Death|13
7869137|NCT01928394|27285787|P18|Follow-up Period|Death|5
7869138|NCT01928394|27285788|P17|Follow-up Period|Death|6
7869139|NCT01928394|27285789|P16|Follow-up Period|Death|0
7869140|NCT01928394|27285790|P15|Follow-up Period|Death|18
7869141|NCT01928394|27285791|P14|Follow-up Period|Death|25
7869142|NCT01928394|27285792|P13|Follow-up Period|Death|11
7869143|NCT01928394|27285793|P12|Follow-up Period|Death|12
7869144|NCT01928394|27285794|P11|Follow-up Period|Death|4
7869145|NCT01928394|27285795|P10|Follow-up Period|Death|2
7869146|NCT01928394|27285796|P9|Follow-up Period|Death|1
7869147|NCT01928394|27285797|P8|Follow-up Period|Death|2
7869148|NCT01928394|27285798|P7|Follow-up Period|Death|6
7869149|NCT01928394|27285799|P6|Follow-up Period|Death|6
7869150|NCT01928394|27285800|P5|Follow-up Period|Death|0
7869151|NCT01928394|27285801|P4|Follow-up Period|Death|6
7869152|NCT01928394|27285802|P3|Follow-up Period|Death|2
7869153|NCT01928394|27285803|P2|Follow-up Period|Death|0
7869154|NCT01928394|27285804|P1|Follow-up Period|Death|0
7869155|NCT01928394|27285782|P23|Follow-up Period|Participant withdrew consent|2
7869156|NCT01928394|27285783|P22|Follow-up Period|Participant withdrew consent|6
7869157|NCT01928394|27285784|P21|Follow-up Period|Participant withdrew consent|4
7869158|NCT01928394|27285785|P20|Follow-up Period|Participant withdrew consent|7
7869159|NCT01928394|27285786|P19|Follow-up Period|Participant withdrew consent|2
7869160|NCT01928394|27285787|P18|Follow-up Period|Participant withdrew consent|3
7869161|NCT01928394|27285788|P17|Follow-up Period|Participant withdrew consent|5
7869162|NCT01928394|27285789|P16|Follow-up Period|Participant withdrew consent|0
7869163|NCT01928394|27285790|P15|Follow-up Period|Participant withdrew consent|7
7869164|NCT01928394|27285791|P14|Follow-up Period|Participant withdrew consent|12
7869165|NCT01928394|27285792|P13|Follow-up Period|Participant withdrew consent|2
7869166|NCT01928394|27285793|P12|Follow-up Period|Participant withdrew consent|8
7869167|NCT01928394|27285794|P11|Follow-up Period|Participant withdrew consent|5
7869168|NCT01928394|27285795|P10|Follow-up Period|Participant withdrew consent|0
7869169|NCT01928394|27285796|P9|Follow-up Period|Participant withdrew consent|0
7869170|NCT01928394|27285797|P8|Follow-up Period|Participant withdrew consent|1
7869171|NCT01928394|27285798|P7|Follow-up Period|Participant withdrew consent|5
7869172|NCT01928394|27285799|P6|Follow-up Period|Participant withdrew consent|2
7869173|NCT01928394|27285800|P5|Follow-up Period|Participant withdrew consent|0
7869174|NCT01928394|27285801|P4|Follow-up Period|Participant withdrew consent|4
7869175|NCT01928394|27285802|P3|Follow-up Period|Participant withdrew consent|1
7869176|NCT01928394|27285803|P2|Follow-up Period|Participant withdrew consent|0
7869177|NCT01928394|27285804|P1|Follow-up Period|Participant withdrew consent|3
7869178|NCT01928394|27285782|P23|Treatment Period|Death|0
7869179|NCT01928394|27285783|P22|Treatment Period|Death|0
7869180|NCT01928394|27285784|P21|Treatment Period|Death|0
7869181|NCT01928394|27285785|P20|Treatment Period|Death|0
7869182|NCT01928394|27285786|P19|Treatment Period|Death|0
7869183|NCT01928394|27285787|P18|Treatment Period|Death|0
7869184|NCT01928394|27285788|P17|Treatment Period|Death|0
7869185|NCT01928394|27285789|P16|Treatment Period|Death|0
7869186|NCT01928394|27285790|P15|Treatment Period|Death|2
7869187|NCT01928394|27285791|P14|Treatment Period|Death|1
7869188|NCT01928394|27285792|P13|Treatment Period|Death|0
7869189|NCT01928394|27285793|P12|Treatment Period|Death|0
7869190|NCT01928394|27285794|P11|Treatment Period|Death|0
7869191|NCT01928394|27285795|P10|Treatment Period|Death|0
7869192|NCT01928394|27285796|P9|Treatment Period|Death|0
7869193|NCT01928394|27285797|P8|Treatment Period|Death|0
7869194|NCT01928394|27285798|P7|Treatment Period|Death|0
7869195|NCT01928394|27285799|P6|Treatment Period|Death|0
7869196|NCT01928394|27285800|P5|Treatment Period|Death|0
7869197|NCT01928394|27285801|P4|Treatment Period|Death|0
7869198|NCT01928394|27285802|P3|Treatment Period|Death|0
7869199|NCT01928394|27285803|P2|Treatment Period|Death|0
7869200|NCT01928394|27285804|P1|Treatment Period|Death|0
7869201|NCT01928394|27285782|P23|Treatment Period|Lost to Follow-up|1
7869202|NCT01928394|27285783|P22|Treatment Period|Lost to Follow-up|0
7869203|NCT01928394|27285784|P21|Treatment Period|Lost to Follow-up|0
7869204|NCT01928394|27285785|P20|Treatment Period|Lost to Follow-up|0
7869205|NCT01928394|27285786|P19|Treatment Period|Lost to Follow-up|0
7869206|NCT01928394|27285787|P18|Treatment Period|Lost to Follow-up|0
7869207|NCT01928394|27285788|P17|Treatment Period|Lost to Follow-up|0
7869208|NCT01928394|27285789|P16|Treatment Period|Lost to Follow-up|0
7869209|NCT01928394|27285790|P15|Treatment Period|Lost to Follow-up|0
7869210|NCT01928394|27285791|P14|Treatment Period|Lost to Follow-up|0
7869211|NCT01928394|27285792|P13|Treatment Period|Lost to Follow-up|0
7869212|NCT01928394|27285793|P12|Treatment Period|Lost to Follow-up|0
7869213|NCT01928394|27285794|P11|Treatment Period|Lost to Follow-up|0
7869214|NCT01928394|27285795|P10|Treatment Period|Lost to Follow-up|0
7869215|NCT01928394|27285796|P9|Treatment Period|Lost to Follow-up|0
7869216|NCT01928394|27285797|P8|Treatment Period|Lost to Follow-up|0
7869217|NCT01928394|27285798|P7|Treatment Period|Lost to Follow-up|0
7869218|NCT01928394|27285799|P6|Treatment Period|Lost to Follow-up|0
7869219|NCT01928394|27285800|P5|Treatment Period|Lost to Follow-up|0
7869220|NCT01928394|27285801|P4|Treatment Period|Lost to Follow-up|0
7869221|NCT01928394|27285802|P3|Treatment Period|Lost to Follow-up|0
7869222|NCT01928394|27285803|P2|Treatment Period|Lost to Follow-up|0
7869223|NCT01928394|27285804|P1|Treatment Period|Lost to Follow-up|0
7869224|NCT01928394|27285782|P23|Treatment Period|Maximum clinical benefit|0
7869225|NCT01928394|27285783|P22|Treatment Period|Maximum clinical benefit|0
7869226|NCT01928394|27285784|P21|Treatment Period|Maximum clinical benefit|2
7869227|NCT01928394|27285785|P20|Treatment Period|Maximum clinical benefit|0
7869228|NCT01928394|27285786|P19|Treatment Period|Maximum clinical benefit|1
7869229|NCT01928394|27285787|P18|Treatment Period|Maximum clinical benefit|1
7869230|NCT01928394|27285788|P17|Treatment Period|Maximum clinical benefit|0
7869231|NCT01928394|27285789|P16|Treatment Period|Maximum clinical benefit|0
7869232|NCT01928394|27285790|P15|Treatment Period|Maximum clinical benefit|1
7869233|NCT01928394|27285791|P14|Treatment Period|Maximum clinical benefit|0
7869234|NCT01928394|27285792|P13|Treatment Period|Maximum clinical benefit|0
7869235|NCT01928394|27285793|P12|Treatment Period|Maximum clinical benefit|1
7869236|NCT01928394|27285794|P11|Treatment Period|Maximum clinical benefit|1
7869237|NCT01928394|27285795|P10|Treatment Period|Maximum clinical benefit|0
7869238|NCT01928394|27285796|P9|Treatment Period|Maximum clinical benefit|0
7869239|NCT01928394|27285797|P8|Treatment Period|Maximum clinical benefit|0
7869240|NCT01928394|27285798|P7|Treatment Period|Maximum clinical benefit|0
7869241|NCT01928394|27285799|P6|Treatment Period|Maximum clinical benefit|0
7869242|NCT01928394|27285800|P5|Treatment Period|Maximum clinical benefit|0
7869243|NCT01928394|27285801|P4|Treatment Period|Maximum clinical benefit|0
7869244|NCT01928394|27285802|P3|Treatment Period|Maximum clinical benefit|0
7869245|NCT01928394|27285803|P2|Treatment Period|Maximum clinical benefit|0
7869246|NCT01928394|27285804|P1|Treatment Period|Maximum clinical benefit|0
7869247|NCT01928394|27285782|P23|Treatment Period|other reason|0
7869248|NCT01928394|27285783|P22|Treatment Period|other reason|0
7869249|NCT01928394|27285784|P21|Treatment Period|other reason|0
7869250|NCT01928394|27285785|P20|Treatment Period|other reason|2
7869251|NCT01928394|27285786|P19|Treatment Period|other reason|2
7869252|NCT01928394|27285787|P18|Treatment Period|other reason|0
7869253|NCT01928394|27285788|P17|Treatment Period|other reason|0
7869254|NCT01928394|27285789|P16|Treatment Period|other reason|0
7869255|NCT01928394|27285790|P15|Treatment Period|other reason|1
7869256|NCT01928394|27285791|P14|Treatment Period|other reason|0
7869257|NCT01928394|27285792|P13|Treatment Period|other reason|1
7869258|NCT01928394|27285793|P12|Treatment Period|other reason|1
7869259|NCT01928394|27285794|P11|Treatment Period|other reason|1
7869260|NCT01928394|27285795|P10|Treatment Period|other reason|0
7869261|NCT01928394|27285796|P9|Treatment Period|other reason|0
7869262|NCT01928394|27285797|P8|Treatment Period|other reason|0
7869263|NCT01928394|27285798|P7|Treatment Period|other reason|0
7869264|NCT01928394|27285799|P6|Treatment Period|other reason|0
7869265|NCT01928394|27285800|P5|Treatment Period|other reason|0
7869266|NCT01928394|27285801|P4|Treatment Period|other reason|0
7869267|NCT01928394|27285802|P3|Treatment Period|other reason|0
7869268|NCT01928394|27285803|P2|Treatment Period|other reason|0
7869269|NCT01928394|27285804|P1|Treatment Period|other reason|0
7869270|NCT01928394|27285782|P23|Treatment Period|Poor/non-compliance|0
7869271|NCT01928394|27285783|P22|Treatment Period|Poor/non-compliance|0
7869272|NCT01928394|27285784|P21|Treatment Period|Poor/non-compliance|0
7869273|NCT01928394|27285785|P20|Treatment Period|Poor/non-compliance|1
7869274|NCT01928394|27285786|P19|Treatment Period|Poor/non-compliance|0
7869275|NCT01928394|27285787|P18|Treatment Period|Poor/non-compliance|1
7869276|NCT01928394|27285788|P17|Treatment Period|Poor/non-compliance|0
7869277|NCT01928394|27285789|P16|Treatment Period|Poor/non-compliance|0
7869278|NCT01928394|27285790|P15|Treatment Period|Poor/non-compliance|1
7869279|NCT01928394|27285791|P14|Treatment Period|Poor/non-compliance|0
7869280|NCT01928394|27285792|P13|Treatment Period|Poor/non-compliance|1
7869281|NCT01928394|27285793|P12|Treatment Period|Poor/non-compliance|0
7869282|NCT01928394|27285794|P11|Treatment Period|Poor/non-compliance|0
7869283|NCT01928394|27285795|P10|Treatment Period|Poor/non-compliance|0
7869284|NCT01928394|27285796|P9|Treatment Period|Poor/non-compliance|0
7869285|NCT01928394|27285797|P8|Treatment Period|Poor/non-compliance|0
7869286|NCT01928394|27285798|P7|Treatment Period|Poor/non-compliance|0
7869287|NCT01928394|27285799|P6|Treatment Period|Poor/non-compliance|0
7869288|NCT01928394|27285800|P5|Treatment Period|Poor/non-compliance|0
7869289|NCT01928394|27285801|P4|Treatment Period|Poor/non-compliance|1
7869290|NCT01928394|27285802|P3|Treatment Period|Poor/non-compliance|0
7869291|NCT01928394|27285803|P2|Treatment Period|Poor/non-compliance|0
7869292|NCT01928394|27285804|P1|Treatment Period|Poor/non-compliance|0
7869293|NCT01928394|27285782|P23|Treatment Period|Participant withdrew consent|0
7869294|NCT01928394|27285783|P22|Treatment Period|Participant withdrew consent|2
7869295|NCT01928394|27285784|P21|Treatment Period|Participant withdrew consent|0
7869296|NCT01928394|27285785|P20|Treatment Period|Participant withdrew consent|1
7869297|NCT01928394|27285786|P19|Treatment Period|Participant withdrew consent|1
7869298|NCT01928394|27285787|P18|Treatment Period|Participant withdrew consent|1
7869299|NCT01928394|27285788|P17|Treatment Period|Participant withdrew consent|2
7869300|NCT01928394|27285789|P16|Treatment Period|Participant withdrew consent|0
7869301|NCT01928394|27285790|P15|Treatment Period|Participant withdrew consent|2
7869302|NCT01928394|27285791|P14|Treatment Period|Participant withdrew consent|0
7869303|NCT01928394|27285792|P13|Treatment Period|Participant withdrew consent|1
7869304|NCT01928394|27285793|P12|Treatment Period|Participant withdrew consent|1
7869305|NCT01928394|27285794|P11|Treatment Period|Participant withdrew consent|1
7869306|NCT01928394|27285795|P10|Treatment Period|Participant withdrew consent|0
7869307|NCT01928394|27285796|P9|Treatment Period|Participant withdrew consent|0
7869308|NCT01928394|27285797|P8|Treatment Period|Participant withdrew consent|1
7869309|NCT01928394|27285798|P7|Treatment Period|Participant withdrew consent|0
7869310|NCT01928394|27285799|P6|Treatment Period|Participant withdrew consent|1
7869311|NCT01928394|27285800|P5|Treatment Period|Participant withdrew consent|0
7869312|NCT01928394|27285801|P4|Treatment Period|Participant withdrew consent|1
7869313|NCT01928394|27285802|P3|Treatment Period|Participant withdrew consent|1
7869314|NCT01928394|27285803|P2|Treatment Period|Participant withdrew consent|0
7869315|NCT01928394|27285804|P1|Treatment Period|Participant withdrew consent|0
7869316|NCT01928394|27285782|P23|Treatment Period|Participant request to stop therapy|3
7869317|NCT01928394|27285783|P22|Treatment Period|Participant request to stop therapy|1
7869318|NCT01928394|27285784|P21|Treatment Period|Participant request to stop therapy|3
7869319|NCT01928394|27285785|P20|Treatment Period|Participant request to stop therapy|1
7869320|NCT01928394|27285786|P19|Treatment Period|Participant request to stop therapy|1
7869321|NCT01928394|27285787|P18|Treatment Period|Participant request to stop therapy|3
7869322|NCT01928394|27285788|P17|Treatment Period|Participant request to stop therapy|1
7869323|NCT01928394|27285789|P16|Treatment Period|Participant request to stop therapy|0
7869324|NCT01928394|27285790|P15|Treatment Period|Participant request to stop therapy|4
7869325|NCT01928394|27285791|P14|Treatment Period|Participant request to stop therapy|2
7869326|NCT01928394|27285792|P13|Treatment Period|Participant request to stop therapy|1
7869327|NCT01928394|27285793|P12|Treatment Period|Participant request to stop therapy|2
7869328|NCT01928394|27285794|P11|Treatment Period|Participant request to stop therapy|3
7869329|NCT01928394|27285795|P10|Treatment Period|Participant request to stop therapy|0
7869330|NCT01928394|27285796|P9|Treatment Period|Participant request to stop therapy|0
7869331|NCT01928394|27285797|P8|Treatment Period|Participant request to stop therapy|0
7869332|NCT01928394|27285798|P7|Treatment Period|Participant request to stop therapy|3
7869333|NCT01928394|27285799|P6|Treatment Period|Participant request to stop therapy|3
7869334|NCT01928394|27285800|P5|Treatment Period|Participant request to stop therapy|0
7869335|NCT01928394|27285801|P4|Treatment Period|Participant request to stop therapy|0
7869336|NCT01928394|27285802|P3|Treatment Period|Participant request to stop therapy|0
7869337|NCT01928394|27285803|P2|Treatment Period|Participant request to stop therapy|0
7869338|NCT01928394|27285804|P1|Treatment Period|Participant request to stop therapy|0
7869339|NCT01928394|27285782|P23|Treatment Period|AE unrelated to study drug|0
7869340|NCT01928394|27285783|P22|Treatment Period|AE unrelated to study drug|1
7869341|NCT01928394|27285784|P21|Treatment Period|AE unrelated to study drug|1
7869342|NCT01928394|27285785|P20|Treatment Period|AE unrelated to study drug|5
7869343|NCT01928394|27285786|P19|Treatment Period|AE unrelated to study drug|3
7869344|NCT01928394|27285787|P18|Treatment Period|AE unrelated to study drug|6
7869345|NCT01928394|27285788|P17|Treatment Period|AE unrelated to study drug|1
7869346|NCT01928394|27285789|P16|Treatment Period|AE unrelated to study drug|1
7869347|NCT01928394|27285790|P15|Treatment Period|AE unrelated to study drug|6
7869348|NCT01928394|27285791|P14|Treatment Period|AE unrelated to study drug|13
7869349|NCT01928394|27285792|P13|Treatment Period|AE unrelated to study drug|6
7869350|NCT01928394|27285793|P12|Treatment Period|AE unrelated to study drug|12
7869351|NCT01928394|27285794|P11|Treatment Period|AE unrelated to study drug|0
7869352|NCT01928394|27285795|P10|Treatment Period|AE unrelated to study drug|2
7869353|NCT01928394|27285796|P9|Treatment Period|AE unrelated to study drug|0
7869354|NCT01928394|27285797|P8|Treatment Period|AE unrelated to study drug|0
7869355|NCT01928394|27285798|P7|Treatment Period|AE unrelated to study drug|1
7869356|NCT01928394|27285799|P6|Treatment Period|AE unrelated to study drug|5
7869357|NCT01928394|27285800|P5|Treatment Period|AE unrelated to study drug|0
7869358|NCT01928394|27285801|P4|Treatment Period|AE unrelated to study drug|3
7869359|NCT01928394|27285802|P3|Treatment Period|AE unrelated to study drug|2
7869360|NCT01928394|27285803|P2|Treatment Period|AE unrelated to study drug|0
7869361|NCT01928394|27285804|P1|Treatment Period|AE unrelated to study drug|0
7869362|NCT01928394|27285782|P23|Treatment Period|Study drug toxicity|4
7869363|NCT01928394|27285783|P22|Treatment Period|Study drug toxicity|7
7869364|NCT01928394|27285784|P21|Treatment Period|Study drug toxicity|4
7869365|NCT01928394|27285785|P20|Treatment Period|Study drug toxicity|15
7869366|NCT01928394|27285786|P19|Treatment Period|Study drug toxicity|12
7869367|NCT01928394|27285787|P18|Treatment Period|Study drug toxicity|3
7869368|NCT01928394|27285788|P17|Treatment Period|Study drug toxicity|3
7869369|NCT01928394|27285789|P16|Treatment Period|Study drug toxicity|0
7869370|NCT01928394|27285790|P15|Treatment Period|Study drug toxicity|12
7869371|NCT01928394|27285791|P14|Treatment Period|Study drug toxicity|5
7869372|NCT01928394|27285792|P13|Treatment Period|Study drug toxicity|7
7869373|NCT01928394|27285793|P12|Treatment Period|Study drug toxicity|3
7869374|NCT01928394|27285794|P11|Treatment Period|Study drug toxicity|2
7869375|NCT01928394|27285795|P10|Treatment Period|Study drug toxicity|5
7869376|NCT01928394|27285796|P9|Treatment Period|Study drug toxicity|0
7869377|NCT01928394|27285797|P8|Treatment Period|Study drug toxicity|1
7869378|NCT01928394|27285798|P7|Treatment Period|Study drug toxicity|7
7869379|NCT01928394|27285799|P6|Treatment Period|Study drug toxicity|9
7869380|NCT01928394|27285800|P5|Treatment Period|Study drug toxicity|0
7869381|NCT01928394|27285801|P4|Treatment Period|Study drug toxicity|3
7869382|NCT01928394|27285802|P3|Treatment Period|Study drug toxicity|3
7869383|NCT01928394|27285803|P2|Treatment Period|Study drug toxicity|1
7869384|NCT01928394|27285804|P1|Treatment Period|Study drug toxicity|1
7869385|NCT01928394|27285782|P23|Treatment Period|Disease progression|31
7869386|NCT01928394|27285783|P22|Treatment Period|Disease progression|31
7869387|NCT01928394|27285784|P21|Treatment Period|Disease progression|30
7869388|NCT01928394|27285785|P20|Treatment Period|Disease progression|71
7869389|NCT01928394|27285786|P19|Treatment Period|Disease progression|50
7869390|NCT01928394|27285787|P18|Treatment Period|Disease progression|56
7869391|NCT01928394|27285788|P17|Treatment Period|Disease progression|43
7869392|NCT01928394|27285789|P16|Treatment Period|Disease progression|1
7869393|NCT01928394|27285790|P15|Treatment Period|Disease progression|59
7869394|NCT01928394|27285791|P14|Treatment Period|Disease progression|118
7869395|NCT01928394|27285792|P13|Treatment Period|Disease progression|38
7869396|NCT01928394|27285793|P12|Treatment Period|Disease progression|73
7869397|NCT01928394|27285794|P11|Treatment Period|Disease progression|22
7869398|NCT01928394|27285795|P10|Treatment Period|Disease progression|11
7869399|NCT01928394|27285796|P9|Treatment Period|Disease progression|3
7869400|NCT01928394|27285797|P8|Treatment Period|Disease progression|16
7869401|NCT01928394|27285798|P7|Treatment Period|Disease progression|38
7869402|NCT01928394|27285799|P6|Treatment Period|Disease progression|25
7869403|NCT01928394|27285800|P5|Treatment Period|Disease progression|3
7869404|NCT01928394|27285801|P4|Treatment Period|Disease progression|48
7869405|NCT01928394|27285802|P3|Treatment Period|Disease progression|12
7869406|NCT01928394|27285803|P2|Treatment Period|Disease progression|2
7869407|NCT01928394|27285804|P1|Treatment Period|Disease progression|17
7869408|NCT01817751|27285876|P1|Overall Study|Physician Decision|1
7869409|NCT01780662|27285888|P3|Overall Study|Ineligible|1
7869410|NCT01780662|27285889|P2|Overall Study|Ineligible|0
7869411|NCT01780662|27285890|P1|Overall Study|Ineligible|0
7869412|NCT01780662|27285888|P3|Overall Study|Protocol Violation|0
7869413|NCT01780662|27285889|P2|Overall Study|Protocol Violation|1
7869414|NCT01780662|27285890|P1|Overall Study|Protocol Violation|0
7869415|NCT01780662|27285888|P3|Overall Study|Physician Decision|7
7869416|NCT01780662|27285889|P2|Overall Study|Physician Decision|5
7869417|NCT01780662|27285890|P1|Overall Study|Physician Decision|0
7869418|NCT01780662|27285888|P3|Overall Study|Adverse Event|2
7869419|NCT01780662|27285889|P2|Overall Study|Adverse Event|0
7869420|NCT01780662|27285890|P1|Overall Study|Adverse Event|1
7869421|NCT01757288|27285907|P3|Overall Study|>2 weeks treatment break|1
7869422|NCT01757288|27285908|P2|Overall Study|>2 weeks treatment break|0
7869423|NCT01757288|27285909|P1|Overall Study|>2 weeks treatment break|0
7869424|NCT01757288|27285907|P3|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
7869425|NCT01757288|27285908|P2|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7869426|NCT01757288|27285909|P1|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7869427|NCT01757288|27285907|P3|Overall Study|Multiple missed appointments|0
7869428|NCT01757288|27285908|P2|Overall Study|Multiple missed appointments|1
7869429|NCT01757288|27285909|P1|Overall Study|Multiple missed appointments|0
7869430|NCT01757288|27285907|P3|Overall Study|Not meeting protocol constraints|1
7869431|NCT01757288|27285908|P2|Overall Study|Not meeting protocol constraints|1
7869432|NCT01757288|27285909|P1|Overall Study|Not meeting protocol constraints|0
7869433|NCT01757288|27285907|P3|Overall Study|Liver metastasis identified at CT simulation|0
7869434|NCT01757288|27285908|P2|Overall Study|Liver metastasis identified at CT simulation|1
7869435|NCT01757288|27285909|P1|Overall Study|Liver metastasis identified at CT simulation|0
7869436|NCT01757288|27285907|P3|Overall Study|Wrong medication administered|0
7869437|NCT01757288|27285908|P2|Overall Study|Wrong medication administered|1
7869438|NCT01757288|27285909|P1|Overall Study|Wrong medication administered|0
7869439|NCT01757288|27285907|P3|Overall Study|Patient death prior to starting treatment|1
7869440|NCT01757288|27285908|P2|Overall Study|Patient death prior to starting treatment|0
7869441|NCT01757288|27285909|P1|Overall Study|Patient death prior to starting treatment|0
7869442|NCT01757288|27285907|P3|Overall Study|Patient off study, IRB hold.|1
7869443|NCT01757288|27285908|P2|Overall Study|Patient off study, IRB hold.|0
7869444|NCT01757288|27285909|P1|Overall Study|Patient off study, IRB hold.|0
7869445|NCT01757288|27285907|P3|Overall Study|Consent withdrawal|4
7869446|NCT01757288|27285908|P2|Overall Study|Consent withdrawal|4
7869447|NCT01757288|27285909|P1|Overall Study|Consent withdrawal|0
7869448|NCT01752920|27285951|P4|Overall Study|Lack of clinical benefit|1
7869449|NCT01752920|27285952|P3|Overall Study|Lack of clinical benefit|1
7869450|NCT01752920|27285953|P2|Overall Study|Lack of clinical benefit|1
7869451|NCT01752920|27285954|P1|Overall Study|Lack of clinical benefit|1
7869452|NCT01752920|27285951|P4|Overall Study|Withdrawal by Subject|1
7869453|NCT01752920|27285952|P3|Overall Study|Withdrawal by Subject|0
7869454|NCT01752920|27285953|P2|Overall Study|Withdrawal by Subject|1
7869455|NCT01752920|27285954|P1|Overall Study|Withdrawal by Subject|0
7869456|NCT01752920|27285951|P4|Overall Study|Study Terminated by Sponsor|1
7869457|NCT01752920|27285952|P3|Overall Study|Study Terminated by Sponsor|0
7869458|NCT01752920|27285953|P2|Overall Study|Study Terminated by Sponsor|0
7869459|NCT01752920|27285954|P1|Overall Study|Study Terminated by Sponsor|0
7869460|NCT01752920|27285951|P4|Overall Study|Radiographic Disease Progression|29
7869461|NCT01752920|27285952|P3|Overall Study|Radiographic Disease Progression|12
7869462|NCT01752920|27285953|P2|Overall Study|Radiographic Disease Progression|7
7869463|NCT01752920|27285954|P1|Overall Study|Radiographic Disease Progression|20
7869464|NCT01752920|27285951|P4|Overall Study|Physician Decision|3
7869465|NCT01752920|27285952|P3|Overall Study|Physician Decision|0
7869466|NCT01752920|27285953|P2|Overall Study|Physician Decision|0
7869467|NCT01752920|27285954|P1|Overall Study|Physician Decision|1
7869468|NCT01752920|27285951|P4|Overall Study|Clinical Disease Progression|13
7869469|NCT01752920|27285952|P3|Overall Study|Clinical Disease Progression|1
7869470|NCT01752920|27285953|P2|Overall Study|Clinical Disease Progression|4
7869471|NCT01752920|27285954|P1|Overall Study|Clinical Disease Progression|6
7869472|NCT01752920|27285951|P4|Overall Study|Adverse Event|10
7869473|NCT01752920|27285952|P3|Overall Study|Adverse Event|5
7869474|NCT01752920|27285953|P2|Overall Study|Adverse Event|0
7869475|NCT01752920|27285954|P1|Overall Study|Adverse Event|1
7869476|NCT01499810|27285993|P1|Overall Study|Withdrawal by Subject|1
7869477|NCT01499810|27285993|P1|Overall Study|Protocol Violation|1
7869478|NCT01499810|27285993|P1|Overall Study|Lost to Follow-up|10
7869479|NCT01410890|27286092|P2|Overall Study|Withdrawal by Subject|1
7869480|NCT01410890|27286093|P1|Overall Study|Withdrawal by Subject|0
7869481|NCT01358721|27286129|P4|Overall Study|Out of State/Unmet Criteria|0
7869482|NCT01358721|27286130|P3|Overall Study|Out of State/Unmet Criteria|1
7869483|NCT01358721|27286131|P2|Overall Study|Out of State/Unmet Criteria|0
7869484|NCT01358721|27286132|P1|Overall Study|Out of State/Unmet Criteria|0
7869485|NCT01358721|27286129|P4|Overall Study|Disease Progression|15
7869486|NCT01358721|27286130|P3|Overall Study|Disease Progression|17
7869487|NCT01358721|27286131|P2|Overall Study|Disease Progression|15
7869488|NCT01358721|27286132|P1|Overall Study|Disease Progression|19
7869489|NCT01358721|27286129|P4|Overall Study|Adverse Event related to study drug|1
7869490|NCT01358721|27286130|P3|Overall Study|Adverse Event related to study drug|0
7869491|NCT01358721|27286131|P2|Overall Study|Adverse Event related to study drug|0
7869492|NCT01358721|27286132|P1|Overall Study|Adverse Event related to study drug|1
7869493|NCT01358721|27286129|P4|Overall Study|Subject No Longer Meets Study Criteria|1
7869494|NCT01358721|27286130|P3|Overall Study|Subject No Longer Meets Study Criteria|0
7869495|NCT01358721|27286131|P2|Overall Study|Subject No Longer Meets Study Criteria|2
7869496|NCT01358721|27286132|P1|Overall Study|Subject No Longer Meets Study Criteria|0
7869497|NCT01358721|27286129|P4|Overall Study|SUBJ request to discontinue study TRT|1
7869498|NCT01358721|27286130|P3|Overall Study|SUBJ request to discontinue study TRT|0
7869499|NCT01358721|27286131|P2|Overall Study|SUBJ request to discontinue study TRT|0
7869500|NCT01358721|27286132|P1|Overall Study|SUBJ request to discontinue study TRT|0
7869501|NCT01358721|27286129|P4|Overall Study|Study Drug Toxicity|5
7869502|NCT01358721|27286130|P3|Overall Study|Study Drug Toxicity|4
7869503|NCT01358721|27286131|P2|Overall Study|Study Drug Toxicity|3
7869504|NCT01358721|27286132|P1|Overall Study|Study Drug Toxicity|1
7869505|NCT01358721|27286129|P4|Overall Study|Death|0
7869506|NCT01358721|27286130|P3|Overall Study|Death|0
7869507|NCT01358721|27286131|P2|Overall Study|Death|2
7869508|NCT01358721|27286132|P1|Overall Study|Death|0
7869509|NCT01358721|27286129|P4|Overall Study|Withdrawal by Subject|1
7869510|NCT01358721|27286130|P3|Overall Study|Withdrawal by Subject|0
7869511|NCT01358721|27286131|P2|Overall Study|Withdrawal by Subject|0
7869512|NCT01358721|27286132|P1|Overall Study|Withdrawal by Subject|0
7869513|NCT01342367|27286184|P2|Overall Study|Withdrawal by Subject|2
7869514|NCT01342367|27286185|P1|Overall Study|Withdrawal by Subject|1
7869515|NCT01342367|27286184|P2|Overall Study|Death|0
7869516|NCT01342367|27286185|P1|Overall Study|Death|1
7869517|NCT01286272|27286195|P2|Overall Study|Ineligible after beginning treatment|3
7869518|NCT01286272|27286196|P1|Overall Study|Ineligible after beginning treatment|1
7869519|NCT01189266|27286209|P3|Overall Study|No treatment|1
7869520|NCT01189266|27286210|P2|Overall Study|No treatment|0
7869521|NCT01189266|27286211|P1|Overall Study|No treatment|0
7869522|NCT01189266|27286209|P3|Overall Study|Patient refuses further therapy|7
7869523|NCT01189266|27286210|P2|Overall Study|Patient refuses further therapy|0
7869524|NCT01189266|27286211|P1|Overall Study|Patient refuses further therapy|1
7869525|NCT01189266|27286209|P3|Overall Study|Withdrawal by Subject|1
7869526|NCT01189266|27286210|P2|Overall Study|Withdrawal by Subject|0
7869527|NCT01189266|27286211|P1|Overall Study|Withdrawal by Subject|0
7869528|NCT01189266|27286209|P3|Overall Study|Protocol Violation|1
7869529|NCT01189266|27286210|P2|Overall Study|Protocol Violation|1
7869530|NCT01189266|27286211|P1|Overall Study|Protocol Violation|0
7869531|NCT01189266|27286209|P3|Overall Study|Physician Decision|1
7869532|NCT01189266|27286210|P2|Overall Study|Physician Decision|0
7869533|NCT01189266|27286211|P1|Overall Study|Physician Decision|0
7869534|NCT01189266|27286209|P3|Overall Study|Lack of Efficacy|44
7869535|NCT01189266|27286210|P2|Overall Study|Lack of Efficacy|5
7869536|NCT01189266|27286211|P1|Overall Study|Lack of Efficacy|4
7869537|NCT01189266|27286209|P3|Overall Study|Death|5
7869538|NCT01189266|27286210|P2|Overall Study|Death|0
7869539|NCT01189266|27286211|P1|Overall Study|Death|0
7869540|NCT01189266|27286209|P3|Overall Study|Adverse Event|5
7869541|NCT01189266|27286210|P2|Overall Study|Adverse Event|0
7869542|NCT01189266|27286211|P1|Overall Study|Adverse Event|1
7869543|NCT00916383|27286274|P1|Overall Study|Protocol Violation|1
7869544|NCT00916383|27286274|P1|Overall Study|Death|1
7869545|NCT00916383|27286274|P1|Overall Study|Adverse Event|1
7869546|NCT00900562|27286305|P2|Overall Study|Unrelated adverse event|0
7869547|NCT00900562|27286306|P1|Overall Study|Unrelated adverse event|1
7869548|NCT00900562|27286305|P2|Overall Study|Withdrawal by Subject|1
7869549|NCT00900562|27286306|P1|Overall Study|Withdrawal by Subject|0
7869550|NCT00900562|27286305|P2|Overall Study|Death|1
7869551|NCT00900562|27286306|P1|Overall Study|Death|1
7869552|NCT00900562|27286305|P2|Overall Study|Toxicity|0
7869553|NCT00900562|27286306|P1|Overall Study|Toxicity|1
7869554|NCT00900562|27286305|P2|Overall Study|Progressive disease|5
7869555|NCT00900562|27286306|P1|Overall Study|Progressive disease|9
7869556|NCT00792948|27286324|P1|Overall Study|Protocol Violation|1
7869557|NCT00792948|27286324|P1|Overall Study|Physician Decision|11
7869558|NCT00792948|27286324|P1|Overall Study|Insurance denial - not treated|1
7869559|NCT00792948|27286324|P1|Overall Study|Ineligible|2
7869560|NCT00792948|27286324|P1|Overall Study|Withdrawal by Subject|3
7869561|NCT00792948|27286324|P1|Overall Study|Death|4
7869562|NCT00792948|27286324|P1|Overall Study|Adverse Event|6
7869563|NCT00713206|27286351|P2|Overall Study|Death|0
7869564|NCT00713206|27286352|P1|Overall Study|Death|1
7869565|NCT00713206|27286351|P2|Overall Study|Lost to Follow-up|4
7869566|NCT00713206|27286352|P1|Overall Study|Lost to Follow-up|4
7869567|NCT00656474|27286358|P1|Overall Study|Other Reason|1
7869568|NCT00412360|27286367|P2|Overall Study|Not Transplanted|2
7869569|NCT00412360|27286368|P1|Overall Study|Not Transplanted|1
7869570|NCT00412360|27286367|P2|Overall Study|Lost to Follow-up|1
7869571|NCT00412360|27286368|P1|Overall Study|Lost to Follow-up|0
7869572|NCT00326417|27286394|P4|Overall Study|Death|0
7869573|NCT00326417|27286395|P3|Overall Study|Death|0
7869574|NCT00326417|27286396|P2|Overall Study|Death|0
7869575|NCT00326417|27286397|P1|Overall Study|Death|7
7869576|NCT00326417|27286394|P4|Overall Study|Arm Closed|3
7869577|NCT00326417|27286395|P3|Overall Study|Arm Closed|0
7869578|NCT00326417|27286396|P2|Overall Study|Arm Closed|0
7869579|NCT00326417|27286397|P1|Overall Study|Arm Closed|7
7869580|NCT00326417|27286394|P4|Overall Study|Withdrawal by Subject|0
7869581|NCT00326417|27286395|P3|Overall Study|Withdrawal by Subject|1
7869582|NCT00326417|27286396|P2|Overall Study|Withdrawal by Subject|0
7869583|NCT00326417|27286397|P1|Overall Study|Withdrawal by Subject|0
7869584|NCT00210119|27286418|P1|Overall Study|Withdrawal by Subject|1
7869585|NCT00210119|27286418|P1|Overall Study|Protocol Violation|1
7869586|NCT00189540|27286425|P2|Overall Study|Death|1
7869587|NCT00189540|27286426|P1|Overall Study|Death|4
7869588|NCT00189540|27286425|P2|Overall Study|Withdrawal by Subject|0
7869589|NCT00189540|27286426|P1|Overall Study|Withdrawal by Subject|3
7869590|NCT04042077|27286502|P2|Overall Study|Lack of Efficacy|1
7869591|NCT04042077|27286503|P1|Overall Study|Lack of Efficacy|0
7869592|NCT04042077|27286502|P2|Overall Study|Withdrawal by Subject|2
7869593|NCT04042077|27286503|P1|Overall Study|Withdrawal by Subject|3
7869594|NCT04042077|27286502|P2|Overall Study|Physician Decision|0
7869595|NCT04042077|27286503|P1|Overall Study|Physician Decision|2
7869596|NCT04042077|27286502|P2|Overall Study|Death|1
7869597|NCT04042077|27286503|P1|Overall Study|Death|2
7869598|NCT04042077|27286502|P2|Overall Study|Adverse Event|1
7869599|NCT04042077|27286503|P1|Overall Study|Adverse Event|0
7869600|NCT03635424|27286549|P1|Overall Study|Device not implanted|1
7869601|NCT03635424|27286549|P1|Overall Study|Death|1
7869602|NCT03635424|27286549|P1|Overall Study|Adverse Event|1
7869603|NCT03567980|27286570|P1|Overall Study|Adverse Event|1
7869604|NCT03539432|27286578|P2|Overall Study|Lost to Follow-up|1
7869605|NCT03539432|27286579|P1|Overall Study|Lost to Follow-up|0
7869606|NCT03526861|27286598|P9|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
7869607|NCT03526861|27286599|P8|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869608|NCT03526861|27286600|P7|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869609|NCT03526861|27286601|P6|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869610|NCT03526861|27286602|P5|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869611|NCT03526861|27286603|P4|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869612|NCT03526861|27286604|P3|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869613|NCT03526861|27286605|P2|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869614|NCT03526861|27286606|P1|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869615|NCT03526861|27286598|P9|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
7869616|NCT03526861|27286599|P8|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869617|NCT03526861|27286600|P7|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869618|NCT03526861|27286601|P6|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869619|NCT03526861|27286602|P5|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869620|NCT03526861|27286603|P4|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869621|NCT03526861|27286604|P3|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869622|NCT03526861|27286605|P2|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869623|NCT03526861|27286606|P1|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7869624|NCT03526861|27286598|P9|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
7869625|NCT03526861|27286599|P8|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869626|NCT03526861|27286600|P7|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869627|NCT03526861|27286601|P6|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869628|NCT03526861|27286602|P5|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869629|NCT03526861|27286603|P4|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869630|NCT03526861|27286604|P3|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869631|NCT03526861|27286605|P2|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869632|NCT03526861|27286606|P1|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869633|NCT03526861|27286598|P9|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869634|NCT03526861|27286599|P8|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869635|NCT03526861|27286600|P7|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869636|NCT03526861|27286601|P6|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869637|NCT03526861|27286602|P5|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869638|NCT03526861|27286603|P4|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7869639|NCT03526861|27286604|P3|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869640|NCT03526861|27286605|P2|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869641|NCT03526861|27286606|P1|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869642|NCT03526861|27286598|P9|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7869643|NCT03526861|27286599|P8|Maintenance Treatment Period|Subject transferred to open-label treatment|2
7869644|NCT03526861|27286600|P7|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7869645|NCT03526861|27286601|P6|Maintenance Treatment Period|Subject transferred to open-label treatment|4
7869646|NCT03526861|27286602|P5|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7869647|NCT03526861|27286603|P4|Maintenance Treatment Period|Subject transferred to open-label treatment|6
7869648|NCT03526861|27286604|P3|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7869649|NCT03526861|27286605|P2|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7869650|NCT03526861|27286606|P1|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7869651|NCT03526861|27286598|P9|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869652|NCT03526861|27286599|P8|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869653|NCT03526861|27286600|P7|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7869654|NCT03526861|27286601|P6|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869655|NCT03526861|27286602|P5|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7869656|NCT03526861|27286603|P4|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7869657|NCT03526861|27286604|P3|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869658|NCT03526861|27286605|P2|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869659|NCT03526861|27286606|P1|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7869660|NCT03526861|27286598|P9|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7869661|NCT03526861|27286599|P8|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7869662|NCT03526861|27286600|P7|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7869663|NCT03526861|27286601|P6|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7869664|NCT03526861|27286602|P5|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7869665|NCT03526861|27286603|P4|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7869666|NCT03526861|27286604|P3|Initial Treatment Period|Subject discontinued IMP before Week 16|8
7869667|NCT03526861|27286605|P2|Initial Treatment Period|Subject discontinued IMP before Week 16|5
7869668|NCT03526861|27286606|P1|Initial Treatment Period|Subject discontinued IMP before Week 16|3
7869669|NCT03526861|27286598|P9|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869670|NCT03526861|27286599|P8|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869671|NCT03526861|27286600|P7|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869672|NCT03526861|27286601|P6|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869673|NCT03526861|27286602|P5|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869674|NCT03526861|27286603|P4|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7869675|NCT03526861|27286604|P3|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
7869676|NCT03526861|27286605|P2|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7869677|NCT03526861|27286606|P1|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
7869678|NCT03526861|27286598|P9|Initial Treatment Period|Not dosed|0
7869679|NCT03526861|27286599|P8|Initial Treatment Period|Not dosed|0
7869680|NCT03526861|27286600|P7|Initial Treatment Period|Not dosed|0
7869681|NCT03526861|27286601|P6|Initial Treatment Period|Not dosed|0
7869682|NCT03526861|27286602|P5|Initial Treatment Period|Not dosed|0
7869683|NCT03526861|27286603|P4|Initial Treatment Period|Not dosed|0
7869684|NCT03526861|27286604|P3|Initial Treatment Period|Not dosed|1
7869685|NCT03526861|27286605|P2|Initial Treatment Period|Not dosed|1
7869686|NCT03526861|27286606|P1|Initial Treatment Period|Not dosed|1
7869687|NCT03474107|27286680|P2|Overall Study|Miscellaneous|6
7869688|NCT03474107|27286681|P1|Overall Study|Miscellaneous|1
7869689|NCT03474107|27286680|P2|Overall Study|Physician Decision|22
7869690|NCT03474107|27286681|P1|Overall Study|Physician Decision|7
7869691|NCT03474107|27286680|P2|Overall Study|Withdrawal by Subject|27
7869692|NCT03474107|27286681|P1|Overall Study|Withdrawal by Subject|15
7869693|NCT03474107|27286680|P2|Overall Study|Protocol Violation|1
7869694|NCT03474107|27286681|P1|Overall Study|Protocol Violation|1
7869695|NCT03474107|27286680|P2|Overall Study|Progressive Disease|180
7869696|NCT03474107|27286681|P1|Overall Study|Progressive Disease|177
7869697|NCT03474107|27286680|P2|Overall Study|Lost to Follow-up|1
7869698|NCT03474107|27286681|P1|Overall Study|Lost to Follow-up|0
7869699|NCT03474107|27286680|P2|Overall Study|Death|2
7869700|NCT03474107|27286681|P1|Overall Study|Death|2
7869701|NCT03474107|27286680|P2|Overall Study|Adverse Event|46
7869702|NCT03474107|27286681|P1|Overall Study|Adverse Event|42
7869703|NCT03347695|27286784|P2|Overall Study|Lost to Follow-up|1
7869704|NCT03347695|27286785|P1|Overall Study|Lost to Follow-up|0
7869705|NCT03347695|27286784|P2|Overall Study|Death|4
7869706|NCT03347695|27286785|P1|Overall Study|Death|0
7869707|NCT03324581|27286813|P3|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7869708|NCT03324581|27286814|P2|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
7869709|NCT03324581|27286815|P1|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7869710|NCT03324581|27286813|P3|Overall Study|Withdrawal by Subject|6
7869711|NCT03324581|27286814|P2|Overall Study|Withdrawal by Subject|8
7869712|NCT03324581|27286815|P1|Overall Study|Withdrawal by Subject|6
7869713|NCT03324581|27286813|P3|Overall Study|Protocol Deviation|4
7869714|NCT03324581|27286814|P2|Overall Study|Protocol Deviation|9
7869715|NCT03324581|27286815|P1|Overall Study|Protocol Deviation|8
7869716|NCT03324581|27286813|P3|Overall Study|Physician Decision|2
7869717|NCT03324581|27286814|P2|Overall Study|Physician Decision|1
7869718|NCT03324581|27286815|P1|Overall Study|Physician Decision|0
7869719|NCT03324581|27286813|P3|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
7869720|NCT03324581|27286814|P2|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7869721|NCT03324581|27286815|P1|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7869722|NCT03324581|27286813|P3|Overall Study|Lost to Follow-up|6
7869723|NCT03324581|27286814|P2|Overall Study|Lost to Follow-up|3
7869724|NCT03324581|27286815|P1|Overall Study|Lost to Follow-up|5
7869725|NCT03324581|27286813|P3|Overall Study|Lack of Efficacy|0
7869726|NCT03324581|27286814|P2|Overall Study|Lack of Efficacy|1
7869727|NCT03324581|27286815|P1|Overall Study|Lack of Efficacy|0
7869728|NCT03324581|27286813|P3|Overall Study|Adverse Event|7
7869729|NCT03324581|27286814|P2|Overall Study|Adverse Event|11
7869730|NCT03324581|27286815|P1|Overall Study|Adverse Event|18
7869819|NCT02825420|27287077|P2|Overall Study|Did not receive PLD|0
7869731|NCT03084471|27286838|P1|Overall Study|Patients who were still on study treatment at Data Cutoff|120
7869732|NCT03084471|27286838|P1|Overall Study|Other (as recorded)|33
7869733|NCT03084471|27286838|P1|Overall Study|Subjective disease progression|359
7869734|NCT03084471|27286838|P1|Overall Study|Disease relapse|181
7869735|NCT03084471|27286838|P1|Overall Study|Withdrawal by Subject|12
7869736|NCT03084471|27286838|P1|Overall Study|Adverse Event|73
7869737|NCT03084471|27286838|P1|Overall Study|Protocol Violation|1
7869738|NCT03084471|27286838|P1|Overall Study|Lack of therapeutic response|2
7869739|NCT03084471|27286838|P1|Overall Study|Condition under investigation worsened|84
7869740|NCT03084471|27286838|P1|Overall Study|Development of study specific discontinuation criteria|2
7869741|NCT03011333|27286862|P7|Overall Study|Lost to Follow-up|5
7869742|NCT03011333|27286863|P6|Overall Study|Lost to Follow-up|4
7869743|NCT03011333|27286864|P5|Overall Study|Lost to Follow-up|4
7869744|NCT03011333|27286865|P4|Overall Study|Lost to Follow-up|1
7869745|NCT03011333|27286866|P3|Overall Study|Lost to Follow-up|0
7869746|NCT03011333|27286867|P2|Overall Study|Lost to Follow-up|1
7869747|NCT03011333|27286868|P1|Overall Study|Lost to Follow-up|0
7869748|NCT03010527|27286894|P3|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7869749|NCT03010527|27286895|P2|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
7869750|NCT03010527|27286896|P1|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7869751|NCT03010527|27286894|P3|Overall Study|WITHDRAWAL CRITERIA #12|2
7869752|NCT03010527|27286895|P2|Overall Study|WITHDRAWAL CRITERIA #12|4
7869753|NCT03010527|27286896|P1|Overall Study|WITHDRAWAL CRITERIA #12|0
7869754|NCT03010527|27286894|P3|Overall Study|WITHDRAWAL CRITERIA #9|6
7869755|NCT03010527|27286895|P2|Overall Study|WITHDRAWAL CRITERIA #9|4
7869756|NCT03010527|27286896|P1|Overall Study|WITHDRAWAL CRITERIA #9|0
7869757|NCT03010527|27286894|P3|Overall Study|Withdrawal by Subject|4
7869758|NCT03010527|27286895|P2|Overall Study|Withdrawal by Subject|3
7869759|NCT03010527|27286896|P1|Overall Study|Withdrawal by Subject|0
7869760|NCT03010527|27286894|P3|Overall Study|Lost to Follow-up|1
7869761|NCT03010527|27286895|P2|Overall Study|Lost to Follow-up|2
7869762|NCT03010527|27286896|P1|Overall Study|Lost to Follow-up|0
7869763|NCT03010527|27286894|P3|Overall Study|Protocol Violation|0
7869764|NCT03010527|27286895|P2|Overall Study|Protocol Violation|1
7869765|NCT03010527|27286896|P1|Overall Study|Protocol Violation|0
7869766|NCT03010527|27286894|P3|Overall Study|Adverse Event|2
7869767|NCT03010527|27286895|P2|Overall Study|Adverse Event|4
7869768|NCT03010527|27286896|P1|Overall Study|Adverse Event|0
7869769|NCT03010527|27286894|P3|Overall Study|Death|1
7869770|NCT03010527|27286895|P2|Overall Study|Death|0
7869771|NCT03010527|27286896|P1|Overall Study|Death|0
7869772|NCT02924129|27286924|P2|Overall Study|Missed Visit|1
7869773|NCT02924129|27286925|P1|Overall Study|Missed Visit|0
7869774|NCT02924129|27286924|P2|Overall Study|Physician Decision|0
7869775|NCT02924129|27286925|P1|Overall Study|Physician Decision|1
7869776|NCT02924129|27286924|P2|Overall Study|Withdrawal by Subject|2
7869777|NCT02924129|27286925|P1|Overall Study|Withdrawal by Subject|2
7869778|NCT02924129|27286924|P2|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
7869779|NCT02924129|27286925|P1|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
7869780|NCT02873338|27286934|P3|Overall Study|Other or Missing|13
7869781|NCT02873338|27286935|P2|Overall Study|Other or Missing|15
7869782|NCT02873338|27286936|P1|Overall Study|Other or Missing|14
7869783|NCT02873338|27286934|P3|Overall Study|Lack of Efficacy|0
7869784|NCT02873338|27286935|P2|Overall Study|Lack of Efficacy|2
7869785|NCT02873338|27286936|P1|Overall Study|Lack of Efficacy|0
7869786|NCT02873338|27286934|P3|Overall Study|Withdrawal by Subject|3
7869787|NCT02873338|27286935|P2|Overall Study|Withdrawal by Subject|1
7869788|NCT02873338|27286936|P1|Overall Study|Withdrawal by Subject|2
7869789|NCT02873338|27286934|P3|Overall Study|Death|1
7869790|NCT02873338|27286935|P2|Overall Study|Death|1
7869791|NCT02873338|27286936|P1|Overall Study|Death|2
7869792|NCT02873338|27286934|P3|Overall Study|Adverse Event|1
7869793|NCT02873338|27286935|P2|Overall Study|Adverse Event|2
7869794|NCT02873338|27286936|P1|Overall Study|Adverse Event|0
7869795|NCT02861586|27286982|P8|Overall Study|Adverse Event|0
7869796|NCT02861586|27286983|P7|Overall Study|Adverse Event|0
7869797|NCT02861586|27286984|P6|Overall Study|Adverse Event|1
7869798|NCT02861586|27286985|P5|Overall Study|Adverse Event|0
7869799|NCT02861586|27286986|P4|Overall Study|Adverse Event|0
7869800|NCT02861586|27286987|P3|Overall Study|Adverse Event|0
7869801|NCT02861586|27286988|P2|Overall Study|Adverse Event|0
7869802|NCT02861586|27286989|P1|Overall Study|Adverse Event|0
7869803|NCT02861586|27286982|P8|Overall Study|Lost to Follow-up|0
7869804|NCT02861586|27286983|P7|Overall Study|Lost to Follow-up|0
7869805|NCT02861586|27286984|P6|Overall Study|Lost to Follow-up|3
7869806|NCT02861586|27286985|P5|Overall Study|Lost to Follow-up|0
7869807|NCT02861586|27286986|P4|Overall Study|Lost to Follow-up|0
7869808|NCT02861586|27286987|P3|Overall Study|Lost to Follow-up|1
7869809|NCT02861586|27286988|P2|Overall Study|Lost to Follow-up|1
7869810|NCT02861586|27286989|P1|Overall Study|Lost to Follow-up|3
7869811|NCT02861586|27286982|P8|Overall Study|Withdrawal by Subject|0
7869812|NCT02861586|27286983|P7|Overall Study|Withdrawal by Subject|1
7869813|NCT02861586|27286984|P6|Overall Study|Withdrawal by Subject|1
7869814|NCT02861586|27286985|P5|Overall Study|Withdrawal by Subject|0
7869815|NCT02861586|27286986|P4|Overall Study|Withdrawal by Subject|0
7869816|NCT02861586|27286987|P3|Overall Study|Withdrawal by Subject|0
7869817|NCT02861586|27286988|P2|Overall Study|Withdrawal by Subject|2
7869818|NCT02861586|27286989|P1|Overall Study|Withdrawal by Subject|1
7869820|NCT02825420|27287078|P1|Overall Study|Did not receive PLD|2
7869821|NCT02825420|27287077|P2|Overall Study|Physician Decision|0
7869822|NCT02825420|27287078|P1|Overall Study|Physician Decision|1
7869823|NCT02825420|27287077|P2|Overall Study|Protocol amendment not signed|1
7869824|NCT02825420|27287078|P1|Overall Study|Protocol amendment not signed|1
7869825|NCT02825420|27287077|P2|Overall Study|Withdrawal by Subject|1
7869826|NCT02825420|27287078|P1|Overall Study|Withdrawal by Subject|1
7869827|NCT02825420|27287077|P2|Overall Study|Lost to Follow-up|2
7869828|NCT02825420|27287078|P1|Overall Study|Lost to Follow-up|2
7869829|NCT02825420|27287077|P2|Overall Study|Progressive disease|1
7869830|NCT02825420|27287078|P1|Overall Study|Progressive disease|6
7869831|NCT02825420|27287077|P2|Overall Study|Death|12
7869832|NCT02825420|27287078|P1|Overall Study|Death|30
7869833|NCT02770820|27287102|P1|Overall Study|Physician Decision|2
7869834|NCT02770820|27287102|P1|Overall Study|Death|1
7869835|NCT02701283|27287110|P2|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
7869836|NCT02701283|27287111|P1|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
7869837|NCT02701283|27287110|P2|Overall Study|Missed 2-year visit|27
7869838|NCT02701283|27287111|P1|Overall Study|Missed 2-year visit|22
7869839|NCT02701283|27287110|P2|Overall Study|Withdrawal by Subject|41
7869840|NCT02701283|27287111|P1|Overall Study|Withdrawal by Subject|12
7869841|NCT02701283|27287110|P2|Overall Study|Lost to Follow-up|8
7869842|NCT02701283|27287111|P1|Overall Study|Lost to Follow-up|3
7869843|NCT02701283|27287110|P2|Overall Study|Death|29
7869844|NCT02701283|27287111|P1|Overall Study|Death|25
7869845|NCT02688621|27287150|P2|Overall Study|Withdrawal by Subject|0
7869846|NCT02688621|27287151|P1|Overall Study|Withdrawal by Subject|1
7869847|NCT02688621|27287150|P2|Overall Study|Lost to Follow-up|15
7869848|NCT02688621|27287151|P1|Overall Study|Lost to Follow-up|38
7869849|NCT02688621|27287150|P2|Overall Study|Pregnancy|3
7869850|NCT02688621|27287151|P1|Overall Study|Pregnancy|1
7869851|NCT02683941|27287169|P2|Open-label Follow-up Phase|Other|1
7869852|NCT02683941|27287170|P1|Open-label Follow-up Phase|Other|8
7869853|NCT02683941|27287169|P2|Open-label Follow-up Phase|Study Termination by the Sponsor|4
7869854|NCT02683941|27287170|P1|Open-label Follow-up Phase|Study Termination by the Sponsor|6
7869855|NCT02683941|27287169|P2|Open-label Follow-up Phase|Lost to Follow-up|0
7869856|NCT02683941|27287170|P1|Open-label Follow-up Phase|Lost to Follow-up|1
7869857|NCT02683941|27287169|P2|Open-label Follow-up Phase|Withdrawal by Subject|3
7869858|NCT02683941|27287170|P1|Open-label Follow-up Phase|Withdrawal by Subject|3
7869859|NCT02683941|27287169|P2|Open-label Treatment Phase|Other|0
7869860|NCT02683941|27287170|P1|Open-label Treatment Phase|Other|1
7869861|NCT02683941|27287169|P2|Open-label Treatment Phase|Study Termination by the Sponsor|9
7869862|NCT02683941|27287170|P1|Open-label Treatment Phase|Study Termination by the Sponsor|18
7869863|NCT02683941|27287169|P2|Open-label Treatment Phase|Disease Progression|2
7869864|NCT02683941|27287170|P1|Open-label Treatment Phase|Disease Progression|1
7869865|NCT02683941|27287169|P2|Open-label Treatment Phase|Withdrawal by Subject|2
7869866|NCT02683941|27287170|P1|Open-label Treatment Phase|Withdrawal by Subject|0
7869867|NCT02683941|27287169|P2|Double-blind Phase|Disease Progression|2
7869868|NCT02683941|27287170|P1|Double-blind Phase|Disease Progression|5
7869869|NCT02683941|27287169|P2|Double-blind Phase|Lost to Follow-up|0
7869870|NCT02683941|27287170|P1|Double-blind Phase|Lost to Follow-up|1
7869871|NCT02683941|27287169|P2|Double-blind Phase|Withdrawal by Subject|2
7869872|NCT02683941|27287170|P1|Double-blind Phase|Withdrawal by Subject|4
7869873|NCT02683941|27287169|P2|Double-blind Phase|Adverse Event|1
7869874|NCT02683941|27287170|P1|Double-blind Phase|Adverse Event|0
7869875|NCT02653664|27287203|P3|6 Month Follow-Up|Subject Declined Assessment Period|0
7869876|NCT02653664|27287204|P2|6 Month Follow-Up|Subject Declined Assessment Period|1
7869877|NCT02653664|27287205|P1|6 Month Follow-Up|Subject Declined Assessment Period|0
7869878|NCT02653664|27287203|P3|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7869879|NCT02653664|27287204|P2|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7869880|NCT02653664|27287205|P1|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7869881|NCT02653664|27287203|P3|6 Month Follow-Up|Lost to Follow-up|9
7869882|NCT02653664|27287204|P2|6 Month Follow-Up|Lost to Follow-up|11
7869883|NCT02653664|27287205|P1|6 Month Follow-Up|Lost to Follow-up|10
7869884|NCT02653664|27287203|P3|6 Month Follow-Up|Withdrawal by Subject|14
7869885|NCT02653664|27287204|P2|6 Month Follow-Up|Withdrawal by Subject|7
7869886|NCT02653664|27287205|P1|6 Month Follow-Up|Withdrawal by Subject|13
7869887|NCT02653664|27287203|P3|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7869888|NCT02653664|27287204|P2|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7869889|NCT02653664|27287205|P1|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
7869890|NCT02653664|27287203|P3|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7869891|NCT02653664|27287204|P2|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7869892|NCT02653664|27287205|P1|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7869893|NCT02653664|27287203|P3|3 Month Follow-Up|Lost to Follow-up|16
7869894|NCT02653664|27287204|P2|3 Month Follow-Up|Lost to Follow-up|8
7869895|NCT02653664|27287205|P1|3 Month Follow-Up|Lost to Follow-up|9
7869896|NCT02653664|27287203|P3|3 Month Follow-Up|Withdrawal by Subject|9
7869897|NCT02653664|27287204|P2|3 Month Follow-Up|Withdrawal by Subject|5
7869898|NCT02653664|27287205|P1|3 Month Follow-Up|Withdrawal by Subject|9
7869899|NCT02653664|27287203|P3|Post-Treatment|Lost to Follow-up|7
7869900|NCT02653664|27287204|P2|Post-Treatment|Lost to Follow-up|1
7869901|NCT02653664|27287205|P1|Post-Treatment|Lost to Follow-up|8
7869902|NCT02653664|27287203|P3|Post-Treatment|Withdrawal by Subject|7
7869903|NCT02653664|27287204|P2|Post-Treatment|Withdrawal by Subject|5
7869904|NCT02653664|27287205|P1|Post-Treatment|Withdrawal by Subject|6
7869905|NCT02552225|27287230|P2|Overall Study|Withdrawal by Subject|0
7869906|NCT02552225|27287231|P1|Overall Study|Withdrawal by Subject|1
7869907|NCT02451943|27287251|P2|Overall Study|Lost to Follow-up|4
7869908|NCT02451943|27287252|P1|Overall Study|Lost to Follow-up|3
7869909|NCT02451943|27287251|P2|Overall Study|Withdrawal by Subject|16
7869910|NCT02451943|27287252|P1|Overall Study|Withdrawal by Subject|13
7869911|NCT02451943|27287251|P2|Overall Study|On Treatment|4
7869912|NCT02451943|27287252|P1|Overall Study|On Treatment|4
7869913|NCT02273726|27287280|P2|Overall Study|Other than specified|30
7869914|NCT02273726|27287281|P1|Overall Study|Other than specified|28
7869915|NCT02273726|27287280|P2|Overall Study|Protocol Violation|0
7869916|NCT02273726|27287281|P1|Overall Study|Protocol Violation|4
7869917|NCT02273726|27287280|P2|Overall Study|Lack of Efficacy|1
7869918|NCT02273726|27287281|P1|Overall Study|Lack of Efficacy|6
7869919|NCT02273726|27287280|P2|Overall Study|Lost to Follow-up|3
7869920|NCT02273726|27287281|P1|Overall Study|Lost to Follow-up|6
7869921|NCT02273726|27287280|P2|Overall Study|Adverse Event|9
7869922|NCT02273726|27287281|P1|Overall Study|Adverse Event|27
7869923|NCT02273726|27287280|P2|Overall Study|Physician Decision|15
7869924|NCT02273726|27287281|P1|Overall Study|Physician Decision|30
7869925|NCT02273726|27287280|P2|Overall Study|Kidney transplant|39
7869926|NCT02273726|27287281|P1|Overall Study|Kidney transplant|31
7869927|NCT02273726|27287280|P2|Overall Study|Withdrawal by Subject|29
7869928|NCT02273726|27287281|P1|Overall Study|Withdrawal by Subject|41
7869929|NCT02273726|27287280|P2|Overall Study|Death|62
7869930|NCT02273726|27287281|P1|Overall Study|Death|70
7869931|NCT02201108|27287309|P2|Overall Study|Withdrawal by Subject|0
7869932|NCT02201108|27287310|P1|Overall Study|Withdrawal by Subject|2
7869933|NCT02201108|27287309|P2|Overall Study|Lack of Efficacy|1
7869934|NCT02201108|27287310|P1|Overall Study|Lack of Efficacy|2
7869935|NCT02201108|27287309|P2|Overall Study|Adverse Event|6
7869936|NCT02201108|27287310|P1|Overall Study|Adverse Event|0
7869937|NCT01912807|27287371|P2|Overall Study|Lost to Follow-up|37
7869938|NCT01912807|27287372|P1|Overall Study|Lost to Follow-up|36
7869939|NCT01912807|27287371|P2|Overall Study|Did not meet elegibility criteria|4
7869940|NCT01912807|27287372|P1|Overall Study|Did not meet elegibility criteria|6
7869941|NCT01877655|27287386|P2|Overall Study|Randomized but Never Received Drug|5
7869942|NCT01877655|27287387|P1|Overall Study|Randomized but Never Received Drug|8
7869943|NCT01877655|27287386|P2|Overall Study|Miscellaneous|4
7869944|NCT01877655|27287387|P1|Overall Study|Miscellaneous|4
7869945|NCT01877655|27287386|P2|Overall Study|Physician Decision|10
7869946|NCT01877655|27287387|P1|Overall Study|Physician Decision|11
7869947|NCT01877655|27287386|P2|Overall Study|Withdrawal by Subject|26
7869948|NCT01877655|27287387|P1|Overall Study|Withdrawal by Subject|18
7869949|NCT01877655|27287386|P2|Overall Study|Death|52
7869950|NCT01877655|27287387|P1|Overall Study|Death|57
7869951|NCT01750918|27287414|P8|Overall Study|Withdrawal by Subject|2
7869952|NCT01750918|27287415|P7|Overall Study|Withdrawal by Subject|2
7869953|NCT01750918|27287416|P6|Overall Study|Withdrawal by Subject|1
7869954|NCT01750918|27287417|P5|Overall Study|Withdrawal by Subject|1
7869955|NCT01750918|27287418|P4|Overall Study|Withdrawal by Subject|2
7869956|NCT01750918|27287419|P3|Overall Study|Withdrawal by Subject|1
7869957|NCT01750918|27287420|P2|Overall Study|Withdrawal by Subject|0
7869958|NCT01750918|27287421|P1|Overall Study|Withdrawal by Subject|0
7869959|NCT01750918|27287414|P8|Overall Study|Lost to Follow-up|1
7869960|NCT01750918|27287415|P7|Overall Study|Lost to Follow-up|0
7869961|NCT01750918|27287416|P6|Overall Study|Lost to Follow-up|0
7869962|NCT01750918|27287417|P5|Overall Study|Lost to Follow-up|0
7869963|NCT01750918|27287418|P4|Overall Study|Lost to Follow-up|2
7869964|NCT01750918|27287419|P3|Overall Study|Lost to Follow-up|2
7869965|NCT01750918|27287420|P2|Overall Study|Lost to Follow-up|0
7869966|NCT01750918|27287421|P1|Overall Study|Lost to Follow-up|0
7869967|NCT01750918|27287414|P8|Overall Study|Last patient transitioned to a rollover protocol|1
7869968|NCT01750918|27287415|P7|Overall Study|Last patient transitioned to a rollover protocol|1
7869969|NCT01750918|27287416|P6|Overall Study|Last patient transitioned to a rollover protocol|2
7869970|NCT01750918|27287417|P5|Overall Study|Last patient transitioned to a rollover protocol|0
7869971|NCT01750918|27287418|P4|Overall Study|Last patient transitioned to a rollover protocol|2
7869972|NCT01750918|27287419|P3|Overall Study|Last patient transitioned to a rollover protocol|5
7869973|NCT01750918|27287420|P2|Overall Study|Last patient transitioned to a rollover protocol|0
7869974|NCT01750918|27287421|P1|Overall Study|Last patient transitioned to a rollover protocol|0
7869975|NCT01489189|27287618|P2|Overall Study|Missed Visit|4
7869976|NCT01489189|27287619|P1|Overall Study|Missed Visit|1
7869977|NCT01489189|27287618|P2|Overall Study|Death|8
7869978|NCT01489189|27287619|P1|Overall Study|Death|10
7869979|NCT01489189|27287618|P2|Overall Study|Withdrawal by Subject|23
7869980|NCT01489189|27287619|P1|Overall Study|Withdrawal by Subject|20
7869981|NCT01412879|27287646|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
7869982|NCT01412879|27287647|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
7869983|NCT01412879|27287648|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
7869984|NCT01412879|27287646|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
7869985|NCT01412879|27287647|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
7869986|NCT01412879|27287648|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
7869987|NCT01412879|27287646|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
7869988|NCT01412879|27287647|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
7869989|NCT01412879|27287648|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
7869990|NCT01412879|27287646|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
7869991|NCT01412879|27287647|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
7869992|NCT01412879|27287648|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
7869993|NCT01412879|27287646|P3|Initial Registration (Induction Therapy)|Adverse Event|0
7869994|NCT01412879|27287647|P2|Initial Registration (Induction Therapy)|Adverse Event|3
7869995|NCT01412879|27287648|P1|Initial Registration (Induction Therapy)|Adverse Event|5
7869996|NCT01402492|27287665|P3|Overall Study|Incarcerated (N=3)|1
7869997|NCT01402492|27287666|P2|Overall Study|Incarcerated (N=3)|0
7869998|NCT01402492|27287667|P1|Overall Study|Incarcerated (N=3)|2
7869999|NCT01402492|27287665|P3|Overall Study|Physician Decision|0
7870000|NCT01402492|27287666|P2|Overall Study|Physician Decision|3
7870001|NCT01402492|27287667|P1|Overall Study|Physician Decision|0
7870002|NCT01402492|27287665|P3|Overall Study|Adverse Event|4
7870003|NCT01402492|27287666|P2|Overall Study|Adverse Event|3
7870004|NCT01402492|27287667|P1|Overall Study|Adverse Event|2
7870005|NCT01402492|27287665|P3|Overall Study|Withdrawal by Subject|11
7870006|NCT01402492|27287666|P2|Overall Study|Withdrawal by Subject|11
7870007|NCT01402492|27287667|P1|Overall Study|Withdrawal by Subject|17
7870008|NCT01236521|27287681|P2|Overall Study|Lost to Follow-up|7
7870009|NCT01236521|27287682|P1|Overall Study|Lost to Follow-up|7
7870010|NCT01236521|27287681|P2|Overall Study|Death|1
7870011|NCT01236521|27287682|P1|Overall Study|Death|2
7870012|NCT01236521|27287681|P2|Overall Study|Withdrawal by Subject|17
7870013|NCT01236521|27287682|P1|Overall Study|Withdrawal by Subject|12
7870014|NCT01222767|27287710|P1|Overall Study|Never treated|1
7870015|NCT01222767|27287710|P1|Overall Study|Surgical resection|1
7870016|NCT01222767|27287710|P1|Overall Study|Adverse Event|2
7870017|NCT01222767|27287710|P1|Overall Study|Progressive disease|13
7870018|NCT01114724|27287728|P1|Overall Study|Withdrawal by Subject|1
7870019|NCT01114724|27287728|P1|Overall Study|Lost to Follow-up|1
7870020|NCT01114724|27287728|P1|Overall Study|Death|8
7870021|NCT00948675|27287752|P2|Overall Study|Lost to Follow-up|0
7870022|NCT00948675|27287753|P1|Overall Study|Lost to Follow-up|1
7870023|NCT00705679|27287793|P5|Overall Study|Withdrawal by Subject|33
7870024|NCT00705679|27287794|P4|Overall Study|Withdrawal by Subject|47
7870025|NCT00705679|27287795|P3|Overall Study|Withdrawal by Subject|68
7870026|NCT00705679|27287796|P2|Overall Study|Withdrawal by Subject|77
7870027|NCT00705679|27287797|P1|Overall Study|Withdrawal by Subject|32
7870028|NCT00705679|27287793|P5|Overall Study|Physician Decision|0
7870029|NCT00705679|27287794|P4|Overall Study|Physician Decision|1
7870030|NCT00705679|27287795|P3|Overall Study|Physician Decision|0
7870031|NCT00705679|27287796|P2|Overall Study|Physician Decision|1
7870032|NCT00705679|27287797|P1|Overall Study|Physician Decision|0
7870033|NCT00705679|27287793|P5|Overall Study|Lost to Follow-up|35
7870034|NCT00705679|27287794|P4|Overall Study|Lost to Follow-up|30
7870035|NCT00705679|27287795|P3|Overall Study|Lost to Follow-up|44
7870036|NCT00705679|27287796|P2|Overall Study|Lost to Follow-up|60
7870037|NCT00705679|27287797|P1|Overall Study|Lost to Follow-up|32
7870038|NCT00705679|27287793|P5|Overall Study|Death|1
7870039|NCT00705679|27287794|P4|Overall Study|Death|2
7870040|NCT00705679|27287795|P3|Overall Study|Death|3
7870041|NCT00705679|27287796|P2|Overall Study|Death|0
7870042|NCT00705679|27287797|P1|Overall Study|Death|0
7870043|NCT00705679|27287793|P5|Overall Study|Adverse Event|0
7870044|NCT00705679|27287794|P4|Overall Study|Adverse Event|0
7870045|NCT00705679|27287795|P3|Overall Study|Adverse Event|0
7870046|NCT00705679|27287796|P2|Overall Study|Adverse Event|1
7870047|NCT00705679|27287797|P1|Overall Study|Adverse Event|1
7870048|NCT00565851|27287851|P8|Chemotherapy Assignment|Still On Chemotherapy|1
7870049|NCT00565851|27287852|P7|Chemotherapy Assignment|Still On Chemotherapy|0
7870050|NCT00565851|27287853|P6|Chemotherapy Assignment|Still On Chemotherapy|1
7870051|NCT00565851|27287854|P5|Chemotherapy Assignment|Still On Chemotherapy|0
7870052|NCT00565851|27287855|P4|Chemotherapy Assignment|Still On Chemotherapy|18
7870053|NCT00565851|27287856|P3|Chemotherapy Assignment|Still On Chemotherapy|0
7870054|NCT00565851|27287857|P2|Chemotherapy Assignment|Still On Chemotherapy|14
7870055|NCT00565851|27287858|P1|Chemotherapy Assignment|Still On Chemotherapy|0
7870056|NCT00565851|27287851|P8|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7870057|NCT00565851|27287852|P7|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7870058|NCT00565851|27287853|P6|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7870059|NCT00565851|27287854|P5|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7870060|NCT00565851|27287855|P4|Chemotherapy Assignment|Never Initiated Chemotherapy|18
7870061|NCT00565851|27287856|P3|Chemotherapy Assignment|Never Initiated Chemotherapy|3
7870062|NCT00565851|27287857|P2|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7870063|NCT00565851|27287858|P1|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7870064|NCT00507026|27287906|P3|Overall Study|Other|0
7870065|NCT00507026|27287907|P2|Overall Study|Other|0
7870066|NCT00507026|27287908|P1|Overall Study|Other|1
7870067|NCT00507026|27287906|P3|Overall Study|Protocol Violation|0
7870068|NCT00507026|27287907|P2|Overall Study|Protocol Violation|0
7870069|NCT00507026|27287908|P1|Overall Study|Protocol Violation|1
7870070|NCT00507026|27287906|P3|Overall Study|Adverse Event|0
7870071|NCT00507026|27287907|P2|Overall Study|Adverse Event|0
7870072|NCT00507026|27287908|P1|Overall Study|Adverse Event|2
7870073|NCT00507026|27287906|P3|Overall Study|Investigator Decision|0
7870074|NCT00507026|27287907|P2|Overall Study|Investigator Decision|0
7870075|NCT00507026|27287908|P1|Overall Study|Investigator Decision|1
7870076|NCT00507026|27287906|P3|Overall Study|Withdrawal by Subject|0
7870077|NCT00507026|27287907|P2|Overall Study|Withdrawal by Subject|0
7870078|NCT00507026|27287908|P1|Overall Study|Withdrawal by Subject|2
7870079|NCT00507026|27287906|P3|Overall Study|Lack of Efficacy|21
7870080|NCT00507026|27287907|P2|Overall Study|Lack of Efficacy|4
7870081|NCT00507026|27287908|P1|Overall Study|Lack of Efficacy|6
7870082|NCT00318643|27287963|P5|Overall Study|Investigator's Decision|1
7870083|NCT00318643|27287964|P4|Overall Study|Investigator's Decision|0
7870084|NCT00318643|27287965|P3|Overall Study|Investigator's Decision|0
7870085|NCT00318643|27287966|P2|Overall Study|Investigator's Decision|0
7870086|NCT00318643|27287967|P1|Overall Study|Investigator's Decision|0
7870087|NCT00318643|27287963|P5|Overall Study|Participant's Decision|1
7870088|NCT00318643|27287964|P4|Overall Study|Participant's Decision|0
7870089|NCT00318643|27287965|P3|Overall Study|Participant's Decision|0
7870090|NCT00318643|27287966|P2|Overall Study|Participant's Decision|0
7870091|NCT00318643|27287967|P1|Overall Study|Participant's Decision|0
7870092|NCT00318643|27287963|P5|Overall Study|Adverse Event|1
7870093|NCT00318643|27287964|P4|Overall Study|Adverse Event|0
7870094|NCT00318643|27287965|P3|Overall Study|Adverse Event|0
7870095|NCT00318643|27287966|P2|Overall Study|Adverse Event|0
7870096|NCT00318643|27287967|P1|Overall Study|Adverse Event|0
